id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
164188630|NCT00463801|593060308|FG000|Overall Study|Protocol Violation|1|||
164188631|NCT00463801|593060308|FG000|Overall Study|Lack of Efficacy|2|||
164188632|NCT00463801|593060308|FG000|Overall Study|Adverse Event|4|||
164188633|NCT00463801|593060308|FG000|Overall Study|Lost to Follow-up|5|||
164188634|NCT00463801|593060308|FG000|Overall Study|No longer require therapy|1|||
164188635|NCT01073163|593060309|FG000|Overall Study|Adverse Event|1|||
164188636|NCT01073163|593060309|FG000|Overall Study|Disease Progression|1|||
164188637|NCT01073163|593060309|FG000|Overall Study|Early termination|1|||
164188638|NCT00802672|593060310|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
164188639|NCT00802672|593060311|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
164188640|NCT00802672|593060312|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
164188641|NCT00802672|593060310|FG000|Overall Study|Adverse Event|1|||
164188642|NCT00802672|593060311|FG001|Overall Study|Adverse Event|1|||
164188643|NCT00802672|593060312|FG002|Overall Study|Adverse Event|1|||
164188644|NCT00802672|593060310|FG000|Overall Study|Protocol Violation|2|||
164188645|NCT00802672|593060311|FG001|Overall Study|Protocol Violation|1|||
164188646|NCT00802672|593060312|FG002|Overall Study|Protocol Violation|1|||
164188647|NCT00802672|593060310|FG000|Overall Study|Lost to Follow-up|5|||
164188648|NCT00802672|593060311|FG001|Overall Study|Lost to Follow-up|5|||
164188649|NCT00802672|593060312|FG002|Overall Study|Lost to Follow-up|3|||
164188650|NCT00802672|593060310|FG000|Overall Study|Withdrawal by Subject|1|||
164188651|NCT00802672|593060311|FG001|Overall Study|Withdrawal by Subject|1|||
164188652|NCT00802672|593060312|FG002|Overall Study|Withdrawal by Subject|2|||
164647557|NCT00563524|594736532|FG000|Overall Study|Adverse Event|0|||
164188653|NCT00802672|593060310|FG000|Overall Study|other|3|||
164188654|NCT00802672|593060311|FG001|Overall Study|other|1|||
164188655|NCT00802672|593060312|FG002|Overall Study|other|2|||
164188656|NCT00703677|593060313|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
164188657|NCT04441788|593060316|FG000|Overall Study|Voluntary Withdrawl|0|||
164188658|NCT04441788|593060317|FG001|Overall Study|Voluntary Withdrawl|1|||
164188659|NCT04441788|593060318|FG002|Overall Study|Voluntary Withdrawl|0|||
164188660|NCT04441788|593060316|FG000|Overall Study|Ineligibility|1|||
164188661|NCT04441788|593060317|FG001|Overall Study|Ineligibility|0|||
164188662|NCT04441788|593060318|FG002|Overall Study|Ineligibility|0|||
164188663|NCT04441788|593060316|FG000|Overall Study|Adverse Event|0|||
164188664|NCT04441788|593060317|FG001|Overall Study|Adverse Event|0|||
164188665|NCT04441788|593060318|FG002|Overall Study|Adverse Event|4|||
164188666|NCT04441788|593060316|FG000|Overall Study|Study Terminated by Sponsor|16|||
164188667|NCT04441788|593060317|FG001|Overall Study|Study Terminated by Sponsor|16|||
164188668|NCT04441788|593060318|FG002|Overall Study|Study Terminated by Sponsor|12|||
164188669|NCT02793947|593060324|FG000|Overall Study|Death|1|||
164188670|NCT02793947|593060325|FG001|Overall Study|Death|0|||
164188671|NCT02793947|593060324|FG000|Overall Study|Physician Decision|1|||
164188672|NCT02793947|593060325|FG001|Overall Study|Physician Decision|5|||
164188673|NCT02959918|593060326|FG000|Overall Study|Adverse Event|1|||
164188674|NCT02959918|593060327|FG001|Overall Study|Adverse Event|1|||
164188675|NCT02959918|593060328|FG002|Overall Study|Adverse Event|2|||
164188676|NCT02959918|593060329|FG003|Overall Study|Adverse Event|0|||
164188677|NCT02959918|593060330|FG004|Overall Study|Adverse Event|0|||
164188678|NCT02959918|593060331|FG005|Overall Study|Adverse Event|2|||
164188679|NCT02959918|593060332|FG006|Overall Study|Adverse Event|2|||
164188680|NCT02959918|593060333|FG007|Overall Study|Adverse Event|1|||
164188681|NCT02959918|593060334|FG008|Overall Study|Adverse Event|2|||
164188682|NCT02959918|593060335|FG009|Overall Study|Adverse Event|1|||
164188683|NCT02959918|593060336|FG010|Overall Study|Adverse Event|1|||
164188684|NCT02959918|593060337|FG011|Overall Study|Adverse Event|3|||
164188685|NCT02959918|593060338|FG012|Overall Study|Adverse Event|2|||
164188686|NCT02959918|593060339|FG013|Overall Study|Adverse Event|4|||
164188687|NCT02959918|593060326|FG000|Overall Study|Lost to Follow-up|0|||
164188688|NCT02959918|593060327|FG001|Overall Study|Lost to Follow-up|0|||
164188689|NCT02959918|593060328|FG002|Overall Study|Lost to Follow-up|0|||
164188690|NCT02959918|593060329|FG003|Overall Study|Lost to Follow-up|0|||
164188691|NCT02959918|593060330|FG004|Overall Study|Lost to Follow-up|0|||
164188692|NCT02959918|593060331|FG005|Overall Study|Lost to Follow-up|0|||
164188693|NCT02959918|593060332|FG006|Overall Study|Lost to Follow-up|0|||
164188694|NCT02959918|593060333|FG007|Overall Study|Lost to Follow-up|0|||
164188695|NCT02959918|593060334|FG008|Overall Study|Lost to Follow-up|0|||
164188696|NCT02959918|593060335|FG009|Overall Study|Lost to Follow-up|1|||
164188697|NCT02959918|593060336|FG010|Overall Study|Lost to Follow-up|0|||
164188698|NCT02959918|593060337|FG011|Overall Study|Lost to Follow-up|0|||
164188699|NCT02959918|593060338|FG012|Overall Study|Lost to Follow-up|1|||
164418114|NCT02391038|593901074|FG000|Overall Study|Progressive disease|3|||
164188700|NCT02959918|593060339|FG013|Overall Study|Lost to Follow-up|0|||
164188701|NCT02959918|593060326|FG000|Overall Study|Withdrawal by Subject|0|||
164188702|NCT02959918|593060327|FG001|Overall Study|Withdrawal by Subject|0|||
164188703|NCT02959918|593060328|FG002|Overall Study|Withdrawal by Subject|1|||
164188704|NCT02959918|593060329|FG003|Overall Study|Withdrawal by Subject|2|||
164188705|NCT02959918|593060330|FG004|Overall Study|Withdrawal by Subject|0|||
164188706|NCT02959918|593060331|FG005|Overall Study|Withdrawal by Subject|0|||
164188707|NCT02959918|593060332|FG006|Overall Study|Withdrawal by Subject|1|||
164188708|NCT02959918|593060333|FG007|Overall Study|Withdrawal by Subject|0|||
164188709|NCT02959918|593060334|FG008|Overall Study|Withdrawal by Subject|1|||
164188710|NCT02959918|593060335|FG009|Overall Study|Withdrawal by Subject|1|||
164188711|NCT02959918|593060336|FG010|Overall Study|Withdrawal by Subject|2|||
164188712|NCT02959918|593060337|FG011|Overall Study|Withdrawal by Subject|3|||
164188713|NCT02959918|593060338|FG012|Overall Study|Withdrawal by Subject|1|||
164188714|NCT02959918|593060339|FG013|Overall Study|Withdrawal by Subject|1|||
164188715|NCT02959918|593060326|FG000|Overall Study|Protocol Violation|0|||
164188716|NCT02959918|593060327|FG001|Overall Study|Protocol Violation|0|||
164188717|NCT02959918|593060328|FG002|Overall Study|Protocol Violation|1|||
164188718|NCT02959918|593060329|FG003|Overall Study|Protocol Violation|0|||
164188719|NCT02959918|593060330|FG004|Overall Study|Protocol Violation|0|||
164188720|NCT02959918|593060331|FG005|Overall Study|Protocol Violation|1|||
164188721|NCT02959918|593060332|FG006|Overall Study|Protocol Violation|0|||
164188722|NCT02959918|593060333|FG007|Overall Study|Protocol Violation|0|||
164188723|NCT02959918|593060334|FG008|Overall Study|Protocol Violation|2|||
164188724|NCT02959918|593060335|FG009|Overall Study|Protocol Violation|1|||
164188725|NCT02959918|593060336|FG010|Overall Study|Protocol Violation|0|||
164188726|NCT02959918|593060337|FG011|Overall Study|Protocol Violation|1|||
164188727|NCT02959918|593060338|FG012|Overall Study|Protocol Violation|1|||
164188728|NCT02959918|593060339|FG013|Overall Study|Protocol Violation|0|||
164188729|NCT02959918|593060326|FG000|Overall Study|Stopping Rule Met|1|||
164188730|NCT02959918|593060327|FG001|Overall Study|Stopping Rule Met|0|||
164188731|NCT02959918|593060328|FG002|Overall Study|Stopping Rule Met|3|||
164188732|NCT02959918|593060329|FG003|Overall Study|Stopping Rule Met|4|||
164188733|NCT02959918|593060330|FG004|Overall Study|Stopping Rule Met|5|||
164188734|NCT02959918|593060331|FG005|Overall Study|Stopping Rule Met|3|||
164188735|NCT02959918|593060332|FG006|Overall Study|Stopping Rule Met|2|||
164188736|NCT02959918|593060333|FG007|Overall Study|Stopping Rule Met|4|||
164188737|NCT02959918|593060334|FG008|Overall Study|Stopping Rule Met|1|||
164188738|NCT02959918|593060335|FG009|Overall Study|Stopping Rule Met|1|||
164188739|NCT02959918|593060336|FG010|Overall Study|Stopping Rule Met|3|||
164188740|NCT02959918|593060337|FG011|Overall Study|Stopping Rule Met|5|||
164188741|NCT02959918|593060338|FG012|Overall Study|Stopping Rule Met|2|||
164188742|NCT02959918|593060339|FG013|Overall Study|Stopping Rule Met|1|||
164188743|NCT02959918|593060326|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
164188744|NCT02959918|593060327|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
164188745|NCT02959918|593060328|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
164188746|NCT02959918|593060329|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
164188747|NCT02959918|593060330|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
164188748|NCT02959918|593060331|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
164188749|NCT02959918|593060332|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
164188750|NCT02959918|593060333|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
164188751|NCT02959918|593060334|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
164188752|NCT02959918|593060335|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
164188753|NCT02959918|593060336|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
164188754|NCT02959918|593060337|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
164188755|NCT02959918|593060338|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
164188756|NCT02959918|593060339|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
164188757|NCT02959918|593060326|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164188758|NCT02959918|593060327|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164188759|NCT02959918|593060328|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164188760|NCT02959918|593060329|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164188761|NCT02959918|593060330|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164188762|NCT02959918|593060331|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164188763|NCT02959918|593060332|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164647558|NCT00563524|594736533|FG001|Overall Study|Adverse Event|1|||
164647559|NCT00563524|594736534|FG002|Overall Study|Adverse Event|0|||
164647560|NCT00563524|594736535|FG003|Overall Study|Adverse Event|0|||
164647561|NCT00563524|594736536|FG004|Overall Study|Adverse Event|2|||
164647562|NCT00563524|594736537|FG005|Overall Study|Adverse Event|0|||
164647563|NCT00563524|594736532|FG000|Overall Study|Lost to Follow-up|1|||
164647564|NCT00563524|594736533|FG001|Overall Study|Lost to Follow-up|0|||
164647565|NCT00563524|594736534|FG002|Overall Study|Lost to Follow-up|0|||
164647566|NCT00563524|594736535|FG003|Overall Study|Lost to Follow-up|0|||
164647567|NCT00563524|594736536|FG004|Overall Study|Lost to Follow-up|0|||
164647568|NCT00563524|594736537|FG005|Overall Study|Lost to Follow-up|0|||
164647569|NCT00563524|594736532|FG000|Overall Study|Protocol Violation|0|||
164647570|NCT00563524|594736533|FG001|Overall Study|Protocol Violation|1|||
164647571|NCT00563524|594736534|FG002|Overall Study|Protocol Violation|0|||
164647572|NCT00563524|594736535|FG003|Overall Study|Protocol Violation|0|||
164647573|NCT00563524|594736536|FG004|Overall Study|Protocol Violation|0|||
164188764|NCT02959918|593060333|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
164418115|NCT02391038|593901075|FG001|Overall Study|Progressive disease|3|||
164188765|NCT02959918|593060334|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164188766|NCT02959918|593060335|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164188767|NCT02959918|593060336|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164188768|NCT02959918|593060337|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164188769|NCT02959918|593060338|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164188770|NCT02959918|593060339|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164188771|NCT02959918|593060326|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164188772|NCT02959918|593060327|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164647574|NCT00563524|594736537|FG005|Overall Study|Protocol Violation|0|||
164647575|NCT00563524|594736532|FG000|Overall Study|Withdrawal by Subject|1|||
164647576|NCT00563524|594736533|FG001|Overall Study|Withdrawal by Subject|1|||
164647577|NCT00563524|594736534|FG002|Overall Study|Withdrawal by Subject|3|||
164647578|NCT00563524|594736535|FG003|Overall Study|Withdrawal by Subject|0|||
164647579|NCT00563524|594736536|FG004|Overall Study|Withdrawal by Subject|0|||
164188773|NCT02959918|593060328|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164188774|NCT02959918|593060329|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164188775|NCT02959918|593060330|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164647580|NCT00563524|594736537|FG005|Overall Study|Withdrawal by Subject|1|||
164647581|NCT01467570|594736539|FG000|Overall Study|Lost to Follow-up|8|||
164647582|NCT01467570|594736540|FG001|Overall Study|Lost to Follow-up|9|||
164647583|NCT03836729|594736544|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
164647584|NCT01392170|594736547|FG000|Overall Study|Withdrawal by Subject|1|||
164647585|NCT01392170|594736547|FG000|Overall Study|Ineligible|1|||
164647586|NCT01313728|594736557|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
164647587|NCT02216214|594736558|FG000|Overall Study|Randomized Never Received Study Drug|1|||
164647588|NCT02216214|594736559|FG001|Overall Study|Randomized Never Received Study Drug|0|||
164647589|NCT02216214|594736558|FG000|Overall Study|Adverse Event|10|||
164647590|NCT02216214|594736559|FG001|Overall Study|Adverse Event|8|||
164647591|NCT02216214|594736558|FG000|Overall Study|Lack of Efficacy|2|||
164647592|NCT02216214|594736559|FG001|Overall Study|Lack of Efficacy|2|||
164647593|NCT02216214|594736558|FG000|Overall Study|Lost to Follow-up|3|||
164647594|NCT02216214|594736559|FG001|Overall Study|Lost to Follow-up|2|||
164647595|NCT02216214|594736558|FG000|Overall Study|Protocol Violation|4|||
164647596|NCT02216214|594736559|FG001|Overall Study|Protocol Violation|2|||
164647597|NCT02216214|594736558|FG000|Overall Study|Withdrawal by Subject|22|||
164647598|NCT02216214|594736559|FG001|Overall Study|Withdrawal by Subject|20|||
164647599|NCT02216214|594736558|FG000|Overall Study|Study Terminated By Sponsor|0|||
164188776|NCT02959918|593060331|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164188777|NCT02959918|593060332|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164188778|NCT02959918|593060333|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164647600|NCT02216214|594736559|FG001|Overall Study|Study Terminated By Sponsor|1|||
164647601|NCT02216214|594736558|FG000|Overall Study|Miscellaneous|1|||
164647602|NCT02216214|594736559|FG001|Overall Study|Miscellaneous|1|||
164647603|NCT05354206|594736560|FG000|Overall Study|Withdrawal by Subject|1|||
164647604|NCT05354206|594736561|FG001|Overall Study|Withdrawal by Subject|0|||
164647605|NCT00713830|594736564|FG000|Overall Study|Adverse Event|23|||
164647606|NCT00713830|594736565|FG001|Overall Study|Adverse Event|71|||
164647607|NCT00713830|594736564|FG000|Overall Study|Lack of Efficacy|24|||
164647608|NCT00713830|594736565|FG001|Overall Study|Lack of Efficacy|16|||
164647609|NCT00713830|594736564|FG000|Overall Study|Lost to Follow-up|2|||
164647610|NCT00713830|594736565|FG001|Overall Study|Lost to Follow-up|9|||
164647611|NCT00713830|594736564|FG000|Overall Study|Withdrawal by Subject|13|||
164647612|NCT00713830|594736565|FG001|Overall Study|Withdrawal by Subject|23|||
164647613|NCT00713830|594736564|FG000|Overall Study|Poor Compliance to Protocol|7|||
164647614|NCT00713830|594736565|FG001|Overall Study|Poor Compliance to Protocol|14|||
164647615|NCT00713830|594736564|FG000|Overall Study|Familial and Personal Reasons|9|||
164647616|NCT00713830|594736565|FG001|Overall Study|Familial and Personal Reasons|34|||
164647617|NCT00713830|594736564|FG000|Overall Study|Sponsor Decision|4|||
164188779|NCT02959918|593060334|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
164188780|NCT02959918|593060335|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164188781|NCT02959918|593060336|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164647618|NCT00713830|594736565|FG001|Overall Study|Sponsor Decision|10|||
164647619|NCT02261974|594736566|FG000|Overall Study|Withdrawal by Subject|3|||
164647620|NCT02261974|594736567|FG001|Overall Study|Withdrawal by Subject|2|||
164188782|NCT02959918|593060337|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164188783|NCT02959918|593060338|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164188784|NCT02959918|593060339|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164188785|NCT02959918|593060326|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188786|NCT02959918|593060327|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188787|NCT02959918|593060328|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188788|NCT02959918|593060329|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188789|NCT02959918|593060330|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188790|NCT02959918|593060331|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188791|NCT02959918|593060332|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188792|NCT02959918|593060333|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188793|NCT02959918|593060334|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188794|NCT02959918|593060335|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
164188795|NCT02959918|593060336|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188796|NCT02959918|593060337|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188797|NCT02959918|593060338|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188798|NCT02959918|593060339|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188799|NCT03173456|593060341|FG000|Baseline|Medication dispensing system malfunction'|0|||
164188800|NCT03173456|593060342|FG001|Baseline|Medication dispensing system malfunction'|1|||
164188801|NCT03173456|593060343|FG002|Baseline|Medication dispensing system malfunction'|0|||
164188802|NCT03173456|593060344|FG003|Baseline|Medication dispensing system malfunction'|0|||
164188803|NCT03173456|593060345|FG004|Baseline|Medication dispensing system malfunction'|2|||
164188804|NCT03173456|593060341|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
164188805|NCT03173456|593060342|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
164188806|NCT03173456|593060343|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
164188807|NCT03173456|593060344|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
164188808|NCT03173456|593060345|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
164188809|NCT01733121|593060346|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
164188810|NCT01733121|593060347|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
164188811|NCT01733121|593060346|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
164188812|NCT01733121|593060347|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
164188813|NCT01733121|593060346|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
164188814|NCT01733121|593060347|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
164188815|NCT01733121|593060346|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
164188816|NCT01733121|593060347|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
164188817|NCT03061188|593060348|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
164188818|NCT03061188|593060349|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
164188819|NCT03061188|593060350|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
164188820|NCT03061188|593060351|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
164188821|NCT03061188|593060348|FG000|On Follow-up for 3 Years|Death|0|||
164188822|NCT03061188|593060349|FG001|On Follow-up for 3 Years|Death|3|||
164188823|NCT03061188|593060350|FG002|On Follow-up for 3 Years|Death|5|||
164188824|NCT03061188|593060351|FG003|On Follow-up for 3 Years|Death|4|||
164188825|NCT03061188|593060348|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
164188826|NCT03061188|593060349|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
164188827|NCT03061188|593060350|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
164188828|NCT03061188|593060351|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
164188829|NCT04865419|593060354|FG000|Overall Study|Other|1|||
164188830|NCT04865419|593060355|FG001|Overall Study|Other|2|||
164188831|NCT04865419|593060356|FG002|Overall Study|Other|2|||
164188832|NCT04865419|593060357|FG003|Overall Study|Other|1|||
164188833|NCT04865419|593060358|FG004|Overall Study|Other|3|||
164188834|NCT04865419|593060359|FG005|Overall Study|Other|0|||
164188835|NCT04865419|593060360|FG006|Overall Study|Other|0|||
164188836|NCT04865419|593060361|FG007|Overall Study|Other|1|||
164188837|NCT04865419|593060362|FG008|Overall Study|Other|0|||
164188838|NCT04865419|593060363|FG009|Overall Study|Other|0|||
164188839|NCT04865419|593060364|FG010|Overall Study|Other|0|||
164188840|NCT04865419|593060354|FG000|Overall Study|Withdrawal by Subject|0|||
164188841|NCT04865419|593060355|FG001|Overall Study|Withdrawal by Subject|1|||
164188842|NCT04865419|593060356|FG002|Overall Study|Withdrawal by Subject|1|||
164188843|NCT04865419|593060357|FG003|Overall Study|Withdrawal by Subject|0|||
164188844|NCT04865419|593060358|FG004|Overall Study|Withdrawal by Subject|0|||
164188845|NCT04865419|593060359|FG005|Overall Study|Withdrawal by Subject|0|||
164188846|NCT04865419|593060360|FG006|Overall Study|Withdrawal by Subject|0|||
164188847|NCT04865419|593060361|FG007|Overall Study|Withdrawal by Subject|1|||
164647621|NCT02261974|594736566|FG000|Overall Study|Pregnancy|0|||
164188848|NCT04865419|593060362|FG008|Overall Study|Withdrawal by Subject|2|||
164188849|NCT04865419|593060363|FG009|Overall Study|Withdrawal by Subject|1|||
164188850|NCT04865419|593060364|FG010|Overall Study|Withdrawal by Subject|0|||
164188851|NCT04865419|593060354|FG000|Overall Study|Study terminated by Sponsor|0|||
164188852|NCT04865419|593060355|FG001|Overall Study|Study terminated by Sponsor|0|||
164188853|NCT04865419|593060356|FG002|Overall Study|Study terminated by Sponsor|0|||
164188854|NCT04865419|593060357|FG003|Overall Study|Study terminated by Sponsor|2|||
164188855|NCT04865419|593060358|FG004|Overall Study|Study terminated by Sponsor|2|||
164188856|NCT04865419|593060359|FG005|Overall Study|Study terminated by Sponsor|0|||
164188857|NCT04865419|593060360|FG006|Overall Study|Study terminated by Sponsor|0|||
164188858|NCT04865419|593060361|FG007|Overall Study|Study terminated by Sponsor|0|||
164188859|NCT04865419|593060362|FG008|Overall Study|Study terminated by Sponsor|0|||
164188860|NCT04865419|593060363|FG009|Overall Study|Study terminated by Sponsor|0|||
164188861|NCT04865419|593060364|FG010|Overall Study|Study terminated by Sponsor|1|||
164188862|NCT04865419|593060354|FG000|Overall Study|Death|3|||
164188863|NCT04865419|593060355|FG001|Overall Study|Death|1|||
164188864|NCT04865419|593060356|FG002|Overall Study|Death|4|||
164188865|NCT04865419|593060357|FG003|Overall Study|Death|2|||
164188866|NCT04865419|593060358|FG004|Overall Study|Death|5|||
164188867|NCT04865419|593060359|FG005|Overall Study|Death|2|||
164188868|NCT04865419|593060360|FG006|Overall Study|Death|1|||
164188869|NCT04865419|593060361|FG007|Overall Study|Death|1|||
164188870|NCT04865419|593060362|FG008|Overall Study|Death|2|||
164188871|NCT04865419|593060363|FG009|Overall Study|Death|2|||
164188872|NCT04865419|593060364|FG010|Overall Study|Death|1|||
164188873|NCT04865419|593060354|FG000|Overall Study|Lost to Follow-up|0|||
164188874|NCT04865419|593060355|FG001|Overall Study|Lost to Follow-up|0|||
164188875|NCT04865419|593060356|FG002|Overall Study|Lost to Follow-up|0|||
164188876|NCT04865419|593060357|FG003|Overall Study|Lost to Follow-up|0|||
164188877|NCT04865419|593060358|FG004|Overall Study|Lost to Follow-up|0|||
164188878|NCT04865419|593060359|FG005|Overall Study|Lost to Follow-up|0|||
164188879|NCT04865419|593060360|FG006|Overall Study|Lost to Follow-up|0|||
164188880|NCT04865419|593060361|FG007|Overall Study|Lost to Follow-up|0|||
164188881|NCT04865419|593060362|FG008|Overall Study|Lost to Follow-up|0|||
164188882|NCT04865419|593060363|FG009|Overall Study|Lost to Follow-up|1|||
164188883|NCT04865419|593060364|FG010|Overall Study|Lost to Follow-up|0|||
164188884|NCT05446142|593060365|FG000|Period 2|Adverse Event|1|||
164188885|NCT05446142|593060366|FG001|Period 2|Adverse Event|0|||
164188886|NCT05446142|593060367|FG002|Period 2|Adverse Event|0|||
164188887|NCT05446142|593060368|FG003|Period 2|Adverse Event|0|||
164188888|NCT05446142|593060369|FG004|Period 2|Adverse Event|0|||
164188889|NCT05446142|593060370|FG005|Period 2|Adverse Event|0|||
164188890|NCT00547157|593060375|FG000|Overall Study|Other|1|||
164188891|NCT00547157|593060376|FG001|Overall Study|Other|0|||
164188892|NCT00547157|593060375|FG000|Overall Study|Death|38|||
164188893|NCT00547157|593060376|FG001|Overall Study|Death|18|||
164188894|NCT00547157|593060375|FG000|Overall Study|Withdrawal by Subject|3|||
164188895|NCT00547157|593060376|FG001|Overall Study|Withdrawal by Subject|1|||
164188896|NCT00547157|593060375|FG000|Overall Study|Administrative decision|3|||
164188897|NCT00547157|593060376|FG001|Overall Study|Administrative decision|2|||
164188898|NCT00547157|593060375|FG000|Overall Study|Lost to Follow-up|4|||
164188899|NCT00547157|593060376|FG001|Overall Study|Lost to Follow-up|2|||
164188900|NCT01151345|593060378|FG000|First Intervention Period|Protocol Violation|0|||
164188901|NCT01151345|593060379|FG001|First Intervention Period|Protocol Violation|1|||
164188902|NCT03883477|593060381|FG000|Overall Study|Death|1|||
164188903|NCT03883477|593060382|FG001|Overall Study|Death|0|||
164188904|NCT03883477|593060381|FG000|Overall Study|Protocol Violation|0|||
164188905|NCT03883477|593060382|FG001|Overall Study|Protocol Violation|1|||
164188906|NCT03853291|593060383|FG000|Overall Study|Lost to Follow-up|1|||
164188907|NCT03853291|593060384|FG001|Overall Study|Lost to Follow-up|2|||
164188908|NCT03853291|593060385|FG002|Overall Study|Lost to Follow-up|0|||
164188909|NCT03853291|593060386|FG003|Overall Study|Lost to Follow-up|0|||
164188910|NCT03853291|593060387|FG004|Overall Study|Lost to Follow-up|0|||
164188911|NCT03853291|593060388|FG005|Overall Study|Lost to Follow-up|0|||
164188912|NCT03853291|593060383|FG000|Overall Study|Determined to be ineligible|1|||
164188913|NCT03853291|593060384|FG001|Overall Study|Determined to be ineligible|1|||
164188914|NCT03853291|593060385|FG002|Overall Study|Determined to be ineligible|0|||
164188915|NCT03853291|593060386|FG003|Overall Study|Determined to be ineligible|0|||
164188916|NCT03853291|593060387|FG004|Overall Study|Determined to be ineligible|0|||
164188917|NCT03853291|593060388|FG005|Overall Study|Determined to be ineligible|0|||
164188918|NCT04186221|593060390|FG000|Overall Study|Death|1|||
164188919|NCT01658904|593060391|FG000|Overall Study|Principal Investigator discretion|2|||
164647622|NCT02261974|594736567|FG001|Overall Study|Pregnancy|1|||
164188920|NCT01658904|593060392|FG001|Overall Study|Principal Investigator discretion|0|||
164188921|NCT01658904|593060393|FG002|Overall Study|Principal Investigator discretion|0|||
164188922|NCT02998996|593060398|FG000|Overall Study|Lost to Follow-up|0|||
164188923|NCT02998996|593060399|FG001|Overall Study|Lost to Follow-up|0|||
164188924|NCT02998996|593060400|FG002|Overall Study|Lost to Follow-up|1|||
164188925|NCT02998996|593060401|FG003|Overall Study|Lost to Follow-up|0|||
164188926|NCT02998996|593060402|FG004|Overall Study|Lost to Follow-up|0|||
164188927|NCT02998996|593060403|FG005|Overall Study|Lost to Follow-up|0|||
164188928|NCT02998996|593060398|FG000|Overall Study|Pregnancy|0|||
164188929|NCT02998996|593060399|FG001|Overall Study|Pregnancy|1|||
164188930|NCT02998996|593060400|FG002|Overall Study|Pregnancy|0|||
164188931|NCT02998996|593060401|FG003|Overall Study|Pregnancy|0|||
164188932|NCT02998996|593060402|FG004|Overall Study|Pregnancy|0|||
164188933|NCT02998996|593060403|FG005|Overall Study|Pregnancy|0|||
164188934|NCT02998996|593060398|FG000|Overall Study|Family reasons|0|||
164188935|NCT02998996|593060399|FG001|Overall Study|Family reasons|0|||
164188936|NCT02998996|593060400|FG002|Overall Study|Family reasons|0|||
164188937|NCT02998996|593060401|FG003|Overall Study|Family reasons|0|||
164188938|NCT02998996|593060402|FG004|Overall Study|Family reasons|1|||
164188939|NCT02998996|593060403|FG005|Overall Study|Family reasons|0|||
164188940|NCT01087203|593060404|FG000|Overall Study|Lost to Follow-up|2|||
164188941|NCT01087203|593060405|FG001|Overall Study|Lost to Follow-up|0|||
164188942|NCT01087203|593060404|FG000|Overall Study|Withdrawal by Subject|2|||
164188943|NCT01087203|593060405|FG001|Overall Study|Withdrawal by Subject|6|||
164188944|NCT01087203|593060404|FG000|Overall Study|Lack of Efficacy|1|||
164188945|NCT01087203|593060405|FG001|Overall Study|Lack of Efficacy|2|||
164188946|NCT01087203|593060404|FG000|Overall Study|Study terminated by sponsor|27|||
164188947|NCT01087203|593060405|FG001|Overall Study|Study terminated by sponsor|27|||
164188948|NCT04074330|593060413|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
164188949|NCT04074330|593060414|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
164188950|NCT04074330|593060415|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
164188951|NCT04074330|593060416|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
164188952|NCT04074330|593060417|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
164188953|NCT04074330|593060418|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
164188954|NCT04074330|593060419|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
164188955|NCT04074330|593060420|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
164188956|NCT04074330|593060421|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
164301366|NCT01709084|593480138|FG000|Overall Study|Not Treated|0|||
164301367|NCT01709084|593480139|FG001|Overall Study|Not Treated|2|||
164647623|NCT02261974|594736566|FG000|Overall Study|Missed treatment cut-off date|6|||
164647624|NCT02261974|594736567|FG001|Overall Study|Missed treatment cut-off date|3|||
164647625|NCT02261974|594736566|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
164647626|NCT02261974|594736567|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
164647627|NCT02261974|594736566|FG000|Overall Study|Lost to Follow-up|2|||
164647628|NCT02261974|594736567|FG001|Overall Study|Lost to Follow-up|0|||
164647629|NCT02261974|594736566|FG000|Overall Study|Adverse Event|1|||
164647630|NCT02261974|594736567|FG001|Overall Study|Adverse Event|0|||
164647631|NCT04440007|594736568|FG000|Overall Study|Adverse Event|0|||
164647632|NCT04440007|594736569|FG001|Overall Study|Adverse Event|1|||
164647633|NCT04440007|594736568|FG000|Overall Study|Lost to Follow-up|1|||
164647634|NCT04440007|594736569|FG001|Overall Study|Lost to Follow-up|3|||
164647635|NCT04440007|594736568|FG000|Overall Study|Death|7|||
164647636|NCT04440007|594736569|FG001|Overall Study|Death|2|||
164301368|NCT00214201|593480140|FG000|Overall Study|Withdrawal by Subject|2|||
164301369|NCT00214201|593480141|FG001|Overall Study|Withdrawal by Subject|0|||
164301370|NCT00214201|593480140|FG000|Overall Study|Death|0|||
164301371|NCT00214201|593480141|FG001|Overall Study|Death|2|||
164301372|NCT00463567|593480145|FG000|Overall Study|Adverse Event|29|||
164301373|NCT00463567|593480146|FG001|Overall Study|Adverse Event|26|||
164301374|NCT00463567|593480147|FG002|Overall Study|Adverse Event|17|||
164301375|NCT00463567|593480148|FG003|Overall Study|Adverse Event|46|||
164301376|NCT00463567|593480149|FG004|Overall Study|Adverse Event|10|||
164301377|NCT00463567|593480150|FG005|Overall Study|Adverse Event|10|||
164301378|NCT00463567|593480151|FG006|Overall Study|Adverse Event|4|||
164301379|NCT00463567|593480145|FG000|Overall Study|Withdrawal by Subject|29|||
164301380|NCT00463567|593480146|FG001|Overall Study|Withdrawal by Subject|22|||
164301381|NCT00463567|593480147|FG002|Overall Study|Withdrawal by Subject|20|||
164301382|NCT00463567|593480148|FG003|Overall Study|Withdrawal by Subject|37|||
164301383|NCT00463567|593480149|FG004|Overall Study|Withdrawal by Subject|6|||
164301384|NCT00463567|593480150|FG005|Overall Study|Withdrawal by Subject|5|||
164301385|NCT00463567|593480151|FG006|Overall Study|Withdrawal by Subject|1|||
164301386|NCT00463567|593480145|FG000|Overall Study|Protocol Deviation|13|||
164301387|NCT00463567|593480146|FG001|Overall Study|Protocol Deviation|9|||
164301388|NCT00463567|593480147|FG002|Overall Study|Protocol Deviation|14|||
164301389|NCT00463567|593480148|FG003|Overall Study|Protocol Deviation|11|||
164301390|NCT00463567|593480149|FG004|Overall Study|Protocol Deviation|1|||
164301391|NCT00463567|593480150|FG005|Overall Study|Protocol Deviation|1|||
164301392|NCT00463567|593480151|FG006|Overall Study|Protocol Deviation|2|||
164301393|NCT00463567|593480145|FG000|Overall Study|Lost to Follow-up|12|||
164301394|NCT00463567|593480146|FG001|Overall Study|Lost to Follow-up|6|||
164301395|NCT00463567|593480147|FG002|Overall Study|Lost to Follow-up|13|||
164301396|NCT00463567|593480148|FG003|Overall Study|Lost to Follow-up|8|||
164301397|NCT00463567|593480149|FG004|Overall Study|Lost to Follow-up|1|||
164301398|NCT00463567|593480150|FG005|Overall Study|Lost to Follow-up|1|||
164301399|NCT00463567|593480151|FG006|Overall Study|Lost to Follow-up|1|||
164301400|NCT00463567|593480145|FG000|Overall Study|Administrative problems|5|||
164301401|NCT00463567|593480146|FG001|Overall Study|Administrative problems|3|||
164301402|NCT00463567|593480147|FG002|Overall Study|Administrative problems|6|||
164301403|NCT00463567|593480148|FG003|Overall Study|Administrative problems|9|||
164188957|NCT04074330|593060422|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
164188958|NCT04074330|593060413|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
164188959|NCT04074330|593060414|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
164188960|NCT04074330|593060415|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
164188961|NCT04074330|593060416|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
164188962|NCT04074330|593060417|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
164188963|NCT04074330|593060418|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
164188964|NCT04074330|593060419|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
164188965|NCT04074330|593060420|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
164188966|NCT04074330|593060421|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
164188967|NCT04074330|593060422|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
164188968|NCT04074330|593060413|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
164188969|NCT04074330|593060414|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
164188970|NCT04074330|593060415|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
164188971|NCT04074330|593060416|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
164188972|NCT04074330|593060417|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
164301989|NCT00248040|593482502|FG002|Overall Study|Death|1|||
164301990|NCT03847896|593482504|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
164301991|NCT03847896|593482505|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
164301992|NCT03847896|593482506|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
164301993|NCT03847896|593482507|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
164301994|NCT03847896|593482508|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
164301995|NCT03847896|593482504|FG000|Overall Study|Withdrawal by Subject|2|||
164301996|NCT03847896|593482505|FG001|Overall Study|Withdrawal by Subject|10|||
164301997|NCT03847896|593482506|FG002|Overall Study|Withdrawal by Subject|5|||
164301998|NCT03847896|593482507|FG003|Overall Study|Withdrawal by Subject|9|||
164301999|NCT03847896|593482508|FG004|Overall Study|Withdrawal by Subject|8|||
164302000|NCT03847896|593482504|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164302001|NCT03847896|593482505|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164302002|NCT03847896|593482506|FG002|Overall Study|Withdrawal by parent/guardian|1|||
164302003|NCT03847896|593482507|FG003|Overall Study|Withdrawal by parent/guardian|0|||
164302004|NCT03847896|593482508|FG004|Overall Study|Withdrawal by parent/guardian|0|||
164302005|NCT03847896|593482504|FG000|Overall Study|Adverse Event|2|||
164302006|NCT03847896|593482505|FG001|Overall Study|Adverse Event|1|||
164302007|NCT03847896|593482506|FG002|Overall Study|Adverse Event|3|||
164302008|NCT03847896|593482507|FG003|Overall Study|Adverse Event|2|||
164302009|NCT03847896|593482508|FG004|Overall Study|Adverse Event|4|||
164302010|NCT03847896|593482504|FG000|Overall Study|A severe exacerbation event|0|||
164302011|NCT03847896|593482505|FG001|Overall Study|A severe exacerbation event|0|||
164302012|NCT03847896|593482506|FG002|Overall Study|A severe exacerbation event|0|||
164302013|NCT03847896|593482507|FG003|Overall Study|A severe exacerbation event|0|||
164302014|NCT03847896|593482508|FG004|Overall Study|A severe exacerbation event|3|||
164302015|NCT03847896|593482504|FG000|Overall Study|Protocol Violation|0|||
164302016|NCT03847896|593482505|FG001|Overall Study|Protocol Violation|2|||
164302017|NCT03847896|593482506|FG002|Overall Study|Protocol Violation|1|||
164302018|NCT03847896|593482507|FG003|Overall Study|Protocol Violation|0|||
164302019|NCT03847896|593482508|FG004|Overall Study|Protocol Violation|2|||
164302020|NCT03847896|593482504|FG000|Overall Study|Lost to Follow-up|0|||
164302021|NCT03847896|593482505|FG001|Overall Study|Lost to Follow-up|0|||
164302022|NCT03847896|593482506|FG002|Overall Study|Lost to Follow-up|0|||
164302023|NCT03847896|593482507|FG003|Overall Study|Lost to Follow-up|1|||
164302024|NCT03847896|593482508|FG004|Overall Study|Lost to Follow-up|0|||
164302025|NCT03847896|593482504|FG000|Overall Study|Condition under investigation worsened|0|||
164302026|NCT03847896|593482505|FG001|Overall Study|Condition under investigation worsened|0|||
164302027|NCT03847896|593482506|FG002|Overall Study|Condition under investigation worsened|0|||
164302028|NCT03847896|593482507|FG003|Overall Study|Condition under investigation worsened|1|||
164302029|NCT03847896|593482508|FG004|Overall Study|Condition under investigation worsened|1|||
164302030|NCT03847896|593482504|FG000|Overall Study|Lack of Efficacy|0|||
164302031|NCT03847896|593482505|FG001|Overall Study|Lack of Efficacy|0|||
164302032|NCT03847896|593482506|FG002|Overall Study|Lack of Efficacy|0|||
164302033|NCT03847896|593482507|FG003|Overall Study|Lack of Efficacy|2|||
164303069|NCT00775190|593486416|FG000|Overall Study|Lost to Follow-up|2|||
164303070|NCT00775190|593486417|FG001|Overall Study|Lost to Follow-up|3|||
164303071|NCT00775190|593486416|FG000|Overall Study|Withdrawal by Subject|1|||
164303072|NCT00775190|593486417|FG001|Overall Study|Withdrawal by Subject|2|||
164303073|NCT00775190|593486416|FG000|Overall Study|Protocol Violation|1|||
164303074|NCT00775190|593486417|FG001|Overall Study|Protocol Violation|0|||
164303075|NCT01710501|593486418|FG000|Overall Study|Lost to Follow-up|2|||
164303076|NCT01710501|593486419|FG001|Overall Study|Lost to Follow-up|0|||
164303077|NCT01710501|593486420|FG002|Overall Study|Lost to Follow-up|0|||
164303078|NCT01376804|593486421|FG000|Treatment Period|Withdrawal by Subject|1|||
164303079|NCT01376804|593486421|FG000|Treatment Period|Adverse Event|6|||
164303080|NCT01376804|593486421|FG000|Treatment Period|Patient did not receive study drug|1|||
164303081|NCT01281124|593486422|FG000|Overall Study|Death|1|||
164303082|NCT05097963|593486423|FG000|Overall Study|Protocol Violation|13|||
164303083|NCT05097963|593486423|FG000|Overall Study|Withdrawal by Subject|21|||
164303084|NCT02492763|593486424|FG000|Overall Study|Withdrawal by Subject|0|||
164303085|NCT02492763|593486425|FG001|Overall Study|Withdrawal by Subject|2|||
164303086|NCT02492763|593486426|FG002|Overall Study|Withdrawal by Subject|1|||
164303087|NCT02492763|593486427|FG003|Overall Study|Withdrawal by Subject|0|||
164303088|NCT02492763|593486424|FG000|Overall Study|Adverse Event|3|||
164303089|NCT02492763|593486425|FG001|Overall Study|Adverse Event|1|||
164303090|NCT02492763|593486426|FG002|Overall Study|Adverse Event|1|||
164303091|NCT02492763|593486427|FG003|Overall Study|Adverse Event|2|||
164303092|NCT02492763|593486424|FG000|Overall Study|Death|0|||
164303093|NCT02492763|593486425|FG001|Overall Study|Death|0|||
164303094|NCT02492763|593486426|FG002|Overall Study|Death|1|||
164303095|NCT02492763|593486427|FG003|Overall Study|Death|0|||
164303096|NCT02492763|593486424|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
164303097|NCT02492763|593486425|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
164303098|NCT02492763|593486426|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
164303099|NCT02492763|593486427|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
164303100|NCT02492763|593486424|FG000|Overall Study|Lost to Follow-up|0|||
164303101|NCT02492763|593486425|FG001|Overall Study|Lost to Follow-up|0|||
164303102|NCT02492763|593486426|FG002|Overall Study|Lost to Follow-up|1|||
164303103|NCT02492763|593486427|FG003|Overall Study|Lost to Follow-up|0|||
164303104|NCT02492763|593486424|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164303105|NCT02492763|593486425|FG001|Overall Study|Non-Compliance With Study Drug|1|||
164303106|NCT02492763|593486426|FG002|Overall Study|Non-Compliance With Study Drug|0|||
164303107|NCT02492763|593486427|FG003|Overall Study|Non-Compliance With Study Drug|0|||
164303108|NCT02492763|593486424|FG000|Overall Study|Screen Failure|0|||
164303109|NCT02492763|593486425|FG001|Overall Study|Screen Failure|0|||
164303110|NCT02492763|593486426|FG002|Overall Study|Screen Failure|0|||
164303111|NCT02492763|593486427|FG003|Overall Study|Screen Failure|1|||
164303112|NCT02492763|593486424|FG000|Overall Study|Study Terminated by Sponsor|13|||
164303113|NCT02492763|593486425|FG001|Overall Study|Study Terminated by Sponsor|10|||
164647637|NCT04440007|594736568|FG000|Overall Study|Physician Decision|1|||
164647638|NCT04440007|594736569|FG001|Overall Study|Physician Decision|1|||
164647639|NCT04440007|594736568|FG000|Overall Study|Withdrawal by Subject|2|||
164647640|NCT04440007|594736569|FG001|Overall Study|Withdrawal by Subject|1|||
164647641|NCT04440007|594736568|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
164647642|NCT04440007|594736569|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
164647643|NCT04440007|594736568|FG000|Overall Study|Discontinued prior to dosing|0|||
164647644|NCT04440007|594736569|FG001|Overall Study|Discontinued prior to dosing|2|||
164647645|NCT01466673|594736570|FG000|Overall Study|Non-compliance with study treatment|2|||
164647646|NCT01466673|594736571|FG001|Overall Study|Non-compliance with study treatment|0|||
164647647|NCT01466673|594736570|FG000|Overall Study|Lost to Follow-up|3|||
164647648|NCT01466673|594736571|FG001|Overall Study|Lost to Follow-up|5|||
164647649|NCT01466673|594736570|FG000|Overall Study|Adverse Event|2|||
164647650|NCT01466673|594736571|FG001|Overall Study|Adverse Event|1|||
164647651|NCT02164539|594736572|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
164647652|NCT02164539|594736573|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
164647653|NCT02164539|594736574|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
164647654|NCT02164539|594736575|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
164532553|NCT03769181|594322078|FG000|Overall Study|Adverse Event|1|||
164532554|NCT03769181|594322079|FG001|Overall Study|Adverse Event|0|||
164303114|NCT02492763|593486426|FG002|Overall Study|Study Terminated by Sponsor|6|||
164303115|NCT02492763|593486427|FG003|Overall Study|Study Terminated by Sponsor|10|||
164303116|NCT02446899|593486428|FG000|Overall Study|Adverse Event|4|||
164418116|NCT02391038|593901076|FG002|Overall Study|Progressive disease|6|||
164303117|NCT02446899|593486429|FG001|Overall Study|Adverse Event|7|||
164303118|NCT02446899|593486428|FG000|Overall Study|Condition Under Investigation Worsened|1|||
164303119|NCT02446899|593486429|FG001|Overall Study|Condition Under Investigation Worsened|4|||
164303120|NCT02446899|593486428|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
164303121|NCT02446899|593486429|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
164303122|NCT02446899|593486428|FG000|Overall Study|Lack of Efficacy|2|||
164532555|NCT03769181|594322080|FG002|Overall Study|Adverse Event|2|||
164532556|NCT03769181|594322081|FG003|Overall Study|Adverse Event|4|||
164532557|NCT03769181|594322078|FG000|Overall Study|Withdrawal by Subject|1|||
164532558|NCT03769181|594322079|FG001|Overall Study|Withdrawal by Subject|0|||
164532559|NCT03769181|594322080|FG002|Overall Study|Withdrawal by Subject|2|||
164532560|NCT03769181|594322081|FG003|Overall Study|Withdrawal by Subject|1|||
164532561|NCT03769181|594322078|FG000|Overall Study|Progressive disease|9|||
164532562|NCT03769181|594322079|FG001|Overall Study|Progressive disease|7|||
164532563|NCT03769181|594322080|FG002|Overall Study|Progressive disease|13|||
164532564|NCT03769181|594322081|FG003|Overall Study|Progressive disease|6|||
164532565|NCT03769181|594322078|FG000|Overall Study|Other - Unspecified|2|||
164532566|NCT03769181|594322079|FG001|Overall Study|Other - Unspecified|1|||
164647655|NCT02164539|594736576|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
164647656|NCT02164539|594736577|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
164647657|NCT02164539|594736578|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
164647658|NCT02164539|594736572|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
164647659|NCT02164539|594736573|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
164647660|NCT02164539|594736574|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
164647661|NCT02164539|594736575|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
164647662|NCT02164539|594736576|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
164532567|NCT03769181|594322080|FG002|Overall Study|Other - Unspecified|0|||
164532568|NCT03769181|594322081|FG003|Overall Study|Other - Unspecified|0|||
164532569|NCT00826111|594322082|FG000|Overall Study|Lost to Follow-up|0|||
164532570|NCT00826111|594322083|FG001|Overall Study|Lost to Follow-up|1|||
164532571|NCT00826111|594322082|FG000|Overall Study|Protocol Violation|1|||
164532572|NCT00826111|594322083|FG001|Overall Study|Protocol Violation|0|||
164532573|NCT00826111|594322082|FG000|Overall Study|Withdrawal by Subject|5|||
164532574|NCT00826111|594322083|FG001|Overall Study|Withdrawal by Subject|0|||
164532575|NCT00826111|594322082|FG000|Overall Study|Physician Decision|1|||
164303123|NCT02446899|593486429|FG001|Overall Study|Lack of Efficacy|8|||
164303124|NCT02446899|593486428|FG000|Overall Study|Lost to Follow-up|1|||
164303125|NCT02446899|593486429|FG001|Overall Study|Lost to Follow-up|3|||
164303126|NCT02446899|593486428|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
164303127|NCT02446899|593486429|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
164303128|NCT02446899|593486428|FG000|Overall Study|Withdrawal by Subject|11|||
164303129|NCT02446899|593486429|FG001|Overall Study|Withdrawal by Subject|19|||
164303130|NCT02446899|593486428|FG000|Overall Study|Miscellaneous|5|||
164303131|NCT02446899|593486429|FG001|Overall Study|Miscellaneous|4|||
164303132|NCT02446899|593486428|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
164303133|NCT02446899|593486429|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
164303134|NCT01002339|593486430|FG000|Overall Study|Withdrawal by Subject|0|||
164303135|NCT01002339|593486431|FG001|Overall Study|Withdrawal by Subject|1|||
164303136|NCT01002339|593486432|FG002|Overall Study|Withdrawal by Subject|0|||
164418117|NCT02959138|593901077|FG000|Overall Study|Enrolled but Never Treated|0|||
164418118|NCT02959138|593901078|FG001|Overall Study|Enrolled but Never Treated|1|||
164418119|NCT02959138|593901079|FG002|Overall Study|Enrolled but Never Treated|0|||
164418120|NCT04213989|593901080|FG000|Overall Study|Withdrawal by Subject|3|||
164418121|NCT04213989|593901081|FG001|Overall Study|Withdrawal by Subject|2|||
164418122|NCT04213989|593901080|FG000|Overall Study|Physician Decision|1|||
164418123|NCT04213989|593901081|FG001|Overall Study|Physician Decision|0|||
164418124|NCT04213989|593901080|FG000|Overall Study|Lost to Follow-up|0|||
164418125|NCT04213989|593901081|FG001|Overall Study|Lost to Follow-up|4|||
164418126|NCT01327547|593901082|FG000|Overall Study|Adverse Event|4|||
164418127|NCT01327547|593901083|FG001|Overall Study|Adverse Event|1|||
164418128|NCT01327547|593901082|FG000|Overall Study|Death|1|||
164418129|NCT01327547|593901083|FG001|Overall Study|Death|2|||
164418130|NCT01327547|593901082|FG000|Overall Study|Lost to Follow-up|6|||
164303137|NCT01002339|593486430|FG000|Overall Study|Incorrect treatment assignment|0|||
164303138|NCT01002339|593486431|FG001|Overall Study|Incorrect treatment assignment|0|||
164303139|NCT01002339|593486432|FG002|Overall Study|Incorrect treatment assignment|1|||
164303140|NCT01002339|593486430|FG000|Overall Study|Protocol Violation|0|||
164303141|NCT01002339|593486431|FG001|Overall Study|Protocol Violation|0|||
164303142|NCT01002339|593486432|FG002|Overall Study|Protocol Violation|2|||
164303143|NCT01002339|593486430|FG000|Overall Study|Lung cancer detected before transplant|0|||
164303144|NCT01002339|593486431|FG001|Overall Study|Lung cancer detected before transplant|0|||
164303145|NCT01002339|593486432|FG002|Overall Study|Lung cancer detected before transplant|1|||
164303146|NCT01002339|593486430|FG000|Overall Study|Randomized. Not transplanted|0|||
164303147|NCT01002339|593486431|FG001|Overall Study|Randomized. Not transplanted|0|||
164532576|NCT00826111|594322083|FG001|Overall Study|Physician Decision|1|||
164303148|NCT01002339|593486432|FG002|Overall Study|Randomized. Not transplanted|1|||
164303149|NCT02215252|593486433|FG000|Overall Study|Adverse Event|1|||
164532577|NCT01195545|594322084|FG000|Overall Study|Protocol Violation|4|||
164532578|NCT00146328|594322085|FG000|Overall Study|Adverse Event|39|||
164532579|NCT00146328|594322086|FG001|Overall Study|Adverse Event|48|||
164532580|NCT00146328|594322087|FG002|Overall Study|Adverse Event|79|||
164303150|NCT02215252|593486434|FG001|Overall Study|Adverse Event|5|||
164303151|NCT02215252|593486435|FG002|Overall Study|Adverse Event|2|||
164303152|NCT02215252|593486433|FG000|Overall Study|Lost to Follow-up|0|||
164303153|NCT02215252|593486434|FG001|Overall Study|Lost to Follow-up|0|||
164303154|NCT02215252|593486435|FG002|Overall Study|Lost to Follow-up|1|||
164303155|NCT02215252|593486433|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
164303156|NCT02215252|593486434|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
164303157|NCT02215252|593486435|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
164303158|NCT02215252|593486433|FG000|Overall Study|Protocol Violation|0|||
164303159|NCT02215252|593486434|FG001|Overall Study|Protocol Violation|1|||
164303160|NCT02215252|593486435|FG002|Overall Study|Protocol Violation|0|||
164303161|NCT02215252|593486433|FG000|Overall Study|Withdrawal by Subject|1|||
164532581|NCT00146328|594322085|FG000|Overall Study|Protocol Violation|11|||
164532582|NCT00146328|594322086|FG001|Overall Study|Protocol Violation|6|||
164532583|NCT00146328|594322087|FG002|Overall Study|Protocol Violation|12|||
164532584|NCT00146328|594322085|FG000|Overall Study|Lost to Follow-up|7|||
164532585|NCT00146328|594322086|FG001|Overall Study|Lost to Follow-up|4|||
164532586|NCT00146328|594322087|FG002|Overall Study|Lost to Follow-up|7|||
164532587|NCT00146328|594322085|FG000|Overall Study|Withdrawal by Subject|16|||
164532588|NCT00146328|594322086|FG001|Overall Study|Withdrawal by Subject|16|||
164532589|NCT00146328|594322087|FG002|Overall Study|Withdrawal by Subject|22|||
164532590|NCT00146328|594322085|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
164532591|NCT00146328|594322086|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
164532592|NCT00146328|594322087|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
164532593|NCT00146328|594322085|FG000|Overall Study|Trial ended/site closed|8|||
164532594|NCT00146328|594322086|FG001|Overall Study|Trial ended/site closed|2|||
164532595|NCT00146328|594322087|FG002|Overall Study|Trial ended/site closed|19|||
164532596|NCT00146328|594322085|FG000|Overall Study|Patient decision to end|0|||
164532597|NCT00146328|594322086|FG001|Overall Study|Patient decision to end|1|||
164532598|NCT00146328|594322087|FG002|Overall Study|Patient decision to end|6|||
164532599|NCT00146328|594322085|FG000|Overall Study|Enroll into other trial|2|||
164532600|NCT00146328|594322086|FG001|Overall Study|Enroll into other trial|4|||
164532601|NCT00146328|594322087|FG002|Overall Study|Enroll into other trial|2|||
164532602|NCT00146328|594322085|FG000|Overall Study|Death|0|||
164532603|NCT00146328|594322086|FG001|Overall Study|Death|1|||
164532604|NCT00146328|594322087|FG002|Overall Study|Death|1|||
164532605|NCT00146328|594322085|FG000|Overall Study|Moved|2|||
164532606|NCT00146328|594322086|FG001|Overall Study|Moved|0|||
164532607|NCT00146328|594322087|FG002|Overall Study|Moved|0|||
164532608|NCT00146328|594322085|FG000|Overall Study|Interaction with other medication|2|||
164532609|NCT00146328|594322086|FG001|Overall Study|Interaction with other medication|0|||
164532610|NCT00146328|594322087|FG002|Overall Study|Interaction with other medication|1|||
164532611|NCT01717989|594322088|FG000|Overall Study|Ineligibility determined|6|||
164532612|NCT01717989|594322088|FG000|Overall Study|Protocol deviation|6|||
164532613|NCT01717989|594322088|FG000|Overall Study|Withdrawal by Subject|11|||
164532614|NCT01717989|594322088|FG000|Overall Study|Physician Decision|2|||
164532615|NCT01717989|594322088|FG000|Overall Study|Lost to Follow-up|11|||
164532616|NCT01717989|594322088|FG000|Overall Study|Death|439|||
164532617|NCT01717989|594322088|FG000|Overall Study|Protocol-specified criteria|551|||
164532618|NCT01717989|594322088|FG000|Overall Study|Other|40|||
164532619|NCT03224325|594322089|FG000|Overall Study|Adverse Event|1|||
164532620|NCT03224325|594322090|FG001|Overall Study|Adverse Event|0|||
164532621|NCT03224325|594322091|FG002|Overall Study|Adverse Event|0|||
164532622|NCT03224325|594322092|FG003|Overall Study|Adverse Event|0|||
164532623|NCT03224325|594322093|FG004|Overall Study|Adverse Event|0|||
164532624|NCT03224325|594322094|FG005|Overall Study|Adverse Event|0|||
164532625|NCT03224325|594322095|FG006|Overall Study|Adverse Event|1|||
164532626|NCT03224325|594322089|FG000|Overall Study|Withdrawal by Subject|0|||
164532627|NCT03224325|594322090|FG001|Overall Study|Withdrawal by Subject|0|||
164532628|NCT03224325|594322091|FG002|Overall Study|Withdrawal by Subject|0|||
164532629|NCT03224325|594322092|FG003|Overall Study|Withdrawal by Subject|1|||
164532630|NCT03224325|594322093|FG004|Overall Study|Withdrawal by Subject|0|||
164532631|NCT03224325|594322094|FG005|Overall Study|Withdrawal by Subject|0|||
164532632|NCT03224325|594322095|FG006|Overall Study|Withdrawal by Subject|0|||
164532633|NCT02072434|594322099|FG000|Overall Study|Protocol Violation|10|||
164532634|NCT02072434|594322100|FG001|Overall Study|Protocol Violation|9|||
164532635|NCT02072434|594322099|FG000|Overall Study|Physician Decision|5|||
164532636|NCT02072434|594322100|FG001|Overall Study|Physician Decision|10|||
164532637|NCT02072434|594322099|FG000|Overall Study|Adverse event, serious fatal|1|||
164532638|NCT02072434|594322100|FG001|Overall Study|Adverse event, serious fatal|6|||
164303162|NCT02215252|593486434|FG001|Overall Study|Withdrawal by Subject|0|||
164532639|NCT02072434|594322099|FG000|Overall Study|Adverse Event|7|||
164532640|NCT02072434|594322100|FG001|Overall Study|Adverse Event|6|||
164532641|NCT02072434|594322099|FG000|Overall Study|Withdrawal by Subject|17|||
164532642|NCT02072434|594322100|FG001|Overall Study|Withdrawal by Subject|29|||
164647663|NCT02164539|594736577|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
164647664|NCT02164539|594736578|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
164647665|NCT02164539|594736572|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
164647666|NCT02164539|594736573|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
164647667|NCT02164539|594736574|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
164647668|NCT02164539|594736575|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
164647669|NCT02164539|594736576|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
164647670|NCT02164539|594736577|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
164647671|NCT02164539|594736578|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
164647672|NCT02164539|594736572|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
164647673|NCT02164539|594736573|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
164303163|NCT02215252|593486435|FG002|Overall Study|Withdrawal by Subject|0|||
164303164|NCT02215252|593486433|FG000|Overall Study|Other|0|||
164303165|NCT02215252|593486434|FG001|Overall Study|Other|1|||
164303166|NCT02215252|593486435|FG002|Overall Study|Other|1|||
164647674|NCT02164539|594736574|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
164647675|NCT02164539|594736575|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
164647676|NCT02164539|594736576|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
164647677|NCT02164539|594736577|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
164647678|NCT02164539|594736578|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
164647679|NCT02164539|594736572|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
164647680|NCT02164539|594736573|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
164647681|NCT02164539|594736574|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
164647682|NCT02164539|594736575|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
164647683|NCT02164539|594736576|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
164647684|NCT02164539|594736577|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
164647685|NCT02164539|594736578|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
164647686|NCT02164539|594736572|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
164647687|NCT02164539|594736573|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
164647688|NCT02164539|594736574|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
164647689|NCT02164539|594736575|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
164647690|NCT02164539|594736576|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
164647691|NCT02164539|594736577|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
164647692|NCT02164539|594736578|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
164647693|NCT01255722|594736579|FG000|Overall Study|Adverse Event|0|||
164647694|NCT01255722|594736580|FG001|Overall Study|Adverse Event|1|||
164647695|NCT01255722|594736581|FG002|Overall Study|Adverse Event|1|||
164647696|NCT01255722|594736579|FG000|Overall Study|asymptomatic patient|1|||
164647697|NCT01255722|594736580|FG001|Overall Study|asymptomatic patient|0|||
164647698|NCT01255722|594736581|FG002|Overall Study|asymptomatic patient|0|||
164647699|NCT01255722|594736579|FG000|Overall Study|beta-blocker contraindicated|2|||
164647700|NCT01255722|594736580|FG001|Overall Study|beta-blocker contraindicated|0|||
164647701|NCT01255722|594736581|FG002|Overall Study|beta-blocker contraindicated|0|||
164647702|NCT01289990|594736585|FG000|Overall Study|Death|0|||
164647703|NCT01289990|594736586|FG001|Overall Study|Death|0|||
164647704|NCT01289990|594736587|FG002|Overall Study|Death|0|||
164647705|NCT01289990|594736588|FG003|Overall Study|Death|1|||
164647706|NCT01289990|594736589|FG004|Overall Study|Death|2|||
164647707|NCT01289990|594736590|FG005|Overall Study|Death|1|||
164647708|NCT01289990|594736591|FG006|Overall Study|Death|0|||
164647709|NCT01289990|594736592|FG007|Overall Study|Death|0|||
164647710|NCT01289990|594736593|FG008|Overall Study|Death|0|||
164647711|NCT01289990|594736594|FG009|Overall Study|Death|0|||
164647712|NCT01289990|594736595|FG010|Overall Study|Death|0|||
164647713|NCT01289990|594736596|FG011|Overall Study|Death|1|||
164647714|NCT01289990|594736597|FG012|Overall Study|Death|0|||
164647715|NCT01289990|594736585|FG000|Overall Study|Lost to Follow-up|3|||
164647716|NCT01289990|594736586|FG001|Overall Study|Lost to Follow-up|2|||
164647717|NCT01289990|594736587|FG002|Overall Study|Lost to Follow-up|5|||
164647718|NCT01289990|594736588|FG003|Overall Study|Lost to Follow-up|5|||
164647719|NCT01289990|594736589|FG004|Overall Study|Lost to Follow-up|3|||
164647720|NCT01289990|594736590|FG005|Overall Study|Lost to Follow-up|4|||
164647721|NCT01289990|594736591|FG006|Overall Study|Lost to Follow-up|2|||
164647722|NCT01289990|594736592|FG007|Overall Study|Lost to Follow-up|2|||
164647723|NCT01289990|594736593|FG008|Overall Study|Lost to Follow-up|1|||
164647724|NCT01289990|594736594|FG009|Overall Study|Lost to Follow-up|4|||
164647725|NCT01289990|594736595|FG010|Overall Study|Lost to Follow-up|2|||
164647726|NCT01289990|594736596|FG011|Overall Study|Lost to Follow-up|1|||
164647727|NCT01289990|594736597|FG012|Overall Study|Lost to Follow-up|2|||
164647728|NCT01289990|594736585|FG000|Overall Study|Withdrawal by Subject|15|||
164647729|NCT01289990|594736586|FG001|Overall Study|Withdrawal by Subject|14|||
164647730|NCT01289990|594736587|FG002|Overall Study|Withdrawal by Subject|12|||
164647731|NCT01289990|594736588|FG003|Overall Study|Withdrawal by Subject|13|||
164647732|NCT01289990|594736589|FG004|Overall Study|Withdrawal by Subject|8|||
164647733|NCT01289990|594736590|FG005|Overall Study|Withdrawal by Subject|7|||
164647734|NCT01289990|594736591|FG006|Overall Study|Withdrawal by Subject|13|||
164303167|NCT00892099|593486436|FG000|Overall Study|Death|1|||
164647735|NCT01289990|594736592|FG007|Overall Study|Withdrawal by Subject|9|||
164647736|NCT01289990|594736593|FG008|Overall Study|Withdrawal by Subject|12|||
164647737|NCT01289990|594736594|FG009|Overall Study|Withdrawal by Subject|13|||
164303168|NCT00892099|593486437|FG001|Overall Study|Death|0|||
164303169|NCT00892099|593486438|FG002|Overall Study|Death|1|||
164303170|NCT00892099|593486436|FG000|Overall Study|Adverse Event|1|||
164303171|NCT00892099|593486437|FG001|Overall Study|Adverse Event|0|||
164303172|NCT00892099|593486438|FG002|Overall Study|Adverse Event|0|||
164303173|NCT00892099|593486436|FG000|Overall Study|replocated|1|||
164303174|NCT00892099|593486437|FG001|Overall Study|replocated|0|||
164303175|NCT00892099|593486438|FG002|Overall Study|replocated|2|||
164303176|NCT00892099|593486436|FG000|Overall Study|Prolonged hospitalization|1|||
164303177|NCT00892099|593486437|FG001|Overall Study|Prolonged hospitalization|0|||
164303178|NCT00892099|593486438|FG002|Overall Study|Prolonged hospitalization|1|||
164303179|NCT00892099|593486436|FG000|Overall Study|no further details|1|||
164303180|NCT00892099|593486437|FG001|Overall Study|no further details|0|||
164303181|NCT00892099|593486438|FG002|Overall Study|no further details|1|||
164303182|NCT00892099|593486436|FG000|Overall Study|kidney function recovered|0|||
164303183|NCT00892099|593486437|FG001|Overall Study|kidney function recovered|1|||
164303184|NCT00892099|593486438|FG002|Overall Study|kidney function recovered|0|||
164303185|NCT00892099|593486436|FG000|Overall Study|investigator decision|0|||
164303186|NCT00892099|593486437|FG001|Overall Study|investigator decision|0|||
164303187|NCT00892099|593486438|FG002|Overall Study|investigator decision|1|||
164303188|NCT00892099|593486436|FG000|Overall Study|Lost to Follow-up|0|||
164303189|NCT00892099|593486437|FG001|Overall Study|Lost to Follow-up|0|||
164303190|NCT00892099|593486438|FG002|Overall Study|Lost to Follow-up|1|||
164303191|NCT03910244|593486439|FG000|Overall Study|Adverse Event|14|||
164303192|NCT03910244|593486440|FG001|Overall Study|Adverse Event|0|||
164303193|NCT03910244|593486439|FG000|Overall Study|Death|1|||
164303194|NCT03910244|593486440|FG001|Overall Study|Death|0|||
164303195|NCT03910244|593486439|FG000|Overall Study|Lost to Follow-up|0|||
164303196|NCT03910244|593486440|FG001|Overall Study|Lost to Follow-up|2|||
164303197|NCT03910244|593486439|FG000|Overall Study|Joint withdrawal decision|1|||
164303198|NCT03910244|593486440|FG001|Overall Study|Joint withdrawal decision|0|||
164303199|NCT03910244|593486439|FG000|Overall Study|Study Terminated by Sponsor|7|||
164303200|NCT03910244|593486440|FG001|Overall Study|Study Terminated by Sponsor|4|||
164303201|NCT03910244|593486439|FG000|Overall Study|Physician Decision|1|||
164303202|NCT03910244|593486440|FG001|Overall Study|Physician Decision|0|||
164303203|NCT03910244|593486439|FG000|Overall Study|Protocol Violation|1|||
164303204|NCT03910244|593486440|FG001|Overall Study|Protocol Violation|0|||
164303205|NCT03910244|593486439|FG000|Overall Study|Withdrawal by Subject|7|||
164303206|NCT03910244|593486440|FG001|Overall Study|Withdrawal by Subject|2|||
164303207|NCT01106690|593486441|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
164303208|NCT01106690|593486442|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
164303209|NCT01106690|593486443|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
164303210|NCT01106690|593486441|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
164303211|NCT01106690|593486442|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
164303212|NCT01106690|593486443|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
164303213|NCT01106690|593486441|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
164418131|NCT01327547|593901083|FG001|Overall Study|Lost to Follow-up|6|||
164418132|NCT01327547|593901082|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
164303214|NCT01106690|593486442|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
164303215|NCT01106690|593486443|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
164303216|NCT01106690|593486441|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
164303217|NCT01106690|593486442|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
164303218|NCT01106690|593486443|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
164303219|NCT01106690|593486441|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
164303220|NCT01106690|593486442|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
164303221|NCT01106690|593486443|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
164303222|NCT01106690|593486441|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
164303223|NCT01106690|593486442|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
164303224|NCT01106690|593486443|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
164303225|NCT01106690|593486441|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
164303226|NCT01106690|593486442|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
164303227|NCT01106690|593486443|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
164303228|NCT01106690|593486441|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
164303229|NCT01106690|593486442|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
164303230|NCT01106690|593486443|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
164303231|NCT01106690|593486441|FG000|Core Period: Baseline to Week 26|Other|10|||
164303232|NCT01106690|593486442|FG001|Core Period: Baseline to Week 26|Other|2|||
164303233|NCT01106690|593486443|FG002|Core Period: Baseline to Week 26|Other|6|||
164303234|NCT01106690|593486441|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
164303235|NCT01106690|593486442|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
164303236|NCT01106690|593486443|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
164303237|NCT01106690|593486441|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
164647738|NCT01289990|594736595|FG010|Overall Study|Withdrawal by Subject|11|||
164647739|NCT01289990|594736596|FG011|Overall Study|Withdrawal by Subject|13|||
164647740|NCT01289990|594736597|FG012|Overall Study|Withdrawal by Subject|16|||
164647741|NCT01289990|594736585|FG000|Overall Study|discontinued in preceding trial|18|||
164647742|NCT01289990|594736586|FG001|Overall Study|discontinued in preceding trial|20|||
164647743|NCT01289990|594736587|FG002|Overall Study|discontinued in preceding trial|41|||
164647744|NCT01289990|594736588|FG003|Overall Study|discontinued in preceding trial|17|||
164647745|NCT01289990|594736589|FG004|Overall Study|discontinued in preceding trial|11|||
164647746|NCT01289990|594736590|FG005|Overall Study|discontinued in preceding trial|12|||
164647747|NCT01289990|594736591|FG006|Overall Study|discontinued in preceding trial|18|||
164647748|NCT01289990|594736592|FG007|Overall Study|discontinued in preceding trial|8|||
164647749|NCT01289990|594736593|FG008|Overall Study|discontinued in preceding trial|17|||
164647750|NCT01289990|594736594|FG009|Overall Study|discontinued in preceding trial|21|||
164647751|NCT01289990|594736595|FG010|Overall Study|discontinued in preceding trial|17|||
164647752|NCT01289990|594736596|FG011|Overall Study|discontinued in preceding trial|17|||
164647753|NCT01289990|594736597|FG012|Overall Study|discontinued in preceding trial|24|||
164647754|NCT01289990|594736585|FG000|Overall Study|did not continue in extension|41|||
164647755|NCT01289990|594736586|FG001|Overall Study|did not continue in extension|45|||
164647756|NCT01289990|594736587|FG002|Overall Study|did not continue in extension|51|||
164647757|NCT01289990|594736588|FG003|Overall Study|did not continue in extension|51|||
164647758|NCT01289990|594736589|FG004|Overall Study|did not continue in extension|48|||
164647759|NCT01289990|594736590|FG005|Overall Study|did not continue in extension|50|||
164647760|NCT01289990|594736591|FG006|Overall Study|did not continue in extension|54|||
164647761|NCT01289990|594736592|FG007|Overall Study|did not continue in extension|36|||
164647762|NCT01289990|594736593|FG008|Overall Study|did not continue in extension|44|||
164647763|NCT01289990|594736594|FG009|Overall Study|did not continue in extension|48|||
164647764|NCT01289990|594736595|FG010|Overall Study|did not continue in extension|45|||
164647765|NCT01289990|594736596|FG011|Overall Study|did not continue in extension|34|||
164647766|NCT01289990|594736597|FG012|Overall Study|did not continue in extension|56|||
164647767|NCT01289990|594736585|FG000|Overall Study|Not treated|0|||
164647768|NCT01289990|594736586|FG001|Overall Study|Not treated|0|||
164647769|NCT01289990|594736587|FG002|Overall Study|Not treated|0|||
164647770|NCT01289990|594736588|FG003|Overall Study|Not treated|0|||
164647771|NCT01289990|594736589|FG004|Overall Study|Not treated|0|||
164647772|NCT01289990|594736590|FG005|Overall Study|Not treated|0|||
164647773|NCT01289990|594736591|FG006|Overall Study|Not treated|1|||
164647774|NCT01289990|594736592|FG007|Overall Study|Not treated|0|||
164647775|NCT01289990|594736593|FG008|Overall Study|Not treated|1|||
164647776|NCT01289990|594736594|FG009|Overall Study|Not treated|0|||
164647777|NCT01289990|594736595|FG010|Overall Study|Not treated|1|||
164647778|NCT01289990|594736596|FG011|Overall Study|Not treated|2|||
164647779|NCT01289990|594736597|FG012|Overall Study|Not treated|0|||
164647780|NCT04529499|594736598|FG000|Overall Study|Withdrawal by Subject|9|||
164647781|NCT04529499|594736599|FG001|Overall Study|Withdrawal by Subject|11|||
164647782|NCT04529499|594736598|FG000|Overall Study|Physician Decision|1|||
164647783|NCT04529499|594736599|FG001|Overall Study|Physician Decision|2|||
164647784|NCT04529499|594736598|FG000|Overall Study|Adverse Event|4|||
164647785|NCT04529499|594736599|FG001|Overall Study|Adverse Event|4|||
164647786|NCT04529499|594736598|FG000|Overall Study|Death|14|||
164647787|NCT04529499|594736599|FG001|Overall Study|Death|11|||
164647788|NCT04529499|594736598|FG000|Overall Study|Lost to Follow-up|1|||
164647789|NCT04529499|594736599|FG001|Overall Study|Lost to Follow-up|1|||
164647790|NCT04529499|594736598|FG000|Overall Study|Others|7|||
164647791|NCT04529499|594736599|FG001|Overall Study|Others|11|||
164647792|NCT00683904|594736600|FG000|Dose Level 1|Disease progression|2|||
164647793|NCT00683904|594736601|FG001|Dose Level 1|Disease progression|0|||
164647794|NCT00683904|594736600|FG000|Dose Level 1|Adverse Event|1|||
164647795|NCT00683904|594736601|FG001|Dose Level 1|Adverse Event|0|||
164647796|NCT00683904|594736600|FG000|Dose Level 2|Adverse Event|0|||
164647797|NCT00683904|594736601|FG001|Dose Level 2|Adverse Event|2|||
164647798|NCT02702271|594736602|FG000|Overall Study|Death|36|||
164647799|NCT02702271|594736603|FG001|Overall Study|Death|7|||
164647800|NCT02702271|594736602|FG000|Overall Study|Lost to Follow-up|12|||
164647801|NCT02702271|594736603|FG001|Overall Study|Lost to Follow-up|0|||
164647802|NCT02702271|594736602|FG000|Overall Study|Withdrawal by Subject|8|||
164647803|NCT02702271|594736603|FG001|Overall Study|Withdrawal by Subject|1|||
164647804|NCT02702271|594736602|FG000|Overall Study|Physician Decision|2|||
164647805|NCT02702271|594736603|FG001|Overall Study|Physician Decision|0|||
164647806|NCT02702271|594736602|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
164647807|NCT02702271|594736603|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
164647808|NCT01494649|594736604|FG000|Overall Study|Lost to Follow-up|0|||
164647809|NCT01494649|594736605|FG001|Overall Study|Lost to Follow-up|1|||
164647810|NCT03091400|594736606|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
164647811|NCT03091400|594736607|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
164647812|NCT00975884|594736608|FG000|Overall Study|Adverse Event|1|||
164647813|NCT00975884|594736609|FG001|Overall Study|Adverse Event|0|||
164647814|NCT00975884|594736608|FG000|Overall Study|Lost to Follow-up|5|||
164647815|NCT00975884|594736609|FG001|Overall Study|Lost to Follow-up|3|||
164647816|NCT00975884|594736608|FG000|Overall Study|Withdrawal by Subject|9|||
164647817|NCT00975884|594736609|FG001|Overall Study|Withdrawal by Subject|9|||
164647818|NCT00975884|594736608|FG000|Overall Study|Other|1|||
164647819|NCT00975884|594736609|FG001|Overall Study|Other|3|||
164647820|NCT03707522|594736612|FG000|Overall Study|Lost to Follow-up|24|||
164647821|NCT03707522|594736613|FG001|Overall Study|Lost to Follow-up|27|||
164647822|NCT03707522|594736614|FG002|Overall Study|Lost to Follow-up|41|||
164647823|NCT03707522|594736615|FG003|Overall Study|Lost to Follow-up|36|||
164647824|NCT03454672|594736616|FG000|Overall Study|Adverse Event|1|||
164647825|NCT03454672|594736617|FG001|Overall Study|Adverse Event|1|||
164647826|NCT03454672|594736616|FG000|Overall Study|Lost to Follow-up|1|||
164647827|NCT03454672|594736617|FG001|Overall Study|Lost to Follow-up|3|||
164647828|NCT03454672|594736616|FG000|Overall Study|painful|1|||
164647829|NCT03454672|594736617|FG001|Overall Study|painful|2|||
164647830|NCT03454672|594736616|FG000|Overall Study|Non-compliance|2|||
164647831|NCT03454672|594736617|FG001|Overall Study|Non-compliance|4|||
164647832|NCT03454672|594736616|FG000|Overall Study|personal reasons|3|||
164647833|NCT03454672|594736617|FG001|Overall Study|personal reasons|2|||
164647834|NCT03454672|594736616|FG000|Overall Study|Withdrawal by Subject|1|||
164647835|NCT03454672|594736617|FG001|Overall Study|Withdrawal by Subject|0|||
164647836|NCT05166512|594736618|FG000|Randomized|Lost to Follow-up|2|||
164647837|NCT05166512|594736619|FG001|Randomized|Lost to Follow-up|0|||
164647838|NCT05166512|594736618|FG000|Randomized|Withdrawal by Subject|1|||
164647839|NCT05166512|594736619|FG001|Randomized|Withdrawal by Subject|0|||
164647840|NCT05166512|594736618|FG000|Baseline Data Collection|Lost to Follow-up|0|||
164647841|NCT05166512|594736619|FG001|Baseline Data Collection|Lost to Follow-up|3|||
164647842|NCT05166512|594736618|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
164647843|NCT05166512|594736619|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
164647844|NCT05166512|594736618|FG000|Baseline Data Collection|Protocol Violation|2|||
164647845|NCT05166512|594736619|FG001|Baseline Data Collection|Protocol Violation|0|||
164647846|NCT05166512|594736618|FG000|4 Month Data Collection|Lost to Follow-up|1|||
164647847|NCT05166512|594736619|FG001|4 Month Data Collection|Lost to Follow-up|0|||
164647848|NCT05166512|594736618|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
164647849|NCT05166512|594736619|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
164647850|NCT05166512|594736618|FG000|12 Month Data Collection|Lost to Follow-up|3|||
164647851|NCT05166512|594736619|FG001|12 Month Data Collection|Lost to Follow-up|1|||
164647852|NCT05166512|594736618|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
164647853|NCT05166512|594736619|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
164647854|NCT00383019|594736620|FG000|Overall Study|Adverse Event|5|||
164647855|NCT00383019|594736621|FG001|Overall Study|Adverse Event|1|||
164647856|NCT00383019|594736620|FG000|Overall Study|Withdrawal by Subject|0|||
164647857|NCT00383019|594736621|FG001|Overall Study|Withdrawal by Subject|1|||
164647858|NCT00659581|594736622|FG000|Overall Study|Adverse Event|1006|||
164647859|NCT00659581|594736622|FG000|Overall Study|Lack of Efficacy|1183|||
164647860|NCT00659581|594736622|FG000|Overall Study|Other|6393|||
164647861|NCT05473247|594736626|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
164647862|NCT00000135|594736627|FG000|Overall Study|Death|27|||
164647863|NCT00000135|594736628|FG001|Overall Study|Death|14|||
164647864|NCT01831596|594736629|FG000|Overall Study|Other|8|||
164647865|NCT02508649|594736632|FG000|Overall Study|Withdrawal by Subject|4|||
164647866|NCT02508649|594736633|FG001|Overall Study|Withdrawal by Subject|6|||
164647867|NCT02508649|594736634|FG002|Overall Study|Withdrawal by Subject|5|||
164532643|NCT02072434|594322099|FG000|Overall Study|Other|14|||
164532644|NCT02072434|594322100|FG001|Overall Study|Other|29|||
164532645|NCT02072434|594322099|FG000|Overall Study|Lost to Follow-up|0|||
164532646|NCT02072434|594322100|FG001|Overall Study|Lost to Follow-up|1|||
164532647|NCT01117454|594322103|FG000|Overall Study|Pregnancy|0|||
164532648|NCT01117454|594322104|FG001|Overall Study|Pregnancy|1|||
164532649|NCT00888433|594322107|FG000|Overall Study|Withdrawal by Subject|1|||
164532650|NCT00888433|594322108|FG001|Overall Study|Withdrawal by Subject|2|||
164532651|NCT00888433|594322107|FG000|Overall Study|Missed Visit|2|||
164532652|NCT00888433|594322108|FG001|Overall Study|Missed Visit|1|||
164532653|NCT00887679|594322109|FG000|Overall Study|Withdrawal by Subject|1|||
164532654|NCT00887679|594322109|FG000|Overall Study|Lost to Follow-up|4|||
164532655|NCT00887679|594322109|FG000|Overall Study|Physician Decision|5|||
164532656|NCT02683941|594322110|FG000|Double-blind Phase|Adverse Event|0|||
164532657|NCT02683941|594322111|FG001|Double-blind Phase|Adverse Event|1|||
164532658|NCT02683941|594322110|FG000|Double-blind Phase|Withdrawal by Subject|4|||
164303238|NCT01106690|593486442|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
164303239|NCT01106690|593486443|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
164532659|NCT02683941|594322111|FG001|Double-blind Phase|Withdrawal by Subject|2|||
164303240|NCT01106690|593486441|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
164532660|NCT02683941|594322110|FG000|Double-blind Phase|Lost to Follow-up|1|||
164647868|NCT02508649|594736635|FG003|Overall Study|Withdrawal by Subject|6|||
164647869|NCT02508649|594736632|FG000|Overall Study|Investigator withdrew the subject|1|||
164647870|NCT02508649|594736633|FG001|Overall Study|Investigator withdrew the subject|2|||
164532661|NCT02683941|594322111|FG001|Double-blind Phase|Lost to Follow-up|0|||
164532662|NCT02683941|594322110|FG000|Double-blind Phase|Disease Progression|5|||
164532663|NCT02683941|594322111|FG001|Double-blind Phase|Disease Progression|2|||
164532664|NCT02683941|594322110|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
164532665|NCT02683941|594322111|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
164532666|NCT02683941|594322110|FG000|Open-label Treatment Phase|Disease Progression|1|||
164532667|NCT02683941|594322111|FG001|Open-label Treatment Phase|Disease Progression|2|||
164532668|NCT02683941|594322110|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
164532669|NCT02683941|594322111|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
164532670|NCT02683941|594322110|FG000|Open-label Treatment Phase|Other|1|||
164532671|NCT02683941|594322111|FG001|Open-label Treatment Phase|Other|0|||
164532672|NCT02683941|594322110|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
164532673|NCT02683941|594322111|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
164532674|NCT02683941|594322110|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
164532675|NCT02683941|594322111|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
164532676|NCT02683941|594322110|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
164532677|NCT02683941|594322111|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
164532678|NCT02683941|594322110|FG000|Open-label Follow-up Phase|Other|8|||
164532679|NCT02683941|594322111|FG001|Open-label Follow-up Phase|Other|1|||
164532680|NCT00146757|594322112|FG000|Overall Study|Death|1|||
164532681|NCT00146757|594322113|FG001|Overall Study|Death|0|||
164532682|NCT00146757|594322112|FG000|Overall Study|Adverse Event|1|||
164532683|NCT00146757|594322113|FG001|Overall Study|Adverse Event|0|||
164532684|NCT00406653|594322116|FG000|Induction Period|Adverse Event|1|||
164532685|NCT00406653|594322117|FG001|Induction Period|Adverse Event|10|||
164532686|NCT00406653|594322118|FG002|Induction Period|Adverse Event|4|||
164532687|NCT00406653|594322119|FG003|Induction Period|Adverse Event|11|||
164532688|NCT00406653|594322120|FG004|Induction Period|Adverse Event|0|||
164532689|NCT00406653|594322121|FG005|Induction Period|Adverse Event|0|||
164532690|NCT00406653|594322122|FG006|Induction Period|Adverse Event|0|||
164532691|NCT00406653|594322116|FG000|Induction Period|Lack of Efficacy|11|||
164532692|NCT00406653|594322117|FG001|Induction Period|Lack of Efficacy|14|||
164532693|NCT00406653|594322118|FG002|Induction Period|Lack of Efficacy|8|||
164532694|NCT00406653|594322119|FG003|Induction Period|Lack of Efficacy|10|||
164532695|NCT00406653|594322120|FG004|Induction Period|Lack of Efficacy|0|||
164532696|NCT00406653|594322121|FG005|Induction Period|Lack of Efficacy|0|||
164532697|NCT00406653|594322122|FG006|Induction Period|Lack of Efficacy|0|||
164532698|NCT00406653|594322116|FG000|Induction Period|Lost to Follow-up|0|||
164532699|NCT00406653|594322117|FG001|Induction Period|Lost to Follow-up|2|||
164532700|NCT00406653|594322118|FG002|Induction Period|Lost to Follow-up|0|||
164532701|NCT00406653|594322119|FG003|Induction Period|Lost to Follow-up|0|||
164532702|NCT00406653|594322120|FG004|Induction Period|Lost to Follow-up|0|||
164532703|NCT00406653|594322121|FG005|Induction Period|Lost to Follow-up|0|||
164532704|NCT00406653|594322122|FG006|Induction Period|Lost to Follow-up|0|||
164532705|NCT00406653|594322116|FG000|Induction Period|Withdrawal of Consent|2|||
164532706|NCT00406653|594322117|FG001|Induction Period|Withdrawal of Consent|5|||
164532707|NCT00406653|594322118|FG002|Induction Period|Withdrawal of Consent|1|||
164532708|NCT00406653|594322119|FG003|Induction Period|Withdrawal of Consent|2|||
164532709|NCT00406653|594322120|FG004|Induction Period|Withdrawal of Consent|0|||
164532710|NCT00406653|594322121|FG005|Induction Period|Withdrawal of Consent|0|||
164532711|NCT00406653|594322122|FG006|Induction Period|Withdrawal of Consent|0|||
164532712|NCT00406653|594322116|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
164532713|NCT00406653|594322117|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
164532714|NCT00406653|594322118|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
164532715|NCT00406653|594322119|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
164532716|NCT00406653|594322120|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
164532717|NCT00406653|594322121|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
164532718|NCT00406653|594322122|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
164532719|NCT00406653|594322116|FG000|Induction Period|Pregnancy|1|||
164532720|NCT00406653|594322117|FG001|Induction Period|Pregnancy|0|||
164532721|NCT00406653|594322118|FG002|Induction Period|Pregnancy|0|||
164532722|NCT00406653|594322119|FG003|Induction Period|Pregnancy|0|||
164532723|NCT00406653|594322120|FG004|Induction Period|Pregnancy|0|||
164532724|NCT00406653|594322121|FG005|Induction Period|Pregnancy|0|||
164532725|NCT00406653|594322122|FG006|Induction Period|Pregnancy|0|||
164532726|NCT00406653|594322116|FG000|Induction Period|Declined participation but followup done|0|||
164532727|NCT00406653|594322117|FG001|Induction Period|Declined participation but followup done|2|||
164303241|NCT01106690|593486442|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
164303242|NCT01106690|593486443|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
164303243|NCT01106690|593486441|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
164532728|NCT00406653|594322118|FG002|Induction Period|Declined participation but followup done|1|||
164532729|NCT00406653|594322119|FG003|Induction Period|Declined participation but followup done|1|||
164532730|NCT00406653|594322120|FG004|Induction Period|Declined participation but followup done|0|||
164589055|NCT01070550|594521373|FG001|Overall Study|Adverse Event|1|||
164532731|NCT00406653|594322121|FG005|Induction Period|Declined participation but followup done|0|||
164532732|NCT00406653|594322122|FG006|Induction Period|Declined participation but followup done|0|||
164532733|NCT00406653|594322116|FG000|Induction Period|Given prohibited drug|0|||
164532734|NCT00406653|594322117|FG001|Induction Period|Given prohibited drug|1|||
164532735|NCT00406653|594322118|FG002|Induction Period|Given prohibited drug|2|||
164532736|NCT00406653|594322119|FG003|Induction Period|Given prohibited drug|0|||
164532737|NCT00406653|594322120|FG004|Induction Period|Given prohibited drug|0|||
164532738|NCT00406653|594322121|FG005|Induction Period|Given prohibited drug|0|||
164532739|NCT00406653|594322122|FG006|Induction Period|Given prohibited drug|0|||
164532740|NCT00406653|594322116|FG000|Induction Period|Incarcerated|0|||
164532741|NCT00406653|594322117|FG001|Induction Period|Incarcerated|0|||
164532742|NCT00406653|594322118|FG002|Induction Period|Incarcerated|1|||
164532743|NCT00406653|594322119|FG003|Induction Period|Incarcerated|0|||
164532744|NCT00406653|594322120|FG004|Induction Period|Incarcerated|0|||
164532745|NCT00406653|594322121|FG005|Induction Period|Incarcerated|0|||
164532746|NCT00406653|594322122|FG006|Induction Period|Incarcerated|0|||
164532747|NCT00406653|594322116|FG000|Induction Period|Patient relocated|0|||
164532748|NCT00406653|594322117|FG001|Induction Period|Patient relocated|0|||
164532749|NCT00406653|594322118|FG002|Induction Period|Patient relocated|1|||
164532750|NCT00406653|594322119|FG003|Induction Period|Patient relocated|0|||
164532751|NCT00406653|594322120|FG004|Induction Period|Patient relocated|0|||
164532752|NCT00406653|594322121|FG005|Induction Period|Patient relocated|0|||
164532753|NCT00406653|594322122|FG006|Induction Period|Patient relocated|0|||
164532754|NCT00406653|594322116|FG000|Maintenance Period|Adverse Event|0|||
164532755|NCT00406653|594322117|FG001|Maintenance Period|Adverse Event|0|||
164532756|NCT00406653|594322118|FG002|Maintenance Period|Adverse Event|0|||
164532757|NCT00406653|594322119|FG003|Maintenance Period|Adverse Event|0|||
164532758|NCT00406653|594322120|FG004|Maintenance Period|Adverse Event|1|||
164532759|NCT00406653|594322121|FG005|Maintenance Period|Adverse Event|1|||
164532760|NCT00406653|594322122|FG006|Maintenance Period|Adverse Event|0|||
164532761|NCT00406653|594322116|FG000|Maintenance Period|Lack of Efficacy|0|||
164532762|NCT00406653|594322117|FG001|Maintenance Period|Lack of Efficacy|0|||
164532763|NCT00406653|594322118|FG002|Maintenance Period|Lack of Efficacy|0|||
164532764|NCT00406653|594322119|FG003|Maintenance Period|Lack of Efficacy|0|||
164532765|NCT00406653|594322120|FG004|Maintenance Period|Lack of Efficacy|20|||
164532766|NCT00406653|594322121|FG005|Maintenance Period|Lack of Efficacy|26|||
164532767|NCT00406653|594322122|FG006|Maintenance Period|Lack of Efficacy|0|||
164532768|NCT00406653|594322116|FG000|Maintenance Period|Lost to Follow-up|0|||
164532769|NCT00406653|594322117|FG001|Maintenance Period|Lost to Follow-up|0|||
164532770|NCT00406653|594322118|FG002|Maintenance Period|Lost to Follow-up|0|||
164532771|NCT00406653|594322119|FG003|Maintenance Period|Lost to Follow-up|0|||
164532772|NCT00406653|594322120|FG004|Maintenance Period|Lost to Follow-up|2|||
164532773|NCT00406653|594322121|FG005|Maintenance Period|Lost to Follow-up|1|||
164647871|NCT02508649|594736634|FG002|Overall Study|Investigator withdrew the subject|1|||
164647872|NCT02508649|594736635|FG003|Overall Study|Investigator withdrew the subject|0|||
164647873|NCT02508649|594736632|FG000|Overall Study|Post randomization screening failure|12|||
164647874|NCT02508649|594736633|FG001|Overall Study|Post randomization screening failure|4|||
164647875|NCT02508649|594736634|FG002|Overall Study|Post randomization screening failure|9|||
164647876|NCT02508649|594736635|FG003|Overall Study|Post randomization screening failure|3|||
164647877|NCT02508649|594736632|FG000|Overall Study|Lost to Follow-up|1|||
164647878|NCT02508649|594736633|FG001|Overall Study|Lost to Follow-up|1|||
164647879|NCT02508649|594736634|FG002|Overall Study|Lost to Follow-up|0|||
164647880|NCT02508649|594736635|FG003|Overall Study|Lost to Follow-up|1|||
164647881|NCT00446134|594736636|FG000|Overall Study|Adverse Event|7|||
164647882|NCT00446134|594736637|FG001|Overall Study|Adverse Event|17|||
164303244|NCT01106690|593486442|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
164647883|NCT00446134|594736638|FG002|Overall Study|Adverse Event|13|||
164647884|NCT00446134|594736639|FG003|Overall Study|Adverse Event|18|||
164647885|NCT00446134|594736636|FG000|Overall Study|Lack of Efficacy|19|||
164647886|NCT00446134|594736637|FG001|Overall Study|Lack of Efficacy|19|||
164647887|NCT00446134|594736638|FG002|Overall Study|Lack of Efficacy|24|||
164532774|NCT00406653|594322122|FG006|Maintenance Period|Lost to Follow-up|0|||
164532775|NCT00406653|594322116|FG000|Maintenance Period|Withdrawal of Consent|0|||
164647888|NCT00446134|594736639|FG003|Overall Study|Lack of Efficacy|19|||
164647889|NCT00446134|594736636|FG000|Overall Study|Protocol Violation|0|||
164647890|NCT00446134|594736637|FG001|Overall Study|Protocol Violation|2|||
164647891|NCT00446134|594736638|FG002|Overall Study|Protocol Violation|1|||
164647892|NCT00446134|594736639|FG003|Overall Study|Protocol Violation|0|||
164647893|NCT00446134|594736636|FG000|Overall Study|Lost to Follow-up|1|||
164647894|NCT00446134|594736637|FG001|Overall Study|Lost to Follow-up|3|||
164532776|NCT00406653|594322117|FG001|Maintenance Period|Withdrawal of Consent|0|||
164532777|NCT00406653|594322118|FG002|Maintenance Period|Withdrawal of Consent|0|||
164532778|NCT00406653|594322119|FG003|Maintenance Period|Withdrawal of Consent|0|||
164532779|NCT00406653|594322120|FG004|Maintenance Period|Withdrawal of Consent|2|||
164532780|NCT00406653|594322121|FG005|Maintenance Period|Withdrawal of Consent|0|||
164532781|NCT00406653|594322122|FG006|Maintenance Period|Withdrawal of Consent|0|||
164532782|NCT00406653|594322116|FG000|Maintenance Period|Pregnancy|0|||
164532783|NCT00406653|594322117|FG001|Maintenance Period|Pregnancy|0|||
164532784|NCT00406653|594322118|FG002|Maintenance Period|Pregnancy|0|||
164532785|NCT00406653|594322119|FG003|Maintenance Period|Pregnancy|0|||
164532786|NCT00406653|594322120|FG004|Maintenance Period|Pregnancy|0|||
164532787|NCT00406653|594322121|FG005|Maintenance Period|Pregnancy|1|||
164532788|NCT00406653|594322122|FG006|Maintenance Period|Pregnancy|0|||
164532789|NCT00406653|594322116|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
164532790|NCT00406653|594322117|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
164532791|NCT00406653|594322118|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
164532792|NCT00406653|594322119|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
164532793|NCT00406653|594322120|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
164532794|NCT00406653|594322121|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
164532795|NCT00406653|594322122|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
164532796|NCT00406653|594322116|FG000|Maintenance Period|Error in disease score evaluation|0|||
164532797|NCT00406653|594322117|FG001|Maintenance Period|Error in disease score evaluation|0|||
164532798|NCT00406653|594322118|FG002|Maintenance Period|Error in disease score evaluation|0|||
164532799|NCT00406653|594322119|FG003|Maintenance Period|Error in disease score evaluation|0|||
164532800|NCT00406653|594322120|FG004|Maintenance Period|Error in disease score evaluation|1|||
164532801|NCT00406653|594322121|FG005|Maintenance Period|Error in disease score evaluation|0|||
164532802|NCT00406653|594322122|FG006|Maintenance Period|Error in disease score evaluation|0|||
164532803|NCT00406653|594322116|FG000|Open-Label Period|Death|0|||
164532804|NCT00406653|594322117|FG001|Open-Label Period|Death|0|||
164532805|NCT00406653|594322118|FG002|Open-Label Period|Death|0|||
164532806|NCT00406653|594322119|FG003|Open-Label Period|Death|0|||
164532807|NCT00406653|594322120|FG004|Open-Label Period|Death|0|||
164532808|NCT00406653|594322121|FG005|Open-Label Period|Death|0|||
164532809|NCT00406653|594322122|FG006|Open-Label Period|Death|1|||
164532810|NCT00406653|594322116|FG000|Open-Label Period|Adverse Event|0|||
164532811|NCT00406653|594322117|FG001|Open-Label Period|Adverse Event|0|||
164532812|NCT00406653|594322118|FG002|Open-Label Period|Adverse Event|0|||
164532813|NCT00406653|594322119|FG003|Open-Label Period|Adverse Event|0|||
164532814|NCT00406653|594322120|FG004|Open-Label Period|Adverse Event|0|||
164532815|NCT00406653|594322121|FG005|Open-Label Period|Adverse Event|0|||
164532816|NCT00406653|594322122|FG006|Open-Label Period|Adverse Event|18|||
164532817|NCT00406653|594322116|FG000|Open-Label Period|Lack of Efficacy|0|||
164532818|NCT00406653|594322117|FG001|Open-Label Period|Lack of Efficacy|0|||
164532819|NCT00406653|594322118|FG002|Open-Label Period|Lack of Efficacy|0|||
164532820|NCT00406653|594322119|FG003|Open-Label Period|Lack of Efficacy|0|||
164532821|NCT00406653|594322120|FG004|Open-Label Period|Lack of Efficacy|0|||
164532822|NCT00406653|594322121|FG005|Open-Label Period|Lack of Efficacy|0|||
164532823|NCT00406653|594322122|FG006|Open-Label Period|Lack of Efficacy|160|||
164532824|NCT00406653|594322116|FG000|Open-Label Period|Lost to Follow-up|0|||
164532825|NCT00406653|594322117|FG001|Open-Label Period|Lost to Follow-up|0|||
164532826|NCT00406653|594322118|FG002|Open-Label Period|Lost to Follow-up|0|||
164532827|NCT00406653|594322119|FG003|Open-Label Period|Lost to Follow-up|0|||
164532828|NCT00406653|594322120|FG004|Open-Label Period|Lost to Follow-up|0|||
164532829|NCT00406653|594322121|FG005|Open-Label Period|Lost to Follow-up|0|||
164303245|NCT01106690|593486443|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
164303246|NCT01106690|593486441|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
164532830|NCT00406653|594322122|FG006|Open-Label Period|Lost to Follow-up|6|||
164532831|NCT00406653|594322116|FG000|Open-Label Period|Withdrawal of Consent|0|||
164532832|NCT00406653|594322117|FG001|Open-Label Period|Withdrawal of Consent|0|||
164532833|NCT00406653|594322118|FG002|Open-Label Period|Withdrawal of Consent|0|||
164532834|NCT00406653|594322119|FG003|Open-Label Period|Withdrawal of Consent|0|||
164532835|NCT00406653|594322120|FG004|Open-Label Period|Withdrawal of Consent|0|||
164532836|NCT00406653|594322121|FG005|Open-Label Period|Withdrawal of Consent|0|||
164532837|NCT00406653|594322122|FG006|Open-Label Period|Withdrawal of Consent|11|||
164532838|NCT00406653|594322116|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
164532839|NCT00406653|594322117|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
164532840|NCT00406653|594322118|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
164532841|NCT00406653|594322119|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
164532842|NCT00406653|594322120|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
164532843|NCT00406653|594322121|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
164532844|NCT00406653|594322122|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
164532845|NCT00406653|594322116|FG000|Open-Label Period|Pregnancy|0|||
164532846|NCT00406653|594322117|FG001|Open-Label Period|Pregnancy|0|||
164532847|NCT00406653|594322118|FG002|Open-Label Period|Pregnancy|0|||
164303247|NCT01106690|593486442|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
164303248|NCT01106690|593486443|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
164303249|NCT01106690|593486441|FG000|Extension Period: Week 26 to Week 52|Other|8|||
164303250|NCT01106690|593486442|FG001|Extension Period: Week 26 to Week 52|Other|3|||
164303251|NCT01106690|593486443|FG002|Extension Period: Week 26 to Week 52|Other|4|||
164303252|NCT01106690|593486441|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
164303253|NCT01106690|593486442|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
164303254|NCT01106690|593486443|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
164303255|NCT04455815|593486444|FG000|Randomisation Phase|Adverse Event|1|||
164303256|NCT04455815|593486445|FG001|Randomisation Phase|Adverse Event|0|||
164303257|NCT04455815|593486444|FG000|Treatment Phase|Adverse Event|0|||
164303258|NCT04455815|593486445|FG001|Treatment Phase|Adverse Event|1|||
164303259|NCT04455815|593486444|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
164303260|NCT04455815|593486445|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
164303261|NCT04455815|593486444|FG000|Treatment Phase|Withdrawal by Subject|1|||
164303262|NCT04455815|593486445|FG001|Treatment Phase|Withdrawal by Subject|1|||
164303263|NCT03219528|593486450|FG000|Overall Study|Lost to Follow-up|5|||
164303264|NCT03219528|593486451|FG001|Overall Study|Lost to Follow-up|4|||
164303265|NCT03219528|593486450|FG000|Overall Study|Withdrawal by Subject|4|||
164303266|NCT03219528|593486451|FG001|Overall Study|Withdrawal by Subject|4|||
164303267|NCT03809104|593486452|FG000|Overall Study|Withdrawal by Subject|3|||
164303268|NCT00790842|593486453|FG000|Dose Level 1|Adverse Event|1|||
164303269|NCT00790842|593486454|FG001|Dose Level 1|Adverse Event|0|||
164303270|NCT00790842|593486455|FG002|Dose Level 1|Adverse Event|0|||
164303271|NCT00790842|593486456|FG003|Dose Level 1|Adverse Event|2|||
164303272|NCT00790842|593486457|FG004|Dose Level 1|Adverse Event|0|||
164303273|NCT00790842|593486458|FG005|Dose Level 1|Adverse Event|0|||
164532848|NCT00406653|594322119|FG003|Open-Label Period|Pregnancy|0|||
164532849|NCT00406653|594322120|FG004|Open-Label Period|Pregnancy|0|||
164532850|NCT00406653|594322121|FG005|Open-Label Period|Pregnancy|0|||
164532851|NCT00406653|594322122|FG006|Open-Label Period|Pregnancy|2|||
164532852|NCT00406653|594322116|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
164532853|NCT00406653|594322117|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
164532854|NCT00406653|594322118|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
164532855|NCT00406653|594322119|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
164532856|NCT00406653|594322120|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
164532857|NCT00406653|594322121|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
164532858|NCT00406653|594322122|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
164532859|NCT00406653|594322116|FG000|Open-Label Period|Declined participation but followup done|0|||
164532860|NCT00406653|594322117|FG001|Open-Label Period|Declined participation but followup done|0|||
164532861|NCT00406653|594322118|FG002|Open-Label Period|Declined participation but followup done|0|||
164532862|NCT00406653|594322119|FG003|Open-Label Period|Declined participation but followup done|0|||
164532863|NCT00406653|594322120|FG004|Open-Label Period|Declined participation but followup done|0|||
164532864|NCT00406653|594322121|FG005|Open-Label Period|Declined participation but followup done|0|||
164532865|NCT00406653|594322122|FG006|Open-Label Period|Declined participation but followup done|8|||
164532866|NCT00406653|594322116|FG000|Open-Label Period|Discontinued by Sponsor|0|||
164532867|NCT00406653|594322117|FG001|Open-Label Period|Discontinued by Sponsor|0|||
164532868|NCT00406653|594322118|FG002|Open-Label Period|Discontinued by Sponsor|0|||
164532869|NCT00406653|594322119|FG003|Open-Label Period|Discontinued by Sponsor|0|||
164532870|NCT00406653|594322120|FG004|Open-Label Period|Discontinued by Sponsor|0|||
164532871|NCT00406653|594322121|FG005|Open-Label Period|Discontinued by Sponsor|0|||
164532872|NCT00406653|594322122|FG006|Open-Label Period|Discontinued by Sponsor|1|||
164532873|NCT00406653|594322116|FG000|Open-Label Period|Refused followup|0|||
164532874|NCT00406653|594322117|FG001|Open-Label Period|Refused followup|0|||
164532875|NCT00406653|594322118|FG002|Open-Label Period|Refused followup|0|||
164532876|NCT00406653|594322119|FG003|Open-Label Period|Refused followup|0|||
164532877|NCT00406653|594322120|FG004|Open-Label Period|Refused followup|0|||
164532878|NCT00406653|594322121|FG005|Open-Label Period|Refused followup|0|||
164532879|NCT00406653|594322122|FG006|Open-Label Period|Refused followup|1|||
164532880|NCT00446992|594322123|FG000|Overall Study|Adverse Event|11|||
164532881|NCT00446992|594322123|FG000|Overall Study|Lost to Follow-up|5|||
164532882|NCT00731120|594322124|FG000|Overall Study|Adverse Event|7|||
164532883|NCT00731120|594322125|FG001|Overall Study|Adverse Event|6|||
164303274|NCT00790842|593486459|FG006|Dose Level 1|Adverse Event|0|||
164303275|NCT00790842|593486460|FG007|Dose Level 1|Adverse Event|1|||
164303276|NCT00790842|593486461|FG008|Dose Level 1|Adverse Event|0|||
164303277|NCT00790842|593486462|FG009|Dose Level 1|Adverse Event|0|||
164303278|NCT00790842|593486463|FG010|Dose Level 1|Adverse Event|0|||
164303279|NCT00790842|593486453|FG000|Dose Level 1|Physician Decision|1|||
164303280|NCT00790842|593486454|FG001|Dose Level 1|Physician Decision|0|||
164303281|NCT00790842|593486455|FG002|Dose Level 1|Physician Decision|0|||
164532884|NCT00731120|594322126|FG002|Overall Study|Adverse Event|8|||
164532885|NCT00731120|594322124|FG000|Overall Study|Lack of Efficacy|4|||
164532886|NCT00731120|594322125|FG001|Overall Study|Lack of Efficacy|5|||
164532887|NCT00731120|594322126|FG002|Overall Study|Lack of Efficacy|4|||
164532888|NCT00731120|594322124|FG000|Overall Study|Noncompliance with Study Drug|3|||
164532889|NCT00731120|594322125|FG001|Overall Study|Noncompliance with Study Drug|3|||
164532890|NCT00731120|594322126|FG002|Overall Study|Noncompliance with Study Drug|1|||
164532891|NCT00731120|594322124|FG000|Overall Study|Protocol Deviations|1|||
164532892|NCT00731120|594322125|FG001|Overall Study|Protocol Deviations|6|||
164532893|NCT00731120|594322126|FG002|Overall Study|Protocol Deviations|1|||
164532894|NCT00731120|594322124|FG000|Overall Study|Withdrawal of Consent|13|||
164532895|NCT00731120|594322125|FG001|Overall Study|Withdrawal of Consent|8|||
164532896|NCT00731120|594322126|FG002|Overall Study|Withdrawal of Consent|4|||
164532897|NCT00731120|594322124|FG000|Overall Study|Lost to Follow-up|10|||
164532898|NCT00731120|594322125|FG001|Overall Study|Lost to Follow-up|15|||
164532899|NCT00731120|594322126|FG002|Overall Study|Lost to Follow-up|17|||
164532900|NCT00731120|594322124|FG000|Overall Study|Other|4|||
164532901|NCT00731120|594322125|FG001|Overall Study|Other|0|||
164532902|NCT00731120|594322126|FG002|Overall Study|Other|1|||
164532903|NCT02349360|594322127|FG000|Overall Study|Withdrawal by Subject|0|||
164532904|NCT02349360|594322128|FG001|Overall Study|Withdrawal by Subject|1|||
164532905|NCT01971203|594322133|FG000|Overall Study|Protocol Violation|3|||
164647895|NCT00446134|594736638|FG002|Overall Study|Lost to Follow-up|1|||
164647896|NCT00446134|594736639|FG003|Overall Study|Lost to Follow-up|1|||
164647897|NCT00446134|594736636|FG000|Overall Study|Withdrawal by Subject|3|||
164647898|NCT00446134|594736637|FG001|Overall Study|Withdrawal by Subject|3|||
164647899|NCT00446134|594736638|FG002|Overall Study|Withdrawal by Subject|1|||
164647900|NCT00446134|594736639|FG003|Overall Study|Withdrawal by Subject|3|||
164647901|NCT00446134|594736636|FG000|Overall Study|Physician Decision|0|||
164647902|NCT00446134|594736637|FG001|Overall Study|Physician Decision|0|||
164647903|NCT00446134|594736638|FG002|Overall Study|Physician Decision|0|||
164647904|NCT00446134|594736639|FG003|Overall Study|Physician Decision|2|||
164647905|NCT00446134|594736636|FG000|Overall Study|Adverse Event-Diarrhea|1|||
164647906|NCT00446134|594736637|FG001|Overall Study|Adverse Event-Diarrhea|1|||
164647907|NCT00446134|594736638|FG002|Overall Study|Adverse Event-Diarrhea|2|||
164647908|NCT00446134|594736639|FG003|Overall Study|Adverse Event-Diarrhea|0|||
164647909|NCT00446134|594736636|FG000|Overall Study|Reason Not Completed|3|||
164647910|NCT00446134|594736637|FG001|Overall Study|Reason Not Completed|0|||
164647911|NCT00446134|594736638|FG002|Overall Study|Reason Not Completed|1|||
164647912|NCT00446134|594736639|FG003|Overall Study|Reason Not Completed|2|||
164647913|NCT00567996|594736643|FG000|Overall Study|Adverse Event|18|||
164647914|NCT00567996|594736644|FG001|Overall Study|Adverse Event|16|||
164647915|NCT00567996|594736645|FG002|Overall Study|Adverse Event|13|||
164647916|NCT00567996|594736643|FG000|Overall Study|Protocol Deviation|9|||
164647917|NCT00567996|594736644|FG001|Overall Study|Protocol Deviation|11|||
164647918|NCT00567996|594736645|FG002|Overall Study|Protocol Deviation|13|||
164647919|NCT00567996|594736643|FG000|Overall Study|Withdrawal by Subject|8|||
164647920|NCT00567996|594736644|FG001|Overall Study|Withdrawal by Subject|12|||
164647921|NCT00567996|594736645|FG002|Overall Study|Withdrawal by Subject|22|||
164647922|NCT00567996|594736643|FG000|Overall Study|Abnormal Lab value(s)|2|||
164647923|NCT00567996|594736644|FG001|Overall Study|Abnormal Lab value(s)|1|||
164647924|NCT00567996|594736645|FG002|Overall Study|Abnormal Lab value(s)|2|||
164647925|NCT00567996|594736643|FG000|Overall Study|Abnormal test procedure result(s)|2|||
164647926|NCT00567996|594736644|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164647927|NCT00567996|594736645|FG002|Overall Study|Abnormal test procedure result(s)|1|||
164647928|NCT00567996|594736643|FG000|Overall Study|Lost to Follow-up|2|||
164647929|NCT00567996|594736644|FG001|Overall Study|Lost to Follow-up|5|||
164647930|NCT00567996|594736645|FG002|Overall Study|Lost to Follow-up|2|||
164647931|NCT00567996|594736643|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164647932|NCT00567996|594736644|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164647933|NCT00567996|594736645|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
164647934|NCT00567996|594736643|FG000|Overall Study|Administrative problems|1|||
164647935|NCT00567996|594736644|FG001|Overall Study|Administrative problems|1|||
164647936|NCT00567996|594736645|FG002|Overall Study|Administrative problems|0|||
164647937|NCT00567996|594736643|FG000|Overall Study|Death|1|||
164647938|NCT00567996|594736644|FG001|Overall Study|Death|0|||
164647939|NCT00567996|594736645|FG002|Overall Study|Death|2|||
164647940|NCT00567996|594736643|FG000|Overall Study|Patient's inability to use the device|0|||
164532906|NCT01971203|594322134|FG001|Overall Study|Protocol Violation|2|||
164647941|NCT00567996|594736644|FG001|Overall Study|Patient's inability to use the device|1|||
164647942|NCT00567996|594736645|FG002|Overall Study|Patient's inability to use the device|0|||
164647943|NCT02956005|594736647|FG000|Overall Study|Not eligible|1|||
164647944|NCT02956005|594736647|FG000|Overall Study|Withdrawal by Subject|3|||
164647945|NCT02956005|594736647|FG000|Overall Study|Physician Decision|12|||
164647946|NCT03125629|594736648|FG000|Overall Study|Withdrawal by Subject|2|||
164647947|NCT03125629|594736648|FG000|Overall Study|Equipment malfunction|1|||
164647948|NCT00743119|594736649|FG000|Overall Study|unreliable|3|||
164532907|NCT01971203|594322133|FG000|Overall Study|Withdrawal by Subject|5|||
164532908|NCT01971203|594322134|FG001|Overall Study|Withdrawal by Subject|6|||
164647949|NCT00743119|594736649|FG000|Overall Study|Withdrawal by Subject|1|||
164647950|NCT02524665|594736650|FG000|Overall Study|Lost to Follow-up|1|||
164647951|NCT02989610|594736651|FG000|Overall Study|Withdrawal by Subject|20|||
164647952|NCT02989610|594736651|FG000|Overall Study|Departure of PI from Site|8|||
164647953|NCT02989610|594736651|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
164647954|NCT02989610|594736651|FG000|Overall Study|Lost to Follow-up|3|||
164647955|NCT02989610|594736651|FG000|Overall Study|Death|3|||
164647956|NCT02989610|594736651|FG000|Overall Study|System Explant|3|||
164647957|NCT02989610|594736651|FG000|Overall Study|Subject Non-Compliance|2|||
164647958|NCT02989610|594736651|FG000|Overall Study|System Revision|2|||
164647959|NCT02989610|594736651|FG000|Overall Study|PI Left, Study Closing|1|||
164647960|NCT02989610|594736651|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
164647961|NCT02989610|594736651|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
164647962|NCT02602080|594736657|FG000|Overall Study|Protocol Violation|6|||
164647963|NCT02602080|594736658|FG001|Overall Study|Protocol Violation|1|||
164647964|NCT02602080|594736659|FG002|Overall Study|Protocol Violation|3|||
164647965|NCT01066039|594736664|FG000|Overall Study|Adverse Event|6|||
164647966|NCT01066039|594736664|FG000|Overall Study|Withdrawal by Subject|17|||
164647967|NCT01066039|594736664|FG000|Overall Study|Protocol Violation|2|||
164647968|NCT01066039|594736664|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
164647969|NCT01066039|594736664|FG000|Overall Study|Investigator's Request|1|||
164647970|NCT01066039|594736664|FG000|Overall Study|Dropout due to Insulin Administration|1|||
164647971|NCT01066039|594736664|FG000|Overall Study|Additional Antihypertensive Required|4|||
164647972|NCT01066039|594736664|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
164647973|NCT01066039|594736664|FG000|Overall Study|Failure to Control Blood Pressure|1|||
164647974|NCT01066039|594736664|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
164647975|NCT02574260|594736665|FG000|Overall Study|Disease Progression|1|||
164647976|NCT04508621|594736666|FG000|Overall Study|Adverse Event|39|||
164647977|NCT04508621|594736667|FG001|Overall Study|Adverse Event|16|||
164647978|NCT04508621|594736666|FG000|Overall Study|Lack of Efficacy|2|||
164647979|NCT04508621|594736667|FG001|Overall Study|Lack of Efficacy|8|||
164647980|NCT04508621|594736666|FG000|Overall Study|Physician Decision|0|||
164647981|NCT04508621|594736667|FG001|Overall Study|Physician Decision|1|||
164647982|NCT04508621|594736666|FG000|Overall Study|Withdrawal by Subject|10|||
164647983|NCT04508621|594736667|FG001|Overall Study|Withdrawal by Subject|14|||
164647984|NCT04508621|594736666|FG000|Overall Study|Lost to Follow-up|12|||
164647985|NCT04508621|594736667|FG001|Overall Study|Lost to Follow-up|9|||
164647986|NCT04508621|594736666|FG000|Overall Study|COVID-19 related crisis|3|||
164647987|NCT04508621|594736667|FG001|Overall Study|COVID-19 related crisis|0|||
164647988|NCT04508621|594736666|FG000|Overall Study|Subject non-compliance|1|||
164647989|NCT04508621|594736667|FG001|Overall Study|Subject non-compliance|0|||
164647990|NCT00752895|594736668|FG000|Overall Study|Withdrawal by Subject|8|||
164647991|NCT00752895|594736669|FG001|Overall Study|Withdrawal by Subject|3|||
164647992|NCT03022799|594736670|FG000|Overall Study|Adverse Event|0|||
164647993|NCT03022799|594736671|FG001|Overall Study|Adverse Event|0|||
164647994|NCT03022799|594736672|FG002|Overall Study|Adverse Event|0|||
164647995|NCT03022799|594736673|FG003|Overall Study|Adverse Event|0|||
164647996|NCT03022799|594736674|FG004|Overall Study|Adverse Event|0|||
164647997|NCT03022799|594736675|FG005|Overall Study|Adverse Event|0|||
164647998|NCT03022799|594736676|FG006|Overall Study|Adverse Event|0|||
164647999|NCT03022799|594736677|FG007|Overall Study|Adverse Event|0|||
164648000|NCT03022799|594736678|FG008|Overall Study|Adverse Event|0|||
164648001|NCT03022799|594736679|FG009|Overall Study|Adverse Event|1|||
164648002|NCT03022799|594736680|FG010|Overall Study|Adverse Event|1|||
164648003|NCT03022799|594736681|FG011|Overall Study|Adverse Event|0|||
164648004|NCT03022799|594736682|FG012|Overall Study|Adverse Event|0|||
164648005|NCT04881448|594736683|FG000|Overall Study|Study cancelled by sponsor|220|||
164648006|NCT04881448|594736683|FG000|Overall Study|Withdrawal by Subject|2|||
164648007|NCT04881448|594736683|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
164648008|NCT01966107|594736685|FG000|Overall Study|excluded from FAS|21|||
164648009|NCT01966107|594736686|FG001|Overall Study|excluded from FAS|20|||
164648010|NCT01966107|594736685|FG000|Overall Study|discontinued treatment|345|||
164648011|NCT01966107|594736686|FG001|Overall Study|discontinued treatment|372|||
164648012|NCT01966107|594736685|FG000|Overall Study|due to study closure|164|||
164648013|NCT01966107|594736686|FG001|Overall Study|due to study closure|186|||
164648014|NCT01966107|594736685|FG000|Overall Study|withdrew from the study|272|||
164648015|NCT01966107|594736686|FG001|Overall Study|withdrew from the study|303|||
164648016|NCT02200614|594736687|FG000|Double Blind Treatment|Adverse Event|86|||
164648017|NCT02200614|594736688|FG001|Double Blind Treatment|Adverse Event|48|||
164648018|NCT02200614|594736687|FG000|Double Blind Treatment|Confirmed metastasis|120|||
164648019|NCT02200614|594736688|FG001|Double Blind Treatment|Confirmed metastasis|140|||
164648020|NCT02200614|594736687|FG000|Double Blind Treatment|Judgment of the investigator|59|||
164648021|NCT02200614|594736688|FG001|Double Blind Treatment|Judgment of the investigator|99|||
164648022|NCT02200614|594736687|FG000|Double Blind Treatment|Metastasis by local reading|1|||
164648023|NCT02200614|594736688|FG001|Double Blind Treatment|Metastasis by local reading|3|||
164648024|NCT02200614|594736687|FG000|Double Blind Treatment|Other reason|6|||
164648025|NCT02200614|594736688|FG001|Double Blind Treatment|Other reason|2|||
164648026|NCT02200614|594736687|FG000|Double Blind Treatment|Personal reason|77|||
164648027|NCT02200614|594736688|FG001|Double Blind Treatment|Personal reason|85|||
164648028|NCT02200614|594736687|FG000|Double Blind Treatment|Protocol deviation|14|||
164648029|NCT02200614|594736688|FG001|Double Blind Treatment|Protocol deviation|7|||
164648030|NCT02200614|594736687|FG000|Double Blind Treatment|Not treated|1|||
164648031|NCT02200614|594736688|FG001|Double Blind Treatment|Not treated|0|||
164648032|NCT02200614|594736687|FG000|Open Label|Adverse Event|41|||
164648033|NCT02200614|594736688|FG001|Open Label|Adverse Event|11|||
164648034|NCT02200614|594736687|FG000|Open Label|Confirmed metastasis|1|||
164648035|NCT02200614|594736688|FG001|Open Label|Confirmed metastasis|0|||
164648036|NCT02200614|594736687|FG000|Open Label|Judgment of the investigator|29|||
164648037|NCT02200614|594736688|FG001|Open Label|Judgment of the investigator|2|||
164648038|NCT02200614|594736687|FG000|Open Label|Metastasis by local reading|138|||
164648039|NCT02200614|594736688|FG001|Open Label|Metastasis by local reading|27|||
164648040|NCT02200614|594736687|FG000|Open Label|Other reason|22|||
164648041|NCT02200614|594736688|FG001|Open Label|Other reason|4|||
164648042|NCT02200614|594736687|FG000|Open Label|Personal reason|60|||
164648043|NCT02200614|594736688|FG001|Open Label|Personal reason|8|||
164648044|NCT02200614|594736687|FG000|Open Label|Protocol deviation|3|||
164648045|NCT02200614|594736688|FG001|Open Label|Protocol deviation|2|||
164648046|NCT02200614|594736687|FG000|Open Label|Missing|2|||
164648047|NCT02200614|594736688|FG001|Open Label|Missing|2|||
164648048|NCT02531698|594736694|FG000|Overall Study|Adverse Event|2|||
164648049|NCT02531698|594736695|FG001|Overall Study|Adverse Event|1|||
164648050|NCT02531698|594736694|FG000|Overall Study|Withdrawal by Subject|6|||
164648051|NCT02531698|594736695|FG001|Overall Study|Withdrawal by Subject|1|||
164648052|NCT02531698|594736694|FG000|Overall Study|Protocol Violation|2|||
164648053|NCT02531698|594736695|FG001|Overall Study|Protocol Violation|0|||
164648054|NCT02531698|594736694|FG000|Overall Study|Lost to Follow-up|1|||
164648055|NCT02531698|594736695|FG001|Overall Study|Lost to Follow-up|0|||
164648056|NCT01861717|594736696|FG000|Overall Study|Lost to Follow-up|1|||
164648057|NCT01861717|594736696|FG000|Overall Study|Withdrawal by Subject|1|||
164648058|NCT02395536|594736700|FG000|Overall Study|Lost to Follow-up|4|||
164648059|NCT02395536|594736701|FG001|Overall Study|Lost to Follow-up|4|||
164648060|NCT02395536|594736700|FG000|Overall Study|Death|2|||
164648061|NCT02395536|594736701|FG001|Overall Study|Death|0|||
164648062|NCT02395536|594736700|FG000|Overall Study|Physician Decision|4|||
164648063|NCT02395536|594736701|FG001|Overall Study|Physician Decision|6|||
164648064|NCT02395536|594736700|FG000|Overall Study|Withdrawal by Subject|9|||
164648065|NCT02395536|594736701|FG001|Overall Study|Withdrawal by Subject|17|||
164648066|NCT02395536|594736700|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
164648067|NCT02395536|594736701|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
164648068|NCT02395536|594736700|FG000|Overall Study|Insurance issue|0|||
164648069|NCT02395536|594736701|FG001|Overall Study|Insurance issue|1|||
164694615|NCT00442546|594903088|FG002|Overall Study|Withdrawal by Subject|7|||
164694616|NCT00442546|594903086|FG000|Overall Study|Randomized But Not Treated|5|||
164694617|NCT00442546|594903087|FG001|Overall Study|Randomized But Not Treated|4|||
164694618|NCT00442546|594903088|FG002|Overall Study|Randomized But Not Treated|6|||
164694619|NCT01253317|594903091|FG000|Overall Study|Adverse Event|2|||
164694620|NCT03183141|594903092|FG000|Overall Study|Withdrawal by Subject|2|||
164303282|NCT00790842|593486456|FG003|Dose Level 1|Physician Decision|0|||
164694621|NCT03183141|594903093|FG001|Overall Study|Withdrawal by Subject|4|||
164694622|NCT03183141|594903092|FG000|Overall Study|Death|0|||
164694623|NCT03183141|594903093|FG001|Overall Study|Death|8|||
164694624|NCT01507090|594903097|FG000|Overall Study|incomplete dataset|18|||
164694625|NCT00546910|594905294|FG000|Overall Study|Adverse Event|2|||
164694626|NCT00546910|594905295|FG001|Overall Study|Adverse Event|3|||
164694627|NCT00546910|594905294|FG000|Overall Study|Lack of Efficacy|5|||
164694628|NCT00546910|594905295|FG001|Overall Study|Lack of Efficacy|7|||
164694629|NCT00546910|594905294|FG000|Overall Study|Physician Decision|0|||
164694630|NCT00546910|594905295|FG001|Overall Study|Physician Decision|1|||
164694631|NCT00546910|594905294|FG000|Overall Study|Withdrawal by Subject|2|||
164694632|NCT00546910|594905295|FG001|Overall Study|Withdrawal by Subject|0|||
164694633|NCT01301482|594905296|FG000|Overall Study|Withdrawal by Subject|1|||
164694634|NCT04039919|594905302|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164694635|NCT04039919|594905303|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164694636|NCT04039919|594905304|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164694637|NCT04039919|594905305|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164694638|NCT04039919|594905306|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164694639|NCT04039919|594905302|FG000|Treatment Period 1|Sponsor's decision|0|||
164694640|NCT04039919|594905303|FG001|Treatment Period 1|Sponsor's decision|0|||
164694641|NCT04039919|594905304|FG002|Treatment Period 1|Sponsor's decision|0|||
164694642|NCT04039919|594905305|FG003|Treatment Period 1|Sponsor's decision|0|||
164694643|NCT04039919|594905306|FG004|Treatment Period 1|Sponsor's decision|16|||
164694644|NCT04039919|594905302|FG000|Treatment Period 5|Withdrawal by Subject|1|||
164694645|NCT04039919|594905303|FG001|Treatment Period 5|Withdrawal by Subject|0|||
164648070|NCT02598622|594738463|FG000|Overall Study|Withdrawal by Subject|3|||
164648071|NCT02598622|594738464|FG001|Overall Study|Withdrawal by Subject|0|||
164648072|NCT02598622|594738463|FG000|Overall Study|Physician Decision|3|||
164648073|NCT02598622|594738464|FG001|Overall Study|Physician Decision|0|||
164648074|NCT01416142|594738467|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
164648075|NCT01416142|594738468|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
164648076|NCT01416142|594738469|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
164648077|NCT02464059|594738470|FG000|Overall Study|Lost to Follow-up|6|||
164648078|NCT02499406|594738473|FG000|Overall Study|missed 3 treatment sessions|4|||
164648079|NCT03591107|594738477|FG000|Overall Study|Same patient in both arms|1|||
164648080|NCT03591107|594738478|FG001|Overall Study|Same patient in both arms|1|||
164648081|NCT03591107|594738477|FG000|Overall Study|Sought care at other clinics|0|||
164648082|NCT03591107|594738478|FG001|Overall Study|Sought care at other clinics|2|||
164648083|NCT03591107|594738477|FG000|Overall Study|Discharged from clinic|0|||
164648084|NCT03591107|594738478|FG001|Overall Study|Discharged from clinic|1|||
164648085|NCT03591107|594738477|FG000|Overall Study|Withdrawal by Subject|0|||
164648086|NCT03591107|594738478|FG001|Overall Study|Withdrawal by Subject|1|||
164648087|NCT00304954|594738479|FG000|Overall Study|Withdrawal by Subject|0|||
164648088|NCT00304954|594738480|FG001|Overall Study|Withdrawal by Subject|0|||
164648089|NCT00304954|594738481|FG002|Overall Study|Withdrawal by Subject|1|||
164648090|NCT00304954|594738482|FG003|Overall Study|Withdrawal by Subject|0|||
164648091|NCT00304954|594738479|FG000|Overall Study|Adverse Event|1|||
164648092|NCT00304954|594738480|FG001|Overall Study|Adverse Event|0|||
164648093|NCT00304954|594738481|FG002|Overall Study|Adverse Event|0|||
164648094|NCT00304954|594738482|FG003|Overall Study|Adverse Event|0|||
164648095|NCT00736099|594738485|FG000|Overall Study|Adverse Event|61|||
164648096|NCT00736099|594738486|FG001|Overall Study|Adverse Event|18|||
164648097|NCT00736099|594738485|FG000|Overall Study|Protocol Violation|10|||
164648098|NCT00736099|594738486|FG001|Overall Study|Protocol Violation|4|||
164648099|NCT00736099|594738485|FG000|Overall Study|Lost to Follow-up|12|||
164648100|NCT00736099|594738486|FG001|Overall Study|Lost to Follow-up|5|||
164648101|NCT00736099|594738485|FG000|Overall Study|Withdrawal by Subject|42|||
164648102|NCT00736099|594738486|FG001|Overall Study|Withdrawal by Subject|13|||
164648103|NCT00736099|594738485|FG000|Overall Study|Lack of Efficacy|15|||
164648104|NCT00736099|594738486|FG001|Overall Study|Lack of Efficacy|8|||
164648105|NCT00736099|594738485|FG000|Overall Study|Other reason|43|||
164648106|NCT00736099|594738486|FG001|Overall Study|Other reason|10|||
164648107|NCT01222715|594738487|FG000|Overall Study|Adverse Event|0|||
164648108|NCT01222715|594738488|FG001|Overall Study|Adverse Event|4|||
164648109|NCT01222715|594738487|FG000|Overall Study|Death|0|||
164648110|NCT01222715|594738488|FG001|Overall Study|Death|1|||
164648111|NCT01222715|594738487|FG000|Overall Study|Lack of Efficacy|22|||
164648112|NCT01222715|594738488|FG001|Overall Study|Lack of Efficacy|14|||
164648113|NCT01222715|594738487|FG000|Overall Study|Physician Decision|12|||
164648114|NCT01222715|594738488|FG001|Overall Study|Physician Decision|2|||
164648115|NCT01222715|594738487|FG000|Overall Study|Refusal of further protocol therapy|0|||
164648116|NCT01222715|594738488|FG001|Overall Study|Refusal of further protocol therapy|4|||
164648117|NCT01222715|594738487|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
164303283|NCT00790842|593486457|FG004|Dose Level 1|Physician Decision|0|||
164303284|NCT00790842|593486458|FG005|Dose Level 1|Physician Decision|0|||
164303285|NCT00790842|593486459|FG006|Dose Level 1|Physician Decision|0|||
164303286|NCT00790842|593486460|FG007|Dose Level 1|Physician Decision|1|||
164303287|NCT00790842|593486461|FG008|Dose Level 1|Physician Decision|0|||
164303288|NCT00790842|593486462|FG009|Dose Level 1|Physician Decision|0|||
164303289|NCT00790842|593486463|FG010|Dose Level 1|Physician Decision|0|||
164303290|NCT00790842|593486453|FG000|Dose Level 1|Withdrawal by Subject|1|||
164648118|NCT01222715|594738488|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
164648119|NCT01222715|594738487|FG000|Overall Study|Ineligible|0|||
164303291|NCT00790842|593486454|FG001|Dose Level 1|Withdrawal by Subject|0|||
164303292|NCT00790842|593486455|FG002|Dose Level 1|Withdrawal by Subject|0|||
164303293|NCT00790842|593486456|FG003|Dose Level 1|Withdrawal by Subject|0|||
164648120|NCT01222715|594738488|FG001|Overall Study|Ineligible|1|||
164648121|NCT01222715|594738487|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
164648122|NCT01222715|594738488|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
164648123|NCT00948025|594738490|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
164648124|NCT00948025|594738491|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
164648125|NCT00948025|594738490|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
164648126|NCT00948025|594738491|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
164303294|NCT00790842|593486457|FG004|Dose Level 1|Withdrawal by Subject|0|||
164303295|NCT00790842|593486458|FG005|Dose Level 1|Withdrawal by Subject|0|||
164303296|NCT00790842|593486459|FG006|Dose Level 1|Withdrawal by Subject|0|||
164648127|NCT00948025|594738490|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
164303297|NCT00790842|593486460|FG007|Dose Level 1|Withdrawal by Subject|0|||
164648128|NCT00948025|594738491|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
164648129|NCT04006847|594738492|FG000|Overall Study|Product issue|1|||
164648130|NCT03555890|594738497|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
164648131|NCT03555890|594738498|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
164648132|NCT03555890|594738499|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
164303298|NCT00790842|593486461|FG008|Dose Level 1|Withdrawal by Subject|0|||
164303299|NCT00790842|593486462|FG009|Dose Level 1|Withdrawal by Subject|0|||
164303300|NCT00790842|593486463|FG010|Dose Level 1|Withdrawal by Subject|0|||
164303301|NCT00790842|593486453|FG000|Dose Level 2|Death|0|||
164303302|NCT00790842|593486454|FG001|Dose Level 2|Death|1|||
164303303|NCT00790842|593486455|FG002|Dose Level 2|Death|0|||
164303304|NCT00790842|593486456|FG003|Dose Level 2|Death|0|||
164303305|NCT00790842|593486457|FG004|Dose Level 2|Death|1|||
164303306|NCT00790842|593486458|FG005|Dose Level 2|Death|0|||
164303307|NCT00790842|593486459|FG006|Dose Level 2|Death|0|||
164303308|NCT00790842|593486460|FG007|Dose Level 2|Death|0|||
164303309|NCT00790842|593486461|FG008|Dose Level 2|Death|0|||
164303310|NCT00790842|593486462|FG009|Dose Level 2|Death|0|||
164303311|NCT00790842|593486463|FG010|Dose Level 2|Death|0|||
164303312|NCT00790842|593486453|FG000|Dose Level 2|Physician Decision|0|||
164303313|NCT00790842|593486454|FG001|Dose Level 2|Physician Decision|1|||
164303314|NCT00790842|593486455|FG002|Dose Level 2|Physician Decision|0|||
164303315|NCT00790842|593486456|FG003|Dose Level 2|Physician Decision|0|||
164303316|NCT00790842|593486457|FG004|Dose Level 2|Physician Decision|0|||
164303317|NCT00790842|593486458|FG005|Dose Level 2|Physician Decision|0|||
164303318|NCT00790842|593486459|FG006|Dose Level 2|Physician Decision|0|||
164303319|NCT00790842|593486460|FG007|Dose Level 2|Physician Decision|0|||
164303320|NCT00790842|593486461|FG008|Dose Level 2|Physician Decision|0|||
164303321|NCT00790842|593486462|FG009|Dose Level 2|Physician Decision|0|||
164303322|NCT00790842|593486463|FG010|Dose Level 2|Physician Decision|0|||
164303323|NCT00790842|593486453|FG000|Dose Level 2|Withdrawal by Subject|0|||
164303324|NCT00790842|593486454|FG001|Dose Level 2|Withdrawal by Subject|1|||
164303325|NCT00790842|593486455|FG002|Dose Level 2|Withdrawal by Subject|0|||
164303326|NCT00790842|593486456|FG003|Dose Level 2|Withdrawal by Subject|0|||
164303327|NCT00790842|593486457|FG004|Dose Level 2|Withdrawal by Subject|0|||
164303328|NCT00790842|593486458|FG005|Dose Level 2|Withdrawal by Subject|0|||
164303329|NCT00790842|593486459|FG006|Dose Level 2|Withdrawal by Subject|0|||
164303330|NCT00790842|593486460|FG007|Dose Level 2|Withdrawal by Subject|0|||
164303331|NCT00790842|593486461|FG008|Dose Level 2|Withdrawal by Subject|0|||
164303332|NCT00790842|593486462|FG009|Dose Level 2|Withdrawal by Subject|0|||
164303333|NCT00790842|593486463|FG010|Dose Level 2|Withdrawal by Subject|0|||
164303334|NCT00790842|593486453|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
164303335|NCT00790842|593486454|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
164303336|NCT00790842|593486455|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
164303337|NCT00790842|593486456|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
164303338|NCT00790842|593486457|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
164303339|NCT00790842|593486458|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
164303340|NCT00790842|593486459|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
164303341|NCT00790842|593486460|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
164303342|NCT00790842|593486461|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
164303343|NCT00790842|593486462|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
164303344|NCT00790842|593486463|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
164303345|NCT00790842|593486453|FG000|Dose Level 3|Adverse Event|0|||
164303346|NCT00790842|593486454|FG001|Dose Level 3|Adverse Event|0|||
164303347|NCT00790842|593486455|FG002|Dose Level 3|Adverse Event|1|||
164303348|NCT00790842|593486456|FG003|Dose Level 3|Adverse Event|0|||
164648133|NCT03555890|594738500|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
164648134|NCT03372369|594738501|FG000|Qualification Period|Withdrawal by Subject|16|||
164648135|NCT03372369|594738502|FG001|Qualification Period|Withdrawal by Subject|13|||
164648136|NCT03372369|594738501|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
164648137|NCT03372369|594738502|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
164648138|NCT03372369|594738501|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
164648139|NCT03372369|594738502|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
164648140|NCT01383954|594738503|FG000|Overall Study|Lack of Efficacy|2|||
164648141|NCT01383954|594738503|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
164648142|NCT01383954|594738503|FG000|Overall Study|Adverse Event|1|||
164648143|NCT01383954|594738503|FG000|Overall Study|Reason Not Specified|9|||
164648144|NCT01791127|594738504|FG000|Overall Study|Death|356|||
164303349|NCT00790842|593486457|FG004|Dose Level 3|Adverse Event|0|||
164303350|NCT00790842|593486458|FG005|Dose Level 3|Adverse Event|0|||
164303351|NCT00790842|593486459|FG006|Dose Level 3|Adverse Event|0|||
164303352|NCT00790842|593486460|FG007|Dose Level 3|Adverse Event|0|||
164303353|NCT00790842|593486461|FG008|Dose Level 3|Adverse Event|0|||
164303354|NCT00790842|593486462|FG009|Dose Level 3|Adverse Event|0|||
164303355|NCT00790842|593486463|FG010|Dose Level 3|Adverse Event|0|||
164303356|NCT00790842|593486453|FG000|Dose Level 3|Withdrawal by Subject|0|||
164303357|NCT00790842|593486454|FG001|Dose Level 3|Withdrawal by Subject|0|||
164303358|NCT00790842|593486455|FG002|Dose Level 3|Withdrawal by Subject|3|||
164303359|NCT00790842|593486456|FG003|Dose Level 3|Withdrawal by Subject|0|||
164648145|NCT01791127|594738504|FG000|Overall Study|Patient has withdrawn from study|293|||
164648146|NCT01791127|594738504|FG000|Overall Study|Lost to Follow-up|42|||
164648147|NCT01791127|594738504|FG000|Overall Study|All Siello leads are explanted|31|||
164648148|NCT01791127|594738504|FG000|Overall Study|Completion of 30 day safety registry|1|||
164648149|NCT01791127|594738504|FG000|Overall Study|Study terminated for EP Passion|749|||
164648150|NCT00520494|594738505|FG000|Overall Study|Withdrawal by Subject|1|||
164648151|NCT04023994|594738511|FG000|Overall Study|Lost to Follow-up|0|||
164648152|NCT04023994|594738512|FG001|Overall Study|Lost to Follow-up|1|||
164648153|NCT04023994|594738513|FG002|Overall Study|Lost to Follow-up|2|||
164648154|NCT04023994|594738514|FG003|Overall Study|Lost to Follow-up|0|||
164648155|NCT04023994|594738515|FG004|Overall Study|Lost to Follow-up|0|||
164648156|NCT04023994|594738516|FG005|Overall Study|Lost to Follow-up|0|||
164648157|NCT04023994|594738511|FG000|Overall Study|Withdrawal by Subject|0|||
164648158|NCT04023994|594738512|FG001|Overall Study|Withdrawal by Subject|0|||
164648159|NCT04023994|594738513|FG002|Overall Study|Withdrawal by Subject|0|||
164648160|NCT04023994|594738514|FG003|Overall Study|Withdrawal by Subject|1|||
164648161|NCT04023994|594738515|FG004|Overall Study|Withdrawal by Subject|0|||
164648162|NCT04023994|594738516|FG005|Overall Study|Withdrawal by Subject|0|||
164648163|NCT00707174|594738517|FG000|Overall Study|Adverse Event|1|||
164648164|NCT00707174|594738518|FG001|Overall Study|Adverse Event|6|||
164648165|NCT00707174|594738517|FG000|Overall Study|Withdrawal by Subject|4|||
164648166|NCT00707174|594738518|FG001|Overall Study|Withdrawal by Subject|1|||
164303360|NCT00790842|593486457|FG004|Dose Level 3|Withdrawal by Subject|0|||
164303361|NCT00790842|593486458|FG005|Dose Level 3|Withdrawal by Subject|0|||
164303362|NCT00790842|593486459|FG006|Dose Level 3|Withdrawal by Subject|0|||
164303363|NCT00790842|593486460|FG007|Dose Level 3|Withdrawal by Subject|0|||
164303364|NCT00790842|593486461|FG008|Dose Level 3|Withdrawal by Subject|0|||
164303365|NCT00790842|593486462|FG009|Dose Level 3|Withdrawal by Subject|2|||
164303366|NCT00790842|593486463|FG010|Dose Level 3|Withdrawal by Subject|0|||
164303367|NCT00790842|593486453|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
164303368|NCT00790842|593486454|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
164303369|NCT00790842|593486455|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
164303370|NCT00790842|593486456|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
164303371|NCT00790842|593486457|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
164303372|NCT00790842|593486458|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
164303373|NCT00790842|593486459|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
164303374|NCT00790842|593486460|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
164303375|NCT00790842|593486461|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
164303376|NCT00790842|593486462|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
164303377|NCT00790842|593486463|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
164303378|NCT00790842|593486453|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
164303379|NCT00790842|593486454|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
164648167|NCT00544557|594738519|FG000|Overall Study|Adverse Event|140|||
164648168|NCT00544557|594738519|FG000|Overall Study|Lack of Efficacy|196|||
164648169|NCT00544557|594738519|FG000|Overall Study|Other|98|||
164648170|NCT00467818|594738520|FG000|Overall Study|Adverse Event|1|||
164648171|NCT00467818|594738521|FG001|Overall Study|Adverse Event|0|||
164648172|NCT00467818|594738520|FG000|Overall Study|Lost to Follow-up|2|||
164648173|NCT00467818|594738521|FG001|Overall Study|Lost to Follow-up|2|||
164648174|NCT01017029|594738522|FG000|Overall Study|Lost to Follow-up|1|||
164648175|NCT01017029|594738523|FG001|Overall Study|Lost to Follow-up|0|||
164648176|NCT01017029|594738522|FG000|Overall Study|Administrative problem|0|||
164648177|NCT01017029|594738523|FG001|Overall Study|Administrative problem|1|||
164648178|NCT01017029|594738522|FG000|Overall Study|Death|3|||
164648179|NCT01017029|594738523|FG001|Overall Study|Death|1|||
164648180|NCT01830920|594738525|FG000|Overall Study|Adverse Event|1|||
164648181|NCT01830920|594738526|FG001|Overall Study|Adverse Event|0|||
164648182|NCT01830920|594738527|FG002|Overall Study|Adverse Event|1|||
164648183|NCT01830920|594738528|FG003|Overall Study|Adverse Event|0|||
164648184|NCT01830920|594738529|FG004|Overall Study|Adverse Event|0|||
164648185|NCT01830920|594738525|FG000|Overall Study|Withdrawal by Subject|2|||
164648186|NCT01830920|594738526|FG001|Overall Study|Withdrawal by Subject|2|||
164648187|NCT01830920|594738527|FG002|Overall Study|Withdrawal by Subject|1|||
164648188|NCT01830920|594738528|FG003|Overall Study|Withdrawal by Subject|7|||
164648189|NCT01830920|594738529|FG004|Overall Study|Withdrawal by Subject|1|||
164648190|NCT01830920|594738525|FG000|Overall Study|Death|3|||
164648191|NCT01830920|594738526|FG001|Overall Study|Death|3|||
164648192|NCT01830920|594738527|FG002|Overall Study|Death|5|||
164648193|NCT01830920|594738528|FG003|Overall Study|Death|4|||
164648194|NCT01830920|594738529|FG004|Overall Study|Death|4|||
164648195|NCT01830920|594738525|FG000|Overall Study|Other|15|||
164303380|NCT00790842|593486455|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
164303381|NCT00790842|593486456|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
164303382|NCT00790842|593486457|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
164648196|NCT01830920|594738526|FG001|Overall Study|Other|1|||
164648197|NCT01830920|594738527|FG002|Overall Study|Other|1|||
164303383|NCT00790842|593486458|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
164303384|NCT00790842|593486459|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
164303385|NCT00790842|593486460|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
164648198|NCT01830920|594738528|FG003|Overall Study|Other|5|||
164648199|NCT01830920|594738529|FG004|Overall Study|Other|3|||
164303386|NCT00790842|593486461|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
164303387|NCT00790842|593486462|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
164303388|NCT00790842|593486463|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
164303389|NCT00790842|593486453|FG000|Dose Level 4|Adverse Event|0|||
164303390|NCT00790842|593486454|FG001|Dose Level 4|Adverse Event|0|||
164303391|NCT00790842|593486455|FG002|Dose Level 4|Adverse Event|0|||
164303392|NCT00790842|593486456|FG003|Dose Level 4|Adverse Event|0|||
164303393|NCT00790842|593486457|FG004|Dose Level 4|Adverse Event|0|||
164303394|NCT00790842|593486458|FG005|Dose Level 4|Adverse Event|0|||
164303395|NCT00790842|593486459|FG006|Dose Level 4|Adverse Event|1|||
164303396|NCT00790842|593486460|FG007|Dose Level 4|Adverse Event|0|||
164303397|NCT00790842|593486461|FG008|Dose Level 4|Adverse Event|0|||
164303398|NCT00790842|593486462|FG009|Dose Level 4|Adverse Event|0|||
164303399|NCT00790842|593486463|FG010|Dose Level 4|Adverse Event|0|||
164303400|NCT00790842|593486453|FG000|Dose Level 4|Physician Decision|0|||
164303401|NCT00790842|593486454|FG001|Dose Level 4|Physician Decision|0|||
164303402|NCT00790842|593486455|FG002|Dose Level 4|Physician Decision|0|||
164303403|NCT00790842|593486456|FG003|Dose Level 4|Physician Decision|0|||
164303404|NCT00790842|593486457|FG004|Dose Level 4|Physician Decision|0|||
164303405|NCT00790842|593486458|FG005|Dose Level 4|Physician Decision|0|||
164303406|NCT00790842|593486459|FG006|Dose Level 4|Physician Decision|1|||
164303407|NCT00790842|593486460|FG007|Dose Level 4|Physician Decision|0|||
164303408|NCT00790842|593486461|FG008|Dose Level 4|Physician Decision|0|||
164303409|NCT00790842|593486462|FG009|Dose Level 4|Physician Decision|0|||
164303410|NCT00790842|593486463|FG010|Dose Level 4|Physician Decision|1|||
164303411|NCT00790842|593486453|FG000|Dose Level 4|Withdrawal by Subject|0|||
164303412|NCT00790842|593486454|FG001|Dose Level 4|Withdrawal by Subject|0|||
164303413|NCT00790842|593486455|FG002|Dose Level 4|Withdrawal by Subject|0|||
164303414|NCT00790842|593486456|FG003|Dose Level 4|Withdrawal by Subject|0|||
164303415|NCT00790842|593486457|FG004|Dose Level 4|Withdrawal by Subject|0|||
164303416|NCT00790842|593486458|FG005|Dose Level 4|Withdrawal by Subject|0|||
164303417|NCT00790842|593486459|FG006|Dose Level 4|Withdrawal by Subject|0|||
164303418|NCT00790842|593486460|FG007|Dose Level 4|Withdrawal by Subject|0|||
164303419|NCT00790842|593486461|FG008|Dose Level 4|Withdrawal by Subject|0|||
164303420|NCT00790842|593486462|FG009|Dose Level 4|Withdrawal by Subject|0|||
164303421|NCT00790842|593486463|FG010|Dose Level 4|Withdrawal by Subject|1|||
164303422|NCT00790842|593486453|FG000|Expansion Cohort|Adverse Event|0|||
164303423|NCT00790842|593486454|FG001|Expansion Cohort|Adverse Event|0|||
164303424|NCT00790842|593486455|FG002|Expansion Cohort|Adverse Event|0|||
164303425|NCT00790842|593486456|FG003|Expansion Cohort|Adverse Event|0|||
164303426|NCT00790842|593486457|FG004|Expansion Cohort|Adverse Event|0|||
164303427|NCT00790842|593486458|FG005|Expansion Cohort|Adverse Event|0|||
164303428|NCT00790842|593486459|FG006|Expansion Cohort|Adverse Event|1|||
164303429|NCT00790842|593486460|FG007|Expansion Cohort|Adverse Event|0|||
164303430|NCT00790842|593486461|FG008|Expansion Cohort|Adverse Event|0|||
164303431|NCT00790842|593486462|FG009|Expansion Cohort|Adverse Event|0|||
164303432|NCT00790842|593486463|FG010|Expansion Cohort|Adverse Event|0|||
164303433|NCT00790842|593486453|FG000|Expansion Cohort|Death|0|||
164303434|NCT00790842|593486454|FG001|Expansion Cohort|Death|0|||
164303435|NCT00790842|593486455|FG002|Expansion Cohort|Death|2|||
164303436|NCT00790842|593486456|FG003|Expansion Cohort|Death|0|||
164303437|NCT00790842|593486457|FG004|Expansion Cohort|Death|0|||
164303438|NCT00790842|593486458|FG005|Expansion Cohort|Death|0|||
164303439|NCT00790842|593486459|FG006|Expansion Cohort|Death|0|||
164188973|NCT04074330|593060418|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
164188974|NCT04074330|593060419|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
164188975|NCT04074330|593060420|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
164188976|NCT04074330|593060421|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
164188977|NCT04074330|593060422|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
164188978|NCT04074330|593060413|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
164648200|NCT00422058|594738531|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
164648201|NCT00422058|594738532|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
164188979|NCT04074330|593060414|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
164188980|NCT04074330|593060415|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
164188981|NCT04074330|593060416|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
164188982|NCT04074330|593060417|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
164188983|NCT04074330|593060418|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
164188984|NCT04074330|593060419|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
164303440|NCT00790842|593486460|FG007|Expansion Cohort|Death|0|||
164303441|NCT00790842|593486461|FG008|Expansion Cohort|Death|0|||
164648202|NCT00422058|594738533|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
164188985|NCT04074330|593060420|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
164188986|NCT04074330|593060421|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
164188987|NCT04074330|593060422|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
164303442|NCT00790842|593486462|FG009|Expansion Cohort|Death|0|||
164303443|NCT00790842|593486463|FG010|Expansion Cohort|Death|0|||
164303444|NCT00790842|593486453|FG000|Expansion Cohort|Physician Decision|0|||
164303445|NCT00790842|593486454|FG001|Expansion Cohort|Physician Decision|0|||
164188988|NCT04074330|593060413|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
164188989|NCT04074330|593060414|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
164188990|NCT04074330|593060415|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
164188991|NCT04074330|593060416|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
164188992|NCT04074330|593060417|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
164188993|NCT04074330|593060418|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
164188994|NCT04074330|593060419|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
164188995|NCT04074330|593060420|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
164188996|NCT04074330|593060421|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
164188997|NCT04074330|593060422|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
164188998|NCT04074330|593060413|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
164188999|NCT04074330|593060414|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
164189000|NCT04074330|593060415|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
164189001|NCT04074330|593060416|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
164189002|NCT04074330|593060417|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
164189003|NCT04074330|593060418|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
164189004|NCT04074330|593060419|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
164189005|NCT04074330|593060420|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
164189006|NCT04074330|593060421|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
164189007|NCT04074330|593060422|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
164189008|NCT04074330|593060413|FG000|Dose Expansion (up to 42 Months)|Death|0|||
164189009|NCT04074330|593060414|FG001|Dose Expansion (up to 42 Months)|Death|0|||
164189010|NCT04074330|593060415|FG002|Dose Expansion (up to 42 Months)|Death|0|||
164189011|NCT04074330|593060416|FG003|Dose Expansion (up to 42 Months)|Death|0|||
164303446|NCT00790842|593486455|FG002|Expansion Cohort|Physician Decision|1|||
164303447|NCT00790842|593486456|FG003|Expansion Cohort|Physician Decision|0|||
164303448|NCT00790842|593486457|FG004|Expansion Cohort|Physician Decision|0|||
164303449|NCT00790842|593486458|FG005|Expansion Cohort|Physician Decision|0|||
164303450|NCT00790842|593486459|FG006|Expansion Cohort|Physician Decision|0|||
164303451|NCT00790842|593486460|FG007|Expansion Cohort|Physician Decision|0|||
164303452|NCT00790842|593486461|FG008|Expansion Cohort|Physician Decision|0|||
164303453|NCT00790842|593486462|FG009|Expansion Cohort|Physician Decision|0|||
164303454|NCT00790842|593486463|FG010|Expansion Cohort|Physician Decision|0|||
164303455|NCT00790842|593486453|FG000|Expansion Cohort|Withdrawal by Subject|0|||
164303456|NCT00790842|593486454|FG001|Expansion Cohort|Withdrawal by Subject|0|||
164303457|NCT00790842|593486455|FG002|Expansion Cohort|Withdrawal by Subject|3|||
164303458|NCT00790842|593486456|FG003|Expansion Cohort|Withdrawal by Subject|0|||
164303459|NCT00790842|593486457|FG004|Expansion Cohort|Withdrawal by Subject|0|||
164303460|NCT00790842|593486458|FG005|Expansion Cohort|Withdrawal by Subject|0|||
164303461|NCT00790842|593486459|FG006|Expansion Cohort|Withdrawal by Subject|0|||
164303462|NCT00790842|593486460|FG007|Expansion Cohort|Withdrawal by Subject|0|||
164303463|NCT00790842|593486461|FG008|Expansion Cohort|Withdrawal by Subject|0|||
164303464|NCT00790842|593486462|FG009|Expansion Cohort|Withdrawal by Subject|0|||
164303465|NCT00790842|593486463|FG010|Expansion Cohort|Withdrawal by Subject|0|||
164303466|NCT00790842|593486453|FG000|Expansion Cohort|Study Closure|0|||
164303467|NCT00790842|593486454|FG001|Expansion Cohort|Study Closure|0|||
164303468|NCT00790842|593486455|FG002|Expansion Cohort|Study Closure|1|||
164303469|NCT00790842|593486456|FG003|Expansion Cohort|Study Closure|0|||
164303470|NCT00790842|593486457|FG004|Expansion Cohort|Study Closure|0|||
164303471|NCT00790842|593486458|FG005|Expansion Cohort|Study Closure|0|||
164303472|NCT00790842|593486459|FG006|Expansion Cohort|Study Closure|0|||
164303473|NCT00790842|593486460|FG007|Expansion Cohort|Study Closure|0|||
164303474|NCT00790842|593486461|FG008|Expansion Cohort|Study Closure|0|||
164303475|NCT00790842|593486462|FG009|Expansion Cohort|Study Closure|0|||
164303476|NCT00790842|593486463|FG010|Expansion Cohort|Study Closure|0|||
164189012|NCT04074330|593060417|FG004|Dose Expansion (up to 42 Months)|Death|0|||
164189013|NCT04074330|593060418|FG005|Dose Expansion (up to 42 Months)|Death|0|||
164303477|NCT02504151|593486464|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
164303478|NCT02504151|593486465|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
164303479|NCT02504151|593486464|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
164303480|NCT02504151|593486465|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
164303481|NCT02504151|593486464|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
164303482|NCT02504151|593486465|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
164303483|NCT02504151|593486464|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
164303484|NCT02504151|593486465|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
164303485|NCT00538902|593486466|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
164303486|NCT00538902|593486467|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
164303487|NCT00538902|593486468|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
164303488|NCT00538902|593486466|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
164303489|NCT00538902|593486467|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
164303490|NCT00538902|593486468|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
164303491|NCT00538902|593486466|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
164303492|NCT00538902|593486467|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
164303493|NCT00538902|593486468|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
164303494|NCT00538902|593486466|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
164303495|NCT00538902|593486467|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
164303496|NCT00538902|593486468|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
164303497|NCT00538902|593486466|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
164303498|NCT00538902|593486467|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
164303499|NCT00538902|593486468|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
164418133|NCT01327547|593901083|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
164418134|NCT01327547|593901082|FG000|Overall Study|Withdrawal by Subject|3|||
164418135|NCT01327547|593901083|FG001|Overall Study|Withdrawal by Subject|7|||
164418136|NCT01327547|593901082|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
164418137|NCT01327547|593901083|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
164418138|NCT01327547|593901082|FG000|Overall Study|Protocol Violation|1|||
164418139|NCT01327547|593901083|FG001|Overall Study|Protocol Violation|0|||
164418140|NCT01327547|593901082|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
164418141|NCT01327547|593901083|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
164418142|NCT01327547|593901082|FG000|Overall Study|Required prohibited medication|2|||
164418143|NCT01327547|593901083|FG001|Overall Study|Required prohibited medication|0|||
164418144|NCT01327547|593901082|FG000|Overall Study|Non-compliance with study procedures|1|||
164418145|NCT01327547|593901083|FG001|Overall Study|Non-compliance with study procedures|0|||
164418146|NCT01327547|593901082|FG000|Overall Study|By investigator in subject's interest|0|||
164418147|NCT01327547|593901083|FG001|Overall Study|By investigator in subject's interest|1|||
164418148|NCT03390036|593901086|FG000|Overall Study|Lost to Follow-up|1|||
164648203|NCT00422058|594738534|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
164648204|NCT00422058|594738535|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
164303500|NCT00538902|593486466|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
164303501|NCT00538902|593486467|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
164303502|NCT00538902|593486468|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
164303503|NCT00538902|593486466|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
164303504|NCT00538902|593486467|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
164303505|NCT00538902|593486468|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
164303506|NCT00538902|593486466|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
164648205|NCT00422058|594738536|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
164303507|NCT00538902|593486467|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
164303508|NCT00538902|593486468|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
164303509|NCT01454102|593486469|FG000|Overall Study|Continuing in the treatment period|0|||
164303510|NCT01454102|593486470|FG001|Overall Study|Continuing in the treatment period|0|||
164303511|NCT01454102|593486471|FG002|Overall Study|Continuing in the treatment period|0|||
164303512|NCT01454102|593486472|FG003|Overall Study|Continuing in the treatment period|0|||
164303513|NCT01454102|593486473|FG004|Overall Study|Continuing in the treatment period|3|||
164303514|NCT01454102|593486474|FG005|Overall Study|Continuing in the treatment period|3|||
164303515|NCT01454102|593486475|FG006|Overall Study|Continuing in the treatment period|2|||
164303516|NCT01454102|593486476|FG007|Overall Study|Continuing in the treatment period|0|||
164303517|NCT01454102|593486477|FG008|Overall Study|Continuing in the treatment period|1|||
164303518|NCT01454102|593486478|FG009|Overall Study|Continuing in the treatment period|0|||
164303519|NCT01454102|593486479|FG010|Overall Study|Continuing in the treatment period|0|||
164303520|NCT01454102|593486480|FG011|Overall Study|Continuing in the treatment period|4|||
164303521|NCT01454102|593486481|FG012|Overall Study|Continuing in the treatment period|7|||
164303522|NCT01454102|593486482|FG013|Overall Study|Continuing in the treatment period|4|||
164303523|NCT01454102|593486483|FG014|Overall Study|Continuing in the treatment period|3|||
164303524|NCT01454102|593486484|FG015|Overall Study|Continuing in the treatment period|1|||
164303525|NCT00705016|593486487|FG000|Overall Study|Adverse Event|6|||
164303526|NCT00705016|593486488|FG001|Overall Study|Adverse Event|11|||
164303527|NCT00705016|593486489|FG002|Overall Study|Adverse Event|10|||
164303528|NCT00705016|593486487|FG000|Overall Study|Death|5|||
164303529|NCT00705016|593486488|FG001|Overall Study|Death|7|||
164303530|NCT00705016|593486489|FG002|Overall Study|Death|5|||
164303531|NCT00705016|593486487|FG000|Overall Study|Protocol Violation|0|||
164303532|NCT00705016|593486488|FG001|Overall Study|Protocol Violation|1|||
164303533|NCT00705016|593486489|FG002|Overall Study|Protocol Violation|1|||
164303534|NCT00705016|593486487|FG000|Overall Study|Withdrawal by Subject|4|||
164303535|NCT00705016|593486488|FG001|Overall Study|Withdrawal by Subject|3|||
164303536|NCT00705016|593486489|FG002|Overall Study|Withdrawal by Subject|2|||
164303537|NCT00705016|593486487|FG000|Overall Study|Progressive Disease|33|||
164303538|NCT00705016|593486488|FG001|Overall Study|Progressive Disease|29|||
164303539|NCT00705016|593486489|FG002|Overall Study|Progressive Disease|33|||
164303540|NCT00705016|593486487|FG000|Overall Study|Symptomatic Deterioration|3|||
164303541|NCT00705016|593486488|FG001|Overall Study|Symptomatic Deterioration|1|||
164303542|NCT00705016|593486489|FG002|Overall Study|Symptomatic Deterioration|1|||
164303543|NCT00705016|593486487|FG000|Overall Study|Other|9|||
164303544|NCT00705016|593486488|FG001|Overall Study|Other|6|||
164303545|NCT00705016|593486489|FG002|Overall Study|Other|6|||
164303546|NCT00942604|593486490|FG000|Overall Study|Protocol Violation|1|||
164303547|NCT00942604|593486491|FG001|Overall Study|Protocol Violation|1|||
164303548|NCT00942604|593486490|FG000|Overall Study|Adverse Event|0|||
164303549|NCT00942604|593486491|FG001|Overall Study|Adverse Event|1|||
164303550|NCT00942604|593486490|FG000|Overall Study|Withdrawal by Subject|0|||
164303551|NCT00942604|593486491|FG001|Overall Study|Withdrawal by Subject|1|||
164303552|NCT00942604|593486490|FG000|Overall Study|Patient relocation|1|||
164303553|NCT00942604|593486491|FG001|Overall Study|Patient relocation|1|||
164303554|NCT01188343|593486492|FG000|Overall Study|Not vaccinated|0|||
164303555|NCT01188343|593486493|FG001|Overall Study|Not vaccinated|2|||
164303556|NCT01188343|593486494|FG002|Overall Study|Not vaccinated|1|||
164303557|NCT01188343|593486492|FG000|Overall Study|Withdrawal by Subject|1|||
164303558|NCT01188343|593486493|FG001|Overall Study|Withdrawal by Subject|24|||
164303559|NCT01188343|593486494|FG002|Overall Study|Withdrawal by Subject|0|||
164303560|NCT04109547|593486495|FG000|Overall Study|Withdrawal by Subject|3|||
164303561|NCT04109547|593486496|FG001|Overall Study|Withdrawal by Subject|2|||
164303562|NCT04109547|593486497|FG002|Overall Study|Withdrawal by Subject|6|||
164303563|NCT04109547|593486498|FG003|Overall Study|Withdrawal by Subject|6|||
164303564|NCT04109547|593486495|FG000|Overall Study|Lost to Follow-up|0|||
164303565|NCT04109547|593486496|FG001|Overall Study|Lost to Follow-up|0|||
164303566|NCT04109547|593486497|FG002|Overall Study|Lost to Follow-up|0|||
164303567|NCT04109547|593486498|FG003|Overall Study|Lost to Follow-up|1|||
164303568|NCT04109547|593486495|FG000|Overall Study|Physician Decision|1|||
164303569|NCT04109547|593486496|FG001|Overall Study|Physician Decision|2|||
164303570|NCT04109547|593486497|FG002|Overall Study|Physician Decision|0|||
164303571|NCT04109547|593486498|FG003|Overall Study|Physician Decision|0|||
164303572|NCT01499355|593486501|FG000|Run-In Period|Study Termination|15|||
164303573|NCT01499355|593486502|FG001|Run-In Period|Study Termination|0|||
164303574|NCT01499355|593486503|FG002|Run-In Period|Study Termination|0|||
164303575|NCT01499355|593486504|FG003|Run-In Period|Study Termination|0|||
164303576|NCT01499355|593486501|FG000|Run-In Period|Other|3|||
164303577|NCT01499355|593486502|FG001|Run-In Period|Other|0|||
164303578|NCT01499355|593486503|FG002|Run-In Period|Other|0|||
164303579|NCT01499355|593486504|FG003|Run-In Period|Other|0|||
164303580|NCT01499355|593486501|FG000|Run-In Period|Death|2|||
164303581|NCT01499355|593486502|FG001|Run-In Period|Death|0|||
164303582|NCT01499355|593486503|FG002|Run-In Period|Death|0|||
164303583|NCT01499355|593486504|FG003|Run-In Period|Death|0|||
164303584|NCT01499355|593486501|FG000|Run-In Period|Investigator Decision|2|||
164303585|NCT01499355|593486502|FG001|Run-In Period|Investigator Decision|0|||
164303586|NCT01499355|593486503|FG002|Run-In Period|Investigator Decision|0|||
164303587|NCT01499355|593486504|FG003|Run-In Period|Investigator Decision|0|||
164303588|NCT01499355|593486501|FG000|Run-In Period|Consent Withdrawn|1|||
164303589|NCT01499355|593486502|FG001|Run-In Period|Consent Withdrawn|0|||
164303590|NCT01499355|593486503|FG002|Run-In Period|Consent Withdrawn|0|||
164303591|NCT01499355|593486504|FG003|Run-In Period|Consent Withdrawn|0|||
164303592|NCT01499355|593486501|FG000|Run-In Period|Adverse Event|8|||
164303593|NCT01499355|593486502|FG001|Run-In Period|Adverse Event|0|||
164303594|NCT01499355|593486503|FG002|Run-In Period|Adverse Event|0|||
164303595|NCT01499355|593486504|FG003|Run-In Period|Adverse Event|0|||
164303596|NCT01499355|593486501|FG000|Double-Blind Period|Adverse Event|0|||
164303597|NCT01499355|593486502|FG001|Double-Blind Period|Adverse Event|2|||
164303598|NCT01499355|593486503|FG002|Double-Blind Period|Adverse Event|3|||
164303599|NCT01499355|593486504|FG003|Double-Blind Period|Adverse Event|2|||
164303600|NCT01499355|593486501|FG000|Double-Blind Period|Study Termination|0|||
164303601|NCT01499355|593486502|FG001|Double-Blind Period|Study Termination|18|||
164303602|NCT01499355|593486503|FG002|Double-Blind Period|Study Termination|16|||
164303603|NCT01499355|593486504|FG003|Double-Blind Period|Study Termination|14|||
164303604|NCT01499355|593486501|FG000|Double-Blind Period|Other|0|||
164303605|NCT01499355|593486502|FG001|Double-Blind Period|Other|1|||
164303606|NCT01499355|593486503|FG002|Double-Blind Period|Other|2|||
164303607|NCT01499355|593486504|FG003|Double-Blind Period|Other|2|||
164303608|NCT01499355|593486501|FG000|Double-Blind Period|Death|0|||
164303609|NCT01499355|593486502|FG001|Double-Blind Period|Death|1|||
164303610|NCT01499355|593486503|FG002|Double-Blind Period|Death|0|||
164303611|NCT01499355|593486504|FG003|Double-Blind Period|Death|0|||
164303612|NCT01499355|593486501|FG000|Double-Blind Period|Investigator Decision|0|||
164303613|NCT01499355|593486502|FG001|Double-Blind Period|Investigator Decision|0|||
164303614|NCT01499355|593486503|FG002|Double-Blind Period|Investigator Decision|3|||
164303615|NCT01499355|593486504|FG003|Double-Blind Period|Investigator Decision|3|||
164303616|NCT01499355|593486501|FG000|Double-Blind Period|Consent Withdrawn|0|||
164303617|NCT01499355|593486502|FG001|Double-Blind Period|Consent Withdrawn|0|||
164303618|NCT01499355|593486503|FG002|Double-Blind Period|Consent Withdrawn|1|||
164303619|NCT01499355|593486504|FG003|Double-Blind Period|Consent Withdrawn|2|||
164303620|NCT01499355|593486501|FG000|Double-Blind Period|Lost to Follow-up|0|||
164303621|NCT01499355|593486502|FG001|Double-Blind Period|Lost to Follow-up|1|||
164303622|NCT01499355|593486503|FG002|Double-Blind Period|Lost to Follow-up|0|||
164303623|NCT01499355|593486504|FG003|Double-Blind Period|Lost to Follow-up|0|||
164303624|NCT02668653|593486505|FG000|Overall Study|Refractory disease|41|||
164303625|NCT02668653|593486506|FG001|Overall Study|Refractory disease|70|||
164303626|NCT02668653|593486505|FG000|Overall Study|Relapse|44|||
164303627|NCT02668653|593486506|FG001|Overall Study|Relapse|65|||
164303628|NCT02668653|593486505|FG000|Overall Study|Adverse Event|58|||
164303629|NCT02668653|593486506|FG001|Overall Study|Adverse Event|23|||
164303630|NCT02668653|593486505|FG000|Overall Study|Subject decision to stop study drug|25|||
164303631|NCT02668653|593486506|FG001|Overall Study|Subject decision to stop study drug|23|||
164303632|NCT02668653|593486505|FG000|Overall Study|Other reasons not specified|16|||
164303633|NCT02668653|593486506|FG001|Overall Study|Other reasons not specified|11|||
164303634|NCT02668653|593486505|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
164303635|NCT02668653|593486506|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
164303636|NCT02668653|593486505|FG000|Overall Study|Investigator decision|10|||
164303637|NCT02668653|593486506|FG001|Overall Study|Investigator decision|7|||
164303638|NCT02668653|593486505|FG000|Overall Study|Failure to meet continuation criteria|5|||
164303639|NCT02668653|593486506|FG001|Overall Study|Failure to meet continuation criteria|12|||
164303640|NCT02668653|593486505|FG000|Overall Study|Lost to Follow-up|1|||
164303641|NCT02668653|593486506|FG001|Overall Study|Lost to Follow-up|0|||
164303642|NCT02668653|593486505|FG000|Overall Study|Pregnancy|0|||
164303643|NCT02668653|593486506|FG001|Overall Study|Pregnancy|1|||
164303644|NCT02668653|593486505|FG000|Overall Study|Death|0|||
164303645|NCT02668653|593486506|FG001|Overall Study|Death|1|||
164303646|NCT00686712|593486508|FG000|Overall Study|Protocol Violation|8|||
164303647|NCT00686712|593486509|FG001|Overall Study|Protocol Violation|8|||
164303648|NCT00686712|593486510|FG002|Overall Study|Protocol Violation|10|||
164303649|NCT00686712|593486508|FG000|Overall Study|Lost to Follow-up|1|||
164303650|NCT00686712|593486509|FG001|Overall Study|Lost to Follow-up|2|||
164303651|NCT00686712|593486510|FG002|Overall Study|Lost to Follow-up|3|||
164303652|NCT00686712|593486508|FG000|Overall Study|Adverse Event|1|||
164303653|NCT00686712|593486509|FG001|Overall Study|Adverse Event|1|||
164303654|NCT00686712|593486510|FG002|Overall Study|Adverse Event|0|||
164303655|NCT01318915|593486511|FG000|Overall Study|Lost to Follow-up|1|||
164303656|NCT03987503|593486512|FG000|Overall Study|Lost to Follow-up|20|||
164303657|NCT03987503|593486512|FG000|Overall Study|Withdrawal by Subject|2|||
164303658|NCT04119414|593486513|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
164303659|NCT01929317|593486527|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
164303660|NCT01929317|593486528|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
164303661|NCT01929317|593486527|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
164303662|NCT01929317|593486528|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
164303663|NCT01929317|593486527|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
164303664|NCT01929317|593486528|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
164303665|NCT01929317|593486527|FG000|Long-term Phase|Adverse Event|5|||
164303666|NCT01929317|593486528|FG001|Long-term Phase|Adverse Event|1|||
164303667|NCT01929317|593486527|FG000|Long-term Phase|Physician Decision|3|||
164303668|NCT01929317|593486528|FG001|Long-term Phase|Physician Decision|0|||
164303669|NCT01929317|593486527|FG000|Long-term Phase|Withdrawal by Subject|4|||
164303670|NCT01929317|593486528|FG001|Long-term Phase|Withdrawal by Subject|0|||
164303671|NCT01929317|593486527|FG000|Long-term Phase|Protocol Violation|1|||
164303672|NCT01929317|593486528|FG001|Long-term Phase|Protocol Violation|0|||
164303673|NCT01929317|593486527|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
164303674|NCT01929317|593486528|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
164303675|NCT01929317|593486527|FG000|Long-term Phase|Study Closed/Terminated|5|||
164303676|NCT01929317|593486528|FG001|Long-term Phase|Study Closed/Terminated|3|||
164303677|NCT01588522|593486548|FG000|Overall Study|Withdrawal by Subject|1|||
164303678|NCT01588522|593486549|FG001|Overall Study|Withdrawal by Subject|5|||
164303679|NCT01588522|593486550|FG002|Overall Study|Withdrawal by Subject|3|||
164303680|NCT01588522|593486551|FG003|Overall Study|Withdrawal by Subject|1|||
164303681|NCT01588522|593486552|FG004|Overall Study|Withdrawal by Subject|2|||
164303682|NCT01588522|593486553|FG005|Overall Study|Withdrawal by Subject|0|||
164303683|NCT01588522|593486548|FG000|Overall Study|Lack of Efficacy|0|||
164303684|NCT01588522|593486549|FG001|Overall Study|Lack of Efficacy|0|||
164303685|NCT01588522|593486550|FG002|Overall Study|Lack of Efficacy|0|||
164303686|NCT01588522|593486551|FG003|Overall Study|Lack of Efficacy|0|||
164303687|NCT01588522|593486552|FG004|Overall Study|Lack of Efficacy|1|||
164303688|NCT01588522|593486553|FG005|Overall Study|Lack of Efficacy|0|||
164303689|NCT01588522|593486548|FG000|Overall Study|Adverse Event|0|||
164532909|NCT01971203|594322133|FG000|Overall Study|Adverse Event|1|||
164532910|NCT01971203|594322134|FG001|Overall Study|Adverse Event|0|||
164303690|NCT01588522|593486549|FG001|Overall Study|Adverse Event|0|||
164303691|NCT01588522|593486550|FG002|Overall Study|Adverse Event|0|||
164303692|NCT01588522|593486551|FG003|Overall Study|Adverse Event|1|||
164303693|NCT01588522|593486552|FG004|Overall Study|Adverse Event|0|||
164303694|NCT01588522|593486553|FG005|Overall Study|Adverse Event|0|||
164303695|NCT01588522|593486548|FG000|Overall Study|Grade 2 alopecia|1|||
164303696|NCT01588522|593486549|FG001|Overall Study|Grade 2 alopecia|0|||
164303697|NCT01588522|593486550|FG002|Overall Study|Grade 2 alopecia|0|||
164303698|NCT01588522|593486551|FG003|Overall Study|Grade 2 alopecia|0|||
164303699|NCT01588522|593486552|FG004|Overall Study|Grade 2 alopecia|0|||
164303700|NCT01588522|593486553|FG005|Overall Study|Grade 2 alopecia|0|||
164303701|NCT01588522|593486548|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
164303702|NCT01588522|593486549|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
164303703|NCT01588522|593486550|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
164303704|NCT01588522|593486551|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
164303705|NCT01588522|593486552|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
164303706|NCT01588522|593486553|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
164303707|NCT01588522|593486548|FG000|Overall Study|Taken off taxane-based regimen|0|||
164303708|NCT01588522|593486549|FG001|Overall Study|Taken off taxane-based regimen|0|||
164303709|NCT01588522|593486550|FG002|Overall Study|Taken off taxane-based regimen|0|||
164303710|NCT01588522|593486551|FG003|Overall Study|Taken off taxane-based regimen|1|||
164303711|NCT01588522|593486552|FG004|Overall Study|Taken off taxane-based regimen|0|||
164303712|NCT01588522|593486553|FG005|Overall Study|Taken off taxane-based regimen|0|||
164303713|NCT01588522|593486548|FG000|Overall Study|Did not initiate chemotherapy|0|||
164303714|NCT01588522|593486549|FG001|Overall Study|Did not initiate chemotherapy|0|||
164303715|NCT01588522|593486550|FG002|Overall Study|Did not initiate chemotherapy|0|||
164303716|NCT01588522|593486551|FG003|Overall Study|Did not initiate chemotherapy|0|||
164303717|NCT01588522|593486552|FG004|Overall Study|Did not initiate chemotherapy|1|||
164303718|NCT01588522|593486553|FG005|Overall Study|Did not initiate chemotherapy|0|||
164303719|NCT02855125|593486558|FG000|Overall Study|Withdrawal by Subject|2|||
164303720|NCT02855125|593486559|FG001|Overall Study|Withdrawal by Subject|2|||
164303721|NCT02855125|593486558|FG000|Overall Study|Clinical Disease Progression|5|||
164303722|NCT02855125|593486559|FG001|Overall Study|Clinical Disease Progression|4|||
164303723|NCT02855125|593486558|FG000|Overall Study|Radiologic Disease Progression|36|||
164303724|NCT02855125|593486559|FG001|Overall Study|Radiologic Disease Progression|39|||
164303725|NCT02855125|593486558|FG000|Overall Study|Adverse Event|11|||
164303726|NCT02855125|593486559|FG001|Overall Study|Adverse Event|7|||
164303727|NCT02855125|593486558|FG000|Overall Study|Physician Decision|1|||
164303728|NCT02855125|593486559|FG001|Overall Study|Physician Decision|0|||
164303729|NCT02855125|593486558|FG000|Overall Study|On Treatment|9|||
164303730|NCT02855125|593486559|FG001|Overall Study|On Treatment|11|||
164303731|NCT02855125|593486558|FG000|Overall Study|Randomized but not treated|0|||
164303732|NCT02855125|593486559|FG001|Overall Study|Randomized but not treated|1|||
164303733|NCT01899040|593486561|FG000|Overall Study|Randomized in error|0|||
164303734|NCT01899040|593486562|FG001|Overall Study|Randomized in error|1|||
164303735|NCT01899040|593486563|FG002|Overall Study|Randomized in error|1|||
164303736|NCT01899040|593486561|FG000|Overall Study|Adverse Event|3|||
164303737|NCT01899040|593486562|FG001|Overall Study|Adverse Event|1|||
164303738|NCT01899040|593486563|FG002|Overall Study|Adverse Event|2|||
164303739|NCT01899040|593486561|FG000|Overall Study|Unspecified reasons|4|||
164303740|NCT01899040|593486562|FG001|Overall Study|Unspecified reasons|4|||
164303741|NCT01899040|593486563|FG002|Overall Study|Unspecified reasons|0|||
164303742|NCT01899040|593486561|FG000|Overall Study|Compliance issues|1|||
164303743|NCT01899040|593486562|FG001|Overall Study|Compliance issues|2|||
164303744|NCT01899040|593486563|FG002|Overall Study|Compliance issues|0|||
164303745|NCT02638220|593486569|FG000|Overall Study|Lost to Follow-up|6|||
164303746|NCT02638220|593486569|FG000|Overall Study|Withdrawal by Subject|3|||
164303747|NCT02638220|593486569|FG000|Overall Study|Physician Decision|1|||
164303748|NCT02638220|593486569|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
164355601|NCT01962207|593676478|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
164355602|NCT01962207|593676479|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
164355603|NCT01962207|593676476|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
164355604|NCT01962207|593676477|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
164355605|NCT01962207|593676478|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
164355606|NCT01962207|593676479|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
164355607|NCT01962207|593676476|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
164355608|NCT01962207|593676477|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
164355609|NCT01962207|593676478|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
164418149|NCT03390036|593901087|FG001|Overall Study|Lost to Follow-up|0|||
164418150|NCT03390036|593901088|FG002|Overall Study|Lost to Follow-up|0|||
164532911|NCT03037619|594322135|FG000|Overall Study|Lost to Follow-up|0|||
164355610|NCT01962207|593676479|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
164355611|NCT01962207|593676476|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
164355612|NCT01962207|593676477|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
164418151|NCT03390036|593901086|FG000|Overall Study|Lack of Efficacy|1|||
164418152|NCT03390036|593901087|FG001|Overall Study|Lack of Efficacy|0|||
164418153|NCT03390036|593901088|FG002|Overall Study|Lack of Efficacy|0|||
164418154|NCT01744496|593901093|FG000|Titration Period|Adverse Event|2|||
164418155|NCT01744496|593901094|FG001|Titration Period|Adverse Event|1|||
164418156|NCT01744496|593901093|FG000|Titration Period|Personal reasons|0|||
164303749|NCT02083354|593488356|FG000|Overall Study|Withdrawal by Subject|9|||
164303750|NCT02083354|593488356|FG000|Overall Study|Lost to Follow-up|1|||
164303751|NCT02083354|593488356|FG000|Overall Study|Adverse Event|3|||
164303752|NCT02083354|593488356|FG000|Overall Study|Disease progression|46|||
164303753|NCT02083354|593488356|FG000|Overall Study|Study closed/terminated|5|||
164303754|NCT01646125|593488357|FG000|Overall Study|Untreated|2|||
164189014|NCT04074330|593060419|FG006|Dose Expansion (up to 42 Months)|Death|0|||
164189015|NCT04074330|593060420|FG007|Dose Expansion (up to 42 Months)|Death|0|||
164189016|NCT04074330|593060421|FG008|Dose Expansion (up to 42 Months)|Death|1|||
164189017|NCT04074330|593060422|FG009|Dose Expansion (up to 42 Months)|Death|0|||
164189018|NCT04074330|593060413|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
164189019|NCT04074330|593060414|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
164189020|NCT04074330|593060415|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
164189021|NCT04074330|593060416|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
164189022|NCT04074330|593060417|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
164189023|NCT04074330|593060418|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
164189024|NCT04074330|593060419|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
164189025|NCT04074330|593060420|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
164189026|NCT04074330|593060421|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
164189027|NCT04074330|593060422|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
164189028|NCT01429298|593060427|FG000|Overall Study|Protocol Violation|4|||
164189029|NCT01429298|593060428|FG001|Overall Study|Protocol Violation|6|||
164189030|NCT02903420|593060429|FG000|Overall Study|Death|3|||
164189031|NCT00181883|593060432|FG000|Overall Study|Lack of Efficacy|2|||
164189032|NCT00181883|593060432|FG000|Overall Study|Treatment Limiting AEs|3|||
164189033|NCT00181883|593060432|FG000|Overall Study|Withdrawal by Subject|4|||
164189034|NCT00181883|593060432|FG000|Overall Study|Lost to Follow-up|1|||
164189035|NCT05305989|593060433|FG000|Overall Study|Other|3|||
164189036|NCT05305989|593060434|FG001|Overall Study|Other|2|||
164189037|NCT05305989|593060435|FG002|Overall Study|Other|0|||
164189038|NCT05305989|593060433|FG000|Overall Study|Sponsor decision|2|||
164189039|NCT05305989|593060434|FG001|Overall Study|Sponsor decision|1|||
164189040|NCT05305989|593060435|FG002|Overall Study|Sponsor decision|0|||
164303755|NCT01646125|593488358|FG001|Overall Study|Untreated|5|||
164303756|NCT01646125|593488357|FG000|Overall Study|Adverse Event|2|||
164303757|NCT01646125|593488358|FG001|Overall Study|Adverse Event|1|||
164303758|NCT01646125|593488357|FG000|Overall Study|Death|1|||
164303759|NCT01646125|593488358|FG001|Overall Study|Death|1|||
164303760|NCT01646125|593488357|FG000|Overall Study|Physician Decision|1|||
164303761|NCT01646125|593488358|FG001|Overall Study|Physician Decision|3|||
164303762|NCT01646125|593488357|FG000|Overall Study|Progressive disease|22|||
164303763|NCT01646125|593488358|FG001|Overall Study|Progressive disease|16|||
164303764|NCT01646125|593488357|FG000|Overall Study|Study terminated by sponsor|2|||
164303765|NCT01646125|593488358|FG001|Overall Study|Study terminated by sponsor|1|||
164303766|NCT01646125|593488357|FG000|Overall Study|Subject/Guardian decision|1|||
164303767|NCT01646125|593488358|FG001|Overall Study|Subject/Guardian decision|1|||
164303768|NCT02105662|593488359|FG000|Overall Study|Lost to Follow-up|5|||
164303769|NCT02105662|593488359|FG000|Overall Study|Withdrawal by Subject|1|||
164303770|NCT01417377|593488362|FG000|Overall Study|Lost to Follow-up|12|||
164303771|NCT01417377|593488362|FG000|Overall Study|Enrolled, but not treated|1|||
164303772|NCT02113982|593488363|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
164303773|NCT02113982|593488364|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
164303774|NCT02113982|593488365|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
164303775|NCT02113982|593488366|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
164303776|NCT02113982|593488367|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
164303777|NCT02113982|593488368|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
164303778|NCT02113982|593488369|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
164303779|NCT02113982|593488370|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
164303780|NCT02113982|593488371|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
164303781|NCT02113982|593488372|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
164303782|NCT02113982|593488373|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
164303783|NCT02113982|593488374|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
164303784|NCT02113982|593488375|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
164303785|NCT02113982|593488376|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
164418157|NCT01744496|593901094|FG001|Titration Period|Personal reasons|1|||
164189041|NCT05305989|593060433|FG000|Overall Study|Protocol Violation|0|||
164189042|NCT05305989|593060434|FG001|Overall Study|Protocol Violation|1|||
164189043|NCT05305989|593060435|FG002|Overall Study|Protocol Violation|0|||
164189044|NCT05305989|593060433|FG000|Overall Study|Investigator decision|1|||
164189045|NCT05305989|593060434|FG001|Overall Study|Investigator decision|2|||
164303786|NCT02113982|593488363|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
164303787|NCT02113982|593488364|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
164303788|NCT02113982|593488365|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
164303789|NCT02113982|593488366|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
164303790|NCT02113982|593488367|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
164303791|NCT02113982|593488368|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
164303792|NCT02113982|593488369|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
164303793|NCT02113982|593488370|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
164303794|NCT02113982|593488371|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
164418158|NCT01744496|593901093|FG000|Maintenance Period|Adverse Event|1|||
164418159|NCT01744496|593901094|FG001|Maintenance Period|Adverse Event|3|||
164418160|NCT01744496|593901093|FG000|Maintenance Period|Protocol Violation|1|||
164418161|NCT01744496|593901094|FG001|Maintenance Period|Protocol Violation|0|||
164418162|NCT01744496|593901093|FG000|Maintenance Period|Withdrawal by Subject|1|||
164418163|NCT01744496|593901094|FG001|Maintenance Period|Withdrawal by Subject|1|||
164303795|NCT02113982|593488372|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
164303796|NCT02113982|593488373|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
164303797|NCT02113982|593488374|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
164303798|NCT02113982|593488375|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
164303799|NCT02113982|593488376|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
164303800|NCT02113982|593488363|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303801|NCT02113982|593488364|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303802|NCT02113982|593488365|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303803|NCT02113982|593488366|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303804|NCT02113982|593488367|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303805|NCT02113982|593488368|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303806|NCT02113982|593488369|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
164303807|NCT02113982|593488370|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303808|NCT02113982|593488371|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303809|NCT02113982|593488372|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303810|NCT02113982|593488373|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303811|NCT02113982|593488374|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303812|NCT02113982|593488375|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303813|NCT02113982|593488376|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303814|NCT02113982|593488363|FG000|Stage 1: Dose Escalation|Transplant|0|||
164303815|NCT02113982|593488364|FG001|Stage 1: Dose Escalation|Transplant|1|||
164303816|NCT02113982|593488365|FG002|Stage 1: Dose Escalation|Transplant|0|||
164303817|NCT02113982|593488366|FG003|Stage 1: Dose Escalation|Transplant|0|||
164303818|NCT02113982|593488367|FG004|Stage 1: Dose Escalation|Transplant|0|||
164303819|NCT02113982|593488368|FG005|Stage 1: Dose Escalation|Transplant|1|||
164303820|NCT02113982|593488369|FG006|Stage 1: Dose Escalation|Transplant|0|||
164303821|NCT02113982|593488370|FG007|Stage 1: Dose Escalation|Transplant|0|||
164303822|NCT02113982|593488371|FG008|Stage 1: Dose Escalation|Transplant|0|||
164303823|NCT02113982|593488372|FG009|Stage 1: Dose Escalation|Transplant|0|||
164303824|NCT02113982|593488373|FG010|Stage 1: Dose Escalation|Transplant|0|||
164303825|NCT02113982|593488374|FG011|Stage 1: Dose Escalation|Transplant|0|||
164303826|NCT02113982|593488375|FG012|Stage 1: Dose Escalation|Transplant|0|||
164303827|NCT02113982|593488376|FG013|Stage 1: Dose Escalation|Transplant|0|||
164532912|NCT03037619|594322136|FG001|Overall Study|Lost to Follow-up|1|||
164532913|NCT00307125|594322137|FG000|Screening Phase|Adverse Event|1|||
164532914|NCT00307125|594322138|FG001|Screening Phase|Adverse Event|0|||
164532915|NCT00307125|594322139|FG002|Screening Phase|Adverse Event|0|||
164532916|NCT00307125|594322137|FG000|Screening Phase|Protocol Violation|27|||
164532917|NCT00307125|594322138|FG001|Screening Phase|Protocol Violation|0|||
164532918|NCT00307125|594322139|FG002|Screening Phase|Protocol Violation|0|||
164532919|NCT00307125|594322137|FG000|Screening Phase|Lost to Follow-up|87|||
164532920|NCT00307125|594322138|FG001|Screening Phase|Lost to Follow-up|0|||
164532921|NCT00307125|594322139|FG002|Screening Phase|Lost to Follow-up|0|||
164532922|NCT00307125|594322137|FG000|Screening Phase|Death|10|||
164648206|NCT00422058|594738531|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
164648207|NCT00422058|594738532|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
164648208|NCT00422058|594738533|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
164648209|NCT00422058|594738534|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
164648210|NCT00422058|594738535|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
164648211|NCT00422058|594738536|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
164648212|NCT00422058|594738531|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
164532923|NCT00307125|594322138|FG001|Screening Phase|Death|0|||
164648213|NCT00422058|594738532|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
164648214|NCT00422058|594738533|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
164303828|NCT02113982|593488363|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
164303829|NCT02113982|593488364|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
164303830|NCT02113982|593488365|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
164532924|NCT00307125|594322139|FG002|Screening Phase|Death|0|||
164532925|NCT00307125|594322137|FG000|Screening Phase|Withdrawal by Subject|77|||
164303831|NCT02113982|593488366|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
164303832|NCT02113982|593488367|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
164303833|NCT02113982|593488368|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
164303834|NCT02113982|593488369|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
164303835|NCT02113982|593488370|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
164303836|NCT02113982|593488371|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
164303837|NCT02113982|593488372|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
164303838|NCT02113982|593488373|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
164303839|NCT02113982|593488374|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
164303840|NCT02113982|593488375|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
164303841|NCT02113982|593488376|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
164532926|NCT00307125|594322138|FG001|Screening Phase|Withdrawal by Subject|0|||
164532927|NCT00307125|594322139|FG002|Screening Phase|Withdrawal by Subject|0|||
164532928|NCT00307125|594322137|FG000|Screening Phase|Physician Decision|26|||
164532929|NCT00307125|594322138|FG001|Screening Phase|Physician Decision|0|||
164532930|NCT00307125|594322139|FG002|Screening Phase|Physician Decision|0|||
164532931|NCT00307125|594322137|FG000|Screening Phase|Sponsor Decision|4|||
164532932|NCT00307125|594322138|FG001|Screening Phase|Sponsor Decision|0|||
164532933|NCT00307125|594322139|FG002|Screening Phase|Sponsor Decision|0|||
164532934|NCT00307125|594322137|FG000|Screening Phase|Study Terminated|17|||
164532935|NCT00307125|594322138|FG001|Screening Phase|Study Terminated|0|||
164532936|NCT00307125|594322139|FG002|Screening Phase|Study Terminated|0|||
164532937|NCT00307125|594322137|FG000|Screening Phase|Graft Loss|3|||
164532938|NCT00307125|594322138|FG001|Screening Phase|Graft Loss|0|||
164532939|NCT00307125|594322139|FG002|Screening Phase|Graft Loss|0|||
164532940|NCT00307125|594322137|FG000|Screening Phase|Graft Failure|8|||
164532941|NCT00307125|594322138|FG001|Screening Phase|Graft Failure|0|||
164532942|NCT00307125|594322139|FG002|Screening Phase|Graft Failure|0|||
164532943|NCT00307125|594322137|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
164532944|NCT00307125|594322138|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
164532945|NCT00307125|594322139|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
164532946|NCT00307125|594322137|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
164532947|NCT00307125|594322138|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
164532948|NCT00307125|594322139|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
164648215|NCT00422058|594738534|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
164532949|NCT00307125|594322137|FG000|Screening Phase|Moved or transferred facilities|34|||
164532950|NCT00307125|594322138|FG001|Screening Phase|Moved or transferred facilities|0|||
164532951|NCT00307125|594322139|FG002|Screening Phase|Moved or transferred facilities|0|||
164532952|NCT00307125|594322137|FG000|Screening Phase|Received Pancreas Transplant|8|||
164532953|NCT00307125|594322138|FG001|Screening Phase|Received Pancreas Transplant|0|||
164532954|NCT00307125|594322139|FG002|Screening Phase|Received Pancreas Transplant|0|||
164532955|NCT00307125|594322137|FG000|Screening Phase|Ineligible for pilot|4|||
164532956|NCT00307125|594322138|FG001|Screening Phase|Ineligible for pilot|0|||
164532957|NCT00307125|594322139|FG002|Screening Phase|Ineligible for pilot|0|||
164532958|NCT00307125|594322137|FG000|Screening Phase|Try to get pregnant|1|||
164532959|NCT00307125|594322138|FG001|Screening Phase|Try to get pregnant|0|||
164532960|NCT00307125|594322139|FG002|Screening Phase|Try to get pregnant|0|||
164532961|NCT00307125|594322137|FG000|Screening Phase|Developed acute leukemia|1|||
164532962|NCT00307125|594322138|FG001|Screening Phase|Developed acute leukemia|0|||
164532963|NCT00307125|594322139|FG002|Screening Phase|Developed acute leukemia|0|||
164532964|NCT00307125|594322137|FG000|Screening Phase|Metastatic colon cancer|1|||
164532965|NCT00307125|594322138|FG001|Screening Phase|Metastatic colon cancer|0|||
164532966|NCT00307125|594322139|FG002|Screening Phase|Metastatic colon cancer|0|||
164532967|NCT00307125|594322137|FG000|Screening Phase|Malignancy|1|||
164532968|NCT00307125|594322138|FG001|Screening Phase|Malignancy|0|||
164532969|NCT00307125|594322139|FG002|Screening Phase|Malignancy|0|||
164532970|NCT00307125|594322137|FG000|Screening Phase|PAK|1|||
164532971|NCT00307125|594322138|FG001|Screening Phase|PAK|0|||
164532972|NCT00307125|594322139|FG002|Screening Phase|PAK|0|||
164532973|NCT00307125|594322137|FG000|Screening Phase|Ineligible|1|||
164532974|NCT00307125|594322138|FG001|Screening Phase|Ineligible|0|||
164532975|NCT00307125|594322139|FG002|Screening Phase|Ineligible|0|||
164532976|NCT00307125|594322137|FG000|Screening Phase|Screen Error|1|||
164532977|NCT00307125|594322138|FG001|Screening Phase|Screen Error|0|||
164648216|NCT00422058|594738535|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
164648217|NCT00422058|594738536|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
164648218|NCT00422058|594738531|FG000|Double-Blind, Week 0-20|Other|11|||
164648219|NCT00422058|594738532|FG001|Double-Blind, Week 0-20|Other|3|||
164532978|NCT00307125|594322139|FG002|Screening Phase|Screen Error|0|||
164532979|NCT00307125|594322137|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
164532980|NCT00307125|594322138|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
164532981|NCT00307125|594322139|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
164532982|NCT00307125|594322137|FG000|Screening Phase|AMR and treated with rituximab|1|||
164648220|NCT00422058|594738533|FG002|Double-Blind, Week 0-20|Other|8|||
164303842|NCT02113982|593488363|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
164532983|NCT00307125|594322138|FG001|Screening Phase|AMR and treated with rituximab|0|||
164303843|NCT02113982|593488364|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
164303844|NCT02113982|593488365|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
164303845|NCT02113982|593488366|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
164303846|NCT02113982|593488367|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
164303847|NCT02113982|593488368|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
164303848|NCT02113982|593488369|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
164303849|NCT02113982|593488370|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
164303850|NCT02113982|593488371|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
164303851|NCT02113982|593488372|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
164303852|NCT02113982|593488373|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
164303853|NCT02113982|593488374|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
164303854|NCT02113982|593488375|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
164303855|NCT02113982|593488376|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
164303856|NCT02113982|593488363|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
164303857|NCT02113982|593488364|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
164303858|NCT02113982|593488365|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
164303859|NCT02113982|593488366|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
164303860|NCT02113982|593488367|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
164303861|NCT02113982|593488368|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
164303862|NCT02113982|593488369|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
164303863|NCT02113982|593488370|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
164303864|NCT02113982|593488371|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
164303865|NCT02113982|593488372|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
164303866|NCT02113982|593488373|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
164303867|NCT02113982|593488374|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
164303868|NCT02113982|593488375|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
164303869|NCT02113982|593488376|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
164303870|NCT02113982|593488363|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
164303871|NCT02113982|593488364|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
164303872|NCT02113982|593488365|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
164303873|NCT02113982|593488366|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
164303874|NCT02113982|593488367|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
164303875|NCT02113982|593488368|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
164303876|NCT02113982|593488369|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
164303877|NCT02113982|593488370|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
164303878|NCT02113982|593488371|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
164303879|NCT02113982|593488372|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
164303880|NCT02113982|593488373|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
164303881|NCT02113982|593488374|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
164303882|NCT02113982|593488375|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
164303883|NCT02113982|593488376|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
164303884|NCT02113982|593488363|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
164303885|NCT02113982|593488364|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
164303886|NCT02113982|593488365|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
164303887|NCT02113982|593488366|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
164303888|NCT02113982|593488367|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
164303889|NCT02113982|593488368|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
164303890|NCT02113982|593488369|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
164303891|NCT02113982|593488370|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
164303892|NCT02113982|593488371|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
164303893|NCT02113982|593488372|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
164303894|NCT02113982|593488373|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
164303895|NCT02113982|593488374|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
164303896|NCT02113982|593488375|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
164303897|NCT02113982|593488376|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
164303898|NCT02113982|593488363|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
164303899|NCT02113982|593488364|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
164303900|NCT02113982|593488365|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
164303901|NCT02113982|593488366|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
164303902|NCT02113982|593488367|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
164303903|NCT02113982|593488368|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
164303904|NCT02113982|593488369|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
164303905|NCT02113982|593488370|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
164303906|NCT02113982|593488371|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
164303907|NCT02113982|593488372|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
164303908|NCT02113982|593488373|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
164303909|NCT02113982|593488374|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
164303910|NCT02113982|593488375|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
164303911|NCT02113982|593488376|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
164303912|NCT02113982|593488363|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164648221|NCT00422058|594738534|FG003|Double-Blind, Week 0-20|Other|8|||
164303913|NCT02113982|593488364|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164303914|NCT02113982|593488365|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164303915|NCT02113982|593488366|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164303916|NCT02113982|593488367|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164303917|NCT02113982|593488368|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164303918|NCT02113982|593488369|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164303919|NCT02113982|593488370|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
164303920|NCT02113982|593488371|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164303921|NCT02113982|593488372|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164303922|NCT02113982|593488373|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164303923|NCT02113982|593488374|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164303924|NCT02113982|593488375|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164303925|NCT02113982|593488376|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164303926|NCT02113982|593488363|FG000|Stage 2: Cohort Expansion|Transplant|0|||
164303927|NCT02113982|593488364|FG001|Stage 2: Cohort Expansion|Transplant|0|||
164303928|NCT02113982|593488365|FG002|Stage 2: Cohort Expansion|Transplant|0|||
164303929|NCT02113982|593488366|FG003|Stage 2: Cohort Expansion|Transplant|0|||
164303930|NCT02113982|593488367|FG004|Stage 2: Cohort Expansion|Transplant|0|||
164303931|NCT02113982|593488368|FG005|Stage 2: Cohort Expansion|Transplant|0|||
164303932|NCT02113982|593488369|FG006|Stage 2: Cohort Expansion|Transplant|0|||
164303933|NCT02113982|593488370|FG007|Stage 2: Cohort Expansion|Transplant|0|||
164303934|NCT02113982|593488371|FG008|Stage 2: Cohort Expansion|Transplant|0|||
164303935|NCT02113982|593488372|FG009|Stage 2: Cohort Expansion|Transplant|4|||
164303936|NCT02113982|593488373|FG010|Stage 2: Cohort Expansion|Transplant|2|||
164303937|NCT02113982|593488374|FG011|Stage 2: Cohort Expansion|Transplant|0|||
164303938|NCT02113982|593488375|FG012|Stage 2: Cohort Expansion|Transplant|0|||
164303939|NCT02113982|593488376|FG013|Stage 2: Cohort Expansion|Transplant|0|||
164303940|NCT02113982|593488363|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
164303941|NCT02113982|593488364|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
164303942|NCT02113982|593488365|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
164303943|NCT02113982|593488366|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
164303944|NCT02113982|593488367|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
164303945|NCT02113982|593488368|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
164303946|NCT02113982|593488369|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
164303947|NCT02113982|593488370|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
164303948|NCT02113982|593488371|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
164303949|NCT02113982|593488372|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
164303950|NCT02113982|593488373|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
164303951|NCT02113982|593488374|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
164303952|NCT02113982|593488375|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
164303953|NCT02113982|593488376|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
164303954|NCT02113982|593488363|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
164303955|NCT02113982|593488364|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
164303956|NCT02113982|593488365|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
164303957|NCT02113982|593488366|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
164418164|NCT01744496|593901093|FG000|Maintenance Period|Subject left town|1|||
164418165|NCT01744496|593901094|FG001|Maintenance Period|Subject left town|0|||
164418166|NCT01284140|593901095|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
164418167|NCT01284140|593901096|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
164418168|NCT01284140|593901095|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
164418169|NCT01284140|593901096|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
164418170|NCT03853317|593901097|FG000|Overall Study|Progressive Disease|5|||
164418171|NCT03853317|593901097|FG000|Overall Study|Adverse Event|1|||
164418172|NCT03853317|593901097|FG000|Overall Study|Death|1|||
164418173|NCT03853317|593901097|FG000|Overall Study|other event|2|||
164418174|NCT01551303|593901109|FG000|Overall Study|failed awareness check on vision test|4|||
164418175|NCT01551303|593901110|FG001|Overall Study|failed awareness check on vision test|7|||
164418176|NCT02141659|593901114|FG000|Overall Study|Major Protocol Deviation|0|||
164418177|NCT02141659|593901115|FG001|Overall Study|Major Protocol Deviation|1|||
164418178|NCT02141659|593901116|FG002|Overall Study|Major Protocol Deviation|0|||
164418179|NCT02141659|593901117|FG003|Overall Study|Major Protocol Deviation|0|||
164418180|NCT02141659|593901118|FG004|Overall Study|Major Protocol Deviation|0|||
164648222|NCT00422058|594738535|FG004|Double-Blind, Week 0-20|Other|4|||
164418181|NCT02141659|593901119|FG005|Overall Study|Major Protocol Deviation|0|||
164418182|NCT02141659|593901114|FG000|Overall Study|Lack of Efficacy|0|||
164418183|NCT02141659|593901115|FG001|Overall Study|Lack of Efficacy|0|||
164418184|NCT02141659|593901116|FG002|Overall Study|Lack of Efficacy|0|||
164648223|NCT00422058|594738536|FG005|Double-Blind, Week 0-20|Other|10|||
164418185|NCT02141659|593901117|FG003|Overall Study|Lack of Efficacy|0|||
164418186|NCT02141659|593901118|FG004|Overall Study|Lack of Efficacy|0|||
164418187|NCT02141659|593901119|FG005|Overall Study|Lack of Efficacy|1|||
164418188|NCT02141659|593901114|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
164418189|NCT02141659|593901115|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
164418190|NCT02141659|593901116|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
164418191|NCT02141659|593901117|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
164418192|NCT02141659|593901118|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
164418193|NCT02141659|593901119|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
164418194|NCT01927731|593901120|FG000|Overall Study|Graft Failure|1|||
164418195|NCT01927731|593901121|FG001|Overall Study|Graft Failure|2|||
164648224|NCT00422058|594738531|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
164648225|NCT00422058|594738532|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
164418196|NCT01927731|593901120|FG000|Overall Study|Physician Decision|2|||
164418197|NCT01927731|593901121|FG001|Overall Study|Physician Decision|3|||
164418198|NCT01927731|593901120|FG000|Overall Study|Withdrawal by Subject|0|||
164418199|NCT01927731|593901121|FG001|Overall Study|Withdrawal by Subject|2|||
164418200|NCT01927731|593901120|FG000|Overall Study|Death|0|||
164418201|NCT01927731|593901121|FG001|Overall Study|Death|3|||
164418202|NCT00305864|593901124|FG000|Overall Study|Ineligible / No protocol treatment|0|||
164418203|NCT00305864|593901125|FG001|Overall Study|Ineligible / No protocol treatment|1|||
164418204|NCT00305864|593901126|FG002|Overall Study|Ineligible / No protocol treatment|1|||
164418205|NCT00305864|593901127|FG003|Overall Study|Ineligible / No protocol treatment|13|||
164418206|NCT02065570|593901128|FG000|Induction Study|Adverse Event|5|||
164418207|NCT02065570|593901129|FG001|Induction Study|Adverse Event|12|||
164418208|NCT02065570|593901130|FG002|Induction Study|Adverse Event|0|||
164418209|NCT02065570|593901131|FG003|Induction Study|Adverse Event|0|||
164418210|NCT02065570|593901128|FG000|Induction Study|Withdrawal by Subject|2|||
164418211|NCT02065570|593901129|FG001|Induction Study|Withdrawal by Subject|3|||
164418212|NCT02065570|593901130|FG002|Induction Study|Withdrawal by Subject|0|||
164418213|NCT02065570|593901131|FG003|Induction Study|Withdrawal by Subject|0|||
164418214|NCT02065570|593901128|FG000|Induction Study|Lost to Follow-up|1|||
164418215|NCT02065570|593901129|FG001|Induction Study|Lost to Follow-up|1|||
164418216|NCT02065570|593901130|FG002|Induction Study|Lost to Follow-up|0|||
164418217|NCT02065570|593901131|FG003|Induction Study|Lost to Follow-up|0|||
164418218|NCT02065570|593901128|FG000|Induction Study|Other, Not Specified|6|||
164418219|NCT02065570|593901129|FG001|Induction Study|Other, Not Specified|5|||
164418220|NCT02065570|593901130|FG002|Induction Study|Other, Not Specified|0|||
164418221|NCT02065570|593901131|FG003|Induction Study|Other, Not Specified|0|||
164418222|NCT02065570|593901128|FG000|Maintenance Study|Adverse Event|0|||
164418223|NCT02065570|593901129|FG001|Maintenance Study|Adverse Event|0|||
164418224|NCT02065570|593901130|FG002|Maintenance Study|Adverse Event|8|||
164418225|NCT02065570|593901131|FG003|Maintenance Study|Adverse Event|8|||
164418226|NCT02065570|593901128|FG000|Maintenance Study|Withdrawal by Subject|0|||
164418227|NCT02065570|593901129|FG001|Maintenance Study|Withdrawal by Subject|0|||
164418228|NCT02065570|593901130|FG002|Maintenance Study|Withdrawal by Subject|1|||
164418229|NCT02065570|593901131|FG003|Maintenance Study|Withdrawal by Subject|4|||
164418230|NCT02065570|593901128|FG000|Maintenance Study|Lost to Follow-up|0|||
164418231|NCT02065570|593901129|FG001|Maintenance Study|Lost to Follow-up|0|||
164418232|NCT02065570|593901130|FG002|Maintenance Study|Lost to Follow-up|2|||
164418233|NCT02065570|593901131|FG003|Maintenance Study|Lost to Follow-up|2|||
164418234|NCT02065570|593901128|FG000|Maintenance Study|Other, Not Specified|0|||
164418235|NCT02065570|593901129|FG001|Maintenance Study|Other, Not Specified|0|||
164418236|NCT02065570|593901130|FG002|Maintenance Study|Other, Not Specified|11|||
164418237|NCT02065570|593901131|FG003|Maintenance Study|Other, Not Specified|5|||
164418238|NCT02743793|593901132|FG000|Overall Study|Death|1|||
164418239|NCT02743793|593901133|FG001|Overall Study|Death|1|||
164418240|NCT02743793|593901132|FG000|Overall Study|Withdrawal by Subject|0|||
164418241|NCT02743793|593901133|FG001|Overall Study|Withdrawal by Subject|1|||
164418242|NCT02743793|593901132|FG000|Overall Study|Screen Failure|4|||
164418243|NCT02743793|593901133|FG001|Overall Study|Screen Failure|0|||
164418244|NCT02743793|593901132|FG000|Overall Study|No Primary Care Physician|0|||
164418245|NCT02743793|593901133|FG001|Overall Study|No Primary Care Physician|1|||
164418246|NCT02743793|593901132|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
164418247|NCT02743793|593901133|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
164418248|NCT02743793|593901132|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
164418249|NCT02743793|593901133|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
164418250|NCT02589392|593901134|FG000|Overall Study|Adverse Event|1|||
164418251|NCT02589392|593901135|FG001|Overall Study|Adverse Event|1|||
164418252|NCT02589392|593901134|FG000|Overall Study|Withdrawal by Subject|1|||
164418253|NCT02589392|593901135|FG001|Overall Study|Withdrawal by Subject|2|||
164418254|NCT02589392|593901134|FG000|Overall Study|Protocol Violation|1|||
164418255|NCT02589392|593901135|FG001|Overall Study|Protocol Violation|1|||
164418256|NCT02589392|593901134|FG000|Overall Study|Lost to Follow-up|2|||
164418257|NCT02589392|593901135|FG001|Overall Study|Lost to Follow-up|2|||
164418258|NCT02589392|593901134|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
164418259|NCT02589392|593901135|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
164418260|NCT00322374|593901137|FG000|Starting Dose|Physician Decision|2|||
164418261|NCT00322374|593901138|FG001|Starting Dose|Physician Decision|0|||
164418262|NCT00322374|593901139|FG002|Starting Dose|Physician Decision|0|||
164418263|NCT00322374|593901140|FG003|Starting Dose|Physician Decision|0|||
164418264|NCT00322374|593901137|FG000|Starting Dose|Study Drug Toxicity|4|||
164418265|NCT00322374|593901138|FG001|Starting Dose|Study Drug Toxicity|0|||
164418266|NCT00322374|593901139|FG002|Starting Dose|Study Drug Toxicity|0|||
164418267|NCT00322374|593901140|FG003|Starting Dose|Study Drug Toxicity|0|||
164418268|NCT00322374|593901137|FG000|First Escalation|Documented Disease Progression|0|||
164418269|NCT00322374|593901138|FG001|First Escalation|Documented Disease Progression|6|||
164418270|NCT00322374|593901139|FG002|First Escalation|Documented Disease Progression|0|||
164418271|NCT00322374|593901140|FG003|First Escalation|Documented Disease Progression|0|||
164418272|NCT00322374|593901137|FG000|First Escalation|Physician Decision|0|||
164418273|NCT00322374|593901138|FG001|First Escalation|Physician Decision|12|||
164418274|NCT00322374|593901139|FG002|First Escalation|Physician Decision|0|||
164418275|NCT00322374|593901140|FG003|First Escalation|Physician Decision|0|||
164418276|NCT00322374|593901137|FG000|First Escalation|Study Drug Toxicity|0|||
164418277|NCT00322374|593901138|FG001|First Escalation|Study Drug Toxicity|11|||
164418278|NCT00322374|593901139|FG002|First Escalation|Study Drug Toxicity|0|||
164418279|NCT00322374|593901140|FG003|First Escalation|Study Drug Toxicity|0|||
164418280|NCT00322374|593901137|FG000|First Escalation|Participant Request|0|||
164418281|NCT00322374|593901138|FG001|First Escalation|Participant Request|1|||
164418282|NCT00322374|593901139|FG002|First Escalation|Participant Request|0|||
164418283|NCT00322374|593901140|FG003|First Escalation|Participant Request|0|||
164418284|NCT00322374|593901137|FG000|Second Escalation|Physician Decision|0|||
164418285|NCT00322374|593901138|FG001|Second Escalation|Physician Decision|0|||
164418286|NCT00322374|593901139|FG002|Second Escalation|Physician Decision|5|||
164418287|NCT00322374|593901140|FG003|Second Escalation|Physician Decision|0|||
164418288|NCT00322374|593901137|FG000|Second Escalation|Study Drug Toxicity|0|||
164418289|NCT00322374|593901138|FG001|Second Escalation|Study Drug Toxicity|0|||
164418290|NCT00322374|593901139|FG002|Second Escalation|Study Drug Toxicity|1|||
164418291|NCT00322374|593901140|FG003|Second Escalation|Study Drug Toxicity|0|||
164418292|NCT03382600|593901141|FG000|Overall Study|Adverse Event|3|||
164418293|NCT03382600|593901142|FG001|Overall Study|Adverse Event|3|||
164418294|NCT03382600|593901141|FG000|Overall Study|Clinical Disease Progression|2|||
164418295|NCT03382600|593901142|FG001|Overall Study|Clinical Disease Progression|4|||
164418296|NCT03382600|593901141|FG000|Overall Study|Radiological Progression|40|||
164418297|NCT03382600|593901142|FG001|Overall Study|Radiological Progression|31|||
164418298|NCT03382600|593901141|FG000|Overall Study|Withdrawal by Subject|0|||
164418299|NCT03382600|593901142|FG001|Overall Study|Withdrawal by Subject|1|||
164418300|NCT03382600|593901141|FG000|Overall Study|Other|9|||
164418301|NCT03382600|593901142|FG001|Overall Study|Other|7|||
164418302|NCT02269943|593901143|FG000|Treatment Period|Death|0|||
164418303|NCT02269943|593901144|FG001|Treatment Period|Death|1|||
164418304|NCT02269943|593901143|FG000|Treatment Period|Adverse Event|1|||
164418305|NCT02269943|593901144|FG001|Treatment Period|Adverse Event|10|||
164418306|NCT02269943|593901143|FG000|Treatment Period|Progressive Disease|5|||
164418307|NCT02269943|593901144|FG001|Treatment Period|Progressive Disease|17|||
164418308|NCT02269943|593901143|FG000|Treatment Period|Symptomatic Deterioration|0|||
164418309|NCT02269943|593901144|FG001|Treatment Period|Symptomatic Deterioration|2|||
164418310|NCT02269943|593901143|FG000|Follow-Up Survival Period|Death|3|||
164418311|NCT02269943|593901144|FG001|Follow-Up Survival Period|Death|16|||
164418312|NCT02269943|593901143|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
164418313|NCT02269943|593901144|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
164418314|NCT02269943|593901143|FG000|Follow-Up Survival Period|Alive|2|||
164418315|NCT02269943|593901144|FG001|Follow-Up Survival Period|Alive|8|||
164418316|NCT04642469|593901145|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
164418317|NCT04642469|593901146|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
164418318|NCT04642469|593901145|FG000|Overall Study|Death|1|||
164418319|NCT04642469|593901146|FG001|Overall Study|Death|2|||
164418320|NCT04642469|593901145|FG000|Overall Study|Study/site closed following amendment 1|11|||
164418321|NCT04642469|593901146|FG001|Overall Study|Study/site closed following amendment 1|11|||
164418322|NCT04642469|593901145|FG000|Overall Study|Other|1|||
164418323|NCT04642469|593901146|FG001|Overall Study|Other|1|||
164418324|NCT04642469|593901145|FG000|Overall Study|Withdrawal by Subject|1|||
164418325|NCT04642469|593901146|FG001|Overall Study|Withdrawal by Subject|0|||
164418326|NCT02733042|593901147|FG000|Overall Study|Adverse Event|1|||
164418327|NCT02733042|593901148|FG001|Overall Study|Adverse Event|0|||
164418328|NCT02733042|593901149|FG002|Overall Study|Adverse Event|1|||
164418329|NCT02733042|593901150|FG003|Overall Study|Adverse Event|1|||
164418330|NCT02733042|593901151|FG004|Overall Study|Adverse Event|0|||
164418331|NCT02733042|593901152|FG005|Overall Study|Adverse Event|0|||
164418332|NCT02733042|593901153|FG006|Overall Study|Adverse Event|0|||
164694646|NCT04039919|594905304|FG002|Treatment Period 5|Withdrawal by Subject|0|||
164418333|NCT02733042|593901154|FG007|Overall Study|Adverse Event|0|||
164418334|NCT02733042|593901155|FG008|Overall Study|Adverse Event|0|||
164418335|NCT02733042|593901156|FG009|Overall Study|Adverse Event|0|||
164418336|NCT02733042|593901157|FG010|Overall Study|Adverse Event|2|||
164418337|NCT02733042|593901158|FG011|Overall Study|Adverse Event|2|||
164418338|NCT02733042|593901159|FG012|Overall Study|Adverse Event|0|||
164418339|NCT02733042|593901160|FG013|Overall Study|Adverse Event|2|||
164418340|NCT02733042|593901161|FG014|Overall Study|Adverse Event|0|||
164418341|NCT02733042|593901162|FG015|Overall Study|Adverse Event|0|||
164418342|NCT02733042|593901163|FG016|Overall Study|Adverse Event|0|||
164418343|NCT02733042|593901164|FG017|Overall Study|Adverse Event|1|||
164418344|NCT02733042|593901165|FG018|Overall Study|Adverse Event|0|||
164418345|NCT02733042|593901147|FG000|Overall Study|Progressive Disease|2|||
164418346|NCT02733042|593901148|FG001|Overall Study|Progressive Disease|1|||
164418347|NCT02733042|593901149|FG002|Overall Study|Progressive Disease|3|||
164418348|NCT02733042|593901150|FG003|Overall Study|Progressive Disease|1|||
164418349|NCT02733042|593901151|FG004|Overall Study|Progressive Disease|2|||
164418350|NCT02733042|593901152|FG005|Overall Study|Progressive Disease|3|||
164418351|NCT02733042|593901153|FG006|Overall Study|Progressive Disease|0|||
164418352|NCT02733042|593901154|FG007|Overall Study|Progressive Disease|3|||
164418353|NCT02733042|593901155|FG008|Overall Study|Progressive Disease|3|||
164418354|NCT02733042|593901156|FG009|Overall Study|Progressive Disease|2|||
164418355|NCT02733042|593901157|FG010|Overall Study|Progressive Disease|2|||
164418356|NCT02733042|593901158|FG011|Overall Study|Progressive Disease|2|||
164418357|NCT02733042|593901159|FG012|Overall Study|Progressive Disease|8|||
164418358|NCT02733042|593901160|FG013|Overall Study|Progressive Disease|1|||
164418359|NCT02733042|593901161|FG014|Overall Study|Progressive Disease|4|||
164418360|NCT02733042|593901162|FG015|Overall Study|Progressive Disease|7|||
164418361|NCT02733042|593901163|FG016|Overall Study|Progressive Disease|2|||
164418362|NCT02733042|593901164|FG017|Overall Study|Progressive Disease|3|||
164418363|NCT02733042|593901165|FG018|Overall Study|Progressive Disease|4|||
164418364|NCT02733042|593901147|FG000|Overall Study|Withdrawal by Subject|0|||
164418365|NCT02733042|593901148|FG001|Overall Study|Withdrawal by Subject|1|||
164418366|NCT02733042|593901149|FG002|Overall Study|Withdrawal by Subject|2|||
164189046|NCT05305989|593060435|FG002|Overall Study|Investigator decision|0|||
164189047|NCT05305989|593060433|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
164189048|NCT05305989|593060434|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
164189049|NCT05305989|593060435|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
164189050|NCT05305989|593060433|FG000|Overall Study|Adverse Event|1|||
164189051|NCT05305989|593060434|FG001|Overall Study|Adverse Event|1|||
164189052|NCT05305989|593060435|FG002|Overall Study|Adverse Event|0|||
164189053|NCT05305989|593060433|FG000|Overall Study|Enrolled but never dosed|3|||
164189054|NCT05305989|593060434|FG001|Overall Study|Enrolled but never dosed|2|||
164189055|NCT05305989|593060435|FG002|Overall Study|Enrolled but never dosed|1|||
164189056|NCT03162328|593060436|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
164189057|NCT03162328|593060437|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
164189058|NCT03162328|593060438|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
164189059|NCT03162328|593060436|FG000|Screening Period|Withdrawal by Subject|1|||
164189060|NCT03162328|593060437|FG001|Screening Period|Withdrawal by Subject|0|||
164189061|NCT03162328|593060438|FG002|Screening Period|Withdrawal by Subject|0|||
164189062|NCT03162328|593060436|FG000|Study Period|Withdrawal by Subject|0|||
164189063|NCT03162328|593060437|FG001|Study Period|Withdrawal by Subject|0|||
164189064|NCT03162328|593060438|FG002|Study Period|Withdrawal by Subject|1|||
164189065|NCT00913770|593060439|FG000|Overall Study|Unable to contact|24|||
164189066|NCT00913770|593060440|FG001|Overall Study|Unable to contact|19|||
164189067|NCT00913770|593060441|FG002|Overall Study|Unable to contact|13|||
164189068|NCT00913770|593060439|FG000|Overall Study|Refused|11|||
164189069|NCT00913770|593060440|FG001|Overall Study|Refused|10|||
164189070|NCT00913770|593060441|FG002|Overall Study|Refused|8|||
164189071|NCT01990768|593060442|FG000|Intervention Started|Found to be ineligible|14|||
164189072|NCT01990768|593060443|FG001|Intervention Started|Found to be ineligible|13|||
164189073|NCT01990768|593060444|FG002|Intervention Started|Found to be ineligible|11|||
164189074|NCT01990768|593060442|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
164189075|NCT01990768|593060443|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
164189076|NCT01990768|593060444|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
164189077|NCT01990768|593060442|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
164189078|NCT01990768|593060443|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
164189079|NCT01990768|593060444|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
164189080|NCT01990768|593060442|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
164189081|NCT01990768|593060443|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
164189082|NCT01990768|593060444|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
164189083|NCT01990768|593060442|FG000|Intervention Started|Patient care priority|1|||
164418367|NCT02733042|593901150|FG003|Overall Study|Withdrawal by Subject|1|||
164418368|NCT02733042|593901151|FG004|Overall Study|Withdrawal by Subject|1|||
164418369|NCT02733042|593901152|FG005|Overall Study|Withdrawal by Subject|0|||
164418370|NCT02733042|593901153|FG006|Overall Study|Withdrawal by Subject|0|||
164418371|NCT02733042|593901154|FG007|Overall Study|Withdrawal by Subject|0|||
164418372|NCT02733042|593901155|FG008|Overall Study|Withdrawal by Subject|1|||
164418373|NCT02733042|593901156|FG009|Overall Study|Withdrawal by Subject|1|||
164418374|NCT02733042|593901157|FG010|Overall Study|Withdrawal by Subject|0|||
164418375|NCT02733042|593901158|FG011|Overall Study|Withdrawal by Subject|2|||
164418376|NCT02733042|593901159|FG012|Overall Study|Withdrawal by Subject|1|||
164418377|NCT02733042|593901160|FG013|Overall Study|Withdrawal by Subject|1|||
164418378|NCT02733042|593901161|FG014|Overall Study|Withdrawal by Subject|0|||
164418379|NCT02733042|593901162|FG015|Overall Study|Withdrawal by Subject|0|||
164418380|NCT02733042|593901163|FG016|Overall Study|Withdrawal by Subject|0|||
164418381|NCT02733042|593901164|FG017|Overall Study|Withdrawal by Subject|0|||
164418382|NCT02733042|593901165|FG018|Overall Study|Withdrawal by Subject|0|||
164418383|NCT02733042|593901147|FG000|Overall Study|Other Reasons|0|||
164418384|NCT02733042|593901148|FG001|Overall Study|Other Reasons|0|||
164418385|NCT02733042|593901149|FG002|Overall Study|Other Reasons|1|||
164418386|NCT02733042|593901150|FG003|Overall Study|Other Reasons|0|||
164418387|NCT02733042|593901151|FG004|Overall Study|Other Reasons|0|||
164418388|NCT02733042|593901152|FG005|Overall Study|Other Reasons|0|||
164418389|NCT02733042|593901153|FG006|Overall Study|Other Reasons|0|||
164418390|NCT02733042|593901154|FG007|Overall Study|Other Reasons|0|||
164418391|NCT02733042|593901155|FG008|Overall Study|Other Reasons|0|||
164418392|NCT02733042|593901156|FG009|Overall Study|Other Reasons|1|||
164418393|NCT02733042|593901157|FG010|Overall Study|Other Reasons|1|||
164418394|NCT02733042|593901158|FG011|Overall Study|Other Reasons|0|||
164418395|NCT02733042|593901159|FG012|Overall Study|Other Reasons|0|||
164418396|NCT02733042|593901160|FG013|Overall Study|Other Reasons|0|||
164418397|NCT02733042|593901161|FG014|Overall Study|Other Reasons|0|||
164418398|NCT02733042|593901162|FG015|Overall Study|Other Reasons|1|||
164418399|NCT02733042|593901163|FG016|Overall Study|Other Reasons|0|||
164418400|NCT02733042|593901164|FG017|Overall Study|Other Reasons|1|||
164418401|NCT02733042|593901165|FG018|Overall Study|Other Reasons|0|||
164418402|NCT02733042|593901147|FG000|Overall Study|Death|0|||
164418403|NCT02733042|593901148|FG001|Overall Study|Death|0|||
164418404|NCT02733042|593901149|FG002|Overall Study|Death|0|||
164648226|NCT00422058|594738533|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
164648227|NCT00422058|594738534|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
164648228|NCT00422058|594738535|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
164648229|NCT00422058|594738536|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
164648230|NCT00422058|594738531|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
164648231|NCT00422058|594738532|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
164648232|NCT00422058|594738533|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
164648233|NCT00422058|594738534|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
164648234|NCT00422058|594738535|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
164648235|NCT00422058|594738536|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
164648236|NCT00422058|594738531|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
164648237|NCT00422058|594738532|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
164648238|NCT00422058|594738533|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
164648239|NCT00422058|594738534|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
164648240|NCT00422058|594738535|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
164648241|NCT00422058|594738536|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
164648242|NCT00422058|594738531|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
164648243|NCT00422058|594738532|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
164648244|NCT00422058|594738533|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
164648245|NCT00422058|594738534|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
164648246|NCT00422058|594738535|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
164648247|NCT00422058|594738536|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
164648248|NCT00422058|594738531|FG000|Open-Label Extension, Week 20-104|Other|13|||
164648249|NCT00422058|594738532|FG001|Open-Label Extension, Week 20-104|Other|14|||
164648250|NCT00422058|594738533|FG002|Open-Label Extension, Week 20-104|Other|6|||
164648251|NCT00422058|594738534|FG003|Open-Label Extension, Week 20-104|Other|13|||
164648252|NCT00422058|594738535|FG004|Open-Label Extension, Week 20-104|Other|16|||
164648253|NCT00422058|594738536|FG005|Open-Label Extension, Week 20-104|Other|18|||
164648254|NCT00572156|594738539|FG000|Overall Study|Adverse Event|3|||
164648255|NCT00572156|594738540|FG001|Overall Study|Adverse Event|1|||
164648256|NCT00572156|594738541|FG002|Overall Study|Adverse Event|5|||
164648257|NCT00572156|594738542|FG003|Overall Study|Adverse Event|1|||
164648258|NCT00572156|594738539|FG000|Overall Study|Lost to Follow-up|1|||
164648259|NCT00572156|594738540|FG001|Overall Study|Lost to Follow-up|1|||
164418405|NCT02733042|593901150|FG003|Overall Study|Death|0|||
164418406|NCT02733042|593901151|FG004|Overall Study|Death|0|||
164418407|NCT02733042|593901152|FG005|Overall Study|Death|0|||
164418408|NCT02733042|593901153|FG006|Overall Study|Death|1|||
164418409|NCT02733042|593901154|FG007|Overall Study|Death|0|||
164418410|NCT02733042|593901155|FG008|Overall Study|Death|1|||
164418411|NCT02733042|593901156|FG009|Overall Study|Death|0|||
164418412|NCT02733042|593901157|FG010|Overall Study|Death|1|||
164418413|NCT02733042|593901158|FG011|Overall Study|Death|0|||
164418414|NCT02733042|593901159|FG012|Overall Study|Death|0|||
164418415|NCT02733042|593901160|FG013|Overall Study|Death|0|||
164648260|NCT00572156|594738541|FG002|Overall Study|Lost to Follow-up|1|||
164648261|NCT00572156|594738542|FG003|Overall Study|Lost to Follow-up|0|||
164648262|NCT00572156|594738539|FG000|Overall Study|Protocol Violation|1|||
164648263|NCT00572156|594738540|FG001|Overall Study|Protocol Violation|2|||
164648264|NCT00572156|594738541|FG002|Overall Study|Protocol Violation|0|||
164648265|NCT00572156|594738542|FG003|Overall Study|Protocol Violation|2|||
164648266|NCT00572156|594738539|FG000|Overall Study|Patient/Parent Decision|1|||
164648267|NCT00572156|594738540|FG001|Overall Study|Patient/Parent Decision|6|||
164648268|NCT00572156|594738541|FG002|Overall Study|Patient/Parent Decision|4|||
164648269|NCT00572156|594738542|FG003|Overall Study|Patient/Parent Decision|3|||
164648270|NCT00572156|594738539|FG000|Overall Study|Sponsor Decision|20|||
164648271|NCT00572156|594738540|FG001|Overall Study|Sponsor Decision|16|||
164648272|NCT00572156|594738541|FG002|Overall Study|Sponsor Decision|17|||
164648273|NCT00572156|594738542|FG003|Overall Study|Sponsor Decision|19|||
164648274|NCT02030834|594738543|FG000|Overall Study|Death|4|||
164648275|NCT02030834|594738544|FG001|Overall Study|Death|0|||
164648276|NCT02030834|594738545|FG002|Overall Study|Death|0|||
164648277|NCT02030834|594738543|FG000|Overall Study|Manufacturing failure|2|||
164648278|NCT02030834|594738544|FG001|Overall Study|Manufacturing failure|0|||
164648279|NCT02030834|594738545|FG002|Overall Study|Manufacturing failure|1|||
164648280|NCT02030834|594738543|FG000|Overall Study|Disease progression|2|||
164648281|NCT02030834|594738544|FG001|Overall Study|Disease progression|0|||
164648282|NCT02030834|594738545|FG002|Overall Study|Disease progression|2|||
164648283|NCT02030834|594738543|FG000|Overall Study|Lost to Follow-up|1|||
164648284|NCT02030834|594738544|FG001|Overall Study|Lost to Follow-up|0|||
164648285|NCT02030834|594738545|FG002|Overall Study|Lost to Follow-up|0|||
164648286|NCT02030834|594738543|FG000|Overall Study|Withdrawal by Subject|1|||
164648287|NCT02030834|594738544|FG001|Overall Study|Withdrawal by Subject|0|||
164648288|NCT02030834|594738545|FG002|Overall Study|Withdrawal by Subject|0|||
164648289|NCT02030834|594738543|FG000|Overall Study|Lack of funding|1|||
164648290|NCT02030834|594738544|FG001|Overall Study|Lack of funding|0|||
164648291|NCT02030834|594738545|FG002|Overall Study|Lack of funding|0|||
164648292|NCT03216954|594738548|FG000|Overall Study|Adverse Event|0|||
164648293|NCT03216954|594738549|FG001|Overall Study|Adverse Event|0|||
164648294|NCT03216954|594738550|FG002|Overall Study|Adverse Event|1|||
164648295|NCT03216954|594738551|FG003|Overall Study|Adverse Event|0|||
164648296|NCT03216954|594738552|FG004|Overall Study|Adverse Event|1|||
164648297|NCT03216954|594738548|FG000|Overall Study|Withdrawal by Subject|2|||
164648298|NCT03216954|594738549|FG001|Overall Study|Withdrawal by Subject|0|||
164648299|NCT03216954|594738550|FG002|Overall Study|Withdrawal by Subject|0|||
164648300|NCT03216954|594738551|FG003|Overall Study|Withdrawal by Subject|0|||
164648301|NCT03216954|594738552|FG004|Overall Study|Withdrawal by Subject|0|||
164648302|NCT03216954|594738548|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
164648303|NCT03216954|594738549|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
164694647|NCT04039919|594905305|FG003|Treatment Period 5|Withdrawal by Subject|0|||
164694648|NCT04039919|594905306|FG004|Treatment Period 5|Withdrawal by Subject|0|||
164418416|NCT02733042|593901161|FG014|Overall Study|Death|1|||
164418417|NCT02733042|593901162|FG015|Overall Study|Death|2|||
164418418|NCT02733042|593901163|FG016|Overall Study|Death|0|||
164418419|NCT02733042|593901164|FG017|Overall Study|Death|0|||
164418420|NCT02733042|593901165|FG018|Overall Study|Death|0|||
164418421|NCT02066532|593901172|FG000|Phase II|Withdrawal by Subject|1|||
164418422|NCT02066532|593901173|FG001|Phase II|Withdrawal by Subject|0|||
164418423|NCT02066532|593901174|FG002|Phase II|Withdrawal by Subject|0|||
164418424|NCT02066532|593901175|FG003|Phase II|Withdrawal by Subject|0|||
164418425|NCT05033080|593901176|FG000|Overall Study|Adverse Event|4|||
164418426|NCT05033080|593901177|FG001|Overall Study|Adverse Event|4|||
164418427|NCT05033080|593901176|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
164418428|NCT05033080|593901177|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
164418429|NCT05033080|593901176|FG000|Overall Study|Lost to Follow-up|1|||
164418430|NCT05033080|593901177|FG001|Overall Study|Lost to Follow-up|0|||
164418431|NCT05033080|593901176|FG000|Overall Study|Other non-compliance|0|||
164418432|NCT05033080|593901177|FG001|Overall Study|Other non-compliance|1|||
164694649|NCT03250299|594905307|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
164694650|NCT03250299|594905308|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
164694651|NCT03250299|594905309|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
164694652|NCT03250299|594905310|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
164694653|NCT03250299|594905311|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
164694654|NCT03250299|594905307|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
164694655|NCT03250299|594905308|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
164694656|NCT03250299|594905309|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
164694657|NCT03250299|594905310|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
164694658|NCT03250299|594905311|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
164694659|NCT03250299|594905307|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
164694660|NCT03250299|594905308|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
164694661|NCT03250299|594905309|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
164694662|NCT03250299|594905310|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
164418433|NCT05033080|593901176|FG000|Overall Study|Physician Decision|0|||
164418434|NCT05033080|593901177|FG001|Overall Study|Physician Decision|1|||
164418435|NCT05033080|593901176|FG000|Overall Study|Other|1|||
164418436|NCT05033080|593901177|FG001|Overall Study|Other|1|||
164418437|NCT02303626|593901178|FG000|Overall Study|Lack of Efficacy|1|||
164418438|NCT02303626|593901179|FG001|Overall Study|Lack of Efficacy|0|||
164418439|NCT02303626|593901180|FG002|Overall Study|Lack of Efficacy|1|||
164418440|NCT02303626|593901178|FG000|Overall Study|Adverse Event|0|||
164418441|NCT02303626|593901179|FG001|Overall Study|Adverse Event|2|||
164418442|NCT02303626|593901180|FG002|Overall Study|Adverse Event|0|||
164418443|NCT02303626|593901178|FG000|Overall Study|Protocol Violation|0|||
164418444|NCT02303626|593901179|FG001|Overall Study|Protocol Violation|1|||
164418445|NCT02303626|593901180|FG002|Overall Study|Protocol Violation|0|||
164418446|NCT02303626|593901178|FG000|Overall Study|Pregnancy|0|||
164418447|NCT02303626|593901179|FG001|Overall Study|Pregnancy|0|||
164418448|NCT02303626|593901180|FG002|Overall Study|Pregnancy|1|||
164418449|NCT02303626|593901178|FG000|Overall Study|Subject Non-Compliance|0|||
164418450|NCT02303626|593901179|FG001|Overall Study|Subject Non-Compliance|0|||
164418451|NCT02303626|593901180|FG002|Overall Study|Subject Non-Compliance|1|||
164418452|NCT05832437|593901181|FG000|Overall Study|time off work|1|||
164418453|NCT05832437|593901182|FG001|Overall Study|time off work|0|||
164418454|NCT05832437|593901183|FG002|Overall Study|time off work|0|||
164418455|NCT05832437|593901184|FG003|Overall Study|time off work|0|||
164418456|NCT05376371|593901185|FG000|Overall Study|change in release date|10|||
164418457|NCT04159415|593901186|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
164418458|NCT04159415|593901187|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
164418459|NCT04159415|593901188|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
164418460|NCT04159415|593901189|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
164418461|NCT04159415|593901190|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
164418462|NCT04159415|593901191|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
164418463|NCT04159415|593901192|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
164418464|NCT04159415|593901193|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
164418465|NCT04159415|593901194|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
164418466|NCT04159415|593901195|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
164418467|NCT04159415|593901186|FG000|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
164418468|NCT04159415|593901187|FG001|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
164418469|NCT04159415|593901188|FG002|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
164418470|NCT04159415|593901189|FG003|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
164418471|NCT04159415|593901190|FG004|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
164418472|NCT04159415|593901191|FG005|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
164418473|NCT04159415|593901192|FG006|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
164418474|NCT04159415|593901193|FG007|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|1|||
164418475|NCT04159415|593901194|FG008|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
164418476|NCT04159415|593901195|FG009|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
164418477|NCT04159415|593901186|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
164418478|NCT04159415|593901187|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
164418479|NCT04159415|593901188|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
164418480|NCT04159415|593901189|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
164418481|NCT04159415|593901190|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
164418482|NCT04159415|593901191|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
164418483|NCT04159415|593901192|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
164418484|NCT04159415|593901193|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|1|||
164418485|NCT04159415|593901194|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
164418486|NCT04159415|593901195|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
164418487|NCT04159415|593901186|FG000|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
164418488|NCT04159415|593901187|FG001|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
164418489|NCT04159415|593901188|FG002|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
164418490|NCT04159415|593901189|FG003|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
164418491|NCT04159415|593901190|FG004|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
164418492|NCT04159415|593901191|FG005|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
164532984|NCT00307125|594322139|FG002|Screening Phase|AMR and treated with rituximab|0|||
164418493|NCT04159415|593901192|FG006|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
164418494|NCT04159415|593901193|FG007|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
164418495|NCT04159415|593901194|FG008|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
164418496|NCT04159415|593901195|FG009|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|1|||
164418497|NCT00337662|593901196|FG000|Study Period II|Lost to Follow-up|0|||
164418498|NCT00337662|593901197|FG001|Study Period II|Lost to Follow-up|0|||
164418499|NCT00337662|593901198|FG002|Study Period II|Lost to Follow-up|0|||
164189084|NCT01990768|593060443|FG001|Intervention Started|Patient care priority|2|||
164418500|NCT00337662|593901199|FG003|Study Period II|Lost to Follow-up|35|||
164418501|NCT00337662|593901196|FG000|Study Period II|Withdrawal by Subject|0|||
164418502|NCT00337662|593901197|FG001|Study Period II|Withdrawal by Subject|0|||
164418503|NCT00337662|593901198|FG002|Study Period II|Withdrawal by Subject|0|||
164418504|NCT00337662|593901199|FG003|Study Period II|Withdrawal by Subject|20|||
164418505|NCT00337662|593901196|FG000|Study Period II|Adverse Event|0|||
164418506|NCT00337662|593901197|FG001|Study Period II|Adverse Event|0|||
164418507|NCT00337662|593901198|FG002|Study Period II|Adverse Event|0|||
164418508|NCT00337662|593901199|FG003|Study Period II|Adverse Event|16|||
164418509|NCT00337662|593901196|FG000|Study Period II|Physician Decision|0|||
164418510|NCT00337662|593901197|FG001|Study Period II|Physician Decision|0|||
164418511|NCT00337662|593901198|FG002|Study Period II|Physician Decision|0|||
164418512|NCT00337662|593901199|FG003|Study Period II|Physician Decision|13|||
164418513|NCT00337662|593901196|FG000|Study Period II|Entry Criteria Not Met|0|||
164418514|NCT00337662|593901197|FG001|Study Period II|Entry Criteria Not Met|0|||
164418515|NCT00337662|593901198|FG002|Study Period II|Entry Criteria Not Met|0|||
164418516|NCT00337662|593901199|FG003|Study Period II|Entry Criteria Not Met|6|||
164418517|NCT00337662|593901196|FG000|Study Period II|Protocol Violation|0|||
164418518|NCT00337662|593901197|FG001|Study Period II|Protocol Violation|0|||
164418519|NCT00337662|593901198|FG002|Study Period II|Protocol Violation|0|||
164418520|NCT00337662|593901199|FG003|Study Period II|Protocol Violation|6|||
164418521|NCT00337662|593901196|FG000|Study Period II|Lack of Efficacy|0|||
164418522|NCT00337662|593901197|FG001|Study Period II|Lack of Efficacy|0|||
164418523|NCT00337662|593901198|FG002|Study Period II|Lack of Efficacy|0|||
164418524|NCT00337662|593901199|FG003|Study Period II|Lack of Efficacy|7|||
164418525|NCT00337662|593901196|FG000|Study Period II|Sponsor Decision|0|||
164418526|NCT00337662|593901197|FG001|Study Period II|Sponsor Decision|0|||
164418527|NCT00337662|593901198|FG002|Study Period II|Sponsor Decision|0|||
164418528|NCT00337662|593901199|FG003|Study Period II|Sponsor Decision|2|||
164418529|NCT00337662|593901196|FG000|Study Period II|Parent/Caregiver Decision|0|||
164418530|NCT00337662|593901197|FG001|Study Period II|Parent/Caregiver Decision|0|||
164418531|NCT00337662|593901198|FG002|Study Period II|Parent/Caregiver Decision|0|||
164418532|NCT00337662|593901199|FG003|Study Period II|Parent/Caregiver Decision|1|||
164189085|NCT01990768|593060444|FG002|Intervention Started|Patient care priority|3|||
164189086|NCT01990768|593060442|FG000|Intervention Started|IV lost|2|||
164418533|NCT00337662|593901196|FG000|Study Period III|Lost to Follow-up|14|||
164418534|NCT00337662|593901197|FG001|Study Period III|Lost to Follow-up|16|||
164418535|NCT00337662|593901198|FG002|Study Period III|Lost to Follow-up|14|||
164418536|NCT00337662|593901199|FG003|Study Period III|Lost to Follow-up|0|||
164418537|NCT00337662|593901196|FG000|Study Period III|Withdrawal by Subject|18|||
164418538|NCT00337662|593901197|FG001|Study Period III|Withdrawal by Subject|14|||
164418539|NCT00337662|593901198|FG002|Study Period III|Withdrawal by Subject|12|||
164418540|NCT00337662|593901199|FG003|Study Period III|Withdrawal by Subject|0|||
164418541|NCT00337662|593901196|FG000|Study Period III|Adverse Event|9|||
164418542|NCT00337662|593901197|FG001|Study Period III|Adverse Event|10|||
164418543|NCT00337662|593901198|FG002|Study Period III|Adverse Event|8|||
164418544|NCT00337662|593901199|FG003|Study Period III|Adverse Event|0|||
164418545|NCT00337662|593901196|FG000|Study Period III|Protocol Violation|3|||
164418546|NCT00337662|593901197|FG001|Study Period III|Protocol Violation|8|||
164418547|NCT00337662|593901198|FG002|Study Period III|Protocol Violation|2|||
164418548|NCT00337662|593901199|FG003|Study Period III|Protocol Violation|0|||
164418549|NCT00337662|593901196|FG000|Study Period III|Physician Decision|6|||
164418550|NCT00337662|593901197|FG001|Study Period III|Physician Decision|5|||
164418551|NCT00337662|593901198|FG002|Study Period III|Physician Decision|0|||
164418552|NCT00337662|593901199|FG003|Study Period III|Physician Decision|0|||
164418553|NCT00337662|593901196|FG000|Study Period III|Entry Criteria Not Met|4|||
164418554|NCT00337662|593901197|FG001|Study Period III|Entry Criteria Not Met|1|||
164418555|NCT00337662|593901198|FG002|Study Period III|Entry Criteria Not Met|3|||
164189087|NCT01990768|593060443|FG001|Intervention Started|IV lost|2|||
164418556|NCT00337662|593901199|FG003|Study Period III|Entry Criteria Not Met|0|||
164418557|NCT00337662|593901196|FG000|Study Period III|Lack of Efficacy|4|||
164418558|NCT00337662|593901197|FG001|Study Period III|Lack of Efficacy|4|||
164418559|NCT00337662|593901198|FG002|Study Period III|Lack of Efficacy|2|||
164418560|NCT00337662|593901199|FG003|Study Period III|Lack of Efficacy|0|||
164418561|NCT00337662|593901196|FG000|Study Period III|Parent/Caregiver Decision|0|||
164418562|NCT00337662|593901197|FG001|Study Period III|Parent/Caregiver Decision|0|||
164418563|NCT00337662|593901198|FG002|Study Period III|Parent/Caregiver Decision|2|||
164418564|NCT00337662|593901199|FG003|Study Period III|Parent/Caregiver Decision|0|||
164418565|NCT00337662|593901196|FG000|Study Period III|Sponsor Decision|1|||
164418566|NCT00337662|593901197|FG001|Study Period III|Sponsor Decision|0|||
164418567|NCT00337662|593901198|FG002|Study Period III|Sponsor Decision|1|||
164418568|NCT00337662|593901199|FG003|Study Period III|Sponsor Decision|0|||
164418569|NCT00337662|593901196|FG000|Study Period III|Clinical Relapse|1|||
164418570|NCT00337662|593901197|FG001|Study Period III|Clinical Relapse|0|||
164418571|NCT00337662|593901198|FG002|Study Period III|Clinical Relapse|0|||
164418572|NCT00337662|593901199|FG003|Study Period III|Clinical Relapse|0|||
164418573|NCT00882921|593901200|FG000|Overall Study|Death|2|||
164418574|NCT00882921|593901200|FG000|Overall Study|Other|3|||
164418575|NCT00882921|593901200|FG000|Overall Study|Lost to Follow-up|2|||
164418576|NCT00882921|593901200|FG000|Overall Study|Termination By Investigator|3|||
164418577|NCT00882921|593901200|FG000|Overall Study|Withdrawal Of Consent|1|||
164418578|NCT01233609|593901212|FG000|Overall Study|Death|1|||
164418579|NCT01233609|593901213|FG001|Overall Study|Death|0|||
164418580|NCT01233609|593901212|FG000|Overall Study|Lost to Follow-up|3|||
164418581|NCT01233609|593901213|FG001|Overall Study|Lost to Follow-up|1|||
164418582|NCT01233609|593901212|FG000|Overall Study|Adverse Event|2|||
164418583|NCT01233609|593901213|FG001|Overall Study|Adverse Event|1|||
164418584|NCT01233609|593901212|FG000|Overall Study|Withdrawal by Subject|3|||
164189088|NCT01990768|593060444|FG002|Intervention Started|IV lost|2|||
164189089|NCT01990768|593060442|FG000|Intervention Started|Required CPR|1|||
164418585|NCT01233609|593901213|FG001|Overall Study|Withdrawal by Subject|0|||
164418586|NCT00383240|593901214|FG000|Overall Study|Adverse Event|4|||
164189090|NCT01990768|593060443|FG001|Intervention Started|Required CPR|1|||
164189091|NCT01990768|593060444|FG002|Intervention Started|Required CPR|0|||
164303958|NCT02113982|593488367|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
164189092|NCT01990768|593060442|FG000|Intervention Started|Seizure or hx of seizure|0|||
164418587|NCT00383240|593901215|FG001|Overall Study|Adverse Event|6|||
164418588|NCT00383240|593901216|FG002|Overall Study|Adverse Event|9|||
164418589|NCT00383240|593901217|FG003|Overall Study|Adverse Event|7|||
164189093|NCT01990768|593060443|FG001|Intervention Started|Seizure or hx of seizure|0|||
164189094|NCT01990768|593060444|FG002|Intervention Started|Seizure or hx of seizure|2|||
164189095|NCT01990768|593060442|FG000|Intervention Started|Discovered to be pregnant|0|||
164189096|NCT01990768|593060443|FG001|Intervention Started|Discovered to be pregnant|1|||
164189097|NCT01990768|593060444|FG002|Intervention Started|Discovered to be pregnant|0|||
164189098|NCT01990768|593060442|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
164189099|NCT01990768|593060443|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
164189100|NCT01990768|593060444|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
164189101|NCT01990768|593060442|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
164189102|NCT01990768|593060443|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
164189103|NCT01990768|593060444|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
164189104|NCT01990768|593060442|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
164189105|NCT01990768|593060443|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
164189106|NCT01990768|593060444|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
164189107|NCT01990768|593060442|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
164189108|NCT01990768|593060443|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
164189109|NCT01990768|593060444|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
164189110|NCT01990768|593060442|FG000|Prehospital Study Drug Infusion|Death|3|||
164189111|NCT01990768|593060443|FG001|Prehospital Study Drug Infusion|Death|1|||
164189112|NCT01990768|593060444|FG002|Prehospital Study Drug Infusion|Death|1|||
164189113|NCT01990768|593060442|FG000|Prehospital Study Drug Infusion|Discharged|2|||
164189114|NCT01990768|593060443|FG001|Prehospital Study Drug Infusion|Discharged|1|||
164189115|NCT01990768|593060444|FG002|Prehospital Study Drug Infusion|Discharged|0|||
164189116|NCT01990768|593060442|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
164189117|NCT01990768|593060443|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
164189118|NCT01990768|593060444|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
164189119|NCT01990768|593060442|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
164189120|NCT01990768|593060443|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
164189121|NCT01990768|593060444|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
164189122|NCT01990768|593060442|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
164189123|NCT01990768|593060443|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
164189124|NCT01990768|593060444|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
164189125|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
164532985|NCT00307125|594322137|FG000|Screening Phase|Coronary artery bypass|1|||
164532986|NCT00307125|594322138|FG001|Screening Phase|Coronary artery bypass|0|||
164418590|NCT00383240|593901214|FG000|Overall Study|Treatment Failure|8|||
164418591|NCT00383240|593901215|FG001|Overall Study|Treatment Failure|13|||
164648304|NCT03216954|594738550|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
164189126|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
164189127|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
164189128|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
164189129|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
164189130|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
164189131|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
164189132|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
164189133|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
164189134|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
164189135|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
164189136|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
164189137|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
164189138|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
164189139|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
164189140|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
164189141|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
164189142|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
164189143|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
164189144|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
164189145|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
164189146|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
164189147|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
164189148|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
164189149|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
164189150|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
164189151|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
164189152|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
164189153|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
164189154|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
164189155|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
164189156|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
164189157|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
164189158|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
164189159|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
164189160|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
164189161|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
164189162|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
164189163|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
164189164|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
164189165|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
164189166|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
164189167|NCT01990768|593060442|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
164189168|NCT01990768|593060443|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
164418592|NCT00383240|593901216|FG002|Overall Study|Treatment Failure|47|||
164418593|NCT00383240|593901217|FG003|Overall Study|Treatment Failure|46|||
164418594|NCT00383240|593901214|FG000|Overall Study|Lost to Follow-up|3|||
164418595|NCT00383240|593901215|FG001|Overall Study|Lost to Follow-up|0|||
164418596|NCT00383240|593901216|FG002|Overall Study|Lost to Follow-up|0|||
164418597|NCT00383240|593901217|FG003|Overall Study|Lost to Follow-up|2|||
164418598|NCT00383240|593901214|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
164418599|NCT00383240|593901215|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
164589056|NCT01070550|594521374|FG002|Overall Study|Adverse Event|3|||
164189169|NCT01990768|593060444|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
164189170|NCT01990768|593060442|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
164189171|NCT01990768|593060443|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
164189172|NCT01990768|593060444|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
164189173|NCT01990768|593060442|FG000|6-Month Follow-up|No contact information|5|||
164189174|NCT01990768|593060443|FG001|6-Month Follow-up|No contact information|6|||
164189175|NCT01990768|593060444|FG002|6-Month Follow-up|No contact information|5|||
164189176|NCT01990768|593060442|FG000|6-Month Follow-up|Homeless|4|||
164189177|NCT01990768|593060443|FG001|6-Month Follow-up|Homeless|3|||
164189178|NCT01990768|593060444|FG002|6-Month Follow-up|Homeless|6|||
164189179|NCT01990768|593060442|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
164189180|NCT01990768|593060443|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
164189181|NCT01990768|593060444|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
164189182|NCT01990768|593060442|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
164189183|NCT01990768|593060443|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
164189184|NCT01990768|593060444|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
164189185|NCT01990768|593060442|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
164189186|NCT01990768|593060443|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
164189187|NCT01990768|593060444|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
164189188|NCT02348008|593060445|FG000|Overall Study|Adverse Event|2|||
164189189|NCT02348008|593060446|FG001|Overall Study|Adverse Event|3|||
164189190|NCT02348008|593060447|FG002|Overall Study|Adverse Event|3|||
164189191|NCT02348008|593060445|FG000|Overall Study|Disease Progression|1|||
164418600|NCT00383240|593901216|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
164418601|NCT00383240|593901217|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
164418602|NCT00383240|593901214|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
164418603|NCT00383240|593901215|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
164418604|NCT00383240|593901216|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
164418605|NCT00383240|593901217|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
164418606|NCT00383240|593901214|FG000|Overall Study|Protocol Violation|4|||
164418607|NCT00383240|593901215|FG001|Overall Study|Protocol Violation|5|||
164418608|NCT00383240|593901216|FG002|Overall Study|Protocol Violation|9|||
164418609|NCT00383240|593901217|FG003|Overall Study|Protocol Violation|6|||
164418610|NCT00383240|593901214|FG000|Overall Study|Did not meet protocol eligibility|9|||
164418611|NCT00383240|593901215|FG001|Overall Study|Did not meet protocol eligibility|4|||
164418612|NCT00383240|593901216|FG002|Overall Study|Did not meet protocol eligibility|9|||
164418613|NCT00383240|593901217|FG003|Overall Study|Did not meet protocol eligibility|3|||
164418614|NCT00383240|593901214|FG000|Overall Study|Administrative|1|||
164418615|NCT00383240|593901215|FG001|Overall Study|Administrative|1|||
164418616|NCT00383240|593901216|FG002|Overall Study|Administrative|0|||
164418617|NCT00383240|593901217|FG003|Overall Study|Administrative|0|||
164418618|NCT02049710|593901218|FG000|Overall Study|Lost to Follow-up|319|||
164189192|NCT02348008|593060446|FG001|Overall Study|Disease Progression|5|||
164418619|NCT02049710|593901219|FG001|Overall Study|Lost to Follow-up|324|||
164589057|NCT01070550|594521375|FG003|Overall Study|Adverse Event|0|||
164418620|NCT06385483|593901220|FG000|Overall Study|Withdrawal by Subject|2|||
164418621|NCT06385483|593901220|FG000|Overall Study|Never start protocol therapy|2|||
164418622|NCT06385483|593901220|FG000|Overall Study|Disease progression|15|||
164418623|NCT03391960|593901221|FG000|Overall Study|Protocol Violation|0|||
164418624|NCT03391960|593901222|FG001|Overall Study|Protocol Violation|0|||
164437423|NCT02914522|593968189|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
164437424|NCT02914522|593968190|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
164437425|NCT02914522|593968191|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
164437426|NCT02914522|593968192|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
164437427|NCT02914522|593968193|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
164437428|NCT02914522|593968183|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
164437429|NCT02914522|593968184|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
164437430|NCT02914522|593968185|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
164437431|NCT02914522|593968186|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
164437432|NCT02914522|593968187|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
164437433|NCT02914522|593968188|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
164437434|NCT02914522|593968189|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
164437435|NCT02914522|593968190|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
164437436|NCT02914522|593968191|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
164437437|NCT02914522|593968192|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
164437438|NCT02914522|593968193|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
164437439|NCT02914522|593968183|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
164437440|NCT02914522|593968184|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
164437441|NCT02914522|593968185|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
164437442|NCT02914522|593968186|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
164437443|NCT02914522|593968187|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
164437444|NCT02914522|593968188|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
164437445|NCT02914522|593968189|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
164437446|NCT02914522|593968190|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
164437447|NCT02914522|593968191|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
164437448|NCT02914522|593968192|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
164437449|NCT02914522|593968193|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
164437450|NCT02914522|593968183|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
164437451|NCT02914522|593968184|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
164437452|NCT02914522|593968185|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
164437453|NCT02914522|593968186|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
164437454|NCT02914522|593968187|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
164437455|NCT02914522|593968188|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
164437456|NCT02914522|593968189|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
164437457|NCT02914522|593968190|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
164437458|NCT02914522|593968191|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
164437459|NCT02914522|593968192|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
164437460|NCT02914522|593968193|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
164437461|NCT02914522|593968183|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
164437462|NCT02914522|593968184|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
164189193|NCT02348008|593060447|FG002|Overall Study|Disease Progression|16|||
164418625|NCT00581113|593902639|FG000|Overall Study|Withdrawal by Subject|0|||
164418626|NCT00581113|593902640|FG001|Overall Study|Withdrawal by Subject|1|||
164418627|NCT04834362|593902644|FG000|Overall Study|Death|1|||
164418628|NCT04834362|593902645|FG001|Overall Study|Death|2|||
164418629|NCT04781647|593902648|FG000|Overall Study|Study terminated by Sponsor|11|||
164418630|NCT04781647|593902649|FG001|Overall Study|Study terminated by Sponsor|9|||
164418631|NCT04781647|593902650|FG002|Overall Study|Study terminated by Sponsor|9|||
164418632|NCT04781647|593902648|FG000|Overall Study|Withdrawal by Subject|1|||
164418633|NCT04781647|593902649|FG001|Overall Study|Withdrawal by Subject|2|||
164189194|NCT02348008|593060445|FG000|Overall Study|Withdrawal by Subject|0|||
164189195|NCT02348008|593060446|FG001|Overall Study|Withdrawal by Subject|1|||
164189196|NCT02348008|593060447|FG002|Overall Study|Withdrawal by Subject|0|||
164189197|NCT02348008|593060445|FG000|Overall Study|Symptomatic Deterioration|0|||
164189198|NCT02348008|593060446|FG001|Overall Study|Symptomatic Deterioration|1|||
164189199|NCT02348008|593060447|FG002|Overall Study|Symptomatic Deterioration|0|||
164189200|NCT02029274|593060449|FG000|Overall Study|Adverse Event|1|||
164189201|NCT02029274|593060450|FG001|Overall Study|Adverse Event|0|||
164189202|NCT02029274|593060451|FG002|Overall Study|Adverse Event|2|||
164189203|NCT02029274|593060452|FG003|Overall Study|Adverse Event|2|||
164189204|NCT01249833|593060454|FG000|Overall Study|Lost to Follow-up|0|||
164189205|NCT01249833|593060455|FG001|Overall Study|Lost to Follow-up|1|||
164299660|NCT01075243|593472886|FG002|Overall Study|Withdrawal by Subject|0|||
164299661|NCT00627393|593472887|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
164299662|NCT00627393|593472888|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
164299663|NCT00627393|593472887|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
164299664|NCT00627393|593472888|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
164299665|NCT00627393|593472887|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
164299666|NCT00627393|593472888|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
164299667|NCT00627393|593472887|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
164299668|NCT00627393|593472888|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
164299669|NCT00551642|593472891|FG000|Treatment Period|Protocol Deviation|6|||
164299670|NCT00551642|593472892|FG001|Treatment Period|Protocol Deviation|11|||
164299671|NCT00551642|593472891|FG000|Treatment Period|Delivery device failure|1|||
164299672|NCT00551642|593472892|FG001|Treatment Period|Delivery device failure|3|||
164299673|NCT00551642|593472891|FG000|Treatment Period|Physician Decision|0|||
164299674|NCT00551642|593472892|FG001|Treatment Period|Physician Decision|1|||
164299675|NCT00551642|593472891|FG000|Treatment Period|Death|33|||
164299676|NCT00551642|593472892|FG001|Treatment Period|Death|31|||
164299677|NCT00551642|593472891|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
164299678|NCT00551642|593472892|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
164299679|NCT00551642|593472891|FG000|Treatment Period|Adverse Event|15|||
164418634|NCT04781647|593902650|FG002|Overall Study|Withdrawal by Subject|0|||
164418635|NCT04781647|593902648|FG000|Overall Study|Adverse Event|0|||
164418636|NCT04781647|593902649|FG001|Overall Study|Adverse Event|1|||
164418637|NCT04781647|593902650|FG002|Overall Study|Adverse Event|1|||
164418638|NCT04781647|593902648|FG000|Overall Study|Protocol Violation|1|||
164418639|NCT04781647|593902649|FG001|Overall Study|Protocol Violation|0|||
164418640|NCT04781647|593902650|FG002|Overall Study|Protocol Violation|0|||
164418641|NCT04781647|593902648|FG000|Overall Study|Pregnancy|0|||
164418642|NCT04781647|593902649|FG001|Overall Study|Pregnancy|0|||
164418643|NCT04781647|593902650|FG002|Overall Study|Pregnancy|1|||
164418644|NCT04781647|593902648|FG000|Overall Study|Virology rebounded|1|||
164418645|NCT04781647|593902649|FG001|Overall Study|Virology rebounded|0|||
164418646|NCT04781647|593902650|FG002|Overall Study|Virology rebounded|0|||
164418647|NCT00329719|593902651|FG000|Overall Study|Lost to Follow-up|0|||
164418648|NCT00329719|593902652|FG001|Overall Study|Lost to Follow-up|0|||
164418649|NCT00329719|593902653|FG002|Overall Study|Lost to Follow-up|0|||
164418650|NCT00329719|593902654|FG003|Overall Study|Lost to Follow-up|1|||
164418651|NCT06017999|593902655|FG000|Overall Study|Withdrawal by Subject|0|||
164299680|NCT00551642|593472892|FG001|Treatment Period|Adverse Event|12|||
164418652|NCT06017999|593902656|FG001|Overall Study|Withdrawal by Subject|4|||
164418653|NCT06017999|593902657|FG002|Overall Study|Withdrawal by Subject|3|||
164418654|NCT06017999|593902655|FG000|Overall Study|Adverse Event|2|||
164418655|NCT06017999|593902656|FG001|Overall Study|Adverse Event|1|||
164189206|NCT00669318|593062042|FG000|Overall Study|Withdrawal by Subject|2|||
164189207|NCT02315664|593062043|FG000|Overall Study|Lost to Follow-up|1|||
164189208|NCT02315664|593062044|FG001|Overall Study|Lost to Follow-up|1|||
164189209|NCT02315664|593062043|FG000|Overall Study|Withdrawal by Subject|0|||
164189210|NCT02315664|593062044|FG001|Overall Study|Withdrawal by Subject|3|||
164189211|NCT01677182|593062045|FG000|Overall Study|Adverse Event|2|||
164189212|NCT01677182|593062046|FG001|Overall Study|Adverse Event|1|||
164189213|NCT01677182|593062047|FG002|Overall Study|Adverse Event|8|||
164189214|NCT01677182|593062045|FG000|Overall Study|Protocol Violation|5|||
164189215|NCT01677182|593062046|FG001|Overall Study|Protocol Violation|1|||
164189216|NCT01677182|593062047|FG002|Overall Study|Protocol Violation|4|||
164189217|NCT01677182|593062045|FG000|Overall Study|Lost to Follow-up|4|||
164189218|NCT01677182|593062046|FG001|Overall Study|Lost to Follow-up|0|||
164189219|NCT01677182|593062047|FG002|Overall Study|Lost to Follow-up|3|||
164189220|NCT01677182|593062045|FG000|Overall Study|Withdrawal by Subject|7|||
164189221|NCT01677182|593062046|FG001|Overall Study|Withdrawal by Subject|12|||
164189222|NCT01677182|593062047|FG002|Overall Study|Withdrawal by Subject|10|||
164189223|NCT01677182|593062045|FG000|Overall Study|Study termination|12|||
164189224|NCT01677182|593062046|FG001|Overall Study|Study termination|9|||
164189225|NCT01677182|593062047|FG002|Overall Study|Study termination|11|||
164189226|NCT01677182|593062045|FG000|Overall Study|Lack of Efficacy|3|||
164189227|NCT01677182|593062046|FG001|Overall Study|Lack of Efficacy|0|||
164189228|NCT01677182|593062047|FG002|Overall Study|Lack of Efficacy|1|||
164189229|NCT01677182|593062045|FG000|Overall Study|Other reasons|1|||
164189230|NCT01677182|593062046|FG001|Overall Study|Other reasons|5|||
164189231|NCT01677182|593062047|FG002|Overall Study|Other reasons|2|||
164189232|NCT00667992|593062050|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
164189233|NCT00667992|593062051|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
164189234|NCT00667992|593062050|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
164189235|NCT00667992|593062051|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
164189236|NCT00667992|593062050|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
164189237|NCT00667992|593062051|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
164189238|NCT00667992|593062050|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
164189239|NCT00667992|593062051|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
164189240|NCT00667992|593062050|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
164189241|NCT00667992|593062051|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
164189242|NCT00667992|593062050|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
164189243|NCT00667992|593062051|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
164189244|NCT00667992|593062050|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
164189245|NCT00667992|593062051|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
164189246|NCT00667992|593062050|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
164189247|NCT00667992|593062051|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
164189248|NCT00667992|593062050|FG000|Wash-out|Not within one doubling dilution|4|||
164189249|NCT00667992|593062051|FG001|Wash-out|Not within one doubling dilution|3|||
164189250|NCT00667992|593062050|FG000|Wash-out|Failure to wash-out|2|||
164189251|NCT00667992|593062051|FG001|Wash-out|Failure to wash-out|2|||
164189252|NCT00667992|593062050|FG000|Wash-out|Withdrawal by Subject|1|||
164189253|NCT00667992|593062051|FG001|Wash-out|Withdrawal by Subject|0|||
164189254|NCT00667992|593062050|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
164189255|NCT00667992|593062051|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
164189256|NCT00667992|593062050|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
164189257|NCT00667992|593062051|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
164189258|NCT02748057|593062055|FG000|Overall Study|Adverse Event|1|||
164189259|NCT02748057|593062056|FG001|Overall Study|Adverse Event|0|||
164189260|NCT02748057|593062055|FG000|Overall Study|Physician Decision|0|||
164189261|NCT02748057|593062056|FG001|Overall Study|Physician Decision|1|||
164189262|NCT02748057|593062055|FG000|Overall Study|Protocol Violation|2|||
164189263|NCT02748057|593062056|FG001|Overall Study|Protocol Violation|1|||
164189264|NCT02748057|593062055|FG000|Overall Study|Participant Moved|1|||
164189265|NCT02748057|593062056|FG001|Overall Study|Participant Moved|0|||
164189266|NCT02748057|593062055|FG000|Overall Study|Withdrawal by Subject|1|||
164189267|NCT02748057|593062056|FG001|Overall Study|Withdrawal by Subject|0|||
164189268|NCT03512353|593062058|FG000|Overall Study|Sponsor Decision|3|||
164189269|NCT03512353|593062058|FG000|Overall Study|Death|1|||
164189270|NCT02090283|593062059|FG000|Overall Study|Withdrawal by Subject|6|||
164189271|NCT02090283|593062060|FG001|Overall Study|Withdrawal by Subject|6|||
164189272|NCT02090283|593062061|FG002|Overall Study|Withdrawal by Subject|6|||
164189273|NCT02090283|593062059|FG000|Overall Study|Sponsor Terminated Study|6|||
164189274|NCT02090283|593062060|FG001|Overall Study|Sponsor Terminated Study|6|||
164189275|NCT02090283|593062061|FG002|Overall Study|Sponsor Terminated Study|1|||
164189276|NCT02090283|593062059|FG000|Overall Study|Lost to Follow-up|2|||
164189277|NCT02090283|593062060|FG001|Overall Study|Lost to Follow-up|2|||
164189278|NCT02090283|593062061|FG002|Overall Study|Lost to Follow-up|3|||
164189279|NCT02090283|593062059|FG000|Overall Study|Adverse Event|1|||
164189280|NCT02090283|593062060|FG001|Overall Study|Adverse Event|1|||
164189281|NCT02090283|593062061|FG002|Overall Study|Adverse Event|0|||
164189282|NCT02090283|593062059|FG000|Overall Study|Protocol Violation|2|||
164303959|NCT02113982|593488368|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
164303960|NCT02113982|593488369|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
164303961|NCT02113982|593488370|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
164303962|NCT02113982|593488371|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
164303963|NCT02113982|593488372|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
164303964|NCT02113982|593488373|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
164303965|NCT02113982|593488374|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
164303966|NCT02113982|593488375|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
164303967|NCT02113982|593488376|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
164303968|NCT02113982|593488363|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303969|NCT02113982|593488364|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303970|NCT02113982|593488365|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303971|NCT02113982|593488366|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303972|NCT02113982|593488367|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303973|NCT02113982|593488368|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303974|NCT02113982|593488369|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303975|NCT02113982|593488370|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303976|NCT02113982|593488371|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303977|NCT02113982|593488372|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303978|NCT02113982|593488373|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303979|NCT02113982|593488374|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
164303980|NCT02113982|593488375|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303981|NCT02113982|593488376|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303982|NCT02113982|593488363|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
164303983|NCT02113982|593488364|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
164303984|NCT02113982|593488365|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
164303985|NCT02113982|593488366|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
164418656|NCT06017999|593902657|FG002|Overall Study|Adverse Event|1|||
164189283|NCT02090283|593062060|FG001|Overall Study|Protocol Violation|0|||
164303986|NCT02113982|593488367|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
164303987|NCT02113982|593488368|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
164532987|NCT00307125|594322139|FG002|Screening Phase|Coronary artery bypass|0|||
164303988|NCT02113982|593488369|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
164303989|NCT02113982|593488370|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
164303990|NCT02113982|593488371|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
164303991|NCT02113982|593488372|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
164303992|NCT02113982|593488373|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
164532988|NCT00307125|594322137|FG000|Pilot Phase|Lost to Follow-up|0|||
164303993|NCT02113982|593488374|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
164303994|NCT02113982|593488375|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
164303995|NCT02113982|593488376|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
164303996|NCT02113982|593488363|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164303997|NCT02113982|593488364|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164303998|NCT02113982|593488365|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164303999|NCT02113982|593488366|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164304000|NCT02113982|593488367|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164304001|NCT02113982|593488368|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164304002|NCT02113982|593488369|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164304003|NCT02113982|593488370|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164304004|NCT02113982|593488371|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164304005|NCT02113982|593488372|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164304006|NCT02113982|593488373|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164304007|NCT02113982|593488374|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
164304008|NCT02113982|593488375|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164304009|NCT02113982|593488376|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164304010|NCT02113982|593488363|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
164304011|NCT02113982|593488364|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
164304012|NCT02113982|593488365|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
164304013|NCT02113982|593488366|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
164304014|NCT02113982|593488367|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
164304015|NCT02113982|593488368|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
164304016|NCT02113982|593488369|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
164304017|NCT02113982|593488370|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
164304018|NCT02113982|593488371|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
164304019|NCT02113982|593488372|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
164304020|NCT02113982|593488373|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
164304021|NCT02113982|593488374|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
164304022|NCT02113982|593488375|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
164304023|NCT02113982|593488376|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
164304024|NCT02113982|593488363|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304025|NCT02113982|593488364|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304026|NCT02113982|593488365|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304027|NCT02113982|593488366|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304028|NCT02113982|593488367|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304029|NCT02113982|593488368|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304030|NCT02113982|593488369|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304031|NCT02113982|593488370|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304032|NCT02113982|593488371|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304033|NCT02113982|593488372|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304034|NCT02113982|593488373|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304035|NCT02113982|593488374|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304036|NCT02113982|593488375|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
164304037|NCT02113982|593488376|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304038|NCT02113982|593488363|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
164304039|NCT02113982|593488364|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
164304040|NCT02113982|593488365|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
164418657|NCT06017999|593902655|FG000|Overall Study|Lost to Follow-up|0|||
164532989|NCT00307125|594322138|FG001|Pilot Phase|Lost to Follow-up|1|||
164304041|NCT02113982|593488366|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
164532990|NCT00307125|594322139|FG002|Pilot Phase|Lost to Follow-up|0|||
164532991|NCT00307125|594322137|FG000|Pilot Phase|Withdrawal by Subject|0|||
164189284|NCT02090283|593062061|FG002|Overall Study|Protocol Violation|0|||
164189285|NCT02171429|593062066|FG000|Overall Study|Other|0|||
164189286|NCT02171429|593062067|FG001|Overall Study|Other|1|||
164189287|NCT02171429|593062068|FG002|Overall Study|Other|1|||
164189288|NCT02171429|593062066|FG000|Overall Study|Non-Compliance|0|||
164189289|NCT02171429|593062067|FG001|Overall Study|Non-Compliance|0|||
164189290|NCT02171429|593062068|FG002|Overall Study|Non-Compliance|1|||
164189291|NCT02171429|593062066|FG000|Overall Study|Physician Decision|0|||
164189292|NCT02171429|593062067|FG001|Overall Study|Physician Decision|0|||
164189293|NCT02171429|593062068|FG002|Overall Study|Physician Decision|1|||
164189294|NCT02171429|593062066|FG000|Overall Study|Withdrawal by Subject|1|||
164189295|NCT02171429|593062067|FG001|Overall Study|Withdrawal by Subject|1|||
164189296|NCT02171429|593062068|FG002|Overall Study|Withdrawal by Subject|1|||
164189297|NCT02171429|593062066|FG000|Overall Study|Lost to Follow-up|0|||
164189298|NCT02171429|593062067|FG001|Overall Study|Lost to Follow-up|1|||
164189299|NCT02171429|593062068|FG002|Overall Study|Lost to Follow-up|0|||
164189300|NCT02171429|593062066|FG000|Overall Study|Death|0|||
164189301|NCT02171429|593062067|FG001|Overall Study|Death|0|||
164189302|NCT02171429|593062068|FG002|Overall Study|Death|1|||
164189303|NCT00281697|593062069|FG000|Overall Study|> 60 days since last dose of study drug|4|||
164189304|NCT00281697|593062070|FG001|Overall Study|> 60 days since last dose of study drug|4|||
164189305|NCT00281697|593062069|FG000|Overall Study|Adverse Event|54|||
164189306|NCT00281697|593062070|FG001|Overall Study|Adverse Event|15|||
164189307|NCT00281697|593062069|FG000|Overall Study|Death|8|||
164189308|NCT00281697|593062070|FG001|Overall Study|Death|3|||
164189309|NCT00281697|593062069|FG000|Overall Study|Disease progression|279|||
164189310|NCT00281697|593062070|FG001|Overall Study|Disease progression|149|||
164189311|NCT00281697|593062069|FG000|Overall Study|Other|5|||
164189312|NCT00281697|593062070|FG001|Overall Study|Other|6|||
164189313|NCT00281697|593062069|FG000|Overall Study|Physician's decision to withdraw|15|||
164189314|NCT00281697|593062070|FG001|Overall Study|Physician's decision to withdraw|12|||
164189315|NCT00281697|593062069|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
164189316|NCT00281697|593062070|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
164189317|NCT00281697|593062069|FG000|Overall Study|Did not receive study drug|3|||
164189318|NCT00281697|593062070|FG001|Overall Study|Did not receive study drug|2|||
164189319|NCT00632125|593062071|FG000|Overall Study|Death|82|||
164189320|NCT00632125|593062071|FG000|Overall Study|Withdrawal by Subject|44|||
164189321|NCT00632125|593062071|FG000|Overall Study|Adverse Event|36|||
164189322|NCT00632125|593062071|FG000|Overall Study|Renal transplantation|17|||
164189323|NCT00632125|593062071|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
164189324|NCT00632125|593062071|FG000|Overall Study|Non-compliance|8|||
164189325|NCT00632125|593062071|FG000|Overall Study|Development of uncontrolled hypertension|5|||
164189326|NCT00632125|593062071|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
164189327|NCT00577772|593062074|FG000|Overall Study|Lost to Follow-up|0|||
164189328|NCT00577772|593062075|FG001|Overall Study|Lost to Follow-up|1|||
164189329|NCT00540644|593062079|FG000|Overall Study|Adverse Event|3|||
164189330|NCT00540644|593062080|FG001|Overall Study|Adverse Event|1|||
164189331|NCT00540644|593062079|FG000|Overall Study|Disease Progression|3|||
164189332|NCT00540644|593062080|FG001|Overall Study|Disease Progression|1|||
164189333|NCT00540644|593062079|FG000|Overall Study|Physician Decision|0|||
164189334|NCT00540644|593062080|FG001|Overall Study|Physician Decision|5|||
164189335|NCT00540644|593062079|FG000|Overall Study|Withdrawal by Subject|2|||
164189336|NCT00540644|593062080|FG001|Overall Study|Withdrawal by Subject|2|||
164189337|NCT00540644|593062079|FG000|Overall Study|Noncomplilance|1|||
164189338|NCT00540644|593062080|FG001|Overall Study|Noncomplilance|0|||
164189339|NCT00105989|593062081|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
164189340|NCT00105989|593062082|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
164189341|NCT00105989|593062081|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
164189342|NCT00105989|593062082|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
164189343|NCT00105989|593062081|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
164189344|NCT00105989|593062082|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
164189345|NCT00105989|593062081|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
164189346|NCT00105989|593062082|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
164189347|NCT00105989|593062081|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
164189348|NCT00105989|593062082|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
164189349|NCT00105989|593062081|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
164189350|NCT00105989|593062082|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
164189351|NCT00105989|593062081|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
164189352|NCT00105989|593062082|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
164189353|NCT00105989|593062081|FG000|Acute - Open Label: Week 0-10|Death|1|||
164189354|NCT00105989|593062082|FG001|Acute - Open Label: Week 0-10|Death|0|||
164189355|NCT00105989|593062081|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
164189356|NCT00105989|593062082|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
164189357|NCT00105989|593062081|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
164189358|NCT00105989|593062082|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
164189359|NCT00105989|593062081|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
164189360|NCT00105989|593062082|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
164189361|NCT00105989|593062081|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
164189362|NCT00105989|593062082|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
164189363|NCT00105989|593062081|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
164189364|NCT00105989|593062082|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
164189365|NCT00105989|593062081|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
164189366|NCT00105989|593062082|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
164189367|NCT00105989|593062081|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
164189368|NCT00105989|593062082|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
164189369|NCT00105989|593062081|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
164189370|NCT00105989|593062082|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
164189371|NCT00105989|593062081|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
164189372|NCT00105989|593062082|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
164189373|NCT00105989|593062081|FG000|Continuation - Open Label:Week 10-34|Death|0|||
164189374|NCT00105989|593062082|FG001|Continuation - Open Label:Week 10-34|Death|0|||
164189375|NCT00105989|593062081|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
164189376|NCT00105989|593062082|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
164189377|NCT00105989|593062081|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
164189378|NCT00105989|593062082|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
164189379|NCT00105989|593062081|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
164189380|NCT00105989|593062082|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
164189381|NCT00105989|593062081|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
164189382|NCT00105989|593062082|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
164189383|NCT00105989|593062081|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
164189384|NCT00105989|593062082|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
164189385|NCT00105989|593062081|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
164189386|NCT00105989|593062082|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
164189387|NCT00105989|593062081|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
164189388|NCT00105989|593062082|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
164189389|NCT00105989|593062081|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
164189390|NCT00105989|593062082|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
164189391|NCT00105989|593062081|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
164189392|NCT00105989|593062082|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
164189393|NCT00105989|593062081|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
164189394|NCT00105989|593062082|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
164189395|NCT00105989|593062081|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
164189396|NCT00105989|593062082|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
164189397|NCT00105989|593062081|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
164189398|NCT00105989|593062082|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
164189399|NCT01716663|593062083|FG000|Overall Study|Withdrawn prior to procedure|4|||
164189400|NCT01716663|593062083|FG000|Overall Study|Treated with non-study catheter|2|||
164189401|NCT01059773|593062084|FG000|Overall Study|Adverse Event|2|||
164189402|NCT01059773|593062085|FG001|Overall Study|Adverse Event|2|||
164189403|NCT01059773|593062084|FG000|Overall Study|Withdrawal by Subject|1|||
164189404|NCT01059773|593062085|FG001|Overall Study|Withdrawal by Subject|5|||
164189405|NCT01059773|593062084|FG000|Overall Study|Lost to Follow-up|1|||
164189406|NCT01059773|593062085|FG001|Overall Study|Lost to Follow-up|1|||
164189407|NCT01059773|593062084|FG000|Overall Study|Pregnancy|1|||
164189408|NCT01059773|593062085|FG001|Overall Study|Pregnancy|1|||
164189409|NCT01059773|593062084|FG000|Overall Study|Protocol Violation|6|||
164189410|NCT01059773|593062085|FG001|Overall Study|Protocol Violation|2|||
164189411|NCT01059773|593062084|FG000|Overall Study|Physician Decision|5|||
164189412|NCT01059773|593062085|FG001|Overall Study|Physician Decision|4|||
164189413|NCT01059773|593062084|FG000|Overall Study|Lack of Efficacy|3|||
164189414|NCT01059773|593062085|FG001|Overall Study|Lack of Efficacy|3|||
164189415|NCT01059773|593062084|FG000|Overall Study|Death|0|||
164189416|NCT01059773|593062085|FG001|Overall Study|Death|1|||
164189417|NCT01059773|593062084|FG000|Overall Study|Malignancy including squamous cell skin|0|||
164189418|NCT01059773|593062085|FG001|Overall Study|Malignancy including squamous cell skin|1|||
164189419|NCT01059773|593062084|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
164189420|NCT01059773|593062085|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
164189421|NCT01059773|593062084|FG000|Overall Study|Other|1|||
164189422|NCT01059773|593062085|FG001|Overall Study|Other|3|||
164189423|NCT01806168|593062088|FG000|Overall Study|Adverse Event|1|||
164189424|NCT01806168|593062089|FG001|Overall Study|Adverse Event|0|||
164189425|NCT01806168|593062090|FG002|Overall Study|Adverse Event|0|||
164189426|NCT01806168|593062088|FG000|Overall Study|Withdrawal by Subject|0|||
164189427|NCT01806168|593062089|FG001|Overall Study|Withdrawal by Subject|1|||
164189428|NCT01806168|593062090|FG002|Overall Study|Withdrawal by Subject|2|||
164189429|NCT01806168|593062088|FG000|Overall Study|Protocol Violation|0|||
164189430|NCT01806168|593062089|FG001|Overall Study|Protocol Violation|0|||
164189431|NCT01806168|593062090|FG002|Overall Study|Protocol Violation|1|||
164189432|NCT02620787|593062093|FG000|Overall Study|Adverse Event|1|||
164189433|NCT02620787|593062094|FG001|Overall Study|Adverse Event|0|||
164189434|NCT02620787|593062093|FG000|Overall Study|Eligibility Criteria Not Met|1|||
164189435|NCT02620787|593062094|FG001|Overall Study|Eligibility Criteria Not Met|0|||
164189436|NCT01462630|593062097|FG000|Overall Study|Did not initiate therapy|3|||
164189437|NCT01462630|593062097|FG000|Overall Study|Death|1|||
164189438|NCT01462630|593062097|FG000|Overall Study|Protocol Violation|2|||
164189439|NCT01462630|593062097|FG000|Overall Study|Adverse Event|1|||
164189440|NCT03665077|593062098|FG000|Overall Study|Lost to Follow-up|2|||
164189441|NCT03665077|593062098|FG000|Overall Study|Physician Decision|2|||
164189442|NCT02364388|593062099|FG000|Overall Study|Protocol Violation|1|||
164189443|NCT02364388|593062099|FG000|Overall Study|Technical Failure|3|||
164189444|NCT02364388|593062099|FG000|Overall Study|No OA/US data|2|||
164189445|NCT02364388|593062099|FG000|Overall Study|No Biopsy|2|||
164189446|NCT00837967|593062100|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
164189447|NCT00837967|593062101|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
164189448|NCT02504320|593062105|FG000|Treatment Period 1|Positive Drug Screen|0|||
164189449|NCT02504320|593062106|FG001|Treatment Period 1|Positive Drug Screen|0|||
164189450|NCT02504320|593062107|FG002|Treatment Period 1|Positive Drug Screen|1|||
164189451|NCT02504320|593062108|FG003|Treatment Period 1|Positive Drug Screen|0|||
164189452|NCT02504320|593062105|FG000|Treatment Period 2|Positive Drug Screen|0|||
164189453|NCT02504320|593062106|FG001|Treatment Period 2|Positive Drug Screen|1|||
164189454|NCT02504320|593062107|FG002|Treatment Period 2|Positive Drug Screen|0|||
164189455|NCT02504320|593062108|FG003|Treatment Period 2|Positive Drug Screen|0|||
164304042|NCT02113982|593488367|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
164304043|NCT02113982|593488368|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
164304044|NCT02113982|593488369|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
164304045|NCT02113982|593488370|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
164304046|NCT02113982|593488371|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
164304047|NCT02113982|593488372|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
164304048|NCT02113982|593488373|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
164304049|NCT02113982|593488374|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
164304050|NCT02113982|593488375|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
164304051|NCT02113982|593488376|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
164304052|NCT02113982|593488363|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
164304053|NCT02113982|593488364|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
164304054|NCT02113982|593488365|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
164304055|NCT02113982|593488366|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
164304056|NCT02113982|593488367|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
164304057|NCT02113982|593488368|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
164304058|NCT02113982|593488369|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
164304059|NCT02113982|593488370|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
164304060|NCT02113982|593488371|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
164304061|NCT02113982|593488372|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
164304062|NCT02113982|593488373|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
164304063|NCT02113982|593488374|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
164304064|NCT02113982|593488375|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
164304065|NCT02113982|593488376|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
164304066|NCT02113982|593488363|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
164304067|NCT02113982|593488364|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
164304068|NCT02113982|593488365|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
164304069|NCT02113982|593488366|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
164304070|NCT02113982|593488367|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
164304071|NCT02113982|593488368|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
164304072|NCT02113982|593488369|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
164304073|NCT02113982|593488370|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
164304074|NCT02113982|593488371|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
164304075|NCT02113982|593488372|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
164304076|NCT02113982|593488373|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
164304077|NCT02113982|593488374|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
164304078|NCT02113982|593488375|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
164304079|NCT02113982|593488376|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
164304080|NCT02113982|593488363|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304081|NCT02113982|593488364|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304082|NCT02113982|593488365|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304083|NCT02113982|593488366|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304084|NCT02113982|593488367|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304085|NCT02113982|593488368|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304086|NCT02113982|593488369|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304087|NCT02113982|593488370|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304088|NCT02113982|593488371|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304089|NCT02113982|593488372|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304090|NCT02113982|593488373|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304091|NCT02113982|593488374|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304092|NCT02113982|593488375|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
164304093|NCT02113982|593488376|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304094|NCT02113982|593488363|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164304095|NCT02113982|593488364|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164304096|NCT02113982|593488365|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164304097|NCT02113982|593488366|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164304098|NCT02113982|593488367|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164304099|NCT02113982|593488368|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164304100|NCT02113982|593488369|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164304101|NCT02113982|593488370|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164304102|NCT02113982|593488371|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164304103|NCT02113982|593488372|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164304104|NCT02113982|593488373|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164304105|NCT02113982|593488374|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164532992|NCT00307125|594322138|FG001|Pilot Phase|Withdrawal by Subject|1|||
164532993|NCT00307125|594322139|FG002|Pilot Phase|Withdrawal by Subject|1|||
164304106|NCT02113982|593488375|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
164304107|NCT02113982|593488376|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164304108|NCT02113982|593488363|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164418658|NCT06017999|593902656|FG001|Overall Study|Lost to Follow-up|0|||
164418659|NCT06017999|593902657|FG002|Overall Study|Lost to Follow-up|1|||
164418660|NCT06017999|593902655|FG000|Overall Study|Physician Decision|1|||
164418661|NCT06017999|593902656|FG001|Overall Study|Physician Decision|1|||
164418662|NCT06017999|593902657|FG002|Overall Study|Physician Decision|0|||
164418663|NCT06017999|593902655|FG000|Overall Study|Non-Compliance|0|||
164418664|NCT06017999|593902656|FG001|Overall Study|Non-Compliance|0|||
164418665|NCT06017999|593902657|FG002|Overall Study|Non-Compliance|1|||
164418666|NCT06017999|593902655|FG000|Overall Study|Lack of Efficacy|1|||
164418667|NCT06017999|593902656|FG001|Overall Study|Lack of Efficacy|0|||
164418668|NCT06017999|593902657|FG002|Overall Study|Lack of Efficacy|7|||
164418669|NCT06017999|593902655|FG000|Overall Study|COVID Positive|0|||
164418670|NCT06017999|593902656|FG001|Overall Study|COVID Positive|1|||
164418671|NCT06017999|593902657|FG002|Overall Study|COVID Positive|0|||
164418672|NCT06017999|593902655|FG000|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
164418673|NCT06017999|593902656|FG001|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
164418674|NCT06017999|593902657|FG002|Overall Study|Did Not Disclose Amount of EtOH Consumed|1|||
164418675|NCT01155388|593902658|FG000|Overall Study|Adverse Event|1|||
164418676|NCT01155388|593902659|FG001|Overall Study|Adverse Event|0|||
164418677|NCT03943589|593902660|FG000|Overall Study|Death|1|||
164418678|NCT03943589|593902660|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
164189456|NCT02504320|593062105|FG000|Treatment Period 3|Positive Drug Screen|0|||
164189457|NCT02504320|593062106|FG001|Treatment Period 3|Positive Drug Screen|0|||
164189458|NCT02504320|593062107|FG002|Treatment Period 3|Positive Drug Screen|0|||
164189459|NCT02504320|593062108|FG003|Treatment Period 3|Positive Drug Screen|1|||
164189460|NCT02504320|593062105|FG000|Treatment Period 3|Adverse Event|0|||
164189461|NCT02504320|593062106|FG001|Treatment Period 3|Adverse Event|0|||
164189462|NCT02504320|593062107|FG002|Treatment Period 3|Adverse Event|1|||
164189463|NCT02504320|593062108|FG003|Treatment Period 3|Adverse Event|0|||
164189464|NCT02306850|593062111|FG000|Overall Study|Lack of Efficacy|2|||
164189465|NCT02420262|593062112|FG000|Overall Study|Adverse Event|1|||
164189466|NCT02420262|593062113|FG001|Overall Study|Adverse Event|0|||
164189467|NCT02420262|593062112|FG000|Overall Study|Withdrawal by Subject|1|||
164189468|NCT02420262|593062113|FG001|Overall Study|Withdrawal by Subject|4|||
164189469|NCT02420262|593062112|FG000|Overall Study|Unclassified|0|||
164189470|NCT02420262|593062113|FG001|Overall Study|Unclassified|1|||
164189471|NCT02497404|593062114|FG000|Overall Study|Adverse Event|1|||
164189472|NCT01408901|593062115|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
164189473|NCT01408901|593062116|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
164189474|NCT01408901|593062117|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
164189475|NCT01408901|593062118|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
164189476|NCT01408901|593062115|FG000|6-Week Follow-Up|Death|1|||
164189477|NCT01408901|593062116|FG001|6-Week Follow-Up|Death|0|||
164189478|NCT01408901|593062117|FG002|6-Week Follow-Up|Death|0|||
164189479|NCT01408901|593062118|FG003|6-Week Follow-Up|Death|0|||
164189480|NCT01408901|593062115|FG000|6-Week Follow-Up|Cancelled visit|0|||
164189481|NCT01408901|593062116|FG001|6-Week Follow-Up|Cancelled visit|1|||
164189482|NCT01408901|593062117|FG002|6-Week Follow-Up|Cancelled visit|0|||
164189483|NCT01408901|593062118|FG003|6-Week Follow-Up|Cancelled visit|2|||
164189484|NCT01408901|593062115|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
164189485|NCT01408901|593062116|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
164189486|NCT01408901|593062117|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
164189487|NCT01408901|593062118|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
164189488|NCT01408901|593062115|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
164418679|NCT04329104|593902661|FG000|Efficacy Study|Withdrawal by Subject|0|||
164418680|NCT04329104|593902662|FG001|Efficacy Study|Withdrawal by Subject|0|||
164418681|NCT04329104|593902663|FG002|Efficacy Study|Withdrawal by Subject|0|||
164418682|NCT04329104|593902664|FG003|Efficacy Study|Withdrawal by Subject|5|||
164418683|NCT04329104|593902665|FG004|Efficacy Study|Withdrawal by Subject|6|||
164418684|NCT04329104|593902666|FG005|Efficacy Study|Withdrawal by Subject|8|||
164418685|NCT01668147|593902669|FG000|Overall Study|Withdrawal by Subject|6|||
164418686|NCT00224133|593902672|FG000|Overall Study|Adverse Event|93|||
164418687|NCT00224133|593902672|FG000|Overall Study|Protocol Violation|6|||
164418688|NCT00224133|593902672|FG000|Overall Study|Withdrawal by Subject|33|||
164418689|NCT00224133|593902672|FG000|Overall Study|Lack of Efficacy|58|||
164418690|NCT00224133|593902672|FG000|Overall Study|Lost to Follow-up|21|||
164418691|NCT00224133|593902672|FG000|Overall Study|Physician Decision|1|||
164189489|NCT01408901|593062116|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
164189490|NCT01408901|593062117|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
164189491|NCT01408901|593062118|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
164189492|NCT01408901|593062115|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
164189493|NCT01408901|593062116|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
164189494|NCT01408901|593062117|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
164418692|NCT00224133|593902672|FG000|Overall Study|Other|14|||
164418693|NCT01238575|593902674|FG000|Overall Study|Lack of Efficacy|2|||
164418694|NCT01238575|593902675|FG001|Overall Study|Lack of Efficacy|4|||
164418695|NCT01238575|593902674|FG000|Overall Study|Adverse Event|2|||
164418696|NCT01238575|593902675|FG001|Overall Study|Adverse Event|0|||
164418697|NCT01702428|593902677|FG000|Overall Study|Adverse Event|2|||
164418698|NCT01702428|593902678|FG001|Overall Study|Adverse Event|0|||
164418699|NCT01702428|593902679|FG002|Overall Study|Adverse Event|0|||
164418700|NCT01702428|593902680|FG003|Overall Study|Adverse Event|0|||
164418701|NCT01702428|593902677|FG000|Overall Study|Lost to Follow-up|33|||
164418702|NCT01702428|593902678|FG001|Overall Study|Lost to Follow-up|41|||
164418703|NCT01702428|593902679|FG002|Overall Study|Lost to Follow-up|37|||
164418704|NCT01702428|593902680|FG003|Overall Study|Lost to Follow-up|44|||
164418705|NCT01702428|593902677|FG000|Overall Study|Parents cannot assist to site|1|||
164418706|NCT01702428|593902678|FG001|Overall Study|Parents cannot assist to site|0|||
164418707|NCT01702428|593902679|FG002|Overall Study|Parents cannot assist to site|1|||
164418708|NCT01702428|593902680|FG003|Overall Study|Parents cannot assist to site|0|||
164418709|NCT01702428|593902677|FG000|Overall Study|Lost Coverage|0|||
164418710|NCT01702428|593902678|FG001|Overall Study|Lost Coverage|0|||
164418711|NCT01702428|593902679|FG002|Overall Study|Lost Coverage|0|||
164418712|NCT01702428|593902680|FG003|Overall Study|Lost Coverage|1|||
164418713|NCT01702428|593902677|FG000|Overall Study|Lost Health Plan|3|||
164418714|NCT01702428|593902678|FG001|Overall Study|Lost Health Plan|5|||
164418715|NCT01702428|593902679|FG002|Overall Study|Lost Health Plan|0|||
164418716|NCT01702428|593902680|FG003|Overall Study|Lost Health Plan|2|||
164418717|NCT01702428|593902677|FG000|Overall Study|Mother transferred care|0|||
164418718|NCT01702428|593902678|FG001|Overall Study|Mother transferred care|1|||
164418719|NCT01702428|593902679|FG002|Overall Study|Mother transferred care|0|||
164418720|NCT01702428|593902680|FG003|Overall Study|Mother transferred care|0|||
164418721|NCT01702428|593902677|FG000|Overall Study|Parents too busy|1|||
164418722|NCT01702428|593902678|FG001|Overall Study|Parents too busy|0|||
164418723|NCT01702428|593902679|FG002|Overall Study|Parents too busy|0|||
164418724|NCT01702428|593902680|FG003|Overall Study|Parents too busy|0|||
164418725|NCT01702428|593902677|FG000|Overall Study|Protocol Violation|3|||
164418726|NCT01702428|593902678|FG001|Overall Study|Protocol Violation|0|||
164418727|NCT01702428|593902679|FG002|Overall Study|Protocol Violation|1|||
164418728|NCT01702428|593902680|FG003|Overall Study|Protocol Violation|0|||
164418729|NCT01702428|593902677|FG000|Overall Study|Withdrawal by Subject|21|||
164418730|NCT01702428|593902678|FG001|Overall Study|Withdrawal by Subject|23|||
164418731|NCT01702428|593902679|FG002|Overall Study|Withdrawal by Subject|14|||
164418732|NCT01702428|593902680|FG003|Overall Study|Withdrawal by Subject|10|||
164418733|NCT02091869|593902681|FG000|Overall Study|Withdrawal by Subject|0|||
164418734|NCT02091869|593902682|FG001|Overall Study|Withdrawal by Subject|3|||
164418735|NCT03685708|593902686|FG000|Overall Study|Withdrawal by Subject|0|||
164418736|NCT03685708|593902687|FG001|Overall Study|Withdrawal by Subject|0|||
164418737|NCT03685708|593902688|FG002|Overall Study|Withdrawal by Subject|1|||
164418738|NCT03685708|593902686|FG000|Overall Study|Screen Fail|0|||
164418739|NCT03685708|593902687|FG001|Overall Study|Screen Fail|1|||
164418740|NCT03685708|593902688|FG002|Overall Study|Screen Fail|1|||
164418741|NCT03685708|593902686|FG000|Overall Study|COVID 19 Pandemic|1|||
164418742|NCT03685708|593902687|FG001|Overall Study|COVID 19 Pandemic|1|||
164418743|NCT03685708|593902688|FG002|Overall Study|COVID 19 Pandemic|6|||
164418744|NCT03685708|593902686|FG000|Overall Study|Disease Progression|0|||
164418745|NCT03685708|593902687|FG001|Overall Study|Disease Progression|0|||
164418746|NCT03685708|593902688|FG002|Overall Study|Disease Progression|1|||
164418747|NCT02771210|593902692|FG000|Period 1|Adverse Event|5|||
164418748|NCT02771210|593902693|FG001|Period 1|Adverse Event|3|||
164418749|NCT02771210|593902692|FG000|Period 1|Lack of Efficacy|3|||
164418750|NCT02771210|593902693|FG001|Period 1|Lack of Efficacy|6|||
164418751|NCT02771210|593902692|FG000|Period 1|Lost to Follow-up|2|||
164418752|NCT02771210|593902693|FG001|Period 1|Lost to Follow-up|0|||
164418753|NCT02771210|593902692|FG000|Period 1|Physician Decision|0|||
164418754|NCT02771210|593902693|FG001|Period 1|Physician Decision|1|||
164418755|NCT02771210|593902692|FG000|Period 1|Withdrawal by Subject|0|||
164418756|NCT02771210|593902693|FG001|Period 1|Withdrawal by Subject|3|||
164418757|NCT02771210|593902692|FG000|Period 1|Withdrawal of informed consent|1|||
164418758|NCT02771210|593902693|FG001|Period 1|Withdrawal of informed consent|5|||
164418759|NCT02771210|593902692|FG000|Period 2|Adverse Event|1|||
164418760|NCT02771210|593902693|FG001|Period 2|Adverse Event|0|||
164418761|NCT02771210|593902692|FG000|Period 2|Lack of Efficacy|0|||
164418762|NCT02771210|593902693|FG001|Period 2|Lack of Efficacy|1|||
164418763|NCT02771210|593902692|FG000|Period 2|Withdrawal by Subject|1|||
164418764|NCT02771210|593902693|FG001|Period 2|Withdrawal by Subject|0|||
164418765|NCT02771210|593902692|FG000|Period 2|Withdrawal of informed consent|0|||
164418766|NCT02771210|593902693|FG001|Period 2|Withdrawal of informed consent|2|||
164418767|NCT04397523|593902694|FG000|Overall Study|Lost to Follow-up|3|||
164418768|NCT04397523|593902694|FG000|Overall Study|Transfer from/to other hospital|8|||
164418769|NCT01275196|593902695|FG000|Overall Study|Adverse Event|3|||
164418770|NCT01275196|593902696|FG001|Overall Study|Adverse Event|5|||
164418771|NCT01275196|593902695|FG000|Overall Study|Withdrawal by Subject|4|||
164418772|NCT01275196|593902696|FG001|Overall Study|Withdrawal by Subject|5|||
164418773|NCT01275196|593902695|FG000|Overall Study|Lost to Follow-up|1|||
164418774|NCT01275196|593902696|FG001|Overall Study|Lost to Follow-up|0|||
164418775|NCT01275196|593902695|FG000|Overall Study|Disease Progression|6|||
164418776|NCT01275196|593902696|FG001|Overall Study|Disease Progression|5|||
164418777|NCT01275196|593902695|FG000|Overall Study|Protocol Violation|1|||
164418778|NCT01275196|593902696|FG001|Overall Study|Protocol Violation|0|||
164418779|NCT01275196|593902695|FG000|Overall Study|Suboptimal response/treatment failure|5|||
164418780|NCT01275196|593902696|FG001|Overall Study|Suboptimal response/treatment failure|6|||
164418781|NCT03230864|593902697|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
164418782|NCT03230864|593902698|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
164418783|NCT03230864|593902699|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
164418784|NCT03230864|593902700|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
164418785|NCT03230864|593902697|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
164418786|NCT03230864|593902698|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
164418787|NCT03230864|593902699|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
164418788|NCT03230864|593902700|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
164418789|NCT03230864|593902697|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
164418790|NCT03230864|593902698|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
164418791|NCT03230864|593902699|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
164418792|NCT03230864|593902700|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
164418793|NCT03230864|593902697|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
164418794|NCT03230864|593902698|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
164418795|NCT03230864|593902699|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
164418796|NCT03230864|593902700|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
164418797|NCT03230864|593902697|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
164418798|NCT03230864|593902698|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
164418799|NCT03230864|593902699|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
164418800|NCT03230864|593902700|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
164418801|NCT03230864|593902697|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
164418802|NCT03230864|593902698|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
164418803|NCT03230864|593902699|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
164418804|NCT03230864|593902700|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
164418805|NCT03230864|593902697|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
164418806|NCT03230864|593902698|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
164418807|NCT03230864|593902699|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
164418808|NCT03230864|593902700|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
164418809|NCT03230864|593902697|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
164418810|NCT03230864|593902698|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
164418811|NCT03230864|593902699|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
164418812|NCT03230864|593902700|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
164418813|NCT03230864|593902697|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
164418814|NCT03230864|593902698|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
164418815|NCT03230864|593902699|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
164418816|NCT03230864|593902700|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
164418817|NCT03230864|593902697|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
164418818|NCT03230864|593902698|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
164418819|NCT03230864|593902699|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
164418820|NCT03230864|593902700|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
164418821|NCT01316692|593902701|FG000|Overall Study|Adverse Event|5|||
164418822|NCT01316692|593902701|FG000|Overall Study|Disease Progression|7|||
164418823|NCT02001974|593902714|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
164418824|NCT02001974|593902715|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
164418825|NCT02001974|593902716|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
164418826|NCT02001974|593902714|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
164418827|NCT02001974|593902715|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
164418828|NCT02001974|593902716|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
164418829|NCT02001974|593902714|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
164418830|NCT02001974|593902715|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
164418831|NCT02001974|593902716|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
164418832|NCT02001974|593902714|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
164418833|NCT02001974|593902715|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
164418834|NCT02001974|593902716|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
164418835|NCT04422639|593902717|FG000|Overall Study|Death|1|||
164418836|NCT04422639|593902718|FG001|Overall Study|Death|0|||
164418837|NCT04422639|593902717|FG000|Overall Study|study closed prior to completion of FU visits|0|||
164418838|NCT04422639|593902718|FG001|Overall Study|study closed prior to completion of FU visits|2|||
164418839|NCT01964521|593902719|FG000|Overall Study|Lost to Follow-up|4|||
164418840|NCT01463293|593902721|FG000|Overall Study|Lost to Follow-up|1|||
164418841|NCT01463293|593902722|FG001|Overall Study|Lost to Follow-up|4|||
164418842|NCT01463293|593902723|FG002|Overall Study|Lost to Follow-up|5|||
164418843|NCT01463293|593902721|FG000|Overall Study|Adverse Event|1|||
164418844|NCT01463293|593902722|FG001|Overall Study|Adverse Event|2|||
164418845|NCT01463293|593902723|FG002|Overall Study|Adverse Event|0|||
164418846|NCT01463293|593902721|FG000|Overall Study|Withdrawal by Subject|4|||
164418847|NCT01463293|593902722|FG001|Overall Study|Withdrawal by Subject|10|||
164418848|NCT01463293|593902723|FG002|Overall Study|Withdrawal by Subject|5|||
164418849|NCT01463293|593902721|FG000|Overall Study|Other|0|||
164418850|NCT01463293|593902722|FG001|Overall Study|Other|0|||
164418851|NCT01463293|593902723|FG002|Overall Study|Other|2|||
164418852|NCT03560245|593902724|FG000|Overall Study|Withdrawal by Subject|3|||
164418853|NCT03560245|593902725|FG001|Overall Study|Withdrawal by Subject|2|||
164418854|NCT03560245|593902724|FG000|Overall Study|Adverse Event|1|||
164418855|NCT03560245|593902725|FG001|Overall Study|Adverse Event|1|||
164418856|NCT03560245|593902724|FG000|Overall Study|Protocol Violation|1|||
164418857|NCT03560245|593902725|FG001|Overall Study|Protocol Violation|0|||
164418858|NCT03560245|593902724|FG000|Overall Study|Death|0|||
164418859|NCT03560245|593902725|FG001|Overall Study|Death|1|||
164418860|NCT03560245|593902724|FG000|Overall Study|Lost to Follow-up|0|||
164189495|NCT01408901|593062118|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
164189496|NCT01408901|593062115|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
164189497|NCT01408901|593062116|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
164189498|NCT01408901|593062117|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
164189499|NCT01408901|593062118|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
164189500|NCT01408901|593062115|FG000|26-Week Follow-Up|Death|0|||
164189501|NCT01408901|593062116|FG001|26-Week Follow-Up|Death|1|||
164189502|NCT01408901|593062117|FG002|26-Week Follow-Up|Death|0|||
164189503|NCT01408901|593062118|FG003|26-Week Follow-Up|Death|0|||
164189504|NCT02098395|593062121|FG000|Overall Study|Protocol Violation|2|||
164189505|NCT02098395|593062122|FG001|Overall Study|Protocol Violation|2|||
164189506|NCT02098395|593062123|FG002|Overall Study|Protocol Violation|0|||
164189507|NCT02098395|593062124|FG003|Overall Study|Protocol Violation|7|||
164189508|NCT02098395|593062121|FG000|Overall Study|Withdrawal by Subject|10|||
164189509|NCT02098395|593062122|FG001|Overall Study|Withdrawal by Subject|10|||
164418861|NCT03560245|593902725|FG001|Overall Study|Lost to Follow-up|1|||
164189510|NCT02098395|593062123|FG002|Overall Study|Withdrawal by Subject|5|||
164189511|NCT02098395|593062124|FG003|Overall Study|Withdrawal by Subject|13|||
164189512|NCT02098395|593062121|FG000|Overall Study|Adverse Event|12|||
164189513|NCT02098395|593062122|FG001|Overall Study|Adverse Event|19|||
164189514|NCT02098395|593062123|FG002|Overall Study|Adverse Event|34|||
164189515|NCT02098395|593062124|FG003|Overall Study|Adverse Event|2|||
164189516|NCT02098395|593062121|FG000|Overall Study|Lost to Follow-up|2|||
164189517|NCT02098395|593062122|FG001|Overall Study|Lost to Follow-up|1|||
164189518|NCT02098395|593062123|FG002|Overall Study|Lost to Follow-up|0|||
164189519|NCT02098395|593062124|FG003|Overall Study|Lost to Follow-up|3|||
164189520|NCT02098395|593062121|FG000|Overall Study|Unclassified|0|||
164189521|NCT02098395|593062122|FG001|Overall Study|Unclassified|0|||
164189522|NCT02098395|593062123|FG002|Overall Study|Unclassified|3|||
164189523|NCT02098395|593062124|FG003|Overall Study|Unclassified|2|||
164189524|NCT00110357|593062130|FG000|Overall Study|Deterioration without progression|2|||
164189525|NCT00110357|593062131|FG001|Overall Study|Deterioration without progression|0|||
164189526|NCT00110357|593062130|FG000|Overall Study|Disease progression/relapse|20|||
164189527|NCT00110357|593062131|FG001|Overall Study|Disease progression/relapse|15|||
164189528|NCT00110357|593062130|FG000|Overall Study|Study Closure|1|||
164189529|NCT00110357|593062131|FG001|Overall Study|Study Closure|0|||
164189530|NCT00110357|593062130|FG000|Overall Study|Study Drug Toxicity|1|||
164189531|NCT00110357|593062131|FG001|Overall Study|Study Drug Toxicity|3|||
164189532|NCT00110357|593062130|FG000|Overall Study|Withdrawal by Subject|3|||
164418862|NCT03560245|593902724|FG000|Overall Study|Physician Decision|0|||
164418863|NCT03560245|593902725|FG001|Overall Study|Physician Decision|1|||
164418864|NCT03560245|593902724|FG000|Overall Study|Other|0|||
164418865|NCT03560245|593902725|FG001|Overall Study|Other|1|||
164418866|NCT00960752|593902733|FG000|Overall Study|Adverse Event|0|||
164532994|NCT02571049|594322140|FG000|Screening|Did not meet entry criteria|2|||
164532995|NCT02571049|594322141|FG001|Screening|Did not meet entry criteria|2|||
164189533|NCT00110357|593062131|FG001|Overall Study|Withdrawal by Subject|1|||
164189534|NCT05285787|593062132|FG000|Overall Study|Withdrawal by Subject|1|||
164189535|NCT04004260|593062133|FG000|Overall Study|Withdrawal by Subject|7|||
164189536|NCT04004260|593062134|FG001|Overall Study|Withdrawal by Subject|3|||
164189537|NCT04004260|593062133|FG000|Overall Study|Lost to Follow-up|22|||
164189538|NCT04004260|593062134|FG001|Overall Study|Lost to Follow-up|12|||
164418867|NCT00960752|593902734|FG001|Overall Study|Adverse Event|0|||
164418868|NCT00960752|593902735|FG002|Overall Study|Adverse Event|1|||
164418869|NCT00960752|593902733|FG000|Overall Study|Progression|0|||
164189539|NCT04004260|593062133|FG000|Overall Study|Did not engage in intervention|13|||
164189540|NCT04004260|593062134|FG001|Overall Study|Did not engage in intervention|17|||
164418870|NCT00960752|593902734|FG001|Overall Study|Progression|0|||
164418871|NCT00960752|593902735|FG002|Overall Study|Progression|1|||
164418872|NCT02058290|593902739|FG000|Overall Study|Protocol Violation|2|||
164418873|NCT02058290|593902740|FG001|Overall Study|Protocol Violation|1|||
164418874|NCT02058290|593902739|FG000|Overall Study|Physician Decision|1|||
164418875|NCT02058290|593902740|FG001|Overall Study|Physician Decision|0|||
164418876|NCT02058290|593902739|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
164418877|NCT02058290|593902740|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
164418878|NCT02058290|593902739|FG000|Overall Study|Withdrawal by Subject|0|||
164418879|NCT02058290|593902740|FG001|Overall Study|Withdrawal by Subject|1|||
164418880|NCT00105586|593902744|FG000|Overall Study|Adverse Event|4|||
164418881|NCT00105586|593902745|FG001|Overall Study|Adverse Event|3|||
164418882|NCT00105586|593902744|FG000|Overall Study|Physician Decision|13|||
164418883|NCT00105586|593902745|FG001|Overall Study|Physician Decision|13|||
164418884|NCT02262260|593902746|FG000|Overall Study|Adverse Event|4|||
164418885|NCT02262260|593902747|FG001|Overall Study|Adverse Event|1|||
164418886|NCT02262260|593902746|FG000|Overall Study|Withdrawal of consent|4|||
164418887|NCT02262260|593902747|FG001|Overall Study|Withdrawal of consent|2|||
164418888|NCT02262260|593902746|FG000|Overall Study|Lost to Follow-up|1|||
164418889|NCT02262260|593902747|FG001|Overall Study|Lost to Follow-up|2|||
164418890|NCT02262260|593902746|FG000|Overall Study|Protocol deviation|2|||
164418891|NCT02262260|593902747|FG001|Overall Study|Protocol deviation|5|||
164418892|NCT01794117|593902750|FG000|Overall Study|Adverse Event|1|||
164418893|NCT01794117|593902751|FG001|Overall Study|Adverse Event|0|||
164189541|NCT02360280|593062138|FG000|Overall Study|Withdrawal by Subject|2|||
164189542|NCT02360280|593062139|FG001|Overall Study|Withdrawal by Subject|0|||
164189543|NCT02360280|593062138|FG000|Overall Study|Adverse Event|0|||
164189544|NCT02360280|593062139|FG001|Overall Study|Adverse Event|1|||
164189545|NCT02360280|593062138|FG000|Overall Study|Lost to Follow-up|1|||
164189546|NCT02360280|593062139|FG001|Overall Study|Lost to Follow-up|0|||
164189547|NCT04633226|593062141|FG000|Overall Study|Withdrawal by parent/guardian|4|||
164189548|NCT04633226|593062141|FG000|Overall Study|Randomized by mistake without study treatment|1|||
164189549|NCT01765569|593062143|FG000|Period B|Withdrawal by Subject|1|||
164189550|NCT01765569|593062143|FG000|Period C|Death|1|||
164189551|NCT05415462|593062147|FG000|Overall Study|Death|18|||
164189552|NCT05415462|593062148|FG001|Overall Study|Death|10|||
164189553|NCT05415462|593062147|FG000|Overall Study|Lost to Follow-up|72|||
164189554|NCT05415462|593062148|FG001|Overall Study|Lost to Follow-up|64|||
164189555|NCT05415462|593062147|FG000|Overall Study|Physician Decision|5|||
164189556|NCT05415462|593062148|FG001|Overall Study|Physician Decision|5|||
164189557|NCT05415462|593062147|FG000|Overall Study|Protocol Deviation|1|||
164189558|NCT05415462|593062148|FG001|Overall Study|Protocol Deviation|0|||
164189559|NCT05415462|593062147|FG000|Overall Study|Withdrawal by Subject|129|||
164189560|NCT05415462|593062148|FG001|Overall Study|Withdrawal by Subject|101|||
164189561|NCT05415462|593062147|FG000|Overall Study|Other Than Specified|8|||
164189562|NCT05415462|593062148|FG001|Overall Study|Other Than Specified|8|||
164189563|NCT01030718|593062149|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
164189564|NCT01030718|593062150|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
164189565|NCT01030718|593062151|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
164189566|NCT01030718|593062149|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
164189567|NCT01030718|593062150|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
164189568|NCT01030718|593062151|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
164189569|NCT01030718|593062149|FG000|Studies CA180-031 and -036 Combined|Death|0|||
164189570|NCT01030718|593062150|FG001|Studies CA180-031 and -036 Combined|Death|1|||
164189571|NCT01030718|593062151|FG002|Studies CA180-031 and -036 Combined|Death|0|||
164189572|NCT01030718|593062149|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
164189573|NCT01030718|593062150|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
164189574|NCT01030718|593062151|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
164189575|NCT01030718|593062149|FG000|Study CA180-036 Only|insufficient effect|1|||
164189576|NCT01030718|593062150|FG001|Study CA180-036 Only|insufficient effect|1|||
164189577|NCT01030718|593062151|FG002|Study CA180-036 Only|insufficient effect|5|||
164189578|NCT01030718|593062149|FG000|Study CA180-036 Only|Adverse Event|2|||
164418894|NCT01794117|593902752|FG002|Overall Study|Adverse Event|0|||
164418895|NCT01794117|593902753|FG003|Overall Study|Adverse Event|0|||
164418896|NCT01794117|593902750|FG000|Overall Study|Participant noncompliance|0|||
164418897|NCT01794117|593902751|FG001|Overall Study|Participant noncompliance|1|||
164189579|NCT01030718|593062150|FG001|Study CA180-036 Only|Adverse Event|3|||
164189580|NCT01030718|593062151|FG002|Study CA180-036 Only|Adverse Event|0|||
164189581|NCT01030718|593062149|FG000|Study CA180-036 Only|Death|0|||
164189582|NCT01030718|593062150|FG001|Study CA180-036 Only|Death|1|||
164189583|NCT01030718|593062151|FG002|Study CA180-036 Only|Death|0|||
164189584|NCT01030718|593062149|FG000|Study CA180-036 Only|Other Reasons|0|||
164189585|NCT01030718|593062150|FG001|Study CA180-036 Only|Other Reasons|2|||
164418898|NCT01794117|593902752|FG002|Overall Study|Participant noncompliance|0|||
164418899|NCT01794117|593902753|FG003|Overall Study|Participant noncompliance|0|||
164418900|NCT01794117|593902750|FG000|Overall Study|Refused further treatment|0|||
164418901|NCT01794117|593902751|FG001|Overall Study|Refused further treatment|2|||
164418902|NCT01794117|593902752|FG002|Overall Study|Refused further treatment|0|||
164418903|NCT01794117|593902753|FG003|Overall Study|Refused further treatment|0|||
164189586|NCT01030718|593062151|FG002|Study CA180-036 Only|Other Reasons|0|||
164189587|NCT00423813|593062152|FG000|Overall Study|Adverse Event|11|||
164189588|NCT00423813|593062153|FG001|Overall Study|Adverse Event|30|||
164189589|NCT00423813|593062154|FG002|Overall Study|Adverse Event|40|||
164189590|NCT00423813|593062152|FG000|Overall Study|Withdrawal by Subject|6|||
164189591|NCT00423813|593062153|FG001|Overall Study|Withdrawal by Subject|8|||
164189592|NCT00423813|593062154|FG002|Overall Study|Withdrawal by Subject|5|||
164189593|NCT00423813|593062152|FG000|Overall Study|Lost to Follow-up|5|||
164189594|NCT00423813|593062153|FG001|Overall Study|Lost to Follow-up|4|||
164189595|NCT00423813|593062154|FG002|Overall Study|Lost to Follow-up|4|||
164189596|NCT00423813|593062152|FG000|Overall Study|Lack of Efficacy|23|||
164189597|NCT00423813|593062153|FG001|Overall Study|Lack of Efficacy|18|||
164189598|NCT00423813|593062154|FG002|Overall Study|Lack of Efficacy|19|||
164189599|NCT00423813|593062152|FG000|Overall Study|Physician Decision|2|||
164189600|NCT00423813|593062153|FG001|Overall Study|Physician Decision|0|||
164189601|NCT00423813|593062154|FG002|Overall Study|Physician Decision|0|||
164189602|NCT00423813|593062152|FG000|Overall Study|Sponsor Decision|0|||
164189603|NCT00423813|593062153|FG001|Overall Study|Sponsor Decision|1|||
164189604|NCT00423813|593062154|FG002|Overall Study|Sponsor Decision|0|||
164189605|NCT00423813|593062152|FG000|Overall Study|Protocol Violation|9|||
164189606|NCT00423813|593062153|FG001|Overall Study|Protocol Violation|4|||
164189607|NCT00423813|593062154|FG002|Overall Study|Protocol Violation|4|||
164189608|NCT00423813|593062152|FG000|Overall Study|Pregnancy|0|||
164189609|NCT00423813|593062153|FG001|Overall Study|Pregnancy|0|||
164189610|NCT00423813|593062154|FG002|Overall Study|Pregnancy|1|||
164189611|NCT00423813|593062152|FG000|Overall Study|Subject started night shift work|1|||
164189612|NCT00423813|593062153|FG001|Overall Study|Subject started night shift work|0|||
164189613|NCT00423813|593062154|FG002|Overall Study|Subject started night shift work|0|||
164189614|NCT00423813|593062152|FG000|Overall Study|Will start exclusionary medications|0|||
164189615|NCT00423813|593062153|FG001|Overall Study|Will start exclusionary medications|1|||
164189616|NCT00423813|593062154|FG002|Overall Study|Will start exclusionary medications|0|||
164189617|NCT00423813|593062152|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
164189618|NCT00423813|593062153|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
164189619|NCT00423813|593062154|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
164189620|NCT01904032|593062156|FG000|Overall Study|Adverse Event|3|||
164189621|NCT01904032|593062157|FG001|Overall Study|Adverse Event|1|||
164189622|NCT01904032|593062156|FG000|Overall Study|Lost to Follow-up|4|||
164189623|NCT01904032|593062157|FG001|Overall Study|Lost to Follow-up|2|||
164189624|NCT00003896|593062170|FG000|Overall Study|Adverse Event|16|||
164189625|NCT00003896|593062170|FG000|Overall Study|Withdrawal by Subject|1|||
164189626|NCT00003896|593062170|FG000|Overall Study|Lack of Efficacy|1|||
164418904|NCT03406702|593902754|FG000|Overall Study|Missed Day 27 Dosing|1|||
164418905|NCT00735644|593902757|FG000|Overall Study|Did not receive study vaccine|0|||
164418906|NCT00735644|593902758|FG001|Overall Study|Did not receive study vaccine|1|||
164418907|NCT00735644|593902759|FG002|Overall Study|Did not receive study vaccine|0|||
164418908|NCT00735644|593902760|FG003|Overall Study|Did not receive study vaccine|0|||
164418909|NCT00735644|593902761|FG004|Overall Study|Did not receive study vaccine|0|||
164418910|NCT00735644|593902757|FG000|Overall Study|Withdrawal by Subject|0|||
164418911|NCT00735644|593902758|FG001|Overall Study|Withdrawal by Subject|1|||
164418912|NCT00735644|593902759|FG002|Overall Study|Withdrawal by Subject|1|||
164418913|NCT00735644|593902760|FG003|Overall Study|Withdrawal by Subject|1|||
164418914|NCT00735644|593902761|FG004|Overall Study|Withdrawal by Subject|0|||
164418915|NCT00514046|593902762|FG000|Overall Study|transferred to another protocol|2|||
164418916|NCT00514046|593902763|FG001|Overall Study|transferred to another protocol|1|||
164418917|NCT00514046|593902764|FG002|Overall Study|transferred to another protocol|3|||
164418918|NCT00514046|593902765|FG003|Overall Study|transferred to another protocol|0|||
164418919|NCT00514046|593902766|FG004|Overall Study|transferred to another protocol|1|||
164418920|NCT00514046|593902767|FG005|Overall Study|transferred to another protocol|0|||
164418921|NCT00514046|593902768|FG006|Overall Study|transferred to another protocol|0|||
164418922|NCT00514046|593902769|FG007|Overall Study|transferred to another protocol|0|||
164418923|NCT00514046|593902770|FG008|Overall Study|transferred to another protocol|0|||
164418924|NCT00514046|593902762|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
164418925|NCT00514046|593902763|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
164418926|NCT00514046|593902764|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
164418927|NCT00514046|593902765|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
164418928|NCT00514046|593902766|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
164418929|NCT00514046|593902767|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
164418930|NCT00514046|593902768|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
164648305|NCT03216954|594738551|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
164189627|NCT00003896|593062170|FG000|Overall Study|Death|3|||
164189628|NCT00003896|593062170|FG000|Overall Study|not protocol specified|3|||
164418931|NCT00514046|593902769|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
164418932|NCT00514046|593902770|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
164189629|NCT00003896|593062170|FG000|Overall Study|ineligible|5|||
164418933|NCT00514046|593902762|FG000|Overall Study|Disease progression on study|0|||
164532996|NCT02571049|594322140|FG000|Randomization|No migraine attack|0|||
164532997|NCT02571049|594322141|FG001|Randomization|No migraine attack|1|||
164532998|NCT02571049|594322140|FG000|Randomization|Adverse Event|0|||
164532999|NCT02571049|594322141|FG001|Randomization|Adverse Event|1|||
164533000|NCT01055262|594322144|FG000|Overall Study|Adverse Event|5|||
164533001|NCT01055262|594322144|FG000|Overall Study|Protocol Violation|3|||
164533002|NCT01055262|594322144|FG000|Overall Study|Uncooperativeness|1|||
164189630|NCT01398358|593062171|FG000|Overall Study|Lost to Follow-up|11|||
164533003|NCT00561951|594322146|FG000|Overall Study|Adverse Event|11|||
164533004|NCT00561951|594322147|FG001|Overall Study|Adverse Event|14|||
164533005|NCT00561951|594322148|FG002|Overall Study|Adverse Event|14|||
164533006|NCT00561951|594322146|FG000|Overall Study|Lack of Efficacy|5|||
164189631|NCT01398358|593062172|FG001|Overall Study|Lost to Follow-up|21|||
164418934|NCT00514046|593902763|FG001|Overall Study|Disease progression on study|0|||
164418935|NCT00514046|593902764|FG002|Overall Study|Disease progression on study|2|||
164418936|NCT00514046|593902765|FG003|Overall Study|Disease progression on study|0|||
164418937|NCT00514046|593902766|FG004|Overall Study|Disease progression on study|0|||
164418938|NCT00514046|593902767|FG005|Overall Study|Disease progression on study|1|||
164418939|NCT00514046|593902768|FG006|Overall Study|Disease progression on study|0|||
164418940|NCT00514046|593902769|FG007|Overall Study|Disease progression on study|0|||
164418941|NCT00514046|593902770|FG008|Overall Study|Disease progression on study|0|||
164418942|NCT00655551|593902771|FG000|All Periods Combined|Adverse Event|0|||
164418943|NCT00655551|593902772|FG001|All Periods Combined|Adverse Event|3|||
164418944|NCT00655551|593902773|FG002|All Periods Combined|Adverse Event|4|||
164418945|NCT00655551|593902771|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
164418946|NCT00655551|593902772|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
164418947|NCT00655551|593902773|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
164189632|NCT01398358|593062173|FG002|Overall Study|Lost to Follow-up|18|||
164189633|NCT01398358|593062171|FG000|Overall Study|Withdrawal by Subject|3|||
164189634|NCT01398358|593062172|FG001|Overall Study|Withdrawal by Subject|2|||
164189635|NCT01398358|593062173|FG002|Overall Study|Withdrawal by Subject|2|||
164189636|NCT01398358|593062171|FG000|Overall Study|no longer eligible|1|||
164189637|NCT01398358|593062172|FG001|Overall Study|no longer eligible|0|||
164189638|NCT01398358|593062173|FG002|Overall Study|no longer eligible|1|||
164189639|NCT02559570|593062175|FG000|Overall Study|Adverse Event|0|||
164189640|NCT02559570|593062176|FG001|Overall Study|Adverse Event|2|||
164189641|NCT02559570|593062177|FG002|Overall Study|Adverse Event|0|||
164189642|NCT02559570|593062178|FG003|Overall Study|Adverse Event|1|||
164189643|NCT02559570|593062179|FG004|Overall Study|Adverse Event|0|||
164189644|NCT02559570|593062175|FG000|Overall Study|Withdrawal of Consent|0|||
164189645|NCT02559570|593062176|FG001|Overall Study|Withdrawal of Consent|0|||
164189646|NCT02559570|593062177|FG002|Overall Study|Withdrawal of Consent|1|||
164189647|NCT02559570|593062178|FG003|Overall Study|Withdrawal of Consent|2|||
164189648|NCT02559570|593062179|FG004|Overall Study|Withdrawal of Consent|1|||
164189649|NCT02559570|593062175|FG000|Overall Study|Lost to Follow-up|1|||
164189650|NCT02559570|593062176|FG001|Overall Study|Lost to Follow-up|0|||
164189651|NCT02559570|593062177|FG002|Overall Study|Lost to Follow-up|0|||
164189652|NCT02559570|593062178|FG003|Overall Study|Lost to Follow-up|0|||
164189653|NCT02559570|593062179|FG004|Overall Study|Lost to Follow-up|0|||
164189654|NCT02559570|593062175|FG000|Overall Study|Protocol Violation|1|||
164189655|NCT02559570|593062176|FG001|Overall Study|Protocol Violation|0|||
164189656|NCT02559570|593062177|FG002|Overall Study|Protocol Violation|0|||
164189657|NCT02559570|593062178|FG003|Overall Study|Protocol Violation|0|||
164189658|NCT02559570|593062179|FG004|Overall Study|Protocol Violation|1|||
164189659|NCT02559570|593062175|FG000|Overall Study|Other Miscellaneous Reasons|0|||
164189660|NCT02559570|593062176|FG001|Overall Study|Other Miscellaneous Reasons|0|||
164189661|NCT02559570|593062177|FG002|Overall Study|Other Miscellaneous Reasons|1|||
164189662|NCT02559570|593062178|FG003|Overall Study|Other Miscellaneous Reasons|0|||
164189663|NCT02559570|593062179|FG004|Overall Study|Other Miscellaneous Reasons|0|||
164189664|NCT01066871|593062184|FG000|Overall Study|Lost to Follow-up|0|||
164189665|NCT01066871|593062185|FG001|Overall Study|Lost to Follow-up|2|||
164189666|NCT01066871|593062186|FG002|Overall Study|Lost to Follow-up|2|||
164189667|NCT01066871|593062187|FG003|Overall Study|Lost to Follow-up|0|||
164189668|NCT01066871|593062184|FG000|Overall Study|Protocol Violation|1|||
164189669|NCT01066871|593062185|FG001|Overall Study|Protocol Violation|0|||
164189670|NCT01066871|593062186|FG002|Overall Study|Protocol Violation|3|||
164418948|NCT00655551|593902771|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
164418949|NCT00655551|593902772|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
164533007|NCT00561951|594322147|FG001|Overall Study|Lack of Efficacy|3|||
164533008|NCT00561951|594322148|FG002|Overall Study|Lack of Efficacy|2|||
164189671|NCT01066871|593062187|FG003|Overall Study|Protocol Violation|2|||
164189672|NCT01066871|593062184|FG000|Overall Study|Lack of Efficacy|0|||
164189673|NCT01066871|593062185|FG001|Overall Study|Lack of Efficacy|0|||
164189674|NCT01066871|593062186|FG002|Overall Study|Lack of Efficacy|0|||
164189675|NCT01066871|593062187|FG003|Overall Study|Lack of Efficacy|1|||
164189676|NCT01066871|593062184|FG000|Overall Study|Withdrawal by Subject|3|||
164189677|NCT01066871|593062185|FG001|Overall Study|Withdrawal by Subject|1|||
164189678|NCT01066871|593062186|FG002|Overall Study|Withdrawal by Subject|0|||
164189679|NCT01066871|593062187|FG003|Overall Study|Withdrawal by Subject|0|||
164189680|NCT01066871|593062184|FG000|Overall Study|Other|0|||
164189681|NCT01066871|593062185|FG001|Overall Study|Other|2|||
164189682|NCT01066871|593062186|FG002|Overall Study|Other|1|||
164189683|NCT01066871|593062187|FG003|Overall Study|Other|2|||
164189684|NCT00845676|593062192|FG000|Overall Study|Virologic breakthrough at week 20|1|||
164189685|NCT00845676|593062192|FG000|Overall Study|Adverse Event|1|||
164189686|NCT00248833|593062197|FG000|Overall Study|Adverse Event|2|||
164189687|NCT00248833|593062198|FG001|Overall Study|Adverse Event|0|||
164189688|NCT00248833|593062199|FG002|Overall Study|Adverse Event|0|||
164189689|NCT00248833|593062197|FG000|Overall Study|Withdrawal by Subject|0|||
164189690|NCT00248833|593062198|FG001|Overall Study|Withdrawal by Subject|1|||
164189691|NCT00248833|593062199|FG002|Overall Study|Withdrawal by Subject|1|||
164189692|NCT00248833|593062197|FG000|Overall Study|Lost to Follow-up|1|||
164189693|NCT00248833|593062198|FG001|Overall Study|Lost to Follow-up|1|||
164189694|NCT00248833|593062199|FG002|Overall Study|Lost to Follow-up|1|||
164189695|NCT00248833|593062197|FG000|Overall Study|Other|0|||
164189696|NCT00248833|593062198|FG001|Overall Study|Other|1|||
164189697|NCT00248833|593062199|FG002|Overall Study|Other|0|||
164189698|NCT01554163|593062200|FG000|Overall Study|Adverse Event|3|||
164189699|NCT01554163|593062201|FG001|Overall Study|Adverse Event|0|||
164189700|NCT01554163|593062200|FG000|Overall Study|Lack of Efficacy|1|||
164189701|NCT01554163|593062201|FG001|Overall Study|Lack of Efficacy|0|||
164189702|NCT01554163|593062200|FG000|Overall Study|Lost to Follow-up|1|||
164189703|NCT01554163|593062201|FG001|Overall Study|Lost to Follow-up|0|||
164189704|NCT01554163|593062200|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164189705|NCT01554163|593062201|FG001|Overall Study|Non-Compliance With Study Drug|1|||
164189706|NCT01554163|593062200|FG000|Overall Study|Protocol Violation|0|||
164189707|NCT01554163|593062201|FG001|Overall Study|Protocol Violation|4|||
164189708|NCT01554163|593062200|FG000|Overall Study|Withdrawal by Subject|1|||
164189709|NCT01554163|593062201|FG001|Overall Study|Withdrawal by Subject|5|||
164189710|NCT01554163|593062200|FG000|Overall Study|Not Treated|1|||
164189711|NCT01554163|593062201|FG001|Overall Study|Not Treated|0|||
164189712|NCT01941537|593062202|FG000|Overall Study|Lack of Efficacy|1|||
164189713|NCT01941537|593062203|FG001|Overall Study|Lack of Efficacy|2|||
164189714|NCT01941537|593062202|FG000|Overall Study|Lost to Follow-up|1|||
164189715|NCT01941537|593062203|FG001|Overall Study|Lost to Follow-up|0|||
164189716|NCT01941537|593062202|FG000|Overall Study|Pregnancy|1|||
164189717|NCT01941537|593062203|FG001|Overall Study|Pregnancy|0|||
164189718|NCT01941537|593062202|FG000|Overall Study|Adverse Event|1|||
164189719|NCT01941537|593062203|FG001|Overall Study|Adverse Event|0|||
164189720|NCT01941537|593062202|FG000|Overall Study|Withdrawal by Subject|0|||
164189721|NCT01941537|593062203|FG001|Overall Study|Withdrawal by Subject|1|||
164189722|NCT02634983|593062205|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
164189723|NCT02634983|593062206|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
164189724|NCT00762762|593063942|FG000|Overall Study|Did not return for appointments|6|||
164189725|NCT00762762|593063943|FG001|Overall Study|Did not return for appointments|8|||
164189726|NCT02489448|593063944|FG000|Overall Study|Death|3|||
164189727|NCT02489448|593063944|FG000|Overall Study|Withdrawal by Subject|2|||
164189728|NCT00215644|593063947|FG000|Overall Study|Disease Progression|28|||
164189729|NCT00215644|593063948|FG001|Overall Study|Disease Progression|10|||
164304109|NCT02113982|593488364|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164304110|NCT02113982|593488365|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164304111|NCT02113982|593488366|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164304112|NCT02113982|593488367|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164304113|NCT02113982|593488368|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164304114|NCT02113982|593488369|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164304115|NCT02113982|593488370|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164304116|NCT02113982|593488371|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164304117|NCT02113982|593488372|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164304118|NCT02113982|593488373|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164304119|NCT02113982|593488374|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164304120|NCT02113982|593488375|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
164304121|NCT02113982|593488376|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164304122|NCT01772316|593488378|FG000|Overall Study|Serious adverse event|1|||
164304123|NCT01772316|593488378|FG000|Overall Study|Inform consent withdrawn|1|||
164304124|NCT01772316|593488378|FG000|Overall Study|Withdrawn by sponsor decision|5|||
164304125|NCT02085161|593488379|FG000|Overall Study|Not Treated|1|||
164304126|NCT02085161|593488380|FG001|Overall Study|Not Treated|0|||
164304127|NCT02085161|593488381|FG002|Overall Study|Not Treated|0|||
164304128|NCT02085161|593488382|FG003|Overall Study|Not Treated|0|||
164418950|NCT00655551|593902773|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
164418951|NCT00655551|593902771|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
164189730|NCT00215644|593063947|FG000|Overall Study|Adverse Event|2|||
164189731|NCT00215644|593063948|FG001|Overall Study|Adverse Event|9|||
164189732|NCT00215644|593063947|FG000|Overall Study|Death|1|||
164418952|NCT00655551|593902772|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
164418953|NCT00655551|593902773|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
164418954|NCT02855164|593902775|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
164418955|NCT02855164|593902776|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
164418956|NCT02855164|593902777|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
164418957|NCT02855164|593902778|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
164418958|NCT02855164|593902779|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
164418959|NCT02855164|593902780|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
164418960|NCT02855164|593902781|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
164418961|NCT02855164|593902782|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
164418962|NCT02855164|593902775|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
164418963|NCT02855164|593902776|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
164418964|NCT02855164|593902777|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
164418965|NCT02855164|593902778|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
164418966|NCT02855164|593902779|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
164418967|NCT02855164|593902780|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
164418968|NCT02855164|593902781|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
164418969|NCT02855164|593902782|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
164418970|NCT02855164|593902775|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
164418971|NCT02855164|593902776|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
164418972|NCT02855164|593902777|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
164418973|NCT02855164|593902778|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
164418974|NCT02855164|593902779|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
164418975|NCT02855164|593902780|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
164418976|NCT02855164|593902781|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
164418977|NCT02855164|593902782|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
164418978|NCT02855164|593902775|FG000|Part C (Randomized Set)|Adverse Event|0|||
164418979|NCT02855164|593902776|FG001|Part C (Randomized Set)|Adverse Event|0|||
164418980|NCT02855164|593902777|FG002|Part C (Randomized Set)|Adverse Event|0|||
164418981|NCT02855164|593902778|FG003|Part C (Randomized Set)|Adverse Event|0|||
164418982|NCT02855164|593902779|FG004|Part C (Randomized Set)|Adverse Event|0|||
164418983|NCT02855164|593902780|FG005|Part C (Randomized Set)|Adverse Event|5|||
164418984|NCT02855164|593902781|FG006|Part C (Randomized Set)|Adverse Event|9|||
164418985|NCT02855164|593902782|FG007|Part C (Randomized Set)|Adverse Event|2|||
164418986|NCT02855164|593902775|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
164418987|NCT02855164|593902776|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
164418988|NCT02855164|593902777|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
164418989|NCT02855164|593902778|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
164418990|NCT02855164|593902779|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
164418991|NCT02855164|593902780|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
164418992|NCT02855164|593902781|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
164418993|NCT02855164|593902782|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
164418994|NCT02855164|593902775|FG000|Part C (Randomized Set)|Physician Decision|0|||
164418995|NCT02855164|593902776|FG001|Part C (Randomized Set)|Physician Decision|0|||
164418996|NCT02855164|593902777|FG002|Part C (Randomized Set)|Physician Decision|0|||
164418997|NCT02855164|593902778|FG003|Part C (Randomized Set)|Physician Decision|0|||
164418998|NCT02855164|593902779|FG004|Part C (Randomized Set)|Physician Decision|0|||
164418999|NCT02855164|593902780|FG005|Part C (Randomized Set)|Physician Decision|1|||
164419000|NCT02855164|593902781|FG006|Part C (Randomized Set)|Physician Decision|0|||
164419001|NCT02855164|593902782|FG007|Part C (Randomized Set)|Physician Decision|1|||
164419002|NCT02855164|593902775|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
164419003|NCT02855164|593902776|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
164419004|NCT02855164|593902777|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
164419005|NCT02855164|593902778|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
164419006|NCT02855164|593902779|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
164419007|NCT02855164|593902780|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
164419008|NCT02855164|593902781|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
164419009|NCT02855164|593902782|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
164419010|NCT03681639|593904561|FG000|Overall Study|Death|4|||
164419011|NCT03681639|593904561|FG000|Overall Study|Lost to Follow-up|2|||
164419012|NCT03681639|593904561|FG000|Overall Study|Withdrawal by Subject|1|||
164419013|NCT03681639|593904561|FG000|Overall Study|Adverse Event|2|||
164419014|NCT01818141|593904562|FG000|Overall Study|Withdrawal by Subject|2|||
164419015|NCT01818141|593904563|FG001|Overall Study|Withdrawal by Subject|0|||
164419016|NCT01818141|593904562|FG000|Overall Study|No baseline C.diff colonies|1|||
164419017|NCT01818141|593904563|FG001|Overall Study|No baseline C.diff colonies|1|||
164419018|NCT01818141|593904562|FG000|Overall Study|Lost to Follow-up|0|||
164419019|NCT01818141|593904563|FG001|Overall Study|Lost to Follow-up|2|||
164419020|NCT03204695|593904564|FG000|Overall Study|Death|1|||
164533009|NCT00561951|594322146|FG000|Overall Study|Lost to Follow-up|1|||
164419021|NCT03204695|593904564|FG000|Overall Study|Participant was treated with another device|1|||
164419022|NCT03204695|593904564|FG000|Overall Study|Physician Decision|2|||
164419023|NCT01755689|593904566|FG000|Overall Study|Withdrawal by Subject|1|||
164419024|NCT01755689|593904567|FG001|Overall Study|Withdrawal by Subject|3|||
164419025|NCT01755689|593904568|FG002|Overall Study|Withdrawal by Subject|2|||
164419026|NCT01755689|593904569|FG003|Overall Study|Withdrawal by Subject|1|||
164419027|NCT01755689|593904570|FG004|Overall Study|Withdrawal by Subject|1|||
164419028|NCT01755689|593904566|FG000|Overall Study|Migrated/moved from study area|0|||
164419029|NCT01755689|593904567|FG001|Overall Study|Migrated/moved from study area|1|||
164419030|NCT01755689|593904568|FG002|Overall Study|Migrated/moved from study area|1|||
164419031|NCT01755689|593904569|FG003|Overall Study|Migrated/moved from study area|1|||
164419032|NCT01755689|593904570|FG004|Overall Study|Migrated/moved from study area|1|||
164419033|NCT01755689|593904566|FG000|Overall Study|Lost to Follow-up|1|||
164419034|NCT01755689|593904567|FG001|Overall Study|Lost to Follow-up|0|||
164419035|NCT01755689|593904568|FG002|Overall Study|Lost to Follow-up|1|||
164419036|NCT01755689|593904569|FG003|Overall Study|Lost to Follow-up|0|||
164419037|NCT01755689|593904570|FG004|Overall Study|Lost to Follow-up|2|||
164419038|NCT01755689|593904566|FG000|Overall Study|Pregnancy|1|||
164419039|NCT01755689|593904567|FG001|Overall Study|Pregnancy|1|||
164419040|NCT01755689|593904568|FG002|Overall Study|Pregnancy|2|||
164419041|NCT01755689|593904569|FG003|Overall Study|Pregnancy|4|||
164419042|NCT01755689|593904570|FG004|Overall Study|Pregnancy|2|||
164419043|NCT01995357|593904571|FG000|Period 5|Lack of Efficacy|1|||
164419044|NCT01995357|593904572|FG001|Period 5|Lack of Efficacy|0|||
164419045|NCT01995357|593904573|FG002|Period 5|Lack of Efficacy|0|||
164419046|NCT01995357|593904574|FG003|Period 5|Lack of Efficacy|0|||
164419047|NCT01995357|593904575|FG004|Period 5|Lack of Efficacy|0|||
164419048|NCT01995357|593904576|FG005|Period 5|Lack of Efficacy|0|||
164419049|NCT01995357|593904571|FG000|Period 5|Adverse Event|1|||
164419050|NCT01995357|593904572|FG001|Period 5|Adverse Event|0|||
164419051|NCT01995357|593904573|FG002|Period 5|Adverse Event|1|||
164419052|NCT01995357|593904574|FG003|Period 5|Adverse Event|0|||
164419053|NCT01995357|593904575|FG004|Period 5|Adverse Event|0|||
164419054|NCT01995357|593904576|FG005|Period 5|Adverse Event|0|||
164419055|NCT01115998|593904579|FG000|Overall Study|Lost to Follow-up|6|||
164419056|NCT01115998|593904580|FG001|Overall Study|Lost to Follow-up|6|||
164419057|NCT01383993|593904585|FG000|Overall Study|Adverse Event|1|||
164419058|NCT01383993|593904586|FG001|Overall Study|Adverse Event|1|||
164419059|NCT01383993|593904587|FG002|Overall Study|Adverse Event|0|||
164419060|NCT01383993|593904585|FG000|Overall Study|Withdrawal by Subject|0|||
164419061|NCT01383993|593904586|FG001|Overall Study|Withdrawal by Subject|0|||
164419062|NCT01383993|593904587|FG002|Overall Study|Withdrawal by Subject|1|||
164419063|NCT01383993|593904585|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
164419064|NCT01383993|593904586|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
164419065|NCT01383993|593904587|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
164419066|NCT00593554|593904588|FG000|Overall Study|Death|1|||
164419067|NCT00593554|593904589|FG001|Overall Study|Death|2|||
164419068|NCT00593554|593904588|FG000|Overall Study|Physician Decision|0|||
164419069|NCT00593554|593904589|FG001|Overall Study|Physician Decision|1|||
164419070|NCT00593554|593904588|FG000|Overall Study|Withdrawal by Subject|1|||
164419071|NCT00593554|593904589|FG001|Overall Study|Withdrawal by Subject|0|||
164419072|NCT00593554|593904588|FG000|Overall Study|Disease Progression|1|||
164419073|NCT00593554|593904589|FG001|Overall Study|Disease Progression|2|||
164419074|NCT00795132|593904593|FG000|Overall Study|Death|1|||
164419075|NCT00795132|593904593|FG000|Overall Study|Relapse|2|||
164419076|NCT00358150|593904598|FG000|Overall Study|Adverse Event|3|||
164419077|NCT00358150|593904598|FG000|Overall Study|Withdrawal by Subject|1|||
164419078|NCT00358150|593904598|FG000|Overall Study|Undefined|3|||
164419079|NCT00179010|593904599|FG000|Overall Study|Muscle probe defective|1|||
164419080|NCT00179010|593904600|FG001|Overall Study|Muscle probe defective|1|||
164419081|NCT00179010|593904599|FG000|Overall Study|Failure to place arterial line|0|||
164419082|NCT00179010|593904600|FG001|Overall Study|Failure to place arterial line|1|||
164419083|NCT04747275|593904612|FG000|Overall Study|Study terminated|0|||
164419084|NCT04747275|593904613|FG001|Overall Study|Study terminated|1|||
164419085|NCT04254679|593904636|FG000|Overall Study|Protocol Violation|1|||
164419086|NCT04254679|593904637|FG001|Overall Study|Protocol Violation|1|||
164419087|NCT04254679|593904636|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
164189733|NCT00215644|593063948|FG001|Overall Study|Death|2|||
164419088|NCT04254679|593904637|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
164419089|NCT04076020|593904649|FG000|Overall Study|Death|4|||
164419090|NCT04076020|593904650|FG001|Overall Study|Death|6|||
164419091|NCT04076020|593904649|FG000|Overall Study|Withdrawal by Subject|12|||
164419092|NCT04076020|593904650|FG001|Overall Study|Withdrawal by Subject|8|||
164419093|NCT00502996|593904667|FG000|Overall Study|Lost to Follow-up|9|||
164419094|NCT00502996|593904667|FG000|Overall Study|Protocol Violation|2|||
164419095|NCT00502996|593904667|FG000|Overall Study|Treatment failure|25|||
164419096|NCT00502996|593904667|FG000|Overall Study|Withdrawal Informed Consent|6|||
164419097|NCT00502996|593904667|FG000|Overall Study|Adverse Event|2|||
164419098|NCT01729728|593904668|FG000|Overall Study|Adverse Event|0|||
164419099|NCT01729728|593904669|FG001|Overall Study|Adverse Event|6|||
164419100|NCT01729728|593904670|FG002|Overall Study|Adverse Event|0|||
164304129|NCT02085161|593488379|FG000|Overall Study|Adverse Event|8|||
164304130|NCT02085161|593488380|FG001|Overall Study|Adverse Event|5|||
164304131|NCT02085161|593488381|FG002|Overall Study|Adverse Event|4|||
164304132|NCT02085161|593488382|FG003|Overall Study|Adverse Event|5|||
164304133|NCT02085161|593488379|FG000|Overall Study|Protocol Violation|0|||
164304134|NCT02085161|593488380|FG001|Overall Study|Protocol Violation|1|||
164304135|NCT02085161|593488381|FG002|Overall Study|Protocol Violation|0|||
164304136|NCT02085161|593488382|FG003|Overall Study|Protocol Violation|1|||
164304137|NCT02085161|593488379|FG000|Overall Study|Withdrawal by Subject|2|||
164304138|NCT02085161|593488380|FG001|Overall Study|Withdrawal by Subject|4|||
164304139|NCT02085161|593488381|FG002|Overall Study|Withdrawal by Subject|0|||
164304140|NCT02085161|593488382|FG003|Overall Study|Withdrawal by Subject|3|||
164304141|NCT02085161|593488379|FG000|Overall Study|Other Reason|1|||
164304142|NCT02085161|593488380|FG001|Overall Study|Other Reason|0|||
164304143|NCT02085161|593488381|FG002|Overall Study|Other Reason|1|||
164304144|NCT02085161|593488382|FG003|Overall Study|Other Reason|1|||
164304145|NCT00068692|593488393|FG000|Step 1: Registration|Disese progression/relapse|5|||
164304146|NCT00068692|593488394|FG001|Step 1: Registration|Disese progression/relapse|0|||
164304147|NCT00068692|593488395|FG002|Step 1: Registration|Disese progression/relapse|0|||
164304148|NCT00068692|593488396|FG003|Step 1: Registration|Disese progression/relapse|0|||
164304149|NCT00068692|593488397|FG004|Step 1: Registration|Disese progression/relapse|0|||
164304150|NCT00068692|593488398|FG005|Step 1: Registration|Disese progression/relapse|0|||
164304151|NCT00068692|593488399|FG006|Step 1: Registration|Disese progression/relapse|0|||
164419101|NCT01729728|593904668|FG000|Overall Study|Protocol Violation|1|||
164419102|NCT01729728|593904669|FG001|Overall Study|Protocol Violation|0|||
164419103|NCT01729728|593904670|FG002|Overall Study|Protocol Violation|1|||
164419104|NCT02056119|593904673|FG000|Overall Study|Death|1|||
164419105|NCT02056119|593904674|FG001|Overall Study|Death|2|||
164419106|NCT02056119|593904673|FG000|Overall Study|Intubated for less than 24 hrs|2|||
164419107|NCT02056119|593904674|FG001|Overall Study|Intubated for less than 24 hrs|7|||
164419108|NCT02056119|593904673|FG000|Overall Study|No aerosol treatments were given.|3|||
164419109|NCT02056119|593904674|FG001|Overall Study|No aerosol treatments were given.|2|||
164419110|NCT02056119|593904673|FG000|Overall Study|Received Metaneb treatment|0|||
164419111|NCT02056119|593904674|FG001|Overall Study|Received Metaneb treatment|2|||
164419112|NCT02056119|593904673|FG000|Overall Study|Protocol Violation|4|||
164419113|NCT02056119|593904674|FG001|Overall Study|Protocol Violation|7|||
164419114|NCT01348854|593904675|FG000|Overall Study|Lost to Follow-up|2|||
164419115|NCT01348854|593904676|FG001|Overall Study|Lost to Follow-up|1|||
164419116|NCT01348854|593904675|FG000|Overall Study|Withdrawal by Subject|1|||
164419117|NCT01348854|593904676|FG001|Overall Study|Withdrawal by Subject|0|||
164419118|NCT00993317|593904677|FG000|Overall Study|Adverse Event|2|||
164419119|NCT00993317|593904678|FG001|Overall Study|Adverse Event|4|||
164419120|NCT00993317|593904677|FG000|Overall Study|Lack of Efficacy|18|||
164419121|NCT00993317|593904678|FG001|Overall Study|Lack of Efficacy|18|||
164419122|NCT00993317|593904677|FG000|Overall Study|Withdrawal by Subject|0|||
164419123|NCT00993317|593904678|FG001|Overall Study|Withdrawal by Subject|2|||
164419124|NCT00993317|593904677|FG000|Overall Study|Investigator's opinion|0|||
164419125|NCT00993317|593904678|FG001|Overall Study|Investigator's opinion|1|||
164419126|NCT00993317|593904677|FG000|Overall Study|Early study termination at the site|1|||
164419127|NCT00993317|593904678|FG001|Overall Study|Early study termination at the site|0|||
164419128|NCT01380990|593904679|FG000|Overall Study|Treatment Failure|1|||
164419129|NCT01380990|593904680|FG001|Overall Study|Treatment Failure|0|||
164419130|NCT01380990|593904679|FG000|Overall Study|Death|0|||
164419131|NCT01380990|593904680|FG001|Overall Study|Death|1|||
164419132|NCT00672958|593904681|FG000|Overall Study|Adverse Event|11|||
164419133|NCT00672958|593904682|FG001|Overall Study|Adverse Event|9|||
164419134|NCT00672958|593904681|FG000|Overall Study|Lack of Efficacy|6|||
164419135|NCT00672958|593904682|FG001|Overall Study|Lack of Efficacy|11|||
164304152|NCT00068692|593488400|FG007|Step 1: Registration|Disese progression/relapse|0|||
164304153|NCT00068692|593488393|FG000|Step 1: Registration|Adverse Event|7|||
164304154|NCT00068692|593488394|FG001|Step 1: Registration|Adverse Event|0|||
164304155|NCT00068692|593488395|FG002|Step 1: Registration|Adverse Event|0|||
164304156|NCT00068692|593488396|FG003|Step 1: Registration|Adverse Event|0|||
164304157|NCT00068692|593488397|FG004|Step 1: Registration|Adverse Event|0|||
164304158|NCT00068692|593488398|FG005|Step 1: Registration|Adverse Event|0|||
164304159|NCT00068692|593488399|FG006|Step 1: Registration|Adverse Event|0|||
164304160|NCT00068692|593488400|FG007|Step 1: Registration|Adverse Event|0|||
164304161|NCT00068692|593488393|FG000|Step 1: Registration|Death|1|||
164304162|NCT00068692|593488394|FG001|Step 1: Registration|Death|0|||
164304163|NCT00068692|593488395|FG002|Step 1: Registration|Death|0|||
164304164|NCT00068692|593488396|FG003|Step 1: Registration|Death|0|||
164304165|NCT00068692|593488397|FG004|Step 1: Registration|Death|0|||
164304166|NCT00068692|593488398|FG005|Step 1: Registration|Death|0|||
164304167|NCT00068692|593488399|FG006|Step 1: Registration|Death|0|||
164419136|NCT00672958|593904681|FG000|Overall Study|Non-compliance with study drug|2|||
164419137|NCT00672958|593904682|FG001|Overall Study|Non-compliance with study drug|3|||
164419138|NCT00672958|593904681|FG000|Overall Study|Protocol deviations|11|||
164419139|NCT00672958|593904682|FG001|Overall Study|Protocol deviations|5|||
164419140|NCT00672958|593904681|FG000|Overall Study|Voluntary withdrawal|12|||
164419141|NCT00672958|593904682|FG001|Overall Study|Voluntary withdrawal|8|||
164419142|NCT00672958|593904681|FG000|Overall Study|Lost to Follow-up|22|||
164419143|NCT00672958|593904682|FG001|Overall Study|Lost to Follow-up|17|||
164419144|NCT00672958|593904681|FG000|Overall Study|Reason not specified|0|||
164419145|NCT00672958|593904682|FG001|Overall Study|Reason not specified|3|||
164419146|NCT02374593|593904683|FG000|Overall Study|non-compliant|2|||
164419147|NCT02374593|593904684|FG001|Overall Study|non-compliant|0|||
164419148|NCT02796963|593904685|FG000|Overall Study|Lost to Follow-up|89|||
164419149|NCT02796963|593904686|FG001|Overall Study|Lost to Follow-up|76|||
164419150|NCT02796963|593904687|FG002|Overall Study|Lost to Follow-up|69|||
164419151|NCT02796963|593904688|FG003|Overall Study|Lost to Follow-up|72|||
164419152|NCT03192215|593904689|FG000|Overall Study|Death|28|||
164419153|NCT03192215|593904690|FG001|Overall Study|Death|23|||
164419154|NCT03192215|593904689|FG000|Overall Study|Lost to Follow-up|10|||
164419155|NCT03192215|593904690|FG001|Overall Study|Lost to Follow-up|15|||
164419156|NCT03192215|593904689|FG000|Overall Study|Withdrawal by Subject|49|||
164419157|NCT03192215|593904690|FG001|Overall Study|Withdrawal by Subject|48|||
164419158|NCT03192215|593904689|FG000|Overall Study|Other as reported in analysis|4|||
164419159|NCT03192215|593904690|FG001|Overall Study|Other as reported in analysis|1|||
164419160|NCT04844918|593904693|FG000|Overall Study|Adverse Event|7|||
164419161|NCT04844918|593904694|FG001|Overall Study|Adverse Event|8|||
164419162|NCT04844918|593904695|FG002|Overall Study|Adverse Event|5|||
164419163|NCT04844918|593904693|FG000|Overall Study|Physician Decision|0|||
164419164|NCT04844918|593904694|FG001|Overall Study|Physician Decision|1|||
164419165|NCT04844918|593904695|FG002|Overall Study|Physician Decision|0|||
164419166|NCT04844918|593904693|FG000|Overall Study|Withdrawal by Subject|6|||
164419167|NCT04844918|593904694|FG001|Overall Study|Withdrawal by Subject|3|||
164419168|NCT04844918|593904695|FG002|Overall Study|Withdrawal by Subject|3|||
164419169|NCT04844918|593904693|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
164419170|NCT04844918|593904694|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
164419171|NCT04844918|593904695|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
164419172|NCT01009047|593904699|FG000|Overall Study|Adverse Event|5|||
164419173|NCT01009047|593904700|FG001|Overall Study|Adverse Event|0|||
164419174|NCT01009047|593904699|FG000|Overall Study|Lost to Follow-up|0|||
164419175|NCT01009047|593904700|FG001|Overall Study|Lost to Follow-up|2|||
164419176|NCT01009047|593904699|FG000|Overall Study|Lack of Efficacy|4|||
164419177|NCT01009047|593904700|FG001|Overall Study|Lack of Efficacy|11|||
164419178|NCT01009047|593904699|FG000|Overall Study|Withdrawal by consent|16|||
164533010|NCT00561951|594322147|FG001|Overall Study|Lost to Follow-up|1|||
164533011|NCT00561951|594322148|FG002|Overall Study|Lost to Follow-up|0|||
164533012|NCT00561951|594322146|FG000|Overall Study|Withdrawal by Subject|10|||
164533013|NCT00561951|594322147|FG001|Overall Study|Withdrawal by Subject|9|||
164533014|NCT00561951|594322148|FG002|Overall Study|Withdrawal by Subject|10|||
164533015|NCT00561951|594322146|FG000|Overall Study|Protocol Violation|4|||
164533016|NCT00561951|594322147|FG001|Overall Study|Protocol Violation|3|||
164533017|NCT00561951|594322148|FG002|Overall Study|Protocol Violation|4|||
164533018|NCT00561951|594322146|FG000|Overall Study|Physician Decision|1|||
164533019|NCT00561951|594322147|FG001|Overall Study|Physician Decision|0|||
164533020|NCT00561951|594322148|FG002|Overall Study|Physician Decision|0|||
164533021|NCT00561951|594322146|FG000|Overall Study|Pregnancy|0|||
164533022|NCT00561951|594322147|FG001|Overall Study|Pregnancy|1|||
164533023|NCT00561951|594322148|FG002|Overall Study|Pregnancy|0|||
164533024|NCT00561951|594322146|FG000|Overall Study|Meet Withdrawal Criterion|0|||
164533025|NCT00561951|594322147|FG001|Overall Study|Meet Withdrawal Criterion|1|||
164533026|NCT00561951|594322148|FG002|Overall Study|Meet Withdrawal Criterion|1|||
164533027|NCT00561951|594322146|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
164533028|NCT00561951|594322147|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
164533029|NCT00561951|594322148|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
164533030|NCT01596621|594322149|FG000|Overall Study|Death|4|||
164533031|NCT01596621|594322149|FG000|Overall Study|Withdrawal by Subject|9|||
164533032|NCT01596621|594322149|FG000|Overall Study|Disease Progression|49|||
164533033|NCT01596621|594322149|FG000|Overall Study|Lost to Follow-up|3|||
164533034|NCT01596621|594322149|FG000|Overall Study|Other than specified|13|||
164533035|NCT00421707|594322150|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
164533036|NCT00421707|594322151|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
164533037|NCT00421707|594322150|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
164533038|NCT00421707|594322151|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
164533039|NCT00421707|594322150|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
164533040|NCT00421707|594322151|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
164419179|NCT01009047|593904700|FG001|Overall Study|Withdrawal by consent|11|||
164419180|NCT01009047|593904699|FG000|Overall Study|Other|3|||
164533041|NCT00421707|594322150|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
164533042|NCT00421707|594322151|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
164533043|NCT00421707|594322150|FG000|Period 2: Washout|Adverse Event|1|||
164533044|NCT00421707|594322151|FG001|Period 2: Washout|Adverse Event|1|||
164533045|NCT00421707|594322150|FG000|Period 2: Washout|Withdrawal by Subject|0|||
164533046|NCT00421707|594322151|FG001|Period 2: Washout|Withdrawal by Subject|1|||
164533047|NCT00421707|594322150|FG000|Period 2: Washout|Lost to Follow-up|0|||
164533048|NCT00421707|594322151|FG001|Period 2: Washout|Lost to Follow-up|1|||
164533049|NCT00421707|594322150|FG000|Period 2: Washout|Other: Pregnancy|0|||
164533050|NCT00421707|594322151|FG001|Period 2: Washout|Other: Pregnancy|1|||
164533051|NCT00421707|594322150|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
164533052|NCT00421707|594322151|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
164533053|NCT00421707|594322150|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
164533054|NCT00421707|594322151|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
164533055|NCT00421707|594322150|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
164533056|NCT00421707|594322151|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
164533057|NCT01723254|594322152|FG000|Overall Study|Conflict with work schedule|0|||
164533058|NCT01723254|594322153|FG001|Overall Study|Conflict with work schedule|0|||
164533059|NCT01723254|594322154|FG002|Overall Study|Conflict with work schedule|0|||
164533060|NCT01723254|594322155|FG003|Overall Study|Conflict with work schedule|0|||
164533061|NCT01723254|594322156|FG004|Overall Study|Conflict with work schedule|0|||
164533062|NCT01723254|594322157|FG005|Overall Study|Conflict with work schedule|0|||
164533063|NCT01723254|594322158|FG006|Overall Study|Conflict with work schedule|0|||
164419181|NCT01009047|593904700|FG001|Overall Study|Other|2|||
164419182|NCT02366936|593904703|FG000|Overall Study|Withdrawal by Subject|2|||
164419183|NCT02366936|593904703|FG000|Overall Study|Lost to Follow-up|4|||
164419184|NCT02366936|593904703|FG000|Overall Study|Physician Decision|2|||
164419185|NCT02878213|593904704|FG000|Overall Study|Withdrawal by Subject|2|||
164419186|NCT02878213|593904704|FG000|Overall Study|Adverse Event|1|||
164419187|NCT01558674|593904705|FG000|Part 1|Study Terminated by Sponsor|10|||
164419188|NCT01558674|593904706|FG001|Part 1|Study Terminated by Sponsor|0|||
164419189|NCT01558674|593904705|FG000|Part 1|Withdrawal by Subject|1|||
164419190|NCT01558674|593904706|FG001|Part 1|Withdrawal by Subject|0|||
164419191|NCT01555021|593904709|FG000|Overall Study|Lost to Follow-up|1|||
164419192|NCT01555021|593904710|FG001|Overall Study|Lost to Follow-up|2|||
164419193|NCT02420327|593904713|FG000|Overall Study|Adverse Event|7|||
164419194|NCT02420327|593904713|FG000|Overall Study|Pregnancy|1|||
164419195|NCT02420327|593904713|FG000|Overall Study|Withdrawal by Subject|6|||
164419196|NCT02420327|593904713|FG000|Overall Study|Lost to Follow-up|1|||
164419197|NCT02420327|593904713|FG000|Overall Study|Protocol Violation|1|||
164419198|NCT01225835|593904716|FG000|Overall Study|Completed protocol|2|||
164419199|NCT01225835|593904717|FG001|Overall Study|Completed protocol|1|||
164419200|NCT01225835|593904716|FG000|Overall Study|Did not meet hCG criterion|2|||
164419201|NCT01225835|593904717|FG001|Overall Study|Did not meet hCG criterion|0|||
164419202|NCT01225835|593904716|FG000|Overall Study|Adverse Event|2|||
164419203|NCT01225835|593904717|FG001|Overall Study|Adverse Event|1|||
164419204|NCT01225835|593904716|FG000|Overall Study|Other|1|||
164419205|NCT01225835|593904717|FG001|Overall Study|Other|1|||
164419206|NCT01146574|593904718|FG000|Overall Study|Death|0|||
164419207|NCT01146574|593904719|FG001|Overall Study|Death|1|||
164419208|NCT01146574|593904720|FG002|Overall Study|Death|1|||
164419209|NCT01146574|593904721|FG003|Overall Study|Death|0|||
164419210|NCT01146574|593904722|FG004|Overall Study|Death|0|||
164419211|NCT01146574|593904723|FG005|Overall Study|Death|0|||
164419212|NCT01146574|593904724|FG006|Overall Study|Death|0|||
164419213|NCT01146574|593904718|FG000|Overall Study|Other reasons|0|||
164419214|NCT01146574|593904719|FG001|Overall Study|Other reasons|0|||
164419215|NCT01146574|593904720|FG002|Overall Study|Other reasons|3|||
164419216|NCT01146574|593904721|FG003|Overall Study|Other reasons|0|||
164419217|NCT01146574|593904722|FG004|Overall Study|Other reasons|0|||
164419218|NCT01146574|593904723|FG005|Overall Study|Other reasons|0|||
164419219|NCT01146574|593904724|FG006|Overall Study|Other reasons|0|||
164419220|NCT01146574|593904718|FG000|Overall Study|Kidney transplant|0|||
164419221|NCT01146574|593904719|FG001|Overall Study|Kidney transplant|0|||
164419222|NCT01146574|593904720|FG002|Overall Study|Kidney transplant|1|||
164419223|NCT01146574|593904721|FG003|Overall Study|Kidney transplant|1|||
164419224|NCT01146574|593904722|FG004|Overall Study|Kidney transplant|0|||
164419225|NCT01146574|593904723|FG005|Overall Study|Kidney transplant|0|||
164419226|NCT01146574|593904724|FG006|Overall Study|Kidney transplant|0|||
164419227|NCT01146574|593904718|FG000|Overall Study|Withdrew consent|0|||
164419228|NCT01146574|593904719|FG001|Overall Study|Withdrew consent|0|||
164419229|NCT01146574|593904720|FG002|Overall Study|Withdrew consent|1|||
164419230|NCT01146574|593904721|FG003|Overall Study|Withdrew consent|1|||
164419231|NCT01146574|593904722|FG004|Overall Study|Withdrew consent|2|||
164419232|NCT01146574|593904723|FG005|Overall Study|Withdrew consent|1|||
164419233|NCT01146574|593904724|FG006|Overall Study|Withdrew consent|1|||
164419234|NCT00876460|593904730|FG000|Combination Therapy Phase|Progressive disease|2|||
164419235|NCT00876460|593904731|FG001|Combination Therapy Phase|Progressive disease|3|||
164419236|NCT00876460|593904732|FG002|Combination Therapy Phase|Progressive disease|3|||
164419237|NCT00876460|593904733|FG003|Combination Therapy Phase|Progressive disease|3|||
164533064|NCT01723254|594322159|FG007|Overall Study|Conflict with work schedule|1|||
164533065|NCT01723254|594322152|FG000|Overall Study|Personal issues|0|||
164533066|NCT01723254|594322153|FG001|Overall Study|Personal issues|0|||
164419238|NCT00876460|593904734|FG004|Combination Therapy Phase|Progressive disease|3|||
164419239|NCT00876460|593904735|FG005|Combination Therapy Phase|Progressive disease|1|||
164419240|NCT00876460|593904736|FG006|Combination Therapy Phase|Progressive disease|1|||
164419241|NCT00876460|593904737|FG007|Combination Therapy Phase|Progressive disease|1|||
164419242|NCT00876460|593904730|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
164419243|NCT00876460|593904731|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
164419244|NCT00876460|593904732|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
164419245|NCT00876460|593904733|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
164419246|NCT00876460|593904734|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
164419247|NCT00876460|593904735|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
164419248|NCT00876460|593904736|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
164419249|NCT00876460|593904737|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
164419250|NCT00876460|593904730|FG000|Combination Therapy Phase|Adverse Event|0|||
164419251|NCT00876460|593904731|FG001|Combination Therapy Phase|Adverse Event|2|||
164419252|NCT00876460|593904732|FG002|Combination Therapy Phase|Adverse Event|0|||
164419253|NCT00876460|593904733|FG003|Combination Therapy Phase|Adverse Event|2|||
164419254|NCT00876460|593904734|FG004|Combination Therapy Phase|Adverse Event|2|||
164419255|NCT00876460|593904735|FG005|Combination Therapy Phase|Adverse Event|0|||
164419256|NCT00876460|593904736|FG006|Combination Therapy Phase|Adverse Event|3|||
164419257|NCT00876460|593904737|FG007|Combination Therapy Phase|Adverse Event|2|||
164419258|NCT00876460|593904730|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
164419259|NCT00876460|593904731|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
164419260|NCT00876460|593904732|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
164533067|NCT01723254|594322154|FG002|Overall Study|Personal issues|0|||
164533068|NCT01723254|594322155|FG003|Overall Study|Personal issues|0|||
164533069|NCT01723254|594322156|FG004|Overall Study|Personal issues|0|||
164533070|NCT01723254|594322157|FG005|Overall Study|Personal issues|1|||
164533071|NCT01723254|594322158|FG006|Overall Study|Personal issues|0|||
164533072|NCT01723254|594322159|FG007|Overall Study|Personal issues|0|||
164533073|NCT01723254|594322152|FG000|Overall Study|No longer have time to participate|0|||
164533074|NCT01723254|594322153|FG001|Overall Study|No longer have time to participate|0|||
164533075|NCT01723254|594322154|FG002|Overall Study|No longer have time to participate|0|||
164533076|NCT01723254|594322155|FG003|Overall Study|No longer have time to participate|1|||
164533077|NCT01723254|594322156|FG004|Overall Study|No longer have time to participate|0|||
164533078|NCT01723254|594322157|FG005|Overall Study|No longer have time to participate|0|||
164533079|NCT01723254|594322158|FG006|Overall Study|No longer have time to participate|0|||
164533080|NCT01723254|594322159|FG007|Overall Study|No longer have time to participate|0|||
164533081|NCT01723254|594322152|FG000|Overall Study|Move/Left to another country/city|0|||
164533082|NCT01723254|594322153|FG001|Overall Study|Move/Left to another country/city|0|||
164533083|NCT01723254|594322154|FG002|Overall Study|Move/Left to another country/city|2|||
164533084|NCT01723254|594322155|FG003|Overall Study|Move/Left to another country/city|1|||
164533085|NCT01723254|594322156|FG004|Overall Study|Move/Left to another country/city|1|||
164533086|NCT01723254|594322157|FG005|Overall Study|Move/Left to another country/city|0|||
164533087|NCT01723254|594322158|FG006|Overall Study|Move/Left to another country/city|0|||
164533088|NCT01723254|594322159|FG007|Overall Study|Move/Left to another country/city|0|||
164533089|NCT01723254|594322152|FG000|Overall Study|Protocol Violation|0|||
164533090|NCT01723254|594322153|FG001|Overall Study|Protocol Violation|1|||
164533091|NCT01723254|594322154|FG002|Overall Study|Protocol Violation|0|||
164533092|NCT01723254|594322155|FG003|Overall Study|Protocol Violation|0|||
164533093|NCT01723254|594322156|FG004|Overall Study|Protocol Violation|0|||
164533094|NCT01723254|594322157|FG005|Overall Study|Protocol Violation|0|||
164533095|NCT01723254|594322158|FG006|Overall Study|Protocol Violation|0|||
164533096|NCT01723254|594322159|FG007|Overall Study|Protocol Violation|0|||
164533097|NCT01723254|594322152|FG000|Overall Study|Withdrawal by Subject|1|||
164533098|NCT01723254|594322153|FG001|Overall Study|Withdrawal by Subject|2|||
164533099|NCT01723254|594322154|FG002|Overall Study|Withdrawal by Subject|1|||
164533100|NCT01723254|594322155|FG003|Overall Study|Withdrawal by Subject|0|||
164533101|NCT01723254|594322156|FG004|Overall Study|Withdrawal by Subject|1|||
164533102|NCT01723254|594322157|FG005|Overall Study|Withdrawal by Subject|1|||
164304168|NCT00068692|593488400|FG007|Step 1: Registration|Death|0|||
164304169|NCT00068692|593488393|FG000|Step 1: Registration|Withdrawal by Subject|11|||
164304170|NCT00068692|593488394|FG001|Step 1: Registration|Withdrawal by Subject|0|||
164304171|NCT00068692|593488395|FG002|Step 1: Registration|Withdrawal by Subject|0|||
164304172|NCT00068692|593488396|FG003|Step 1: Registration|Withdrawal by Subject|0|||
164304173|NCT00068692|593488397|FG004|Step 1: Registration|Withdrawal by Subject|0|||
164419261|NCT00876460|593904733|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
164419262|NCT00876460|593904734|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
164419263|NCT00876460|593904735|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
164419264|NCT00876460|593904736|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
164419265|NCT00876460|593904737|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
164419266|NCT00876460|593904730|FG000|Combination Therapy Phase|Other reason not defined above|0|||
164419267|NCT00876460|593904731|FG001|Combination Therapy Phase|Other reason not defined above|0|||
164419268|NCT00876460|593904732|FG002|Combination Therapy Phase|Other reason not defined above|0|||
164533103|NCT01723254|594322158|FG006|Overall Study|Withdrawal by Subject|1|||
164533104|NCT01723254|594322159|FG007|Overall Study|Withdrawal by Subject|2|||
164533105|NCT01201265|594322160|FG000|Overall Study|Death|14|||
164533106|NCT01201265|594322160|FG000|Overall Study|Insufficient Therapeutic Response|3|||
164533107|NCT01201265|594322160|FG000|Overall Study|Lost to Follow-up|10|||
164533108|NCT01201265|594322160|FG000|Overall Study|Withdrawal by Subject|7|||
164533109|NCT01201265|594322160|FG000|Overall Study|Disease Progression|4|||
164533110|NCT01898923|594322164|FG000|Overall Study|Lack of Efficacy|5|||
164533111|NCT01898923|594322165|FG001|Overall Study|Lack of Efficacy|6|||
164533112|NCT01898923|594322164|FG000|Overall Study|Adverse Event|3|||
164533113|NCT01898923|594322165|FG001|Overall Study|Adverse Event|1|||
164533114|NCT01898923|594322164|FG000|Overall Study|Lost to Follow-up|0|||
164533115|NCT01898923|594322165|FG001|Overall Study|Lost to Follow-up|1|||
164533116|NCT01898923|594322164|FG000|Overall Study|Withdrawal by Subject|4|||
164533117|NCT01898923|594322165|FG001|Overall Study|Withdrawal by Subject|7|||
164533118|NCT01898923|594322164|FG000|Overall Study|Physician Decision|3|||
164533119|NCT01898923|594322165|FG001|Overall Study|Physician Decision|4|||
164533120|NCT01898923|594322164|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
164533121|NCT01898923|594322165|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
164533122|NCT00723021|594322166|FG000|Intervention Period 4|Adverse Event|0|||
164533123|NCT00723021|594322167|FG001|Intervention Period 4|Adverse Event|0|||
164533124|NCT00723021|594322168|FG002|Intervention Period 4|Adverse Event|0|||
164533125|NCT00723021|594322169|FG003|Intervention Period 4|Adverse Event|0|||
164533126|NCT00723021|594322170|FG004|Intervention Period 4|Adverse Event|1|||
164533127|NCT02975700|594322175|FG000|Overall Study|Adverse Event|1|||
164533128|NCT02975700|594322175|FG000|Overall Study|Progressive disease|3|||
164533129|NCT02975700|594322175|FG000|Overall Study|Failed screening criteria|2|||
164533130|NCT02441686|594322176|FG000|Induction|Adverse Event|4|||
164533131|NCT02441686|594322176|FG000|Induction|Complicating disease|1|||
164533132|NCT02441686|594322176|FG000|Induction|Physician Decision|1|||
164533133|NCT02441686|594322176|FG000|Induction|Withdrawal by Subject|1|||
164533134|NCT02441686|594322176|FG000|Induction|Did not receive treatment|1|||
164533135|NCT02441686|594322176|FG000|Maintenance|Remaining on Treatment|23|||
164533136|NCT02441686|594322176|FG000|Maintenance|Physician Decision|1|||
164533137|NCT02441686|594322176|FG000|Maintenance|Adverse Event|3|||
164533138|NCT02441686|594322176|FG000|Maintenance|Progressive Disease|10|||
164533139|NCT02441686|594322176|FG000|Maintenance|Withdrawal by Subject|1|||
164533140|NCT05497284|594322177|FG000|Overall Study|Adverse Event|1|||
164533141|NCT05497284|594322178|FG001|Overall Study|Adverse Event|0|||
164533142|NCT05497284|594322177|FG000|Overall Study|Physician Decision|0|||
164533143|NCT05497284|594322178|FG001|Overall Study|Physician Decision|1|||
164533144|NCT05497284|594322177|FG000|Overall Study|Study terminated by sponsor|7|||
164533145|NCT05497284|594322178|FG001|Overall Study|Study terminated by sponsor|4|||
164533146|NCT05497284|594322177|FG000|Overall Study|Subject Decision|0|||
164533147|NCT05497284|594322178|FG001|Overall Study|Subject Decision|1|||
164533148|NCT02254278|594322196|FG000|Overall Study|Protocol Violation|1|||
164533149|NCT02254278|594322197|FG001|Overall Study|Protocol Violation|1|||
164533150|NCT02903368|594322198|FG000|Part 1|Adverse Event|3|||
164533151|NCT02903368|594322199|FG001|Part 1|Adverse Event|0|||
164533152|NCT02903368|594322200|FG002|Part 1|Adverse Event|0|||
164533153|NCT02903368|594322201|FG003|Part 1|Adverse Event|0|||
164533154|NCT02903368|594322198|FG000|Part 1|Withdrawal by Subject|1|||
164533155|NCT02903368|594322199|FG001|Part 1|Withdrawal by Subject|0|||
164533156|NCT02903368|594322200|FG002|Part 1|Withdrawal by Subject|0|||
164533157|NCT02903368|594322201|FG003|Part 1|Withdrawal by Subject|0|||
164533158|NCT02903368|594322198|FG000|Part 2|Adverse Event|0|||
164533159|NCT02903368|594322199|FG001|Part 2|Adverse Event|0|||
164533160|NCT02903368|594322200|FG002|Part 2|Adverse Event|5|||
164533161|NCT02903368|594322201|FG003|Part 2|Adverse Event|0|||
164533162|NCT02903368|594322198|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
164533163|NCT02903368|594322199|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
164533164|NCT02903368|594322200|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
164533165|NCT02903368|594322201|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
164533166|NCT02903368|594322198|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
164533167|NCT02903368|594322199|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
164533168|NCT02903368|594322200|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
164533169|NCT02903368|594322201|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
164533170|NCT02903368|594322198|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
164648306|NCT03216954|594738552|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
164533171|NCT02903368|594322199|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
164533172|NCT02903368|594322200|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
164533173|NCT02903368|594322201|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
164533174|NCT05437510|594322202|FG000|Overall Study|Adverse Event|2|||
164533175|NCT05437510|594322203|FG001|Overall Study|Adverse Event|1|||
164533176|NCT05437510|594322202|FG000|Overall Study|Protocol Deviation|1|||
164533177|NCT05437510|594322203|FG001|Overall Study|Protocol Deviation|6|||
164533178|NCT05437510|594322202|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
164533179|NCT05437510|594322203|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
164533180|NCT05437510|594322202|FG000|Overall Study|Lost to Follow-up|265|||
164533181|NCT05437510|594322203|FG001|Overall Study|Lost to Follow-up|358|||
164533182|NCT00147823|594322206|FG000|Overall Study|Lost to Follow-up|6|||
164533183|NCT00147823|594322207|FG001|Overall Study|Lost to Follow-up|12|||
164533184|NCT00147823|594322206|FG000|Overall Study|Physician Decision|1|||
164533185|NCT00147823|594322207|FG001|Overall Study|Physician Decision|0|||
164533186|NCT00147823|594322206|FG000|Overall Study|Withdrawal by Subject|0|||
164533187|NCT00147823|594322207|FG001|Overall Study|Withdrawal by Subject|1|||
164533188|NCT00147823|594322206|FG000|Overall Study|Did not receive vitoss due to infection|6|||
164533189|NCT00147823|594322207|FG001|Overall Study|Did not receive vitoss due to infection|2|||
164588960|NCT03894904|594519298|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
164588961|NCT00365976|594519299|FG000|Overall Study|Withdrawal by Subject|1|||
164588962|NCT00365976|594519300|FG001|Overall Study|Withdrawal by Subject|5|||
164588963|NCT03090737|594519301|FG000|Overall Study|Other reasons|1|||
164588964|NCT03090737|594519301|FG000|Overall Study|Completed treatment as per protocol|17|||
164588965|NCT03090737|594519301|FG000|Overall Study|Maximum clinical benefit|2|||
164588966|NCT03090737|594519301|FG000|Overall Study|Adverse event unrelated to study drug|7|||
164588967|NCT03090737|594519301|FG000|Overall Study|Study drug toxicity|4|||
164588968|NCT03090737|594519301|FG000|Overall Study|Disease progression|98|||
164588969|NCT03596177|594519302|FG000|Single Blind Period|Withdrawal by Subject|1|||
164588970|NCT03596177|594519303|FG001|Single Blind Period|Withdrawal by Subject|1|||
164588971|NCT03596177|594519302|FG000|Single Blind Period|Other|1|||
164588972|NCT03596177|594519303|FG001|Single Blind Period|Other|0|||
164588973|NCT03596177|594519302|FG000|Double Blind Period|Withdrawal by Subject|0|||
164588974|NCT03596177|594519303|FG001|Double Blind Period|Withdrawal by Subject|1|||
164588975|NCT03596177|594519302|FG000|Double Blind Period|Other|0|||
164588976|NCT03596177|594519303|FG001|Double Blind Period|Other|4|||
164588977|NCT03596177|594519302|FG000|Double Blind Period|Death during safety follow-up|0|||
164588978|NCT03596177|594519303|FG001|Double Blind Period|Death during safety follow-up|1|||
164588979|NCT03103750|594519304|FG000|Overall Study|Adverse Event|1|||
164588980|NCT03103750|594519305|FG001|Overall Study|Adverse Event|0|||
164588981|NCT03103750|594519304|FG000|Overall Study|Lost to Follow-up|1|||
164588982|NCT03103750|594519305|FG001|Overall Study|Lost to Follow-up|0|||
164588983|NCT03103750|594519304|FG000|Overall Study|PET Equipment Related|2|||
164588984|NCT03103750|594519305|FG001|Overall Study|PET Equipment Related|2|||
164588985|NCT04400318|594521328|FG000|Overall Study|Adverse Event|1|||
164588986|NCT04400318|594521329|FG001|Overall Study|Adverse Event|0|||
164588987|NCT04400318|594521328|FG000|Overall Study|Withdrawal by Subject|1|||
164588988|NCT04400318|594521329|FG001|Overall Study|Withdrawal by Subject|1|||
164588989|NCT04400318|594521328|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
164588990|NCT04400318|594521329|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
164588991|NCT00953043|594521332|FG000|Overall Study|Withdrawal by Subject|4|||
164588992|NCT00953043|594521333|FG001|Overall Study|Withdrawal by Subject|0|||
164588993|NCT00953043|594521332|FG000|Overall Study|Physician Decision|0|||
164419269|NCT00876460|593904733|FG003|Combination Therapy Phase|Other reason not defined above|0|||
164419270|NCT00876460|593904734|FG004|Combination Therapy Phase|Other reason not defined above|0|||
164419271|NCT00876460|593904735|FG005|Combination Therapy Phase|Other reason not defined above|0|||
164419272|NCT00876460|593904736|FG006|Combination Therapy Phase|Other reason not defined above|1|||
164419273|NCT00876460|593904737|FG007|Combination Therapy Phase|Other reason not defined above|2|||
164419274|NCT00876460|593904730|FG000|Combination Therapy Phase|Not treated|0|||
164419275|NCT00876460|593904731|FG001|Combination Therapy Phase|Not treated|0|||
164419276|NCT00876460|593904732|FG002|Combination Therapy Phase|Not treated|0|||
164419277|NCT00876460|593904733|FG003|Combination Therapy Phase|Not treated|0|||
164419278|NCT00876460|593904734|FG004|Combination Therapy Phase|Not treated|0|||
164419279|NCT00876460|593904735|FG005|Combination Therapy Phase|Not treated|0|||
164419280|NCT00876460|593904736|FG006|Combination Therapy Phase|Not treated|1|||
164419281|NCT00876460|593904737|FG007|Combination Therapy Phase|Not treated|0|||
164419282|NCT00876460|593904730|FG000|Mono Therapy Phase|Progressive disease|0|||
164419283|NCT00876460|593904731|FG001|Mono Therapy Phase|Progressive disease|0|||
164419284|NCT00876460|593904732|FG002|Mono Therapy Phase|Progressive disease|0|||
164419285|NCT00876460|593904733|FG003|Mono Therapy Phase|Progressive disease|0|||
164419286|NCT00876460|593904734|FG004|Mono Therapy Phase|Progressive disease|2|||
164419287|NCT00876460|593904735|FG005|Mono Therapy Phase|Progressive disease|0|||
164419288|NCT00876460|593904736|FG006|Mono Therapy Phase|Progressive disease|1|||
164419289|NCT00876460|593904737|FG007|Mono Therapy Phase|Progressive disease|3|||
164419290|NCT00876460|593904730|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
164419291|NCT00876460|593904731|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
164588994|NCT00953043|594521333|FG001|Overall Study|Physician Decision|2|||
164588995|NCT03509207|594521334|FG000|Overall Study|Death|2|||
164588996|NCT02078713|594521335|FG000|Overall Study|Lost to Follow-up|49|||
164419292|NCT00876460|593904732|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
164419293|NCT00876460|593904733|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
164419294|NCT00876460|593904734|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
164419295|NCT00876460|593904735|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
164419296|NCT00876460|593904736|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
164419297|NCT00876460|593904737|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
164419298|NCT00876460|593904730|FG000|Mono Therapy Phase|Adverse Event|0|||
164419299|NCT00876460|593904731|FG001|Mono Therapy Phase|Adverse Event|0|||
164419300|NCT00876460|593904732|FG002|Mono Therapy Phase|Adverse Event|0|||
164419301|NCT00876460|593904733|FG003|Mono Therapy Phase|Adverse Event|1|||
164419302|NCT00876460|593904734|FG004|Mono Therapy Phase|Adverse Event|0|||
164419303|NCT00876460|593904735|FG005|Mono Therapy Phase|Adverse Event|0|||
164419304|NCT00876460|593904736|FG006|Mono Therapy Phase|Adverse Event|0|||
164533190|NCT05199571|594325288|FG000|Treatment period|Participant decision|3|||
164533191|NCT05199571|594325288|FG000|Treatment period|Physician Decision|1|||
164533192|NCT05199571|594325288|FG000|Post-treatment follow up period|Participant decision|3|||
164533193|NCT02892344|594325289|FG000|Overall Study|Protocol deviation|3|||
164533194|NCT02892344|594325290|FG001|Overall Study|Protocol deviation|4|||
164533195|NCT02892344|594325289|FG000|Overall Study|Adverse Event|1|||
164533196|NCT02892344|594325290|FG001|Overall Study|Adverse Event|8|||
164533197|NCT02892344|594325289|FG000|Overall Study|Lost to Follow-up|0|||
164533198|NCT02892344|594325290|FG001|Overall Study|Lost to Follow-up|1|||
164533199|NCT02892344|594325289|FG000|Overall Study|Non-compliance with study treatment|0|||
164533200|NCT02892344|594325290|FG001|Overall Study|Non-compliance with study treatment|1|||
164533201|NCT02892344|594325289|FG000|Overall Study|Physician Decision|0|||
164533202|NCT02892344|594325290|FG001|Overall Study|Physician Decision|2|||
164533203|NCT02892344|594325289|FG000|Overall Study|Subject/guardian decision|0|||
164533204|NCT02892344|594325290|FG001|Overall Study|Subject/guardian decision|4|||
164533205|NCT02892344|594325289|FG000|Overall Study|Technical problems|0|||
164533206|NCT02892344|594325290|FG001|Overall Study|Technical problems|1|||
164533207|NCT03938454|594325291|FG000|Overall Study|Protocol Violation|1|||
164533208|NCT03938454|594325291|FG000|Overall Study|Withdrawal by Subject|2|||
164533209|NCT03938454|594325291|FG000|Overall Study|Lost to Follow-up|3|||
164533210|NCT04441905|594325292|FG000|Overall Study|Lost to Follow-up|1|||
164533211|NCT04441905|594325293|FG001|Overall Study|Lost to Follow-up|0|||
164533212|NCT04441905|594325294|FG002|Overall Study|Lost to Follow-up|0|||
164533213|NCT04441905|594325295|FG003|Overall Study|Lost to Follow-up|0|||
164533214|NCT04441905|594325296|FG004|Overall Study|Lost to Follow-up|0|||
164533215|NCT04441905|594325297|FG005|Overall Study|Lost to Follow-up|0|||
164533216|NCT04441905|594325292|FG000|Overall Study|Enrolled but treatment not administered|0|||
164533217|NCT04441905|594325293|FG001|Overall Study|Enrolled but treatment not administered|1|||
164533218|NCT04441905|594325294|FG002|Overall Study|Enrolled but treatment not administered|0|||
164533219|NCT04441905|594325295|FG003|Overall Study|Enrolled but treatment not administered|0|||
164533220|NCT04441905|594325296|FG004|Overall Study|Enrolled but treatment not administered|0|||
164533221|NCT04441905|594325297|FG005|Overall Study|Enrolled but treatment not administered|0|||
164533222|NCT04441905|594325292|FG000|Overall Study|Became ineligible after enrollment|0|||
164533223|NCT04441905|594325293|FG001|Overall Study|Became ineligible after enrollment|0|||
164533224|NCT04441905|594325294|FG002|Overall Study|Became ineligible after enrollment|0|||
164533225|NCT04441905|594325295|FG003|Overall Study|Became ineligible after enrollment|0|||
164533226|NCT04441905|594325296|FG004|Overall Study|Became ineligible after enrollment|1|||
164533227|NCT04441905|594325297|FG005|Overall Study|Became ineligible after enrollment|0|||
164533228|NCT03922802|594325298|FG000|Overall Study|Withdrawal by Subject|4|||
164533229|NCT04486716|594325299|FG000|Core Phase|Subject decision|6|||
164533230|NCT04486716|594325299|FG000|Core Phase|Adverse Event|5|||
164533231|NCT04486716|594325299|FG000|Core Phase|Lost to Follow-up|1|||
164533232|NCT04486716|594325299|FG000|Core Phase|Physician Decision|1|||
164533233|NCT04486716|594325299|FG000|Core Phase|Enrolled subjects not treated|9|||
164533234|NCT05888103|594325300|FG000|Overall Study|Participant decision|3|||
164533235|NCT05888103|594325301|FG001|Overall Study|Participant decision|3|||
164533236|NCT04987307|594325302|FG000|Overall Study|Protocol-specified criteria|2|||
164533237|NCT04987307|594325303|FG001|Overall Study|Protocol-specified criteria|0|||
164533238|NCT04987307|594325304|FG002|Overall Study|Protocol-specified criteria|0|||
164533239|NCT04987307|594325305|FG003|Overall Study|Protocol-specified criteria|3|||
164533240|NCT04987307|594325302|FG000|Overall Study|Withdrawal by Subject|34|||
164189734|NCT00215644|593063947|FG000|Overall Study|Withdrawal by Subject|1|||
164533241|NCT04987307|594325303|FG001|Overall Study|Withdrawal by Subject|30|||
164533242|NCT04987307|594325304|FG002|Overall Study|Withdrawal by Subject|29|||
164533243|NCT04987307|594325305|FG003|Overall Study|Withdrawal by Subject|35|||
164533244|NCT04987307|594325302|FG000|Overall Study|Decision by sponsor|10|||
164533245|NCT04987307|594325303|FG001|Overall Study|Decision by sponsor|13|||
164533246|NCT04987307|594325304|FG002|Overall Study|Decision by sponsor|11|||
164533247|NCT04987307|594325305|FG003|Overall Study|Decision by sponsor|9|||
164419305|NCT00876460|593904737|FG007|Mono Therapy Phase|Adverse Event|0|||
164533248|NCT04987307|594325302|FG000|Overall Study|Lost to Follow-up|1|||
164533249|NCT04987307|594325303|FG001|Overall Study|Lost to Follow-up|0|||
164533250|NCT04987307|594325304|FG002|Overall Study|Lost to Follow-up|0|||
164533251|NCT04987307|594325305|FG003|Overall Study|Lost to Follow-up|0|||
164533252|NCT03650400|594325312|FG000|Overall Study|Study terminated by sponsor|0|||
164533253|NCT03650400|594325313|FG001|Overall Study|Study terminated by sponsor|5|||
164533254|NCT01028222|594325314|FG000|Overall Study|Protocol deviation|1|||
164533255|NCT01028222|594325315|FG001|Overall Study|Protocol deviation|0|||
164533256|NCT01028222|594325314|FG000|Overall Study|Disease progression|33|||
164533257|NCT01028222|594325315|FG001|Overall Study|Disease progression|9|||
164533258|NCT01028222|594325314|FG000|Overall Study|Administrative problems|1|||
164533259|NCT01028222|594325315|FG001|Overall Study|Administrative problems|1|||
164533260|NCT01028222|594325314|FG000|Overall Study|Lost to Follow-up|0|||
164533261|NCT01028222|594325315|FG001|Overall Study|Lost to Follow-up|1|||
164533262|NCT01028222|594325314|FG000|Overall Study|Withdrawal by Subject|1|||
164533263|NCT01028222|594325315|FG001|Overall Study|Withdrawal by Subject|0|||
164533264|NCT01028222|594325314|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
164533265|NCT01028222|594325315|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
164533266|NCT01028222|594325314|FG000|Overall Study|Adverse Event|2|||
164533267|NCT01028222|594325315|FG001|Overall Study|Adverse Event|0|||
164189735|NCT00215644|593063948|FG001|Overall Study|Withdrawal by Subject|0|||
164189736|NCT00215644|593063947|FG000|Overall Study|Other|3|||
164189737|NCT00215644|593063948|FG001|Overall Study|Other|15|||
164189738|NCT00215644|593063947|FG000|Overall Study|Randomized but Not Treated|1|||
164189739|NCT00215644|593063948|FG001|Overall Study|Randomized but Not Treated|0|||
164189740|NCT02861664|593063949|FG000|Overall Study|Withdrawal of Consent|0|||
164189741|NCT02861664|593063950|FG001|Overall Study|Withdrawal of Consent|1|||
164189742|NCT02542397|593063951|FG000|Overall Study|Death|2|||
164189743|NCT02542397|593063951|FG000|Overall Study|Physician Decision|6|||
164189744|NCT02542397|593063951|FG000|Overall Study|Withdrawal by Subject|6|||
164189745|NCT02542397|593063951|FG000|Overall Study|Lost to Follow-up|2|||
164189746|NCT00493012|593063954|FG000|Overall Study|Lost to Follow-up|18|||
164189747|NCT00493012|593063955|FG001|Overall Study|Lost to Follow-up|17|||
164189748|NCT04147247|593063957|FG000|Overall Study|Progressive disease|3|||
164189749|NCT04147247|593063958|FG001|Overall Study|Progressive disease|3|||
164189750|NCT04147247|593063959|FG002|Overall Study|Progressive disease|4|||
164189751|NCT04147247|593063960|FG003|Overall Study|Progressive disease|4|||
164189752|NCT04147247|593063961|FG004|Overall Study|Progressive disease|3|||
164189753|NCT04147247|593063957|FG000|Overall Study|Physician Decision|0|||
164189754|NCT04147247|593063958|FG001|Overall Study|Physician Decision|1|||
164189755|NCT04147247|593063959|FG002|Overall Study|Physician Decision|0|||
164189756|NCT04147247|593063960|FG003|Overall Study|Physician Decision|0|||
164533268|NCT00792805|594325317|FG000|Overall Study|Adverse Event|12|||
164533269|NCT00792805|594325318|FG001|Overall Study|Adverse Event|10|||
164533270|NCT00792805|594325319|FG002|Overall Study|Adverse Event|10|||
164533271|NCT00792805|594325317|FG000|Overall Study|Subject withdrew consent|5|||
164533272|NCT00792805|594325318|FG001|Overall Study|Subject withdrew consent|6|||
164533273|NCT00792805|594325319|FG002|Overall Study|Subject withdrew consent|5|||
164533274|NCT00792805|594325317|FG000|Overall Study|Administrative problems|2|||
164533275|NCT00792805|594325318|FG001|Overall Study|Administrative problems|0|||
164533276|NCT00792805|594325319|FG002|Overall Study|Administrative problems|4|||
164533277|NCT00792805|594325317|FG000|Overall Study|Abnormal test procedure result(s)|1|||
164533278|NCT00792805|594325318|FG001|Overall Study|Abnormal test procedure result(s)|2|||
164533279|NCT00792805|594325319|FG002|Overall Study|Abnormal test procedure result(s)|0|||
164533280|NCT00792805|594325317|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164533281|NCT00792805|594325318|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
164533282|NCT00792805|594325319|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
164533283|NCT00792805|594325317|FG000|Overall Study|Lost to Follow-up|1|||
164533284|NCT00792805|594325318|FG001|Overall Study|Lost to Follow-up|1|||
164533285|NCT00792805|594325319|FG002|Overall Study|Lost to Follow-up|6|||
164533286|NCT00792805|594325317|FG000|Overall Study|Abnormal laboratory value(s)|0|||
164533287|NCT00792805|594325318|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164533288|NCT00792805|594325319|FG002|Overall Study|Abnormal laboratory value(s)|1|||
164533289|NCT00792805|594325317|FG000|Overall Study|Protocol deviation|0|||
164533290|NCT00792805|594325318|FG001|Overall Study|Protocol deviation|1|||
164533291|NCT00792805|594325319|FG002|Overall Study|Protocol deviation|1|||
164533292|NCT05541861|594325320|FG000|Overall Study|Withdrawal by Subject|0|||
164533293|NCT05541861|594325321|FG001|Overall Study|Withdrawal by Subject|0|||
164533294|NCT05541861|594325322|FG002|Overall Study|Withdrawal by Subject|0|||
164533295|NCT05541861|594325323|FG003|Overall Study|Withdrawal by Subject|0|||
164533296|NCT05541861|594325324|FG004|Overall Study|Withdrawal by Subject|0|||
164533297|NCT05541861|594325325|FG005|Overall Study|Withdrawal by Subject|0|||
164533298|NCT05541861|594325326|FG006|Overall Study|Withdrawal by Subject|2|||
164533299|NCT05541861|594325327|FG007|Overall Study|Withdrawal by Subject|0|||
164533300|NCT05541861|594325328|FG008|Overall Study|Withdrawal by Subject|0|||
164533301|NCT05541861|594325320|FG000|Overall Study|Randomized but not dosed|0|||
164189757|NCT04147247|593063961|FG004|Overall Study|Physician Decision|0|||
164189758|NCT04147247|593063957|FG000|Overall Study|Clinical Disease Progression|0|||
164189759|NCT04147247|593063958|FG001|Overall Study|Clinical Disease Progression|0|||
164533302|NCT05541861|594325321|FG001|Overall Study|Randomized but not dosed|1|||
164304174|NCT00068692|593488398|FG005|Step 1: Registration|Withdrawal by Subject|0|||
164304175|NCT00068692|593488399|FG006|Step 1: Registration|Withdrawal by Subject|0|||
164304176|NCT00068692|593488400|FG007|Step 1: Registration|Withdrawal by Subject|0|||
164304177|NCT00068692|593488393|FG000|Step 1: Registration|Alternative therapy|2|||
164304178|NCT00068692|593488394|FG001|Step 1: Registration|Alternative therapy|0|||
164304179|NCT00068692|593488395|FG002|Step 1: Registration|Alternative therapy|0|||
164304180|NCT00068692|593488396|FG003|Step 1: Registration|Alternative therapy|0|||
164304181|NCT00068692|593488397|FG004|Step 1: Registration|Alternative therapy|0|||
164533303|NCT05541861|594325322|FG002|Overall Study|Randomized but not dosed|1|||
164304182|NCT00068692|593488398|FG005|Step 1: Registration|Alternative therapy|0|||
164304183|NCT00068692|593488399|FG006|Step 1: Registration|Alternative therapy|0|||
164304184|NCT00068692|593488400|FG007|Step 1: Registration|Alternative therapy|0|||
164304185|NCT00068692|593488393|FG000|Step 1: Registration|Complicating disease|2|||
164304186|NCT00068692|593488394|FG001|Step 1: Registration|Complicating disease|0|||
164304187|NCT00068692|593488395|FG002|Step 1: Registration|Complicating disease|0|||
164304188|NCT00068692|593488396|FG003|Step 1: Registration|Complicating disease|0|||
164533304|NCT05541861|594325323|FG003|Overall Study|Randomized but not dosed|0|||
164533305|NCT05541861|594325324|FG004|Overall Study|Randomized but not dosed|0|||
164533306|NCT05541861|594325325|FG005|Overall Study|Randomized but not dosed|0|||
164533307|NCT05541861|594325326|FG006|Overall Study|Randomized but not dosed|1|||
164533308|NCT05541861|594325327|FG007|Overall Study|Randomized but not dosed|0|||
164533309|NCT05541861|594325328|FG008|Overall Study|Randomized but not dosed|1|||
164533310|NCT04452877|594325329|FG000|Overall Study|Adverse Event|5|||
164533311|NCT04452877|594325329|FG000|Overall Study|Lost to Follow-up|1|||
164533312|NCT04452877|594325329|FG000|Overall Study|Physician Decision|4|||
164533313|NCT04452877|594325329|FG000|Overall Study|Progressive Disease|18|||
164533314|NCT04452877|594325329|FG000|Overall Study|Withdrawal by Subject|3|||
164533315|NCT05678959|594325330|FG000|Overall Study|Study Terminated by Sponsor|76|||
164533316|NCT05678959|594325331|FG001|Overall Study|Study Terminated by Sponsor|76|||
164533317|NCT05678959|594325330|FG000|Overall Study|Physician Decision|2|||
164533318|NCT05678959|594325331|FG001|Overall Study|Physician Decision|3|||
164533319|NCT05678959|594325330|FG000|Overall Study|Adverse Event|1|||
164533320|NCT05678959|594325331|FG001|Overall Study|Adverse Event|1|||
164533321|NCT05678959|594325330|FG000|Overall Study|Guardian Decision|1|||
164533322|NCT05678959|594325331|FG001|Overall Study|Guardian Decision|0|||
164533323|NCT05678959|594325330|FG000|Overall Study|Protocol Deviation|0|||
164533324|NCT05678959|594325331|FG001|Overall Study|Protocol Deviation|1|||
164533325|NCT05678959|594325330|FG000|Overall Study|Subject Decision|1|||
164533326|NCT05678959|594325331|FG001|Overall Study|Subject Decision|0|||
164533327|NCT05678959|594325330|FG000|Overall Study|Technical Problem|0|||
164533328|NCT05678959|594325331|FG001|Overall Study|Technical Problem|1|||
164533329|NCT02276872|594325332|FG000|Overall Study|Adverse Event|1|||
164533330|NCT02276872|594325333|FG001|Overall Study|Adverse Event|0|||
164533331|NCT02276872|594325334|FG002|Overall Study|Adverse Event|0|||
164533332|NCT04175808|594325335|FG000|Part A|Miscellaneous|2|||
164533333|NCT04175808|594325336|FG001|Part A|Miscellaneous|0|||
164533334|NCT04175808|594325337|FG002|Part A|Miscellaneous|0|||
164533335|NCT04175808|594325338|FG003|Part A|Miscellaneous|0|||
164533336|NCT04175808|594325339|FG004|Part A|Miscellaneous|0|||
164533337|NCT04175808|594325340|FG005|Part A|Miscellaneous|0|||
164533338|NCT04175808|594325341|FG006|Part A|Miscellaneous|0|||
164533339|NCT02544217|594325343|FG000|Overall Study|Withdrawal by Subject|1|||
164533340|NCT02544217|594325344|FG001|Overall Study|Withdrawal by Subject|1|||
164533341|NCT02544217|594325345|FG002|Overall Study|Withdrawal by Subject|0|||
164533342|NCT02544217|594325346|FG003|Overall Study|Withdrawal by Subject|0|||
164533343|NCT02544217|594325347|FG004|Overall Study|Withdrawal by Subject|0|||
164533344|NCT02544217|594325348|FG005|Overall Study|Withdrawal by Subject|0|||
164533345|NCT02065336|594325349|FG000|Extension Phase|Study Terminated by Sponsor|0|||
164533346|NCT02065336|594325350|FG001|Extension Phase|Study Terminated by Sponsor|0|||
164533347|NCT02065336|594325351|FG002|Extension Phase|Study Terminated by Sponsor|0|||
164533348|NCT02065336|594325352|FG003|Extension Phase|Study Terminated by Sponsor|0|||
164533349|NCT02065336|594325353|FG004|Extension Phase|Study Terminated by Sponsor|0|||
164533350|NCT02065336|594325354|FG005|Extension Phase|Study Terminated by Sponsor|0|||
164533351|NCT02065336|594325355|FG006|Extension Phase|Study Terminated by Sponsor|0|||
164533352|NCT02065336|594325356|FG007|Extension Phase|Study Terminated by Sponsor|0|||
164533353|NCT02065336|594325357|FG008|Extension Phase|Study Terminated by Sponsor|2|||
164533354|NCT02065336|594325358|FG009|Extension Phase|Study Terminated by Sponsor|8|||
164533355|NCT03226392|594325359|FG000|Overall Study|Protocol Deviation|1|||
164304189|NCT00068692|593488397|FG004|Step 1: Registration|Complicating disease|0|||
164533356|NCT03226392|594325360|FG001|Overall Study|Protocol Deviation|0|||
164533357|NCT03226392|594325359|FG000|Overall Study|Physician Decision|1|||
164533358|NCT03226392|594325360|FG001|Overall Study|Physician Decision|0|||
164533359|NCT03226392|594325359|FG000|Overall Study|Lost to Follow-up|1|||
164533360|NCT03226392|594325360|FG001|Overall Study|Lost to Follow-up|0|||
164533361|NCT03226392|594325359|FG000|Overall Study|Adverse Event|1|||
164533362|NCT03226392|594325360|FG001|Overall Study|Adverse Event|0|||
164533363|NCT03226392|594325359|FG000|Overall Study|Technical Problems|0|||
164533364|NCT03226392|594325360|FG001|Overall Study|Technical Problems|2|||
164533365|NCT03226392|594325359|FG000|Overall Study|Subject/Guardian Decision|7|||
164533366|NCT03226392|594325360|FG001|Overall Study|Subject/Guardian Decision|6|||
164533367|NCT03056755|594325361|FG000|Core Phase|Progressive disease|89|||
164533368|NCT03056755|594325362|FG001|Core Phase|Progressive disease|88|||
164533369|NCT03056755|594325363|FG002|Core Phase|Progressive disease|90|||
164533370|NCT03056755|594325361|FG000|Core Phase|Adverse Event|20|||
164533371|NCT03056755|594325362|FG001|Core Phase|Adverse Event|14|||
164533372|NCT03056755|594325363|FG002|Core Phase|Adverse Event|13|||
164533373|NCT03056755|594325361|FG000|Core Phase|Physician Decision|7|||
164533374|NCT03056755|594325362|FG001|Core Phase|Physician Decision|13|||
164533375|NCT03056755|594325363|FG002|Core Phase|Physician Decision|5|||
164533376|NCT03056755|594325361|FG000|Core Phase|Subject/guardian decision|5|||
164189760|NCT04147247|593063959|FG002|Overall Study|Clinical Disease Progression|0|||
164189761|NCT04147247|593063960|FG003|Overall Study|Clinical Disease Progression|0|||
164189762|NCT04147247|593063961|FG004|Overall Study|Clinical Disease Progression|1|||
164189763|NCT04147247|593063957|FG000|Overall Study|Adverse Event|0|||
164189764|NCT04147247|593063958|FG001|Overall Study|Adverse Event|0|||
164189765|NCT04147247|593063959|FG002|Overall Study|Adverse Event|1|||
164189766|NCT04147247|593063960|FG003|Overall Study|Adverse Event|0|||
164189767|NCT04147247|593063961|FG004|Overall Study|Adverse Event|1|||
164189768|NCT01724177|593063962|FG000|Overall Study|Adverse Event|8|||
164189769|NCT01724177|593063962|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
164533377|NCT03056755|594325362|FG001|Core Phase|Subject/guardian decision|8|||
164533378|NCT03056755|594325363|FG002|Core Phase|Subject/guardian decision|4|||
164189770|NCT01724177|593063962|FG000|Overall Study|Nervous participant|1|||
164189771|NCT01724177|593063962|FG000|Overall Study|Serious Adverse Event Related|1|||
164189772|NCT00327340|593063967|FG000|Overall Study|Withdrawal by Subject|1|||
164189773|NCT00327340|593063968|FG001|Overall Study|Withdrawal by Subject|5|||
164189774|NCT00327340|593063967|FG000|Overall Study|Physician Decision|1|||
164189775|NCT00327340|593063968|FG001|Overall Study|Physician Decision|1|||
164189776|NCT00327340|593063967|FG000|Overall Study|Disease Progression|10|||
164189777|NCT00327340|593063968|FG001|Overall Study|Disease Progression|19|||
164189778|NCT00327340|593063967|FG000|Overall Study|Symptomatic Disease|0|||
164189779|NCT00327340|593063968|FG001|Overall Study|Symptomatic Disease|2|||
164189780|NCT00327340|593063967|FG000|Overall Study|Adverse Event|3|||
164189781|NCT00327340|593063968|FG001|Overall Study|Adverse Event|3|||
164189782|NCT00206427|593063972|FG000|Overall Study|Adverse Event|2|||
164189783|NCT04085601|593063973|FG000|Overall Study|Lost to Follow-up|1|||
164189784|NCT04085601|593063974|FG001|Overall Study|Lost to Follow-up|0|||
164189785|NCT04085601|593063973|FG000|Overall Study|Death|1|||
164189786|NCT04085601|593063974|FG001|Overall Study|Death|1|||
164189787|NCT03492437|593063975|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164189788|NCT03492437|593063976|FG001|Treatment Period 2|Withdrawal by Subject|1|||
164189789|NCT02915159|593063978|FG000|Overall Study|Participant no longer meets criteria|2|||
164189790|NCT02915159|593063979|FG001|Overall Study|Participant no longer meets criteria|0|||
164189791|NCT02915159|593063978|FG000|Overall Study|poor/non-compliance|1|||
164189792|NCT02915159|593063979|FG001|Overall Study|poor/non-compliance|0|||
164189793|NCT02915159|593063978|FG000|Overall Study|Participant withdrew consent|5|||
164189794|NCT02915159|593063979|FG001|Overall Study|Participant withdrew consent|1|||
164189795|NCT02915159|593063978|FG000|Overall Study|Request to discontinue treatment|1|||
164189796|NCT02915159|593063979|FG001|Overall Study|Request to discontinue treatment|2|||
164189797|NCT02915159|593063978|FG000|Overall Study|Adverse Event|2|||
164189798|NCT02915159|593063979|FG001|Overall Study|Adverse Event|2|||
164189799|NCT02915159|593063978|FG000|Overall Study|Lack of Efficacy|0|||
164189800|NCT02915159|593063979|FG001|Overall Study|Lack of Efficacy|3|||
164189801|NCT04534517|593063980|FG000|Overall Study|Adverse Event|1|||
164189802|NCT04534517|593063980|FG000|Overall Study|Withdrawal by Subject|1|||
164189803|NCT04534517|593063980|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
164189804|NCT04534517|593063980|FG000|Overall Study|COVID-19 Related|1|||
164304190|NCT00068692|593488398|FG005|Step 1: Registration|Complicating disease|0|||
164304191|NCT00068692|593488399|FG006|Step 1: Registration|Complicating disease|0|||
164304192|NCT00068692|593488400|FG007|Step 1: Registration|Complicating disease|0|||
164304193|NCT00068692|593488393|FG000|Step 1: Registration|Protocol Violation|1|||
164304194|NCT00068692|593488394|FG001|Step 1: Registration|Protocol Violation|0|||
164304195|NCT00068692|593488395|FG002|Step 1: Registration|Protocol Violation|0|||
164304196|NCT00068692|593488396|FG003|Step 1: Registration|Protocol Violation|0|||
164304197|NCT00068692|593488397|FG004|Step 1: Registration|Protocol Violation|0|||
164533379|NCT03056755|594325361|FG000|Core Phase|Death|3|||
164533380|NCT03056755|594325362|FG001|Core Phase|Death|2|||
164533381|NCT03056755|594325363|FG002|Core Phase|Death|4|||
164533382|NCT03056755|594325361|FG000|Core Phase|Protocol deviation|1|||
164533383|NCT03056755|594325362|FG001|Core Phase|Protocol deviation|1|||
164533384|NCT03056755|594325363|FG002|Core Phase|Protocol deviation|0|||
164533385|NCT03056755|594325361|FG000|Core Phase|Technical problems|1|||
164189805|NCT02121795|593063981|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
164189806|NCT02121795|593063982|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
164189807|NCT02121795|593063981|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
164304198|NCT00068692|593488398|FG005|Step 1: Registration|Protocol Violation|0|||
164304199|NCT00068692|593488399|FG006|Step 1: Registration|Protocol Violation|0|||
164304200|NCT00068692|593488400|FG007|Step 1: Registration|Protocol Violation|0|||
164304201|NCT00068692|593488393|FG000|Step 1: Registration|Not eligible|6|||
164304202|NCT00068692|593488394|FG001|Step 1: Registration|Not eligible|0|||
164304203|NCT00068692|593488395|FG002|Step 1: Registration|Not eligible|0|||
164304204|NCT00068692|593488396|FG003|Step 1: Registration|Not eligible|0|||
164304205|NCT00068692|593488397|FG004|Step 1: Registration|Not eligible|0|||
164304206|NCT00068692|593488398|FG005|Step 1: Registration|Not eligible|0|||
164304207|NCT00068692|593488399|FG006|Step 1: Registration|Not eligible|0|||
164304208|NCT00068692|593488400|FG007|Step 1: Registration|Not eligible|0|||
164304209|NCT00068692|593488393|FG000|Step 1: Registration|Other|2|||
164304210|NCT00068692|593488394|FG001|Step 1: Registration|Other|0|||
164304211|NCT00068692|593488395|FG002|Step 1: Registration|Other|0|||
164304212|NCT00068692|593488396|FG003|Step 1: Registration|Other|0|||
164304213|NCT00068692|593488397|FG004|Step 1: Registration|Other|0|||
164304214|NCT00068692|593488398|FG005|Step 1: Registration|Other|0|||
164304215|NCT00068692|593488399|FG006|Step 1: Registration|Other|0|||
164533386|NCT03056755|594325362|FG001|Core Phase|Technical problems|0|||
164533387|NCT03056755|594325363|FG002|Core Phase|Technical problems|0|||
164533388|NCT03056755|594325361|FG000|Extension Phase|Physician Decision|1|||
164533389|NCT03056755|594325362|FG001|Extension Phase|Physician Decision|0|||
164533390|NCT03056755|594325363|FG002|Extension Phase|Physician Decision|3|||
164533391|NCT03056755|594325361|FG000|Extension Phase|Adverse Event|0|||
164533392|NCT03056755|594325362|FG001|Extension Phase|Adverse Event|0|||
164533393|NCT03056755|594325363|FG002|Extension Phase|Adverse Event|1|||
164533394|NCT03056755|594325361|FG000|Extension Phase|Subject/guardian decision|0|||
164533395|NCT03056755|594325362|FG001|Extension Phase|Subject/guardian decision|0|||
164533396|NCT03056755|594325363|FG002|Extension Phase|Subject/guardian decision|1|||
164304216|NCT00068692|593488400|FG007|Step 1: Registration|Other|0|||
164304217|NCT00068692|593488393|FG000|Step 1: Registration|Not start protocol therapy|3|||
164304218|NCT00068692|593488394|FG001|Step 1: Registration|Not start protocol therapy|0|||
164304219|NCT00068692|593488395|FG002|Step 1: Registration|Not start protocol therapy|0|||
164304220|NCT00068692|593488396|FG003|Step 1: Registration|Not start protocol therapy|0|||
164304221|NCT00068692|593488397|FG004|Step 1: Registration|Not start protocol therapy|0|||
164304222|NCT00068692|593488398|FG005|Step 1: Registration|Not start protocol therapy|0|||
164304223|NCT00068692|593488399|FG006|Step 1: Registration|Not start protocol therapy|0|||
164304224|NCT00068692|593488400|FG007|Step 1: Registration|Not start protocol therapy|0|||
164304225|NCT00068692|593488393|FG000|Step 1: Registration|Registered but not randomized|0|||
164533397|NCT00402363|594325364|FG000|Overall Study|Adverse Event|9|||
164533398|NCT00402363|594325365|FG001|Overall Study|Adverse Event|14|||
164533399|NCT00402363|594325366|FG002|Overall Study|Adverse Event|2|||
164533400|NCT00402363|594325367|FG003|Overall Study|Adverse Event|2|||
164533401|NCT00402363|594325364|FG000|Overall Study|Withdrew Consent|10|||
164533402|NCT00402363|594325365|FG001|Overall Study|Withdrew Consent|5|||
164533403|NCT00402363|594325366|FG002|Overall Study|Withdrew Consent|2|||
164533404|NCT00402363|594325367|FG003|Overall Study|Withdrew Consent|1|||
164533405|NCT00402363|594325364|FG000|Overall Study|Protocol Violation|3|||
164533406|NCT00402363|594325365|FG001|Overall Study|Protocol Violation|5|||
164533407|NCT00402363|594325366|FG002|Overall Study|Protocol Violation|0|||
164533408|NCT00402363|594325367|FG003|Overall Study|Protocol Violation|3|||
164533409|NCT00402363|594325364|FG000|Overall Study|Lost to Follow-up|5|||
164533410|NCT00402363|594325365|FG001|Overall Study|Lost to Follow-up|4|||
164533411|NCT00402363|594325366|FG002|Overall Study|Lost to Follow-up|0|||
164533412|NCT00402363|594325367|FG003|Overall Study|Lost to Follow-up|2|||
164533413|NCT00402363|594325364|FG000|Overall Study|"Captured as Other"|6|||
164533414|NCT00402363|594325365|FG001|Overall Study|"Captured as Other"|2|||
164533415|NCT00402363|594325366|FG002|Overall Study|"Captured as Other"|2|||
164304226|NCT00068692|593488394|FG001|Step 1: Registration|Registered but not randomized|1|||
164304227|NCT00068692|593488395|FG002|Step 1: Registration|Registered but not randomized|0|||
164304228|NCT00068692|593488396|FG003|Step 1: Registration|Registered but not randomized|0|||
164304229|NCT00068692|593488397|FG004|Step 1: Registration|Registered but not randomized|0|||
164304230|NCT00068692|593488398|FG005|Step 1: Registration|Registered but not randomized|0|||
164533416|NCT00402363|594325367|FG003|Overall Study|"Captured as Other"|2|||
164533417|NCT04667949|594325375|FG000|Overall Study|Adverse Event|0|||
164533418|NCT04667949|594325376|FG001|Overall Study|Adverse Event|2|||
164533419|NCT04667949|594325375|FG000|Overall Study|Lost to Follow-up|0|||
164533420|NCT04667949|594325376|FG001|Overall Study|Lost to Follow-up|1|||
164533421|NCT04667949|594325375|FG000|Overall Study|Physician Decision|0|||
164533422|NCT04667949|594325376|FG001|Overall Study|Physician Decision|2|||
164304231|NCT00068692|593488399|FG006|Step 1: Registration|Registered but not randomized|0|||
164304232|NCT00068692|593488400|FG007|Step 1: Registration|Registered but not randomized|0|||
164304233|NCT00068692|593488393|FG000|Step 2: Randomization|Disesae progression/replase|0|||
164533423|NCT04667949|594325375|FG000|Overall Study|Subject decision|1|||
164533424|NCT04667949|594325376|FG001|Overall Study|Subject decision|7|||
164533425|NCT04504630|594325377|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
164533426|NCT04504630|594325378|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
164304234|NCT00068692|593488394|FG001|Step 2: Randomization|Disesae progression/replase|0|||
164304235|NCT00068692|593488395|FG002|Step 2: Randomization|Disesae progression/replase|1|||
164304236|NCT00068692|593488396|FG003|Step 2: Randomization|Disesae progression/replase|1|||
164304237|NCT00068692|593488397|FG004|Step 2: Randomization|Disesae progression/replase|0|||
164304238|NCT00068692|593488398|FG005|Step 2: Randomization|Disesae progression/replase|0|||
164304239|NCT00068692|593488399|FG006|Step 2: Randomization|Disesae progression/replase|0|||
164304240|NCT00068692|593488400|FG007|Step 2: Randomization|Disesae progression/replase|0|||
164304241|NCT00068692|593488393|FG000|Step 2: Randomization|Adverse Event|0|||
164304242|NCT00068692|593488394|FG001|Step 2: Randomization|Adverse Event|0|||
164304243|NCT00068692|593488395|FG002|Step 2: Randomization|Adverse Event|4|||
164304244|NCT00068692|593488396|FG003|Step 2: Randomization|Adverse Event|2|||
164304245|NCT00068692|593488397|FG004|Step 2: Randomization|Adverse Event|2|||
164304246|NCT00068692|593488398|FG005|Step 2: Randomization|Adverse Event|3|||
164304247|NCT00068692|593488399|FG006|Step 2: Randomization|Adverse Event|4|||
164304248|NCT00068692|593488400|FG007|Step 2: Randomization|Adverse Event|4|||
164304249|NCT00068692|593488393|FG000|Step 2: Randomization|Death|0|||
164304250|NCT00068692|593488394|FG001|Step 2: Randomization|Death|0|||
164304251|NCT00068692|593488395|FG002|Step 2: Randomization|Death|0|||
164304252|NCT00068692|593488396|FG003|Step 2: Randomization|Death|0|||
164304253|NCT00068692|593488397|FG004|Step 2: Randomization|Death|1|||
164304254|NCT00068692|593488398|FG005|Step 2: Randomization|Death|0|||
164304255|NCT00068692|593488399|FG006|Step 2: Randomization|Death|0|||
164304256|NCT00068692|593488400|FG007|Step 2: Randomization|Death|1|||
164304257|NCT00068692|593488393|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
164304258|NCT00068692|593488394|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
164304259|NCT00068692|593488395|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
164304260|NCT00068692|593488396|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
164304261|NCT00068692|593488397|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
164304262|NCT00068692|593488398|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
164304263|NCT00068692|593488399|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
164304264|NCT00068692|593488400|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
164304265|NCT00068692|593488393|FG000|Step 2: Randomization|alternative therapy|0|||
164304266|NCT00068692|593488394|FG001|Step 2: Randomization|alternative therapy|0|||
164304267|NCT00068692|593488395|FG002|Step 2: Randomization|alternative therapy|0|||
164304268|NCT00068692|593488396|FG003|Step 2: Randomization|alternative therapy|1|||
164304269|NCT00068692|593488397|FG004|Step 2: Randomization|alternative therapy|1|||
164304270|NCT00068692|593488398|FG005|Step 2: Randomization|alternative therapy|0|||
164304271|NCT00068692|593488399|FG006|Step 2: Randomization|alternative therapy|0|||
164304272|NCT00068692|593488400|FG007|Step 2: Randomization|alternative therapy|0|||
164304273|NCT00068692|593488393|FG000|Step 2: Randomization|Physician Decision|0|||
164304274|NCT00068692|593488394|FG001|Step 2: Randomization|Physician Decision|0|||
164304275|NCT00068692|593488395|FG002|Step 2: Randomization|Physician Decision|0|||
164304276|NCT00068692|593488396|FG003|Step 2: Randomization|Physician Decision|1|||
164304277|NCT00068692|593488397|FG004|Step 2: Randomization|Physician Decision|1|||
164304278|NCT00068692|593488398|FG005|Step 2: Randomization|Physician Decision|0|||
164304279|NCT00068692|593488399|FG006|Step 2: Randomization|Physician Decision|0|||
164304280|NCT00068692|593488400|FG007|Step 2: Randomization|Physician Decision|0|||
164304281|NCT00068692|593488393|FG000|Step 2: Randomization|Other|0|||
164304282|NCT00068692|593488394|FG001|Step 2: Randomization|Other|0|||
164304283|NCT00068692|593488395|FG002|Step 2: Randomization|Other|0|||
164304284|NCT00068692|593488396|FG003|Step 2: Randomization|Other|1|||
164304285|NCT00068692|593488397|FG004|Step 2: Randomization|Other|0|||
164304286|NCT00068692|593488398|FG005|Step 2: Randomization|Other|1|||
164304287|NCT00068692|593488399|FG006|Step 2: Randomization|Other|0|||
164304288|NCT00068692|593488400|FG007|Step 2: Randomization|Other|0|||
164304289|NCT00068692|593488393|FG000|Step 2: Randomization|never start protocol therapy|0|||
164304290|NCT00068692|593488394|FG001|Step 2: Randomization|never start protocol therapy|0|||
164304291|NCT00068692|593488395|FG002|Step 2: Randomization|never start protocol therapy|1|||
164304292|NCT00068692|593488396|FG003|Step 2: Randomization|never start protocol therapy|0|||
164304293|NCT00068692|593488397|FG004|Step 2: Randomization|never start protocol therapy|1|||
164304294|NCT00068692|593488398|FG005|Step 2: Randomization|never start protocol therapy|0|||
164304295|NCT00068692|593488399|FG006|Step 2: Randomization|never start protocol therapy|0|||
164304296|NCT00068692|593488400|FG007|Step 2: Randomization|never start protocol therapy|0|||
164304297|NCT01600716|593488402|FG000|Overall Study|Other Reasons|3|||
164304298|NCT01600716|593488403|FG001|Overall Study|Other Reasons|1|||
164304299|NCT01600716|593488402|FG000|Overall Study|Personal Reasons|0|||
164304300|NCT01600716|593488403|FG001|Overall Study|Personal Reasons|2|||
164304301|NCT01600716|593488402|FG000|Overall Study|Lost to Follow-up|0|||
164304302|NCT01600716|593488403|FG001|Overall Study|Lost to Follow-up|2|||
164304303|NCT01600716|593488402|FG000|Overall Study|Pregnancy|1|||
164304304|NCT01600716|593488403|FG001|Overall Study|Pregnancy|0|||
164304305|NCT01600716|593488402|FG000|Overall Study|Lack of Efficacy|2|||
164304306|NCT01600716|593488403|FG001|Overall Study|Lack of Efficacy|1|||
164304307|NCT01600716|593488402|FG000|Overall Study|Adverse Event|1|||
164304308|NCT01600716|593488403|FG001|Overall Study|Adverse Event|1|||
164304309|NCT03557034|593488406|FG000|Overall Study|Withdrawal by Subject|1|||
164304310|NCT03557034|593488407|FG001|Overall Study|Withdrawal by Subject|0|||
164304311|NCT03349034|593488410|FG000|Overall Study|catheters dislodged during transport|2|||
164304312|NCT03349034|593488411|FG001|Overall Study|catheters dislodged during transport|0|||
164304313|NCT03349034|593488410|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
164304314|NCT03349034|593488411|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
164304315|NCT03349034|593488410|FG000|Overall Study|soft tissue flap used|1|||
164304316|NCT03349034|593488411|FG001|Overall Study|soft tissue flap used|0|||
164304317|NCT03349034|593488410|FG000|Overall Study|Other|0|||
164304318|NCT03349034|593488411|FG001|Overall Study|Other|1|||
164304319|NCT00123422|593488412|FG000|Overall Study|Physician Decision|2|||
164304320|NCT00123422|593488413|FG001|Overall Study|Physician Decision|2|||
164304321|NCT00123422|593488414|FG002|Overall Study|Physician Decision|6|||
164304322|NCT00123422|593488412|FG000|Overall Study|Withdrawal by Subject|1|||
164304323|NCT00123422|593488413|FG001|Overall Study|Withdrawal by Subject|2|||
164304324|NCT00123422|593488414|FG002|Overall Study|Withdrawal by Subject|2|||
164304325|NCT00123422|593488412|FG000|Overall Study|Lost to Follow-up|1|||
164304326|NCT00123422|593488413|FG001|Overall Study|Lost to Follow-up|2|||
164304327|NCT00123422|593488414|FG002|Overall Study|Lost to Follow-up|2|||
164304328|NCT00602472|593488419|FG000|Overall Study|Adverse Event|5|||
164304329|NCT00602472|593488420|FG001|Overall Study|Adverse Event|23|||
164304330|NCT00602472|593488419|FG000|Overall Study|Protocol Violation|4|||
164304331|NCT00602472|593488420|FG001|Overall Study|Protocol Violation|19|||
164304332|NCT00602472|593488419|FG000|Overall Study|Withdrawal by Subject|8|||
164304333|NCT00602472|593488420|FG001|Overall Study|Withdrawal by Subject|14|||
164304334|NCT00602472|593488419|FG000|Overall Study|Other incl. lack of efficacy|4|||
164304335|NCT00602472|593488420|FG001|Overall Study|Other incl. lack of efficacy|2|||
164304336|NCT01938716|593488421|FG000|Overall Study|Physician Decision|2|||
164304337|NCT01938716|593488421|FG000|Overall Study|Withdrawal by Subject|2|||
164304338|NCT01908803|593488422|FG000|Overall Study|Adverse Event|1|||
164304339|NCT01908803|593488423|FG001|Overall Study|Adverse Event|0|||
164304340|NCT01908803|593488422|FG000|Overall Study|Physician Decision|0|||
164304341|NCT01908803|593488423|FG001|Overall Study|Physician Decision|1|||
164304342|NCT01908803|593488422|FG000|Overall Study|Withdrawal by Subject|1|||
164304343|NCT01908803|593488423|FG001|Overall Study|Withdrawal by Subject|0|||
164304344|NCT01908803|593488422|FG000|Overall Study|Randomization Error|1|||
164304345|NCT01908803|593488423|FG001|Overall Study|Randomization Error|0|||
164304346|NCT01908803|593488422|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
164304347|NCT01908803|593488423|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
164304348|NCT00823615|593488424|FG000|Period 2|Lost to Follow-up|2|||
164304349|NCT00823615|593488425|FG001|Period 2|Lost to Follow-up|0|||
164304350|NCT00823615|593488424|FG000|Period 2|Time/Job Conflict|1|||
164304351|NCT00823615|593488425|FG001|Period 2|Time/Job Conflict|2|||
164304352|NCT00098813|593488426|FG000|Overall Study|Death|8|||
164304353|NCT00098813|593488426|FG000|Overall Study|Protocol Violation|1|||
164304354|NCT00098813|593488426|FG000|Overall Study|Withdrawal by Subject|7|||
164304355|NCT00098813|593488426|FG000|Overall Study|Progression of Disease|1|||
164304356|NCT00098813|593488426|FG000|Overall Study|Other complicating disease|1|||
164304357|NCT00098813|593488426|FG000|Overall Study|Reversal of RAI resistance|1|||
164304358|NCT00433004|593488428|FG000|Overall Study|Lost to Follow-up|5|||
164304359|NCT00433004|593488429|FG001|Overall Study|Lost to Follow-up|7|||
164304360|NCT04730271|593488431|FG000|Overall Study|Adverse Event|0|||
164304361|NCT04730271|593488432|FG001|Overall Study|Adverse Event|2|||
164304362|NCT04730271|593488431|FG000|Overall Study|Withdrawal by Subject|1|||
164304363|NCT04730271|593488432|FG001|Overall Study|Withdrawal by Subject|1|||
164304364|NCT04730271|593488431|FG000|Overall Study|Protocol Violation|7|||
164304365|NCT04730271|593488432|FG001|Overall Study|Protocol Violation|13|||
164304366|NCT04730271|593488431|FG000|Overall Study|Lost to Follow-up|3|||
164304367|NCT04730271|593488432|FG001|Overall Study|Lost to Follow-up|3|||
164304368|NCT04730271|593488431|FG000|Overall Study|Death|1|||
164304369|NCT04730271|593488432|FG001|Overall Study|Death|0|||
164304370|NCT00998296|593488433|FG000|Overall Study|Progressive disease|0|||
164304371|NCT00998296|593488434|FG001|Overall Study|Progressive disease|1|||
164304372|NCT00998296|593488435|FG002|Overall Study|Progressive disease|0|||
164304373|NCT00998296|593488436|FG003|Overall Study|Progressive disease|0|||
164304374|NCT00998296|593488437|FG004|Overall Study|Progressive disease|0|||
164304375|NCT00998296|593488438|FG005|Overall Study|Progressive disease|0|||
164304376|NCT00998296|593488439|FG006|Overall Study|Progressive disease|1|||
164304377|NCT00998296|593488440|FG007|Overall Study|Progressive disease|0|||
164304378|NCT00998296|593488441|FG008|Overall Study|Progressive disease|0|||
164304379|NCT00998296|593488442|FG009|Overall Study|Progressive disease|14|||
164304380|NCT00998296|593488443|FG010|Overall Study|Progressive disease|5|||
164304381|NCT00998296|593488433|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
164304382|NCT00998296|593488434|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
164304383|NCT00998296|593488435|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
164304384|NCT00998296|593488436|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
164304385|NCT00998296|593488437|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
164189808|NCT02121795|593063982|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
164189809|NCT02121795|593063981|FG000|Double-Blind Phase|Lost to Follow-up|7|||
164189810|NCT02121795|593063982|FG001|Double-Blind Phase|Lost to Follow-up|4|||
164189811|NCT02121795|593063981|FG000|Double-Blind Phase|Physician Decision|2|||
164189812|NCT02121795|593063982|FG001|Double-Blind Phase|Physician Decision|5|||
164189813|NCT02121795|593063981|FG000|Double-Blind Phase|Adverse Event|5|||
164189814|NCT02121795|593063982|FG001|Double-Blind Phase|Adverse Event|0|||
164189815|NCT02121795|593063981|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
164189816|NCT02121795|593063982|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
164189817|NCT02121795|593063981|FG000|Double-Blind Phase|Protocol Violation|0|||
164189818|NCT02121795|593063982|FG001|Double-Blind Phase|Protocol Violation|3|||
164189819|NCT02121795|593063981|FG000|Double-Blind Phase|Death|1|||
164189820|NCT02121795|593063982|FG001|Double-Blind Phase|Death|1|||
164189821|NCT02121795|593063981|FG000|Open-Label Phase|Physician Decision|8|||
164189822|NCT02121795|593063982|FG001|Open-Label Phase|Physician Decision|8|||
164189823|NCT02121795|593063981|FG000|Open-Label Phase|Withdrawal by Subject|3|||
164189824|NCT02121795|593063982|FG001|Open-Label Phase|Withdrawal by Subject|2|||
164189825|NCT02121795|593063981|FG000|Open-Label Phase|Lost to Follow-up|1|||
164189826|NCT02121795|593063982|FG001|Open-Label Phase|Lost to Follow-up|0|||
164189827|NCT01914393|593063983|FG000|Overall Study|Protocol Violation|11|||
164189828|NCT01914393|593063984|FG001|Overall Study|Protocol Violation|3|||
164189829|NCT01914393|593063985|FG002|Overall Study|Protocol Violation|19|||
164189830|NCT01914393|593063983|FG000|Overall Study|Lack of Efficacy|11|||
164189831|NCT01914393|593063984|FG001|Overall Study|Lack of Efficacy|16|||
164189832|NCT01914393|593063985|FG002|Overall Study|Lack of Efficacy|5|||
164189833|NCT01914393|593063983|FG000|Overall Study|no reason given|14|||
164189834|NCT01914393|593063984|FG001|Overall Study|no reason given|8|||
164189835|NCT01914393|593063985|FG002|Overall Study|no reason given|16|||
164189836|NCT01914393|593063983|FG000|Overall Study|Adverse Event|29|||
164189837|NCT01914393|593063984|FG001|Overall Study|Adverse Event|18|||
164189838|NCT01914393|593063985|FG002|Overall Study|Adverse Event|31|||
164189839|NCT01914393|593063983|FG000|Overall Study|Withdrawal by Subject|38|||
164189840|NCT01914393|593063984|FG001|Overall Study|Withdrawal by Subject|20|||
164189841|NCT01914393|593063985|FG002|Overall Study|Withdrawal by Subject|47|||
164189842|NCT01914393|593063983|FG000|Overall Study|Lost to Follow-up|12|||
164189843|NCT01914393|593063984|FG001|Overall Study|Lost to Follow-up|6|||
164189844|NCT01914393|593063985|FG002|Overall Study|Lost to Follow-up|19|||
164189845|NCT01914393|593063983|FG000|Overall Study|subject never dosed|0|||
164189846|NCT01914393|593063984|FG001|Overall Study|subject never dosed|0|||
164189847|NCT01914393|593063985|FG002|Overall Study|subject never dosed|1|||
164189848|NCT00572455|593063986|FG000|Stage I (14 Days)|Adverse Event|0|||
164189849|NCT00572455|593063987|FG001|Stage I (14 Days)|Adverse Event|0|||
164189850|NCT00572455|593063988|FG002|Stage I (14 Days)|Adverse Event|0|||
164189851|NCT00572455|593063989|FG003|Stage I (14 Days)|Adverse Event|0|||
164189852|NCT00572455|593063990|FG004|Stage I (14 Days)|Adverse Event|0|||
164189853|NCT00572455|593063991|FG005|Stage I (14 Days)|Adverse Event|3|||
164189854|NCT00572455|593063992|FG006|Stage I (14 Days)|Adverse Event|0|||
164189855|NCT00572455|593063993|FG007|Stage I (14 Days)|Adverse Event|0|||
164189856|NCT00572455|593063994|FG008|Stage I (14 Days)|Adverse Event|0|||
164189857|NCT00572455|593063995|FG009|Stage I (14 Days)|Adverse Event|0|||
164189858|NCT00572455|593063996|FG010|Stage I (14 Days)|Adverse Event|0|||
164189859|NCT00572455|593063997|FG011|Stage I (14 Days)|Adverse Event|0|||
164189860|NCT00572455|593063998|FG012|Stage I (14 Days)|Adverse Event|0|||
164189861|NCT00572455|593063999|FG013|Stage I (14 Days)|Adverse Event|0|||
164189862|NCT00572455|593063986|FG000|Stage I (14 Days)|Other|0|||
164189863|NCT00572455|593063987|FG001|Stage I (14 Days)|Other|0|||
164189864|NCT00572455|593063988|FG002|Stage I (14 Days)|Other|0|||
164189865|NCT00572455|593063989|FG003|Stage I (14 Days)|Other|0|||
164189866|NCT00572455|593063990|FG004|Stage I (14 Days)|Other|1|||
164189867|NCT00572455|593063991|FG005|Stage I (14 Days)|Other|0|||
164189868|NCT00572455|593063992|FG006|Stage I (14 Days)|Other|0|||
164189869|NCT00572455|593063993|FG007|Stage I (14 Days)|Other|0|||
164189870|NCT00572455|593063994|FG008|Stage I (14 Days)|Other|0|||
164189871|NCT00572455|593063995|FG009|Stage I (14 Days)|Other|0|||
164189872|NCT00572455|593063996|FG010|Stage I (14 Days)|Other|0|||
164189873|NCT00572455|593063997|FG011|Stage I (14 Days)|Other|0|||
164189874|NCT00572455|593063998|FG012|Stage I (14 Days)|Other|0|||
164189875|NCT00572455|593063999|FG013|Stage I (14 Days)|Other|0|||
164189876|NCT00572455|593063986|FG000|Stage II (28 Days)|Adverse Event|0|||
164189877|NCT00572455|593063987|FG001|Stage II (28 Days)|Adverse Event|0|||
164189878|NCT00572455|593063988|FG002|Stage II (28 Days)|Adverse Event|0|||
164189879|NCT00572455|593063989|FG003|Stage II (28 Days)|Adverse Event|0|||
164189880|NCT00572455|593063990|FG004|Stage II (28 Days)|Adverse Event|0|||
164189881|NCT00572455|593063991|FG005|Stage II (28 Days)|Adverse Event|0|||
164189882|NCT00572455|593063992|FG006|Stage II (28 Days)|Adverse Event|0|||
164189883|NCT00572455|593063993|FG007|Stage II (28 Days)|Adverse Event|0|||
164189884|NCT00572455|593063994|FG008|Stage II (28 Days)|Adverse Event|1|||
164189885|NCT00572455|593063995|FG009|Stage II (28 Days)|Adverse Event|3|||
164189886|NCT00572455|593063996|FG010|Stage II (28 Days)|Adverse Event|3|||
164189887|NCT00572455|593063997|FG011|Stage II (28 Days)|Adverse Event|4|||
164189888|NCT00572455|593063998|FG012|Stage II (28 Days)|Adverse Event|5|||
164304386|NCT00998296|593488438|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
164304387|NCT00998296|593488439|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
164304388|NCT00998296|593488440|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
164304389|NCT00998296|593488441|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
164304390|NCT00998296|593488442|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
164304391|NCT00998296|593488443|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
164304392|NCT00998296|593488433|FG000|Overall Study|Other adverse event|0|||
164304393|NCT00998296|593488434|FG001|Overall Study|Other adverse event|0|||
164304394|NCT00998296|593488435|FG002|Overall Study|Other adverse event|0|||
164304395|NCT00998296|593488436|FG003|Overall Study|Other adverse event|0|||
164304396|NCT00998296|593488437|FG004|Overall Study|Other adverse event|1|||
164304397|NCT00998296|593488438|FG005|Overall Study|Other adverse event|0|||
164304398|NCT00998296|593488439|FG006|Overall Study|Other adverse event|0|||
164304399|NCT00998296|593488440|FG007|Overall Study|Other adverse event|0|||
164304400|NCT00998296|593488441|FG008|Overall Study|Other adverse event|0|||
164304401|NCT00998296|593488442|FG009|Overall Study|Other adverse event|1|||
164533427|NCT04504630|594325377|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
164533428|NCT04504630|594325378|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
164533429|NCT00568321|594325379|FG000|Overall Study|Adverse Event|1|||
164533430|NCT00568321|594325380|FG001|Overall Study|Adverse Event|0|||
164533431|NCT00568321|594325381|FG002|Overall Study|Adverse Event|0|||
164533432|NCT00568321|594325379|FG000|Overall Study|Lack of Efficacy|8|||
164533433|NCT00568321|594325380|FG001|Overall Study|Lack of Efficacy|5|||
164533434|NCT00568321|594325381|FG002|Overall Study|Lack of Efficacy|6|||
164533435|NCT00568321|594325379|FG000|Overall Study|Lost to Follow-up|0|||
164533436|NCT00568321|594325380|FG001|Overall Study|Lost to Follow-up|0|||
164533437|NCT00568321|594325381|FG002|Overall Study|Lost to Follow-up|1|||
164533438|NCT00568321|594325379|FG000|Overall Study|Withdrawal by Subject|2|||
164533439|NCT00568321|594325380|FG001|Overall Study|Withdrawal by Subject|0|||
164533440|NCT00568321|594325381|FG002|Overall Study|Withdrawal by Subject|0|||
164533441|NCT00568321|594325379|FG000|Overall Study|Protocol Violation|0|||
164533442|NCT00568321|594325380|FG001|Overall Study|Protocol Violation|0|||
164533443|NCT00568321|594325381|FG002|Overall Study|Protocol Violation|1|||
164533444|NCT00568321|594325379|FG000|Overall Study|Randomized, not treated|2|||
164533445|NCT00568321|594325380|FG001|Overall Study|Randomized, not treated|0|||
164533446|NCT00568321|594325381|FG002|Overall Study|Randomized, not treated|1|||
164533447|NCT00937833|594325383|FG000|Overall Study|Protocol Violation|1|||
164533448|NCT00937833|594325384|FG001|Overall Study|Protocol Violation|2|||
164533449|NCT00937833|594325383|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
164533450|NCT00937833|594325384|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
164533451|NCT00937833|594325383|FG000|Overall Study|Lost to Follow-up|10|||
164533452|NCT00937833|594325384|FG001|Overall Study|Lost to Follow-up|8|||
164533453|NCT00937833|594325383|FG000|Overall Study|Withdrawal by Subject|4|||
164533454|NCT00937833|594325384|FG001|Overall Study|Withdrawal by Subject|6|||
164533455|NCT03215758|594325385|FG000|Overall Study|Technical Problems|1|||
164533456|NCT03215758|594325386|FG001|Overall Study|Technical Problems|0|||
164533457|NCT03215758|594325385|FG000|Overall Study|Protocol deviation|0|||
164533458|NCT03215758|594325386|FG001|Overall Study|Protocol deviation|1|||
164533459|NCT03215758|594325385|FG000|Overall Study|Physician Decision|0|||
164533460|NCT03215758|594325386|FG001|Overall Study|Physician Decision|1|||
164304402|NCT00998296|593488443|FG010|Overall Study|Other adverse event|2|||
164304403|NCT00998296|593488433|FG000|Overall Study|Refused to continue taking trial med.|0|||
164304404|NCT00998296|593488434|FG001|Overall Study|Refused to continue taking trial med.|0|||
164304405|NCT00998296|593488435|FG002|Overall Study|Refused to continue taking trial med.|0|||
164304406|NCT00998296|593488436|FG003|Overall Study|Refused to continue taking trial med.|0|||
164304407|NCT00998296|593488437|FG004|Overall Study|Refused to continue taking trial med.|0|||
164533461|NCT03215758|594325385|FG000|Overall Study|Death|0|||
164533462|NCT03215758|594325386|FG001|Overall Study|Death|1|||
164533463|NCT03215758|594325385|FG000|Overall Study|Adverse Event|1|||
164533464|NCT03215758|594325386|FG001|Overall Study|Adverse Event|2|||
164533465|NCT03215758|594325385|FG000|Overall Study|Subject/Guardian Decision|3|||
164533466|NCT03215758|594325386|FG001|Overall Study|Subject/Guardian Decision|3|||
164304408|NCT00998296|593488438|FG005|Overall Study|Refused to continue taking trial med.|0|||
164304409|NCT00998296|593488439|FG006|Overall Study|Refused to continue taking trial med.|0|||
164304410|NCT00998296|593488440|FG007|Overall Study|Refused to continue taking trial med.|0|||
164533467|NCT03278106|594325388|FG000|Overall Study|No protocol treatment|1|||
164533468|NCT02175004|594325389|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
164533469|NCT02175004|594325390|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
164533470|NCT02175004|594325389|FG000|Overall Study|Investigator Judgment|1|||
164533471|NCT02175004|594325390|FG001|Overall Study|Investigator Judgment|4|||
164533472|NCT02175004|594325389|FG000|Overall Study|Voluntary Withdrawal|6|||
164533473|NCT02175004|594325390|FG001|Overall Study|Voluntary Withdrawal|19|||
164533474|NCT02175004|594325389|FG000|Overall Study|Liver Transplant|1|||
164533475|NCT02175004|594325390|FG001|Overall Study|Liver Transplant|0|||
164648307|NCT04333199|594738555|FG000|Evaluated Patients|Lost to Follow-up|0|||
164304411|NCT00998296|593488441|FG008|Overall Study|Refused to continue taking trial med.|0|||
164304412|NCT00998296|593488442|FG009|Overall Study|Refused to continue taking trial med.|2|||
164304413|NCT00998296|593488443|FG010|Overall Study|Refused to continue taking trial med.|0|||
164304414|NCT00998296|593488433|FG000|Overall Study|Reason other than those specified above|0|||
164304415|NCT00998296|593488434|FG001|Overall Study|Reason other than those specified above|0|||
164304416|NCT00998296|593488435|FG002|Overall Study|Reason other than those specified above|0|||
164304417|NCT00998296|593488436|FG003|Overall Study|Reason other than those specified above|0|||
164304418|NCT00998296|593488437|FG004|Overall Study|Reason other than those specified above|0|||
164304419|NCT00998296|593488438|FG005|Overall Study|Reason other than those specified above|0|||
164304420|NCT00998296|593488439|FG006|Overall Study|Reason other than those specified above|0|||
164304421|NCT00998296|593488440|FG007|Overall Study|Reason other than those specified above|0|||
164304422|NCT00998296|593488441|FG008|Overall Study|Reason other than those specified above|0|||
164304423|NCT00998296|593488442|FG009|Overall Study|Reason other than those specified above|1|||
164304424|NCT00998296|593488443|FG010|Overall Study|Reason other than those specified above|0|||
164304425|NCT04396639|593488446|FG000|Overall Study|Withdrawal by Subject|1|||
164304426|NCT04396639|593488446|FG000|Overall Study|Other|1|||
164304427|NCT02106390|593488447|FG000|Overall Study|Withdrawal by Subject|15|||
164304428|NCT02106390|593488448|FG001|Overall Study|Withdrawal by Subject|16|||
164304429|NCT02106390|593488449|FG002|Overall Study|Withdrawal by Subject|15|||
164304430|NCT02106390|593488447|FG000|Overall Study|Lost to Follow-up|25|||
164304431|NCT02106390|593488448|FG001|Overall Study|Lost to Follow-up|20|||
164304432|NCT02106390|593488449|FG002|Overall Study|Lost to Follow-up|13|||
164304433|NCT02106390|593488447|FG000|Overall Study|Other: Administrative Reason|8|||
164304434|NCT02106390|593488448|FG001|Overall Study|Other: Administrative Reason|5|||
164304435|NCT02106390|593488449|FG002|Overall Study|Other: Administrative Reason|12|||
164304436|NCT02106390|593488447|FG000|Overall Study|Other: Unspecified|1|||
164304437|NCT02106390|593488448|FG001|Overall Study|Other: Unspecified|4|||
164304438|NCT02106390|593488449|FG002|Overall Study|Other: Unspecified|2|||
164304439|NCT02106390|593488447|FG000|Overall Study|Adverse Event|0|||
164304440|NCT02106390|593488448|FG001|Overall Study|Adverse Event|2|||
164304441|NCT02106390|593488449|FG002|Overall Study|Adverse Event|1|||
164304442|NCT02106390|593488447|FG000|Overall Study|Protocol Violation|0|||
164304443|NCT02106390|593488448|FG001|Overall Study|Protocol Violation|1|||
164304444|NCT02106390|593488449|FG002|Overall Study|Protocol Violation|0|||
164304445|NCT05029362|593488450|FG000|Overall Study|Lost to Follow-up|9|||
164304446|NCT00419952|593488454|FG000|Overall Study|Adverse Event|8|||
164304447|NCT00419952|593488455|FG001|Overall Study|Adverse Event|10|||
164304448|NCT00419952|593488454|FG000|Overall Study|Withdrawal by Subject|44|||
164304449|NCT00419952|593488455|FG001|Overall Study|Withdrawal by Subject|43|||
164304450|NCT00419952|593488454|FG000|Overall Study|Lost to Follow-up|43|||
164304451|NCT00419952|593488455|FG001|Overall Study|Lost to Follow-up|34|||
164304452|NCT00419952|593488454|FG000|Overall Study|Protocol Violation|32|||
164304453|NCT00419952|593488455|FG001|Overall Study|Protocol Violation|24|||
164304454|NCT00419952|593488454|FG000|Overall Study|Pregnancy|4|||
164304455|NCT00419952|593488455|FG001|Overall Study|Pregnancy|2|||
164304456|NCT00419952|593488454|FG000|Overall Study|Physician Decision|1|||
164304457|NCT00419952|593488455|FG001|Overall Study|Physician Decision|3|||
164304458|NCT00419952|593488454|FG000|Overall Study|Incorrectly enrolled|10|||
164304459|NCT00419952|593488455|FG001|Overall Study|Incorrectly enrolled|3|||
164304460|NCT00419952|593488454|FG000|Overall Study|Intake of prohibited medication|2|||
164304461|NCT00419952|593488455|FG001|Overall Study|Intake of prohibited medication|2|||
164304462|NCT00419952|593488454|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
164304463|NCT00419952|593488455|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
164304464|NCT00419952|593488454|FG000|Overall Study|Diary or medication non-compliance|2|||
164304465|NCT00419952|593488455|FG001|Overall Study|Diary or medication non-compliance|4|||
164304466|NCT00419952|593488454|FG000|Overall Study|Abnormal ECG|1|||
164304467|NCT00419952|593488455|FG001|Overall Study|Abnormal ECG|0|||
164304468|NCT03126591|593488460|FG000|Overall Study|Death|6|||
164304469|NCT03126591|593488461|FG001|Overall Study|Death|3|||
164304470|NCT03126591|593488462|FG002|Overall Study|Death|17|||
164304471|NCT03126591|593488460|FG000|Overall Study|Progressive Disease|0|||
164304472|NCT03126591|593488461|FG001|Overall Study|Progressive Disease|1|||
164304473|NCT03126591|593488462|FG002|Overall Study|Progressive Disease|2|||
164304474|NCT03126591|593488460|FG000|Overall Study|Terminated by Sponsor|0|||
164304475|NCT03126591|593488461|FG001|Overall Study|Terminated by Sponsor|1|||
164304476|NCT03126591|593488462|FG002|Overall Study|Terminated by Sponsor|4|||
164304477|NCT03126591|593488460|FG000|Overall Study|Withdrawal by Subject|1|||
164419306|NCT01216293|593904745|FG000|Main Study|Adverse Event|1|||
164419307|NCT01216293|593904746|FG001|Main Study|Adverse Event|4|||
164304478|NCT03126591|593488461|FG001|Overall Study|Withdrawal by Subject|1|||
164304479|NCT03126591|593488462|FG002|Overall Study|Withdrawal by Subject|4|||
164304480|NCT03722238|593488465|FG000|Overall Study|Protocol Violation|1|||
164304481|NCT03722238|593488466|FG001|Overall Study|Protocol Violation|0|||
164304482|NCT03722238|593488465|FG000|Overall Study|Physician Decision|1|||
164304483|NCT03722238|593488466|FG001|Overall Study|Physician Decision|0|||
164304484|NCT03722238|593488465|FG000|Overall Study|Death|1|||
164304485|NCT03722238|593488466|FG001|Overall Study|Death|0|||
164304486|NCT03722238|593488465|FG000|Overall Study|Lost to Follow-up|6|||
164304487|NCT03722238|593488466|FG001|Overall Study|Lost to Follow-up|0|||
164304488|NCT03722238|593488465|FG000|Overall Study|Partial missing data|44|||
164304489|NCT03722238|593488466|FG001|Overall Study|Partial missing data|1|||
164304490|NCT03722238|593488465|FG000|Overall Study|Withdrawal by Subject|2|||
164304491|NCT03722238|593488466|FG001|Overall Study|Withdrawal by Subject|0|||
164304492|NCT03722238|593488465|FG000|Overall Study|Other|4|||
164304493|NCT03722238|593488466|FG001|Overall Study|Other|0|||
164304494|NCT03722238|593488465|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
164304495|NCT03722238|593488466|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
164304496|NCT03722238|593488465|FG000|Overall Study|Did not meet risk classification group criteria|90|||
164304497|NCT03722238|593488466|FG001|Overall Study|Did not meet risk classification group criteria|0|||
164304498|NCT03722238|593488465|FG000|Overall Study|Did not sign consent|17|||
164304499|NCT03722238|593488466|FG001|Overall Study|Did not sign consent|0|||
164304500|NCT03722238|593488465|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
164304501|NCT03722238|593488466|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
164304502|NCT03722238|593488465|FG000|Overall Study|Not willing to purchase study medication|142|||
164304503|NCT03722238|593488466|FG001|Overall Study|Not willing to purchase study medication|0|||
164304504|NCT03722238|593488465|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
164304505|NCT03722238|593488466|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
164304506|NCT02085460|593488467|FG000|Overall Study|Adverse Event|2|||
164304507|NCT02085460|593488468|FG001|Overall Study|Adverse Event|2|||
164304508|NCT02085460|593488469|FG002|Overall Study|Adverse Event|1|||
164304509|NCT02085460|593488467|FG000|Overall Study|Physician Decision|1|||
164304510|NCT02085460|593488468|FG001|Overall Study|Physician Decision|1|||
164304511|NCT02085460|593488469|FG002|Overall Study|Physician Decision|2|||
164304512|NCT02085460|593488467|FG000|Overall Study|Withdrawal by Subject|11|||
164304513|NCT02085460|593488468|FG001|Overall Study|Withdrawal by Subject|5|||
164304514|NCT02085460|593488469|FG002|Overall Study|Withdrawal by Subject|7|||
164304515|NCT01285323|593488470|FG000|Overall Study|Adverse Event|9|||
164304516|NCT01285323|593488471|FG001|Overall Study|Adverse Event|8|||
164304517|NCT01285323|593488470|FG000|Overall Study|Lack of Efficacy|4|||
164304518|NCT01285323|593488471|FG001|Overall Study|Lack of Efficacy|2|||
164304519|NCT01285323|593488470|FG000|Overall Study|Withdrawal by Subject|15|||
164304520|NCT01285323|593488471|FG001|Overall Study|Withdrawal by Subject|11|||
164304521|NCT01285323|593488470|FG000|Overall Study|Protocol Violation|1|||
164304522|NCT01285323|593488471|FG001|Overall Study|Protocol Violation|2|||
164304523|NCT01285323|593488470|FG000|Overall Study|Non-compliance with study procedures|2|||
164304524|NCT01285323|593488471|FG001|Overall Study|Non-compliance with study procedures|3|||
164304525|NCT01285323|593488470|FG000|Overall Study|Lost to Follow-up|1|||
164304526|NCT01285323|593488471|FG001|Overall Study|Lost to Follow-up|1|||
164304527|NCT01285323|593488470|FG000|Overall Study|Other|1|||
164304528|NCT01285323|593488471|FG001|Overall Study|Other|3|||
164304529|NCT02606643|593488472|FG000|Overall Study|did not meet inclusion criteria|1|||
164304530|NCT02606643|593488473|FG001|Overall Study|did not meet inclusion criteria|3|||
164304531|NCT02158546|593488480|FG000|Overall Study|Physician Decision|0|||
164304532|NCT02158546|593488481|FG001|Overall Study|Physician Decision|1|||
164304533|NCT02158546|593488482|FG002|Overall Study|Physician Decision|0|||
164304534|NCT02158546|593488483|FG003|Overall Study|Physician Decision|0|||
164304535|NCT02158546|593488480|FG000|Overall Study|Non-compliance|0|||
164304536|NCT02158546|593488481|FG001|Overall Study|Non-compliance|1|||
164304537|NCT02158546|593488482|FG002|Overall Study|Non-compliance|0|||
164304538|NCT02158546|593488483|FG003|Overall Study|Non-compliance|1|||
164304539|NCT02158546|593488480|FG000|Overall Study|Failure to meet eligibility criteria|0|||
164304540|NCT02158546|593488481|FG001|Overall Study|Failure to meet eligibility criteria|1|||
164304541|NCT02158546|593488482|FG002|Overall Study|Failure to meet eligibility criteria|0|||
164304542|NCT02158546|593488483|FG003|Overall Study|Failure to meet eligibility criteria|0|||
164304543|NCT02158546|593488480|FG000|Overall Study|Lack of Efficacy|1|||
164304544|NCT02158546|593488481|FG001|Overall Study|Lack of Efficacy|1|||
164304545|NCT02158546|593488482|FG002|Overall Study|Lack of Efficacy|0|||
164304546|NCT02158546|593488483|FG003|Overall Study|Lack of Efficacy|0|||
164304547|NCT02158546|593488480|FG000|Overall Study|Adverse Event|2|||
164304548|NCT02158546|593488481|FG001|Overall Study|Adverse Event|2|||
164304549|NCT02158546|593488482|FG002|Overall Study|Adverse Event|0|||
164304550|NCT02158546|593488483|FG003|Overall Study|Adverse Event|0|||
164304551|NCT02158546|593488480|FG000|Overall Study|Withdrawal by Subject|6|||
164304552|NCT02158546|593488481|FG001|Overall Study|Withdrawal by Subject|2|||
164304553|NCT02158546|593488482|FG002|Overall Study|Withdrawal by Subject|1|||
164304554|NCT02158546|593488483|FG003|Overall Study|Withdrawal by Subject|0|||
164304555|NCT02158546|593488480|FG000|Overall Study|Lost to Follow-up|5|||
164304556|NCT02158546|593488481|FG001|Overall Study|Lost to Follow-up|4|||
164304557|NCT02158546|593488482|FG002|Overall Study|Lost to Follow-up|0|||
164304558|NCT02158546|593488483|FG003|Overall Study|Lost to Follow-up|1|||
164304559|NCT02158546|593488480|FG000|Overall Study|Site Excluded|5|||
164304560|NCT02158546|593488481|FG001|Overall Study|Site Excluded|5|||
164304561|NCT02158546|593488482|FG002|Overall Study|Site Excluded|3|||
164304562|NCT02158546|593488483|FG003|Overall Study|Site Excluded|4|||
164304563|NCT02351817|593488485|FG000|Period 1|Adverse Event|1|||
164304564|NCT02351817|593488486|FG001|Period 1|Adverse Event|2|||
164304565|NCT02351817|593488485|FG000|Period 1|Lack of Efficacy|0|||
164304566|NCT02351817|593488486|FG001|Period 1|Lack of Efficacy|1|||
164304567|NCT02351817|593488485|FG000|Period 2|Adverse Event|0|||
164304568|NCT02351817|593488486|FG001|Period 2|Adverse Event|2|||
164304569|NCT02351817|593488485|FG000|Period 2|Protocol Violation|1|||
164304570|NCT02351817|593488486|FG001|Period 2|Protocol Violation|0|||
164304571|NCT00561925|593488491|FG000|14 Day Lead-In Period|Adverse Event|38|||
164304572|NCT00561925|593488492|FG001|14 Day Lead-In Period|Adverse Event|0|||
164304573|NCT00561925|593488493|FG002|14 Day Lead-In Period|Adverse Event|0|||
164304574|NCT00561925|593488494|FG003|14 Day Lead-In Period|Adverse Event|0|||
164304575|NCT00561925|593488495|FG004|14 Day Lead-In Period|Adverse Event|0|||
164304576|NCT00561925|593488491|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
164304577|NCT00561925|593488492|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
164304578|NCT00561925|593488493|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
164304579|NCT00561925|593488494|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
164304580|NCT00561925|593488495|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
164304581|NCT00561925|593488491|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
164304582|NCT00561925|593488492|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
164304583|NCT00561925|593488493|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
164304584|NCT00561925|593488494|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
164304585|NCT00561925|593488495|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
164304586|NCT00561925|593488491|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
164304587|NCT00561925|593488492|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
164304588|NCT00561925|593488493|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
164304589|NCT00561925|593488494|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
164304590|NCT00561925|593488495|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
164304591|NCT00561925|593488491|FG000|14 Day Lead-In Period|Other|5|||
164304592|NCT00561925|593488492|FG001|14 Day Lead-In Period|Other|0|||
164304593|NCT00561925|593488493|FG002|14 Day Lead-In Period|Other|0|||
164304594|NCT00561925|593488494|FG003|14 Day Lead-In Period|Other|0|||
164304595|NCT00561925|593488495|FG004|14 Day Lead-In Period|Other|0|||
164304596|NCT00561925|593488491|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
164304597|NCT00561925|593488492|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
164304598|NCT00561925|593488493|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
164304599|NCT00561925|593488494|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
164304600|NCT00561925|593488495|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
164304601|NCT00561925|593488491|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
164304602|NCT00561925|593488492|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
164304603|NCT00561925|593488493|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
164304604|NCT00561925|593488494|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
164304605|NCT00561925|593488495|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
164304606|NCT00561925|593488491|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
164304607|NCT00561925|593488492|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
164304608|NCT00561925|593488493|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
164304609|NCT00561925|593488494|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
164304610|NCT00561925|593488495|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
164304611|NCT00561925|593488491|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
164304612|NCT00561925|593488492|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
164304613|NCT00561925|593488493|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
164304614|NCT00561925|593488494|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
164304615|NCT00561925|593488495|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
164304616|NCT00561925|593488491|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
164304617|NCT00561925|593488492|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
164304618|NCT00561925|593488493|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
164304619|NCT00561925|593488494|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
164304620|NCT00561925|593488495|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
164304621|NCT00561925|593488491|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
164304622|NCT00561925|593488492|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
164304623|NCT00561925|593488493|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
164304624|NCT00561925|593488494|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
164304625|NCT00561925|593488495|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
164304626|NCT00561925|593488491|FG000|144-week Double-blind, Double-dummy|Death|0|||
164304627|NCT00561925|593488492|FG001|144-week Double-blind, Double-dummy|Death|6|||
164304628|NCT00561925|593488493|FG002|144-week Double-blind, Double-dummy|Death|3|||
164304629|NCT00561925|593488494|FG003|144-week Double-blind, Double-dummy|Death|0|||
164304630|NCT00561925|593488495|FG004|144-week Double-blind, Double-dummy|Death|0|||
164304631|NCT00561925|593488491|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
164304632|NCT00561925|593488492|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
164304633|NCT00561925|593488493|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
164304634|NCT00561925|593488494|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
164304635|NCT00561925|593488495|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
164304636|NCT00561925|593488491|FG000|144-week Double-blind, Double-dummy|Other|0|||
164304637|NCT00561925|593488492|FG001|144-week Double-blind, Double-dummy|Other|8|||
164304638|NCT00561925|593488493|FG002|144-week Double-blind, Double-dummy|Other|11|||
164304639|NCT00561925|593488494|FG003|144-week Double-blind, Double-dummy|Other|0|||
164304640|NCT00561925|593488495|FG004|144-week Double-blind, Double-dummy|Other|0|||
164304641|NCT00561925|593488491|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
164304642|NCT00561925|593488492|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
164304643|NCT00561925|593488493|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
164304644|NCT00561925|593488494|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
164304645|NCT00561925|593488495|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
164304646|NCT00684021|593488498|FG000|Overall Study|MRI Contraindicated|1|||
164304647|NCT00684021|593488499|FG001|Overall Study|MRI Contraindicated|1|||
164304648|NCT00684021|593488500|FG002|Overall Study|MRI Contraindicated|1|||
164304649|NCT00684021|593488501|FG003|Overall Study|MRI Contraindicated|0|||
164304650|NCT00684021|593488498|FG000|Overall Study|MRI not performed|0|||
164304651|NCT00684021|593488499|FG001|Overall Study|MRI not performed|1|||
164304652|NCT00684021|593488500|FG002|Overall Study|MRI not performed|1|||
164304653|NCT00684021|593488501|FG003|Overall Study|MRI not performed|2|||
164304654|NCT00684021|593488498|FG000|Overall Study|Death|1|||
164304655|NCT00684021|593488499|FG001|Overall Study|Death|0|||
164304656|NCT00684021|593488500|FG002|Overall Study|Death|0|||
164304657|NCT00684021|593488501|FG003|Overall Study|Death|0|||
164304658|NCT00891904|593488502|FG000|Overall Study|Death|1|||
164304659|NCT00891904|593488502|FG000|Overall Study|Adverse Event|1|||
164304660|NCT01208207|593488503|FG000|Part I|Adverse Event|19|||
164304661|NCT01208207|593488504|FG001|Part I|Adverse Event|2|||
164304662|NCT01208207|593488505|FG002|Part I|Adverse Event|6|||
164304663|NCT01208207|593488506|FG003|Part I|Adverse Event|0|||
164304664|NCT01208207|593488507|FG004|Part I|Adverse Event|0|||
164304665|NCT01208207|593488508|FG005|Part I|Adverse Event|0|||
164304666|NCT01208207|593488509|FG006|Part I|Adverse Event|0|||
164304667|NCT01208207|593488503|FG000|Part I|Lack of Efficacy|21|||
164304668|NCT01208207|593488504|FG001|Part I|Lack of Efficacy|3|||
164304669|NCT01208207|593488505|FG002|Part I|Lack of Efficacy|2|||
164304670|NCT01208207|593488506|FG003|Part I|Lack of Efficacy|0|||
164304671|NCT01208207|593488507|FG004|Part I|Lack of Efficacy|0|||
164304672|NCT01208207|593488508|FG005|Part I|Lack of Efficacy|0|||
164304673|NCT01208207|593488509|FG006|Part I|Lack of Efficacy|0|||
164304674|NCT01208207|593488503|FG000|Part I|Lost to Follow-up|6|||
164304675|NCT01208207|593488504|FG001|Part I|Lost to Follow-up|1|||
164304676|NCT01208207|593488505|FG002|Part I|Lost to Follow-up|0|||
164304677|NCT01208207|593488506|FG003|Part I|Lost to Follow-up|0|||
164304678|NCT01208207|593488507|FG004|Part I|Lost to Follow-up|0|||
164304679|NCT01208207|593488508|FG005|Part I|Lost to Follow-up|0|||
164304680|NCT01208207|593488509|FG006|Part I|Lost to Follow-up|0|||
164304681|NCT01208207|593488503|FG000|Part I|Non-Compliance With Study Drug|1|||
164304682|NCT01208207|593488504|FG001|Part I|Non-Compliance With Study Drug|0|||
164304683|NCT01208207|593488505|FG002|Part I|Non-Compliance With Study Drug|1|||
164304684|NCT01208207|593488506|FG003|Part I|Non-Compliance With Study Drug|0|||
164304685|NCT01208207|593488507|FG004|Part I|Non-Compliance With Study Drug|0|||
164304686|NCT01208207|593488508|FG005|Part I|Non-Compliance With Study Drug|0|||
164304687|NCT01208207|593488509|FG006|Part I|Non-Compliance With Study Drug|0|||
164304688|NCT01208207|593488503|FG000|Part I|Physician Decision|0|||
164304689|NCT01208207|593488504|FG001|Part I|Physician Decision|1|||
164304690|NCT01208207|593488505|FG002|Part I|Physician Decision|0|||
164304691|NCT01208207|593488506|FG003|Part I|Physician Decision|0|||
164304692|NCT01208207|593488507|FG004|Part I|Physician Decision|0|||
164304693|NCT01208207|593488508|FG005|Part I|Physician Decision|0|||
164304694|NCT01208207|593488509|FG006|Part I|Physician Decision|0|||
164304695|NCT01208207|593488503|FG000|Part I|Progressive Disease|1|||
164304696|NCT01208207|593488504|FG001|Part I|Progressive Disease|0|||
164304697|NCT01208207|593488505|FG002|Part I|Progressive Disease|0|||
164304698|NCT01208207|593488506|FG003|Part I|Progressive Disease|0|||
164304699|NCT01208207|593488507|FG004|Part I|Progressive Disease|0|||
164304700|NCT01208207|593488508|FG005|Part I|Progressive Disease|0|||
164304701|NCT01208207|593488509|FG006|Part I|Progressive Disease|0|||
164304702|NCT01208207|593488503|FG000|Part I|Protocol Violation|8|||
164304703|NCT01208207|593488504|FG001|Part I|Protocol Violation|0|||
164304704|NCT01208207|593488505|FG002|Part I|Protocol Violation|2|||
164304705|NCT01208207|593488506|FG003|Part I|Protocol Violation|0|||
164304706|NCT01208207|593488507|FG004|Part I|Protocol Violation|0|||
164304707|NCT01208207|593488508|FG005|Part I|Protocol Violation|0|||
164304708|NCT01208207|593488509|FG006|Part I|Protocol Violation|0|||
164304709|NCT01208207|593488503|FG000|Part I|Withdrawal by Subject|14|||
164304710|NCT01208207|593488504|FG001|Part I|Withdrawal by Subject|4|||
164304711|NCT01208207|593488505|FG002|Part I|Withdrawal by Subject|4|||
164304712|NCT01208207|593488506|FG003|Part I|Withdrawal by Subject|0|||
164304713|NCT01208207|593488507|FG004|Part I|Withdrawal by Subject|0|||
164304714|NCT01208207|593488508|FG005|Part I|Withdrawal by Subject|0|||
164304715|NCT01208207|593488509|FG006|Part I|Withdrawal by Subject|0|||
164304716|NCT01208207|593488503|FG000|Part II|Withdrawal by Subject|0|||
164304717|NCT01208207|593488504|FG001|Part II|Withdrawal by Subject|0|||
164304718|NCT01208207|593488505|FG002|Part II|Withdrawal by Subject|0|||
164304719|NCT01208207|593488506|FG003|Part II|Withdrawal by Subject|10|||
164304720|NCT01208207|593488507|FG004|Part II|Withdrawal by Subject|9|||
164304721|NCT01208207|593488508|FG005|Part II|Withdrawal by Subject|3|||
164304722|NCT01208207|593488509|FG006|Part II|Withdrawal by Subject|5|||
164304723|NCT01208207|593488503|FG000|Part II|Adverse Event|0|||
164304724|NCT01208207|593488504|FG001|Part II|Adverse Event|0|||
164304725|NCT01208207|593488505|FG002|Part II|Adverse Event|0|||
164304726|NCT01208207|593488506|FG003|Part II|Adverse Event|5|||
164304727|NCT01208207|593488507|FG004|Part II|Adverse Event|9|||
164304728|NCT01208207|593488508|FG005|Part II|Adverse Event|4|||
164304729|NCT01208207|593488509|FG006|Part II|Adverse Event|2|||
164304730|NCT01208207|593488503|FG000|Part II|Lack of Efficacy|0|||
164304731|NCT01208207|593488504|FG001|Part II|Lack of Efficacy|0|||
164304732|NCT01208207|593488505|FG002|Part II|Lack of Efficacy|0|||
164304733|NCT01208207|593488506|FG003|Part II|Lack of Efficacy|6|||
164304734|NCT01208207|593488507|FG004|Part II|Lack of Efficacy|4|||
164304735|NCT01208207|593488508|FG005|Part II|Lack of Efficacy|3|||
164304736|NCT01208207|593488509|FG006|Part II|Lack of Efficacy|3|||
164304737|NCT01208207|593488503|FG000|Part II|Lost to Follow-up|0|||
164304738|NCT01208207|593488504|FG001|Part II|Lost to Follow-up|0|||
164304739|NCT01208207|593488505|FG002|Part II|Lost to Follow-up|0|||
164304740|NCT01208207|593488506|FG003|Part II|Lost to Follow-up|4|||
164304741|NCT01208207|593488507|FG004|Part II|Lost to Follow-up|0|||
164304742|NCT01208207|593488508|FG005|Part II|Lost to Follow-up|2|||
164304743|NCT01208207|593488509|FG006|Part II|Lost to Follow-up|1|||
164304744|NCT01208207|593488503|FG000|Part II|Non-Compliance With Study Drug|0|||
164304745|NCT01208207|593488504|FG001|Part II|Non-Compliance With Study Drug|0|||
164304746|NCT01208207|593488505|FG002|Part II|Non-Compliance With Study Drug|0|||
164304747|NCT01208207|593488506|FG003|Part II|Non-Compliance With Study Drug|4|||
164304748|NCT01208207|593488507|FG004|Part II|Non-Compliance With Study Drug|1|||
164304749|NCT01208207|593488508|FG005|Part II|Non-Compliance With Study Drug|1|||
164304750|NCT01208207|593488509|FG006|Part II|Non-Compliance With Study Drug|0|||
164304751|NCT01208207|593488503|FG000|Part II|Physician Decision|0|||
164304752|NCT01208207|593488504|FG001|Part II|Physician Decision|0|||
164304753|NCT01208207|593488505|FG002|Part II|Physician Decision|0|||
164304754|NCT01208207|593488506|FG003|Part II|Physician Decision|1|||
164304755|NCT01208207|593488507|FG004|Part II|Physician Decision|0|||
164304756|NCT01208207|593488508|FG005|Part II|Physician Decision|2|||
164304757|NCT01208207|593488509|FG006|Part II|Physician Decision|0|||
164304758|NCT01208207|593488503|FG000|Part II|Protocol Violation|0|||
164304759|NCT01208207|593488504|FG001|Part II|Protocol Violation|0|||
164304760|NCT01208207|593488505|FG002|Part II|Protocol Violation|0|||
164304761|NCT01208207|593488506|FG003|Part II|Protocol Violation|1|||
164304762|NCT01208207|593488507|FG004|Part II|Protocol Violation|0|||
164304763|NCT01208207|593488508|FG005|Part II|Protocol Violation|0|||
164304764|NCT01208207|593488509|FG006|Part II|Protocol Violation|0|||
164304765|NCT01208207|593488503|FG000|Part II|Technical Problems|0|||
164304766|NCT01208207|593488504|FG001|Part II|Technical Problems|0|||
164304767|NCT01208207|593488505|FG002|Part II|Technical Problems|0|||
164304768|NCT01208207|593488506|FG003|Part II|Technical Problems|1|||
164304769|NCT01208207|593488507|FG004|Part II|Technical Problems|0|||
164304770|NCT01208207|593488508|FG005|Part II|Technical Problems|1|||
164304771|NCT01208207|593488509|FG006|Part II|Technical Problems|0|||
164304772|NCT04041414|593488512|FG000|Overall Study|Lost to Follow-up|1|||
164304773|NCT04041414|593488513|FG001|Overall Study|Lost to Follow-up|2|||
164304774|NCT00665652|593488514|FG000|Overall Study|Adverse Event|4|||
164304775|NCT00665652|593488514|FG000|Overall Study|Death|1|||
164304776|NCT00665652|593488514|FG000|Overall Study|No longer met inclusion criteria.|1|||
164304777|NCT02556177|593488518|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
164304778|NCT02556177|593488519|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
164304779|NCT01055197|593488532|FG000|Overall Study|Protocol Violation|7|||
164304780|NCT01055197|593488533|FG001|Overall Study|Protocol Violation|2|||
164304781|NCT01055197|593488532|FG000|Overall Study|Withdrawal by Subject|2|||
164304782|NCT01055197|593488533|FG001|Overall Study|Withdrawal by Subject|0|||
164304783|NCT00734539|593488534|FG000|Main Study|Death|33|||
164304784|NCT00734539|593488535|FG001|Main Study|Death|32|||
164304785|NCT00734539|593488534|FG000|Main Study|Physician Decision|2|||
164304786|NCT00734539|593488535|FG001|Main Study|Physician Decision|0|||
164304787|NCT00734539|593488534|FG000|Main Study|Withdrawal by Subject|1|||
164304788|NCT00734539|593488535|FG001|Main Study|Withdrawal by Subject|3|||
164304789|NCT00734539|593488534|FG000|Main Study|Enrolled in error; ineligible|1|||
164304790|NCT00734539|593488535|FG001|Main Study|Enrolled in error; ineligible|0|||
164304791|NCT01782378|593488536|FG000|First Series|Lost to Follow-up|7|||
164304792|NCT01782378|593488537|FG001|First Series|Lost to Follow-up|8|||
164304793|NCT01782378|593488536|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
164304794|NCT01782378|593488537|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
164304795|NCT01782378|593488536|FG000|Second Series|Lost to Follow-up|8|||
164304796|NCT01782378|593488537|FG001|Second Series|Lost to Follow-up|7|||
164304797|NCT01782378|593488536|FG000|Second Series|Did not choose to complete S2 Optional|18|||
164304798|NCT01782378|593488537|FG001|Second Series|Did not choose to complete S2 Optional|0|||
164304799|NCT00830440|593488538|FG000|Overall Study|Protocol Violation|1|||
164304800|NCT00830440|593488539|FG001|Overall Study|Protocol Violation|0|||
164304801|NCT00830440|593488538|FG000|Overall Study|Withdrawal by Subject|1|||
164304802|NCT00830440|593488539|FG001|Overall Study|Withdrawal by Subject|0|||
164304803|NCT00830440|593488538|FG000|Overall Study|unsuccessful procedure|4|||
164304804|NCT00830440|593488539|FG001|Overall Study|unsuccessful procedure|0|||
164304805|NCT00830440|593488538|FG000|Overall Study|Adverse Event|2|||
164304806|NCT00830440|593488539|FG001|Overall Study|Adverse Event|0|||
164304807|NCT01663103|593488542|FG000|Overall Study|Withdrawal by Subject|1|||
164304808|NCT01663103|593488543|FG001|Overall Study|Withdrawal by Subject|2|||
164304809|NCT01663103|593488542|FG000|Overall Study|Adverse Event|1|||
164304810|NCT01663103|593488543|FG001|Overall Study|Adverse Event|0|||
164304811|NCT01663103|593488542|FG000|Overall Study|dog bite|1|||
164304812|NCT01663103|593488543|FG001|Overall Study|dog bite|0|||
164304813|NCT01721044|593488548|FG000|Treatment Period|Adverse Event|7|||
164304814|NCT01721044|593488549|FG001|Treatment Period|Adverse Event|7|||
164304815|NCT01721044|593488550|FG002|Treatment Period|Adverse Event|10|||
164304816|NCT01721044|593488548|FG000|Treatment Period|Death|0|||
164304817|NCT01721044|593488549|FG001|Treatment Period|Death|0|||
164304818|NCT01721044|593488550|FG002|Treatment Period|Death|1|||
164304819|NCT01721044|593488548|FG000|Treatment Period|Lack of Efficacy|16|||
164304820|NCT01721044|593488549|FG001|Treatment Period|Lack of Efficacy|4|||
164304821|NCT01721044|593488550|FG002|Treatment Period|Lack of Efficacy|4|||
164304822|NCT01721044|593488548|FG000|Treatment Period|Lost to Follow-up|0|||
164304823|NCT01721044|593488549|FG001|Treatment Period|Lost to Follow-up|0|||
164304824|NCT01721044|593488550|FG002|Treatment Period|Lost to Follow-up|1|||
164304825|NCT01721044|593488548|FG000|Treatment Period|Physician Decision|1|||
164304826|NCT01721044|593488549|FG001|Treatment Period|Physician Decision|0|||
164304827|NCT01721044|593488550|FG002|Treatment Period|Physician Decision|2|||
164304828|NCT01721044|593488548|FG000|Treatment Period|Protocol Violation|1|||
164304829|NCT01721044|593488549|FG001|Treatment Period|Protocol Violation|0|||
164304830|NCT01721044|593488550|FG002|Treatment Period|Protocol Violation|0|||
164304831|NCT01721044|593488548|FG000|Treatment Period|Withdrawal by Subject|7|||
164304832|NCT01721044|593488549|FG001|Treatment Period|Withdrawal by Subject|6|||
164304833|NCT01721044|593488550|FG002|Treatment Period|Withdrawal by Subject|1|||
164304834|NCT02420821|593488559|FG000|Overall Study|Lost to Follow-up|6|||
164304835|NCT02420821|593488560|FG001|Overall Study|Lost to Follow-up|6|||
164304836|NCT02420821|593488559|FG000|Overall Study|Non-compliance|0|||
164304837|NCT02420821|593488560|FG001|Overall Study|Non-compliance|2|||
164304838|NCT02420821|593488559|FG000|Overall Study|Physician Decision|6|||
164304839|NCT02420821|593488560|FG001|Overall Study|Physician Decision|2|||
164304840|NCT02420821|593488559|FG000|Overall Study|Withdrawal by Subject|32|||
164304841|NCT02420821|593488560|FG001|Overall Study|Withdrawal by Subject|25|||
164304842|NCT02420821|593488559|FG000|Overall Study|Death|270|||
164304843|NCT02420821|593488560|FG001|Overall Study|Death|263|||
164304844|NCT02420821|593488559|FG000|Overall Study|Study Terminated By Sponsor|145|||
164304845|NCT02420821|593488560|FG001|Overall Study|Study Terminated By Sponsor|149|||
164304846|NCT02420821|593488559|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
164304847|NCT02420821|593488560|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
164304848|NCT02420821|593488559|FG000|Overall Study|Adverse Event|0|||
164304849|NCT02420821|593488560|FG001|Overall Study|Adverse Event|1|||
164304850|NCT02420821|593488559|FG000|Overall Study|Protinuria|0|||
164304851|NCT02420821|593488560|FG001|Overall Study|Protinuria|1|||
164304852|NCT02420821|593488559|FG000|Overall Study|Progressive Disease|1|||
164304853|NCT02420821|593488560|FG001|Overall Study|Progressive Disease|1|||
164304854|NCT02420821|593488559|FG000|Overall Study|Disease Progression|0|||
164304855|NCT02420821|593488560|FG001|Overall Study|Disease Progression|1|||
164304856|NCT02420821|593488559|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
164304857|NCT02420821|593488560|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
164304858|NCT04467905|593488561|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
164304859|NCT04467905|593488562|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
164304860|NCT04467905|593488563|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
164304861|NCT04467905|593488561|FG000|Overall Study|Conversion to SR|0|||
164304862|NCT04467905|593488562|FG001|Overall Study|Conversion to SR|0|||
164304863|NCT04467905|593488563|FG002|Overall Study|Conversion to SR|3|||
164304864|NCT04467905|593488561|FG000|Overall Study|Technical issue with Holter ECG|0|||
164304865|NCT04467905|593488562|FG001|Overall Study|Technical issue with Holter ECG|0|||
164304866|NCT04467905|593488563|FG002|Overall Study|Technical issue with Holter ECG|3|||
164304867|NCT04467905|593488561|FG000|Overall Study|Hemodynamic instability|0|||
164419308|NCT01216293|593904747|FG002|Main Study|Adverse Event|2|||
164304868|NCT04467905|593488562|FG001|Overall Study|Hemodynamic instability|0|||
164304869|NCT04467905|593488563|FG002|Overall Study|Hemodynamic instability|1|||
164304870|NCT04467905|593488561|FG000|Overall Study|Site misinterpretation of protocol|0|||
164304871|NCT04467905|593488562|FG001|Overall Study|Site misinterpretation of protocol|0|||
164304872|NCT04467905|593488563|FG002|Overall Study|Site misinterpretation of protocol|1|||
164304873|NCT02202759|593490476|FG000|Overall Study|Study Terminated by Sponsor|3|||
164304874|NCT02202759|593490477|FG001|Overall Study|Study Terminated by Sponsor|3|||
164304875|NCT02202759|593490478|FG002|Overall Study|Study Terminated by Sponsor|3|||
164304876|NCT02202759|593490476|FG000|Overall Study|Withdrawal by Subject|2|||
164304877|NCT02202759|593490477|FG001|Overall Study|Withdrawal by Subject|1|||
164304878|NCT02202759|593490478|FG002|Overall Study|Withdrawal by Subject|1|||
164304879|NCT02202759|593490476|FG000|Overall Study|Reason not Specified|4|||
164304880|NCT02202759|593490477|FG001|Overall Study|Reason not Specified|11|||
164304881|NCT02202759|593490478|FG002|Overall Study|Reason not Specified|10|||
164304882|NCT01590888|593490479|FG000|Overall Study|Adverse Event|3|||
164304883|NCT01590888|593490480|FG001|Overall Study|Adverse Event|0|||
164304884|NCT01590888|593490481|FG002|Overall Study|Adverse Event|1|||
164304885|NCT01590888|593490479|FG000|Overall Study|Lost to Follow-up|1|||
164304886|NCT01590888|593490480|FG001|Overall Study|Lost to Follow-up|0|||
164304887|NCT01590888|593490481|FG002|Overall Study|Lost to Follow-up|0|||
164304888|NCT04953728|593490482|FG000|Overall Study|Withdrawal by Subject|3|||
164304889|NCT04953728|593490482|FG000|Overall Study|Physician Decision|1|||
164304890|NCT02331277|593490483|FG000|Overall Study|Withdrawal by Subject|1|||
164304891|NCT02331277|593490484|FG001|Overall Study|Withdrawal by Subject|0|||
164304892|NCT01071798|593490486|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
164304893|NCT01071798|593490486|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
164304894|NCT01071798|593490486|FG000|Participants Who Received One Cycle|Patient requirement|20|||
164304895|NCT01071798|593490486|FG000|Participants Who Received One Cycle|Death|5|||
164304896|NCT01071798|593490486|FG000|Participants Who Received One Cycle|Change of therapy|6|||
164304897|NCT01071798|593490486|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
164304898|NCT01071798|593490486|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
164304899|NCT01071798|593490486|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
164304900|NCT01071798|593490486|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
164304901|NCT01071798|593490486|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
164304902|NCT01759446|593490489|FG000|Overall Study|Protocol Violation|1|||
164304903|NCT01759446|593490490|FG001|Overall Study|Protocol Violation|0|||
164304904|NCT01759446|593490491|FG002|Overall Study|Protocol Violation|1|||
164304905|NCT01759446|593490492|FG003|Overall Study|Protocol Violation|0|||
164304906|NCT01759446|593490493|FG004|Overall Study|Protocol Violation|0|||
164304907|NCT01759446|593490489|FG000|Overall Study|Withdrawal by Subject|0|||
164304908|NCT01759446|593490490|FG001|Overall Study|Withdrawal by Subject|1|||
164304909|NCT01759446|593490491|FG002|Overall Study|Withdrawal by Subject|0|||
164304910|NCT01759446|593490492|FG003|Overall Study|Withdrawal by Subject|1|||
164304911|NCT01759446|593490493|FG004|Overall Study|Withdrawal by Subject|0|||
164304912|NCT01760733|593490494|FG000|Waiting List|Death|18|||
164304913|NCT01760733|593490494|FG000|Waiting List|Removed from waiting list|41|||
164304914|NCT01760733|593490494|FG000|Waiting List|Not received a transplant yet|13|||
164304915|NCT01760733|593490494|FG000|Transplanted|Not reached 10 years post transplant|184|||
164304916|NCT01760733|593490494|FG000|Transplanted|Death|26|||
164304917|NCT01760733|593490494|FG000|Transplanted|Graft loss|7|||
164304918|NCT00815659|593490497|FG000|Overall Study|Adverse Event|9|||
164304919|NCT00815659|593490497|FG000|Overall Study|Withdrawal by Subject|9|||
164304920|NCT00815659|593490497|FG000|Overall Study|Lost to Follow-up|4|||
164304921|NCT00815659|593490497|FG000|Overall Study|Protocol Violation|1|||
164304922|NCT00719472|593490498|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
164304923|NCT00719472|593490498|FG000|Enrolled in Study|Subject decision to withdraw|8|||
164304924|NCT00719472|593490498|FG000|Enrolled in Study|Various Reasons|17|||
164304925|NCT00719472|593490498|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
164304926|NCT00719472|593490498|FG000|Received Cycle 1 Treatment|Death|5|||
164304927|NCT00719472|593490498|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
164304928|NCT00719472|593490498|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
164304929|NCT00719472|593490498|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
164304930|NCT00719472|593490498|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
164304931|NCT00719472|593490498|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
164304932|NCT00719472|593490498|FG000|Received Cycle 2 Treatment|Death|6|||
164304933|NCT00719472|593490498|FG000|Received Cycle 2 Treatment|Disease progression|3|||
164304934|NCT00719472|593490498|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
164304935|NCT00719472|593490498|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
164304936|NCT00719472|593490498|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
164304937|NCT00719472|593490498|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
164304938|NCT03584789|593490502|FG000|Overall Study|refused EHR permission|19|||
164304939|NCT03584789|593490503|FG001|Overall Study|refused EHR permission|28|||
164304940|NCT03584789|593490504|FG002|Overall Study|refused EHR permission|23|||
164533476|NCT02175004|594325389|FG000|Overall Study|Disease Progression|1|||
164304941|NCT03584789|593490502|FG000|Overall Study|patients tied to a provider who retired|0|||
164304942|NCT03584789|593490503|FG001|Overall Study|patients tied to a provider who retired|0|||
164304943|NCT03584789|593490504|FG002|Overall Study|patients tied to a provider who retired|3|||
164304944|NCT04646044|593490506|FG000|Overall Study|Lost to Follow-up|0|||
164304945|NCT04646044|593490507|FG001|Overall Study|Lost to Follow-up|0|||
164304946|NCT04646044|593490508|FG002|Overall Study|Lost to Follow-up|1|||
164304947|NCT04646044|593490509|FG003|Overall Study|Lost to Follow-up|0|||
164304948|NCT04646044|593490506|FG000|Overall Study|Withdrawal by Subject|0|||
164304949|NCT04646044|593490507|FG001|Overall Study|Withdrawal by Subject|1|||
164304950|NCT04646044|593490508|FG002|Overall Study|Withdrawal by Subject|0|||
164304951|NCT04646044|593490509|FG003|Overall Study|Withdrawal by Subject|0|||
164304952|NCT00742235|593490510|FG000|Overall Study|Lost to Follow-up|0|||
164304953|NCT00742235|593490511|FG001|Overall Study|Lost to Follow-up|31|||
164304954|NCT02346721|593490514|FG000|Overall Study|Withdrew Consent|3|||
164304955|NCT02346721|593490514|FG000|Overall Study|Lack of Efficacy|1|||
164304956|NCT01544335|593490515|FG000|Overall Study|Lost to Follow-up|27|||
164304957|NCT01544335|593490515|FG000|Overall Study|Death|4|||
164304958|NCT01544335|593490515|FG000|Overall Study|Disease progression|3|||
164304959|NCT01544335|593490515|FG000|Overall Study|Baseline Measurements not Available|19|||
164304960|NCT02488915|593490523|FG000|Overall Study|Death|21|||
164304961|NCT02488915|593490523|FG000|Overall Study|Lost to Follow-up|4|||
164304962|NCT02488915|593490523|FG000|Overall Study|Withdrawal by Subject|1|||
164304963|NCT01532986|593490524|FG000|Overall Study|Death|9|||
164304964|NCT01532986|593490525|FG001|Overall Study|Death|9|||
164304965|NCT01532986|593490524|FG000|Overall Study|Withdrawal by Subject|7|||
164304966|NCT01532986|593490525|FG001|Overall Study|Withdrawal by Subject|10|||
164304967|NCT01532986|593490524|FG000|Overall Study|Physician Decision|7|||
164304968|NCT01532986|593490525|FG001|Overall Study|Physician Decision|5|||
164304969|NCT00885170|593490530|FG000|Overall Study|Adverse Event|12|||
164304970|NCT00885170|593490531|FG001|Overall Study|Adverse Event|4|||
164304971|NCT00885170|593490530|FG000|Overall Study|Excessive bone loss|6|||
164304972|NCT00885170|593490531|FG001|Overall Study|Excessive bone loss|3|||
164304973|NCT00885170|593490530|FG000|Overall Study|Lost to Follow-up|2|||
164304974|NCT00885170|593490531|FG001|Overall Study|Lost to Follow-up|1|||
164304975|NCT00885170|593490530|FG000|Overall Study|Physician Decision|2|||
164304976|NCT00885170|593490531|FG001|Overall Study|Physician Decision|1|||
164304977|NCT00885170|593490530|FG000|Overall Study|Protocol Violation|3|||
164304978|NCT00885170|593490531|FG001|Overall Study|Protocol Violation|1|||
164304979|NCT00885170|593490530|FG000|Overall Study|Withdrawal by Subject|13|||
164304980|NCT00885170|593490531|FG001|Overall Study|Withdrawal by Subject|13|||
164304981|NCT03771664|593490532|FG000|Overall Study|Adverse Event|1|||
164304982|NCT03771664|593490533|FG001|Overall Study|Adverse Event|0|||
164304983|NCT03771664|593490532|FG000|Overall Study|Lost to Follow-up|1|||
164304984|NCT03771664|593490533|FG001|Overall Study|Lost to Follow-up|0|||
164304985|NCT03771664|593490532|FG000|Overall Study|Withdrawal by Participant|1|||
164304986|NCT03771664|593490533|FG001|Overall Study|Withdrawal by Participant|4|||
164304987|NCT03771664|593490532|FG000|Overall Study|Randomized but not Treated|0|||
164304988|NCT03771664|593490533|FG001|Overall Study|Randomized but not Treated|1|||
164304989|NCT02120898|593490534|FG000|Overall Study|Withdrawal by Subject|4|||
164304990|NCT02120898|593490535|FG001|Overall Study|Withdrawal by Subject|2|||
164304991|NCT02120898|593490536|FG002|Overall Study|Withdrawal by Subject|2|||
164304992|NCT02120898|593490534|FG000|Overall Study|Non-compliance with study drug|3|||
164304993|NCT02120898|593490535|FG001|Overall Study|Non-compliance with study drug|0|||
164304994|NCT02120898|593490536|FG002|Overall Study|Non-compliance with study drug|0|||
164304995|NCT02120898|593490534|FG000|Overall Study|Adverse Event|1|||
164304996|NCT02120898|593490535|FG001|Overall Study|Adverse Event|2|||
164304997|NCT02120898|593490536|FG002|Overall Study|Adverse Event|1|||
164304998|NCT02120898|593490534|FG000|Overall Study|Protocol Violation|1|||
164304999|NCT02120898|593490535|FG001|Overall Study|Protocol Violation|2|||
164305000|NCT02120898|593490536|FG002|Overall Study|Protocol Violation|0|||
164305001|NCT02120898|593490534|FG000|Overall Study|Lost to Follow-up|0|||
164648308|NCT04333199|594738556|FG001|Evaluated Patients|Lost to Follow-up|1|||
164648309|NCT04333199|594738557|FG002|Evaluated Patients|Lost to Follow-up|2|||
164305002|NCT02120898|593490535|FG001|Overall Study|Lost to Follow-up|0|||
164305003|NCT02120898|593490536|FG002|Overall Study|Lost to Follow-up|1|||
164305004|NCT01046396|593490537|FG000|Overall Study|Withdrawal by Subject|5|||
164305005|NCT02161016|593490541|FG000|Overall Study|withdrawn by IRB|1|||
164305006|NCT03818321|593490542|FG000|Overall Study|Withdrawal by Subject|1|||
164305007|NCT03818321|593490543|FG001|Overall Study|Withdrawal by Subject|2|||
164305008|NCT00275509|593490544|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
164305009|NCT00275509|593490545|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
164305010|NCT00380367|593490548|FG000|Overall Study|Lost to Follow-up|1|||
164305011|NCT00380367|593490548|FG000|Overall Study|Withdrawal by Subject|1|||
164305012|NCT01605799|593490549|FG000|Overall Study|Withdrawal by Subject|2|||
164305013|NCT01605799|593490550|FG001|Overall Study|Withdrawal by Subject|1|||
164305014|NCT00499083|593490552|FG000|Overall Study|Not evaluable|3|||
164305015|NCT00477386|593490556|FG000|Overall Study|Adverse Event|4|||
164305016|NCT00477386|593490557|FG001|Overall Study|Adverse Event|8|||
164533477|NCT02175004|594325390|FG001|Overall Study|Disease Progression|0|||
164533478|NCT02175004|594325389|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
164533479|NCT02175004|594325390|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
164533480|NCT03952806|594325395|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
164533481|NCT03952806|594325396|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
164533482|NCT03952806|594325395|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
164533483|NCT03952806|594325396|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
164533484|NCT03952806|594325395|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
164533485|NCT03952806|594325396|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
164533486|NCT03952806|594325395|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
164533487|NCT03952806|594325396|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
164533488|NCT03952806|594325395|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
164533489|NCT03952806|594325396|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
164305017|NCT00477386|593490556|FG000|Overall Study|Disease progression, relapse|3|||
164305018|NCT00477386|593490557|FG001|Overall Study|Disease progression, relapse|4|||
164305019|NCT00477386|593490556|FG000|Overall Study|Disease progression, refractory|1|||
164305020|NCT00477386|593490557|FG001|Overall Study|Disease progression, refractory|3|||
164305021|NCT00477386|593490556|FG000|Overall Study|Other|1|||
164305022|NCT00477386|593490557|FG001|Overall Study|Other|2|||
164305023|NCT00477386|593490556|FG000|Overall Study|Physician Decision|1|||
164305024|NCT00477386|593490557|FG001|Overall Study|Physician Decision|0|||
164305025|NCT00477386|593490556|FG000|Overall Study|Withdrawal by Subject|1|||
164305026|NCT00477386|593490557|FG001|Overall Study|Withdrawal by Subject|0|||
164305027|NCT01254422|593490558|FG000|Overall Study|Protocol Violation|1|||
164305028|NCT01254422|593490559|FG001|Overall Study|Protocol Violation|0|||
164305029|NCT01254422|593490558|FG000|Overall Study|Adverse Event|1|||
164305030|NCT01254422|593490559|FG001|Overall Study|Adverse Event|0|||
164305031|NCT01254422|593490558|FG000|Overall Study|Serious adverse event|0|||
164305032|NCT01254422|593490559|FG001|Overall Study|Serious adverse event|1|||
164305033|NCT01254422|593490558|FG000|Overall Study|Lost to Follow-up|1|||
164305034|NCT01254422|593490559|FG001|Overall Study|Lost to Follow-up|0|||
164305035|NCT00643162|593490560|FG000|Overall Study|Withdrawal by Subject|1|||
164305036|NCT00643162|593490561|FG001|Overall Study|Withdrawal by Subject|1|||
164305037|NCT01812252|593490568|FG000|Overall Study|Persistent Disease|1|||
164533490|NCT03952806|594325395|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
164533491|NCT03952806|594325396|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
164533492|NCT03952806|594325395|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
164533493|NCT03952806|594325396|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
164533494|NCT03952806|594325395|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
164533495|NCT03952806|594325396|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
164533496|NCT03952806|594325395|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
164533497|NCT03952806|594325396|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
164533498|NCT03952806|594325395|FG000|OLE Phase (48 Weeks)|Other|16|||
164533499|NCT03952806|594325396|FG001|OLE Phase (48 Weeks)|Other|13|||
164533500|NCT01137955|594325397|FG000|Overall Study|Withdrawal by Subject|5|||
164533501|NCT01137955|594325398|FG001|Overall Study|Withdrawal by Subject|4|||
164533502|NCT05341115|594325400|FG000|Overall Study|Adverse Event|1|||
164533503|NCT05341115|594325400|FG000|Overall Study|Lost to Follow-up|1|||
164533504|NCT04263909|594325406|FG000|Overall Study|Physician Decision|1|||
164533505|NCT04263909|594325407|FG001|Overall Study|Physician Decision|0|||
164533506|NCT04263909|594325408|FG002|Overall Study|Physician Decision|0|||
164533507|NCT04263909|594325406|FG000|Overall Study|Adverse Event|3|||
164533508|NCT04263909|594325407|FG001|Overall Study|Adverse Event|0|||
164533509|NCT04263909|594325408|FG002|Overall Study|Adverse Event|0|||
164533510|NCT04263909|594325406|FG000|Overall Study|Protocol Violation|5|||
164533511|NCT04263909|594325407|FG001|Overall Study|Protocol Violation|0|||
164533512|NCT04263909|594325408|FG002|Overall Study|Protocol Violation|0|||
164533513|NCT05630001|594325409|FG000|Overall Study|Adverse Event|1|||
164533514|NCT00068588|594325410|FG000|Overall Study|Adverse Event|0|||
164533515|NCT00068588|594325411|FG001|Overall Study|Adverse Event|0|||
164305038|NCT01812252|593490569|FG001|Overall Study|Persistent Disease|0|||
164533516|NCT00068588|594325412|FG002|Overall Study|Adverse Event|2|||
164533517|NCT00068588|594325410|FG000|Overall Study|Withdrawal by Subject|0|||
164533518|NCT00068588|594325411|FG001|Overall Study|Withdrawal by Subject|0|||
164533519|NCT00068588|594325412|FG002|Overall Study|Withdrawal by Subject|1|||
164533520|NCT00068588|594325410|FG000|Overall Study|Poor KPS|0|||
164305039|NCT01812252|593490568|FG000|Overall Study|Not transplanted|11|||
164533521|NCT00068588|594325411|FG001|Overall Study|Poor KPS|0|||
164305040|NCT01812252|593490569|FG001|Overall Study|Not transplanted|11|||
164305041|NCT01812252|593490568|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
164305042|NCT01812252|593490569|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
164305043|NCT01812252|593490568|FG000|Overall Study|Withdrawal by Subject|1|||
164305044|NCT01812252|593490569|FG001|Overall Study|Withdrawal by Subject|1|||
164305045|NCT01812252|593490568|FG000|Overall Study|Screen Failure|1|||
164533522|NCT00068588|594325412|FG002|Overall Study|Poor KPS|1|||
164533523|NCT05386680|594325413|FG000|Overall Study|Guardian decision|2|||
164533524|NCT03946670|594325414|FG000|Overall Study|Progressive Disease|34|||
164533525|NCT03946670|594325415|FG001|Overall Study|Progressive Disease|27|||
164533526|NCT03946670|594325414|FG000|Overall Study|Adverse Event|7|||
164533527|NCT03946670|594325415|FG001|Overall Study|Adverse Event|10|||
164533528|NCT03946670|594325414|FG000|Overall Study|Physician Decision|6|||
164533529|NCT03946670|594325415|FG001|Overall Study|Physician Decision|5|||
164533530|NCT03946670|594325414|FG000|Overall Study|Death|5|||
164533531|NCT03946670|594325415|FG001|Overall Study|Death|8|||
164533532|NCT03946670|594325414|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
164533533|NCT03946670|594325415|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
164533534|NCT03946670|594325414|FG000|Overall Study|Subject Decision|4|||
164533535|NCT03946670|594325415|FG001|Overall Study|Subject Decision|5|||
164533536|NCT03946670|594325414|FG000|Overall Study|Study Terminated By Sponsor|2|||
164533537|NCT03946670|594325415|FG001|Overall Study|Study Terminated By Sponsor|0|||
164533538|NCT03946670|594325414|FG000|Overall Study|New Therapy For Study Indication|1|||
164533539|NCT03946670|594325415|FG001|Overall Study|New Therapy For Study Indication|0|||
164533540|NCT03946670|594325414|FG000|Overall Study|Not Treated|1|||
164305046|NCT01812252|593490569|FG001|Overall Study|Screen Failure|0|||
164305047|NCT01656408|593490570|FG000|Overall Study|Adverse Event|0|||
164305048|NCT01656408|593490571|FG001|Overall Study|Adverse Event|0|||
164305049|NCT01656408|593490572|FG002|Overall Study|Adverse Event|1|||
164305050|NCT01656408|593490573|FG003|Overall Study|Adverse Event|0|||
164305051|NCT01656408|593490574|FG004|Overall Study|Adverse Event|0|||
164305052|NCT01656408|593490575|FG005|Overall Study|Adverse Event|1|||
164305053|NCT01656408|593490576|FG006|Overall Study|Adverse Event|1|||
164305054|NCT01656408|593490577|FG007|Overall Study|Adverse Event|0|||
164305055|NCT01656408|593490578|FG008|Overall Study|Adverse Event|1|||
164305056|NCT01656408|593490579|FG009|Overall Study|Adverse Event|0|||
164305057|NCT01656408|593490570|FG000|Overall Study|Physician Decision|1|||
164305058|NCT01656408|593490571|FG001|Overall Study|Physician Decision|0|||
164305059|NCT01656408|593490572|FG002|Overall Study|Physician Decision|1|||
164305060|NCT01656408|593490573|FG003|Overall Study|Physician Decision|0|||
164305061|NCT01656408|593490574|FG004|Overall Study|Physician Decision|1|||
164305062|NCT01656408|593490575|FG005|Overall Study|Physician Decision|1|||
164305063|NCT01656408|593490576|FG006|Overall Study|Physician Decision|0|||
164533541|NCT03946670|594325415|FG001|Overall Study|Not Treated|1|||
164533542|NCT02027701|594325419|FG000|Overall Study|Adverse Event|3|||
164533543|NCT02027701|594325419|FG000|Overall Study|Lack of Efficacy|8|||
164533544|NCT02027701|594325419|FG000|Overall Study|Physician Decision|2|||
164533545|NCT02027701|594325419|FG000|Overall Study|Withdrawal by Subject|3|||
164533546|NCT02875977|594325420|FG000|Overall Study|Lost to Follow-up|42|||
164533547|NCT02875977|594325421|FG001|Overall Study|Lost to Follow-up|29|||
164533548|NCT00820027|594325422|FG000|Overall Study|Adverse Event|15|||
164533549|NCT00820027|594325423|FG001|Overall Study|Adverse Event|8|||
164533550|NCT00820027|594325424|FG002|Overall Study|Adverse Event|10|||
164533551|NCT00820027|594325425|FG003|Overall Study|Adverse Event|5|||
164533552|NCT00820027|594325422|FG000|Overall Study|Lack of Efficacy|2|||
164533553|NCT00820027|594325423|FG001|Overall Study|Lack of Efficacy|1|||
164533554|NCT00820027|594325424|FG002|Overall Study|Lack of Efficacy|2|||
164533555|NCT00820027|594325425|FG003|Overall Study|Lack of Efficacy|2|||
164533556|NCT00820027|594325422|FG000|Overall Study|Physician Decision|0|||
164533557|NCT00820027|594325423|FG001|Overall Study|Physician Decision|1|||
164533558|NCT00820027|594325424|FG002|Overall Study|Physician Decision|1|||
164533559|NCT00820027|594325425|FG003|Overall Study|Physician Decision|0|||
164305064|NCT01656408|593490577|FG007|Overall Study|Physician Decision|1|||
164305065|NCT01656408|593490578|FG008|Overall Study|Physician Decision|1|||
164533560|NCT00820027|594325422|FG000|Overall Study|Protocol Violation|3|||
164533561|NCT00820027|594325423|FG001|Overall Study|Protocol Violation|0|||
164533562|NCT00820027|594325424|FG002|Overall Study|Protocol Violation|4|||
164305066|NCT01656408|593490579|FG009|Overall Study|Physician Decision|3|||
164305067|NCT04634253|593490582|FG000|Overall Study|Adverse Event|1|||
164305068|NCT04634253|593490583|FG001|Overall Study|Adverse Event|1|||
164305069|NCT04634253|593490584|FG002|Overall Study|Adverse Event|0|||
164305070|NCT04634253|593490582|FG000|Overall Study|Physician Decision|0|||
164305071|NCT04634253|593490583|FG001|Overall Study|Physician Decision|1|||
164305072|NCT04634253|593490584|FG002|Overall Study|Physician Decision|0|||
164305073|NCT04634253|593490582|FG000|Overall Study|Withdrawal by Subject|1|||
164305074|NCT04634253|593490583|FG001|Overall Study|Withdrawal by Subject|0|||
164533563|NCT00820027|594325425|FG003|Overall Study|Protocol Violation|0|||
164305075|NCT04634253|593490584|FG002|Overall Study|Withdrawal by Subject|3|||
164305076|NCT01457703|593490585|FG000|Overall Study|Screen Failure|5|||
164305077|NCT01457703|593490586|FG001|Overall Study|Screen Failure|7|||
164305078|NCT01457703|593490585|FG000|Overall Study|Withdrawal by Subject|1|||
164305079|NCT01457703|593490586|FG001|Overall Study|Withdrawal by Subject|4|||
164533564|NCT00820027|594325422|FG000|Overall Study|Withdrawal by Subject|6|||
164533565|NCT00820027|594325423|FG001|Overall Study|Withdrawal by Subject|4|||
164533566|NCT00820027|594325424|FG002|Overall Study|Withdrawal by Subject|4|||
164305080|NCT01658436|593490587|FG000|Overall Study|Adverse Event|6|||
164305081|NCT01658436|593490588|FG001|Overall Study|Adverse Event|5|||
164305082|NCT01658436|593490587|FG000|Overall Study|Physician Decision|1|||
164305083|NCT01658436|593490588|FG001|Overall Study|Physician Decision|0|||
164305084|NCT01658436|593490587|FG000|Overall Study|Progressive disease|12|||
164305085|NCT01658436|593490588|FG001|Overall Study|Progressive disease|4|||
164533567|NCT00820027|594325425|FG003|Overall Study|Withdrawal by Subject|6|||
164533568|NCT02604433|594325426|FG000|Overall Study|Withdrawal by Subject|37|||
164305086|NCT01658436|593490587|FG000|Overall Study|Study terminated by sponsor|0|||
164305087|NCT01658436|593490588|FG001|Overall Study|Study terminated by sponsor|1|||
164305088|NCT01658436|593490587|FG000|Overall Study|Subject/guardian decision|0|||
164305089|NCT01658436|593490588|FG001|Overall Study|Subject/guardian decision|1|||
164305090|NCT01658436|593490587|FG000|Overall Study|Death|1|||
164533569|NCT02604433|594325427|FG001|Overall Study|Withdrawal by Subject|16|||
164533570|NCT02604433|594325426|FG000|Overall Study|Adverse Event|4|||
164533571|NCT02604433|594325427|FG001|Overall Study|Adverse Event|0|||
164533572|NCT02604433|594325426|FG000|Overall Study|Other reasons|3|||
164533573|NCT02604433|594325427|FG001|Overall Study|Other reasons|5|||
164533574|NCT02604433|594325426|FG000|Overall Study|Death|4|||
164533575|NCT02604433|594325427|FG001|Overall Study|Death|1|||
164533576|NCT02604433|594325426|FG000|Overall Study|Transition to Rollover Protocol|169|||
164533577|NCT02604433|594325427|FG001|Overall Study|Transition to Rollover Protocol|82|||
164533578|NCT02604433|594325426|FG000|Overall Study|Physician Decision|1|||
164533579|NCT02604433|594325427|FG001|Overall Study|Physician Decision|1|||
164533580|NCT02604433|594325426|FG000|Overall Study|Lack of Efficacy|0|||
164533581|NCT02604433|594325427|FG001|Overall Study|Lack of Efficacy|1|||
164533582|NCT03285178|594325428|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
164533583|NCT03285178|594325429|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
164533584|NCT03285178|594325430|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
164305091|NCT01658436|593490588|FG001|Overall Study|Death|0|||
164305092|NCT00926237|593490589|FG000|Overall Study|Withdrawal by Subject|2|||
164305093|NCT00926237|593490590|FG001|Overall Study|Withdrawal by Subject|1|||
164305094|NCT03133793|593490591|FG000|Overall Study|Withdrawal by Subject|0|||
164305095|NCT03133793|593490592|FG001|Overall Study|Withdrawal by Subject|4|||
164305096|NCT03133793|593490593|FG002|Overall Study|Withdrawal by Subject|2|||
164305097|NCT03133793|593490594|FG003|Overall Study|Withdrawal by Subject|4|||
164305098|NCT03133793|593490591|FG000|Overall Study|Lost to Follow-up|1|||
164305099|NCT03133793|593490592|FG001|Overall Study|Lost to Follow-up|0|||
164305100|NCT03133793|593490593|FG002|Overall Study|Lost to Follow-up|2|||
164305101|NCT03133793|593490594|FG003|Overall Study|Lost to Follow-up|0|||
164305102|NCT03133793|593490591|FG000|Overall Study|Death|0|||
164305103|NCT03133793|593490592|FG001|Overall Study|Death|0|||
164305104|NCT03133793|593490593|FG002|Overall Study|Death|0|||
164533585|NCT03285178|594325431|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
164533586|NCT03285178|594325432|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
164533587|NCT03285178|594325433|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
164533588|NCT03285178|594325434|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
164533589|NCT03285178|594325428|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
164533590|NCT03285178|594325429|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
164533591|NCT03285178|594325430|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
164533592|NCT03285178|594325431|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
164533593|NCT03285178|594325432|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
164533594|NCT03285178|594325433|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
164533595|NCT03285178|594325434|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
164588997|NCT02078713|594521336|FG001|Overall Study|Lost to Follow-up|55|||
164305105|NCT03133793|593490594|FG003|Overall Study|Death|1|||
164305106|NCT03486834|593490595|FG000|Overall Study|Withdrawal by Subject|46|||
164305107|NCT03486834|593490596|FG001|Overall Study|Withdrawal by Subject|46|||
164305108|NCT03486834|593490597|FG002|Overall Study|Withdrawal by Subject|52|||
164305109|NCT03486834|593490595|FG000|Overall Study|Adverse Event|8|||
164305110|NCT03486834|593490596|FG001|Overall Study|Adverse Event|7|||
164305111|NCT03486834|593490597|FG002|Overall Study|Adverse Event|0|||
164305112|NCT03486834|593490595|FG000|Overall Study|Lost to Follow-up|41|||
164305113|NCT03486834|593490596|FG001|Overall Study|Lost to Follow-up|24|||
164305114|NCT03486834|593490597|FG002|Overall Study|Lost to Follow-up|39|||
164305115|NCT03486834|593490595|FG000|Overall Study|Non-compliance with Study Drug|2|||
164305116|NCT03486834|593490596|FG001|Overall Study|Non-compliance with Study Drug|2|||
164305117|NCT03486834|593490597|FG002|Overall Study|Non-compliance with Study Drug|0|||
164305118|NCT03486834|593490595|FG000|Overall Study|Physician Decision|5|||
164305119|NCT03486834|593490596|FG001|Overall Study|Physician Decision|2|||
164305120|NCT03486834|593490597|FG002|Overall Study|Physician Decision|3|||
164305121|NCT03486834|593490595|FG000|Overall Study|Pregnancy|10|||
164305122|NCT03486834|593490596|FG001|Overall Study|Pregnancy|12|||
164305123|NCT03486834|593490597|FG002|Overall Study|Pregnancy|12|||
164305124|NCT03486834|593490595|FG000|Overall Study|Protocol Deviation|2|||
164305125|NCT03486834|593490596|FG001|Overall Study|Protocol Deviation|3|||
164305126|NCT03486834|593490597|FG002|Overall Study|Protocol Deviation|3|||
164305127|NCT03486834|593490595|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
164533596|NCT03285178|594325428|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
164533597|NCT03285178|594325429|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
164533598|NCT03285178|594325430|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
164533599|NCT03285178|594325431|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
164533600|NCT03285178|594325432|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
164533601|NCT03285178|594325433|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
164305128|NCT03486834|593490596|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
164305129|NCT03486834|593490597|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
164305130|NCT03486834|593490595|FG000|Overall Study|Randomized but not treated|4|||
164305131|NCT03486834|593490596|FG001|Overall Study|Randomized but not treated|4|||
164305132|NCT03486834|593490597|FG002|Overall Study|Randomized but not treated|1|||
164305133|NCT00888940|593490598|FG000|Overall Study|Adverse Event|12|||
164305134|NCT00888940|593490599|FG001|Overall Study|Adverse Event|3|||
164305135|NCT00888940|593490598|FG000|Overall Study|Lost to Follow-up|5|||
164305136|NCT00888940|593490599|FG001|Overall Study|Lost to Follow-up|5|||
164305137|NCT00888940|593490598|FG000|Overall Study|Randomized Not Treated|11|||
164305138|NCT00888940|593490599|FG001|Overall Study|Randomized Not Treated|13|||
164305139|NCT00432172|593490600|FG000|Overall Study|Physician Decision|0|||
164305140|NCT00432172|593490601|FG001|Overall Study|Physician Decision|0|||
164305141|NCT00432172|593490602|FG002|Overall Study|Physician Decision|2|||
164305142|NCT00432172|593490603|FG003|Overall Study|Physician Decision|0|||
164305143|NCT00432172|593490600|FG000|Overall Study|Adverse Event|4|||
164305144|NCT00432172|593490601|FG001|Overall Study|Adverse Event|2|||
164305145|NCT00432172|593490602|FG002|Overall Study|Adverse Event|4|||
164305146|NCT00432172|593490603|FG003|Overall Study|Adverse Event|3|||
164305147|NCT00432172|593490600|FG000|Overall Study|Disease progression|0|||
164305148|NCT00432172|593490601|FG001|Overall Study|Disease progression|2|||
164305149|NCT00432172|593490602|FG002|Overall Study|Disease progression|5|||
164305150|NCT00432172|593490603|FG003|Overall Study|Disease progression|1|||
164305151|NCT00432172|593490600|FG000|Overall Study|Withdrawal by Subject|0|||
164305152|NCT00432172|593490601|FG001|Overall Study|Withdrawal by Subject|1|||
164305153|NCT00432172|593490602|FG002|Overall Study|Withdrawal by Subject|0|||
164305154|NCT00432172|593490603|FG003|Overall Study|Withdrawal by Subject|2|||
164305155|NCT00432172|593490600|FG000|Overall Study|No treatment received|2|||
164305156|NCT00432172|593490601|FG001|Overall Study|No treatment received|2|||
164533602|NCT03285178|594325434|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
164533603|NCT03285178|594325428|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
164533604|NCT03285178|594325429|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
164533605|NCT03285178|594325430|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
164533606|NCT03285178|594325431|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
164533607|NCT03285178|594325432|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
164533608|NCT03285178|594325433|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
164533609|NCT03285178|594325434|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
164533610|NCT03285178|594325428|FG000|Single-Blind Run-In Period|Physician Decision|2|||
164533611|NCT03285178|594325429|FG001|Single-Blind Run-In Period|Physician Decision|0|||
164533612|NCT03285178|594325430|FG002|Single-Blind Run-In Period|Physician Decision|0|||
164533613|NCT03285178|594325431|FG003|Single-Blind Run-In Period|Physician Decision|0|||
164533614|NCT03285178|594325432|FG004|Single-Blind Run-In Period|Physician Decision|0|||
164533615|NCT03285178|594325433|FG005|Single-Blind Run-In Period|Physician Decision|0|||
164533616|NCT03285178|594325434|FG006|Single-Blind Run-In Period|Physician Decision|0|||
164533617|NCT03285178|594325428|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
164533618|NCT03285178|594325429|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
164533619|NCT03285178|594325430|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
164533620|NCT03285178|594325431|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
164533621|NCT03285178|594325432|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
164533622|NCT03285178|594325433|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
164588998|NCT02078713|594521337|FG002|Overall Study|Lost to Follow-up|0|||
164305157|NCT00432172|593490602|FG002|Overall Study|No treatment received|0|||
164305158|NCT00432172|593490603|FG003|Overall Study|No treatment received|1|||
164305159|NCT00515619|593490604|FG000|Overall Study|Adverse Event|34|||
164305160|NCT00515619|593490604|FG000|Overall Study|Lack of Efficacy|92|||
164305161|NCT00515619|593490604|FG000|Overall Study|Withdrawal by Subject|66|||
164305162|NCT00515619|593490604|FG000|Overall Study|Protocol Violation|3|||
164305163|NCT00515619|593490604|FG000|Overall Study|Lost to Follow-up|4|||
164305164|NCT00515619|593490604|FG000|Overall Study|Unsatisfactory compliance|6|||
164533623|NCT03285178|594325434|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
164305165|NCT00515619|593490604|FG000|Overall Study|Other: Site discontinuing trials|2|||
164305166|NCT00515619|593490604|FG000|Overall Study|Other: Subject cannot attend visits|2|||
164305167|NCT00515619|593490604|FG000|Overall Study|Other: Subject required surgery|1|||
164305168|NCT00515619|593490604|FG000|Overall Study|Other: Subject moved to another country|1|||
164305169|NCT00515619|593490604|FG000|Overall Study|Other: Investigator decision|1|||
164305170|NCT00515619|593490604|FG000|Overall Study|Other: Subject became pregnant|1|||
164305171|NCT00515619|593490604|FG000|Overall Study|Other: Request from sponsor|1|||
164305172|NCT00515619|593490604|FG000|Overall Study|Other: Drug available on license|1|||
164305173|NCT00515619|593490604|FG000|Overall Study|Other: Subject interested in other AED|1|||
164305174|NCT02379091|593490605|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
164305175|NCT02379091|593490606|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
164305176|NCT02379091|593490607|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
164305177|NCT02379091|593490608|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
164305178|NCT02379091|593490605|FG000|Overall Study|Principal Investigator Discretion|0|||
164305179|NCT02379091|593490606|FG001|Overall Study|Principal Investigator Discretion|1|||
164305180|NCT02379091|593490607|FG002|Overall Study|Principal Investigator Discretion|0|||
164305181|NCT02379091|593490608|FG003|Overall Study|Principal Investigator Discretion|0|||
164305182|NCT02379091|593490605|FG000|Overall Study|Lost to Follow-up|0|||
164305183|NCT02379091|593490606|FG001|Overall Study|Lost to Follow-up|0|||
164305184|NCT02379091|593490607|FG002|Overall Study|Lost to Follow-up|0|||
164305185|NCT02379091|593490608|FG003|Overall Study|Lost to Follow-up|1|||
164305186|NCT02379091|593490605|FG000|Overall Study|Voluntary Withdrawal|2|||
164305187|NCT02379091|593490606|FG001|Overall Study|Voluntary Withdrawal|5|||
164305188|NCT02379091|593490607|FG002|Overall Study|Voluntary Withdrawal|2|||
164305189|NCT02379091|593490608|FG003|Overall Study|Voluntary Withdrawal|4|||
164305190|NCT02379091|593490605|FG000|Overall Study|Study Termination|7|||
164305191|NCT02379091|593490606|FG001|Overall Study|Study Termination|2|||
164305192|NCT02379091|593490607|FG002|Overall Study|Study Termination|5|||
164305193|NCT02379091|593490608|FG003|Overall Study|Study Termination|8|||
164305194|NCT02379091|593490605|FG000|Overall Study|Lack of Efficacy|3|||
164305195|NCT02379091|593490606|FG001|Overall Study|Lack of Efficacy|0|||
164305196|NCT02379091|593490607|FG002|Overall Study|Lack of Efficacy|0|||
164305197|NCT02379091|593490608|FG003|Overall Study|Lack of Efficacy|0|||
164305198|NCT03326713|593490610|FG000|Overall Study|Death|2|||
164533624|NCT03285178|594325428|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164533625|NCT03285178|594325429|FG001|Double-Blind Treatment Period|Adverse Event|0|||
164533626|NCT03285178|594325430|FG002|Double-Blind Treatment Period|Adverse Event|0|||
164533627|NCT03285178|594325431|FG003|Double-Blind Treatment Period|Adverse Event|0|||
164533628|NCT03285178|594325432|FG004|Double-Blind Treatment Period|Adverse Event|0|||
164533629|NCT03285178|594325433|FG005|Double-Blind Treatment Period|Adverse Event|0|||
164533630|NCT03285178|594325434|FG006|Double-Blind Treatment Period|Adverse Event|2|||
164533631|NCT03285178|594325428|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
164533632|NCT03285178|594325429|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
164533633|NCT03285178|594325430|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
164533634|NCT03285178|594325431|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
164533635|NCT03285178|594325432|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
164533636|NCT03285178|594325433|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
164533637|NCT03285178|594325434|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
164533638|NCT03285178|594325428|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164533639|NCT03285178|594325429|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164533640|NCT03285178|594325430|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
164533641|NCT03285178|594325431|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
164533642|NCT03285178|594325432|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164533643|NCT03285178|594325433|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
164533644|NCT03285178|594325434|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
164533645|NCT03285178|594325428|FG000|Double-Blind Treatment Period|COVID-19|0|||
164533646|NCT03285178|594325429|FG001|Double-Blind Treatment Period|COVID-19|0|||
164533647|NCT03285178|594325430|FG002|Double-Blind Treatment Period|COVID-19|1|||
164533648|NCT03285178|594325431|FG003|Double-Blind Treatment Period|COVID-19|0|||
164533649|NCT03285178|594325432|FG004|Double-Blind Treatment Period|COVID-19|0|||
164533650|NCT03285178|594325433|FG005|Double-Blind Treatment Period|COVID-19|0|||
164533651|NCT03285178|594325434|FG006|Double-Blind Treatment Period|COVID-19|0|||
164533652|NCT01128894|594325435|FG000|Overall Study|Adverse Event|31|||
164305199|NCT03326713|593490611|FG001|Overall Study|Death|1|||
164305200|NCT03326713|593490612|FG002|Overall Study|Death|0|||
164305201|NCT03326713|593490610|FG000|Overall Study|Lost to Follow-up|20|||
164305202|NCT03326713|593490611|FG001|Overall Study|Lost to Follow-up|21|||
164305203|NCT03326713|593490612|FG002|Overall Study|Lost to Follow-up|33|||
164305204|NCT03326713|593490610|FG000|Overall Study|Withdrawal by Subject|1|||
164305205|NCT03326713|593490611|FG001|Overall Study|Withdrawal by Subject|2|||
164305206|NCT03326713|593490612|FG002|Overall Study|Withdrawal by Subject|11|||
164305207|NCT03326713|593490610|FG000|Overall Study|Found Ineligible|11|||
164533653|NCT01128894|594325436|FG001|Overall Study|Adverse Event|41|||
164533654|NCT01128894|594325435|FG000|Overall Study|Protocol Violation|2|||
164533655|NCT01128894|594325436|FG001|Overall Study|Protocol Violation|1|||
164533656|NCT01128894|594325435|FG000|Overall Study|Noncompliance|4|||
164533657|NCT01128894|594325436|FG001|Overall Study|Noncompliance|5|||
164533658|NCT01128894|594325435|FG000|Overall Study|Lost to Follow-up|8|||
164533659|NCT01128894|594325436|FG001|Overall Study|Lost to Follow-up|8|||
164533660|NCT01128894|594325435|FG000|Overall Study|Withdrawal by Subject|10|||
164533661|NCT01128894|594325436|FG001|Overall Study|Withdrawal by Subject|12|||
164533662|NCT01128894|594325435|FG000|Overall Study|Physician Decision|2|||
164533663|NCT01128894|594325436|FG001|Overall Study|Physician Decision|1|||
164533664|NCT01128894|594325435|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
164533665|NCT01128894|594325436|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
164533666|NCT03437278|594325437|FG000|Overall Study|Adverse Event|0|||
164533667|NCT03437278|594325438|FG001|Overall Study|Adverse Event|0|||
164533668|NCT03437278|594325439|FG002|Overall Study|Adverse Event|1|||
164305208|NCT03326713|593490611|FG001|Overall Study|Found Ineligible|11|||
164533669|NCT03437278|594325437|FG000|Overall Study|Progressive disease|1|||
164533670|NCT03437278|594325438|FG001|Overall Study|Progressive disease|0|||
164533671|NCT03437278|594325439|FG002|Overall Study|Progressive disease|0|||
164533672|NCT03437278|594325437|FG000|Overall Study|Physician Decision|1|||
164533673|NCT03437278|594325438|FG001|Overall Study|Physician Decision|0|||
164533674|NCT03437278|594325439|FG002|Overall Study|Physician Decision|1|||
164305209|NCT03326713|593490612|FG002|Overall Study|Found Ineligible|8|||
164305210|NCT00771758|593490613|FG000|Overall Study|Adverse Event|2|||
164305211|NCT00771758|593490614|FG001|Overall Study|Adverse Event|8|||
164305212|NCT00771758|593490615|FG002|Overall Study|Adverse Event|1|||
164305213|NCT00771758|593490613|FG000|Overall Study|Lack of Efficacy|0|||
164305214|NCT00771758|593490614|FG001|Overall Study|Lack of Efficacy|2|||
164305215|NCT00771758|593490615|FG002|Overall Study|Lack of Efficacy|1|||
164305216|NCT00771758|593490613|FG000|Overall Study|Lost to Follow-up|1|||
164305217|NCT00771758|593490614|FG001|Overall Study|Lost to Follow-up|0|||
164305218|NCT00771758|593490615|FG002|Overall Study|Lost to Follow-up|0|||
164305219|NCT00771758|593490613|FG000|Overall Study|Protocol Violation|1|||
164305220|NCT00771758|593490614|FG001|Overall Study|Protocol Violation|0|||
164305221|NCT00771758|593490615|FG002|Overall Study|Protocol Violation|0|||
164305222|NCT00771758|593490613|FG000|Overall Study|Withdrawal by Subject|1|||
164305223|NCT00771758|593490614|FG001|Overall Study|Withdrawal by Subject|0|||
164305224|NCT00771758|593490615|FG002|Overall Study|Withdrawal by Subject|0|||
164305225|NCT00771758|593490613|FG000|Overall Study|Other|3|||
164305226|NCT00771758|593490614|FG001|Overall Study|Other|2|||
164533675|NCT01128738|594325440|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
164533676|NCT01128738|594325441|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
164533677|NCT01128738|594325440|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
164533678|NCT01128738|594325441|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
164533679|NCT01128738|594325440|FG000|Second TP|Lost to Follow-up|0|||
164533680|NCT01128738|594325441|FG001|Second TP|Lost to Follow-up|1|||
164533681|NCT01128738|594325440|FG000|Second TP|Withdrawal by Subject|0|||
164533682|NCT01128738|594325441|FG001|Second TP|Withdrawal by Subject|2|||
164533683|NCT00973362|594325442|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
164305227|NCT00771758|593490615|FG002|Overall Study|Other|0|||
164305228|NCT03067077|593490616|FG000|Overall Study|Did not receive surgery|4|||
164305229|NCT03067077|593490617|FG001|Overall Study|Did not receive surgery|5|||
164305230|NCT03067077|593490616|FG000|Overall Study|Lost to Follow-up|3|||
164305231|NCT03067077|593490617|FG001|Overall Study|Lost to Follow-up|2|||
164305232|NCT00935584|593490620|FG000|Overall Study|Withdrawal by Subject|9|||
164533684|NCT00973362|594325443|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
164533685|NCT00973362|594325442|FG000|Baseline Evaluation|No colposcopy visit|62|||
164533686|NCT00973362|594325443|FG001|Baseline Evaluation|No colposcopy visit|0|||
164533687|NCT00973362|594325442|FG000|Baseline Evaluation|Inevaluable|686|||
164533688|NCT00973362|594325443|FG001|Baseline Evaluation|Inevaluable|223|||
164533689|NCT00973362|594325442|FG000|3-Year Follow-up|Lost to Follow-up|17|||
164533690|NCT00973362|594325443|FG001|3-Year Follow-up|Lost to Follow-up|0|||
164533691|NCT05116046|594325446|FG000|Overall Study|Withdrawal by parent/guardian|2|||
164533692|NCT05116046|594325447|FG001|Overall Study|Withdrawal by parent/guardian|1|||
164533693|NCT05116046|594325448|FG002|Overall Study|Withdrawal by parent/guardian|1|||
164533694|NCT05116046|594325446|FG000|Overall Study|Study terminated by sponsor|14|||
164533695|NCT05116046|594325447|FG001|Overall Study|Study terminated by sponsor|16|||
164533696|NCT05116046|594325448|FG002|Overall Study|Study terminated by sponsor|1|||
164533697|NCT04328727|594325450|FG000|Overall Study|Guardian Decision|1|||
164533698|NCT04328727|594325450|FG000|Overall Study|Participant decision|4|||
164533699|NCT04328727|594325450|FG000|Overall Study|Death|3|||
164533700|NCT02604212|594325455|FG000|Overall Study|Study Terminated by Sponsor|2|||
164305233|NCT00935584|593490621|FG001|Overall Study|Withdrawal by Subject|0|||
164533701|NCT02604212|594325456|FG001|Overall Study|Study Terminated by Sponsor|1|||
164533702|NCT02604212|594325457|FG002|Overall Study|Study Terminated by Sponsor|3|||
164305234|NCT00935584|593490620|FG000|Overall Study|Death|3|||
164305235|NCT00935584|593490621|FG001|Overall Study|Death|0|||
164305236|NCT00935584|593490620|FG000|Overall Study|Lost to Follow-up|8|||
164305237|NCT00935584|593490621|FG001|Overall Study|Lost to Follow-up|0|||
164533703|NCT02604212|594325458|FG003|Overall Study|Study Terminated by Sponsor|3|||
164305238|NCT00935584|593490620|FG000|Overall Study|No show|9|||
164533704|NCT02604212|594325455|FG000|Overall Study|Withdrawal by Subject|0|||
164533705|NCT02604212|594325456|FG001|Overall Study|Withdrawal by Subject|0|||
164533706|NCT02604212|594325457|FG002|Overall Study|Withdrawal by Subject|1|||
164533707|NCT02604212|594325458|FG003|Overall Study|Withdrawal by Subject|0|||
164533708|NCT00343252|594325462|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
164533709|NCT00343252|594325463|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
164533710|NCT00343252|594325462|FG000|6 Months (All Treated Participants)|Death|0|||
164533711|NCT00343252|594325463|FG001|6 Months (All Treated Participants)|Death|2|||
164533712|NCT00343252|594325462|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
164533713|NCT00343252|594325463|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
164533714|NCT00343252|594325462|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
164533715|NCT00343252|594325463|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
164533716|NCT00343252|594325462|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
164533717|NCT00343252|594325463|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
164533718|NCT00343252|594325462|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
164533719|NCT00343252|594325463|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
164533720|NCT00343252|594325462|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
164533721|NCT00343252|594325463|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
164533722|NCT00343252|594325462|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
164533723|NCT00343252|594325463|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
164533724|NCT00343252|594325462|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
164533725|NCT00343252|594325463|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
164533726|NCT00343252|594325462|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
164533727|NCT00343252|594325463|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
164533728|NCT00343252|594325462|FG000|12 Months (All Treated Participants)|Death|3|||
164533729|NCT00343252|594325463|FG001|12 Months (All Treated Participants)|Death|3|||
164533730|NCT00343252|594325462|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
164305239|NCT00935584|593490621|FG001|Overall Study|No show|0|||
164305240|NCT00935584|593490620|FG000|Overall Study|Relocated|3|||
164305241|NCT00935584|593490621|FG001|Overall Study|Relocated|0|||
164305242|NCT00935584|593490620|FG000|Overall Study|Patient changed provider|3|||
164305243|NCT00935584|593490621|FG001|Overall Study|Patient changed provider|0|||
164305244|NCT00935584|593490620|FG000|Overall Study|Provider dropped out of study|14|||
164305245|NCT00935584|593490621|FG001|Overall Study|Provider dropped out of study|4|||
164305246|NCT00687193|593490622|FG000|Overall Study|Adverse Event|0|||
164305247|NCT00687193|593490623|FG001|Overall Study|Adverse Event|1|||
164305248|NCT00687193|593490624|FG002|Overall Study|Adverse Event|2|||
164305249|NCT00687193|593490625|FG003|Overall Study|Adverse Event|3|||
164305250|NCT00687193|593490626|FG004|Overall Study|Adverse Event|0|||
164305251|NCT00687193|593490627|FG005|Overall Study|Adverse Event|2|||
164305252|NCT00687193|593490622|FG000|Overall Study|Lack of Efficacy|1|||
164305253|NCT00687193|593490623|FG001|Overall Study|Lack of Efficacy|1|||
164533731|NCT00343252|594325463|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
164533732|NCT00343252|594325462|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
164533733|NCT00343252|594325463|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
164305254|NCT00687193|593490624|FG002|Overall Study|Lack of Efficacy|0|||
164305255|NCT00687193|593490625|FG003|Overall Study|Lack of Efficacy|0|||
164305256|NCT00687193|593490626|FG004|Overall Study|Lack of Efficacy|0|||
164305257|NCT00687193|593490627|FG005|Overall Study|Lack of Efficacy|2|||
164305258|NCT00687193|593490622|FG000|Overall Study|Protocol Violation|1|||
164305259|NCT00687193|593490623|FG001|Overall Study|Protocol Violation|2|||
164305260|NCT00687193|593490624|FG002|Overall Study|Protocol Violation|0|||
164305261|NCT00687193|593490625|FG003|Overall Study|Protocol Violation|1|||
164305262|NCT00687193|593490626|FG004|Overall Study|Protocol Violation|2|||
164305263|NCT00687193|593490627|FG005|Overall Study|Protocol Violation|0|||
164305264|NCT02514083|593490632|FG000|Overall Study|Adverse Event|1|||
164305265|NCT02017405|593490633|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
164305266|NCT02017405|593490634|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
164305267|NCT02017405|593490635|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
164305268|NCT02017405|593490636|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
164305269|NCT02017405|593490637|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
164305270|NCT02017405|593490638|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
164305271|NCT02017405|593490633|FG000|Open-label Phase|Adverse Event|1|||
164305272|NCT02017405|593490634|FG001|Open-label Phase|Adverse Event|1|||
164305273|NCT02017405|593490635|FG002|Open-label Phase|Adverse Event|0|||
164305274|NCT02017405|593490636|FG003|Open-label Phase|Adverse Event|0|||
164305275|NCT02017405|593490637|FG004|Open-label Phase|Adverse Event|0|||
164588999|NCT02078713|594521338|FG003|Overall Study|Lost to Follow-up|0|||
164305276|NCT02017405|593490638|FG005|Open-label Phase|Adverse Event|0|||
164305277|NCT02273596|593491684|FG000|24-Week Treatment Period|Adverse Event|3|||
164305278|NCT02273596|593491684|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
164305279|NCT02273596|593491684|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
164533734|NCT00343252|594325462|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
164533735|NCT00343252|594325463|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
164533736|NCT00343252|594325462|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
164533737|NCT00343252|594325463|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
164533738|NCT00343252|594325462|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
164533739|NCT00343252|594325463|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
164533740|NCT00343252|594325462|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
164533741|NCT00343252|594325463|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
164533742|NCT00343252|594325462|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
164533743|NCT00343252|594325463|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
164305280|NCT02273596|593491684|FG000|24-Week Treatment Period|Physician Decision|1|||
164305281|NCT02273596|593491684|FG000|24-Week Treatment Period|Protocol Deviation|1|||
164305282|NCT02273596|593491684|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
164305283|NCT02273596|593491684|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
164305284|NCT02273596|593491684|FG000|Extension Period|Lost to Follow-up|1|||
164305285|NCT02273596|593491684|FG000|Extension Period|Protocol Deviation|1|||
164305286|NCT02139592|593491686|FG000|Overall Study|Case Report Forms Uncollected|8|||
164305287|NCT02873702|593491691|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
164305288|NCT02873702|593491692|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
164305289|NCT02873702|593491693|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
164305290|NCT02873702|593491694|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
164305291|NCT02873702|593491691|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
164305292|NCT02873702|593491692|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
164305293|NCT02873702|593491693|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
164305294|NCT02873702|593491694|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
164305295|NCT02873702|593491691|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
164305296|NCT02873702|593491692|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
164533744|NCT00343252|594325462|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
164533745|NCT00343252|594325463|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
164533746|NCT00343252|594325462|FG000|18 Months (All Treated Participants)|Death|4|||
164533747|NCT00343252|594325463|FG001|18 Months (All Treated Participants)|Death|5|||
164533748|NCT00343252|594325462|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
164533749|NCT00343252|594325463|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
164533750|NCT00343252|594325462|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
164533751|NCT00343252|594325463|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
164533752|NCT00343252|594325462|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
164533753|NCT00343252|594325463|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
164533754|NCT00343252|594325462|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
164533755|NCT00343252|594325463|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
164533756|NCT00343252|594325462|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
164533757|NCT00343252|594325463|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
164533758|NCT00343252|594325462|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
164533759|NCT00343252|594325463|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
164533760|NCT00343252|594325462|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
164533761|NCT00343252|594325463|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
164533762|NCT01026454|594325464|FG000|Second Intervention|Pregnancy|1|||
164533763|NCT01026454|594325465|FG001|Second Intervention|Pregnancy|1|||
164533764|NCT02893930|594325466|FG000|Overall Study|Adverse Event|3|||
164533765|NCT02893930|594325466|FG000|Overall Study|Death|1|||
164533766|NCT02893930|594325466|FG000|Overall Study|Disease progression|5|||
164533767|NCT02893930|594325466|FG000|Overall Study|Withdrawal by Subject|2|||
164533768|NCT02893930|594325466|FG000|Overall Study|Physician Decision|1|||
164533769|NCT02893930|594325466|FG000|Overall Study|Ineligible|1|||
164533770|NCT01592864|594325469|FG000|Overall Study|Withdrawal by Subject|0|||
164305297|NCT02873702|593491693|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
164305298|NCT02873702|593491694|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
164305299|NCT02873702|593491691|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
164305300|NCT02873702|593491692|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
164305301|NCT02873702|593491693|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
164305302|NCT02873702|593491694|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
164305303|NCT02873702|593491691|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
164305304|NCT02873702|593491692|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
164305305|NCT02873702|593491693|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
164533771|NCT01592864|594325470|FG001|Overall Study|Withdrawal by Subject|1|||
164533772|NCT04379518|594325477|FG000|Overall Study|Physician Decision|2|||
164533773|NCT04379518|594325478|FG001|Overall Study|Physician Decision|0|||
164533774|NCT04379518|594325479|FG002|Overall Study|Physician Decision|0|||
164533775|NCT04379518|594325480|FG003|Overall Study|Physician Decision|0|||
164533776|NCT04379518|594325481|FG004|Overall Study|Physician Decision|0|||
164533777|NCT04379518|594325477|FG000|Overall Study|Withdrawal by Subject|1|||
164533778|NCT04379518|594325478|FG001|Overall Study|Withdrawal by Subject|0|||
164533779|NCT04379518|594325479|FG002|Overall Study|Withdrawal by Subject|0|||
164533780|NCT04379518|594325480|FG003|Overall Study|Withdrawal by Subject|0|||
164533781|NCT04379518|594325481|FG004|Overall Study|Withdrawal by Subject|0|||
164533782|NCT05135000|594325482|FG000|Overall Study|Adverse Event|2|||
164533783|NCT05135000|594325483|FG001|Overall Study|Adverse Event|0|||
164533784|NCT05135000|594325482|FG000|Overall Study|Lost to Follow-up|1|||
164533785|NCT05135000|594325483|FG001|Overall Study|Lost to Follow-up|0|||
164533786|NCT05135000|594325482|FG000|Overall Study|Study Terminated by Sponsor|6|||
164533787|NCT05135000|594325483|FG001|Overall Study|Study Terminated by Sponsor|3|||
164533788|NCT04266301|594327117|FG000|Overall Study|Progressive Disease|111|||
164533789|NCT04266301|594327118|FG001|Overall Study|Progressive Disease|92|||
164533790|NCT04266301|594327117|FG000|Overall Study|Adverse Event|41|||
164533791|NCT04266301|594327118|FG001|Overall Study|Adverse Event|43|||
164533792|NCT04266301|594327117|FG000|Overall Study|Death|26|||
164533793|NCT04266301|594327118|FG001|Overall Study|Death|35|||
164533794|NCT04266301|594327117|FG000|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
164533795|NCT04266301|594327118|FG001|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
164533796|NCT04266301|594327117|FG000|Overall Study|Study Terminated by Sponsor|22|||
164533797|NCT04266301|594327118|FG001|Overall Study|Study Terminated by Sponsor|27|||
164533798|NCT04266301|594327117|FG000|Overall Study|Participant Decision|22|||
164533799|NCT04266301|594327118|FG001|Overall Study|Participant Decision|28|||
164533800|NCT04266301|594327117|FG000|Overall Study|Physician Decision|14|||
164533801|NCT04266301|594327118|FG001|Overall Study|Physician Decision|9|||
164533802|NCT04266301|594327117|FG000|Overall Study|New Therapy for Study Indication|2|||
164533803|NCT04266301|594327118|FG001|Overall Study|New Therapy for Study Indication|4|||
164533804|NCT04266301|594327117|FG000|Overall Study|Protocol Deviation|2|||
164533805|NCT04266301|594327118|FG001|Overall Study|Protocol Deviation|4|||
164533806|NCT04266301|594327117|FG000|Overall Study|Guardian Decision|1|||
164533807|NCT04266301|594327118|FG001|Overall Study|Guardian Decision|0|||
164533808|NCT04266301|594327117|FG000|Overall Study|Lost to Follow-up|1|||
164533809|NCT04266301|594327118|FG001|Overall Study|Lost to Follow-up|0|||
164533810|NCT04266301|594327117|FG000|Overall Study|Participants Not Treated|1|||
164533811|NCT04266301|594327118|FG001|Overall Study|Participants Not Treated|1|||
164533812|NCT00162032|594327121|FG000|Overall Study|Lost to Follow-up|4|||
164533813|NCT00162032|594327122|FG001|Overall Study|Lost to Follow-up|2|||
164533814|NCT00162032|594327121|FG000|Overall Study|Reason not specified|1|||
164533815|NCT00162032|594327122|FG001|Overall Study|Reason not specified|0|||
164533816|NCT02977988|594327123|FG000|Overall Study|Lost to Follow-up|13|||
164533817|NCT02977988|594327124|FG001|Overall Study|Lost to Follow-up|7|||
164533818|NCT03840486|594327125|FG000|Overall Study|Withdrawal by Subject|0|||
164533819|NCT03840486|594327126|FG001|Overall Study|Withdrawal by Subject|1|||
164533820|NCT03840486|594327127|FG002|Overall Study|Withdrawal by Subject|0|||
164533821|NCT03840486|594327128|FG003|Overall Study|Withdrawal by Subject|0|||
164533822|NCT03840486|594327129|FG004|Overall Study|Withdrawal by Subject|0|||
164533823|NCT03840486|594327130|FG005|Overall Study|Withdrawal by Subject|0|||
164533824|NCT03840486|594327131|FG006|Overall Study|Withdrawal by Subject|0|||
164533825|NCT03840486|594327132|FG007|Overall Study|Withdrawal by Subject|0|||
164533826|NCT03840486|594327133|FG008|Overall Study|Withdrawal by Subject|0|||
164533827|NCT03840486|594327134|FG009|Overall Study|Withdrawal by Subject|0|||
164533828|NCT03840486|594327135|FG010|Overall Study|Withdrawal by Subject|0|||
164533829|NCT03840486|594327136|FG011|Overall Study|Withdrawal by Subject|0|||
164533830|NCT04652726|594327137|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
164533831|NCT04652726|594327138|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
164533832|NCT04652726|594327139|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
164533833|NCT04652726|594327137|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
164533834|NCT04652726|594327138|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
164533835|NCT04652726|594327139|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
164533836|NCT03780725|594327140|FG000|Overall Study|Progression of disease|3|||
164533837|NCT03780725|594327141|FG001|Overall Study|Progression of disease|4|||
164533838|NCT03780725|594327140|FG000|Overall Study|Adverse Event|0|||
164533839|NCT03780725|594327141|FG001|Overall Study|Adverse Event|1|||
164533840|NCT02738008|594327142|FG000|Overall Study|Study Terminated by Sponsor|1|||
164533841|NCT02738008|594327143|FG001|Overall Study|Study Terminated by Sponsor|5|||
164533842|NCT02738008|594327144|FG002|Overall Study|Study Terminated by Sponsor|3|||
164533843|NCT02738008|594327142|FG000|Overall Study|Adverse Event|0|||
164533844|NCT02738008|594327143|FG001|Overall Study|Adverse Event|1|||
164533845|NCT02738008|594327144|FG002|Overall Study|Adverse Event|2|||
164533846|NCT05192382|594327145|FG000|RC Phase (Up to Week 24)|Adverse Event|1|||
164533847|NCT05192382|594327146|FG001|RC Phase (Up to Week 24)|Adverse Event|1|||
164533848|NCT05192382|594327147|FG002|RC Phase (Up to Week 24)|Adverse Event|0|||
164533849|NCT05192382|594327145|FG000|RC Phase (Up to Week 24)|Withdrawal by Subject|1|||
164533850|NCT05192382|594327146|FG001|RC Phase (Up to Week 24)|Withdrawal by Subject|2|||
164533851|NCT05192382|594327147|FG002|RC Phase (Up to Week 24)|Withdrawal by Subject|0|||
164533852|NCT05192382|594327145|FG000|OLE Phase (Up to Week 200)|Discontinued|1|||
164533853|NCT05192382|594327146|FG001|OLE Phase (Up to Week 200)|Discontinued|4|||
164533854|NCT05192382|594327147|FG002|OLE Phase (Up to Week 200)|Discontinued|1|||
164533855|NCT05192382|594327145|FG000|OLE Phase (Up to Week 200)|Ongoing|49|||
164305306|NCT02873702|593491694|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
164305307|NCT01177397|593491695|FG000|Overall Study|Protocol Violation|0|||
164305308|NCT01177397|593491696|FG001|Overall Study|Protocol Violation|0|||
164305309|NCT01177397|593491697|FG002|Overall Study|Protocol Violation|0|||
164305310|NCT01177397|593491698|FG003|Overall Study|Protocol Violation|0|||
164305311|NCT01177397|593491699|FG004|Overall Study|Protocol Violation|0|||
164305312|NCT01177397|593491700|FG005|Overall Study|Protocol Violation|1|||
164305313|NCT01177397|593491701|FG006|Overall Study|Protocol Violation|0|||
164305314|NCT01177397|593491702|FG007|Overall Study|Protocol Violation|0|||
164305315|NCT01177397|593491703|FG008|Overall Study|Protocol Violation|0|||
164305316|NCT01177397|593491704|FG009|Overall Study|Protocol Violation|0|||
164305317|NCT01177397|593491705|FG010|Overall Study|Protocol Violation|0|||
164305318|NCT01177397|593491706|FG011|Overall Study|Protocol Violation|0|||
164305319|NCT01177397|593491695|FG000|Overall Study|Lost to Follow-up|0|||
164533856|NCT05192382|594327146|FG001|OLE Phase (Up to Week 200)|Ongoing|48|||
164533857|NCT05192382|594327147|FG002|OLE Phase (Up to Week 200)|Ongoing|10|||
164305320|NCT01177397|593491696|FG001|Overall Study|Lost to Follow-up|0|||
164305321|NCT01177397|593491697|FG002|Overall Study|Lost to Follow-up|0|||
164305322|NCT01177397|593491698|FG003|Overall Study|Lost to Follow-up|0|||
164305323|NCT01177397|593491699|FG004|Overall Study|Lost to Follow-up|1|||
164305324|NCT01177397|593491700|FG005|Overall Study|Lost to Follow-up|0|||
164305325|NCT01177397|593491701|FG006|Overall Study|Lost to Follow-up|0|||
164305326|NCT01177397|593491702|FG007|Overall Study|Lost to Follow-up|2|||
164305327|NCT01177397|593491703|FG008|Overall Study|Lost to Follow-up|0|||
164305328|NCT01177397|593491704|FG009|Overall Study|Lost to Follow-up|0|||
164305329|NCT01177397|593491705|FG010|Overall Study|Lost to Follow-up|0|||
164305330|NCT01177397|593491706|FG011|Overall Study|Lost to Follow-up|0|||
164305331|NCT01177397|593491695|FG000|Overall Study|Death|0|||
164305332|NCT01177397|593491696|FG001|Overall Study|Death|0|||
164305333|NCT01177397|593491697|FG002|Overall Study|Death|1|||
164305334|NCT01177397|593491698|FG003|Overall Study|Death|1|||
164305335|NCT01177397|593491699|FG004|Overall Study|Death|0|||
164305336|NCT01177397|593491700|FG005|Overall Study|Death|0|||
164305337|NCT01177397|593491701|FG006|Overall Study|Death|0|||
164305338|NCT01177397|593491702|FG007|Overall Study|Death|5|||
164305339|NCT01177397|593491703|FG008|Overall Study|Death|2|||
164305340|NCT01177397|593491704|FG009|Overall Study|Death|1|||
164305341|NCT01177397|593491705|FG010|Overall Study|Death|0|||
164305342|NCT01177397|593491706|FG011|Overall Study|Death|0|||
164305343|NCT01177397|593491695|FG000|Overall Study|Withdrawal by Subject|0|||
164305344|NCT01177397|593491696|FG001|Overall Study|Withdrawal by Subject|0|||
164305345|NCT01177397|593491697|FG002|Overall Study|Withdrawal by Subject|1|||
164305346|NCT01177397|593491698|FG003|Overall Study|Withdrawal by Subject|1|||
164305347|NCT01177397|593491699|FG004|Overall Study|Withdrawal by Subject|1|||
164305348|NCT01177397|593491700|FG005|Overall Study|Withdrawal by Subject|2|||
164305349|NCT01177397|593491701|FG006|Overall Study|Withdrawal by Subject|0|||
164305350|NCT01177397|593491702|FG007|Overall Study|Withdrawal by Subject|5|||
164305351|NCT01177397|593491703|FG008|Overall Study|Withdrawal by Subject|9|||
164305352|NCT01177397|593491704|FG009|Overall Study|Withdrawal by Subject|1|||
164305353|NCT01177397|593491705|FG010|Overall Study|Withdrawal by Subject|1|||
164305354|NCT01177397|593491706|FG011|Overall Study|Withdrawal by Subject|0|||
164305355|NCT01177397|593491695|FG000|Overall Study|Adverse Event|0|||
164305356|NCT01177397|593491696|FG001|Overall Study|Adverse Event|0|||
164305357|NCT01177397|593491697|FG002|Overall Study|Adverse Event|1|||
164305358|NCT01177397|593491698|FG003|Overall Study|Adverse Event|2|||
164305359|NCT01177397|593491699|FG004|Overall Study|Adverse Event|0|||
164305360|NCT01177397|593491700|FG005|Overall Study|Adverse Event|12|||
164305361|NCT01177397|593491701|FG006|Overall Study|Adverse Event|1|||
164305362|NCT01177397|593491702|FG007|Overall Study|Adverse Event|14|||
164305363|NCT01177397|593491703|FG008|Overall Study|Adverse Event|8|||
164305364|NCT01177397|593491704|FG009|Overall Study|Adverse Event|6|||
164305365|NCT01177397|593491705|FG010|Overall Study|Adverse Event|3|||
164305366|NCT01177397|593491706|FG011|Overall Study|Adverse Event|7|||
164305367|NCT01177397|593491695|FG000|Overall Study|Disease progression|1|||
164533858|NCT02604199|594327153|FG000|Overall Study|Pregnancy|0|||
164305368|NCT01177397|593491696|FG001|Overall Study|Disease progression|2|||
164305369|NCT01177397|593491697|FG002|Overall Study|Disease progression|5|||
164305370|NCT01177397|593491698|FG003|Overall Study|Disease progression|5|||
164305371|NCT01177397|593491699|FG004|Overall Study|Disease progression|4|||
164305372|NCT01177397|593491700|FG005|Overall Study|Disease progression|10|||
164305373|NCT01177397|593491701|FG006|Overall Study|Disease progression|10|||
164305374|NCT01177397|593491702|FG007|Overall Study|Disease progression|21|||
164305375|NCT01177397|593491703|FG008|Overall Study|Disease progression|18|||
164305376|NCT01177397|593491704|FG009|Overall Study|Disease progression|12|||
164305377|NCT01177397|593491705|FG010|Overall Study|Disease progression|10|||
164305378|NCT01177397|593491706|FG011|Overall Study|Disease progression|8|||
164305379|NCT01177397|593491695|FG000|Overall Study|Other reasons|0|||
164305380|NCT01177397|593491696|FG001|Overall Study|Other reasons|0|||
164305381|NCT01177397|593491697|FG002|Overall Study|Other reasons|1|||
164305382|NCT01177397|593491698|FG003|Overall Study|Other reasons|0|||
164305383|NCT01177397|593491699|FG004|Overall Study|Other reasons|1|||
164305384|NCT01177397|593491700|FG005|Overall Study|Other reasons|1|||
164305385|NCT01177397|593491701|FG006|Overall Study|Other reasons|2|||
164305386|NCT01177397|593491702|FG007|Overall Study|Other reasons|6|||
164305387|NCT01177397|593491703|FG008|Overall Study|Other reasons|10|||
164305388|NCT01177397|593491704|FG009|Overall Study|Other reasons|8|||
164305389|NCT01177397|593491705|FG010|Overall Study|Other reasons|0|||
164305390|NCT01177397|593491706|FG011|Overall Study|Other reasons|2|||
164305391|NCT01528969|593491707|FG000|Overall Study|absent from the school at baseline|2|||
164305392|NCT01528969|593491708|FG001|Overall Study|absent from the school at baseline|0|||
164305393|NCT03085797|593491709|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
164305394|NCT03085797|593491710|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
164305395|NCT03085797|593491709|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
164305396|NCT03085797|593491710|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
164305397|NCT03085797|593491709|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
164305398|NCT03085797|593491710|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
164305399|NCT04050202|593491717|FG000|Overall Study|Lost to Follow-up|2|||
164305400|NCT01554241|593491718|FG000|Overall Study|Death|3|||
164305401|NCT01554241|593491719|FG001|Overall Study|Death|1|||
164305402|NCT01554241|593491720|FG002|Overall Study|Death|1|||
164305403|NCT01554241|593491721|FG003|Overall Study|Death|0|||
164305404|NCT01554241|593491718|FG000|Overall Study|protocol specified renal stone|0|||
164305405|NCT01554241|593491719|FG001|Overall Study|protocol specified renal stone|0|||
164305406|NCT01554241|593491720|FG002|Overall Study|protocol specified renal stone|0|||
164305407|NCT01554241|593491721|FG003|Overall Study|protocol specified renal stone|1|||
164305408|NCT01554241|593491718|FG000|Overall Study|protocol specified change in eGFR|0|||
164305409|NCT01554241|593491719|FG001|Overall Study|protocol specified change in eGFR|0|||
164305410|NCT01554241|593491720|FG002|Overall Study|protocol specified change in eGFR|1|||
164305411|NCT01554241|593491721|FG003|Overall Study|protocol specified change in eGFR|0|||
164305412|NCT01554241|593491718|FG000|Overall Study|Withdrawal by Subject|0|||
164305413|NCT01554241|593491719|FG001|Overall Study|Withdrawal by Subject|0|||
164305414|NCT01554241|593491720|FG002|Overall Study|Withdrawal by Subject|2|||
164305415|NCT01554241|593491721|FG003|Overall Study|Withdrawal by Subject|0|||
164305416|NCT05661409|593491722|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
164305417|NCT05661409|593491723|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
164305418|NCT05661409|593491724|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
164305419|NCT05661409|593491725|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
164305420|NCT05661409|593491726|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
164305421|NCT05661409|593491727|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
164305422|NCT05661409|593491722|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
164305423|NCT05661409|593491723|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
164305424|NCT05661409|593491724|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
164305425|NCT05661409|593491725|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
164305426|NCT05661409|593491726|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
164305427|NCT05661409|593491727|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
164305428|NCT05661409|593491722|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
164305429|NCT05661409|593491723|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
164305430|NCT05661409|593491724|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
164305431|NCT05661409|593491725|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
164305432|NCT05661409|593491726|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
164305433|NCT05661409|593491727|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
164305434|NCT05661409|593491722|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
164305435|NCT05661409|593491723|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
164305436|NCT05661409|593491724|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
164305437|NCT05661409|593491725|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
164305438|NCT05661409|593491726|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
164305439|NCT05661409|593491727|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
164305440|NCT05661409|593491722|FG000|Overall Study|Miscommu-nication about administration|0|||
164305441|NCT05661409|593491723|FG001|Overall Study|Miscommu-nication about administration|0|||
164305442|NCT05661409|593491724|FG002|Overall Study|Miscommu-nication about administration|0|||
164305443|NCT05661409|593491725|FG003|Overall Study|Miscommu-nication about administration|0|||
164305444|NCT05661409|593491726|FG004|Overall Study|Miscommu-nication about administration|0|||
164305445|NCT05661409|593491727|FG005|Overall Study|Miscommu-nication about administration|1|||
164305446|NCT03198507|593491728|FG000|Overall Study|Withdrawal by Subject|1|||
164305447|NCT03198507|593491729|FG001|Overall Study|Withdrawal by Subject|0|||
164305448|NCT00724698|593491730|FG000|Overall Study|Adverse Event|9|||
164305449|NCT00724698|593491730|FG000|Overall Study|Failure of Therapy|4|||
164305450|NCT00724698|593491730|FG000|Overall Study|Poor Compliance|16|||
164305451|NCT00724698|593491730|FG000|Overall Study|Lost to Follow-up|36|||
164305452|NCT00724698|593491730|FG000|Overall Study|No Info|25|||
164305453|NCT01411891|593491733|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
164305454|NCT01411891|593491734|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
164305455|NCT04614974|593491735|FG000|Overall Study|Lost to Follow-up|14|||
164305456|NCT04614974|593491736|FG001|Overall Study|Lost to Follow-up|11|||
164305457|NCT00658359|593491738|FG000|Overall Study|Death|3|||
164305458|NCT00658359|593491739|FG001|Overall Study|Death|1|||
164305459|NCT00658359|593491740|FG002|Overall Study|Death|2|||
164305460|NCT00658359|593491738|FG000|Overall Study|Adverse Event|13|||
164305461|NCT00658359|593491739|FG001|Overall Study|Adverse Event|6|||
164305462|NCT00658359|593491740|FG002|Overall Study|Adverse Event|9|||
164305463|NCT00658359|593491738|FG000|Overall Study|Protocol Violation|1|||
164305464|NCT00658359|593491739|FG001|Overall Study|Protocol Violation|0|||
164305465|NCT00658359|593491740|FG002|Overall Study|Protocol Violation|0|||
164305466|NCT00658359|593491738|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
164305467|NCT00658359|593491739|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
164305468|NCT00658359|593491740|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
164305469|NCT00658359|593491738|FG000|Overall Study|Withdrawal by Subject|7|||
164305470|NCT00658359|593491739|FG001|Overall Study|Withdrawal by Subject|4|||
164305471|NCT00658359|593491740|FG002|Overall Study|Withdrawal by Subject|2|||
164305472|NCT00658359|593491738|FG000|Overall Study|Lost to Follow-up|2|||
164305473|NCT00658359|593491739|FG001|Overall Study|Lost to Follow-up|2|||
164305474|NCT00658359|593491740|FG002|Overall Study|Lost to Follow-up|4|||
164305475|NCT00658359|593491738|FG000|Overall Study|Lack of Efficacy|0|||
164305476|NCT00658359|593491739|FG001|Overall Study|Lack of Efficacy|1|||
164305477|NCT00658359|593491740|FG002|Overall Study|Lack of Efficacy|0|||
164305478|NCT01075685|593491741|FG000|Overall Study|Protocol Violation|9|||
164305479|NCT01075685|593491742|FG001|Overall Study|Protocol Violation|1|||
164305480|NCT01075685|593491741|FG000|Overall Study|Withdrawal by Subject|20|||
164305481|NCT01075685|593491742|FG001|Overall Study|Withdrawal by Subject|5|||
164305482|NCT01075685|593491741|FG000|Overall Study|Lost to Follow-up|563|||
164305483|NCT01075685|593491742|FG001|Overall Study|Lost to Follow-up|220|||
164305484|NCT03196349|593491745|FG000|Overall Study|Did not receive study drug|0|||
164305485|NCT03196349|593491746|FG001|Overall Study|Did not receive study drug|1|||
164305486|NCT03196349|593491747|FG002|Overall Study|Did not receive study drug|2|||
164305487|NCT03196349|593491745|FG000|Overall Study|No data entered|2|||
164305488|NCT03196349|593491746|FG001|Overall Study|No data entered|4|||
164305489|NCT03196349|593491747|FG002|Overall Study|No data entered|0|||
164305490|NCT03196349|593491745|FG000|Overall Study|Study Terminated early|15|||
164305491|NCT03196349|593491746|FG001|Overall Study|Study Terminated early|9|||
164305492|NCT03196349|593491747|FG002|Overall Study|Study Terminated early|11|||
164305493|NCT03388164|593491752|FG000|Overall Study|Withdrawal by Subject|3|||
164305494|NCT03388164|593491753|FG001|Overall Study|Withdrawal by Subject|1|||
164305495|NCT03023397|593491754|FG000|Run-In|Failed screening allergen challenge|1|||
164305496|NCT03023397|593491755|FG001|Run-In|Failed screening allergen challenge|0|||
164305497|NCT03023397|593491756|FG002|Run-In|Failed screening allergen challenge|0|||
164305498|NCT03023397|593491754|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
164305499|NCT03023397|593491755|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
164305500|NCT03023397|593491756|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
164305501|NCT00363480|593491757|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
164305502|NCT00363480|593491757|FG000|Overall Study|Adverse Event|4|||
164305503|NCT00363480|593491757|FG000|Overall Study|Lost to Follow-up|5|||
164305504|NCT00363480|593491757|FG000|Overall Study|Withdrawal by Subject|5|||
164305505|NCT00363480|593491757|FG000|Overall Study|Non-compliance of subject|1|||
164305506|NCT00363480|593491757|FG000|Overall Study|Participant discontinued on its own|1|||
164305507|NCT02129699|593491764|FG000|Overall Study|Did not start treatment|3|||
164305508|NCT02129699|593491765|FG001|Overall Study|Did not start treatment|2|||
164305509|NCT01394016|593491766|FG000|Overall Study|Progressive Disease|2|||
164305510|NCT01394016|593491767|FG001|Overall Study|Progressive Disease|0|||
164305511|NCT01394016|593491768|FG002|Overall Study|Progressive Disease|0|||
164305512|NCT01394016|593491769|FG003|Overall Study|Progressive Disease|0|||
164305513|NCT01394016|593491770|FG004|Overall Study|Progressive Disease|0|||
164305514|NCT01394016|593491771|FG005|Overall Study|Progressive Disease|0|||
164305515|NCT01394016|593491772|FG006|Overall Study|Progressive Disease|0|||
164419309|NCT01216293|593904745|FG000|Main Study|Major Protocol Deviation|1|||
164305516|NCT01394016|593491773|FG007|Overall Study|Progressive Disease|0|||
164305517|NCT01394016|593491774|FG008|Overall Study|Progressive Disease|0|||
164305518|NCT01394016|593491775|FG009|Overall Study|Progressive Disease|0|||
164305519|NCT01394016|593491776|FG010|Overall Study|Progressive Disease|0|||
164305520|NCT01394016|593491777|FG011|Overall Study|Progressive Disease|0|||
164305521|NCT01394016|593491778|FG012|Overall Study|Progressive Disease|0|||
164305522|NCT01394016|593491779|FG013|Overall Study|Progressive Disease|0|||
164305523|NCT01394016|593491780|FG014|Overall Study|Progressive Disease|0|||
164305524|NCT01394016|593491781|FG015|Overall Study|Progressive Disease|0|||
164533859|NCT02604199|594327154|FG001|Overall Study|Pregnancy|0|||
164305525|NCT01394016|593491782|FG016|Overall Study|Progressive Disease|0|||
164305526|NCT01394016|593491783|FG017|Overall Study|Progressive Disease|0|||
164305527|NCT01394016|593491784|FG018|Overall Study|Progressive Disease|0|||
164305528|NCT01394016|593491766|FG000|Overall Study|Withdrawal by Subject|0|||
164305529|NCT01394016|593491767|FG001|Overall Study|Withdrawal by Subject|0|||
164305530|NCT01394016|593491768|FG002|Overall Study|Withdrawal by Subject|0|||
164305531|NCT01394016|593491769|FG003|Overall Study|Withdrawal by Subject|0|||
164305532|NCT01394016|593491770|FG004|Overall Study|Withdrawal by Subject|0|||
164305533|NCT01394016|593491771|FG005|Overall Study|Withdrawal by Subject|0|||
164305534|NCT01394016|593491772|FG006|Overall Study|Withdrawal by Subject|0|||
164305535|NCT01394016|593491773|FG007|Overall Study|Withdrawal by Subject|1|||
164305536|NCT01394016|593491774|FG008|Overall Study|Withdrawal by Subject|1|||
164305537|NCT01394016|593491775|FG009|Overall Study|Withdrawal by Subject|1|||
164305538|NCT01394016|593491776|FG010|Overall Study|Withdrawal by Subject|4|||
164305539|NCT01394016|593491777|FG011|Overall Study|Withdrawal by Subject|0|||
164305540|NCT01394016|593491778|FG012|Overall Study|Withdrawal by Subject|0|||
164305541|NCT01394016|593491779|FG013|Overall Study|Withdrawal by Subject|3|||
164305542|NCT01394016|593491780|FG014|Overall Study|Withdrawal by Subject|1|||
164305543|NCT01394016|593491781|FG015|Overall Study|Withdrawal by Subject|3|||
164305544|NCT01394016|593491782|FG016|Overall Study|Withdrawal by Subject|1|||
164305545|NCT01394016|593491783|FG017|Overall Study|Withdrawal by Subject|1|||
164305546|NCT01394016|593491784|FG018|Overall Study|Withdrawal by Subject|2|||
164305547|NCT01394016|593491766|FG000|Overall Study|Adverse Event|0|||
164305548|NCT01394016|593491767|FG001|Overall Study|Adverse Event|0|||
164305549|NCT01394016|593491768|FG002|Overall Study|Adverse Event|0|||
164305550|NCT01394016|593491769|FG003|Overall Study|Adverse Event|0|||
164305551|NCT01394016|593491770|FG004|Overall Study|Adverse Event|0|||
164305552|NCT01394016|593491771|FG005|Overall Study|Adverse Event|0|||
164305553|NCT01394016|593491772|FG006|Overall Study|Adverse Event|0|||
164305554|NCT01394016|593491773|FG007|Overall Study|Adverse Event|0|||
164305555|NCT01394016|593491774|FG008|Overall Study|Adverse Event|0|||
164305556|NCT01394016|593491775|FG009|Overall Study|Adverse Event|1|||
164305557|NCT01394016|593491776|FG010|Overall Study|Adverse Event|0|||
164305558|NCT01394016|593491777|FG011|Overall Study|Adverse Event|0|||
164305559|NCT01394016|593491778|FG012|Overall Study|Adverse Event|0|||
164305560|NCT01394016|593491779|FG013|Overall Study|Adverse Event|0|||
164305561|NCT01394016|593491780|FG014|Overall Study|Adverse Event|0|||
164305562|NCT01394016|593491781|FG015|Overall Study|Adverse Event|0|||
164305563|NCT01394016|593491782|FG016|Overall Study|Adverse Event|1|||
164305564|NCT01394016|593491783|FG017|Overall Study|Adverse Event|1|||
164305565|NCT01394016|593491784|FG018|Overall Study|Adverse Event|0|||
164305566|NCT01394016|593491766|FG000|Overall Study|Sponsor Decision|0|||
164305567|NCT01394016|593491767|FG001|Overall Study|Sponsor Decision|0|||
164305568|NCT01394016|593491768|FG002|Overall Study|Sponsor Decision|0|||
164305569|NCT01394016|593491769|FG003|Overall Study|Sponsor Decision|0|||
164305570|NCT01394016|593491770|FG004|Overall Study|Sponsor Decision|0|||
164305571|NCT01394016|593491771|FG005|Overall Study|Sponsor Decision|0|||
164305572|NCT01394016|593491772|FG006|Overall Study|Sponsor Decision|0|||
164305573|NCT01394016|593491773|FG007|Overall Study|Sponsor Decision|0|||
164305574|NCT01394016|593491774|FG008|Overall Study|Sponsor Decision|0|||
164305575|NCT01394016|593491775|FG009|Overall Study|Sponsor Decision|0|||
164305576|NCT01394016|593491776|FG010|Overall Study|Sponsor Decision|0|||
164305577|NCT01394016|593491777|FG011|Overall Study|Sponsor Decision|0|||
164305578|NCT01394016|593491778|FG012|Overall Study|Sponsor Decision|1|||
164305579|NCT01394016|593491779|FG013|Overall Study|Sponsor Decision|0|||
164305580|NCT01394016|593491780|FG014|Overall Study|Sponsor Decision|0|||
164305581|NCT01394016|593491781|FG015|Overall Study|Sponsor Decision|0|||
164305582|NCT01394016|593491782|FG016|Overall Study|Sponsor Decision|0|||
164305583|NCT01394016|593491783|FG017|Overall Study|Sponsor Decision|0|||
164305584|NCT01394016|593491784|FG018|Overall Study|Sponsor Decision|0|||
164305585|NCT01394016|593491766|FG000|Overall Study|Lost to Follow-up|0|||
164305586|NCT01394016|593491767|FG001|Overall Study|Lost to Follow-up|0|||
164305587|NCT01394016|593491768|FG002|Overall Study|Lost to Follow-up|0|||
164305588|NCT01394016|593491769|FG003|Overall Study|Lost to Follow-up|0|||
164305589|NCT01394016|593491770|FG004|Overall Study|Lost to Follow-up|0|||
164305590|NCT01394016|593491771|FG005|Overall Study|Lost to Follow-up|0|||
164533860|NCT02604199|594327155|FG002|Overall Study|Pregnancy|0|||
164533861|NCT02604199|594327156|FG003|Overall Study|Pregnancy|1|||
164305591|NCT01394016|593491772|FG006|Overall Study|Lost to Follow-up|0|||
164305592|NCT01394016|593491773|FG007|Overall Study|Lost to Follow-up|0|||
164305593|NCT01394016|593491774|FG008|Overall Study|Lost to Follow-up|0|||
164305594|NCT01394016|593491775|FG009|Overall Study|Lost to Follow-up|0|||
164305595|NCT01394016|593491776|FG010|Overall Study|Lost to Follow-up|0|||
164305596|NCT01394016|593491777|FG011|Overall Study|Lost to Follow-up|0|||
164305597|NCT01394016|593491778|FG012|Overall Study|Lost to Follow-up|0|||
164305598|NCT01394016|593491779|FG013|Overall Study|Lost to Follow-up|0|||
164305599|NCT01394016|593491780|FG014|Overall Study|Lost to Follow-up|0|||
164305600|NCT01394016|593491781|FG015|Overall Study|Lost to Follow-up|0|||
164305601|NCT01394016|593491782|FG016|Overall Study|Lost to Follow-up|0|||
164305602|NCT01394016|593491783|FG017|Overall Study|Lost to Follow-up|0|||
164305603|NCT01394016|593491784|FG018|Overall Study|Lost to Follow-up|1|||
164305604|NCT03534804|593491785|FG000|Overall Study|Withdrawal by Subject|1|||
164305605|NCT04161157|593491789|FG000|Overall Study|Lost to Follow-up|4|||
164305606|NCT04161157|593491789|FG000|Overall Study|Death|3|||
164305607|NCT04161157|593491789|FG000|Overall Study|Ineligible|2|||
164305608|NCT04161157|593491789|FG000|Overall Study|Withdrawal by Subject|4|||
164305609|NCT02991768|593491798|FG000|Overall Study|Physician Decision|4|||
164305610|NCT05786651|593491801|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
164305611|NCT01442103|593493143|FG000|Overall Study|Lost to Follow-up|2|||
164305612|NCT02605122|593493146|FG000|Overall Study|Withdrawal by Subject|4|||
164305613|NCT02605122|593493147|FG001|Overall Study|Withdrawal by Subject|1|||
164305614|NCT02605122|593493146|FG000|Overall Study|Lost to Follow-up|1|||
164305615|NCT02605122|593493147|FG001|Overall Study|Lost to Follow-up|1|||
164305616|NCT00807001|593493149|FG000|Overall Study|Non-compliance|0|||
164305617|NCT00807001|593493150|FG001|Overall Study|Non-compliance|1|||
164305618|NCT00807001|593493151|FG002|Overall Study|Non-compliance|0|||
164305619|NCT00807001|593493152|FG003|Overall Study|Non-compliance|0|||
164305620|NCT00807001|593493153|FG004|Overall Study|Non-compliance|0|||
164305621|NCT01399372|593493155|FG000|Overall Study|Protocol Violation|3|||
164305622|NCT01399372|593493156|FG001|Overall Study|Protocol Violation|1|||
164305623|NCT01027273|593493159|FG000|Overall Study|Lost to Follow-up|57|||
164533862|NCT02604199|594327153|FG000|Overall Study|Study terminated by sponsor|0|||
164533863|NCT02604199|594327154|FG001|Overall Study|Study terminated by sponsor|2|||
164533864|NCT02604199|594327155|FG002|Overall Study|Study terminated by sponsor|0|||
164533865|NCT02604199|594327156|FG003|Overall Study|Study terminated by sponsor|2|||
164533866|NCT02604199|594327153|FG000|Overall Study|Withdrawal by Subject|0|||
164533867|NCT02604199|594327154|FG001|Overall Study|Withdrawal by Subject|1|||
164533868|NCT02604199|594327155|FG002|Overall Study|Withdrawal by Subject|0|||
164533869|NCT02604199|594327156|FG003|Overall Study|Withdrawal by Subject|0|||
164305624|NCT01027273|593493160|FG001|Overall Study|Lost to Follow-up|31|||
164305625|NCT01027273|593493159|FG000|Overall Study|Death|2|||
164305626|NCT01027273|593493160|FG001|Overall Study|Death|2|||
164305627|NCT04313244|593493161|FG000|Overall Study|Withdrawal of Consent|3|||
164305628|NCT04313244|593493162|FG001|Overall Study|Withdrawal of Consent|3|||
164305629|NCT04313244|593493161|FG000|Overall Study|Met Exclusion Criteria|1|||
164305630|NCT04313244|593493162|FG001|Overall Study|Met Exclusion Criteria|0|||
164305631|NCT04313244|593493161|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
164305632|NCT04313244|593493162|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
164305633|NCT00043979|593493163|FG000|Period 1|recipient with progressive disease|7|||
164305634|NCT00043979|593493164|FG001|Period 1|recipient with progressive disease|4|||
164305635|NCT00043979|593493165|FG002|Period 1|recipient with progressive disease|3|||
164305636|NCT03096288|593493167|FG000|Overall Study|Withdrawal by Subject|0|||
164305637|NCT03096288|593493168|FG001|Overall Study|Withdrawal by Subject|1|||
164305638|NCT03096288|593493169|FG002|Overall Study|Withdrawal by Subject|0|||
164305639|NCT03096288|593493170|FG003|Overall Study|Withdrawal by Subject|1|||
164305640|NCT02560558|593493171|FG000|Overall Study|Adverse Event|1|||
164305641|NCT02560558|593493172|FG001|Overall Study|Adverse Event|0|||
164305642|NCT02560558|593493171|FG000|Overall Study|Death|0|||
164305643|NCT02560558|593493172|FG001|Overall Study|Death|2|||
164305644|NCT02560558|593493171|FG000|Overall Study|Lost to Follow-up|0|||
164305645|NCT02560558|593493172|FG001|Overall Study|Lost to Follow-up|4|||
164305646|NCT02560558|593493171|FG000|Overall Study|Protocol Violation|3|||
164305647|NCT02560558|593493172|FG001|Overall Study|Protocol Violation|0|||
164305648|NCT02560558|593493171|FG000|Overall Study|Withdrawal by Subject|3|||
164305649|NCT02560558|593493172|FG001|Overall Study|Withdrawal by Subject|0|||
164305650|NCT02819804|593493173|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
164305651|NCT03967444|593493174|FG000|Overall Study|Lost to Follow-up|1|||
164305652|NCT03967444|593493175|FG001|Overall Study|Lost to Follow-up|2|||
164305653|NCT02858362|593493176|FG000|Overall Study|Protocol Violation|0|||
164305654|NCT02858362|593493177|FG001|Overall Study|Protocol Violation|1|||
164305655|NCT02858362|593493178|FG002|Overall Study|Protocol Violation|0|||
164305656|NCT02858362|593493176|FG000|Overall Study|Withdrawal by Subject|1|||
164305657|NCT02858362|593493177|FG001|Overall Study|Withdrawal by Subject|0|||
164305658|NCT02858362|593493178|FG002|Overall Study|Withdrawal by Subject|0|||
164305659|NCT02858362|593493176|FG000|Overall Study|Early Study Termination|0|||
164305660|NCT02858362|593493177|FG001|Overall Study|Early Study Termination|0|||
164305661|NCT02858362|593493178|FG002|Overall Study|Early Study Termination|3|||
164305662|NCT02858362|593493176|FG000|Overall Study|Lost to Follow-up|1|||
164305663|NCT02858362|593493177|FG001|Overall Study|Lost to Follow-up|0|||
164533870|NCT04702776|594327160|FG000|Overall Study|Adverse Event|1|||
164533871|NCT04702776|594327161|FG001|Overall Study|Adverse Event|2|||
164533872|NCT04702776|594327162|FG002|Overall Study|Adverse Event|1|||
164305664|NCT02858362|593493178|FG002|Overall Study|Lost to Follow-up|0|||
164305665|NCT01821118|593493184|FG000|Overall Study|Death|0|||
164305666|NCT01821118|593493185|FG001|Overall Study|Death|1|||
164305667|NCT00686686|593493186|FG000|Overall Study|Non-compliance|1|||
164305668|NCT00686686|593493186|FG000|Overall Study|Adverse Event|2|||
164305669|NCT00686686|593493186|FG000|Overall Study|Lost to Follow-up|3|||
164305670|NCT00131248|593493187|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
164305671|NCT00131248|593493188|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
164305672|NCT00318643|593493193|FG000|Overall Study|Adverse Event|0|||
164305673|NCT00318643|593493194|FG001|Overall Study|Adverse Event|0|||
164305674|NCT00318643|593493195|FG002|Overall Study|Adverse Event|0|||
164305675|NCT00318643|593493196|FG003|Overall Study|Adverse Event|0|||
164305676|NCT00318643|593493197|FG004|Overall Study|Adverse Event|1|||
164305677|NCT00318643|593493193|FG000|Overall Study|Participant's Decision|0|||
164305678|NCT00318643|593493194|FG001|Overall Study|Participant's Decision|0|||
164305679|NCT00318643|593493195|FG002|Overall Study|Participant's Decision|0|||
164305680|NCT00318643|593493196|FG003|Overall Study|Participant's Decision|0|||
164305681|NCT00318643|593493197|FG004|Overall Study|Participant's Decision|1|||
164305682|NCT00318643|593493193|FG000|Overall Study|Investigator's Decision|0|||
164305683|NCT00318643|593493194|FG001|Overall Study|Investigator's Decision|0|||
164305684|NCT00318643|593493195|FG002|Overall Study|Investigator's Decision|0|||
164305685|NCT00318643|593493196|FG003|Overall Study|Investigator's Decision|0|||
164305686|NCT00318643|593493197|FG004|Overall Study|Investigator's Decision|1|||
164305687|NCT05038982|593493198|FG000|Overall Study|Withdrawal by Subject|0|||
164305688|NCT05038982|593493199|FG001|Overall Study|Withdrawal by Subject|2|||
164305689|NCT02691507|593493202|FG000|Overall Study|Missed Visit 3|0|||
164305690|NCT02691507|593493203|FG001|Overall Study|Missed Visit 3|1|||
164305691|NCT03739203|593493210|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
164305692|NCT03739203|593493211|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
164305693|NCT03739203|593493212|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
164305694|NCT03739203|593493210|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
164305695|NCT03739203|593493211|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
164305696|NCT03739203|593493212|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
164305697|NCT03739203|593493210|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
164305698|NCT03739203|593493211|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
164305699|NCT03739203|593493212|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
164305700|NCT03739203|593493210|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
164305701|NCT03739203|593493211|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
164305702|NCT03739203|593493212|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
164305703|NCT03739203|593493210|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
164305704|NCT03739203|593493211|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
164305705|NCT03739203|593493212|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
164305706|NCT03739203|593493210|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
164305707|NCT03739203|593493211|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
164305708|NCT03739203|593493212|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
164305709|NCT03739203|593493210|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
164305710|NCT03739203|593493211|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
164305711|NCT03739203|593493212|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
164305712|NCT03739203|593493210|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
164305713|NCT03739203|593493211|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
164305714|NCT03739203|593493212|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
164305715|NCT03739203|593493210|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
164305716|NCT03739203|593493211|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
164305717|NCT03739203|593493212|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
164305718|NCT03739203|593493210|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
164305719|NCT03739203|593493211|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
164305720|NCT03739203|593493212|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
164305721|NCT03739203|593493210|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
164305722|NCT03739203|593493211|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
164305723|NCT03739203|593493212|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
164305724|NCT01519921|593493216|FG000|Overall Study|Adverse Event|10|||
164305725|NCT01519921|593493217|FG001|Overall Study|Adverse Event|9|||
164305726|NCT01519921|593493216|FG000|Overall Study|Lack of Efficacy|4|||
164305727|NCT01519921|593493217|FG001|Overall Study|Lack of Efficacy|3|||
164305728|NCT01519921|593493216|FG000|Overall Study|Withdrawal by Subject|3|||
164305729|NCT01519921|593493217|FG001|Overall Study|Withdrawal by Subject|0|||
164305730|NCT01519921|593493216|FG000|Overall Study|Lost to Follow-up|2|||
164305731|NCT01519921|593493217|FG001|Overall Study|Lost to Follow-up|1|||
164305732|NCT01519921|593493216|FG000|Overall Study|Treatment refusal|2|||
164305733|NCT01519921|593493217|FG001|Overall Study|Treatment refusal|1|||
164305734|NCT01519921|593493216|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
164305735|NCT01519921|593493217|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
164305736|NCT01216189|593493218|FG000|Overall Study|Lost to Follow-up|21|||
164305737|NCT01216189|593493219|FG001|Overall Study|Lost to Follow-up|3|||
164305738|NCT01216189|593493218|FG000|Overall Study|Death|4|||
164305739|NCT01216189|593493219|FG001|Overall Study|Death|2|||
164305740|NCT01143246|593493220|FG000|Overall Study|Adverse Event|24|||
164305741|NCT01143246|593493221|FG001|Overall Study|Adverse Event|28|||
164305742|NCT01143246|593493220|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
164305743|NCT01143246|593493221|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
164305744|NCT01143246|593493220|FG000|Overall Study|Lost to Follow-up|0|||
164305745|NCT01143246|593493221|FG001|Overall Study|Lost to Follow-up|1|||
164305746|NCT01143246|593493220|FG000|Overall Study|Death|16|||
164305747|NCT01143246|593493221|FG001|Overall Study|Death|15|||
164305748|NCT01143246|593493220|FG000|Overall Study|Reason not Specified|3|||
164305749|NCT01143246|593493221|FG001|Overall Study|Reason not Specified|5|||
164305750|NCT01146795|593493222|FG000|Overall Study|Withdrawal by Subject|4|||
164305751|NCT01146795|593493222|FG000|Overall Study|Adverse Event|6|||
164305752|NCT01146795|593493222|FG000|Overall Study|Still in treatment at study closure|10|||
164305753|NCT05375760|593493223|FG000|Overall Study|Adverse Event|1|||
164305754|NCT05375760|593493224|FG001|Overall Study|Adverse Event|0|||
164305755|NCT05375760|593493223|FG000|Overall Study|Death|0|||
164305756|NCT05375760|593493224|FG001|Overall Study|Death|1|||
164305757|NCT05375760|593493223|FG000|Overall Study|Lost to Follow-up|6|||
164305758|NCT05375760|593493224|FG001|Overall Study|Lost to Follow-up|6|||
164305759|NCT05375760|593493223|FG000|Overall Study|Withdrawal by Subject|17|||
164305760|NCT05375760|593493224|FG001|Overall Study|Withdrawal by Subject|19|||
164305761|NCT05375760|593493223|FG000|Overall Study|Dosing halted by FDA|96|||
164305762|NCT05375760|593493224|FG001|Overall Study|Dosing halted by FDA|100|||
164305763|NCT05375760|593493223|FG000|Overall Study|Not compliant with study visit|2|||
164305764|NCT05375760|593493224|FG001|Overall Study|Not compliant with study visit|0|||
164305765|NCT05375760|593493223|FG000|Overall Study|Physician Decision|1|||
164305766|NCT05375760|593493224|FG001|Overall Study|Physician Decision|0|||
164305767|NCT05375760|593493223|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
164305768|NCT05375760|593493224|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
164305769|NCT05375760|593493223|FG000|Overall Study|Participant moved|1|||
164305770|NCT05375760|593493224|FG001|Overall Study|Participant moved|0|||
164305771|NCT03853109|593493225|FG000|Overall Study|Withdrawal by Subject|0|||
164305772|NCT03853109|593493226|FG001|Overall Study|Withdrawal by Subject|0|||
164305773|NCT03853109|593493227|FG002|Overall Study|Withdrawal by Subject|1|||
164305774|NCT03853109|593493228|FG003|Overall Study|Withdrawal by Subject|2|||
164305775|NCT03853109|593493229|FG004|Overall Study|Withdrawal by Subject|1|||
164305776|NCT03853109|593493230|FG005|Overall Study|Withdrawal by Subject|4|||
164305777|NCT03853109|593493231|FG006|Overall Study|Withdrawal by Subject|5|||
164305778|NCT03853109|593493232|FG007|Overall Study|Withdrawal by Subject|3|||
164305779|NCT03853109|593493225|FG000|Overall Study|Decision by Sponsor|0|||
164305780|NCT03853109|593493226|FG001|Overall Study|Decision by Sponsor|0|||
164305781|NCT03853109|593493227|FG002|Overall Study|Decision by Sponsor|1|||
164305782|NCT03853109|593493228|FG003|Overall Study|Decision by Sponsor|0|||
164305783|NCT03853109|593493229|FG004|Overall Study|Decision by Sponsor|1|||
164305784|NCT03853109|593493230|FG005|Overall Study|Decision by Sponsor|1|||
164305785|NCT03853109|593493231|FG006|Overall Study|Decision by Sponsor|10|||
164305786|NCT03853109|593493232|FG007|Overall Study|Decision by Sponsor|2|||
164305787|NCT03853109|593493225|FG000|Overall Study|Lost to Follow-up|0|||
164305788|NCT03853109|593493226|FG001|Overall Study|Lost to Follow-up|0|||
164305789|NCT03853109|593493227|FG002|Overall Study|Lost to Follow-up|0|||
164305790|NCT03853109|593493228|FG003|Overall Study|Lost to Follow-up|0|||
164305791|NCT03853109|593493229|FG004|Overall Study|Lost to Follow-up|1|||
164305792|NCT03853109|593493230|FG005|Overall Study|Lost to Follow-up|3|||
164305793|NCT03853109|593493231|FG006|Overall Study|Lost to Follow-up|0|||
164305794|NCT03853109|593493232|FG007|Overall Study|Lost to Follow-up|0|||
164305795|NCT03853109|593493225|FG000|Overall Study|Death|2|||
164305796|NCT03853109|593493226|FG001|Overall Study|Death|5|||
164305797|NCT03853109|593493227|FG002|Overall Study|Death|8|||
164305798|NCT03853109|593493228|FG003|Overall Study|Death|10|||
164305799|NCT03853109|593493229|FG004|Overall Study|Death|3|||
164305800|NCT03853109|593493230|FG005|Overall Study|Death|20|||
164305801|NCT03853109|593493231|FG006|Overall Study|Death|10|||
164305802|NCT03853109|593493232|FG007|Overall Study|Death|5|||
164305803|NCT04032093|593493235|FG000|Overall Study|Lost to Follow-up|7|||
164305804|NCT04032093|593493236|FG001|Overall Study|Lost to Follow-up|7|||
164305805|NCT04032093|593493237|FG002|Overall Study|Lost to Follow-up|6|||
164305806|NCT04032093|593493238|FG003|Overall Study|Lost to Follow-up|10|||
164305807|NCT04032093|593493239|FG004|Overall Study|Lost to Follow-up|13|||
164305808|NCT04032093|593493240|FG005|Overall Study|Lost to Follow-up|7|||
164305809|NCT04032093|593493241|FG006|Overall Study|Lost to Follow-up|7|||
164305810|NCT04032093|593493242|FG007|Overall Study|Lost to Follow-up|5|||
164305811|NCT04032093|593493243|FG008|Overall Study|Lost to Follow-up|9|||
164305812|NCT04032093|593493244|FG009|Overall Study|Lost to Follow-up|12|||
164305813|NCT04032093|593493235|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
164305814|NCT04032093|593493236|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
164305815|NCT04032093|593493237|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
164305816|NCT04032093|593493238|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
164305817|NCT04032093|593493239|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
164305818|NCT04032093|593493240|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
164305819|NCT04032093|593493241|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
164305820|NCT04032093|593493242|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
164305821|NCT04032093|593493243|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
164305822|NCT04032093|593493244|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
164305823|NCT04032093|593493235|FG000|Overall Study|Other|1|||
164305824|NCT04032093|593493236|FG001|Overall Study|Other|0|||
164305825|NCT04032093|593493237|FG002|Overall Study|Other|0|||
164305826|NCT04032093|593493238|FG003|Overall Study|Other|1|||
164305827|NCT04032093|593493239|FG004|Overall Study|Other|1|||
164305828|NCT04032093|593493240|FG005|Overall Study|Other|0|||
164305829|NCT04032093|593493241|FG006|Overall Study|Other|0|||
164305830|NCT04032093|593493242|FG007|Overall Study|Other|0|||
164305831|NCT04032093|593493243|FG008|Overall Study|Other|0|||
164305832|NCT04032093|593493244|FG009|Overall Study|Other|1|||
164305833|NCT04032093|593493235|FG000|Overall Study|Withdrawal by Subject|1|||
164305834|NCT04032093|593493236|FG001|Overall Study|Withdrawal by Subject|3|||
164305835|NCT04032093|593493237|FG002|Overall Study|Withdrawal by Subject|2|||
164305836|NCT04032093|593493238|FG003|Overall Study|Withdrawal by Subject|2|||
164305837|NCT04032093|593493239|FG004|Overall Study|Withdrawal by Subject|3|||
164305838|NCT04032093|593493240|FG005|Overall Study|Withdrawal by Subject|0|||
164305839|NCT04032093|593493241|FG006|Overall Study|Withdrawal by Subject|0|||
164305840|NCT04032093|593493242|FG007|Overall Study|Withdrawal by Subject|0|||
164305841|NCT04032093|593493243|FG008|Overall Study|Withdrawal by Subject|0|||
164305842|NCT04032093|593493244|FG009|Overall Study|Withdrawal by Subject|0|||
164305843|NCT04032093|593493235|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164305844|NCT04032093|593493236|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164305845|NCT04032093|593493237|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
164305846|NCT04032093|593493238|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
164305847|NCT04032093|593493239|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
164305848|NCT04032093|593493240|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
164305849|NCT04032093|593493241|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
164305850|NCT04032093|593493242|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
164305851|NCT04032093|593493243|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
164305852|NCT04032093|593493244|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
164305853|NCT04032093|593493235|FG000|Overall Study|Adverse Event|0|||
164305854|NCT04032093|593493236|FG001|Overall Study|Adverse Event|0|||
164305855|NCT04032093|593493237|FG002|Overall Study|Adverse Event|0|||
164305856|NCT04032093|593493238|FG003|Overall Study|Adverse Event|0|||
164305857|NCT04032093|593493239|FG004|Overall Study|Adverse Event|0|||
164305858|NCT04032093|593493240|FG005|Overall Study|Adverse Event|0|||
164305859|NCT04032093|593493241|FG006|Overall Study|Adverse Event|0|||
164305860|NCT04032093|593493242|FG007|Overall Study|Adverse Event|0|||
164305861|NCT04032093|593493243|FG008|Overall Study|Adverse Event|0|||
164305862|NCT04032093|593493244|FG009|Overall Study|Adverse Event|1|||
164305863|NCT04032093|593493235|FG000|Overall Study|Physician Decision|0|||
164305864|NCT04032093|593493236|FG001|Overall Study|Physician Decision|0|||
164305865|NCT04032093|593493237|FG002|Overall Study|Physician Decision|0|||
164305866|NCT04032093|593493238|FG003|Overall Study|Physician Decision|0|||
164305867|NCT04032093|593493239|FG004|Overall Study|Physician Decision|0|||
164305868|NCT04032093|593493240|FG005|Overall Study|Physician Decision|1|||
164305869|NCT04032093|593493241|FG006|Overall Study|Physician Decision|0|||
164305870|NCT04032093|593493242|FG007|Overall Study|Physician Decision|0|||
164305871|NCT04032093|593493243|FG008|Overall Study|Physician Decision|0|||
164305872|NCT04032093|593493244|FG009|Overall Study|Physician Decision|0|||
164305873|NCT02565108|593493247|FG000|Overall Study|Adverse Event|1|||
164305874|NCT02565108|593493248|FG001|Overall Study|Adverse Event|0|||
164305875|NCT02565108|593493247|FG000|Overall Study|Withdrew Consent|1|||
164305876|NCT02565108|593493248|FG001|Overall Study|Withdrew Consent|0|||
164305877|NCT01310075|593493249|FG000|Overall Study|Lost to Follow-up|1|||
164305878|NCT01310075|593493250|FG001|Overall Study|Lost to Follow-up|0|||
164305879|NCT01310075|593493249|FG000|Overall Study|Physician Decision|10|||
164305880|NCT01310075|593493250|FG001|Overall Study|Physician Decision|7|||
164305881|NCT01310075|593493249|FG000|Overall Study|Protocol Violation|2|||
164305882|NCT01310075|593493250|FG001|Overall Study|Protocol Violation|2|||
164305883|NCT01310075|593493249|FG000|Overall Study|Withdrawal by Subject|1|||
164305884|NCT01310075|593493250|FG001|Overall Study|Withdrawal by Subject|1|||
164305885|NCT02745119|593493255|FG000|Overall Study|Adverse Event|1|||
164305886|NCT02745119|593493256|FG001|Overall Study|Adverse Event|0|||
164305887|NCT02745119|593493257|FG002|Overall Study|Adverse Event|1|||
164305888|NCT02745119|593493258|FG003|Overall Study|Adverse Event|3|||
164305889|NCT02745119|593493255|FG000|Overall Study|Death|3|||
164305890|NCT02745119|593493256|FG001|Overall Study|Death|3|||
164305891|NCT02745119|593493257|FG002|Overall Study|Death|0|||
164305892|NCT02745119|593493258|FG003|Overall Study|Death|4|||
164305893|NCT02745119|593493255|FG000|Overall Study|Lost to Follow-up|0|||
164305894|NCT02745119|593493256|FG001|Overall Study|Lost to Follow-up|0|||
164305895|NCT02745119|593493257|FG002|Overall Study|Lost to Follow-up|0|||
164305896|NCT02745119|593493258|FG003|Overall Study|Lost to Follow-up|1|||
164305897|NCT02745119|593493255|FG000|Overall Study|Protocol Deviation|0|||
164305898|NCT02745119|593493256|FG001|Overall Study|Protocol Deviation|0|||
164305899|NCT02745119|593493257|FG002|Overall Study|Protocol Deviation|0|||
164305900|NCT02745119|593493258|FG003|Overall Study|Protocol Deviation|1|||
164305901|NCT02745119|593493255|FG000|Overall Study|Withdrawal by Subject|7|||
164305902|NCT02745119|593493256|FG001|Overall Study|Withdrawal by Subject|15|||
164305903|NCT02745119|593493257|FG002|Overall Study|Withdrawal by Subject|8|||
164305904|NCT02745119|593493258|FG003|Overall Study|Withdrawal by Subject|14|||
164305905|NCT02745119|593493255|FG000|Overall Study|Study Terminated by Sponsor|134|||
164305906|NCT02745119|593493256|FG001|Overall Study|Study Terminated by Sponsor|252|||
164305907|NCT02745119|593493257|FG002|Overall Study|Study Terminated by Sponsor|135|||
164305908|NCT02745119|593493258|FG003|Overall Study|Study Terminated by Sponsor|251|||
164305909|NCT02745119|593493255|FG000|Overall Study|Physician Decision|0|||
164305910|NCT02745119|593493256|FG001|Overall Study|Physician Decision|2|||
164305911|NCT02745119|593493257|FG002|Overall Study|Physician Decision|2|||
164305912|NCT02745119|593493258|FG003|Overall Study|Physician Decision|2|||
164305913|NCT02745119|593493255|FG000|Overall Study|Reason Not Specified|0|||
164305914|NCT02745119|593493256|FG001|Overall Study|Reason Not Specified|2|||
164305915|NCT02745119|593493257|FG002|Overall Study|Reason Not Specified|0|||
164305916|NCT02745119|593493258|FG003|Overall Study|Reason Not Specified|1|||
164305917|NCT00960999|593493259|FG000|Overall Study|Withdrawal by Subject|1|||
164305918|NCT00960999|593493260|FG001|Overall Study|Withdrawal by Subject|0|||
164305919|NCT00960999|593493259|FG000|Overall Study|Protocol Violation|5|||
164305920|NCT00960999|593493260|FG001|Overall Study|Protocol Violation|2|||
164305921|NCT00960999|593493259|FG000|Overall Study|RT dose constraints not met|2|||
164305922|NCT00960999|593493260|FG001|Overall Study|RT dose constraints not met|0|||
164305923|NCT02536963|593493261|FG000|Overall Study|Withdrawal by Subject|18|||
164305924|NCT02425943|593493262|FG000|Overall Study|Adverse Event|3|||
164305925|NCT02425943|593493263|FG001|Overall Study|Adverse Event|1|||
164305926|NCT02425943|593493262|FG000|Overall Study|Lost to Follow-up|59|||
164305927|NCT02425943|593493263|FG001|Overall Study|Lost to Follow-up|37|||
164305928|NCT02425943|593493262|FG000|Overall Study|Protocol Violation|4|||
164305929|NCT02425943|593493263|FG001|Overall Study|Protocol Violation|1|||
164305930|NCT02425943|593493262|FG000|Overall Study|Withdrawal by Subject|64|||
164305931|NCT02425943|593493263|FG001|Overall Study|Withdrawal by Subject|31|||
164305932|NCT02425943|593493262|FG000|Overall Study|Other|6|||
164305933|NCT02425943|593493263|FG001|Overall Study|Other|0|||
164305934|NCT02141204|593493264|FG000|Overall Study|Lost to Follow-up|2|||
164305935|NCT02141204|593493265|FG001|Overall Study|Lost to Follow-up|1|||
164305936|NCT02141204|593493264|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
164305937|NCT02141204|593493265|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
164305938|NCT02141204|593493264|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
164305939|NCT02141204|593493265|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
164305940|NCT02141204|593493264|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
164305941|NCT02141204|593493265|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
164305942|NCT01209325|593493266|FG000|Overall Study|Lost to Follow-up|24|||
164305943|NCT01209325|593493266|FG000|Overall Study|Adverse Event|1|||
164305944|NCT01209325|593493266|FG000|Overall Study|Relocated|3|||
164305945|NCT01209325|593493266|FG000|Overall Study|Refusal after starting therapy|8|||
164305946|NCT01209325|593493266|FG000|Overall Study|Protocol Violation|4|||
164305947|NCT01209325|593493266|FG000|Overall Study|Refusal prior to therapy|1|||
164305948|NCT01209325|593493266|FG000|Overall Study|Incarceration|2|||
164305949|NCT03529422|593493275|FG000|Overall Study|Withdrawal by Subject|1|||
164305950|NCT03529422|593493275|FG000|Overall Study|Protocol Violation|1|||
164305951|NCT03529422|593493275|FG000|Overall Study|Disease progression|2|||
164305952|NCT02484391|593493276|FG000|Overall Study|Lack of Efficacy|15|||
164305953|NCT02484391|593493277|FG001|Overall Study|Lack of Efficacy|14|||
164305954|NCT02484391|593493278|FG002|Overall Study|Lack of Efficacy|3|||
164305955|NCT02484391|593493276|FG000|Overall Study|Lost to Follow-up|0|||
164305956|NCT02484391|593493277|FG001|Overall Study|Lost to Follow-up|0|||
164305957|NCT02484391|593493278|FG002|Overall Study|Lost to Follow-up|2|||
164305958|NCT02484391|593493276|FG000|Overall Study|Physician Decision|1|||
164305959|NCT02484391|593493277|FG001|Overall Study|Physician Decision|3|||
164305960|NCT02484391|593493278|FG002|Overall Study|Physician Decision|0|||
164305961|NCT02484391|593493276|FG000|Overall Study|Went to Transplant|5|||
164305962|NCT02484391|593493277|FG001|Overall Study|Went to Transplant|3|||
164305963|NCT02484391|593493278|FG002|Overall Study|Went to Transplant|2|||
164305964|NCT04922216|593493279|FG000|Overall Study|Withdrawal by Subject|0|||
164305965|NCT04922216|593493280|FG001|Overall Study|Withdrawal by Subject|1|||
164305966|NCT04922216|593493281|FG002|Overall Study|Withdrawal by Subject|0|||
164305967|NCT04922216|593493282|FG003|Overall Study|Withdrawal by Subject|0|||
164305968|NCT04922216|593493283|FG004|Overall Study|Withdrawal by Subject|0|||
164305969|NCT04922216|593493284|FG005|Overall Study|Withdrawal by Subject|0|||
164305970|NCT04922216|593493285|FG006|Overall Study|Withdrawal by Subject|0|||
164305971|NCT04922216|593493286|FG007|Overall Study|Withdrawal by Subject|2|||
164305972|NCT04922216|593493287|FG008|Overall Study|Withdrawal by Subject|0|||
164305973|NCT04922216|593493288|FG009|Overall Study|Withdrawal by Subject|0|||
164305974|NCT04922216|593493289|FG010|Overall Study|Withdrawal by Subject|0|||
164305975|NCT04922216|593493290|FG011|Overall Study|Withdrawal by Subject|0|||
164305976|NCT04922216|593493291|FG012|Overall Study|Withdrawal by Subject|1|||
164305977|NCT04922216|593493292|FG013|Overall Study|Withdrawal by Subject|1|||
164305978|NCT04922216|593493293|FG014|Overall Study|Withdrawal by Subject|1|||
164305979|NCT04922216|593493294|FG015|Overall Study|Withdrawal by Subject|0|||
164305980|NCT04922216|593493295|FG016|Overall Study|Withdrawal by Subject|0|||
164305981|NCT04922216|593493296|FG017|Overall Study|Withdrawal by Subject|1|||
164305982|NCT04922216|593493297|FG018|Overall Study|Withdrawal by Subject|1|||
164305983|NCT04922216|593493298|FG019|Overall Study|Withdrawal by Subject|1|||
164305984|NCT04922216|593493299|FG020|Overall Study|Withdrawal by Subject|1|||
164305985|NCT04922216|593493300|FG021|Overall Study|Withdrawal by Subject|0|||
164305986|NCT04922216|593493301|FG022|Overall Study|Withdrawal by Subject|0|||
164305987|NCT04922216|593493302|FG023|Overall Study|Withdrawal by Subject|2|||
164533873|NCT04702776|594327160|FG000|Overall Study|Lost to Follow-up|2|||
164533874|NCT04702776|594327161|FG001|Overall Study|Lost to Follow-up|1|||
164533875|NCT04702776|594327162|FG002|Overall Study|Lost to Follow-up|4|||
164533876|NCT04702776|594327160|FG000|Overall Study|Protocol Violation|2|||
164533877|NCT04702776|594327161|FG001|Overall Study|Protocol Violation|2|||
164533878|NCT04702776|594327162|FG002|Overall Study|Protocol Violation|3|||
164533879|NCT02076178|594327165|FG000|Oral Phase|Adverse Event|0|||
164533880|NCT02076178|594327166|FG001|Oral Phase|Adverse Event|7|||
164533881|NCT02076178|594327165|FG000|Oral Phase|Withdrawal by Subject|0|||
164533882|NCT02076178|594327166|FG001|Oral Phase|Withdrawal by Subject|4|||
164533883|NCT02076178|594327165|FG000|Oral Phase|Physician Decision|0|||
164533884|NCT02076178|594327166|FG001|Oral Phase|Physician Decision|1|||
164533885|NCT02076178|594327165|FG000|Injection Phase|Protocol defined stopping criteria|1|||
164533886|NCT02076178|594327166|FG001|Injection Phase|Protocol defined stopping criteria|0|||
164533887|NCT02076178|594327165|FG000|Injection Phase|Withdrawal by Subject|0|||
164533888|NCT02076178|594327166|FG001|Injection Phase|Withdrawal by Subject|3|||
164533889|NCT02076178|594327165|FG000|Injection Phase|Physician Decision|0|||
164533890|NCT02076178|594327166|FG001|Injection Phase|Physician Decision|3|||
164533891|NCT02076178|594327165|FG000|Injection Phase|Lost to Follow-up|0|||
164533892|NCT02076178|594327166|FG001|Injection Phase|Lost to Follow-up|1|||
164533893|NCT00051363|594327169|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
164533894|NCT00051363|594327170|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
164533895|NCT00051363|594327169|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
164533896|NCT00051363|594327170|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
164533897|NCT00051363|594327169|FG000|Overall Study|Death|2|||
164533898|NCT00051363|594327170|FG001|Overall Study|Death|2|||
164533899|NCT00051363|594327169|FG000|Overall Study|Excluded Pre-Randomization|2|||
164533900|NCT00051363|594327170|FG001|Overall Study|Excluded Pre-Randomization|5|||
164533901|NCT03370471|594327171|FG000|Overall Study|Withdrawal by Subject|6|||
164533902|NCT03370471|594327172|FG001|Overall Study|Withdrawal by Subject|1|||
164533903|NCT03370471|594327171|FG000|Overall Study|Unable to access veins for blood draw|0|||
164533904|NCT03370471|594327172|FG001|Overall Study|Unable to access veins for blood draw|1|||
164533905|NCT03370471|594327171|FG000|Overall Study|Screen fail|1|||
164533906|NCT03370471|594327172|FG001|Overall Study|Screen fail|0|||
164533907|NCT01765179|594327174|FG000|Overall Study|Adverse Event|3|||
164533908|NCT01765179|594327174|FG000|Overall Study|Lost to Follow-up|5|||
164533909|NCT01765179|594327174|FG000|Overall Study|Non-compliance with study drug|2|||
164533910|NCT01765179|594327174|FG000|Overall Study|Protocol Violation|1|||
164533911|NCT01765179|594327174|FG000|Overall Study|Withdrawal by Subject|8|||
164533912|NCT01765179|594327174|FG000|Overall Study|Hematocrit >54%|3|||
164533913|NCT01765179|594327174|FG000|Overall Study|prohibited med|1|||
164533914|NCT01765179|594327174|FG000|Overall Study|Out of country unable to finish study|1|||
164533915|NCT01765179|594327174|FG000|Overall Study|lack of venous access|1|||
164533916|NCT01765179|594327174|FG000|Overall Study|work conflict|1|||
164533917|NCT01765179|594327174|FG000|Overall Study|Ca elevated 10.6|1|||
164533918|NCT05358717|594327175|FG000|Overall Study|Adverse Event|0|||
164533919|NCT05358717|594327176|FG001|Overall Study|Adverse Event|1|||
164305988|NCT04922216|593493303|FG024|Overall Study|Withdrawal by Subject|0|||
164305989|NCT04922216|593493304|FG025|Overall Study|Withdrawal by Subject|0|||
164305990|NCT04922216|593493305|FG026|Overall Study|Withdrawal by Subject|1|||
164305991|NCT04922216|593493306|FG027|Overall Study|Withdrawal by Subject|0|||
164305992|NCT04922216|593493307|FG028|Overall Study|Withdrawal by Subject|0|||
164305993|NCT04922216|593493308|FG029|Overall Study|Withdrawal by Subject|0|||
164533920|NCT05358717|594327177|FG002|Overall Study|Adverse Event|1|||
164533921|NCT05358717|594327175|FG000|Overall Study|Death|1|||
164533922|NCT05358717|594327176|FG001|Overall Study|Death|1|||
164533923|NCT05358717|594327177|FG002|Overall Study|Death|0|||
164533924|NCT05358717|594327175|FG000|Overall Study|Withdrawal by Subject|1|||
164533925|NCT05358717|594327176|FG001|Overall Study|Withdrawal by Subject|1|||
164533926|NCT05358717|594327177|FG002|Overall Study|Withdrawal by Subject|2|||
164533927|NCT05358717|594327175|FG000|Overall Study|Study Paused by Sponsor in United States|0|||
164305994|NCT04922216|593493309|FG030|Overall Study|Withdrawal by Subject|1|||
164305995|NCT04922216|593493310|FG031|Overall Study|Withdrawal by Subject|0|||
164305996|NCT04922216|593493279|FG000|Overall Study|Lost to Follow-up|1|||
164305997|NCT04922216|593493280|FG001|Overall Study|Lost to Follow-up|0|||
164305998|NCT04922216|593493281|FG002|Overall Study|Lost to Follow-up|2|||
164305999|NCT04922216|593493282|FG003|Overall Study|Lost to Follow-up|0|||
164306000|NCT04922216|593493283|FG004|Overall Study|Lost to Follow-up|0|||
164306001|NCT04922216|593493284|FG005|Overall Study|Lost to Follow-up|2|||
164306002|NCT04922216|593493285|FG006|Overall Study|Lost to Follow-up|0|||
164306003|NCT04922216|593493286|FG007|Overall Study|Lost to Follow-up|1|||
164306004|NCT04922216|593493287|FG008|Overall Study|Lost to Follow-up|1|||
164306005|NCT04922216|593493288|FG009|Overall Study|Lost to Follow-up|2|||
164306006|NCT04922216|593493289|FG010|Overall Study|Lost to Follow-up|2|||
164306007|NCT04922216|593493290|FG011|Overall Study|Lost to Follow-up|1|||
164306008|NCT04922216|593493291|FG012|Overall Study|Lost to Follow-up|1|||
164306009|NCT04922216|593493292|FG013|Overall Study|Lost to Follow-up|0|||
164306010|NCT04922216|593493293|FG014|Overall Study|Lost to Follow-up|1|||
164306011|NCT04922216|593493294|FG015|Overall Study|Lost to Follow-up|0|||
164306012|NCT04922216|593493295|FG016|Overall Study|Lost to Follow-up|0|||
164306013|NCT04922216|593493296|FG017|Overall Study|Lost to Follow-up|2|||
164306014|NCT04922216|593493297|FG018|Overall Study|Lost to Follow-up|1|||
164306015|NCT04922216|593493298|FG019|Overall Study|Lost to Follow-up|0|||
164306016|NCT04922216|593493299|FG020|Overall Study|Lost to Follow-up|1|||
164306017|NCT04922216|593493300|FG021|Overall Study|Lost to Follow-up|0|||
164306018|NCT04922216|593493301|FG022|Overall Study|Lost to Follow-up|2|||
164306019|NCT04922216|593493302|FG023|Overall Study|Lost to Follow-up|1|||
164306020|NCT04922216|593493303|FG024|Overall Study|Lost to Follow-up|0|||
164306021|NCT04922216|593493304|FG025|Overall Study|Lost to Follow-up|2|||
164306022|NCT04922216|593493305|FG026|Overall Study|Lost to Follow-up|0|||
164306023|NCT04922216|593493306|FG027|Overall Study|Lost to Follow-up|0|||
164306024|NCT04922216|593493307|FG028|Overall Study|Lost to Follow-up|1|||
164306025|NCT04922216|593493308|FG029|Overall Study|Lost to Follow-up|0|||
164306026|NCT04922216|593493309|FG030|Overall Study|Lost to Follow-up|2|||
164306027|NCT04922216|593493310|FG031|Overall Study|Lost to Follow-up|1|||
164306028|NCT03207763|593494660|FG000|Overall Study|Lost to Follow-up|1|||
164306029|NCT03207763|593494661|FG001|Overall Study|Lost to Follow-up|0|||
164306030|NCT02102204|593494662|FG000|Overall Study|Withdrawal by Subject|137|||
164306031|NCT02102204|593494662|FG000|Overall Study|Death|92|||
164306032|NCT02102204|593494662|FG000|Overall Study|Lost to Follow-up|65|||
164306033|NCT02102204|593494662|FG000|Overall Study|Sponsor Decision|5|||
164306034|NCT02102204|593494662|FG000|Overall Study|Ongoing|5|||
164306035|NCT03751657|593494663|FG000|Overall Study|Physician Decision|0|||
164306036|NCT03751657|593494664|FG001|Overall Study|Physician Decision|1|||
164306037|NCT03751657|593494663|FG000|Overall Study|Withdrawal by Subject|1|||
164306038|NCT03751657|593494664|FG001|Overall Study|Withdrawal by Subject|1|||
164306039|NCT03751657|593494663|FG000|Overall Study|Lost to Follow-up|2|||
164306040|NCT03751657|593494664|FG001|Overall Study|Lost to Follow-up|1|||
164306041|NCT00990704|593494665|FG000|Overall Study|Adverse Event|1|||
164306042|NCT00990704|593494666|FG001|Overall Study|Adverse Event|1|||
164306043|NCT00990704|593494665|FG000|Overall Study|Physician Decision|0|||
164306044|NCT00990704|593494666|FG001|Overall Study|Physician Decision|1|||
164306045|NCT03894813|593494673|FG000|Overall Study|Adverse Event|1|||
164306046|NCT03894813|593494674|FG001|Overall Study|Adverse Event|1|||
164306047|NCT03894813|593494673|FG000|Overall Study|Lack of Efficacy|3|||
164306048|NCT03894813|593494674|FG001|Overall Study|Lack of Efficacy|3|||
164306049|NCT03894813|593494673|FG000|Overall Study|Lost to Follow-up|1|||
164306050|NCT03894813|593494674|FG001|Overall Study|Lost to Follow-up|0|||
164306051|NCT03894813|593494673|FG000|Overall Study|Pregnancy|2|||
164306052|NCT03894813|593494674|FG001|Overall Study|Pregnancy|1|||
164306053|NCT03894813|593494673|FG000|Overall Study|Protocol Violation|3|||
164306054|NCT03894813|593494674|FG001|Overall Study|Protocol Violation|7|||
164306055|NCT03894813|593494673|FG000|Overall Study|Withdrawal by Subject|1|||
164306056|NCT03894813|593494674|FG001|Overall Study|Withdrawal by Subject|3|||
164306057|NCT03894813|593494673|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
164306058|NCT03894813|593494674|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
164306059|NCT02269267|593494676|FG000|Overall Study|Death|5|||
164306060|NCT03773796|593494677|FG000|Overall Study|Adverse Event|1|||
164306061|NCT03773796|593494677|FG000|Overall Study|Withdrawal by Subject|1|||
164306062|NCT03773796|593494677|FG000|Overall Study|Lack of Efficacy|1|||
164306063|NCT03805659|593494678|FG000|Overall Study|Withdrawal by Subject|0|||
164306064|NCT03805659|593494679|FG001|Overall Study|Withdrawal by Subject|1|||
164306065|NCT00145158|593494682|FG000|Overall Study|premature withdrawal|2|||
164306066|NCT00145158|593494683|FG001|Overall Study|premature withdrawal|3|||
164306067|NCT02741518|593494684|FG000|Overall Study|Withdrawal by Subject|1|||
164306068|NCT02741518|593494685|FG001|Overall Study|Withdrawal by Subject|1|||
164306069|NCT00476008|593494686|FG000|Overall Study|Adverse Event|4|||
164306070|NCT00476008|593494687|FG001|Overall Study|Adverse Event|4|||
164306071|NCT00476008|593494686|FG000|Overall Study|Placebo concerns|2|||
164306072|NCT00476008|593494687|FG001|Overall Study|Placebo concerns|2|||
164306073|NCT00476008|593494686|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
164306074|NCT00476008|593494687|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
164306075|NCT00476008|593494686|FG000|Overall Study|Withdrawal by Subject|0|||
164306076|NCT00476008|593494687|FG001|Overall Study|Withdrawal by Subject|1|||
164306077|NCT00476008|593494686|FG000|Overall Study|Death|1|||
164306078|NCT00476008|593494687|FG001|Overall Study|Death|0|||
164306079|NCT01788358|593494688|FG000|Overall Study|Other|11|||
164306080|NCT01788358|593494688|FG000|Overall Study|Logistical difficulties|1|||
164306081|NCT01788358|593494688|FG000|Overall Study|Lost to Follow-up|5|||
164306082|NCT01788358|593494688|FG000|Overall Study|Protocol Violation|3|||
164306083|NCT01788358|593494688|FG000|Overall Study|Withdrawal by Subject|26|||
164306084|NCT01788358|593494688|FG000|Overall Study|Lack of Efficacy|1|||
164306085|NCT01788358|593494688|FG000|Overall Study|Adverse Event|51|||
164306086|NCT01227018|593494689|FG000|Overall Study|Disease progression|9|||
164306087|NCT01227018|593494689|FG000|Overall Study|Toxicity|2|||
164306088|NCT01227018|593494689|FG000|Overall Study|Withdrew after beginning treatment|4|||
164306089|NCT00499616|593494697|FG000|Overall Study|Death|1|||
164306090|NCT00499616|593494698|FG001|Overall Study|Death|5|||
164306091|NCT00499616|593494699|FG002|Overall Study|Death|3|||
164306092|NCT00499616|593494700|FG003|Overall Study|Death|1|||
164306093|NCT00499616|593494697|FG000|Overall Study|Lack of Efficacy|5|||
164306094|NCT00499616|593494698|FG001|Overall Study|Lack of Efficacy|0|||
164306095|NCT00499616|593494699|FG002|Overall Study|Lack of Efficacy|19|||
164306096|NCT00499616|593494700|FG003|Overall Study|Lack of Efficacy|0|||
164306097|NCT00499616|593494697|FG000|Overall Study|Lost to Follow-up|0|||
164306098|NCT00499616|593494698|FG001|Overall Study|Lost to Follow-up|0|||
164306099|NCT00499616|593494699|FG002|Overall Study|Lost to Follow-up|1|||
164306100|NCT00499616|593494700|FG003|Overall Study|Lost to Follow-up|0|||
164306101|NCT00499616|593494697|FG000|Overall Study|Physician Decision|6|||
164306102|NCT00499616|593494698|FG001|Overall Study|Physician Decision|16|||
164306103|NCT00499616|593494699|FG002|Overall Study|Physician Decision|9|||
164306104|NCT00499616|593494700|FG003|Overall Study|Physician Decision|0|||
164306105|NCT00499616|593494697|FG000|Overall Study|Withdrawal by Subject|1|||
164306106|NCT00499616|593494698|FG001|Overall Study|Withdrawal by Subject|0|||
164306107|NCT00499616|593494699|FG002|Overall Study|Withdrawal by Subject|1|||
164306108|NCT00499616|593494700|FG003|Overall Study|Withdrawal by Subject|0|||
164306109|NCT00499616|593494697|FG000|Overall Study|Ineligible|1|||
164306110|NCT00499616|593494698|FG001|Overall Study|Ineligible|2|||
164306111|NCT00499616|593494699|FG002|Overall Study|Ineligible|0|||
164306112|NCT00499616|593494700|FG003|Overall Study|Ineligible|15|||
164306113|NCT00499616|593494697|FG000|Overall Study|Not evaluable|0|||
164306114|NCT00499616|593494698|FG001|Overall Study|Not evaluable|0|||
164306115|NCT00499616|593494699|FG002|Overall Study|Not evaluable|0|||
164306116|NCT00499616|593494700|FG003|Overall Study|Not evaluable|41|||
164306117|NCT00499616|593494697|FG000|Overall Study|Patient/Parent Refusal|1|||
164306118|NCT00499616|593494698|FG001|Overall Study|Patient/Parent Refusal|5|||
164306119|NCT00499616|593494699|FG002|Overall Study|Patient/Parent Refusal|3|||
164306120|NCT00499616|593494700|FG003|Overall Study|Patient/Parent Refusal|0|||
164306121|NCT00808080|593494703|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
164306122|NCT02803580|593494706|FG000|Overall Study|Death|13|||
164306123|NCT02803580|593494706|FG000|Overall Study|Lost to Follow-up|19|||
164306124|NCT02803580|593494706|FG000|Overall Study|Withdrawal by Subject|3|||
164306125|NCT02803580|593494706|FG000|Overall Study|Inclusion in clinical trial|1|||
164306126|NCT01837823|593494707|FG000|Overall Study|Lost to Follow-up|6|||
164306127|NCT03052400|593494708|FG000|Overall Study|Lost to Follow-up|1|||
164306128|NCT03052400|593494709|FG001|Overall Study|Lost to Follow-up|0|||
164306129|NCT03052400|593494708|FG000|Overall Study|Withdrawal by Subject|0|||
164306130|NCT03052400|593494709|FG001|Overall Study|Withdrawal by Subject|1|||
164306131|NCT01358721|593494710|FG000|Overall Study|Withdrawal by Subject|0|||
164306132|NCT01358721|593494711|FG001|Overall Study|Withdrawal by Subject|0|||
164306133|NCT01358721|593494712|FG002|Overall Study|Withdrawal by Subject|0|||
164306134|NCT01358721|593494713|FG003|Overall Study|Withdrawal by Subject|1|||
164306135|NCT01358721|593494710|FG000|Overall Study|Death|0|||
164306136|NCT01358721|593494711|FG001|Overall Study|Death|2|||
164306137|NCT01358721|593494712|FG002|Overall Study|Death|0|||
164306138|NCT01358721|593494713|FG003|Overall Study|Death|0|||
164306139|NCT01358721|593494710|FG000|Overall Study|Study Drug Toxicity|1|||
164306140|NCT01358721|593494711|FG001|Overall Study|Study Drug Toxicity|3|||
164306141|NCT01358721|593494712|FG002|Overall Study|Study Drug Toxicity|4|||
164306142|NCT01358721|593494713|FG003|Overall Study|Study Drug Toxicity|5|||
164306143|NCT01358721|593494710|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
164306144|NCT01358721|593494711|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
164306145|NCT01358721|593494712|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
164306146|NCT01358721|593494713|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
164306147|NCT01358721|593494710|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
164306148|NCT01358721|593494711|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
164306149|NCT01358721|593494712|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
164306150|NCT01358721|593494713|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
164306151|NCT01358721|593494710|FG000|Overall Study|Adverse Event related to study drug|1|||
164306152|NCT01358721|593494711|FG001|Overall Study|Adverse Event related to study drug|0|||
164306153|NCT01358721|593494712|FG002|Overall Study|Adverse Event related to study drug|0|||
164306154|NCT01358721|593494713|FG003|Overall Study|Adverse Event related to study drug|1|||
164306155|NCT01358721|593494710|FG000|Overall Study|Disease Progression|19|||
164306156|NCT01358721|593494711|FG001|Overall Study|Disease Progression|15|||
164306157|NCT01358721|593494712|FG002|Overall Study|Disease Progression|17|||
164306158|NCT01358721|593494713|FG003|Overall Study|Disease Progression|15|||
164306159|NCT01358721|593494710|FG000|Overall Study|Out of State/Unmet Criteria|0|||
164306160|NCT01358721|593494711|FG001|Overall Study|Out of State/Unmet Criteria|0|||
164306161|NCT01358721|593494712|FG002|Overall Study|Out of State/Unmet Criteria|1|||
164306162|NCT01358721|593494713|FG003|Overall Study|Out of State/Unmet Criteria|0|||
164306163|NCT00867815|593494714|FG000|Overall Study|Lost to Follow-up|1|||
164306164|NCT00001213|593494715|FG000|Overall Study|Death|18|||
164306165|NCT02636595|593494716|FG000|Overall Study|Lost to Follow-up|1|||
164306166|NCT02636595|593494716|FG000|Overall Study|Other|1|||
164306167|NCT05782179|593494718|FG000|Overall Study|Adverse Event|0|||
164306168|NCT05782179|593494719|FG001|Overall Study|Adverse Event|0|||
164306169|NCT05782179|593494720|FG002|Overall Study|Adverse Event|2|||
164306170|NCT05782179|593494721|FG003|Overall Study|Adverse Event|0|||
164306171|NCT05782179|593494722|FG004|Overall Study|Adverse Event|0|||
164306172|NCT05782179|593494723|FG005|Overall Study|Adverse Event|0|||
164306173|NCT00831181|593494726|FG000|Overall Study|Adverse Event|12|||
164306174|NCT05021978|593494729|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
164306175|NCT05021978|593494730|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
164306176|NCT05021978|593494731|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
164306177|NCT05021978|593494732|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
164306178|NCT05021978|593494729|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
164306179|NCT05021978|593494730|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
164306180|NCT05021978|593494731|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
164306181|NCT05021978|593494732|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
164306182|NCT00196313|593494733|FG000|Overall Study|Protocol Violation|2|||
164306183|NCT00196313|593494734|FG001|Overall Study|Protocol Violation|3|||
164306184|NCT00196313|593494733|FG000|Overall Study|Withdrawal by Subject|3|||
164306185|NCT00196313|593494734|FG001|Overall Study|Withdrawal by Subject|1|||
164306186|NCT00196313|593494733|FG000|Overall Study|Adverse Event|3|||
164306187|NCT00196313|593494734|FG001|Overall Study|Adverse Event|1|||
164306188|NCT00196313|593494733|FG000|Overall Study|Subject Pregnant|1|||
164306189|NCT00196313|593494734|FG001|Overall Study|Subject Pregnant|1|||
164306190|NCT00196313|593494733|FG000|Overall Study|Lost to Follow-up|2|||
164306191|NCT00196313|593494734|FG001|Overall Study|Lost to Follow-up|2|||
164306192|NCT04639258|593494735|FG000|Overall Study|Screen failure|5|||
164306193|NCT04639258|593494735|FG000|Overall Study|Physician Decision|2|||
164306194|NCT04639258|593494735|FG000|Overall Study|Early study termination|3|||
164306195|NCT04639258|593494735|FG000|Overall Study|Withdrawal by Subject|1|||
164306196|NCT00414596|593494737|FG000|Overall Study|Protocol Violation|2|||
164306197|NCT01635153|593494739|FG000|Overall Study|Lost to Follow-up|40|||
164306198|NCT01635153|593494740|FG001|Overall Study|Lost to Follow-up|43|||
164306199|NCT02754440|593494741|FG000|Overall Study|Protocol Violation|3|||
164306200|NCT02754440|593494742|FG001|Overall Study|Protocol Violation|2|||
164306201|NCT02754440|593494743|FG002|Overall Study|Protocol Violation|2|||
164306202|NCT02754440|593494744|FG003|Overall Study|Protocol Violation|6|||
164306203|NCT02754440|593494741|FG000|Overall Study|Adverse Event|3|||
164306204|NCT02754440|593494742|FG001|Overall Study|Adverse Event|1|||
164306205|NCT02754440|593494743|FG002|Overall Study|Adverse Event|0|||
164306206|NCT02754440|593494744|FG003|Overall Study|Adverse Event|9|||
164306207|NCT02754440|593494741|FG000|Overall Study|Withdrawal by Subject|0|||
164306208|NCT02754440|593494742|FG001|Overall Study|Withdrawal by Subject|0|||
164306209|NCT02754440|593494743|FG002|Overall Study|Withdrawal by Subject|0|||
164306210|NCT02754440|593494744|FG003|Overall Study|Withdrawal by Subject|1|||
164306211|NCT02754440|593494741|FG000|Overall Study|Equipment failure|0|||
164306212|NCT02754440|593494742|FG001|Overall Study|Equipment failure|5|||
164306213|NCT02754440|593494743|FG002|Overall Study|Equipment failure|5|||
164306214|NCT02754440|593494744|FG003|Overall Study|Equipment failure|7|||
164306215|NCT02754440|593494741|FG000|Overall Study|Subject issues not resulting in AE|0|||
164306216|NCT02754440|593494742|FG001|Overall Study|Subject issues not resulting in AE|0|||
164306217|NCT02754440|593494743|FG002|Overall Study|Subject issues not resulting in AE|0|||
164306218|NCT02754440|593494744|FG003|Overall Study|Subject issues not resulting in AE|12|||
164306219|NCT02558296|593494745|FG000|Completed the Study Through Week 24|Adverse Event|9|||
164306220|NCT02558296|593494746|FG001|Completed the Study Through Week 24|Adverse Event|3|||
164306221|NCT02558296|593494745|FG000|Completed the Study Through Week 24|Death|7|||
164306222|NCT02558296|593494746|FG001|Completed the Study Through Week 24|Death|7|||
164306223|NCT02558296|593494745|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
164306224|NCT02558296|593494746|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
164306225|NCT02558296|593494745|FG000|Completed the Study Through Week 24|Physician Decision|1|||
164306226|NCT02558296|593494746|FG001|Completed the Study Through Week 24|Physician Decision|0|||
164419310|NCT01216293|593904746|FG001|Main Study|Major Protocol Deviation|0|||
164419311|NCT01216293|593904747|FG002|Main Study|Major Protocol Deviation|1|||
164419312|NCT01216293|593904745|FG000|Main Study|Lost to Follow-up|3|||
164419313|NCT01216293|593904746|FG001|Main Study|Lost to Follow-up|1|||
164419314|NCT01216293|593904747|FG002|Main Study|Lost to Follow-up|0|||
164419315|NCT01216293|593904745|FG000|Main Study|Voluntary Withdrawal|2|||
164419316|NCT01216293|593904746|FG001|Main Study|Voluntary Withdrawal|2|||
164419317|NCT01216293|593904747|FG002|Main Study|Voluntary Withdrawal|2|||
164419318|NCT01216293|593904745|FG000|Main Study|Other Reason Not Specified|0|||
164419319|NCT01216293|593904746|FG001|Main Study|Other Reason Not Specified|1|||
164419320|NCT01216293|593904747|FG002|Main Study|Other Reason Not Specified|1|||
164419321|NCT01216293|593904745|FG000|Main Study|Randomized, Not Treated|1|||
164419322|NCT01216293|593904746|FG001|Main Study|Randomized, Not Treated|0|||
164419323|NCT01216293|593904747|FG002|Main Study|Randomized, Not Treated|0|||
164419324|NCT01216293|593904745|FG000|Calcium Absorption Substudy|Adverse Event|0|||
164419325|NCT01216293|593904746|FG001|Calcium Absorption Substudy|Adverse Event|2|||
164419326|NCT01216293|593904747|FG002|Calcium Absorption Substudy|Adverse Event|0|||
164419327|NCT01216293|593904745|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
164419328|NCT01216293|593904746|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
164419329|NCT01216293|593904747|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
164419330|NCT01216293|593904745|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
164419331|NCT01216293|593904746|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
164419332|NCT01216293|593904747|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
164419333|NCT01040780|593906412|FG000|Overall Study|Protocol Violation|1|||
164306227|NCT02558296|593494745|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
164306228|NCT02558296|593494746|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
164306229|NCT02558296|593494745|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
164306230|NCT02558296|593494746|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
164306231|NCT02558296|593494745|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
164306232|NCT02558296|593494746|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
164306233|NCT02558296|593494745|FG000|Completed the Study|Adverse Event|14|||
164306234|NCT02558296|593494746|FG001|Completed the Study|Adverse Event|5|||
164306235|NCT02558296|593494745|FG000|Completed the Study|Death|39|||
164306236|NCT02558296|593494746|FG001|Completed the Study|Death|25|||
164306237|NCT02558296|593494745|FG000|Completed the Study|Lost to Follow-up|31|||
164306238|NCT02558296|593494746|FG001|Completed the Study|Lost to Follow-up|23|||
164306239|NCT02558296|593494745|FG000|Completed the Study|Physician Decision|6|||
164306240|NCT02558296|593494746|FG001|Completed the Study|Physician Decision|0|||
164306241|NCT02558296|593494745|FG000|Completed the Study|Protocol Violation|2|||
164306242|NCT02558296|593494746|FG001|Completed the Study|Protocol Violation|1|||
164306243|NCT02558296|593494745|FG000|Completed the Study|Withdrawal by Subject|53|||
164306244|NCT02558296|593494746|FG001|Completed the Study|Withdrawal by Subject|31|||
164306245|NCT02558296|593494745|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
164306246|NCT02558296|593494746|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
164306247|NCT01189032|593494751|FG000|Overall Study|Adverse Event|1|||
164306248|NCT01189032|593494752|FG001|Overall Study|Adverse Event|3|||
164306249|NCT01189032|593494753|FG002|Overall Study|Adverse Event|4|||
164306250|NCT01189032|593494751|FG000|Overall Study|Lack of Efficacy|2|||
164419334|NCT01040780|593906413|FG001|Overall Study|Protocol Violation|3|||
164306251|NCT01189032|593494752|FG001|Overall Study|Lack of Efficacy|3|||
164306252|NCT01189032|593494753|FG002|Overall Study|Lack of Efficacy|0|||
164306253|NCT01189032|593494751|FG000|Overall Study|Withdrawal by Subject|1|||
164306254|NCT01189032|593494752|FG001|Overall Study|Withdrawal by Subject|0|||
164306255|NCT01189032|593494753|FG002|Overall Study|Withdrawal by Subject|1|||
164306256|NCT01189032|593494751|FG000|Overall Study|Protocol Violation|1|||
164306257|NCT01189032|593494752|FG001|Overall Study|Protocol Violation|1|||
164306258|NCT01189032|593494753|FG002|Overall Study|Protocol Violation|1|||
164306259|NCT01995838|593494758|FG000|Overall Study|Lost to Follow-up|0|||
164306260|NCT01995838|593494759|FG001|Overall Study|Lost to Follow-up|1|||
164306261|NCT01995838|593494760|FG002|Overall Study|Lost to Follow-up|0|||
164306262|NCT01995838|593494761|FG003|Overall Study|Lost to Follow-up|0|||
164306263|NCT01995838|593494762|FG004|Overall Study|Lost to Follow-up|0|||
164306264|NCT01995838|593494763|FG005|Overall Study|Lost to Follow-up|0|||
164306265|NCT01995838|593494764|FG006|Overall Study|Lost to Follow-up|1|||
164306266|NCT01995838|593494758|FG000|Overall Study|Participant choice|2|||
164306267|NCT01995838|593494759|FG001|Overall Study|Participant choice|0|||
164306268|NCT01995838|593494760|FG002|Overall Study|Participant choice|0|||
164306269|NCT01995838|593494761|FG003|Overall Study|Participant choice|0|||
164306270|NCT01995838|593494762|FG004|Overall Study|Participant choice|0|||
164306271|NCT01995838|593494763|FG005|Overall Study|Participant choice|1|||
164306272|NCT01995838|593494764|FG006|Overall Study|Participant choice|1|||
164306273|NCT01995838|593494758|FG000|Overall Study|Adverse Event|0|||
164306274|NCT01995838|593494759|FG001|Overall Study|Adverse Event|0|||
164306275|NCT01995838|593494760|FG002|Overall Study|Adverse Event|0|||
164306276|NCT01995838|593494761|FG003|Overall Study|Adverse Event|0|||
164306277|NCT01995838|593494762|FG004|Overall Study|Adverse Event|0|||
164306278|NCT01995838|593494763|FG005|Overall Study|Adverse Event|0|||
164306279|NCT01995838|593494764|FG006|Overall Study|Adverse Event|1|||
164306280|NCT01995838|593494758|FG000|Overall Study|Withdrawal by Subject|0|||
164306281|NCT01995838|593494759|FG001|Overall Study|Withdrawal by Subject|0|||
164306282|NCT01995838|593494760|FG002|Overall Study|Withdrawal by Subject|0|||
164306283|NCT01995838|593494761|FG003|Overall Study|Withdrawal by Subject|0|||
164306284|NCT01995838|593494762|FG004|Overall Study|Withdrawal by Subject|1|||
164306285|NCT01995838|593494763|FG005|Overall Study|Withdrawal by Subject|0|||
164306286|NCT01995838|593494764|FG006|Overall Study|Withdrawal by Subject|0|||
164306287|NCT01995838|593494758|FG000|Overall Study|Other|3|||
164306288|NCT01995838|593494759|FG001|Overall Study|Other|1|||
164306289|NCT01995838|593494760|FG002|Overall Study|Other|0|||
164306290|NCT01995838|593494761|FG003|Overall Study|Other|2|||
164306291|NCT01995838|593494762|FG004|Overall Study|Other|1|||
164306292|NCT01995838|593494763|FG005|Overall Study|Other|1|||
164306293|NCT01995838|593494764|FG006|Overall Study|Other|2|||
164306294|NCT01967576|593494765|FG000|Overall Study|Withdrawal by Subject|3|||
164306295|NCT01967576|593494765|FG000|Overall Study|Progressed/Removed from treatment|1|||
164306296|NCT01967576|593494765|FG000|Overall Study|Study closing at site|1|||
164306297|NCT01967576|593494765|FG000|Overall Study|Adverse Event|1|||
164306298|NCT01967576|593494765|FG000|Overall Study|Refused further treatment|1|||
164306299|NCT00345358|593494766|FG000|Primary Vaccination Phase|Other|0|||
164306300|NCT00345358|593494767|FG001|Primary Vaccination Phase|Other|1|||
164306301|NCT00345358|593494768|FG002|Primary Vaccination Phase|Other|1|||
164306302|NCT00345358|593494769|FG003|Primary Vaccination Phase|Other|0|||
164306303|NCT00345358|593494766|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
164306304|NCT00345358|593494767|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
164306305|NCT00345358|593494768|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
164306306|NCT00345358|593494769|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
164306307|NCT00345358|593494766|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
164306308|NCT00345358|593494767|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
164306309|NCT00345358|593494768|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
164306310|NCT00345358|593494769|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
164306311|NCT00345358|593494766|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
164306312|NCT00345358|593494767|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
164306313|NCT00345358|593494768|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
164306314|NCT00345358|593494769|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
164306315|NCT00345358|593494766|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
164306316|NCT00345358|593494767|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
164306317|NCT00345358|593494768|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
164306318|NCT00345358|593494769|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
164306319|NCT00345358|593494766|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
164306320|NCT00345358|593494767|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
164306321|NCT00345358|593494768|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
164306322|NCT00345358|593494769|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
164306323|NCT02592798|593494770|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
164306324|NCT02592798|593494771|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
164306325|NCT02592798|593494770|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
164306326|NCT02592798|593494771|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
164306327|NCT02592798|593494770|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
164306328|NCT02592798|593494771|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
164306329|NCT02592798|593494770|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
164306330|NCT02592798|593494771|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
164306331|NCT02592798|593494770|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
164306332|NCT02592798|593494771|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
164306333|NCT02592798|593494770|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
164306334|NCT02592798|593494771|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
164306335|NCT02592798|593494770|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
164306336|NCT02592798|593494771|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
164306337|NCT02592798|593494770|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
164306338|NCT02592798|593494771|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
164306339|NCT02592798|593494770|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
164306340|NCT02592798|593494771|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
164306341|NCT02592798|593494770|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
164306342|NCT02592798|593494771|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
164306343|NCT02592798|593494770|FG000|Transition From DB2 to OLE|Other reasons|1|||
164306344|NCT02592798|593494771|FG001|Transition From DB2 to OLE|Other reasons|0|||
164306345|NCT02592798|593494770|FG000|Open Label Period (OLE)|Other reasons|0|||
164306346|NCT02592798|593494771|FG001|Open Label Period (OLE)|Other reasons|2|||
164306347|NCT02592798|593494770|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
164419335|NCT00654940|593906414|FG000|Period 1|Adverse Event|0|||
164419336|NCT00654940|593906415|FG001|Period 1|Adverse Event|1|||
164419337|NCT00654940|593906414|FG000|Period 1|Intolerable Pain Level|1|||
164419338|NCT00654940|593906415|FG001|Period 1|Intolerable Pain Level|0|||
164419339|NCT02169830|593906416|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
164419340|NCT02169830|593906417|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
164419341|NCT02169830|593906418|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
164419342|NCT02169830|593906416|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
164419343|NCT02169830|593906417|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
164419344|NCT02169830|593906418|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
164419345|NCT02169830|593906416|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
164419346|NCT02169830|593906417|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
164419347|NCT02169830|593906418|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
164419348|NCT02169830|593906416|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
164419349|NCT02169830|593906417|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
164419350|NCT02169830|593906418|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
164419351|NCT02169830|593906416|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
164419352|NCT02169830|593906417|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
164419353|NCT02169830|593906418|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
164419354|NCT01349829|593906419|FG000|Overall Study|Lost to Follow-up|4|||
164419355|NCT01349829|593906420|FG001|Overall Study|Lost to Follow-up|8|||
164419356|NCT01349829|593906419|FG000|Overall Study|Consent withdrawal|3|||
164419357|NCT01349829|593906420|FG001|Overall Study|Consent withdrawal|8|||
164419358|NCT01349829|593906419|FG000|Overall Study|Migrated/moved|2|||
164419359|NCT01349829|593906420|FG001|Overall Study|Migrated/moved|7|||
164419360|NCT02555371|593906421|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
164419361|NCT02555371|593906422|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
164419362|NCT02555371|593906423|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
164419363|NCT02555371|593906424|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
164419364|NCT02555371|593906425|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
164419365|NCT02555371|593906421|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
164419366|NCT02555371|593906422|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
164419367|NCT02555371|593906423|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
164419368|NCT02555371|593906424|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
164419369|NCT02555371|593906425|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
164419370|NCT02555371|593906421|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
164419371|NCT02555371|593906422|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
164419372|NCT02555371|593906423|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
164419373|NCT02555371|593906424|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
164419374|NCT02555371|593906425|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
164419375|NCT02555371|593906421|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
164419376|NCT02555371|593906422|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
164419377|NCT02555371|593906423|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
164419378|NCT02555371|593906424|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
164419379|NCT02555371|593906425|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
164419380|NCT02555371|593906421|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
164419381|NCT02555371|593906422|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
164419382|NCT02555371|593906423|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
164419383|NCT02555371|593906424|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
164419384|NCT02555371|593906425|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
164419385|NCT02555371|593906421|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
164419386|NCT02555371|593906422|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
164419387|NCT02555371|593906423|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
164419388|NCT02555371|593906424|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
164419389|NCT02555371|593906425|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
164419390|NCT02555371|593906421|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
164419391|NCT02555371|593906422|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
164419392|NCT02555371|593906423|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
164419393|NCT02555371|593906424|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
164419394|NCT02555371|593906425|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
164419395|NCT02555371|593906421|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
164419396|NCT02555371|593906422|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
164419397|NCT02555371|593906423|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
164419398|NCT02555371|593906424|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
164419399|NCT02555371|593906425|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
164419400|NCT02555371|593906421|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
164419401|NCT02555371|593906422|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
164419402|NCT02555371|593906423|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
164419403|NCT02555371|593906424|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
164419404|NCT02555371|593906425|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
164419405|NCT02555371|593906421|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
164419406|NCT02555371|593906422|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
164419407|NCT02555371|593906423|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
164419408|NCT02555371|593906424|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
164419409|NCT02555371|593906425|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
164419410|NCT02555371|593906421|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
164419411|NCT02555371|593906422|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
164419412|NCT02555371|593906423|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
164419413|NCT02555371|593906424|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
164419414|NCT02555371|593906425|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
164419415|NCT02555371|593906421|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
164419416|NCT02555371|593906422|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
164419417|NCT02555371|593906423|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
164419418|NCT02555371|593906424|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
164419419|NCT02555371|593906425|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
164419420|NCT02555371|593906421|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
164419421|NCT02555371|593906422|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
164419422|NCT02555371|593906423|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
164419423|NCT02555371|593906424|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
164419424|NCT02555371|593906425|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
164419425|NCT02555371|593906421|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
164419426|NCT02555371|593906422|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
164419427|NCT02555371|593906423|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
164419428|NCT02555371|593906424|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
164419429|NCT02555371|593906425|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
164419430|NCT00777803|593906428|FG000|Overall Study|Lost to Follow-up|12|||
164419431|NCT00777803|593906429|FG001|Overall Study|Lost to Follow-up|5|||
164419432|NCT00777803|593906428|FG000|Overall Study|Adverse Event|1|||
164419433|NCT00777803|593906429|FG001|Overall Study|Adverse Event|0|||
164419434|NCT00777803|593906428|FG000|Overall Study|Non-compliance|2|||
164419435|NCT00777803|593906429|FG001|Overall Study|Non-compliance|2|||
164419436|NCT02930122|593906434|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
164419437|NCT02930122|593906435|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
164419438|NCT02609659|593906436|FG000|Overall Study|Adverse Event|1|||
164419439|NCT02609659|593906436|FG000|Overall Study|Lost to Follow-up|6|||
164419440|NCT02609659|593906436|FG000|Overall Study|Other|1|||
164419441|NCT01004250|593906439|FG000|Induction Therapy Period|Adverse Event|10|||
164419442|NCT01004250|593906439|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
164419443|NCT01004250|593906439|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
164419444|NCT01004250|593906439|FG000|Induction Therapy Period|Physician Decision|2|||
164419445|NCT01004250|593906439|FG000|Maintenance Therapy Period|Adverse Event|15|||
164419446|NCT01004250|593906439|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
164419447|NCT01004250|593906439|FG000|Maintenance Therapy Period|Protocol Violation|1|||
164419448|NCT01004250|593906439|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
164419449|NCT01004250|593906439|FG000|Maintenance Therapy Period|Physician Decision|4|||
164419450|NCT01004250|593906439|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
164419451|NCT04129580|593906440|FG000|Overall Study|Lost to Follow-up|14|||
164419452|NCT04129580|593906441|FG001|Overall Study|Lost to Follow-up|25|||
164419453|NCT01853254|593906442|FG000|Overall Study|Abnormal Laboratory Test|1|||
164419454|NCT01853254|593906442|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
164419455|NCT01853254|593906442|FG000|Overall Study|Death|1|||
164419456|NCT01853254|593906442|FG000|Overall Study|Failure to Return|43|||
164419457|NCT01853254|593906442|FG000|Overall Study|Insufficient Therapeutic Response|22|||
164419458|NCT01853254|593906442|FG000|Overall Study|Refusal of Treatment|1|||
164419459|NCT01853254|593906442|FG000|Overall Study|Other Protocol Violation|1|||
164419460|NCT01853254|593906442|FG000|Overall Study|Withdrawal of Consent|16|||
164419461|NCT01853254|593906442|FG000|Overall Study|Administrative/Other|16|||
164419462|NCT02462083|593906443|FG000|Overall Study|Sponsor request|39|||
164419463|NCT02462083|593906443|FG000|Overall Study|Withdrawal by Subject|87|||
164419464|NCT02462083|593906443|FG000|Overall Study|Lost to Follow-up|41|||
164419465|NCT02462083|593906443|FG000|Overall Study|Lack of Efficacy|151|||
164419466|NCT02462083|593906443|FG000|Overall Study|Pregnancy|1|||
164419467|NCT02462083|593906443|FG000|Overall Study|Protocol Violation|6|||
164419468|NCT02462083|593906443|FG000|Overall Study|Adverse Event|33|||
164419469|NCT02462083|593906443|FG000|Overall Study|Worsening condition|16|||
164533928|NCT05358717|594327176|FG001|Overall Study|Study Paused by Sponsor in United States|2|||
164419470|NCT02462083|593906443|FG000|Overall Study|Other than specified|45|||
164419471|NCT02711995|593906444|FG000|Washout (90 Days)|Conflicting medication|1|||
164419472|NCT02176928|593906449|FG000|Overall Study|Lost to Follow-up|2|||
164419473|NCT02176928|593906450|FG001|Overall Study|Lost to Follow-up|4|||
164419474|NCT01642186|593906454|FG000|Overall Study|Death|0|||
164419475|NCT01642186|593906455|FG001|Overall Study|Death|2|||
164419476|NCT01642186|593906456|FG002|Overall Study|Death|2|||
164419477|NCT01642186|593906454|FG000|Overall Study|Lost to Follow-up|0|||
164419478|NCT01642186|593906455|FG001|Overall Study|Lost to Follow-up|0|||
164533929|NCT05358717|594327177|FG002|Overall Study|Study Paused by Sponsor in United States|0|||
164419479|NCT01642186|593906456|FG002|Overall Study|Lost to Follow-up|1|||
164419480|NCT00163215|593906457|FG000|Overall Study|Lack of Efficacy|3|||
164419481|NCT00163215|593906457|FG000|Overall Study|Withdrawal by Subject|5|||
164419482|NCT00163215|593906457|FG000|Overall Study|Other|7|||
164419483|NCT01809210|593906458|FG000|Overall Study|Withdrawal by Subject|0|||
164419484|NCT01809210|593906459|FG001|Overall Study|Withdrawal by Subject|0|||
164419485|NCT01809210|593906460|FG002|Overall Study|Withdrawal by Subject|1|||
164419486|NCT01809210|593906461|FG003|Overall Study|Withdrawal by Subject|1|||
164419487|NCT01809210|593906462|FG004|Overall Study|Withdrawal by Subject|1|||
164419488|NCT01809210|593906463|FG005|Overall Study|Withdrawal by Subject|0|||
164419489|NCT01809210|593906464|FG006|Overall Study|Withdrawal by Subject|4|||
164419490|NCT01809210|593906458|FG000|Overall Study|Death|1|||
164419491|NCT01809210|593906459|FG001|Overall Study|Death|1|||
164419492|NCT01809210|593906460|FG002|Overall Study|Death|2|||
164419493|NCT01809210|593906461|FG003|Overall Study|Death|0|||
164419494|NCT01809210|593906462|FG004|Overall Study|Death|1|||
164419495|NCT01809210|593906463|FG005|Overall Study|Death|3|||
164419496|NCT01809210|593906464|FG006|Overall Study|Death|1|||
164419497|NCT00590980|593906465|FG000|Overall Study|Did not meet all inclusion criteria|10|||
164419498|NCT00504348|593906466|FG000|Overall Study|Adverse Event|3|||
164419499|NCT00504348|593906466|FG000|Overall Study|Lack of Efficacy|4|||
164419500|NCT00504348|593906466|FG000|Overall Study|Physician Decision|1|||
164419501|NCT01023308|593906467|FG000|Overall Study|Abnormal test proceedure results|3|||
164419502|NCT01023308|593906468|FG001|Overall Study|Abnormal test proceedure results|8|||
164419503|NCT01023308|593906467|FG000|Overall Study|Administrative problems|2|||
164419504|NCT01023308|593906468|FG001|Overall Study|Administrative problems|1|||
164419505|NCT01023308|593906467|FG000|Overall Study|Adverse Event|130|||
164419506|NCT01023308|593906468|FG001|Overall Study|Adverse Event|66|||
164419507|NCT01023308|593906467|FG000|Overall Study|Death|21|||
164419508|NCT01023308|593906468|FG001|Overall Study|Death|17|||
164419509|NCT01023308|593906467|FG000|Overall Study|Disease progression|82|||
164419510|NCT01023308|593906468|FG001|Overall Study|Disease progression|153|||
164419511|NCT01023308|593906467|FG000|Overall Study|New Cancer therapy|4|||
164419512|NCT01023308|593906468|FG001|Overall Study|New Cancer therapy|7|||
164419513|NCT01023308|593906467|FG000|Overall Study|Protocol Violation|3|||
164419514|NCT01023308|593906468|FG001|Overall Study|Protocol Violation|4|||
164419515|NCT01023308|593906467|FG000|Overall Study|Untreated|5|||
164419516|NCT01023308|593906468|FG001|Overall Study|Untreated|5|||
164419517|NCT01023308|593906467|FG000|Overall Study|Lost to Follow-up|1|||
164419518|NCT01023308|593906468|FG001|Overall Study|Lost to Follow-up|0|||
164419519|NCT01023308|593906467|FG000|Overall Study|Withdrawal by Subject|34|||
164419520|NCT01023308|593906468|FG001|Overall Study|Withdrawal by Subject|18|||
164419521|NCT01646320|593906474|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
164419522|NCT01646320|593906475|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
164419523|NCT01646320|593906474|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
164419524|NCT01646320|593906475|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
164419525|NCT01646320|593906474|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
164419526|NCT01646320|593906475|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
164419527|NCT01646320|593906474|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
164419528|NCT01646320|593906475|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
164419529|NCT01646320|593906474|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
164419530|NCT01646320|593906475|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
164419531|NCT01646320|593906474|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
164419532|NCT01646320|593906475|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
164419533|NCT01646320|593906474|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
164419534|NCT01646320|593906475|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
164419535|NCT01646320|593906474|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
164419536|NCT01646320|593906475|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
164419537|NCT01646320|593906474|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
164419538|NCT01646320|593906475|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
164419539|NCT01646320|593906474|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
164419540|NCT01646320|593906475|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
164419541|NCT01646320|593906474|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
164419542|NCT01646320|593906475|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
164419543|NCT01489020|593906476|FG000|Overall Study|Withdrawal by Subject|1|||
164419544|NCT01489020|593906477|FG001|Overall Study|Withdrawal by Subject|0|||
164419545|NCT01489020|593906478|FG002|Overall Study|Withdrawal by Subject|0|||
164533930|NCT02640157|594327178|FG000|Overall Study|Adverse Event|2|||
164306348|NCT02592798|593494771|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
164306349|NCT02592798|593494770|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
164306350|NCT02592798|593494771|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
164306351|NCT02592798|593494770|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
164306352|NCT02592798|593494771|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
164306353|NCT02592798|593494770|FG000|Open Label Period (OLE)|Adverse Event|0|||
164306354|NCT02592798|593494771|FG001|Open Label Period (OLE)|Adverse Event|1|||
164306355|NCT01696188|593494772|FG000|Overall Study|Protocol Violation|1|||
164306356|NCT01696188|593494773|FG001|Overall Study|Protocol Violation|1|||
164306357|NCT02668393|593494774|FG000|Overall Study|Progressive disease|6|||
164306358|NCT02668393|593494775|FG001|Overall Study|Progressive disease|3|||
164189889|NCT00572455|593063999|FG013|Stage II (28 Days)|Adverse Event|1|||
164306359|NCT02668393|593494774|FG000|Overall Study|Adverse Event|0|||
164306360|NCT02668393|593494775|FG001|Overall Study|Adverse Event|2|||
164419546|NCT01489020|593906479|FG003|Overall Study|Withdrawal by Subject|0|||
164419547|NCT01489020|593906480|FG004|Overall Study|Withdrawal by Subject|0|||
164419548|NCT01489020|593906481|FG005|Overall Study|Withdrawal by Subject|0|||
164419549|NCT01489020|593906476|FG000|Overall Study|Adverse Event|0|||
164419550|NCT01489020|593906477|FG001|Overall Study|Adverse Event|0|||
164419551|NCT01489020|593906478|FG002|Overall Study|Adverse Event|3|||
164419552|NCT01489020|593906479|FG003|Overall Study|Adverse Event|0|||
164419553|NCT01489020|593906480|FG004|Overall Study|Adverse Event|3|||
164419554|NCT01489020|593906481|FG005|Overall Study|Adverse Event|0|||
164419555|NCT01489020|593906476|FG000|Overall Study|Concomitant disease|0|||
164419556|NCT01489020|593906477|FG001|Overall Study|Concomitant disease|0|||
164419557|NCT01489020|593906478|FG002|Overall Study|Concomitant disease|0|||
164419558|NCT01489020|593906479|FG003|Overall Study|Concomitant disease|0|||
164419559|NCT01489020|593906480|FG004|Overall Study|Concomitant disease|3|||
164419560|NCT01489020|593906481|FG005|Overall Study|Concomitant disease|0|||
164419561|NCT02451930|593906484|FG000|Overall Study|Death|0|||
164419562|NCT02451930|593906485|FG001|Overall Study|Death|15|||
164419563|NCT02451930|593906484|FG000|Overall Study|Lost to Follow-up|0|||
164419564|NCT02451930|593906485|FG001|Overall Study|Lost to Follow-up|3|||
164419565|NCT02451930|593906484|FG000|Overall Study|Sponsor Decision|2|||
164419566|NCT02451930|593906485|FG001|Overall Study|Sponsor Decision|10|||
164419567|NCT02451930|593906484|FG000|Overall Study|Withdrawal by Subject|0|||
164419568|NCT02451930|593906485|FG001|Overall Study|Withdrawal by Subject|1|||
164419569|NCT02451930|593906484|FG000|Overall Study|Other|0|||
164419570|NCT02451930|593906485|FG001|Overall Study|Other|1|||
164419571|NCT00262743|593906486|FG000|Overall Study|Adverse Event|0|||
164419572|NCT00262743|593906487|FG001|Overall Study|Adverse Event|9|||
164419573|NCT00262743|593906486|FG000|Overall Study|Disease progression|0|||
164419574|NCT00262743|593906487|FG001|Overall Study|Disease progression|3|||
164419575|NCT02485353|593906490|FG000|Overall Study|Death|1|||
164419576|NCT02485353|593906490|FG000|Overall Study|Disease Progression|1|||
164419577|NCT01950273|593906495|FG000|Overall Study|Protocol Violation|1|||
164419578|NCT01950273|593906496|FG001|Overall Study|Protocol Violation|0|||
164419579|NCT01950273|593906495|FG000|Overall Study|Withdrawal by Subject|2|||
164419580|NCT01950273|593906496|FG001|Overall Study|Withdrawal by Subject|0|||
164419581|NCT01950273|593906495|FG000|Overall Study|Other not defined above|1|||
164419582|NCT01950273|593906496|FG001|Overall Study|Other not defined above|0|||
164419583|NCT04430335|593906497|FG000|Overall Study|Withdrawal by Subject|1|||
164419584|NCT03249376|593906501|FG000|Overall Study|Adverse Event|11|||
164419585|NCT03249376|593906502|FG001|Overall Study|Adverse Event|5|||
164419586|NCT03249376|593906501|FG000|Overall Study|Lack of Efficacy|2|||
164419587|NCT03249376|593906502|FG001|Overall Study|Lack of Efficacy|4|||
164419588|NCT03249376|593906501|FG000|Overall Study|Protocol Violation|3|||
164419589|NCT03249376|593906502|FG001|Overall Study|Protocol Violation|2|||
164419590|NCT03249376|593906501|FG000|Overall Study|Physician Decision|0|||
164419591|NCT03249376|593906502|FG001|Overall Study|Physician Decision|2|||
164419592|NCT03249376|593906501|FG000|Overall Study|Withdrawal by Subject|3|||
164419593|NCT03249376|593906502|FG001|Overall Study|Withdrawal by Subject|9|||
164419594|NCT03249376|593906501|FG000|Overall Study|LTFU|2|||
164419595|NCT03249376|593906502|FG001|Overall Study|LTFU|1|||
164419596|NCT00627042|593906506|FG000|Overall Study|Withdrawal by Subject|2|||
164533931|NCT02640157|594327179|FG001|Overall Study|Adverse Event|2|||
164306361|NCT02668393|593494774|FG000|Overall Study|Withdrawal from the trial|0|||
164306362|NCT02668393|593494775|FG001|Overall Study|Withdrawal from the trial|1|||
164419597|NCT00531011|593906507|FG000|Overall Study|Withdrawal by Subject|2|||
164419598|NCT00531011|593906508|FG001|Overall Study|Withdrawal by Subject|4|||
164419599|NCT00531011|593906507|FG000|Overall Study|Death|1|||
164419600|NCT00531011|593906508|FG001|Overall Study|Death|0|||
164419601|NCT00531011|593906507|FG000|Overall Study|Lost to Follow-up|1|||
164419602|NCT00531011|593906508|FG001|Overall Study|Lost to Follow-up|0|||
164419603|NCT00531011|593906507|FG000|Overall Study|Physician Decision|0|||
164419604|NCT00531011|593906508|FG001|Overall Study|Physician Decision|3|||
164419605|NCT03268590|593906509|FG000|Overall Study|Previously unknown exclusion criteria|1|||
164306363|NCT02668393|593494774|FG000|Overall Study|Lack of benefit and side effects|1|||
164419606|NCT02823964|593906512|FG000|Overall Study|Adverse Event|2|||
164306364|NCT02668393|593494775|FG001|Overall Study|Lack of benefit and side effects|0|||
164306365|NCT00174187|593494778|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
164306366|NCT00174187|593494779|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
164306367|NCT00174187|593494780|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
164306368|NCT00174187|593494778|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
164306369|NCT00174187|593494779|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
164306370|NCT00174187|593494780|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
164306371|NCT00174187|593494778|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
164306372|NCT00174187|593494779|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
164306373|NCT00174187|593494780|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
164306374|NCT00174187|593494778|FG000|Period 1 (up to 3 Years)|Other|0|||
164306375|NCT00174187|593494779|FG001|Period 1 (up to 3 Years)|Other|1|||
164306376|NCT00174187|593494780|FG002|Period 1 (up to 3 Years)|Other|0|||
164306377|NCT00174187|593494778|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
164306378|NCT00174187|593494779|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
164306379|NCT00174187|593494780|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
164306380|NCT00174187|593494778|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
164306381|NCT00174187|593494779|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
164306382|NCT00174187|593494780|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
164306383|NCT00174187|593494778|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
164306384|NCT00174187|593494779|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
164306385|NCT00174187|593494780|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
164306386|NCT00174187|593494778|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
164306387|NCT00174187|593494779|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
164306388|NCT00174187|593494780|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
164306389|NCT00174187|593494778|FG000|Period 2 (After 3 Years)|Other|0|||
164306390|NCT00174187|593494779|FG001|Period 2 (After 3 Years)|Other|0|||
164306391|NCT00174187|593494780|FG002|Period 2 (After 3 Years)|Other|5|||
164306392|NCT01285557|593494781|FG000|Overall Study|Death|173|||
164306393|NCT01285557|593494782|FG001|Overall Study|Death|90|||
164306394|NCT01285557|593494781|FG000|Overall Study|Lost to Follow-up|6|||
164306395|NCT01285557|593494782|FG001|Overall Study|Lost to Follow-up|2|||
164306396|NCT01285557|593494781|FG000|Overall Study|Withdrew Consent|6|||
164306397|NCT01285557|593494782|FG001|Overall Study|Withdrew Consent|1|||
164306398|NCT01285557|593494781|FG000|Overall Study|Sponsor Study Termination|23|||
164306399|NCT01285557|593494782|FG001|Overall Study|Sponsor Study Termination|13|||
164306400|NCT01285557|593494781|FG000|Overall Study|Randomized but not treated|1|||
164306401|NCT01285557|593494782|FG001|Overall Study|Randomized but not treated|1|||
164306402|NCT01285557|593494781|FG000|Overall Study|Study follow-up ongoing|28|||
164306403|NCT01285557|593494782|FG001|Overall Study|Study follow-up ongoing|14|||
164306404|NCT01285557|593494781|FG000|Overall Study|Sponsor Decision|2|||
164306405|NCT01285557|593494782|FG001|Overall Study|Sponsor Decision|1|||
164306406|NCT02000115|593494783|FG000|Overall Study|Death|56|||
164306407|NCT02000115|593494784|FG001|Overall Study|Death|45|||
164306408|NCT02000115|593494785|FG002|Overall Study|Death|0|||
164306409|NCT02000115|593494786|FG003|Overall Study|Death|0|||
164306410|NCT02000115|593494783|FG000|Overall Study|Missed Visit|6|||
164306411|NCT02000115|593494784|FG001|Overall Study|Missed Visit|8|||
164306412|NCT02000115|593494785|FG002|Overall Study|Missed Visit|1|||
164306413|NCT02000115|593494786|FG003|Overall Study|Missed Visit|0|||
164306414|NCT02000115|593494783|FG000|Overall Study|Protocol Violation|2|||
164306415|NCT02000115|593494784|FG001|Overall Study|Protocol Violation|1|||
164306416|NCT02000115|593494785|FG002|Overall Study|Protocol Violation|0|||
164306417|NCT02000115|593494786|FG003|Overall Study|Protocol Violation|0|||
164306418|NCT02000115|593494783|FG000|Overall Study|Physician Decision|2|||
164306419|NCT02000115|593494784|FG001|Overall Study|Physician Decision|0|||
164306420|NCT02000115|593494785|FG002|Overall Study|Physician Decision|0|||
164306421|NCT02000115|593494786|FG003|Overall Study|Physician Decision|0|||
164306422|NCT02000115|593494783|FG000|Overall Study|Withdrawal by Subject|11|||
164306423|NCT02000115|593494784|FG001|Overall Study|Withdrawal by Subject|11|||
164306424|NCT02000115|593494785|FG002|Overall Study|Withdrawal by Subject|0|||
164306425|NCT02000115|593494786|FG003|Overall Study|Withdrawal by Subject|0|||
164306426|NCT02000115|593494783|FG000|Overall Study|Lost to Follow-up|0|||
164306427|NCT02000115|593494784|FG001|Overall Study|Lost to Follow-up|1|||
164306428|NCT02000115|593494785|FG002|Overall Study|Lost to Follow-up|0|||
164306429|NCT02000115|593494786|FG003|Overall Study|Lost to Follow-up|0|||
164306430|NCT02000115|593494783|FG000|Overall Study|Non-compliance|2|||
164306431|NCT02000115|593494784|FG001|Overall Study|Non-compliance|1|||
164306432|NCT02000115|593494785|FG002|Overall Study|Non-compliance|0|||
164306433|NCT02000115|593494786|FG003|Overall Study|Non-compliance|0|||
164306434|NCT02000115|593494783|FG000|Overall Study|Withdrawn on day of randomization|0|||
164306435|NCT02000115|593494784|FG001|Overall Study|Withdrawn on day of randomization|1|||
164306436|NCT02000115|593494785|FG002|Overall Study|Withdrawn on day of randomization|0|||
164306437|NCT02000115|593494786|FG003|Overall Study|Withdrawn on day of randomization|0|||
164306438|NCT02000115|593494783|FG000|Overall Study|Still on Study|0|||
164306439|NCT02000115|593494784|FG001|Overall Study|Still on Study|0|||
164419607|NCT02823964|593906512|FG000|Overall Study|Physician Decision|1|||
164419608|NCT02823964|593906512|FG000|Overall Study|Lack of Efficacy|1|||
164419609|NCT02823964|593906512|FG000|Overall Study|Withdrawal by Subject|1|||
164419610|NCT00794820|593906517|FG000|Overall Study|Adverse Event|11|||
164419611|NCT00794820|593906517|FG000|Overall Study|Secondary Malignancies|2|||
164419612|NCT00794820|593906517|FG000|Overall Study|Resistant Disease|2|||
164419613|NCT00794820|593906517|FG000|Overall Study|Ineligible/Screen Failure|1|||
164419614|NCT03537261|593906522|FG000|Overall Study|Lost to Follow-up|4|||
164419615|NCT03537261|593906523|FG001|Overall Study|Lost to Follow-up|5|||
164419616|NCT03537261|593906522|FG000|Overall Study|Withdrawal by Subject|4|||
164419617|NCT03537261|593906523|FG001|Overall Study|Withdrawal by Subject|6|||
164419618|NCT03537261|593906522|FG000|Overall Study|Did not return study questionnaires|0|||
164419619|NCT03537261|593906523|FG001|Overall Study|Did not return study questionnaires|1|||
164419620|NCT00610675|593906524|FG000|Overall Study|Untreated|4|||
164419621|NCT00610675|593906524|FG000|Overall Study|Adverse Event|67|||
164419622|NCT00610675|593906524|FG000|Overall Study|Insufficient Effect|31|||
164419623|NCT00610675|593906524|FG000|Overall Study|Withdrawal by Subject|28|||
164419624|NCT00610675|593906524|FG000|Overall Study|Reasons unrelated to trial|27|||
164419625|NCT00610675|593906524|FG000|Overall Study|Lack of Compliance|7|||
164419626|NCT00610675|593906524|FG000|Overall Study|Lost to Follow-up|31|||
164419627|NCT00610675|593906524|FG000|Overall Study|Other reason (not specified)|25|||
164419628|NCT01458249|593906525|FG000|Overall Study|Not treated|1|||
164419629|NCT01458249|593906525|FG000|Overall Study|Adverse Event|4|||
164419630|NCT01458249|593906525|FG000|Overall Study|Other|2|||
164419631|NCT01458249|593906525|FG000|Overall Study|Ongoing|1|||
164419632|NCT03220737|593906526|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
164419633|NCT03220737|593906527|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
164419634|NCT03220737|593906528|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
164419635|NCT03220737|593906529|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
164419636|NCT03220737|593906530|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
164419637|NCT03220737|593906531|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
164419638|NCT03220737|593906532|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
164419639|NCT03220737|593906526|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
164419640|NCT03220737|593906527|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
164419641|NCT03220737|593906528|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
164419642|NCT03220737|593906529|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
164419643|NCT03220737|593906530|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
164419644|NCT03220737|593906531|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
164419645|NCT03220737|593906532|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
164419646|NCT03220737|593906526|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
164419647|NCT03220737|593906527|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
164419648|NCT03220737|593906528|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
164419649|NCT03220737|593906529|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
164419650|NCT03220737|593906530|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
164419651|NCT03220737|593906531|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
164419652|NCT03220737|593906532|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
164419653|NCT03220737|593906526|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
164419654|NCT03220737|593906527|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
164419655|NCT03220737|593906528|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
164419656|NCT03220737|593906529|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
164419657|NCT03220737|593906530|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
164419658|NCT03220737|593906531|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
164419659|NCT03220737|593906532|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
164419660|NCT03220737|593906526|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
164419661|NCT03220737|593906527|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
164419662|NCT03220737|593906528|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
164419663|NCT03220737|593906529|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
164419664|NCT03220737|593906530|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
164419665|NCT03220737|593906531|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
164419666|NCT03220737|593906532|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
164533932|NCT02640157|594327180|FG002|Overall Study|Adverse Event|1|||
164419667|NCT03220737|593906526|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
164419668|NCT03220737|593906527|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
164419669|NCT03220737|593906528|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
164419670|NCT03220737|593906529|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
164419671|NCT03220737|593906530|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
164419672|NCT03220737|593906531|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
164419673|NCT03220737|593906532|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
164419674|NCT03220737|593906526|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
164419675|NCT03220737|593906527|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
164533933|NCT02640157|594327178|FG000|Overall Study|Withdrew consent|2|||
164533934|NCT02640157|594327179|FG001|Overall Study|Withdrew consent|0|||
164306440|NCT02000115|593494785|FG002|Overall Study|Still on Study|0|||
164306441|NCT02000115|593494786|FG003|Overall Study|Still on Study|53|||
164306442|NCT03278249|593494789|FG000|Overall Study|Withdrawal by Subject|2|||
164306443|NCT03278249|593494789|FG000|Overall Study|Lost to Follow-up|1|||
164306444|NCT02656693|593496776|FG000|Overall Study|Pregnancy|1|||
164306445|NCT02656693|593496777|FG001|Overall Study|Pregnancy|1|||
164306446|NCT02656693|593496778|FG002|Overall Study|Pregnancy|1|||
164306447|NCT02656693|593496776|FG000|Overall Study|Bariatric surgery|0|||
164306448|NCT02656693|593496777|FG001|Overall Study|Bariatric surgery|1|||
164306449|NCT02656693|593496778|FG002|Overall Study|Bariatric surgery|2|||
164306450|NCT02565784|593496779|FG000|First Treatment|Adverse Event|1|||
164306451|NCT02565784|593496779|FG000|First Treatment|Withdrawal by Subject|1|||
164306452|NCT02565784|593496779|FG000|Second Treatment|Withdrawal by Subject|2|||
164306453|NCT02948634|593496784|FG000|Overall Study|Lack of efficacy and study suspended|10|||
164306454|NCT02948634|593496785|FG001|Overall Study|Lack of efficacy and study suspended|2|||
164306455|NCT00753649|593496790|FG000|Overall Study|Migrated/moved from study area|1|||
164306456|NCT00753649|593496791|FG001|Overall Study|Migrated/moved from study area|0|||
164306457|NCT00753649|593496790|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
164306458|NCT00753649|593496791|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
164306459|NCT00753649|593496790|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
164306460|NCT00753649|593496791|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
164306461|NCT00753649|593496790|FG000|Overall Study|Protocol Violation|2|||
164306462|NCT00753649|593496791|FG001|Overall Study|Protocol Violation|0|||
164306463|NCT01039519|593496797|FG000|Treatment|Progressive disease|20|||
164306464|NCT01039519|593496797|FG000|Treatment|Treatment failure|2|||
164306465|NCT01039519|593496797|FG000|Treatment|Adverse Event|3|||
164306466|NCT01039519|593496797|FG000|Treatment|Physician Decision|2|||
164306467|NCT01039519|593496797|FG000|Survival Follow-up|Death|23|||
164306468|NCT01039519|593496797|FG000|Survival Follow-up|Sponsor decision|4|||
164306469|NCT01255436|593496800|FG000|Overall Study|Lost to Follow-up|178|||
164306470|NCT01255436|593496801|FG001|Overall Study|Lost to Follow-up|191|||
164306471|NCT01255436|593496800|FG000|Overall Study|Death, stroke, or MI|4|||
164306472|NCT01255436|593496801|FG001|Overall Study|Death, stroke, or MI|3|||
164306473|NCT04816669|593496802|FG000|Part 1|Adverse Event|1|||
164306474|NCT04816669|593496803|FG001|Part 1|Adverse Event|1|||
164306475|NCT04816669|593496804|FG002|Part 1|Adverse Event|0|||
164306476|NCT04816669|593496805|FG003|Part 1|Adverse Event|0|||
164306477|NCT04816669|593496802|FG000|Part 1|Lost to Follow-up|2|||
164306478|NCT04816669|593496803|FG001|Part 1|Lost to Follow-up|2|||
164306479|NCT04816669|593496804|FG002|Part 1|Lost to Follow-up|0|||
164306480|NCT04816669|593496805|FG003|Part 1|Lost to Follow-up|0|||
164306481|NCT04816669|593496802|FG000|Part 1|Protocol Violation|0|||
164306482|NCT04816669|593496803|FG001|Part 1|Protocol Violation|1|||
164306483|NCT04816669|593496804|FG002|Part 1|Protocol Violation|0|||
164306484|NCT04816669|593496805|FG003|Part 1|Protocol Violation|0|||
164306485|NCT04816669|593496802|FG000|Part 1|Withdrawal by Subject|1|||
164306486|NCT04816669|593496803|FG001|Part 1|Withdrawal by Subject|2|||
164306487|NCT04816669|593496804|FG002|Part 1|Withdrawal by Subject|0|||
164306488|NCT04816669|593496805|FG003|Part 1|Withdrawal by Subject|0|||
164306489|NCT04816669|593496802|FG000|Part 2|Other|0|||
164306490|NCT04816669|593496803|FG001|Part 2|Other|0|||
164306491|NCT04816669|593496804|FG002|Part 2|Other|1|||
164306492|NCT04816669|593496805|FG003|Part 2|Other|0|||
164306493|NCT04816669|593496802|FG000|Part 2|Withdrawal by Subject|0|||
164306494|NCT04816669|593496803|FG001|Part 2|Withdrawal by Subject|0|||
164306495|NCT04816669|593496804|FG002|Part 2|Withdrawal by Subject|0|||
164306496|NCT04816669|593496805|FG003|Part 2|Withdrawal by Subject|1|||
164306497|NCT04816669|593496802|FG000|Part 2|Lost to Follow-up|0|||
164306498|NCT04816669|593496803|FG001|Part 2|Lost to Follow-up|0|||
164306499|NCT04816669|593496804|FG002|Part 2|Lost to Follow-up|1|||
164306500|NCT04816669|593496805|FG003|Part 2|Lost to Follow-up|0|||
164419676|NCT03220737|593906528|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
164306501|NCT01229267|593496806|FG000|Overall Study|Adverse Event|4|||
164306502|NCT01229267|593496807|FG001|Overall Study|Adverse Event|6|||
164419677|NCT03220737|593906529|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
164306503|NCT01229267|593496808|FG002|Overall Study|Adverse Event|3|||
164306504|NCT01229267|593496809|FG003|Overall Study|Adverse Event|2|||
164306505|NCT01229267|593496810|FG004|Overall Study|Adverse Event|10|||
164306506|NCT01229267|593496806|FG000|Overall Study|Death|40|||
164306507|NCT01229267|593496807|FG001|Overall Study|Death|37|||
164306508|NCT01229267|593496808|FG002|Overall Study|Death|35|||
164306509|NCT01229267|593496809|FG003|Overall Study|Death|13|||
164306510|NCT01229267|593496810|FG004|Overall Study|Death|103|||
164306511|NCT01229267|593496806|FG000|Overall Study|Withdrawal by Subject|23|||
164306512|NCT01229267|593496807|FG001|Overall Study|Withdrawal by Subject|22|||
164306513|NCT01229267|593496808|FG002|Overall Study|Withdrawal by Subject|32|||
164306514|NCT01229267|593496809|FG003|Overall Study|Withdrawal by Subject|14|||
164306515|NCT01229267|593496810|FG004|Overall Study|Withdrawal by Subject|59|||
164306516|NCT01229267|593496806|FG000|Overall Study|Protocol Violation|0|||
164306517|NCT01229267|593496807|FG001|Overall Study|Protocol Violation|1|||
164306518|NCT01229267|593496808|FG002|Overall Study|Protocol Violation|0|||
164419678|NCT03220737|593906530|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
164419679|NCT03220737|593906531|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
164419680|NCT03220737|593906532|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
164419681|NCT03220737|593906526|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
164419682|NCT03220737|593906527|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
164419683|NCT03220737|593906528|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
164419684|NCT03220737|593906529|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
164419685|NCT03220737|593906530|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
164419686|NCT03220737|593906531|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
164419687|NCT03220737|593906532|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
164419688|NCT00983619|593906540|FG000|Overall Study|Lost to Follow-up|0|||
164419689|NCT00983619|593906541|FG001|Overall Study|Lost to Follow-up|1|||
164419690|NCT00983619|593906542|FG002|Overall Study|Lost to Follow-up|0|||
164419691|NCT00983619|593906543|FG003|Overall Study|Lost to Follow-up|0|||
164419692|NCT00983619|593906544|FG004|Overall Study|Lost to Follow-up|0|||
164419693|NCT00983619|593906545|FG005|Overall Study|Lost to Follow-up|2|||
164419694|NCT00983619|593906546|FG006|Overall Study|Lost to Follow-up|0|||
164419695|NCT00983619|593906547|FG007|Overall Study|Lost to Follow-up|0|||
164419696|NCT00983619|593906548|FG008|Overall Study|Lost to Follow-up|0|||
164419697|NCT00983619|593906549|FG009|Overall Study|Lost to Follow-up|0|||
164419698|NCT00983619|593906550|FG010|Overall Study|Lost to Follow-up|0|||
164419699|NCT00983619|593906551|FG011|Overall Study|Lost to Follow-up|2|||
164419700|NCT00983619|593906540|FG000|Overall Study|Withdrawal by Subject|2|||
164533935|NCT02640157|594327180|FG002|Overall Study|Withdrew consent|2|||
164533936|NCT02640157|594327178|FG000|Overall Study|Lost to Follow-up|9|||
164533937|NCT02640157|594327179|FG001|Overall Study|Lost to Follow-up|2|||
164533938|NCT02640157|594327180|FG002|Overall Study|Lost to Follow-up|7|||
164533939|NCT02640157|594327178|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
164533940|NCT02640157|594327179|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
164533941|NCT02640157|594327180|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
164533942|NCT00710021|594327181|FG000|Overall Study|Lost to Follow-up|1|||
164533943|NCT00710021|594327182|FG001|Overall Study|Lost to Follow-up|0|||
164533944|NCT00710021|594327183|FG002|Overall Study|Lost to Follow-up|0|||
164533945|NCT00710021|594327181|FG000|Overall Study|Subject's Decision|0|||
164533946|NCT00710021|594327182|FG001|Overall Study|Subject's Decision|1|||
164533947|NCT00710021|594327183|FG002|Overall Study|Subject's Decision|0|||
164533948|NCT00710021|594327181|FG000|Overall Study|Subject misrandomized|0|||
164533949|NCT00710021|594327182|FG001|Overall Study|Subject misrandomized|1|||
164533950|NCT00710021|594327183|FG002|Overall Study|Subject misrandomized|1|||
164533951|NCT00710021|594327181|FG000|Overall Study|Physician Decision|0|||
164533952|NCT00710021|594327182|FG001|Overall Study|Physician Decision|1|||
164533953|NCT00710021|594327183|FG002|Overall Study|Physician Decision|0|||
164533954|NCT00026208|594327184|FG000|Overall Study|Complications of auto accident|1|||
164533955|NCT00026208|594327185|FG001|Overall Study|Complications of auto accident|0|||
164533956|NCT04837040|594327189|FG000|RC Phase (Up to Week 36)|Withdrawal by Subject|0|||
164533957|NCT04837040|594327190|FG001|RC Phase (Up to Week 36)|Withdrawal by Subject|1|||
164533958|NCT02961218|594327191|FG000|Overall Study|Lost to Follow-up|0|||
164533959|NCT02961218|594327192|FG001|Overall Study|Lost to Follow-up|2|||
164533960|NCT02961218|594327191|FG000|Overall Study|Physician Decision|0|||
164533961|NCT02961218|594327192|FG001|Overall Study|Physician Decision|2|||
164533962|NCT02961218|594327191|FG000|Overall Study|Subject/Guardian Decision|3|||
164533963|NCT02961218|594327192|FG001|Overall Study|Subject/Guardian Decision|1|||
164533964|NCT00602667|594327193|FG000|Overall Study|Still on Therapy|0|||
164533965|NCT00602667|594327194|FG001|Overall Study|Still on Therapy|2|||
164533966|NCT00602667|594327195|FG002|Overall Study|Still on Therapy|2|||
164533967|NCT00602667|594327193|FG000|Overall Study|Death|0|||
164533968|NCT00602667|594327194|FG001|Overall Study|Death|1|||
164533969|NCT00602667|594327195|FG002|Overall Study|Death|1|||
164533970|NCT00602667|594327193|FG000|Overall Study|Family request|3|||
164533971|NCT00602667|594327194|FG001|Overall Study|Family request|25|||
164533972|NCT00602667|594327195|FG002|Overall Study|Family request|6|||
164533973|NCT00602667|594327193|FG000|Overall Study|Excessive toxicity|1|||
164533974|NCT00602667|594327194|FG001|Overall Study|Excessive toxicity|1|||
164533975|NCT00602667|594327195|FG002|Overall Study|Excessive toxicity|0|||
164533976|NCT00602667|594327193|FG000|Overall Study|Second malignancy|0|||
164533977|NCT00602667|594327194|FG001|Overall Study|Second malignancy|1|||
164533978|NCT00602667|594327195|FG002|Overall Study|Second malignancy|0|||
164533979|NCT00602667|594327193|FG000|Overall Study|Physician Decision|2|||
164419701|NCT00983619|593906541|FG001|Overall Study|Withdrawal by Subject|1|||
164533980|NCT00602667|594327194|FG001|Overall Study|Physician Decision|3|||
164533981|NCT00602667|594327195|FG002|Overall Study|Physician Decision|8|||
164533982|NCT00602667|594327193|FG000|Overall Study|Progressive disease|13|||
164533983|NCT00602667|594327194|FG001|Overall Study|Progressive disease|48|||
164533984|NCT00602667|594327195|FG002|Overall Study|Progressive disease|45|||
164533985|NCT00602667|594327193|FG000|Overall Study|Progressive disease prior to therapy|0|||
164533986|NCT00602667|594327194|FG001|Overall Study|Progressive disease prior to therapy|0|||
164306519|NCT01229267|593496809|FG003|Overall Study|Protocol Violation|0|||
164306520|NCT01229267|593496810|FG004|Overall Study|Protocol Violation|0|||
164306521|NCT01229267|593496806|FG000|Overall Study|Progressive disease|0|||
164306522|NCT01229267|593496807|FG001|Overall Study|Progressive disease|0|||
164306523|NCT01229267|593496808|FG002|Overall Study|Progressive disease|0|||
164306524|NCT01229267|593496809|FG003|Overall Study|Progressive disease|0|||
164306525|NCT01229267|593496810|FG004|Overall Study|Progressive disease|1|||
164306526|NCT01229267|593496806|FG000|Overall Study|Physician Decision|8|||
164306527|NCT01229267|593496807|FG001|Overall Study|Physician Decision|11|||
164306528|NCT01229267|593496808|FG002|Overall Study|Physician Decision|8|||
164306529|NCT01229267|593496809|FG003|Overall Study|Physician Decision|3|||
164306530|NCT01229267|593496810|FG004|Overall Study|Physician Decision|25|||
164306531|NCT01229267|593496806|FG000|Overall Study|Lost to Follow-up|6|||
164306532|NCT01229267|593496807|FG001|Overall Study|Lost to Follow-up|5|||
164306533|NCT01229267|593496808|FG002|Overall Study|Lost to Follow-up|8|||
164306534|NCT01229267|593496809|FG003|Overall Study|Lost to Follow-up|3|||
164306535|NCT01229267|593496810|FG004|Overall Study|Lost to Follow-up|22|||
164306536|NCT02223858|593496812|FG000|Overall Study|Death|1|||
164306537|NCT02223858|593496813|FG001|Overall Study|Death|1|||
164306538|NCT02223858|593496812|FG000|Overall Study|Lost to Follow-up|6|||
164306539|NCT02223858|593496813|FG001|Overall Study|Lost to Follow-up|11|||
164306540|NCT02223858|593496812|FG000|Overall Study|Withdrawal by Subject|8|||
164306541|NCT02223858|593496813|FG001|Overall Study|Withdrawal by Subject|5|||
164306542|NCT02223858|593496812|FG000|Overall Study|Refused|9|||
164306543|NCT02223858|593496813|FG001|Overall Study|Refused|9|||
164306544|NCT00241839|593496814|FG000|Overall Study|Withdrawal by Subject|18|||
164306545|NCT00241839|593496815|FG001|Overall Study|Withdrawal by Subject|17|||
164306546|NCT00241839|593496814|FG000|Overall Study|Adverse Event|1|||
164306547|NCT00241839|593496815|FG001|Overall Study|Adverse Event|1|||
164306548|NCT06170242|593496816|FG000|Overall Study|Lost to Follow-up|0|||
164306549|NCT06170242|593496817|FG001|Overall Study|Lost to Follow-up|0|||
164306550|NCT06170242|593496818|FG002|Overall Study|Lost to Follow-up|1|||
164306551|NCT06170242|593496819|FG003|Overall Study|Lost to Follow-up|1|||
164306552|NCT02976038|593496820|FG000|Overall Study|Physician Decision|22|||
164306553|NCT02976038|593496820|FG000|Overall Study|Withdrawal by Subject|3|||
164306554|NCT02976038|593496820|FG000|Overall Study|Lost to Follow-up|2|||
164306555|NCT02976038|593496820|FG000|Overall Study|Adverse Event|1|||
164306556|NCT02919995|593496823|FG000|Overall Study|Adverse Event|0|||
164306557|NCT02919995|593496824|FG001|Overall Study|Adverse Event|0|||
164306558|NCT02919995|593496825|FG002|Overall Study|Adverse Event|0|||
164306559|NCT02919995|593496826|FG003|Overall Study|Adverse Event|0|||
164306560|NCT02919995|593496827|FG004|Overall Study|Adverse Event|0|||
164306561|NCT02919995|593496828|FG005|Overall Study|Adverse Event|1|||
164306562|NCT01263197|593496840|FG000|First Intervention (Period 1)|Adverse Event|0|||
164306563|NCT01263197|593496841|FG001|First Intervention (Period 1)|Adverse Event|0|||
164306564|NCT01263197|593496842|FG002|First Intervention (Period 1)|Adverse Event|0|||
164306565|NCT01263197|593496843|FG003|First Intervention (Period 1)|Adverse Event|0|||
164306566|NCT01263197|593496844|FG004|First Intervention (Period 1)|Adverse Event|0|||
164306567|NCT01263197|593496845|FG005|First Intervention (Period 1)|Adverse Event|1|||
164306568|NCT01263197|593496840|FG000|Washout Period 1|Protocol Violation|0|||
164306569|NCT01263197|593496841|FG001|Washout Period 1|Protocol Violation|0|||
164306570|NCT01263197|593496842|FG002|Washout Period 1|Protocol Violation|0|||
164306571|NCT01263197|593496843|FG003|Washout Period 1|Protocol Violation|0|||
164306572|NCT01263197|593496844|FG004|Washout Period 1|Protocol Violation|1|||
164306573|NCT01263197|593496845|FG005|Washout Period 1|Protocol Violation|0|||
164306574|NCT01263197|593496840|FG000|Washout Period 2|Physician Decision|0|||
164306575|NCT01263197|593496841|FG001|Washout Period 2|Physician Decision|0|||
164306576|NCT01263197|593496842|FG002|Washout Period 2|Physician Decision|0|||
164306577|NCT01263197|593496843|FG003|Washout Period 2|Physician Decision|0|||
164306578|NCT01263197|593496844|FG004|Washout Period 2|Physician Decision|0|||
164306579|NCT01263197|593496845|FG005|Washout Period 2|Physician Decision|1|||
164306580|NCT01263197|593496840|FG000|Washout Period 2|Protocol Violation|0|||
164306581|NCT01263197|593496841|FG001|Washout Period 2|Protocol Violation|0|||
164306582|NCT01263197|593496842|FG002|Washout Period 2|Protocol Violation|0|||
164306583|NCT01263197|593496843|FG003|Washout Period 2|Protocol Violation|1|||
164306584|NCT01263197|593496844|FG004|Washout Period 2|Protocol Violation|0|||
164306585|NCT01263197|593496845|FG005|Washout Period 2|Protocol Violation|0|||
164306586|NCT01263197|593496840|FG000|Third Intervention (Period 3)|Adverse Event|0|||
164306587|NCT01263197|593496841|FG001|Third Intervention (Period 3)|Adverse Event|1|||
164306588|NCT01263197|593496842|FG002|Third Intervention (Period 3)|Adverse Event|0|||
164306589|NCT01263197|593496843|FG003|Third Intervention (Period 3)|Adverse Event|0|||
164306590|NCT01263197|593496844|FG004|Third Intervention (Period 3)|Adverse Event|0|||
164306591|NCT01263197|593496845|FG005|Third Intervention (Period 3)|Adverse Event|0|||
164306592|NCT02577718|593496846|FG000|Overall Study|Death|6|||
164306593|NCT02577718|593496846|FG000|Overall Study|Withdrawal by Subject|2|||
164306594|NCT02194985|593496847|FG000|Overall Study|Adverse Event|1|||
164306595|NCT02194985|593496847|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
164419702|NCT00983619|593906542|FG002|Overall Study|Withdrawal by Subject|1|||
164419703|NCT00983619|593906543|FG003|Overall Study|Withdrawal by Subject|3|||
164419704|NCT00983619|593906544|FG004|Overall Study|Withdrawal by Subject|1|||
164419705|NCT00983619|593906545|FG005|Overall Study|Withdrawal by Subject|23|||
164419706|NCT00983619|593906546|FG006|Overall Study|Withdrawal by Subject|0|||
164419707|NCT00983619|593906547|FG007|Overall Study|Withdrawal by Subject|0|||
164419708|NCT00983619|593906548|FG008|Overall Study|Withdrawal by Subject|0|||
164419709|NCT00983619|593906549|FG009|Overall Study|Withdrawal by Subject|0|||
164419710|NCT00983619|593906550|FG010|Overall Study|Withdrawal by Subject|1|||
164419711|NCT00983619|593906551|FG011|Overall Study|Withdrawal by Subject|1|||
164419712|NCT00983619|593906540|FG000|Overall Study|Death|0|||
164419713|NCT00983619|593906541|FG001|Overall Study|Death|2|||
164419714|NCT00983619|593906542|FG002|Overall Study|Death|2|||
164419715|NCT00983619|593906543|FG003|Overall Study|Death|1|||
164419716|NCT00983619|593906544|FG004|Overall Study|Death|2|||
164419717|NCT00983619|593906545|FG005|Overall Study|Death|30|||
164419718|NCT00983619|593906546|FG006|Overall Study|Death|1|||
164419719|NCT00983619|593906547|FG007|Overall Study|Death|0|||
164419720|NCT00983619|593906548|FG008|Overall Study|Death|1|||
164419721|NCT00983619|593906549|FG009|Overall Study|Death|2|||
164419722|NCT00983619|593906550|FG010|Overall Study|Death|9|||
164419723|NCT00983619|593906551|FG011|Overall Study|Death|8|||
164419724|NCT00983619|593906540|FG000|Overall Study|Other|1|||
164419725|NCT00983619|593906541|FG001|Overall Study|Other|0|||
164419726|NCT00983619|593906542|FG002|Overall Study|Other|0|||
164419727|NCT00983619|593906543|FG003|Overall Study|Other|1|||
164419728|NCT00983619|593906544|FG004|Overall Study|Other|0|||
164419729|NCT00983619|593906545|FG005|Overall Study|Other|12|||
164419730|NCT00983619|593906546|FG006|Overall Study|Other|2|||
164419731|NCT00983619|593906547|FG007|Overall Study|Other|2|||
164419732|NCT00983619|593906548|FG008|Overall Study|Other|0|||
164419733|NCT00983619|593906549|FG009|Overall Study|Other|1|||
164419734|NCT00983619|593906550|FG010|Overall Study|Other|1|||
164419735|NCT00983619|593906551|FG011|Overall Study|Other|0|||
164419736|NCT02443103|593906553|FG000|Overall Study|Adverse Event|2|||
164419737|NCT02443103|593906553|FG000|Overall Study|Noncompliance|1|||
164419738|NCT01313923|593906554|FG000|Overall Study|Physician Decision|3|||
164419739|NCT01388530|593906555|FG000|Overall Study|Lost to Follow-up|5|||
164419740|NCT02204293|593906556|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
164419741|NCT02204293|593906557|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
164419742|NCT02204293|593906558|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
164419743|NCT02204293|593906559|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
164419744|NCT02204293|593906560|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
164419745|NCT02204293|593906561|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
164419746|NCT02204293|593906556|FG000|Core Study Part I|Adverse Event|1|||
164419747|NCT02204293|593906557|FG001|Core Study Part I|Adverse Event|0|||
164419748|NCT02204293|593906558|FG002|Core Study Part I|Adverse Event|0|||
164419749|NCT02204293|593906559|FG003|Core Study Part I|Adverse Event|0|||
164419750|NCT02204293|593906560|FG004|Core Study Part I|Adverse Event|0|||
164419751|NCT02204293|593906561|FG005|Core Study Part I|Adverse Event|0|||
164419752|NCT02204293|593906556|FG000|Core Study Part I|Physician Decision|0|||
164419753|NCT02204293|593906557|FG001|Core Study Part I|Physician Decision|3|||
164419754|NCT02204293|593906558|FG002|Core Study Part I|Physician Decision|0|||
164419755|NCT02204293|593906559|FG003|Core Study Part I|Physician Decision|0|||
164419756|NCT02204293|593906560|FG004|Core Study Part I|Physician Decision|0|||
164419757|NCT02204293|593906561|FG005|Core Study Part I|Physician Decision|0|||
164419758|NCT02204293|593906556|FG000|LTE Phase|Study Suspended|0|||
164419759|NCT02204293|593906557|FG001|LTE Phase|Study Suspended|0|||
164419760|NCT02204293|593906558|FG002|LTE Phase|Study Suspended|0|||
164419761|NCT02204293|593906559|FG003|LTE Phase|Study Suspended|0|||
164419762|NCT02204293|593906560|FG004|LTE Phase|Study Suspended|0|||
164419763|NCT02204293|593906561|FG005|LTE Phase|Study Suspended|7|||
164419764|NCT03051659|593906562|FG000|Treatment Period|Withdrawal by Subject|0|||
164419765|NCT03051659|593906563|FG001|Treatment Period|Withdrawal by Subject|2|||
164419766|NCT03051659|593906562|FG000|Survival Follow-up|Lost to Follow-up|23|||
164419767|NCT03051659|593906563|FG001|Survival Follow-up|Lost to Follow-up|22|||
164419768|NCT01266993|593906564|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
164419769|NCT01266993|593906565|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
164419770|NCT01266993|593906564|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
164533987|NCT00602667|594327195|FG002|Overall Study|Progressive disease prior to therapy|1|||
164419771|NCT01266993|593906565|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
164419772|NCT04779242|593906566|FG000|Overall Study|Adverse Event|1|||
164419773|NCT04779242|593906567|FG001|Overall Study|Adverse Event|1|||
164419774|NCT04779242|593906566|FG000|Overall Study|Lost to Follow-up|2|||
164419775|NCT04779242|593906567|FG001|Overall Study|Lost to Follow-up|4|||
164419776|NCT04779242|593906566|FG000|Overall Study|Withdrawal by Subject|7|||
164589058|NCT01070550|594521376|FG004|Overall Study|Adverse Event|0|||
164419777|NCT04779242|593906567|FG001|Overall Study|Withdrawal by Subject|9|||
164419778|NCT04779242|593906566|FG000|Overall Study|Death|6|||
164419779|NCT04779242|593906567|FG001|Overall Study|Death|6|||
164419780|NCT04779242|593906566|FG000|Overall Study|COVID-19 related reasons|2|||
164419781|NCT04779242|593906567|FG001|Overall Study|COVID-19 related reasons|1|||
164419782|NCT04779242|593906566|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
164419783|NCT04779242|593906567|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
164419784|NCT04779242|593906566|FG000|Overall Study|Martial Law in Ukraine|2|||
164419785|NCT04779242|593906567|FG001|Overall Study|Martial Law in Ukraine|3|||
164419786|NCT00849680|593906572|FG000|Overall Study|Adverse Event|0|||
164419787|NCT00849680|593906573|FG001|Overall Study|Adverse Event|0|||
164419788|NCT00849680|593906574|FG002|Overall Study|Adverse Event|0|||
164419789|NCT00849680|593906575|FG003|Overall Study|Adverse Event|0|||
164419790|NCT00849680|593906576|FG004|Overall Study|Adverse Event|0|||
164419791|NCT00849680|593906577|FG005|Overall Study|Adverse Event|0|||
164419792|NCT00849680|593906578|FG006|Overall Study|Adverse Event|2|||
164419793|NCT00849680|593906579|FG007|Overall Study|Adverse Event|0|||
164419794|NCT00849680|593906572|FG000|Overall Study|Lost to Follow-up|7|||
164419795|NCT00849680|593906573|FG001|Overall Study|Lost to Follow-up|3|||
164419796|NCT00849680|593906574|FG002|Overall Study|Lost to Follow-up|12|||
164419797|NCT00849680|593906575|FG003|Overall Study|Lost to Follow-up|11|||
164419798|NCT00849680|593906576|FG004|Overall Study|Lost to Follow-up|8|||
164419799|NCT00849680|593906577|FG005|Overall Study|Lost to Follow-up|11|||
164419800|NCT00849680|593906578|FG006|Overall Study|Lost to Follow-up|12|||
164419801|NCT00849680|593906579|FG007|Overall Study|Lost to Follow-up|5|||
164419802|NCT00849680|593906572|FG000|Overall Study|Subject moved|1|||
164419803|NCT00849680|593906573|FG001|Overall Study|Subject moved|0|||
164419804|NCT00849680|593906574|FG002|Overall Study|Subject moved|3|||
164419805|NCT00849680|593906575|FG003|Overall Study|Subject moved|1|||
164419806|NCT00849680|593906576|FG004|Overall Study|Subject moved|0|||
164419807|NCT00849680|593906577|FG005|Overall Study|Subject moved|2|||
164419808|NCT00849680|593906578|FG006|Overall Study|Subject moved|2|||
164419809|NCT00849680|593906579|FG007|Overall Study|Subject moved|2|||
164419810|NCT00849680|593906572|FG000|Overall Study|Withdrawal by Subject|2|||
164419811|NCT00849680|593906573|FG001|Overall Study|Withdrawal by Subject|0|||
164419812|NCT00849680|593906574|FG002|Overall Study|Withdrawal by Subject|0|||
164533988|NCT04765059|594327198|FG000|Overall Study|Failure to meet randomization criteria|1|||
164533989|NCT04765059|594327199|FG001|Overall Study|Failure to meet randomization criteria|0|||
164533990|NCT04765059|594327198|FG000|Overall Study|Withdrawal by Subject|1|||
164533991|NCT04765059|594327199|FG001|Overall Study|Withdrawal by Subject|4|||
164533992|NCT04765059|594327198|FG000|Overall Study|Lost to Follow-up|1|||
164533993|NCT04765059|594327199|FG001|Overall Study|Lost to Follow-up|1|||
164533994|NCT04765059|594327198|FG000|Overall Study|Death|25|||
164533995|NCT04765059|594327199|FG001|Overall Study|Death|28|||
164533996|NCT04765059|594327198|FG000|Overall Study|Participants ongoing study at data cutoff date of 28-Oct-24|21|||
164533997|NCT04765059|594327199|FG001|Overall Study|Participants ongoing study at data cutoff date of 28-Oct-24|16|||
164533998|NCT04300309|594327200|FG000|Overall Study|Lost to Follow-up|1|||
164533999|NCT04300309|594327201|FG001|Overall Study|Lost to Follow-up|0|||
164534000|NCT04647526|594327202|FG000|Overall Study|Death|13|||
164534001|NCT04647526|594327203|FG001|Overall Study|Death|76|||
164534002|NCT04647526|594327204|FG002|Overall Study|Death|32|||
164534003|NCT04647526|594327205|FG003|Overall Study|Death|0|||
164534004|NCT04647526|594327202|FG000|Overall Study|Lost to Follow-up|1|||
164534005|NCT04647526|594327203|FG001|Overall Study|Lost to Follow-up|0|||
164534006|NCT04647526|594327204|FG002|Overall Study|Lost to Follow-up|1|||
164534007|NCT04647526|594327205|FG003|Overall Study|Lost to Follow-up|0|||
164534008|NCT04647526|594327202|FG000|Overall Study|Withdrawal by Subject|4|||
164534009|NCT04647526|594327203|FG001|Overall Study|Withdrawal by Subject|15|||
164534010|NCT04647526|594327204|FG002|Overall Study|Withdrawal by Subject|8|||
164534011|NCT04647526|594327205|FG003|Overall Study|Withdrawal by Subject|1|||
164534012|NCT04647526|594327202|FG000|Overall Study|Incorrect enrollment|0|||
164534013|NCT04647526|594327203|FG001|Overall Study|Incorrect enrollment|1|||
164534014|NCT04647526|594327204|FG002|Overall Study|Incorrect enrollment|1|||
164534015|NCT04647526|594327205|FG003|Overall Study|Incorrect enrollment|0|||
164534016|NCT04647526|594327202|FG000|Overall Study|Physician Decision|0|||
164534017|NCT04647526|594327203|FG001|Overall Study|Physician Decision|1|||
164534018|NCT04647526|594327204|FG002|Overall Study|Physician Decision|1|||
164534019|NCT04647526|594327205|FG003|Overall Study|Physician Decision|0|||
164534020|NCT04647526|594327202|FG000|Overall Study|Ongoing|9|||
164534021|NCT04647526|594327203|FG001|Overall Study|Ongoing|183|||
164534022|NCT04647526|594327204|FG002|Overall Study|Ongoing|93|||
164534023|NCT04647526|594327205|FG003|Overall Study|Ongoing|15|||
164534024|NCT04150029|594327206|FG000|Overall Study|Disease Relapse|0|||
164534025|NCT04150029|594327207|FG001|Overall Study|Disease Relapse|18|||
164419813|NCT00849680|593906575|FG003|Overall Study|Withdrawal by Subject|2|||
164419814|NCT00849680|593906576|FG004|Overall Study|Withdrawal by Subject|2|||
164419815|NCT00849680|593906577|FG005|Overall Study|Withdrawal by Subject|2|||
164419816|NCT00849680|593906578|FG006|Overall Study|Withdrawal by Subject|1|||
164534026|NCT04150029|594327206|FG000|Overall Study|Progressive Disease|2|||
164534027|NCT04150029|594327207|FG001|Overall Study|Progressive Disease|16|||
164534028|NCT04150029|594327206|FG000|Overall Study|Adverse Event|1|||
164534029|NCT04150029|594327207|FG001|Overall Study|Adverse Event|11|||
164306596|NCT02194985|593496847|FG000|Overall Study|Physician Decision|4|||
164306597|NCT02194985|593496847|FG000|Overall Study|Lost to Follow-up|1|||
164306598|NCT02194985|593496847|FG000|Overall Study|Withdrawal by Subject|2|||
164306599|NCT00346697|593496851|FG000|Overall Study|Lost to Follow-up|0|||
164306600|NCT00346697|593496852|FG001|Overall Study|Lost to Follow-up|1|||
164306601|NCT01012440|593496853|FG000|Overall Study|Withdrawal by Subject|2|||
164306602|NCT00594815|593496854|FG000|Overall Study|Never Treated|3|||
164306603|NCT00594815|593496854|FG000|Overall Study|Withdrawal by Subject|2|||
164306604|NCT00594815|593496854|FG000|Overall Study|Toxicity|4|||
164306605|NCT02557139|593496855|FG000|Overall Study|Significant liver elevation|1|||
164306606|NCT02557139|593496856|FG001|Overall Study|Significant liver elevation|0|||
164306607|NCT02557139|593496857|FG002|Overall Study|Significant liver elevation|1|||
164306608|NCT02557139|593496855|FG000|Overall Study|Withdrawal by Subject|1|||
164306609|NCT02557139|593496856|FG001|Overall Study|Withdrawal by Subject|0|||
164306610|NCT02557139|593496857|FG002|Overall Study|Withdrawal by Subject|0|||
164306611|NCT02557139|593496855|FG000|Overall Study|Illness of prohibited medication|0|||
164306612|NCT02557139|593496856|FG001|Overall Study|Illness of prohibited medication|0|||
164306613|NCT02557139|593496857|FG002|Overall Study|Illness of prohibited medication|1|||
164306614|NCT02284243|593496858|FG000|Overall Study|Lack of Efficacy|3|||
164306615|NCT02284243|593496859|FG001|Overall Study|Lack of Efficacy|3|||
164306616|NCT02284243|593496858|FG000|Overall Study|Adverse Event|1|||
164306617|NCT02284243|593496859|FG001|Overall Study|Adverse Event|0|||
164306618|NCT01932437|593496861|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
164306619|NCT01932437|593496862|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
164306620|NCT01932437|593496863|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
164306621|NCT01932437|593496864|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
164306622|NCT01932437|593496865|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
164306623|NCT01932437|593496866|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
164306624|NCT04269889|593496867|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
164306625|NCT00949702|593496872|FG000|Overall Study|Death|40|||
164306626|NCT00949702|593496872|FG000|Overall Study|Disease progression|7|||
164306627|NCT00949702|593496872|FG000|Overall Study|Withdrawal of consent|1|||
164306628|NCT01654302|593496873|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
164306629|NCT01654302|593496874|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
164306630|NCT02699749|593496877|FG000|Overall Study|Other|0|||
164306631|NCT02699749|593496878|FG001|Overall Study|Other|0|||
164306632|NCT02699749|593496879|FG002|Overall Study|Other|2|||
164306633|NCT02699749|593496880|FG003|Overall Study|Other|0|||
164306634|NCT02699749|593496881|FG004|Overall Study|Other|0|||
164306635|NCT02699749|593496882|FG005|Overall Study|Other|1|||
164306636|NCT02699749|593496883|FG006|Overall Study|Other|1|||
164306637|NCT02699749|593496884|FG007|Overall Study|Other|0|||
164306638|NCT02699749|593496885|FG008|Overall Study|Other|0|||
164306639|NCT02699749|593496886|FG009|Overall Study|Other|0|||
164306640|NCT02699749|593496887|FG010|Overall Study|Other|1|||
164306641|NCT02699749|593496888|FG011|Overall Study|Other|0|||
164306642|NCT02699749|593496889|FG012|Overall Study|Other|0|||
164306643|NCT02699749|593496890|FG013|Overall Study|Other|0|||
164306644|NCT02699749|593496877|FG000|Overall Study|Progressive Disease|3|||
164306645|NCT02699749|593496878|FG001|Overall Study|Progressive Disease|3|||
164306646|NCT02699749|593496879|FG002|Overall Study|Progressive Disease|14|||
164306647|NCT02699749|593496880|FG003|Overall Study|Progressive Disease|3|||
164306648|NCT02699749|593496881|FG004|Overall Study|Progressive Disease|3|||
164419817|NCT00849680|593906579|FG007|Overall Study|Withdrawal by Subject|1|||
164419818|NCT00849680|593906572|FG000|Overall Study|Subject unable to comply with protocol|1|||
164419819|NCT00849680|593906573|FG001|Overall Study|Subject unable to comply with protocol|0|||
164419820|NCT00849680|593906574|FG002|Overall Study|Subject unable to comply with protocol|0|||
164419821|NCT00849680|593906575|FG003|Overall Study|Subject unable to comply with protocol|0|||
164419822|NCT00849680|593906576|FG004|Overall Study|Subject unable to comply with protocol|0|||
164419823|NCT00849680|593906577|FG005|Overall Study|Subject unable to comply with protocol|0|||
164419824|NCT00849680|593906578|FG006|Overall Study|Subject unable to comply with protocol|0|||
164419825|NCT00849680|593906579|FG007|Overall Study|Subject unable to comply with protocol|0|||
164419826|NCT00003458|593906584|FG000|Overall Study|Not evaluable|4|||
164419827|NCT04714216|593908570|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
164419828|NCT04714216|593908570|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
164419829|NCT03095599|593908571|FG000|Overall Study|Withdrawal by Subject|1|||
164419830|NCT03095599|593908572|FG001|Overall Study|Withdrawal by Subject|0|||
164419831|NCT03095599|593908571|FG000|Overall Study|Lost to Follow-up|1|||
164419832|NCT03095599|593908572|FG001|Overall Study|Lost to Follow-up|0|||
164419833|NCT03095599|593908571|FG000|Overall Study|Withdrawal prior to vaccination|1|||
164419834|NCT03095599|593908572|FG001|Overall Study|Withdrawal prior to vaccination|0|||
164419835|NCT00513019|593908574|FG000|Overall Study|Adverse Event|1|||
164419836|NCT00513019|593908575|FG001|Overall Study|Adverse Event|0|||
164419837|NCT00513019|593908574|FG000|Overall Study|Withdrawal by Subject|4|||
164419838|NCT00513019|593908575|FG001|Overall Study|Withdrawal by Subject|5|||
164534030|NCT04150029|594327206|FG000|Overall Study|Physician Decision|0|||
164534031|NCT04150029|594327207|FG001|Overall Study|Physician Decision|10|||
164534032|NCT04150029|594327206|FG000|Overall Study|Study Terminated by Sponsor|1|||
164534033|NCT04150029|594327207|FG001|Overall Study|Study Terminated by Sponsor|10|||
164534034|NCT04150029|594327206|FG000|Overall Study|Death|0|||
164534035|NCT04150029|594327207|FG001|Overall Study|Death|8|||
164534036|NCT04150029|594327206|FG000|Overall Study|Participant Decision|0|||
164534037|NCT04150029|594327207|FG001|Overall Study|Participant Decision|7|||
164534038|NCT04150029|594327206|FG000|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|1|||
164534039|NCT04150029|594327207|FG001|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|5|||
164534040|NCT03282240|594327208|FG000|Overall Study|Adverse Event|2|||
164534041|NCT03282240|594327209|FG001|Overall Study|Adverse Event|2|||
164534042|NCT03282240|594327210|FG002|Overall Study|Adverse Event|0|||
164534043|NCT03282240|594327208|FG000|Overall Study|Lost to Follow-up|3|||
164534044|NCT03282240|594327209|FG001|Overall Study|Lost to Follow-up|0|||
164534045|NCT03282240|594327210|FG002|Overall Study|Lost to Follow-up|0|||
164534046|NCT03282240|594327208|FG000|Overall Study|Protocol Deviation|4|||
164534047|NCT03282240|594327209|FG001|Overall Study|Protocol Deviation|1|||
164534048|NCT03282240|594327210|FG002|Overall Study|Protocol Deviation|2|||
164534049|NCT03282240|594327208|FG000|Overall Study|Withdrawal by Subject|1|||
164534050|NCT03282240|594327209|FG001|Overall Study|Withdrawal by Subject|0|||
164534051|NCT03282240|594327210|FG002|Overall Study|Withdrawal by Subject|1|||
164534052|NCT01675479|594327211|FG000|Overall Study|Lost to Follow-up|11|||
164534053|NCT02910739|594327212|FG000|Overall Study|Adverse Event|1|||
164534054|NCT02910739|594327213|FG001|Overall Study|Adverse Event|0|||
164534055|NCT02910739|594327214|FG002|Overall Study|Adverse Event|0|||
164534056|NCT02910739|594327215|FG003|Overall Study|Adverse Event|0|||
164534057|NCT03816891|594327216|FG000|Double-Blind Period|Withdrawal by Subject|1|||
164534058|NCT03816891|594327217|FG001|Double-Blind Period|Withdrawal by Subject|2|||
164534059|NCT03816891|594327218|FG002|Double-Blind Period|Withdrawal by Subject|0|||
164534060|NCT03816891|594327219|FG003|Double-Blind Period|Withdrawal by Subject|2|||
164534061|NCT03816891|594327220|FG004|Double-Blind Period|Withdrawal by Subject|0|||
164534062|NCT03816891|594327221|FG005|Double-Blind Period|Withdrawal by Subject|0|||
164534063|NCT03816891|594327216|FG000|Double-Blind Period|Adverse Event|0|||
164534064|NCT03816891|594327217|FG001|Double-Blind Period|Adverse Event|0|||
164534065|NCT03816891|594327218|FG002|Double-Blind Period|Adverse Event|2|||
164534066|NCT03816891|594327219|FG003|Double-Blind Period|Adverse Event|0|||
164534067|NCT03816891|594327220|FG004|Double-Blind Period|Adverse Event|0|||
164534068|NCT03816891|594327221|FG005|Double-Blind Period|Adverse Event|0|||
164534069|NCT03816891|594327216|FG000|Double-Blind Period|Lost to Follow-up|2|||
164534070|NCT03816891|594327217|FG001|Double-Blind Period|Lost to Follow-up|0|||
164306649|NCT02699749|593496882|FG005|Overall Study|Progressive Disease|7|||
164306650|NCT02699749|593496883|FG006|Overall Study|Progressive Disease|5|||
164306651|NCT02699749|593496884|FG007|Overall Study|Progressive Disease|5|||
164306652|NCT02699749|593496885|FG008|Overall Study|Progressive Disease|6|||
164306653|NCT02699749|593496886|FG009|Overall Study|Progressive Disease|6|||
164306654|NCT02699749|593496887|FG010|Overall Study|Progressive Disease|5|||
164306655|NCT02699749|593496888|FG011|Overall Study|Progressive Disease|4|||
164306656|NCT02699749|593496889|FG012|Overall Study|Progressive Disease|3|||
164306657|NCT02699749|593496890|FG013|Overall Study|Progressive Disease|5|||
164306658|NCT02699749|593496877|FG000|Overall Study|Death|0|||
164306659|NCT02699749|593496878|FG001|Overall Study|Death|0|||
164306660|NCT02699749|593496879|FG002|Overall Study|Death|0|||
164306661|NCT02699749|593496880|FG003|Overall Study|Death|0|||
164306662|NCT02699749|593496881|FG004|Overall Study|Death|0|||
164306663|NCT02699749|593496882|FG005|Overall Study|Death|0|||
164306664|NCT02699749|593496883|FG006|Overall Study|Death|0|||
164306665|NCT02699749|593496884|FG007|Overall Study|Death|0|||
164306666|NCT02699749|593496885|FG008|Overall Study|Death|0|||
164306667|NCT02699749|593496886|FG009|Overall Study|Death|0|||
164306668|NCT02699749|593496887|FG010|Overall Study|Death|0|||
164306669|NCT02699749|593496888|FG011|Overall Study|Death|0|||
164534071|NCT03816891|594327218|FG002|Double-Blind Period|Lost to Follow-up|0|||
164534072|NCT03816891|594327219|FG003|Double-Blind Period|Lost to Follow-up|0|||
164306670|NCT02699749|593496889|FG012|Overall Study|Death|0|||
164534073|NCT03816891|594327220|FG004|Double-Blind Period|Lost to Follow-up|0|||
164306671|NCT02699749|593496890|FG013|Overall Study|Death|1|||
164306672|NCT02699749|593496877|FG000|Overall Study|Lost to Follow-up|0|||
164306673|NCT02699749|593496878|FG001|Overall Study|Lost to Follow-up|0|||
164306674|NCT02699749|593496879|FG002|Overall Study|Lost to Follow-up|0|||
164306675|NCT02699749|593496880|FG003|Overall Study|Lost to Follow-up|0|||
164306676|NCT02699749|593496881|FG004|Overall Study|Lost to Follow-up|0|||
164306677|NCT02699749|593496882|FG005|Overall Study|Lost to Follow-up|1|||
164534074|NCT03816891|594327221|FG005|Double-Blind Period|Lost to Follow-up|1|||
164534075|NCT03816891|594327216|FG000|Double-Blind Period|Physician Decision|0|||
164534076|NCT03816891|594327217|FG001|Double-Blind Period|Physician Decision|0|||
164534077|NCT03816891|594327218|FG002|Double-Blind Period|Physician Decision|0|||
164534078|NCT03816891|594327219|FG003|Double-Blind Period|Physician Decision|1|||
164534079|NCT03816891|594327220|FG004|Double-Blind Period|Physician Decision|0|||
164534080|NCT03816891|594327221|FG005|Double-Blind Period|Physician Decision|0|||
164306678|NCT02699749|593496883|FG006|Overall Study|Lost to Follow-up|0|||
164306679|NCT02699749|593496884|FG007|Overall Study|Lost to Follow-up|1|||
164306680|NCT02699749|593496885|FG008|Overall Study|Lost to Follow-up|0|||
164306681|NCT02699749|593496886|FG009|Overall Study|Lost to Follow-up|0|||
164306682|NCT02699749|593496887|FG010|Overall Study|Lost to Follow-up|0|||
164306683|NCT02699749|593496888|FG011|Overall Study|Lost to Follow-up|0|||
164306684|NCT02699749|593496889|FG012|Overall Study|Lost to Follow-up|0|||
164306685|NCT02699749|593496890|FG013|Overall Study|Lost to Follow-up|0|||
164306686|NCT02377817|593496892|FG000|Overall Study|Transportation/childcare barriers.|2|||
164306687|NCT02377817|593496893|FG001|Overall Study|Transportation/childcare barriers.|0|||
164306688|NCT02377817|593496892|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
164306689|NCT02377817|593496893|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
164306690|NCT04139018|593496894|FG000|Overall Study|Screen fail|1|||
164306691|NCT04139018|593496895|FG001|Overall Study|Screen fail|0|||
164306692|NCT04139018|593496894|FG000|Overall Study|Withdrawal by Subject|2|||
164306693|NCT04139018|593496895|FG001|Overall Study|Withdrawal by Subject|0|||
164306694|NCT04139018|593496894|FG000|Overall Study|Lost to Follow-up|0|||
164306695|NCT04139018|593496895|FG001|Overall Study|Lost to Follow-up|1|||
164306696|NCT03614156|593496912|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
164306697|NCT03614156|593496913|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
164306698|NCT03614156|593496914|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
164306699|NCT03614156|593496915|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
164306700|NCT03614156|593496912|FG000|Open-Label Treatment Period|Adverse Event|7|||
164306701|NCT03614156|593496913|FG001|Open-Label Treatment Period|Adverse Event|0|||
164306702|NCT03614156|593496914|FG002|Open-Label Treatment Period|Adverse Event|0|||
164306703|NCT03614156|593496915|FG003|Open-Label Treatment Period|Adverse Event|0|||
164306704|NCT03614156|593496912|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
164306705|NCT03614156|593496913|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
164306706|NCT03614156|593496914|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
164306707|NCT03614156|593496915|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
164306708|NCT03614156|593496912|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
164306709|NCT03614156|593496913|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
164306710|NCT03614156|593496914|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
164306711|NCT03614156|593496915|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
164306712|NCT03614156|593496912|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
164306713|NCT03614156|593496913|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
164306714|NCT03614156|593496914|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
164306715|NCT03614156|593496915|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
164306716|NCT03614156|593496912|FG000|Open-Label Treatment Period|Protocol Violation|2|||
164306717|NCT03614156|593496913|FG001|Open-Label Treatment Period|Protocol Violation|0|||
164306718|NCT03614156|593496914|FG002|Open-Label Treatment Period|Protocol Violation|0|||
164306719|NCT03614156|593496915|FG003|Open-Label Treatment Period|Protocol Violation|0|||
164306720|NCT03614156|593496912|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
164306721|NCT03614156|593496913|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
164306722|NCT03614156|593496914|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
164306723|NCT03614156|593496915|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
164306724|NCT03614156|593496912|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
164306725|NCT03614156|593496913|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
164306726|NCT03614156|593496914|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
164306727|NCT03614156|593496915|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
164306728|NCT03614156|593496912|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
164306729|NCT03614156|593496913|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
164306730|NCT03614156|593496914|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
164306731|NCT03614156|593496915|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
164306732|NCT03614156|593496912|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
164306733|NCT03614156|593496913|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
164306734|NCT03614156|593496914|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
164306735|NCT03614156|593496915|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
164306736|NCT03614156|593496912|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
164306737|NCT03614156|593496913|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
164534081|NCT03816891|594327216|FG000|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
164534082|NCT03816891|594327217|FG001|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
164534083|NCT03816891|594327218|FG002|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
164534084|NCT03816891|594327219|FG003|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
164534085|NCT03816891|594327220|FG004|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
164534086|NCT03816891|594327221|FG005|Double-Blind Period|Coronavirus Disease (COVID-19)|1|||
164306738|NCT03614156|593496914|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
164306739|NCT03614156|593496915|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
164306740|NCT03614156|593496912|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
164306741|NCT03614156|593496913|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
164306742|NCT03614156|593496914|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
164306743|NCT03614156|593496915|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
164306744|NCT03614156|593496912|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
164306745|NCT03614156|593496913|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
164306746|NCT03614156|593496914|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
164306747|NCT03614156|593496915|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
164306748|NCT03614156|593496912|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
164306749|NCT03614156|593496913|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
164306750|NCT03614156|593496914|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
164306751|NCT03614156|593496915|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
164306752|NCT03614156|593496912|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
164306753|NCT03614156|593496913|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
164306754|NCT03614156|593496914|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
164306755|NCT03614156|593496915|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
164306756|NCT03614156|593496912|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
164306757|NCT03614156|593496913|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
164306758|NCT03614156|593496914|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
164306759|NCT03614156|593496915|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
164306760|NCT03614156|593496912|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
164306761|NCT03614156|593496913|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
164306762|NCT03614156|593496914|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
164306763|NCT03614156|593496915|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
164306764|NCT01094119|593496916|FG000|Overall Study|Lack of Efficacy|2|||
164306765|NCT01094119|593496917|FG001|Overall Study|Lack of Efficacy|4|||
164306766|NCT01106248|593496920|FG000|Overall Study|Adverse Event|1|||
164306767|NCT01106248|593496920|FG000|Overall Study|Administrative|2|||
164306768|NCT00357903|593496921|FG000|Overall Study|Adverse Event|87|||
164306769|NCT00357903|593496922|FG001|Overall Study|Adverse Event|4|||
164306770|NCT00357903|593496921|FG000|Overall Study|Death|33|||
164306771|NCT00357903|593496922|FG001|Overall Study|Death|0|||
164306772|NCT00357903|593496921|FG000|Overall Study|Lost to Follow-up|23|||
164306773|NCT00357903|593496922|FG001|Overall Study|Lost to Follow-up|4|||
164306774|NCT00357903|593496921|FG000|Overall Study|Physician Decision|39|||
164306775|NCT00357903|593496922|FG001|Overall Study|Physician Decision|5|||
164306776|NCT00357903|593496921|FG000|Overall Study|Withdrawal by Subject|57|||
164306777|NCT00357903|593496922|FG001|Overall Study|Withdrawal by Subject|7|||
164306778|NCT00357903|593496921|FG000|Overall Study|Completed month 12 only|0|||
164306779|NCT00357903|593496922|FG001|Overall Study|Completed month 12 only|1|||
164306780|NCT00357903|593496921|FG000|Overall Study|Protocol issues|14|||
164306781|NCT00357903|593496922|FG001|Overall Study|Protocol issues|3|||
164306782|NCT00357903|593496921|FG000|Overall Study|Response status|61|||
164306783|NCT00357903|593496922|FG001|Overall Study|Response status|9|||
164306784|NCT00357903|593496921|FG000|Overall Study|Other|49|||
164306785|NCT00357903|593496922|FG001|Overall Study|Other|10|||
164306786|NCT00606593|593496923|FG000|Overall Study|Adverse Event|0|||
164306787|NCT00606593|593496924|FG001|Overall Study|Adverse Event|0|||
164306788|NCT00606593|593496925|FG002|Overall Study|Adverse Event|0|||
164306789|NCT00606593|593496926|FG003|Overall Study|Adverse Event|1|||
164306790|NCT00606593|593496927|FG004|Overall Study|Adverse Event|1|||
164306791|NCT00606593|593496928|FG005|Overall Study|Adverse Event|0|||
164306792|NCT00606593|593496929|FG006|Overall Study|Adverse Event|1|||
164306793|NCT00606593|593496930|FG007|Overall Study|Adverse Event|2|||
164306794|NCT00606593|593496931|FG008|Overall Study|Adverse Event|1|||
164306795|NCT00606593|593496932|FG009|Overall Study|Adverse Event|0|||
164306796|NCT00606593|593496923|FG000|Overall Study|Withdrawal of consent|1|||
164306797|NCT00606593|593496924|FG001|Overall Study|Withdrawal of consent|0|||
164306798|NCT00606593|593496925|FG002|Overall Study|Withdrawal of consent|1|||
164306799|NCT00606593|593496926|FG003|Overall Study|Withdrawal of consent|0|||
164306800|NCT00606593|593496927|FG004|Overall Study|Withdrawal of consent|0|||
164306801|NCT00606593|593496928|FG005|Overall Study|Withdrawal of consent|0|||
164306802|NCT00606593|593496929|FG006|Overall Study|Withdrawal of consent|0|||
164306803|NCT00606593|593496930|FG007|Overall Study|Withdrawal of consent|0|||
164306804|NCT00606593|593496931|FG008|Overall Study|Withdrawal of consent|0|||
164306805|NCT00606593|593496932|FG009|Overall Study|Withdrawal of consent|0|||
164306806|NCT00606593|593496923|FG000|Overall Study|Administrative/Other|0|||
164306807|NCT00606593|593496924|FG001|Overall Study|Administrative/Other|0|||
164306808|NCT00606593|593496925|FG002|Overall Study|Administrative/Other|1|||
164306809|NCT00606593|593496926|FG003|Overall Study|Administrative/Other|0|||
164306810|NCT00606593|593496927|FG004|Overall Study|Administrative/Other|0|||
164306811|NCT00606593|593496928|FG005|Overall Study|Administrative/Other|0|||
164306812|NCT00606593|593496929|FG006|Overall Study|Administrative/Other|0|||
164306813|NCT00606593|593496930|FG007|Overall Study|Administrative/Other|0|||
164306814|NCT00606593|593496931|FG008|Overall Study|Administrative/Other|0|||
164534087|NCT03816891|594327216|FG000|Double-Blind Period|Other|1|||
164534088|NCT03816891|594327217|FG001|Double-Blind Period|Other|0|||
164534089|NCT03816891|594327218|FG002|Double-Blind Period|Other|0|||
164534090|NCT03816891|594327219|FG003|Double-Blind Period|Other|0|||
164534091|NCT03816891|594327220|FG004|Double-Blind Period|Other|0|||
164306815|NCT00606593|593496932|FG009|Overall Study|Administrative/Other|0|||
164306816|NCT01160822|593496933|FG000|Overall Study|Adverse Event|0|||
164306817|NCT01160822|593496934|FG001|Overall Study|Adverse Event|0|||
164306818|NCT01160822|593496935|FG002|Overall Study|Adverse Event|0|||
164306819|NCT01160822|593496936|FG003|Overall Study|Adverse Event|0|||
164306820|NCT01160822|593496937|FG004|Overall Study|Adverse Event|1|||
164306821|NCT01160822|593496938|FG005|Overall Study|Adverse Event|2|||
164306822|NCT01160822|593496939|FG006|Overall Study|Adverse Event|5|||
164306823|NCT01160822|593496933|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164306824|NCT01160822|593496934|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164306825|NCT01160822|593496935|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
164306826|NCT01160822|593496936|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
164306827|NCT01160822|593496937|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
164306828|NCT01160822|593496938|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
164306829|NCT01160822|593496939|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
164306830|NCT01160822|593496933|FG000|Overall Study|Withdrawal by Subject|0|||
164306831|NCT01160822|593496934|FG001|Overall Study|Withdrawal by Subject|0|||
164306832|NCT01160822|593496935|FG002|Overall Study|Withdrawal by Subject|0|||
164306833|NCT01160822|593496936|FG003|Overall Study|Withdrawal by Subject|0|||
164306834|NCT01160822|593496937|FG004|Overall Study|Withdrawal by Subject|0|||
164306835|NCT01160822|593496938|FG005|Overall Study|Withdrawal by Subject|0|||
164306836|NCT01160822|593496939|FG006|Overall Study|Withdrawal by Subject|1|||
164306837|NCT01160822|593496933|FG000|Overall Study|Lost to Follow-up|0|||
164306838|NCT01160822|593496934|FG001|Overall Study|Lost to Follow-up|0|||
164306839|NCT01160822|593496935|FG002|Overall Study|Lost to Follow-up|0|||
164306840|NCT01160822|593496936|FG003|Overall Study|Lost to Follow-up|0|||
164306841|NCT01160822|593496937|FG004|Overall Study|Lost to Follow-up|1|||
164306842|NCT01160822|593496938|FG005|Overall Study|Lost to Follow-up|0|||
164306843|NCT01160822|593496939|FG006|Overall Study|Lost to Follow-up|0|||
164306844|NCT01160822|593496933|FG000|Overall Study|Administrative problems|0|||
164306845|NCT01160822|593496934|FG001|Overall Study|Administrative problems|0|||
164306846|NCT01160822|593496935|FG002|Overall Study|Administrative problems|0|||
164306847|NCT01160822|593496936|FG003|Overall Study|Administrative problems|0|||
164306848|NCT01160822|593496937|FG004|Overall Study|Administrative problems|1|||
164306849|NCT01160822|593496938|FG005|Overall Study|Administrative problems|0|||
164306850|NCT01160822|593496939|FG006|Overall Study|Administrative problems|0|||
164306851|NCT01160822|593496933|FG000|Overall Study|Protocol deviation|0|||
164306852|NCT01160822|593496934|FG001|Overall Study|Protocol deviation|0|||
164306853|NCT01160822|593496935|FG002|Overall Study|Protocol deviation|0|||
164306854|NCT01160822|593496936|FG003|Overall Study|Protocol deviation|0|||
164306855|NCT01160822|593496937|FG004|Overall Study|Protocol deviation|2|||
164306856|NCT01160822|593496938|FG005|Overall Study|Protocol deviation|0|||
164306857|NCT01160822|593496939|FG006|Overall Study|Protocol deviation|0|||
164306858|NCT00759941|593496947|FG000|Overall Study|Use of medication|1|||
164306859|NCT00759941|593496948|FG001|Overall Study|Use of medication|0|||
164306860|NCT00759941|593496947|FG000|Overall Study|Adverse Event|1|||
164306861|NCT00759941|593496948|FG001|Overall Study|Adverse Event|0|||
164306862|NCT00759941|593496947|FG000|Overall Study|Exited in error by site|1|||
164306863|NCT00759941|593496948|FG001|Overall Study|Exited in error by site|1|||
164306864|NCT00354432|593496949|FG000|Overall Study|Adverse Event|3|||
164306865|NCT00354432|593496950|FG001|Overall Study|Adverse Event|1|||
164306866|NCT00354432|593496951|FG002|Overall Study|Adverse Event|5|||
164306867|NCT00354432|593496952|FG003|Overall Study|Adverse Event|5|||
164306868|NCT00354432|593496949|FG000|Overall Study|Off/Toxicity|3|||
164306869|NCT00354432|593496950|FG001|Overall Study|Off/Toxicity|7|||
164306870|NCT00354432|593496951|FG002|Overall Study|Off/Toxicity|5|||
164306871|NCT00354432|593496952|FG003|Overall Study|Off/Toxicity|5|||
164306872|NCT03863080|593496953|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
164306873|NCT03863080|593496954|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
164306874|NCT03863080|593496955|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
164306875|NCT03863080|593496956|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
164306876|NCT03863080|593496953|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
164306877|NCT03863080|593496954|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
164306878|NCT03863080|593496955|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
164306879|NCT03863080|593496956|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
164306880|NCT03863080|593496953|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
164306881|NCT03863080|593496954|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
164306882|NCT03863080|593496955|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
164306883|NCT03863080|593496956|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
164534092|NCT03816891|594327221|FG005|Double-Blind Period|Other|0|||
164534093|NCT03816891|594327216|FG000|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
164534094|NCT03816891|594327217|FG001|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
164534095|NCT03816891|594327218|FG002|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|4|||
164534096|NCT03816891|594327219|FG003|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|3|||
164534097|NCT03816891|594327220|FG004|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|2|||
164534098|NCT03816891|594327221|FG005|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
164534099|NCT03816891|594327216|FG000|Open-Label Period (Phase 2b Only)|Adverse Event|0|||
164534100|NCT03816891|594327217|FG001|Open-Label Period (Phase 2b Only)|Adverse Event|0|||
164534101|NCT03816891|594327218|FG002|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
164534102|NCT03816891|594327219|FG003|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
164534103|NCT03816891|594327220|FG004|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
164534104|NCT03816891|594327221|FG005|Open-Label Period (Phase 2b Only)|Adverse Event|1|||
164534105|NCT03816891|594327216|FG000|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
164534106|NCT03816891|594327217|FG001|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
164534107|NCT03816891|594327218|FG002|Open-Label Period (Phase 2b Only)|Lack of Efficacy|1|||
164534108|NCT03816891|594327219|FG003|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
164534109|NCT03816891|594327220|FG004|Open-Label Period (Phase 2b Only)|Lack of Efficacy|3|||
164534110|NCT03816891|594327221|FG005|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
164534111|NCT03816891|594327216|FG000|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
164534112|NCT03816891|594327217|FG001|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
164534113|NCT03816891|594327218|FG002|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
164534114|NCT03816891|594327219|FG003|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
164534115|NCT03816891|594327220|FG004|Open-Label Period (Phase 2b Only)|Lost to Follow-up|1|||
164534116|NCT03816891|594327221|FG005|Open-Label Period (Phase 2b Only)|Lost to Follow-up|1|||
164534117|NCT03816891|594327216|FG000|Open-Label Period (Phase 2b Only)|Other|0|||
164534118|NCT03816891|594327217|FG001|Open-Label Period (Phase 2b Only)|Other|0|||
164534119|NCT03816891|594327218|FG002|Open-Label Period (Phase 2b Only)|Other|0|||
164534120|NCT03816891|594327219|FG003|Open-Label Period (Phase 2b Only)|Other|0|||
164534121|NCT03816891|594327220|FG004|Open-Label Period (Phase 2b Only)|Other|0|||
164534122|NCT03816891|594327221|FG005|Open-Label Period (Phase 2b Only)|Other|1|||
164534123|NCT02577029|594327222|FG000|Overall Study|Adverse Event|1|||
164534124|NCT02577029|594327223|FG001|Overall Study|Adverse Event|0|||
164534125|NCT02577029|594327224|FG002|Overall Study|Adverse Event|2|||
164534126|NCT02577029|594327225|FG003|Overall Study|Adverse Event|0|||
164534127|NCT02577029|594327226|FG004|Overall Study|Adverse Event|1|||
164534128|NCT02577029|594327227|FG005|Overall Study|Adverse Event|0|||
164534129|NCT02577029|594327228|FG006|Overall Study|Adverse Event|0|||
164534130|NCT02577029|594327229|FG007|Overall Study|Adverse Event|0|||
164534131|NCT02577029|594327222|FG000|Overall Study|Withdrawal by Subject|0|||
164534132|NCT02577029|594327223|FG001|Overall Study|Withdrawal by Subject|0|||
164534133|NCT02577029|594327224|FG002|Overall Study|Withdrawal by Subject|0|||
164534134|NCT02577029|594327225|FG003|Overall Study|Withdrawal by Subject|0|||
164534135|NCT02577029|594327226|FG004|Overall Study|Withdrawal by Subject|0|||
164534136|NCT02577029|594327227|FG005|Overall Study|Withdrawal by Subject|1|||
164534137|NCT02577029|594327228|FG006|Overall Study|Withdrawal by Subject|0|||
164534138|NCT02577029|594327229|FG007|Overall Study|Withdrawal by Subject|0|||
164534139|NCT02577029|594327222|FG000|Overall Study|Sponsor Termination of the Study|9|||
164534140|NCT02577029|594327223|FG001|Overall Study|Sponsor Termination of the Study|2|||
164534141|NCT02577029|594327224|FG002|Overall Study|Sponsor Termination of the Study|5|||
164534142|NCT02577029|594327225|FG003|Overall Study|Sponsor Termination of the Study|12|||
164534143|NCT02577029|594327226|FG004|Overall Study|Sponsor Termination of the Study|10|||
164534144|NCT02577029|594327227|FG005|Overall Study|Sponsor Termination of the Study|12|||
164534145|NCT02577029|594327228|FG006|Overall Study|Sponsor Termination of the Study|12|||
164534146|NCT02577029|594327229|FG007|Overall Study|Sponsor Termination of the Study|12|||
164534147|NCT05666505|594327230|FG000|Overall Study|Withdrawn due to caregiver consent obtained from non-legal guardian|1|||
164534148|NCT03566810|594328453|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
164534149|NCT03566810|594328454|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
164534150|NCT03566810|594328455|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
164534151|NCT03566810|594328456|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
164534152|NCT01444651|594328458|FG000|Overall Study|Adverse Event|3|||
164534153|NCT01444651|594328459|FG001|Overall Study|Adverse Event|2|||
164648310|NCT01333475|594738559|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
164534154|NCT01444651|594328458|FG000|Overall Study|Lost to Follow-up|5|||
164534155|NCT01444651|594328459|FG001|Overall Study|Lost to Follow-up|5|||
164534156|NCT01444651|594328458|FG000|Overall Study|Non-fasting|2|||
164534157|NCT01444651|594328459|FG001|Overall Study|Non-fasting|1|||
164534158|NCT01444651|594328458|FG000|Overall Study|Missing data|1|||
164534159|NCT01444651|594328459|FG001|Overall Study|Missing data|1|||
164534160|NCT03338192|594328460|FG000|Year One to Year Two|High Blood Pressure|7|||
164534161|NCT03338192|594328461|FG001|Year One to Year Two|High Blood Pressure|1|||
164534162|NCT03338192|594328460|FG000|Year One to Year Two|HIV +|1|||
164534163|NCT03338192|594328461|FG001|Year One to Year Two|HIV +|0|||
164534164|NCT03338192|594328460|FG000|Year Two to Year Four|High Blood Pressure|1|||
164534165|NCT03338192|594328461|FG001|Year Two to Year Four|High Blood Pressure|0|||
164534166|NCT03338192|594328460|FG000|Year Two to Year Four|HIV +|2|||
164534167|NCT03338192|594328461|FG001|Year Two to Year Four|HIV +|0|||
164534168|NCT03338192|594328460|FG000|Year Four to Year Six|High Blood Pressure|2|||
164534169|NCT03338192|594328461|FG001|Year Four to Year Six|High Blood Pressure|1|||
164534170|NCT03236246|594328466|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
164534171|NCT03236246|594328467|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
164534172|NCT03236246|594328466|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
164534173|NCT03236246|594328467|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
164534174|NCT03236246|594328466|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
164534175|NCT03236246|594328467|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
164534176|NCT03236246|594328466|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
164534177|NCT03236246|594328467|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
164534178|NCT03236246|594328466|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
164534179|NCT03236246|594328467|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
164534180|NCT03236246|594328466|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
164534181|NCT03236246|594328467|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
164534182|NCT03236246|594328466|FG000|24-Week Dose Titration Period|Death|3|||
164534183|NCT03236246|594328467|FG001|24-Week Dose Titration Period|Death|1|||
164534184|NCT03236246|594328466|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
164534185|NCT03236246|594328467|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
164534186|NCT03236246|594328466|FG000|24-Week Dose Titration Period|Adverse Event|7|||
164534187|NCT03236246|594328467|FG001|24-Week Dose Titration Period|Adverse Event|8|||
164534188|NCT03236246|594328466|FG000|24-Week Dose Titration Period|Captured as Other|1|||
164534189|NCT03236246|594328467|FG001|24-Week Dose Titration Period|Captured as Other|2|||
164534190|NCT03236246|594328466|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
164534191|NCT03236246|594328467|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
164534192|NCT03236246|594328466|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
164534193|NCT03236246|594328467|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
164534194|NCT03236246|594328466|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
164534195|NCT03236246|594328467|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
164534196|NCT03236246|594328466|FG000|24-Week Dose Maintenance Period|Death|0|||
164534197|NCT03236246|594328467|FG001|24-Week Dose Maintenance Period|Death|1|||
164534198|NCT03236246|594328466|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
164534199|NCT03236246|594328467|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
164534200|NCT02952001|594328468|FG000|Overall Study|Adverse Event|3|||
164534201|NCT02952001|594328469|FG001|Overall Study|Adverse Event|0|||
164534202|NCT02952001|594328468|FG000|Overall Study|Prohibited therapy|10|||
164534203|NCT02952001|594328469|FG001|Overall Study|Prohibited therapy|3|||
164534204|NCT02952001|594328468|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
164534205|NCT02952001|594328469|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
164534206|NCT04796896|594328470|FG000|Overall Study|Adverse Event|1|||
164534207|NCT04796896|594328471|FG001|Overall Study|Adverse Event|0|||
164534208|NCT04796896|594328472|FG002|Overall Study|Adverse Event|0|||
164534209|NCT04796896|594328473|FG003|Overall Study|Adverse Event|0|||
164534210|NCT04796896|594328474|FG004|Overall Study|Adverse Event|0|||
164534211|NCT04796896|594328475|FG005|Overall Study|Adverse Event|1|||
164534212|NCT04796896|594328476|FG006|Overall Study|Adverse Event|1|||
164534213|NCT04796896|594328477|FG007|Overall Study|Adverse Event|0|||
164534214|NCT04796896|594328478|FG008|Overall Study|Adverse Event|1|||
164534215|NCT04796896|594328479|FG009|Overall Study|Adverse Event|1|||
164534216|NCT04796896|594328480|FG010|Overall Study|Adverse Event|1|||
164534217|NCT04796896|594328481|FG011|Overall Study|Adverse Event|0|||
164534218|NCT04796896|594328470|FG000|Overall Study|Lost to Follow-up|24|||
164534219|NCT04796896|594328471|FG001|Overall Study|Lost to Follow-up|15|||
164534220|NCT04796896|594328472|FG002|Overall Study|Lost to Follow-up|6|||
164534221|NCT04796896|594328473|FG003|Overall Study|Lost to Follow-up|4|||
164534222|NCT04796896|594328474|FG004|Overall Study|Lost to Follow-up|21|||
164534223|NCT04796896|594328475|FG005|Overall Study|Lost to Follow-up|55|||
164534224|NCT04796896|594328476|FG006|Overall Study|Lost to Follow-up|237|||
164534225|NCT04796896|594328477|FG007|Overall Study|Lost to Follow-up|52|||
164534226|NCT04796896|594328478|FG008|Overall Study|Lost to Follow-up|221|||
164534227|NCT04796896|594328479|FG009|Overall Study|Lost to Follow-up|43|||
164534228|NCT04796896|594328480|FG010|Overall Study|Lost to Follow-up|142|||
164534229|NCT04796896|594328481|FG011|Overall Study|Lost to Follow-up|18|||
164534230|NCT04796896|594328470|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
164534231|NCT04796896|594328471|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
164534232|NCT04796896|594328472|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
164534233|NCT04796896|594328473|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
164534234|NCT04796896|594328474|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
164534235|NCT04796896|594328475|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
164534236|NCT04796896|594328476|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
164534237|NCT04796896|594328477|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
164534238|NCT04796896|594328478|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
164534239|NCT04796896|594328479|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
164534240|NCT04796896|594328480|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
164534241|NCT04796896|594328481|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
164534242|NCT04796896|594328470|FG000|Overall Study|Physician Decision|1|||
164534243|NCT04796896|594328471|FG001|Overall Study|Physician Decision|0|||
164534244|NCT04796896|594328472|FG002|Overall Study|Physician Decision|0|||
164534245|NCT04796896|594328473|FG003|Overall Study|Physician Decision|0|||
164534246|NCT04796896|594328474|FG004|Overall Study|Physician Decision|0|||
164534247|NCT04796896|594328475|FG005|Overall Study|Physician Decision|3|||
164534248|NCT04796896|594328476|FG006|Overall Study|Physician Decision|18|||
164534249|NCT04796896|594328477|FG007|Overall Study|Physician Decision|1|||
164534250|NCT04796896|594328478|FG008|Overall Study|Physician Decision|7|||
164534251|NCT04796896|594328479|FG009|Overall Study|Physician Decision|0|||
164534252|NCT04796896|594328480|FG010|Overall Study|Physician Decision|5|||
164534253|NCT04796896|594328481|FG011|Overall Study|Physician Decision|0|||
164534254|NCT04796896|594328470|FG000|Overall Study|Withdrawal by Subject|36|||
164534255|NCT04796896|594328471|FG001|Overall Study|Withdrawal by Subject|31|||
164534256|NCT04796896|594328472|FG002|Overall Study|Withdrawal by Subject|11|||
164534257|NCT04796896|594328473|FG003|Overall Study|Withdrawal by Subject|8|||
164534258|NCT04796896|594328474|FG004|Overall Study|Withdrawal by Subject|16|||
164534259|NCT04796896|594328475|FG005|Overall Study|Withdrawal by Subject|162|||
164534260|NCT04796896|594328476|FG006|Overall Study|Withdrawal by Subject|299|||
164534261|NCT04796896|594328477|FG007|Overall Study|Withdrawal by Subject|149|||
164534262|NCT04796896|594328478|FG008|Overall Study|Withdrawal by Subject|303|||
164534263|NCT04796896|594328479|FG009|Overall Study|Withdrawal by Subject|94|||
164534264|NCT04796896|594328480|FG010|Overall Study|Withdrawal by Subject|192|||
164534265|NCT04796896|594328481|FG011|Overall Study|Withdrawal by Subject|16|||
164534266|NCT04796896|594328470|FG000|Overall Study|Other Than Specified|6|||
164534267|NCT04796896|594328471|FG001|Overall Study|Other Than Specified|5|||
164534268|NCT04796896|594328472|FG002|Overall Study|Other Than Specified|3|||
164534269|NCT04796896|594328473|FG003|Overall Study|Other Than Specified|2|||
164534270|NCT04796896|594328474|FG004|Overall Study|Other Than Specified|6|||
164534271|NCT04796896|594328475|FG005|Overall Study|Other Than Specified|31|||
164534272|NCT04796896|594328476|FG006|Overall Study|Other Than Specified|86|||
164534273|NCT04796896|594328477|FG007|Overall Study|Other Than Specified|66|||
164534274|NCT04796896|594328478|FG008|Overall Study|Other Than Specified|388|||
164534275|NCT04796896|594328479|FG009|Overall Study|Other Than Specified|48|||
164534276|NCT04796896|594328480|FG010|Overall Study|Other Than Specified|258|||
164534277|NCT04796896|594328481|FG011|Overall Study|Other Than Specified|4|||
164534278|NCT04796896|594328470|FG000|Overall Study|Protocol Deviation|0|||
164534279|NCT04796896|594328471|FG001|Overall Study|Protocol Deviation|0|||
164534280|NCT04796896|594328472|FG002|Overall Study|Protocol Deviation|0|||
164534281|NCT04796896|594328473|FG003|Overall Study|Protocol Deviation|1|||
164534282|NCT04796896|594328474|FG004|Overall Study|Protocol Deviation|1|||
164534283|NCT04796896|594328475|FG005|Overall Study|Protocol Deviation|2|||
164534284|NCT04796896|594328476|FG006|Overall Study|Protocol Deviation|2|||
164534285|NCT04796896|594328477|FG007|Overall Study|Protocol Deviation|2|||
164534286|NCT04796896|594328478|FG008|Overall Study|Protocol Deviation|2|||
164534287|NCT04796896|594328479|FG009|Overall Study|Protocol Deviation|1|||
164534288|NCT04796896|594328480|FG010|Overall Study|Protocol Deviation|0|||
164534289|NCT04796896|594328481|FG011|Overall Study|Protocol Deviation|0|||
164534290|NCT04796896|594328470|FG000|Overall Study|Missing|0|||
164534291|NCT04796896|594328471|FG001|Overall Study|Missing|0|||
164534292|NCT04796896|594328472|FG002|Overall Study|Missing|0|||
164534293|NCT04796896|594328473|FG003|Overall Study|Missing|0|||
164534294|NCT04796896|594328474|FG004|Overall Study|Missing|0|||
164534295|NCT04796896|594328475|FG005|Overall Study|Missing|0|||
164534296|NCT04796896|594328476|FG006|Overall Study|Missing|2|||
164534297|NCT04796896|594328477|FG007|Overall Study|Missing|1|||
164534298|NCT04796896|594328478|FG008|Overall Study|Missing|2|||
164534299|NCT04796896|594328479|FG009|Overall Study|Missing|1|||
164534300|NCT04796896|594328480|FG010|Overall Study|Missing|1|||
164534301|NCT04796896|594328481|FG011|Overall Study|Missing|0|||
164534302|NCT04796896|594328470|FG000|Overall Study|Death|0|||
164534303|NCT04796896|594328471|FG001|Overall Study|Death|0|||
164534304|NCT04796896|594328472|FG002|Overall Study|Death|0|||
164534305|NCT04796896|594328473|FG003|Overall Study|Death|0|||
164534306|NCT04796896|594328474|FG004|Overall Study|Death|0|||
164534307|NCT04796896|594328475|FG005|Overall Study|Death|0|||
164534308|NCT04796896|594328476|FG006|Overall Study|Death|0|||
164534309|NCT04796896|594328477|FG007|Overall Study|Death|0|||
164534310|NCT04796896|594328478|FG008|Overall Study|Death|1|||
164534311|NCT04796896|594328479|FG009|Overall Study|Death|0|||
164534312|NCT04796896|594328480|FG010|Overall Study|Death|0|||
164534313|NCT04796896|594328481|FG011|Overall Study|Death|0|||
164534314|NCT01637623|594328482|FG000|Overall Study|Lost to Follow-up|0|||
164534315|NCT01637623|594328483|FG001|Overall Study|Lost to Follow-up|0|||
164534316|NCT01637623|594328484|FG002|Overall Study|Lost to Follow-up|2|||
164534317|NCT01637623|594328482|FG000|Overall Study|Physician Decision|1|||
164534318|NCT01637623|594328483|FG001|Overall Study|Physician Decision|0|||
164534319|NCT01637623|594328484|FG002|Overall Study|Physician Decision|1|||
164534320|NCT02824263|594328487|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
164534321|NCT02824263|594328488|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
164534322|NCT02824263|594328487|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
164534323|NCT02824263|594328488|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
164534324|NCT01676909|594328489|FG000|Overall Study|Withdrawal by Subject|3|||
164534325|NCT01676909|594328490|FG001|Overall Study|Withdrawal by Subject|5|||
164534326|NCT01676909|594328489|FG000|Overall Study|Lost to Follow-up|15|||
164534327|NCT01676909|594328490|FG001|Overall Study|Lost to Follow-up|9|||
164534328|NCT04615247|594328491|FG000|Overall Study|Adverse Event|0|||
164534329|NCT04615247|594328492|FG001|Overall Study|Adverse Event|2|||
164534330|NCT04615247|594328491|FG000|Overall Study|Withdrawal by Subject|1|||
164534331|NCT04615247|594328492|FG001|Overall Study|Withdrawal by Subject|1|||
164534332|NCT00823901|594328495|FG000|Overall Study|Adverse Event|1|||
164534333|NCT00823901|594328496|FG001|Overall Study|Adverse Event|1|||
164534334|NCT00823901|594328495|FG000|Overall Study|Lack of Efficacy|1|||
164534335|NCT00823901|594328496|FG001|Overall Study|Lack of Efficacy|0|||
164534336|NCT00823901|594328495|FG000|Overall Study|Lost to Follow-up|2|||
164534337|NCT00823901|594328496|FG001|Overall Study|Lost to Follow-up|1|||
164534338|NCT01369511|594328497|FG000|Overall Study|Adverse Event|1|||
164534339|NCT01369511|594328498|FG001|Overall Study|Adverse Event|1|||
164534340|NCT01369511|594328499|FG002|Overall Study|Adverse Event|5|||
164534341|NCT01369511|594328500|FG003|Overall Study|Adverse Event|0|||
164534342|NCT01369511|594328497|FG000|Overall Study|Entry criteria not met|2|||
164534343|NCT01369511|594328498|FG001|Overall Study|Entry criteria not met|0|||
164534344|NCT01369511|594328499|FG002|Overall Study|Entry criteria not met|0|||
164534345|NCT01369511|594328500|FG003|Overall Study|Entry criteria not met|1|||
164534346|NCT01369511|594328497|FG000|Overall Study|Lost to Follow-up|0|||
164534347|NCT01369511|594328498|FG001|Overall Study|Lost to Follow-up|1|||
164534348|NCT01369511|594328499|FG002|Overall Study|Lost to Follow-up|1|||
164534349|NCT01369511|594328500|FG003|Overall Study|Lost to Follow-up|2|||
164534350|NCT01369511|594328497|FG000|Overall Study|Protocol Violation|0|||
164534351|NCT01369511|594328498|FG001|Overall Study|Protocol Violation|1|||
164534352|NCT01369511|594328499|FG002|Overall Study|Protocol Violation|0|||
164534353|NCT01369511|594328500|FG003|Overall Study|Protocol Violation|2|||
164534354|NCT01369511|594328497|FG000|Overall Study|Physician Decision|3|||
164534355|NCT01369511|594328498|FG001|Overall Study|Physician Decision|4|||
164534356|NCT01369511|594328499|FG002|Overall Study|Physician Decision|0|||
164534357|NCT01369511|594328500|FG003|Overall Study|Physician Decision|0|||
164534358|NCT01369511|594328497|FG000|Overall Study|Sponsor decision|2|||
164534359|NCT01369511|594328498|FG001|Overall Study|Sponsor decision|0|||
164534360|NCT01369511|594328499|FG002|Overall Study|Sponsor decision|1|||
164534361|NCT01369511|594328500|FG003|Overall Study|Sponsor decision|0|||
164534362|NCT01369511|594328497|FG000|Overall Study|Withdrawal by Subject|5|||
164534363|NCT01369511|594328498|FG001|Overall Study|Withdrawal by Subject|6|||
164534364|NCT01369511|594328499|FG002|Overall Study|Withdrawal by Subject|4|||
164534365|NCT01369511|594328500|FG003|Overall Study|Withdrawal by Subject|6|||
164534366|NCT01376349|594328501|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
164534367|NCT01376349|594328502|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
164534368|NCT01376349|594328503|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
164534369|NCT01376349|594328501|FG000|Raondomized Treatment|Adverse Event|13|||
164534370|NCT01376349|594328502|FG001|Raondomized Treatment|Adverse Event|17|||
164534371|NCT01376349|594328503|FG002|Raondomized Treatment|Adverse Event|14|||
164534372|NCT01376349|594328501|FG000|Raondomized Treatment|Unkown|1|||
164534373|NCT01376349|594328502|FG001|Raondomized Treatment|Unkown|2|||
164534374|NCT01376349|594328503|FG002|Raondomized Treatment|Unkown|1|||
164534375|NCT01376349|594328501|FG000|Raondomized Treatment|Alternative Treatment|0|||
164534376|NCT01376349|594328502|FG001|Raondomized Treatment|Alternative Treatment|0|||
164534377|NCT01376349|594328503|FG002|Raondomized Treatment|Alternative Treatment|1|||
164534378|NCT00718640|594328504|FG000|Overall Study|Adverse Event|4|||
164534379|NCT00718640|594328504|FG000|Overall Study|Death|1|||
164534380|NCT00718640|594328504|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
164534381|NCT02147353|594328505|FG000|Overall Study|Lost to Follow-up|2|||
164534382|NCT02147353|594328506|FG001|Overall Study|Lost to Follow-up|0|||
164534383|NCT02147353|594328505|FG000|Overall Study|unable to make visits|4|||
164534384|NCT02147353|594328506|FG001|Overall Study|unable to make visits|0|||
164534385|NCT02147353|594328505|FG000|Overall Study|medication noncompliance|3|||
164534386|NCT02147353|594328506|FG001|Overall Study|medication noncompliance|0|||
164534387|NCT02121834|594328511|FG000|Overall Study|Protocol Violation|0|||
164534388|NCT02121834|594328512|FG001|Overall Study|Protocol Violation|1|||
164534389|NCT02121834|594328513|FG002|Overall Study|Protocol Violation|0|||
164534390|NCT02121834|594328514|FG003|Overall Study|Protocol Violation|0|||
164534391|NCT02121834|594328515|FG004|Overall Study|Protocol Violation|0|||
164534392|NCT02121834|594328516|FG005|Overall Study|Protocol Violation|0|||
164534393|NCT02121834|594328517|FG006|Overall Study|Protocol Violation|0|||
164534394|NCT02121834|594328511|FG000|Overall Study|Withdrawal by Subject|0|||
164534395|NCT02121834|594328512|FG001|Overall Study|Withdrawal by Subject|1|||
164534396|NCT02121834|594328513|FG002|Overall Study|Withdrawal by Subject|1|||
164534397|NCT02121834|594328514|FG003|Overall Study|Withdrawal by Subject|0|||
164534398|NCT02121834|594328515|FG004|Overall Study|Withdrawal by Subject|0|||
164534399|NCT02121834|594328516|FG005|Overall Study|Withdrawal by Subject|0|||
164534400|NCT02121834|594328517|FG006|Overall Study|Withdrawal by Subject|0|||
164534401|NCT02121834|594328511|FG000|Overall Study|Lost to Follow-up|0|||
164534402|NCT02121834|594328512|FG001|Overall Study|Lost to Follow-up|0|||
164534403|NCT02121834|594328513|FG002|Overall Study|Lost to Follow-up|1|||
164534404|NCT02121834|594328514|FG003|Overall Study|Lost to Follow-up|0|||
164534405|NCT02121834|594328515|FG004|Overall Study|Lost to Follow-up|0|||
164534406|NCT02121834|594328516|FG005|Overall Study|Lost to Follow-up|0|||
164534407|NCT02121834|594328517|FG006|Overall Study|Lost to Follow-up|0|||
164534408|NCT02578862|594328518|FG000|Overall Study|Withdrawal by Subject|0|||
164534409|NCT02578862|594328519|FG001|Overall Study|Withdrawal by Subject|1|||
164534410|NCT02578862|594328518|FG000|Overall Study|Unplanned unilateral procedure|0|||
164534411|NCT02578862|594328519|FG001|Overall Study|Unplanned unilateral procedure|1|||
164534412|NCT01230788|594328527|FG000|Overall Study|Prescribed exclusion drug|1|||
164534413|NCT01142596|594328528|FG000|Overall Study|Withdrawal by Subject|9|||
164534414|NCT01142596|594328529|FG001|Overall Study|Withdrawal by Subject|35|||
164534415|NCT01142596|594328528|FG000|Overall Study|Adverse Event|8|||
164534416|NCT01142596|594328529|FG001|Overall Study|Adverse Event|35|||
164534417|NCT01142596|594328528|FG000|Overall Study|Lack of Efficacy|5|||
164534418|NCT01142596|594328529|FG001|Overall Study|Lack of Efficacy|9|||
164534419|NCT01142596|594328528|FG000|Overall Study|Lost to Follow-up|2|||
164534420|NCT01142596|594328529|FG001|Overall Study|Lost to Follow-up|3|||
164534421|NCT01142596|594328528|FG000|Overall Study|Other reason (not specified)|5|||
164534422|NCT01142596|594328529|FG001|Overall Study|Other reason (not specified)|4|||
164534423|NCT01294683|594328532|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
164534424|NCT01294683|594328533|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
164534425|NCT01294683|594328532|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
164534426|NCT01294683|594328533|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
164534427|NCT01294683|594328532|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
164534428|NCT01294683|594328533|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
164534429|NCT01294683|594328532|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
164534430|NCT01294683|594328533|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
164534431|NCT01294683|594328532|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
164534432|NCT01294683|594328533|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
164534433|NCT01294683|594328532|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
164534434|NCT01294683|594328533|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
164534435|NCT01294683|594328532|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
164534436|NCT01294683|594328533|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
164534437|NCT01294683|594328532|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
164534438|NCT01294683|594328533|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
164534439|NCT01294683|594328532|FG000|Post Crossover (Period III)|Adverse Event|6|||
164534440|NCT01294683|594328533|FG001|Post Crossover (Period III)|Adverse Event|6|||
164534441|NCT01294683|594328532|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
164534442|NCT01294683|594328533|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
164534443|NCT01294683|594328532|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
164534444|NCT01294683|594328533|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
164534445|NCT01294683|594328532|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
164534446|NCT01294683|594328533|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
164534447|NCT01794923|594328534|FG000|Overall Study|Adverse Event|0|||
164534448|NCT01794923|594328535|FG001|Overall Study|Adverse Event|0|||
164534449|NCT01794923|594328536|FG002|Overall Study|Adverse Event|1|||
164534450|NCT01881750|594328537|FG000|Overall Study|Changes in concomitant therapies|2|||
164534451|NCT01881750|594328538|FG001|Overall Study|Changes in concomitant therapies|3|||
164534452|NCT01881750|594328537|FG000|Overall Study|Lost to Follow-up|0|||
164534453|NCT01881750|594328538|FG001|Overall Study|Lost to Follow-up|1|||
164534454|NCT04751656|594329810|FG000|Overall Study|Lost to Follow-up|1|||
164534455|NCT01485354|594329814|FG000|Overall Study|Withdrawal by Subject|5|||
164534456|NCT01103245|594329816|FG000|Overall Study|Withdrawal by Subject|1|||
164534457|NCT01103245|594329817|FG001|Overall Study|Withdrawal by Subject|0|||
164534458|NCT01103245|594329818|FG002|Overall Study|Withdrawal by Subject|3|||
164534459|NCT01103245|594329819|FG003|Overall Study|Withdrawal by Subject|0|||
164534460|NCT01103245|594329816|FG000|Overall Study|Inadequate IV access|1|||
164534461|NCT01103245|594329817|FG001|Overall Study|Inadequate IV access|0|||
164534462|NCT01103245|594329818|FG002|Overall Study|Inadequate IV access|0|||
164534463|NCT01103245|594329819|FG003|Overall Study|Inadequate IV access|0|||
164534464|NCT01103245|594329816|FG000|Overall Study|Adverse Event|0|||
164534465|NCT01103245|594329817|FG001|Overall Study|Adverse Event|2|||
164534466|NCT01103245|594329818|FG002|Overall Study|Adverse Event|1|||
164534467|NCT01103245|594329819|FG003|Overall Study|Adverse Event|0|||
164534468|NCT01103245|594329816|FG000|Overall Study|Physician Decision|1|||
164306884|NCT01967238|593496958|FG000|Overall Study|Adverse Event|1|||
164306885|NCT01967238|593496959|FG001|Overall Study|Adverse Event|1|||
164306886|NCT01967238|593496960|FG002|Overall Study|Adverse Event|0|||
164306887|NCT01967238|593496958|FG000|Overall Study|Lost to Follow-up|1|||
164306888|NCT01967238|593496959|FG001|Overall Study|Lost to Follow-up|0|||
164306889|NCT01967238|593496960|FG002|Overall Study|Lost to Follow-up|1|||
164306890|NCT01967238|593496958|FG000|Overall Study|Withdrawal by Subject|0|||
164306891|NCT01967238|593496959|FG001|Overall Study|Withdrawal by Subject|0|||
164306892|NCT01967238|593496960|FG002|Overall Study|Withdrawal by Subject|1|||
164306893|NCT03493464|593496961|FG000|Overall Study|Surgery not performed|1|||
164306894|NCT04949490|593496965|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
164306895|NCT04949490|593496966|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
164306896|NCT04949490|593496967|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
164306897|NCT04949490|593496968|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
164306898|NCT04949490|593496969|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
164306899|NCT04949490|593496970|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
164306900|NCT04949490|593496965|FG000|Group A and Group B|Withdrawal by Subject|0|||
164306901|NCT04949490|593496966|FG001|Group A and Group B|Withdrawal by Subject|0|||
164306902|NCT04949490|593496967|FG002|Group A and Group B|Withdrawal by Subject|1|||
164306903|NCT04949490|593496968|FG003|Group A and Group B|Withdrawal by Subject|0|||
164306904|NCT04949490|593496969|FG004|Group A and Group B|Withdrawal by Subject|0|||
164306905|NCT04949490|593496970|FG005|Group A and Group B|Withdrawal by Subject|0|||
164306906|NCT04949490|593496965|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
164306907|NCT04949490|593496966|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
164306908|NCT04949490|593496967|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
164306909|NCT04949490|593496968|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
164306910|NCT04949490|593496969|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
164306911|NCT04949490|593496970|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
164306912|NCT04949490|593496965|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
164306913|NCT04949490|593496966|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
164306914|NCT04949490|593496967|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
164306915|NCT04949490|593496968|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
164306916|NCT04949490|593496969|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
164306917|NCT04949490|593496970|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
164306918|NCT02864394|593496972|FG000|Overall Study|Death|184|||
164306919|NCT02864394|593496973|FG001|Overall Study|Death|189|||
164306920|NCT02864394|593496972|FG000|Overall Study|Lost to Follow-up|0|||
164306921|NCT02864394|593496973|FG001|Overall Study|Lost to Follow-up|2|||
164306922|NCT02864394|593496972|FG000|Overall Study|Sponsor Decision|26|||
164306923|NCT02864394|593496973|FG001|Overall Study|Sponsor Decision|11|||
164306924|NCT02864394|593496972|FG000|Overall Study|Withdrawal by Subject|3|||
164306925|NCT02864394|593496973|FG001|Overall Study|Withdrawal by Subject|10|||
164306926|NCT05232682|593496974|FG000|Overall Study|Lost to Follow-up|2|||
164306927|NCT02604160|593499134|FG000|Overall Study|Protocol Violation|0|||
164306928|NCT02604160|593499135|FG001|Overall Study|Protocol Violation|1|||
164306929|NCT02604160|593499134|FG000|Overall Study|Physician Decision|0|||
164306930|NCT02604160|593499135|FG001|Overall Study|Physician Decision|1|||
164306931|NCT01596062|593499136|FG000|Overall Study|Adverse Event|1|||
164306932|NCT01596062|593499137|FG001|Overall Study|Adverse Event|0|||
164306933|NCT01596062|593499138|FG002|Overall Study|Adverse Event|2|||
164306934|NCT01596062|593499136|FG000|Overall Study|Lack of Efficacy|0|||
164306935|NCT01596062|593499137|FG001|Overall Study|Lack of Efficacy|0|||
164306936|NCT01596062|593499138|FG002|Overall Study|Lack of Efficacy|1|||
164306937|NCT01069900|593499139|FG000|Overall Study|Technical problems|0|||
164306938|NCT01069900|593499140|FG001|Overall Study|Technical problems|1|||
164306939|NCT01069900|593499139|FG000|Overall Study|Lost to Follow-up|7|||
164306940|NCT01069900|593499140|FG001|Overall Study|Lost to Follow-up|1|||
164306941|NCT01069900|593499139|FG000|Overall Study|Withdrawal by Subject|6|||
164306942|NCT01069900|593499140|FG001|Overall Study|Withdrawal by Subject|1|||
164306943|NCT01069900|593499139|FG000|Overall Study|Protocol Violation|4|||
164306944|NCT01069900|593499140|FG001|Overall Study|Protocol Violation|1|||
164306945|NCT01069900|593499139|FG000|Overall Study|Insufficient Therapeutic effect|1|||
164306946|NCT01069900|593499140|FG001|Overall Study|Insufficient Therapeutic effect|0|||
164306947|NCT03180840|593499141|FG000|Overall Study|Withdrawal by Subject|1|||
164306948|NCT01168219|593499145|FG000|Overall Study|off study before starting treatment|2|||
164306949|NCT01168219|593499145|FG000|Overall Study|withdrew before transplant|1|||
164306950|NCT01168219|593499145|FG000|Overall Study|ineligible due to CML|2|||
164306951|NCT02405442|593499147|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
164306952|NCT02405442|593499148|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
164306953|NCT02405442|593499149|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
164306954|NCT02405442|593499150|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
164306955|NCT02405442|593499147|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
164306956|NCT02405442|593499148|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
164534469|NCT01103245|594329817|FG001|Overall Study|Physician Decision|0|||
164534470|NCT01103245|594329818|FG002|Overall Study|Physician Decision|0|||
164534471|NCT01103245|594329819|FG003|Overall Study|Physician Decision|0|||
164534472|NCT03078907|594329825|FG000|Overall Study|Adverse Event|2|||
164534473|NCT03078907|594329826|FG001|Overall Study|Adverse Event|0|||
164534474|NCT03078907|594329825|FG000|Overall Study|Other|1|||
164534475|NCT03078907|594329826|FG001|Overall Study|Other|0|||
164534476|NCT03078907|594329825|FG000|Overall Study|Protocol Violation|0|||
164534477|NCT03078907|594329826|FG001|Overall Study|Protocol Violation|1|||
164534478|NCT01955122|594329827|FG000|Overall Study|Physician Decision|5|||
164534479|NCT01955122|594329828|FG001|Overall Study|Physician Decision|5|||
164534480|NCT01672788|594329829|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
164534481|NCT01672788|594329830|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
164534482|NCT01672788|594329831|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
164534483|NCT01672788|594329832|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
164534484|NCT02464228|594329837|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
164534485|NCT02464228|594329838|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
164534486|NCT02464228|594329839|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
164534487|NCT02464228|594329840|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
164534488|NCT02464228|594329837|FG000|Overall Study|Physician Decision|2|||
164534489|NCT02464228|594329838|FG001|Overall Study|Physician Decision|0|||
164534490|NCT02464228|594329839|FG002|Overall Study|Physician Decision|1|||
164534491|NCT02464228|594329840|FG003|Overall Study|Physician Decision|0|||
164534492|NCT02464228|594329837|FG000|Overall Study|Miscellaneous|1|||
164534493|NCT02464228|594329838|FG001|Overall Study|Miscellaneous|0|||
164534494|NCT02464228|594329839|FG002|Overall Study|Miscellaneous|1|||
164534495|NCT02464228|594329840|FG003|Overall Study|Miscellaneous|0|||
164534496|NCT02464228|594329837|FG000|Overall Study|Adverse Event|9|||
164534497|NCT02464228|594329838|FG001|Overall Study|Adverse Event|0|||
164534498|NCT02464228|594329839|FG002|Overall Study|Adverse Event|3|||
164534499|NCT02464228|594329840|FG003|Overall Study|Adverse Event|0|||
164534500|NCT02464228|594329837|FG000|Overall Study|Withdrawal by Subject|1|||
164534501|NCT02464228|594329838|FG001|Overall Study|Withdrawal by Subject|1|||
164534502|NCT02464228|594329839|FG002|Overall Study|Withdrawal by Subject|1|||
164534503|NCT02464228|594329840|FG003|Overall Study|Withdrawal by Subject|0|||
164534504|NCT02464228|594329837|FG000|Overall Study|Disease Progression|22|||
164534505|NCT02464228|594329838|FG001|Overall Study|Disease Progression|12|||
164534506|NCT02464228|594329839|FG002|Overall Study|Disease Progression|5|||
164534507|NCT02464228|594329840|FG003|Overall Study|Disease Progression|2|||
164534508|NCT01681628|594329843|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
164534509|NCT01681628|594329844|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
164534510|NCT01681628|594329843|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
164534511|NCT01681628|594329844|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
164534512|NCT01681628|594329843|FG000|19 Months Follow-up|Death|1|||
164534513|NCT01681628|594329844|FG001|19 Months Follow-up|Death|0|||
164534514|NCT01681628|594329843|FG000|19 Months Follow-up|Lost to Follow-up|61|||
164534515|NCT01681628|594329844|FG001|19 Months Follow-up|Lost to Follow-up|43|||
164534516|NCT01794520|594329853|FG000|Overall Study|Adverse events- related to progression|0|||
164534517|NCT01794520|594329854|FG001|Overall Study|Adverse events- related to progression|0|||
164534518|NCT01794520|594329855|FG002|Overall Study|Adverse events- related to progression|1|||
164534519|NCT01794520|594329856|FG003|Overall Study|Adverse events- related to progression|2|||
164534520|NCT01794520|594329857|FG004|Overall Study|Adverse events- related to progression|0|||
164534521|NCT01794520|594329858|FG005|Overall Study|Adverse events- related to progression|1|||
164534522|NCT01794520|594329859|FG006|Overall Study|Adverse events- related to progression|0|||
164534523|NCT01794520|594329853|FG000|Overall Study|Adverse event- not related to progression|1|||
164534524|NCT01794520|594329854|FG001|Overall Study|Adverse event- not related to progression|1|||
164534525|NCT01794520|594329855|FG002|Overall Study|Adverse event- not related to progression|0|||
164534526|NCT01794520|594329856|FG003|Overall Study|Adverse event- not related to progression|0|||
164534527|NCT01794520|594329857|FG004|Overall Study|Adverse event- not related to progression|2|||
164534528|NCT01794520|594329858|FG005|Overall Study|Adverse event- not related to progression|0|||
164534529|NCT01794520|594329859|FG006|Overall Study|Adverse event- not related to progression|0|||
164534530|NCT01794520|594329853|FG000|Overall Study|Progressive disease|5|||
164534531|NCT01794520|594329854|FG001|Overall Study|Progressive disease|6|||
164534532|NCT01794520|594329855|FG002|Overall Study|Progressive disease|2|||
164534533|NCT01794520|594329856|FG003|Overall Study|Progressive disease|5|||
164534534|NCT01794520|594329857|FG004|Overall Study|Progressive disease|27|||
164534535|NCT01794520|594329858|FG005|Overall Study|Progressive disease|18|||
164534536|NCT01794520|594329859|FG006|Overall Study|Progressive disease|0|||
164534537|NCT01794520|594329853|FG000|Overall Study|Withdrew consent|0|||
164534538|NCT01794520|594329854|FG001|Overall Study|Withdrew consent|0|||
164534539|NCT01794520|594329855|FG002|Overall Study|Withdrew consent|1|||
164534540|NCT01794520|594329856|FG003|Overall Study|Withdrew consent|1|||
164534541|NCT01794520|594329857|FG004|Overall Study|Withdrew consent|0|||
164534542|NCT01794520|594329858|FG005|Overall Study|Withdrew consent|0|||
164534543|NCT01794520|594329859|FG006|Overall Study|Withdrew consent|0|||
164534544|NCT01794520|594329853|FG000|Overall Study|Lost to Follow-up|0|||
164534545|NCT01794520|594329854|FG001|Overall Study|Lost to Follow-up|0|||
164534546|NCT01794520|594329855|FG002|Overall Study|Lost to Follow-up|0|||
164534547|NCT01794520|594329856|FG003|Overall Study|Lost to Follow-up|0|||
164534548|NCT01794520|594329857|FG004|Overall Study|Lost to Follow-up|1|||
164534549|NCT01794520|594329858|FG005|Overall Study|Lost to Follow-up|0|||
164534550|NCT01794520|594329859|FG006|Overall Study|Lost to Follow-up|0|||
164534551|NCT01794520|594329853|FG000|Overall Study|Toxicity|0|||
164534552|NCT01794520|594329854|FG001|Overall Study|Toxicity|2|||
164534553|NCT01794520|594329855|FG002|Overall Study|Toxicity|0|||
164534554|NCT01794520|594329856|FG003|Overall Study|Toxicity|0|||
164534555|NCT01794520|594329857|FG004|Overall Study|Toxicity|0|||
164534556|NCT01794520|594329858|FG005|Overall Study|Toxicity|0|||
164534557|NCT01794520|594329859|FG006|Overall Study|Toxicity|0|||
164534558|NCT01794520|594329853|FG000|Overall Study|Study terminated by sponsor|0|||
164534559|NCT01794520|594329854|FG001|Overall Study|Study terminated by sponsor|0|||
164534560|NCT01794520|594329855|FG002|Overall Study|Study terminated by sponsor|1|||
164534561|NCT01794520|594329856|FG003|Overall Study|Study terminated by sponsor|0|||
164419839|NCT00742885|593908576|FG000|Overall Study|Lost to Follow-up|1|||
164419840|NCT00742885|593908577|FG001|Overall Study|Lost to Follow-up|0|||
164419841|NCT00322868|593908578|FG000|Overall Study|disease progression|1|||
164419842|NCT03615482|593908579|FG000|Overall Study|Death|1|||
164419843|NCT03615482|593908580|FG001|Overall Study|Death|0|||
164419844|NCT03615482|593908579|FG000|Overall Study|Lost to Follow-up|7|||
164419845|NCT03615482|593908580|FG001|Overall Study|Lost to Follow-up|7|||
164419846|NCT03615482|593908579|FG000|Overall Study|Physician Decision|2|||
164419847|NCT03615482|593908580|FG001|Overall Study|Physician Decision|3|||
164419848|NCT03615482|593908579|FG000|Overall Study|Withdrawal by Subject|7|||
164419849|NCT03615482|593908580|FG001|Overall Study|Withdrawal by Subject|7|||
164419850|NCT01852162|593908582|FG000|Overall Study|Adverse Event|1|||
164419851|NCT01852162|593908583|FG001|Overall Study|Adverse Event|0|||
164419852|NCT01852162|593908582|FG000|Overall Study|Withdrawal by Subject|3|||
164419853|NCT01852162|593908583|FG001|Overall Study|Withdrawal by Subject|1|||
164419854|NCT01500226|593908586|FG000|Overall Study|Adverse Event|31|||
164419855|NCT01500226|593908587|FG001|Overall Study|Adverse Event|38|||
164419856|NCT01500226|593908586|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
164419857|NCT01500226|593908587|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
164419858|NCT01500226|593908586|FG000|Overall Study|Withdrawal by Subject|93|||
164419859|NCT01500226|593908587|FG001|Overall Study|Withdrawal by Subject|96|||
164419860|NCT01500226|593908586|FG000|Overall Study|Death|12|||
164419861|NCT01500226|593908587|FG001|Overall Study|Death|4|||
164419862|NCT01500226|593908586|FG000|Overall Study|Disease Progression|16|||
164419863|NCT01500226|593908587|FG001|Overall Study|Disease Progression|14|||
164419864|NCT01500226|593908586|FG000|Overall Study|Protocol Violation|53|||
164419865|NCT01500226|593908587|FG001|Overall Study|Protocol Violation|39|||
164419866|NCT01500226|593908586|FG000|Overall Study|Physician Decision|17|||
164419867|NCT01500226|593908587|FG001|Overall Study|Physician Decision|15|||
164419868|NCT01500226|593908586|FG000|Overall Study|Lack of Efficacy|14|||
164419869|NCT01500226|593908587|FG001|Overall Study|Lack of Efficacy|30|||
164419870|NCT01500226|593908586|FG000|Overall Study|Lost to Follow-up|9|||
164419871|NCT01500226|593908587|FG001|Overall Study|Lost to Follow-up|5|||
164419872|NCT01500226|593908586|FG000|Overall Study|Other Reasons|19|||
164419873|NCT01500226|593908587|FG001|Overall Study|Other Reasons|16|||
164419874|NCT02955277|593908588|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
164419875|NCT02955277|593908589|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
164419876|NCT02955277|593908588|FG000|Post to Follow-up|Lost to Follow-up|8|||
164419877|NCT02955277|593908589|FG001|Post to Follow-up|Lost to Follow-up|11|||
164419878|NCT04212169|593908590|FG000|Overall Study|Adverse Event|0|||
164419879|NCT04212169|593908591|FG001|Overall Study|Adverse Event|0|||
164419880|NCT04212169|593908592|FG002|Overall Study|Adverse Event|0|||
164419881|NCT04212169|593908593|FG003|Overall Study|Adverse Event|2|||
164419882|NCT04212169|593908590|FG000|Overall Study|Lost to Follow-up|1|||
164419883|NCT04212169|593908591|FG001|Overall Study|Lost to Follow-up|0|||
164419884|NCT04212169|593908592|FG002|Overall Study|Lost to Follow-up|0|||
164419885|NCT04212169|593908593|FG003|Overall Study|Lost to Follow-up|2|||
164419886|NCT04212169|593908590|FG000|Overall Study|Withdrawal by Subject|10|||
164419887|NCT04212169|593908591|FG001|Overall Study|Withdrawal by Subject|2|||
164419888|NCT04212169|593908592|FG002|Overall Study|Withdrawal by Subject|5|||
164419889|NCT04212169|593908593|FG003|Overall Study|Withdrawal by Subject|7|||
164419890|NCT04212169|593908590|FG000|Overall Study|Other reason, unspecified|3|||
164419891|NCT04212169|593908591|FG001|Overall Study|Other reason, unspecified|1|||
164419892|NCT04212169|593908592|FG002|Overall Study|Other reason, unspecified|0|||
164419893|NCT04212169|593908593|FG003|Overall Study|Other reason, unspecified|2|||
164419894|NCT02018861|593908598|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
164419895|NCT02018861|593908599|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
164419896|NCT02018861|593908600|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
164419897|NCT02018861|593908601|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
164534562|NCT01794520|594329857|FG004|Overall Study|Study terminated by sponsor|1|||
164534563|NCT01794520|594329858|FG005|Overall Study|Study terminated by sponsor|0|||
164306957|NCT02405442|593499149|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
164306958|NCT02405442|593499150|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
164306959|NCT02405442|593499147|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
164306960|NCT02405442|593499148|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
164306961|NCT02405442|593499149|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
164306962|NCT02405442|593499150|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
164306963|NCT02405442|593499147|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
164306964|NCT02405442|593499148|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
164306965|NCT02405442|593499149|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
164419898|NCT02018861|593908602|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
164306966|NCT02405442|593499150|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
164306967|NCT02405442|593499147|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
164306968|NCT02405442|593499148|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
164306969|NCT02405442|593499149|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
164306970|NCT02405442|593499150|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
164306971|NCT02405442|593499147|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
164306972|NCT02405442|593499148|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
164306973|NCT02405442|593499149|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
164306974|NCT02405442|593499150|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
164306975|NCT02405442|593499147|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
164306976|NCT02405442|593499148|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
164306977|NCT02405442|593499149|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
164306978|NCT02405442|593499150|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
164306979|NCT02405442|593499147|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
164306980|NCT02405442|593499148|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
164419899|NCT02018861|593908603|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
164419900|NCT02018861|593908604|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
164419901|NCT02018861|593908605|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
164419902|NCT02018861|593908606|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
164419903|NCT02018861|593908607|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
164419904|NCT02018861|593908598|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
164419905|NCT02018861|593908599|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
164419906|NCT02018861|593908600|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
164419907|NCT02018861|593908601|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
164419908|NCT02018861|593908602|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
164419909|NCT02018861|593908603|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
164419910|NCT02018861|593908604|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
164419911|NCT02018861|593908605|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
164306981|NCT02405442|593499149|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
164306982|NCT02405442|593499150|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
164306983|NCT02405442|593499147|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
164419912|NCT02018861|593908606|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
164419913|NCT02018861|593908607|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
164419914|NCT02018861|593908598|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
164419915|NCT02018861|593908599|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
164419916|NCT02018861|593908600|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
164419917|NCT02018861|593908601|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
164419918|NCT02018861|593908602|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
164419919|NCT02018861|593908603|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
164419920|NCT02018861|593908604|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
164419921|NCT02018861|593908605|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
164419922|NCT02018861|593908606|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
164419923|NCT02018861|593908607|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
164419924|NCT02018861|593908598|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
164419925|NCT02018861|593908599|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
164419926|NCT02018861|593908600|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
164419927|NCT02018861|593908601|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
164419928|NCT02018861|593908602|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
164419929|NCT02018861|593908603|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
164419930|NCT02018861|593908604|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
164419931|NCT02018861|593908605|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
164419932|NCT02018861|593908606|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
164306984|NCT02405442|593499148|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
164648311|NCT01333475|594738560|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
164419933|NCT02018861|593908607|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
164419934|NCT02018861|593908598|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
164419935|NCT02018861|593908599|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
164419936|NCT02018861|593908600|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
164419937|NCT02018861|593908601|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
164419938|NCT02018861|593908602|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
164419939|NCT02018861|593908603|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
164419940|NCT02018861|593908604|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
164419941|NCT02018861|593908605|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
164419942|NCT02018861|593908606|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
164419943|NCT02018861|593908607|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
164419944|NCT02018861|593908598|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
164419945|NCT02018861|593908599|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
164419946|NCT02018861|593908600|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
164419947|NCT02018861|593908601|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
164419948|NCT02018861|593908602|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
164419949|NCT02018861|593908603|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
164419950|NCT02018861|593908604|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
164419951|NCT02018861|593908605|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
164419952|NCT02018861|593908606|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
164419953|NCT02018861|593908607|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
164419954|NCT02018861|593908598|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
164419955|NCT02018861|593908599|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
164419956|NCT02018861|593908600|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
164419957|NCT02018861|593908601|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
164419958|NCT02018861|593908602|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
164419959|NCT02018861|593908603|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
164419960|NCT02018861|593908604|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
164419961|NCT02018861|593908605|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
164419962|NCT02018861|593908606|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
164419963|NCT02018861|593908607|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
164419964|NCT02018861|593908598|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
164419965|NCT02018861|593908599|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
164419966|NCT02018861|593908600|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
164419967|NCT02018861|593908601|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
164419968|NCT02018861|593908602|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
164419969|NCT02018861|593908603|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
164419970|NCT02018861|593908604|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
164419971|NCT02018861|593908605|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
164419972|NCT02018861|593908606|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
164419973|NCT02018861|593908607|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
164419974|NCT02018861|593908598|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
164419975|NCT02018861|593908599|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
164419976|NCT02018861|593908600|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
164419977|NCT02018861|593908601|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
164419978|NCT02018861|593908602|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
164419979|NCT02018861|593908603|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
164419980|NCT02018861|593908604|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
164419981|NCT02018861|593908605|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
164419982|NCT02018861|593908606|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
164419983|NCT02018861|593908607|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
164419984|NCT02018861|593908598|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
164419985|NCT02018861|593908599|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
164419986|NCT02018861|593908600|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
164419987|NCT02018861|593908601|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
164419988|NCT02018861|593908602|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
164419989|NCT02018861|593908603|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
164419990|NCT02018861|593908604|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
164419991|NCT02018861|593908605|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
164419992|NCT02018861|593908606|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
164419993|NCT02018861|593908607|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
164419994|NCT02018861|593908598|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
164306985|NCT02405442|593499149|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
164306986|NCT02405442|593499150|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
164306987|NCT02405442|593499147|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
164306988|NCT02405442|593499148|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
164306989|NCT02405442|593499149|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
164306990|NCT02405442|593499150|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
164306991|NCT02405442|593499147|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
164306992|NCT02405442|593499148|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
164306993|NCT02405442|593499149|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
164306994|NCT02405442|593499150|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
164306995|NCT02405442|593499147|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
164306996|NCT02405442|593499148|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
164306997|NCT02405442|593499149|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
164306998|NCT02405442|593499150|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
164306999|NCT02405442|593499147|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
164307000|NCT02405442|593499148|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
164307001|NCT02405442|593499149|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
164307002|NCT02405442|593499150|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
164307003|NCT02405442|593499147|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
164307004|NCT02405442|593499148|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
164307005|NCT02405442|593499149|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
164307006|NCT02405442|593499150|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
164307007|NCT00337675|593499153|FG000|Overall Study|Adverse Event|10|||
164307008|NCT00337675|593499154|FG001|Overall Study|Adverse Event|9|||
164307009|NCT00337675|593499155|FG002|Overall Study|Adverse Event|19|||
164307010|NCT00337675|593499153|FG000|Overall Study|Lack of Efficacy|10|||
164307011|NCT00337675|593499154|FG001|Overall Study|Lack of Efficacy|7|||
164307012|NCT00337675|593499155|FG002|Overall Study|Lack of Efficacy|9|||
164307013|NCT00337675|593499153|FG000|Overall Study|Lost to Follow-up|22|||
164307014|NCT00337675|593499154|FG001|Overall Study|Lost to Follow-up|19|||
164307015|NCT00337675|593499155|FG002|Overall Study|Lost to Follow-up|17|||
164307016|NCT00337675|593499153|FG000|Overall Study|Physician Decision|9|||
164307017|NCT00337675|593499154|FG001|Overall Study|Physician Decision|17|||
164307018|NCT00337675|593499155|FG002|Overall Study|Physician Decision|14|||
164307019|NCT00337675|593499153|FG000|Overall Study|Protocol Violation|21|||
164307020|NCT00337675|593499154|FG001|Overall Study|Protocol Violation|24|||
164307021|NCT00337675|593499155|FG002|Overall Study|Protocol Violation|19|||
164307022|NCT00337675|593499153|FG000|Overall Study|Withdrawal by Subject|25|||
164307023|NCT00337675|593499154|FG001|Overall Study|Withdrawal by Subject|25|||
164307024|NCT00337675|593499155|FG002|Overall Study|Withdrawal by Subject|19|||
164307025|NCT00337675|593499153|FG000|Overall Study|Progressive Disease|0|||
164307026|NCT00337675|593499154|FG001|Overall Study|Progressive Disease|2|||
164307027|NCT00337675|593499155|FG002|Overall Study|Progressive Disease|0|||
164307028|NCT00337675|593499153|FG000|Overall Study|Trial Terminated|0|||
164307029|NCT00337675|593499154|FG001|Overall Study|Trial Terminated|0|||
164307030|NCT00337675|593499155|FG002|Overall Study|Trial Terminated|2|||
164307031|NCT00859456|593499156|FG000|Overall Study|Adverse Event|3|||
164307032|NCT00859456|593499156|FG000|Overall Study|Progressive disease|2|||
164307033|NCT00859456|593499156|FG000|Overall Study|Non-compliance|3|||
164307034|NCT02015637|593499161|FG000|Overall Study|Lost to Follow-up|3|||
164307035|NCT02015637|593499162|FG001|Overall Study|Lost to Follow-up|5|||
164307036|NCT02015637|593499161|FG000|Overall Study|Adverse Event|3|||
164307037|NCT02015637|593499162|FG001|Overall Study|Adverse Event|0|||
164419995|NCT02018861|593908599|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
164307038|NCT02015637|593499161|FG000|Overall Study|Did not take study drug|2|||
164307039|NCT02015637|593499162|FG001|Overall Study|Did not take study drug|0|||
164419996|NCT02018861|593908600|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
164419997|NCT02018861|593908601|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
164419998|NCT02018861|593908602|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
164419999|NCT02018861|593908603|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
164420000|NCT02018861|593908604|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
164420001|NCT02018861|593908605|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
164420002|NCT02018861|593908606|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
164420003|NCT02018861|593908607|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
164420004|NCT02018861|593908598|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
164420005|NCT02018861|593908599|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
164420006|NCT02018861|593908600|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
164420007|NCT02018861|593908601|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
164420008|NCT02018861|593908602|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
164420009|NCT02018861|593908603|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
164534564|NCT01794520|594329859|FG006|Overall Study|Study terminated by sponsor|7|||
164534565|NCT01794520|594329853|FG000|Overall Study|Death|0|||
164534566|NCT01794520|594329854|FG001|Overall Study|Death|0|||
164534567|NCT01794520|594329855|FG002|Overall Study|Death|0|||
164534568|NCT01794520|594329856|FG003|Overall Study|Death|0|||
164534569|NCT01794520|594329857|FG004|Overall Study|Death|1|||
164534570|NCT01794520|594329858|FG005|Overall Study|Death|0|||
164534571|NCT01794520|594329859|FG006|Overall Study|Death|22|||
164534572|NCT01794520|594329853|FG000|Overall Study|Other, not specified|0|||
164534573|NCT01794520|594329854|FG001|Overall Study|Other, not specified|0|||
164534574|NCT01794520|594329855|FG002|Overall Study|Other, not specified|1|||
164534575|NCT01794520|594329856|FG003|Overall Study|Other, not specified|1|||
164534576|NCT01794520|594329857|FG004|Overall Study|Other, not specified|4|||
164534577|NCT01794520|594329858|FG005|Overall Study|Other, not specified|1|||
164534578|NCT01794520|594329859|FG006|Overall Study|Other, not specified|2|||
164534579|NCT02021292|594329860|FG000|Overall Study|Physician Decision|0|||
164534580|NCT02021292|594329861|FG001|Overall Study|Physician Decision|1|||
164534581|NCT02021292|594329860|FG000|Overall Study|Lost to Follow-up|0|||
164534582|NCT02021292|594329861|FG001|Overall Study|Lost to Follow-up|1|||
164534583|NCT02021292|594329860|FG000|Overall Study|Death|0|||
164534584|NCT02021292|594329861|FG001|Overall Study|Death|1|||
164534585|NCT04356183|594329862|FG000|Overall Study|Lost to Follow-up|1|||
164534586|NCT04356183|594329863|FG001|Overall Study|Lost to Follow-up|0|||
164534587|NCT04356183|594329862|FG000|Overall Study|Withdrawal by Subject|1|||
164534588|NCT04356183|594329863|FG001|Overall Study|Withdrawal by Subject|1|||
164534589|NCT05972733|594329866|FG000|Overall Study|Lost to Follow-up|2|||
164534590|NCT05972733|594329866|FG000|Overall Study|Withdrawal by Subject|1|||
164534591|NCT01177787|594329867|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
164534592|NCT01177787|594329867|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
164534593|NCT01177787|594329867|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
164534594|NCT00818389|594329870|FG000|Overall Study|Death|1|||
164534595|NCT00818389|594329871|FG001|Overall Study|Death|3|||
164534596|NCT00818389|594329870|FG000|Overall Study|ALS Disease Progression|1|||
164534597|NCT00818389|594329871|FG001|Overall Study|ALS Disease Progression|0|||
164534598|NCT00818389|594329870|FG000|Overall Study|Withdrawal by Subject|2|||
164534599|NCT00818389|594329871|FG001|Overall Study|Withdrawal by Subject|2|||
164534600|NCT00818389|594329870|FG000|Overall Study|Adverse Event|0|||
164534601|NCT00818389|594329871|FG001|Overall Study|Adverse Event|1|||
164534602|NCT05193500|594329874|FG000|Overall Study|Withdrawal by Subject|7|||
164534603|NCT05193500|594329875|FG001|Overall Study|Withdrawal by Subject|4|||
164534604|NCT05193500|594329876|FG002|Overall Study|Withdrawal by Subject|3|||
164534605|NCT05193500|594329877|FG003|Overall Study|Withdrawal by Subject|5|||
164534606|NCT03871829|594329878|FG000|Overall Study|Lost to Follow-up|0|||
164534607|NCT03871829|594329879|FG001|Overall Study|Lost to Follow-up|1|||
164534608|NCT03871829|594329878|FG000|Overall Study|Withdrawal by Subject|1|||
164534609|NCT03871829|594329879|FG001|Overall Study|Withdrawal by Subject|1|||
164534610|NCT03871829|594329878|FG000|Overall Study|Death|12|||
164534611|NCT03871829|594329879|FG001|Overall Study|Death|8|||
164534612|NCT03871829|594329878|FG000|Overall Study|Study terminated by sponsor|31|||
164534613|NCT03871829|594329879|FG001|Overall Study|Study terminated by sponsor|34|||
164534614|NCT02993523|594329880|FG000|Overall Study|Withdrew Consent|0|||
164534615|NCT02993523|594329881|FG001|Overall Study|Withdrew Consent|0|||
164534616|NCT02993523|594329882|FG002|Overall Study|Withdrew Consent|2|||
164534617|NCT02993523|594329883|FG003|Overall Study|Withdrew Consent|9|||
164534618|NCT02993523|594329884|FG004|Overall Study|Withdrew Consent|0|||
164534619|NCT02993523|594329880|FG000|Overall Study|Lost to Follow-up|0|||
164534620|NCT02993523|594329881|FG001|Overall Study|Lost to Follow-up|0|||
164534621|NCT02993523|594329882|FG002|Overall Study|Lost to Follow-up|3|||
164534622|NCT02993523|594329883|FG003|Overall Study|Lost to Follow-up|6|||
164534623|NCT02993523|594329884|FG004|Overall Study|Lost to Follow-up|0|||
164534624|NCT02993523|594329880|FG000|Overall Study|Death|1|||
164534625|NCT02993523|594329881|FG001|Overall Study|Death|1|||
164534626|NCT02993523|594329882|FG002|Overall Study|Death|138|||
164534627|NCT02993523|594329883|FG003|Overall Study|Death|222|||
164534628|NCT02993523|594329884|FG004|Overall Study|Death|6|||
164534629|NCT02993523|594329880|FG000|Overall Study|Reason not Specified|0|||
164534630|NCT02993523|594329881|FG001|Overall Study|Reason not Specified|0|||
164534631|NCT02993523|594329882|FG002|Overall Study|Reason not Specified|1|||
164534632|NCT02993523|594329883|FG003|Overall Study|Reason not Specified|1|||
164534633|NCT02993523|594329884|FG004|Overall Study|Reason not Specified|0|||
164534634|NCT03694418|594329885|FG000|Overall Study|Lost to Follow-up|115|||
164534635|NCT03694418|594329886|FG001|Overall Study|Lost to Follow-up|23|||
164420010|NCT02018861|593908604|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
164534636|NCT03694418|594329887|FG002|Overall Study|Lost to Follow-up|12|||
164534637|NCT03694418|594329888|FG003|Overall Study|Lost to Follow-up|12|||
164534638|NCT03694418|594329889|FG004|Overall Study|Lost to Follow-up|13|||
164534639|NCT01139021|594329892|FG000|Overall Study|Adverse Event|0|||
164534640|NCT01139021|594329893|FG001|Overall Study|Adverse Event|0|||
164534641|NCT01139021|594329894|FG002|Overall Study|Adverse Event|0|||
164534642|NCT01139021|594329895|FG003|Overall Study|Adverse Event|0|||
164534643|NCT01139021|594329896|FG004|Overall Study|Adverse Event|1|||
164534644|NCT01139021|594329897|FG005|Overall Study|Adverse Event|0|||
164534645|NCT01139021|594329892|FG000|Overall Study|Lost to Follow-up|0|||
164534646|NCT01139021|594329893|FG001|Overall Study|Lost to Follow-up|0|||
164534647|NCT01139021|594329894|FG002|Overall Study|Lost to Follow-up|0|||
164534648|NCT01139021|594329895|FG003|Overall Study|Lost to Follow-up|0|||
164534649|NCT01139021|594329896|FG004|Overall Study|Lost to Follow-up|2|||
164534650|NCT01139021|594329897|FG005|Overall Study|Lost to Follow-up|0|||
164534651|NCT01139021|594329892|FG000|Overall Study|Protocol Violation|1|||
164534652|NCT01139021|594329893|FG001|Overall Study|Protocol Violation|0|||
164534653|NCT01139021|594329894|FG002|Overall Study|Protocol Violation|0|||
164534654|NCT01139021|594329895|FG003|Overall Study|Protocol Violation|0|||
164534655|NCT01139021|594329896|FG004|Overall Study|Protocol Violation|2|||
164534656|NCT01139021|594329897|FG005|Overall Study|Protocol Violation|0|||
164534657|NCT01139021|594329892|FG000|Overall Study|Withdrawal by Subject|0|||
164534658|NCT01139021|594329893|FG001|Overall Study|Withdrawal by Subject|0|||
164534659|NCT01139021|594329894|FG002|Overall Study|Withdrawal by Subject|0|||
164534660|NCT01139021|594329895|FG003|Overall Study|Withdrawal by Subject|1|||
164534661|NCT01139021|594329896|FG004|Overall Study|Withdrawal by Subject|4|||
164534662|NCT01139021|594329897|FG005|Overall Study|Withdrawal by Subject|0|||
164534663|NCT05458479|594329898|FG000|Overall Study|Lost to Follow-up|1|||
164534664|NCT00784693|594329899|FG000|Overall Study|Lost to Follow-up|0|||
164534665|NCT00784693|594329900|FG001|Overall Study|Lost to Follow-up|1|||
164534666|NCT00784693|594329899|FG000|Overall Study|Lack of Efficacy|1|||
164534667|NCT00784693|594329900|FG001|Overall Study|Lack of Efficacy|1|||
164534668|NCT00784693|594329899|FG000|Overall Study|Withdrawal by Subject|0|||
164534669|NCT00784693|594329900|FG001|Overall Study|Withdrawal by Subject|4|||
164534670|NCT00784693|594329899|FG000|Overall Study|Randomized but not Treated|1|||
164534671|NCT00784693|594329900|FG001|Overall Study|Randomized but not Treated|0|||
164534672|NCT00784693|594329899|FG000|Overall Study|Other|1|||
164534673|NCT00784693|594329900|FG001|Overall Study|Other|0|||
164534674|NCT01978262|594329901|FG000|Overall Study|Withdrawal by Subject|9|||
164534675|NCT01978262|594329901|FG000|Overall Study|Lost to Follow-up|2|||
164534676|NCT02982187|594329902|FG000|Overall Study|Withdrawal by Subject|0|||
164534677|NCT02982187|594329903|FG001|Overall Study|Withdrawal by Subject|0|||
164534678|NCT02982187|594329904|FG002|Overall Study|Withdrawal by Subject|0|||
164534679|NCT02982187|594329905|FG003|Overall Study|Withdrawal by Subject|0|||
164534680|NCT02982187|594329906|FG004|Overall Study|Withdrawal by Subject|0|||
164534681|NCT02982187|594329907|FG005|Overall Study|Withdrawal by Subject|0|||
164534682|NCT02982187|594329908|FG006|Overall Study|Withdrawal by Subject|1|||
164534683|NCT02982187|594329909|FG007|Overall Study|Withdrawal by Subject|0|||
164534684|NCT02202551|594329910|FG000|Overall Study|Adverse Event|8|||
164534685|NCT02202551|594329911|FG001|Overall Study|Adverse Event|19|||
164534686|NCT02202551|594329912|FG002|Overall Study|Adverse Event|5|||
164534687|NCT02202551|594329913|FG003|Overall Study|Adverse Event|9|||
164534688|NCT02202551|594329910|FG000|Overall Study|Death|3|||
164534689|NCT02202551|594329911|FG001|Overall Study|Death|2|||
164534690|NCT02202551|594329912|FG002|Overall Study|Death|1|||
164534691|NCT02202551|594329913|FG003|Overall Study|Death|1|||
164534692|NCT02202551|594329910|FG000|Overall Study|Lost to Follow-up|0|||
164534693|NCT02202551|594329911|FG001|Overall Study|Lost to Follow-up|1|||
164534694|NCT02202551|594329912|FG002|Overall Study|Lost to Follow-up|0|||
164534695|NCT02202551|594329913|FG003|Overall Study|Lost to Follow-up|1|||
164534696|NCT02202551|594329910|FG000|Overall Study|Needed to take excluded medication|0|||
164534697|NCT02202551|594329911|FG001|Overall Study|Needed to take excluded medication|2|||
164534698|NCT02202551|594329912|FG002|Overall Study|Needed to take excluded medication|0|||
164534699|NCT02202551|594329913|FG003|Overall Study|Needed to take excluded medication|1|||
164534700|NCT02202551|594329910|FG000|Overall Study|Subject moved away|0|||
164534701|NCT02202551|594329911|FG001|Overall Study|Subject moved away|1|||
164534702|NCT02202551|594329912|FG002|Overall Study|Subject moved away|0|||
164534703|NCT02202551|594329913|FG003|Overall Study|Subject moved away|0|||
164534704|NCT02202551|594329910|FG000|Overall Study|DBS surgery|3|||
164534705|NCT02202551|594329911|FG001|Overall Study|DBS surgery|0|||
164534706|NCT02202551|594329912|FG002|Overall Study|DBS surgery|0|||
164534707|NCT02202551|594329913|FG003|Overall Study|DBS surgery|0|||
164534708|NCT02202551|594329910|FG000|Overall Study|Dyskinesia upon taper|1|||
164534709|NCT02202551|594329911|FG001|Overall Study|Dyskinesia upon taper|0|||
164534710|NCT02202551|594329912|FG002|Overall Study|Dyskinesia upon taper|0|||
164534711|NCT02202551|594329913|FG003|Overall Study|Dyskinesia upon taper|0|||
164534712|NCT02202551|594329910|FG000|Overall Study|Lack of Efficacy|0|||
164307040|NCT00927953|593499167|FG000|Overall Study|Death|2|||
164307041|NCT00927953|593499168|FG001|Overall Study|Death|1|||
164534713|NCT02202551|594329911|FG001|Overall Study|Lack of Efficacy|1|||
164534714|NCT02202551|594329912|FG002|Overall Study|Lack of Efficacy|0|||
164534715|NCT02202551|594329913|FG003|Overall Study|Lack of Efficacy|0|||
164534716|NCT02202551|594329910|FG000|Overall Study|Physician Decision|1|||
164534717|NCT02202551|594329911|FG001|Overall Study|Physician Decision|0|||
164534718|NCT02202551|594329912|FG002|Overall Study|Physician Decision|0|||
164534719|NCT02202551|594329913|FG003|Overall Study|Physician Decision|0|||
164534720|NCT02202551|594329910|FG000|Overall Study|Site closure|3|||
164534721|NCT02202551|594329911|FG001|Overall Study|Site closure|0|||
164534722|NCT02202551|594329912|FG002|Overall Study|Site closure|0|||
164534723|NCT02202551|594329913|FG003|Overall Study|Site closure|1|||
164534724|NCT02202551|594329910|FG000|Overall Study|Unable to complete visits per protocol|1|||
164534725|NCT02202551|594329911|FG001|Overall Study|Unable to complete visits per protocol|0|||
164534726|NCT02202551|594329912|FG002|Overall Study|Unable to complete visits per protocol|0|||
164534727|NCT02202551|594329913|FG003|Overall Study|Unable to complete visits per protocol|0|||
164534728|NCT02202551|594329910|FG000|Overall Study|Worsening Dyskinesia|0|||
164534729|NCT02202551|594329911|FG001|Overall Study|Worsening Dyskinesia|0|||
164534730|NCT02202551|594329912|FG002|Overall Study|Worsening Dyskinesia|0|||
164534731|NCT02202551|594329913|FG003|Overall Study|Worsening Dyskinesia|1|||
164534732|NCT02202551|594329910|FG000|Overall Study|Protocol Violation|0|||
164534733|NCT02202551|594329911|FG001|Overall Study|Protocol Violation|1|||
164534734|NCT02202551|594329912|FG002|Overall Study|Protocol Violation|0|||
164534735|NCT02202551|594329913|FG003|Overall Study|Protocol Violation|0|||
164534736|NCT02202551|594329910|FG000|Overall Study|Sponsor's decision|2|||
164534737|NCT02202551|594329911|FG001|Overall Study|Sponsor's decision|0|||
164534738|NCT02202551|594329912|FG002|Overall Study|Sponsor's decision|0|||
164534739|NCT02202551|594329913|FG003|Overall Study|Sponsor's decision|0|||
164534740|NCT02202551|594329910|FG000|Overall Study|Subject unwilling to proceed|1|||
164534741|NCT02202551|594329911|FG001|Overall Study|Subject unwilling to proceed|5|||
164534742|NCT02202551|594329912|FG002|Overall Study|Subject unwilling to proceed|3|||
164534743|NCT02202551|594329913|FG003|Overall Study|Subject unwilling to proceed|5|||
164534744|NCT02202551|594329910|FG000|Overall Study|Subject consent withdrawn|0|||
164534745|NCT02202551|594329911|FG001|Overall Study|Subject consent withdrawn|3|||
164534746|NCT02202551|594329912|FG002|Overall Study|Subject consent withdrawn|1|||
164534747|NCT02202551|594329913|FG003|Overall Study|Subject consent withdrawn|2|||
164534748|NCT02202551|594329910|FG000|Overall Study|eGFR<50mL/min/m2|2|||
164534749|NCT02202551|594329911|FG001|Overall Study|eGFR<50mL/min/m2|2|||
164534750|NCT02202551|594329912|FG002|Overall Study|eGFR<50mL/min/m2|0|||
164307042|NCT02863419|593499169|FG000|Overall Study|Lost to Follow-up|0|||
164307043|NCT02863419|593499170|FG001|Overall Study|Lost to Follow-up|1|||
164534751|NCT02202551|594329913|FG003|Overall Study|eGFR<50mL/min/m2|1|||
164534752|NCT02349451|594329917|FG000|Overall Study|Withdrawal by Subject|0|||
164534753|NCT02349451|594329918|FG001|Overall Study|Withdrawal by Subject|1|||
164307044|NCT02863419|593499171|FG002|Overall Study|Lost to Follow-up|4|||
164307045|NCT02863419|593499169|FG000|Overall Study|Withdrawal by Subject|5|||
164307046|NCT02863419|593499170|FG001|Overall Study|Withdrawal by Subject|5|||
164307047|NCT02863419|593499171|FG002|Overall Study|Withdrawal by Subject|3|||
164307048|NCT02863419|593499169|FG000|Overall Study|Died|3|||
164307049|NCT02863419|593499170|FG001|Overall Study|Died|4|||
164307050|NCT02863419|593499171|FG002|Overall Study|Died|1|||
164307051|NCT01491607|593499174|FG000|Overall Study|Lost to Follow-up|7|||
164307052|NCT01491607|593499174|FG000|Overall Study|Withdrawal by Subject|3|||
164307053|NCT01317277|593499175|FG000|Overall Study|Lost to Follow-up|3|||
164307054|NCT01317277|593499176|FG001|Overall Study|Lost to Follow-up|1|||
164307055|NCT01317277|593499175|FG000|Overall Study|Lost MEMS|1|||
164307056|NCT01317277|593499176|FG001|Overall Study|Lost MEMS|1|||
164307057|NCT01317277|593499175|FG000|Overall Study|Unable to comply with intervention|1|||
164307058|NCT01317277|593499176|FG001|Overall Study|Unable to comply with intervention|0|||
164307059|NCT01317277|593499175|FG000|Overall Study|Withdrawal by Subject|1|||
164307060|NCT01317277|593499176|FG001|Overall Study|Withdrawal by Subject|0|||
164307061|NCT01317277|593499175|FG000|Overall Study|Adverse Event|1|||
164307062|NCT01317277|593499176|FG001|Overall Study|Adverse Event|0|||
164307063|NCT00297258|593499183|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
164307064|NCT00297258|593499183|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
164307065|NCT00297258|593499183|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
164307066|NCT00297258|593499183|FG000|Overall Study|Intercurrent Illness|3|||
164307067|NCT00297258|593499183|FG000|Overall Study|Intercurrent Death|2|||
164307068|NCT00297258|593499183|FG000|Overall Study|Deteriorization of General Condition|1|||
164307069|NCT00297258|593499183|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
164307070|NCT00297258|593499183|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
164307071|NCT00297258|593499183|FG000|Overall Study|Switch to Commercial Treatment|1|||
164307072|NCT00297258|593499183|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
164307073|NCT02454517|593499184|FG000|Overall Study|Withdrawal by Subject|3|||
164307074|NCT02454517|593499185|FG001|Overall Study|Withdrawal by Subject|0|||
164534754|NCT02349451|594329919|FG002|Overall Study|Withdrawal by Subject|2|||
164534755|NCT02349451|594329920|FG003|Overall Study|Withdrawal by Subject|1|||
164307075|NCT02454517|593499184|FG000|Overall Study|Lost to Follow-up|4|||
164307076|NCT02454517|593499185|FG001|Overall Study|Lost to Follow-up|7|||
164307077|NCT02454517|593499184|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
164307078|NCT02454517|593499185|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
164307079|NCT00473382|593499186|FG000|Core Study|Adverse Event|3|||
164534756|NCT01423253|594329925|FG000|Overall Study|Adverse Event|2|||
164534757|NCT01423253|594329925|FG000|Overall Study|Lack of Efficacy|2|||
164534758|NCT01423253|594329925|FG000|Overall Study|Lost to Follow-up|1|||
164307080|NCT00473382|593499187|FG001|Core Study|Adverse Event|1|||
164307081|NCT00473382|593499188|FG002|Core Study|Adverse Event|1|||
164307082|NCT00473382|593499186|FG000|Core Study|Death|3|||
164307083|NCT00473382|593499187|FG001|Core Study|Death|5|||
164307084|NCT00473382|593499188|FG002|Core Study|Death|10|||
164307085|NCT00473382|593499186|FG000|Core Study|Lost to Follow-up|3|||
164307086|NCT00473382|593499187|FG001|Core Study|Lost to Follow-up|3|||
164307087|NCT00473382|593499188|FG002|Core Study|Lost to Follow-up|3|||
164307088|NCT00473382|593499186|FG000|Core Study|Physician Decision|1|||
164307089|NCT00473382|593499187|FG001|Core Study|Physician Decision|2|||
164307090|NCT00473382|593499188|FG002|Core Study|Physician Decision|2|||
164307091|NCT00473382|593499186|FG000|Core Study|Subject non-compliance|5|||
164307092|NCT00473382|593499187|FG001|Core Study|Subject non-compliance|2|||
164307093|NCT00473382|593499188|FG002|Core Study|Subject non-compliance|1|||
164307094|NCT00473382|593499186|FG000|Core Study|Subject needed other treatment|1|||
164307095|NCT00473382|593499187|FG001|Core Study|Subject needed other treatment|3|||
164307096|NCT00473382|593499188|FG002|Core Study|Subject needed other treatment|2|||
164307097|NCT00473382|593499186|FG000|Core Study|Subject's decision|12|||
164307098|NCT00473382|593499187|FG001|Core Study|Subject's decision|11|||
164307099|NCT00473382|593499188|FG002|Core Study|Subject's decision|10|||
164307100|NCT00473382|593499186|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
164307101|NCT00473382|593499187|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
164307102|NCT00473382|593499188|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
164307103|NCT00473382|593499186|FG000|Open-label Extension Through Month 48|Death|1|||
164307104|NCT00473382|593499187|FG001|Open-label Extension Through Month 48|Death|3|||
164307105|NCT00473382|593499188|FG002|Open-label Extension Through Month 48|Death|3|||
164307106|NCT00473382|593499186|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
164307107|NCT00473382|593499187|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
164307108|NCT00473382|593499188|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
164307109|NCT00473382|593499186|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
164307110|NCT00473382|593499187|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
164307111|NCT00473382|593499188|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
164307112|NCT00473382|593499186|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
164307113|NCT00473382|593499187|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
164307114|NCT00473382|593499188|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
164307115|NCT00473382|593499186|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
164307116|NCT00473382|593499187|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
164307117|NCT00473382|593499188|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
164307118|NCT00473382|593499186|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
164307119|NCT00473382|593499187|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
164307120|NCT00473382|593499188|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
164307121|NCT00473382|593499186|FG000|Open-label Extension Through Month 60|Death|1|||
164420011|NCT02018861|593908605|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
164307122|NCT00473382|593499187|FG001|Open-label Extension Through Month 60|Death|7|||
164420012|NCT02018861|593908606|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
164420013|NCT02018861|593908607|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
164420014|NCT02018861|593908598|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
164420015|NCT02018861|593908599|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
164420016|NCT02018861|593908600|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
164420017|NCT02018861|593908601|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
164420018|NCT02018861|593908602|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
164420019|NCT02018861|593908603|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
164420020|NCT02018861|593908604|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
164420021|NCT02018861|593908605|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
164420022|NCT02018861|593908606|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
164420023|NCT02018861|593908607|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
164420024|NCT02819479|593908610|FG000|Overall Study|Adverse Event|2|||
164420025|NCT00506285|593908612|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
164420026|NCT00506285|593908613|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
164420027|NCT00506285|593908612|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
164420028|NCT00506285|593908613|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
164420029|NCT00506285|593908612|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
164420030|NCT00506285|593908613|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
164420031|NCT00506285|593908612|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
164420032|NCT00506285|593908613|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
164420033|NCT00506285|593908612|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
164420034|NCT00506285|593908613|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
164420035|NCT00551213|593908616|FG000|Overall Study|Adverse Event|6|||
164420036|NCT00551213|593908617|FG001|Overall Study|Adverse Event|3|||
164420037|NCT00551213|593908616|FG000|Overall Study|Progressive Disease|41|||
164307123|NCT00473382|593499188|FG002|Open-label Extension Through Month 60|Death|4|||
164534759|NCT01423253|594329925|FG000|Overall Study|Protocol Violation|2|||
164534760|NCT01423253|594329925|FG000|Overall Study|Withdrawal by Subject|2|||
164534761|NCT00392327|594329928|FG000|Overall Study|Death|1|||
164534762|NCT00392327|594329929|FG001|Overall Study|Death|0|||
164534763|NCT00392327|594329930|FG002|Overall Study|Death|1|||
164534764|NCT00392327|594329931|FG003|Overall Study|Death|0|||
164534765|NCT00392327|594329932|FG004|Overall Study|Death|0|||
164534766|NCT00392327|594329933|FG005|Overall Study|Death|0|||
164534767|NCT00392327|594329934|FG006|Overall Study|Death|0|||
164534768|NCT00392327|594329935|FG007|Overall Study|Death|0|||
164534769|NCT00392327|594329928|FG000|Overall Study|Lack of Efficacy|8|||
164534770|NCT00392327|594329929|FG001|Overall Study|Lack of Efficacy|8|||
164534771|NCT00392327|594329930|FG002|Overall Study|Lack of Efficacy|9|||
164534772|NCT00392327|594329931|FG003|Overall Study|Lack of Efficacy|6|||
164534773|NCT00392327|594329932|FG004|Overall Study|Lack of Efficacy|3|||
164534774|NCT00392327|594329933|FG005|Overall Study|Lack of Efficacy|3|||
164534775|NCT00392327|594329934|FG006|Overall Study|Lack of Efficacy|3|||
164534776|NCT00392327|594329935|FG007|Overall Study|Lack of Efficacy|3|||
164534777|NCT00392327|594329928|FG000|Overall Study|Physician Decision|3|||
164534778|NCT00392327|594329929|FG001|Overall Study|Physician Decision|5|||
164534779|NCT00392327|594329930|FG002|Overall Study|Physician Decision|2|||
164534780|NCT00392327|594329931|FG003|Overall Study|Physician Decision|2|||
164534781|NCT00392327|594329932|FG004|Overall Study|Physician Decision|0|||
164534782|NCT00392327|594329933|FG005|Overall Study|Physician Decision|1|||
164534783|NCT00392327|594329934|FG006|Overall Study|Physician Decision|5|||
164534784|NCT00392327|594329935|FG007|Overall Study|Physician Decision|3|||
164534785|NCT00392327|594329928|FG000|Overall Study|Protocol Violation|0|||
164534786|NCT00392327|594329929|FG001|Overall Study|Protocol Violation|0|||
164534787|NCT00392327|594329930|FG002|Overall Study|Protocol Violation|1|||
164534788|NCT00392327|594329931|FG003|Overall Study|Protocol Violation|0|||
164534789|NCT00392327|594329932|FG004|Overall Study|Protocol Violation|0|||
164534790|NCT00392327|594329933|FG005|Overall Study|Protocol Violation|0|||
164534791|NCT00392327|594329934|FG006|Overall Study|Protocol Violation|0|||
164534792|NCT00392327|594329935|FG007|Overall Study|Protocol Violation|0|||
164534793|NCT00392327|594329928|FG000|Overall Study|Withdrawal by Subject|3|||
164534794|NCT00392327|594329929|FG001|Overall Study|Withdrawal by Subject|2|||
164534795|NCT00392327|594329930|FG002|Overall Study|Withdrawal by Subject|4|||
164534796|NCT00392327|594329931|FG003|Overall Study|Withdrawal by Subject|6|||
164307124|NCT00473382|593499186|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
164307125|NCT00473382|593499187|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
164307126|NCT00473382|593499188|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
164307127|NCT00473382|593499186|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
164307128|NCT00473382|593499187|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
164307129|NCT00473382|593499188|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
164307130|NCT00473382|593499186|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
164307131|NCT00473382|593499187|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
164307132|NCT00473382|593499188|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
164307133|NCT00473382|593499186|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
164307134|NCT00473382|593499187|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
164307135|NCT00473382|593499188|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
164307136|NCT02999672|593499189|FG000|Overall Study|Death|0|||
164307137|NCT02999672|593499190|FG001|Overall Study|Death|1|||
164307138|NCT02999672|593499189|FG000|Overall Study|Study Terminated by Sponsor|0|||
164307139|NCT02999672|593499190|FG001|Overall Study|Study Terminated by Sponsor|1|||
164307140|NCT02999672|593499189|FG000|Overall Study|Progressive Disease|9|||
164307141|NCT02999672|593499190|FG001|Overall Study|Progressive Disease|5|||
164420038|NCT00551213|593908617|FG001|Overall Study|Progressive Disease|12|||
164420039|NCT00551213|593908616|FG000|Overall Study|Withdrawal by Subject|2|||
164420040|NCT00551213|593908617|FG001|Overall Study|Withdrawal by Subject|0|||
164420041|NCT00551213|593908616|FG000|Overall Study|Not Treated|1|||
164420042|NCT00551213|593908617|FG001|Overall Study|Not Treated|2|||
164534797|NCT00392327|594329932|FG004|Overall Study|Withdrawal by Subject|0|||
164307142|NCT02999672|593499189|FG000|Overall Study|Adverse Event|4|||
164420043|NCT00962585|593908618|FG000|Overall Study|Adverse Event|0|||
164420044|NCT00962585|593908619|FG001|Overall Study|Adverse Event|2|||
164420045|NCT00962585|593908620|FG002|Overall Study|Adverse Event|1|||
164420046|NCT00962585|593908621|FG003|Overall Study|Adverse Event|0|||
164420047|NCT00962585|593908618|FG000|Overall Study|Lost to Follow-up|3|||
164420048|NCT00962585|593908619|FG001|Overall Study|Lost to Follow-up|0|||
164420049|NCT00962585|593908620|FG002|Overall Study|Lost to Follow-up|1|||
164420050|NCT00962585|593908621|FG003|Overall Study|Lost to Follow-up|0|||
164420051|NCT00962585|593908618|FG000|Overall Study|Protocol Violation|0|||
164420052|NCT00962585|593908619|FG001|Overall Study|Protocol Violation|0|||
164420053|NCT00962585|593908620|FG002|Overall Study|Protocol Violation|1|||
164420054|NCT00962585|593908621|FG003|Overall Study|Protocol Violation|0|||
164534798|NCT00392327|594329933|FG005|Overall Study|Withdrawal by Subject|1|||
164534799|NCT00392327|594329934|FG006|Overall Study|Withdrawal by Subject|1|||
164420055|NCT00962585|593908618|FG000|Overall Study|Withdrawal by Subject|1|||
164420056|NCT00962585|593908619|FG001|Overall Study|Withdrawal by Subject|0|||
164420057|NCT00962585|593908620|FG002|Overall Study|Withdrawal by Subject|0|||
164420058|NCT00962585|593908621|FG003|Overall Study|Withdrawal by Subject|0|||
164420059|NCT00962585|593908618|FG000|Overall Study|Withdrew Consent|2|||
164420060|NCT00962585|593908619|FG001|Overall Study|Withdrew Consent|0|||
164420061|NCT00962585|593908620|FG002|Overall Study|Withdrew Consent|0|||
164420062|NCT00962585|593908621|FG003|Overall Study|Withdrew Consent|0|||
164420063|NCT02254421|593908624|FG000|Overall Study|Randomized but Not Treated|1|||
164534800|NCT00392327|594329935|FG007|Overall Study|Withdrawal by Subject|5|||
164534801|NCT00392327|594329928|FG000|Overall Study|Ineligible|0|||
164534802|NCT00392327|594329929|FG001|Overall Study|Ineligible|4|||
164534803|NCT00392327|594329930|FG002|Overall Study|Ineligible|3|||
164534804|NCT00392327|594329931|FG003|Overall Study|Ineligible|2|||
164534805|NCT00392327|594329932|FG004|Overall Study|Ineligible|0|||
164534806|NCT00392327|594329933|FG005|Overall Study|Ineligible|0|||
164534807|NCT00392327|594329934|FG006|Overall Study|Ineligible|0|||
164534808|NCT00392327|594329935|FG007|Overall Study|Ineligible|0|||
164534809|NCT00894686|594329936|FG000|Overall Study|Withdrawal by Subject|50|||
164534810|NCT00894686|594329936|FG000|Overall Study|Physician Decision|1|||
164534811|NCT00894686|594329936|FG000|Overall Study|Other|5|||
164534812|NCT03267940|594329937|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
164534813|NCT03267940|594329938|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
164534814|NCT03267940|594329939|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
164534815|NCT03267940|594329940|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
164534816|NCT03267940|594329941|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
164534817|NCT03267940|594329942|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
164534818|NCT03267940|594329937|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
164534819|NCT03267940|594329938|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
164534820|NCT03267940|594329939|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
164534821|NCT03267940|594329940|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
164534822|NCT03267940|594329941|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
164534823|NCT03267940|594329942|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
164534824|NCT03267940|594329937|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
164534825|NCT03267940|594329938|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
164534826|NCT03267940|594329939|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
164534827|NCT03267940|594329940|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
164534828|NCT03267940|594329941|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
164534829|NCT03267940|594329942|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
164534830|NCT03267940|594329937|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
164534831|NCT03267940|594329938|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
164534832|NCT03267940|594329939|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
164534833|NCT03267940|594329940|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
164534834|NCT03267940|594329941|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
164534835|NCT03267940|594329942|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
164534836|NCT03267940|594329937|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
164534837|NCT03267940|594329938|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
164534838|NCT03267940|594329939|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
164534839|NCT03267940|594329940|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
164534840|NCT03267940|594329941|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
164534841|NCT03267940|594329942|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
164534842|NCT03267940|594329937|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
164307143|NCT02999672|593499190|FG001|Overall Study|Adverse Event|0|||
164307144|NCT03565497|593499191|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
164307145|NCT03565497|593499192|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
164307146|NCT03565497|593499193|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
164307147|NCT03565497|593499191|FG000|Overall Study|Lost to Follow-up|1|||
164307148|NCT03565497|593499192|FG001|Overall Study|Lost to Follow-up|1|||
164307149|NCT03565497|593499193|FG002|Overall Study|Lost to Follow-up|2|||
164307150|NCT03565497|593499191|FG000|Overall Study|Withdrawal by Subject|1|||
164307151|NCT03565497|593499192|FG001|Overall Study|Withdrawal by Subject|1|||
164307152|NCT03565497|593499193|FG002|Overall Study|Withdrawal by Subject|1|||
164307153|NCT01470326|593499194|FG000|Overall Study|Protocol Violation|32|||
164307154|NCT01470326|593499194|FG000|Overall Study|No Drug Administration Information|2|||
164307155|NCT01470326|593499194|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
164307156|NCT01166282|593499195|FG000|Open-label Period|Adverse Event|0|||
164307157|NCT01166282|593499196|FG001|Open-label Period|Adverse Event|0|||
164307158|NCT01166282|593499197|FG002|Open-label Period|Adverse Event|6|||
164307159|NCT01166282|593499195|FG000|Open-label Period|Withdrawal by Subject|0|||
164307160|NCT01166282|593499196|FG001|Open-label Period|Withdrawal by Subject|0|||
164420064|NCT02254421|593908625|FG001|Overall Study|Randomized but Not Treated|0|||
164420065|NCT02254421|593908624|FG000|Overall Study|Death|0|||
164420066|NCT02254421|593908625|FG001|Overall Study|Death|2|||
164420067|NCT02254421|593908624|FG000|Overall Study|Withdrew Consent|1|||
164420068|NCT02254421|593908625|FG001|Overall Study|Withdrew Consent|1|||
164420069|NCT00432679|593908636|FG000|Overall Study|Adverse Event|2|||
164420070|NCT00432679|593908637|FG001|Overall Study|Adverse Event|1|||
164420071|NCT00432679|593908636|FG000|Overall Study|Withdrawal by Subject|3|||
164420072|NCT00432679|593908637|FG001|Overall Study|Withdrawal by Subject|2|||
164420073|NCT03405662|593908638|FG000|Overall Study|COVID-19 restriction|1|||
164420074|NCT03405662|593908639|FG001|Overall Study|COVID-19 restriction|0|||
164420075|NCT03405662|593908638|FG000|Overall Study|unblinding|0|||
164420076|NCT03405662|593908639|FG001|Overall Study|unblinding|1|||
164420077|NCT03405662|593908638|FG000|Overall Study|placement in memory care facility|0|||
164420078|NCT03405662|593908639|FG001|Overall Study|placement in memory care facility|2|||
164534843|NCT03267940|594329938|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
164534844|NCT03267940|594329939|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
164534845|NCT03267940|594329940|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
164534846|NCT03267940|594329941|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
164534847|NCT03267940|594329942|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
164534848|NCT03267940|594329937|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
164534849|NCT03267940|594329938|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
164534850|NCT03267940|594329939|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
164534851|NCT03267940|594329940|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
164534852|NCT03267940|594329941|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
164534853|NCT03267940|594329942|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
164534854|NCT03267940|594329937|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
164534855|NCT03267940|594329938|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
164534856|NCT03267940|594329939|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
164534857|NCT03267940|594329940|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
164534858|NCT03267940|594329941|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
164534859|NCT03267940|594329942|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
164534860|NCT03267940|594329937|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
164534861|NCT03267940|594329938|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
164534862|NCT03267940|594329939|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
164534863|NCT03267940|594329940|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
164534864|NCT03267940|594329941|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
164534865|NCT03267940|594329942|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
164534866|NCT01759407|594329952|FG000|Overall Study|Protocol Violation|0|||
164534867|NCT01759407|594329953|FG001|Overall Study|Protocol Violation|2|||
164534868|NCT04526197|594329956|FG000|Period 1|Adverse Event|0|||
164534869|NCT04526197|594329957|FG001|Period 1|Adverse Event|1|||
164534870|NCT04526197|594329956|FG000|Period 1|Withdrawal by Subject|1|||
164534871|NCT04526197|594329957|FG001|Period 1|Withdrawal by Subject|0|||
164534872|NCT04526197|594329956|FG000|Period 2|Adverse Event|0|||
164534873|NCT04526197|594329957|FG001|Period 2|Adverse Event|1|||
164534874|NCT04526197|594329956|FG000|Period 2|Withdrawal by Subject|0|||
164534875|NCT04526197|594329957|FG001|Period 2|Withdrawal by Subject|1|||
164534876|NCT01209143|594329958|FG000|Overall Study|Adverse Event|2|||
164534877|NCT01209143|594329959|FG001|Overall Study|Adverse Event|1|||
164534878|NCT01209143|594329958|FG000|Overall Study|Death|0|||
164534879|NCT01209143|594329959|FG001|Overall Study|Death|1|||
164534880|NCT01209143|594329958|FG000|Overall Study|Physician Decision|3|||
164534881|NCT01209143|594329959|FG001|Overall Study|Physician Decision|1|||
164534882|NCT01209143|594329958|FG000|Overall Study|Lost to Follow-up|1|||
164534883|NCT01209143|594329959|FG001|Overall Study|Lost to Follow-up|0|||
164534884|NCT01209143|594329958|FG000|Overall Study|Withdrawal by Subject|2|||
164534885|NCT01209143|594329959|FG001|Overall Study|Withdrawal by Subject|1|||
164534886|NCT01209143|594329958|FG000|Overall Study|Disease progression|11|||
164534887|NCT01209143|594329959|FG001|Overall Study|Disease progression|16|||
164420079|NCT00280293|593908640|FG000|Overall Study|Protocol Violation|3|||
164534888|NCT01136811|594329960|FG000|Overall Study|Physician Decision|11|||
164534889|NCT01116882|594329969|FG000|30-day|Lost to Follow-up|50|||
164534890|NCT01116882|594329970|FG001|30-day|Lost to Follow-up|21|||
164534891|NCT01116882|594329969|FG000|30-day|Withdrawal by Subject|2|||
164534892|NCT01116882|594329970|FG001|30-day|Withdrawal by Subject|4|||
164534893|NCT01116882|594329969|FG000|30-day|Other Reasons|16|||
164534894|NCT01116882|594329970|FG001|30-day|Other Reasons|6|||
164534895|NCT01116882|594329969|FG000|12-month|Lost to Follow-up|111|||
164648312|NCT01333475|594738559|FG000|Overall Study|Toxicity|1|||
164420080|NCT00280293|593908641|FG001|Overall Study|Protocol Violation|0|||
164534896|NCT01116882|594329970|FG001|12-month|Lost to Follow-up|42|||
164534897|NCT01116882|594329969|FG000|12-month|Other Reasons|151|||
164534898|NCT01116882|594329970|FG001|12-month|Other Reasons|49|||
164534899|NCT01116882|594329969|FG000|12-month|Withdrawal by Subject|5|||
164307161|NCT01166282|593499197|FG002|Open-label Period|Withdrawal by Subject|4|||
164307162|NCT01166282|593499195|FG000|Open-label Period|Lack of Efficacy|0|||
164307163|NCT01166282|593499196|FG001|Open-label Period|Lack of Efficacy|0|||
164307164|NCT01166282|593499197|FG002|Open-label Period|Lack of Efficacy|2|||
164307165|NCT01166282|593499195|FG000|Open-label Period|Remission|0|||
164307166|NCT01166282|593499196|FG001|Open-label Period|Remission|0|||
164307167|NCT01166282|593499197|FG002|Open-label Period|Remission|4|||
164307168|NCT01166282|593499195|FG000|Open-label Period|Irregular Compliance|0|||
164307169|NCT01166282|593499196|FG001|Open-label Period|Irregular Compliance|0|||
164307170|NCT01166282|593499197|FG002|Open-label Period|Irregular Compliance|1|||
164307171|NCT02561832|593499206|FG000|Overall Study|Withdrawal by Subject|1|||
164307172|NCT02561832|593499207|FG001|Overall Study|Withdrawal by Subject|1|||
164307173|NCT02561832|593499206|FG000|Overall Study|Adverse Event|3|||
164307174|NCT02561832|593499207|FG001|Overall Study|Adverse Event|0|||
164307175|NCT02561832|593499206|FG000|Overall Study|Disease progression|3|||
164307176|NCT02561832|593499207|FG001|Overall Study|Disease progression|3|||
164307177|NCT02892448|593499208|FG000|Overall Study|Screening failure|2|||
164307178|NCT02892448|593499209|FG001|Overall Study|Screening failure|2|||
164307179|NCT02892448|593499210|FG002|Overall Study|Screening failure|1|||
164307180|NCT03214666|593499211|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
164307181|NCT03214666|593499212|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
164307182|NCT03214666|593499213|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
164307183|NCT03214666|593499214|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
164307184|NCT03214666|593499215|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
164307185|NCT03214666|593499216|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
164307186|NCT03048578|593499217|FG000|Overall Study|Withdrawal by Subject|5|||
164307187|NCT03048578|593499218|FG001|Overall Study|Withdrawal by Subject|6|||
164307188|NCT03048578|593499217|FG000|Overall Study|Lost to Follow-up|22|||
164307189|NCT03048578|593499218|FG001|Overall Study|Lost to Follow-up|10|||
164307190|NCT03048578|593499217|FG000|Overall Study|Adverse Event|1|||
164307191|NCT03048578|593499218|FG001|Overall Study|Adverse Event|2|||
164307192|NCT03048578|593499217|FG000|Overall Study|Terminated|3|||
164307193|NCT03048578|593499218|FG001|Overall Study|Terminated|2|||
164307194|NCT02023697|593499223|FG000|Treatment Period|Radiological progression|13|||
164307195|NCT02023697|593499224|FG001|Treatment Period|Radiological progression|17|||
164307196|NCT02023697|593499225|FG002|Treatment Period|Radiological progression|26|||
164307197|NCT02023697|593499223|FG000|Treatment Period|Never Treated|5|||
164307198|NCT02023697|593499224|FG001|Treatment Period|Never Treated|6|||
164307199|NCT02023697|593499225|FG002|Treatment Period|Never Treated|10|||
164307200|NCT02023697|593499223|FG000|Treatment Period|Adverse Event|13|||
164307201|NCT02023697|593499224|FG001|Treatment Period|Adverse Event|25|||
164307202|NCT02023697|593499225|FG002|Treatment Period|Adverse Event|23|||
164307203|NCT02023697|593499223|FG000|Treatment Period|Logistical difficulties|1|||
164307204|NCT02023697|593499224|FG001|Treatment Period|Logistical difficulties|1|||
164307205|NCT02023697|593499225|FG002|Treatment Period|Logistical difficulties|1|||
164307206|NCT02023697|593499223|FG000|Treatment Period|Clinical progression|10|||
164307207|NCT02023697|593499224|FG001|Treatment Period|Clinical progression|8|||
164307208|NCT02023697|593499225|FG002|Treatment Period|Clinical progression|28|||
164307209|NCT02023697|593499223|FG000|Treatment Period|Withdrawal by Subject|4|||
164307210|NCT02023697|593499224|FG001|Treatment Period|Withdrawal by Subject|5|||
164307211|NCT02023697|593499225|FG002|Treatment Period|Withdrawal by Subject|13|||
164307212|NCT02023697|593499223|FG000|Treatment Period|Safety outcome reached|0|||
164307213|NCT02023697|593499224|FG001|Treatment Period|Safety outcome reached|1|||
164307214|NCT02023697|593499225|FG002|Treatment Period|Safety outcome reached|0|||
164307215|NCT02023697|593499223|FG000|Treatment Period|Physician Decision|0|||
164307216|NCT02023697|593499224|FG001|Treatment Period|Physician Decision|0|||
164307217|NCT02023697|593499225|FG002|Treatment Period|Physician Decision|1|||
164307218|NCT02023697|593499223|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
164307219|NCT02023697|593499224|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
164307220|NCT02023697|593499225|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
164307221|NCT02023697|593499223|FG000|Active Follow-up Period|Lost to Follow-up|1|||
164307222|NCT02023697|593499224|FG001|Active Follow-up Period|Lost to Follow-up|1|||
164307223|NCT02023697|593499225|FG002|Active Follow-up Period|Lost to Follow-up|1|||
164534900|NCT01116882|594329970|FG001|12-month|Withdrawal by Subject|8|||
164307224|NCT02023697|593499223|FG000|Active Follow-up Period|Deterioration of general condition|1|||
164307225|NCT02023697|593499224|FG001|Active Follow-up Period|Deterioration of general condition|1|||
164307226|NCT02023697|593499225|FG002|Active Follow-up Period|Deterioration of general condition|1|||
164307227|NCT02023697|593499223|FG000|Active Follow-up Period|Other unspecified|2|||
164307228|NCT02023697|593499224|FG001|Active Follow-up Period|Other unspecified|0|||
164307229|NCT02023697|593499225|FG002|Active Follow-up Period|Other unspecified|1|||
164307230|NCT02023697|593499223|FG000|Active Follow-up Period|Clinical progression|0|||
164307231|NCT02023697|593499224|FG001|Active Follow-up Period|Clinical progression|2|||
164307232|NCT02023697|593499225|FG002|Active Follow-up Period|Clinical progression|1|||
164307233|NCT02023697|593499223|FG000|Active Follow-up Period|Radiological progression|0|||
164534901|NCT00547365|594329971|FG000|Overall Study|Physician Decision|1|||
164307234|NCT02023697|593499224|FG001|Active Follow-up Period|Radiological progression|0|||
164307235|NCT02023697|593499225|FG002|Active Follow-up Period|Radiological progression|1|||
164307236|NCT02023697|593499223|FG000|Active Follow-up Period|Death|83|||
164307237|NCT02023697|593499224|FG001|Active Follow-up Period|Death|82|||
164307238|NCT02023697|593499225|FG002|Active Follow-up Period|Death|87|||
164307239|NCT02023697|593499223|FG000|Long-term Follow-up Period|Death|9|||
164307240|NCT02023697|593499224|FG001|Long-term Follow-up Period|Death|6|||
164307241|NCT02023697|593499225|FG002|Long-term Follow-up Period|Death|4|||
164307242|NCT02023697|593499223|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
164307243|NCT02023697|593499224|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
164307244|NCT02023697|593499225|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
164307245|NCT02023697|593499223|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
164307246|NCT02023697|593499224|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
164307247|NCT02023697|593499225|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
164307248|NCT02023697|593499223|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
164420081|NCT00280293|593908640|FG000|Overall Study|Physician Decision|5|||
164420082|NCT00280293|593908641|FG001|Overall Study|Physician Decision|4|||
164420083|NCT00280293|593908640|FG000|Overall Study|Lost to Follow-up|14|||
164420084|NCT00280293|593908641|FG001|Overall Study|Lost to Follow-up|12|||
164420085|NCT00280293|593908640|FG000|Overall Study|Withdrawal by Subject|3|||
164420086|NCT00280293|593908641|FG001|Overall Study|Withdrawal by Subject|5|||
164420087|NCT00280293|593908640|FG000|Overall Study|Incarceration/Legal Reasons|1|||
164420088|NCT00280293|593908641|FG001|Overall Study|Incarceration/Legal Reasons|1|||
164420089|NCT00280293|593908640|FG000|Overall Study|Adverse Event|0|||
164420090|NCT00280293|593908641|FG001|Overall Study|Adverse Event|1|||
164420091|NCT01177813|593908642|FG000|Overall Study|Adverse Event|8|||
164420092|NCT01177813|593908643|FG001|Overall Study|Adverse Event|2|||
164420093|NCT01177813|593908644|FG002|Overall Study|Adverse Event|4|||
164420094|NCT01177813|593908645|FG003|Overall Study|Adverse Event|6|||
164420095|NCT01177813|593908646|FG004|Overall Study|Adverse Event|3|||
164420096|NCT01177813|593908642|FG000|Overall Study|Lack of Efficacy|1|||
164420097|NCT01177813|593908643|FG001|Overall Study|Lack of Efficacy|0|||
164420098|NCT01177813|593908644|FG002|Overall Study|Lack of Efficacy|0|||
164420099|NCT01177813|593908645|FG003|Overall Study|Lack of Efficacy|0|||
164420100|NCT01177813|593908646|FG004|Overall Study|Lack of Efficacy|0|||
164420101|NCT01177813|593908642|FG000|Overall Study|Protocol Violation|3|||
164420102|NCT01177813|593908643|FG001|Overall Study|Protocol Violation|2|||
164420103|NCT01177813|593908644|FG002|Overall Study|Protocol Violation|2|||
164420104|NCT01177813|593908645|FG003|Overall Study|Protocol Violation|0|||
164420105|NCT01177813|593908646|FG004|Overall Study|Protocol Violation|1|||
164420106|NCT01177813|593908642|FG000|Overall Study|Lost to Follow-up|12|||
164420107|NCT01177813|593908643|FG001|Overall Study|Lost to Follow-up|5|||
164420108|NCT01177813|593908644|FG002|Overall Study|Lost to Follow-up|6|||
164420109|NCT01177813|593908645|FG003|Overall Study|Lost to Follow-up|3|||
164420110|NCT01177813|593908646|FG004|Overall Study|Lost to Follow-up|0|||
164420111|NCT01177813|593908642|FG000|Overall Study|Withdrawal by Subject|12|||
164420112|NCT01177813|593908643|FG001|Overall Study|Withdrawal by Subject|7|||
164420113|NCT01177813|593908644|FG002|Overall Study|Withdrawal by Subject|6|||
164420114|NCT01177813|593908645|FG003|Overall Study|Withdrawal by Subject|5|||
164420115|NCT01177813|593908646|FG004|Overall Study|Withdrawal by Subject|3|||
164420116|NCT01177813|593908642|FG000|Overall Study|Other reason not defined above|5|||
164420117|NCT01177813|593908643|FG001|Overall Study|Other reason not defined above|2|||
164420118|NCT01177813|593908644|FG002|Overall Study|Other reason not defined above|2|||
164420119|NCT01177813|593908645|FG003|Overall Study|Other reason not defined above|3|||
164420120|NCT01177813|593908646|FG004|Overall Study|Other reason not defined above|2|||
164420121|NCT04011384|593908651|FG000|Overall Study|Withdrawal by Subject|2|||
164420122|NCT04011384|593908652|FG001|Overall Study|Withdrawal by Subject|0|||
164420123|NCT04827134|593908655|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
164420124|NCT04827134|593908656|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
164420125|NCT04827134|593908657|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
164420126|NCT04827134|593908658|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
164420127|NCT04716881|593908663|FG000|Overall Study|Adverse Event|1|||
164420128|NCT04716881|593908663|FG000|Overall Study|Lost to Follow-up|1|||
164420129|NCT01630590|593908664|FG000|Overall Study|Adverse Event|9|||
164420130|NCT01630590|593908664|FG000|Overall Study|Lack of Efficacy|37|||
164420131|NCT01630590|593908664|FG000|Overall Study|Withdrawal by Subject|4|||
164420132|NCT01630590|593908664|FG000|Overall Study|2nd primary tumor|2|||
164420133|NCT01630590|593908664|FG000|Overall Study|Automobile accident|1|||
164420134|NCT01630590|593908664|FG000|Overall Study|Maximum benefit|4|||
164420135|NCT01751113|593908665|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
164420136|NCT01751113|593908666|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
164420137|NCT01751113|593908667|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
164420138|NCT01751113|593908668|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
164420139|NCT01751113|593908669|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
164420140|NCT01751113|593908670|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
164420141|NCT01751113|593908665|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
164534902|NCT00547365|594329971|FG000|Overall Study|Lost to Follow-up|1|||
164534903|NCT00547365|594329971|FG000|Overall Study|Protocol Violation|2|||
164534904|NCT00547365|594329971|FG000|Overall Study|death (not related to study)|4|||
164534905|NCT01572922|594329973|FG000|Overall Study|Adverse Event|1|||
164534906|NCT01572922|594329973|FG000|Overall Study|Protocol Violation|1|||
164534907|NCT01572922|594329973|FG000|Overall Study|Death|1|||
164534908|NCT04641299|594331504|FG000|Overall Study|Adverse Event|0|||
164534909|NCT04641299|594331505|FG001|Overall Study|Adverse Event|0|||
164534910|NCT04641299|594331506|FG002|Overall Study|Adverse Event|2|||
164534911|NCT04641299|594331507|FG003|Overall Study|Adverse Event|0|||
164534912|NCT04641299|594331504|FG000|Overall Study|Lost to Follow-up|0|||
164534913|NCT04641299|594331505|FG001|Overall Study|Lost to Follow-up|1|||
164534914|NCT04641299|594331506|FG002|Overall Study|Lost to Follow-up|0|||
164534915|NCT04641299|594331507|FG003|Overall Study|Lost to Follow-up|0|||
164534916|NCT04641299|594331504|FG000|Overall Study|Withdrawal by Subject|1|||
164534917|NCT04641299|594331505|FG001|Overall Study|Withdrawal by Subject|0|||
164534918|NCT04641299|594331506|FG002|Overall Study|Withdrawal by Subject|0|||
164534919|NCT04641299|594331507|FG003|Overall Study|Withdrawal by Subject|0|||
164534920|NCT04641299|594331504|FG000|Overall Study|Reason not given|1|||
164534921|NCT04641299|594331505|FG001|Overall Study|Reason not given|0|||
164534922|NCT04641299|594331506|FG002|Overall Study|Reason not given|0|||
164534923|NCT04641299|594331507|FG003|Overall Study|Reason not given|0|||
164534924|NCT01128361|594331510|FG000|Overall Study|Lost to Follow-up|0|||
164534925|NCT01128361|594331511|FG001|Overall Study|Lost to Follow-up|1|||
164534926|NCT01128361|594331510|FG000|Overall Study|Withdrawal by Subject|5|||
164534927|NCT01128361|594331511|FG001|Overall Study|Withdrawal by Subject|2|||
164534928|NCT05736211|594331518|FG000|Overall Study|Lost to Follow-up|6|||
164534929|NCT05736211|594331519|FG001|Overall Study|Lost to Follow-up|0|||
164534930|NCT01176968|594331521|FG000|Overall Study|Adverse Event|10|||
164534931|NCT01176968|594331522|FG001|Overall Study|Adverse Event|11|||
164534932|NCT01176968|594331521|FG000|Overall Study|Death|2|||
164534933|NCT01176968|594331522|FG001|Overall Study|Death|3|||
164534934|NCT01176968|594331521|FG000|Overall Study|Lack of Efficacy|0|||
164534935|NCT01176968|594331522|FG001|Overall Study|Lack of Efficacy|1|||
164534936|NCT01176968|594331521|FG000|Overall Study|Lost to Follow-up|16|||
164534937|NCT01176968|594331522|FG001|Overall Study|Lost to Follow-up|14|||
164420142|NCT01751113|593908666|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
164420143|NCT01751113|593908667|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
164420144|NCT01751113|593908668|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
164420145|NCT01751113|593908669|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
164420146|NCT01751113|593908670|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
164420147|NCT00363896|593908671|FG000|Overall Study|Withdrawal by Subject|29|||
164420148|NCT00363896|593908672|FG001|Overall Study|Withdrawal by Subject|16|||
164420149|NCT00363896|593908671|FG000|Overall Study|Adverse Event|24|||
164420150|NCT00363896|593908672|FG001|Overall Study|Adverse Event|13|||
164420151|NCT00363896|593908671|FG000|Overall Study|COPD exacerbation|13|||
164420152|NCT00363896|593908672|FG001|Overall Study|COPD exacerbation|7|||
164420153|NCT00363896|593908671|FG000|Overall Study|Lack of Efficacy|12|||
164420154|NCT00363896|593908672|FG001|Overall Study|Lack of Efficacy|8|||
164420155|NCT00363896|593908671|FG000|Overall Study|Protocol Violation|6|||
164420156|NCT00363896|593908672|FG001|Overall Study|Protocol Violation|1|||
164420157|NCT00363896|593908671|FG000|Overall Study|Lost to Follow-up|3|||
164420158|NCT00363896|593908672|FG001|Overall Study|Lost to Follow-up|0|||
164420159|NCT00363896|593908671|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
164420160|NCT00363896|593908672|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
164420161|NCT00363896|593908671|FG000|Overall Study|Other|1|||
164420162|NCT00363896|593908672|FG001|Overall Study|Other|2|||
164420163|NCT04147260|593908677|FG000|Overall Study|Adverse Event|1|||
164420164|NCT04147260|593908678|FG001|Overall Study|Adverse Event|0|||
164420165|NCT04147260|593908679|FG002|Overall Study|Adverse Event|1|||
164420166|NCT04147260|593908680|FG003|Overall Study|Adverse Event|2|||
164534938|NCT01176968|594331521|FG000|Overall Study|Withdrawal by Subject|48|||
164534939|NCT01176968|594331522|FG001|Overall Study|Withdrawal by Subject|48|||
164534940|NCT01176968|594331521|FG000|Overall Study|Protocol Violation|2|||
164534941|NCT01176968|594331522|FG001|Overall Study|Protocol Violation|1|||
164534942|NCT01176968|594331521|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
164534943|NCT01176968|594331522|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
164534944|NCT01176968|594331521|FG000|Overall Study|Study terminated by sponsor|0|||
164534945|NCT01176968|594331522|FG001|Overall Study|Study terminated by sponsor|1|||
164534946|NCT01176968|594331521|FG000|Overall Study|Reason not defined|5|||
164534947|NCT01176968|594331522|FG001|Overall Study|Reason not defined|3|||
164534948|NCT04288778|594331537|FG000|Overall Study|Withdrawal by Subject|2|||
164420167|NCT04147260|593908681|FG004|Overall Study|Adverse Event|0|||
164420168|NCT04147260|593908677|FG000|Overall Study|Withdrawal by Subject|0|||
164420169|NCT04147260|593908678|FG001|Overall Study|Withdrawal by Subject|0|||
164420170|NCT04147260|593908679|FG002|Overall Study|Withdrawal by Subject|1|||
164420171|NCT04147260|593908680|FG003|Overall Study|Withdrawal by Subject|1|||
164534949|NCT04288778|594331537|FG000|Overall Study|Adverse Event|5|||
164589059|NCT01070550|594521377|FG005|Overall Study|Adverse Event|0|||
164420172|NCT04147260|593908681|FG004|Overall Study|Withdrawal by Subject|0|||
164420173|NCT01651936|593908682|FG000|Base Study|Adverse Event|3|||
164420174|NCT01651936|593908683|FG001|Base Study|Adverse Event|0|||
164420175|NCT01651936|593908684|FG002|Base Study|Adverse Event|0|||
164420176|NCT01651936|593908682|FG000|Base Study|Withdrawal by Subject|1|||
164420177|NCT01651936|593908683|FG001|Base Study|Withdrawal by Subject|1|||
164420178|NCT01651936|593908684|FG002|Base Study|Withdrawal by Subject|0|||
164420179|NCT01651936|593908682|FG000|Base Study|Early Escape|2|||
164420180|NCT01651936|593908683|FG001|Base Study|Early Escape|8|||
164420181|NCT01651936|593908684|FG002|Base Study|Early Escape|0|||
164420182|NCT01651936|593908682|FG000|Base Study|Study terminated by sponsor|21|||
164420183|NCT01651936|593908683|FG001|Base Study|Study terminated by sponsor|16|||
164420184|NCT01651936|593908684|FG002|Base Study|Study terminated by sponsor|0|||
164420185|NCT01651936|593908682|FG000|Extension Study|Lack of Efficacy|0|||
164420186|NCT01651936|593908683|FG001|Extension Study|Lack of Efficacy|0|||
164420187|NCT01651936|593908684|FG002|Extension Study|Lack of Efficacy|1|||
164420188|NCT01651936|593908682|FG000|Extension Study|Study terminated by sponsor|0|||
164420189|NCT01651936|593908683|FG001|Extension Study|Study terminated by sponsor|0|||
164420190|NCT01651936|593908684|FG002|Extension Study|Study terminated by sponsor|13|||
164420191|NCT02471404|593908692|FG000|Overall Study|Adverse Event|7|||
164420192|NCT02471404|593908693|FG001|Overall Study|Adverse Event|1|||
164420193|NCT02471404|593908694|FG002|Overall Study|Adverse Event|2|||
164420194|NCT02471404|593908692|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
164420195|NCT02471404|593908693|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
164420196|NCT02471404|593908694|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
164420197|NCT02471404|593908692|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
164420198|NCT02471404|593908693|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
164420199|NCT02471404|593908694|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
164420200|NCT02471404|593908692|FG000|Overall Study|Lost to Follow-up|1|||
164420201|NCT02471404|593908693|FG001|Overall Study|Lost to Follow-up|1|||
164420202|NCT02471404|593908694|FG002|Overall Study|Lost to Follow-up|3|||
164420203|NCT02471404|593908692|FG000|Overall Study|Protocol Violation|1|||
164420204|NCT02471404|593908693|FG001|Overall Study|Protocol Violation|0|||
164420205|NCT02471404|593908694|FG002|Overall Study|Protocol Violation|0|||
164420206|NCT02471404|593908692|FG000|Overall Study|Withdrawal by Subject|8|||
164420207|NCT02471404|593908693|FG001|Overall Study|Withdrawal by Subject|4|||
164534950|NCT04288778|594331537|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164534951|NCT04288778|594331537|FG000|Overall Study|Other|1|||
164534952|NCT04288778|594331537|FG000|Overall Study|Started but not treated|2|||
164534953|NCT04442737|594331538|FG000|Overall Study|Lost to Follow-up|1|||
164534954|NCT04442737|594331539|FG001|Overall Study|Lost to Follow-up|3|||
164534955|NCT04442737|594331538|FG000|Overall Study|Withdrawal by Subject|3|||
164534956|NCT04442737|594331539|FG001|Overall Study|Withdrawal by Subject|2|||
164534957|NCT04442737|594331538|FG000|Overall Study|Adverse Event|3|||
164534958|NCT04442737|594331539|FG001|Overall Study|Adverse Event|2|||
164534959|NCT04442737|594331538|FG000|Overall Study|Death|0|||
164534960|NCT04442737|594331539|FG001|Overall Study|Death|1|||
164534961|NCT04442737|594331538|FG000|Overall Study|Protocol Violation|0|||
164534962|NCT04442737|594331539|FG001|Overall Study|Protocol Violation|2|||
164420208|NCT02471404|593908694|FG002|Overall Study|Withdrawal by Subject|5|||
164420209|NCT02471404|593908692|FG000|Overall Study|Other reasons not specified|10|||
164420210|NCT02471404|593908693|FG001|Overall Study|Other reasons not specified|7|||
164420211|NCT02471404|593908694|FG002|Overall Study|Other reasons not specified|12|||
164420212|NCT02207374|593908695|FG000|Overall Study|Withdrawal by Subject|5|||
164420213|NCT02207374|593908696|FG001|Overall Study|Withdrawal by Subject|9|||
164420214|NCT02207374|593908697|FG002|Overall Study|Withdrawal by Subject|4|||
164420215|NCT02207374|593908695|FG000|Overall Study|Death|1|||
164420216|NCT02207374|593908696|FG001|Overall Study|Death|0|||
164420217|NCT02207374|593908697|FG002|Overall Study|Death|1|||
164420218|NCT02207374|593908695|FG000|Overall Study|Missing follow-up information|0|||
164420219|NCT02207374|593908696|FG001|Overall Study|Missing follow-up information|1|||
164420220|NCT02207374|593908697|FG002|Overall Study|Missing follow-up information|1|||
164420221|NCT02087150|593908698|FG000|Overall Study|Death|0|||
164420222|NCT02087150|593908699|FG001|Overall Study|Death|1|||
164420223|NCT02087150|593908700|FG002|Overall Study|Death|0|||
164420224|NCT02087150|593908698|FG000|Overall Study|Lost to Follow-up|6|||
164420225|NCT02087150|593908699|FG001|Overall Study|Lost to Follow-up|13|||
164420226|NCT02087150|593908700|FG002|Overall Study|Lost to Follow-up|7|||
164420227|NCT02087150|593908698|FG000|Overall Study|Withdrawal by Subject|2|||
164420228|NCT02087150|593908699|FG001|Overall Study|Withdrawal by Subject|5|||
164420229|NCT02087150|593908700|FG002|Overall Study|Withdrawal by Subject|3|||
164534963|NCT04442737|594331538|FG000|Overall Study|Other|1|||
164534964|NCT04442737|594331539|FG001|Overall Study|Other|1|||
164534965|NCT05057247|594331544|FG000|Overall Study|Death|4|||
164420230|NCT02087150|593908698|FG000|Overall Study|Physician Decision|0|||
164420231|NCT02087150|593908699|FG001|Overall Study|Physician Decision|1|||
164420232|NCT02087150|593908700|FG002|Overall Study|Physician Decision|0|||
164420233|NCT02087150|593908698|FG000|Overall Study|Procedure not done|1|||
164534966|NCT05057247|594331544|FG000|Overall Study|Physician Decision|3|||
164534967|NCT05057247|594331544|FG000|Overall Study|Progressive Disease|7|||
164534968|NCT05057247|594331544|FG000|Overall Study|Withdrawal by Subject|3|||
164534969|NCT05057247|594331544|FG000|Overall Study|Adverse Event|6|||
164534970|NCT05057247|594331544|FG000|Overall Study|Subject Non-Compliance|1|||
164534971|NCT05057247|594331544|FG000|Overall Study|On treatment|2|||
164534972|NCT02168842|594331545|FG000|Overall Study|Withdrawal by Subject|5|||
164534973|NCT02168842|594331546|FG001|Overall Study|Withdrawal by Subject|3|||
164534974|NCT02168842|594331545|FG000|Overall Study|Lost to Follow-up|0|||
164534975|NCT02168842|594331546|FG001|Overall Study|Lost to Follow-up|2|||
164534976|NCT02168842|594331545|FG000|Overall Study|Death|2|||
164534977|NCT02168842|594331546|FG001|Overall Study|Death|1|||
164534978|NCT02168842|594331545|FG000|Overall Study|Physician Decision|1|||
164534979|NCT02168842|594331546|FG001|Overall Study|Physician Decision|2|||
164534980|NCT01067326|594331549|FG000|Overall Study|Adverse Event|0|||
164420234|NCT02087150|593908699|FG001|Overall Study|Procedure not done|13|||
164534981|NCT01067326|594331550|FG001|Overall Study|Adverse Event|2|||
164534982|NCT01067326|594331549|FG000|Overall Study|Withdrawal by Subject|1|||
164534983|NCT01067326|594331550|FG001|Overall Study|Withdrawal by Subject|0|||
164534984|NCT01067326|594331549|FG000|Overall Study|Early Study Termination|1|||
164534985|NCT01067326|594331550|FG001|Overall Study|Early Study Termination|1|||
164534986|NCT01176773|594331551|FG000|Overall Study|Screen Failure|2|||
164534987|NCT01176773|594331551|FG000|Overall Study|Withdrew consent|1|||
164534988|NCT01498289|594331554|FG000|Overall Study|Adverse Event|16|||
164534989|NCT01498289|594331555|FG001|Overall Study|Adverse Event|18|||
164534990|NCT01498289|594331554|FG000|Overall Study|Death|6|||
164534991|NCT01498289|594331555|FG001|Overall Study|Death|8|||
164534992|NCT01498289|594331554|FG000|Overall Study|Withdrawal unrelated to AE|16|||
164534993|NCT01498289|594331555|FG001|Overall Study|Withdrawal unrelated to AE|16|||
164534994|NCT01498289|594331554|FG000|Overall Study|Progression/relapse|53|||
164534995|NCT01498289|594331555|FG001|Overall Study|Progression/relapse|59|||
164534996|NCT01498289|594331554|FG000|Overall Study|Not protocol specified|7|||
164534997|NCT01498289|594331555|FG001|Overall Study|Not protocol specified|2|||
164534998|NCT01498289|594331554|FG000|Overall Study|Reason under review|0|||
164534999|NCT01498289|594331555|FG001|Overall Study|Reason under review|1|||
164535000|NCT01290601|594331563|FG000|Overall Study|Adverse Event|0|||
164648313|NCT01333475|594738560|FG001|Overall Study|Toxicity|3|||
164420235|NCT02087150|593908700|FG002|Overall Study|Procedure not done|0|||
164420236|NCT02087150|593908698|FG000|Overall Study|F/U not completed w/in study window|0|||
164420237|NCT02087150|593908699|FG001|Overall Study|F/U not completed w/in study window|0|||
164420238|NCT02087150|593908700|FG002|Overall Study|F/U not completed w/in study window|1|||
164420239|NCT02087150|593908698|FG000|Overall Study|Other|1|||
164420240|NCT02087150|593908699|FG001|Overall Study|Other|0|||
164420241|NCT02087150|593908700|FG002|Overall Study|Other|0|||
164420242|NCT02087150|593908698|FG000|Overall Study|Pt moved out of town|0|||
164420243|NCT02087150|593908699|FG001|Overall Study|Pt moved out of town|1|||
164420244|NCT02087150|593908700|FG002|Overall Study|Pt moved out of town|0|||
164420245|NCT00785538|593908701|FG000|Treatment Period|Adverse Event|1|||
164420246|NCT00785538|593908702|FG001|Treatment Period|Adverse Event|2|||
164420247|NCT00785538|593908703|FG002|Treatment Period|Adverse Event|2|||
164420248|NCT00785538|593908704|FG003|Treatment Period|Adverse Event|0|||
164420249|NCT00785538|593908701|FG000|Treatment Period|Withdrawal by Subject|0|||
164420250|NCT00785538|593908702|FG001|Treatment Period|Withdrawal by Subject|0|||
164420251|NCT00785538|593908703|FG002|Treatment Period|Withdrawal by Subject|0|||
164535001|NCT01290601|594331564|FG001|Overall Study|Adverse Event|2|||
164535002|NCT01290601|594331565|FG002|Overall Study|Adverse Event|0|||
164535003|NCT01290601|594331566|FG003|Overall Study|Adverse Event|0|||
164535004|NCT01290601|594331563|FG000|Overall Study|Lack of Efficacy|2|||
164535005|NCT01290601|594331564|FG001|Overall Study|Lack of Efficacy|1|||
164648314|NCT02981602|594738561|FG000|Overall Study|Adverse Event|0|||
164420252|NCT00785538|593908704|FG003|Treatment Period|Withdrawal by Subject|1|||
164420253|NCT00683449|593908705|FG000|Overall Study|Lost to Follow-up|0|||
164420254|NCT00683449|593908706|FG001|Overall Study|Lost to Follow-up|1|||
164420255|NCT00683449|593908707|FG002|Overall Study|Lost to Follow-up|0|||
164420256|NCT00683449|593908708|FG003|Overall Study|Lost to Follow-up|0|||
164420257|NCT00683449|593908709|FG004|Overall Study|Lost to Follow-up|0|||
164420258|NCT01000376|593908715|FG000|Cycle 1 Day 1|Adverse Event|1|||
164420259|NCT01000376|593908716|FG001|Cycle 1 Day 1|Adverse Event|0|||
164420260|NCT01000376|593908715|FG000|Cycle 1 Day 1|Progressive Disease|1|||
164648315|NCT02981602|594738562|FG001|Overall Study|Adverse Event|0|||
164648316|NCT02981602|594738563|FG002|Overall Study|Adverse Event|0|||
164648317|NCT02981602|594738564|FG003|Overall Study|Adverse Event|1|||
164648318|NCT02981602|594738565|FG004|Overall Study|Adverse Event|0|||
164648319|NCT00666718|594738566|FG000|Overall Study|Adverse Event|0|||
164648320|NCT00666718|594738567|FG001|Overall Study|Adverse Event|1|||
164420261|NCT01000376|593908716|FG001|Cycle 1 Day 1|Progressive Disease|0|||
164420262|NCT00507026|593908717|FG000|Overall Study|Lack of Efficacy|6|||
164420263|NCT00507026|593908718|FG001|Overall Study|Lack of Efficacy|4|||
164420264|NCT00507026|593908719|FG002|Overall Study|Lack of Efficacy|21|||
164535006|NCT01290601|594331565|FG002|Overall Study|Lack of Efficacy|0|||
164535007|NCT01290601|594331566|FG003|Overall Study|Lack of Efficacy|0|||
164648321|NCT00666718|594738566|FG000|Overall Study|Death|1|||
164648322|NCT00666718|594738567|FG001|Overall Study|Death|0|||
164648323|NCT00666718|594738566|FG000|Overall Study|Lost to Follow-up|1|||
164648324|NCT00666718|594738567|FG001|Overall Study|Lost to Follow-up|0|||
164648325|NCT00666718|594738566|FG000|Overall Study|Entry Criteria Not Met|2|||
164648326|NCT00666718|594738567|FG001|Overall Study|Entry Criteria Not Met|0|||
164648327|NCT00666718|594738566|FG000|Overall Study|Protocol Violation|1|||
164648328|NCT00666718|594738567|FG001|Overall Study|Protocol Violation|3|||
164648329|NCT00666718|594738566|FG000|Overall Study|Withdrawal by Subject|7|||
164648330|NCT00666718|594738567|FG001|Overall Study|Withdrawal by Subject|12|||
164648331|NCT00666718|594738566|FG000|Overall Study|Physician Decision|0|||
164648332|NCT00666718|594738567|FG001|Overall Study|Physician Decision|2|||
164420265|NCT00507026|593908717|FG000|Overall Study|Withdrawal by Subject|2|||
164420266|NCT00507026|593908718|FG001|Overall Study|Withdrawal by Subject|0|||
164420267|NCT00507026|593908719|FG002|Overall Study|Withdrawal by Subject|0|||
164420268|NCT00507026|593908717|FG000|Overall Study|Investigator Decision|1|||
164420269|NCT00507026|593908718|FG001|Overall Study|Investigator Decision|0|||
164420270|NCT00507026|593908719|FG002|Overall Study|Investigator Decision|0|||
164420271|NCT00507026|593908717|FG000|Overall Study|Adverse Event|2|||
164420272|NCT00507026|593908718|FG001|Overall Study|Adverse Event|0|||
164420273|NCT00507026|593908719|FG002|Overall Study|Adverse Event|0|||
164420274|NCT00507026|593908717|FG000|Overall Study|Protocol Violation|1|||
164420275|NCT00507026|593908718|FG001|Overall Study|Protocol Violation|0|||
164420276|NCT00507026|593908719|FG002|Overall Study|Protocol Violation|0|||
164420277|NCT00507026|593908717|FG000|Overall Study|Other|1|||
164420278|NCT00507026|593908718|FG001|Overall Study|Other|0|||
164420279|NCT00507026|593908719|FG002|Overall Study|Other|0|||
164420280|NCT04230980|593908720|FG000|Overall Study|Lost to Follow-up|1|||
164420281|NCT04230980|593908721|FG001|Overall Study|Lost to Follow-up|2|||
164420282|NCT04230980|593908720|FG000|Overall Study|Adverse Event|0|||
164420283|NCT04230980|593908721|FG001|Overall Study|Adverse Event|1|||
164420284|NCT04285229|593908722|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
164420285|NCT04285229|593908723|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164420286|NCT04285229|593908724|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164420287|NCT04285229|593908725|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164420288|NCT04285229|593908726|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164420289|NCT04285229|593908727|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164420290|NCT04285229|593908722|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
164420291|NCT04285229|593908723|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
164420292|NCT04285229|593908724|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
164420293|NCT04285229|593908725|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
164420294|NCT04285229|593908726|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
164420295|NCT04285229|593908727|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
164420296|NCT04285229|593908722|FG000|Extended Treatment Period|Adverse Event|0|||
164420297|NCT04285229|593908723|FG001|Extended Treatment Period|Adverse Event|0|||
164420298|NCT04285229|593908724|FG002|Extended Treatment Period|Adverse Event|0|||
164420299|NCT04285229|593908725|FG003|Extended Treatment Period|Adverse Event|1|||
164420300|NCT04285229|593908726|FG004|Extended Treatment Period|Adverse Event|0|||
164420301|NCT04285229|593908727|FG005|Extended Treatment Period|Adverse Event|0|||
164420302|NCT04285229|593908722|FG000|Extended Treatment Period|Physician Decision|0|||
164420303|NCT04285229|593908723|FG001|Extended Treatment Period|Physician Decision|0|||
164420304|NCT04285229|593908724|FG002|Extended Treatment Period|Physician Decision|1|||
164420305|NCT04285229|593908725|FG003|Extended Treatment Period|Physician Decision|0|||
164420306|NCT04285229|593908726|FG004|Extended Treatment Period|Physician Decision|0|||
164648333|NCT02567266|594738577|FG000|Overall Study|Withdrawal by Subject|10|||
164420307|NCT04285229|593908727|FG005|Extended Treatment Period|Physician Decision|0|||
164420308|NCT04285229|593908722|FG000|Follow-up Period|Adverse Event|0|||
164420309|NCT04285229|593908723|FG001|Follow-up Period|Adverse Event|0|||
164420310|NCT04285229|593908724|FG002|Follow-up Period|Adverse Event|0|||
164420311|NCT04285229|593908725|FG003|Follow-up Period|Adverse Event|0|||
164420312|NCT04285229|593908726|FG004|Follow-up Period|Adverse Event|1|||
164420313|NCT04285229|593908727|FG005|Follow-up Period|Adverse Event|4|||
164420314|NCT04285229|593908722|FG000|Follow-up Period|Withdrawal by Subject|0|||
164420315|NCT04285229|593908723|FG001|Follow-up Period|Withdrawal by Subject|0|||
164420316|NCT04285229|593908724|FG002|Follow-up Period|Withdrawal by Subject|0|||
164420317|NCT04285229|593908725|FG003|Follow-up Period|Withdrawal by Subject|0|||
164420318|NCT04285229|593908726|FG004|Follow-up Period|Withdrawal by Subject|0|||
164420319|NCT04285229|593908727|FG005|Follow-up Period|Withdrawal by Subject|5|||
164420320|NCT04285229|593908722|FG000|Follow-up Period|Covid-19|0|||
164420321|NCT04285229|593908723|FG001|Follow-up Period|Covid-19|0|||
164420322|NCT04285229|593908724|FG002|Follow-up Period|Covid-19|0|||
164648334|NCT02567266|594738578|FG001|Overall Study|Withdrawal by Subject|7|||
164648335|NCT02567266|594738579|FG002|Overall Study|Withdrawal by Subject|6|||
164648336|NCT02567266|594738577|FG000|Overall Study|Lost to Follow-up|13|||
164648337|NCT02567266|594738578|FG001|Overall Study|Lost to Follow-up|8|||
164420323|NCT04285229|593908725|FG003|Follow-up Period|Covid-19|0|||
164420324|NCT04285229|593908726|FG004|Follow-up Period|Covid-19|0|||
164648338|NCT02567266|594738579|FG002|Overall Study|Lost to Follow-up|10|||
164648339|NCT02983227|594738580|FG000|Overall Study|Adverse Event|21|||
164648340|NCT02983227|594738581|FG001|Overall Study|Adverse Event|3|||
164648341|NCT02983227|594738580|FG000|Overall Study|Death|3|||
164648342|NCT02983227|594738581|FG001|Overall Study|Death|0|||
164648343|NCT02983227|594738580|FG000|Overall Study|Lack of Efficacy|8|||
164648344|NCT02983227|594738581|FG001|Overall Study|Lack of Efficacy|1|||
164648345|NCT02983227|594738580|FG000|Overall Study|Lost to Follow-up|3|||
164420325|NCT04285229|593908727|FG005|Follow-up Period|Covid-19|2|||
164420326|NCT04285229|593908722|FG000|Follow-up Period|Physician Decision|0|||
164420327|NCT04285229|593908723|FG001|Follow-up Period|Physician Decision|0|||
164420328|NCT04285229|593908724|FG002|Follow-up Period|Physician Decision|0|||
164535008|NCT01290601|594331563|FG000|Overall Study|Lost to Follow-up|7|||
164535009|NCT01290601|594331564|FG001|Overall Study|Lost to Follow-up|2|||
164535010|NCT01290601|594331565|FG002|Overall Study|Lost to Follow-up|0|||
164535011|NCT01290601|594331566|FG003|Overall Study|Lost to Follow-up|0|||
164535012|NCT01290601|594331563|FG000|Overall Study|Other|1|||
164535013|NCT01290601|594331564|FG001|Overall Study|Other|0|||
164535014|NCT01290601|594331565|FG002|Overall Study|Other|0|||
164535015|NCT01290601|594331566|FG003|Overall Study|Other|0|||
164535016|NCT01290601|594331563|FG000|Overall Study|Protocol Violation|1|||
164535017|NCT01290601|594331564|FG001|Overall Study|Protocol Violation|0|||
164535018|NCT01290601|594331565|FG002|Overall Study|Protocol Violation|0|||
164535019|NCT01290601|594331566|FG003|Overall Study|Protocol Violation|0|||
164535020|NCT00775450|594331567|FG000|Overall Study|Serious Adverse Event|2|||
164535021|NCT00775450|594331568|FG001|Overall Study|Serious Adverse Event|0|||
164535022|NCT00775450|594331569|FG002|Overall Study|Serious Adverse Event|0|||
164535023|NCT00775450|594331570|FG003|Overall Study|Serious Adverse Event|0|||
164535024|NCT00775450|594331571|FG004|Overall Study|Serious Adverse Event|0|||
164535025|NCT00775450|594331567|FG000|Overall Study|Protocol Violation|0|||
164535026|NCT00775450|594331568|FG001|Overall Study|Protocol Violation|0|||
164535027|NCT00775450|594331569|FG002|Overall Study|Protocol Violation|0|||
164535028|NCT00775450|594331570|FG003|Overall Study|Protocol Violation|0|||
164420329|NCT04285229|593908725|FG003|Follow-up Period|Physician Decision|0|||
164420330|NCT04285229|593908726|FG004|Follow-up Period|Physician Decision|0|||
164535029|NCT00775450|594331571|FG004|Overall Study|Protocol Violation|1|||
164535030|NCT00775450|594331567|FG000|Overall Study|Withdrawal by Subject|1|||
164535031|NCT00775450|594331568|FG001|Overall Study|Withdrawal by Subject|0|||
164535032|NCT00775450|594331569|FG002|Overall Study|Withdrawal by Subject|0|||
164535033|NCT00775450|594331570|FG003|Overall Study|Withdrawal by Subject|0|||
164535034|NCT00775450|594331571|FG004|Overall Study|Withdrawal by Subject|1|||
164535035|NCT00752622|594331590|FG000|Induction Phase|Adverse Event|3|||
164535036|NCT00752622|594331590|FG000|Induction Phase|Other|3|||
164535037|NCT00752622|594331590|FG000|Induction Phase|Non-responder|14|||
164535038|NCT00752622|594331590|FG000|Induction Phase|Withdrawal by Subject|1|||
164535039|NCT00752622|594331590|FG000|Induction Phase|Premature study termination|14|||
164535040|NCT00752622|594331590|FG000|Observational Phase|Premature Study Termination|36|||
164535041|NCT00752622|594331590|FG000|Observational Phase|Non-responder|2|||
164535042|NCT00752622|594331590|FG000|Observational Phase|Withdrawal by Subject|2|||
164535043|NCT00752622|594331590|FG000|Observational Phase|Adverse Event|1|||
164535044|NCT00752622|594331590|FG000|Observational Phase|Other|2|||
164535045|NCT00752622|594331590|FG000|Interventional Phase|Non-responder|2|||
164535046|NCT00752622|594331590|FG000|Interventional Phase|Physician Decision|1|||
164535047|NCT00752622|594331590|FG000|Interventional Phase|Premature Study Termination|5|||
164648346|NCT02983227|594738581|FG001|Overall Study|Lost to Follow-up|0|||
164648347|NCT02983227|594738580|FG000|Overall Study|Multiple Reasons|2|||
164648348|NCT02983227|594738581|FG001|Overall Study|Multiple Reasons|1|||
164648349|NCT02983227|594738580|FG000|Overall Study|Physician Decision|3|||
164648350|NCT02983227|594738581|FG001|Overall Study|Physician Decision|1|||
164648351|NCT02983227|594738580|FG000|Overall Study|Withdrawal by Subject|19|||
164648352|NCT02983227|594738581|FG001|Overall Study|Withdrawal by Subject|8|||
164648353|NCT00527397|594738586|FG000|Overall Study|Adverse Event|3|||
164420331|NCT04285229|593908727|FG005|Follow-up Period|Physician Decision|1|||
164420332|NCT02213055|593908728|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
164648354|NCT00527397|594738586|FG000|Overall Study|Lack of Efficacy|1|||
164648355|NCT00527397|594738586|FG000|Overall Study|Protocol Violation|1|||
164648356|NCT00527397|594738586|FG000|Overall Study|Withdrawal by Subject|6|||
164535048|NCT00576836|594331592|FG000|Overall Study|Death|0|||
164535049|NCT00576836|594331593|FG001|Overall Study|Death|1|||
164535050|NCT00576836|594331592|FG000|Overall Study|Physician Decision|0|||
164535051|NCT00576836|594331593|FG001|Overall Study|Physician Decision|1|||
164535052|NCT00132496|594331597|FG000|Overall Study|Withdrawal by Subject|1|||
164535053|NCT00132496|594331598|FG001|Overall Study|Withdrawal by Subject|2|||
164535054|NCT00132496|594331597|FG000|Overall Study|Physician Decision|1|||
164535055|NCT00132496|594331598|FG001|Overall Study|Physician Decision|0|||
164648357|NCT00527397|594738586|FG000|Overall Study|Study terminated by sponsor|13|||
164648358|NCT02065791|594738590|FG000|Overall Study|Closed Site|1|||
164648359|NCT02065791|594738591|FG001|Overall Study|Closed Site|1|||
164535056|NCT00986440|594331601|FG000|Overall Study|Progressive disease|27|||
164420333|NCT02213055|593908729|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
164420334|NCT02213055|593908728|FG000|Overall Study|Protocol was not Followed during Study|1|||
164420335|NCT02213055|593908729|FG001|Overall Study|Protocol was not Followed during Study|0|||
164420336|NCT02213055|593908728|FG000|Overall Study|Documentation Issue at Enrollment|1|||
164420337|NCT02213055|593908729|FG001|Overall Study|Documentation Issue at Enrollment|0|||
164420338|NCT02213055|593908728|FG000|Overall Study|Documentation Issue during Study|10|||
164420339|NCT02213055|593908729|FG001|Overall Study|Documentation Issue during Study|0|||
164420340|NCT02213055|593908728|FG000|Overall Study|Did not have Live Lice|8|||
164420341|NCT02213055|593908729|FG001|Overall Study|Did not have Live Lice|0|||
164420342|NCT02213055|593908728|FG000|Overall Study|Had another Treatment during the Study|3|||
164420343|NCT02213055|593908729|FG001|Overall Study|Had another Treatment during the Study|0|||
164420344|NCT02213055|593908728|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
164420345|NCT02213055|593908729|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
164420346|NCT02213055|593908728|FG000|Overall Study|Did not Return to School|5|||
164420347|NCT02213055|593908729|FG001|Overall Study|Did not Return to School|0|||
164420348|NCT02061761|593908730|FG000|Overall Study|Disease progression|2|||
164420349|NCT02061761|593908731|FG001|Overall Study|Disease progression|8|||
164420350|NCT02061761|593908732|FG002|Overall Study|Disease progression|4|||
164420351|NCT02061761|593908733|FG003|Overall Study|Disease progression|5|||
164420352|NCT02061761|593908734|FG004|Overall Study|Disease progression|9|||
164420353|NCT02061761|593908735|FG005|Overall Study|Disease progression|3|||
164420354|NCT02061761|593908736|FG006|Overall Study|Disease progression|1|||
164420355|NCT02061761|593908737|FG007|Overall Study|Disease progression|2|||
164420356|NCT02061761|593908738|FG008|Overall Study|Disease progression|28|||
164420357|NCT02061761|593908730|FG000|Overall Study|Study Drug toxicity|0|||
164420358|NCT02061761|593908731|FG001|Overall Study|Study Drug toxicity|0|||
164420359|NCT02061761|593908732|FG002|Overall Study|Study Drug toxicity|0|||
164420360|NCT02061761|593908733|FG003|Overall Study|Study Drug toxicity|0|||
164420361|NCT02061761|593908734|FG004|Overall Study|Study Drug toxicity|0|||
164420362|NCT02061761|593908735|FG005|Overall Study|Study Drug toxicity|1|||
164420363|NCT02061761|593908736|FG006|Overall Study|Study Drug toxicity|0|||
164420364|NCT02061761|593908737|FG007|Overall Study|Study Drug toxicity|2|||
164420365|NCT02061761|593908738|FG008|Overall Study|Study Drug toxicity|6|||
164420366|NCT02061761|593908730|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
164420367|NCT02061761|593908731|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
164420368|NCT02061761|593908732|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
164420369|NCT02061761|593908733|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
164420370|NCT02061761|593908734|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
164420371|NCT02061761|593908735|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
164420372|NCT02061761|593908736|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
164420373|NCT02061761|593908737|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
164420374|NCT02061761|593908738|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
164420375|NCT02061761|593908730|FG000|Overall Study|Participant request to discontinue study treatment|0|||
164420376|NCT02061761|593908731|FG001|Overall Study|Participant request to discontinue study treatment|0|||
164420377|NCT02061761|593908732|FG002|Overall Study|Participant request to discontinue study treatment|2|||
164420378|NCT02061761|593908733|FG003|Overall Study|Participant request to discontinue study treatment|2|||
164420379|NCT02061761|593908734|FG004|Overall Study|Participant request to discontinue study treatment|0|||
164420380|NCT02061761|593908735|FG005|Overall Study|Participant request to discontinue study treatment|1|||
164420381|NCT02061761|593908736|FG006|Overall Study|Participant request to discontinue study treatment|0|||
164648360|NCT02065791|594738590|FG000|Overall Study|Withdrawal by Subject|11|||
164648361|NCT02065791|594738591|FG001|Overall Study|Withdrawal by Subject|5|||
164648362|NCT02065791|594738590|FG000|Overall Study|Lost to Follow-up|13|||
164648363|NCT02065791|594738591|FG001|Overall Study|Lost to Follow-up|9|||
164648364|NCT04529096|594738592|FG000|Overall Study|Adverse Event|6|||
164648365|NCT04529096|594738593|FG001|Overall Study|Adverse Event|1|||
164648366|NCT04529096|594738592|FG000|Overall Study|Lack of Efficacy|1|||
164648367|NCT04529096|594738593|FG001|Overall Study|Lack of Efficacy|0|||
164648368|NCT04529096|594738592|FG000|Overall Study|Lost to Follow-up|1|||
164420382|NCT02061761|593908737|FG007|Overall Study|Participant request to discontinue study treatment|0|||
164420383|NCT02061761|593908738|FG008|Overall Study|Participant request to discontinue study treatment|2|||
164420384|NCT02061761|593908730|FG000|Overall Study|Withdrawal by Subject|0|||
164420385|NCT02061761|593908731|FG001|Overall Study|Withdrawal by Subject|0|||
164420386|NCT02061761|593908732|FG002|Overall Study|Withdrawal by Subject|0|||
164420387|NCT02061761|593908733|FG003|Overall Study|Withdrawal by Subject|0|||
164420388|NCT02061761|593908734|FG004|Overall Study|Withdrawal by Subject|0|||
164648369|NCT04529096|594738593|FG001|Overall Study|Lost to Follow-up|1|||
164648370|NCT04529096|594738592|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164420389|NCT02061761|593908735|FG005|Overall Study|Withdrawal by Subject|0|||
164648371|NCT04529096|594738593|FG001|Overall Study|Non-Compliance With Study Drug|1|||
164648372|NCT04529096|594738592|FG000|Overall Study|Physician Decision|1|||
164648373|NCT04529096|594738593|FG001|Overall Study|Physician Decision|3|||
164648374|NCT04529096|594738592|FG000|Overall Study|Withdrawal by Subject|5|||
164648375|NCT04529096|594738593|FG001|Overall Study|Withdrawal by Subject|0|||
164648376|NCT03467971|594738594|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164648377|NCT03467971|594738595|FG001|Treatment Period 2|Withdrawal by Subject|1|||
164648378|NCT01619085|594738596|FG000|Overall Study|Adverse Event|231|||
164648379|NCT01619085|594738596|FG000|Overall Study|Protocol Violation|4|||
164648380|NCT01619085|594738596|FG000|Overall Study|Lost to Follow-up|3|||
164648381|NCT01619085|594738596|FG000|Overall Study|Withdrawal by Subject|45|||
164648382|NCT01619085|594738596|FG000|Overall Study|Other than specified|96|||
164648383|NCT01619085|594738596|FG000|Overall Study|Not treated|1|||
164648384|NCT01619085|594738596|FG000|Overall Study|Death|145|||
164648385|NCT00883129|594738599|FG000|Overall Study|Adverse Event|7|||
164648386|NCT00883129|594738600|FG001|Overall Study|Adverse Event|15|||
164648387|NCT00883129|594738599|FG000|Overall Study|Withdrawal by Subject|8|||
164648388|NCT00883129|594738600|FG001|Overall Study|Withdrawal by Subject|9|||
164648389|NCT00883129|594738599|FG000|Overall Study|Non-compliance|3|||
164648390|NCT00883129|594738600|FG001|Overall Study|Non-compliance|6|||
164648391|NCT00883129|594738599|FG000|Overall Study|Lost to Follow-up|1|||
164648392|NCT00883129|594738600|FG001|Overall Study|Lost to Follow-up|2|||
164648393|NCT00883129|594738599|FG000|Overall Study|Death|1|||
164648394|NCT00883129|594738600|FG001|Overall Study|Death|2|||
164648395|NCT00883129|594738599|FG000|Overall Study|Defined Treatment Failure|0|||
164648396|NCT00883129|594738600|FG001|Overall Study|Defined Treatment Failure|2|||
164648397|NCT00759759|594738601|FG000|Overall Study|didn't return for period 2|1|||
164648398|NCT00759759|594738602|FG001|Overall Study|didn't return for period 2|0|||
164648399|NCT00759759|594738601|FG000|Overall Study|Didn't receive drug in period 2|1|||
164648400|NCT00759759|594738602|FG001|Overall Study|Didn't receive drug in period 2|0|||
164648401|NCT00759759|594738601|FG000|Overall Study|Withdrawal by Subject|2|||
164648402|NCT00759759|594738602|FG001|Overall Study|Withdrawal by Subject|1|||
164648403|NCT00701558|594738605|FG000|Overall Study|Death|7|||
164648404|NCT00701558|594738605|FG000|Overall Study|Lost to Follow-up|8|||
164648405|NCT00833976|594740144|FG000|Overall Study|Withdrawal by Subject|5|||
164648406|NCT00833976|594740144|FG000|Overall Study|Lost to Follow-up|4|||
164648407|NCT00833976|594740144|FG000|Overall Study|Did not meet eligibility criteria|41|||
164648408|NCT00833976|594740144|FG000|Overall Study|Physician Decision|1|||
164648409|NCT01246973|594740149|FG000|Overall Study|Other|38|||
164648410|NCT01246973|594740150|FG001|Overall Study|Other|25|||
164648411|NCT01246973|594740149|FG000|Overall Study|Adverse Event|16|||
164648412|NCT01246973|594740150|FG001|Overall Study|Adverse Event|9|||
164648413|NCT01246973|594740149|FG000|Overall Study|Withdrawal by Subject|7|||
164648414|NCT01246973|594740150|FG001|Overall Study|Withdrawal by Subject|13|||
164648415|NCT00678379|594740151|FG000|Overall Study|Injection performed after tonsillectomy|2|||
164648416|NCT00678379|594740152|FG001|Overall Study|Injection performed after tonsillectomy|0|||
164648417|NCT00678379|594740153|FG002|Overall Study|Injection performed after tonsillectomy|1|||
164648418|NCT00678379|594740151|FG000|Overall Study|Incomplete Data|4|||
164420390|NCT02061761|593908736|FG006|Overall Study|Withdrawal by Subject|0|||
164420391|NCT02061761|593908737|FG007|Overall Study|Withdrawal by Subject|0|||
164420392|NCT02061761|593908738|FG008|Overall Study|Withdrawal by Subject|2|||
164420393|NCT02061761|593908730|FG000|Overall Study|Maximum clinical benefit|0|||
164420394|NCT02061761|593908731|FG001|Overall Study|Maximum clinical benefit|0|||
164420395|NCT02061761|593908732|FG002|Overall Study|Maximum clinical benefit|0|||
164420396|NCT02061761|593908733|FG003|Overall Study|Maximum clinical benefit|1|||
164420397|NCT02061761|593908734|FG004|Overall Study|Maximum clinical benefit|0|||
164420398|NCT02061761|593908735|FG005|Overall Study|Maximum clinical benefit|0|||
164420399|NCT02061761|593908736|FG006|Overall Study|Maximum clinical benefit|0|||
164420400|NCT02061761|593908737|FG007|Overall Study|Maximum clinical benefit|0|||
164420401|NCT02061761|593908738|FG008|Overall Study|Maximum clinical benefit|6|||
164420402|NCT02061761|593908730|FG000|Overall Study|Participant no longer meets study criteria|0|||
164535057|NCT00986440|594331602|FG001|Overall Study|Progressive disease|37|||
164535058|NCT00986440|594331601|FG000|Overall Study|Serious adverse event or adverse event|9|||
164535059|NCT00986440|594331602|FG001|Overall Study|Serious adverse event or adverse event|2|||
164535060|NCT00986440|594331601|FG000|Overall Study|Withdrawal by Subject|1|||
164535061|NCT00986440|594331602|FG001|Overall Study|Withdrawal by Subject|2|||
164535062|NCT00986440|594331601|FG000|Overall Study|Screen failure (not dosed)|4|||
164535063|NCT00986440|594331602|FG001|Overall Study|Screen failure (not dosed)|2|||
164535064|NCT00388154|594331603|FG000|Overall Study|Withdrawal by Subject|1|||
164535065|NCT00178126|594331604|FG000|Overall Study|Lost to Follow-up|21|||
164535066|NCT00178126|594331605|FG001|Overall Study|Lost to Follow-up|21|||
164648419|NCT00678379|594740152|FG001|Overall Study|Incomplete Data|3|||
164648420|NCT00678379|594740153|FG002|Overall Study|Incomplete Data|3|||
164648421|NCT01835470|594740154|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
164648422|NCT01835470|594740154|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
164535067|NCT00178126|594331604|FG000|Overall Study|did not receive intervention|4|||
164535068|NCT00178126|594331605|FG001|Overall Study|did not receive intervention|6|||
164648423|NCT01011907|594740155|FG000|Overall Study|Withdrawal by Subject|13|||
164648424|NCT01011907|594740156|FG001|Overall Study|Withdrawal by Subject|11|||
164648425|NCT01011907|594740155|FG000|Overall Study|Adverse Event|1|||
164648426|NCT01011907|594740156|FG001|Overall Study|Adverse Event|4|||
164535069|NCT01074216|594331606|FG000|Overall Study|Physician Decision|1|||
164535070|NCT01074216|594331606|FG000|Overall Study|Not Treated|12|||
164535071|NCT05056987|594331609|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
164535072|NCT05056987|594331610|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
164535073|NCT05056987|594331609|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
164535074|NCT05056987|594331610|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
164535075|NCT01575028|594331611|FG000|Overall Study|Physician Decision|0|||
164535076|NCT01575028|594331612|FG001|Overall Study|Physician Decision|1|||
164535077|NCT01182194|594331613|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
164535078|NCT01182194|594331614|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
164535079|NCT00796120|594331615|FG000|Overall Study|Death|3|||
164535080|NCT00796120|594331616|FG001|Overall Study|Death|0|||
164535081|NCT00796120|594331615|FG000|Overall Study|Adverse Event|11|||
164535082|NCT00796120|594331616|FG001|Overall Study|Adverse Event|6|||
164535083|NCT00796120|594331615|FG000|Overall Study|Progressive disease|22|||
164535084|NCT00796120|594331616|FG001|Overall Study|Progressive disease|13|||
164535085|NCT00796120|594331615|FG000|Overall Study|Participant refusal|3|||
164535086|NCT00796120|594331616|FG001|Overall Study|Participant refusal|4|||
164535087|NCT00796120|594331615|FG000|Overall Study|Other|6|||
164535088|NCT00796120|594331616|FG001|Overall Study|Other|17|||
164535089|NCT00796120|594331615|FG000|Overall Study|Physician Decision|16|||
164535090|NCT00796120|594331616|FG001|Overall Study|Physician Decision|17|||
164535091|NCT00796120|594331615|FG000|Overall Study|Randomized but not treated|0|||
164535092|NCT00796120|594331616|FG001|Overall Study|Randomized but not treated|3|||
164535093|NCT02520284|594331617|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
164535094|NCT02520284|594331618|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
164535095|NCT02520284|594331619|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
164535096|NCT02520284|594331617|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
164535097|NCT02520284|594331618|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
164535098|NCT02520284|594331619|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
164535099|NCT02520284|594331617|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
164535100|NCT02520284|594331618|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
164535101|NCT02520284|594331619|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
164535102|NCT02520284|594331617|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
164535103|NCT02520284|594331618|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
164535104|NCT02520284|594331619|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
164535105|NCT02520284|594331617|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
164535106|NCT02520284|594331618|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
164535107|NCT02520284|594331619|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
164535108|NCT02520284|594331617|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
164535109|NCT02520284|594331618|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
164535110|NCT02520284|594331619|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
164535111|NCT02520284|594331617|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
164535112|NCT02520284|594331618|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
164535113|NCT02520284|594331619|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
164535114|NCT02520284|594331617|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
164535115|NCT02520284|594331618|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
164535116|NCT02520284|594331619|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
164535117|NCT02520284|594331617|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
164535118|NCT02520284|594331618|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
164535119|NCT02520284|594331619|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
164535120|NCT02520284|594331617|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
164535121|NCT02520284|594331618|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
164535122|NCT02520284|594331619|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
164535123|NCT02520284|594331617|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
164535124|NCT02520284|594331618|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
164535125|NCT02520284|594331619|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
164535126|NCT03737474|594331620|FG000|Overall Study|Adverse Event|18|||
164535127|NCT03737474|594331621|FG001|Overall Study|Adverse Event|48|||
164535128|NCT03737474|594331620|FG000|Overall Study|Lack of Efficacy|1|||
164535129|NCT03737474|594331621|FG001|Overall Study|Lack of Efficacy|3|||
164535130|NCT03737474|594331620|FG000|Overall Study|Protocol Violation|0|||
164535131|NCT03737474|594331621|FG001|Overall Study|Protocol Violation|8|||
164535132|NCT03737474|594331620|FG000|Overall Study|Withdrawal by Subject|5|||
164535133|NCT03737474|594331621|FG001|Overall Study|Withdrawal by Subject|20|||
164535134|NCT03737474|594331620|FG000|Overall Study|Non-compliance With Study Drug|0|||
164535135|NCT03737474|594331621|FG001|Overall Study|Non-compliance With Study Drug|1|||
164535136|NCT03737474|594331620|FG000|Overall Study|Physician Decision|1|||
164535137|NCT03737474|594331621|FG001|Overall Study|Physician Decision|4|||
164535138|NCT01139658|594331624|FG000|Overall Study|Adverse Event|10|||
164535139|NCT01139658|594331625|FG001|Overall Study|Adverse Event|27|||
164535140|NCT01139658|594331624|FG000|Overall Study|Lack of Efficacy|15|||
164535141|NCT01139658|594331625|FG001|Overall Study|Lack of Efficacy|7|||
164535142|NCT01139658|594331624|FG000|Overall Study|Withdrawal by Subject|2|||
164535143|NCT01139658|594331625|FG001|Overall Study|Withdrawal by Subject|4|||
164535144|NCT01139658|594331624|FG000|Overall Study|No documentation of treatment|1|||
164535145|NCT01139658|594331625|FG001|Overall Study|No documentation of treatment|0|||
164535146|NCT01139658|594331624|FG000|Overall Study|Other|28|||
164535147|NCT01139658|594331625|FG001|Overall Study|Other|75|||
164535148|NCT00753272|594331633|FG000|Overall Study|Adverse Event|878|||
164535149|NCT00753272|594331634|FG001|Overall Study|Adverse Event|869|||
164535150|NCT00753272|594331633|FG000|Overall Study|Protocol Violation|28|||
164535151|NCT00753272|594331634|FG001|Overall Study|Protocol Violation|46|||
164535152|NCT00753272|594331633|FG000|Overall Study|Withdrawal by Subject|2481|||
164535153|NCT00753272|594331634|FG001|Overall Study|Withdrawal by Subject|2407|||
164535154|NCT00753272|594331633|FG000|Overall Study|Lost to Follow-up|491|||
164535155|NCT00753272|594331634|FG001|Overall Study|Lost to Follow-up|497|||
164535156|NCT00753272|594331633|FG000|Overall Study|Other|1104|||
164535157|NCT00753272|594331634|FG001|Overall Study|Other|1088|||
164535158|NCT00803270|594331635|FG000|Overall Study|Lost to Follow-up|1|||
164535159|NCT00803270|594331636|FG001|Overall Study|Lost to Follow-up|2|||
164535160|NCT01966471|594331637|FG000|Overall Study|Death|44|||
164535161|NCT01966471|594331638|FG001|Overall Study|Death|56|||
164535162|NCT01966471|594331637|FG000|Overall Study|Lost to Follow-up|46|||
164535163|NCT01966471|594331638|FG001|Overall Study|Lost to Follow-up|39|||
164535164|NCT01966471|594331637|FG000|Overall Study|Various reasons|4|||
164535165|NCT01966471|594331638|FG001|Overall Study|Various reasons|4|||
164535166|NCT01966471|594331637|FG000|Overall Study|Physician Decision|7|||
164535167|NCT01966471|594331638|FG001|Overall Study|Physician Decision|5|||
164535168|NCT01966471|594331637|FG000|Overall Study|Study Terminated By Sponsor|758|||
164535169|NCT01966471|594331638|FG001|Overall Study|Study Terminated By Sponsor|773|||
164535170|NCT01966471|594331637|FG000|Overall Study|Withdrawal by Subject|59|||
164535171|NCT01966471|594331638|FG001|Overall Study|Withdrawal by Subject|51|||
164535172|NCT02092220|594331641|FG000|Period 1|Unrelated Illness|0|||
164535173|NCT02092220|594331642|FG001|Period 1|Unrelated Illness|2|||
164535174|NCT02092220|594331641|FG000|Period 2|Severe Hypoglycaemia|1|||
164535175|NCT02092220|594331642|FG001|Period 2|Severe Hypoglycaemia|0|||
164535176|NCT02092220|594331641|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
164535177|NCT02092220|594331642|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
164535178|NCT00960531|594331643|FG000|Overall Study|Lack of Efficacy|1|||
164535179|NCT00960531|594331644|FG001|Overall Study|Lack of Efficacy|0|||
164535180|NCT00960531|594331645|FG002|Overall Study|Lack of Efficacy|0|||
164535181|NCT00960531|594331646|FG003|Overall Study|Lack of Efficacy|0|||
164535182|NCT00960531|594331647|FG004|Overall Study|Lack of Efficacy|0|||
164535183|NCT00960531|594331648|FG005|Overall Study|Lack of Efficacy|0|||
164535184|NCT00960531|594331649|FG006|Overall Study|Lack of Efficacy|0|||
164535185|NCT00960531|594331650|FG007|Overall Study|Lack of Efficacy|0|||
164535186|NCT00960531|594331651|FG008|Overall Study|Lack of Efficacy|0|||
164535187|NCT00960531|594331652|FG009|Overall Study|Lack of Efficacy|0|||
164535188|NCT00960531|594331643|FG000|Overall Study|Withdrawal by Subject|1|||
164535189|NCT00960531|594331644|FG001|Overall Study|Withdrawal by Subject|0|||
164535190|NCT00960531|594331645|FG002|Overall Study|Withdrawal by Subject|5|||
164535191|NCT00960531|594331646|FG003|Overall Study|Withdrawal by Subject|2|||
164535192|NCT00960531|594331647|FG004|Overall Study|Withdrawal by Subject|0|||
164535193|NCT00960531|594331648|FG005|Overall Study|Withdrawal by Subject|0|||
164535194|NCT00960531|594331649|FG006|Overall Study|Withdrawal by Subject|2|||
164535195|NCT00960531|594331650|FG007|Overall Study|Withdrawal by Subject|0|||
164535196|NCT00960531|594331651|FG008|Overall Study|Withdrawal by Subject|1|||
164535197|NCT00960531|594331652|FG009|Overall Study|Withdrawal by Subject|0|||
164535198|NCT00960531|594331643|FG000|Overall Study|Caregiver Request|2|||
164535199|NCT00960531|594331644|FG001|Overall Study|Caregiver Request|0|||
164535200|NCT00960531|594331645|FG002|Overall Study|Caregiver Request|6|||
164535201|NCT00960531|594331646|FG003|Overall Study|Caregiver Request|5|||
164535202|NCT00960531|594331647|FG004|Overall Study|Caregiver Request|0|||
164535203|NCT00960531|594331648|FG005|Overall Study|Caregiver Request|2|||
164535204|NCT00960531|594331649|FG006|Overall Study|Caregiver Request|3|||
164535205|NCT00960531|594331650|FG007|Overall Study|Caregiver Request|1|||
164535206|NCT00960531|594331651|FG008|Overall Study|Caregiver Request|3|||
164535207|NCT00960531|594331652|FG009|Overall Study|Caregiver Request|0|||
164535208|NCT00960531|594331643|FG000|Overall Study|Investigator Request|0|||
164535209|NCT00960531|594331644|FG001|Overall Study|Investigator Request|0|||
164535210|NCT00960531|594331645|FG002|Overall Study|Investigator Request|1|||
164535211|NCT00960531|594331646|FG003|Overall Study|Investigator Request|0|||
164535212|NCT00960531|594331647|FG004|Overall Study|Investigator Request|0|||
164535213|NCT00960531|594331648|FG005|Overall Study|Investigator Request|0|||
164535214|NCT00960531|594331649|FG006|Overall Study|Investigator Request|0|||
164535215|NCT00960531|594331650|FG007|Overall Study|Investigator Request|0|||
164535216|NCT00960531|594331651|FG008|Overall Study|Investigator Request|0|||
164535217|NCT00960531|594331652|FG009|Overall Study|Investigator Request|0|||
164535218|NCT00960531|594331643|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
164535219|NCT00960531|594331644|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
164535220|NCT00960531|594331645|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
164535221|NCT00960531|594331646|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
164535222|NCT00960531|594331647|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
164535223|NCT00960531|594331648|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
164535224|NCT00960531|594331649|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
164535225|NCT00960531|594331650|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
164535226|NCT00960531|594331651|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
164535227|NCT00960531|594331652|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
164535228|NCT00960531|594331643|FG000|Overall Study|Lost to Follow-up|0|||
164535229|NCT00960531|594331644|FG001|Overall Study|Lost to Follow-up|0|||
164535230|NCT00960531|594331645|FG002|Overall Study|Lost to Follow-up|1|||
164535231|NCT00960531|594331646|FG003|Overall Study|Lost to Follow-up|0|||
164535232|NCT00960531|594331647|FG004|Overall Study|Lost to Follow-up|0|||
164535233|NCT00960531|594331648|FG005|Overall Study|Lost to Follow-up|0|||
164535234|NCT00960531|594331649|FG006|Overall Study|Lost to Follow-up|1|||
164535235|NCT00960531|594331650|FG007|Overall Study|Lost to Follow-up|0|||
164535236|NCT00960531|594331651|FG008|Overall Study|Lost to Follow-up|0|||
164535237|NCT00960531|594331652|FG009|Overall Study|Lost to Follow-up|0|||
164535238|NCT00960531|594331643|FG000|Overall Study|Failed to Return|2|||
164535239|NCT00960531|594331644|FG001|Overall Study|Failed to Return|0|||
164535240|NCT00960531|594331645|FG002|Overall Study|Failed to Return|0|||
164535241|NCT00960531|594331646|FG003|Overall Study|Failed to Return|0|||
164535242|NCT00960531|594331647|FG004|Overall Study|Failed to Return|0|||
164535243|NCT00960531|594331648|FG005|Overall Study|Failed to Return|0|||
164535244|NCT00960531|594331649|FG006|Overall Study|Failed to Return|0|||
164535245|NCT00960531|594331650|FG007|Overall Study|Failed to Return|2|||
164535246|NCT00960531|594331651|FG008|Overall Study|Failed to Return|0|||
164535247|NCT00960531|594331652|FG009|Overall Study|Failed to Return|0|||
164535248|NCT00960531|594331643|FG000|Overall Study|Adverse Event (AE)|2|||
164535249|NCT00960531|594331644|FG001|Overall Study|Adverse Event (AE)|0|||
164535250|NCT00960531|594331645|FG002|Overall Study|Adverse Event (AE)|0|||
164535251|NCT00960531|594331646|FG003|Overall Study|Adverse Event (AE)|0|||
164535252|NCT00960531|594331647|FG004|Overall Study|Adverse Event (AE)|0|||
164535253|NCT00960531|594331648|FG005|Overall Study|Adverse Event (AE)|1|||
164535254|NCT00960531|594331649|FG006|Overall Study|Adverse Event (AE)|2|||
164535255|NCT00960531|594331650|FG007|Overall Study|Adverse Event (AE)|0|||
164535256|NCT00960531|594331651|FG008|Overall Study|Adverse Event (AE)|2|||
164535257|NCT00960531|594331652|FG009|Overall Study|Adverse Event (AE)|0|||
164535258|NCT00960531|594331643|FG000|Overall Study|Reason not Specified|2|||
164535259|NCT00960531|594331644|FG001|Overall Study|Reason not Specified|1|||
164535260|NCT00960531|594331645|FG002|Overall Study|Reason not Specified|13|||
164535261|NCT00960531|594331646|FG003|Overall Study|Reason not Specified|1|||
164535262|NCT00960531|594331647|FG004|Overall Study|Reason not Specified|2|||
164535263|NCT00960531|594331648|FG005|Overall Study|Reason not Specified|0|||
164535264|NCT00960531|594331649|FG006|Overall Study|Reason not Specified|16|||
164535265|NCT00960531|594331650|FG007|Overall Study|Reason not Specified|0|||
164535266|NCT00960531|594331651|FG008|Overall Study|Reason not Specified|8|||
164535267|NCT00960531|594331652|FG009|Overall Study|Reason not Specified|1|||
164535268|NCT00593957|594331653|FG000|Overall Study|Physician Decision|0|||
164535269|NCT00593957|594331654|FG001|Overall Study|Physician Decision|1|||
164535270|NCT00593957|594331655|FG002|Overall Study|Physician Decision|2|||
164535271|NCT00494481|594331658|FG000|Overall Study|Condition under investigation worsened|11|||
164535272|NCT00494481|594331659|FG001|Overall Study|Condition under investigation worsened|13|||
164535273|NCT00494481|594331658|FG000|Overall Study|Adverse Event|15|||
164535274|NCT00494481|594331659|FG001|Overall Study|Adverse Event|11|||
164535275|NCT00494481|594331658|FG000|Overall Study|Other|1|||
164535276|NCT00494481|594331659|FG001|Overall Study|Other|0|||
164535277|NCT00494481|594331658|FG000|Overall Study|Never received IP|2|||
164535278|NCT00494481|594331659|FG001|Overall Study|Never received IP|0|||
164535279|NCT01030198|594331660|FG000|Overall Study|Could not measure efficacy accurately|0|||
164535280|NCT01030198|594331661|FG001|Overall Study|Could not measure efficacy accurately|7|||
164535281|NCT01411839|594331663|FG000|Overall Study|Lost to Follow-up|4|||
164535282|NCT01411839|594331664|FG001|Overall Study|Lost to Follow-up|3|||
164535283|NCT05089656|594331668|FG000|Period 1 - First Intervention (52 weeks)|Physician Decision|1|||
164535284|NCT05089656|594331669|FG001|Period 1 - First Intervention (52 weeks)|Physician Decision|0|||
164535285|NCT05089656|594331668|FG000|Period 1 - First Intervention (52 weeks)|Guardian decision|1|||
164535286|NCT05089656|594331669|FG001|Period 1 - First Intervention (52 weeks)|Guardian decision|0|||
164535287|NCT05089656|594331668|FG000|Period 1 - First Intervention (52 weeks)|Adverse Event|0|||
164535288|NCT05089656|594331669|FG001|Period 1 - First Intervention (52 weeks)|Adverse Event|1|||
164535289|NCT05089656|594331668|FG000|Period 1 - First Intervention (52 weeks)|Protocol-specified withdrawal criterion met|6|||
164535290|NCT05089656|594331669|FG001|Period 1 - First Intervention (52 weeks)|Protocol-specified withdrawal criterion met|4|||
164535291|NCT02535416|594331670|FG000|Overall Study|Family bereavement overseas|1|||
164535292|NCT02535416|594331671|FG001|Overall Study|Family bereavement overseas|0|||
164535293|NCT02535416|594331672|FG002|Overall Study|Family bereavement overseas|0|||
164535294|NCT02535416|594331673|FG003|Overall Study|Family bereavement overseas|0|||
164535295|NCT02535416|594331674|FG004|Overall Study|Family bereavement overseas|0|||
164535296|NCT02535416|594331675|FG005|Overall Study|Family bereavement overseas|0|||
164535297|NCT02535416|594331676|FG006|Overall Study|Family bereavement overseas|0|||
164535298|NCT02535416|594331677|FG007|Overall Study|Family bereavement overseas|0|||
164535299|NCT02535416|594331678|FG008|Overall Study|Family bereavement overseas|0|||
164535300|NCT01890148|594334034|FG000|Overall Study|Adverse Event|1|||
164535301|NCT05104476|594334042|FG000|Overall Study|Randomized But Not Treated|1|||
164535302|NCT05104476|594334043|FG001|Overall Study|Randomized But Not Treated|2|||
164535303|NCT05104476|594334042|FG000|Overall Study|Adverse Event|2|||
164535304|NCT05104476|594334043|FG001|Overall Study|Adverse Event|2|||
164535305|NCT05104476|594334042|FG000|Overall Study|Withdrawal by Subject|3|||
164535306|NCT05104476|594334043|FG001|Overall Study|Withdrawal by Subject|3|||
164535307|NCT05104476|594334042|FG000|Overall Study|Other Than Specified|0|||
164535308|NCT05104476|594334043|FG001|Overall Study|Other Than Specified|3|||
164535309|NCT04658186|594334046|FG000|Overall Study|Adverse Event|4|||
164535310|NCT04658186|594334047|FG001|Overall Study|Adverse Event|18|||
164535311|NCT04658186|594334048|FG002|Overall Study|Adverse Event|15|||
164535312|NCT04658186|594334046|FG000|Overall Study|Lack of Efficacy|1|||
164535313|NCT04658186|594334047|FG001|Overall Study|Lack of Efficacy|1|||
164535314|NCT04658186|594334048|FG002|Overall Study|Lack of Efficacy|0|||
164535315|NCT04658186|594334046|FG000|Overall Study|Protocol Violation|0|||
164535316|NCT04658186|594334047|FG001|Overall Study|Protocol Violation|0|||
164535317|NCT04658186|594334048|FG002|Overall Study|Protocol Violation|1|||
164535318|NCT04658186|594334046|FG000|Overall Study|Lost to Follow-up|0|||
164535319|NCT04658186|594334047|FG001|Overall Study|Lost to Follow-up|0|||
164535320|NCT04658186|594334048|FG002|Overall Study|Lost to Follow-up|2|||
164535321|NCT04658186|594334046|FG000|Overall Study|Participant Not Eligible. Randomized In Error|1|||
164535322|NCT04658186|594334047|FG001|Overall Study|Participant Not Eligible. Randomized In Error|0|||
164535323|NCT04658186|594334048|FG002|Overall Study|Participant Not Eligible. Randomized In Error|1|||
164535324|NCT04658186|594334046|FG000|Overall Study|Participant is Moving in Another Province|0|||
164535325|NCT04658186|594334047|FG001|Overall Study|Participant is Moving in Another Province|1|||
164535326|NCT04658186|594334048|FG002|Overall Study|Participant is Moving in Another Province|0|||
164535327|NCT04658186|594334046|FG000|Overall Study|Non-Compliance|0|||
164535328|NCT04658186|594334047|FG001|Overall Study|Non-Compliance|1|||
164535329|NCT04658186|594334048|FG002|Overall Study|Non-Compliance|1|||
164535330|NCT04658186|594334046|FG000|Overall Study|Site Closure; Participant declined transfer|0|||
164535331|NCT04658186|594334047|FG001|Overall Study|Site Closure; Participant declined transfer|1|||
164535332|NCT04658186|594334048|FG002|Overall Study|Site Closure; Participant declined transfer|0|||
164535333|NCT04658186|594334046|FG000|Overall Study|Dropout on the Promotor's Decision|0|||
164535334|NCT04658186|594334047|FG001|Overall Study|Dropout on the Promotor's Decision|0|||
164535335|NCT04658186|594334048|FG002|Overall Study|Dropout on the Promotor's Decision|1|||
164535336|NCT04658186|594334046|FG000|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
164535337|NCT04658186|594334047|FG001|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
164535338|NCT04658186|594334048|FG002|Overall Study|Worsening Symptoms; Participant Withdrew|1|||
164535339|NCT04658186|594334046|FG000|Overall Study|PI Decision due to Participant Safety|0|||
164535340|NCT04658186|594334047|FG001|Overall Study|PI Decision due to Participant Safety|0|||
164535341|NCT04658186|594334048|FG002|Overall Study|PI Decision due to Participant Safety|1|||
164535342|NCT04658186|594334046|FG000|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|5|||
164535343|NCT04658186|594334047|FG001|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|6|||
164535344|NCT04658186|594334048|FG002|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|3|||
164535345|NCT04098068|594334049|FG000|Overall Study|Disease Progression|7|||
164535346|NCT04098068|594334049|FG000|Overall Study|Withdrawal by Subject|2|||
164535347|NCT04098068|594334049|FG000|Overall Study|New Cancer Diagnosis|1|||
164535348|NCT00744523|594334050|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
164535349|NCT00744523|594334051|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
164535350|NCT03588728|594334055|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
164535351|NCT03588728|594334056|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
164535352|NCT03588728|594334057|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
164535353|NCT03588728|594334058|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
164535354|NCT03588728|594334055|FG000|Overall Study|Lab shut down due to COVID-19|0|||
164535355|NCT03588728|594334056|FG001|Overall Study|Lab shut down due to COVID-19|0|||
164535356|NCT03588728|594334057|FG002|Overall Study|Lab shut down due to COVID-19|0|||
164535357|NCT03588728|594334058|FG003|Overall Study|Lab shut down due to COVID-19|1|||
164535358|NCT03588728|594334055|FG000|Overall Study|multiple technical issues|1|||
164535359|NCT03588728|594334056|FG001|Overall Study|multiple technical issues|0|||
164535360|NCT03588728|594334057|FG002|Overall Study|multiple technical issues|0|||
164535361|NCT03588728|594334058|FG003|Overall Study|multiple technical issues|0|||
164535362|NCT03588728|594334055|FG000|Overall Study|Hospitalized for COVID|1|||
164535363|NCT03588728|594334056|FG001|Overall Study|Hospitalized for COVID|0|||
164535364|NCT03588728|594334057|FG002|Overall Study|Hospitalized for COVID|0|||
164535365|NCT03588728|594334058|FG003|Overall Study|Hospitalized for COVID|0|||
164535366|NCT03588728|594334055|FG000|Overall Study|Schedule change unable to attend sessions|1|||
164535367|NCT03588728|594334056|FG001|Overall Study|Schedule change unable to attend sessions|0|||
164535368|NCT03588728|594334057|FG002|Overall Study|Schedule change unable to attend sessions|0|||
164535369|NCT03588728|594334058|FG003|Overall Study|Schedule change unable to attend sessions|0|||
164535370|NCT01388790|594334059|FG000|Overall Study|Ongoing at data cut-off date|8|||
164535371|NCT00528866|594334060|FG000|Overall Study|Protocol Violation|6|||
164535372|NCT00993915|594334061|FG000|Overall Study|Insufficient clinical response|3|||
164535373|NCT00993915|594334061|FG000|Overall Study|Withdrawal by Subject|2|||
164535374|NCT00993915|594334061|FG000|Overall Study|Other|1|||
164535375|NCT00993915|594334061|FG000|Overall Study|Ongoing|3|||
164535376|NCT01386658|594334062|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
164535377|NCT01386658|594334063|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
164535378|NCT01386658|594334062|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
164535379|NCT01386658|594334063|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
164535380|NCT02465463|594334064|FG000|Overall Study|Lost to Follow-up|2|||
164535381|NCT02465463|594334065|FG001|Overall Study|Lost to Follow-up|1|||
164535382|NCT02465463|594334064|FG000|Overall Study|Death|1|||
164535383|NCT02465463|594334065|FG001|Overall Study|Death|0|||
164535384|NCT02465463|594334064|FG000|Overall Study|Protocol Violation|1|||
164535385|NCT02465463|594334065|FG001|Overall Study|Protocol Violation|0|||
164535386|NCT00323297|594334068|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
164535387|NCT00323297|594334069|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
164535388|NCT00323297|594334068|FG000|Part A (Double Blind Randomized)|Death|0|||
164535389|NCT00323297|594334069|FG001|Part A (Double Blind Randomized)|Death|1|||
164535390|NCT00323297|594334068|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
164535391|NCT00323297|594334069|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
164535392|NCT00323297|594334068|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
164535393|NCT00323297|594334069|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
164535394|NCT00323297|594334068|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
164535395|NCT00323297|594334069|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
164535396|NCT00323297|594334068|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
164535397|NCT00323297|594334069|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
164535398|NCT00323297|594334068|FG000|Part B (Open-label)|Death|0|||
164535399|NCT00323297|594334069|FG001|Part B (Open-label)|Death|1|||
164535400|NCT00323297|594334068|FG000|Part B (Open-label)|Reason unspecified|0|||
164535401|NCT00323297|594334069|FG001|Part B (Open-label)|Reason unspecified|1|||
164535402|NCT00323297|594334068|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
164535403|NCT00323297|594334069|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
164535404|NCT00323297|594334068|FG000|Part B (Open-label)|Lack of Efficacy|3|||
164535405|NCT00323297|594334069|FG001|Part B (Open-label)|Lack of Efficacy|1|||
164535406|NCT00323297|594334068|FG000|Part B (Open-label)|Adverse Event|5|||
164535407|NCT00323297|594334069|FG001|Part B (Open-label)|Adverse Event|5|||
164535408|NCT00323297|594334068|FG000|Part B (Open-label)|Protocol Violation|0|||
164535409|NCT00323297|594334069|FG001|Part B (Open-label)|Protocol Violation|1|||
164535410|NCT01749540|594334072|FG000|Overall Study|Protocol Violation|0|||
164535411|NCT01749540|594334073|FG001|Overall Study|Protocol Violation|0|||
164535412|NCT01749540|594334074|FG002|Overall Study|Protocol Violation|0|||
164535413|NCT01749540|594334075|FG003|Overall Study|Protocol Violation|0|||
164535414|NCT01749540|594334076|FG004|Overall Study|Protocol Violation|0|||
164535415|NCT01749540|594334077|FG005|Overall Study|Protocol Violation|1|||
164535416|NCT01749540|594334078|FG006|Overall Study|Protocol Violation|1|||
164535417|NCT01749540|594334072|FG000|Overall Study|Withdrawal by Subject|0|||
164535418|NCT01749540|594334073|FG001|Overall Study|Withdrawal by Subject|0|||
164535419|NCT01749540|594334074|FG002|Overall Study|Withdrawal by Subject|0|||
164535420|NCT01749540|594334075|FG003|Overall Study|Withdrawal by Subject|1|||
164535421|NCT01749540|594334076|FG004|Overall Study|Withdrawal by Subject|0|||
164535422|NCT01749540|594334077|FG005|Overall Study|Withdrawal by Subject|0|||
164535423|NCT01749540|594334078|FG006|Overall Study|Withdrawal by Subject|0|||
164535424|NCT01749540|594334072|FG000|Overall Study|Initiated into extension study A536-06|0|||
164535425|NCT01749540|594334073|FG001|Overall Study|Initiated into extension study A536-06|0|||
164535426|NCT01749540|594334074|FG002|Overall Study|Initiated into extension study A536-06|0|||
164535427|NCT01749540|594334075|FG003|Overall Study|Initiated into extension study A536-06|0|||
164535428|NCT01749540|594334076|FG004|Overall Study|Initiated into extension study A536-06|0|||
164535429|NCT01749540|594334077|FG005|Overall Study|Initiated into extension study A536-06|2|||
164535430|NCT01749540|594334078|FG006|Overall Study|Initiated into extension study A536-06|24|||
164535431|NCT01323634|594334079|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
164535432|NCT01323634|594334080|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
164535433|NCT01323634|594334081|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
164535434|NCT01323634|594334079|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
164535435|NCT01323634|594334080|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
164535436|NCT01323634|594334081|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
164535437|NCT01323634|594334079|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
164535438|NCT01323634|594334080|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
164535439|NCT01323634|594334081|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
164535440|NCT01323634|594334079|FG000|2-week Run-in Period|Physician Decision|5|||
164535441|NCT01323634|594334080|FG001|2-week Run-in Period|Physician Decision|0|||
164535442|NCT01323634|594334081|FG002|2-week Run-in Period|Physician Decision|0|||
164535443|NCT01323634|594334079|FG000|2-week Run-in Period|Protocol Violation|1|||
164420403|NCT02061761|593908731|FG001|Overall Study|Participant no longer meets study criteria|0|||
164420404|NCT02061761|593908732|FG002|Overall Study|Participant no longer meets study criteria|0|||
164420405|NCT02061761|593908733|FG003|Overall Study|Participant no longer meets study criteria|0|||
164420406|NCT02061761|593908734|FG004|Overall Study|Participant no longer meets study criteria|0|||
164420407|NCT02061761|593908735|FG005|Overall Study|Participant no longer meets study criteria|0|||
164420408|NCT02061761|593908736|FG006|Overall Study|Participant no longer meets study criteria|0|||
164420409|NCT02061761|593908737|FG007|Overall Study|Participant no longer meets study criteria|0|||
164420410|NCT02061761|593908738|FG008|Overall Study|Participant no longer meets study criteria|1|||
164420411|NCT02061761|593908730|FG000|Overall Study|Other reasons|0|||
164420412|NCT02061761|593908731|FG001|Overall Study|Other reasons|0|||
164420413|NCT02061761|593908732|FG002|Overall Study|Other reasons|0|||
164420414|NCT02061761|593908733|FG003|Overall Study|Other reasons|0|||
164420415|NCT02061761|593908734|FG004|Overall Study|Other reasons|2|||
164420416|NCT02061761|593908735|FG005|Overall Study|Other reasons|0|||
164420417|NCT02061761|593908736|FG006|Overall Study|Other reasons|0|||
164420418|NCT02061761|593908737|FG007|Overall Study|Other reasons|0|||
164420419|NCT02061761|593908738|FG008|Overall Study|Other reasons|6|||
164420420|NCT01024751|593908739|FG000|Enrolled Participants|Ineligible at baseline|3|||
164420421|NCT01024751|593908740|FG001|Enrolled Participants|Ineligible at baseline|4|||
164420422|NCT01024751|593908739|FG000|Eligible Participants|Withdrawal by Subject|0|||
164420423|NCT01024751|593908740|FG001|Eligible Participants|Withdrawal by Subject|1|||
164420424|NCT01024751|593908739|FG000|Eligible Participants|Lost to Follow-up|0|||
164420425|NCT01024751|593908740|FG001|Eligible Participants|Lost to Follow-up|1|||
164420426|NCT01024751|593908739|FG000|Eligible Participants|Ineligible|0|||
164420427|NCT01024751|593908740|FG001|Eligible Participants|Ineligible|1|||
164420428|NCT03246672|593908745|FG000|Overall Study|Lost to Follow-up|2|||
164420429|NCT03260504|593908746|FG000|Overall Study|Adverse Event|0|||
164420430|NCT03260504|593908747|FG001|Overall Study|Adverse Event|1|||
164420431|NCT00967018|593908748|FG000|Overall Study|Adverse Event|2|||
164420432|NCT00967018|593908748|FG000|Overall Study|Physician Decision|7|||
164420433|NCT00967018|593908748|FG000|Overall Study|Lost to Follow-up|2|||
164420434|NCT00967018|593908748|FG000|Overall Study|Withdrawal by Subject|1|||
164420435|NCT00967018|593908748|FG000|Overall Study|Miscellaneous Reasons|9|||
164420436|NCT01734434|593908751|FG000|Overall Study|Death Infant|3|||
164420437|NCT01734434|593908752|FG001|Overall Study|Death Infant|1|||
164420438|NCT01734434|593908753|FG002|Overall Study|Death Infant|17|||
164420439|NCT01734434|593908754|FG003|Overall Study|Death Infant|5|||
164420440|NCT01734434|593908751|FG000|Overall Study|Lost to Follow-up|2|||
164420441|NCT01734434|593908752|FG001|Overall Study|Lost to Follow-up|9|||
164420442|NCT01734434|593908753|FG002|Overall Study|Lost to Follow-up|67|||
164420443|NCT01734434|593908754|FG003|Overall Study|Lost to Follow-up|11|||
164420444|NCT01734434|593908751|FG000|Overall Study|No Live Birth|1|||
164420445|NCT01734434|593908752|FG001|Overall Study|No Live Birth|2|||
164420446|NCT01734434|593908753|FG002|Overall Study|No Live Birth|32|||
164420447|NCT01734434|593908754|FG003|Overall Study|No Live Birth|6|||
164420448|NCT01734434|593908751|FG000|Overall Study|Withdrawal by Subject|4|||
164420449|NCT01734434|593908752|FG001|Overall Study|Withdrawal by Subject|0|||
164420450|NCT01734434|593908753|FG002|Overall Study|Withdrawal by Subject|8|||
164420451|NCT01734434|593908754|FG003|Overall Study|Withdrawal by Subject|1|||
164420452|NCT01734434|593908751|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
164420453|NCT01734434|593908752|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
164420454|NCT01734434|593908753|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
164420455|NCT01734434|593908754|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
164420456|NCT01734434|593908751|FG000|Overall Study|Subject Not Reachable|0|||
164420457|NCT01734434|593908752|FG001|Overall Study|Subject Not Reachable|0|||
164420458|NCT01734434|593908753|FG002|Overall Study|Subject Not Reachable|1|||
164535444|NCT01323634|594334080|FG001|2-week Run-in Period|Protocol Violation|0|||
164535445|NCT01323634|594334081|FG002|2-week Run-in Period|Protocol Violation|0|||
164420459|NCT01734434|593908754|FG003|Overall Study|Subject Not Reachable|0|||
164420460|NCT01734434|593908751|FG000|Overall Study|Treatment Defaulter|0|||
164420461|NCT01734434|593908752|FG001|Overall Study|Treatment Defaulter|0|||
164535446|NCT01323634|594334079|FG000|2-week Run-in Period|Adverse Event|1|||
164535447|NCT01323634|594334080|FG001|2-week Run-in Period|Adverse Event|0|||
164535448|NCT01323634|594334081|FG002|2-week Run-in Period|Adverse Event|0|||
164535449|NCT01323634|594334079|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
164535450|NCT01323634|594334080|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
164535451|NCT01323634|594334081|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
164535452|NCT01323634|594334079|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164535453|NCT01323634|594334080|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164535454|NCT01323634|594334081|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
164535455|NCT01323634|594334079|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164535456|NCT01323634|594334080|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
164535457|NCT01323634|594334081|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
164535458|NCT01323634|594334079|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164535459|NCT01323634|594334080|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
164535460|NCT01323634|594334081|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
164535461|NCT01323634|594334079|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
164535462|NCT01323634|594334080|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
164535463|NCT01323634|594334081|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
164535464|NCT01323634|594334079|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164535465|NCT01323634|594334080|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
164535466|NCT01323634|594334081|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
164535467|NCT01323634|594334079|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
164535468|NCT01323634|594334080|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
164535469|NCT01323634|594334081|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
164535470|NCT01948908|594334082|FG000|Overall Study|Protocol Violation|1|||
164535471|NCT01948908|594334083|FG001|Overall Study|Protocol Violation|0|||
164535472|NCT01948908|594334084|FG002|Overall Study|Protocol Violation|2|||
164535473|NCT01585987|594334085|FG000|Randomized|Withdrawal by Subject|0|||
164535474|NCT01585987|594334086|FG001|Randomized|Withdrawal by Subject|4|||
164535475|NCT01585987|594334085|FG000|Randomized|No longer met criteria|0|||
164535476|NCT01585987|594334086|FG001|Randomized|No longer met criteria|2|||
164535477|NCT01585987|594334085|FG000|Treated|Disease Progression|39|||
164535478|NCT01585987|594334086|FG001|Treated|Disease Progression|36|||
164535479|NCT01585987|594334085|FG000|Treated|Study Drug Toxicity|9|||
164420462|NCT01734434|593908753|FG002|Overall Study|Treatment Defaulter|1|||
164420463|NCT01734434|593908754|FG003|Overall Study|Treatment Defaulter|0|||
164420464|NCT01734434|593908751|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
164420465|NCT01734434|593908752|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
164420466|NCT01734434|593908753|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
164420467|NCT01734434|593908754|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
164420468|NCT01734434|593908751|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
164420469|NCT01734434|593908752|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
164420470|NCT01734434|593908753|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
164420471|NCT01734434|593908754|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
164420472|NCT02718417|593910943|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
164420473|NCT02718417|593910944|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
164420474|NCT02718417|593910945|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
164420475|NCT02718417|593910943|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
164420476|NCT02718417|593910944|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
164420477|NCT02718417|593910945|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
164420478|NCT02718417|593910943|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
164420479|NCT02718417|593910944|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
164420480|NCT02718417|593910945|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
164420481|NCT02718417|593910943|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
164420482|NCT02718417|593910944|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
164420483|NCT02718417|593910945|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
164420484|NCT02718417|593910943|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
164420485|NCT02718417|593910944|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
164420486|NCT02718417|593910945|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
164420487|NCT02718417|593910943|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
164420488|NCT02718417|593910944|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
164420489|NCT02718417|593910945|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
164420490|NCT02718417|593910943|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
164420491|NCT02718417|593910944|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
164420492|NCT02718417|593910945|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
164420493|NCT02718417|593910943|FG000|Chemotherapy Phase (CP)|Other|2|||
164420494|NCT02718417|593910944|FG001|Chemotherapy Phase (CP)|Other|0|||
164420495|NCT02718417|593910945|FG002|Chemotherapy Phase (CP)|Other|1|||
164420496|NCT02718417|593910943|FG000|Maintenance Phase (MP)|Adverse Event|21|||
164420497|NCT02718417|593910944|FG001|Maintenance Phase (MP)|Adverse Event|26|||
164420498|NCT02718417|593910945|FG002|Maintenance Phase (MP)|Adverse Event|0|||
164420499|NCT02718417|593910943|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
164420500|NCT02718417|593910944|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
164420501|NCT02718417|593910945|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
164420502|NCT02718417|593910943|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
164420503|NCT02718417|593910944|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
164535480|NCT01585987|594334086|FG001|Treated|Study Drug Toxicity|5|||
164535481|NCT01585987|594334085|FG000|Treated|Adverse Event|3|||
164535482|NCT01585987|594334086|FG001|Treated|Adverse Event|0|||
164535483|NCT01585987|594334085|FG000|Treated|Withdrawal by Subject|1|||
164535484|NCT01585987|594334086|FG001|Treated|Withdrawal by Subject|2|||
164535485|NCT01585987|594334085|FG000|Treated|Death|1|||
164535486|NCT01585987|594334086|FG001|Treated|Death|0|||
164535487|NCT01585987|594334085|FG000|Treated|Lost to Follow-up|0|||
164535488|NCT01585987|594334086|FG001|Treated|Lost to Follow-up|1|||
164535489|NCT01585987|594334085|FG000|Treated|Maximum Clinical Benefit|0|||
164535490|NCT01585987|594334086|FG001|Treated|Maximum Clinical Benefit|1|||
164535491|NCT01585987|594334085|FG000|Treated|Non-Specified|1|||
164535492|NCT01585987|594334086|FG001|Treated|Non-Specified|2|||
164535493|NCT01585987|594334085|FG000|Treated|Subject Request|0|||
164535494|NCT01585987|594334086|FG001|Treated|Subject Request|1|||
164535495|NCT01585987|594334085|FG000|Treated|Poor/Non-Compliance|0|||
164535496|NCT01585987|594334086|FG001|Treated|Poor/Non-Compliance|1|||
164535497|NCT03291587|594334087|FG000|Overall Study|Lost to Follow-up|62|||
164535498|NCT03291587|594334088|FG001|Overall Study|Lost to Follow-up|43|||
164535499|NCT03291587|594334087|FG000|Overall Study|Refused to Answer|5|||
164535500|NCT03291587|594334088|FG001|Overall Study|Refused to Answer|2|||
164535501|NCT03291587|594334087|FG000|Overall Study|Death|2|||
164535502|NCT03291587|594334088|FG001|Overall Study|Death|4|||
164535503|NCT03291587|594334087|FG000|Overall Study|Not interested in participating|8|||
164535504|NCT03291587|594334088|FG001|Overall Study|Not interested in participating|6|||
164535505|NCT03291587|594334087|FG000|Overall Study|Too busy to participate|4|||
164535506|NCT03291587|594334088|FG001|Overall Study|Too busy to participate|2|||
164535507|NCT01211522|594334089|FG000|Overall Study|Withdrawal by Subject|3|||
164535508|NCT01211522|594334090|FG001|Overall Study|Withdrawal by Subject|7|||
164535509|NCT01211522|594334091|FG002|Overall Study|Withdrawal by Subject|5|||
164535510|NCT02411578|594334092|FG000|Crossover Trial Phase|Pregnancy|0|||
164535511|NCT02411578|594334093|FG001|Crossover Trial Phase|Pregnancy|1|||
164535512|NCT02973048|594334094|FG000|Overall Study|Epidural catheter insertion failure|1|||
164535513|NCT02973048|594334095|FG001|Overall Study|Epidural catheter insertion failure|0|||
164535514|NCT02973048|594334094|FG000|Overall Study|Withdrawal by Subject|0|||
164535515|NCT02973048|594334095|FG001|Overall Study|Withdrawal by Subject|3|||
164535516|NCT00332189|594334096|FG000|Overall Study|Adverse Event|3|||
164535517|NCT00332189|594334096|FG000|Overall Study|Uncooperative/Noncompliant|3|||
164535518|NCT00332189|594334096|FG000|Overall Study|Withdrawal by Subject|9|||
164535519|NCT00332189|594334096|FG000|Overall Study|Lack of Efficacy|4|||
164535520|NCT00332189|594334096|FG000|Overall Study|Moved out of country|2|||
164535521|NCT02370043|594334097|FG000|Overall Study|Withdrawal by Subject|0|||
164535522|NCT02370043|594334098|FG001|Overall Study|Withdrawal by Subject|0|||
164535523|NCT02370043|594334099|FG002|Overall Study|Withdrawal by Subject|0|||
164535524|NCT02370043|594334100|FG003|Overall Study|Withdrawal by Subject|0|||
164535525|NCT02370043|594334101|FG004|Overall Study|Withdrawal by Subject|1|||
164535526|NCT02370043|594334102|FG005|Overall Study|Withdrawal by Subject|1|||
164535527|NCT01231516|594334103|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
164535528|NCT01231516|594334104|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
164535529|NCT01231516|594334103|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
164535530|NCT01231516|594334104|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
164535531|NCT01231516|594334103|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
164535532|NCT01231516|594334104|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
164535533|NCT01231516|594334103|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
164535534|NCT01231516|594334104|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
164535535|NCT01231516|594334103|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
164535536|NCT01231516|594334104|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
164535537|NCT01231516|594334103|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
164535538|NCT01231516|594334104|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
164535539|NCT01231516|594334103|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
164535540|NCT01231516|594334104|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
164535541|NCT01231516|594334103|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
164535542|NCT01231516|594334104|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
164535543|NCT01231516|594334103|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
164535544|NCT01231516|594334104|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
164535545|NCT01231516|594334103|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
164535546|NCT01231516|594334104|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
164535547|NCT01231516|594334103|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
164535548|NCT01231516|594334104|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
164535549|NCT01231516|594334103|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
164535550|NCT01231516|594334104|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
164535551|NCT01231516|594334103|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
164589060|NCT01070550|594521372|FG000|Overall Study|Death|20|||
164535552|NCT01231516|594334104|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
164535553|NCT01231516|594334103|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
164535554|NCT01231516|594334104|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
164535555|NCT01231516|594334103|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
164535556|NCT01231516|594334104|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
164535557|NCT01231516|594334103|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
164535558|NCT01231516|594334104|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
164535559|NCT01906346|594334105|FG000|Overall Study|AEs|1|||
164535560|NCT02279862|594334108|FG000|Overall Study|Study drug toxicity|3|||
164535561|NCT02279862|594334109|FG001|Overall Study|Study drug toxicity|6|||
164535562|NCT02279862|594334108|FG000|Overall Study|No longer meets criteria|0|||
164535563|NCT02279862|594334109|FG001|Overall Study|No longer meets criteria|1|||
164535564|NCT02279862|594334108|FG000|Overall Study|Administrative reason by sponsor|0|||
164535565|NCT02279862|594334109|FG001|Overall Study|Administrative reason by sponsor|1|||
164535566|NCT02279862|594334108|FG000|Overall Study|Disease progression|5|||
164535567|NCT02279862|594334109|FG001|Overall Study|Disease progression|2|||
164535568|NCT02279862|594334108|FG000|Overall Study|Study closed by sponsor|16|||
164535569|NCT02279862|594334109|FG001|Overall Study|Study closed by sponsor|13|||
164535570|NCT02279862|594334108|FG000|Overall Study|Other|1|||
164535571|NCT02279862|594334109|FG001|Overall Study|Other|2|||
164535572|NCT02279862|594334108|FG000|Overall Study|Withdrawal by Subject|1|||
164535573|NCT02279862|594334109|FG001|Overall Study|Withdrawal by Subject|0|||
164535574|NCT05266586|594334113|FG000|Overall Study|Adverse Event|2|||
164535575|NCT05266586|594334114|FG001|Overall Study|Adverse Event|2|||
164535576|NCT05266586|594334115|FG002|Overall Study|Adverse Event|1|||
164535577|NCT05266586|594334113|FG000|Overall Study|Withdrawal by Subject|1|||
164535578|NCT05266586|594334114|FG001|Overall Study|Withdrawal by Subject|0|||
164535579|NCT05266586|594334115|FG002|Overall Study|Withdrawal by Subject|1|||
164535580|NCT05266586|594334113|FG000|Overall Study|Non-compliance with study drug|0|||
164535581|NCT05266586|594334114|FG001|Overall Study|Non-compliance with study drug|1|||
164535582|NCT05266586|594334115|FG002|Overall Study|Non-compliance with study drug|0|||
164535583|NCT05266586|594334113|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
164648427|NCT00350519|594740161|FG000|Overall Study|Death|0|||
164648428|NCT00350519|594740162|FG001|Overall Study|Death|1|||
164535584|NCT05266586|594334114|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
164535585|NCT05266586|594334115|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
164535586|NCT02225353|594334116|FG000|Overall Study|Lost to Follow-up|0|||
164535587|NCT02225353|594334117|FG001|Overall Study|Lost to Follow-up|1|||
164535588|NCT02225353|594334118|FG002|Overall Study|Lost to Follow-up|3|||
164535589|NCT02225353|594334116|FG000|Overall Study|Protocol Violation|4|||
164535590|NCT02225353|594334117|FG001|Overall Study|Protocol Violation|5|||
164535591|NCT02225353|594334118|FG002|Overall Study|Protocol Violation|12|||
164535592|NCT03707925|594334119|FG000|Overall Study|Inevaluable|1|||
164535593|NCT01193920|594334120|FG000|Overall Study|Withdrawal by Subject|1|||
164535594|NCT01193920|594334121|FG001|Overall Study|Withdrawal by Subject|0|||
164535595|NCT01193920|594334122|FG002|Overall Study|Withdrawal by Subject|5|||
164535596|NCT01193920|594334123|FG003|Overall Study|Withdrawal by Subject|1|||
164535597|NCT01193920|594334124|FG004|Overall Study|Withdrawal by Subject|3|||
164535598|NCT01193920|594334125|FG005|Overall Study|Withdrawal by Subject|1|||
164535599|NCT01193920|594334126|FG006|Overall Study|Withdrawal by Subject|3|||
164535600|NCT01193920|594334127|FG007|Overall Study|Withdrawal by Subject|0|||
164535601|NCT01193920|594334128|FG008|Overall Study|Withdrawal by Subject|1|||
164535602|NCT01193920|594334129|FG009|Overall Study|Withdrawal by Subject|0|||
164535603|NCT01193920|594334120|FG000|Overall Study|Lost to Follow-up|1|||
164535604|NCT01193920|594334121|FG001|Overall Study|Lost to Follow-up|0|||
164535605|NCT01193920|594334122|FG002|Overall Study|Lost to Follow-up|1|||
164535606|NCT01193920|594334123|FG003|Overall Study|Lost to Follow-up|1|||
164535607|NCT01193920|594334124|FG004|Overall Study|Lost to Follow-up|3|||
164535608|NCT01193920|594334125|FG005|Overall Study|Lost to Follow-up|3|||
164535609|NCT01193920|594334126|FG006|Overall Study|Lost to Follow-up|1|||
164535610|NCT01193920|594334127|FG007|Overall Study|Lost to Follow-up|0|||
164535611|NCT01193920|594334128|FG008|Overall Study|Lost to Follow-up|2|||
164535612|NCT01193920|594334129|FG009|Overall Study|Lost to Follow-up|3|||
164648429|NCT00350519|594740161|FG000|Overall Study|Physician Decision|0|||
164648430|NCT00350519|594740162|FG001|Overall Study|Physician Decision|1|||
164648431|NCT00350519|594740161|FG000|Overall Study|Protocol Violation|1|||
164648432|NCT00350519|594740162|FG001|Overall Study|Protocol Violation|2|||
164535613|NCT01193920|594334120|FG000|Overall Study|Protocol Violation|1|||
164535614|NCT01193920|594334121|FG001|Overall Study|Protocol Violation|0|||
164535615|NCT01193920|594334122|FG002|Overall Study|Protocol Violation|0|||
164535616|NCT01193920|594334123|FG003|Overall Study|Protocol Violation|0|||
164535617|NCT01193920|594334124|FG004|Overall Study|Protocol Violation|0|||
164535618|NCT01193920|594334125|FG005|Overall Study|Protocol Violation|0|||
164648433|NCT00350519|594740161|FG000|Overall Study|Withdrawal by Subject|3|||
164648434|NCT00350519|594740162|FG001|Overall Study|Withdrawal by Subject|2|||
164648435|NCT01637961|594740164|FG000|Overall Study|Ineligible: wrong primary|1|||
164648436|NCT01637961|594740164|FG000|Overall Study|Ineligible: inadequate pathology|1|||
164648437|NCT02239601|594740170|FG000|Overall Study|Withdrawal by Subject|3|||
164648438|NCT02239601|594740171|FG001|Overall Study|Withdrawal by Subject|4|||
164648439|NCT02239601|594740170|FG000|Overall Study|Protocol Violation|4|||
164648440|NCT02239601|594740171|FG001|Overall Study|Protocol Violation|2|||
164648441|NCT04682639|594740172|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
164648442|NCT04682639|594740173|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
164648443|NCT04682639|594740174|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
164648444|NCT04682639|594740175|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
164648445|NCT04682639|594740176|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
164648446|NCT04682639|594740172|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
164648447|NCT04682639|594740173|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
164648448|NCT04682639|594740174|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
164648449|NCT04682639|594740175|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164648450|NCT04682639|594740176|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164648451|NCT04682639|594740172|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
164648452|NCT04682639|594740173|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
164648453|NCT04682639|594740174|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164648454|NCT04682639|594740175|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164648455|NCT04682639|594740176|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164648456|NCT04682639|594740172|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
164648457|NCT04682639|594740173|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
164648458|NCT04682639|594740174|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
164648459|NCT04682639|594740175|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
164648460|NCT04682639|594740176|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
164648461|NCT04682639|594740172|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
164648462|NCT04682639|594740173|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
164648463|NCT04682639|594740174|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
164648464|NCT04682639|594740175|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
164648465|NCT04682639|594740176|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
164648466|NCT04682639|594740172|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
164648467|NCT04682639|594740173|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
164648468|NCT04682639|594740174|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
164535619|NCT01193920|594334126|FG006|Overall Study|Protocol Violation|0|||
164648469|NCT04682639|594740175|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
164648470|NCT04682639|594740176|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
164648471|NCT04682639|594740172|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
164648472|NCT04682639|594740173|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
164648473|NCT04682639|594740174|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
164648474|NCT04682639|594740175|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
164648475|NCT04682639|594740176|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
164648476|NCT04682639|594740172|FG000|OLE Period (28 Weeks)|Other|1|||
164648477|NCT04682639|594740173|FG001|OLE Period (28 Weeks)|Other|2|||
164648478|NCT04682639|594740174|FG002|OLE Period (28 Weeks)|Other|0|||
164648479|NCT04682639|594740175|FG003|OLE Period (28 Weeks)|Other|0|||
164648480|NCT04682639|594740176|FG004|OLE Period (28 Weeks)|Other|1|||
164535620|NCT01193920|594334127|FG007|Overall Study|Protocol Violation|0|||
164535621|NCT01193920|594334128|FG008|Overall Study|Protocol Violation|0|||
164535622|NCT01193920|594334129|FG009|Overall Study|Protocol Violation|0|||
164535623|NCT01193920|594334120|FG000|Overall Study|Death|0|||
164535624|NCT01193920|594334121|FG001|Overall Study|Death|0|||
164535625|NCT01193920|594334122|FG002|Overall Study|Death|0|||
164535626|NCT01193920|594334123|FG003|Overall Study|Death|1|||
164535627|NCT01193920|594334124|FG004|Overall Study|Death|0|||
164535628|NCT01193920|594334125|FG005|Overall Study|Death|0|||
164535629|NCT01193920|594334126|FG006|Overall Study|Death|2|||
164535630|NCT01193920|594334127|FG007|Overall Study|Death|3|||
164535631|NCT01193920|594334128|FG008|Overall Study|Death|2|||
164535632|NCT01193920|594334129|FG009|Overall Study|Death|4|||
164535633|NCT01193920|594334120|FG000|Overall Study|Unable to classify|0|||
164535634|NCT01193920|594334121|FG001|Overall Study|Unable to classify|0|||
164535635|NCT01193920|594334122|FG002|Overall Study|Unable to classify|0|||
164535636|NCT01193920|594334123|FG003|Overall Study|Unable to classify|1|||
164535637|NCT01193920|594334124|FG004|Overall Study|Unable to classify|0|||
164535638|NCT01193920|594334125|FG005|Overall Study|Unable to classify|0|||
164535639|NCT01193920|594334126|FG006|Overall Study|Unable to classify|0|||
164535640|NCT01193920|594334127|FG007|Overall Study|Unable to classify|1|||
164535641|NCT01193920|594334128|FG008|Overall Study|Unable to classify|0|||
164535642|NCT01193920|594334129|FG009|Overall Study|Unable to classify|0|||
164535643|NCT03431857|594334130|FG000|Overall Study|Death|6|||
164535644|NCT03431857|594334130|FG000|Overall Study|Lost to Follow-up|41|||
164535645|NCT03431857|594334130|FG000|Overall Study|Adverse Event|6|||
164535646|NCT03431857|594334130|FG000|Overall Study|Withdrawal by Subject|1|||
164535647|NCT01323621|594334131|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
164535648|NCT01323621|594334132|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
164535649|NCT01323621|594334133|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
164535650|NCT01323621|594334131|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
164535651|NCT01323621|594334132|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
164535652|NCT01323621|594334133|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
164535653|NCT01323621|594334131|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
164535654|NCT01323621|594334132|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
164535655|NCT01323621|594334133|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
164535656|NCT01323621|594334131|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
164535657|NCT01323621|594334132|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
164535658|NCT01323621|594334133|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
164535659|NCT01323621|594334131|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
164535660|NCT01323621|594334132|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
164535661|NCT01323621|594334133|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
164535662|NCT01323621|594334131|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
164535663|NCT01323621|594334132|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
164535664|NCT01323621|594334133|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
164535665|NCT01323621|594334131|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
164535666|NCT01323621|594334132|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
164535667|NCT01323621|594334133|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
164535668|NCT01323621|594334131|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
164535669|NCT01323621|594334132|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
164535670|NCT01323621|594334133|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
164535671|NCT01323621|594334131|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
164535672|NCT01323621|594334132|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
164535673|NCT01323621|594334133|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
164535674|NCT01323621|594334131|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164535675|NCT01323621|594334132|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
164535676|NCT01323621|594334133|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164535677|NCT01323621|594334131|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
164535678|NCT01323621|594334132|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
164535679|NCT01323621|594334133|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
164535680|NCT01323621|594334131|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
164535681|NCT01323621|594334132|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
164535682|NCT01323621|594334133|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
164535683|NCT01117857|594334134|FG000|Overall Study|Lost to Follow-up|4|||
164535684|NCT01117857|594334134|FG000|Overall Study|Withdrawal by Subject|4|||
164535685|NCT01117857|594334134|FG000|Overall Study|Physician Decision|1|||
164535686|NCT01119001|594334135|FG000|Overall Study|Withdrawal by Subject|2|||
164535687|NCT00954421|594334136|FG000|Screening|screen failures|3|||
164535688|NCT00954421|594334136|FG000|6 Months of DBS|Withdrawal by Subject|1|||
164535689|NCT00954421|594334136|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
164535690|NCT00403754|594334137|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
164535691|NCT00403754|594334138|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
164535692|NCT00403754|594334139|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
164535693|NCT00403754|594334140|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
164535694|NCT00403754|594334137|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
164535695|NCT00403754|594334138|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
164535696|NCT00403754|594334139|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
164535697|NCT00403754|594334140|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
164535698|NCT03951220|594334147|FG000|Overall Study|Withdrawal by Subject|9|||
164535699|NCT03951220|594334148|FG001|Overall Study|Withdrawal by Subject|2|||
164535700|NCT03951220|594334149|FG002|Overall Study|Withdrawal by Subject|0|||
164535701|NCT05245097|594334150|FG000|Overall Study|Adverse Event|13|||
164535702|NCT05245097|594334151|FG001|Overall Study|Adverse Event|2|||
164535703|NCT05245097|594334150|FG000|Overall Study|Protocol Violation|8|||
164535704|NCT05245097|594334151|FG001|Overall Study|Protocol Violation|6|||
164535705|NCT05245097|594334150|FG000|Overall Study|Withdrawal by Subject|18|||
164535706|NCT05245097|594334151|FG001|Overall Study|Withdrawal by Subject|0|||
164535707|NCT05245097|594334150|FG000|Overall Study|Death|6|||
164535708|NCT05245097|594334151|FG001|Overall Study|Death|7|||
164535709|NCT05245097|594334150|FG000|Overall Study|Physician Decision|6|||
164535710|NCT05245097|594334151|FG001|Overall Study|Physician Decision|0|||
164535711|NCT05245097|594334150|FG000|Overall Study|Relocation|4|||
164535712|NCT05245097|594334151|FG001|Overall Study|Relocation|3|||
164535713|NCT04683731|594334152|FG000|Overall Study|Withdrawal by Subject|1|||
164535714|NCT04683731|594334153|FG001|Overall Study|Withdrawal by Subject|0|||
164589061|NCT01070550|594521373|FG001|Overall Study|Death|4|||
164589062|NCT01070550|594521374|FG002|Overall Study|Death|3|||
164535715|NCT04683731|594334154|FG002|Overall Study|Withdrawal by Subject|3|||
164535716|NCT04683731|594334155|FG003|Overall Study|Withdrawal by Subject|2|||
164535717|NCT04683731|594334152|FG000|Overall Study|Determined patient was not eligible|3|||
164535718|NCT04683731|594334153|FG001|Overall Study|Determined patient was not eligible|3|||
164535719|NCT04683731|594334154|FG002|Overall Study|Determined patient was not eligible|12|||
164535720|NCT04683731|594334155|FG003|Overall Study|Determined patient was not eligible|3|||
164535721|NCT00883051|594334156|FG000|Overall Study|Lost to Follow-up|0|||
164535722|NCT00883051|594334157|FG001|Overall Study|Lost to Follow-up|0|||
164535723|NCT00883051|594334158|FG002|Overall Study|Lost to Follow-up|0|||
164535724|NCT00883051|594334159|FG003|Overall Study|Lost to Follow-up|0|||
164535725|NCT00883051|594334160|FG004|Overall Study|Lost to Follow-up|1|||
164535726|NCT00883051|594334156|FG000|Overall Study|Did not use study medication|24|||
164535727|NCT00883051|594334157|FG001|Overall Study|Did not use study medication|22|||
164535728|NCT00883051|594334158|FG002|Overall Study|Did not use study medication|29|||
164535729|NCT00883051|594334159|FG003|Overall Study|Did not use study medication|29|||
164535730|NCT00883051|594334160|FG004|Overall Study|Did not use study medication|17|||
164535731|NCT03604523|594334163|FG000|Overall Study|Physician Decision|1|||
164535732|NCT03604523|594334164|FG001|Overall Study|Physician Decision|0|||
164535733|NCT00458341|594334165|FG000|Cycle 1|Adverse Event|1|||
164535734|NCT00458341|594334166|FG001|Cycle 1|Adverse Event|0|||
164535735|NCT05461794|594334167|FG000|Overall Study|Withdrawal by Subject|1|||
164535736|NCT05461794|594334168|FG001|Overall Study|Withdrawal by Subject|1|||
164535737|NCT05461794|594334169|FG002|Overall Study|Withdrawal by Subject|3|||
164535738|NCT05461794|594334167|FG000|Overall Study|Study Terminated By Sponsor|18|||
164535739|NCT05461794|594334168|FG001|Overall Study|Study Terminated By Sponsor|13|||
164535740|NCT05461794|594334169|FG002|Overall Study|Study Terminated By Sponsor|16|||
164535741|NCT05461794|594334167|FG000|Overall Study|Death|20|||
164535742|NCT05461794|594334168|FG001|Overall Study|Death|5|||
164535743|NCT05461794|594334169|FG002|Overall Study|Death|19|||
164535744|NCT00810394|594334172|FG000|Overall Study|Withdrawal by Subject|3|||
164535745|NCT00467285|594334175|FG000|Overall Study|Lost to Follow-up|4|||
164535746|NCT00467285|594334176|FG001|Overall Study|Lost to Follow-up|4|||
164535747|NCT03891524|594334177|FG000|Overall Study|Death|0|||
164535748|NCT03891524|594334178|FG001|Overall Study|Death|0|||
164535749|NCT03891524|594334179|FG002|Overall Study|Death|0|||
164535750|NCT03891524|594334180|FG003|Overall Study|Death|0|||
164535751|NCT03891524|594334181|FG004|Overall Study|Death|0|||
164535752|NCT03891524|594334182|FG005|Overall Study|Death|0|||
164535753|NCT03891524|594334183|FG006|Overall Study|Death|0|||
164535754|NCT03891524|594334184|FG007|Overall Study|Death|1|||
164535755|NCT03891524|594334177|FG000|Overall Study|Withdrawal by Subject|0|||
164535756|NCT03891524|594334178|FG001|Overall Study|Withdrawal by Subject|1|||
164535757|NCT03891524|594334179|FG002|Overall Study|Withdrawal by Subject|2|||
164535758|NCT03891524|594334180|FG003|Overall Study|Withdrawal by Subject|1|||
164535759|NCT03891524|594334181|FG004|Overall Study|Withdrawal by Subject|2|||
164535760|NCT03891524|594334182|FG005|Overall Study|Withdrawal by Subject|2|||
164535761|NCT03891524|594334183|FG006|Overall Study|Withdrawal by Subject|2|||
164535762|NCT03891524|594334184|FG007|Overall Study|Withdrawal by Subject|1|||
164535763|NCT01210118|594334185|FG000|Overall Study|Lost to Follow-up|1|||
164535764|NCT01210118|594334186|FG001|Overall Study|Lost to Follow-up|1|||
164535765|NCT01210118|594334185|FG000|Overall Study|Protocol Violation|1|||
164535766|NCT01210118|594334186|FG001|Overall Study|Protocol Violation|1|||
164535767|NCT01210118|594334185|FG000|Overall Study|Spontaneous abortion|1|||
164535768|NCT01210118|594334186|FG001|Overall Study|Spontaneous abortion|3|||
164535769|NCT01079130|594334187|FG000|Overall Study|Adverse Event|1|||
164535770|NCT01079130|594334188|FG001|Overall Study|Adverse Event|1|||
164535771|NCT01079130|594334189|FG002|Overall Study|Adverse Event|0|||
164535772|NCT01079130|594334190|FG003|Overall Study|Adverse Event|1|||
164535773|NCT01079130|594334191|FG004|Overall Study|Adverse Event|5|||
164535774|NCT01079130|594334192|FG005|Overall Study|Adverse Event|1|||
164535775|NCT01079130|594334187|FG000|Overall Study|Administrative problems|1|||
164535776|NCT01079130|594334188|FG001|Overall Study|Administrative problems|3|||
164535777|NCT01079130|594334189|FG002|Overall Study|Administrative problems|0|||
164535778|NCT01079130|594334190|FG003|Overall Study|Administrative problems|0|||
164535779|NCT01079130|594334191|FG004|Overall Study|Administrative problems|0|||
164535780|NCT01079130|594334192|FG005|Overall Study|Administrative problems|1|||
164535781|NCT01079130|594334187|FG000|Overall Study|Withdrawal by Subject|0|||
164535782|NCT01079130|594334188|FG001|Overall Study|Withdrawal by Subject|1|||
164535783|NCT01079130|594334189|FG002|Overall Study|Withdrawal by Subject|0|||
164535784|NCT01079130|594334190|FG003|Overall Study|Withdrawal by Subject|0|||
164535785|NCT01079130|594334191|FG004|Overall Study|Withdrawal by Subject|1|||
164535786|NCT01079130|594334192|FG005|Overall Study|Withdrawal by Subject|3|||
164535787|NCT01079130|594334187|FG000|Overall Study|Protocol deviation|0|||
164535788|NCT01079130|594334188|FG001|Overall Study|Protocol deviation|2|||
164535789|NCT01079130|594334189|FG002|Overall Study|Protocol deviation|1|||
164535790|NCT01079130|594334190|FG003|Overall Study|Protocol deviation|2|||
164535791|NCT01079130|594334191|FG004|Overall Study|Protocol deviation|0|||
164535792|NCT01079130|594334192|FG005|Overall Study|Protocol deviation|0|||
164535793|NCT01079130|594334187|FG000|Overall Study|Abnormal test procedure result(s)|0|||
164535794|NCT01079130|594334188|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164535795|NCT01079130|594334189|FG002|Overall Study|Abnormal test procedure result(s)|0|||
164535796|NCT01079130|594334190|FG003|Overall Study|Abnormal test procedure result(s)|0|||
164535797|NCT01079130|594334191|FG004|Overall Study|Abnormal test procedure result(s)|1|||
164535798|NCT01079130|594334192|FG005|Overall Study|Abnormal test procedure result(s)|0|||
164535799|NCT01079130|594334187|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164535800|NCT01079130|594334188|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164535801|NCT01079130|594334189|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
164535802|NCT01079130|594334190|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
164535803|NCT01079130|594334191|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
164535804|NCT01079130|594334192|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
164535805|NCT01079130|594334187|FG000|Overall Study|Lost to Follow-up|0|||
164535806|NCT01079130|594334188|FG001|Overall Study|Lost to Follow-up|0|||
164535807|NCT01079130|594334189|FG002|Overall Study|Lost to Follow-up|0|||
164535808|NCT01079130|594334190|FG003|Overall Study|Lost to Follow-up|0|||
164535809|NCT01079130|594334191|FG004|Overall Study|Lost to Follow-up|1|||
164535810|NCT01079130|594334192|FG005|Overall Study|Lost to Follow-up|0|||
164535811|NCT01696942|594334199|FG000|Overall Study|Withdrawal by Subject|1|||
164535812|NCT01696942|594334200|FG001|Overall Study|Withdrawal by Subject|0|||
164535813|NCT01696942|594334199|FG000|Overall Study|Protocol Violation|1|||
164535814|NCT01696942|594334200|FG001|Overall Study|Protocol Violation|2|||
164535815|NCT01696942|594334199|FG000|Overall Study|screen failure|0|||
164535816|NCT01696942|594334200|FG001|Overall Study|screen failure|1|||
164535817|NCT01598311|594334201|FG000|Overall Study|Physician Decision|4|||
164535818|NCT01598311|594334202|FG001|Overall Study|Physician Decision|5|||
164535819|NCT01598311|594334201|FG000|Overall Study|Adverse Event|9|||
164535820|NCT01598311|594334202|FG001|Overall Study|Adverse Event|13|||
164535821|NCT01598311|594334201|FG000|Overall Study|Lost to Follow-up|7|||
164648481|NCT04682639|594740172|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
164648482|NCT04682639|594740173|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
164648483|NCT04682639|594740174|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
164648484|NCT04682639|594740175|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
164648485|NCT04682639|594740176|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
164648486|NCT04682639|594740172|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
164648487|NCT04682639|594740173|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
164648488|NCT04682639|594740174|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
164648489|NCT04682639|594740175|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
164648490|NCT04682639|594740176|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
164648491|NCT04682639|594740172|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
164648492|NCT04682639|594740173|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
164648493|NCT04682639|594740174|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
164648494|NCT04682639|594740175|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
164648495|NCT04682639|594740176|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
164648496|NCT04682639|594740172|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
164648497|NCT04682639|594740173|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
164648498|NCT04682639|594740174|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
164648499|NCT04682639|594740175|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
164648500|NCT04682639|594740176|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
164648501|NCT04388527|594740177|FG000|Overall Study|Death|14|||
164648502|NCT04388527|594740177|FG000|Overall Study|Withdrawal by Subject|2|||
164648503|NCT04388527|594740177|FG000|Overall Study|Lost to Follow-up|1|||
164648504|NCT00331773|594740181|FG000|Overall Study|Withdrawal by Subject|6|||
164648505|NCT00331773|594740182|FG001|Overall Study|Withdrawal by Subject|4|||
164648506|NCT00331773|594740181|FG000|Overall Study|Protocol Violation|10|||
164648507|NCT00331773|594740182|FG001|Overall Study|Protocol Violation|3|||
164648508|NCT02773446|594740183|FG000|First Admission|Withdrawal by Subject|0|||
164648509|NCT02773446|594740184|FG001|First Admission|Withdrawal by Subject|0|||
164648510|NCT02773446|594740185|FG002|First Admission|Withdrawal by Subject|0|||
164648511|NCT02773446|594740186|FG003|First Admission|Withdrawal by Subject|1|||
164648512|NCT02773446|594740187|FG004|First Admission|Withdrawal by Subject|0|||
164648513|NCT02773446|594740188|FG005|First Admission|Withdrawal by Subject|0|||
164648514|NCT02773446|594740183|FG000|First Admission|Lost to Follow-up|1|||
164648515|NCT02773446|594740184|FG001|First Admission|Lost to Follow-up|0|||
164648516|NCT02773446|594740185|FG002|First Admission|Lost to Follow-up|0|||
164535822|NCT01598311|594334202|FG001|Overall Study|Lost to Follow-up|12|||
164535823|NCT01598311|594334201|FG000|Overall Study|Withdrawal by Subject|9|||
164535824|NCT01598311|594334202|FG001|Overall Study|Withdrawal by Subject|13|||
164535825|NCT01598311|594334201|FG000|Overall Study|No reason provided.|0|||
164535826|NCT01598311|594334202|FG001|Overall Study|No reason provided.|5|||
164648517|NCT02773446|594740186|FG003|First Admission|Lost to Follow-up|0|||
164648518|NCT02773446|594740187|FG004|First Admission|Lost to Follow-up|0|||
164648519|NCT02773446|594740188|FG005|First Admission|Lost to Follow-up|0|||
164648520|NCT02513459|594740189|FG000|Overall Study|Adverse Event|7|||
164535827|NCT01598311|594334201|FG000|Overall Study|Randomized but never treated|8|||
164648521|NCT02513459|594740189|FG000|Overall Study|Withdrew consent|5|||
164535828|NCT01598311|594334202|FG001|Overall Study|Randomized but never treated|5|||
164535829|NCT01598311|594334201|FG000|Overall Study|Treated but no confirmed CDAD|9|||
164535830|NCT01598311|594334202|FG001|Overall Study|Treated but no confirmed CDAD|8|||
164535831|NCT01598311|594334201|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
164535832|NCT01598311|594334202|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
164535833|NCT03144804|594334203|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
164535834|NCT00959647|594334204|FG000|Overall Study|Adverse Event|2|||
164535835|NCT00959647|594334204|FG000|Overall Study|Progressive disease|6|||
164535836|NCT00959647|594334204|FG000|Overall Study|Study terminated by sponsor|4|||
164535837|NCT00959647|594334204|FG000|Overall Study|Withdrawal by Subject|7|||
164535838|NCT04223856|594334205|FG000|Overall Study|Progressive disease|153|||
164535839|NCT04223856|594334206|FG001|Overall Study|Progressive disease|73|||
164535840|NCT04223856|594334205|FG000|Overall Study|Adverse Event|97|||
164535841|NCT04223856|594334206|FG001|Overall Study|Adverse Event|62|||
164535842|NCT04223856|594334205|FG000|Overall Study|Physician Decision|9|||
164535843|NCT04223856|594334206|FG001|Overall Study|Physician Decision|28|||
164535844|NCT04223856|594334205|FG000|Overall Study|Withdrawal by Subject|22|||
164535845|NCT04223856|594334206|FG001|Overall Study|Withdrawal by Subject|24|||
164535846|NCT04223856|594334205|FG000|Overall Study|Other|7|||
164535847|NCT04223856|594334206|FG001|Overall Study|Other|2|||
164535848|NCT04223856|594334205|FG000|Overall Study|Randomized but not treated|2|||
164535849|NCT04223856|594334206|FG001|Overall Study|Randomized but not treated|11|||
164535850|NCT04223856|594334205|FG000|Overall Study|On-treatment|144|||
164535851|NCT04223856|594334206|FG001|Overall Study|On-treatment|0|||
164535852|NCT06515483|594334207|FG000|Overall Study|Subject withdraw due to family issues|1|||
164535853|NCT06515483|594334208|FG001|Overall Study|Subject withdraw due to family issues|0|||
164535854|NCT00523718|594335834|FG000|Overall Study|Withdrawal by Subject|1|||
164535855|NCT00523718|594335835|FG001|Overall Study|Withdrawal by Subject|0|||
164535856|NCT00523718|594335834|FG000|Overall Study|Protocol Violation|2|||
164535857|NCT00523718|594335835|FG001|Overall Study|Protocol Violation|0|||
164535858|NCT01306890|594335836|FG000|Overall Study|Adverse Event|2|||
164535859|NCT01306890|594335836|FG000|Overall Study|Death|1223|||
164535860|NCT01306890|594335836|FG000|Overall Study|Lost to Follow-up|58|||
164535861|NCT01306890|594335836|FG000|Overall Study|Withdrawal by Subject|88|||
164535862|NCT01306890|594335836|FG000|Overall Study|Unspecified reasons|104|||
164535863|NCT01306890|594335836|FG000|Overall Study|Study Termination|3|||
164535864|NCT01306890|594335836|FG000|Overall Study|No discontinuation documentation|41|||
164535865|NCT02217436|594335837|FG000|Overall Study|Protocol Violation|1|||
164535866|NCT02217436|594335838|FG001|Overall Study|Protocol Violation|1|||
164535867|NCT02217436|594335837|FG000|Overall Study|Incomplete data|0|||
164535868|NCT02217436|594335838|FG001|Overall Study|Incomplete data|1|||
164535869|NCT00234494|594335843|FG000|Overall Study|Protocol Violation|2|||
164535870|NCT02634346|594335847|FG000|Overall Study|Withdrawal by Subject|8|||
164535871|NCT02634346|594335848|FG001|Overall Study|Withdrawal by Subject|9|||
164535872|NCT02634346|594335849|FG002|Overall Study|Withdrawal by Subject|8|||
164535873|NCT02634346|594335847|FG000|Overall Study|Adverse Event|2|||
164535874|NCT02634346|594335848|FG001|Overall Study|Adverse Event|2|||
164535875|NCT02634346|594335849|FG002|Overall Study|Adverse Event|7|||
164535876|NCT02634346|594335847|FG000|Overall Study|Lack of Efficacy|1|||
164535877|NCT02634346|594335848|FG001|Overall Study|Lack of Efficacy|2|||
164535878|NCT02634346|594335849|FG002|Overall Study|Lack of Efficacy|8|||
164535879|NCT02634346|594335847|FG000|Overall Study|Lost to Follow-up|1|||
164535880|NCT02634346|594335848|FG001|Overall Study|Lost to Follow-up|0|||
164535881|NCT02634346|594335849|FG002|Overall Study|Lost to Follow-up|0|||
164535882|NCT02634346|594335847|FG000|Overall Study|Protocol Violation|0|||
164535883|NCT02634346|594335848|FG001|Overall Study|Protocol Violation|1|||
164535884|NCT02634346|594335849|FG002|Overall Study|Protocol Violation|0|||
164535885|NCT02170389|594335850|FG000|Overall Study|Study terminated prior to start of treat|1|||
164535886|NCT00992511|594335851|FG000|Overall Study|Migrated/moved from study area|1|||
164535887|NCT00992511|594335852|FG001|Overall Study|Migrated/moved from study area|0|||
164535888|NCT00992511|594335853|FG002|Overall Study|Migrated/moved from study area|1|||
164535889|NCT00992511|594335854|FG003|Overall Study|Migrated/moved from study area|2|||
164648522|NCT02513459|594740189|FG000|Overall Study|Loss of efficacy|2|||
164648523|NCT02513459|594740189|FG000|Overall Study|Pregnancy|2|||
164535890|NCT00992511|594335851|FG000|Overall Study|Lost to Follow-up|1|||
164648524|NCT02513459|594740189|FG000|Overall Study|Subject decision|2|||
164648525|NCT02513459|594740189|FG000|Overall Study|Lack of response|1|||
164535891|NCT00992511|594335852|FG001|Overall Study|Lost to Follow-up|0|||
164535892|NCT00992511|594335853|FG002|Overall Study|Lost to Follow-up|0|||
164535893|NCT00992511|594335854|FG003|Overall Study|Lost to Follow-up|2|||
164535894|NCT00992511|594335851|FG000|Overall Study|Withdrawal by Subject|0|||
164535895|NCT00992511|594335852|FG001|Overall Study|Withdrawal by Subject|0|||
164535896|NCT00992511|594335853|FG002|Overall Study|Withdrawal by Subject|1|||
164535897|NCT00992511|594335854|FG003|Overall Study|Withdrawal by Subject|1|||
164648526|NCT02513459|594740189|FG000|Overall Study|Reproductive plans|1|||
164535898|NCT01180998|594335860|FG000|Overall Study|Poor Vision|0|||
164535899|NCT01180998|594335861|FG001|Overall Study|Poor Vision|2|||
164535900|NCT01180998|594335862|FG002|Overall Study|Poor Vision|2|||
164535901|NCT01180998|594335860|FG000|Overall Study|Lost to Follow-up|0|||
164535902|NCT01180998|594335861|FG001|Overall Study|Lost to Follow-up|0|||
164535903|NCT01180998|594335862|FG002|Overall Study|Lost to Follow-up|1|||
164535904|NCT01180998|594335860|FG000|Overall Study|Protocol Violation|1|||
164535905|NCT01180998|594335861|FG001|Overall Study|Protocol Violation|2|||
164535906|NCT01180998|594335862|FG002|Overall Study|Protocol Violation|0|||
164535907|NCT01180998|594335860|FG000|Overall Study|Withdrawal by Subject|0|||
164535908|NCT01180998|594335861|FG001|Overall Study|Withdrawal by Subject|0|||
164535909|NCT01180998|594335862|FG002|Overall Study|Withdrawal by Subject|1|||
164535910|NCT01180998|594335860|FG000|Overall Study|Poor comfort|3|||
164535911|NCT01180998|594335861|FG001|Overall Study|Poor comfort|0|||
164535912|NCT01180998|594335862|FG002|Overall Study|Poor comfort|4|||
164535913|NCT01180998|594335860|FG000|Overall Study|Poor lens handling|0|||
164535914|NCT01180998|594335861|FG001|Overall Study|Poor lens handling|0|||
164535915|NCT01180998|594335862|FG002|Overall Study|Poor lens handling|2|||
164535916|NCT03801902|594335863|FG000|Overall Study|Did not receive protocol treatment.|1|||
164535917|NCT03801902|594335864|FG001|Overall Study|Did not receive protocol treatment.|0|||
164535918|NCT03801902|594335865|FG002|Overall Study|Did not receive protocol treatment.|0|||
164535919|NCT03801902|594335866|FG003|Overall Study|Did not receive protocol treatment.|0|||
164535920|NCT04485104|594335869|FG000|Overall Study|Physician Decision|2|||
164535921|NCT04485104|594335870|FG001|Overall Study|Physician Decision|0|||
164535922|NCT04485104|594335869|FG000|Overall Study|Decision by sponsor|0|||
164535923|NCT04485104|594335870|FG001|Overall Study|Decision by sponsor|1|||
164535924|NCT00908232|594335871|FG000|Cycle 1 to 4|Death|5|||
164535925|NCT00908232|594335872|FG001|Cycle 1 to 4|Death|0|||
164535926|NCT00908232|594335873|FG002|Cycle 1 to 4|Death|0|||
164535927|NCT00908232|594335874|FG003|Cycle 1 to 4|Death|0|||
164535928|NCT00908232|594335871|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
164535929|NCT00908232|594335872|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
164535930|NCT00908232|594335873|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
164535931|NCT00908232|594335874|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
164648527|NCT02513459|594740189|FG000|Overall Study|Surgery planned-- not done|1|||
164648528|NCT00923195|594740190|FG000|Overall Study|Death|0|||
164648529|NCT00923195|594740191|FG001|Overall Study|Death|1|||
164648530|NCT00525031|594740192|FG000|Overall Study|Disease Progression|1|||
164648531|NCT00525031|594740193|FG001|Overall Study|Disease Progression|1|||
164648532|NCT01613131|594740194|FG000|Overall Study|Withdrawal by Subject|3|||
164648533|NCT01613131|594740195|FG001|Overall Study|Withdrawal by Subject|5|||
164648534|NCT02454972|594740198|FG000|Overall Study|Progressive disease|17|||
164648535|NCT02454972|594740199|FG001|Overall Study|Progressive disease|16|||
164648536|NCT02454972|594740200|FG002|Overall Study|Progressive disease|59|||
164648537|NCT02454972|594740201|FG003|Overall Study|Progressive disease|23|||
164648538|NCT02454972|594740202|FG004|Overall Study|Progressive disease|16|||
164648539|NCT02454972|594740203|FG005|Overall Study|Progressive disease|12|||
164648540|NCT02454972|594740204|FG006|Overall Study|Progressive disease|19|||
164648541|NCT02454972|594740205|FG007|Overall Study|Progressive disease|27|||
164648542|NCT02454972|594740206|FG008|Overall Study|Progressive disease|0|||
164648543|NCT02454972|594740198|FG000|Overall Study|Death|0|||
164648544|NCT02454972|594740199|FG001|Overall Study|Death|0|||
164648545|NCT02454972|594740200|FG002|Overall Study|Death|5|||
164648546|NCT02454972|594740201|FG003|Overall Study|Death|1|||
164648547|NCT02454972|594740202|FG004|Overall Study|Death|0|||
164648548|NCT02454972|594740203|FG005|Overall Study|Death|0|||
164648549|NCT02454972|594740204|FG006|Overall Study|Death|0|||
164648550|NCT02454972|594740205|FG007|Overall Study|Death|0|||
164648551|NCT02454972|594740206|FG008|Overall Study|Death|95|||
164648552|NCT02454972|594740198|FG000|Overall Study|Physician Decision|0|||
164648553|NCT02454972|594740199|FG001|Overall Study|Physician Decision|1|||
164648554|NCT02454972|594740200|FG002|Overall Study|Physician Decision|2|||
164648555|NCT02454972|594740201|FG003|Overall Study|Physician Decision|1|||
164648556|NCT02454972|594740202|FG004|Overall Study|Physician Decision|2|||
164648557|NCT02454972|594740203|FG005|Overall Study|Physician Decision|0|||
164535932|NCT00908232|594335871|FG000|Cycle 1 to 4|Progressive Disease|6|||
164535933|NCT00908232|594335872|FG001|Cycle 1 to 4|Progressive Disease|0|||
164535934|NCT00908232|594335873|FG002|Cycle 1 to 4|Progressive Disease|0|||
164535935|NCT00908232|594335874|FG003|Cycle 1 to 4|Progressive Disease|0|||
164535936|NCT00908232|594335871|FG000|Cycle 1 to 4|Adverse Event|12|||
164648558|NCT02454972|594740204|FG006|Overall Study|Physician Decision|0|||
164535937|NCT00908232|594335872|FG001|Cycle 1 to 4|Adverse Event|0|||
164535938|NCT00908232|594335873|FG002|Cycle 1 to 4|Adverse Event|0|||
164535939|NCT00908232|594335874|FG003|Cycle 1 to 4|Adverse Event|0|||
164535940|NCT00908232|594335871|FG000|Cycle 1 to 4|Other|1|||
164535941|NCT00908232|594335872|FG001|Cycle 1 to 4|Other|0|||
164648559|NCT02454972|594740205|FG007|Overall Study|Physician Decision|1|||
164648560|NCT02454972|594740206|FG008|Overall Study|Physician Decision|0|||
164648561|NCT02454972|594740198|FG000|Overall Study|Non treatment-related adverse event|2|||
164648562|NCT02454972|594740199|FG001|Overall Study|Non treatment-related adverse event|0|||
164648563|NCT02454972|594740200|FG002|Overall Study|Non treatment-related adverse event|1|||
164648564|NCT02454972|594740201|FG003|Overall Study|Non treatment-related adverse event|0|||
164535942|NCT00908232|594335873|FG002|Cycle 1 to 4|Other|0|||
164535943|NCT00908232|594335874|FG003|Cycle 1 to 4|Other|0|||
164535944|NCT00908232|594335871|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
164535945|NCT00908232|594335872|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
164535946|NCT00908232|594335873|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
164535947|NCT00908232|594335874|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
164535948|NCT00908232|594335871|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
164535949|NCT00908232|594335872|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
164535950|NCT00908232|594335873|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
164535951|NCT00908232|594335874|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
164535952|NCT00908232|594335871|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
164535953|NCT00908232|594335872|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
164535954|NCT00908232|594335873|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
164535955|NCT00908232|594335874|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
164535956|NCT00908232|594335871|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
164535957|NCT00908232|594335872|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
164535958|NCT00908232|594335873|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
164535959|NCT00908232|594335874|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
164535960|NCT00908232|594335871|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
164535961|NCT00908232|594335872|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
164535962|NCT00908232|594335873|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
164535963|NCT00908232|594335874|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
164535964|NCT00908232|594335871|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
164535965|NCT00908232|594335872|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
164535966|NCT00908232|594335873|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
164535967|NCT00908232|594335874|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
164535968|NCT00908232|594335871|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
164535969|NCT00908232|594335872|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
164535970|NCT00908232|594335873|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
164535971|NCT00908232|594335874|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
164535972|NCT00908232|594335871|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
164535973|NCT00908232|594335872|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
164535974|NCT00908232|594335873|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
164535975|NCT00908232|594335874|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
164535976|NCT03153137|594335875|FG000|Overall Study|Lost to Follow-up|1|||
164535977|NCT03153137|594335876|FG001|Overall Study|Lost to Follow-up|0|||
164535978|NCT03153137|594335875|FG000|Overall Study|Withdrawal by Subject|2|||
164535979|NCT03153137|594335876|FG001|Overall Study|Withdrawal by Subject|1|||
164535980|NCT03153137|594335875|FG000|Overall Study|Physician Decision|0|||
164535981|NCT03153137|594335876|FG001|Overall Study|Physician Decision|3|||
164535982|NCT00195507|594335880|FG000|Overall Study|Adverse Event|24|||
164535983|NCT00195507|594335881|FG001|Overall Study|Adverse Event|13|||
164535984|NCT00195507|594335880|FG000|Overall Study|Death|0|||
164535985|NCT00195507|594335881|FG001|Overall Study|Death|1|||
164535986|NCT00195507|594335880|FG000|Overall Study|Failed to Return|4|||
164535987|NCT00195507|594335881|FG001|Overall Study|Failed to Return|3|||
164535988|NCT00195507|594335880|FG000|Overall Study|Physician Decision|1|||
164535989|NCT00195507|594335881|FG001|Overall Study|Physician Decision|2|||
164535990|NCT00195507|594335880|FG000|Overall Study|Lost to Follow-up|3|||
164535991|NCT00195507|594335881|FG001|Overall Study|Lost to Follow-up|2|||
164535992|NCT00195507|594335880|FG000|Overall Study|Protocol Violation|5|||
164535993|NCT00195507|594335881|FG001|Overall Study|Protocol Violation|4|||
164535994|NCT00195507|594335880|FG000|Overall Study|Lack of Efficacy|40|||
164535995|NCT00195507|594335881|FG001|Overall Study|Lack of Efficacy|67|||
164535996|NCT00195507|594335880|FG000|Overall Study|Withdrawal by Subject|16|||
164535997|NCT00195507|594335881|FG001|Overall Study|Withdrawal by Subject|23|||
164535998|NCT00195507|594335880|FG000|Overall Study|Protocol Deviation|6|||
164535999|NCT00195507|594335881|FG001|Overall Study|Protocol Deviation|3|||
164536000|NCT02260882|594335882|FG000|Overall Study|Protocol Violation|0|||
164536001|NCT02260882|594335883|FG001|Overall Study|Protocol Violation|1|||
164536002|NCT00559585|594335889|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
164536003|NCT00559585|594335890|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
164536004|NCT00559585|594335889|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
164536005|NCT00559585|594335890|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
164536006|NCT00559585|594335889|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
164536007|NCT00559585|594335890|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
164536008|NCT00559585|594335889|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
164536009|NCT00559585|594335890|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
164536010|NCT00559585|594335889|FG000|Double Blind ST Period Main Study|Death|1|||
164536011|NCT00559585|594335890|FG001|Double Blind ST Period Main Study|Death|1|||
164536012|NCT00559585|594335889|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
164536013|NCT00559585|594335890|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
164648565|NCT02454972|594740202|FG004|Overall Study|Non treatment-related adverse event|0|||
164648566|NCT02454972|594740203|FG005|Overall Study|Non treatment-related adverse event|1|||
164648567|NCT02454972|594740204|FG006|Overall Study|Non treatment-related adverse event|0|||
164648568|NCT02454972|594740205|FG007|Overall Study|Non treatment-related adverse event|1|||
164648569|NCT02454972|594740206|FG008|Overall Study|Non treatment-related adverse event|0|||
164648570|NCT02454972|594740198|FG000|Overall Study|Treatment-related adverse events|0|||
164648571|NCT02454972|594740199|FG001|Overall Study|Treatment-related adverse events|1|||
164648572|NCT02454972|594740200|FG002|Overall Study|Treatment-related adverse events|1|||
164648573|NCT02454972|594740201|FG003|Overall Study|Treatment-related adverse events|0|||
164648574|NCT02454972|594740202|FG004|Overall Study|Treatment-related adverse events|2|||
164648575|NCT02454972|594740203|FG005|Overall Study|Treatment-related adverse events|0|||
164648576|NCT02454972|594740204|FG006|Overall Study|Treatment-related adverse events|0|||
164648577|NCT02454972|594740205|FG007|Overall Study|Treatment-related adverse events|2|||
164648578|NCT02454972|594740206|FG008|Overall Study|Treatment-related adverse events|0|||
164648579|NCT02454972|594740198|FG000|Overall Study|Patient moves to compassionate use|0|||
164648580|NCT02454972|594740199|FG001|Overall Study|Patient moves to compassionate use|0|||
164648581|NCT02454972|594740200|FG002|Overall Study|Patient moves to compassionate use|0|||
164648582|NCT02454972|594740201|FG003|Overall Study|Patient moves to compassionate use|0|||
164648583|NCT02454972|594740202|FG004|Overall Study|Patient moves to compassionate use|0|||
164648584|NCT02454972|594740203|FG005|Overall Study|Patient moves to compassionate use|0|||
164648585|NCT02454972|594740204|FG006|Overall Study|Patient moves to compassionate use|2|||
164536014|NCT00559585|594335889|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
164536015|NCT00559585|594335890|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
164536016|NCT00559585|594335889|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
164536017|NCT00559585|594335890|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
164536018|NCT00559585|594335889|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
164536019|NCT00559585|594335890|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
164536020|NCT00559585|594335889|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
164536021|NCT00559585|594335890|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
164536022|NCT00559585|594335889|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
164536023|NCT00559585|594335890|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
164536024|NCT00559585|594335889|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
164536025|NCT00559585|594335890|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
164536026|NCT00559585|594335889|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
164536027|NCT00559585|594335890|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
164536028|NCT00559585|594335889|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
164536029|NCT00559585|594335890|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
164536030|NCT00559585|594335889|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
164536031|NCT00559585|594335890|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
164536032|NCT00559585|594335889|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
164536033|NCT00559585|594335890|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
164536034|NCT00559585|594335889|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
164536035|NCT00559585|594335890|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
164536036|NCT00559585|594335889|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
164536037|NCT00559585|594335890|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
164536038|NCT00559585|594335889|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
164536039|NCT00559585|594335890|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
164536040|NCT00559585|594335889|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
164536041|NCT00559585|594335890|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
164536042|NCT00559585|594335889|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
164536043|NCT00559585|594335890|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
164536044|NCT00559585|594335889|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
164536045|NCT00559585|594335890|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
164536046|NCT00559585|594335889|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
164536047|NCT00559585|594335890|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
164536048|NCT00559585|594335889|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
164536049|NCT00559585|594335890|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
164536050|NCT00559585|594335889|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
164536051|NCT00559585|594335890|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
164536052|NCT00559585|594335889|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
164536053|NCT00559585|594335890|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
164648586|NCT02454972|594740205|FG007|Overall Study|Patient moves to compassionate use|0|||
164648587|NCT02454972|594740206|FG008|Overall Study|Patient moves to compassionate use|0|||
164536054|NCT00559585|594335889|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
164536055|NCT00559585|594335890|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
164648588|NCT02454972|594740198|FG000|Overall Study|Withdrawal by Subject|0|||
164648589|NCT02454972|594740199|FG001|Overall Study|Withdrawal by Subject|1|||
164536056|NCT00559585|594335889|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
164536057|NCT00559585|594335890|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
164536058|NCT04209621|594335891|FG000|Overall Study|Death|1|||
164536059|NCT04209621|594335891|FG000|Overall Study|Study Terminated Early|2|||
164536060|NCT00769860|594335894|FG000|Overall Study|Withdrawal by Subject|2|||
164536061|NCT00769860|594335895|FG001|Overall Study|Withdrawal by Subject|0|||
164536062|NCT01106404|594335898|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
164536063|NCT01106404|594335899|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
164536064|NCT01106404|594335898|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
164536065|NCT01106404|594335899|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
164536066|NCT01106404|594335898|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
164536067|NCT01106404|594335899|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
164536068|NCT01106404|594335898|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
164536069|NCT01106404|594335899|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
164536070|NCT01774084|594335900|FG000|Overall Study|Personal reasons|1|||
164536071|NCT01774084|594335901|FG001|Overall Study|Personal reasons|0|||
164536072|NCT03026127|594335905|FG000|CRISP R61|Adverse Event|5|||
164536073|NCT03026127|594335906|FG001|CRISP R61|Adverse Event|0|||
164536074|NCT03026127|594335907|FG002|CRISP R61|Adverse Event|0|||
164536075|NCT03026127|594335905|FG000|CRISP R61|Lost to Follow-up|2|||
164536076|NCT03026127|594335906|FG001|CRISP R61|Lost to Follow-up|0|||
164536077|NCT03026127|594335907|FG002|CRISP R61|Lost to Follow-up|0|||
164536078|NCT03026127|594335905|FG000|CRISP R61|Dropped before therapy|5|||
164536079|NCT03026127|594335906|FG001|CRISP R61|Dropped before therapy|0|||
164536080|NCT03026127|594335907|FG002|CRISP R61|Dropped before therapy|0|||
164536081|NCT03026127|594335905|FG000|CRISP R33|Lost to Follow-up|0|||
164536082|NCT03026127|594335906|FG001|CRISP R33|Lost to Follow-up|5|||
164536083|NCT03026127|594335907|FG002|CRISP R33|Lost to Follow-up|4|||
164536084|NCT03026127|594335905|FG000|CRISP R33|Adverse Event|0|||
164536085|NCT03026127|594335906|FG001|CRISP R33|Adverse Event|9|||
164536086|NCT03026127|594335907|FG002|CRISP R33|Adverse Event|5|||
164536087|NCT03026127|594335905|FG000|CRISP R33|Withdrawal by Subject|0|||
164536088|NCT03026127|594335906|FG001|CRISP R33|Withdrawal by Subject|9|||
164536089|NCT03026127|594335907|FG002|CRISP R33|Withdrawal by Subject|1|||
164536090|NCT03026127|594335905|FG000|CRISP R33|Lack of Efficacy|0|||
164536091|NCT03026127|594335906|FG001|CRISP R33|Lack of Efficacy|3|||
164536092|NCT03026127|594335907|FG002|CRISP R33|Lack of Efficacy|2|||
164536093|NCT03026127|594335905|FG000|CRISP R33|Physician Decision|0|||
164536094|NCT03026127|594335906|FG001|CRISP R33|Physician Decision|3|||
164536095|NCT03026127|594335907|FG002|CRISP R33|Physician Decision|1|||
164536096|NCT03026127|594335905|FG000|CRISP R33|Transportation|0|||
164536097|NCT03026127|594335906|FG001|CRISP R33|Transportation|2|||
164536098|NCT03026127|594335907|FG002|CRISP R33|Transportation|1|||
164536099|NCT01182766|594335908|FG000|Overall Study|Lost to Follow-up|32|||
164536100|NCT01182766|594335909|FG001|Overall Study|Lost to Follow-up|36|||
164536101|NCT01182766|594335910|FG002|Overall Study|Lost to Follow-up|29|||
164536102|NCT01182766|594335908|FG000|Overall Study|Withdrawal by Subject|14|||
164536103|NCT01182766|594335909|FG001|Overall Study|Withdrawal by Subject|3|||
164536104|NCT01182766|594335910|FG002|Overall Study|Withdrawal by Subject|6|||
164536105|NCT01182766|594335908|FG000|Overall Study|Physician Decision|1|||
164536106|NCT01182766|594335909|FG001|Overall Study|Physician Decision|0|||
164536107|NCT01182766|594335910|FG002|Overall Study|Physician Decision|0|||
164536108|NCT01182766|594335908|FG000|Overall Study|Non-compliance|1|||
164536109|NCT01182766|594335909|FG001|Overall Study|Non-compliance|1|||
164536110|NCT01182766|594335910|FG002|Overall Study|Non-compliance|1|||
164536111|NCT03027557|594335911|FG000|Overall Study|Adverse Event|1|||
164536112|NCT03027557|594335912|FG001|Overall Study|Adverse Event|0|||
164536113|NCT03027557|594335913|FG002|Overall Study|Adverse Event|0|||
164536114|NCT02430051|594335916|FG000|Overall Study|Withdrawal by Subject|6|||
164536115|NCT02430051|594335917|FG001|Overall Study|Withdrawal by Subject|3|||
164536116|NCT02430051|594335916|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
164536117|NCT02430051|594335917|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
164536118|NCT02430051|594335916|FG000|Overall Study|Protocol Violation|1|||
164536119|NCT02430051|594335917|FG001|Overall Study|Protocol Violation|0|||
164536120|NCT02030405|594335920|FG000|Overall Study|Withdrawal by Subject|1|||
164536121|NCT02030405|594335920|FG000|Overall Study|Lost to Follow-up|1|||
164536122|NCT02513745|594335924|FG000|Overall Study|Criteria at time of surgery not met.|3|||
164648590|NCT02454972|594740200|FG002|Overall Study|Withdrawal by Subject|5|||
164536123|NCT02513745|594335925|FG001|Overall Study|Criteria at time of surgery not met.|3|||
164536124|NCT00381303|594335926|FG000|Overall Study|Lost to Follow-up|25|||
164536125|NCT00381303|594335927|FG001|Overall Study|Lost to Follow-up|9|||
164536126|NCT00381303|594335926|FG000|Overall Study|AE/HIV-related event|22|||
164536127|NCT00381303|594335927|FG001|Overall Study|AE/HIV-related event|6|||
164536128|NCT00381303|594335926|FG000|Overall Study|Non-Adherence|13|||
164536129|NCT00381303|594335927|FG001|Overall Study|Non-Adherence|6|||
164536130|NCT00381303|594335926|FG000|Overall Study|Withdrawal by Subject|13|||
164536131|NCT00381303|594335927|FG001|Overall Study|Withdrawal by Subject|6|||
164536132|NCT00381303|594335926|FG000|Overall Study|Virologic failure|6|||
164536133|NCT00381303|594335927|FG001|Overall Study|Virologic failure|4|||
164536134|NCT00381303|594335926|FG000|Overall Study|Ineligible to continue the trial|2|||
164536135|NCT00381303|594335927|FG001|Overall Study|Ineligible to continue the trial|1|||
164536136|NCT00381303|594335926|FG000|Overall Study|Pregnancy|2|||
164536137|NCT00381303|594335927|FG001|Overall Study|Pregnancy|0|||
164536138|NCT00381303|594335926|FG000|Overall Study|Physician Decision|1|||
164536139|NCT00381303|594335927|FG001|Overall Study|Physician Decision|0|||
164536140|NCT00381303|594335926|FG000|Overall Study|Physician's decision to close the site|3|||
164536141|NCT00381303|594335927|FG001|Overall Study|Physician's decision to close the site|1|||
164536142|NCT00381303|594335926|FG000|Overall Study|Subject moved out of state|2|||
164536143|NCT00381303|594335927|FG001|Overall Study|Subject moved out of state|0|||
164536144|NCT00381303|594335926|FG000|Overall Study|Subject taking too many different meds|1|||
164536145|NCT00381303|594335927|FG001|Overall Study|Subject taking too many different meds|0|||
164536146|NCT00381303|594335926|FG000|Overall Study|No virologic response by week 12|1|||
164536147|NCT00381303|594335927|FG001|Overall Study|No virologic response by week 12|0|||
164536148|NCT00381303|594335926|FG000|Overall Study|Subject was too busy for appointments|1|||
164536149|NCT00381303|594335927|FG001|Overall Study|Subject was too busy for appointments|0|||
164536150|NCT00381303|594335926|FG000|Overall Study|Subject did not continue visits|1|||
164536151|NCT00381303|594335927|FG001|Overall Study|Subject did not continue visits|0|||
164536152|NCT00381303|594335926|FG000|Overall Study|Subject primary physician's decision|1|||
164536153|NCT00381303|594335927|FG001|Overall Study|Subject primary physician's decision|0|||
164536154|NCT01777269|594335928|FG000|Overall Study|Adverse Event|24|||
164536155|NCT01777269|594335929|FG001|Overall Study|Adverse Event|33|||
164536156|NCT01777269|594335928|FG000|Overall Study|Lack of Efficacy|8|||
164536157|NCT01777269|594335929|FG001|Overall Study|Lack of Efficacy|10|||
164536158|NCT01777269|594335928|FG000|Overall Study|Protocol Violation|4|||
164536159|NCT01777269|594335929|FG001|Overall Study|Protocol Violation|4|||
164648591|NCT02454972|594740201|FG003|Overall Study|Withdrawal by Subject|2|||
164648592|NCT02454972|594740202|FG004|Overall Study|Withdrawal by Subject|3|||
164648593|NCT02454972|594740203|FG005|Overall Study|Withdrawal by Subject|2|||
164648594|NCT02454972|594740204|FG006|Overall Study|Withdrawal by Subject|0|||
164648595|NCT02454972|594740205|FG007|Overall Study|Withdrawal by Subject|1|||
164648596|NCT02454972|594740206|FG008|Overall Study|Withdrawal by Subject|2|||
164648597|NCT02454972|594740198|FG000|Overall Study|Multiple delay/holds on treatment|0|||
164648598|NCT02454972|594740199|FG001|Overall Study|Multiple delay/holds on treatment|0|||
164648599|NCT02454972|594740200|FG002|Overall Study|Multiple delay/holds on treatment|0|||
164648600|NCT02454972|594740201|FG003|Overall Study|Multiple delay/holds on treatment|1|||
164648601|NCT02454972|594740202|FG004|Overall Study|Multiple delay/holds on treatment|0|||
164648602|NCT02454972|594740203|FG005|Overall Study|Multiple delay/holds on treatment|0|||
164648603|NCT02454972|594740204|FG006|Overall Study|Multiple delay/holds on treatment|0|||
164648604|NCT02454972|594740205|FG007|Overall Study|Multiple delay/holds on treatment|0|||
164648605|NCT02454972|594740206|FG008|Overall Study|Multiple delay/holds on treatment|0|||
164648606|NCT02454972|594740198|FG000|Overall Study|Never treated|0|||
164648607|NCT02454972|594740199|FG001|Overall Study|Never treated|0|||
164648608|NCT02454972|594740200|FG002|Overall Study|Never treated|3|||
164648609|NCT02454972|594740201|FG003|Overall Study|Never treated|1|||
164648610|NCT02454972|594740202|FG004|Overall Study|Never treated|1|||
164648611|NCT02454972|594740203|FG005|Overall Study|Never treated|0|||
164648612|NCT02454972|594740204|FG006|Overall Study|Never treated|0|||
164648613|NCT02454972|594740205|FG007|Overall Study|Never treated|0|||
164648614|NCT02454972|594740206|FG008|Overall Study|Never treated|5|||
164648615|NCT02454972|594740198|FG000|Overall Study|Lost to Follow-up|0|||
164648616|NCT02454972|594740199|FG001|Overall Study|Lost to Follow-up|0|||
164648617|NCT02454972|594740200|FG002|Overall Study|Lost to Follow-up|0|||
164648618|NCT02454972|594740201|FG003|Overall Study|Lost to Follow-up|0|||
164648619|NCT02454972|594740202|FG004|Overall Study|Lost to Follow-up|0|||
164648620|NCT02454972|594740203|FG005|Overall Study|Lost to Follow-up|0|||
164648621|NCT02454972|594740204|FG006|Overall Study|Lost to Follow-up|0|||
164648622|NCT02454972|594740205|FG007|Overall Study|Lost to Follow-up|0|||
164648623|NCT02454972|594740206|FG008|Overall Study|Lost to Follow-up|2|||
164648624|NCT02454972|594740198|FG000|Overall Study|Study termination|0|||
164648625|NCT02454972|594740199|FG001|Overall Study|Study termination|0|||
164648626|NCT02454972|594740200|FG002|Overall Study|Study termination|0|||
164648627|NCT02454972|594740201|FG003|Overall Study|Study termination|0|||
164648628|NCT02454972|594740202|FG004|Overall Study|Study termination|0|||
164536160|NCT01777269|594335928|FG000|Overall Study|Participants reached stopping criteria|1|||
164536161|NCT01777269|594335929|FG001|Overall Study|Participants reached stopping criteria|1|||
164536162|NCT01777269|594335928|FG000|Overall Study|Lost to Follow-up|4|||
164648629|NCT02454972|594740203|FG005|Overall Study|Study termination|0|||
164648630|NCT02454972|594740204|FG006|Overall Study|Study termination|0|||
164648631|NCT02454972|594740205|FG007|Overall Study|Study termination|0|||
164648632|NCT02454972|594740206|FG008|Overall Study|Study termination|6|||
164648633|NCT00787566|594740207|FG000|Overall Study|AE related to chemotherapy|0|||
164648634|NCT00787566|594740208|FG001|Overall Study|AE related to chemotherapy|1|||
164536163|NCT01777269|594335929|FG001|Overall Study|Lost to Follow-up|0|||
164536164|NCT01777269|594335928|FG000|Overall Study|Physician Decision|5|||
164648635|NCT00787566|594740209|FG002|Overall Study|AE related to chemotherapy|0|||
164648636|NCT02140164|594740210|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
164648637|NCT01814761|594740215|FG000|Overall Study|Other Reasons|1|||
164648638|NCT01814761|594740216|FG001|Overall Study|Other Reasons|10|||
164648639|NCT01814761|594740215|FG000|Overall Study|Ocular Adverse Event|6|||
164648640|NCT01814761|594740216|FG001|Overall Study|Ocular Adverse Event|15|||
164648641|NCT01814761|594740215|FG000|Overall Study|Lost to Follow-up|1|||
164648642|NCT01814761|594740216|FG001|Overall Study|Lost to Follow-up|5|||
164648643|NCT00775983|594740217|FG000|Overall Study|Protocol Violation|1|||
164648644|NCT00775983|594740218|FG001|Overall Study|Protocol Violation|2|||
164648645|NCT01020305|594740221|FG000|Overall Study|Adverse Event|2|||
164648646|NCT01070966|594740224|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
164648647|NCT01070966|594740224|FG000|Participants for Safety Evaluation|Off-label use|9|||
164648648|NCT01070966|594740224|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
164648649|NCT01070966|594740224|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
164648650|NCT01070966|594740224|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
164648651|NCT01070966|594740224|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
164648652|NCT01070966|594740224|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
164648653|NCT01070966|594740224|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
164648654|NCT01725113|594740225|FG000|Overall Study|Kidney Transplant|1|||
164648655|NCT01725113|594740226|FG001|Overall Study|Kidney Transplant|1|||
164648656|NCT01725113|594740225|FG000|Overall Study|Withdrawal by Subject|0|||
164648657|NCT01725113|594740226|FG001|Overall Study|Withdrawal by Subject|1|||
164648658|NCT02753400|594740228|FG000|Overall Study|Adverse Event|3|||
164648659|NCT02753400|594740229|FG001|Overall Study|Adverse Event|0|||
164648660|NCT02753400|594740228|FG000|Overall Study|Withdrawal by Subject|2|||
164648661|NCT02753400|594740229|FG001|Overall Study|Withdrawal by Subject|1|||
164648662|NCT03989115|594740230|FG000|Overall Study|Withdrawal by Subject|2|||
164648663|NCT03989115|594740231|FG001|Overall Study|Withdrawal by Subject|1|||
164648664|NCT03989115|594740232|FG002|Overall Study|Withdrawal by Subject|3|||
164648665|NCT03989115|594740233|FG003|Overall Study|Withdrawal by Subject|0|||
164648666|NCT03989115|594740234|FG004|Overall Study|Withdrawal by Subject|17|||
164648667|NCT03989115|594740235|FG005|Overall Study|Withdrawal by Subject|1|||
164648668|NCT03989115|594740236|FG006|Overall Study|Withdrawal by Subject|0|||
164648669|NCT03989115|594740237|FG007|Overall Study|Withdrawal by Subject|0|||
164648670|NCT03989115|594740230|FG000|Overall Study|Sponsor decision to terminate the study|1|||
164648671|NCT03989115|594740231|FG001|Overall Study|Sponsor decision to terminate the study|1|||
164648672|NCT03989115|594740232|FG002|Overall Study|Sponsor decision to terminate the study|0|||
164648673|NCT03989115|594740233|FG003|Overall Study|Sponsor decision to terminate the study|1|||
164648674|NCT03989115|594740234|FG004|Overall Study|Sponsor decision to terminate the study|11|||
164648675|NCT03989115|594740235|FG005|Overall Study|Sponsor decision to terminate the study|0|||
164648676|NCT03989115|594740236|FG006|Overall Study|Sponsor decision to terminate the study|2|||
164648677|NCT03989115|594740237|FG007|Overall Study|Sponsor decision to terminate the study|1|||
164648678|NCT03989115|594740230|FG000|Overall Study|Lost to Follow-up|2|||
164648679|NCT03989115|594740231|FG001|Overall Study|Lost to Follow-up|0|||
164648680|NCT03989115|594740232|FG002|Overall Study|Lost to Follow-up|0|||
164648681|NCT03989115|594740233|FG003|Overall Study|Lost to Follow-up|0|||
164648682|NCT03989115|594740234|FG004|Overall Study|Lost to Follow-up|1|||
164648683|NCT03989115|594740235|FG005|Overall Study|Lost to Follow-up|0|||
164648684|NCT03989115|594740236|FG006|Overall Study|Lost to Follow-up|0|||
164648685|NCT03989115|594740237|FG007|Overall Study|Lost to Follow-up|0|||
164648686|NCT03989115|594740230|FG000|Overall Study|Death|2|||
164648687|NCT03989115|594740231|FG001|Overall Study|Death|2|||
164648688|NCT03989115|594740232|FG002|Overall Study|Death|9|||
164648689|NCT03989115|594740233|FG003|Overall Study|Death|6|||
164648690|NCT03989115|594740234|FG004|Overall Study|Death|31|||
164648691|NCT03989115|594740235|FG005|Overall Study|Death|6|||
164648692|NCT03989115|594740236|FG006|Overall Study|Death|2|||
164648693|NCT03989115|594740237|FG007|Overall Study|Death|3|||
164648694|NCT03989115|594740230|FG000|Overall Study|Other|1|||
164648695|NCT03989115|594740231|FG001|Overall Study|Other|2|||
164648696|NCT03989115|594740232|FG002|Overall Study|Other|0|||
164648697|NCT03989115|594740233|FG003|Overall Study|Other|0|||
164648698|NCT03989115|594740234|FG004|Overall Study|Other|5|||
164648699|NCT03989115|594740235|FG005|Overall Study|Other|0|||
164648700|NCT03989115|594740236|FG006|Overall Study|Other|0|||
164648701|NCT03989115|594740237|FG007|Overall Study|Other|0|||
164648702|NCT01415921|594740238|FG000|Overall Study|Adverse Event|0|||
164648703|NCT01415921|594740239|FG001|Overall Study|Adverse Event|1|||
164648704|NCT01415921|594740238|FG000|Overall Study|Physician Decision|1|||
164648705|NCT01415921|594740239|FG001|Overall Study|Physician Decision|1|||
164648706|NCT01415921|594740238|FG000|Overall Study|Withdrawal by Subject|0|||
164648707|NCT01415921|594740239|FG001|Overall Study|Withdrawal by Subject|1|||
164648708|NCT01415921|594740238|FG000|Overall Study|Other|2|||
164648709|NCT01415921|594740239|FG001|Overall Study|Other|0|||
164648710|NCT00697112|594740244|FG000|Overall Study|Adverse Event|8|||
164536165|NCT01777269|594335929|FG001|Overall Study|Physician Decision|2|||
164536166|NCT01777269|594335928|FG000|Overall Study|Withdrawal by Subject|9|||
164536167|NCT01777269|594335929|FG001|Overall Study|Withdrawal by Subject|9|||
164536168|NCT00504881|594335930|FG000|Overall Study|Lack of Efficacy|1|||
164536169|NCT00504881|594335931|FG001|Overall Study|Lack of Efficacy|5|||
164536170|NCT00504881|594335930|FG000|Overall Study|Lost to Follow-up|0|||
164536171|NCT00504881|594335931|FG001|Overall Study|Lost to Follow-up|2|||
164536172|NCT00504881|594335930|FG000|Overall Study|Withdrawal by Subject|1|||
164536173|NCT00504881|594335931|FG001|Overall Study|Withdrawal by Subject|4|||
164536174|NCT00504881|594335930|FG000|Overall Study|Non-Compliance|1|||
164536175|NCT00504881|594335931|FG001|Overall Study|Non-Compliance|0|||
164536176|NCT00504881|594335930|FG000|Overall Study|No Birth Control|0|||
164536177|NCT00504881|594335931|FG001|Overall Study|No Birth Control|1|||
164536178|NCT00504881|594335930|FG000|Overall Study|Safety Visit not performed|0|||
164536179|NCT00504881|594335931|FG001|Overall Study|Safety Visit not performed|1|||
164536180|NCT00504881|594335930|FG000|Overall Study|AE, serious fatal|0|||
164536181|NCT00504881|594335931|FG001|Overall Study|AE, serious fatal|1|||
164536182|NCT00504881|594335930|FG000|Overall Study|SAE, non-fatal|2|||
164536183|NCT00504881|594335931|FG001|Overall Study|SAE, non-fatal|6|||
164536184|NCT00504881|594335930|FG000|Overall Study|AE, non-serious non-fatal|4|||
164536185|NCT00504881|594335931|FG001|Overall Study|AE, non-serious non-fatal|14|||
164536186|NCT00504881|594335930|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
164536187|NCT00504881|594335931|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
164536188|NCT00504881|594335930|FG000|Overall Study|AE of unknown type|1|||
164536189|NCT00504881|594335931|FG001|Overall Study|AE of unknown type|0|||
164536190|NCT01009554|594335936|FG000|Overall Study|Adverse Event|1|||
164536191|NCT01009554|594335937|FG001|Overall Study|Adverse Event|1|||
164536192|NCT01009554|594335936|FG000|Overall Study|Withdrawal by Subject|1|||
164536193|NCT01009554|594335937|FG001|Overall Study|Withdrawal by Subject|3|||
164536194|NCT01009554|594335936|FG000|Overall Study|Noncompliant with Study Product|0|||
164536195|NCT01009554|594335937|FG001|Overall Study|Noncompliant with Study Product|3|||
164536196|NCT01605253|594335938|FG000|Overall Study|Physician Decision|3|||
164536197|NCT01605253|594335939|FG001|Overall Study|Physician Decision|2|||
164536198|NCT01605253|594335938|FG000|Overall Study|Lost to Follow-up|3|||
164536199|NCT01605253|594335939|FG001|Overall Study|Lost to Follow-up|1|||
164536200|NCT02554903|594335940|FG000|Overall Study|Death|1|||
164536201|NCT02554903|594335941|FG001|Overall Study|Death|1|||
164536202|NCT02554903|594335940|FG000|Overall Study|Physician Decision|2|||
164536203|NCT02554903|594335941|FG001|Overall Study|Physician Decision|2|||
164536204|NCT02554903|594335940|FG000|Overall Study|Heart Transplant|1|||
164536205|NCT02554903|594335941|FG001|Overall Study|Heart Transplant|2|||
164536206|NCT04427501|594335949|FG000|Overall Study|Death|0|||
164536207|NCT04427501|594335950|FG001|Overall Study|Death|0|||
164536208|NCT04427501|594335951|FG002|Overall Study|Death|0|||
164536209|NCT04427501|594335952|FG003|Overall Study|Death|0|||
164536210|NCT04427501|594335953|FG004|Overall Study|Death|0|||
164536211|NCT04427501|594335954|FG005|Overall Study|Death|15|||
164536212|NCT04427501|594335955|FG006|Overall Study|Death|0|||
164536213|NCT04427501|594335956|FG007|Overall Study|Death|0|||
164536214|NCT04427501|594335957|FG008|Overall Study|Death|0|||
164536215|NCT04427501|594335958|FG009|Overall Study|Death|0|||
164536216|NCT04427501|594335959|FG010|Overall Study|Death|0|||
164536217|NCT04427501|594335960|FG011|Overall Study|Death|0|||
164536218|NCT04427501|594335949|FG000|Overall Study|Lost to Follow-up|5|||
164536219|NCT04427501|594335950|FG001|Overall Study|Lost to Follow-up|1|||
164536220|NCT04427501|594335951|FG002|Overall Study|Lost to Follow-up|2|||
164536221|NCT04427501|594335952|FG003|Overall Study|Lost to Follow-up|0|||
164536222|NCT04427501|594335953|FG004|Overall Study|Lost to Follow-up|2|||
164536223|NCT04427501|594335954|FG005|Overall Study|Lost to Follow-up|11|||
164536224|NCT04427501|594335955|FG006|Overall Study|Lost to Follow-up|10|||
164536225|NCT04427501|594335956|FG007|Overall Study|Lost to Follow-up|10|||
164536226|NCT04427501|594335957|FG008|Overall Study|Lost to Follow-up|2|||
164536227|NCT04427501|594335958|FG009|Overall Study|Lost to Follow-up|5|||
164536228|NCT04427501|594335959|FG010|Overall Study|Lost to Follow-up|2|||
164536229|NCT04427501|594335960|FG011|Overall Study|Lost to Follow-up|0|||
164536230|NCT04427501|594335949|FG000|Overall Study|Physician Decision|0|||
164536231|NCT04427501|594335950|FG001|Overall Study|Physician Decision|3|||
164536232|NCT04427501|594335951|FG002|Overall Study|Physician Decision|0|||
164536233|NCT04427501|594335952|FG003|Overall Study|Physician Decision|0|||
164536234|NCT04427501|594335953|FG004|Overall Study|Physician Decision|0|||
164536235|NCT04427501|594335954|FG005|Overall Study|Physician Decision|0|||
164536236|NCT04427501|594335955|FG006|Overall Study|Physician Decision|2|||
164536237|NCT04427501|594335956|FG007|Overall Study|Physician Decision|0|||
164536238|NCT04427501|594335957|FG008|Overall Study|Physician Decision|0|||
164536239|NCT04427501|594335958|FG009|Overall Study|Physician Decision|0|||
164536240|NCT04427501|594335959|FG010|Overall Study|Physician Decision|0|||
164536241|NCT04427501|594335960|FG011|Overall Study|Physician Decision|0|||
164536242|NCT04427501|594335949|FG000|Overall Study|Withdrawal by Subject|9|||
164536243|NCT04427501|594335950|FG001|Overall Study|Withdrawal by Subject|2|||
164536244|NCT04427501|594335951|FG002|Overall Study|Withdrawal by Subject|2|||
164536245|NCT04427501|594335952|FG003|Overall Study|Withdrawal by Subject|3|||
164536246|NCT04427501|594335953|FG004|Overall Study|Withdrawal by Subject|7|||
164536247|NCT04427501|594335954|FG005|Overall Study|Withdrawal by Subject|25|||
164536248|NCT04427501|594335955|FG006|Overall Study|Withdrawal by Subject|15|||
164536249|NCT04427501|594335956|FG007|Overall Study|Withdrawal by Subject|7|||
164536250|NCT04427501|594335957|FG008|Overall Study|Withdrawal by Subject|4|||
164536251|NCT04427501|594335958|FG009|Overall Study|Withdrawal by Subject|1|||
164536252|NCT04427501|594335959|FG010|Overall Study|Withdrawal by Subject|4|||
164536253|NCT04427501|594335960|FG011|Overall Study|Withdrawal by Subject|0|||
164648711|NCT00697112|594740244|FG000|Overall Study|Lost to Follow-up|1|||
164648712|NCT00697112|594740244|FG000|Overall Study|Did not meet inclusion criteria|1|||
164648713|NCT00720304|594740247|FG000|Overall Study|Withdrawal by Subject|14|||
164648714|NCT00720304|594740248|FG001|Overall Study|Withdrawal by Subject|1|||
164648715|NCT00720304|594740247|FG000|Overall Study|Death|1|||
164648716|NCT00720304|594740248|FG001|Overall Study|Death|0|||
164648717|NCT00720304|594740247|FG000|Overall Study|Physician Decision|5|||
164648718|NCT00720304|594740248|FG001|Overall Study|Physician Decision|2|||
164648719|NCT00720304|594740247|FG000|Overall Study|Adverse Event|3|||
164648720|NCT00720304|594740248|FG001|Overall Study|Adverse Event|1|||
164648721|NCT00720304|594740247|FG000|Overall Study|Disease progression|6|||
164648722|NCT00720304|594740248|FG001|Overall Study|Disease progression|1|||
164648723|NCT04330482|594740251|FG000|Overall Study|Lost to Follow-up|2|||
164648724|NCT04330482|594740252|FG001|Overall Study|Lost to Follow-up|1|||
164648725|NCT04330482|594740251|FG000|Overall Study|Withdrawal by Subject|0|||
164648726|NCT04330482|594740252|FG001|Overall Study|Withdrawal by Subject|3|||
164648727|NCT02725671|594740254|FG000|Overall Study|Lost to Follow-up|1|||
164648728|NCT02354976|594740257|FG000|Overall Study|Other - reason not specified|1|||
164648729|NCT02354976|594740258|FG001|Overall Study|Other - reason not specified|0|||
164648730|NCT02354976|594740259|FG002|Overall Study|Other - reason not specified|1|||
164648731|NCT02354976|594740257|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
164648732|NCT02354976|594740258|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
164648733|NCT02354976|594740259|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
164648734|NCT02354976|594740257|FG000|Overall Study|Adverse Event|1|||
164648735|NCT02354976|594740258|FG001|Overall Study|Adverse Event|0|||
164648736|NCT02354976|594740259|FG002|Overall Study|Adverse Event|2|||
164648737|NCT01706770|594740260|FG000|Overall Study|Lost to Follow-up|1|||
164648738|NCT01706770|594740261|FG001|Overall Study|Lost to Follow-up|0|||
164648739|NCT01706770|594740260|FG000|Overall Study|Physician Decision|1|||
164648740|NCT01706770|594740261|FG001|Overall Study|Physician Decision|0|||
164648741|NCT00068445|594740262|FG000|Randomization|Cancel|1|||
164648742|NCT00068445|594740263|FG001|Randomization|Cancel|3|||
164648743|NCT00068445|594740262|FG000|Randomization|Ineligible|1|||
164648744|NCT00068445|594740263|FG001|Randomization|Ineligible|1|||
164648745|NCT00068445|594740262|FG000|Treatment|Refused Further Treatment|13|||
164648746|NCT00068445|594740263|FG001|Treatment|Refused Further Treatment|10|||
164648747|NCT00068445|594740262|FG000|Treatment|Adverse Event|7|||
164648748|NCT00068445|594740263|FG001|Treatment|Adverse Event|1|||
164648749|NCT00068445|594740262|FG000|Treatment|Other (Specifics not available)|9|||
164648750|NCT00068445|594740263|FG001|Treatment|Other (Specifics not available)|5|||
164648751|NCT01155284|594740264|FG000|Overall Study|Withdrawal by Subject|4|||
164648752|NCT01155284|594740265|FG001|Overall Study|Withdrawal by Subject|3|||
164648753|NCT01155284|594740264|FG000|Overall Study|Lost to Follow-up|1|||
164648754|NCT01155284|594740265|FG001|Overall Study|Lost to Follow-up|2|||
164648755|NCT01155284|594740264|FG000|Overall Study|Physician Decision|1|||
164648756|NCT01155284|594740265|FG001|Overall Study|Physician Decision|0|||
164648757|NCT01155284|594740264|FG000|Overall Study|Adverse Event|1|||
164648758|NCT01155284|594740265|FG001|Overall Study|Adverse Event|0|||
164648759|NCT01896700|594740266|FG000|Overall Study|Adverse Event|4|||
164536254|NCT04427501|594335949|FG000|Overall Study|Other - as reported by the investigator|1|||
164648760|NCT01896700|594740267|FG001|Overall Study|Adverse Event|5|||
164648761|NCT01896700|594740266|FG000|Overall Study|Withdrawal by Subject|0|||
164648762|NCT01896700|594740267|FG001|Overall Study|Withdrawal by Subject|1|||
164648763|NCT00123487|594740268|FG000|Randomized|Death prior to starting treatment|0|||
164648764|NCT00123487|594740269|FG001|Randomized|Death prior to starting treatment|1|||
164648765|NCT00123487|594740268|FG000|Randomized|SAE prior to starting treatment|1|||
164648766|NCT00123487|594740269|FG001|Randomized|SAE prior to starting treatment|0|||
164648767|NCT00123487|594740268|FG000|Treated With Study Drug|Adverse Event|23|||
164648768|NCT00123487|594740269|FG001|Treated With Study Drug|Adverse Event|22|||
164648769|NCT00123487|594740268|FG000|Treated With Study Drug|Disease Progression|141|||
164648770|NCT00123487|594740269|FG001|Treated With Study Drug|Disease Progression|122|||
164648771|NCT00123487|594740268|FG000|Treated With Study Drug|Physician Decision|8|||
164648772|NCT00123487|594740269|FG001|Treated With Study Drug|Physician Decision|9|||
164648773|NCT00123487|594740268|FG000|Treated With Study Drug|Other|59|||
164648774|NCT00123487|594740269|FG001|Treated With Study Drug|Other|58|||
164648775|NCT00123487|594740268|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
164648776|NCT00123487|594740269|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
164648777|NCT00123487|594740268|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
164648778|NCT00123487|594740269|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
164648779|NCT00123487|594740268|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
164648780|NCT00123487|594740269|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
164648781|NCT01656967|594740272|FG000|Overall Study|faulty monitor|1|||
164648782|NCT01656967|594740273|FG001|Overall Study|faulty monitor|0|||
164648783|NCT01656967|594740272|FG000|Overall Study|unsuccessful ETT insertion|3|||
164648784|NCT01656967|594740273|FG001|Overall Study|unsuccessful ETT insertion|2|||
164648785|NCT03273257|594740274|FG000|Overall Study|Death|0|||
164648786|NCT03273257|594740275|FG001|Overall Study|Death|1|||
164648787|NCT03273257|594740274|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
164648788|NCT03273257|594740275|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
164648789|NCT03273257|594740274|FG000|Overall Study|Study terminated|3|||
164648790|NCT03273257|594740275|FG001|Overall Study|Study terminated|2|||
164648791|NCT01898884|594740277|FG000|Multiple Dose Period|Adverse Event|0|||
164648792|NCT01898884|594740278|FG001|Multiple Dose Period|Adverse Event|0|||
164648793|NCT01898884|594740279|FG002|Multiple Dose Period|Adverse Event|0|||
164648794|NCT01898884|594740280|FG003|Multiple Dose Period|Adverse Event|0|||
164648795|NCT01898884|594740281|FG004|Multiple Dose Period|Adverse Event|0|||
164648796|NCT01898884|594740282|FG005|Multiple Dose Period|Adverse Event|0|||
164648797|NCT01898884|594740283|FG006|Multiple Dose Period|Adverse Event|1|||
164648798|NCT01898884|594740284|FG007|Multiple Dose Period|Adverse Event|0|||
164648799|NCT01898884|594740285|FG008|Multiple Dose Period|Adverse Event|0|||
164648800|NCT01898884|594740277|FG000|Multiple Dose Period|Randomized Not Treated|0|||
164648801|NCT01898884|594740278|FG001|Multiple Dose Period|Randomized Not Treated|0|||
164648802|NCT01898884|594740279|FG002|Multiple Dose Period|Randomized Not Treated|0|||
164648803|NCT01898884|594740280|FG003|Multiple Dose Period|Randomized Not Treated|0|||
164648804|NCT01898884|594740281|FG004|Multiple Dose Period|Randomized Not Treated|0|||
164648805|NCT01898884|594740282|FG005|Multiple Dose Period|Randomized Not Treated|0|||
164648806|NCT01898884|594740283|FG006|Multiple Dose Period|Randomized Not Treated|0|||
164648807|NCT01898884|594740284|FG007|Multiple Dose Period|Randomized Not Treated|0|||
164648808|NCT01898884|594740285|FG008|Multiple Dose Period|Randomized Not Treated|1|||
164648809|NCT00434148|594740286|FG000|Overall Study|Adverse Event|18|||
164648810|NCT00434148|594740287|FG001|Overall Study|Adverse Event|18|||
164648811|NCT00434148|594740286|FG000|Overall Study|Lack of Efficacy|25|||
164648812|NCT00434148|594740287|FG001|Overall Study|Lack of Efficacy|28|||
164648813|NCT00434148|594740286|FG000|Overall Study|Withdrawal by Subject|15|||
164648814|NCT00434148|594740287|FG001|Overall Study|Withdrawal by Subject|15|||
164648815|NCT00434148|594740286|FG000|Overall Study|Protocol Violation|4|||
164648816|NCT00434148|594740287|FG001|Overall Study|Protocol Violation|0|||
164648817|NCT00434148|594740286|FG000|Overall Study|Administrative problems|6|||
164648818|NCT00434148|594740287|FG001|Overall Study|Administrative problems|10|||
164648819|NCT00434148|594740286|FG000|Overall Study|Lost to Follow-up|0|||
164648820|NCT00434148|594740287|FG001|Overall Study|Lost to Follow-up|1|||
164648821|NCT00434148|594740286|FG000|Overall Study|Condition no longer requires study drug|1|||
164648822|NCT00434148|594740287|FG001|Overall Study|Condition no longer requires study drug|0|||
164648823|NCT00434148|594740286|FG000|Overall Study|Abnormal test procedure result|0|||
164648824|NCT00434148|594740287|FG001|Overall Study|Abnormal test procedure result|1|||
164648825|NCT01556165|594740288|FG000|Overall Study|Adverse Event|5|||
164648826|NCT01556165|594740289|FG001|Overall Study|Adverse Event|3|||
164648827|NCT01556165|594740288|FG000|Overall Study|Protocol Violation|0|||
164648828|NCT01556165|594740289|FG001|Overall Study|Protocol Violation|3|||
164648829|NCT01556165|594740288|FG000|Overall Study|Withdrawal of Consent|7|||
164648830|NCT01556165|594740289|FG001|Overall Study|Withdrawal of Consent|1|||
164648831|NCT01640964|594740292|FG000|Overall Study|Lost to Follow-up|0|||
164648832|NCT01640964|594740293|FG001|Overall Study|Lost to Follow-up|0|||
164648833|NCT01640964|594740294|FG002|Overall Study|Lost to Follow-up|1|||
164648834|NCT01640964|594740292|FG000|Overall Study|Protocol Deviation|1|||
164648835|NCT01640964|594740293|FG001|Overall Study|Protocol Deviation|1|||
164648836|NCT01640964|594740294|FG002|Overall Study|Protocol Deviation|2|||
164648837|NCT00681824|594741692|FG000|Overall Study|withdrawn by investigator|0|||
164648838|NCT00681824|594741693|FG001|Overall Study|withdrawn by investigator|0|||
164648839|NCT00681824|594741694|FG002|Overall Study|withdrawn by investigator|1|||
164648840|NCT00681824|594741692|FG000|Overall Study|scheduling conflict|1|||
164648841|NCT00681824|594741693|FG001|Overall Study|scheduling conflict|0|||
164648842|NCT00681824|594741694|FG002|Overall Study|scheduling conflict|0|||
164648843|NCT00681824|594741692|FG000|Overall Study|Death|0|||
164648844|NCT00681824|594741693|FG001|Overall Study|Death|1|||
164648845|NCT00681824|594741694|FG002|Overall Study|Death|0|||
164648846|NCT03724916|594741695|FG000|Overall Study|Withdrawal by Subject|0|||
164648847|NCT03724916|594741696|FG001|Overall Study|Withdrawal by Subject|1|||
164648848|NCT03724916|594741697|FG002|Overall Study|Withdrawal by Subject|1|||
164648849|NCT03724916|594741698|FG003|Overall Study|Withdrawal by Subject|2|||
164648850|NCT03724916|594741695|FG000|Overall Study|Randomized but not Treated|1|||
164648851|NCT03724916|594741696|FG001|Overall Study|Randomized but not Treated|0|||
164648852|NCT03724916|594741697|FG002|Overall Study|Randomized but not Treated|0|||
164536255|NCT04427501|594335950|FG001|Overall Study|Other - as reported by the investigator|0|||
164536256|NCT04427501|594335951|FG002|Overall Study|Other - as reported by the investigator|0|||
164536257|NCT04427501|594335952|FG003|Overall Study|Other - as reported by the investigator|0|||
164536258|NCT04427501|594335953|FG004|Overall Study|Other - as reported by the investigator|0|||
164536259|NCT04427501|594335954|FG005|Overall Study|Other - as reported by the investigator|6|||
164536260|NCT04427501|594335955|FG006|Overall Study|Other - as reported by the investigator|6|||
164536261|NCT04427501|594335956|FG007|Overall Study|Other - as reported by the investigator|0|||
164536262|NCT04427501|594335957|FG008|Overall Study|Other - as reported by the investigator|0|||
164536263|NCT04427501|594335958|FG009|Overall Study|Other - as reported by the investigator|0|||
164536264|NCT04427501|594335959|FG010|Overall Study|Other - as reported by the investigator|0|||
164536265|NCT04427501|594335960|FG011|Overall Study|Other - as reported by the investigator|0|||
164536266|NCT04427501|594335949|FG000|Overall Study|Other|0|||
164536267|NCT04427501|594335950|FG001|Overall Study|Other|0|||
164536268|NCT04427501|594335951|FG002|Overall Study|Other|0|||
164536269|NCT04427501|594335952|FG003|Overall Study|Other|0|||
164536270|NCT04427501|594335953|FG004|Overall Study|Other|0|||
164536271|NCT04427501|594335954|FG005|Overall Study|Other|0|||
164536272|NCT04427501|594335955|FG006|Overall Study|Other|0|||
164536273|NCT04427501|594335956|FG007|Overall Study|Other|0|||
164536274|NCT04427501|594335957|FG008|Overall Study|Other|0|||
164536275|NCT04427501|594335958|FG009|Overall Study|Other|0|||
164536276|NCT04427501|594335959|FG010|Overall Study|Other|0|||
164536277|NCT04427501|594335960|FG011|Overall Study|Other|1|||
164536278|NCT03170154|594335961|FG000|Overall Study|Lost to Follow-up|4|||
164536279|NCT03170154|594335961|FG000|Overall Study|Death|2|||
164536280|NCT03170154|594335961|FG000|Overall Study|Withdrawal by Subject|2|||
164536281|NCT04936841|594335962|FG000|Overall Study|Death|1|||
164536282|NCT04343248|594335967|FG000|Overall Study|Withdrawal by Subject|5|||
164536283|NCT04343248|594335968|FG001|Overall Study|Withdrawal by Subject|6|||
164536284|NCT04343248|594335967|FG000|Overall Study|Death|1|||
164536285|NCT04343248|594335968|FG001|Overall Study|Death|2|||
164536286|NCT04343248|594335967|FG000|Overall Study|Lost to Follow-up|9|||
164536287|NCT04343248|594335968|FG001|Overall Study|Lost to Follow-up|6|||
164536288|NCT04343248|594335967|FG000|Overall Study|Physician Decision|0|||
164536289|NCT04343248|594335968|FG001|Overall Study|Physician Decision|1|||
164536290|NCT04343248|594335967|FG000|Overall Study|Adverse Event|1|||
164536291|NCT04343248|594335968|FG001|Overall Study|Adverse Event|0|||
164536292|NCT02730598|594335971|FG000|Overall Study|Withdrawal by Subject|3|||
164536293|NCT02730598|594335972|FG001|Overall Study|Withdrawal by Subject|3|||
164536294|NCT02730598|594335971|FG000|Overall Study|Protocol Violation|0|||
164536295|NCT02730598|594335972|FG001|Overall Study|Protocol Violation|1|||
164536296|NCT02730598|594335971|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
164536297|NCT02730598|594335972|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
164536298|NCT04824521|594335973|FG000|Overall Study|Lost to Follow-up|1|||
164536299|NCT01920594|594337973|FG000|Overall Study|Adverse Event|4|||
164536300|NCT01920594|594337974|FG001|Overall Study|Adverse Event|2|||
164536301|NCT01920594|594337973|FG000|Overall Study|Lost to Follow-up|1|||
164536302|NCT01920594|594337974|FG001|Overall Study|Lost to Follow-up|0|||
164536303|NCT01920594|594337973|FG000|Overall Study|Recovery|2|||
164536304|NCT01920594|594337974|FG001|Overall Study|Recovery|0|||
164536305|NCT01920594|594337973|FG000|Overall Study|Investigator discretion|0|||
164536306|NCT01920594|594337974|FG001|Overall Study|Investigator discretion|1|||
164536307|NCT04906616|594337975|FG000|Overall Study|Divorce|3|||
164536308|NCT04906616|594337976|FG001|Overall Study|Divorce|2|||
164536309|NCT01521897|594337977|FG000|Overall Study|Protocol Violation|18|||
164536310|NCT01521897|594337977|FG000|Overall Study|Lost to Follow-up|5|||
164536311|NCT02194062|594337978|FG000|Overall Study|Lost to Follow-up|2|||
164536312|NCT02194062|594337979|FG001|Overall Study|Lost to Follow-up|2|||
164536313|NCT02194062|594337980|FG002|Overall Study|Lost to Follow-up|5|||
164536314|NCT04147234|594337981|FG000|Overall Study|Clinical deterioration|0|||
164536315|NCT04147234|594337982|FG001|Overall Study|Clinical deterioration|0|||
164536316|NCT04147234|594337983|FG002|Overall Study|Clinical deterioration|1|||
164536317|NCT04147234|594337984|FG003|Overall Study|Clinical deterioration|0|||
164536318|NCT04147234|594337985|FG004|Overall Study|Clinical deterioration|0|||
164536319|NCT04147234|594337986|FG005|Overall Study|Clinical deterioration|0|||
164536320|NCT04147234|594337987|FG006|Overall Study|Clinical deterioration|0|||
164536321|NCT04147234|594337981|FG000|Overall Study|Withdrawal by Subject|0|||
164536322|NCT04147234|594337982|FG001|Overall Study|Withdrawal by Subject|1|||
164536323|NCT04147234|594337983|FG002|Overall Study|Withdrawal by Subject|1|||
164536324|NCT04147234|594337984|FG003|Overall Study|Withdrawal by Subject|0|||
164536325|NCT04147234|594337985|FG004|Overall Study|Withdrawal by Subject|0|||
164536326|NCT04147234|594337986|FG005|Overall Study|Withdrawal by Subject|0|||
164536327|NCT04147234|594337987|FG006|Overall Study|Withdrawal by Subject|0|||
164536328|NCT04147234|594337981|FG000|Overall Study|Clinical disease progression|1|||
164536329|NCT04147234|594337982|FG001|Overall Study|Clinical disease progression|3|||
164536330|NCT04147234|594337983|FG002|Overall Study|Clinical disease progression|1|||
164536331|NCT04147234|594337984|FG003|Overall Study|Clinical disease progression|1|||
164536332|NCT04147234|594337985|FG004|Overall Study|Clinical disease progression|0|||
164536333|NCT04147234|594337986|FG005|Overall Study|Clinical disease progression|1|||
164536334|NCT04147234|594337987|FG006|Overall Study|Clinical disease progression|0|||
164536335|NCT04147234|594337981|FG000|Overall Study|Objective disease progression|6|||
164536336|NCT04147234|594337982|FG001|Overall Study|Objective disease progression|4|||
164536337|NCT04147234|594337983|FG002|Overall Study|Objective disease progression|3|||
164536338|NCT04147234|594337984|FG003|Overall Study|Objective disease progression|3|||
164536339|NCT04147234|594337985|FG004|Overall Study|Objective disease progression|5|||
164536340|NCT04147234|594337986|FG005|Overall Study|Objective disease progression|2|||
164536341|NCT04147234|594337987|FG006|Overall Study|Objective disease progression|3|||
164536342|NCT04147234|594337981|FG000|Overall Study|Adverse Event|0|||
164536343|NCT04147234|594337982|FG001|Overall Study|Adverse Event|0|||
164536344|NCT04147234|594337983|FG002|Overall Study|Adverse Event|0|||
164536345|NCT04147234|594337984|FG003|Overall Study|Adverse Event|0|||
164536346|NCT04147234|594337985|FG004|Overall Study|Adverse Event|1|||
164536347|NCT04147234|594337986|FG005|Overall Study|Adverse Event|0|||
164536348|NCT04147234|594337987|FG006|Overall Study|Adverse Event|0|||
164536349|NCT01754857|594337992|FG000|Overall Study|Adverse Event|7|||
164536350|NCT01754857|594337992|FG000|Overall Study|Disease progression|3|||
164536351|NCT01754857|594337992|FG000|Overall Study|Physician Decision|2|||
164536352|NCT01754857|594337992|FG000|Overall Study|Withdrawal by Subject|3|||
164536353|NCT01754857|594337992|FG000|Overall Study|other complicating disease|1|||
164536354|NCT01754857|594337992|FG000|Overall Study|ineligible to continue onto maintenance|1|||
164536355|NCT01754857|594337992|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
164536356|NCT01754857|594337992|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
164536357|NCT00564018|594337996|FG000|Overall Study|Withdrawal by Subject|2|||
164536358|NCT00564018|594337997|FG001|Overall Study|Withdrawal by Subject|3|||
164536359|NCT00564018|594337998|FG002|Overall Study|Withdrawal by Subject|1|||
164536360|NCT01145755|594338003|FG000|Overall Study|Adverse Event|2|||
164536361|NCT01145755|594338004|FG001|Overall Study|Adverse Event|4|||
164536362|NCT01145755|594338005|FG002|Overall Study|Adverse Event|2|||
164536363|NCT01145755|594338003|FG000|Overall Study|Withdrawal by Subject|2|||
164536364|NCT01145755|594338004|FG001|Overall Study|Withdrawal by Subject|2|||
164536365|NCT01145755|594338005|FG002|Overall Study|Withdrawal by Subject|2|||
164536366|NCT01145755|594338003|FG000|Overall Study|Lost to Follow-up|2|||
164536367|NCT01145755|594338004|FG001|Overall Study|Lost to Follow-up|3|||
164536368|NCT01145755|594338005|FG002|Overall Study|Lost to Follow-up|1|||
164536369|NCT01145755|594338003|FG000|Overall Study|Protocol Violation|0|||
164536370|NCT01145755|594338004|FG001|Overall Study|Protocol Violation|3|||
164536371|NCT01145755|594338005|FG002|Overall Study|Protocol Violation|1|||
164536372|NCT01145755|594338003|FG000|Overall Study|Study Closure|14|||
164536373|NCT01145755|594338004|FG001|Overall Study|Study Closure|14|||
164536374|NCT01145755|594338005|FG002|Overall Study|Study Closure|17|||
164536375|NCT01145755|594338003|FG000|Overall Study|Lack of Efficacy|0|||
164536376|NCT01145755|594338004|FG001|Overall Study|Lack of Efficacy|1|||
164648853|NCT03724916|594741698|FG003|Overall Study|Randomized but not Treated|0|||
164648854|NCT04575038|594741699|FG000|Overall Study|Withdrawal by Subject|1|||
164648855|NCT04575038|594741700|FG001|Overall Study|Withdrawal by Subject|1|||
164648856|NCT04335110|594741707|FG000|Overall Study|Withdrawal by Subject|1|||
164648857|NCT04335110|594741708|FG001|Overall Study|Withdrawal by Subject|1|||
164648858|NCT04335110|594741707|FG000|Overall Study|Death|0|||
164648859|NCT04335110|594741708|FG001|Overall Study|Death|1|||
164648860|NCT03101293|594741711|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
164536377|NCT01145755|594338005|FG002|Overall Study|Lack of Efficacy|0|||
164536378|NCT01145755|594338003|FG000|Overall Study|Patient could not swollow medication|0|||
164536379|NCT01145755|594338004|FG001|Overall Study|Patient could not swollow medication|0|||
164536380|NCT01145755|594338005|FG002|Overall Study|Patient could not swollow medication|1|||
164536381|NCT01145755|594338003|FG000|Overall Study|Withdrawal by Subject|0|||
164536382|NCT01145755|594338004|FG001|Overall Study|Withdrawal by Subject|0|||
164536383|NCT01145755|594338005|FG002|Overall Study|Withdrawal by Subject|1|||
164536384|NCT01145755|594338003|FG000|Overall Study|Positive urine ethanol|0|||
164536385|NCT01145755|594338004|FG001|Overall Study|Positive urine ethanol|1|||
164536386|NCT01145755|594338005|FG002|Overall Study|Positive urine ethanol|0|||
164536387|NCT00372385|594338006|FG000|Overall Study|Adverse Event|6|||
164536388|NCT00372385|594338007|FG001|Overall Study|Adverse Event|11|||
164536389|NCT00372385|594338008|FG002|Overall Study|Adverse Event|9|||
164536390|NCT00372385|594338009|FG003|Overall Study|Adverse Event|7|||
164536391|NCT00372385|594338006|FG000|Overall Study|Noncompliance|0|||
164536392|NCT00372385|594338007|FG001|Overall Study|Noncompliance|1|||
164648861|NCT03101293|594741712|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
164648862|NCT03333382|594741719|FG000|Overall Study|Lost to Follow-up|1|||
164536393|NCT00372385|594338008|FG002|Overall Study|Noncompliance|1|||
164536394|NCT00372385|594338009|FG003|Overall Study|Noncompliance|1|||
164536395|NCT00372385|594338006|FG000|Overall Study|Physician Decision|1|||
164536396|NCT00372385|594338007|FG001|Overall Study|Physician Decision|0|||
164536397|NCT00372385|594338008|FG002|Overall Study|Physician Decision|0|||
164536398|NCT00372385|594338009|FG003|Overall Study|Physician Decision|0|||
164536399|NCT00372385|594338006|FG000|Overall Study|Lost to Follow-up|2|||
164536400|NCT00372385|594338007|FG001|Overall Study|Lost to Follow-up|0|||
164536401|NCT00372385|594338008|FG002|Overall Study|Lost to Follow-up|0|||
164536402|NCT00372385|594338009|FG003|Overall Study|Lost to Follow-up|0|||
164536403|NCT00372385|594338006|FG000|Overall Study|Withdrawal by Subject|2|||
164536404|NCT00372385|594338007|FG001|Overall Study|Withdrawal by Subject|1|||
164536405|NCT00372385|594338008|FG002|Overall Study|Withdrawal by Subject|0|||
164536406|NCT00372385|594338009|FG003|Overall Study|Withdrawal by Subject|0|||
164536407|NCT00372385|594338006|FG000|Overall Study|Refusal of Treatment|3|||
164536408|NCT00372385|594338007|FG001|Overall Study|Refusal of Treatment|6|||
164536409|NCT00372385|594338008|FG002|Overall Study|Refusal of Treatment|0|||
164536410|NCT00372385|594338009|FG003|Overall Study|Refusal of Treatment|0|||
164536411|NCT00372385|594338006|FG000|Overall Study|No Response|1|||
164536412|NCT00372385|594338007|FG001|Overall Study|No Response|1|||
164536413|NCT00372385|594338008|FG002|Overall Study|No Response|0|||
164536414|NCT00372385|594338009|FG003|Overall Study|No Response|0|||
164536415|NCT00372385|594338006|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
164536416|NCT00372385|594338007|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
164536417|NCT00372385|594338008|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
164536418|NCT00372385|594338009|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
164536419|NCT00372385|594338006|FG000|Overall Study|Virologic Stopping Rule|17|||
164536420|NCT00372385|594338007|FG001|Overall Study|Virologic Stopping Rule|0|||
164536421|NCT00372385|594338008|FG002|Overall Study|Virologic Stopping Rule|0|||
164536422|NCT00372385|594338009|FG003|Overall Study|Virologic Stopping Rule|0|||
164536423|NCT04226833|594338010|FG000|Overall Study|Death|0|||
164536424|NCT04226833|594338011|FG001|Overall Study|Death|0|||
164536425|NCT04226833|594338012|FG002|Overall Study|Death|1|||
164536426|NCT04226833|594338013|FG003|Overall Study|Death|0|||
164536427|NCT02876835|594338016|FG000|Treatment Period (51.1 Month)|Other|1|||
164536428|NCT02876835|594338017|FG001|Treatment Period (51.1 Month)|Other|0|||
164536429|NCT02876835|594338016|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
164536430|NCT02876835|594338017|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
164536431|NCT02876835|594338016|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
164536432|NCT02876835|594338017|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
164536433|NCT02876835|594338016|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
164536434|NCT02876835|594338017|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
164536435|NCT03049735|594338022|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
164536436|NCT03049735|594338023|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
164536437|NCT03049735|594338024|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
164536438|NCT03049735|594338022|FG000|Overall Study|Other|5|||
164536439|NCT03049735|594338023|FG001|Overall Study|Other|3|||
164536440|NCT03049735|594338024|FG002|Overall Study|Other|1|||
164536441|NCT03049735|594338022|FG000|Overall Study|Lack of Efficacy|4|||
164536442|NCT03049735|594338023|FG001|Overall Study|Lack of Efficacy|0|||
164536443|NCT03049735|594338024|FG002|Overall Study|Lack of Efficacy|3|||
164536444|NCT03049735|594338022|FG000|Overall Study|Protocol deviation|1|||
164536445|NCT03049735|594338023|FG001|Overall Study|Protocol deviation|0|||
164536446|NCT03049735|594338024|FG002|Overall Study|Protocol deviation|0|||
164536447|NCT03049735|594338022|FG000|Overall Study|Pregnancy|0|||
164536448|NCT03049735|594338023|FG001|Overall Study|Pregnancy|0|||
164536449|NCT03049735|594338024|FG002|Overall Study|Pregnancy|1|||
164536450|NCT03049735|594338022|FG000|Overall Study|Adverse Event|7|||
164536451|NCT03049735|594338023|FG001|Overall Study|Adverse Event|18|||
164536452|NCT03049735|594338024|FG002|Overall Study|Adverse Event|5|||
164536453|NCT03049735|594338022|FG000|Overall Study|Withdrawal by Subject|10|||
164536454|NCT03049735|594338023|FG001|Overall Study|Withdrawal by Subject|3|||
164536455|NCT03049735|594338024|FG002|Overall Study|Withdrawal by Subject|7|||
164648863|NCT03333382|594741720|FG001|Overall Study|Lost to Follow-up|0|||
164648864|NCT00660790|594741729|FG000|Baseline to 3 Months|Death|1|||
164648865|NCT00660790|594741729|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
164648866|NCT00660790|594741729|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
164648867|NCT00686374|594741735|FG000|Overall Study|Lack of Efficacy|10|||
164536456|NCT03049735|594338022|FG000|Overall Study|Lost to Follow-up|1|||
164536457|NCT03049735|594338023|FG001|Overall Study|Lost to Follow-up|5|||
164536458|NCT03049735|594338024|FG002|Overall Study|Lost to Follow-up|5|||
164536459|NCT03254485|594338025|FG000|Overall Study|Adverse Event|3|||
164536460|NCT03254485|594338026|FG001|Overall Study|Adverse Event|0|||
164536461|NCT03254485|594338027|FG002|Overall Study|Adverse Event|0|||
164536462|NCT03254485|594338028|FG003|Overall Study|Adverse Event|6|||
164536463|NCT03254485|594338025|FG000|Overall Study|Protocol Violation|6|||
164536464|NCT03254485|594338026|FG001|Overall Study|Protocol Violation|0|||
164536465|NCT03254485|594338027|FG002|Overall Study|Protocol Violation|0|||
164536466|NCT03254485|594338028|FG003|Overall Study|Protocol Violation|2|||
164536467|NCT03254485|594338025|FG000|Overall Study|Withdrawal by Subject|1|||
164536468|NCT03254485|594338026|FG001|Overall Study|Withdrawal by Subject|0|||
164536469|NCT03254485|594338027|FG002|Overall Study|Withdrawal by Subject|0|||
164648868|NCT00686374|594741735|FG000|Overall Study|Adverse Event|8|||
164536470|NCT03254485|594338028|FG003|Overall Study|Withdrawal by Subject|4|||
164536471|NCT03254485|594338025|FG000|Overall Study|Death|0|||
164536472|NCT03254485|594338026|FG001|Overall Study|Death|0|||
164536473|NCT03254485|594338027|FG002|Overall Study|Death|0|||
164536474|NCT03254485|594338028|FG003|Overall Study|Death|1|||
164536475|NCT03254485|594338025|FG000|Overall Study|Lost to Follow-up|1|||
164536476|NCT03254485|594338026|FG001|Overall Study|Lost to Follow-up|0|||
164536477|NCT03254485|594338027|FG002|Overall Study|Lost to Follow-up|0|||
164536478|NCT03254485|594338028|FG003|Overall Study|Lost to Follow-up|0|||
164536479|NCT03254485|594338025|FG000|Overall Study|Other|1|||
164536480|NCT03254485|594338026|FG001|Overall Study|Other|0|||
164536481|NCT03254485|594338027|FG002|Overall Study|Other|0|||
164536482|NCT03254485|594338028|FG003|Overall Study|Other|2|||
164536483|NCT02146326|594338029|FG000|Overall Study|Lost to Follow-up|3|||
164536484|NCT02146326|594338030|FG001|Overall Study|Lost to Follow-up|3|||
164536485|NCT02146326|594338031|FG002|Overall Study|Lost to Follow-up|11|||
164536486|NCT02146326|594338032|FG003|Overall Study|Lost to Follow-up|19|||
164536487|NCT02146326|594338029|FG000|Overall Study|Withdrawal by Subject|2|||
164536488|NCT02146326|594338030|FG001|Overall Study|Withdrawal by Subject|1|||
164536489|NCT02146326|594338031|FG002|Overall Study|Withdrawal by Subject|15|||
164536490|NCT02146326|594338032|FG003|Overall Study|Withdrawal by Subject|11|||
164536491|NCT02146326|594338029|FG000|Overall Study|Separated from mental health center|23|||
164536492|NCT02146326|594338030|FG001|Overall Study|Separated from mental health center|33|||
164536493|NCT02146326|594338031|FG002|Overall Study|Separated from mental health center|0|||
164536494|NCT02146326|594338032|FG003|Overall Study|Separated from mental health center|0|||
164536495|NCT02146326|594338029|FG000|Overall Study|Incarcerated|0|||
164536496|NCT02146326|594338030|FG001|Overall Study|Incarcerated|0|||
164536497|NCT02146326|594338031|FG002|Overall Study|Incarcerated|3|||
164536498|NCT02146326|594338032|FG003|Overall Study|Incarcerated|8|||
164536499|NCT02146326|594338029|FG000|Overall Study|Death|0|||
164536500|NCT02146326|594338030|FG001|Overall Study|Death|0|||
164536501|NCT02146326|594338031|FG002|Overall Study|Death|4|||
164536502|NCT02146326|594338032|FG003|Overall Study|Death|4|||
164536503|NCT02146326|594338029|FG000|Overall Study|Unable to complete interview|0|||
164536504|NCT02146326|594338030|FG001|Overall Study|Unable to complete interview|0|||
164536505|NCT02146326|594338031|FG002|Overall Study|Unable to complete interview|10|||
164536506|NCT02146326|594338032|FG003|Overall Study|Unable to complete interview|6|||
164536507|NCT03153111|594338033|FG000|Overall Study|Death|2|||
164536508|NCT03153111|594338034|FG001|Overall Study|Death|5|||
164536509|NCT03153111|594338033|FG000|Overall Study|Lost to Follow-up|1|||
164536510|NCT03153111|594338034|FG001|Overall Study|Lost to Follow-up|0|||
164536511|NCT03153111|594338033|FG000|Overall Study|Physician Decision|5|||
164536512|NCT03153111|594338034|FG001|Overall Study|Physician Decision|1|||
164536513|NCT03153111|594338033|FG000|Overall Study|Withdrawal by Subject|3|||
164536514|NCT03153111|594338034|FG001|Overall Study|Withdrawal by Subject|3|||
164536515|NCT02958267|594338035|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
164536516|NCT02958267|594338036|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
164536517|NCT02958267|594338035|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
164536518|NCT02958267|594338036|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
164536519|NCT02958267|594338035|FG000|Follow-up Visits|Additional treatment pursued|2|||
164536520|NCT02958267|594338036|FG001|Follow-up Visits|Additional treatment pursued|1|||
164536521|NCT00777946|594338039|FG000|Overall Study|Adverse Event|11|||
164536522|NCT00777946|594338040|FG001|Overall Study|Adverse Event|1|||
164536523|NCT00777946|594338041|FG002|Overall Study|Adverse Event|3|||
164536524|NCT00777946|594338039|FG000|Overall Study|Lack of Efficacy|0|||
164536525|NCT00777946|594338040|FG001|Overall Study|Lack of Efficacy|0|||
164536526|NCT00777946|594338041|FG002|Overall Study|Lack of Efficacy|9|||
164536527|NCT00777946|594338039|FG000|Overall Study|Condition no longer required study drug|1|||
164536528|NCT00777946|594338040|FG001|Overall Study|Condition no longer required study drug|0|||
164536529|NCT00777946|594338041|FG002|Overall Study|Condition no longer required study drug|0|||
164536530|NCT00777946|594338039|FG000|Overall Study|Patient withdrew consent|3|||
164536531|NCT00777946|594338040|FG001|Overall Study|Patient withdrew consent|2|||
164536532|NCT00777946|594338041|FG002|Overall Study|Patient withdrew consent|3|||
164536533|NCT00777946|594338039|FG000|Overall Study|Lost to Follow-up|3|||
164536534|NCT00777946|594338040|FG001|Overall Study|Lost to Follow-up|1|||
164536535|NCT00777946|594338041|FG002|Overall Study|Lost to Follow-up|0|||
164536536|NCT00777946|594338039|FG000|Overall Study|Protocol deviation|2|||
164536537|NCT00777946|594338040|FG001|Overall Study|Protocol deviation|1|||
164536538|NCT00777946|594338041|FG002|Overall Study|Protocol deviation|1|||
164536539|NCT00777946|594338039|FG000|Overall Study|Randomized in error|1|||
164536540|NCT00777946|594338040|FG001|Overall Study|Randomized in error|1|||
164536541|NCT00777946|594338041|FG002|Overall Study|Randomized in error|0|||
164536542|NCT02684357|594338042|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
164536543|NCT02684357|594338043|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
164536544|NCT02684357|594338044|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
164536545|NCT02684357|594338045|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
164536546|NCT02684357|594338046|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
164536547|NCT02684357|594338047|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
164536548|NCT02684357|594338042|FG000|Part A|Lost to Follow-up|0|||
164536549|NCT02684357|594338043|FG001|Part A|Lost to Follow-up|2|||
164536550|NCT02684357|594338044|FG002|Part A|Lost to Follow-up|2|||
164536551|NCT02684357|594338045|FG003|Part A|Lost to Follow-up|0|||
164536552|NCT02684357|594338046|FG004|Part A|Lost to Follow-up|0|||
164536553|NCT02684357|594338047|FG005|Part A|Lost to Follow-up|0|||
164536554|NCT02684357|594338042|FG000|Part A|Withdrawal by Subject|3|||
164536555|NCT02684357|594338043|FG001|Part A|Withdrawal by Subject|0|||
164536556|NCT02684357|594338044|FG002|Part A|Withdrawal by Subject|0|||
164536557|NCT02684357|594338045|FG003|Part A|Withdrawal by Subject|0|||
164536558|NCT02684357|594338046|FG004|Part A|Withdrawal by Subject|0|||
164536559|NCT02684357|594338047|FG005|Part A|Withdrawal by Subject|0|||
164536560|NCT02684357|594338042|FG000|Part A|Other|0|||
164536561|NCT02684357|594338043|FG001|Part A|Other|1|||
164536562|NCT02684357|594338044|FG002|Part A|Other|0|||
164536563|NCT02684357|594338045|FG003|Part A|Other|0|||
164536564|NCT02684357|594338046|FG004|Part A|Other|0|||
164536565|NCT02684357|594338047|FG005|Part A|Other|0|||
164536566|NCT02684357|594338042|FG000|Part B|Adverse Event (Other)|0|||
164536567|NCT02684357|594338043|FG001|Part B|Adverse Event (Other)|0|||
164536568|NCT02684357|594338044|FG002|Part B|Adverse Event (Other)|0|||
164536569|NCT02684357|594338045|FG003|Part B|Adverse Event (Other)|1|||
164536570|NCT02684357|594338046|FG004|Part B|Adverse Event (Other)|1|||
164536571|NCT02684357|594338047|FG005|Part B|Adverse Event (Other)|1|||
164536572|NCT02684357|594338042|FG000|Part B|Lost to Follow-up|0|||
164536573|NCT02684357|594338043|FG001|Part B|Lost to Follow-up|0|||
164536574|NCT02684357|594338044|FG002|Part B|Lost to Follow-up|0|||
164536575|NCT02684357|594338045|FG003|Part B|Lost to Follow-up|1|||
164536576|NCT02684357|594338046|FG004|Part B|Lost to Follow-up|1|||
164536577|NCT02684357|594338047|FG005|Part B|Lost to Follow-up|7|||
164536578|NCT02684357|594338042|FG000|Part B|Withdrawal by Subject|0|||
164536579|NCT02684357|594338043|FG001|Part B|Withdrawal by Subject|0|||
164536580|NCT02684357|594338044|FG002|Part B|Withdrawal by Subject|0|||
164536581|NCT02684357|594338045|FG003|Part B|Withdrawal by Subject|0|||
164536582|NCT02684357|594338046|FG004|Part B|Withdrawal by Subject|2|||
164536583|NCT02684357|594338047|FG005|Part B|Withdrawal by Subject|4|||
164536584|NCT02684357|594338042|FG000|Part B|Other|0|||
164536585|NCT02684357|594338043|FG001|Part B|Other|0|||
164536586|NCT02684357|594338044|FG002|Part B|Other|0|||
164536587|NCT02684357|594338045|FG003|Part B|Other|1|||
164536588|NCT02684357|594338046|FG004|Part B|Other|0|||
164536589|NCT02684357|594338047|FG005|Part B|Other|1|||
164536590|NCT01853982|594338048|FG000|Overall Study|Withdrawal by Subject|1|||
164536591|NCT01853982|594338049|FG001|Overall Study|Withdrawal by Subject|0|||
164536592|NCT01853982|594338048|FG000|Overall Study|Death|1|||
164536593|NCT01853982|594338049|FG001|Overall Study|Death|0|||
164536594|NCT01853982|594338048|FG000|Overall Study|Lost to Follow-up|0|||
164536595|NCT01853982|594338049|FG001|Overall Study|Lost to Follow-up|1|||
164536596|NCT00390910|594338050|FG000|Overall Study|Adverse Event|1|||
164536597|NCT00390910|594338051|FG001|Overall Study|Adverse Event|0|||
164536598|NCT00390910|594338052|FG002|Overall Study|Adverse Event|0|||
164536599|NCT00390910|594338050|FG000|Overall Study|Lost to Follow-up|0|||
164536600|NCT00390910|594338051|FG001|Overall Study|Lost to Follow-up|1|||
164536601|NCT00390910|594338052|FG002|Overall Study|Lost to Follow-up|5|||
164536602|NCT00390910|594338050|FG000|Overall Study|Withdrawal by Subject|1|||
164536603|NCT00390910|594338051|FG001|Overall Study|Withdrawal by Subject|3|||
164536604|NCT00390910|594338052|FG002|Overall Study|Withdrawal by Subject|2|||
164536605|NCT00390910|594338050|FG000|Overall Study|Migrated/moved from study area|0|||
164536606|NCT00390910|594338051|FG001|Overall Study|Migrated/moved from study area|0|||
164536607|NCT00390910|594338052|FG002|Overall Study|Migrated/moved from study area|3|||
164536608|NCT00475033|594338054|FG000|Infant Series|Failed to return|3|||
164536609|NCT00475033|594338055|FG001|Infant Series|Failed to return|4|||
164536610|NCT00475033|594338054|FG000|Infant Series|Parent or legal guardian request|1|||
164536611|NCT00475033|594338055|FG001|Infant Series|Parent or legal guardian request|5|||
164536612|NCT00475033|594338054|FG000|Infant Series|Protocol Violation|1|||
164536613|NCT00475033|594338055|FG001|Infant Series|Protocol Violation|2|||
164536614|NCT00475033|594338054|FG000|Infant Series|Lost to Follow-up|2|||
164536615|NCT00475033|594338055|FG001|Infant Series|Lost to Follow-up|0|||
164536616|NCT00475033|594338054|FG000|Infant Series|Adverse Event|0|||
164536617|NCT00475033|594338055|FG001|Infant Series|Adverse Event|2|||
164536618|NCT00475033|594338054|FG000|After the Infant Series|Adverse Event|0|||
164536619|NCT00475033|594338055|FG001|After the Infant Series|Adverse Event|4|||
164536620|NCT00475033|594338054|FG000|After the Infant Series|Parent or legal guardian request|2|||
164536621|NCT00475033|594338055|FG001|After the Infant Series|Parent or legal guardian request|2|||
164536622|NCT00475033|594338054|FG000|After the Infant Series|Failed to return|2|||
164536623|NCT00475033|594338055|FG001|After the Infant Series|Failed to return|1|||
164536624|NCT00475033|594338054|FG000|After the Infant Series|Protocol Violation|1|||
164536625|NCT00475033|594338055|FG001|After the Infant Series|Protocol Violation|0|||
164536626|NCT00475033|594338054|FG000|After the Infant Series|Lost to Follow-up|1|||
164536627|NCT00475033|594338055|FG001|After the Infant Series|Lost to Follow-up|0|||
164536628|NCT00475033|594338054|FG000|After the Infant Series|Other|0|||
164536629|NCT00475033|594338055|FG001|After the Infant Series|Other|1|||
164536630|NCT00475033|594338054|FG000|Toddler Dose|Parent or legal guardian request|2|||
164536631|NCT00475033|594338055|FG001|Toddler Dose|Parent or legal guardian request|0|||
164536632|NCT00475033|594338054|FG000|Toddler Dose|Failed to return|1|||
164536633|NCT00475033|594338055|FG001|Toddler Dose|Failed to return|0|||
164536634|NCT00475033|594338054|FG000|Toddler Dose|Lost to Follow-up|1|||
164536635|NCT00475033|594338055|FG001|Toddler Dose|Lost to Follow-up|0|||
164536636|NCT01422850|594338059|FG000|Overall Study|Physician Decision|3|||
164536637|NCT04484831|594338060|FG000|Overall Study|Withdrawal by Subject|1|||
164536638|NCT04484831|594338061|FG001|Overall Study|Withdrawal by Subject|0|||
164536639|NCT00174265|594338063|FG000|Overall Study|Adverse Event|7|||
164536640|NCT00174265|594338064|FG001|Overall Study|Adverse Event|4|||
164536641|NCT00174265|594338063|FG000|Overall Study|Lack of Efficacy|2|||
164536642|NCT00174265|594338064|FG001|Overall Study|Lack of Efficacy|2|||
164536643|NCT00174265|594338063|FG000|Overall Study|Withdrawal by Subject|3|||
164536644|NCT00174265|594338064|FG001|Overall Study|Withdrawal by Subject|5|||
164536645|NCT00174265|594338063|FG000|Overall Study|Lost to Follow-up|1|||
164536646|NCT00174265|594338064|FG001|Overall Study|Lost to Follow-up|0|||
164536647|NCT00174265|594338063|FG000|Overall Study|Other (Not specified)|16|||
164536648|NCT00174265|594338064|FG001|Overall Study|Other (Not specified)|10|||
164536649|NCT03231943|594338066|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
164536650|NCT03231943|594338067|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
164536651|NCT03231943|594338068|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
164536652|NCT03231943|594338069|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
164536653|NCT03231943|594338070|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
164536654|NCT03231943|594338071|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
164536655|NCT03231943|594338072|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
164536656|NCT03231943|594338073|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
164536657|NCT03231943|594338074|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
164536658|NCT03231943|594338075|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
164536659|NCT03231943|594338076|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
164536660|NCT03231943|594338077|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
164536661|NCT03231943|594338078|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
164536662|NCT03231943|594338066|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
164536663|NCT03231943|594338067|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
164536664|NCT03231943|594338068|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
164536665|NCT03231943|594338069|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
164536666|NCT03231943|594338070|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
164536667|NCT03231943|594338071|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
164536668|NCT03231943|594338072|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
164536669|NCT03231943|594338073|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
164536670|NCT03231943|594338074|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
164536671|NCT03231943|594338075|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
164536672|NCT03231943|594338076|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
164536673|NCT03231943|594338077|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
164536674|NCT03231943|594338078|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
164536675|NCT03231943|594338066|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
164536676|NCT03231943|594338067|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
164536677|NCT03231943|594338068|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
164536678|NCT03231943|594338069|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
164536679|NCT03231943|594338070|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
164536680|NCT03231943|594338071|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
164536681|NCT03231943|594338072|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
164536682|NCT03231943|594338073|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
164536683|NCT03231943|594338074|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
164536684|NCT03231943|594338075|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
164536685|NCT03231943|594338076|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
164536686|NCT03231943|594338077|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
164536687|NCT03231943|594338078|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
164536688|NCT03231943|594338066|FG000|Part 2|Adverse Event|0|||
164536689|NCT03231943|594338067|FG001|Part 2|Adverse Event|0|||
164536690|NCT03231943|594338068|FG002|Part 2|Adverse Event|0|||
164536691|NCT03231943|594338069|FG003|Part 2|Adverse Event|0|||
164536692|NCT03231943|594338070|FG004|Part 2|Adverse Event|0|||
164536693|NCT03231943|594338071|FG005|Part 2|Adverse Event|0|||
164536694|NCT03231943|594338072|FG006|Part 2|Adverse Event|0|||
164536695|NCT03231943|594338073|FG007|Part 2|Adverse Event|0|||
164536696|NCT03231943|594338074|FG008|Part 2|Adverse Event|0|||
164536697|NCT03231943|594338075|FG009|Part 2|Adverse Event|0|||
164536698|NCT03231943|594338076|FG010|Part 2|Adverse Event|1|||
164536699|NCT03231943|594338077|FG011|Part 2|Adverse Event|0|||
164536700|NCT03231943|594338078|FG012|Part 2|Adverse Event|0|||
164536701|NCT03231943|594338066|FG000|Part 2|Withdrawal by Subject|0|||
164536702|NCT03231943|594338067|FG001|Part 2|Withdrawal by Subject|0|||
164536703|NCT03231943|594338068|FG002|Part 2|Withdrawal by Subject|0|||
164536704|NCT03231943|594338069|FG003|Part 2|Withdrawal by Subject|0|||
164536705|NCT03231943|594338070|FG004|Part 2|Withdrawal by Subject|0|||
164536706|NCT03231943|594338071|FG005|Part 2|Withdrawal by Subject|0|||
164536707|NCT03231943|594338072|FG006|Part 2|Withdrawal by Subject|0|||
164536708|NCT03231943|594338073|FG007|Part 2|Withdrawal by Subject|0|||
164536709|NCT03231943|594338074|FG008|Part 2|Withdrawal by Subject|0|||
164536710|NCT03231943|594338075|FG009|Part 2|Withdrawal by Subject|0|||
164536711|NCT03231943|594338076|FG010|Part 2|Withdrawal by Subject|0|||
164536712|NCT03231943|594338077|FG011|Part 2|Withdrawal by Subject|1|||
164536713|NCT03231943|594338078|FG012|Part 2|Withdrawal by Subject|0|||
164536714|NCT03040622|594338079|FG000|Overall Study|unable to implant device|3|||
164536715|NCT01335009|594338080|FG000|Overall Study|Too ill to travel to study sites|1|||
164536716|NCT01335009|594338081|FG001|Overall Study|Too ill to travel to study sites|0|||
164536717|NCT01335009|594338080|FG000|Overall Study|Death|28|||
164536718|NCT01335009|594338081|FG001|Overall Study|Death|32|||
164536719|NCT01335009|594338080|FG000|Overall Study|Withdrawal by Subject|1|||
164536720|NCT01335009|594338081|FG001|Overall Study|Withdrawal by Subject|1|||
164536721|NCT01335009|594338080|FG000|Overall Study|Lost to Follow-up|1|||
164536722|NCT01335009|594338081|FG001|Overall Study|Lost to Follow-up|0|||
164536723|NCT02818920|594338082|FG000|Overall Study|Unresectable|4|||
164536724|NCT02818920|594338082|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
164536725|NCT02818920|594338082|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
164536726|NCT02818920|594338082|FG000|Overall Study|Adverse Event|3|||
164536727|NCT02818920|594338082|FG000|Overall Study|Developed Other Disease|1|||
164536728|NCT02818920|594338082|FG000|Overall Study|Refused Further Treatment|1|||
164536729|NCT00445068|594338083|FG000|Overall Study|Disease progression|26|||
164536730|NCT00445068|594338083|FG000|Overall Study|Adverse Event|5|||
164536731|NCT00445068|594338083|FG000|Overall Study|Abnormal laboratory value|2|||
164536732|NCT00445068|594338083|FG000|Overall Study|Withdrawal by Subject|2|||
164536733|NCT00445068|594338083|FG000|Overall Study|Death|1|||
164536734|NCT02673619|594338084|FG000|Overall Study|Lost to Follow-up|1|||
164536735|NCT02673619|594338085|FG001|Overall Study|Lost to Follow-up|0|||
164536736|NCT02673619|594338086|FG002|Overall Study|Lost to Follow-up|0|||
164536737|NCT02673619|594338087|FG003|Overall Study|Lost to Follow-up|0|||
164536738|NCT02673619|594338084|FG000|Overall Study|Withdrawal by Subject|1|||
164536739|NCT02673619|594338085|FG001|Overall Study|Withdrawal by Subject|1|||
164536740|NCT02673619|594338086|FG002|Overall Study|Withdrawal by Subject|1|||
164536741|NCT02673619|594338087|FG003|Overall Study|Withdrawal by Subject|0|||
164536742|NCT02673619|594338084|FG000|Overall Study|Adverse Event|0|||
164536743|NCT02673619|594338085|FG001|Overall Study|Adverse Event|0|||
164536744|NCT02673619|594338086|FG002|Overall Study|Adverse Event|1|||
164536745|NCT02673619|594338087|FG003|Overall Study|Adverse Event|0|||
164536746|NCT02673619|594338084|FG000|Overall Study|Lack of Efficacy|0|||
164536747|NCT02673619|594338085|FG001|Overall Study|Lack of Efficacy|0|||
164536748|NCT02673619|594338086|FG002|Overall Study|Lack of Efficacy|1|||
164536749|NCT02673619|594338087|FG003|Overall Study|Lack of Efficacy|0|||
164536750|NCT03444324|594338088|FG000|Overall Study|Withdrawal by Subject|0|||
164536751|NCT03444324|594338089|FG001|Overall Study|Withdrawal by Subject|1|||
164536752|NCT03444324|594338088|FG000|Overall Study|Lost to Follow-up|4|||
164536753|NCT03444324|594338089|FG001|Overall Study|Lost to Follow-up|2|||
164536754|NCT03444324|594338088|FG000|Overall Study|Protocol Violation|0|||
164536755|NCT03444324|594338089|FG001|Overall Study|Protocol Violation|1|||
164536756|NCT03444324|594338088|FG000|Overall Study|Lack of Trial Compliance|1|||
164536757|NCT03444324|594338089|FG001|Overall Study|Lack of Trial Compliance|1|||
164536758|NCT03444324|594338088|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
164536759|NCT03444324|594338089|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
164536760|NCT00658684|594338091|FG000|Overall Study|Adverse Event|10|||
164536761|NCT00658684|594338092|FG001|Overall Study|Adverse Event|8|||
164536762|NCT00658684|594338093|FG002|Overall Study|Adverse Event|2|||
164536763|NCT00658684|594338094|FG003|Overall Study|Adverse Event|0|||
164536764|NCT00658684|594338091|FG000|Overall Study|Withdrawal by Subject|6|||
164536765|NCT00658684|594338092|FG001|Overall Study|Withdrawal by Subject|4|||
164648869|NCT00686374|594741735|FG000|Overall Study|Withdrew consent|5|||
164536766|NCT00658684|594338093|FG002|Overall Study|Withdrawal by Subject|1|||
164536767|NCT00658684|594338094|FG003|Overall Study|Withdrawal by Subject|1|||
164536768|NCT00658684|594338091|FG000|Overall Study|Lack of Efficacy|1|||
164536769|NCT00658684|594338092|FG001|Overall Study|Lack of Efficacy|1|||
164536770|NCT00658684|594338093|FG002|Overall Study|Lack of Efficacy|0|||
164536771|NCT00658684|594338094|FG003|Overall Study|Lack of Efficacy|0|||
164536772|NCT00658684|594338091|FG000|Overall Study|Protocol Violation|1|||
164536773|NCT00658684|594338092|FG001|Overall Study|Protocol Violation|1|||
164536774|NCT00658684|594338093|FG002|Overall Study|Protocol Violation|0|||
164536775|NCT00658684|594338094|FG003|Overall Study|Protocol Violation|0|||
164536776|NCT00658684|594338091|FG000|Overall Study|Pregnancy|1|||
164536777|NCT00658684|594338092|FG001|Overall Study|Pregnancy|1|||
164536778|NCT00658684|594338093|FG002|Overall Study|Pregnancy|0|||
164536779|NCT00658684|594338094|FG003|Overall Study|Pregnancy|0|||
164536780|NCT00688103|594338095|FG000|Overall Study|Adverse Event|4|||
164536781|NCT00688103|594338096|FG001|Overall Study|Adverse Event|1|||
164536782|NCT00688103|594338095|FG000|Overall Study|Lack of Efficacy|11|||
164536783|NCT00688103|594338096|FG001|Overall Study|Lack of Efficacy|1|||
164536784|NCT00688103|594338095|FG000|Overall Study|Withdrawal by Subject|4|||
164536785|NCT00688103|594338096|FG001|Overall Study|Withdrawal by Subject|2|||
164536786|NCT00688103|594338095|FG000|Overall Study|complex reasons|11|||
164536787|NCT00688103|594338096|FG001|Overall Study|complex reasons|9|||
164536788|NCT06071754|594338097|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
164536789|NCT03226275|594338098|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
164536790|NCT03226275|594338099|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
164536791|NCT03226275|594338100|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
164536792|NCT03226275|594338101|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
164536793|NCT03226275|594338098|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
164536794|NCT03226275|594338099|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
164536795|NCT03226275|594338100|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
164536796|NCT03226275|594338101|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
164536797|NCT05959629|594338104|FG000|Overall Study|partially necrotic/technical issues|2|||
164536798|NCT05959629|594338105|FG001|Overall Study|partially necrotic/technical issues|2|||
164536799|NCT01436071|594339540|FG000|Overall Study|Adverse Event|1|||
164536800|NCT01436071|594339541|FG001|Overall Study|Adverse Event|0|||
164536801|NCT01436071|594339540|FG000|Overall Study|Lack of Efficacy|16|||
164536802|NCT01436071|594339541|FG001|Overall Study|Lack of Efficacy|7|||
164536803|NCT01436071|594339540|FG000|Overall Study|Protocol Violation|0|||
164536804|NCT01436071|594339541|FG001|Overall Study|Protocol Violation|1|||
164536805|NCT01436071|594339540|FG000|Overall Study|Lost to Follow-up|3|||
164536806|NCT01436071|594339541|FG001|Overall Study|Lost to Follow-up|1|||
164536807|NCT01436071|594339540|FG000|Overall Study|Physician Decision|1|||
164536808|NCT01436071|594339541|FG001|Overall Study|Physician Decision|0|||
164536809|NCT01436071|594339540|FG000|Overall Study|Withdrawal by Subject|2|||
164536810|NCT01436071|594339541|FG001|Overall Study|Withdrawal by Subject|2|||
164536811|NCT01436071|594339540|FG000|Overall Study|Did Not Receive Trial Medication|3|||
164536812|NCT01436071|594339541|FG001|Overall Study|Did Not Receive Trial Medication|3|||
164536813|NCT03808688|594339544|FG000|Overall Study|Adverse Event|13|||
164536814|NCT03808688|594339545|FG001|Overall Study|Adverse Event|17|||
164536815|NCT03808688|594339544|FG000|Overall Study|Lack of Efficacy|2|||
164536816|NCT03808688|594339545|FG001|Overall Study|Lack of Efficacy|0|||
164536817|NCT03808688|594339544|FG000|Overall Study|Lost to Follow-up|0|||
164536818|NCT03808688|594339545|FG001|Overall Study|Lost to Follow-up|2|||
164536819|NCT03808688|594339544|FG000|Overall Study|Withdrawal by Subject|1|||
164536820|NCT03808688|594339545|FG001|Overall Study|Withdrawal by Subject|0|||
164536821|NCT03808688|594339544|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
164536822|NCT03808688|594339545|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
164536823|NCT03808688|594339544|FG000|Overall Study|IOP Too High|1|||
164536824|NCT03808688|594339545|FG001|Overall Study|IOP Too High|1|||
164536825|NCT03808688|594339544|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
164536826|NCT03808688|594339545|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
164536827|NCT03808688|594339544|FG000|Overall Study|Visit Out of Window|0|||
164536828|NCT03808688|594339545|FG001|Overall Study|Visit Out of Window|1|||
164536829|NCT03808688|594339544|FG000|Overall Study|Medication Non-Compliance|0|||
164536830|NCT03808688|594339545|FG001|Overall Study|Medication Non-Compliance|1|||
164536831|NCT03335163|594339549|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
164536832|NCT03335163|594339549|FG000|Overall Study|Withdrawal by Subject|18|||
164536833|NCT01215175|594339551|FG000|Overall Study|Lost to Follow-up|0|||
164536834|NCT01215175|594339552|FG001|Overall Study|Lost to Follow-up|1|||
164536835|NCT01215175|594339553|FG002|Overall Study|Lost to Follow-up|0|||
164536836|NCT01215175|594339554|FG003|Overall Study|Lost to Follow-up|1|||
164536837|NCT01215175|594339555|FG004|Overall Study|Lost to Follow-up|0|||
164536838|NCT01016964|594339556|FG000|Overall Study|Lost to Follow-up|3|||
164536839|NCT01016964|594339557|FG001|Overall Study|Lost to Follow-up|3|||
164536840|NCT03872453|594339558|FG000|Overall Study|Adverse Event|1|||
164536841|NCT03872453|594339559|FG001|Overall Study|Adverse Event|1|||
164536842|NCT03872453|594339560|FG002|Overall Study|Adverse Event|0|||
164536843|NCT03872453|594339561|FG003|Overall Study|Adverse Event|0|||
164536844|NCT03872453|594339558|FG000|Overall Study|Lost to Follow-up|8|||
164536845|NCT03872453|594339559|FG001|Overall Study|Lost to Follow-up|7|||
164536846|NCT03872453|594339560|FG002|Overall Study|Lost to Follow-up|4|||
164536847|NCT03872453|594339561|FG003|Overall Study|Lost to Follow-up|4|||
164536848|NCT03872453|594339558|FG000|Overall Study|Never Treated Migraine|19|||
164536849|NCT03872453|594339559|FG001|Overall Study|Never Treated Migraine|17|||
164536850|NCT03872453|594339560|FG002|Overall Study|Never Treated Migraine|13|||
164536851|NCT03872453|594339561|FG003|Overall Study|Never Treated Migraine|12|||
164536852|NCT03872453|594339558|FG000|Overall Study|Pregnancy|1|||
164536853|NCT03872453|594339559|FG001|Overall Study|Pregnancy|0|||
164536854|NCT03872453|594339560|FG002|Overall Study|Pregnancy|0|||
164536855|NCT03872453|594339561|FG003|Overall Study|Pregnancy|0|||
164536856|NCT03872453|594339558|FG000|Overall Study|Protocol Deviation|2|||
164536857|NCT03872453|594339559|FG001|Overall Study|Protocol Deviation|0|||
164536858|NCT03872453|594339560|FG002|Overall Study|Protocol Deviation|0|||
164536859|NCT03872453|594339561|FG003|Overall Study|Protocol Deviation|2|||
164536860|NCT03872453|594339558|FG000|Overall Study|Withdrawal by Subject|0|||
164536861|NCT03872453|594339559|FG001|Overall Study|Withdrawal by Subject|1|||
164536862|NCT03872453|594339560|FG002|Overall Study|Withdrawal by Subject|2|||
164536863|NCT03872453|594339561|FG003|Overall Study|Withdrawal by Subject|0|||
164536864|NCT03872453|594339558|FG000|Overall Study|Other Than Specified|1|||
164536865|NCT03872453|594339559|FG001|Overall Study|Other Than Specified|0|||
164536866|NCT03872453|594339560|FG002|Overall Study|Other Than Specified|0|||
164536867|NCT03872453|594339561|FG003|Overall Study|Other Than Specified|0|||
164536868|NCT00352885|594339562|FG000|Overall Study|Withdrawal by Subject|0|||
164536869|NCT00352885|594339563|FG001|Overall Study|Withdrawal by Subject|3|||
164536870|NCT00352885|594339562|FG000|Overall Study|Development of major depression|0|||
164536871|NCT00352885|594339563|FG001|Overall Study|Development of major depression|1|||
164536872|NCT00352885|594339562|FG000|Overall Study|Progression of metastatic melanoma|5|||
164536873|NCT00352885|594339563|FG001|Overall Study|Progression of metastatic melanoma|3|||
164536874|NCT00352885|594339562|FG000|Overall Study|Side effects of IL-2 administration|1|||
164536875|NCT00352885|594339563|FG001|Overall Study|Side effects of IL-2 administration|0|||
164536876|NCT01678209|594339564|FG000|Overall Study|could not scan twice|1|||
164536877|NCT01678209|594339565|FG001|Overall Study|could not scan twice|1|||
164536878|NCT01678209|594339566|FG002|Overall Study|could not scan twice|1|||
164536879|NCT01678209|594339564|FG000|Overall Study|scheduling conflicts|0|||
164536880|NCT01678209|594339565|FG001|Overall Study|scheduling conflicts|0|||
164536881|NCT01678209|594339566|FG002|Overall Study|scheduling conflicts|1|||
164536882|NCT01678209|594339564|FG000|Overall Study|screen fail|16|||
164536883|NCT01678209|594339565|FG001|Overall Study|screen fail|17|||
164536884|NCT01678209|594339566|FG002|Overall Study|screen fail|16|||
164536885|NCT03756350|594339571|FG000|Overall Study|Lost to Follow-up|1|||
164536886|NCT00440700|594339574|FG000|Overall Study|Withdrawal by Subject|8|||
164536887|NCT00440700|594339575|FG001|Overall Study|Withdrawal by Subject|8|||
164536888|NCT00440700|594339576|FG002|Overall Study|Withdrawal by Subject|4|||
164536889|NCT01096342|594339577|FG000|Overall Study|Protocol Violation|1|||
164536890|NCT00385203|594339578|FG000|Overall Study|Adverse Event|5|||
164536891|NCT00385203|594339579|FG001|Overall Study|Adverse Event|4|||
164536892|NCT00385203|594339578|FG000|Overall Study|Death|1|||
164536893|NCT00385203|594339579|FG001|Overall Study|Death|0|||
164536894|NCT00385203|594339578|FG000|Overall Study|Condition under investigation worsened|18|||
164536895|NCT00385203|594339579|FG001|Overall Study|Condition under investigation worsened|3|||
164536896|NCT00385203|594339578|FG000|Overall Study|Incorrect enrollment|2|||
164536897|NCT00385203|594339579|FG001|Overall Study|Incorrect enrollment|0|||
164536898|NCT03422172|594339580|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
164536899|NCT03422172|594339580|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
164536900|NCT03422172|594339580|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
164536901|NCT00293722|594339589|FG000|Overall Study|Other|427|||
164536902|NCT01008696|594339590|FG000|Overall Study|Participant's evasion of hospital visit|5|||
164536903|NCT01008696|594339591|FG001|Overall Study|Participant's evasion of hospital visit|4|||
164536904|NCT01008696|594339590|FG000|Overall Study|Withdrawal by Subject|2|||
164536905|NCT01008696|594339591|FG001|Overall Study|Withdrawal by Subject|4|||
164536906|NCT01008696|594339590|FG000|Overall Study|Physician Decision|5|||
164536907|NCT01008696|594339591|FG001|Overall Study|Physician Decision|1|||
164536908|NCT01008696|594339590|FG000|Overall Study|Adverse Event|1|||
164536909|NCT01008696|594339591|FG001|Overall Study|Adverse Event|0|||
164536910|NCT01008696|594339590|FG000|Overall Study|Participants' non-cooperation|2|||
164536911|NCT01008696|594339591|FG001|Overall Study|Participants' non-cooperation|3|||
164536912|NCT01008696|594339590|FG000|Overall Study|Other|2|||
164648870|NCT00686374|594741735|FG000|Overall Study|Lost to Follow-up|1|||
164648871|NCT00686374|594741735|FG000|Overall Study|Missing reason|33|||
164648872|NCT00686374|594741735|FG000|Overall Study|Other, not specified|4|||
164648873|NCT00618774|594741736|FG000|Overall Study|Adverse Event|5|||
164648874|NCT00618774|594741737|FG001|Overall Study|Adverse Event|3|||
164648875|NCT00618774|594741736|FG000|Overall Study|Withdrawal by Subject|1|||
164648876|NCT00618774|594741737|FG001|Overall Study|Withdrawal by Subject|0|||
164648877|NCT02424565|594741739|FG000|Period 1 (D0)|Protocol Violation|0|||
164648878|NCT02424565|594741740|FG001|Period 1 (D0)|Protocol Violation|1|||
164648879|NCT02143947|594741741|FG000|Overall Study|Lost to Follow-up|4|||
164648880|NCT02143947|594741742|FG001|Overall Study|Lost to Follow-up|2|||
164648881|NCT01808209|594741743|FG000|Overall Study|Lost to Follow-up|0|||
164648882|NCT01808209|594741744|FG001|Overall Study|Lost to Follow-up|1|||
164648883|NCT00685919|594741751|FG000|Overall Study|Withdrawal by Subject|0|||
164648884|NCT00685919|594741752|FG001|Overall Study|Withdrawal by Subject|0|||
164648885|NCT00685919|594741753|FG002|Overall Study|Withdrawal by Subject|1|||
164536913|NCT01008696|594339591|FG001|Overall Study|Other|3|||
164648886|NCT00685919|594741754|FG003|Overall Study|Withdrawal by Subject|0|||
164648887|NCT00685919|594741751|FG000|Overall Study|Physician Decision|1|||
164648888|NCT00685919|594741752|FG001|Overall Study|Physician Decision|0|||
164648889|NCT00685919|594741753|FG002|Overall Study|Physician Decision|0|||
164536914|NCT01008696|594339590|FG000|Overall Study|Other|0|||
164536915|NCT01008696|594339591|FG001|Overall Study|Other|2|||
164536916|NCT04498169|594339592|FG000|Study Completion|Adverse Event|1|||
164536917|NCT04498169|594339593|FG001|Study Completion|Adverse Event|1|||
164536918|NCT04964960|594339594|FG000|Overall Study|Withdrawal by Subject|1|||
164536919|NCT04964960|594339594|FG000|Overall Study|Did not complete cycles|1|||
164536920|NCT02076113|594339595|FG000|Overall Study|Lost to Follow-up|4|||
164536921|NCT02076113|594339596|FG001|Overall Study|Lost to Follow-up|1|||
164536922|NCT02076113|594339595|FG000|Overall Study|Withdrawal by Subject|2|||
164536923|NCT02076113|594339596|FG001|Overall Study|Withdrawal by Subject|3|||
164536924|NCT02076113|594339595|FG000|Overall Study|Death|1|||
164536925|NCT02076113|594339596|FG001|Overall Study|Death|3|||
164536926|NCT02960854|594339597|FG000|Overall Study|Not Disclosed|2|||
164536927|NCT02960854|594339598|FG001|Overall Study|Not Disclosed|2|||
164536928|NCT02960854|594339597|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
164536929|NCT02960854|594339598|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
164536930|NCT02960854|594339597|FG000|Overall Study|Subject Withdrew Consent|0|||
164536931|NCT02960854|594339598|FG001|Overall Study|Subject Withdrew Consent|1|||
164536932|NCT02960854|594339597|FG000|Overall Study|Death|4|||
164536933|NCT02960854|594339598|FG001|Overall Study|Death|6|||
164536934|NCT00221195|594339599|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
164536935|NCT00221195|594339600|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
164536936|NCT00221195|594339599|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
164536937|NCT00221195|594339600|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
164536938|NCT00221195|594339599|FG000|Washout Period (Months 7-9)|Death|0|||
164536939|NCT00221195|594339600|FG001|Washout Period (Months 7-9)|Death|1|||
164536940|NCT00221195|594339599|FG000|Therapy 2 (Months 10-15)|Death|1|||
164536941|NCT00221195|594339600|FG001|Therapy 2 (Months 10-15)|Death|0|||
164536942|NCT00221195|594339599|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
164536943|NCT00221195|594339600|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
164536944|NCT01383161|594339602|FG000|Overall Study|Adverse Event|5|||
164536945|NCT01383161|594339603|FG001|Overall Study|Adverse Event|1|||
164536946|NCT01383161|594339602|FG000|Overall Study|Withdrawal by Subject|0|||
164536947|NCT01383161|594339603|FG001|Overall Study|Withdrawal by Subject|2|||
164536948|NCT01383161|594339602|FG000|Overall Study|Lack of Efficacy|0|||
164536949|NCT01383161|594339603|FG001|Overall Study|Lack of Efficacy|1|||
164536950|NCT00833911|594339604|FG000|Titration|Adverse Event|18|||
164536951|NCT00833911|594339604|FG000|Titration|Withdrawal by Subject|3|||
164536952|NCT00833911|594339604|FG000|Maintenance Phase I|Adverse Event|73|||
164536953|NCT00833911|594339604|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
164536954|NCT00833911|594339604|FG000|Maintenance Phase I|Physician Decision|10|||
164536955|NCT00833911|594339604|FG000|Maintenance Phase I|Lack of Efficacy|4|||
164536956|NCT00833911|594339604|FG000|Maintenance Phase II|Adverse Event|6|||
164536957|NCT00833911|594339604|FG000|Maintenance Phase II|Physician Decision|2|||
164536958|NCT00833911|594339604|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
164536959|NCT00833911|594339604|FG000|Maintenance Phase II|Lack of Efficacy|1|||
164536960|NCT03942406|594339613|FG000|Overall Study|Lost to Follow-up|4|||
164536961|NCT03942406|594339614|FG001|Overall Study|Lost to Follow-up|5|||
164536962|NCT03942406|594339615|FG002|Overall Study|Lost to Follow-up|3|||
164536963|NCT03942406|594339616|FG003|Overall Study|Lost to Follow-up|7|||
164536964|NCT03942406|594339617|FG004|Overall Study|Lost to Follow-up|1|||
164536965|NCT03942406|594339618|FG005|Overall Study|Lost to Follow-up|0|||
164536966|NCT03942406|594339619|FG006|Overall Study|Lost to Follow-up|0|||
164536967|NCT03942406|594339613|FG000|Overall Study|Withdrawal by Subject|3|||
164536968|NCT03942406|594339614|FG001|Overall Study|Withdrawal by Subject|1|||
164536969|NCT03942406|594339615|FG002|Overall Study|Withdrawal by Subject|1|||
164536970|NCT03942406|594339616|FG003|Overall Study|Withdrawal by Subject|3|||
164536971|NCT03942406|594339617|FG004|Overall Study|Withdrawal by Subject|0|||
164536972|NCT03942406|594339618|FG005|Overall Study|Withdrawal by Subject|0|||
164536973|NCT03942406|594339619|FG006|Overall Study|Withdrawal by Subject|0|||
164536974|NCT03942406|594339613|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
164536975|NCT03942406|594339614|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
164536976|NCT03942406|594339615|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
164536977|NCT03942406|594339616|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
164536978|NCT03942406|594339617|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
164536979|NCT03942406|594339618|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
164536980|NCT03942406|594339619|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
164536981|NCT02616614|594339620|FG000|Overall Study|Withdrawal by Subject|10|||
164536982|NCT02616614|594339621|FG001|Overall Study|Withdrawal by Subject|5|||
164536983|NCT02616614|594339622|FG002|Overall Study|Withdrawal by Subject|6|||
164536984|NCT02616614|594339620|FG000|Overall Study|Physician Decision|2|||
164536985|NCT02616614|594339621|FG001|Overall Study|Physician Decision|1|||
164536986|NCT02616614|594339622|FG002|Overall Study|Physician Decision|0|||
164648890|NCT00685919|594741754|FG003|Overall Study|Physician Decision|0|||
164536987|NCT02616614|594339620|FG000|Overall Study|Adverse Event|1|||
164536988|NCT02616614|594339621|FG001|Overall Study|Adverse Event|4|||
164536989|NCT02616614|594339622|FG002|Overall Study|Adverse Event|1|||
164536990|NCT02616614|594339620|FG000|Overall Study|Protocol Violation|0|||
164536991|NCT02616614|594339621|FG001|Overall Study|Protocol Violation|3|||
164536992|NCT02616614|594339622|FG002|Overall Study|Protocol Violation|1|||
164536993|NCT02616614|594339620|FG000|Overall Study|Prohibited Medication|12|||
164536994|NCT02616614|594339621|FG001|Overall Study|Prohibited Medication|9|||
164536995|NCT02616614|594339622|FG002|Overall Study|Prohibited Medication|5|||
164536996|NCT02616614|594339620|FG000|Overall Study|More than 3 applications missed|6|||
164536997|NCT02616614|594339621|FG001|Overall Study|More than 3 applications missed|8|||
164536998|NCT02616614|594339622|FG002|Overall Study|More than 3 applications missed|1|||
164536999|NCT02616614|594339620|FG000|Overall Study|Lost to Follow-up|31|||
164537000|NCT02616614|594339621|FG001|Overall Study|Lost to Follow-up|28|||
164537001|NCT02616614|594339622|FG002|Overall Study|Lost to Follow-up|13|||
164537002|NCT02616614|594339620|FG000|Overall Study|Pregnancy|2|||
164537003|NCT02616614|594339621|FG001|Overall Study|Pregnancy|0|||
164537004|NCT02616614|594339622|FG002|Overall Study|Pregnancy|1|||
164537005|NCT02616614|594339620|FG000|Overall Study|Other|1|||
164537006|NCT02616614|594339621|FG001|Overall Study|Other|2|||
164537007|NCT02616614|594339622|FG002|Overall Study|Other|1|||
164537008|NCT02748018|594339623|FG000|Study Period|Adverse Event|1|||
164537009|NCT02748018|594339624|FG001|Study Period|Adverse Event|3|||
164537010|NCT02748018|594339625|FG002|Study Period|Adverse Event|4|||
164537011|NCT02748018|594339626|FG003|Study Period|Adverse Event|0|||
164537012|NCT02748018|594339627|FG004|Study Period|Adverse Event|3|||
164537013|NCT02748018|594339628|FG005|Study Period|Adverse Event|3|||
164537014|NCT02748018|594339623|FG000|Study Period|Withdrawal by Subject|7|||
164537015|NCT02748018|594339624|FG001|Study Period|Withdrawal by Subject|4|||
164537016|NCT02748018|594339625|FG002|Study Period|Withdrawal by Subject|4|||
164537017|NCT02748018|594339626|FG003|Study Period|Withdrawal by Subject|11|||
164537018|NCT02748018|594339627|FG004|Study Period|Withdrawal by Subject|12|||
164537019|NCT02748018|594339628|FG005|Study Period|Withdrawal by Subject|10|||
164537020|NCT02748018|594339623|FG000|Study Period|Pregnancy|0|||
164537021|NCT02748018|594339624|FG001|Study Period|Pregnancy|1|||
164537022|NCT02748018|594339625|FG002|Study Period|Pregnancy|0|||
164537023|NCT02748018|594339626|FG003|Study Period|Pregnancy|0|||
164537024|NCT02748018|594339627|FG004|Study Period|Pregnancy|1|||
164537025|NCT02748018|594339628|FG005|Study Period|Pregnancy|0|||
164537026|NCT02748018|594339623|FG000|Study Period|Physician Decision|2|||
164537027|NCT02748018|594339624|FG001|Study Period|Physician Decision|2|||
164537028|NCT02748018|594339625|FG002|Study Period|Physician Decision|1|||
164537029|NCT02748018|594339626|FG003|Study Period|Physician Decision|0|||
164537030|NCT02748018|594339627|FG004|Study Period|Physician Decision|2|||
164537031|NCT02748018|594339628|FG005|Study Period|Physician Decision|0|||
164537032|NCT02748018|594339623|FG000|Study Period|Lost to Follow-up|0|||
164537033|NCT02748018|594339624|FG001|Study Period|Lost to Follow-up|0|||
164537034|NCT02748018|594339625|FG002|Study Period|Lost to Follow-up|0|||
164537035|NCT02748018|594339626|FG003|Study Period|Lost to Follow-up|2|||
164537036|NCT02748018|594339627|FG004|Study Period|Lost to Follow-up|0|||
164537037|NCT02748018|594339628|FG005|Study Period|Lost to Follow-up|1|||
164537038|NCT02748018|594339623|FG000|Continuation Period|Adverse Event|2|||
164537039|NCT02748018|594339624|FG001|Continuation Period|Adverse Event|0|||
164537040|NCT02748018|594339625|FG002|Continuation Period|Adverse Event|1|||
164537041|NCT02748018|594339626|FG003|Continuation Period|Adverse Event|1|||
164537042|NCT02748018|594339627|FG004|Continuation Period|Adverse Event|1|||
164537043|NCT02748018|594339628|FG005|Continuation Period|Adverse Event|4|||
164537044|NCT02748018|594339623|FG000|Continuation Period|Withdrawal by Subject|3|||
164537045|NCT02748018|594339624|FG001|Continuation Period|Withdrawal by Subject|5|||
164537046|NCT02748018|594339625|FG002|Continuation Period|Withdrawal by Subject|3|||
164537047|NCT02748018|594339626|FG003|Continuation Period|Withdrawal by Subject|9|||
164537048|NCT02748018|594339627|FG004|Continuation Period|Withdrawal by Subject|11|||
164537049|NCT02748018|594339628|FG005|Continuation Period|Withdrawal by Subject|1|||
164537050|NCT02748018|594339623|FG000|Continuation Period|Lost to Follow-up|0|||
164537051|NCT02748018|594339624|FG001|Continuation Period|Lost to Follow-up|2|||
164537052|NCT02748018|594339625|FG002|Continuation Period|Lost to Follow-up|1|||
164537053|NCT02748018|594339626|FG003|Continuation Period|Lost to Follow-up|0|||
164537054|NCT02748018|594339627|FG004|Continuation Period|Lost to Follow-up|1|||
164537055|NCT02748018|594339628|FG005|Continuation Period|Lost to Follow-up|0|||
164537056|NCT02748018|594339623|FG000|Continuation Period|Pregnancy|1|||
164537057|NCT02748018|594339624|FG001|Continuation Period|Pregnancy|2|||
164537058|NCT02748018|594339625|FG002|Continuation Period|Pregnancy|0|||
164537059|NCT02748018|594339626|FG003|Continuation Period|Pregnancy|0|||
164537060|NCT02748018|594339627|FG004|Continuation Period|Pregnancy|0|||
164537061|NCT02748018|594339628|FG005|Continuation Period|Pregnancy|0|||
164537062|NCT02748018|594339623|FG000|Continuation Period|Physician Decision|0|||
164537063|NCT02748018|594339624|FG001|Continuation Period|Physician Decision|1|||
164537064|NCT02748018|594339625|FG002|Continuation Period|Physician Decision|2|||
164537065|NCT02748018|594339626|FG003|Continuation Period|Physician Decision|0|||
164537066|NCT02748018|594339627|FG004|Continuation Period|Physician Decision|2|||
164537067|NCT02748018|594339628|FG005|Continuation Period|Physician Decision|1|||
164537068|NCT02748018|594339623|FG000|Continuation Period|Protocol Violation|0|||
164537069|NCT02748018|594339624|FG001|Continuation Period|Protocol Violation|1|||
164537070|NCT02748018|594339625|FG002|Continuation Period|Protocol Violation|0|||
164537071|NCT02748018|594339626|FG003|Continuation Period|Protocol Violation|0|||
164537072|NCT02748018|594339627|FG004|Continuation Period|Protocol Violation|0|||
164537073|NCT02748018|594339628|FG005|Continuation Period|Protocol Violation|0|||
164537074|NCT02249767|594339634|FG000|Overall Study|Did not use medication|8|||
164537075|NCT02249767|594339635|FG001|Overall Study|Did not use medication|9|||
164537076|NCT02249767|594339636|FG002|Overall Study|Did not use medication|8|||
164537077|NCT01862640|594339641|FG000|Overall Study|Adverse Event|4|||
164537078|NCT01862640|594339642|FG001|Overall Study|Adverse Event|10|||
164537079|NCT01862640|594339643|FG002|Overall Study|Adverse Event|6|||
164537080|NCT01862640|594339644|FG003|Overall Study|Adverse Event|8|||
164537081|NCT01862640|594339641|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
164537082|NCT01862640|594339642|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
164537083|NCT01862640|594339643|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
164537084|NCT01862640|594339644|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
164537085|NCT01862640|594339641|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
164537086|NCT01862640|594339642|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
164537087|NCT01862640|594339643|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
164537088|NCT01862640|594339644|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
164537089|NCT01862640|594339641|FG000|Overall Study|Withdrawal by Subject|2|||
164537090|NCT01862640|594339642|FG001|Overall Study|Withdrawal by Subject|4|||
164537091|NCT01862640|594339643|FG002|Overall Study|Withdrawal by Subject|8|||
164537092|NCT01862640|594339644|FG003|Overall Study|Withdrawal by Subject|5|||
164537093|NCT01862640|594339641|FG000|Overall Study|Protocol Deviation|0|||
164537094|NCT01862640|594339642|FG001|Overall Study|Protocol Deviation|0|||
164537095|NCT01862640|594339643|FG002|Overall Study|Protocol Deviation|1|||
164537096|NCT01862640|594339644|FG003|Overall Study|Protocol Deviation|0|||
164537097|NCT03294109|594339647|FG000|Overall Study|Withdrawal by Subject|6|||
164537098|NCT03294109|594339648|FG001|Overall Study|Withdrawal by Subject|5|||
164537099|NCT02804178|594339649|FG000|Overall Study|Adverse Event|1|||
164537100|NCT00412971|594339654|FG000|Overall Study|Lost to Follow-up|17|||
164537101|NCT00412971|594339655|FG001|Overall Study|Lost to Follow-up|9|||
164537102|NCT00412971|594339654|FG000|Overall Study|Protocol Violation|13|||
164537103|NCT00412971|594339655|FG001|Overall Study|Protocol Violation|1|||
164537104|NCT01387230|594339656|FG000|Overall Study|Adverse Event|0|||
164537105|NCT01387230|594339657|FG001|Overall Study|Adverse Event|1|||
164537106|NCT01387230|594339658|FG002|Overall Study|Adverse Event|3|||
164537107|NCT01387230|594339656|FG000|Overall Study|Lack of Efficacy|8|||
164537108|NCT01387230|594339657|FG001|Overall Study|Lack of Efficacy|5|||
164537109|NCT01387230|594339658|FG002|Overall Study|Lack of Efficacy|4|||
164537110|NCT01387230|594339656|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
164537111|NCT01387230|594339657|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
164537112|NCT01387230|594339658|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
164537113|NCT01387230|594339656|FG000|Overall Study|Lost to Follow-up|0|||
164537114|NCT01387230|594339657|FG001|Overall Study|Lost to Follow-up|0|||
164537115|NCT01387230|594339658|FG002|Overall Study|Lost to Follow-up|1|||
164537116|NCT01387230|594339656|FG000|Overall Study|Withdrawal by Subject|4|||
164537117|NCT01387230|594339657|FG001|Overall Study|Withdrawal by Subject|1|||
164537118|NCT01387230|594339658|FG002|Overall Study|Withdrawal by Subject|0|||
164537119|NCT01163721|594339659|FG000|Overall Study|Adverse Event|5|||
164537120|NCT01163721|594339660|FG001|Overall Study|Adverse Event|6|||
164537121|NCT01163721|594339659|FG000|Overall Study|Withdrawal by Subject|3|||
164537122|NCT01163721|594339660|FG001|Overall Study|Withdrawal by Subject|4|||
164537123|NCT01163721|594339659|FG000|Overall Study|Lost to Follow-up|0|||
164537124|NCT01163721|594339660|FG001|Overall Study|Lost to Follow-up|1|||
164537125|NCT01163721|594339659|FG000|Overall Study|Physician Decision|0|||
164537126|NCT01163721|594339660|FG001|Overall Study|Physician Decision|1|||
164537127|NCT00633061|594339661|FG000|Overall Study|Study closed|86|||
164537128|NCT00633061|594339662|FG001|Overall Study|Study closed|0|||
164537129|NCT02708095|594339663|FG000|Overall Study|Adverse Event|4|||
164537130|NCT02708095|594339664|FG001|Overall Study|Adverse Event|10|||
164537131|NCT02708095|594339665|FG002|Overall Study|Adverse Event|11|||
164537132|NCT02708095|594339663|FG000|Overall Study|Lack of Efficacy|9|||
164648891|NCT04228302|594741755|FG000|Overall Study|Adverse Event|0|||
164648892|NCT04228302|594741756|FG001|Overall Study|Adverse Event|0|||
164648893|NCT04228302|594741757|FG002|Overall Study|Adverse Event|0|||
164537133|NCT02708095|594339664|FG001|Overall Study|Lack of Efficacy|3|||
164537134|NCT02708095|594339665|FG002|Overall Study|Lack of Efficacy|0|||
164537135|NCT02708095|594339663|FG000|Overall Study|Lost to Follow-up|2|||
164537136|NCT02708095|594339664|FG001|Overall Study|Lost to Follow-up|0|||
164537137|NCT02708095|594339665|FG002|Overall Study|Lost to Follow-up|0|||
164537138|NCT02708095|594339663|FG000|Overall Study|Physician Decision|2|||
164537139|NCT02708095|594339664|FG001|Overall Study|Physician Decision|3|||
164648894|NCT04228302|594741758|FG003|Overall Study|Adverse Event|0|||
164537140|NCT02708095|594339665|FG002|Overall Study|Physician Decision|2|||
164537141|NCT02708095|594339663|FG000|Overall Study|Protocol Violation|0|||
164537142|NCT02708095|594339664|FG001|Overall Study|Protocol Violation|0|||
164537143|NCT02708095|594339665|FG002|Overall Study|Protocol Violation|1|||
164537144|NCT02708095|594339663|FG000|Overall Study|Withdrawal by Subject|5|||
164537145|NCT02708095|594339664|FG001|Overall Study|Withdrawal by Subject|3|||
164537146|NCT02708095|594339665|FG002|Overall Study|Withdrawal by Subject|4|||
164537147|NCT05066724|594339681|FG000|Overall Study|Adverse Event|1|||
164537148|NCT05066724|594339681|FG000|Overall Study|Non-Compliance With Study Drug|5|||
164537149|NCT05066724|594339681|FG000|Overall Study|Withdrawal by Subject|6|||
164537150|NCT05066724|594339681|FG000|Overall Study|Physician Decision|2|||
164537151|NCT02244996|594339692|FG000|Overall Study|Lack of Efficacy|2|||
164537152|NCT02244996|594339693|FG001|Overall Study|Lack of Efficacy|6|||
164537153|NCT03471871|594339694|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
164537154|NCT03471871|594339695|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
164537155|NCT03471871|594339696|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
164537156|NCT03471871|594339697|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
164537157|NCT03471871|594339698|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
164537158|NCT03471871|594339694|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
164537159|NCT03471871|594339695|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
164537160|NCT03471871|594339696|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
164537161|NCT03471871|594339697|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
164537162|NCT03471871|594339698|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
164537163|NCT03471871|594339694|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
164537164|NCT03471871|594339695|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
164537165|NCT03471871|594339696|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
164537166|NCT03471871|594339697|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
164537167|NCT03471871|594339698|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
164537168|NCT03471871|594339694|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
164537169|NCT03471871|594339695|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
164537170|NCT03471871|594339696|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
164537171|NCT03471871|594339697|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
164537172|NCT03471871|594339698|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
164537173|NCT03471871|594339694|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
164537174|NCT03471871|594339695|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
164537175|NCT03471871|594339696|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
164537176|NCT03471871|594339697|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
164537177|NCT03471871|594339698|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
164537178|NCT00047320|594339699|FG000|Overall Study|Lack of Efficacy|8|||
164537179|NCT00047320|594339699|FG000|Overall Study|Lost to Follow-up|1|||
164537180|NCT00047320|594339699|FG000|Overall Study|Physician Decision|8|||
164537181|NCT00047320|594339699|FG000|Overall Study|Withdrawal by Subject|9|||
164537182|NCT00047320|594339699|FG000|Overall Study|Ineligible|2|||
164537183|NCT03602261|594339700|FG000|Overall Study|Adverse Event|5|||
164537184|NCT03602261|594339701|FG001|Overall Study|Adverse Event|1|||
164537185|NCT03602261|594339700|FG000|Overall Study|Physician Decision|1|||
164537186|NCT03602261|594339701|FG001|Overall Study|Physician Decision|0|||
164537187|NCT03602261|594339700|FG000|Overall Study|Withdrawal by Subject|1|||
164537188|NCT03602261|594339701|FG001|Overall Study|Withdrawal by Subject|1|||
164537189|NCT03602261|594339700|FG000|Overall Study|Lack of Efficacy|0|||
164537190|NCT03602261|594339701|FG001|Overall Study|Lack of Efficacy|1|||
164537191|NCT03602261|594339700|FG000|Overall Study|Subject moving out of state|1|||
164537192|NCT03602261|594339701|FG001|Overall Study|Subject moving out of state|0|||
164537193|NCT01423812|594341618|FG000|Overall Study|Lost to Follow-up|2|||
164537194|NCT01423812|594341619|FG001|Overall Study|Lost to Follow-up|2|||
164537195|NCT01423812|594341618|FG000|Overall Study|Withdrawal by Subject|1|||
164537196|NCT01423812|594341619|FG001|Overall Study|Withdrawal by Subject|2|||
164537197|NCT06069778|594341620|FG000|Overall Study|Withdrawal by Subject|1|||
164537198|NCT02310672|594341621|FG000|Overall Study|Death|1|||
164537199|NCT02310672|594341621|FG000|Overall Study|Lost to Follow-up|1|||
164537200|NCT02310672|594341621|FG000|Overall Study|Withdrawal by Subject|1|||
164537201|NCT02310672|594341621|FG000|Overall Study|Sponsor's decision|12|||
164537202|NCT04704336|594341625|FG000|Overall Study|Death|2|||
164537203|NCT04704336|594341626|FG001|Overall Study|Death|2|||
164537204|NCT04704336|594341625|FG000|Overall Study|Lost to Follow-up|33|||
164537205|NCT04704336|594341626|FG001|Overall Study|Lost to Follow-up|40|||
164537206|NCT01214187|594341627|FG000|Overall Study|Adverse Event|6|||
164537207|NCT01214187|594341628|FG001|Overall Study|Adverse Event|2|||
164537208|NCT01214187|594341627|FG000|Overall Study|Death|1|||
164537209|NCT01214187|594341628|FG001|Overall Study|Death|1|||
164537210|NCT01214187|594341627|FG000|Overall Study|Withdrawal by Subject|0|||
164537211|NCT01214187|594341628|FG001|Overall Study|Withdrawal by Subject|3|||
164589063|NCT01070550|594521375|FG003|Overall Study|Death|0|||
164537212|NCT02308007|594341637|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
164537213|NCT02308007|594341638|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
164537214|NCT02308007|594341639|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
164537215|NCT02308007|594341637|FG000|Overall Study|Positive for STD at Baseline|7|||
164537216|NCT02308007|594341638|FG001|Overall Study|Positive for STD at Baseline|11|||
164537217|NCT02308007|594341639|FG002|Overall Study|Positive for STD at Baseline|7|||
164537218|NCT02308007|594341637|FG000|Overall Study|Lost to Follow-up|3|||
164537219|NCT02308007|594341638|FG001|Overall Study|Lost to Follow-up|0|||
164537220|NCT02308007|594341639|FG002|Overall Study|Lost to Follow-up|1|||
164537221|NCT03118674|594341640|FG000|Overall Study|Lost to Follow-up|2|||
164537222|NCT03118674|594341640|FG000|Overall Study|Screen Faliure|8|||
164537223|NCT03118674|594341640|FG000|Overall Study|Withdrawal by Subject|5|||
164537224|NCT01233869|594341641|FG000|Initial Treatment Period (24 Months)|Death|1|||
164537225|NCT01233869|594341642|FG001|Initial Treatment Period (24 Months)|Death|0|||
164537226|NCT01233869|594341643|FG002|Initial Treatment Period (24 Months)|Death|0|||
164537227|NCT01233869|594341644|FG003|Initial Treatment Period (24 Months)|Death|0|||
164537228|NCT01233869|594341641|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
164537229|NCT01233869|594341642|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
164537230|NCT01233869|594341643|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
164537231|NCT01233869|594341644|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
164537232|NCT01233869|594341641|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
164537233|NCT01233869|594341642|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
164537234|NCT01233869|594341643|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
164537235|NCT01233869|594341644|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
164537236|NCT01233869|594341641|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
164537237|NCT01233869|594341642|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
164537238|NCT01233869|594341643|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
164537239|NCT01233869|594341644|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
164537240|NCT01233869|594341641|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
164537241|NCT01233869|594341642|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
164537242|NCT01233869|594341643|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
164537243|NCT01233869|594341644|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
164537244|NCT01233869|594341641|FG000|Extended Treatment Period (46 Months)|Other|3|||
164537245|NCT01233869|594341642|FG001|Extended Treatment Period (46 Months)|Other|0|||
164537246|NCT01233869|594341643|FG002|Extended Treatment Period (46 Months)|Other|0|||
164537247|NCT01233869|594341644|FG003|Extended Treatment Period (46 Months)|Other|3|||
164537248|NCT01233869|594341641|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
164537249|NCT01233869|594341642|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
164537250|NCT01233869|594341643|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
164537251|NCT01233869|594341644|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
164537252|NCT01324323|594341645|FG000|Overall Study|Withdrawal by Subject|1|||
164537253|NCT00537485|594341646|FG000|Overall Study|Adverse Event|10|||
164537254|NCT00537485|594341647|FG001|Overall Study|Adverse Event|5|||
164537255|NCT00537485|594341646|FG000|Overall Study|Withdrawal by Subject|3|||
164537256|NCT00537485|594341647|FG001|Overall Study|Withdrawal by Subject|2|||
164537257|NCT00537485|594341646|FG000|Overall Study|Withdrawal by Subject|1|||
164537258|NCT00537485|594341647|FG001|Overall Study|Withdrawal by Subject|3|||
164537259|NCT00537485|594341646|FG000|Overall Study|Physician Decision|1|||
164537260|NCT00537485|594341647|FG001|Overall Study|Physician Decision|0|||
164537261|NCT02119325|594341656|FG000|Washout Period 1|Adverse Event|0|||
164537262|NCT02119325|594341657|FG001|Washout Period 1|Adverse Event|1|||
164537263|NCT01601847|594341658|FG000|Overall Study|Death|1|||
164537264|NCT01601847|594341659|FG001|Overall Study|Death|0|||
164537265|NCT01601847|594341658|FG000|Overall Study|Withdrawal by Subject|11|||
164537266|NCT01601847|594341659|FG001|Overall Study|Withdrawal by Subject|7|||
164537267|NCT01601847|594341658|FG000|Overall Study|Lost to Follow-up|1|||
164537268|NCT01601847|594341659|FG001|Overall Study|Lost to Follow-up|3|||
164537269|NCT00631189|594341660|FG000|Initial Phase|Protocol Violation|347|||
164537270|NCT00631189|594341661|FG001|Initial Phase|Protocol Violation|0|||
164537271|NCT00631189|594341662|FG002|Initial Phase|Protocol Violation|0|||
164537272|NCT00631189|594341663|FG003|Initial Phase|Protocol Violation|0|||
164537273|NCT00631189|594341660|FG000|Initial Phase|Withdrawal by Subject|4|||
164537274|NCT00631189|594341661|FG001|Initial Phase|Withdrawal by Subject|0|||
164537275|NCT00631189|594341662|FG002|Initial Phase|Withdrawal by Subject|0|||
164537276|NCT00631189|594341663|FG003|Initial Phase|Withdrawal by Subject|0|||
164537277|NCT00631189|594341660|FG000|Treatment Phase|Withdrawal by Subject|0|||
164537278|NCT00631189|594341661|FG001|Treatment Phase|Withdrawal by Subject|2|||
164537279|NCT00631189|594341662|FG002|Treatment Phase|Withdrawal by Subject|1|||
164537280|NCT00631189|594341663|FG003|Treatment Phase|Withdrawal by Subject|1|||
164537281|NCT00631189|594341660|FG000|Treatment Phase|Protocol Violation|0|||
164537282|NCT00631189|594341661|FG001|Treatment Phase|Protocol Violation|1|||
164537283|NCT00631189|594341662|FG002|Treatment Phase|Protocol Violation|6|||
164537284|NCT00631189|594341663|FG003|Treatment Phase|Protocol Violation|2|||
164537285|NCT00631189|594341660|FG000|Treatment Phase|Adverse Event|0|||
164537286|NCT00631189|594341661|FG001|Treatment Phase|Adverse Event|3|||
164537287|NCT00631189|594341662|FG002|Treatment Phase|Adverse Event|2|||
164537288|NCT00631189|594341663|FG003|Treatment Phase|Adverse Event|4|||
164537289|NCT00631189|594341660|FG000|Treatment Phase|Lost to Follow-up|0|||
164537290|NCT00631189|594341661|FG001|Treatment Phase|Lost to Follow-up|1|||
164537291|NCT00631189|594341662|FG002|Treatment Phase|Lost to Follow-up|0|||
164537292|NCT00631189|594341663|FG003|Treatment Phase|Lost to Follow-up|0|||
164537293|NCT00631189|594341660|FG000|Treatment Phase|Pregnancy|0|||
164537294|NCT00631189|594341661|FG001|Treatment Phase|Pregnancy|0|||
164537295|NCT00631189|594341662|FG002|Treatment Phase|Pregnancy|1|||
164537296|NCT00631189|594341663|FG003|Treatment Phase|Pregnancy|0|||
164537297|NCT00631189|594341660|FG000|Treatment Phase|patient did not take pravastatin|0|||
164537298|NCT00631189|594341661|FG001|Treatment Phase|patient did not take pravastatin|0|||
164537299|NCT00631189|594341662|FG002|Treatment Phase|patient did not take pravastatin|1|||
164537300|NCT00631189|594341663|FG003|Treatment Phase|patient did not take pravastatin|0|||
164537301|NCT04464265|594341664|FG000|Overall Study|Physician Decision|2|||
164537302|NCT00954174|594341671|FG000|Overall Study|Adverse Event|28|||
164537303|NCT00954174|594341672|FG001|Overall Study|Adverse Event|23|||
164537304|NCT00954174|594341673|FG002|Overall Study|Adverse Event|4|||
164537305|NCT00954174|594341674|FG003|Overall Study|Adverse Event|9|||
164537306|NCT00954174|594341671|FG000|Overall Study|Death|4|||
164537307|NCT00954174|594341672|FG001|Overall Study|Death|2|||
164537308|NCT00954174|594341673|FG002|Overall Study|Death|0|||
164537309|NCT00954174|594341674|FG003|Overall Study|Death|0|||
164537310|NCT00954174|594341671|FG000|Overall Study|Lack of Efficacy|32|||
164537311|NCT00954174|594341672|FG001|Overall Study|Lack of Efficacy|22|||
164537312|NCT00954174|594341673|FG002|Overall Study|Lack of Efficacy|8|||
164537313|NCT00954174|594341674|FG003|Overall Study|Lack of Efficacy|6|||
164537314|NCT00954174|594341671|FG000|Overall Study|Withdrawal by Subject|14|||
164537315|NCT00954174|594341672|FG001|Overall Study|Withdrawal by Subject|10|||
164537316|NCT00954174|594341673|FG002|Overall Study|Withdrawal by Subject|4|||
164537317|NCT00954174|594341674|FG003|Overall Study|Withdrawal by Subject|3|||
164537318|NCT00954174|594341671|FG000|Overall Study|Medical Reason|4|||
164537319|NCT00954174|594341672|FG001|Overall Study|Medical Reason|2|||
164537320|NCT00954174|594341673|FG002|Overall Study|Medical Reason|1|||
164537321|NCT00954174|594341674|FG003|Overall Study|Medical Reason|0|||
164537322|NCT00954174|594341671|FG000|Overall Study|Ineligible|40|||
164537323|NCT00954174|594341672|FG001|Overall Study|Ineligible|47|||
164537324|NCT00954174|594341673|FG002|Overall Study|Ineligible|7|||
164537325|NCT00954174|594341674|FG003|Overall Study|Ineligible|4|||
164537326|NCT00954174|594341671|FG000|Overall Study|Never Treated|4|||
164537327|NCT00954174|594341672|FG001|Overall Study|Never Treated|17|||
164537328|NCT00954174|594341673|FG002|Overall Study|Never Treated|0|||
164537329|NCT00954174|594341674|FG003|Overall Study|Never Treated|3|||
164537330|NCT02234323|594341675|FG000|All Enrolled|Not Treated: Completed study in database|2|||
164537331|NCT02234323|594341675|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
164537332|NCT02234323|594341675|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
164537333|NCT02234323|594341675|FG000|All Treated|Death|1|||
164537334|NCT02234323|594341675|FG000|All Treated|Physician Decision|5|||
164537335|NCT02234323|594341675|FG000|All Treated|Lack of Efficacy|3|||
164537336|NCT02234323|594341675|FG000|All Treated|Exceeded lab value limit|2|||
164537337|NCT02234323|594341675|FG000|All Treated|Other|7|||
164537338|NCT01372410|594341676|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
164537339|NCT01372410|594341677|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
164537340|NCT01372410|594341678|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
164537341|NCT01372410|594341679|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
164537342|NCT01372410|594341680|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
164537343|NCT01372410|594341681|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
164537344|NCT01372410|594341682|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
164537345|NCT01372410|594341683|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
164537346|NCT01372410|594341676|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
164537347|NCT01372410|594341677|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
164537348|NCT01372410|594341678|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
164537349|NCT01372410|594341679|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
164648895|NCT04228302|594741759|FG004|Overall Study|Adverse Event|1|||
164648896|NCT04228302|594741760|FG005|Overall Study|Adverse Event|0|||
164537350|NCT01372410|594341680|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
164537351|NCT01372410|594341681|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
164537352|NCT01372410|594341682|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
164537353|NCT01372410|594341683|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
164648897|NCT02732561|594741761|FG000|Overall Study|Lost to Follow-up|1|||
164537354|NCT01372410|594341676|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
164537355|NCT01372410|594341677|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
164537356|NCT01372410|594341678|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
164537357|NCT01372410|594341679|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
164648898|NCT02732561|594741762|FG001|Overall Study|Lost to Follow-up|1|||
164537358|NCT01372410|594341680|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
164537359|NCT01372410|594341681|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
164537360|NCT01372410|594341682|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
164537361|NCT01372410|594341683|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
164537362|NCT01372410|594341676|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
164537363|NCT01372410|594341677|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
164537364|NCT01372410|594341678|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
164537365|NCT01372410|594341679|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
164537366|NCT01372410|594341680|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
164537367|NCT01372410|594341681|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
164537368|NCT01372410|594341682|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
164537369|NCT01372410|594341683|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
164537370|NCT01372410|594341676|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
164537371|NCT01372410|594341677|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
164537372|NCT01372410|594341678|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
164537373|NCT01372410|594341679|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
164537374|NCT01372410|594341680|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
164537375|NCT01372410|594341681|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
164537376|NCT01372410|594341682|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
164537377|NCT01372410|594341683|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
164537378|NCT01372410|594341676|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
164537379|NCT01372410|594341677|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
164537380|NCT01372410|594341678|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
164537381|NCT01372410|594341679|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
164537382|NCT01372410|594341680|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
164537383|NCT01372410|594341681|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
164537384|NCT01372410|594341682|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
164537385|NCT01372410|594341683|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
164537386|NCT01372410|594341676|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
164537387|NCT01372410|594341677|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
164537388|NCT01372410|594341678|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
164537389|NCT01372410|594341679|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
164537390|NCT01372410|594341680|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
164537391|NCT01372410|594341681|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
164537392|NCT01372410|594341682|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
164537393|NCT01372410|594341683|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
164537394|NCT01372410|594341676|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
164537395|NCT01372410|594341677|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
164537396|NCT01372410|594341678|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
164537397|NCT01372410|594341679|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
164537398|NCT01372410|594341680|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
164537399|NCT01372410|594341681|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
164537400|NCT01372410|594341682|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
164537401|NCT01372410|594341683|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
164537402|NCT01372410|594341676|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
164537403|NCT01372410|594341677|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
164537404|NCT01372410|594341678|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
164537405|NCT01372410|594341679|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
164537406|NCT01372410|594341680|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
164537407|NCT01372410|594341681|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
164537408|NCT01372410|594341682|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
164537409|NCT01372410|594341683|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
164537410|NCT01372410|594341676|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
164537411|NCT01372410|594341677|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
164537412|NCT01372410|594341678|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
164537413|NCT01372410|594341679|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
164537414|NCT01372410|594341680|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
164537415|NCT01372410|594341681|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
164537416|NCT01372410|594341682|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
164537417|NCT01372410|594341683|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
164537418|NCT02644941|594341684|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
164537419|NCT02644941|594341685|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
164537420|NCT04585646|594341686|FG000|First Intervention|Physician Decision|1|||
164537421|NCT04585646|594341687|FG001|First Intervention|Physician Decision|0|||
164537422|NCT04585646|594341686|FG000|First Intervention|Lost to Follow-up|0|||
164537423|NCT04585646|594341687|FG001|First Intervention|Lost to Follow-up|3|||
164537424|NCT04585646|594341686|FG000|First Intervention|Withdrawal by Subject|0|||
164648899|NCT02732561|594741761|FG000|Overall Study|Withdrawal by Subject|1|||
164537425|NCT04585646|594341687|FG001|First Intervention|Withdrawal by Subject|1|||
164537426|NCT00867113|594341688|FG000|Treatment Period|Adverse Event|15|||
164537427|NCT00867113|594341688|FG000|Treatment Period|Death|2|||
164537428|NCT00867113|594341688|FG000|Treatment Period|Withdrawal by Subject|19|||
164537429|NCT00867113|594341688|FG000|Treatment Period|Lost to Follow-up|3|||
164537430|NCT00867113|594341688|FG000|Treatment Period|Administrative problems|1|||
164537431|NCT00867113|594341688|FG000|Treatment Period|Disease progression/relapse|1|||
164537432|NCT00867113|594341688|FG000|Treatment Period|Protocol Violation|4|||
164537433|NCT00867113|594341688|FG000|Post Treatment After Survival Follow-up|Death|1|||
164537434|NCT00867113|594341688|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
164537435|NCT00867113|594341688|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
164537436|NCT00867113|594341688|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
164537437|NCT01145495|594341689|FG000|Overall Study|Adverse Event|6|||
164537438|NCT01145495|594341689|FG000|Overall Study|Withdrawal by Subject|6|||
164537439|NCT01145495|594341689|FG000|Overall Study|Disease progression after respone|2|||
164537440|NCT01886313|594341692|FG000|Overall Study|Adverse Event|1|||
164537441|NCT01886313|594341693|FG001|Overall Study|Adverse Event|1|||
164537442|NCT04614662|594341694|FG000|Overall Study|Withdrawal by Subject|0|||
164537443|NCT04614662|594341695|FG001|Overall Study|Withdrawal by Subject|1|||
164537444|NCT01603082|594341697|FG000|Overall Study|Adverse Event|0|||
164537445|NCT01603082|594341698|FG001|Overall Study|Adverse Event|1|||
164537446|NCT01603082|594341697|FG000|Overall Study|Withdrawal by Subject|1|||
164537447|NCT01603082|594341698|FG001|Overall Study|Withdrawal by Subject|0|||
164537448|NCT01603082|594341697|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
164537449|NCT01603082|594341698|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
164537450|NCT02178553|594341704|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
164537451|NCT02178553|594341705|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
164537452|NCT02178553|594341704|FG000|Overall Study|Physician Decision|0|||
164537453|NCT02178553|594341705|FG001|Overall Study|Physician Decision|4|||
164537454|NCT02178553|594341704|FG000|Overall Study|Technical problem with injection|1|||
164537455|NCT02178553|594341705|FG001|Overall Study|Technical problem with injection|3|||
164537456|NCT05085665|594341706|FG000|Overall Study|Physician Decision|2|||
164537457|NCT01641809|594341708|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
164537458|NCT01641809|594341709|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
164537459|NCT01641809|594341710|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
164537460|NCT01641809|594341711|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
164537461|NCT01641809|594341708|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
164537462|NCT01641809|594341709|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
164537463|NCT01641809|594341710|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
164537464|NCT01641809|594341711|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
164537465|NCT01641809|594341708|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
164537466|NCT01641809|594341709|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
164537467|NCT01641809|594341710|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
164648900|NCT02732561|594741762|FG001|Overall Study|Withdrawal by Subject|0|||
164648901|NCT04736576|594741763|FG000|Overall Study|Progressive disease|3|||
164537468|NCT01641809|594341711|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
164537469|NCT01641809|594341708|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
164537470|NCT01641809|594341709|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
164537471|NCT01641809|594341710|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
164537472|NCT01641809|594341711|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
164537473|NCT01641809|594341708|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
164537474|NCT01641809|594341709|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
164537475|NCT01641809|594341710|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
164537476|NCT01641809|594341711|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
164537477|NCT01641809|594341708|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
164537478|NCT01641809|594341709|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
164537479|NCT01641809|594341710|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
164537480|NCT01641809|594341711|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
164537481|NCT01641809|594341708|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
164648902|NCT04736576|594741764|FG001|Overall Study|Progressive disease|1|||
164648903|NCT04736576|594741763|FG000|Overall Study|Death|1|||
164648904|NCT04736576|594741764|FG001|Overall Study|Death|0|||
164537482|NCT01641809|594341709|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
164537483|NCT01641809|594341710|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
164537484|NCT01641809|594341711|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
164537485|NCT01641809|594341708|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
164537486|NCT01641809|594341709|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
164537487|NCT01641809|594341710|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
164648905|NCT05180630|594741765|FG000|First Intervention|Physician Decision|0|||
164648906|NCT05180630|594741766|FG001|First Intervention|Physician Decision|0|||
164537488|NCT01641809|594341711|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
164537489|NCT01641809|594341708|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
164537490|NCT01641809|594341709|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
164537491|NCT01641809|594341710|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
164537492|NCT01641809|594341711|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
164537493|NCT01641809|594341708|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
164537494|NCT01641809|594341709|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
164537495|NCT01641809|594341710|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
164537496|NCT01641809|594341711|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
164648907|NCT05180630|594741767|FG002|First Intervention|Physician Decision|3|||
164648908|NCT00709735|594741770|FG000|Overall Study|Lost to Follow-up|1|||
164648909|NCT00709735|594741771|FG001|Overall Study|Lost to Follow-up|1|||
164648910|NCT00709735|594741770|FG000|Overall Study|Relapse into Opioid Abuse|0|||
164648911|NCT00709735|594741771|FG001|Overall Study|Relapse into Opioid Abuse|1|||
164648912|NCT00709735|594741770|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
164648913|NCT00709735|594741771|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
164648914|NCT00963599|594741772|FG000|Overall Study|Adverse Event|2|||
164648915|NCT00963599|594741773|FG001|Overall Study|Adverse Event|0|||
164648916|NCT00963599|594741774|FG002|Overall Study|Adverse Event|1|||
164648917|NCT00963599|594741775|FG003|Overall Study|Adverse Event|2|||
164648918|NCT00963599|594741772|FG000|Overall Study|Lack of Efficacy|0|||
164648919|NCT00963599|594741773|FG001|Overall Study|Lack of Efficacy|2|||
164648920|NCT00963599|594741774|FG002|Overall Study|Lack of Efficacy|1|||
164648921|NCT00963599|594741775|FG003|Overall Study|Lack of Efficacy|4|||
164648922|NCT00963599|594741772|FG000|Overall Study|Lost to Follow-up|0|||
164648923|NCT00963599|594741773|FG001|Overall Study|Lost to Follow-up|1|||
164648924|NCT00963599|594741774|FG002|Overall Study|Lost to Follow-up|1|||
164648925|NCT00963599|594741775|FG003|Overall Study|Lost to Follow-up|1|||
164648926|NCT00963599|594741772|FG000|Overall Study|Protocol Violation|2|||
164648927|NCT00963599|594741773|FG001|Overall Study|Protocol Violation|2|||
164648928|NCT00963599|594741774|FG002|Overall Study|Protocol Violation|3|||
164648929|NCT00963599|594741775|FG003|Overall Study|Protocol Violation|4|||
164648930|NCT00963599|594741772|FG000|Overall Study|Withdrawal by Subject|2|||
164648931|NCT00963599|594741773|FG001|Overall Study|Withdrawal by Subject|1|||
164648932|NCT00963599|594741774|FG002|Overall Study|Withdrawal by Subject|3|||
164648933|NCT00963599|594741775|FG003|Overall Study|Withdrawal by Subject|3|||
164648934|NCT00190684|594741778|FG000|Overall Study|Adverse Event|86|||
164648935|NCT00190684|594741778|FG000|Overall Study|Satisfactory response|80|||
164648936|NCT00190684|594741778|FG000|Overall Study|Lack of efficacy|204|||
164648937|NCT00190684|594741778|FG000|Overall Study|Lost to Follow-up|232|||
164648938|NCT00190684|594741778|FG000|Overall Study|Patient moved|60|||
164648939|NCT00190684|594741778|FG000|Overall Study|Patient Decision|432|||
164648940|NCT00190684|594741778|FG000|Overall Study|Clinical relapse|67|||
164648941|NCT00190684|594741778|FG000|Overall Study|Sponsor's decision|17|||
164648942|NCT00190684|594741778|FG000|Overall Study|Physician Decision|84|||
164648943|NCT00190684|594741778|FG000|Overall Study|Protocol Violation|123|||
164648944|NCT00190684|594741778|FG000|Overall Study|Study Period III Completed|103|||
164648945|NCT00190684|594741778|FG000|Overall Study|Study Period V Completed|1|||
164648946|NCT00423488|594741782|FG000|Overall Study|No evidence of study drug intake|2|||
164648947|NCT00423488|594741783|FG001|Overall Study|No evidence of study drug intake|1|||
164648948|NCT00423488|594741782|FG000|Overall Study|No post baseline data|3|||
164648949|NCT00423488|594741783|FG001|Overall Study|No post baseline data|0|||
164648950|NCT03118765|594741784|FG000|Overall Study|Withdrawal by Subject|0|||
164648951|NCT03118765|594741785|FG001|Overall Study|Withdrawal by Subject|0|||
164648952|NCT03118765|594741786|FG002|Overall Study|Withdrawal by Subject|1|||
164648953|NCT03118765|594741787|FG003|Overall Study|Withdrawal by Subject|0|||
164648954|NCT03118765|594741788|FG004|Overall Study|Withdrawal by Subject|0|||
164648955|NCT03118765|594741784|FG000|Overall Study|Adverse Event|1|||
164648956|NCT03118765|594741785|FG001|Overall Study|Adverse Event|1|||
164648957|NCT03118765|594741786|FG002|Overall Study|Adverse Event|1|||
164648958|NCT03118765|594741787|FG003|Overall Study|Adverse Event|1|||
164648959|NCT03118765|594741788|FG004|Overall Study|Adverse Event|1|||
164648960|NCT03118765|594741784|FG000|Overall Study|Non compliance with Study Procedures|0|||
164648961|NCT03118765|594741785|FG001|Overall Study|Non compliance with Study Procedures|0|||
164537497|NCT01641809|594341708|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
164648962|NCT03118765|594741786|FG002|Overall Study|Non compliance with Study Procedures|0|||
164648963|NCT03118765|594741787|FG003|Overall Study|Non compliance with Study Procedures|1|||
164537498|NCT01641809|594341709|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
164537499|NCT01641809|594341710|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
164648964|NCT03118765|594741788|FG004|Overall Study|Non compliance with Study Procedures|0|||
164648965|NCT03118765|594741784|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
164648966|NCT03118765|594741785|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
164648967|NCT03118765|594741786|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
164648968|NCT03118765|594741787|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
164537500|NCT01641809|594341711|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
164537501|NCT01641809|594341708|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
164537502|NCT01641809|594341709|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
164537503|NCT01641809|594341710|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
164537504|NCT01641809|594341711|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
164537505|NCT01641809|594341708|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
164537506|NCT01641809|594341709|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
164537507|NCT01641809|594341710|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
164537508|NCT01641809|594341711|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
164537509|NCT01641809|594341708|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
164537510|NCT01641809|594341709|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
164537511|NCT01641809|594341710|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
164537512|NCT01641809|594341711|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
164537513|NCT01641809|594341708|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
164537514|NCT01641809|594341709|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
164537515|NCT01641809|594341710|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
164537516|NCT01641809|594341711|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
164537517|NCT01641809|594341708|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
164537518|NCT01641809|594341709|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
164537519|NCT01641809|594341710|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
164537520|NCT01641809|594341711|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
164537521|NCT01641809|594341708|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
164537522|NCT01641809|594341709|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
164537523|NCT01641809|594341710|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
164537524|NCT01641809|594341711|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
164537525|NCT01641809|594341708|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
164537526|NCT01641809|594341709|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
164537527|NCT01641809|594341710|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
164537528|NCT01641809|594341711|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
164537529|NCT01717768|594341712|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
164537530|NCT01717768|594341713|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
164537531|NCT01717768|594341714|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
164537532|NCT01717768|594341715|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
164537533|NCT01717768|594341716|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
164537534|NCT01717768|594341717|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
164537535|NCT01717768|594341718|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
164537536|NCT01717768|594341719|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
164537537|NCT01717768|594341720|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
164537538|NCT01717768|594341721|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
164537539|NCT01717768|594341722|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
164537540|NCT01717768|594341723|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
164537541|NCT01717768|594341712|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
164537542|NCT01717768|594341713|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
164537543|NCT01717768|594341714|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
164537544|NCT01717768|594341715|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
164537545|NCT01717768|594341716|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
164537546|NCT01717768|594341717|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
164537547|NCT01717768|594341718|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
164537548|NCT01717768|594341719|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
164537549|NCT01717768|594341720|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
164537550|NCT01717768|594341721|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
164537551|NCT01717768|594341722|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
164537552|NCT01717768|594341723|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
164537553|NCT01717768|594341712|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
164537554|NCT01717768|594341713|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
164537555|NCT01717768|594341714|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
164537556|NCT01717768|594341715|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
164537557|NCT01717768|594341716|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
164537558|NCT01717768|594341717|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
164537559|NCT01717768|594341718|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
164537560|NCT01717768|594341719|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
164537561|NCT01717768|594341720|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
164537562|NCT01717768|594341721|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
164537563|NCT01717768|594341722|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
164537564|NCT01717768|594341723|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
164537565|NCT01717768|594341712|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
164537566|NCT01717768|594341713|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
164537567|NCT01717768|594341714|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
164537568|NCT01717768|594341715|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
164537569|NCT01717768|594341716|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
164537570|NCT01717768|594341717|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
164537571|NCT01717768|594341718|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
164537572|NCT01717768|594341719|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
164537573|NCT01717768|594341720|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
164537574|NCT01717768|594341721|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
164537575|NCT01717768|594341722|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
164537576|NCT01717768|594341723|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
164537577|NCT00448435|594341724|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
164537578|NCT00448435|594341725|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
164537579|NCT04195581|594341726|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
164537580|NCT04195581|594341726|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
164537581|NCT04195581|594341726|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
164537582|NCT04195581|594341726|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
164537583|NCT04195581|594341726|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
164537584|NCT04195581|594341726|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
164537585|NCT00821431|594341727|FG000|Overall Study|Adverse Event|6|||
164537586|NCT00821431|594341728|FG001|Overall Study|Adverse Event|3|||
164537587|NCT00821431|594341727|FG000|Overall Study|Withdrawal by Subject|5|||
164537588|NCT00821431|594341728|FG001|Overall Study|Withdrawal by Subject|0|||
164537589|NCT00821431|594341727|FG000|Overall Study|Lost to Follow-up|1|||
164537590|NCT00821431|594341728|FG001|Overall Study|Lost to Follow-up|0|||
164537591|NCT00821431|594341727|FG000|Overall Study|Protocol Violation|3|||
164537592|NCT00821431|594341728|FG001|Overall Study|Protocol Violation|1|||
164537593|NCT00821431|594341727|FG000|Overall Study|Physician Decision|0|||
164537594|NCT00821431|594341728|FG001|Overall Study|Physician Decision|1|||
164537595|NCT04233164|594341734|FG000|Overall Study|Unable to obtain specimen|0|||
164537596|NCT04233164|594341735|FG001|Overall Study|Unable to obtain specimen|1|||
164537597|NCT01699789|594341736|FG000|Overall Study|Withdrawal by Subject|18|||
164537598|NCT01699789|594341737|FG001|Overall Study|Withdrawal by Subject|23|||
164537599|NCT01699789|594341736|FG000|Overall Study|Death|1|||
164537600|NCT01699789|594341737|FG001|Overall Study|Death|2|||
164537601|NCT01699789|594341736|FG000|Overall Study|Lost to Follow-up|83|||
164537602|NCT01699789|594341737|FG001|Overall Study|Lost to Follow-up|101|||
164537603|NCT00639223|594341738|FG000|Overall Study|Lost to Follow-up|0|||
164537604|NCT00639223|594341739|FG001|Overall Study|Lost to Follow-up|2|||
164537605|NCT04201821|594341740|FG000|Overall Study|Withdrawal by Subject|2|||
164537606|NCT00651157|594341741|FG000|Overall Study|Death|1|||
164537607|NCT00651157|594341741|FG000|Overall Study|Protocol Violation|1|||
164537608|NCT00364156|594341748|FG000|Overall Study|Withdrawal by Subject|73|||
164537609|NCT00364156|594341749|FG001|Overall Study|Withdrawal by Subject|80|||
164537610|NCT00364156|594341748|FG000|Overall Study|Protocol Violation|6|||
164537611|NCT00364156|594341749|FG001|Overall Study|Protocol Violation|1|||
164537612|NCT01050205|594341750|FG000|Overall Study|Lost to Follow-up|7|||
164537613|NCT01050205|594341751|FG001|Overall Study|Lost to Follow-up|1|||
164537614|NCT01050205|594341750|FG000|Overall Study|Withdrawal by Subject|1|||
164537615|NCT01050205|594341751|FG001|Overall Study|Withdrawal by Subject|1|||
164537616|NCT01050205|594341750|FG000|Overall Study|Relocated from area|1|||
164537617|NCT01050205|594341751|FG001|Overall Study|Relocated from area|2|||
164537618|NCT01050205|594341750|FG000|Overall Study|Discontinued Intervention|2|||
164537619|NCT01050205|594341751|FG001|Overall Study|Discontinued Intervention|0|||
164537620|NCT01472380|594341752|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
164537621|NCT01472380|594341752|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
164648969|NCT03118765|594741788|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
164648970|NCT03118765|594741784|FG000|Overall Study|COPD Exacerbation|1|||
164648971|NCT03118765|594741785|FG001|Overall Study|COPD Exacerbation|0|||
164648972|NCT03118765|594741786|FG002|Overall Study|COPD Exacerbation|0|||
164648973|NCT03118765|594741787|FG003|Overall Study|COPD Exacerbation|1|||
164648974|NCT03118765|594741788|FG004|Overall Study|COPD Exacerbation|0|||
164537622|NCT02511678|594341753|FG000|Overall Study|Withdrawal by Subject|2|||
164537623|NCT02511678|594341753|FG000|Overall Study|Lost to Follow-up|4|||
164537624|NCT02511678|594341753|FG000|Overall Study|Death|19|||
164537625|NCT02511678|594341753|FG000|Overall Study|Adverse Event|1|||
164537626|NCT02511678|594341753|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
164537627|NCT02511678|594341753|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
164537628|NCT02511678|594341753|FG000|Overall Study|Required Radiofrequency Ablation|1|||
164537629|NCT02511678|594341753|FG000|Overall Study|Biopsy was Negative|1|||
164537630|NCT02511678|594341753|FG000|Overall Study|Protocol Violation|1|||
164537631|NCT02511678|594341753|FG000|Overall Study|Received Radiation Treatment|1|||
164648975|NCT03118765|594741784|FG000|Overall Study|Lost to Follow-up|1|||
164537632|NCT01295281|594341756|FG000|First Intervention (7 Days)|Death|0|||
164537633|NCT01295281|594341757|FG001|First Intervention (7 Days)|Death|1|||
164537634|NCT00292461|594341758|FG000|Overall Study|Adverse Event|4|||
164537635|NCT00292461|594341759|FG001|Overall Study|Adverse Event|2|||
164537636|NCT00292461|594341758|FG000|Overall Study|Lack of Efficacy|1|||
164537637|NCT00292461|594341759|FG001|Overall Study|Lack of Efficacy|0|||
164537638|NCT00292461|594341758|FG000|Overall Study|Withdrawal by Subject|0|||
164537639|NCT00292461|594341759|FG001|Overall Study|Withdrawal by Subject|1|||
164537640|NCT00292461|594341758|FG000|Overall Study|Protocol Violation|4|||
164537641|NCT00292461|594341759|FG001|Overall Study|Protocol Violation|3|||
164537642|NCT00292461|594341758|FG000|Overall Study|Lost to Follow-up|1|||
164537643|NCT00292461|594341759|FG001|Overall Study|Lost to Follow-up|0|||
164537644|NCT02000427|594341760|FG000|Overall Study|Death|22|||
164537645|NCT05125679|594341763|FG000|Overall Study|Study Terminated by Sponsor|2|||
164537646|NCT05125679|594341764|FG001|Overall Study|Study Terminated by Sponsor|5|||
164537647|NCT03829319|594341765|FG000|Overall Study|Sponsor's Decision|4|||
164537648|NCT03829319|594341766|FG001|Overall Study|Sponsor's Decision|90|||
164537649|NCT03829319|594341767|FG002|Overall Study|Sponsor's Decision|102|||
164537650|NCT03829319|594341765|FG000|Overall Study|Withdrawal by Subject|1|||
164537651|NCT03829319|594341766|FG001|Overall Study|Withdrawal by Subject|5|||
164537652|NCT03829319|594341767|FG002|Overall Study|Withdrawal by Subject|4|||
164537653|NCT03829319|594341765|FG000|Overall Study|Physician Decision|0|||
164537654|NCT03829319|594341766|FG001|Overall Study|Physician Decision|3|||
164537655|NCT03829319|594341767|FG002|Overall Study|Physician Decision|0|||
164537656|NCT03829319|594341765|FG000|Overall Study|Lost to Follow-up|0|||
164537657|NCT03829319|594341766|FG001|Overall Study|Lost to Follow-up|0|||
164537658|NCT03829319|594341767|FG002|Overall Study|Lost to Follow-up|1|||
164537659|NCT03829319|594341765|FG000|Overall Study|Death|8|||
164537660|NCT03829319|594341766|FG001|Overall Study|Death|277|||
164537661|NCT03829319|594341767|FG002|Overall Study|Death|266|||
164537662|NCT04484259|594341768|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
164537663|NCT04484259|594341769|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
164537664|NCT04484259|594341770|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
164537665|NCT04484259|594341771|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
164537666|NCT04484259|594341772|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
164537667|NCT04484259|594341768|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
164537668|NCT04484259|594341769|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
164537669|NCT04484259|594341770|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
164537670|NCT04484259|594341771|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
164537671|NCT04484259|594341772|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
164537672|NCT04484259|594341768|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
164537673|NCT04484259|594341769|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
164537674|NCT04484259|594341770|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
164537675|NCT04484259|594341771|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
164537676|NCT04484259|594341772|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
164537677|NCT04484259|594341768|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
164537678|NCT04484259|594341769|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
164537679|NCT04484259|594341770|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
164537680|NCT04484259|594341771|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
164537681|NCT04484259|594341772|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
164537682|NCT04484259|594341768|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
164537683|NCT04484259|594341769|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
164537684|NCT04484259|594341770|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
164648976|NCT03118765|594741785|FG001|Overall Study|Lost to Follow-up|0|||
164537685|NCT04484259|594341771|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
164537686|NCT04484259|594341772|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
164648977|NCT03118765|594741786|FG002|Overall Study|Lost to Follow-up|1|||
164648978|NCT03118765|594741787|FG003|Overall Study|Lost to Follow-up|0|||
164648979|NCT03118765|594741788|FG004|Overall Study|Lost to Follow-up|0|||
164648980|NCT03118765|594741784|FG000|Overall Study|Sponsor Decision|1|||
164648981|NCT03118765|594741785|FG001|Overall Study|Sponsor Decision|0|||
164648982|NCT03118765|594741786|FG002|Overall Study|Sponsor Decision|1|||
164648983|NCT03118765|594741787|FG003|Overall Study|Sponsor Decision|0|||
164648984|NCT03118765|594741788|FG004|Overall Study|Sponsor Decision|1|||
164648985|NCT02643966|594741789|FG000|First Screening Round|ineligible|1|||
164537687|NCT04484259|594341768|FG000|Randomized Treatment|Withdrawal by Subject|1|||
164537688|NCT04484259|594341769|FG001|Randomized Treatment|Withdrawal by Subject|0|||
164537689|NCT04484259|594341770|FG002|Randomized Treatment|Withdrawal by Subject|0|||
164537690|NCT04484259|594341771|FG003|Randomized Treatment|Withdrawal by Subject|0|||
164537691|NCT04484259|594341772|FG004|Randomized Treatment|Withdrawal by Subject|0|||
164648986|NCT02643966|594741789|FG000|First Screening Round|excluded from analysis|2|||
164648987|NCT02643966|594741789|FG000|First Screening Round|Lost to Follow-up|56|||
164648988|NCT02643966|594741789|FG000|First Screening Round|Withdrawal by Subject|28|||
164537692|NCT04498832|594341773|FG000|Overall Study|Adverse Event|1|||
164537693|NCT04498832|594341774|FG001|Overall Study|Adverse Event|3|||
164537694|NCT04498832|594341773|FG000|Overall Study|Withdrawal by Subject|0|||
164537695|NCT04498832|594341774|FG001|Overall Study|Withdrawal by Subject|1|||
164537696|NCT04029480|594341779|FG000|Overall Study|Physician Decision|0|||
164537697|NCT04029480|594341780|FG001|Overall Study|Physician Decision|0|||
164537698|NCT04029480|594341781|FG002|Overall Study|Physician Decision|2|||
164537699|NCT04029480|594341782|FG003|Overall Study|Physician Decision|1|||
164537700|NCT04029480|594341779|FG000|Overall Study|Withdrawal by Subject|2|||
164537701|NCT04029480|594341780|FG001|Overall Study|Withdrawal by Subject|0|||
164537702|NCT04029480|594341781|FG002|Overall Study|Withdrawal by Subject|1|||
164537703|NCT04029480|594341782|FG003|Overall Study|Withdrawal by Subject|1|||
164537704|NCT06268288|594341783|FG000|Overall Study|Withdrawal by Subject|1|||
164537705|NCT06268288|594341784|FG001|Overall Study|Withdrawal by Subject|2|||
164537706|NCT01019980|594341788|FG000|Overall Study|Drug not available.|2|||
164537707|NCT01019980|594341789|FG001|Overall Study|Drug not available.|0|||
164537708|NCT02038920|594341793|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
164537709|NCT02038920|594341794|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
164537710|NCT02038920|594341795|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
164537711|NCT02038920|594341796|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
164537712|NCT02038920|594341797|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
164537713|NCT02038920|594341798|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
164537714|NCT02038920|594341793|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
164537715|NCT02038920|594341794|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
164537716|NCT02038920|594341795|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
164537717|NCT02038920|594341796|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
164537718|NCT02038920|594341797|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
164537719|NCT02038920|594341798|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
164537720|NCT02038920|594341793|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
164537721|NCT02038920|594341794|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
164537722|NCT02038920|594341795|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
164537723|NCT02038920|594341796|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
164537724|NCT02038920|594341797|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
164537725|NCT02038920|594341798|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
164537726|NCT02038920|594341793|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
164537727|NCT02038920|594341794|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
164537728|NCT02038920|594341795|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
164537729|NCT02038920|594341796|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
164537730|NCT02038920|594341797|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
164537731|NCT02038920|594341798|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
164537732|NCT02038920|594341793|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
164537733|NCT02038920|594341794|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
164537734|NCT02038920|594341795|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
164537735|NCT02038920|594341796|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
164537736|NCT02038920|594341797|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
164537737|NCT02038920|594341798|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
164537738|NCT02038920|594341793|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
164537739|NCT02038920|594341794|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
164537740|NCT02038920|594341795|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
164537741|NCT02038920|594341796|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
164537742|NCT02038920|594341797|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
164537743|NCT02038920|594341798|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
164537744|NCT02038920|594341793|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
164537745|NCT02038920|594341794|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
164537746|NCT02038920|594341795|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
164537747|NCT02038920|594341796|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
164537748|NCT02038920|594341797|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
164589064|NCT01070550|594521376|FG004|Overall Study|Death|0|||
164589065|NCT01070550|594521377|FG005|Overall Study|Death|0|||
164589066|NCT01070550|594521372|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
164589067|NCT01070550|594521373|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
164589068|NCT01070550|594521374|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
164589069|NCT01070550|594521375|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
164589070|NCT01070550|594521376|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
164589071|NCT01070550|594521377|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
164589072|NCT01070550|594521372|FG000|Overall Study|Early termination|3|||
164589073|NCT01070550|594521373|FG001|Overall Study|Early termination|0|||
164537749|NCT02038920|594341798|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
164537750|NCT02038920|594341793|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
164537751|NCT02038920|594341794|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
164537752|NCT02038920|594341795|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
164537753|NCT02038920|594341796|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
164537754|NCT02038920|594341797|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
164537755|NCT02038920|594341798|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
164537756|NCT02038920|594341793|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
164537757|NCT02038920|594341794|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
164537758|NCT02038920|594341795|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
164537759|NCT02038920|594341796|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
164537760|NCT02038920|594341797|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
164537761|NCT02038920|594341798|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
164537762|NCT02038920|594341793|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
164537763|NCT02038920|594341794|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
164537764|NCT02038920|594341795|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
164537765|NCT02038920|594341796|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
164537766|NCT02038920|594341797|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
164537767|NCT02038920|594341798|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
164537768|NCT02038920|594341793|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
164537769|NCT02038920|594341794|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
164537770|NCT02038920|594341795|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
164537771|NCT02038920|594341796|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
164537772|NCT02038920|594341797|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
164537773|NCT02038920|594341798|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
164537774|NCT02038920|594341793|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
164537775|NCT02038920|594341794|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
164537776|NCT02038920|594341795|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
164537777|NCT02038920|594341796|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
164537778|NCT02038920|594341797|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
164537779|NCT02038920|594341798|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
164537780|NCT04821869|594341799|FG000|Overall Study|Adverse Event|4|||
164537781|NCT04821869|594341799|FG000|Overall Study|Withdrawal by Subject|2|||
164537782|NCT04821869|594341799|FG000|Overall Study|Did not meet FEV1 criteria|1|||
164537783|NCT01313117|594341805|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
164537784|NCT01313117|594341805|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
164537785|NCT04890054|594343167|FG000|Overall Study|Lost to Follow-up|202|||
164537786|NCT04890054|594343168|FG001|Overall Study|Lost to Follow-up|219|||
164537787|NCT04313153|594343169|FG000|Overall Study|Adverse Event (includes Death)|14|||
164648989|NCT02643966|594741789|FG000|First Screening Round|Death|1|||
164648990|NCT02643966|594741789|FG000|Between First and Second Screening|Lost to Follow-up|65|||
164648991|NCT02643966|594741789|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
164648992|NCT02643966|594741789|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
164648993|NCT02643966|594741789|FG000|Second Screening Round|Withdrawal by Subject|20|||
164648994|NCT02643966|594741789|FG000|Second Screening Round|Lost to Follow-up|57|||
164537788|NCT04313153|594343170|FG001|Overall Study|Adverse Event (includes Death)|19|||
164537789|NCT04313153|594343171|FG002|Overall Study|Adverse Event (includes Death)|10|||
164537790|NCT04313153|594343169|FG000|Overall Study|Physician Decision|4|||
164537791|NCT04313153|594343170|FG001|Overall Study|Physician Decision|2|||
164537792|NCT04313153|594343171|FG002|Overall Study|Physician Decision|1|||
164537793|NCT04313153|594343169|FG000|Overall Study|Withdrawal by Subject|7|||
164537794|NCT04313153|594343170|FG001|Overall Study|Withdrawal by Subject|6|||
164537795|NCT04313153|594343171|FG002|Overall Study|Withdrawal by Subject|2|||
164537796|NCT04313153|594343169|FG000|Overall Study|Lack of Efficacy|3|||
164537797|NCT04313153|594343170|FG001|Overall Study|Lack of Efficacy|3|||
164537798|NCT04313153|594343171|FG002|Overall Study|Lack of Efficacy|0|||
164537799|NCT04313153|594343169|FG000|Overall Study|Lost to Follow-up|1|||
164537800|NCT04313153|594343170|FG001|Overall Study|Lost to Follow-up|0|||
164537801|NCT04313153|594343171|FG002|Overall Study|Lost to Follow-up|2|||
164537802|NCT04313153|594343169|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
164537803|NCT04313153|594343170|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
164537804|NCT04313153|594343171|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
164537805|NCT04313153|594343169|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
164537806|NCT04313153|594343170|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
164537807|NCT04313153|594343171|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
164537808|NCT04313153|594343169|FG000|Overall Study|Change in Dialysis Modality|0|||
164648995|NCT02643966|594741789|FG000|Second Screening Round|Physician Decision|2|||
164648996|NCT02643966|594741789|FG000|Second Screening Round|Death|4|||
164648997|NCT02643966|594741789|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
164537809|NCT04313153|594343170|FG001|Overall Study|Change in Dialysis Modality|1|||
164537810|NCT04313153|594343171|FG002|Overall Study|Change in Dialysis Modality|2|||
164537811|NCT04313153|594343169|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
164537812|NCT04313153|594343170|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
164537813|NCT04313153|594343171|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
164537814|NCT04313153|594343169|FG000|Overall Study|Other|5|||
164537815|NCT04313153|594343170|FG001|Overall Study|Other|3|||
164537816|NCT04313153|594343171|FG002|Overall Study|Other|2|||
164537817|NCT05586269|594343172|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
164537818|NCT05586269|594343173|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
164537819|NCT05586269|594343174|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
164537820|NCT05586269|594343175|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
164537821|NCT05586269|594343172|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
164537822|NCT05586269|594343173|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
164537823|NCT05586269|594343174|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
164537824|NCT05586269|594343175|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
164537825|NCT03047551|594343176|FG000|Overall Study|Did not receive TAS|1|||
164537826|NCT03047551|594343177|FG001|Overall Study|Did not receive TAS|0|||
164537827|NCT03047551|594343176|FG000|Overall Study|Physician Decision|1|||
164537828|NCT03047551|594343177|FG001|Overall Study|Physician Decision|0|||
164537829|NCT03047551|594343176|FG000|Overall Study|Withdrawal by Subject|0|||
164537830|NCT03047551|594343177|FG001|Overall Study|Withdrawal by Subject|1|||
164537831|NCT03047551|594343176|FG000|Overall Study|Probe malfunction|0|||
164537832|NCT03047551|594343177|FG001|Overall Study|Probe malfunction|1|||
164537833|NCT03047551|594343176|FG000|Overall Study|Ineligible|0|||
164537834|NCT03047551|594343177|FG001|Overall Study|Ineligible|1|||
164537835|NCT00726622|594343178|FG000|Overall Study|Withdrawal by Subject|16|||
164537836|NCT00726622|594343179|FG001|Overall Study|Withdrawal by Subject|2|||
164537837|NCT00726622|594343178|FG000|Overall Study|Physician Decision|0|||
164537838|NCT00726622|594343179|FG001|Overall Study|Physician Decision|1|||
164537839|NCT00726622|594343178|FG000|Overall Study|Metastasis|2|||
164537840|NCT00726622|594343179|FG001|Overall Study|Metastasis|0|||
164537841|NCT02462928|594343181|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
164537842|NCT02462928|594343182|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
164537843|NCT02462928|594343183|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
164537844|NCT02462928|594343181|FG000|Overall Study|Adverse Event|47|||
164537845|NCT02462928|594343182|FG001|Overall Study|Adverse Event|51|||
164537846|NCT02462928|594343183|FG002|Overall Study|Adverse Event|25|||
164537847|NCT02462928|594343181|FG000|Overall Study|Lack of Efficacy|3|||
164537848|NCT02462928|594343182|FG001|Overall Study|Lack of Efficacy|8|||
164537849|NCT02462928|594343183|FG002|Overall Study|Lack of Efficacy|3|||
164537850|NCT02462928|594343181|FG000|Overall Study|Lost to Follow-up|4|||
164537851|NCT02462928|594343182|FG001|Overall Study|Lost to Follow-up|4|||
164537852|NCT02462928|594343183|FG002|Overall Study|Lost to Follow-up|1|||
164537853|NCT02462928|594343181|FG000|Overall Study|Withdrawal by Patient|31|||
164648998|NCT02643966|594741789|FG000|Between Second and Third Screening|Death|1|||
164648999|NCT02643966|594741789|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
164649000|NCT02643966|594741789|FG000|Third Screening Round|PI excluded|2|||
164649001|NCT02643966|594741789|FG000|Third Screening Round|Lost to Follow-up|241|||
164649002|NCT01493531|594741790|FG000|Overall Study|Adverse Event|4|||
164649003|NCT01493531|594741791|FG001|Overall Study|Adverse Event|12|||
164649004|NCT01493531|594741792|FG002|Overall Study|Adverse Event|9|||
164649005|NCT01493531|594741790|FG000|Overall Study|Gout flare|3|||
164649006|NCT01493531|594741791|FG001|Overall Study|Gout flare|0|||
164649007|NCT01493531|594741792|FG002|Overall Study|Gout flare|2|||
164649008|NCT01493531|594741790|FG000|Overall Study|Protocol Violation|8|||
164649009|NCT01493531|594741791|FG001|Overall Study|Protocol Violation|15|||
164649010|NCT01493531|594741792|FG002|Overall Study|Protocol Violation|12|||
164537854|NCT02462928|594343182|FG001|Overall Study|Withdrawal by Patient|21|||
164537855|NCT02462928|594343183|FG002|Overall Study|Withdrawal by Patient|21|||
164537856|NCT02462928|594343181|FG000|Overall Study|Protocol Violation|0|||
164537857|NCT02462928|594343182|FG001|Overall Study|Protocol Violation|1|||
164537858|NCT02462928|594343183|FG002|Overall Study|Protocol Violation|0|||
164537859|NCT02462928|594343181|FG000|Overall Study|Reason not Specified|4|||
164537860|NCT02462928|594343182|FG001|Overall Study|Reason not Specified|6|||
164537861|NCT02462928|594343183|FG002|Overall Study|Reason not Specified|5|||
164537862|NCT00395863|594343184|FG000|Overall Study|Patients did not complete both exams|2|||
164537863|NCT00395863|594343185|FG001|Overall Study|Patients did not complete both exams|3|||
164537864|NCT01940354|594343189|FG000|Overall Study|Withdrawal by Subject|4|||
164537865|NCT01940354|594343190|FG001|Overall Study|Withdrawal by Subject|2|||
164537866|NCT02020863|594343191|FG000|Overall Study|Discovery of Metastatic disease|4|||
164649011|NCT01493531|594741790|FG000|Overall Study|Sponsor terminated study|5|||
164649012|NCT01493531|594741791|FG001|Overall Study|Sponsor terminated study|2|||
164649013|NCT01493531|594741792|FG002|Overall Study|Sponsor terminated study|3|||
164649014|NCT01493531|594741790|FG000|Overall Study|Lost to Follow-up|5|||
164537867|NCT02020863|594343191|FG000|Overall Study|Team chose not to place an a line|1|||
164537868|NCT00928564|594343196|FG000|Overall Study|Lost to Follow-up|6|||
164537869|NCT00928564|594343197|FG001|Overall Study|Lost to Follow-up|0|||
164537870|NCT01170039|594343200|FG000|Overall Study|Withdrawal by Subject|5|||
164537871|NCT01170039|594343201|FG001|Overall Study|Withdrawal by Subject|3|||
164537872|NCT01170039|594343200|FG000|Overall Study|Lack of funding, drug not available|3|||
164537873|NCT01170039|594343201|FG001|Overall Study|Lack of funding, drug not available|3|||
164537874|NCT01990534|594343202|FG000|Overall Study|Death|22|||
164537875|NCT01990534|594343202|FG000|Overall Study|Progressive disease|3|||
164537876|NCT01990534|594343202|FG000|Overall Study|Protocol Violation|1|||
164537877|NCT01990534|594343202|FG000|Overall Study|Withdrawal of Informed Consent|2|||
164537878|NCT01990534|594343202|FG000|Overall Study|Symptomatic Deterioration|1|||
164537879|NCT01990534|594343202|FG000|Overall Study|Withdrawal by Subject|3|||
164537880|NCT01990534|594343202|FG000|Overall Study|Reason not Specified|2|||
164537881|NCT01990534|594343202|FG000|Overall Study|Lost to Follow-up|1|||
164537882|NCT01831544|594343203|FG000|Overall Study|Death|1|||
164537883|NCT01831544|594343203|FG000|Overall Study|Still on original MVAD device|2|||
164537884|NCT01131351|594343206|FG000|Overall Study|Adverse Event|0|||
164537885|NCT01131351|594343207|FG001|Overall Study|Adverse Event|2|||
164537886|NCT01131351|594343206|FG000|Overall Study|Protocol Deviation|0|||
164537887|NCT01131351|594343207|FG001|Overall Study|Protocol Deviation|1|||
164537888|NCT01205438|594343208|FG000|Overall Study|Adverse Event|19|||
164537889|NCT01205438|594343209|FG001|Overall Study|Adverse Event|17|||
164649015|NCT01493531|594741791|FG001|Overall Study|Lost to Follow-up|7|||
164649016|NCT01493531|594741792|FG002|Overall Study|Lost to Follow-up|11|||
164537890|NCT01205438|594343210|FG002|Overall Study|Adverse Event|24|||
164537891|NCT01205438|594343208|FG000|Overall Study|Death|1|||
164537892|NCT01205438|594343209|FG001|Overall Study|Death|1|||
164537893|NCT01205438|594343210|FG002|Overall Study|Death|3|||
164537894|NCT01205438|594343208|FG000|Overall Study|Entry Criteria Not Met|16|||
164537895|NCT01205438|594343209|FG001|Overall Study|Entry Criteria Not Met|15|||
164537896|NCT01205438|594343210|FG002|Overall Study|Entry Criteria Not Met|13|||
164537897|NCT01205438|594343208|FG000|Overall Study|Lack of Efficacy|14|||
164537898|NCT01205438|594343209|FG001|Overall Study|Lack of Efficacy|11|||
164537899|NCT01205438|594343210|FG002|Overall Study|Lack of Efficacy|14|||
164537900|NCT01205438|594343208|FG000|Overall Study|Lost to Follow-up|6|||
164537901|NCT01205438|594343209|FG001|Overall Study|Lost to Follow-up|7|||
164537902|NCT01205438|594343210|FG002|Overall Study|Lost to Follow-up|8|||
164537903|NCT01205438|594343208|FG000|Overall Study|Withdrawal by Subject|19|||
164537904|NCT01205438|594343209|FG001|Overall Study|Withdrawal by Subject|25|||
164537905|NCT01205438|594343210|FG002|Overall Study|Withdrawal by Subject|19|||
164537906|NCT01205438|594343208|FG000|Overall Study|Physician Decision|0|||
164537907|NCT01205438|594343209|FG001|Overall Study|Physician Decision|3|||
164537908|NCT01205438|594343210|FG002|Overall Study|Physician Decision|2|||
164537909|NCT01205438|594343208|FG000|Overall Study|Protocol Violation|2|||
164537910|NCT01205438|594343209|FG001|Overall Study|Protocol Violation|7|||
164537911|NCT01205438|594343210|FG002|Overall Study|Protocol Violation|4|||
164537912|NCT01205438|594343208|FG000|Overall Study|Sponsor Decision|0|||
164537913|NCT01205438|594343209|FG001|Overall Study|Sponsor Decision|1|||
164537914|NCT01205438|594343210|FG002|Overall Study|Sponsor Decision|1|||
164537915|NCT04606771|594343214|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
164537916|NCT04606771|594343215|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
164537917|NCT04606771|594343214|FG000|Overall Study|Death|5|||
164537918|NCT04606771|594343215|FG001|Overall Study|Death|6|||
164537919|NCT04606771|594343214|FG000|Overall Study|Wrong randomisation|0|||
164537920|NCT04606771|594343215|FG001|Overall Study|Wrong randomisation|1|||
164537921|NCT03083847|594343219|FG000|Main|Physician Decision|0|||
164537922|NCT03083847|594343220|FG001|Main|Physician Decision|0|||
164537923|NCT03083847|594343221|FG002|Main|Physician Decision|0|||
164537924|NCT03083847|594343222|FG003|Main|Physician Decision|0|||
164537925|NCT03083847|594343223|FG004|Main|Physician Decision|0|||
164537926|NCT03083847|594343224|FG005|Main|Physician Decision|1|||
164537927|NCT03083847|594343225|FG006|Main|Physician Decision|0|||
164537928|NCT03083847|594343226|FG007|Main|Physician Decision|0|||
164537929|NCT03083847|594343227|FG008|Main|Physician Decision|0|||
164537930|NCT03083847|594343228|FG009|Main|Physician Decision|0|||
164537931|NCT03083847|594343219|FG000|Main|Pregnancy|0|||
164537932|NCT03083847|594343220|FG001|Main|Pregnancy|0|||
164537933|NCT03083847|594343221|FG002|Main|Pregnancy|0|||
164537934|NCT03083847|594343222|FG003|Main|Pregnancy|0|||
164537935|NCT03083847|594343223|FG004|Main|Pregnancy|0|||
164537936|NCT03083847|594343224|FG005|Main|Pregnancy|0|||
164537937|NCT03083847|594343225|FG006|Main|Pregnancy|0|||
164537938|NCT03083847|594343226|FG007|Main|Pregnancy|1|||
164537939|NCT03083847|594343227|FG008|Main|Pregnancy|0|||
164537940|NCT03083847|594343228|FG009|Main|Pregnancy|0|||
164537941|NCT03083847|594343219|FG000|Main|Adverse Event|0|||
164537942|NCT03083847|594343220|FG001|Main|Adverse Event|0|||
164537943|NCT03083847|594343221|FG002|Main|Adverse Event|0|||
164537944|NCT03083847|594343222|FG003|Main|Adverse Event|0|||
164537945|NCT03083847|594343223|FG004|Main|Adverse Event|0|||
164537946|NCT03083847|594343224|FG005|Main|Adverse Event|0|||
164537947|NCT03083847|594343225|FG006|Main|Adverse Event|0|||
164649017|NCT01493531|594741790|FG000|Overall Study|Withdrawal by Subject|16|||
164649018|NCT01493531|594741791|FG001|Overall Study|Withdrawal by Subject|13|||
164649019|NCT01493531|594741792|FG002|Overall Study|Withdrawal by Subject|11|||
164649020|NCT01493531|594741790|FG000|Overall Study|Death|0|||
164649021|NCT01493531|594741791|FG001|Overall Study|Death|1|||
164649022|NCT01493531|594741792|FG002|Overall Study|Death|0|||
164649023|NCT03835975|594741797|FG000|Overall Study|Lost to Follow-up|1|||
164649024|NCT03835975|594741798|FG001|Overall Study|Lost to Follow-up|1|||
164649025|NCT03835975|594741799|FG002|Overall Study|Lost to Follow-up|0|||
164649026|NCT03835975|594741800|FG003|Overall Study|Lost to Follow-up|0|||
164649027|NCT03835975|594741801|FG004|Overall Study|Lost to Follow-up|0|||
164649028|NCT03835975|594741797|FG000|Overall Study|No longer met eligibility criteria|0|||
164649029|NCT03835975|594741798|FG001|Overall Study|No longer met eligibility criteria|1|||
164649030|NCT03835975|594741799|FG002|Overall Study|No longer met eligibility criteria|0|||
164649031|NCT03835975|594741800|FG003|Overall Study|No longer met eligibility criteria|0|||
164649032|NCT03835975|594741801|FG004|Overall Study|No longer met eligibility criteria|0|||
164649033|NCT03835975|594741797|FG000|Overall Study|Protocol Violation|1|||
164649034|NCT03835975|594741798|FG001|Overall Study|Protocol Violation|1|||
164649035|NCT03835975|594741799|FG002|Overall Study|Protocol Violation|2|||
164649036|NCT03835975|594741800|FG003|Overall Study|Protocol Violation|0|||
164649037|NCT03835975|594741801|FG004|Overall Study|Protocol Violation|0|||
164649038|NCT03835975|594741797|FG000|Overall Study|Withdrawal by Subject|1|||
164649039|NCT03835975|594741798|FG001|Overall Study|Withdrawal by Subject|0|||
164649040|NCT03835975|594741799|FG002|Overall Study|Withdrawal by Subject|1|||
164649041|NCT03835975|594741800|FG003|Overall Study|Withdrawal by Subject|1|||
164649042|NCT03835975|594741801|FG004|Overall Study|Withdrawal by Subject|0|||
164649043|NCT01612702|594741802|FG000|Overall Study|Protocol Violation|11|||
164649044|NCT01612702|594741803|FG001|Overall Study|Protocol Violation|11|||
164649045|NCT03070431|594741804|FG000|Overall Study|Withdrawal by Subject|2|||
164649046|NCT03070431|594741804|FG000|Overall Study|Lost to Follow-up|2|||
164649047|NCT00370396|594741807|FG000|Overall Study|Withdrawal by Subject|0|||
164649048|NCT00370396|594741808|FG001|Overall Study|Withdrawal by Subject|0|||
164649049|NCT00370396|594741809|FG002|Overall Study|Withdrawal by Subject|1|||
164649050|NCT00370396|594741807|FG000|Overall Study|Lost to Follow-up|11|||
164649051|NCT00370396|594741808|FG001|Overall Study|Lost to Follow-up|1|||
164649052|NCT00370396|594741809|FG002|Overall Study|Lost to Follow-up|0|||
164649053|NCT05788237|594741818|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
164649054|NCT05788237|594741819|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
164649055|NCT05788237|594741820|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
164649056|NCT05788237|594741821|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
164649057|NCT05788237|594741818|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
164649058|NCT05788237|594741819|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
164649059|NCT05788237|594741820|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
164649060|NCT05788237|594741821|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
164649061|NCT05788237|594741818|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
164649062|NCT05788237|594741819|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
164649063|NCT05788237|594741820|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
164649064|NCT05788237|594741821|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
164649065|NCT05788237|594741818|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
164649066|NCT05788237|594741819|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
164649067|NCT05788237|594741820|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
164649068|NCT05788237|594741821|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
164649069|NCT05788237|594741818|FG000|SSA (Approximately 2 Months)|Death|0|||
164649070|NCT05788237|594741819|FG001|SSA (Approximately 2 Months)|Death|1|||
164649071|NCT05788237|594741820|FG002|SSA (Approximately 2 Months)|Death|0|||
164649072|NCT05788237|594741821|FG003|SSA (Approximately 2 Months)|Death|0|||
164649073|NCT05788237|594741818|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
164649074|NCT05788237|594741819|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
164649075|NCT05788237|594741820|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
164649076|NCT05788237|594741821|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
164649077|NCT05788237|594741818|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
164649078|NCT05788237|594741819|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
164649079|NCT05788237|594741820|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
164649080|NCT05788237|594741821|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
164649081|NCT05788237|594741818|FG000|SSB (Approximately 1 Month)|Other|0|||
164649082|NCT05788237|594741819|FG001|SSB (Approximately 1 Month)|Other|0|||
164649083|NCT05788237|594741820|FG002|SSB (Approximately 1 Month)|Other|0|||
164649084|NCT05788237|594741821|FG003|SSB (Approximately 1 Month)|Other|1|||
164649085|NCT03471182|594743145|FG000|Overall Study|Withdrawal by Subject|1|||
164649086|NCT03471182|594743146|FG001|Overall Study|Withdrawal by Subject|1|||
164649087|NCT03471182|594743147|FG002|Overall Study|Withdrawal by Subject|0|||
164649088|NCT03471182|594743145|FG000|Overall Study|Technical failure|2|||
164649089|NCT03471182|594743146|FG001|Overall Study|Technical failure|0|||
164649090|NCT03471182|594743147|FG002|Overall Study|Technical failure|0|||
164649091|NCT03451331|594743151|FG000|Overall Study|Withdrawal by Subject|1|||
164649092|NCT03451331|594743152|FG001|Overall Study|Withdrawal by Subject|0|||
164649093|NCT03451331|594743151|FG000|Overall Study|Unable to start treatment.|1|||
164649094|NCT03451331|594743152|FG001|Overall Study|Unable to start treatment.|1|||
164649095|NCT00289731|594743153|FG000|Overall Study|Adverse Event|1|||
164649096|NCT00289731|594743154|FG001|Overall Study|Adverse Event|2|||
164649097|NCT00289731|594743155|FG002|Overall Study|Adverse Event|2|||
164649098|NCT00289731|594743153|FG000|Overall Study|Other|1|||
164649099|NCT00289731|594743154|FG001|Overall Study|Other|0|||
164649100|NCT00289731|594743155|FG002|Overall Study|Other|0|||
164649101|NCT01170364|594743158|FG000|Overall Study|Protocol Violation|4|||
164649102|NCT01170364|594743159|FG001|Overall Study|Protocol Violation|1|||
164649103|NCT00368537|594743161|FG000|Randomization|No study drug dosed|13|||
164649104|NCT00368537|594743162|FG001|Randomization|No study drug dosed|6|||
164649105|NCT00368537|594743161|FG000|Baseline Participants|Lost to Follow-up|16|||
164649106|NCT00368537|594743162|FG001|Baseline Participants|Lost to Follow-up|17|||
164649107|NCT00368537|594743161|FG000|Baseline Participants|Withdrawal by Subject|6|||
164649108|NCT00368537|594743162|FG001|Baseline Participants|Withdrawal by Subject|4|||
164649109|NCT00368537|594743161|FG000|Baseline Participants|Death|1|||
164649110|NCT00368537|594743162|FG001|Baseline Participants|Death|2|||
164649111|NCT00368537|594743161|FG000|Baseline Participants|No susceptibility|1|||
164649112|NCT00368537|594743162|FG001|Baseline Participants|No susceptibility|0|||
164649113|NCT00368537|594743161|FG000|Baseline Participants|Patient uncompliant|0|||
164649114|NCT00368537|594743162|FG001|Baseline Participants|Patient uncompliant|1|||
164649115|NCT01368276|594743174|FG000|Overall Study|Death|1|||
164649116|NCT01368276|594743175|FG001|Overall Study|Death|10|||
164649117|NCT01427920|594743176|FG000|Overall Study|Adverse Event|1|||
164649118|NCT01427920|594743177|FG001|Overall Study|Adverse Event|2|||
164649119|NCT01427920|594743176|FG000|Overall Study|Lack of Efficacy|1|||
164649120|NCT01427920|594743177|FG001|Overall Study|Lack of Efficacy|0|||
164649121|NCT01427920|594743176|FG000|Overall Study|Protocol Violation|1|||
164649122|NCT01427920|594743177|FG001|Overall Study|Protocol Violation|3|||
164649123|NCT01427920|594743176|FG000|Overall Study|Withdrawal Criteria|4|||
164649124|NCT01427920|594743177|FG001|Overall Study|Withdrawal Criteria|4|||
164649125|NCT01427920|594743176|FG000|Overall Study|Unclassified|2|||
164649126|NCT01427920|594743177|FG001|Overall Study|Unclassified|8|||
164649127|NCT03341273|594743178|FG000|Overall Study|Lost to Follow-up|7|||
164649128|NCT03341273|594743179|FG001|Overall Study|Lost to Follow-up|7|||
164649129|NCT03341273|594743178|FG000|Overall Study|Withdrawal by Subject|4|||
164649130|NCT03341273|594743179|FG001|Overall Study|Withdrawal by Subject|2|||
164649131|NCT03341273|594743178|FG000|Overall Study|Physician Decision|1|||
164649132|NCT03341273|594743179|FG001|Overall Study|Physician Decision|0|||
164649133|NCT03341273|594743178|FG000|Overall Study|Protocol Violation|0|||
164649134|NCT03341273|594743179|FG001|Overall Study|Protocol Violation|1|||
164649135|NCT03341273|594743178|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
164649136|NCT03341273|594743179|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
164649137|NCT03341273|594743178|FG000|Overall Study|Became ineligible after enrollment|1|||
164649138|NCT03341273|594743179|FG001|Overall Study|Became ineligible after enrollment|0|||
164649139|NCT03341273|594743178|FG000|Overall Study|Not Eligible at Enrollment|0|||
164649140|NCT03341273|594743179|FG001|Overall Study|Not Eligible at Enrollment|1|||
164649141|NCT03341273|594743178|FG000|Overall Study|Participant incarcerated|1|||
164649142|NCT03341273|594743179|FG001|Overall Study|Participant incarcerated|0|||
164649143|NCT01717456|594743182|FG000|End of Treatment|Physician Decision|0|||
164649144|NCT01717456|594743183|FG001|End of Treatment|Physician Decision|1|||
164649145|NCT01717456|594743182|FG000|End of Treatment|Lost to Follow-up|0|||
164649146|NCT01717456|594743183|FG001|End of Treatment|Lost to Follow-up|1|||
164649147|NCT01717456|594743182|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
164649148|NCT01717456|594743183|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
164649149|NCT03066440|594743190|FG000|Overall Study|Physician Decision|1|||
164649150|NCT03066440|594743191|FG001|Overall Study|Physician Decision|1|||
164649151|NCT03066440|594743190|FG000|Overall Study|Protocol Violation|0|||
164649152|NCT03066440|594743191|FG001|Overall Study|Protocol Violation|2|||
164649153|NCT00736333|594743192|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
164649154|NCT00736333|594743192|FG000|Overall Study|Data Missing|2|||
164649155|NCT00736333|594743192|FG000|Overall Study|Tumor Progression|75|||
164649156|NCT00736333|594743192|FG000|Overall Study|Toxicity|6|||
164649157|NCT00736333|594743192|FG000|Overall Study|Withdrawal by Subject|10|||
164649158|NCT00736333|594743192|FG000|Overall Study|Death|7|||
164649159|NCT00736333|594743192|FG000|Overall Study|Other|4|||
164649160|NCT04991311|594743194|FG000|Overall Study|Adverse Event|1|||
164649161|NCT00054275|594743196|FG000|Overall Study|Withdrawal by Subject|4|||
164649162|NCT00054275|594743196|FG000|Overall Study|Adverse Event|5|||
164649163|NCT00054275|594743196|FG000|Overall Study|Progressive disease in cycle 1|1|||
164649164|NCT00054275|594743196|FG000|Overall Study|Physician Decision|1|||
164649165|NCT01106352|594743197|FG000|Overall Study|Subjects untreated|0|||
164649166|NCT01106352|594743198|FG001|Overall Study|Subjects untreated|0|||
164649167|NCT01106352|594743199|FG002|Overall Study|Subjects untreated|0|||
164649168|NCT01106352|594743200|FG003|Overall Study|Subjects untreated|3|||
164649169|NCT01106352|594743201|FG004|Overall Study|Subjects untreated|4|||
164649170|NCT01106352|594743197|FG000|Overall Study|Sponsor Decision|1|||
164649171|NCT01106352|594743198|FG001|Overall Study|Sponsor Decision|0|||
164649172|NCT01106352|594743199|FG002|Overall Study|Sponsor Decision|0|||
164649173|NCT01106352|594743200|FG003|Overall Study|Sponsor Decision|0|||
164649174|NCT01106352|594743201|FG004|Overall Study|Sponsor Decision|0|||
164649175|NCT01106352|594743197|FG000|Overall Study|Too ill to come in for the visit|0|||
164649176|NCT01106352|594743198|FG001|Overall Study|Too ill to come in for the visit|0|||
164649177|NCT01106352|594743199|FG002|Overall Study|Too ill to come in for the visit|1|||
164649178|NCT01106352|594743200|FG003|Overall Study|Too ill to come in for the visit|0|||
164649179|NCT01106352|594743201|FG004|Overall Study|Too ill to come in for the visit|0|||
164649180|NCT01106352|594743197|FG000|Overall Study|Lost to Follow-up|0|||
164649181|NCT01106352|594743198|FG001|Overall Study|Lost to Follow-up|0|||
164649182|NCT01106352|594743199|FG002|Overall Study|Lost to Follow-up|0|||
164649183|NCT01106352|594743200|FG003|Overall Study|Lost to Follow-up|0|||
164649184|NCT01106352|594743201|FG004|Overall Study|Lost to Follow-up|1|||
164649185|NCT01106352|594743197|FG000|Overall Study|Death|0|||
164649186|NCT01106352|594743198|FG001|Overall Study|Death|0|||
164649187|NCT01106352|594743199|FG002|Overall Study|Death|1|||
164649188|NCT01106352|594743200|FG003|Overall Study|Death|3|||
164649189|NCT01106352|594743201|FG004|Overall Study|Death|1|||
164649190|NCT01106352|594743197|FG000|Overall Study|Disease progression|0|||
164649191|NCT01106352|594743198|FG001|Overall Study|Disease progression|0|||
164649192|NCT01106352|594743199|FG002|Overall Study|Disease progression|0|||
164649193|NCT01106352|594743200|FG003|Overall Study|Disease progression|1|||
164649194|NCT01106352|594743201|FG004|Overall Study|Disease progression|0|||
164649195|NCT01106352|594743197|FG000|Overall Study|Withdrawal by Subject|0|||
164649196|NCT01106352|594743198|FG001|Overall Study|Withdrawal by Subject|0|||
164649197|NCT01106352|594743199|FG002|Overall Study|Withdrawal by Subject|0|||
164649198|NCT01106352|594743200|FG003|Overall Study|Withdrawal by Subject|3|||
164649199|NCT01106352|594743201|FG004|Overall Study|Withdrawal by Subject|2|||
164649200|NCT01106352|594743197|FG000|Overall Study|Went on hospice|0|||
164649201|NCT01106352|594743198|FG001|Overall Study|Went on hospice|0|||
164649202|NCT01106352|594743199|FG002|Overall Study|Went on hospice|0|||
164649203|NCT01106352|594743200|FG003|Overall Study|Went on hospice|1|||
164649204|NCT01106352|594743201|FG004|Overall Study|Went on hospice|0|||
164649205|NCT01106352|594743197|FG000|Overall Study|Subject entered hospice|0|||
164649206|NCT01106352|594743198|FG001|Overall Study|Subject entered hospice|0|||
164649207|NCT01106352|594743199|FG002|Overall Study|Subject entered hospice|0|||
164649208|NCT01106352|594743200|FG003|Overall Study|Subject entered hospice|1|||
164649209|NCT01106352|594743201|FG004|Overall Study|Subject entered hospice|0|||
164649210|NCT01106352|594743197|FG000|Overall Study|Home hospice since July 2013|0|||
164649211|NCT01106352|594743198|FG001|Overall Study|Home hospice since July 2013|0|||
164649212|NCT01106352|594743199|FG002|Overall Study|Home hospice since July 2013|0|||
164649213|NCT01106352|594743200|FG003|Overall Study|Home hospice since July 2013|1|||
164649214|NCT01106352|594743201|FG004|Overall Study|Home hospice since July 2013|0|||
164649215|NCT03944707|594743202|FG000|Overall Study|Adverse Event|0|||
164649216|NCT03944707|594743203|FG001|Overall Study|Adverse Event|2|||
164649217|NCT03944707|594743202|FG000|Overall Study|Study terminated by sponsor|12|||
164649218|NCT03944707|594743203|FG001|Overall Study|Study terminated by sponsor|7|||
164649219|NCT03944707|594743202|FG000|Overall Study|Subject decision|0|||
164649220|NCT03944707|594743203|FG001|Overall Study|Subject decision|1|||
164649221|NCT02444182|594743205|FG000|Overall Study|non-compliance|2|||
164649222|NCT02444182|594743206|FG001|Overall Study|non-compliance|1|||
164649223|NCT02444182|594743205|FG000|Overall Study|Lost to Follow-up|0|||
164649224|NCT02444182|594743206|FG001|Overall Study|Lost to Follow-up|4|||
164649225|NCT01959230|594743207|FG000|Overall Study|Failure to follow study procedures|0|||
164649226|NCT01959230|594743208|FG001|Overall Study|Failure to follow study procedures|1|||
164649227|NCT01959230|594743207|FG000|Overall Study|Administrative reasons|2|||
164649228|NCT01959230|594743208|FG001|Overall Study|Administrative reasons|0|||
164649229|NCT01959230|594743207|FG000|Overall Study|Withdrawal by Subject|2|||
164649230|NCT01959230|594743208|FG001|Overall Study|Withdrawal by Subject|0|||
164649231|NCT01453374|594743209|FG000|Overall Study|Adverse Event|7|||
164649232|NCT01453374|594743209|FG000|Overall Study|Lack of Efficacy|1|||
164649233|NCT01453374|594743209|FG000|Overall Study|Lost to Follow-up|3|||
164649234|NCT01453374|594743209|FG000|Overall Study|Withdrawal by Subject|5|||
164649235|NCT01453374|594743209|FG000|Overall Study|Incarcerated|2|||
164649236|NCT00751998|594743210|FG000|Overall Study|Lost to Follow-up|7|||
164649237|NCT00751998|594743210|FG000|Overall Study|Death|11|||
164649238|NCT00751998|594743210|FG000|Overall Study|Withdrawal by Subject|2|||
164649239|NCT00996918|594743214|FG000|Overall Study|Lack of Efficacy|1|||
164649240|NCT00996918|594743215|FG001|Overall Study|Lack of Efficacy|1|||
164649241|NCT00996918|594743216|FG002|Overall Study|Lack of Efficacy|2|||
164649242|NCT00996918|594743217|FG003|Overall Study|Lack of Efficacy|2|||
164649243|NCT00996918|594743218|FG004|Overall Study|Lack of Efficacy|0|||
164649244|NCT00996918|594743214|FG000|Overall Study|Adverse Event|2|||
164649245|NCT00996918|594743215|FG001|Overall Study|Adverse Event|5|||
164649246|NCT00996918|594743216|FG002|Overall Study|Adverse Event|2|||
164649247|NCT00996918|594743217|FG003|Overall Study|Adverse Event|6|||
164649248|NCT00996918|594743218|FG004|Overall Study|Adverse Event|0|||
164649249|NCT00996918|594743214|FG000|Overall Study|Withdrawal by Subject|1|||
164649250|NCT00996918|594743215|FG001|Overall Study|Withdrawal by Subject|4|||
164649251|NCT00996918|594743216|FG002|Overall Study|Withdrawal by Subject|3|||
164649252|NCT00996918|594743217|FG003|Overall Study|Withdrawal by Subject|3|||
164649253|NCT00996918|594743218|FG004|Overall Study|Withdrawal by Subject|2|||
164649254|NCT00996918|594743214|FG000|Overall Study|Physician Decision|1|||
164649255|NCT00996918|594743215|FG001|Overall Study|Physician Decision|0|||
164649256|NCT00996918|594743216|FG002|Overall Study|Physician Decision|0|||
164649257|NCT00996918|594743217|FG003|Overall Study|Physician Decision|0|||
164649258|NCT00996918|594743218|FG004|Overall Study|Physician Decision|0|||
164649259|NCT00996918|594743214|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
164649260|NCT00996918|594743215|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
164649261|NCT00996918|594743216|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
164649262|NCT00996918|594743217|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
164649263|NCT00996918|594743218|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
164649264|NCT00996918|594743214|FG000|Overall Study|Loss of Caregiver|0|||
164649265|NCT00996918|594743215|FG001|Overall Study|Loss of Caregiver|1|||
164649266|NCT00996918|594743216|FG002|Overall Study|Loss of Caregiver|0|||
164649267|NCT00996918|594743217|FG003|Overall Study|Loss of Caregiver|0|||
164649268|NCT00996918|594743218|FG004|Overall Study|Loss of Caregiver|0|||
164649269|NCT00996918|594743214|FG000|Overall Study|Other|3|||
164649270|NCT00996918|594743215|FG001|Overall Study|Other|1|||
164649271|NCT00996918|594743216|FG002|Overall Study|Other|0|||
164649272|NCT00996918|594743217|FG003|Overall Study|Other|0|||
164649273|NCT00996918|594743218|FG004|Overall Study|Other|0|||
164649274|NCT01965535|594743221|FG000|Overall Study|Lack of Efficacy|2|||
164649275|NCT01965535|594743222|FG001|Overall Study|Lack of Efficacy|1|||
164649276|NCT00829439|594743224|FG000|Overall Study|Adverse Event|0|||
164649277|NCT00829439|594743225|FG001|Overall Study|Adverse Event|0|||
164649278|NCT00829439|594743226|FG002|Overall Study|Adverse Event|1|||
164649279|NCT00829439|594743227|FG003|Overall Study|Adverse Event|0|||
164649280|NCT02525562|594743228|FG000|Overall Study|Death|9|||
164649281|NCT02525562|594743229|FG001|Overall Study|Death|0|||
164649282|NCT02525562|594743230|FG002|Overall Study|Death|0|||
164649283|NCT02525562|594743228|FG000|Overall Study|Lost to Follow-up|19|||
164649284|NCT02525562|594743229|FG001|Overall Study|Lost to Follow-up|0|||
164649285|NCT02525562|594743230|FG002|Overall Study|Lost to Follow-up|0|||
164649286|NCT02525562|594743228|FG000|Overall Study|Withdrawal by Subject|37|||
164649287|NCT02525562|594743229|FG001|Overall Study|Withdrawal by Subject|0|||
164649288|NCT02525562|594743230|FG002|Overall Study|Withdrawal by Subject|0|||
164649289|NCT02525562|594743228|FG000|Overall Study|Revision/Removal of Study Device|4|||
164649290|NCT02525562|594743229|FG001|Overall Study|Revision/Removal of Study Device|0|||
164649291|NCT02525562|594743230|FG002|Overall Study|Revision/Removal of Study Device|0|||
164649292|NCT02525562|594743228|FG000|Overall Study|Study Closed by Sponsor|154|||
164649293|NCT02525562|594743229|FG001|Overall Study|Study Closed by Sponsor|0|||
164649294|NCT02525562|594743230|FG002|Overall Study|Study Closed by Sponsor|0|||
164649295|NCT00886782|594743231|FG000|Overall Study|Disease progression|3|||
164649296|NCT00886782|594743232|FG001|Overall Study|Disease progression|3|||
164649297|NCT00886782|594743233|FG002|Overall Study|Disease progression|3|||
164649298|NCT00886782|594743231|FG000|Overall Study|Study drug toxicity|0|||
164649299|NCT00886782|594743232|FG001|Overall Study|Study drug toxicity|0|||
164649300|NCT00886782|594743233|FG002|Overall Study|Study drug toxicity|1|||
164649301|NCT00886782|594743231|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
164649302|NCT00886782|594743232|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
164649303|NCT00886782|594743233|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
164649304|NCT01946282|594743234|FG000|Year 1|Did not return FIT kit|4186|||
164649305|NCT01946282|594743235|FG001|Year 1|Did not return FIT kit|608|||
164649306|NCT01946282|594743236|FG002|Year 1|Did not return FIT kit|654|||
164649307|NCT01946282|594743234|FG000|Year 2|Did not return FIT kit|803|||
164649308|NCT01946282|594743235|FG001|Year 2|Did not return FIT kit|131|||
164649309|NCT01946282|594743236|FG002|Year 2|Did not return FIT kit|115|||
164649310|NCT01946282|594743234|FG000|Year 3|Did not return FIT kit|288|||
164649311|NCT01946282|594743235|FG001|Year 3|Did not return FIT kit|43|||
164649312|NCT01946282|594743236|FG002|Year 3|Did not return FIT kit|30|||
164649313|NCT03031431|594743237|FG000|Overall Study|Infant removed by maternal request|1|||
164649314|NCT04130919|594743238|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
164649315|NCT04130919|594743239|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
164649316|NCT04130919|594743240|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
164649317|NCT04130919|594743241|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
164649318|NCT04130919|594743242|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
164649319|NCT04130919|594743243|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
164649320|NCT04130919|594743238|FG000|Blinded Treatment Phase|Adverse Event|0|||
164649321|NCT04130919|594743239|FG001|Blinded Treatment Phase|Adverse Event|0|||
164649322|NCT04130919|594743240|FG002|Blinded Treatment Phase|Adverse Event|1|||
164649323|NCT04130919|594743241|FG003|Blinded Treatment Phase|Adverse Event|0|||
164649324|NCT04130919|594743242|FG004|Blinded Treatment Phase|Adverse Event|0|||
164649325|NCT04130919|594743243|FG005|Blinded Treatment Phase|Adverse Event|0|||
164649326|NCT04130919|594743238|FG000|Blinded Treatment Phase|Disease worsening|0|||
164649327|NCT04130919|594743239|FG001|Blinded Treatment Phase|Disease worsening|0|||
164649328|NCT04130919|594743240|FG002|Blinded Treatment Phase|Disease worsening|1|||
164649329|NCT04130919|594743241|FG003|Blinded Treatment Phase|Disease worsening|0|||
164649330|NCT04130919|594743242|FG004|Blinded Treatment Phase|Disease worsening|0|||
164649331|NCT04130919|594743243|FG005|Blinded Treatment Phase|Disease worsening|0|||
164649332|NCT04130919|594743238|FG000|Blinded Treatment Phase|Investigator's decision|0|||
164649333|NCT04130919|594743239|FG001|Blinded Treatment Phase|Investigator's decision|1|||
164649334|NCT04130919|594743240|FG002|Blinded Treatment Phase|Investigator's decision|0|||
164649335|NCT04130919|594743241|FG003|Blinded Treatment Phase|Investigator's decision|0|||
164649336|NCT04130919|594743242|FG004|Blinded Treatment Phase|Investigator's decision|0|||
164649337|NCT04130919|594743243|FG005|Blinded Treatment Phase|Investigator's decision|0|||
164649338|NCT04130919|594743238|FG000|Blinded Treatment Phase|Withdrew consent|1|||
164649339|NCT04130919|594743239|FG001|Blinded Treatment Phase|Withdrew consent|0|||
164649340|NCT04130919|594743240|FG002|Blinded Treatment Phase|Withdrew consent|0|||
164649341|NCT04130919|594743241|FG003|Blinded Treatment Phase|Withdrew consent|0|||
164649342|NCT04130919|594743242|FG004|Blinded Treatment Phase|Withdrew consent|0|||
164649343|NCT04130919|594743243|FG005|Blinded Treatment Phase|Withdrew consent|0|||
164649344|NCT04130919|594743238|FG000|Open-label Treatment Phase|Withdrew consent|0|||
164649345|NCT04130919|594743239|FG001|Open-label Treatment Phase|Withdrew consent|0|||
164649346|NCT04130919|594743240|FG002|Open-label Treatment Phase|Withdrew consent|0|||
164649347|NCT04130919|594743241|FG003|Open-label Treatment Phase|Withdrew consent|1|||
164649348|NCT04130919|594743242|FG004|Open-label Treatment Phase|Withdrew consent|1|||
164649349|NCT04130919|594743243|FG005|Open-label Treatment Phase|Withdrew consent|1|||
164649350|NCT04130919|594743238|FG000|Open-label Treatment Phase|Disease worsening|0|||
164649351|NCT04130919|594743239|FG001|Open-label Treatment Phase|Disease worsening|0|||
164649352|NCT04130919|594743240|FG002|Open-label Treatment Phase|Disease worsening|0|||
164649353|NCT04130919|594743241|FG003|Open-label Treatment Phase|Disease worsening|1|||
164649354|NCT04130919|594743242|FG004|Open-label Treatment Phase|Disease worsening|0|||
164649355|NCT04130919|594743243|FG005|Open-label Treatment Phase|Disease worsening|1|||
164649356|NCT04130919|594743238|FG000|Open-label Treatment Phase|Investigator's decision|0|||
164649357|NCT04130919|594743239|FG001|Open-label Treatment Phase|Investigator's decision|0|||
164649358|NCT04130919|594743240|FG002|Open-label Treatment Phase|Investigator's decision|0|||
164649359|NCT04130919|594743241|FG003|Open-label Treatment Phase|Investigator's decision|1|||
164649360|NCT04130919|594743242|FG004|Open-label Treatment Phase|Investigator's decision|0|||
164649361|NCT04130919|594743243|FG005|Open-label Treatment Phase|Investigator's decision|0|||
164649362|NCT04130919|594743238|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
164649363|NCT04130919|594743239|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
164649364|NCT04130919|594743240|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
164649365|NCT04130919|594743241|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
164649366|NCT04130919|594743242|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
164649367|NCT04130919|594743243|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
164649368|NCT04130919|594743238|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
164649369|NCT04130919|594743239|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
164649370|NCT04130919|594743240|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
164649371|NCT04130919|594743241|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
164649372|NCT04130919|594743242|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
164649373|NCT04130919|594743243|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
164649374|NCT02400905|594743245|FG000|Overall Study|Death|24|||
164649375|NCT02400905|594743245|FG000|Overall Study|Lost to Follow-up|18|||
164649376|NCT02400905|594743245|FG000|Overall Study|Withdrawal by Subject|16|||
164649377|NCT02400905|594743245|FG000|Overall Study|Physician Decision|4|||
164649378|NCT02400905|594743245|FG000|Overall Study|Other|1|||
164649379|NCT03196791|594743248|FG000|Overall Study|Protocol Violation|7|||
164649380|NCT03196791|594743249|FG001|Overall Study|Protocol Violation|3|||
164649381|NCT03196791|594743248|FG000|Overall Study|Withdrawal by Subject|3|||
164649382|NCT03196791|594743249|FG001|Overall Study|Withdrawal by Subject|2|||
164649383|NCT01749033|594743253|FG000|Overall Study|Did not receive allocated intervention|3|||
164649384|NCT01749033|594743254|FG001|Overall Study|Did not receive allocated intervention|3|||
164649385|NCT01749033|594743255|FG002|Overall Study|Did not receive allocated intervention|0|||
164649386|NCT01749033|594743253|FG000|Overall Study|Lost to Follow-up|0|||
164649387|NCT01749033|594743254|FG001|Overall Study|Lost to Follow-up|2|||
164649388|NCT01749033|594743255|FG002|Overall Study|Lost to Follow-up|1|||
164649389|NCT01039584|594743256|FG000|Overall Study|Withdrawal by Subject|4|||
164649390|NCT01039584|594743257|FG001|Overall Study|Withdrawal by Subject|2|||
164649391|NCT01039584|594743258|FG002|Overall Study|Withdrawal by Subject|1|||
164649392|NCT01039584|594743256|FG000|Overall Study|Protocol Violation|10|||
164649393|NCT01039584|594743257|FG001|Overall Study|Protocol Violation|4|||
164649394|NCT01039584|594743258|FG002|Overall Study|Protocol Violation|6|||
164649395|NCT01039584|594743256|FG000|Overall Study|Lost to Follow-up|5|||
164649396|NCT01039584|594743257|FG001|Overall Study|Lost to Follow-up|3|||
164649397|NCT01039584|594743258|FG002|Overall Study|Lost to Follow-up|4|||
164649398|NCT01039584|594743256|FG000|Overall Study|Negative Baseline culture for Candida|59|||
164649399|NCT01039584|594743257|FG001|Overall Study|Negative Baseline culture for Candida|59|||
164649400|NCT01039584|594743258|FG002|Overall Study|Negative Baseline culture for Candida|24|||
164649401|NCT01039584|594743256|FG000|Overall Study|Lack of Efficacy|7|||
164649402|NCT01039584|594743257|FG001|Overall Study|Lack of Efficacy|6|||
164649403|NCT01039584|594743258|FG002|Overall Study|Lack of Efficacy|10|||
164649404|NCT01039584|594743256|FG000|Overall Study|other|1|||
164649405|NCT01039584|594743257|FG001|Overall Study|other|3|||
164649406|NCT01039584|594743258|FG002|Overall Study|other|1|||
164649407|NCT01039584|594743256|FG000|Overall Study|Pap smear with significant pathology|10|||
164649408|NCT01039584|594743257|FG001|Overall Study|Pap smear with significant pathology|10|||
164649409|NCT01039584|594743258|FG002|Overall Study|Pap smear with significant pathology|3|||
164649410|NCT01039584|594743256|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
164649411|NCT01039584|594743257|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
164649412|NCT01039584|594743258|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
164649413|NCT00051636|594743259|FG000|Period 1 - Core|Adverse Event|2|||
164649414|NCT00051636|594743260|FG001|Period 1 - Core|Adverse Event|2|||
164649415|NCT00051636|594743259|FG000|Period 1 - Core|Protocol Violation|1|||
164649416|NCT00051636|594743260|FG001|Period 1 - Core|Protocol Violation|0|||
164649417|NCT00051636|594743259|FG000|Period 1 - Core|Withdrawal by Subject|1|||
164649418|NCT00051636|594743260|FG001|Period 1 - Core|Withdrawal by Subject|2|||
164649419|NCT00051636|594743259|FG000|Period 1 - Core|Lost to Follow-up|0|||
164649420|NCT00051636|594743260|FG001|Period 1 - Core|Lost to Follow-up|2|||
164649421|NCT00051636|594743259|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
164649422|NCT00051636|594743260|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
164649423|NCT00051636|594743259|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
164649424|NCT00051636|594743260|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
164649425|NCT00051636|594743259|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
164649426|NCT00051636|594743260|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
164649427|NCT00051636|594743259|FG000|Period 2- Extended Observation Period|Death|4|||
164649428|NCT00051636|594743260|FG001|Period 2- Extended Observation Period|Death|5|||
164649429|NCT00051636|594743259|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
164649430|NCT00051636|594743260|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
164649431|NCT00479765|594743261|FG000|Overall Study|study terminated|4|||
164649432|NCT03550794|594743262|FG000|Overall Study|No longer met inclusion criteria|1|||
164649433|NCT03550794|594743263|FG001|Overall Study|No longer met inclusion criteria|2|||
164649434|NCT03550794|594743262|FG000|Overall Study|Goals of care changed|1|||
164649435|NCT03550794|594743263|FG001|Overall Study|Goals of care changed|0|||
164649436|NCT03550794|594743262|FG000|Overall Study|Withdrawal by Subject|2|||
164649437|NCT03550794|594743263|FG001|Overall Study|Withdrawal by Subject|0|||
164649438|NCT03550794|594743262|FG000|Overall Study|Death|0|||
164649439|NCT03550794|594743263|FG001|Overall Study|Death|1|||
164649440|NCT01890785|594743264|FG000|Third Intervention|Withdrawal by Subject|0|||
164649441|NCT01890785|594743265|FG001|Third Intervention|Withdrawal by Subject|1|||
164649442|NCT01890785|594743266|FG002|Third Intervention|Withdrawal by Subject|0|||
164649443|NCT01890785|594743267|FG003|Third Intervention|Withdrawal by Subject|0|||
164649444|NCT01890785|594743268|FG004|Third Intervention|Withdrawal by Subject|0|||
164649445|NCT01890785|594743269|FG005|Third Intervention|Withdrawal by Subject|0|||
164649446|NCT00558519|594743270|FG000|Overall Study|Ph+|20|||
164649447|NCT00558519|594743270|FG000|Overall Study|Ineligible|1|||
164649448|NCT00558519|594743270|FG000|Overall Study|Insufficient data|1|||
164649449|NCT00558519|594743270|FG000|Overall Study|Never received treatment|1|||
164649450|NCT03001011|594743271|FG000|Overall Study|Adverse Event|9|||
164649451|NCT03001011|594743272|FG001|Overall Study|Adverse Event|3|||
164649452|NCT03001011|594743271|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
164649453|NCT03001011|594743272|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
164649454|NCT03001011|594743271|FG000|Overall Study|Other than specified above|3|||
164649455|NCT03001011|594743272|FG001|Overall Study|Other than specified above|8|||
164649456|NCT03077828|594743274|FG000|Treatment Cycles|Death|1|||
164649457|NCT03077828|594743274|FG000|Treatment Cycles|Withdrawal by Subject|1|||
164649458|NCT03077828|594743274|FG000|Treatment Cycles|Screen Fail|2|||
164649459|NCT03077828|594743274|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
164649460|NCT03077828|594743274|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
164649461|NCT03077828|594743274|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
164649462|NCT03077828|594743274|FG000|Follow-up|Patients still in follow-up|15|||
164649463|NCT02392559|594743275|FG000|Overall Study|Withdrawal by Subject|0|||
164649464|NCT02392559|594743276|FG001|Overall Study|Withdrawal by Subject|1|||
164649465|NCT02340078|594743277|FG000|Overall Study|Protocol Violation|1|||
164649466|NCT00944125|594743280|FG000|3 to 6 Months|Withdrawal by Subject|0|||
164649467|NCT00944125|594743281|FG001|3 to 6 Months|Withdrawal by Subject|2|||
164649468|NCT00944125|594743280|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
164649469|NCT00944125|594743281|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
164649470|NCT04816877|594743284|FG000|Overall Study|Withdrawal by Subject|1|||
164649471|NCT04816877|594743285|FG001|Overall Study|Withdrawal by Subject|0|||
164649472|NCT02176642|594743286|FG000|Overall Study|Withdrawal by Subject|0|||
164649473|NCT02176642|594743287|FG001|Overall Study|Withdrawal by Subject|1|||
164649474|NCT00295620|594743289|FG000|Overall Study|Lost to Follow-up|9|||
164649475|NCT00295620|594743290|FG001|Overall Study|Lost to Follow-up|5|||
164649476|NCT00295620|594743289|FG000|Overall Study|Withdrawal by Subject|37|||
164649477|NCT00295620|594743290|FG001|Overall Study|Withdrawal by Subject|50|||
164649478|NCT00295620|594743289|FG000|Overall Study|Death|206|||
164649479|NCT00295620|594743290|FG001|Overall Study|Death|207|||
164649480|NCT00295620|594743289|FG000|Overall Study|Other reasons|10|||
164649481|NCT00295620|594743290|FG001|Overall Study|Other reasons|9|||
164649482|NCT00295620|594743289|FG000|Overall Study|Discontinuation by sponsor|580|||
164649483|NCT00295620|594743290|FG001|Overall Study|Discontinuation by sponsor|593|||
164649484|NCT00295620|594743289|FG000|Overall Study|Protocol Violation|30|||
164649485|NCT00295620|594743290|FG001|Overall Study|Protocol Violation|32|||
164649486|NCT00217971|594743291|FG000|Overall Study|Adverse Event|1|||
164649487|NCT00217971|594743292|FG001|Overall Study|Adverse Event|1|||
164649488|NCT00217971|594743291|FG000|Overall Study|Lost to Follow-up|15|||
164649489|NCT00217971|594743292|FG001|Overall Study|Lost to Follow-up|19|||
164649490|NCT00217971|594743291|FG000|Overall Study|Physician Decision|0|||
164649491|NCT00217971|594743292|FG001|Overall Study|Physician Decision|1|||
164649492|NCT00217971|594743291|FG000|Overall Study|Withdrawal by Subject|7|||
164649493|NCT00217971|594743292|FG001|Overall Study|Withdrawal by Subject|12|||
164649494|NCT00217971|594743291|FG000|Overall Study|non compliant|1|||
164649495|NCT00217971|594743292|FG001|Overall Study|non compliant|0|||
164649496|NCT00808015|594743293|FG000|Overall Study|Death|1|||
164649497|NCT00808015|594743293|FG000|Overall Study|Lack of Efficacy|58|||
164649498|NCT00808015|594743293|FG000|Overall Study|Lost to Follow-up|76|||
164649499|NCT00808015|594743293|FG000|Overall Study|Participants not willing to participate|158|||
164649500|NCT00808015|594743293|FG000|Overall Study|Adverse Event|22|||
164649501|NCT00808015|594743293|FG000|Overall Study|Other|25|||
164649502|NCT00808015|594743293|FG000|Overall Study|Enrolled but not treated|4|||
164649503|NCT00084617|594743294|FG000|Overall Study|Withdrawal by Subject|7|||
164649504|NCT00084617|594743294|FG000|Overall Study|Lack of Efficacy|1|||
164649505|NCT00084617|594743294|FG000|Overall Study|Protocol Violation|1|||
164649506|NCT03338673|594743295|FG000|Overall Study|Lost to Follow-up|1|||
164649507|NCT03338673|594743296|FG001|Overall Study|Lost to Follow-up|1|||
164649508|NCT01963676|594744989|FG000|Overall Study|Withdrawal by Subject|1|||
164649509|NCT01963676|594744990|FG001|Overall Study|Withdrawal by Subject|0|||
164649510|NCT03627195|594744991|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
164649511|NCT03627195|594744992|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
164649512|NCT03627195|594744993|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
164649513|NCT03627195|594744994|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
164649514|NCT03627195|594744995|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
164649515|NCT03627195|594744996|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
164649516|NCT00096382|594744999|FG000|Overall Study|Not treated|1|||
164649517|NCT00096382|594745000|FG001|Overall Study|Not treated|0|||
164649518|NCT00096382|594744999|FG000|Overall Study|Death during treatment|1|||
164649519|NCT00096382|594745000|FG001|Overall Study|Death during treatment|0|||
164649520|NCT01977352|594745011|FG000|Overall Study|Lost to Follow-up|1|||
164649521|NCT01977352|594745012|FG001|Overall Study|Lost to Follow-up|2|||
164649522|NCT00409188|594745013|FG000|Overall Study|Ongoing at data cut-off|383|||
164649523|NCT00409188|594745014|FG001|Overall Study|Ongoing at data cut-off|175|||
164649524|NCT01835132|594745015|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
164649525|NCT01681771|594745016|FG000|Overall Study|Lost to Follow-up|4|||
164649526|NCT01681771|594745017|FG001|Overall Study|Lost to Follow-up|2|||
164649527|NCT03208933|594745021|FG000|Overall Study|Death|3|||
164649528|NCT03208933|594745021|FG000|Overall Study|Withdrawal by Subject|3|||
164649529|NCT03208933|594745021|FG000|Overall Study|Adverse Event|1|||
164649530|NCT03208933|594745021|FG000|Overall Study|Lost to Follow-up|2|||
164649531|NCT03208933|594745021|FG000|Overall Study|Physician Decision|3|||
164649532|NCT03208933|594745021|FG000|Overall Study|Protocol Violation|1|||
164649533|NCT04242186|594745029|FG000|Overall Study|Death|5|||
164649534|NCT00550420|594745030|FG000|Overall Study|Adverse Event|28|||
164649535|NCT00550420|594745030|FG000|Overall Study|Lost to Follow-up|8|||
164649536|NCT00550420|594745030|FG000|Overall Study|Protocol Violation|11|||
164649537|NCT00550420|594745030|FG000|Overall Study|Withdrawal by Subject|30|||
164649538|NCT00550420|594745030|FG000|Overall Study|Still in study at termination|206|||
164649539|NCT00550420|594745030|FG000|Overall Study|Missing|2|||
164649540|NCT00550420|594745030|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
164649541|NCT00550420|594745030|FG000|Overall Study|Investigators opinion|1|||
164649542|NCT00550420|594745030|FG000|Overall Study|Lack of curative effect|1|||
164649543|NCT00550420|594745030|FG000|Overall Study|Unethical stop of enrollment|2|||
164649544|NCT00550420|594745030|FG000|Overall Study|Caregiver's decision to withdraw|1|||
164649545|NCT00550420|594745030|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
164649546|NCT00550420|594745030|FG000|Overall Study|Exclusion criteria|1|||
164649547|NCT00550420|594745030|FG000|Overall Study|Prohibited medicine|1|||
164649548|NCT01872689|594745035|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
164649549|NCT01872689|594745036|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
164649550|NCT01872689|594745037|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
164649551|NCT01872689|594745038|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
164649552|NCT01872689|594745035|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
164649553|NCT01872689|594745036|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
164649554|NCT01872689|594745037|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
164649555|NCT01872689|594745038|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
164649556|NCT01872689|594745035|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
164649557|NCT01872689|594745036|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
164649558|NCT01872689|594745037|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
164649559|NCT01872689|594745038|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
164649560|NCT01872689|594745035|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
164649561|NCT01872689|594745036|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
164649562|NCT01872689|594745037|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
164649563|NCT01872689|594745038|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
164649564|NCT01872689|594745035|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
164649565|NCT01872689|594745036|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
164649566|NCT01872689|594745037|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
164649567|NCT01872689|594745038|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
164649568|NCT01872689|594745035|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
164649569|NCT01872689|594745036|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
164649570|NCT01872689|594745037|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
164649571|NCT01872689|594745038|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
164649572|NCT01872689|594745035|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
164649573|NCT01872689|594745036|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
164649574|NCT01872689|594745037|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
164649575|NCT01872689|594745038|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
164649576|NCT01872689|594745035|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
164649577|NCT01872689|594745036|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
164649578|NCT01872689|594745037|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
164649579|NCT01872689|594745038|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
164649580|NCT01872689|594745035|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
164649581|NCT01872689|594745036|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
164649582|NCT01872689|594745037|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
164649583|NCT01872689|594745038|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
164649584|NCT01872689|594745035|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
164649585|NCT01872689|594745036|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
164649586|NCT01872689|594745037|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
164649587|NCT01872689|594745038|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
164649588|NCT01872689|594745035|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
164649589|NCT01872689|594745036|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
164649590|NCT01872689|594745037|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
164649591|NCT01872689|594745038|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
164537948|NCT03083847|594343226|FG007|Main|Adverse Event|2|||
164537949|NCT03083847|594343227|FG008|Main|Adverse Event|0|||
164537950|NCT03083847|594343228|FG009|Main|Adverse Event|0|||
164537951|NCT03083847|594343219|FG000|Main|Withdrawal by Subject|0|||
164537952|NCT03083847|594343220|FG001|Main|Withdrawal by Subject|0|||
164537953|NCT03083847|594343221|FG002|Main|Withdrawal by Subject|0|||
164537954|NCT03083847|594343222|FG003|Main|Withdrawal by Subject|0|||
164537955|NCT03083847|594343223|FG004|Main|Withdrawal by Subject|0|||
164537956|NCT03083847|594343224|FG005|Main|Withdrawal by Subject|0|||
164537957|NCT03083847|594343225|FG006|Main|Withdrawal by Subject|1|||
164537958|NCT03083847|594343226|FG007|Main|Withdrawal by Subject|1|||
164537959|NCT03083847|594343227|FG008|Main|Withdrawal by Subject|0|||
164537960|NCT03083847|594343228|FG009|Main|Withdrawal by Subject|0|||
164537961|NCT02596620|594343231|FG000|Overall Study|Lost to Follow-up|1|||
164537962|NCT02596620|594343232|FG001|Overall Study|Lost to Follow-up|1|||
164537963|NCT01054144|594343233|FG000|Overall Study|Death|2|||
164537964|NCT02856893|594343234|FG000|Overall Study|Lack of Efficacy|27|||
164537965|NCT02856893|594343235|FG001|Overall Study|Lack of Efficacy|15|||
164537966|NCT02856893|594343236|FG002|Overall Study|Lack of Efficacy|19|||
164537967|NCT02856893|594343234|FG000|Overall Study|Death|1|||
164537968|NCT02856893|594343235|FG001|Overall Study|Death|0|||
164537969|NCT02856893|594343236|FG002|Overall Study|Death|0|||
164537970|NCT02856893|594343234|FG000|Overall Study|Adverse Event|2|||
164537971|NCT02856893|594343235|FG001|Overall Study|Adverse Event|0|||
164649592|NCT01872689|594745035|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
164649593|NCT01872689|594745036|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
164649594|NCT01872689|594745037|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
164649595|NCT01872689|594745038|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
164649596|NCT01872689|594745035|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
164649597|NCT01872689|594745036|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
164649598|NCT01872689|594745037|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
164649599|NCT01872689|594745038|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
164649600|NCT01872689|594745035|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
164649601|NCT01872689|594745036|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
164649602|NCT01872689|594745037|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
164649603|NCT01872689|594745038|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
164649604|NCT02762565|594745039|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
164649605|NCT01113710|594745040|FG000|Overall Study|Adverse Event|64|||
164649606|NCT01113710|594745040|FG000|Overall Study|Lack of Efficacy|41|||
164649607|NCT01113710|594745040|FG000|Overall Study|No Information Available|40|||
164649608|NCT01113710|594745040|FG000|Overall Study|Withdrawal by Subject|28|||
164649609|NCT01113710|594745040|FG000|Overall Study|Lost to Follow-up|20|||
164649610|NCT01113710|594745040|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
164649611|NCT01113710|594745040|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
164649612|NCT01113710|594745040|FG000|Overall Study|Lack of Patient's Compliance|8|||
164649613|NCT01113710|594745040|FG000|Overall Study|Other|7|||
164649614|NCT01113710|594745040|FG000|Overall Study|Adverse Event/Other|5|||
164649615|NCT01113710|594745040|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
164649616|NCT01113710|594745040|FG000|Overall Study|Lack of Efficacy/Other|4|||
164649617|NCT01113710|594745040|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
164649618|NCT01113710|594745040|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
164649619|NCT01113710|594745040|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
164649620|NCT01113710|594745040|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
164649621|NCT01113710|594745040|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
164649622|NCT01113710|594745040|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
164649623|NCT01113710|594745040|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
164649624|NCT01113710|594745040|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
164649625|NCT01113710|594745040|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
164649626|NCT01113710|594745040|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
164649627|NCT01113710|594745040|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
164649628|NCT01113710|594745040|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
164649629|NCT01113710|594745040|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
164649630|NCT01042977|594745042|FG000|Overall Study|Adverse Event|4|||
164649631|NCT01042977|594745043|FG001|Overall Study|Adverse Event|12|||
164649632|NCT01042977|594745042|FG000|Overall Study|Death|2|||
164649633|NCT01042977|594745043|FG001|Overall Study|Death|1|||
164649634|NCT01042977|594745042|FG000|Overall Study|Withdrawal by Subject|8|||
164649635|NCT01042977|594745043|FG001|Overall Study|Withdrawal by Subject|16|||
164649636|NCT01042977|594745042|FG000|Overall Study|Lost to Follow-up|0|||
164649637|NCT01042977|594745043|FG001|Overall Study|Lost to Follow-up|2|||
164649638|NCT01042977|594745042|FG000|Overall Study|Poor/non-compliance|3|||
164649639|NCT01042977|594745043|FG001|Overall Study|Poor/non-compliance|4|||
164649640|NCT01042977|594745042|FG000|Overall Study|Subject no longer meets study criteria|15|||
164649641|NCT01042977|594745043|FG001|Overall Study|Subject no longer meets study criteria|13|||
164649642|NCT01042977|594745042|FG000|Overall Study|Incorrect enrollment|6|||
164649643|NCT01042977|594745043|FG001|Overall Study|Incorrect enrollment|4|||
164649644|NCT01042977|594745042|FG000|Overall Study|Safety|0|||
164649645|NCT01042977|594745043|FG001|Overall Study|Safety|2|||
164649646|NCT01042977|594745042|FG000|Overall Study|Administrative reason by sponsor|0|||
164649647|NCT01042977|594745043|FG001|Overall Study|Administrative reason by sponsor|1|||
164649648|NCT01042977|594745042|FG000|Overall Study|Various|3|||
164649649|NCT01042977|594745043|FG001|Overall Study|Various|0|||
164649650|NCT02499354|594745044|FG000|Overall Study|Withdrawal by Subject|1|||
164649651|NCT02499354|594745045|FG001|Overall Study|Withdrawal by Subject|0|||
164649652|NCT01677910|594745046|FG000|Double-Blind Treatment Period|Adverse Event|6|||
164649653|NCT01677910|594745047|FG001|Double-Blind Treatment Period|Adverse Event|2|||
164649654|NCT01677910|594745048|FG002|Double-Blind Treatment Period|Adverse Event|3|||
164649655|NCT01677910|594745049|FG003|Double-Blind Treatment Period|Adverse Event|0|||
164649656|NCT01677910|594745046|FG000|Double-Blind Treatment Period|Physician Decision|0|||
164649657|NCT01677910|594745047|FG001|Double-Blind Treatment Period|Physician Decision|0|||
164649658|NCT01677910|594745048|FG002|Double-Blind Treatment Period|Physician Decision|1|||
164649659|NCT01677910|594745049|FG003|Double-Blind Treatment Period|Physician Decision|0|||
164649660|NCT01677910|594745046|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
164649661|NCT01677910|594745047|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
164649662|NCT01677910|594745048|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
164649663|NCT01677910|594745049|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
164649664|NCT01677910|594745046|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
164649665|NCT01677910|594745047|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
164649666|NCT01677910|594745048|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
164649667|NCT01677910|594745049|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
164649668|NCT01677910|594745046|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
164649669|NCT01677910|594745047|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
164649670|NCT01677910|594745048|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
164649671|NCT01677910|594745049|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
164649672|NCT01677910|594745046|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
164649673|NCT01677910|594745047|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
164649674|NCT01677910|594745048|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
164649675|NCT01677910|594745049|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
164649676|NCT01677910|594745046|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
164649677|NCT01677910|594745047|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
164649678|NCT01677910|594745048|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
164649679|NCT01677910|594745049|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
164649680|NCT01677910|594745046|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
164649681|NCT01677910|594745047|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
164649682|NCT01677910|594745048|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
164649683|NCT01677910|594745049|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
164649684|NCT01677910|594745046|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
164649685|NCT01677910|594745047|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
164649686|NCT01677910|594745048|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
164649687|NCT01677910|594745049|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
164649688|NCT01677910|594745046|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
164649689|NCT01677910|594745047|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
164649690|NCT01677910|594745048|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
164649691|NCT01677910|594745049|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
164649692|NCT01703741|594745051|FG000|Overall Study|Withdrawal by Subject|6|||
164649693|NCT01703741|594745051|FG000|Overall Study|Adverse Event|2|||
164649694|NCT01703741|594745051|FG000|Overall Study|Physician Decision|2|||
164649695|NCT01703741|594745051|FG000|Overall Study|Protocol Violation|1|||
164649696|NCT01703741|594745051|FG000|Overall Study|Lost to Follow-up|3|||
164649697|NCT01703741|594745051|FG000|Overall Study|Subject did not want to continue|2|||
164649698|NCT01703741|594745051|FG000|Overall Study|Subject cannot comply with study visits|1|||
164649699|NCT01703741|594745051|FG000|Overall Study|Subject started testosterone injections|1|||
164649700|NCT04132232|594745052|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
164649701|NCT04132232|594745053|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
164649702|NCT04132232|594745052|FG000|Overall Study|Lost to Follow-up|6|||
164649703|NCT04132232|594745053|FG001|Overall Study|Lost to Follow-up|7|||
164649704|NCT00755937|594745054|FG000|Recruitment|Unknown if infliximab received|164|||
164649705|NCT00755937|594745054|FG000|Observational Follow-up|Lost to Follow-up|148|||
164649706|NCT03876873|594745055|FG000|Overall Study|Physician Decision|0|||
164649707|NCT03876873|594745056|FG001|Overall Study|Physician Decision|1|||
164649708|NCT03547531|594745057|FG000|Overall Study|not coming in data collection : sick|2|||
164649709|NCT03547531|594745058|FG001|Overall Study|not coming in data collection : sick|2|||
164649710|NCT03547531|594745057|FG000|Overall Study|having family occasion|0|||
164649711|NCT03547531|594745058|FG001|Overall Study|having family occasion|2|||
164649712|NCT02117479|594745068|FG000|Overall Study|Death|13|||
164649713|NCT02117479|594745069|FG001|Overall Study|Death|8|||
164649714|NCT02117479|594745068|FG000|Overall Study|Adverse Event|8|||
164649715|NCT02117479|594745069|FG001|Overall Study|Adverse Event|16|||
164649716|NCT02117479|594745068|FG000|Overall Study|Subject decision|8|||
164649717|NCT02117479|594745069|FG001|Overall Study|Subject decision|9|||
164649718|NCT02117479|594745068|FG000|Overall Study|Disease progression|104|||
164649719|NCT02117479|594745069|FG001|Overall Study|Disease progression|108|||
164649720|NCT02117479|594745068|FG000|Overall Study|Noncompliance with study treatment|1|||
164649721|NCT02117479|594745069|FG001|Overall Study|Noncompliance with study treatment|0|||
164649722|NCT02117479|594745068|FG000|Overall Study|Study terminated by the sponsor|4|||
164649723|NCT02117479|594745069|FG001|Overall Study|Study terminated by the sponsor|6|||
164649724|NCT02117479|594745068|FG000|Overall Study|Physician Decision|7|||
164649725|NCT02117479|594745069|FG001|Overall Study|Physician Decision|2|||
164649726|NCT02117479|594745068|FG000|Overall Study|Other unspecified|11|||
164649727|NCT02117479|594745069|FG001|Overall Study|Other unspecified|7|||
164649728|NCT01223196|594745074|FG000|Overall Study|Lost to Follow-up|2|||
164649729|NCT01223196|594745075|FG001|Overall Study|Lost to Follow-up|0|||
164649730|NCT01223196|594745074|FG000|Overall Study|Physician Decision|1|||
164649731|NCT01223196|594745075|FG001|Overall Study|Physician Decision|0|||
164649732|NCT01223196|594745074|FG000|Overall Study|Withdrawal by Subject|1|||
164649733|NCT01223196|594745075|FG001|Overall Study|Withdrawal by Subject|0|||
164649734|NCT02629133|594745076|FG000|Overall Study|Lost to Follow-up|3|||
164537972|NCT02856893|594343236|FG002|Overall Study|Adverse Event|0|||
164537973|NCT02856893|594343234|FG000|Overall Study|Physician Decision|0|||
164537974|NCT02856893|594343235|FG001|Overall Study|Physician Decision|2|||
164537975|NCT02856893|594343236|FG002|Overall Study|Physician Decision|3|||
164537976|NCT02856893|594343234|FG000|Overall Study|Withdrawal by Subject|1|||
164537977|NCT02856893|594343235|FG001|Overall Study|Withdrawal by Subject|1|||
164537978|NCT02856893|594343236|FG002|Overall Study|Withdrawal by Subject|0|||
164537979|NCT02856893|594343234|FG000|Overall Study|Other reasons|2|||
164537980|NCT02856893|594343235|FG001|Overall Study|Other reasons|1|||
164537981|NCT02856893|594343236|FG002|Overall Study|Other reasons|2|||
164537982|NCT01284062|594343239|FG000|Overall Study|Adverse Event|4|||
164537983|NCT01284062|594343240|FG001|Overall Study|Adverse Event|5|||
164537984|NCT01284062|594343241|FG002|Overall Study|Adverse Event|0|||
164537985|NCT01284062|594343242|FG003|Overall Study|Adverse Event|5|||
164537986|NCT01284062|594343239|FG000|Overall Study|Lack of Efficacy|3|||
164537987|NCT01284062|594343240|FG001|Overall Study|Lack of Efficacy|2|||
164537988|NCT01284062|594343241|FG002|Overall Study|Lack of Efficacy|2|||
164537989|NCT01284062|594343242|FG003|Overall Study|Lack of Efficacy|1|||
164537990|NCT01284062|594343239|FG000|Overall Study|Medication error without adverse event|0|||
164537991|NCT01284062|594343240|FG001|Overall Study|Medication error without adverse event|0|||
164537992|NCT01284062|594343241|FG002|Overall Study|Medication error without adverse event|1|||
164537993|NCT01284062|594343242|FG003|Overall Study|Medication error without adverse event|0|||
164537994|NCT01284062|594343239|FG000|Overall Study|Protocol Violation|1|||
164537995|NCT01284062|594343240|FG001|Overall Study|Protocol Violation|0|||
164537996|NCT01284062|594343241|FG002|Overall Study|Protocol Violation|0|||
164537997|NCT01284062|594343242|FG003|Overall Study|Protocol Violation|2|||
164537998|NCT01284062|594343239|FG000|Overall Study|Withdrawal by Subject|3|||
164537999|NCT01284062|594343240|FG001|Overall Study|Withdrawal by Subject|1|||
164538000|NCT01284062|594343241|FG002|Overall Study|Withdrawal by Subject|2|||
164538001|NCT01284062|594343242|FG003|Overall Study|Withdrawal by Subject|5|||
164538002|NCT01284062|594343239|FG000|Overall Study|Other|0|||
164538003|NCT01284062|594343240|FG001|Overall Study|Other|0|||
164538004|NCT01284062|594343241|FG002|Overall Study|Other|0|||
164538005|NCT01284062|594343242|FG003|Overall Study|Other|1|||
164538006|NCT01284062|594343239|FG000|Overall Study|Site Closed|0|||
164538007|NCT01284062|594343240|FG001|Overall Study|Site Closed|0|||
164538008|NCT01284062|594343241|FG002|Overall Study|Site Closed|1|||
164538009|NCT01284062|594343242|FG003|Overall Study|Site Closed|0|||
164538010|NCT03189862|594343243|FG000|Overall Study|Withdrawal by Subject|1|||
164538011|NCT03189862|594343244|FG001|Overall Study|Withdrawal by Subject|0|||
164538012|NCT03189862|594343243|FG000|Overall Study|Lost to Follow-up|54|||
164538013|NCT03189862|594343244|FG001|Overall Study|Lost to Follow-up|62|||
164538014|NCT00931944|594343248|FG000|Overall Study|Adverse Event|4|||
164538015|NCT00931944|594343248|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
164538016|NCT00931944|594343248|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
164538017|NCT00931944|594343248|FG000|Overall Study|Death|28|||
164538018|NCT00931944|594343248|FG000|Overall Study|Other|2|||
164538019|NCT00634010|594343255|FG000|Overall Study|Adverse Event|2|||
164538020|NCT00634010|594343256|FG001|Overall Study|Adverse Event|5|||
164538021|NCT00634010|594343255|FG000|Overall Study|Withdrawal by Subject|5|||
164538022|NCT00634010|594343256|FG001|Overall Study|Withdrawal by Subject|6|||
164538023|NCT00634010|594343255|FG000|Overall Study|Physician Decision|1|||
164538024|NCT00634010|594343256|FG001|Overall Study|Physician Decision|1|||
164538025|NCT00634010|594343255|FG000|Overall Study|Disease Progression|1|||
164538026|NCT00634010|594343256|FG001|Overall Study|Disease Progression|1|||
164538027|NCT00634010|594343255|FG000|Overall Study|Non-Compliant|1|||
164538028|NCT00634010|594343256|FG001|Overall Study|Non-Compliant|1|||
164538029|NCT02545322|594343257|FG000|Overall Study|Withdrawal by Subject|3|||
164538030|NCT00882310|594343258|FG000|Overall Study|Screen Failure|10|||
164538031|NCT00882310|594343258|FG000|Overall Study|Never received treatment|1|||
164538032|NCT00882310|594343258|FG000|Overall Study|Death|6|||
164538033|NCT00882310|594343258|FG000|Overall Study|Progression of disease|4|||
164538034|NCT00882310|594343258|FG000|Overall Study|Adverse Event|1|||
164538035|NCT01395316|594343259|FG000|Overall Study|Lost to Follow-up|2|||
164538036|NCT01395316|594343259|FG000|Overall Study|poor MRI quality|1|||
164538037|NCT01313650|594343269|FG000|Overall Study|Adverse Event|9|||
164538038|NCT01313650|594343270|FG001|Overall Study|Adverse Event|34|||
164538039|NCT01313650|594343271|FG002|Overall Study|Adverse Event|24|||
164538040|NCT01313650|594343272|FG003|Overall Study|Adverse Event|23|||
164538041|NCT01313650|594343269|FG000|Overall Study|Lack of Efficacy|37|||
164538042|NCT01313650|594343270|FG001|Overall Study|Lack of Efficacy|20|||
164538043|NCT01313650|594343271|FG002|Overall Study|Lack of Efficacy|32|||
164538044|NCT01313650|594343272|FG003|Overall Study|Lack of Efficacy|20|||
164538045|NCT01313650|594343269|FG000|Overall Study|Lost to Follow-up|1|||
164538046|NCT01313650|594343270|FG001|Overall Study|Lost to Follow-up|0|||
164538047|NCT01313650|594343271|FG002|Overall Study|Lost to Follow-up|3|||
164538048|NCT01313650|594343272|FG003|Overall Study|Lost to Follow-up|2|||
164538049|NCT01313650|594343269|FG000|Overall Study|Withdrawal by Subject|16|||
164538050|NCT01313650|594343270|FG001|Overall Study|Withdrawal by Subject|20|||
164649735|NCT02629133|594745077|FG001|Overall Study|Lost to Follow-up|1|||
164649736|NCT02629133|594745076|FG000|Overall Study|Withdrawal by Subject|1|||
164649737|NCT02629133|594745077|FG001|Overall Study|Withdrawal by Subject|1|||
164649738|NCT02598193|594745078|FG000|Overall Study|Adverse Event|13|||
164649739|NCT02598193|594745078|FG000|Overall Study|Withdrawal by Subject|1|||
164649740|NCT02598193|594745078|FG000|Overall Study|Listed in active lung transplant list|1|||
164649741|NCT02598193|594745078|FG000|Overall Study|Does not want to take Nintedanib|1|||
164649742|NCT00078819|594745080|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
164649743|NCT00078819|594745081|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
164649744|NCT00078819|594745082|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
164649745|NCT00078819|594745083|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
164649746|NCT00078819|594745080|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
164649747|NCT00078819|594745081|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
164649748|NCT00078819|594745082|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
164649749|NCT00078819|594745083|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
164649750|NCT00078819|594745080|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
164649751|NCT00078819|594745081|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
164649752|NCT00078819|594745082|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
164649753|NCT00078819|594745083|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
164649754|NCT00078819|594745080|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
164649755|NCT00078819|594745081|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
164649756|NCT00078819|594745082|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
164649757|NCT00078819|594745083|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
164649758|NCT00078819|594745080|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
164649759|NCT00078819|594745081|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
164649760|NCT00078819|594745082|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
164649761|NCT00078819|594745083|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
164649762|NCT00078819|594745080|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
164649763|NCT00078819|594745081|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
164649764|NCT00078819|594745082|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
164649765|NCT00078819|594745083|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
164649766|NCT00078819|594745080|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
164649767|NCT00078819|594745081|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
164649768|NCT00078819|594745082|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
164649769|NCT00078819|594745083|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
164649770|NCT00078819|594745080|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
164649771|NCT00078819|594745081|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
164649772|NCT00078819|594745082|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
164649773|NCT00078819|594745083|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
164649774|NCT03012815|594745084|FG000|Overall Study|Lost to Follow-up|1|||
164649775|NCT03012815|594745085|FG001|Overall Study|Lost to Follow-up|0|||
164649776|NCT03012815|594745084|FG000|Overall Study|Physician Decision|3|||
164649777|NCT03012815|594745085|FG001|Overall Study|Physician Decision|2|||
164649778|NCT03012815|594745084|FG000|Overall Study|Adverse Event|1|||
164649779|NCT03012815|594745085|FG001|Overall Study|Adverse Event|0|||
164649780|NCT01462695|594745086|FG000|Overall Study|Adverse Event|1|||
164649781|NCT01462695|594745087|FG001|Overall Study|Adverse Event|1|||
164649782|NCT01462695|594745086|FG000|Overall Study|Death|2|||
164649783|NCT01462695|594745087|FG001|Overall Study|Death|0|||
164649784|NCT01462695|594745086|FG000|Overall Study|Lack of Efficacy|6|||
164649785|NCT01462695|594745087|FG001|Overall Study|Lack of Efficacy|12|||
164649786|NCT01462695|594745086|FG000|Overall Study|Physician Decision|5|||
164649787|NCT01462695|594745087|FG001|Overall Study|Physician Decision|0|||
164649788|NCT01462695|594745086|FG000|Overall Study|Withdrawal by Subject|2|||
164649789|NCT01462695|594745087|FG001|Overall Study|Withdrawal by Subject|0|||
164649790|NCT01462695|594745086|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
164649791|NCT01462695|594745087|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
164649792|NCT00879970|594745088|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
164649793|NCT00879970|594745089|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
164649794|NCT00879970|594745090|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
164649795|NCT00879970|594745091|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
164649796|NCT00879970|594745092|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
164649797|NCT00879970|594745088|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
164649798|NCT00879970|594745089|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
164649799|NCT00879970|594745090|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
164649800|NCT00879970|594745091|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
164649801|NCT00879970|594745092|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
164649802|NCT00879970|594745088|FG000|Period 1 TZD Randomization|Death|2|||
164420504|NCT02718417|593910945|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
164649803|NCT00879970|594745089|FG001|Period 1 TZD Randomization|Death|1|||
164649804|NCT00879970|594745090|FG002|Period 1 TZD Randomization|Death|0|||
164649805|NCT00879970|594745091|FG003|Period 1 TZD Randomization|Death|0|||
164649806|NCT00879970|594745092|FG004|Period 1 TZD Randomization|Death|0|||
164649807|NCT00879970|594745088|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
164649808|NCT00879970|594745089|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
164649809|NCT00879970|594745090|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
164649810|NCT00879970|594745091|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
164649811|NCT00879970|594745092|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
164649812|NCT00879970|594745088|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
164649813|NCT00879970|594745089|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
164649814|NCT00879970|594745090|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
164649815|NCT00879970|594745091|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
164649816|NCT00879970|594745092|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
164649817|NCT00879970|594745088|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
164649818|NCT00879970|594745089|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
164649819|NCT00879970|594745090|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
164649820|NCT00879970|594745091|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
164649821|NCT00879970|594745092|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
164649822|NCT00879970|594745088|FG000|Period 2 Vitamin D Randomization|Death|0|||
164649823|NCT00879970|594745089|FG001|Period 2 Vitamin D Randomization|Death|0|||
164649824|NCT00879970|594745090|FG002|Period 2 Vitamin D Randomization|Death|0|||
164649825|NCT00879970|594745091|FG003|Period 2 Vitamin D Randomization|Death|2|||
164649826|NCT00879970|594745092|FG004|Period 2 Vitamin D Randomization|Death|0|||
164649827|NCT01256398|594745094|FG000|Overall Study|Withdrawal by Subject|1|||
164649828|NCT00995488|594745095|FG000|Overall Study|Withdrawal by Subject|1|||
164649829|NCT01174368|594745098|FG000|Overall Study|Withdrawal by Subject|1|||
164649830|NCT04380701|594745105|FG000|Overall Study|Pregnancy|0|||
164649831|NCT04380701|594745106|FG001|Overall Study|Pregnancy|0|||
164649832|NCT04380701|594745107|FG002|Overall Study|Pregnancy|0|||
164649833|NCT04380701|594745108|FG003|Overall Study|Pregnancy|0|||
164649834|NCT04380701|594745109|FG004|Overall Study|Pregnancy|0|||
164649835|NCT04380701|594745110|FG005|Overall Study|Pregnancy|0|||
164649836|NCT04380701|594745111|FG006|Overall Study|Pregnancy|0|||
164649837|NCT04380701|594745112|FG007|Overall Study|Pregnancy|0|||
164649838|NCT04380701|594745113|FG008|Overall Study|Pregnancy|0|||
164649839|NCT04380701|594745114|FG009|Overall Study|Pregnancy|0|||
164649840|NCT04380701|594745115|FG010|Overall Study|Pregnancy|0|||
164649841|NCT04380701|594745116|FG011|Overall Study|Pregnancy|0|||
164649842|NCT04380701|594745117|FG012|Overall Study|Pregnancy|0|||
164649843|NCT04380701|594745118|FG013|Overall Study|Pregnancy|0|||
164649844|NCT04380701|594745119|FG014|Overall Study|Pregnancy|0|||
164649845|NCT04380701|594745120|FG015|Overall Study|Pregnancy|0|||
164649846|NCT04380701|594745121|FG016|Overall Study|Pregnancy|0|||
164649847|NCT04380701|594745122|FG017|Overall Study|Pregnancy|0|||
164649848|NCT04380701|594745123|FG018|Overall Study|Pregnancy|0|||
164649849|NCT04380701|594745124|FG019|Overall Study|Pregnancy|0|||
164649850|NCT04380701|594745125|FG020|Overall Study|Pregnancy|0|||
164649851|NCT04380701|594745126|FG021|Overall Study|Pregnancy|0|||
164649852|NCT04380701|594745127|FG022|Overall Study|Pregnancy|0|||
164649853|NCT04380701|594745128|FG023|Overall Study|Pregnancy|0|||
164649854|NCT04380701|594745129|FG024|Overall Study|Pregnancy|0|||
164649855|NCT04380701|594745130|FG025|Overall Study|Pregnancy|0|||
164649856|NCT04380701|594745131|FG026|Overall Study|Pregnancy|0|||
164649857|NCT04380701|594745132|FG027|Overall Study|Pregnancy|0|||
164649858|NCT04380701|594745133|FG028|Overall Study|Pregnancy|0|||
164649859|NCT04380701|594745134|FG029|Overall Study|Pregnancy|0|||
164649860|NCT04380701|594745135|FG030|Overall Study|Pregnancy|0|||
164649861|NCT04380701|594745136|FG031|Overall Study|Pregnancy|0|||
164649862|NCT04380701|594745137|FG032|Overall Study|Pregnancy|1|||
164649863|NCT04380701|594745138|FG033|Overall Study|Pregnancy|0|||
164649864|NCT04380701|594745105|FG000|Overall Study|Lost to Follow-up|0|||
164649865|NCT04380701|594745106|FG001|Overall Study|Lost to Follow-up|0|||
164649866|NCT04380701|594745107|FG002|Overall Study|Lost to Follow-up|0|||
164649867|NCT04380701|594745108|FG003|Overall Study|Lost to Follow-up|0|||
164649868|NCT04380701|594745109|FG004|Overall Study|Lost to Follow-up|0|||
164649869|NCT04380701|594745110|FG005|Overall Study|Lost to Follow-up|0|||
164649870|NCT04380701|594745111|FG006|Overall Study|Lost to Follow-up|0|||
164649871|NCT04380701|594745112|FG007|Overall Study|Lost to Follow-up|0|||
164649872|NCT04380701|594745113|FG008|Overall Study|Lost to Follow-up|0|||
164649873|NCT04380701|594745114|FG009|Overall Study|Lost to Follow-up|0|||
164649874|NCT04380701|594745115|FG010|Overall Study|Lost to Follow-up|0|||
164649875|NCT04380701|594745116|FG011|Overall Study|Lost to Follow-up|0|||
164649876|NCT04380701|594745117|FG012|Overall Study|Lost to Follow-up|0|||
164649877|NCT04380701|594745118|FG013|Overall Study|Lost to Follow-up|0|||
164649878|NCT04380701|594745119|FG014|Overall Study|Lost to Follow-up|0|||
164649879|NCT04380701|594745120|FG015|Overall Study|Lost to Follow-up|0|||
164649880|NCT04380701|594745121|FG016|Overall Study|Lost to Follow-up|0|||
164538051|NCT01313650|594343271|FG002|Overall Study|Withdrawal by Subject|15|||
164538052|NCT01313650|594343272|FG003|Overall Study|Withdrawal by Subject|15|||
164538053|NCT01313650|594343269|FG000|Overall Study|Protocol Violation|4|||
164538054|NCT01313650|594343270|FG001|Overall Study|Protocol Violation|7|||
164538055|NCT01313650|594343271|FG002|Overall Study|Protocol Violation|5|||
164538056|NCT01313650|594343272|FG003|Overall Study|Protocol Violation|6|||
164538057|NCT01313650|594343269|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
164538058|NCT01313650|594343270|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
164538059|NCT01313650|594343271|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
164538060|NCT01313650|594343272|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
164538061|NCT04786119|594343273|FG000|Overall Study|Withdrawal by Subject|4|||
164538062|NCT04786119|594343274|FG001|Overall Study|Withdrawal by Subject|5|||
164538063|NCT04786119|594343273|FG000|Overall Study|Lost to Follow-up|5|||
164538064|NCT04786119|594343274|FG001|Overall Study|Lost to Follow-up|5|||
164538065|NCT04786119|594343273|FG000|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|1|||
164538066|NCT04786119|594343274|FG001|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|0|||
164538067|NCT02593786|594343277|FG000|Overall Study|Disease progression|12|||
164538068|NCT02593786|594343278|FG001|Overall Study|Disease progression|16|||
164538069|NCT02593786|594343279|FG002|Overall Study|Disease progression|10|||
164538070|NCT02593786|594343280|FG003|Overall Study|Disease progression|7|||
164538071|NCT02593786|594343277|FG000|Overall Study|Study drug toxicity|1|||
164538072|NCT02593786|594343278|FG001|Overall Study|Study drug toxicity|0|||
164538073|NCT02593786|594343279|FG002|Overall Study|Study drug toxicity|0|||
164538074|NCT02593786|594343280|FG003|Overall Study|Study drug toxicity|0|||
164538075|NCT02593786|594343277|FG000|Overall Study|Adverse event unrelated to study drug|1|||
164538076|NCT02593786|594343278|FG001|Overall Study|Adverse event unrelated to study drug|1|||
164538077|NCT02593786|594343279|FG002|Overall Study|Adverse event unrelated to study drug|1|||
164538078|NCT02593786|594343280|FG003|Overall Study|Adverse event unrelated to study drug|0|||
164538079|NCT02593786|594343277|FG000|Overall Study|Participant request to discontinue study therapy|0|||
164538080|NCT02593786|594343278|FG001|Overall Study|Participant request to discontinue study therapy|2|||
164538081|NCT02593786|594343279|FG002|Overall Study|Participant request to discontinue study therapy|0|||
164538082|NCT02593786|594343280|FG003|Overall Study|Participant request to discontinue study therapy|0|||
164538083|NCT02593786|594343277|FG000|Overall Study|Other reasons|1|||
164538084|NCT02593786|594343278|FG001|Overall Study|Other reasons|1|||
164538085|NCT02593786|594343279|FG002|Overall Study|Other reasons|0|||
164538086|NCT02593786|594343280|FG003|Overall Study|Other reasons|5|||
164538087|NCT01839487|594343281|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
164538088|NCT01839487|594343282|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
164538089|NCT01839487|594343283|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
164538090|NCT01839487|594343284|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
164538091|NCT01839487|594343285|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
164538092|NCT01839487|594343286|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
164538093|NCT01839487|594343281|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
164538094|NCT01839487|594343282|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
164538095|NCT01839487|594343283|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
164538096|NCT01839487|594343284|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
164538097|NCT01839487|594343285|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
164538098|NCT01839487|594343286|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
164538099|NCT01839487|594343281|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
164538100|NCT01839487|594343282|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
164538101|NCT01839487|594343283|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
164538102|NCT01839487|594343284|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
164538103|NCT01839487|594343285|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
164538104|NCT01839487|594343286|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
164538105|NCT01839487|594343281|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
164538106|NCT01839487|594343282|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
164538107|NCT01839487|594343283|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
164538108|NCT01839487|594343284|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
164538109|NCT01839487|594343285|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
164538110|NCT01839487|594343286|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
164538111|NCT01839487|594343281|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
164538112|NCT01839487|594343282|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
164538113|NCT01839487|594343283|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
164538114|NCT01839487|594343284|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
164538115|NCT01839487|594343285|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
164538116|NCT01839487|594343286|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
164538117|NCT01839487|594343281|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
164538118|NCT01839487|594343282|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
164649881|NCT04380701|594745122|FG017|Overall Study|Lost to Follow-up|0|||
164649882|NCT04380701|594745123|FG018|Overall Study|Lost to Follow-up|0|||
164649883|NCT04380701|594745124|FG019|Overall Study|Lost to Follow-up|0|||
164649884|NCT04380701|594745125|FG020|Overall Study|Lost to Follow-up|1|||
164649885|NCT04380701|594745126|FG021|Overall Study|Lost to Follow-up|0|||
164649886|NCT04380701|594745127|FG022|Overall Study|Lost to Follow-up|0|||
164649887|NCT04380701|594745128|FG023|Overall Study|Lost to Follow-up|1|||
164649888|NCT04380701|594745129|FG024|Overall Study|Lost to Follow-up|0|||
164649889|NCT04380701|594745130|FG025|Overall Study|Lost to Follow-up|0|||
164649890|NCT04380701|594745131|FG026|Overall Study|Lost to Follow-up|0|||
164649891|NCT04380701|594745132|FG027|Overall Study|Lost to Follow-up|0|||
164649892|NCT04380701|594745133|FG028|Overall Study|Lost to Follow-up|0|||
164649893|NCT04380701|594745134|FG029|Overall Study|Lost to Follow-up|1|||
164649894|NCT04380701|594745135|FG030|Overall Study|Lost to Follow-up|0|||
164649895|NCT04380701|594745136|FG031|Overall Study|Lost to Follow-up|0|||
164649896|NCT04380701|594745137|FG032|Overall Study|Lost to Follow-up|0|||
164649897|NCT04380701|594745138|FG033|Overall Study|Lost to Follow-up|1|||
164649898|NCT04380701|594745105|FG000|Overall Study|Private reason(s)|0|||
164649899|NCT04380701|594745106|FG001|Overall Study|Private reason(s)|0|||
164649900|NCT04380701|594745107|FG002|Overall Study|Private reason(s)|0|||
164649901|NCT04380701|594745108|FG003|Overall Study|Private reason(s)|0|||
164649902|NCT04380701|594745109|FG004|Overall Study|Private reason(s)|0|||
164649903|NCT04380701|594745110|FG005|Overall Study|Private reason(s)|0|||
164649904|NCT04380701|594745111|FG006|Overall Study|Private reason(s)|1|||
164649905|NCT04380701|594745112|FG007|Overall Study|Private reason(s)|0|||
164649906|NCT04380701|594745113|FG008|Overall Study|Private reason(s)|1|||
164649907|NCT04380701|594745114|FG009|Overall Study|Private reason(s)|1|||
164649908|NCT04380701|594745115|FG010|Overall Study|Private reason(s)|0|||
164649909|NCT04380701|594745116|FG011|Overall Study|Private reason(s)|0|||
164649910|NCT04380701|594745117|FG012|Overall Study|Private reason(s)|0|||
164649911|NCT04380701|594745118|FG013|Overall Study|Private reason(s)|0|||
164649912|NCT04380701|594745119|FG014|Overall Study|Private reason(s)|0|||
164649913|NCT04380701|594745120|FG015|Overall Study|Private reason(s)|0|||
164649914|NCT04380701|594745121|FG016|Overall Study|Private reason(s)|0|||
164649915|NCT04380701|594745122|FG017|Overall Study|Private reason(s)|0|||
164649916|NCT04380701|594745123|FG018|Overall Study|Private reason(s)|0|||
164649917|NCT04380701|594745124|FG019|Overall Study|Private reason(s)|0|||
164649918|NCT04380701|594745125|FG020|Overall Study|Private reason(s)|0|||
164649919|NCT04380701|594745126|FG021|Overall Study|Private reason(s)|0|||
164649920|NCT04380701|594745127|FG022|Overall Study|Private reason(s)|0|||
164649921|NCT04380701|594745128|FG023|Overall Study|Private reason(s)|1|||
164649922|NCT04380701|594745129|FG024|Overall Study|Private reason(s)|0|||
164649923|NCT04380701|594745130|FG025|Overall Study|Private reason(s)|0|||
164649924|NCT04380701|594745131|FG026|Overall Study|Private reason(s)|0|||
164649925|NCT04380701|594745132|FG027|Overall Study|Private reason(s)|0|||
164649926|NCT04380701|594745133|FG028|Overall Study|Private reason(s)|0|||
164649927|NCT04380701|594745134|FG029|Overall Study|Private reason(s)|1|||
164649928|NCT04380701|594745135|FG030|Overall Study|Private reason(s)|0|||
164649929|NCT04380701|594745136|FG031|Overall Study|Private reason(s)|0|||
164649930|NCT04380701|594745137|FG032|Overall Study|Private reason(s)|0|||
164649931|NCT04380701|594745138|FG033|Overall Study|Private reason(s)|0|||
164649932|NCT04380701|594745105|FG000|Overall Study|Withdrawal by Subject|0|||
164649933|NCT04380701|594745106|FG001|Overall Study|Withdrawal by Subject|0|||
164649934|NCT04380701|594745107|FG002|Overall Study|Withdrawal by Subject|0|||
164649935|NCT04380701|594745108|FG003|Overall Study|Withdrawal by Subject|0|||
164649936|NCT04380701|594745109|FG004|Overall Study|Withdrawal by Subject|0|||
164649937|NCT04380701|594745110|FG005|Overall Study|Withdrawal by Subject|0|||
164649938|NCT04380701|594745111|FG006|Overall Study|Withdrawal by Subject|1|||
164649939|NCT04380701|594745112|FG007|Overall Study|Withdrawal by Subject|1|||
164649940|NCT04380701|594745113|FG008|Overall Study|Withdrawal by Subject|0|||
164649941|NCT04380701|594745114|FG009|Overall Study|Withdrawal by Subject|0|||
164649942|NCT04380701|594745115|FG010|Overall Study|Withdrawal by Subject|0|||
164649943|NCT04380701|594745116|FG011|Overall Study|Withdrawal by Subject|1|||
164649944|NCT04380701|594745117|FG012|Overall Study|Withdrawal by Subject|0|||
164649945|NCT04380701|594745118|FG013|Overall Study|Withdrawal by Subject|1|||
164649946|NCT04380701|594745119|FG014|Overall Study|Withdrawal by Subject|0|||
164649947|NCT04380701|594745120|FG015|Overall Study|Withdrawal by Subject|0|||
164649948|NCT04380701|594745121|FG016|Overall Study|Withdrawal by Subject|1|||
164649949|NCT04380701|594745122|FG017|Overall Study|Withdrawal by Subject|0|||
164649950|NCT04380701|594745123|FG018|Overall Study|Withdrawal by Subject|0|||
164649951|NCT04380701|594745124|FG019|Overall Study|Withdrawal by Subject|0|||
164649952|NCT04380701|594745125|FG020|Overall Study|Withdrawal by Subject|0|||
164649953|NCT04380701|594745126|FG021|Overall Study|Withdrawal by Subject|0|||
164649954|NCT04380701|594745127|FG022|Overall Study|Withdrawal by Subject|2|||
164649955|NCT04380701|594745128|FG023|Overall Study|Withdrawal by Subject|2|||
164649956|NCT04380701|594745129|FG024|Overall Study|Withdrawal by Subject|1|||
164649957|NCT04380701|594745130|FG025|Overall Study|Withdrawal by Subject|1|||
164649958|NCT04380701|594745131|FG026|Overall Study|Withdrawal by Subject|0|||
164649959|NCT04380701|594745132|FG027|Overall Study|Withdrawal by Subject|0|||
164538119|NCT01839487|594343283|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
164538120|NCT01839487|594343284|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
164538121|NCT01839487|594343285|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
164538122|NCT01839487|594343286|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
164538123|NCT01839487|594343281|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
164538124|NCT01839487|594343282|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
164538125|NCT01839487|594343283|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
164538126|NCT01839487|594343284|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
164538127|NCT01839487|594343285|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
164538128|NCT01839487|594343286|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
164538129|NCT01839487|594343281|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
164538130|NCT01839487|594343282|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
164538131|NCT01839487|594343283|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
164538132|NCT01839487|594343284|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
164538133|NCT01839487|594343285|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
164538134|NCT01839487|594343286|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
164538135|NCT01839487|594343281|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
164538136|NCT01839487|594343282|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
164538137|NCT01839487|594343283|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
164538138|NCT01839487|594343284|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
164538139|NCT01839487|594343285|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
164538140|NCT01839487|594343286|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
164538141|NCT03610165|594343288|FG000|Overall Study|Device didn't work|0|||
164538142|NCT03610165|594343289|FG001|Overall Study|Device didn't work|1|||
164538143|NCT00866697|594343297|FG000|Overall Study|Study closed/terminated|156|||
164538144|NCT00866697|594343298|FG001|Overall Study|Study closed/terminated|138|||
164538145|NCT00866697|594343297|FG000|Overall Study|Lost to Follow-up|22|||
164538146|NCT00866697|594343298|FG001|Overall Study|Lost to Follow-up|28|||
164538147|NCT00866697|594343297|FG000|Overall Study|Physician Decision|3|||
164538148|NCT00866697|594343298|FG001|Overall Study|Physician Decision|5|||
164538149|NCT00866697|594343297|FG000|Overall Study|Withdrawal by Subject|33|||
164538150|NCT00866697|594343298|FG001|Overall Study|Withdrawal by Subject|57|||
164538151|NCT02906787|594343301|FG000|Overall Study|Withdrawal by Subject|12|||
164538152|NCT02906787|594343302|FG001|Overall Study|Withdrawal by Subject|10|||
164538153|NCT02906787|594343301|FG000|Overall Study|Missed|24|||
164538154|NCT02906787|594343302|FG001|Overall Study|Missed|22|||
164538155|NCT03901053|594343305|FG000|Overall Study|Lost to Follow-up|6|||
164538156|NCT03901053|594343306|FG001|Overall Study|Lost to Follow-up|2|||
164538157|NCT03901053|594343305|FG000|Overall Study|Withdrawal by Subject|4|||
164538158|NCT03901053|594343306|FG001|Overall Study|Withdrawal by Subject|3|||
164538159|NCT03901053|594343305|FG000|Overall Study|Unsatisfactory Device|1|||
164538160|NCT03901053|594343306|FG001|Overall Study|Unsatisfactory Device|2|||
164538161|NCT03901053|594343305|FG000|Overall Study|No longer meets study criteria|1|||
164538162|NCT03901053|594343306|FG001|Overall Study|No longer meets study criteria|3|||
164538163|NCT03901053|594343305|FG000|Overall Study|Subject's Medical Status|0|||
164538164|NCT03901053|594343306|FG001|Overall Study|Subject's Medical Status|1|||
164538165|NCT03901053|594343305|FG000|Overall Study|Screening Failure|1|||
164538166|NCT03901053|594343306|FG001|Overall Study|Screening Failure|0|||
164538167|NCT03442114|594343307|FG000|Overall Study|Lost to Follow-up|13|||
164538168|NCT03442114|594343308|FG001|Overall Study|Lost to Follow-up|13|||
164538169|NCT03442114|594343307|FG000|Overall Study|Physician Decision|2|||
164538170|NCT03442114|594343308|FG001|Overall Study|Physician Decision|2|||
164538171|NCT03442114|594343307|FG000|Overall Study|Protocol Violation|0|||
164538172|NCT03442114|594343308|FG001|Overall Study|Protocol Violation|2|||
164538173|NCT03442114|594343307|FG000|Overall Study|Withdrawal by Subject|1|||
164538174|NCT03442114|594343308|FG001|Overall Study|Withdrawal by Subject|3|||
164538175|NCT03442114|594343307|FG000|Overall Study|Guardianship Change|0|||
164538176|NCT03442114|594343308|FG001|Overall Study|Guardianship Change|1|||
164538177|NCT04752475|594344777|FG000|Overall Study|Withdrawal by Subject|1|||
164538178|NCT04752475|594344778|FG001|Overall Study|Withdrawal by Subject|1|||
164538179|NCT01310803|594344784|FG000|Overall Study|Subject terminated by Sponsor|1|||
164538180|NCT01310803|594344785|FG001|Overall Study|Subject terminated by Sponsor|0|||
164538181|NCT02113579|594344788|FG000|Overall Study|Adverse Event|1|||
164538182|NCT02113579|594344789|FG001|Overall Study|Adverse Event|0|||
164538183|NCT02113579|594344788|FG000|Overall Study|Withdrawal by Subject|3|||
164538184|NCT02113579|594344789|FG001|Overall Study|Withdrawal by Subject|2|||
164538185|NCT02113579|594344788|FG000|Overall Study|Lost to Follow-up|6|||
164538186|NCT02113579|594344789|FG001|Overall Study|Lost to Follow-up|2|||
164538187|NCT00594516|594344793|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
164538188|NCT00594516|594344794|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
164538189|NCT00594516|594344795|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
164538190|NCT00594516|594344793|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
164649960|NCT04380701|594745133|FG028|Overall Study|Withdrawal by Subject|0|||
164649961|NCT04380701|594745134|FG029|Overall Study|Withdrawal by Subject|0|||
164649962|NCT04380701|594745135|FG030|Overall Study|Withdrawal by Subject|0|||
164649963|NCT04380701|594745136|FG031|Overall Study|Withdrawal by Subject|0|||
164649964|NCT04380701|594745137|FG032|Overall Study|Withdrawal by Subject|0|||
164649965|NCT04380701|594745138|FG033|Overall Study|Withdrawal by Subject|0|||
164649966|NCT04380701|594745105|FG000|Overall Study|Adverse Event|0|||
164649967|NCT04380701|594745106|FG001|Overall Study|Adverse Event|0|||
164649968|NCT04380701|594745107|FG002|Overall Study|Adverse Event|0|||
164649969|NCT04380701|594745108|FG003|Overall Study|Adverse Event|0|||
164649970|NCT04380701|594745109|FG004|Overall Study|Adverse Event|0|||
164649971|NCT04380701|594745110|FG005|Overall Study|Adverse Event|1|||
164649972|NCT04380701|594745111|FG006|Overall Study|Adverse Event|0|||
164649973|NCT04380701|594745112|FG007|Overall Study|Adverse Event|0|||
164649974|NCT04380701|594745113|FG008|Overall Study|Adverse Event|0|||
164649975|NCT04380701|594745114|FG009|Overall Study|Adverse Event|0|||
164649976|NCT04380701|594745115|FG010|Overall Study|Adverse Event|0|||
164649977|NCT04380701|594745116|FG011|Overall Study|Adverse Event|0|||
164649978|NCT04380701|594745117|FG012|Overall Study|Adverse Event|0|||
164649979|NCT04380701|594745118|FG013|Overall Study|Adverse Event|0|||
164649980|NCT04380701|594745119|FG014|Overall Study|Adverse Event|0|||
164649981|NCT04380701|594745120|FG015|Overall Study|Adverse Event|1|||
164649982|NCT04380701|594745121|FG016|Overall Study|Adverse Event|0|||
164649983|NCT04380701|594745122|FG017|Overall Study|Adverse Event|0|||
164649984|NCT04380701|594745123|FG018|Overall Study|Adverse Event|0|||
164649985|NCT04380701|594745124|FG019|Overall Study|Adverse Event|1|||
164649986|NCT04380701|594745125|FG020|Overall Study|Adverse Event|0|||
164649987|NCT04380701|594745126|FG021|Overall Study|Adverse Event|0|||
164649988|NCT04380701|594745127|FG022|Overall Study|Adverse Event|0|||
164649989|NCT04380701|594745128|FG023|Overall Study|Adverse Event|0|||
164649990|NCT04380701|594745129|FG024|Overall Study|Adverse Event|0|||
164649991|NCT04380701|594745130|FG025|Overall Study|Adverse Event|0|||
164649992|NCT04380701|594745131|FG026|Overall Study|Adverse Event|0|||
164649993|NCT04380701|594745132|FG027|Overall Study|Adverse Event|0|||
164649994|NCT04380701|594745133|FG028|Overall Study|Adverse Event|0|||
164649995|NCT04380701|594745134|FG029|Overall Study|Adverse Event|0|||
164649996|NCT04380701|594745135|FG030|Overall Study|Adverse Event|0|||
164649997|NCT04380701|594745136|FG031|Overall Study|Adverse Event|0|||
164649998|NCT04380701|594745137|FG032|Overall Study|Adverse Event|0|||
164649999|NCT04380701|594745138|FG033|Overall Study|Adverse Event|0|||
164650000|NCT04380701|594745105|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
164650001|NCT04380701|594745106|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
164650002|NCT04380701|594745107|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
164650003|NCT04380701|594745108|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
164650004|NCT04380701|594745109|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
164650005|NCT04380701|594745110|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
164650006|NCT04380701|594745111|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
164650007|NCT04380701|594745112|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
164650008|NCT04380701|594745113|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
164650009|NCT04380701|594745114|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
164650010|NCT04380701|594745115|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
164650011|NCT04380701|594745116|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
164650012|NCT04380701|594745117|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
164650013|NCT04380701|594745118|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
164650014|NCT04380701|594745119|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
164650015|NCT04380701|594745120|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
164650016|NCT04380701|594745121|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
164650017|NCT04380701|594745122|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
164650018|NCT04380701|594745123|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
164650019|NCT04380701|594745124|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
164650020|NCT04380701|594745125|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
164650021|NCT04380701|594745126|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
164650022|NCT04380701|594745127|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
164650023|NCT04380701|594745128|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
164650024|NCT04380701|594745129|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
164650025|NCT04380701|594745130|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
164650026|NCT04380701|594745131|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
164650027|NCT04380701|594745132|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
164650028|NCT04380701|594745133|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
164650029|NCT04380701|594745134|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
164650030|NCT04380701|594745135|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
164650031|NCT04380701|594745136|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
164650032|NCT04380701|594745137|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
164650033|NCT04380701|594745138|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
164650034|NCT04380701|594745105|FG000|Overall Study|Physician Decision|0|||
164650035|NCT04380701|594745106|FG001|Overall Study|Physician Decision|0|||
164650036|NCT04380701|594745107|FG002|Overall Study|Physician Decision|0|||
164650037|NCT04380701|594745108|FG003|Overall Study|Physician Decision|0|||
164650038|NCT04380701|594745109|FG004|Overall Study|Physician Decision|0|||
164650039|NCT04380701|594745110|FG005|Overall Study|Physician Decision|0|||
164650040|NCT04380701|594745111|FG006|Overall Study|Physician Decision|0|||
164650041|NCT04380701|594745112|FG007|Overall Study|Physician Decision|0|||
164650042|NCT04380701|594745113|FG008|Overall Study|Physician Decision|0|||
164650043|NCT04380701|594745114|FG009|Overall Study|Physician Decision|0|||
164650044|NCT04380701|594745115|FG010|Overall Study|Physician Decision|0|||
164650045|NCT04380701|594745116|FG011|Overall Study|Physician Decision|0|||
164650046|NCT04380701|594745117|FG012|Overall Study|Physician Decision|0|||
164650047|NCT04380701|594745118|FG013|Overall Study|Physician Decision|0|||
164650048|NCT04380701|594745119|FG014|Overall Study|Physician Decision|0|||
164650049|NCT04380701|594745120|FG015|Overall Study|Physician Decision|0|||
164650050|NCT04380701|594745121|FG016|Overall Study|Physician Decision|0|||
164650051|NCT04380701|594745122|FG017|Overall Study|Physician Decision|0|||
164650052|NCT04380701|594745123|FG018|Overall Study|Physician Decision|0|||
164650053|NCT04380701|594745124|FG019|Overall Study|Physician Decision|0|||
164650054|NCT04380701|594745125|FG020|Overall Study|Physician Decision|0|||
164650055|NCT04380701|594745126|FG021|Overall Study|Physician Decision|0|||
164650056|NCT04380701|594745127|FG022|Overall Study|Physician Decision|0|||
164650057|NCT04380701|594745128|FG023|Overall Study|Physician Decision|0|||
164650058|NCT04380701|594745129|FG024|Overall Study|Physician Decision|2|||
164650059|NCT04380701|594745130|FG025|Overall Study|Physician Decision|0|||
164650060|NCT04380701|594745131|FG026|Overall Study|Physician Decision|0|||
164650061|NCT04380701|594745132|FG027|Overall Study|Physician Decision|0|||
164650062|NCT04380701|594745133|FG028|Overall Study|Physician Decision|0|||
164650063|NCT04380701|594745134|FG029|Overall Study|Physician Decision|0|||
164650064|NCT04380701|594745135|FG030|Overall Study|Physician Decision|0|||
164650065|NCT04380701|594745136|FG031|Overall Study|Physician Decision|0|||
164650066|NCT04380701|594745137|FG032|Overall Study|Physician Decision|0|||
164650067|NCT04380701|594745138|FG033|Overall Study|Physician Decision|0|||
164650068|NCT04380701|594745105|FG000|Overall Study|Death|0|||
164650069|NCT04380701|594745106|FG001|Overall Study|Death|0|||
164650070|NCT04380701|594745107|FG002|Overall Study|Death|0|||
164650071|NCT04380701|594745108|FG003|Overall Study|Death|0|||
164650072|NCT04380701|594745109|FG004|Overall Study|Death|0|||
164650073|NCT04380701|594745110|FG005|Overall Study|Death|0|||
164650074|NCT04380701|594745111|FG006|Overall Study|Death|0|||
164650075|NCT04380701|594745112|FG007|Overall Study|Death|0|||
164650076|NCT04380701|594745113|FG008|Overall Study|Death|0|||
164650077|NCT04380701|594745114|FG009|Overall Study|Death|0|||
164650078|NCT04380701|594745115|FG010|Overall Study|Death|0|||
164650079|NCT04380701|594745116|FG011|Overall Study|Death|0|||
164650080|NCT04380701|594745117|FG012|Overall Study|Death|0|||
164650081|NCT04380701|594745118|FG013|Overall Study|Death|0|||
164650082|NCT04380701|594745119|FG014|Overall Study|Death|0|||
164650083|NCT04380701|594745120|FG015|Overall Study|Death|0|||
164650084|NCT04380701|594745121|FG016|Overall Study|Death|0|||
164650085|NCT04380701|594745122|FG017|Overall Study|Death|0|||
164650086|NCT04380701|594745123|FG018|Overall Study|Death|0|||
164650087|NCT04380701|594745124|FG019|Overall Study|Death|0|||
164650088|NCT04380701|594745125|FG020|Overall Study|Death|0|||
164650089|NCT04380701|594745126|FG021|Overall Study|Death|0|||
164650090|NCT04380701|594745127|FG022|Overall Study|Death|0|||
164650091|NCT04380701|594745128|FG023|Overall Study|Death|0|||
164650092|NCT04380701|594745129|FG024|Overall Study|Death|1|||
164650093|NCT04380701|594745130|FG025|Overall Study|Death|0|||
164650094|NCT04380701|594745131|FG026|Overall Study|Death|0|||
164650095|NCT04380701|594745132|FG027|Overall Study|Death|0|||
164650096|NCT04380701|594745133|FG028|Overall Study|Death|0|||
164650097|NCT04380701|594745134|FG029|Overall Study|Death|0|||
164650098|NCT04380701|594745135|FG030|Overall Study|Death|0|||
164650099|NCT04380701|594745136|FG031|Overall Study|Death|0|||
164650100|NCT04380701|594745137|FG032|Overall Study|Death|0|||
164650101|NCT04380701|594745138|FG033|Overall Study|Death|0|||
164650102|NCT04380701|594745105|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650103|NCT04380701|594745106|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650104|NCT04380701|594745107|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650105|NCT04380701|594745108|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650106|NCT04380701|594745109|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650107|NCT04380701|594745110|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650108|NCT04380701|594745111|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650109|NCT04380701|594745112|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650110|NCT04380701|594745113|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650111|NCT04380701|594745114|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650112|NCT04380701|594745115|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650113|NCT04380701|594745116|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650114|NCT04380701|594745117|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650115|NCT04380701|594745118|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650116|NCT04380701|594745119|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650117|NCT04380701|594745120|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650118|NCT04380701|594745121|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650119|NCT04380701|594745122|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650120|NCT04380701|594745123|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650121|NCT04380701|594745124|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650122|NCT04380701|594745125|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650123|NCT04380701|594745126|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
164650124|NCT04380701|594745127|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
164650125|NCT04380701|594745128|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
164650126|NCT04380701|594745129|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
164650127|NCT04380701|594745130|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650128|NCT04380701|594745131|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650129|NCT04380701|594745132|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650130|NCT04380701|594745133|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650131|NCT04380701|594745134|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650132|NCT04380701|594745135|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650133|NCT04380701|594745136|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650134|NCT04380701|594745137|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650135|NCT04380701|594745138|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164650136|NCT01864525|594745139|FG000|Overall Study|Adverse Event|1|||
164650137|NCT01864525|594745140|FG001|Overall Study|Adverse Event|0|||
164650138|NCT03296553|594745141|FG000|Overall Study|Withdrawal by Subject|1|||
164650139|NCT03296553|594745142|FG001|Overall Study|Withdrawal by Subject|1|||
164650140|NCT03296553|594745141|FG000|Overall Study|Death|1|||
164650141|NCT03296553|594745142|FG001|Overall Study|Death|0|||
164650142|NCT00065065|594745143|FG000|Overall Study|Adverse Event|3|||
164650143|NCT00065065|594745144|FG001|Overall Study|Adverse Event|2|||
164650144|NCT00065065|594745143|FG000|Overall Study|Withdrawal by Subject|1|||
164650145|NCT00065065|594745144|FG001|Overall Study|Withdrawal by Subject|5|||
164650146|NCT00065065|594745143|FG000|Overall Study|Lack of Efficacy|4|||
164650147|NCT00065065|594745144|FG001|Overall Study|Lack of Efficacy|11|||
164650148|NCT00065065|594745143|FG000|Overall Study|Other|2|||
164650149|NCT00065065|594745144|FG001|Overall Study|Other|2|||
164650150|NCT01050673|594745145|FG000|Overall Study|Physician Decision|4|||
164650151|NCT01050673|594745146|FG001|Overall Study|Physician Decision|5|||
164650152|NCT04363736|594745147|FG000|Overall Study|Withdrawal by Subject|1|||
164650153|NCT04363736|594745148|FG001|Overall Study|Withdrawal by Subject|0|||
164650154|NCT04363736|594745147|FG000|Overall Study|Lost to Follow-up|10|||
164650155|NCT04363736|594745148|FG001|Overall Study|Lost to Follow-up|7|||
164650156|NCT04363736|594745147|FG000|Overall Study|Death|8|||
164650157|NCT04363736|594745148|FG001|Overall Study|Death|6|||
164650158|NCT03797222|594745149|FG000|Overall Study|Withdrawal by Subject|1|||
164650159|NCT03125915|594745159|FG000|1 Month Follow up|Lost to Follow-up|3|||
164650160|NCT03125915|594745160|FG001|1 Month Follow up|Lost to Follow-up|3|||
164650161|NCT03125915|594745161|FG002|1 Month Follow up|Lost to Follow-up|2|||
164650162|NCT03125915|594745162|FG003|1 Month Follow up|Lost to Follow-up|3|||
164650163|NCT03125915|594745159|FG000|3 Month Follow-up|Lost to Follow-up|6|||
164650164|NCT03125915|594745160|FG001|3 Month Follow-up|Lost to Follow-up|4|||
164650165|NCT03125915|594745161|FG002|3 Month Follow-up|Lost to Follow-up|4|||
164650166|NCT03125915|594745162|FG003|3 Month Follow-up|Lost to Follow-up|2|||
164650167|NCT03125915|594745159|FG000|6 Month Follow-up|Lost to Follow-up|7|||
164650168|NCT03125915|594745160|FG001|6 Month Follow-up|Lost to Follow-up|3|||
164650169|NCT03125915|594745161|FG002|6 Month Follow-up|Lost to Follow-up|6|||
164650170|NCT03125915|594745162|FG003|6 Month Follow-up|Lost to Follow-up|3|||
164650171|NCT01309828|594745163|FG000|Overall Study|Adverse Event|10|||
164650172|NCT01309828|594745164|FG001|Overall Study|Adverse Event|11|||
164650173|NCT01309828|594745163|FG000|Overall Study|Voluntary Withdrawal|5|||
164650174|NCT01309828|594745164|FG001|Overall Study|Voluntary Withdrawal|4|||
164650175|NCT01309828|594745163|FG000|Overall Study|Major Protocol Deviation|0|||
164650176|NCT01309828|594745164|FG001|Overall Study|Major Protocol Deviation|1|||
164650177|NCT01309828|594745163|FG000|Overall Study|Other|1|||
164650178|NCT01309828|594745164|FG001|Overall Study|Other|0|||
164650179|NCT02556632|594745165|FG000|Overall Study|Lost to Follow-up|1|||
164650180|NCT02556632|594745166|FG001|Overall Study|Lost to Follow-up|0|||
164650181|NCT02556632|594745167|FG002|Overall Study|Lost to Follow-up|0|||
164650182|NCT02556632|594745165|FG000|Overall Study|Disliked Intervention|1|||
164650183|NCT02556632|594745166|FG001|Overall Study|Disliked Intervention|1|||
164650184|NCT02556632|594745167|FG002|Overall Study|Disliked Intervention|1|||
164650185|NCT02556632|594745165|FG000|Overall Study|No Reason|1|||
164650186|NCT02556632|594745166|FG001|Overall Study|No Reason|0|||
164650187|NCT02556632|594745167|FG002|Overall Study|No Reason|1|||
164650188|NCT02556632|594745165|FG000|Overall Study|Personal Issues|0|||
164650189|NCT02556632|594745166|FG001|Overall Study|Personal Issues|1|||
164650190|NCT02556632|594745167|FG002|Overall Study|Personal Issues|1|||
164650191|NCT02556632|594745165|FG000|Overall Study|Changed Mind|0|||
164650192|NCT02556632|594745166|FG001|Overall Study|Changed Mind|1|||
164650193|NCT02556632|594745167|FG002|Overall Study|Changed Mind|0|||
164650194|NCT02556632|594745165|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
164650195|NCT02556632|594745166|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
164650196|NCT02556632|594745167|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
164650197|NCT02556632|594745165|FG000|Overall Study|Unrelated Adverse Event|1|||
164650198|NCT02556632|594745166|FG001|Overall Study|Unrelated Adverse Event|0|||
164650199|NCT02556632|594745167|FG002|Overall Study|Unrelated Adverse Event|3|||
164650200|NCT02556632|594745165|FG000|Overall Study|Related Adverse Event|0|||
164650201|NCT02556632|594745166|FG001|Overall Study|Related Adverse Event|1|||
164650202|NCT02556632|594745167|FG002|Overall Study|Related Adverse Event|0|||
164650203|NCT02556632|594745165|FG000|Overall Study|Possibly Related Adverse Event|0|||
164650204|NCT02556632|594745166|FG001|Overall Study|Possibly Related Adverse Event|0|||
164650205|NCT02556632|594745167|FG002|Overall Study|Possibly Related Adverse Event|1|||
164650206|NCT02556632|594745165|FG000|Overall Study|Did Not Start RT|0|||
164650207|NCT02556632|594745166|FG001|Overall Study|Did Not Start RT|1|||
164650208|NCT02556632|594745167|FG002|Overall Study|Did Not Start RT|0|||
164650209|NCT02556632|594745165|FG000|Overall Study|Ineligible|0|||
164650210|NCT02556632|594745166|FG001|Overall Study|Ineligible|1|||
164650211|NCT02556632|594745167|FG002|Overall Study|Ineligible|0|||
164650212|NCT02556632|594745165|FG000|Overall Study|Disliked Study Procedures|0|||
164650213|NCT02556632|594745166|FG001|Overall Study|Disliked Study Procedures|0|||
164650214|NCT02556632|594745167|FG002|Overall Study|Disliked Study Procedures|1|||
164650215|NCT02556632|594745165|FG000|Overall Study|Treatment or Change Delay|0|||
164650216|NCT02556632|594745166|FG001|Overall Study|Treatment or Change Delay|0|||
164650217|NCT02556632|594745167|FG002|Overall Study|Treatment or Change Delay|1|||
164650218|NCT01625286|594745179|FG000|Overall Study|Adverse Event|0|||
164650219|NCT01625286|594745180|FG001|Overall Study|Adverse Event|0|||
164650220|NCT01625286|594745181|FG002|Overall Study|Adverse Event|0|||
164650221|NCT01625286|594745182|FG003|Overall Study|Adverse Event|0|||
164650222|NCT01625286|594745183|FG004|Overall Study|Adverse Event|1|||
164650223|NCT01625286|594745184|FG005|Overall Study|Adverse Event|2|||
164650224|NCT01625286|594745185|FG006|Overall Study|Adverse Event|1|||
164650225|NCT01625286|594745179|FG000|Overall Study|Death|0|||
164650226|NCT01625286|594745180|FG001|Overall Study|Death|0|||
164650227|NCT01625286|594745181|FG002|Overall Study|Death|1|||
164650228|NCT01625286|594745182|FG003|Overall Study|Death|1|||
164650229|NCT01625286|594745183|FG004|Overall Study|Death|0|||
164650230|NCT01625286|594745184|FG005|Overall Study|Death|11|||
164650231|NCT01625286|594745185|FG006|Overall Study|Death|16|||
164650232|NCT01625286|594745179|FG000|Overall Study|Withdrawal by Subject|0|||
164650233|NCT01625286|594745180|FG001|Overall Study|Withdrawal by Subject|1|||
164650234|NCT01625286|594745181|FG002|Overall Study|Withdrawal by Subject|0|||
164650235|NCT01625286|594745182|FG003|Overall Study|Withdrawal by Subject|1|||
164650236|NCT01625286|594745183|FG004|Overall Study|Withdrawal by Subject|0|||
164650237|NCT01625286|594745184|FG005|Overall Study|Withdrawal by Subject|0|||
164650238|NCT01625286|594745185|FG006|Overall Study|Withdrawal by Subject|1|||
164650239|NCT01625286|594745179|FG000|Overall Study|Any reason not specifically recorded|0|||
164650240|NCT01625286|594745180|FG001|Overall Study|Any reason not specifically recorded|0|||
164650241|NCT01625286|594745181|FG002|Overall Study|Any reason not specifically recorded|0|||
164650242|NCT01625286|594745182|FG003|Overall Study|Any reason not specifically recorded|0|||
164650243|NCT01625286|594745183|FG004|Overall Study|Any reason not specifically recorded|0|||
164650244|NCT01625286|594745184|FG005|Overall Study|Any reason not specifically recorded|1|||
164650245|NCT01625286|594745185|FG006|Overall Study|Any reason not specifically recorded|0|||
164650246|NCT01625286|594745179|FG000|Overall Study|Progressive disease|6|||
164650247|NCT01625286|594745180|FG001|Overall Study|Progressive disease|3|||
164650248|NCT01625286|594745181|FG002|Overall Study|Progressive disease|4|||
164650249|NCT01625286|594745182|FG003|Overall Study|Progressive disease|5|||
164650250|NCT01625286|594745183|FG004|Overall Study|Progressive disease|5|||
164650251|NCT01625286|594745184|FG005|Overall Study|Progressive disease|0|||
164650252|NCT01625286|594745185|FG006|Overall Study|Progressive disease|0|||
164650253|NCT01625286|594745179|FG000|Overall Study|Lost to Follow-up|0|||
164650254|NCT01625286|594745180|FG001|Overall Study|Lost to Follow-up|0|||
164650255|NCT01625286|594745181|FG002|Overall Study|Lost to Follow-up|0|||
164650256|NCT01625286|594745182|FG003|Overall Study|Lost to Follow-up|0|||
164650257|NCT01625286|594745183|FG004|Overall Study|Lost to Follow-up|0|||
164650258|NCT01625286|594745184|FG005|Overall Study|Lost to Follow-up|0|||
164650259|NCT01625286|594745185|FG006|Overall Study|Lost to Follow-up|1|||
164650260|NCT04355767|594745186|FG000|Overall Study|Withdrawal by Subject|2|||
164650261|NCT04355767|594745187|FG001|Overall Study|Withdrawal by Subject|2|||
164650262|NCT04355767|594745186|FG000|Overall Study|Death|5|||
164650263|NCT04355767|594745187|FG001|Overall Study|Death|1|||
164650264|NCT01999322|594745188|FG000|Overall Study|Adverse Event|1|||
164650265|NCT01999322|594745189|FG001|Overall Study|Adverse Event|0|||
164650266|NCT04523831|594745199|FG000|Overall Study|Lost to Follow-up|15|||
164538191|NCT00594516|594344794|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
164538192|NCT00594516|594344795|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
164538193|NCT00594516|594344793|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
164538194|NCT00594516|594344794|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
164538195|NCT00594516|594344795|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
164538196|NCT00594516|594344793|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
164538197|NCT00594516|594344794|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
164538198|NCT00594516|594344795|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
164538199|NCT00594516|594344793|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
164538200|NCT00594516|594344794|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
164538201|NCT00594516|594344795|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
164538202|NCT00594516|594344793|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
164538203|NCT00594516|594344794|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
164538204|NCT00594516|594344795|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
164538205|NCT00594516|594344793|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
164538206|NCT00594516|594344794|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
164538207|NCT00594516|594344795|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
164538208|NCT00594516|594344793|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
164538209|NCT00594516|594344794|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
164538210|NCT00594516|594344795|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
164538211|NCT00594516|594344793|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
164538212|NCT00594516|594344794|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
164538213|NCT00594516|594344795|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
164538214|NCT03873493|594344796|FG000|Overall Study|Withdrawal by Subject|1|||
164538215|NCT03873493|594344796|FG000|Overall Study|Death|9|||
164538216|NCT03873493|594344796|FG000|Overall Study|Lost to Follow-up|1|||
164538217|NCT03873493|594344796|FG000|Overall Study|Study Terminated by Sponsor|1|||
164538218|NCT03873493|594344796|FG000|Overall Study|Other|2|||
164538219|NCT00702845|594344797|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
164538220|NCT00702845|594344798|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
164538221|NCT00702845|594344797|FG000|Overall Study|Too high ovarian response|5|||
164650267|NCT04523831|594745200|FG001|Overall Study|Lost to Follow-up|17|||
164650268|NCT04523831|594745199|FG000|Overall Study|Death|0|||
164650269|NCT04523831|594745200|FG001|Overall Study|Death|3|||
164650270|NCT04523831|594745199|FG000|Overall Study|Adverse Event|2|||
164650271|NCT04523831|594745200|FG001|Overall Study|Adverse Event|0|||
164650272|NCT00995930|594745201|FG000|Overall Study|Protocol deviation|2|||
164650273|NCT00995930|594745202|FG001|Overall Study|Protocol deviation|5|||
164650274|NCT00995930|594745201|FG000|Overall Study|Death|0|||
164650275|NCT00995930|594745202|FG001|Overall Study|Death|1|||
164650276|NCT00995930|594745201|FG000|Overall Study|Administrative problems|4|||
164650277|NCT00995930|594745202|FG001|Overall Study|Administrative problems|2|||
164650278|NCT00995930|594745201|FG000|Overall Study|Lost to Follow-up|1|||
164650279|NCT00995930|594745202|FG001|Overall Study|Lost to Follow-up|2|||
164650280|NCT00995930|594745201|FG000|Overall Study|Withdrawal by Subject|3|||
164650281|NCT00995930|594745202|FG001|Overall Study|Withdrawal by Subject|4|||
164650282|NCT00995930|594745201|FG000|Overall Study|Adverse Event|11|||
164650283|NCT00995930|594745202|FG001|Overall Study|Adverse Event|14|||
164650284|NCT00766506|594747106|FG000|Overall Study|Use rescue medication after 3 hours|3|||
164650285|NCT00766506|594747107|FG001|Overall Study|Use rescue medication after 3 hours|0|||
164650286|NCT00766506|594747106|FG000|Overall Study|Other|2|||
164650287|NCT00766506|594747107|FG001|Overall Study|Other|2|||
164650288|NCT03053622|594747108|FG000|Overall Study|Lost to Follow-up|0|||
164650289|NCT03053622|594747109|FG001|Overall Study|Lost to Follow-up|0|||
164650290|NCT03053622|594747110|FG002|Overall Study|Lost to Follow-up|0|||
164650291|NCT03053622|594747111|FG003|Overall Study|Lost to Follow-up|1|||
164650292|NCT01246986|594747112|FG000|Overall Study|Lost to Follow-up|0|||
164650293|NCT01246986|594747113|FG001|Overall Study|Lost to Follow-up|1|||
164650294|NCT01246986|594747114|FG002|Overall Study|Lost to Follow-up|3|||
164650295|NCT01246986|594747115|FG003|Overall Study|Lost to Follow-up|0|||
164650296|NCT01246986|594747116|FG004|Overall Study|Lost to Follow-up|0|||
164650297|NCT01246986|594747117|FG005|Overall Study|Lost to Follow-up|1|||
164650298|NCT01246986|594747118|FG006|Overall Study|Lost to Follow-up|0|||
164650299|NCT01246986|594747112|FG000|Overall Study|Withdrawal by Subject|3|||
164650300|NCT01246986|594747113|FG001|Overall Study|Withdrawal by Subject|4|||
164650301|NCT01246986|594747114|FG002|Overall Study|Withdrawal by Subject|3|||
164650302|NCT01246986|594747115|FG003|Overall Study|Withdrawal by Subject|0|||
164538222|NCT00702845|594344798|FG001|Overall Study|Too high ovarian response|1|||
164538223|NCT00702845|594344797|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
164650303|NCT01246986|594747116|FG004|Overall Study|Withdrawal by Subject|4|||
164650304|NCT01246986|594747117|FG005|Overall Study|Withdrawal by Subject|0|||
164650305|NCT01246986|594747118|FG006|Overall Study|Withdrawal by Subject|0|||
164650306|NCT01440647|594747123|FG000|Overall Study|Death|2|||
164650307|NCT01440647|594747124|FG001|Overall Study|Death|3|||
164650308|NCT01406873|594747138|FG000|Overall Study|Withdrawal by Subject|1|||
164650309|NCT01406873|594747139|FG001|Overall Study|Withdrawal by Subject|1|||
164650310|NCT03990389|594747140|FG000|Overall Study|Lost to Follow-up|3|||
164650311|NCT03990389|594747141|FG001|Overall Study|Lost to Follow-up|0|||
164650312|NCT00207714|594747142|FG000|Overall Study|Adverse Event|6|||
164650313|NCT00207714|594747143|FG001|Overall Study|Adverse Event|2|||
164650314|NCT00207714|594747144|FG002|Overall Study|Adverse Event|4|||
164650315|NCT00207714|594747145|FG003|Overall Study|Adverse Event|3|||
164650316|NCT00207714|594747146|FG004|Overall Study|Adverse Event|1|||
164650317|NCT00207714|594747142|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
164650318|NCT00207714|594747143|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
164650319|NCT00207714|594747144|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
164650320|NCT00207714|594747145|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
164650321|NCT00207714|594747146|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
164650322|NCT00207714|594747142|FG000|Overall Study|Other|3|||
164650323|NCT00207714|594747143|FG001|Overall Study|Other|2|||
164650324|NCT00207714|594747144|FG002|Overall Study|Other|5|||
164650325|NCT00207714|594747145|FG003|Overall Study|Other|1|||
164650326|NCT00207714|594747146|FG004|Overall Study|Other|0|||
164650327|NCT02595528|594747147|FG000|Overall Study|Withdrawal by Subject|1|||
164650328|NCT02595528|594747148|FG001|Overall Study|Withdrawal by Subject|2|||
164650329|NCT02595528|594747149|FG002|Overall Study|Withdrawal by Subject|1|||
164650330|NCT02595528|594747150|FG003|Overall Study|Withdrawal by Subject|3|||
164650331|NCT02595528|594747147|FG000|Overall Study|Lost to Follow-up|1|||
164650332|NCT02595528|594747148|FG001|Overall Study|Lost to Follow-up|1|||
164650333|NCT02595528|594747149|FG002|Overall Study|Lost to Follow-up|0|||
164650334|NCT02595528|594747150|FG003|Overall Study|Lost to Follow-up|1|||
164650335|NCT03202511|594747151|FG000|Overall Study|Withdrawal by Subject|1|||
164650336|NCT03202511|594747152|FG001|Overall Study|Withdrawal by Subject|0|||
164650337|NCT00686790|594747153|FG000|Overall Study|Adverse Event|2|||
164650338|NCT00686790|594747153|FG000|Overall Study|Withdrawal by Subject|1|||
164650339|NCT00686790|594747153|FG000|Overall Study|Death|1|||
164650340|NCT00686790|594747153|FG000|Overall Study|Lost to Follow-up|12|||
164650341|NCT03862625|594747156|FG000|Overall Study|Lost to Follow-up|0|||
164650342|NCT03862625|594747157|FG001|Overall Study|Lost to Follow-up|1|||
164650343|NCT02082912|594747158|FG000|Overall Study|Physician Decision|0|||
164650344|NCT02082912|594747159|FG001|Overall Study|Physician Decision|1|||
164650345|NCT02614703|594747160|FG000|Overall Study|Withdrawal by Subject|7|||
164650346|NCT02614703|594747161|FG001|Overall Study|Withdrawal by Subject|1|||
164650347|NCT00856778|594747165|FG000|Overall Study|Adverse Event|7|||
164650348|NCT00856778|594747165|FG000|Overall Study|Withdrawal by Subject|10|||
164650349|NCT00856778|594747165|FG000|Overall Study|Study deviation|2|||
164650350|NCT00856778|594747165|FG000|Overall Study|Lost to Follow-up|5|||
164650351|NCT00265083|594747166|FG000|Overall Study|Adverse Event|5|||
164650352|NCT00265083|594747167|FG001|Overall Study|Adverse Event|13|||
164650353|NCT00265083|594747168|FG002|Overall Study|Adverse Event|15|||
164650354|NCT00265083|594747166|FG000|Overall Study|Lost to Follow-up|3|||
164650355|NCT00265083|594747167|FG001|Overall Study|Lost to Follow-up|4|||
164650356|NCT00265083|594747168|FG002|Overall Study|Lost to Follow-up|4|||
164650357|NCT00265083|594747166|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
164650358|NCT00265083|594747167|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
164650359|NCT00265083|594747168|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
164650360|NCT00265083|594747166|FG000|Overall Study|Other|1|||
164650361|NCT00265083|594747167|FG001|Overall Study|Other|12|||
164650362|NCT00265083|594747168|FG002|Overall Study|Other|9|||
164650363|NCT00854620|594747169|FG000|Overall Study|Adverse Event|1|||
164650364|NCT00782275|594747172|FG000|Overall Study|Adverse Event|11|||
164650365|NCT00782275|594747172|FG000|Overall Study|Withdrawal by Subject|1|||
164650366|NCT00782275|594747172|FG000|Overall Study|Progressive Disease|21|||
164650367|NCT00782275|594747172|FG000|Overall Study|Physician Decision|4|||
164650368|NCT00782275|594747172|FG000|Overall Study|Not started treatment|1|||
164650369|NCT00782275|594747172|FG000|Overall Study|Other|3|||
164650370|NCT04378010|594747173|FG000|Overall Study|Adverse Event|8|||
164650371|NCT04378010|594747174|FG001|Overall Study|Adverse Event|14|||
164650372|NCT04378010|594747175|FG002|Overall Study|Adverse Event|4|||
164650373|NCT04378010|594747173|FG000|Overall Study|Withdrawal by Subject|0|||
164650374|NCT04378010|594747174|FG001|Overall Study|Withdrawal by Subject|2|||
164650375|NCT04378010|594747175|FG002|Overall Study|Withdrawal by Subject|1|||
164650376|NCT04378010|594747173|FG000|Overall Study|Protocol Violation|2|||
164650377|NCT04378010|594747174|FG001|Overall Study|Protocol Violation|1|||
164650378|NCT04378010|594747175|FG002|Overall Study|Protocol Violation|4|||
164650379|NCT04378010|594747173|FG000|Overall Study|Study terminated by Sponsor|22|||
164650380|NCT04378010|594747174|FG001|Overall Study|Study terminated by Sponsor|16|||
164650381|NCT04378010|594747175|FG002|Overall Study|Study terminated by Sponsor|22|||
164189890|NCT00572455|593063986|FG000|Stage II (28 Days)|Death|0|||
164189891|NCT00572455|593063987|FG001|Stage II (28 Days)|Death|0|||
164650382|NCT04378010|594747173|FG000|Overall Study|Subject inability to complete study visit|0|||
164650383|NCT04378010|594747174|FG001|Overall Study|Subject inability to complete study visit|0|||
164650384|NCT04378010|594747175|FG002|Overall Study|Subject inability to complete study visit|1|||
164650385|NCT04378010|594747173|FG000|Overall Study|Subject never dosed|0|||
164650386|NCT04378010|594747174|FG001|Overall Study|Subject never dosed|1|||
164650387|NCT04378010|594747175|FG002|Overall Study|Subject never dosed|0|||
164650388|NCT02019979|594747176|FG000|Overall Study|study terminated|14|||
164650389|NCT01456052|594747181|FG000|Overall Study|Adverse Event|1|||
164650390|NCT01456052|594747182|FG001|Overall Study|Adverse Event|1|||
164650391|NCT01456052|594747183|FG002|Overall Study|Adverse Event|2|||
164650392|NCT01456052|594747181|FG000|Overall Study|Consent withdrawn|0|||
164650393|NCT01456052|594747182|FG001|Overall Study|Consent withdrawn|2|||
164650394|NCT01456052|594747183|FG002|Overall Study|Consent withdrawn|1|||
164650395|NCT01456052|594747181|FG000|Overall Study|Protocol Violation|0|||
164650396|NCT01456052|594747182|FG001|Overall Study|Protocol Violation|1|||
164650397|NCT01456052|594747183|FG002|Overall Study|Protocol Violation|0|||
164650398|NCT01456052|594747181|FG000|Overall Study|Physician Decision|1|||
164650399|NCT01456052|594747182|FG001|Overall Study|Physician Decision|0|||
164650400|NCT01456052|594747183|FG002|Overall Study|Physician Decision|1|||
164650401|NCT01456052|594747181|FG000|Overall Study|Treatment Failure|0|||
164650402|NCT01456052|594747182|FG001|Overall Study|Treatment Failure|1|||
164650403|NCT01456052|594747183|FG002|Overall Study|Treatment Failure|1|||
164650404|NCT02770716|594747186|FG000|Overall Study|Death|101|||
164650405|NCT02770716|594747187|FG001|Overall Study|Death|45|||
164650406|NCT02770716|594747186|FG000|Overall Study|Withdrawal by Subject|4|||
164650407|NCT02770716|594747187|FG001|Overall Study|Withdrawal by Subject|2|||
164650408|NCT02770716|594747186|FG000|Overall Study|Lost to Follow-up|1|||
164650409|NCT02770716|594747187|FG001|Overall Study|Lost to Follow-up|0|||
164650410|NCT02770716|594747186|FG000|Overall Study|Various reasons|6|||
164650411|NCT02770716|594747187|FG001|Overall Study|Various reasons|2|||
164650412|NCT02041494|594747190|FG000|Overall Study|Death|1|||
164650413|NCT02041494|594747191|FG001|Overall Study|Death|3|||
164650414|NCT02041494|594747190|FG000|Overall Study|Lost to Follow-up|2|||
164650415|NCT02041494|594747191|FG001|Overall Study|Lost to Follow-up|6|||
164650416|NCT02041494|594747190|FG000|Overall Study|study terminated|16|||
164650417|NCT02041494|594747191|FG001|Overall Study|study terminated|11|||
164650418|NCT01238822|594747197|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
164650419|NCT02487979|594747200|FG000|Overall Study|Physician Decision|2|||
164650420|NCT02487979|594747200|FG000|Overall Study|Withdrawal by Subject|2|||
164650421|NCT02487979|594747200|FG000|Overall Study|Progressive Disease|17|||
164650422|NCT00447694|594747201|FG000|Overall Study|Adverse Event|2|||
164650423|NCT00447694|594747201|FG000|Overall Study|Abnormal laboratory value|1|||
164650424|NCT00447694|594747201|FG000|Overall Study|Abnormal test procedure result|1|||
164650425|NCT00447694|594747201|FG000|Overall Study|Withdrawal by Subject|2|||
164650426|NCT02410837|594747202|FG000|Overall Study|Death|387|||
164538224|NCT00702845|594344798|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
164538225|NCT00702845|594344797|FG000|Overall Study|Insufficient ovarian response|1|||
164538226|NCT00702845|594344798|FG001|Overall Study|Insufficient ovarian response|0|||
164538227|NCT00702845|594344797|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
164538228|NCT00702845|594344798|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
164538229|NCT00702845|594344797|FG000|Overall Study|No or abnormal fertilization|4|||
164538230|NCT00702845|594344798|FG001|Overall Study|No or abnormal fertilization|2|||
164538231|NCT00702845|594344797|FG000|Overall Study|Patient's decision|2|||
164538232|NCT00702845|594344798|FG001|Overall Study|Patient's decision|1|||
164538233|NCT00702845|594344797|FG000|Overall Study|Not randomized|0|||
164538234|NCT00702845|594344798|FG001|Overall Study|Not randomized|1|||
164538235|NCT01448213|594344805|FG000|Overall Study|Lost to Follow-up|12|||
164538236|NCT01448213|594344806|FG001|Overall Study|Lost to Follow-up|10|||
164538237|NCT01448213|594344805|FG000|Overall Study|Adverse Event|4|||
164538238|NCT01448213|594344806|FG001|Overall Study|Adverse Event|10|||
164538239|NCT01448213|594344805|FG000|Overall Study|Protocol Violation|1|||
164538240|NCT01448213|594344806|FG001|Overall Study|Protocol Violation|2|||
164538241|NCT03434353|594344807|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
164538242|NCT03434353|594344808|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
164538243|NCT03434353|594344809|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
164538244|NCT03434353|594344810|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
164538245|NCT03434353|594344811|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
164538246|NCT03434353|594344807|FG000|Overall Study|Withdrew consent|1|||
164538247|NCT03434353|594344808|FG001|Overall Study|Withdrew consent|0|||
164538248|NCT03434353|594344809|FG002|Overall Study|Withdrew consent|3|||
164538249|NCT03434353|594344810|FG003|Overall Study|Withdrew consent|0|||
164650427|NCT02410837|594747202|FG000|Overall Study|Lost to Follow-up|50|||
164650428|NCT02410837|594747202|FG000|Overall Study|Withdrawal by Subject|44|||
164650429|NCT02410837|594747202|FG000|Overall Study|Physician Decision|6|||
164650430|NCT02410837|594747202|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
164650431|NCT01169987|594747203|FG000|Overall Study|Withdrawal by Subject|3|||
164650432|NCT01169987|594747203|FG000|Overall Study|Lost to Follow-up|24|||
164650433|NCT01169987|594747203|FG000|Overall Study|Other|4|||
164650434|NCT00386100|594747205|FG000|Overall Study|Did not receive study medication|6|||
164650435|NCT00386100|594747206|FG001|Overall Study|Did not receive study medication|4|||
164650436|NCT00386100|594747205|FG000|Overall Study|Adverse Event|15|||
164650437|NCT00386100|594747206|FG001|Overall Study|Adverse Event|25|||
164650438|NCT00386100|594747205|FG000|Overall Study|Death|0|||
164650439|NCT00386100|594747206|FG001|Overall Study|Death|1|||
164650440|NCT00386100|594747205|FG000|Overall Study|Insufficient therapeutic effect|30|||
164650441|NCT00386100|594747206|FG001|Overall Study|Insufficient therapeutic effect|6|||
164650442|NCT00386100|594747205|FG000|Overall Study|Lost to Follow-up|29|||
164650443|NCT00386100|594747206|FG001|Overall Study|Lost to Follow-up|29|||
164650444|NCT00386100|594747205|FG000|Overall Study|Non-compliance|18|||
164650445|NCT00386100|594747206|FG001|Overall Study|Non-compliance|19|||
164650446|NCT00386100|594747205|FG000|Overall Study|Protocol Violation|5|||
164650447|NCT00386100|594747206|FG001|Overall Study|Protocol Violation|3|||
164650448|NCT00386100|594747205|FG000|Overall Study|Withdrawal by Subject|32|||
164650449|NCT00386100|594747206|FG001|Overall Study|Withdrawal by Subject|31|||
164650450|NCT00386100|594747205|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
164650451|NCT00386100|594747206|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
164650452|NCT00386100|594747205|FG000|Overall Study|BMD <2.5|1|||
164650453|NCT00386100|594747206|FG001|Overall Study|BMD <2.5|0|||
164650454|NCT00386100|594747205|FG000|Overall Study|Consecutive elevated Hba1C|1|||
164650455|NCT00386100|594747206|FG001|Overall Study|Consecutive elevated Hba1C|0|||
164650456|NCT00386100|594747205|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
164650457|NCT00386100|594747206|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
164650458|NCT00386100|594747205|FG000|Overall Study|Laboratory findings|1|||
164650459|NCT00386100|594747206|FG001|Overall Study|Laboratory findings|0|||
164650460|NCT00386100|594747205|FG000|Overall Study|Participant's concern due to CPK levels|1|||
164650461|NCT00386100|594747206|FG001|Overall Study|Participant's concern due to CPK levels|0|||
164650462|NCT00386100|594747205|FG000|Overall Study|Participant moving out of state|2|||
164650463|NCT00386100|594747206|FG001|Overall Study|Participant moving out of state|0|||
164650464|NCT00386100|594747205|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
164650465|NCT00386100|594747206|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
164650466|NCT00386100|594747205|FG000|Overall Study|Didn't meet entry criteria|1|||
164650467|NCT00386100|594747206|FG001|Overall Study|Didn't meet entry criteria|1|||
164650468|NCT00386100|594747205|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
164650469|NCT00386100|594747206|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
164650470|NCT00386100|594747205|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
164650471|NCT00386100|594747206|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
164650472|NCT00386100|594747205|FG000|Overall Study|Bad metabolic control & patient security|1|||
164650473|NCT00386100|594747206|FG001|Overall Study|Bad metabolic control & patient security|0|||
164650474|NCT00386100|594747205|FG000|Overall Study|Bone loss by DXA bone scan|1|||
164650475|NCT00386100|594747206|FG001|Overall Study|Bone loss by DXA bone scan|0|||
164650476|NCT00386100|594747205|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
164650477|NCT00386100|594747206|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
164650478|NCT00386100|594747205|FG000|Overall Study|7.6% bone loss|1|||
164650479|NCT00386100|594747206|FG001|Overall Study|7.6% bone loss|0|||
164650480|NCT00386100|594747205|FG000|Overall Study|Osteoporosis|0|||
164650481|NCT00386100|594747206|FG001|Overall Study|Osteoporosis|1|||
164650482|NCT00386100|594747205|FG000|Overall Study|Positive pregnancy test|1|||
164650483|NCT00386100|594747206|FG001|Overall Study|Positive pregnancy test|3|||
164650484|NCT00386100|594747205|FG000|Overall Study|Out of country for 5 months|1|||
164650485|NCT00386100|594747206|FG001|Overall Study|Out of country for 5 months|0|||
164650486|NCT00386100|594747205|FG000|Overall Study|Hb1Ac >8%|0|||
164650487|NCT00386100|594747206|FG001|Overall Study|Hb1Ac >8%|1|||
164650488|NCT00386100|594747205|FG000|Overall Study|Participant randomized in error|1|||
164650489|NCT00386100|594747206|FG001|Overall Study|Participant randomized in error|0|||
164650490|NCT00849524|594747213|FG000|Overall Study|Lack of Efficacy|3|||
164650491|NCT01825876|594747214|FG000|Period 2|Withdrawal by Subject|0|||
164650492|NCT01825876|594747215|FG001|Period 2|Withdrawal by Subject|1|||
164650493|NCT01027884|594747220|FG000|Overall Study|Adverse Event|2|||
164650494|NCT01027884|594747221|FG001|Overall Study|Adverse Event|1|||
164650495|NCT01027884|594747220|FG000|Overall Study|Protocol Violation|1|||
164650496|NCT01027884|594747221|FG001|Overall Study|Protocol Violation|0|||
164650497|NCT01027884|594747220|FG000|Overall Study|Non-compliance|1|||
164650498|NCT01027884|594747221|FG001|Overall Study|Non-compliance|1|||
164650499|NCT01027884|594747220|FG000|Overall Study|Withdrawal by Subject|0|||
164650500|NCT01027884|594747221|FG001|Overall Study|Withdrawal by Subject|1|||
164650501|NCT01027884|594747220|FG000|Overall Study|Lost to Follow-up|0|||
164650502|NCT01027884|594747221|FG001|Overall Study|Lost to Follow-up|1|||
164650503|NCT01027884|594747220|FG000|Overall Study|Spinal fixation surgery|0|||
164650504|NCT01027884|594747221|FG001|Overall Study|Spinal fixation surgery|3|||
164650505|NCT03636542|594747222|FG000|Overall Study|Lost to Follow-up|1|||
164650506|NCT03636542|594747223|FG001|Overall Study|Lost to Follow-up|1|||
164189892|NCT00572455|593063988|FG002|Stage II (28 Days)|Death|0|||
164650507|NCT03636542|594747222|FG000|Overall Study|Physician Decision|0|||
164650508|NCT03636542|594747223|FG001|Overall Study|Physician Decision|1|||
164650509|NCT03636542|594747222|FG000|Overall Study|Withdrawal by Subject|1|||
164189893|NCT00572455|593063989|FG003|Stage II (28 Days)|Death|0|||
164650510|NCT03636542|594747223|FG001|Overall Study|Withdrawal by Subject|0|||
164650511|NCT03670537|594747224|FG000|Overall Study|Protocol Violation|1|||
164650512|NCT02059187|594747227|FG000|Overall Study|Adverse Event|0|||
164650513|NCT02059187|594747228|FG001|Overall Study|Adverse Event|3|||
164650514|NCT02059187|594747227|FG000|Overall Study|Death|1|||
164650515|NCT02059187|594747228|FG001|Overall Study|Death|1|||
164650516|NCT02059187|594747227|FG000|Overall Study|Lost to Follow-up|9|||
164650517|NCT02059187|594747228|FG001|Overall Study|Lost to Follow-up|8|||
164650518|NCT02059187|594747227|FG000|Overall Study|Non-compliance with study drug|1|||
164650519|NCT02059187|594747228|FG001|Overall Study|Non-compliance with study drug|0|||
164650520|NCT02059187|594747227|FG000|Overall Study|Physician Decision|1|||
164650521|NCT02059187|594747228|FG001|Overall Study|Physician Decision|2|||
164650522|NCT02059187|594747227|FG000|Overall Study|Protocol Violation|1|||
164650523|NCT02059187|594747228|FG001|Overall Study|Protocol Violation|0|||
164650524|NCT02059187|594747227|FG000|Overall Study|Withdrawal by Subject|12|||
164650525|NCT02059187|594747228|FG001|Overall Study|Withdrawal by Subject|8|||
164650526|NCT03751020|594747229|FG000|Overall Study|Withdrawal by Subject|2|||
164650527|NCT03751020|594747230|FG001|Overall Study|Withdrawal by Subject|0|||
164650528|NCT03751020|594747231|FG002|Overall Study|Withdrawal by Subject|0|||
164650529|NCT03751020|594747229|FG000|Overall Study|Lost to Follow-up|7|||
164650530|NCT03751020|594747230|FG001|Overall Study|Lost to Follow-up|4|||
164650531|NCT03751020|594747231|FG002|Overall Study|Lost to Follow-up|10|||
164650532|NCT00528879|594747232|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
164650533|NCT00528879|594747233|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
164650534|NCT00528879|594747234|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
164650535|NCT00528879|594747235|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
164650536|NCT00528879|594747232|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
164650537|NCT00528879|594747233|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
164650538|NCT00528879|594747234|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
164650539|NCT00528879|594747235|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
164650540|NCT00528879|594747232|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
164650541|NCT00528879|594747233|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
164650542|NCT00528879|594747234|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
164650543|NCT00528879|594747235|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
164650544|NCT00528879|594747232|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
164650545|NCT00528879|594747233|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
164650546|NCT00528879|594747234|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
164650547|NCT00528879|594747235|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
164650548|NCT00528879|594747232|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
164650549|NCT00528879|594747233|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
164650550|NCT00528879|594747234|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
164650551|NCT00528879|594747235|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
164650552|NCT00528879|594747232|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
164650553|NCT00528879|594747233|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
164650554|NCT00528879|594747234|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
164650555|NCT00528879|594747235|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
164650556|NCT00528879|594747232|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
164650557|NCT00528879|594747233|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
164650558|NCT00528879|594747234|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
164650559|NCT00528879|594747235|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
164650560|NCT00528879|594747232|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
164650561|NCT00528879|594747233|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
164650562|NCT00528879|594747234|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
164650563|NCT00528879|594747235|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
164650564|NCT00528879|594747232|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
164650565|NCT00528879|594747233|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
164650566|NCT00528879|594747234|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
164650567|NCT00528879|594747235|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
164650568|NCT00528879|594747232|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
164650569|NCT00528879|594747233|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
164650570|NCT00528879|594747234|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
164650571|NCT00528879|594747235|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
164650572|NCT00528879|594747232|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
164650573|NCT00528879|594747233|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
164650574|NCT00528879|594747234|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
164650575|NCT00528879|594747235|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
164650576|NCT00528879|594747232|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
164650577|NCT00528879|594747233|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
164650578|NCT00528879|594747234|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
164650579|NCT00528879|594747235|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
164650580|NCT00528879|594747232|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
164650581|NCT00528879|594747233|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
164650582|NCT00528879|594747234|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
164650583|NCT00528879|594747235|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
164650584|NCT00528879|594747232|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
164650585|NCT00528879|594747233|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
164650586|NCT00528879|594747234|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
164650587|NCT00528879|594747235|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
164650588|NCT00528879|594747232|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
164650589|NCT00528879|594747233|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
164650590|NCT00528879|594747234|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
164650591|NCT00528879|594747235|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
164650592|NCT00528879|594747232|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
164650593|NCT00528879|594747233|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
164650594|NCT00528879|594747234|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
164650595|NCT00528879|594747235|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
164650596|NCT01159769|594747236|FG000|Overall Study|Adverse Event|1|||
164650597|NCT02555618|594747237|FG000|Overall Study|Sponsor's Circumstances|1|||
164650598|NCT02555618|594747238|FG001|Overall Study|Sponsor's Circumstances|0|||
164650599|NCT02217345|594747239|FG000|Overall Study|Lost to Follow-up|2|||
164650600|NCT02217345|594747240|FG001|Overall Study|Lost to Follow-up|1|||
164650601|NCT02217345|594747239|FG000|Overall Study|Withdrawal by Subject|3|||
164650602|NCT02217345|594747240|FG001|Overall Study|Withdrawal by Subject|2|||
164650603|NCT02217345|594747239|FG000|Overall Study|Adverse Event|2|||
164650604|NCT02217345|594747240|FG001|Overall Study|Adverse Event|1|||
164650605|NCT02217345|594747239|FG000|Overall Study|Physician Decision|0|||
164650606|NCT02217345|594747240|FG001|Overall Study|Physician Decision|1|||
164650607|NCT00845026|594747241|FG000|Study Period III|Adverse Event|23|||
164650608|NCT00845026|594747242|FG001|Study Period III|Adverse Event|19|||
164650609|NCT00845026|594747241|FG000|Study Period III|Perceived lack of efficacy|27|||
164650610|NCT00845026|594747242|FG001|Study Period III|Perceived lack of efficacy|15|||
164650611|NCT00845026|594747241|FG000|Study Period III|Withdrawal by Subject|19|||
164650612|NCT00845026|594747242|FG001|Study Period III|Withdrawal by Subject|15|||
164650613|NCT00845026|594747241|FG000|Study Period III|Entry Criteria not met|8|||
164650614|NCT00845026|594747242|FG001|Study Period III|Entry Criteria not met|11|||
164650615|NCT00845026|594747241|FG000|Study Period III|Lost to Follow-up|4|||
164650616|NCT00845026|594747242|FG001|Study Period III|Lost to Follow-up|5|||
164650617|NCT00845026|594747241|FG000|Study Period III|Protocol Violation|8|||
164650618|NCT00845026|594747242|FG001|Study Period III|Protocol Violation|1|||
164650619|NCT00845026|594747241|FG000|Study Period III|Scheduled conflict|3|||
164650620|NCT00845026|594747242|FG001|Study Period III|Scheduled conflict|1|||
164650621|NCT00845026|594747241|FG000|Study Period III|Subject is moving or has moved|2|||
164650622|NCT00845026|594747242|FG001|Study Period III|Subject is moving or has moved|4|||
164650623|NCT00845026|594747241|FG000|Study Period III|Transportation issues|1|||
164650624|NCT00845026|594747242|FG001|Study Period III|Transportation issues|1|||
164650625|NCT00845026|594747241|FG000|Study Period IV|Adverse Event|4|||
164650626|NCT00845026|594747242|FG001|Study Period IV|Adverse Event|0|||
164650627|NCT00845026|594747241|FG000|Study Period IV|Perceived lack of efficacy|2|||
164650628|NCT00845026|594747242|FG001|Study Period IV|Perceived lack of efficacy|1|||
164650629|NCT00845026|594747241|FG000|Study Period IV|Protocol Violation|3|||
164650630|NCT00845026|594747242|FG001|Study Period IV|Protocol Violation|1|||
164650631|NCT00845026|594747241|FG000|Study Period IV|Lost to Follow-up|1|||
164650632|NCT00845026|594747242|FG001|Study Period IV|Lost to Follow-up|0|||
164650633|NCT00845026|594747241|FG000|Study Period IV|Withdrawal by Subject|4|||
164650634|NCT00845026|594747242|FG001|Study Period IV|Withdrawal by Subject|1|||
164650635|NCT00845026|594747241|FG000|Study Period IV|Entry Criteria Not Met|1|||
164650636|NCT00845026|594747242|FG001|Study Period IV|Entry Criteria Not Met|0|||
164650637|NCT00845026|594747241|FG000|Study Period IV|Subject is moving or has moved|0|||
164650638|NCT00845026|594747242|FG001|Study Period IV|Subject is moving or has moved|1|||
164650639|NCT00845026|594747241|FG000|Study Period IV|Scheduling conflict|1|||
164650640|NCT00845026|594747242|FG001|Study Period IV|Scheduling conflict|0|||
164650641|NCT01325532|594747243|FG000|Overall Study|Withdrawal by Subject|2|||
164650642|NCT01325532|594747244|FG001|Overall Study|Withdrawal by Subject|0|||
164650643|NCT00061945|594747251|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
164650644|NCT00061945|594747252|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
164650645|NCT00061945|594747251|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
164650646|NCT00061945|594747252|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
164650647|NCT00061945|594747251|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
164650648|NCT00061945|594747252|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
164650649|NCT00061945|594747251|FG000|Course IV: Alemtuzumab|Early exits|6|||
164650650|NCT00061945|594747252|FG001|Course IV: Alemtuzumab|Early exits|15|||
164650651|NCT03672396|594747253|FG000|Overall Study|Withdrawal by Subject|4|||
164650652|NCT03672396|594747253|FG000|Overall Study|Physician Decision|1|||
164650653|NCT03672396|594747253|FG000|Overall Study|Adverse Event|1|||
164650654|NCT01364298|594747254|FG000|Overall Study|Adverse Event|3|||
164650655|NCT01364298|594747255|FG001|Overall Study|Adverse Event|4|||
164650656|NCT01364298|594747254|FG000|Overall Study|Lack of adherence to treatment|1|||
164650657|NCT01364298|594747255|FG001|Overall Study|Lack of adherence to treatment|3|||
164650658|NCT01364298|594747254|FG000|Overall Study|Lack of Efficacy|1|||
164650659|NCT01364298|594747255|FG001|Overall Study|Lack of Efficacy|0|||
164650660|NCT01364298|594747254|FG000|Overall Study|Lost to Follow-up|5|||
164650661|NCT01364298|594747255|FG001|Overall Study|Lost to Follow-up|10|||
164650662|NCT01364298|594747254|FG000|Overall Study|Withdrawal by Subject|3|||
164650663|NCT01364298|594747255|FG001|Overall Study|Withdrawal by Subject|3|||
164650664|NCT01364298|594747254|FG000|Overall Study|Other|1|||
164650665|NCT01364298|594747255|FG001|Overall Study|Other|3|||
164650666|NCT03712228|594747258|FG000|Treatment Period 1|Lack of Efficacy|0|||
164650667|NCT03712228|594747259|FG001|Treatment Period 1|Lack of Efficacy|0|||
164650668|NCT03712228|594747260|FG002|Treatment Period 1|Lack of Efficacy|0|||
164650669|NCT03712228|594747261|FG003|Treatment Period 1|Lack of Efficacy|0|||
164650670|NCT03712228|594747262|FG004|Treatment Period 1|Lack of Efficacy|0|||
164650671|NCT03712228|594747263|FG005|Treatment Period 1|Lack of Efficacy|1|||
164650672|NCT03712228|594747258|FG000|Treatment Period 2|Pregnancy|0|||
164650673|NCT03712228|594747259|FG001|Treatment Period 2|Pregnancy|0|||
164650674|NCT03712228|594747260|FG002|Treatment Period 2|Pregnancy|0|||
164650675|NCT03712228|594747261|FG003|Treatment Period 2|Pregnancy|1|||
164650676|NCT03712228|594747262|FG004|Treatment Period 2|Pregnancy|0|||
164650677|NCT03712228|594747263|FG005|Treatment Period 2|Pregnancy|0|||
164650678|NCT03712228|594747258|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164650679|NCT03712228|594747259|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164650680|NCT03712228|594747260|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164650681|NCT03712228|594747261|FG003|Treatment Period 2|Withdrawal by Subject|1|||
164650682|NCT03712228|594747262|FG004|Treatment Period 2|Withdrawal by Subject|0|||
164650683|NCT03712228|594747263|FG005|Treatment Period 2|Withdrawal by Subject|0|||
164650684|NCT01964105|594747264|FG000|Overall Study|Lost to Follow-up|2|||
164650685|NCT01964105|594747265|FG001|Overall Study|Lost to Follow-up|13|||
164650686|NCT01964105|594747266|FG002|Overall Study|Lost to Follow-up|0|||
164650687|NCT01254045|594747269|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
164650688|NCT01254045|594747270|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
164650689|NCT01254045|594747271|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
164650690|NCT01254045|594747272|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
164650691|NCT01254045|594747273|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
164650692|NCT01254045|594747274|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
164650693|NCT00597207|594747275|FG000|Overall Study|Lost to Follow-up|5|||
164650694|NCT00597207|594747276|FG001|Overall Study|Lost to Follow-up|7|||
164650695|NCT00520351|594747277|FG000|First Intervention|Withdrawal by Subject|1|||
164650696|NCT00520351|594747278|FG001|First Intervention|Withdrawal by Subject|1|||
164650697|NCT01021137|594747281|FG000|Overall Study|Lost to Follow-up|9|||
164650698|NCT01021137|594747282|FG001|Overall Study|Lost to Follow-up|4|||
164650699|NCT01021137|594747283|FG002|Overall Study|Lost to Follow-up|2|||
164650700|NCT01021137|594747284|FG003|Overall Study|Lost to Follow-up|6|||
164650701|NCT01021137|594747281|FG000|Overall Study|Withdrawal by Subject|1|||
164650702|NCT01021137|594747282|FG001|Overall Study|Withdrawal by Subject|0|||
164650703|NCT01021137|594747283|FG002|Overall Study|Withdrawal by Subject|0|||
164650704|NCT01021137|594747284|FG003|Overall Study|Withdrawal by Subject|3|||
164650705|NCT00725725|594747285|FG000|Overall Study|Adverse Event|1|||
164650706|NCT00725725|594747286|FG001|Overall Study|Adverse Event|3|||
164650707|NCT00725725|594747287|FG002|Overall Study|Adverse Event|2|||
164650708|NCT00725725|594747285|FG000|Overall Study|Lost to Follow-up|2|||
164650709|NCT00725725|594747286|FG001|Overall Study|Lost to Follow-up|0|||
164650710|NCT00725725|594747287|FG002|Overall Study|Lost to Follow-up|2|||
164650711|NCT00725725|594747285|FG000|Overall Study|Withdrawal by Subject|1|||
164650712|NCT00725725|594747286|FG001|Overall Study|Withdrawal by Subject|0|||
164650713|NCT00725725|594747287|FG002|Overall Study|Withdrawal by Subject|1|||
164650714|NCT00725725|594747285|FG000|Overall Study|Protocol Violation|0|||
164650715|NCT00725725|594747286|FG001|Overall Study|Protocol Violation|1|||
164650716|NCT00725725|594747287|FG002|Overall Study|Protocol Violation|0|||
164650717|NCT04288115|594747289|FG000|Overall Study|Withdrawal by Subject|0|||
164650718|NCT04288115|594747290|FG001|Overall Study|Withdrawal by Subject|1|||
164650719|NCT04288115|594747289|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
164650720|NCT04288115|594747290|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
164650721|NCT00729365|594747291|FG000|Overall Study|Physician Decision|33|||
164650722|NCT00729365|594747292|FG001|Overall Study|Physician Decision|6|||
164650723|NCT00729365|594747293|FG002|Overall Study|Physician Decision|7|||
164650724|NCT00928135|594747296|FG000|Overall Study|Withdrawal by Subject|1|||
164650725|NCT00928135|594747297|FG001|Overall Study|Withdrawal by Subject|0|||
164650726|NCT04556838|594747302|FG000|Overall Study|Withdrawal by Subject|3|||
164650727|NCT04556838|594747303|FG001|Overall Study|Withdrawal by Subject|1|||
164650728|NCT04556838|594747304|FG002|Overall Study|Withdrawal by Subject|2|||
164650729|NCT04556838|594747302|FG000|Overall Study|Adverse Event|0|||
164650730|NCT04556838|594747303|FG001|Overall Study|Adverse Event|1|||
164650731|NCT04556838|594747304|FG002|Overall Study|Adverse Event|1|||
164650732|NCT04556838|594747302|FG000|Overall Study|Lost to Follow-up|0|||
164650733|NCT04556838|594747303|FG001|Overall Study|Lost to Follow-up|0|||
164650734|NCT04556838|594747304|FG002|Overall Study|Lost to Follow-up|2|||
164650735|NCT04556838|594747302|FG000|Overall Study|Subject travel|0|||
164650736|NCT04556838|594747303|FG001|Overall Study|Subject travel|1|||
164650737|NCT04556838|594747304|FG002|Overall Study|Subject travel|0|||
164650738|NCT04556838|594747302|FG000|Overall Study|Physician Decision|1|||
164650739|NCT04556838|594747303|FG001|Overall Study|Physician Decision|0|||
164650740|NCT04556838|594747304|FG002|Overall Study|Physician Decision|0|||
164650741|NCT03877237|594749238|FG000|Overall Study|Adverse Event|1|||
164650742|NCT03877237|594749239|FG001|Overall Study|Adverse Event|2|||
164650743|NCT03877237|594749238|FG000|Overall Study|Death|3|||
164650744|NCT03877237|594749239|FG001|Overall Study|Death|2|||
164650745|NCT03877237|594749238|FG000|Overall Study|Physician Decision|1|||
164650746|NCT03877237|594749239|FG001|Overall Study|Physician Decision|0|||
164650747|NCT03877237|594749238|FG000|Overall Study|Withdrawal by Subject|0|||
164650748|NCT03877237|594749239|FG001|Overall Study|Withdrawal by Subject|2|||
164650749|NCT00382291|594749240|FG000|Overall Study|Adverse Event|1|||
164650750|NCT00382291|594749241|FG001|Overall Study|Adverse Event|2|||
164650751|NCT00382291|594749242|FG002|Overall Study|Adverse Event|2|||
164650752|NCT00382291|594749240|FG000|Overall Study|Protocol Violation|1|||
164650753|NCT00382291|594749241|FG001|Overall Study|Protocol Violation|0|||
164650754|NCT00382291|594749242|FG002|Overall Study|Protocol Violation|0|||
164650755|NCT00382291|594749240|FG000|Overall Study|Temporary study suspension|2|||
164650756|NCT00382291|594749241|FG001|Overall Study|Temporary study suspension|2|||
164650757|NCT00382291|594749242|FG002|Overall Study|Temporary study suspension|5|||
164650758|NCT00382291|594749240|FG000|Overall Study|Withdrawal by Subject|0|||
164650759|NCT00382291|594749241|FG001|Overall Study|Withdrawal by Subject|2|||
164650760|NCT00382291|594749242|FG002|Overall Study|Withdrawal by Subject|0|||
164650761|NCT00382291|594749240|FG000|Overall Study|Physician Decision|0|||
164650762|NCT00382291|594749241|FG001|Overall Study|Physician Decision|1|||
164650763|NCT00382291|594749242|FG002|Overall Study|Physician Decision|0|||
164650764|NCT00382291|594749240|FG000|Overall Study|Lack of Efficacy|0|||
164650765|NCT00382291|594749241|FG001|Overall Study|Lack of Efficacy|0|||
164650766|NCT00382291|594749242|FG002|Overall Study|Lack of Efficacy|1|||
164650767|NCT02266706|594749243|FG000|Overall Study|Withdrawal by Subject|0|||
164650768|NCT02266706|594749244|FG001|Overall Study|Withdrawal by Subject|1|||
164650769|NCT02266706|594749245|FG002|Overall Study|Withdrawal by Subject|1|||
164650770|NCT02266706|594749246|FG003|Overall Study|Withdrawal by Subject|0|||
164650771|NCT02266706|594749247|FG004|Overall Study|Withdrawal by Subject|0|||
164650772|NCT02266706|594749248|FG005|Overall Study|Withdrawal by Subject|1|||
164650773|NCT02266706|594749249|FG006|Overall Study|Withdrawal by Subject|0|||
164650774|NCT02266706|594749250|FG007|Overall Study|Withdrawal by Subject|0|||
164650775|NCT02266706|594749251|FG008|Overall Study|Withdrawal by Subject|0|||
164650776|NCT02266706|594749243|FG000|Overall Study|Screen failure|0|||
164650777|NCT02266706|594749244|FG001|Overall Study|Screen failure|0|||
164650778|NCT02266706|594749245|FG002|Overall Study|Screen failure|0|||
164650779|NCT02266706|594749246|FG003|Overall Study|Screen failure|0|||
164650780|NCT02266706|594749247|FG004|Overall Study|Screen failure|0|||
164650781|NCT02266706|594749248|FG005|Overall Study|Screen failure|1|||
164650782|NCT02266706|594749249|FG006|Overall Study|Screen failure|1|||
164650783|NCT02266706|594749250|FG007|Overall Study|Screen failure|0|||
164650784|NCT02266706|594749251|FG008|Overall Study|Screen failure|0|||
164650785|NCT02266706|594749243|FG000|Overall Study|Enrollment in another study|0|||
164650786|NCT02266706|594749244|FG001|Overall Study|Enrollment in another study|0|||
164650787|NCT02266706|594749245|FG002|Overall Study|Enrollment in another study|0|||
164650788|NCT02266706|594749246|FG003|Overall Study|Enrollment in another study|1|||
164650789|NCT02266706|594749247|FG004|Overall Study|Enrollment in another study|0|||
164650790|NCT02266706|594749248|FG005|Overall Study|Enrollment in another study|0|||
164650791|NCT02266706|594749249|FG006|Overall Study|Enrollment in another study|0|||
164650792|NCT02266706|594749250|FG007|Overall Study|Enrollment in another study|0|||
164650793|NCT02266706|594749251|FG008|Overall Study|Enrollment in another study|0|||
164650794|NCT01792284|594749253|FG000|Lead-in Period|Adverse Event|15|||
164650795|NCT01792284|594749254|FG001|Lead-in Period|Adverse Event|0|||
164650796|NCT01792284|594749255|FG002|Lead-in Period|Adverse Event|0|||
164650797|NCT01792284|594749253|FG000|Lead-in Period|Lost to Follow-up|2|||
164650798|NCT01792284|594749254|FG001|Lead-in Period|Lost to Follow-up|0|||
164650799|NCT01792284|594749255|FG002|Lead-in Period|Lost to Follow-up|0|||
164650800|NCT01792284|594749253|FG000|Lead-in Period|Protocol Violation|1|||
164650801|NCT01792284|594749254|FG001|Lead-in Period|Protocol Violation|0|||
164650802|NCT01792284|594749255|FG002|Lead-in Period|Protocol Violation|0|||
164650803|NCT01792284|594749253|FG000|Lead-in Period|Withdrawal by Subject|10|||
164650804|NCT01792284|594749254|FG001|Lead-in Period|Withdrawal by Subject|0|||
164650805|NCT01792284|594749255|FG002|Lead-in Period|Withdrawal by Subject|0|||
164650806|NCT01792284|594749253|FG000|Lead-in Period|Physician Decision|1|||
164650807|NCT01792284|594749254|FG001|Lead-in Period|Physician Decision|0|||
164650808|NCT01792284|594749255|FG002|Lead-in Period|Physician Decision|0|||
164650809|NCT01792284|594749253|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
164650810|NCT01792284|594749254|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
164650811|NCT01792284|594749255|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
164650812|NCT01792284|594749253|FG000|Randomization Period 1|Withdrawal by Subject|0|||
164650813|NCT01792284|594749254|FG001|Randomization Period 1|Withdrawal by Subject|1|||
164650814|NCT01792284|594749255|FG002|Randomization Period 1|Withdrawal by Subject|1|||
164650815|NCT01792284|594749253|FG000|Randomization Period 1|Physician Decision|0|||
164650816|NCT01792284|594749254|FG001|Randomization Period 1|Physician Decision|1|||
164650817|NCT01792284|594749255|FG002|Randomization Period 1|Physician Decision|1|||
164650818|NCT01792284|594749253|FG000|Randomization Period 1|Adverse Event|0|||
164650819|NCT01792284|594749254|FG001|Randomization Period 1|Adverse Event|0|||
164650820|NCT01792284|594749255|FG002|Randomization Period 1|Adverse Event|2|||
164650821|NCT01792284|594749253|FG000|Randomization Period 1|Lost to Follow-up|0|||
164650822|NCT01792284|594749254|FG001|Randomization Period 1|Lost to Follow-up|0|||
164650823|NCT01792284|594749255|FG002|Randomization Period 1|Lost to Follow-up|1|||
164650824|NCT01792284|594749253|FG000|Randomization Period 2|Protocol Violation|0|||
164650825|NCT01792284|594749254|FG001|Randomization Period 2|Protocol Violation|1|||
164650826|NCT01792284|594749255|FG002|Randomization Period 2|Protocol Violation|0|||
164650827|NCT01792284|594749253|FG000|Randomization Period 2|Withdrawal by Subject|0|||
164650828|NCT01792284|594749254|FG001|Randomization Period 2|Withdrawal by Subject|2|||
164650829|NCT01792284|594749255|FG002|Randomization Period 2|Withdrawal by Subject|0|||
164650830|NCT00379587|594749256|FG000|Overall Study|Lost to Follow-up|2|||
164650831|NCT03237611|594749258|FG000|Overall Study|Withdrawal by Subject|1|||
164650832|NCT03237611|594749258|FG000|Overall Study|Ineligible|1|||
164650833|NCT00534092|594749262|FG000|Overall Study|Lost to Follow-up|1|||
164650834|NCT00534092|594749263|FG001|Overall Study|Lost to Follow-up|0|||
164650835|NCT00534092|594749262|FG000|Overall Study|personal reasons/family concerns|1|||
164650836|NCT00534092|594749263|FG001|Overall Study|personal reasons/family concerns|0|||
164650837|NCT01169649|594749264|FG000|Overall Study|Patient Not Treated|3|||
164650838|NCT01059071|594749267|FG000|Overall Study|Lack of Efficacy|1|||
164650839|NCT01059071|594749268|FG001|Overall Study|Lack of Efficacy|4|||
164650840|NCT01059071|594749269|FG002|Overall Study|Lack of Efficacy|2|||
164650841|NCT01059071|594749270|FG003|Overall Study|Lack of Efficacy|3|||
164650842|NCT01059071|594749267|FG000|Overall Study|Withdrawal by Subject|1|||
164650843|NCT01059071|594749268|FG001|Overall Study|Withdrawal by Subject|0|||
164650844|NCT01059071|594749269|FG002|Overall Study|Withdrawal by Subject|0|||
164650845|NCT01059071|594749270|FG003|Overall Study|Withdrawal by Subject|2|||
164650846|NCT01059071|594749267|FG000|Overall Study|Physician Decision|0|||
164650847|NCT01059071|594749268|FG001|Overall Study|Physician Decision|0|||
164650848|NCT01059071|594749269|FG002|Overall Study|Physician Decision|0|||
164650849|NCT01059071|594749270|FG003|Overall Study|Physician Decision|1|||
164650850|NCT02962882|594749271|FG000|Overall Study|Adverse Event|2|||
164650851|NCT02962882|594749271|FG000|Overall Study|Withdrawal by Subject|2|||
164650852|NCT02962882|594749271|FG000|Overall Study|Transfer from ICU|32|||
164650853|NCT04741503|594749272|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
164650854|NCT04741503|594749273|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
164650855|NCT04741503|594749274|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
164650856|NCT04741503|594749272|FG000|Initial Enrollment|Overquotas removed|0|||
164650857|NCT04741503|594749273|FG001|Initial Enrollment|Overquotas removed|0|||
164650858|NCT04741503|594749274|FG002|Initial Enrollment|Overquotas removed|186|||
164650859|NCT04741503|594749272|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
164650860|NCT04741503|594749273|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
164650861|NCT04741503|594749274|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
164650862|NCT00881959|594749285|FG000|Overall Study|Lost to Follow-up|2|||
164650863|NCT00881959|594749286|FG001|Overall Study|Lost to Follow-up|4|||
164650864|NCT02791659|594749287|FG000|Overall Study|Protocol Violation|0|||
164650865|NCT02791659|594749288|FG001|Overall Study|Protocol Violation|1|||
164650866|NCT01904383|594749289|FG000|Overall Study|CRF not collected|117|||
164650867|NCT01904383|594749289|FG000|Overall Study|Reason not listed|147|||
164650868|NCT01904383|594749289|FG000|Overall Study|Lost to Follow-up|674|||
164650869|NCT01904383|594749289|FG000|Overall Study|Lack of Efficacy|370|||
164650870|NCT01904383|594749289|FG000|Overall Study|Improvement|141|||
164650871|NCT01904383|594749289|FG000|Overall Study|Adverse Event|271|||
164650872|NCT01904383|594749289|FG000|Overall Study|No patient visit after entry|54|||
164650873|NCT04313283|594749292|FG000|Overall Study|did not complete intervention|4|||
164650874|NCT04356573|594749293|FG000|Overall Study|Didn't Qualify|1|||
164650875|NCT04356573|594749294|FG001|Overall Study|Didn't Qualify|0|||
164650876|NCT01244815|594749297|FG000|Overall Study|Not Treated|0|||
164650877|NCT01244815|594749298|FG001|Overall Study|Not Treated|1|||
164650878|NCT01244815|594749299|FG002|Overall Study|Not Treated|0|||
164650879|NCT01244815|594749300|FG003|Overall Study|Not Treated|0|||
164650880|NCT01244815|594749297|FG000|Overall Study|Adverse Event|4|||
164650881|NCT01244815|594749298|FG001|Overall Study|Adverse Event|7|||
164650882|NCT01244815|594749299|FG002|Overall Study|Adverse Event|5|||
164650883|NCT01244815|594749300|FG003|Overall Study|Adverse Event|5|||
164650884|NCT01244815|594749297|FG000|Overall Study|Treatment Failure|0|||
164650885|NCT01244815|594749298|FG001|Overall Study|Treatment Failure|0|||
164650886|NCT01244815|594749299|FG002|Overall Study|Treatment Failure|0|||
164650887|NCT01244815|594749300|FG003|Overall Study|Treatment Failure|1|||
164650888|NCT01244815|594749297|FG000|Overall Study|Lost to Follow-up|3|||
164650889|NCT01244815|594749298|FG001|Overall Study|Lost to Follow-up|2|||
164650890|NCT01244815|594749299|FG002|Overall Study|Lost to Follow-up|3|||
164650891|NCT01244815|594749300|FG003|Overall Study|Lost to Follow-up|2|||
164650892|NCT01244815|594749297|FG000|Overall Study|Withdrawal by Subject|0|||
164650893|NCT01244815|594749298|FG001|Overall Study|Withdrawal by Subject|2|||
164650894|NCT01244815|594749299|FG002|Overall Study|Withdrawal by Subject|0|||
164650895|NCT01244815|594749300|FG003|Overall Study|Withdrawal by Subject|3|||
164650896|NCT01244815|594749297|FG000|Overall Study|Protocol Violation|7|||
164650897|NCT01244815|594749298|FG001|Overall Study|Protocol Violation|4|||
164650898|NCT01244815|594749299|FG002|Overall Study|Protocol Violation|3|||
164650899|NCT01244815|594749300|FG003|Overall Study|Protocol Violation|1|||
164650900|NCT01244815|594749297|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
164650901|NCT01244815|594749298|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
164650902|NCT01244815|594749299|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
164650903|NCT01244815|594749300|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
164650904|NCT00472446|594749301|FG000|Overall Study|Protocol Violation|0|||
164650905|NCT00472446|594749302|FG001|Overall Study|Protocol Violation|0|||
164650906|NCT00472446|594749303|FG002|Overall Study|Protocol Violation|0|||
164650907|NCT00472446|594749304|FG003|Overall Study|Protocol Violation|1|||
164650908|NCT00472446|594749301|FG000|Overall Study|Reintervention|0|||
164650909|NCT00472446|594749302|FG001|Overall Study|Reintervention|0|||
164650910|NCT00472446|594749303|FG002|Overall Study|Reintervention|1|||
164650911|NCT00472446|594749304|FG003|Overall Study|Reintervention|1|||
164650912|NCT00472446|594749301|FG000|Overall Study|Questionnaires not returned|5|||
164650913|NCT00472446|594749302|FG001|Overall Study|Questionnaires not returned|6|||
164650914|NCT00472446|594749303|FG002|Overall Study|Questionnaires not returned|6|||
164650915|NCT00472446|594749304|FG003|Overall Study|Questionnaires not returned|4|||
164650916|NCT03211156|594749305|FG000|Overall Study|Withdrawal by Subject|0|||
164650917|NCT03211156|594749306|FG001|Overall Study|Withdrawal by Subject|2|||
164650918|NCT03211156|594749305|FG000|Overall Study|Lost to Follow-up|1|||
164650919|NCT03211156|594749306|FG001|Overall Study|Lost to Follow-up|1|||
164650920|NCT03211156|594749305|FG000|Overall Study|Adverse Event|1|||
164650921|NCT03211156|594749306|FG001|Overall Study|Adverse Event|0|||
164650922|NCT00837577|594749308|FG000|Double-blind Period|Clinical Adverse Event|1|||
164650923|NCT00837577|594749309|FG001|Double-blind Period|Clinical Adverse Event|0|||
164650924|NCT00837577|594749308|FG000|Double-blind Period|Withdrawal by Subject|1|||
164650925|NCT00837577|594749309|FG001|Double-blind Period|Withdrawal by Subject|0|||
164650926|NCT00837577|594749308|FG000|Open-label Period|Clinical Adverse Event|2|||
164650927|NCT00837577|594749309|FG001|Open-label Period|Clinical Adverse Event|2|||
164650928|NCT00837577|594749308|FG000|Open-label Period|Laboratory Adverse Event|0|||
164650929|NCT00837577|594749309|FG001|Open-label Period|Laboratory Adverse Event|1|||
164650930|NCT00837577|594749308|FG000|Open-label Period|Lack of Efficacy|4|||
164650931|NCT00837577|594749309|FG001|Open-label Period|Lack of Efficacy|3|||
164650932|NCT00837577|594749308|FG000|Open-label Period|Withdrawal by Subject|1|||
164650933|NCT00837577|594749309|FG001|Open-label Period|Withdrawal by Subject|2|||
164650934|NCT00837577|594749308|FG000|Open-label Period|Other Reason|1|||
164650935|NCT00837577|594749309|FG001|Open-label Period|Other Reason|1|||
164650936|NCT02624518|594749312|FG000|Overall Study|Physician Decision|1|||
164650937|NCT00272961|594749313|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
164650938|NCT00272961|594749314|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
164650939|NCT00272961|594749315|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
164650940|NCT00272961|594749316|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
164650941|NCT00272961|594749317|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
164650942|NCT00272961|594749313|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
164650943|NCT00272961|594749314|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
164650944|NCT00272961|594749315|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
164650945|NCT00272961|594749316|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
164650946|NCT00272961|594749317|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
164650947|NCT00272961|594749313|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
164650948|NCT00272961|594749314|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
164650949|NCT00272961|594749315|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
164650950|NCT00272961|594749316|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
164650951|NCT00272961|594749317|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
164650952|NCT00272961|594749313|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
164650953|NCT00272961|594749314|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
164650954|NCT00272961|594749315|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
164650955|NCT00272961|594749316|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
164650956|NCT00272961|594749317|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
164650957|NCT00272961|594749313|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
164650958|NCT00272961|594749314|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
164650959|NCT00272961|594749315|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
164650960|NCT00272961|594749316|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
164650961|NCT00272961|594749317|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
164650962|NCT00272961|594749313|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
164650963|NCT00272961|594749314|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
164650964|NCT00272961|594749315|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
164650965|NCT00272961|594749316|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
164650966|NCT00272961|594749317|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
164650967|NCT00272961|594749313|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
164650968|NCT00272961|594749314|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
164650969|NCT00272961|594749315|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
164650970|NCT00272961|594749316|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
164650971|NCT00272961|594749317|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
164650972|NCT00272961|594749313|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
164650973|NCT00272961|594749314|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
164650974|NCT00272961|594749315|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
164650975|NCT00272961|594749316|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
164650976|NCT00272961|594749317|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
164650977|NCT01507831|594749318|FG000|Overall Study|Randomized but not treated|0|||
164650978|NCT01507831|594749319|FG001|Overall Study|Randomized but not treated|3|||
164650979|NCT01507831|594749318|FG000|Overall Study|Adverse Event|48|||
164650980|NCT01507831|594749319|FG001|Overall Study|Adverse Event|113|||
164650981|NCT01507831|594749318|FG000|Overall Study|Death|6|||
164650982|NCT01507831|594749319|FG001|Overall Study|Death|2|||
164650983|NCT01507831|594749318|FG000|Overall Study|Poor compliance to protocol|38|||
164650984|NCT01507831|594749319|FG001|Overall Study|Poor compliance to protocol|60|||
164650985|NCT01507831|594749318|FG000|Overall Study|Physician Decision|0|||
164650986|NCT01507831|594749319|FG001|Overall Study|Physician Decision|4|||
164650987|NCT01507831|594749318|FG000|Overall Study|Participant moved|5|||
164650988|NCT01507831|594749319|FG001|Overall Study|Participant moved|19|||
164650989|NCT01507831|594749318|FG000|Overall Study|Consent withdrawn by participant|34|||
164650990|NCT01507831|594749319|FG001|Overall Study|Consent withdrawn by participant|72|||
164650991|NCT01507831|594749318|FG000|Overall Study|Related to study drug administration|5|||
164650992|NCT01507831|594749319|FG001|Overall Study|Related to study drug administration|14|||
164650993|NCT01507831|594749318|FG000|Overall Study|Last visit outside protocol visit window|51|||
164650994|NCT01507831|594749319|FG001|Overall Study|Last visit outside protocol visit window|143|||
164650995|NCT01507831|594749318|FG000|Overall Study|Selection criteria finally not met|0|||
164650996|NCT01507831|594749319|FG001|Overall Study|Selection criteria finally not met|1|||
164650997|NCT01507831|594749318|FG000|Overall Study|Site closure|0|||
164650998|NCT01507831|594749319|FG001|Overall Study|Site closure|3|||
164650999|NCT01507831|594749318|FG000|Overall Study|Potential lost to follow-up|3|||
164651000|NCT01507831|594749319|FG001|Overall Study|Potential lost to follow-up|0|||
164651001|NCT01507831|594749318|FG000|Overall Study|Other|3|||
164651002|NCT01507831|594749319|FG001|Overall Study|Other|6|||
164651003|NCT03652961|594749320|FG000|Overall Study|Lost to Follow-up|3|||
164651004|NCT03652961|594749320|FG000|Overall Study|Screen Failure|1|||
164651005|NCT01280981|594749323|FG000|Overall Study|Withdrawal by Subject|11|||
164651006|NCT01280981|594749323|FG000|Overall Study|Protocol Violation|2|||
164651007|NCT01280981|594749323|FG000|Overall Study|Lack of Efficacy|13|||
164651008|NCT01280981|594749323|FG000|Overall Study|Lost to Follow-up|3|||
164651009|NCT01280981|594749323|FG000|Overall Study|Adverse Event|6|||
164651010|NCT01280981|594749323|FG000|Overall Study|Irregular or discontinued menses|3|||
164651011|NCT01280981|594749323|FG000|Overall Study|Failed to return|45|||
164651012|NCT01280981|594749323|FG000|Overall Study|Non-compliance with protocol|3|||
164651013|NCT01280981|594749323|FG000|Overall Study|Withdrawal of consent|3|||
164651014|NCT01280981|594749323|FG000|Overall Study|Elective surgery|2|||
164651015|NCT01280981|594749323|FG000|Overall Study|Study site closure|1|||
164651016|NCT01610167|594749326|FG000|Overall Study|Scheduling conflict.|0|||
164651017|NCT01610167|594749327|FG001|Overall Study|Scheduling conflict.|0|||
164651018|NCT01610167|594749328|FG002|Overall Study|Scheduling conflict.|2|||
164651019|NCT03276962|594749333|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
164651020|NCT03276962|594749334|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
164651021|NCT03276962|594749335|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
164651022|NCT03276962|594749336|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
164651023|NCT03276962|594749337|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
164651024|NCT03276962|594749333|FG000|Overall Study|Protocol Deviation|2|||
164651025|NCT03276962|594749334|FG001|Overall Study|Protocol Deviation|0|||
164651026|NCT03276962|594749335|FG002|Overall Study|Protocol Deviation|1|||
164651027|NCT03276962|594749336|FG003|Overall Study|Protocol Deviation|2|||
164651028|NCT03276962|594749337|FG004|Overall Study|Protocol Deviation|1|||
164651029|NCT03276962|594749333|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
164651030|NCT03276962|594749334|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
164651031|NCT03276962|594749335|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
164651032|NCT03276962|594749336|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
164651033|NCT03276962|594749337|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
164651034|NCT03276962|594749333|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
164651035|NCT03276962|594749334|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
164651036|NCT03276962|594749335|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
164651037|NCT03276962|594749336|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
164651038|NCT03276962|594749337|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
164651039|NCT03276962|594749333|FG000|Overall Study|Lost to Follow-up|10|||
164651040|NCT03276962|594749334|FG001|Overall Study|Lost to Follow-up|10|||
164651041|NCT03276962|594749335|FG002|Overall Study|Lost to Follow-up|4|||
164651042|NCT03276962|594749336|FG003|Overall Study|Lost to Follow-up|6|||
164651043|NCT03276962|594749337|FG004|Overall Study|Lost to Follow-up|10|||
164651044|NCT03276962|594749333|FG000|Overall Study|Other|0|||
164651045|NCT03276962|594749334|FG001|Overall Study|Other|2|||
164651046|NCT03276962|594749335|FG002|Overall Study|Other|0|||
164651047|NCT03276962|594749336|FG003|Overall Study|Other|2|||
164651048|NCT03276962|594749337|FG004|Overall Study|Other|1|||
164651049|NCT01358708|594749338|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
164651050|NCT01358708|594749339|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164651051|NCT01358708|594749338|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
164651052|NCT01358708|594749339|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
164651053|NCT03056001|594749343|FG000|Overall Study|Death|24|||
164651054|NCT02766400|594749350|FG000|Overall Study|Death|1|||
164651055|NCT02766400|594749351|FG001|Overall Study|Death|2|||
164651056|NCT02766400|594749350|FG000|Overall Study|Withdrawal by Subject|1|||
164651057|NCT02766400|594749351|FG001|Overall Study|Withdrawal by Subject|0|||
164651058|NCT03499249|594749357|FG000|Overall Study|Physician Decision|1|||
164651059|NCT01374906|594749358|FG000|Overall Study|Abnormal laboratory value(s)|0|||
164651060|NCT01374906|594749359|FG001|Overall Study|Abnormal laboratory value(s)|3|||
164651061|NCT01374906|594749358|FG000|Overall Study|Administrative problems|2|||
164651062|NCT01374906|594749359|FG001|Overall Study|Administrative problems|2|||
164651063|NCT01374906|594749358|FG000|Overall Study|Adverse Event|10|||
164651064|NCT01374906|594749359|FG001|Overall Study|Adverse Event|11|||
164651065|NCT01374906|594749358|FG000|Overall Study|Death|0|||
164651066|NCT01374906|594749359|FG001|Overall Study|Death|2|||
164651067|NCT01374906|594749358|FG000|Overall Study|Protocol Violation|2|||
164651068|NCT01374906|594749359|FG001|Overall Study|Protocol Violation|2|||
164651069|NCT01374906|594749358|FG000|Overall Study|Withdrawal by Subject|15|||
164651070|NCT01374906|594749359|FG001|Overall Study|Withdrawal by Subject|9|||
164651071|NCT01374906|594749358|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
164651072|NCT01374906|594749359|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
164651073|NCT02475980|594749364|FG000|Overall Study|Lost to Follow-up|4|||
164651074|NCT02475980|594749364|FG000|Overall Study|Withdrawal by Subject|1|||
164651075|NCT01458119|594749372|FG000|Overall Study|Physician Decision|4|||
164651076|NCT01458119|594749372|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
164651077|NCT01458119|594749372|FG000|Overall Study|Pregnancy|1|||
164651078|NCT01458119|594749372|FG000|Overall Study|Death|2|||
164651079|NCT01458119|594749372|FG000|Overall Study|Adverse Event|1|||
164651080|NCT01458119|594749372|FG000|Overall Study|Consent Withdrawn by Participant|8|||
164651081|NCT01458119|594749372|FG000|Overall Study|Non-compliance With Study Drug|3|||
164651082|NCT03033069|594749373|FG000|Overall Study|Adverse Event|6|||
164651083|NCT03033069|594749374|FG001|Overall Study|Adverse Event|7|||
164651084|NCT03033069|594749375|FG002|Overall Study|Adverse Event|4|||
164651085|NCT03033069|594749376|FG003|Overall Study|Adverse Event|6|||
164651086|NCT03033069|594749373|FG000|Overall Study|Lack of Efficacy|0|||
164651087|NCT03033069|594749374|FG001|Overall Study|Lack of Efficacy|0|||
164651088|NCT03033069|594749375|FG002|Overall Study|Lack of Efficacy|1|||
164651089|NCT03033069|594749376|FG003|Overall Study|Lack of Efficacy|0|||
164651090|NCT03033069|594749373|FG000|Overall Study|Lost to Follow-up|6|||
164651091|NCT03033069|594749374|FG001|Overall Study|Lost to Follow-up|5|||
164651092|NCT03033069|594749375|FG002|Overall Study|Lost to Follow-up|5|||
164651093|NCT03033069|594749376|FG003|Overall Study|Lost to Follow-up|6|||
164651094|NCT03033069|594749373|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164651095|NCT03033069|594749374|FG001|Overall Study|Non-Compliance With Study Drug|1|||
164651096|NCT03033069|594749375|FG002|Overall Study|Non-Compliance With Study Drug|1|||
164651097|NCT03033069|594749376|FG003|Overall Study|Non-Compliance With Study Drug|0|||
164651098|NCT03033069|594749373|FG000|Overall Study|Protocol Deviation|0|||
164651099|NCT03033069|594749374|FG001|Overall Study|Protocol Deviation|1|||
164420505|NCT02718417|593910943|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
164420506|NCT02718417|593910944|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
164420507|NCT02718417|593910945|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
164420508|NCT02718417|593910943|FG000|Maintenance Phase (MP)|Physician's decision|6|||
164420509|NCT02718417|593910944|FG001|Maintenance Phase (MP)|Physician's decision|7|||
164420510|NCT02718417|593910945|FG002|Maintenance Phase (MP)|Physician's decision|0|||
164420511|NCT02718417|593910943|FG000|Maintenance Phase (MP)|Progressive disease|100|||
164420512|NCT02718417|593910944|FG001|Maintenance Phase (MP)|Progressive disease|88|||
164420513|NCT02718417|593910945|FG002|Maintenance Phase (MP)|Progressive disease|0|||
164420514|NCT02718417|593910943|FG000|Maintenance Phase (MP)|Other|2|||
164420515|NCT02718417|593910944|FG001|Maintenance Phase (MP)|Other|1|||
164420516|NCT02718417|593910945|FG002|Maintenance Phase (MP)|Other|0|||
164420517|NCT02718417|593910943|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
164420518|NCT02718417|593910944|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
164420519|NCT02718417|593910945|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
164420520|NCT02718417|593910943|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
164420521|NCT02718417|593910944|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
164420522|NCT02718417|593910945|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
164420523|NCT02718417|593910943|FG000|Observation Phase (OP)|Adverse Event|0|||
164420524|NCT02718417|593910944|FG001|Observation Phase (OP)|Adverse Event|0|||
164420525|NCT02718417|593910945|FG002|Observation Phase (OP)|Adverse Event|1|||
164420526|NCT02718417|593910943|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
164420527|NCT02718417|593910944|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
164420528|NCT02718417|593910945|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
164420529|NCT02718417|593910943|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
164420530|NCT02718417|593910944|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
164420531|NCT02718417|593910945|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
164420532|NCT02718417|593910943|FG000|Observation Phase (OP)|Physician Decision|0|||
164420533|NCT02718417|593910944|FG001|Observation Phase (OP)|Physician Decision|0|||
164420534|NCT02718417|593910945|FG002|Observation Phase (OP)|Physician Decision|9|||
164420535|NCT02718417|593910943|FG000|Observation Phase (OP)|Progressive disease|0|||
164420536|NCT02718417|593910944|FG001|Observation Phase (OP)|Progressive disease|0|||
164420537|NCT02718417|593910945|FG002|Observation Phase (OP)|Progressive disease|92|||
164420538|NCT02718417|593910943|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
164420539|NCT02718417|593910944|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
164420540|NCT02718417|593910945|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
164420541|NCT02718417|593910943|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
164420542|NCT02718417|593910944|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
164420543|NCT02718417|593910945|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
164420544|NCT02718417|593910943|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
164420545|NCT02718417|593910944|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
164420546|NCT02718417|593910945|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
164420547|NCT02718417|593910943|FG000|Observation Phase (OP)|Other|0|||
164420548|NCT02718417|593910944|FG001|Observation Phase (OP)|Other|0|||
164420549|NCT02718417|593910945|FG002|Observation Phase (OP)|Other|7|||
164420550|NCT02718417|593910943|FG000|Follow-up Phase|Adverse Event|3|||
164420551|NCT02718417|593910944|FG001|Follow-up Phase|Adverse Event|1|||
164420552|NCT02718417|593910945|FG002|Follow-up Phase|Adverse Event|1|||
164420553|NCT02718417|593910943|FG000|Follow-up Phase|Other|4|||
164420554|NCT02718417|593910944|FG001|Follow-up Phase|Other|6|||
164420555|NCT02718417|593910945|FG002|Follow-up Phase|Other|4|||
164420556|NCT02718417|593910943|FG000|Follow-up Phase|Withdrawal by Subject|19|||
164420557|NCT02718417|593910944|FG001|Follow-up Phase|Withdrawal by Subject|17|||
164420558|NCT02718417|593910945|FG002|Follow-up Phase|Withdrawal by Subject|5|||
164420559|NCT02718417|593910943|FG000|Follow-up Phase|Study terminated by sponsor|100|||
164420560|NCT02718417|593910944|FG001|Follow-up Phase|Study terminated by sponsor|138|||
164420561|NCT02718417|593910945|FG002|Follow-up Phase|Study terminated by sponsor|6|||
164420562|NCT02718417|593910943|FG000|Follow-up Phase|Lost to Follow-up|2|||
164420563|NCT02718417|593910944|FG001|Follow-up Phase|Lost to Follow-up|3|||
164420564|NCT02718417|593910945|FG002|Follow-up Phase|Lost to Follow-up|0|||
164420565|NCT02718417|593910943|FG000|Follow-up Phase|Death leading to discontinuation|7|||
164420566|NCT02718417|593910944|FG001|Follow-up Phase|Death leading to discontinuation|7|||
164420567|NCT02718417|593910945|FG002|Follow-up Phase|Death leading to discontinuation|3|||
164420568|NCT02718417|593910943|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
164420569|NCT02718417|593910944|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
164420570|NCT02718417|593910945|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
164420571|NCT02718417|593910943|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
164420572|NCT02718417|593910944|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
164420573|NCT02718417|593910945|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
164538250|NCT03434353|594344811|FG004|Overall Study|Withdrew consent|0|||
164538251|NCT03434353|594344807|FG000|Overall Study|Adverse Event|1|||
164538252|NCT03434353|594344808|FG001|Overall Study|Adverse Event|0|||
164651100|NCT03033069|594749375|FG002|Overall Study|Protocol Deviation|0|||
164538253|NCT03434353|594344809|FG002|Overall Study|Adverse Event|0|||
164538254|NCT03434353|594344810|FG003|Overall Study|Adverse Event|0|||
164538255|NCT03434353|594344811|FG004|Overall Study|Adverse Event|1|||
164538256|NCT03434353|594344807|FG000|Overall Study|Lost to Follow-up|2|||
164538257|NCT03434353|594344808|FG001|Overall Study|Lost to Follow-up|0|||
164538258|NCT03434353|594344809|FG002|Overall Study|Lost to Follow-up|0|||
164538259|NCT03434353|594344810|FG003|Overall Study|Lost to Follow-up|0|||
164538260|NCT03434353|594344811|FG004|Overall Study|Lost to Follow-up|0|||
164538261|NCT03503513|594344816|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
164538262|NCT03503513|594344816|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
164538263|NCT03503513|594344816|FG000|Overall Study|Physician Decision|3|||
164651101|NCT03033069|594749376|FG003|Overall Study|Protocol Deviation|0|||
164651102|NCT03033069|594749373|FG000|Overall Study|Withdrawal by Subject|10|||
164651103|NCT03033069|594749374|FG001|Overall Study|Withdrawal by Subject|10|||
164651104|NCT03033069|594749375|FG002|Overall Study|Withdrawal by Subject|11|||
164651105|NCT03033069|594749376|FG003|Overall Study|Withdrawal by Subject|6|||
164651106|NCT03033069|594749373|FG000|Overall Study|Withdrawal By Caregiver|1|||
164651107|NCT03033069|594749374|FG001|Overall Study|Withdrawal By Caregiver|0|||
164651108|NCT03033069|594749375|FG002|Overall Study|Withdrawal By Caregiver|0|||
164651109|NCT03033069|594749376|FG003|Overall Study|Withdrawal By Caregiver|0|||
164651110|NCT03033069|594749373|FG000|Overall Study|Reason not Specified|0|||
164651111|NCT03033069|594749374|FG001|Overall Study|Reason not Specified|1|||
164651112|NCT03033069|594749375|FG002|Overall Study|Reason not Specified|0|||
164651113|NCT03033069|594749376|FG003|Overall Study|Reason not Specified|1|||
164651114|NCT00430638|594749377|FG000|Overall Study|Adverse Event|15|||
164651115|NCT00430638|594749378|FG001|Overall Study|Adverse Event|15|||
164651116|NCT00430638|594749377|FG000|Overall Study|Uncontrolled blood pressure|48|||
164651117|NCT00430638|594749378|FG001|Overall Study|Uncontrolled blood pressure|13|||
164651118|NCT00430638|594749377|FG000|Overall Study|Lost to Follow-up|1|||
164651119|NCT00430638|594749378|FG001|Overall Study|Lost to Follow-up|7|||
164651120|NCT00430638|594749377|FG000|Overall Study|Protocol Violation|6|||
164651121|NCT00430638|594749378|FG001|Overall Study|Protocol Violation|4|||
164651122|NCT00430638|594749377|FG000|Overall Study|Withdrawal by Subject|4|||
164651123|NCT00430638|594749378|FG001|Overall Study|Withdrawal by Subject|6|||
164651124|NCT00430638|594749377|FG000|Overall Study|Non-compliant|2|||
164651125|NCT00430638|594749378|FG001|Overall Study|Non-compliant|1|||
164651126|NCT00430638|594749377|FG000|Overall Study|Other|2|||
164651127|NCT00430638|594749378|FG001|Overall Study|Other|2|||
164651128|NCT01529749|594749379|FG000|Overall Study|Lost to Follow-up|0|||
164651129|NCT01529749|594749380|FG001|Overall Study|Lost to Follow-up|1|||
164651130|NCT01529749|594749381|FG002|Overall Study|Lost to Follow-up|1|||
164651131|NCT01529749|594749382|FG003|Overall Study|Lost to Follow-up|0|||
164651132|NCT01529749|594749379|FG000|Overall Study|Physician Decision|0|||
164651133|NCT01529749|594749380|FG001|Overall Study|Physician Decision|0|||
164651134|NCT01529749|594749381|FG002|Overall Study|Physician Decision|0|||
164651135|NCT01529749|594749382|FG003|Overall Study|Physician Decision|1|||
164651136|NCT01529749|594749379|FG000|Overall Study|Withdrawal by Subject|0|||
164651137|NCT01529749|594749380|FG001|Overall Study|Withdrawal by Subject|1|||
164651138|NCT01529749|594749381|FG002|Overall Study|Withdrawal by Subject|1|||
164651139|NCT01529749|594749382|FG003|Overall Study|Withdrawal by Subject|0|||
164651140|NCT01529749|594749379|FG000|Overall Study|Protocol Violation|0|||
164651141|NCT01529749|594749380|FG001|Overall Study|Protocol Violation|0|||
164651142|NCT01529749|594749381|FG002|Overall Study|Protocol Violation|0|||
164651143|NCT01529749|594749382|FG003|Overall Study|Protocol Violation|1|||
164651144|NCT00789828|594749383|FG000|Core Period (48 Weeks)|Administrative problems|0|||
164651145|NCT00789828|594749384|FG001|Core Period (48 Weeks)|Administrative problems|1|||
164651146|NCT00789828|594749383|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
164651147|NCT00789828|594749384|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
164651148|NCT00789828|594749383|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
164651149|NCT00789828|594749384|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
164651150|NCT00789828|594749383|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
164651151|NCT00789828|594749384|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
164651152|NCT00789828|594749383|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
164651153|NCT00789828|594749384|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
164651154|NCT00789828|594749383|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
164651155|NCT00789828|594749384|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
164651156|NCT00789828|594749383|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
164651157|NCT00789828|594749384|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
164651158|NCT00789828|594749383|FG000|Open-label Extension Period (4 Years)|Death|1|||
164651159|NCT00789828|594749384|FG001|Open-label Extension Period (4 Years)|Death|0|||
164651160|NCT00789828|594749383|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
164651161|NCT00789828|594749384|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
164538264|NCT03503513|594344816|FG000|Overall Study|Withdrawal by Subject|2|||
164651162|NCT00789828|594749383|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
164651163|NCT00789828|594749384|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
164651164|NCT02623426|594749385|FG000|Overall Study|Lost to Follow-up|0|||
164651165|NCT02623426|594749386|FG001|Overall Study|Lost to Follow-up|0|||
164651166|NCT02623426|594749387|FG002|Overall Study|Lost to Follow-up|1|||
164651167|NCT02623426|594749385|FG000|Overall Study|Withdrawal by Subject|1|||
164651168|NCT02623426|594749386|FG001|Overall Study|Withdrawal by Subject|2|||
164651169|NCT02623426|594749387|FG002|Overall Study|Withdrawal by Subject|2|||
164651170|NCT02094937|594749388|FG000|8 Weeks in Period 1|Adverse Event|9|||
164651171|NCT02094937|594749389|FG001|8 Weeks in Period 1|Adverse Event|0|||
164651172|NCT02094937|594749390|FG002|8 Weeks in Period 1|Adverse Event|0|||
164651173|NCT02094937|594749391|FG003|8 Weeks in Period 1|Adverse Event|0|||
164651174|NCT02094937|594749388|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
164651175|NCT02094937|594749389|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
164651176|NCT02094937|594749390|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
164651177|NCT02094937|594749391|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
164651178|NCT02094937|594749388|FG000|8 Weeks in Period 1|Protocol Violation|2|||
164651179|NCT02094937|594749389|FG001|8 Weeks in Period 1|Protocol Violation|0|||
164651180|NCT02094937|594749390|FG002|8 Weeks in Period 1|Protocol Violation|0|||
164651181|NCT02094937|594749391|FG003|8 Weeks in Period 1|Protocol Violation|0|||
164651182|NCT02094937|594749388|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
164651183|NCT02094937|594749389|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
164651184|NCT02094937|594749390|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
164651185|NCT02094937|594749391|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
164651186|NCT02094937|594749388|FG000|8 Weeks in Period 1|Physician Decision|1|||
164651187|NCT02094937|594749389|FG001|8 Weeks in Period 1|Physician Decision|0|||
164651188|NCT02094937|594749390|FG002|8 Weeks in Period 1|Physician Decision|0|||
164651189|NCT02094937|594749391|FG003|8 Weeks in Period 1|Physician Decision|0|||
164651190|NCT02094937|594749388|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
164651191|NCT02094937|594749389|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
164651192|NCT02094937|594749390|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
164651193|NCT02094937|594749391|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
164651194|NCT02094937|594749388|FG000|12 Weeks in Period 2|Adverse Event|0|||
164651195|NCT02094937|594749389|FG001|12 Weeks in Period 2|Adverse Event|2|||
164651196|NCT02094937|594749390|FG002|12 Weeks in Period 2|Adverse Event|4|||
164651197|NCT02094937|594749391|FG003|12 Weeks in Period 2|Adverse Event|1|||
164651198|NCT02094937|594749388|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
164651199|NCT02094937|594749389|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
164651200|NCT02094937|594749390|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
164651201|NCT02094937|594749391|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
164651202|NCT02094937|594749388|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
164651203|NCT02094937|594749389|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
164651204|NCT02094937|594749390|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
164651205|NCT02094937|594749391|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
164651206|NCT02094937|594749388|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
164651207|NCT02094937|594749389|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
164651208|NCT02094937|594749390|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
164651209|NCT02094937|594749391|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
164651210|NCT02094937|594749388|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
164651211|NCT02094937|594749389|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
164651212|NCT02094937|594749390|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
164651213|NCT02094937|594749391|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
164651214|NCT05458895|594749392|FG000|Overall Study|Withdrawal by Subject|8|||
164651215|NCT05458895|594749392|FG000|Overall Study|Lost to Follow-up|17|||
164651216|NCT05458895|594749392|FG000|Overall Study|Pregnancy|2|||
164651217|NCT05458895|594749392|FG000|Overall Study|Withdrawal by Study Team|1|||
164651218|NCT04639310|594749393|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
164651219|NCT04639310|594749394|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
164651220|NCT05166421|594749395|FG000|Overall Study|Other|3|||
164651221|NCT05166421|594749396|FG001|Overall Study|Other|1|||
164651222|NCT05166421|594749397|FG002|Overall Study|Other|1|||
164651223|NCT05166421|594749395|FG000|Overall Study|Withdrawal by Subject|5|||
164651224|NCT05166421|594749396|FG001|Overall Study|Withdrawal by Subject|3|||
164651225|NCT05166421|594749397|FG002|Overall Study|Withdrawal by Subject|6|||
164651226|NCT05166421|594749395|FG000|Overall Study|Lost to Follow-up|4|||
164651227|NCT05166421|594749396|FG001|Overall Study|Lost to Follow-up|1|||
164651228|NCT05166421|594749397|FG002|Overall Study|Lost to Follow-up|7|||
164651229|NCT03770000|594751478|FG000|Overall Study|Premature discontinuation due to PD|0|||
164651230|NCT03770000|594751479|FG001|Overall Study|Premature discontinuation due to PD|0|||
164651231|NCT03770000|594751480|FG002|Overall Study|Premature discontinuation due to PD|1|||
164651232|NCT03770000|594751481|FG003|Overall Study|Premature discontinuation due to PD|3|||
164651233|NCT03770000|594751482|FG004|Overall Study|Premature discontinuation due to PD|2|||
164651234|NCT02290028|594751484|FG000|Overall Study|Death|217|||
164651235|NCT02290028|594751484|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
164651236|NCT02290028|594751484|FG000|Overall Study|No longer under care of study physician|76|||
164651237|NCT02290028|594751484|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
164651238|NCT02290028|594751484|FG000|Overall Study|Withdrawal by Subject|52|||
164651239|NCT02290028|594751484|FG000|Overall Study|Study site closure|44|||
164651240|NCT02290028|594751484|FG000|Overall Study|Lost to Follow-up|34|||
164651241|NCT02290028|594751484|FG000|Overall Study|Miscellaneous|10|||
164651242|NCT02290028|594751484|FG000|Overall Study|Transition to EP PASSION|1295|||
164651243|NCT02290028|594751484|FG000|Overall Study|Planned study completion at 12 months|257|||
164651244|NCT00833547|594751485|FG000|Overall Study|Withdrawal by Subject|2|||
164651245|NCT00833547|594751486|FG001|Overall Study|Withdrawal by Subject|2|||
164651246|NCT00566098|594751488|FG000|Collection of MILs|Withdrawal by Subject|1|||
164651247|NCT00566098|594751488|FG000|Collection of MILs|Relapsed|1|||
164651248|NCT00566098|594751488|FG000|Generation of MILs Product|Relapsed|1|||
164651249|NCT00566098|594751488|FG000|Administration of ASCT+MILs|Death|10|||
164651250|NCT00566098|594751488|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
164651251|NCT02236754|594751489|FG000|Overall Study|Withdrawal by Subject|1|||
164651252|NCT02236754|594751490|FG001|Overall Study|Withdrawal by Subject|0|||
164651253|NCT01326702|594751491|FG000|Overall Study|Other|1|||
164651254|NCT01326702|594751492|FG001|Overall Study|Other|0|||
164651255|NCT01326702|594751493|FG002|Overall Study|Other|0|||
164651256|NCT01326702|594751494|FG003|Overall Study|Other|0|||
164651257|NCT01326702|594751495|FG004|Overall Study|Other|0|||
164651258|NCT01326702|594751496|FG005|Overall Study|Other|1|||
164651259|NCT01326702|594751497|FG006|Overall Study|Other|0|||
164651260|NCT01326702|594751491|FG000|Overall Study|progressive disease|1|||
164651261|NCT01326702|594751492|FG001|Overall Study|progressive disease|1|||
164651262|NCT01326702|594751493|FG002|Overall Study|progressive disease|3|||
164651263|NCT01326702|594751494|FG003|Overall Study|progressive disease|1|||
164651264|NCT01326702|594751495|FG004|Overall Study|progressive disease|3|||
164651265|NCT01326702|594751496|FG005|Overall Study|progressive disease|2|||
164651266|NCT01326702|594751497|FG006|Overall Study|progressive disease|3|||
164651267|NCT01326702|594751491|FG000|Overall Study|Death|0|||
164651268|NCT01326702|594751492|FG001|Overall Study|Death|1|||
164651269|NCT01326702|594751493|FG002|Overall Study|Death|0|||
164651270|NCT01326702|594751494|FG003|Overall Study|Death|0|||
164651271|NCT01326702|594751495|FG004|Overall Study|Death|0|||
164651272|NCT01326702|594751496|FG005|Overall Study|Death|0|||
164651273|NCT01326702|594751497|FG006|Overall Study|Death|0|||
164651274|NCT01326702|594751491|FG000|Overall Study|Adverse Event|0|||
164651275|NCT01326702|594751492|FG001|Overall Study|Adverse Event|0|||
164651276|NCT01326702|594751493|FG002|Overall Study|Adverse Event|1|||
164651277|NCT01326702|594751494|FG003|Overall Study|Adverse Event|1|||
164651278|NCT01326702|594751495|FG004|Overall Study|Adverse Event|0|||
164651279|NCT01326702|594751496|FG005|Overall Study|Adverse Event|3|||
164651280|NCT01326702|594751497|FG006|Overall Study|Adverse Event|1|||
164651281|NCT01326702|594751491|FG000|Overall Study|Withdrawal by Subject|0|||
164651282|NCT01326702|594751492|FG001|Overall Study|Withdrawal by Subject|0|||
164651283|NCT01326702|594751493|FG002|Overall Study|Withdrawal by Subject|1|||
164538265|NCT03503513|594344816|FG000|Overall Study|Lost to Follow-up|1|||
164538266|NCT03739762|594344817|FG000|Overall Study|Lost to Follow-up|1|||
164538267|NCT03739762|594344818|FG001|Overall Study|Lost to Follow-up|1|||
164538268|NCT03739762|594344817|FG000|Overall Study|Withdrawal by Subject|2|||
164538269|NCT03739762|594344818|FG001|Overall Study|Withdrawal by Subject|6|||
164538270|NCT00929656|594344819|FG000|Overall Study|Lost to Follow-up|0|||
164538271|NCT00929656|594344820|FG001|Overall Study|Lost to Follow-up|1|||
164538272|NCT00607880|594344821|FG000|Overall Study|Unable to place port due to occlusion|1|||
164538273|NCT00607880|594344822|FG001|Overall Study|Unable to place port due to occlusion|0|||
164538274|NCT03308942|594344823|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
164538275|NCT03308942|594344824|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
164538276|NCT03308942|594344825|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
164538277|NCT03308942|594344826|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
164538278|NCT03308942|594344827|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
164538279|NCT03308942|594344823|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
164538280|NCT03308942|594344824|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
164538281|NCT03308942|594344825|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
164538282|NCT03308942|594344826|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
164538283|NCT03308942|594344827|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
164538284|NCT03308942|594344823|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
164538285|NCT03308942|594344824|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
164538286|NCT03308942|594344825|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
164538287|NCT03308942|594344826|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
164538288|NCT03308942|594344827|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
164651284|NCT01326702|594751494|FG003|Overall Study|Withdrawal by Subject|0|||
164651285|NCT01326702|594751495|FG004|Overall Study|Withdrawal by Subject|1|||
164538289|NCT03308942|594344823|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
164538290|NCT03308942|594344824|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
164538291|NCT03308942|594344825|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
164538292|NCT03308942|594344826|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
164538293|NCT03308942|594344827|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
164538294|NCT03308942|594344823|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
164538295|NCT03308942|594344824|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
164538296|NCT03308942|594344825|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
164538297|NCT03308942|594344826|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
164538298|NCT03308942|594344827|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
164538299|NCT03308942|594344823|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
164538300|NCT03308942|594344824|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
164538301|NCT03308942|594344825|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
164538302|NCT03308942|594344826|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
164538303|NCT03308942|594344827|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
164538304|NCT03308942|594344823|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
164538305|NCT03308942|594344824|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
164538306|NCT03308942|594344825|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
164589074|NCT01070550|594521374|FG002|Overall Study|Early termination|0|||
164589075|NCT01070550|594521375|FG003|Overall Study|Early termination|0|||
164589076|NCT01070550|594521376|FG004|Overall Study|Early termination|0|||
164589077|NCT01070550|594521377|FG005|Overall Study|Early termination|0|||
164589078|NCT01070550|594521372|FG000|Overall Study|Failed to return|450|||
164589079|NCT01070550|594521373|FG001|Overall Study|Failed to return|33|||
164589080|NCT01070550|594521374|FG002|Overall Study|Failed to return|144|||
164589081|NCT01070550|594521375|FG003|Overall Study|Failed to return|40|||
164589082|NCT01070550|594521376|FG004|Overall Study|Failed to return|1|||
164589083|NCT01070550|594521377|FG005|Overall Study|Failed to return|2|||
164589084|NCT01070550|594521372|FG000|Overall Study|Incomplete treatment|2|||
164589085|NCT01070550|594521373|FG001|Overall Study|Incomplete treatment|0|||
164589086|NCT01070550|594521374|FG002|Overall Study|Incomplete treatment|0|||
164589087|NCT01070550|594521375|FG003|Overall Study|Incomplete treatment|0|||
164589088|NCT01070550|594521376|FG004|Overall Study|Incomplete treatment|0|||
164589089|NCT01070550|594521377|FG005|Overall Study|Incomplete treatment|0|||
164589090|NCT01070550|594521372|FG000|Overall Study|Lab test not done|22|||
164589091|NCT01070550|594521373|FG001|Overall Study|Lab test not done|3|||
164589092|NCT01070550|594521374|FG002|Overall Study|Lab test not done|4|||
164589093|NCT01070550|594521375|FG003|Overall Study|Lab test not done|1|||
164589094|NCT01070550|594521376|FG004|Overall Study|Lab test not done|0|||
164589095|NCT01070550|594521377|FG005|Overall Study|Lab test not done|1|||
164589096|NCT01070550|594521372|FG000|Overall Study|Lack of Efficacy|65|||
164589097|NCT01070550|594521373|FG001|Overall Study|Lack of Efficacy|1|||
164589098|NCT01070550|594521374|FG002|Overall Study|Lack of Efficacy|5|||
164589099|NCT01070550|594521375|FG003|Overall Study|Lack of Efficacy|5|||
164589100|NCT01070550|594521376|FG004|Overall Study|Lack of Efficacy|0|||
164589101|NCT01070550|594521377|FG005|Overall Study|Lack of Efficacy|1|||
164589102|NCT01070550|594521372|FG000|Overall Study|Miscellaneous|12|||
164589103|NCT01070550|594521373|FG001|Overall Study|Miscellaneous|2|||
164589104|NCT01070550|594521374|FG002|Overall Study|Miscellaneous|3|||
164589105|NCT01070550|594521375|FG003|Overall Study|Miscellaneous|1|||
164589106|NCT01070550|594521376|FG004|Overall Study|Miscellaneous|0|||
164589107|NCT01070550|594521377|FG005|Overall Study|Miscellaneous|0|||
164589108|NCT01070550|594521372|FG000|Overall Study|New treatment started|3|||
164589109|NCT01070550|594521373|FG001|Overall Study|New treatment started|1|||
164589110|NCT01070550|594521374|FG002|Overall Study|New treatment started|0|||
164589111|NCT01070550|594521375|FG003|Overall Study|New treatment started|2|||
164589112|NCT01070550|594521376|FG004|Overall Study|New treatment started|0|||
164589113|NCT01070550|594521377|FG005|Overall Study|New treatment started|0|||
164589114|NCT01070550|594521372|FG000|Overall Study|Non-responders|493|||
164589115|NCT01070550|594521373|FG001|Overall Study|Non-responders|4|||
164589116|NCT01070550|594521374|FG002|Overall Study|Non-responders|21|||
164589117|NCT01070550|594521375|FG003|Overall Study|Non-responders|20|||
164589118|NCT01070550|594521376|FG004|Overall Study|Non-responders|0|||
164589119|NCT01070550|594521377|FG005|Overall Study|Non-responders|2|||
164589120|NCT01070550|594521372|FG000|Overall Study|Not categorized|33|||
164589121|NCT01070550|594521373|FG001|Overall Study|Not categorized|2|||
164589122|NCT01070550|594521374|FG002|Overall Study|Not categorized|6|||
164589123|NCT01070550|594521375|FG003|Overall Study|Not categorized|1|||
164589124|NCT01070550|594521376|FG004|Overall Study|Not categorized|0|||
164589125|NCT01070550|594521377|FG005|Overall Study|Not categorized|1|||
164589126|NCT01070550|594521372|FG000|Overall Study|Protocol Violation|15|||
164589127|NCT01070550|594521373|FG001|Overall Study|Protocol Violation|1|||
164589128|NCT01070550|594521374|FG002|Overall Study|Protocol Violation|1|||
164589129|NCT01070550|594521375|FG003|Overall Study|Protocol Violation|1|||
164651286|NCT01326702|594751496|FG005|Overall Study|Withdrawal by Subject|1|||
164651287|NCT01326702|594751497|FG006|Overall Study|Withdrawal by Subject|3|||
164651288|NCT01326702|594751491|FG000|Overall Study|Not Treated|0|||
164651289|NCT01326702|594751492|FG001|Overall Study|Not Treated|0|||
164651290|NCT01326702|594751493|FG002|Overall Study|Not Treated|0|||
164651291|NCT01326702|594751494|FG003|Overall Study|Not Treated|1|||
164651292|NCT01326702|594751495|FG004|Overall Study|Not Treated|0|||
164651293|NCT01326702|594751496|FG005|Overall Study|Not Treated|1|||
164651294|NCT01326702|594751497|FG006|Overall Study|Not Treated|0|||
164651295|NCT02270983|594751498|FG000|Overall Study|Adverse Event|3|||
164651296|NCT02270983|594751499|FG001|Overall Study|Adverse Event|2|||
164538307|NCT03308942|594344826|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
164651297|NCT02270983|594751500|FG002|Overall Study|Adverse Event|6|||
164651298|NCT02270983|594751498|FG000|Overall Study|Lack of Efficacy|2|||
164651299|NCT02270983|594751499|FG001|Overall Study|Lack of Efficacy|1|||
164651300|NCT02270983|594751500|FG002|Overall Study|Lack of Efficacy|1|||
164651301|NCT02270983|594751498|FG000|Overall Study|Withdrawal by Subject|1|||
164651302|NCT02270983|594751499|FG001|Overall Study|Withdrawal by Subject|0|||
164651303|NCT02270983|594751500|FG002|Overall Study|Withdrawal by Subject|2|||
164651304|NCT02270983|594751498|FG000|Overall Study|Lost to Follow-up|1|||
164651305|NCT02270983|594751499|FG001|Overall Study|Lost to Follow-up|1|||
164651306|NCT02270983|594751500|FG002|Overall Study|Lost to Follow-up|2|||
164651307|NCT02270983|594751498|FG000|Overall Study|Protocol Violation|1|||
164651308|NCT02270983|594751499|FG001|Overall Study|Protocol Violation|1|||
164651309|NCT02270983|594751500|FG002|Overall Study|Protocol Violation|1|||
164651310|NCT02270983|594751498|FG000|Overall Study|family emergency|0|||
164651311|NCT02270983|594751499|FG001|Overall Study|family emergency|1|||
164651312|NCT02270983|594751500|FG002|Overall Study|family emergency|0|||
164651313|NCT02270983|594751498|FG000|Overall Study|study procedure non-compliance|1|||
164651314|NCT02270983|594751499|FG001|Overall Study|study procedure non-compliance|0|||
164651315|NCT02270983|594751500|FG002|Overall Study|study procedure non-compliance|0|||
164651316|NCT02270983|594751498|FG000|Overall Study|moved away from study site|0|||
164651317|NCT02270983|594751499|FG001|Overall Study|moved away from study site|1|||
164651318|NCT02270983|594751500|FG002|Overall Study|moved away from study site|0|||
164651319|NCT02919475|594751501|FG000|Overall Study|Adverse Event|3|||
164651320|NCT02919475|594751502|FG001|Overall Study|Adverse Event|3|||
164651321|NCT02919475|594751503|FG002|Overall Study|Adverse Event|3|||
164651322|NCT02919475|594751504|FG003|Overall Study|Adverse Event|9|||
164651323|NCT02919475|594751505|FG004|Overall Study|Adverse Event|2|||
164651324|NCT02919475|594751501|FG000|Overall Study|Death|0|||
164651325|NCT02919475|594751502|FG001|Overall Study|Death|1|||
164651326|NCT02919475|594751503|FG002|Overall Study|Death|0|||
164651327|NCT02919475|594751504|FG003|Overall Study|Death|0|||
164651328|NCT02919475|594751505|FG004|Overall Study|Death|0|||
164651329|NCT02919475|594751501|FG000|Overall Study|Lost to Follow-up|0|||
164651330|NCT02919475|594751502|FG001|Overall Study|Lost to Follow-up|0|||
164651331|NCT02919475|594751503|FG002|Overall Study|Lost to Follow-up|0|||
164651332|NCT02919475|594751504|FG003|Overall Study|Lost to Follow-up|1|||
164651333|NCT02919475|594751505|FG004|Overall Study|Lost to Follow-up|0|||
164651334|NCT02919475|594751501|FG000|Overall Study|Withdrawal by Subject|2|||
164651335|NCT02919475|594751502|FG001|Overall Study|Withdrawal by Subject|3|||
164651336|NCT02919475|594751503|FG002|Overall Study|Withdrawal by Subject|1|||
164651337|NCT02919475|594751504|FG003|Overall Study|Withdrawal by Subject|2|||
164651338|NCT02919475|594751505|FG004|Overall Study|Withdrawal by Subject|2|||
164651339|NCT02919475|594751501|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
164651340|NCT02919475|594751502|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
164651341|NCT02919475|594751503|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
164538308|NCT03308942|594344827|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
164538309|NCT01524133|594344833|FG000|Treatment Phase|Withdrawal by Subject|13|||
164538310|NCT01524133|594344834|FG001|Treatment Phase|Withdrawal by Subject|28|||
164538311|NCT01524133|594344835|FG002|Treatment Phase|Withdrawal by Subject|31|||
164651342|NCT02919475|594751504|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
164651343|NCT02919475|594751505|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
164651344|NCT00275028|594751506|FG000|Overall Study|Withdrew consent before treatment began|1|||
164651345|NCT00275028|594751506|FG000|Overall Study|Withdrawal by Subject|5|||
164651346|NCT00275028|594751506|FG000|Overall Study|Adverse Event|9|||
164651347|NCT00275028|594751506|FG000|Overall Study|Progressive Disease|30|||
164651348|NCT00275028|594751506|FG000|Overall Study|Physician Decision|2|||
164651349|NCT02323295|594751511|FG000|Overall Study|Adverse Event|0|||
164538312|NCT01524133|594344833|FG000|Treatment Phase|Physician Decision|6|||
164538313|NCT01524133|594344834|FG001|Treatment Phase|Physician Decision|3|||
164651350|NCT02323295|594751512|FG001|Overall Study|Adverse Event|1|||
164651351|NCT02323295|594751511|FG000|Overall Study|Withdrawal by Subject|0|||
164651352|NCT02323295|594751512|FG001|Overall Study|Withdrawal by Subject|1|||
164651353|NCT02323295|594751511|FG000|Overall Study|Patient did not have surgery as planned.|0|||
164651354|NCT02323295|594751512|FG001|Overall Study|Patient did not have surgery as planned.|1|||
164538314|NCT01524133|594344835|FG002|Treatment Phase|Physician Decision|3|||
164651355|NCT00830063|594751513|FG000|Overall Study|Adverse Event|7|||
164651356|NCT00830063|594751514|FG001|Overall Study|Adverse Event|13|||
164651357|NCT00830063|594751515|FG002|Overall Study|Adverse Event|16|||
164651358|NCT00830063|594751516|FG003|Overall Study|Adverse Event|13|||
164651359|NCT00830063|594751513|FG000|Overall Study|Death|1|||
164651360|NCT00830063|594751514|FG001|Overall Study|Death|0|||
164651361|NCT00830063|594751515|FG002|Overall Study|Death|0|||
164651362|NCT00830063|594751516|FG003|Overall Study|Death|0|||
164651363|NCT00830063|594751513|FG000|Overall Study|Lost to Follow-up|0|||
164651364|NCT00830063|594751514|FG001|Overall Study|Lost to Follow-up|0|||
164651365|NCT00830063|594751515|FG002|Overall Study|Lost to Follow-up|3|||
164651366|NCT00830063|594751516|FG003|Overall Study|Lost to Follow-up|1|||
164651367|NCT00830063|594751513|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
164651368|NCT00830063|594751514|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
164651369|NCT00830063|594751515|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
164651370|NCT00830063|594751516|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
164651371|NCT00830063|594751513|FG000|Overall Study|Lack of Efficacy|51|||
164651372|NCT00830063|594751514|FG001|Overall Study|Lack of Efficacy|23|||
164651373|NCT00830063|594751515|FG002|Overall Study|Lack of Efficacy|25|||
164651374|NCT00830063|594751516|FG003|Overall Study|Lack of Efficacy|32|||
164651375|NCT00830063|594751513|FG000|Overall Study|Other|5|||
164651376|NCT00830063|594751514|FG001|Overall Study|Other|5|||
164651377|NCT00830063|594751515|FG002|Overall Study|Other|8|||
164651378|NCT00830063|594751516|FG003|Overall Study|Other|6|||
164651379|NCT00830063|594751513|FG000|Overall Study|Withdrawal by Subject|16|||
164651380|NCT00830063|594751514|FG001|Overall Study|Withdrawal by Subject|10|||
164651381|NCT00830063|594751515|FG002|Overall Study|Withdrawal by Subject|16|||
164651382|NCT00830063|594751516|FG003|Overall Study|Withdrawal by Subject|13|||
164651383|NCT00830063|594751513|FG000|Overall Study|Protocol Violation|1|||
164651384|NCT00830063|594751514|FG001|Overall Study|Protocol Violation|0|||
164651385|NCT00830063|594751515|FG002|Overall Study|Protocol Violation|3|||
164651386|NCT00830063|594751516|FG003|Overall Study|Protocol Violation|2|||
164651387|NCT00830063|594751513|FG000|Overall Study|Randomized But Not Treated|0|||
164651388|NCT00830063|594751514|FG001|Overall Study|Randomized But Not Treated|2|||
164651389|NCT00830063|594751515|FG002|Overall Study|Randomized But Not Treated|0|||
164651390|NCT00830063|594751516|FG003|Overall Study|Randomized But Not Treated|2|||
164651391|NCT01847313|594751519|FG000|Overall Study|Death|0|||
164651392|NCT01847313|594751520|FG001|Overall Study|Death|1|||
164651393|NCT01847313|594751519|FG000|Overall Study|Withdrawal by Subject|0|||
164651394|NCT01847313|594751520|FG001|Overall Study|Withdrawal by Subject|1|||
164651395|NCT02370784|594751521|FG000|Overall Study|Patient started prohibited medication|0|||
164651396|NCT02370784|594751522|FG001|Overall Study|Patient started prohibited medication|1|||
164651397|NCT00598559|594751523|FG000|Overall Study|Adverse Event|11|||
164651398|NCT00598559|594751524|FG001|Overall Study|Adverse Event|7|||
164651399|NCT00598559|594751525|FG002|Overall Study|Adverse Event|0|||
164651400|NCT00598559|594751523|FG000|Overall Study|Withdrawal by Subject|2|||
164651401|NCT00598559|594751524|FG001|Overall Study|Withdrawal by Subject|2|||
164651402|NCT00598559|594751525|FG002|Overall Study|Withdrawal by Subject|0|||
164651403|NCT00598559|594751523|FG000|Overall Study|Protocol Non-compliance|1|||
164651404|NCT00598559|594751524|FG001|Overall Study|Protocol Non-compliance|0|||
164651405|NCT00598559|594751525|FG002|Overall Study|Protocol Non-compliance|0|||
164651406|NCT00598559|594751523|FG000|Overall Study|Early discharge from hospital|9|||
164651407|NCT00598559|594751524|FG001|Overall Study|Early discharge from hospital|12|||
164651408|NCT00598559|594751525|FG002|Overall Study|Early discharge from hospital|3|||
164651409|NCT00598559|594751523|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
164651410|NCT00598559|594751524|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
164651411|NCT00598559|594751525|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
164651412|NCT03763331|594751528|FG000|Overall Study|Lost to Follow-up|1|||
164651413|NCT03763331|594751529|FG001|Overall Study|Lost to Follow-up|0|||
164651414|NCT03763331|594751528|FG000|Overall Study|Withdrawal by Subject|1|||
164651415|NCT03763331|594751529|FG001|Overall Study|Withdrawal by Subject|0|||
164651416|NCT03763331|594751528|FG000|Overall Study|Non-compliance|0|||
164651417|NCT03763331|594751529|FG001|Overall Study|Non-compliance|3|||
164651418|NCT01155063|594751530|FG000|Overall Study|Adverse Event|1|||
164651419|NCT01155063|594751530|FG000|Overall Study|Withdrawal by Subject|1|||
164651420|NCT01155063|594751530|FG000|Overall Study|Study terminated by sponsor|87|||
164651421|NCT00936884|594751531|FG000|Double-blind|Withdrawal by Subject|6|||
164651422|NCT00936884|594751532|FG001|Double-blind|Withdrawal by Subject|4|||
164651423|NCT00936884|594751533|FG002|Double-blind|Withdrawal by Subject|0|||
164651424|NCT00936884|594751531|FG000|Double-blind|Death|2|||
164651425|NCT00936884|594751532|FG001|Double-blind|Death|1|||
164651426|NCT00936884|594751533|FG002|Double-blind|Death|0|||
164651427|NCT00936884|594751531|FG000|Double-blind|Lack of Efficacy|1|||
164651428|NCT00936884|594751532|FG001|Double-blind|Lack of Efficacy|1|||
164651429|NCT00936884|594751533|FG002|Double-blind|Lack of Efficacy|0|||
164651430|NCT00936884|594751531|FG000|Double-blind|Adverse Event|1|||
164651431|NCT00936884|594751532|FG001|Double-blind|Adverse Event|0|||
164651432|NCT00936884|594751533|FG002|Double-blind|Adverse Event|0|||
164651433|NCT00936884|594751531|FG000|Double-blind|Physician Decision|1|||
164651434|NCT00936884|594751532|FG001|Double-blind|Physician Decision|0|||
164651435|NCT00936884|594751533|FG002|Double-blind|Physician Decision|0|||
164651436|NCT00936884|594751531|FG000|Double-blind|No post baseline diary entry|1|||
164651437|NCT00936884|594751532|FG001|Double-blind|No post baseline diary entry|0|||
164651438|NCT00936884|594751533|FG002|Double-blind|No post baseline diary entry|0|||
164651439|NCT00936884|594751531|FG000|Double-blind|Did not receive study drug|0|||
164651440|NCT00936884|594751532|FG001|Double-blind|Did not receive study drug|1|||
164651441|NCT00936884|594751533|FG002|Double-blind|Did not receive study drug|0|||
164651442|NCT01663714|594751534|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
164651443|NCT01663714|594751534|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
164651444|NCT01663714|594751534|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
164651445|NCT01663714|594751534|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
164651446|NCT01663714|594751534|FG000|Long-Term Follow-Up|Death|4|||
164651447|NCT01663714|594751534|FG000|Long-Term Follow-Up|Non-compliance|1|||
164651448|NCT00597584|594751535|FG000|Overall Study|Adverse Event|4|||
164651449|NCT00597584|594751536|FG001|Overall Study|Adverse Event|2|||
164651450|NCT00597584|594751535|FG000|Overall Study|Death|53|||
164651451|NCT00597584|594751536|FG001|Overall Study|Death|30|||
164651452|NCT00597584|594751535|FG000|Overall Study|Lack of Efficacy|1|||
164651453|NCT00597584|594751536|FG001|Overall Study|Lack of Efficacy|0|||
164651454|NCT00597584|594751535|FG000|Overall Study|Lost to Follow-up|2|||
164651455|NCT00597584|594751536|FG001|Overall Study|Lost to Follow-up|4|||
164651456|NCT00597584|594751535|FG000|Overall Study|Physician Decision|3|||
164651457|NCT00597584|594751536|FG001|Overall Study|Physician Decision|0|||
164651458|NCT00597584|594751535|FG000|Overall Study|Pregnancy|2|||
164651459|NCT00597584|594751536|FG001|Overall Study|Pregnancy|0|||
164651460|NCT00597584|594751535|FG000|Overall Study|Withdrawal by Subject|44|||
164651461|NCT00597584|594751536|FG001|Overall Study|Withdrawal by Subject|12|||
164651462|NCT00597584|594751535|FG000|Overall Study|Discontinued Dialysis|0|||
164651463|NCT00597584|594751536|FG001|Overall Study|Discontinued Dialysis|1|||
164651464|NCT00597584|594751535|FG000|Overall Study|Lost ability to consent|1|||
164651465|NCT00597584|594751536|FG001|Overall Study|Lost ability to consent|1|||
164651466|NCT00597584|594751535|FG000|Overall Study|Never dosed|1|||
164651467|NCT00597584|594751536|FG001|Overall Study|Never dosed|0|||
164651468|NCT00597584|594751535|FG000|Overall Study|Relocation|8|||
164651469|NCT00597584|594751536|FG001|Overall Study|Relocation|6|||
164651470|NCT00597584|594751535|FG000|Overall Study|Renal transplant|9|||
164651471|NCT00597584|594751536|FG001|Overall Study|Renal transplant|7|||
164651472|NCT02280421|594751537|FG000|Washout (2 Weeks)|Adverse Event|0|||
164651473|NCT02280421|594751538|FG001|Washout (2 Weeks)|Adverse Event|1|||
164651474|NCT02280421|594751537|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
164651475|NCT02280421|594751538|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
164651476|NCT03840811|594751545|FG000|Overall Study|Lost to Follow-up|0|||
164651477|NCT03840811|594751546|FG001|Overall Study|Lost to Follow-up|0|||
164651478|NCT03840811|594751547|FG002|Overall Study|Lost to Follow-up|1|||
164651479|NCT04126733|594751560|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
164651480|NCT04126733|594751560|FG000|Treatment Period|Adverse Event|8|||
164651481|NCT04126733|594751560|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
164651482|NCT04126733|594751560|FG000|Treatment Period|Physician Decision|5|||
164651483|NCT04126733|594751560|FG000|Treatment Period|Death|1|||
164651484|NCT04126733|594751560|FG000|Treatment Period|Other Reasons|2|||
164651485|NCT04126733|594751560|FG000|Active Follow-up Period|Death|13|||
164651486|NCT04126733|594751560|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
164651487|NCT04126733|594751560|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
164651488|NCT04126733|594751560|FG000|Active Follow-up Period|Other Reasons|1|||
164651489|NCT04126733|594751560|FG000|Long-term Follow-up Period|Death|22|||
164651490|NCT04126733|594751560|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
164651491|NCT04126733|594751560|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
164651492|NCT03870997|594751561|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
164651493|NCT03870997|594751562|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
164651494|NCT03870997|594751563|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
164651495|NCT03870997|594751564|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
164651496|NCT03870997|594751565|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
164651497|NCT03870997|594751566|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
164651498|NCT03726437|594751567|FG000|Overall Study|Lost to Follow-up|85|||
164651499|NCT03726437|594751568|FG001|Overall Study|Lost to Follow-up|76|||
164651500|NCT01889862|594751570|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
164651501|NCT01889862|594751571|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
164651502|NCT01889862|594751572|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
164651503|NCT01889862|594751573|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
164651504|NCT01889862|594751574|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
164651505|NCT01889862|594751570|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
164651506|NCT01889862|594751571|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
164651507|NCT01889862|594751572|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
164651508|NCT01889862|594751573|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
164651509|NCT01889862|594751574|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
164651510|NCT01889862|594751570|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
164538315|NCT01524133|594344833|FG000|Treatment Phase|Lost to Follow-up|0|||
164538316|NCT01524133|594344834|FG001|Treatment Phase|Lost to Follow-up|1|||
164538317|NCT01524133|594344835|FG002|Treatment Phase|Lost to Follow-up|2|||
164538318|NCT01524133|594344833|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
164538319|NCT01524133|594344834|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
164538320|NCT01524133|594344835|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
164538321|NCT01524133|594344833|FG000|Overall Study 52 Weeks|Physician Decision|1|||
164538322|NCT01524133|594344834|FG001|Overall Study 52 Weeks|Physician Decision|0|||
164538323|NCT01524133|594344835|FG002|Overall Study 52 Weeks|Physician Decision|2|||
164538324|NCT01524133|594344833|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
164538325|NCT01524133|594344834|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
164538326|NCT01524133|594344835|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
164538327|NCT01087957|594344836|FG000|Overall Study|Death|2|||
164538328|NCT01087957|594344837|FG001|Overall Study|Death|2|||
164538329|NCT01087957|594344836|FG000|Overall Study|Lost to Follow-up|3|||
164538330|NCT01087957|594344837|FG001|Overall Study|Lost to Follow-up|4|||
164538331|NCT01087957|594344836|FG000|Overall Study|Protocol Violation|13|||
164538332|NCT01087957|594344837|FG001|Overall Study|Protocol Violation|25|||
164538333|NCT01087957|594344836|FG000|Overall Study|Withdrawal by Subject|18|||
164538334|NCT01087957|594344837|FG001|Overall Study|Withdrawal by Subject|15|||
164538335|NCT01087957|594344836|FG000|Overall Study|Physician Decision|5|||
164538336|NCT01087957|594344837|FG001|Overall Study|Physician Decision|9|||
164538337|NCT01207596|594344839|FG000|Overall Study|Physician Decision|4|||
164538338|NCT01207596|594344839|FG000|Overall Study|Lack of Efficacy|1|||
164538339|NCT01207596|594344839|FG000|Overall Study|Adverse Event|3|||
164538340|NCT01207596|594344839|FG000|Overall Study|Withdrawal by Subject|1|||
164538341|NCT00216203|594344840|FG000|Overall Study|Withdrawal by Subject|2|||
164538342|NCT00733304|594344841|FG000|Overall Study|Adverse Event|3|||
164538343|NCT00733304|594344842|FG001|Overall Study|Adverse Event|0|||
164538344|NCT00733304|594344843|FG002|Overall Study|Adverse Event|0|||
164538345|NCT00733304|594344841|FG000|Overall Study|Lack of Efficacy|0|||
164538346|NCT00733304|594344842|FG001|Overall Study|Lack of Efficacy|0|||
164538347|NCT00733304|594344843|FG002|Overall Study|Lack of Efficacy|2|||
164538348|NCT00733304|594344841|FG000|Overall Study|Lost to Follow-up|0|||
164538349|NCT00733304|594344842|FG001|Overall Study|Lost to Follow-up|1|||
164538350|NCT00733304|594344843|FG002|Overall Study|Lost to Follow-up|0|||
164538351|NCT00733304|594344841|FG000|Overall Study|Physician Decision|3|||
164538352|NCT00733304|594344842|FG001|Overall Study|Physician Decision|1|||
164538353|NCT00733304|594344843|FG002|Overall Study|Physician Decision|3|||
164538354|NCT00733304|594344841|FG000|Overall Study|Withdrawal by Subject|1|||
164538355|NCT00733304|594344842|FG001|Overall Study|Withdrawal by Subject|1|||
164538356|NCT00733304|594344843|FG002|Overall Study|Withdrawal by Subject|0|||
164538357|NCT03155373|594344853|FG000|Overall Study|No longer required surgery|1|||
164538358|NCT03155373|594344853|FG000|Overall Study|Protocol Violation|1|||
164538359|NCT03155373|594344853|FG000|Overall Study|Death|2|||
164538360|NCT03155373|594344853|FG000|Overall Study|Withdrawal by Subject|3|||
164538361|NCT00528567|594344854|FG000|Overall Study|Death|4|||
164538362|NCT00528567|594344855|FG001|Overall Study|Death|5|||
164538363|NCT00528567|594344854|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
164538364|NCT00528567|594344855|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
164538365|NCT00528567|594344854|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
164538366|NCT00528567|594344855|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
164538367|NCT00528567|594344854|FG000|Overall Study|Violation Criteria at Entry|3|||
164538368|NCT00528567|594344855|FG001|Overall Study|Violation Criteria at Entry|17|||
164538369|NCT00528567|594344854|FG000|Overall Study|Withdrew Consent|59|||
164538370|NCT00528567|594344855|FG001|Overall Study|Withdrew Consent|55|||
164538371|NCT00528567|594344854|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
164651511|NCT01889862|594751571|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
164651512|NCT01889862|594751572|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
164538372|NCT00528567|594344855|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
164651513|NCT01889862|594751573|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
164538373|NCT00528567|594344854|FG000|Overall Study|Failure to Return|1|||
164538374|NCT00528567|594344855|FG001|Overall Study|Failure to Return|4|||
164538375|NCT00528567|594344854|FG000|Overall Study|Other Protocol Violation|5|||
164538376|NCT00528567|594344855|FG001|Overall Study|Other Protocol Violation|21|||
164651514|NCT01889862|594751574|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
164651515|NCT01889862|594751570|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
164651516|NCT01889862|594751571|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
164538377|NCT00528567|594344854|FG000|Overall Study|Administrative/Other|22|||
164538378|NCT00528567|594344855|FG001|Overall Study|Administrative/Other|75|||
164538379|NCT01122576|594344856|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
164538380|NCT01122576|594344857|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
164538381|NCT01122576|594344858|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
164538382|NCT01122576|594344856|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
164538383|NCT01122576|594344857|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
164651517|NCT01889862|594751572|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
164651518|NCT01889862|594751573|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
164651519|NCT01889862|594751574|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
164651520|NCT01889862|594751570|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
164651521|NCT01889862|594751571|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
164651522|NCT01889862|594751572|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
164651523|NCT01889862|594751573|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
164651524|NCT01889862|594751574|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
164651525|NCT01889862|594751570|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
164651526|NCT01889862|594751571|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
164651527|NCT01889862|594751572|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
164651528|NCT01889862|594751573|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
164651529|NCT01889862|594751574|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
164651530|NCT01889862|594751570|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
164651531|NCT01889862|594751571|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
164651532|NCT01889862|594751572|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
164651533|NCT01889862|594751573|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
164651534|NCT01889862|594751574|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
164651535|NCT01889862|594751570|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
164651536|NCT01889862|594751571|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
164651537|NCT01889862|594751572|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
164651538|NCT01889862|594751573|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
164651539|NCT01889862|594751574|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
164651540|NCT01889862|594751570|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
164651541|NCT01889862|594751571|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
164651542|NCT01889862|594751572|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
164651543|NCT01889862|594751573|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
164651544|NCT01889862|594751574|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
164651545|NCT01889862|594751570|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
164651546|NCT01889862|594751571|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
164651547|NCT01889862|594751572|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
164651548|NCT01889862|594751573|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
164651549|NCT01889862|594751574|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
164651550|NCT00033631|594751575|FG000|Overall Study|Protocol Violation|14|||
164651551|NCT00033631|594751576|FG001|Overall Study|Protocol Violation|11|||
164651552|NCT00033631|594751575|FG000|Overall Study|Withdrawal by Subject|4|||
164651553|NCT00033631|594751576|FG001|Overall Study|Withdrawal by Subject|4|||
164651554|NCT00667719|594751579|FG000|Overall Study|Adverse Event|39|||
164651555|NCT00667719|594751579|FG000|Overall Study|Abnormal Test Procedure|1|||
164651556|NCT00667719|594751579|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
164651557|NCT00667719|594751579|FG000|Overall Study|Protocol Violation|3|||
164651558|NCT00667719|594751579|FG000|Overall Study|Withdrawal by Subject|17|||
164651559|NCT00667719|594751579|FG000|Overall Study|Lost to Follow-up|8|||
164651560|NCT01827371|594751580|FG000|Overall Study|Adverse Event|0|||
164651561|NCT01827371|594751581|FG001|Overall Study|Adverse Event|0|||
164651562|NCT01827371|594751582|FG002|Overall Study|Adverse Event|4|||
164651563|NCT01827371|594751583|FG003|Overall Study|Adverse Event|2|||
164651564|NCT01827371|594751580|FG000|Overall Study|Lost to Follow-up|0|||
164651565|NCT01827371|594751581|FG001|Overall Study|Lost to Follow-up|2|||
164651566|NCT01827371|594751582|FG002|Overall Study|Lost to Follow-up|0|||
164651567|NCT01827371|594751583|FG003|Overall Study|Lost to Follow-up|4|||
164651568|NCT01827371|594751580|FG000|Overall Study|Protocol Violation|1|||
164651569|NCT01827371|594751581|FG001|Overall Study|Protocol Violation|0|||
164651570|NCT01827371|594751582|FG002|Overall Study|Protocol Violation|0|||
164651571|NCT01827371|594751583|FG003|Overall Study|Protocol Violation|0|||
164651572|NCT01827371|594751580|FG000|Overall Study|Withdrawal by Subject|1|||
164651573|NCT01827371|594751581|FG001|Overall Study|Withdrawal by Subject|2|||
164651574|NCT01827371|594751582|FG002|Overall Study|Withdrawal by Subject|2|||
164651575|NCT01827371|594751583|FG003|Overall Study|Withdrawal by Subject|3|||
164651576|NCT01827371|594751580|FG000|Overall Study|Physician Decision|0|||
164651577|NCT01827371|594751581|FG001|Overall Study|Physician Decision|1|||
164651578|NCT01827371|594751582|FG002|Overall Study|Physician Decision|0|||
164651579|NCT01827371|594751583|FG003|Overall Study|Physician Decision|1|||
164651580|NCT01827371|594751580|FG000|Overall Study|Temporary study halt to vaccinations|11|||
164651581|NCT01827371|594751581|FG001|Overall Study|Temporary study halt to vaccinations|2|||
164651582|NCT01827371|594751582|FG002|Overall Study|Temporary study halt to vaccinations|5|||
164651583|NCT01827371|594751583|FG003|Overall Study|Temporary study halt to vaccinations|13|||
164651584|NCT00950599|594751584|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
164651585|NCT00950599|594751585|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
164651586|NCT00950599|594751586|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
164651587|NCT00950599|594751587|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
164651588|NCT00950599|594751588|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
164651589|NCT00950599|594751589|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
164651590|NCT00950599|594751590|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
164651591|NCT00950599|594751591|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
164651592|NCT00950599|594751592|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
164651593|NCT00950599|594751593|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
164651594|NCT00950599|594751584|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164651595|NCT00950599|594751585|FG001|Double-Blind Treatment Period|Adverse Event|1|||
164651596|NCT00950599|594751586|FG002|Double-Blind Treatment Period|Adverse Event|1|||
164651597|NCT00950599|594751587|FG003|Double-Blind Treatment Period|Adverse Event|1|||
164651598|NCT00950599|594751588|FG004|Double-Blind Treatment Period|Adverse Event|1|||
164651599|NCT00950599|594751589|FG005|Double-Blind Treatment Period|Adverse Event|1|||
164651600|NCT00950599|594751590|FG006|Double-Blind Treatment Period|Adverse Event|0|||
164651601|NCT00950599|594751591|FG007|Double-Blind Treatment Period|Adverse Event|0|||
164651602|NCT00950599|594751592|FG008|Double-Blind Treatment Period|Adverse Event|0|||
164651603|NCT00950599|594751593|FG009|Double-Blind Treatment Period|Adverse Event|0|||
164651604|NCT00950599|594751584|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
164651605|NCT00950599|594751585|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
164651606|NCT00950599|594751586|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
164651607|NCT00950599|594751587|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
164651608|NCT00950599|594751588|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
164651609|NCT00950599|594751589|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
164651610|NCT00950599|594751590|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
164651611|NCT00950599|594751591|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
164651612|NCT00950599|594751592|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
164651613|NCT00950599|594751593|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
164651614|NCT00950599|594751584|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
164651615|NCT00950599|594751585|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
164651616|NCT00950599|594751586|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
164651617|NCT00950599|594751587|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
164651618|NCT00950599|594751588|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
164651619|NCT00950599|594751589|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
164651620|NCT00950599|594751590|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
164651621|NCT00950599|594751591|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
164651622|NCT00950599|594751592|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
164651623|NCT00950599|594751593|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
164651624|NCT00950599|594751584|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
164651625|NCT00950599|594751585|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
164651626|NCT00950599|594751586|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
164651627|NCT00950599|594751587|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
164651628|NCT00950599|594751588|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
164651629|NCT00950599|594751589|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
164651630|NCT00950599|594751590|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
164651631|NCT00950599|594751591|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
164651632|NCT00950599|594751592|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
164651633|NCT00950599|594751593|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
164651634|NCT00950599|594751584|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
164651635|NCT00950599|594751585|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
164651636|NCT00950599|594751586|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
164651637|NCT00950599|594751587|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
164651638|NCT00950599|594751588|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
164651639|NCT00950599|594751589|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
164651640|NCT00950599|594751590|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
164651641|NCT00950599|594751591|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
164651642|NCT00950599|594751592|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
164651643|NCT00950599|594751593|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
164651644|NCT00950599|594751584|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
164651645|NCT00950599|594751585|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
164651646|NCT00950599|594751586|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
164651647|NCT00950599|594751587|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
164651648|NCT00950599|594751588|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
164651649|NCT00950599|594751589|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
164651650|NCT00950599|594751590|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
164651651|NCT00950599|594751591|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
164651652|NCT00950599|594751592|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
164651653|NCT00950599|594751593|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
164651654|NCT00950599|594751584|FG000|Follow-Up Period|Adverse Event|0|||
164651655|NCT00950599|594751585|FG001|Follow-Up Period|Adverse Event|0|||
164651656|NCT00950599|594751586|FG002|Follow-Up Period|Adverse Event|0|||
164651657|NCT00950599|594751587|FG003|Follow-Up Period|Adverse Event|0|||
164651658|NCT00950599|594751588|FG004|Follow-Up Period|Adverse Event|0|||
164651659|NCT00950599|594751589|FG005|Follow-Up Period|Adverse Event|0|||
164651660|NCT00950599|594751590|FG006|Follow-Up Period|Adverse Event|0|||
164651661|NCT00950599|594751591|FG007|Follow-Up Period|Adverse Event|0|||
164651662|NCT00950599|594751592|FG008|Follow-Up Period|Adverse Event|1|||
164651663|NCT00950599|594751593|FG009|Follow-Up Period|Adverse Event|0|||
164651664|NCT00950599|594751584|FG000|Follow-Up Period|Lack of Efficacy|0|||
164651665|NCT00950599|594751585|FG001|Follow-Up Period|Lack of Efficacy|0|||
164651666|NCT00950599|594751586|FG002|Follow-Up Period|Lack of Efficacy|0|||
164651667|NCT00950599|594751587|FG003|Follow-Up Period|Lack of Efficacy|0|||
164651668|NCT00950599|594751588|FG004|Follow-Up Period|Lack of Efficacy|0|||
164651669|NCT00950599|594751589|FG005|Follow-Up Period|Lack of Efficacy|0|||
164651670|NCT00950599|594751590|FG006|Follow-Up Period|Lack of Efficacy|0|||
164651671|NCT00950599|594751591|FG007|Follow-Up Period|Lack of Efficacy|0|||
164651672|NCT00950599|594751592|FG008|Follow-Up Period|Lack of Efficacy|3|||
164651673|NCT00950599|594751593|FG009|Follow-Up Period|Lack of Efficacy|0|||
164651674|NCT00950599|594751584|FG000|Follow-Up Period|Lost to Follow-up|0|||
164651675|NCT00950599|594751585|FG001|Follow-Up Period|Lost to Follow-up|0|||
164651676|NCT00950599|594751586|FG002|Follow-Up Period|Lost to Follow-up|0|||
164651677|NCT00950599|594751587|FG003|Follow-Up Period|Lost to Follow-up|0|||
164651678|NCT00950599|594751588|FG004|Follow-Up Period|Lost to Follow-up|0|||
164651679|NCT00950599|594751589|FG005|Follow-Up Period|Lost to Follow-up|0|||
164651680|NCT00950599|594751590|FG006|Follow-Up Period|Lost to Follow-up|0|||
164651681|NCT00950599|594751591|FG007|Follow-Up Period|Lost to Follow-up|0|||
164651682|NCT00950599|594751592|FG008|Follow-Up Period|Lost to Follow-up|5|||
164651683|NCT00950599|594751593|FG009|Follow-Up Period|Lost to Follow-up|1|||
164651684|NCT00950599|594751584|FG000|Follow-Up Period|Physician Decision|0|||
164651685|NCT00950599|594751585|FG001|Follow-Up Period|Physician Decision|0|||
164651686|NCT00950599|594751586|FG002|Follow-Up Period|Physician Decision|0|||
164651687|NCT00950599|594751587|FG003|Follow-Up Period|Physician Decision|0|||
164651688|NCT00950599|594751588|FG004|Follow-Up Period|Physician Decision|0|||
164651689|NCT00950599|594751589|FG005|Follow-Up Period|Physician Decision|0|||
164651690|NCT00950599|594751590|FG006|Follow-Up Period|Physician Decision|0|||
164651691|NCT00950599|594751591|FG007|Follow-Up Period|Physician Decision|0|||
164651692|NCT00950599|594751592|FG008|Follow-Up Period|Physician Decision|1|||
164651693|NCT00950599|594751593|FG009|Follow-Up Period|Physician Decision|0|||
164651694|NCT00950599|594751584|FG000|Follow-Up Period|Poor/Noncompliance|0|||
164651695|NCT00950599|594751585|FG001|Follow-Up Period|Poor/Noncompliance|0|||
164538384|NCT01122576|594344858|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
164538385|NCT01122576|594344856|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
164538386|NCT01122576|594344857|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
164538387|NCT01122576|594344858|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
164538388|NCT05696236|594344859|FG000|Overall Study|Lost to Follow-up|1|||
164538389|NCT05696236|594344860|FG001|Overall Study|Lost to Follow-up|0|||
164538390|NCT05696236|594344859|FG000|Overall Study|Later determined to not be eligible for participation|0|||
164538391|NCT05696236|594344860|FG001|Overall Study|Later determined to not be eligible for participation|1|||
164538392|NCT05696236|594344859|FG000|Overall Study|Withdrawal by Subject|2|||
164538393|NCT05696236|594344860|FG001|Overall Study|Withdrawal by Subject|2|||
164538394|NCT01829360|594344861|FG000|Overall Study|Protocol Violation|0|||
164538395|NCT01829360|594344862|FG001|Overall Study|Protocol Violation|0|||
164538396|NCT01829360|594344863|FG002|Overall Study|Protocol Violation|1|||
164538397|NCT01829360|594344864|FG003|Overall Study|Protocol Violation|0|||
164538398|NCT00041067|594344867|FG000|Overall Study|Adverse Event|20|||
164538399|NCT00041067|594344867|FG000|Overall Study|Progression|19|||
164538400|NCT00041067|594344867|FG000|Overall Study|Patient refusal|12|||
164538401|NCT00041067|594344867|FG000|Overall Study|Other reasons|23|||
164538402|NCT00041067|594344867|FG000|Overall Study|Ineligible|2|||
164538403|NCT00778622|594344868|FG000|Overall Study|Adverse Event|5|||
164538404|NCT00778622|594344869|FG001|Overall Study|Adverse Event|4|||
164538405|NCT00778622|594344870|FG002|Overall Study|Adverse Event|7|||
164538406|NCT00778622|594344868|FG000|Overall Study|Withdrawal by Subject|4|||
164538407|NCT00778622|594344869|FG001|Overall Study|Withdrawal by Subject|5|||
164651696|NCT00950599|594751586|FG002|Follow-Up Period|Poor/Noncompliance|0|||
164651697|NCT00950599|594751587|FG003|Follow-Up Period|Poor/Noncompliance|0|||
164651698|NCT00950599|594751588|FG004|Follow-Up Period|Poor/Noncompliance|0|||
164651699|NCT00950599|594751589|FG005|Follow-Up Period|Poor/Noncompliance|0|||
164651700|NCT00950599|594751590|FG006|Follow-Up Period|Poor/Noncompliance|0|||
164651701|NCT00950599|594751591|FG007|Follow-Up Period|Poor/Noncompliance|0|||
164651702|NCT00950599|594751592|FG008|Follow-Up Period|Poor/Noncompliance|1|||
164538408|NCT00778622|594344870|FG002|Overall Study|Withdrawal by Subject|5|||
164651703|NCT00950599|594751593|FG009|Follow-Up Period|Poor/Noncompliance|0|||
164651704|NCT00950599|594751584|FG000|Follow-Up Period|Subject withdrew Consent|0|||
164651705|NCT00950599|594751585|FG001|Follow-Up Period|Subject withdrew Consent|0|||
164651706|NCT00950599|594751586|FG002|Follow-Up Period|Subject withdrew Consent|0|||
164538409|NCT00778622|594344868|FG000|Overall Study|Lost to Follow-up|3|||
164538410|NCT00778622|594344869|FG001|Overall Study|Lost to Follow-up|3|||
164651707|NCT00950599|594751587|FG003|Follow-Up Period|Subject withdrew Consent|0|||
164651708|NCT00950599|594751588|FG004|Follow-Up Period|Subject withdrew Consent|0|||
164651709|NCT00950599|594751589|FG005|Follow-Up Period|Subject withdrew Consent|0|||
164651710|NCT00950599|594751590|FG006|Follow-Up Period|Subject withdrew Consent|0|||
164651711|NCT00950599|594751591|FG007|Follow-Up Period|Subject withdrew Consent|0|||
164651712|NCT00950599|594751592|FG008|Follow-Up Period|Subject withdrew Consent|2|||
164651713|NCT00950599|594751593|FG009|Follow-Up Period|Subject withdrew Consent|1|||
164651714|NCT00971204|594751594|FG000|Overall Study|Did not meet all criteria-not treated|14|||
164651715|NCT00971204|594751594|FG000|Overall Study|Lost to Follow-up|10|||
164651716|NCT02729194|594751595|FG000|Overall Study|Withdrawal by Subject|3|||
164651717|NCT01361607|594751598|FG000|Overall Study|Adverse Event|38|||
164651718|NCT01361607|594751599|FG001|Overall Study|Adverse Event|29|||
164651719|NCT01361607|594751598|FG000|Overall Study|Withdrawal by Subject|19|||
164651720|NCT01361607|594751599|FG001|Overall Study|Withdrawal by Subject|8|||
164651721|NCT01361607|594751598|FG000|Overall Study|Withdrawal by Investigator|5|||
164651722|NCT01361607|594751599|FG001|Overall Study|Withdrawal by Investigator|3|||
164651723|NCT01361607|594751598|FG000|Overall Study|Lost to Follow-up|1|||
164651724|NCT01361607|594751599|FG001|Overall Study|Lost to Follow-up|0|||
164651725|NCT01361607|594751598|FG000|Overall Study|Met Withdrawal Criteria|1|||
164651726|NCT01361607|594751599|FG001|Overall Study|Met Withdrawal Criteria|1|||
164651727|NCT02741271|594751610|FG000|Overall Study|Lost to Follow-up|2|||
164651728|NCT02741271|594751611|FG001|Overall Study|Lost to Follow-up|0|||
164651729|NCT02741271|594751610|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164651730|NCT02741271|594751611|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
164651731|NCT00373685|594751612|FG000|Overall Study|Death|2|||
164651732|NCT00373685|594751613|FG001|Overall Study|Death|1|||
164651733|NCT00373685|594751612|FG000|Overall Study|Adverse Event|278|||
164651734|NCT00373685|594751613|FG001|Overall Study|Adverse Event|253|||
164651735|NCT00373685|594751612|FG000|Overall Study|Insufficient clinical response|169|||
164651736|NCT00373685|594751613|FG001|Overall Study|Insufficient clinical response|119|||
164651737|NCT00373685|594751612|FG000|Overall Study|Did not meet entrance criteria|167|||
164651738|NCT00373685|594751613|FG001|Overall Study|Did not meet entrance criteria|184|||
164651739|NCT00373685|594751612|FG000|Overall Study|Lost to follow up|83|||
164651740|NCT00373685|594751613|FG001|Overall Study|Lost to follow up|103|||
164651741|NCT00373685|594751612|FG000|Overall Study|No longer willing to participate|337|||
164651742|NCT00373685|594751613|FG001|Overall Study|No longer willing to participate|352|||
164651743|NCT00373685|594751612|FG000|Overall Study|Other|149|||
164651744|NCT00373685|594751613|FG001|Overall Study|Other|146|||
164651745|NCT00373685|594751612|FG000|Overall Study|Protocol Violation|191|||
164651746|NCT00373685|594751613|FG001|Overall Study|Protocol Violation|182|||
164651747|NCT00373685|594751612|FG000|Overall Study|Final Status Unknown|12|||
164651748|NCT00373685|594751613|FG001|Overall Study|Final Status Unknown|4|||
164651749|NCT00373685|594751612|FG000|Overall Study|Randomized, not treated|51|||
164651750|NCT00373685|594751613|FG001|Overall Study|Randomized, not treated|77|||
164651751|NCT02570165|594751614|FG000|Overall Study|Adverse Event|1|||
164651752|NCT02570165|594751615|FG001|Overall Study|Adverse Event|0|||
164651753|NCT02570165|594751616|FG002|Overall Study|Adverse Event|2|||
164651754|NCT02570165|594751617|FG003|Overall Study|Adverse Event|0|||
164651755|NCT02570165|594751618|FG004|Overall Study|Adverse Event|0|||
164651756|NCT02570165|594751619|FG005|Overall Study|Adverse Event|0|||
164651757|NCT02570165|594751620|FG006|Overall Study|Adverse Event|0|||
164651758|NCT02570165|594751614|FG000|Overall Study|Lack of Efficacy|0|||
164651759|NCT02570165|594751615|FG001|Overall Study|Lack of Efficacy|1|||
164538411|NCT00778622|594344870|FG002|Overall Study|Lost to Follow-up|2|||
164538412|NCT00778622|594344868|FG000|Overall Study|Protocol Violation|0|||
164538413|NCT00778622|594344869|FG001|Overall Study|Protocol Violation|3|||
164538414|NCT00778622|594344870|FG002|Overall Study|Protocol Violation|0|||
164538415|NCT00778622|594344868|FG000|Overall Study|Lack of Efficacy|2|||
164538416|NCT00778622|594344869|FG001|Overall Study|Lack of Efficacy|0|||
164538417|NCT00778622|594344870|FG002|Overall Study|Lack of Efficacy|0|||
164538418|NCT00778622|594344868|FG000|Overall Study|immigration|1|||
164538419|NCT00778622|594344869|FG001|Overall Study|immigration|0|||
164538420|NCT00778622|594344870|FG002|Overall Study|immigration|0|||
164538421|NCT00778622|594344868|FG000|Overall Study|Other|1|||
164538422|NCT00778622|594344869|FG001|Overall Study|Other|0|||
164538423|NCT00778622|594344870|FG002|Overall Study|Other|1|||
164538424|NCT01968070|594344871|FG000|Period 1|Withdrawal by Subject|0|||
164538425|NCT01968070|594344872|FG001|Period 1|Withdrawal by Subject|1|||
164538426|NCT01968070|594344873|FG002|Period 1|Withdrawal by Subject|0|||
164538427|NCT01968070|594344874|FG003|Period 1|Withdrawal by Subject|0|||
164538428|NCT01968070|594344875|FG004|Period 1|Withdrawal by Subject|0|||
164538429|NCT01968070|594344876|FG005|Period 1|Withdrawal by Subject|0|||
164538430|NCT01968070|594344877|FG006|Period 1|Withdrawal by Subject|1|||
164538431|NCT01968070|594344878|FG007|Period 1|Withdrawal by Subject|0|||
164538432|NCT01968070|594344879|FG008|Period 1|Withdrawal by Subject|0|||
164538433|NCT01968070|594344880|FG009|Period 1|Withdrawal by Subject|0|||
164538434|NCT01968070|594344881|FG010|Period 1|Withdrawal by Subject|0|||
164538435|NCT01968070|594344882|FG011|Period 1|Withdrawal by Subject|0|||
164538436|NCT01968070|594344883|FG012|Period 1|Withdrawal by Subject|0|||
164651760|NCT02570165|594751616|FG002|Overall Study|Lack of Efficacy|0|||
164651761|NCT02570165|594751617|FG003|Overall Study|Lack of Efficacy|0|||
164651762|NCT02570165|594751618|FG004|Overall Study|Lack of Efficacy|4|||
164651763|NCT02570165|594751619|FG005|Overall Study|Lack of Efficacy|0|||
164651764|NCT02570165|594751620|FG006|Overall Study|Lack of Efficacy|0|||
164651765|NCT02570165|594751614|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
164651766|NCT02570165|594751615|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
164651767|NCT02570165|594751616|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
164651768|NCT02570165|594751617|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
164651769|NCT02570165|594751618|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
164651770|NCT02570165|594751619|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
164651771|NCT02570165|594751620|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
164651772|NCT02570165|594751614|FG000|Overall Study|Lost to Follow-up|0|||
164651773|NCT02570165|594751615|FG001|Overall Study|Lost to Follow-up|0|||
164651774|NCT02570165|594751616|FG002|Overall Study|Lost to Follow-up|1|||
164651775|NCT02570165|594751617|FG003|Overall Study|Lost to Follow-up|1|||
164651776|NCT02570165|594751618|FG004|Overall Study|Lost to Follow-up|0|||
164651777|NCT02570165|594751619|FG005|Overall Study|Lost to Follow-up|0|||
164651778|NCT02570165|594751620|FG006|Overall Study|Lost to Follow-up|0|||
164651779|NCT02570165|594751614|FG000|Overall Study|Physician Decision|0|||
164651780|NCT02570165|594751615|FG001|Overall Study|Physician Decision|1|||
164651781|NCT02570165|594751616|FG002|Overall Study|Physician Decision|0|||
164651782|NCT02570165|594751617|FG003|Overall Study|Physician Decision|0|||
164651783|NCT02570165|594751618|FG004|Overall Study|Physician Decision|0|||
164651784|NCT02570165|594751619|FG005|Overall Study|Physician Decision|0|||
164651785|NCT02570165|594751620|FG006|Overall Study|Physician Decision|0|||
164651786|NCT02570165|594751614|FG000|Overall Study|Withdrawal by Subject|0|||
164651787|NCT02570165|594751615|FG001|Overall Study|Withdrawal by Subject|0|||
164651788|NCT02570165|594751616|FG002|Overall Study|Withdrawal by Subject|0|||
164651789|NCT02570165|594751617|FG003|Overall Study|Withdrawal by Subject|2|||
164651790|NCT02570165|594751618|FG004|Overall Study|Withdrawal by Subject|1|||
164651791|NCT02570165|594751619|FG005|Overall Study|Withdrawal by Subject|0|||
164651792|NCT02570165|594751620|FG006|Overall Study|Withdrawal by Subject|0|||
164651793|NCT02570165|594751614|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
164651794|NCT02570165|594751615|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
164651795|NCT02570165|594751616|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
164651796|NCT02570165|594751617|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
164651797|NCT02570165|594751618|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
164651798|NCT02570165|594751619|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
164651799|NCT02570165|594751620|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
164651800|NCT02570165|594751614|FG000|Overall Study|Withdrawal Request by GSK|0|||
164651801|NCT02570165|594751615|FG001|Overall Study|Withdrawal Request by GSK|0|||
164651802|NCT02570165|594751616|FG002|Overall Study|Withdrawal Request by GSK|2|||
164651803|NCT02570165|594751617|FG003|Overall Study|Withdrawal Request by GSK|0|||
164651804|NCT02570165|594751618|FG004|Overall Study|Withdrawal Request by GSK|0|||
164651805|NCT02570165|594751619|FG005|Overall Study|Withdrawal Request by GSK|0|||
164651806|NCT02570165|594751620|FG006|Overall Study|Withdrawal Request by GSK|0|||
164651807|NCT01953783|594751621|FG000|Overall Study|Progressive disease|2|||
164651808|NCT01789281|594751622|FG000|Overall Study|Disease progression|15|||
164651809|NCT01789281|594751623|FG001|Overall Study|Disease progression|4|||
164651810|NCT01789281|594751622|FG000|Overall Study|Adverse Event|5|||
164651811|NCT01789281|594751623|FG001|Overall Study|Adverse Event|5|||
164651812|NCT01789281|594751622|FG000|Overall Study|Withdrawal by Subject|1|||
164651813|NCT01789281|594751623|FG001|Overall Study|Withdrawal by Subject|0|||
164651814|NCT01789281|594751622|FG000|Overall Study|Lost to Follow-up|1|||
164651815|NCT01789281|594751623|FG001|Overall Study|Lost to Follow-up|0|||
164651816|NCT01789281|594751622|FG000|Overall Study|Administrative problems|0|||
164651817|NCT01789281|594751623|FG001|Overall Study|Administrative problems|1|||
164651818|NCT01252238|594751624|FG000|Overall Study|Sponsor terminated study|4|||
164651819|NCT01252238|594751625|FG001|Overall Study|Sponsor terminated study|4|||
164651820|NCT01252238|594751626|FG002|Overall Study|Sponsor terminated study|4|||
164651821|NCT00411762|594751628|FG000|Overall Study|Withdrawal by Subject|5|||
164651822|NCT04428502|594751629|FG000|Overall Study|Did not meet entrance criteria|14|||
164651823|NCT02295280|594751631|FG000|Overall Study|Adverse Event|0|||
164651824|NCT02295280|594751632|FG001|Overall Study|Adverse Event|1|||
164651825|NCT02875067|594751633|FG000|Overall Study|Withdrawal by Subject|1|||
164651826|NCT02875067|594751633|FG000|Overall Study|Withdrawal by Termination of Study|5|||
164651827|NCT01430104|594751634|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
164651828|NCT02713243|594751636|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
164651829|NCT02713243|594751637|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
164651830|NCT02713243|594751636|FG000|Overall Study|Administrative problems|0|||
164651831|NCT02713243|594751637|FG001|Overall Study|Administrative problems|1|||
164651832|NCT02713243|594751636|FG000|Overall Study|Protocol deviation|0|||
164651833|NCT02713243|594751637|FG001|Overall Study|Protocol deviation|1|||
164651834|NCT03404206|594751645|FG000|Overall Study|Withdrawal by Subject|1|||
164651835|NCT03404206|594751646|FG001|Overall Study|Withdrawal by Subject|1|||
164651836|NCT03404206|594751647|FG002|Overall Study|Withdrawal by Subject|0|||
164651837|NCT03404206|594751645|FG000|Overall Study|Lost to Follow-up|3|||
164651838|NCT03404206|594751646|FG001|Overall Study|Lost to Follow-up|1|||
164651839|NCT03404206|594751647|FG002|Overall Study|Lost to Follow-up|0|||
164651840|NCT01133392|594751648|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
164651841|NCT01133392|594751649|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
164651842|NCT01133392|594751648|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
164651843|NCT01133392|594751649|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
164651844|NCT03751124|594751650|FG000|Overall Study|Adverse Event|4|||
164651845|NCT03751124|594751651|FG001|Overall Study|Adverse Event|3|||
164651846|NCT03751124|594751650|FG000|Overall Study|Protocol Deviation|0|||
164651847|NCT03751124|594751651|FG001|Overall Study|Protocol Deviation|1|||
164651848|NCT03751124|594751650|FG000|Overall Study|Lost to Follow-up|6|||
164651849|NCT03751124|594751651|FG001|Overall Study|Lost to Follow-up|4|||
164651850|NCT03751124|594751650|FG000|Overall Study|Withdrawal by Subject|6|||
164651851|NCT03751124|594751651|FG001|Overall Study|Withdrawal by Subject|8|||
164651852|NCT03751124|594751650|FG000|Overall Study|Lack of Efficacy|1|||
164651853|NCT03751124|594751651|FG001|Overall Study|Lack of Efficacy|1|||
164651854|NCT03751124|594751650|FG000|Overall Study|Pregnancy|0|||
164651855|NCT03751124|594751651|FG001|Overall Study|Pregnancy|1|||
164651856|NCT03751124|594751650|FG000|Overall Study|Other|9|||
164651857|NCT03751124|594751651|FG001|Overall Study|Other|9|||
164651858|NCT03751124|594751650|FG000|Overall Study|Participants who did not receive any study drug|0|||
164651859|NCT03751124|594751651|FG001|Overall Study|Participants who did not receive any study drug|1|||
164651860|NCT00555399|594751654|FG000|Overall Study|Withdrawal by Subject|0|||
164651861|NCT00555399|594751655|FG001|Overall Study|Withdrawal by Subject|0|||
164651862|NCT00555399|594751656|FG002|Overall Study|Withdrawal by Subject|1|||
164651863|NCT00555399|594751657|FG003|Overall Study|Withdrawal by Subject|0|||
164651864|NCT00555399|594751658|FG004|Overall Study|Withdrawal by Subject|0|||
164651865|NCT00555399|594751659|FG005|Overall Study|Withdrawal by Subject|0|||
164651866|NCT00555399|594751660|FG006|Overall Study|Withdrawal by Subject|0|||
164651867|NCT00555399|594751661|FG007|Overall Study|Withdrawal by Subject|0|||
164651868|NCT00555399|594751662|FG008|Overall Study|Withdrawal by Subject|0|||
164651869|NCT00555399|594751663|FG009|Overall Study|Withdrawal by Subject|0|||
164651870|NCT00555399|594751664|FG010|Overall Study|Withdrawal by Subject|0|||
164651871|NCT00555399|594751665|FG011|Overall Study|Withdrawal by Subject|1|||
164651872|NCT00555399|594751654|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
164651873|NCT00555399|594751655|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
164651874|NCT00555399|594751656|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
164651875|NCT00555399|594751657|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
164651876|NCT00555399|594751658|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
164651877|NCT00555399|594751659|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
164651878|NCT00555399|594751660|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
164651879|NCT00555399|594751661|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
164651880|NCT00555399|594751662|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
164651881|NCT00555399|594751663|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
164651882|NCT00555399|594751664|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
164651883|NCT00555399|594751665|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
164651884|NCT03262233|594752890|FG000|Overall Study|Withdrawal by Subject|12|||
164651885|NCT03262233|594752891|FG001|Overall Study|Withdrawal by Subject|8|||
164651886|NCT03262233|594752892|FG002|Overall Study|Withdrawal by Subject|21|||
164651887|NCT03262233|594752893|FG003|Overall Study|Withdrawal by Subject|13|||
164651888|NCT03262233|594752890|FG000|Overall Study|Declined due to shock|1|||
164651889|NCT03262233|594752891|FG001|Overall Study|Declined due to shock|2|||
164651890|NCT03262233|594752892|FG002|Overall Study|Declined due to shock|2|||
164651891|NCT03262233|594752893|FG003|Overall Study|Declined due to shock|3|||
164651892|NCT03262233|594752890|FG000|Overall Study|Protocol Violation|5|||
164651893|NCT03262233|594752891|FG001|Overall Study|Protocol Violation|10|||
164651894|NCT03262233|594752892|FG002|Overall Study|Protocol Violation|2|||
164651895|NCT03262233|594752893|FG003|Overall Study|Protocol Violation|13|||
164651896|NCT03262233|594752890|FG000|Overall Study|data collection artifact|0|||
164651897|NCT03262233|594752891|FG001|Overall Study|data collection artifact|1|||
164651898|NCT03262233|594752892|FG002|Overall Study|data collection artifact|0|||
164651899|NCT03262233|594752893|FG003|Overall Study|data collection artifact|0|||
164651900|NCT01120600|594752896|FG000|Overall Study|Adverse Event|7|||
164651901|NCT01120600|594752897|FG001|Overall Study|Adverse Event|7|||
164651902|NCT01120600|594752896|FG000|Overall Study|Excessive Bone Loss|0|||
164651903|NCT01120600|594752897|FG001|Overall Study|Excessive Bone Loss|4|||
164651904|NCT01120600|594752896|FG000|Overall Study|Lost to Follow-up|1|||
164651905|NCT01120600|594752897|FG001|Overall Study|Lost to Follow-up|3|||
164651906|NCT01120600|594752896|FG000|Overall Study|Physician Decision|1|||
164651907|NCT01120600|594752897|FG001|Overall Study|Physician Decision|3|||
164651908|NCT01120600|594752896|FG000|Overall Study|Protocol Violation|0|||
164651909|NCT01120600|594752897|FG001|Overall Study|Protocol Violation|4|||
164651910|NCT01120600|594752896|FG000|Overall Study|Withdrawal by Subject|10|||
164651911|NCT01120600|594752897|FG001|Overall Study|Withdrawal by Subject|11|||
164651912|NCT01165242|594752900|FG000|Overall Study|Unreachable Subjects|1|||
164651913|NCT01165242|594752901|FG001|Overall Study|Unreachable Subjects|0|||
164651914|NCT01165242|594752902|FG002|Overall Study|Unreachable Subjects|0|||
164651915|NCT01165242|594752900|FG000|Overall Study|Incarcerated Subjects|0|||
164651916|NCT01165242|594752901|FG001|Overall Study|Incarcerated Subjects|1|||
164651917|NCT01165242|594752902|FG002|Overall Study|Incarcerated Subjects|0|||
164651918|NCT01165242|594752900|FG000|Overall Study|Visit 2 Declined by Subject|0|||
164651919|NCT01165242|594752901|FG001|Overall Study|Visit 2 Declined by Subject|0|||
164651920|NCT01165242|594752902|FG002|Overall Study|Visit 2 Declined by Subject|1|||
164651921|NCT01165242|594752900|FG000|Overall Study|Withdrawal by Subject|0|||
164651922|NCT01165242|594752901|FG001|Overall Study|Withdrawal by Subject|2|||
164651923|NCT01165242|594752902|FG002|Overall Study|Withdrawal by Subject|2|||
164651924|NCT01165242|594752900|FG000|Overall Study|Extended Holiday|0|||
164651925|NCT01165242|594752901|FG001|Overall Study|Extended Holiday|0|||
164651926|NCT01165242|594752902|FG002|Overall Study|Extended Holiday|1|||
164651927|NCT01165242|594752900|FG000|Overall Study|Lost to Follow-up|9|||
164651928|NCT01165242|594752901|FG001|Overall Study|Lost to Follow-up|7|||
164651929|NCT01165242|594752902|FG002|Overall Study|Lost to Follow-up|10|||
164651930|NCT03372083|594752903|FG000|Overall Study|Adverse Event|3|||
164651931|NCT03372083|594752903|FG000|Overall Study|Physician Decision|1|||
164651932|NCT03372083|594752903|FG000|Overall Study|Withdrawal by Subject|1|||
164651933|NCT01690520|594752906|FG000|Overall Study|Death|25|||
164651934|NCT01690520|594752907|FG001|Overall Study|Death|21|||
164651935|NCT01690520|594752906|FG000|Overall Study|Lost to Follow-up|2|||
164651936|NCT01690520|594752907|FG001|Overall Study|Lost to Follow-up|3|||
164651937|NCT01690520|594752906|FG000|Overall Study|Withdrawal by Subject|2|||
164651938|NCT01690520|594752907|FG001|Overall Study|Withdrawal by Subject|0|||
164651939|NCT01690520|594752906|FG000|Overall Study|Relapse|0|||
164651940|NCT01690520|594752907|FG001|Overall Study|Relapse|1|||
164651941|NCT01690520|594752906|FG000|Overall Study|Other|0|||
164651942|NCT01690520|594752907|FG001|Overall Study|Other|1|||
164651943|NCT01690520|594752906|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
164651944|NCT01690520|594752907|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
164651945|NCT01270841|594752908|FG000|Overall Study|Adverse Event|0|||
164651946|NCT01270841|594752909|FG001|Overall Study|Adverse Event|1|||
164651947|NCT01270841|594752910|FG002|Overall Study|Adverse Event|0|||
164651948|NCT01270841|594752911|FG003|Overall Study|Adverse Event|3|||
164651949|NCT01270841|594752908|FG000|Overall Study|Withdrawal by Subject|3|||
164651950|NCT01270841|594752909|FG001|Overall Study|Withdrawal by Subject|2|||
164651951|NCT01270841|594752910|FG002|Overall Study|Withdrawal by Subject|3|||
164651952|NCT01270841|594752911|FG003|Overall Study|Withdrawal by Subject|3|||
164651953|NCT01270841|594752908|FG000|Overall Study|Lost to Follow-up|3|||
164651954|NCT01270841|594752909|FG001|Overall Study|Lost to Follow-up|1|||
164651955|NCT01270841|594752910|FG002|Overall Study|Lost to Follow-up|4|||
164651956|NCT01270841|594752911|FG003|Overall Study|Lost to Follow-up|2|||
164651957|NCT01270841|594752908|FG000|Overall Study|Physician Decision|0|||
164651958|NCT01270841|594752909|FG001|Overall Study|Physician Decision|1|||
164651959|NCT01270841|594752910|FG002|Overall Study|Physician Decision|0|||
164651960|NCT01270841|594752911|FG003|Overall Study|Physician Decision|0|||
164651961|NCT01270841|594752908|FG000|Overall Study|Did not qualify|6|||
164651962|NCT01270841|594752909|FG001|Overall Study|Did not qualify|3|||
164651963|NCT01270841|594752910|FG002|Overall Study|Did not qualify|4|||
164651964|NCT01270841|594752911|FG003|Overall Study|Did not qualify|5|||
164651965|NCT01270841|594752908|FG000|Overall Study|Protocol Violation|1|||
164651966|NCT01270841|594752909|FG001|Overall Study|Protocol Violation|5|||
164651967|NCT01270841|594752910|FG002|Overall Study|Protocol Violation|0|||
164651968|NCT01270841|594752911|FG003|Overall Study|Protocol Violation|0|||
164651969|NCT01270841|594752908|FG000|Overall Study|Enrolled in error|0|||
164651970|NCT01270841|594752909|FG001|Overall Study|Enrolled in error|1|||
164651971|NCT01270841|594752910|FG002|Overall Study|Enrolled in error|0|||
164651972|NCT01270841|594752911|FG003|Overall Study|Enrolled in error|0|||
164651973|NCT01375010|594752912|FG000|Overall Study|Lost to Follow-up|8|||
164651974|NCT01375010|594752913|FG001|Overall Study|Lost to Follow-up|2|||
164651975|NCT01375010|594752912|FG000|Overall Study|Withdrawal by Subject|4|||
164651976|NCT01375010|594752913|FG001|Overall Study|Withdrawal by Subject|2|||
164651977|NCT02402933|594752914|FG000|Overall Study|Withdrawal by Subject|4|||
164651978|NCT02402933|594752914|FG000|Overall Study|Discontinued; Site Termination|10|||
164651979|NCT02544633|594752917|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
164651980|NCT02544633|594752918|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
164651981|NCT02544633|594752919|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
164651982|NCT02544633|594752920|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
164651983|NCT02544633|594752917|FG000|Treatment Period|Adverse Event|7|||
164651984|NCT02544633|594752918|FG001|Treatment Period|Adverse Event|4|||
164651985|NCT02544633|594752919|FG002|Treatment Period|Adverse Event|0|||
164651986|NCT02544633|594752920|FG003|Treatment Period|Adverse Event|5|||
164651987|NCT02544633|594752917|FG000|Treatment Period|Lack of Efficacy|17|||
164651988|NCT02544633|594752918|FG001|Treatment Period|Lack of Efficacy|11|||
164651989|NCT02544633|594752919|FG002|Treatment Period|Lack of Efficacy|5|||
164651990|NCT02544633|594752920|FG003|Treatment Period|Lack of Efficacy|5|||
164651991|NCT02544633|594752917|FG000|Treatment Period|Global Deterioration of Health|3|||
164651992|NCT02544633|594752918|FG001|Treatment Period|Global Deterioration of Health|3|||
164651993|NCT02544633|594752919|FG002|Treatment Period|Global Deterioration of Health|0|||
164651994|NCT02544633|594752920|FG003|Treatment Period|Global Deterioration of Health|1|||
164651995|NCT02544633|594752917|FG000|Treatment Period|Withdrawal by Subject|1|||
164651996|NCT02544633|594752918|FG001|Treatment Period|Withdrawal by Subject|0|||
164651997|NCT02544633|594752919|FG002|Treatment Period|Withdrawal by Subject|0|||
164651998|NCT02544633|594752920|FG003|Treatment Period|Withdrawal by Subject|0|||
164651999|NCT02544633|594752917|FG000|Treatment Period|Lost to Follow-up|0|||
164652000|NCT02544633|594752918|FG001|Treatment Period|Lost to Follow-up|1|||
164652001|NCT02544633|594752919|FG002|Treatment Period|Lost to Follow-up|0|||
164652002|NCT02544633|594752920|FG003|Treatment Period|Lost to Follow-up|0|||
164652003|NCT02544633|594752917|FG000|Treatment Period|Death|0|||
164652004|NCT02544633|594752918|FG001|Treatment Period|Death|0|||
164652005|NCT02544633|594752919|FG002|Treatment Period|Death|1|||
164652006|NCT02544633|594752920|FG003|Treatment Period|Death|0|||
164652007|NCT02544633|594752917|FG000|Treatment Period|Non-compliance|0|||
164652008|NCT02544633|594752918|FG001|Treatment Period|Non-compliance|0|||
164652009|NCT02544633|594752919|FG002|Treatment Period|Non-compliance|1|||
164652010|NCT02544633|594752920|FG003|Treatment Period|Non-compliance|0|||
164652011|NCT02544633|594752917|FG000|Treatment Period|Clinical Disease Progression|0|||
164652012|NCT02544633|594752918|FG001|Treatment Period|Clinical Disease Progression|0|||
164652013|NCT02544633|594752919|FG002|Treatment Period|Clinical Disease Progression|0|||
164652014|NCT02544633|594752920|FG003|Treatment Period|Clinical Disease Progression|1|||
164652015|NCT02544633|594752917|FG000|Survival Follow-up Period|Death|12|||
164652016|NCT02544633|594752918|FG001|Survival Follow-up Period|Death|14|||
164652017|NCT02544633|594752919|FG002|Survival Follow-up Period|Death|3|||
164652018|NCT02544633|594752920|FG003|Survival Follow-up Period|Death|9|||
164652019|NCT02544633|594752917|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
164652020|NCT02544633|594752918|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
164538437|NCT01968070|594344884|FG013|Period 1|Withdrawal by Subject|0|||
164538438|NCT01968070|594344885|FG014|Period 1|Withdrawal by Subject|0|||
164538439|NCT01968070|594344886|FG015|Period 1|Withdrawal by Subject|1|||
164538440|NCT01968070|594344887|FG016|Period 1|Withdrawal by Subject|0|||
164538441|NCT01968070|594344888|FG017|Period 1|Withdrawal by Subject|0|||
164538442|NCT01968070|594344871|FG000|Period 1|Protocol Violation|0|||
164538443|NCT01968070|594344872|FG001|Period 1|Protocol Violation|0|||
164538444|NCT01968070|594344873|FG002|Period 1|Protocol Violation|0|||
164538445|NCT01968070|594344874|FG003|Period 1|Protocol Violation|1|||
164538446|NCT01968070|594344875|FG004|Period 1|Protocol Violation|1|||
164538447|NCT01968070|594344876|FG005|Period 1|Protocol Violation|0|||
164538448|NCT01968070|594344877|FG006|Period 1|Protocol Violation|0|||
164538449|NCT01968070|594344878|FG007|Period 1|Protocol Violation|0|||
164538450|NCT01968070|594344879|FG008|Period 1|Protocol Violation|0|||
164538451|NCT01968070|594344880|FG009|Period 1|Protocol Violation|0|||
164538452|NCT01968070|594344881|FG010|Period 1|Protocol Violation|0|||
164538453|NCT01968070|594344882|FG011|Period 1|Protocol Violation|0|||
164538454|NCT01968070|594344883|FG012|Period 1|Protocol Violation|0|||
164538455|NCT01968070|594344884|FG013|Period 1|Protocol Violation|0|||
164538456|NCT01968070|594344885|FG014|Period 1|Protocol Violation|0|||
164538457|NCT01968070|594344886|FG015|Period 1|Protocol Violation|0|||
164538458|NCT01968070|594344887|FG016|Period 1|Protocol Violation|0|||
164538459|NCT01968070|594344888|FG017|Period 1|Protocol Violation|0|||
164538460|NCT01968070|594344871|FG000|Period 1|Lost to Follow-up|0|||
164538461|NCT01968070|594344872|FG001|Period 1|Lost to Follow-up|0|||
164538462|NCT01968070|594344873|FG002|Period 1|Lost to Follow-up|0|||
164538463|NCT01968070|594344874|FG003|Period 1|Lost to Follow-up|1|||
164538464|NCT01968070|594344875|FG004|Period 1|Lost to Follow-up|0|||
164538465|NCT01968070|594344876|FG005|Period 1|Lost to Follow-up|0|||
164538466|NCT01968070|594344877|FG006|Period 1|Lost to Follow-up|0|||
164538467|NCT01968070|594344878|FG007|Period 1|Lost to Follow-up|0|||
164538468|NCT01968070|594344879|FG008|Period 1|Lost to Follow-up|0|||
164538469|NCT01968070|594344880|FG009|Period 1|Lost to Follow-up|0|||
164538470|NCT01968070|594344881|FG010|Period 1|Lost to Follow-up|0|||
164538471|NCT01968070|594344882|FG011|Period 1|Lost to Follow-up|0|||
164538472|NCT01968070|594344883|FG012|Period 1|Lost to Follow-up|0|||
164538473|NCT01968070|594344884|FG013|Period 1|Lost to Follow-up|0|||
164538474|NCT01968070|594344885|FG014|Period 1|Lost to Follow-up|0|||
164538475|NCT01968070|594344886|FG015|Period 1|Lost to Follow-up|0|||
164538476|NCT01968070|594344887|FG016|Period 1|Lost to Follow-up|0|||
164538477|NCT01968070|594344888|FG017|Period 1|Lost to Follow-up|0|||
164538478|NCT01968070|594344871|FG000|Period 1|Adverse Event|0|||
164538479|NCT01968070|594344872|FG001|Period 1|Adverse Event|0|||
164538480|NCT01968070|594344873|FG002|Period 1|Adverse Event|0|||
164538481|NCT01968070|594344874|FG003|Period 1|Adverse Event|0|||
164538482|NCT01968070|594344875|FG004|Period 1|Adverse Event|0|||
164652021|NCT02544633|594752919|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
164652022|NCT02544633|594752920|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
164652023|NCT02544633|594752917|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
164652024|NCT02544633|594752918|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
164652025|NCT02544633|594752919|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
164652026|NCT02544633|594752920|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
164652027|NCT02544633|594752917|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
164652028|NCT02544633|594752918|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
164652029|NCT02544633|594752919|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
164652030|NCT02544633|594752920|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
164652031|NCT01623830|594752923|FG000|Overall Study|Withdrawal by Subject|6|||
164652032|NCT01623830|594752924|FG001|Overall Study|Withdrawal by Subject|7|||
164652033|NCT01623830|594752923|FG000|Overall Study|Exclusion from Study|1|||
164652034|NCT01623830|594752924|FG001|Overall Study|Exclusion from Study|2|||
164652035|NCT02468557|594752925|FG000|Overall Study|Adverse Event|1|||
164652036|NCT02468557|594752925|FG000|Overall Study|Death|1|||
164652037|NCT02468557|594752925|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
164652038|NCT02468557|594752925|FG000|Overall Study|All Enrolled but Never Dosed|4|||
164652039|NCT01605461|594752926|FG000|Overall Study|Lost to Follow-up|3|||
164652040|NCT01605461|594752926|FG000|Overall Study|Withdrawal by Subject|1|||
164652041|NCT02024698|594752927|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
164652042|NCT02024698|594752928|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
164652043|NCT03322462|594752929|FG000|Overall Study|Technical difficulties|2|||
164652044|NCT03322462|594752929|FG000|Overall Study|Other|1|||
164652045|NCT00515073|594752934|FG000|Overall Study|Withdrawal by Subject|1|||
164652046|NCT00515073|594752934|FG000|Overall Study|Physician Decision|1|||
164652047|NCT02764489|594752935|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
164652048|NCT02764489|594752936|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
164652049|NCT02764489|594752935|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
164652050|NCT02764489|594752936|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
164652051|NCT02764489|594752935|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
164652052|NCT02764489|594752936|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
164652053|NCT02764489|594752935|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
164652054|NCT02764489|594752936|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
164652055|NCT01625845|594752937|FG000|Overall Study|Adverse Event|1|||
164652056|NCT01625845|594752938|FG001|Overall Study|Adverse Event|2|||
164652057|NCT01625845|594752937|FG000|Overall Study|Lost to Follow-up|2|||
164652058|NCT01625845|594752938|FG001|Overall Study|Lost to Follow-up|1|||
164652059|NCT01625845|594752937|FG000|Overall Study|Withdrawal by Subject|2|||
164652060|NCT01625845|594752938|FG001|Overall Study|Withdrawal by Subject|0|||
164652061|NCT02853929|594752939|FG000|Overall Study|Lost to Follow-up|3|||
164652062|NCT02853929|594752940|FG001|Overall Study|Lost to Follow-up|0|||
164652063|NCT02853929|594752939|FG000|Overall Study|Withdrawal by Subject|1|||
164652064|NCT02853929|594752940|FG001|Overall Study|Withdrawal by Subject|0|||
164652065|NCT02853929|594752939|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
164652066|NCT02853929|594752940|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
164652067|NCT01294592|594752941|FG000|Overall Study|Adverse Event|28|||
164652068|NCT01294592|594752942|FG001|Overall Study|Adverse Event|13|||
164652069|NCT01294592|594752941|FG000|Overall Study|Lack of Efficacy|7|||
164652070|NCT01294592|594752942|FG001|Overall Study|Lack of Efficacy|5|||
164652071|NCT01294592|594752941|FG000|Overall Study|Protocol Violation|1|||
164652072|NCT01294592|594752942|FG001|Overall Study|Protocol Violation|7|||
164652073|NCT01294592|594752941|FG000|Overall Study|Lost to Follow-up|7|||
164652074|NCT01294592|594752942|FG001|Overall Study|Lost to Follow-up|9|||
164652075|NCT01294592|594752941|FG000|Overall Study|Physician Decision|6|||
164652076|NCT01294592|594752942|FG001|Overall Study|Physician Decision|11|||
164652077|NCT01294592|594752941|FG000|Overall Study|Withdrawal by Subject|28|||
164652078|NCT01294592|594752942|FG001|Overall Study|Withdrawal by Subject|28|||
164652079|NCT00623623|594752943|FG000|Overall Study|Previous enrolment into this study|1|||
164652080|NCT00623623|594752944|FG001|Overall Study|Previous enrolment into this study|1|||
164652081|NCT00693784|594752945|FG000|Overall Study|Lost to Follow-up|2|||
164652082|NCT00693784|594752945|FG000|Overall Study|Withdrawal by Subject|2|||
164652083|NCT02265952|594752946|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
164652084|NCT02265952|594752947|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
164652085|NCT02265952|594752946|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
164652086|NCT02265952|594752947|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
164652087|NCT00326885|594752950|FG000|Overall Study|Adverse Event|1|||
164652088|NCT00326885|594752950|FG000|Overall Study|Withdrawal by Subject|3|||
164652089|NCT00326885|594752950|FG000|Overall Study|Physician Decision|1|||
164652090|NCT00326885|594752950|FG000|Overall Study|Hospice withdrew consent|2|||
164652091|NCT01759381|594752955|FG000|Overall Study|Death|1|||
164652092|NCT01759381|594752956|FG001|Overall Study|Death|0|||
164652093|NCT00738673|594752958|FG000|Overall Study|Adverse Event|1|||
164652094|NCT00738673|594752959|FG001|Overall Study|Adverse Event|0|||
164652095|NCT00738673|594752958|FG000|Overall Study|Lack of Efficacy|19|||
164652096|NCT00738673|594752959|FG001|Overall Study|Lack of Efficacy|8|||
164652097|NCT00738673|594752958|FG000|Overall Study|Protocol Violation|1|||
164652098|NCT00738673|594752959|FG001|Overall Study|Protocol Violation|2|||
164652099|NCT00738673|594752958|FG000|Overall Study|Withdrawal by Subject|3|||
164652100|NCT00738673|594752959|FG001|Overall Study|Withdrawal by Subject|1|||
164652101|NCT02736227|594752960|FG000|Overall Study|Withdrawal by Subject|0|||
164652102|NCT02736227|594752961|FG001|Overall Study|Withdrawal by Subject|0|||
164652103|NCT02736227|594752962|FG002|Overall Study|Withdrawal by Subject|1|||
164652104|NCT02736227|594752960|FG000|Overall Study|Physician Decision|0|||
164652105|NCT02736227|594752961|FG001|Overall Study|Physician Decision|0|||
164652106|NCT02736227|594752962|FG002|Overall Study|Physician Decision|5|||
164652107|NCT02736227|594752960|FG000|Overall Study|Non Compliant|0|||
164652108|NCT02736227|594752961|FG001|Overall Study|Non Compliant|0|||
164652109|NCT02736227|594752962|FG002|Overall Study|Non Compliant|2|||
164652110|NCT00068237|594752970|FG000|Overall Study|Ineligible|3|||
164652111|NCT00068237|594752970|FG000|Overall Study|No protocol treatment received|2|||
164652112|NCT05288673|594752971|FG000|Overall Study|Consent withdrawn by subject|0|||
164652113|NCT05288673|594752972|FG001|Overall Study|Consent withdrawn by subject|0|||
164652114|NCT05288673|594752973|FG002|Overall Study|Consent withdrawn by subject|1|||
164652115|NCT03056352|594752974|FG000|Overall Study|Lost to Follow-up|1|||
164652116|NCT00571922|594752975|FG000|Overall Study|Completion unknown|36|||
164652117|NCT00571922|594752976|FG001|Overall Study|Completion unknown|36|||
164652118|NCT02971605|594752977|FG000|Overall Study|Withdrawal by Subject|1|||
164652119|NCT01154153|594752980|FG000|Overall Study|Poor compliance to protocol|2|||
164652120|NCT01154153|594752981|FG001|Overall Study|Poor compliance to protocol|0|||
164652121|NCT01154153|594752980|FG000|Overall Study|Unable to use labs|2|||
164652122|NCT01154153|594752981|FG001|Overall Study|Unable to use labs|3|||
164652123|NCT01154153|594752980|FG000|Overall Study|Withdrew consent|1|||
164652124|NCT01154153|594752981|FG001|Overall Study|Withdrew consent|0|||
164652125|NCT00964223|594752982|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
164652126|NCT03439293|594752983|FG000|Overall Study|Death|22|||
164652127|NCT03439293|594752983|FG000|Overall Study|Withdrawal by Subject|8|||
164652128|NCT03439293|594752983|FG000|Overall Study|Lost to Follow-up|2|||
164652129|NCT03439293|594752983|FG000|Overall Study|Reason Not Specified|28|||
164652130|NCT03439293|594752983|FG000|Overall Study|Missing|1|||
164652131|NCT00869089|594752986|FG000|Overall Study|Lost to Follow-up|1|||
164652132|NCT00869089|594752986|FG000|Overall Study|Withdrawal by Subject|1|||
164652133|NCT00869089|594752986|FG000|Overall Study|Screen Fail|1|||
164652134|NCT01169844|594752987|FG000|Overall Study|Adverse Event|0|||
164652135|NCT01169844|594752988|FG001|Overall Study|Adverse Event|1|||
164652136|NCT01169844|594752987|FG000|Overall Study|Patient withdrew consent|4|||
164652137|NCT01169844|594752988|FG001|Overall Study|Patient withdrew consent|0|||
164652138|NCT01169844|594752987|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164652139|NCT01169844|594752988|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164652140|NCT00435825|594752992|FG000|Overall Study|Abnormality of Laboratory Test|0|||
164652141|NCT00435825|594752993|FG001|Overall Study|Abnormality of Laboratory Test|1|||
164652142|NCT00435825|594752994|FG002|Overall Study|Abnormality of Laboratory Test|0|||
164652143|NCT00435825|594752995|FG003|Overall Study|Abnormality of Laboratory Test|0|||
164652144|NCT00435825|594752992|FG000|Overall Study|Insufficient Therapeutic Response|3|||
164652145|NCT00435825|594752993|FG001|Overall Study|Insufficient Therapeutic Response|1|||
164652146|NCT00435825|594752994|FG002|Overall Study|Insufficient Therapeutic Response|0|||
164652147|NCT00435825|594752995|FG003|Overall Study|Insufficient Therapeutic Response|3|||
164652148|NCT00435825|594752992|FG000|Overall Study|Other Protocol Violation|1|||
164652149|NCT00435825|594752993|FG001|Overall Study|Other Protocol Violation|0|||
164652150|NCT00435825|594752994|FG002|Overall Study|Other Protocol Violation|0|||
164652151|NCT00435825|594752995|FG003|Overall Study|Other Protocol Violation|0|||
164652152|NCT00435825|594752992|FG000|Overall Study|Refused treatment|2|||
164652153|NCT00435825|594752993|FG001|Overall Study|Refused treatment|0|||
164652154|NCT00435825|594752994|FG002|Overall Study|Refused treatment|0|||
164652155|NCT00435825|594752995|FG003|Overall Study|Refused treatment|5|||
164652156|NCT00435825|594752992|FG000|Overall Study|Failure to return|5|||
164652157|NCT00435825|594752993|FG001|Overall Study|Failure to return|0|||
164652158|NCT00435825|594752994|FG002|Overall Study|Failure to return|4|||
164652159|NCT00435825|594752995|FG003|Overall Study|Failure to return|0|||
164652160|NCT00435825|594752992|FG000|Overall Study|Did not receive study drug|1|||
164652161|NCT00435825|594752993|FG001|Overall Study|Did not receive study drug|0|||
164652162|NCT00435825|594752994|FG002|Overall Study|Did not receive study drug|2|||
164652163|NCT00435825|594752995|FG003|Overall Study|Did not receive study drug|0|||
164652164|NCT00435825|594752992|FG000|Overall Study|Did not enter follow-up|0|||
164652165|NCT00435825|594752993|FG001|Overall Study|Did not enter follow-up|4|||
164652166|NCT00435825|594752994|FG002|Overall Study|Did not enter follow-up|1|||
164652167|NCT00435825|594752995|FG003|Overall Study|Did not enter follow-up|3|||
164652168|NCT00435825|594752992|FG000|Overall Study|Did not complete full follow-up period|6|||
164652169|NCT00435825|594752993|FG001|Overall Study|Did not complete full follow-up period|6|||
164652170|NCT00435825|594752994|FG002|Overall Study|Did not complete full follow-up period|4|||
164652171|NCT00435825|594752995|FG003|Overall Study|Did not complete full follow-up period|5|||
164652172|NCT05003167|594752996|FG000|Overall Study|Withdrawal by Subject|1|||
164652173|NCT01010230|594752997|FG000|Overall Study|Withdrawal by Subject|6|||
164652174|NCT01010230|594752998|FG001|Overall Study|Withdrawal by Subject|5|||
164652175|NCT01010230|594752997|FG000|Overall Study|Lost to Follow-up|4|||
164652176|NCT01010230|594752998|FG001|Overall Study|Lost to Follow-up|2|||
164652177|NCT02367781|594753001|FG000|Overall Study|Withdrawal by Subject|20|||
164652178|NCT02367781|594753002|FG001|Overall Study|Withdrawal by Subject|13|||
164652179|NCT02367781|594753001|FG000|Overall Study|Protocol Violation|0|||
164652180|NCT02367781|594753002|FG001|Overall Study|Protocol Violation|1|||
164652181|NCT02367781|594753001|FG000|Overall Study|Physician Decision|7|||
164652182|NCT02367781|594753002|FG001|Overall Study|Physician Decision|0|||
164652183|NCT02367781|594753001|FG000|Overall Study|Randomized in Error|5|||
164652184|NCT02367781|594753002|FG001|Overall Study|Randomized in Error|4|||
164652185|NCT02367781|594753001|FG000|Overall Study|Non-Compliance|1|||
164652186|NCT02367781|594753002|FG001|Overall Study|Non-Compliance|0|||
164652187|NCT02367781|594753001|FG000|Overall Study|Lost to Follow-up|1|||
164652188|NCT02367781|594753002|FG001|Overall Study|Lost to Follow-up|2|||
164652189|NCT02367781|594753001|FG000|Overall Study|Death|330|||
164652190|NCT02367781|594753002|FG001|Overall Study|Death|176|||
164652191|NCT02367781|594753001|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
164652192|NCT02367781|594753002|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
164652193|NCT02367781|594753001|FG000|Overall Study|Prolonged Hospitalization|1|||
164652194|NCT02367781|594753002|FG001|Overall Study|Prolonged Hospitalization|0|||
164652195|NCT02367781|594753001|FG000|Overall Study|Death Prior First Dose|1|||
164652196|NCT02367781|594753002|FG001|Overall Study|Death Prior First Dose|0|||
164652197|NCT02367781|594753001|FG000|Overall Study|Administrative-Change Facility|1|||
164652198|NCT02367781|594753002|FG001|Overall Study|Administrative-Change Facility|0|||
164652199|NCT02367781|594753001|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
164652200|NCT02367781|594753002|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
164652201|NCT02367781|594753001|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
164652202|NCT02367781|594753002|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
164652203|NCT02367781|594753001|FG000|Overall Study|Study Terminated by Sponsor|3|||
164652204|NCT02367781|594753002|FG001|Overall Study|Study Terminated by Sponsor|1|||
164652205|NCT02367781|594753001|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
164652206|NCT02367781|594753002|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
164652207|NCT02367781|594753001|FG000|Overall Study|Sponsor Decision|2|||
164652208|NCT02367781|594753002|FG001|Overall Study|Sponsor Decision|0|||
164652209|NCT02367781|594753001|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
164652210|NCT02367781|594753002|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
164652211|NCT00343642|594755036|FG000|Overall Study|Lost to Follow-up|0|||
164652212|NCT00343642|594755037|FG001|Overall Study|Lost to Follow-up|1|||
164652213|NCT00343642|594755038|FG002|Overall Study|Lost to Follow-up|0|||
164652214|NCT00343642|594755036|FG000|Overall Study|Pregnancy|1|||
164652215|NCT00343642|594755037|FG001|Overall Study|Pregnancy|0|||
164652216|NCT00343642|594755038|FG002|Overall Study|Pregnancy|2|||
164652217|NCT00343642|594755036|FG000|Overall Study|Withdrawal by Subject|2|||
164652218|NCT00343642|594755037|FG001|Overall Study|Withdrawal by Subject|3|||
164652219|NCT00343642|594755038|FG002|Overall Study|Withdrawal by Subject|4|||
164652220|NCT00343642|594755036|FG000|Overall Study|Adverse Event|0|||
164652221|NCT00343642|594755037|FG001|Overall Study|Adverse Event|0|||
164652222|NCT00343642|594755038|FG002|Overall Study|Adverse Event|1|||
164652223|NCT00343642|594755036|FG000|Overall Study|Flare up|6|||
164652224|NCT00343642|594755037|FG001|Overall Study|Flare up|4|||
164652225|NCT00343642|594755038|FG002|Overall Study|Flare up|0|||
164652226|NCT00860574|594755041|FG000|Overall Study|Death|2|||
164652227|NCT00860574|594755041|FG000|Overall Study|Relapse|1|||
164652228|NCT02496221|594755042|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
164652229|NCT02496221|594755043|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
164652230|NCT02496221|594755042|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
164652231|NCT02496221|594755043|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
164652232|NCT02496221|594755042|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
164652233|NCT02496221|594755043|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
164652234|NCT01335399|594755044|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
164652235|NCT01335399|594755045|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
164652236|NCT01335399|594755044|FG000|Pre-treatment Period|Participant request to discontinue|0|||
164652237|NCT01335399|594755045|FG001|Pre-treatment Period|Participant request to discontinue|1|||
164652238|NCT01335399|594755044|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
164652239|NCT01335399|594755045|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
164652240|NCT01335399|594755044|FG000|Pre-treatment Period|Consent withdrawal|3|||
164652241|NCT01335399|594755045|FG001|Pre-treatment Period|Consent withdrawal|0|||
164652242|NCT01335399|594755044|FG000|Treatment Period|Disease progression|117|||
164652243|NCT01335399|594755045|FG001|Treatment Period|Disease progression|145|||
164652244|NCT01335399|594755044|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
164652245|NCT01335399|594755045|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
164652246|NCT01335399|594755044|FG000|Treatment Period|Study drug toxicity|52|||
164652247|NCT01335399|594755045|FG001|Treatment Period|Study drug toxicity|64|||
164652248|NCT01335399|594755044|FG000|Treatment Period|Participant request to discontinue|30|||
164652249|NCT01335399|594755045|FG001|Treatment Period|Participant request to discontinue|22|||
164652250|NCT01335399|594755044|FG000|Treatment Period|Other reasons|30|||
164652251|NCT01335399|594755045|FG001|Treatment Period|Other reasons|30|||
164652252|NCT01335399|594755044|FG000|Treatment Period|Consent withdrawal|10|||
164652253|NCT01335399|594755045|FG001|Treatment Period|Consent withdrawal|7|||
164652254|NCT01335399|594755044|FG000|Treatment Period|Death|7|||
164652255|NCT01335399|594755045|FG001|Treatment Period|Death|6|||
164652256|NCT01335399|594755044|FG000|Treatment Period|Poor/Non-compliance|3|||
164652257|NCT01335399|594755045|FG001|Treatment Period|Poor/Non-compliance|4|||
164652258|NCT01335399|594755044|FG000|Treatment Period|Lost to Follow-up|2|||
164652259|NCT01335399|594755045|FG001|Treatment Period|Lost to Follow-up|2|||
164652260|NCT01335399|594755044|FG000|Treatment Period|Maximum clinical benefit|1|||
164652261|NCT01335399|594755045|FG001|Treatment Period|Maximum clinical benefit|1|||
164652262|NCT01335399|594755044|FG000|Treatment Period|No longer meet study criteria|1|||
164652263|NCT01335399|594755045|FG001|Treatment Period|No longer meet study criteria|1|||
164652264|NCT01335399|594755044|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
164652265|NCT01335399|594755045|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
164652266|NCT02092961|594755046|FG000|Overall Study|Not reported|1|||
164652267|NCT02092961|594755047|FG001|Overall Study|Not reported|0|||
164652268|NCT02092961|594755048|FG002|Overall Study|Not reported|1|||
164652269|NCT02092961|594755046|FG000|Overall Study|Study stopped|13|||
164652270|NCT02092961|594755047|FG001|Overall Study|Study stopped|9|||
164652271|NCT02092961|594755048|FG002|Overall Study|Study stopped|12|||
164652272|NCT02092961|594755046|FG000|Overall Study|Lack of therapeutic response|2|||
164652273|NCT02092961|594755047|FG001|Overall Study|Lack of therapeutic response|1|||
164652274|NCT02092961|594755048|FG002|Overall Study|Lack of therapeutic response|3|||
164652275|NCT02092961|594755046|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
164652276|NCT02092961|594755047|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
164652277|NCT02092961|594755048|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
164652278|NCT02092961|594755046|FG000|Overall Study|Adverse Event|2|||
164652279|NCT02092961|594755047|FG001|Overall Study|Adverse Event|4|||
164652280|NCT02092961|594755048|FG002|Overall Study|Adverse Event|0|||
164652281|NCT01393990|594755049|FG000|Overall Study|Adverse Event|0|||
164652282|NCT01393990|594755050|FG001|Overall Study|Adverse Event|0|||
164652283|NCT01393990|594755051|FG002|Overall Study|Adverse Event|0|||
164652284|NCT01393990|594755052|FG003|Overall Study|Adverse Event|0|||
164652285|NCT01393990|594755053|FG004|Overall Study|Adverse Event|0|||
164652286|NCT01393990|594755054|FG005|Overall Study|Adverse Event|0|||
164652287|NCT01393990|594755055|FG006|Overall Study|Adverse Event|0|||
164652288|NCT01393990|594755056|FG007|Overall Study|Adverse Event|0|||
164652289|NCT01393990|594755057|FG008|Overall Study|Adverse Event|0|||
164652290|NCT01393990|594755058|FG009|Overall Study|Adverse Event|0|||
164652291|NCT01393990|594755059|FG010|Overall Study|Adverse Event|0|||
164652292|NCT01393990|594755060|FG011|Overall Study|Adverse Event|0|||
164652293|NCT01393990|594755061|FG012|Overall Study|Adverse Event|0|||
164652294|NCT01393990|594755062|FG013|Overall Study|Adverse Event|0|||
164652295|NCT01393990|594755063|FG014|Overall Study|Adverse Event|1|||
164652296|NCT01393990|594755064|FG015|Overall Study|Adverse Event|1|||
164652297|NCT01393990|594755065|FG016|Overall Study|Adverse Event|0|||
164652298|NCT01393990|594755066|FG017|Overall Study|Adverse Event|0|||
164652299|NCT01393990|594755049|FG000|Overall Study|Progressive Disease|1|||
164652300|NCT01393990|594755050|FG001|Overall Study|Progressive Disease|0|||
164652301|NCT01393990|594755051|FG002|Overall Study|Progressive Disease|0|||
164652302|NCT01393990|594755052|FG003|Overall Study|Progressive Disease|1|||
164652303|NCT01393990|594755053|FG004|Overall Study|Progressive Disease|1|||
164189894|NCT00572455|593063990|FG004|Stage II (28 Days)|Death|0|||
164652304|NCT01393990|594755054|FG005|Overall Study|Progressive Disease|1|||
164652305|NCT01393990|594755055|FG006|Overall Study|Progressive Disease|1|||
164652306|NCT01393990|594755056|FG007|Overall Study|Progressive Disease|1|||
164652307|NCT01393990|594755057|FG008|Overall Study|Progressive Disease|3|||
164652308|NCT01393990|594755058|FG009|Overall Study|Progressive Disease|1|||
164189895|NCT00572455|593063991|FG005|Stage II (28 Days)|Death|0|||
164652309|NCT01393990|594755059|FG010|Overall Study|Progressive Disease|0|||
164652310|NCT01393990|594755060|FG011|Overall Study|Progressive Disease|0|||
164652311|NCT01393990|594755061|FG012|Overall Study|Progressive Disease|0|||
164652312|NCT01393990|594755062|FG013|Overall Study|Progressive Disease|1|||
164652313|NCT01393990|594755063|FG014|Overall Study|Progressive Disease|6|||
164652314|NCT01393990|594755064|FG015|Overall Study|Progressive Disease|1|||
164652315|NCT01393990|594755065|FG016|Overall Study|Progressive Disease|0|||
164652316|NCT01393990|594755066|FG017|Overall Study|Progressive Disease|0|||
164652317|NCT01393990|594755049|FG000|Overall Study|Death|0|||
164652318|NCT01393990|594755050|FG001|Overall Study|Death|0|||
164652319|NCT01393990|594755051|FG002|Overall Study|Death|0|||
164652320|NCT01393990|594755052|FG003|Overall Study|Death|0|||
164652321|NCT01393990|594755053|FG004|Overall Study|Death|1|||
164652322|NCT01393990|594755054|FG005|Overall Study|Death|0|||
164652323|NCT01393990|594755055|FG006|Overall Study|Death|0|||
164652324|NCT01393990|594755056|FG007|Overall Study|Death|0|||
164652325|NCT01393990|594755057|FG008|Overall Study|Death|0|||
164652326|NCT01393990|594755058|FG009|Overall Study|Death|0|||
164652327|NCT01393990|594755059|FG010|Overall Study|Death|0|||
164652328|NCT01393990|594755060|FG011|Overall Study|Death|0|||
164652329|NCT01393990|594755061|FG012|Overall Study|Death|0|||
164652330|NCT01393990|594755062|FG013|Overall Study|Death|1|||
164652331|NCT01393990|594755063|FG014|Overall Study|Death|1|||
164652332|NCT01393990|594755064|FG015|Overall Study|Death|0|||
164652333|NCT01393990|594755065|FG016|Overall Study|Death|0|||
164652334|NCT01393990|594755066|FG017|Overall Study|Death|0|||
164652335|NCT01393990|594755049|FG000|Overall Study|Withdrawal by Subject|0|||
164652336|NCT01393990|594755050|FG001|Overall Study|Withdrawal by Subject|0|||
164652337|NCT01393990|594755051|FG002|Overall Study|Withdrawal by Subject|0|||
164652338|NCT01393990|594755052|FG003|Overall Study|Withdrawal by Subject|0|||
164652339|NCT01393990|594755053|FG004|Overall Study|Withdrawal by Subject|0|||
164652340|NCT01393990|594755054|FG005|Overall Study|Withdrawal by Subject|0|||
164652341|NCT01393990|594755055|FG006|Overall Study|Withdrawal by Subject|0|||
164652342|NCT01393990|594755056|FG007|Overall Study|Withdrawal by Subject|0|||
164652343|NCT01393990|594755057|FG008|Overall Study|Withdrawal by Subject|0|||
164652344|NCT01393990|594755058|FG009|Overall Study|Withdrawal by Subject|0|||
164652345|NCT01393990|594755059|FG010|Overall Study|Withdrawal by Subject|0|||
164652346|NCT01393990|594755060|FG011|Overall Study|Withdrawal by Subject|0|||
164652347|NCT01393990|594755061|FG012|Overall Study|Withdrawal by Subject|0|||
164652348|NCT01393990|594755062|FG013|Overall Study|Withdrawal by Subject|0|||
164652349|NCT01393990|594755063|FG014|Overall Study|Withdrawal by Subject|1|||
164652350|NCT01393990|594755064|FG015|Overall Study|Withdrawal by Subject|1|||
164652351|NCT01393990|594755065|FG016|Overall Study|Withdrawal by Subject|0|||
164652352|NCT01393990|594755066|FG017|Overall Study|Withdrawal by Subject|0|||
164652353|NCT00331630|594755076|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
164652354|NCT00331630|594755076|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
164652355|NCT00331630|594755076|FG000|Follow up for 5 Years|Death|5|||
164652356|NCT00331630|594755076|FG000|Follow up for 5 Years|Data collection was stopped|24|||
164652357|NCT01133821|594755078|FG000|Overall Study|Lost to Follow-up|8|||
164652358|NCT01133821|594755079|FG001|Overall Study|Lost to Follow-up|11|||
164652359|NCT01133821|594755078|FG000|Overall Study|Withdrawal by Subject|8|||
164652360|NCT01133821|594755079|FG001|Overall Study|Withdrawal by Subject|3|||
164652361|NCT01133821|594755078|FG000|Overall Study|preferred other treatment|1|||
164652362|NCT01133821|594755079|FG001|Overall Study|preferred other treatment|1|||
164652363|NCT01133821|594755078|FG000|Overall Study|Protocol Violation|0|||
164652364|NCT01133821|594755079|FG001|Overall Study|Protocol Violation|1|||
164538483|NCT01968070|594344876|FG005|Period 1|Adverse Event|0|||
164538484|NCT01968070|594344877|FG006|Period 1|Adverse Event|1|||
164538485|NCT01968070|594344878|FG007|Period 1|Adverse Event|0|||
164538486|NCT01968070|594344879|FG008|Period 1|Adverse Event|0|||
164538487|NCT01968070|594344880|FG009|Period 1|Adverse Event|0|||
164538488|NCT01968070|594344881|FG010|Period 1|Adverse Event|0|||
164538489|NCT01968070|594344882|FG011|Period 1|Adverse Event|0|||
164538490|NCT01968070|594344883|FG012|Period 1|Adverse Event|0|||
164538491|NCT01968070|594344884|FG013|Period 1|Adverse Event|0|||
164538492|NCT01968070|594344885|FG014|Period 1|Adverse Event|0|||
164538493|NCT01968070|594344886|FG015|Period 1|Adverse Event|0|||
164538494|NCT01968070|594344887|FG016|Period 1|Adverse Event|0|||
164538495|NCT01968070|594344888|FG017|Period 1|Adverse Event|0|||
164538496|NCT01968070|594344871|FG000|Period 1|Physician Decision|0|||
164538497|NCT01968070|594344872|FG001|Period 1|Physician Decision|0|||
164538498|NCT01968070|594344873|FG002|Period 1|Physician Decision|0|||
164538499|NCT01968070|594344874|FG003|Period 1|Physician Decision|0|||
164538500|NCT01968070|594344875|FG004|Period 1|Physician Decision|0|||
164652365|NCT01133821|594755078|FG000|Overall Study|Refused participation|1|||
164538501|NCT01968070|594344876|FG005|Period 1|Physician Decision|0|||
164538502|NCT01968070|594344877|FG006|Period 1|Physician Decision|0|||
164538503|NCT01968070|594344878|FG007|Period 1|Physician Decision|0|||
164652366|NCT01133821|594755079|FG001|Overall Study|Refused participation|3|||
164652367|NCT01859390|594755082|FG000|Overall Study|Insufficient Sputum Collected|1|||
164652368|NCT01859390|594755083|FG001|Overall Study|Insufficient Sputum Collected|3|||
164652369|NCT01859390|594755082|FG000|Overall Study|Sample Missing Collection Date|0|||
164652370|NCT01859390|594755083|FG001|Overall Study|Sample Missing Collection Date|1|||
164652371|NCT01859390|594755082|FG000|Overall Study|Tube Cracked|0|||
164538504|NCT01968070|594344879|FG008|Period 1|Physician Decision|0|||
164652372|NCT01859390|594755083|FG001|Overall Study|Tube Cracked|2|||
164652373|NCT01859390|594755082|FG000|Overall Study|Shipment Error|0|||
164652374|NCT01859390|594755083|FG001|Overall Study|Shipment Error|1|||
164652375|NCT02451670|594755084|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
164652376|NCT02451670|594755085|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
164538505|NCT01968070|594344880|FG009|Period 1|Physician Decision|0|||
164652377|NCT00463866|594755089|FG000|Overall Study|Adverse Event|70|||
164652378|NCT00463866|594755090|FG001|Overall Study|Adverse Event|93|||
164652379|NCT00463866|594755089|FG000|Overall Study|Withdrawal by Subject|81|||
164652380|NCT00463866|594755090|FG001|Overall Study|Withdrawal by Subject|79|||
164652381|NCT00463866|594755089|FG000|Overall Study|Lost to Follow-up|46|||
164652382|NCT00463866|594755090|FG001|Overall Study|Lost to Follow-up|55|||
164652383|NCT00463866|594755089|FG000|Overall Study|Incorrect Enrolment|64|||
164652384|NCT00463866|594755090|FG001|Overall Study|Incorrect Enrolment|66|||
164652385|NCT00463866|594755089|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
164652386|NCT00463866|594755090|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
164652387|NCT00463866|594755089|FG000|Overall Study|Safety Reason|1|||
164652388|NCT00463866|594755090|FG001|Overall Study|Safety Reason|3|||
164652389|NCT00463866|594755089|FG000|Overall Study|Mis-Randomization of subject|0|||
164652390|NCT00463866|594755090|FG001|Overall Study|Mis-Randomization of subject|1|||
164652391|NCT00463866|594755089|FG000|Overall Study|Other|22|||
164652392|NCT00463866|594755090|FG001|Overall Study|Other|22|||
164652393|NCT01084005|594755091|FG000|Overall Study|Adverse Event|1|||
164652394|NCT01084005|594755092|FG001|Overall Study|Adverse Event|8|||
164652395|NCT01084005|594755091|FG000|Overall Study|Protocol Violation|3|||
164652396|NCT01084005|594755092|FG001|Overall Study|Protocol Violation|7|||
164652397|NCT01084005|594755091|FG000|Overall Study|Withdrawal by Subject|1|||
164652398|NCT01084005|594755092|FG001|Overall Study|Withdrawal by Subject|1|||
164652399|NCT02480010|594755097|FG000|Overall Study|Adverse Event|3|||
164652400|NCT02480010|594755098|FG001|Overall Study|Adverse Event|1|||
164652401|NCT02480010|594755097|FG000|Overall Study|Death|1|||
164652402|NCT02480010|594755098|FG001|Overall Study|Death|0|||
164652403|NCT02480010|594755097|FG000|Overall Study|Insufficient therapeutic response|31|||
164652404|NCT02480010|594755098|FG001|Overall Study|Insufficient therapeutic response|29|||
164652405|NCT02480010|594755097|FG000|Overall Study|Refused Treatment|0|||
164652406|NCT02480010|594755098|FG001|Overall Study|Refused Treatment|3|||
164652407|NCT00606684|594755099|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
164652408|NCT00606684|594755100|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
164652409|NCT00606684|594755101|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
164652410|NCT00606684|594755102|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
164652411|NCT00606684|594755103|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
164652412|NCT00606684|594755104|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
164652413|NCT00606684|594755105|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
164652414|NCT00606684|594755099|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
164652415|NCT00606684|594755100|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
164652416|NCT00606684|594755101|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
164652417|NCT00606684|594755102|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
164652418|NCT00606684|594755103|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
164652419|NCT00606684|594755104|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
164652420|NCT00606684|594755105|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
164652421|NCT00606684|594755099|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
164652422|NCT00606684|594755100|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
164652423|NCT00606684|594755101|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
164652424|NCT00606684|594755102|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
164652425|NCT00606684|594755103|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
164652426|NCT00606684|594755104|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
164652427|NCT00606684|594755105|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
164652428|NCT00606684|594755099|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
164652429|NCT00606684|594755100|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
164652430|NCT00606684|594755101|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
164652431|NCT00606684|594755102|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
164652432|NCT00606684|594755103|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
164652433|NCT00606684|594755104|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
164652434|NCT00606684|594755105|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
164652435|NCT00606684|594755099|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
164652436|NCT00606684|594755100|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
164652437|NCT00606684|594755101|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
164652438|NCT00606684|594755102|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
164652439|NCT00606684|594755103|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
164652440|NCT00606684|594755104|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
164652441|NCT00606684|594755105|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
164652442|NCT00606684|594755099|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
164652443|NCT00606684|594755100|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
164652444|NCT00606684|594755101|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
164652445|NCT00606684|594755102|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
164652446|NCT00606684|594755103|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
164538506|NCT01968070|594344881|FG010|Period 1|Physician Decision|0|||
164538507|NCT01968070|594344882|FG011|Period 1|Physician Decision|1|||
164538508|NCT01968070|594344883|FG012|Period 1|Physician Decision|0|||
164538509|NCT01968070|594344884|FG013|Period 1|Physician Decision|0|||
164538510|NCT01968070|594344885|FG014|Period 1|Physician Decision|0|||
164538511|NCT01968070|594344886|FG015|Period 1|Physician Decision|0|||
164538512|NCT01968070|594344887|FG016|Period 1|Physician Decision|0|||
164538513|NCT01968070|594344888|FG017|Period 1|Physician Decision|0|||
164538514|NCT01968070|594344871|FG000|Period 2|Withdrawal by Subject|0|||
164538515|NCT01968070|594344872|FG001|Period 2|Withdrawal by Subject|0|||
164538516|NCT01968070|594344873|FG002|Period 2|Withdrawal by Subject|0|||
164538517|NCT01968070|594344874|FG003|Period 2|Withdrawal by Subject|0|||
164538518|NCT01968070|594344875|FG004|Period 2|Withdrawal by Subject|1|||
164538519|NCT01968070|594344876|FG005|Period 2|Withdrawal by Subject|0|||
164538520|NCT01968070|594344877|FG006|Period 2|Withdrawal by Subject|0|||
164538521|NCT01968070|594344878|FG007|Period 2|Withdrawal by Subject|0|||
164538522|NCT01968070|594344879|FG008|Period 2|Withdrawal by Subject|0|||
164538523|NCT01968070|594344880|FG009|Period 2|Withdrawal by Subject|0|||
164538524|NCT01968070|594344881|FG010|Period 2|Withdrawal by Subject|0|||
164538525|NCT01968070|594344882|FG011|Period 2|Withdrawal by Subject|0|||
164538526|NCT01968070|594344883|FG012|Period 2|Withdrawal by Subject|0|||
164538527|NCT01968070|594344884|FG013|Period 2|Withdrawal by Subject|0|||
164538528|NCT01968070|594344885|FG014|Period 2|Withdrawal by Subject|0|||
164538529|NCT01968070|594344886|FG015|Period 2|Withdrawal by Subject|0|||
164538530|NCT01968070|594344887|FG016|Period 2|Withdrawal by Subject|0|||
164538531|NCT01968070|594344888|FG017|Period 2|Withdrawal by Subject|0|||
164538532|NCT01843218|594344893|FG000|Overall Study|Withdrawal by Subject|5|||
164538533|NCT01891721|594344896|FG000|Overall Study|Lost to Follow-up|10|||
164538534|NCT01891721|594344897|FG001|Overall Study|Lost to Follow-up|5|||
164538535|NCT01891721|594344898|FG002|Overall Study|Lost to Follow-up|1|||
164538536|NCT04908189|594344899|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
164538537|NCT04908189|594344900|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
164538538|NCT04908189|594344901|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
164538539|NCT04908189|594344899|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
164538540|NCT04908189|594344900|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
164538541|NCT04908189|594344901|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
164538542|NCT04908189|594344899|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
164538543|NCT04908189|594344900|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
164538544|NCT04908189|594344901|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
164538545|NCT04908189|594344899|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
164538546|NCT04908189|594344900|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
164538547|NCT04908189|594344901|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
164538548|NCT04908189|594344899|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
164538549|NCT04908189|594344900|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
164538550|NCT04908189|594344901|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
164538551|NCT04908189|594344899|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
164538552|NCT04908189|594344900|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
164538553|NCT04908189|594344901|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
164538554|NCT04908189|594344899|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
164538555|NCT04908189|594344900|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
164538556|NCT04908189|594344901|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
164538557|NCT04908189|594344899|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
164538558|NCT04908189|594344900|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
164538559|NCT04908189|594344901|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
164538560|NCT04908189|594344899|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
164538561|NCT04908189|594344900|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
164538562|NCT04908189|594344901|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
164538563|NCT04908189|594344899|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
164538564|NCT04908189|594344900|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
164538565|NCT04908189|594344901|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
164538566|NCT04908189|594344899|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
164538567|NCT04908189|594344900|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
164538568|NCT04908189|594344901|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
164538569|NCT04908189|594344899|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
164652447|NCT00606684|594755104|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
164538570|NCT04908189|594344900|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
164538571|NCT04908189|594344901|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
164652448|NCT00606684|594755105|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
164652449|NCT00606684|594755099|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
164538572|NCT05118204|594344902|FG000|Overall Study|Lost to Follow-up|3|||
164538573|NCT05118204|594344903|FG001|Overall Study|Lost to Follow-up|2|||
164538574|NCT05118204|594344902|FG000|Overall Study|Withdrawal by Subject|0|||
164538575|NCT05118204|594344903|FG001|Overall Study|Withdrawal by Subject|2|||
164538576|NCT00607022|594344904|FG000|Overall Study|Withdrawal by Subject|1|||
164538577|NCT00607022|594344905|FG001|Overall Study|Withdrawal by Subject|0|||
164538578|NCT00607022|594344906|FG002|Overall Study|Withdrawal by Subject|0|||
164538579|NCT05393037|594344907|FG000|Part A|Death|1|||
164538580|NCT05393037|594344908|FG001|Part A|Death|0|||
164538581|NCT05393037|594344907|FG000|Part A|Lost to Follow-up|1|||
164538582|NCT05393037|594344908|FG001|Part A|Lost to Follow-up|1|||
164538583|NCT05393037|594344907|FG000|Part A|Withdrawal by Subject|2|||
164538584|NCT05393037|594344908|FG001|Part A|Withdrawal by Subject|4|||
164538585|NCT05393037|594344907|FG000|Part B|Lost to Follow-up|1|||
164538586|NCT05393037|594344908|FG001|Part B|Lost to Follow-up|0|||
164538587|NCT04409353|594344909|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
164538588|NCT04409353|594344910|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
164538589|NCT04409353|594344911|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
164538590|NCT04409353|594344909|FG000|Overall Study|Lost to Follow-up|6|||
164538591|NCT04409353|594344910|FG001|Overall Study|Lost to Follow-up|8|||
164538592|NCT04409353|594344911|FG002|Overall Study|Lost to Follow-up|7|||
164538593|NCT04409353|594344909|FG000|Overall Study|Major surgery during participation window|4|||
164538594|NCT04409353|594344910|FG001|Overall Study|Major surgery during participation window|3|||
164538595|NCT04409353|594344911|FG002|Overall Study|Major surgery during participation window|3|||
164538596|NCT04409353|594344909|FG000|Overall Study|Life event occurred during participation window|3|||
164538597|NCT04409353|594344910|FG001|Overall Study|Life event occurred during participation window|2|||
164538598|NCT04409353|594344911|FG002|Overall Study|Life event occurred during participation window|4|||
164538599|NCT04409353|594344909|FG000|Overall Study|Lack of Efficacy|4|||
164538600|NCT04409353|594344910|FG001|Overall Study|Lack of Efficacy|1|||
164538601|NCT04409353|594344911|FG002|Overall Study|Lack of Efficacy|3|||
164538602|NCT04409353|594344909|FG000|Overall Study|Adverse Event|2|||
164538603|NCT04409353|594344910|FG001|Overall Study|Adverse Event|1|||
164538604|NCT04409353|594344911|FG002|Overall Study|Adverse Event|1|||
164538605|NCT04409353|594344909|FG000|Overall Study|Disease burden - unable to participate|0|||
164538606|NCT04409353|594344910|FG001|Overall Study|Disease burden - unable to participate|1|||
164538607|NCT04409353|594344911|FG002|Overall Study|Disease burden - unable to participate|1|||
164538608|NCT04409353|594344909|FG000|Overall Study|Intervention too complicated|1|||
164538609|NCT04409353|594344910|FG001|Overall Study|Intervention too complicated|0|||
164538610|NCT04409353|594344911|FG002|Overall Study|Intervention too complicated|1|||
164538611|NCT01012739|594344912|FG000|Treatment Period 1|Adverse Event|0|||
164538612|NCT01012739|594344913|FG001|Treatment Period 1|Adverse Event|0|||
164538613|NCT01012739|594344914|FG002|Treatment Period 1|Adverse Event|0|||
164538614|NCT01012739|594344915|FG003|Treatment Period 1|Adverse Event|1|||
164538615|NCT01012739|594344912|FG000|Treatment Period 2|Abnormal test procedure results|0|||
164538616|NCT01012739|594344913|FG001|Treatment Period 2|Abnormal test procedure results|0|||
164538617|NCT01012739|594344914|FG002|Treatment Period 2|Abnormal test procedure results|0|||
164538618|NCT01012739|594344915|FG003|Treatment Period 2|Abnormal test procedure results|1|||
164538619|NCT04540133|594344916|FG000|Overall Study|Lost to Follow-up|1|||
164538620|NCT04540133|594344917|FG001|Overall Study|Lost to Follow-up|0|||
164538621|NCT04014361|594344918|FG000|Period 2|Physician Decision|0|||
164538622|NCT04014361|594344919|FG001|Period 2|Physician Decision|0|||
164538623|NCT04014361|594344920|FG002|Period 2|Physician Decision|0|||
164538624|NCT04014361|594344921|FG003|Period 2|Physician Decision|1|||
164538625|NCT04014361|594344922|FG004|Period 2|Physician Decision|0|||
164538626|NCT04014361|594344923|FG005|Period 2|Physician Decision|0|||
164538627|NCT04014361|594344924|FG006|Period 2|Physician Decision|0|||
164538628|NCT04014361|594344925|FG007|Period 2|Physician Decision|0|||
164538629|NCT06308666|594344926|FG000|Overall Study|Withdrawal by Subject|1|||
164538630|NCT06308666|594344926|FG000|Overall Study|Protocol Violation|2|||
164538631|NCT01130051|594344932|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
164538632|NCT01130051|594344933|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
164538633|NCT01130051|594344932|FG000|Washout Period of 14 Days|Protocol Violation|1|||
164538634|NCT01130051|594344933|FG001|Washout Period of 14 Days|Protocol Violation|1|||
164538635|NCT01658826|594344937|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
164538636|NCT01658826|594344938|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
164538637|NCT01658826|594344937|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
164652450|NCT00606684|594755100|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
164538638|NCT01658826|594344938|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
164538639|NCT01658826|594344937|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
164538640|NCT01658826|594344938|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
164538641|NCT01658826|594344937|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
164538642|NCT01658826|594344938|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
164538643|NCT01658826|594344937|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
164538644|NCT01658826|594344938|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
164538645|NCT01658826|594344937|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
164538646|NCT01658826|594344938|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
164538647|NCT01658826|594344937|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
164538648|NCT01658826|594344938|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
164538649|NCT01658826|594344937|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
164538650|NCT01658826|594344938|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
164538651|NCT01658826|594344937|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
164538652|NCT01658826|594344938|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
164538653|NCT02383589|594344940|FG000|Treatment Period|Adverse Event|1|||
164538654|NCT02383589|594344941|FG001|Treatment Period|Adverse Event|3|||
164538655|NCT02383589|594344940|FG000|Treatment Period|Lost to Follow-up|0|||
164538656|NCT02383589|594344941|FG001|Treatment Period|Lost to Follow-up|1|||
164538657|NCT02383589|594344940|FG000|Treatment Period|Withdrawal by Subject|0|||
164538658|NCT02383589|594344941|FG001|Treatment Period|Withdrawal by Subject|5|||
164538659|NCT02383589|594344940|FG000|Treatment Period|Non-compliance with study drug|0|||
164538660|NCT02383589|594344941|FG001|Treatment Period|Non-compliance with study drug|1|||
164538661|NCT02383589|594344940|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
164538662|NCT02383589|594344941|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
164538663|NCT02383589|594344940|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
164538664|NCT02383589|594344941|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
164538665|NCT02383589|594344940|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
164538666|NCT02383589|594344941|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
164538667|NCT04600336|594344942|FG000|Initial Treatment|Withdrawal by Subject|1|||
164538668|NCT04600336|594344943|FG001|Initial Treatment|Withdrawal by Subject|2|||
164538669|NCT04600336|594344944|FG002|Initial Treatment|Withdrawal by Subject|0|||
164538670|NCT04600336|594344945|FG003|Initial Treatment|Withdrawal by Subject|0|||
164538671|NCT04600336|594344942|FG000|Initial Treatment|Adverse Event|0|||
164538672|NCT04600336|594344943|FG001|Initial Treatment|Adverse Event|2|||
164538673|NCT04600336|594344944|FG002|Initial Treatment|Adverse Event|0|||
164538674|NCT04600336|594344945|FG003|Initial Treatment|Adverse Event|0|||
164538675|NCT04600336|594344942|FG000|Initial Treatment|Other complicating disease|0|||
164538676|NCT04600336|594344943|FG001|Initial Treatment|Other complicating disease|0|||
164538677|NCT04600336|594344944|FG002|Initial Treatment|Other complicating disease|1|||
164538678|NCT04600336|594344945|FG003|Initial Treatment|Other complicating disease|0|||
164538679|NCT04600336|594344942|FG000|Crossover Treatment|Withdrawal by Subject|0|||
164538680|NCT04600336|594344943|FG001|Crossover Treatment|Withdrawal by Subject|0|||
164538681|NCT04600336|594344944|FG002|Crossover Treatment|Withdrawal by Subject|2|||
164538682|NCT04600336|594344945|FG003|Crossover Treatment|Withdrawal by Subject|1|||
164538683|NCT04600336|594344942|FG000|Crossover Treatment|Adverse Event|0|||
164538684|NCT04600336|594344943|FG001|Crossover Treatment|Adverse Event|0|||
164538685|NCT04600336|594344944|FG002|Crossover Treatment|Adverse Event|1|||
164538686|NCT04600336|594344945|FG003|Crossover Treatment|Adverse Event|1|||
164538687|NCT04223791|594344946|FG000|Overall Study|Lost to Follow-up|0|||
164538688|NCT04223791|594344947|FG001|Overall Study|Lost to Follow-up|4|||
164538689|NCT04223791|594344946|FG000|Overall Study|Physician Decision|5|||
164538690|NCT04223791|594344947|FG001|Overall Study|Physician Decision|1|||
164538691|NCT04223791|594344946|FG000|Overall Study|Protocol Violation|1|||
164538692|NCT04223791|594344947|FG001|Overall Study|Protocol Violation|1|||
164538693|NCT04223791|594344946|FG000|Overall Study|Withdrawal by Subject|10|||
164538694|NCT04223791|594344947|FG001|Overall Study|Withdrawal by Subject|12|||
164538695|NCT04223791|594344946|FG000|Overall Study|Pregnancy|1|||
164538696|NCT04223791|594344947|FG001|Overall Study|Pregnancy|1|||
164538697|NCT04223791|594344946|FG000|Overall Study|Ongoing in Study|305|||
164538698|NCT04223791|594344947|FG001|Overall Study|Ongoing in Study|302|||
164538699|NCT01493557|594346232|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
164538700|NCT01493557|594346233|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
164538701|NCT01493557|594346234|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
164538702|NCT01493557|594346232|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
164538703|NCT01493557|594346233|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
164538704|NCT01493557|594346234|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
164538705|NCT01493557|594346232|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
164538706|NCT01493557|594346233|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
164538707|NCT01493557|594346234|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
164538708|NCT01493557|594346232|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
164538709|NCT01493557|594346233|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
164589130|NCT01070550|594521376|FG004|Overall Study|Protocol Violation|0|||
164589131|NCT01070550|594521377|FG005|Overall Study|Protocol Violation|0|||
164538710|NCT01493557|594346234|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
164538711|NCT01493557|594346232|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
164538712|NCT01493557|594346233|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
164538713|NCT01493557|594346234|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
164538714|NCT01493557|594346232|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
164538715|NCT01493557|594346233|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
164538716|NCT01493557|594346234|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
164538717|NCT01493557|594346232|FG000|Not Randomized to Management Strategies|Early termination|0|||
164538718|NCT01493557|594346233|FG001|Not Randomized to Management Strategies|Early termination|0|||
164538719|NCT01493557|594346234|FG002|Not Randomized to Management Strategies|Early termination|34|||
164538720|NCT01493557|594346232|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
164538721|NCT01493557|594346233|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
164538722|NCT01493557|594346234|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
164538723|NCT01493557|594346232|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
164538724|NCT01493557|594346233|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
164538725|NCT01493557|594346234|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
164538726|NCT01493557|594346232|FG000|Randomized to Management Strategies|Other adverse event|8|||
164538727|NCT01493557|594346233|FG001|Randomized to Management Strategies|Other adverse event|5|||
164538728|NCT01493557|594346234|FG002|Randomized to Management Strategies|Other adverse event|0|||
164538729|NCT01493557|594346232|FG000|Randomized to Management Strategies|Protocol Violation|3|||
164538730|NCT01493557|594346233|FG001|Randomized to Management Strategies|Protocol Violation|0|||
164538731|NCT01493557|594346234|FG002|Randomized to Management Strategies|Protocol Violation|0|||
164538732|NCT01493557|594346232|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
164538733|NCT01493557|594346233|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
164538734|NCT01493557|594346234|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
164538735|NCT01493557|594346232|FG000|Randomized to Management Strategies|Other than stated above|1|||
164538736|NCT01493557|594346233|FG001|Randomized to Management Strategies|Other than stated above|3|||
164538737|NCT01493557|594346234|FG002|Randomized to Management Strategies|Other than stated above|0|||
164538738|NCT01493557|594346232|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
164538739|NCT01493557|594346233|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
164538740|NCT01493557|594346234|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
164538741|NCT01493557|594346232|FG000|Adding the Second Strategy|Other adverse event|1|||
164538742|NCT01493557|594346233|FG001|Adding the Second Strategy|Other adverse event|2|||
164538743|NCT01493557|594346234|FG002|Adding the Second Strategy|Other adverse event|0|||
164538744|NCT01493557|594346232|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
164538745|NCT01493557|594346233|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
164538746|NCT01493557|594346234|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
164538747|NCT02973425|594346236|FG000|Overall Study|Lost to Follow-up|49|||
164538748|NCT02973425|594346237|FG001|Overall Study|Lost to Follow-up|53|||
164538749|NCT00909792|594346238|FG000|Period 1|Did not meet inclusion criteria|0|||
164538750|NCT00909792|594346239|FG001|Period 1|Did not meet inclusion criteria|1|||
164538751|NCT00909792|594346238|FG000|Period 2|Biomicroscopy|1|||
164538752|NCT00909792|594346239|FG001|Period 2|Biomicroscopy|0|||
164538753|NCT00909792|594346238|FG000|Period 2|Lost to Follow-up|0|||
164538754|NCT00909792|594346239|FG001|Period 2|Lost to Follow-up|1|||
164538755|NCT03823404|594346240|FG000|Overall Study|Lost to Follow-up|1|||
164538756|NCT03823404|594346241|FG001|Overall Study|Lost to Follow-up|2|||
164538757|NCT03823404|594346242|FG002|Overall Study|Lost to Follow-up|3|||
164538758|NCT03823404|594346240|FG000|Overall Study|Protocol Violation|2|||
164652451|NCT00606684|594755101|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
164652452|NCT00606684|594755102|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
164652453|NCT00606684|594755103|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
164652454|NCT00606684|594755104|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
164652455|NCT00606684|594755105|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
164652456|NCT00606684|594755099|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164652457|NCT00606684|594755100|FG001|Double-Blind Treatment Period|Adverse Event|3|||
164652458|NCT00606684|594755101|FG002|Double-Blind Treatment Period|Adverse Event|2|||
164538759|NCT03823404|594346241|FG001|Overall Study|Protocol Violation|0|||
164538760|NCT03823404|594346242|FG002|Overall Study|Protocol Violation|2|||
164538761|NCT03823404|594346240|FG000|Overall Study|Adverse Event|35|||
164538762|NCT03823404|594346241|FG001|Overall Study|Adverse Event|38|||
164538763|NCT03823404|594346242|FG002|Overall Study|Adverse Event|8|||
164538764|NCT03823404|594346240|FG000|Overall Study|Withdrawal by Subject|38|||
164538765|NCT03823404|594346241|FG001|Overall Study|Withdrawal by Subject|40|||
164538766|NCT03823404|594346242|FG002|Overall Study|Withdrawal by Subject|35|||
164652459|NCT00606684|594755102|FG003|Double-Blind Treatment Period|Adverse Event|4|||
164652460|NCT00606684|594755103|FG004|Double-Blind Treatment Period|Adverse Event|2|||
164538767|NCT03823404|594346240|FG000|Overall Study|Death|4|||
164538768|NCT03823404|594346241|FG001|Overall Study|Death|0|||
164538769|NCT03823404|594346242|FG002|Overall Study|Death|0|||
164538770|NCT03823404|594346240|FG000|Overall Study|Other: Various reasons provided|5|||
164538771|NCT03823404|594346241|FG001|Overall Study|Other: Various reasons provided|5|||
164538772|NCT03823404|594346242|FG002|Overall Study|Other: Various reasons provided|6|||
164538773|NCT00059839|594346244|FG000|Overall Study|Death|1|||
164538774|NCT00059839|594346245|FG001|Overall Study|Death|1|||
164538775|NCT00059839|594346244|FG000|Overall Study|Lack of Efficacy|6|||
164538776|NCT00059839|594346245|FG001|Overall Study|Lack of Efficacy|5|||
164538777|NCT00059839|594346244|FG000|Overall Study|Lost to Follow-up|2|||
164538778|NCT00059839|594346245|FG001|Overall Study|Lost to Follow-up|0|||
164538779|NCT00059839|594346244|FG000|Overall Study|Physician Decision|1|||
164538780|NCT00059839|594346245|FG001|Overall Study|Physician Decision|2|||
164538781|NCT00059839|594346244|FG000|Overall Study|Withdrawal by Subject|1|||
164538782|NCT00059839|594346245|FG001|Overall Study|Withdrawal by Subject|6|||
164538783|NCT00059839|594346244|FG000|Overall Study|Ineligible|1|||
164538784|NCT00059839|594346245|FG001|Overall Study|Ineligible|3|||
164538785|NCT02224599|594346248|FG000|Overall Study|Physician Decision|1|||
164538786|NCT02224599|594346248|FG000|Overall Study|Progression of Disease|1|||
164538787|NCT01330914|594346249|FG000|Overall Study|Withdrawal by Subject|4|||
164538788|NCT01330914|594346249|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
164538789|NCT03085758|594346256|FG000|Overall Study|Death|26|||
164538790|NCT03085758|594346257|FG001|Overall Study|Death|24|||
164538791|NCT03085758|594346258|FG002|Overall Study|Death|53|||
164538792|NCT03085758|594346256|FG000|Overall Study|Lost to Follow-up|1|||
164538793|NCT03085758|594346257|FG001|Overall Study|Lost to Follow-up|1|||
164538794|NCT03085758|594346258|FG002|Overall Study|Lost to Follow-up|1|||
164538795|NCT03085758|594346256|FG000|Overall Study|Withdrawal by Subject|2|||
164538796|NCT03085758|594346257|FG001|Overall Study|Withdrawal by Subject|2|||
164538797|NCT03085758|594346258|FG002|Overall Study|Withdrawal by Subject|1|||
164538798|NCT03085758|594346256|FG000|Overall Study|Refusal to recall it up to day 90|0|||
164538799|NCT03085758|594346257|FG001|Overall Study|Refusal to recall it up to day 90|0|||
164538800|NCT03085758|594346258|FG002|Overall Study|Refusal to recall it up to day 90|1|||
164538801|NCT03085758|594346256|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
164538802|NCT03085758|594346257|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
164538803|NCT03085758|594346258|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
164538804|NCT03974334|594346259|FG000|Overall Study|Lost to Follow-up|1|||
164538805|NCT00312221|594346266|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
164538806|NCT00312221|594346267|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
164538807|NCT00312221|594346268|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
164538808|NCT00312221|594346269|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
164538809|NCT00312221|594346266|FG000|Open-label Run-in Period|Adverse Event|74|||
164538810|NCT00312221|594346267|FG001|Open-label Run-in Period|Adverse Event|0|||
164538811|NCT00312221|594346268|FG002|Open-label Run-in Period|Adverse Event|0|||
164538812|NCT00312221|594346269|FG003|Open-label Run-in Period|Adverse Event|0|||
164538813|NCT00312221|594346266|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
164538814|NCT00312221|594346267|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
164538815|NCT00312221|594346268|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
164538816|NCT00312221|594346269|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
164538817|NCT00312221|594346266|FG000|Open-label Run-in Period|Administrative|42|||
164538818|NCT00312221|594346267|FG001|Open-label Run-in Period|Administrative|0|||
164538819|NCT00312221|594346268|FG002|Open-label Run-in Period|Administrative|0|||
164538820|NCT00312221|594346269|FG003|Open-label Run-in Period|Administrative|0|||
164538821|NCT00312221|594346266|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
164538822|NCT00312221|594346267|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
164538823|NCT00312221|594346268|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
164538824|NCT00312221|594346269|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
164538825|NCT00312221|594346266|FG000|Open-label Run-in Period|Did not qualify|5|||
164538826|NCT00312221|594346267|FG001|Open-label Run-in Period|Did not qualify|0|||
164538827|NCT00312221|594346268|FG002|Open-label Run-in Period|Did not qualify|0|||
164538828|NCT00312221|594346269|FG003|Open-label Run-in Period|Did not qualify|0|||
164538829|NCT00312221|594346266|FG000|Double-blind Phase|Withdrawal by Subject|0|||
164538830|NCT00312221|594346267|FG001|Double-blind Phase|Withdrawal by Subject|6|||
164538831|NCT00312221|594346268|FG002|Double-blind Phase|Withdrawal by Subject|8|||
164538832|NCT00312221|594346269|FG003|Double-blind Phase|Withdrawal by Subject|7|||
164538833|NCT00312221|594346266|FG000|Double-blind Phase|Adverse Event|0|||
164538834|NCT00312221|594346267|FG001|Double-blind Phase|Adverse Event|10|||
164538835|NCT00312221|594346268|FG002|Double-blind Phase|Adverse Event|19|||
164538836|NCT00312221|594346269|FG003|Double-blind Phase|Adverse Event|18|||
164538837|NCT00312221|594346266|FG000|Double-blind Phase|Lost to Follow-up|0|||
164538838|NCT00312221|594346267|FG001|Double-blind Phase|Lost to Follow-up|0|||
164538839|NCT00312221|594346268|FG002|Double-blind Phase|Lost to Follow-up|2|||
164538840|NCT00312221|594346269|FG003|Double-blind Phase|Lost to Follow-up|2|||
164538841|NCT00312221|594346266|FG000|Double-blind Phase|Administrative|0|||
164538842|NCT00312221|594346267|FG001|Double-blind Phase|Administrative|26|||
164538843|NCT00312221|594346268|FG002|Double-blind Phase|Administrative|37|||
164652461|NCT00606684|594755104|FG005|Double-Blind Treatment Period|Adverse Event|0|||
164652462|NCT00606684|594755105|FG006|Double-Blind Treatment Period|Adverse Event|1|||
164652463|NCT00606684|594755099|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
164652464|NCT00606684|594755100|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
164652465|NCT00606684|594755101|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
164652466|NCT00606684|594755102|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
164652467|NCT00606684|594755103|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
164652468|NCT00606684|594755104|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
164652469|NCT00606684|594755105|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
164652470|NCT00606684|594755099|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
164652471|NCT00606684|594755100|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
164652472|NCT00606684|594755101|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
164652473|NCT00606684|594755102|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
164652474|NCT00606684|594755103|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
164652475|NCT00606684|594755104|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
164652476|NCT00606684|594755105|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
164652477|NCT00606684|594755099|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
164652478|NCT00606684|594755100|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
164652479|NCT00606684|594755101|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
164652480|NCT00606684|594755102|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
164652481|NCT00606684|594755103|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
164652482|NCT00606684|594755104|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
164652483|NCT00606684|594755105|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
164652484|NCT00606684|594755099|FG000|Double-Blind Treatment Period|Physician Decision|0|||
164652485|NCT00606684|594755100|FG001|Double-Blind Treatment Period|Physician Decision|5|||
164538844|NCT00312221|594346269|FG003|Double-blind Phase|Administrative|33|||
164538845|NCT00312221|594346266|FG000|Double-blind Phase|Lack of Efficacy|0|||
164538846|NCT00312221|594346267|FG001|Double-blind Phase|Lack of Efficacy|17|||
164538847|NCT00312221|594346268|FG002|Double-blind Phase|Lack of Efficacy|6|||
164538848|NCT00312221|594346269|FG003|Double-blind Phase|Lack of Efficacy|10|||
164538849|NCT02060721|594346270|FG000|Overall Study|Lost to Follow-up|1|||
164538850|NCT02060721|594346270|FG000|Overall Study|Physician Decision|2|||
164538851|NCT02060721|594346270|FG000|Overall Study|Death|14|||
164538852|NCT02060721|594346270|FG000|Overall Study|Withdrawal by Subject|2|||
164652486|NCT00606684|594755101|FG002|Double-Blind Treatment Period|Physician Decision|1|||
164652487|NCT00606684|594755102|FG003|Double-Blind Treatment Period|Physician Decision|0|||
164652488|NCT00606684|594755103|FG004|Double-Blind Treatment Period|Physician Decision|3|||
164652489|NCT00606684|594755104|FG005|Double-Blind Treatment Period|Physician Decision|1|||
164652490|NCT00606684|594755105|FG006|Double-Blind Treatment Period|Physician Decision|2|||
164652491|NCT00606684|594755099|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164652492|NCT00606684|594755100|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
164652493|NCT00606684|594755101|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
164652494|NCT00606684|594755102|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
164652495|NCT00606684|594755103|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
164652496|NCT00606684|594755104|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
164652497|NCT00606684|594755105|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164652498|NCT03568500|594755106|FG000|Overall Study|Lost to Follow-up|1|||
164652499|NCT03568500|594755107|FG001|Overall Study|Lost to Follow-up|1|||
164652500|NCT03568500|594755108|FG002|Overall Study|Lost to Follow-up|2|||
164652501|NCT03568500|594755106|FG000|Overall Study|Adverse Event|1|||
164652502|NCT03568500|594755107|FG001|Overall Study|Adverse Event|1|||
164652503|NCT03568500|594755108|FG002|Overall Study|Adverse Event|2|||
164652504|NCT03568500|594755106|FG000|Overall Study|Physician Decision|1|||
164652505|NCT03568500|594755107|FG001|Overall Study|Physician Decision|0|||
164652506|NCT03568500|594755108|FG002|Overall Study|Physician Decision|0|||
164652507|NCT03568500|594755106|FG000|Overall Study|Withdrawal by Subject|4|||
164652508|NCT03568500|594755107|FG001|Overall Study|Withdrawal by Subject|2|||
164652509|NCT03568500|594755108|FG002|Overall Study|Withdrawal by Subject|0|||
164652510|NCT03568500|594755106|FG000|Overall Study|Technical Problems|2|||
164652511|NCT03568500|594755107|FG001|Overall Study|Technical Problems|1|||
164652512|NCT03568500|594755108|FG002|Overall Study|Technical Problems|0|||
164652513|NCT03568500|594755106|FG000|Overall Study|Participant Noncompliance|1|||
164652514|NCT03568500|594755107|FG001|Overall Study|Participant Noncompliance|1|||
164652515|NCT03568500|594755108|FG002|Overall Study|Participant Noncompliance|0|||
164652516|NCT03377556|594755122|FG000|Overall Study|Adverse Event|5|||
164652517|NCT03377556|594755122|FG000|Overall Study|Refusal unrelated to adverse events|1|||
164652518|NCT03377556|594755122|FG000|Overall Study|Progression/relapse|38|||
164652519|NCT03377556|594755122|FG000|Overall Study|Death|3|||
164652520|NCT00827827|594755123|FG000|Overall Study|Lost to Follow-up|3|||
164652521|NCT00827827|594755124|FG001|Overall Study|Lost to Follow-up|0|||
164652522|NCT00827827|594755123|FG000|Overall Study|Fall at home- hospitalization|1|||
164652523|NCT00827827|594755124|FG001|Overall Study|Fall at home- hospitalization|0|||
164652524|NCT00827827|594755123|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
164652525|NCT00827827|594755124|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
164652526|NCT00827827|594755123|FG000|Overall Study|Gout|1|||
164652527|NCT00827827|594755124|FG001|Overall Study|Gout|0|||
164652528|NCT00827827|594755123|FG000|Overall Study|Transportation issues|1|||
164652529|NCT00827827|594755124|FG001|Overall Study|Transportation issues|0|||
164652530|NCT00827827|594755123|FG000|Overall Study|Burned with water at home|1|||
164652531|NCT00827827|594755124|FG001|Overall Study|Burned with water at home|0|||
164652532|NCT01165684|594755130|FG000|Overall Study|Adverse Event|1|||
164652533|NCT01165684|594755131|FG001|Overall Study|Adverse Event|1|||
164652534|NCT01165684|594755130|FG000|Overall Study|Lack of Efficacy|2|||
164652535|NCT01165684|594755131|FG001|Overall Study|Lack of Efficacy|1|||
164652536|NCT01165684|594755130|FG000|Overall Study|Protocol Violation|7|||
164652537|NCT01165684|594755131|FG001|Overall Study|Protocol Violation|15|||
164652538|NCT01165684|594755130|FG000|Overall Study|Withdrawal Criteria|2|||
164652539|NCT01165684|594755131|FG001|Overall Study|Withdrawal Criteria|13|||
164652540|NCT01165684|594755130|FG000|Overall Study|Unclassified|16|||
164652541|NCT01165684|594755131|FG001|Overall Study|Unclassified|22|||
164652542|NCT01886300|594755134|FG000|Overall Study|Trial terminated by sponsor|16|||
164652543|NCT00901628|594755135|FG000|Overall Study|disconnection of catheter|4|||
164652544|NCT00901628|594755136|FG001|Overall Study|disconnection of catheter|8|||
164652545|NCT00901628|594755135|FG000|Overall Study|disconnection of drain|0|||
164652546|NCT00901628|594755136|FG001|Overall Study|disconnection of drain|1|||
164652547|NCT00901628|594755135|FG000|Overall Study|peroneal nerve palsy|0|||
164652548|NCT00901628|594755136|FG001|Overall Study|peroneal nerve palsy|1|||
164652549|NCT02008721|594755137|FG000|Overall Study|Withdrawal by Subject|5|||
164652550|NCT02008721|594755138|FG001|Overall Study|Withdrawal by Subject|1|||
164652551|NCT02008721|594755137|FG000|Overall Study|Death|4|||
164652552|NCT02008721|594755138|FG001|Overall Study|Death|2|||
164652553|NCT02008721|594755137|FG000|Overall Study|Adverse Event|3|||
164652554|NCT02008721|594755138|FG001|Overall Study|Adverse Event|5|||
164652555|NCT02008721|594755137|FG000|Overall Study|Protocol Violation|3|||
164652556|NCT02008721|594755138|FG001|Overall Study|Protocol Violation|2|||
164652557|NCT00295854|594755141|FG000|Overall Study|Adverse Event|7|||
164652558|NCT00295854|594755142|FG001|Overall Study|Adverse Event|7|||
164652559|NCT00295854|594755143|FG002|Overall Study|Adverse Event|6|||
164652560|NCT00295854|594755141|FG000|Overall Study|Protocol Violation|1|||
164652561|NCT00295854|594755142|FG001|Overall Study|Protocol Violation|1|||
164652562|NCT00295854|594755143|FG002|Overall Study|Protocol Violation|1|||
164652563|NCT00295854|594755141|FG000|Overall Study|Lost to Follow-up|2|||
164538853|NCT02060721|594346270|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
164538854|NCT01026142|594346271|FG000|Overall Study|Death|136|||
164538855|NCT01026142|594346272|FG001|Overall Study|Death|134|||
164538856|NCT01026142|594346271|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
164589132|NCT01070550|594521372|FG000|Overall Study|Relapse|44|||
164589133|NCT01070550|594521373|FG001|Overall Study|Relapse|5|||
164589134|NCT01070550|594521374|FG002|Overall Study|Relapse|14|||
164589135|NCT01070550|594521375|FG003|Overall Study|Relapse|4|||
164589136|NCT01070550|594521376|FG004|Overall Study|Relapse|0|||
164589137|NCT01070550|594521377|FG005|Overall Study|Relapse|0|||
164589138|NCT01070550|594521372|FG000|Overall Study|Result not available|3|||
164589139|NCT01070550|594521373|FG001|Overall Study|Result not available|1|||
164589140|NCT01070550|594521374|FG002|Overall Study|Result not available|3|||
164589141|NCT01070550|594521375|FG003|Overall Study|Result not available|0|||
164589142|NCT01070550|594521376|FG004|Overall Study|Result not available|0|||
164589143|NCT01070550|594521377|FG005|Overall Study|Result not available|0|||
164589144|NCT01070550|594521372|FG000|Overall Study|Screen failure|1|||
164589145|NCT01070550|594521373|FG001|Overall Study|Screen failure|0|||
164589146|NCT01070550|594521374|FG002|Overall Study|Screen failure|0|||
164589147|NCT01070550|594521375|FG003|Overall Study|Screen failure|0|||
164589148|NCT01070550|594521376|FG004|Overall Study|Screen failure|0|||
164589149|NCT01070550|594521377|FG005|Overall Study|Screen failure|0|||
164589150|NCT01070550|594521372|FG000|Overall Study|Sponsor decision|1|||
164589151|NCT01070550|594521373|FG001|Overall Study|Sponsor decision|0|||
164589152|NCT01070550|594521374|FG002|Overall Study|Sponsor decision|0|||
164589153|NCT01070550|594521375|FG003|Overall Study|Sponsor decision|0|||
164589154|NCT01070550|594521376|FG004|Overall Study|Sponsor decision|0|||
164589155|NCT01070550|594521377|FG005|Overall Study|Sponsor decision|0|||
164589156|NCT01070550|594521372|FG000|Overall Study|Treatment duration shortened|1|||
164589157|NCT01070550|594521373|FG001|Overall Study|Treatment duration shortened|0|||
164589158|NCT01070550|594521374|FG002|Overall Study|Treatment duration shortened|0|||
164589159|NCT01070550|594521375|FG003|Overall Study|Treatment duration shortened|0|||
164589160|NCT01070550|594521376|FG004|Overall Study|Treatment duration shortened|0|||
164589161|NCT01070550|594521377|FG005|Overall Study|Treatment duration shortened|0|||
164589162|NCT01070550|594521372|FG000|Overall Study|Treatment interrupted|7|||
164589163|NCT01070550|594521373|FG001|Overall Study|Treatment interrupted|0|||
164589164|NCT01070550|594521374|FG002|Overall Study|Treatment interrupted|1|||
164589165|NCT01070550|594521375|FG003|Overall Study|Treatment interrupted|1|||
164589166|NCT01070550|594521376|FG004|Overall Study|Treatment interrupted|0|||
164589167|NCT01070550|594521377|FG005|Overall Study|Treatment interrupted|0|||
164589168|NCT01070550|594521372|FG000|Overall Study|Treatment not started|14|||
164589169|NCT01070550|594521373|FG001|Overall Study|Treatment not started|2|||
164589170|NCT01070550|594521374|FG002|Overall Study|Treatment not started|4|||
164589171|NCT01070550|594521375|FG003|Overall Study|Treatment not started|0|||
164589172|NCT01070550|594521376|FG004|Overall Study|Treatment not started|0|||
164589173|NCT01070550|594521377|FG005|Overall Study|Treatment not started|0|||
164589174|NCT01070550|594521372|FG000|Overall Study|Treatment restarted|0|||
164589175|NCT01070550|594521373|FG001|Overall Study|Treatment restarted|1|||
164589176|NCT01070550|594521374|FG002|Overall Study|Treatment restarted|0|||
164589177|NCT01070550|594521375|FG003|Overall Study|Treatment restarted|0|||
164589178|NCT01070550|594521376|FG004|Overall Study|Treatment restarted|0|||
164589179|NCT01070550|594521377|FG005|Overall Study|Treatment restarted|0|||
164589180|NCT01070550|594521372|FG000|Overall Study|Treatment stopped|3|||
164589181|NCT01070550|594521373|FG001|Overall Study|Treatment stopped|0|||
164589182|NCT01070550|594521374|FG002|Overall Study|Treatment stopped|0|||
164589183|NCT01070550|594521375|FG003|Overall Study|Treatment stopped|0|||
164589184|NCT01070550|594521376|FG004|Overall Study|Treatment stopped|0|||
164589185|NCT01070550|594521377|FG005|Overall Study|Treatment stopped|0|||
164589186|NCT01070550|594521372|FG000|Overall Study|Treatment unavailable|1|||
164589187|NCT01070550|594521373|FG001|Overall Study|Treatment unavailable|0|||
164589188|NCT01070550|594521374|FG002|Overall Study|Treatment unavailable|0|||
164589189|NCT01070550|594521375|FG003|Overall Study|Treatment unavailable|0|||
164589190|NCT01070550|594521376|FG004|Overall Study|Treatment unavailable|0|||
164589191|NCT01070550|594521377|FG005|Overall Study|Treatment unavailable|0|||
164589192|NCT01070550|594521372|FG000|Overall Study|Treatment was stopped early|7|||
164589193|NCT01070550|594521373|FG001|Overall Study|Treatment was stopped early|0|||
164589194|NCT01070550|594521374|FG002|Overall Study|Treatment was stopped early|0|||
164589195|NCT01070550|594521375|FG003|Overall Study|Treatment was stopped early|0|||
164589196|NCT01070550|594521376|FG004|Overall Study|Treatment was stopped early|0|||
164589197|NCT01070550|594521377|FG005|Overall Study|Treatment was stopped early|0|||
164589198|NCT01070550|594521372|FG000|Overall Study|Other|5|||
164589199|NCT01070550|594521373|FG001|Overall Study|Other|0|||
164589200|NCT01070550|594521374|FG002|Overall Study|Other|0|||
164589201|NCT01070550|594521375|FG003|Overall Study|Other|1|||
164589202|NCT01070550|594521376|FG004|Overall Study|Other|0|||
164589203|NCT01070550|594521377|FG005|Overall Study|Other|0|||
164652564|NCT00295854|594755142|FG001|Overall Study|Lost to Follow-up|0|||
164652565|NCT00295854|594755143|FG002|Overall Study|Lost to Follow-up|1|||
164189896|NCT00572455|593063992|FG006|Stage II (28 Days)|Death|0|||
164189897|NCT00572455|593063993|FG007|Stage II (28 Days)|Death|0|||
164189898|NCT00572455|593063994|FG008|Stage II (28 Days)|Death|1|||
164189899|NCT00572455|593063995|FG009|Stage II (28 Days)|Death|0|||
164189900|NCT00572455|593063996|FG010|Stage II (28 Days)|Death|0|||
164189901|NCT00572455|593063997|FG011|Stage II (28 Days)|Death|0|||
164189902|NCT00572455|593063998|FG012|Stage II (28 Days)|Death|0|||
164189903|NCT00572455|593063999|FG013|Stage II (28 Days)|Death|0|||
164189904|NCT00572455|593063986|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
164189905|NCT00572455|593063987|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
164189906|NCT00572455|593063988|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
164189907|NCT00572455|593063989|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
164189908|NCT00572455|593063990|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
164652566|NCT00295854|594755141|FG000|Overall Study|Withdrawal by Subject|3|||
164652567|NCT00295854|594755142|FG001|Overall Study|Withdrawal by Subject|7|||
164652568|NCT00295854|594755143|FG002|Overall Study|Withdrawal by Subject|4|||
164652569|NCT00295854|594755141|FG000|Overall Study|did not continue to meet criteria|1|||
164652570|NCT00295854|594755142|FG001|Overall Study|did not continue to meet criteria|1|||
164652571|NCT00295854|594755143|FG002|Overall Study|did not continue to meet criteria|2|||
164652572|NCT00295854|594755141|FG000|Overall Study|required a prohibited medication|1|||
164652573|NCT00295854|594755142|FG001|Overall Study|required a prohibited medication|0|||
164652574|NCT00295854|594755143|FG002|Overall Study|required a prohibited medication|0|||
164652575|NCT00295854|594755141|FG000|Overall Study|Other|3|||
164652576|NCT00295854|594755142|FG001|Overall Study|Other|5|||
164652577|NCT00295854|594755143|FG002|Overall Study|Other|1|||
164652578|NCT01967888|594755146|FG000|Overall Study|Lost to Follow-up|6|||
164652579|NCT01967888|594755147|FG001|Overall Study|Lost to Follow-up|4|||
164652580|NCT01967888|594755146|FG000|Overall Study|Withdrawal by Subject|1|||
164652581|NCT01967888|594755147|FG001|Overall Study|Withdrawal by Subject|1|||
164652582|NCT01967888|594755146|FG000|Overall Study|Did Not Have Transplant|1|||
164652583|NCT01967888|594755147|FG001|Overall Study|Did Not Have Transplant|0|||
164652584|NCT01967888|594755146|FG000|Overall Study|Research visit not done, data recorded|1|||
164652585|NCT01967888|594755147|FG001|Overall Study|Research visit not done, data recorded|0|||
164652586|NCT01967888|594755146|FG000|Overall Study|Subject excluded after randomization|1|||
164652587|NCT01967888|594755147|FG001|Overall Study|Subject excluded after randomization|0|||
164652588|NCT01967888|594755146|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
164652589|NCT01967888|594755147|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
164652590|NCT01967888|594755146|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
164652591|NCT01967888|594755147|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
164652592|NCT03175120|594755151|FG000|Overall Study|Adverse Event|2|||
164652593|NCT03175120|594755152|FG001|Overall Study|Adverse Event|2|||
164652594|NCT03175120|594755151|FG000|Overall Study|Protocol Violation|5|||
164652595|NCT03175120|594755152|FG001|Overall Study|Protocol Violation|2|||
164652596|NCT03175120|594755151|FG000|Overall Study|Lost to Follow-up|1|||
164652597|NCT03175120|594755152|FG001|Overall Study|Lost to Follow-up|0|||
164652598|NCT03175120|594755151|FG000|Overall Study|Withdrawal by Subject|2|||
164652599|NCT03175120|594755152|FG001|Overall Study|Withdrawal by Subject|5|||
164652600|NCT03175120|594755151|FG000|Overall Study|Other|2|||
164652601|NCT03175120|594755152|FG001|Overall Study|Other|3|||
164652602|NCT04120194|594755153|FG000|Overall Study|Lost to Follow-up|11|||
164652603|NCT04120194|594755154|FG001|Overall Study|Lost to Follow-up|8|||
164652604|NCT04120194|594755153|FG000|Overall Study|Adverse Event|4|||
164652605|NCT04120194|594755154|FG001|Overall Study|Adverse Event|5|||
164652606|NCT04120194|594755153|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
164652607|NCT04120194|594755154|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
164652608|NCT04120194|594755153|FG000|Overall Study|Miscellaneous|4|||
164652609|NCT04120194|594755154|FG001|Overall Study|Miscellaneous|5|||
164652610|NCT02622074|594755155|FG000|Overall Study|Death|4|||
164652611|NCT02622074|594755156|FG001|Overall Study|Death|0|||
164652612|NCT02622074|594755157|FG002|Overall Study|Death|0|||
164652613|NCT02622074|594755158|FG003|Overall Study|Death|1|||
164652614|NCT02622074|594755159|FG004|Overall Study|Death|1|||
164652615|NCT02622074|594755160|FG005|Overall Study|Death|0|||
164652616|NCT02622074|594755155|FG000|Overall Study|Withdrawal by Subject|0|||
164652617|NCT02622074|594755156|FG001|Overall Study|Withdrawal by Subject|1|||
164652618|NCT02622074|594755157|FG002|Overall Study|Withdrawal by Subject|0|||
164652619|NCT02622074|594755158|FG003|Overall Study|Withdrawal by Subject|0|||
164652620|NCT02622074|594755159|FG004|Overall Study|Withdrawal by Subject|0|||
164652621|NCT02622074|594755160|FG005|Overall Study|Withdrawal by Subject|0|||
164652622|NCT02114931|594755161|FG000|Overall Study|Withdrawal by Subject|15|||
164652623|NCT02114931|594755162|FG001|Overall Study|Withdrawal by Subject|18|||
164652624|NCT02114931|594755161|FG000|Overall Study|Adverse Event|4|||
164652625|NCT02114931|594755162|FG001|Overall Study|Adverse Event|6|||
164652626|NCT02114931|594755161|FG000|Overall Study|Lost to Follow-up|3|||
164652627|NCT02114931|594755162|FG001|Overall Study|Lost to Follow-up|3|||
164652628|NCT02114931|594755161|FG000|Overall Study|Physician Decision|1|||
164652629|NCT02114931|594755162|FG001|Overall Study|Physician Decision|2|||
164652630|NCT02114931|594755161|FG000|Overall Study|Other|2|||
164652631|NCT02114931|594755162|FG001|Overall Study|Other|1|||
164652632|NCT03565211|594755166|FG000|Overall Study|Withdrawal by Subject|2|||
164652633|NCT03565211|594755166|FG000|Overall Study|Lost to Follow-up|1|||
164652634|NCT03565211|594755166|FG000|Overall Study|Adverse Event|44|||
164652635|NCT03565211|594755166|FG000|Overall Study|Personal issues|1|||
164652636|NCT00986154|594755167|FG000|Overall Study|Death|136|||
164652637|NCT00986154|594755168|FG001|Overall Study|Death|127|||
164652638|NCT00986154|594755167|FG000|Overall Study|Lost to Follow-up|7|||
164652639|NCT00986154|594755168|FG001|Overall Study|Lost to Follow-up|4|||
164652640|NCT00986154|594755167|FG000|Overall Study|Withdrawal by Subject|32|||
164652641|NCT00986154|594755168|FG001|Overall Study|Withdrawal by Subject|33|||
164652642|NCT00986154|594755167|FG000|Overall Study|investigator/subject decide not continue|6|||
164538857|NCT01026142|594346272|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
164538858|NCT01019317|594346273|FG000|Overall Study|Not Eligible|4|||
164538859|NCT00728481|594346274|FG000|Overall Study|Withdrawal by Subject|0|||
164538860|NCT00728481|594346275|FG001|Overall Study|Withdrawal by Subject|1|||
164538861|NCT00728481|594346274|FG000|Overall Study|Adverse Event|0|||
164538862|NCT00728481|594346275|FG001|Overall Study|Adverse Event|1|||
164538863|NCT00728481|594346274|FG000|Overall Study|Study medication non-compliance|0|||
164538864|NCT00728481|594346275|FG001|Overall Study|Study medication non-compliance|2|||
164538865|NCT00728481|594346274|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
164538866|NCT00728481|594346275|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
164538867|NCT03690141|594346276|FG000|Overall Study|Adverse Event|5|||
164538868|NCT03690141|594346276|FG000|Overall Study|Withdrawal by Subject|3|||
164652643|NCT00986154|594755168|FG001|Overall Study|investigator/subject decide not continue|3|||
164652644|NCT00986154|594755167|FG000|Overall Study|never received study drug|25|||
164652645|NCT00986154|594755168|FG001|Overall Study|never received study drug|27|||
164652646|NCT00267007|594755169|FG000|Overall Study|Withdrawal by Subject|6|||
164652647|NCT00267007|594755170|FG001|Overall Study|Withdrawal by Subject|0|||
164652648|NCT00267007|594755169|FG000|Overall Study|Lost to Follow-up|1|||
164652649|NCT00267007|594755170|FG001|Overall Study|Lost to Follow-up|0|||
164652650|NCT00267007|594755169|FG000|Overall Study|Non-compliance|0|||
164652651|NCT00267007|594755170|FG001|Overall Study|Non-compliance|1|||
164652652|NCT00267007|594755169|FG000|Overall Study|Adverse Event|1|||
164652653|NCT00267007|594755170|FG001|Overall Study|Adverse Event|0|||
164652654|NCT01205529|594755172|FG000|Overall Study|Procedure Cancelled|4|||
164652655|NCT01205529|594755172|FG000|Overall Study|Withdrawal by Subject|2|||
164652656|NCT01205529|594755172|FG000|Overall Study|Physician Decision|4|||
164652657|NCT01205529|594755172|FG000|Overall Study|Unstable post op|15|||
164652658|NCT01205529|594755172|FG000|Overall Study|No longer met criteria|30|||
164652659|NCT03840135|594755173|FG000|Overall Study|Protocol Violation|6|||
164652660|NCT03840135|594755174|FG001|Overall Study|Protocol Violation|1|||
164652661|NCT03840135|594755173|FG000|Overall Study|Withdrawal by Subject|1|||
164652662|NCT03840135|594755174|FG001|Overall Study|Withdrawal by Subject|0|||
164652663|NCT04133519|594755175|FG000|Overall Study|Withdrawal by Subject|5|||
164652664|NCT04133519|594755176|FG001|Overall Study|Withdrawal by Subject|4|||
164652665|NCT04133519|594755175|FG000|Overall Study|Protocol Violation|0|||
164652666|NCT04133519|594755176|FG001|Overall Study|Protocol Violation|1|||
164652667|NCT04133519|594755175|FG000|Overall Study|Never started treatment|1|||
164652668|NCT04133519|594755176|FG001|Overall Study|Never started treatment|1|||
164652669|NCT00323609|594755177|FG000|Overall Study|Death|16|||
164538869|NCT03690141|594346276|FG000|Overall Study|Physician Decision|4|||
164538870|NCT03690141|594346276|FG000|Overall Study|Disease progression|4|||
164538871|NCT01505010|594346277|FG000|Overall Study|Protocol Violation|0|||
164538872|NCT01505010|594346278|FG001|Overall Study|Protocol Violation|1|||
164652670|NCT00323609|594755178|FG001|Overall Study|Death|21|||
164652671|NCT00323609|594755179|FG002|Overall Study|Death|0|||
164652672|NCT00323609|594755180|FG003|Overall Study|Death|0|||
164652673|NCT00323609|594755177|FG000|Overall Study|Lost to Follow-up|9|||
164652674|NCT00323609|594755178|FG001|Overall Study|Lost to Follow-up|10|||
164652675|NCT00323609|594755179|FG002|Overall Study|Lost to Follow-up|0|||
164652676|NCT00323609|594755180|FG003|Overall Study|Lost to Follow-up|0|||
164652677|NCT00323609|594755177|FG000|Overall Study|Physician Decision|2|||
164652678|NCT00323609|594755178|FG001|Overall Study|Physician Decision|0|||
164302034|NCT03847896|593482508|FG004|Overall Study|Lack of Efficacy|2|||
164538873|NCT01505010|594346277|FG000|Overall Study|Lost to Follow-up|0|||
164538874|NCT01505010|594346278|FG001|Overall Study|Lost to Follow-up|1|||
164652679|NCT00323609|594755179|FG002|Overall Study|Physician Decision|0|||
164652680|NCT00323609|594755180|FG003|Overall Study|Physician Decision|1|||
164652681|NCT00323609|594755177|FG000|Overall Study|Withdrawal by Subject|11|||
164652682|NCT00323609|594755178|FG001|Overall Study|Withdrawal by Subject|23|||
164652683|NCT00323609|594755179|FG002|Overall Study|Withdrawal by Subject|4|||
164652684|NCT00323609|594755180|FG003|Overall Study|Withdrawal by Subject|4|||
164652685|NCT00323609|594755177|FG000|Overall Study|Other non-VCF-related medical condition|3|||
164652686|NCT00323609|594755178|FG001|Overall Study|Other non-VCF-related medical condition|2|||
164538875|NCT04744285|594346279|FG000|Overall Study|Withdrawal by Subject|1|||
164538876|NCT04744285|594346280|FG001|Overall Study|Withdrawal by Subject|1|||
164538877|NCT04744285|594346281|FG002|Overall Study|Withdrawal by Subject|2|||
164302035|NCT03847896|593482504|FG000|Overall Study|Other reasons|3|||
164538878|NCT04744285|594346282|FG003|Overall Study|Withdrawal by Subject|1|||
164538879|NCT01251120|594346285|FG000|Overall Study|Lack of Efficacy|0|||
164538880|NCT01251120|594346286|FG001|Overall Study|Lack of Efficacy|1|||
164538881|NCT01822522|594346291|FG000|Overall Study|Adverse Event|1|||
164538882|NCT01822522|594346292|FG001|Overall Study|Adverse Event|1|||
164538883|NCT01822522|594346293|FG002|Overall Study|Adverse Event|1|||
164538884|NCT01822522|594346294|FG003|Overall Study|Adverse Event|0|||
164538885|NCT01822522|594346295|FG004|Overall Study|Adverse Event|0|||
164538886|NCT01822522|594346296|FG005|Overall Study|Adverse Event|1|||
164538887|NCT01822522|594346291|FG000|Overall Study|Death|3|||
164538888|NCT01822522|594346292|FG001|Overall Study|Death|0|||
164538889|NCT01822522|594346293|FG002|Overall Study|Death|2|||
164538890|NCT01822522|594346294|FG003|Overall Study|Death|0|||
164538891|NCT01822522|594346295|FG004|Overall Study|Death|0|||
164538892|NCT01822522|594346296|FG005|Overall Study|Death|0|||
164538893|NCT01822522|594346291|FG000|Overall Study|Lost to Follow-up|0|||
164538894|NCT01822522|594346292|FG001|Overall Study|Lost to Follow-up|0|||
164538895|NCT01822522|594346293|FG002|Overall Study|Lost to Follow-up|1|||
164538896|NCT01822522|594346294|FG003|Overall Study|Lost to Follow-up|1|||
164538897|NCT01822522|594346295|FG004|Overall Study|Lost to Follow-up|0|||
164538898|NCT01822522|594346296|FG005|Overall Study|Lost to Follow-up|1|||
164538899|NCT01822522|594346291|FG000|Overall Study|Withdrawal by Subject|0|||
164538900|NCT01822522|594346292|FG001|Overall Study|Withdrawal by Subject|0|||
164538901|NCT01822522|594346293|FG002|Overall Study|Withdrawal by Subject|0|||
164538902|NCT01822522|594346294|FG003|Overall Study|Withdrawal by Subject|1|||
164538903|NCT01822522|594346295|FG004|Overall Study|Withdrawal by Subject|0|||
164538904|NCT01822522|594346296|FG005|Overall Study|Withdrawal by Subject|0|||
164538905|NCT01822522|594346291|FG000|Overall Study|Lack of Efficacy|0|||
164538906|NCT01822522|594346292|FG001|Overall Study|Lack of Efficacy|0|||
164538907|NCT01822522|594346293|FG002|Overall Study|Lack of Efficacy|0|||
164538908|NCT01822522|594346294|FG003|Overall Study|Lack of Efficacy|0|||
164538909|NCT01822522|594346295|FG004|Overall Study|Lack of Efficacy|0|||
164538910|NCT01822522|594346296|FG005|Overall Study|Lack of Efficacy|2|||
164538911|NCT00890929|594346297|FG000|Overall Study|Death before treatment|2|||
164538912|NCT00890929|594346297|FG000|Overall Study|Withdrawal by Subject|3|||
164538913|NCT00890929|594346297|FG000|Overall Study|Physician Decision|1|||
164538914|NCT00108069|594346298|FG000|Overall Study|Never rec'd study drug|0|||
164538915|NCT00108069|594346299|FG001|Overall Study|Never rec'd study drug|1|||
164538916|NCT00108069|594346298|FG000|Overall Study|Adverse Event|1|||
164538917|NCT00108069|594346299|FG001|Overall Study|Adverse Event|1|||
164538918|NCT00108069|594346298|FG000|Overall Study|Withdrawal by Subject|1|||
164538919|NCT00108069|594346299|FG001|Overall Study|Withdrawal by Subject|0|||
164538920|NCT00108069|594346298|FG000|Overall Study|Death|1|||
164538921|NCT00108069|594346299|FG001|Overall Study|Death|0|||
164538922|NCT00108069|594346298|FG000|Overall Study|Progessive disease|27|||
164538923|NCT00108069|594346299|FG001|Overall Study|Progessive disease|11|||
164538924|NCT02558231|594346300|FG000|Overall Study|Death|4|||
164538925|NCT02558231|594346301|FG001|Overall Study|Death|12|||
164538926|NCT02558231|594346300|FG000|Overall Study|Lost to Follow-up|7|||
164538927|NCT02558231|594346301|FG001|Overall Study|Lost to Follow-up|4|||
164538928|NCT02558231|594346300|FG000|Overall Study|Withdrawal by Subject|7|||
164538929|NCT02558231|594346301|FG001|Overall Study|Withdrawal by Subject|4|||
164538930|NCT02558231|594346300|FG000|Overall Study|Physician Decision|7|||
164538931|NCT02558231|594346301|FG001|Overall Study|Physician Decision|5|||
164538932|NCT02558231|594346300|FG000|Overall Study|Sponsor Decision|0|||
164538933|NCT02558231|594346301|FG001|Overall Study|Sponsor Decision|1|||
164538934|NCT03836807|594346308|FG000|Overall Study|Physician Decision|1|||
164538935|NCT03836807|594346309|FG001|Overall Study|Physician Decision|0|||
164538936|NCT00685685|594346310|FG000|Washout Period of 7 Days|Adverse Event|2|||
164538937|NCT00685685|594346311|FG001|Washout Period of 7 Days|Adverse Event|0|||
164538938|NCT00685685|594346310|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
164538939|NCT00685685|594346311|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
164538940|NCT04029116|594346312|FG000|Overall Study|Adverse Event|0|||
164538941|NCT04029116|594346313|FG001|Overall Study|Adverse Event|2|||
164538942|NCT04029116|594346312|FG000|Overall Study|Lost to Follow-up|3|||
164538943|NCT04029116|594346313|FG001|Overall Study|Lost to Follow-up|5|||
164538944|NCT04029116|594346312|FG000|Overall Study|Physician Decision|2|||
164538945|NCT04029116|594346313|FG001|Overall Study|Physician Decision|0|||
164538946|NCT04029116|594346312|FG000|Overall Study|Pregnancy|1|||
164538947|NCT04029116|594346313|FG001|Overall Study|Pregnancy|2|||
164538948|NCT04029116|594346312|FG000|Overall Study|Withdrawal by Subject|4|||
164538949|NCT04029116|594346313|FG001|Overall Study|Withdrawal by Subject|6|||
164538950|NCT04029116|594346312|FG000|Overall Study|Other|2|||
164652687|NCT00323609|594755179|FG002|Overall Study|Other non-VCF-related medical condition|0|||
164652688|NCT00323609|594755180|FG003|Overall Study|Other non-VCF-related medical condition|0|||
164652689|NCT00323609|594755177|FG000|Overall Study|Sponsor discontinued trial|29|||
164652690|NCT00323609|594755178|FG001|Overall Study|Sponsor discontinued trial|29|||
164652691|NCT00323609|594755179|FG002|Overall Study|Sponsor discontinued trial|0|||
164652692|NCT00323609|594755180|FG003|Overall Study|Sponsor discontinued trial|0|||
164652693|NCT00323609|594755177|FG000|Overall Study|Unrelenting or severe back pain|1|||
164538951|NCT04029116|594346313|FG001|Overall Study|Other|1|||
164538952|NCT02401412|594346314|FG000|Overall Study|Lost to Follow-up|1|||
164538953|NCT02401412|594346315|FG001|Overall Study|Lost to Follow-up|0|||
164538954|NCT02401412|594346314|FG000|Overall Study|Discontinued Intervention|15|||
164538955|NCT02401412|594346315|FG001|Overall Study|Discontinued Intervention|21|||
164538956|NCT02401412|594346314|FG000|Overall Study|Withdrawal by Subject|4|||
164538957|NCT02401412|594346315|FG001|Overall Study|Withdrawal by Subject|4|||
164538958|NCT02401412|594346314|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
164538959|NCT02401412|594346315|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
164538960|NCT02401412|594346314|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
164538961|NCT02401412|594346315|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
164538962|NCT03684642|594346322|FG000|Overall Study|Adverse Event|6|||
164538963|NCT03684642|594346323|FG001|Overall Study|Adverse Event|15|||
164538964|NCT03684642|594346324|FG002|Overall Study|Adverse Event|11|||
164538965|NCT03684642|594346322|FG000|Overall Study|Withdrawal by Subject|35|||
164538966|NCT03684642|594346323|FG001|Overall Study|Withdrawal by Subject|53|||
164538967|NCT03684642|594346324|FG002|Overall Study|Withdrawal by Subject|23|||
164538968|NCT03684642|594346322|FG000|Overall Study|Lack of Efficacy|0|||
164538969|NCT03684642|594346323|FG001|Overall Study|Lack of Efficacy|0|||
164538970|NCT03684642|594346324|FG002|Overall Study|Lack of Efficacy|1|||
164538971|NCT03684642|594346322|FG000|Overall Study|Poor compliance to protocol|0|||
164538972|NCT03684642|594346323|FG001|Overall Study|Poor compliance to protocol|4|||
164538973|NCT03684642|594346324|FG002|Overall Study|Poor compliance to protocol|1|||
164538974|NCT03684642|594346322|FG000|Overall Study|Other than specified|62|||
164538975|NCT03684642|594346323|FG001|Overall Study|Other than specified|60|||
164538976|NCT03684642|594346324|FG002|Overall Study|Other than specified|67|||
164538977|NCT03684642|594346322|FG000|Overall Study|Randomized and not treated|0|||
164538978|NCT03684642|594346323|FG001|Overall Study|Randomized and not treated|0|||
164538979|NCT03684642|594346324|FG002|Overall Study|Randomized and not treated|1|||
164538980|NCT03684642|594346322|FG000|Overall Study|Missing completion status but alive at last contact|0|||
164538981|NCT03684642|594346323|FG001|Overall Study|Missing completion status but alive at last contact|1|||
164538982|NCT03684642|594346324|FG002|Overall Study|Missing completion status but alive at last contact|2|||
164538983|NCT01431534|594346325|FG000|Treatment Phase|Adverse Event|0|||
164538984|NCT01431534|594346326|FG001|Treatment Phase|Adverse Event|0|||
164538985|NCT01431534|594346327|FG002|Treatment Phase|Adverse Event|1|||
164538986|NCT01431534|594346325|FG000|Treatment Phase|Progressive Disease|4|||
164538987|NCT01431534|594346326|FG001|Treatment Phase|Progressive Disease|3|||
164538988|NCT01431534|594346327|FG002|Treatment Phase|Progressive Disease|10|||
164538989|NCT00688181|594346331|FG000|Overall Study|Lost to Follow-up|17|||
164538990|NCT00688181|594346331|FG000|Overall Study|Unknown Reason|4|||
164538991|NCT00688181|594346331|FG000|Overall Study|Non-clinical Reason|2|||
164538992|NCT02846532|594346332|FG000|Overall Study|Lost to Follow-up|0|||
164538993|NCT02846532|594346333|FG001|Overall Study|Lost to Follow-up|1|||
164538994|NCT02846532|594346334|FG002|Overall Study|Lost to Follow-up|1|||
164538995|NCT02846532|594346332|FG000|Overall Study|Withdrawal by Subject|1|||
164538996|NCT02846532|594346333|FG001|Overall Study|Withdrawal by Subject|2|||
164538997|NCT02846532|594346334|FG002|Overall Study|Withdrawal by Subject|0|||
164538998|NCT04252287|594346335|FG000|Overall Study|Death|5|||
164538999|NCT04252287|594346336|FG001|Overall Study|Death|3|||
164539000|NCT04252287|594346335|FG000|Overall Study|Lost to Follow-up|4|||
164539001|NCT04252287|594346336|FG001|Overall Study|Lost to Follow-up|6|||
164539002|NCT04252287|594346335|FG000|Overall Study|Withdrawal by Subject|19|||
164539003|NCT04252287|594346336|FG001|Overall Study|Withdrawal by Subject|16|||
164539004|NCT04252287|594346335|FG000|Overall Study|Protocol Violation|3|||
164539005|NCT04252287|594346336|FG001|Overall Study|Protocol Violation|4|||
164539006|NCT00835120|594346338|FG000|Overall Study|Lack of Efficacy|1|||
164539007|NCT00835120|594346338|FG000|Overall Study|Lost to Follow-up|3|||
164539008|NCT00835120|594346338|FG000|Overall Study|Adverse Event|2|||
164539009|NCT00835120|594346338|FG000|Overall Study|Withdrawal by Subject|2|||
164539010|NCT00447382|594346339|FG000|Overall Study|Adverse Event|1|||
164539011|NCT00447382|594346340|FG001|Overall Study|Adverse Event|1|||
164539012|NCT00447382|594346339|FG000|Overall Study|Lack of Efficacy|1|||
164539013|NCT00447382|594346340|FG001|Overall Study|Lack of Efficacy|0|||
164539014|NCT00447382|594346339|FG000|Overall Study|Protocol Violation|2|||
164539015|NCT00447382|594346340|FG001|Overall Study|Protocol Violation|0|||
164539016|NCT00447382|594346339|FG000|Overall Study|Unclassified|2|||
164539017|NCT00447382|594346340|FG001|Overall Study|Unclassified|5|||
164539018|NCT00977574|594346341|FG000|Overall Study|Never Treated|4|||
164539019|NCT00977574|594346342|FG001|Overall Study|Never Treated|2|||
164539020|NCT00977574|594346343|FG002|Overall Study|Never Treated|4|||
164539021|NCT03627767|594348384|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
164539022|NCT03627767|594348385|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
164189909|NCT00572455|593063991|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
164189910|NCT00572455|593063992|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
164189911|NCT00572455|593063993|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
164189912|NCT00572455|593063994|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
164189913|NCT00572455|593063995|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
164189914|NCT00572455|593063996|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
164189915|NCT00572455|593063997|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
164189916|NCT00572455|593063998|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
164189917|NCT00572455|593063999|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
164189918|NCT00572455|593063986|FG000|Stage II (28 Days)|Other|0|||
164189919|NCT00572455|593063987|FG001|Stage II (28 Days)|Other|0|||
164189920|NCT00572455|593063988|FG002|Stage II (28 Days)|Other|0|||
164189921|NCT00572455|593063989|FG003|Stage II (28 Days)|Other|0|||
164539023|NCT03627767|594348386|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
164539024|NCT03627767|594348387|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
164539025|NCT03627767|594348388|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
164539026|NCT03627767|594348384|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
164539027|NCT03627767|594348385|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
164189922|NCT00572455|593063990|FG004|Stage II (28 Days)|Other|0|||
164189923|NCT00572455|593063991|FG005|Stage II (28 Days)|Other|0|||
164189924|NCT00572455|593063992|FG006|Stage II (28 Days)|Other|0|||
164189925|NCT00572455|593063993|FG007|Stage II (28 Days)|Other|0|||
164189926|NCT00572455|593063994|FG008|Stage II (28 Days)|Other|1|||
164189927|NCT00572455|593063995|FG009|Stage II (28 Days)|Other|0|||
164189928|NCT00572455|593063996|FG010|Stage II (28 Days)|Other|0|||
164189929|NCT00572455|593063997|FG011|Stage II (28 Days)|Other|0|||
164189930|NCT00572455|593063998|FG012|Stage II (28 Days)|Other|0|||
164189931|NCT00572455|593063999|FG013|Stage II (28 Days)|Other|0|||
164302036|NCT03847896|593482505|FG001|Overall Study|Other reasons|3|||
164539028|NCT03627767|594348386|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
164189932|NCT00572455|593063986|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
164189933|NCT00572455|593063987|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
164189934|NCT00572455|593063988|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
164189935|NCT00572455|593063989|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
164189936|NCT00572455|593063990|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
164189937|NCT00572455|593063991|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
164189938|NCT00572455|593063992|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
164189939|NCT00572455|593063993|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
164189940|NCT00572455|593063994|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
164189941|NCT00572455|593063995|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
164189942|NCT00572455|593063996|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
164189943|NCT00572455|593063997|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
164189944|NCT00572455|593063998|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
164189945|NCT00572455|593063999|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
164189946|NCT02609386|593064000|FG000|Overall Study|Withdrawal by Subject|6|||
164189947|NCT02609386|593064001|FG001|Overall Study|Withdrawal by Subject|1|||
164189948|NCT02609386|593064000|FG000|Overall Study|Lost to Follow-up|3|||
164189949|NCT02609386|593064001|FG001|Overall Study|Lost to Follow-up|5|||
164189950|NCT02609386|593064000|FG000|Overall Study|Death|19|||
164189951|NCT02609386|593064001|FG001|Overall Study|Death|9|||
164189952|NCT02609386|593064000|FG000|Overall Study|Physician Decision|0|||
164189953|NCT02609386|593064001|FG001|Overall Study|Physician Decision|2|||
164189954|NCT00610168|593064002|FG000|Overall Study|Withdrawal by Subject|2|||
164189955|NCT00610168|593064003|FG001|Overall Study|Withdrawal by Subject|0|||
164189956|NCT00613821|593064009|FG000|Overall Study|Withdrawal by Subject|1|||
164189957|NCT00613821|593064010|FG001|Overall Study|Withdrawal by Subject|0|||
164539029|NCT03627767|594348387|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
164539030|NCT03627767|594348388|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
164539031|NCT03627767|594348384|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
164539032|NCT03627767|594348385|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
164539033|NCT03627767|594348386|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
164539034|NCT03627767|594348387|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
164539035|NCT03627767|594348388|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
164539036|NCT03627767|594348384|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
164539037|NCT03627767|594348385|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
164539038|NCT03627767|594348386|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
164539039|NCT03627767|594348387|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
164539040|NCT03627767|594348388|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
164539041|NCT03627767|594348384|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
164539042|NCT03627767|594348385|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
164539043|NCT03627767|594348386|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
164539044|NCT03627767|594348387|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
164539045|NCT03627767|594348388|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
164539046|NCT03627767|594348384|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
164539047|NCT03627767|594348385|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
164539048|NCT03627767|594348386|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
164539049|NCT03627767|594348387|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
164539050|NCT03627767|594348388|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
164539051|NCT03627767|594348384|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
164539052|NCT03627767|594348385|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
164539053|NCT03627767|594348386|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
164539054|NCT03627767|594348387|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
164539055|NCT03627767|594348388|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
164539056|NCT03627767|594348384|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
164539057|NCT03627767|594348385|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
164539058|NCT03627767|594348386|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
164539059|NCT03627767|594348387|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
164539060|NCT03627767|594348388|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
164539061|NCT03627767|594348384|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
164539062|NCT03627767|594348385|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
164539063|NCT03627767|594348386|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
164189958|NCT00613821|593064009|FG000|Overall Study|Physician Decision|1|||
164189959|NCT00613821|593064010|FG001|Overall Study|Physician Decision|1|||
164189960|NCT00141518|593064011|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
164189961|NCT00141518|593064012|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
164189962|NCT00141518|593064013|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
164189963|NCT00141518|593064011|FG000|Overall Study|Adverse Event|7|||
164189964|NCT00141518|593064012|FG001|Overall Study|Adverse Event|5|||
164189965|NCT00141518|593064013|FG002|Overall Study|Adverse Event|2|||
164189966|NCT00141518|593064011|FG000|Overall Study|Withdrawal by Subject|2|||
164189967|NCT00141518|593064012|FG001|Overall Study|Withdrawal by Subject|0|||
164189968|NCT00141518|593064013|FG002|Overall Study|Withdrawal by Subject|2|||
164189969|NCT00141518|593064011|FG000|Overall Study|Protocol Violation|1|||
164189970|NCT00141518|593064012|FG001|Overall Study|Protocol Violation|1|||
164189971|NCT00141518|593064013|FG002|Overall Study|Protocol Violation|2|||
164189972|NCT00141518|593064011|FG000|Overall Study|Lack of Efficacy|5|||
164189973|NCT00141518|593064012|FG001|Overall Study|Lack of Efficacy|0|||
164189974|NCT00141518|593064013|FG002|Overall Study|Lack of Efficacy|0|||
164189975|NCT02896569|593064014|FG000|Overall Study|Lost to Follow-up|2|||
164189976|NCT02896569|593064015|FG001|Overall Study|Lost to Follow-up|1|||
164189977|NCT02896569|593064014|FG000|Overall Study|Physician Decision|1|||
164189978|NCT02896569|593064015|FG001|Overall Study|Physician Decision|3|||
164189979|NCT02896569|593064014|FG000|Overall Study|Adverse Event|0|||
164189980|NCT02896569|593064015|FG001|Overall Study|Adverse Event|1|||
164189981|NCT02896569|593064014|FG000|Overall Study|Withdrawal by Subject|1|||
164189982|NCT02896569|593064015|FG001|Overall Study|Withdrawal by Subject|0|||
164189983|NCT03060291|593064020|FG000|3-month Follow-up|Declined to respond|8|||
164189984|NCT03060291|593064021|FG001|3-month Follow-up|Declined to respond|10|||
164189985|NCT03060291|593064022|FG002|3-month Follow-up|Declined to respond|2|||
164189986|NCT03060291|593064020|FG000|6-month Follow-up|Declined to respond|7|||
164189987|NCT03060291|593064021|FG001|6-month Follow-up|Declined to respond|13|||
164189988|NCT03060291|593064022|FG002|6-month Follow-up|Declined to respond|4|||
164189989|NCT03060291|593064020|FG000|12-month Follow-up|Declined to respond|7|||
164189990|NCT03060291|593064021|FG001|12-month Follow-up|Declined to respond|16|||
164189991|NCT03060291|593064022|FG002|12-month Follow-up|Declined to respond|6|||
164189992|NCT01509664|593064025|FG000|Overall Study|Lost to Follow-up|15|||
164189993|NCT01509664|593064026|FG001|Overall Study|Lost to Follow-up|21|||
164189994|NCT01210222|593064029|FG000|Overall Study|Ineligible|2|||
164189995|NCT01210222|593064029|FG000|Overall Study|Never treated|1|||
164189996|NCT00941304|593064030|FG000|Overall Study|Lost to Follow-up|1|||
164189997|NCT00941304|593064031|FG001|Overall Study|Lost to Follow-up|0|||
164189998|NCT00941304|593064032|FG002|Overall Study|Lost to Follow-up|0|||
164189999|NCT00941304|593064033|FG003|Overall Study|Lost to Follow-up|0|||
164190000|NCT00941304|593064034|FG004|Overall Study|Lost to Follow-up|0|||
164190001|NCT00320788|593064038|FG000|Overall Study|Adverse Event|0|||
164190002|NCT00320788|593064039|FG001|Overall Study|Adverse Event|0|||
164190003|NCT00320788|593064040|FG002|Overall Study|Adverse Event|0|||
164190004|NCT00320788|593064041|FG003|Overall Study|Adverse Event|1|||
164190005|NCT00320788|593064042|FG004|Overall Study|Adverse Event|0|||
164190006|NCT00320788|593064038|FG000|Overall Study|Death|0|||
164190007|NCT00320788|593064039|FG001|Overall Study|Death|0|||
164190008|NCT00320788|593064040|FG002|Overall Study|Death|1|||
164190009|NCT00320788|593064041|FG003|Overall Study|Death|0|||
164190010|NCT00320788|593064042|FG004|Overall Study|Death|1|||
164190011|NCT00320788|593064038|FG000|Overall Study|Lost to Follow-up|0|||
164190012|NCT00320788|593064039|FG001|Overall Study|Lost to Follow-up|2|||
164190013|NCT00320788|593064040|FG002|Overall Study|Lost to Follow-up|1|||
164190014|NCT00320788|593064041|FG003|Overall Study|Lost to Follow-up|0|||
164190015|NCT00320788|593064042|FG004|Overall Study|Lost to Follow-up|0|||
164190016|NCT00320788|593064038|FG000|Overall Study|Decision by the Sponsor|1|||
164190017|NCT00320788|593064039|FG001|Overall Study|Decision by the Sponsor|1|||
164190018|NCT00320788|593064040|FG002|Overall Study|Decision by the Sponsor|0|||
164190019|NCT00320788|593064041|FG003|Overall Study|Decision by the Sponsor|0|||
164190020|NCT00320788|593064042|FG004|Overall Study|Decision by the Sponsor|1|||
164539064|NCT03627767|594348387|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
164539065|NCT03627767|594348388|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
164539066|NCT03627767|594348384|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
164539067|NCT03627767|594348385|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
164539068|NCT03627767|594348386|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
164190021|NCT00320788|593064038|FG000|Overall Study|Other|1|||
164190022|NCT00320788|593064039|FG001|Overall Study|Other|2|||
164190023|NCT00320788|593064040|FG002|Overall Study|Other|1|||
164539069|NCT03627767|594348387|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
164190024|NCT00320788|593064041|FG003|Overall Study|Other|1|||
164190025|NCT00320788|593064042|FG004|Overall Study|Other|1|||
164190026|NCT00320788|593064038|FG000|Overall Study|Physician Decision|1|||
164190027|NCT00320788|593064039|FG001|Overall Study|Physician Decision|1|||
164190028|NCT00320788|593064040|FG002|Overall Study|Physician Decision|0|||
164190029|NCT00320788|593064041|FG003|Overall Study|Physician Decision|0|||
164190030|NCT00320788|593064042|FG004|Overall Study|Physician Decision|0|||
164190031|NCT00320788|593064038|FG000|Overall Study|Protocol Violation|0|||
164190032|NCT00320788|593064039|FG001|Overall Study|Protocol Violation|0|||
164190033|NCT00320788|593064040|FG002|Overall Study|Protocol Violation|0|||
164190034|NCT00320788|593064041|FG003|Overall Study|Protocol Violation|0|||
164190035|NCT00320788|593064042|FG004|Overall Study|Protocol Violation|1|||
164190036|NCT00320788|593064038|FG000|Overall Study|Withdrawal by Subject|3|||
164190037|NCT00320788|593064039|FG001|Overall Study|Withdrawal by Subject|0|||
164190038|NCT00320788|593064040|FG002|Overall Study|Withdrawal by Subject|0|||
164190039|NCT00320788|593064041|FG003|Overall Study|Withdrawal by Subject|3|||
164190040|NCT00320788|593064042|FG004|Overall Study|Withdrawal by Subject|1|||
164190041|NCT00184093|593064049|FG000|Overall Study|Adverse Event|3|||
164190042|NCT00184093|593064049|FG000|Overall Study|Lost to Follow-up|3|||
164190043|NCT00184093|593064049|FG000|Overall Study|Physician Decision|1|||
164190044|NCT00184093|593064049|FG000|Overall Study|Withdrawal by Subject|2|||
164190045|NCT00805129|593064054|FG000|Overall Study|Not treated|1|||
164190046|NCT00571662|593064055|FG000|Overall Study|Withdrawal by Subject|2|||
164190047|NCT00571662|593064055|FG000|Overall Study|psychiatric instability|1|||
164190048|NCT00571662|593064055|FG000|Overall Study|Adverse Event|5|||
164190049|NCT03681184|593064058|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
164190050|NCT03681184|593064059|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
164190051|NCT02710084|593064064|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
164652694|NCT00323609|594755178|FG001|Overall Study|Unrelenting or severe back pain|1|||
164190052|NCT02710084|593064065|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
164190053|NCT00792116|593064070|FG000|Overall Study|Lost to Follow-up|0|||
164190054|NCT00792116|593064071|FG001|Overall Study|Lost to Follow-up|1|||
164190055|NCT00792116|593064070|FG000|Overall Study|Discontnued intervention|1|||
164190056|NCT00792116|593064071|FG001|Overall Study|Discontnued intervention|0|||
164190057|NCT02453256|593064072|FG000|Double Blind Period|Death|1|||
164190058|NCT02453256|593064073|FG001|Double Blind Period|Death|1|||
164190059|NCT02453256|593064072|FG000|Double Blind Period|Adverse Event|3|||
164190060|NCT02453256|593064073|FG001|Double Blind Period|Adverse Event|2|||
164190061|NCT02453256|593064072|FG000|Double Blind Period|Withdrawal by Subject|9|||
164190062|NCT02453256|593064073|FG001|Double Blind Period|Withdrawal by Subject|5|||
164190063|NCT02453256|593064072|FG000|Double Blind Period|Other|0|||
164190064|NCT02453256|593064073|FG001|Double Blind Period|Other|1|||
164190065|NCT02453256|593064072|FG000|Open Label Period|Adverse Event|1|||
164190066|NCT02453256|593064073|FG001|Open Label Period|Adverse Event|3|||
164190067|NCT02453256|593064072|FG000|Open Label Period|Death|0|||
164190068|NCT02453256|593064073|FG001|Open Label Period|Death|1|||
164190069|NCT02453256|593064072|FG000|Open Label Period|Lost to Follow-up|1|||
164190070|NCT02453256|593064073|FG001|Open Label Period|Lost to Follow-up|0|||
164190071|NCT02453256|593064072|FG000|Open Label Period|Other|0|||
164190072|NCT02453256|593064073|FG001|Open Label Period|Other|2|||
164190073|NCT02453256|593064072|FG000|Open Label Period|Withdrawal by Subject|5|||
164190074|NCT02453256|593064073|FG001|Open Label Period|Withdrawal by Subject|1|||
164190075|NCT03373461|593064076|FG000|Part 2|Adverse Event|0|||
164190076|NCT03373461|593064077|FG001|Part 2|Adverse Event|1|||
164190077|NCT03373461|593064078|FG002|Part 2|Adverse Event|0|||
164190078|NCT03373461|593064079|FG003|Part 2|Adverse Event|0|||
164190079|NCT03373461|593064080|FG004|Part 2|Adverse Event|1|||
164190080|NCT01366638|593064081|FG000|Overall Study|Withdrawal by Subject|0|||
164190081|NCT01366638|593064082|FG001|Overall Study|Withdrawal by Subject|0|||
164190082|NCT01366638|593064083|FG002|Overall Study|Withdrawal by Subject|6|||
164190083|NCT01366638|593064081|FG000|Overall Study|Other|1|||
164190084|NCT01366638|593064082|FG001|Overall Study|Other|0|||
164190085|NCT01366638|593064083|FG002|Overall Study|Other|0|||
164190086|NCT01243177|593064084|FG000|Overall Study|Lack of Efficacy|47|||
164190087|NCT01243177|593064085|FG001|Overall Study|Lack of Efficacy|31|||
164190088|NCT01243177|593064084|FG000|Overall Study|Protocol Violation|11|||
164190089|NCT01243177|593064085|FG001|Overall Study|Protocol Violation|10|||
164190090|NCT01243177|593064084|FG000|Overall Study|Lost to Follow-up|15|||
164190091|NCT01243177|593064085|FG001|Overall Study|Lost to Follow-up|18|||
164190092|NCT01243177|593064084|FG000|Overall Study|Withdrawal by Subject|46|||
164190093|NCT01243177|593064085|FG001|Overall Study|Withdrawal by Subject|38|||
164190094|NCT01243177|593064084|FG000|Overall Study|AE, serious fatal|0|||
164190095|NCT01243177|593064085|FG001|Overall Study|AE, serious fatal|1|||
164190096|NCT01243177|593064084|FG000|Overall Study|SAE, non-fatal|7|||
164190097|NCT01243177|593064085|FG001|Overall Study|SAE, non-fatal|9|||
164190098|NCT01243177|593064084|FG000|Overall Study|AE, non-serious non-fatal|40|||
164190099|NCT01243177|593064085|FG001|Overall Study|AE, non-serious non-fatal|58|||
164652695|NCT00323609|594755179|FG002|Overall Study|Unrelenting or severe back pain|0|||
164420574|NCT02718417|593910943|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
164190100|NCT01243177|593064084|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
164190101|NCT01243177|593064085|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
164190102|NCT01243177|593064084|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
164190103|NCT01243177|593064085|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
164190104|NCT01243177|593064084|FG000|Overall Study|Other Reason|11|||
164190105|NCT01243177|593064085|FG001|Overall Study|Other Reason|12|||
164190106|NCT05259163|593066220|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
164190107|NCT05259163|593066221|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
164652696|NCT00323609|594755180|FG003|Overall Study|Unrelenting or severe back pain|0|||
164539070|NCT03627767|594348388|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
164539071|NCT03627767|594348384|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
164539072|NCT03627767|594348385|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
164539073|NCT03627767|594348386|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
164539074|NCT03627767|594348387|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
164539075|NCT03627767|594348388|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
164539076|NCT03627767|594348384|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
164539077|NCT03627767|594348385|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
164539078|NCT03627767|594348386|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
164539079|NCT03627767|594348387|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
164539080|NCT03627767|594348388|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
164539081|NCT03627767|594348384|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
164539082|NCT03627767|594348385|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
164539083|NCT03627767|594348386|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
164539084|NCT03627767|594348387|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
164539085|NCT03627767|594348388|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
164539086|NCT03627767|594348384|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
164539087|NCT03627767|594348385|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
164539088|NCT03627767|594348386|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
164539089|NCT03627767|594348387|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
164539090|NCT03627767|594348388|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
164539091|NCT03627767|594348384|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
164539092|NCT03627767|594348385|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
164539093|NCT03627767|594348386|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
164539094|NCT03627767|594348387|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
164652697|NCT00323609|594755177|FG000|Overall Study|Logistical withdrawal|9|||
164652698|NCT00323609|594755178|FG001|Overall Study|Logistical withdrawal|5|||
164652699|NCT00323609|594755179|FG002|Overall Study|Logistical withdrawal|0|||
164652700|NCT00323609|594755180|FG003|Overall Study|Logistical withdrawal|1|||
164652701|NCT00323609|594755177|FG000|Overall Study|Other reason|11|||
164652702|NCT00323609|594755178|FG001|Overall Study|Other reason|8|||
164652703|NCT00323609|594755179|FG002|Overall Study|Other reason|4|||
164652704|NCT00323609|594755180|FG003|Overall Study|Other reason|9|||
164652705|NCT01684722|594755186|FG000|Overall Study|Lost to Follow-up|78|||
164652706|NCT01684722|594755187|FG001|Overall Study|Lost to Follow-up|56|||
164652707|NCT01684722|594755188|FG002|Overall Study|Lost to Follow-up|75|||
164652708|NCT01684722|594755189|FG003|Overall Study|Lost to Follow-up|89|||
164652709|NCT01684722|594755186|FG000|Overall Study|Death|19|||
164652710|NCT01684722|594755187|FG001|Overall Study|Death|21|||
164652711|NCT01684722|594755188|FG002|Overall Study|Death|19|||
164652712|NCT01684722|594755189|FG003|Overall Study|Death|21|||
164652713|NCT01664494|594755190|FG000|Overall Study|Withdrawal by Subject|27|||
164652714|NCT01664494|594755190|FG000|Overall Study|Death|18|||
164652715|NCT01664494|594755190|FG000|Overall Study|Other|49|||
164652716|NCT01664494|594755190|FG000|Overall Study|Lost to Follow-up|99|||
164652717|NCT00219557|594755191|FG000|Phase 1|Lack of Efficacy|3|||
164652718|NCT00219557|594755192|FG001|Phase 1|Lack of Efficacy|0|||
164652719|NCT00219557|594755193|FG002|Phase 1|Lack of Efficacy|0|||
164652720|NCT00219557|594755191|FG000|Phase 1|Adverse Event|2|||
164652721|NCT00219557|594755192|FG001|Phase 1|Adverse Event|0|||
164652722|NCT00219557|594755193|FG002|Phase 1|Adverse Event|0|||
164652723|NCT00219557|594755191|FG000|Phase 1|Withdrawal by Subject|1|||
164652724|NCT00219557|594755192|FG001|Phase 1|Withdrawal by Subject|0|||
164652725|NCT00219557|594755193|FG002|Phase 1|Withdrawal by Subject|0|||
164652726|NCT00219557|594755191|FG000|Phase 1|Started chemotherapy at other institute|1|||
164652727|NCT00219557|594755192|FG001|Phase 1|Started chemotherapy at other institute|0|||
164652728|NCT00219557|594755193|FG002|Phase 1|Started chemotherapy at other institute|0|||
164652729|NCT00219557|594755191|FG000|Phase 2|Lack of Efficacy|0|||
164652730|NCT00219557|594755192|FG001|Phase 2|Lack of Efficacy|21|||
164652731|NCT00219557|594755193|FG002|Phase 2|Lack of Efficacy|15|||
164652732|NCT00219557|594755191|FG000|Phase 2|Adverse Event|0|||
164652733|NCT00219557|594755192|FG001|Phase 2|Adverse Event|22|||
164652734|NCT00219557|594755193|FG002|Phase 2|Adverse Event|2|||
164652735|NCT00219557|594755191|FG000|Phase 2|Death|0|||
164652736|NCT00219557|594755192|FG001|Phase 2|Death|8|||
164652737|NCT00219557|594755193|FG002|Phase 2|Death|2|||
164652738|NCT00219557|594755191|FG000|Phase 2|Other|0|||
164652739|NCT00219557|594755192|FG001|Phase 2|Other|8|||
164652740|NCT00219557|594755193|FG002|Phase 2|Other|6|||
164652741|NCT00219557|594755191|FG000|Phase 2|Withdrawal by Subject|0|||
164652742|NCT00219557|594755192|FG001|Phase 2|Withdrawal by Subject|9|||
164652743|NCT00219557|594755193|FG002|Phase 2|Withdrawal by Subject|5|||
164652744|NCT00219557|594755191|FG000|Phase 2|Treatment not received|0|||
164652745|NCT00219557|594755192|FG001|Phase 2|Treatment not received|1|||
164652746|NCT00219557|594755193|FG002|Phase 2|Treatment not received|3|||
164539095|NCT03627767|594348388|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
164539096|NCT03627767|594348384|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
164539097|NCT03627767|594348385|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
164539098|NCT03627767|594348386|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
164539099|NCT03627767|594348387|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
164539100|NCT03627767|594348388|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
164539101|NCT03627767|594348384|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
164652747|NCT03063632|594755194|FG000|Overall Study|Death|4|||
164652748|NCT03063632|594755195|FG001|Overall Study|Death|6|||
164652749|NCT03063632|594755194|FG000|Overall Study|Lost to Follow-up|0|||
164652750|NCT03063632|594755195|FG001|Overall Study|Lost to Follow-up|1|||
164652751|NCT03063632|594755194|FG000|Overall Study|Withdrawal by Subject|0|||
164652752|NCT03063632|594755195|FG001|Overall Study|Withdrawal by Subject|2|||
164652753|NCT03063632|594755194|FG000|Overall Study|Physician Decision|2|||
164652754|NCT03063632|594755195|FG001|Overall Study|Physician Decision|0|||
164652755|NCT03063632|594755194|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
164539102|NCT03627767|594348385|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
164539103|NCT03627767|594348386|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
164539104|NCT03627767|594348387|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
164539105|NCT03627767|594348388|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
164539106|NCT03627767|594348384|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
164539107|NCT03627767|594348385|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
164539108|NCT03627767|594348386|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
164539109|NCT03627767|594348387|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
164539110|NCT03627767|594348388|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
164539111|NCT03627767|594348384|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
164539112|NCT03627767|594348385|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
164539113|NCT03627767|594348386|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
164539114|NCT03627767|594348387|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
164539115|NCT03627767|594348388|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
164539116|NCT03627767|594348384|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
164539117|NCT03627767|594348385|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
164539118|NCT03627767|594348386|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
164539119|NCT03627767|594348387|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
164539120|NCT03627767|594348388|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
164539121|NCT00283049|594348389|FG000|Overall Study|Adverse Event|6|||
164539122|NCT00283049|594348390|FG001|Overall Study|Adverse Event|1|||
164539123|NCT00283049|594348391|FG002|Overall Study|Adverse Event|4|||
164539124|NCT00283049|594348389|FG000|Overall Study|Protocol Violation|3|||
164539125|NCT00283049|594348390|FG001|Overall Study|Protocol Violation|0|||
164539126|NCT00283049|594348391|FG002|Overall Study|Protocol Violation|3|||
164539127|NCT00283049|594348389|FG000|Overall Study|Death|1|||
164539128|NCT00283049|594348390|FG001|Overall Study|Death|1|||
164539129|NCT00283049|594348391|FG002|Overall Study|Death|1|||
164539130|NCT00283049|594348389|FG000|Overall Study|Lack of Efficacy|0|||
164539131|NCT00283049|594348390|FG001|Overall Study|Lack of Efficacy|1|||
164539132|NCT00283049|594348391|FG002|Overall Study|Lack of Efficacy|1|||
164539133|NCT00283049|594348389|FG000|Overall Study|Lost to Follow-up|4|||
164539134|NCT00283049|594348390|FG001|Overall Study|Lost to Follow-up|2|||
164539135|NCT00283049|594348391|FG002|Overall Study|Lost to Follow-up|5|||
164539136|NCT00283049|594348389|FG000|Overall Study|Withdrawal by Subject|26|||
164539137|NCT00283049|594348390|FG001|Overall Study|Withdrawal by Subject|24|||
164539138|NCT00283049|594348391|FG002|Overall Study|Withdrawal by Subject|19|||
164539139|NCT00283049|594348389|FG000|Overall Study|Discontinuation of Study|18|||
164539140|NCT00283049|594348390|FG001|Overall Study|Discontinuation of Study|16|||
164539141|NCT00283049|594348391|FG002|Overall Study|Discontinuation of Study|20|||
164539142|NCT00283049|594348389|FG000|Overall Study|No longer requires study treatment|0|||
164539143|NCT00283049|594348390|FG001|Overall Study|No longer requires study treatment|0|||
164539144|NCT00283049|594348391|FG002|Overall Study|No longer requires study treatment|1|||
164539145|NCT02953639|594348392|FG000|Overall Study|Adverse Event|2|||
164539146|NCT02953639|594348393|FG001|Overall Study|Adverse Event|0|||
164539147|NCT02953639|594348394|FG002|Overall Study|Adverse Event|1|||
164539148|NCT02953639|594348392|FG000|Overall Study|Lost to Follow-up|8|||
164539149|NCT02953639|594348393|FG001|Overall Study|Lost to Follow-up|4|||
164539150|NCT02953639|594348394|FG002|Overall Study|Lost to Follow-up|3|||
164539151|NCT02953639|594348392|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164539152|NCT02953639|594348393|FG001|Overall Study|Non-Compliance With Study Drug|2|||
164539153|NCT02953639|594348394|FG002|Overall Study|Non-Compliance With Study Drug|1|||
164539154|NCT02953639|594348392|FG000|Overall Study|Multiple Reasons|1|||
164539155|NCT02953639|594348393|FG001|Overall Study|Multiple Reasons|0|||
164539156|NCT02953639|594348394|FG002|Overall Study|Multiple Reasons|1|||
164539157|NCT02953639|594348392|FG000|Overall Study|Physician Decision|1|||
164190108|NCT05251233|593066222|FG000|Overall Study|Disease progression - did not start treatment|0|||
164190109|NCT05251233|593066223|FG001|Overall Study|Disease progression - did not start treatment|0|||
164190110|NCT05251233|593066224|FG002|Overall Study|Disease progression - did not start treatment|5|||
164190111|NCT05251233|593066222|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
164190112|NCT05251233|593066223|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
164190113|NCT05251233|593066224|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
164190114|NCT05251233|593066222|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
164190115|NCT05251233|593066223|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
164190116|NCT05251233|593066224|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
164190117|NCT05251233|593066222|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
164190118|NCT05251233|593066223|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
164190119|NCT05251233|593066224|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
164190120|NCT05251233|593066222|FG000|Overall Study|Death - did not start treatment|3|||
164190121|NCT05251233|593066223|FG001|Overall Study|Death - did not start treatment|0|||
164190122|NCT05251233|593066224|FG002|Overall Study|Death - did not start treatment|0|||
164190123|NCT05251233|593066222|FG000|Overall Study|Withdrawal by Subject|2|||
164190124|NCT05251233|593066223|FG001|Overall Study|Withdrawal by Subject|2|||
164190125|NCT05251233|593066224|FG002|Overall Study|Withdrawal by Subject|0|||
164190126|NCT05251233|593066222|FG000|Overall Study|Other complicating disease|2|||
164190127|NCT05251233|593066223|FG001|Overall Study|Other complicating disease|1|||
164190128|NCT05251233|593066224|FG002|Overall Study|Other complicating disease|0|||
164190129|NCT05251233|593066222|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
164190130|NCT05251233|593066223|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
164190131|NCT05251233|593066224|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
164190132|NCT05251233|593066222|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
164190133|NCT05251233|593066223|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
164190134|NCT05251233|593066224|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
164190135|NCT01639144|593066227|FG000|Overall Study|Withdrawal by Subject|4|||
164190136|NCT01639144|593066228|FG001|Overall Study|Withdrawal by Subject|2|||
164190137|NCT01639144|593066227|FG000|Overall Study|Physician Decision|2|||
164190138|NCT01639144|593066228|FG001|Overall Study|Physician Decision|0|||
164190139|NCT01639144|593066227|FG000|Overall Study|Met postoperative exclusion criteria|4|||
164190140|NCT01639144|593066228|FG001|Overall Study|Met postoperative exclusion criteria|3|||
164190141|NCT01000974|593066229|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
164190142|NCT01000974|593066230|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
164190143|NCT01000974|593066231|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
164190144|NCT01000974|593066229|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
164190145|NCT01000974|593066230|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
164190146|NCT01000974|593066231|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
164190147|NCT01000974|593066229|FG000|Primary Vaccination Phase|Protocol Violation|40|||
164190148|NCT01000974|593066230|FG001|Primary Vaccination Phase|Protocol Violation|3|||
164190149|NCT01000974|593066231|FG002|Primary Vaccination Phase|Protocol Violation|2|||
164190150|NCT01000974|593066229|FG000|Primary Vaccination Phase|Adverse Event|14|||
164190151|NCT01000974|593066230|FG001|Primary Vaccination Phase|Adverse Event|2|||
164539158|NCT02953639|594348393|FG001|Overall Study|Physician Decision|0|||
164539159|NCT02953639|594348394|FG002|Overall Study|Physician Decision|0|||
164539160|NCT02953639|594348392|FG000|Overall Study|Withdrawal by Subject|7|||
164539161|NCT02953639|594348393|FG001|Overall Study|Withdrawal by Subject|8|||
164539162|NCT02953639|594348394|FG002|Overall Study|Withdrawal by Subject|10|||
164539163|NCT02953639|594348392|FG000|Overall Study|Completed or Discontinued information is missing|1|||
164539164|NCT02953639|594348393|FG001|Overall Study|Completed or Discontinued information is missing|0|||
164539165|NCT02953639|594348394|FG002|Overall Study|Completed or Discontinued information is missing|0|||
164539166|NCT01667081|594348395|FG000|Overall Study|Death|43|||
164539167|NCT01667081|594348396|FG001|Overall Study|Death|3|||
164539168|NCT01667081|594348395|FG000|Overall Study|Lost to Follow-up|99|||
164539169|NCT01667081|594348396|FG001|Overall Study|Lost to Follow-up|48|||
164539170|NCT01667081|594348395|FG000|Overall Study|Physician Decision|16|||
164539171|NCT01667081|594348396|FG001|Overall Study|Physician Decision|2|||
164190152|NCT01000974|593066231|FG002|Primary Vaccination Phase|Adverse Event|2|||
164190153|NCT01000974|593066229|FG000|Primary Vaccination Phase|Other|4|||
164190154|NCT01000974|593066230|FG001|Primary Vaccination Phase|Other|9|||
164539172|NCT01667081|594348395|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
164190155|NCT01000974|593066231|FG002|Primary Vaccination Phase|Other|12|||
164539173|NCT01667081|594348396|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
164539174|NCT01667081|594348395|FG000|Overall Study|Withdrawal by Subject|90|||
164539175|NCT01667081|594348396|FG001|Overall Study|Withdrawal by Subject|35|||
164539176|NCT03034460|594348397|FG000|Overall Study|Adverse Event|0|||
164190156|NCT01000974|593066229|FG000|Booster Vaccination Phase|Protocol Violation|0|||
164190157|NCT01000974|593066230|FG001|Booster Vaccination Phase|Protocol Violation|0|||
164190158|NCT01000974|593066231|FG002|Booster Vaccination Phase|Protocol Violation|2|||
164190159|NCT01000974|593066229|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
164190160|NCT01000974|593066230|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
164190161|NCT01000974|593066231|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
164190162|NCT01000974|593066229|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
164190163|NCT01000974|593066230|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
164190164|NCT01000974|593066231|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
164190165|NCT01000974|593066229|FG000|Booster Vaccination Phase|Other|24|||
164190166|NCT01000974|593066230|FG001|Booster Vaccination Phase|Other|6|||
164190167|NCT01000974|593066231|FG002|Booster Vaccination Phase|Other|4|||
164190168|NCT03365934|593066232|FG000|Overall Study|Adverse Event|1|||
164190169|NCT03365934|593066232|FG000|Overall Study|Withdrawal by Subject|1|||
164190170|NCT01307891|593066233|FG000|Overall Study|Progressive Disease|3|||
164190171|NCT01307891|593066234|FG001|Overall Study|Progressive Disease|1|||
164190172|NCT02937740|593066235|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
164190173|NCT02937740|593066236|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
164190174|NCT02937740|593066235|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
164190175|NCT02937740|593066236|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
164190176|NCT02937740|593066235|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
164190177|NCT02937740|593066236|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
164190178|NCT02937740|593066235|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
164190179|NCT02937740|593066236|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
164190180|NCT02937740|593066235|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
164190181|NCT02937740|593066236|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
164190182|NCT02937740|593066235|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
164190183|NCT02937740|593066236|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
164190184|NCT04194489|593066237|FG000|Overall Study|Withdrawal by Subject|5|||
164190185|NCT04194489|593066237|FG000|Overall Study|Lost to Follow-up|48|||
164190186|NCT02964338|593066240|FG000|Overall Study|Sponsor terminated study for futility|12|||
164190187|NCT02964338|593066241|FG001|Overall Study|Sponsor terminated study for futility|15|||
164190188|NCT02964338|593066242|FG002|Overall Study|Sponsor terminated study for futility|14|||
164190189|NCT02964338|593066240|FG000|Overall Study|Lack of Efficacy|0|||
164190190|NCT02964338|593066241|FG001|Overall Study|Lack of Efficacy|3|||
164190191|NCT02964338|593066242|FG002|Overall Study|Lack of Efficacy|0|||
164190192|NCT02964338|593066240|FG000|Overall Study|Lost to Follow-up|1|||
164190193|NCT02964338|593066241|FG001|Overall Study|Lost to Follow-up|0|||
164190194|NCT02964338|593066242|FG002|Overall Study|Lost to Follow-up|3|||
164190195|NCT02964338|593066240|FG000|Overall Study|Protocol Violation|0|||
164190196|NCT02964338|593066241|FG001|Overall Study|Protocol Violation|1|||
164190197|NCT02964338|593066242|FG002|Overall Study|Protocol Violation|0|||
164190198|NCT02964338|593066240|FG000|Overall Study|Withdrawal by Subject|1|||
164190199|NCT02964338|593066241|FG001|Overall Study|Withdrawal by Subject|3|||
164190200|NCT02964338|593066242|FG002|Overall Study|Withdrawal by Subject|1|||
164190201|NCT02964338|593066240|FG000|Overall Study|Adverse Event|2|||
164420575|NCT02718417|593910944|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
164539177|NCT03034460|594348398|FG001|Overall Study|Adverse Event|1|||
164539178|NCT03034460|594348397|FG000|Overall Study|Withdrawal by Subject|2|||
164539179|NCT03034460|594348398|FG001|Overall Study|Withdrawal by Subject|2|||
164539180|NCT03034460|594348397|FG000|Overall Study|Personal Reasons|1|||
164539181|NCT03034460|594348398|FG001|Overall Study|Personal Reasons|0|||
164539182|NCT02294682|594348399|FG000|Overall Study|Could not swallow pills|1|||
164539183|NCT02294682|594348400|FG001|Overall Study|Could not swallow pills|0|||
164539184|NCT01516970|594348401|FG000|Overall Study|Lost to Follow-up|7|||
164539185|NCT01516970|594348402|FG001|Overall Study|Lost to Follow-up|8|||
164539186|NCT01516970|594348401|FG000|Overall Study|Adverse Event|1|||
164539187|NCT01516970|594348402|FG001|Overall Study|Adverse Event|5|||
164539188|NCT01516970|594348401|FG000|Overall Study|Withdrawal by Subject|1|||
164420576|NCT02718417|593910945|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
164539189|NCT01516970|594348402|FG001|Overall Study|Withdrawal by Subject|1|||
164539190|NCT01516970|594348401|FG000|Overall Study|Other|9|||
164539191|NCT01516970|594348402|FG001|Overall Study|Other|7|||
164539192|NCT02366728|594348403|FG000|Overall Study|Death|0|||
164539193|NCT02366728|594348404|FG001|Overall Study|Death|0|||
164539194|NCT02366728|594348405|FG002|Overall Study|Death|1|||
164539195|NCT02366728|594348403|FG000|Overall Study|Adverse Event|1|||
164539196|NCT02366728|594348404|FG001|Overall Study|Adverse Event|0|||
164539197|NCT02366728|594348405|FG002|Overall Study|Adverse Event|0|||
164539198|NCT02366728|594348403|FG000|Overall Study|Screen Failure|2|||
164539199|NCT02366728|594348404|FG001|Overall Study|Screen Failure|1|||
164539200|NCT02366728|594348405|FG002|Overall Study|Screen Failure|0|||
164539201|NCT02366728|594348403|FG000|Overall Study|Only yielded 2 vaccines|1|||
164539202|NCT02366728|594348404|FG001|Overall Study|Only yielded 2 vaccines|0|||
164539203|NCT02366728|594348405|FG002|Overall Study|Only yielded 2 vaccines|0|||
164539204|NCT01399190|594348408|FG000|Overall Study|Not Eligible for Final Analysis|5|||
164539205|NCT01399190|594348408|FG000|Overall Study|Adverse Event|8|||
164539206|NCT01399190|594348408|FG000|Overall Study|Participant's Request|5|||
164539207|NCT01399190|594348408|FG000|Overall Study|Physician Decision|2|||
164652756|NCT03063632|594755195|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
164652757|NCT01612156|594755196|FG000|Overall Study|Protocol Violation|2|||
164652758|NCT01612156|594755197|FG001|Overall Study|Protocol Violation|0|||
164652759|NCT00410410|594755198|FG000|Induction Period (IP)|Death|1|||
164652760|NCT00410410|594755199|FG001|Induction Period (IP)|Death|0|||
164652761|NCT00410410|594755200|FG002|Induction Period (IP)|Death|0|||
164652762|NCT00410410|594755201|FG003|Induction Period (IP)|Death|0|||
164652763|NCT00410410|594755202|FG004|Induction Period (IP)|Death|0|||
164652764|NCT00410410|594755203|FG005|Induction Period (IP)|Death|0|||
164652765|NCT00410410|594755204|FG006|Induction Period (IP)|Death|0|||
164652766|NCT00410410|594755205|FG007|Induction Period (IP)|Death|0|||
164652767|NCT00410410|594755206|FG008|Induction Period (IP)|Death|0|||
164652768|NCT00410410|594755198|FG000|Induction Period (IP)|Adverse Event|3|||
164652769|NCT00410410|594755199|FG001|Induction Period (IP)|Adverse Event|4|||
164652770|NCT00410410|594755200|FG002|Induction Period (IP)|Adverse Event|2|||
164652771|NCT00410410|594755201|FG003|Induction Period (IP)|Adverse Event|4|||
164652772|NCT00410410|594755202|FG004|Induction Period (IP)|Adverse Event|1|||
164652773|NCT00410410|594755203|FG005|Induction Period (IP)|Adverse Event|0|||
164652774|NCT00410410|594755204|FG006|Induction Period (IP)|Adverse Event|0|||
164652775|NCT00410410|594755205|FG007|Induction Period (IP)|Adverse Event|0|||
164652776|NCT00410410|594755206|FG008|Induction Period (IP)|Adverse Event|0|||
164652777|NCT00410410|594755198|FG000|Induction Period (IP)|Lack of Efficacy|26|||
164652778|NCT00410410|594755199|FG001|Induction Period (IP)|Lack of Efficacy|24|||
164652779|NCT00410410|594755200|FG002|Induction Period (IP)|Lack of Efficacy|8|||
164652780|NCT00410410|594755201|FG003|Induction Period (IP)|Lack of Efficacy|8|||
164652781|NCT00410410|594755202|FG004|Induction Period (IP)|Lack of Efficacy|7|||
164652782|NCT00410410|594755203|FG005|Induction Period (IP)|Lack of Efficacy|7|||
164652783|NCT00410410|594755204|FG006|Induction Period (IP)|Lack of Efficacy|0|||
164652784|NCT00410410|594755205|FG007|Induction Period (IP)|Lack of Efficacy|0|||
164652785|NCT00410410|594755206|FG008|Induction Period (IP)|Lack of Efficacy|0|||
164652786|NCT00410410|594755198|FG000|Induction Period (IP)|Lost to Follow-up|2|||
164652787|NCT00410410|594755199|FG001|Induction Period (IP)|Lost to Follow-up|2|||
164652788|NCT00410410|594755200|FG002|Induction Period (IP)|Lost to Follow-up|2|||
164652789|NCT00410410|594755201|FG003|Induction Period (IP)|Lost to Follow-up|3|||
164652790|NCT00410410|594755202|FG004|Induction Period (IP)|Lost to Follow-up|0|||
164652791|NCT00410410|594755203|FG005|Induction Period (IP)|Lost to Follow-up|1|||
164652792|NCT00410410|594755204|FG006|Induction Period (IP)|Lost to Follow-up|0|||
164652793|NCT00410410|594755205|FG007|Induction Period (IP)|Lost to Follow-up|0|||
164652794|NCT00410410|594755206|FG008|Induction Period (IP)|Lost to Follow-up|0|||
164652795|NCT00410410|594755198|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
164652796|NCT00410410|594755199|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
164652797|NCT00410410|594755200|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
164652798|NCT00410410|594755201|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
164652799|NCT00410410|594755202|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
164652800|NCT00410410|594755203|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
164539208|NCT03829241|594348412|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
164539209|NCT03829241|594348413|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
164652801|NCT00410410|594755204|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
164652802|NCT00410410|594755205|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
164652803|NCT00410410|594755206|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
164652804|NCT00410410|594755198|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
164652805|NCT00410410|594755199|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
164652806|NCT00410410|594755200|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
164652807|NCT00410410|594755201|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
164652808|NCT00410410|594755202|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
164652809|NCT00410410|594755203|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
164652810|NCT00410410|594755204|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
164652811|NCT00410410|594755205|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
164652812|NCT00410410|594755206|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
164652813|NCT00410410|594755198|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
164539210|NCT03829241|594348412|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
164539211|NCT03829241|594348413|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
164539212|NCT03829241|594348412|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
164539213|NCT03829241|594348413|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
164539214|NCT03829241|594348412|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
164539215|NCT03829241|594348413|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
164539216|NCT03829241|594348412|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
164539217|NCT03829241|594348413|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
164539218|NCT03829241|594348412|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
164539219|NCT03829241|594348413|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
164539220|NCT03829241|594348412|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
164539221|NCT03829241|594348413|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
164539222|NCT03829241|594348412|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
164539223|NCT03829241|594348413|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
164539224|NCT03829241|594348412|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
164539225|NCT03829241|594348413|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
164539226|NCT03829241|594348412|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
164539227|NCT03829241|594348413|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
164539228|NCT03829241|594348412|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
164539229|NCT03829241|594348413|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
164539230|NCT03829241|594348412|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
164539231|NCT03829241|594348413|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
164539232|NCT03829241|594348412|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
164539233|NCT03829241|594348413|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
164539234|NCT03829241|594348412|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
164539235|NCT03829241|594348413|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
164539236|NCT00698451|594348414|FG000|Overall Study|Adverse Event|22|||
164539237|NCT00698451|594348414|FG000|Overall Study|Physician Decision|2|||
164539238|NCT00698451|594348414|FG000|Overall Study|Protocol Violation|6|||
164539239|NCT00698451|594348414|FG000|Overall Study|Withdrawal by Subject|6|||
164539240|NCT00698451|594348414|FG000|Overall Study|Disease progression|3|||
164652814|NCT00410410|594755199|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
164652815|NCT00410410|594755200|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
164652816|NCT00410410|594755201|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
164652817|NCT00410410|594755202|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
164652818|NCT00410410|594755203|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
164652819|NCT00410410|594755204|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
164652820|NCT00410410|594755205|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
164652821|NCT00410410|594755206|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
164652822|NCT00410410|594755198|FG000|Induction Period (IP)|Other|0|||
164652823|NCT00410410|594755199|FG001|Induction Period (IP)|Other|0|||
164652824|NCT00410410|594755200|FG002|Induction Period (IP)|Other|1|||
164652825|NCT00410410|594755201|FG003|Induction Period (IP)|Other|0|||
164652826|NCT00410410|594755202|FG004|Induction Period (IP)|Other|0|||
164652827|NCT00410410|594755203|FG005|Induction Period (IP)|Other|0|||
164652828|NCT00410410|594755204|FG006|Induction Period (IP)|Other|0|||
164652829|NCT00410410|594755205|FG007|Induction Period (IP)|Other|0|||
164652830|NCT00410410|594755206|FG008|Induction Period (IP)|Other|0|||
164652831|NCT00410410|594755198|FG000|Maintenance Period (MP)|Death|0|||
164652832|NCT00410410|594755199|FG001|Maintenance Period (MP)|Death|0|||
164652833|NCT00410410|594755200|FG002|Maintenance Period (MP)|Death|0|||
164652834|NCT00410410|594755201|FG003|Maintenance Period (MP)|Death|0|||
164652835|NCT00410410|594755202|FG004|Maintenance Period (MP)|Death|0|||
164652836|NCT00410410|594755203|FG005|Maintenance Period (MP)|Death|0|||
164652837|NCT00410410|594755204|FG006|Maintenance Period (MP)|Death|1|||
164652838|NCT00410410|594755205|FG007|Maintenance Period (MP)|Death|0|||
164652839|NCT00410410|594755206|FG008|Maintenance Period (MP)|Death|0|||
164652840|NCT00410410|594755198|FG000|Maintenance Period (MP)|Adverse Event|0|||
164652841|NCT00410410|594755199|FG001|Maintenance Period (MP)|Adverse Event|0|||
164652842|NCT00410410|594755200|FG002|Maintenance Period (MP)|Adverse Event|0|||
164652843|NCT00410410|594755201|FG003|Maintenance Period (MP)|Adverse Event|0|||
164652844|NCT00410410|594755202|FG004|Maintenance Period (MP)|Adverse Event|0|||
164652845|NCT00410410|594755203|FG005|Maintenance Period (MP)|Adverse Event|0|||
164652846|NCT00410410|594755204|FG006|Maintenance Period (MP)|Adverse Event|1|||
164652847|NCT00410410|594755205|FG007|Maintenance Period (MP)|Adverse Event|3|||
164652848|NCT00410410|594755206|FG008|Maintenance Period (MP)|Adverse Event|0|||
164652849|NCT00410410|594755198|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
164652850|NCT00410410|594755199|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
164652851|NCT00410410|594755200|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
164652852|NCT00410410|594755201|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
164652853|NCT00410410|594755202|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
164652854|NCT00410410|594755203|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
164190202|NCT02964338|593066241|FG001|Overall Study|Adverse Event|1|||
164190203|NCT02964338|593066242|FG002|Overall Study|Adverse Event|1|||
164190204|NCT02964338|593066240|FG000|Overall Study|Non-compliant with e-diary|0|||
164190205|NCT02964338|593066241|FG001|Overall Study|Non-compliant with e-diary|1|||
164190206|NCT02964338|593066242|FG002|Overall Study|Non-compliant with e-diary|0|||
164190207|NCT02964338|593066240|FG000|Overall Study|Did not meet criteria|1|||
164190208|NCT02964338|593066241|FG001|Overall Study|Did not meet criteria|0|||
164190209|NCT02964338|593066242|FG002|Overall Study|Did not meet criteria|0|||
164190210|NCT02239640|593066243|FG000|Overall Study|Withdrawal by Subject|3|||
164190211|NCT02239640|593066243|FG000|Overall Study|Lost to Follow-up|72|||
164190212|NCT02239640|593066243|FG000|Overall Study|Death|142|||
164190213|NCT02291029|593066245|FG000|Overall Study|Withdrawal by Subject|0|||
164190214|NCT02291029|593066246|FG001|Overall Study|Withdrawal by Subject|0|||
164190215|NCT02291029|593066247|FG002|Overall Study|Withdrawal by Subject|1|||
164190216|NCT02291029|593066248|FG003|Overall Study|Withdrawal by Subject|0|||
164190217|NCT02291029|593066249|FG004|Overall Study|Withdrawal by Subject|0|||
164190218|NCT02291029|593066250|FG005|Overall Study|Withdrawal by Subject|0|||
164190219|NCT02291029|593066245|FG000|Overall Study|Adverse Event|0|||
164190220|NCT02291029|593066246|FG001|Overall Study|Adverse Event|1|||
164190221|NCT02291029|593066247|FG002|Overall Study|Adverse Event|0|||
164190222|NCT02291029|593066248|FG003|Overall Study|Adverse Event|0|||
164190223|NCT02291029|593066249|FG004|Overall Study|Adverse Event|0|||
164190224|NCT02291029|593066250|FG005|Overall Study|Adverse Event|0|||
164190225|NCT03872843|593066251|FG000|Overall Study|Lost to Follow-up|5|||
164190226|NCT03872843|593066252|FG001|Overall Study|Lost to Follow-up|7|||
164190227|NCT00823264|593066253|FG000|Overall Study|Protocol Violation|2|||
164190228|NCT00823264|593066254|FG001|Overall Study|Protocol Violation|0|||
164190229|NCT00856999|593066255|FG000|Overall Study|Withdrawal by Subject|5|||
164190230|NCT02465437|593066256|FG000|Overall Study|Physician Decision|0|||
164190231|NCT02465437|593066257|FG001|Overall Study|Physician Decision|0|||
164190232|NCT02465437|593066258|FG002|Overall Study|Physician Decision|1|||
164190233|NCT02465437|593066259|FG003|Overall Study|Physician Decision|0|||
164190234|NCT02465437|593066256|FG000|Overall Study|Withdrawal by Subject|1|||
164190235|NCT02465437|593066257|FG001|Overall Study|Withdrawal by Subject|0|||
164190236|NCT02465437|593066258|FG002|Overall Study|Withdrawal by Subject|0|||
164190237|NCT02465437|593066259|FG003|Overall Study|Withdrawal by Subject|1|||
164190238|NCT02465437|593066256|FG000|Overall Study|Adverse Event|0|||
164539241|NCT02315898|594348417|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
164539242|NCT02315898|594348418|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
164539243|NCT02315898|594348419|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
164539244|NCT02315898|594348420|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
164190239|NCT02465437|593066257|FG001|Overall Study|Adverse Event|1|||
164190240|NCT02465437|593066258|FG002|Overall Study|Adverse Event|0|||
164539245|NCT02445755|594348421|FG000|Overall Study|Withdrawal by Subject|2|||
164190241|NCT02465437|593066259|FG003|Overall Study|Adverse Event|0|||
164190242|NCT00003483|593066260|FG000|Overall Study|Not evaluable|1|||
164190243|NCT01308463|593066261|FG000|Overall Study|Study Discontinued|23|||
164190244|NCT01308463|593066261|FG000|Overall Study|Death|4|||
164190245|NCT01308463|593066261|FG000|Overall Study|Revision|2|||
164190246|NCT00103662|593066264|FG000|Overall Study|Entered Rescue Procedure|0|||
164190247|NCT00103662|593066265|FG001|Overall Study|Entered Rescue Procedure|7|||
164190248|NCT00103662|593066264|FG000|Overall Study|Death|7|||
164190249|NCT00103662|593066265|FG001|Overall Study|Death|7|||
164190250|NCT00103662|593066264|FG000|Overall Study|Elective Withdrawal|5|||
164652855|NCT00410410|594755204|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
164652856|NCT00410410|594755205|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
164652857|NCT00410410|594755206|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
164652858|NCT00410410|594755198|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
164652859|NCT00410410|594755199|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
164652860|NCT00410410|594755200|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
164652861|NCT00410410|594755201|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
164652862|NCT00410410|594755202|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
164652863|NCT00410410|594755203|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
164652864|NCT00410410|594755204|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
164652865|NCT00410410|594755205|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
164652866|NCT00410410|594755206|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
164652867|NCT00410410|594755198|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
164652868|NCT00410410|594755199|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
164652869|NCT00410410|594755200|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
164652870|NCT00410410|594755201|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
164652871|NCT00410410|594755202|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
164652872|NCT00410410|594755203|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
164652873|NCT00410410|594755204|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
164652874|NCT00410410|594755205|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
164652875|NCT00410410|594755206|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
164652876|NCT00410410|594755198|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
164652877|NCT00410410|594755199|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
164652878|NCT00410410|594755200|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
164652879|NCT00410410|594755201|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
164652880|NCT00410410|594755202|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
164652881|NCT00410410|594755203|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
164652882|NCT00410410|594755204|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
164652883|NCT00410410|594755205|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
164652884|NCT00410410|594755206|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
164652885|NCT00410410|594755198|FG000|Open-Label Period (OL)|Death|0|||
164652886|NCT00410410|594755199|FG001|Open-Label Period (OL)|Death|0|||
164652887|NCT00410410|594755200|FG002|Open-Label Period (OL)|Death|0|||
164652888|NCT00410410|594755201|FG003|Open-Label Period (OL)|Death|0|||
164652889|NCT00410410|594755202|FG004|Open-Label Period (OL)|Death|0|||
164652890|NCT00410410|594755203|FG005|Open-Label Period (OL)|Death|0|||
164652891|NCT00410410|594755204|FG006|Open-Label Period (OL)|Death|0|||
164652892|NCT00410410|594755205|FG007|Open-Label Period (OL)|Death|0|||
164652893|NCT00410410|594755206|FG008|Open-Label Period (OL)|Death|1|||
164652894|NCT00410410|594755198|FG000|Open-Label Period (OL)|Adverse Event|0|||
164652895|NCT00410410|594755199|FG001|Open-Label Period (OL)|Adverse Event|0|||
164652896|NCT00410410|594755200|FG002|Open-Label Period (OL)|Adverse Event|0|||
164652897|NCT00410410|594755201|FG003|Open-Label Period (OL)|Adverse Event|0|||
164652898|NCT00410410|594755202|FG004|Open-Label Period (OL)|Adverse Event|0|||
164652899|NCT00410410|594755203|FG005|Open-Label Period (OL)|Adverse Event|0|||
164652900|NCT00410410|594755204|FG006|Open-Label Period (OL)|Adverse Event|0|||
164652901|NCT00410410|594755205|FG007|Open-Label Period (OL)|Adverse Event|0|||
164652902|NCT00410410|594755206|FG008|Open-Label Period (OL)|Adverse Event|10|||
164652903|NCT00410410|594755198|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
164652904|NCT00410410|594755199|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
164652905|NCT00410410|594755200|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
164652906|NCT00410410|594755201|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
164652907|NCT00410410|594755202|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
164652908|NCT00410410|594755203|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
164652909|NCT00410410|594755204|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
164652910|NCT00410410|594755205|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
164652911|NCT00410410|594755206|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
164652912|NCT00410410|594755198|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
164652913|NCT00410410|594755199|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
164652914|NCT00410410|594755200|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
164652915|NCT00410410|594755201|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
164652916|NCT00410410|594755202|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
164652917|NCT00410410|594755203|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
164652918|NCT00410410|594755204|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
164652919|NCT00410410|594755205|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
164652920|NCT00410410|594755206|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
164652921|NCT00410410|594755198|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
164652922|NCT00410410|594755199|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
164652923|NCT00410410|594755200|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
164652924|NCT00410410|594755201|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
164652925|NCT00410410|594755202|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
164652926|NCT00410410|594755203|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
164652927|NCT00410410|594755204|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
164190251|NCT00103662|593066265|FG001|Overall Study|Elective Withdrawal|5|||
164190252|NCT00103662|593066264|FG000|Overall Study|Lost to Follow-up|0|||
164190253|NCT00103662|593066265|FG001|Overall Study|Lost to Follow-up|1|||
164190254|NCT00103662|593066264|FG000|Overall Study|Other|6|||
164539246|NCT02445755|594348421|FG000|Overall Study|Protocol Violation|6|||
164539247|NCT02445755|594348421|FG000|Overall Study|Screen Failure|5|||
164539248|NCT03239483|594348422|FG000|Overall Study|Lost to Follow-up|1|||
164539249|NCT03239483|594348423|FG001|Overall Study|Lost to Follow-up|0|||
164539250|NCT03239483|594348422|FG000|Overall Study|Withdrawal by Subject|1|||
164539251|NCT03239483|594348423|FG001|Overall Study|Withdrawal by Subject|0|||
164539252|NCT05352048|594348424|FG000|Overall Study|Lost to Follow-up|1|||
164539253|NCT05352048|594348424|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
164539254|NCT03678103|594348434|FG000|Overall Study|Withdrawn prior to completion|4|||
164539255|NCT01674712|594348436|FG000|Overall Study|Adverse Event|5|||
164539256|NCT01674712|594348437|FG001|Overall Study|Adverse Event|6|||
164539257|NCT01674712|594348438|FG002|Overall Study|Adverse Event|3|||
164190255|NCT00103662|593066265|FG001|Overall Study|Other|9|||
164190256|NCT00103662|593066264|FG000|Overall Study|Failed mobilization|0|||
164190257|NCT00103662|593066265|FG001|Overall Study|Failed mobilization|4|||
164190258|NCT00103662|593066264|FG000|Overall Study|Intercurrent illness|1|||
164190259|NCT00103662|593066265|FG001|Overall Study|Intercurrent illness|0|||
164190260|NCT03280056|593066266|FG000|Overall Study|Withdrawal by Subject|12|||
164190261|NCT03280056|593066267|FG001|Overall Study|Withdrawal by Subject|14|||
164190262|NCT03280056|593066266|FG000|Overall Study|Death|9|||
164190263|NCT03280056|593066267|FG001|Overall Study|Death|2|||
164190264|NCT03280056|593066266|FG000|Overall Study|Adverse Event|1|||
164190265|NCT03280056|593066267|FG001|Overall Study|Adverse Event|3|||
164190266|NCT03280056|593066266|FG000|Overall Study|Lost to Follow-up|1|||
164190267|NCT03280056|593066267|FG001|Overall Study|Lost to Follow-up|1|||
164190268|NCT03280056|593066266|FG000|Overall Study|Physician Decision|0|||
164190269|NCT03280056|593066267|FG001|Overall Study|Physician Decision|1|||
164190270|NCT03280056|593066266|FG000|Overall Study|Early Discontinuation|1|||
164190271|NCT03280056|593066267|FG001|Overall Study|Early Discontinuation|0|||
164190272|NCT01135524|593066268|FG000|Overall Study|Withdrawal by Subject|14|||
164190273|NCT01135524|593066268|FG000|Overall Study|Adverse Event|20|||
164190274|NCT01135524|593066268|FG000|Overall Study|Lost to Follow-up|3|||
164190275|NCT01135524|593066268|FG000|Overall Study|Administrative|151|||
164190276|NCT01135524|593066268|FG000|Overall Study|Lack of Efficacy|8|||
164190277|NCT02907463|593066270|FG000|Overall Study|Lost to Follow-up|17|||
164190278|NCT02907463|593066270|FG000|Overall Study|Death|10|||
164190279|NCT02907463|593066270|FG000|Overall Study|Withdrawal by Subject|4|||
164190280|NCT02907463|593066270|FG000|Overall Study|MIS Approach was not used|2|||
164190281|NCT02907463|593066270|FG000|Overall Study|Not Implanted with Study Device|2|||
164190282|NCT02907463|593066270|FG000|Overall Study|Device Explanted|1|||
164190283|NCT02907463|593066270|FG000|Overall Study|Missing Exit Form|1|||
164190284|NCT01266824|593066271|FG000|Overall Study|Study terminated prior to completion|2|||
164190285|NCT01266824|593066272|FG001|Overall Study|Study terminated prior to completion|3|||
164190286|NCT02302846|593066273|FG000|Overall Study|Withdrawal by Subject|1|||
164190287|NCT00397189|593066274|FG000|3 Weeks Period|Lost to Follow-up|5|||
164190288|NCT00397189|593066275|FG001|3 Weeks Period|Lost to Follow-up|4|||
164190289|NCT00397189|593066274|FG000|3 Weeks Period|Adverse Event|3|||
164190290|NCT00397189|593066275|FG001|3 Weeks Period|Adverse Event|2|||
164190291|NCT00397189|593066274|FG000|3 Weeks Period|Withdrawal by Subject|13|||
164190292|NCT00397189|593066275|FG001|3 Weeks Period|Withdrawal by Subject|9|||
164190293|NCT00397189|593066274|FG000|3 Weeks Period|Physician Decision|0|||
164539258|NCT01674712|594348439|FG003|Overall Study|Adverse Event|4|||
164539259|NCT01674712|594348440|FG004|Overall Study|Adverse Event|6|||
164539260|NCT01674712|594348436|FG000|Overall Study|Lost to Follow-up|1|||
164539261|NCT01674712|594348437|FG001|Overall Study|Lost to Follow-up|0|||
164539262|NCT01674712|594348438|FG002|Overall Study|Lost to Follow-up|0|||
164539263|NCT01674712|594348439|FG003|Overall Study|Lost to Follow-up|0|||
164190294|NCT00397189|593066275|FG001|3 Weeks Period|Physician Decision|2|||
164190295|NCT00397189|593066274|FG000|3 Weeks Period|Protocol Violation|0|||
164190296|NCT00397189|593066275|FG001|3 Weeks Period|Protocol Violation|3|||
164190297|NCT00397189|593066274|FG000|3 Weeks Period|Other|0|||
164190298|NCT00397189|593066275|FG001|3 Weeks Period|Other|2|||
164190299|NCT01447407|593066278|FG000|Overall Study|Withdrawal by Subject|2|||
164190300|NCT01447407|593066279|FG001|Overall Study|Withdrawal by Subject|0|||
164190301|NCT01447407|593066280|FG002|Overall Study|Withdrawal by Subject|0|||
164190302|NCT01447407|593066281|FG003|Overall Study|Withdrawal by Subject|1|||
164190303|NCT01447407|593066278|FG000|Overall Study|Physician Decision|0|||
164190304|NCT01447407|593066279|FG001|Overall Study|Physician Decision|0|||
164190305|NCT01447407|593066280|FG002|Overall Study|Physician Decision|1|||
164539264|NCT01674712|594348440|FG004|Overall Study|Lost to Follow-up|0|||
164539265|NCT01674712|594348436|FG000|Overall Study|Protocol Violation|2|||
164190306|NCT01447407|593066281|FG003|Overall Study|Physician Decision|1|||
164190307|NCT00872521|593066284|FG000|Completed PAD Induction|Patient choice|0|||
164190308|NCT00872521|593066285|FG001|Completed PAD Induction|Patient choice|1|||
164302037|NCT03847896|593482506|FG002|Overall Study|Other reasons|1|||
164652928|NCT00410410|594755205|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
164652929|NCT00410410|594755206|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
164652930|NCT00410410|594755198|FG000|Open-Label Period (OL)|Pregnancy|0|||
164652931|NCT00410410|594755199|FG001|Open-Label Period (OL)|Pregnancy|0|||
164652932|NCT00410410|594755200|FG002|Open-Label Period (OL)|Pregnancy|0|||
164652933|NCT00410410|594755201|FG003|Open-Label Period (OL)|Pregnancy|0|||
164652934|NCT00410410|594755202|FG004|Open-Label Period (OL)|Pregnancy|0|||
164652935|NCT00410410|594755203|FG005|Open-Label Period (OL)|Pregnancy|0|||
164652936|NCT00410410|594755204|FG006|Open-Label Period (OL)|Pregnancy|0|||
164652937|NCT00410410|594755205|FG007|Open-Label Period (OL)|Pregnancy|0|||
164652938|NCT00410410|594755206|FG008|Open-Label Period (OL)|Pregnancy|1|||
164652939|NCT00410410|594755198|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
164652940|NCT00410410|594755199|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
164652941|NCT00410410|594755200|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
164652942|NCT00410410|594755201|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
164652943|NCT00410410|594755202|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
164652944|NCT00410410|594755203|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
164652945|NCT00410410|594755204|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
164652946|NCT00410410|594755205|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
164652947|NCT00410410|594755206|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
164652948|NCT00410410|594755198|FG000|Open-Label Period (OL)|Other|0|||
164652949|NCT00410410|594755199|FG001|Open-Label Period (OL)|Other|0|||
164652950|NCT00410410|594755200|FG002|Open-Label Period (OL)|Other|0|||
164652951|NCT00410410|594755201|FG003|Open-Label Period (OL)|Other|0|||
164652952|NCT00410410|594755202|FG004|Open-Label Period (OL)|Other|0|||
164652953|NCT00410410|594755203|FG005|Open-Label Period (OL)|Other|0|||
164652954|NCT00410410|594755204|FG006|Open-Label Period (OL)|Other|0|||
164652955|NCT00410410|594755205|FG007|Open-Label Period (OL)|Other|0|||
164652956|NCT00410410|594755206|FG008|Open-Label Period (OL)|Other|7|||
164652957|NCT01783496|594755207|FG000|Overall Study|Lost to Follow-up|0|||
164652958|NCT01783496|594755208|FG001|Overall Study|Lost to Follow-up|0|||
164652959|NCT01783496|594755209|FG002|Overall Study|Lost to Follow-up|0|||
164652960|NCT01783496|594755210|FG003|Overall Study|Lost to Follow-up|2|||
164652961|NCT01783496|594755211|FG004|Overall Study|Lost to Follow-up|0|||
164652962|NCT01783496|594755212|FG005|Overall Study|Lost to Follow-up|1|||
164652963|NCT01783496|594755207|FG000|Overall Study|Withdrawal by Subject|1|||
164652964|NCT01783496|594755208|FG001|Overall Study|Withdrawal by Subject|0|||
164652965|NCT01783496|594755209|FG002|Overall Study|Withdrawal by Subject|0|||
164652966|NCT01783496|594755210|FG003|Overall Study|Withdrawal by Subject|0|||
164652967|NCT01783496|594755211|FG004|Overall Study|Withdrawal by Subject|0|||
164652968|NCT01783496|594755212|FG005|Overall Study|Withdrawal by Subject|0|||
164652969|NCT01023269|594755213|FG000|Overall Study|early termination of the study|2|||
164652970|NCT01023269|594755214|FG001|Overall Study|early termination of the study|0|||
164652971|NCT00106028|594755215|FG000|Overall Study|Adverse Event|3|||
164652972|NCT00106028|594755216|FG001|Overall Study|Adverse Event|2|||
164652973|NCT00106028|594755215|FG000|Overall Study|Protocol Violation|1|||
164652974|NCT00106028|594755216|FG001|Overall Study|Protocol Violation|1|||
164652975|NCT00106028|594755215|FG000|Overall Study|Withdrawal by Subject|2|||
164652976|NCT00106028|594755216|FG001|Overall Study|Withdrawal by Subject|8|||
164652977|NCT00106028|594755215|FG000|Overall Study|Lost to Follow-up|0|||
164652978|NCT00106028|594755216|FG001|Overall Study|Lost to Follow-up|1|||
164652979|NCT00947011|594755217|FG000|Overall Study|Study was terminated,PI left institution|12|||
164652980|NCT05266456|594755220|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
164652981|NCT05266456|594755221|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
164652982|NCT05266456|594755222|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
164652983|NCT05266456|594755223|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
164652984|NCT05266456|594755220|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
164652985|NCT05266456|594755221|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
164652986|NCT05266456|594755222|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
164652987|NCT05266456|594755223|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
164652988|NCT05266456|594755220|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
164652989|NCT05266456|594755221|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
164652990|NCT05266456|594755222|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
164652991|NCT05266456|594755223|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
164652992|NCT05266456|594755220|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
164652993|NCT05266456|594755221|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
164652994|NCT05266456|594755222|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
164652995|NCT05266456|594755223|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
164652996|NCT05266456|594755220|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
164652997|NCT05266456|594755221|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
164652998|NCT05266456|594755222|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
164652999|NCT05266456|594755223|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
164653000|NCT02746705|594755230|FG000|Overall Study|Physician Decision|1|||
164539266|NCT01674712|594348437|FG001|Overall Study|Protocol Violation|0|||
164539267|NCT01674712|594348438|FG002|Overall Study|Protocol Violation|0|||
164539268|NCT01674712|594348439|FG003|Overall Study|Protocol Violation|0|||
164539269|NCT01674712|594348440|FG004|Overall Study|Protocol Violation|0|||
164539270|NCT01674712|594348436|FG000|Overall Study|Withdrawal by Subject|2|||
164539271|NCT01674712|594348437|FG001|Overall Study|Withdrawal by Subject|2|||
164539272|NCT01674712|594348438|FG002|Overall Study|Withdrawal by Subject|5|||
164539273|NCT01674712|594348439|FG003|Overall Study|Withdrawal by Subject|4|||
164539274|NCT01674712|594348440|FG004|Overall Study|Withdrawal by Subject|3|||
164539275|NCT01674712|594348436|FG000|Overall Study|Administrative|0|||
164539276|NCT01674712|594348437|FG001|Overall Study|Administrative|1|||
164539277|NCT01674712|594348438|FG002|Overall Study|Administrative|0|||
164539278|NCT01674712|594348439|FG003|Overall Study|Administrative|0|||
164539279|NCT01674712|594348440|FG004|Overall Study|Administrative|1|||
164539280|NCT01674712|594348436|FG000|Overall Study|Lack of Efficacy|0|||
164539281|NCT01674712|594348437|FG001|Overall Study|Lack of Efficacy|0|||
164539282|NCT01674712|594348438|FG002|Overall Study|Lack of Efficacy|1|||
164539283|NCT01674712|594348439|FG003|Overall Study|Lack of Efficacy|0|||
164539284|NCT01674712|594348440|FG004|Overall Study|Lack of Efficacy|1|||
164539285|NCT00056862|594348441|FG000|Overall Study|Protocol Violation|1|||
164539286|NCT00056862|594348442|FG001|Overall Study|Protocol Violation|0|||
164539287|NCT00381563|594348449|FG000|Overall Study|Withdrawal by Subject|5|||
164539288|NCT00381563|594348450|FG001|Overall Study|Withdrawal by Subject|5|||
164539289|NCT00381563|594348449|FG000|Overall Study|Lost to Follow-up|2|||
164539290|NCT00381563|594348450|FG001|Overall Study|Lost to Follow-up|0|||
164539291|NCT00381563|594348449|FG000|Overall Study|Protocol Violation|0|||
164539292|NCT00381563|594348450|FG001|Overall Study|Protocol Violation|1|||
164539293|NCT00024167|594348451|FG000|Overall Study|Death|53|||
164539294|NCT00024167|594348452|FG001|Overall Study|Death|47|||
164539295|NCT01109173|594348453|FG000|Overall Study|Adverse Event|15|||
164539296|NCT01109173|594348454|FG001|Overall Study|Adverse Event|17|||
164539297|NCT01109173|594348455|FG002|Overall Study|Adverse Event|9|||
164539298|NCT01109173|594348456|FG003|Overall Study|Adverse Event|6|||
164539299|NCT01109173|594348453|FG000|Overall Study|Lost to Follow-up|0|||
164653001|NCT02746705|594755231|FG001|Overall Study|Physician Decision|1|||
164653002|NCT02746705|594755230|FG000|Overall Study|Lost to Follow-up|1|||
164653003|NCT02746705|594755231|FG001|Overall Study|Lost to Follow-up|0|||
164653004|NCT02746705|594755230|FG000|Overall Study|outlier scores deemed not valid|0|||
164653005|NCT02746705|594755231|FG001|Overall Study|outlier scores deemed not valid|1|||
164653006|NCT00479401|594755232|FG000|Overall Study|Adverse Event|24|||
164653007|NCT00479401|594755233|FG001|Overall Study|Adverse Event|20|||
164653008|NCT00479401|594755234|FG002|Overall Study|Adverse Event|4|||
164653009|NCT00479401|594755232|FG000|Overall Study|Lack of Efficacy|2|||
164653010|NCT00479401|594755233|FG001|Overall Study|Lack of Efficacy|2|||
164653011|NCT00479401|594755234|FG002|Overall Study|Lack of Efficacy|4|||
164653012|NCT00479401|594755232|FG000|Overall Study|Protocol Violation|2|||
164653013|NCT00479401|594755233|FG001|Overall Study|Protocol Violation|1|||
164653014|NCT00479401|594755234|FG002|Overall Study|Protocol Violation|1|||
164653015|NCT00479401|594755232|FG000|Overall Study|Lost to Follow-up|1|||
164653016|NCT00479401|594755233|FG001|Overall Study|Lost to Follow-up|1|||
164653017|NCT00479401|594755234|FG002|Overall Study|Lost to Follow-up|1|||
164653018|NCT00479401|594755232|FG000|Overall Study|Withdrawal by Subject|16|||
164653019|NCT00479401|594755233|FG001|Overall Study|Withdrawal by Subject|10|||
164653020|NCT00479401|594755234|FG002|Overall Study|Withdrawal by Subject|2|||
164653021|NCT00479401|594755232|FG000|Overall Study|Exclusion criteria, relocation|4|||
164653022|NCT00479401|594755233|FG001|Overall Study|Exclusion criteria, relocation|3|||
164653023|NCT00479401|594755234|FG002|Overall Study|Exclusion criteria, relocation|0|||
164653024|NCT05478603|594755235|FG000|Overall Study|Withdrawal by Subject|0|||
164653025|NCT05478603|594755236|FG001|Overall Study|Withdrawal by Subject|1|||
164653026|NCT05478603|594755237|FG002|Overall Study|Withdrawal by Subject|0|||
164653027|NCT05478603|594755238|FG003|Overall Study|Withdrawal by Subject|0|||
164653028|NCT03634488|594755241|FG000|Overall Study|Death|1|||
164653029|NCT03634488|594755242|FG001|Overall Study|Death|0|||
164653030|NCT03634488|594755243|FG002|Overall Study|Death|0|||
164653031|NCT03634488|594755241|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
164653032|NCT03634488|594755242|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
164653033|NCT03634488|594755243|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
164653034|NCT00530439|594755251|FG000|Overall Study|GDM|9|||
164653035|NCT00530439|594755252|FG001|Overall Study|GDM|3|||
164653036|NCT00530439|594755251|FG000|Overall Study|Withdraw|18|||
164539300|NCT01109173|594348454|FG001|Overall Study|Lost to Follow-up|1|||
164539301|NCT01109173|594348455|FG002|Overall Study|Lost to Follow-up|0|||
164653037|NCT00530439|594755252|FG001|Overall Study|Withdraw|14|||
164653038|NCT00530439|594755251|FG000|Overall Study|Missed abortion|1|||
164653039|NCT00530439|594755252|FG001|Overall Study|Missed abortion|4|||
164653040|NCT00530439|594755251|FG000|Overall Study|Misclassification|2|||
164653041|NCT00530439|594755252|FG001|Overall Study|Misclassification|0|||
164539302|NCT01109173|594348456|FG003|Overall Study|Lost to Follow-up|0|||
164539303|NCT01109173|594348453|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
164539304|NCT01109173|594348454|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
164539305|NCT01109173|594348455|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
164539306|NCT01109173|594348456|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
164539307|NCT01109173|594348453|FG000|Overall Study|Noncompliance|0|||
164539308|NCT01109173|594348454|FG001|Overall Study|Noncompliance|1|||
164539309|NCT01109173|594348455|FG002|Overall Study|Noncompliance|0|||
164539310|NCT01109173|594348456|FG003|Overall Study|Noncompliance|0|||
164539311|NCT01109173|594348453|FG000|Overall Study|Treatment Failure|25|||
164539312|NCT01109173|594348454|FG001|Overall Study|Treatment Failure|32|||
164539313|NCT01109173|594348455|FG002|Overall Study|Treatment Failure|69|||
164539314|NCT01109173|594348456|FG003|Overall Study|Treatment Failure|64|||
164539315|NCT01109173|594348453|FG000|Overall Study|Protocol Violation|4|||
164539316|NCT01109173|594348454|FG001|Overall Study|Protocol Violation|5|||
164539317|NCT01109173|594348455|FG002|Overall Study|Protocol Violation|1|||
164539318|NCT01109173|594348456|FG003|Overall Study|Protocol Violation|2|||
164539319|NCT01109173|594348453|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
164539320|NCT01109173|594348454|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
164539321|NCT01109173|594348455|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
164539322|NCT01109173|594348456|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
164539323|NCT01109173|594348453|FG000|Overall Study|Not Specifiied|5|||
164539324|NCT01109173|594348454|FG001|Overall Study|Not Specifiied|4|||
164539325|NCT01109173|594348455|FG002|Overall Study|Not Specifiied|9|||
164539326|NCT01109173|594348456|FG003|Overall Study|Not Specifiied|14|||
164539327|NCT01132612|594348457|FG000|Overall Study|Death|0|||
164539328|NCT01132612|594348458|FG001|Overall Study|Death|0|||
164539329|NCT01132612|594348459|FG002|Overall Study|Death|1|||
164539330|NCT01132612|594348457|FG000|Overall Study|Protocol deviation|0|||
164539331|NCT01132612|594348458|FG001|Overall Study|Protocol deviation|0|||
164653042|NCT00530439|594755251|FG000|Overall Study|Twin pregnancy|0|||
164190309|NCT00872521|593066286|FG002|Completed PAD Induction|Patient choice|0|||
164190310|NCT00872521|593066284|FG000|Completed PAD Induction|Disease progression|0|||
164190311|NCT00872521|593066285|FG001|Completed PAD Induction|Disease progression|2|||
164190312|NCT00872521|593066286|FG002|Completed PAD Induction|Disease progression|0|||
164190313|NCT00872521|593066284|FG000|Completed PAD Induction|Adverse Event|4|||
164190314|NCT00872521|593066285|FG001|Completed PAD Induction|Adverse Event|0|||
164190315|NCT00872521|593066286|FG002|Completed PAD Induction|Adverse Event|0|||
164190316|NCT00872521|593066284|FG000|Completed PAD Induction|Death|1|||
164190317|NCT00872521|593066285|FG001|Completed PAD Induction|Death|1|||
164190318|NCT00872521|593066286|FG002|Completed PAD Induction|Death|0|||
164190319|NCT00872521|593066284|FG000|Primary Endpoint Analysis|Other|1|||
164190320|NCT00872521|593066285|FG001|Primary Endpoint Analysis|Other|2|||
164190321|NCT00872521|593066286|FG002|Primary Endpoint Analysis|Other|0|||
164190322|NCT00872521|593066284|FG000|Primary Endpoint Analysis|Patient choice|0|||
164190323|NCT00872521|593066285|FG001|Primary Endpoint Analysis|Patient choice|1|||
164190324|NCT00872521|593066286|FG002|Primary Endpoint Analysis|Patient choice|0|||
164190325|NCT00872521|593066284|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
164190326|NCT00872521|593066285|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
164190327|NCT00872521|593066286|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
164190328|NCT00872521|593066284|FG000|Primary Endpoint Analysis|Patient response missing|0|||
164190329|NCT00872521|593066285|FG001|Primary Endpoint Analysis|Patient response missing|0|||
164190330|NCT00872521|593066286|FG002|Primary Endpoint Analysis|Patient response missing|1|||
164190331|NCT00872521|593066284|FG000|Completed 3-month Follow up|Other|0|||
164190332|NCT00872521|593066285|FG001|Completed 3-month Follow up|Other|2|||
164190333|NCT00872521|593066286|FG002|Completed 3-month Follow up|Other|0|||
164190334|NCT00872521|593066284|FG000|Completed 3-month Follow up|Physician Decision|0|||
164190335|NCT00872521|593066285|FG001|Completed 3-month Follow up|Physician Decision|1|||
164190336|NCT00872521|593066286|FG002|Completed 3-month Follow up|Physician Decision|0|||
164190337|NCT00872521|593066284|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
164190338|NCT00872521|593066285|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
164190339|NCT00872521|593066286|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
164539332|NCT01132612|594348459|FG002|Overall Study|Protocol deviation|3|||
164539333|NCT01132612|594348457|FG000|Overall Study|Lost to Follow-up|2|||
164539334|NCT01132612|594348458|FG001|Overall Study|Lost to Follow-up|2|||
164653043|NCT00530439|594755252|FG001|Overall Study|Twin pregnancy|2|||
164190340|NCT01029262|593066292|FG000|Overall Study|Adverse Event|9|||
164190341|NCT01029262|593066293|FG001|Overall Study|Adverse Event|52|||
164190342|NCT01029262|593066292|FG000|Overall Study|Lack of therapeutic effect|57|||
164190343|NCT01029262|593066293|FG001|Overall Study|Lack of therapeutic effect|76|||
164190344|NCT01029262|593066292|FG000|Overall Study|Withdrawal by Subject|10|||
164539335|NCT01132612|594348459|FG002|Overall Study|Lost to Follow-up|7|||
164539336|NCT01132612|594348457|FG000|Overall Study|Adverse Event|5|||
164539337|NCT01132612|594348458|FG001|Overall Study|Adverse Event|2|||
164539338|NCT01132612|594348459|FG002|Overall Study|Adverse Event|15|||
164539339|NCT01132612|594348457|FG000|Overall Study|Withdrawal by Subject|5|||
164190345|NCT01029262|593066293|FG001|Overall Study|Withdrawal by Subject|17|||
164190346|NCT01029262|593066292|FG000|Overall Study|Protocol Violation|2|||
164190347|NCT01029262|593066293|FG001|Overall Study|Protocol Violation|3|||
164190348|NCT01029262|593066292|FG000|Overall Study|Miscellaneous|1|||
164190349|NCT01029262|593066293|FG001|Overall Study|Miscellaneous|9|||
164190350|NCT01029262|593066292|FG000|Overall Study|Death|0|||
164190351|NCT01029262|593066293|FG001|Overall Study|Death|3|||
164190352|NCT01001910|593066294|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
164190353|NCT01468454|593066295|FG000|Overall Study|Did not have surgery after PET|9|||
164190354|NCT03200548|593066296|FG000|Overall Study|Withdrawal by Subject|5|||
164190355|NCT03200548|593066297|FG001|Overall Study|Withdrawal by Subject|11|||
164190356|NCT03200548|593066298|FG002|Overall Study|Withdrawal by Subject|7|||
164190357|NCT03200548|593066299|FG003|Overall Study|Withdrawal by Subject|6|||
164190358|NCT03428100|593066300|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
164190359|NCT03428100|593066301|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190360|NCT03428100|593066302|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
164190361|NCT03428100|593066303|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
164190362|NCT03428100|593066304|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190363|NCT03428100|593066305|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190364|NCT03428100|593066306|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190365|NCT03428100|593066307|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190366|NCT03428100|593066308|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190367|NCT03428100|593066309|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190368|NCT03428100|593066310|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190369|NCT03428100|593066311|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190370|NCT03428100|593066312|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190371|NCT03428100|593066313|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190372|NCT03428100|593066314|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190373|NCT03428100|593066315|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190374|NCT03428100|593066316|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190375|NCT03428100|593066317|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190376|NCT03428100|593066318|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190377|NCT03428100|593066300|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
164190378|NCT03428100|593066301|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
164190379|NCT03428100|593066302|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
164190380|NCT03428100|593066303|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
164190381|NCT03428100|593066304|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190382|NCT03428100|593066305|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190383|NCT03428100|593066306|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190384|NCT03428100|593066307|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190385|NCT03428100|593066308|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190386|NCT03428100|593066309|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190387|NCT03428100|593066310|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190388|NCT03428100|593066311|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190389|NCT03428100|593066312|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190390|NCT03428100|593066313|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190391|NCT03428100|593066314|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190392|NCT03428100|593066315|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190393|NCT03428100|593066316|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190394|NCT03428100|593066317|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190395|NCT03428100|593066318|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190396|NCT03428100|593066300|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190397|NCT03428100|593066301|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
164190398|NCT03428100|593066302|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
164190399|NCT03428100|593066303|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190400|NCT03428100|593066304|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190401|NCT03428100|593066305|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190402|NCT03428100|593066306|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190403|NCT03428100|593066307|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190404|NCT03428100|593066308|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190405|NCT03428100|593066309|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190406|NCT03428100|593066310|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190407|NCT03428100|593066311|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190408|NCT03428100|593066312|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190409|NCT03428100|593066313|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190410|NCT03428100|593066314|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190411|NCT03428100|593066315|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190412|NCT03428100|593066316|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190413|NCT03428100|593066317|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190414|NCT03428100|593066318|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190415|NCT03428100|593066300|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
164190416|NCT03428100|593066301|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190417|NCT03428100|593066302|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190418|NCT03428100|593066303|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190419|NCT03428100|593066304|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190420|NCT03428100|593066305|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190421|NCT03428100|593066306|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190422|NCT03428100|593066307|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164653044|NCT00530439|594755251|FG000|Overall Study|Severe malformation/abortion|0|||
164653045|NCT00530439|594755252|FG001|Overall Study|Severe malformation/abortion|3|||
164653046|NCT00928252|594757042|FG000|Overall Study|Physician Decision|3|||
164653047|NCT02257632|594757043|FG000|Overall Study|Withdrawal by Subject|0|||
164653048|NCT02257632|594757044|FG001|Overall Study|Withdrawal by Subject|1|||
164653049|NCT02257632|594757043|FG000|Overall Study|Adverse Event|1|||
164653050|NCT02257632|594757044|FG001|Overall Study|Adverse Event|2|||
164653051|NCT00720798|594757048|FG000|Overall Study|Adverse Event|304|||
164653052|NCT00720798|594757048|FG000|Overall Study|Death|39|||
164653053|NCT00720798|594757048|FG000|Overall Study|Insufficient Therapeutic Response|129|||
164653054|NCT00720798|594757048|FG000|Overall Study|Protocol Violation|4|||
164653055|NCT00720798|594757048|FG000|Overall Study|Refused Treatment|151|||
164653056|NCT00720798|594757048|FG000|Overall Study|Failure to Return|46|||
164653057|NCT00720798|594757048|FG000|Overall Study|Reason not Specified|83|||
164653058|NCT02806232|594757051|FG000|Overall Study|Lost to Follow-up|1|||
164653059|NCT02806232|594757052|FG001|Overall Study|Lost to Follow-up|2|||
164653060|NCT02806232|594757053|FG002|Overall Study|Lost to Follow-up|1|||
164653061|NCT02806232|594757054|FG003|Overall Study|Lost to Follow-up|0|||
164653062|NCT02806232|594757055|FG004|Overall Study|Lost to Follow-up|0|||
164653063|NCT02806232|594757056|FG005|Overall Study|Lost to Follow-up|1|||
164653064|NCT02806232|594757057|FG006|Overall Study|Lost to Follow-up|0|||
164653065|NCT02806232|594757058|FG007|Overall Study|Lost to Follow-up|0|||
164653066|NCT02806232|594757059|FG008|Overall Study|Lost to Follow-up|0|||
164653067|NCT02806232|594757051|FG000|Overall Study|Withdrawal by Subject|0|||
164653068|NCT02806232|594757052|FG001|Overall Study|Withdrawal by Subject|2|||
164653069|NCT02806232|594757053|FG002|Overall Study|Withdrawal by Subject|0|||
164653070|NCT02806232|594757054|FG003|Overall Study|Withdrawal by Subject|0|||
164653071|NCT02806232|594757055|FG004|Overall Study|Withdrawal by Subject|2|||
164653072|NCT02806232|594757056|FG005|Overall Study|Withdrawal by Subject|1|||
164653073|NCT02806232|594757057|FG006|Overall Study|Withdrawal by Subject|0|||
164653074|NCT02806232|594757058|FG007|Overall Study|Withdrawal by Subject|0|||
164653075|NCT02806232|594757059|FG008|Overall Study|Withdrawal by Subject|0|||
164653076|NCT00434161|594757060|FG000|Overall Study|Adverse Event|5|||
164653077|NCT00434161|594757061|FG001|Overall Study|Adverse Event|1|||
164653078|NCT00434161|594757062|FG002|Overall Study|Adverse Event|4|||
164653079|NCT00434161|594757060|FG000|Overall Study|Lost to Follow-up|0|||
164653080|NCT00434161|594757061|FG001|Overall Study|Lost to Follow-up|1|||
164653081|NCT00434161|594757062|FG002|Overall Study|Lost to Follow-up|0|||
164653082|NCT00434161|594757060|FG000|Overall Study|Death|1|||
164653083|NCT00434161|594757061|FG001|Overall Study|Death|0|||
164653084|NCT00434161|594757062|FG002|Overall Study|Death|1|||
164653085|NCT00434161|594757060|FG000|Overall Study|Non-Compliance|1|||
164653086|NCT00434161|594757061|FG001|Overall Study|Non-Compliance|1|||
164653087|NCT00434161|594757062|FG002|Overall Study|Non-Compliance|0|||
164653088|NCT00434161|594757060|FG000|Overall Study|Withdrawal by Subject|2|||
164653089|NCT00434161|594757061|FG001|Overall Study|Withdrawal by Subject|0|||
164653090|NCT00434161|594757062|FG002|Overall Study|Withdrawal by Subject|3|||
164653091|NCT00434161|594757060|FG000|Overall Study|Logistical error study assessments|1|||
164653092|NCT00434161|594757061|FG001|Overall Study|Logistical error study assessments|0|||
164653093|NCT00434161|594757062|FG002|Overall Study|Logistical error study assessments|3|||
164653094|NCT01621490|594757063|FG000|Overall Study|Subject no longer meets study criteria|0|||
164653095|NCT01621490|594757064|FG001|Overall Study|Subject no longer meets study criteria|0|||
164190423|NCT03428100|593066308|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190424|NCT03428100|593066309|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164653096|NCT01621490|594757065|FG002|Overall Study|Subject no longer meets study criteria|0|||
164653097|NCT01621490|594757066|FG003|Overall Study|Subject no longer meets study criteria|0|||
164653098|NCT01621490|594757067|FG004|Overall Study|Subject no longer meets study criteria|1|||
164653099|NCT01621490|594757068|FG005|Overall Study|Subject no longer meets study criteria|0|||
164653100|NCT01621490|594757069|FG006|Overall Study|Subject no longer meets study criteria|0|||
164653101|NCT01621490|594757070|FG007|Overall Study|Subject no longer meets study criteria|0|||
164653102|NCT01621490|594757071|FG008|Overall Study|Subject no longer meets study criteria|0|||
164190425|NCT03428100|593066310|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190426|NCT03428100|593066311|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190427|NCT03428100|593066312|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190428|NCT03428100|593066313|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190429|NCT03428100|593066314|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190430|NCT03428100|593066315|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190431|NCT03428100|593066316|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190432|NCT03428100|593066317|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190433|NCT03428100|593066318|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190434|NCT03428100|593066300|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190435|NCT03428100|593066301|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
164190436|NCT03428100|593066302|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190437|NCT03428100|593066303|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190438|NCT03428100|593066304|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190439|NCT03428100|593066305|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190440|NCT03428100|593066306|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190441|NCT03428100|593066307|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190442|NCT03428100|593066308|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190443|NCT03428100|593066309|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190444|NCT03428100|593066310|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190445|NCT03428100|593066311|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190446|NCT03428100|593066312|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190447|NCT03428100|593066313|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190448|NCT03428100|593066314|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190449|NCT03428100|593066315|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190450|NCT03428100|593066316|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190451|NCT03428100|593066317|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190452|NCT03428100|593066318|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190453|NCT03428100|593066300|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
164190454|NCT03428100|593066301|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
164190455|NCT03428100|593066302|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
164190456|NCT03428100|593066303|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
164190457|NCT03428100|593066304|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
164190458|NCT03428100|593066305|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
164190459|NCT03428100|593066306|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
164190460|NCT03428100|593066307|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
164190461|NCT03428100|593066308|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
164190462|NCT03428100|593066309|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
164190463|NCT03428100|593066310|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
164190464|NCT03428100|593066311|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
164190465|NCT03428100|593066312|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
164190466|NCT03428100|593066313|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
164190467|NCT03428100|593066314|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
164190468|NCT03428100|593066315|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
164190469|NCT03428100|593066316|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
164190470|NCT03428100|593066317|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
164190471|NCT03428100|593066318|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
164190472|NCT03428100|593066300|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
164190473|NCT03428100|593066301|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
164190474|NCT03428100|593066302|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
164190475|NCT03428100|593066303|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
164190476|NCT03428100|593066304|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
164190477|NCT03428100|593066305|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
164190478|NCT03428100|593066306|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
164190479|NCT03428100|593066307|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
164190480|NCT03428100|593066308|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
164190481|NCT03428100|593066309|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
164190482|NCT03428100|593066310|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
164190483|NCT03428100|593066311|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
164190484|NCT03428100|593066312|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
164190485|NCT03428100|593066313|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
164190486|NCT03428100|593066314|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
164190487|NCT03428100|593066315|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
164190488|NCT03428100|593066316|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
164190489|NCT03428100|593066317|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
164539340|NCT01132612|594348458|FG001|Overall Study|Withdrawal by Subject|8|||
164539341|NCT01132612|594348459|FG002|Overall Study|Withdrawal by Subject|19|||
164539342|NCT01132612|594348457|FG000|Overall Study|Administrative problems|5|||
164539343|NCT01132612|594348458|FG001|Overall Study|Administrative problems|1|||
164539344|NCT01132612|594348459|FG002|Overall Study|Administrative problems|52|||
164539345|NCT01132612|594348457|FG000|Overall Study|Lack of Efficacy|23|||
164539346|NCT01132612|594348458|FG001|Overall Study|Lack of Efficacy|22|||
164539347|NCT01132612|594348459|FG002|Overall Study|Lack of Efficacy|73|||
164539348|NCT02252536|594348463|FG000|Overall Study|Lost to Follow-up|5|||
164539349|NCT02252536|594348464|FG001|Overall Study|Lost to Follow-up|3|||
164539350|NCT01438151|594348465|FG000|Overall Study|study terminated|8|||
164539351|NCT00006392|594348474|FG000|Overall Study|Ineligible|11|||
164539352|NCT00006392|594348475|FG001|Overall Study|Ineligible|3|||
164539353|NCT00006392|594348476|FG002|Overall Study|Ineligible|5|||
164539354|NCT00006392|594348477|FG003|Overall Study|Ineligible|5|||
164539355|NCT00006392|594348474|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
164539356|NCT00006392|594348475|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
164539357|NCT00006392|594348476|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
164539358|NCT00006392|594348477|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
164539359|NCT02459769|594348478|FG000|Overall Study|Withdrawal by Subject|7|||
164539360|NCT02459769|594348479|FG001|Overall Study|Withdrawal by Subject|4|||
164539361|NCT02459769|594348480|FG002|Overall Study|Withdrawal by Subject|8|||
164539362|NCT02459769|594348481|FG003|Overall Study|Withdrawal by Subject|5|||
164539363|NCT02459769|594348478|FG000|Overall Study|Lost to Follow-up|1|||
164539364|NCT02459769|594348479|FG001|Overall Study|Lost to Follow-up|0|||
164539365|NCT02459769|594348480|FG002|Overall Study|Lost to Follow-up|1|||
164539366|NCT02459769|594348481|FG003|Overall Study|Lost to Follow-up|0|||
164539367|NCT01186796|594348482|FG000|Overall Study|Adverse Event|3|||
164539368|NCT01186796|594348483|FG001|Overall Study|Adverse Event|0|||
164539369|NCT01186796|594348482|FG000|Overall Study|Withdrawal by Subject|1|||
164539370|NCT01186796|594348483|FG001|Overall Study|Withdrawal by Subject|1|||
164539371|NCT01186796|594348482|FG000|Overall Study|Protocol Violation|0|||
164539372|NCT01186796|594348483|FG001|Overall Study|Protocol Violation|1|||
164539373|NCT03838198|594348484|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
164539374|NCT03838198|594348485|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
164539375|NCT03838198|594348486|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
164539376|NCT03838198|594348487|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
164539377|NCT03838198|594348484|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
164539378|NCT03838198|594348485|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
164539379|NCT03838198|594348486|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
164539380|NCT03838198|594348487|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
164539381|NCT02378220|594348488|FG000|Overall Study|Death|6|||
164539382|NCT02378220|594348489|FG001|Overall Study|Death|1|||
164539383|NCT00578786|594348492|FG000|Overall Study|Adverse Event|27|||
164539384|NCT00578786|594348493|FG001|Overall Study|Adverse Event|37|||
164539385|NCT00578786|594348494|FG002|Overall Study|Adverse Event|17|||
164539386|NCT00578786|594348492|FG000|Overall Study|Lack of Efficacy|2|||
164539387|NCT00578786|594348493|FG001|Overall Study|Lack of Efficacy|5|||
164539388|NCT00578786|594348494|FG002|Overall Study|Lack of Efficacy|2|||
164539389|NCT00578786|594348492|FG000|Overall Study|Early Escape from Prior Study|2|||
164539390|NCT00578786|594348493|FG001|Overall Study|Early Escape from Prior Study|1|||
164539391|NCT00578786|594348494|FG002|Overall Study|Early Escape from Prior Study|2|||
164539392|NCT00578786|594348492|FG000|Overall Study|Withdrawal by Subject|7|||
164539393|NCT00578786|594348493|FG001|Overall Study|Withdrawal by Subject|8|||
164539394|NCT00578786|594348494|FG002|Overall Study|Withdrawal by Subject|5|||
164539395|NCT00578786|594348492|FG000|Overall Study|Protocol Violation|0|||
164539396|NCT00578786|594348493|FG001|Overall Study|Protocol Violation|3|||
164539397|NCT00578786|594348494|FG002|Overall Study|Protocol Violation|1|||
164539398|NCT00578786|594348492|FG000|Overall Study|Physician Decision|1|||
164539399|NCT00578786|594348493|FG001|Overall Study|Physician Decision|0|||
164539400|NCT00578786|594348494|FG002|Overall Study|Physician Decision|1|||
164539401|NCT00578786|594348492|FG000|Overall Study|Sponsor Decision|0|||
164539402|NCT00578786|594348493|FG001|Overall Study|Sponsor Decision|0|||
164653103|NCT01621490|594757072|FG009|Overall Study|Subject no longer meets study criteria|0|||
164653104|NCT01621490|594757073|FG010|Overall Study|Subject no longer meets study criteria|0|||
164653105|NCT01621490|594757063|FG000|Overall Study|Maximum clinical benefit|3|||
164653106|NCT01621490|594757064|FG001|Overall Study|Maximum clinical benefit|2|||
164653107|NCT01621490|594757065|FG002|Overall Study|Maximum clinical benefit|0|||
164539403|NCT00578786|594348494|FG002|Overall Study|Sponsor Decision|1|||
164539404|NCT00578786|594348492|FG000|Overall Study|Lost to Follow-up|0|||
164539405|NCT00578786|594348493|FG001|Overall Study|Lost to Follow-up|4|||
164539406|NCT00578786|594348494|FG002|Overall Study|Lost to Follow-up|0|||
164539407|NCT00578786|594348492|FG000|Overall Study|Pregnancy|0|||
164539408|NCT00578786|594348493|FG001|Overall Study|Pregnancy|1|||
164539409|NCT00578786|594348494|FG002|Overall Study|Pregnancy|0|||
164539410|NCT00578786|594348492|FG000|Overall Study|Not Otherwise Specified|0|||
164539411|NCT00578786|594348493|FG001|Overall Study|Not Otherwise Specified|4|||
164539412|NCT00578786|594348494|FG002|Overall Study|Not Otherwise Specified|1|||
164539413|NCT00578786|594348492|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
164539414|NCT00578786|594348493|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
164539415|NCT00578786|594348494|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
164539416|NCT00117507|594348499|FG000|Overall Study|Adverse Event|4|||
164539417|NCT00117507|594348499|FG000|Overall Study|Abnormal laboratory values|3|||
164539418|NCT00117507|594348499|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164539419|NCT00117507|594348499|FG000|Overall Study|Patient withdrew consent|4|||
164539420|NCT00117507|594348499|FG000|Overall Study|Death|3|||
164539421|NCT00866723|594348500|FG000|Overall Study|Withdrawal by Subject|1|||
164539422|NCT00866723|594348500|FG000|Overall Study|Disease Progression|4|||
164539423|NCT05105789|594348501|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
164539424|NCT01003990|594348505|FG000|Overall Study|Adverse Event|8|||
164539425|NCT01003990|594348506|FG001|Overall Study|Adverse Event|5|||
164539426|NCT01003990|594348507|FG002|Overall Study|Adverse Event|11|||
164539427|NCT01003990|594348505|FG000|Overall Study|Death|0|||
164539428|NCT01003990|594348506|FG001|Overall Study|Death|8|||
164539429|NCT01003990|594348507|FG002|Overall Study|Death|1|||
164539430|NCT01003990|594348505|FG000|Overall Study|Lack of Efficacy|10|||
164539431|NCT01003990|594348506|FG001|Overall Study|Lack of Efficacy|2|||
164539432|NCT01003990|594348507|FG002|Overall Study|Lack of Efficacy|3|||
164539433|NCT01003990|594348505|FG000|Overall Study|Lost to Follow-up|30|||
164539434|NCT01003990|594348506|FG001|Overall Study|Lost to Follow-up|12|||
164539435|NCT01003990|594348507|FG002|Overall Study|Lost to Follow-up|7|||
164539436|NCT01003990|594348505|FG000|Overall Study|Reasons Not Identified|14|||
164539437|NCT01003990|594348506|FG001|Overall Study|Reasons Not Identified|13|||
164539438|NCT01003990|594348507|FG002|Overall Study|Reasons Not Identified|8|||
164539439|NCT01003990|594348505|FG000|Overall Study|Poor/Non-compliance|4|||
164539440|NCT01003990|594348506|FG001|Overall Study|Poor/Non-compliance|3|||
164539441|NCT01003990|594348507|FG002|Overall Study|Poor/Non-compliance|2|||
164539442|NCT01003990|594348505|FG000|Overall Study|Pregnancy|10|||
164539443|NCT01003990|594348506|FG001|Overall Study|Pregnancy|2|||
164539444|NCT01003990|594348507|FG002|Overall Study|Pregnancy|4|||
164539445|NCT01003990|594348505|FG000|Overall Study|No Longer Met Study Criteria|4|||
164539446|NCT01003990|594348506|FG001|Overall Study|No Longer Met Study Criteria|1|||
164539447|NCT01003990|594348507|FG002|Overall Study|No Longer Met Study Criteria|0|||
164539448|NCT01003990|594348505|FG000|Overall Study|Subject Withdrew Consent|12|||
164539449|NCT01003990|594348506|FG001|Overall Study|Subject Withdrew Consent|5|||
164539450|NCT01003990|594348507|FG002|Overall Study|Subject Withdrew Consent|7|||
164539451|NCT01271803|594348508|FG000|Overall Study|Progressive disease|0|||
164539452|NCT01271803|594348509|FG001|Overall Study|Progressive disease|0|||
164539453|NCT01271803|594348510|FG002|Overall Study|Progressive disease|2|||
164539454|NCT01271803|594348508|FG000|Overall Study|Death|53|||
164539455|NCT01271803|594348509|FG001|Overall Study|Death|34|||
164539456|NCT01271803|594348510|FG002|Overall Study|Death|0|||
164539457|NCT01271803|594348508|FG000|Overall Study|Withdrawal by Subject|1|||
164539458|NCT01271803|594348509|FG001|Overall Study|Withdrawal by Subject|5|||
164539459|NCT01271803|594348510|FG002|Overall Study|Withdrawal by Subject|0|||
164539460|NCT01271803|594348508|FG000|Overall Study|Lost to Follow-up|1|||
164539461|NCT01271803|594348509|FG001|Overall Study|Lost to Follow-up|0|||
164539462|NCT01271803|594348510|FG002|Overall Study|Lost to Follow-up|0|||
164539463|NCT05211739|594348511|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
164539464|NCT05211739|594348512|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
164539465|NCT05211739|594348511|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
164539466|NCT05211739|594348512|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
164190490|NCT03428100|593066318|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
164190491|NCT03428100|593066300|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
164190492|NCT03428100|593066301|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
164190493|NCT03428100|593066302|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
164539467|NCT05211739|594348511|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
164539468|NCT05211739|594348512|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
164539469|NCT05211739|594348511|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
164190494|NCT03428100|593066303|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
164190495|NCT03428100|593066304|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
164190496|NCT03428100|593066305|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
164190497|NCT03428100|593066306|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
164190498|NCT03428100|593066307|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
164539470|NCT05211739|594348512|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
164539471|NCT04178967|594348513|FG000|Induction Period|Adverse Event|4|||
164539472|NCT04178967|594348514|FG001|Induction Period|Adverse Event|6|||
164539473|NCT04178967|594348515|FG002|Induction Period|Adverse Event|0|||
164190499|NCT03428100|593066308|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
164539474|NCT04178967|594348516|FG003|Induction Period|Adverse Event|0|||
164539475|NCT04178967|594348517|FG004|Induction Period|Adverse Event|0|||
164539476|NCT04178967|594348518|FG005|Induction Period|Adverse Event|0|||
164190500|NCT03428100|593066309|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
164190501|NCT03428100|593066310|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
164190502|NCT03428100|593066311|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
164190503|NCT03428100|593066312|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
164190504|NCT03428100|593066313|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
164190505|NCT03428100|593066314|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
164190506|NCT03428100|593066315|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
164190507|NCT03428100|593066316|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
164190508|NCT03428100|593066317|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
164190509|NCT03428100|593066318|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
164190510|NCT03428100|593066300|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190511|NCT03428100|593066301|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190512|NCT03428100|593066302|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190513|NCT03428100|593066303|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190514|NCT03428100|593066304|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190515|NCT03428100|593066305|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190516|NCT03428100|593066306|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190517|NCT03428100|593066307|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
164190518|NCT03428100|593066308|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190519|NCT03428100|593066309|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190520|NCT03428100|593066310|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190521|NCT03428100|593066311|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
164190522|NCT03428100|593066312|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
164190523|NCT03428100|593066313|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190524|NCT03428100|593066314|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
164190525|NCT03428100|593066315|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190526|NCT03428100|593066316|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190527|NCT03428100|593066317|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
164190528|NCT03428100|593066318|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190529|NCT03428100|593066300|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
164190530|NCT03428100|593066301|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
164190531|NCT03428100|593066302|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
164190532|NCT03428100|593066303|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
164539477|NCT04178967|594348519|FG006|Induction Period|Adverse Event|0|||
164539478|NCT04178967|594348520|FG007|Induction Period|Adverse Event|0|||
164539479|NCT04178967|594348521|FG008|Induction Period|Adverse Event|0|||
164539480|NCT04178967|594348522|FG009|Induction Period|Adverse Event|0|||
164539481|NCT04178967|594348523|FG010|Induction Period|Adverse Event|0|||
164539482|NCT04178967|594348513|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
164539483|NCT04178967|594348514|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
164539484|NCT04178967|594348515|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
164539485|NCT04178967|594348516|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
164539486|NCT04178967|594348517|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
164539487|NCT04178967|594348518|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
164539488|NCT04178967|594348519|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
164539489|NCT04178967|594348520|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
164539490|NCT04178967|594348521|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
164539491|NCT04178967|594348522|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
164539492|NCT04178967|594348523|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
164539493|NCT04178967|594348513|FG000|Induction Period|Lack of Efficacy|4|||
164539494|NCT04178967|594348514|FG001|Induction Period|Lack of Efficacy|1|||
164539495|NCT04178967|594348515|FG002|Induction Period|Lack of Efficacy|0|||
164539496|NCT04178967|594348516|FG003|Induction Period|Lack of Efficacy|0|||
164539497|NCT04178967|594348517|FG004|Induction Period|Lack of Efficacy|0|||
164539498|NCT04178967|594348518|FG005|Induction Period|Lack of Efficacy|0|||
164539499|NCT04178967|594348519|FG006|Induction Period|Lack of Efficacy|0|||
164539500|NCT04178967|594348520|FG007|Induction Period|Lack of Efficacy|0|||
164539501|NCT04178967|594348521|FG008|Induction Period|Lack of Efficacy|0|||
164539502|NCT04178967|594348522|FG009|Induction Period|Lack of Efficacy|0|||
164539503|NCT04178967|594348523|FG010|Induction Period|Lack of Efficacy|0|||
164539504|NCT04178967|594348513|FG000|Induction Period|Protocol Violation|0|||
164539505|NCT04178967|594348514|FG001|Induction Period|Protocol Violation|6|||
164539506|NCT04178967|594348515|FG002|Induction Period|Protocol Violation|0|||
164539507|NCT04178967|594348516|FG003|Induction Period|Protocol Violation|0|||
164539508|NCT04178967|594348517|FG004|Induction Period|Protocol Violation|0|||
164539509|NCT04178967|594348518|FG005|Induction Period|Protocol Violation|0|||
164539510|NCT04178967|594348519|FG006|Induction Period|Protocol Violation|0|||
164539511|NCT04178967|594348520|FG007|Induction Period|Protocol Violation|0|||
164539512|NCT04178967|594348521|FG008|Induction Period|Protocol Violation|0|||
164539513|NCT04178967|594348522|FG009|Induction Period|Protocol Violation|0|||
164539514|NCT04178967|594348523|FG010|Induction Period|Protocol Violation|0|||
164539515|NCT04178967|594348513|FG000|Induction Period|Withdrawal by Subject|6|||
164539516|NCT04178967|594348514|FG001|Induction Period|Withdrawal by Subject|4|||
164539517|NCT04178967|594348515|FG002|Induction Period|Withdrawal by Subject|0|||
164539518|NCT04178967|594348516|FG003|Induction Period|Withdrawal by Subject|0|||
164539519|NCT04178967|594348517|FG004|Induction Period|Withdrawal by Subject|0|||
164539520|NCT04178967|594348518|FG005|Induction Period|Withdrawal by Subject|0|||
164539521|NCT04178967|594348519|FG006|Induction Period|Withdrawal by Subject|0|||
164539522|NCT04178967|594348520|FG007|Induction Period|Withdrawal by Subject|0|||
164539523|NCT04178967|594348521|FG008|Induction Period|Withdrawal by Subject|0|||
164539524|NCT04178967|594348522|FG009|Induction Period|Withdrawal by Subject|0|||
164539525|NCT04178967|594348523|FG010|Induction Period|Withdrawal by Subject|0|||
164539526|NCT04178967|594348513|FG000|Induction Period|Lost to Follow-up|2|||
164539527|NCT04178967|594348514|FG001|Induction Period|Lost to Follow-up|0|||
164539528|NCT04178967|594348515|FG002|Induction Period|Lost to Follow-up|0|||
164539529|NCT04178967|594348516|FG003|Induction Period|Lost to Follow-up|0|||
164539530|NCT04178967|594348517|FG004|Induction Period|Lost to Follow-up|0|||
164539531|NCT04178967|594348518|FG005|Induction Period|Lost to Follow-up|0|||
164539532|NCT04178967|594348519|FG006|Induction Period|Lost to Follow-up|0|||
164539533|NCT04178967|594348520|FG007|Induction Period|Lost to Follow-up|0|||
164539534|NCT04178967|594348521|FG008|Induction Period|Lost to Follow-up|0|||
164539535|NCT04178967|594348522|FG009|Induction Period|Lost to Follow-up|0|||
164539536|NCT04178967|594348523|FG010|Induction Period|Lost to Follow-up|0|||
164539537|NCT04178967|594348513|FG000|Induction Period|Participant Missed Study Visits|0|||
164539538|NCT04178967|594348514|FG001|Induction Period|Participant Missed Study Visits|1|||
164539539|NCT04178967|594348515|FG002|Induction Period|Participant Missed Study Visits|0|||
164539540|NCT04178967|594348516|FG003|Induction Period|Participant Missed Study Visits|0|||
164539541|NCT04178967|594348517|FG004|Induction Period|Participant Missed Study Visits|0|||
164539542|NCT04178967|594348518|FG005|Induction Period|Participant Missed Study Visits|0|||
164539543|NCT04178967|594348519|FG006|Induction Period|Participant Missed Study Visits|0|||
164539544|NCT04178967|594348520|FG007|Induction Period|Participant Missed Study Visits|0|||
164539545|NCT04178967|594348521|FG008|Induction Period|Participant Missed Study Visits|0|||
164539546|NCT04178967|594348522|FG009|Induction Period|Participant Missed Study Visits|0|||
164539547|NCT04178967|594348523|FG010|Induction Period|Participant Missed Study Visits|0|||
164539548|NCT04178967|594348513|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
164539549|NCT04178967|594348514|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
164539550|NCT04178967|594348515|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
164539551|NCT04178967|594348516|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
164539552|NCT04178967|594348517|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
164539553|NCT04178967|594348518|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
164539554|NCT04178967|594348519|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
164539555|NCT04178967|594348520|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
164539556|NCT04178967|594348521|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
164539557|NCT04178967|594348522|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
164539558|NCT04178967|594348523|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
164539559|NCT04178967|594348513|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164539560|NCT04178967|594348514|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164539561|NCT04178967|594348515|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164539562|NCT04178967|594348516|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164539563|NCT04178967|594348517|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164539564|NCT04178967|594348518|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
164539565|NCT04178967|594348519|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164539566|NCT04178967|594348520|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164539567|NCT04178967|594348521|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164539568|NCT04178967|594348522|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164539569|NCT04178967|594348523|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164539570|NCT04178967|594348513|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164539571|NCT04178967|594348514|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164539572|NCT04178967|594348515|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164539573|NCT04178967|594348516|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
164539574|NCT04178967|594348517|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164539575|NCT04178967|594348518|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164539576|NCT04178967|594348519|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164539577|NCT04178967|594348520|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164539578|NCT04178967|594348521|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164539579|NCT04178967|594348522|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164539580|NCT04178967|594348523|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164539581|NCT04178967|594348513|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
164539582|NCT04178967|594348514|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
164539583|NCT04178967|594348515|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
164539584|NCT04178967|594348516|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
164539585|NCT04178967|594348517|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
164539586|NCT04178967|594348518|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
164539587|NCT04178967|594348519|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
164539588|NCT04178967|594348520|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
164539589|NCT04178967|594348521|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
164539590|NCT04178967|594348522|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
164539591|NCT04178967|594348523|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
164539592|NCT04178967|594348513|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
164539593|NCT04178967|594348514|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
164539594|NCT04178967|594348515|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
164539595|NCT04178967|594348516|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
164539596|NCT04178967|594348517|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
164539597|NCT04178967|594348518|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
164539598|NCT04178967|594348519|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
164539599|NCT04178967|594348520|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
164539600|NCT04178967|594348521|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
164539601|NCT04178967|594348522|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
164539602|NCT04178967|594348523|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
164539603|NCT04178967|594348513|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
164539604|NCT04178967|594348514|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
164539605|NCT04178967|594348515|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
164539606|NCT04178967|594348516|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
164539607|NCT04178967|594348517|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
164539608|NCT04178967|594348518|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
164539609|NCT04178967|594348519|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
164539610|NCT04178967|594348520|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
164539611|NCT04178967|594348521|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
164539612|NCT04178967|594348522|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
164539613|NCT04178967|594348523|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
164539614|NCT04178967|594348513|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
164539615|NCT04178967|594348514|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
164539616|NCT04178967|594348515|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
164539617|NCT04178967|594348516|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
164539618|NCT04178967|594348517|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
164539619|NCT04178967|594348518|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
164539620|NCT04178967|594348519|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
164539621|NCT04178967|594348520|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
164539622|NCT04178967|594348521|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
164539623|NCT04178967|594348522|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
164539624|NCT04178967|594348523|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
164539625|NCT04178967|594348513|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
164539626|NCT04178967|594348514|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
164539627|NCT04178967|594348515|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
164539628|NCT04178967|594348516|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
164539629|NCT04178967|594348517|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
164539630|NCT04178967|594348518|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
164539631|NCT04178967|594348519|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
164539632|NCT04178967|594348520|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
164539633|NCT04178967|594348521|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
164539634|NCT04178967|594348522|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
164539635|NCT04178967|594348523|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
164539636|NCT04178967|594348513|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164539637|NCT04178967|594348514|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164539638|NCT04178967|594348515|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164539639|NCT04178967|594348516|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164539640|NCT04178967|594348517|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164539641|NCT04178967|594348518|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164539642|NCT04178967|594348519|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164653108|NCT01621490|594757066|FG003|Overall Study|Maximum clinical benefit|0|||
164539643|NCT04178967|594348520|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164539644|NCT04178967|594348521|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
164653109|NCT01621490|594757067|FG004|Overall Study|Maximum clinical benefit|0|||
164653110|NCT01621490|594757068|FG005|Overall Study|Maximum clinical benefit|0|||
164539645|NCT04178967|594348522|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
164539646|NCT04178967|594348523|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
164539647|NCT04178967|594348513|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164539648|NCT04178967|594348514|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164539649|NCT04178967|594348515|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164539650|NCT04178967|594348516|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164539651|NCT04178967|594348517|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164539652|NCT04178967|594348518|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164539653|NCT04178967|594348519|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164539654|NCT04178967|594348520|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164539655|NCT04178967|594348521|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164539656|NCT04178967|594348522|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
164539657|NCT04178967|594348523|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164539658|NCT04178967|594348513|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164539659|NCT04178967|594348514|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164539660|NCT04178967|594348515|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164539661|NCT04178967|594348516|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164539662|NCT04178967|594348517|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164539663|NCT04178967|594348518|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164539664|NCT04178967|594348519|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164539665|NCT04178967|594348520|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164539666|NCT04178967|594348521|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
164539667|NCT04178967|594348522|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
164539668|NCT04178967|594348523|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
164539669|NCT04178967|594348513|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
164539670|NCT04178967|594348514|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
164539671|NCT04178967|594348515|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
164539672|NCT04178967|594348516|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
164539673|NCT04178967|594348517|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
164539674|NCT04178967|594348518|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
164539675|NCT04178967|594348519|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
164539676|NCT04178967|594348520|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
164539677|NCT04178967|594348521|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
164539678|NCT04178967|594348522|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
164539679|NCT04178967|594348523|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
164539680|NCT04178967|594348513|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
164539681|NCT04178967|594348514|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
164539682|NCT04178967|594348515|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
164539683|NCT04178967|594348516|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
164539684|NCT04178967|594348517|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
164539685|NCT04178967|594348518|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
164539686|NCT04178967|594348519|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
164539687|NCT04178967|594348520|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
164539688|NCT04178967|594348521|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
164539689|NCT04178967|594348522|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
164539690|NCT04178967|594348523|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
164539691|NCT01975428|594348527|FG000|Overall Study|Lost to Follow-up|17|||
164539692|NCT01975428|594348528|FG001|Overall Study|Lost to Follow-up|4|||
164539693|NCT01975428|594348527|FG000|Overall Study|Withdrawal by Subject|3|||
164539694|NCT01975428|594348528|FG001|Overall Study|Withdrawal by Subject|10|||
164539695|NCT02187809|594348529|FG000|Overall Study|The study was terminated|3|||
164539696|NCT00628251|594348530|FG000|Randomised Part|Withdrawal by Subject|0|||
164539697|NCT00628251|594348531|FG001|Randomised Part|Withdrawal by Subject|0|||
164539698|NCT00628251|594348532|FG002|Randomised Part|Withdrawal by Subject|1|||
164539699|NCT00628251|594348530|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
164539700|NCT00628251|594348531|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
164539701|NCT00628251|594348532|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
164539702|NCT00628251|594348530|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
164539703|NCT00628251|594348531|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
164539704|NCT00628251|594348532|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
164539705|NCT00628251|594348530|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
164539706|NCT00628251|594348531|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
164190533|NCT03428100|593066304|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
164190534|NCT03428100|593066305|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
164420577|NCT02718417|593910943|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
164539707|NCT00628251|594348532|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
164539708|NCT00628251|594348530|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
164539709|NCT00628251|594348531|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
164539710|NCT00628251|594348532|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
164539711|NCT00628251|594348530|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
164539712|NCT00628251|594348531|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
164539713|NCT00628251|594348532|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
164539714|NCT02066051|594348533|FG000|Overall Study|Subject developed active GVHD|1|||
164539715|NCT01272947|594348534|FG000|Overall Study|Abnormal Laboratory Value|2|||
164539716|NCT01272947|594348535|FG001|Overall Study|Abnormal Laboratory Value|2|||
164539717|NCT02019420|594348538|FG000|Overall Study|Did not receive study drug|2|||
164539718|NCT02019420|594348539|FG001|Overall Study|Did not receive study drug|2|||
164539719|NCT02019420|594348538|FG000|Overall Study|Withdrawal by Subject|1|||
164539720|NCT02019420|594348539|FG001|Overall Study|Withdrawal by Subject|3|||
164539721|NCT02019420|594348538|FG000|Overall Study|At request of sponsor or investigator|0|||
164539722|NCT02019420|594348539|FG001|Overall Study|At request of sponsor or investigator|1|||
164539723|NCT02019420|594348538|FG000|Overall Study|Death|104|||
164539724|NCT02019420|594348539|FG001|Overall Study|Death|99|||
164539725|NCT02019420|594348538|FG000|Overall Study|Transferred to other care facility|1|||
164539726|NCT02019420|594348539|FG001|Overall Study|Transferred to other care facility|1|||
164539727|NCT02469896|594348540|FG000|Overall Study|Withdrawal by Subject|2|||
164539728|NCT02469896|594348541|FG001|Overall Study|Withdrawal by Subject|0|||
164539729|NCT02510560|594348542|FG000|Overall Study|Discontinued from Treatment|27|||
164539730|NCT02510560|594348543|FG001|Overall Study|Discontinued from Treatment|18|||
164539731|NCT02510560|594348544|FG002|Overall Study|Discontinued from Treatment|19|||
164539732|NCT02510560|594348542|FG000|Overall Study|Other|4|||
164539733|NCT02510560|594348543|FG001|Overall Study|Other|4|||
164539734|NCT02510560|594348544|FG002|Overall Study|Other|3|||
164539735|NCT01294150|594348545|FG000|Overall Study|Physician Decision|2|||
164539736|NCT01294150|594348546|FG001|Overall Study|Physician Decision|2|||
164539737|NCT02608879|594348547|FG000|Overall Study|Lost to Follow-up|1|||
164539738|NCT02608879|594348548|FG001|Overall Study|Lost to Follow-up|0|||
164539739|NCT02608879|594348549|FG002|Overall Study|Lost to Follow-up|0|||
164539740|NCT02608879|594348547|FG000|Overall Study|Did not meet continuation criteria|0|||
164539741|NCT02608879|594348548|FG001|Overall Study|Did not meet continuation criteria|0|||
164539742|NCT02608879|594348549|FG002|Overall Study|Did not meet continuation criteria|3|||
164539743|NCT01621542|594348550|FG000|Overall Study|Adverse Event|0|||
164539744|NCT01621542|594348551|FG001|Overall Study|Adverse Event|0|||
164539745|NCT01621542|594348552|FG002|Overall Study|Adverse Event|1|||
164539746|NCT01621542|594348553|FG003|Overall Study|Adverse Event|3|||
164539747|NCT01621542|594348554|FG004|Overall Study|Adverse Event|0|||
164539748|NCT01621542|594348555|FG005|Overall Study|Adverse Event|0|||
164539749|NCT01621542|594348550|FG000|Overall Study|Death|0|||
164539750|NCT01621542|594348551|FG001|Overall Study|Death|1|||
164539751|NCT01621542|594348552|FG002|Overall Study|Death|0|||
164539752|NCT01621542|594348553|FG003|Overall Study|Death|0|||
164539753|NCT01621542|594348554|FG004|Overall Study|Death|0|||
164539754|NCT01621542|594348555|FG005|Overall Study|Death|0|||
164539755|NCT01621542|594348550|FG000|Overall Study|Physician Decision|1|||
164539756|NCT01621542|594348551|FG001|Overall Study|Physician Decision|0|||
164539757|NCT01621542|594348552|FG002|Overall Study|Physician Decision|1|||
164539758|NCT01621542|594348553|FG003|Overall Study|Physician Decision|13|||
164539759|NCT01621542|594348554|FG004|Overall Study|Physician Decision|3|||
164539760|NCT01621542|594348555|FG005|Overall Study|Physician Decision|1|||
164539761|NCT01621542|594348550|FG000|Overall Study|Withdrawal by Subject|2|||
164539762|NCT01621542|594348551|FG001|Overall Study|Withdrawal by Subject|0|||
164539763|NCT01621542|594348552|FG002|Overall Study|Withdrawal by Subject|1|||
164539764|NCT01621542|594348553|FG003|Overall Study|Withdrawal by Subject|3|||
164539765|NCT01621542|594348554|FG004|Overall Study|Withdrawal by Subject|3|||
164539766|NCT01621542|594348555|FG005|Overall Study|Withdrawal by Subject|3|||
164539767|NCT01621542|594348550|FG000|Overall Study|progression/treatment failure|2|||
164539768|NCT01621542|594348551|FG001|Overall Study|progression/treatment failure|4|||
164539769|NCT01621542|594348552|FG002|Overall Study|progression/treatment failure|3|||
164539770|NCT01621542|594348553|FG003|Overall Study|progression/treatment failure|7|||
164539771|NCT01621542|594348554|FG004|Overall Study|progression/treatment failure|3|||
164539772|NCT01621542|594348555|FG005|Overall Study|progression/treatment failure|5|||
164539773|NCT01621542|594348550|FG000|Overall Study|Protocol Violation|0|||
164539774|NCT01621542|594348551|FG001|Overall Study|Protocol Violation|0|||
164539775|NCT01621542|594348552|FG002|Overall Study|Protocol Violation|0|||
164539776|NCT01621542|594348553|FG003|Overall Study|Protocol Violation|1|||
164539777|NCT01621542|594348554|FG004|Overall Study|Protocol Violation|0|||
164539778|NCT01621542|594348555|FG005|Overall Study|Protocol Violation|0|||
164539779|NCT01621542|594348550|FG000|Overall Study|study stopped by sponsor|0|||
164539780|NCT01621542|594348551|FG001|Overall Study|study stopped by sponsor|0|||
164539781|NCT01621542|594348552|FG002|Overall Study|study stopped by sponsor|0|||
164539782|NCT01621542|594348553|FG003|Overall Study|study stopped by sponsor|1|||
164539783|NCT01621542|594348554|FG004|Overall Study|study stopped by sponsor|0|||
164539784|NCT01621542|594348555|FG005|Overall Study|study stopped by sponsor|0|||
164539785|NCT02742766|594348556|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
164539786|NCT02742766|594348557|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
164539787|NCT02742766|594348558|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
164539788|NCT02742766|594348559|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
164539789|NCT02742766|594348560|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
164539790|NCT02742766|594348561|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
164539791|NCT02742766|594348562|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
164539792|NCT02742766|594348563|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
164539793|NCT02742766|594348564|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
164539794|NCT02742766|594348565|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
164539795|NCT02742766|594348566|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
164539796|NCT02742766|594348567|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
164539797|NCT02742766|594348568|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
164539798|NCT02742766|594348569|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
164539799|NCT02742766|594348570|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
164539800|NCT02742766|594348571|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
164539801|NCT02742766|594348572|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
164539802|NCT02742766|594348573|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
164539803|NCT02742766|594348574|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
164539804|NCT02742766|594348556|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
164539805|NCT02742766|594348557|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
164539806|NCT02742766|594348558|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
164539807|NCT02742766|594348559|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
164539808|NCT02742766|594348560|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
164539809|NCT02742766|594348561|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
164539810|NCT02742766|594348562|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
164539811|NCT02742766|594348563|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
164539812|NCT02742766|594348564|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
164539813|NCT02742766|594348565|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
164539814|NCT02742766|594348566|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
164539815|NCT02742766|594348567|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
164539816|NCT02742766|594348568|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
164539817|NCT02742766|594348569|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
164539818|NCT02742766|594348570|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
164539819|NCT02742766|594348571|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
164539820|NCT02742766|594348572|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
164539821|NCT02742766|594348573|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
164539822|NCT02742766|594348574|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
164539823|NCT03739437|594348575|FG000|Overall Study|Lost to Follow-up|2|||
164539824|NCT03739437|594348576|FG001|Overall Study|Lost to Follow-up|5|||
164539825|NCT01351623|594348577|FG000|Overall Study|Protocol Violation|2|||
164539826|NCT01351623|594348577|FG000|Overall Study|Adverse Event|4|||
164539827|NCT01351623|594348577|FG000|Overall Study|Withdrawal by Subject|1|||
164539828|NCT01351623|594348577|FG000|Overall Study|Death|2|||
164539829|NCT01130974|594348579|FG000|Overall Study|Protocol Violation|10|||
164539830|NCT01130974|594348580|FG001|Overall Study|Protocol Violation|10|||
164539831|NCT01130974|594348579|FG000|Overall Study|Withdrawal by Subject|0|||
164539832|NCT01130974|594348580|FG001|Overall Study|Withdrawal by Subject|1|||
164539833|NCT01130974|594348579|FG000|Overall Study|Ineligibility criteria|5|||
164539834|NCT01130974|594348580|FG001|Overall Study|Ineligibility criteria|2|||
164539835|NCT03359590|594348582|FG000|First Intervention|Withdrawal by Subject|1|||
164539836|NCT03359590|594348583|FG001|First Intervention|Withdrawal by Subject|1|||
164539837|NCT03359590|594348582|FG000|First Intervention|Protocol Violation|0|||
164539838|NCT03359590|594348583|FG001|First Intervention|Protocol Violation|1|||
164539839|NCT02536755|594348584|FG000|Overall Study|Adverse Event|4|||
164539840|NCT02540538|594348585|FG000|Overall Study|Pregnancy|0|||
164539841|NCT02540538|594348586|FG001|Overall Study|Pregnancy|1|||
164539842|NCT02540538|594348587|FG002|Overall Study|Pregnancy|0|||
164539843|NCT04598477|594348589|FG000|Overall Study|Adverse Event|2|||
164539844|NCT04598477|594348590|FG001|Overall Study|Adverse Event|0|||
164539845|NCT04598477|594348589|FG000|Overall Study|Death|0|||
164539846|NCT04598477|594348590|FG001|Overall Study|Death|1|||
164539847|NCT04598477|594348589|FG000|Overall Study|Lost to Follow-up|1|||
164539848|NCT04598477|594348590|FG001|Overall Study|Lost to Follow-up|0|||
164539849|NCT04598477|594348589|FG000|Overall Study|Physician Decision|7|||
164539850|NCT04598477|594348590|FG001|Overall Study|Physician Decision|2|||
164539851|NCT04598477|594348589|FG000|Overall Study|Pregnancy|0|||
164539852|NCT04598477|594348590|FG001|Overall Study|Pregnancy|1|||
164539853|NCT04598477|594348589|FG000|Overall Study|Requires Prohibited Medication|0|||
164539854|NCT04598477|594348590|FG001|Overall Study|Requires Prohibited Medication|1|||
164539855|NCT04598477|594348589|FG000|Overall Study|Study Terminated by Sponsor|18|||
164539856|NCT04598477|594348590|FG001|Overall Study|Study Terminated by Sponsor|12|||
164539857|NCT04598477|594348589|FG000|Overall Study|Withdrawal by Subject|16|||
164539858|NCT04598477|594348590|FG001|Overall Study|Withdrawal by Subject|12|||
164539859|NCT04598477|594348589|FG000|Overall Study|Other|15|||
164539860|NCT04598477|594348590|FG001|Overall Study|Other|8|||
164539861|NCT05579990|594348600|FG000|Overall Study|Lost to Follow-up|3|||
164539862|NCT00671554|594348611|FG000|Overall Study|Disease progression|3|||
164539863|NCT00332839|594350512|FG000|Core (Months 0 - 12)|Administrative problems|1|||
164539864|NCT00332839|594350513|FG001|Core (Months 0 - 12)|Administrative problems|1|||
164539865|NCT00332839|594350512|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
164539866|NCT00332839|594350513|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
164539867|NCT00332839|594350512|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
164539868|NCT00332839|594350513|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
164539869|NCT00332839|594350512|FG000|Core (Months 0 - 12)|Adverse Event|5|||
164539870|NCT00332839|594350513|FG001|Core (Months 0 - 12)|Adverse Event|15|||
164539871|NCT00332839|594350512|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
164539872|NCT00332839|594350513|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
164539873|NCT00332839|594350512|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
164539874|NCT00332839|594350513|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
164539875|NCT00332839|594350512|FG000|Follow-up (Months 12 - 60)|Death|1|||
164539876|NCT00332839|594350513|FG001|Follow-up (Months 12 - 60)|Death|1|||
164539877|NCT01876251|594350514|FG000|Overall Study|Clinical progression|1|||
164539878|NCT01876251|594350515|FG001|Overall Study|Clinical progression|0|||
164539879|NCT01876251|594350516|FG002|Overall Study|Clinical progression|0|||
164539880|NCT01876251|594350514|FG000|Overall Study|Death|2|||
164539881|NCT01876251|594350515|FG001|Overall Study|Death|0|||
164539882|NCT01876251|594350516|FG002|Overall Study|Death|1|||
164539883|NCT01876251|594350514|FG000|Overall Study|Participant started new treatment|1|||
164539884|NCT01876251|594350515|FG001|Overall Study|Participant started new treatment|0|||
164539885|NCT01876251|594350516|FG002|Overall Study|Participant started new treatment|1|||
164539886|NCT01876251|594350514|FG000|Overall Study|Participant refused further follow-up|0|||
164539887|NCT01876251|594350515|FG001|Overall Study|Participant refused further follow-up|0|||
164539888|NCT01876251|594350516|FG002|Overall Study|Participant refused further follow-up|1|||
164539889|NCT01876251|594350514|FG000|Overall Study|Study terminated|1|||
164539890|NCT01876251|594350515|FG001|Overall Study|Study terminated|0|||
164539891|NCT01876251|594350516|FG002|Overall Study|Study terminated|0|||
164539892|NCT01876251|594350514|FG000|Overall Study|Objective progression or relapse|10|||
164539893|NCT01876251|594350515|FG001|Overall Study|Objective progression or relapse|3|||
164539894|NCT01876251|594350516|FG002|Overall Study|Objective progression or relapse|8|||
164539895|NCT03876171|594350525|FG000|Overall Study|Withdrawal by Subject|3|||
164539896|NCT03876171|594350526|FG001|Overall Study|Withdrawal by Subject|3|||
164539897|NCT03876171|594350525|FG000|Overall Study|Re-arrest|0|||
164539898|NCT03876171|594350526|FG001|Overall Study|Re-arrest|4|||
164539899|NCT02012296|594350527|FG000|Overall Study|Lack of Efficacy|0|||
164539900|NCT02012296|594350528|FG001|Overall Study|Lack of Efficacy|0|||
164539901|NCT02012296|594350529|FG002|Overall Study|Lack of Efficacy|15|||
164539902|NCT02012296|594350527|FG000|Overall Study|Adverse Event|0|||
164539903|NCT02012296|594350528|FG001|Overall Study|Adverse Event|0|||
164539904|NCT02012296|594350529|FG002|Overall Study|Adverse Event|2|||
164539905|NCT02012296|594350527|FG000|Overall Study|Early study closure|0|||
164539906|NCT02012296|594350528|FG001|Overall Study|Early study closure|0|||
164539907|NCT02012296|594350529|FG002|Overall Study|Early study closure|5|||
164539908|NCT02012296|594350527|FG000|Overall Study|Protocol Violation|0|||
164539909|NCT02012296|594350528|FG001|Overall Study|Protocol Violation|1|||
164539910|NCT02012296|594350529|FG002|Overall Study|Protocol Violation|0|||
164539911|NCT00727649|594350532|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
164539912|NCT00727649|594350533|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
164539913|NCT00727649|594350532|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
164539914|NCT00727649|594350533|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
164539915|NCT00727649|594350532|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
164539916|NCT00727649|594350533|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
164539917|NCT00727649|594350532|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
164539918|NCT00727649|594350533|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
164539919|NCT00727649|594350532|FG000|Second Intervention (4-weeks)|Death|1|||
164539920|NCT00727649|594350533|FG001|Second Intervention (4-weeks)|Death|0|||
164539921|NCT00727649|594350532|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
164539922|NCT00727649|594350533|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
164190535|NCT03428100|593066306|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
164539923|NCT00727649|594350532|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
164539924|NCT00727649|594350533|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
164539925|NCT01650285|594350534|FG000|Overall Study|Adverse Event|1|||
164539926|NCT04163900|594350535|FG000|Overall Study|Radiological disease progression|112|||
164539927|NCT04163900|594350536|FG001|Overall Study|Radiological disease progression|127|||
164539928|NCT04163900|594350535|FG000|Overall Study|Study closure|98|||
164539929|NCT04163900|594350536|FG001|Overall Study|Study closure|133|||
164539930|NCT04163900|594350535|FG000|Overall Study|Adverse Event|78|||
164539931|NCT04163900|594350536|FG001|Overall Study|Adverse Event|32|||
164539932|NCT04163900|594350535|FG000|Overall Study|Withdrawal by Subject|37|||
164539933|NCT04163900|594350536|FG001|Overall Study|Withdrawal by Subject|34|||
164539934|NCT04163900|594350535|FG000|Overall Study|Death|29|||
164539935|NCT04163900|594350536|FG001|Overall Study|Death|16|||
164539936|NCT04163900|594350535|FG000|Overall Study|Physician Decision|17|||
164539937|NCT04163900|594350536|FG001|Overall Study|Physician Decision|25|||
164539938|NCT04163900|594350535|FG000|Overall Study|Clinical disease progression|14|||
164539939|NCT04163900|594350536|FG001|Overall Study|Clinical disease progression|13|||
164539940|NCT04163900|594350535|FG000|Overall Study|Protocol Violation|3|||
164539941|NCT04163900|594350536|FG001|Overall Study|Protocol Violation|4|||
164539942|NCT04163900|594350535|FG000|Overall Study|Lost to Follow-up|0|||
164539943|NCT04163900|594350536|FG001|Overall Study|Lost to Follow-up|1|||
164539944|NCT01830855|594350537|FG000|Overall Study|Other|7|||
164539945|NCT01830855|594350538|FG001|Overall Study|Other|1|||
164539946|NCT01830855|594350539|FG002|Overall Study|Other|4|||
164539947|NCT01830855|594350540|FG003|Overall Study|Other|4|||
164539948|NCT01830855|594350537|FG000|Overall Study|Medication error without associated AE|1|||
164539949|NCT01830855|594350538|FG001|Overall Study|Medication error without associated AE|0|||
164539950|NCT01830855|594350539|FG002|Overall Study|Medication error without associated AE|0|||
164539951|NCT01830855|594350540|FG003|Overall Study|Medication error without associated AE|1|||
164539952|NCT01830855|594350537|FG000|Overall Study|Pregnancy|3|||
164539953|NCT01830855|594350538|FG001|Overall Study|Pregnancy|1|||
164539954|NCT01830855|594350539|FG002|Overall Study|Pregnancy|2|||
164539955|NCT01830855|594350540|FG003|Overall Study|Pregnancy|1|||
164539956|NCT01830855|594350537|FG000|Overall Study|No longer meets eligibility criteria|11|||
164539957|NCT01830855|594350538|FG001|Overall Study|No longer meets eligibility criteria|2|||
164539958|NCT01830855|594350539|FG002|Overall Study|No longer meets eligibility criteria|3|||
164539959|NCT01830855|594350540|FG003|Overall Study|No longer meets eligibility criteria|5|||
164539960|NCT01830855|594350537|FG000|Overall Study|Adverse Event|11|||
164539961|NCT01830855|594350538|FG001|Overall Study|Adverse Event|5|||
164539962|NCT01830855|594350539|FG002|Overall Study|Adverse Event|6|||
164539963|NCT01830855|594350540|FG003|Overall Study|Adverse Event|3|||
164539964|NCT01830855|594350537|FG000|Overall Study|Protocol deviation|10|||
164539965|NCT01830855|594350538|FG001|Overall Study|Protocol deviation|5|||
164539966|NCT01830855|594350539|FG002|Overall Study|Protocol deviation|6|||
164539967|NCT01830855|594350540|FG003|Overall Study|Protocol deviation|6|||
164539968|NCT01830855|594350537|FG000|Overall Study|Withdrawal by Subject|33|||
164539969|NCT01830855|594350538|FG001|Overall Study|Withdrawal by Subject|14|||
164539970|NCT01830855|594350539|FG002|Overall Study|Withdrawal by Subject|10|||
164539971|NCT01830855|594350540|FG003|Overall Study|Withdrawal by Subject|12|||
164539972|NCT01830855|594350537|FG000|Overall Study|No longer willing to participate|32|||
164539973|NCT01830855|594350538|FG001|Overall Study|No longer willing to participate|13|||
164539974|NCT01830855|594350539|FG002|Overall Study|No longer willing to participate|12|||
164539975|NCT01830855|594350540|FG003|Overall Study|No longer willing to participate|17|||
164539976|NCT01830855|594350537|FG000|Overall Study|Lost to Follow-up|47|||
164539977|NCT01830855|594350538|FG001|Overall Study|Lost to Follow-up|20|||
164539978|NCT01830855|594350539|FG002|Overall Study|Lost to Follow-up|23|||
164539979|NCT01830855|594350540|FG003|Overall Study|Lost to Follow-up|33|||
164539980|NCT01950247|594350544|FG000|Overall Study|Withdrawal by Subject|28|||
164539981|NCT01950247|594350545|FG001|Overall Study|Withdrawal by Subject|13|||
164653111|NCT01621490|594757069|FG006|Overall Study|Maximum clinical benefit|1|||
164653112|NCT01621490|594757070|FG007|Overall Study|Maximum clinical benefit|2|||
164653113|NCT01621490|594757071|FG008|Overall Study|Maximum clinical benefit|2|||
164653114|NCT01621490|594757072|FG009|Overall Study|Maximum clinical benefit|0|||
164653115|NCT01621490|594757073|FG010|Overall Study|Maximum clinical benefit|0|||
164653116|NCT01621490|594757063|FG000|Overall Study|Withdrawal by Subject|1|||
164653117|NCT01621490|594757064|FG001|Overall Study|Withdrawal by Subject|0|||
164653118|NCT01621490|594757065|FG002|Overall Study|Withdrawal by Subject|0|||
164653119|NCT01621490|594757066|FG003|Overall Study|Withdrawal by Subject|0|||
164653120|NCT01621490|594757067|FG004|Overall Study|Withdrawal by Subject|0|||
164653121|NCT01621490|594757068|FG005|Overall Study|Withdrawal by Subject|1|||
164653122|NCT01621490|594757069|FG006|Overall Study|Withdrawal by Subject|0|||
164653123|NCT01621490|594757070|FG007|Overall Study|Withdrawal by Subject|0|||
164653124|NCT01621490|594757071|FG008|Overall Study|Withdrawal by Subject|0|||
164653125|NCT01621490|594757072|FG009|Overall Study|Withdrawal by Subject|0|||
164653126|NCT01621490|594757073|FG010|Overall Study|Withdrawal by Subject|0|||
164653127|NCT01621490|594757063|FG000|Overall Study|Subject request to discontinue study|1|||
164653128|NCT01621490|594757064|FG001|Overall Study|Subject request to discontinue study|3|||
164653129|NCT01621490|594757065|FG002|Overall Study|Subject request to discontinue study|1|||
164653130|NCT01621490|594757066|FG003|Overall Study|Subject request to discontinue study|1|||
164539982|NCT01950247|594350544|FG000|Overall Study|Lost to Follow-up|18|||
164539983|NCT01950247|594350545|FG001|Overall Study|Lost to Follow-up|16|||
164539984|NCT01950247|594350544|FG000|Overall Study|Physician Decision|3|||
164539985|NCT01950247|594350545|FG001|Overall Study|Physician Decision|4|||
164539986|NCT01950247|594350544|FG000|Overall Study|Adverse Event|3|||
164539987|NCT01950247|594350545|FG001|Overall Study|Adverse Event|2|||
164539988|NCT01950247|594350544|FG000|Overall Study|Death|1|||
164539989|NCT01950247|594350545|FG001|Overall Study|Death|1|||
164539990|NCT01950247|594350544|FG000|Overall Study|Not Defined|4|||
164539991|NCT01950247|594350545|FG001|Overall Study|Not Defined|10|||
164539992|NCT01798992|594350548|FG000|Overall Study|Administrative withdrawal|0|||
164539993|NCT01798992|594350549|FG001|Overall Study|Administrative withdrawal|1|||
164539994|NCT01798992|594350550|FG002|Overall Study|Administrative withdrawal|0|||
164539995|NCT01798992|594350551|FG003|Overall Study|Administrative withdrawal|1|||
164539996|NCT01798992|594350548|FG000|Overall Study|Lost to Follow-up|0|||
164539997|NCT01798992|594350549|FG001|Overall Study|Lost to Follow-up|1|||
164539998|NCT01798992|594350550|FG002|Overall Study|Lost to Follow-up|1|||
164539999|NCT01798992|594350551|FG003|Overall Study|Lost to Follow-up|0|||
164540000|NCT01798992|594350548|FG000|Overall Study|Insufficient biopsy tissue|0|||
164540001|NCT01798992|594350549|FG001|Overall Study|Insufficient biopsy tissue|0|||
164540002|NCT01798992|594350550|FG002|Overall Study|Insufficient biopsy tissue|1|||
164540003|NCT01798992|594350551|FG003|Overall Study|Insufficient biopsy tissue|0|||
164540004|NCT00434421|594350552|FG000|Overall Study|Withdrawal by Subject|1|||
164540005|NCT00434421|594350552|FG000|Overall Study|Non-compliance with study treatment|1|||
164540006|NCT03842163|594350553|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
164540007|NCT03842163|594350553|FG000|Overall Study|Scintigraphy was not performed|44|||
164540008|NCT01187550|594350555|FG000|Overall Study|Protocol Violation|3|||
164540009|NCT01187550|594350556|FG001|Overall Study|Protocol Violation|1|||
164540010|NCT01187550|594350555|FG000|Overall Study|Other|3|||
164540011|NCT01187550|594350556|FG001|Overall Study|Other|0|||
164540012|NCT01187550|594350555|FG000|Overall Study|Randomized but not treated|8|||
164540013|NCT01187550|594350556|FG001|Overall Study|Randomized but not treated|0|||
164540014|NCT00129623|594350557|FG000|Overall Study|Adverse Event|3|||
164540015|NCT00129623|594350558|FG001|Overall Study|Adverse Event|7|||
164540016|NCT00129623|594350557|FG000|Overall Study|Refused Treatment|5|||
164540017|NCT00129623|594350558|FG001|Overall Study|Refused Treatment|3|||
164540018|NCT00129623|594350557|FG000|Overall Study|Failure to Return|1|||
164540019|NCT00129623|594350558|FG001|Overall Study|Failure to Return|1|||
164540020|NCT00129623|594350557|FG000|Overall Study|Relocated job out of state|1|||
164540021|NCT00129623|594350558|FG001|Overall Study|Relocated job out of state|0|||
164540022|NCT00129623|594350557|FG000|Overall Study|Uncertainty to return|0|||
164540023|NCT00129623|594350558|FG001|Overall Study|Uncertainty to return|1|||
164540024|NCT00596934|594350559|FG000|Overall Study|Protocol Violation|1|||
164540025|NCT00596934|594350559|FG000|Overall Study|Withdrawal by Subject|1|||
164540026|NCT01296035|594350560|FG000|Overall Study|Withdrawal by Subject|1|||
164540027|NCT01807923|594350564|FG000|Overall Study|Adverse Event|2|||
164540028|NCT01807923|594350565|FG001|Overall Study|Adverse Event|1|||
164540029|NCT01807923|594350566|FG002|Overall Study|Adverse Event|2|||
164540030|NCT01807923|594350564|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
164540031|NCT01807923|594350565|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
164540032|NCT01807923|594350566|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
164540033|NCT01807923|594350564|FG000|Overall Study|Physician Decision|0|||
164540034|NCT01807923|594350565|FG001|Overall Study|Physician Decision|0|||
164540035|NCT01807923|594350566|FG002|Overall Study|Physician Decision|1|||
164540036|NCT01807923|594350564|FG000|Overall Study|Not Eligible (Genotype)|0|||
164540037|NCT01807923|594350565|FG001|Overall Study|Not Eligible (Genotype)|0|||
164540038|NCT01807923|594350566|FG002|Overall Study|Not Eligible (Genotype)|1|||
164540039|NCT01807923|594350564|FG000|Overall Study|Randomized But Not Treated|3|||
164540040|NCT01807923|594350565|FG001|Overall Study|Randomized But Not Treated|2|||
164540041|NCT01807923|594350566|FG002|Overall Study|Randomized But Not Treated|5|||
164540042|NCT00995007|594350568|FG000|Overall Study|Withdrew consent|1|||
164540043|NCT00995007|594350569|FG001|Overall Study|Withdrew consent|0|||
164540044|NCT00995007|594350568|FG000|Overall Study|Refused further treatment|8|||
164540045|NCT00995007|594350569|FG001|Overall Study|Refused further treatment|2|||
164540046|NCT00995007|594350568|FG000|Overall Study|Toxicity|8|||
164540047|NCT00995007|594350569|FG001|Overall Study|Toxicity|0|||
164540048|NCT03933397|594350570|FG000|Overall Study|No emergency department visit|65|||
164540049|NCT03933397|594350571|FG001|Overall Study|No emergency department visit|71|||
164540050|NCT03933397|594350570|FG000|Overall Study|Missed emergency department visit|25|||
164540051|NCT03933397|594350571|FG001|Overall Study|Missed emergency department visit|30|||
164540052|NCT03933397|594350570|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
164540053|NCT03933397|594350571|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
164540054|NCT03933397|594350570|FG000|Overall Study|Withdrawal by Subject|1|||
164540055|NCT03933397|594350571|FG001|Overall Study|Withdrawal by Subject|0|||
164540056|NCT03933397|594350570|FG000|Overall Study|Physician Decision|1|||
164540057|NCT03933397|594350571|FG001|Overall Study|Physician Decision|1|||
164540058|NCT03933397|594350570|FG000|Overall Study|missing pain score|1|||
164540059|NCT03933397|594350571|FG001|Overall Study|missing pain score|1|||
164540060|NCT03933397|594350570|FG000|Overall Study|Confirmed COVID-19|1|||
164540061|NCT03933397|594350571|FG001|Overall Study|Confirmed COVID-19|2|||
164540062|NCT01237340|594350573|FG000|Overall Study|Adverse Event|3|||
164540063|NCT01237340|594350573|FG000|Overall Study|Withdrawal by Subject|1|||
164540064|NCT01237340|594350573|FG000|Overall Study|Early termination of the trial|36|||
164540065|NCT01610687|594350574|FG000|Overall Study|Lack of Efficacy|26|||
164540066|NCT01610687|594350574|FG000|Overall Study|Adverse Event|18|||
164540067|NCT01610687|594350574|FG000|Overall Study|Moved out of area|6|||
164540068|NCT01610687|594350574|FG000|Overall Study|Withdrawal by Subject|7|||
164540069|NCT01610687|594350574|FG000|Overall Study|Lost to Follow-up|4|||
164540070|NCT01610687|594350574|FG000|Overall Study|Symptom control without study medication|2|||
164540071|NCT01610687|594350574|FG000|Overall Study|Unable to make journey|1|||
164540072|NCT01610687|594350574|FG000|Overall Study|Death|1|||
164540073|NCT01610687|594350574|FG000|Overall Study|Cannabis affecting job|1|||
164540074|NCT01610687|594350574|FG000|Overall Study|Felt more alter without study medication|1|||
164540075|NCT03675776|594350577|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
164540076|NCT03675776|594350578|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
164540077|NCT03675776|594350579|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
164540078|NCT03675776|594350577|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
164540079|NCT03675776|594350578|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
164540080|NCT03675776|594350579|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
164540081|NCT01093625|594350580|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
164540082|NCT01093625|594350581|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
164540083|NCT01093625|594350580|FG000|2-Week Visit|Withdrawal by Subject|1|||
164540084|NCT01093625|594350581|FG001|2-Week Visit|Withdrawal by Subject|0|||
164540085|NCT01093625|594350580|FG000|1-Month Visit|Lost to Follow-up|2|||
164540086|NCT01093625|594350581|FG001|1-Month Visit|Lost to Follow-up|0|||
164540087|NCT01093625|594350580|FG000|3-Month Visit|Lost to Follow-up|2|||
164540088|NCT01093625|594350581|FG001|3-Month Visit|Lost to Follow-up|0|||
164540089|NCT01093625|594350580|FG000|6-Month Visit|Withdrawal by Subject|6|||
164540090|NCT01093625|594350581|FG001|6-Month Visit|Withdrawal by Subject|7|||
164540091|NCT01093625|594350580|FG000|6-Month Visit|Lost to Follow-up|2|||
164540092|NCT01093625|594350581|FG001|6-Month Visit|Lost to Follow-up|2|||
164540093|NCT01093625|594350580|FG000|1-Year Visit|Lost to Follow-up|5|||
164540094|NCT01093625|594350581|FG001|1-Year Visit|Lost to Follow-up|3|||
164540095|NCT00698932|594350582|FG000|Overall Study|Adverse Event|0|||
164540096|NCT00698932|594350583|FG001|Overall Study|Adverse Event|2|||
164540097|NCT00698932|594350582|FG000|Overall Study|Incorrect enrollment|0|||
164540098|NCT00698932|594350583|FG001|Overall Study|Incorrect enrollment|2|||
164540099|NCT00698932|594350582|FG000|Overall Study|Study specific discontinuation criteria|3|||
164540100|NCT00698932|594350583|FG001|Overall Study|Study specific discontinuation criteria|4|||
164540101|NCT00698932|594350582|FG000|Overall Study|Withdrawal by Subject|11|||
164540102|NCT00698932|594350583|FG001|Overall Study|Withdrawal by Subject|23|||
164540103|NCT00698932|594350582|FG000|Overall Study|Lost to Follow-up|6|||
164540104|NCT00698932|594350583|FG001|Overall Study|Lost to Follow-up|1|||
164540105|NCT00698932|594350582|FG000|Overall Study|Severe non-compliance to protocol|1|||
164540106|NCT00698932|594350583|FG001|Overall Study|Severe non-compliance to protocol|2|||
164190536|NCT03428100|593066307|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
164190537|NCT03428100|593066308|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
164190538|NCT03428100|593066309|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
164190539|NCT03428100|593066310|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
164190540|NCT03428100|593066311|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
164190541|NCT03428100|593066312|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
164190542|NCT03428100|593066313|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
164190543|NCT03428100|593066314|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
164190544|NCT03428100|593066315|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
164190545|NCT03428100|593066316|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
164190546|NCT03428100|593066317|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
164190547|NCT03428100|593066318|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
164190548|NCT03428100|593066300|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190549|NCT03428100|593066301|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190550|NCT03428100|593066302|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190551|NCT03428100|593066303|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190552|NCT03428100|593066304|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190553|NCT03428100|593066305|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190554|NCT03428100|593066306|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
164190555|NCT03428100|593066307|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164302038|NCT03847896|593482507|FG003|Overall Study|Other reasons|2|||
164540107|NCT00698932|594350582|FG000|Overall Study|Safety reasons|0|||
164540108|NCT00698932|594350583|FG001|Overall Study|Safety reasons|2|||
164540109|NCT00698932|594350582|FG000|Overall Study|Death|1|||
164540110|NCT00698932|594350583|FG001|Overall Study|Death|0|||
164540111|NCT02014740|594350584|FG000|Overall Study|Lost to Follow-up|4|||
164540112|NCT02014740|594350585|FG001|Overall Study|Lost to Follow-up|4|||
164540113|NCT02014740|594350584|FG000|Overall Study|Withdrawal by Subject|2|||
164540114|NCT02014740|594350585|FG001|Overall Study|Withdrawal by Subject|1|||
164540115|NCT02281357|594350586|FG000|Overall Study|Adverse Event|2|||
164540116|NCT02281357|594350587|FG001|Overall Study|Adverse Event|1|||
164540117|NCT02281357|594350586|FG000|Overall Study|Lost to Follow-up|1|||
164540118|NCT02281357|594350587|FG001|Overall Study|Lost to Follow-up|0|||
164540119|NCT02281357|594350586|FG000|Overall Study|Withdrawal by Subject|4|||
164540120|NCT02281357|594350587|FG001|Overall Study|Withdrawal by Subject|3|||
164540121|NCT01162239|594350588|FG000|Treatment Phase|Withdrawal by Subject|1|||
164540122|NCT01162239|594350589|FG001|Treatment Phase|Withdrawal by Subject|3|||
164540123|NCT01162239|594350590|FG002|Treatment Phase|Withdrawal by Subject|2|||
164540124|NCT01162239|594350591|FG003|Treatment Phase|Withdrawal by Subject|3|||
164540125|NCT01162239|594350588|FG000|Treatment Phase|Death|0|||
164540126|NCT01162239|594350589|FG001|Treatment Phase|Death|0|||
164540127|NCT01162239|594350590|FG002|Treatment Phase|Death|0|||
164540128|NCT01162239|594350591|FG003|Treatment Phase|Death|1|||
164540129|NCT01162239|594350588|FG000|Treatment Phase|Lost to Follow-up|5|||
164540130|NCT01162239|594350589|FG001|Treatment Phase|Lost to Follow-up|4|||
164540131|NCT01162239|594350590|FG002|Treatment Phase|Lost to Follow-up|2|||
164540132|NCT01162239|594350591|FG003|Treatment Phase|Lost to Follow-up|1|||
164540133|NCT01162239|594350588|FG000|Extended Follow-up|Lost to Follow-up|8|||
164540134|NCT01162239|594350589|FG001|Extended Follow-up|Lost to Follow-up|13|||
164540135|NCT01162239|594350590|FG002|Extended Follow-up|Lost to Follow-up|8|||
164540136|NCT01162239|594350591|FG003|Extended Follow-up|Lost to Follow-up|6|||
164540137|NCT06132425|594350592|FG000|Overall Study|Withdrawal by Subject|3|||
164540138|NCT06132425|594350593|FG001|Overall Study|Withdrawal by Subject|0|||
164540139|NCT06132425|594350592|FG000|Overall Study|Did not follow study instructions|0|||
164540140|NCT06132425|594350593|FG001|Overall Study|Did not follow study instructions|2|||
164540141|NCT06132425|594350592|FG000|Overall Study|Lost to Follow-up|3|||
164540142|NCT06132425|594350593|FG001|Overall Study|Lost to Follow-up|5|||
164540143|NCT04448756|594350596|FG000|Overall Study|Adverse Event|0|||
164540144|NCT04448756|594350597|FG001|Overall Study|Adverse Event|1|||
164540145|NCT04448756|594350598|FG002|Overall Study|Adverse Event|0|||
164540146|NCT04448756|594350596|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
164540147|NCT04448756|594350597|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
164540148|NCT04448756|594350598|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
164540149|NCT04448756|594350596|FG000|Overall Study|Withdrawal by Subject|0|||
164540150|NCT04448756|594350597|FG001|Overall Study|Withdrawal by Subject|3|||
164540151|NCT04448756|594350598|FG002|Overall Study|Withdrawal by Subject|1|||
164540152|NCT04448756|594350596|FG000|Overall Study|Death|2|||
164540153|NCT04448756|594350597|FG001|Overall Study|Death|1|||
164540154|NCT04448756|594350598|FG002|Overall Study|Death|0|||
164540155|NCT02733185|594350599|FG000|Overall Study|Withdrawal by Subject|12|||
164540156|NCT02733185|594350600|FG001|Overall Study|Withdrawal by Subject|10|||
164540157|NCT02733185|594350601|FG002|Overall Study|Withdrawal by Subject|17|||
164540158|NCT02733185|594350602|FG003|Overall Study|Withdrawal by Subject|21|||
164540159|NCT02733185|594350599|FG000|Overall Study|Death|46|||
164540160|NCT02733185|594350600|FG001|Overall Study|Death|34|||
164540161|NCT02733185|594350601|FG002|Overall Study|Death|35|||
164540162|NCT02733185|594350602|FG003|Overall Study|Death|43|||
164540163|NCT02733185|594350599|FG000|Overall Study|Lost to Follow-up|17|||
164540164|NCT02733185|594350600|FG001|Overall Study|Lost to Follow-up|18|||
164540165|NCT02733185|594350601|FG002|Overall Study|Lost to Follow-up|16|||
164540166|NCT02733185|594350602|FG003|Overall Study|Lost to Follow-up|11|||
164540167|NCT02499770|594350606|FG000|Overall Study|Death|17|||
164540168|NCT02499770|594350607|FG001|Overall Study|Death|56|||
164540169|NCT02499770|594350606|FG000|Overall Study|Study completion|1|||
164540170|NCT02499770|594350607|FG001|Overall Study|Study completion|10|||
164540171|NCT02499770|594350606|FG000|Overall Study|Withdrawal by Subject|0|||
164540172|NCT02499770|594350607|FG001|Overall Study|Withdrawal by Subject|7|||
164540173|NCT02499770|594350606|FG000|Overall Study|Lost to Follow-up|0|||
164540174|NCT02499770|594350607|FG001|Overall Study|Lost to Follow-up|2|||
164540175|NCT02499770|594350606|FG000|Overall Study|Subject declined further treatment|1|||
164540176|NCT02499770|594350607|FG001|Overall Study|Subject declined further treatment|0|||
164540177|NCT02499770|594350606|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
164540178|NCT02499770|594350607|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
164190556|NCT03428100|593066308|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164540179|NCT02499770|594350606|FG000|Overall Study|Randomized but not enrolled|0|||
164540180|NCT02499770|594350607|FG001|Overall Study|Randomized but not enrolled|1|||
164540181|NCT02129205|594350610|FG000|Overall Study|Withdrawal by Subject|0|||
164540182|NCT02129205|594350611|FG001|Overall Study|Withdrawal by Subject|0|||
164540183|NCT02129205|594350612|FG002|Overall Study|Withdrawal by Subject|0|||
164540184|NCT02129205|594350613|FG003|Overall Study|Withdrawal by Subject|0|||
164540185|NCT02129205|594350614|FG004|Overall Study|Withdrawal by Subject|1|||
164540186|NCT02129205|594350615|FG005|Overall Study|Withdrawal by Subject|1|||
164540187|NCT02129205|594350616|FG006|Overall Study|Withdrawal by Subject|1|||
164540188|NCT02129205|594350617|FG007|Overall Study|Withdrawal by Subject|0|||
164540189|NCT02129205|594350618|FG008|Overall Study|Withdrawal by Subject|1|||
164540190|NCT02129205|594350619|FG009|Overall Study|Withdrawal by Subject|0|||
164540191|NCT02129205|594350610|FG000|Overall Study|Other|1|||
164540192|NCT02129205|594350611|FG001|Overall Study|Other|0|||
164540193|NCT02129205|594350612|FG002|Overall Study|Other|0|||
164540194|NCT02129205|594350613|FG003|Overall Study|Other|0|||
164540195|NCT02129205|594350614|FG004|Overall Study|Other|2|||
164540196|NCT02129205|594350615|FG005|Overall Study|Other|3|||
164540197|NCT02129205|594350616|FG006|Overall Study|Other|3|||
164540198|NCT02129205|594350617|FG007|Overall Study|Other|2|||
164540199|NCT02129205|594350618|FG008|Overall Study|Other|1|||
164540200|NCT02129205|594350619|FG009|Overall Study|Other|0|||
164540201|NCT02877927|594350620|FG000|Overall Study|Adverse Event|1|||
164540202|NCT02877927|594350621|FG001|Overall Study|Adverse Event|0|||
164540203|NCT02877927|594350620|FG000|Overall Study|Lost to Follow-up|37|||
164540204|NCT02877927|594350621|FG001|Overall Study|Lost to Follow-up|38|||
164540205|NCT02877927|594350620|FG000|Overall Study|Withdrawal by Subject|11|||
164540206|NCT02877927|594350621|FG001|Overall Study|Withdrawal by Subject|12|||
164540207|NCT02877927|594350620|FG000|Overall Study|Physician Decision|0|||
164540208|NCT02877927|594350621|FG001|Overall Study|Physician Decision|1|||
164540209|NCT02877927|594350620|FG000|Overall Study|Missed EOT/PTE Visit|5|||
164540210|NCT02877927|594350621|FG001|Overall Study|Missed EOT/PTE Visit|6|||
164540211|NCT00708175|594350622|FG000|Overall Study|Adverse Event|4|||
164540212|NCT00708175|594350623|FG001|Overall Study|Adverse Event|5|||
164540213|NCT00708175|594350622|FG000|Overall Study|Protocol Violation|2|||
164540214|NCT00708175|594350623|FG001|Overall Study|Protocol Violation|3|||
164540215|NCT00708175|594350622|FG000|Overall Study|Lost to Follow-up|5|||
164540216|NCT00708175|594350623|FG001|Overall Study|Lost to Follow-up|3|||
164540217|NCT00708175|594350622|FG000|Overall Study|Withdrawal by Subject|5|||
164540218|NCT00708175|594350623|FG001|Overall Study|Withdrawal by Subject|7|||
164540219|NCT00708175|594350622|FG000|Overall Study|BMD loss >7%|2|||
164540220|NCT00708175|594350623|FG001|Overall Study|BMD loss >7%|3|||
164540221|NCT01093326|594350625|FG000|Overall Study|Death|0|||
164540222|NCT01093326|594350626|FG001|Overall Study|Death|1|||
164540223|NCT01093326|594350627|FG002|Overall Study|Death|0|||
164540224|NCT01093326|594350625|FG000|Overall Study|Lack of Efficacy|7|||
164540225|NCT01093326|594350626|FG001|Overall Study|Lack of Efficacy|6|||
164540226|NCT01093326|594350627|FG002|Overall Study|Lack of Efficacy|3|||
164540227|NCT01093326|594350625|FG000|Overall Study|Lost to Follow-up|2|||
164540228|NCT01093326|594350626|FG001|Overall Study|Lost to Follow-up|5|||
164540229|NCT01093326|594350627|FG002|Overall Study|Lost to Follow-up|4|||
164540230|NCT01093326|594350625|FG000|Overall Study|Physician Decision|3|||
164540231|NCT01093326|594350626|FG001|Overall Study|Physician Decision|1|||
164540232|NCT01093326|594350627|FG002|Overall Study|Physician Decision|3|||
164540233|NCT01093326|594350625|FG000|Overall Study|Withdrawal by Subject|30|||
164540234|NCT01093326|594350626|FG001|Overall Study|Withdrawal by Subject|27|||
164540235|NCT01093326|594350627|FG002|Overall Study|Withdrawal by Subject|26|||
164540236|NCT01093326|594350625|FG000|Overall Study|Adverse Event|2|||
164540237|NCT01093326|594350626|FG001|Overall Study|Adverse Event|1|||
164540238|NCT01093326|594350627|FG002|Overall Study|Adverse Event|4|||
164540239|NCT01093326|594350625|FG000|Overall Study|Other|0|||
164540240|NCT01093326|594350626|FG001|Overall Study|Other|0|||
164540241|NCT01093326|594350627|FG002|Overall Study|Other|1|||
164540242|NCT04435782|594350628|FG000|Overall Study|Study terminated by sponsor|4|||
164540243|NCT03672461|594350629|FG000|Overall Study|COVID Related|4|||
164540244|NCT03672461|594350630|FG001|Overall Study|COVID Related|2|||
164540245|NCT03672461|594350629|FG000|Overall Study|Adverse Event|2|||
164540246|NCT03672461|594350630|FG001|Overall Study|Adverse Event|0|||
164540247|NCT03672461|594350629|FG000|Overall Study|Serious Adverse Event|0|||
164540248|NCT03672461|594350630|FG001|Overall Study|Serious Adverse Event|1|||
164540249|NCT03672461|594350629|FG000|Overall Study|Too Busy|3|||
164540250|NCT03672461|594350630|FG001|Overall Study|Too Busy|1|||
164540251|NCT03672461|594350629|FG000|Overall Study|Lost to Follow-up|1|||
164540252|NCT03672461|594350630|FG001|Overall Study|Lost to Follow-up|2|||
164540253|NCT03672461|594350629|FG000|Overall Study|Family|2|||
164540254|NCT03672461|594350630|FG001|Overall Study|Family|2|||
164540255|NCT03672461|594350629|FG000|Overall Study|No remote technology access|0|||
164540256|NCT03672461|594350630|FG001|Overall Study|No remote technology access|1|||
164540257|NCT03672461|594350629|FG000|Overall Study|Withdrawal by Subject|1|||
164540258|NCT03672461|594350630|FG001|Overall Study|Withdrawal by Subject|0|||
164540259|NCT03672461|594350629|FG000|Overall Study|Cannot tolerate intervention|1|||
164540260|NCT03672461|594350630|FG001|Overall Study|Cannot tolerate intervention|0|||
164540261|NCT03672461|594350629|FG000|Overall Study|Incomplete outcome data|6|||
164540262|NCT03672461|594350630|FG001|Overall Study|Incomplete outcome data|1|||
164540263|NCT04225806|594350631|FG000|Overall Study|Trial termination|15|||
164540264|NCT07052682|594350634|FG000|Overall Study|Withdrawal by Subject|4|||
164540265|NCT05460273|594350635|FG000|Overall Study|Death|43|||
164540266|NCT05460273|594350636|FG001|Overall Study|Death|9|||
164540267|NCT05460273|594350635|FG000|Overall Study|Lost to Follow-up|7|||
164540268|NCT05460273|594350636|FG001|Overall Study|Lost to Follow-up|0|||
164540269|NCT05460273|594350635|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
164540270|NCT05460273|594350636|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
164540271|NCT04124614|594350637|FG000|Placebo Run-in Period|Not Randomized|34|||
164540272|NCT04124614|594350638|FG001|Placebo Run-in Period|Not Randomized|0|||
164190557|NCT03428100|593066309|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190558|NCT03428100|593066310|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190559|NCT03428100|593066311|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190560|NCT03428100|593066312|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190561|NCT03428100|593066313|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190562|NCT03428100|593066314|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190563|NCT03428100|593066315|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190564|NCT03428100|593066316|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190565|NCT03428100|593066317|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190566|NCT03428100|593066318|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
164190567|NCT03428100|593066300|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
164190568|NCT03428100|593066301|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
164190569|NCT03428100|593066302|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
164190570|NCT03428100|593066303|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
164190571|NCT03428100|593066304|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
164190572|NCT03428100|593066305|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
164190573|NCT03428100|593066306|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
164190574|NCT03428100|593066307|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
164190575|NCT03428100|593066308|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
164190576|NCT03428100|593066309|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
164190577|NCT03428100|593066310|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
164190578|NCT03428100|593066311|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
164190579|NCT03428100|593066312|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
164190580|NCT03428100|593066313|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
164190581|NCT03428100|593066314|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
164190582|NCT03428100|593066315|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
164190583|NCT03428100|593066316|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
164190584|NCT03428100|593066317|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
164190585|NCT03428100|593066318|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
164190586|NCT03428100|593066300|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
164190587|NCT03428100|593066301|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
164190588|NCT03428100|593066302|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
164190589|NCT03428100|593066303|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
164190590|NCT03428100|593066304|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
164190591|NCT03428100|593066305|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
164190592|NCT03428100|593066306|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
164190593|NCT03428100|593066307|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
164190594|NCT03428100|593066308|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
164190595|NCT03428100|593066309|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
164190596|NCT03428100|593066310|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
164190597|NCT03428100|593066311|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
164190598|NCT03428100|593066312|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
164190599|NCT03428100|593066313|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
164190600|NCT03428100|593066314|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
164190601|NCT03428100|593066315|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
164190602|NCT03428100|593066316|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
164190603|NCT03428100|593066317|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
164190604|NCT03428100|593066318|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
164190605|NCT01048541|593066321|FG000|Overall Study|Withdrawal by Subject|1|||
164190606|NCT01048541|593066322|FG001|Overall Study|Withdrawal by Subject|0|||
164190607|NCT00922116|593066323|FG000|Overall Study|Adverse Event|4|||
164190608|NCT00922116|593066323|FG000|Overall Study|Death|1|||
164190609|NCT00922116|593066323|FG000|Overall Study|Lost to Follow-up|1|||
164190610|NCT00922116|593066323|FG000|Overall Study|Withdrawal by Subject|4|||
164190611|NCT00922116|593066323|FG000|Overall Study|Other|5|||
164190612|NCT02258659|593066325|FG000|Overall Study|Withdrawal by Subject|1|||
164190613|NCT03990051|593066326|FG000|Masked Period|Lost to Follow-up|1|||
164190614|NCT03990051|593066327|FG001|Masked Period|Lost to Follow-up|0|||
164190615|NCT03990051|593066326|FG000|Long Term Period|Death|1|||
164190616|NCT03990051|593066327|FG001|Long Term Period|Death|1|||
164190617|NCT03990051|593066326|FG000|Long Term Period|Lost to Follow-up|7|||
164190618|NCT03990051|593066327|FG001|Long Term Period|Lost to Follow-up|2|||
164190619|NCT01411852|593066328|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
164190620|NCT01411852|593066329|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
164540273|NCT04124614|594350639|FG002|Placebo Run-in Period|Not Randomized|0|||
164540274|NCT04124614|594350637|FG000|Double Blind Treatment Period|Adverse Event|0|||
164540275|NCT04124614|594350638|FG001|Double Blind Treatment Period|Adverse Event|7|||
164540276|NCT04124614|594350639|FG002|Double Blind Treatment Period|Adverse Event|22|||
164540277|NCT04124614|594350637|FG000|Double Blind Treatment Period|Death|0|||
164540278|NCT04124614|594350638|FG001|Double Blind Treatment Period|Death|0|||
164540279|NCT04124614|594350639|FG002|Double Blind Treatment Period|Death|1|||
164540280|NCT04124614|594350637|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
164540281|NCT04124614|594350638|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
164540282|NCT04124614|594350639|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
164540283|NCT04124614|594350637|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
164540284|NCT04124614|594350638|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
164540285|NCT04124614|594350639|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
164540286|NCT04124614|594350637|FG000|Double Blind Treatment Period|Physician Decision|0|||
164540287|NCT04124614|594350638|FG001|Double Blind Treatment Period|Physician Decision|0|||
164540288|NCT04124614|594350639|FG002|Double Blind Treatment Period|Physician Decision|3|||
164540289|NCT04124614|594350637|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
164540290|NCT04124614|594350638|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
164540291|NCT04124614|594350639|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
164540292|NCT04124614|594350637|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
164540293|NCT04124614|594350638|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
164540294|NCT04124614|594350639|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
164540295|NCT04124614|594350637|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
164540296|NCT04124614|594350638|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
164540297|NCT04124614|594350639|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
164540298|NCT05749952|594350640|FG000|Symphonie Aqua System - Non-Digital|Lost to Follow-up|2|||
164540299|NCT00257166|594351852|FG000|Overall Study|Adverse Event|18|||
164540300|NCT00257166|594351853|FG001|Overall Study|Adverse Event|13|||
164540301|NCT00257166|594351852|FG000|Overall Study|Laboratory abnormality|1|||
164540302|NCT00257166|594351853|FG001|Overall Study|Laboratory abnormality|0|||
164540303|NCT00257166|594351852|FG000|Overall Study|Lost to Follow-up|8|||
164540304|NCT00257166|594351853|FG001|Overall Study|Lost to Follow-up|1|||
164540305|NCT00257166|594351852|FG000|Overall Study|Withdrawal by Subject|9|||
164540306|NCT00257166|594351853|FG001|Overall Study|Withdrawal by Subject|2|||
164540307|NCT00257166|594351852|FG000|Overall Study|Other|16|||
164540308|NCT00257166|594351853|FG001|Overall Study|Other|21|||
164540309|NCT00257166|594351852|FG000|Overall Study|Randomized, but not treated|1|||
164540310|NCT00257166|594351853|FG001|Overall Study|Randomized, but not treated|0|||
164540311|NCT02592551|594351854|FG000|Overall Study|Not evaluable|1|||
164540312|NCT02592551|594351855|FG001|Overall Study|Not evaluable|3|||
164540313|NCT02592551|594351856|FG002|Overall Study|Not evaluable|0|||
164540314|NCT00761306|594351857|FG000|Overall Study|Adverse Event|5|||
164540315|NCT00761306|594351857|FG000|Overall Study|Lack of Efficacy|4|||
164540316|NCT00761306|594351857|FG000|Overall Study|Protocol Violation|2|||
164540317|NCT00761306|594351857|FG000|Overall Study|Withdrawal of Consent|3|||
164540318|NCT00761306|594351857|FG000|Overall Study|Lost to Follow-up|1|||
164540319|NCT00761306|594351857|FG000|Overall Study|Administrative or Other Reasons|5|||
164540320|NCT05162027|594351858|FG000|Overall Study|Adverse Event|1|||
164540321|NCT05162027|594351859|FG001|Overall Study|Adverse Event|0|||
164540322|NCT00993954|594351861|FG000|Overall Study|Protocol Violation|21|||
164540323|NCT00993954|594351862|FG001|Overall Study|Protocol Violation|2|||
164540324|NCT00907257|594351868|FG000|Overall Study|Adverse Event|0|||
164540325|NCT00907257|594351869|FG001|Overall Study|Adverse Event|4|||
164540326|NCT00907257|594351868|FG000|Overall Study|Protocol Violation|1|||
164540327|NCT00907257|594351869|FG001|Overall Study|Protocol Violation|2|||
164540328|NCT00907257|594351868|FG000|Overall Study|Lost to Follow-up|3|||
164540329|NCT00907257|594351869|FG001|Overall Study|Lost to Follow-up|3|||
164540330|NCT00907257|594351868|FG000|Overall Study|Withdrawal by Subject|1|||
164540331|NCT00907257|594351869|FG001|Overall Study|Withdrawal by Subject|2|||
164540332|NCT00907257|594351868|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
164540333|NCT00907257|594351869|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
164540334|NCT00907257|594351868|FG000|Overall Study|Moved|1|||
164540335|NCT00907257|594351869|FG001|Overall Study|Moved|0|||
164540336|NCT00907257|594351868|FG000|Overall Study|Personal Reasons|6|||
164653131|NCT01621490|594757067|FG004|Overall Study|Subject request to discontinue study|0|||
164540337|NCT00907257|594351869|FG001|Overall Study|Personal Reasons|1|||
164540338|NCT01873417|594351871|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
164540339|NCT01873417|594351871|FG000|Overall Study|Adverse Event|24|||
164540340|NCT01873417|594351871|FG000|Overall Study|Lost to Follow-up|2|||
164540341|NCT01873417|594351871|FG000|Overall Study|Withdrawal by Subject|2|||
164540342|NCT01873417|594351871|FG000|Overall Study|Physician Decision|3|||
164540343|NCT00785044|594351872|FG000|Overall Study|Dosed at non-participating sites|152|||
164540344|NCT00785044|594351872|FG000|Overall Study|Death|77|||
164540345|NCT00785044|594351872|FG000|Overall Study|Lost to Follow-up|266|||
164540346|NCT00785044|594351872|FG000|Overall Study|Withdrawal by Subject|1|||
164540347|NCT01628107|594351873|FG000|Overall Study|Withdrawal by Subject|17|||
164540348|NCT01628107|594351873|FG000|Overall Study|Lost to Follow-up|4|||
164540349|NCT01628107|594351873|FG000|Overall Study|Adverse Event|33|||
164540350|NCT01628107|594351873|FG000|Overall Study|Physician Decision|2|||
164540351|NCT01628107|594351873|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
164540352|NCT01628107|594351873|FG000|Overall Study|Non-compliant with Study Procedures|10|||
164540353|NCT01628107|594351873|FG000|Overall Study|Not Treated|8|||
164540354|NCT01628107|594351873|FG000|Overall Study|Sponsor Decision|11|||
164540355|NCT01628107|594351873|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
164540356|NCT01628107|594351873|FG000|Overall Study|Relocated|8|||
164540357|NCT01628107|594351873|FG000|Overall Study|Kidney Transplant|9|||
164540358|NCT01628107|594351873|FG000|Overall Study|Use of Standard of Care|9|||
164540359|NCT01069120|594351874|FG000|Overall Study|Study prematurely terminated|27|||
164540360|NCT00763971|594351875|FG000|Overall Study|Adverse Event|5|||
164540361|NCT00763971|594351876|FG001|Overall Study|Adverse Event|2|||
164540362|NCT00763971|594351877|FG002|Overall Study|Adverse Event|4|||
164540363|NCT00763971|594351875|FG000|Overall Study|Protocol Violation|3|||
164540364|NCT00763971|594351876|FG001|Overall Study|Protocol Violation|3|||
164540365|NCT00763971|594351877|FG002|Overall Study|Protocol Violation|2|||
164540366|NCT00763971|594351875|FG000|Overall Study|Withdrawal by Subject|4|||
164540367|NCT00763971|594351876|FG001|Overall Study|Withdrawal by Subject|5|||
164540368|NCT00763971|594351877|FG002|Overall Study|Withdrawal by Subject|5|||
164540369|NCT00763971|594351875|FG000|Overall Study|Lost to Follow-up|0|||
164540370|NCT00763971|594351876|FG001|Overall Study|Lost to Follow-up|1|||
164540371|NCT00763971|594351877|FG002|Overall Study|Lost to Follow-up|0|||
164540372|NCT00763971|594351875|FG000|Overall Study|Lack of Efficacy|11|||
164540373|NCT00763971|594351876|FG001|Overall Study|Lack of Efficacy|22|||
164540374|NCT00763971|594351877|FG002|Overall Study|Lack of Efficacy|54|||
164540375|NCT00763971|594351875|FG000|Overall Study|Unable to swallow capsule|2|||
164540376|NCT00763971|594351876|FG001|Overall Study|Unable to swallow capsule|1|||
164540377|NCT00763971|594351877|FG002|Overall Study|Unable to swallow capsule|1|||
164540378|NCT00763971|594351875|FG000|Overall Study|Personal reason|3|||
164540379|NCT00763971|594351876|FG001|Overall Study|Personal reason|0|||
164540380|NCT00763971|594351877|FG002|Overall Study|Personal reason|0|||
164540381|NCT00763971|594351875|FG000|Overall Study|Exclusion criteria met|1|||
164540382|NCT00763971|594351876|FG001|Overall Study|Exclusion criteria met|0|||
164540383|NCT00763971|594351877|FG002|Overall Study|Exclusion criteria met|0|||
164540384|NCT00763971|594351875|FG000|Overall Study|Sponsor decision|1|||
164540385|NCT00763971|594351876|FG001|Overall Study|Sponsor decision|0|||
164540386|NCT00763971|594351877|FG002|Overall Study|Sponsor decision|0|||
164540387|NCT00763971|594351875|FG000|Overall Study|Due to holiday season|2|||
164540388|NCT00763971|594351876|FG001|Overall Study|Due to holiday season|0|||
164540389|NCT00763971|594351877|FG002|Overall Study|Due to holiday season|1|||
164540390|NCT00763971|594351875|FG000|Overall Study|Randomization error|0|||
164540391|NCT00763971|594351876|FG001|Overall Study|Randomization error|0|||
164540392|NCT00763971|594351877|FG002|Overall Study|Randomization error|1|||
164540393|NCT00763971|594351875|FG000|Overall Study|Medical monitor decision|0|||
164540394|NCT00763971|594351876|FG001|Overall Study|Medical monitor decision|0|||
164540395|NCT00763971|594351877|FG002|Overall Study|Medical monitor decision|1|||
164540396|NCT00763971|594351875|FG000|Overall Study|Moved to another country|0|||
164540397|NCT00763971|594351876|FG001|Overall Study|Moved to another country|1|||
164540398|NCT00763971|594351877|FG002|Overall Study|Moved to another country|0|||
164540399|NCT00763971|594351875|FG000|Overall Study|Subject wanted dose reduction|0|||
164540400|NCT00763971|594351876|FG001|Overall Study|Subject wanted dose reduction|1|||
164540401|NCT00763971|594351877|FG002|Overall Study|Subject wanted dose reduction|0|||
164540402|NCT00763971|594351875|FG000|Overall Study|Lack of availability|0|||
164540403|NCT00763971|594351876|FG001|Overall Study|Lack of availability|1|||
164540404|NCT00763971|594351877|FG002|Overall Study|Lack of availability|0|||
164540405|NCT00763971|594351875|FG000|Overall Study|Performed final visit on phone|0|||
164540406|NCT00763971|594351876|FG001|Overall Study|Performed final visit on phone|1|||
164540407|NCT00763971|594351877|FG002|Overall Study|Performed final visit on phone|0|||
164540408|NCT00763971|594351875|FG000|Overall Study|Participation in 489-326 required|1|||
164540409|NCT00763971|594351876|FG001|Overall Study|Participation in 489-326 required|0|||
164540410|NCT00763971|594351877|FG002|Overall Study|Participation in 489-326 required|0|||
164540411|NCT02713542|594351878|FG000|Overall Study|Use of prohibited medication|14|||
164540412|NCT02713542|594351879|FG001|Overall Study|Use of prohibited medication|5|||
164540413|NCT02713542|594351878|FG000|Overall Study|Withdrawal by Subject|4|||
164540414|NCT02713542|594351879|FG001|Overall Study|Withdrawal by Subject|1|||
164540415|NCT03631667|594351880|FG000|Overall Study|Withdrawal by Subject|3|||
164540416|NCT00884325|594351892|FG000|Overall Study|Lost to Follow-up|1|||
164540417|NCT00884325|594351893|FG001|Overall Study|Lost to Follow-up|2|||
164540418|NCT00884325|594351892|FG000|Overall Study|Lack of Efficacy|0|||
164540419|NCT00884325|594351893|FG001|Overall Study|Lack of Efficacy|1|||
164540420|NCT00884325|594351892|FG000|Overall Study|Withdrawal by Subject|1|||
164540421|NCT00884325|594351893|FG001|Overall Study|Withdrawal by Subject|1|||
164540422|NCT00884325|594351892|FG000|Overall Study|Not provided|1|||
164540423|NCT00884325|594351893|FG001|Overall Study|Not provided|0|||
164540424|NCT01446016|594351894|FG000|Overall Study|Lost to Follow-up|3|||
164540425|NCT01446016|594351894|FG000|Overall Study|Withdrawal by Subject|1|||
164540426|NCT01446016|594351894|FG000|Overall Study|Toxicity|3|||
164540427|NCT00436618|594351901|FG000|Overall Study|Withdrawal by Subject|5|||
164540428|NCT00436618|594351902|FG001|Overall Study|Withdrawal by Subject|8|||
164540429|NCT00436618|594351903|FG002|Overall Study|Withdrawal by Subject|11|||
164540430|NCT00436618|594351901|FG000|Overall Study|Adverse Event|8|||
164540431|NCT00436618|594351902|FG001|Overall Study|Adverse Event|8|||
164540432|NCT00436618|594351903|FG002|Overall Study|Adverse Event|9|||
164540433|NCT00436618|594351901|FG000|Overall Study|Alternate Treatment|3|||
164540434|NCT00436618|594351902|FG001|Overall Study|Alternate Treatment|4|||
164540435|NCT00436618|594351903|FG002|Overall Study|Alternate Treatment|12|||
164540436|NCT00436618|594351901|FG000|Overall Study|Other Medical Problems|3|||
164540437|NCT00436618|594351902|FG001|Overall Study|Other Medical Problems|1|||
164540438|NCT00436618|594351903|FG002|Overall Study|Other Medical Problems|7|||
164540439|NCT00436618|594351901|FG000|Overall Study|Death|4|||
164540440|NCT00436618|594351902|FG001|Overall Study|Death|2|||
164540441|NCT00436618|594351903|FG002|Overall Study|Death|3|||
164540442|NCT00436618|594351901|FG000|Overall Study|New Primary or Other Reasons|6|||
164540443|NCT00436618|594351902|FG001|Overall Study|New Primary or Other Reasons|2|||
164540444|NCT00436618|594351903|FG002|Overall Study|New Primary or Other Reasons|12|||
164540445|NCT00436618|594351901|FG000|Overall Study|Still on treatment|1|||
164540446|NCT00436618|594351902|FG001|Overall Study|Still on treatment|2|||
164540447|NCT00436618|594351903|FG002|Overall Study|Still on treatment|7|||
164540448|NCT00698204|594351904|FG000|Overall Study|Withdrawal by Subject|1|||
164540449|NCT00698204|594351905|FG001|Overall Study|Withdrawal by Subject|0|||
164540450|NCT01949155|594351906|FG000|Overall Study|Lost to Follow-up|1|||
164540451|NCT01949155|594351907|FG001|Overall Study|Lost to Follow-up|0|||
164540452|NCT01949155|594351906|FG000|Overall Study|Protocol Violation|1|||
164540453|NCT01949155|594351907|FG001|Overall Study|Protocol Violation|0|||
164540454|NCT00314249|594351908|FG000|Overall Study|Adverse Event|73|||
164540455|NCT00314249|594351909|FG001|Overall Study|Adverse Event|94|||
164540456|NCT00314249|594351908|FG000|Overall Study|Lack of Efficacy|33|||
164540457|NCT00314249|594351909|FG001|Overall Study|Lack of Efficacy|24|||
164540458|NCT00314249|594351908|FG000|Overall Study|Withdrawal by Subject|21|||
164540459|NCT00314249|594351909|FG001|Overall Study|Withdrawal by Subject|28|||
164540460|NCT00314249|594351908|FG000|Overall Study|Lost to Follow-up|15|||
164540461|NCT00314249|594351909|FG001|Overall Study|Lost to Follow-up|9|||
164540462|NCT00314249|594351908|FG000|Overall Study|Physician Decision|1|||
164540463|NCT00314249|594351909|FG001|Overall Study|Physician Decision|1|||
164540464|NCT00314249|594351908|FG000|Overall Study|Withdrawn for other reasons|4|||
164540465|NCT00314249|594351909|FG001|Overall Study|Withdrawn for other reasons|1|||
164540466|NCT00314249|594351908|FG000|Overall Study|Non-Compliant|5|||
164540467|NCT00314249|594351909|FG001|Overall Study|Non-Compliant|6|||
164540468|NCT01245387|594351916|FG000|Overall Study|Lost to Follow-up|106|||
164540469|NCT01245387|594351916|FG000|Overall Study|Lack of Efficacy|195|||
164540470|NCT01245387|594351916|FG000|Overall Study|Adverse Event|9|||
164540471|NCT01245387|594351916|FG000|Overall Study|Death|3|||
164540472|NCT01245387|594351916|FG000|Overall Study|Other|131|||
164540473|NCT01245387|594351916|FG000|Overall Study|Missing discontinuation status|369|||
164540474|NCT00601705|594351917|FG000|Overall Study|Withdrawal by Subject|1|||
164540475|NCT04513665|594351918|FG000|Overall Study|Adverse Event|2|||
164190621|NCT01411852|593066328|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
164190622|NCT01411852|593066329|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
164190623|NCT01411852|593066328|FG000|Prehospital Intervention Phase|Found to be under age|0|||
164190624|NCT01411852|593066329|FG001|Prehospital Intervention Phase|Found to be under age|1|||
164190625|NCT01411852|593066328|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
164190626|NCT01411852|593066329|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
164190627|NCT01411852|593066328|FG000|Hospital Intervention Phase|Severe head injury|5|||
164190628|NCT01411852|593066329|FG001|Hospital Intervention Phase|Severe head injury|4|||
164190629|NCT01411852|593066328|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
164540476|NCT04513665|594351919|FG001|Overall Study|Adverse Event|0|||
164540477|NCT04513665|594351918|FG000|Overall Study|Lack of Efficacy|14|||
164540478|NCT04513665|594351919|FG001|Overall Study|Lack of Efficacy|0|||
164540479|NCT02146599|594351923|FG000|Overall Study|Failed to meet inclusion criteria|5|||
164540480|NCT02101021|594351927|FG000|Overall Study|Death|4|||
164540481|NCT02101021|594351928|FG001|Overall Study|Death|3|||
164540482|NCT02101021|594351929|FG002|Overall Study|Death|6|||
164540483|NCT02101021|594351930|FG003|Overall Study|Death|0|||
164540484|NCT02101021|594351931|FG004|Overall Study|Death|3|||
164540485|NCT02101021|594351927|FG000|Overall Study|Withdrew Consent from study|1|||
164540486|NCT02101021|594351928|FG001|Overall Study|Withdrew Consent from study|1|||
164540487|NCT02101021|594351929|FG002|Overall Study|Withdrew Consent from study|0|||
164540488|NCT02101021|594351930|FG003|Overall Study|Withdrew Consent from study|2|||
164540489|NCT02101021|594351931|FG004|Overall Study|Withdrew Consent from study|0|||
164540490|NCT02101021|594351927|FG000|Overall Study|Lost to Follow-up|1|||
164540491|NCT02101021|594351928|FG001|Overall Study|Lost to Follow-up|0|||
164540492|NCT02101021|594351929|FG002|Overall Study|Lost to Follow-up|0|||
164540493|NCT02101021|594351930|FG003|Overall Study|Lost to Follow-up|0|||
164540494|NCT02101021|594351931|FG004|Overall Study|Lost to Follow-up|0|||
164540495|NCT02101021|594351927|FG000|Overall Study|Study Terminated by Sponsor|1|||
164540496|NCT02101021|594351928|FG001|Overall Study|Study Terminated by Sponsor|0|||
164540497|NCT02101021|594351929|FG002|Overall Study|Study Terminated by Sponsor|1|||
164540498|NCT02101021|594351930|FG003|Overall Study|Study Terminated by Sponsor|1|||
164540499|NCT02101021|594351931|FG004|Overall Study|Study Terminated by Sponsor|1|||
164540500|NCT01368042|594351932|FG000|Overall Study|Death|14|||
164540501|NCT01368042|594351932|FG000|Overall Study|Protocol Violation|11|||
164540502|NCT01368042|594351932|FG000|Overall Study|Lost to Follow-up|4|||
164540503|NCT01368042|594351932|FG000|Overall Study|Transplanted|1|||
164540504|NCT02632721|594351933|FG000|Overall Study|Adverse Event|0|||
164540505|NCT02632721|594351934|FG001|Overall Study|Adverse Event|0|||
164540506|NCT02632721|594351935|FG002|Overall Study|Adverse Event|2|||
164540507|NCT02632721|594351936|FG003|Overall Study|Adverse Event|5|||
164540508|NCT02632721|594351937|FG004|Overall Study|Adverse Event|3|||
164540509|NCT02632721|594351933|FG000|Overall Study|Dose limiting toxicity|0|||
164540510|NCT02632721|594351934|FG001|Overall Study|Dose limiting toxicity|0|||
164540511|NCT02632721|594351935|FG002|Overall Study|Dose limiting toxicity|0|||
164540512|NCT02632721|594351936|FG003|Overall Study|Dose limiting toxicity|1|||
164540513|NCT02632721|594351937|FG004|Overall Study|Dose limiting toxicity|0|||
164540514|NCT02632721|594351933|FG000|Overall Study|Progressive disease|3|||
164540515|NCT02632721|594351934|FG001|Overall Study|Progressive disease|0|||
164540516|NCT02632721|594351935|FG002|Overall Study|Progressive disease|4|||
164540517|NCT02632721|594351936|FG003|Overall Study|Progressive disease|6|||
164540518|NCT02632721|594351937|FG004|Overall Study|Progressive disease|5|||
164540519|NCT02632721|594351933|FG000|Overall Study|Refused to continue taking trial medication|0|||
164540520|NCT02632721|594351934|FG001|Overall Study|Refused to continue taking trial medication|1|||
164540521|NCT02632721|594351935|FG002|Overall Study|Refused to continue taking trial medication|1|||
164540522|NCT02632721|594351936|FG003|Overall Study|Refused to continue taking trial medication|1|||
164540523|NCT02632721|594351937|FG004|Overall Study|Refused to continue taking trial medication|2|||
164540524|NCT02632721|594351933|FG000|Overall Study|Inadequate clinical condition|0|||
164540525|NCT02632721|594351934|FG001|Overall Study|Inadequate clinical condition|0|||
164540526|NCT02632721|594351935|FG002|Overall Study|Inadequate clinical condition|0|||
164540527|NCT02632721|594351936|FG003|Overall Study|Inadequate clinical condition|0|||
164540528|NCT02632721|594351937|FG004|Overall Study|Inadequate clinical condition|1|||
164540529|NCT02632721|594351933|FG000|Overall Study|No meet eligibility|0|||
164540530|NCT02632721|594351934|FG001|Overall Study|No meet eligibility|0|||
164540531|NCT02632721|594351935|FG002|Overall Study|No meet eligibility|0|||
164540532|NCT02632721|594351936|FG003|Overall Study|No meet eligibility|0|||
164540533|NCT02632721|594351937|FG004|Overall Study|No meet eligibility|1|||
164540534|NCT02632721|594351933|FG000|Overall Study|Allergic reaction|0|||
164540535|NCT02632721|594351934|FG001|Overall Study|Allergic reaction|0|||
164540536|NCT02632721|594351935|FG002|Overall Study|Allergic reaction|0|||
164540537|NCT02632721|594351936|FG003|Overall Study|Allergic reaction|1|||
164540538|NCT02632721|594351937|FG004|Overall Study|Allergic reaction|0|||
164540539|NCT02632721|594351933|FG000|Overall Study|Receiving Decitabine locally|0|||
164540540|NCT02632721|594351934|FG001|Overall Study|Receiving Decitabine locally|0|||
164540541|NCT02632721|594351935|FG002|Overall Study|Receiving Decitabine locally|1|||
164540542|NCT02632721|594351936|FG003|Overall Study|Receiving Decitabine locally|0|||
164540543|NCT02632721|594351937|FG004|Overall Study|Receiving Decitabine locally|0|||
164540544|NCT02632721|594351933|FG000|Overall Study|No benefit from study treatment|1|||
164540545|NCT02632721|594351934|FG001|Overall Study|No benefit from study treatment|1|||
164540546|NCT02632721|594351935|FG002|Overall Study|No benefit from study treatment|0|||
164540547|NCT02632721|594351936|FG003|Overall Study|No benefit from study treatment|0|||
164540548|NCT02632721|594351937|FG004|Overall Study|No benefit from study treatment|1|||
164540549|NCT02632721|594351933|FG000|Overall Study|Patient wish for other treatment|0|||
164540550|NCT02632721|594351934|FG001|Overall Study|Patient wish for other treatment|1|||
164540551|NCT02632721|594351935|FG002|Overall Study|Patient wish for other treatment|0|||
164540552|NCT02632721|594351936|FG003|Overall Study|Patient wish for other treatment|0|||
164540553|NCT02632721|594351937|FG004|Overall Study|Patient wish for other treatment|0|||
164540554|NCT02632721|594351933|FG000|Overall Study|Relapsed Pneumonia|0|||
164540555|NCT02632721|594351934|FG001|Overall Study|Relapsed Pneumonia|0|||
164540556|NCT02632721|594351935|FG002|Overall Study|Relapsed Pneumonia|0|||
164540557|NCT02632721|594351936|FG003|Overall Study|Relapsed Pneumonia|0|||
164540558|NCT02632721|594351937|FG004|Overall Study|Relapsed Pneumonia|1|||
164540559|NCT02632721|594351933|FG000|Overall Study|Therapy refractory AML|0|||
164540560|NCT02632721|594351934|FG001|Overall Study|Therapy refractory AML|0|||
164540561|NCT02632721|594351935|FG002|Overall Study|Therapy refractory AML|0|||
164540562|NCT02632721|594351936|FG003|Overall Study|Therapy refractory AML|0|||
164540563|NCT02632721|594351937|FG004|Overall Study|Therapy refractory AML|1|||
164540564|NCT02632721|594351933|FG000|Overall Study|Increase of white blood cell count|0|||
164540565|NCT02632721|594351934|FG001|Overall Study|Increase of white blood cell count|0|||
164540566|NCT02632721|594351935|FG002|Overall Study|Increase of white blood cell count|0|||
164540567|NCT02632721|594351936|FG003|Overall Study|Increase of white blood cell count|0|||
164540568|NCT02632721|594351937|FG004|Overall Study|Increase of white blood cell count|1|||
164540569|NCT02632721|594351933|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
164540570|NCT02632721|594351934|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
164540571|NCT02632721|594351935|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
164540572|NCT02632721|594351936|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
164540573|NCT02632721|594351937|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
164540574|NCT00544648|594351938|FG000|Overall Study|Withdrawal by Subject|1|||
164540575|NCT00544648|594351939|FG001|Overall Study|Withdrawal by Subject|0|||
164540576|NCT00544648|594351938|FG000|Overall Study|Adverse Event|1|||
164540577|NCT00544648|594351939|FG001|Overall Study|Adverse Event|1|||
164540578|NCT00544648|594351938|FG000|Overall Study|progression of disease|1|||
164540579|NCT00544648|594351939|FG001|Overall Study|progression of disease|0|||
164540580|NCT02966223|594351943|FG000|Overall Study|Physician Decision|3|||
164540581|NCT02966223|594351943|FG000|Overall Study|Withdrawal by Subject|11|||
164540582|NCT02966223|594351943|FG000|Overall Study|Lost to Follow-up|1|||
164540583|NCT01326728|594351944|FG000|Overall Study|Death|13|||
164540584|NCT01326728|594351945|FG001|Overall Study|Death|0|||
164540585|NCT01326728|594351944|FG000|Overall Study|Early closure of study|34|||
164540586|NCT01326728|594351945|FG001|Overall Study|Early closure of study|9|||
164540587|NCT01184053|594351946|FG000|Overall Study|progression while on treatment|3|||
164540588|NCT04399122|594351949|FG000|Overall Study|Lost to Follow-up|2|||
164540589|NCT04399122|594351950|FG001|Overall Study|Lost to Follow-up|0|||
164540590|NCT04399122|594351949|FG000|Overall Study|Withdrawal by Subject|1|||
164540591|NCT04399122|594351950|FG001|Overall Study|Withdrawal by Subject|0|||
164540592|NCT01174238|594351954|FG000|Overall Study|Lost to Follow-up|2|||
164540593|NCT02322229|594351956|FG000|Overall Study|Physician Decision|2|||
164540594|NCT03065023|594351957|FG000|Overall Study|Progressive Disease|0|||
164540595|NCT03065023|594351958|FG001|Overall Study|Progressive Disease|1|||
164540596|NCT03065023|594351959|FG002|Overall Study|Progressive Disease|0|||
164540597|NCT03065023|594351960|FG003|Overall Study|Progressive Disease|0|||
164540598|NCT03065023|594351961|FG004|Overall Study|Progressive Disease|0|||
164540599|NCT03065023|594351957|FG000|Overall Study|Death|2|||
164540600|NCT03065023|594351958|FG001|Overall Study|Death|0|||
164540601|NCT03065023|594351959|FG002|Overall Study|Death|1|||
164540602|NCT03065023|594351960|FG003|Overall Study|Death|1|||
164540603|NCT03065023|594351961|FG004|Overall Study|Death|0|||
164540604|NCT03065023|594351957|FG000|Overall Study|Lost to Follow-up|0|||
164540605|NCT03065023|594351958|FG001|Overall Study|Lost to Follow-up|1|||
164540606|NCT03065023|594351959|FG002|Overall Study|Lost to Follow-up|0|||
164540607|NCT03065023|594351960|FG003|Overall Study|Lost to Follow-up|0|||
164540608|NCT03065023|594351961|FG004|Overall Study|Lost to Follow-up|0|||
164540609|NCT03065023|594351957|FG000|Overall Study|Participant Decision|0|||
164540610|NCT03065023|594351958|FG001|Overall Study|Participant Decision|0|||
164540611|NCT03065023|594351959|FG002|Overall Study|Participant Decision|0|||
164540612|NCT03065023|594351960|FG003|Overall Study|Participant Decision|1|||
164540613|NCT03065023|594351961|FG004|Overall Study|Participant Decision|0|||
164540614|NCT03065023|594351957|FG000|Overall Study|Withdrawal by Subject|0|||
164540615|NCT03065023|594351958|FG001|Overall Study|Withdrawal by Subject|0|||
164540616|NCT03065023|594351959|FG002|Overall Study|Withdrawal by Subject|0|||
164540617|NCT03065023|594351960|FG003|Overall Study|Withdrawal by Subject|1|||
164540618|NCT03065023|594351961|FG004|Overall Study|Withdrawal by Subject|0|||
164540619|NCT00705432|594351962|FG000|Treatment Period|Adverse Event|45|||
164540620|NCT00705432|594351963|FG001|Treatment Period|Adverse Event|37|||
164540621|NCT00705432|594351964|FG002|Treatment Period|Adverse Event|51|||
164540622|NCT00705432|594351965|FG003|Treatment Period|Adverse Event|12|||
164540623|NCT00705432|594351966|FG004|Treatment Period|Adverse Event|8|||
164540624|NCT00705432|594351967|FG005|Treatment Period|Adverse Event|9|||
164540625|NCT00705432|594351962|FG000|Treatment Period|Treatment failure|92|||
164540626|NCT00705432|594351963|FG001|Treatment Period|Treatment failure|42|||
164540627|NCT00705432|594351964|FG002|Treatment Period|Treatment failure|33|||
164190630|NCT01411852|593066329|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
164190631|NCT01411852|593066328|FG000|Hospital Intervention Phase|Miscommunication error|1|||
164190632|NCT01411852|593066329|FG001|Hospital Intervention Phase|Miscommunication error|2|||
164540628|NCT00705432|594351965|FG003|Treatment Period|Treatment failure|25|||
164540629|NCT00705432|594351966|FG004|Treatment Period|Treatment failure|13|||
164540630|NCT00705432|594351967|FG005|Treatment Period|Treatment failure|14|||
164540631|NCT00705432|594351962|FG000|Treatment Period|Non medical reason|26|||
164540632|NCT00705432|594351963|FG001|Treatment Period|Non medical reason|32|||
164540633|NCT00705432|594351964|FG002|Treatment Period|Non medical reason|37|||
164540634|NCT00705432|594351965|FG003|Treatment Period|Non medical reason|4|||
164540635|NCT00705432|594351966|FG004|Treatment Period|Non medical reason|7|||
164540636|NCT00705432|594351967|FG005|Treatment Period|Non medical reason|7|||
164540637|NCT00705432|594351962|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
164540638|NCT00705432|594351963|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
164540639|NCT00705432|594351964|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
164540640|NCT00705432|594351965|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
164540641|NCT00705432|594351966|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
164540642|NCT00705432|594351967|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
164540643|NCT00705432|594351962|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
164540644|NCT00705432|594351963|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
164540645|NCT00705432|594351964|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
164540646|NCT00705432|594351965|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
164540647|NCT00705432|594351966|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
164540648|NCT00705432|594351967|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
164540649|NCT01102803|594351968|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
164540650|NCT01102803|594351969|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
164540651|NCT01102803|594351968|FG000|Post to Follow-Up|Lost to Follow-up|1|||
164540652|NCT01102803|594351969|FG001|Post to Follow-Up|Lost to Follow-up|3|||
164540653|NCT00521053|594351970|FG000|Observation Phase|Disease Progression|55|||
164540654|NCT00521053|594351970|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
164540655|NCT00521053|594351970|FG000|Observation Phase|Death|2|||
164540656|NCT00521053|594351970|FG000|Observation Phase|Adverse Event|1|||
164540657|NCT00521053|594351970|FG000|Observation Phase|Other non-study melanoma treatment|1|||
164540658|NCT00521053|594351970|FG000|Observation Phase|Physician Decision|1|||
164540659|NCT01557348|594351971|FG000|Overall Study|Adverse Event|6|||
164540660|NCT01557348|594351972|FG001|Overall Study|Adverse Event|16|||
164540661|NCT01557348|594351971|FG000|Overall Study|Infusion reaction event|5|||
164540662|NCT01557348|594351972|FG001|Overall Study|Infusion reaction event|5|||
164540663|NCT01557348|594351971|FG000|Overall Study|Death|7|||
164540664|NCT01557348|594351972|FG001|Overall Study|Death|4|||
164540665|NCT01557348|594351971|FG000|Overall Study|Insufficient Therapeutic Response|13|||
164540666|NCT01557348|594351972|FG001|Overall Study|Insufficient Therapeutic Response|28|||
164540667|NCT01557348|594351971|FG000|Overall Study|Withdrawal by Subject|5|||
164540668|NCT01557348|594351972|FG001|Overall Study|Withdrawal by Subject|4|||
164540669|NCT01557348|594351971|FG000|Overall Study|Lost to Follow-up|26|||
164540670|NCT01557348|594351972|FG001|Overall Study|Lost to Follow-up|22|||
164540671|NCT01557348|594351971|FG000|Overall Study|Administrative|18|||
164540672|NCT01557348|594351972|FG001|Overall Study|Administrative|11|||
164540673|NCT01667107|594351973|FG000|Overall Study|Adverse Event|4|||
164540674|NCT01667107|594351974|FG001|Overall Study|Adverse Event|3|||
164540675|NCT01667107|594351973|FG000|Overall Study|Tolerability issues|0|||
164540676|NCT01667107|594351974|FG001|Overall Study|Tolerability issues|2|||
164540677|NCT01667107|594351973|FG000|Overall Study|Protocol Violation|0|||
164540678|NCT01667107|594351974|FG001|Overall Study|Protocol Violation|1|||
164540679|NCT01667107|594351973|FG000|Overall Study|Lack of Efficacy|0|||
164540680|NCT01667107|594351974|FG001|Overall Study|Lack of Efficacy|1|||
164540681|NCT03427125|594351975|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
164540682|NCT03427125|594351976|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
164540683|NCT03427125|594351977|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
164540684|NCT05390580|594351978|FG000|Overall Study|Physician Decision|3|||
164540685|NCT05390580|594351979|FG001|Overall Study|Physician Decision|2|||
164540686|NCT04376060|594351981|FG000|Overall Study|Physician Decision|1|||
164540687|NCT04275297|594351982|FG000|Overall Study|Lost to Follow-up|1|||
164540688|NCT04275297|594351983|FG001|Overall Study|Lost to Follow-up|1|||
164540689|NCT01791803|594351984|FG000|Overall Study|Withdrawal by Subject|0|||
164540690|NCT01791803|594351985|FG001|Overall Study|Withdrawal by Subject|0|||
164540691|NCT01791803|594351986|FG002|Overall Study|Withdrawal by Subject|0|||
164540692|NCT01791803|594351987|FG003|Overall Study|Withdrawal by Subject|2|||
164540693|NCT01791803|594351984|FG000|Overall Study|Physician Decision|0|||
164540694|NCT01791803|594351985|FG001|Overall Study|Physician Decision|2|||
164540695|NCT01791803|594351986|FG002|Overall Study|Physician Decision|0|||
164540696|NCT01791803|594351987|FG003|Overall Study|Physician Decision|1|||
164540697|NCT01791803|594351984|FG000|Overall Study|Death|0|||
164653132|NCT01621490|594757068|FG005|Overall Study|Subject request to discontinue study|2|||
164653133|NCT01621490|594757069|FG006|Overall Study|Subject request to discontinue study|1|||
164653134|NCT01621490|594757070|FG007|Overall Study|Subject request to discontinue study|0|||
164653135|NCT01621490|594757071|FG008|Overall Study|Subject request to discontinue study|1|||
164540698|NCT01791803|594351985|FG001|Overall Study|Death|0|||
164540699|NCT01791803|594351986|FG002|Overall Study|Death|2|||
164540700|NCT01791803|594351987|FG003|Overall Study|Death|2|||
164540701|NCT04572854|594351988|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
164540702|NCT04572854|594351989|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
164540703|NCT04572854|594351990|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
164540704|NCT04572854|594351991|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
164540705|NCT04572854|594351988|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
164540706|NCT04572854|594351989|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
164540707|NCT04572854|594351990|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
164540708|NCT04572854|594351991|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
164540709|NCT00972777|594351994|FG000|Overall Study|Adverse Event|3|||
164540710|NCT00972777|594351995|FG001|Overall Study|Adverse Event|2|||
164540711|NCT00972777|594351994|FG000|Overall Study|Lost to Follow-up|0|||
164540712|NCT00972777|594351995|FG001|Overall Study|Lost to Follow-up|4|||
164540713|NCT00972777|594351994|FG000|Overall Study|Withdrawal by Subject|4|||
164540714|NCT00972777|594351995|FG001|Overall Study|Withdrawal by Subject|5|||
164540715|NCT00972777|594351994|FG000|Overall Study|Physician Decision|4|||
164540716|NCT00972777|594351995|FG001|Overall Study|Physician Decision|0|||
164540717|NCT00972777|594351994|FG000|Overall Study|Protocol Violation|0|||
164540718|NCT00972777|594351995|FG001|Overall Study|Protocol Violation|2|||
164540719|NCT00972777|594351994|FG000|Overall Study|Screening Failure|2|||
164540720|NCT00972777|594351995|FG001|Overall Study|Screening Failure|1|||
164540721|NCT00972777|594351994|FG000|Overall Study|Missed visit|1|||
164540722|NCT00972777|594351995|FG001|Overall Study|Missed visit|0|||
164540723|NCT04667247|594351998|FG000|Overall Study|Withdrawal by Subject|0|||
164540724|NCT04667247|594351999|FG001|Overall Study|Withdrawal by Subject|1|||
164540725|NCT02246582|594353596|FG000|Overall Study|Withdrawal by Subject|3|||
164540726|NCT02246582|594353597|FG001|Overall Study|Withdrawal by Subject|4|||
164190633|NCT01411852|593066328|FG000|Hospital Intervention Phase|CPR administered|3|||
164190634|NCT01411852|593066329|FG001|Hospital Intervention Phase|CPR administered|1|||
164190635|NCT01411852|593066328|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
164540727|NCT02060383|594353599|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
164540728|NCT02060383|594353600|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
164540729|NCT02060383|594353601|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
164540730|NCT02060383|594353602|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
164540731|NCT02060383|594353603|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
164540732|NCT02060383|594353599|FG000|Core Phase|Adverse Event|2|||
164540733|NCT02060383|594353600|FG001|Core Phase|Adverse Event|0|||
164540734|NCT02060383|594353601|FG002|Core Phase|Adverse Event|0|||
164540735|NCT02060383|594353602|FG003|Core Phase|Adverse Event|2|||
164540736|NCT02060383|594353603|FG004|Core Phase|Adverse Event|6|||
164540737|NCT02060383|594353599|FG000|Core Phase|Administrative problems|0|||
164540738|NCT02060383|594353600|FG001|Core Phase|Administrative problems|1|||
164540739|NCT02060383|594353601|FG002|Core Phase|Administrative problems|0|||
164540740|NCT02060383|594353602|FG003|Core Phase|Administrative problems|0|||
164540741|NCT02060383|594353603|FG004|Core Phase|Administrative problems|0|||
164540742|NCT02060383|594353599|FG000|Core Phase|Protocol Violation|0|||
164540743|NCT02060383|594353600|FG001|Core Phase|Protocol Violation|0|||
164540744|NCT02060383|594353601|FG002|Core Phase|Protocol Violation|0|||
164540745|NCT02060383|594353602|FG003|Core Phase|Protocol Violation|1|||
164540746|NCT02060383|594353603|FG004|Core Phase|Protocol Violation|0|||
164540747|NCT02060383|594353599|FG000|Core Phase|Withdrawal by Subject|0|||
164540748|NCT02060383|594353600|FG001|Core Phase|Withdrawal by Subject|0|||
164540749|NCT02060383|594353601|FG002|Core Phase|Withdrawal by Subject|0|||
164540750|NCT02060383|594353602|FG003|Core Phase|Withdrawal by Subject|4|||
164540751|NCT02060383|594353603|FG004|Core Phase|Withdrawal by Subject|2|||
164540752|NCT02060383|594353599|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
164540753|NCT02060383|594353600|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
164540754|NCT02060383|594353601|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
164540755|NCT02060383|594353602|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
164540756|NCT02060383|594353603|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
164540757|NCT02060383|594353599|FG000|Extension Phase|Adverse Event|1|||
164540758|NCT02060383|594353600|FG001|Extension Phase|Adverse Event|1|||
164540759|NCT02060383|594353601|FG002|Extension Phase|Adverse Event|2|||
164653136|NCT01621490|594757072|FG009|Overall Study|Subject request to discontinue study|0|||
164190636|NCT01411852|593066329|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
164190637|NCT01411852|593066328|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
164190638|NCT01411852|593066329|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
164190639|NCT01411852|593066328|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
164190640|NCT01411852|593066329|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
164190641|NCT01411852|593066328|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
164190642|NCT01411852|593066329|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
164190643|NCT01411852|593066328|FG000|Hospital Intervention Phase|Other ineligible|2|||
164190644|NCT01411852|593066329|FG001|Hospital Intervention Phase|Other ineligible|2|||
164540760|NCT02060383|594353602|FG003|Extension Phase|Adverse Event|0|||
164540761|NCT02060383|594353603|FG004|Extension Phase|Adverse Event|1|||
164653137|NCT01621490|594757073|FG010|Overall Study|Subject request to discontinue study|0|||
164653138|NCT01621490|594757063|FG000|Overall Study|Adverse event unrelated to study drug|1|||
164540762|NCT02060383|594353599|FG000|Extension Phase|Withdrawal by Subject|0|||
164540763|NCT02060383|594353600|FG001|Extension Phase|Withdrawal by Subject|1|||
164540764|NCT02060383|594353601|FG002|Extension Phase|Withdrawal by Subject|0|||
164540765|NCT02060383|594353602|FG003|Extension Phase|Withdrawal by Subject|0|||
164540766|NCT02060383|594353603|FG004|Extension Phase|Withdrawal by Subject|2|||
164540767|NCT02060383|594353599|FG000|Extension Phase|Administrative problems|1|||
164540768|NCT02060383|594353600|FG001|Extension Phase|Administrative problems|0|||
164540769|NCT02060383|594353601|FG002|Extension Phase|Administrative problems|0|||
164540770|NCT02060383|594353602|FG003|Extension Phase|Administrative problems|0|||
164540771|NCT02060383|594353603|FG004|Extension Phase|Administrative problems|0|||
164540772|NCT02060383|594353599|FG000|Extension Phase|Death|0|||
164540773|NCT02060383|594353600|FG001|Extension Phase|Death|0|||
164540774|NCT02060383|594353601|FG002|Extension Phase|Death|1|||
164540775|NCT02060383|594353602|FG003|Extension Phase|Death|0|||
164540776|NCT02060383|594353603|FG004|Extension Phase|Death|1|||
164540777|NCT02060383|594353599|FG000|Extension Phase|Protocol Violation|0|||
164540778|NCT02060383|594353600|FG001|Extension Phase|Protocol Violation|0|||
164540779|NCT02060383|594353601|FG002|Extension Phase|Protocol Violation|0|||
164540780|NCT02060383|594353602|FG003|Extension Phase|Protocol Violation|0|||
164540781|NCT02060383|594353603|FG004|Extension Phase|Protocol Violation|1|||
164540782|NCT03426787|594353604|FG000|Overall Study|Withdrawal by Subject|6|||
164540783|NCT03426787|594353604|FG000|Overall Study|Lost to Follow-up|7|||
164540784|NCT03426787|594353604|FG000|Overall Study|Unrelated to intervention death|1|||
164540785|NCT02460497|594353609|FG000|Overall Study|Participant Requested Withdrawal|4|||
164540786|NCT02460497|594353609|FG000|Overall Study|Non-Compliance|1|||
164540787|NCT02460497|594353609|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
164540788|NCT02460497|594353609|FG000|Overall Study|Lost to Follow-up|2|||
164540789|NCT02460497|594353609|FG000|Overall Study|Investigator Decision|1|||
164540790|NCT00908583|594353610|FG000|Phase 1|Withdrawal by Subject|1|||
164540791|NCT00908583|594353610|FG000|Phase 1|Adverse Event|4|||
164540792|NCT00908583|594353610|FG000|Phase 2|Physician Decision|1|||
164540793|NCT00908583|594353610|FG000|Phase 2|Adverse Event|1|||
164540794|NCT00908583|594353610|FG000|Phase 3|Adverse Event|2|||
164540795|NCT00908583|594353610|FG000|Phase 4|Adverse Event|1|||
164540796|NCT00908583|594353610|FG000|Phase 4|Physician Decision|1|||
164540797|NCT00908583|594353610|FG000|Phase 5|Adverse Event|3|||
164540798|NCT00860951|594353613|FG000|Overall Study|Withdrawal by Subject|2|||
164540799|NCT00860951|594353613|FG000|Overall Study|Lost to Follow-up|5|||
164540800|NCT02982239|594353614|FG000|Overall Study|Lost to Follow-up|3|||
164540801|NCT02982239|594353615|FG001|Overall Study|Lost to Follow-up|2|||
164540802|NCT02230254|594353616|FG000|Overall Study|Lost to Follow-up|3|||
164540803|NCT00295633|594353617|FG000|Overall Study|Lack of Efficacy|19|||
164540804|NCT00295633|594353618|FG001|Overall Study|Lack of Efficacy|7|||
164540805|NCT00295633|594353619|FG002|Overall Study|Lack of Efficacy|16|||
164540806|NCT00295633|594353617|FG000|Overall Study|Withdrawal of consent by subject|16|||
164540807|NCT00295633|594353618|FG001|Overall Study|Withdrawal of consent by subject|16|||
164540808|NCT00295633|594353619|FG002|Overall Study|Withdrawal of consent by subject|26|||
164540809|NCT00295633|594353617|FG000|Overall Study|Adverse Event|9|||
164540810|NCT00295633|594353618|FG001|Overall Study|Adverse Event|17|||
164540811|NCT00295633|594353619|FG002|Overall Study|Adverse Event|9|||
164540812|NCT00295633|594353617|FG000|Overall Study|Lost to Follow-up|6|||
164540813|NCT00295633|594353618|FG001|Overall Study|Lost to Follow-up|11|||
164540814|NCT00295633|594353619|FG002|Overall Study|Lost to Follow-up|7|||
164540815|NCT00295633|594353617|FG000|Overall Study|Physician Decision|9|||
164540816|NCT00295633|594353618|FG001|Overall Study|Physician Decision|10|||
164540817|NCT00295633|594353619|FG002|Overall Study|Physician Decision|8|||
164540818|NCT00295633|594353617|FG000|Overall Study|Poor/Noncompliance|2|||
164540819|NCT00295633|594353618|FG001|Overall Study|Poor/Noncompliance|2|||
164653139|NCT01621490|594757064|FG001|Overall Study|Adverse event unrelated to study drug|1|||
164653140|NCT01621490|594757065|FG002|Overall Study|Adverse event unrelated to study drug|0|||
164653141|NCT01621490|594757066|FG003|Overall Study|Adverse event unrelated to study drug|0|||
164653142|NCT01621490|594757067|FG004|Overall Study|Adverse event unrelated to study drug|0|||
164653143|NCT01621490|594757068|FG005|Overall Study|Adverse event unrelated to study drug|0|||
164653144|NCT01621490|594757069|FG006|Overall Study|Adverse event unrelated to study drug|0|||
164653145|NCT01621490|594757070|FG007|Overall Study|Adverse event unrelated to study drug|2|||
164653146|NCT01621490|594757071|FG008|Overall Study|Adverse event unrelated to study drug|0|||
164653147|NCT01621490|594757072|FG009|Overall Study|Adverse event unrelated to study drug|0|||
164653148|NCT01621490|594757073|FG010|Overall Study|Adverse event unrelated to study drug|0|||
164653149|NCT01621490|594757063|FG000|Overall Study|Disease progression|27|||
164653150|NCT01621490|594757064|FG001|Overall Study|Disease progression|28|||
164653151|NCT01621490|594757065|FG002|Overall Study|Disease progression|1|||
164653152|NCT01621490|594757066|FG003|Overall Study|Disease progression|5|||
164653153|NCT01621490|594757067|FG004|Overall Study|Disease progression|3|||
164653154|NCT01621490|594757068|FG005|Overall Study|Disease progression|8|||
164653155|NCT01621490|594757069|FG006|Overall Study|Disease progression|7|||
164653156|NCT01621490|594757070|FG007|Overall Study|Disease progression|1|||
164653157|NCT01621490|594757071|FG008|Overall Study|Disease progression|4|||
164653158|NCT01621490|594757072|FG009|Overall Study|Disease progression|1|||
164653159|NCT01621490|594757073|FG010|Overall Study|Disease progression|1|||
164653160|NCT01621490|594757063|FG000|Overall Study|Study drug toxicity|1|||
164540820|NCT00295633|594353619|FG002|Overall Study|Poor/Noncompliance|6|||
164540821|NCT00295633|594353617|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
164653161|NCT01621490|594757064|FG001|Overall Study|Study drug toxicity|4|||
164540822|NCT00295633|594353618|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
164540823|NCT00295633|594353619|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
164540824|NCT00295633|594353617|FG000|Overall Study|Death|1|||
164540825|NCT00295633|594353618|FG001|Overall Study|Death|1|||
164540826|NCT00295633|594353619|FG002|Overall Study|Death|0|||
164540827|NCT00295633|594353617|FG000|Overall Study|Administrative reason by sponsor|0|||
164540828|NCT00295633|594353618|FG001|Overall Study|Administrative reason by sponsor|0|||
164540829|NCT00295633|594353619|FG002|Overall Study|Administrative reason by sponsor|1|||
164540830|NCT00404066|594353626|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
164540831|NCT00404066|594353626|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
164540832|NCT00791258|594353627|FG000|Overall Study|Adverse Event|87|||
164540833|NCT00791258|594353627|FG000|Overall Study|Lost to Follow-up|18|||
164540834|NCT00791258|594353627|FG000|Overall Study|Protocol Violation|109|||
164540835|NCT00791258|594353627|FG000|Overall Study|Withdrawal by Subject|40|||
164540836|NCT00791258|594353627|FG000|Overall Study|Did not take medication for >3 days|1|||
164540837|NCT00791258|594353627|FG000|Overall Study|subject left area|2|||
164540838|NCT00791258|594353627|FG000|Overall Study|non-compliance|3|||
164540839|NCT00791258|594353627|FG000|Overall Study|Subject incarcerated|1|||
164540840|NCT00791258|594353627|FG000|Overall Study|Subject required restricted medication|1|||
164540841|NCT00791258|594353627|FG000|Overall Study|Lack of Efficacy|1|||
164540842|NCT02448225|594353634|FG000|Overall Study|Withdrawal by Subject|1|||
164540843|NCT02448225|594353634|FG000|Overall Study|Did not get FSPG scan|18|||
164540844|NCT02448225|594353634|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
164540845|NCT01287364|594353637|FG000|Overall Study|Adverse Event|0|||
164540846|NCT01287364|594353638|FG001|Overall Study|Adverse Event|3|||
164540847|NCT01287364|594353637|FG000|Overall Study|Protocol Violation|5|||
164540848|NCT01287364|594353638|FG001|Overall Study|Protocol Violation|5|||
164540849|NCT01287364|594353637|FG000|Overall Study|Other Reason|4|||
164540850|NCT01287364|594353638|FG001|Overall Study|Other Reason|2|||
164540851|NCT05372653|594353643|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
164540852|NCT05372653|594353644|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
164540853|NCT05372653|594353643|FG000|Overall Study|Adverse Event|0|||
164540854|NCT05372653|594353644|FG001|Overall Study|Adverse Event|1|||
164540855|NCT00711529|594353645|FG000|Overall Study|Protocol Violation|2|||
164540856|NCT00711529|594353646|FG001|Overall Study|Protocol Violation|0|||
164540857|NCT00711529|594353645|FG000|Overall Study|Withdrawal by Subject|2|||
164540858|NCT00711529|594353646|FG001|Overall Study|Withdrawal by Subject|6|||
164540859|NCT03740997|594353647|FG000|Overall Study|Withdrawal by Subject|1|||
164540860|NCT03740997|594353648|FG001|Overall Study|Withdrawal by Subject|0|||
164540861|NCT03740997|594353647|FG000|Overall Study|Participant was unable to complete study procedures|1|||
164540862|NCT03740997|594353648|FG001|Overall Study|Participant was unable to complete study procedures|0|||
164540863|NCT04246801|594353650|FG000|Overall Study|Adverse Event|1|||
164540864|NCT04246801|594353651|FG001|Overall Study|Adverse Event|1|||
164540865|NCT04246801|594353650|FG000|Overall Study|Protocol Violation|1|||
164540866|NCT04246801|594353651|FG001|Overall Study|Protocol Violation|1|||
164540867|NCT04246801|594353650|FG000|Overall Study|Lack of Efficacy|0|||
164540868|NCT04246801|594353651|FG001|Overall Study|Lack of Efficacy|2|||
164540869|NCT04246801|594353650|FG000|Overall Study|Lost to Follow-up|1|||
164540870|NCT04246801|594353651|FG001|Overall Study|Lost to Follow-up|1|||
164540871|NCT04246801|594353650|FG000|Overall Study|Withdrawal by Subject|2|||
164540872|NCT04246801|594353651|FG001|Overall Study|Withdrawal by Subject|1|||
164540873|NCT03044249|594353652|FG000|Overall Study|Adverse Event|4|||
164540874|NCT03044249|594353653|FG001|Overall Study|Adverse Event|9|||
164540875|NCT03044249|594353652|FG000|Overall Study|Lost to Follow-up|1|||
164540876|NCT03044249|594353653|FG001|Overall Study|Lost to Follow-up|0|||
164540877|NCT03044249|594353652|FG000|Overall Study|Non-compliance with Study Drug|1|||
164540878|NCT03044249|594353653|FG001|Overall Study|Non-compliance with Study Drug|0|||
164540879|NCT03044249|594353652|FG000|Overall Study|Study Terminated by Sponsor|2|||
164540880|NCT03044249|594353653|FG001|Overall Study|Study Terminated by Sponsor|0|||
164540881|NCT03044249|594353652|FG000|Overall Study|Withdrawal by Subject|2|||
164540882|NCT03044249|594353653|FG001|Overall Study|Withdrawal by Subject|5|||
164540883|NCT00955279|594353654|FG000|Overall Study|Other|0|||
164540884|NCT00955279|594353655|FG001|Overall Study|Other|0|||
164540885|NCT00955279|594353656|FG002|Overall Study|Other|3|||
164540886|NCT00955279|594353654|FG000|Overall Study|Death|1|||
164540887|NCT00955279|594353655|FG001|Overall Study|Death|1|||
164540888|NCT00955279|594353656|FG002|Overall Study|Death|1|||
164540889|NCT00955279|594353654|FG000|Overall Study|Lost to Follow-up|0|||
164540890|NCT00955279|594353655|FG001|Overall Study|Lost to Follow-up|3|||
164540891|NCT00955279|594353656|FG002|Overall Study|Lost to Follow-up|1|||
164540892|NCT00955279|594353654|FG000|Overall Study|Withdrawal by Subject|2|||
164540893|NCT00955279|594353655|FG001|Overall Study|Withdrawal by Subject|0|||
164540894|NCT00955279|594353656|FG002|Overall Study|Withdrawal by Subject|3|||
164540895|NCT02663271|594353663|FG000|Overall Study|Withdrawal by Subject|5|||
164540896|NCT02663271|594353663|FG000|Overall Study|Lack of Efficacy|1|||
164540897|NCT01572675|594353664|FG000|Overall Study|End of prescribed treatment|140|||
164540898|NCT01572675|594353665|FG001|Overall Study|End of prescribed treatment|118|||
164540899|NCT01572675|594353664|FG000|Overall Study|Recovery|16|||
164540900|NCT01572675|594353665|FG001|Overall Study|Recovery|23|||
164540901|NCT01572675|594353664|FG000|Overall Study|Lack of Efficacy|31|||
164540902|NCT01572675|594353665|FG001|Overall Study|Lack of Efficacy|31|||
164540903|NCT01572675|594353664|FG000|Overall Study|Intolerance|6|||
164540904|NCT01572675|594353665|FG001|Overall Study|Intolerance|5|||
164540905|NCT01572675|594353664|FG000|Overall Study|Improved symptoms|8|||
164540906|NCT01572675|594353665|FG001|Overall Study|Improved symptoms|2|||
164540907|NCT01572675|594353664|FG000|Overall Study|Surgical intervention|3|||
164540908|NCT01572675|594353665|FG001|Overall Study|Surgical intervention|6|||
164540909|NCT01572675|594353664|FG000|Overall Study|Withdrawal by Subject|5|||
164540910|NCT01572675|594353665|FG001|Overall Study|Withdrawal by Subject|1|||
164540911|NCT01572675|594353664|FG000|Overall Study|Physician Decision|2|||
164540912|NCT01572675|594353665|FG001|Overall Study|Physician Decision|2|||
164540913|NCT01572675|594353664|FG000|Overall Study|Death unrelated to coxibs|1|||
164540914|NCT01572675|594353665|FG001|Overall Study|Death unrelated to coxibs|1|||
164540915|NCT01572675|594353664|FG000|Overall Study|Other disease detected|1|||
164540916|NCT01572675|594353665|FG001|Overall Study|Other disease detected|1|||
164540917|NCT01572675|594353664|FG000|Overall Study|Unknown reason|1|||
164540918|NCT01572675|594353665|FG001|Overall Study|Unknown reason|1|||
164540919|NCT01572675|594353664|FG000|Overall Study|Rheumatologist new evaluation|0|||
164540920|NCT01572675|594353665|FG001|Overall Study|Rheumatologist new evaluation|1|||
164540921|NCT01572675|594353664|FG000|Overall Study|Missing data|1|||
164540922|NCT01572675|594353665|FG001|Overall Study|Missing data|4|||
164540923|NCT01572675|594353664|FG000|Overall Study|Lost to Follow-up|22|||
164540924|NCT01572675|594353665|FG001|Overall Study|Lost to Follow-up|27|||
164540925|NCT00999713|594353666|FG000|Overall Study|Physician Decision|2|||
164540926|NCT00999713|594353667|FG001|Overall Study|Physician Decision|0|||
164540927|NCT03346057|594353670|FG000|Overall Study|Death|1|||
164540928|NCT03346057|594353671|FG001|Overall Study|Death|2|||
164540929|NCT03346057|594353672|FG002|Overall Study|Death|0|||
164540930|NCT03346057|594353673|FG003|Overall Study|Death|0|||
164540931|NCT03346057|594353670|FG000|Overall Study|Lost to Follow-up|0|||
164540932|NCT03346057|594353671|FG001|Overall Study|Lost to Follow-up|2|||
164540933|NCT03346057|594353672|FG002|Overall Study|Lost to Follow-up|1|||
164540934|NCT03346057|594353673|FG003|Overall Study|Lost to Follow-up|0|||
164540935|NCT03346057|594353670|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
164540936|NCT03346057|594353671|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
164540937|NCT03346057|594353672|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
164540938|NCT03346057|594353673|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
164540939|NCT03346057|594353670|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
164540940|NCT03346057|594353671|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
164540941|NCT03346057|594353672|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
164540942|NCT03346057|594353673|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
164540943|NCT03346057|594353670|FG000|Overall Study|Physician Decision|3|||
164540944|NCT03346057|594353671|FG001|Overall Study|Physician Decision|2|||
164540945|NCT03346057|594353672|FG002|Overall Study|Physician Decision|0|||
164540946|NCT03346057|594353673|FG003|Overall Study|Physician Decision|2|||
164540947|NCT03346057|594353670|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
164540948|NCT03346057|594353671|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
164540949|NCT03346057|594353672|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
164540950|NCT03346057|594353673|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
164540951|NCT03346057|594353670|FG000|Overall Study|Withdrawal by Subject|1|||
164540952|NCT03346057|594353671|FG001|Overall Study|Withdrawal by Subject|0|||
164540953|NCT03346057|594353672|FG002|Overall Study|Withdrawal by Subject|0|||
164540954|NCT03346057|594353673|FG003|Overall Study|Withdrawal by Subject|0|||
164540955|NCT02921269|594353674|FG000|Overall Study|Did not complete DLT period|1|||
164540956|NCT00387764|594353685|FG000|Overall Study|Adverse Event|12|||
164540957|NCT00387764|594353685|FG000|Overall Study|Withdrawal by Subject|8|||
164540958|NCT00387764|594353685|FG000|Overall Study|Sponsor Terminated Study|1|||
164540959|NCT00387764|594353685|FG000|Overall Study|Physician Decision|1|||
164540960|NCT00387764|594353685|FG000|Overall Study|Other|2|||
164540961|NCT00387764|594353685|FG000|Overall Study|Death|7|||
164540962|NCT02301936|594353686|FG000|Overall Study|Lost to Follow-up|1|||
164540963|NCT02301936|594353687|FG001|Overall Study|Lost to Follow-up|0|||
164540964|NCT05975840|594353692|FG000|Overall Study|Other|1|||
164540965|NCT05975840|594353693|FG001|Overall Study|Other|0|||
164540966|NCT05975840|594353694|FG002|Overall Study|Other|0|||
164540967|NCT05975840|594353695|FG003|Overall Study|Other|0|||
164540968|NCT05975840|594353696|FG004|Overall Study|Other|1|||
164540969|NCT05975840|594353697|FG005|Overall Study|Other|0|||
164540970|NCT05975840|594353698|FG006|Overall Study|Other|0|||
164540971|NCT05975840|594353699|FG007|Overall Study|Other|0|||
164540972|NCT05975840|594353692|FG000|Overall Study|Lost to Follow-up|3|||
164540973|NCT05975840|594353693|FG001|Overall Study|Lost to Follow-up|6|||
164540974|NCT05975840|594353694|FG002|Overall Study|Lost to Follow-up|3|||
164540975|NCT05975840|594353695|FG003|Overall Study|Lost to Follow-up|1|||
164540976|NCT05975840|594353696|FG004|Overall Study|Lost to Follow-up|4|||
164540977|NCT05975840|594353697|FG005|Overall Study|Lost to Follow-up|1|||
164540978|NCT05975840|594353698|FG006|Overall Study|Lost to Follow-up|2|||
164540979|NCT05975840|594353699|FG007|Overall Study|Lost to Follow-up|4|||
164540980|NCT05975840|594353692|FG000|Overall Study|Migrated/moved from the study area|1|||
164540981|NCT05975840|594353693|FG001|Overall Study|Migrated/moved from the study area|0|||
164540982|NCT05975840|594353694|FG002|Overall Study|Migrated/moved from the study area|0|||
164540983|NCT05975840|594353695|FG003|Overall Study|Migrated/moved from the study area|0|||
164540984|NCT05975840|594353696|FG004|Overall Study|Migrated/moved from the study area|0|||
164540985|NCT05975840|594353697|FG005|Overall Study|Migrated/moved from the study area|0|||
164540986|NCT05975840|594353698|FG006|Overall Study|Migrated/moved from the study area|0|||
164540987|NCT05975840|594353699|FG007|Overall Study|Migrated/moved from the study area|0|||
164540988|NCT05975840|594353692|FG000|Overall Study|Withdrawal by Subject|0|||
164540989|NCT05975840|594353693|FG001|Overall Study|Withdrawal by Subject|5|||
164540990|NCT05975840|594353694|FG002|Overall Study|Withdrawal by Subject|2|||
164540991|NCT05975840|594353695|FG003|Overall Study|Withdrawal by Subject|2|||
164540992|NCT05975840|594353696|FG004|Overall Study|Withdrawal by Subject|0|||
164540993|NCT05975840|594353697|FG005|Overall Study|Withdrawal by Subject|2|||
164540994|NCT05975840|594353698|FG006|Overall Study|Withdrawal by Subject|2|||
164540995|NCT05975840|594353699|FG007|Overall Study|Withdrawal by Subject|1|||
164540996|NCT05975840|594353692|FG000|Overall Study|Protocol Violation|0|||
164540997|NCT05975840|594353693|FG001|Overall Study|Protocol Violation|1|||
164540998|NCT05975840|594353694|FG002|Overall Study|Protocol Violation|0|||
164540999|NCT05975840|594353695|FG003|Overall Study|Protocol Violation|0|||
164541000|NCT05975840|594353696|FG004|Overall Study|Protocol Violation|0|||
164541001|NCT05975840|594353697|FG005|Overall Study|Protocol Violation|0|||
164541002|NCT05975840|594353698|FG006|Overall Study|Protocol Violation|0|||
164541003|NCT05975840|594353699|FG007|Overall Study|Protocol Violation|0|||
164541004|NCT05975840|594353692|FG000|Overall Study|Adverse Event|0|||
164541005|NCT05975840|594353693|FG001|Overall Study|Adverse Event|0|||
164541006|NCT05975840|594353694|FG002|Overall Study|Adverse Event|0|||
164541007|NCT05975840|594353695|FG003|Overall Study|Adverse Event|1|||
164541008|NCT05975840|594353696|FG004|Overall Study|Adverse Event|0|||
164541009|NCT05975840|594353697|FG005|Overall Study|Adverse Event|0|||
164541010|NCT05975840|594353698|FG006|Overall Study|Adverse Event|0|||
164541011|NCT05975840|594353699|FG007|Overall Study|Adverse Event|0|||
164541012|NCT05975840|594353692|FG000|Overall Study|Death|0|||
164541013|NCT05975840|594353693|FG001|Overall Study|Death|1|||
164541014|NCT05975840|594353694|FG002|Overall Study|Death|0|||
164541015|NCT05975840|594353695|FG003|Overall Study|Death|0|||
164541016|NCT05975840|594353696|FG004|Overall Study|Death|0|||
164541017|NCT05975840|594353697|FG005|Overall Study|Death|0|||
164541018|NCT05975840|594353698|FG006|Overall Study|Death|0|||
164541019|NCT05975840|594353699|FG007|Overall Study|Death|1|||
164541020|NCT00232141|594353702|FG000|Overall Study|Adverse Event|9|||
164541021|NCT00232141|594353703|FG001|Overall Study|Adverse Event|4|||
164541022|NCT00232141|594353702|FG000|Overall Study|Lack of Efficacy|0|||
164541023|NCT00232141|594353703|FG001|Overall Study|Lack of Efficacy|3|||
164541024|NCT00232141|594353702|FG000|Overall Study|Lost to Follow-up|9|||
164541025|NCT00232141|594353703|FG001|Overall Study|Lost to Follow-up|6|||
164541026|NCT00232141|594353702|FG000|Overall Study|Other|8|||
164541027|NCT00232141|594353703|FG001|Overall Study|Other|10|||
164541028|NCT00232141|594353702|FG000|Overall Study|Withdrawal by Subject|5|||
164541029|NCT00232141|594353703|FG001|Overall Study|Withdrawal by Subject|3|||
164541030|NCT00601250|594353707|FG000|Overall Study|Adverse Event|3|||
164541031|NCT00601250|594353708|FG001|Overall Study|Adverse Event|9|||
164541032|NCT00601250|594353707|FG000|Overall Study|Protocol Violation|3|||
164541033|NCT00601250|594353708|FG001|Overall Study|Protocol Violation|2|||
164541034|NCT00601250|594353707|FG000|Overall Study|Lost to Follow-up|2|||
164541035|NCT00601250|594353708|FG001|Overall Study|Lost to Follow-up|6|||
164541036|NCT00601250|594353707|FG000|Overall Study|Withdrawal by Subject|4|||
164541037|NCT00601250|594353708|FG001|Overall Study|Withdrawal by Subject|13|||
164541038|NCT00601250|594353707|FG000|Overall Study|Other incl. lack of efficacy|2|||
164541039|NCT00601250|594353708|FG001|Overall Study|Other incl. lack of efficacy|9|||
164541040|NCT01810016|594353709|FG000|Overall Study|Progressive disease|1|||
164541041|NCT01810016|594353710|FG001|Overall Study|Progressive disease|1|||
164541042|NCT01810016|594353711|FG002|Overall Study|Progressive disease|0|||
164541043|NCT01810016|594353709|FG000|Overall Study|Death|0|||
164541044|NCT01810016|594353710|FG001|Overall Study|Death|0|||
164541045|NCT01810016|594353711|FG002|Overall Study|Death|1|||
164541046|NCT04263896|594353714|FG000|Overall Study|Withdrawal by Subject|2|||
164541047|NCT04263896|594353715|FG001|Overall Study|Withdrawal by Subject|4|||
164653162|NCT01621490|594757065|FG002|Overall Study|Study drug toxicity|5|||
164541048|NCT04263896|594353714|FG000|Overall Study|converted to open procedure|0|||
164541049|NCT04263896|594353715|FG001|Overall Study|converted to open procedure|1|||
164541050|NCT04263896|594353714|FG000|Overall Study|Lost to Follow-up|9|||
164541051|NCT04263896|594353715|FG001|Overall Study|Lost to Follow-up|11|||
164541052|NCT04263896|594353714|FG000|Overall Study|surveys lost in mail|5|||
164541053|NCT04263896|594353715|FG001|Overall Study|surveys lost in mail|3|||
164541054|NCT04263896|594353714|FG000|Overall Study|excluded from analysis|1|||
164541055|NCT04263896|594353715|FG001|Overall Study|excluded from analysis|0|||
164541056|NCT06950879|594353716|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
164541057|NCT00659529|594355667|FG000|Overall Study|Withdrawal by Subject|4|||
164541058|NCT00659529|594355667|FG000|Overall Study|Protocol Violation|3|||
164541059|NCT00659529|594355667|FG000|Overall Study|Screen failure|9|||
164541060|NCT01086410|594355668|FG000|Overall Study|Adverse Event|1|||
164541061|NCT01086410|594355669|FG001|Overall Study|Adverse Event|0|||
164541062|NCT01086410|594355670|FG002|Overall Study|Adverse Event|0|||
164541063|NCT01086410|594355671|FG003|Overall Study|Adverse Event|2|||
164541064|NCT01086410|594355668|FG000|Overall Study|Lack of Efficacy|1|||
164541065|NCT01086410|594355669|FG001|Overall Study|Lack of Efficacy|1|||
164541066|NCT01086410|594355670|FG002|Overall Study|Lack of Efficacy|0|||
164541067|NCT01086410|594355671|FG003|Overall Study|Lack of Efficacy|0|||
164541068|NCT01086410|594355668|FG000|Overall Study|Protocol Violation|1|||
164541069|NCT01086410|594355669|FG001|Overall Study|Protocol Violation|1|||
164541070|NCT01086410|594355670|FG002|Overall Study|Protocol Violation|0|||
164541071|NCT01086410|594355671|FG003|Overall Study|Protocol Violation|0|||
164541072|NCT01086410|594355668|FG000|Overall Study|Lost to Follow-up|0|||
164541073|NCT01086410|594355669|FG001|Overall Study|Lost to Follow-up|0|||
164541074|NCT01086410|594355670|FG002|Overall Study|Lost to Follow-up|1|||
164541075|NCT01086410|594355671|FG003|Overall Study|Lost to Follow-up|0|||
164541076|NCT00930722|594355672|FG000|Overall Study|Lost to Follow-up|16|||
164541077|NCT00930722|594355672|FG000|Overall Study|No longer willing to participate|9|||
164541078|NCT00930722|594355672|FG000|Overall Study|Study terminated by sponsor|2|||
164541079|NCT03523728|594355673|FG000|Stage 1 (24 Months)|Adverse Event|2|||
164541080|NCT03523728|594355674|FG001|Stage 1 (24 Months)|Adverse Event|2|||
164541081|NCT03523728|594355675|FG002|Stage 1 (24 Months)|Adverse Event|4|||
164541082|NCT03523728|594355676|FG003|Stage 1 (24 Months)|Adverse Event|0|||
164541083|NCT03523728|594355677|FG004|Stage 1 (24 Months)|Adverse Event|0|||
164541084|NCT03523728|594355673|FG000|Stage 1 (24 Months)|Progressive disease|0|||
164541085|NCT03523728|594355674|FG001|Stage 1 (24 Months)|Progressive disease|0|||
164541086|NCT03523728|594355675|FG002|Stage 1 (24 Months)|Progressive disease|1|||
164541087|NCT03523728|594355676|FG003|Stage 1 (24 Months)|Progressive disease|0|||
164541088|NCT03523728|594355677|FG004|Stage 1 (24 Months)|Progressive disease|0|||
164541089|NCT03523728|594355673|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
164541090|NCT03523728|594355674|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
164541091|NCT03523728|594355675|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
164541092|NCT03523728|594355676|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
164541093|NCT03523728|594355677|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
164541094|NCT03523728|594355673|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
164541095|NCT03523728|594355674|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
164541096|NCT03523728|594355675|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
164541097|NCT03523728|594355676|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
164541098|NCT03523728|594355677|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
164541099|NCT03523728|594355673|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
164541100|NCT03523728|594355674|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
164541101|NCT03523728|594355675|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
164541102|NCT03523728|594355676|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
164541103|NCT03523728|594355677|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
164541104|NCT03523728|594355673|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
164541105|NCT03523728|594355674|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
164541106|NCT03523728|594355675|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
164541107|NCT03523728|594355676|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
164541108|NCT03523728|594355677|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
164541109|NCT03523728|594355673|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
164541110|NCT03523728|594355674|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
164541111|NCT03523728|594355675|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
164541112|NCT03523728|594355676|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
164541113|NCT03523728|594355677|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
164541114|NCT03523728|594355673|FG000|Stage 2 (24 Months)|Adverse Event|0|||
164541115|NCT03523728|594355674|FG001|Stage 2 (24 Months)|Adverse Event|0|||
164541116|NCT03523728|594355675|FG002|Stage 2 (24 Months)|Adverse Event|0|||
164541117|NCT03523728|594355676|FG003|Stage 2 (24 Months)|Adverse Event|1|||
164541118|NCT03523728|594355677|FG004|Stage 2 (24 Months)|Adverse Event|2|||
164541119|NCT03523728|594355673|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
164541120|NCT03523728|594355674|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
164541121|NCT03523728|594355675|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
164541122|NCT03523728|594355676|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
164541123|NCT03523728|594355677|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
164541124|NCT03523728|594355673|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
164541125|NCT03523728|594355674|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
164541126|NCT03523728|594355675|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
164541127|NCT03523728|594355676|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
164541128|NCT03523728|594355677|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
164541129|NCT03523728|594355673|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
164541130|NCT03523728|594355674|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
164541131|NCT03523728|594355675|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
164541132|NCT03523728|594355676|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
164541133|NCT03523728|594355677|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
164541134|NCT03523728|594355673|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
164541135|NCT03523728|594355674|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
164541136|NCT03523728|594355675|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
164541137|NCT03523728|594355676|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
164541138|NCT03523728|594355677|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
164541139|NCT00621751|594355678|FG000|Overall Study|Adverse Event|0|||
164541140|NCT00621751|594355679|FG001|Overall Study|Adverse Event|1|||
164541141|NCT03383289|594355690|FG000|Overall Study|Death|83|||
164541142|NCT03383289|594355691|FG001|Overall Study|Death|78|||
164541143|NCT03383289|594355690|FG000|Overall Study|discharge from facility|84|||
164541144|NCT03383289|594355691|FG001|Overall Study|discharge from facility|84|||
164541145|NCT03383289|594355690|FG000|Overall Study|Withdrawal by Subject|4|||
164541146|NCT03383289|594355691|FG001|Overall Study|Withdrawal by Subject|1|||
164541147|NCT01641237|594355692|FG000|Period II|Withdrawal by Subject|1|||
164541148|NCT01641237|594355693|FG001|Period II|Withdrawal by Subject|0|||
164541149|NCT01641237|594355694|FG002|Period II|Withdrawal by Subject|0|||
164541150|NCT01641237|594355695|FG003|Period II|Withdrawal by Subject|0|||
164541151|NCT01641237|594355692|FG000|Period III|Lost to Follow-up|1|||
164541152|NCT01641237|594355693|FG001|Period III|Lost to Follow-up|0|||
164541153|NCT01641237|594355694|FG002|Period III|Lost to Follow-up|0|||
164541154|NCT01641237|594355695|FG003|Period III|Lost to Follow-up|0|||
164541155|NCT00832117|594355696|FG000|Overall Study|Death|1|||
164541156|NCT00832117|594355696|FG000|Overall Study|Disease Progression|11|||
164541157|NCT04439071|594355697|FG000|Overall Study|Lost to Follow-up|0|||
164541158|NCT04439071|594355698|FG001|Overall Study|Lost to Follow-up|3|||
164541159|NCT04439071|594355697|FG000|Overall Study|Withdrawal by Subject|3|||
164541160|NCT04439071|594355698|FG001|Overall Study|Withdrawal by Subject|8|||
164541161|NCT04439071|594355697|FG000|Overall Study|Death|6|||
164541162|NCT04439071|594355698|FG001|Overall Study|Death|4|||
164541163|NCT04439071|594355697|FG000|Overall Study|Other than specified|3|||
164541164|NCT04439071|594355698|FG001|Overall Study|Other than specified|3|||
164541165|NCT04439071|594355697|FG000|Overall Study|Randomized but not treated|2|||
164541166|NCT04439071|594355698|FG001|Overall Study|Randomized but not treated|0|||
164541167|NCT01301456|594355699|FG000|Stage 1|Withdrawal by Subject|0|||
164541168|NCT01301456|594355700|FG001|Stage 1|Withdrawal by Subject|0|||
164541169|NCT01301456|594355701|FG002|Stage 1|Withdrawal by Subject|1|||
164541170|NCT01301456|594355702|FG003|Stage 1|Withdrawal by Subject|0|||
164541171|NCT01301456|594355703|FG004|Stage 1|Withdrawal by Subject|1|||
164541172|NCT01301456|594355704|FG005|Stage 1|Withdrawal by Subject|0|||
164541173|NCT01301456|594355705|FG006|Stage 1|Withdrawal by Subject|0|||
164541174|NCT01301456|594355706|FG007|Stage 1|Withdrawal by Subject|0|||
164541175|NCT01301456|594355707|FG008|Stage 1|Withdrawal by Subject|0|||
164541176|NCT01301456|594355708|FG009|Stage 1|Withdrawal by Subject|0|||
164541177|NCT01301456|594355709|FG010|Stage 1|Withdrawal by Subject|0|||
164541178|NCT01301456|594355710|FG011|Stage 1|Withdrawal by Subject|0|||
164541179|NCT01301456|594355699|FG000|Stage 1|Randomized but not treated|0|||
164541180|NCT01301456|594355700|FG001|Stage 1|Randomized but not treated|0|||
164541181|NCT01301456|594355701|FG002|Stage 1|Randomized but not treated|0|||
164541182|NCT01301456|594355702|FG003|Stage 1|Randomized but not treated|0|||
164541183|NCT01301456|594355703|FG004|Stage 1|Randomized but not treated|0|||
164541184|NCT01301456|594355704|FG005|Stage 1|Randomized but not treated|0|||
164541185|NCT01301456|594355705|FG006|Stage 1|Randomized but not treated|1|||
164541186|NCT01301456|594355706|FG007|Stage 1|Randomized but not treated|0|||
164541187|NCT01301456|594355707|FG008|Stage 1|Randomized but not treated|0|||
164541188|NCT01301456|594355708|FG009|Stage 1|Randomized but not treated|0|||
164541189|NCT01301456|594355709|FG010|Stage 1|Randomized but not treated|0|||
164541190|NCT01301456|594355710|FG011|Stage 1|Randomized but not treated|0|||
164541191|NCT01301456|594355699|FG000|Stage 2|Adverse Event|0|||
164541192|NCT01301456|594355700|FG001|Stage 2|Adverse Event|0|||
164541193|NCT01301456|594355701|FG002|Stage 2|Adverse Event|0|||
164541194|NCT01301456|594355702|FG003|Stage 2|Adverse Event|0|||
164541195|NCT01301456|594355703|FG004|Stage 2|Adverse Event|0|||
164541196|NCT01301456|594355704|FG005|Stage 2|Adverse Event|0|||
164541197|NCT01301456|594355705|FG006|Stage 2|Adverse Event|0|||
164541198|NCT01301456|594355706|FG007|Stage 2|Adverse Event|0|||
164541199|NCT01301456|594355707|FG008|Stage 2|Adverse Event|0|||
164541200|NCT01301456|594355708|FG009|Stage 2|Adverse Event|0|||
164541201|NCT01301456|594355709|FG010|Stage 2|Adverse Event|1|||
164541202|NCT01301456|594355710|FG011|Stage 2|Adverse Event|0|||
164541203|NCT00892177|594355711|FG000|Phase II|Ineligible|0|||
164541204|NCT00892177|594355712|FG001|Phase II|Ineligible|0|||
164541205|NCT00892177|594355713|FG002|Phase II|Ineligible|0|||
164541206|NCT00892177|594355714|FG003|Phase II|Ineligible|0|||
164541207|NCT00892177|594355715|FG004|Phase II|Ineligible|1|||
164541208|NCT00892177|594355716|FG005|Phase II|Ineligible|1|||
164541209|NCT00892177|594355711|FG000|Phase II|Withdrawal by Subject|0|||
164541210|NCT00892177|594355712|FG001|Phase II|Withdrawal by Subject|0|||
164541211|NCT00892177|594355713|FG002|Phase II|Withdrawal by Subject|0|||
164541212|NCT00892177|594355714|FG003|Phase II|Withdrawal by Subject|0|||
164541213|NCT00892177|594355715|FG004|Phase II|Withdrawal by Subject|4|||
164541214|NCT00892177|594355716|FG005|Phase II|Withdrawal by Subject|1|||
164541215|NCT03583450|594355717|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
164541216|NCT03583450|594355718|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
164541217|NCT01186939|594355719|FG000|Overall Study|Death|7|||
164541218|NCT01186939|594355719|FG000|Overall Study|Withdrawal by Subject|2|||
164541219|NCT01186939|594355719|FG000|Overall Study|No longer receiving clinical benefit|17|||
164541220|NCT01186939|594355719|FG000|Overall Study|Program closed|5|||
164541221|NCT01186939|594355719|FG000|Overall Study|Sponsor decision|4|||
164541222|NCT01186939|594355719|FG000|Overall Study|Started additional treatment|1|||
164541223|NCT01186939|594355719|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
164541224|NCT01186939|594355719|FG000|Overall Study|Myocardial infarction|1|||
164541225|NCT01186939|594355719|FG000|Overall Study|Bone marrow transplant|1|||
164541226|NCT01186939|594355719|FG000|Overall Study|Transformation to AML|1|||
164541227|NCT05097716|594355720|FG000|Period 1|Adverse Event|1|||
164541228|NCT05097716|594355720|FG000|Period 1|Close contact with highly-transmissible infection|1|||
164541229|NCT02066311|594355723|FG000|Overall Study|Adverse Event|4|||
164541230|NCT02066311|594355723|FG000|Overall Study|Withdrawal by Subject|1|||
164541231|NCT01372150|594355724|FG000|Overall Study|Lack of Efficacy|3|||
164541232|NCT01372150|594355725|FG001|Overall Study|Lack of Efficacy|0|||
164541233|NCT01372150|594355726|FG002|Overall Study|Lack of Efficacy|1|||
164541234|NCT01372150|594355724|FG000|Overall Study|Lost to Follow-up|4|||
164541235|NCT01372150|594355725|FG001|Overall Study|Lost to Follow-up|5|||
164541236|NCT01372150|594355726|FG002|Overall Study|Lost to Follow-up|6|||
164541237|NCT01372150|594355724|FG000|Overall Study|Protocol Violation|1|||
164541238|NCT01372150|594355725|FG001|Overall Study|Protocol Violation|0|||
164541239|NCT01372150|594355726|FG002|Overall Study|Protocol Violation|3|||
164541240|NCT01372150|594355724|FG000|Overall Study|Withdrawal by Subject|2|||
164541241|NCT01372150|594355725|FG001|Overall Study|Withdrawal by Subject|7|||
164541242|NCT01372150|594355726|FG002|Overall Study|Withdrawal by Subject|2|||
164541243|NCT01372150|594355724|FG000|Overall Study|Other|1|||
164541244|NCT01372150|594355725|FG001|Overall Study|Other|0|||
164541245|NCT01372150|594355726|FG002|Overall Study|Other|2|||
164541246|NCT01372150|594355724|FG000|Overall Study|Adverse Event|2|||
164541247|NCT01372150|594355725|FG001|Overall Study|Adverse Event|1|||
164541248|NCT01372150|594355726|FG002|Overall Study|Adverse Event|2|||
164541249|NCT01372150|594355724|FG000|Overall Study|Randomized but not treated|0|||
164541250|NCT01372150|594355725|FG001|Overall Study|Randomized but not treated|1|||
164541251|NCT01372150|594355726|FG002|Overall Study|Randomized but not treated|0|||
164541252|NCT02316340|594355727|FG000|First Progression|Clinical progression|2|||
164541253|NCT02316340|594355728|FG001|First Progression|Clinical progression|1|||
164541254|NCT02316340|594355727|FG000|First Progression|Withdrawal by Subject|1|||
164541255|NCT02316340|594355728|FG001|First Progression|Withdrawal by Subject|0|||
164541256|NCT01835015|594355729|FG000|Overall Study|Adverse Event|0|||
164541257|NCT01835015|594355730|FG001|Overall Study|Adverse Event|0|||
164541258|NCT01835015|594355731|FG002|Overall Study|Adverse Event|1|||
164541259|NCT01835015|594355732|FG003|Overall Study|Adverse Event|0|||
164541260|NCT01835015|594355733|FG004|Overall Study|Adverse Event|0|||
164541261|NCT00975715|594355734|FG000|Titration Period|Adverse Event|6|||
164541262|NCT00975715|594355735|FG001|Titration Period|Adverse Event|0|||
164541263|NCT00975715|594355734|FG000|Titration Period|Protocol Violation|1|||
164541264|NCT00975715|594355735|FG001|Titration Period|Protocol Violation|0|||
164541265|NCT00975715|594355734|FG000|Maintenance Period|Adverse Event|2|||
164541266|NCT00975715|594355735|FG001|Maintenance Period|Adverse Event|1|||
164541267|NCT01241552|594355736|FG000|Overall Study|Lack of Efficacy|1|||
164541268|NCT01241552|594355737|FG001|Overall Study|Lack of Efficacy|0|||
164541269|NCT01241552|594355738|FG002|Overall Study|Lack of Efficacy|0|||
164541270|NCT01241552|594355739|FG003|Overall Study|Lack of Efficacy|0|||
164541271|NCT01241552|594355736|FG000|Overall Study|Death|26|||
164541272|NCT01241552|594355737|FG001|Overall Study|Death|30|||
164541273|NCT01241552|594355738|FG002|Overall Study|Death|20|||
164541274|NCT01241552|594355739|FG003|Overall Study|Death|25|||
164541275|NCT01241552|594355736|FG000|Overall Study|Adverse Event|1|||
164541276|NCT01241552|594355737|FG001|Overall Study|Adverse Event|1|||
164541277|NCT01241552|594355738|FG002|Overall Study|Adverse Event|0|||
164541278|NCT01241552|594355739|FG003|Overall Study|Adverse Event|0|||
164541279|NCT01241552|594355736|FG000|Overall Study|Technical Problems|2|||
164541280|NCT01241552|594355737|FG001|Overall Study|Technical Problems|0|||
164541281|NCT01241552|594355738|FG002|Overall Study|Technical Problems|2|||
164541282|NCT01241552|594355739|FG003|Overall Study|Technical Problems|2|||
164541283|NCT01241552|594355736|FG000|Overall Study|Progressive Disease|0|||
164541284|NCT01241552|594355737|FG001|Overall Study|Progressive Disease|0|||
164541285|NCT01241552|594355738|FG002|Overall Study|Progressive Disease|1|||
164541286|NCT01241552|594355739|FG003|Overall Study|Progressive Disease|2|||
164541287|NCT01241552|594355736|FG000|Overall Study|Protocol Violation|0|||
164541288|NCT01241552|594355737|FG001|Overall Study|Protocol Violation|2|||
164541289|NCT01241552|594355738|FG002|Overall Study|Protocol Violation|6|||
164541290|NCT01241552|594355739|FG003|Overall Study|Protocol Violation|1|||
164541291|NCT01241552|594355736|FG000|Overall Study|Withdrawal by Subject|7|||
164541292|NCT01241552|594355737|FG001|Overall Study|Withdrawal by Subject|15|||
164541293|NCT01241552|594355738|FG002|Overall Study|Withdrawal by Subject|14|||
164541294|NCT01241552|594355739|FG003|Overall Study|Withdrawal by Subject|15|||
164541295|NCT01241552|594355736|FG000|Overall Study|Physician Decision|2|||
164541296|NCT01241552|594355737|FG001|Overall Study|Physician Decision|4|||
164541297|NCT01241552|594355738|FG002|Overall Study|Physician Decision|2|||
164541298|NCT01241552|594355739|FG003|Overall Study|Physician Decision|3|||
164541299|NCT01241552|594355736|FG000|Overall Study|Lost to Follow-up|2|||
164541300|NCT01241552|594355737|FG001|Overall Study|Lost to Follow-up|11|||
164541301|NCT01241552|594355738|FG002|Overall Study|Lost to Follow-up|15|||
164541302|NCT01241552|594355739|FG003|Overall Study|Lost to Follow-up|16|||
164541303|NCT04004429|594355740|FG000|Overall Study|Protocol Violation|1|||
164541304|NCT04004429|594355741|FG001|Overall Study|Protocol Violation|0|||
164541305|NCT04004429|594355742|FG002|Overall Study|Protocol Violation|0|||
164541306|NCT04004429|594355740|FG000|Overall Study|Physician Decision|0|||
164541307|NCT04004429|594355741|FG001|Overall Study|Physician Decision|1|||
164541308|NCT04004429|594355742|FG002|Overall Study|Physician Decision|1|||
164541309|NCT04004429|594355740|FG000|Overall Study|Withdrawal by Subject|1|||
164541310|NCT04004429|594355741|FG001|Overall Study|Withdrawal by Subject|1|||
164541311|NCT04004429|594355742|FG002|Overall Study|Withdrawal by Subject|1|||
164541312|NCT02606461|594355748|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
164541313|NCT02606461|594355749|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
164541314|NCT02606461|594355750|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
164541315|NCT02606461|594355751|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
164541316|NCT02606461|594355752|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
164541317|NCT02606461|594355753|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
164541318|NCT05395104|594355754|FG000|Overall Study|Met Liver Stopping Criteria|1|||
164541319|NCT05395104|594355754|FG000|Overall Study|Withdrawal by Subject|1|||
164541320|NCT04060563|594355755|FG000|Overall Study|Lost to Follow-up|1|||
164541321|NCT04060563|594355756|FG001|Overall Study|Lost to Follow-up|1|||
164541322|NCT04060563|594355755|FG000|Overall Study|Physician Decision|0|||
164653163|NCT01621490|594757066|FG003|Overall Study|Study drug toxicity|3|||
164653164|NCT01621490|594757067|FG004|Overall Study|Study drug toxicity|1|||
164653165|NCT01621490|594757068|FG005|Overall Study|Study drug toxicity|10|||
164653166|NCT01621490|594757069|FG006|Overall Study|Study drug toxicity|1|||
164541323|NCT04060563|594355756|FG001|Overall Study|Physician Decision|1|||
164541324|NCT00851682|594355757|FG000|Overall Study|screen failure|5|||
164541325|NCT00851682|594355758|FG001|Overall Study|screen failure|0|||
164541326|NCT01379573|594355766|FG000|Overall Study|Lost to Follow-up|1|||
164541327|NCT01379573|594355766|FG000|Overall Study|Screen Failure|10|||
164541328|NCT04422990|594355767|FG000|Overall Study|Withdrawal by Subject|0|||
164541329|NCT04422990|594355768|FG001|Overall Study|Withdrawal by Subject|1|||
164541330|NCT04422990|594355767|FG000|Overall Study|Travel|3|||
164541331|NCT04422990|594355768|FG001|Overall Study|Travel|0|||
164541332|NCT00770770|594355771|FG000|Overall Study|Lost to Follow-up|1|||
164541333|NCT00770770|594355772|FG001|Overall Study|Lost to Follow-up|0|||
164541334|NCT00770770|594355771|FG000|Overall Study|Withdrawal by Subject|1|||
164541335|NCT00770770|594355772|FG001|Overall Study|Withdrawal by Subject|0|||
164541336|NCT00770770|594355771|FG000|Overall Study|Death|0|||
164541337|NCT00770770|594355772|FG001|Overall Study|Death|1|||
164541338|NCT00770770|594355771|FG000|Overall Study|Study Terminated|8|||
164541339|NCT00770770|594355772|FG001|Overall Study|Study Terminated|0|||
164541340|NCT02486653|594355773|FG000|Overall Study|Withdrawal by Subject|1|||
164541341|NCT02486653|594355774|FG001|Overall Study|Withdrawal by Subject|3|||
164541342|NCT02486653|594355773|FG000|Overall Study|Protocol Violation|1|||
164541343|NCT02486653|594355774|FG001|Overall Study|Protocol Violation|0|||
164541344|NCT02486653|594355773|FG000|Overall Study|surgery cancelled|4|||
164541345|NCT02486653|594355774|FG001|Overall Study|surgery cancelled|1|||
164541346|NCT00800436|594355775|FG000|Overall Study|Withdrawal by Subject|0|||
164541347|NCT00800436|594355776|FG001|Overall Study|Withdrawal by Subject|0|||
164541348|NCT00800436|594355777|FG002|Overall Study|Withdrawal by Subject|1|||
164541349|NCT00800436|594355778|FG003|Overall Study|Withdrawal by Subject|1|||
164541350|NCT00800436|594355779|FG004|Overall Study|Withdrawal by Subject|0|||
164541351|NCT00800436|594355780|FG005|Overall Study|Withdrawal by Subject|0|||
164541352|NCT00800436|594355781|FG006|Overall Study|Withdrawal by Subject|0|||
164541353|NCT01829425|594355797|FG000|Overall Study|Withdrawal by Subject|4|||
164541354|NCT01829425|594355798|FG001|Overall Study|Withdrawal by Subject|3|||
164541355|NCT01829425|594355797|FG000|Overall Study|Lost to Follow-up|2|||
164541356|NCT01829425|594355798|FG001|Overall Study|Lost to Follow-up|1|||
164541357|NCT03681951|594355799|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
164541358|NCT03681951|594355800|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
164541359|NCT03681951|594355801|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
164653167|NCT01621490|594757070|FG007|Overall Study|Study drug toxicity|4|||
164653168|NCT01621490|594757071|FG008|Overall Study|Study drug toxicity|1|||
164541360|NCT03681951|594355802|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
164541361|NCT03681951|594355803|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
164541362|NCT03681951|594355804|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
164541363|NCT03681951|594355805|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
164541364|NCT03681951|594355806|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
164541365|NCT03681951|594355799|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
164541366|NCT03681951|594355800|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
164541367|NCT03681951|594355801|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
164541368|NCT03681951|594355802|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
164541369|NCT03681951|594355803|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
164541370|NCT03681951|594355804|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
164541371|NCT03681951|594355805|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
164541372|NCT03681951|594355806|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
164541373|NCT03681951|594355799|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
164541374|NCT03681951|594355800|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
164541375|NCT03681951|594355801|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
164541376|NCT03681951|594355802|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
164541377|NCT03681951|594355803|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
164541378|NCT03681951|594355804|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
164541379|NCT03681951|594355805|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
164541380|NCT03681951|594355806|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
164541381|NCT01020448|594355807|FG000|Pre-assignment|Adverse Event|6|||
164541382|NCT01020448|594355807|FG000|Pre-assignment|Withdrawal by Subject|5|||
164541383|NCT01020448|594355807|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
164541384|NCT01020448|594355807|FG000|Treatment|Adverse Event|11|||
164541385|NCT01020448|594355807|FG000|Treatment|Consent Withdrawn|3|||
164541386|NCT01020448|594355807|FG000|Treatment|Disease Progression|2|||
164541387|NCT01020448|594355807|FG000|Treatment|Lack of Efficacy|8|||
164541388|NCT01020448|594355807|FG000|Treatment|Lost to Follow-up|2|||
164541389|NCT01230554|594355808|FG000|Overall Study|Lost to Follow-up|2|||
164541390|NCT01230554|594355808|FG000|Overall Study|Inability to maintain visit schedule|1|||
164541391|NCT01006265|594355819|FG000|Overall Study|Lost to Follow-up|1|||
164541392|NCT01006265|594355820|FG001|Overall Study|Lost to Follow-up|0|||
164541393|NCT01006265|594355821|FG002|Overall Study|Lost to Follow-up|1|||
164541394|NCT01006265|594355822|FG003|Overall Study|Lost to Follow-up|0|||
164541395|NCT01006265|594355819|FG000|Overall Study|Withdrawal by Subject|4|||
164541396|NCT01006265|594355820|FG001|Overall Study|Withdrawal by Subject|7|||
164541397|NCT01006265|594355821|FG002|Overall Study|Withdrawal by Subject|5|||
164541398|NCT01006265|594355822|FG003|Overall Study|Withdrawal by Subject|5|||
164541399|NCT01006265|594355819|FG000|Overall Study|Administrative reason|1|||
164541400|NCT01006265|594355820|FG001|Overall Study|Administrative reason|2|||
164541401|NCT01006265|594355821|FG002|Overall Study|Administrative reason|3|||
164541402|NCT01006265|594355822|FG003|Overall Study|Administrative reason|0|||
164541403|NCT01390272|594355823|FG000|Overall Study|Death|3|||
164541404|NCT01390272|594355824|FG001|Overall Study|Death|2|||
164541405|NCT01390272|594355823|FG000|Overall Study|Withdrawal by Subject|9|||
164541406|NCT01390272|594355824|FG001|Overall Study|Withdrawal by Subject|5|||
164541407|NCT01390272|594355823|FG000|Overall Study|Patient moved, no longer eligible|5|||
164541408|NCT01390272|594355824|FG001|Overall Study|Patient moved, no longer eligible|8|||
164541409|NCT01177384|594355825|FG000|Overall Study|Adverse Event|6|||
164541410|NCT01177384|594355826|FG001|Overall Study|Adverse Event|4|||
164541411|NCT01177384|594355825|FG000|Overall Study|Lack of Efficacy|0|||
164541412|NCT01177384|594355826|FG001|Overall Study|Lack of Efficacy|1|||
164541413|NCT01177384|594355825|FG000|Overall Study|Lost to Follow-up|3|||
164541414|NCT01177384|594355826|FG001|Overall Study|Lost to Follow-up|4|||
164541415|NCT01177384|594355825|FG000|Overall Study|Physician Decision|0|||
164541416|NCT01177384|594355826|FG001|Overall Study|Physician Decision|3|||
164541417|NCT01177384|594355825|FG000|Overall Study|Protocol Violation|0|||
164541418|NCT01177384|594355826|FG001|Overall Study|Protocol Violation|2|||
164653169|NCT01621490|594757072|FG009|Overall Study|Study drug toxicity|0|||
164653170|NCT01621490|594757073|FG010|Overall Study|Study drug toxicity|0|||
164653171|NCT01621490|594757063|FG000|Overall Study|Death|0|||
164541419|NCT01177384|594355825|FG000|Overall Study|Withdrawal by Subject|5|||
164541420|NCT01177384|594355826|FG001|Overall Study|Withdrawal by Subject|12|||
164541421|NCT01849497|594355827|FG000|Overall Study|Withdrawal by Subject|1|||
164541422|NCT01849497|594355828|FG001|Overall Study|Withdrawal by Subject|2|||
164541423|NCT01849497|594355827|FG000|Overall Study|Sponsor Decision|0|||
164541424|NCT01849497|594355828|FG001|Overall Study|Sponsor Decision|1|||
164541425|NCT01849497|594355827|FG000|Overall Study|Lost to Follow-up|0|||
164541426|NCT01849497|594355828|FG001|Overall Study|Lost to Follow-up|1|||
164541427|NCT00590044|594355829|FG000|Overall Study|Withdrawal by Subject|2|||
164541428|NCT00590044|594355830|FG001|Overall Study|Withdrawal by Subject|2|||
164653172|NCT01621490|594757064|FG001|Overall Study|Death|0|||
164541429|NCT00590044|594355829|FG000|Overall Study|wrong insulin arm assigned|1|||
164541430|NCT00590044|594355830|FG001|Overall Study|wrong insulin arm assigned|0|||
164541431|NCT00590044|594355829|FG000|Overall Study|Protocol Violation|1|||
164541432|NCT00590044|594355830|FG001|Overall Study|Protocol Violation|0|||
164541433|NCT01514136|594355831|FG000|Test Period 1; Test A|Protocol Violation|1|||
164541434|NCT01514136|594355832|FG001|Test Period 1; Test A|Protocol Violation|0|||
164541435|NCT01514136|594355833|FG002|Test Period 1; Test A|Protocol Violation|0|||
164541436|NCT01514136|594355834|FG003|Test Period 1; Test A|Protocol Violation|0|||
164541437|NCT01514136|594355835|FG004|Test Period 1; Test A|Protocol Violation|0|||
164541438|NCT01514136|594355836|FG005|Test Period 1; Test A|Protocol Violation|0|||
164541439|NCT01514136|594355837|FG006|Test Period 1; Test A|Protocol Violation|0|||
164541440|NCT01514136|594355838|FG007|Test Period 1; Test A|Protocol Violation|0|||
164541441|NCT01514136|594355831|FG000|Test Period 1; Test A|Break from study holiday|2|||
164541442|NCT01514136|594355832|FG001|Test Period 1; Test A|Break from study holiday|0|||
164541443|NCT01514136|594355833|FG002|Test Period 1; Test A|Break from study holiday|0|||
164541444|NCT01514136|594355834|FG003|Test Period 1; Test A|Break from study holiday|0|||
164541445|NCT01514136|594355835|FG004|Test Period 1; Test A|Break from study holiday|0|||
164541446|NCT01514136|594355836|FG005|Test Period 1; Test A|Break from study holiday|0|||
164541447|NCT01514136|594355837|FG006|Test Period 1; Test A|Break from study holiday|0|||
164541448|NCT01514136|594355838|FG007|Test Period 1; Test A|Break from study holiday|0|||
164541449|NCT01514136|594355831|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
164541450|NCT01514136|594355832|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
164541451|NCT01514136|594355833|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
164541452|NCT01514136|594355834|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
164541453|NCT01514136|594355835|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
164541454|NCT01514136|594355836|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
164541455|NCT01514136|594355837|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
164541456|NCT01514136|594355838|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
164541457|NCT01514136|594355831|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
164541458|NCT01514136|594355832|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
164541459|NCT01514136|594355833|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
164541460|NCT01514136|594355834|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
164541461|NCT01514136|594355835|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
164541462|NCT01514136|594355836|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
164541463|NCT01514136|594355837|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
164541464|NCT01514136|594355838|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
164541465|NCT01514136|594355831|FG000|Test Period 2; Test A*|Adverse Event|0|||
164541466|NCT01514136|594355832|FG001|Test Period 2; Test A*|Adverse Event|0|||
164541467|NCT01514136|594355833|FG002|Test Period 2; Test A*|Adverse Event|0|||
164541468|NCT01514136|594355834|FG003|Test Period 2; Test A*|Adverse Event|0|||
164541469|NCT01514136|594355835|FG004|Test Period 2; Test A*|Adverse Event|1|||
164541470|NCT01514136|594355836|FG005|Test Period 2; Test A*|Adverse Event|0|||
164541471|NCT01514136|594355837|FG006|Test Period 2; Test A*|Adverse Event|0|||
164541472|NCT01514136|594355838|FG007|Test Period 2; Test A*|Adverse Event|0|||
164541473|NCT01514136|594355831|FG000|Test Period 2; Test A*|Holiday|0|||
164541474|NCT01514136|594355832|FG001|Test Period 2; Test A*|Holiday|0|||
164541475|NCT01514136|594355833|FG002|Test Period 2; Test A*|Holiday|0|||
164541476|NCT01514136|594355834|FG003|Test Period 2; Test A*|Holiday|0|||
164541477|NCT01514136|594355835|FG004|Test Period 2; Test A*|Holiday|1|||
164541478|NCT01514136|594355836|FG005|Test Period 2; Test A*|Holiday|0|||
164541479|NCT01514136|594355837|FG006|Test Period 2; Test A*|Holiday|0|||
164541480|NCT01514136|594355838|FG007|Test Period 2; Test A*|Holiday|0|||
164541481|NCT01514136|594355831|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
164541482|NCT01514136|594355832|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
164541483|NCT01514136|594355833|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
164541484|NCT01514136|594355834|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
164541485|NCT01514136|594355835|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
164541486|NCT01514136|594355836|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
164541487|NCT01514136|594355837|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
164541488|NCT01514136|594355838|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
164541489|NCT01514136|594355831|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
164541490|NCT01514136|594355832|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
164541491|NCT01514136|594355833|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
164541492|NCT01514136|594355834|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
164541493|NCT01514136|594355835|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
164541494|NCT01514136|594355836|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
164541495|NCT01514136|594355837|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
164541496|NCT01514136|594355838|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
164541497|NCT01514136|594355831|FG000|Test Period 2; Test C*|holiday|0|||
164541498|NCT01514136|594355832|FG001|Test Period 2; Test C*|holiday|0|||
164541499|NCT01514136|594355833|FG002|Test Period 2; Test C*|holiday|0|||
164541500|NCT01514136|594355834|FG003|Test Period 2; Test C*|holiday|0|||
164541501|NCT01514136|594355835|FG004|Test Period 2; Test C*|holiday|0|||
164541502|NCT01514136|594355836|FG005|Test Period 2; Test C*|holiday|0|||
164541503|NCT01514136|594355837|FG006|Test Period 2; Test C*|holiday|1|||
164541504|NCT01514136|594355838|FG007|Test Period 2; Test C*|holiday|0|||
164541505|NCT01514136|594355831|FG000|Test Period 2; Test C*|Protocol Violation|0|||
164541506|NCT01514136|594355832|FG001|Test Period 2; Test C*|Protocol Violation|0|||
164541507|NCT01514136|594355833|FG002|Test Period 2; Test C*|Protocol Violation|0|||
164541508|NCT01514136|594355834|FG003|Test Period 2; Test C*|Protocol Violation|0|||
164541509|NCT01514136|594355835|FG004|Test Period 2; Test C*|Protocol Violation|0|||
164541510|NCT01514136|594355836|FG005|Test Period 2; Test C*|Protocol Violation|0|||
164541511|NCT01514136|594355837|FG006|Test Period 2; Test C*|Protocol Violation|1|||
164541512|NCT01514136|594355838|FG007|Test Period 2; Test C*|Protocol Violation|0|||
164541513|NCT00888381|594355839|FG000|Overall Study|Lost to Follow-up|0|||
164541514|NCT00888381|594355840|FG001|Overall Study|Lost to Follow-up|1|||
164541515|NCT02729740|594355841|FG000|Overall Study|Early Termination|130|||
164541516|NCT02729740|594355841|FG000|Overall Study|Other|1|||
164541517|NCT00307333|594355842|FG000|Overall Study|Lost to Follow-up|11|||
164541518|NCT00307333|594355843|FG001|Overall Study|Lost to Follow-up|3|||
164541519|NCT00757003|594355847|FG000|Overall Study|Death|33|||
164541520|NCT00757003|594355847|FG000|Overall Study|Lost to Follow-up|9|||
164541521|NCT00757003|594355847|FG000|Overall Study|Withdrawal by Subject|4|||
164541522|NCT00757003|594355847|FG000|Overall Study|Surgically explanted|2|||
164541523|NCT00757003|594355847|FG000|Overall Study|Not implanted|1|||
164541524|NCT04166383|594355850|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
164541525|NCT04166383|594355850|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
164541526|NCT04166383|594355850|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
164541527|NCT03044886|594355851|FG000|Overall Study|Lost to Follow-up|15|||
164541528|NCT03044886|594355852|FG001|Overall Study|Lost to Follow-up|10|||
164541529|NCT03044886|594355853|FG002|Overall Study|Lost to Follow-up|12|||
164541530|NCT00375219|594355856|FG000|Overall Study|Failure to achieve a response|16|||
164541531|NCT00375219|594355857|FG001|Overall Study|Failure to achieve a response|2|||
164541532|NCT00375219|594355858|FG002|Overall Study|Failure to achieve a response|0|||
164541533|NCT00375219|594355856|FG000|Overall Study|Adverse Event|8|||
164541534|NCT00375219|594355857|FG001|Overall Study|Adverse Event|2|||
164541535|NCT00375219|594355858|FG002|Overall Study|Adverse Event|1|||
164541536|NCT00375219|594355856|FG000|Overall Study|Protocol Violation|1|||
164541537|NCT00375219|594355857|FG001|Overall Study|Protocol Violation|0|||
164541538|NCT00375219|594355858|FG002|Overall Study|Protocol Violation|1|||
164541539|NCT00375219|594355856|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
164541540|NCT00375219|594355857|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
164541541|NCT00375219|594355858|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
164541542|NCT00375219|594355856|FG000|Overall Study|Lost to Follow-up|1|||
164541543|NCT00375219|594355857|FG001|Overall Study|Lost to Follow-up|1|||
164541544|NCT00375219|594355858|FG002|Overall Study|Lost to Follow-up|0|||
164541545|NCT00375219|594355856|FG000|Overall Study|Disease progression|18|||
164541546|NCT00375219|594355857|FG001|Overall Study|Disease progression|9|||
164541547|NCT00375219|594355858|FG002|Overall Study|Disease progression|12|||
164541548|NCT00375219|594355856|FG000|Overall Study|Death|4|||
164541549|NCT00375219|594355857|FG001|Overall Study|Death|3|||
164541550|NCT00375219|594355858|FG002|Overall Study|Death|7|||
164541551|NCT00375219|594355856|FG000|Overall Study|Hematologic resistance|1|||
164541552|NCT00375219|594355857|FG001|Overall Study|Hematologic resistance|0|||
164541553|NCT00375219|594355858|FG002|Overall Study|Hematologic resistance|0|||
164541554|NCT00375219|594355856|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
164541555|NCT00375219|594355857|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
164541556|NCT00375219|594355858|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
164541557|NCT00375219|594355856|FG000|Overall Study|Allograft|2|||
164541558|NCT00375219|594355857|FG001|Overall Study|Allograft|0|||
164541559|NCT00375219|594355858|FG002|Overall Study|Allograft|0|||
164541560|NCT00375219|594355856|FG000|Overall Study|Cord blood transplantation|1|||
164190645|NCT01411852|593066328|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
164190646|NCT01411852|593066329|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
164190647|NCT01411852|593066328|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
164190648|NCT01411852|593066329|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
164190649|NCT01411852|593066328|FG000|Hospital Intervention Phase|Vascular access failed|1|||
164190650|NCT01411852|593066329|FG001|Hospital Intervention Phase|Vascular access failed|0|||
164541561|NCT00375219|594355857|FG001|Overall Study|Cord blood transplantation|0|||
164541562|NCT00375219|594355858|FG002|Overall Study|Cord blood transplantation|0|||
164541563|NCT00375219|594355856|FG000|Overall Study|Withdrawal by Subject|1|||
164541564|NCT00375219|594355857|FG001|Overall Study|Withdrawal by Subject|0|||
164190651|NCT00272844|593066330|FG000|Overall Study|Withdrawal by Subject|5|||
164190652|NCT03193047|593066331|FG000|Overall Study|Physician Decision|1|||
164541565|NCT00375219|594355858|FG002|Overall Study|Withdrawal by Subject|0|||
164541566|NCT02684279|594355861|FG000|Overall Study|Adverse Event|87|||
164541567|NCT02684279|594355861|FG000|Overall Study|Lack of Efficacy|4|||
164541568|NCT02684279|594355861|FG000|Overall Study|Lost to Follow-up|61|||
164541569|NCT02684279|594355861|FG000|Overall Study|Protocol Violation|6|||
164541570|NCT02684279|594355861|FG000|Overall Study|Pregnancy|8|||
164541571|NCT02684279|594355861|FG000|Overall Study|Withdrawal by Subject|92|||
164541572|NCT02684279|594355861|FG000|Overall Study|non-compliance with study drug|9|||
164541573|NCT02684279|594355861|FG000|Overall Study|non compliance with study visits|2|||
164541574|NCT02684279|594355861|FG000|Overall Study|subject to have surgery|1|||
164541575|NCT02684279|594355861|FG000|Overall Study|family emergency|1|||
164541576|NCT02684279|594355861|FG000|Overall Study|Site closures|7|||
164541577|NCT02684279|594355861|FG000|Overall Study|Physician Decision|1|||
164541578|NCT00228566|594355862|FG000|Overall Study|Adverse Event|31|||
164541579|NCT00228566|594355862|FG000|Overall Study|Lack of Efficacy|14|||
164541580|NCT00228566|594355862|FG000|Overall Study|Lost to Follow-up|16|||
164541581|NCT00228566|594355862|FG000|Overall Study|Physician Decision|5|||
164541582|NCT00228566|594355862|FG000|Overall Study|Withdrawal by Subject|4|||
164541583|NCT00228566|594355862|FG000|Overall Study|Miscellaneous|1|||
164541584|NCT01479829|594355863|FG000|Overall Study|Withdrawal by Subject|8|||
164541585|NCT01479829|594355864|FG001|Overall Study|Withdrawal by Subject|10|||
164541586|NCT02229539|594357142|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
164541587|NCT02229539|594357143|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
164541588|NCT02229539|594357144|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
164541589|NCT02229539|594357142|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
164541590|NCT02229539|594357143|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
164541591|NCT02229539|594357144|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
164541592|NCT02229539|594357142|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
164541593|NCT02229539|594357143|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
164541594|NCT02229539|594357144|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
164541595|NCT02229539|594357142|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
164541596|NCT02229539|594357143|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
164541597|NCT02229539|594357144|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
164541598|NCT02229539|594357142|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
164541599|NCT02229539|594357143|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
164541600|NCT02229539|594357144|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
164541601|NCT02229539|594357142|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
164541602|NCT02229539|594357143|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
164541603|NCT02229539|594357144|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
164541604|NCT03441334|594357145|FG000|Overall Study|Withdrawal by Subject|1|||
164541605|NCT03441334|594357146|FG001|Overall Study|Withdrawal by Subject|0|||
164541606|NCT00088907|594357147|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
164541607|NCT00088907|594357148|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
164541608|NCT00088907|594357147|FG000|Randomized Study (Step 1)|Adverse Event|14|||
164541609|NCT00088907|594357148|FG001|Randomized Study (Step 1)|Adverse Event|19|||
164541610|NCT00088907|594357147|FG000|Randomized Study (Step 1)|Death|11|||
164541611|NCT00088907|594357148|FG001|Randomized Study (Step 1)|Death|12|||
164541612|NCT00088907|594357147|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
164541613|NCT00088907|594357148|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
164541614|NCT00088907|594357147|FG000|Randomized Study (Step 1)|complicating disease|3|||
164541615|NCT00088907|594357148|FG001|Randomized Study (Step 1)|complicating disease|1|||
164541616|NCT00088907|594357147|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
164541617|NCT00088907|594357148|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
164541618|NCT00088907|594357147|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
164541619|NCT00088907|594357148|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
164541620|NCT00088907|594357147|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
164541621|NCT00088907|594357148|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
164541622|NCT00088907|594357147|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
164541623|NCT00088907|594357148|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
164541624|NCT00088907|594357147|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
164541625|NCT00088907|594357148|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
164541626|NCT00088907|594357147|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
164541627|NCT00088907|594357148|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
164541628|NCT00682448|594357153|FG000|Overall Study|Adverse Event|1|||
164541629|NCT00682448|594357154|FG001|Overall Study|Adverse Event|2|||
164541630|NCT00682448|594357153|FG000|Overall Study|Lack of Efficacy|1|||
164541631|NCT00682448|594357154|FG001|Overall Study|Lack of Efficacy|0|||
164541632|NCT00682448|594357153|FG000|Overall Study|Lost to Follow-up|1|||
164541633|NCT00682448|594357154|FG001|Overall Study|Lost to Follow-up|3|||
164541634|NCT00682448|594357153|FG000|Overall Study|Pregnancy|0|||
164653173|NCT01621490|594757065|FG002|Overall Study|Death|0|||
164420578|NCT02718417|593910944|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
164541635|NCT00682448|594357154|FG001|Overall Study|Pregnancy|1|||
164541636|NCT00682448|594357153|FG000|Overall Study|Withdrawal by Subject|2|||
164420579|NCT02718417|593910945|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
164541637|NCT00682448|594357154|FG001|Overall Study|Withdrawal by Subject|0|||
164541638|NCT00268437|594357157|FG000|Overall Study|Ineligible|1|||
164541639|NCT00525044|594357158|FG000|Overall Study|Lost to Follow-up|0|||
164541640|NCT00525044|594357159|FG001|Overall Study|Lost to Follow-up|1|||
164541641|NCT02553265|594357160|FG000|Enrollment|Death|0|||
164541642|NCT02553265|594357161|FG001|Enrollment|Death|0|||
164541643|NCT02553265|594357162|FG002|Enrollment|Death|1|||
164541644|NCT02553265|594357160|FG000|First Intervention (28 Days)|Adverse Event|1|||
164541645|NCT02553265|594357161|FG001|First Intervention (28 Days)|Adverse Event|0|||
164541646|NCT02553265|594357162|FG002|First Intervention (28 Days)|Adverse Event|0|||
164541647|NCT02553265|594357160|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
164541648|NCT02553265|594357161|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
164541649|NCT02553265|594357162|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
164541650|NCT02553265|594357160|FG000|Second Intervention (28 Days)|Adverse Event|1|||
164541651|NCT02553265|594357161|FG001|Second Intervention (28 Days)|Adverse Event|0|||
164541652|NCT02553265|594357162|FG002|Second Intervention (28 Days)|Adverse Event|0|||
164541653|NCT02553265|594357160|FG000|Third Intervention (28 Days)|Adverse Event|1|||
164541654|NCT02553265|594357161|FG001|Third Intervention (28 Days)|Adverse Event|0|||
164541655|NCT02553265|594357162|FG002|Third Intervention (28 Days)|Adverse Event|0|||
164541656|NCT02553265|594357160|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
164541657|NCT02553265|594357161|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
164541658|NCT02553265|594357162|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
164541659|NCT01022996|594357165|FG000|Overall Study|Adverse Event|14|||
164541660|NCT01022996|594357165|FG000|Overall Study|Withdrawal by Subject|3|||
164541661|NCT01022996|594357165|FG000|Overall Study|Lost to Follow-up|1|||
164541662|NCT01022996|594357165|FG000|Overall Study|Administrative problems|6|||
164541663|NCT01022996|594357165|FG000|Overall Study|Disease Progression|32|||
164541664|NCT01022996|594357165|FG000|Overall Study|Protocol Violation|1|||
164541665|NCT02767323|594357166|FG000|Overall Study|Withdrawal by Subject|17|||
164541666|NCT02767323|594357167|FG001|Overall Study|Withdrawal by Subject|5|||
164541667|NCT02767323|594357168|FG002|Overall Study|Withdrawal by Subject|13|||
164541668|NCT02767323|594357169|FG003|Overall Study|Withdrawal by Subject|0|||
164541669|NCT02767323|594357166|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
164541670|NCT02767323|594357167|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
164541671|NCT02767323|594357168|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
164541672|NCT02767323|594357169|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
164541673|NCT02023242|594357170|FG000|Overall Study|Lost to Follow-up|3|||
164541674|NCT02023242|594357171|FG001|Overall Study|Lost to Follow-up|1|||
164541675|NCT02023242|594357170|FG000|Overall Study|Death|0|||
164541676|NCT02023242|594357171|FG001|Overall Study|Death|1|||
164541677|NCT00710879|594357172|FG000|Overall Study|Lost to Follow-up|2|||
164541678|NCT00710879|594357173|FG001|Overall Study|Lost to Follow-up|1|||
164541679|NCT00710879|594357172|FG000|Overall Study|Protocol Violation|0|||
164541680|NCT00710879|594357173|FG001|Overall Study|Protocol Violation|3|||
164541681|NCT01274715|594357174|FG000|Overall Study|Lost to Follow-up|1|||
164541682|NCT01274715|594357174|FG000|Overall Study|After consent, met exclusion criteria.|1|||
164541683|NCT01274715|594357174|FG000|Overall Study|After consent, met exclusion criteria.|1|||
164541684|NCT01274715|594357174|FG000|Overall Study|After consent, met exclusion criteria.|1|||
164541685|NCT01195090|594357180|FG000|Overall Study|Adverse Event|1|||
164541686|NCT01195090|594357181|FG001|Overall Study|Adverse Event|2|||
164541687|NCT01195090|594357180|FG000|Overall Study|Lost to Follow-up|2|||
164541688|NCT01195090|594357181|FG001|Overall Study|Lost to Follow-up|2|||
164541689|NCT01195090|594357180|FG000|Overall Study|Protocol Violation|3|||
164541690|NCT01195090|594357181|FG001|Overall Study|Protocol Violation|4|||
164541691|NCT05111041|594357182|FG000|Overall Study|Lost to Follow-up|6|||
164541692|NCT05111041|594357183|FG001|Overall Study|Lost to Follow-up|7|||
164541693|NCT05111041|594357182|FG000|Overall Study|Withdrawal by Subject|1|||
164541694|NCT05111041|594357183|FG001|Overall Study|Withdrawal by Subject|0|||
164541695|NCT04912245|594357184|FG000|Overall Study|Withdrawal by Subject|21|||
164541696|NCT04912245|594357185|FG001|Overall Study|Withdrawal by Subject|4|||
164541697|NCT04912245|594357184|FG000|Overall Study|Lost to Follow-up|5|||
164541698|NCT04912245|594357185|FG001|Overall Study|Lost to Follow-up|11|||
164541699|NCT01011439|594357186|FG000|Overall Study|Death|37|||
164653174|NCT01621490|594757066|FG003|Overall Study|Death|0|||
164541700|NCT01011439|594357186|FG000|Overall Study|Lost to Follow-up|4|||
164541701|NCT01011439|594357186|FG000|Overall Study|Withdrawal by Subject|1|||
164653175|NCT01621490|594757067|FG004|Overall Study|Death|0|||
164541702|NCT01011439|594357186|FG000|Overall Study|Sponsor's decision|15|||
164541703|NCT00058552|594357187|FG000|Overall Study|Died prior to receiving treatment|4|||
164541704|NCT00058552|594357188|FG001|Overall Study|Died prior to receiving treatment|2|||
164653176|NCT01621490|594757068|FG005|Overall Study|Death|0|||
164541705|NCT00058552|594357187|FG000|Overall Study|Disease progression|52|||
164541706|NCT00058552|594357188|FG001|Overall Study|Disease progression|44|||
164541707|NCT00058552|594357187|FG000|Overall Study|Adverse Event|4|||
164541708|NCT00058552|594357188|FG001|Overall Study|Adverse Event|2|||
164541709|NCT00058552|594357187|FG000|Overall Study|Withdrawal by Subject|3|||
164541710|NCT00058552|594357188|FG001|Overall Study|Withdrawal by Subject|5|||
164653177|NCT01621490|594757069|FG006|Overall Study|Death|0|||
164541711|NCT00058552|594357187|FG000|Overall Study|Physician Decision|2|||
164541712|NCT00058552|594357188|FG001|Overall Study|Physician Decision|5|||
164541713|NCT00058552|594357187|FG000|Overall Study|Clinical disease progression|0|||
164541714|NCT00058552|594357188|FG001|Overall Study|Clinical disease progression|4|||
164541715|NCT00210184|594357189|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
164541716|NCT03198520|594357192|FG000|Overall Study|Physician Decision|2|||
164541717|NCT03198520|594357192|FG000|Overall Study|Protocol Violation|2|||
164541718|NCT03198520|594357192|FG000|Overall Study|Withdrawal by Subject|1|||
164541719|NCT03198520|594357192|FG000|Overall Study|Study Ended|1|||
164541720|NCT00823823|594357193|FG000|Overall Study|Lost to Follow-up|3|||
164541721|NCT00823823|594357194|FG001|Overall Study|Lost to Follow-up|1|||
164541722|NCT00823823|594357193|FG000|Overall Study|Protocol Violation|5|||
164541723|NCT00823823|594357194|FG001|Overall Study|Protocol Violation|5|||
164541724|NCT03781323|594357195|FG000|Overall Study|Withdrawal by Subject|1|||
164541725|NCT01338415|594357196|FG000|Core + Extension|Adverse Event|8|||
164541726|NCT01338415|594357197|FG001|Core + Extension|Adverse Event|6|||
164541727|NCT01338415|594357198|FG002|Core + Extension|Adverse Event|0|||
164541728|NCT01338415|594357196|FG000|Core + Extension|Withdrawal by Subject|1|||
164541729|NCT01338415|594357197|FG001|Core + Extension|Withdrawal by Subject|1|||
164541730|NCT01338415|594357198|FG002|Core + Extension|Withdrawal by Subject|0|||
164541731|NCT01338415|594357196|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
164541732|NCT01338415|594357197|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
164541733|NCT01338415|594357198|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
164541734|NCT01338415|594357196|FG000|Core + Extension|Other (administrative reason)|1|||
164541735|NCT01338415|594357197|FG001|Core + Extension|Other (administrative reason)|0|||
164541736|NCT01338415|594357198|FG002|Core + Extension|Other (administrative reason)|0|||
164541737|NCT01338415|594357196|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
164541738|NCT01338415|594357197|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
164541739|NCT01338415|594357198|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
164541740|NCT01338415|594357196|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
164541741|NCT01338415|594357197|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
164541742|NCT01338415|594357198|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
164541743|NCT01338415|594357196|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
164541744|NCT01338415|594357197|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
164541745|NCT01338415|594357198|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
164541746|NCT01338415|594357196|FG000|Exceptional Use Treatment Period|Death|0|||
164541747|NCT01338415|594357197|FG001|Exceptional Use Treatment Period|Death|0|||
164541748|NCT01338415|594357198|FG002|Exceptional Use Treatment Period|Death|1|||
164541749|NCT01118325|594357199|FG000|Overall Study|Adverse Event|1|||
164541750|NCT01118325|594357200|FG001|Overall Study|Adverse Event|0|||
164541751|NCT01118325|594357201|FG002|Overall Study|Adverse Event|1|||
164541752|NCT00536809|594357202|FG000|Phase II|Adverse Event|1|||
164541753|NCT00536809|594357202|FG000|Phase II|Referred for surgical resection|1|||
164541754|NCT03334409|594357203|FG000|Overall Study|Did not meet inclusion criteria|1|||
164541755|NCT03334409|594357204|FG001|Overall Study|Did not meet inclusion criteria|0|||
164541756|NCT00233363|594357212|FG000|Overall Study|Adverse Event|1|||
164541757|NCT00233363|594357213|FG001|Overall Study|Adverse Event|2|||
164541758|NCT00233363|594357212|FG000|Overall Study|Lack of Efficacy|0|||
164541759|NCT00233363|594357213|FG001|Overall Study|Lack of Efficacy|2|||
164541760|NCT00233363|594357212|FG000|Overall Study|Withdrawal by Subject|1|||
164541761|NCT00233363|594357213|FG001|Overall Study|Withdrawal by Subject|1|||
164541762|NCT00233363|594357212|FG000|Overall Study|Aggravation of complication|1|||
164541763|NCT00233363|594357213|FG001|Overall Study|Aggravation of complication|0|||
164541764|NCT01526551|594357216|FG000|Overall Study|Lack of returned parental consent form|424|||
164541765|NCT00874770|594357217|FG000|Overall Study|Lack of Efficacy|2|||
164541766|NCT00874770|594357218|FG001|Overall Study|Lack of Efficacy|0|||
164541767|NCT00874770|594357219|FG002|Overall Study|Lack of Efficacy|0|||
164541768|NCT00874770|594357220|FG003|Overall Study|Lack of Efficacy|2|||
164541769|NCT00874770|594357217|FG000|Overall Study|Adverse Event|1|||
164541770|NCT00874770|594357218|FG001|Overall Study|Adverse Event|1|||
164541771|NCT00874770|594357219|FG002|Overall Study|Adverse Event|4|||
164541772|NCT00874770|594357220|FG003|Overall Study|Adverse Event|2|||
164541773|NCT00874770|594357217|FG000|Overall Study|Lost to Follow-up|1|||
164541774|NCT00874770|594357218|FG001|Overall Study|Lost to Follow-up|0|||
164541775|NCT00874770|594357219|FG002|Overall Study|Lost to Follow-up|0|||
164541776|NCT00874770|594357220|FG003|Overall Study|Lost to Follow-up|1|||
164541777|NCT00874770|594357217|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
164541778|NCT00874770|594357218|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
164420580|NCT02718417|593910943|FG000|Long-term Follow-up Phase|Other|0|||
164541779|NCT00874770|594357219|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
164541780|NCT00874770|594357220|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
164541781|NCT00718549|594357221|FG000|Induction Phase|Disease Progression|1|||
164541782|NCT00718549|594357222|FG001|Induction Phase|Disease Progression|0|||
164541783|NCT00718549|594357223|FG002|Induction Phase|Disease Progression|0|||
164541784|NCT00718549|594357221|FG000|Induction Phase|Eligibility Criteria Violation|2|||
164541785|NCT00718549|594357222|FG001|Induction Phase|Eligibility Criteria Violation|0|||
164541786|NCT00718549|594357223|FG002|Induction Phase|Eligibility Criteria Violation|0|||
164541787|NCT00718549|594357221|FG000|Induction Phase|Early Termination - No Additional Info|59|||
164541788|NCT00718549|594357222|FG001|Induction Phase|Early Termination - No Additional Info|0|||
164541789|NCT00718549|594357223|FG002|Induction Phase|Early Termination - No Additional Info|0|||
164541790|NCT00718549|594357221|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
164541791|NCT00718549|594357222|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
164541792|NCT00718549|594357223|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
164541793|NCT00718549|594357221|FG000|Maintenance/ Observation Phase|Death|0|||
164541794|NCT00718549|594357222|FG001|Maintenance/ Observation Phase|Death|1|||
164541795|NCT00718549|594357223|FG002|Maintenance/ Observation Phase|Death|2|||
164541796|NCT00718549|594357221|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
164541797|NCT00718549|594357222|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
164541798|NCT00718549|594357223|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
164541799|NCT00718549|594357221|FG000|Maintenance/ Observation Phase|Progression|0|||
164541800|NCT00718549|594357222|FG001|Maintenance/ Observation Phase|Progression|5|||
164541801|NCT00718549|594357223|FG002|Maintenance/ Observation Phase|Progression|14|||
164541802|NCT00718549|594357221|FG000|Maintenance/ Observation Phase|Relapse|0|||
164541803|NCT00718549|594357222|FG001|Maintenance/ Observation Phase|Relapse|3|||
164541804|NCT00718549|594357223|FG002|Maintenance/ Observation Phase|Relapse|2|||
164541805|NCT00239226|594357224|FG000|Overall Study|permAF during stabilization period|0|||
164541806|NCT00239226|594357225|FG001|Overall Study|permAF during stabilization period|0|||
164541807|NCT00239226|594357226|FG002|Overall Study|permAF during stabilization period|0|||
164541808|NCT00239226|594357227|FG003|Overall Study|permAF during stabilization period|3|||
164541809|NCT00239226|594357224|FG000|Overall Study|Lost to Follow-up|1|||
164541810|NCT00239226|594357225|FG001|Overall Study|Lost to Follow-up|0|||
164541811|NCT00239226|594357226|FG002|Overall Study|Lost to Follow-up|1|||
164541812|NCT00239226|594357227|FG003|Overall Study|Lost to Follow-up|0|||
164541813|NCT01303965|594357229|FG000|Overall Study|Adverse Event|1|||
164541814|NCT01303965|594357230|FG001|Overall Study|Adverse Event|1|||
164541815|NCT01303965|594357229|FG000|Overall Study|Death|0|||
164541816|NCT01303965|594357230|FG001|Overall Study|Death|3|||
164541817|NCT01303965|594357229|FG000|Overall Study|Withdrawal by Subject|1|||
164541818|NCT01303965|594357230|FG001|Overall Study|Withdrawal by Subject|0|||
164541819|NCT01303965|594357229|FG000|Overall Study|Disease Progression|1|||
164541820|NCT01303965|594357230|FG001|Overall Study|Disease Progression|6|||
164541821|NCT04534491|594357232|FG000|Overall Study|Not completed end-of-study interview|24|||
164541822|NCT04534491|594357232|FG000|Overall Study|Non-users|70|||
164541823|NCT04534491|594357232|FG000|Overall Study|Non-verifiable users|58|||
164541824|NCT02871778|594357235|FG000|Part A: Treatment Period 1|Adverse Event|1|||
164541825|NCT02871778|594357236|FG001|Part A: Treatment Period 1|Adverse Event|1|||
164541826|NCT02871778|594357237|FG002|Part A: Treatment Period 1|Adverse Event|1|||
164541827|NCT02871778|594357238|FG003|Part A: Treatment Period 1|Adverse Event|0|||
164541828|NCT02871778|594357239|FG004|Part A: Treatment Period 1|Adverse Event|0|||
164541829|NCT02871778|594357240|FG005|Part A: Treatment Period 1|Adverse Event|0|||
164541830|NCT02871778|594357241|FG006|Part A: Treatment Period 1|Adverse Event|0|||
164541831|NCT02871778|594357242|FG007|Part A: Treatment Period 1|Adverse Event|0|||
164541832|NCT02871778|594357235|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
164541833|NCT02871778|594357236|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
164541834|NCT02871778|594357237|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
164541835|NCT02871778|594357238|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
164541836|NCT02871778|594357239|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
164541837|NCT02871778|594357240|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
164541838|NCT02871778|594357241|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
164541839|NCT02871778|594357242|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
164541840|NCT02871778|594357235|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
164541841|NCT02871778|594357236|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
164541842|NCT02871778|594357237|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
164653178|NCT01621490|594757070|FG007|Overall Study|Death|0|||
164190653|NCT03193047|593066332|FG001|Overall Study|Physician Decision|0|||
164190654|NCT03193047|593066331|FG000|Overall Study|Participant Left State|1|||
164541843|NCT02871778|594357238|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
164541844|NCT02871778|594357239|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
164541845|NCT02871778|594357240|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
164541846|NCT02871778|594357241|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
164653179|NCT01621490|594757071|FG008|Overall Study|Death|1|||
164541847|NCT02871778|594357242|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
164541848|NCT02871778|594357235|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
164653180|NCT01621490|594757072|FG009|Overall Study|Death|0|||
164541849|NCT02871778|594357236|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
164541850|NCT02871778|594357237|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
164541851|NCT02871778|594357238|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
164541852|NCT02871778|594357239|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
164541853|NCT02871778|594357240|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
164541854|NCT02871778|594357241|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
164541855|NCT02871778|594357242|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
164541856|NCT02871778|594357235|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
164541857|NCT02871778|594357236|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
164541858|NCT02871778|594357237|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
164541859|NCT02871778|594357238|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
164541860|NCT02871778|594357239|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
164541861|NCT02871778|594357240|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
164541862|NCT02871778|594357241|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
164541863|NCT02871778|594357242|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
164541864|NCT02871778|594357235|FG000|Part A: Treatment Period 2|Adverse Event|2|||
164541865|NCT02871778|594357236|FG001|Part A: Treatment Period 2|Adverse Event|2|||
164541866|NCT02871778|594357237|FG002|Part A: Treatment Period 2|Adverse Event|0|||
164541867|NCT02871778|594357238|FG003|Part A: Treatment Period 2|Adverse Event|0|||
164541868|NCT02871778|594357239|FG004|Part A: Treatment Period 2|Adverse Event|0|||
164541869|NCT02871778|594357240|FG005|Part A: Treatment Period 2|Adverse Event|0|||
164541870|NCT02871778|594357241|FG006|Part A: Treatment Period 2|Adverse Event|0|||
164541871|NCT02871778|594357242|FG007|Part A: Treatment Period 2|Adverse Event|0|||
164541872|NCT02871778|594357235|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
164541873|NCT02871778|594357236|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
164541874|NCT02871778|594357237|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
164190655|NCT03193047|593066332|FG001|Overall Study|Participant Left State|0|||
164190656|NCT00791700|593066335|FG000|Overall Study|Insufficient clinical response|1|||
164190657|NCT00791700|593066336|FG001|Overall Study|Insufficient clinical response|4|||
164190658|NCT00791700|593066337|FG002|Overall Study|Insufficient clinical response|1|||
164190659|NCT00791700|593066338|FG003|Overall Study|Insufficient clinical response|8|||
164541875|NCT02871778|594357238|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
164541876|NCT02871778|594357239|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
164541877|NCT02871778|594357240|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
164541878|NCT02871778|594357241|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
164541879|NCT02871778|594357242|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
164541880|NCT02871778|594357235|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
164541881|NCT02871778|594357236|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
164541882|NCT02871778|594357237|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
164541883|NCT02871778|594357238|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
164541884|NCT02871778|594357239|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
164541885|NCT02871778|594357240|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
164541886|NCT02871778|594357241|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
164541887|NCT02871778|594357242|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
164541888|NCT02871778|594357235|FG000|Part B: Treatment Period 3|Adverse Event|0|||
164541889|NCT02871778|594357236|FG001|Part B: Treatment Period 3|Adverse Event|0|||
164541890|NCT02871778|594357237|FG002|Part B: Treatment Period 3|Adverse Event|0|||
164541891|NCT02871778|594357238|FG003|Part B: Treatment Period 3|Adverse Event|0|||
164541892|NCT02871778|594357239|FG004|Part B: Treatment Period 3|Adverse Event|1|||
164541893|NCT02871778|594357240|FG005|Part B: Treatment Period 3|Adverse Event|1|||
164541894|NCT02871778|594357241|FG006|Part B: Treatment Period 3|Adverse Event|1|||
164541895|NCT02871778|594357242|FG007|Part B: Treatment Period 3|Adverse Event|0|||
164541896|NCT02653300|594357244|FG000|Overall Study|Withdrawal by Subject|2|||
164541897|NCT00369785|594357245|FG000|Overall Study|Physician Decision|3|||
164541898|NCT00369785|594357246|FG001|Overall Study|Physician Decision|2|||
164541899|NCT00369785|594357245|FG000|Overall Study|Death|1|||
164541900|NCT00369785|594357246|FG001|Overall Study|Death|2|||
164541901|NCT00369785|594357245|FG000|Overall Study|Withdrawal by Subject|7|||
164541902|NCT00369785|594357246|FG001|Overall Study|Withdrawal by Subject|6|||
164541903|NCT00369785|594357245|FG000|Overall Study|Toxicity|6|||
164653181|NCT01621490|594757073|FG010|Overall Study|Death|0|||
164541904|NCT00369785|594357246|FG001|Overall Study|Toxicity|4|||
164541905|NCT00369785|594357245|FG000|Overall Study|Never started|0|||
164541906|NCT00369785|594357246|FG001|Overall Study|Never started|2|||
164541907|NCT00369785|594357245|FG000|Overall Study|Progression|4|||
164541908|NCT00369785|594357246|FG001|Overall Study|Progression|4|||
164541909|NCT00369785|594357245|FG000|Overall Study|Multiple reasons|6|||
164541910|NCT00369785|594357246|FG001|Overall Study|Multiple reasons|5|||
164541911|NCT00800683|594357247|FG000|Overall Study|Adverse Event|11|||
164541912|NCT00800683|594357248|FG001|Overall Study|Adverse Event|8|||
164541913|NCT00800683|594357247|FG000|Overall Study|Lost to Follow-up|3|||
164302039|NCT03847896|593482508|FG004|Overall Study|Other reasons|1|||
164541914|NCT00800683|594357248|FG001|Overall Study|Lost to Follow-up|1|||
164541915|NCT00800683|594357247|FG000|Overall Study|Withdrawal by Subject|1|||
164541916|NCT00800683|594357248|FG001|Overall Study|Withdrawal by Subject|7|||
164541917|NCT00800683|594357247|FG000|Overall Study|Lack of Efficacy|1|||
164541918|NCT00800683|594357248|FG001|Overall Study|Lack of Efficacy|1|||
164541919|NCT00800683|594357247|FG000|Overall Study|Other|1|||
164541920|NCT00800683|594357248|FG001|Overall Study|Other|2|||
164541921|NCT02247960|594357249|FG000|Patient Consent and Randomization|Physician Decision|2|||
164541922|NCT02247960|594357250|FG001|Patient Consent and Randomization|Physician Decision|2|||
164541923|NCT02247960|594357249|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
164541924|NCT02247960|594357250|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
164541925|NCT02247960|594357249|FG000|Catheter Removed|Lost to Follow-up|7|||
164541926|NCT02247960|594357250|FG001|Catheter Removed|Lost to Follow-up|10|||
164541927|NCT01848353|594357251|FG000|Phase 1|Withdrawal by Subject|3|||
164541928|NCT01848353|594357252|FG001|Phase 1|Withdrawal by Subject|1|||
164541929|NCT01848353|594357253|FG002|Phase 1|Withdrawal by Subject|0|||
164541930|NCT01848353|594357254|FG003|Phase 1|Withdrawal by Subject|0|||
164541931|NCT01848353|594357251|FG000|Phase 2|Withdrawal by Subject|3|||
164541932|NCT01848353|594357252|FG001|Phase 2|Withdrawal by Subject|2|||
164541933|NCT01848353|594357253|FG002|Phase 2|Withdrawal by Subject|0|||
164541934|NCT01848353|594357254|FG003|Phase 2|Withdrawal by Subject|0|||
164541935|NCT01848353|594357251|FG000|Phase 3|Withdrawal by Subject|1|||
164541936|NCT01848353|594357252|FG001|Phase 3|Withdrawal by Subject|1|||
164541937|NCT01848353|594357253|FG002|Phase 3|Withdrawal by Subject|0|||
164541938|NCT01848353|594357254|FG003|Phase 3|Withdrawal by Subject|0|||
164541939|NCT03606980|594357259|FG000|Overall Study|Lost to Follow-up|3|||
164541940|NCT03606980|594357260|FG001|Overall Study|Lost to Follow-up|2|||
164541941|NCT03606980|594357261|FG002|Overall Study|Lost to Follow-up|3|||
164541942|NCT03606980|594357259|FG000|Overall Study|Withdrawal by Subject|1|||
164541943|NCT03606980|594357260|FG001|Overall Study|Withdrawal by Subject|0|||
164541944|NCT03606980|594357261|FG002|Overall Study|Withdrawal by Subject|4|||
164541945|NCT00911625|594357266|FG000|Overall Study|Lost to Follow-up|7|||
164541946|NCT00911625|594357267|FG001|Overall Study|Lost to Follow-up|0|||
164541947|NCT03785678|594357270|FG000|Overall Study|Death|44|||
164541948|NCT03785678|594357271|FG001|Overall Study|Death|42|||
164541949|NCT03785678|594357270|FG000|Overall Study|Lost to Follow-up|4|||
164541950|NCT03785678|594357271|FG001|Overall Study|Lost to Follow-up|2|||
164541951|NCT03785678|594357270|FG000|Overall Study|Physician Decision|0|||
164541952|NCT03785678|594357271|FG001|Overall Study|Physician Decision|2|||
164541953|NCT03785678|594357270|FG000|Overall Study|Withdrawal by Subject|5|||
164541954|NCT03785678|594357271|FG001|Overall Study|Withdrawal by Subject|3|||
164541955|NCT01159912|594357272|FG000|Overall Study|Adverse Event|2|||
164541956|NCT01159912|594357273|FG001|Overall Study|Adverse Event|2|||
164541957|NCT01159912|594357274|FG002|Overall Study|Adverse Event|3|||
164541958|NCT01159912|594357272|FG000|Overall Study|Lack of Efficacy|23|||
164541959|NCT01159912|594357273|FG001|Overall Study|Lack of Efficacy|15|||
164541960|NCT01159912|594357274|FG002|Overall Study|Lack of Efficacy|14|||
164541961|NCT01159912|594357272|FG000|Overall Study|Protocol Violation|1|||
164541962|NCT01159912|594357273|FG001|Overall Study|Protocol Violation|2|||
164541963|NCT01159912|594357274|FG002|Overall Study|Protocol Violation|3|||
164541964|NCT01159912|594357272|FG000|Overall Study|Lost to Follow-up|4|||
164541965|NCT01159912|594357273|FG001|Overall Study|Lost to Follow-up|0|||
164541966|NCT01159912|594357274|FG002|Overall Study|Lost to Follow-up|0|||
164541967|NCT01159912|594357272|FG000|Overall Study|Physician Decision|0|||
164541968|NCT01159912|594357273|FG001|Overall Study|Physician Decision|0|||
164541969|NCT01159912|594357274|FG002|Overall Study|Physician Decision|3|||
164541970|NCT01159912|594357272|FG000|Overall Study|Withdrawal by Subject|10|||
164541971|NCT01159912|594357273|FG001|Overall Study|Withdrawal by Subject|3|||
164541972|NCT01159912|594357274|FG002|Overall Study|Withdrawal by Subject|3|||
164541973|NCT01444456|594357275|FG000|Overall Study|Withdrawal by Subject|21|||
164541974|NCT01444456|594357275|FG000|Overall Study|Physician Decision|9|||
164541975|NCT01444456|594357275|FG000|Overall Study|Lost to Follow-up|37|||
164541976|NCT01444456|594357275|FG000|Overall Study|Death|73|||
164541977|NCT01444456|594357275|FG000|Overall Study|Ineligibility determined|23|||
164541978|NCT01444456|594357275|FG000|Overall Study|Other|18|||
164541979|NCT01444456|594357275|FG000|Overall Study|Not treated|104|||
164541980|NCT04050670|594358920|FG000|Period 3|Physician Decision|0|||
164541981|NCT04050670|594358921|FG001|Period 3|Physician Decision|1|||
164541982|NCT04050670|594358922|FG002|Period 3|Physician Decision|0|||
164541983|NCT02142738|594358923|FG000|Overall Study|Adverse Event|13|||
164541984|NCT02142738|594358924|FG001|Overall Study|Adverse Event|9|||
164541985|NCT02142738|594358923|FG000|Overall Study|Death|92|||
164541986|NCT02142738|594358924|FG001|Overall Study|Death|112|||
164541987|NCT02142738|594358923|FG000|Overall Study|Lost to Follow-up|0|||
164541988|NCT02142738|594358924|FG001|Overall Study|Lost to Follow-up|3|||
164541989|NCT02142738|594358923|FG000|Overall Study|Withdrawal by Subject|6|||
164541990|NCT02142738|594358924|FG001|Overall Study|Withdrawal by Subject|7|||
164541991|NCT02142738|594358923|FG000|Overall Study|Follow up ended by sponsor|43|||
164541992|NCT02142738|594358924|FG001|Overall Study|Follow up ended by sponsor|20|||
164541993|NCT02615470|594358925|FG000|Overall Study|Lost to Follow-up|21|||
164541994|NCT02615470|594358926|FG001|Overall Study|Lost to Follow-up|32|||
164541995|NCT03713034|594358927|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
164541996|NCT03713034|594358928|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
164541997|NCT00880555|594358933|FG000|Overall Study|Physician Decision|0|||
164541998|NCT00880555|594358934|FG001|Overall Study|Physician Decision|8|||
164541999|NCT00880555|594358935|FG002|Overall Study|Physician Decision|0|||
164542000|NCT00880555|594358936|FG003|Overall Study|Physician Decision|2|||
164542001|NCT00880555|594358937|FG004|Overall Study|Physician Decision|1|||
164542002|NCT00880555|594358938|FG005|Overall Study|Physician Decision|0|||
164542003|NCT00880555|594358933|FG000|Overall Study|Withdrawal by Subject|1|||
164542004|NCT00880555|594358934|FG001|Overall Study|Withdrawal by Subject|1|||
164542005|NCT00880555|594358935|FG002|Overall Study|Withdrawal by Subject|0|||
164542006|NCT00880555|594358936|FG003|Overall Study|Withdrawal by Subject|0|||
164542007|NCT00880555|594358937|FG004|Overall Study|Withdrawal by Subject|0|||
164542008|NCT00880555|594358938|FG005|Overall Study|Withdrawal by Subject|0|||
164542009|NCT00880555|594358933|FG000|Overall Study|Lack of resources (hired rater)|9|||
164542010|NCT00880555|594358934|FG001|Overall Study|Lack of resources (hired rater)|7|||
164542011|NCT00880555|594358935|FG002|Overall Study|Lack of resources (hired rater)|5|||
164542012|NCT00880555|594358936|FG003|Overall Study|Lack of resources (hired rater)|0|||
164542013|NCT00880555|594358937|FG004|Overall Study|Lack of resources (hired rater)|0|||
164542014|NCT00880555|594358938|FG005|Overall Study|Lack of resources (hired rater)|0|||
164542015|NCT00880555|594358933|FG000|Overall Study|Death|0|||
164542016|NCT00880555|594358934|FG001|Overall Study|Death|0|||
164542017|NCT00880555|594358935|FG002|Overall Study|Death|0|||
164542018|NCT00880555|594358936|FG003|Overall Study|Death|0|||
164542019|NCT00880555|594358937|FG004|Overall Study|Death|0|||
164542020|NCT00880555|594358938|FG005|Overall Study|Death|1|||
164542021|NCT00880555|594358933|FG000|Overall Study|Lost to Follow-up|0|||
164542022|NCT00880555|594358934|FG001|Overall Study|Lost to Follow-up|1|||
164542023|NCT00880555|594358935|FG002|Overall Study|Lost to Follow-up|0|||
164542024|NCT00880555|594358936|FG003|Overall Study|Lost to Follow-up|0|||
164542025|NCT00880555|594358937|FG004|Overall Study|Lost to Follow-up|0|||
164542026|NCT00880555|594358938|FG005|Overall Study|Lost to Follow-up|0|||
164542027|NCT02982590|594358940|FG000|Overall Study|Lost to Follow-up|0|||
164542028|NCT02982590|594358941|FG001|Overall Study|Lost to Follow-up|1|||
164542029|NCT02982590|594358940|FG000|Overall Study|Death|4|||
164542030|NCT02982590|594358941|FG001|Overall Study|Death|0|||
164542031|NCT04196803|594358942|FG000|Overall Study|Withdrawal by Subject|1|||
164542032|NCT04196803|594358943|FG001|Overall Study|Withdrawal by Subject|3|||
164542033|NCT04196803|594358942|FG000|Overall Study|Adverse Event|4|||
164542034|NCT04196803|594358943|FG001|Overall Study|Adverse Event|2|||
164542035|NCT04196803|594358942|FG000|Overall Study|Lost to Follow-up|0|||
164542036|NCT04196803|594358943|FG001|Overall Study|Lost to Follow-up|1|||
164542037|NCT01168973|594358944|FG000|Overall Study|Progressive Disease|341|||
164542038|NCT01168973|594358945|FG001|Overall Study|Progressive Disease|429|||
164542039|NCT01168973|594358944|FG000|Overall Study|Adverse Event|94|||
164542040|NCT01168973|594358945|FG001|Overall Study|Adverse Event|55|||
164542041|NCT01168973|594358944|FG000|Overall Study|Withdrawal by Subject|90|||
164542042|NCT01168973|594358945|FG001|Overall Study|Withdrawal by Subject|53|||
164542043|NCT01168973|594358944|FG000|Overall Study|Death|42|||
164542044|NCT01168973|594358945|FG001|Overall Study|Death|45|||
164542045|NCT01168973|594358944|FG000|Overall Study|Physician Decision|37|||
164542046|NCT01168973|594358945|FG001|Overall Study|Physician Decision|19|||
164542047|NCT01168973|594358944|FG000|Overall Study|Sponsor Decision|2|||
164542048|NCT01168973|594358945|FG001|Overall Study|Sponsor Decision|1|||
164542049|NCT01168973|594358944|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
164542050|NCT01168973|594358945|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
164542051|NCT00419120|594358948|FG000|Long Term Follow up Period|study ongoing|10|||
164542052|NCT00388505|594358949|FG000|Overall Study|Adverse Event or Death|43|||
164653182|NCT01621490|594757063|FG000|Overall Study|Other reasons|7|||
164542053|NCT00388505|594358950|FG001|Overall Study|Adverse Event or Death|17|||
164542054|NCT00388505|594358949|FG000|Overall Study|Withdrawal by Subject|24|||
164542055|NCT00388505|594358950|FG001|Overall Study|Withdrawal by Subject|9|||
164542056|NCT00388505|594358949|FG000|Overall Study|Lost to Follow-up|5|||
164542057|NCT00388505|594358950|FG001|Overall Study|Lost to Follow-up|3|||
164542058|NCT00388505|594358949|FG000|Overall Study|Inappropriate Enrollment|0|||
164542059|NCT00388505|594358950|FG001|Overall Study|Inappropriate Enrollment|1|||
164542060|NCT00388505|594358949|FG000|Overall Study|Administrative Reason|1|||
164542061|NCT00388505|594358950|FG001|Overall Study|Administrative Reason|0|||
164542062|NCT00388505|594358949|FG000|Overall Study|Protocol Violation|6|||
164542063|NCT00388505|594358950|FG001|Overall Study|Protocol Violation|5|||
164542064|NCT00388505|594358949|FG000|Overall Study|Unable to classify|4|||
164542065|NCT00388505|594358950|FG001|Overall Study|Unable to classify|3|||
164542066|NCT01809132|594358953|FG000|Overall Study|Withdrawal by Subject|0|||
164542067|NCT01809132|594358954|FG001|Overall Study|Withdrawal by Subject|0|||
164542068|NCT01809132|594358955|FG002|Overall Study|Withdrawal by Subject|1|||
164542069|NCT04854434|594358956|FG000|Overall Study|Death|1|||
164542070|NCT04854434|594358957|FG001|Overall Study|Death|3|||
164542071|NCT04854434|594358958|FG002|Overall Study|Death|4|||
164542072|NCT04854434|594358956|FG000|Overall Study|Study Terminated by Sponsor|2|||
164542073|NCT04854434|594358957|FG001|Overall Study|Study Terminated by Sponsor|0|||
164542074|NCT04854434|594358958|FG002|Overall Study|Study Terminated by Sponsor|0|||
164542075|NCT04854434|594358956|FG000|Overall Study|Other|1|||
164542076|NCT04854434|594358957|FG001|Overall Study|Other|1|||
164542077|NCT04854434|594358958|FG002|Overall Study|Other|0|||
164542078|NCT03349775|594358959|FG000|Overall Study|Side Effects|1|||
164542079|NCT03349775|594358960|FG001|Overall Study|Side Effects|2|||
164542080|NCT03349775|594358959|FG000|Overall Study|Withdrawal by Subject|1|||
164542081|NCT03349775|594358960|FG001|Overall Study|Withdrawal by Subject|1|||
164542082|NCT03349775|594358959|FG000|Overall Study|No primary outcome measurements|0|||
164542083|NCT03349775|594358960|FG001|Overall Study|No primary outcome measurements|1|||
164542084|NCT02667275|594358961|FG000|Overall Study|Protocol Violation|11|||
164542085|NCT02667275|594358962|FG001|Overall Study|Protocol Violation|7|||
164542086|NCT02667275|594358961|FG000|Overall Study|Lost to Follow-up|0|||
164542087|NCT02667275|594358962|FG001|Overall Study|Lost to Follow-up|2|||
164542088|NCT02667275|594358961|FG000|Overall Study|Withdrawal by Subject|0|||
164542089|NCT02667275|594358962|FG001|Overall Study|Withdrawal by Subject|5|||
164542090|NCT02667275|594358961|FG000|Overall Study|Discontinued early without completing|0|||
164542091|NCT02667275|594358962|FG001|Overall Study|Discontinued early without completing|1|||
164542092|NCT01756040|594358963|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
164542093|NCT01756040|594358963|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
164542094|NCT01756040|594358963|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
164542095|NCT04479436|594358964|FG000|Overall Study|Progressive disease|26|||
164542096|NCT04479436|594358965|FG001|Overall Study|Progressive disease|1|||
164542097|NCT04479436|594358964|FG000|Overall Study|Adverse Event|6|||
164542098|NCT04479436|594358965|FG001|Overall Study|Adverse Event|0|||
164542099|NCT04479436|594358964|FG000|Overall Study|Withdrawal by Subject|5|||
164542100|NCT04479436|594358965|FG001|Overall Study|Withdrawal by Subject|0|||
164542101|NCT04479436|594358964|FG000|Overall Study|Clinical progression|1|||
164542102|NCT04479436|594358965|FG001|Overall Study|Clinical progression|0|||
164542103|NCT04479436|594358964|FG000|Overall Study|Physician Decision|1|||
164542104|NCT04479436|594358965|FG001|Overall Study|Physician Decision|0|||
164542105|NCT01848288|594358966|FG000|Overall Study|Death|1|||
164542106|NCT01848288|594358966|FG000|Overall Study|Protocol Violation|1|||
164542107|NCT01848288|594358966|FG000|Overall Study|Withdrawal by Subject|1|||
164542108|NCT01007032|594358967|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
164542109|NCT01007032|594358968|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
164542110|NCT01007032|594358969|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
164542111|NCT01007032|594358970|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
164542112|NCT01007032|594358967|FG000|Overall Study|Withdrawal by Subject|0|||
164542113|NCT01007032|594358968|FG001|Overall Study|Withdrawal by Subject|0|||
164542114|NCT01007032|594358969|FG002|Overall Study|Withdrawal by Subject|0|||
164542115|NCT01007032|594358970|FG003|Overall Study|Withdrawal by Subject|1|||
164542116|NCT02716675|594358980|FG000|Overall Study|Death|2|||
164542117|NCT02716675|594358981|FG001|Overall Study|Death|3|||
164542118|NCT02716675|594358982|FG002|Overall Study|Death|0|||
164542119|NCT02716675|594358980|FG000|Overall Study|Physician Decision|2|||
164542120|NCT02716675|594358981|FG001|Overall Study|Physician Decision|1|||
164542121|NCT02716675|594358982|FG002|Overall Study|Physician Decision|1|||
164542122|NCT02716675|594358980|FG000|Overall Study|Lost to Follow-up|100|||
164542123|NCT02716675|594358981|FG001|Overall Study|Lost to Follow-up|87|||
164542124|NCT02716675|594358982|FG002|Overall Study|Lost to Follow-up|99|||
164542125|NCT02716675|594358980|FG000|Overall Study|Withdrawal by Subject|22|||
164542126|NCT02716675|594358981|FG001|Overall Study|Withdrawal by Subject|25|||
164542127|NCT02716675|594358982|FG002|Overall Study|Withdrawal by Subject|20|||
164542128|NCT02716675|594358980|FG000|Overall Study|Protocol Violation|0|||
164542129|NCT02716675|594358981|FG001|Overall Study|Protocol Violation|3|||
164542130|NCT02716675|594358982|FG002|Overall Study|Protocol Violation|1|||
164542131|NCT02716675|594358980|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
164542132|NCT02716675|594358981|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
164542133|NCT02716675|594358982|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
164542134|NCT02716675|594358980|FG000|Overall Study|Other|38|||
164542135|NCT02716675|594358981|FG001|Overall Study|Other|47|||
164542136|NCT02716675|594358982|FG002|Overall Study|Other|48|||
164542137|NCT00290290|594358985|FG000|Overall Study|Death|3|||
164542138|NCT00290290|594358986|FG001|Overall Study|Death|4|||
164542139|NCT00290290|594358985|FG000|Overall Study|Withdrawal by Subject|2|||
164542140|NCT00290290|594358986|FG001|Overall Study|Withdrawal by Subject|2|||
164542141|NCT00290290|594358985|FG000|Overall Study|Underwent clean surgical procedure|13|||
164542142|NCT00290290|594358986|FG001|Overall Study|Underwent clean surgical procedure|12|||
164542143|NCT00003895|594358989|FG000|Overall Study|Adverse Event|4|||
164542144|NCT00003895|594358990|FG001|Overall Study|Adverse Event|0|||
164542145|NCT00003895|594358989|FG000|Overall Study|Lack of Efficacy|1|||
164542146|NCT00003895|594358990|FG001|Overall Study|Lack of Efficacy|1|||
164542147|NCT00003895|594358989|FG000|Overall Study|Patient Vacation|2|||
164542148|NCT00003895|594358990|FG001|Overall Study|Patient Vacation|0|||
164542149|NCT00003895|594358989|FG000|Overall Study|Withdrawal by Subject|0|||
164542150|NCT00003895|594358990|FG001|Overall Study|Withdrawal by Subject|3|||
164542151|NCT01380730|594358991|FG000|Overall Study|Death|0|||
164542152|NCT01380730|594358992|FG001|Overall Study|Death|0|||
164542153|NCT01380730|594358993|FG002|Overall Study|Death|0|||
164542154|NCT01380730|594358994|FG003|Overall Study|Death|0|||
164542155|NCT01380730|594358995|FG004|Overall Study|Death|1|||
164542156|NCT01380730|594358996|FG005|Overall Study|Death|0|||
164542157|NCT01380730|594358997|FG006|Overall Study|Death|0|||
164542158|NCT01380730|594358998|FG007|Overall Study|Death|0|||
164542159|NCT00467779|594359004|FG000|Stage 1|Adverse Event|1|||
164542160|NCT00467779|594359005|FG001|Stage 1|Adverse Event|0|||
164542161|NCT00467779|594359006|FG002|Stage 1|Adverse Event|0|||
164542162|NCT00467779|594359007|FG003|Stage 1|Adverse Event|0|||
164542163|NCT00467779|594359008|FG004|Stage 1|Adverse Event|0|||
164542164|NCT00467779|594359009|FG005|Stage 1|Adverse Event|1|||
164542165|NCT00467779|594359010|FG006|Stage 1|Adverse Event|2|||
164542166|NCT00467779|594359011|FG007|Stage 1|Adverse Event|1|||
164542167|NCT00467779|594359012|FG008|Stage 1|Adverse Event|0|||
164542168|NCT00467779|594359013|FG009|Stage 1|Adverse Event|0|||
164542169|NCT00467779|594359014|FG010|Stage 1|Adverse Event|0|||
164542170|NCT00467779|594359015|FG011|Stage 1|Adverse Event|0|||
164542171|NCT00467779|594359016|FG012|Stage 1|Adverse Event|0|||
164542172|NCT00467779|594359017|FG013|Stage 1|Adverse Event|0|||
164542173|NCT00467779|594359018|FG014|Stage 1|Adverse Event|0|||
164542174|NCT00467779|594359004|FG000|Stage 1|Disease Progression|2|||
164542175|NCT00467779|594359005|FG001|Stage 1|Disease Progression|2|||
164542176|NCT00467779|594359006|FG002|Stage 1|Disease Progression|2|||
164542177|NCT00467779|594359007|FG003|Stage 1|Disease Progression|3|||
164542178|NCT00467779|594359008|FG004|Stage 1|Disease Progression|2|||
164542179|NCT00467779|594359009|FG005|Stage 1|Disease Progression|2|||
164542180|NCT00467779|594359010|FG006|Stage 1|Disease Progression|4|||
164542181|NCT00467779|594359011|FG007|Stage 1|Disease Progression|5|||
164542182|NCT00467779|594359012|FG008|Stage 1|Disease Progression|0|||
164542183|NCT00467779|594359013|FG009|Stage 1|Disease Progression|0|||
164542184|NCT00467779|594359014|FG010|Stage 1|Disease Progression|0|||
164542185|NCT00467779|594359015|FG011|Stage 1|Disease Progression|0|||
164542186|NCT00467779|594359016|FG012|Stage 1|Disease Progression|0|||
164542187|NCT00467779|594359017|FG013|Stage 1|Disease Progression|0|||
164542188|NCT00467779|594359018|FG014|Stage 1|Disease Progression|0|||
164542189|NCT00467779|594359004|FG000|Stage 1|Unspecified Reason|1|||
164542190|NCT00467779|594359005|FG001|Stage 1|Unspecified Reason|0|||
164542191|NCT00467779|594359006|FG002|Stage 1|Unspecified Reason|1|||
164542192|NCT00467779|594359007|FG003|Stage 1|Unspecified Reason|0|||
164542193|NCT00467779|594359008|FG004|Stage 1|Unspecified Reason|1|||
164542194|NCT00467779|594359009|FG005|Stage 1|Unspecified Reason|2|||
164542195|NCT00467779|594359010|FG006|Stage 1|Unspecified Reason|0|||
164542196|NCT00467779|594359011|FG007|Stage 1|Unspecified Reason|0|||
164542197|NCT00467779|594359012|FG008|Stage 1|Unspecified Reason|0|||
164542198|NCT00467779|594359013|FG009|Stage 1|Unspecified Reason|0|||
164542199|NCT00467779|594359014|FG010|Stage 1|Unspecified Reason|0|||
164542200|NCT00467779|594359015|FG011|Stage 1|Unspecified Reason|0|||
164542201|NCT00467779|594359016|FG012|Stage 1|Unspecified Reason|0|||
164653183|NCT01621490|594757064|FG001|Overall Study|Other reasons|6|||
164653184|NCT01621490|594757065|FG002|Overall Study|Other reasons|4|||
164653185|NCT01621490|594757066|FG003|Overall Study|Other reasons|1|||
164653186|NCT01621490|594757067|FG004|Overall Study|Other reasons|1|||
164653187|NCT01621490|594757068|FG005|Overall Study|Other reasons|3|||
164653188|NCT01621490|594757069|FG006|Overall Study|Other reasons|1|||
164653189|NCT01621490|594757070|FG007|Overall Study|Other reasons|1|||
164653190|NCT01621490|594757071|FG008|Overall Study|Other reasons|1|||
164653191|NCT01621490|594757072|FG009|Overall Study|Other reasons|0|||
164653192|NCT01621490|594757073|FG010|Overall Study|Other reasons|0|||
164653193|NCT00506753|594757074|FG000|Overall Study|Lost to Follow-up|21|||
164653194|NCT00506753|594757075|FG001|Overall Study|Lost to Follow-up|15|||
164653195|NCT00461500|594757076|FG000|Overall Study|Adverse Event|1|||
164653196|NCT00461500|594757077|FG001|Overall Study|Adverse Event|0|||
164653197|NCT00461500|594757076|FG000|Overall Study|Lack of Efficacy|0|||
164653198|NCT00461500|594757077|FG001|Overall Study|Lack of Efficacy|1|||
164653199|NCT00461500|594757076|FG000|Overall Study|Expired Drug Treatment|1|||
164542202|NCT00467779|594359017|FG013|Stage 1|Unspecified Reason|0|||
164653200|NCT00461500|594757077|FG001|Overall Study|Expired Drug Treatment|1|||
164653201|NCT00461500|594757076|FG000|Overall Study|Study Stopped|1|||
164542203|NCT00467779|594359018|FG014|Stage 1|Unspecified Reason|0|||
164542204|NCT00467779|594359004|FG000|Stage 1|Physician Decision|0|||
164542205|NCT00467779|594359005|FG001|Stage 1|Physician Decision|1|||
164542206|NCT00467779|594359006|FG002|Stage 1|Physician Decision|0|||
164542207|NCT00467779|594359007|FG003|Stage 1|Physician Decision|0|||
164542208|NCT00467779|594359008|FG004|Stage 1|Physician Decision|0|||
164542209|NCT00467779|594359009|FG005|Stage 1|Physician Decision|0|||
164653202|NCT00461500|594757077|FG001|Overall Study|Study Stopped|2|||
164542210|NCT00467779|594359010|FG006|Stage 1|Physician Decision|0|||
164542211|NCT00467779|594359011|FG007|Stage 1|Physician Decision|0|||
164542212|NCT00467779|594359012|FG008|Stage 1|Physician Decision|0|||
164542213|NCT00467779|594359013|FG009|Stage 1|Physician Decision|0|||
164542214|NCT00467779|594359014|FG010|Stage 1|Physician Decision|0|||
164542215|NCT00467779|594359015|FG011|Stage 1|Physician Decision|0|||
164542216|NCT00467779|594359016|FG012|Stage 1|Physician Decision|0|||
164542217|NCT00467779|594359017|FG013|Stage 1|Physician Decision|0|||
164542218|NCT00467779|594359018|FG014|Stage 1|Physician Decision|0|||
164542219|NCT00467779|594359004|FG000|Stage 1|Withdrawal by Subject|0|||
164542220|NCT00467779|594359005|FG001|Stage 1|Withdrawal by Subject|0|||
164542221|NCT00467779|594359006|FG002|Stage 1|Withdrawal by Subject|0|||
164542222|NCT00467779|594359007|FG003|Stage 1|Withdrawal by Subject|0|||
164542223|NCT00467779|594359008|FG004|Stage 1|Withdrawal by Subject|0|||
164542224|NCT00467779|594359009|FG005|Stage 1|Withdrawal by Subject|0|||
164542225|NCT00467779|594359010|FG006|Stage 1|Withdrawal by Subject|1|||
164542226|NCT00467779|594359011|FG007|Stage 1|Withdrawal by Subject|1|||
164542227|NCT00467779|594359012|FG008|Stage 1|Withdrawal by Subject|0|||
164542228|NCT00467779|594359013|FG009|Stage 1|Withdrawal by Subject|0|||
164542229|NCT00467779|594359014|FG010|Stage 1|Withdrawal by Subject|0|||
164542230|NCT00467779|594359015|FG011|Stage 1|Withdrawal by Subject|0|||
164542231|NCT00467779|594359016|FG012|Stage 1|Withdrawal by Subject|0|||
164542232|NCT00467779|594359017|FG013|Stage 1|Withdrawal by Subject|0|||
164542233|NCT00467779|594359018|FG014|Stage 1|Withdrawal by Subject|0|||
164542234|NCT00467779|594359004|FG000|Stage 1A|Adverse Event|0|||
164542235|NCT00467779|594359005|FG001|Stage 1A|Adverse Event|0|||
164542236|NCT00467779|594359006|FG002|Stage 1A|Adverse Event|0|||
164542237|NCT00467779|594359007|FG003|Stage 1A|Adverse Event|0|||
164542238|NCT00467779|594359008|FG004|Stage 1A|Adverse Event|0|||
164542239|NCT00467779|594359009|FG005|Stage 1A|Adverse Event|0|||
164542240|NCT00467779|594359010|FG006|Stage 1A|Adverse Event|0|||
164542241|NCT00467779|594359011|FG007|Stage 1A|Adverse Event|0|||
164542242|NCT00467779|594359012|FG008|Stage 1A|Adverse Event|0|||
164542243|NCT00467779|594359013|FG009|Stage 1A|Adverse Event|0|||
164542244|NCT00467779|594359014|FG010|Stage 1A|Adverse Event|0|||
164542245|NCT00467779|594359015|FG011|Stage 1A|Adverse Event|0|||
164542246|NCT00467779|594359016|FG012|Stage 1A|Adverse Event|1|||
164542247|NCT00467779|594359017|FG013|Stage 1A|Adverse Event|0|||
164542248|NCT00467779|594359018|FG014|Stage 1A|Adverse Event|0|||
164542249|NCT00467779|594359004|FG000|Stage 1A|Death|0|||
164542250|NCT00467779|594359005|FG001|Stage 1A|Death|0|||
164542251|NCT00467779|594359006|FG002|Stage 1A|Death|0|||
164542252|NCT00467779|594359007|FG003|Stage 1A|Death|0|||
164542253|NCT00467779|594359008|FG004|Stage 1A|Death|0|||
164542254|NCT00467779|594359009|FG005|Stage 1A|Death|0|||
164542255|NCT00467779|594359010|FG006|Stage 1A|Death|0|||
164542256|NCT00467779|594359011|FG007|Stage 1A|Death|0|||
164542257|NCT00467779|594359012|FG008|Stage 1A|Death|0|||
164542258|NCT00467779|594359013|FG009|Stage 1A|Death|0|||
164542259|NCT00467779|594359014|FG010|Stage 1A|Death|0|||
164542260|NCT00467779|594359015|FG011|Stage 1A|Death|1|||
164542261|NCT00467779|594359016|FG012|Stage 1A|Death|1|||
164542262|NCT00467779|594359017|FG013|Stage 1A|Death|0|||
164542263|NCT00467779|594359018|FG014|Stage 1A|Death|0|||
164542264|NCT00467779|594359004|FG000|Stage 1A|Disease Progression|0|||
164542265|NCT00467779|594359005|FG001|Stage 1A|Disease Progression|0|||
164542266|NCT00467779|594359006|FG002|Stage 1A|Disease Progression|0|||
164542267|NCT00467779|594359007|FG003|Stage 1A|Disease Progression|0|||
164542268|NCT00467779|594359008|FG004|Stage 1A|Disease Progression|0|||
164542269|NCT00467779|594359009|FG005|Stage 1A|Disease Progression|0|||
164542270|NCT00467779|594359010|FG006|Stage 1A|Disease Progression|0|||
164542271|NCT00467779|594359011|FG007|Stage 1A|Disease Progression|0|||
164542272|NCT00467779|594359012|FG008|Stage 1A|Disease Progression|0|||
164542273|NCT00467779|594359013|FG009|Stage 1A|Disease Progression|2|||
164542274|NCT00467779|594359014|FG010|Stage 1A|Disease Progression|2|||
164542275|NCT00467779|594359015|FG011|Stage 1A|Disease Progression|5|||
164542276|NCT00467779|594359016|FG012|Stage 1A|Disease Progression|2|||
164653203|NCT00461500|594757076|FG000|Overall Study|Drug Treatment Misuse|1|||
164542277|NCT00467779|594359017|FG013|Stage 1A|Disease Progression|0|||
164542278|NCT00467779|594359018|FG014|Stage 1A|Disease Progression|0|||
164653204|NCT00461500|594757077|FG001|Overall Study|Drug Treatment Misuse|0|||
164190660|NCT00791700|593066335|FG000|Overall Study|No longer willing to participate|1|||
164542279|NCT00467779|594359004|FG000|Stage 1A|Physician Decision|0|||
164542280|NCT00467779|594359005|FG001|Stage 1A|Physician Decision|0|||
164542281|NCT00467779|594359006|FG002|Stage 1A|Physician Decision|0|||
164542282|NCT00467779|594359007|FG003|Stage 1A|Physician Decision|0|||
164542283|NCT00467779|594359008|FG004|Stage 1A|Physician Decision|0|||
164542284|NCT00467779|594359009|FG005|Stage 1A|Physician Decision|0|||
164542285|NCT00467779|594359010|FG006|Stage 1A|Physician Decision|0|||
164542286|NCT00467779|594359011|FG007|Stage 1A|Physician Decision|0|||
164542287|NCT00467779|594359012|FG008|Stage 1A|Physician Decision|0|||
164542288|NCT00467779|594359013|FG009|Stage 1A|Physician Decision|1|||
164542289|NCT00467779|594359014|FG010|Stage 1A|Physician Decision|0|||
164542290|NCT00467779|594359015|FG011|Stage 1A|Physician Decision|0|||
164542291|NCT00467779|594359016|FG012|Stage 1A|Physician Decision|0|||
164542292|NCT00467779|594359017|FG013|Stage 1A|Physician Decision|0|||
164542293|NCT00467779|594359018|FG014|Stage 1A|Physician Decision|0|||
164542294|NCT00467779|594359004|FG000|Stage 1A|Withdrawal by Subject|0|||
164542295|NCT00467779|594359005|FG001|Stage 1A|Withdrawal by Subject|0|||
164542296|NCT00467779|594359006|FG002|Stage 1A|Withdrawal by Subject|0|||
164542297|NCT00467779|594359007|FG003|Stage 1A|Withdrawal by Subject|0|||
164542298|NCT00467779|594359008|FG004|Stage 1A|Withdrawal by Subject|0|||
164542299|NCT00467779|594359009|FG005|Stage 1A|Withdrawal by Subject|0|||
164542300|NCT00467779|594359010|FG006|Stage 1A|Withdrawal by Subject|0|||
164542301|NCT00467779|594359011|FG007|Stage 1A|Withdrawal by Subject|0|||
164542302|NCT00467779|594359012|FG008|Stage 1A|Withdrawal by Subject|0|||
164542303|NCT00467779|594359013|FG009|Stage 1A|Withdrawal by Subject|0|||
164542304|NCT00467779|594359014|FG010|Stage 1A|Withdrawal by Subject|1|||
164542305|NCT00467779|594359015|FG011|Stage 1A|Withdrawal by Subject|1|||
164542306|NCT00467779|594359016|FG012|Stage 1A|Withdrawal by Subject|1|||
164542307|NCT00467779|594359017|FG013|Stage 1A|Withdrawal by Subject|0|||
164542308|NCT00467779|594359018|FG014|Stage 1A|Withdrawal by Subject|0|||
164542309|NCT00467779|594359004|FG000|Stage 1A|Unspecified Reason|0|||
164542310|NCT00467779|594359005|FG001|Stage 1A|Unspecified Reason|0|||
164542311|NCT00467779|594359006|FG002|Stage 1A|Unspecified Reason|0|||
164542312|NCT00467779|594359007|FG003|Stage 1A|Unspecified Reason|0|||
164542313|NCT00467779|594359008|FG004|Stage 1A|Unspecified Reason|0|||
164542314|NCT00467779|594359009|FG005|Stage 1A|Unspecified Reason|0|||
164542315|NCT00467779|594359010|FG006|Stage 1A|Unspecified Reason|0|||
164542316|NCT00467779|594359011|FG007|Stage 1A|Unspecified Reason|0|||
164542317|NCT00467779|594359012|FG008|Stage 1A|Unspecified Reason|0|||
164542318|NCT00467779|594359013|FG009|Stage 1A|Unspecified Reason|0|||
164542319|NCT00467779|594359014|FG010|Stage 1A|Unspecified Reason|0|||
164542320|NCT00467779|594359015|FG011|Stage 1A|Unspecified Reason|1|||
164542321|NCT00467779|594359016|FG012|Stage 1A|Unspecified Reason|1|||
164542322|NCT00467779|594359017|FG013|Stage 1A|Unspecified Reason|0|||
164542323|NCT00467779|594359018|FG014|Stage 1A|Unspecified Reason|0|||
164542324|NCT00467779|594359004|FG000|Stage 2|Adverse Event|0|||
164542325|NCT00467779|594359005|FG001|Stage 2|Adverse Event|0|||
164542326|NCT00467779|594359006|FG002|Stage 2|Adverse Event|0|||
164542327|NCT00467779|594359007|FG003|Stage 2|Adverse Event|0|||
164542328|NCT00467779|594359008|FG004|Stage 2|Adverse Event|0|||
164542329|NCT00467779|594359009|FG005|Stage 2|Adverse Event|0|||
164542330|NCT00467779|594359010|FG006|Stage 2|Adverse Event|0|||
164542331|NCT00467779|594359011|FG007|Stage 2|Adverse Event|0|||
164542332|NCT00467779|594359012|FG008|Stage 2|Adverse Event|1|||
164542333|NCT00467779|594359013|FG009|Stage 2|Adverse Event|0|||
164542334|NCT00467779|594359014|FG010|Stage 2|Adverse Event|0|||
164542335|NCT00467779|594359015|FG011|Stage 2|Adverse Event|0|||
164542336|NCT00467779|594359016|FG012|Stage 2|Adverse Event|0|||
164542337|NCT00467779|594359017|FG013|Stage 2|Adverse Event|0|||
164542338|NCT00467779|594359018|FG014|Stage 2|Adverse Event|0|||
164542339|NCT00467779|594359004|FG000|Stage 2|Death|0|||
164542340|NCT00467779|594359005|FG001|Stage 2|Death|0|||
164542341|NCT00467779|594359006|FG002|Stage 2|Death|0|||
164542342|NCT00467779|594359007|FG003|Stage 2|Death|0|||
164542343|NCT00467779|594359008|FG004|Stage 2|Death|0|||
164542344|NCT00467779|594359009|FG005|Stage 2|Death|0|||
164542345|NCT00467779|594359010|FG006|Stage 2|Death|0|||
164542346|NCT00467779|594359011|FG007|Stage 2|Death|0|||
164542347|NCT00467779|594359012|FG008|Stage 2|Death|1|||
164542348|NCT00467779|594359013|FG009|Stage 2|Death|0|||
164190661|NCT00791700|593066336|FG001|Overall Study|No longer willing to participate|1|||
164190662|NCT00791700|593066337|FG002|Overall Study|No longer willing to participate|0|||
164190663|NCT00791700|593066338|FG003|Overall Study|No longer willing to participate|8|||
164190664|NCT00791700|593066335|FG000|Overall Study|Non-compliance with study treatment|0|||
164190665|NCT00791700|593066336|FG001|Overall Study|Non-compliance with study treatment|2|||
164190666|NCT00791700|593066337|FG002|Overall Study|Non-compliance with study treatment|0|||
164190667|NCT00791700|593066338|FG003|Overall Study|Non-compliance with study treatment|4|||
164190668|NCT00791700|593066335|FG000|Overall Study|Withdrawn due to pregnancy|0|||
164190669|NCT00791700|593066336|FG001|Overall Study|Withdrawn due to pregnancy|0|||
164190670|NCT00791700|593066337|FG002|Overall Study|Withdrawn due to pregnancy|0|||
164542349|NCT00467779|594359014|FG010|Stage 2|Death|0|||
164542350|NCT00467779|594359015|FG011|Stage 2|Death|0|||
164542351|NCT00467779|594359016|FG012|Stage 2|Death|0|||
164190671|NCT00791700|593066338|FG003|Overall Study|Withdrawn due to pregnancy|1|||
164542352|NCT00467779|594359017|FG013|Stage 2|Death|0|||
164542353|NCT00467779|594359018|FG014|Stage 2|Death|0|||
164542354|NCT00467779|594359004|FG000|Stage 2|Disease Progression|0|||
164542355|NCT00467779|594359005|FG001|Stage 2|Disease Progression|0|||
164542356|NCT00467779|594359006|FG002|Stage 2|Disease Progression|0|||
164542357|NCT00467779|594359007|FG003|Stage 2|Disease Progression|0|||
164542358|NCT00467779|594359008|FG004|Stage 2|Disease Progression|0|||
164542359|NCT00467779|594359009|FG005|Stage 2|Disease Progression|0|||
164542360|NCT00467779|594359010|FG006|Stage 2|Disease Progression|0|||
164542361|NCT00467779|594359011|FG007|Stage 2|Disease Progression|0|||
164542362|NCT00467779|594359012|FG008|Stage 2|Disease Progression|16|||
164542363|NCT00467779|594359013|FG009|Stage 2|Disease Progression|0|||
164542364|NCT00467779|594359014|FG010|Stage 2|Disease Progression|0|||
164542365|NCT00467779|594359015|FG011|Stage 2|Disease Progression|0|||
164542366|NCT00467779|594359016|FG012|Stage 2|Disease Progression|0|||
164542367|NCT00467779|594359017|FG013|Stage 2|Disease Progression|0|||
164542368|NCT00467779|594359018|FG014|Stage 2|Disease Progression|0|||
164542369|NCT00467779|594359004|FG000|Stage 2|Unspecified Reason|0|||
164542370|NCT00467779|594359005|FG001|Stage 2|Unspecified Reason|0|||
164542371|NCT00467779|594359006|FG002|Stage 2|Unspecified Reason|0|||
164542372|NCT00467779|594359007|FG003|Stage 2|Unspecified Reason|0|||
164542373|NCT00467779|594359008|FG004|Stage 2|Unspecified Reason|0|||
164542374|NCT00467779|594359009|FG005|Stage 2|Unspecified Reason|0|||
164542375|NCT00467779|594359010|FG006|Stage 2|Unspecified Reason|0|||
164542376|NCT00467779|594359011|FG007|Stage 2|Unspecified Reason|0|||
164542377|NCT00467779|594359012|FG008|Stage 2|Unspecified Reason|3|||
164542378|NCT00467779|594359013|FG009|Stage 2|Unspecified Reason|0|||
164542379|NCT00467779|594359014|FG010|Stage 2|Unspecified Reason|0|||
164542380|NCT00467779|594359015|FG011|Stage 2|Unspecified Reason|0|||
164542381|NCT00467779|594359016|FG012|Stage 2|Unspecified Reason|0|||
164542382|NCT00467779|594359017|FG013|Stage 2|Unspecified Reason|0|||
164542383|NCT00467779|594359018|FG014|Stage 2|Unspecified Reason|0|||
164542384|NCT00467779|594359004|FG000|Stage 2A|Adverse Event|0|||
164542385|NCT00467779|594359005|FG001|Stage 2A|Adverse Event|0|||
164542386|NCT00467779|594359006|FG002|Stage 2A|Adverse Event|0|||
164542387|NCT00467779|594359007|FG003|Stage 2A|Adverse Event|0|||
164542388|NCT00467779|594359008|FG004|Stage 2A|Adverse Event|0|||
164542389|NCT00467779|594359009|FG005|Stage 2A|Adverse Event|0|||
164542390|NCT00467779|594359010|FG006|Stage 2A|Adverse Event|0|||
164542391|NCT00467779|594359011|FG007|Stage 2A|Adverse Event|0|||
164542392|NCT00467779|594359012|FG008|Stage 2A|Adverse Event|0|||
164542393|NCT00467779|594359013|FG009|Stage 2A|Adverse Event|0|||
164542394|NCT00467779|594359014|FG010|Stage 2A|Adverse Event|0|||
164542395|NCT00467779|594359015|FG011|Stage 2A|Adverse Event|0|||
164542396|NCT00467779|594359016|FG012|Stage 2A|Adverse Event|0|||
164542397|NCT00467779|594359017|FG013|Stage 2A|Adverse Event|2|||
164542398|NCT00467779|594359018|FG014|Stage 2A|Adverse Event|0|||
164542399|NCT00467779|594359004|FG000|Stage 2A|Death|0|||
164542400|NCT00467779|594359005|FG001|Stage 2A|Death|0|||
164542401|NCT00467779|594359006|FG002|Stage 2A|Death|0|||
164542402|NCT00467779|594359007|FG003|Stage 2A|Death|0|||
164542403|NCT00467779|594359008|FG004|Stage 2A|Death|0|||
164542404|NCT00467779|594359009|FG005|Stage 2A|Death|0|||
164542405|NCT00467779|594359010|FG006|Stage 2A|Death|0|||
164542406|NCT00467779|594359011|FG007|Stage 2A|Death|0|||
164542407|NCT00467779|594359012|FG008|Stage 2A|Death|0|||
164542408|NCT00467779|594359013|FG009|Stage 2A|Death|0|||
164542409|NCT00467779|594359014|FG010|Stage 2A|Death|0|||
164542410|NCT00467779|594359015|FG011|Stage 2A|Death|0|||
164542411|NCT00467779|594359016|FG012|Stage 2A|Death|0|||
164542412|NCT00467779|594359017|FG013|Stage 2A|Death|1|||
164542413|NCT00467779|594359018|FG014|Stage 2A|Death|0|||
164542414|NCT00467779|594359004|FG000|Stage 2A|Disease Progression|0|||
164542415|NCT00467779|594359005|FG001|Stage 2A|Disease Progression|0|||
164542416|NCT00467779|594359006|FG002|Stage 2A|Disease Progression|0|||
164542417|NCT00467779|594359007|FG003|Stage 2A|Disease Progression|0|||
164542418|NCT00467779|594359008|FG004|Stage 2A|Disease Progression|0|||
164542419|NCT00467779|594359009|FG005|Stage 2A|Disease Progression|0|||
164542420|NCT00467779|594359010|FG006|Stage 2A|Disease Progression|0|||
164542421|NCT00467779|594359011|FG007|Stage 2A|Disease Progression|0|||
164542422|NCT00467779|594359012|FG008|Stage 2A|Disease Progression|0|||
164542423|NCT00467779|594359013|FG009|Stage 2A|Disease Progression|0|||
164542424|NCT00467779|594359014|FG010|Stage 2A|Disease Progression|0|||
164542425|NCT00467779|594359015|FG011|Stage 2A|Disease Progression|0|||
164542426|NCT00467779|594359016|FG012|Stage 2A|Disease Progression|0|||
164542427|NCT00467779|594359017|FG013|Stage 2A|Disease Progression|10|||
164542428|NCT00467779|594359018|FG014|Stage 2A|Disease Progression|0|||
164542429|NCT00467779|594359004|FG000|Stage 2A|Unspecified Reason|0|||
164542430|NCT00467779|594359005|FG001|Stage 2A|Unspecified Reason|0|||
164542431|NCT00467779|594359006|FG002|Stage 2A|Unspecified Reason|0|||
164542432|NCT00467779|594359007|FG003|Stage 2A|Unspecified Reason|0|||
164542433|NCT00467779|594359008|FG004|Stage 2A|Unspecified Reason|0|||
164542434|NCT00467779|594359009|FG005|Stage 2A|Unspecified Reason|0|||
164542435|NCT00467779|594359010|FG006|Stage 2A|Unspecified Reason|0|||
164542436|NCT00467779|594359011|FG007|Stage 2A|Unspecified Reason|0|||
164542437|NCT00467779|594359012|FG008|Stage 2A|Unspecified Reason|0|||
164542438|NCT00467779|594359013|FG009|Stage 2A|Unspecified Reason|0|||
164542439|NCT00467779|594359014|FG010|Stage 2A|Unspecified Reason|0|||
164542440|NCT00467779|594359015|FG011|Stage 2A|Unspecified Reason|0|||
164542441|NCT00467779|594359016|FG012|Stage 2A|Unspecified Reason|0|||
164542442|NCT00467779|594359017|FG013|Stage 2A|Unspecified Reason|7|||
164542443|NCT00467779|594359018|FG014|Stage 2A|Unspecified Reason|0|||
164542444|NCT00467779|594359004|FG000|Stage 2A|Withdrawal by Subject|0|||
164542445|NCT00467779|594359005|FG001|Stage 2A|Withdrawal by Subject|0|||
164542446|NCT00467779|594359006|FG002|Stage 2A|Withdrawal by Subject|0|||
164542447|NCT00467779|594359007|FG003|Stage 2A|Withdrawal by Subject|0|||
164542448|NCT00467779|594359008|FG004|Stage 2A|Withdrawal by Subject|0|||
164542449|NCT00467779|594359009|FG005|Stage 2A|Withdrawal by Subject|0|||
164542450|NCT00467779|594359010|FG006|Stage 2A|Withdrawal by Subject|0|||
164542451|NCT00467779|594359011|FG007|Stage 2A|Withdrawal by Subject|0|||
164542452|NCT00467779|594359012|FG008|Stage 2A|Withdrawal by Subject|0|||
164542453|NCT00467779|594359013|FG009|Stage 2A|Withdrawal by Subject|0|||
164542454|NCT00467779|594359014|FG010|Stage 2A|Withdrawal by Subject|0|||
164542455|NCT00467779|594359015|FG011|Stage 2A|Withdrawal by Subject|0|||
164542456|NCT00467779|594359016|FG012|Stage 2A|Withdrawal by Subject|0|||
164542457|NCT00467779|594359017|FG013|Stage 2A|Withdrawal by Subject|1|||
164542458|NCT00467779|594359018|FG014|Stage 2A|Withdrawal by Subject|0|||
164542459|NCT00467779|594359004|FG000|Stage 3|Adverse Event|0|||
164542460|NCT00467779|594359005|FG001|Stage 3|Adverse Event|0|||
164542461|NCT00467779|594359006|FG002|Stage 3|Adverse Event|0|||
164542462|NCT00467779|594359007|FG003|Stage 3|Adverse Event|0|||
164542463|NCT00467779|594359008|FG004|Stage 3|Adverse Event|0|||
164542464|NCT00467779|594359009|FG005|Stage 3|Adverse Event|0|||
164542465|NCT00467779|594359010|FG006|Stage 3|Adverse Event|0|||
164542466|NCT00467779|594359011|FG007|Stage 3|Adverse Event|0|||
164542467|NCT00467779|594359012|FG008|Stage 3|Adverse Event|0|||
164542468|NCT00467779|594359013|FG009|Stage 3|Adverse Event|0|||
164542469|NCT00467779|594359014|FG010|Stage 3|Adverse Event|0|||
164542470|NCT00467779|594359015|FG011|Stage 3|Adverse Event|0|||
164542471|NCT00467779|594359016|FG012|Stage 3|Adverse Event|0|||
164542472|NCT00467779|594359017|FG013|Stage 3|Adverse Event|0|||
164542473|NCT00467779|594359018|FG014|Stage 3|Adverse Event|2|||
164542474|NCT00467779|594359004|FG000|Stage 3|Death|0|||
164542475|NCT00467779|594359005|FG001|Stage 3|Death|0|||
164542476|NCT00467779|594359006|FG002|Stage 3|Death|0|||
164542477|NCT00467779|594359007|FG003|Stage 3|Death|0|||
164542478|NCT00467779|594359008|FG004|Stage 3|Death|0|||
164542479|NCT00467779|594359009|FG005|Stage 3|Death|0|||
164542480|NCT00467779|594359010|FG006|Stage 3|Death|0|||
164542481|NCT00467779|594359011|FG007|Stage 3|Death|0|||
164542482|NCT00467779|594359012|FG008|Stage 3|Death|0|||
164542483|NCT00467779|594359013|FG009|Stage 3|Death|0|||
164542484|NCT00467779|594359014|FG010|Stage 3|Death|0|||
164542485|NCT00467779|594359015|FG011|Stage 3|Death|0|||
164542486|NCT00467779|594359016|FG012|Stage 3|Death|0|||
164542487|NCT00467779|594359017|FG013|Stage 3|Death|0|||
164542488|NCT00467779|594359018|FG014|Stage 3|Death|1|||
164542489|NCT00467779|594359004|FG000|Stage 3|Disease Progression|0|||
164542490|NCT00467779|594359005|FG001|Stage 3|Disease Progression|0|||
164542491|NCT00467779|594359006|FG002|Stage 3|Disease Progression|0|||
164542492|NCT00467779|594359007|FG003|Stage 3|Disease Progression|0|||
164542493|NCT00467779|594359008|FG004|Stage 3|Disease Progression|0|||
164542494|NCT00467779|594359009|FG005|Stage 3|Disease Progression|0|||
164542495|NCT00467779|594359010|FG006|Stage 3|Disease Progression|0|||
164542496|NCT00467779|594359011|FG007|Stage 3|Disease Progression|0|||
164542497|NCT00467779|594359012|FG008|Stage 3|Disease Progression|0|||
164542498|NCT00467779|594359013|FG009|Stage 3|Disease Progression|0|||
164542499|NCT00467779|594359014|FG010|Stage 3|Disease Progression|0|||
164542500|NCT00467779|594359015|FG011|Stage 3|Disease Progression|0|||
164542501|NCT00467779|594359016|FG012|Stage 3|Disease Progression|0|||
164542502|NCT00467779|594359017|FG013|Stage 3|Disease Progression|0|||
164542503|NCT00467779|594359018|FG014|Stage 3|Disease Progression|9|||
164542504|NCT00467779|594359004|FG000|Stage 3|Unspecified Reason|0|||
164542505|NCT00467779|594359005|FG001|Stage 3|Unspecified Reason|0|||
164542506|NCT00467779|594359006|FG002|Stage 3|Unspecified Reason|0|||
164542507|NCT00467779|594359007|FG003|Stage 3|Unspecified Reason|0|||
164542508|NCT00467779|594359008|FG004|Stage 3|Unspecified Reason|0|||
164542509|NCT00467779|594359009|FG005|Stage 3|Unspecified Reason|0|||
164542510|NCT00467779|594359010|FG006|Stage 3|Unspecified Reason|0|||
164542511|NCT00467779|594359011|FG007|Stage 3|Unspecified Reason|0|||
164542512|NCT00467779|594359012|FG008|Stage 3|Unspecified Reason|0|||
164542513|NCT00467779|594359013|FG009|Stage 3|Unspecified Reason|0|||
164542514|NCT00467779|594359014|FG010|Stage 3|Unspecified Reason|0|||
164542515|NCT00467779|594359015|FG011|Stage 3|Unspecified Reason|0|||
164542516|NCT00467779|594359016|FG012|Stage 3|Unspecified Reason|0|||
164542517|NCT00467779|594359017|FG013|Stage 3|Unspecified Reason|0|||
164542518|NCT00467779|594359018|FG014|Stage 3|Unspecified Reason|5|||
164542519|NCT01509079|594359019|FG000|Overall Study|Lack of Efficacy|0|||
164542520|NCT01509079|594359020|FG001|Overall Study|Lack of Efficacy|2|||
164542521|NCT01509079|594359019|FG000|Overall Study|started an excluded medication|0|||
164542522|NCT01509079|594359020|FG001|Overall Study|started an excluded medication|1|||
164542523|NCT01205230|594359021|FG000|Overall Study|Adverse Event|4|||
164542524|NCT01205230|594359022|FG001|Overall Study|Adverse Event|0|||
164542525|NCT01205230|594359021|FG000|Overall Study|Physician Decision|1|||
164542526|NCT01205230|594359022|FG001|Overall Study|Physician Decision|0|||
164542527|NCT03945591|594359023|FG000|Overall Study|Participant not transplanted|1|||
164542528|NCT03945591|594359023|FG000|Overall Study|Change in treatment plan|3|||
164542529|NCT03945591|594359023|FG000|Overall Study|Adverse Event|1|||
164542530|NCT00041080|594359024|FG000|Overall Study|Adverse Event|21|||
164542531|NCT00041080|594359025|FG001|Overall Study|Adverse Event|1|||
164542532|NCT00041080|594359024|FG000|Overall Study|Withdrawal by Subject|6|||
164542533|NCT00041080|594359025|FG001|Overall Study|Withdrawal by Subject|6|||
164542534|NCT00041080|594359024|FG000|Overall Study|Concommitant Illness/Other|1|||
164542535|NCT00041080|594359025|FG001|Overall Study|Concommitant Illness/Other|2|||
164542536|NCT00041080|594359024|FG000|Overall Study|Did not start therapy|1|||
164542537|NCT00041080|594359025|FG001|Overall Study|Did not start therapy|1|||
164542538|NCT00041080|594359024|FG000|Overall Study|Ineligible|1|||
164542539|NCT00041080|594359025|FG001|Overall Study|Ineligible|0|||
164542540|NCT02428855|594359026|FG000|Overall Study|Withdrawal by Subject|2|||
164542541|NCT00359021|594359027|FG000|Overall Study|Adverse Event|26|||
164542542|NCT00359021|594359028|FG001|Overall Study|Adverse Event|8|||
164542543|NCT00359021|594359027|FG000|Overall Study|Subject Non-Compliant|1|||
164542544|NCT00359021|594359028|FG001|Overall Study|Subject Non-Compliant|2|||
164542545|NCT00359021|594359027|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
164542546|NCT00359021|594359028|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
164542547|NCT00359021|594359027|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
164542548|NCT00359021|594359028|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
164542549|NCT00359021|594359027|FG000|Overall Study|Withdrawal by Subject|2|||
164542550|NCT00359021|594359028|FG001|Overall Study|Withdrawal by Subject|9|||
164542551|NCT00359021|594359027|FG000|Overall Study|Lost to Follow-up|1|||
164542552|NCT00359021|594359028|FG001|Overall Study|Lost to Follow-up|0|||
164542553|NCT00359021|594359027|FG000|Overall Study|Other|4|||
164542554|NCT00359021|594359028|FG001|Overall Study|Other|1|||
164542555|NCT00359021|594359027|FG000|Overall Study|Pregnancy|1|||
164542556|NCT00359021|594359028|FG001|Overall Study|Pregnancy|0|||
164542557|NCT03861936|594359029|FG000|Overall Study|Withdrawal by Subject|4|||
164542558|NCT03861936|594359030|FG001|Overall Study|Withdrawal by Subject|1|||
164542559|NCT03861936|594359031|FG002|Overall Study|Withdrawal by Subject|3|||
164542560|NCT03861936|594359029|FG000|Overall Study|Lost to Follow-up|5|||
164542561|NCT03861936|594359030|FG001|Overall Study|Lost to Follow-up|3|||
164542562|NCT03861936|594359031|FG002|Overall Study|Lost to Follow-up|3|||
164542563|NCT03861936|594359029|FG000|Overall Study|Physician Decision|0|||
164542564|NCT03861936|594359030|FG001|Overall Study|Physician Decision|1|||
164542565|NCT03861936|594359031|FG002|Overall Study|Physician Decision|0|||
164542566|NCT03861936|594359029|FG000|Overall Study|Protocol Deviation|0|||
164542567|NCT03861936|594359030|FG001|Overall Study|Protocol Deviation|0|||
164542568|NCT03861936|594359031|FG002|Overall Study|Protocol Deviation|1|||
164542569|NCT03861936|594359029|FG000|Overall Study|Reason not Specified|5|||
164542570|NCT03861936|594359030|FG001|Overall Study|Reason not Specified|5|||
164542571|NCT03861936|594359031|FG002|Overall Study|Reason not Specified|3|||
164542572|NCT01670539|594359036|FG000|Overall Study|Death|3|||
164542573|NCT01670539|594359037|FG001|Overall Study|Death|5|||
164542574|NCT01670539|594359036|FG000|Overall Study|Withdrawal by Subject|3|||
164542575|NCT01670539|594359037|FG001|Overall Study|Withdrawal by Subject|0|||
164542576|NCT04353596|594359038|FG000|Overall Study|Protocol Violation|4|||
164542577|NCT04353596|594359039|FG001|Overall Study|Protocol Violation|4|||
164542578|NCT04353596|594359038|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
164542579|NCT04353596|594359039|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
164542580|NCT01236573|594359042|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
164542581|NCT01236573|594359043|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
164542582|NCT01236573|594359044|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
164542583|NCT01236573|594359045|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
164542584|NCT01236573|594359046|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
164542585|NCT01236573|594359047|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
164542586|NCT01236573|594359048|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
164542587|NCT01236573|594359049|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
164542588|NCT01236573|594359050|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
164542589|NCT01236573|594359051|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
164542590|NCT01236573|594359052|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
164542591|NCT01236573|594359042|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
164542592|NCT01236573|594359043|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
164542593|NCT01236573|594359044|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
164542594|NCT01236573|594359045|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
164542595|NCT01236573|594359046|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
164542596|NCT01236573|594359047|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
164542597|NCT01236573|594359048|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
164542598|NCT01236573|594359049|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
164542599|NCT01236573|594359050|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
164542600|NCT01236573|594359051|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
164542601|NCT01236573|594359052|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
164542602|NCT01236573|594359042|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
164542603|NCT01236573|594359043|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
164542604|NCT01236573|594359044|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
164190672|NCT00791700|593066335|FG000|Overall Study|Other|0|||
164190673|NCT00791700|593066336|FG001|Overall Study|Other|1|||
164190674|NCT00791700|593066337|FG002|Overall Study|Other|0|||
164190675|NCT00791700|593066338|FG003|Overall Study|Other|1|||
164190676|NCT00791700|593066335|FG000|Overall Study|Death|0|||
164190677|NCT00791700|593066336|FG001|Overall Study|Death|0|||
164190678|NCT00791700|593066337|FG002|Overall Study|Death|0|||
164190679|NCT00791700|593066338|FG003|Overall Study|Death|1|||
164190680|NCT00791700|593066335|FG000|Overall Study|Lost to Follow-up|4|||
164190681|NCT00791700|593066336|FG001|Overall Study|Lost to Follow-up|3|||
164542605|NCT01236573|594359045|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
164190682|NCT00791700|593066337|FG002|Overall Study|Lost to Follow-up|4|||
164190683|NCT00791700|593066338|FG003|Overall Study|Lost to Follow-up|6|||
164190684|NCT00791700|593066335|FG000|Overall Study|Adverse Event|0|||
164190685|NCT00791700|593066336|FG001|Overall Study|Adverse Event|0|||
164190686|NCT00791700|593066337|FG002|Overall Study|Adverse Event|1|||
164190687|NCT00791700|593066338|FG003|Overall Study|Adverse Event|1|||
164190688|NCT00996034|593066341|FG000|Overall Study|Lost to Follow-up|2|||
164190689|NCT00996034|593066341|FG000|Overall Study|withdrawn by PI|1|||
164190690|NCT01720524|593066342|FG000|Part A|Insufficient Clinical Response|2|||
164190691|NCT01720524|593066343|FG001|Part A|Insufficient Clinical Response|4|||
164190692|NCT01720524|593066342|FG000|Part A|Adverse Event|2|||
164190693|NCT01720524|593066343|FG001|Part A|Adverse Event|2|||
164190694|NCT01720524|593066342|FG000|Part A|Death|2|||
164190695|NCT01720524|593066343|FG001|Part A|Death|1|||
164190696|NCT01720524|593066342|FG000|Part A|Lost to Follow-up|0|||
164190697|NCT01720524|593066343|FG001|Part A|Lost to Follow-up|1|||
164190698|NCT01720524|593066342|FG000|Part A|Missed 28 day follow-up visit|1|||
164190699|NCT01720524|593066343|FG001|Part A|Missed 28 day follow-up visit|1|||
164190700|NCT01720524|593066342|FG000|Part A|Withdrawal by Subject|0|||
164190701|NCT01720524|593066343|FG001|Part A|Withdrawal by Subject|1|||
164190702|NCT01720524|593066342|FG000|Part A|Other|0|||
164190703|NCT01720524|593066343|FG001|Part A|Other|1|||
164190704|NCT01720524|593066342|FG000|Part A|Lost to Follow-up|0|||
164190705|NCT01720524|593066343|FG001|Part A|Lost to Follow-up|1|||
164190706|NCT01720524|593066342|FG000|Part B|No longer willing to participate in study|1|||
164190707|NCT01720524|593066343|FG001|Part B|No longer willing to participate in study|4|||
164190708|NCT01720524|593066342|FG000|Part B|Other|2|||
164190709|NCT01720524|593066343|FG001|Part B|Other|0|||
164190710|NCT01720524|593066342|FG000|Part B|Lost to Follow-up|2|||
164190711|NCT01720524|593066343|FG001|Part B|Lost to Follow-up|3|||
164190712|NCT01720524|593066342|FG000|Part B|Death|0|||
164190713|NCT01720524|593066343|FG001|Part B|Death|2|||
164190714|NCT00527826|593066347|FG000|Overall Study|Adverse Event|10|||
164190715|NCT00527826|593066348|FG001|Overall Study|Adverse Event|10|||
164190716|NCT00527826|593066347|FG000|Overall Study|Lost to Follow-up|3|||
164190717|NCT00527826|593066348|FG001|Overall Study|Lost to Follow-up|2|||
164190718|NCT00527826|593066347|FG000|Overall Study|Withdrawal by Subject|5|||
164190719|NCT00527826|593066348|FG001|Overall Study|Withdrawal by Subject|8|||
164190720|NCT00527826|593066347|FG000|Overall Study|Inclusion Criteria Not Met|3|||
164190721|NCT00527826|593066348|FG001|Overall Study|Inclusion Criteria Not Met|3|||
164542606|NCT01236573|594359046|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
164542607|NCT01236573|594359047|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
164542608|NCT01236573|594359048|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
164542609|NCT01236573|594359049|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
164542610|NCT01236573|594359050|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
164542611|NCT01236573|594359051|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
164542612|NCT01236573|594359052|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
164542613|NCT05418673|594359053|FG000|Overall Study|Study Terminated by Sponsor|2|||
164542614|NCT05418673|594359054|FG001|Overall Study|Study Terminated by Sponsor|4|||
164542615|NCT05418673|594359053|FG000|Overall Study|Lost to Follow-up|1|||
164542616|NCT05418673|594359054|FG001|Overall Study|Lost to Follow-up|0|||
164190722|NCT00527826|593066347|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
164190723|NCT00527826|593066348|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
164190724|NCT00527826|593066347|FG000|Overall Study|Additional Intake of Viani forte|0|||
164190725|NCT00527826|593066348|FG001|Overall Study|Additional Intake of Viani forte|1|||
164190726|NCT00527826|593066347|FG000|Overall Study|Participant moved away|0|||
164542617|NCT02665052|594359055|FG000|Overall Study|Lost to Follow-up|1|||
164190727|NCT00527826|593066348|FG001|Overall Study|Participant moved away|1|||
164190728|NCT00158262|593066349|FG000|Overall Study|Lost to Follow-up|1|||
164190729|NCT00158262|593066350|FG001|Overall Study|Lost to Follow-up|1|||
164190730|NCT03293394|593066358|FG000|Follow-up (6 Months)|Adverse Event|4|||
164190731|NCT03293394|593066359|FG001|Follow-up (6 Months)|Adverse Event|2|||
164190732|NCT02716584|593066360|FG000|Overall Study|Lost to Follow-up|8|||
164190733|NCT02716584|593066361|FG001|Overall Study|Lost to Follow-up|5|||
164190734|NCT00420628|593066362|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
164190735|NCT00420628|593066363|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
164190736|NCT00420628|593066362|FG000|Overall Study|Lost to Follow-up|3|||
164190737|NCT00420628|593066363|FG001|Overall Study|Lost to Follow-up|2|||
164542618|NCT02665052|594359056|FG001|Overall Study|Lost to Follow-up|0|||
164542619|NCT02665052|594359057|FG002|Overall Study|Lost to Follow-up|0|||
164542620|NCT02665052|594359058|FG003|Overall Study|Lost to Follow-up|0|||
164542621|NCT02665052|594359055|FG000|Overall Study|Withdrawal by Subject|1|||
164542622|NCT02665052|594359056|FG001|Overall Study|Withdrawal by Subject|1|||
164542623|NCT02665052|594359057|FG002|Overall Study|Withdrawal by Subject|0|||
164542624|NCT02665052|594359058|FG003|Overall Study|Withdrawal by Subject|5|||
164542625|NCT02665052|594359055|FG000|Overall Study|Adverse Event|1|||
164542626|NCT02665052|594359056|FG001|Overall Study|Adverse Event|1|||
164542627|NCT02665052|594359057|FG002|Overall Study|Adverse Event|0|||
164542628|NCT02665052|594359058|FG003|Overall Study|Adverse Event|0|||
164542629|NCT02234284|594359059|FG000|Overall Study|Death|4|||
164542630|NCT02234284|594359060|FG001|Overall Study|Death|2|||
164542631|NCT02234284|594359059|FG000|Overall Study|Withdrawal by Subject|1|||
164542632|NCT02234284|594359060|FG001|Overall Study|Withdrawal by Subject|0|||
164542633|NCT02234284|594359059|FG000|Overall Study|Lost to Follow-up|20|||
164542634|NCT02234284|594359060|FG001|Overall Study|Lost to Follow-up|7|||
164542635|NCT01986920|594359063|FG000|A- 101 25%|Withdrawal by Subject|1|||
164542636|NCT01986920|594359064|FG001|A- 101 25%|Withdrawal by Subject|0|||
164542637|NCT01986920|594359065|FG002|A- 101 25%|Withdrawal by Subject|0|||
164542638|NCT01986920|594359066|FG003|A- 101 25%|Withdrawal by Subject|0|||
164542639|NCT01986920|594359063|FG000|A-101 32.5%|Withdrawal by Subject|0|||
164542640|NCT01986920|594359064|FG001|A-101 32.5%|Withdrawal by Subject|1|||
164542641|NCT01986920|594359065|FG002|A-101 32.5%|Withdrawal by Subject|0|||
164542642|NCT01986920|594359066|FG003|A-101 32.5%|Withdrawal by Subject|0|||
164542643|NCT01986920|594359063|FG000|A-101 40%|Withdrawal by Subject|0|||
164542644|NCT01986920|594359064|FG001|A-101 40%|Withdrawal by Subject|0|||
164542645|NCT01986920|594359065|FG002|A-101 40%|Withdrawal by Subject|1|||
164542646|NCT01986920|594359066|FG003|A-101 40%|Withdrawal by Subject|0|||
164542647|NCT01986920|594359063|FG000|Placebo|Withdrawal by Subject|0|||
164542648|NCT01986920|594359064|FG001|Placebo|Withdrawal by Subject|0|||
164542649|NCT01986920|594359065|FG002|Placebo|Withdrawal by Subject|0|||
164542650|NCT01986920|594359066|FG003|Placebo|Withdrawal by Subject|1|||
164542651|NCT03023059|594359069|FG000|Overall Study|Withdrawal by Subject|5|||
164542652|NCT05215262|594359070|FG000|Overall Study|Lost to Follow-up|12|||
164542653|NCT05215262|594359071|FG001|Overall Study|Lost to Follow-up|0|||
164542654|NCT04880447|594359073|FG000|Overall Study|No vaccination information|1|||
164542655|NCT04880447|594359073|FG000|Overall Study|No adverse event information (missing information)|1|||
164542656|NCT04880447|594359073|FG000|Overall Study|Disease not covered in this study|35|||
164542657|NCT01353508|594359074|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
164542658|NCT01353508|594359075|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
164542659|NCT01353508|594359076|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
164542660|NCT01353508|594359077|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
164542661|NCT01353508|594359074|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
164542662|NCT01353508|594359075|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
164542663|NCT01353508|594359076|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
164542664|NCT01353508|594359077|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
164542665|NCT02092350|594359082|FG000|Overall Study|Adverse Event|0|||
164542666|NCT02092350|594359083|FG001|Overall Study|Adverse Event|3|||
164542667|NCT02092350|594359082|FG000|Overall Study|Death|2|||
164542668|NCT02092350|594359083|FG001|Overall Study|Death|5|||
164542669|NCT02092350|594359082|FG000|Overall Study|Lost to Follow-up|3|||
164542670|NCT02092350|594359083|FG001|Overall Study|Lost to Follow-up|1|||
164542671|NCT02092350|594359082|FG000|Overall Study|Protocol Violation|1|||
164542672|NCT02092350|594359083|FG001|Overall Study|Protocol Violation|0|||
164542673|NCT02092350|594359082|FG000|Overall Study|Physician Decision|1|||
164542674|NCT02092350|594359083|FG001|Overall Study|Physician Decision|1|||
164542675|NCT02092350|594359082|FG000|Overall Study|Screen Failure|1|||
164542676|NCT02092350|594359083|FG001|Overall Study|Screen Failure|0|||
164542677|NCT02092350|594359082|FG000|Overall Study|Withdrawal by Subject|2|||
164542678|NCT02092350|594359083|FG001|Overall Study|Withdrawal by Subject|2|||
164542679|NCT00646906|594359085|FG000|Crossover Period 1|Withdrawal by Subject|1|||
164542680|NCT00646906|594359086|FG001|Crossover Period 1|Withdrawal by Subject|0|||
164542681|NCT00646906|594359087|FG002|Crossover Period 1|Withdrawal by Subject|0|||
164542682|NCT00646906|594359088|FG003|Crossover Period 1|Withdrawal by Subject|0|||
164542683|NCT00646906|594359089|FG004|Crossover Period 1|Withdrawal by Subject|0|||
164542684|NCT00646906|594359090|FG005|Crossover Period 1|Withdrawal by Subject|1|||
164542685|NCT00646906|594359091|FG006|Crossover Period 1|Withdrawal by Subject|0|||
164542686|NCT00646906|594359085|FG000|Crossover Period 2|Withdrawal by Subject|0|||
164542687|NCT00646906|594359086|FG001|Crossover Period 2|Withdrawal by Subject|1|||
164542688|NCT00646906|594359087|FG002|Crossover Period 2|Withdrawal by Subject|2|||
164542689|NCT00646906|594359088|FG003|Crossover Period 2|Withdrawal by Subject|1|||
164542690|NCT00646906|594359089|FG004|Crossover Period 2|Withdrawal by Subject|0|||
164542691|NCT00646906|594359090|FG005|Crossover Period 2|Withdrawal by Subject|0|||
164542692|NCT00646906|594359091|FG006|Crossover Period 2|Withdrawal by Subject|0|||
164542693|NCT00646906|594359085|FG000|Crossover Period 2|Physician Decision|0|||
164542694|NCT00646906|594359086|FG001|Crossover Period 2|Physician Decision|0|||
164542695|NCT00646906|594359087|FG002|Crossover Period 2|Physician Decision|0|||
164542696|NCT00646906|594359088|FG003|Crossover Period 2|Physician Decision|0|||
164542697|NCT00646906|594359089|FG004|Crossover Period 2|Physician Decision|0|||
164542698|NCT00646906|594359090|FG005|Crossover Period 2|Physician Decision|0|||
164542699|NCT00646906|594359091|FG006|Crossover Period 2|Physician Decision|1|||
164542700|NCT00433914|594359097|FG000|Overall Study|Withdrawal by Subject|0|||
164542701|NCT00433914|594359098|FG001|Overall Study|Withdrawal by Subject|2|||
164542702|NCT00433914|594359097|FG000|Overall Study|Lost to Follow-up|0|||
164190738|NCT00420628|593066362|FG000|Overall Study|Adverse Event|1|||
164190739|NCT00420628|593066363|FG001|Overall Study|Adverse Event|0|||
164190740|NCT01903993|593066364|FG000|Overall Study|Death|118|||
164190741|NCT01903993|593066365|FG001|Overall Study|Death|121|||
164190742|NCT01903993|593066364|FG000|Overall Study|Withdrawal by Subject|15|||
164190743|NCT01903993|593066365|FG001|Overall Study|Withdrawal by Subject|4|||
164190744|NCT01903993|593066364|FG000|Overall Study|Lost to Follow-up|2|||
164190745|NCT01903993|593066365|FG001|Overall Study|Lost to Follow-up|3|||
164190746|NCT01903993|593066364|FG000|Overall Study|Study Terminated by Sponsor|8|||
164190747|NCT01903993|593066365|FG001|Overall Study|Study Terminated by Sponsor|14|||
164190748|NCT01903993|593066364|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
164190749|NCT01903993|593066365|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
164190750|NCT03283930|593066366|FG000|Overall Study|Scheduling conflict|8|||
164190751|NCT03283930|593066367|FG001|Overall Study|Scheduling conflict|10|||
164190752|NCT03283930|593066366|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
164190753|NCT03283930|593066367|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
164190754|NCT03283930|593066366|FG000|Overall Study|Technical software issue|2|||
164190755|NCT03283930|593066367|FG001|Overall Study|Technical software issue|2|||
164190756|NCT02588664|593066368|FG000|Overall Study|Death|56|||
164190757|NCT02588664|593066369|FG001|Overall Study|Death|55|||
164190758|NCT02588664|593066368|FG000|Overall Study|Lost to Follow-up|1305|||
164190759|NCT02588664|593066369|FG001|Overall Study|Lost to Follow-up|990|||
164190760|NCT02500719|593066370|FG000|Overall Study|Lost to Follow-up|2|||
164190761|NCT02500719|593066371|FG001|Overall Study|Lost to Follow-up|3|||
164190762|NCT02500719|593066370|FG000|Overall Study|Trauma history|1|||
164190763|NCT02500719|593066371|FG001|Overall Study|Trauma history|0|||
164190764|NCT02500719|593066370|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
164190765|NCT02500719|593066371|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
164190766|NCT02500719|593066370|FG000|Overall Study|Did not meet criteria for PTSD|0|||
164190767|NCT02500719|593066371|FG001|Overall Study|Did not meet criteria for PTSD|1|||
164190768|NCT02500719|593066370|FG000|Overall Study|Claustrophobia|0|||
164190769|NCT02500719|593066371|FG001|Overall Study|Claustrophobia|1|||
164190770|NCT02500719|593066370|FG000|Overall Study|History of head trauma|0|||
164190771|NCT02500719|593066371|FG001|Overall Study|History of head trauma|1|||
164190772|NCT02787083|593066372|FG000|Overall Study|Adverse Event|1|||
164190773|NCT02787083|593066373|FG001|Overall Study|Adverse Event|0|||
164190774|NCT02787083|593066372|FG000|Overall Study|Withdrawal by Subject|2|||
164190775|NCT02787083|593066373|FG001|Overall Study|Withdrawal by Subject|2|||
164190776|NCT00154375|593066374|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
164190777|NCT00154375|593066375|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
164190778|NCT00154375|593066374|FG000|Overall Study|Adverse Event|18|||
164190779|NCT00154375|593066375|FG001|Overall Study|Adverse Event|20|||
164190780|NCT00154375|593066374|FG000|Overall Study|Withdrawal by Subject|14|||
164542703|NCT00433914|594359098|FG001|Overall Study|Lost to Follow-up|1|||
164542704|NCT02844920|594359099|FG000|Overall Study|Lost to Follow-up|2|||
164542705|NCT02678416|594359104|FG000|Part 1|Withdrawal by Subject|1|||
164542706|NCT02678416|594359104|FG000|Part 2|Adverse Event|2|||
164542707|NCT02678416|594359104|FG000|Part 2|Withdrawal by Subject|1|||
164542708|NCT01910116|594359110|FG000|Overall Study|Adverse Event|0|||
164190781|NCT00154375|593066375|FG001|Overall Study|Withdrawal by Subject|10|||
164190782|NCT00154375|593066374|FG000|Overall Study|Death|5|||
164190783|NCT00154375|593066375|FG001|Overall Study|Death|13|||
164190784|NCT00154375|593066374|FG000|Overall Study|Study drug no longer required|5|||
164190785|NCT00154375|593066375|FG001|Overall Study|Study drug no longer required|3|||
164190786|NCT00154375|593066374|FG000|Overall Study|Lost to Follow-up|2|||
164190787|NCT00154375|593066375|FG001|Overall Study|Lost to Follow-up|1|||
164190788|NCT00154375|593066374|FG000|Overall Study|Abnormal laboratory value(s)|0|||
164190789|NCT00154375|593066375|FG001|Overall Study|Abnormal laboratory value(s)|2|||
164190790|NCT00154375|593066374|FG000|Overall Study|Protocol Violation|0|||
164190791|NCT00154375|593066375|FG001|Overall Study|Protocol Violation|1|||
164190792|NCT00154375|593066374|FG000|Overall Study|Suspected progression of disease|44|||
164190793|NCT00154375|593066375|FG001|Overall Study|Suspected progression of disease|30|||
164190794|NCT03538691|593066376|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
164542709|NCT01910116|594359111|FG001|Overall Study|Adverse Event|3|||
164542710|NCT01910116|594359110|FG000|Overall Study|Lack of Efficacy|3|||
164542711|NCT01910116|594359111|FG001|Overall Study|Lack of Efficacy|4|||
164302040|NCT02395471|593482509|FG000|Overall Study|Lost to Follow-up|2|||
164542712|NCT01910116|594359110|FG000|Overall Study|Lost to Follow-up|1|||
164542713|NCT01910116|594359111|FG001|Overall Study|Lost to Follow-up|0|||
164542714|NCT01910116|594359110|FG000|Overall Study|Protocol Violation|1|||
164542715|NCT01910116|594359111|FG001|Overall Study|Protocol Violation|2|||
164542716|NCT01910116|594359110|FG000|Overall Study|Withdrawal by Subject|8|||
164542717|NCT01910116|594359111|FG001|Overall Study|Withdrawal by Subject|3|||
164542718|NCT01910116|594359110|FG000|Overall Study|uncertain allocation|1|||
164542719|NCT01910116|594359111|FG001|Overall Study|uncertain allocation|3|||
164542720|NCT01910116|594359110|FG000|Overall Study|incomplete data|0|||
164542721|NCT01910116|594359111|FG001|Overall Study|incomplete data|1|||
164542722|NCT01179672|594360940|FG000|Overall Study|Adverse Event|17|||
164542723|NCT01179672|594360941|FG001|Overall Study|Adverse Event|8|||
164542724|NCT01179672|594360940|FG000|Overall Study|Withdrawal by Subject|10|||
164542725|NCT01179672|594360941|FG001|Overall Study|Withdrawal by Subject|12|||
164542726|NCT01179672|594360940|FG000|Overall Study|Entry Criteria Not Met|0|||
164542727|NCT01179672|594360941|FG001|Overall Study|Entry Criteria Not Met|2|||
164542728|NCT01179672|594360940|FG000|Overall Study|Lost to Follow-up|0|||
164542729|NCT01179672|594360941|FG001|Overall Study|Lost to Follow-up|1|||
164542730|NCT01179672|594360940|FG000|Overall Study|Protocol Violation|2|||
164542731|NCT01179672|594360941|FG001|Overall Study|Protocol Violation|2|||
164542732|NCT01179672|594360940|FG000|Overall Study|Physician Decision|1|||
164542733|NCT01179672|594360941|FG001|Overall Study|Physician Decision|1|||
164542734|NCT02164929|594360942|FG000|Overall Study|Converted to open procedure|1|||
164542735|NCT02164929|594360943|FG001|Overall Study|Converted to open procedure|0|||
164542736|NCT02164929|594360944|FG002|Overall Study|Converted to open procedure|0|||
164542737|NCT02164929|594360945|FG003|Overall Study|Converted to open procedure|2|||
164542738|NCT02164929|594360942|FG000|Overall Study|Failed regional block|0|||
164542739|NCT02164929|594360943|FG001|Overall Study|Failed regional block|0|||
164542740|NCT02164929|594360944|FG002|Overall Study|Failed regional block|1|||
164542741|NCT02164929|594360945|FG003|Overall Study|Failed regional block|0|||
164542742|NCT00365456|594360949|FG000|Trial Period I (12 Months)|Adverse Event|84|||
164542743|NCT00365456|594360950|FG001|Trial Period I (12 Months)|Adverse Event|0|||
164542744|NCT00365456|594360949|FG000|Trial Period I (12 Months)|Non-compliance|3|||
164542745|NCT00365456|594360950|FG001|Trial Period I (12 Months)|Non-compliance|0|||
164542746|NCT00365456|594360949|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
164542747|NCT00365456|594360950|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
164542748|NCT00365456|594360949|FG000|Trial Period I (12 Months)|Other|11|||
164542749|NCT00365456|594360950|FG001|Trial Period I (12 Months)|Other|0|||
164542750|NCT00365456|594360949|FG000|Trial Period II (12 Months)|Adverse Event|0|||
164542751|NCT00365456|594360950|FG001|Trial Period II (12 Months)|Adverse Event|6|||
164542752|NCT00365456|594360949|FG000|Trial Period II (12 Months)|Non-compliance|0|||
164542753|NCT00365456|594360950|FG001|Trial Period II (12 Months)|Non-compliance|2|||
164542754|NCT00365456|594360949|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
164542755|NCT00365456|594360950|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
164542756|NCT00365456|594360949|FG000|Trial Period II (12 Months)|Other|0|||
164542757|NCT00365456|594360950|FG001|Trial Period II (12 Months)|Other|1|||
164542758|NCT00365456|594360949|FG000|Trial Period III (12 Months)|Adverse Event|13|||
164542759|NCT00365456|594360950|FG001|Trial Period III (12 Months)|Adverse Event|3|||
164542760|NCT00365456|594360949|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
164542761|NCT00365456|594360950|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
164542762|NCT00365456|594360949|FG000|Trial Period III (12 Months)|Other|1|||
164542763|NCT00365456|594360950|FG001|Trial Period III (12 Months)|Other|1|||
164542764|NCT04754802|594360952|FG000|Overall Study|Lost to Follow-up|0|||
164542765|NCT04754802|594360953|FG001|Overall Study|Lost to Follow-up|2|||
164542766|NCT04754802|594360952|FG000|Overall Study|Withdrawal by Subject|2|||
164542767|NCT04754802|594360953|FG001|Overall Study|Withdrawal by Subject|0|||
164542768|NCT00701090|594360956|FG000|Overall Study|Adverse Event|11|||
164542769|NCT00701090|594360957|FG001|Overall Study|Adverse Event|2|||
164542770|NCT00701090|594360956|FG000|Overall Study|Death|0|||
164542771|NCT00701090|594360957|FG001|Overall Study|Death|1|||
164542772|NCT00701090|594360956|FG000|Overall Study|Lack of Efficacy|5|||
164542773|NCT00701090|594360957|FG001|Overall Study|Lack of Efficacy|4|||
164542774|NCT00701090|594360956|FG000|Overall Study|Lost to Follow-up|9|||
164542775|NCT00701090|594360957|FG001|Overall Study|Lost to Follow-up|9|||
164653205|NCT00461500|594757076|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
164190795|NCT03538691|593066377|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
164190796|NCT03538691|593066378|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
164542776|NCT00701090|594360956|FG000|Overall Study|Physician Decision|3|||
164542777|NCT00701090|594360957|FG001|Overall Study|Physician Decision|4|||
164542778|NCT00701090|594360956|FG000|Overall Study|Protocol Violation|2|||
164542779|NCT00701090|594360957|FG001|Overall Study|Protocol Violation|3|||
164542780|NCT00701090|594360956|FG000|Overall Study|Withdrawal by Subject|11|||
164542781|NCT00701090|594360957|FG001|Overall Study|Withdrawal by Subject|16|||
164653206|NCT00461500|594757077|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
164542782|NCT00701090|594360956|FG000|Overall Study|Other|7|||
164542783|NCT00701090|594360957|FG001|Overall Study|Other|12|||
164542784|NCT00873366|594360958|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
164542785|NCT00873366|594360958|FG000|Overall Study|Off tamoxifen due to side effects|2|||
164542786|NCT00873366|594360958|FG000|Overall Study|Refused to continue DM-BT testing|3|||
164542787|NCT01576172|594360959|FG000|Overall Study|Ineligible|2|||
164542788|NCT01576172|594360960|FG001|Overall Study|Ineligible|1|||
164542789|NCT01576172|594360959|FG000|Overall Study|Withdrawal by Subject|2|||
164542790|NCT01576172|594360960|FG001|Overall Study|Withdrawal by Subject|0|||
164542791|NCT01576172|594360959|FG000|Overall Study|Insurance issue|1|||
164542792|NCT01576172|594360960|FG001|Overall Study|Insurance issue|0|||
164542793|NCT00962390|594360969|FG000|Overall Study|Adverse Event|0|||
164542794|NCT00962390|594360970|FG001|Overall Study|Adverse Event|0|||
164542795|NCT00962390|594360971|FG002|Overall Study|Adverse Event|3|||
164542796|NCT00962390|594360972|FG003|Overall Study|Adverse Event|1|||
164542797|NCT00962390|594360969|FG000|Overall Study|Lost to Follow-up|2|||
164542798|NCT00962390|594360970|FG001|Overall Study|Lost to Follow-up|2|||
164542799|NCT00962390|594360971|FG002|Overall Study|Lost to Follow-up|0|||
164542800|NCT00962390|594360972|FG003|Overall Study|Lost to Follow-up|0|||
164542801|NCT00962390|594360969|FG000|Overall Study|Protocol Violation|1|||
164542802|NCT00962390|594360970|FG001|Overall Study|Protocol Violation|0|||
164542803|NCT00962390|594360971|FG002|Overall Study|Protocol Violation|0|||
164542804|NCT00962390|594360972|FG003|Overall Study|Protocol Violation|0|||
164542805|NCT00962390|594360969|FG000|Overall Study|Withdrawal by Subject|1|||
164542806|NCT00962390|594360970|FG001|Overall Study|Withdrawal by Subject|1|||
164542807|NCT00962390|594360971|FG002|Overall Study|Withdrawal by Subject|1|||
164542808|NCT00962390|594360972|FG003|Overall Study|Withdrawal by Subject|0|||
164542809|NCT02613884|594360973|FG000|Overall Study|Death|1|||
164542810|NCT02613884|594360973|FG000|Overall Study|Lost to Follow-up|1|||
164542811|NCT01299376|594360979|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
164542812|NCT01299376|594360980|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
164542813|NCT01299376|594360979|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
164542814|NCT01299376|594360980|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
164542815|NCT01299376|594360979|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
164542816|NCT01299376|594360980|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
164542817|NCT01299376|594360979|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
164542818|NCT01299376|594360980|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
164542819|NCT01299376|594360979|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
164542820|NCT01299376|594360980|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
164542821|NCT01299376|594360979|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
164542822|NCT01299376|594360980|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
164542823|NCT01299376|594360979|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
164542824|NCT01299376|594360980|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
164542825|NCT01299376|594360979|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
164542826|NCT01299376|594360980|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
164542827|NCT01299376|594360979|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
164542828|NCT01299376|594360980|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
164542829|NCT01299376|594360979|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
164542830|NCT01299376|594360980|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
164542831|NCT01299376|594360979|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
164542832|NCT01299376|594360980|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
164542833|NCT00766090|594360981|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164542834|NCT00766090|594360982|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164542835|NCT00766090|594360983|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164542836|NCT00766090|594360984|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164542837|NCT00766090|594360985|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164542838|NCT00766090|594360986|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164542839|NCT00766090|594360987|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164542840|NCT00766090|594360988|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164542841|NCT00766090|594360989|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
164542842|NCT00766090|594360990|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164542843|NCT00766090|594360991|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164542844|NCT00766090|594360992|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164542845|NCT00766090|594360981|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
164542846|NCT00766090|594360982|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
164542847|NCT00766090|594360983|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
164542848|NCT00766090|594360984|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
164542849|NCT00766090|594360985|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
164542850|NCT00766090|594360986|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
164542851|NCT00766090|594360987|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
164542852|NCT00766090|594360988|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
164542853|NCT00766090|594360989|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
164542854|NCT00766090|594360990|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
164542855|NCT00766090|594360991|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
164542856|NCT00766090|594360992|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
164653207|NCT00461500|594757076|FG000|Overall Study|Lost to Follow-up|2|||
164542857|NCT00766090|594360981|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
164542858|NCT00766090|594360982|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164542859|NCT00766090|594360983|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164542860|NCT00766090|594360984|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
164542861|NCT00766090|594360985|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164542862|NCT00766090|594360986|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164542863|NCT00766090|594360987|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164542864|NCT00766090|594360988|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164542865|NCT00766090|594360989|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164542866|NCT00766090|594360990|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164542867|NCT00766090|594360991|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164542868|NCT00766090|594360992|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164542869|NCT00766090|594360981|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
164542870|NCT00766090|594360982|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
164542871|NCT00766090|594360983|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
164542872|NCT00766090|594360984|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
164542873|NCT00766090|594360985|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
164542874|NCT00766090|594360986|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
164542875|NCT00766090|594360987|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
164542876|NCT00766090|594360988|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
164542877|NCT00766090|594360989|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
164542878|NCT00766090|594360990|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
164542879|NCT00766090|594360991|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
164542880|NCT00766090|594360992|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
164542881|NCT00766090|594360981|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164542882|NCT00766090|594360982|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164542883|NCT00766090|594360983|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164542884|NCT00766090|594360984|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164542885|NCT00766090|594360985|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
164542886|NCT00766090|594360986|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164542887|NCT00766090|594360987|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164542888|NCT00766090|594360988|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164542889|NCT00766090|594360989|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164542890|NCT00766090|594360990|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164542891|NCT00766090|594360991|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164542892|NCT00766090|594360992|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164542893|NCT00766090|594360981|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
164542894|NCT00766090|594360982|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
164542895|NCT00766090|594360983|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
164542896|NCT00766090|594360984|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
164542897|NCT00766090|594360985|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
164542898|NCT00766090|594360986|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
164542899|NCT00766090|594360987|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
164542900|NCT00766090|594360988|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
164542901|NCT00766090|594360989|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
164542902|NCT00766090|594360990|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
164542903|NCT00766090|594360991|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
164542904|NCT00766090|594360992|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
164542905|NCT00766090|594360981|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
164542906|NCT00766090|594360982|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
164542907|NCT00766090|594360983|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
164542908|NCT00766090|594360984|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
164542909|NCT00766090|594360985|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
164542910|NCT00766090|594360986|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
164542911|NCT00766090|594360987|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
164542912|NCT00766090|594360988|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
164542913|NCT00766090|594360989|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
164542914|NCT00766090|594360990|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
164542915|NCT00766090|594360991|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
164542916|NCT00766090|594360992|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
164542917|NCT00766090|594360981|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
164542918|NCT00766090|594360982|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
164542919|NCT00766090|594360983|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
164542920|NCT00766090|594360984|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
164542921|NCT00766090|594360985|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
164542922|NCT00766090|594360986|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
164542923|NCT00766090|594360987|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
164542924|NCT00766090|594360988|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
164542925|NCT00766090|594360989|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
164542926|NCT00766090|594360990|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
164190797|NCT03538691|593066379|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
164190798|NCT03538691|593066376|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
164190799|NCT03538691|593066377|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
164190800|NCT03538691|593066378|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
164190801|NCT03538691|593066379|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
164190802|NCT03538691|593066376|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
164190803|NCT03538691|593066377|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
164190804|NCT03538691|593066378|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
164190805|NCT03538691|593066379|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
164190806|NCT03538691|593066376|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
164190807|NCT03538691|593066377|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
164190808|NCT03538691|593066378|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
164190809|NCT03538691|593066379|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
164190810|NCT03538691|593066376|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
164190811|NCT03538691|593066377|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
164190812|NCT03538691|593066378|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
164190813|NCT03538691|593066379|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
164190814|NCT03538691|593066376|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
164190815|NCT03538691|593066377|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
164190816|NCT03538691|593066378|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
164190817|NCT03538691|593066379|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
164190818|NCT03538691|593066376|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
164190819|NCT03538691|593066377|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
164542927|NCT00766090|594360991|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
164542928|NCT00766090|594360992|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
164542929|NCT00766090|594360981|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
164190820|NCT03538691|593066378|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
164190821|NCT03538691|593066379|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
164190822|NCT03538691|593066376|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
164190823|NCT03538691|593066377|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
164190824|NCT03538691|593066378|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
164190825|NCT03538691|593066379|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
164190826|NCT03538691|593066376|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
164190827|NCT03538691|593066377|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
164190828|NCT03538691|593066378|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
164190829|NCT03538691|593066379|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
164190830|NCT03538691|593066376|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
164190831|NCT03538691|593066377|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
164190832|NCT03538691|593066378|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
164190833|NCT03538691|593066379|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
164190834|NCT03538691|593066376|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
164190835|NCT03538691|593066377|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
164190836|NCT03538691|593066378|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
164190837|NCT03538691|593066379|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
164190838|NCT03538691|593066376|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
164190839|NCT03538691|593066377|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
164190840|NCT03538691|593066378|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
164190841|NCT03538691|593066379|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
164190842|NCT03538691|593066376|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
164190843|NCT03538691|593066377|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
164190844|NCT03538691|593066378|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
164190845|NCT03538691|593066379|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
164190846|NCT03538691|593066376|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
164190847|NCT03538691|593066377|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
164190848|NCT03538691|593066378|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
164190849|NCT03538691|593066379|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
164190850|NCT03538691|593066376|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
164190851|NCT03538691|593066377|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
164190852|NCT03538691|593066378|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
164542930|NCT00766090|594360982|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
164653208|NCT00461500|594757077|FG001|Overall Study|Lost to Follow-up|2|||
164653209|NCT01267266|594757083|FG000|Enrollment Phase|Withdrawal by Subject|2|||
164653210|NCT01267266|594757084|FG001|Enrollment Phase|Withdrawal by Subject|0|||
164653211|NCT01267266|594757083|FG000|Lead-in Phase|Lack of Efficacy|20|||
164653212|NCT01267266|594757084|FG001|Lead-in Phase|Lack of Efficacy|0|||
164653213|NCT01267266|594757083|FG000|Lead-in Phase|Adverse Event|2|||
164653214|NCT01267266|594757084|FG001|Lead-in Phase|Adverse Event|0|||
164653215|NCT01267266|594757083|FG000|Lead-in Phase|Withdrawal by Subject|1|||
164653216|NCT01267266|594757084|FG001|Lead-in Phase|Withdrawal by Subject|0|||
164653217|NCT01335477|594757086|FG000|Overall Study|Adverse Event|30|||
164653218|NCT01335477|594757087|FG001|Overall Study|Adverse Event|42|||
164653219|NCT01335477|594757086|FG000|Overall Study|Non compliant with protocol|0|||
164653220|NCT01335477|594757087|FG001|Overall Study|Non compliant with protocol|2|||
164653221|NCT01335477|594757086|FG000|Overall Study|Lost to Follow-up|1|||
164653222|NCT01335477|594757087|FG001|Overall Study|Lost to Follow-up|2|||
164653223|NCT01335477|594757086|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
164653224|NCT01335477|594757087|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
164653225|NCT01335477|594757086|FG000|Overall Study|Not treated|1|||
164653226|NCT01335477|594757087|FG001|Overall Study|Not treated|2|||
164653227|NCT01335477|594757086|FG000|Overall Study|Reason other than those stated above|2|||
164653228|NCT01335477|594757087|FG001|Overall Study|Reason other than those stated above|2|||
164653229|NCT03549130|594757089|FG000|Overall Study|Adverse Event|0|||
164653230|NCT03549130|594757090|FG001|Overall Study|Adverse Event|1|||
164653231|NCT03549130|594757089|FG000|Overall Study|Lost to Follow-up|0|||
164653232|NCT03549130|594757090|FG001|Overall Study|Lost to Follow-up|1|||
164653233|NCT01078623|594757091|FG000|Treatment Period 1|Adverse Event|1|||
164653234|NCT01078623|594757092|FG001|Treatment Period 1|Adverse Event|1|||
164653235|NCT01078623|594757093|FG002|Treatment Period 1|Adverse Event|1|||
164653236|NCT01078623|594757094|FG003|Treatment Period 1|Adverse Event|0|||
164653237|NCT01078623|594757095|FG004|Treatment Period 1|Adverse Event|0|||
164653238|NCT01078623|594757096|FG005|Treatment Period 1|Adverse Event|0|||
164653239|NCT01078623|594757097|FG006|Treatment Period 1|Adverse Event|1|||
164653240|NCT01078623|594757098|FG007|Treatment Period 1|Adverse Event|0|||
164653241|NCT01078623|594757099|FG008|Treatment Period 1|Adverse Event|1|||
164653242|NCT01078623|594757100|FG009|Treatment Period 1|Adverse Event|1|||
164653243|NCT01078623|594757101|FG010|Treatment Period 1|Adverse Event|0|||
164653244|NCT01078623|594757102|FG011|Treatment Period 1|Adverse Event|0|||
164653245|NCT01078623|594757103|FG012|Treatment Period 1|Adverse Event|0|||
164653246|NCT01078623|594757104|FG013|Treatment Period 1|Adverse Event|0|||
164653247|NCT01078623|594757105|FG014|Treatment Period 1|Adverse Event|0|||
164653248|NCT01078623|594757106|FG015|Treatment Period 1|Adverse Event|0|||
164653249|NCT01078623|594757107|FG016|Treatment Period 1|Adverse Event|0|||
164653250|NCT01078623|594757108|FG017|Treatment Period 1|Adverse Event|0|||
164653251|NCT01078623|594757109|FG018|Treatment Period 1|Adverse Event|0|||
164653252|NCT01078623|594757110|FG019|Treatment Period 1|Adverse Event|0|||
164653253|NCT01078623|594757091|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164653254|NCT01078623|594757092|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164653255|NCT01078623|594757093|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164653256|NCT01078623|594757094|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164653257|NCT01078623|594757095|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164653258|NCT01078623|594757096|FG005|Treatment Period 1|Withdrawal by Subject|0|||
164653259|NCT01078623|594757097|FG006|Treatment Period 1|Withdrawal by Subject|0|||
164653260|NCT01078623|594757098|FG007|Treatment Period 1|Withdrawal by Subject|1|||
164653261|NCT01078623|594757099|FG008|Treatment Period 1|Withdrawal by Subject|0|||
164653262|NCT01078623|594757100|FG009|Treatment Period 1|Withdrawal by Subject|0|||
164653263|NCT01078623|594757101|FG010|Treatment Period 1|Withdrawal by Subject|1|||
164653264|NCT01078623|594757102|FG011|Treatment Period 1|Withdrawal by Subject|0|||
164653265|NCT01078623|594757103|FG012|Treatment Period 1|Withdrawal by Subject|0|||
164653266|NCT01078623|594757104|FG013|Treatment Period 1|Withdrawal by Subject|0|||
164653267|NCT01078623|594757105|FG014|Treatment Period 1|Withdrawal by Subject|0|||
164653268|NCT01078623|594757106|FG015|Treatment Period 1|Withdrawal by Subject|0|||
164653269|NCT01078623|594757107|FG016|Treatment Period 1|Withdrawal by Subject|0|||
164653270|NCT01078623|594757108|FG017|Treatment Period 1|Withdrawal by Subject|0|||
164653271|NCT01078623|594757109|FG018|Treatment Period 1|Withdrawal by Subject|0|||
164653272|NCT01078623|594757110|FG019|Treatment Period 1|Withdrawal by Subject|0|||
164653273|NCT01078623|594757091|FG000|Treatment Period 1|Protocol Violation|0|||
164653274|NCT01078623|594757092|FG001|Treatment Period 1|Protocol Violation|0|||
164653275|NCT01078623|594757093|FG002|Treatment Period 1|Protocol Violation|0|||
164653276|NCT01078623|594757094|FG003|Treatment Period 1|Protocol Violation|0|||
164653277|NCT01078623|594757095|FG004|Treatment Period 1|Protocol Violation|0|||
164653278|NCT01078623|594757096|FG005|Treatment Period 1|Protocol Violation|1|||
164653279|NCT01078623|594757097|FG006|Treatment Period 1|Protocol Violation|0|||
164653280|NCT01078623|594757098|FG007|Treatment Period 1|Protocol Violation|0|||
164653281|NCT01078623|594757099|FG008|Treatment Period 1|Protocol Violation|0|||
164653282|NCT01078623|594757100|FG009|Treatment Period 1|Protocol Violation|0|||
164653283|NCT01078623|594757101|FG010|Treatment Period 1|Protocol Violation|0|||
164653284|NCT01078623|594757102|FG011|Treatment Period 1|Protocol Violation|0|||
164542931|NCT00766090|594360983|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
164542932|NCT00766090|594360984|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
164542933|NCT00766090|594360985|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
164542934|NCT00766090|594360986|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
164542935|NCT00766090|594360987|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
164542936|NCT00766090|594360988|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
164542937|NCT00766090|594360989|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
164542938|NCT00766090|594360990|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
164542939|NCT00766090|594360991|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
164542940|NCT00766090|594360992|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
164542941|NCT00766090|594360981|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
164542942|NCT00766090|594360982|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
164542943|NCT00766090|594360983|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
164542944|NCT00766090|594360984|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
164542945|NCT00766090|594360985|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
164542946|NCT00766090|594360986|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
164542947|NCT00766090|594360987|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
164542948|NCT00766090|594360988|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
164542949|NCT00766090|594360989|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
164542950|NCT00766090|594360990|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
164542951|NCT00766090|594360991|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
164542952|NCT00766090|594360992|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
164542953|NCT03024970|594360995|FG000|First Intervention|Adverse Event|1|||
164542954|NCT03024970|594360996|FG001|First Intervention|Adverse Event|0|||
164542955|NCT03024970|594360995|FG000|Second Intervention|Lost to Follow-up|1|||
164190853|NCT03538691|593066379|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
164190854|NCT03538691|593066376|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
164190855|NCT03538691|593066377|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
164190856|NCT03538691|593066378|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
164190857|NCT03538691|593066379|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
164190858|NCT03538691|593066376|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
164190859|NCT03538691|593066377|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
164190860|NCT03538691|593066378|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
164190861|NCT03538691|593066379|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
164190862|NCT03538691|593066376|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
164190863|NCT03538691|593066377|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
164190864|NCT03538691|593066378|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
164190865|NCT03538691|593066379|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
164190866|NCT03538691|593066376|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
164190867|NCT03538691|593066377|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
164190868|NCT03538691|593066378|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
164190869|NCT03538691|593066379|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
164190870|NCT03538691|593066376|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
164190871|NCT03538691|593066377|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
164190872|NCT03538691|593066378|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
164190873|NCT03538691|593066379|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
164190874|NCT03538691|593066376|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
164190875|NCT03538691|593066377|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
164190876|NCT03538691|593066378|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
164190877|NCT03538691|593066379|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
164190878|NCT03538691|593066376|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
164190879|NCT03538691|593066377|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
164190880|NCT03538691|593066378|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
164190881|NCT03538691|593066379|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
164190882|NCT03538691|593066376|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
164190883|NCT03538691|593066377|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
164190884|NCT03538691|593066378|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
164190885|NCT03538691|593066379|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
164190886|NCT03538691|593066376|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
164190887|NCT03538691|593066377|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
164190888|NCT03538691|593066378|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
164190889|NCT03538691|593066379|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
164542956|NCT03024970|594360996|FG001|Second Intervention|Lost to Follow-up|0|||
164542957|NCT00131469|594360997|FG000|Overall Study|Withdrawal by Subject|3|||
164302041|NCT02395471|593482510|FG001|Overall Study|Lost to Follow-up|0|||
164190890|NCT03538691|593066376|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
164190891|NCT03538691|593066377|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
164190892|NCT03538691|593066378|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
164190893|NCT03538691|593066379|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
164190894|NCT03538691|593066376|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
164190895|NCT03538691|593066377|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
164190896|NCT03538691|593066378|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
164190897|NCT03538691|593066379|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
164190898|NCT03538691|593066376|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
164190899|NCT03538691|593066377|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
164190900|NCT03538691|593066378|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
164190901|NCT03538691|593066379|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
164190902|NCT03538691|593066376|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
164190903|NCT03538691|593066377|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
164190904|NCT03538691|593066378|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
164190905|NCT03538691|593066379|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
164190906|NCT00481767|593066381|FG000|Overall Study|Withdrawal by Subject|16|||
164190907|NCT00481767|593066382|FG001|Overall Study|Withdrawal by Subject|11|||
164190908|NCT00481767|593066381|FG000|Overall Study|Lost to Follow-up|16|||
164190909|NCT00481767|593066382|FG001|Overall Study|Lost to Follow-up|10|||
164190910|NCT00636636|593066383|FG000|Overall Study|Other reason|4|||
164190911|NCT00636636|593066384|FG001|Overall Study|Other reason|6|||
164190912|NCT00636636|593066383|FG000|Overall Study|Adverse Event|19|||
164190913|NCT00636636|593066384|FG001|Overall Study|Adverse Event|8|||
164190914|NCT00636636|593066383|FG000|Overall Study|Lack of Efficacy|7|||
164190915|NCT00636636|593066384|FG001|Overall Study|Lack of Efficacy|12|||
164190916|NCT00636636|593066383|FG000|Overall Study|Protocol Violation|2|||
164190917|NCT00636636|593066384|FG001|Overall Study|Protocol Violation|2|||
164190918|NCT00636636|593066383|FG000|Overall Study|Lost to Follow-up|0|||
164190919|NCT00636636|593066384|FG001|Overall Study|Lost to Follow-up|1|||
164190920|NCT00636636|593066383|FG000|Overall Study|Death|0|||
164190921|NCT00636636|593066384|FG001|Overall Study|Death|1|||
164190922|NCT00636636|593066383|FG000|Overall Study|Withdrawal by Subject|4|||
164190923|NCT00636636|593066384|FG001|Overall Study|Withdrawal by Subject|9|||
164190924|NCT00524173|593066385|FG000|Overall Study|Lost to Follow-up|0|||
164190925|NCT00524173|593066386|FG001|Overall Study|Lost to Follow-up|1|||
164190926|NCT00524173|593066385|FG000|Overall Study|Death|1|||
164190927|NCT00524173|593066386|FG001|Overall Study|Death|0|||
164542958|NCT00131469|594360998|FG001|Overall Study|Withdrawal by Subject|4|||
164542959|NCT00131469|594360997|FG000|Overall Study|Protocol Violation|3|||
164542960|NCT00131469|594360998|FG001|Overall Study|Protocol Violation|1|||
164542961|NCT00131469|594360997|FG000|Overall Study|Death|0|||
164542962|NCT00131469|594360998|FG001|Overall Study|Death|1|||
164542963|NCT00131469|594360997|FG000|Overall Study|Lost to Follow-up|0|||
164542964|NCT00131469|594360998|FG001|Overall Study|Lost to Follow-up|1|||
164542965|NCT00131469|594360997|FG000|Overall Study|scan not analyzable|3|||
164542966|NCT00131469|594360998|FG001|Overall Study|scan not analyzable|6|||
164542967|NCT00574288|594360999|FG000|Overall Study|Adverse Event|2|||
164542968|NCT00574288|594361000|FG001|Overall Study|Adverse Event|0|||
164542969|NCT00574288|594361001|FG002|Overall Study|Adverse Event|0|||
164542970|NCT00574288|594361002|FG003|Overall Study|Adverse Event|0|||
164542971|NCT00574288|594361003|FG004|Overall Study|Adverse Event|1|||
164542972|NCT00574288|594361004|FG005|Overall Study|Adverse Event|0|||
164542973|NCT00574288|594361005|FG006|Overall Study|Adverse Event|0|||
164542974|NCT00574288|594360999|FG000|Overall Study|Death|0|||
164542975|NCT00574288|594361000|FG001|Overall Study|Death|0|||
164542976|NCT00574288|594361001|FG002|Overall Study|Death|0|||
164542977|NCT00574288|594361002|FG003|Overall Study|Death|0|||
164542978|NCT00574288|594361003|FG004|Overall Study|Death|0|||
164542979|NCT00574288|594361004|FG005|Overall Study|Death|25|||
164190928|NCT00524173|593066385|FG000|Overall Study|Had not reached endpoint at study close|4|||
164190929|NCT00524173|593066386|FG001|Overall Study|Had not reached endpoint at study close|1|||
164190930|NCT03300180|593066387|FG000|Baseline|Withdrawal by Subject|4|||
164542980|NCT00574288|594361005|FG006|Overall Study|Death|21|||
164542981|NCT00574288|594360999|FG000|Overall Study|Lost to Follow-up|0|||
164542982|NCT00574288|594361000|FG001|Overall Study|Lost to Follow-up|0|||
164542983|NCT00574288|594361001|FG002|Overall Study|Lost to Follow-up|0|||
164542984|NCT00574288|594361002|FG003|Overall Study|Lost to Follow-up|0|||
164542985|NCT00574288|594361003|FG004|Overall Study|Lost to Follow-up|0|||
164542986|NCT00574288|594361004|FG005|Overall Study|Lost to Follow-up|1|||
164190931|NCT03300180|593066388|FG001|Baseline|Withdrawal by Subject|6|||
164190932|NCT03300180|593066389|FG002|Baseline|Withdrawal by Subject|4|||
164542987|NCT00574288|594361005|FG006|Overall Study|Lost to Follow-up|2|||
164542988|NCT00574288|594360999|FG000|Overall Study|Study Terminated By Sponsor|0|||
164190933|NCT03300180|593066387|FG000|6 Month Outcome|Withdrawal by Subject|12|||
164190934|NCT03300180|593066388|FG001|6 Month Outcome|Withdrawal by Subject|12|||
164190935|NCT03300180|593066389|FG002|6 Month Outcome|Withdrawal by Subject|19|||
164190936|NCT03300180|593066387|FG000|6 Month Outcome|Death|2|||
164190937|NCT03300180|593066388|FG001|6 Month Outcome|Death|4|||
164190938|NCT03300180|593066389|FG002|6 Month Outcome|Death|3|||
164190939|NCT03300180|593066387|FG000|6 Month Outcome|Missed Assessment|43|||
164190940|NCT03300180|593066388|FG001|6 Month Outcome|Missed Assessment|52|||
164190941|NCT03300180|593066389|FG002|6 Month Outcome|Missed Assessment|46|||
164190942|NCT03300180|593066387|FG000|12 Month Outcome|Withdrawal by Subject|3|||
164190943|NCT03300180|593066388|FG001|12 Month Outcome|Withdrawal by Subject|6|||
164190944|NCT03300180|593066389|FG002|12 Month Outcome|Withdrawal by Subject|6|||
164190945|NCT03300180|593066387|FG000|12 Month Outcome|Death|9|||
164190946|NCT03300180|593066388|FG001|12 Month Outcome|Death|6|||
164190947|NCT03300180|593066389|FG002|12 Month Outcome|Death|6|||
164190948|NCT03300180|593066387|FG000|12 Month Outcome|Missed Assessment|62|||
164190949|NCT03300180|593066388|FG001|12 Month Outcome|Missed Assessment|59|||
164190950|NCT03300180|593066389|FG002|12 Month Outcome|Missed Assessment|58|||
164190951|NCT03300180|593066387|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
164190952|NCT03300180|593066388|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
164190953|NCT03300180|593066389|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
164190954|NCT03300180|593066387|FG000|18 Month Outcome Assessment|Death|8|||
164190955|NCT03300180|593066388|FG001|18 Month Outcome Assessment|Death|5|||
164190956|NCT03300180|593066389|FG002|18 Month Outcome Assessment|Death|5|||
164190957|NCT03300180|593066387|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
164190958|NCT03300180|593066388|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
164190959|NCT03300180|593066389|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
164190960|NCT03300180|593066387|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
164190961|NCT03300180|593066388|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
164190962|NCT03300180|593066389|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
164190963|NCT03300180|593066387|FG000|24 Month Outcome Assessment|Death|13|||
164190964|NCT03300180|593066388|FG001|24 Month Outcome Assessment|Death|13|||
164190965|NCT03300180|593066389|FG002|24 Month Outcome Assessment|Death|3|||
164190966|NCT03300180|593066387|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
164190967|NCT03300180|593066388|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
164190968|NCT03300180|593066389|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
164190969|NCT00103285|593067733|FG000|Induction|Adverse Event|14|||
164190970|NCT00103285|593067734|FG001|Induction|Adverse Event|0|||
164190971|NCT00103285|593067735|FG002|Induction|Adverse Event|0|||
164190972|NCT00103285|593067736|FG003|Induction|Adverse Event|0|||
164190973|NCT00103285|593067737|FG004|Induction|Adverse Event|0|||
164190974|NCT00103285|593067738|FG005|Induction|Adverse Event|0|||
164190975|NCT00103285|593067739|FG006|Induction|Adverse Event|0|||
164190976|NCT00103285|593067740|FG007|Induction|Adverse Event|0|||
164190977|NCT00103285|593067733|FG000|Induction|Death|24|||
164190978|NCT00103285|593067734|FG001|Induction|Death|0|||
164190979|NCT00103285|593067735|FG002|Induction|Death|0|||
164190980|NCT00103285|593067736|FG003|Induction|Death|0|||
164190981|NCT00103285|593067737|FG004|Induction|Death|0|||
164190982|NCT00103285|593067738|FG005|Induction|Death|0|||
164190983|NCT00103285|593067739|FG006|Induction|Death|0|||
164190984|NCT00103285|593067740|FG007|Induction|Death|0|||
164190985|NCT00103285|593067733|FG000|Induction|Physician Decision|103|||
164190986|NCT00103285|593067734|FG001|Induction|Physician Decision|0|||
164190987|NCT00103285|593067735|FG002|Induction|Physician Decision|0|||
164190988|NCT00103285|593067736|FG003|Induction|Physician Decision|0|||
164190989|NCT00103285|593067737|FG004|Induction|Physician Decision|0|||
164190990|NCT00103285|593067738|FG005|Induction|Physician Decision|0|||
164190991|NCT00103285|593067739|FG006|Induction|Physician Decision|0|||
164190992|NCT00103285|593067740|FG007|Induction|Physician Decision|0|||
164190993|NCT00103285|593067733|FG000|Induction|Withdrawal by Subject|1|||
164190994|NCT00103285|593067734|FG001|Induction|Withdrawal by Subject|0|||
164190995|NCT00103285|593067735|FG002|Induction|Withdrawal by Subject|0|||
164190996|NCT00103285|593067736|FG003|Induction|Withdrawal by Subject|0|||
164190997|NCT00103285|593067737|FG004|Induction|Withdrawal by Subject|0|||
164190998|NCT00103285|593067738|FG005|Induction|Withdrawal by Subject|0|||
164190999|NCT00103285|593067739|FG006|Induction|Withdrawal by Subject|0|||
164191000|NCT00103285|593067740|FG007|Induction|Withdrawal by Subject|0|||
164191001|NCT00103285|593067733|FG000|Induction|Ineligible|43|||
164191002|NCT00103285|593067734|FG001|Induction|Ineligible|0|||
164191003|NCT00103285|593067735|FG002|Induction|Ineligible|0|||
164191004|NCT00103285|593067736|FG003|Induction|Ineligible|0|||
164191005|NCT00103285|593067737|FG004|Induction|Ineligible|0|||
164191006|NCT00103285|593067738|FG005|Induction|Ineligible|0|||
164191007|NCT00103285|593067739|FG006|Induction|Ineligible|0|||
164191008|NCT00103285|593067740|FG007|Induction|Ineligible|0|||
164191009|NCT00103285|593067733|FG000|Induction|Refusal|906|||
164191010|NCT00103285|593067734|FG001|Induction|Refusal|0|||
164191011|NCT00103285|593067735|FG002|Induction|Refusal|0|||
164191012|NCT00103285|593067736|FG003|Induction|Refusal|0|||
164191013|NCT00103285|593067737|FG004|Induction|Refusal|0|||
164191014|NCT00103285|593067738|FG005|Induction|Refusal|0|||
164191015|NCT00103285|593067739|FG006|Induction|Refusal|0|||
164191016|NCT00103285|593067740|FG007|Induction|Refusal|0|||
164191017|NCT00103285|593067733|FG000|Induction|Other|258|||
164191018|NCT00103285|593067734|FG001|Induction|Other|0|||
164191019|NCT00103285|593067735|FG002|Induction|Other|0|||
164191020|NCT00103285|593067736|FG003|Induction|Other|0|||
164191021|NCT00103285|593067737|FG004|Induction|Other|0|||
164191022|NCT00103285|593067738|FG005|Induction|Other|0|||
164191023|NCT00103285|593067739|FG006|Induction|Other|0|||
164191024|NCT00103285|593067740|FG007|Induction|Other|0|||
164191025|NCT00103285|593067733|FG000|Response Assignment|Adverse Event|0|||
164191026|NCT00103285|593067734|FG001|Response Assignment|Adverse Event|8|||
164191027|NCT00103285|593067735|FG002|Response Assignment|Adverse Event|3|||
164191028|NCT00103285|593067736|FG003|Response Assignment|Adverse Event|2|||
164191029|NCT00103285|593067737|FG004|Response Assignment|Adverse Event|3|||
164191030|NCT00103285|593067738|FG005|Response Assignment|Adverse Event|1|||
164191031|NCT00103285|593067739|FG006|Response Assignment|Adverse Event|1|||
164191032|NCT00103285|593067740|FG007|Response Assignment|Adverse Event|2|||
164191033|NCT00103285|593067733|FG000|Response Assignment|Death|0|||
164191034|NCT00103285|593067734|FG001|Response Assignment|Death|5|||
164191035|NCT00103285|593067735|FG002|Response Assignment|Death|2|||
164191036|NCT00103285|593067736|FG003|Response Assignment|Death|2|||
164191037|NCT00103285|593067737|FG004|Response Assignment|Death|3|||
164191038|NCT00103285|593067738|FG005|Response Assignment|Death|1|||
164191039|NCT00103285|593067739|FG006|Response Assignment|Death|0|||
164191040|NCT00103285|593067740|FG007|Response Assignment|Death|8|||
164191041|NCT00103285|593067733|FG000|Response Assignment|Lost to Follow-up|0|||
164191042|NCT00103285|593067734|FG001|Response Assignment|Lost to Follow-up|9|||
164191043|NCT00103285|593067735|FG002|Response Assignment|Lost to Follow-up|5|||
164191044|NCT00103285|593067736|FG003|Response Assignment|Lost to Follow-up|5|||
164191045|NCT00103285|593067737|FG004|Response Assignment|Lost to Follow-up|1|||
164191046|NCT00103285|593067738|FG005|Response Assignment|Lost to Follow-up|2|||
164191047|NCT00103285|593067739|FG006|Response Assignment|Lost to Follow-up|2|||
164191048|NCT00103285|593067740|FG007|Response Assignment|Lost to Follow-up|5|||
164191049|NCT00103285|593067733|FG000|Response Assignment|Physician Decision|0|||
164191050|NCT00103285|593067734|FG001|Response Assignment|Physician Decision|13|||
164191051|NCT00103285|593067735|FG002|Response Assignment|Physician Decision|14|||
164191052|NCT00103285|593067736|FG003|Response Assignment|Physician Decision|9|||
164542989|NCT00574288|594361000|FG001|Overall Study|Study Terminated By Sponsor|0|||
164542990|NCT00574288|594361001|FG002|Overall Study|Study Terminated By Sponsor|0|||
164542991|NCT00574288|594361002|FG003|Overall Study|Study Terminated By Sponsor|0|||
164191053|NCT00103285|593067737|FG004|Response Assignment|Physician Decision|13|||
164191054|NCT00103285|593067738|FG005|Response Assignment|Physician Decision|7|||
164191055|NCT00103285|593067739|FG006|Response Assignment|Physician Decision|4|||
164191056|NCT00103285|593067740|FG007|Response Assignment|Physician Decision|35|||
164191057|NCT00103285|593067733|FG000|Response Assignment|Protocol Violation|0|||
164191058|NCT00103285|593067734|FG001|Response Assignment|Protocol Violation|2|||
164191059|NCT00103285|593067735|FG002|Response Assignment|Protocol Violation|0|||
164191060|NCT00103285|593067736|FG003|Response Assignment|Protocol Violation|0|||
164191061|NCT00103285|593067737|FG004|Response Assignment|Protocol Violation|0|||
164191062|NCT00103285|593067738|FG005|Response Assignment|Protocol Violation|0|||
164191063|NCT00103285|593067739|FG006|Response Assignment|Protocol Violation|0|||
164191064|NCT00103285|593067740|FG007|Response Assignment|Protocol Violation|0|||
164191065|NCT00103285|593067733|FG000|Response Assignment|Withdrawal by Subject|0|||
164191066|NCT00103285|593067734|FG001|Response Assignment|Withdrawal by Subject|4|||
164191067|NCT00103285|593067735|FG002|Response Assignment|Withdrawal by Subject|1|||
164191068|NCT00103285|593067736|FG003|Response Assignment|Withdrawal by Subject|1|||
164191069|NCT00103285|593067737|FG004|Response Assignment|Withdrawal by Subject|2|||
164191070|NCT00103285|593067738|FG005|Response Assignment|Withdrawal by Subject|2|||
164191071|NCT00103285|593067739|FG006|Response Assignment|Withdrawal by Subject|0|||
164191072|NCT00103285|593067740|FG007|Response Assignment|Withdrawal by Subject|2|||
164542992|NCT00574288|594361003|FG004|Overall Study|Study Terminated By Sponsor|0|||
164542993|NCT00574288|594361004|FG005|Overall Study|Study Terminated By Sponsor|0|||
164191073|NCT00103285|593067733|FG000|Response Assignment|Ineligible|0|||
164191074|NCT00103285|593067734|FG001|Response Assignment|Ineligible|8|||
164191075|NCT00103285|593067735|FG002|Response Assignment|Ineligible|6|||
164191076|NCT00103285|593067736|FG003|Response Assignment|Ineligible|2|||
164191077|NCT00103285|593067737|FG004|Response Assignment|Ineligible|0|||
164191078|NCT00103285|593067738|FG005|Response Assignment|Ineligible|3|||
164191079|NCT00103285|593067739|FG006|Response Assignment|Ineligible|1|||
164191080|NCT00103285|593067740|FG007|Response Assignment|Ineligible|5|||
164191081|NCT00103285|593067733|FG000|Response Assignment|Refusal|0|||
164191082|NCT00103285|593067734|FG001|Response Assignment|Refusal|53|||
164191083|NCT00103285|593067735|FG002|Response Assignment|Refusal|5|||
164191084|NCT00103285|593067736|FG003|Response Assignment|Refusal|3|||
164191085|NCT00103285|593067737|FG004|Response Assignment|Refusal|25|||
164191086|NCT00103285|593067738|FG005|Response Assignment|Refusal|15|||
164191087|NCT00103285|593067739|FG006|Response Assignment|Refusal|30|||
164191088|NCT00103285|593067740|FG007|Response Assignment|Refusal|10|||
164191089|NCT00103285|593067733|FG000|Response Assignment|Other|0|||
164191090|NCT00103285|593067734|FG001|Response Assignment|Other|30|||
164191091|NCT00103285|593067735|FG002|Response Assignment|Other|48|||
164191092|NCT00103285|593067736|FG003|Response Assignment|Other|38|||
164191093|NCT00103285|593067737|FG004|Response Assignment|Other|37|||
164191094|NCT00103285|593067738|FG005|Response Assignment|Other|17|||
164191095|NCT00103285|593067739|FG006|Response Assignment|Other|11|||
164191096|NCT00103285|593067740|FG007|Response Assignment|Other|53|||
164191097|NCT00452439|593067741|FG000|Overall Study|Lost to Follow-up|1|||
164191098|NCT00452439|593067742|FG001|Overall Study|Lost to Follow-up|1|||
164191099|NCT00452439|593067741|FG000|Overall Study|Refused Treatment|4|||
164191100|NCT00452439|593067742|FG001|Overall Study|Refused Treatment|3|||
164191101|NCT00452439|593067741|FG000|Overall Study|Death|3|||
164191102|NCT00452439|593067742|FG001|Overall Study|Death|1|||
164191103|NCT00452439|593067741|FG000|Overall Study|Bone Marrow Transplant|0|||
164191104|NCT00452439|593067742|FG001|Overall Study|Bone Marrow Transplant|1|||
164191105|NCT00452439|593067741|FG000|Overall Study|Too Ill to Continue|0|||
164191106|NCT00452439|593067742|FG001|Overall Study|Too Ill to Continue|1|||
164191107|NCT00452439|593067741|FG000|Overall Study|Failed to achieve complete response|2|||
164191108|NCT00452439|593067742|FG001|Overall Study|Failed to achieve complete response|0|||
164191109|NCT00452439|593067741|FG000|Overall Study|Relapse|3|||
164191110|NCT00452439|593067742|FG001|Overall Study|Relapse|0|||
164191111|NCT00452439|593067741|FG000|Overall Study|Fracture|1|||
164191112|NCT00452439|593067742|FG001|Overall Study|Fracture|0|||
164191113|NCT01381926|593067745|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
164191114|NCT01381926|593067746|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
164191115|NCT01381926|593067745|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
164191116|NCT01381926|593067746|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
164191117|NCT02624947|593067751|FG000|Maternal Participants|Adverse Event|5|||
164191118|NCT02624947|593067752|FG001|Maternal Participants|Adverse Event|0|||
164191119|NCT02624947|593067751|FG000|Maternal Participants|Investigator Decision|5|||
164191120|NCT02624947|593067752|FG001|Maternal Participants|Investigator Decision|3|||
164191121|NCT02624947|593067751|FG000|Maternal Participants|Lost to Follow-up|54|||
164191122|NCT02624947|593067752|FG001|Maternal Participants|Lost to Follow-up|24|||
164191123|NCT02624947|593067751|FG000|Maternal Participants|Non Compliance|8|||
164191124|NCT02624947|593067752|FG001|Maternal Participants|Non Compliance|5|||
164191125|NCT02624947|593067751|FG000|Maternal Participants|Sponsor Request|1|||
164191126|NCT02624947|593067752|FG001|Maternal Participants|Sponsor Request|1|||
164191127|NCT02624947|593067751|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
164191128|NCT02624947|593067752|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
164191129|NCT02624947|593067751|FG000|Maternal Participants|Miscellaneous|23|||
164191130|NCT02624947|593067752|FG001|Maternal Participants|Miscellaneous|15|||
164191131|NCT02624947|593067751|FG000|Infant Participants|Adverse Event|18|||
164191132|NCT02624947|593067752|FG001|Infant Participants|Adverse Event|11|||
164191133|NCT02624947|593067751|FG000|Infant Participants|Investigator Decision|5|||
164191134|NCT02624947|593067752|FG001|Infant Participants|Investigator Decision|4|||
164191135|NCT02624947|593067751|FG000|Infant Participants|Lost to Follow-up|93|||
164191136|NCT02624947|593067752|FG001|Infant Participants|Lost to Follow-up|58|||
164542994|NCT00574288|594361005|FG006|Overall Study|Study Terminated By Sponsor|5|||
164542995|NCT00574288|594360999|FG000|Overall Study|Progressive Disease|17|||
164542996|NCT00574288|594361000|FG001|Overall Study|Progressive Disease|2|||
164542997|NCT00574288|594361001|FG002|Overall Study|Progressive Disease|3|||
164542998|NCT00574288|594361002|FG003|Overall Study|Progressive Disease|2|||
164542999|NCT00574288|594361003|FG004|Overall Study|Progressive Disease|1|||
164543000|NCT00574288|594361004|FG005|Overall Study|Progressive Disease|0|||
164543001|NCT00574288|594361005|FG006|Overall Study|Progressive Disease|0|||
164543002|NCT00574288|594360999|FG000|Overall Study|Other|1|||
164543003|NCT00574288|594361000|FG001|Overall Study|Other|1|||
164543004|NCT00574288|594361001|FG002|Overall Study|Other|0|||
164543005|NCT00574288|594361002|FG003|Overall Study|Other|0|||
164191137|NCT02624947|593067751|FG000|Infant Participants|Non Compliance|17|||
164191138|NCT02624947|593067752|FG001|Infant Participants|Non Compliance|7|||
164191139|NCT02624947|593067751|FG000|Infant Participants|Sponsor Request|0|||
164191140|NCT02624947|593067752|FG001|Infant Participants|Sponsor Request|1|||
164191141|NCT02624947|593067751|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
164191142|NCT02624947|593067752|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
164191143|NCT02624947|593067751|FG000|Infant Participants|Miscellaneous|50|||
164543006|NCT00574288|594361003|FG004|Overall Study|Other|0|||
164543007|NCT00574288|594361004|FG005|Overall Study|Other|0|||
164191144|NCT02624947|593067752|FG001|Infant Participants|Miscellaneous|26|||
164191145|NCT03654729|593067761|FG000|Overall Study|Death|9|||
164191146|NCT03654729|593067762|FG001|Overall Study|Death|9|||
164191147|NCT03654729|593067763|FG002|Overall Study|Death|16|||
164191148|NCT03654729|593067761|FG000|Overall Study|Withdrawal by Subject|8|||
164543008|NCT00574288|594361005|FG006|Overall Study|Other|0|||
164543009|NCT01106027|594361006|FG000|Overall Study|Lost graft early, discontinued|1|||
164191149|NCT03654729|593067762|FG001|Overall Study|Withdrawal by Subject|6|||
164191150|NCT03654729|593067763|FG002|Overall Study|Withdrawal by Subject|4|||
164543010|NCT00356889|594361007|FG000|Overall Study|Protocol Violation|2|||
164543011|NCT00356889|594361007|FG000|Overall Study|Adverse Event|1|||
164543012|NCT00736034|594361008|FG000|Overall Study|Adverse Event|2|||
164543013|NCT02289352|594361009|FG000|Overall Study|Withdrawal by Subject|1|||
164543014|NCT02289352|594361010|FG001|Overall Study|Withdrawal by Subject|1|||
164543015|NCT02289352|594361011|FG002|Overall Study|Withdrawal by Subject|0|||
164543016|NCT03123250|594361012|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
164543017|NCT02361944|594361013|FG000|Overall Study|surgery cancellation|0|||
164543018|NCT02361944|594361014|FG001|Overall Study|surgery cancellation|1|||
164543019|NCT00773136|594361041|FG000|Overall Study|Physician Decision|2|||
164543020|NCT02463071|594361051|FG000|Overall Study|Adverse Event|3|||
164543021|NCT02463071|594361052|FG001|Overall Study|Adverse Event|5|||
164543022|NCT02463071|594361053|FG002|Overall Study|Adverse Event|1|||
164543023|NCT02463071|594361051|FG000|Overall Study|Death|1|||
164543024|NCT02463071|594361052|FG001|Overall Study|Death|0|||
164543025|NCT02463071|594361053|FG002|Overall Study|Death|0|||
164543026|NCT02463071|594361051|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
164543027|NCT02463071|594361052|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164543028|NCT02463071|594361053|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
164543029|NCT02463071|594361051|FG000|Overall Study|Reason not specified|7|||
164543030|NCT02463071|594361052|FG001|Overall Study|Reason not specified|9|||
164543031|NCT02463071|594361053|FG002|Overall Study|Reason not specified|4|||
164543032|NCT02463071|594361051|FG000|Overall Study|Protocol Violation|0|||
164543033|NCT02463071|594361052|FG001|Overall Study|Protocol Violation|2|||
164543034|NCT02463071|594361053|FG002|Overall Study|Protocol Violation|0|||
164543035|NCT02463071|594361051|FG000|Overall Study|Lost to Follow-up|0|||
164543036|NCT02463071|594361052|FG001|Overall Study|Lost to Follow-up|0|||
164543037|NCT02463071|594361053|FG002|Overall Study|Lost to Follow-up|1|||
164543038|NCT00175877|594361070|FG000|Overall Study|Adverse Event|136|||
164543039|NCT00175877|594361070|FG000|Overall Study|Withdrawal by Subject|141|||
164543040|NCT00175877|594361070|FG000|Overall Study|Lost to Follow-up|9|||
164543041|NCT00175877|594361070|FG000|Overall Study|Lack of Efficacy|26|||
164543042|NCT00175877|594361070|FG000|Overall Study|Protocol Violation|15|||
164543043|NCT00175877|594361070|FG000|Overall Study|Other Reason|20|||
164543044|NCT00175877|594361070|FG000|Overall Study|AE & Other|1|||
164543045|NCT00175877|594361070|FG000|Overall Study|Withdrawal by subject & Other|1|||
164543046|NCT02054325|594361074|FG000|Overall Study|Lost to Follow-up|8|||
164543047|NCT02054325|594361075|FG001|Overall Study|Lost to Follow-up|5|||
164543048|NCT02374021|594361076|FG000|Overall Study|Adverse Event|1|||
164543049|NCT02374021|594361077|FG001|Overall Study|Adverse Event|0|||
164543050|NCT02374021|594361076|FG000|Overall Study|Lost to Follow-up|3|||
164543051|NCT02374021|594361077|FG001|Overall Study|Lost to Follow-up|2|||
164543052|NCT02374021|594361076|FG000|Overall Study|Physician Decision|0|||
164543053|NCT02374021|594361077|FG001|Overall Study|Physician Decision|3|||
164543054|NCT02374021|594361076|FG000|Overall Study|Withdrawal by Subject|6|||
164543055|NCT02374021|594361077|FG001|Overall Study|Withdrawal by Subject|5|||
164543056|NCT02374021|594361076|FG000|Overall Study|Poor Adherence|0|||
164543057|NCT02374021|594361077|FG001|Overall Study|Poor Adherence|1|||
164543058|NCT02374021|594361076|FG000|Overall Study|Scan protocol not followed|0|||
164543059|NCT02374021|594361077|FG001|Overall Study|Scan protocol not followed|1|||
164543060|NCT02374021|594361076|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
164543061|NCT02374021|594361077|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
164543062|NCT00617604|594361078|FG000|Overall Study|Death|2|||
164543063|NCT00617604|594361079|FG001|Overall Study|Death|1|||
164543064|NCT00617604|594361078|FG000|Overall Study|Lost to Follow-up|1|||
164543065|NCT00617604|594361079|FG001|Overall Study|Lost to Follow-up|0|||
164543066|NCT00617604|594361078|FG000|Overall Study|Miscellaneous Reasons|8|||
164543067|NCT00617604|594361079|FG001|Overall Study|Miscellaneous Reasons|10|||
164543068|NCT00617604|594361078|FG000|Overall Study|Withdrawal by Subject|4|||
164543069|NCT00617604|594361079|FG001|Overall Study|Withdrawal by Subject|6|||
164543070|NCT00617604|594361078|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
164543071|NCT00617604|594361079|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
164543072|NCT00732251|594361080|FG000|Overall Study|Lost to Follow-up|3|||
164543073|NCT00732251|594361080|FG000|Overall Study|Withdrawal by Subject|3|||
164543074|NCT00732251|594361080|FG000|Overall Study|Early Term due to Site Closure|1|||
164543075|NCT04029961|594361081|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
164543076|NCT04029961|594361082|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
164543077|NCT04029961|594361081|FG000|Overall Study|Change in Treatment Course|0|||
164543078|NCT04029961|594361082|FG001|Overall Study|Change in Treatment Course|1|||
164543079|NCT00688155|594361085|FG000|Overall Study|Withdrawal by Subject|2|||
164543080|NCT00688155|594361086|FG001|Overall Study|Withdrawal by Subject|2|||
164543081|NCT00688155|594361087|FG002|Overall Study|Withdrawal by Subject|1|||
164543082|NCT00688155|594361088|FG003|Overall Study|Withdrawal by Subject|1|||
164543083|NCT03184077|594361089|FG000|Overall Study|Lost to Follow-up|21|||
164543084|NCT03184077|594361090|FG001|Overall Study|Lost to Follow-up|21|||
164543085|NCT04136184|594361091|FG000|Overall Study|Lost to Follow-up|0|||
164543086|NCT04136184|594361092|FG001|Overall Study|Lost to Follow-up|3|||
164543087|NCT04136184|594361091|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
164543088|NCT04136184|594361092|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
164543089|NCT03318978|594361093|FG000|Overall Study|Withdrawal by Subject|1|||
164543090|NCT03007979|594361096|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
164543091|NCT03734016|594361097|FG000|Overall Study|Sponsor Ended Study|225|||
164543092|NCT03734016|594361098|FG001|Overall Study|Sponsor Ended Study|200|||
164543093|NCT03734016|594361097|FG000|Overall Study|Death|69|||
164543094|NCT03734016|594361098|FG001|Overall Study|Death|83|||
164543095|NCT03734016|594361097|FG000|Overall Study|Withdrawal by Subject|21|||
164543096|NCT03734016|594361098|FG001|Overall Study|Withdrawal by Subject|27|||
164543097|NCT03734016|594361097|FG000|Overall Study|Physician Decision|1|||
164543098|NCT03734016|594361098|FG001|Overall Study|Physician Decision|12|||
164543099|NCT03734016|594361097|FG000|Overall Study|Lost to Follow-up|6|||
164543100|NCT03734016|594361098|FG001|Overall Study|Lost to Follow-up|2|||
164543101|NCT03734016|594361097|FG000|Overall Study|Miscellaneous|5|||
164543102|NCT03734016|594361098|FG001|Overall Study|Miscellaneous|1|||
164543103|NCT01298518|594361101|FG000|Overall Study|Withdrawal by Subject|0|||
164543104|NCT01298518|594361102|FG001|Overall Study|Withdrawal by Subject|0|||
164543105|NCT01298518|594361103|FG002|Overall Study|Withdrawal by Subject|1|||
164543106|NCT01979835|594361104|FG000|Primary Outcome SA Measurment|failed insertion|18|||
164543107|NCT01979835|594361104|FG000|Follow-up|Lost to Follow-up|32|||
164543108|NCT03697720|594362679|FG000|Overall Study|Lost to Follow-up|7|||
164543109|NCT00382720|594362687|FG000|Overall Study|Adverse Event|21|||
164543110|NCT00382720|594362688|FG001|Overall Study|Adverse Event|23|||
164543111|NCT00382720|594362689|FG002|Overall Study|Adverse Event|15|||
164543112|NCT00382720|594362687|FG000|Overall Study|Protocol Violation|2|||
164543113|NCT00382720|594362688|FG001|Overall Study|Protocol Violation|5|||
164543114|NCT00382720|594362689|FG002|Overall Study|Protocol Violation|1|||
164543115|NCT00382720|594362687|FG000|Overall Study|Death|0|||
164543116|NCT00382720|594362688|FG001|Overall Study|Death|1|||
164543117|NCT00382720|594362689|FG002|Overall Study|Death|2|||
164543118|NCT00382720|594362687|FG000|Overall Study|Progressive disease|37|||
164543119|NCT00382720|594362688|FG001|Overall Study|Progressive disease|28|||
164543120|NCT00382720|594362689|FG002|Overall Study|Progressive disease|38|||
164543121|NCT00382720|594362687|FG000|Overall Study|Withdrew consent|1|||
164543122|NCT00382720|594362688|FG001|Overall Study|Withdrew consent|1|||
164543123|NCT00382720|594362689|FG002|Overall Study|Withdrew consent|2|||
164543124|NCT00382720|594362687|FG000|Overall Study|Withdrawal by Subject|11|||
164543125|NCT00382720|594362688|FG001|Overall Study|Withdrawal by Subject|20|||
164543126|NCT00382720|594362689|FG002|Overall Study|Withdrawal by Subject|12|||
164543127|NCT00382720|594362687|FG000|Overall Study|Surgery|1|||
164543128|NCT00382720|594362688|FG001|Overall Study|Surgery|1|||
164543129|NCT00382720|594362689|FG002|Overall Study|Surgery|4|||
164543130|NCT00382720|594362687|FG000|Overall Study|Patient did not receive study medication|1|||
164543131|NCT00382720|594362688|FG001|Overall Study|Patient did not receive study medication|1|||
164543132|NCT00382720|594362689|FG002|Overall Study|Patient did not receive study medication|4|||
164543133|NCT00382720|594362687|FG000|Overall Study|Clinically progressive disease|0|||
164543134|NCT00382720|594362688|FG001|Overall Study|Clinically progressive disease|1|||
164543135|NCT00382720|594362689|FG002|Overall Study|Clinically progressive disease|0|||
164543136|NCT00382720|594362687|FG000|Overall Study|Good prognosis|0|||
164543137|NCT00382720|594362688|FG001|Overall Study|Good prognosis|1|||
164543138|NCT00382720|594362689|FG002|Overall Study|Good prognosis|0|||
164543139|NCT00382720|594362687|FG000|Overall Study|Investigator/Clinical decision|5|||
164543140|NCT00382720|594362688|FG001|Overall Study|Investigator/Clinical decision|6|||
164543141|NCT00382720|594362689|FG002|Overall Study|Investigator/Clinical decision|6|||
164543142|NCT00382720|594362687|FG000|Overall Study|Discontinued at end of study|0|||
164543143|NCT00382720|594362688|FG001|Overall Study|Discontinued at end of study|1|||
164543144|NCT00382720|594362689|FG002|Overall Study|Discontinued at end of study|2|||
164543145|NCT02737852|594362692|FG000|Overall Study|Withdrawal by Subject|2|||
164543146|NCT03688880|594362693|FG000|Overall Study|Withdrawal by Subject|0|||
164653285|NCT01078623|594757103|FG012|Treatment Period 1|Protocol Violation|0|||
164543147|NCT03688880|594362694|FG001|Overall Study|Withdrawal by Subject|2|||
164543148|NCT03688880|594362693|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
164543149|NCT03688880|594362694|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
164543150|NCT03688880|594362693|FG000|Overall Study|Lost to Follow-up|4|||
164543151|NCT03688880|594362694|FG001|Overall Study|Lost to Follow-up|7|||
164543152|NCT03688880|594362693|FG000|Overall Study|Adverse Event|0|||
164543153|NCT03688880|594362694|FG001|Overall Study|Adverse Event|2|||
164543154|NCT03688880|594362693|FG000|Overall Study|Device deficiencies|0|||
164543155|NCT03688880|594362694|FG001|Overall Study|Device deficiencies|2|||
164543156|NCT03688880|594362693|FG000|Overall Study|Other|10|||
164543157|NCT03688880|594362694|FG001|Overall Study|Other|16|||
164543158|NCT01183143|594362695|FG000|Overall Study|Protocol Violation|115|||
164543159|NCT01183143|594362695|FG000|Overall Study|Withdrawal by Subject|19|||
164543160|NCT01183143|594362695|FG000|Overall Study|Subject Questionnaires not returned|5|||
164543161|NCT01183143|594362695|FG000|Overall Study|Subjects enrolled, but not treated|11|||
164543162|NCT01704287|594362697|FG000|Initial Treatment Period|Death|139|||
164543163|NCT01704287|594362698|FG001|Initial Treatment Period|Death|129|||
164543164|NCT01704287|594362699|FG002|Initial Treatment Period|Death|71|||
164543165|NCT01704287|594362700|FG003|Initial Treatment Period|Death|0|||
164543166|NCT01704287|594362701|FG004|Initial Treatment Period|Death|0|||
164543167|NCT01704287|594362697|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
164543168|NCT01704287|594362698|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
164543169|NCT01704287|594362699|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
164543170|NCT01704287|594362700|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
164543171|NCT01704287|594362701|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
164543172|NCT01704287|594362697|FG000|Initial Treatment Period|Lost to Follow-up|5|||
164543173|NCT01704287|594362698|FG001|Initial Treatment Period|Lost to Follow-up|3|||
164543174|NCT01704287|594362699|FG002|Initial Treatment Period|Lost to Follow-up|0|||
164543175|NCT01704287|594362700|FG003|Initial Treatment Period|Lost to Follow-up|0|||
164543176|NCT01704287|594362701|FG004|Initial Treatment Period|Lost to Follow-up|0|||
164543177|NCT01704287|594362697|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
164543178|NCT01704287|594362698|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
164543179|NCT01704287|594362699|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
164543180|NCT01704287|594362700|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
164543181|NCT01704287|594362701|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
164543182|NCT01704287|594362697|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
164543183|NCT01704287|594362698|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
164543184|NCT01704287|594362699|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
164543185|NCT01704287|594362700|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
164543186|NCT01704287|594362701|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
164543187|NCT01704287|594362697|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
164543188|NCT01704287|594362698|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
164543189|NCT01704287|594362699|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
164543190|NCT01704287|594362700|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
164543191|NCT01704287|594362701|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
164543192|NCT01704287|594362697|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
164543193|NCT01704287|594362698|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
164543194|NCT01704287|594362699|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
164543195|NCT01704287|594362700|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
164543196|NCT01704287|594362701|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
164543197|NCT01717287|594362702|FG000|Overall Study|Lost to Follow-up|0|||
164543198|NCT01717287|594362703|FG001|Overall Study|Lost to Follow-up|2|||
164543199|NCT01717287|594362702|FG000|Overall Study|Protocol Violation|0|||
164543200|NCT01717287|594362703|FG001|Overall Study|Protocol Violation|1|||
164543201|NCT04024228|594362704|FG000|Overall Study|Adverse Event|1|||
164543202|NCT04024228|594362705|FG001|Overall Study|Adverse Event|0|||
164543203|NCT04024228|594362704|FG000|Overall Study|Protocol Deviation|0|||
164543204|NCT04024228|594362705|FG001|Overall Study|Protocol Deviation|2|||
164543205|NCT04024228|594362704|FG000|Overall Study|Withdrawal by Subject|3|||
164543206|NCT04024228|594362705|FG001|Overall Study|Withdrawal by Subject|4|||
164543207|NCT04490395|594362709|FG000|Overall Study|Lost to Follow-up|0|||
164543208|NCT04490395|594362710|FG001|Overall Study|Lost to Follow-up|1|||
164543209|NCT00938717|594362711|FG000|Overall Study|Adverse Event|10|||
164543210|NCT00938717|594362712|FG001|Overall Study|Adverse Event|41|||
164543211|NCT00938717|594362711|FG000|Overall Study|Protocol Violation|11|||
164543212|NCT00938717|594362712|FG001|Overall Study|Protocol Violation|8|||
164543213|NCT00938717|594362711|FG000|Overall Study|Withdrawal by Subject|26|||
164191151|NCT03654729|593067761|FG000|Overall Study|Study terminated by Sponsor|3|||
164191152|NCT03654729|593067762|FG001|Overall Study|Study terminated by Sponsor|5|||
164191153|NCT03654729|593067763|FG002|Overall Study|Study terminated by Sponsor|4|||
164543214|NCT00938717|594362712|FG001|Overall Study|Withdrawal by Subject|24|||
164543215|NCT00938717|594362711|FG000|Overall Study|Lost to Follow-up|13|||
164543216|NCT00938717|594362712|FG001|Overall Study|Lost to Follow-up|18|||
164543217|NCT00938717|594362711|FG000|Overall Study|Lack of Efficacy|33|||
164543218|NCT00938717|594362712|FG001|Overall Study|Lack of Efficacy|15|||
164543219|NCT00938717|594362711|FG000|Overall Study|Other reason|5|||
164543220|NCT00938717|594362712|FG001|Overall Study|Other reason|2|||
164543221|NCT01942148|594362720|FG000|Overall Study|Adverse Event|4|||
164543222|NCT01942148|594362720|FG000|Overall Study|Lack of Efficacy|2|||
164543223|NCT01942148|594362720|FG000|Overall Study|Physician Decision|11|||
164543224|NCT01942148|594362720|FG000|Overall Study|Protocol Violation|1|||
164543225|NCT01942148|594362720|FG000|Overall Study|Withdrawal by Subject|8|||
164543226|NCT01942148|594362720|FG000|Overall Study|Use of the prohibition medicine|1|||
164543227|NCT02248259|594362721|FG000|Treatment Period 1|Adverse Event|0|||
164543228|NCT02248259|594362722|FG001|Treatment Period 1|Adverse Event|0|||
164543229|NCT02248259|594362723|FG002|Treatment Period 1|Adverse Event|1|||
164543230|NCT02248259|594362724|FG003|Treatment Period 1|Adverse Event|0|||
164543231|NCT02807480|594362727|FG000|Overall Study|Withdrawal by Subject|14|||
164543232|NCT02807480|594362728|FG001|Overall Study|Withdrawal by Subject|10|||
164191154|NCT03654729|593067761|FG000|Overall Study|Not reported|2|||
164420581|NCT02718417|593910944|FG001|Long-term Follow-up Phase|Other|2|||
164543233|NCT02163187|594362731|FG000|Overall Study|Device removed|1|||
164543234|NCT02163187|594362732|FG001|Overall Study|Device removed|0|||
164543235|NCT02163187|594362731|FG000|Overall Study|Progressive disease|1|||
164543236|NCT02163187|594362732|FG001|Overall Study|Progressive disease|0|||
164543237|NCT02369848|594362733|FG000|Overall Study|Death|1|||
164543238|NCT02369848|594362733|FG000|Overall Study|Withdrawal by Subject|2|||
164543239|NCT02369848|594362733|FG000|Overall Study|Lost to Follow-up|1|||
164543240|NCT00257725|594362734|FG000|Overall Study|Adverse Event|3|||
164543241|NCT02573870|594362735|FG000|Overall Study|Adverse Event|0|||
164543242|NCT02573870|594362736|FG001|Overall Study|Adverse Event|2|||
164543243|NCT02573870|594362735|FG000|Overall Study|Lack of Efficacy|0|||
164543244|NCT02573870|594362736|FG001|Overall Study|Lack of Efficacy|1|||
164543245|NCT02573870|594362735|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
164543246|NCT02573870|594362736|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
164543247|NCT02573870|594362735|FG000|Overall Study|Lost to Follow-up|0|||
164543248|NCT02573870|594362736|FG001|Overall Study|Lost to Follow-up|1|||
164543249|NCT02573870|594362735|FG000|Overall Study|Other: Fail to Meet Visit|0|||
164543250|NCT02573870|594362736|FG001|Overall Study|Other: Fail to Meet Visit|2|||
164543251|NCT01858532|594362737|FG000|Overall Study|Adverse Event|58|||
164543252|NCT01858532|594362738|FG001|Overall Study|Adverse Event|50|||
164543253|NCT01858532|594362739|FG002|Overall Study|Adverse Event|23|||
164543254|NCT01858532|594362740|FG003|Overall Study|Adverse Event|28|||
164543255|NCT01858532|594362737|FG000|Overall Study|Withdrew consent|71|||
164543256|NCT01858532|594362738|FG001|Overall Study|Withdrew consent|93|||
164543257|NCT01858532|594362739|FG002|Overall Study|Withdrew consent|46|||
164543258|NCT01858532|594362740|FG003|Overall Study|Withdrew consent|27|||
164543259|NCT01858532|594362737|FG000|Overall Study|Lost to Follow-up|17|||
164543260|NCT01858532|594362738|FG001|Overall Study|Lost to Follow-up|26|||
164543261|NCT01858532|594362739|FG002|Overall Study|Lost to Follow-up|11|||
164543262|NCT01858532|594362740|FG003|Overall Study|Lost to Follow-up|14|||
164543263|NCT01858532|594362737|FG000|Overall Study|Deterioration of medical status|3|||
164543264|NCT01858532|594362738|FG001|Overall Study|Deterioration of medical status|4|||
164543265|NCT01858532|594362739|FG002|Overall Study|Deterioration of medical status|3|||
164543266|NCT01858532|594362740|FG003|Overall Study|Deterioration of medical status|7|||
164543267|NCT01858532|594362737|FG000|Overall Study|Investigator request|3|||
164543268|NCT01858532|594362738|FG001|Overall Study|Investigator request|4|||
164543269|NCT01858532|594362739|FG002|Overall Study|Investigator request|2|||
164543270|NCT01858532|594362740|FG003|Overall Study|Investigator request|6|||
164543271|NCT01858532|594362737|FG000|Overall Study|Other, not specified|29|||
164543272|NCT01858532|594362738|FG001|Overall Study|Other, not specified|15|||
164543273|NCT01858532|594362739|FG002|Overall Study|Other, not specified|13|||
164543274|NCT01858532|594362740|FG003|Overall Study|Other, not specified|11|||
164543275|NCT00514514|594362741|FG000|Pre-phase|Death|10|||
164543276|NCT00514514|594362742|FG001|Pre-phase|Death|0|||
164543277|NCT00514514|594362743|FG002|Pre-phase|Death|0|||
164543278|NCT00514514|594362741|FG000|Pre-phase|administrative problems|2|||
164543279|NCT00514514|594362742|FG001|Pre-phase|administrative problems|0|||
164543280|NCT00514514|594362743|FG002|Pre-phase|administrative problems|0|||
164543281|NCT00514514|594362741|FG000|Pre-phase|Protocol Violation|6|||
164543282|NCT00514514|594362742|FG001|Pre-phase|Protocol Violation|0|||
164543283|NCT00514514|594362743|FG002|Pre-phase|Protocol Violation|0|||
164543284|NCT00514514|594362741|FG000|Pre-phase|condition no longer requires study drug|7|||
164543285|NCT00514514|594362742|FG001|Pre-phase|condition no longer requires study drug|0|||
164543286|NCT00514514|594362743|FG002|Pre-phase|condition no longer requires study drug|0|||
164543287|NCT00514514|594362741|FG000|Pre-phase|abnormal test procedure results|15|||
164543288|NCT00514514|594362742|FG001|Pre-phase|abnormal test procedure results|0|||
164543289|NCT00514514|594362743|FG002|Pre-phase|abnormal test procedure results|0|||
164543290|NCT00514514|594362741|FG000|Pre-phase|Lost to Follow-up|2|||
164653286|NCT01078623|594757104|FG013|Treatment Period 1|Protocol Violation|0|||
164653287|NCT01078623|594757105|FG014|Treatment Period 1|Protocol Violation|0|||
164543291|NCT00514514|594362742|FG001|Pre-phase|Lost to Follow-up|0|||
164543292|NCT00514514|594362743|FG002|Pre-phase|Lost to Follow-up|0|||
164653288|NCT01078623|594757106|FG015|Treatment Period 1|Protocol Violation|0|||
164653289|NCT01078623|594757107|FG016|Treatment Period 1|Protocol Violation|0|||
164653290|NCT01078623|594757108|FG017|Treatment Period 1|Protocol Violation|0|||
164653291|NCT01078623|594757109|FG018|Treatment Period 1|Protocol Violation|0|||
164543293|NCT00514514|594362741|FG000|Pre-phase|abnormal lab values|23|||
164543294|NCT00514514|594362742|FG001|Pre-phase|abnormal lab values|0|||
164653292|NCT01078623|594757110|FG019|Treatment Period 1|Protocol Violation|0|||
164543295|NCT00514514|594362743|FG002|Pre-phase|abnormal lab values|0|||
164543296|NCT00514514|594362741|FG000|Pre-phase|Lack of Efficacy|35|||
164543297|NCT00514514|594362742|FG001|Pre-phase|Lack of Efficacy|0|||
164653293|NCT01078623|594757091|FG000|Treatment Period 2|Adverse Event|0|||
164543298|NCT00514514|594362743|FG002|Pre-phase|Lack of Efficacy|0|||
164543299|NCT00514514|594362741|FG000|Pre-phase|Adverse Event|137|||
164543300|NCT00514514|594362742|FG001|Pre-phase|Adverse Event|0|||
164543301|NCT00514514|594362743|FG002|Pre-phase|Adverse Event|0|||
164653294|NCT01078623|594757092|FG001|Treatment Period 2|Adverse Event|0|||
164543302|NCT00514514|594362741|FG000|Pre-phase|Withdrawal by Subject|66|||
164543303|NCT00514514|594362742|FG001|Pre-phase|Withdrawal by Subject|0|||
164543304|NCT00514514|594362743|FG002|Pre-phase|Withdrawal by Subject|0|||
164543305|NCT00514514|594362741|FG000|Randomized - 9 Month|Death|3|||
164543306|NCT00514514|594362742|FG001|Randomized - 9 Month|Death|2|||
164543307|NCT00514514|594362743|FG002|Randomized - 9 Month|Death|2|||
164543308|NCT00514514|594362741|FG000|Randomized - 9 Month|Administrative problems|1|||
164543309|NCT00514514|594362742|FG001|Randomized - 9 Month|Administrative problems|1|||
164543310|NCT00514514|594362743|FG002|Randomized - 9 Month|Administrative problems|2|||
164543311|NCT00514514|594362741|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
164543312|NCT00514514|594362742|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
164543313|NCT00514514|594362743|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
164543314|NCT00514514|594362741|FG000|Randomized - 9 Month|Protocol Violation|1|||
164543315|NCT00514514|594362742|FG001|Randomized - 9 Month|Protocol Violation|1|||
164543316|NCT00514514|594362743|FG002|Randomized - 9 Month|Protocol Violation|0|||
164543317|NCT00514514|594362741|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
164543318|NCT00514514|594362742|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
164543319|NCT00514514|594362743|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
164543320|NCT00514514|594362741|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
164543321|NCT00514514|594362742|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
164543322|NCT00514514|594362743|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
164543323|NCT00514514|594362741|FG000|Randomized - 9 Month|Adverse Event|25|||
164543324|NCT00514514|594362742|FG001|Randomized - 9 Month|Adverse Event|44|||
164543325|NCT00514514|594362743|FG002|Randomized - 9 Month|Adverse Event|27|||
164543326|NCT00514514|594362741|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
164543327|NCT00514514|594362742|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
164543328|NCT00514514|594362743|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
164543329|NCT00514514|594362741|FG000|Extension - 4 Years|Lost to Follow-up|12|||
164191155|NCT03654729|593067762|FG001|Overall Study|Not reported|4|||
164191156|NCT03654729|593067763|FG002|Overall Study|Not reported|5|||
164191157|NCT03654729|593067761|FG000|Overall Study|Progressive disease|3|||
164191158|NCT03654729|593067762|FG001|Overall Study|Progressive disease|0|||
164191159|NCT03654729|593067763|FG002|Overall Study|Progressive disease|0|||
164191160|NCT03654729|593067761|FG000|Overall Study|Lost to Follow-up|2|||
164191161|NCT03654729|593067762|FG001|Overall Study|Lost to Follow-up|0|||
164191162|NCT03654729|593067763|FG002|Overall Study|Lost to Follow-up|0|||
164191163|NCT03654729|593067761|FG000|Overall Study|Physician Decision|2|||
164191164|NCT03654729|593067762|FG001|Overall Study|Physician Decision|0|||
164191165|NCT03654729|593067763|FG002|Overall Study|Physician Decision|0|||
164543330|NCT00514514|594362742|FG001|Extension - 4 Years|Lost to Follow-up|10|||
164543331|NCT00514514|594362743|FG002|Extension - 4 Years|Lost to Follow-up|9|||
164543332|NCT00514514|594362741|FG000|Extension - 4 Years|Administrative problems|3|||
164543333|NCT00514514|594362742|FG001|Extension - 4 Years|Administrative problems|1|||
164543334|NCT00514514|594362743|FG002|Extension - 4 Years|Administrative problems|1|||
164543335|NCT00514514|594362741|FG000|Extension - 4 Years|Death|8|||
164543336|NCT00514514|594362742|FG001|Extension - 4 Years|Death|3|||
164543337|NCT00514514|594362743|FG002|Extension - 4 Years|Death|6|||
164543338|NCT00514514|594362741|FG000|Extension - 4 Years|Adverse Event|9|||
164543339|NCT00514514|594362742|FG001|Extension - 4 Years|Adverse Event|6|||
164543340|NCT00514514|594362743|FG002|Extension - 4 Years|Adverse Event|3|||
164543341|NCT02081534|594362750|FG000|Overall Study|Adverse Event|5|||
164543342|NCT02081534|594362751|FG001|Overall Study|Adverse Event|4|||
164543343|NCT02081534|594362752|FG002|Overall Study|Adverse Event|3|||
164543344|NCT02081534|594362753|FG003|Overall Study|Adverse Event|10|||
164543345|NCT02081534|594362754|FG004|Overall Study|Adverse Event|2|||
164543346|NCT02081534|594362755|FG005|Overall Study|Adverse Event|8|||
164543347|NCT02081534|594362756|FG006|Overall Study|Adverse Event|2|||
164543348|NCT02081534|594362750|FG000|Overall Study|Withdrawal by Subject|0|||
164543349|NCT02081534|594362751|FG001|Overall Study|Withdrawal by Subject|1|||
164543350|NCT02081534|594362752|FG002|Overall Study|Withdrawal by Subject|1|||
164543351|NCT02081534|594362753|FG003|Overall Study|Withdrawal by Subject|1|||
164191166|NCT03654729|593067761|FG000|Overall Study|Protocol Violation|1|||
164191167|NCT03654729|593067762|FG001|Overall Study|Protocol Violation|1|||
164191168|NCT03654729|593067763|FG002|Overall Study|Protocol Violation|0|||
164543352|NCT02081534|594362754|FG004|Overall Study|Withdrawal by Subject|1|||
164543353|NCT02081534|594362755|FG005|Overall Study|Withdrawal by Subject|0|||
164543354|NCT02081534|594362756|FG006|Overall Study|Withdrawal by Subject|1|||
164543355|NCT02081534|594362750|FG000|Overall Study|Protocol Violation|0|||
164543356|NCT02081534|594362751|FG001|Overall Study|Protocol Violation|3|||
164543357|NCT02081534|594362752|FG002|Overall Study|Protocol Violation|0|||
164543358|NCT02081534|594362753|FG003|Overall Study|Protocol Violation|0|||
164543359|NCT02081534|594362754|FG004|Overall Study|Protocol Violation|0|||
164543360|NCT02081534|594362755|FG005|Overall Study|Protocol Violation|0|||
164543361|NCT02081534|594362756|FG006|Overall Study|Protocol Violation|1|||
164191169|NCT03654729|593067761|FG000|Overall Study|Non-compliance with study drug|0|||
164191170|NCT03654729|593067762|FG001|Overall Study|Non-compliance with study drug|1|||
164191171|NCT03654729|593067763|FG002|Overall Study|Non-compliance with study drug|0|||
164543362|NCT02081534|594362750|FG000|Overall Study|Lost to Follow-up|0|||
164543363|NCT02081534|594362751|FG001|Overall Study|Lost to Follow-up|0|||
164543364|NCT02081534|594362752|FG002|Overall Study|Lost to Follow-up|0|||
164543365|NCT02081534|594362753|FG003|Overall Study|Lost to Follow-up|2|||
164543366|NCT02081534|594362754|FG004|Overall Study|Lost to Follow-up|1|||
164543367|NCT02081534|594362755|FG005|Overall Study|Lost to Follow-up|1|||
164543368|NCT02081534|594362756|FG006|Overall Study|Lost to Follow-up|0|||
164543369|NCT01841749|594362762|FG000|Overall Study|Protocol Violation|1|||
164543370|NCT02285920|594362763|FG000|Overall Study|Kidney transplantation|2|||
164543371|NCT02285920|594362764|FG001|Overall Study|Kidney transplantation|2|||
164543372|NCT02285920|594362765|FG002|Overall Study|Kidney transplantation|2|||
164543373|NCT02285920|594362766|FG003|Overall Study|Kidney transplantation|0|||
164543374|NCT02285920|594362763|FG000|Overall Study|Change to peritoneal dialysis|0|||
164543375|NCT02285920|594362764|FG001|Overall Study|Change to peritoneal dialysis|0|||
164543376|NCT02285920|594362765|FG002|Overall Study|Change to peritoneal dialysis|1|||
164543377|NCT02285920|594362766|FG003|Overall Study|Change to peritoneal dialysis|0|||
164543378|NCT02285920|594362763|FG000|Overall Study|Transfer to non-participating unit|0|||
164543379|NCT02285920|594362764|FG001|Overall Study|Transfer to non-participating unit|1|||
164543380|NCT02285920|594362765|FG002|Overall Study|Transfer to non-participating unit|0|||
164543381|NCT02285920|594362766|FG003|Overall Study|Transfer to non-participating unit|0|||
164543382|NCT02285920|594362763|FG000|Overall Study|Dialysis discontinuation|0|||
164543383|NCT02285920|594362764|FG001|Overall Study|Dialysis discontinuation|1|||
164543384|NCT02285920|594362765|FG002|Overall Study|Dialysis discontinuation|0|||
164543385|NCT02285920|594362766|FG003|Overall Study|Dialysis discontinuation|0|||
164543386|NCT02285920|594362763|FG000|Overall Study|Death|2|||
164543387|NCT02285920|594362764|FG001|Overall Study|Death|0|||
164543388|NCT02285920|594362765|FG002|Overall Study|Death|2|||
164543389|NCT02285920|594362766|FG003|Overall Study|Death|1|||
164543390|NCT00677820|594362767|FG000|Overall Study|Lost to Follow-up|1|||
164543391|NCT00677820|594362768|FG001|Overall Study|Lost to Follow-up|0|||
164543392|NCT01480284|594362769|FG000|Overall Study|Withdrawal by Subject|2|||
164543393|NCT01480284|594362770|FG001|Overall Study|Withdrawal by Subject|0|||
164543394|NCT01480284|594362769|FG000|Overall Study|Adverse Event|1|||
164543395|NCT01480284|594362770|FG001|Overall Study|Adverse Event|0|||
164543396|NCT01480284|594362769|FG000|Overall Study|Study closed/terminated|3|||
164543397|NCT01480284|594362770|FG001|Overall Study|Study closed/terminated|0|||
164543398|NCT01480284|594362769|FG000|Overall Study|Lost to Follow-up|1|||
164543399|NCT01480284|594362770|FG001|Overall Study|Lost to Follow-up|0|||
164543400|NCT01480284|594362769|FG000|Overall Study|Physician Decision|1|||
164543401|NCT01480284|594362770|FG001|Overall Study|Physician Decision|0|||
164543402|NCT00066742|594362773|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
164543403|NCT00066742|594362773|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
164543404|NCT00066742|594362773|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
164543405|NCT00066742|594362773|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
164543406|NCT00066742|594362773|FG000|Induction Chemoradiotherapy|Ineligible|3|||
164543407|NCT00066742|594362773|FG000|Consolidation Chemotherapy|not protocol specified|1|||
164543408|NCT00066742|594362773|FG000|Consolidation Chemotherapy|Ineligible|2|||
164543409|NCT02357134|594362774|FG000|Overall Study|Lost to Follow-up|1|||
164543410|NCT02357134|594362775|FG001|Overall Study|Lost to Follow-up|0|||
164543411|NCT02357134|594362776|FG002|Overall Study|Lost to Follow-up|0|||
164543412|NCT02357134|594362777|FG003|Overall Study|Lost to Follow-up|0|||
164543413|NCT03374995|594362783|FG000|Overall Study|Withdrawal by Subject|0|||
164543414|NCT03374995|594362784|FG001|Overall Study|Withdrawal by Subject|1|||
164543415|NCT01383096|594362787|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
164543416|NCT01383096|594362788|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
164543417|NCT01383096|594362789|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
164543418|NCT01383096|594362787|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
164543419|NCT01383096|594362788|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
164543420|NCT01383096|594362789|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
164543421|NCT01383096|594362787|FG000|Third Intervention (8 Days)|Elevated AST|0|||
164543422|NCT01383096|594362788|FG001|Third Intervention (8 Days)|Elevated AST|1|||
164543423|NCT01383096|594362789|FG002|Third Intervention (8 Days)|Elevated AST|0|||
164543424|NCT01383096|594362787|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
164543425|NCT01383096|594362788|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
164543426|NCT01383096|594362789|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
164543427|NCT01383096|594362787|FG000|Third Intervention (8 Days)|Adverse Event|1|||
164543428|NCT01383096|594362788|FG001|Third Intervention (8 Days)|Adverse Event|0|||
164543429|NCT01383096|594362789|FG002|Third Intervention (8 Days)|Adverse Event|0|||
164543430|NCT01383096|594362787|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
164543431|NCT01383096|594362788|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
164543432|NCT01383096|594362789|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
164653295|NCT01078623|594757093|FG002|Treatment Period 2|Adverse Event|0|||
164653296|NCT01078623|594757094|FG003|Treatment Period 2|Adverse Event|0|||
164543433|NCT01383096|594362787|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
164543434|NCT01383096|594362788|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
164543435|NCT01383096|594362789|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
164543436|NCT01383096|594362787|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
164543437|NCT01383096|594362788|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
164543438|NCT01383096|594362789|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
164543439|NCT01383096|594362787|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
164543440|NCT01383096|594362788|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
164543441|NCT01383096|594362789|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
164543442|NCT01383096|594362787|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
164543443|NCT01383096|594362788|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
164543444|NCT01383096|594362789|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
164543445|NCT01383096|594362787|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
164543446|NCT01383096|594362788|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
164543447|NCT01383096|594362789|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
164543448|NCT01211535|594362790|FG000|Overall Study|Adverse Event|0|||
164543449|NCT01211535|594362791|FG001|Overall Study|Adverse Event|1|||
164543450|NCT03593850|594362797|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
164543451|NCT03593850|594362798|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
164543452|NCT02490475|594362799|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
164543453|NCT02490475|594362800|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
164543454|NCT02490475|594362801|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
164543455|NCT02490475|594362802|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
164543456|NCT02490475|594362799|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
164543457|NCT02490475|594362800|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
164543458|NCT02490475|594362801|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
164543459|NCT02490475|594362802|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
164543460|NCT02490475|594362799|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
164543461|NCT02490475|594362800|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
164543462|NCT02490475|594362801|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
164543463|NCT02490475|594362802|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
164543464|NCT02490475|594362799|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
164543465|NCT02490475|594362800|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
164543466|NCT02490475|594362801|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
164543467|NCT02490475|594362802|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
164543468|NCT02490475|594362799|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
164543469|NCT02490475|594362800|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
164543470|NCT02490475|594362801|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
164543471|NCT02490475|594362802|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
164543472|NCT02490475|594362799|FG000|Period 2: Extension Phase|Refused Treatment|0|||
164543473|NCT02490475|594362800|FG001|Period 2: Extension Phase|Refused Treatment|0|||
164543474|NCT02490475|594362801|FG002|Period 2: Extension Phase|Refused Treatment|0|||
164543475|NCT02490475|594362802|FG003|Period 2: Extension Phase|Refused Treatment|1|||
164543476|NCT02490475|594362799|FG000|Period 2: Extension Phase|Adverse Event|0|||
164543477|NCT02490475|594362800|FG001|Period 2: Extension Phase|Adverse Event|0|||
164543478|NCT02490475|594362801|FG002|Period 2: Extension Phase|Adverse Event|1|||
164653297|NCT01078623|594757095|FG004|Treatment Period 2|Adverse Event|0|||
164653298|NCT01078623|594757096|FG005|Treatment Period 2|Adverse Event|0|||
164653299|NCT01078623|594757097|FG006|Treatment Period 2|Adverse Event|1|||
164653300|NCT01078623|594757098|FG007|Treatment Period 2|Adverse Event|0|||
164653301|NCT01078623|594757099|FG008|Treatment Period 2|Adverse Event|0|||
164653302|NCT01078623|594757100|FG009|Treatment Period 2|Adverse Event|0|||
164653303|NCT01078623|594757101|FG010|Treatment Period 2|Adverse Event|0|||
164653304|NCT01078623|594757102|FG011|Treatment Period 2|Adverse Event|0|||
164653305|NCT01078623|594757103|FG012|Treatment Period 2|Adverse Event|0|||
164191172|NCT03654729|593067761|FG000|Overall Study|Site terminated by Sponsor|1|||
164653306|NCT01078623|594757104|FG013|Treatment Period 2|Adverse Event|0|||
164653307|NCT01078623|594757105|FG014|Treatment Period 2|Adverse Event|0|||
164653308|NCT01078623|594757106|FG015|Treatment Period 2|Adverse Event|0|||
164653309|NCT01078623|594757107|FG016|Treatment Period 2|Adverse Event|0|||
164653310|NCT01078623|594757108|FG017|Treatment Period 2|Adverse Event|0|||
164653311|NCT01078623|594757109|FG018|Treatment Period 2|Adverse Event|1|||
164653312|NCT01078623|594757110|FG019|Treatment Period 2|Adverse Event|0|||
164653313|NCT01078623|594757091|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164653314|NCT01078623|594757092|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164653315|NCT01078623|594757093|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164653316|NCT01078623|594757094|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164191173|NCT03654729|593067762|FG001|Overall Study|Site terminated by Sponsor|0|||
164191174|NCT03654729|593067763|FG002|Overall Study|Site terminated by Sponsor|0|||
164302197|NCT01134055|593482561|FG005|Overall Study|Adverse Event|7|||
164191175|NCT00588146|593067764|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
164191176|NCT00588146|593067765|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
164191177|NCT02100839|593067766|FG000|Multiple Ascending Dose|Adverse Event|2|||
164191178|NCT02100839|593067767|FG001|Multiple Ascending Dose|Adverse Event|0|||
164191179|NCT02100839|593067766|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
164191180|NCT02100839|593067767|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
164191181|NCT03272347|593067769|FG000|Overall Study|Death|0|||
164191182|NCT03272347|593067770|FG001|Overall Study|Death|0|||
164191183|NCT03272347|593067771|FG002|Overall Study|Death|0|||
164191184|NCT03272347|593067772|FG003|Overall Study|Death|1|||
164191185|NCT03272347|593067769|FG000|Overall Study|Lost to Follow-up|1|||
164191186|NCT03272347|593067770|FG001|Overall Study|Lost to Follow-up|3|||
164191187|NCT03272347|593067771|FG002|Overall Study|Lost to Follow-up|5|||
164191188|NCT03272347|593067772|FG003|Overall Study|Lost to Follow-up|1|||
164191189|NCT03272347|593067769|FG000|Overall Study|Physician Decision|4|||
164191190|NCT03272347|593067770|FG001|Overall Study|Physician Decision|2|||
164191191|NCT03272347|593067771|FG002|Overall Study|Physician Decision|5|||
164191192|NCT03272347|593067772|FG003|Overall Study|Physician Decision|4|||
164191193|NCT03272347|593067769|FG000|Overall Study|Screen Failure|1|||
164191194|NCT03272347|593067770|FG001|Overall Study|Screen Failure|0|||
164191195|NCT03272347|593067771|FG002|Overall Study|Screen Failure|0|||
164191196|NCT03272347|593067772|FG003|Overall Study|Screen Failure|0|||
164191197|NCT03272347|593067769|FG000|Overall Study|Withdrawal by Subject|5|||
164191198|NCT03272347|593067770|FG001|Overall Study|Withdrawal by Subject|1|||
164191199|NCT03272347|593067771|FG002|Overall Study|Withdrawal by Subject|2|||
164191200|NCT03272347|593067772|FG003|Overall Study|Withdrawal by Subject|1|||
164191201|NCT01971567|593067773|FG000|Overall Study|Withdrawal by Subject|3|||
164191202|NCT01971567|593067774|FG001|Overall Study|Withdrawal by Subject|2|||
164191203|NCT01971567|593067773|FG000|Overall Study|Lost to Follow-up|1|||
164191204|NCT01971567|593067774|FG001|Overall Study|Lost to Follow-up|0|||
164191205|NCT00391872|593067775|FG000|Overall Study|Protocol Violation|7|||
164191206|NCT00391872|593067776|FG001|Overall Study|Protocol Violation|2|||
164191207|NCT00391872|593067775|FG000|Overall Study|Withdrawal by Subject|296|||
164191208|NCT00391872|593067776|FG001|Overall Study|Withdrawal by Subject|249|||
164191209|NCT00391872|593067775|FG000|Overall Study|Reason unknown|2|||
164191210|NCT00391872|593067776|FG001|Overall Study|Reason unknown|4|||
164191211|NCT00391872|593067775|FG000|Overall Study|Lost to Follow-up|2|||
164191212|NCT00391872|593067776|FG001|Overall Study|Lost to Follow-up|0|||
164191213|NCT04826484|593067777|FG000|Overall Study|Lost to Follow-up|2|||
164191214|NCT04826484|593067778|FG001|Overall Study|Lost to Follow-up|0|||
164191215|NCT02581488|593067779|FG000|Overall Study|Adverse Event|6|||
164191216|NCT02581488|593067780|FG001|Overall Study|Adverse Event|7|||
164191217|NCT02581488|593067779|FG000|Overall Study|Lost to Follow-up|1|||
164191218|NCT02581488|593067780|FG001|Overall Study|Lost to Follow-up|0|||
164191219|NCT02581488|593067779|FG000|Overall Study|Withdrawal by Subject|1|||
164191220|NCT02581488|593067780|FG001|Overall Study|Withdrawal by Subject|0|||
164191221|NCT02581488|593067779|FG000|Overall Study|Non-Compliance|1|||
164191222|NCT02581488|593067780|FG001|Overall Study|Non-Compliance|0|||
164191223|NCT02581488|593067779|FG000|Overall Study|Protocol Violation|0|||
164191224|NCT02581488|593067780|FG001|Overall Study|Protocol Violation|4|||
164191225|NCT03373760|593067795|FG000|Overall Study|Adverse Event|8|||
164191226|NCT03373760|593067795|FG000|Overall Study|Disease Progression|46|||
164191227|NCT03373760|593067795|FG000|Overall Study|Death|4|||
164191228|NCT00003537|593067798|FG000|Overall Study|Not evalauable|1|||
164191229|NCT01001520|593067799|FG000|Medication Period 1|Withdrawal by Subject|2|||
164191230|NCT01001520|593067800|FG001|Medication Period 1|Withdrawal by Subject|2|||
164191231|NCT01001520|593067799|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
164191232|NCT01001520|593067800|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
164191233|NCT01001520|593067799|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
164191234|NCT01001520|593067800|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
164191235|NCT01001520|593067799|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
164191236|NCT01001520|593067800|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
164191237|NCT01001520|593067799|FG000|Washout Period|Withdrawal by Subject|2|||
164191238|NCT01001520|593067800|FG001|Washout Period|Withdrawal by Subject|1|||
164191239|NCT01001520|593067799|FG000|Medication Period 2|Withdrawal by Subject|0|||
164191240|NCT01001520|593067800|FG001|Medication Period 2|Withdrawal by Subject|3|||
164191241|NCT01896193|593067809|FG000|Overall Study|Lack of Efficacy|20|||
164191242|NCT01896193|593067810|FG001|Overall Study|Lack of Efficacy|11|||
164191243|NCT01896193|593067809|FG000|Overall Study|Protocol Violation|0|||
164191244|NCT01896193|593067810|FG001|Overall Study|Protocol Violation|1|||
164191245|NCT01896193|593067809|FG000|Overall Study|Withdrew Consent|1|||
164191246|NCT01896193|593067810|FG001|Overall Study|Withdrew Consent|0|||
164191247|NCT01300247|593067811|FG000|Overall Study|Death|1|||
164191248|NCT01300247|593067812|FG001|Overall Study|Death|1|||
164191249|NCT01300247|593067811|FG000|Overall Study|Lost to Follow-up|2|||
164191250|NCT01300247|593067812|FG001|Overall Study|Lost to Follow-up|0|||
164191251|NCT01300247|593067811|FG000|Overall Study|Withdrawal by Subject|1|||
164191252|NCT01300247|593067812|FG001|Overall Study|Withdrawal by Subject|0|||
164191253|NCT01300247|593067811|FG000|Overall Study|Non-Compliance|0|||
164191254|NCT01300247|593067812|FG001|Overall Study|Non-Compliance|1|||
164191255|NCT03743025|593067814|FG000|Overall Study|Surgery was cancelled|2|||
164191256|NCT03743025|593067815|FG001|Overall Study|Surgery was cancelled|1|||
164191257|NCT04501952|593067816|FG000|Overall Study|Adverse Event|0|||
164191258|NCT04501952|593067817|FG001|Overall Study|Adverse Event|3|||
164191259|NCT04501952|593067816|FG000|Overall Study|Investigator's Discretion|0|||
164191260|NCT04501952|593067817|FG001|Overall Study|Investigator's Discretion|1|||
164191261|NCT04501952|593067816|FG000|Overall Study|Protocol Violation|1|||
164191262|NCT04501952|593067817|FG001|Overall Study|Protocol Violation|1|||
164191263|NCT04501952|593067816|FG000|Overall Study|Withdrew Consent|5|||
164191264|NCT04501952|593067817|FG001|Overall Study|Withdrew Consent|4|||
164191265|NCT04501952|593067816|FG000|Overall Study|Lost to Follow-up|7|||
164543479|NCT02490475|594362802|FG003|Period 2: Extension Phase|Adverse Event|0|||
164543480|NCT00616434|594362804|FG000|Overall Study|Adverse Event|5|||
164543481|NCT00616434|594362805|FG001|Overall Study|Adverse Event|2|||
164543482|NCT00616434|594362804|FG000|Overall Study|Physician Decision|0|||
164543483|NCT00616434|594362805|FG001|Overall Study|Physician Decision|4|||
164543484|NCT00616434|594362804|FG000|Overall Study|Withdrawal by Subject|1|||
164543485|NCT00616434|594362805|FG001|Overall Study|Withdrawal by Subject|1|||
164543486|NCT00616434|594362804|FG000|Overall Study|Protocol deviation|0|||
164543487|NCT00616434|594362805|FG001|Overall Study|Protocol deviation|1|||
164543488|NCT00914927|594362809|FG000|Overall Study|Adverse Event|0|||
164543489|NCT00914927|594362810|FG001|Overall Study|Adverse Event|0|||
164543490|NCT00914927|594362811|FG002|Overall Study|Adverse Event|0|||
164543491|NCT00914927|594362812|FG003|Overall Study|Adverse Event|0|||
164543492|NCT00914927|594362813|FG004|Overall Study|Adverse Event|1|||
164543493|NCT00914927|594362814|FG005|Overall Study|Adverse Event|0|||
164543494|NCT00914927|594362815|FG006|Overall Study|Adverse Event|0|||
164543495|NCT00914927|594362809|FG000|Overall Study|Withdrawal by Subject|0|||
164543496|NCT00914927|594362810|FG001|Overall Study|Withdrawal by Subject|1|||
164543497|NCT00914927|594362811|FG002|Overall Study|Withdrawal by Subject|0|||
164543498|NCT00914927|594362812|FG003|Overall Study|Withdrawal by Subject|1|||
164543499|NCT00914927|594362813|FG004|Overall Study|Withdrawal by Subject|0|||
164543500|NCT00914927|594362814|FG005|Overall Study|Withdrawal by Subject|0|||
164543501|NCT00914927|594362815|FG006|Overall Study|Withdrawal by Subject|0|||
164543502|NCT00914927|594362809|FG000|Overall Study|Lost to Follow-up|0|||
164543503|NCT00914927|594362810|FG001|Overall Study|Lost to Follow-up|0|||
164543504|NCT00914927|594362811|FG002|Overall Study|Lost to Follow-up|0|||
164543505|NCT00914927|594362812|FG003|Overall Study|Lost to Follow-up|1|||
164543506|NCT00914927|594362813|FG004|Overall Study|Lost to Follow-up|0|||
164543507|NCT00914927|594362814|FG005|Overall Study|Lost to Follow-up|0|||
164543508|NCT00914927|594362815|FG006|Overall Study|Lost to Follow-up|0|||
164543509|NCT00914927|594362809|FG000|Overall Study|Administrative/Other|2|||
164543510|NCT00914927|594362810|FG001|Overall Study|Administrative/Other|1|||
164543511|NCT00914927|594362811|FG002|Overall Study|Administrative/Other|0|||
164543512|NCT00914927|594362812|FG003|Overall Study|Administrative/Other|0|||
164543513|NCT00914927|594362813|FG004|Overall Study|Administrative/Other|1|||
164543514|NCT00914927|594362814|FG005|Overall Study|Administrative/Other|0|||
164543515|NCT00914927|594362815|FG006|Overall Study|Administrative/Other|0|||
164543516|NCT01994382|594362816|FG000|Overall Study|Informed consent withdrawn|0|||
164543517|NCT01994382|594362817|FG001|Overall Study|Informed consent withdrawn|0|||
164543518|NCT01994382|594362818|FG002|Overall Study|Informed consent withdrawn|0|||
164543519|NCT01994382|594362819|FG003|Overall Study|Informed consent withdrawn|0|||
164543520|NCT01994382|594362820|FG004|Overall Study|Informed consent withdrawn|0|||
164543521|NCT01994382|594362821|FG005|Overall Study|Informed consent withdrawn|0|||
164543522|NCT01994382|594362822|FG006|Overall Study|Informed consent withdrawn|1|||
164543523|NCT01994382|594362823|FG007|Overall Study|Informed consent withdrawn|0|||
164543524|NCT01994382|594362824|FG008|Overall Study|Informed consent withdrawn|0|||
164543525|NCT01994382|594362825|FG009|Overall Study|Informed consent withdrawn|0|||
164543526|NCT01994382|594362826|FG010|Overall Study|Informed consent withdrawn|0|||
164543527|NCT01994382|594362827|FG011|Overall Study|Informed consent withdrawn|0|||
164543528|NCT01994382|594362828|FG012|Overall Study|Informed consent withdrawn|0|||
164543529|NCT01994382|594362829|FG013|Overall Study|Informed consent withdrawn|0|||
164543530|NCT01994382|594362830|FG014|Overall Study|Informed consent withdrawn|0|||
164191266|NCT04501952|593067817|FG001|Overall Study|Lost to Follow-up|2|||
164191267|NCT04501952|593067816|FG000|Overall Study|Randomized and Never Treated|13|||
164543531|NCT01994382|594362831|FG015|Overall Study|Informed consent withdrawn|0|||
164543532|NCT01994382|594362832|FG016|Overall Study|Informed consent withdrawn|0|||
164543533|NCT01994382|594362816|FG000|Overall Study|Progressive disease|3|||
164543534|NCT01994382|594362817|FG001|Overall Study|Progressive disease|4|||
164191268|NCT04501952|593067817|FG001|Overall Study|Randomized and Never Treated|9|||
164543535|NCT01994382|594362818|FG002|Overall Study|Progressive disease|4|||
164543536|NCT01994382|594362819|FG003|Overall Study|Progressive disease|3|||
164543537|NCT01994382|594362820|FG004|Overall Study|Progressive disease|2|||
164191269|NCT03382418|593067824|FG000|Overall Study|Withdrawal by Subject|1|||
164543538|NCT01994382|594362821|FG005|Overall Study|Progressive disease|3|||
164191270|NCT03382418|593067825|FG001|Overall Study|Withdrawal by Subject|0|||
164653317|NCT01078623|594757095|FG004|Treatment Period 2|Withdrawal by Subject|0|||
164653318|NCT01078623|594757096|FG005|Treatment Period 2|Withdrawal by Subject|1|||
164653319|NCT01078623|594757097|FG006|Treatment Period 2|Withdrawal by Subject|0|||
164543539|NCT01994382|594362822|FG006|Overall Study|Progressive disease|3|||
164543540|NCT01994382|594362823|FG007|Overall Study|Progressive disease|6|||
164543541|NCT01994382|594362824|FG008|Overall Study|Progressive disease|2|||
164543542|NCT01994382|594362825|FG009|Overall Study|Progressive disease|2|||
164543543|NCT01994382|594362826|FG010|Overall Study|Progressive disease|13|||
164543544|NCT01994382|594362827|FG011|Overall Study|Progressive disease|8|||
164543545|NCT01994382|594362828|FG012|Overall Study|Progressive disease|7|||
164543546|NCT01994382|594362829|FG013|Overall Study|Progressive disease|3|||
164543547|NCT01994382|594362830|FG014|Overall Study|Progressive disease|6|||
164543548|NCT01994382|594362831|FG015|Overall Study|Progressive disease|44|||
164543549|NCT01994382|594362832|FG016|Overall Study|Progressive disease|28|||
164543550|NCT01994382|594362816|FG000|Overall Study|Physician Decision|0|||
164543551|NCT01994382|594362817|FG001|Overall Study|Physician Decision|1|||
164543552|NCT01994382|594362818|FG002|Overall Study|Physician Decision|0|||
164543553|NCT01994382|594362819|FG003|Overall Study|Physician Decision|0|||
164543554|NCT01994382|594362820|FG004|Overall Study|Physician Decision|0|||
164543555|NCT01994382|594362821|FG005|Overall Study|Physician Decision|0|||
164543556|NCT01994382|594362822|FG006|Overall Study|Physician Decision|0|||
164543557|NCT01994382|594362823|FG007|Overall Study|Physician Decision|0|||
164543558|NCT01994382|594362824|FG008|Overall Study|Physician Decision|0|||
164543559|NCT01994382|594362825|FG009|Overall Study|Physician Decision|0|||
164543560|NCT01994382|594362826|FG010|Overall Study|Physician Decision|3|||
164543561|NCT01994382|594362827|FG011|Overall Study|Physician Decision|1|||
164543562|NCT01994382|594362828|FG012|Overall Study|Physician Decision|1|||
164543563|NCT01994382|594362829|FG013|Overall Study|Physician Decision|0|||
164543564|NCT01994382|594362830|FG014|Overall Study|Physician Decision|1|||
164543565|NCT01994382|594362831|FG015|Overall Study|Physician Decision|4|||
164543566|NCT01994382|594362832|FG016|Overall Study|Physician Decision|2|||
164543567|NCT01994382|594362816|FG000|Overall Study|Death|0|||
164543568|NCT01994382|594362817|FG001|Overall Study|Death|0|||
164543569|NCT01994382|594362818|FG002|Overall Study|Death|0|||
164543570|NCT01994382|594362819|FG003|Overall Study|Death|0|||
164543571|NCT01994382|594362820|FG004|Overall Study|Death|1|||
164543572|NCT01994382|594362821|FG005|Overall Study|Death|0|||
164543573|NCT01994382|594362822|FG006|Overall Study|Death|0|||
164543574|NCT01994382|594362823|FG007|Overall Study|Death|0|||
164543575|NCT01994382|594362824|FG008|Overall Study|Death|1|||
164543576|NCT01994382|594362825|FG009|Overall Study|Death|1|||
164543577|NCT01994382|594362826|FG010|Overall Study|Death|0|||
164543578|NCT01994382|594362827|FG011|Overall Study|Death|0|||
164543579|NCT01994382|594362828|FG012|Overall Study|Death|0|||
164543580|NCT01994382|594362829|FG013|Overall Study|Death|0|||
164543581|NCT01994382|594362830|FG014|Overall Study|Death|0|||
164543582|NCT01994382|594362831|FG015|Overall Study|Death|1|||
164543583|NCT01994382|594362832|FG016|Overall Study|Death|0|||
164543584|NCT01994382|594362816|FG000|Overall Study|Adverse Event|0|||
164543585|NCT01994382|594362817|FG001|Overall Study|Adverse Event|1|||
164543586|NCT01994382|594362818|FG002|Overall Study|Adverse Event|2|||
164543587|NCT01994382|594362819|FG003|Overall Study|Adverse Event|0|||
164543588|NCT01994382|594362820|FG004|Overall Study|Adverse Event|0|||
164543589|NCT01994382|594362821|FG005|Overall Study|Adverse Event|0|||
164543590|NCT01994382|594362822|FG006|Overall Study|Adverse Event|0|||
164543591|NCT01994382|594362823|FG007|Overall Study|Adverse Event|0|||
164543592|NCT01994382|594362824|FG008|Overall Study|Adverse Event|0|||
164543593|NCT01994382|594362825|FG009|Overall Study|Adverse Event|0|||
164543594|NCT01994382|594362826|FG010|Overall Study|Adverse Event|15|||
164543595|NCT01994382|594362827|FG011|Overall Study|Adverse Event|2|||
164543596|NCT01994382|594362828|FG012|Overall Study|Adverse Event|7|||
164543597|NCT01994382|594362829|FG013|Overall Study|Adverse Event|3|||
164543598|NCT01994382|594362830|FG014|Overall Study|Adverse Event|17|||
164543599|NCT01994382|594362831|FG015|Overall Study|Adverse Event|6|||
164543600|NCT01994382|594362832|FG016|Overall Study|Adverse Event|3|||
164543601|NCT01994382|594362816|FG000|Overall Study|Other than specified|0|||
164543602|NCT01994382|594362817|FG001|Overall Study|Other than specified|0|||
164543603|NCT01994382|594362818|FG002|Overall Study|Other than specified|0|||
164543604|NCT01994382|594362819|FG003|Overall Study|Other than specified|0|||
164543605|NCT01994382|594362820|FG004|Overall Study|Other than specified|0|||
164543606|NCT01994382|594362821|FG005|Overall Study|Other than specified|0|||
164543607|NCT01994382|594362822|FG006|Overall Study|Other than specified|0|||
164543608|NCT01994382|594362823|FG007|Overall Study|Other than specified|0|||
164543609|NCT01994382|594362824|FG008|Overall Study|Other than specified|0|||
164543610|NCT01994382|594362825|FG009|Overall Study|Other than specified|0|||
164543611|NCT01994382|594362826|FG010|Overall Study|Other than specified|2|||
164543612|NCT01994382|594362827|FG011|Overall Study|Other than specified|0|||
164543613|NCT01994382|594362828|FG012|Overall Study|Other than specified|2|||
164543614|NCT01994382|594362829|FG013|Overall Study|Other than specified|0|||
164543615|NCT01994382|594362830|FG014|Overall Study|Other than specified|0|||
164543616|NCT01994382|594362831|FG015|Overall Study|Other than specified|4|||
164653320|NCT01078623|594757098|FG007|Treatment Period 2|Withdrawal by Subject|0|||
164653321|NCT01078623|594757099|FG008|Treatment Period 2|Withdrawal by Subject|0|||
164653322|NCT01078623|594757100|FG009|Treatment Period 2|Withdrawal by Subject|0|||
164653323|NCT01078623|594757101|FG010|Treatment Period 2|Withdrawal by Subject|0|||
164653324|NCT01078623|594757102|FG011|Treatment Period 2|Withdrawal by Subject|0|||
164653325|NCT01078623|594757103|FG012|Treatment Period 2|Withdrawal by Subject|0|||
164653326|NCT01078623|594757104|FG013|Treatment Period 2|Withdrawal by Subject|0|||
164653327|NCT01078623|594757105|FG014|Treatment Period 2|Withdrawal by Subject|0|||
164653328|NCT01078623|594757106|FG015|Treatment Period 2|Withdrawal by Subject|0|||
164653329|NCT01078623|594757107|FG016|Treatment Period 2|Withdrawal by Subject|0|||
164653330|NCT01078623|594757108|FG017|Treatment Period 2|Withdrawal by Subject|0|||
164653331|NCT01078623|594757109|FG018|Treatment Period 2|Withdrawal by Subject|0|||
164653332|NCT01078623|594757110|FG019|Treatment Period 2|Withdrawal by Subject|0|||
164653333|NCT01078623|594757091|FG000|Treatment Period 3|Adverse Event|0|||
164653334|NCT01078623|594757092|FG001|Treatment Period 3|Adverse Event|0|||
164653335|NCT01078623|594757093|FG002|Treatment Period 3|Adverse Event|0|||
164653336|NCT01078623|594757094|FG003|Treatment Period 3|Adverse Event|0|||
164653337|NCT01078623|594757095|FG004|Treatment Period 3|Adverse Event|1|||
164653338|NCT01078623|594757096|FG005|Treatment Period 3|Adverse Event|0|||
164653339|NCT01078623|594757097|FG006|Treatment Period 3|Adverse Event|0|||
164653340|NCT01078623|594757098|FG007|Treatment Period 3|Adverse Event|0|||
164653341|NCT01078623|594757099|FG008|Treatment Period 3|Adverse Event|0|||
164653342|NCT01078623|594757100|FG009|Treatment Period 3|Adverse Event|0|||
164653343|NCT01078623|594757101|FG010|Treatment Period 3|Adverse Event|0|||
164653344|NCT01078623|594757102|FG011|Treatment Period 3|Adverse Event|0|||
164653345|NCT01078623|594757103|FG012|Treatment Period 3|Adverse Event|0|||
164653346|NCT01078623|594757104|FG013|Treatment Period 3|Adverse Event|1|||
164653347|NCT01078623|594757105|FG014|Treatment Period 3|Adverse Event|0|||
164653348|NCT01078623|594757106|FG015|Treatment Period 3|Adverse Event|0|||
164653349|NCT01078623|594757107|FG016|Treatment Period 3|Adverse Event|0|||
164653350|NCT01078623|594757108|FG017|Treatment Period 3|Adverse Event|0|||
164653351|NCT01078623|594757109|FG018|Treatment Period 3|Adverse Event|0|||
164653352|NCT01078623|594757110|FG019|Treatment Period 3|Adverse Event|0|||
164653353|NCT01078623|594757091|FG000|Treatment Period 4|Adverse Event|0|||
164653354|NCT01078623|594757092|FG001|Treatment Period 4|Adverse Event|0|||
164653355|NCT01078623|594757093|FG002|Treatment Period 4|Adverse Event|1|||
164653356|NCT01078623|594757094|FG003|Treatment Period 4|Adverse Event|0|||
164653357|NCT01078623|594757095|FG004|Treatment Period 4|Adverse Event|0|||
164653358|NCT01078623|594757096|FG005|Treatment Period 4|Adverse Event|0|||
164653359|NCT01078623|594757097|FG006|Treatment Period 4|Adverse Event|0|||
164653360|NCT01078623|594757098|FG007|Treatment Period 4|Adverse Event|0|||
164653361|NCT01078623|594757099|FG008|Treatment Period 4|Adverse Event|0|||
164653362|NCT01078623|594757100|FG009|Treatment Period 4|Adverse Event|0|||
164653363|NCT01078623|594757101|FG010|Treatment Period 4|Adverse Event|0|||
164653364|NCT01078623|594757102|FG011|Treatment Period 4|Adverse Event|0|||
164653365|NCT01078623|594757103|FG012|Treatment Period 4|Adverse Event|0|||
164653366|NCT01078623|594757104|FG013|Treatment Period 4|Adverse Event|0|||
164191271|NCT03382418|593067826|FG002|Overall Study|Withdrawal by Subject|0|||
164191272|NCT03382418|593067824|FG000|Overall Study|Lost to Follow-up|2|||
164191273|NCT03382418|593067825|FG001|Overall Study|Lost to Follow-up|3|||
164191274|NCT03382418|593067826|FG002|Overall Study|Lost to Follow-up|0|||
164191275|NCT01189461|593067836|FG000|Overall Study|Lack of Efficacy|13|||
164191276|NCT01189461|593067836|FG000|Overall Study|Lost to Follow-up|1|||
164191277|NCT01189461|593067836|FG000|Overall Study|Withdrawal by Subject|6|||
164191278|NCT01189461|593067836|FG000|Overall Study|Protocol Violation|1|||
164191279|NCT01189461|593067836|FG000|Overall Study|Adverse Event|2|||
164191280|NCT01189461|593067836|FG000|Overall Study|Did not meet entrance criteria|3|||
164191281|NCT01189461|593067836|FG000|Overall Study|Other|8|||
164191282|NCT05095311|593067842|FG000|Overall Study|Lost to Follow-up|7|||
164191283|NCT05095311|593067843|FG001|Overall Study|Lost to Follow-up|0|||
164191284|NCT05095311|593067844|FG002|Overall Study|Lost to Follow-up|0|||
164191285|NCT02385110|593067847|FG000|Overall Study|Early Death|1|||
164191286|NCT02385110|593067848|FG001|Overall Study|Early Death|0|||
164191287|NCT00534638|593067849|FG000|Overall Study|Withdrawal by Subject|3|||
164191288|NCT00534638|593067850|FG001|Overall Study|Withdrawal by Subject|4|||
164191289|NCT00534638|593067849|FG000|Overall Study|Migrated/moved from study area|13|||
164191290|NCT00534638|593067850|FG001|Overall Study|Migrated/moved from study area|11|||
164191291|NCT00534638|593067849|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
164191292|NCT00534638|593067850|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
164191293|NCT00534638|593067849|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
164191294|NCT00534638|593067850|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
164191295|NCT00534638|593067849|FG000|Overall Study|Other|1685|||
164191296|NCT00534638|593067850|FG001|Overall Study|Other|902|||
164191297|NCT00282152|593067853|FG000|Overall Study|Withdrawal by Subject|1|||
164191298|NCT00282152|593067854|FG001|Overall Study|Withdrawal by Subject|0|||
164191299|NCT00585325|593067855|FG000|Overall Study|Withdrawal by Subject|1|||
164191300|NCT00585325|593067856|FG001|Overall Study|Withdrawal by Subject|1|||
164191301|NCT03301831|593067857|FG000|Overall Study|Lost to Follow-up|5|||
164191302|NCT03301831|593067858|FG001|Overall Study|Lost to Follow-up|3|||
164191303|NCT03301831|593067857|FG000|Overall Study|Protocol Violation|4|||
164191304|NCT03301831|593067858|FG001|Overall Study|Protocol Violation|0|||
164191305|NCT03301831|593067857|FG000|Overall Study|Withdrawal by Subject|11|||
164191306|NCT03301831|593067858|FG001|Overall Study|Withdrawal by Subject|0|||
164191307|NCT01919164|593069490|FG000|Overall Study|Adverse Event|6|||
164191308|NCT01919164|593069491|FG001|Overall Study|Adverse Event|4|||
164191309|NCT01919164|593069492|FG002|Overall Study|Adverse Event|9|||
164191310|NCT01919164|593069493|FG003|Overall Study|Adverse Event|3|||
164191311|NCT01919164|593069494|FG004|Overall Study|Adverse Event|2|||
164191312|NCT01919164|593069490|FG000|Overall Study|Lost to Follow-up|2|||
164191313|NCT01919164|593069491|FG001|Overall Study|Lost to Follow-up|2|||
164191314|NCT01919164|593069492|FG002|Overall Study|Lost to Follow-up|2|||
164191315|NCT01919164|593069493|FG003|Overall Study|Lost to Follow-up|0|||
164191316|NCT01919164|593069494|FG004|Overall Study|Lost to Follow-up|4|||
164191317|NCT01919164|593069490|FG000|Overall Study|Death|1|||
164191318|NCT01919164|593069491|FG001|Overall Study|Death|0|||
164191319|NCT01919164|593069492|FG002|Overall Study|Death|0|||
164191320|NCT01919164|593069493|FG003|Overall Study|Death|0|||
164191321|NCT01919164|593069494|FG004|Overall Study|Death|0|||
164191322|NCT01919164|593069490|FG000|Overall Study|Protocol Violation|6|||
164191323|NCT01919164|593069491|FG001|Overall Study|Protocol Violation|0|||
164191324|NCT01919164|593069492|FG002|Overall Study|Protocol Violation|3|||
164191325|NCT01919164|593069493|FG003|Overall Study|Protocol Violation|2|||
164191326|NCT01919164|593069494|FG004|Overall Study|Protocol Violation|2|||
164191327|NCT01919164|593069490|FG000|Overall Study|Disease progression|2|||
164191328|NCT01919164|593069491|FG001|Overall Study|Disease progression|2|||
164191329|NCT01919164|593069492|FG002|Overall Study|Disease progression|1|||
164191330|NCT01919164|593069493|FG003|Overall Study|Disease progression|2|||
164191331|NCT01919164|593069494|FG004|Overall Study|Disease progression|1|||
164191332|NCT01919164|593069490|FG000|Overall Study|Withdrew consent|13|||
164191333|NCT01919164|593069491|FG001|Overall Study|Withdrew consent|13|||
164191334|NCT01919164|593069492|FG002|Overall Study|Withdrew consent|14|||
164191335|NCT01919164|593069493|FG003|Overall Study|Withdrew consent|14|||
164191336|NCT01919164|593069494|FG004|Overall Study|Withdrew consent|9|||
164191337|NCT01919164|593069490|FG000|Overall Study|Other Un-specified|13|||
164191338|NCT01919164|593069491|FG001|Overall Study|Other Un-specified|9|||
164191339|NCT01919164|593069492|FG002|Overall Study|Other Un-specified|8|||
164191340|NCT01919164|593069493|FG003|Overall Study|Other Un-specified|7|||
164191341|NCT01919164|593069494|FG004|Overall Study|Other Un-specified|15|||
164191342|NCT01239394|593069495|FG000|Overall Study|Adverse Event|1|||
164191343|NCT00905632|593069497|FG000|Overall Study|Adverse Event|0|||
164191344|NCT00905632|593069498|FG001|Overall Study|Adverse Event|0|||
164191345|NCT00905632|593069499|FG002|Overall Study|Adverse Event|0|||
164191346|NCT00905632|593069500|FG003|Overall Study|Adverse Event|0|||
164191347|NCT00905632|593069501|FG004|Overall Study|Adverse Event|0|||
164191348|NCT00905632|593069502|FG005|Overall Study|Adverse Event|1|||
164191349|NCT00905632|593069503|FG006|Overall Study|Adverse Event|4|||
164191350|NCT03569098|593069504|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
164191351|NCT03569098|593069505|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
164191352|NCT03569098|593069506|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
164191353|NCT03569098|593069504|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
164191354|NCT03569098|593069505|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
164191355|NCT03569098|593069506|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
164191356|NCT03569098|593069504|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
164191357|NCT03569098|593069505|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
164191358|NCT03569098|593069506|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
164191359|NCT03569098|593069504|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
164191360|NCT03569098|593069505|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
164191361|NCT03569098|593069506|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
164191362|NCT03569098|593069504|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
164191363|NCT03569098|593069505|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
164191364|NCT03569098|593069506|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
164191365|NCT03569098|593069504|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
164191366|NCT03569098|593069505|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
164191367|NCT03569098|593069506|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
164191368|NCT03569098|593069504|FG000|Double-Blind Treatment Cycle 1|Other|1|||
164191369|NCT03569098|593069505|FG001|Double-Blind Treatment Cycle 1|Other|0|||
164191370|NCT03569098|593069506|FG002|Double-Blind Treatment Cycle 1|Other|1|||
164191371|NCT03569098|593069504|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
164191372|NCT03569098|593069505|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
164191373|NCT03569098|593069506|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
164191374|NCT03569098|593069504|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
164191375|NCT03569098|593069505|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
164191376|NCT03569098|593069506|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
164543617|NCT01994382|594362832|FG016|Overall Study|Other than specified|4|||
164543618|NCT01994382|594362816|FG000|Overall Study|Withdrawal by Subject|0|||
164543619|NCT01994382|594362817|FG001|Overall Study|Withdrawal by Subject|0|||
164543620|NCT01994382|594362818|FG002|Overall Study|Withdrawal by Subject|0|||
164191377|NCT03569098|593069504|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
164191378|NCT03569098|593069505|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
164191379|NCT03569098|593069506|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
164191380|NCT03569098|593069504|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
164191381|NCT03569098|593069505|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
164191382|NCT03569098|593069506|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
164191383|NCT03569098|593069504|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
164191384|NCT03569098|593069505|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
164191385|NCT03569098|593069506|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
164191386|NCT03569098|593069504|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
164191387|NCT03569098|593069505|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
164191388|NCT03569098|593069506|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
164191389|NCT02485483|593069511|FG000|Overall Study|Depression at baseline|15|||
164191390|NCT02485483|593069512|FG001|Overall Study|Depression at baseline|0|||
164191391|NCT02485483|593069511|FG000|Overall Study|Discontinued after baseline|39|||
164191392|NCT02485483|593069512|FG001|Overall Study|Discontinued after baseline|0|||
164191393|NCT00377637|593069513|FG000|Induction Phase|Adverse Event|12|||
164191394|NCT00377637|593069514|FG001|Induction Phase|Adverse Event|21|||
164191395|NCT00377637|593069515|FG002|Induction Phase|Adverse Event|0|||
164191396|NCT00377637|593069516|FG003|Induction Phase|Adverse Event|0|||
164191397|NCT00377637|593069513|FG000|Induction Phase|Deterioration/serum creatinine|2|||
164191398|NCT00377637|593069514|FG001|Induction Phase|Deterioration/serum creatinine|0|||
164191399|NCT00377637|593069515|FG002|Induction Phase|Deterioration/serum creatinine|0|||
164191400|NCT00377637|593069516|FG003|Induction Phase|Deterioration/serum creatinine|0|||
164191401|NCT00377637|593069513|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
164191402|NCT00377637|593069514|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
164191403|NCT00377637|593069515|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
164191404|NCT00377637|593069516|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
164191405|NCT00377637|593069513|FG000|Induction Phase|Lost to Follow-up|2|||
164191406|NCT00377637|593069514|FG001|Induction Phase|Lost to Follow-up|1|||
164191407|NCT00377637|593069515|FG002|Induction Phase|Lost to Follow-up|0|||
164191408|NCT00377637|593069516|FG003|Induction Phase|Lost to Follow-up|0|||
164191409|NCT00377637|593069513|FG000|Induction Phase|Death|1|||
164191410|NCT00377637|593069514|FG001|Induction Phase|Death|3|||
164191411|NCT00377637|593069515|FG002|Induction Phase|Death|0|||
164191412|NCT00377637|593069516|FG003|Induction Phase|Death|0|||
164191413|NCT00377637|593069513|FG000|Induction Phase|Withdrawal by Subject|5|||
164191414|NCT00377637|593069514|FG001|Induction Phase|Withdrawal by Subject|6|||
164543621|NCT01994382|594362819|FG003|Overall Study|Withdrawal by Subject|0|||
164191415|NCT00377637|593069515|FG002|Induction Phase|Withdrawal by Subject|0|||
164191416|NCT00377637|593069516|FG003|Induction Phase|Withdrawal by Subject|0|||
164191417|NCT00377637|593069513|FG000|Induction Phase|Physician Decision|3|||
164191418|NCT00377637|593069514|FG001|Induction Phase|Physician Decision|1|||
164191419|NCT00377637|593069515|FG002|Induction Phase|Physician Decision|0|||
164191420|NCT00377637|593069516|FG003|Induction Phase|Physician Decision|0|||
164191421|NCT00377637|593069513|FG000|Induction Phase|Sponsor decision|1|||
164191422|NCT00377637|593069514|FG001|Induction Phase|Sponsor decision|2|||
164191423|NCT00377637|593069515|FG002|Induction Phase|Sponsor decision|0|||
164191424|NCT00377637|593069516|FG003|Induction Phase|Sponsor decision|0|||
164191425|NCT00377637|593069513|FG000|Induction Phase|Non-Compliance|1|||
164191426|NCT00377637|593069514|FG001|Induction Phase|Non-Compliance|0|||
164191427|NCT00377637|593069515|FG002|Induction Phase|Non-Compliance|0|||
164191428|NCT00377637|593069516|FG003|Induction Phase|Non-Compliance|0|||
164191429|NCT00377637|593069513|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
164191430|NCT00377637|593069514|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
164191431|NCT00377637|593069515|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
164191432|NCT00377637|593069516|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
164191433|NCT00377637|593069513|FG000|Maintenance Phase|Adverse Event|0|||
164191434|NCT00377637|593069514|FG001|Maintenance Phase|Adverse Event|0|||
164191435|NCT00377637|593069515|FG002|Maintenance Phase|Adverse Event|29|||
164191436|NCT00377637|593069516|FG003|Maintenance Phase|Adverse Event|43|||
164191437|NCT00377637|593069513|FG000|Maintenance Phase|Physician Decision|0|||
164191438|NCT00377637|593069514|FG001|Maintenance Phase|Physician Decision|0|||
164191439|NCT00377637|593069515|FG002|Maintenance Phase|Physician Decision|5|||
164191440|NCT00377637|593069516|FG003|Maintenance Phase|Physician Decision|4|||
164191441|NCT00377637|593069513|FG000|Maintenance Phase|Lost to Follow-up|0|||
164191442|NCT00377637|593069514|FG001|Maintenance Phase|Lost to Follow-up|0|||
164191443|NCT00377637|593069515|FG002|Maintenance Phase|Lost to Follow-up|3|||
164191444|NCT00377637|593069516|FG003|Maintenance Phase|Lost to Follow-up|1|||
164191445|NCT00377637|593069513|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164191446|NCT00377637|593069514|FG001|Maintenance Phase|Withdrawal by Subject|0|||
164191447|NCT00377637|593069515|FG002|Maintenance Phase|Withdrawal by Subject|3|||
164191448|NCT00377637|593069516|FG003|Maintenance Phase|Withdrawal by Subject|3|||
164191449|NCT00377637|593069513|FG000|Maintenance Phase|Sponsor decision|0|||
164191450|NCT00377637|593069514|FG001|Maintenance Phase|Sponsor decision|0|||
164191451|NCT00377637|593069515|FG002|Maintenance Phase|Sponsor decision|2|||
164191452|NCT00377637|593069516|FG003|Maintenance Phase|Sponsor decision|3|||
164191453|NCT00377637|593069513|FG000|Maintenance Phase|Non-compliance|0|||
164191454|NCT00377637|593069514|FG001|Maintenance Phase|Non-compliance|0|||
164191455|NCT00377637|593069515|FG002|Maintenance Phase|Non-compliance|1|||
164191456|NCT00377637|593069516|FG003|Maintenance Phase|Non-compliance|1|||
164191457|NCT00377637|593069513|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
164191458|NCT00377637|593069514|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
164191459|NCT00377637|593069515|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
164191460|NCT00377637|593069516|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
164191461|NCT00377637|593069513|FG000|Maintenance Phase|Death|0|||
164191462|NCT00377637|593069514|FG001|Maintenance Phase|Death|0|||
164191463|NCT00377637|593069515|FG002|Maintenance Phase|Death|0|||
164191464|NCT00377637|593069516|FG003|Maintenance Phase|Death|1|||
164191465|NCT02922153|593069518|FG000|Overall Study|Death|8|||
164191466|NCT02922153|593069519|FG001|Overall Study|Death|1|||
164191467|NCT02922153|593069518|FG000|Overall Study|Lost to Follow-up|1|||
164191468|NCT02922153|593069519|FG001|Overall Study|Lost to Follow-up|0|||
164191469|NCT02922153|593069518|FG000|Overall Study|Physician Decision|1|||
164191470|NCT02922153|593069519|FG001|Overall Study|Physician Decision|1|||
164191471|NCT00522548|593069522|FG000|Overall Study|Adverse Event|2|||
164191472|NCT00522548|593069523|FG001|Overall Study|Adverse Event|2|||
164191473|NCT00522548|593069522|FG000|Overall Study|Withdrawal by Subject|0|||
164191474|NCT00522548|593069523|FG001|Overall Study|Withdrawal by Subject|2|||
164191475|NCT00956839|593069524|FG000|Overall Study|Lost to Follow-up|3|||
164191476|NCT00956839|593069525|FG001|Overall Study|Lost to Follow-up|0|||
164191477|NCT00956839|593069526|FG002|Overall Study|Lost to Follow-up|3|||
164191478|NCT03506438|593069527|FG000|Overall Study|Lost to Follow-up|8|||
164191479|NCT03506438|593069528|FG001|Overall Study|Lost to Follow-up|7|||
164191480|NCT03506438|593069529|FG002|Overall Study|Lost to Follow-up|8|||
164191481|NCT03506438|593069530|FG003|Overall Study|Lost to Follow-up|7|||
164191482|NCT03506438|593069531|FG004|Overall Study|Lost to Follow-up|0|||
164191483|NCT03506438|593069532|FG005|Overall Study|Lost to Follow-up|0|||
164191484|NCT01128296|593069533|FG000|Overall Study|Physician Decision|0|||
164191485|NCT01128296|593069534|FG001|Overall Study|Physician Decision|0|||
164191486|NCT01128296|593069535|FG002|Overall Study|Physician Decision|0|||
164191487|NCT01128296|593069536|FG003|Overall Study|Physician Decision|0|||
164191488|NCT01128296|593069537|FG004|Overall Study|Physician Decision|0|||
164191489|NCT01128296|593069538|FG005|Overall Study|Physician Decision|3|||
164191490|NCT01128296|593069533|FG000|Overall Study|Withdrawal by Subject|0|||
164191491|NCT01128296|593069534|FG001|Overall Study|Withdrawal by Subject|0|||
164191492|NCT01128296|593069535|FG002|Overall Study|Withdrawal by Subject|0|||
164191493|NCT01128296|593069536|FG003|Overall Study|Withdrawal by Subject|0|||
164191494|NCT01128296|593069537|FG004|Overall Study|Withdrawal by Subject|0|||
164191495|NCT01128296|593069538|FG005|Overall Study|Withdrawal by Subject|2|||
164191496|NCT04155463|593069539|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
164191497|NCT04155463|593069540|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
164191498|NCT00113295|593069541|FG000|Overall Study|Adverse Event|4|||
164191499|NCT00113295|593069542|FG001|Overall Study|Adverse Event|1|||
164191500|NCT00113295|593069541|FG000|Overall Study|Unrelated Medical Illness|1|||
164191501|NCT00113295|593069542|FG001|Overall Study|Unrelated Medical Illness|0|||
164191502|NCT01714544|593069543|FG000|Overall Study|Lost to Follow-up|1|||
164191503|NCT01714544|593069543|FG000|Overall Study|Physician Decision|1|||
164191504|NCT01714544|593069543|FG000|Overall Study|Withdrawal by Subject|1|||
164191505|NCT01053741|593069544|FG000|2nd Study Intervention|Physician Decision|0|||
164191506|NCT01053741|593069545|FG001|2nd Study Intervention|Physician Decision|1|||
164191507|NCT00666211|593069546|FG000|Overall Study|Withdrawal by Subject|10|||
164191508|NCT00666211|593069547|FG001|Overall Study|Withdrawal by Subject|13|||
164191509|NCT00666211|593069546|FG000|Overall Study|went off medication, no more pain|1|||
164191510|NCT00666211|593069547|FG001|Overall Study|went off medication, no more pain|0|||
164191511|NCT00666211|593069546|FG000|Overall Study|patient non-compliant|6|||
164191512|NCT00666211|593069547|FG001|Overall Study|patient non-compliant|6|||
164191513|NCT00666211|593069546|FG000|Overall Study|disease progression|1|||
164191514|NCT00666211|593069547|FG001|Overall Study|disease progression|8|||
164191515|NCT00666211|593069546|FG000|Overall Study|Lost to Follow-up|2|||
164191516|NCT00666211|593069547|FG001|Overall Study|Lost to Follow-up|0|||
164191517|NCT00666211|593069546|FG000|Overall Study|toxicity|0|||
164191518|NCT00666211|593069547|FG001|Overall Study|toxicity|2|||
164191519|NCT00666211|593069546|FG000|Overall Study|hospital admission|0|||
164191520|NCT00666211|593069547|FG001|Overall Study|hospital admission|5|||
164191521|NCT00666211|593069546|FG000|Overall Study|Death|0|||
164191522|NCT00666211|593069547|FG001|Overall Study|Death|2|||
164191523|NCT00666211|593069546|FG000|Overall Study|off tx for other complicating disease|0|||
164191524|NCT00666211|593069547|FG001|Overall Study|off tx for other complicating disease|1|||
164191525|NCT00666211|593069546|FG000|Overall Study|Physician Decision|0|||
164191526|NCT00666211|593069547|FG001|Overall Study|Physician Decision|1|||
164191527|NCT02824224|593069550|FG000|Overall Study|Discontinued, IUS expulsion|0|||
164191528|NCT02824224|593069551|FG001|Overall Study|Discontinued, IUS expulsion|1|||
164191529|NCT02824224|593069550|FG000|Overall Study|Did not show up for allocation visit|2|||
164191530|NCT02824224|593069551|FG001|Overall Study|Did not show up for allocation visit|0|||
164191531|NCT04668209|593069552|FG000|Overall Study|Withdrawal by Subject|2|||
164191532|NCT04668209|593069553|FG001|Overall Study|Withdrawal by Subject|2|||
164191533|NCT04668209|593069552|FG000|Overall Study|Lost to Follow-up|3|||
164191534|NCT04668209|593069553|FG001|Overall Study|Lost to Follow-up|4|||
164191535|NCT04668209|593069552|FG000|Overall Study|Subject Expired|2|||
164191536|NCT04668209|593069553|FG001|Overall Study|Subject Expired|0|||
164191537|NCT04668209|593069552|FG000|Overall Study|Withdrawn from study|0|||
164191538|NCT04668209|593069553|FG001|Overall Study|Withdrawn from study|1|||
164191539|NCT04668209|593069552|FG000|Overall Study|Adverse Event|0|||
164191540|NCT04668209|593069553|FG001|Overall Study|Adverse Event|1|||
164191541|NCT05225558|593069554|FG000|Overall Study|Withdrawal by Subject|4|||
164191542|NCT05225558|593069555|FG001|Overall Study|Withdrawal by Subject|3|||
164191543|NCT05225558|593069554|FG000|Overall Study|Adverse Event|1|||
164191544|NCT05225558|593069555|FG001|Overall Study|Adverse Event|0|||
164191545|NCT05225558|593069554|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
164191546|NCT05225558|593069555|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
164191547|NCT05225558|593069554|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
164191548|NCT05225558|593069555|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
164191549|NCT00875563|593069557|FG000|Overall Study|Death|4|||
164191550|NCT00875563|593069557|FG000|Overall Study|Withdrawal by Subject|7|||
164191551|NCT00875563|593069557|FG000|Overall Study|No long-term (3-5 year) consent|6|||
164191552|NCT00875563|593069557|FG000|Overall Study|Still be eligible for follow-up|7|||
164191553|NCT00313846|593069558|FG000|Overall Study|Withdrawal by Subject|2|||
164191554|NCT00313846|593069559|FG001|Overall Study|Withdrawal by Subject|0|||
164191555|NCT00313846|593069558|FG000|Overall Study|Adverse Event|1|||
164191556|NCT00313846|593069559|FG001|Overall Study|Adverse Event|8|||
164191557|NCT00313846|593069558|FG000|Overall Study|Administrative|2|||
164191558|NCT00313846|593069559|FG001|Overall Study|Administrative|3|||
164191559|NCT02592447|593069562|FG000|Overall Study|Lost to Follow-up|1|||
164191560|NCT02592447|593069563|FG001|Overall Study|Lost to Follow-up|0|||
164191561|NCT02592447|593069562|FG000|Overall Study|Ineligible after randomization|1|||
164191562|NCT02592447|593069563|FG001|Overall Study|Ineligible after randomization|0|||
164191563|NCT02592447|593069562|FG000|Overall Study|Withdrawal by Subject|0|||
164191564|NCT02592447|593069563|FG001|Overall Study|Withdrawal by Subject|1|||
164191565|NCT02028507|593069564|FG000|Overall Study|Progressive Disease|122|||
164191566|NCT02028507|593069565|FG001|Overall Study|Progressive Disease|90|||
164191567|NCT02028507|593069566|FG002|Overall Study|Progressive Disease|102|||
164191568|NCT02028507|593069567|FG003|Overall Study|Progressive Disease|89|||
164653367|NCT01078623|594757105|FG014|Treatment Period 4|Adverse Event|0|||
164653368|NCT01078623|594757106|FG015|Treatment Period 4|Adverse Event|0|||
164653369|NCT01078623|594757107|FG016|Treatment Period 4|Adverse Event|0|||
164653370|NCT01078623|594757108|FG017|Treatment Period 4|Adverse Event|0|||
164653371|NCT01078623|594757109|FG018|Treatment Period 4|Adverse Event|0|||
164653372|NCT01078623|594757110|FG019|Treatment Period 4|Adverse Event|0|||
164653373|NCT01078623|594757091|FG000|Treatment Period 4|Withdrawal by Subject|0|||
164653374|NCT01078623|594757092|FG001|Treatment Period 4|Withdrawal by Subject|0|||
164653375|NCT01078623|594757093|FG002|Treatment Period 4|Withdrawal by Subject|0|||
164653376|NCT01078623|594757094|FG003|Treatment Period 4|Withdrawal by Subject|0|||
164653377|NCT01078623|594757095|FG004|Treatment Period 4|Withdrawal by Subject|0|||
164653378|NCT01078623|594757096|FG005|Treatment Period 4|Withdrawal by Subject|0|||
164653379|NCT01078623|594757097|FG006|Treatment Period 4|Withdrawal by Subject|0|||
164543622|NCT01994382|594362820|FG004|Overall Study|Withdrawal by Subject|0|||
164543623|NCT01994382|594362821|FG005|Overall Study|Withdrawal by Subject|0|||
164543624|NCT01994382|594362822|FG006|Overall Study|Withdrawal by Subject|0|||
164543625|NCT01994382|594362823|FG007|Overall Study|Withdrawal by Subject|0|||
164543626|NCT01994382|594362824|FG008|Overall Study|Withdrawal by Subject|0|||
164543627|NCT01994382|594362825|FG009|Overall Study|Withdrawal by Subject|0|||
164543628|NCT01994382|594362826|FG010|Overall Study|Withdrawal by Subject|6|||
164543629|NCT01994382|594362827|FG011|Overall Study|Withdrawal by Subject|0|||
164543630|NCT01994382|594362828|FG012|Overall Study|Withdrawal by Subject|2|||
164543631|NCT01994382|594362829|FG013|Overall Study|Withdrawal by Subject|0|||
164543632|NCT01994382|594362830|FG014|Overall Study|Withdrawal by Subject|4|||
164543633|NCT01994382|594362831|FG015|Overall Study|Withdrawal by Subject|3|||
164543634|NCT01994382|594362832|FG016|Overall Study|Withdrawal by Subject|0|||
164543635|NCT01994382|594362816|FG000|Overall Study|Lost to Follow-up|0|||
164543636|NCT01994382|594362817|FG001|Overall Study|Lost to Follow-up|0|||
164543637|NCT01994382|594362818|FG002|Overall Study|Lost to Follow-up|0|||
164543638|NCT01994382|594362819|FG003|Overall Study|Lost to Follow-up|0|||
164543639|NCT01994382|594362820|FG004|Overall Study|Lost to Follow-up|0|||
164543640|NCT01994382|594362821|FG005|Overall Study|Lost to Follow-up|0|||
164543641|NCT01994382|594362822|FG006|Overall Study|Lost to Follow-up|0|||
164543642|NCT01994382|594362823|FG007|Overall Study|Lost to Follow-up|0|||
164543643|NCT01994382|594362824|FG008|Overall Study|Lost to Follow-up|0|||
164543644|NCT01994382|594362825|FG009|Overall Study|Lost to Follow-up|0|||
164543645|NCT01994382|594362826|FG010|Overall Study|Lost to Follow-up|1|||
164543646|NCT01994382|594362827|FG011|Overall Study|Lost to Follow-up|0|||
164543647|NCT01994382|594362828|FG012|Overall Study|Lost to Follow-up|0|||
164543648|NCT01994382|594362829|FG013|Overall Study|Lost to Follow-up|0|||
164543649|NCT01994382|594362830|FG014|Overall Study|Lost to Follow-up|0|||
164543650|NCT01994382|594362831|FG015|Overall Study|Lost to Follow-up|0|||
164543651|NCT01994382|594362832|FG016|Overall Study|Lost to Follow-up|0|||
164543652|NCT01994382|594362816|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
164543653|NCT01994382|594362817|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
164543654|NCT01994382|594362818|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
164543655|NCT01994382|594362819|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
164543656|NCT01994382|594362820|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
164543657|NCT01994382|594362821|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
164543658|NCT01994382|594362822|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
164543659|NCT01994382|594362823|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
164543660|NCT01994382|594362824|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
164543661|NCT01994382|594362825|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
164543662|NCT01994382|594362826|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
164543663|NCT01994382|594362827|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
164543664|NCT01994382|594362828|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
164543665|NCT01994382|594362829|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
164543666|NCT01994382|594362830|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
164543667|NCT01994382|594362831|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
164543668|NCT01994382|594362832|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
164543669|NCT01994382|594362816|FG000|Overall Study|Protocol violation/noncompliance|0|||
164543670|NCT01994382|594362817|FG001|Overall Study|Protocol violation/noncompliance|0|||
164543671|NCT01994382|594362818|FG002|Overall Study|Protocol violation/noncompliance|0|||
164543672|NCT01994382|594362819|FG003|Overall Study|Protocol violation/noncompliance|0|||
164543673|NCT01994382|594362820|FG004|Overall Study|Protocol violation/noncompliance|0|||
164543674|NCT01994382|594362821|FG005|Overall Study|Protocol violation/noncompliance|0|||
164543675|NCT01994382|594362822|FG006|Overall Study|Protocol violation/noncompliance|0|||
164653380|NCT01078623|594757098|FG007|Treatment Period 4|Withdrawal by Subject|0|||
164653381|NCT01078623|594757099|FG008|Treatment Period 4|Withdrawal by Subject|0|||
164653382|NCT01078623|594757100|FG009|Treatment Period 4|Withdrawal by Subject|0|||
164191569|NCT02028507|593069564|FG000|Overall Study|Adverse Event|8|||
164191570|NCT02028507|593069565|FG001|Overall Study|Adverse Event|25|||
164191571|NCT02028507|593069566|FG002|Overall Study|Adverse Event|3|||
164191572|NCT02028507|593069567|FG003|Overall Study|Adverse Event|16|||
164191573|NCT02028507|593069564|FG000|Overall Study|Withdrawal by Subject|6|||
164191574|NCT02028507|593069565|FG001|Overall Study|Withdrawal by Subject|8|||
164191575|NCT02028507|593069566|FG002|Overall Study|Withdrawal by Subject|5|||
164191576|NCT02028507|593069567|FG003|Overall Study|Withdrawal by Subject|9|||
164191577|NCT02028507|593069564|FG000|Overall Study|Protocol Violation|2|||
164191578|NCT02028507|593069565|FG001|Overall Study|Protocol Violation|4|||
164191579|NCT02028507|593069566|FG002|Overall Study|Protocol Violation|1|||
164191580|NCT02028507|593069567|FG003|Overall Study|Protocol Violation|3|||
164191581|NCT02028507|593069564|FG000|Overall Study|Physician Decision|0|||
164191582|NCT02028507|593069565|FG001|Overall Study|Physician Decision|4|||
164191583|NCT02028507|593069566|FG002|Overall Study|Physician Decision|0|||
164191584|NCT02028507|593069567|FG003|Overall Study|Physician Decision|0|||
164191585|NCT02028507|593069564|FG000|Overall Study|Death|1|||
164191586|NCT02028507|593069565|FG001|Overall Study|Death|0|||
164191587|NCT02028507|593069566|FG002|Overall Study|Death|1|||
164191588|NCT02028507|593069567|FG003|Overall Study|Death|3|||
164191589|NCT02028507|593069564|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
164191590|NCT02028507|593069565|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
164191591|NCT02028507|593069566|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
164191592|NCT02028507|593069567|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
164191593|NCT02028507|593069564|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
164191594|NCT02028507|593069565|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
164191595|NCT02028507|593069566|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
164191596|NCT02028507|593069567|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
164191597|NCT02028507|593069564|FG000|Overall Study|Randomized But Not Treated|3|||
164191598|NCT02028507|593069565|FG001|Overall Study|Randomized But Not Treated|6|||
164191599|NCT02028507|593069566|FG002|Overall Study|Randomized But Not Treated|0|||
164191600|NCT02028507|593069567|FG003|Overall Study|Randomized But Not Treated|4|||
164191601|NCT02028507|593069564|FG000|Overall Study|Enzyme defect|0|||
164191602|NCT02028507|593069565|FG001|Overall Study|Enzyme defect|0|||
164191603|NCT02028507|593069566|FG002|Overall Study|Enzyme defect|0|||
164191604|NCT02028507|593069567|FG003|Overall Study|Enzyme defect|1|||
164191605|NCT02028507|593069564|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
164191606|NCT02028507|593069565|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
164191607|NCT02028507|593069566|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
164191608|NCT02028507|593069567|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
164191609|NCT02028507|593069564|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
164191610|NCT02028507|593069565|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
164191611|NCT02028507|593069566|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
164191612|NCT02028507|593069567|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
164191613|NCT00618826|593069568|FG000|Overall Study|Adverse Event|1|||
164191614|NCT01556932|593069569|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
164191615|NCT01556932|593069570|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
164191616|NCT02105285|593069577|FG000|Overall Study|Adverse Event|1|||
164191617|NCT02105285|593069578|FG001|Overall Study|Adverse Event|1|||
164191618|NCT02105285|593069579|FG002|Overall Study|Adverse Event|0|||
164191619|NCT02105285|593069577|FG000|Overall Study|Protocol Violation|0|||
164191620|NCT02105285|593069578|FG001|Overall Study|Protocol Violation|1|||
164191621|NCT02105285|593069579|FG002|Overall Study|Protocol Violation|0|||
164191622|NCT02105285|593069577|FG000|Overall Study|Withdrawal by Subject|1|||
164191623|NCT02105285|593069578|FG001|Overall Study|Withdrawal by Subject|0|||
164191624|NCT02105285|593069579|FG002|Overall Study|Withdrawal by Subject|0|||
164191625|NCT01421641|593069580|FG000|Overall Study|Protocol Violation|2|||
164191626|NCT01421641|593069581|FG001|Overall Study|Protocol Violation|2|||
164191627|NCT02420119|593069582|FG000|Overall Study|insufficient laboratory data|5|||
164191628|NCT03231306|593069583|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
164191629|NCT03231306|593069583|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
164191630|NCT03231306|593069583|FG000|Overall Study|Treatment delay > 21 days|2|||
164191631|NCT03231306|593069583|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
164543676|NCT01994382|594362823|FG007|Overall Study|Protocol violation/noncompliance|0|||
164543677|NCT01994382|594362824|FG008|Overall Study|Protocol violation/noncompliance|0|||
164191632|NCT03231306|593069583|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
164191633|NCT03231306|593069583|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
164191634|NCT03231306|593069583|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
164191635|NCT03231306|593069583|FG000|Overall Study|More than 1 Reason|2|||
164191636|NCT01502033|593069584|FG000|Overall Study|1 participant had scalp discomfort|1|||
164191637|NCT01502033|593069584|FG000|Overall Study|1 participant had worsening depression|1|||
164191638|NCT01502033|593069584|FG000|Overall Study|1 participant went back to school|1|||
164191639|NCT02983045|593069585|FG000|Overall Study|Withdrawal by Subject|0|||
164191640|NCT02983045|593069586|FG001|Overall Study|Withdrawal by Subject|1|||
164191641|NCT02983045|593069587|FG002|Overall Study|Withdrawal by Subject|0|||
164191642|NCT02983045|593069588|FG003|Overall Study|Withdrawal by Subject|5|||
164191643|NCT02983045|593069589|FG004|Overall Study|Withdrawal by Subject|0|||
164191644|NCT02983045|593069590|FG005|Overall Study|Withdrawal by Subject|72|||
164191645|NCT02983045|593069591|FG006|Overall Study|Withdrawal by Subject|0|||
164191646|NCT02983045|593069592|FG007|Overall Study|Withdrawal by Subject|0|||
164191647|NCT02983045|593069593|FG008|Overall Study|Withdrawal by Subject|0|||
164191648|NCT02983045|593069594|FG009|Overall Study|Withdrawal by Subject|2|||
164191649|NCT02983045|593069585|FG000|Overall Study|Lost to Follow-up|0|||
164191650|NCT02983045|593069586|FG001|Overall Study|Lost to Follow-up|0|||
164191651|NCT02983045|593069587|FG002|Overall Study|Lost to Follow-up|0|||
164191652|NCT02983045|593069588|FG003|Overall Study|Lost to Follow-up|0|||
164191653|NCT02983045|593069589|FG004|Overall Study|Lost to Follow-up|0|||
164191654|NCT02983045|593069590|FG005|Overall Study|Lost to Follow-up|10|||
164191655|NCT02983045|593069591|FG006|Overall Study|Lost to Follow-up|0|||
164191656|NCT02983045|593069592|FG007|Overall Study|Lost to Follow-up|0|||
164191657|NCT02983045|593069593|FG008|Overall Study|Lost to Follow-up|0|||
164191658|NCT02983045|593069594|FG009|Overall Study|Lost to Follow-up|0|||
164191659|NCT01808261|593069595|FG000|Overall Study|Physician Decision|0|||
164191660|NCT01808261|593069596|FG001|Overall Study|Physician Decision|2|||
164191661|NCT01808261|593069595|FG000|Overall Study|Study Closed/Terminated|25|||
164191662|NCT01808261|593069596|FG001|Overall Study|Study Closed/Terminated|23|||
164191663|NCT01808261|593069595|FG000|Overall Study|Adverse event, non-fatal|2|||
164191664|NCT01808261|593069596|FG001|Overall Study|Adverse event, non-fatal|0|||
164191665|NCT01808261|593069595|FG000|Overall Study|Consent withdrawn by subject|6|||
164191666|NCT01808261|593069596|FG001|Overall Study|Consent withdrawn by subject|7|||
164191667|NCT01808261|593069595|FG000|Overall Study|Lost to Follow-up|3|||
164191668|NCT01808261|593069596|FG001|Overall Study|Lost to Follow-up|1|||
164191669|NCT02585713|593069597|FG000|Overall Study|Withdrew prior to treatment|2|||
164191670|NCT02585713|593069598|FG001|Overall Study|Withdrew prior to treatment|7|||
164191671|NCT02585713|593069597|FG000|Overall Study|Other|3|||
164191672|NCT02585713|593069598|FG001|Overall Study|Other|1|||
164191673|NCT02080364|593069601|FG000|Baseline Period|Protocol Violation|2|||
164191674|NCT02080364|593069602|FG001|Baseline Period|Protocol Violation|1|||
164191675|NCT02080364|593069603|FG002|Baseline Period|Protocol Violation|0|||
164191676|NCT02080364|593069604|FG003|Baseline Period|Protocol Violation|0|||
164191677|NCT02080364|593069601|FG000|Baseline Period|Other|0|||
164191678|NCT02080364|593069602|FG001|Baseline Period|Other|1|||
164191679|NCT02080364|593069603|FG002|Baseline Period|Other|1|||
164191680|NCT02080364|593069604|FG003|Baseline Period|Other|0|||
164191681|NCT02080364|593069601|FG000|Treatment Period|Adverse Event|10|||
164191682|NCT02080364|593069602|FG001|Treatment Period|Adverse Event|15|||
164191683|NCT02080364|593069603|FG002|Treatment Period|Adverse Event|11|||
164191684|NCT02080364|593069604|FG003|Treatment Period|Adverse Event|14|||
164191685|NCT02080364|593069601|FG000|Treatment Period|Lost to Follow-up|2|||
164191686|NCT02080364|593069602|FG001|Treatment Period|Lost to Follow-up|3|||
164191687|NCT02080364|593069603|FG002|Treatment Period|Lost to Follow-up|5|||
164191688|NCT02080364|593069604|FG003|Treatment Period|Lost to Follow-up|0|||
164191689|NCT02080364|593069601|FG000|Treatment Period|Protocol Violation|5|||
164191690|NCT02080364|593069602|FG001|Treatment Period|Protocol Violation|3|||
164191691|NCT02080364|593069603|FG002|Treatment Period|Protocol Violation|5|||
164191692|NCT02080364|593069604|FG003|Treatment Period|Protocol Violation|1|||
164191693|NCT02080364|593069601|FG000|Treatment Period|Withdrawal by Subject|16|||
164191694|NCT02080364|593069602|FG001|Treatment Period|Withdrawal by Subject|16|||
164191695|NCT02080364|593069603|FG002|Treatment Period|Withdrawal by Subject|15|||
164191696|NCT02080364|593069604|FG003|Treatment Period|Withdrawal by Subject|10|||
164191697|NCT02080364|593069601|FG000|Treatment Period|Study Terminated by Sponsor|0|||
164191698|NCT02080364|593069602|FG001|Treatment Period|Study Terminated by Sponsor|0|||
164191699|NCT02080364|593069603|FG002|Treatment Period|Study Terminated by Sponsor|180|||
164191700|NCT02080364|593069604|FG003|Treatment Period|Study Terminated by Sponsor|183|||
164191701|NCT02080364|593069601|FG000|Treatment Period|Other|14|||
164191702|NCT02080364|593069602|FG001|Treatment Period|Other|12|||
164191703|NCT02080364|593069603|FG002|Treatment Period|Other|21|||
164191704|NCT02080364|593069604|FG003|Treatment Period|Other|16|||
164191705|NCT02609984|593069605|FG000|Overall Study|Death|29|||
164191706|NCT02609984|593069606|FG001|Overall Study|Death|26|||
164191707|NCT02609984|593069605|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
164191708|NCT02609984|593069606|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
164191709|NCT02609984|593069605|FG000|Overall Study|Lost to Follow-up|1|||
164191710|NCT02609984|593069606|FG001|Overall Study|Lost to Follow-up|2|||
164191711|NCT02609984|593069605|FG000|Overall Study|Withdrawal by Subject|0|||
164191712|NCT02609984|593069606|FG001|Overall Study|Withdrawal by Subject|1|||
164191713|NCT02609984|593069605|FG000|Overall Study|Disease Progression|2|||
164191714|NCT02609984|593069606|FG001|Overall Study|Disease Progression|0|||
164191715|NCT00991289|593069607|FG000|Overall Study|Adverse Event|1|||
164191716|NCT00991289|593069607|FG000|Overall Study|Physician Decision|2|||
164191717|NCT00991289|593069607|FG000|Overall Study|Withdrawal by Subject|3|||
164191718|NCT00991289|593069607|FG000|Overall Study|Lost to Follow-up|4|||
164191719|NCT00991289|593069607|FG000|Overall Study|Protocol Violation|2|||
164191720|NCT02256839|593069609|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
164191721|NCT02256839|593069610|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
164191722|NCT01843803|593069611|FG000|Overall Study|not a Veteran, did not see provider|1|||
164191723|NCT01843803|593069612|FG001|Overall Study|not a Veteran, did not see provider|3|||
164191724|NCT00436826|593069616|FG000|Double Blind Period (DBP)|Adverse Event|2|||
164191725|NCT00436826|593069617|FG001|Double Blind Period (DBP)|Adverse Event|0|||
164191726|NCT00436826|593069618|FG002|Double Blind Period (DBP)|Adverse Event|0|||
164191727|NCT00436826|593069619|FG003|Double Blind Period (DBP)|Adverse Event|0|||
164191728|NCT00436826|593069620|FG004|Double Blind Period (DBP)|Adverse Event|0|||
164191729|NCT00436826|593069621|FG005|Double Blind Period (DBP)|Adverse Event|0|||
164191730|NCT00436826|593069616|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
164191731|NCT00436826|593069617|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
164191732|NCT00436826|593069618|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
164191733|NCT00436826|593069619|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
164191734|NCT00436826|593069620|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
164191735|NCT00436826|593069621|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
164191736|NCT00436826|593069616|FG000|Double Blind Period (DBP)|Other|10|||
164191737|NCT00436826|593069617|FG001|Double Blind Period (DBP)|Other|11|||
164191738|NCT00436826|593069618|FG002|Double Blind Period (DBP)|Other|0|||
164191739|NCT00436826|593069619|FG003|Double Blind Period (DBP)|Other|0|||
164191740|NCT00436826|593069620|FG004|Double Blind Period (DBP)|Other|0|||
164191741|NCT00436826|593069621|FG005|Double Blind Period (DBP)|Other|0|||
164191742|NCT00436826|593069616|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
164191743|NCT00436826|593069617|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
164191744|NCT00436826|593069618|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
164191745|NCT00436826|593069619|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
164191746|NCT00436826|593069620|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
164191747|NCT00436826|593069621|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
164191748|NCT00436826|593069616|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
164191749|NCT00436826|593069617|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
164191750|NCT00436826|593069618|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
164191751|NCT00436826|593069619|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
164191752|NCT00436826|593069620|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
164191753|NCT00436826|593069621|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
164191754|NCT00436826|593069616|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
164191755|NCT00436826|593069617|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
164191756|NCT00436826|593069618|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
164191757|NCT00436826|593069619|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
164191758|NCT00436826|593069620|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
164191759|NCT00436826|593069621|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
164191760|NCT00784719|593069622|FG000|Overall Study|Adverse Event|0|||
164191761|NCT00784719|593069623|FG001|Overall Study|Adverse Event|2|||
164191762|NCT00784719|593069624|FG002|Overall Study|Adverse Event|0|||
164191763|NCT00784719|593069625|FG003|Overall Study|Adverse Event|0|||
164191764|NCT00784719|593069626|FG004|Overall Study|Adverse Event|1|||
164191765|NCT00784719|593069627|FG005|Overall Study|Adverse Event|1|||
164191766|NCT00784719|593069628|FG006|Overall Study|Adverse Event|1|||
164191767|NCT00784719|593069622|FG000|Overall Study|Lost to Follow-up|0|||
164191768|NCT00784719|593069623|FG001|Overall Study|Lost to Follow-up|0|||
164191769|NCT00784719|593069624|FG002|Overall Study|Lost to Follow-up|0|||
164191770|NCT00784719|593069625|FG003|Overall Study|Lost to Follow-up|0|||
164191771|NCT00784719|593069626|FG004|Overall Study|Lost to Follow-up|1|||
164191772|NCT00784719|593069627|FG005|Overall Study|Lost to Follow-up|1|||
164191773|NCT00784719|593069628|FG006|Overall Study|Lost to Follow-up|0|||
164191774|NCT00784719|593069622|FG000|Overall Study|Other|2|||
164191775|NCT00784719|593069623|FG001|Overall Study|Other|1|||
164191776|NCT00784719|593069624|FG002|Overall Study|Other|1|||
164191777|NCT00784719|593069625|FG003|Overall Study|Other|0|||
164191778|NCT00784719|593069626|FG004|Overall Study|Other|2|||
164191779|NCT00784719|593069627|FG005|Overall Study|Other|1|||
164191780|NCT00784719|593069628|FG006|Overall Study|Other|3|||
164191781|NCT00784719|593069622|FG000|Overall Study|Withdrawal by Subject|1|||
164191782|NCT00784719|593069623|FG001|Overall Study|Withdrawal by Subject|0|||
164191783|NCT00784719|593069624|FG002|Overall Study|Withdrawal by Subject|0|||
164543678|NCT01994382|594362825|FG009|Overall Study|Protocol violation/noncompliance|0|||
164543679|NCT01994382|594362826|FG010|Overall Study|Protocol violation/noncompliance|0|||
164191784|NCT00784719|593069625|FG003|Overall Study|Withdrawal by Subject|0|||
164191785|NCT00784719|593069626|FG004|Overall Study|Withdrawal by Subject|2|||
164191786|NCT00784719|593069627|FG005|Overall Study|Withdrawal by Subject|0|||
164191787|NCT00784719|593069628|FG006|Overall Study|Withdrawal by Subject|1|||
164191788|NCT02401035|593069632|FG000|Overall Study|Withdrawal by Subject|1|||
164191789|NCT02401035|593069633|FG001|Overall Study|Withdrawal by Subject|0|||
164191790|NCT00869128|593069634|FG000|Overall Study|lack of Compliance|6|||
164191791|NCT00869128|593069635|FG001|Overall Study|lack of Compliance|6|||
164191792|NCT00985686|593069641|FG000|Overall Study|Lost to Follow-up|1|||
164191793|NCT00985686|593069642|FG001|Overall Study|Lost to Follow-up|1|||
164191794|NCT00985686|593069643|FG002|Overall Study|Lost to Follow-up|0|||
164191795|NCT00985686|593069644|FG003|Overall Study|Lost to Follow-up|2|||
164191796|NCT03046953|593069645|FG000|Overall Study|Relapse/progressive disease|21|||
164191797|NCT03046953|593069645|FG000|Overall Study|Death|2|||
164191798|NCT03046953|593069645|FG000|Overall Study|Withdrawal by Subject|3|||
164191799|NCT04039204|593069647|FG000|Overall Study|Withdrawal by Subject|0|||
164191800|NCT04039204|593069648|FG001|Overall Study|Withdrawal by Subject|2|||
164191801|NCT00396383|593069655|FG000|Overall Study|Death|2|||
164191802|NCT00396383|593069655|FG000|Overall Study|Lost to Follow-up|1|||
164191803|NCT01124292|593069656|FG000|Overall Study|Lost to Follow-up|2|||
164191804|NCT01124292|593069657|FG001|Overall Study|Lost to Follow-up|4|||
164191805|NCT01124292|593069658|FG002|Overall Study|Lost to Follow-up|3|||
164191806|NCT01124292|593069656|FG000|Overall Study|Physician Decision|0|||
164191807|NCT01124292|593069657|FG001|Overall Study|Physician Decision|3|||
164191808|NCT01124292|593069658|FG002|Overall Study|Physician Decision|2|||
164191809|NCT01124292|593069656|FG000|Overall Study|Withdrawal by Subject|0|||
164191810|NCT01124292|593069657|FG001|Overall Study|Withdrawal by Subject|6|||
164191811|NCT01124292|593069658|FG002|Overall Study|Withdrawal by Subject|2|||
164191812|NCT01124292|593069656|FG000|Overall Study|medical issue unrelated to the study|0|||
164191813|NCT01124292|593069657|FG001|Overall Study|medical issue unrelated to the study|0|||
164191814|NCT01124292|593069658|FG002|Overall Study|medical issue unrelated to the study|2|||
164191815|NCT01124292|593069656|FG000|Overall Study|piercing track closed|0|||
164191816|NCT01124292|593069657|FG001|Overall Study|piercing track closed|2|||
164191817|NCT01124292|593069658|FG002|Overall Study|piercing track closed|1|||
164191818|NCT01237327|593069659|FG000|Overall Study|Protocol Violation: Core Study|1|||
164191819|NCT01237327|593069660|FG001|Overall Study|Protocol Violation: Core Study|0|||
164191820|NCT01237327|593069659|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
164191821|NCT01237327|593069660|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
164191822|NCT01237327|593069659|FG000|Overall Study|Progression of Disease: Core Study|18|||
164191823|NCT01237327|593069660|FG001|Overall Study|Progression of Disease: Core Study|22|||
164191824|NCT01237327|593069659|FG000|Overall Study|Progression of Disease: Extension Study|15|||
164191825|NCT01237327|593069660|FG001|Overall Study|Progression of Disease: Extension Study|13|||
164191826|NCT01237327|593069659|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
164191827|NCT01237327|593069660|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
164191828|NCT01237327|593069659|FG000|Overall Study|Withdrawal by Subject|1|||
164302198|NCT01134055|593482562|FG006|Overall Study|Adverse Event|2|||
164653383|NCT01078623|594757101|FG010|Treatment Period 4|Withdrawal by Subject|0|||
164653384|NCT01078623|594757102|FG011|Treatment Period 4|Withdrawal by Subject|0|||
164653385|NCT01078623|594757103|FG012|Treatment Period 4|Withdrawal by Subject|0|||
164653386|NCT01078623|594757104|FG013|Treatment Period 4|Withdrawal by Subject|0|||
164653387|NCT01078623|594757105|FG014|Treatment Period 4|Withdrawal by Subject|0|||
164653388|NCT01078623|594757106|FG015|Treatment Period 4|Withdrawal by Subject|1|||
164653389|NCT01078623|594757107|FG016|Treatment Period 4|Withdrawal by Subject|0|||
164653390|NCT01078623|594757108|FG017|Treatment Period 4|Withdrawal by Subject|0|||
164191829|NCT01237327|593069660|FG001|Overall Study|Withdrawal by Subject|3|||
164191830|NCT01237327|593069659|FG000|Overall Study|Lost to Follow-up|3|||
164191831|NCT01237327|593069660|FG001|Overall Study|Lost to Follow-up|0|||
164191832|NCT02557516|593069661|FG000|Overall Study|Adverse Event|1|||
164191833|NCT02557516|593069662|FG001|Overall Study|Adverse Event|0|||
164191834|NCT02557516|593069663|FG002|Overall Study|Adverse Event|2|||
164191835|NCT02557516|593069664|FG003|Overall Study|Adverse Event|1|||
164191836|NCT02557516|593069661|FG000|Overall Study|Disease progression|0|||
164191837|NCT02557516|593069662|FG001|Overall Study|Disease progression|2|||
164191838|NCT02557516|593069663|FG002|Overall Study|Disease progression|0|||
164191839|NCT02557516|593069664|FG003|Overall Study|Disease progression|0|||
164191840|NCT02557516|593069661|FG000|Overall Study|Physician Decision|0|||
164191841|NCT02557516|593069662|FG001|Overall Study|Physician Decision|2|||
164191842|NCT02557516|593069663|FG002|Overall Study|Physician Decision|0|||
164191843|NCT02557516|593069664|FG003|Overall Study|Physician Decision|0|||
164191844|NCT02557516|593069661|FG000|Overall Study|Sponsor decision|0|||
164191845|NCT02557516|593069662|FG001|Overall Study|Sponsor decision|1|||
164191846|NCT02557516|593069663|FG002|Overall Study|Sponsor decision|2|||
164191847|NCT02557516|593069664|FG003|Overall Study|Sponsor decision|8|||
164191848|NCT01972464|593069665|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
164191849|NCT01972464|593069666|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
164191850|NCT01972464|593069665|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
164191851|NCT01972464|593069666|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
164191852|NCT01972464|593069665|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
164191853|NCT01972464|593069666|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
164191854|NCT01972464|593069665|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
164191855|NCT01972464|593069666|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
164191856|NCT02358031|593071861|FG000|Overall Study|Death|253|||
164191857|NCT02358031|593071862|FG001|Overall Study|Death|237|||
164191858|NCT02358031|593071863|FG002|Overall Study|Death|266|||
164191859|NCT02358031|593071861|FG000|Overall Study|Lost to Follow-up|1|||
164191860|NCT02358031|593071862|FG001|Overall Study|Lost to Follow-up|1|||
164191861|NCT02358031|593071863|FG002|Overall Study|Lost to Follow-up|0|||
164191862|NCT02358031|593071861|FG000|Overall Study|Withdrawal by Subject|19|||
164191863|NCT02358031|593071862|FG001|Overall Study|Withdrawal by Subject|14|||
164191864|NCT02358031|593071863|FG002|Overall Study|Withdrawal by Subject|18|||
164191865|NCT02358031|593071861|FG000|Overall Study|Sponsor Decision|26|||
164191866|NCT02358031|593071862|FG001|Overall Study|Sponsor Decision|28|||
164191867|NCT02358031|593071863|FG002|Overall Study|Sponsor Decision|16|||
164191868|NCT04980014|593071872|FG000|Overall Study|Participants who are Duplicated|1|||
164191869|NCT04980014|593071872|FG000|Overall Study|Follow-up Failure|13|||
164191870|NCT04980014|593071872|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
164191871|NCT04980014|593071872|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
164191872|NCT04980014|593071872|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
164191873|NCT00940888|593071873|FG000|Overall Study|Unsuccessful Implant|4|||
164191874|NCT00940888|593071873|FG000|Overall Study|Death|461|||
164191875|NCT00940888|593071873|FG000|Overall Study|Withdrawn - Non-Death|364|||
164191876|NCT00940888|593071873|FG000|Overall Study|Lost to Follow-up|6|||
164191877|NCT01409915|593071877|FG000|Overall Study|Adverse Event|0|||
164191878|NCT01409915|593071878|FG001|Overall Study|Adverse Event|2|||
164191879|NCT01409915|593071877|FG000|Overall Study|Withdrawal by Subject|0|||
164191880|NCT01409915|593071878|FG001|Overall Study|Withdrawal by Subject|1|||
164191881|NCT01409915|593071877|FG000|Overall Study|Protocol Violation|1|||
164191882|NCT01409915|593071878|FG001|Overall Study|Protocol Violation|0|||
164191883|NCT02250300|593071882|FG000|Expansion Phase|Death|6|||
164191884|NCT02250300|593071883|FG001|Expansion Phase|Death|7|||
164191885|NCT02250300|593071884|FG002|Expansion Phase|Death|0|||
164191886|NCT02250300|593071885|FG003|Expansion Phase|Death|0|||
164191887|NCT00715559|593071887|FG000|Overall Study|medication not tolerated - nausea|1|||
164191888|NCT00758498|593071888|FG000|Overall Study|Adverse Event|2|||
164191889|NCT00758498|593071889|FG001|Overall Study|Adverse Event|2|||
164191890|NCT00758498|593071890|FG002|Overall Study|Adverse Event|3|||
164191891|NCT00758498|593071888|FG000|Overall Study|Subject legally detained out of state|1|||
164191892|NCT00758498|593071889|FG001|Overall Study|Subject legally detained out of state|0|||
164191893|NCT00758498|593071890|FG002|Overall Study|Subject legally detained out of state|0|||
164191894|NCT00758498|593071888|FG000|Overall Study|Withdrawal by Subject|0|||
164191895|NCT00758498|593071889|FG001|Overall Study|Withdrawal by Subject|0|||
164191896|NCT00758498|593071890|FG002|Overall Study|Withdrawal by Subject|1|||
164191897|NCT00758498|593071888|FG000|Overall Study|Noncompliance to study procedures|0|||
164191898|NCT00758498|593071889|FG001|Overall Study|Noncompliance to study procedures|0|||
164191899|NCT00758498|593071890|FG002|Overall Study|Noncompliance to study procedures|1|||
164191900|NCT01845597|593071891|FG000|Overall Study|Death|8|||
164191901|NCT01845597|593071891|FG000|Overall Study|Lost to Follow-up|22|||
164191902|NCT01516736|593071895|FG000|Overall Study|Withdrawal by Subject|10|||
164191903|NCT01516736|593071896|FG001|Overall Study|Withdrawal by Subject|4|||
164191904|NCT01516736|593071895|FG000|Overall Study|Adverse Event|4|||
164191905|NCT01516736|593071896|FG001|Overall Study|Adverse Event|5|||
164191906|NCT01516736|593071895|FG000|Overall Study|Death|3|||
164191907|NCT01516736|593071896|FG001|Overall Study|Death|1|||
164191908|NCT01516736|593071895|FG000|Overall Study|Physician Decision|2|||
164191909|NCT01516736|593071896|FG001|Overall Study|Physician Decision|1|||
164191910|NCT01516736|593071895|FG000|Overall Study|Lack of Efficacy|1|||
164191911|NCT01516736|593071896|FG001|Overall Study|Lack of Efficacy|0|||
164191912|NCT01516736|593071895|FG000|Overall Study|Protocol Violation|0|||
164191913|NCT01516736|593071896|FG001|Overall Study|Protocol Violation|1|||
164191914|NCT01516736|593071895|FG000|Overall Study|Other (not specified)|0|||
164191915|NCT01516736|593071896|FG001|Overall Study|Other (not specified)|1|||
164191916|NCT00524771|593071899|FG000|Overall Study|Protocol Violation|220|||
164191917|NCT00524771|593071900|FG001|Overall Study|Protocol Violation|585|||
164191918|NCT02781818|593071901|FG000|Overall Study|Lost to Follow-up|4|||
164191919|NCT02781818|593071902|FG001|Overall Study|Lost to Follow-up|2|||
164191920|NCT02781818|593071903|FG002|Overall Study|Lost to Follow-up|1|||
164191921|NCT01877668|593071904|FG000|Overall Study|Death|0|||
164191922|NCT01877668|593071905|FG001|Overall Study|Death|0|||
164191923|NCT01877668|593071906|FG002|Overall Study|Death|0|||
164191924|NCT01877668|593071907|FG003|Overall Study|Death|1|||
164191925|NCT01877668|593071908|FG004|Overall Study|Death|0|||
164191926|NCT01877668|593071904|FG000|Overall Study|No longer met study criteria|1|||
164191927|NCT01877668|593071905|FG001|Overall Study|No longer met study criteria|0|||
164191928|NCT01877668|593071906|FG002|Overall Study|No longer met study criteria|1|||
164191929|NCT01877668|593071907|FG003|Overall Study|No longer met study criteria|0|||
164191930|NCT01877668|593071908|FG004|Overall Study|No longer met study criteria|0|||
164191931|NCT01877668|593071904|FG000|Overall Study|Insufficient clinical response|0|||
164191932|NCT01877668|593071905|FG001|Overall Study|Insufficient clinical response|1|||
164191933|NCT01877668|593071906|FG002|Overall Study|Insufficient clinical response|2|||
164191934|NCT01877668|593071907|FG003|Overall Study|Insufficient clinical response|2|||
164191935|NCT01877668|593071908|FG004|Overall Study|Insufficient clinical response|0|||
164191936|NCT01877668|593071904|FG000|Overall Study|Lost to Follow-up|0|||
164191937|NCT01877668|593071905|FG001|Overall Study|Lost to Follow-up|2|||
164191938|NCT01877668|593071906|FG002|Overall Study|Lost to Follow-up|1|||
164191939|NCT01877668|593071907|FG003|Overall Study|Lost to Follow-up|0|||
164191940|NCT01877668|593071908|FG004|Overall Study|Lost to Follow-up|0|||
164191941|NCT01877668|593071904|FG000|Overall Study|Withdrawal by Subject|2|||
164191942|NCT01877668|593071905|FG001|Overall Study|Withdrawal by Subject|0|||
164191943|NCT01877668|593071906|FG002|Overall Study|Withdrawal by Subject|3|||
164191944|NCT01877668|593071907|FG003|Overall Study|Withdrawal by Subject|2|||
164191945|NCT01877668|593071908|FG004|Overall Study|Withdrawal by Subject|2|||
164191946|NCT01877668|593071904|FG000|Overall Study|Other|1|||
164191947|NCT01877668|593071905|FG001|Overall Study|Other|1|||
164191948|NCT01877668|593071906|FG002|Overall Study|Other|1|||
164191949|NCT01877668|593071907|FG003|Overall Study|Other|1|||
164191950|NCT01877668|593071908|FG004|Overall Study|Other|3|||
164191951|NCT01877668|593071904|FG000|Overall Study|Protocol Violation|1|||
164191952|NCT01877668|593071905|FG001|Overall Study|Protocol Violation|1|||
164191953|NCT01877668|593071906|FG002|Overall Study|Protocol Violation|0|||
164191954|NCT01877668|593071907|FG003|Overall Study|Protocol Violation|0|||
164191955|NCT01877668|593071908|FG004|Overall Study|Protocol Violation|3|||
164191956|NCT01877668|593071904|FG000|Overall Study|Adverse event related to study drug|2|||
164191957|NCT01877668|593071905|FG001|Overall Study|Adverse event related to study drug|2|||
164191958|NCT01877668|593071906|FG002|Overall Study|Adverse event related to study drug|2|||
164191959|NCT01877668|593071907|FG003|Overall Study|Adverse event related to study drug|2|||
164191960|NCT01877668|593071908|FG004|Overall Study|Adverse event related to study drug|1|||
164191961|NCT01877668|593071904|FG000|Overall Study|Adverse event unrelated to study drug|4|||
164191962|NCT01877668|593071905|FG001|Overall Study|Adverse event unrelated to study drug|1|||
164191963|NCT01877668|593071906|FG002|Overall Study|Adverse event unrelated to study drug|2|||
164191964|NCT01877668|593071907|FG003|Overall Study|Adverse event unrelated to study drug|0|||
164191965|NCT01877668|593071908|FG004|Overall Study|Adverse event unrelated to study drug|1|||
164191966|NCT02317991|593071909|FG000|Overall Study|Adverse Event|12|||
164191967|NCT02317991|593071909|FG000|Overall Study|Death|4|||
164191968|NCT02317991|593071909|FG000|Overall Study|Withdrawal by Subject|8|||
164191969|NCT02317991|593071909|FG000|Overall Study|Progressive Disease|41|||
164191970|NCT01223404|593071910|FG000|First Intervention (1 Day)|Adverse Event|0|||
164191971|NCT01223404|593071911|FG001|First Intervention (1 Day)|Adverse Event|0|||
164191972|NCT01223404|593071912|FG002|First Intervention (1 Day)|Adverse Event|0|||
164191973|NCT01223404|593071913|FG003|First Intervention (1 Day)|Adverse Event|1|||
164191974|NCT01223404|593071914|FG004|First Intervention (1 Day)|Adverse Event|0|||
164191975|NCT01223404|593071915|FG005|First Intervention (1 Day)|Adverse Event|0|||
164191976|NCT01223404|593071910|FG000|Second Intervention (1 Day)|Adverse Event|1|||
164191977|NCT01223404|593071911|FG001|Second Intervention (1 Day)|Adverse Event|0|||
164191978|NCT01223404|593071912|FG002|Second Intervention (1 Day)|Adverse Event|0|||
164191979|NCT01223404|593071913|FG003|Second Intervention (1 Day)|Adverse Event|0|||
164191980|NCT01223404|593071914|FG004|Second Intervention (1 Day)|Adverse Event|0|||
164191981|NCT01223404|593071915|FG005|Second Intervention (1 Day)|Adverse Event|0|||
164191982|NCT01223404|593071910|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
164191983|NCT01223404|593071911|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
164191984|NCT01223404|593071912|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
164191985|NCT01223404|593071913|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
164191986|NCT01223404|593071914|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
164191987|NCT01223404|593071915|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
164191988|NCT02492165|593071916|FG000|Overall Study|Withdrawal by Subject|0|||
164191989|NCT02492165|593071917|FG001|Overall Study|Withdrawal by Subject|1|||
164191990|NCT02492165|593071918|FG002|Overall Study|Withdrawal by Subject|0|||
164191991|NCT02492165|593071919|FG003|Overall Study|Withdrawal by Subject|0|||
164191992|NCT00707057|593071920|FG000|Overall Study|Withdrawal by Subject|8|||
164191993|NCT00707057|593071921|FG001|Overall Study|Withdrawal by Subject|3|||
164191994|NCT00707057|593071920|FG000|Overall Study|Dosed incorrectly|0|||
164191995|NCT00707057|593071921|FG001|Overall Study|Dosed incorrectly|1|||
164191996|NCT01697800|593071922|FG000|Overall Study|Death|0|||
164191997|NCT01697800|593071923|FG001|Overall Study|Death|1|||
164191998|NCT00954122|593071924|FG000|Overall Study|Withdrawal by Subject|5|||
164191999|NCT00954122|593071924|FG000|Overall Study|Adverse Event|1|||
164192000|NCT00954122|593071924|FG000|Overall Study|Safety Reason|1|||
164192001|NCT01957579|593071929|FG000|Overall Study|Withdrawal of concent|0|||
164192002|NCT01957579|593071930|FG001|Overall Study|Withdrawal of concent|1|||
164192003|NCT01957579|593071931|FG002|Overall Study|Withdrawal of concent|0|||
164192004|NCT01957579|593071932|FG003|Overall Study|Withdrawal of concent|0|||
164192005|NCT01957579|593071929|FG000|Overall Study|Death|0|||
164192006|NCT01957579|593071930|FG001|Overall Study|Death|0|||
164192007|NCT01957579|593071931|FG002|Overall Study|Death|2|||
164192008|NCT01957579|593071932|FG003|Overall Study|Death|0|||
164192009|NCT02019550|593071933|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
164192010|NCT02019550|593071934|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
164192011|NCT02750332|593071936|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164192012|NCT02750332|593071937|FG001|Treatment Period 1|Withdrawal by Subject|1|||
164192013|NCT00823134|593071943|FG000|Overall Study|Invalid measurement|1|||
164192014|NCT03316586|593071954|FG000|Overall Study|Adverse Event|2|||
164192015|NCT03316586|593071954|FG000|Overall Study|Physician Decision|3|||
164192016|NCT03316586|593071954|FG000|Overall Study|Lack of Efficacy|10|||
164192017|NCT03316586|593071954|FG000|Overall Study|still on treatment|1|||
164192018|NCT03316586|593071954|FG000|Overall Study|Patient needed radiation therapy|1|||
164192019|NCT03316586|593071954|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
164192020|NCT00994110|593071955|FG000|Overall Study|Withdrawal by Subject|9|||
164192021|NCT00994110|593071956|FG001|Overall Study|Withdrawal by Subject|9|||
164192022|NCT00994110|593071955|FG000|Overall Study|Not Treated|4|||
164192023|NCT00994110|593071956|FG001|Overall Study|Not Treated|8|||
164192024|NCT00994110|593071955|FG000|Overall Study|Adverse Event|1|||
164192025|NCT00994110|593071956|FG001|Overall Study|Adverse Event|0|||
164192026|NCT00994110|593071955|FG000|Overall Study|Patient not resected|41|||
164192027|NCT00994110|593071956|FG001|Overall Study|Patient not resected|52|||
164192028|NCT00994110|593071955|FG000|Overall Study|Pt not eligible|10|||
164192029|NCT00994110|593071956|FG001|Overall Study|Pt not eligible|5|||
164192030|NCT00619827|593071957|FG000|Overall Study|Adverse Event|1|||
164192031|NCT00619827|593071958|FG001|Overall Study|Adverse Event|2|||
164192032|NCT00619827|593071957|FG000|Overall Study|Withdrawal by Subject|2|||
164192033|NCT00619827|593071958|FG001|Overall Study|Withdrawal by Subject|2|||
164192034|NCT02806713|593071959|FG000|Overall Study|Urethral injury during procedure|1|||
164192035|NCT02806713|593071960|FG001|Overall Study|Urethral injury during procedure|0|||
164192036|NCT02806713|593071959|FG000|Overall Study|cancelled surgery|1|||
164192037|NCT02806713|593071960|FG001|Overall Study|cancelled surgery|2|||
164192038|NCT02163395|593071961|FG000|Overall Study|Withdrawal by Subject|1|||
164192039|NCT02163395|593071961|FG000|Overall Study|Lost to Follow-up|3|||
164192040|NCT02163395|593071961|FG000|Overall Study|Adverse Event|1|||
164192041|NCT04878055|593071962|FG000|Overall Study|Patient transferred in another department|0|||
164192042|NCT04878055|593071963|FG001|Overall Study|Patient transferred in another department|2|||
164192043|NCT04878055|593071962|FG000|Overall Study|Physician Decision|1|||
164543680|NCT01994382|594362827|FG011|Overall Study|Protocol violation/noncompliance|1|||
164543681|NCT01994382|594362828|FG012|Overall Study|Protocol violation/noncompliance|0|||
164543682|NCT01994382|594362829|FG013|Overall Study|Protocol violation/noncompliance|0|||
164192044|NCT04878055|593071963|FG001|Overall Study|Physician Decision|1|||
164192045|NCT04878055|593071962|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
164192046|NCT04878055|593071963|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
164192047|NCT04878055|593071962|FG000|Overall Study|Adverse Event|12|||
164192048|NCT04878055|593071963|FG001|Overall Study|Adverse Event|7|||
164192049|NCT04878055|593071962|FG000|Overall Study|Other|5|||
164192050|NCT04878055|593071963|FG001|Overall Study|Other|0|||
164192051|NCT04878055|593071962|FG000|Overall Study|Withdrawal by Subject|7|||
164192052|NCT04878055|593071963|FG001|Overall Study|Withdrawal by Subject|3|||
164192053|NCT04878055|593071962|FG000|Overall Study|Lost to Follow-up|10|||
164192054|NCT04878055|593071963|FG001|Overall Study|Lost to Follow-up|1|||
164192055|NCT01968811|593071964|FG000|Overall Study|Protocol Violation|4|||
164192056|NCT01968811|593071964|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
164192057|NCT01178125|593071966|FG000|Overall Study|Lost to Follow-up|397|||
164192058|NCT01178125|593071966|FG000|Overall Study|Adverse Event|244|||
164192059|NCT01178125|593071966|FG000|Overall Study|Withdrawal by Subject|209|||
164192060|NCT01178125|593071966|FG000|Overall Study|Noncompliance|184|||
164192061|NCT01178125|593071966|FG000|Overall Study|Pregnancy|55|||
164192062|NCT01178125|593071966|FG000|Overall Study|Other Reason|39|||
164192063|NCT01178125|593071966|FG000|Overall Study|Sponsor Decision|28|||
164192064|NCT01178125|593071966|FG000|Overall Study|Protocol Violation|17|||
164192065|NCT01178125|593071966|FG000|Overall Study|Investigator Decision|5|||
164192066|NCT01004978|593071967|FG000|Overall Study|Disease progression|31|||
164192067|NCT01004978|593071968|FG001|Overall Study|Disease progression|48|||
164192068|NCT01004978|593071967|FG000|Overall Study|Adverse Event|42|||
164192069|NCT01004978|593071968|FG001|Overall Study|Adverse Event|22|||
164192070|NCT01004978|593071967|FG000|Overall Study|Death|3|||
164192071|NCT01004978|593071968|FG001|Overall Study|Death|2|||
164192072|NCT01004978|593071967|FG000|Overall Study|Withdrawal by Subject|16|||
164192073|NCT01004978|593071968|FG001|Overall Study|Withdrawal by Subject|16|||
164192074|NCT01004978|593071967|FG000|Overall Study|Alternative therapy|4|||
164192075|NCT01004978|593071968|FG001|Overall Study|Alternative therapy|8|||
164192076|NCT01004978|593071967|FG000|Overall Study|Physician Decision|6|||
164192077|NCT01004978|593071968|FG001|Overall Study|Physician Decision|3|||
164192078|NCT01004978|593071967|FG000|Overall Study|Other complicating disease|2|||
164192079|NCT01004978|593071968|FG001|Overall Study|Other complicating disease|2|||
164192080|NCT01004978|593071967|FG000|Overall Study|Protocol Violation|2|||
164192081|NCT01004978|593071968|FG001|Overall Study|Protocol Violation|3|||
164192082|NCT01004978|593071967|FG000|Overall Study|Non-compliance|3|||
164192083|NCT01004978|593071968|FG001|Overall Study|Non-compliance|2|||
164192084|NCT01004978|593071967|FG000|Overall Study|Ineligible|1|||
164192085|NCT01004978|593071968|FG001|Overall Study|Ineligible|0|||
164192086|NCT01004978|593071967|FG000|Overall Study|Unblinded|0|||
164192087|NCT01004978|593071968|FG001|Overall Study|Unblinded|1|||
164192088|NCT01004978|593071967|FG000|Overall Study|Performance status worsening|0|||
164192089|NCT01004978|593071968|FG001|Overall Study|Performance status worsening|1|||
164192090|NCT01004978|593071967|FG000|Overall Study|Never started treatment|8|||
164192091|NCT01004978|593071968|FG001|Overall Study|Never started treatment|9|||
164192092|NCT00369915|593071969|FG000|Overall Study|expected side effects|2|||
164192093|NCT00369915|593071970|FG001|Overall Study|expected side effects|1|||
164192094|NCT00369915|593071969|FG000|Overall Study|Withdrawal by Subject|4|||
164192095|NCT00369915|593071970|FG001|Overall Study|Withdrawal by Subject|1|||
164192096|NCT00369915|593071969|FG000|Overall Study|W/drawl by investigators|0|||
164192097|NCT00369915|593071970|FG001|Overall Study|W/drawl by investigators|1|||
164192098|NCT00268983|593071976|FG000|Overall Study|Death|3|||
164192099|NCT00268983|593071977|FG001|Overall Study|Death|0|||
164192100|NCT02532374|593071980|FG000|Overall Study|Withdrawal by Subject|1|||
164192101|NCT02532374|593071980|FG000|Overall Study|Physician Decision|1|||
164192102|NCT01089127|593071981|FG000|Overall Study|Adverse Event|5|||
164192103|NCT01089127|593071982|FG001|Overall Study|Adverse Event|1|||
164192104|NCT01089127|593071983|FG002|Overall Study|Adverse Event|1|||
164192105|NCT01089127|593071984|FG003|Overall Study|Adverse Event|0|||
164192106|NCT01089127|593071985|FG004|Overall Study|Adverse Event|0|||
164192107|NCT01089127|593071986|FG005|Overall Study|Adverse Event|1|||
164192108|NCT01089127|593071981|FG000|Overall Study|Subject withdrew consent|0|||
164192109|NCT01089127|593071982|FG001|Overall Study|Subject withdrew consent|1|||
164192110|NCT01089127|593071983|FG002|Overall Study|Subject withdrew consent|1|||
164192111|NCT01089127|593071984|FG003|Overall Study|Subject withdrew consent|1|||
164192112|NCT01089127|593071985|FG004|Overall Study|Subject withdrew consent|0|||
164192113|NCT01089127|593071986|FG005|Overall Study|Subject withdrew consent|2|||
164192114|NCT01089127|593071981|FG000|Overall Study|Abnormal test procedure result(s)|2|||
164192115|NCT01089127|593071982|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164192116|NCT01089127|593071983|FG002|Overall Study|Abnormal test procedure result(s)|0|||
164192117|NCT01089127|593071984|FG003|Overall Study|Abnormal test procedure result(s)|0|||
164192118|NCT01089127|593071985|FG004|Overall Study|Abnormal test procedure result(s)|0|||
164192119|NCT01089127|593071986|FG005|Overall Study|Abnormal test procedure result(s)|0|||
164192120|NCT01089127|593071981|FG000|Overall Study|Lost to Follow-up|1|||
164192121|NCT01089127|593071982|FG001|Overall Study|Lost to Follow-up|1|||
164192122|NCT01089127|593071983|FG002|Overall Study|Lost to Follow-up|0|||
164192123|NCT01089127|593071984|FG003|Overall Study|Lost to Follow-up|0|||
164192124|NCT01089127|593071985|FG004|Overall Study|Lost to Follow-up|1|||
164192125|NCT01089127|593071986|FG005|Overall Study|Lost to Follow-up|0|||
164192126|NCT01089127|593071981|FG000|Overall Study|Protocol deviation|0|||
164192127|NCT01089127|593071982|FG001|Overall Study|Protocol deviation|1|||
164192128|NCT01089127|593071983|FG002|Overall Study|Protocol deviation|0|||
164192129|NCT01089127|593071984|FG003|Overall Study|Protocol deviation|0|||
164192130|NCT01089127|593071985|FG004|Overall Study|Protocol deviation|1|||
164192131|NCT01089127|593071986|FG005|Overall Study|Protocol deviation|0|||
164192132|NCT00511810|593071989|FG000|Overall Study|Lost to Follow-up|1|||
164192133|NCT00511810|593071990|FG001|Overall Study|Lost to Follow-up|2|||
164192134|NCT00511810|593071989|FG000|Overall Study|Lack of Efficacy|0|||
164192135|NCT00511810|593071990|FG001|Overall Study|Lack of Efficacy|2|||
164192136|NCT00511810|593071989|FG000|Overall Study|Refused second scn|0|||
164192137|NCT00511810|593071990|FG001|Overall Study|Refused second scn|1|||
164192138|NCT02659943|593071991|FG000|Overall Study|Switched to alternative treatment|1|||
164192139|NCT02659943|593071992|FG001|Overall Study|Switched to alternative treatment|1|||
164192140|NCT02659943|593071993|FG002|Overall Study|Switched to alternative treatment|0|||
164192141|NCT02659943|593071994|FG003|Overall Study|Switched to alternative treatment|2|||
164192142|NCT02659943|593071995|FG004|Overall Study|Switched to alternative treatment|1|||
164192143|NCT02659943|593071996|FG005|Overall Study|Switched to alternative treatment|0|||
164192144|NCT02659943|593071997|FG006|Overall Study|Switched to alternative treatment|1|||
164192145|NCT02659943|593071991|FG000|Overall Study|Disease progression on study|0|||
164192146|NCT02659943|593071992|FG001|Overall Study|Disease progression on study|1|||
164192147|NCT02659943|593071993|FG002|Overall Study|Disease progression on study|1|||
164192148|NCT02659943|593071994|FG003|Overall Study|Disease progression on study|1|||
164192149|NCT02659943|593071995|FG004|Overall Study|Disease progression on study|1|||
164192150|NCT02659943|593071996|FG005|Overall Study|Disease progression on study|4|||
164192151|NCT02659943|593071997|FG006|Overall Study|Disease progression on study|0|||
164192152|NCT02659943|593071991|FG000|Overall Study|Patient's condition per principal investigator|0|||
164192153|NCT02659943|593071992|FG001|Overall Study|Patient's condition per principal investigator|0|||
164192154|NCT02659943|593071993|FG002|Overall Study|Patient's condition per principal investigator|0|||
164192155|NCT02659943|593071994|FG003|Overall Study|Patient's condition per principal investigator|0|||
164192156|NCT02659943|593071995|FG004|Overall Study|Patient's condition per principal investigator|0|||
164192157|NCT02659943|593071996|FG005|Overall Study|Patient's condition per principal investigator|1|||
164192158|NCT02659943|593071997|FG006|Overall Study|Patient's condition per principal investigator|0|||
164192159|NCT02659943|593071991|FG000|Overall Study|Ineligible|0|||
164192160|NCT02659943|593071992|FG001|Overall Study|Ineligible|0|||
164192161|NCT02659943|593071993|FG002|Overall Study|Ineligible|0|||
164192162|NCT02659943|593071994|FG003|Overall Study|Ineligible|0|||
164192163|NCT02659943|593071995|FG004|Overall Study|Ineligible|0|||
164192164|NCT02659943|593071996|FG005|Overall Study|Ineligible|0|||
164192165|NCT02659943|593071997|FG006|Overall Study|Ineligible|1|||
164192166|NCT02659943|593071991|FG000|Overall Study|No longer meets eligibility|0|||
164192167|NCT02659943|593071992|FG001|Overall Study|No longer meets eligibility|0|||
164192168|NCT02659943|593071993|FG002|Overall Study|No longer meets eligibility|0|||
164192169|NCT02659943|593071994|FG003|Overall Study|No longer meets eligibility|0|||
164192170|NCT02659943|593071995|FG004|Overall Study|No longer meets eligibility|0|||
164192171|NCT02659943|593071996|FG005|Overall Study|No longer meets eligibility|0|||
164192172|NCT02659943|593071997|FG006|Overall Study|No longer meets eligibility|1|||
164192173|NCT02659943|593071991|FG000|Overall Study|No treatment, per protocol|0|||
164192174|NCT02659943|593071992|FG001|Overall Study|No treatment, per protocol|0|||
164192175|NCT02659943|593071993|FG002|Overall Study|No treatment, per protocol|0|||
164192176|NCT02659943|593071994|FG003|Overall Study|No treatment, per protocol|0|||
164192177|NCT02659943|593071995|FG004|Overall Study|No treatment, per protocol|0|||
164192178|NCT02659943|593071996|FG005|Overall Study|No treatment, per protocol|0|||
164192179|NCT02659943|593071997|FG006|Overall Study|No treatment, per protocol|3|||
164192180|NCT01096160|593072001|FG000|Overall Study|Adverse Event|0|||
164192181|NCT01096160|593072002|FG001|Overall Study|Adverse Event|0|||
164192182|NCT01096160|593072003|FG002|Overall Study|Adverse Event|1|||
164192183|NCT01096160|593072004|FG003|Overall Study|Adverse Event|0|||
164192184|NCT01096160|593072005|FG004|Overall Study|Adverse Event|0|||
164192185|NCT01096160|593072006|FG005|Overall Study|Adverse Event|0|||
164192186|NCT01096160|593072007|FG006|Overall Study|Adverse Event|0|||
164192187|NCT01096160|593072008|FG007|Overall Study|Adverse Event|0|||
164192188|NCT01096160|593072009|FG008|Overall Study|Adverse Event|0|||
164192189|NCT01096160|593072010|FG009|Overall Study|Adverse Event|1|||
164192190|NCT01096160|593072001|FG000|Overall Study|Met stopping criteria per protocol|0|||
164192191|NCT01096160|593072002|FG001|Overall Study|Met stopping criteria per protocol|0|||
164192192|NCT01096160|593072003|FG002|Overall Study|Met stopping criteria per protocol|0|||
164192193|NCT01096160|593072004|FG003|Overall Study|Met stopping criteria per protocol|0|||
164192194|NCT01096160|593072005|FG004|Overall Study|Met stopping criteria per protocol|1|||
164192195|NCT01096160|593072006|FG005|Overall Study|Met stopping criteria per protocol|0|||
164192196|NCT01096160|593072007|FG006|Overall Study|Met stopping criteria per protocol|2|||
164192197|NCT01096160|593072008|FG007|Overall Study|Met stopping criteria per protocol|0|||
164192198|NCT01096160|593072009|FG008|Overall Study|Met stopping criteria per protocol|2|||
164192199|NCT01096160|593072010|FG009|Overall Study|Met stopping criteria per protocol|0|||
164192200|NCT04767373|593072014|FG000|Overall Study|Death|6|||
164192201|NCT04767373|593072015|FG001|Overall Study|Death|3|||
164192202|NCT04767373|593072014|FG000|Overall Study|Lost to Follow-up|67|||
164192203|NCT04767373|593072015|FG001|Overall Study|Lost to Follow-up|35|||
164192204|NCT04767373|593072014|FG000|Overall Study|Physician Decision|15|||
164192205|NCT04767373|593072015|FG001|Overall Study|Physician Decision|4|||
164192206|NCT04767373|593072014|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164192207|NCT04767373|593072015|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
164192208|NCT04767373|593072014|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
164192209|NCT04767373|593072015|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
164192210|NCT04767373|593072014|FG000|Overall Study|Other|1|||
164192211|NCT04767373|593072015|FG001|Overall Study|Other|2|||
164192212|NCT02472886|593072030|FG000|Overall Study|Lack of Efficacy|0|||
164192213|NCT02472886|593072031|FG001|Overall Study|Lack of Efficacy|2|||
164192214|NCT02472886|593072032|FG002|Overall Study|Lack of Efficacy|1|||
164192215|NCT04346199|593072033|FG000|Overall Study|Death|8|||
164192216|NCT04346199|593072034|FG001|Overall Study|Death|9|||
164192217|NCT04346199|593072033|FG000|Overall Study|Lost to Follow-up|0|||
164192218|NCT04346199|593072034|FG001|Overall Study|Lost to Follow-up|1|||
164192219|NCT04346199|593072033|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
164192220|NCT04346199|593072034|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
164192221|NCT04346199|593072033|FG000|Overall Study|Withdrawal by Subject|5|||
164192222|NCT04346199|593072034|FG001|Overall Study|Withdrawal by Subject|1|||
164192223|NCT04533438|593072035|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
164192224|NCT04533438|593072036|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
164192225|NCT05568797|593072037|FG000|Overall Study|Adverse Event|0|||
164192226|NCT05568797|593072038|FG001|Overall Study|Adverse Event|8|||
164192227|NCT05568797|593072037|FG000|Overall Study|Lost to Follow-up|2|||
164192228|NCT05568797|593072038|FG001|Overall Study|Lost to Follow-up|3|||
164192229|NCT05568797|593072037|FG000|Overall Study|Withdrawal by Subject|1|||
164192230|NCT05568797|593072038|FG001|Overall Study|Withdrawal by Subject|10|||
164192231|NCT05568797|593072037|FG000|Overall Study|Other|2|||
164192232|NCT05568797|593072038|FG001|Overall Study|Other|2|||
164192233|NCT00099632|593072039|FG000|Overall Study|Lost to Follow-up|1|||
164192234|NCT00099632|593072040|FG001|Overall Study|Lost to Follow-up|0|||
164192235|NCT00099632|593072041|FG002|Overall Study|Lost to Follow-up|3|||
164192236|NCT00099632|593072042|FG003|Overall Study|Lost to Follow-up|1|||
164192237|NCT00099632|593072043|FG004|Overall Study|Lost to Follow-up|1|||
164192238|NCT00099632|593072044|FG005|Overall Study|Lost to Follow-up|0|||
164192239|NCT00099632|593072039|FG000|Overall Study|Withdrawal by Subject|0|||
164192240|NCT00099632|593072040|FG001|Overall Study|Withdrawal by Subject|1|||
164192241|NCT00099632|593072041|FG002|Overall Study|Withdrawal by Subject|0|||
164192242|NCT00099632|593072042|FG003|Overall Study|Withdrawal by Subject|0|||
164192243|NCT00099632|593072043|FG004|Overall Study|Withdrawal by Subject|0|||
164192244|NCT00099632|593072044|FG005|Overall Study|Withdrawal by Subject|1|||
164192245|NCT00099632|593072039|FG000|Overall Study|Protocol Violation|0|||
164192246|NCT00099632|593072040|FG001|Overall Study|Protocol Violation|0|||
164192247|NCT00099632|593072041|FG002|Overall Study|Protocol Violation|0|||
164192248|NCT00099632|593072042|FG003|Overall Study|Protocol Violation|0|||
164192249|NCT00099632|593072043|FG004|Overall Study|Protocol Violation|0|||
164192250|NCT00099632|593072044|FG005|Overall Study|Protocol Violation|1|||
164192251|NCT03131687|593072045|FG000|Overall Study|Adverse Event|0|||
164192252|NCT03131687|593072046|FG001|Overall Study|Adverse Event|1|||
164192253|NCT03131687|593072047|FG002|Overall Study|Adverse Event|0|||
164192254|NCT03131687|593072048|FG003|Overall Study|Adverse Event|1|||
164192255|NCT03131687|593072049|FG004|Overall Study|Adverse Event|2|||
164192256|NCT03131687|593072050|FG005|Overall Study|Adverse Event|2|||
164192257|NCT03131687|593072045|FG000|Overall Study|Death|1|||
164192258|NCT03131687|593072046|FG001|Overall Study|Death|0|||
164192259|NCT03131687|593072047|FG002|Overall Study|Death|0|||
164192260|NCT03131687|593072048|FG003|Overall Study|Death|0|||
164192261|NCT03131687|593072049|FG004|Overall Study|Death|0|||
164192262|NCT03131687|593072050|FG005|Overall Study|Death|0|||
164192263|NCT03131687|593072045|FG000|Overall Study|Withdrawal by Subject|3|||
164192264|NCT03131687|593072046|FG001|Overall Study|Withdrawal by Subject|3|||
164192265|NCT03131687|593072047|FG002|Overall Study|Withdrawal by Subject|3|||
164192266|NCT03131687|593072048|FG003|Overall Study|Withdrawal by Subject|1|||
164192267|NCT03131687|593072049|FG004|Overall Study|Withdrawal by Subject|2|||
164192268|NCT03131687|593072050|FG005|Overall Study|Withdrawal by Subject|1|||
164192269|NCT03131687|593072045|FG000|Overall Study|Lost to Follow-up|1|||
164192270|NCT03131687|593072046|FG001|Overall Study|Lost to Follow-up|4|||
164192271|NCT03131687|593072047|FG002|Overall Study|Lost to Follow-up|0|||
164192272|NCT03131687|593072048|FG003|Overall Study|Lost to Follow-up|1|||
164192273|NCT03131687|593072049|FG004|Overall Study|Lost to Follow-up|4|||
164192274|NCT03131687|593072050|FG005|Overall Study|Lost to Follow-up|2|||
164192275|NCT03131687|593072045|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
164192276|NCT03131687|593072046|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
164192277|NCT03131687|593072047|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
164192278|NCT03131687|593072048|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
164192279|NCT03131687|593072049|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
164192280|NCT03131687|593072050|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
164192281|NCT03131687|593072045|FG000|Overall Study|Principle Investigator Decision|0|||
164192282|NCT03131687|593072046|FG001|Overall Study|Principle Investigator Decision|1|||
164192283|NCT03131687|593072047|FG002|Overall Study|Principle Investigator Decision|0|||
164192284|NCT03131687|593072048|FG003|Overall Study|Principle Investigator Decision|0|||
164192285|NCT03131687|593072049|FG004|Overall Study|Principle Investigator Decision|0|||
164192286|NCT03131687|593072050|FG005|Overall Study|Principle Investigator Decision|0|||
164192287|NCT03131687|593072045|FG000|Overall Study|Inadvertent Enrollment|0|||
164192288|NCT03131687|593072046|FG001|Overall Study|Inadvertent Enrollment|0|||
164192289|NCT03131687|593072047|FG002|Overall Study|Inadvertent Enrollment|0|||
164192290|NCT03131687|593072048|FG003|Overall Study|Inadvertent Enrollment|1|||
164192291|NCT03131687|593072049|FG004|Overall Study|Inadvertent Enrollment|0|||
164192292|NCT03131687|593072050|FG005|Overall Study|Inadvertent Enrollment|0|||
164192293|NCT02137226|593072051|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
164192294|NCT02137226|593072052|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
164192295|NCT02137226|593072053|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
164192296|NCT02137226|593072054|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
164192297|NCT02137226|593072055|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
164192298|NCT02137226|593072051|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
164192299|NCT02137226|593072052|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
164192300|NCT02137226|593072053|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
164192301|NCT02137226|593072054|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
164192302|NCT02137226|593072055|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
164192303|NCT02137226|593072051|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
164192304|NCT02137226|593072052|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
164192305|NCT02137226|593072053|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
164192306|NCT02137226|593072054|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
164192307|NCT02137226|593072055|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
164192308|NCT02137226|593072051|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
164192309|NCT02137226|593072052|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
164192310|NCT02137226|593072053|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
164192311|NCT02137226|593072054|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
164192312|NCT02137226|593072055|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
164192313|NCT02137226|593072051|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
164192314|NCT02137226|593072052|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
164192315|NCT02137226|593072053|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
164192316|NCT02137226|593072054|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
164192317|NCT02137226|593072055|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
164192318|NCT02137226|593072051|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
164192319|NCT02137226|593072052|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
164192320|NCT02137226|593072053|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
164192321|NCT02137226|593072054|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
164192322|NCT02137226|593072055|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
164192323|NCT02137226|593072051|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
164192324|NCT02137226|593072052|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
164192325|NCT02137226|593072053|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
164192326|NCT02137226|593072054|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
164192327|NCT02137226|593072055|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
164192328|NCT02137226|593072051|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
164192329|NCT02137226|593072052|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
164192330|NCT02137226|593072053|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
164192331|NCT02137226|593072054|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
164192332|NCT02137226|593072055|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
164192333|NCT02137226|593072051|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
164192334|NCT02137226|593072052|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
164192335|NCT02137226|593072053|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
164192336|NCT02137226|593072054|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
164192337|NCT02137226|593072055|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
164192338|NCT02137226|593072051|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
164192339|NCT02137226|593072052|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
164192340|NCT02137226|593072053|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
164192341|NCT02137226|593072054|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
164192342|NCT02137226|593072055|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
164192343|NCT02137226|593072051|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
164192344|NCT02137226|593072052|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
164192345|NCT02137226|593072053|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
164192346|NCT02137226|593072054|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
164192347|NCT02137226|593072055|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
164192348|NCT02137226|593072051|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
164543683|NCT01994382|594362830|FG014|Overall Study|Protocol violation/noncompliance|0|||
164543684|NCT01994382|594362831|FG015|Overall Study|Protocol violation/noncompliance|0|||
164192349|NCT02137226|593072052|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
164192350|NCT02137226|593072053|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
164192351|NCT02137226|593072054|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
164192352|NCT02137226|593072055|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
164192353|NCT03472521|593072062|FG000|Overall Study|Lost to Follow-up|3|||
164192354|NCT03472521|593072063|FG001|Overall Study|Lost to Follow-up|2|||
164192355|NCT03472521|593072062|FG000|Overall Study|Discontinued intervention|3|||
164192356|NCT03472521|593072063|FG001|Overall Study|Discontinued intervention|1|||
164192357|NCT01603407|593072064|FG000|Overall Study|Adverse Event|1|||
164192358|NCT01603407|593072065|FG001|Overall Study|Adverse Event|1|||
164192359|NCT01603407|593072066|FG002|Overall Study|Adverse Event|1|||
164192360|NCT01603407|593072064|FG000|Overall Study|Protocol Violation|2|||
164192361|NCT01603407|593072065|FG001|Overall Study|Protocol Violation|2|||
164192362|NCT01603407|593072066|FG002|Overall Study|Protocol Violation|0|||
164192363|NCT01603407|593072064|FG000|Overall Study|Withdrawal by Subject|8|||
164192364|NCT01603407|593072065|FG001|Overall Study|Withdrawal by Subject|5|||
164192365|NCT01603407|593072066|FG002|Overall Study|Withdrawal by Subject|7|||
164192366|NCT01603407|593072064|FG000|Overall Study|Lost to Follow-up|0|||
164192367|NCT01603407|593072065|FG001|Overall Study|Lost to Follow-up|3|||
164192368|NCT01603407|593072066|FG002|Overall Study|Lost to Follow-up|2|||
164192369|NCT01325350|593073909|FG000|Overall Study|Adverse Event|3|||
164192370|NCT01325350|593073910|FG001|Overall Study|Adverse Event|3|||
164192371|NCT01325350|593073911|FG002|Overall Study|Adverse Event|3|||
164192372|NCT01325350|593073912|FG003|Overall Study|Adverse Event|1|||
164192373|NCT01325350|593073913|FG004|Overall Study|Adverse Event|2|||
164192374|NCT01325350|593073909|FG000|Overall Study|Pregnancy|0|||
164192375|NCT01325350|593073910|FG001|Overall Study|Pregnancy|0|||
164192376|NCT01325350|593073911|FG002|Overall Study|Pregnancy|1|||
164192377|NCT01325350|593073912|FG003|Overall Study|Pregnancy|0|||
164192378|NCT01325350|593073913|FG004|Overall Study|Pregnancy|1|||
164192379|NCT01325350|593073909|FG000|Overall Study|Lost to Follow-up|1|||
164192380|NCT01325350|593073910|FG001|Overall Study|Lost to Follow-up|0|||
164192381|NCT01325350|593073911|FG002|Overall Study|Lost to Follow-up|5|||
164192382|NCT01325350|593073912|FG003|Overall Study|Lost to Follow-up|1|||
164192383|NCT01325350|593073913|FG004|Overall Study|Lost to Follow-up|5|||
164192384|NCT01325350|593073909|FG000|Overall Study|Personal Reasons|2|||
164192385|NCT01325350|593073910|FG001|Overall Study|Personal Reasons|1|||
164192386|NCT01325350|593073911|FG002|Overall Study|Personal Reasons|6|||
164192387|NCT01325350|593073912|FG003|Overall Study|Personal Reasons|5|||
164192388|NCT01325350|593073913|FG004|Overall Study|Personal Reasons|3|||
164192389|NCT01325350|593073909|FG000|Overall Study|Protocol Violation|0|||
164192390|NCT01325350|593073910|FG001|Overall Study|Protocol Violation|0|||
164192391|NCT01325350|593073911|FG002|Overall Study|Protocol Violation|0|||
164192392|NCT01325350|593073912|FG003|Overall Study|Protocol Violation|1|||
164192393|NCT01325350|593073913|FG004|Overall Study|Protocol Violation|0|||
164192394|NCT01325350|593073909|FG000|Overall Study|Withdrawal by Subject|0|||
164192395|NCT01325350|593073910|FG001|Overall Study|Withdrawal by Subject|0|||
164192396|NCT01325350|593073911|FG002|Overall Study|Withdrawal by Subject|1|||
164192397|NCT01325350|593073912|FG003|Overall Study|Withdrawal by Subject|1|||
164192398|NCT01325350|593073913|FG004|Overall Study|Withdrawal by Subject|0|||
164192399|NCT01325350|593073909|FG000|Overall Study|Did Not Receive Treatment|0|||
164192400|NCT01325350|593073910|FG001|Overall Study|Did Not Receive Treatment|1|||
164192401|NCT01325350|593073911|FG002|Overall Study|Did Not Receive Treatment|1|||
164192402|NCT01325350|593073912|FG003|Overall Study|Did Not Receive Treatment|0|||
164192403|NCT01325350|593073913|FG004|Overall Study|Did Not Receive Treatment|1|||
164192404|NCT02692586|593073914|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
164192405|NCT02692586|593073914|FG000|Overall Study|Received adjunctive thrombolytics|2|||
164192406|NCT01396083|593073918|FG000|Overall Study|Adverse Event|2|||
164192407|NCT01396083|593073919|FG001|Overall Study|Adverse Event|28|||
164192408|NCT01396083|593073918|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164192409|NCT01396083|593073919|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
164192410|NCT01396083|593073918|FG000|Overall Study|Consent withdrawn|4|||
164192411|NCT01396083|593073919|FG001|Overall Study|Consent withdrawn|5|||
164192412|NCT01396083|593073918|FG000|Overall Study|Protocol deviation(s)|0|||
164192413|NCT01396083|593073919|FG001|Overall Study|Protocol deviation(s)|1|||
164192414|NCT01396083|593073918|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164192415|NCT01396083|593073919|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164192416|NCT01396083|593073918|FG000|Overall Study|Administrative problems|1|||
164653391|NCT01078623|594757109|FG018|Treatment Period 4|Withdrawal by Subject|0|||
164192417|NCT01396083|593073919|FG001|Overall Study|Administrative problems|0|||
164192418|NCT01396083|593073918|FG000|Overall Study|Lost to Follow-up|1|||
164192419|NCT01396083|593073919|FG001|Overall Study|Lost to Follow-up|0|||
164192420|NCT01063855|593073920|FG000|Overall Study|Adverse Event|4|||
164192421|NCT01063855|593073921|FG001|Overall Study|Adverse Event|4|||
164192422|NCT01063855|593073920|FG000|Overall Study|Death|0|||
164192423|NCT01063855|593073921|FG001|Overall Study|Death|1|||
164653392|NCT01078623|594757110|FG019|Treatment Period 4|Withdrawal by Subject|0|||
164192424|NCT01063855|593073920|FG000|Overall Study|Lost to Follow-up|8|||
164192425|NCT01063855|593073921|FG001|Overall Study|Lost to Follow-up|4|||
164192426|NCT01063855|593073920|FG000|Overall Study|Pregnancy|1|||
164192427|NCT01063855|593073921|FG001|Overall Study|Pregnancy|0|||
164192428|NCT01063855|593073920|FG000|Overall Study|Lack of Efficacy|0|||
164192429|NCT01063855|593073921|FG001|Overall Study|Lack of Efficacy|1|||
164192430|NCT01063855|593073920|FG000|Overall Study|Withdrawal by Subject|11|||
164192431|NCT01063855|593073921|FG001|Overall Study|Withdrawal by Subject|8|||
164192432|NCT01063855|593073920|FG000|Overall Study|Reason not specified|13|||
164192433|NCT01063855|593073921|FG001|Overall Study|Reason not specified|11|||
164192434|NCT01165307|593073922|FG000|Overall Study|Lost to Follow-up|11|||
164192435|NCT01165307|593073923|FG001|Overall Study|Lost to Follow-up|3|||
164192436|NCT01165307|593073922|FG000|Overall Study|Withdrawal by Subject|2|||
164192437|NCT01165307|593073923|FG001|Overall Study|Withdrawal by Subject|0|||
164192438|NCT01165307|593073922|FG000|Overall Study|Subject not available for contact|1|||
164192439|NCT01165307|593073923|FG001|Overall Study|Subject not available for contact|0|||
164192440|NCT03234036|593073927|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
164192441|NCT03234036|593073928|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
164192442|NCT03234036|593073929|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
164192443|NCT03234036|593073930|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
164192444|NCT02999789|593073933|FG000|Overall Study|Withdrawal by Subject|0|||
164192445|NCT02999789|593073934|FG001|Overall Study|Withdrawal by Subject|1|||
164192446|NCT02999789|593073933|FG000|Overall Study|Became ineligible|1|||
164192447|NCT02999789|593073934|FG001|Overall Study|Became ineligible|2|||
164192448|NCT01111565|593073949|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
164192449|NCT01111565|593073950|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
164192450|NCT01111565|593073951|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
164192451|NCT01111565|593073952|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
164192452|NCT01111565|593073953|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
164192453|NCT01111565|593073949|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
164192454|NCT01111565|593073950|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
164192455|NCT01111565|593073951|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
164192456|NCT01111565|593073952|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
164192457|NCT01111565|593073953|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
164192458|NCT01111565|593073949|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
164192459|NCT01111565|593073950|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
164192460|NCT01111565|593073951|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
164192461|NCT01111565|593073952|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
164192462|NCT01111565|593073953|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
164192463|NCT01111565|593073949|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
164192464|NCT01111565|593073950|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
164192465|NCT01111565|593073951|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
164192466|NCT01111565|593073952|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
164192467|NCT01111565|593073953|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
164192468|NCT01111565|593073949|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
164192469|NCT01111565|593073950|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
164192470|NCT01111565|593073951|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
164192471|NCT01111565|593073952|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
164192472|NCT01111565|593073953|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
164192473|NCT01111565|593073949|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
164192474|NCT01111565|593073950|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
164192475|NCT01111565|593073951|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
164192476|NCT01111565|593073952|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
164192477|NCT01111565|593073953|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
164192478|NCT01111565|593073949|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
164192479|NCT01111565|593073950|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
164192480|NCT01111565|593073951|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
164192481|NCT01111565|593073952|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
164192482|NCT01111565|593073953|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
164192483|NCT01111565|593073949|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
164192484|NCT01111565|593073950|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
164192485|NCT01111565|593073951|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
164192486|NCT01111565|593073952|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
164192487|NCT01111565|593073953|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
164192488|NCT01111565|593073949|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
164192489|NCT01111565|593073950|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
164192490|NCT01111565|593073951|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
164192491|NCT01111565|593073952|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
164192492|NCT01111565|593073953|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
164192493|NCT01111565|593073949|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
164192494|NCT01111565|593073950|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
164653393|NCT00910858|594757124|FG000|Pharmacokinetic Phase|Adverse Event|1|||
164192495|NCT01111565|593073951|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
164192496|NCT01111565|593073952|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
164192497|NCT01111565|593073953|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
164192498|NCT01111565|593073949|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
164192499|NCT01111565|593073950|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
164192500|NCT01111565|593073951|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
164192501|NCT01111565|593073952|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
164192502|NCT01111565|593073953|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
164192503|NCT01111565|593073949|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
164192504|NCT01111565|593073950|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
164192505|NCT01111565|593073951|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
164192506|NCT01111565|593073952|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
164192507|NCT01111565|593073953|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
164192508|NCT02683239|593073957|FG000|Overall Study|Protocol Violation|35|||
164192509|NCT02683239|593073958|FG001|Overall Study|Protocol Violation|23|||
164192510|NCT02683239|593073959|FG002|Overall Study|Protocol Violation|26|||
164192511|NCT02683239|593073960|FG003|Overall Study|Protocol Violation|4|||
164192512|NCT02683239|593073961|FG004|Overall Study|Protocol Violation|35|||
164192513|NCT02683239|593073962|FG005|Overall Study|Protocol Violation|4|||
164192514|NCT02683239|593073963|FG006|Overall Study|Protocol Violation|5|||
164192515|NCT02683239|593073957|FG000|Overall Study|Adverse Event|64|||
164192516|NCT02683239|593073958|FG001|Overall Study|Adverse Event|39|||
164192517|NCT02683239|593073959|FG002|Overall Study|Adverse Event|42|||
164192518|NCT02683239|593073960|FG003|Overall Study|Adverse Event|16|||
164192519|NCT02683239|593073961|FG004|Overall Study|Adverse Event|189|||
164192520|NCT02683239|593073962|FG005|Overall Study|Adverse Event|9|||
164192521|NCT02683239|593073963|FG006|Overall Study|Adverse Event|9|||
164192522|NCT02683239|593073957|FG000|Overall Study|Physician Decision|38|||
164192523|NCT02683239|593073958|FG001|Overall Study|Physician Decision|19|||
164192524|NCT02683239|593073959|FG002|Overall Study|Physician Decision|14|||
164192525|NCT02683239|593073960|FG003|Overall Study|Physician Decision|73|||
164192526|NCT02683239|593073961|FG004|Overall Study|Physician Decision|143|||
164192527|NCT02683239|593073962|FG005|Overall Study|Physician Decision|14|||
164192528|NCT02683239|593073963|FG006|Overall Study|Physician Decision|15|||
164192529|NCT02683239|593073957|FG000|Overall Study|Withdrawal by Subject|187|||
164192530|NCT02683239|593073958|FG001|Overall Study|Withdrawal by Subject|99|||
164192531|NCT02683239|593073959|FG002|Overall Study|Withdrawal by Subject|91|||
164192532|NCT02683239|593073960|FG003|Overall Study|Withdrawal by Subject|18|||
164192533|NCT02683239|593073961|FG004|Overall Study|Withdrawal by Subject|248|||
164192534|NCT02683239|593073962|FG005|Overall Study|Withdrawal by Subject|22|||
164192535|NCT02683239|593073963|FG006|Overall Study|Withdrawal by Subject|28|||
164192536|NCT02683239|593073957|FG000|Overall Study|Lost to Follow-up|77|||
164192537|NCT02683239|593073958|FG001|Overall Study|Lost to Follow-up|24|||
164192538|NCT02683239|593073959|FG002|Overall Study|Lost to Follow-up|25|||
164192539|NCT02683239|593073960|FG003|Overall Study|Lost to Follow-up|7|||
164192540|NCT02683239|593073961|FG004|Overall Study|Lost to Follow-up|88|||
164192541|NCT02683239|593073962|FG005|Overall Study|Lost to Follow-up|8|||
164192542|NCT02683239|593073963|FG006|Overall Study|Lost to Follow-up|11|||
164192543|NCT02683239|593073957|FG000|Overall Study|Death|9|||
164192544|NCT02683239|593073958|FG001|Overall Study|Death|5|||
164192545|NCT02683239|593073959|FG002|Overall Study|Death|8|||
164192546|NCT02683239|593073960|FG003|Overall Study|Death|0|||
164192547|NCT02683239|593073961|FG004|Overall Study|Death|12|||
164192548|NCT02683239|593073962|FG005|Overall Study|Death|1|||
164192549|NCT02683239|593073963|FG006|Overall Study|Death|0|||
164192550|NCT02683239|593073957|FG000|Overall Study|Lack of Efficacy|50|||
164192551|NCT02683239|593073958|FG001|Overall Study|Lack of Efficacy|23|||
164192552|NCT02683239|593073959|FG002|Overall Study|Lack of Efficacy|12|||
164192553|NCT02683239|593073960|FG003|Overall Study|Lack of Efficacy|2|||
164192554|NCT02683239|593073961|FG004|Overall Study|Lack of Efficacy|29|||
164192555|NCT02683239|593073962|FG005|Overall Study|Lack of Efficacy|2|||
164192556|NCT02683239|593073963|FG006|Overall Study|Lack of Efficacy|3|||
164192557|NCT02683239|593073957|FG000|Overall Study|Missing data|0|||
164192558|NCT02683239|593073958|FG001|Overall Study|Missing data|1|||
164192559|NCT02683239|593073959|FG002|Overall Study|Missing data|1|||
164192560|NCT02683239|593073960|FG003|Overall Study|Missing data|0|||
164192561|NCT02683239|593073961|FG004|Overall Study|Missing data|1|||
164192562|NCT02683239|593073962|FG005|Overall Study|Missing data|0|||
164192563|NCT02683239|593073963|FG006|Overall Study|Missing data|0|||
164192564|NCT00521365|593073966|FG000|Overall Study|Adverse Event|3|||
164192565|NCT00521365|593073966|FG000|Overall Study|Lost to Follow-up|6|||
164543685|NCT01994382|594362832|FG016|Overall Study|Protocol violation/noncompliance|2|||
164192566|NCT00521365|593073966|FG000|Overall Study|Protocol deviation|2|||
164192567|NCT00521365|593073966|FG000|Overall Study|Drug compliance|3|||
164192568|NCT00521365|593073966|FG000|Overall Study|Usage of not allowed drugs|6|||
164192569|NCT00368108|593073967|FG000|Overall Study|Adverse Event|38|||
164192570|NCT00368108|593073968|FG001|Overall Study|Adverse Event|26|||
164192571|NCT00368108|593073969|FG002|Overall Study|Adverse Event|44|||
164192572|NCT00368108|593073967|FG000|Overall Study|Abnormal Laboratory Value|0|||
164192573|NCT00368108|593073968|FG001|Overall Study|Abnormal Laboratory Value|0|||
164192574|NCT00368108|593073969|FG002|Overall Study|Abnormal Laboratory Value|3|||
164192575|NCT00368108|593073967|FG000|Overall Study|Protocol Violation|5|||
164192576|NCT00368108|593073968|FG001|Overall Study|Protocol Violation|9|||
164192577|NCT00368108|593073969|FG002|Overall Study|Protocol Violation|9|||
164192578|NCT00368108|593073967|FG000|Overall Study|Withdrawal by Subject|9|||
164192579|NCT00368108|593073968|FG001|Overall Study|Withdrawal by Subject|3|||
164192580|NCT00368108|593073969|FG002|Overall Study|Withdrawal by Subject|5|||
164192581|NCT00368108|593073967|FG000|Overall Study|Lack of Efficacy|7|||
164192582|NCT00368108|593073968|FG001|Overall Study|Lack of Efficacy|8|||
164192583|NCT00368108|593073969|FG002|Overall Study|Lack of Efficacy|5|||
164192584|NCT00368108|593073967|FG000|Overall Study|Physician Decision|2|||
164192585|NCT00368108|593073968|FG001|Overall Study|Physician Decision|0|||
164192586|NCT00368108|593073969|FG002|Overall Study|Physician Decision|1|||
164192587|NCT00368108|593073967|FG000|Overall Study|Other|3|||
164192588|NCT00368108|593073968|FG001|Overall Study|Other|7|||
164192589|NCT00368108|593073969|FG002|Overall Study|Other|1|||
164192590|NCT03150082|593073970|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
164192591|NCT03150082|593073971|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
164192592|NCT01718483|593073972|FG000|Overall Study|Withdrawal by Subject|14|||
164192593|NCT01718483|593073973|FG001|Overall Study|Withdrawal by Subject|12|||
164192594|NCT01718483|593073972|FG000|Overall Study|Adverse Event|5|||
164192595|NCT01718483|593073973|FG001|Overall Study|Adverse Event|12|||
164192596|NCT01718483|593073972|FG000|Overall Study|Lost to Follow-up|8|||
164192597|NCT01718483|593073973|FG001|Overall Study|Lost to Follow-up|3|||
164192598|NCT01718483|593073972|FG000|Overall Study|Protocol Violation|4|||
164192599|NCT01718483|593073973|FG001|Overall Study|Protocol Violation|2|||
164192600|NCT01718483|593073972|FG000|Overall Study|Other|1|||
164192601|NCT01718483|593073973|FG001|Overall Study|Other|4|||
164192602|NCT01718483|593073972|FG000|Overall Study|Pregnancy|1|||
164192603|NCT01718483|593073973|FG001|Overall Study|Pregnancy|1|||
164192604|NCT01718483|593073972|FG000|Overall Study|Lack of Efficacy|1|||
164192605|NCT01718483|593073973|FG001|Overall Study|Lack of Efficacy|0|||
164192606|NCT04131712|593073978|FG000|Overall Study|COVID related|0|||
164192607|NCT04131712|593073979|FG001|Overall Study|COVID related|0|||
164192608|NCT04131712|593073980|FG002|Overall Study|COVID related|2|||
164192609|NCT04131712|593073981|FG003|Overall Study|COVID related|0|||
164192610|NCT04131712|593073978|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
164192611|NCT04131712|593073979|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
164192612|NCT04131712|593073980|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
164192613|NCT04131712|593073981|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
164192614|NCT02299388|593073984|FG000|Overall Study|Withdrawal by Subject|0|||
164192615|NCT02299388|593073985|FG001|Overall Study|Withdrawal by Subject|1|||
164192616|NCT03334188|593073986|FG000|Overall Study|Withdrawal by Subject|0|||
164192617|NCT03334188|593073987|FG001|Overall Study|Withdrawal by Subject|1|||
164192618|NCT03334188|593073986|FG000|Overall Study|Death|1|||
164192619|NCT03334188|593073987|FG001|Overall Study|Death|0|||
164192620|NCT03334188|593073986|FG000|Overall Study|Never had qualifying clinic visit|7|||
164192621|NCT03334188|593073987|FG001|Overall Study|Never had qualifying clinic visit|7|||
164192622|NCT01093586|593073992|FG000|Overall Study|Failed to engraft|3|||
164192623|NCT00357877|593073993|FG000|Overall Study|Death|2|||
164192624|NCT00357877|593073994|FG001|Overall Study|Death|1|||
164192625|NCT00357877|593073993|FG000|Overall Study|Lost to Follow-up|20|||
164192626|NCT00357877|593073994|FG001|Overall Study|Lost to Follow-up|23|||
164192627|NCT00357877|593073993|FG000|Overall Study|Withdrawal by Subject|3|||
164192628|NCT00357877|593073994|FG001|Overall Study|Withdrawal by Subject|3|||
164192629|NCT00357877|593073993|FG000|Overall Study|Administrative withdrawal|1|||
164192630|NCT00357877|593073994|FG001|Overall Study|Administrative withdrawal|1|||
164192631|NCT00357877|593073993|FG000|Overall Study|Other|0|||
164192632|NCT00357877|593073994|FG001|Overall Study|Other|2|||
164192633|NCT00613366|593074004|FG000|Overall Study|Withdrawal by Subject|3|||
164192634|NCT00613366|593074005|FG001|Overall Study|Withdrawal by Subject|2|||
164192635|NCT00943397|593074006|FG000|Overall Study|Adverse Event|0|||
164192636|NCT00943397|593074007|FG001|Overall Study|Adverse Event|6|||
164653394|NCT00910858|594757125|FG001|Pharmacokinetic Phase|Adverse Event|0|||
164653395|NCT00910858|594757126|FG002|Pharmacokinetic Phase|Adverse Event|0|||
164653396|NCT00910858|594757124|FG000|Monotherapy Phase|Adverse Event|3|||
164192637|NCT00943397|593074006|FG000|Overall Study|Lost to Follow-up|0|||
164192638|NCT00943397|593074007|FG001|Overall Study|Lost to Follow-up|4|||
164192639|NCT00943397|593074006|FG000|Overall Study|Protocol Violation|2|||
164192640|NCT00943397|593074007|FG001|Overall Study|Protocol Violation|5|||
164192641|NCT00943397|593074006|FG000|Overall Study|Withdrawal by Subject|1|||
164192642|NCT00943397|593074007|FG001|Overall Study|Withdrawal by Subject|1|||
164192643|NCT00943397|593074006|FG000|Overall Study|Site terminated and other|12|||
164192644|NCT00943397|593074007|FG001|Overall Study|Site terminated and other|56|||
164192645|NCT02948829|593074008|FG000|Overall Study|Lost to Follow-up|2|||
164192646|NCT02948829|593074008|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
164192647|NCT02948829|593074008|FG000|Overall Study|Pregnancy|1|||
164192648|NCT02948829|593074008|FG000|Overall Study|Other: Reason not Specified|8|||
164192649|NCT01719380|593074026|FG000|Overall Study|Adverse Event|0|||
164192650|NCT01719380|593074027|FG001|Overall Study|Adverse Event|0|||
164192651|NCT01719380|593074028|FG002|Overall Study|Adverse Event|1|||
164192652|NCT01719380|593074029|FG003|Overall Study|Adverse Event|2|||
164192653|NCT01719380|593074030|FG004|Overall Study|Adverse Event|0|||
164192654|NCT01719380|593074031|FG005|Overall Study|Adverse Event|1|||
164192655|NCT01719380|593074032|FG006|Overall Study|Adverse Event|0|||
164192656|NCT01719380|593074033|FG007|Overall Study|Adverse Event|1|||
164192657|NCT01719380|593074034|FG008|Overall Study|Adverse Event|4|||
164192658|NCT01719380|593074035|FG009|Overall Study|Adverse Event|3|||
164192659|NCT01719380|593074026|FG000|Overall Study|Death|0|||
164192660|NCT01719380|593074027|FG001|Overall Study|Death|1|||
164192661|NCT01719380|593074028|FG002|Overall Study|Death|0|||
164192662|NCT01719380|593074029|FG003|Overall Study|Death|0|||
164192663|NCT01719380|593074030|FG004|Overall Study|Death|0|||
164192664|NCT01719380|593074031|FG005|Overall Study|Death|0|||
164192665|NCT01719380|593074032|FG006|Overall Study|Death|0|||
164192666|NCT01719380|593074033|FG007|Overall Study|Death|0|||
164192667|NCT01719380|593074034|FG008|Overall Study|Death|3|||
164192668|NCT01719380|593074035|FG009|Overall Study|Death|3|||
164192669|NCT01719380|593074026|FG000|Overall Study|Participant/Guardian Decision|0|||
164192670|NCT01719380|593074027|FG001|Overall Study|Participant/Guardian Decision|0|||
164192671|NCT01719380|593074028|FG002|Overall Study|Participant/Guardian Decision|1|||
164192672|NCT01719380|593074029|FG003|Overall Study|Participant/Guardian Decision|0|||
164192673|NCT01719380|593074030|FG004|Overall Study|Participant/Guardian Decision|0|||
164192674|NCT01719380|593074031|FG005|Overall Study|Participant/Guardian Decision|0|||
164192675|NCT01719380|593074032|FG006|Overall Study|Participant/Guardian Decision|0|||
164192676|NCT01719380|593074033|FG007|Overall Study|Participant/Guardian Decision|0|||
164192677|NCT01719380|593074034|FG008|Overall Study|Participant/Guardian Decision|2|||
164192678|NCT01719380|593074035|FG009|Overall Study|Participant/Guardian Decision|2|||
164192679|NCT01719380|593074026|FG000|Overall Study|Physician Decision|0|||
164192680|NCT01719380|593074027|FG001|Overall Study|Physician Decision|0|||
164192681|NCT01719380|593074028|FG002|Overall Study|Physician Decision|2|||
164192682|NCT01719380|593074029|FG003|Overall Study|Physician Decision|0|||
164192683|NCT01719380|593074030|FG004|Overall Study|Physician Decision|0|||
164192684|NCT01719380|593074031|FG005|Overall Study|Physician Decision|0|||
164192685|NCT01719380|593074032|FG006|Overall Study|Physician Decision|0|||
164192686|NCT01719380|593074033|FG007|Overall Study|Physician Decision|0|||
164192687|NCT01719380|593074034|FG008|Overall Study|Physician Decision|1|||
164192688|NCT01719380|593074035|FG009|Overall Study|Physician Decision|1|||
164192689|NCT01719380|593074026|FG000|Overall Study|Lack of Efficacy|2|||
164192690|NCT01719380|593074027|FG001|Overall Study|Lack of Efficacy|6|||
164192691|NCT01719380|593074028|FG002|Overall Study|Lack of Efficacy|5|||
164192692|NCT01719380|593074029|FG003|Overall Study|Lack of Efficacy|6|||
164192693|NCT01719380|593074030|FG004|Overall Study|Lack of Efficacy|3|||
164543686|NCT01994382|594362816|FG000|Overall Study|Rolled over to Phase 2a|0|||
164543687|NCT01994382|594362817|FG001|Overall Study|Rolled over to Phase 2a|0|||
164543688|NCT01994382|594362818|FG002|Overall Study|Rolled over to Phase 2a|1|||
164543689|NCT01994382|594362819|FG003|Overall Study|Rolled over to Phase 2a|0|||
164543690|NCT01994382|594362820|FG004|Overall Study|Rolled over to Phase 2a|0|||
164543691|NCT01994382|594362821|FG005|Overall Study|Rolled over to Phase 2a|0|||
164543692|NCT01994382|594362822|FG006|Overall Study|Rolled over to Phase 2a|0|||
164543693|NCT01994382|594362823|FG007|Overall Study|Rolled over to Phase 2a|0|||
164543694|NCT01994382|594362824|FG008|Overall Study|Rolled over to Phase 2a|0|||
164543695|NCT01994382|594362825|FG009|Overall Study|Rolled over to Phase 2a|2|||
164543696|NCT01994382|594362826|FG010|Overall Study|Rolled over to Phase 2a|0|||
164543697|NCT01994382|594362827|FG011|Overall Study|Rolled over to Phase 2a|0|||
164543698|NCT01994382|594362828|FG012|Overall Study|Rolled over to Phase 2a|0|||
164192694|NCT01719380|593074031|FG005|Overall Study|Lack of Efficacy|7|||
164192695|NCT01719380|593074032|FG006|Overall Study|Lack of Efficacy|10|||
164192696|NCT01719380|593074033|FG007|Overall Study|Lack of Efficacy|6|||
164192697|NCT01719380|593074034|FG008|Overall Study|Lack of Efficacy|39|||
164192698|NCT01719380|593074035|FG009|Overall Study|Lack of Efficacy|42|||
164192699|NCT01719380|593074026|FG000|Overall Study|Progressive Disease|0|||
164192700|NCT01719380|593074027|FG001|Overall Study|Progressive Disease|0|||
164192701|NCT01719380|593074028|FG002|Overall Study|Progressive Disease|0|||
164543699|NCT01994382|594362829|FG013|Overall Study|Rolled over to Phase 2a|0|||
164543700|NCT01994382|594362830|FG014|Overall Study|Rolled over to Phase 2a|0|||
164543701|NCT01994382|594362831|FG015|Overall Study|Rolled over to Phase 2a|0|||
164192702|NCT01719380|593074029|FG003|Overall Study|Progressive Disease|0|||
164192703|NCT01719380|593074030|FG004|Overall Study|Progressive Disease|0|||
164192704|NCT01719380|593074031|FG005|Overall Study|Progressive Disease|0|||
164192705|NCT01719380|593074032|FG006|Overall Study|Progressive Disease|0|||
164192706|NCT01719380|593074033|FG007|Overall Study|Progressive Disease|0|||
164192707|NCT01719380|593074034|FG008|Overall Study|Progressive Disease|1|||
164192708|NCT01719380|593074035|FG009|Overall Study|Progressive Disease|0|||
164192709|NCT00249873|593074036|FG000|Overall Study|Not treated|7|||
164192710|NCT00249873|593074037|FG001|Overall Study|Not treated|8|||
164192711|NCT00249873|593074036|FG000|Overall Study|Significant thrombocytopenia|9|||
164192712|NCT00249873|593074037|FG001|Overall Study|Significant thrombocytopenia|8|||
164192713|NCT00249873|593074036|FG000|Overall Study|Severe allergic reaction|8|||
164192714|NCT00249873|593074037|FG001|Overall Study|Severe allergic reaction|1|||
164192715|NCT00249873|593074036|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
164192716|NCT00249873|593074037|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
164192717|NCT00249873|593074036|FG000|Overall Study|Other Serious Adverse Event|86|||
164192718|NCT00249873|593074037|FG001|Overall Study|Other Serious Adverse Event|97|||
164192719|NCT00249873|593074036|FG000|Overall Study|Qualifying condition not present|20|||
164192720|NCT00249873|593074037|FG001|Overall Study|Qualifying condition not present|23|||
164192721|NCT00249873|593074036|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
164192722|NCT00249873|593074037|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
164192723|NCT00249873|593074036|FG000|Overall Study|Withdrawal by Subject|504|||
164192724|NCT00249873|593074037|FG001|Overall Study|Withdrawal by Subject|466|||
164192725|NCT00249873|593074036|FG000|Overall Study|Lost to Follow-up|4|||
164192726|NCT00249873|593074037|FG001|Overall Study|Lost to Follow-up|7|||
164192727|NCT00249873|593074036|FG000|Overall Study|Minor bleeding|99|||
164192728|NCT00249873|593074037|FG001|Overall Study|Minor bleeding|37|||
164192729|NCT00249873|593074036|FG000|Overall Study|Non-compliance|41|||
164192730|NCT00249873|593074037|FG001|Overall Study|Non-compliance|46|||
164192731|NCT00249873|593074036|FG000|Overall Study|Other non serious Adverse Event|112|||
164192732|NCT00249873|593074037|FG001|Overall Study|Other non serious Adverse Event|108|||
164192733|NCT00249873|593074036|FG000|Overall Study|Other contraindicated medication|1|||
164192734|NCT00249873|593074037|FG001|Overall Study|Other contraindicated medication|0|||
164192735|NCT00249873|593074036|FG000|Overall Study|Patient not wish to continue after May08|3|||
164192736|NCT00249873|593074037|FG001|Overall Study|Patient not wish to continue after May08|4|||
164192737|NCT00249873|593074036|FG000|Overall Study|Physician withdrew consent|59|||
164192738|NCT00249873|593074037|FG001|Overall Study|Physician withdrew consent|60|||
164192739|NCT00249873|593074036|FG000|Overall Study|Open label clopidogrel required|31|||
164192740|NCT00249873|593074037|FG001|Overall Study|Open label clopidogrel required|42|||
164192741|NCT00249873|593074036|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
164192742|NCT00249873|593074037|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
164192743|NCT00249873|593074036|FG000|Overall Study|Oral anticoagulant required|159|||
164192744|NCT00249873|593074037|FG001|Overall Study|Oral anticoagulant required|157|||
164192745|NCT00249873|593074036|FG000|Overall Study|Study drug intolerance|5|||
164192746|NCT00249873|593074037|FG001|Overall Study|Study drug intolerance|0|||
164192747|NCT00249873|593074036|FG000|Overall Study|Surgery/ procedure|9|||
164192748|NCT00249873|593074037|FG001|Overall Study|Surgery/ procedure|9|||
164192749|NCT00249873|593074036|FG000|Overall Study|Event related to cardiac condition|12|||
164192750|NCT00249873|593074037|FG001|Overall Study|Event related to cardiac condition|21|||
164192751|NCT00249873|593074036|FG000|Overall Study|Thromboembolic/outcome event|82|||
164192752|NCT00249873|593074037|FG001|Overall Study|Thromboembolic/outcome event|122|||
164192753|NCT02762084|593074040|FG000|Overall Study|Withdrawal by Subject|1|||
164192754|NCT02762084|593074041|FG001|Overall Study|Withdrawal by Subject|0|||
164192755|NCT02762084|593074042|FG002|Overall Study|Withdrawal by Subject|0|||
164192756|NCT02762084|593074040|FG000|Overall Study|Adverse Event|0|||
164192757|NCT02762084|593074041|FG001|Overall Study|Adverse Event|0|||
164192758|NCT02762084|593074042|FG002|Overall Study|Adverse Event|1|||
164192759|NCT00928434|593074043|FG000|Overall Study|Adverse Event|14|||
164192760|NCT00928434|593074044|FG001|Overall Study|Adverse Event|5|||
164192761|NCT00928434|593074045|FG002|Overall Study|Adverse Event|18|||
164192762|NCT00928434|593074043|FG000|Overall Study|Protocol Violation|5|||
164192763|NCT00928434|593074044|FG001|Overall Study|Protocol Violation|0|||
164192764|NCT00928434|593074045|FG002|Overall Study|Protocol Violation|8|||
164192765|NCT00928434|593074043|FG000|Overall Study|Physician Decision|2|||
164192766|NCT00928434|593074044|FG001|Overall Study|Physician Decision|0|||
164192767|NCT00928434|593074045|FG002|Overall Study|Physician Decision|3|||
164192768|NCT00928434|593074043|FG000|Overall Study|Lost to Follow-up|1|||
164192769|NCT00928434|593074044|FG001|Overall Study|Lost to Follow-up|0|||
164192770|NCT00928434|593074045|FG002|Overall Study|Lost to Follow-up|3|||
164192771|NCT00928434|593074043|FG000|Overall Study|Withdrawal by Subject|5|||
164192772|NCT00928434|593074044|FG001|Overall Study|Withdrawal by Subject|3|||
164192773|NCT00928434|593074045|FG002|Overall Study|Withdrawal by Subject|2|||
164192774|NCT00928434|593074043|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
164192775|NCT00928434|593074044|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
164192776|NCT00928434|593074045|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
164192777|NCT00928434|593074043|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
164192778|NCT00928434|593074044|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
164192779|NCT00928434|593074045|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
164192780|NCT00928434|593074043|FG000|Overall Study|Other (not meeting above criteria)|5|||
164302199|NCT01134055|593482556|FG000|Overall Study|Lost to Follow-up|0|||
164192781|NCT00928434|593074044|FG001|Overall Study|Other (not meeting above criteria)|1|||
164192782|NCT00928434|593074045|FG002|Overall Study|Other (not meeting above criteria)|2|||
164192783|NCT00716456|593074046|FG000|Overall Study|Adverse Event|0|||
164192784|NCT00716456|593074047|FG001|Overall Study|Adverse Event|2|||
164192785|NCT00716456|593074048|FG002|Overall Study|Adverse Event|0|||
164192786|NCT00447772|593074049|FG000|Overall Study|Lack of Efficacy|3|||
164192787|NCT00447772|593074049|FG000|Overall Study|Insufficient compliance|6|||
164192788|NCT00447772|593074049|FG000|Overall Study|Discontinuation of drug therapy|1|||
164192789|NCT00447772|593074049|FG000|Overall Study|Lost to Follow-up|9|||
164192790|NCT00447772|593074049|FG000|Overall Study|Withdrawal by Subject|1|||
164192791|NCT00447772|593074049|FG000|Overall Study|Unable to attend all study visits|2|||
164192792|NCT00447772|593074049|FG000|Overall Study|Adverse Event|1|||
164192793|NCT00447772|593074049|FG000|Overall Study|Patient relocated|1|||
164192794|NCT00447772|593074049|FG000|Overall Study|Incomplete documentation at visit 1|1|||
164192795|NCT00447772|593074049|FG000|Overall Study|Chemotherapy for lung cancer|1|||
164192796|NCT00447772|593074049|FG000|Overall Study|Premature re-injection required|1|||
164192797|NCT01765296|593074050|FG000|Overall Study|Protocol Violation|0|||
164192798|NCT01765296|593074051|FG001|Overall Study|Protocol Violation|5|||
164192799|NCT01765296|593074052|FG002|Overall Study|Protocol Violation|4|||
164192800|NCT01765296|593074050|FG000|Overall Study|Withdrawal by Subject|4|||
164192801|NCT01765296|593074051|FG001|Overall Study|Withdrawal by Subject|2|||
164192802|NCT01765296|593074052|FG002|Overall Study|Withdrawal by Subject|2|||
164192803|NCT01765296|593074050|FG000|Overall Study|Adverse Event|1|||
164192804|NCT01765296|593074051|FG001|Overall Study|Adverse Event|13|||
164192805|NCT01765296|593074052|FG002|Overall Study|Adverse Event|5|||
164192806|NCT01765296|593074050|FG000|Overall Study|Lack of Efficacy|0|||
164192807|NCT01765296|593074051|FG001|Overall Study|Lack of Efficacy|0|||
164192808|NCT01765296|593074052|FG002|Overall Study|Lack of Efficacy|2|||
164192809|NCT03478371|593074054|FG000|Overall Study|non-compliance|1|||
164192810|NCT03478371|593074054|FG000|Overall Study|Lost to Follow-up|4|||
164192811|NCT00627497|593074055|FG000|Overall Study|Lost to Follow-up|1|||
164192812|NCT00627497|593074056|FG001|Overall Study|Lost to Follow-up|1|||
164192813|NCT00627497|593074057|FG002|Overall Study|Lost to Follow-up|0|||
164192814|NCT00627497|593074058|FG003|Overall Study|Lost to Follow-up|0|||
164192815|NCT00838097|593074059|FG000|Overall Study|Ineligibility determined|6|||
164192816|NCT00838097|593074059|FG000|Overall Study|Adverse Event|2|||
164192817|NCT00838097|593074059|FG000|Overall Study|Withdrawal by Subject|3|||
164192818|NCT00838097|593074059|FG000|Overall Study|Requirement for alternative therapy|2|||
164192819|NCT00838097|593074059|FG000|Overall Study|Physician Decision|4|||
164192820|NCT00838097|593074059|FG000|Overall Study|Lost to Follow-up|11|||
164192821|NCT00838097|593074059|FG000|Overall Study|Death|6|||
164192822|NCT00838097|593074059|FG000|Overall Study|Protocol-specified criteria|142|||
164192823|NCT03134911|593074066|FG000|Overall Study|Screen failure|31|||
164192824|NCT03134911|593074066|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
164192825|NCT01118663|593074067|FG000|Overall Study|Adverse Event|2|||
164192826|NCT01118663|593074068|FG001|Overall Study|Adverse Event|1|||
164192827|NCT01118663|593074067|FG000|Overall Study|Withdrawal by Subject|0|||
164192828|NCT01118663|593074068|FG001|Overall Study|Withdrawal by Subject|1|||
164192829|NCT00656175|593074069|FG000|Overall Study|Adverse Event|1|||
164192830|NCT00656175|593074070|FG001|Overall Study|Adverse Event|0|||
164192831|NCT00656175|593074069|FG000|Overall Study|Transportation issues|0|||
164192832|NCT00656175|593074070|FG001|Overall Study|Transportation issues|1|||
164192833|NCT00672633|593074074|FG000|Overall Study|Withdrawal by Subject|0|||
164192834|NCT00672633|593074075|FG001|Overall Study|Withdrawal by Subject|1|||
164192835|NCT02824627|593074076|FG000|Overall Study|Adverse Event|1|||
164192836|NCT02824627|593074077|FG001|Overall Study|Adverse Event|2|||
164192837|NCT02824627|593074076|FG000|Overall Study|Lost to Follow-up|2|||
164192838|NCT02824627|593074077|FG001|Overall Study|Lost to Follow-up|1|||
164192839|NCT01868165|593074078|FG000|Overall Study|Withdrawal by Subject|36|||
164192840|NCT01868165|593074078|FG000|Overall Study|Physician Decision|2|||
164192841|NCT01868165|593074078|FG000|Overall Study|Lost to Follow-up|3|||
164192842|NCT01868165|593074078|FG000|Overall Study|Death|4|||
164192843|NCT05664581|593075629|FG000|Overall Study|Withdrawal by Subject|2|||
164192844|NCT03101150|593075630|FG000|Overall Study|Lost to Follow-up|2|||
164192845|NCT03101150|593075631|FG001|Overall Study|Lost to Follow-up|4|||
164192846|NCT03101150|593075630|FG000|Overall Study|Miscarriage|3|||
164192847|NCT03101150|593075631|FG001|Overall Study|Miscarriage|6|||
164192848|NCT01317641|593075635|FG000|Overall Study|Not treated|0|||
164192849|NCT01317641|593075636|FG001|Overall Study|Not treated|0|||
164192850|NCT01317641|593075637|FG002|Overall Study|Not treated|0|||
164192851|NCT01317641|593075638|FG003|Overall Study|Not treated|0|||
164192852|NCT01317641|593075639|FG004|Overall Study|Not treated|0|||
164192853|NCT01317641|593075640|FG005|Overall Study|Not treated|0|||
164192854|NCT01317641|593075641|FG006|Overall Study|Not treated|0|||
164192855|NCT01317641|593075642|FG007|Overall Study|Not treated|1|||
164192856|NCT01317641|593075643|FG008|Overall Study|Not treated|1|||
164192857|NCT01317641|593075635|FG000|Overall Study|Adverse Event|0|||
164192858|NCT01317641|593075636|FG001|Overall Study|Adverse Event|1|||
164192859|NCT01317641|593075637|FG002|Overall Study|Adverse Event|0|||
164192860|NCT01317641|593075638|FG003|Overall Study|Adverse Event|1|||
164192861|NCT01317641|593075639|FG004|Overall Study|Adverse Event|0|||
164192862|NCT01317641|593075640|FG005|Overall Study|Adverse Event|0|||
164192863|NCT01317641|593075641|FG006|Overall Study|Adverse Event|2|||
164192864|NCT01317641|593075642|FG007|Overall Study|Adverse Event|1|||
164192865|NCT01317641|593075643|FG008|Overall Study|Adverse Event|0|||
164192866|NCT01317641|593075635|FG000|Overall Study|Protocol Violation|1|||
164192867|NCT01317641|593075636|FG001|Overall Study|Protocol Violation|0|||
164192868|NCT01317641|593075637|FG002|Overall Study|Protocol Violation|0|||
164192869|NCT01317641|593075638|FG003|Overall Study|Protocol Violation|0|||
164192870|NCT01317641|593075639|FG004|Overall Study|Protocol Violation|0|||
164192871|NCT01317641|593075640|FG005|Overall Study|Protocol Violation|0|||
164192872|NCT01317641|593075641|FG006|Overall Study|Protocol Violation|0|||
164192873|NCT01317641|593075642|FG007|Overall Study|Protocol Violation|0|||
164192874|NCT01317641|593075643|FG008|Overall Study|Protocol Violation|0|||
164192875|NCT01317641|593075635|FG000|Overall Study|Disease progression|0|||
164192876|NCT01317641|593075636|FG001|Overall Study|Disease progression|0|||
164192877|NCT01317641|593075637|FG002|Overall Study|Disease progression|0|||
164192878|NCT01317641|593075638|FG003|Overall Study|Disease progression|0|||
164192879|NCT01317641|593075639|FG004|Overall Study|Disease progression|0|||
164192880|NCT01317641|593075640|FG005|Overall Study|Disease progression|0|||
164192881|NCT01317641|593075641|FG006|Overall Study|Disease progression|0|||
164192882|NCT01317641|593075642|FG007|Overall Study|Disease progression|3|||
164192883|NCT01317641|593075643|FG008|Overall Study|Disease progression|4|||
164192884|NCT01317641|593075635|FG000|Overall Study|Withdrawal by Subject|0|||
164192885|NCT01317641|593075636|FG001|Overall Study|Withdrawal by Subject|0|||
164192886|NCT01317641|593075637|FG002|Overall Study|Withdrawal by Subject|0|||
164192887|NCT01317641|593075638|FG003|Overall Study|Withdrawal by Subject|0|||
164192888|NCT01317641|593075639|FG004|Overall Study|Withdrawal by Subject|0|||
164192889|NCT01317641|593075640|FG005|Overall Study|Withdrawal by Subject|0|||
164192890|NCT01317641|593075641|FG006|Overall Study|Withdrawal by Subject|1|||
164192891|NCT01317641|593075642|FG007|Overall Study|Withdrawal by Subject|0|||
164192892|NCT01317641|593075643|FG008|Overall Study|Withdrawal by Subject|0|||
164192893|NCT00329108|593075644|FG000|Overall Study|Adverse Event|2|||
164192894|NCT00329108|593075645|FG001|Overall Study|Adverse Event|2|||
164192895|NCT00329108|593075644|FG000|Overall Study|Lack of Efficacy|3|||
164192896|NCT00329108|593075645|FG001|Overall Study|Lack of Efficacy|3|||
164192897|NCT00329108|593075644|FG000|Overall Study|Withdrawal by Subject|0|||
164192898|NCT00329108|593075645|FG001|Overall Study|Withdrawal by Subject|2|||
164192899|NCT00329108|593075644|FG000|Overall Study|symptomatic deterioration|1|||
164192900|NCT00329108|593075645|FG001|Overall Study|symptomatic deterioration|1|||
164192901|NCT00329108|593075644|FG000|Overall Study|Subject no longer willing to participate|2|||
164192902|NCT00329108|593075645|FG001|Overall Study|Subject no longer willing to participate|2|||
164192903|NCT00329108|593075644|FG000|Overall Study|study terminated by sponsor|1|||
164192904|NCT00329108|593075645|FG001|Overall Study|study terminated by sponsor|0|||
164192905|NCT00329108|593075644|FG000|Overall Study|withdrew patient after SAE resolved|1|||
164192906|NCT00329108|593075645|FG001|Overall Study|withdrew patient after SAE resolved|0|||
164192907|NCT00329108|593075644|FG000|Overall Study|Protocol Violation|0|||
164192908|NCT00329108|593075645|FG001|Overall Study|Protocol Violation|2|||
164192909|NCT01302418|593075646|FG000|Overall Study|Protocol Violation|9|||
164192910|NCT01302418|593075646|FG000|Overall Study|Non-evaluable|9|||
164192911|NCT02498678|593075654|FG000|Overall Study|interference from the surgical team|0|||
164192912|NCT02498678|593075655|FG001|Overall Study|interference from the surgical team|2|||
164192913|NCT03257436|593075656|FG000|Overall Study|Withdrawal by Subject|76|||
164192914|NCT03257436|593075656|FG000|Overall Study|Death|19|||
164192915|NCT01619852|593075657|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
164192916|NCT01619852|593075658|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
164192917|NCT01619852|593075657|FG000|3 Month Follow up|Lost to Follow-up|31|||
164192918|NCT01619852|593075658|FG001|3 Month Follow up|Lost to Follow-up|34|||
164192919|NCT00970489|593075659|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
164192920|NCT00970489|593075660|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
164192921|NCT05417412|593075661|FG000|Overall Study|Lost to Follow-up|2|||
164192922|NCT01576575|593075662|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
164192923|NCT01576575|593075662|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
164192924|NCT01576575|593075662|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
164192925|NCT00891813|593075663|FG000|Overall Study|Adverse Event|3|||
164192926|NCT00891813|593075663|FG000|Overall Study|Withdrawal by Subject|1|||
164192927|NCT00891813|593075663|FG000|Overall Study|Patient Noncompliance|6|||
164192928|NCT00891813|593075663|FG000|Overall Study|Protocol Violation|2|||
164192929|NCT01723072|593075668|FG000|Overall Study|Withdrawal by Subject|7|||
164192930|NCT01723072|593075669|FG001|Overall Study|Withdrawal by Subject|13|||
164192931|NCT01723072|593075668|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
164192932|NCT01723072|593075669|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
164192933|NCT01723072|593075668|FG000|Overall Study|Other|4|||
164543702|NCT01994382|594362832|FG016|Overall Study|Rolled over to Phase 2a|0|||
164543703|NCT04667377|594362833|FG000|Dose Escalation Period|Other not specified below|3|||
164192934|NCT01723072|593075669|FG001|Overall Study|Other|3|||
164192935|NCT01610037|593075673|FG000|All Patients|Adverse Event|27|||
164192936|NCT01610037|593075674|FG001|All Patients|Adverse Event|22|||
164192937|NCT01610037|593075675|FG002|All Patients|Adverse Event|26|||
164192938|NCT01610037|593075673|FG000|All Patients|Withdrawal by Subject|12|||
164192939|NCT01610037|593075674|FG001|All Patients|Withdrawal by Subject|10|||
164192940|NCT01610037|593075675|FG002|All Patients|Withdrawal by Subject|20|||
164192941|NCT01610037|593075673|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
164192942|NCT01610037|593075674|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
164192943|NCT01610037|593075675|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
164192944|NCT01610037|593075673|FG000|All Patients|Death|4|||
164192945|NCT01610037|593075674|FG001|All Patients|Death|2|||
164192946|NCT01610037|593075675|FG002|All Patients|Death|1|||
164192947|NCT01610037|593075673|FG000|All Patients|Protocol deviation|4|||
164192948|NCT01610037|593075674|FG001|All Patients|Protocol deviation|3|||
164192949|NCT01610037|593075675|FG002|All Patients|Protocol deviation|3|||
164192950|NCT01610037|593075673|FG000|All Patients|Abnormal laboratory value|1|||
164192951|NCT01610037|593075674|FG001|All Patients|Abnormal laboratory value|1|||
164192952|NCT01610037|593075675|FG002|All Patients|Abnormal laboratory value|0|||
164192953|NCT01610037|593075673|FG000|All Patients|Administrative problems|1|||
164192954|NCT01610037|593075674|FG001|All Patients|Administrative problems|4|||
164192955|NCT01610037|593075675|FG002|All Patients|Administrative problems|4|||
164192956|NCT01610037|593075673|FG000|All Patients|Lost to Follow-up|1|||
164192957|NCT01610037|593075674|FG001|All Patients|Lost to Follow-up|0|||
164192958|NCT01610037|593075675|FG002|All Patients|Lost to Follow-up|0|||
164192959|NCT01610037|593075673|FG000|All Patients|Abnormal test procedure result(s)|0|||
164192960|NCT01610037|593075674|FG001|All Patients|Abnormal test procedure result(s)|1|||
164192961|NCT01610037|593075675|FG002|All Patients|Abnormal test procedure result(s)|3|||
164192962|NCT01610037|593075673|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
164192963|NCT01610037|593075674|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
164192964|NCT01610037|593075675|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
164192965|NCT01610037|593075673|FG000|Treatment and Follow up Period|Death|10|||
164192966|NCT01610037|593075674|FG001|Treatment and Follow up Period|Death|5|||
164192967|NCT01610037|593075675|FG002|Treatment and Follow up Period|Death|4|||
164192968|NCT01610037|593075673|FG000|Treatment and Follow up Period|Administrative problems|1|||
164192969|NCT01610037|593075674|FG001|Treatment and Follow up Period|Administrative problems|3|||
164192970|NCT01610037|593075675|FG002|Treatment and Follow up Period|Administrative problems|2|||
164192971|NCT01610037|593075673|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
164192972|NCT01610037|593075674|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
164192973|NCT01610037|593075675|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
164192974|NCT03489343|593075682|FG000|Overall Study|Documented progressive disease|1|||
164192975|NCT03489343|593075683|FG001|Overall Study|Documented progressive disease|0|||
164192976|NCT03489343|593075684|FG002|Overall Study|Documented progressive disease|3|||
164192977|NCT03489343|593075685|FG003|Overall Study|Documented progressive disease|1|||
164192978|NCT03489343|593075686|FG004|Overall Study|Documented progressive disease|3|||
164192979|NCT03489343|593075687|FG005|Overall Study|Documented progressive disease|5|||
164192980|NCT03489343|593075688|FG006|Overall Study|Documented progressive disease|4|||
164192981|NCT03489343|593075682|FG000|Overall Study|Adverse Event|0|||
164192982|NCT03489343|593075683|FG001|Overall Study|Adverse Event|1|||
164192983|NCT03489343|593075684|FG002|Overall Study|Adverse Event|0|||
164192984|NCT03489343|593075685|FG003|Overall Study|Adverse Event|0|||
164192985|NCT03489343|593075686|FG004|Overall Study|Adverse Event|0|||
164192986|NCT03489343|593075687|FG005|Overall Study|Adverse Event|1|||
164192987|NCT03489343|593075688|FG006|Overall Study|Adverse Event|0|||
164192988|NCT03489343|593075682|FG000|Overall Study|Withdrawal by Subject|0|||
164192989|NCT03489343|593075683|FG001|Overall Study|Withdrawal by Subject|0|||
164192990|NCT03489343|593075684|FG002|Overall Study|Withdrawal by Subject|0|||
164192991|NCT03489343|593075685|FG003|Overall Study|Withdrawal by Subject|1|||
164192992|NCT03489343|593075686|FG004|Overall Study|Withdrawal by Subject|0|||
164192993|NCT03489343|593075687|FG005|Overall Study|Withdrawal by Subject|1|||
164192994|NCT03489343|593075688|FG006|Overall Study|Withdrawal by Subject|1|||
164192995|NCT03489343|593075682|FG000|Overall Study|Clinical progression|0|||
164192996|NCT03489343|593075683|FG001|Overall Study|Clinical progression|0|||
164192997|NCT03489343|593075684|FG002|Overall Study|Clinical progression|0|||
164192998|NCT03489343|593075685|FG003|Overall Study|Clinical progression|1|||
164192999|NCT03489343|593075686|FG004|Overall Study|Clinical progression|0|||
164193000|NCT03489343|593075687|FG005|Overall Study|Clinical progression|0|||
164193001|NCT03489343|593075688|FG006|Overall Study|Clinical progression|1|||
164193002|NCT00327717|593075689|FG000|Overall Study|Adverse Event|6|||
164193003|NCT00327717|593075690|FG001|Overall Study|Adverse Event|6|||
164193004|NCT00327717|593075689|FG000|Overall Study|Lack of Efficacy|0|||
164193005|NCT00327717|593075690|FG001|Overall Study|Lack of Efficacy|1|||
164193006|NCT00327717|593075689|FG000|Overall Study|Withdrawal by Subject|3|||
164193007|NCT00327717|593075690|FG001|Overall Study|Withdrawal by Subject|7|||
164193008|NCT01630135|593075693|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
164193009|NCT01630135|593075694|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
164193010|NCT02658669|593075695|FG000|Overall Study|Lost to Follow-up|7|||
164193011|NCT02658669|593075696|FG001|Overall Study|Lost to Follow-up|5|||
164193012|NCT03311841|593075705|FG000|14-day Wash-out|Adverse Event|0|||
164193013|NCT03311841|593075706|FG001|14-day Wash-out|Adverse Event|1|||
164193014|NCT03311841|593075707|FG002|14-day Wash-out|Adverse Event|0|||
164193015|NCT03311841|593075708|FG003|14-day Wash-out|Adverse Event|0|||
164193016|NCT03311841|593075709|FG004|14-day Wash-out|Adverse Event|0|||
164543704|NCT04667377|594362834|FG001|Dose Escalation Period|Other not specified below|3|||
164543705|NCT04667377|594362835|FG002|Dose Escalation Period|Other not specified below|2|||
164543706|NCT04667377|594362836|FG003|Dose Escalation Period|Other not specified below|1|||
164543707|NCT04667377|594362837|FG004|Dose Escalation Period|Other not specified below|3|||
164543708|NCT04667377|594362833|FG000|Dose Escalation Period|Protocol Violation|2|||
164543709|NCT04667377|594362834|FG001|Dose Escalation Period|Protocol Violation|2|||
164543710|NCT04667377|594362835|FG002|Dose Escalation Period|Protocol Violation|0|||
164543711|NCT04667377|594362836|FG003|Dose Escalation Period|Protocol Violation|2|||
164543712|NCT04667377|594362837|FG004|Dose Escalation Period|Protocol Violation|1|||
164543713|NCT04667377|594362833|FG000|Dose Escalation Period|Burden of study procedures|2|||
164543714|NCT04667377|594362834|FG001|Dose Escalation Period|Burden of study procedures|1|||
164543715|NCT04667377|594362835|FG002|Dose Escalation Period|Burden of study procedures|1|||
164543716|NCT04667377|594362836|FG003|Dose Escalation Period|Burden of study procedures|1|||
164543717|NCT04667377|594362837|FG004|Dose Escalation Period|Burden of study procedures|5|||
164543718|NCT04667377|594362833|FG000|Dose Escalation Period|Change of residence|0|||
164543719|NCT04667377|594362834|FG001|Dose Escalation Period|Change of residence|0|||
164543720|NCT04667377|594362835|FG002|Dose Escalation Period|Change of residence|1|||
164543721|NCT04667377|594362836|FG003|Dose Escalation Period|Change of residence|0|||
164543722|NCT04667377|594362837|FG004|Dose Escalation Period|Change of residence|0|||
164543723|NCT04667377|594362833|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
164543724|NCT04667377|594362834|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
164543725|NCT04667377|594362835|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
164543726|NCT04667377|594362836|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
164543727|NCT04667377|594362837|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
164543728|NCT04667377|594362833|FG000|Dose Escalation Period|Adverse Event|9|||
164543729|NCT04667377|594362834|FG001|Dose Escalation Period|Adverse Event|10|||
164543730|NCT04667377|594362835|FG002|Dose Escalation Period|Adverse Event|12|||
164543731|NCT04667377|594362836|FG003|Dose Escalation Period|Adverse Event|17|||
164543732|NCT04667377|594362837|FG004|Dose Escalation Period|Adverse Event|3|||
164543733|NCT04667377|594362833|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
164543734|NCT04667377|594362834|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
164543735|NCT04667377|594362835|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
164543736|NCT04667377|594362836|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
164543737|NCT04667377|594362837|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
164543738|NCT04667377|594362833|FG000|Dose Escalation Period|Not treated|1|||
164543739|NCT04667377|594362834|FG001|Dose Escalation Period|Not treated|0|||
164543740|NCT04667377|594362835|FG002|Dose Escalation Period|Not treated|0|||
164543741|NCT04667377|594362836|FG003|Dose Escalation Period|Not treated|0|||
164543742|NCT04667377|594362837|FG004|Dose Escalation Period|Not treated|0|||
164543743|NCT04667377|594362833|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
164543744|NCT04667377|594362834|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
164543745|NCT04667377|594362835|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
164543746|NCT04667377|594362836|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
164543747|NCT04667377|594362837|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
164543748|NCT04667377|594362833|FG000|Dose Escalation Period|Lost to Follow-up|0|||
164543749|NCT04667377|594362834|FG001|Dose Escalation Period|Lost to Follow-up|1|||
164543750|NCT04667377|594362835|FG002|Dose Escalation Period|Lost to Follow-up|0|||
164543751|NCT04667377|594362836|FG003|Dose Escalation Period|Lost to Follow-up|0|||
164543752|NCT04667377|594362837|FG004|Dose Escalation Period|Lost to Follow-up|0|||
164543753|NCT04667377|594362833|FG000|Maintenance Period|Perceived lack of efficacy|0|||
164543754|NCT04667377|594362834|FG001|Maintenance Period|Perceived lack of efficacy|2|||
164543755|NCT04667377|594362835|FG002|Maintenance Period|Perceived lack of efficacy|1|||
164543756|NCT04667377|594362836|FG003|Maintenance Period|Perceived lack of efficacy|0|||
164543757|NCT04667377|594362837|FG004|Maintenance Period|Perceived lack of efficacy|1|||
164543758|NCT04667377|594362833|FG000|Maintenance Period|Adverse Event|2|||
164653397|NCT00910858|594757125|FG001|Monotherapy Phase|Adverse Event|2|||
164653398|NCT00910858|594757126|FG002|Monotherapy Phase|Adverse Event|0|||
164653399|NCT00910858|594757124|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
164193017|NCT03311841|593075705|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
164193018|NCT03311841|593075706|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
164193019|NCT03311841|593075707|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
164193020|NCT03311841|593075708|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
164543759|NCT04667377|594362834|FG001|Maintenance Period|Adverse Event|8|||
164543760|NCT04667377|594362835|FG002|Maintenance Period|Adverse Event|5|||
164543761|NCT04667377|594362836|FG003|Maintenance Period|Adverse Event|4|||
164543762|NCT04667377|594362837|FG004|Maintenance Period|Adverse Event|1|||
164193021|NCT03311841|593075709|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
164193022|NCT00977613|593075712|FG000|Overall Study|Lost to Follow-up|16|||
164193023|NCT05464420|593075713|FG000|Overall Study|Death|0|||
164193024|NCT05464420|593075714|FG001|Overall Study|Death|0|||
164193025|NCT05464420|593075715|FG002|Overall Study|Death|0|||
164193026|NCT05464420|593075716|FG003|Overall Study|Death|1|||
164193027|NCT05464420|593075713|FG000|Overall Study|Lost to Follow-up|16|||
164193028|NCT05464420|593075714|FG001|Overall Study|Lost to Follow-up|11|||
164193029|NCT05464420|593075715|FG002|Overall Study|Lost to Follow-up|11|||
164193030|NCT05464420|593075716|FG003|Overall Study|Lost to Follow-up|11|||
164193031|NCT05464420|593075713|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
164193032|NCT05464420|593075714|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
164193033|NCT05464420|593075715|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
164193034|NCT05464420|593075716|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
164193035|NCT05464420|593075713|FG000|Overall Study|Withdrawal by Subject|4|||
164193036|NCT05464420|593075714|FG001|Overall Study|Withdrawal by Subject|8|||
164193037|NCT05464420|593075715|FG002|Overall Study|Withdrawal by Subject|3|||
164193038|NCT05464420|593075716|FG003|Overall Study|Withdrawal by Subject|1|||
164193039|NCT05464420|593075713|FG000|Overall Study|Protocol Violation|0|||
164193040|NCT05464420|593075714|FG001|Overall Study|Protocol Violation|0|||
164193041|NCT05464420|593075715|FG002|Overall Study|Protocol Violation|1|||
164193042|NCT05464420|593075716|FG003|Overall Study|Protocol Violation|1|||
164193043|NCT05464420|593075713|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
164193044|NCT05464420|593075714|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
164193045|NCT05464420|593075715|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
164193046|NCT05464420|593075716|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
164193047|NCT01383018|593075719|FG000|Overall Study|Adverse Event|14|||
164193048|NCT01383018|593075719|FG000|Overall Study|Death|10|||
164193049|NCT01383018|593075719|FG000|Overall Study|Lost to Follow-up|5|||
164193050|NCT01383018|593075719|FG000|Overall Study|Physician Decision|5|||
164193051|NCT01383018|593075719|FG000|Overall Study|Withdrawal by Subject|9|||
164193052|NCT01383018|593075719|FG000|Overall Study|Subject not implanted|76|||
164193053|NCT01383018|593075719|FG000|Overall Study|Missed Visit|247|||
164193054|NCT01383018|593075719|FG000|Overall Study|Site closed early-not compliance related|7|||
164193055|NCT01383018|593075719|FG000|Overall Study|Patient moved away from site|1|||
164193056|NCT01383018|593075719|FG000|Overall Study|Subject Incarcerated|1|||
164193057|NCT01051817|593075720|FG000|Overall Study|Adverse Event|0|||
164193058|NCT01051817|593075721|FG001|Overall Study|Adverse Event|2|||
164193059|NCT01051817|593075720|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
164193060|NCT01051817|593075721|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
164193061|NCT01051817|593075720|FG000|Overall Study|Withdrawal by Subject|3|||
164193062|NCT01051817|593075721|FG001|Overall Study|Withdrawal by Subject|5|||
164193063|NCT01051817|593075720|FG000|Overall Study|Protocol Violation|0|||
164193064|NCT01051817|593075721|FG001|Overall Study|Protocol Violation|1|||
164193065|NCT01598610|593075724|FG000|Overall Study|Adverse Event|1|||
164193066|NCT00627926|593075725|FG000|Overall Study|Adverse Event|26|||
164193067|NCT00627926|593075726|FG001|Overall Study|Adverse Event|37|||
164193068|NCT00627926|593075727|FG002|Overall Study|Adverse Event|36|||
164193069|NCT00627926|593075725|FG000|Overall Study|Death|1|||
164193070|NCT00627926|593075726|FG001|Overall Study|Death|0|||
164193071|NCT00627926|593075727|FG002|Overall Study|Death|0|||
164193072|NCT00627926|593075725|FG000|Overall Study|Lost to Follow-up|4|||
164193073|NCT00627926|593075726|FG001|Overall Study|Lost to Follow-up|3|||
164193074|NCT00627926|593075727|FG002|Overall Study|Lost to Follow-up|4|||
164193075|NCT00627926|593075725|FG000|Overall Study|Withdrawal by Subject|2|||
164193076|NCT00627926|593075726|FG001|Overall Study|Withdrawal by Subject|1|||
164193077|NCT00627926|593075727|FG002|Overall Study|Withdrawal by Subject|0|||
164193078|NCT00627926|593075725|FG000|Overall Study|Lack of Efficacy|118|||
164193079|NCT00627926|593075726|FG001|Overall Study|Lack of Efficacy|40|||
164193080|NCT00627926|593075727|FG002|Overall Study|Lack of Efficacy|38|||
164193081|NCT00627926|593075725|FG000|Overall Study|Noncompliance/unspecified|8|||
164193082|NCT00627926|593075726|FG001|Overall Study|Noncompliance/unspecified|23|||
164193083|NCT00627926|593075727|FG002|Overall Study|Noncompliance/unspecified|17|||
164193084|NCT02989402|593075729|FG000|Overall Study|Adverse event, or serious adverse event|4|||
164193085|NCT02989402|593075729|FG000|Overall Study|Death|2|||
164193086|NCT02989402|593075729|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
164193087|NCT02989402|593075729|FG000|Overall Study|Lost to Follow-up|8|||
164653400|NCT00910858|594757125|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
164193088|NCT02989402|593075729|FG000|Overall Study|Patient no longer on monotherapy|1|||
164193089|NCT02989402|593075729|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
164193090|NCT02989402|593075729|FG000|Overall Study|Withdrawal by Subject|7|||
164193091|NCT02989402|593075729|FG000|Overall Study|Other|2|||
164193092|NCT03066830|593075730|FG000|Overall Study|At the Participant's own Request|16|||
164653401|NCT00910858|594757126|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
164653402|NCT00910858|594757124|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
164193093|NCT03066830|593075731|FG001|Overall Study|At the Participant's own Request|17|||
164193094|NCT03066830|593075730|FG000|Overall Study|Other|3|||
164193095|NCT03066830|593075731|FG001|Overall Study|Other|0|||
164193096|NCT03066830|593075730|FG000|Overall Study|Poor Compliance to Protocol|1|||
164193097|NCT03066830|593075731|FG001|Overall Study|Poor Compliance to Protocol|0|||
164193098|NCT03066830|593075730|FG000|Overall Study|Adverse Event|2|||
164193099|NCT03066830|593075731|FG001|Overall Study|Adverse Event|2|||
164193100|NCT03066830|593075730|FG000|Overall Study|Lost to Follow-up|11|||
164193101|NCT03066830|593075731|FG001|Overall Study|Lost to Follow-up|3|||
164193102|NCT03414229|593075732|FG000|Overall Study|Adverse Event|1|||
164193103|NCT03414229|593075733|FG001|Overall Study|Adverse Event|0|||
164193104|NCT03414229|593075734|FG002|Overall Study|Adverse Event|2|||
164193105|NCT03414229|593075735|FG003|Overall Study|Adverse Event|1|||
164193106|NCT03414229|593075732|FG000|Overall Study|Lack of Efficacy|7|||
164193107|NCT03414229|593075733|FG001|Overall Study|Lack of Efficacy|4|||
164193108|NCT03414229|593075734|FG002|Overall Study|Lack of Efficacy|1|||
164193109|NCT03414229|593075735|FG003|Overall Study|Lack of Efficacy|9|||
164193110|NCT03414229|593075732|FG000|Overall Study|Change in therapy|1|||
164193111|NCT03414229|593075733|FG001|Overall Study|Change in therapy|0|||
164193112|NCT03414229|593075734|FG002|Overall Study|Change in therapy|0|||
164193113|NCT03414229|593075735|FG003|Overall Study|Change in therapy|0|||
164193114|NCT03414229|593075732|FG000|Overall Study|Pregnancy|0|||
164193115|NCT03414229|593075733|FG001|Overall Study|Pregnancy|0|||
164193116|NCT03414229|593075734|FG002|Overall Study|Pregnancy|1|||
164193117|NCT03414229|593075735|FG003|Overall Study|Pregnancy|0|||
164193118|NCT03414229|593075732|FG000|Overall Study|Withdrawal by Subject|0|||
164193119|NCT03414229|593075733|FG001|Overall Study|Withdrawal by Subject|1|||
164193120|NCT03414229|593075734|FG002|Overall Study|Withdrawal by Subject|1|||
164193121|NCT03414229|593075735|FG003|Overall Study|Withdrawal by Subject|0|||
164193122|NCT02797678|593075759|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
164193123|NCT02797678|593075760|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
164193124|NCT02797678|593075761|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
164193125|NCT02797678|593075762|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
164193126|NCT02797678|593075759|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
164193127|NCT02797678|593075760|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
164193128|NCT02797678|593075761|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
164193129|NCT02797678|593075762|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
164193130|NCT02797678|593075759|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
164193131|NCT02797678|593075760|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
164193132|NCT02797678|593075761|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
164193133|NCT02797678|593075762|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
164193134|NCT02149264|593075771|FG000|Overall Study|Withdrawal by Subject|9|||
164193135|NCT02149264|593075771|FG000|Overall Study|Adverse Event|7|||
164193136|NCT02149264|593075771|FG000|Overall Study|Physician Decision|3|||
164193137|NCT02149264|593075771|FG000|Overall Study|Protocol Violation|1|||
164193138|NCT01938846|593075774|FG000|Overall Study|Progressive disease|26|||
164193139|NCT01938846|593075775|FG001|Overall Study|Progressive disease|18|||
164193140|NCT01938846|593075776|FG002|Overall Study|Progressive disease|16|||
164193141|NCT01938846|593075774|FG000|Overall Study|Adverse Event|8|||
164193142|NCT01938846|593075775|FG001|Overall Study|Adverse Event|4|||
164193143|NCT01938846|593075776|FG002|Overall Study|Adverse Event|3|||
164193144|NCT01938846|593075774|FG000|Overall Study|Withdrawal by Subject|2|||
164193145|NCT01938846|593075775|FG001|Overall Study|Withdrawal by Subject|2|||
164193146|NCT01938846|593075776|FG002|Overall Study|Withdrawal by Subject|1|||
164193147|NCT01938846|593075774|FG000|Overall Study|Other than listed|5|||
164193148|NCT01938846|593075775|FG001|Overall Study|Other than listed|1|||
164193149|NCT01938846|593075776|FG002|Overall Study|Other than listed|4|||
164193150|NCT02499120|593075780|FG000|Overall Study|Death|52|||
164193151|NCT02499120|593075781|FG001|Overall Study|Death|43|||
164193152|NCT02499120|593075780|FG000|Overall Study|Lost to Follow-up|1|||
164193153|NCT02499120|593075781|FG001|Overall Study|Lost to Follow-up|2|||
164193154|NCT02499120|593075780|FG000|Overall Study|Participant refused further follow-up|1|||
164193155|NCT02499120|593075781|FG001|Overall Study|Participant refused further follow-up|0|||
164193156|NCT02499120|593075780|FG000|Overall Study|Withdrawal by Subject|2|||
164193157|NCT02499120|593075781|FG001|Overall Study|Withdrawal by Subject|5|||
164193158|NCT02499120|593075780|FG000|Overall Study|Other|9|||
164193159|NCT02499120|593075781|FG001|Overall Study|Other|10|||
164193160|NCT02282163|593075782|FG000|Overall Study|Protocol Violation|1|||
164193161|NCT01839916|593075783|FG000|Overall Study|Death|9|||
164193162|NCT01839916|593075783|FG000|Overall Study|Physician Decision|17|||
164193163|NCT01839916|593075783|FG000|Overall Study|Relapse|12|||
164193164|NCT01839916|593075783|FG000|Overall Study|GVHD|2|||
164193165|NCT01839916|593075783|FG000|Overall Study|Graft Failure|1|||
164193166|NCT01216332|593075785|FG000|Overall Study|Withdrawal by Subject|4|||
164193167|NCT01216332|593075786|FG001|Overall Study|Withdrawal by Subject|0|||
164193168|NCT03677869|593075787|FG000|Overall Study|Withdrawal by Subject|1|||
164193169|NCT05219968|593075788|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
164193170|NCT05219968|593075789|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
164193171|NCT05219968|593075790|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
164193172|NCT05219968|593075791|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
164193173|NCT05219968|593075792|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
164193174|NCT05219968|593075788|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
164193175|NCT05219968|593075789|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
164193176|NCT05219968|593075790|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
164193177|NCT05219968|593075791|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
164193178|NCT05219968|593075792|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
164193179|NCT05219968|593075788|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
164193180|NCT05219968|593075789|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
164193181|NCT05219968|593075790|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
164193182|NCT05219968|593075791|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
164193183|NCT05219968|593075792|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
164193184|NCT05219968|593075788|FG000|Week 24 Treatment Period|Adverse Event|3|||
164193185|NCT05219968|593075789|FG001|Week 24 Treatment Period|Adverse Event|0|||
164193186|NCT05219968|593075790|FG002|Week 24 Treatment Period|Adverse Event|0|||
164193187|NCT05219968|593075791|FG003|Week 24 Treatment Period|Adverse Event|0|||
164193188|NCT05219968|593075792|FG004|Week 24 Treatment Period|Adverse Event|0|||
164193189|NCT05219968|593075788|FG000|Week 24 Treatment Period|Physician Decision|0|||
164193190|NCT05219968|593075789|FG001|Week 24 Treatment Period|Physician Decision|1|||
164193191|NCT05219968|593075790|FG002|Week 24 Treatment Period|Physician Decision|0|||
164193192|NCT05219968|593075791|FG003|Week 24 Treatment Period|Physician Decision|0|||
164193193|NCT05219968|593075792|FG004|Week 24 Treatment Period|Physician Decision|0|||
164193194|NCT05219968|593075788|FG000|Week 24 Treatment Period|Other, not specified|3|||
164193195|NCT05219968|593075789|FG001|Week 24 Treatment Period|Other, not specified|0|||
164193196|NCT05219968|593075790|FG002|Week 24 Treatment Period|Other, not specified|0|||
164193197|NCT05219968|593075791|FG003|Week 24 Treatment Period|Other, not specified|0|||
164193198|NCT05219968|593075792|FG004|Week 24 Treatment Period|Other, not specified|0|||
164193199|NCT05219968|593075788|FG000|Safety Extension Period|Treatment administration failure|0|||
164193200|NCT05219968|593075789|FG001|Safety Extension Period|Treatment administration failure|0|||
164193201|NCT05219968|593075790|FG002|Safety Extension Period|Treatment administration failure|0|||
164193202|NCT05219968|593075791|FG003|Safety Extension Period|Treatment administration failure|1|||
164193203|NCT05219968|593075792|FG004|Safety Extension Period|Treatment administration failure|4|||
164193204|NCT05219968|593075788|FG000|Safety Extension Period|Bilateral dislodgement|0|||
164193205|NCT05219968|593075789|FG001|Safety Extension Period|Bilateral dislodgement|0|||
164193206|NCT05219968|593075790|FG002|Safety Extension Period|Bilateral dislodgement|4|||
164193207|NCT05219968|593075791|FG003|Safety Extension Period|Bilateral dislodgement|0|||
164193208|NCT05219968|593075792|FG004|Safety Extension Period|Bilateral dislodgement|1|||
164193209|NCT05219968|593075788|FG000|Safety Extension Period|Withdrawal by Subject|0|||
164193210|NCT05219968|593075789|FG001|Safety Extension Period|Withdrawal by Subject|0|||
164193211|NCT05219968|593075790|FG002|Safety Extension Period|Withdrawal by Subject|2|||
164193212|NCT05219968|593075791|FG003|Safety Extension Period|Withdrawal by Subject|0|||
164193213|NCT05219968|593075792|FG004|Safety Extension Period|Withdrawal by Subject|4|||
164193214|NCT05219968|593075788|FG000|Safety Extension Period|Adverse Event|0|||
164193215|NCT05219968|593075789|FG001|Safety Extension Period|Adverse Event|0|||
164193216|NCT05219968|593075790|FG002|Safety Extension Period|Adverse Event|2|||
164193217|NCT05219968|593075791|FG003|Safety Extension Period|Adverse Event|1|||
164193218|NCT05219968|593075792|FG004|Safety Extension Period|Adverse Event|1|||
164193219|NCT05219968|593075788|FG000|Safety Extension Period|Lost to Follow-up|0|||
164193220|NCT05219968|593075789|FG001|Safety Extension Period|Lost to Follow-up|0|||
164193221|NCT05219968|593075790|FG002|Safety Extension Period|Lost to Follow-up|0|||
164193222|NCT05219968|593075791|FG003|Safety Extension Period|Lost to Follow-up|1|||
164193223|NCT05219968|593075792|FG004|Safety Extension Period|Lost to Follow-up|0|||
164193224|NCT03877224|593075793|FG000|Overall Study|Death|3|||
164193225|NCT03877224|593075794|FG001|Overall Study|Death|2|||
164193226|NCT03877224|593075793|FG000|Overall Study|Withdrawal by Subject|1|||
164193227|NCT03877224|593075794|FG001|Overall Study|Withdrawal by Subject|6|||
164193228|NCT03877224|593075793|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
164193229|NCT03877224|593075794|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
164193230|NCT04587336|593075797|FG000|Overall Study|Lost to Follow-up|1|||
164193231|NCT04587336|593075798|FG001|Overall Study|Lost to Follow-up|0|||
164193232|NCT01212094|593077446|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
164193233|NCT01212094|593077447|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
164193234|NCT01212094|593077448|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
164193235|NCT01212094|593077446|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
164193236|NCT01212094|593077447|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
164193237|NCT01212094|593077448|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
164193238|NCT01212094|593077446|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
164543763|NCT04667377|594362833|FG000|Maintenance Period|Adverse event: COVID infection|0|||
164193239|NCT01212094|593077447|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
164193240|NCT01212094|593077448|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
164193241|NCT01212094|593077446|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
164193242|NCT01212094|593077447|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
164193243|NCT01212094|593077448|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
164193244|NCT01212094|593077446|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
164193245|NCT01212094|593077447|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
164193246|NCT01212094|593077448|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
164193247|NCT01212094|593077446|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
164193248|NCT01212094|593077447|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
164193249|NCT01212094|593077448|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
164193250|NCT02787304|593077450|FG000|Overall Study|Adverse Event|9|||
164193251|NCT02787304|593077451|FG001|Overall Study|Adverse Event|3|||
164193252|NCT02787304|593077452|FG002|Overall Study|Adverse Event|8|||
164193253|NCT02787304|593077453|FG003|Overall Study|Adverse Event|1|||
164193254|NCT02787304|593077450|FG000|Overall Study|Withdrawal by Subject|1|||
164193255|NCT02787304|593077451|FG001|Overall Study|Withdrawal by Subject|4|||
164193256|NCT02787304|593077452|FG002|Overall Study|Withdrawal by Subject|0|||
164193257|NCT02787304|593077453|FG003|Overall Study|Withdrawal by Subject|0|||
164193258|NCT02787304|593077450|FG000|Overall Study|Lost to Follow-up|1|||
164193259|NCT02787304|593077451|FG001|Overall Study|Lost to Follow-up|0|||
164193260|NCT02787304|593077452|FG002|Overall Study|Lost to Follow-up|0|||
164193261|NCT02787304|593077453|FG003|Overall Study|Lost to Follow-up|1|||
164193262|NCT02787304|593077450|FG000|Overall Study|Noncompliance with study drug|0|||
164193263|NCT02787304|593077451|FG001|Overall Study|Noncompliance with study drug|0|||
164193264|NCT02787304|593077452|FG002|Overall Study|Noncompliance with study drug|1|||
164193265|NCT02787304|593077453|FG003|Overall Study|Noncompliance with study drug|0|||
164193266|NCT02787304|593077450|FG000|Overall Study|Physician Decision|0|||
164193267|NCT02787304|593077451|FG001|Overall Study|Physician Decision|0|||
164193268|NCT02787304|593077452|FG002|Overall Study|Physician Decision|1|||
164193269|NCT02787304|593077453|FG003|Overall Study|Physician Decision|0|||
164193270|NCT02787304|593077450|FG000|Overall Study|Study terminated by sponsor|25|||
164193271|NCT02787304|593077451|FG001|Overall Study|Study terminated by sponsor|31|||
164193272|NCT02787304|593077452|FG002|Overall Study|Study terminated by sponsor|31|||
164193273|NCT02787304|593077453|FG003|Overall Study|Study terminated by sponsor|32|||
164193274|NCT04771013|593077456|FG000|Overall Study|Withdrawal by Subject|2|||
164193275|NCT04771013|593077457|FG001|Overall Study|Withdrawal by Subject|0|||
164193276|NCT04771013|593077456|FG000|Overall Study|Death|0|||
164193277|NCT04771013|593077457|FG001|Overall Study|Death|5|||
164193278|NCT04771013|593077456|FG000|Overall Study|Referred to another hospital before day 20|0|||
164193279|NCT04771013|593077457|FG001|Overall Study|Referred to another hospital before day 20|1|||
164193280|NCT01051921|593077458|FG000|Overall Study|Physician Decision|9|||
164193281|NCT01051921|593077458|FG000|Overall Study|Adverse Event|8|||
164193282|NCT01051921|593077458|FG000|Overall Study|Withdrawal by Subject|7|||
164193283|NCT01051921|593077458|FG000|Overall Study|Lost to Follow-up|4|||
164193284|NCT01051921|593077458|FG000|Overall Study|virological failure|1|||
164193285|NCT01051921|593077458|FG000|Overall Study|patient moved|1|||
164193286|NCT00379834|593077459|FG000|Overall Study|Time constraints|2|||
164193287|NCT01519817|593077460|FG000|Overall Study|Withdrawal by Subject|1|||
164193288|NCT01519817|593077461|FG001|Overall Study|Withdrawal by Subject|0|||
164193289|NCT01519817|593077462|FG002|Overall Study|Withdrawal by Subject|0|||
164193290|NCT01519817|593077463|FG003|Overall Study|Withdrawal by Subject|0|||
164193291|NCT01519817|593077460|FG000|Overall Study|Off study due to infection|0|||
164193292|NCT01519817|593077461|FG001|Overall Study|Off study due to infection|0|||
164193293|NCT01519817|593077462|FG002|Overall Study|Off study due to infection|0|||
164193294|NCT01519817|593077463|FG003|Overall Study|Off study due to infection|1|||
164193295|NCT01716806|593077466|FG000|Overall Study|Patient withdrawal of consent|4|||
164193296|NCT01716806|593077467|FG001|Overall Study|Patient withdrawal of consent|2|||
164193297|NCT01716806|593077468|FG002|Overall Study|Patient withdrawal of consent|4|||
164193298|NCT01716806|593077469|FG003|Overall Study|Patient withdrawal of consent|3|||
164193299|NCT01716806|593077470|FG004|Overall Study|Patient withdrawal of consent|2|||
164193300|NCT01716806|593077471|FG005|Overall Study|Patient withdrawal of consent|0|||
164193301|NCT01716806|593077466|FG000|Overall Study|Lost to Follow-up|3|||
164193302|NCT01716806|593077467|FG001|Overall Study|Lost to Follow-up|3|||
164193303|NCT01716806|593077468|FG002|Overall Study|Lost to Follow-up|0|||
164193304|NCT01716806|593077469|FG003|Overall Study|Lost to Follow-up|2|||
164193305|NCT01716806|593077470|FG004|Overall Study|Lost to Follow-up|1|||
164193306|NCT01716806|593077471|FG005|Overall Study|Lost to Follow-up|0|||
164193307|NCT01716806|593077466|FG000|Overall Study|Death|13|||
164193308|NCT01716806|593077467|FG001|Overall Study|Death|9|||
164193309|NCT01716806|593077468|FG002|Overall Study|Death|12|||
164193310|NCT01716806|593077469|FG003|Overall Study|Death|4|||
164193311|NCT01716806|593077470|FG004|Overall Study|Death|10|||
164193312|NCT01716806|593077471|FG005|Overall Study|Death|5|||
164193313|NCT01716806|593077466|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
164653403|NCT00910858|594757125|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
164653404|NCT00910858|594757126|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
164653405|NCT00910858|594757124|FG000|Monotherapy Phase|Protocol Violation|1|||
164653406|NCT00910858|594757125|FG001|Monotherapy Phase|Protocol Violation|0|||
164653407|NCT00910858|594757126|FG002|Monotherapy Phase|Protocol Violation|0|||
164653408|NCT00910858|594757124|FG000|Monotherapy Phase|Other|3|||
164653409|NCT00910858|594757125|FG001|Monotherapy Phase|Other|4|||
164653410|NCT00910858|594757126|FG002|Monotherapy Phase|Other|2|||
164653411|NCT00910858|594757124|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
164653412|NCT00910858|594757125|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
164653413|NCT00910858|594757126|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
164653414|NCT00910858|594757124|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
164653415|NCT00910858|594757125|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
164653416|NCT00910858|594757126|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
164653417|NCT00910858|594757124|FG000|Combined Treatment Phase|Protocol Violation|1|||
164653418|NCT00910858|594757125|FG001|Combined Treatment Phase|Protocol Violation|0|||
164653419|NCT00910858|594757126|FG002|Combined Treatment Phase|Protocol Violation|0|||
164653420|NCT00910858|594757124|FG000|Combined Treatment Phase|Other|0|||
164653421|NCT00910858|594757125|FG001|Combined Treatment Phase|Other|2|||
164653422|NCT00910858|594757126|FG002|Combined Treatment Phase|Other|1|||
164653423|NCT00447603|594757133|FG000|Screening|Withdrawal by Subject|1|||
164653424|NCT00447603|594757134|FG001|Screening|Withdrawal by Subject|0|||
164653425|NCT00447603|594757135|FG002|Screening|Withdrawal by Subject|0|||
164653426|NCT00447603|594757133|FG000|Screening|Protocol Violation|1|||
164653427|NCT00447603|594757134|FG001|Screening|Protocol Violation|0|||
164653428|NCT00447603|594757135|FG002|Screening|Protocol Violation|0|||
164653429|NCT00447603|594757133|FG000|Screening|Screen Failure|4|||
164653430|NCT00447603|594757134|FG001|Screening|Screen Failure|0|||
164653431|NCT00447603|594757135|FG002|Screening|Screen Failure|0|||
164653432|NCT00447603|594757133|FG000|Screening|Study Terminated by Sponsor|15|||
164653433|NCT00447603|594757134|FG001|Screening|Study Terminated by Sponsor|0|||
164653434|NCT00447603|594757135|FG002|Screening|Study Terminated by Sponsor|0|||
164653435|NCT00447603|594757133|FG000|Filter Period|Adverse Event|0|||
164653436|NCT00447603|594757134|FG001|Filter Period|Adverse Event|0|||
164653437|NCT00447603|594757135|FG002|Filter Period|Adverse Event|1|||
164653438|NCT00447603|594757133|FG000|Filter Period|Screen Failure|0|||
164653439|NCT00447603|594757134|FG001|Filter Period|Screen Failure|3|||
164653440|NCT00447603|594757135|FG002|Filter Period|Screen Failure|4|||
164653441|NCT00447603|594757133|FG000|Filter Period|Study terminated by Sponsor|0|||
164653442|NCT00447603|594757134|FG001|Filter Period|Study terminated by Sponsor|1|||
164653443|NCT00447603|594757135|FG002|Filter Period|Study terminated by Sponsor|10|||
164653444|NCT01907737|594757142|FG000|Overall Study|Withdrawal by Subject|1|||
164653445|NCT00608205|594757161|FG000|Overall Study|Adverse Event|3|||
164653446|NCT00608205|594757162|FG001|Overall Study|Adverse Event|2|||
164653447|NCT00608205|594757161|FG000|Overall Study|Patient non-compliant|0|||
164653448|NCT00608205|594757162|FG001|Overall Study|Patient non-compliant|1|||
164653449|NCT01797120|594757163|FG000|Overall Study|Disesae progression|37|||
164653450|NCT01797120|594757164|FG001|Overall Study|Disesae progression|49|||
164653451|NCT01797120|594757163|FG000|Overall Study|Adverse Event|13|||
164653452|NCT01797120|594757164|FG001|Overall Study|Adverse Event|5|||
164653453|NCT01797120|594757163|FG000|Overall Study|Withdrawal by Subject|6|||
164653454|NCT01797120|594757164|FG001|Overall Study|Withdrawal by Subject|6|||
164653455|NCT01797120|594757163|FG000|Overall Study|Symptomatic progression|2|||
164653456|NCT01797120|594757164|FG001|Overall Study|Symptomatic progression|1|||
164653457|NCT01797120|594757163|FG000|Overall Study|Non-compliance|1|||
164653458|NCT01797120|594757164|FG001|Overall Study|Non-compliance|0|||
164653459|NCT01797120|594757163|FG000|Overall Study|Physician Decision|3|||
164653460|NCT01797120|594757164|FG001|Overall Study|Physician Decision|0|||
164653461|NCT01797120|594757163|FG000|Overall Study|still on treatment|2|||
164653462|NCT01797120|594757164|FG001|Overall Study|still on treatment|4|||
164653463|NCT01797120|594757163|FG000|Overall Study|never start protocol therapy|2|||
164653464|NCT01797120|594757164|FG001|Overall Study|never start protocol therapy|0|||
164653465|NCT05751629|594757182|FG000|Overall Study|Withdrawal by Subject|6|||
164653466|NCT05751629|594757182|FG000|Overall Study|Death|25|||
164653467|NCT05751629|594757182|FG000|Overall Study|Study Site Closed|9|||
164653468|NCT05751629|594757182|FG000|Overall Study|Physician Decision|1|||
164653469|NCT01909466|594757184|FG000|Overall Study|Lost to Follow-up|5|||
164653470|NCT01909466|594757185|FG001|Overall Study|Lost to Follow-up|7|||
164653471|NCT01909466|594757184|FG000|Overall Study|Adverse Event|3|||
164653472|NCT01909466|594757185|FG001|Overall Study|Adverse Event|4|||
164653473|NCT01909466|594757184|FG000|Overall Study|Met Withdrawal Criteria|0|||
164653474|NCT01909466|594757185|FG001|Overall Study|Met Withdrawal Criteria|3|||
164653475|NCT01909466|594757184|FG000|Overall Study|Physician Decision|2|||
164653476|NCT01909466|594757185|FG001|Overall Study|Physician Decision|0|||
164653477|NCT01909466|594757184|FG000|Overall Study|Withdrawal by Subject|11|||
164653478|NCT01909466|594757185|FG001|Overall Study|Withdrawal by Subject|9|||
164653479|NCT01909466|594757184|FG000|Overall Study|Lack of Efficacy|1|||
164653480|NCT01909466|594757185|FG001|Overall Study|Lack of Efficacy|0|||
164193314|NCT01716806|593077467|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
164193315|NCT01716806|593077468|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
164193316|NCT01716806|593077469|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
164193317|NCT01716806|593077470|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
164193318|NCT01716806|593077471|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
164193319|NCT01716806|593077466|FG000|Overall Study|PI decision|0|||
164193320|NCT01716806|593077467|FG001|Overall Study|PI decision|0|||
164193321|NCT01716806|593077468|FG002|Overall Study|PI decision|0|||
164193322|NCT01716806|593077469|FG003|Overall Study|PI decision|0|||
164193323|NCT01716806|593077470|FG004|Overall Study|PI decision|1|||
164193324|NCT01716806|593077471|FG005|Overall Study|PI decision|0|||
164193325|NCT01716806|593077466|FG000|Overall Study|Change in performance status|1|||
164193326|NCT01716806|593077467|FG001|Overall Study|Change in performance status|0|||
164193327|NCT01716806|593077468|FG002|Overall Study|Change in performance status|0|||
164193328|NCT01716806|593077469|FG003|Overall Study|Change in performance status|0|||
164193329|NCT01716806|593077470|FG004|Overall Study|Change in performance status|0|||
164193330|NCT01716806|593077471|FG005|Overall Study|Change in performance status|0|||
164193331|NCT01716806|593077466|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
164193332|NCT01716806|593077467|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
164193333|NCT01716806|593077468|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
164193334|NCT01716806|593077469|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
164193335|NCT01716806|593077470|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
164193336|NCT01716806|593077471|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
164193337|NCT01716806|593077466|FG000|Overall Study|Sponsor direction|7|||
164193338|NCT01716806|593077467|FG001|Overall Study|Sponsor direction|8|||
164193339|NCT01716806|593077468|FG002|Overall Study|Sponsor direction|5|||
164193340|NCT01716806|593077469|FG003|Overall Study|Sponsor direction|12|||
164193341|NCT01716806|593077470|FG004|Overall Study|Sponsor direction|16|||
164193342|NCT01716806|593077471|FG005|Overall Study|Sponsor direction|1|||
164193343|NCT00735709|593077474|FG000|Overall Study|Adverse Event|2|||
164193344|NCT00735709|593077475|FG001|Overall Study|Adverse Event|3|||
164193345|NCT00735709|593077476|FG002|Overall Study|Adverse Event|1|||
164193346|NCT00735709|593077477|FG003|Overall Study|Adverse Event|5|||
164193347|NCT00735709|593077474|FG000|Overall Study|Lack of Efficacy|8|||
164193348|NCT00735709|593077475|FG001|Overall Study|Lack of Efficacy|4|||
164193349|NCT00735709|593077476|FG002|Overall Study|Lack of Efficacy|2|||
164193350|NCT00735709|593077477|FG003|Overall Study|Lack of Efficacy|3|||
164193351|NCT00735709|593077474|FG000|Overall Study|Noncompliance|0|||
164193352|NCT00735709|593077475|FG001|Overall Study|Noncompliance|0|||
164193353|NCT00735709|593077476|FG002|Overall Study|Noncompliance|1|||
164193354|NCT00735709|593077477|FG003|Overall Study|Noncompliance|0|||
164193355|NCT00735709|593077474|FG000|Overall Study|Protocol deviations|1|||
164193356|NCT00735709|593077475|FG001|Overall Study|Protocol deviations|2|||
164193357|NCT00735709|593077476|FG002|Overall Study|Protocol deviations|1|||
164193358|NCT00735709|593077477|FG003|Overall Study|Protocol deviations|1|||
164193359|NCT00735709|593077474|FG000|Overall Study|Voluntary Withdrawal|1|||
164193360|NCT00735709|593077475|FG001|Overall Study|Voluntary Withdrawal|3|||
164193361|NCT00735709|593077476|FG002|Overall Study|Voluntary Withdrawal|5|||
164193362|NCT00735709|593077477|FG003|Overall Study|Voluntary Withdrawal|7|||
164193363|NCT00735709|593077474|FG000|Overall Study|Lost to Follow-up|0|||
164193364|NCT00735709|593077475|FG001|Overall Study|Lost to Follow-up|1|||
164193365|NCT00735709|593077476|FG002|Overall Study|Lost to Follow-up|1|||
164193366|NCT00735709|593077477|FG003|Overall Study|Lost to Follow-up|1|||
164193367|NCT00735709|593077474|FG000|Overall Study|Excluded medication|1|||
164193368|NCT00735709|593077475|FG001|Overall Study|Excluded medication|0|||
164193369|NCT00735709|593077476|FG002|Overall Study|Excluded medication|0|||
164193370|NCT00735709|593077477|FG003|Overall Study|Excluded medication|1|||
164193371|NCT01145482|593077478|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
164193372|NCT01145482|593077479|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
164193373|NCT04547140|593077480|FG000|Overall Study|Adverse Event|0|||
164193374|NCT04547140|593077481|FG001|Overall Study|Adverse Event|1|||
164193375|NCT04547140|593077480|FG000|Overall Study|Withdrawal by Subject|0|||
164193376|NCT04547140|593077481|FG001|Overall Study|Withdrawal by Subject|1|||
164193377|NCT04547140|593077480|FG000|Overall Study|Lost to Follow-up|3|||
164193378|NCT04547140|593077481|FG001|Overall Study|Lost to Follow-up|1|||
164193379|NCT04547140|593077480|FG000|Overall Study|Death|2|||
164193380|NCT04547140|593077481|FG001|Overall Study|Death|1|||
164193381|NCT04547140|593077480|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
164193382|NCT04547140|593077481|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
164193383|NCT04547140|593077480|FG000|Overall Study|Pregnancy|1|||
164193384|NCT04547140|593077481|FG001|Overall Study|Pregnancy|0|||
164193385|NCT04547140|593077480|FG000|Overall Study|Reason Not Specified|4|||
164193386|NCT04547140|593077481|FG001|Overall Study|Reason Not Specified|1|||
164193387|NCT02119299|593077482|FG000|Overall Study|Withdrawal by Subject|7|||
164193388|NCT02119299|593077482|FG000|Overall Study|Lack of Efficacy|1|||
164193389|NCT02119299|593077482|FG000|Overall Study|Pregnancy|1|||
164193390|NCT00873730|593077483|FG000|Overall Study|Protocol Deviation|5|||
164193391|NCT00873730|593077484|FG001|Overall Study|Protocol Deviation|2|||
164193392|NCT00873730|593077483|FG000|Overall Study|Adverse Event|0|||
164193393|NCT00873730|593077484|FG001|Overall Study|Adverse Event|2|||
164193394|NCT00873730|593077483|FG000|Overall Study|Withdrawal by Subject|0|||
164193395|NCT00873730|593077484|FG001|Overall Study|Withdrawal by Subject|1|||
164193396|NCT00873730|593077483|FG000|Overall Study|Sponsor decision|1|||
164193397|NCT00873730|593077484|FG001|Overall Study|Sponsor decision|0|||
164193398|NCT04613739|593077485|FG000|Overall Study|Lost to Follow-up|6|||
164193399|NCT04613739|593077486|FG001|Overall Study|Lost to Follow-up|9|||
164193400|NCT04613739|593077485|FG000|Overall Study|potentially duplicative/fraudulent|1|||
164193401|NCT04613739|593077486|FG001|Overall Study|potentially duplicative/fraudulent|3|||
164193402|NCT03442088|593077487|FG000|Overall Study|Adverse Event|1|||
164193403|NCT03442088|593077487|FG000|Overall Study|Lack of Efficacy|2|||
164193404|NCT03442088|593077487|FG000|Overall Study|Lost to Follow-up|2|||
164193405|NCT01051557|593077490|FG000|Overall Study|Physician Decision|1|||
164193406|NCT01051557|593077491|FG001|Overall Study|Physician Decision|0|||
164193407|NCT01051557|593077492|FG002|Overall Study|Physician Decision|0|||
164193408|NCT01051557|593077493|FG003|Overall Study|Physician Decision|0|||
164193409|NCT01051557|593077494|FG004|Overall Study|Physician Decision|0|||
164193410|NCT01051557|593077495|FG005|Overall Study|Physician Decision|0|||
164193411|NCT01051557|593077496|FG006|Overall Study|Physician Decision|0|||
164193412|NCT01051557|593077490|FG000|Overall Study|disease progression|3|||
164193413|NCT01051557|593077491|FG001|Overall Study|disease progression|3|||
164193414|NCT01051557|593077492|FG002|Overall Study|disease progression|5|||
164193415|NCT01051557|593077493|FG003|Overall Study|disease progression|2|||
164193416|NCT01051557|593077494|FG004|Overall Study|disease progression|4|||
164193417|NCT01051557|593077495|FG005|Overall Study|disease progression|3|||
164193418|NCT01051557|593077496|FG006|Overall Study|disease progression|1|||
164193419|NCT01051557|593077490|FG000|Overall Study|Withdrawal by Subject|0|||
164193420|NCT01051557|593077491|FG001|Overall Study|Withdrawal by Subject|0|||
164193421|NCT01051557|593077492|FG002|Overall Study|Withdrawal by Subject|1|||
164193422|NCT01051557|593077493|FG003|Overall Study|Withdrawal by Subject|0|||
164193423|NCT01051557|593077494|FG004|Overall Study|Withdrawal by Subject|2|||
164193424|NCT01051557|593077495|FG005|Overall Study|Withdrawal by Subject|0|||
164193425|NCT01051557|593077496|FG006|Overall Study|Withdrawal by Subject|1|||
164193426|NCT01051557|593077490|FG000|Overall Study|Adverse Event|0|||
164193427|NCT01051557|593077491|FG001|Overall Study|Adverse Event|0|||
164193428|NCT01051557|593077492|FG002|Overall Study|Adverse Event|0|||
164193429|NCT01051557|593077493|FG003|Overall Study|Adverse Event|1|||
164193430|NCT01051557|593077494|FG004|Overall Study|Adverse Event|1|||
164193431|NCT01051557|593077495|FG005|Overall Study|Adverse Event|3|||
164193432|NCT01051557|593077496|FG006|Overall Study|Adverse Event|4|||
164193433|NCT00130689|593077497|FG000|Overall Study|Progressive Disease|29|||
164193434|NCT00130689|593077497|FG000|Overall Study|Death|1|||
164193435|NCT00130689|593077497|FG000|Overall Study|Clinical Deterioration|4|||
164193436|NCT00130689|593077497|FG000|Overall Study|Withdrawal by Subject|3|||
164193437|NCT00130689|593077497|FG000|Overall Study|Ineligible|6|||
164193438|NCT00766597|593077498|FG000|Overall Study|Unexpected closure of study|4|||
164193439|NCT00766597|593077498|FG000|Overall Study|Without CCR5-tropic virus|5|||
164193440|NCT00048035|593077499|FG000|Core Period|Early Withdrawals|4|||
164193441|NCT00048035|593077500|FG001|Core Period|Early Withdrawals|2|||
164193442|NCT00048035|593077501|FG002|Core Period|Early Withdrawals|1|||
164193443|NCT00048035|593077502|FG003|Core Period|Early Withdrawals|1|||
164193444|NCT00048035|593077503|FG004|Core Period|Early Withdrawals|1|||
164193445|NCT00048035|593077504|FG005|Core Period|Early Withdrawals|1|||
164193446|NCT00048035|593077505|FG006|Core Period|Early Withdrawals|0|||
164193447|NCT00048035|593077506|FG007|Core Period|Early Withdrawals|0|||
164193448|NCT00048035|593077499|FG000|Extension Year 1|Early Withdrawals|0|||
164193449|NCT00048035|593077500|FG001|Extension Year 1|Early Withdrawals|0|||
164193450|NCT00048035|593077501|FG002|Extension Year 1|Early Withdrawals|0|||
164193451|NCT00048035|593077502|FG003|Extension Year 1|Early Withdrawals|0|||
164193452|NCT00048035|593077503|FG004|Extension Year 1|Early Withdrawals|0|||
164193453|NCT00048035|593077504|FG005|Extension Year 1|Early Withdrawals|0|||
164193454|NCT00048035|593077505|FG006|Extension Year 1|Early Withdrawals|11|||
164193455|NCT00048035|593077506|FG007|Extension Year 1|Early Withdrawals|11|||
164193456|NCT00048035|593077499|FG000|Extension Year 2|Early Withdrawals|0|||
164193457|NCT00048035|593077500|FG001|Extension Year 2|Early Withdrawals|0|||
164193458|NCT00048035|593077501|FG002|Extension Year 2|Early Withdrawals|0|||
164193459|NCT00048035|593077502|FG003|Extension Year 2|Early Withdrawals|0|||
164193460|NCT00048035|593077503|FG004|Extension Year 2|Early Withdrawals|0|||
164193461|NCT00048035|593077504|FG005|Extension Year 2|Early Withdrawals|0|||
164193462|NCT00048035|593077505|FG006|Extension Year 2|Early Withdrawals|3|||
164193463|NCT00048035|593077506|FG007|Extension Year 2|Early Withdrawals|3|||
164193464|NCT05137717|593077511|FG000|Overall Study|Death|2|||
164193465|NCT05137717|593077511|FG000|Overall Study|Withdrawal by Subject|6|||
164193466|NCT02619617|593077512|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
164193467|NCT02619617|593077513|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
164193468|NCT02619617|593077512|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
164193469|NCT02619617|593077513|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
164193470|NCT00509899|593077514|FG000|Overall Study|Progressive disease|1|||
164193471|NCT00509899|593077515|FG001|Overall Study|Progressive disease|3|||
164193472|NCT00509899|593077516|FG002|Overall Study|Progressive disease|5|||
164193473|NCT00509899|593077517|FG003|Overall Study|Progressive disease|1|||
164193474|NCT00509899|593077518|FG004|Overall Study|Progressive disease|0|||
164193475|NCT00509899|593077519|FG005|Overall Study|Progressive disease|1|||
164193476|NCT00509899|593077520|FG006|Overall Study|Progressive disease|0|||
164193477|NCT00509899|593077521|FG007|Overall Study|Progressive disease|0|||
164193478|NCT00509899|593077514|FG000|Overall Study|Unacceptable Toxicity|1|||
164193479|NCT00509899|593077515|FG001|Overall Study|Unacceptable Toxicity|0|||
164193480|NCT00509899|593077516|FG002|Overall Study|Unacceptable Toxicity|0|||
164193481|NCT00509899|593077517|FG003|Overall Study|Unacceptable Toxicity|2|||
164193482|NCT00509899|593077518|FG004|Overall Study|Unacceptable Toxicity|0|||
164193483|NCT00509899|593077519|FG005|Overall Study|Unacceptable Toxicity|0|||
164193484|NCT00509899|593077520|FG006|Overall Study|Unacceptable Toxicity|0|||
164193485|NCT00509899|593077521|FG007|Overall Study|Unacceptable Toxicity|0|||
164193486|NCT00509899|593077514|FG000|Overall Study|Withdrawal by Subject|6|||
164193487|NCT00509899|593077515|FG001|Overall Study|Withdrawal by Subject|2|||
164193488|NCT00509899|593077516|FG002|Overall Study|Withdrawal by Subject|3|||
164193489|NCT00509899|593077517|FG003|Overall Study|Withdrawal by Subject|0|||
164193490|NCT00509899|593077518|FG004|Overall Study|Withdrawal by Subject|3|||
164193491|NCT00509899|593077519|FG005|Overall Study|Withdrawal by Subject|2|||
164193492|NCT00509899|593077520|FG006|Overall Study|Withdrawal by Subject|0|||
164193493|NCT00509899|593077521|FG007|Overall Study|Withdrawal by Subject|0|||
164193494|NCT00509899|593077514|FG000|Overall Study|Physician Decision|4|||
164193495|NCT00509899|593077515|FG001|Overall Study|Physician Decision|2|||
164193496|NCT00509899|593077516|FG002|Overall Study|Physician Decision|7|||
164193497|NCT00509899|593077517|FG003|Overall Study|Physician Decision|0|||
164193498|NCT00509899|593077518|FG004|Overall Study|Physician Decision|1|||
164193499|NCT00509899|593077519|FG005|Overall Study|Physician Decision|4|||
164193500|NCT00509899|593077520|FG006|Overall Study|Physician Decision|0|||
164193501|NCT00509899|593077521|FG007|Overall Study|Physician Decision|0|||
164193502|NCT00509899|593077514|FG000|Overall Study|Intercurrent Illness|1|||
164193503|NCT00509899|593077515|FG001|Overall Study|Intercurrent Illness|0|||
164193504|NCT00509899|593077516|FG002|Overall Study|Intercurrent Illness|0|||
164193505|NCT00509899|593077517|FG003|Overall Study|Intercurrent Illness|1|||
164193506|NCT00509899|593077518|FG004|Overall Study|Intercurrent Illness|0|||
164193507|NCT00509899|593077519|FG005|Overall Study|Intercurrent Illness|1|||
164193508|NCT00509899|593077520|FG006|Overall Study|Intercurrent Illness|0|||
164193509|NCT00509899|593077521|FG007|Overall Study|Intercurrent Illness|0|||
164193510|NCT00509899|593077514|FG000|Overall Study|Death|2|||
164193511|NCT00509899|593077515|FG001|Overall Study|Death|2|||
164193512|NCT00509899|593077516|FG002|Overall Study|Death|3|||
164193513|NCT00509899|593077517|FG003|Overall Study|Death|0|||
164193514|NCT00509899|593077518|FG004|Overall Study|Death|1|||
164193515|NCT00509899|593077519|FG005|Overall Study|Death|1|||
164193516|NCT00509899|593077520|FG006|Overall Study|Death|1|||
164193517|NCT00509899|593077521|FG007|Overall Study|Death|1|||
164193518|NCT00509899|593077514|FG000|Overall Study|Lack of Efficacy|1|||
164193519|NCT00509899|593077515|FG001|Overall Study|Lack of Efficacy|0|||
164193520|NCT00509899|593077516|FG002|Overall Study|Lack of Efficacy|2|||
164193521|NCT00509899|593077517|FG003|Overall Study|Lack of Efficacy|0|||
164193522|NCT00509899|593077518|FG004|Overall Study|Lack of Efficacy|0|||
164193523|NCT00509899|593077519|FG005|Overall Study|Lack of Efficacy|1|||
164193524|NCT00509899|593077520|FG006|Overall Study|Lack of Efficacy|0|||
164543764|NCT04667377|594362834|FG001|Maintenance Period|Adverse event: COVID infection|1|||
164653481|NCT00772577|594757188|FG000|Overall Study|Adverse Event|6|||
164193525|NCT00509899|593077521|FG007|Overall Study|Lack of Efficacy|0|||
164193526|NCT01254656|593077522|FG000|Overall Study|Discontinued due to termination of study|40|||
164193527|NCT01254656|593077523|FG001|Overall Study|Discontinued due to termination of study|39|||
164193528|NCT01254656|593077524|FG002|Overall Study|Discontinued due to termination of study|13|||
164193529|NCT01254656|593077522|FG000|Overall Study|Lack of Efficacy|3|||
164193530|NCT01254656|593077523|FG001|Overall Study|Lack of Efficacy|0|||
164193531|NCT01254656|593077524|FG002|Overall Study|Lack of Efficacy|0|||
164193532|NCT01254656|593077522|FG000|Overall Study|Lost to Follow-up|1|||
164193533|NCT01254656|593077523|FG001|Overall Study|Lost to Follow-up|0|||
164193534|NCT01254656|593077524|FG002|Overall Study|Lost to Follow-up|2|||
164193535|NCT01254656|593077522|FG000|Overall Study|Withdrawal by Subject|2|||
164193536|NCT01254656|593077523|FG001|Overall Study|Withdrawal by Subject|2|||
164193537|NCT01254656|593077524|FG002|Overall Study|Withdrawal by Subject|1|||
164193538|NCT01254656|593077522|FG000|Overall Study|Pregnancy|0|||
164193539|NCT01254656|593077523|FG001|Overall Study|Pregnancy|0|||
164193540|NCT01254656|593077524|FG002|Overall Study|Pregnancy|2|||
164193541|NCT01254656|593077522|FG000|Overall Study|Adverse Event|1|||
164193542|NCT01254656|593077523|FG001|Overall Study|Adverse Event|1|||
164193543|NCT01254656|593077524|FG002|Overall Study|Adverse Event|0|||
164193544|NCT01254656|593077522|FG000|Overall Study|Death|0|||
164193545|NCT01254656|593077523|FG001|Overall Study|Death|1|||
164193546|NCT01254656|593077524|FG002|Overall Study|Death|0|||
164193547|NCT02326272|593077527|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193548|NCT02326272|593077528|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
164193549|NCT02326272|593077529|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
164193550|NCT02326272|593077530|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193551|NCT02326272|593077531|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193552|NCT02326272|593077532|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193553|NCT02326272|593077533|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193554|NCT02326272|593077534|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193555|NCT02326272|593077535|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193556|NCT02326272|593077536|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193557|NCT02326272|593077537|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193558|NCT02326272|593077538|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193559|NCT02326272|593077539|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193560|NCT02326272|593077540|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193561|NCT02326272|593077541|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193562|NCT02326272|593077527|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
164193563|NCT02326272|593077528|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
164193564|NCT02326272|593077529|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193565|NCT02326272|593077530|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193566|NCT02326272|593077531|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193567|NCT02326272|593077532|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193568|NCT02326272|593077533|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193569|NCT02326272|593077534|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193570|NCT02326272|593077535|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193571|NCT02326272|593077536|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193572|NCT02326272|593077537|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193573|NCT02326272|593077538|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193574|NCT02326272|593077539|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193575|NCT02326272|593077540|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193576|NCT02326272|593077541|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193577|NCT02326272|593077527|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
164193578|NCT02326272|593077528|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
164193579|NCT02326272|593077529|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
164193580|NCT02326272|593077530|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164193581|NCT02326272|593077531|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164193582|NCT02326272|593077532|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164193583|NCT02326272|593077533|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164193584|NCT02326272|593077534|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164193585|NCT02326272|593077535|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164193586|NCT02326272|593077536|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164193587|NCT02326272|593077537|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164193588|NCT02326272|593077538|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164193589|NCT02326272|593077539|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164193590|NCT02326272|593077540|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164193591|NCT02326272|593077541|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164193592|NCT02326272|593077527|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193593|NCT02326272|593077528|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193594|NCT02326272|593077529|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
164193595|NCT02326272|593077530|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193596|NCT02326272|593077531|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193597|NCT02326272|593077532|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193598|NCT02326272|593077533|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193599|NCT02326272|593077534|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193600|NCT02326272|593077535|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193601|NCT02326272|593077536|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193602|NCT02326272|593077537|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193603|NCT02326272|593077538|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193604|NCT02326272|593077539|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193605|NCT02326272|593077540|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193606|NCT02326272|593077541|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193607|NCT02326272|593077527|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193608|NCT02326272|593077528|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193609|NCT02326272|593077529|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
164193610|NCT02326272|593077530|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193611|NCT02326272|593077531|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193612|NCT02326272|593077532|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193613|NCT02326272|593077533|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193614|NCT02326272|593077534|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193615|NCT02326272|593077535|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193616|NCT02326272|593077536|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193617|NCT02326272|593077537|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193618|NCT02326272|593077538|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193619|NCT02326272|593077539|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193620|NCT02326272|593077540|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193621|NCT02326272|593077541|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193622|NCT02326272|593077527|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193623|NCT02326272|593077528|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193624|NCT02326272|593077529|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
164193625|NCT02326272|593077530|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193626|NCT02326272|593077531|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193627|NCT02326272|593077532|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193628|NCT02326272|593077533|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193629|NCT02326272|593077534|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193630|NCT02326272|593077535|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193631|NCT02326272|593077536|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193632|NCT02326272|593077537|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193633|NCT02326272|593077538|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193634|NCT02326272|593077539|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193635|NCT02326272|593077540|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193636|NCT02326272|593077541|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193637|NCT02326272|593077527|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193638|NCT02326272|593077528|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193639|NCT02326272|593077529|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
164193640|NCT02326272|593077530|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193641|NCT02326272|593077531|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193642|NCT02326272|593077532|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193643|NCT02326272|593077533|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193644|NCT02326272|593077534|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193645|NCT02326272|593077535|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193646|NCT02326272|593077536|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193647|NCT02326272|593077537|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193648|NCT02326272|593077538|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193649|NCT02326272|593077539|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193650|NCT02326272|593077540|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193651|NCT02326272|593077541|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164543765|NCT04667377|594362835|FG002|Maintenance Period|Adverse event: COVID infection|0|||
164543766|NCT04667377|594362836|FG003|Maintenance Period|Adverse event: COVID infection|0|||
164543767|NCT04667377|594362837|FG004|Maintenance Period|Adverse event: COVID infection|0|||
164543768|NCT04667377|594362833|FG000|Maintenance Period|COVID-related|0|||
164543769|NCT04667377|594362834|FG001|Maintenance Period|COVID-related|0|||
164543770|NCT04667377|594362835|FG002|Maintenance Period|COVID-related|1|||
164543771|NCT04667377|594362836|FG003|Maintenance Period|COVID-related|1|||
164543772|NCT04667377|594362837|FG004|Maintenance Period|COVID-related|0|||
164543773|NCT04667377|594362833|FG000|Maintenance Period|Protocol Violation|1|||
164543774|NCT04667377|594362834|FG001|Maintenance Period|Protocol Violation|0|||
164543775|NCT04667377|594362835|FG002|Maintenance Period|Protocol Violation|0|||
164543776|NCT04667377|594362836|FG003|Maintenance Period|Protocol Violation|0|||
164543777|NCT04667377|594362837|FG004|Maintenance Period|Protocol Violation|1|||
164543778|NCT04667377|594362833|FG000|Maintenance Period|Burden of study procedures|1|||
164543779|NCT04667377|594362834|FG001|Maintenance Period|Burden of study procedures|2|||
164543780|NCT04667377|594362835|FG002|Maintenance Period|Burden of study procedures|0|||
164543781|NCT04667377|594362836|FG003|Maintenance Period|Burden of study procedures|1|||
164543782|NCT04667377|594362837|FG004|Maintenance Period|Burden of study procedures|0|||
164543783|NCT04667377|594362833|FG000|Maintenance Period|Change of residence|0|||
164543784|NCT04667377|594362834|FG001|Maintenance Period|Change of residence|1|||
164193652|NCT02326272|593077527|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164193653|NCT02326272|593077528|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164193654|NCT02326272|593077529|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164193655|NCT02326272|593077530|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164193656|NCT02326272|593077531|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
164193657|NCT02326272|593077532|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
164193658|NCT02326272|593077533|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
164193659|NCT02326272|593077534|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
164193660|NCT02326272|593077535|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
164193661|NCT02326272|593077536|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164193662|NCT02326272|593077537|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164193663|NCT02326272|593077538|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164193664|NCT02326272|593077539|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164193665|NCT02326272|593077540|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164193666|NCT02326272|593077541|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164193667|NCT02326272|593077527|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164193668|NCT02326272|593077528|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164193669|NCT02326272|593077529|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164193670|NCT02326272|593077530|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164193671|NCT02326272|593077531|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164193672|NCT02326272|593077532|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
164193673|NCT02326272|593077533|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
164193674|NCT02326272|593077534|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164193675|NCT02326272|593077535|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
164193676|NCT02326272|593077536|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
164193677|NCT02326272|593077537|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164193678|NCT02326272|593077538|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164193679|NCT02326272|593077539|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164193680|NCT02326272|593077540|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164193681|NCT02326272|593077541|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164193682|NCT02326272|593077527|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193683|NCT02326272|593077528|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193684|NCT02326272|593077529|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193685|NCT02326272|593077530|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193686|NCT02326272|593077531|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193687|NCT02326272|593077532|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
164193688|NCT02326272|593077533|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193689|NCT02326272|593077534|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
164193690|NCT02326272|593077535|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193691|NCT02326272|593077536|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193692|NCT02326272|593077537|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193693|NCT02326272|593077538|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193694|NCT02326272|593077539|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193695|NCT02326272|593077540|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193696|NCT02326272|593077541|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193697|NCT02326272|593077527|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164193698|NCT02326272|593077528|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164193699|NCT02326272|593077529|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164193700|NCT02326272|593077530|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164193701|NCT02326272|593077531|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164193702|NCT02326272|593077532|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
164193703|NCT02326272|593077533|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164193704|NCT02326272|593077534|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164193705|NCT02326272|593077535|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164193706|NCT02326272|593077536|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164193707|NCT02326272|593077537|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164193708|NCT02326272|593077538|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164193709|NCT02326272|593077539|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164193710|NCT02326272|593077540|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164193711|NCT02326272|593077541|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164193712|NCT02326272|593077527|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193713|NCT02326272|593077528|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193714|NCT02326272|593077529|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193715|NCT02326272|593077530|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193716|NCT02326272|593077531|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193717|NCT02326272|593077532|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193718|NCT02326272|593077533|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193719|NCT02326272|593077534|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
164193720|NCT02326272|593077535|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193721|NCT02326272|593077536|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193722|NCT02326272|593077537|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193723|NCT02326272|593077538|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193724|NCT02326272|593077539|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193725|NCT02326272|593077540|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193726|NCT02326272|593077541|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193727|NCT02326272|593077527|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193728|NCT02326272|593077528|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193729|NCT02326272|593077529|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193730|NCT02326272|593077530|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193731|NCT02326272|593077531|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193732|NCT02326272|593077532|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193733|NCT02326272|593077533|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
164193734|NCT02326272|593077534|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193735|NCT02326272|593077535|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193736|NCT02326272|593077536|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193737|NCT02326272|593077537|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193738|NCT02326272|593077538|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193739|NCT02326272|593077539|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193740|NCT02326272|593077540|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193741|NCT02326272|593077541|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193742|NCT02326272|593077527|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193743|NCT02326272|593077528|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193744|NCT02326272|593077529|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193745|NCT02326272|593077530|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193746|NCT02326272|593077531|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193747|NCT02326272|593077532|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193748|NCT02326272|593077533|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193749|NCT02326272|593077534|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193750|NCT02326272|593077535|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
164193751|NCT02326272|593077536|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193752|NCT02326272|593077537|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193753|NCT02326272|593077538|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193754|NCT02326272|593077539|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193755|NCT02326272|593077540|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193756|NCT02326272|593077541|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193757|NCT02326272|593077527|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164193758|NCT02326272|593077528|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164193759|NCT02326272|593077529|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164193760|NCT02326272|593077530|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164193761|NCT02326272|593077531|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164193762|NCT02326272|593077532|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
164193763|NCT02326272|593077533|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
164193764|NCT02326272|593077534|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
164193765|NCT02326272|593077535|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
164193766|NCT02326272|593077536|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164193767|NCT02326272|593077537|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164193768|NCT02326272|593077538|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164193769|NCT02326272|593077539|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164193770|NCT02326272|593077540|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164193771|NCT02326272|593077541|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164193772|NCT02326272|593077527|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193773|NCT02326272|593077528|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193774|NCT02326272|593077529|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193775|NCT02326272|593077530|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193776|NCT02326272|593077531|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164543785|NCT04667377|594362835|FG002|Maintenance Period|Change of residence|0|||
164543786|NCT04667377|594362836|FG003|Maintenance Period|Change of residence|0|||
164193777|NCT02326272|593077532|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
164193778|NCT02326272|593077533|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193779|NCT02326272|593077534|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193780|NCT02326272|593077535|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193781|NCT02326272|593077536|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193782|NCT02326272|593077537|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193783|NCT02326272|593077538|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193784|NCT02326272|593077539|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193785|NCT02326272|593077540|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193786|NCT02326272|593077541|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193787|NCT02326272|593077527|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193788|NCT02326272|593077528|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193789|NCT02326272|593077529|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193790|NCT02326272|593077530|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193791|NCT02326272|593077531|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193792|NCT02326272|593077532|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193793|NCT02326272|593077533|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
164193794|NCT02326272|593077534|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193795|NCT02326272|593077535|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193796|NCT02326272|593077536|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193797|NCT02326272|593077537|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193798|NCT02326272|593077538|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193799|NCT02326272|593077539|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193800|NCT02326272|593077540|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193801|NCT02326272|593077541|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193802|NCT02326272|593077527|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
164193803|NCT02326272|593077528|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
164193804|NCT02326272|593077529|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
164193805|NCT02326272|593077530|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
164193806|NCT02326272|593077531|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
164193807|NCT02326272|593077532|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
164193808|NCT02326272|593077533|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
164193809|NCT02326272|593077534|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
164193810|NCT02326272|593077535|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
164193811|NCT02326272|593077536|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
164193812|NCT02326272|593077537|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
164193813|NCT02326272|593077538|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
164193814|NCT02326272|593077539|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
164193815|NCT02326272|593077540|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
164193816|NCT02326272|593077541|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
164193817|NCT02326272|593077527|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164193818|NCT02326272|593077528|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164193819|NCT02326272|593077529|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164193820|NCT02326272|593077530|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164193821|NCT02326272|593077531|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164193822|NCT02326272|593077532|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164193823|NCT02326272|593077533|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164193824|NCT02326272|593077534|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164193825|NCT02326272|593077535|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164193826|NCT02326272|593077536|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164193827|NCT02326272|593077537|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
164193828|NCT02326272|593077538|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
164193829|NCT02326272|593077539|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
164193830|NCT02326272|593077540|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164193831|NCT02326272|593077541|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
164193832|NCT02326272|593077527|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164193833|NCT02326272|593077528|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164193834|NCT02326272|593077529|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164193835|NCT02326272|593077530|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164193836|NCT02326272|593077531|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164193837|NCT02326272|593077532|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164193838|NCT02326272|593077533|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164653482|NCT00772577|594757189|FG001|Overall Study|Adverse Event|3|||
164193839|NCT02326272|593077534|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164193840|NCT02326272|593077535|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164193841|NCT02326272|593077536|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164193842|NCT02326272|593077537|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
164193843|NCT02326272|593077538|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164193844|NCT02326272|593077539|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
164193845|NCT02326272|593077540|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164193846|NCT02326272|593077541|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164193847|NCT02326272|593077527|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193848|NCT02326272|593077528|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193849|NCT02326272|593077529|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193850|NCT02326272|593077530|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193851|NCT02326272|593077531|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193852|NCT02326272|593077532|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193853|NCT02326272|593077533|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193854|NCT02326272|593077534|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193855|NCT02326272|593077535|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193856|NCT02326272|593077536|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193857|NCT02326272|593077537|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193858|NCT02326272|593077538|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
164193859|NCT02326272|593077539|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193860|NCT02326272|593077540|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193861|NCT02326272|593077541|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193862|NCT02326272|593077527|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164193863|NCT02326272|593077528|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164193864|NCT02326272|593077529|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164193865|NCT02326272|593077530|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164193866|NCT02326272|593077531|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164193867|NCT02326272|593077532|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164193868|NCT02326272|593077533|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164193869|NCT02326272|593077534|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164193870|NCT02326272|593077535|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164193871|NCT02326272|593077536|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164193872|NCT02326272|593077537|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
164193873|NCT02326272|593077538|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164193874|NCT02326272|593077539|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
164193875|NCT02326272|593077540|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164193876|NCT02326272|593077541|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
164193877|NCT02326272|593077527|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193878|NCT02326272|593077528|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193879|NCT02326272|593077529|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193880|NCT02326272|593077530|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193881|NCT02326272|593077531|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193882|NCT02326272|593077532|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193883|NCT02326272|593077533|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193884|NCT02326272|593077534|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193885|NCT02326272|593077535|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193886|NCT02326272|593077536|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193887|NCT02326272|593077537|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193888|NCT02326272|593077538|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
164193889|NCT02326272|593077539|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193890|NCT02326272|593077540|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193891|NCT02326272|593077541|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
164193892|NCT02326272|593077527|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164193893|NCT02326272|593077528|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164193894|NCT02326272|593077529|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164193895|NCT02326272|593077530|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164193896|NCT02326272|593077531|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164193897|NCT02326272|593077532|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164302200|NCT01134055|593482557|FG001|Overall Study|Lost to Follow-up|1|||
164543787|NCT04667377|594362837|FG004|Maintenance Period|Change of residence|1|||
164543788|NCT04667377|594362833|FG000|Maintenance Period|Missing|1|||
164543789|NCT04667377|594362834|FG001|Maintenance Period|Missing|0|||
164543790|NCT04667377|594362835|FG002|Maintenance Period|Missing|0|||
164193898|NCT02326272|593077533|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164193899|NCT02326272|593077534|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164193900|NCT02326272|593077535|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164193901|NCT02326272|593077536|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164193902|NCT02326272|593077537|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164193903|NCT02326272|593077538|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
164193904|NCT02326272|593077539|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
164193905|NCT02326272|593077540|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164193906|NCT02326272|593077541|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
164193907|NCT02326272|593077527|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164193908|NCT02326272|593077528|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164193909|NCT02326272|593077529|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164193910|NCT02326272|593077530|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164193911|NCT02326272|593077531|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164193912|NCT02326272|593077532|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164543791|NCT04667377|594362836|FG003|Maintenance Period|Missing|0|||
164543792|NCT04667377|594362837|FG004|Maintenance Period|Missing|0|||
164543793|NCT04667377|594362833|FG000|Maintenance Period|Other than listed above|2|||
164543794|NCT04667377|594362834|FG001|Maintenance Period|Other than listed above|0|||
164543795|NCT04667377|594362835|FG002|Maintenance Period|Other than listed above|3|||
164543796|NCT04667377|594362836|FG003|Maintenance Period|Other than listed above|2|||
164543797|NCT04667377|594362837|FG004|Maintenance Period|Other than listed above|6|||
164543798|NCT04667377|594362833|FG000|Maintenance Period|Withdrawal by Subject|0|||
164543799|NCT04667377|594362834|FG001|Maintenance Period|Withdrawal by Subject|1|||
164543800|NCT04667377|594362835|FG002|Maintenance Period|Withdrawal by Subject|0|||
164543801|NCT04667377|594362836|FG003|Maintenance Period|Withdrawal by Subject|0|||
164543802|NCT04667377|594362837|FG004|Maintenance Period|Withdrawal by Subject|0|||
164543803|NCT04667377|594362833|FG000|Maintenance Period|Lost to Follow-up|1|||
164543804|NCT04667377|594362834|FG001|Maintenance Period|Lost to Follow-up|0|||
164543805|NCT04667377|594362835|FG002|Maintenance Period|Lost to Follow-up|1|||
164543806|NCT04667377|594362836|FG003|Maintenance Period|Lost to Follow-up|0|||
164543807|NCT04667377|594362837|FG004|Maintenance Period|Lost to Follow-up|1|||
164543808|NCT02319668|594362838|FG000|Overall Study|Other (Not specified)|0|||
164543809|NCT02319668|594362839|FG001|Overall Study|Other (Not specified)|2|||
164543810|NCT01161043|594362840|FG000|Overall Study|Withdrawal by Subject|3|||
164543811|NCT02170779|594362844|FG000|Overall Study|Withdrawal by Subject|1|||
164543812|NCT02170779|594362845|FG001|Overall Study|Withdrawal by Subject|0|||
164543813|NCT02170779|594362844|FG000|Overall Study|Lost to Follow-up|0|||
164543814|NCT02170779|594362845|FG001|Overall Study|Lost to Follow-up|1|||
164543815|NCT00199836|594362850|FG000|Overall Study|Progressive Disease|5|||
164543816|NCT00199836|594362850|FG000|Overall Study|Death|1|||
164543817|NCT02003014|594362851|FG000|Overall Study|Case report forms uncollected|9|||
164543818|NCT02003014|594362851|FG000|Overall Study|Treatment started after contract period|1|||
164543819|NCT02003014|594362851|FG000|Overall Study|Patient did not visit the study site|5|||
164543820|NCT02003014|594362851|FG000|Overall Study|Investigator's transfer|4|||
164543821|NCT00445224|594362854|FG000|Specific Exercises|Withdrawal by Subject|3|||
164543822|NCT00445224|594362855|FG001|Specific Exercises|Withdrawal by Subject|3|||
164543823|NCT00445224|594362854|FG000|Specific Exercises|Withdrawal by Subject|1|||
164543824|NCT00445224|594362855|FG001|Specific Exercises|Withdrawal by Subject|0|||
164543825|NCT01624259|594362856|FG000|Overall Study|Adverse Event|18|||
164543826|NCT01624259|594362857|FG001|Overall Study|Adverse Event|18|||
164543827|NCT01624259|594362856|FG000|Overall Study|Protocol Violation|1|||
164543828|NCT01624259|594362857|FG001|Overall Study|Protocol Violation|2|||
164543829|NCT01624259|594362856|FG000|Overall Study|Withdrawal by Subject|5|||
164543830|NCT01624259|594362857|FG001|Overall Study|Withdrawal by Subject|7|||
164543831|NCT01624259|594362856|FG000|Overall Study|Physician Decision|1|||
164543832|NCT01624259|594362857|FG001|Overall Study|Physician Decision|1|||
164543833|NCT01624259|594362856|FG000|Overall Study|Lost to Follow-up|2|||
164543834|NCT01624259|594362857|FG001|Overall Study|Lost to Follow-up|3|||
164543835|NCT01624259|594362856|FG000|Overall Study|Abnormal laboratory measure|3|||
164543836|NCT01624259|594362857|FG001|Overall Study|Abnormal laboratory measure|0|||
164543837|NCT02273726|594362858|FG000|Overall Study|Death|70|||
164543838|NCT02273726|594362859|FG001|Overall Study|Death|62|||
164193913|NCT02326272|593077533|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164193914|NCT02326272|593077534|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164193915|NCT02326272|593077535|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164543839|NCT02273726|594362858|FG000|Overall Study|Withdrawal by Subject|41|||
164543840|NCT02273726|594362859|FG001|Overall Study|Withdrawal by Subject|29|||
164543841|NCT02273726|594362858|FG000|Overall Study|Kidney transplant|31|||
164543842|NCT02273726|594362859|FG001|Overall Study|Kidney transplant|39|||
164543843|NCT02273726|594362858|FG000|Overall Study|Physician Decision|30|||
164543844|NCT02273726|594362859|FG001|Overall Study|Physician Decision|15|||
164543845|NCT02273726|594362858|FG000|Overall Study|Adverse Event|27|||
164543846|NCT02273726|594362859|FG001|Overall Study|Adverse Event|9|||
164543847|NCT02273726|594362858|FG000|Overall Study|Lost to Follow-up|6|||
164543848|NCT02273726|594362859|FG001|Overall Study|Lost to Follow-up|3|||
164543849|NCT02273726|594362858|FG000|Overall Study|Lack of Efficacy|6|||
164543850|NCT02273726|594362859|FG001|Overall Study|Lack of Efficacy|1|||
164543851|NCT02273726|594362858|FG000|Overall Study|Protocol Violation|4|||
164543852|NCT02273726|594362859|FG001|Overall Study|Protocol Violation|0|||
164543853|NCT02273726|594362858|FG000|Overall Study|Other than specified|28|||
164543854|NCT02273726|594362859|FG001|Overall Study|Other than specified|30|||
164543855|NCT02322125|594364574|FG000|Overall Study|Withdrawal by Subject|2|||
164543856|NCT04096274|594364583|FG000|Phase I|Lost to Follow-up|5|||
164543857|NCT04096274|594364584|FG001|Phase I|Lost to Follow-up|5|||
164543858|NCT04096274|594364583|FG000|Phase II|Lost to Follow-up|11|||
164543859|NCT04096274|594364584|FG001|Phase II|Lost to Follow-up|11|||
164543860|NCT04042740|594364585|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
164543861|NCT04042740|594364585|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
164543862|NCT01462435|594364587|FG000|Overall Study|Lack of Efficacy|1|||
164653483|NCT00772577|594757188|FG000|Overall Study|Abnormal laboratory values|0|||
164653484|NCT00772577|594757189|FG001|Overall Study|Abnormal laboratory values|1|||
164653485|NCT00772577|594757188|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164653486|NCT00772577|594757189|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
164653487|NCT00772577|594757188|FG000|Overall Study|Patient withdrew consent|8|||
164653488|NCT00772577|594757189|FG001|Overall Study|Patient withdrew consent|5|||
164193916|NCT02326272|593077536|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164193917|NCT02326272|593077537|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164543863|NCT01462435|594364588|FG001|Overall Study|Lack of Efficacy|0|||
164543864|NCT01462435|594364589|FG002|Overall Study|Lack of Efficacy|0|||
164543865|NCT01462435|594364590|FG003|Overall Study|Lack of Efficacy|3|||
164543866|NCT01462435|594364587|FG000|Overall Study|Physician Decision|0|||
164543867|NCT01462435|594364588|FG001|Overall Study|Physician Decision|0|||
164543868|NCT01462435|594364589|FG002|Overall Study|Physician Decision|1|||
164543869|NCT01462435|594364590|FG003|Overall Study|Physician Decision|0|||
164543870|NCT01462435|594364587|FG000|Overall Study|Withdrawal by Subject|0|||
164543871|NCT01462435|594364588|FG001|Overall Study|Withdrawal by Subject|0|||
164543872|NCT01462435|594364589|FG002|Overall Study|Withdrawal by Subject|0|||
164543873|NCT01462435|594364590|FG003|Overall Study|Withdrawal by Subject|1|||
164543874|NCT01462435|594364587|FG000|Overall Study|Lost to Follow-up|0|||
164193918|NCT02326272|593077538|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
164193919|NCT02326272|593077539|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164193920|NCT02326272|593077540|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164193921|NCT02326272|593077541|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164193922|NCT02326272|593077527|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193923|NCT02326272|593077528|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193924|NCT02326272|593077529|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193925|NCT02326272|593077530|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193926|NCT02326272|593077531|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193927|NCT02326272|593077532|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193928|NCT02326272|593077533|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193929|NCT02326272|593077534|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193930|NCT02326272|593077535|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193931|NCT02326272|593077536|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193932|NCT02326272|593077537|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193933|NCT02326272|593077538|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193934|NCT02326272|593077539|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
164193935|NCT02326272|593077540|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193936|NCT02326272|593077541|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193937|NCT01265394|593077546|FG000|Overall Study|Subjects withdrawn|37|||
164193938|NCT01348139|593077550|FG000|Period 1|Adverse Event|1|||
164193939|NCT01348139|593077551|FG001|Period 1|Adverse Event|0|||
164193940|NCT01348139|593077552|FG002|Period 1|Adverse Event|0|||
164193941|NCT01348139|593077553|FG003|Period 1|Adverse Event|0|||
164193942|NCT01348139|593077554|FG004|Period 1|Adverse Event|0|||
164193943|NCT01348139|593077555|FG005|Period 1|Adverse Event|0|||
164193944|NCT02254772|593077558|FG000|Overall Study|Ineligible|1|||
164193945|NCT02254772|593077558|FG000|Overall Study|Withdrawal by Subject|1|||
164193946|NCT00483652|593077559|FG000|Double-blind Treatment Period|Protocol Violation|2|||
164193947|NCT00483652|593077560|FG001|Double-blind Treatment Period|Protocol Violation|1|||
164543875|NCT01462435|594364588|FG001|Overall Study|Lost to Follow-up|0|||
164543876|NCT01462435|594364589|FG002|Overall Study|Lost to Follow-up|0|||
164193948|NCT00483652|593077559|FG000|Double-blind Treatment Period|Adverse Event|3|||
164193949|NCT00483652|593077560|FG001|Double-blind Treatment Period|Adverse Event|4|||
164193950|NCT00483652|593077559|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
164193951|NCT00483652|593077560|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
164193952|NCT00483652|593077559|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
164193953|NCT00483652|593077560|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
164193954|NCT03006562|593077561|FG000|Overall Study|Lost to Follow-up|0|||
164193955|NCT03006562|593077562|FG001|Overall Study|Lost to Follow-up|1|||
164193956|NCT02427841|593077571|FG000|Overall Study|Lack of Efficacy|5|||
164193957|NCT02427841|593077571|FG000|Overall Study|Physician Decision|2|||
164193958|NCT02427841|593077571|FG000|Overall Study|Withdrawal by Subject|1|||
164193959|NCT01841970|593077572|FG000|Overall Study|Withdrawal by Subject|1|||
164193960|NCT01841970|593077572|FG000|Overall Study|Physician Decision|2|||
164193961|NCT01841970|593077572|FG000|Overall Study|Lost to Follow-up|8|||
164193962|NCT03075267|593077583|FG000|Overall Study|Protocol Violation|1|||
164193963|NCT03075267|593077584|FG001|Overall Study|Protocol Violation|0|||
164193964|NCT03075267|593077585|FG002|Overall Study|Protocol Violation|0|||
164543877|NCT01462435|594364590|FG003|Overall Study|Lost to Follow-up|1|||
164543878|NCT05092919|594364591|FG000|Overall Study|Lost to Follow-up|7|||
164543879|NCT05092919|594364591|FG000|Overall Study|Withdrawal by Subject|2|||
164543880|NCT03281668|594364595|FG000|Overall Study|Physician Decision|1|||
164653489|NCT00772577|594757188|FG000|Overall Study|Lost to Follow-up|4|||
164193965|NCT03874013|593077586|FG000|Overall Study|Adverse Event|0|||
164193966|NCT03874013|593077587|FG001|Overall Study|Adverse Event|1|||
164193967|NCT00274742|593077588|FG000|Overall Study|Adverse Event|0|||
164193968|NCT00274742|593077589|FG001|Overall Study|Adverse Event|4|||
164543881|NCT03281668|594364595|FG000|Overall Study|scheduling conflict, family circumstance|2|||
164543882|NCT03281668|594364595|FG000|Overall Study|Withdrawal by Subject|4|||
164543883|NCT03281668|594364595|FG000|Overall Study|Lost to Follow-up|1|||
164193969|NCT00274742|593077590|FG002|Overall Study|Adverse Event|1|||
164193970|NCT00274742|593077591|FG003|Overall Study|Adverse Event|4|||
164193971|NCT00274742|593077592|FG004|Overall Study|Adverse Event|12|||
164193972|NCT00274742|593077593|FG005|Overall Study|Adverse Event|3|||
164193973|NCT00274742|593077588|FG000|Overall Study|Lost to Follow-up|0|||
164193974|NCT00274742|593077589|FG001|Overall Study|Lost to Follow-up|0|||
164193975|NCT00274742|593077590|FG002|Overall Study|Lost to Follow-up|0|||
164543884|NCT01543152|594364596|FG000|Overall Study|Withdrawal by Subject|0|||
164543885|NCT01543152|594364597|FG001|Overall Study|Withdrawal by Subject|2|||
164543886|NCT01543152|594364598|FG002|Overall Study|Withdrawal by Subject|0|||
164543887|NCT01543152|594364599|FG003|Overall Study|Withdrawal by Subject|0|||
164543888|NCT01543152|594364600|FG004|Overall Study|Withdrawal by Subject|0|||
164543889|NCT01838616|594364603|FG000|Titration Period|Adverse Event|18|||
164543890|NCT01838616|594364604|FG001|Titration Period|Adverse Event|48|||
164543891|NCT01838616|594364603|FG000|Titration Period|Lack of Efficacy|5|||
164543892|NCT01838616|594364604|FG001|Titration Period|Lack of Efficacy|12|||
164543893|NCT01838616|594364603|FG000|Titration Period|Withdrawal by Subject|5|||
164543894|NCT01838616|594364604|FG001|Titration Period|Withdrawal by Subject|5|||
164543895|NCT01838616|594364603|FG000|Titration Period|Technical problems|1|||
164543896|NCT01838616|594364604|FG001|Titration Period|Technical problems|0|||
164543897|NCT01838616|594364603|FG000|Titration Period|Other|1|||
164543898|NCT01838616|594364604|FG001|Titration Period|Other|0|||
164543899|NCT01838616|594364603|FG000|Titration Period|Protocol Violation|0|||
164543900|NCT01838616|594364604|FG001|Titration Period|Protocol Violation|1|||
164543901|NCT01838616|594364603|FG000|Continuation Period|Lack of Efficacy|3|||
164543902|NCT01838616|594364604|FG001|Continuation Period|Lack of Efficacy|5|||
164543903|NCT01838616|594364603|FG000|Continuation Period|Adverse Event|8|||
164543904|NCT01838616|594364604|FG001|Continuation Period|Adverse Event|4|||
164543905|NCT01838616|594364603|FG000|Continuation Period|Protocol Violation|2|||
164543906|NCT01838616|594364604|FG001|Continuation Period|Protocol Violation|0|||
164543907|NCT01838616|594364603|FG000|Continuation Period|Lost to Follow-up|1|||
164543908|NCT01838616|594364604|FG001|Continuation Period|Lost to Follow-up|0|||
164543909|NCT01838616|594364603|FG000|Continuation Period|Withdrawal by Subject|0|||
164543910|NCT01838616|594364604|FG001|Continuation Period|Withdrawal by Subject|4|||
164543911|NCT01838616|594364603|FG000|Continuation Period|Technical problems|0|||
164543912|NCT01838616|594364604|FG001|Continuation Period|Technical problems|1|||
164543913|NCT01838616|594364603|FG000|Pick-up Arm|Lack of Efficacy|4|||
164543914|NCT01838616|594364604|FG001|Pick-up Arm|Lack of Efficacy|0|||
164543915|NCT01838616|594364603|FG000|Pick-up Arm|Adverse Event|9|||
164543916|NCT01838616|594364604|FG001|Pick-up Arm|Adverse Event|0|||
164193976|NCT00274742|593077591|FG003|Overall Study|Lost to Follow-up|0|||
164193977|NCT00274742|593077592|FG004|Overall Study|Lost to Follow-up|1|||
164193978|NCT00274742|593077593|FG005|Overall Study|Lost to Follow-up|0|||
164193979|NCT00274742|593077588|FG000|Overall Study|End of Study|0|||
164193980|NCT00274742|593077589|FG001|Overall Study|End of Study|0|||
164193981|NCT00274742|593077590|FG002|Overall Study|End of Study|0|||
164193982|NCT00274742|593077591|FG003|Overall Study|End of Study|1|||
164193983|NCT00274742|593077592|FG004|Overall Study|End of Study|0|||
164193984|NCT00274742|593077593|FG005|Overall Study|End of Study|0|||
164193985|NCT00274742|593077588|FG000|Overall Study|Disease Progression|0|||
164193986|NCT00274742|593077589|FG001|Overall Study|Disease Progression|1|||
164193987|NCT00274742|593077590|FG002|Overall Study|Disease Progression|1|||
164193988|NCT00274742|593077591|FG003|Overall Study|Disease Progression|0|||
164193989|NCT00274742|593077592|FG004|Overall Study|Disease Progression|1|||
164193990|NCT00274742|593077593|FG005|Overall Study|Disease Progression|0|||
164193991|NCT00274742|593077588|FG000|Overall Study|Other|0|||
164193992|NCT00274742|593077589|FG001|Overall Study|Other|3|||
164193993|NCT00274742|593077590|FG002|Overall Study|Other|0|||
164193994|NCT00274742|593077591|FG003|Overall Study|Other|0|||
164193995|NCT00274742|593077592|FG004|Overall Study|Other|2|||
164193996|NCT00274742|593077593|FG005|Overall Study|Other|0|||
164193997|NCT03421379|593077594|FG000|Period 1|Withdrawal by Subject|0|||
164193998|NCT03421379|593077595|FG001|Period 1|Withdrawal by Subject|1|||
164193999|NCT03421379|593077594|FG000|Period 1|Physician Decision|1|||
164194000|NCT03421379|593077595|FG001|Period 1|Physician Decision|1|||
164194001|NCT03421379|593077594|FG000|Period 1|Did not receive treatment|1|||
164543917|NCT01838616|594364603|FG000|Pick-up Arm|Withdrawal by Subject|1|||
164543918|NCT01838616|594364604|FG001|Pick-up Arm|Withdrawal by Subject|0|||
164543919|NCT01838616|594364603|FG000|Pick-up Arm|Technical problems|1|||
164543920|NCT01838616|594364604|FG001|Pick-up Arm|Technical problems|0|||
164194002|NCT03421379|593077595|FG001|Period 1|Did not receive treatment|2|||
164194003|NCT03771963|593077600|FG000|Overall Study|Lost to Follow-up|22|||
164194004|NCT03771963|593077600|FG000|Overall Study|Withdrawal of Consent|10|||
164194005|NCT00102596|593077601|FG000|Part A|Screen failures|6|||
164543921|NCT01227187|594364606|FG000|Overall Study|Physician Decision|0|||
164543922|NCT01227187|594364607|FG001|Overall Study|Physician Decision|0|||
164543923|NCT01227187|594364608|FG002|Overall Study|Physician Decision|0|||
164543924|NCT01227187|594364609|FG003|Overall Study|Physician Decision|1|||
164543925|NCT01566773|594364611|FG000|Overall Study|Protocol specified criteria|4|||
164543926|NCT01566773|594364611|FG000|Overall Study|Protocol Violation|4|||
164194006|NCT00102596|593077602|FG001|Part A|Screen failures|0|||
164194007|NCT00102596|593077601|FG000|Part A|Adverse Event|1|||
164543927|NCT01566773|594364611|FG000|Overall Study|Withdrawal by Subject|9|||
164194008|NCT00102596|593077602|FG001|Part A|Adverse Event|0|||
164194009|NCT02039778|593077607|FG000|Overall Study|Death|2|||
164194010|NCT02039778|593077607|FG000|Overall Study|Withdrawal by Subject|1|||
164194011|NCT02039778|593077607|FG000|Overall Study|Never started the protocol treatment|1|||
164194012|NCT01670045|593077609|FG000|Overall Study|Withdrawal by Subject|3|||
164194013|NCT01670045|593077609|FG000|Overall Study|Adverse Event|1|||
164543928|NCT01566773|594364611|FG000|Overall Study|Administrative reason|1|||
164543929|NCT01566773|594364611|FG000|Overall Study|Adverse Event|10|||
164543930|NCT01566773|594364611|FG000|Overall Study|Physician Decision|2|||
164543931|NCT04784897|594364613|FG000|Overall Study|Death|4|||
164543932|NCT04784897|594364614|FG001|Overall Study|Death|2|||
164543933|NCT04784897|594364615|FG002|Overall Study|Death|1|||
164543934|NCT04784897|594364613|FG000|Overall Study|Withdrawal by Subject|0|||
164543935|NCT04784897|594364614|FG001|Overall Study|Withdrawal by Subject|0|||
164543936|NCT04784897|594364615|FG002|Overall Study|Withdrawal by Subject|1|||
164543937|NCT01671111|594364618|FG000|Overall Study|Adverse Event|2|||
164543938|NCT01671111|594364618|FG000|Overall Study|Lack of Efficacy|1|||
164543939|NCT01671111|594364618|FG000|Overall Study|Withdrawal by Subject|2|||
164543940|NCT01671111|594364618|FG000|Overall Study|Physician Decision|1|||
164543941|NCT01671111|594364618|FG000|Overall Study|Other|24|||
164543942|NCT01537198|594364622|FG000|Overall Study|RSV infection|2|||
164543943|NCT01537198|594364622|FG000|Overall Study|Adverse Event|4|||
164543944|NCT01537198|594364622|FG000|Overall Study|No Further Visits to the Clinic|37|||
164543945|NCT01537198|594364622|FG000|Overall Study|Other|111|||
164543946|NCT00496730|594364629|FG000|Overall Study|Lost to Follow-up|4|||
164194014|NCT01670045|593077609|FG000|Overall Study|Death|1|||
164194015|NCT01670045|593077609|FG000|Overall Study|Lost to Follow-up|11|||
164194016|NCT01462110|593077610|FG000|Overall Study|Adverse Event|1|||
164194017|NCT01462110|593077611|FG001|Overall Study|Adverse Event|0|||
164194018|NCT05279131|593077612|FG000|Overall Study|Lost to Follow-up|1|||
164194019|NCT05279131|593077612|FG000|Overall Study|Death|1|||
164194020|NCT05279131|593077612|FG000|Overall Study|Physician Decision|1|||
164194021|NCT00964028|593077613|FG000|Overall Study|Withdrawal by Subject|0|||
164194022|NCT00964028|593077614|FG001|Overall Study|Withdrawal by Subject|1|||
164194023|NCT00069823|593077621|FG000|Overall Study|Did not have follow-up diary cards|6|||
164194024|NCT00069823|593077622|FG001|Overall Study|Did not have follow-up diary cards|3|||
164194025|NCT00419757|593079320|FG000|Overall Study|Adverse Event|1|||
164194026|NCT00419757|593079321|FG001|Overall Study|Adverse Event|4|||
164194027|NCT00419757|593079320|FG000|Overall Study|Lost to Follow-up|1|||
164194028|NCT00419757|593079321|FG001|Overall Study|Lost to Follow-up|4|||
164194029|NCT00419757|593079320|FG000|Overall Study|Withdrawal by Subject|7|||
164194030|NCT00419757|593079321|FG001|Overall Study|Withdrawal by Subject|1|||
164194031|NCT00419757|593079320|FG000|Overall Study|Protocol Violation|2|||
164194032|NCT00419757|593079321|FG001|Overall Study|Protocol Violation|3|||
164194033|NCT00419757|593079320|FG000|Overall Study|Study specific discontinuation criteria|4|||
164194034|NCT00419757|593079321|FG001|Overall Study|Study specific discontinuation criteria|8|||
164194035|NCT00419757|593079320|FG000|Overall Study|Multiple reasons|3|||
164194036|NCT00419757|593079321|FG001|Overall Study|Multiple reasons|1|||
164194037|NCT03934216|593079327|FG000|Overall Study|Other Reasons|5|||
164194038|NCT03934216|593079328|FG001|Overall Study|Other Reasons|5|||
164194039|NCT03934216|593079327|FG000|Overall Study|Adverse Event|22|||
164194040|NCT03934216|593079328|FG001|Overall Study|Adverse Event|11|||
164194041|NCT03934216|593079327|FG000|Overall Study|Lack of Efficacy|8|||
164194042|NCT03934216|593079328|FG001|Overall Study|Lack of Efficacy|7|||
164194043|NCT03934216|593079327|FG000|Overall Study|Lost to Follow-up|2|||
164194044|NCT03934216|593079328|FG001|Overall Study|Lost to Follow-up|0|||
164194045|NCT03934216|593079327|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164194046|NCT03934216|593079328|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164194047|NCT03934216|593079327|FG000|Overall Study|Pregnancy|1|||
164194048|NCT03934216|593079328|FG001|Overall Study|Pregnancy|0|||
164194049|NCT03934216|593079327|FG000|Overall Study|Withdrawal by Subject|18|||
164194050|NCT03934216|593079328|FG001|Overall Study|Withdrawal by Subject|6|||
164194051|NCT03934216|593079327|FG000|Overall Study|Randomized but not treated|1|||
164194052|NCT03934216|593079328|FG001|Overall Study|Randomized but not treated|1|||
164194053|NCT01711983|593079330|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
164194054|NCT01711983|593079330|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
164194055|NCT01711983|593079330|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
164194056|NCT01711983|593079330|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
164194057|NCT00735943|593079331|FG000|Overall Study|Lost to Follow-up|1|||
164543947|NCT00496730|594364630|FG001|Overall Study|Lost to Follow-up|3|||
164543948|NCT00496730|594364629|FG000|Overall Study|Withdrawal by Subject|2|||
164543949|NCT00496730|594364630|FG001|Overall Study|Withdrawal by Subject|2|||
164543950|NCT03962738|594364637|FG000|Overall Study|Protocol Deviation|3|||
164543951|NCT03962738|594364638|FG001|Overall Study|Protocol Deviation|0|||
164543952|NCT03962738|594364639|FG002|Overall Study|Protocol Deviation|1|||
164543953|NCT03962738|594364640|FG003|Overall Study|Protocol Deviation|1|||
164543954|NCT03962738|594364637|FG000|Overall Study|Withdrawal by Subject|4|||
164543955|NCT03962738|594364638|FG001|Overall Study|Withdrawal by Subject|0|||
164194058|NCT00735943|593079331|FG000|Overall Study|Adverse Event|1|||
164194059|NCT01064414|593079332|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
164194060|NCT01064414|593079333|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
164194061|NCT01064414|593079334|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
164194062|NCT01064414|593079332|FG000|Core Period: Baseline to Week 26|Death|0|||
164194063|NCT01064414|593079333|FG001|Core Period: Baseline to Week 26|Death|1|||
164543956|NCT03962738|594364639|FG002|Overall Study|Withdrawal by Subject|0|||
164543957|NCT03962738|594364640|FG003|Overall Study|Withdrawal by Subject|0|||
164543958|NCT03962738|594364637|FG000|Overall Study|Lost to Follow-up|0|||
164543959|NCT03962738|594364638|FG001|Overall Study|Lost to Follow-up|0|||
164543960|NCT03962738|594364639|FG002|Overall Study|Lost to Follow-up|1|||
164543961|NCT03962738|594364640|FG003|Overall Study|Lost to Follow-up|0|||
164543962|NCT04556136|594364644|FG000|Overall Study|Lost to Follow-up|6|||
164543963|NCT04556136|594364645|FG001|Overall Study|Lost to Follow-up|6|||
164543964|NCT04556136|594364644|FG000|Overall Study|Physician Decision|2|||
164543965|NCT04556136|594364645|FG001|Overall Study|Physician Decision|1|||
164543966|NCT04556136|594364644|FG000|Overall Study|Withdrawal by Subject|2|||
164543967|NCT04556136|594364645|FG001|Overall Study|Withdrawal by Subject|1|||
164543968|NCT03492554|594364648|FG000|Overall Study|Protocol Violation|0|||
164543969|NCT03492554|594364649|FG001|Overall Study|Protocol Violation|14|||
164543970|NCT04340557|594364650|FG000|Overall Study|Transferred to ICU and/or death|1|||
164543971|NCT04340557|594364651|FG001|Overall Study|Transferred to ICU and/or death|2|||
164543972|NCT01221727|594364652|FG000|Overall Study|Physician Decision|2|||
164543973|NCT01221727|594364653|FG001|Overall Study|Physician Decision|0|||
164543974|NCT01221727|594364652|FG000|Overall Study|Withdrawal by Subject|1|||
164543975|NCT01221727|594364653|FG001|Overall Study|Withdrawal by Subject|1|||
164543976|NCT01010633|594364654|FG000|Overall Study|Adverse Event|1|||
164543977|NCT01010633|594364655|FG001|Overall Study|Adverse Event|1|||
164543978|NCT01010633|594364654|FG000|Overall Study|Protocol Violation|1|||
164543979|NCT01010633|594364655|FG001|Overall Study|Protocol Violation|2|||
164543980|NCT01010633|594364654|FG000|Overall Study|Withdrawal by Subject|2|||
164543981|NCT01010633|594364655|FG001|Overall Study|Withdrawal by Subject|1|||
164543982|NCT01010633|594364654|FG000|Overall Study|Investigator decision|0|||
164543983|NCT01010633|594364655|FG001|Overall Study|Investigator decision|1|||
164543984|NCT02941926|594364656|FG000|Core Phase|Progressive disease|1109|||
164543985|NCT02941926|594364656|FG000|Core Phase|Adverse Event|504|||
164543986|NCT02941926|594364656|FG000|Core Phase|Subject/guardian decision|127|||
164543987|NCT02941926|594364656|FG000|Core Phase|Physician Decision|112|||
164543988|NCT02941926|594364656|FG000|Core Phase|Death|46|||
164543989|NCT02941926|594364656|FG000|Core Phase|Protocol deviation|34|||
164543990|NCT02941926|594364656|FG000|Core Phase|Lost to Follow-up|8|||
164543991|NCT02941926|594364656|FG000|Core Phase|Technical problems|5|||
164543992|NCT02941926|594364656|FG000|Extension Phase|Physician Decision|155|||
164543993|NCT02941926|594364656|FG000|Extension Phase|Progressive disease|115|||
164543994|NCT02941926|594364656|FG000|Extension Phase|Adverse Event|13|||
164543995|NCT02941926|594364656|FG000|Extension Phase|Subject/Guardian decision|12|||
164543996|NCT02941926|594364656|FG000|Extension Phase|Death|6|||
164543997|NCT00097773|594364657|FG000|Overall Study|Lost to Follow-up|2|||
164543998|NCT00097773|594364658|FG001|Overall Study|Lost to Follow-up|2|||
164543999|NCT00097773|594364659|FG002|Overall Study|Lost to Follow-up|0|||
164544000|NCT00097773|594364660|FG003|Overall Study|Lost to Follow-up|1|||
164544001|NCT00097773|594364657|FG000|Overall Study|Physician Decision|2|||
164544002|NCT00097773|594364658|FG001|Overall Study|Physician Decision|2|||
164544003|NCT00097773|594364659|FG002|Overall Study|Physician Decision|3|||
164544004|NCT00097773|594364660|FG003|Overall Study|Physician Decision|1|||
164544005|NCT00097773|594364657|FG000|Overall Study|Withdrawal by Subject|3|||
164544006|NCT00097773|594364658|FG001|Overall Study|Withdrawal by Subject|3|||
164544007|NCT00097773|594364659|FG002|Overall Study|Withdrawal by Subject|3|||
164544008|NCT00097773|594364660|FG003|Overall Study|Withdrawal by Subject|1|||
164544009|NCT00097773|594364657|FG000|Overall Study|Adverse Event|0|||
164544010|NCT00097773|594364658|FG001|Overall Study|Adverse Event|1|||
164544011|NCT00097773|594364659|FG002|Overall Study|Adverse Event|0|||
164544012|NCT00097773|594364660|FG003|Overall Study|Adverse Event|0|||
164544013|NCT00097773|594364657|FG000|Overall Study|Other|1|||
164544014|NCT00097773|594364658|FG001|Overall Study|Other|0|||
164544015|NCT00097773|594364659|FG002|Overall Study|Other|2|||
164544016|NCT00097773|594364660|FG003|Overall Study|Other|0|||
164544017|NCT01494350|594364661|FG000|Overall Study|Worsening of lesion|1|||
164544018|NCT00474708|594364662|FG000|Overall Study|Lack of Efficacy|11|||
164544019|NCT00474708|594364663|FG001|Overall Study|Lack of Efficacy|5|||
164544020|NCT00474708|594364662|FG000|Overall Study|Suicide ideation/behavior|0|||
164544021|NCT00474708|594364663|FG001|Overall Study|Suicide ideation/behavior|1|||
164544022|NCT00474708|594364662|FG000|Overall Study|Withdrawal by Subject|7|||
164544023|NCT00474708|594364663|FG001|Overall Study|Withdrawal by Subject|0|||
164544024|NCT00474708|594364662|FG000|Overall Study|Lack of compliance|12|||
164544025|NCT00474708|594364663|FG001|Overall Study|Lack of compliance|4|||
164544026|NCT00474708|594364662|FG000|Overall Study|Lost to Follow-up|18|||
164544027|NCT00474708|594364663|FG001|Overall Study|Lost to Follow-up|9|||
164544028|NCT00474708|594364662|FG000|Overall Study|Physician Decision|9|||
164544029|NCT00474708|594364663|FG001|Overall Study|Physician Decision|6|||
164544030|NCT03700320|594364664|FG000|Overall Study|Adverse Event|5|||
164544031|NCT03700320|594364665|FG001|Overall Study|Adverse Event|31|||
164544032|NCT03700320|594364664|FG000|Overall Study|Lack of Efficacy|2|||
164544033|NCT03700320|594364665|FG001|Overall Study|Lack of Efficacy|5|||
164544034|NCT03700320|594364664|FG000|Overall Study|Withdrawal by Subject|29|||
164544035|NCT03700320|594364665|FG001|Overall Study|Withdrawal by Subject|75|||
164544036|NCT03700320|594364664|FG000|Overall Study|Lost to Follow-up|16|||
164544037|NCT03700320|594364665|FG001|Overall Study|Lost to Follow-up|23|||
164544038|NCT03700320|594364664|FG000|Overall Study|Pregnancy|2|||
164544039|NCT03700320|594364665|FG001|Overall Study|Pregnancy|4|||
164544040|NCT03700320|594364664|FG000|Overall Study|Protocol Deviation|7|||
164544041|NCT03700320|594364665|FG001|Overall Study|Protocol Deviation|31|||
164544042|NCT03700320|594364664|FG000|Overall Study|Non-compliance with Study Drug|1|||
164544043|NCT03700320|594364665|FG001|Overall Study|Non-compliance with Study Drug|3|||
164544044|NCT03700320|594364664|FG000|Overall Study|Reason not Specified|0|||
164544045|NCT03700320|594364665|FG001|Overall Study|Reason not Specified|1|||
164544046|NCT04305275|594364666|FG000|Overall Study|Adverse Event|4|||
164544047|NCT04305275|594364667|FG001|Overall Study|Adverse Event|0|||
164544048|NCT04305275|594364666|FG000|Overall Study|Lost to Follow-up|1|||
164544049|NCT04305275|594364667|FG001|Overall Study|Lost to Follow-up|1|||
164544050|NCT04305275|594364666|FG000|Overall Study|Withdrawal by Participant|8|||
164544051|NCT04305275|594364667|FG001|Overall Study|Withdrawal by Participant|1|||
164544052|NCT03061175|594364668|FG000|Baseline|Participant was deemed ineligible|1|||
164544053|NCT03061175|594364669|FG001|Baseline|Participant was deemed ineligible|0|||
164544054|NCT03061175|594364668|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
164544055|NCT03061175|594364669|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
164544056|NCT03061175|594364668|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
164544057|NCT03061175|594364669|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
164544058|NCT03061175|594364668|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
164544059|NCT03061175|594364669|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
164544060|NCT00760669|594364670|FG000|Overall Study|Not assessed for overall improvement|18|||
164544061|NCT00760669|594364670|FG000|Overall Study|Participants missing efficacy assessment|6|||
164544062|NCT00760669|594364670|FG000|Overall Study|Participants with overlapping cases|1|||
164544063|NCT00760669|594364670|FG000|Overall Study|Took drug before entering in contract|5|||
164544064|NCT02456662|594364674|FG000|Overall Study|Lost to Follow-up|2|||
164544065|NCT02456662|594364675|FG001|Overall Study|Lost to Follow-up|1|||
164544066|NCT00504153|594364680|FG000|Overall Study|Withdrawal by Subject|1|||
164544067|NCT00504153|594364680|FG000|Overall Study|Adverse Event|4|||
164544068|NCT00504153|594364680|FG000|Overall Study|Death|1|||
164544069|NCT00805025|594364681|FG000|Overall Study|Screened but not enrolled/treated|42|||
164544070|NCT00805025|594364681|FG000|Overall Study|Adverse Event|4|||
164544071|NCT00805025|594364681|FG000|Overall Study|Withdrawal by Subject|2|||
164544072|NCT00805025|594364681|FG000|Overall Study|Physician Decision|1|||
164544073|NCT00932425|594364687|FG000|Overall Study|Lost to Follow-up|0|||
164544074|NCT00932425|594364688|FG001|Overall Study|Lost to Follow-up|1|||
164544075|NCT00932425|594364687|FG000|Overall Study|Withdrawal by Subject|0|||
164544076|NCT00932425|594364688|FG001|Overall Study|Withdrawal by Subject|1|||
164544077|NCT01252810|594364689|FG000|Overall Study|Withdrawal by Subject|4|||
164544078|NCT01252810|594364690|FG001|Overall Study|Withdrawal by Subject|1|||
164544079|NCT01252810|594364689|FG000|Overall Study|Lost to Follow-up|0|||
164544080|NCT01252810|594364690|FG001|Overall Study|Lost to Follow-up|1|||
164544081|NCT01252810|594364689|FG000|Overall Study|Physician Decision|2|||
164544082|NCT01252810|594364690|FG001|Overall Study|Physician Decision|1|||
164544083|NCT01252810|594364689|FG000|Overall Study|Various reasons|8|||
164544084|NCT01252810|594364690|FG001|Overall Study|Various reasons|0|||
164544085|NCT02811549|594364692|FG000|Overall Study|Lost to Follow-up|1|||
164544086|NCT02811549|594364692|FG000|Overall Study|Withdrawal by Subject|3|||
164544087|NCT02811549|594364692|FG000|Overall Study|Subject screen failed|4|||
164544088|NCT02811549|594364692|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
164544089|NCT05293743|594364693|FG000|Overall Study|Withdrawal by Subject|1|||
164544090|NCT05293743|594364694|FG001|Overall Study|Withdrawal by Subject|0|||
164544091|NCT01889238|594364699|FG000|Overall Study|Death|1|||
164544092|NCT01889238|594364699|FG000|Overall Study|Withdrawal by Subject|1|||
164544093|NCT01889238|594364699|FG000|Overall Study|Adverse Event|6|||
164544094|NCT01889238|594364699|FG000|Overall Study|Disease Progression|104|||
164544095|NCT01889238|594364699|FG000|Overall Study|Other|6|||
164544096|NCT01200238|594364705|FG000|Overall Study|Adverse Event|2|||
164544097|NCT01200238|594364706|FG001|Overall Study|Adverse Event|1|||
164544098|NCT01200238|594364705|FG000|Overall Study|Progressive Disease|5|||
164653490|NCT00772577|594757189|FG001|Overall Study|Lost to Follow-up|3|||
164653491|NCT00772577|594757188|FG000|Overall Study|Administrative problems|2|||
164544099|NCT01200238|594364706|FG001|Overall Study|Progressive Disease|8|||
164544100|NCT01200238|594364705|FG000|Overall Study|Withdrawal by Subject|0|||
164544101|NCT01200238|594364706|FG001|Overall Study|Withdrawal by Subject|1|||
164544102|NCT02717754|594364707|FG000|Overall Study|Incorrect Infusion Duration|0|||
164544103|NCT02717754|594364708|FG001|Overall Study|Incorrect Infusion Duration|0|||
164544104|NCT02717754|594364709|FG002|Overall Study|Incorrect Infusion Duration|0|||
164544105|NCT02717754|594364710|FG003|Overall Study|Incorrect Infusion Duration|10|||
164544106|NCT02717754|594364711|FG004|Overall Study|Incorrect Infusion Duration|20|||
164544107|NCT02717754|594364712|FG005|Overall Study|Incorrect Infusion Duration|20|||
164544108|NCT00482703|594364713|FG000|Overall Study|Poor compliance|1|||
164653492|NCT00772577|594757189|FG001|Overall Study|Administrative problems|1|||
164544109|NCT00482703|594364714|FG001|Overall Study|Poor compliance|0|||
164544110|NCT00667823|594364716|FG000|Overall Study|Lost to Follow-up|5|||
164544111|NCT00667823|594364716|FG000|Overall Study|Adverse Event|7|||
164544112|NCT00667823|594364716|FG000|Overall Study|Death|182|||
164544113|NCT00667823|594364716|FG000|Overall Study|Withdrawal by Subject|12|||
164544114|NCT00667823|594364716|FG000|Overall Study|Other|8|||
164544115|NCT00667823|594364716|FG000|Overall Study|Missing (completion page missing)|2|||
164544116|NCT04360551|594366129|FG000|Overall Study|Withdrawal by Subject|1|||
164544117|NCT04360551|594366130|FG001|Overall Study|Withdrawal by Subject|0|||
164544118|NCT03496012|594366134|FG000|Overall Study|Withdrawal by Subject|2|||
164544119|NCT03496012|594366135|FG001|Overall Study|Withdrawal by Subject|0|||
164544120|NCT03496012|594366136|FG002|Overall Study|Withdrawal by Subject|2|||
164544121|NCT03496012|594366134|FG000|Overall Study|Adverse Event|0|||
164544122|NCT03496012|594366135|FG001|Overall Study|Adverse Event|0|||
164544123|NCT03496012|594366136|FG002|Overall Study|Adverse Event|1|||
164544124|NCT03496012|594366134|FG000|Overall Study|Reason Not Specified|2|||
164544125|NCT03496012|594366135|FG001|Overall Study|Reason Not Specified|0|||
164544126|NCT03496012|594366136|FG002|Overall Study|Reason Not Specified|1|||
164544127|NCT01524198|594366137|FG000|Overall Study|Protocol Violation|8|||
164544128|NCT01524198|594366138|FG001|Overall Study|Protocol Violation|6|||
164544129|NCT01524198|594366137|FG000|Overall Study|Withdrawal by Subject|15|||
164544130|NCT01524198|594366138|FG001|Overall Study|Withdrawal by Subject|10|||
164544131|NCT02232802|594366139|FG000|Period 1|Sponsor request|1|||
164544132|NCT02232802|594366140|FG001|Period 1|Sponsor request|0|||
164544133|NCT02232802|594366139|FG000|Period 1|Adverse Event|1|||
164544134|NCT02232802|594366140|FG001|Period 1|Adverse Event|1|||
164544135|NCT00885703|594366146|FG000|Overall Study|Death|9|||
164544136|NCT00885703|594366147|FG001|Overall Study|Death|7|||
164544137|NCT00885703|594366148|FG002|Overall Study|Death|8|||
164544138|NCT00885703|594366149|FG003|Overall Study|Death|7|||
164544139|NCT00885703|594366150|FG004|Overall Study|Death|7|||
164544140|NCT00885703|594366151|FG005|Overall Study|Death|8|||
164194064|NCT01064414|593079334|FG002|Core Period: Baseline to Week 26|Death|0|||
164194065|NCT01064414|593079332|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
164194066|NCT01064414|593079333|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
164194067|NCT01064414|593079334|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
164194068|NCT01064414|593079332|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
164194069|NCT01064414|593079333|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
164194070|NCT01064414|593079334|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
164544141|NCT00885703|594366152|FG006|Overall Study|Death|4|||
164544142|NCT00885703|594366146|FG000|Overall Study|Lost to Follow-up|0|||
164544143|NCT00885703|594366147|FG001|Overall Study|Lost to Follow-up|0|||
164544144|NCT00885703|594366148|FG002|Overall Study|Lost to Follow-up|1|||
164544145|NCT00885703|594366149|FG003|Overall Study|Lost to Follow-up|0|||
164544146|NCT00885703|594366150|FG004|Overall Study|Lost to Follow-up|0|||
164544147|NCT00885703|594366151|FG005|Overall Study|Lost to Follow-up|1|||
164544148|NCT00885703|594366152|FG006|Overall Study|Lost to Follow-up|0|||
164544149|NCT00885703|594366146|FG000|Overall Study|Withdrawal by Subject|0|||
164544150|NCT00885703|594366147|FG001|Overall Study|Withdrawal by Subject|0|||
164544151|NCT00885703|594366148|FG002|Overall Study|Withdrawal by Subject|0|||
164544152|NCT00885703|594366149|FG003|Overall Study|Withdrawal by Subject|1|||
164544153|NCT00885703|594366150|FG004|Overall Study|Withdrawal by Subject|3|||
164544154|NCT00885703|594366151|FG005|Overall Study|Withdrawal by Subject|1|||
164544155|NCT00885703|594366152|FG006|Overall Study|Withdrawal by Subject|1|||
164544156|NCT00885703|594366146|FG000|Overall Study|Ineligible (no CM)|1|||
164544157|NCT00885703|594366147|FG001|Overall Study|Ineligible (no CM)|3|||
164194071|NCT01064414|593079332|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
164544158|NCT00885703|594366148|FG002|Overall Study|Ineligible (no CM)|2|||
164544159|NCT00885703|594366149|FG003|Overall Study|Ineligible (no CM)|1|||
164544160|NCT00885703|594366150|FG004|Overall Study|Ineligible (no CM)|2|||
164544161|NCT00885703|594366151|FG005|Overall Study|Ineligible (no CM)|3|||
164544162|NCT00885703|594366152|FG006|Overall Study|Ineligible (no CM)|1|||
164544163|NCT00346073|594366153|FG000|Overall Study|Serious Adverse Event|2|||
164544164|NCT00346073|594366154|FG001|Overall Study|Serious Adverse Event|0|||
164544165|NCT00346073|594366153|FG000|Overall Study|Lost to Follow-up|39|||
164544166|NCT00346073|594366154|FG001|Overall Study|Lost to Follow-up|24|||
164544167|NCT02053168|594366162|FG000|Overall Study|Withdrawal by Subject|1|||
164544168|NCT02053168|594366162|FG000|Overall Study|Physician Decision|1|||
164544169|NCT02053168|594366162|FG000|Overall Study|Lost to Follow-up|1|||
164544170|NCT02687542|594366163|FG000|Overall Study|Medication error without associated AEs|0|||
164544171|NCT02687542|594366164|FG001|Overall Study|Medication error without associated AEs|0|||
164653493|NCT00772577|594757188|FG000|Overall Study|Protocol Deviation|3|||
164544172|NCT02687542|594366165|FG002|Overall Study|Medication error without associated AEs|0|||
164544173|NCT02687542|594366166|FG003|Overall Study|Medication error without associated AEs|0|||
164544174|NCT02687542|594366167|FG004|Overall Study|Medication error without associated AEs|1|||
164544175|NCT02687542|594366163|FG000|Overall Study|Lost to Follow-up|0|||
164544176|NCT02687542|594366164|FG001|Overall Study|Lost to Follow-up|0|||
164194072|NCT01064414|593079333|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
164194073|NCT01064414|593079334|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
164194074|NCT01064414|593079332|FG000|Core Period: Baseline to Week 26|Other|4|||
164194075|NCT01064414|593079333|FG001|Core Period: Baseline to Week 26|Other|7|||
164194076|NCT01064414|593079334|FG002|Core Period: Baseline to Week 26|Other|2|||
164194077|NCT01064414|593079332|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
164194078|NCT01064414|593079333|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
164194079|NCT01064414|593079334|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
164194080|NCT01064414|593079332|FG000|Extension Period: Week 26 to Week 52|Death|0|||
164194081|NCT01064414|593079333|FG001|Extension Period: Week 26 to Week 52|Death|1|||
164194082|NCT01064414|593079334|FG002|Extension Period: Week 26 to Week 52|Death|0|||
164194083|NCT01064414|593079332|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
164194084|NCT01064414|593079333|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
164194085|NCT01064414|593079334|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
164194086|NCT01064414|593079332|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
164194087|NCT01064414|593079333|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
164194088|NCT01064414|593079334|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
164194089|NCT01064414|593079332|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
164194090|NCT01064414|593079333|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
164194091|NCT01064414|593079334|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
164194092|NCT01064414|593079332|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
164194093|NCT01064414|593079333|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
164194094|NCT01064414|593079334|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
164194095|NCT01064414|593079332|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
164194096|NCT01064414|593079333|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
164194097|NCT01064414|593079334|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
164194098|NCT01064414|593079332|FG000|Extension Period: Week 26 to Week 52|Other|5|||
164194099|NCT01064414|593079333|FG001|Extension Period: Week 26 to Week 52|Other|2|||
164194100|NCT01064414|593079334|FG002|Extension Period: Week 26 to Week 52|Other|1|||
164194101|NCT00165503|593079337|FG000|Overall Study|Death|1|||
164194102|NCT00165503|593079337|FG000|Overall Study|Lost to Follow-up|12|||
164194103|NCT00165503|593079337|FG000|Overall Study|Unresectable|3|||
164194104|NCT00643201|593079338|FG000|Randomized, Completed 6 Months of Study|Death|20|||
164194105|NCT00643201|593079339|FG001|Randomized, Completed 6 Months of Study|Death|26|||
164194106|NCT00643201|593079338|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
164194107|NCT00643201|593079339|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
164194108|NCT00643201|593079338|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
164194109|NCT00643201|593079339|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
164194110|NCT00643201|593079338|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
164194111|NCT00643201|593079339|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
164194112|NCT00643201|593079338|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
164194113|NCT00643201|593079339|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
164194114|NCT00643201|593079338|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
164194115|NCT00643201|593079339|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
164194116|NCT00643201|593079338|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
164194117|NCT00643201|593079339|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
164194118|NCT00643201|593079338|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
164194119|NCT00643201|593079339|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
164194120|NCT00643201|593079338|FG000|Randomized, Completed 6 Months of Study|Other|107|||
164194121|NCT00643201|593079339|FG001|Randomized, Completed 6 Months of Study|Other|107|||
164194122|NCT00643201|593079338|FG000|Completed Study Follow Up|Death|28|||
164194123|NCT00643201|593079339|FG001|Completed Study Follow Up|Death|34|||
164194124|NCT00643201|593079338|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
164194125|NCT00643201|593079339|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
164194126|NCT00643201|593079338|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
164194127|NCT00643201|593079339|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
164544177|NCT02687542|594366165|FG002|Overall Study|Lost to Follow-up|0|||
164544178|NCT02687542|594366166|FG003|Overall Study|Lost to Follow-up|0|||
164544179|NCT02687542|594366167|FG004|Overall Study|Lost to Follow-up|1|||
164194128|NCT00643201|593079338|FG000|Completed Study Follow Up|non-specified|1|||
164194129|NCT00643201|593079339|FG001|Completed Study Follow Up|non-specified|0|||
164194130|NCT02976519|593079340|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
164194131|NCT02976519|593079341|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
164194132|NCT02976519|593079342|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
164544180|NCT02687542|594366163|FG000|Overall Study|Protocol Violation|0|||
164544181|NCT02687542|594366164|FG001|Overall Study|Protocol Violation|1|||
164544182|NCT02687542|594366165|FG002|Overall Study|Protocol Violation|0|||
164544183|NCT02687542|594366166|FG003|Overall Study|Protocol Violation|0|||
164544184|NCT02687542|594366167|FG004|Overall Study|Protocol Violation|0|||
164544185|NCT02687542|594366163|FG000|Overall Study|Other|5|||
164544186|NCT02687542|594366164|FG001|Overall Study|Other|9|||
164544187|NCT02687542|594366165|FG002|Overall Study|Other|10|||
164544188|NCT02687542|594366166|FG003|Overall Study|Other|6|||
164544189|NCT02687542|594366167|FG004|Overall Study|Other|5|||
164544190|NCT02687542|594366163|FG000|Overall Study|Adverse Event|3|||
164544191|NCT02687542|594366164|FG001|Overall Study|Adverse Event|1|||
164544192|NCT02687542|594366165|FG002|Overall Study|Adverse Event|3|||
164544193|NCT02687542|594366166|FG003|Overall Study|Adverse Event|2|||
164544194|NCT02687542|594366167|FG004|Overall Study|Adverse Event|9|||
164544195|NCT02687542|594366163|FG000|Overall Study|Withdrawal by Subject|0|||
164544196|NCT02687542|594366164|FG001|Overall Study|Withdrawal by Subject|1|||
164544197|NCT02687542|594366165|FG002|Overall Study|Withdrawal by Subject|1|||
164544198|NCT02687542|594366166|FG003|Overall Study|Withdrawal by Subject|2|||
164544199|NCT02687542|594366167|FG004|Overall Study|Withdrawal by Subject|4|||
164544200|NCT00636675|594366168|FG000|Overall Study|Lost to Follow-up|121|||
164544201|NCT00636675|594366169|FG001|Overall Study|Lost to Follow-up|31|||
164544202|NCT00636675|594366168|FG000|Overall Study|Withdrawal by Subject|19|||
164544203|NCT00636675|594366169|FG001|Overall Study|Withdrawal by Subject|10|||
164544204|NCT00096785|594366171|FG000|Overall Study|Lost to Follow-up|1|||
164544205|NCT00096785|594366172|FG001|Overall Study|Lost to Follow-up|0|||
164544206|NCT00096785|594366171|FG000|Overall Study|Withdrawal by Subject|0|||
164544207|NCT00096785|594366172|FG001|Overall Study|Withdrawal by Subject|1|||
164544208|NCT00096785|594366171|FG000|Overall Study|Relocated|1|||
164544209|NCT00096785|594366172|FG001|Overall Study|Relocated|0|||
164544210|NCT00833053|594366173|FG000|Overall Study|Adverse Event|4|||
164544211|NCT00833053|594366174|FG001|Overall Study|Adverse Event|0|||
164544212|NCT00833053|594366173|FG000|Overall Study|Treatment Failure|3|||
164544213|NCT00833053|594366174|FG001|Overall Study|Treatment Failure|1|||
164544214|NCT00833053|594366173|FG000|Overall Study|Withdrawal by Subject|0|||
164544215|NCT00833053|594366174|FG001|Overall Study|Withdrawal by Subject|1|||
164544216|NCT00833053|594366173|FG000|Overall Study|Protocol Violation|2|||
164544217|NCT00833053|594366174|FG001|Overall Study|Protocol Violation|1|||
164544218|NCT00762892|594366177|FG000|Overall Study|Lost to Follow-up|2|||
164544219|NCT00762892|594366178|FG001|Overall Study|Lost to Follow-up|5|||
164544220|NCT00762892|594366177|FG000|Overall Study|Withdrawal by Subject|0|||
164544221|NCT00762892|594366178|FG001|Overall Study|Withdrawal by Subject|1|||
164544222|NCT00762892|594366177|FG000|Overall Study|Death|1|||
164544223|NCT00762892|594366178|FG001|Overall Study|Death|0|||
164544224|NCT00762892|594366177|FG000|Overall Study|Pregnancy|1|||
164544225|NCT00762892|594366178|FG001|Overall Study|Pregnancy|0|||
164544226|NCT00762892|594366177|FG000|Overall Study|Incarceration|1|||
164544227|NCT00762892|594366178|FG001|Overall Study|Incarceration|0|||
164544228|NCT02234479|594366179|FG000|Overall Study|Withdrawal by Subject|1|||
164544229|NCT02234479|594366180|FG001|Overall Study|Withdrawal by Subject|3|||
164544230|NCT00326209|594366181|FG000|Overall Study|Adverse Event|28|||
164544231|NCT00326209|594366181|FG000|Overall Study|Withdrawal by Subject|22|||
164653494|NCT00772577|594757189|FG001|Overall Study|Protocol Deviation|2|||
164653495|NCT00672620|594757190|FG000|Overall Study|Adverse Event|7|||
164653496|NCT00672620|594757191|FG001|Overall Study|Adverse Event|7|||
164544232|NCT00326209|594366181|FG000|Overall Study|Lack of Efficacy|31|||
164544233|NCT00326209|594366181|FG000|Overall Study|Lost to Follow-up|18|||
164544234|NCT00326209|594366181|FG000|Overall Study|Participant non-compliant|6|||
164544235|NCT00326209|594366181|FG000|Overall Study|Sponsor closed study|173|||
164544236|NCT00326209|594366181|FG000|Overall Study|Prohibited medication use|1|||
164544237|NCT00326209|594366181|FG000|Overall Study|Violation of entry criteria|1|||
164544238|NCT00326209|594366181|FG000|Overall Study|Withdrawn in error|1|||
164544239|NCT00326209|594366181|FG000|Overall Study|Pregnancy|1|||
164544240|NCT01490814|594366183|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
164544241|NCT01490814|594366184|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
164544242|NCT01490814|594366183|FG000|Overall Study|Physician Decision|1|||
164544243|NCT01490814|594366184|FG001|Overall Study|Physician Decision|0|||
164544244|NCT01490814|594366183|FG000|Overall Study|Withdrawal by Subject|0|||
164544245|NCT01490814|594366184|FG001|Overall Study|Withdrawal by Subject|5|||
164544246|NCT00113074|594366188|FG000|Overall Study|Lost to Follow-up|10|||
164544247|NCT00113074|594366189|FG001|Overall Study|Lost to Follow-up|10|||
164544248|NCT00113074|594366190|FG002|Overall Study|Lost to Follow-up|14|||
164544249|NCT03680911|594366191|FG000|At Home Treatment|Study Termination|3|||
164544250|NCT03680911|594366192|FG001|At Home Treatment|Study Termination|0|||
164653497|NCT00672620|594757192|FG002|Overall Study|Adverse Event|12|||
164653498|NCT00672620|594757193|FG003|Overall Study|Adverse Event|17|||
164544251|NCT03680911|594366191|FG000|At Home Treatment|Lost to Follow-up|0|||
164544252|NCT03680911|594366192|FG001|At Home Treatment|Lost to Follow-up|1|||
164544253|NCT03680911|594366191|FG000|At Home Treatment|Withdrawal by Subject|0|||
164544254|NCT03680911|594366192|FG001|At Home Treatment|Withdrawal by Subject|2|||
164544255|NCT03680911|594366191|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
164544256|NCT03680911|594366192|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
164544257|NCT00935272|594366193|FG000|Overall Study|Lost to Follow-up|10|||
164544258|NCT00935272|594366194|FG001|Overall Study|Lost to Follow-up|3|||
164544259|NCT00935272|594366193|FG000|Overall Study|Withdrawal by Subject|8|||
164544260|NCT00935272|594366194|FG001|Overall Study|Withdrawal by Subject|2|||
164544261|NCT00935272|594366193|FG000|Overall Study|Physician Decision|1|||
164544262|NCT00935272|594366194|FG001|Overall Study|Physician Decision|0|||
164544263|NCT00935272|594366193|FG000|Overall Study|Protocol Violation|0|||
164544264|NCT00935272|594366194|FG001|Overall Study|Protocol Violation|1|||
164544265|NCT01478360|594366195|FG000|Overall Study|Lost to Follow-up|1|||
164544266|NCT01478360|594366196|FG001|Overall Study|Lost to Follow-up|0|||
164544267|NCT01478360|594366195|FG000|Overall Study|Adverse Event|0|||
164544268|NCT01478360|594366196|FG001|Overall Study|Adverse Event|1|||
164544269|NCT01478360|594366195|FG000|Overall Study|Administrative problems|1|||
164544270|NCT01478360|594366196|FG001|Overall Study|Administrative problems|2|||
164544271|NCT02243865|594366202|FG000|Overall Study|Protocol Violation|1|||
164544272|NCT02243865|594366203|FG001|Overall Study|Protocol Violation|3|||
164544273|NCT02243865|594366202|FG000|Overall Study|Lost to Follow-up|1|||
164544274|NCT02243865|594366203|FG001|Overall Study|Lost to Follow-up|1|||
164544275|NCT02243865|594366202|FG000|Overall Study|Withdrawal by Subject|1|||
164544276|NCT02243865|594366203|FG001|Overall Study|Withdrawal by Subject|0|||
164544277|NCT02243865|594366202|FG000|Overall Study|Adverse Event|1|||
164544278|NCT02243865|594366203|FG001|Overall Study|Adverse Event|1|||
164544279|NCT03654976|594366204|FG000|Overall Study|Withdrawal by Subject|12|||
164544280|NCT03654976|594366205|FG001|Overall Study|Withdrawal by Subject|11|||
164544281|NCT03654976|594366204|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
164544282|NCT03654976|594366205|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
164544283|NCT03654976|594366204|FG000|Overall Study|Adverse Event|5|||
164544284|NCT03654976|594366205|FG001|Overall Study|Adverse Event|0|||
164544285|NCT03654976|594366204|FG000|Overall Study|Lost to Follow-up|2|||
164544286|NCT03654976|594366205|FG001|Overall Study|Lost to Follow-up|0|||
164544287|NCT03654976|594366204|FG000|Overall Study|Lack of Efficacy|0|||
164544288|NCT03654976|594366205|FG001|Overall Study|Lack of Efficacy|1|||
164544289|NCT00117598|594366206|FG000|Prior to Treatment Cross Over|Death|40|||
164544290|NCT00117598|594366207|FG001|Prior to Treatment Cross Over|Death|41|||
164544291|NCT00117598|594366208|FG002|Prior to Treatment Cross Over|Death|37|||
164544292|NCT00117598|594366209|FG003|Prior to Treatment Cross Over|Death|0|||
164544293|NCT00117598|594366210|FG004|Prior to Treatment Cross Over|Death|0|||
164544294|NCT00117598|594366206|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
164544295|NCT00117598|594366207|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
164544296|NCT00117598|594366208|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
164544297|NCT00117598|594366209|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
164544298|NCT00117598|594366210|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
164544299|NCT00117598|594366206|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
164544300|NCT00117598|594366207|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
164544301|NCT00117598|594366208|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
164544302|NCT00117598|594366209|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
164544303|NCT00117598|594366210|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
164544304|NCT00117598|594366206|FG000|Prior to Treatment Cross Over|Other|15|||
164544305|NCT00117598|594366207|FG001|Prior to Treatment Cross Over|Other|9|||
164544306|NCT00117598|594366208|FG002|Prior to Treatment Cross Over|Other|9|||
164544307|NCT00117598|594366209|FG003|Prior to Treatment Cross Over|Other|0|||
164544308|NCT00117598|594366210|FG004|Prior to Treatment Cross Over|Other|0|||
164544309|NCT00117598|594366206|FG000|After Treament Cross Over|Death|0|||
164544310|NCT00117598|594366207|FG001|After Treament Cross Over|Death|0|||
164544311|NCT00117598|594366208|FG002|After Treament Cross Over|Death|0|||
164544312|NCT00117598|594366209|FG003|After Treament Cross Over|Death|1|||
164544313|NCT00117598|594366210|FG004|After Treament Cross Over|Death|2|||
164544314|NCT00117598|594366206|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
164544315|NCT00117598|594366207|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
164544316|NCT00117598|594366208|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
164544317|NCT00117598|594366209|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
164544318|NCT00117598|594366210|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
164544319|NCT00117598|594366206|FG000|After Treament Cross Over|Other|0|||
164544320|NCT00117598|594366207|FG001|After Treament Cross Over|Other|0|||
164544321|NCT00117598|594366208|FG002|After Treament Cross Over|Other|0|||
164544322|NCT00117598|594366209|FG003|After Treament Cross Over|Other|1|||
164544323|NCT00117598|594366210|FG004|After Treament Cross Over|Other|2|||
164544324|NCT01235793|594366211|FG000|Overall Study|Death|6|||
164544325|NCT00545064|594366217|FG000|Overall Study|Lost to Follow-up|3|||
164544326|NCT00545064|594366217|FG000|Overall Study|Withdrawal by Subject|2|||
164544327|NCT00545064|594366217|FG000|Overall Study|did not complete course of treatment|1|||
164544328|NCT00545064|594366217|FG000|Overall Study|cancel all appointments, no rebooking|1|||
164544329|NCT00545064|594366217|FG000|Overall Study|inclement weather|1|||
164544330|NCT05093322|594366220|FG000|Overall Study|Death|6|||
164544331|NCT05093322|594366221|FG001|Overall Study|Death|2|||
164544332|NCT05093322|594366220|FG000|Overall Study|Other|4|||
164544333|NCT05093322|594366221|FG001|Overall Study|Other|1|||
164544334|NCT00898443|594366222|FG000|Overall Study|Withdrawal by Subject|1|||
164544335|NCT00898443|594366223|FG001|Overall Study|Withdrawal by Subject|0|||
164194133|NCT02976519|593079343|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
164544336|NCT00074581|594366227|FG000|Overall Study|Death|15|||
164544337|NCT00074581|594366228|FG001|Overall Study|Death|16|||
164544338|NCT00074581|594366227|FG000|Overall Study|Withdrawal by Subject|50|||
164544339|NCT00074581|594366228|FG001|Overall Study|Withdrawal by Subject|49|||
164544340|NCT00074581|594366227|FG000|Overall Study|Unable to adhere to visit schedule|13|||
164544341|NCT00074581|594366228|FG001|Overall Study|Unable to adhere to visit schedule|14|||
164544342|NCT00074581|594366227|FG000|Overall Study|Relocated|14|||
164544343|NCT00074581|594366228|FG001|Overall Study|Relocated|9|||
164544344|NCT00074581|594366227|FG000|Overall Study|Were withdrawn by investigator|5|||
164194134|NCT02976519|593079344|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
164194135|NCT02976519|593079345|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
164194136|NCT02976519|593079346|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
164194137|NCT02976519|593079340|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
164194138|NCT02976519|593079341|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
164194139|NCT02976519|593079342|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
164194140|NCT02976519|593079343|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
164194141|NCT02976519|593079344|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
164194142|NCT02976519|593079345|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
164194143|NCT02976519|593079346|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
164194144|NCT02976519|593079340|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
164194145|NCT02976519|593079341|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
164194146|NCT02976519|593079342|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
164194147|NCT02976519|593079343|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
164194148|NCT02976519|593079344|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
164194149|NCT02976519|593079345|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
164194150|NCT02976519|593079346|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
164194151|NCT02976519|593079340|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
164194152|NCT02976519|593079341|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
164194153|NCT02976519|593079342|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
164194154|NCT02976519|593079343|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
164544345|NCT00074581|594366228|FG001|Overall Study|Were withdrawn by investigator|2|||
164544346|NCT00074581|594366227|FG000|Overall Study|Lost to Follow-up|16|||
164544347|NCT00074581|594366228|FG001|Overall Study|Lost to Follow-up|11|||
164544348|NCT00074581|594366227|FG000|Overall Study|Ended relationship w. index participant|117|||
164544349|NCT00074581|594366228|FG001|Overall Study|Ended relationship w. index participant|106|||
164544350|NCT00074581|594366227|FG000|Overall Study|Other|14|||
164544351|NCT00074581|594366228|FG001|Overall Study|Other|19|||
164544352|NCT01770912|594366229|FG000|Overall Study|Lost to Follow-up|2|||
164544353|NCT01770912|594366230|FG001|Overall Study|Lost to Follow-up|0|||
164544354|NCT03250832|594366232|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
164544355|NCT03250832|594366233|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
164544356|NCT03250832|594366234|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
164544357|NCT03250832|594366235|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
164194155|NCT02976519|593079344|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
164194156|NCT02976519|593079345|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
164194157|NCT02976519|593079346|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
164194158|NCT02976519|593079340|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
164194159|NCT02976519|593079341|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
164194160|NCT02976519|593079342|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
164194161|NCT02976519|593079343|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
164194162|NCT02976519|593079344|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
164194163|NCT02976519|593079345|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
164194164|NCT02976519|593079346|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
164194165|NCT02346708|593079347|FG000|Overall Study|Adverse Event|2|||
164194166|NCT02346708|593079348|FG001|Overall Study|Adverse Event|0|||
164194167|NCT02346708|593079347|FG000|Overall Study|Protocol Violation|0|||
164194168|NCT02346708|593079348|FG001|Overall Study|Protocol Violation|1|||
164194169|NCT01781962|593079351|FG000|Overall Study|Other Miscellaneous Reasons|5|||
164544358|NCT03250832|594366236|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
164544359|NCT03250832|594366237|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
164544360|NCT03250832|594366238|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
164544361|NCT03250832|594366239|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
164544362|NCT03250832|594366240|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
164544363|NCT03250832|594366241|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
164544364|NCT03250832|594366242|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
164544365|NCT03250832|594366243|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
164544366|NCT03250832|594366232|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
164544367|NCT03250832|594366233|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
164544368|NCT03250832|594366234|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
164544369|NCT03250832|594366235|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
164544370|NCT03250832|594366236|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
164544371|NCT03250832|594366237|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
164544372|NCT03250832|594366238|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
164544373|NCT03250832|594366239|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
164544374|NCT03250832|594366240|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
164544375|NCT03250832|594366241|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
164544376|NCT03250832|594366242|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
164544377|NCT03250832|594366243|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
164544378|NCT03250832|594366232|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
164544379|NCT03250832|594366233|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
164544380|NCT03250832|594366234|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
164544381|NCT03250832|594366235|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
164544382|NCT03250832|594366236|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
164544383|NCT03250832|594366237|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
164544384|NCT03250832|594366238|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
164544385|NCT03250832|594366239|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
164544386|NCT03250832|594366240|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
164544387|NCT03250832|594366241|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
164544388|NCT03250832|594366242|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
164544389|NCT03250832|594366243|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
164544390|NCT03250832|594366232|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
164544391|NCT03250832|594366233|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
164544392|NCT03250832|594366234|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
164544393|NCT03250832|594366235|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
164544394|NCT03250832|594366236|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
164544395|NCT03250832|594366237|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
164544396|NCT03250832|594366238|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
164544397|NCT03250832|594366239|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
164544398|NCT03250832|594366240|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
164544399|NCT03250832|594366241|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
164544400|NCT03250832|594366242|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
164544401|NCT03250832|594366243|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
164544402|NCT03250832|594366232|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
164544403|NCT03250832|594366233|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
164544404|NCT03250832|594366234|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
164544405|NCT03250832|594366235|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
164544406|NCT03250832|594366236|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
164544407|NCT03250832|594366237|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
164544408|NCT03250832|594366238|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
164544409|NCT03250832|594366239|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
164544410|NCT03250832|594366240|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
164544411|NCT03250832|594366241|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
164544412|NCT03250832|594366242|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
164544413|NCT03250832|594366243|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
164544414|NCT03250832|594366232|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
164544415|NCT03250832|594366233|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
164544416|NCT03250832|594366234|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
164544417|NCT03250832|594366235|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
164544418|NCT03250832|594366236|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
164544419|NCT03250832|594366237|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
164544420|NCT03250832|594366238|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
164544421|NCT03250832|594366239|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
164544422|NCT03250832|594366240|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
164544423|NCT03250832|594366241|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
164544424|NCT03250832|594366242|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
164544425|NCT03250832|594366243|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
164544426|NCT03250832|594366232|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
164653499|NCT00672620|594757190|FG000|Overall Study|Lack of Efficacy|1|||
164653500|NCT00672620|594757191|FG001|Overall Study|Lack of Efficacy|2|||
164194170|NCT01278342|593079354|FG000|Overall Study|Physician Decision|0|||
164194171|NCT01278342|593079355|FG001|Overall Study|Physician Decision|1|||
164194172|NCT01278342|593079356|FG002|Overall Study|Physician Decision|0|||
164194173|NCT01278342|593079354|FG000|Overall Study|Lost to Follow-up|1|||
164544427|NCT03250832|594366233|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
164544428|NCT03250832|594366234|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
164544429|NCT03250832|594366235|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
164544430|NCT03250832|594366236|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
164544431|NCT03250832|594366237|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
164544432|NCT03250832|594366238|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
164544433|NCT03250832|594366239|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
164544434|NCT03250832|594366240|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
164544435|NCT03250832|594366241|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
164544436|NCT03250832|594366242|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
164544437|NCT03250832|594366243|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
164544438|NCT03250832|594366232|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
164544439|NCT03250832|594366233|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
164544440|NCT03250832|594366234|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
164544441|NCT03250832|594366235|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
164544442|NCT03250832|594366236|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
164544443|NCT03250832|594366237|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
164544444|NCT03250832|594366238|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
164544445|NCT03250832|594366239|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
164544446|NCT03250832|594366240|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
164544447|NCT03250832|594366241|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
164544448|NCT03250832|594366242|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
164544449|NCT03250832|594366243|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
164544450|NCT03250832|594366232|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
164544451|NCT03250832|594366233|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
164544452|NCT03250832|594366234|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
164544453|NCT03250832|594366235|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
164544454|NCT03250832|594366236|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
164544455|NCT03250832|594366237|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
164544456|NCT03250832|594366238|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
164544457|NCT03250832|594366239|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
164544458|NCT03250832|594366240|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
164544459|NCT03250832|594366241|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
164544460|NCT03250832|594366242|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
164544461|NCT03250832|594366243|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
164544462|NCT03250832|594366232|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
164544463|NCT03250832|594366233|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
164544464|NCT03250832|594366234|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
164544465|NCT03250832|594366235|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
164544466|NCT03250832|594366236|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
164544467|NCT03250832|594366237|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
164544468|NCT03250832|594366238|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
164544469|NCT03250832|594366239|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
164544470|NCT03250832|594366240|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
164544471|NCT03250832|594366241|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
164544472|NCT03250832|594366242|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
164544473|NCT03250832|594366243|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
164544474|NCT03250832|594366232|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
164544475|NCT03250832|594366233|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
164544476|NCT03250832|594366234|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
164544477|NCT03250832|594366235|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
164544478|NCT03250832|594366236|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
164544479|NCT03250832|594366237|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
164544480|NCT03250832|594366238|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
164194174|NCT01278342|593079355|FG001|Overall Study|Lost to Follow-up|0|||
164194175|NCT01278342|593079356|FG002|Overall Study|Lost to Follow-up|0|||
164194176|NCT01278342|593079354|FG000|Overall Study|Administrative problems|2|||
164194177|NCT01278342|593079355|FG001|Overall Study|Administrative problems|0|||
164194178|NCT01278342|593079356|FG002|Overall Study|Administrative problems|0|||
164194179|NCT01278342|593079354|FG000|Overall Study|Other|1|||
164194180|NCT01278342|593079355|FG001|Overall Study|Other|0|||
164194181|NCT01278342|593079356|FG002|Overall Study|Other|0|||
164544481|NCT03250832|594366239|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
164544482|NCT03250832|594366240|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
164544483|NCT03250832|594366241|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
164544484|NCT03250832|594366242|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
164544485|NCT03250832|594366243|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
164544486|NCT03250832|594366232|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
164544487|NCT03250832|594366233|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
164544488|NCT03250832|594366234|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
164544489|NCT03250832|594366235|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
164544490|NCT03250832|594366236|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
164544491|NCT03250832|594366237|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
164544492|NCT03250832|594366238|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
164544493|NCT03250832|594366239|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
164544494|NCT03250832|594366240|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
164544495|NCT03250832|594366241|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
164544496|NCT03250832|594366242|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
164544497|NCT03250832|594366243|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
164544498|NCT01708291|594366244|FG000|Overall Study|fighting|2|||
164544499|NCT01708291|594366245|FG001|Overall Study|fighting|1|||
164544500|NCT02303704|594366246|FG000|Overall Study|Protocol Violation|5|||
164544501|NCT02303704|594366247|FG001|Overall Study|Protocol Violation|9|||
164544502|NCT04411628|594366249|FG000|Overall Study|Withdrawal by Subject|1|||
164544503|NCT04411628|594366250|FG001|Overall Study|Withdrawal by Subject|1|||
164544504|NCT04411628|594366251|FG002|Overall Study|Withdrawal by Subject|2|||
164544505|NCT04411628|594366252|FG003|Overall Study|Withdrawal by Subject|0|||
164544506|NCT04411628|594366249|FG000|Overall Study|Lost to Follow-up|0|||
164544507|NCT04411628|594366250|FG001|Overall Study|Lost to Follow-up|1|||
164544508|NCT04411628|594366251|FG002|Overall Study|Lost to Follow-up|0|||
164544509|NCT04411628|594366252|FG003|Overall Study|Lost to Follow-up|0|||
164544510|NCT01034540|594366253|FG000|Overall Study|Adverse Event|0|||
164544511|NCT01034540|594366254|FG001|Overall Study|Adverse Event|1|||
164544512|NCT01721876|594366257|FG000|Overall Study|Not treated|1|||
164544513|NCT01721876|594366258|FG001|Overall Study|Not treated|4|||
164544514|NCT01721876|594366257|FG000|Overall Study|Disease progression / relapse|123|||
164544515|NCT01721876|594366258|FG001|Overall Study|Disease progression / relapse|156|||
164544516|NCT01721876|594366257|FG000|Overall Study|Death|6|||
164544517|NCT01721876|594366258|FG001|Overall Study|Death|13|||
164544518|NCT01721876|594366257|FG000|Overall Study|Adverse Event|41|||
164544519|NCT01721876|594366258|FG001|Overall Study|Adverse Event|165|||
164544520|NCT01721876|594366257|FG000|Overall Study|Protocol Violation|2|||
164544521|NCT01721876|594366258|FG001|Overall Study|Protocol Violation|1|||
164544522|NCT01721876|594366257|FG000|Overall Study|Withdrawal by Subject|15|||
164544523|NCT01721876|594366258|FG001|Overall Study|Withdrawal by Subject|38|||
164544524|NCT01721876|594366257|FG000|Overall Study|Reason not listed|34|||
164544525|NCT01721876|594366258|FG001|Overall Study|Reason not listed|63|||
164544526|NCT01721876|594366257|FG000|Overall Study|Sponsor terminated trial|0|||
164544527|NCT01721876|594366258|FG001|Overall Study|Sponsor terminated trial|4|||
164544528|NCT03805750|594366259|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
164544529|NCT03805750|594366260|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
164544530|NCT00493220|594366261|FG000|Third Intervention|Withdrawal by Subject|1|||
164544531|NCT00493220|594366262|FG001|Third Intervention|Withdrawal by Subject|0|||
164544532|NCT00493220|594366263|FG002|Third Intervention|Withdrawal by Subject|0|||
164544533|NCT00493220|594366264|FG003|Third Intervention|Withdrawal by Subject|0|||
164544534|NCT00493220|594366265|FG004|Third Intervention|Withdrawal by Subject|0|||
164544535|NCT00493220|594366266|FG005|Third Intervention|Withdrawal by Subject|0|||
164544536|NCT00310804|594366267|FG000|Overall Study|Lost to Follow-up|2|||
164544537|NCT00310804|594366268|FG001|Overall Study|Lost to Follow-up|0|||
164544538|NCT00310804|594366267|FG000|Overall Study|Withdrawal by Subject|3|||
164544539|NCT00310804|594366268|FG001|Overall Study|Withdrawal by Subject|0|||
164544540|NCT02844816|594366270|FG000|Overall Study|No protocol treatment received|5|||
164544541|NCT02844816|594366271|FG001|Overall Study|No protocol treatment received|1|||
164544542|NCT02844816|594366270|FG000|Overall Study|Ineligible|22|||
164544543|NCT02844816|594366271|FG001|Overall Study|Ineligible|15|||
164544544|NCT02844816|594366270|FG000|Overall Study|Participant refusal|5|||
164544545|NCT02844816|594366271|FG001|Overall Study|Participant refusal|5|||
164544546|NCT02844816|594366270|FG000|Overall Study|Adverse Event|5|||
164544547|NCT02844816|594366271|FG001|Overall Study|Adverse Event|4|||
164544548|NCT02844816|594366270|FG000|Overall Study|Death|0|||
164544549|NCT02844816|594366271|FG001|Overall Study|Death|1|||
164544550|NCT02844816|594366270|FG000|Overall Study|Disease progression/recurrence|50|||
164544551|NCT02844816|594366271|FG001|Overall Study|Disease progression/recurrence|24|||
164544552|NCT02844816|594366270|FG000|Overall Study|Physician Decision|1|||
164544553|NCT02844816|594366271|FG001|Overall Study|Physician Decision|1|||
164544554|NCT01428661|594366274|FG000|Double-Masked Phase|Protocol Violation|9|||
164544555|NCT01428661|594366275|FG001|Double-Masked Phase|Protocol Violation|4|||
164544556|NCT01428661|594366276|FG002|Double-Masked Phase|Protocol Violation|0|||
164544557|NCT01428661|594366274|FG000|Double-Masked Phase|Adverse Event|13|||
164544558|NCT01428661|594366275|FG001|Double-Masked Phase|Adverse Event|4|||
164544559|NCT01428661|594366276|FG002|Double-Masked Phase|Adverse Event|0|||
164544560|NCT01428661|594366274|FG000|Double-Masked Phase|Lost to Follow-up|14|||
164544561|NCT01428661|594366275|FG001|Double-Masked Phase|Lost to Follow-up|14|||
164653501|NCT00672620|594757192|FG002|Overall Study|Lack of Efficacy|2|||
164544562|NCT01428661|594366276|FG002|Double-Masked Phase|Lost to Follow-up|0|||
164544563|NCT01428661|594366274|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
164544564|NCT01428661|594366275|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
164544565|NCT01428661|594366276|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
164544566|NCT01428661|594366274|FG000|Double-Masked Phase|Lack of Efficacy|2|||
164544567|NCT01428661|594366275|FG001|Double-Masked Phase|Lack of Efficacy|1|||
164544568|NCT01428661|594366276|FG002|Double-Masked Phase|Lack of Efficacy|0|||
164544569|NCT01428661|594366274|FG000|Double-Masked Phase|*Various|1|||
164544570|NCT01428661|594366275|FG001|Double-Masked Phase|*Various|6|||
164544571|NCT01428661|594366276|FG002|Double-Masked Phase|*Various|0|||
164544572|NCT01428661|594366274|FG000|Open Label Extension|Protocol Violation|0|||
164544573|NCT01428661|594366275|FG001|Open Label Extension|Protocol Violation|0|||
164544574|NCT01428661|594366276|FG002|Open Label Extension|Protocol Violation|9|||
164544575|NCT01428661|594366274|FG000|Open Label Extension|Adverse Event|0|||
164544576|NCT01428661|594366275|FG001|Open Label Extension|Adverse Event|0|||
164544577|NCT01428661|594366276|FG002|Open Label Extension|Adverse Event|15|||
164544578|NCT01428661|594366274|FG000|Open Label Extension|Lost to Follow-up|0|||
164544579|NCT01428661|594366275|FG001|Open Label Extension|Lost to Follow-up|0|||
164544580|NCT01428661|594366276|FG002|Open Label Extension|Lost to Follow-up|38|||
164544581|NCT01428661|594366274|FG000|Open Label Extension|Withdrawal by Subject|0|||
164544582|NCT01428661|594366275|FG001|Open Label Extension|Withdrawal by Subject|0|||
164544583|NCT01428661|594366276|FG002|Open Label Extension|Withdrawal by Subject|49|||
164544584|NCT01428661|594366274|FG000|Open Label Extension|Lack of Efficacy|0|||
164544585|NCT01428661|594366275|FG001|Open Label Extension|Lack of Efficacy|0|||
164544586|NCT01428661|594366276|FG002|Open Label Extension|Lack of Efficacy|24|||
164544587|NCT01428661|594366274|FG000|Open Label Extension|**Various|0|||
164544588|NCT01428661|594366275|FG001|Open Label Extension|**Various|0|||
164544589|NCT01428661|594366276|FG002|Open Label Extension|**Various|185|||
164544590|NCT04376827|594366278|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
164544591|NCT04376827|594366279|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
164544592|NCT04376827|594366278|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
164544593|NCT04376827|594366279|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
164544594|NCT04376827|594366278|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
164544595|NCT04376827|594366279|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
164544596|NCT04376827|594366278|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
164544597|NCT04376827|594366279|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
164544598|NCT04376827|594366278|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
164544599|NCT04376827|594366279|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
164544600|NCT01490450|594367592|FG000|Period 1|Lack of Efficacy|2|||
164544601|NCT01490450|594367593|FG001|Period 1|Lack of Efficacy|0|||
164544602|NCT01490450|594367594|FG002|Period 1|Lack of Efficacy|3|||
164544603|NCT01490450|594367595|FG003|Period 1|Lack of Efficacy|0|||
164544604|NCT01490450|594367592|FG000|Period 1|Adverse Event|0|||
164544605|NCT01490450|594367593|FG001|Period 1|Adverse Event|0|||
164544606|NCT01490450|594367594|FG002|Period 1|Adverse Event|0|||
164544607|NCT01490450|594367595|FG003|Period 1|Adverse Event|5|||
164544608|NCT01490450|594367592|FG000|Period 1|Request to discontinue treatment|1|||
164544609|NCT01490450|594367593|FG001|Period 1|Request to discontinue treatment|0|||
164544610|NCT01490450|594367594|FG002|Period 1|Request to discontinue treatment|0|||
164544611|NCT01490450|594367595|FG003|Period 1|Request to discontinue treatment|0|||
164544612|NCT01490450|594367592|FG000|Period 1|Withdrawal by Subject|0|||
164544613|NCT01490450|594367593|FG001|Period 1|Withdrawal by Subject|0|||
164544614|NCT01490450|594367594|FG002|Period 1|Withdrawal by Subject|0|||
164544615|NCT01490450|594367595|FG003|Period 1|Withdrawal by Subject|3|||
164544616|NCT01490450|594367592|FG000|Period 1|No longer met study criteria|0|||
164544617|NCT01490450|594367593|FG001|Period 1|No longer met study criteria|1|||
164544618|NCT01490450|594367594|FG002|Period 1|No longer met study criteria|1|||
164544619|NCT01490450|594367595|FG003|Period 1|No longer met study criteria|0|||
164544620|NCT01490450|594367592|FG000|Period 2|Lack of Efficacy|0|||
164544621|NCT01490450|594367593|FG001|Period 2|Lack of Efficacy|0|||
164544622|NCT01490450|594367594|FG002|Period 2|Lack of Efficacy|0|||
164302201|NCT01134055|593482558|FG002|Overall Study|Lost to Follow-up|0|||
164544623|NCT01490450|594367595|FG003|Period 2|Lack of Efficacy|1|||
164544624|NCT01490450|594367592|FG000|Period 2|Adverse Event|1|||
164544625|NCT01490450|594367593|FG001|Period 2|Adverse Event|1|||
164544626|NCT01490450|594367594|FG002|Period 2|Adverse Event|0|||
164544627|NCT01490450|594367595|FG003|Period 2|Adverse Event|1|||
164544628|NCT01490450|594367592|FG000|Period 2|Withdrawal by Subject|1|||
164544629|NCT01490450|594367593|FG001|Period 2|Withdrawal by Subject|0|||
164544630|NCT01490450|594367594|FG002|Period 2|Withdrawal by Subject|0|||
164544631|NCT01490450|594367595|FG003|Period 2|Withdrawal by Subject|0|||
164544632|NCT01490450|594367592|FG000|Period 2|Lost to Follow-up|0|||
164544633|NCT01490450|594367593|FG001|Period 2|Lost to Follow-up|0|||
164544634|NCT01490450|594367594|FG002|Period 2|Lost to Follow-up|0|||
164653502|NCT00672620|594757193|FG003|Overall Study|Lack of Efficacy|0|||
164653503|NCT00672620|594757190|FG000|Overall Study|Noncompliance with Study Drug|3|||
164544635|NCT01490450|594367595|FG003|Period 2|Lost to Follow-up|2|||
164544636|NCT00404820|594367596|FG000|Overall Study|Adverse Event|4|||
164544637|NCT00404820|594367597|FG001|Overall Study|Adverse Event|16|||
164544638|NCT00404820|594367596|FG000|Overall Study|Withdrawal by Subject|5|||
164544639|NCT00404820|594367597|FG001|Overall Study|Withdrawal by Subject|3|||
164544640|NCT00404820|594367596|FG000|Overall Study|Lost to Follow-up|7|||
164544641|NCT00404820|594367597|FG001|Overall Study|Lost to Follow-up|3|||
164544642|NCT00404820|594367596|FG000|Overall Study|Administrative problems|2|||
164544643|NCT00404820|594367597|FG001|Overall Study|Administrative problems|0|||
164544644|NCT00404820|594367596|FG000|Overall Study|Death|1|||
164544645|NCT00404820|594367597|FG001|Overall Study|Death|0|||
164544646|NCT00404820|594367596|FG000|Overall Study|Other|0|||
164544647|NCT00404820|594367597|FG001|Overall Study|Other|2|||
164544648|NCT00176605|594367598|FG000|Overall Study|Withdrawal by Subject|2|||
164544649|NCT03785925|594367599|FG000|Overall Study|Withdrawal by Subject|15|||
164544650|NCT03785925|594367599|FG000|Overall Study|Lost to Follow-up|1|||
164544651|NCT02187471|594367600|FG000|Overall Study|Protocol Violation|4|||
164544652|NCT02187471|594367601|FG001|Overall Study|Protocol Violation|5|||
164544653|NCT02187471|594367602|FG002|Overall Study|Protocol Violation|4|||
164544654|NCT02187471|594367603|FG003|Overall Study|Protocol Violation|4|||
164544655|NCT02187471|594367600|FG000|Overall Study|Missing|0|||
164544656|NCT02187471|594367601|FG001|Overall Study|Missing|0|||
164544657|NCT02187471|594367602|FG002|Overall Study|Missing|0|||
164544658|NCT02187471|594367603|FG003|Overall Study|Missing|1|||
164544659|NCT02187471|594367600|FG000|Overall Study|Lack of Efficacy|18|||
164544660|NCT02187471|594367601|FG001|Overall Study|Lack of Efficacy|9|||
164544661|NCT02187471|594367602|FG002|Overall Study|Lack of Efficacy|13|||
164544662|NCT02187471|594367603|FG003|Overall Study|Lack of Efficacy|11|||
164544663|NCT02187471|594367600|FG000|Overall Study|Adverse Event|24|||
164544664|NCT02187471|594367601|FG001|Overall Study|Adverse Event|34|||
164544665|NCT02187471|594367602|FG002|Overall Study|Adverse Event|44|||
164544666|NCT02187471|594367603|FG003|Overall Study|Adverse Event|36|||
164544667|NCT02187471|594367600|FG000|Overall Study|Withdrawal by Subject|23|||
164544668|NCT02187471|594367601|FG001|Overall Study|Withdrawal by Subject|29|||
164544669|NCT02187471|594367602|FG002|Overall Study|Withdrawal by Subject|22|||
164544670|NCT02187471|594367603|FG003|Overall Study|Withdrawal by Subject|24|||
164544671|NCT02187471|594367600|FG000|Overall Study|Other|7|||
164544672|NCT02187471|594367601|FG001|Overall Study|Other|5|||
164544673|NCT02187471|594367602|FG002|Overall Study|Other|3|||
164544674|NCT02187471|594367603|FG003|Overall Study|Other|4|||
164544675|NCT00957528|594367604|FG000|Overall Study|Protocol Violation|0|||
164544676|NCT00957528|594367605|FG001|Overall Study|Protocol Violation|1|||
164544677|NCT00957528|594367606|FG002|Overall Study|Protocol Violation|0|||
164544678|NCT00957528|594367604|FG000|Overall Study|Withdrawal by Subject|0|||
164544679|NCT00957528|594367605|FG001|Overall Study|Withdrawal by Subject|0|||
164544680|NCT00957528|594367606|FG002|Overall Study|Withdrawal by Subject|1|||
164544681|NCT02318667|594367607|FG000|Overall Study|Adverse Event|1|||
164544682|NCT02318667|594367607|FG000|Overall Study|Lack of Efficacy|6|||
164544683|NCT02318667|594367607|FG000|Overall Study|Protocol Violation|2|||
164544684|NCT01101438|594367609|FG000|Overall Study|Withdrawal by Subject|8|||
164544685|NCT01101438|594367610|FG001|Overall Study|Withdrawal by Subject|9|||
164544686|NCT02289742|594367619|FG000|First Wear Period|Adverse event prior to treatment|0|||
164544687|NCT02289742|594367620|FG001|First Wear Period|Adverse event prior to treatment|1|||
164544688|NCT02289742|594367621|FG002|First Wear Period|Adverse event prior to treatment|0|||
164544689|NCT02289742|594367622|FG003|First Wear Period|Adverse event prior to treatment|0|||
164544690|NCT02289742|594367619|FG000|First Wear Period|Adverse Event|0|||
164544691|NCT02289742|594367620|FG001|First Wear Period|Adverse Event|0|||
164544692|NCT02289742|594367621|FG002|First Wear Period|Adverse Event|1|||
164544693|NCT02289742|594367622|FG003|First Wear Period|Adverse Event|0|||
164544694|NCT02289742|594367619|FG000|First Wear Period|Other prior to treatment|0|||
164544695|NCT02289742|594367620|FG001|First Wear Period|Other prior to treatment|0|||
164544696|NCT02289742|594367621|FG002|First Wear Period|Other prior to treatment|0|||
164544697|NCT02289742|594367622|FG003|First Wear Period|Other prior to treatment|1|||
164544698|NCT02289742|594367619|FG000|Third Wear Period|Adverse Event|0|||
164544699|NCT02289742|594367620|FG001|Third Wear Period|Adverse Event|1|||
164544700|NCT02289742|594367621|FG002|Third Wear Period|Adverse Event|0|||
164544701|NCT02289742|594367622|FG003|Third Wear Period|Adverse Event|0|||
164544702|NCT02289742|594367619|FG000|Third Wear Period|Reason not given|0|||
164544703|NCT02289742|594367620|FG001|Third Wear Period|Reason not given|0|||
164544704|NCT02289742|594367621|FG002|Third Wear Period|Reason not given|0|||
164544705|NCT02289742|594367622|FG003|Third Wear Period|Reason not given|1|||
164544706|NCT00709111|594367623|FG000|Overall Study|Withdrawal by Subject|1|||
164544707|NCT00709111|594367623|FG000|Overall Study|Unable to attend clinic visits|1|||
164544708|NCT02865018|594367624|FG000|Overall Study|Withdrawal by Subject|1|||
164544709|NCT01735279|594367629|FG000|Overall Study|Lost to Follow-up|11|||
164544710|NCT01735279|594367630|FG001|Overall Study|Lost to Follow-up|8|||
164544711|NCT00294060|594367631|FG000|Overall Study|Death|225|||
164544712|NCT00294060|594367631|FG000|Overall Study|Other|59|||
164544713|NCT00294060|594367631|FG000|Overall Study|Lost to Follow-up|55|||
164544714|NCT00294060|594367631|FG000|Overall Study|Withdrawal by Subject|11|||
164544715|NCT00294060|594367631|FG000|Overall Study|Physician Decision|797|||
164544716|NCT00294060|594367631|FG000|Overall Study|Medical condition|3|||
164544717|NCT00294060|594367631|FG000|Overall Study|Device explanted/not replaced|23|||
164544718|NCT00806195|594367632|FG000|Overall Study|Death|6|||
164544719|NCT00806195|594367633|FG001|Overall Study|Death|0|||
164544720|NCT00806195|594367634|FG002|Overall Study|Death|1|||
164544721|NCT00806195|594367635|FG003|Overall Study|Death|0|||
164544722|NCT00806195|594367632|FG000|Overall Study|Adverse Event|25|||
164544723|NCT00806195|594367633|FG001|Overall Study|Adverse Event|5|||
164544724|NCT00806195|594367634|FG002|Overall Study|Adverse Event|11|||
164544725|NCT00806195|594367635|FG003|Overall Study|Adverse Event|2|||
164544726|NCT00806195|594367632|FG000|Overall Study|Withdrawal by Subject|119|||
164544727|NCT00806195|594367633|FG001|Overall Study|Withdrawal by Subject|31|||
164544728|NCT00806195|594367634|FG002|Overall Study|Withdrawal by Subject|76|||
164544729|NCT00806195|594367635|FG003|Overall Study|Withdrawal by Subject|35|||
164544730|NCT00806195|594367632|FG000|Overall Study|Lost to Follow-up|217|||
164544731|NCT00806195|594367633|FG001|Overall Study|Lost to Follow-up|66|||
164544732|NCT00806195|594367634|FG002|Overall Study|Lost to Follow-up|90|||
164544733|NCT00806195|594367635|FG003|Overall Study|Lost to Follow-up|34|||
164544734|NCT00806195|594367632|FG000|Overall Study|Inappropriate Enrollment|0|||
164544735|NCT00806195|594367633|FG001|Overall Study|Inappropriate Enrollment|1|||
164544736|NCT00806195|594367634|FG002|Overall Study|Inappropriate Enrollment|0|||
164544737|NCT00806195|594367635|FG003|Overall Study|Inappropriate Enrollment|0|||
164544738|NCT00806195|594367632|FG000|Overall Study|Administrative Reason|113|||
164544739|NCT00806195|594367633|FG001|Overall Study|Administrative Reason|35|||
164544740|NCT00806195|594367634|FG002|Overall Study|Administrative Reason|66|||
164544741|NCT00806195|594367635|FG003|Overall Study|Administrative Reason|26|||
164544742|NCT00806195|594367632|FG000|Overall Study|Protocol Violation|34|||
164544743|NCT00806195|594367633|FG001|Overall Study|Protocol Violation|24|||
164544744|NCT00806195|594367634|FG002|Overall Study|Protocol Violation|26|||
164544745|NCT00806195|594367635|FG003|Overall Study|Protocol Violation|9|||
164544746|NCT00139776|594367636|FG000|Period I|Did not enter Period II|575|||
164544747|NCT00139776|594367637|FG001|Period I|Did not enter Period II|0|||
164544748|NCT00139776|594367638|FG002|Period I|Did not enter Period II|0|||
164544749|NCT00139776|594367639|FG003|Period I|Did not enter Period II|0|||
164544750|NCT00139776|594367636|FG000|Period II|Not Randomized into Period III|0|||
164544751|NCT00139776|594367637|FG001|Period II|Not Randomized into Period III|322|||
164544752|NCT00139776|594367638|FG002|Period II|Not Randomized into Period III|0|||
164544753|NCT00139776|594367639|FG003|Period II|Not Randomized into Period III|0|||
164544754|NCT00139776|594367636|FG000|Period III|Adverse Event|0|||
164544755|NCT00139776|594367637|FG001|Period III|Adverse Event|0|||
164544756|NCT00139776|594367638|FG002|Period III|Adverse Event|22|||
164544757|NCT00139776|594367639|FG003|Period III|Adverse Event|23|||
164544758|NCT00139776|594367636|FG000|Period III|Other|0|||
164544759|NCT00139776|594367637|FG001|Period III|Other|0|||
164544760|NCT00139776|594367638|FG002|Period III|Other|23|||
164544761|NCT00139776|594367639|FG003|Period III|Other|34|||
164544762|NCT00139776|594367636|FG000|Period III|Lack of Efficacy|0|||
164544763|NCT00139776|594367637|FG001|Period III|Lack of Efficacy|0|||
164544764|NCT00139776|594367638|FG002|Period III|Lack of Efficacy|10|||
164544765|NCT00139776|594367639|FG003|Period III|Lack of Efficacy|24|||
164544766|NCT00139776|594367636|FG000|Period III|Lost to Follow-up|0|||
164544767|NCT00139776|594367637|FG001|Period III|Lost to Follow-up|0|||
164544768|NCT00139776|594367638|FG002|Period III|Lost to Follow-up|5|||
164544769|NCT00139776|594367639|FG003|Period III|Lost to Follow-up|4|||
164544770|NCT00139776|594367636|FG000|Period III|Withdrawal by Subject|0|||
164544771|NCT00139776|594367637|FG001|Period III|Withdrawal by Subject|0|||
164544772|NCT00139776|594367638|FG002|Period III|Withdrawal by Subject|16|||
164544773|NCT00139776|594367639|FG003|Period III|Withdrawal by Subject|21|||
164544774|NCT00187096|594367643|FG000|Overall Study|unacceptable toxicity|0|||
164544775|NCT00187096|594367644|FG001|Overall Study|unacceptable toxicity|0|||
164544776|NCT00187096|594367645|FG002|Overall Study|unacceptable toxicity|1|||
164544777|NCT01911442|594367652|FG000|Overall Study|Adverse Event|2|||
164544778|NCT01911442|594367653|FG001|Overall Study|Adverse Event|2|||
164544779|NCT01911442|594367654|FG002|Overall Study|Adverse Event|4|||
164544780|NCT01911442|594367652|FG000|Overall Study|Lack of Efficacy|1|||
164544781|NCT01911442|594367653|FG001|Overall Study|Lack of Efficacy|1|||
164544782|NCT01911442|594367654|FG002|Overall Study|Lack of Efficacy|1|||
164544783|NCT01911442|594367652|FG000|Overall Study|Lost to Follow-up|2|||
164544784|NCT01911442|594367653|FG001|Overall Study|Lost to Follow-up|0|||
164544785|NCT01911442|594367654|FG002|Overall Study|Lost to Follow-up|1|||
164544786|NCT01911442|594367652|FG000|Overall Study|Withdrawal by Subject|1|||
164544787|NCT01911442|594367653|FG001|Overall Study|Withdrawal by Subject|0|||
164544788|NCT01911442|594367654|FG002|Overall Study|Withdrawal by Subject|6|||
164544789|NCT01911442|594367652|FG000|Overall Study|Mother's Work Schedule|0|||
164544790|NCT01911442|594367653|FG001|Overall Study|Mother's Work Schedule|1|||
164544791|NCT01911442|594367654|FG002|Overall Study|Mother's Work Schedule|0|||
164544792|NCT01519934|594367662|FG000|Overall Study|Lost to Follow-up|3|||
164544793|NCT00922480|594367663|FG000|Main Study|Protocol Violation|3|||
164544794|NCT00922480|594367664|FG001|Main Study|Protocol Violation|6|||
164544795|NCT00922480|594367663|FG000|Main Study|Adverse Event|6|||
164544796|NCT00922480|594367664|FG001|Main Study|Adverse Event|7|||
164544797|NCT00922480|594367663|FG000|Main Study|Lack of Efficacy|3|||
164544798|NCT00922480|594367664|FG001|Main Study|Lack of Efficacy|0|||
164544799|NCT00922480|594367663|FG000|Main Study|Withdrawal by Subject|20|||
164544800|NCT00922480|594367664|FG001|Main Study|Withdrawal by Subject|15|||
164544801|NCT00922480|594367663|FG000|Main Study|Lost to Follow-up|5|||
164544802|NCT00922480|594367664|FG001|Main Study|Lost to Follow-up|0|||
164544803|NCT00922480|594367663|FG000|Main Study|Physician Decision|0|||
164544804|NCT00922480|594367664|FG001|Main Study|Physician Decision|1|||
164544805|NCT00922480|594367663|FG000|Extension Study|Protocol Violation|3|||
164544806|NCT00922480|594367664|FG001|Extension Study|Protocol Violation|0|||
164544807|NCT00922480|594367663|FG000|Extension Study|Adverse Event|1|||
164544808|NCT00922480|594367664|FG001|Extension Study|Adverse Event|1|||
164544809|NCT00922480|594367663|FG000|Extension Study|Withdrawal by Subject|1|||
164544810|NCT00922480|594367664|FG001|Extension Study|Withdrawal by Subject|1|||
164544811|NCT00922480|594367663|FG000|Extension Study|Others|0|||
164544812|NCT00922480|594367664|FG001|Extension Study|Others|1|||
164544813|NCT00971178|594367671|FG000|Overall Study|Lost to Follow-up|2|||
164544814|NCT00971178|594367672|FG001|Overall Study|Lost to Follow-up|2|||
164544815|NCT00971178|594367673|FG002|Overall Study|Lost to Follow-up|2|||
164544816|NCT02161575|594367674|FG000|Overall Study|Protocol Violation|8|||
164544817|NCT02161575|594367674|FG000|Overall Study|Lack of Efficacy|1|||
164544818|NCT02161575|594367674|FG000|Overall Study|Adverse Event|2|||
164544819|NCT00714285|594367679|FG000|Overall Study|Lost to Follow-up|0|||
164544820|NCT00714285|594367680|FG001|Overall Study|Lost to Follow-up|2|||
164544821|NCT00714285|594367681|FG002|Overall Study|Lost to Follow-up|0|||
164544822|NCT00714285|594367682|FG003|Overall Study|Lost to Follow-up|1|||
164544823|NCT00714285|594367679|FG000|Overall Study|Migrated/moved from study area|0|||
164544824|NCT00714285|594367680|FG001|Overall Study|Migrated/moved from study area|1|||
164544825|NCT00714285|594367681|FG002|Overall Study|Migrated/moved from study area|0|||
164544826|NCT00714285|594367682|FG003|Overall Study|Migrated/moved from study area|0|||
164544827|NCT02138617|594367683|FG000|Overall Study|Death|1|||
164544828|NCT02138617|594367684|FG001|Overall Study|Death|2|||
164544829|NCT02138617|594367685|FG002|Overall Study|Death|2|||
164544830|NCT02138617|594367683|FG000|Overall Study|Adverse Event|8|||
164544831|NCT02138617|594367684|FG001|Overall Study|Adverse Event|5|||
164544832|NCT02138617|594367685|FG002|Overall Study|Adverse Event|2|||
164544833|NCT02138617|594367683|FG000|Overall Study|Disease Progression|20|||
164544834|NCT02138617|594367684|FG001|Overall Study|Disease Progression|13|||
164544835|NCT02138617|594367685|FG002|Overall Study|Disease Progression|4|||
164544836|NCT02138617|594367683|FG000|Overall Study|Withdrawal by Subject|7|||
164544837|NCT02138617|594367684|FG001|Overall Study|Withdrawal by Subject|10|||
164544838|NCT02138617|594367685|FG002|Overall Study|Withdrawal by Subject|2|||
164544839|NCT02138617|594367683|FG000|Overall Study|other complicating disease|0|||
164544840|NCT02138617|594367684|FG001|Overall Study|other complicating disease|2|||
164544841|NCT02138617|594367685|FG002|Overall Study|other complicating disease|0|||
164544842|NCT02138617|594367683|FG000|Overall Study|Protocol Violation|1|||
164544843|NCT02138617|594367684|FG001|Overall Study|Protocol Violation|0|||
164544844|NCT02138617|594367685|FG002|Overall Study|Protocol Violation|0|||
164544845|NCT02138617|594367683|FG000|Overall Study|Physician Decision|7|||
164544846|NCT02138617|594367684|FG001|Overall Study|Physician Decision|6|||
164544847|NCT02138617|594367685|FG002|Overall Study|Physician Decision|0|||
164544848|NCT02138617|594367683|FG000|Overall Study|financial reason|0|||
164544849|NCT02138617|594367684|FG001|Overall Study|financial reason|1|||
164544850|NCT02138617|594367685|FG002|Overall Study|financial reason|0|||
164544851|NCT02138617|594367683|FG000|Overall Study|other therapy|3|||
164544852|NCT02138617|594367684|FG001|Overall Study|other therapy|4|||
164544853|NCT02138617|594367685|FG002|Overall Study|other therapy|0|||
164544854|NCT01970488|594367686|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
164544855|NCT01970488|594367687|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
164544856|NCT01970488|594367688|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
164544857|NCT01970488|594367689|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
164544858|NCT01970488|594367690|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
164544859|NCT01970488|594367686|FG000|Part 1: Through Week 16|Protocol Violation|1|||
164544860|NCT01970488|594367687|FG001|Part 1: Through Week 16|Protocol Violation|2|||
164544861|NCT01970488|594367688|FG002|Part 1: Through Week 16|Protocol Violation|0|||
164544862|NCT01970488|594367689|FG003|Part 1: Through Week 16|Protocol Violation|0|||
164544863|NCT01970488|594367690|FG004|Part 1: Through Week 16|Protocol Violation|0|||
164544864|NCT01970488|594367686|FG000|Part 1: Through Week 16|Adverse Event|6|||
164544865|NCT01970488|594367687|FG001|Part 1: Through Week 16|Adverse Event|5|||
164544866|NCT01970488|594367688|FG002|Part 1: Through Week 16|Adverse Event|0|||
164544867|NCT01970488|594367689|FG003|Part 1: Through Week 16|Adverse Event|0|||
164544868|NCT01970488|594367690|FG004|Part 1: Through Week 16|Adverse Event|0|||
164544869|NCT01970488|594367686|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
164544870|NCT01970488|594367687|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
164544871|NCT01970488|594367688|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
164544872|NCT01970488|594367689|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
164544873|NCT01970488|594367690|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
164544874|NCT01970488|594367686|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
164544875|NCT01970488|594367687|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
164544876|NCT01970488|594367688|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
164544877|NCT01970488|594367689|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
164544878|NCT01970488|594367690|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
164544879|NCT01970488|594367686|FG000|Part 2: Post Week 16|Physician Decision|0|||
164544880|NCT01970488|594367687|FG001|Part 2: Post Week 16|Physician Decision|0|||
164544881|NCT01970488|594367688|FG002|Part 2: Post Week 16|Physician Decision|0|||
164544882|NCT01970488|594367689|FG003|Part 2: Post Week 16|Physician Decision|0|||
164544883|NCT01970488|594367690|FG004|Part 2: Post Week 16|Physician Decision|1|||
164544884|NCT01970488|594367686|FG000|Part 2: Post Week 16|Non-compliance|0|||
164544885|NCT01970488|594367687|FG001|Part 2: Post Week 16|Non-compliance|0|||
164544886|NCT01970488|594367688|FG002|Part 2: Post Week 16|Non-compliance|1|||
164544887|NCT01970488|594367689|FG003|Part 2: Post Week 16|Non-compliance|0|||
164544888|NCT01970488|594367690|FG004|Part 2: Post Week 16|Non-compliance|0|||
164544889|NCT01970488|594367686|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
164544890|NCT01970488|594367687|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
164544891|NCT01970488|594367688|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
164544892|NCT01970488|594367689|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
164544893|NCT01970488|594367690|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
164544894|NCT01970488|594367686|FG000|Part 2: Post Week 16|Adverse Event|0|||
164544895|NCT01970488|594367687|FG001|Part 2: Post Week 16|Adverse Event|0|||
164544896|NCT01970488|594367688|FG002|Part 2: Post Week 16|Adverse Event|5|||
164544897|NCT01970488|594367689|FG003|Part 2: Post Week 16|Adverse Event|1|||
164544898|NCT01970488|594367690|FG004|Part 2: Post Week 16|Adverse Event|1|||
164544899|NCT01970488|594367686|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
164544900|NCT01970488|594367687|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
164544901|NCT01970488|594367688|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
164544902|NCT01970488|594367689|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
164544903|NCT01970488|594367690|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
164544904|NCT01970488|594367686|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
164544905|NCT01970488|594367687|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
164544906|NCT01970488|594367688|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
164544907|NCT01970488|594367689|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
164544908|NCT01970488|594367690|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
164544909|NCT05525689|594367691|FG000|Overall Study|Lost to Follow-up|1|||
164544910|NCT05525689|594367692|FG001|Overall Study|Lost to Follow-up|0|||
164544911|NCT01231659|594367693|FG000|Overall Study|Adverse Event|9|||
164544912|NCT01231659|594367693|FG000|Overall Study|Disease Progression|48|||
164544913|NCT01231659|594367693|FG000|Overall Study|Death|2|||
164544914|NCT01231659|594367693|FG000|Overall Study|Patient refused to complete study visit|1|||
164544915|NCT01231659|594367693|FG000|Overall Study|Other protocol defined criteria|12|||
164544916|NCT01075412|594367694|FG000|Overall Study|Withdrawal by Subject|0|||
164544917|NCT01075412|594367695|FG001|Overall Study|Withdrawal by Subject|1|||
164544918|NCT00509067|594367696|FG000|Overall Study|Lost to Follow-up|1|||
164544919|NCT00509067|594367697|FG001|Overall Study|Lost to Follow-up|1|||
164544920|NCT00509067|594367696|FG000|Overall Study|Adverse Event|3|||
164544921|NCT00509067|594367697|FG001|Overall Study|Adverse Event|1|||
164544922|NCT00509067|594367696|FG000|Overall Study|Protocol Violation|0|||
164544923|NCT00509067|594367697|FG001|Overall Study|Protocol Violation|3|||
164544924|NCT03716050|594367698|FG000|Overall Study|Lost to Follow-up|0|||
164544925|NCT03716050|594367699|FG001|Overall Study|Lost to Follow-up|0|||
164544926|NCT03716050|594367700|FG002|Overall Study|Lost to Follow-up|1|||
164544927|NCT03716050|594367701|FG003|Overall Study|Lost to Follow-up|0|||
164544928|NCT03716050|594367702|FG004|Overall Study|Lost to Follow-up|0|||
164544929|NCT03716050|594367703|FG005|Overall Study|Lost to Follow-up|0|||
164544930|NCT03716050|594367704|FG006|Overall Study|Lost to Follow-up|0|||
164544931|NCT03716050|594367705|FG007|Overall Study|Lost to Follow-up|0|||
164544932|NCT03716050|594367698|FG000|Overall Study|Physician Decision|0|||
164544933|NCT03716050|594367699|FG001|Overall Study|Physician Decision|0|||
164544934|NCT03716050|594367700|FG002|Overall Study|Physician Decision|0|||
164544935|NCT03716050|594367701|FG003|Overall Study|Physician Decision|1|||
164544936|NCT03716050|594367702|FG004|Overall Study|Physician Decision|0|||
164544937|NCT03716050|594367703|FG005|Overall Study|Physician Decision|0|||
164544938|NCT03716050|594367704|FG006|Overall Study|Physician Decision|0|||
164544939|NCT03716050|594367705|FG007|Overall Study|Physician Decision|0|||
164544940|NCT03716050|594367698|FG000|Overall Study|Protocol Violation|0|||
164544941|NCT03716050|594367699|FG001|Overall Study|Protocol Violation|0|||
164544942|NCT03716050|594367700|FG002|Overall Study|Protocol Violation|0|||
164544943|NCT03716050|594367701|FG003|Overall Study|Protocol Violation|1|||
164544944|NCT03716050|594367702|FG004|Overall Study|Protocol Violation|0|||
164544945|NCT03716050|594367703|FG005|Overall Study|Protocol Violation|0|||
164544946|NCT03716050|594367704|FG006|Overall Study|Protocol Violation|0|||
164544947|NCT03716050|594367705|FG007|Overall Study|Protocol Violation|2|||
164544948|NCT00529451|594367706|FG000|Overall Study|Subject withdrew consent|16|||
164544949|NCT00529451|594367707|FG001|Overall Study|Subject withdrew consent|21|||
164544950|NCT00529451|594367708|FG002|Overall Study|Subject withdrew consent|13|||
164544951|NCT00529451|594367709|FG003|Overall Study|Subject withdrew consent|12|||
164544952|NCT00529451|594367706|FG000|Overall Study|Adverse Event|9|||
164544953|NCT00529451|594367707|FG001|Overall Study|Adverse Event|16|||
164544954|NCT00529451|594367708|FG002|Overall Study|Adverse Event|14|||
164544955|NCT00529451|594367709|FG003|Overall Study|Adverse Event|8|||
164544956|NCT00529451|594367706|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
164544957|NCT00529451|594367707|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
164544958|NCT00529451|594367708|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
164544959|NCT00529451|594367709|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
164544960|NCT00529451|594367706|FG000|Overall Study|Lost to Follow-up|4|||
164544961|NCT00529451|594367707|FG001|Overall Study|Lost to Follow-up|7|||
164544962|NCT00529451|594367708|FG002|Overall Study|Lost to Follow-up|4|||
164544963|NCT00529451|594367709|FG003|Overall Study|Lost to Follow-up|4|||
164544964|NCT00529451|594367706|FG000|Overall Study|Protocol deviation|1|||
164544965|NCT00529451|594367707|FG001|Overall Study|Protocol deviation|1|||
164544966|NCT00529451|594367708|FG002|Overall Study|Protocol deviation|4|||
164544967|NCT00529451|594367709|FG003|Overall Study|Protocol deviation|1|||
164544968|NCT00529451|594367706|FG000|Overall Study|Administrative problems|1|||
164544969|NCT00529451|594367707|FG001|Overall Study|Administrative problems|1|||
164544970|NCT00529451|594367708|FG002|Overall Study|Administrative problems|0|||
164544971|NCT00529451|594367709|FG003|Overall Study|Administrative problems|2|||
164544972|NCT02566577|594367710|FG000|Overall Study|Withdrawal by Subject|1|||
164544973|NCT02566577|594367711|FG001|Overall Study|Withdrawal by Subject|1|||
164544974|NCT02566577|594367710|FG000|Overall Study|Equipment failure|1|||
164544975|NCT02566577|594367711|FG001|Overall Study|Equipment failure|1|||
164544976|NCT02566577|594367710|FG000|Overall Study|Physical limitation|1|||
164544977|NCT02566577|594367711|FG001|Overall Study|Physical limitation|0|||
164544978|NCT01009034|594367712|FG000|Overall Study|Lost to Follow-up|2|||
164544979|NCT01009034|594367712|FG000|Overall Study|Withdrawal by Subject|2|||
164544980|NCT03098836|594367716|FG000|Overall Study|Adverse Event|1|||
164544981|NCT03098836|594367717|FG001|Overall Study|Adverse Event|3|||
164544982|NCT03098836|594367716|FG000|Overall Study|Lack of Efficacy|30|||
164544983|NCT03098836|594367717|FG001|Overall Study|Lack of Efficacy|15|||
164544984|NCT03098836|594367716|FG000|Overall Study|Physician Decision|2|||
164544985|NCT03098836|594367717|FG001|Overall Study|Physician Decision|1|||
164544986|NCT03098836|594367716|FG000|Overall Study|Withdrawal by Subject|3|||
164544987|NCT03098836|594367717|FG001|Overall Study|Withdrawal by Subject|2|||
164544988|NCT03986866|594367718|FG000|Overall Study|Withdrawal by Subject|0|||
164544989|NCT03986866|594367719|FG001|Overall Study|Withdrawal by Subject|3|||
164544990|NCT03986866|594367718|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
164544991|NCT03986866|594367719|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
164544992|NCT01660451|594367720|FG000|Overall Study|Protocol Violation|0|||
164544993|NCT01660451|594367721|FG001|Overall Study|Protocol Violation|1|||
164544994|NCT01660451|594367722|FG002|Overall Study|Protocol Violation|1|||
164544995|NCT01660451|594367720|FG000|Overall Study|AE not associated with clinical disease progression|13|||
164544996|NCT01660451|594367721|FG001|Overall Study|AE not associated with clinical disease progression|10|||
164544997|NCT01660451|594367722|FG002|Overall Study|AE not associated with clinical disease progression|40|||
164194182|NCT02154139|593079362|FG000|Overall Study|Injection not administered|2|||
164194183|NCT02154139|593079362|FG000|Overall Study|Other|2|||
164194184|NCT02154139|593079362|FG000|Overall Study|Investigator transferred|3|||
164194185|NCT00473655|593079365|FG000|Overall Study|Lost to Follow-up|9|||
164194186|NCT00473655|593079366|FG001|Overall Study|Lost to Follow-up|5|||
164194187|NCT00473655|593079367|FG002|Overall Study|Lost to Follow-up|8|||
164194188|NCT00807885|593079382|FG000|Overall Study|Lost to Follow-up|0|||
164194189|NCT00807885|593079383|FG001|Overall Study|Lost to Follow-up|0|||
164194190|NCT00807885|593079384|FG002|Overall Study|Lost to Follow-up|0|||
164194191|NCT00807885|593079385|FG003|Overall Study|Lost to Follow-up|0|||
164194192|NCT00807885|593079386|FG004|Overall Study|Lost to Follow-up|0|||
164194193|NCT00807885|593079387|FG005|Overall Study|Lost to Follow-up|1|||
164544998|NCT01660451|594367720|FG000|Overall Study|AE associated with clinical disease progression|1|||
164544999|NCT01660451|594367721|FG001|Overall Study|AE associated with clinical disease progression|3|||
164545000|NCT01660451|594367722|FG002|Overall Study|AE associated with clinical disease progression|11|||
164545001|NCT01660451|594367720|FG000|Overall Study|Sponsor Decision|0|||
164545002|NCT01660451|594367721|FG001|Overall Study|Sponsor Decision|0|||
164545003|NCT01660451|594367722|FG002|Overall Study|Sponsor Decision|1|||
164545004|NCT01660451|594367720|FG000|Overall Study|Protocol Deviation|0|||
164545005|NCT01660451|594367721|FG001|Overall Study|Protocol Deviation|0|||
164545006|NCT01660451|594367722|FG002|Overall Study|Protocol Deviation|1|||
164545007|NCT01660451|594367720|FG000|Overall Study|Physician Decision|1|||
164653504|NCT00672620|594757191|FG001|Overall Study|Noncompliance with Study Drug|4|||
164194194|NCT00807885|593079388|FG006|Overall Study|Lost to Follow-up|0|||
164194195|NCT00807885|593079389|FG007|Overall Study|Lost to Follow-up|0|||
164194196|NCT00807885|593079390|FG008|Overall Study|Lost to Follow-up|0|||
164194197|NCT02899065|593079391|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
164194198|NCT02899065|593079392|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
164194199|NCT02899065|593079391|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
164194200|NCT02899065|593079392|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
164194201|NCT02899065|593079391|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
164194202|NCT02899065|593079392|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
164194203|NCT00186485|593079394|FG000|Overall Study|Lost to Follow-up|3|||
164194204|NCT01166750|593079395|FG000|Overall Study|Lost to Follow-up|1|||
164194205|NCT01166750|593079396|FG001|Overall Study|Lost to Follow-up|0|||
164194206|NCT05225389|593079397|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
164194207|NCT02417753|593079398|FG000|Overall Study|Death|1|||
164194208|NCT04805671|593079399|FG000|Overall Study|Death|2|||
164194209|NCT04805671|593079400|FG001|Overall Study|Death|7|||
164194210|NCT04805671|593079399|FG000|Overall Study|Lost to Follow-up|1|||
164194211|NCT04805671|593079400|FG001|Overall Study|Lost to Follow-up|0|||
164194212|NCT04805671|593079399|FG000|Overall Study|Withdrawal by Subject|9|||
164194213|NCT04805671|593079400|FG001|Overall Study|Withdrawal by Subject|7|||
164194214|NCT04805671|593079399|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
164194215|NCT04805671|593079400|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
164194216|NCT03804268|593079401|FG000|Overall Study|Adverse Event|2|||
164194217|NCT03804268|593079402|FG001|Overall Study|Adverse Event|2|||
164194218|NCT03804268|593079401|FG000|Overall Study|Withdrawal by Subject|2|||
164194219|NCT03804268|593079402|FG001|Overall Study|Withdrawal by Subject|0|||
164194220|NCT03804268|593079401|FG000|Overall Study|Lost to Follow-up|1|||
164194221|NCT03804268|593079402|FG001|Overall Study|Lost to Follow-up|0|||
164194222|NCT03804268|593079401|FG000|Overall Study|Physician Decision|2|||
164194223|NCT03804268|593079402|FG001|Overall Study|Physician Decision|0|||
164194224|NCT02849587|593079403|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
164194225|NCT02849587|593079404|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
164194226|NCT02849587|593079405|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
164194227|NCT02849587|593079403|FG000|Overall Study|Withdrawal by Subject|0|||
164194228|NCT02849587|593079404|FG001|Overall Study|Withdrawal by Subject|1|||
164194229|NCT02849587|593079405|FG002|Overall Study|Withdrawal by Subject|0|||
164194230|NCT03380377|593079406|FG000|Overall Study|Physician Decision|1|||
164194231|NCT03380377|593079406|FG000|Overall Study|Withdrawal by Subject|1|||
164194232|NCT00385918|593079407|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
164194233|NCT00385918|593079408|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
164194234|NCT00385918|593079409|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
164194235|NCT00385918|593079407|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
164194236|NCT00385918|593079408|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
164194237|NCT00385918|593079409|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
164194238|NCT00385918|593079407|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
164194239|NCT00385918|593079408|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
164194240|NCT00385918|593079409|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
164194241|NCT00385918|593079407|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
164194242|NCT00385918|593079408|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
164194243|NCT00385918|593079409|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
164194244|NCT00385918|593079407|FG000|Intervention Phase After Randomization|Physician Decision|1|||
164545008|NCT01660451|594367721|FG001|Overall Study|Physician Decision|2|||
164545009|NCT01660451|594367722|FG002|Overall Study|Physician Decision|5|||
164545010|NCT01660451|594367720|FG000|Overall Study|Withdrawal by Subject|1|||
164545011|NCT01660451|594367721|FG001|Overall Study|Withdrawal by Subject|1|||
164545012|NCT01660451|594367722|FG002|Overall Study|Withdrawal by Subject|20|||
164545013|NCT01660451|594367720|FG000|Overall Study|Trial closure.|0|||
164545014|NCT01660451|594367721|FG001|Overall Study|Trial closure.|0|||
164545015|NCT01660451|594367722|FG002|Overall Study|Trial closure.|1|||
164545016|NCT01660451|594367720|FG000|Overall Study|Switching to other therapy|0|||
164545017|NCT01660451|594367721|FG001|Overall Study|Switching to other therapy|1|||
164545018|NCT01660451|594367722|FG002|Overall Study|Switching to other therapy|1|||
164545019|NCT01660451|594367720|FG000|Overall Study|Progressive disease - clinical progression|4|||
164545020|NCT01660451|594367721|FG001|Overall Study|Progressive disease - clinical progression|10|||
164194245|NCT00385918|593079408|FG001|Intervention Phase After Randomization|Physician Decision|0|||
164194246|NCT00385918|593079409|FG002|Intervention Phase After Randomization|Physician Decision|0|||
164545021|NCT01660451|594367722|FG002|Overall Study|Progressive disease - clinical progression|9|||
164545022|NCT01660451|594367720|FG000|Overall Study|Progressive disease - radiological progression|12|||
164545023|NCT01660451|594367721|FG001|Overall Study|Progressive disease - radiological progression|23|||
164653505|NCT00672620|594757192|FG002|Overall Study|Noncompliance with Study Drug|0|||
164545024|NCT01660451|594367722|FG002|Overall Study|Progressive disease - radiological progression|50|||
164545025|NCT01660451|594367720|FG000|Overall Study|Death|1|||
164545026|NCT01660451|594367721|FG001|Overall Study|Death|0|||
164545027|NCT01660451|594367722|FG002|Overall Study|Death|1|||
164545028|NCT01660451|594367720|FG000|Overall Study|Other|0|||
164545029|NCT01660451|594367721|FG001|Overall Study|Other|0|||
164545030|NCT01660451|594367722|FG002|Overall Study|Other|1|||
164545031|NCT03337542|594367730|FG000|Overall Study|Withdrew Consent|17|||
164545032|NCT03337542|594367730|FG000|Overall Study|Allergic Adverse Event|1|||
164545033|NCT03337542|594367730|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
164545034|NCT03337542|594367730|FG000|Overall Study|Lost to Follow-up|1|||
164545035|NCT03337542|594367730|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
164545036|NCT00282295|594367731|FG000|Overall Study|Adverse Event|0|||
164545037|NCT00282295|594367732|FG001|Overall Study|Adverse Event|1|||
164545038|NCT00282295|594367733|FG002|Overall Study|Adverse Event|0|||
164545039|NCT00282295|594367731|FG000|Overall Study|Serious Adverse Events|0|||
164545040|NCT00282295|594367732|FG001|Overall Study|Serious Adverse Events|0|||
164545041|NCT00282295|594367733|FG002|Overall Study|Serious Adverse Events|1|||
164545042|NCT00282295|594367731|FG000|Overall Study|Protocol Violation|0|||
164545043|NCT00282295|594367732|FG001|Overall Study|Protocol Violation|2|||
164545044|NCT00282295|594367733|FG002|Overall Study|Protocol Violation|1|||
164545045|NCT00282295|594367731|FG000|Overall Study|Withdrawal by Subject|2|||
164545046|NCT00282295|594367732|FG001|Overall Study|Withdrawal by Subject|6|||
164545047|NCT00282295|594367733|FG002|Overall Study|Withdrawal by Subject|4|||
164545048|NCT00282295|594367731|FG000|Overall Study|Lost to Follow-up|1|||
164545049|NCT00282295|594367732|FG001|Overall Study|Lost to Follow-up|7|||
164545050|NCT00282295|594367733|FG002|Overall Study|Lost to Follow-up|2|||
164545051|NCT00282295|594367731|FG000|Overall Study|Other|0|||
164545052|NCT00282295|594367732|FG001|Overall Study|Other|1|||
164545053|NCT00282295|594367733|FG002|Overall Study|Other|0|||
164545054|NCT06156215|594367736|FG000|Overall Study|Withdrawal by Subject|2|||
164545055|NCT06156215|594367737|FG001|Overall Study|Withdrawal by Subject|4|||
164545056|NCT06156215|594367738|FG002|Overall Study|Withdrawal by Subject|4|||
164545057|NCT06156215|594367739|FG003|Overall Study|Withdrawal by Subject|0|||
164545058|NCT06156215|594367740|FG004|Overall Study|Withdrawal by Subject|2|||
164545059|NCT06156215|594367741|FG005|Overall Study|Withdrawal by Subject|2|||
164545060|NCT06156215|594367736|FG000|Overall Study|Left ED without completing study|9|||
164545061|NCT06156215|594367737|FG001|Overall Study|Left ED without completing study|3|||
164545062|NCT06156215|594367738|FG002|Overall Study|Left ED without completing study|9|||
164545063|NCT06156215|594367739|FG003|Overall Study|Left ED without completing study|0|||
164545064|NCT06156215|594367740|FG004|Overall Study|Left ED without completing study|8|||
164545065|NCT06156215|594367741|FG005|Overall Study|Left ED without completing study|16|||
164545066|NCT06156215|594367736|FG000|Overall Study|Physician Decision|1|||
164545067|NCT06156215|594367737|FG001|Overall Study|Physician Decision|0|||
164545068|NCT06156215|594367738|FG002|Overall Study|Physician Decision|0|||
164545069|NCT06156215|594367739|FG003|Overall Study|Physician Decision|0|||
164545070|NCT06156215|594367740|FG004|Overall Study|Physician Decision|0|||
164545071|NCT06156215|594367741|FG005|Overall Study|Physician Decision|0|||
164545072|NCT06156215|594367736|FG000|Overall Study|Became or found ineligible|2|||
164545073|NCT06156215|594367737|FG001|Overall Study|Became or found ineligible|0|||
164545074|NCT06156215|594367738|FG002|Overall Study|Became or found ineligible|2|||
164545075|NCT06156215|594367739|FG003|Overall Study|Became or found ineligible|0|||
164545076|NCT06156215|594367740|FG004|Overall Study|Became or found ineligible|1|||
164545077|NCT06156215|594367741|FG005|Overall Study|Became or found ineligible|2|||
164545078|NCT04198623|594369333|FG000|Overall Study|1 patient was taken off due to covid-19 pandemic shut down|1|||
164545079|NCT00736255|594369343|FG000|Overall Study|Adverse Event|1|||
164545080|NCT00736255|594369344|FG001|Overall Study|Adverse Event|0|||
164545081|NCT00736255|594369343|FG000|Overall Study|Physician Decision|1|||
164545082|NCT00736255|594369344|FG001|Overall Study|Physician Decision|0|||
164545083|NCT00736255|594369343|FG000|Overall Study|Non-compliance|1|||
164545084|NCT00736255|594369344|FG001|Overall Study|Non-compliance|1|||
164545085|NCT00457015|594369346|FG000|Overall Study|Left study site against medical advice|0|||
164545086|NCT00457015|594369347|FG001|Overall Study|Left study site against medical advice|1|||
164545087|NCT03670953|594369348|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
164545088|NCT03670953|594369349|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
164545089|NCT03670953|594369350|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
164545090|NCT03670953|594369351|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
164545091|NCT03670953|594369348|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
164545092|NCT03670953|594369349|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
164545093|NCT03670953|594369350|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
164545094|NCT03670953|594369351|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
164545095|NCT03670953|594369348|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
164545096|NCT03670953|594369349|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
164545097|NCT03670953|594369350|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
164545098|NCT03670953|594369351|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
164545099|NCT03670953|594369348|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
164545100|NCT03670953|594369349|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
164545101|NCT03670953|594369350|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
164545102|NCT03670953|594369351|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
164545103|NCT03670953|594369348|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
164545104|NCT03670953|594369349|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
164545105|NCT03670953|594369350|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
164545106|NCT03670953|594369351|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
164545107|NCT03670953|594369348|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
164545108|NCT03670953|594369349|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
164545109|NCT03670953|594369350|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
164545110|NCT03670953|594369351|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
164545111|NCT03670953|594369348|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
164545112|NCT03670953|594369349|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
164545113|NCT03670953|594369350|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
164545114|NCT03670953|594369351|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
164545115|NCT03670953|594369348|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
164545116|NCT03670953|594369349|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
164545117|NCT03670953|594369350|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
164545118|NCT03670953|594369351|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
164545119|NCT03670953|594369348|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
164545120|NCT03670953|594369349|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
164545121|NCT03670953|594369350|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
164545122|NCT03670953|594369351|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
164545123|NCT03670953|594369348|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
164545124|NCT03670953|594369349|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
164545125|NCT03670953|594369350|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
164545126|NCT03670953|594369351|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
164545127|NCT03670953|594369348|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
164545128|NCT03670953|594369349|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
164545129|NCT03670953|594369350|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
164545130|NCT03670953|594369351|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
164545131|NCT03670953|594369348|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
164545132|NCT03670953|594369349|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
164545133|NCT03670953|594369350|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
164545134|NCT03670953|594369351|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
164545135|NCT03670953|594369348|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
164545136|NCT03670953|594369349|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
164545137|NCT03670953|594369350|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
164545138|NCT03670953|594369351|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
164545139|NCT03670953|594369348|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
164545140|NCT03670953|594369349|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
164545141|NCT03670953|594369350|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
164545142|NCT03670953|594369351|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
164545143|NCT03670953|594369348|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
164545144|NCT03670953|594369349|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
164545145|NCT03670953|594369350|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
164545146|NCT03670953|594369351|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
164545147|NCT03670953|594369348|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
164545148|NCT03670953|594369349|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
164545149|NCT03670953|594369350|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
164545150|NCT03670953|594369351|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
164545151|NCT03670953|594369348|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
164545152|NCT03670953|594369349|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
164545153|NCT03670953|594369350|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
164545154|NCT03670953|594369351|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
164545155|NCT03670953|594369348|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
164545156|NCT03670953|594369349|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
164545157|NCT03670953|594369350|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
164545158|NCT03670953|594369351|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
164545159|NCT04179734|594369352|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
164545160|NCT04179734|594369353|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
164545161|NCT04179734|594369352|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
164545162|NCT04179734|594369353|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
164545163|NCT00937937|594369354|FG000|Overall Study|Adverse Event|6|||
164545164|NCT00937937|594369354|FG000|Overall Study|Withdrawal by Subject|2|||
164545165|NCT00937937|594369354|FG000|Overall Study|Progression/relapse|61|||
164545166|NCT00937937|594369354|FG000|Overall Study|Death|1|||
164545167|NCT00937937|594369354|FG000|Overall Study|Other|2|||
164545168|NCT00054704|594369355|FG000|Overall Study|Lack of Efficacy|2|||
164545169|NCT00054704|594369356|FG001|Overall Study|Lack of Efficacy|3|||
164545170|NCT00054704|594369355|FG000|Overall Study|Adverse Event|3|||
164545171|NCT00054704|594369356|FG001|Overall Study|Adverse Event|1|||
164545172|NCT00054704|594369355|FG000|Overall Study|Lost to Follow-up|0|||
164545173|NCT00054704|594369356|FG001|Overall Study|Lost to Follow-up|1|||
164545174|NCT00362414|594369357|FG000|Overall Study|Death|2|||
164545175|NCT00362414|594369357|FG000|Overall Study|Adverse Event|1|||
164545176|NCT01785160|594369364|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
164545177|NCT01785160|594369364|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
164545178|NCT00549939|594369371|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
164545179|NCT00549939|594369372|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
164545180|NCT00549939|594369373|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
164545181|NCT00549939|594369371|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
164545182|NCT00549939|594369372|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
164545183|NCT00549939|594369373|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
164545184|NCT00549939|594369371|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
164545185|NCT00549939|594369372|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
164545186|NCT00549939|594369373|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
164545187|NCT00549939|594369371|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
164545188|NCT00549939|594369372|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
164545189|NCT00549939|594369373|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
164545190|NCT00549939|594369371|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
164545191|NCT00549939|594369372|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
164545192|NCT00549939|594369373|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
164545193|NCT00549939|594369371|FG000|40-week Open Label Treatment Period|Other|0|||
164545194|NCT00549939|594369372|FG001|40-week Open Label Treatment Period|Other|1|||
164545195|NCT00549939|594369373|FG002|40-week Open Label Treatment Period|Other|4|||
164545196|NCT03677596|594369374|FG000|Overall Study|Adverse Event|0|||
164545197|NCT03677596|594369375|FG001|Overall Study|Adverse Event|1|||
164545198|NCT03677596|594369374|FG000|Overall Study|Death|10|||
164545199|NCT03677596|594369375|FG001|Overall Study|Death|6|||
164545200|NCT03677596|594369374|FG000|Overall Study|Lost to Follow-up|0|||
164545201|NCT03677596|594369375|FG001|Overall Study|Lost to Follow-up|1|||
164545202|NCT03677596|594369374|FG000|Overall Study|Progressive Disease|8|||
164545203|NCT03677596|594369375|FG001|Overall Study|Progressive Disease|8|||
164545204|NCT03677596|594369374|FG000|Overall Study|Withdrawal by Subject|3|||
164545205|NCT03677596|594369375|FG001|Overall Study|Withdrawal by Subject|0|||
164545206|NCT03677596|594369374|FG000|Overall Study|Disease Relapse|2|||
164545207|NCT03677596|594369375|FG001|Overall Study|Disease Relapse|2|||
164545208|NCT03677596|594369374|FG000|Overall Study|Other|0|||
164545209|NCT03677596|594369375|FG001|Overall Study|Other|1|||
164545210|NCT01360554|594369376|FG000|Overall Study|Death|359|||
164545211|NCT01360554|594369377|FG001|Overall Study|Death|371|||
164545212|NCT01360554|594369376|FG000|Overall Study|Lost to Follow-up|4|||
164545213|NCT01360554|594369377|FG001|Overall Study|Lost to Follow-up|4|||
164545214|NCT01360554|594369376|FG000|Overall Study|Withdrawal by Subject|23|||
164545215|NCT01360554|594369377|FG001|Overall Study|Withdrawal by Subject|24|||
164545216|NCT01360554|594369376|FG000|Overall Study|Study terminated by sponsor|49|||
164545217|NCT01360554|594369377|FG001|Overall Study|Study terminated by sponsor|37|||
164545218|NCT01360554|594369376|FG000|Overall Study|Other, not specified|1|||
164194247|NCT00385918|593079407|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
164194248|NCT00385918|593079408|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
164194249|NCT00385918|593079409|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
164194250|NCT00128661|593079410|FG000|Overall Study|Adverse Event|14|||
164194251|NCT00128661|593079411|FG001|Overall Study|Adverse Event|11|||
164194252|NCT00128661|593079410|FG000|Overall Study|Lost to Follow-up|10|||
164194253|NCT00128661|593079411|FG001|Overall Study|Lost to Follow-up|7|||
164194254|NCT00128661|593079410|FG000|Overall Study|Withdrawal by Subject|243|||
164194255|NCT00128661|593079411|FG001|Overall Study|Withdrawal by Subject|232|||
164194256|NCT00128661|593079410|FG000|Overall Study|Other|7|||
164194257|NCT00128661|593079411|FG001|Overall Study|Other|8|||
164194258|NCT01261390|593079412|FG000|Overall Study|Significant Concurrent Illness|1|||
164194259|NCT01261390|593079413|FG001|Overall Study|Significant Concurrent Illness|0|||
164545219|NCT01360554|594369377|FG001|Overall Study|Other, not specified|0|||
164194260|NCT01261390|593079414|FG002|Overall Study|Significant Concurrent Illness|1|||
164194261|NCT01261390|593079415|FG003|Overall Study|Significant Concurrent Illness|0|||
164194262|NCT01261390|593079412|FG000|Overall Study|Dissatisfaction with Treatment|2|||
164545220|NCT01360554|594369376|FG000|Overall Study|Randomized but not treated.|3|||
164545221|NCT01360554|594369377|FG001|Overall Study|Randomized but not treated.|3|||
164545222|NCT01131676|594369384|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
164545223|NCT01131676|594369385|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
164545224|NCT01131676|594369386|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
164545225|NCT01131676|594369384|FG000|Discontinuation From Treatment|Not treated|4|||
164545226|NCT01131676|594369385|FG001|Discontinuation From Treatment|Not treated|2|||
164545227|NCT01131676|594369386|FG002|Discontinuation From Treatment|Not treated|2|||
164545228|NCT01131676|594369384|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
164545229|NCT01131676|594369385|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
164545230|NCT01131676|594369386|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
164545231|NCT01131676|594369384|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
164545232|NCT01131676|594369385|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
164545233|NCT01131676|594369386|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
164545234|NCT01131676|594369384|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
164545235|NCT01131676|594369385|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
164545236|NCT01131676|594369386|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
164545237|NCT01131676|594369384|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
164545238|NCT01131676|594369385|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
164545239|NCT01131676|594369386|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
164545240|NCT01131676|594369384|FG000|Discontinuation From Treatment|Other than those specified|162|||
164545241|NCT01131676|594369385|FG001|Discontinuation From Treatment|Other than those specified|142|||
164545242|NCT01131676|594369386|FG002|Discontinuation From Treatment|Other than those specified|125|||
164545243|NCT01131676|594369384|FG000|Discontinuation From Treatment|Adverse Event|303|||
164545244|NCT01131676|594369385|FG001|Discontinuation From Treatment|Adverse Event|267|||
164545245|NCT01131676|594369386|FG002|Discontinuation From Treatment|Adverse Event|273|||
164545246|NCT01131676|594369384|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
164545247|NCT01131676|594369385|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
164545248|NCT01131676|594369386|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
164545249|NCT01131676|594369384|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
164545250|NCT01131676|594369385|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
164545251|NCT01131676|594369386|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
164545252|NCT01131676|594369384|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
164545253|NCT01131676|594369385|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
164545254|NCT01131676|594369386|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
164545255|NCT01131676|594369384|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
164545256|NCT01131676|594369385|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
164545257|NCT01131676|594369386|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
164545258|NCT01131676|594369384|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
164545259|NCT01131676|594369385|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
164545260|NCT01131676|594369386|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
164545261|NCT01131676|594369384|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
164545262|NCT01131676|594369385|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
164545263|NCT01131676|594369386|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
164545264|NCT01816061|594369388|FG000|Overall Study|Lost to Follow-up|13|||
164545265|NCT01816061|594369389|FG001|Overall Study|Lost to Follow-up|24|||
164545266|NCT00702325|594369401|FG000|Overall Study|Adverse Event|1|||
164545267|NCT00702325|594369402|FG001|Overall Study|Adverse Event|0|||
164545268|NCT00702325|594369401|FG000|Overall Study|Withdrawal by Subject|7|||
164545269|NCT00702325|594369402|FG001|Overall Study|Withdrawal by Subject|7|||
164545270|NCT00702325|594369401|FG000|Overall Study|Lost to Follow-up|3|||
164545271|NCT00702325|594369402|FG001|Overall Study|Lost to Follow-up|4|||
164545272|NCT00702325|594369401|FG000|Overall Study|Incorrect enrollment|5|||
164545273|NCT00702325|594369402|FG001|Overall Study|Incorrect enrollment|7|||
164545274|NCT00702325|594369401|FG000|Overall Study|Developed study discontinuation criteria|18|||
164545275|NCT00702325|594369402|FG001|Overall Study|Developed study discontinuation criteria|28|||
164545276|NCT00702325|594369401|FG000|Overall Study|Severe noncompliance to protocol|3|||
164545277|NCT00702325|594369402|FG001|Overall Study|Severe noncompliance to protocol|3|||
164545278|NCT00702325|594369401|FG000|Overall Study|Termination due to lab results|1|||
164545279|NCT00702325|594369402|FG001|Overall Study|Termination due to lab results|0|||
164545280|NCT00702325|594369401|FG000|Overall Study|Didn't follow study medication dosage|0|||
164545281|NCT00702325|594369402|FG001|Overall Study|Didn't follow study medication dosage|2|||
164545282|NCT00702325|594369401|FG000|Overall Study|Withdrew consent|0|||
164545283|NCT00702325|594369402|FG001|Overall Study|Withdrew consent|1|||
164545284|NCT00702325|594369401|FG000|Overall Study|Incorrectly Discontinued|0|||
164194263|NCT01261390|593079413|FG001|Overall Study|Dissatisfaction with Treatment|1|||
164194264|NCT01261390|593079414|FG002|Overall Study|Dissatisfaction with Treatment|1|||
164194265|NCT01261390|593079415|FG003|Overall Study|Dissatisfaction with Treatment|2|||
164194266|NCT01261390|593079412|FG000|Overall Study|Relocation|0|||
164545285|NCT00702325|594369402|FG001|Overall Study|Incorrectly Discontinued|1|||
164545286|NCT01022502|594369405|FG000|Overall Study|Adverse Event|1|||
164545287|NCT01022502|594369405|FG000|Overall Study|employment related reasons|1|||
164545288|NCT01022502|594369405|FG000|Overall Study|Withdrawal by Subject|1|||
164545289|NCT01289821|594369409|FG000|Treatment Period|Withdrawal by Subject|1|||
164545290|NCT01289821|594369409|FG000|Treatment Period|Physician Decision|3|||
164545291|NCT01289821|594369409|FG000|Treatment Period|Adverse Event|4|||
164545292|NCT01289821|594369409|FG000|Treatment Period|Radiological Progression|43|||
164545293|NCT01289821|594369409|FG000|Treatment Period|Clinical Progression|2|||
164545294|NCT01289821|594369409|FG000|Treatment Period|Therapeutic procedure required|1|||
164545295|NCT01289821|594369409|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
164545296|NCT01289821|594369409|FG000|Safety Follow-up Period|Protocol Violation|3|||
164545297|NCT01289821|594369409|FG000|Safety Follow-up Period|Unspecified reason|1|||
164545298|NCT01289821|594369409|FG000|Survival Follow-up Period|Protocol Violation|1|||
164545299|NCT01289821|594369409|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
164545300|NCT01289821|594369409|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
164545301|NCT02790138|594369414|FG000|Overall Study|Adverse Event|5|||
164545302|NCT02790138|594369415|FG001|Overall Study|Adverse Event|2|||
164545303|NCT02790138|594369414|FG000|Overall Study|Significant Protocol Deviation|0|||
164545304|NCT02790138|594369415|FG001|Overall Study|Significant Protocol Deviation|1|||
164545305|NCT02790138|594369414|FG000|Overall Study|Lost to Follow-up|1|||
164545306|NCT02790138|594369415|FG001|Overall Study|Lost to Follow-up|0|||
164545307|NCT02790138|594369414|FG000|Overall Study|Voluntary Withdrawal|8|||
164545308|NCT02790138|594369415|FG001|Overall Study|Voluntary Withdrawal|9|||
164545309|NCT02790138|594369414|FG000|Overall Study|Lack of Efficacy|6|||
164545310|NCT02790138|594369415|FG001|Overall Study|Lack of Efficacy|7|||
164545311|NCT02790138|594369414|FG000|Overall Study|Reason not Specified|1|||
164545312|NCT02790138|594369415|FG001|Overall Study|Reason not Specified|0|||
164545313|NCT03199040|594369416|FG000|Overall Study|Lack of Efficacy|2|||
164545314|NCT03199040|594369417|FG001|Overall Study|Lack of Efficacy|0|||
164545315|NCT03199040|594369416|FG000|Overall Study|Withdrawal by Subject|2|||
164545316|NCT03199040|594369417|FG001|Overall Study|Withdrawal by Subject|0|||
164545317|NCT03199040|594369416|FG000|Overall Study|Adverse Event|0|||
164545318|NCT03199040|594369417|FG001|Overall Study|Adverse Event|1|||
164545319|NCT03199040|594369416|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
164545320|NCT03199040|594369417|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
164545321|NCT01226459|594369418|FG000|Overall Study|Adverse Event|2|||
164545322|NCT01226459|594369419|FG001|Overall Study|Adverse Event|8|||
164545323|NCT01226459|594369418|FG000|Overall Study|Protocol Violation|4|||
164545324|NCT01226459|594369419|FG001|Overall Study|Protocol Violation|3|||
164545325|NCT01226459|594369418|FG000|Overall Study|Withdrawal by Subject|10|||
164545326|NCT01226459|594369419|FG001|Overall Study|Withdrawal by Subject|13|||
164545327|NCT01226459|594369418|FG000|Overall Study|Lost to Follow-up|4|||
164545328|NCT01226459|594369419|FG001|Overall Study|Lost to Follow-up|8|||
164545329|NCT01226459|594369418|FG000|Overall Study|Pregnancy|1|||
164545330|NCT01226459|594369419|FG001|Overall Study|Pregnancy|0|||
164545331|NCT01092143|594369423|FG000|Overall Study|Adverse Event|10|||
164545332|NCT01092143|594369424|FG001|Overall Study|Adverse Event|5|||
164545333|NCT01092143|594369425|FG002|Overall Study|Adverse Event|1|||
164545334|NCT01092143|594369426|FG003|Overall Study|Adverse Event|4|||
164545335|NCT01092143|594369427|FG004|Overall Study|Adverse Event|3|||
164545336|NCT01092143|594369423|FG000|Overall Study|Lost to Follow-up|1|||
164545337|NCT01092143|594369424|FG001|Overall Study|Lost to Follow-up|0|||
164545338|NCT01092143|594369425|FG002|Overall Study|Lost to Follow-up|1|||
164545339|NCT01092143|594369426|FG003|Overall Study|Lost to Follow-up|0|||
164545340|NCT01092143|594369427|FG004|Overall Study|Lost to Follow-up|0|||
164545341|NCT01092143|594369423|FG000|Overall Study|Consent withdrawn|2|||
164545342|NCT01092143|594369424|FG001|Overall Study|Consent withdrawn|1|||
164545343|NCT01092143|594369425|FG002|Overall Study|Consent withdrawn|0|||
164545344|NCT01092143|594369426|FG003|Overall Study|Consent withdrawn|1|||
164545345|NCT01092143|594369427|FG004|Overall Study|Consent withdrawn|3|||
164545346|NCT01092143|594369423|FG000|Overall Study|Not treated|0|||
164545347|NCT01092143|594369424|FG001|Overall Study|Not treated|0|||
164545348|NCT01092143|594369425|FG002|Overall Study|Not treated|1|||
164545349|NCT01092143|594369426|FG003|Overall Study|Not treated|0|||
164545350|NCT01092143|594369427|FG004|Overall Study|Not treated|0|||
164545351|NCT01092143|594369423|FG000|Overall Study|did not reversibility criteria|0|||
164545352|NCT01092143|594369424|FG001|Overall Study|did not reversibility criteria|0|||
164545353|NCT01092143|594369425|FG002|Overall Study|did not reversibility criteria|1|||
164545354|NCT01092143|594369426|FG003|Overall Study|did not reversibility criteria|0|||
164545355|NCT01092143|594369427|FG004|Overall Study|did not reversibility criteria|0|||
164653506|NCT00672620|594757193|FG003|Overall Study|Noncompliance with Study Drug|2|||
164653507|NCT00672620|594757190|FG000|Overall Study|Protocol Deviations|5|||
164545356|NCT01092143|594369423|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
164545357|NCT01092143|594369424|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
164545358|NCT01092143|594369425|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
164545359|NCT01092143|594369426|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
164545360|NCT01092143|594369427|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
164545361|NCT01092143|594369423|FG000|Overall Study|Ineligible patient|1|||
164545362|NCT01092143|594369424|FG001|Overall Study|Ineligible patient|0|||
164545363|NCT01092143|594369425|FG002|Overall Study|Ineligible patient|0|||
164545364|NCT01092143|594369426|FG003|Overall Study|Ineligible patient|0|||
164545365|NCT01092143|594369427|FG004|Overall Study|Ineligible patient|0|||
164545366|NCT01092143|594369423|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
164545367|NCT01092143|594369424|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
164545368|NCT01092143|594369425|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
164545369|NCT01092143|594369426|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
164545370|NCT01092143|594369427|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
164545371|NCT01092143|594369423|FG000|Overall Study|Patient travel|0|||
164653508|NCT00672620|594757191|FG001|Overall Study|Protocol Deviations|7|||
164194267|NCT01261390|593079413|FG001|Overall Study|Relocation|1|||
164194268|NCT01261390|593079414|FG002|Overall Study|Relocation|0|||
164194269|NCT01261390|593079415|FG003|Overall Study|Relocation|0|||
164194270|NCT01261390|593079412|FG000|Overall Study|Loss of Interest in the Study|3|||
164194271|NCT01261390|593079413|FG001|Overall Study|Loss of Interest in the Study|1|||
164194272|NCT01261390|593079414|FG002|Overall Study|Loss of Interest in the Study|0|||
164194273|NCT01261390|593079415|FG003|Overall Study|Loss of Interest in the Study|0|||
164194274|NCT01261390|593079412|FG000|Overall Study|Lost to Follow-up|1|||
164194275|NCT01261390|593079413|FG001|Overall Study|Lost to Follow-up|6|||
164194276|NCT01261390|593079414|FG002|Overall Study|Lost to Follow-up|5|||
164194277|NCT01261390|593079415|FG003|Overall Study|Lost to Follow-up|6|||
164194278|NCT01951417|593079417|FG000|Overall Study|Withdrawal by Subject|1|||
164194279|NCT01951417|593079417|FG000|Overall Study|Protocol Violation|2|||
164194280|NCT01951417|593079417|FG000|Overall Study|Lost to Follow-up|6|||
164194281|NCT04010461|593079418|FG000|Overall Study|COVID based withdrawal|5|||
164194282|NCT04010461|593079418|FG000|Overall Study|Withdrawal by Subject|5|||
164194283|NCT04010461|593079418|FG000|Overall Study|Adverse Event|1|||
164194284|NCT04010461|593079418|FG000|Overall Study|No Motor Threshold obtainable|1|||
164194285|NCT04010461|593079418|FG000|Overall Study|Physician Decision|1|||
164194286|NCT01026948|593079419|FG000|Overall Study|Physician Decision|8|||
164194287|NCT03360019|593079423|FG000|Overall Study|Withdrawal by Subject|2|||
164194288|NCT03360019|593079424|FG001|Overall Study|Withdrawal by Subject|0|||
164194289|NCT03360019|593079425|FG002|Overall Study|Withdrawal by Subject|0|||
164194290|NCT03360019|593079423|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
164194291|NCT03360019|593079424|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
164194292|NCT03360019|593079425|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
164194293|NCT00753675|593079428|FG000|Overall Study|other reason|11|||
164194294|NCT00753675|593079429|FG001|Overall Study|other reason|12|||
164194295|NCT00753675|593079430|FG002|Overall Study|other reason|13|||
164194296|NCT00753675|593079428|FG000|Overall Study|Death|1|||
164194297|NCT00753675|593079429|FG001|Overall Study|Death|2|||
164194298|NCT00753675|593079430|FG002|Overall Study|Death|4|||
164194299|NCT00753675|593079428|FG000|Overall Study|Adverse Event|11|||
164194300|NCT00753675|593079429|FG001|Overall Study|Adverse Event|9|||
164194301|NCT00753675|593079430|FG002|Overall Study|Adverse Event|4|||
164194302|NCT00753675|593079428|FG000|Overall Study|Objective progression of disease|35|||
164194303|NCT00753675|593079429|FG001|Overall Study|Objective progression of disease|35|||
164194304|NCT00753675|593079430|FG002|Overall Study|Objective progression of disease|35|||
164194305|NCT00753675|593079428|FG000|Overall Study|Withdrawal by Subject|0|||
164194306|NCT00753675|593079429|FG001|Overall Study|Withdrawal by Subject|1|||
164194307|NCT00753675|593079430|FG002|Overall Study|Withdrawal by Subject|0|||
164194308|NCT00753675|593079428|FG000|Overall Study|Lost to Follow-up|1|||
164194309|NCT00753675|593079429|FG001|Overall Study|Lost to Follow-up|0|||
164194310|NCT00753675|593079430|FG002|Overall Study|Lost to Follow-up|0|||
164194311|NCT02106351|593079435|FG000|Treatment Cycle 1|Adverse Event|2|||
164194312|NCT02106351|593079436|FG001|Treatment Cycle 1|Adverse Event|0|||
164653509|NCT00672620|594757192|FG002|Overall Study|Protocol Deviations|2|||
164194313|NCT02106351|593079437|FG002|Treatment Cycle 1|Adverse Event|0|||
164194314|NCT02106351|593079435|FG000|Treatment Cycle 1|Consent withdrawn|1|||
164194315|NCT02106351|593079436|FG001|Treatment Cycle 1|Consent withdrawn|0|||
164194316|NCT02106351|593079437|FG002|Treatment Cycle 1|Consent withdrawn|2|||
164194317|NCT02106351|593079435|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
164194318|NCT02106351|593079436|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
164194319|NCT02106351|593079437|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
164194320|NCT02106351|593079435|FG000|Treatment Cycle 1|Other|0|||
164194321|NCT02106351|593079436|FG001|Treatment Cycle 1|Other|3|||
164194322|NCT02106351|593079437|FG002|Treatment Cycle 1|Other|1|||
164194323|NCT02106351|593079435|FG000|Treatment Cycle 1|Randomised but not treated|1|||
164194324|NCT02106351|593079436|FG001|Treatment Cycle 1|Randomised but not treated|0|||
164194325|NCT02106351|593079437|FG002|Treatment Cycle 1|Randomised but not treated|1|||
164545372|NCT01092143|594369424|FG001|Overall Study|Patient travel|0|||
164545373|NCT01092143|594369425|FG002|Overall Study|Patient travel|0|||
164545374|NCT01092143|594369426|FG003|Overall Study|Patient travel|0|||
164545375|NCT01092143|594369427|FG004|Overall Study|Patient travel|1|||
164545376|NCT01092143|594369423|FG000|Overall Study|Non compliance with study medication|0|||
164545377|NCT01092143|594369424|FG001|Overall Study|Non compliance with study medication|0|||
164545378|NCT01092143|594369425|FG002|Overall Study|Non compliance with study medication|0|||
164545379|NCT01092143|594369426|FG003|Overall Study|Non compliance with study medication|0|||
164545380|NCT01092143|594369427|FG004|Overall Study|Non compliance with study medication|1|||
164545381|NCT01092143|594369423|FG000|Overall Study|Randomized by mistake|0|||
164545382|NCT01092143|594369424|FG001|Overall Study|Randomized by mistake|0|||
164545383|NCT01092143|594369425|FG002|Overall Study|Randomized by mistake|0|||
164545384|NCT01092143|594369426|FG003|Overall Study|Randomized by mistake|1|||
164545385|NCT01092143|594369427|FG004|Overall Study|Randomized by mistake|0|||
164545386|NCT01092143|594369423|FG000|Overall Study|Pregnancy|0|||
164545387|NCT01092143|594369424|FG001|Overall Study|Pregnancy|0|||
164545388|NCT01092143|594369425|FG002|Overall Study|Pregnancy|0|||
164545389|NCT01092143|594369426|FG003|Overall Study|Pregnancy|1|||
164545390|NCT01092143|594369427|FG004|Overall Study|Pregnancy|0|||
164545391|NCT04688775|594369432|FG000|Placebo-controlled Period|Randomized, not treated|1|||
164545392|NCT04688775|594369433|FG001|Placebo-controlled Period|Randomized, not treated|1|||
164545393|NCT04688775|594369434|FG002|Placebo-controlled Period|Randomized, not treated|0|||
164545394|NCT04688775|594369435|FG003|Placebo-controlled Period|Randomized, not treated|0|||
164545395|NCT04688775|594369432|FG000|Placebo-controlled Period|Adverse Event|2|||
164545396|NCT04688775|594369433|FG001|Placebo-controlled Period|Adverse Event|0|||
164545397|NCT04688775|594369434|FG002|Placebo-controlled Period|Adverse Event|0|||
164545398|NCT04688775|594369435|FG003|Placebo-controlled Period|Adverse Event|0|||
164545399|NCT04688775|594369432|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
164545400|NCT04688775|594369433|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
164545401|NCT04688775|594369434|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
164545402|NCT04688775|594369435|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
164545403|NCT04688775|594369432|FG000|Placebo-controlled Period|Protocol Violation|0|||
164545404|NCT04688775|594369433|FG001|Placebo-controlled Period|Protocol Violation|1|||
164545405|NCT04688775|594369434|FG002|Placebo-controlled Period|Protocol Violation|0|||
164545406|NCT04688775|594369435|FG003|Placebo-controlled Period|Protocol Violation|0|||
164545407|NCT04688775|594369432|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
164545408|NCT04688775|594369433|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
164545409|NCT04688775|594369434|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
164545410|NCT04688775|594369435|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
164545411|NCT04688775|594369432|FG000|Placebo-controlled Period|Other reasons|0|||
164545412|NCT04688775|594369433|FG001|Placebo-controlled Period|Other reasons|1|||
164545413|NCT04688775|594369434|FG002|Placebo-controlled Period|Other reasons|0|||
164545414|NCT04688775|594369435|FG003|Placebo-controlled Period|Other reasons|0|||
164545415|NCT04688775|594369432|FG000|Delayed Start Period|Adverse Event|0|||
164545416|NCT04688775|594369433|FG001|Delayed Start Period|Adverse Event|0|||
164545417|NCT04688775|594369434|FG002|Delayed Start Period|Adverse Event|1|||
164545418|NCT04688775|594369435|FG003|Delayed Start Period|Adverse Event|0|||
164545419|NCT04688775|594369432|FG000|Delayed Start Period|Lack of Efficacy|0|||
164545420|NCT04688775|594369433|FG001|Delayed Start Period|Lack of Efficacy|0|||
164545421|NCT04688775|594369434|FG002|Delayed Start Period|Lack of Efficacy|0|||
164545422|NCT04688775|594369435|FG003|Delayed Start Period|Lack of Efficacy|3|||
164545423|NCT04688775|594369432|FG000|Delayed Start Period|Withdrawal by Subject|0|||
164545424|NCT04688775|594369433|FG001|Delayed Start Period|Withdrawal by Subject|0|||
164545425|NCT04688775|594369434|FG002|Delayed Start Period|Withdrawal by Subject|2|||
164545426|NCT04688775|594369435|FG003|Delayed Start Period|Withdrawal by Subject|4|||
164545427|NCT04688775|594369432|FG000|Delayed Start Period|Lost to Follow-up|0|||
164545428|NCT04688775|594369433|FG001|Delayed Start Period|Lost to Follow-up|0|||
164545429|NCT04688775|594369434|FG002|Delayed Start Period|Lost to Follow-up|2|||
164545430|NCT04688775|594369435|FG003|Delayed Start Period|Lost to Follow-up|1|||
164545431|NCT04688775|594369432|FG000|Delayed Start Period|other reasons|0|||
164545432|NCT04688775|594369433|FG001|Delayed Start Period|other reasons|0|||
164545433|NCT04688775|594369434|FG002|Delayed Start Period|other reasons|1|||
164545434|NCT04688775|594369435|FG003|Delayed Start Period|other reasons|0|||
164545435|NCT01536951|594369437|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
164545436|NCT01536951|594369438|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
164545437|NCT01536951|594369439|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
164545438|NCT01536951|594369440|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
164545439|NCT01536951|594369441|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
164545440|NCT01536951|594369442|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
164545441|NCT01536951|594369443|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
164545442|NCT01536951|594369444|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
164545443|NCT01536951|594369445|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
164545444|NCT01536951|594369437|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
164545445|NCT01536951|594369438|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
164545446|NCT01536951|594369439|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
164545447|NCT01536951|594369440|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
164545448|NCT01536951|594369441|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
164545449|NCT01536951|594369442|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
164545450|NCT01536951|594369443|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
164545451|NCT01536951|594369444|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
164545452|NCT01536951|594369445|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
164545453|NCT01843972|594369448|FG000|Overall Study|Withdrawal by Subject|0|||
164545454|NCT01843972|594369449|FG001|Overall Study|Withdrawal by Subject|0|||
164545455|NCT01843972|594369450|FG002|Overall Study|Withdrawal by Subject|0|||
164545456|NCT01843972|594369451|FG003|Overall Study|Withdrawal by Subject|0|||
164545457|NCT01843972|594369452|FG004|Overall Study|Withdrawal by Subject|1|||
164545458|NCT01843972|594369453|FG005|Overall Study|Withdrawal by Subject|0|||
164545459|NCT01843972|594369454|FG006|Overall Study|Withdrawal by Subject|0|||
164545460|NCT01843972|594369455|FG007|Overall Study|Withdrawal by Subject|0|||
164545461|NCT01843972|594369456|FG008|Overall Study|Withdrawal by Subject|0|||
164545462|NCT01843972|594369457|FG009|Overall Study|Withdrawal by Subject|0|||
164545463|NCT01854645|594369458|FG000|Overall Study|Protocol-Specified Criteria|13|||
164545464|NCT01854645|594369459|FG001|Overall Study|Protocol-Specified Criteria|10|||
164545465|NCT01854645|594369460|FG002|Overall Study|Protocol-Specified Criteria|8|||
164545466|NCT01854645|594369461|FG003|Overall Study|Protocol-Specified Criteria|5|||
164545467|NCT01854645|594369462|FG004|Overall Study|Protocol-Specified Criteria|7|||
164545468|NCT01854645|594369458|FG000|Overall Study|Administrative Reasons / Missing|0|||
164545469|NCT01854645|594369459|FG001|Overall Study|Administrative Reasons / Missing|0|||
164545470|NCT01854645|594369460|FG002|Overall Study|Administrative Reasons / Missing|0|||
164545471|NCT01854645|594369461|FG003|Overall Study|Administrative Reasons / Missing|1|||
164545472|NCT01854645|594369462|FG004|Overall Study|Administrative Reasons / Missing|1|||
164545473|NCT01854645|594369458|FG000|Overall Study|Protocol Violation|3|||
164545474|NCT01854645|594369459|FG001|Overall Study|Protocol Violation|0|||
164545475|NCT01854645|594369460|FG002|Overall Study|Protocol Violation|5|||
164545476|NCT01854645|594369461|FG003|Overall Study|Protocol Violation|4|||
164545477|NCT01854645|594369462|FG004|Overall Study|Protocol Violation|1|||
164545478|NCT01854645|594369458|FG000|Overall Study|Lost to Follow-up|10|||
164545479|NCT01854645|594369459|FG001|Overall Study|Lost to Follow-up|7|||
164545480|NCT01854645|594369460|FG002|Overall Study|Lost to Follow-up|8|||
164545481|NCT01854645|594369461|FG003|Overall Study|Lost to Follow-up|5|||
164545482|NCT01854645|594369462|FG004|Overall Study|Lost to Follow-up|0|||
164545483|NCT01854645|594369458|FG000|Overall Study|Physician Decision|1|||
164545484|NCT01854645|594369459|FG001|Overall Study|Physician Decision|5|||
164545485|NCT01854645|594369460|FG002|Overall Study|Physician Decision|3|||
164545486|NCT01854645|594369461|FG003|Overall Study|Physician Decision|3|||
164545487|NCT01854645|594369462|FG004|Overall Study|Physician Decision|7|||
164545488|NCT01854645|594369458|FG000|Overall Study|Withdrawal by Subject|31|||
164545489|NCT01854645|594369459|FG001|Overall Study|Withdrawal by Subject|41|||
164545490|NCT01854645|594369460|FG002|Overall Study|Withdrawal by Subject|30|||
164545491|NCT01854645|594369461|FG003|Overall Study|Withdrawal by Subject|21|||
164545492|NCT01854645|594369462|FG004|Overall Study|Withdrawal by Subject|24|||
164545493|NCT01854645|594369458|FG000|Overall Study|Lack of Efficacy|7|||
164545494|NCT01854645|594369459|FG001|Overall Study|Lack of Efficacy|12|||
164545495|NCT01854645|594369460|FG002|Overall Study|Lack of Efficacy|9|||
164545496|NCT01854645|594369461|FG003|Overall Study|Lack of Efficacy|3|||
164545497|NCT01854645|594369462|FG004|Overall Study|Lack of Efficacy|9|||
164545498|NCT01854645|594369458|FG000|Overall Study|Adverse Event|33|||
164545499|NCT01854645|594369459|FG001|Overall Study|Adverse Event|31|||
164545500|NCT01854645|594369460|FG002|Overall Study|Adverse Event|19|||
164545501|NCT01854645|594369461|FG003|Overall Study|Adverse Event|20|||
164545502|NCT01854645|594369462|FG004|Overall Study|Adverse Event|11|||
164545503|NCT00545402|594369463|FG000|Overall Study|Discontinuation of treatment|17|||
164545504|NCT00545402|594369464|FG001|Overall Study|Discontinuation of treatment|9|||
164545505|NCT00545402|594369463|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
164545506|NCT00545402|594369464|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
164545507|NCT00545402|594369463|FG000|Overall Study|Death|5|||
164545508|NCT00545402|594369464|FG001|Overall Study|Death|7|||
164545509|NCT00545402|594369463|FG000|Overall Study|Graft loss|2|||
164545510|NCT00545402|594369464|FG001|Overall Study|Graft loss|4|||
164545511|NCT00545402|594369463|FG000|Overall Study|Withdrawal by Subject|0|||
164545512|NCT00545402|594369464|FG001|Overall Study|Withdrawal by Subject|1|||
164545513|NCT00545402|594369463|FG000|Overall Study|Protocol Violation|1|||
164545514|NCT00545402|594369464|FG001|Overall Study|Protocol Violation|0|||
164545515|NCT00545402|594369463|FG000|Overall Study|Reason not specified|1|||
164545516|NCT00545402|594369464|FG001|Overall Study|Reason not specified|1|||
164545517|NCT01817751|594369465|FG000|Overall Study|Physician Decision|1|||
164545518|NCT00555477|594369466|FG000|Overall Study|Adverse Event|0|||
164545519|NCT00555477|594369467|FG001|Overall Study|Adverse Event|9|||
164545520|NCT00555477|594369466|FG000|Overall Study|Withdrawal by Subject|1|||
164545521|NCT00555477|594369467|FG001|Overall Study|Withdrawal by Subject|2|||
164545522|NCT00555477|594369466|FG000|Overall Study|Physician Decision|1|||
164545523|NCT00555477|594369467|FG001|Overall Study|Physician Decision|2|||
164545524|NCT00382018|594369468|FG000|Overall Study|Progression|0|||
164545525|NCT00382018|594369469|FG001|Overall Study|Progression|136|||
164545526|NCT00382018|594369470|FG002|Overall Study|Progression|51|||
164545527|NCT00382018|594369471|FG003|Overall Study|Progression|43|||
164545528|NCT00382018|594369468|FG000|Overall Study|Death|0|||
164545529|NCT00382018|594369469|FG001|Overall Study|Death|9|||
164545530|NCT00382018|594369470|FG002|Overall Study|Death|7|||
164545531|NCT00382018|594369471|FG003|Overall Study|Death|11|||
164545532|NCT00382018|594369468|FG000|Overall Study|Withdrawal by Subject|0|||
164545533|NCT00382018|594369469|FG001|Overall Study|Withdrawal by Subject|4|||
164545534|NCT00382018|594369470|FG002|Overall Study|Withdrawal by Subject|3|||
164545535|NCT00382018|594369471|FG003|Overall Study|Withdrawal by Subject|4|||
164545536|NCT00382018|594369468|FG000|Overall Study|Other, not protocol specified|0|||
164545537|NCT00382018|594369469|FG001|Overall Study|Other, not protocol specified|16|||
164545538|NCT00382018|594369470|FG002|Overall Study|Other, not protocol specified|3|||
164545539|NCT00382018|594369471|FG003|Overall Study|Other, not protocol specified|1|||
164545540|NCT01984164|594369472|FG000|Overall Study|Withdrawal by Subject|4|||
164545541|NCT01984164|594369473|FG001|Overall Study|Withdrawal by Subject|3|||
164545542|NCT01984164|594369472|FG000|Overall Study|Adverse Event|5|||
164545543|NCT01984164|594369473|FG001|Overall Study|Adverse Event|19|||
164545544|NCT01984164|594369472|FG000|Overall Study|Lost to Follow-up|1|||
164545545|NCT01984164|594369473|FG001|Overall Study|Lost to Follow-up|3|||
164545546|NCT00427349|594369477|FG000|Overall Study|Lack of Efficacy|23|||
164545547|NCT00427349|594369477|FG000|Overall Study|Adverse Event|14|||
164545548|NCT00427349|594369477|FG000|Overall Study|Death|1|||
164545549|NCT00427349|594369477|FG000|Overall Study|Withdrawal by Subject|3|||
164545550|NCT00427349|594369477|FG000|Overall Study|Alternative therapy|1|||
164545551|NCT00427349|594369477|FG000|Overall Study|Other|2|||
164545552|NCT00427349|594369477|FG000|Overall Study|Ineligible|1|||
164545553|NCT00427349|594369477|FG000|Overall Study|Never started therapy|1|||
164545554|NCT00475722|594369480|FG000|Overall Study|Withdrawal by Subject|12|||
164545555|NCT00475722|594369481|FG001|Overall Study|Withdrawal by Subject|12|||
164545556|NCT00475722|594369480|FG000|Overall Study|Protocol Violation|3|||
164545557|NCT00475722|594369481|FG001|Overall Study|Protocol Violation|0|||
164545558|NCT00698997|594369482|FG000|Overall Study|Lost to Follow-up|3|||
164545559|NCT00698997|594369483|FG001|Overall Study|Lost to Follow-up|0|||
164545560|NCT00698997|594369482|FG000|Overall Study|Withdrawal by Subject|7|||
164545561|NCT00698997|594369483|FG001|Overall Study|Withdrawal by Subject|27|||
164545562|NCT00916279|594369486|FG000|Overall Study|Death|2|||
164545563|NCT00916279|594369486|FG000|Overall Study|Lost to Follow-up|2|||
164545564|NCT00290186|594369496|FG000|Overall Study|Adverse Event|1|||
164545565|NCT00290186|594369497|FG001|Overall Study|Adverse Event|1|||
164545566|NCT00290186|594369496|FG000|Overall Study|Lost to Follow-up|3|||
164545567|NCT00290186|594369497|FG001|Overall Study|Lost to Follow-up|2|||
164545568|NCT00290186|594369496|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
164545569|NCT00290186|594369497|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
164545570|NCT00290186|594369496|FG000|Overall Study|Withdrawal by Subject|0|||
164545571|NCT00290186|594369497|FG001|Overall Study|Withdrawal by Subject|1|||
164545572|NCT00262522|594369501|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
164545573|NCT00262522|594369502|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
164545574|NCT00262522|594369503|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
164545575|NCT00262522|594369504|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
164545576|NCT00262522|594369501|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
164545577|NCT00262522|594369502|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
164545578|NCT00262522|594369503|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
164545579|NCT00262522|594369504|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
164545580|NCT00262522|594369501|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
164545581|NCT00262522|594369502|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
164545582|NCT00262522|594369503|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
164545583|NCT00262522|594369504|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
164545584|NCT00262522|594369501|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
164545585|NCT00262522|594369502|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
164545586|NCT00262522|594369503|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
164545587|NCT00262522|594369504|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
164545588|NCT00262522|594369501|FG000|Study Start Through 8 Weeks|Death|1|||
164545589|NCT00262522|594369502|FG001|Study Start Through 8 Weeks|Death|0|||
164545590|NCT00262522|594369503|FG002|Study Start Through 8 Weeks|Death|0|||
164545591|NCT00262522|594369504|FG003|Study Start Through 8 Weeks|Death|0|||
164545592|NCT00262522|594369501|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
164545593|NCT00262522|594369502|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
164545594|NCT00262522|594369503|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
164545595|NCT00262522|594369504|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
164545596|NCT00262522|594369501|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
164545597|NCT00262522|594369502|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
164545598|NCT00262522|594369503|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
164653510|NCT00672620|594757193|FG003|Overall Study|Protocol Deviations|5|||
164545599|NCT00262522|594369504|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
164545600|NCT00262522|594369501|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
164545601|NCT00262522|594369502|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
164545602|NCT00262522|594369503|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
164545603|NCT00262522|594369504|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
164545604|NCT00262522|594369501|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
164545605|NCT00262522|594369502|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
164545606|NCT00262522|594369503|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
164545607|NCT00262522|594369504|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
164545608|NCT00262522|594369501|FG000|Study Start Through 48 Weeks|Death|2|||
164545609|NCT00262522|594369502|FG001|Study Start Through 48 Weeks|Death|0|||
164545610|NCT00262522|594369503|FG002|Study Start Through 48 Weeks|Death|1|||
164545611|NCT00262522|594369504|FG003|Study Start Through 48 Weeks|Death|0|||
164545612|NCT00262522|594369501|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
164545613|NCT00262522|594369502|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
164545614|NCT00262522|594369503|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
164545615|NCT00262522|594369504|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
164545616|NCT00262522|594369501|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
164545617|NCT00262522|594369502|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
164545618|NCT00262522|594369503|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
164545619|NCT00262522|594369504|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
164545620|NCT00262522|594369501|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
164545621|NCT00262522|594369502|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
164545622|NCT00262522|594369503|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
164545623|NCT00262522|594369504|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
164545624|NCT00262522|594369501|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
164545625|NCT00262522|594369502|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
164545626|NCT00262522|594369503|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
164545627|NCT00262522|594369504|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
164545628|NCT00262522|594369501|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
164545629|NCT00262522|594369502|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
164545630|NCT00262522|594369503|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
164545631|NCT00262522|594369504|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
164545632|NCT00262522|594369501|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
164545633|NCT00262522|594369502|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
164545634|NCT00262522|594369503|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
164545635|NCT00262522|594369504|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
164545636|NCT00262522|594369501|FG000|Study Start Through 96 Weeks|Death|2|||
164545637|NCT00262522|594369502|FG001|Study Start Through 96 Weeks|Death|0|||
164545638|NCT00262522|594369503|FG002|Study Start Through 96 Weeks|Death|2|||
164545639|NCT00262522|594369504|FG003|Study Start Through 96 Weeks|Death|0|||
164545640|NCT00262522|594369501|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
164545641|NCT00262522|594369502|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
164545642|NCT00262522|594369503|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
164545643|NCT00262522|594369504|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
164545644|NCT00262522|594369501|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
164545645|NCT00262522|594369502|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
164545646|NCT00262522|594369503|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
164545647|NCT00262522|594369504|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
164545648|NCT01877915|594369505|FG000|Overall Study|Lost to Follow-up|10|||
164545649|NCT01877915|594369506|FG001|Overall Study|Lost to Follow-up|9|||
164545650|NCT01877915|594369505|FG000|Overall Study|Withdrawal by Subject|42|||
164545651|NCT01877915|594369506|FG001|Overall Study|Withdrawal by Subject|55|||
164545652|NCT01877915|594369505|FG000|Overall Study|Other|2|||
164545653|NCT01877915|594369506|FG001|Overall Study|Other|4|||
164545654|NCT00798135|594369507|FG000|Overall Study|Disease progression, relapse|11|||
164545655|NCT00798135|594369507|FG000|Overall Study|Disease progression, refractory|1|||
164545656|NCT00798135|594369507|FG000|Overall Study|Physician Decision|1|||
164545657|NCT02228720|594369508|FG000|Open Label - Day 30|Lost to Follow-up|1|||
164545658|NCT01401842|594369509|FG000|Overall Study|Withdrawal by Subject|3|||
164545659|NCT01401842|594369510|FG001|Overall Study|Withdrawal by Subject|2|||
164545660|NCT01401842|594369509|FG000|Overall Study|academic reason|4|||
164545661|NCT01401842|594369510|FG001|Overall Study|academic reason|1|||
164545662|NCT01401842|594369509|FG000|Overall Study|changed companies|20|||
164545663|NCT01401842|594369510|FG001|Overall Study|changed companies|34|||
164545664|NCT01401842|594369509|FG000|Overall Study|discharged from US Army|3|||
164545665|NCT01401842|594369510|FG001|Overall Study|discharged from US Army|4|||
164545666|NCT01401842|594369509|FG000|Overall Study|invalid follow-up strength data|1|||
164545667|NCT01401842|594369510|FG001|Overall Study|invalid follow-up strength data|4|||
164545668|NCT01401842|594369509|FG000|Overall Study|on profile|9|||
164545669|NCT01401842|594369510|FG001|Overall Study|on profile|5|||
164545670|NCT01401842|594369509|FG000|Overall Study|other/unknown|28|||
164545671|NCT01401842|594369510|FG001|Overall Study|other/unknown|17|||
164545672|NCT03828292|594369513|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
164545673|NCT03828292|594369514|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
164545674|NCT03828292|594369515|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
164545675|NCT03828292|594369516|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
164545676|NCT03828292|594369517|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
164545677|NCT03828292|594369518|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
164545678|NCT03828292|594369513|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
164545679|NCT03828292|594369514|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
164545680|NCT03828292|594369515|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
164545681|NCT03828292|594369516|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
164545682|NCT03828292|594369517|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
164545683|NCT03828292|594369518|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
164545684|NCT03828292|594369513|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
164545685|NCT03828292|594369514|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
164545686|NCT03828292|594369515|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
164545687|NCT03828292|594369516|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
164545688|NCT03828292|594369517|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
164545689|NCT03828292|594369518|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
164545690|NCT03828292|594369513|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
164545691|NCT03828292|594369514|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
164545692|NCT03828292|594369515|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
164545693|NCT03828292|594369516|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
164545694|NCT03828292|594369517|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
164545695|NCT03828292|594369518|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
164545696|NCT03828292|594369513|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
164545697|NCT03828292|594369514|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
164545698|NCT03828292|594369515|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
164545699|NCT03828292|594369516|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
164545700|NCT03828292|594369517|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
164545701|NCT03828292|594369518|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
164545702|NCT05050318|594371120|FG000|Overall Study|Protocol Deviation|1|||
164545703|NCT05050318|594371121|FG001|Overall Study|Protocol Deviation|0|||
164545704|NCT05050318|594371122|FG002|Overall Study|Protocol Deviation|0|||
164545705|NCT03227471|594371125|FG000|Overall Study|Withdrawal by Subject|0|||
164545706|NCT03227471|594371126|FG001|Overall Study|Withdrawal by Subject|0|||
164545707|NCT03227471|594371127|FG002|Overall Study|Withdrawal by Subject|0|||
164545708|NCT03227471|594371128|FG003|Overall Study|Withdrawal by Subject|0|||
164545709|NCT03227471|594371129|FG004|Overall Study|Withdrawal by Subject|1|||
164545710|NCT03227471|594371130|FG005|Overall Study|Withdrawal by Subject|0|||
164545711|NCT03227471|594371131|FG006|Overall Study|Withdrawal by Subject|0|||
164545712|NCT03227471|594371132|FG007|Overall Study|Withdrawal by Subject|0|||
164545713|NCT03227471|594371133|FG008|Overall Study|Withdrawal by Subject|0|||
164545714|NCT03227471|594371134|FG009|Overall Study|Withdrawal by Subject|0|||
164545715|NCT03227471|594371135|FG010|Overall Study|Withdrawal by Subject|0|||
164545716|NCT03227471|594371136|FG011|Overall Study|Withdrawal by Subject|0|||
164545717|NCT03227471|594371137|FG012|Overall Study|Withdrawal by Subject|1|||
164545718|NCT03227471|594371138|FG013|Overall Study|Withdrawal by Subject|0|||
164545719|NCT03227471|594371139|FG014|Overall Study|Withdrawal by Subject|0|||
164545720|NCT03227471|594371125|FG000|Overall Study|Randomized, Never Dosed|0|||
164545721|NCT03227471|594371126|FG001|Overall Study|Randomized, Never Dosed|0|||
164545722|NCT03227471|594371127|FG002|Overall Study|Randomized, Never Dosed|0|||
164545723|NCT03227471|594371128|FG003|Overall Study|Randomized, Never Dosed|0|||
164545724|NCT03227471|594371129|FG004|Overall Study|Randomized, Never Dosed|0|||
164545725|NCT03227471|594371130|FG005|Overall Study|Randomized, Never Dosed|0|||
164545726|NCT03227471|594371131|FG006|Overall Study|Randomized, Never Dosed|0|||
164545727|NCT03227471|594371132|FG007|Overall Study|Randomized, Never Dosed|0|||
164545728|NCT03227471|594371133|FG008|Overall Study|Randomized, Never Dosed|0|||
164545729|NCT03227471|594371134|FG009|Overall Study|Randomized, Never Dosed|0|||
164545730|NCT03227471|594371135|FG010|Overall Study|Randomized, Never Dosed|0|||
164545731|NCT03227471|594371136|FG011|Overall Study|Randomized, Never Dosed|0|||
164653511|NCT00672620|594757190|FG000|Overall Study|Withdrawal of Consent|6|||
164653512|NCT00672620|594757191|FG001|Overall Study|Withdrawal of Consent|12|||
164545732|NCT03227471|594371137|FG012|Overall Study|Randomized, Never Dosed|0|||
164545733|NCT03227471|594371138|FG013|Overall Study|Randomized, Never Dosed|0|||
164545734|NCT03227471|594371139|FG014|Overall Study|Randomized, Never Dosed|1|||
164545735|NCT02833974|594371140|FG000|Overall Study|Lost to Follow-up|1|||
164545736|NCT02833974|594371141|FG001|Overall Study|Lost to Follow-up|0|||
164653513|NCT00672620|594757192|FG002|Overall Study|Withdrawal of Consent|5|||
164653514|NCT00672620|594757193|FG003|Overall Study|Withdrawal of Consent|6|||
164194326|NCT02106351|593079435|FG000|Treatment Cycle 2|Adverse Event|0|||
164545737|NCT02833974|594371140|FG000|Overall Study|Adverse Event|0|||
164545738|NCT02833974|594371141|FG001|Overall Study|Adverse Event|3|||
164545739|NCT04419610|594371142|FG000|Overall Study|Withdrawal by Subject|3|||
164545740|NCT04419610|594371143|FG001|Overall Study|Withdrawal by Subject|1|||
164545741|NCT04419610|594371142|FG000|Overall Study|Adverse Event|1|||
164545742|NCT04419610|594371143|FG001|Overall Study|Adverse Event|0|||
164545743|NCT04419610|594371142|FG000|Overall Study|discharged early|1|||
164545744|NCT04419610|594371143|FG001|Overall Study|discharged early|1|||
164545745|NCT03197493|594371147|FG000|Overall Study|Withdrawal by Subject|5|||
164545746|NCT01469182|594371148|FG000|Overall Study|Adverse Event|21|||
164545747|NCT01469182|594371149|FG001|Overall Study|Adverse Event|3|||
164545748|NCT01469182|594371148|FG000|Overall Study|Lost to Follow-up|3|||
164545749|NCT01469182|594371149|FG001|Overall Study|Lost to Follow-up|0|||
164545750|NCT01469182|594371148|FG000|Overall Study|Withdrawal by Subject|4|||
164545751|NCT01469182|594371149|FG001|Overall Study|Withdrawal by Subject|1|||
164545752|NCT01469182|594371148|FG000|Overall Study|Protocol Violation|4|||
164545753|NCT01469182|594371149|FG001|Overall Study|Protocol Violation|2|||
164545754|NCT01469182|594371148|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
164545755|NCT01469182|594371149|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
164545756|NCT02236520|594371151|FG000|Overall Study|Physician Decision|0|||
164545757|NCT02236520|594371152|FG001|Overall Study|Physician Decision|5|||
164545758|NCT02236520|594371153|FG002|Overall Study|Physician Decision|0|||
164545759|NCT02236520|594371154|FG003|Overall Study|Physician Decision|0|||
164545760|NCT02236520|594371151|FG000|Overall Study|Withdrawal by Subject|1|||
164545761|NCT02236520|594371152|FG001|Overall Study|Withdrawal by Subject|0|||
164545762|NCT02236520|594371153|FG002|Overall Study|Withdrawal by Subject|0|||
164545763|NCT02236520|594371154|FG003|Overall Study|Withdrawal by Subject|1|||
164545764|NCT02236520|594371151|FG000|Overall Study|Pregnancy|1|||
164545765|NCT02236520|594371152|FG001|Overall Study|Pregnancy|0|||
164545766|NCT02236520|594371153|FG002|Overall Study|Pregnancy|0|||
164545767|NCT02236520|594371154|FG003|Overall Study|Pregnancy|0|||
164545768|NCT01033734|594371155|FG000|Overall Study|Withdrawal by Subject|1|||
164545769|NCT00915772|594371159|FG000|Overall Study|Adverse Event|12|||
164545770|NCT00915772|594371160|FG001|Overall Study|Adverse Event|13|||
164545771|NCT00915772|594371161|FG002|Overall Study|Adverse Event|11|||
164545772|NCT00915772|594371159|FG000|Overall Study|Protocol Violation|4|||
164545773|NCT00915772|594371160|FG001|Overall Study|Protocol Violation|1|||
164545774|NCT00915772|594371161|FG002|Overall Study|Protocol Violation|2|||
164545775|NCT00915772|594371159|FG000|Overall Study|Lost to Follow-up|1|||
164545776|NCT00915772|594371160|FG001|Overall Study|Lost to Follow-up|2|||
164545777|NCT00915772|594371161|FG002|Overall Study|Lost to Follow-up|2|||
164545778|NCT00915772|594371159|FG000|Overall Study|Lack of Efficacy|9|||
164545779|NCT00915772|594371160|FG001|Overall Study|Lack of Efficacy|15|||
164545780|NCT00915772|594371161|FG002|Overall Study|Lack of Efficacy|3|||
164545781|NCT00915772|594371159|FG000|Overall Study|Refused to continue trial medication|6|||
164545782|NCT00915772|594371160|FG001|Overall Study|Refused to continue trial medication|8|||
164545783|NCT00915772|594371161|FG002|Overall Study|Refused to continue trial medication|4|||
164545784|NCT00915772|594371159|FG000|Overall Study|Any other reason|4|||
164545785|NCT00915772|594371160|FG001|Overall Study|Any other reason|7|||
164545786|NCT00915772|594371161|FG002|Overall Study|Any other reason|7|||
164545787|NCT01365039|594371162|FG000|Overall Study|Study related symptoms and complaints|1|||
164545788|NCT01365039|594371163|FG001|Overall Study|Study related symptoms and complaints|0|||
164545789|NCT00111800|594371166|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
164545790|NCT00111800|594371167|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
164545791|NCT00111800|594371168|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
164545792|NCT00111800|594371169|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
164545793|NCT00111800|594371170|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
164545794|NCT00111800|594371171|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
164545795|NCT00111800|594371166|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
164545796|NCT00111800|594371167|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
164545797|NCT00111800|594371168|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
164545798|NCT00111800|594371169|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
164545799|NCT00111800|594371170|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
164545800|NCT00111800|594371171|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
164545801|NCT00111800|594371166|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
164545802|NCT00111800|594371167|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
164545803|NCT00111800|594371168|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
164545804|NCT00111800|594371169|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
164545805|NCT00111800|594371170|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
164545806|NCT00111800|594371171|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
164545807|NCT00111800|594371166|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
164545808|NCT00111800|594371167|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
164545809|NCT00111800|594371168|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
164545810|NCT00111800|594371169|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
164545811|NCT00111800|594371170|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
164545812|NCT00111800|594371171|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
164545813|NCT00111800|594371166|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
164545814|NCT00111800|594371167|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
164545815|NCT00111800|594371168|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
164545816|NCT00111800|594371169|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
164545817|NCT00111800|594371170|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
164545818|NCT00111800|594371171|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
164545819|NCT00111800|594371166|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
164545820|NCT00111800|594371167|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
164545821|NCT00111800|594371168|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
164545822|NCT00111800|594371169|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
164545823|NCT00111800|594371170|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
164545824|NCT00111800|594371171|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
164545825|NCT00111800|594371166|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
164545826|NCT00111800|594371167|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
164545827|NCT00111800|594371168|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
164545828|NCT00111800|594371169|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
164545829|NCT00111800|594371170|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
164545830|NCT00111800|594371171|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
164545831|NCT00111800|594371166|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
164545832|NCT00111800|594371167|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
164545833|NCT00111800|594371168|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
164545834|NCT00111800|594371169|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
164545835|NCT00111800|594371170|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
164545836|NCT00111800|594371171|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
164545837|NCT00111800|594371166|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
164545838|NCT00111800|594371167|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
164545839|NCT00111800|594371168|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
164545840|NCT00111800|594371169|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
164545841|NCT00111800|594371170|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
164545842|NCT00111800|594371171|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
164545843|NCT00111800|594371166|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
164545844|NCT00111800|594371167|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
164545845|NCT00111800|594371168|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
164545846|NCT00111800|594371169|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
164545847|NCT00111800|594371170|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
164545848|NCT00111800|594371171|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
164545849|NCT00111800|594371166|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
164545850|NCT00111800|594371167|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
164545851|NCT00111800|594371168|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
164545852|NCT00111800|594371169|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
164545853|NCT00111800|594371170|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
164545854|NCT00111800|594371171|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
164545855|NCT00111800|594371166|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
164545856|NCT00111800|594371167|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
164545857|NCT00111800|594371168|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
164545858|NCT00111800|594371169|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
164545859|NCT00111800|594371170|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
164545860|NCT00111800|594371171|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
164545861|NCT00111800|594371166|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
164545862|NCT00111800|594371167|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
164545863|NCT00111800|594371168|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
164545864|NCT00111800|594371169|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
164545865|NCT00111800|594371170|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
164545866|NCT00111800|594371171|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
164545867|NCT00111800|594371166|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
164545868|NCT00111800|594371167|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
164545869|NCT00111800|594371168|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
164653515|NCT00672620|594757190|FG000|Overall Study|Lost to Follow-up|8|||
164653516|NCT00672620|594757191|FG001|Overall Study|Lost to Follow-up|19|||
164194327|NCT02106351|593079436|FG001|Treatment Cycle 2|Adverse Event|2|||
164545870|NCT00111800|594371169|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
164545871|NCT00111800|594371170|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
164545872|NCT00111800|594371171|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
164545873|NCT00111800|594371166|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
164545874|NCT00111800|594371167|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
164545875|NCT00111800|594371168|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
164545876|NCT00111800|594371169|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
164545877|NCT00111800|594371170|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
164653517|NCT00672620|594757192|FG002|Overall Study|Lost to Follow-up|8|||
164653518|NCT00672620|594757193|FG003|Overall Study|Lost to Follow-up|11|||
164653519|NCT00672620|594757190|FG000|Overall Study|Reason not Specified|3|||
164653520|NCT00672620|594757191|FG001|Overall Study|Reason not Specified|3|||
164653521|NCT00672620|594757192|FG002|Overall Study|Reason not Specified|2|||
164653522|NCT00672620|594757193|FG003|Overall Study|Reason not Specified|1|||
164653523|NCT02965820|594757194|FG000|Period 2, Second 30 Days|Adverse Event|1|||
164653524|NCT02965820|594757195|FG001|Period 2, Second 30 Days|Adverse Event|1|||
164653525|NCT04272775|594757202|FG000|Overall Study|Study Terminated by Sponsor|1|||
164653526|NCT04272775|594757203|FG001|Overall Study|Study Terminated by Sponsor|0|||
164653527|NCT04272775|594757202|FG000|Overall Study|Protocol Violation|0|||
164653528|NCT04272775|594757203|FG001|Overall Study|Protocol Violation|1|||
164653529|NCT04272775|594757202|FG000|Overall Study|Symptomatic Deterioration|1|||
164653530|NCT04272775|594757203|FG001|Overall Study|Symptomatic Deterioration|1|||
164653531|NCT04272775|594757202|FG000|Overall Study|Withdrawal by Subject|1|||
164653532|NCT04272775|594757203|FG001|Overall Study|Withdrawal by Subject|2|||
164653533|NCT04272775|594757202|FG000|Overall Study|Adverse Event|1|||
164653534|NCT04272775|594757203|FG001|Overall Study|Adverse Event|2|||
164653535|NCT04272775|594757202|FG000|Overall Study|Progressive Disease|3|||
164653536|NCT04272775|594757203|FG001|Overall Study|Progressive Disease|1|||
164653537|NCT02063698|594757209|FG000|Overall Study|did not complete booklet for days 2-8|1|||
164653538|NCT02063698|594757210|FG001|Overall Study|did not complete booklet for days 2-8|2|||
164653539|NCT01092702|594757211|FG000|Overall Study|Withdrawal by Subject|7|||
164653540|NCT01092702|594757211|FG000|Overall Study|Lost to Follow-up|2|||
164653541|NCT00449930|594757212|FG000|Overall Study|Adverse Event|9|||
164653542|NCT00449930|594757213|FG001|Overall Study|Adverse Event|19|||
164653543|NCT00449930|594757212|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
164653544|NCT00449930|594757213|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
164653545|NCT00449930|594757212|FG000|Overall Study|Lack of Efficacy|10|||
164653546|NCT00449930|594757213|FG001|Overall Study|Lack of Efficacy|1|||
164653547|NCT00449930|594757212|FG000|Overall Study|Lost to Follow-up|9|||
164653548|NCT00449930|594757213|FG001|Overall Study|Lost to Follow-up|14|||
164653549|NCT00449930|594757212|FG000|Overall Study|Physician Decision|1|||
164653550|NCT00449930|594757213|FG001|Overall Study|Physician Decision|2|||
164653551|NCT00449930|594757212|FG000|Overall Study|Protocol Violation|14|||
164653552|NCT00449930|594757213|FG001|Overall Study|Protocol Violation|15|||
164653553|NCT00449930|594757212|FG000|Overall Study|Withdrawal by Subject|16|||
164653554|NCT00449930|594757213|FG001|Overall Study|Withdrawal by Subject|23|||
164653555|NCT00449930|594757212|FG000|Overall Study|Glycemic discontinuation criteria|1|||
164653556|NCT00449930|594757213|FG001|Overall Study|Glycemic discontinuation criteria|1|||
164653557|NCT00575328|594757215|FG000|Overall Study|Adverse Event|1|||
164653558|NCT00575328|594757216|FG001|Overall Study|Adverse Event|1|||
164653559|NCT00575328|594757215|FG000|Overall Study|Lost to Follow-up|2|||
164653560|NCT00575328|594757216|FG001|Overall Study|Lost to Follow-up|1|||
164653561|NCT02124746|594757217|FG000|Overall Study|Adverse Event|2|||
164653562|NCT02124746|594757218|FG001|Overall Study|Adverse Event|1|||
164653563|NCT02124746|594757219|FG002|Overall Study|Adverse Event|2|||
164653564|NCT02124746|594757217|FG000|Overall Study|Death|2|||
164653565|NCT02124746|594757218|FG001|Overall Study|Death|1|||
164653566|NCT02124746|594757219|FG002|Overall Study|Death|3|||
164653567|NCT02124746|594757217|FG000|Overall Study|Lack of Efficacy|3|||
164653568|NCT02124746|594757218|FG001|Overall Study|Lack of Efficacy|2|||
164653569|NCT02124746|594757219|FG002|Overall Study|Lack of Efficacy|2|||
164653570|NCT02124746|594757217|FG000|Overall Study|Physician Decision|6|||
164653571|NCT02124746|594757218|FG001|Overall Study|Physician Decision|4|||
164653572|NCT02124746|594757219|FG002|Overall Study|Physician Decision|5|||
164653573|NCT02124746|594757217|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164653574|NCT02124746|594757218|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164653575|NCT02124746|594757219|FG002|Overall Study|Non-Compliance with Study Drug|0|||
164653576|NCT02124746|594757217|FG000|Overall Study|Withdrawal by Subject|3|||
164653577|NCT02124746|594757218|FG001|Overall Study|Withdrawal by Subject|3|||
164653578|NCT02124746|594757219|FG002|Overall Study|Withdrawal by Subject|0|||
164653579|NCT02124746|594757217|FG000|Overall Study|Study Terminated by Sponsor|0|||
164653580|NCT02124746|594757218|FG001|Overall Study|Study Terminated by Sponsor|0|||
164653581|NCT02124746|594757219|FG002|Overall Study|Study Terminated by Sponsor|6|||
164653582|NCT02124746|594757217|FG000|Overall Study|Disease Progression|3|||
164653583|NCT02124746|594757218|FG001|Overall Study|Disease Progression|6|||
164545878|NCT00111800|594371171|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
164545879|NCT00111800|594371166|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
164545880|NCT00111800|594371167|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
164545881|NCT00111800|594371168|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
164545882|NCT00111800|594371169|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
164545883|NCT00111800|594371170|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
164545884|NCT00111800|594371171|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
164545885|NCT00111800|594371166|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
164545886|NCT00111800|594371167|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
164545887|NCT00111800|594371168|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
164545888|NCT00111800|594371169|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
164545889|NCT00111800|594371170|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
164545890|NCT00111800|594371171|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
164545891|NCT00111800|594371166|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
164545892|NCT00111800|594371167|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
164545893|NCT00111800|594371168|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
164545894|NCT00111800|594371169|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
164545895|NCT00111800|594371170|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
164545896|NCT00111800|594371171|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
164545897|NCT00111800|594371166|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
164545898|NCT00111800|594371167|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
164545899|NCT00111800|594371168|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
164545900|NCT00111800|594371169|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
164545901|NCT00111800|594371170|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
164545902|NCT00111800|594371171|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
164545903|NCT00111800|594371166|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
164545904|NCT00111800|594371167|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
164545905|NCT00111800|594371168|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
164545906|NCT00111800|594371169|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
164545907|NCT00111800|594371170|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
164545908|NCT00111800|594371171|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
164545909|NCT00111800|594371166|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
164545910|NCT00111800|594371167|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
164545911|NCT00111800|594371168|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
164545912|NCT00111800|594371169|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
164545913|NCT00111800|594371170|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
164545914|NCT00111800|594371171|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
164545915|NCT00111800|594371166|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
164545916|NCT00111800|594371167|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
164545917|NCT00111800|594371168|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
164545918|NCT00111800|594371169|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
164545919|NCT00111800|594371170|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
164545920|NCT00111800|594371171|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
164545921|NCT00111800|594371166|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
164545922|NCT00111800|594371167|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
164545923|NCT00111800|594371168|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
164545924|NCT00111800|594371169|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
164545925|NCT00111800|594371170|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
164545926|NCT00111800|594371171|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
164545927|NCT00111800|594371166|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
164545928|NCT00111800|594371167|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
164545929|NCT00111800|594371168|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
164545930|NCT00111800|594371169|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
164545931|NCT00111800|594371170|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
164545932|NCT00111800|594371171|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
164545933|NCT00111800|594371166|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
164545934|NCT00111800|594371167|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
164545935|NCT00111800|594371168|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
164545936|NCT00111800|594371169|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
164545937|NCT00111800|594371170|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
164545938|NCT00111800|594371171|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
164653584|NCT02124746|594757219|FG002|Overall Study|Disease Progression|4|||
164545939|NCT00111800|594371166|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
164545940|NCT00111800|594371167|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
164545941|NCT00111800|594371168|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
164545942|NCT00111800|594371169|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
164545943|NCT00111800|594371170|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
164545944|NCT00111800|594371171|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
164545945|NCT02752035|594371172|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
164545946|NCT02752035|594371173|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
164545947|NCT02752035|594371174|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
164545948|NCT02752035|594371175|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
164545949|NCT02752035|594371172|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
164545950|NCT02752035|594371173|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
164545951|NCT02752035|594371174|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
164545952|NCT02752035|594371175|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
164545953|NCT02752035|594371172|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
164545954|NCT02752035|594371173|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
164545955|NCT02752035|594371174|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
164545956|NCT02752035|594371175|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
164545957|NCT02752035|594371172|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
164545958|NCT02752035|594371173|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
164545959|NCT02752035|594371174|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
164545960|NCT02752035|594371175|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
164545961|NCT02752035|594371172|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
164545962|NCT02752035|594371173|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
164545963|NCT02752035|594371174|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
164545964|NCT02752035|594371175|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
164545965|NCT02752035|594371172|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
164545966|NCT02752035|594371173|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
164545967|NCT02752035|594371174|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
164545968|NCT02752035|594371175|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
164545969|NCT02752035|594371172|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
164545970|NCT02752035|594371173|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
164545971|NCT02752035|594371174|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
164653585|NCT01722266|594757220|FG000|Overall Study|Withdrawal by Subject|1|||
164653586|NCT01722266|594757221|FG001|Overall Study|Withdrawal by Subject|2|||
164653587|NCT01722266|594757222|FG002|Overall Study|Withdrawal by Subject|0|||
164653588|NCT01722266|594757223|FG003|Overall Study|Withdrawal by Subject|0|||
164653589|NCT01722266|594757220|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
164653590|NCT01722266|594757221|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
164653591|NCT01722266|594757222|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
164653592|NCT01722266|594757223|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
164653593|NCT01722266|594757220|FG000|Overall Study|Dropped out due to Nausea|0|||
164653594|NCT01722266|594757221|FG001|Overall Study|Dropped out due to Nausea|0|||
164653595|NCT01722266|594757222|FG002|Overall Study|Dropped out due to Nausea|2|||
164653596|NCT01722266|594757223|FG003|Overall Study|Dropped out due to Nausea|0|||
164653597|NCT00124449|594757228|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
164653598|NCT00124449|594757229|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
164653599|NCT00124449|594757228|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
164653600|NCT00124449|594757229|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
164653601|NCT00124449|594757228|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
164653602|NCT00124449|594757229|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
164653603|NCT00124449|594757228|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
164653604|NCT00124449|594757229|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
164653605|NCT00124449|594757228|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
164653606|NCT00124449|594757229|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
164653607|NCT00124449|594757228|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
164653608|NCT00124449|594757229|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
164653609|NCT00124449|594757228|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
164653610|NCT00124449|594757229|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
164653611|NCT00124449|594757228|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
164653612|NCT00124449|594757229|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
164545972|NCT02752035|594371175|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
164653613|NCT00124449|594757228|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
164653614|NCT00124449|594757229|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
164653615|NCT00124449|594757228|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
164653616|NCT00124449|594757229|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
164545973|NCT02752035|594371172|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
164545974|NCT02752035|594371173|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
164545975|NCT02752035|594371174|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
164545976|NCT02752035|594371175|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
164545977|NCT02752035|594371172|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
164545978|NCT02752035|594371173|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
164545979|NCT02752035|594371174|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
164545980|NCT02752035|594371175|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
164545981|NCT02752035|594371172|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
164545982|NCT02752035|594371173|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
164545983|NCT02752035|594371174|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
164545984|NCT02752035|594371175|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
164545985|NCT02752035|594371172|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
164545986|NCT02752035|594371173|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
164545987|NCT02752035|594371174|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
164545988|NCT02752035|594371175|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
164545989|NCT02752035|594371172|FG000|Randomization: Approximately 3 Years|Death|0|||
164545990|NCT02752035|594371173|FG001|Randomization: Approximately 3 Years|Death|25|||
164545991|NCT02752035|594371174|FG002|Randomization: Approximately 3 Years|Death|13|||
164545992|NCT02752035|594371175|FG003|Randomization: Approximately 3 Years|Death|4|||
164545993|NCT02752035|594371172|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
164545994|NCT02752035|594371173|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
164545995|NCT02752035|594371174|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
164545996|NCT02752035|594371175|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
164545997|NCT02752035|594371172|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
164545998|NCT02752035|594371173|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
164545999|NCT02752035|594371174|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
164546000|NCT02752035|594371175|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
164546001|NCT02752035|594371172|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
164546002|NCT02752035|594371173|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
164546003|NCT02752035|594371174|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
164546004|NCT02752035|594371175|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
164546005|NCT02752035|594371172|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
164546006|NCT02752035|594371173|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
164546007|NCT02752035|594371174|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
164546008|NCT02752035|594371175|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
164546009|NCT02752035|594371172|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
164546010|NCT02752035|594371173|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
164546011|NCT02752035|594371174|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
164546012|NCT02752035|594371175|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
164546013|NCT03668600|594371180|FG000|Overall Study|Study Terminated by the Sponsor|157|||
164546014|NCT03668600|594371180|FG000|Overall Study|Protocol Violation|1|||
164546015|NCT03668600|594371180|FG000|Overall Study|Pregnancy|1|||
164546016|NCT03668600|594371180|FG000|Overall Study|Lost to Follow-up|7|||
164546017|NCT03668600|594371180|FG000|Overall Study|Withdrawal by Subject|56|||
164546018|NCT03668600|594371180|FG000|Overall Study|Lack of Efficacy|7|||
164546019|NCT03668600|594371180|FG000|Overall Study|Adverse Event|1|||
164546020|NCT01263483|594371181|FG000|Overall Study|Adverse Event|4|||
164546021|NCT01263483|594371182|FG001|Overall Study|Adverse Event|0|||
164546022|NCT01263483|594371183|FG002|Overall Study|Adverse Event|3|||
164546023|NCT01263483|594371181|FG000|Overall Study|Withdrawal by Subject|1|||
164546024|NCT01263483|594371182|FG001|Overall Study|Withdrawal by Subject|0|||
164546025|NCT01263483|594371183|FG002|Overall Study|Withdrawal by Subject|0|||
164546026|NCT01263483|594371181|FG000|Overall Study|Lack of Efficacy|2|||
164546027|NCT01263483|594371182|FG001|Overall Study|Lack of Efficacy|0|||
164546028|NCT01263483|594371183|FG002|Overall Study|Lack of Efficacy|0|||
164546029|NCT01263483|594371181|FG000|Overall Study|Protocol Violation|0|||
164546030|NCT01263483|594371182|FG001|Overall Study|Protocol Violation|1|||
164546031|NCT01263483|594371183|FG002|Overall Study|Protocol Violation|1|||
164546032|NCT01263483|594371181|FG000|Overall Study|Participant Unavailability|0|||
164546033|NCT01263483|594371182|FG001|Overall Study|Participant Unavailability|1|||
164546034|NCT01263483|594371183|FG002|Overall Study|Participant Unavailability|1|||
164546035|NCT02577406|594371184|FG000|Randomized Period|Death|1|||
164546036|NCT02577406|594371185|FG001|Randomized Period|Death|0|||
164546037|NCT02577406|594371184|FG000|Randomized Period|Other reasons|0|||
164194328|NCT02106351|593079437|FG002|Treatment Cycle 2|Adverse Event|0|||
164546038|NCT02577406|594371185|FG001|Randomized Period|Other reasons|20|||
164546039|NCT02577406|594371184|FG000|Treatment Period|Death|38|||
164546040|NCT02577406|594371185|FG001|Treatment Period|Death|23|||
164546041|NCT02577406|594371184|FG000|Treatment Period|Adverse Event|17|||
164546042|NCT02577406|594371185|FG001|Treatment Period|Adverse Event|12|||
164194329|NCT02106351|593079435|FG000|Treatment Cycle 2|Consent withdrawn|0|||
164546043|NCT02577406|594371184|FG000|Treatment Period|Progressive Disease|53|||
164546044|NCT02577406|594371185|FG001|Treatment Period|Progressive Disease|37|||
164546045|NCT02577406|594371184|FG000|Treatment Period|Withdrawal by Subject|10|||
164546046|NCT02577406|594371185|FG001|Treatment Period|Withdrawal by Subject|24|||
164546047|NCT02577406|594371184|FG000|Treatment Period|Lost to Follow-up|0|||
164546048|NCT02577406|594371185|FG001|Treatment Period|Lost to Follow-up|1|||
164546049|NCT02577406|594371184|FG000|Treatment Period|Transition to commercially available treatment|1|||
164546050|NCT02577406|594371185|FG001|Treatment Period|Transition to commercially available treatment|1|||
164546051|NCT02577406|594371184|FG000|Treatment Period|Physician Decision|1|||
164546052|NCT02577406|594371185|FG001|Treatment Period|Physician Decision|0|||
164546053|NCT02577406|594371184|FG000|Treatment Period|Disease Relapse|28|||
164546054|NCT02577406|594371185|FG001|Treatment Period|Disease Relapse|1|||
164546055|NCT02577406|594371184|FG000|Treatment Period|Protocol Violation|0|||
164546056|NCT02577406|594371185|FG001|Treatment Period|Protocol Violation|1|||
164546057|NCT02577406|594371184|FG000|Treatment Period|Other Reasons|3|||
164546058|NCT02577406|594371185|FG001|Treatment Period|Other Reasons|39|||
164546059|NCT02577406|594371184|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
164546060|NCT02577406|594371185|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
164546061|NCT01555151|594371188|FG000|Overall Study|Withdrawal by Subject|6|||
164546062|NCT01555151|594371189|FG001|Overall Study|Withdrawal by Subject|2|||
164546063|NCT01555151|594371190|FG002|Overall Study|Withdrawal by Subject|0|||
164546064|NCT01555151|594371191|FG003|Overall Study|Withdrawal by Subject|2|||
164546065|NCT01555151|594371188|FG000|Overall Study|Administrative|3|||
164546066|NCT01555151|594371189|FG001|Overall Study|Administrative|1|||
164546067|NCT01555151|594371190|FG002|Overall Study|Administrative|2|||
164546068|NCT01555151|594371191|FG003|Overall Study|Administrative|0|||
164546069|NCT01555151|594371188|FG000|Overall Study|Protocol Violation|3|||
164546070|NCT01555151|594371189|FG001|Overall Study|Protocol Violation|3|||
164546071|NCT01555151|594371190|FG002|Overall Study|Protocol Violation|3|||
164546072|NCT01555151|594371191|FG003|Overall Study|Protocol Violation|5|||
164546073|NCT01555151|594371188|FG000|Overall Study|Adverse Event|1|||
164546074|NCT01555151|594371189|FG001|Overall Study|Adverse Event|2|||
164546075|NCT01555151|594371190|FG002|Overall Study|Adverse Event|1|||
164546076|NCT01555151|594371191|FG003|Overall Study|Adverse Event|2|||
164546077|NCT01555151|594371188|FG000|Overall Study|Lost to Follow-up|0|||
164546078|NCT01555151|594371189|FG001|Overall Study|Lost to Follow-up|0|||
164546079|NCT01555151|594371190|FG002|Overall Study|Lost to Follow-up|0|||
164546080|NCT01555151|594371191|FG003|Overall Study|Lost to Follow-up|1|||
164546081|NCT01961349|594371192|FG000|Overall Study|Withdrawal by Subject|1|||
164546082|NCT01961349|594371193|FG001|Overall Study|Withdrawal by Subject|4|||
164546083|NCT01961349|594371194|FG002|Overall Study|Withdrawal by Subject|0|||
164546084|NCT01961349|594371192|FG000|Overall Study|Adverse Event|0|||
164546085|NCT01961349|594371193|FG001|Overall Study|Adverse Event|0|||
164546086|NCT01961349|594371194|FG002|Overall Study|Adverse Event|1|||
164546087|NCT01961349|594371192|FG000|Overall Study|registration error, personal reason etc|2|||
164546088|NCT01961349|594371193|FG001|Overall Study|registration error, personal reason etc|2|||
164546089|NCT01961349|594371194|FG002|Overall Study|registration error, personal reason etc|1|||
164546090|NCT02343159|594371201|FG000|Overall Study|Early Study Termination|16|||
164546091|NCT02343159|594371202|FG001|Overall Study|Early Study Termination|19|||
164546092|NCT02343159|594371203|FG002|Overall Study|Early Study Termination|23|||
164546093|NCT02343159|594371201|FG000|Overall Study|Physician Decision|2|||
164546094|NCT02343159|594371202|FG001|Overall Study|Physician Decision|0|||
164546095|NCT02343159|594371203|FG002|Overall Study|Physician Decision|1|||
164546096|NCT02343159|594371201|FG000|Overall Study|Withdrawal by Subject|3|||
164546097|NCT02343159|594371202|FG001|Overall Study|Withdrawal by Subject|0|||
164546098|NCT02343159|594371203|FG002|Overall Study|Withdrawal by Subject|2|||
164546099|NCT02343159|594371201|FG000|Overall Study|Lost to Follow-up|0|||
164546100|NCT02343159|594371202|FG001|Overall Study|Lost to Follow-up|2|||
164546101|NCT02343159|594371203|FG002|Overall Study|Lost to Follow-up|2|||
164546102|NCT02343159|594371201|FG000|Overall Study|Adverse Event|4|||
164546103|NCT02343159|594371202|FG001|Overall Study|Adverse Event|4|||
164546104|NCT02343159|594371203|FG002|Overall Study|Adverse Event|2|||
164546105|NCT02343159|594371201|FG000|Overall Study|Sponsor Decision|0|||
164546106|NCT02343159|594371202|FG001|Overall Study|Sponsor Decision|1|||
164546107|NCT02343159|594371203|FG002|Overall Study|Sponsor Decision|0|||
164546108|NCT02343159|594371201|FG000|Overall Study|Enrollment Error|1|||
164546109|NCT02343159|594371202|FG001|Overall Study|Enrollment Error|0|||
164546110|NCT02343159|594371203|FG002|Overall Study|Enrollment Error|0|||
164546111|NCT02114268|594371204|FG000|Overall Study|Lost to Follow-up|4|||
164546112|NCT02114268|594371205|FG001|Overall Study|Lost to Follow-up|1|||
164546113|NCT02114268|594371206|FG002|Overall Study|Lost to Follow-up|1|||
164546114|NCT02114268|594371207|FG003|Overall Study|Lost to Follow-up|0|||
164546115|NCT02114268|594371208|FG004|Overall Study|Lost to Follow-up|0|||
164546116|NCT02114268|594371209|FG005|Overall Study|Lost to Follow-up|2|||
164546117|NCT02114268|594371204|FG000|Overall Study|Withdrawal by Subject|1|||
164546118|NCT02114268|594371205|FG001|Overall Study|Withdrawal by Subject|0|||
164546119|NCT02114268|594371206|FG002|Overall Study|Withdrawal by Subject|0|||
164546120|NCT02114268|594371207|FG003|Overall Study|Withdrawal by Subject|0|||
164546121|NCT02114268|594371208|FG004|Overall Study|Withdrawal by Subject|0|||
164546122|NCT02114268|594371209|FG005|Overall Study|Withdrawal by Subject|1|||
164546123|NCT02114268|594371204|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
164546124|NCT02114268|594371205|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
164546125|NCT02114268|594371206|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
164546126|NCT02114268|594371207|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
164546127|NCT02114268|594371208|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
164546128|NCT02114268|594371209|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
164546129|NCT03086057|594371212|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
164546130|NCT03086057|594371213|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
164546131|NCT03086057|594371214|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
164546132|NCT03086057|594371215|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
164546133|NCT03086057|594371212|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
164546134|NCT03086057|594371213|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
164546135|NCT03086057|594371214|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
164546136|NCT03086057|594371215|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
164546137|NCT03086057|594371212|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
164546138|NCT03086057|594371213|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
164546139|NCT03086057|594371214|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
164546140|NCT03086057|594371215|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
164546141|NCT03086057|594371212|FG000|Stage 1: PrEP Uptake|Death|1|||
164546142|NCT03086057|594371213|FG001|Stage 1: PrEP Uptake|Death|0|||
164546143|NCT03086057|594371214|FG002|Stage 1: PrEP Uptake|Death|0|||
164546144|NCT03086057|594371215|FG003|Stage 1: PrEP Uptake|Death|0|||
164546145|NCT03086057|594371212|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
164546146|NCT03086057|594371213|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
164546147|NCT03086057|594371214|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
164546148|NCT03086057|594371215|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
164546149|NCT03086057|594371212|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
164546150|NCT03086057|594371213|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
164546151|NCT03086057|594371214|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
164546152|NCT03086057|594371215|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
164546153|NCT03086057|594371212|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
164546154|NCT03086057|594371213|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
164546155|NCT03086057|594371214|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
164546156|NCT03086057|594371215|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
164546157|NCT01786603|594371218|FG000|Overall Study|Death|5|||
164546158|NCT01786603|594371219|FG001|Overall Study|Death|1|||
164546159|NCT01786603|594371218|FG000|Overall Study|Adverse Event|6|||
164546160|NCT01786603|594371219|FG001|Overall Study|Adverse Event|2|||
164546161|NCT01786603|594371218|FG000|Overall Study|Physician decision to withdraw|6|||
164546162|NCT01786603|594371219|FG001|Overall Study|Physician decision to withdraw|7|||
164546163|NCT01786603|594371218|FG000|Overall Study|Lost to Follow-up|1|||
164546164|NCT01786603|594371219|FG001|Overall Study|Lost to Follow-up|2|||
164546165|NCT03519867|594371220|FG000|Overall Study|Adverse Event|1|||
164546166|NCT03519867|594371221|FG001|Overall Study|Adverse Event|1|||
164546167|NCT03519867|594371222|FG002|Overall Study|Adverse Event|0|||
164546168|NCT03519867|594371223|FG003|Overall Study|Adverse Event|0|||
164546169|NCT03519867|594371224|FG004|Overall Study|Adverse Event|0|||
164546170|NCT03519867|594371225|FG005|Overall Study|Adverse Event|0|||
164546171|NCT03519867|594371226|FG006|Overall Study|Adverse Event|0|||
164546172|NCT03519867|594371227|FG007|Overall Study|Adverse Event|0|||
164546173|NCT03519867|594371228|FG008|Overall Study|Adverse Event|0|||
164546174|NCT03519867|594371229|FG009|Overall Study|Adverse Event|0|||
164546175|NCT03519867|594371220|FG000|Overall Study|Protocol Violation|0|||
164546176|NCT03519867|594371221|FG001|Overall Study|Protocol Violation|0|||
164546177|NCT03519867|594371222|FG002|Overall Study|Protocol Violation|0|||
164546178|NCT03519867|594371223|FG003|Overall Study|Protocol Violation|0|||
164546179|NCT03519867|594371224|FG004|Overall Study|Protocol Violation|0|||
164546180|NCT03519867|594371225|FG005|Overall Study|Protocol Violation|1|||
164546181|NCT03519867|594371226|FG006|Overall Study|Protocol Violation|0|||
164546182|NCT03519867|594371227|FG007|Overall Study|Protocol Violation|0|||
164546183|NCT03519867|594371228|FG008|Overall Study|Protocol Violation|0|||
164546184|NCT03519867|594371229|FG009|Overall Study|Protocol Violation|0|||
164546185|NCT03519867|594371220|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
164546186|NCT03519867|594371221|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
164546187|NCT03519867|594371222|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
164546188|NCT03519867|594371223|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
164546189|NCT03519867|594371224|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
164546190|NCT03519867|594371225|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
164546191|NCT03519867|594371226|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
164546192|NCT03519867|594371227|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
164546193|NCT03519867|594371228|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
164546194|NCT03519867|594371229|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
164546195|NCT03519867|594371220|FG000|Overall Study|Admin. of other reversal agent|1|||
164546196|NCT03519867|594371221|FG001|Overall Study|Admin. of other reversal agent|1|||
164546197|NCT03519867|594371222|FG002|Overall Study|Admin. of other reversal agent|0|||
164546198|NCT03519867|594371223|FG003|Overall Study|Admin. of other reversal agent|0|||
164546199|NCT03519867|594371224|FG004|Overall Study|Admin. of other reversal agent|0|||
164546200|NCT03519867|594371225|FG005|Overall Study|Admin. of other reversal agent|1|||
164546201|NCT03519867|594371226|FG006|Overall Study|Admin. of other reversal agent|0|||
164546202|NCT03519867|594371227|FG007|Overall Study|Admin. of other reversal agent|0|||
164546203|NCT03519867|594371228|FG008|Overall Study|Admin. of other reversal agent|0|||
164546204|NCT03519867|594371229|FG009|Overall Study|Admin. of other reversal agent|0|||
164546205|NCT03519867|594371220|FG000|Overall Study|Reason not provided|1|||
164546206|NCT03519867|594371221|FG001|Overall Study|Reason not provided|1|||
164546207|NCT03519867|594371222|FG002|Overall Study|Reason not provided|1|||
164546208|NCT03519867|594371223|FG003|Overall Study|Reason not provided|1|||
164546209|NCT03519867|594371224|FG004|Overall Study|Reason not provided|0|||
164546210|NCT03519867|594371225|FG005|Overall Study|Reason not provided|1|||
164546211|NCT03519867|594371226|FG006|Overall Study|Reason not provided|0|||
164546212|NCT03519867|594371227|FG007|Overall Study|Reason not provided|1|||
164546213|NCT03519867|594371228|FG008|Overall Study|Reason not provided|1|||
164546214|NCT03519867|594371229|FG009|Overall Study|Reason not provided|0|||
164546215|NCT01977820|594371232|FG000|Overall Study|Sponsor terminated the study|1|||
164546216|NCT01977820|594371233|FG001|Overall Study|Sponsor terminated the study|1|||
164546217|NCT05082376|594371236|FG000|Overall Study|Lost to Follow-up|2|||
164546218|NCT02568475|594371237|FG000|Overall Study|Lost to Follow-up|40|||
164546219|NCT02568475|594371238|FG001|Overall Study|Lost to Follow-up|39|||
164546220|NCT02568475|594371237|FG000|Overall Study|Withdrawal by Subject|2|||
164546221|NCT02568475|594371238|FG001|Overall Study|Withdrawal by Subject|0|||
164546222|NCT02568475|594371237|FG000|Overall Study|Discharged home|4|||
164546223|NCT02568475|594371238|FG001|Overall Study|Discharged home|4|||
164546224|NCT02568475|594371237|FG000|Overall Study|Short-term: Discharge location unknown|4|||
164546225|NCT02568475|594371238|FG001|Overall Study|Short-term: Discharge location unknown|0|||
164546226|NCT02568475|594371237|FG000|Overall Study|Transferred to another facility|1|||
164546227|NCT02568475|594371238|FG001|Overall Study|Transferred to another facility|0|||
164546228|NCT02625233|594371239|FG000|Overall Study|Adverse Event|2|||
164546229|NCT02625233|594371240|FG001|Overall Study|Adverse Event|0|||
164546230|NCT04814823|594371241|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
164546231|NCT05678257|594371246|FG000|Overall Study|Withdrawal by Subject|2|||
164546232|NCT05678257|594371247|FG001|Overall Study|Withdrawal by Subject|0|||
164546233|NCT05678257|594371248|FG002|Overall Study|Withdrawal by Subject|5|||
164546234|NCT05678257|594371246|FG000|Overall Study|Physician Decision|1|||
164546235|NCT05678257|594371247|FG001|Overall Study|Physician Decision|0|||
164546236|NCT05678257|594371248|FG002|Overall Study|Physician Decision|1|||
164546237|NCT05678257|594371246|FG000|Overall Study|Adverse Event|1|||
164546238|NCT05678257|594371247|FG001|Overall Study|Adverse Event|3|||
164546239|NCT05678257|594371248|FG002|Overall Study|Adverse Event|1|||
164546240|NCT05678257|594371246|FG000|Overall Study|Progressive disease|11|||
164546241|NCT05678257|594371247|FG001|Overall Study|Progressive disease|18|||
164546242|NCT05678257|594371248|FG002|Overall Study|Progressive disease|7|||
164546243|NCT05678257|594371246|FG000|Overall Study|No longer clinically benefitting|2|||
164546244|NCT05678257|594371247|FG001|Overall Study|No longer clinically benefitting|1|||
164546245|NCT05678257|594371248|FG002|Overall Study|No longer clinically benefitting|0|||
164546246|NCT05678257|594371246|FG000|Overall Study|Sponsor decision|5|||
164546247|NCT05678257|594371247|FG001|Overall Study|Sponsor decision|9|||
164546248|NCT05678257|594371248|FG002|Overall Study|Sponsor decision|8|||
164546249|NCT05678257|594371246|FG000|Overall Study|Protocol Violation|0|||
164546250|NCT05678257|594371247|FG001|Overall Study|Protocol Violation|0|||
164546251|NCT05678257|594371248|FG002|Overall Study|Protocol Violation|1|||
164546252|NCT05678257|594371246|FG000|Overall Study|Patient non-compliance|0|||
164546253|NCT05678257|594371247|FG001|Overall Study|Patient non-compliance|0|||
164546254|NCT05678257|594371248|FG002|Overall Study|Patient non-compliance|3|||
164546255|NCT01045798|594371249|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
164546256|NCT01045798|594371250|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
164546257|NCT01045798|594371249|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
164546258|NCT01045798|594371250|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
164546259|NCT01045798|594371249|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
164546260|NCT01045798|594371250|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
164546261|NCT01045798|594371249|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
164546262|NCT01045798|594371250|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
164546263|NCT01449461|594371251|FG000|Overall Study|Adverse Event|0|||
164546264|NCT01449461|594371252|FG001|Overall Study|Adverse Event|3|||
164546265|NCT01449461|594371253|FG002|Overall Study|Adverse Event|2|||
164546266|NCT01449461|594371254|FG003|Overall Study|Adverse Event|3|||
164546267|NCT01449461|594371255|FG004|Overall Study|Adverse Event|4|||
164546268|NCT01449461|594371256|FG005|Overall Study|Adverse Event|4|||
164546269|NCT01449461|594371251|FG000|Overall Study|Death|0|||
164546270|NCT01449461|594371252|FG001|Overall Study|Death|2|||
164546271|NCT01449461|594371253|FG002|Overall Study|Death|0|||
164194330|NCT02106351|593079436|FG001|Treatment Cycle 2|Consent withdrawn|1|||
164194331|NCT02106351|593079437|FG002|Treatment Cycle 2|Consent withdrawn|1|||
164194332|NCT02106351|593079435|FG000|Treatment Cycle 2|Other|0|||
164194333|NCT02106351|593079436|FG001|Treatment Cycle 2|Other|2|||
164194334|NCT02106351|593079437|FG002|Treatment Cycle 2|Other|2|||
164194335|NCT02106351|593079435|FG000|Treatment Cycle 3|Adverse Event|0|||
164194336|NCT02106351|593079436|FG001|Treatment Cycle 3|Adverse Event|1|||
164194337|NCT02106351|593079437|FG002|Treatment Cycle 3|Adverse Event|0|||
164194338|NCT02106351|593079435|FG000|Treatment Cycle 3|Consent withdrawn|0|||
164194339|NCT02106351|593079436|FG001|Treatment Cycle 3|Consent withdrawn|0|||
164194340|NCT02106351|593079437|FG002|Treatment Cycle 3|Consent withdrawn|2|||
164194341|NCT02106351|593079435|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
164194342|NCT02106351|593079436|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
164194343|NCT02106351|593079437|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
164194344|NCT02106351|593079435|FG000|Treatment Cycle 3|Other|0|||
164194345|NCT02106351|593079436|FG001|Treatment Cycle 3|Other|2|||
164194346|NCT02106351|593079437|FG002|Treatment Cycle 3|Other|3|||
164194347|NCT02106351|593079435|FG000|Treatment Cycle 4|Consent withdrawn|0|||
164194348|NCT02106351|593079436|FG001|Treatment Cycle 4|Consent withdrawn|0|||
164194349|NCT02106351|593079437|FG002|Treatment Cycle 4|Consent withdrawn|2|||
164194350|NCT02106351|593079435|FG000|Treatment Cycle 4|Other|0|||
164194351|NCT02106351|593079436|FG001|Treatment Cycle 4|Other|1|||
164194352|NCT02106351|593079437|FG002|Treatment Cycle 4|Other|0|||
164194353|NCT01801111|593079438|FG000|Overall Study|Adverse Event|12|||
164194354|NCT01801111|593079438|FG000|Overall Study|Death|8|||
164194355|NCT01801111|593079438|FG000|Overall Study|Physician Decision|5|||
164194356|NCT01801111|593079438|FG000|Overall Study|Other|1|||
164194357|NCT01801111|593079438|FG000|Overall Study|Withdrawal by Subject|4|||
164194358|NCT01801111|593079438|FG000|Overall Study|Study Terminated by Sponsor|27|||
164194359|NCT01801111|593079438|FG000|Overall Study|Progressive Disease|81|||
164194360|NCT01210482|593079439|FG000|Overall Study|Protocol Violation|1|||
164194361|NCT01210482|593079439|FG000|Overall Study|Case Report Forms were not collected|18|||
164194362|NCT01210482|593079439|FG000|Overall Study|Duplicated|2|||
164194363|NCT01210482|593079439|FG000|Overall Study|No Drug Administration|28|||
164194364|NCT01223937|593079440|FG000|Overall Study|Withdrawal by Subject|3|||
164194365|NCT01223937|593079441|FG001|Overall Study|Withdrawal by Subject|2|||
164194366|NCT01223937|593079440|FG000|Overall Study|Lost to Follow-up|1|||
164194367|NCT01223937|593079441|FG001|Overall Study|Lost to Follow-up|4|||
164194368|NCT01223937|593079440|FG000|Overall Study|Adverse Event|1|||
164194369|NCT01223937|593079441|FG001|Overall Study|Adverse Event|4|||
164194370|NCT01223937|593079440|FG000|Overall Study|Protocol Violation|8|||
164194371|NCT01223937|593079441|FG001|Overall Study|Protocol Violation|7|||
164194372|NCT01223937|593079440|FG000|Overall Study|Other|4|||
164194373|NCT01223937|593079441|FG001|Overall Study|Other|1|||
164194374|NCT05176717|593079442|FG000|Overall Study|Sponsor Decision|1|||
164194375|NCT05176717|593079443|FG001|Overall Study|Sponsor Decision|2|||
164194376|NCT05176717|593079444|FG002|Overall Study|Sponsor Decision|2|||
164194377|NCT03284853|593079445|FG000|Overall Study|Adverse Event|40|||
164194378|NCT03284853|593079446|FG001|Overall Study|Adverse Event|4|||
164194379|NCT03284853|593079445|FG000|Overall Study|Withdrawal by Subject|5|||
164194380|NCT03284853|593079446|FG001|Overall Study|Withdrawal by Subject|1|||
164194381|NCT03284853|593079445|FG000|Overall Study|Lost to Follow-up|1|||
164194382|NCT03284853|593079446|FG001|Overall Study|Lost to Follow-up|0|||
164194383|NCT03284853|593079445|FG000|Overall Study|Lack of Efficacy|1|||
164194384|NCT03284853|593079446|FG001|Overall Study|Lack of Efficacy|0|||
164194385|NCT03284853|593079445|FG000|Overall Study|Disallowed Concurrent Medication|1|||
164194386|NCT03284853|593079446|FG001|Overall Study|Disallowed Concurrent Medication|1|||
164194387|NCT03284853|593079445|FG000|Overall Study|Protocol Violation|3|||
164194388|NCT03284853|593079446|FG001|Overall Study|Protocol Violation|3|||
164194389|NCT03284853|593079445|FG000|Overall Study|Death|0|||
164194390|NCT03284853|593079446|FG001|Overall Study|Death|1|||
164546272|NCT01449461|594371254|FG003|Overall Study|Death|0|||
164546273|NCT01449461|594371255|FG004|Overall Study|Death|7|||
164546274|NCT01449461|594371256|FG005|Overall Study|Death|1|||
164194391|NCT03284853|593079445|FG000|Overall Study|Other - Reason not reported in CSR|4|||
164194392|NCT03284853|593079446|FG001|Overall Study|Other - Reason not reported in CSR|3|||
164194393|NCT00765817|593079448|FG000|Overall Study|Adverse Event|13|||
164194394|NCT00765817|593079449|FG001|Overall Study|Adverse Event|1|||
164194395|NCT00765817|593079448|FG000|Overall Study|Death|0|||
164194396|NCT00765817|593079449|FG001|Overall Study|Death|1|||
164194397|NCT00765817|593079448|FG000|Overall Study|Entry criteria not met|2|||
164194398|NCT00765817|593079449|FG001|Overall Study|Entry criteria not met|2|||
164194399|NCT00765817|593079448|FG000|Overall Study|Loss of glucose control|0|||
164194400|NCT00765817|593079449|FG001|Overall Study|Loss of glucose control|2|||
164194401|NCT00765817|593079448|FG000|Overall Study|Lost to Follow-up|1|||
164194402|NCT00765817|593079449|FG001|Overall Study|Lost to Follow-up|3|||
164194403|NCT00765817|593079448|FG000|Overall Study|Physician Decision|2|||
164194404|NCT00765817|593079449|FG001|Overall Study|Physician Decision|1|||
164194405|NCT00765817|593079448|FG000|Overall Study|Protocol Violation|1|||
164546275|NCT01449461|594371251|FG000|Overall Study|Physician Decision|0|||
164546276|NCT01449461|594371252|FG001|Overall Study|Physician Decision|1|||
164546277|NCT01449461|594371253|FG002|Overall Study|Physician Decision|0|||
164653617|NCT00124449|594757228|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
164194406|NCT00765817|593079449|FG001|Overall Study|Protocol Violation|1|||
164546278|NCT01449461|594371254|FG003|Overall Study|Physician Decision|4|||
164546279|NCT01449461|594371255|FG004|Overall Study|Physician Decision|1|||
164546280|NCT01449461|594371256|FG005|Overall Study|Physician Decision|0|||
164546281|NCT01449461|594371251|FG000|Overall Study|Documented Progressive Disease|4|||
164194407|NCT00765817|593079448|FG000|Overall Study|Subject decision|7|||
164194408|NCT00765817|593079449|FG001|Overall Study|Subject decision|11|||
164194409|NCT02058589|593079451|FG000|Overall Study|Serious Adverse Event|1|||
164194410|NCT02058589|593079452|FG001|Overall Study|Serious Adverse Event|1|||
164546282|NCT01449461|594371252|FG001|Overall Study|Documented Progressive Disease|7|||
164546283|NCT01449461|594371253|FG002|Overall Study|Documented Progressive Disease|14|||
164194411|NCT02058589|593079451|FG000|Overall Study|Non-Serious Adverse Event|1|||
164194412|NCT02058589|593079452|FG001|Overall Study|Non-Serious Adverse Event|0|||
164194413|NCT02058589|593079451|FG000|Overall Study|Withdrawal by Subject|0|||
164194414|NCT02058589|593079452|FG001|Overall Study|Withdrawal by Subject|1|||
164194415|NCT02143024|593079453|FG000|Overall Study|Lost to Follow-up|1|||
164194416|NCT02143024|593079454|FG001|Overall Study|Lost to Follow-up|1|||
164194417|NCT02143024|593079453|FG000|Overall Study|Withdrawal by Subject|1|||
164194418|NCT02143024|593079454|FG001|Overall Study|Withdrawal by Subject|0|||
164194419|NCT02308228|593079455|FG000|Overall Study|Adverse Event|3|||
164194420|NCT02308228|593079456|FG001|Overall Study|Adverse Event|4|||
164194421|NCT02308228|593079455|FG000|Overall Study|Withdrawal by Subject|5|||
164194422|NCT02308228|593079456|FG001|Overall Study|Withdrawal by Subject|3|||
164194423|NCT06597084|593079457|FG000|Overall Study|Withdrawal by Subject|4|||
164194424|NCT06597084|593079458|FG001|Overall Study|Withdrawal by Subject|9|||
164194425|NCT06597084|593079457|FG000|Overall Study|Consent was not given by the patient until V2|0|||
164194426|NCT06597084|593079458|FG001|Overall Study|Consent was not given by the patient until V2|3|||
164194427|NCT06597084|593079457|FG000|Overall Study|Physician Decision|1|||
164194428|NCT06597084|593079458|FG001|Overall Study|Physician Decision|0|||
164194429|NCT06597084|593079457|FG000|Overall Study|Adverse Event|3|||
164194430|NCT06597084|593079458|FG001|Overall Study|Adverse Event|2|||
164194431|NCT06597084|593079457|FG000|Overall Study|Death|4|||
164194432|NCT06597084|593079458|FG001|Overall Study|Death|0|||
164194433|NCT06597084|593079457|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
164194434|NCT06597084|593079458|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
164194435|NCT06597084|593079457|FG000|Overall Study|Lost to Follow-up|4|||
164194436|NCT06597084|593079458|FG001|Overall Study|Lost to Follow-up|2|||
164194437|NCT06597084|593079457|FG000|Overall Study|Other. Not specified|1|||
164194438|NCT06597084|593079458|FG001|Overall Study|Other. Not specified|0|||
164194439|NCT00490971|593079463|FG000|Acute/Continuation|Adverse Event|62|||
164194440|NCT00490971|593079464|FG001|Acute/Continuation|Adverse Event|13|||
164194441|NCT00490971|593079465|FG002|Acute/Continuation|Adverse Event|0|||
164194442|NCT00490971|593079466|FG003|Acute/Continuation|Adverse Event|0|||
164194443|NCT00490971|593079467|FG004|Acute/Continuation|Adverse Event|0|||
164194444|NCT00490971|593079463|FG000|Acute/Continuation|Death|2|||
164194445|NCT00490971|593079464|FG001|Acute/Continuation|Death|0|||
164194446|NCT00490971|593079465|FG002|Acute/Continuation|Death|0|||
164194447|NCT00490971|593079466|FG003|Acute/Continuation|Death|0|||
164194448|NCT00490971|593079467|FG004|Acute/Continuation|Death|0|||
164194449|NCT00490971|593079463|FG000|Acute/Continuation|Lack of Efficacy|106|||
164194450|NCT00490971|593079464|FG001|Acute/Continuation|Lack of Efficacy|12|||
164194451|NCT00490971|593079465|FG002|Acute/Continuation|Lack of Efficacy|0|||
164194452|NCT00490971|593079466|FG003|Acute/Continuation|Lack of Efficacy|0|||
164194453|NCT00490971|593079467|FG004|Acute/Continuation|Lack of Efficacy|0|||
164194454|NCT00490971|593079463|FG000|Acute/Continuation|Lost to Follow-up|23|||
164194455|NCT00490971|593079464|FG001|Acute/Continuation|Lost to Follow-up|7|||
164546284|NCT01449461|594371254|FG003|Overall Study|Documented Progressive Disease|15|||
164546285|NCT01449461|594371255|FG004|Overall Study|Documented Progressive Disease|24|||
164546286|NCT01449461|594371256|FG005|Overall Study|Documented Progressive Disease|5|||
164546287|NCT01449461|594371251|FG000|Overall Study|Clinical Progressive Disease|2|||
164546288|NCT01449461|594371252|FG001|Overall Study|Clinical Progressive Disease|2|||
164546289|NCT01449461|594371253|FG002|Overall Study|Clinical Progressive Disease|0|||
164546290|NCT01449461|594371254|FG003|Overall Study|Clinical Progressive Disease|3|||
164194456|NCT00490971|593079465|FG002|Acute/Continuation|Lost to Follow-up|0|||
164653618|NCT00124449|594757229|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
164194457|NCT00490971|593079466|FG003|Acute/Continuation|Lost to Follow-up|0|||
164194458|NCT00490971|593079467|FG004|Acute/Continuation|Lost to Follow-up|0|||
164194459|NCT00490971|593079463|FG000|Acute/Continuation|Protocol Violation|10|||
164194460|NCT00490971|593079464|FG001|Acute/Continuation|Protocol Violation|2|||
164194461|NCT00490971|593079465|FG002|Acute/Continuation|Protocol Violation|0|||
164194462|NCT00490971|593079466|FG003|Acute/Continuation|Protocol Violation|0|||
164194463|NCT00490971|593079467|FG004|Acute/Continuation|Protocol Violation|0|||
164546291|NCT01449461|594371255|FG004|Overall Study|Clinical Progressive Disease|4|||
164546292|NCT01449461|594371256|FG005|Overall Study|Clinical Progressive Disease|2|||
164546293|NCT01449461|594371251|FG000|Overall Study|Protocol Violation|0|||
164546294|NCT01449461|594371252|FG001|Overall Study|Protocol Violation|0|||
164546295|NCT01449461|594371253|FG002|Overall Study|Protocol Violation|0|||
164546296|NCT01449461|594371254|FG003|Overall Study|Protocol Violation|1|||
164546297|NCT01449461|594371255|FG004|Overall Study|Protocol Violation|0|||
164546298|NCT01449461|594371256|FG005|Overall Study|Protocol Violation|0|||
164546299|NCT01449461|594371251|FG000|Overall Study|Site Terminated by Sponsor|0|||
164546300|NCT01449461|594371252|FG001|Overall Study|Site Terminated by Sponsor|1|||
164546301|NCT01449461|594371253|FG002|Overall Study|Site Terminated by Sponsor|2|||
164546302|NCT01449461|594371254|FG003|Overall Study|Site Terminated by Sponsor|3|||
164546303|NCT01449461|594371255|FG004|Overall Study|Site Terminated by Sponsor|4|||
164546304|NCT01449461|594371256|FG005|Overall Study|Site Terminated by Sponsor|1|||
164546305|NCT01449461|594371251|FG000|Overall Study|Withdrawal by Subject|0|||
164546306|NCT01449461|594371252|FG001|Overall Study|Withdrawal by Subject|1|||
164546307|NCT01449461|594371253|FG002|Overall Study|Withdrawal by Subject|0|||
164546308|NCT01449461|594371254|FG003|Overall Study|Withdrawal by Subject|0|||
164546309|NCT01449461|594371255|FG004|Overall Study|Withdrawal by Subject|2|||
164546310|NCT01449461|594371256|FG005|Overall Study|Withdrawal by Subject|1|||
164546311|NCT01449461|594371251|FG000|Overall Study|Reason not Specified|0|||
164546312|NCT01449461|594371252|FG001|Overall Study|Reason not Specified|1|||
164546313|NCT01449461|594371253|FG002|Overall Study|Reason not Specified|0|||
164546314|NCT01449461|594371254|FG003|Overall Study|Reason not Specified|3|||
164546315|NCT01449461|594371255|FG004|Overall Study|Reason not Specified|2|||
164546316|NCT01449461|594371256|FG005|Overall Study|Reason not Specified|1|||
164546317|NCT05314517|594371257|FG000|Double-blind Period|Adverse Event|4|||
164546318|NCT05314517|594371258|FG001|Double-blind Period|Adverse Event|0|||
164546319|NCT05314517|594371259|FG002|Double-blind Period|Adverse Event|0|||
164546320|NCT05314517|594371260|FG003|Double-blind Period|Adverse Event|0|||
164546321|NCT05314517|594371257|FG000|Double-blind Period|Noncompliance|0|||
164546322|NCT05314517|594371258|FG001|Double-blind Period|Noncompliance|1|||
164546323|NCT05314517|594371259|FG002|Double-blind Period|Noncompliance|0|||
164546324|NCT05314517|594371260|FG003|Double-blind Period|Noncompliance|0|||
164546325|NCT05314517|594371257|FG000|Double-blind Period|Randomized, not treated|1|||
164546326|NCT05314517|594371258|FG001|Double-blind Period|Randomized, not treated|0|||
164546327|NCT05314517|594371259|FG002|Double-blind Period|Randomized, not treated|0|||
164546328|NCT05314517|594371260|FG003|Double-blind Period|Randomized, not treated|0|||
164546329|NCT05314517|594371257|FG000|Open-label Extension|Adverse Event|0|||
164546330|NCT05314517|594371258|FG001|Open-label Extension|Adverse Event|0|||
164546331|NCT05314517|594371259|FG002|Open-label Extension|Adverse Event|1|||
164546332|NCT05314517|594371260|FG003|Open-label Extension|Adverse Event|2|||
164546333|NCT05314517|594371257|FG000|Open-label Extension|Investigator decision|0|||
164546334|NCT05314517|594371258|FG001|Open-label Extension|Investigator decision|0|||
164546335|NCT05314517|594371259|FG002|Open-label Extension|Investigator decision|1|||
164546336|NCT05314517|594371260|FG003|Open-label Extension|Investigator decision|0|||
164546337|NCT05314517|594371257|FG000|Open-label Extension|Lost to Follow-up|0|||
164546338|NCT05314517|594371258|FG001|Open-label Extension|Lost to Follow-up|0|||
164546339|NCT05314517|594371259|FG002|Open-label Extension|Lost to Follow-up|0|||
164546340|NCT05314517|594371260|FG003|Open-label Extension|Lost to Follow-up|1|||
164546341|NCT05314517|594371257|FG000|Open-label Extension|Withdrawal by Subject|0|||
164194464|NCT00490971|593079463|FG000|Acute/Continuation|Withdrawal by Subject|92|||
164194465|NCT00490971|593079464|FG001|Acute/Continuation|Withdrawal by Subject|24|||
164546342|NCT05314517|594371258|FG001|Open-label Extension|Withdrawal by Subject|0|||
164546343|NCT05314517|594371259|FG002|Open-label Extension|Withdrawal by Subject|1|||
164546344|NCT05314517|594371260|FG003|Open-label Extension|Withdrawal by Subject|2|||
164546345|NCT05314517|594371257|FG000|Open-label Extension|Use of prohibited medication|0|||
164546346|NCT05314517|594371258|FG001|Open-label Extension|Use of prohibited medication|0|||
164546347|NCT05314517|594371259|FG002|Open-label Extension|Use of prohibited medication|1|||
164653619|NCT00124449|594757228|FG000|18-Month Untreated Observation Period|Relocated|1|||
164194466|NCT00490971|593079465|FG002|Acute/Continuation|Withdrawal by Subject|0|||
164194467|NCT00490971|593079466|FG003|Acute/Continuation|Withdrawal by Subject|0|||
164653620|NCT00124449|594757229|FG001|18-Month Untreated Observation Period|Relocated|0|||
164194468|NCT00490971|593079467|FG004|Acute/Continuation|Withdrawal by Subject|0|||
164194469|NCT00490971|593079463|FG000|Acute/Continuation|Other|11|||
164653621|NCT03811249|594757230|FG000|Overall Study|Withdrawal by Subject|44|||
164194470|NCT00490971|593079464|FG001|Acute/Continuation|Other|4|||
164194471|NCT00490971|593079465|FG002|Acute/Continuation|Other|0|||
164546348|NCT05314517|594371260|FG003|Open-label Extension|Use of prohibited medication|0|||
164546349|NCT05314517|594371257|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
164546350|NCT05314517|594371258|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
164546351|NCT05314517|594371259|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
164546352|NCT05314517|594371260|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
164546353|NCT02592018|594371263|FG000|Overall Study|Adverse Event|1|||
164653622|NCT03811249|594757230|FG000|Overall Study|Missed Visit|24|||
164194472|NCT00490971|593079466|FG003|Acute/Continuation|Other|0|||
164194473|NCT00490971|593079467|FG004|Acute/Continuation|Other|0|||
164194474|NCT00490971|593079463|FG000|Maintenance|Adverse Event|0|||
164194475|NCT00490971|593079464|FG001|Maintenance|Adverse Event|0|||
164194476|NCT00490971|593079465|FG002|Maintenance|Adverse Event|4|||
164194477|NCT00490971|593079466|FG003|Maintenance|Adverse Event|5|||
164194478|NCT00490971|593079467|FG004|Maintenance|Adverse Event|7|||
164194479|NCT00490971|593079463|FG000|Maintenance|Death|0|||
164194480|NCT00490971|593079464|FG001|Maintenance|Death|0|||
164194481|NCT00490971|593079465|FG002|Maintenance|Death|0|||
164194482|NCT00490971|593079466|FG003|Maintenance|Death|2|||
164194483|NCT00490971|593079467|FG004|Maintenance|Death|0|||
164194484|NCT00490971|593079463|FG000|Maintenance|Lost to Follow-up|0|||
164194485|NCT00490971|593079464|FG001|Maintenance|Lost to Follow-up|0|||
164194486|NCT00490971|593079465|FG002|Maintenance|Lost to Follow-up|5|||
164194487|NCT00490971|593079466|FG003|Maintenance|Lost to Follow-up|8|||
164194488|NCT00490971|593079467|FG004|Maintenance|Lost to Follow-up|10|||
164194489|NCT00490971|593079463|FG000|Maintenance|Pregnancy|0|||
164194490|NCT00490971|593079464|FG001|Maintenance|Pregnancy|0|||
164194491|NCT00490971|593079465|FG002|Maintenance|Pregnancy|1|||
164194492|NCT00490971|593079466|FG003|Maintenance|Pregnancy|0|||
164194493|NCT00490971|593079467|FG004|Maintenance|Pregnancy|0|||
164194494|NCT00490971|593079463|FG000|Maintenance|Protocol Violation|0|||
164194495|NCT00490971|593079464|FG001|Maintenance|Protocol Violation|0|||
164194496|NCT00490971|593079465|FG002|Maintenance|Protocol Violation|4|||
164194497|NCT00490971|593079466|FG003|Maintenance|Protocol Violation|1|||
164194498|NCT00490971|593079467|FG004|Maintenance|Protocol Violation|1|||
164194499|NCT00490971|593079463|FG000|Maintenance|Withdrawal by Subject|0|||
164194500|NCT00490971|593079464|FG001|Maintenance|Withdrawal by Subject|0|||
164194501|NCT00490971|593079465|FG002|Maintenance|Withdrawal by Subject|26|||
164194502|NCT00490971|593079466|FG003|Maintenance|Withdrawal by Subject|28|||
164194503|NCT00490971|593079467|FG004|Maintenance|Withdrawal by Subject|18|||
164194504|NCT00490971|593079463|FG000|Maintenance|Other|0|||
164194505|NCT00490971|593079464|FG001|Maintenance|Other|0|||
164194506|NCT00490971|593079465|FG002|Maintenance|Other|11|||
164194507|NCT00490971|593079466|FG003|Maintenance|Other|9|||
164194508|NCT00490971|593079467|FG004|Maintenance|Other|3|||
164194509|NCT03999749|593079469|FG000|Overall Study|Toxicity|16|||
164546354|NCT02592018|594371263|FG000|Overall Study|Lost to Follow-up|1|||
164546355|NCT02710136|594371264|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
164546356|NCT02710136|594371265|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
164546357|NCT02269787|594371269|FG000|Overall Study|Lost to Follow-up|20|||
164546358|NCT02269787|594371270|FG001|Overall Study|Lost to Follow-up|6|||
164546359|NCT02269787|594371269|FG000|Overall Study|Death|2|||
164546360|NCT02269787|594371270|FG001|Overall Study|Death|3|||
164546361|NCT02269787|594371269|FG000|Overall Study|Incapacitated|0|||
164546362|NCT02269787|594371270|FG001|Overall Study|Incapacitated|1|||
164546363|NCT00574145|594372706|FG000|Overall Study|Withdrawal by Subject|2|||
164546364|NCT00574145|594372707|FG001|Overall Study|Withdrawal by Subject|1|||
164546365|NCT04183790|594372708|FG000|Overall Study|Participants did not rollover to Part B|12|||
164546366|NCT04183790|594372709|FG001|Overall Study|Participants did not rollover to Part B|0|||
164546367|NCT04183790|594372708|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
164546368|NCT04183790|594372709|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
164546369|NCT04183790|594372708|FG000|Overall Study|Commercial drug is available for participant|6|||
164546370|NCT04183790|594372709|FG001|Overall Study|Commercial drug is available for participant|0|||
164546371|NCT04183790|594372708|FG000|Overall Study|Adverse Event|1|||
164546372|NCT04183790|594372709|FG001|Overall Study|Adverse Event|0|||
164546373|NCT04183790|594372708|FG000|Overall Study|Not enrolled in 107 study|0|||
164546374|NCT04183790|594372709|FG001|Overall Study|Not enrolled in 107 study|2|||
164194510|NCT03999749|593079469|FG000|Overall Study|Withdrawal by Subject|3|||
164194511|NCT03999749|593079469|FG000|Overall Study|Disease progression|26|||
164194512|NCT03999749|593079469|FG000|Overall Study|Physician Decision|4|||
164194513|NCT03999749|593079469|FG000|Overall Study|Death|5|||
164194514|NCT03999749|593079469|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
164194515|NCT00255164|593079470|FG000|Overall Study|Adverse Event|10|||
164194516|NCT00255164|593079471|FG001|Overall Study|Adverse Event|6|||
164194517|NCT00255164|593079472|FG002|Overall Study|Adverse Event|9|||
164194518|NCT00255164|593079470|FG000|Overall Study|Lost to Follow-up|4|||
164194519|NCT00255164|593079471|FG001|Overall Study|Lost to Follow-up|3|||
164194520|NCT00255164|593079472|FG002|Overall Study|Lost to Follow-up|4|||
164546375|NCT01251653|594372710|FG000|Overall Study|Progressive Disease|1|||
164546376|NCT01251653|594372711|FG001|Overall Study|Progressive Disease|7|||
164546377|NCT01251653|594372712|FG002|Overall Study|Progressive Disease|16|||
164194521|NCT00255164|593079470|FG000|Overall Study|Withdrawal by Subject|18|||
164194522|NCT00255164|593079471|FG001|Overall Study|Withdrawal by Subject|17|||
164194523|NCT00255164|593079472|FG002|Overall Study|Withdrawal by Subject|8|||
164194524|NCT00255164|593079470|FG000|Overall Study|Noncompliance|0|||
164194525|NCT00255164|593079471|FG001|Overall Study|Noncompliance|1|||
164194526|NCT00255164|593079472|FG002|Overall Study|Noncompliance|2|||
164194527|NCT00255164|593079470|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
164194528|NCT00255164|593079471|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
164546378|NCT01251653|594372713|FG003|Overall Study|Progressive Disease|4|||
164546379|NCT01251653|594372714|FG004|Overall Study|Progressive Disease|0|||
164546380|NCT01251653|594372715|FG005|Overall Study|Progressive Disease|17|||
164546381|NCT01251653|594372716|FG006|Overall Study|Progressive Disease|14|||
164546382|NCT01251653|594372717|FG007|Overall Study|Progressive Disease|7|||
164546383|NCT01251653|594372718|FG008|Overall Study|Progressive Disease|5|||
164546384|NCT01251653|594372710|FG000|Overall Study|Dose-limiting toxicity|0|||
164546385|NCT01251653|594372711|FG001|Overall Study|Dose-limiting toxicity|1|||
164546386|NCT01251653|594372712|FG002|Overall Study|Dose-limiting toxicity|1|||
164546387|NCT01251653|594372713|FG003|Overall Study|Dose-limiting toxicity|1|||
164653623|NCT01504867|594757234|FG000|Overall Study|Inclusion criteria not met|2|||
164653624|NCT01504867|594757235|FG001|Overall Study|Inclusion criteria not met|2|||
164653625|NCT01504867|594757234|FG000|Overall Study|Consent revoked|5|||
164653626|NCT01504867|594757235|FG001|Overall Study|Consent revoked|1|||
164546388|NCT01251653|594372714|FG004|Overall Study|Dose-limiting toxicity|0|||
164546389|NCT01251653|594372715|FG005|Overall Study|Dose-limiting toxicity|0|||
164546390|NCT01251653|594372716|FG006|Overall Study|Dose-limiting toxicity|2|||
164546391|NCT01251653|594372717|FG007|Overall Study|Dose-limiting toxicity|0|||
164546392|NCT01251653|594372718|FG008|Overall Study|Dose-limiting toxicity|0|||
164546393|NCT01251653|594372710|FG000|Overall Study|Adverse Event|1|||
164546394|NCT01251653|594372711|FG001|Overall Study|Adverse Event|0|||
164546395|NCT01251653|594372712|FG002|Overall Study|Adverse Event|2|||
164546396|NCT01251653|594372713|FG003|Overall Study|Adverse Event|1|||
164546397|NCT01251653|594372714|FG004|Overall Study|Adverse Event|1|||
164546398|NCT01251653|594372715|FG005|Overall Study|Adverse Event|0|||
164546399|NCT01251653|594372716|FG006|Overall Study|Adverse Event|2|||
164546400|NCT01251653|594372717|FG007|Overall Study|Adverse Event|2|||
164546401|NCT01251653|594372718|FG008|Overall Study|Adverse Event|1|||
164546402|NCT01251653|594372710|FG000|Overall Study|Withdrawal by Subject|1|||
164546403|NCT01251653|594372711|FG001|Overall Study|Withdrawal by Subject|0|||
164546404|NCT01251653|594372712|FG002|Overall Study|Withdrawal by Subject|1|||
164546405|NCT01251653|594372713|FG003|Overall Study|Withdrawal by Subject|0|||
164546406|NCT01251653|594372714|FG004|Overall Study|Withdrawal by Subject|1|||
164546407|NCT01251653|594372715|FG005|Overall Study|Withdrawal by Subject|1|||
164546408|NCT01251653|594372716|FG006|Overall Study|Withdrawal by Subject|0|||
164546409|NCT01251653|594372717|FG007|Overall Study|Withdrawal by Subject|1|||
164546410|NCT01251653|594372718|FG008|Overall Study|Withdrawal by Subject|0|||
164546411|NCT01251653|594372710|FG000|Overall Study|Other reason not mentioned above|0|||
164546412|NCT01251653|594372711|FG001|Overall Study|Other reason not mentioned above|0|||
164546413|NCT01251653|594372712|FG002|Overall Study|Other reason not mentioned above|0|||
164546414|NCT01251653|594372713|FG003|Overall Study|Other reason not mentioned above|0|||
164546415|NCT01251653|594372714|FG004|Overall Study|Other reason not mentioned above|0|||
164546416|NCT01251653|594372715|FG005|Overall Study|Other reason not mentioned above|0|||
164546417|NCT01251653|594372716|FG006|Overall Study|Other reason not mentioned above|0|||
164546418|NCT01251653|594372717|FG007|Overall Study|Other reason not mentioned above|2|||
164546419|NCT01251653|594372718|FG008|Overall Study|Other reason not mentioned above|0|||
164546420|NCT00847145|594372719|FG000|Overall Study|AE or Death|0|||
164546421|NCT00847145|594372720|FG001|Overall Study|AE or Death|1|||
164546422|NCT00847145|594372721|FG002|Overall Study|AE or Death|1|||
164546423|NCT00847145|594372722|FG003|Overall Study|AE or Death|0|||
164546424|NCT00847145|594372723|FG004|Overall Study|AE or Death|0|||
164546425|NCT00847145|594372724|FG005|Overall Study|AE or Death|0|||
164546426|NCT00847145|594372725|FG006|Overall Study|AE or Death|0|||
164546427|NCT00847145|594372726|FG007|Overall Study|AE or Death|0|||
164546428|NCT00847145|594372719|FG000|Overall Study|Withdrawal by Subject|3|||
164546429|NCT00847145|594372720|FG001|Overall Study|Withdrawal by Subject|4|||
164546430|NCT00847145|594372721|FG002|Overall Study|Withdrawal by Subject|6|||
164546431|NCT00847145|594372722|FG003|Overall Study|Withdrawal by Subject|1|||
164546432|NCT00847145|594372723|FG004|Overall Study|Withdrawal by Subject|0|||
164546433|NCT00847145|594372724|FG005|Overall Study|Withdrawal by Subject|0|||
164546434|NCT00847145|594372725|FG006|Overall Study|Withdrawal by Subject|1|||
164546435|NCT00847145|594372726|FG007|Overall Study|Withdrawal by Subject|1|||
164546436|NCT00847145|594372719|FG000|Overall Study|Lost to Follow-up|3|||
164653627|NCT03124381|594757241|FG000|Overall Study|Lost to Follow-up|1|||
164653628|NCT03124381|594757242|FG001|Overall Study|Lost to Follow-up|1|||
164546437|NCT00847145|594372720|FG001|Overall Study|Lost to Follow-up|1|||
164546438|NCT00847145|594372721|FG002|Overall Study|Lost to Follow-up|1|||
164546439|NCT00847145|594372722|FG003|Overall Study|Lost to Follow-up|0|||
164653629|NCT03124381|594757241|FG000|Overall Study|Withdrawal by Subject|6|||
164194529|NCT00255164|593079472|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
164546440|NCT00847145|594372723|FG004|Overall Study|Lost to Follow-up|4|||
164546441|NCT00847145|594372724|FG005|Overall Study|Lost to Follow-up|4|||
164546442|NCT00847145|594372725|FG006|Overall Study|Lost to Follow-up|8|||
164546443|NCT00847145|594372726|FG007|Overall Study|Lost to Follow-up|2|||
164546444|NCT00847145|594372719|FG000|Overall Study|Inappropriate enrollment|0|||
164653630|NCT03124381|594757242|FG001|Overall Study|Withdrawal by Subject|3|||
164546445|NCT00847145|594372720|FG001|Overall Study|Inappropriate enrollment|0|||
164653631|NCT03124381|594757241|FG000|Overall Study|Protocol Violation|0|||
164546446|NCT00847145|594372721|FG002|Overall Study|Inappropriate enrollment|0|||
164546447|NCT00847145|594372722|FG003|Overall Study|Inappropriate enrollment|0|||
164546448|NCT00847145|594372723|FG004|Overall Study|Inappropriate enrollment|1|||
164546449|NCT00847145|594372724|FG005|Overall Study|Inappropriate enrollment|0|||
164546450|NCT00847145|594372725|FG006|Overall Study|Inappropriate enrollment|0|||
164546451|NCT00847145|594372726|FG007|Overall Study|Inappropriate enrollment|0|||
164546452|NCT00847145|594372719|FG000|Overall Study|Protocol Violation|0|||
164546453|NCT00847145|594372720|FG001|Overall Study|Protocol Violation|0|||
164546454|NCT00847145|594372721|FG002|Overall Study|Protocol Violation|3|||
164546455|NCT00847145|594372722|FG003|Overall Study|Protocol Violation|0|||
164546456|NCT00847145|594372723|FG004|Overall Study|Protocol Violation|1|||
164546457|NCT00847145|594372724|FG005|Overall Study|Protocol Violation|0|||
164546458|NCT00847145|594372725|FG006|Overall Study|Protocol Violation|0|||
164546459|NCT00847145|594372726|FG007|Overall Study|Protocol Violation|1|||
164546460|NCT01439282|594372727|FG000|Overall Study|Adverse Event|5|||
164546461|NCT01439282|594372728|FG001|Overall Study|Adverse Event|0|||
164546462|NCT01439282|594372727|FG000|Overall Study|Withdrawal by Subject|2|||
164546463|NCT01439282|594372728|FG001|Overall Study|Withdrawal by Subject|0|||
164546464|NCT01439282|594372727|FG000|Overall Study|Other|1|||
164546465|NCT01439282|594372728|FG001|Overall Study|Other|1|||
164546466|NCT00980200|594372730|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
164546467|NCT00980200|594372731|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
164546468|NCT00980200|594372732|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
164546469|NCT00980200|594372733|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
164546470|NCT00980200|594372734|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
164546471|NCT00980200|594372730|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
164546472|NCT00980200|594372731|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
164546473|NCT00980200|594372732|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
164546474|NCT00980200|594372733|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
164546475|NCT00980200|594372734|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
164546476|NCT01617460|594372735|FG000|Overall Study|Adverse Event|10|||
164546477|NCT01617460|594372735|FG000|Overall Study|Physician Decision|16|||
164546478|NCT01617460|594372735|FG000|Overall Study|Protocol Violation|5|||
164546479|NCT01617460|594372735|FG000|Overall Study|Withdrawal by Subject|9|||
164546480|NCT02966509|594372736|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
164546481|NCT02966509|594372737|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
164546482|NCT02966509|594372736|FG000|Baseline Satisfaction Survey|Death|0|||
164546483|NCT02966509|594372737|FG001|Baseline Satisfaction Survey|Death|1|||
164546484|NCT02966509|594372736|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
164546485|NCT02966509|594372737|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
164546486|NCT02966509|594372736|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
164546487|NCT02966509|594372737|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
164546488|NCT02966509|594372736|FG000|6 Month Satisfaction Decision Survey|Death|22|||
164546489|NCT02966509|594372737|FG001|6 Month Satisfaction Decision Survey|Death|25|||
164546490|NCT02966509|594372736|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
164546491|NCT02966509|594372737|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
164546492|NCT02966509|594372736|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
164546493|NCT02966509|594372737|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
164546494|NCT02966509|594372736|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
164546495|NCT02966509|594372737|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
164546496|NCT02966509|594372736|FG000|6 Month Satisfaction Survey|Death|36|||
164546497|NCT02966509|594372737|FG001|6 Month Satisfaction Survey|Death|33|||
164546498|NCT02966509|594372736|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
164546499|NCT02966509|594372737|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
164546500|NCT02966509|594372736|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
164546501|NCT02966509|594372737|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
164546502|NCT02966509|594372736|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
164546503|NCT02966509|594372737|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
164546504|NCT02966509|594372736|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
164546505|NCT02966509|594372737|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
164546506|NCT02966509|594372736|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
164546507|NCT02966509|594372737|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
164546508|NCT02982954|594372738|FG000|Overall Study|Death|55|||
164546509|NCT02982954|594372739|FG001|Overall Study|Death|29|||
164546510|NCT02982954|594372740|FG002|Overall Study|Death|15|||
164546511|NCT02982954|594372741|FG003|Overall Study|Death|20|||
164546512|NCT02982954|594372738|FG000|Overall Study|Lost to Follow-up|2|||
164546513|NCT02982954|594372739|FG001|Overall Study|Lost to Follow-up|1|||
164546514|NCT02982954|594372740|FG002|Overall Study|Lost to Follow-up|0|||
164546515|NCT02982954|594372741|FG003|Overall Study|Lost to Follow-up|0|||
164546516|NCT02982954|594372738|FG000|Overall Study|Participant withdrew consent|7|||
164546517|NCT02982954|594372739|FG001|Overall Study|Participant withdrew consent|5|||
164546518|NCT02982954|594372740|FG002|Overall Study|Participant withdrew consent|1|||
164546519|NCT02982954|594372741|FG003|Overall Study|Participant withdrew consent|1|||
164546520|NCT02982954|594372738|FG000|Overall Study|Other reasons|42|||
164546521|NCT02982954|594372739|FG001|Overall Study|Other reasons|17|||
164546522|NCT02982954|594372740|FG002|Overall Study|Other reasons|12|||
164546523|NCT02982954|594372741|FG003|Overall Study|Other reasons|3|||
164546524|NCT02982954|594372738|FG000|Overall Study|Premature site closure|0|||
164546525|NCT02982954|594372739|FG001|Overall Study|Premature site closure|0|||
164546526|NCT02982954|594372740|FG002|Overall Study|Premature site closure|0|||
164546527|NCT02982954|594372741|FG003|Overall Study|Premature site closure|1|||
164546528|NCT02603120|594372742|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
164546529|NCT02603120|594372743|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
164546530|NCT02603120|594372742|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
164546531|NCT02603120|594372743|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
164546532|NCT02603120|594372742|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
164546533|NCT02603120|594372743|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
164546534|NCT02603120|594372742|FG000|Double-Blind Treatment Phase|Death|2|||
164546535|NCT02603120|594372743|FG001|Double-Blind Treatment Phase|Death|0|||
164546536|NCT02603120|594372742|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
164546537|NCT02603120|594372743|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
164546538|NCT02603120|594372742|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
164546539|NCT02603120|594372743|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
164546540|NCT02603120|594372742|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
164546541|NCT02603120|594372743|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
164546542|NCT02603120|594372742|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
164546543|NCT02603120|594372743|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
164546544|NCT02603120|594372742|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
164546545|NCT02603120|594372743|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
164546546|NCT02603120|594372742|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
164546547|NCT02603120|594372743|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
164546548|NCT02603120|594372742|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
164546549|NCT02603120|594372743|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
164546550|NCT02603120|594372742|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
164546551|NCT02603120|594372743|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
164546552|NCT02603120|594372742|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
164546553|NCT02603120|594372743|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
164546554|NCT02603120|594372742|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
164546555|NCT02603120|594372743|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
164546556|NCT00916357|594372745|FG000|Period 1|Withdrawal by Subject|1|||
164546557|NCT00916357|594372746|FG001|Period 1|Withdrawal by Subject|0|||
164546558|NCT00916357|594372747|FG002|Period 1|Withdrawal by Subject|0|||
164546559|NCT00916357|594372748|FG003|Period 1|Withdrawal by Subject|0|||
164546560|NCT00916357|594372749|FG004|Period 1|Withdrawal by Subject|0|||
164546561|NCT00916357|594372750|FG005|Period 1|Withdrawal by Subject|0|||
164546562|NCT00916357|594372745|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
164546563|NCT00916357|594372746|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
164546564|NCT00916357|594372747|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
164546565|NCT00916357|594372748|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
164546566|NCT00916357|594372749|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
164546567|NCT00916357|594372750|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
164546568|NCT03810781|594372754|FG000|Overall Study|COVID shut down|2|||
164546569|NCT03807349|594372757|FG000|Overall Study|Early Study Termination|9|||
164546570|NCT00094770|594372758|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
164546571|NCT00094770|594372759|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
164546572|NCT00094770|594372758|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
164546573|NCT00094770|594372759|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
164546574|NCT00094770|594372758|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
164546575|NCT00094770|594372759|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
164546576|NCT00094770|594372758|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
164546577|NCT00094770|594372759|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
164546578|NCT00094770|594372758|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
164546579|NCT00094770|594372759|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
164546580|NCT00094770|594372758|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
164546581|NCT00094770|594372759|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
164546582|NCT00094770|594372758|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
164546583|NCT00094770|594372759|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
164546584|NCT00094770|594372758|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
164546585|NCT00094770|594372759|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
164546586|NCT00094770|594372758|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
164546587|NCT00094770|594372759|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
164546588|NCT00094770|594372758|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
164546589|NCT00094770|594372759|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
164546590|NCT00094770|594372758|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
164546591|NCT00094770|594372759|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
164546592|NCT00094770|594372758|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
164546593|NCT00094770|594372759|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
164546594|NCT00094770|594372758|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
164546595|NCT00094770|594372759|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
164546596|NCT00094770|594372758|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
164546597|NCT00094770|594372759|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
164546598|NCT00094770|594372758|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
164546599|NCT00094770|594372759|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
164546600|NCT00094770|594372758|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
164546601|NCT00094770|594372759|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
164546602|NCT00094770|594372758|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
164546603|NCT00094770|594372759|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
164546604|NCT00094770|594372758|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
164546605|NCT00094770|594372759|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
164194530|NCT00255164|593079470|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
164546606|NCT00424749|594372761|FG000|Overall Study|Withdrawal by Subject|1|||
164546607|NCT04109222|594372762|FG000|Overall Study|Adverse Event|1|||
164546608|NCT04109222|594372763|FG001|Overall Study|Adverse Event|0|||
164546609|NCT04109222|594372764|FG002|Overall Study|Adverse Event|0|||
164546610|NCT01111851|594372768|FG000|Overall Study|All planned PET scans were not obtained.|2|||
164546611|NCT01111851|594372769|FG001|Overall Study|All planned PET scans were not obtained.|0|||
164546612|NCT05500274|594372770|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
164546613|NCT05500274|594372771|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
164546614|NCT05500274|594372770|FG000|Overall Study|Lost to Follow-up|76|||
164546615|NCT05500274|594372771|FG001|Overall Study|Lost to Follow-up|51|||
164546616|NCT00596947|594372772|FG000|Overall Study|study halted due to low enrollment|5|||
164546617|NCT00596947|594372773|FG001|Overall Study|study halted due to low enrollment|3|||
164546618|NCT00596947|594372772|FG000|Overall Study|Lost to Follow-up|1|||
164546619|NCT00596947|594372773|FG001|Overall Study|Lost to Follow-up|0|||
164546620|NCT03000179|594372774|FG000|Overall Study|Lost to Follow-up|2|||
164546621|NCT00073528|594372781|FG000|Overall Study|Death|488|||
164546622|NCT00073528|594372782|FG001|Overall Study|Death|473|||
164546623|NCT00073528|594372781|FG000|Overall Study|Lost to Follow-up|52|||
164546624|NCT00073528|594372782|FG001|Overall Study|Lost to Follow-up|45|||
164546625|NCT00073528|594372781|FG000|Overall Study|Withdrawal by Subject|50|||
164546626|NCT00073528|594372782|FG001|Overall Study|Withdrawal by Subject|45|||
164546627|NCT00073528|594372781|FG000|Overall Study|Study terminated by Sponsor|10|||
164546628|NCT00073528|594372782|FG001|Overall Study|Study terminated by Sponsor|29|||
164546629|NCT00073528|594372781|FG000|Overall Study|Other|18|||
164546630|NCT00073528|594372782|FG001|Overall Study|Other|19|||
164546631|NCT00073528|594372781|FG000|Overall Study|Other|9|||
164546632|NCT00073528|594372782|FG001|Overall Study|Other|12|||
164546633|NCT00073528|594372781|FG000|Overall Study|Protocol Violation|3|||
164546634|NCT00073528|594372782|FG001|Overall Study|Protocol Violation|5|||
164546635|NCT04037748|594372789|FG000|Treatment Period 1|Withdrawal by Subject|3|||
164546636|NCT04037748|594372790|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164546637|NCT04037748|594372789|FG000|Treatment Period 1|Adverse Event|1|||
164546638|NCT04037748|594372790|FG001|Treatment Period 1|Adverse Event|1|||
164546639|NCT04037748|594372789|FG000|Treatment Period 1|Protocol Violation|4|||
164546640|NCT04037748|594372790|FG001|Treatment Period 1|Protocol Violation|5|||
164546641|NCT04037748|594372789|FG000|Treatment Period 2|Adverse Event|0|||
164546642|NCT04037748|594372790|FG001|Treatment Period 2|Adverse Event|1|||
164546643|NCT04037748|594372789|FG000|Treatment Period 2|Protocol Violation|2|||
164546644|NCT04037748|594372790|FG001|Treatment Period 2|Protocol Violation|0|||
164546645|NCT00397033|594372795|FG000|Overall Study|Adverse Event|7|||
164546646|NCT00397033|594372796|FG001|Overall Study|Adverse Event|10|||
164546647|NCT00397033|594372797|FG002|Overall Study|Adverse Event|4|||
164546648|NCT00397033|594372795|FG000|Overall Study|Lack of Efficacy|22|||
164546649|NCT00397033|594372796|FG001|Overall Study|Lack of Efficacy|12|||
164546650|NCT00397033|594372797|FG002|Overall Study|Lack of Efficacy|9|||
164546651|NCT00397033|594372795|FG000|Overall Study|Lost to Follow-up|3|||
164546652|NCT00397033|594372796|FG001|Overall Study|Lost to Follow-up|3|||
164546653|NCT00397033|594372797|FG002|Overall Study|Lost to Follow-up|3|||
164546654|NCT00397033|594372795|FG000|Overall Study|Withdrawal by Subject|12|||
164546655|NCT00397033|594372796|FG001|Overall Study|Withdrawal by Subject|7|||
164546656|NCT00397033|594372797|FG002|Overall Study|Withdrawal by Subject|5|||
164546657|NCT00397033|594372795|FG000|Overall Study|Other|0|||
164546658|NCT00397033|594372796|FG001|Overall Study|Other|5|||
164546659|NCT00397033|594372797|FG002|Overall Study|Other|2|||
164546660|NCT01721057|594372798|FG000|Treatment Period|Withdrawal by Subject|11|||
164546661|NCT01721057|594372799|FG001|Treatment Period|Withdrawal by Subject|5|||
164546662|NCT01721057|594372800|FG002|Treatment Period|Withdrawal by Subject|8|||
164653632|NCT03124381|594757242|FG001|Overall Study|Protocol Violation|1|||
164653633|NCT03124381|594757241|FG000|Overall Study|Adverse Event|1|||
164546663|NCT01721057|594372801|FG003|Treatment Period|Withdrawal by Subject|0|||
164546664|NCT01721057|594372802|FG004|Treatment Period|Withdrawal by Subject|0|||
164653634|NCT03124381|594757242|FG001|Overall Study|Adverse Event|1|||
164546665|NCT01721057|594372803|FG005|Treatment Period|Withdrawal by Subject|0|||
164546666|NCT01721057|594372804|FG006|Treatment Period|Withdrawal by Subject|0|||
164546667|NCT01721057|594372798|FG000|Treatment Period|Adverse Event|7|||
164546668|NCT01721057|594372799|FG001|Treatment Period|Adverse Event|10|||
164546669|NCT01721057|594372800|FG002|Treatment Period|Adverse Event|12|||
164546670|NCT01721057|594372801|FG003|Treatment Period|Adverse Event|0|||
164546671|NCT01721057|594372802|FG004|Treatment Period|Adverse Event|0|||
164546672|NCT01721057|594372803|FG005|Treatment Period|Adverse Event|0|||
164546673|NCT01721057|594372804|FG006|Treatment Period|Adverse Event|0|||
164546674|NCT01721057|594372798|FG000|Treatment Period|Lack of Efficacy|7|||
164546675|NCT01721057|594372799|FG001|Treatment Period|Lack of Efficacy|3|||
164546676|NCT01721057|594372800|FG002|Treatment Period|Lack of Efficacy|0|||
164546677|NCT01721057|594372801|FG003|Treatment Period|Lack of Efficacy|0|||
164546678|NCT01721057|594372802|FG004|Treatment Period|Lack of Efficacy|0|||
164546679|NCT01721057|594372803|FG005|Treatment Period|Lack of Efficacy|0|||
164546680|NCT01721057|594372804|FG006|Treatment Period|Lack of Efficacy|0|||
164546681|NCT01721057|594372798|FG000|Treatment Period|Lost to Follow-up|1|||
164546682|NCT01721057|594372799|FG001|Treatment Period|Lost to Follow-up|0|||
164546683|NCT01721057|594372800|FG002|Treatment Period|Lost to Follow-up|0|||
164546684|NCT01721057|594372801|FG003|Treatment Period|Lost to Follow-up|0|||
164546685|NCT01721057|594372802|FG004|Treatment Period|Lost to Follow-up|0|||
164546686|NCT01721057|594372803|FG005|Treatment Period|Lost to Follow-up|0|||
164546687|NCT01721057|594372804|FG006|Treatment Period|Lost to Follow-up|0|||
164546688|NCT01721057|594372798|FG000|Treatment Period|Physician Decision|0|||
164546689|NCT01721057|594372799|FG001|Treatment Period|Physician Decision|1|||
164546690|NCT01721057|594372800|FG002|Treatment Period|Physician Decision|3|||
164546691|NCT01721057|594372801|FG003|Treatment Period|Physician Decision|0|||
164546692|NCT01721057|594372802|FG004|Treatment Period|Physician Decision|0|||
164546693|NCT01721057|594372803|FG005|Treatment Period|Physician Decision|0|||
164546694|NCT01721057|594372804|FG006|Treatment Period|Physician Decision|0|||
164546695|NCT01721057|594372798|FG000|Treatment Period|Death|2|||
164546696|NCT01721057|594372799|FG001|Treatment Period|Death|0|||
164546697|NCT01721057|594372800|FG002|Treatment Period|Death|0|||
164546698|NCT01721057|594372801|FG003|Treatment Period|Death|0|||
164546699|NCT01721057|594372802|FG004|Treatment Period|Death|0|||
164546700|NCT01721057|594372803|FG005|Treatment Period|Death|0|||
164546701|NCT01721057|594372804|FG006|Treatment Period|Death|0|||
164546702|NCT01721057|594372798|FG000|Rescue Period|Adverse Event|0|||
164546703|NCT01721057|594372799|FG001|Rescue Period|Adverse Event|0|||
164546704|NCT01721057|594372800|FG002|Rescue Period|Adverse Event|0|||
164546705|NCT01721057|594372801|FG003|Rescue Period|Adverse Event|1|||
164546706|NCT01721057|594372802|FG004|Rescue Period|Adverse Event|0|||
164546707|NCT01721057|594372803|FG005|Rescue Period|Adverse Event|0|||
164546708|NCT01721057|594372804|FG006|Rescue Period|Adverse Event|0|||
164546709|NCT01721057|594372798|FG000|Rescue Period|Lack of Efficacy|0|||
164546710|NCT01721057|594372799|FG001|Rescue Period|Lack of Efficacy|0|||
164546711|NCT01721057|594372800|FG002|Rescue Period|Lack of Efficacy|0|||
164546712|NCT01721057|594372801|FG003|Rescue Period|Lack of Efficacy|2|||
164546713|NCT01721057|594372802|FG004|Rescue Period|Lack of Efficacy|0|||
164546714|NCT01721057|594372803|FG005|Rescue Period|Lack of Efficacy|0|||
164546715|NCT01721057|594372804|FG006|Rescue Period|Lack of Efficacy|0|||
164546716|NCT04702737|594372805|FG000|Overall Study|Decision by Sponsor|1|||
164546717|NCT04702737|594372805|FG000|Overall Study|Withdrawal of Consent from Study|3|||
164546718|NCT04702737|594372805|FG000|Overall Study|Lost to Follow-up|1|||
164546719|NCT04702737|594372805|FG000|Overall Study|Death|35|||
164546720|NCT02064920|594372808|FG000|Overall Study|Adverse Event|0|||
164546721|NCT02064920|594372809|FG001|Overall Study|Adverse Event|4|||
164546722|NCT02064920|594372808|FG000|Overall Study|Physician Decision|0|||
164546723|NCT02064920|594372809|FG001|Overall Study|Physician Decision|1|||
164546724|NCT02064920|594372808|FG000|Overall Study|Technical Problems|0|||
164546725|NCT02064920|594372809|FG001|Overall Study|Technical Problems|1|||
164546726|NCT02064920|594372808|FG000|Overall Study|Withdrawal by Subject|1|||
164546727|NCT02064920|594372809|FG001|Overall Study|Withdrawal by Subject|3|||
164653635|NCT03124381|594757241|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
164653636|NCT03124381|594757242|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
164546728|NCT02109562|594372810|FG000|Overall Study|Insufficient clinical response|2|||
164546729|NCT02109562|594372811|FG001|Overall Study|Insufficient clinical response|0|||
164546730|NCT02109562|594372812|FG002|Overall Study|Insufficient clinical response|4|||
164546731|NCT02109562|594372810|FG000|Overall Study|Adverse Event|0|||
164546732|NCT02109562|594372811|FG001|Overall Study|Adverse Event|2|||
164546733|NCT02109562|594372812|FG002|Overall Study|Adverse Event|3|||
164546734|NCT02109562|594372810|FG000|Overall Study|Lost to Follow-up|1|||
164546735|NCT02109562|594372811|FG001|Overall Study|Lost to Follow-up|0|||
164546736|NCT02109562|594372812|FG002|Overall Study|Lost to Follow-up|1|||
164546737|NCT02109562|594372810|FG000|Overall Study|Protocol Violation|0|||
164546738|NCT02109562|594372811|FG001|Overall Study|Protocol Violation|3|||
164546739|NCT02109562|594372812|FG002|Overall Study|Protocol Violation|1|||
164546740|NCT02109562|594372810|FG000|Overall Study|Withdrawal by Subject|20|||
164546741|NCT02109562|594372811|FG001|Overall Study|Withdrawal by Subject|25|||
164546742|NCT02109562|594372812|FG002|Overall Study|Withdrawal by Subject|21|||
164546743|NCT02109562|594372810|FG000|Overall Study|Physician Decision|3|||
164546744|NCT02109562|594372811|FG001|Overall Study|Physician Decision|4|||
164546745|NCT02109562|594372812|FG002|Overall Study|Physician Decision|5|||
164546746|NCT04425720|594372813|FG000|Overall Study|Withdrawal by Subject|0|||
164546747|NCT04425720|594372814|FG001|Overall Study|Withdrawal by Subject|20|||
164546748|NCT00807742|594372815|FG000|Overall Study|Death|9|||
164546749|NCT00807742|594372816|FG001|Overall Study|Death|2|||
164546750|NCT00807742|594372815|FG000|Overall Study|Withdrawal by Subject|2|||
164546751|NCT00807742|594372816|FG001|Overall Study|Withdrawal by Subject|1|||
164546752|NCT00807742|594372815|FG000|Overall Study|Lost to Follow-up|35|||
164546753|NCT00807742|594372816|FG001|Overall Study|Lost to Follow-up|51|||
164546754|NCT02044133|594372817|FG000|Overall Study|Lost to Follow-up|1|||
164546755|NCT02044133|594372818|FG001|Overall Study|Lost to Follow-up|1|||
164546756|NCT02044133|594372817|FG000|Overall Study|Death|1|||
164546757|NCT02044133|594372818|FG001|Overall Study|Death|0|||
164546758|NCT02044133|594372817|FG000|Overall Study|Release|3|||
164546759|NCT02044133|594372818|FG001|Overall Study|Release|4|||
164546760|NCT02044133|594372817|FG000|Overall Study|Transfer|1|||
164546761|NCT02044133|594372818|FG001|Overall Study|Transfer|0|||
164546762|NCT02044133|594372817|FG000|Overall Study|refusal of blood sampling|0|||
164546763|NCT02044133|594372818|FG001|Overall Study|refusal of blood sampling|1|||
164546764|NCT04085523|594372819|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
164546765|NCT04085523|594372820|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
164546766|NCT04085523|594372821|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
164546767|NCT04085523|594372822|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
164546768|NCT04085523|594372823|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
164546769|NCT04085523|594372824|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
164546770|NCT05318937|594372829|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164546771|NCT05318937|594372830|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164546772|NCT05318937|594372829|FG000|Overall Study|Lost to Follow-up|0|||
164546773|NCT05318937|594372830|FG001|Overall Study|Lost to Follow-up|1|||
164546774|NCT05318937|594372829|FG000|Overall Study|Withdrawal by Subject|0|||
164546775|NCT05318937|594372830|FG001|Overall Study|Withdrawal by Subject|2|||
164546776|NCT05318937|594372829|FG000|Overall Study|Protocol Violation|0|||
164546777|NCT05318937|594372830|FG001|Overall Study|Protocol Violation|1|||
164546778|NCT04722042|594372831|FG000|Overall Study|Withdrawal by Subject|2|||
164546779|NCT04722042|594372832|FG001|Overall Study|Withdrawal by Subject|1|||
164546780|NCT04722042|594372833|FG002|Overall Study|Withdrawal by Subject|0|||
164546781|NCT02046096|594372841|FG000|Overall Study|Death|28|||
164546782|NCT02046096|594372842|FG001|Overall Study|Death|45|||
164546783|NCT02046096|594372841|FG000|Overall Study|Lost to Follow-up|9|||
164546784|NCT02046096|594372842|FG001|Overall Study|Lost to Follow-up|20|||
164546785|NCT02046096|594372841|FG000|Overall Study|Withdrawal by Subject|5|||
164546786|NCT02046096|594372842|FG001|Overall Study|Withdrawal by Subject|17|||
164546787|NCT02046096|594372841|FG000|Overall Study|Other endpoint|2|||
164546788|NCT02046096|594372842|FG001|Overall Study|Other endpoint|19|||
164546789|NCT04969276|594372843|FG000|Overall Study|Protocol Deviation|0|||
164546790|NCT04969276|594372844|FG001|Overall Study|Protocol Deviation|1|||
164546791|NCT04969276|594372845|FG002|Overall Study|Protocol Deviation|0|||
164546792|NCT04969276|594372843|FG000|Overall Study|Withdrawal by Subject|1|||
164546793|NCT04969276|594372844|FG001|Overall Study|Withdrawal by Subject|10|||
164546794|NCT04969276|594372845|FG002|Overall Study|Withdrawal by Subject|0|||
164546795|NCT04969276|594372843|FG000|Overall Study|Lost to Follow-up|0|||
164546796|NCT04969276|594372844|FG001|Overall Study|Lost to Follow-up|1|||
164546797|NCT04969276|594372845|FG002|Overall Study|Lost to Follow-up|0|||
164546798|NCT00853749|594372851|FG000|Overall Study|Lost to Follow-up|0|||
164546799|NCT00853749|594372852|FG001|Overall Study|Lost to Follow-up|1|||
164546800|NCT00687440|594372853|FG000|Overall Study|Adverse Event|3|||
164546801|NCT00687440|594372853|FG000|Overall Study|Lost to Follow-up|3|||
164546802|NCT00687440|594372853|FG000|Overall Study|Lack of Efficacy|2|||
164546803|NCT00687440|594372853|FG000|Overall Study|Death|2|||
164546804|NCT00687440|594372853|FG000|Overall Study|Other|1|||
164546805|NCT00687440|594372853|FG000|Overall Study|Missing|1|||
164546806|NCT00430482|594372855|FG000|Completed Treatment|Insufficient Treatment|7|||
164546807|NCT00430482|594372856|FG001|Completed Treatment|Insufficient Treatment|11|||
164194531|NCT00255164|593079471|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
164546808|NCT00583024|594372859|FG000|Overall Study|Lost to Follow-up|4|||
164546809|NCT04259411|594374022|FG000|Overall Study|Death|1|||
164546810|NCT04259411|594374022|FG000|Overall Study|Missed visit|2|||
164546811|NCT00766038|594374025|FG000|Overall Study|Lost to Follow-up|15|||
164546812|NCT00766038|594374026|FG001|Overall Study|Lost to Follow-up|14|||
164546813|NCT00449670|594374027|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
164546814|NCT00449670|594374028|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
164546815|NCT00449670|594374027|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
164546816|NCT00449670|594374028|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
164546817|NCT00449670|594374027|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
164653637|NCT02473510|594757245|FG000|Overall Study|Lost to Follow-up|1|||
164546818|NCT00449670|594374028|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
164546819|NCT00449670|594374027|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
164546820|NCT00449670|594374028|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
164546821|NCT00449670|594374027|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
164546822|NCT00449670|594374028|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
164546823|NCT00449670|594374027|FG000|Booster Phase (Study no.109873)|Other|0|||
164546824|NCT00449670|594374028|FG001|Booster Phase (Study no.109873)|Other|2|||
164546825|NCT01502709|594374032|FG000|Overall Study|Lost to Follow-up|4|||
164546826|NCT01502709|594374033|FG001|Overall Study|Lost to Follow-up|0|||
164546827|NCT03703882|594374034|FG000|Overall Study|Adverse Event|1|||
164546828|NCT03703882|594374035|FG001|Overall Study|Adverse Event|0|||
164546829|NCT03703882|594374034|FG000|Overall Study|Lost to Follow-up|0|||
164546830|NCT03703882|594374035|FG001|Overall Study|Lost to Follow-up|2|||
164546831|NCT03703882|594374034|FG000|Overall Study|Non-compliance with study drug|0|||
164546832|NCT03703882|594374035|FG001|Overall Study|Non-compliance with study drug|1|||
164546833|NCT03703882|594374034|FG000|Overall Study|Physician Decision|0|||
164546834|NCT03703882|594374035|FG001|Overall Study|Physician Decision|1|||
164546835|NCT03703882|594374034|FG000|Overall Study|Progressive disease|1|||
164546836|NCT03703882|594374035|FG001|Overall Study|Progressive disease|0|||
164546837|NCT03703882|594374034|FG000|Overall Study|Withdrawal by parent/guardian|1|||
164546838|NCT03703882|594374035|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164546839|NCT03703882|594374034|FG000|Overall Study|Starting another treatment|0|||
164546840|NCT03703882|594374035|FG001|Overall Study|Starting another treatment|1|||
164546841|NCT03703882|594374034|FG000|Overall Study|noncompliance with study procedures|0|||
164546842|NCT03703882|594374035|FG001|Overall Study|noncompliance with study procedures|1|||
164546843|NCT02263079|594374043|FG000|Overall Study|Physician Decision|1|||
164546844|NCT02263079|594374044|FG001|Overall Study|Physician Decision|0|||
164546845|NCT02263079|594374045|FG002|Overall Study|Physician Decision|0|||
164546846|NCT02263079|594374043|FG000|Overall Study|Withdrawal by Subject|2|||
164546847|NCT02263079|594374044|FG001|Overall Study|Withdrawal by Subject|8|||
164546848|NCT02263079|594374045|FG002|Overall Study|Withdrawal by Subject|0|||
164546849|NCT00840086|594374046|FG000|Overall Study|Adverse Event|1|||
164546850|NCT00840086|594374046|FG000|Overall Study|Protocol Violation|2|||
164546851|NCT00840086|594374046|FG000|Overall Study|Lost to Follow-up|1|||
164546852|NCT03332498|594374047|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
164546853|NCT03332498|594374048|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
164546854|NCT03332498|594374049|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
164546855|NCT00253643|594374052|FG000|Overall Study|Withdrawal by Subject|0|||
164546856|NCT00253643|594374053|FG001|Overall Study|Withdrawal by Subject|0|||
164546857|NCT00253643|594374054|FG002|Overall Study|Withdrawal by Subject|1|||
164546858|NCT00253643|594374055|FG003|Overall Study|Withdrawal by Subject|1|||
164546859|NCT00253643|594374052|FG000|Overall Study|Non-Compliance|0|||
164546860|NCT00253643|594374053|FG001|Overall Study|Non-Compliance|0|||
164546861|NCT00253643|594374054|FG002|Overall Study|Non-Compliance|0|||
164546862|NCT00253643|594374055|FG003|Overall Study|Non-Compliance|2|||
164546863|NCT05807464|594374058|FG000|Overall Study|Adverse Event|1|||
164546864|NCT04451161|594374061|FG000|Overall Study|Lost to Follow-up|28|||
164546865|NCT04451161|594374062|FG001|Overall Study|Lost to Follow-up|37|||
164546866|NCT04451161|594374063|FG002|Overall Study|Lost to Follow-up|22|||
164546867|NCT04451161|594374064|FG003|Overall Study|Lost to Follow-up|13|||
164546868|NCT04451161|594374065|FG004|Overall Study|Lost to Follow-up|11|||
164546869|NCT04451161|594374066|FG005|Overall Study|Lost to Follow-up|14|||
164546870|NCT04451161|594374061|FG000|Overall Study|Withdrawal by Subject|3|||
164546871|NCT04451161|594374062|FG001|Overall Study|Withdrawal by Subject|0|||
164546872|NCT04451161|594374063|FG002|Overall Study|Withdrawal by Subject|0|||
164546873|NCT04451161|594374064|FG003|Overall Study|Withdrawal by Subject|0|||
164546874|NCT04451161|594374065|FG004|Overall Study|Withdrawal by Subject|2|||
164546875|NCT04451161|594374066|FG005|Overall Study|Withdrawal by Subject|4|||
164546876|NCT03596866|594374067|FG000|Overall Study|Site terminated by Sponsor|64|||
164546877|NCT03596866|594374068|FG001|Overall Study|Site terminated by Sponsor|65|||
164194532|NCT00255164|593079472|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
164546878|NCT03596866|594374067|FG000|Overall Study|Death|37|||
164546879|NCT03596866|594374068|FG001|Overall Study|Death|24|||
164546880|NCT03596866|594374067|FG000|Overall Study|Withdrawal by Subject|4|||
164546881|NCT03596866|594374068|FG001|Overall Study|Withdrawal by Subject|6|||
164546882|NCT03596866|594374067|FG000|Overall Study|Missing|0|||
164546883|NCT03596866|594374068|FG001|Overall Study|Missing|6|||
164546884|NCT03596866|594374067|FG000|Overall Study|Lost to Follow-up|2|||
164546885|NCT03596866|594374068|FG001|Overall Study|Lost to Follow-up|3|||
164546886|NCT03596866|594374067|FG000|Overall Study|Protocol Violation|1|||
164546887|NCT03596866|594374068|FG001|Overall Study|Protocol Violation|0|||
164546888|NCT03596866|594374067|FG000|Overall Study|Reason Not Specified|14|||
164546889|NCT03596866|594374068|FG001|Overall Study|Reason Not Specified|13|||
164546890|NCT04770532|594374069|FG000|Overall Study|Withdrawal by Subject|0|||
164546891|NCT04770532|594374070|FG001|Overall Study|Withdrawal by Subject|3|||
164546892|NCT04770532|594374069|FG000|Overall Study|Physician Decision|1|||
164546893|NCT04770532|594374070|FG001|Overall Study|Physician Decision|0|||
164546894|NCT04770532|594374069|FG000|Overall Study|Death|2|||
164546895|NCT04770532|594374070|FG001|Overall Study|Death|2|||
164546896|NCT04206605|594374074|FG000|Overall Study|Adverse Event|0|||
164546897|NCT04206605|594374075|FG001|Overall Study|Adverse Event|1|||
164546898|NCT04206605|594374074|FG000|Overall Study|Withdrawal by Subject|1|||
164546899|NCT04206605|594374075|FG001|Overall Study|Withdrawal by Subject|0|||
164546900|NCT00003702|594374081|FG000|Overall Study|Ineligible cell types|2|||
164546901|NCT00003702|594374082|FG001|Overall Study|Ineligible cell types|2|||
164546902|NCT00003702|594374081|FG000|Overall Study|Did not meet criteria for persistence|8|||
164546903|NCT00003702|594374082|FG001|Overall Study|Did not meet criteria for persistence|5|||
164546904|NCT00003702|594374081|FG000|Overall Study|WHO score > 6|2|||
164546905|NCT00003702|594374082|FG001|Overall Study|WHO score > 6|1|||
164546906|NCT00003702|594374081|FG000|Overall Study|Inadequate documentation of disease|1|||
164546907|NCT00003702|594374082|FG001|Overall Study|Inadequate documentation of disease|3|||
164546908|NCT00843518|594374083|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
164546909|NCT00843518|594374084|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
164546910|NCT00843518|594374083|FG000|Period 2 (Double-blind Treatment)|Death|0|||
164546911|NCT00843518|594374084|FG001|Period 2 (Double-blind Treatment)|Death|1|||
164546912|NCT00843518|594374083|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
164546913|NCT00843518|594374084|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
164546914|NCT00843518|594374083|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
164546915|NCT00843518|594374084|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
164546916|NCT00843518|594374083|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
164546917|NCT00843518|594374084|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
164546918|NCT00843518|594374083|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
164546919|NCT00843518|594374084|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
164546920|NCT00843518|594374083|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
164546921|NCT00843518|594374084|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
164546922|NCT00827606|594374085|FG000|Overall Study|Protocol Violation|4|||
164546923|NCT00827606|594374086|FG001|Overall Study|Protocol Violation|3|||
164546924|NCT00827606|594374085|FG000|Overall Study|Lost to Follow-up|3|||
164546925|NCT00827606|594374086|FG001|Overall Study|Lost to Follow-up|1|||
164546926|NCT00827606|594374085|FG000|Overall Study|Withdrawal by Subject|7|||
164546927|NCT00827606|594374086|FG001|Overall Study|Withdrawal by Subject|6|||
164546928|NCT00827606|594374085|FG000|Overall Study|Pregnancy|0|||
164546929|NCT00827606|594374086|FG001|Overall Study|Pregnancy|1|||
164546930|NCT00827606|594374085|FG000|Overall Study|Other|5|||
164546931|NCT00827606|594374086|FG001|Overall Study|Other|13|||
164546932|NCT00827606|594374085|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
164546933|NCT00827606|594374086|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
164546934|NCT00827606|594374085|FG000|Overall Study|Adverse Event|4|||
164546935|NCT00827606|594374086|FG001|Overall Study|Adverse Event|2|||
164546936|NCT00243386|594374089|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
164546937|NCT00243386|594374090|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
164546938|NCT00243386|594374091|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
164546939|NCT00243386|594374089|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
164546940|NCT00243386|594374090|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
164546941|NCT00243386|594374091|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
164546942|NCT00243386|594374089|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
164546943|NCT00243386|594374090|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
164546944|NCT00243386|594374091|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
164546945|NCT00243386|594374089|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
164546946|NCT00243386|594374090|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
164546947|NCT00243386|594374091|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
164546948|NCT00243386|594374089|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
164546949|NCT00243386|594374090|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
164546950|NCT00243386|594374091|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
164546951|NCT00243386|594374089|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
164546952|NCT00243386|594374090|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
164546953|NCT00243386|594374091|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
164546954|NCT00243386|594374089|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
164546955|NCT00243386|594374090|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
164546956|NCT00243386|594374091|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
164546957|NCT00243386|594374089|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
164546958|NCT00243386|594374090|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
164546959|NCT00243386|594374091|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
164546960|NCT04995055|594374092|FG000|Period 1|COVID-19 Related|1|||
164546961|NCT04995055|594374093|FG001|Period 1|COVID-19 Related|0|||
164546962|NCT04995055|594374092|FG000|Period 1|Withdrawal by Subject|0|||
164546963|NCT04995055|594374093|FG001|Period 1|Withdrawal by Subject|1|||
164546964|NCT04995055|594374092|FG000|Period 1|Subject discontinued due to timing|4|||
164546965|NCT04995055|594374093|FG001|Period 1|Subject discontinued due to timing|4|||
164546966|NCT03418129|594374094|FG000|Overall Study|Lost to Follow-up|11|||
164546967|NCT03418129|594374095|FG001|Overall Study|Lost to Follow-up|20|||
164546968|NCT03418129|594374096|FG002|Overall Study|Lost to Follow-up|15|||
164546969|NCT03418129|594374094|FG000|Overall Study|Withdrawal by Subject|3|||
164546970|NCT03418129|594374095|FG001|Overall Study|Withdrawal by Subject|6|||
164546971|NCT03418129|594374096|FG002|Overall Study|Withdrawal by Subject|4|||
164546972|NCT02664272|594374097|FG000|Overall Study|Fluoroscopic images not made available|2|||
164546973|NCT03073980|594374098|FG000|Overall Study|Lost to Follow-up|10|||
164546974|NCT03073980|594374099|FG001|Overall Study|Lost to Follow-up|2|||
164546975|NCT03073980|594374100|FG002|Overall Study|Lost to Follow-up|9|||
164546976|NCT03073980|594374098|FG000|Overall Study|No post-procedure data|0|||
164546977|NCT03073980|594374099|FG001|Overall Study|No post-procedure data|0|||
164546978|NCT03073980|594374100|FG002|Overall Study|No post-procedure data|2|||
164546979|NCT04810689|594374101|FG000|Overall Study|Withdrawal by Subject|0|||
164546980|NCT04810689|594374102|FG001|Overall Study|Withdrawal by Subject|1|||
164546981|NCT01940471|594374103|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
164546982|NCT01940471|594374104|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
164546983|NCT01940471|594374105|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
164546984|NCT01940471|594374106|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
164546985|NCT01940471|594374103|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
164546986|NCT01940471|594374104|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
164546987|NCT01940471|594374105|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
164546988|NCT01940471|594374106|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
164546989|NCT01940471|594374103|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
164546990|NCT01940471|594374104|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
164546991|NCT01940471|594374105|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
164546992|NCT01940471|594374106|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
164546993|NCT01940471|594374103|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
164546994|NCT01940471|594374104|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
164546995|NCT01940471|594374105|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
164546996|NCT01940471|594374106|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
164546997|NCT01940471|594374103|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
164546998|NCT01940471|594374104|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
164546999|NCT01940471|594374105|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
164547000|NCT01940471|594374106|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
164547001|NCT01940471|594374103|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
164547002|NCT01940471|594374104|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
164547003|NCT01940471|594374105|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
164547004|NCT01940471|594374106|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
164547005|NCT01940471|594374103|FG000|Period 1: Double-blind Phase|Death|2|||
164547006|NCT01940471|594374104|FG001|Period 1: Double-blind Phase|Death|1|||
164547007|NCT01940471|594374105|FG002|Period 1: Double-blind Phase|Death|0|||
164547008|NCT01940471|594374106|FG003|Period 1: Double-blind Phase|Death|0|||
164547009|NCT01940471|594374103|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
164547010|NCT01940471|594374104|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
164547011|NCT01940471|594374105|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
164547012|NCT01940471|594374106|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
164547013|NCT01940471|594374103|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
164547014|NCT01940471|594374104|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
164547015|NCT01940471|594374105|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
164547016|NCT01940471|594374106|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
164547017|NCT01940471|594374103|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
164547018|NCT01940471|594374104|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
164547019|NCT01940471|594374105|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
164547020|NCT01940471|594374106|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
164547021|NCT01940471|594374103|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
164547022|NCT01940471|594374104|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
164547023|NCT01940471|594374105|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
164547024|NCT01940471|594374106|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
164547025|NCT01940471|594374103|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
164547026|NCT01940471|594374104|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
164547027|NCT01940471|594374105|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
164547028|NCT01940471|594374106|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
164547029|NCT01940471|594374103|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
164547030|NCT01940471|594374104|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
164547031|NCT01940471|594374105|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
164547032|NCT01940471|594374106|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
164653638|NCT02473510|594757246|FG001|Overall Study|Lost to Follow-up|2|||
164547033|NCT01940471|594374103|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
164547034|NCT01940471|594374104|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
164547035|NCT01940471|594374105|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
164547036|NCT01940471|594374106|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
164547037|NCT01940471|594374103|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
164547038|NCT01940471|594374104|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
164547039|NCT01940471|594374105|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
164547040|NCT01940471|594374106|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
164547041|NCT01940471|594374103|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
164547042|NCT01940471|594374104|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
164547043|NCT01940471|594374105|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
164547044|NCT01940471|594374106|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
164547045|NCT01940471|594374103|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
164547046|NCT01940471|594374104|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
164547047|NCT01940471|594374105|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
164547048|NCT01940471|594374106|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
164547049|NCT01940471|594374103|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
164547050|NCT01940471|594374104|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
164547051|NCT01940471|594374105|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
164547052|NCT01940471|594374106|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
164547053|NCT01940471|594374103|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
164547054|NCT01940471|594374104|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
164547055|NCT01940471|594374105|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
164547056|NCT01940471|594374106|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
164547057|NCT01940471|594374103|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
164547058|NCT01940471|594374104|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
164547059|NCT01940471|594374105|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
164547060|NCT01940471|594374106|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
164547061|NCT01940471|594374103|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
164547062|NCT01940471|594374104|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
164547063|NCT01940471|594374105|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
164547064|NCT01940471|594374106|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
164547065|NCT01358760|594374107|FG000|Overall Study|Adverse Event|3|||
164547066|NCT01358760|594374108|FG001|Overall Study|Adverse Event|4|||
164547067|NCT01358760|594374109|FG002|Overall Study|Adverse Event|3|||
164547068|NCT01358760|594374107|FG000|Overall Study|Lost to Follow-up|1|||
164547069|NCT01358760|594374108|FG001|Overall Study|Lost to Follow-up|1|||
164547070|NCT01358760|594374109|FG002|Overall Study|Lost to Follow-up|3|||
164547071|NCT01358760|594374107|FG000|Overall Study|Withdrawal by Subject|5|||
164547072|NCT01358760|594374108|FG001|Overall Study|Withdrawal by Subject|3|||
164547073|NCT01358760|594374109|FG002|Overall Study|Withdrawal by Subject|2|||
164547074|NCT01358760|594374107|FG000|Overall Study|Physician Decision|1|||
164547075|NCT01358760|594374108|FG001|Overall Study|Physician Decision|0|||
164547076|NCT01358760|594374109|FG002|Overall Study|Physician Decision|1|||
164547077|NCT01358760|594374107|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
164547078|NCT01358760|594374108|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
164547079|NCT01358760|594374109|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
164547080|NCT04695392|594374110|FG000|Overall Study|Withdrawn by parent/guardian|0|||
164547081|NCT04695392|594374111|FG001|Overall Study|Withdrawn by parent/guardian|1|||
164547082|NCT04695392|594374110|FG000|Overall Study|Withdrawn by physician|0|||
164547083|NCT04695392|594374111|FG001|Overall Study|Withdrawn by physician|1|||
164547084|NCT01506960|594374114|FG000|Overall Study|Did not meet angiographic criteria|47|||
164547085|NCT00450723|594374115|FG000|Overall Study|Physician Decision|5|||
164547086|NCT01846624|594374116|FG000|Overall Study|Died during induction, no midostaurin|1|||
164547087|NCT01202279|594374121|FG000|Overall Study|Adverse Event|8|||
164547088|NCT01202279|594374122|FG001|Overall Study|Adverse Event|6|||
164547089|NCT01202279|594374121|FG000|Overall Study|Withdrawal by Subject|13|||
164547090|NCT01202279|594374122|FG001|Overall Study|Withdrawal by Subject|10|||
164547091|NCT01202279|594374121|FG000|Overall Study|Physician Decision|0|||
164547092|NCT01202279|594374122|FG001|Overall Study|Physician Decision|1|||
164547093|NCT01202279|594374121|FG000|Overall Study|Lost to Follow-up|10|||
164547094|NCT01202279|594374122|FG001|Overall Study|Lost to Follow-up|7|||
164547095|NCT01202279|594374121|FG000|Overall Study|Protocol Violation|1|||
164547096|NCT01202279|594374122|FG001|Overall Study|Protocol Violation|1|||
164547097|NCT01202279|594374121|FG000|Overall Study|study compliance|5|||
164547098|NCT01202279|594374122|FG001|Overall Study|study compliance|2|||
164547099|NCT02047253|594374123|FG000|Overall Study|Lost to Follow-up|8|||
164547100|NCT03574753|594374124|FG000|Overall Study|Adverse Event|3|||
164547101|NCT03574753|594374124|FG000|Overall Study|Progression/relapse|19|||
164547102|NCT03574753|594374124|FG000|Overall Study|Death|1|||
164547103|NCT03472924|594374126|FG000|Overall Study|Adverse Event|1|||
164547104|NCT03472924|594374127|FG001|Overall Study|Adverse Event|0|||
164547105|NCT02546765|594374129|FG000|Overall Study|Withdrawal by Subject|0|||
164547106|NCT02546765|594374130|FG001|Overall Study|Withdrawal by Subject|1|||
164547107|NCT02546765|594374131|FG002|Overall Study|Withdrawal by Subject|0|||
164547108|NCT02546765|594374132|FG003|Overall Study|Withdrawal by Subject|0|||
164547109|NCT00609986|594374135|FG000|Overall Study|Did not receive transplant or treatment|8|||
164547110|NCT00609986|594374136|FG001|Overall Study|Did not receive transplant or treatment|3|||
164547111|NCT03520959|594374138|FG000|Overall Study|Study terminated by Sponsor|0|||
164547112|NCT03520959|594374139|FG001|Overall Study|Study terminated by Sponsor|1|||
164547113|NCT00402649|594375244|FG000|Overall Study|Lost to Follow-up|1|||
164547114|NCT00402649|594375244|FG000|Overall Study|Withdrawal by Subject|1|||
164547115|NCT01368536|594375246|FG000|Overall Study|Adverse Event|5|||
164547116|NCT01368536|594375247|FG001|Overall Study|Adverse Event|6|||
164547117|NCT01368536|594375248|FG002|Overall Study|Adverse Event|8|||
164547118|NCT01368536|594375246|FG000|Overall Study|Abnormal laboratory value(s)|0|||
164547119|NCT01368536|594375247|FG001|Overall Study|Abnormal laboratory value(s)|1|||
164547120|NCT01368536|594375248|FG002|Overall Study|Abnormal laboratory value(s)|2|||
164547121|NCT01368536|594375246|FG000|Overall Study|Abnormal test procedure result(s)|0|||
164547122|NCT01368536|594375247|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164547123|NCT01368536|594375248|FG002|Overall Study|Abnormal test procedure result(s)|1|||
164547124|NCT01368536|594375246|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
164547125|NCT01368536|594375247|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164547126|NCT01368536|594375248|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
164547127|NCT01368536|594375246|FG000|Overall Study|No longer required study medication|0|||
164547128|NCT01368536|594375247|FG001|Overall Study|No longer required study medication|0|||
164547129|NCT01368536|594375248|FG002|Overall Study|No longer required study medication|1|||
164547130|NCT01368536|594375246|FG000|Overall Study|Withdrawal by Subject|2|||
164547131|NCT01368536|594375247|FG001|Overall Study|Withdrawal by Subject|5|||
164547132|NCT01368536|594375248|FG002|Overall Study|Withdrawal by Subject|4|||
164547133|NCT01368536|594375246|FG000|Overall Study|Lost to Follow-up|3|||
164547134|NCT01368536|594375247|FG001|Overall Study|Lost to Follow-up|3|||
164547135|NCT01368536|594375248|FG002|Overall Study|Lost to Follow-up|5|||
164547136|NCT01368536|594375246|FG000|Overall Study|Administrative problems|34|||
164547137|NCT01368536|594375247|FG001|Overall Study|Administrative problems|39|||
164547138|NCT01368536|594375248|FG002|Overall Study|Administrative problems|35|||
164547139|NCT01368536|594375246|FG000|Overall Study|Protocol deviation|0|||
164547140|NCT01368536|594375247|FG001|Overall Study|Protocol deviation|3|||
164547141|NCT01368536|594375248|FG002|Overall Study|Protocol deviation|1|||
164547142|NCT00383084|594375255|FG000|Overall Study|Withdrawal by Subject|12|||
164547143|NCT00383084|594375256|FG001|Overall Study|Withdrawal by Subject|10|||
164547144|NCT02113436|594375257|FG000|Period 1: 8 Weeks|Adverse Event|1|||
164547145|NCT02113436|594375258|FG001|Period 1: 8 Weeks|Adverse Event|0|||
164547146|NCT02113436|594375259|FG002|Period 1: 8 Weeks|Adverse Event|0|||
164547147|NCT02113436|594375260|FG003|Period 1: 8 Weeks|Adverse Event|0|||
164547148|NCT02113436|594375257|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
164547149|NCT02113436|594375258|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
164547150|NCT02113436|594375259|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
164547151|NCT02113436|594375260|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
164547152|NCT02113436|594375257|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
164547153|NCT02113436|594375258|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
164547154|NCT02113436|594375259|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
164547155|NCT02113436|594375260|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
164547156|NCT02113436|594375257|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
164547157|NCT02113436|594375258|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
164547158|NCT02113436|594375259|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
164547159|NCT02113436|594375260|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
164547160|NCT02113436|594375257|FG000|Period 2: 16 Weeks|Adverse Event|0|||
164547161|NCT02113436|594375258|FG001|Period 2: 16 Weeks|Adverse Event|0|||
164547162|NCT02113436|594375259|FG002|Period 2: 16 Weeks|Adverse Event|4|||
164547163|NCT02113436|594375260|FG003|Period 2: 16 Weeks|Adverse Event|5|||
164547164|NCT02113436|594375257|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
164547165|NCT02113436|594375258|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
164547166|NCT02113436|594375259|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
164547167|NCT02113436|594375260|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
164547168|NCT02113436|594375257|FG000|Period 2: 16 Weeks|Physician Decision|0|||
164547169|NCT02113436|594375258|FG001|Period 2: 16 Weeks|Physician Decision|0|||
164547170|NCT02113436|594375259|FG002|Period 2: 16 Weeks|Physician Decision|2|||
164547171|NCT02113436|594375260|FG003|Period 2: 16 Weeks|Physician Decision|0|||
164547172|NCT02113436|594375257|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
164547173|NCT02113436|594375258|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
164547174|NCT02113436|594375259|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
164547175|NCT02113436|594375260|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
164547176|NCT01486927|594375261|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
164547177|NCT01486927|594375261|FG000|Overall Study|Physician Decision|1|||
164547178|NCT01486927|594375261|FG000|Overall Study|50 Exposure days not reached|2|||
164547179|NCT01486927|594375261|FG000|Overall Study|Withdrawal by Subject|8|||
164547180|NCT01486927|594375261|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
164547181|NCT01148537|594375265|FG000|Overall Study|Withdrawal by Subject|1|||
164547182|NCT01148537|594375266|FG001|Overall Study|Withdrawal by Subject|0|||
164547183|NCT01148537|594375267|FG002|Overall Study|Withdrawal by Subject|2|||
164547184|NCT01148537|594375265|FG000|Overall Study|Adverse Event|2|||
164547185|NCT01148537|594375266|FG001|Overall Study|Adverse Event|0|||
164547186|NCT01148537|594375267|FG002|Overall Study|Adverse Event|1|||
164547187|NCT05895552|594375268|FG000|Overall Study|Adverse Event|2|||
164547188|NCT05895552|594375269|FG001|Overall Study|Adverse Event|2|||
164547189|NCT05895552|594375270|FG002|Overall Study|Adverse Event|1|||
164547190|NCT05895552|594375268|FG000|Overall Study|Lost to Follow-up|0|||
164547191|NCT05895552|594375269|FG001|Overall Study|Lost to Follow-up|1|||
164547192|NCT05895552|594375270|FG002|Overall Study|Lost to Follow-up|0|||
164547193|NCT05895552|594375268|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164547194|NCT05895552|594375269|FG001|Overall Study|Non-Compliance With Study Drug|1|||
164547195|NCT05895552|594375270|FG002|Overall Study|Non-Compliance With Study Drug|0|||
164547196|NCT05895552|594375268|FG000|Overall Study|Protocol Deviation|0|||
164547197|NCT05895552|594375269|FG001|Overall Study|Protocol Deviation|0|||
164547198|NCT05895552|594375270|FG002|Overall Study|Protocol Deviation|2|||
164547199|NCT05895552|594375268|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
164547200|NCT05895552|594375269|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
164547201|NCT05895552|594375270|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
164547202|NCT05895552|594375268|FG000|Overall Study|Withdrawal by Subject|2|||
164547203|NCT05895552|594375269|FG001|Overall Study|Withdrawal by Subject|2|||
164547204|NCT05895552|594375270|FG002|Overall Study|Withdrawal by Subject|4|||
164547205|NCT03810911|594375271|FG000|Overall Study|Death|1|||
164547206|NCT03810911|594375272|FG001|Overall Study|Death|1|||
164547207|NCT03810911|594375271|FG000|Overall Study|Withdrawal by Subject|1|||
164547208|NCT03810911|594375272|FG001|Overall Study|Withdrawal by Subject|1|||
164547209|NCT05374525|594375273|FG000|Overall Study|Adverse Event|5|||
164653639|NCT00990093|594757247|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
164653640|NCT00990093|594757248|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
164653641|NCT00990093|594757247|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
164653642|NCT00990093|594757248|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
164653643|NCT00990093|594757247|FG000|Test Period 1 (1-14 Days)|Other|1|||
164653644|NCT00990093|594757248|FG001|Test Period 1 (1-14 Days)|Other|0|||
164653645|NCT00990093|594757247|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
164653646|NCT00990093|594757248|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
164653647|NCT00990093|594757247|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
164653648|NCT00990093|594757248|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
164653649|NCT00990093|594757247|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
164653650|NCT00990093|594757248|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
164653651|NCT00990093|594757247|FG000|Test Period 2 (15-28 Days)|Other|0|||
164653652|NCT00990093|594757248|FG001|Test Period 2 (15-28 Days)|Other|1|||
164653653|NCT00378482|594757253|FG000|Overall Study|Lost to Follow-up|1|||
164653654|NCT00378482|594757253|FG000|Overall Study|Lack of Efficacy|8|||
164653655|NCT00378482|594757253|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
164653656|NCT00378482|594757253|FG000|Overall Study|Withdrawal by Subject|4|||
164653657|NCT00378482|594757253|FG000|Overall Study|Adverse Event|9|||
164653658|NCT03185949|594757254|FG000|ITT Analysis|Withdrawal by Subject|4|||
164653659|NCT03185949|594757255|FG001|ITT Analysis|Withdrawal by Subject|3|||
164653660|NCT03185949|594757254|FG000|PP Analysis|Protocol Violation|2|||
164653661|NCT03185949|594757255|FG001|PP Analysis|Protocol Violation|2|||
164653662|NCT03185949|594757254|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
164653663|NCT03185949|594757255|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
164653664|NCT03342898|594758927|FG000|Overall Study|Adverse Event|3|||
164547210|NCT05374525|594375274|FG001|Overall Study|Adverse Event|6|||
164547211|NCT05374525|594375273|FG000|Overall Study|Lost to Follow-up|3|||
164547212|NCT05374525|594375274|FG001|Overall Study|Lost to Follow-up|3|||
164547213|NCT05374525|594375273|FG000|Overall Study|Physician Decision|2|||
164653665|NCT03342898|594758928|FG001|Overall Study|Adverse Event|1|||
164653666|NCT03342898|594758929|FG002|Overall Study|Adverse Event|0|||
164547214|NCT05374525|594375274|FG001|Overall Study|Physician Decision|2|||
164547215|NCT05374525|594375273|FG000|Overall Study|Withdrawal by Subject|26|||
164653667|NCT03342898|594758927|FG000|Overall Study|Lost to Follow-up|44|||
164653668|NCT03342898|594758928|FG001|Overall Study|Lost to Follow-up|40|||
164653669|NCT03342898|594758929|FG002|Overall Study|Lost to Follow-up|42|||
164653670|NCT03342898|594758927|FG000|Overall Study|Withdrawal of Consent|5|||
164547216|NCT05374525|594375274|FG001|Overall Study|Withdrawal by Subject|8|||
164547217|NCT01349101|594375278|FG000|Overall Study|Disease Progression|1|||
164653671|NCT03342898|594758928|FG001|Overall Study|Withdrawal of Consent|9|||
164547218|NCT01349101|594375279|FG001|Overall Study|Disease Progression|1|||
164547219|NCT01349101|594375278|FG000|Overall Study|Death|3|||
164547220|NCT01349101|594375279|FG001|Overall Study|Death|8|||
164547221|NCT00271596|594375282|FG000|Overall Study|Protocol Violation|1|||
164547222|NCT00271596|594375283|FG001|Overall Study|Protocol Violation|0|||
164547223|NCT00271596|594375282|FG000|Overall Study|Withdrawal by Subject|0|||
164547224|NCT00271596|594375283|FG001|Overall Study|Withdrawal by Subject|1|||
164547225|NCT04707157|594375284|FG000|Overall Study|Adverse Event|12|||
164547226|NCT04707157|594375285|FG001|Overall Study|Adverse Event|3|||
164547227|NCT04707157|594375284|FG000|Overall Study|Lost to Follow-up|2|||
164547228|NCT04707157|594375285|FG001|Overall Study|Lost to Follow-up|0|||
164547229|NCT04707157|594375284|FG000|Overall Study|Sponsor's decision|1|||
164547230|NCT04707157|594375285|FG001|Overall Study|Sponsor's decision|0|||
164547231|NCT04707157|594375284|FG000|Overall Study|Physician Decision|8|||
164547232|NCT04707157|594375285|FG001|Overall Study|Physician Decision|5|||
164547233|NCT04707157|594375284|FG000|Overall Study|Protocol Deviation|1|||
164547234|NCT04707157|594375285|FG001|Overall Study|Protocol Deviation|0|||
164547235|NCT04707157|594375284|FG000|Overall Study|Withdrawal by Subject|1|||
164547236|NCT04707157|594375285|FG001|Overall Study|Withdrawal by Subject|1|||
164547237|NCT02969915|594375286|FG000|Overall Study|Death|104|||
164547238|NCT02969915|594375287|FG001|Overall Study|Death|125|||
164547239|NCT02969915|594375286|FG000|Overall Study|Lost to Follow-up|108|||
164547240|NCT02969915|594375287|FG001|Overall Study|Lost to Follow-up|112|||
164547241|NCT02969915|594375286|FG000|Overall Study|Censored due to COVID-19|481|||
164547242|NCT02969915|594375287|FG001|Overall Study|Censored due to COVID-19|471|||
164547243|NCT03625687|594375293|FG000|Overall Study|Death|1|||
164547244|NCT01431274|594375294|FG000|Overall Study|Adverse Event|51|||
164547245|NCT01431274|594375295|FG001|Overall Study|Adverse Event|37|||
164547246|NCT01431274|594375296|FG002|Overall Study|Adverse Event|43|||
164547247|NCT01431274|594375297|FG003|Overall Study|Adverse Event|30|||
164547248|NCT01431274|594375298|FG004|Overall Study|Adverse Event|37|||
164547249|NCT01431274|594375294|FG000|Overall Study|Consent withdrawn not due to AE|29|||
164547250|NCT01431274|594375295|FG001|Overall Study|Consent withdrawn not due to AE|20|||
164547251|NCT01431274|594375296|FG002|Overall Study|Consent withdrawn not due to AE|17|||
164547252|NCT01431274|594375297|FG003|Overall Study|Consent withdrawn not due to AE|20|||
164547253|NCT01431274|594375298|FG004|Overall Study|Consent withdrawn not due to AE|11|||
164547254|NCT01431274|594375294|FG000|Overall Study|Non compliant with protocol|5|||
164547255|NCT01431274|594375295|FG001|Overall Study|Non compliant with protocol|8|||
164547256|NCT01431274|594375296|FG002|Overall Study|Non compliant with protocol|4|||
164547257|NCT01431274|594375297|FG003|Overall Study|Non compliant with protocol|4|||
164547258|NCT01431274|594375298|FG004|Overall Study|Non compliant with protocol|4|||
164547259|NCT01431274|594375294|FG000|Overall Study|Lost to Follow-up|6|||
164547260|NCT01431274|594375295|FG001|Overall Study|Lost to Follow-up|7|||
164547261|NCT01431274|594375296|FG002|Overall Study|Lost to Follow-up|1|||
164547262|NCT01431274|594375297|FG003|Overall Study|Lost to Follow-up|4|||
164547263|NCT01431274|594375298|FG004|Overall Study|Lost to Follow-up|0|||
164547264|NCT01431274|594375294|FG000|Overall Study|Other reason not stated above|6|||
164547265|NCT01431274|594375295|FG001|Overall Study|Other reason not stated above|5|||
164547266|NCT01431274|594375296|FG002|Overall Study|Other reason not stated above|7|||
164547267|NCT01431274|594375297|FG003|Overall Study|Other reason not stated above|2|||
164547268|NCT01431274|594375298|FG004|Overall Study|Other reason not stated above|4|||
164547269|NCT01069172|594375299|FG000|Overall Study|Withdrawal by Subject|1|||
164547270|NCT01069172|594375300|FG001|Overall Study|Withdrawal by Subject|0|||
164547271|NCT00133991|594375305|FG000|Overall Study|Death|4|||
164547272|NCT00974675|594375309|FG000|Overall Study|Adverse Event|2|||
164547273|NCT00974675|594375310|FG001|Overall Study|Adverse Event|1|||
164547274|NCT00974675|594375311|FG002|Overall Study|Adverse Event|1|||
164547275|NCT00974675|594375312|FG003|Overall Study|Adverse Event|1|||
164547276|NCT00974675|594375309|FG000|Overall Study|Physician Decision|0|||
164547277|NCT00974675|594375310|FG001|Overall Study|Physician Decision|0|||
164547278|NCT00974675|594375311|FG002|Overall Study|Physician Decision|1|||
164547279|NCT00974675|594375312|FG003|Overall Study|Physician Decision|0|||
164547280|NCT00974675|594375309|FG000|Overall Study|Participant on holiday; unable to attend|0|||
164547281|NCT00974675|594375310|FG001|Overall Study|Participant on holiday; unable to attend|0|||
164547282|NCT00974675|594375311|FG002|Overall Study|Participant on holiday; unable to attend|0|||
164547283|NCT00974675|594375312|FG003|Overall Study|Participant on holiday; unable to attend|1|||
164547284|NCT01378858|594375315|FG000|Overall Study|Withdrawal by Subject|4|||
164547285|NCT01378858|594375316|FG001|Overall Study|Withdrawal by Subject|4|||
164547286|NCT03159091|594375319|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
164547287|NCT03159091|594375320|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
164547288|NCT03159091|594375319|FG000|Overall Study|Patient has taken no dose of study drug|0|||
164547289|NCT03159091|594375320|FG001|Overall Study|Patient has taken no dose of study drug|1|||
164547290|NCT00943579|594375326|FG000|Overall Study|Adverse Event|4|||
164547291|NCT00943579|594375327|FG001|Overall Study|Adverse Event|3|||
164547292|NCT00943579|594375326|FG000|Overall Study|Lack of Efficacy|2|||
164547293|NCT00943579|594375327|FG001|Overall Study|Lack of Efficacy|2|||
164547294|NCT00418665|594375328|FG000|Treatment Period|Ineligibility determined|1|||
164547295|NCT00418665|594375329|FG001|Treatment Period|Ineligibility determined|1|||
164547296|NCT00418665|594375330|FG002|Treatment Period|Ineligibility determined|0|||
164547297|NCT00418665|594375328|FG000|Treatment Period|Adverse Event|2|||
164547298|NCT00418665|594375329|FG001|Treatment Period|Adverse Event|2|||
164547299|NCT00418665|594375330|FG002|Treatment Period|Adverse Event|0|||
164547300|NCT00418665|594375328|FG000|Treatment Period|Withdrawal by Subject|0|||
164547301|NCT00418665|594375329|FG001|Treatment Period|Withdrawal by Subject|3|||
164547302|NCT00418665|594375330|FG002|Treatment Period|Withdrawal by Subject|1|||
164547303|NCT00418665|594375328|FG000|Treatment Period|Requirement for alternative therapy|1|||
164547304|NCT00418665|594375329|FG001|Treatment Period|Requirement for alternative therapy|0|||
164547305|NCT00418665|594375330|FG002|Treatment Period|Requirement for alternative therapy|0|||
164547306|NCT00418665|594375328|FG000|Treatment Period|Physician Decision|1|||
164547307|NCT00418665|594375329|FG001|Treatment Period|Physician Decision|0|||
164547308|NCT00418665|594375330|FG002|Treatment Period|Physician Decision|3|||
164547309|NCT00418665|594375328|FG000|Treatment Extension|Adverse Event|1|||
164547310|NCT00418665|594375329|FG001|Treatment Extension|Adverse Event|0|||
164547311|NCT00418665|594375330|FG002|Treatment Extension|Adverse Event|0|||
164547312|NCT00418665|594375328|FG000|Treatment Extension|Withdrawal by Subject|1|||
164547313|NCT00418665|594375329|FG001|Treatment Extension|Withdrawal by Subject|0|||
164547314|NCT00418665|594375330|FG002|Treatment Extension|Withdrawal by Subject|0|||
164547315|NCT00418665|594375328|FG000|Treatment Extension|Requirement for alternative therapy|2|||
164547316|NCT00418665|594375329|FG001|Treatment Extension|Requirement for alternative therapy|2|||
164547317|NCT00418665|594375330|FG002|Treatment Extension|Requirement for alternative therapy|0|||
164547318|NCT00418665|594375328|FG000|Treatment Extension|Physician Decision|2|||
164547319|NCT00418665|594375329|FG001|Treatment Extension|Physician Decision|2|||
164547320|NCT00418665|594375330|FG002|Treatment Extension|Physician Decision|1|||
164547321|NCT00418665|594375328|FG000|Treatment Extension|Death|0|||
164547322|NCT00418665|594375329|FG001|Treatment Extension|Death|0|||
164547323|NCT00418665|594375330|FG002|Treatment Extension|Death|1|||
164547324|NCT05937165|594375333|FG000|Overall Study|Withdrawal by Subject|0|||
164547325|NCT05937165|594375334|FG001|Overall Study|Withdrawal by Subject|1|||
164547326|NCT01538628|594375335|FG000|Overall Study|Withdrawal by Subject|1|||
164547327|NCT01538628|594375336|FG001|Overall Study|Withdrawal by Subject|1|||
164547328|NCT01538628|594375335|FG000|Overall Study|Lost to Follow-up|0|||
164547329|NCT01538628|594375336|FG001|Overall Study|Lost to Follow-up|1|||
164547330|NCT01357577|594375337|FG000|Overall Study|Lost to Follow-up|20|||
164547331|NCT01357577|594375338|FG001|Overall Study|Lost to Follow-up|16|||
164547332|NCT01357577|594375337|FG000|Overall Study|Withdrawal by Subject|16|||
164547333|NCT01357577|594375338|FG001|Overall Study|Withdrawal by Subject|8|||
164547334|NCT01357577|594375337|FG000|Overall Study|look at data in database?|1|||
164547335|NCT01357577|594375338|FG001|Overall Study|look at data in database?|2|||
164547336|NCT05493280|594375339|FG000|Part 2 intervention (7 months)|Withdrawal by Subject|1|||
164547337|NCT05493280|594375340|FG001|Part 2 intervention (7 months)|Withdrawal by Subject|0|||
164547338|NCT00307151|594376743|FG000|Overall Study|Death|4|||
164547339|NCT00307151|594376744|FG001|Overall Study|Death|3|||
164547340|NCT00307151|594376745|FG002|Overall Study|Death|10|||
164547341|NCT00307151|594376746|FG003|Overall Study|Death|3|||
164547342|NCT00307151|594376743|FG000|Overall Study|Severe debilitation, unable to continue|1|||
164547343|NCT00307151|594376744|FG001|Overall Study|Severe debilitation, unable to continue|0|||
164547344|NCT00307151|594376745|FG002|Overall Study|Severe debilitation, unable to continue|0|||
164547345|NCT00307151|594376746|FG003|Overall Study|Severe debilitation, unable to continue|0|||
164547346|NCT00307151|594376743|FG000|Overall Study|Subject unable to get to clinic|1|||
164547347|NCT00307151|594376744|FG001|Overall Study|Subject unable to get to clinic|0|||
164547348|NCT00307151|594376745|FG002|Overall Study|Subject unable to get to clinic|6|||
164547349|NCT00307151|594376746|FG003|Overall Study|Subject unable to get to clinic|2|||
164547350|NCT00307151|594376743|FG000|Overall Study|Withdrew consent|0|||
164547351|NCT00307151|594376744|FG001|Overall Study|Withdrew consent|1|||
164547352|NCT00307151|594376745|FG002|Overall Study|Withdrew consent|1|||
164547353|NCT00307151|594376746|FG003|Overall Study|Withdrew consent|3|||
164547354|NCT00307151|594376743|FG000|Overall Study|Not willing to adhere to study reqs|2|||
164547355|NCT00307151|594376744|FG001|Overall Study|Not willing to adhere to study reqs|0|||
164547356|NCT00307151|594376745|FG002|Overall Study|Not willing to adhere to study reqs|2|||
164547357|NCT00307151|594376746|FG003|Overall Study|Not willing to adhere to study reqs|2|||
164547358|NCT00307151|594376743|FG000|Overall Study|Clinic unable to contact subject|3|||
164547359|NCT00307151|594376744|FG001|Overall Study|Clinic unable to contact subject|3|||
164547360|NCT00307151|594376745|FG002|Overall Study|Clinic unable to contact subject|1|||
164547361|NCT00307151|594376746|FG003|Overall Study|Clinic unable to contact subject|1|||
164547362|NCT00075400|594376747|FG000|Overall Study|Ineligible: wrong primary|1|||
164547363|NCT00075400|594376747|FG000|Overall Study|Never treated|2|||
164547364|NCT00516048|594376749|FG000|Overall Study|Death|0|||
164547365|NCT00516048|594376750|FG001|Overall Study|Death|0|||
164547366|NCT00516048|594376751|FG002|Overall Study|Death|1|||
164547367|NCT00516048|594376749|FG000|Overall Study|Subject Decision|0|||
164547368|NCT00516048|594376750|FG001|Overall Study|Subject Decision|2|||
164547369|NCT00516048|594376751|FG002|Overall Study|Subject Decision|0|||
164547370|NCT01321710|594376757|FG000|Overall Study|Lost to Follow-up|4|||
164547371|NCT01321710|594376758|FG001|Overall Study|Lost to Follow-up|5|||
164547372|NCT01321710|594376759|FG002|Overall Study|Lost to Follow-up|0|||
164547373|NCT01761292|594376760|FG000|Part 1|Adverse Event|1|||
164547374|NCT01761292|594376760|FG000|Part 1|not receiving treatment in Part 1|1|||
164547375|NCT01761292|594376760|FG000|Extension 1|Withdrawal by Subject|1|||
164547376|NCT02554019|594376761|FG000|Overall Study|Withdrawal by Subject|1|||
164547377|NCT02554019|594376762|FG001|Overall Study|Withdrawal by Subject|0|||
164547378|NCT02554019|594376763|FG002|Overall Study|Withdrawal by Subject|2|||
164547379|NCT02554019|594376761|FG000|Overall Study|Adverse Event|1|||
164547380|NCT02554019|594376762|FG001|Overall Study|Adverse Event|0|||
164547381|NCT02554019|594376763|FG002|Overall Study|Adverse Event|0|||
164547382|NCT00390546|594376764|FG000|Overall Study|Renal impairment|1|||
164547383|NCT00390546|594376765|FG001|Overall Study|Renal impairment|0|||
164547384|NCT00390546|594376764|FG000|Overall Study|Physician Decision|5|||
164547385|NCT00390546|594376765|FG001|Overall Study|Physician Decision|5|||
164547386|NCT02463409|594376766|FG000|Overall Study|Withdrawal by Subject|1|||
164547387|NCT02463409|594376766|FG000|Overall Study|Screen failure|1|||
164547388|NCT01308008|594376767|FG000|4 Weeks|Illness, disinterest, time|9|||
164547389|NCT01308008|594376768|FG001|4 Weeks|Illness, disinterest, time|2|||
164547390|NCT03577730|594376769|FG000|Overall Study|Physician Decision|3|||
164547391|NCT03577730|594376770|FG001|Overall Study|Physician Decision|1|||
164547392|NCT03577730|594376769|FG000|Overall Study|Did not receive allocated intervention|1|||
164547393|NCT03577730|594376770|FG001|Overall Study|Did not receive allocated intervention|0|||
164547394|NCT01444742|594376771|FG000|Overall Study|Death|1|||
164547395|NCT02187172|594376772|FG000|Overall Study|Lost to Follow-up|1|||
164547396|NCT02187172|594376773|FG001|Overall Study|Lost to Follow-up|2|||
164547397|NCT02187172|594376772|FG000|Overall Study|Lack of Efficacy|1|||
164547398|NCT02187172|594376773|FG001|Overall Study|Lack of Efficacy|2|||
164547399|NCT02187172|594376772|FG000|Overall Study|Adverse Event|0|||
164547400|NCT02187172|594376773|FG001|Overall Study|Adverse Event|1|||
164547401|NCT02187172|594376772|FG000|Overall Study|Physician Decision|1|||
164547402|NCT02187172|594376773|FG001|Overall Study|Physician Decision|1|||
164547403|NCT05611671|594376782|FG000|Overall Study|Adverse Event|1|||
164547404|NCT05611671|594376783|FG001|Overall Study|Adverse Event|1|||
164547405|NCT05611671|594376784|FG002|Overall Study|Adverse Event|0|||
164547406|NCT05611671|594376785|FG003|Overall Study|Adverse Event|1|||
164547407|NCT05611671|594376782|FG000|Overall Study|Lack of Efficacy|1|||
164547408|NCT05611671|594376783|FG001|Overall Study|Lack of Efficacy|0|||
164547409|NCT05611671|594376784|FG002|Overall Study|Lack of Efficacy|1|||
164547410|NCT05611671|594376785|FG003|Overall Study|Lack of Efficacy|2|||
164547411|NCT05611671|594376782|FG000|Overall Study|Lost to Follow-up|0|||
164547412|NCT05611671|594376783|FG001|Overall Study|Lost to Follow-up|0|||
164547413|NCT05611671|594376784|FG002|Overall Study|Lost to Follow-up|0|||
164547414|NCT05611671|594376785|FG003|Overall Study|Lost to Follow-up|1|||
164547415|NCT05611671|594376782|FG000|Overall Study|Protocol Violation|0|||
164547416|NCT05611671|594376783|FG001|Overall Study|Protocol Violation|1|||
164547417|NCT05611671|594376784|FG002|Overall Study|Protocol Violation|0|||
164194533|NCT00255164|593079470|FG000|Overall Study|Possible Barrett's Esophagus|1|||
164194534|NCT00255164|593079471|FG001|Overall Study|Possible Barrett's Esophagus|3|||
164547418|NCT05611671|594376785|FG003|Overall Study|Protocol Violation|0|||
164547419|NCT05611671|594376782|FG000|Overall Study|Withdrawal by Subject|2|||
164547420|NCT05611671|594376783|FG001|Overall Study|Withdrawal by Subject|1|||
164547421|NCT05611671|594376784|FG002|Overall Study|Withdrawal by Subject|2|||
164547422|NCT05611671|594376785|FG003|Overall Study|Withdrawal by Subject|1|||
164547423|NCT03179891|594376788|FG000|First Intervention|Withdrawal by Subject|1|||
164547424|NCT03179891|594376789|FG001|First Intervention|Withdrawal by Subject|1|||
164547425|NCT03179891|594376788|FG000|First Intervention|Unspecified reason|1|||
164547426|NCT03179891|594376789|FG001|First Intervention|Unspecified reason|0|||
164547427|NCT03179891|594376788|FG000|First Intervention|Protocol Violation|0|||
164547428|NCT03179891|594376789|FG001|First Intervention|Protocol Violation|1|||
164547429|NCT01648790|594376794|FG000|Treatment 3|Withdrawal by Subject|0|||
164547430|NCT01648790|594376795|FG001|Treatment 3|Withdrawal by Subject|0|||
164547431|NCT01648790|594376796|FG002|Treatment 3|Withdrawal by Subject|0|||
164194535|NCT00255164|593079472|FG002|Overall Study|Possible Barrett's Esophagus|8|||
164194536|NCT00255164|593079470|FG000|Overall Study|Esophageal Stricture|0|||
164194537|NCT00255164|593079471|FG001|Overall Study|Esophageal Stricture|0|||
164547432|NCT01648790|594376797|FG003|Treatment 3|Withdrawal by Subject|1|||
164547433|NCT01648790|594376798|FG004|Treatment 3|Withdrawal by Subject|0|||
164547434|NCT02159729|594376802|FG000|Overall Study|Adverse Event|0|||
164547435|NCT02159729|594376803|FG001|Overall Study|Adverse Event|1|||
164653672|NCT03342898|594758929|FG002|Overall Study|Withdrawal of Consent|11|||
164547436|NCT02159729|594376802|FG000|Overall Study|Subject's Request|13|||
164547437|NCT02159729|594376803|FG001|Overall Study|Subject's Request|10|||
164547438|NCT02159729|594376802|FG000|Overall Study|Lost to Follow-up|24|||
164547439|NCT02159729|594376803|FG001|Overall Study|Lost to Follow-up|9|||
164547440|NCT02159729|594376802|FG000|Overall Study|Non compliance|2|||
164547441|NCT02159729|594376803|FG001|Overall Study|Non compliance|0|||
164547442|NCT02159729|594376802|FG000|Overall Study|Other Unspecified|3|||
164547443|NCT02159729|594376803|FG001|Overall Study|Other Unspecified|1|||
164547444|NCT02636582|594376804|FG000|Overall Study|Surgical Pathology|1|||
164547445|NCT02636582|594376805|FG001|Overall Study|Surgical Pathology|0|||
164547446|NCT00573430|594376806|FG000|Overall Study|Incorrect enrollment of randomization|0|||
164547447|NCT00573430|594376807|FG001|Overall Study|Incorrect enrollment of randomization|4|||
164547448|NCT00573430|594376808|FG002|Overall Study|Incorrect enrollment of randomization|3|||
164547449|NCT00573430|594376806|FG000|Overall Study|Adverse Event|0|||
164547450|NCT00573430|594376807|FG001|Overall Study|Adverse Event|0|||
164547451|NCT00573430|594376808|FG002|Overall Study|Adverse Event|2|||
164547452|NCT00573430|594376806|FG000|Overall Study|Withdrawal by Subject|1|||
164547453|NCT00573430|594376807|FG001|Overall Study|Withdrawal by Subject|0|||
164547454|NCT00573430|594376808|FG002|Overall Study|Withdrawal by Subject|1|||
164547455|NCT00573430|594376806|FG000|Overall Study|Protocol Violation|0|||
164547456|NCT00573430|594376807|FG001|Overall Study|Protocol Violation|1|||
164547457|NCT00573430|594376808|FG002|Overall Study|Protocol Violation|1|||
164547458|NCT00573430|594376806|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164547459|NCT00573430|594376807|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164547460|NCT00573430|594376808|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
164547461|NCT00454857|594376809|FG000|Overall Study|Withdrawal by Subject|15|||
164547462|NCT00454857|594376809|FG000|Overall Study|Lost to Follow-up|16|||
164547463|NCT00454857|594376809|FG000|Overall Study|Noncompliance|6|||
164547464|NCT00454857|594376809|FG000|Overall Study|Death|5|||
164547465|NCT00454857|594376809|FG000|Overall Study|Other|11|||
164547466|NCT00454857|594376809|FG000|Overall Study|Reason unknown|1|||
164547467|NCT00829179|594376810|FG000|Overall Study|Withdrawal by Subject|1|||
164547468|NCT03374189|594376816|FG000|Overall Study|Lost to Follow-up|1|||
164547469|NCT03374189|594376817|FG001|Overall Study|Lost to Follow-up|0|||
164547470|NCT02018822|594376818|FG000|Overall Study|filling replaced by crown|0|||
164547471|NCT02018822|594376819|FG001|Overall Study|filling replaced by crown|1|||
164547472|NCT02018822|594376820|FG002|Overall Study|filling replaced by crown|0|||
164547473|NCT02018822|594376818|FG000|Overall Study|Physician Decision|0|||
164547474|NCT02018822|594376819|FG001|Overall Study|Physician Decision|1|||
164547475|NCT02018822|594376820|FG002|Overall Study|Physician Decision|1|||
164547476|NCT02018822|594376818|FG000|Overall Study|Lost to Follow-up|6|||
164547477|NCT02018822|594376819|FG001|Overall Study|Lost to Follow-up|6|||
164547478|NCT02018822|594376820|FG002|Overall Study|Lost to Follow-up|5|||
164547479|NCT00715026|594376821|FG000|Overall Study|Withdrawal by Subject|5|||
164547480|NCT00715026|594376821|FG000|Overall Study|Lost to Follow-up|3|||
164547481|NCT00715026|594376821|FG000|Overall Study|Protocol Violation|1|||
164547482|NCT00715026|594376821|FG000|Overall Study|Surgery done on non-study consented hip|1|||
164547483|NCT04232553|594376827|FG000|Overall Study|Adverse Event|3|||
164547484|NCT04232553|594376828|FG001|Overall Study|Adverse Event|2|||
164547485|NCT04232553|594376829|FG002|Overall Study|Adverse Event|1|||
164547486|NCT04232553|594376830|FG003|Overall Study|Adverse Event|2|||
164547487|NCT04232553|594376831|FG004|Overall Study|Adverse Event|1|||
164547488|NCT04232553|594376832|FG005|Overall Study|Adverse Event|1|||
164547489|NCT04232553|594376833|FG006|Overall Study|Adverse Event|0|||
164547490|NCT04232553|594376834|FG007|Overall Study|Adverse Event|0|||
164547491|NCT04232553|594376835|FG008|Overall Study|Adverse Event|0|||
164547492|NCT04232553|594376827|FG000|Overall Study|Death|0|||
164547493|NCT04232553|594376828|FG001|Overall Study|Death|1|||
164547494|NCT04232553|594376829|FG002|Overall Study|Death|0|||
164547495|NCT04232553|594376830|FG003|Overall Study|Death|1|||
164547496|NCT04232553|594376831|FG004|Overall Study|Death|0|||
164547497|NCT04232553|594376832|FG005|Overall Study|Death|0|||
164547498|NCT04232553|594376833|FG006|Overall Study|Death|0|||
164547499|NCT04232553|594376834|FG007|Overall Study|Death|0|||
164547500|NCT04232553|594376835|FG008|Overall Study|Death|0|||
164547501|NCT04232553|594376827|FG000|Overall Study|Lack of Efficacy|0|||
164547502|NCT04232553|594376828|FG001|Overall Study|Lack of Efficacy|2|||
164653673|NCT03342898|594758927|FG000|Overall Study|Death|0|||
164547503|NCT04232553|594376829|FG002|Overall Study|Lack of Efficacy|0|||
164547504|NCT04232553|594376830|FG003|Overall Study|Lack of Efficacy|0|||
164547505|NCT04232553|594376831|FG004|Overall Study|Lack of Efficacy|0|||
164547506|NCT04232553|594376832|FG005|Overall Study|Lack of Efficacy|0|||
164547507|NCT04232553|594376833|FG006|Overall Study|Lack of Efficacy|0|||
164547508|NCT04232553|594376834|FG007|Overall Study|Lack of Efficacy|0|||
164547509|NCT04232553|594376835|FG008|Overall Study|Lack of Efficacy|1|||
164653674|NCT03342898|594758928|FG001|Overall Study|Death|1|||
164547510|NCT04232553|594376827|FG000|Overall Study|Lost to Follow-up|0|||
164547511|NCT04232553|594376828|FG001|Overall Study|Lost to Follow-up|1|||
164547512|NCT04232553|594376829|FG002|Overall Study|Lost to Follow-up|0|||
164547513|NCT04232553|594376830|FG003|Overall Study|Lost to Follow-up|0|||
164547514|NCT04232553|594376831|FG004|Overall Study|Lost to Follow-up|1|||
164547515|NCT04232553|594376832|FG005|Overall Study|Lost to Follow-up|0|||
164547516|NCT04232553|594376833|FG006|Overall Study|Lost to Follow-up|0|||
164547517|NCT04232553|594376834|FG007|Overall Study|Lost to Follow-up|0|||
164547518|NCT04232553|594376835|FG008|Overall Study|Lost to Follow-up|1|||
164547519|NCT04232553|594376827|FG000|Overall Study|Other - As reported by the investigator|0|||
164547520|NCT04232553|594376828|FG001|Overall Study|Other - As reported by the investigator|1|||
164653675|NCT03342898|594758929|FG002|Overall Study|Death|1|||
164547521|NCT04232553|594376829|FG002|Overall Study|Other - As reported by the investigator|0|||
164547522|NCT04232553|594376830|FG003|Overall Study|Other - As reported by the investigator|0|||
164547523|NCT04232553|594376831|FG004|Overall Study|Other - As reported by the investigator|0|||
164547524|NCT04232553|594376832|FG005|Overall Study|Other - As reported by the investigator|0|||
164547525|NCT04232553|594376833|FG006|Overall Study|Other - As reported by the investigator|0|||
164547526|NCT04232553|594376834|FG007|Overall Study|Other - As reported by the investigator|0|||
164547527|NCT04232553|594376835|FG008|Overall Study|Other - As reported by the investigator|0|||
164547528|NCT04232553|594376827|FG000|Overall Study|Physician Decision|1|||
164547529|NCT04232553|594376828|FG001|Overall Study|Physician Decision|1|||
164547530|NCT04232553|594376829|FG002|Overall Study|Physician Decision|0|||
164547531|NCT04232553|594376830|FG003|Overall Study|Physician Decision|0|||
164547532|NCT04232553|594376831|FG004|Overall Study|Physician Decision|1|||
164547533|NCT04232553|594376832|FG005|Overall Study|Physician Decision|0|||
164547534|NCT04232553|594376833|FG006|Overall Study|Physician Decision|0|||
164547535|NCT04232553|594376834|FG007|Overall Study|Physician Decision|0|||
164547536|NCT04232553|594376835|FG008|Overall Study|Physician Decision|0|||
164547537|NCT04232553|594376827|FG000|Overall Study|Pregnancy|1|||
164547538|NCT04232553|594376828|FG001|Overall Study|Pregnancy|0|||
164547539|NCT04232553|594376829|FG002|Overall Study|Pregnancy|0|||
164547540|NCT04232553|594376830|FG003|Overall Study|Pregnancy|0|||
164547541|NCT04232553|594376831|FG004|Overall Study|Pregnancy|0|||
164547542|NCT04232553|594376832|FG005|Overall Study|Pregnancy|0|||
164547543|NCT04232553|594376833|FG006|Overall Study|Pregnancy|0|||
164547544|NCT04232553|594376834|FG007|Overall Study|Pregnancy|0|||
164547545|NCT04232553|594376835|FG008|Overall Study|Pregnancy|0|||
164547546|NCT04232553|594376827|FG000|Overall Study|Withdrawal by Subject|7|||
164547547|NCT04232553|594376828|FG001|Overall Study|Withdrawal by Subject|5|||
164547548|NCT04232553|594376829|FG002|Overall Study|Withdrawal by Subject|0|||
164547549|NCT04232553|594376830|FG003|Overall Study|Withdrawal by Subject|0|||
164547550|NCT04232553|594376831|FG004|Overall Study|Withdrawal by Subject|2|||
164547551|NCT04232553|594376832|FG005|Overall Study|Withdrawal by Subject|2|||
164547552|NCT04232553|594376833|FG006|Overall Study|Withdrawal by Subject|0|||
164547553|NCT04232553|594376834|FG007|Overall Study|Withdrawal by Subject|2|||
164547554|NCT04232553|594376835|FG008|Overall Study|Withdrawal by Subject|0|||
164547555|NCT02184195|594376836|FG000|Overall Study|Patient decision|5|||
164547556|NCT02184195|594376837|FG001|Overall Study|Patient decision|2|||
164547557|NCT02184195|594376836|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164547558|NCT02184195|594376837|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
164547559|NCT02184195|594376836|FG000|Overall Study|Death|67|||
164547560|NCT02184195|594376837|FG001|Overall Study|Death|44|||
164547561|NCT02184195|594376836|FG000|Overall Study|Lost to Follow-up|1|||
164547562|NCT02184195|594376837|FG001|Overall Study|Lost to Follow-up|5|||
164547563|NCT02184195|594376836|FG000|Overall Study|Other|0|||
164547564|NCT02184195|594376837|FG001|Overall Study|Other|3|||
164547565|NCT01987960|594376838|FG000|Period 1|Adverse Event|24|||
164547566|NCT01987960|594376839|FG001|Period 1|Adverse Event|0|||
164547567|NCT01987960|594376840|FG002|Period 1|Adverse Event|0|||
164547568|NCT01987960|594376841|FG003|Period 1|Adverse Event|0|||
164547569|NCT01987960|594376838|FG000|Period 1|Lack of Efficacy|4|||
164547570|NCT01987960|594376839|FG001|Period 1|Lack of Efficacy|0|||
164547571|NCT01987960|594376840|FG002|Period 1|Lack of Efficacy|0|||
164547572|NCT01987960|594376841|FG003|Period 1|Lack of Efficacy|0|||
164547573|NCT01987960|594376838|FG000|Period 1|Non-compliance with IMP|6|||
164547574|NCT01987960|594376839|FG001|Period 1|Non-compliance with IMP|0|||
164547575|NCT01987960|594376840|FG002|Period 1|Non-compliance with IMP|0|||
164547576|NCT01987960|594376841|FG003|Period 1|Non-compliance with IMP|0|||
164547577|NCT01987960|594376838|FG000|Period 1|Protocol Violation|12|||
164547578|NCT01987960|594376839|FG001|Period 1|Protocol Violation|0|||
164547579|NCT01987960|594376840|FG002|Period 1|Protocol Violation|0|||
164547580|NCT01987960|594376841|FG003|Period 1|Protocol Violation|0|||
164547581|NCT01987960|594376838|FG000|Period 1|Withdrawal by Subject|21|||
164547582|NCT01987960|594376839|FG001|Period 1|Withdrawal by Subject|0|||
164547583|NCT01987960|594376840|FG002|Period 1|Withdrawal by Subject|0|||
164547584|NCT01987960|594376841|FG003|Period 1|Withdrawal by Subject|0|||
164547585|NCT01987960|594376838|FG000|Period 1|Lost to Follow-up|40|||
164547586|NCT01987960|594376839|FG001|Period 1|Lost to Follow-up|0|||
164547587|NCT01987960|594376840|FG002|Period 1|Lost to Follow-up|0|||
164547588|NCT01987960|594376841|FG003|Period 1|Lost to Follow-up|0|||
164547589|NCT01987960|594376838|FG000|Period 1|administrative or other reason|75|||
164547590|NCT01987960|594376839|FG001|Period 1|administrative or other reason|0|||
164547591|NCT01987960|594376840|FG002|Period 1|administrative or other reason|0|||
164547592|NCT01987960|594376841|FG003|Period 1|administrative or other reason|0|||
164547593|NCT01987960|594376838|FG000|Period 1|Withdrawal of consent before treatment|4|||
164547594|NCT01987960|594376839|FG001|Period 1|Withdrawal of consent before treatment|0|||
164547595|NCT01987960|594376840|FG002|Period 1|Withdrawal of consent before treatment|0|||
164547596|NCT01987960|594376841|FG003|Period 1|Withdrawal of consent before treatment|0|||
164547597|NCT01987960|594376838|FG000|Period 2|Adverse Event|0|||
164547598|NCT01987960|594376839|FG001|Period 2|Adverse Event|0|||
164547599|NCT01987960|594376840|FG002|Period 2|Adverse Event|1|||
164547600|NCT01987960|594376841|FG003|Period 2|Adverse Event|0|||
164194538|NCT00255164|593079472|FG002|Overall Study|Esophageal Stricture|1|||
164194539|NCT00255164|593079470|FG000|Overall Study|Therapeutic Failure|11|||
164194540|NCT00255164|593079471|FG001|Overall Study|Therapeutic Failure|2|||
164194541|NCT00255164|593079472|FG002|Overall Study|Therapeutic Failure|3|||
164194542|NCT04754542|593079475|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
164194543|NCT04754542|593079476|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
164194544|NCT03627832|593080911|FG000|Overall Study|Withdrawal by Subject|10|||
164194545|NCT03627832|593080912|FG001|Overall Study|Withdrawal by Subject|1|||
164194546|NCT04110314|593080918|FG000|Overall Study|Did not meet inclusion criteria|35255|||
164194547|NCT04110314|593080919|FG001|Overall Study|Did not meet inclusion criteria|35104|||
164194548|NCT04110314|593080920|FG002|Overall Study|Did not meet inclusion criteria|35636|||
164194549|NCT04110314|593080921|FG003|Overall Study|Did not meet inclusion criteria|35135|||
164194550|NCT04110314|593080922|FG004|Overall Study|Did not meet inclusion criteria|35247|||
164194551|NCT04110314|593080923|FG005|Overall Study|Did not meet inclusion criteria|35727|||
164194552|NCT00737100|593080927|FG000|Overall Study|Adverse Event|6|||
164194553|NCT00737100|593080928|FG001|Overall Study|Adverse Event|5|||
164194554|NCT00737100|593080929|FG002|Overall Study|Adverse Event|3|||
164194555|NCT00737100|593080927|FG000|Overall Study|Lost to Follow-up|0|||
164194556|NCT00737100|593080928|FG001|Overall Study|Lost to Follow-up|1|||
164194557|NCT00737100|593080929|FG002|Overall Study|Lost to Follow-up|0|||
164194558|NCT00737100|593080927|FG000|Overall Study|Withdrawal by Subject|0|||
164194559|NCT00737100|593080928|FG001|Overall Study|Withdrawal by Subject|0|||
164194560|NCT00737100|593080929|FG002|Overall Study|Withdrawal by Subject|3|||
164194561|NCT00737100|593080927|FG000|Overall Study|Reason discontinued not explained above|1|||
164194562|NCT00737100|593080928|FG001|Overall Study|Reason discontinued not explained above|1|||
164194563|NCT00737100|593080929|FG002|Overall Study|Reason discontinued not explained above|1|||
164194564|NCT01607593|593080934|FG000|Overall Study|Adverse Event|15|||
164194565|NCT01607593|593080934|FG000|Overall Study|Lack of Efficacy|16|||
164194566|NCT01607593|593080934|FG000|Overall Study|Lost to Follow-up|25|||
164194567|NCT01607593|593080934|FG000|Overall Study|Continuation|33|||
164194568|NCT01607593|593080934|FG000|Overall Study|Other|4|||
164194569|NCT00115778|593080935|FG000|Overall Study|Withdrawal by Subject|0|||
164194570|NCT00115778|593080936|FG001|Overall Study|Withdrawal by Subject|1|||
164194571|NCT03713684|593080941|FG000|Overall Study|Adverse Event|1|||
164194572|NCT03713684|593080942|FG001|Overall Study|Adverse Event|3|||
164194573|NCT03713684|593080943|FG002|Overall Study|Adverse Event|1|||
164194574|NCT03713684|593080944|FG003|Overall Study|Adverse Event|0|||
164194575|NCT03713684|593080941|FG000|Overall Study|Poor compliance to protocol|2|||
164194576|NCT03713684|593080942|FG001|Overall Study|Poor compliance to protocol|1|||
164194577|NCT03713684|593080943|FG002|Overall Study|Poor compliance to protocol|0|||
164194578|NCT03713684|593080944|FG003|Overall Study|Poor compliance to protocol|1|||
164194579|NCT03713684|593080941|FG000|Overall Study|Withdrawal by Subject|14|||
164194580|NCT03713684|593080942|FG001|Overall Study|Withdrawal by Subject|6|||
164194581|NCT03713684|593080943|FG002|Overall Study|Withdrawal by Subject|14|||
164194582|NCT03713684|593080944|FG003|Overall Study|Withdrawal by Subject|16|||
164194583|NCT03713684|593080941|FG000|Overall Study|Other than specified|69|||
164194584|NCT03713684|593080942|FG001|Overall Study|Other than specified|77|||
164194585|NCT03713684|593080943|FG002|Overall Study|Other than specified|73|||
164194586|NCT03713684|593080944|FG003|Overall Study|Other than specified|70|||
164194587|NCT00528424|593080945|FG000|Overall Study|Lost to Follow-up|13|||
164194588|NCT00528424|593080945|FG000|Overall Study|Withdrew consent|2|||
164194589|NCT00528424|593080945|FG000|Overall Study|Administrative reason|2|||
164194590|NCT00528424|593080945|FG000|Overall Study|Other|12|||
164194591|NCT02515630|593080946|FG000|Overall Study|Withdrawal by Subject|5|||
164194592|NCT02515630|593080946|FG000|Overall Study|Adverse Event|4|||
164194593|NCT02515630|593080946|FG000|Overall Study|Physician Decision|4|||
164194594|NCT02515630|593080946|FG000|Overall Study|Death|2|||
164194595|NCT02515630|593080946|FG000|Overall Study|Disease Progression|1|||
164194596|NCT02595502|593080949|FG000|Period 1|Adverse Event|0|||
164194597|NCT02595502|593080950|FG001|Period 1|Adverse Event|1|||
164194598|NCT02595502|593080949|FG000|Period 1|Withdrawal by Subject|1|||
164194599|NCT02595502|593080950|FG001|Period 1|Withdrawal by Subject|0|||
164547601|NCT01987960|594376838|FG000|Period 2|Withdrawal by Subject|0|||
164547602|NCT01987960|594376839|FG001|Period 2|Withdrawal by Subject|0|||
164194600|NCT02595502|593080949|FG000|Period 1|Lost to Follow-up|0|||
164194601|NCT02595502|593080950|FG001|Period 1|Lost to Follow-up|1|||
164194602|NCT02595502|593080949|FG000|Period 2|Adverse Event|1|||
164194603|NCT02595502|593080950|FG001|Period 2|Adverse Event|1|||
164194604|NCT02595502|593080949|FG000|Period 2|Received incorrect lens at Period 1|0|||
164194605|NCT02595502|593080950|FG001|Period 2|Received incorrect lens at Period 1|1|||
164194606|NCT02595502|593080949|FG000|Period 3|Protocol Violation|0|||
164547603|NCT01987960|594376840|FG002|Period 2|Withdrawal by Subject|1|||
164194607|NCT02595502|593080950|FG001|Period 3|Protocol Violation|1|||
164194608|NCT02595502|593080949|FG000|Period 3|Lost to Follow-up|1|||
164194609|NCT02595502|593080950|FG001|Period 3|Lost to Follow-up|0|||
164194610|NCT02595502|593080949|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
164547604|NCT01987960|594376841|FG003|Period 2|Withdrawal by Subject|0|||
164547605|NCT01987960|594376838|FG000|Period 2|Administrative or other reason|0|||
164547606|NCT01987960|594376839|FG001|Period 2|Administrative or other reason|5|||
164547607|NCT01987960|594376840|FG002|Period 2|Administrative or other reason|7|||
164547608|NCT01987960|594376841|FG003|Period 2|Administrative or other reason|0|||
164547609|NCT01987960|594376838|FG000|Period 3|Adverse Event|0|||
164547610|NCT01987960|594376839|FG001|Period 3|Adverse Event|0|||
164547611|NCT01987960|594376840|FG002|Period 3|Adverse Event|0|||
164547612|NCT01987960|594376841|FG003|Period 3|Adverse Event|7|||
164547613|NCT01987960|594376838|FG000|Period 3|Non-compliance with IMP|0|||
164547614|NCT01987960|594376839|FG001|Period 3|Non-compliance with IMP|0|||
164547615|NCT01987960|594376840|FG002|Period 3|Non-compliance with IMP|0|||
164547616|NCT01987960|594376841|FG003|Period 3|Non-compliance with IMP|1|||
164547617|NCT01987960|594376838|FG000|Period 3|Protocol Violation|0|||
164547618|NCT01987960|594376839|FG001|Period 3|Protocol Violation|0|||
164547619|NCT01987960|594376840|FG002|Period 3|Protocol Violation|0|||
164547620|NCT01987960|594376841|FG003|Period 3|Protocol Violation|6|||
164547621|NCT01987960|594376838|FG000|Period 3|Withdrawal by Subject|0|||
164547622|NCT01987960|594376839|FG001|Period 3|Withdrawal by Subject|0|||
164547623|NCT01987960|594376840|FG002|Period 3|Withdrawal by Subject|0|||
164547624|NCT01987960|594376841|FG003|Period 3|Withdrawal by Subject|9|||
164547625|NCT01987960|594376838|FG000|Period 3|Lost to Follow-up|0|||
164547626|NCT01987960|594376839|FG001|Period 3|Lost to Follow-up|0|||
164547627|NCT01987960|594376840|FG002|Period 3|Lost to Follow-up|0|||
164547628|NCT01987960|594376841|FG003|Period 3|Lost to Follow-up|5|||
164547629|NCT01987960|594376838|FG000|Period 3|Administrative or other reason|0|||
164194611|NCT02595502|593080950|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
164194612|NCT00974311|593080951|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
164194613|NCT00974311|593080952|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
164194614|NCT00974311|593080951|FG000|DB Phase (up to 24 Months)|Death|561|||
164194615|NCT00974311|593080952|FG001|DB Phase (up to 24 Months)|Death|298|||
164194616|NCT00974311|593080951|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
164547630|NCT01987960|594376839|FG001|Period 3|Administrative or other reason|0|||
164547631|NCT01987960|594376840|FG002|Period 3|Administrative or other reason|0|||
164547632|NCT01987960|594376841|FG003|Period 3|Administrative or other reason|43|||
164547633|NCT00789880|594376843|FG000|Overall Study|Adverse Event|0|||
164547634|NCT00789880|594376844|FG001|Overall Study|Adverse Event|0|||
164194617|NCT00974311|593080952|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
164194618|NCT00974311|593080951|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
164194619|NCT00974311|593080952|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
164194620|NCT00974311|593080951|FG000|DB Phase (up to 24 Months)|Other|1|||
164194621|NCT00974311|593080952|FG001|DB Phase (up to 24 Months)|Other|0|||
164194622|NCT00974311|593080951|FG000|OLE Phase (up to 77 Months)|Death|14|||
164194623|NCT00974311|593080952|FG001|OLE Phase (up to 77 Months)|Death|21|||
164194624|NCT00974311|593080951|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
164194625|NCT00974311|593080952|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
164194626|NCT00974311|593080951|FG000|OLE Phase (up to 77 Months)|Other|15|||
164194627|NCT00974311|593080952|FG001|OLE Phase (up to 77 Months)|Other|2|||
164194628|NCT00974311|593080951|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
164194629|NCT00974311|593080952|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
164194630|NCT03286218|593080955|FG000|Qualification Phase Period 1|Adverse Event|1|||
164194631|NCT03286218|593080956|FG001|Qualification Phase Period 1|Adverse Event|0|||
164194632|NCT03286218|593080957|FG002|Qualification Phase Period 1|Adverse Event|0|||
164547635|NCT00789880|594376845|FG002|Overall Study|Adverse Event|0|||
164547636|NCT00789880|594376846|FG003|Overall Study|Adverse Event|0|||
164547637|NCT00789880|594376847|FG004|Overall Study|Adverse Event|1|||
164547638|NCT00789880|594376848|FG005|Overall Study|Adverse Event|0|||
164547639|NCT00789880|594376843|FG000|Overall Study|Protocol Violation|0|||
164547640|NCT00789880|594376844|FG001|Overall Study|Protocol Violation|1|||
164547641|NCT00789880|594376845|FG002|Overall Study|Protocol Violation|0|||
164547642|NCT00789880|594376846|FG003|Overall Study|Protocol Violation|1|||
164547643|NCT00789880|594376847|FG004|Overall Study|Protocol Violation|0|||
164547644|NCT00789880|594376848|FG005|Overall Study|Protocol Violation|0|||
164547645|NCT00789880|594376843|FG000|Overall Study|Withdrawal by Subject|1|||
164547646|NCT00789880|594376844|FG001|Overall Study|Withdrawal by Subject|0|||
164547647|NCT00789880|594376845|FG002|Overall Study|Withdrawal by Subject|0|||
164547648|NCT00789880|594376846|FG003|Overall Study|Withdrawal by Subject|0|||
164547649|NCT00789880|594376847|FG004|Overall Study|Withdrawal by Subject|2|||
164547650|NCT00789880|594376848|FG005|Overall Study|Withdrawal by Subject|0|||
164547651|NCT01177683|594376849|FG000|Study Treatment|Disease Progressions during treatment|2|||
164547652|NCT01177683|594376850|FG001|Study Treatment|Disease Progressions during treatment|0|||
164547653|NCT01177683|594376851|FG002|Study Treatment|Disease Progressions during treatment|3|||
164547654|NCT01177683|594376849|FG000|Study Treatment|Adverse Event|0|||
164547655|NCT01177683|594376850|FG001|Study Treatment|Adverse Event|1|||
164547656|NCT01177683|594376851|FG002|Study Treatment|Adverse Event|12|||
164194633|NCT03286218|593080958|FG003|Qualification Phase Period 1|Adverse Event|0|||
164194634|NCT03286218|593080959|FG004|Qualification Phase Period 1|Adverse Event|0|||
164194635|NCT03286218|593080960|FG005|Qualification Phase Period 1|Adverse Event|0|||
164194636|NCT03286218|593080961|FG006|Qualification Phase Period 1|Adverse Event|0|||
164194637|NCT03286218|593080962|FG007|Qualification Phase Period 1|Adverse Event|0|||
164194638|NCT03286218|593080963|FG008|Qualification Phase Period 1|Adverse Event|0|||
164194639|NCT03286218|593080964|FG009|Qualification Phase Period 1|Adverse Event|0|||
164194640|NCT03286218|593080965|FG010|Qualification Phase Period 1|Adverse Event|0|||
164194641|NCT03286218|593080966|FG011|Qualification Phase Period 1|Adverse Event|0|||
164194642|NCT03286218|593080955|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
164194643|NCT03286218|593080956|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
164194644|NCT03286218|593080957|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
164194645|NCT03286218|593080958|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
164194646|NCT03286218|593080959|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
164194647|NCT03286218|593080960|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
164194648|NCT03286218|593080961|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
164194649|NCT03286218|593080962|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
164194650|NCT03286218|593080963|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
164194651|NCT03286218|593080964|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
164194652|NCT03286218|593080965|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
164194653|NCT03286218|593080966|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
164194654|NCT03286218|593080955|FG000|Qualification Phase Period 2|Adverse Event|0|||
164194655|NCT03286218|593080956|FG001|Qualification Phase Period 2|Adverse Event|1|||
164194656|NCT03286218|593080957|FG002|Qualification Phase Period 2|Adverse Event|0|||
164194657|NCT03286218|593080958|FG003|Qualification Phase Period 2|Adverse Event|0|||
164194658|NCT03286218|593080959|FG004|Qualification Phase Period 2|Adverse Event|0|||
164194659|NCT03286218|593080960|FG005|Qualification Phase Period 2|Adverse Event|0|||
164194660|NCT03286218|593080961|FG006|Qualification Phase Period 2|Adverse Event|0|||
164194661|NCT03286218|593080962|FG007|Qualification Phase Period 2|Adverse Event|0|||
164194662|NCT03286218|593080963|FG008|Qualification Phase Period 2|Adverse Event|0|||
164194663|NCT03286218|593080964|FG009|Qualification Phase Period 2|Adverse Event|0|||
164194664|NCT03286218|593080965|FG010|Qualification Phase Period 2|Adverse Event|0|||
164194665|NCT03286218|593080966|FG011|Qualification Phase Period 2|Adverse Event|0|||
164194666|NCT03286218|593080955|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
164194667|NCT03286218|593080956|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
164194668|NCT03286218|593080957|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
164194669|NCT03286218|593080958|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
164194670|NCT03286218|593080959|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
164194671|NCT03286218|593080960|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
164194672|NCT03286218|593080961|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
164194673|NCT03286218|593080962|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
164194674|NCT03286218|593080963|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
164194675|NCT03286218|593080964|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
164194676|NCT03286218|593080965|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
164194677|NCT03286218|593080966|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
164194678|NCT03286218|593080955|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
164194679|NCT03286218|593080956|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
164194680|NCT03286218|593080957|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
164194681|NCT03286218|593080958|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
164194682|NCT03286218|593080959|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
164194683|NCT03286218|593080960|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
164194684|NCT03286218|593080961|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
164194685|NCT03286218|593080962|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
164194686|NCT03286218|593080963|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
164194687|NCT03286218|593080964|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
164194688|NCT03286218|593080965|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
164194689|NCT03286218|593080966|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
164194690|NCT03286218|593080955|FG000|Qualification Phase Period 2|Protocol Violation|2|||
164194691|NCT03286218|593080956|FG001|Qualification Phase Period 2|Protocol Violation|0|||
164194692|NCT03286218|593080957|FG002|Qualification Phase Period 2|Protocol Violation|0|||
164194693|NCT03286218|593080958|FG003|Qualification Phase Period 2|Protocol Violation|0|||
164194694|NCT03286218|593080959|FG004|Qualification Phase Period 2|Protocol Violation|0|||
164194695|NCT03286218|593080960|FG005|Qualification Phase Period 2|Protocol Violation|0|||
164194696|NCT03286218|593080961|FG006|Qualification Phase Period 2|Protocol Violation|0|||
164194697|NCT03286218|593080962|FG007|Qualification Phase Period 2|Protocol Violation|0|||
164194698|NCT03286218|593080963|FG008|Qualification Phase Period 2|Protocol Violation|0|||
164194699|NCT03286218|593080964|FG009|Qualification Phase Period 2|Protocol Violation|0|||
164194700|NCT03286218|593080965|FG010|Qualification Phase Period 2|Protocol Violation|0|||
164194701|NCT03286218|593080966|FG011|Qualification Phase Period 2|Protocol Violation|0|||
164194702|NCT03286218|593080955|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
164194703|NCT03286218|593080956|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
164194704|NCT03286218|593080957|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
164194705|NCT03286218|593080958|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
164194706|NCT03286218|593080959|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
164194707|NCT03286218|593080960|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
164194708|NCT03286218|593080961|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
164194709|NCT03286218|593080962|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
164194710|NCT03286218|593080963|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
164194711|NCT03286218|593080964|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
164194712|NCT03286218|593080965|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
164194713|NCT03286218|593080966|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
164194714|NCT03286218|593080955|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
164194715|NCT03286218|593080956|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
164194716|NCT03286218|593080957|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
164194717|NCT03286218|593080958|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
164194718|NCT03286218|593080959|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
164194719|NCT03286218|593080960|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
164547657|NCT01177683|594376849|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
164547658|NCT01177683|594376850|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
164194720|NCT03286218|593080961|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
164194721|NCT03286218|593080962|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
164194722|NCT03286218|593080963|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
164194723|NCT03286218|593080964|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
164194724|NCT03286218|593080965|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
164194725|NCT03286218|593080966|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
164194726|NCT03286218|593080955|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
164194727|NCT03286218|593080956|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
164194728|NCT03286218|593080957|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
164194729|NCT03286218|593080958|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
164194730|NCT03286218|593080959|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
164194731|NCT03286218|593080960|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
164194732|NCT03286218|593080961|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
164194733|NCT03286218|593080962|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
164194734|NCT03286218|593080963|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
164194735|NCT03286218|593080964|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
164194736|NCT03286218|593080965|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
164194737|NCT03286218|593080966|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
164194738|NCT00458003|593080967|FG000|Overall Study|Non protocol spinal anesthesia|1|||
164194739|NCT00458003|593080968|FG001|Overall Study|Non protocol spinal anesthesia|1|||
164194740|NCT04556760|593080969|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
164194741|NCT04556760|593080970|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
164194742|NCT04556760|593080971|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
164194743|NCT04556760|593080972|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
164194744|NCT04556760|593080973|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
164194745|NCT04556760|593080974|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
164194746|NCT04556760|593080969|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
164547659|NCT01177683|594376851|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
164194747|NCT04556760|593080970|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
164194748|NCT04556760|593080971|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
164194749|NCT04556760|593080972|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
164194750|NCT04556760|593080973|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
164194751|NCT04556760|593080974|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
164194752|NCT02513550|593080975|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
164194753|NCT02513550|593080976|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
164194754|NCT02513550|593080977|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
164194755|NCT02513550|593080978|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
164194756|NCT02513550|593080979|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
164194757|NCT02513550|593080980|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
164547660|NCT01177683|594376849|FG000|Study Treatment|Alternative therapy|0|||
164547661|NCT01177683|594376850|FG001|Study Treatment|Alternative therapy|0|||
164547662|NCT01177683|594376851|FG002|Study Treatment|Alternative therapy|4|||
164547663|NCT01177683|594376849|FG000|Study Treatment|Physician Decision|1|||
164653676|NCT03342898|594758927|FG000|Overall Study|Reason not Specified|2|||
164194758|NCT02513550|593080975|FG000|Double Blind Treatment Period|Adverse Event|5|||
164194759|NCT02513550|593080976|FG001|Double Blind Treatment Period|Adverse Event|13|||
164194760|NCT02513550|593080977|FG002|Double Blind Treatment Period|Adverse Event|17|||
164194761|NCT02513550|593080978|FG003|Double Blind Treatment Period|Adverse Event|0|||
164194762|NCT02513550|593080979|FG004|Double Blind Treatment Period|Adverse Event|1|||
164194763|NCT02513550|593080980|FG005|Double Blind Treatment Period|Adverse Event|0|||
164194764|NCT02513550|593080975|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
164194765|NCT02513550|593080976|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
164194766|NCT02513550|593080977|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
164194767|NCT02513550|593080978|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
164194768|NCT02513550|593080979|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
164194769|NCT02513550|593080980|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
164194770|NCT02513550|593080975|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
164194771|NCT02513550|593080976|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
164194772|NCT02513550|593080977|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
164194773|NCT02513550|593080978|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
164194774|NCT02513550|593080979|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
164194775|NCT02513550|593080980|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
164194776|NCT02513550|593080975|FG000|Double Blind Treatment Period|Protocol Violation|1|||
164194777|NCT02513550|593080976|FG001|Double Blind Treatment Period|Protocol Violation|1|||
164194778|NCT02513550|593080977|FG002|Double Blind Treatment Period|Protocol Violation|4|||
164194779|NCT02513550|593080978|FG003|Double Blind Treatment Period|Protocol Violation|0|||
164194780|NCT02513550|593080979|FG004|Double Blind Treatment Period|Protocol Violation|0|||
164194781|NCT02513550|593080980|FG005|Double Blind Treatment Period|Protocol Violation|0|||
164194782|NCT02513550|593080975|FG000|Double Blind Treatment Period|Physician Decision|2|||
164194783|NCT02513550|593080976|FG001|Double Blind Treatment Period|Physician Decision|0|||
164194784|NCT02513550|593080977|FG002|Double Blind Treatment Period|Physician Decision|4|||
164194785|NCT02513550|593080978|FG003|Double Blind Treatment Period|Physician Decision|0|||
164194786|NCT02513550|593080979|FG004|Double Blind Treatment Period|Physician Decision|0|||
164194787|NCT02513550|593080980|FG005|Double Blind Treatment Period|Physician Decision|0|||
164194788|NCT02513550|593080975|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
164194789|NCT02513550|593080976|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
164194790|NCT02513550|593080977|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
164194791|NCT02513550|593080978|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
164194792|NCT02513550|593080979|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
164194793|NCT02513550|593080980|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
164194794|NCT02513550|593080975|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
164194795|NCT02513550|593080976|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
164194796|NCT02513550|593080977|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
164547664|NCT01177683|594376850|FG001|Study Treatment|Physician Decision|0|||
164547665|NCT01177683|594376851|FG002|Study Treatment|Physician Decision|1|||
164547666|NCT01177683|594376849|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
164547667|NCT01177683|594376850|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
164547668|NCT01177683|594376851|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
164547669|NCT01177683|594376849|FG000|Study Treatment|Symptomatic Deterioration|0|||
164547670|NCT01177683|594376850|FG001|Study Treatment|Symptomatic Deterioration|0|||
164547671|NCT01177683|594376851|FG002|Study Treatment|Symptomatic Deterioration|1|||
164194797|NCT02513550|593080978|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
164194798|NCT02513550|593080979|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
164194799|NCT02513550|593080980|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
164194800|NCT02513550|593080975|FG000|Double Blind Treatment Period|Due to personal business|2|||
164194801|NCT02513550|593080976|FG001|Double Blind Treatment Period|Due to personal business|0|||
164194802|NCT02513550|593080977|FG002|Double Blind Treatment Period|Due to personal business|1|||
164194803|NCT02513550|593080978|FG003|Double Blind Treatment Period|Due to personal business|0|||
164194804|NCT02513550|593080979|FG004|Double Blind Treatment Period|Due to personal business|0|||
164194805|NCT02513550|593080980|FG005|Double Blind Treatment Period|Due to personal business|0|||
164194806|NCT02513550|593080975|FG000|Double Blind Treatment Period|Death|1|||
164194807|NCT02513550|593080976|FG001|Double Blind Treatment Period|Death|0|||
164194808|NCT02513550|593080977|FG002|Double Blind Treatment Period|Death|2|||
164194809|NCT02513550|593080978|FG003|Double Blind Treatment Period|Death|0|||
164194810|NCT02513550|593080979|FG004|Double Blind Treatment Period|Death|0|||
164194811|NCT02513550|593080980|FG005|Double Blind Treatment Period|Death|0|||
164194812|NCT02513550|593080975|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
164194813|NCT02513550|593080976|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
164194814|NCT02513550|593080977|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
164547672|NCT01177683|594376849|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
164547673|NCT01177683|594376850|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
164194815|NCT02513550|593080978|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
164194816|NCT02513550|593080979|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
164194817|NCT02513550|593080980|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
164194818|NCT02513550|593080975|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
164194819|NCT02513550|593080976|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
164194820|NCT02513550|593080977|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
164547674|NCT01177683|594376851|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
164547675|NCT01177683|594376849|FG000|Follow up|Patient lost to follow up|0|||
164547676|NCT01177683|594376850|FG001|Follow up|Patient lost to follow up|0|||
164547677|NCT01177683|594376851|FG002|Follow up|Patient lost to follow up|2|||
164547678|NCT01177683|594376849|FG000|Follow up|Death|2|||
164547679|NCT01177683|594376850|FG001|Follow up|Death|1|||
164194821|NCT02513550|593080978|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
164194822|NCT02513550|593080979|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
164194823|NCT02513550|593080980|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
164194824|NCT02513550|593080975|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
164194825|NCT02513550|593080976|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
164194826|NCT02513550|593080977|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
164194827|NCT02513550|593080978|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
164194828|NCT02513550|593080979|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
164194829|NCT02513550|593080980|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
164194830|NCT02513550|593080975|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
164194831|NCT02513550|593080976|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
164194832|NCT02513550|593080977|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
164194833|NCT02513550|593080978|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
164194834|NCT02513550|593080979|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
164194835|NCT02513550|593080980|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
164194836|NCT02513550|593080975|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
164194837|NCT02513550|593080976|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
164194838|NCT02513550|593080977|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
164194839|NCT02513550|593080978|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
164194840|NCT02513550|593080979|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
164194841|NCT02513550|593080980|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
164194842|NCT02513550|593080975|FG000|Post-Treatment Follow-up Period|Death|0|||
164194843|NCT02513550|593080976|FG001|Post-Treatment Follow-up Period|Death|0|||
164194844|NCT02513550|593080977|FG002|Post-Treatment Follow-up Period|Death|1|||
164194845|NCT02513550|593080978|FG003|Post-Treatment Follow-up Period|Death|0|||
164194846|NCT02513550|593080979|FG004|Post-Treatment Follow-up Period|Death|0|||
164194847|NCT02513550|593080980|FG005|Post-Treatment Follow-up Period|Death|0|||
164194848|NCT02513550|593080975|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
164194849|NCT02513550|593080976|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
164194850|NCT02513550|593080977|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
164194851|NCT02513550|593080978|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
164547680|NCT01177683|594376851|FG002|Follow up|Death|7|||
164547681|NCT01177683|594376849|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
164547682|NCT01177683|594376850|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
164547683|NCT01177683|594376851|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
164547684|NCT06347731|594376852|FG000|Overall Study|Death|1|||
164547685|NCT06347731|594376852|FG000|Overall Study|Protocol Violation|1|||
164547686|NCT06347731|594376852|FG000|Overall Study|Withdrawal by Subject|2|||
164547687|NCT01131520|594376854|FG000|Overall Study|Computer problem|1|||
164547688|NCT01131520|594376855|FG001|Overall Study|Computer problem|0|||
164547689|NCT01131520|594376854|FG000|Overall Study|Counselor not available|0|||
164547690|NCT01131520|594376855|FG001|Overall Study|Counselor not available|3|||
164194852|NCT02513550|593080979|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
164194853|NCT02513550|593080980|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
164194854|NCT02513550|593080975|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
164194855|NCT02513550|593080976|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
164194856|NCT02513550|593080977|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
164194857|NCT02513550|593080978|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
164194858|NCT02513550|593080979|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
164194859|NCT02513550|593080980|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
164194860|NCT02513550|593080975|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
164194861|NCT02513550|593080976|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
164547691|NCT01131520|594376854|FG000|Overall Study|Subject changed history after enrollment|0|||
164547692|NCT01131520|594376855|FG001|Overall Study|Subject changed history after enrollment|1|||
164547693|NCT03302975|594376859|FG000|Overall Study|Lost to Follow-up|4|||
164547694|NCT01436084|594376860|FG000|Overall Study|Disease Progression|2|||
164547695|NCT01436084|594376860|FG000|Overall Study|Withdrawal by Subject|1|||
164547696|NCT01436084|594376860|FG000|Overall Study|Early Closure of Study|1|||
164547697|NCT04066491|594376865|FG000|Overall Study|Randomized, not treated|0|||
164653677|NCT03342898|594758928|FG001|Overall Study|Reason not Specified|2|||
164547698|NCT04066491|594376866|FG001|Overall Study|Randomized, not treated|0|||
164547699|NCT04066491|594376867|FG002|Overall Study|Randomized, not treated|2|||
164547700|NCT04506086|594376868|FG000|Overall Study|Withdrawal by Subject|2|||
164547701|NCT04490018|594376869|FG000|Overall Study|Protocol Violation|0|||
164547702|NCT04490018|594376870|FG001|Overall Study|Protocol Violation|2|||
164547703|NCT04490018|594376871|FG002|Overall Study|Protocol Violation|1|||
164547704|NCT04490018|594376869|FG000|Overall Study|Lost to Follow-up|2|||
164547705|NCT04490018|594376870|FG001|Overall Study|Lost to Follow-up|2|||
164547706|NCT04490018|594376871|FG002|Overall Study|Lost to Follow-up|0|||
164547707|NCT04490018|594376869|FG000|Overall Study|Withdrawal by Subject|2|||
164547708|NCT04490018|594376870|FG001|Overall Study|Withdrawal by Subject|1|||
164547709|NCT04490018|594376871|FG002|Overall Study|Withdrawal by Subject|0|||
164547710|NCT04490018|594376869|FG000|Overall Study|Withdrawal by parent/guardian|2|||
164547711|NCT04490018|594376870|FG001|Overall Study|Withdrawal by parent/guardian|3|||
164547712|NCT04490018|594376871|FG002|Overall Study|Withdrawal by parent/guardian|0|||
164547713|NCT01392677|594376874|FG000|Overall Study|Adverse Event|3|||
164547714|NCT01392677|594376875|FG001|Overall Study|Adverse Event|1|||
164547715|NCT01392677|594376874|FG000|Overall Study|Withdrawal by Subject|0|||
164547716|NCT01392677|594376875|FG001|Overall Study|Withdrawal by Subject|2|||
164547717|NCT01392677|594376874|FG000|Overall Study|Incorrect enrollment|2|||
164547718|NCT01392677|594376875|FG001|Overall Study|Incorrect enrollment|3|||
164653678|NCT03342898|594758929|FG002|Overall Study|Reason not Specified|0|||
164194862|NCT02513550|593080977|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
164194863|NCT02513550|593080978|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
164194864|NCT02513550|593080979|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
164194865|NCT02513550|593080980|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
164194866|NCT02849743|593080981|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
164194867|NCT02849743|593080982|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
164194868|NCT02849743|593080981|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
164194869|NCT02849743|593080982|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
164194870|NCT02168491|593080985|FG000|Overall Study|Withdrawal by Subject|1|||
164194871|NCT00809445|593080986|FG000|1 Month Follow-up|Lost contact|1|||
164194872|NCT00809445|593080987|FG001|1 Month Follow-up|Lost contact|2|||
164194873|NCT00809445|593080988|FG002|1 Month Follow-up|Lost contact|1|||
164194874|NCT00809445|593080986|FG000|1 Month Follow-up|Withdrew consent|1|||
164194875|NCT00809445|593080987|FG001|1 Month Follow-up|Withdrew consent|1|||
164194876|NCT00809445|593080988|FG002|1 Month Follow-up|Withdrew consent|1|||
164194877|NCT00809445|593080986|FG000|1 Month Follow-up|Death|0|||
164194878|NCT00809445|593080987|FG001|1 Month Follow-up|Death|1|||
164194879|NCT00809445|593080988|FG002|1 Month Follow-up|Death|1|||
164194880|NCT00809445|593080986|FG000|1 Month Follow-up|Incarcerated|0|||
164194881|NCT00809445|593080987|FG001|1 Month Follow-up|Incarcerated|0|||
164194882|NCT00809445|593080988|FG002|1 Month Follow-up|Incarcerated|1|||
164194883|NCT00809445|593080986|FG000|6 Month Follow-up|Lost contact|16|||
164194884|NCT00809445|593080987|FG001|6 Month Follow-up|Lost contact|14|||
164194885|NCT00809445|593080988|FG002|6 Month Follow-up|Lost contact|14|||
164194886|NCT00809445|593080986|FG000|6 Month Follow-up|Death|2|||
164194887|NCT00809445|593080987|FG001|6 Month Follow-up|Death|1|||
164194888|NCT00809445|593080988|FG002|6 Month Follow-up|Death|1|||
164194889|NCT00809445|593080986|FG000|6 Month Follow-up|Incarcerated|6|||
164194890|NCT00809445|593080987|FG001|6 Month Follow-up|Incarcerated|8|||
164194891|NCT00809445|593080988|FG002|6 Month Follow-up|Incarcerated|8|||
164194892|NCT00809445|593080986|FG000|6 Month Follow-up|Withdrew consent|0|||
164194893|NCT00809445|593080987|FG001|6 Month Follow-up|Withdrew consent|0|||
164194894|NCT00809445|593080988|FG002|6 Month Follow-up|Withdrew consent|1|||
164194895|NCT04919317|593080989|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
164194896|NCT04919317|593080990|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
164194897|NCT04919317|593080989|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
164194898|NCT04919317|593080990|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
164547719|NCT01392677|594376874|FG000|Overall Study|Other reason|3|||
164547720|NCT01392677|594376875|FG001|Overall Study|Other reason|2|||
164653679|NCT03997448|594758930|FG000|Study Treatment|Disease Progression|1|||
164653680|NCT03997448|594758930|FG000|Study Treatment|Symptomatic Deterioration|1|||
164653681|NCT03997448|594758930|FG000|Follow up|Death|2|||
164653682|NCT03997448|594758930|FG000|Follow up|study terminated|1|||
164653683|NCT01312779|594758931|FG000|Overall Study|Withdrawal by Subject|2|||
164653684|NCT01312779|594758931|FG000|Overall Study|Death|3|||
164194899|NCT01566604|593080991|FG000|Overall Study|Patient's inability to use the device|1|||
164194900|NCT01566604|593080992|FG001|Overall Study|Patient's inability to use the device|0|||
164194901|NCT01566604|593080991|FG000|Overall Study|Administrative problems|1|||
164194902|NCT01566604|593080992|FG001|Overall Study|Administrative problems|0|||
164194903|NCT01566604|593080991|FG000|Overall Study|Lack of Efficacy|1|||
164194904|NCT01566604|593080992|FG001|Overall Study|Lack of Efficacy|2|||
164547721|NCT03996876|594376878|FG000|Overall Study|Incomplete Data|2|||
164194905|NCT01566604|593080991|FG000|Overall Study|Protocol deviation|2|||
164194906|NCT01566604|593080992|FG001|Overall Study|Protocol deviation|0|||
164194907|NCT01566604|593080991|FG000|Overall Study|Abnormal laboratory value|2|||
164194908|NCT01566604|593080992|FG001|Overall Study|Abnormal laboratory value|0|||
164194909|NCT01566604|593080991|FG000|Overall Study|Death|4|||
164194910|NCT01566604|593080992|FG001|Overall Study|Death|1|||
164194911|NCT01566604|593080991|FG000|Overall Study|Adverse Event|4|||
164194912|NCT01566604|593080992|FG001|Overall Study|Adverse Event|2|||
164653685|NCT01312779|594758931|FG000|Overall Study|Not Implanted with Device|27|||
164653686|NCT02482805|594758932|FG000|Overall Study|Lost to Follow-up|4|||
164653687|NCT02482805|594758933|FG001|Overall Study|Lost to Follow-up|4|||
164653688|NCT02482805|594758934|FG002|Overall Study|Lost to Follow-up|0|||
164653689|NCT01806597|594758935|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
164653690|NCT01806597|594758936|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
164653691|NCT01806597|594758937|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
164653692|NCT01806597|594758938|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
164653693|NCT01806597|594758939|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
164653694|NCT01806597|594758940|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
164653695|NCT01806597|594758935|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
164653696|NCT01806597|594758936|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
164653697|NCT01806597|594758937|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
164653698|NCT01806597|594758938|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
164653699|NCT01806597|594758939|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
164653700|NCT01806597|594758940|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
164653701|NCT01806597|594758935|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
164653702|NCT01806597|594758936|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
164653703|NCT01806597|594758937|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
164653704|NCT01806597|594758938|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
164653705|NCT01806597|594758939|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
164653706|NCT01806597|594758940|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
164653707|NCT01806597|594758935|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
164653708|NCT01806597|594758936|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
164653709|NCT01806597|594758937|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
164653710|NCT01806597|594758938|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
164653711|NCT01806597|594758939|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
164653712|NCT01806597|594758940|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
164653713|NCT01806597|594758935|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
164653714|NCT01806597|594758936|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
164653715|NCT01806597|594758937|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
164653716|NCT01806597|594758938|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
164653717|NCT01806597|594758939|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
164653718|NCT01806597|594758940|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
164653719|NCT01806597|594758935|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
164653720|NCT01806597|594758936|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
164653721|NCT01806597|594758937|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
164653722|NCT01806597|594758938|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
164653723|NCT01806597|594758939|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
164653724|NCT01806597|594758940|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
164653725|NCT01806597|594758935|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
164194913|NCT01566604|593080991|FG000|Overall Study|Withdrawal by Subject|9|||
164194914|NCT01566604|593080992|FG001|Overall Study|Withdrawal by Subject|6|||
164194915|NCT01443858|593080999|FG000|Overall Study|Withdrawal by Subject|9|||
164194916|NCT01443858|593081000|FG001|Overall Study|Withdrawal by Subject|8|||
164194917|NCT01443858|593081001|FG002|Overall Study|Withdrawal by Subject|5|||
164194918|NCT01443858|593080999|FG000|Overall Study|Lack of Efficacy|1|||
164194919|NCT01443858|593081000|FG001|Overall Study|Lack of Efficacy|0|||
164194920|NCT01443858|593081001|FG002|Overall Study|Lack of Efficacy|0|||
164194921|NCT01443858|593080999|FG000|Overall Study|Lost to Follow-up|5|||
164194922|NCT01443858|593081000|FG001|Overall Study|Lost to Follow-up|5|||
164194923|NCT01443858|593081001|FG002|Overall Study|Lost to Follow-up|2|||
164194924|NCT06060496|593081002|FG000|Overall Study|Withdrawal by Subject|2|||
164194925|NCT06060496|593081002|FG000|Overall Study|Lost to Follow-up|2|||
164194926|NCT00321906|593081005|FG000|Overall Study|Adverse Event|36|||
164194927|NCT00321906|593081006|FG001|Overall Study|Adverse Event|44|||
164194928|NCT00321906|593081005|FG000|Overall Study|Death|9|||
164194929|NCT00321906|593081006|FG001|Overall Study|Death|6|||
164194930|NCT00321906|593081005|FG000|Overall Study|Lost to Follow-up|1|||
164194931|NCT00321906|593081006|FG001|Overall Study|Lost to Follow-up|2|||
164194932|NCT00321906|593081005|FG000|Overall Study|Withdrawal by Subject|0|||
164194933|NCT00321906|593081006|FG001|Overall Study|Withdrawal by Subject|4|||
164194934|NCT02221648|593081007|FG000|Overall Study|Withdrawal by Subject|3|||
164194935|NCT02221648|593081008|FG001|Overall Study|Withdrawal by Subject|3|||
164194936|NCT00149396|593081011|FG000|Overall Study|Death|15|||
164194937|NCT00149396|593081011|FG000|Overall Study|Withdrawal by Subject|1|||
164194938|NCT00149396|593081011|FG000|Overall Study|Subject noncompliance|2|||
164194939|NCT00149396|593081011|FG000|Overall Study|other treatment|5|||
164194940|NCT00810069|593081012|FG000|Lead-in Period I|Adverse Event|43|||
164194941|NCT00810069|593081013|FG001|Lead-in Period I|Adverse Event|0|||
164194942|NCT00810069|593081014|FG002|Lead-in Period I|Adverse Event|0|||
164194943|NCT00810069|593081012|FG000|Lead-in Period I|Lack of Efficacy|1|||
164194944|NCT00810069|593081013|FG001|Lead-in Period I|Lack of Efficacy|0|||
164194945|NCT00810069|593081014|FG002|Lead-in Period I|Lack of Efficacy|0|||
164194946|NCT00810069|593081012|FG000|Lead-in Period I|Lost to Follow-up|19|||
164194947|NCT00810069|593081013|FG001|Lead-in Period I|Lost to Follow-up|0|||
164194948|NCT00810069|593081014|FG002|Lead-in Period I|Lost to Follow-up|0|||
164194949|NCT00810069|593081012|FG000|Lead-in Period I|Physician Decision|1|||
164194950|NCT00810069|593081013|FG001|Lead-in Period I|Physician Decision|0|||
164194951|NCT00810069|593081014|FG002|Lead-in Period I|Physician Decision|0|||
164194952|NCT00810069|593081012|FG000|Lead-in Period I|Protocol Violation|1|||
164194953|NCT00810069|593081013|FG001|Lead-in Period I|Protocol Violation|0|||
164194954|NCT00810069|593081014|FG002|Lead-in Period I|Protocol Violation|0|||
164194955|NCT00810069|593081012|FG000|Lead-in Period I|Withdrawal by Subject|46|||
164194956|NCT00810069|593081013|FG001|Lead-in Period I|Withdrawal by Subject|0|||
164194957|NCT00810069|593081014|FG002|Lead-in Period I|Withdrawal by Subject|0|||
164194958|NCT00810069|593081012|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
164194959|NCT00810069|593081013|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
164194960|NCT00810069|593081014|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
164194961|NCT00810069|593081012|FG000|Lead-in Period I|Randomization criteria not met|158|||
164194962|NCT00810069|593081013|FG001|Lead-in Period I|Randomization criteria not met|0|||
164194963|NCT00810069|593081014|FG002|Lead-in Period I|Randomization criteria not met|0|||
164194964|NCT00810069|593081012|FG000|Double-Blind Period II|Adverse Event|0|||
164194965|NCT00810069|593081013|FG001|Double-Blind Period II|Adverse Event|9|||
164194966|NCT00810069|593081014|FG002|Double-Blind Period II|Adverse Event|8|||
164194967|NCT00810069|593081012|FG000|Double-Blind Period II|Lack of Efficacy|0|||
164194968|NCT00810069|593081013|FG001|Double-Blind Period II|Lack of Efficacy|7|||
164194969|NCT00810069|593081014|FG002|Double-Blind Period II|Lack of Efficacy|12|||
164194970|NCT00810069|593081012|FG000|Double-Blind Period II|Lost to Follow-up|0|||
164194971|NCT00810069|593081013|FG001|Double-Blind Period II|Lost to Follow-up|9|||
164194972|NCT00810069|593081014|FG002|Double-Blind Period II|Lost to Follow-up|9|||
164194973|NCT00810069|593081012|FG000|Double-Blind Period II|Physician Decision|0|||
164194974|NCT00810069|593081013|FG001|Double-Blind Period II|Physician Decision|0|||
164194975|NCT00810069|593081014|FG002|Double-Blind Period II|Physician Decision|1|||
164194976|NCT00810069|593081012|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
164194977|NCT00810069|593081013|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
164194978|NCT00810069|593081014|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
164194979|NCT00810069|593081012|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
164194980|NCT00810069|593081013|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
164194981|NCT00810069|593081014|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
164194982|NCT00810069|593081012|FG000|Double-Blind Period II|Clinical relapse|0|||
164194983|NCT00810069|593081013|FG001|Double-Blind Period II|Clinical relapse|3|||
164194984|NCT00810069|593081014|FG002|Double-Blind Period II|Clinical relapse|0|||
164194985|NCT00810069|593081012|FG000|Double-Blind Period II|Protocol Violation|0|||
164194986|NCT00810069|593081013|FG001|Double-Blind Period II|Protocol Violation|7|||
164194987|NCT00810069|593081014|FG002|Double-Blind Period II|Protocol Violation|6|||
164194988|NCT00426764|593081017|FG000|Overall Study|Protocol Violation|1|||
164194989|NCT00426764|593081017|FG000|Overall Study|Withdrawal by Subject|4|||
164194990|NCT00426764|593081017|FG000|Overall Study|Physician Decision|6|||
164194991|NCT00426764|593081017|FG000|Overall Study|Compassionate Use|1|||
164194992|NCT00426764|593081017|FG000|Overall Study|Progressive Disease|83|||
164194993|NCT00426764|593081017|FG000|Overall Study|Adverse Event|24|||
164194994|NCT00426764|593081017|FG000|Overall Study|Other|1|||
164194995|NCT00426764|593081017|FG000|Overall Study|Death|1|||
164194996|NCT00426764|593081017|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
164194997|NCT01922258|593081018|FG000|Overall Study|Lost to Follow-up|1|||
164194998|NCT01922258|593081019|FG001|Overall Study|Lost to Follow-up|1|||
164194999|NCT01922258|593081018|FG000|Overall Study|Adverse Event|9|||
164195000|NCT01922258|593081019|FG001|Overall Study|Adverse Event|2|||
164195001|NCT01922258|593081018|FG000|Overall Study|Met Withdrawal Criteria|0|||
164195002|NCT01922258|593081019|FG001|Overall Study|Met Withdrawal Criteria|4|||
164195003|NCT01922258|593081018|FG000|Overall Study|Withdrawn by the Investigator|1|||
164195004|NCT01922258|593081019|FG001|Overall Study|Withdrawn by the Investigator|4|||
164195005|NCT01922258|593081018|FG000|Overall Study|Withdrawal by participant|5|||
164195006|NCT01922258|593081019|FG001|Overall Study|Withdrawal by participant|5|||
164195007|NCT03113968|593081020|FG000|Overall Study|Withdrawal by Subject|31|||
164195008|NCT03113968|593081021|FG001|Overall Study|Withdrawal by Subject|4|||
164195009|NCT00901342|593081022|FG000|Overall Study|Adverse Event|1|||
164195010|NCT00901342|593081022|FG000|Overall Study|Death|4|||
164195011|NCT00901342|593081022|FG000|Overall Study|Disease progression|1|||
164195012|NCT00901342|593081022|FG000|Overall Study|Withdrawal by Subject|9|||
164195013|NCT02782741|593081023|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
164195014|NCT02782741|593081024|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
164195015|NCT02782741|593081025|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
164195016|NCT02782741|593081023|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
164195017|NCT02782741|593081024|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
164195018|NCT02782741|593081025|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
164195019|NCT02782741|593081023|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
164195020|NCT02782741|593081024|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
164195021|NCT02782741|593081025|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
164195022|NCT02782741|593081023|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
164195023|NCT02782741|593081024|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
164195024|NCT02782741|593081025|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
164195025|NCT02782741|593081023|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
164195026|NCT02782741|593081024|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
164195027|NCT02782741|593081025|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
164195028|NCT05116202|593081026|FG000|Overall Study|Study Terminated by Sponsor|21|||
164195029|NCT05116202|593081027|FG001|Overall Study|Study Terminated by Sponsor|38|||
164195030|NCT05116202|593081028|FG002|Overall Study|Study Terminated by Sponsor|17|||
164195031|NCT05116202|593081029|FG003|Overall Study|Study Terminated by Sponsor|18|||
164195032|NCT05116202|593081030|FG004|Overall Study|Study Terminated by Sponsor|0|||
164195033|NCT05116202|593081026|FG000|Overall Study|Withdrawal by Subject|0|||
164195034|NCT05116202|593081027|FG001|Overall Study|Withdrawal by Subject|1|||
164195035|NCT05116202|593081028|FG002|Overall Study|Withdrawal by Subject|1|||
164195036|NCT05116202|593081029|FG003|Overall Study|Withdrawal by Subject|1|||
164195037|NCT05116202|593081030|FG004|Overall Study|Withdrawal by Subject|1|||
164195038|NCT05116202|593081026|FG000|Overall Study|Lost to Follow-up|0|||
164195039|NCT05116202|593081027|FG001|Overall Study|Lost to Follow-up|0|||
164195040|NCT05116202|593081028|FG002|Overall Study|Lost to Follow-up|0|||
164195041|NCT05116202|593081029|FG003|Overall Study|Lost to Follow-up|0|||
164195042|NCT05116202|593081030|FG004|Overall Study|Lost to Follow-up|2|||
164195043|NCT05116202|593081026|FG000|Overall Study|Death|1|||
164195044|NCT05116202|593081027|FG001|Overall Study|Death|1|||
164195045|NCT05116202|593081028|FG002|Overall Study|Death|2|||
164195046|NCT05116202|593081029|FG003|Overall Study|Death|1|||
164195047|NCT05116202|593081030|FG004|Overall Study|Death|5|||
164195048|NCT02686164|593081034|FG000|Overall Study|Adverse Event|1|||
164195049|NCT02686164|593081034|FG000|Overall Study|Withdrawal of consent|1|||
164195050|NCT02686164|593081034|FG000|Overall Study|Clinical progression|1|||
164195051|NCT01827592|593081037|FG000|Overall Study|Adverse Event|11|||
164547722|NCT03996876|594376879|FG001|Overall Study|Incomplete Data|4|||
164547723|NCT00121108|594376880|FG000|Overall Study|Lost to Follow-up|10|||
164547724|NCT00121108|594376881|FG001|Overall Study|Lost to Follow-up|22|||
164195052|NCT01827592|593081038|FG001|Overall Study|Adverse Event|9|||
164195053|NCT01827592|593081039|FG002|Overall Study|Adverse Event|2|||
164195054|NCT01827592|593081037|FG000|Overall Study|Physician Decision|0|||
164195055|NCT01827592|593081038|FG001|Overall Study|Physician Decision|2|||
164195056|NCT01827592|593081039|FG002|Overall Study|Physician Decision|1|||
164195057|NCT01827592|593081037|FG000|Overall Study|Protocol Violation|2|||
164195058|NCT01827592|593081038|FG001|Overall Study|Protocol Violation|1|||
164195059|NCT01827592|593081039|FG002|Overall Study|Protocol Violation|0|||
164195060|NCT01827592|593081037|FG000|Overall Study|Lost to Follow-up|1|||
164195061|NCT01827592|593081038|FG001|Overall Study|Lost to Follow-up|2|||
164195062|NCT01827592|593081039|FG002|Overall Study|Lost to Follow-up|2|||
164195063|NCT01827592|593081037|FG000|Overall Study|Withdrawal by Subject|12|||
164195064|NCT01827592|593081038|FG001|Overall Study|Withdrawal by Subject|11|||
164195065|NCT01827592|593081039|FG002|Overall Study|Withdrawal by Subject|11|||
164195066|NCT01827592|593081037|FG000|Overall Study|Patient's substantial non-compliance|1|||
164195067|NCT01827592|593081038|FG001|Overall Study|Patient's substantial non-compliance|1|||
164195068|NCT01827592|593081039|FG002|Overall Study|Patient's substantial non-compliance|6|||
164195069|NCT01827592|593081037|FG000|Overall Study|Trial terminated by Sponsor|47|||
164195070|NCT01827592|593081038|FG001|Overall Study|Trial terminated by Sponsor|53|||
164195071|NCT01827592|593081039|FG002|Overall Study|Trial terminated by Sponsor|51|||
164195072|NCT01827592|593081037|FG000|Overall Study|Others|0|||
164195073|NCT01827592|593081038|FG001|Overall Study|Others|1|||
164195074|NCT01827592|593081039|FG002|Overall Study|Others|3|||
164195075|NCT02324361|593081040|FG000|Overall Study|Lost to Follow-up|5|||
164195076|NCT02324361|593081041|FG001|Overall Study|Lost to Follow-up|2|||
164195077|NCT02329327|593081049|FG000|Overall Study|Death|78|||
164195078|NCT02329327|593081050|FG001|Overall Study|Death|0|||
164195079|NCT02329327|593081049|FG000|Overall Study|Withdrawal by Subject|3|||
164195080|NCT02329327|593081050|FG001|Overall Study|Withdrawal by Subject|0|||
164195081|NCT02329327|593081049|FG000|Overall Study|Lost to Follow-up|4|||
164195082|NCT02329327|593081050|FG001|Overall Study|Lost to Follow-up|0|||
164195083|NCT03560869|593081051|FG000|Overall Study|Withdrawal by Subject|3|||
164195084|NCT03560869|593081052|FG001|Overall Study|Withdrawal by Subject|4|||
164195085|NCT03560869|593081051|FG000|Overall Study|Screening failure|4|||
164195086|NCT03560869|593081052|FG001|Overall Study|Screening failure|4|||
164195087|NCT03560869|593081051|FG000|Overall Study|Withdrawal by PI|0|||
164195088|NCT03560869|593081052|FG001|Overall Study|Withdrawal by PI|1|||
164195089|NCT03718429|593081053|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
164195090|NCT03718429|593081054|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
164195091|NCT03718429|593081055|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
164195092|NCT03718429|593081056|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
164195093|NCT02346877|593081057|FG000|Overall Study|Adverse Event|1|||
164195094|NCT02346877|593081058|FG001|Overall Study|Adverse Event|0|||
164195095|NCT02346877|593081057|FG000|Overall Study|Administrative Decision|1|||
164195096|NCT02346877|593081058|FG001|Overall Study|Administrative Decision|0|||
164195097|NCT02346877|593081057|FG000|Overall Study|Sponsor Decision|12|||
164195098|NCT02346877|593081058|FG001|Overall Study|Sponsor Decision|0|||
164195099|NCT02346877|593081057|FG000|Overall Study|Missing|5|||
164547725|NCT00121108|594376880|FG000|Overall Study|Withdrawal by Subject|106|||
164547726|NCT00121108|594376881|FG001|Overall Study|Withdrawal by Subject|195|||
164547727|NCT00121108|594376880|FG000|Overall Study|Death|5|||
164547728|NCT00121108|594376881|FG001|Overall Study|Death|8|||
164547729|NCT01380379|594376882|FG000|Overall Study|Pregnancy|1|||
164547730|NCT06608368|594376885|FG000|Overall Study|Family Emergency|0|||
164547731|NCT06608368|594376886|FG001|Overall Study|Family Emergency|1|||
164547732|NCT06608368|594376887|FG002|Overall Study|Family Emergency|0|||
164547733|NCT06608368|594376885|FG000|Overall Study|Scheduling Issues|0|||
164547734|NCT06608368|594376886|FG001|Overall Study|Scheduling Issues|1|||
164547735|NCT06608368|594376887|FG002|Overall Study|Scheduling Issues|0|||
164547736|NCT03977974|594376888|FG000|Period 2|Adverse Event|0|||
164547737|NCT03977974|594376889|FG001|Period 2|Adverse Event|0|||
164547738|NCT03977974|594376890|FG002|Period 2|Adverse Event|0|||
164547739|NCT03977974|594376891|FG003|Period 2|Adverse Event|0|||
164547740|NCT03977974|594376892|FG004|Period 2|Adverse Event|1|||
164547741|NCT03977974|594376893|FG005|Period 2|Adverse Event|0|||
164547742|NCT03977974|594376894|FG006|Period 2|Adverse Event|0|||
164547743|NCT03977974|594376895|FG007|Period 2|Adverse Event|0|||
164547744|NCT03977974|594376896|FG008|Period 2|Adverse Event|0|||
164547745|NCT03977974|594376897|FG009|Period 2|Adverse Event|0|||
164547746|NCT03977974|594376898|FG010|Period 2|Adverse Event|0|||
164547747|NCT03977974|594376899|FG011|Period 2|Adverse Event|0|||
164547748|NCT03977974|594376900|FG012|Period 2|Adverse Event|0|||
164653726|NCT01806597|594758936|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
164653727|NCT01806597|594758937|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
164653728|NCT01806597|594758938|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
164195100|NCT02346877|593081058|FG001|Overall Study|Missing|0|||
164195101|NCT01386606|593083222|FG000|Overall Study|Adverse Event|0|||
164195102|NCT01386606|593083223|FG001|Overall Study|Adverse Event|1|||
164195103|NCT01386606|593083224|FG002|Overall Study|Adverse Event|0|||
164195104|NCT01386606|593083225|FG003|Overall Study|Adverse Event|0|||
164547749|NCT03080883|594376901|FG000|Overall Study|Withdrawal by Subject|11|||
164547750|NCT03080883|594376902|FG001|Overall Study|Withdrawal by Subject|15|||
164547751|NCT03080883|594376901|FG000|Overall Study|Adverse Event|22|||
164547752|NCT03080883|594376902|FG001|Overall Study|Adverse Event|22|||
164547753|NCT03080883|594376901|FG000|Overall Study|Alternative Therapy|0|||
164547754|NCT03080883|594376902|FG001|Overall Study|Alternative Therapy|3|||
164547755|NCT03080883|594376901|FG000|Overall Study|Other Complicating Disease|9|||
164195105|NCT01386606|593083222|FG000|Overall Study|Withdrawal by Subject|0|||
164547756|NCT03080883|594376902|FG001|Overall Study|Other Complicating Disease|5|||
164195106|NCT01386606|593083223|FG001|Overall Study|Withdrawal by Subject|1|||
164195107|NCT01386606|593083224|FG002|Overall Study|Withdrawal by Subject|1|||
164195108|NCT01386606|593083225|FG003|Overall Study|Withdrawal by Subject|0|||
164195109|NCT01386606|593083222|FG000|Overall Study|Protocol Violation|1|||
164195110|NCT01386606|593083223|FG001|Overall Study|Protocol Violation|0|||
164195111|NCT01386606|593083224|FG002|Overall Study|Protocol Violation|1|||
164195112|NCT01386606|593083225|FG003|Overall Study|Protocol Violation|1|||
164195113|NCT01386606|593083222|FG000|Overall Study|Lost to Follow-up|2|||
164195114|NCT01386606|593083223|FG001|Overall Study|Lost to Follow-up|0|||
164195115|NCT01386606|593083224|FG002|Overall Study|Lost to Follow-up|0|||
164195116|NCT01386606|593083225|FG003|Overall Study|Lost to Follow-up|0|||
164195117|NCT01386606|593083222|FG000|Overall Study|Subject incarcerated|0|||
164195118|NCT01386606|593083223|FG001|Overall Study|Subject incarcerated|1|||
164195119|NCT01386606|593083224|FG002|Overall Study|Subject incarcerated|0|||
164195120|NCT01386606|593083225|FG003|Overall Study|Subject incarcerated|0|||
164195121|NCT01386606|593083222|FG000|Overall Study|Unable to draw PK|1|||
164195122|NCT01386606|593083223|FG001|Overall Study|Unable to draw PK|0|||
164195123|NCT01386606|593083224|FG002|Overall Study|Unable to draw PK|0|||
164195124|NCT01386606|593083225|FG003|Overall Study|Unable to draw PK|0|||
164195125|NCT01386606|593083222|FG000|Overall Study|T levels too high|0|||
164195126|NCT01386606|593083223|FG001|Overall Study|T levels too high|1|||
164195127|NCT01386606|593083224|FG002|Overall Study|T levels too high|1|||
164195128|NCT01386606|593083225|FG003|Overall Study|T levels too high|0|||
164547757|NCT03080883|594376901|FG000|Overall Study|Death|21|||
164547758|NCT03080883|594376902|FG001|Overall Study|Death|16|||
164547759|NCT03080883|594376901|FG000|Overall Study|Physician Decision|2|||
164547760|NCT03080883|594376902|FG001|Overall Study|Physician Decision|2|||
164547761|NCT03080883|594376901|FG000|Overall Study|Disease Progression|2|||
164547762|NCT03080883|594376902|FG001|Overall Study|Disease Progression|8|||
164547763|NCT03080883|594376901|FG000|Overall Study|Lost to Follow-up|1|||
164547764|NCT03080883|594376902|FG001|Overall Study|Lost to Follow-up|1|||
164195129|NCT00593814|593083227|FG000|Overall Study|Death|7|||
164195130|NCT00593814|593083228|FG001|Overall Study|Death|0|||
164195131|NCT00593814|593083227|FG000|Overall Study|Withdrawal by Subject|7|||
164195132|NCT00593814|593083228|FG001|Overall Study|Withdrawal by Subject|0|||
164195133|NCT00593814|593083227|FG000|Overall Study|Lost to Follow-up|7|||
164195134|NCT00593814|593083228|FG001|Overall Study|Lost to Follow-up|0|||
164195135|NCT00593814|593083227|FG000|Overall Study|Physician Decision|3|||
164195136|NCT00593814|593083228|FG001|Overall Study|Physician Decision|0|||
164195137|NCT02723188|593083231|FG000|Overall Study|Withdrawal by Subject|1|||
164195138|NCT02723188|593083232|FG001|Overall Study|Withdrawal by Subject|0|||
164195139|NCT02723188|593083233|FG002|Overall Study|Withdrawal by Subject|0|||
164195140|NCT03110354|593083237|FG000|Overall Study|Death|1|||
164195141|NCT03110354|593083238|FG001|Overall Study|Death|0|||
164195142|NCT03110354|593083239|FG002|Overall Study|Death|0|||
164195143|NCT03110354|593083240|FG003|Overall Study|Death|1|||
164195144|NCT03110354|593083241|FG004|Overall Study|Death|0|||
164195145|NCT03110354|593083237|FG000|Overall Study|Start of new therapy|0|||
164195146|NCT03110354|593083238|FG001|Overall Study|Start of new therapy|0|||
164195147|NCT03110354|593083239|FG002|Overall Study|Start of new therapy|0|||
164195148|NCT03110354|593083240|FG003|Overall Study|Start of new therapy|0|||
164195149|NCT03110354|593083241|FG004|Overall Study|Start of new therapy|1|||
164195150|NCT03110354|593083237|FG000|Overall Study|Failure to achieve response|2|||
164195151|NCT03110354|593083238|FG001|Overall Study|Failure to achieve response|3|||
164195152|NCT03110354|593083239|FG002|Overall Study|Failure to achieve response|0|||
164195153|NCT03110354|593083240|FG003|Overall Study|Failure to achieve response|2|||
164195154|NCT03110354|593083241|FG004|Overall Study|Failure to achieve response|1|||
164195155|NCT03110354|593083237|FG000|Overall Study|Progressive disease|1|||
164195156|NCT03110354|593083238|FG001|Overall Study|Progressive disease|1|||
164195157|NCT03110354|593083239|FG002|Overall Study|Progressive disease|3|||
164195158|NCT03110354|593083240|FG003|Overall Study|Progressive disease|4|||
164195159|NCT03110354|593083241|FG004|Overall Study|Progressive disease|2|||
164195160|NCT03110354|593083237|FG000|Overall Study|Adverse Event|0|||
164195161|NCT03110354|593083238|FG001|Overall Study|Adverse Event|0|||
164195162|NCT03110354|593083239|FG002|Overall Study|Adverse Event|0|||
164195163|NCT03110354|593083240|FG003|Overall Study|Adverse Event|2|||
164195164|NCT03110354|593083241|FG004|Overall Study|Adverse Event|2|||
164195165|NCT03110354|593083237|FG000|Overall Study|Other|0|||
164195166|NCT03110354|593083238|FG001|Overall Study|Other|0|||
164195167|NCT03110354|593083239|FG002|Overall Study|Other|0|||
164195168|NCT03110354|593083240|FG003|Overall Study|Other|1|||
164195169|NCT03110354|593083241|FG004|Overall Study|Other|1|||
164195170|NCT02026141|593083248|FG000|Overall Study|Protocol Violation|0|||
164547765|NCT00388973|594378193|FG000|Overall Study|Adverse Event|16|||
164547766|NCT00388973|594378194|FG001|Overall Study|Adverse Event|6|||
164547767|NCT00388973|594378193|FG000|Overall Study|Lack of Efficacy|1|||
164195171|NCT02026141|593083249|FG001|Overall Study|Protocol Violation|1|||
164195172|NCT02169505|593083250|FG000|Overall Study|Withdrawal by Subject|1|||
164195173|NCT02735980|593083251|FG000|Overall Study|Adverse Event|0|||
164195174|NCT02735980|593083252|FG001|Overall Study|Adverse Event|4|||
164195175|NCT02735980|593083253|FG002|Overall Study|Adverse Event|1|||
164195176|NCT02735980|593083251|FG000|Overall Study|Death|5|||
164195177|NCT02735980|593083252|FG001|Overall Study|Death|4|||
164195178|NCT02735980|593083253|FG002|Overall Study|Death|0|||
164195179|NCT02735980|593083251|FG000|Overall Study|Physician Decision|3|||
164195180|NCT02735980|593083252|FG001|Overall Study|Physician Decision|1|||
164195181|NCT02735980|593083253|FG002|Overall Study|Physician Decision|0|||
164195182|NCT02735980|593083251|FG000|Overall Study|Screen failure|1|||
164195183|NCT02735980|593083252|FG001|Overall Study|Screen failure|0|||
164653729|NCT01806597|594758939|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
164653730|NCT01806597|594758940|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
164195184|NCT02735980|593083253|FG002|Overall Study|Screen failure|0|||
164195185|NCT02735980|593083251|FG000|Overall Study|Withdrawal by Subject|1|||
164195186|NCT02735980|593083252|FG001|Overall Study|Withdrawal by Subject|2|||
164195187|NCT02735980|593083253|FG002|Overall Study|Withdrawal by Subject|0|||
164195188|NCT00917124|593083257|FG000|Overall Study|Protocol Violation|4|||
164195189|NCT00917124|593083258|FG001|Overall Study|Protocol Violation|6|||
164195190|NCT02185417|593083260|FG000|Overall Study|Death|448|||
164195191|NCT02185417|593083261|FG001|Overall Study|Death|446|||
164195192|NCT02185417|593083262|FG002|Overall Study|Death|0|||
164195193|NCT02185417|593083260|FG000|Overall Study|Withdrawal by Subject|7|||
164195194|NCT02185417|593083261|FG001|Overall Study|Withdrawal by Subject|12|||
164195195|NCT02185417|593083262|FG002|Overall Study|Withdrawal by Subject|0|||
164195196|NCT03131167|593083263|FG000|Overall Study|Other (Unspecified)|0|||
164195197|NCT03131167|593083264|FG001|Overall Study|Other (Unspecified)|0|||
164195198|NCT03131167|593083265|FG002|Overall Study|Other (Unspecified)|0|||
164195199|NCT03131167|593083266|FG003|Overall Study|Other (Unspecified)|0|||
164195200|NCT03131167|593083267|FG004|Overall Study|Other (Unspecified)|0|||
164195201|NCT03131167|593083268|FG005|Overall Study|Other (Unspecified)|1|||
164195202|NCT03131167|593083269|FG006|Overall Study|Other (Unspecified)|0|||
164195203|NCT03131167|593083270|FG007|Overall Study|Other (Unspecified)|0|||
164195204|NCT03131167|593083271|FG008|Overall Study|Other (Unspecified)|0|||
164195205|NCT03131167|593083272|FG009|Overall Study|Other (Unspecified)|0|||
164195206|NCT03131167|593083273|FG010|Overall Study|Other (Unspecified)|0|||
164195207|NCT03131167|593083274|FG011|Overall Study|Other (Unspecified)|0|||
164195208|NCT03131167|593083275|FG012|Overall Study|Other (Unspecified)|0|||
164195209|NCT00126594|593083280|FG000|Overall Study|Ineligible|2|||
164195210|NCT00126594|593083281|FG001|Overall Study|Ineligible|0|||
164195211|NCT00126594|593083280|FG000|Overall Study|Withdrawal by Subject|0|||
164195212|NCT00126594|593083281|FG001|Overall Study|Withdrawal by Subject|4|||
164195213|NCT00126594|593083280|FG000|Overall Study|Physician Decision|1|||
164195214|NCT00126594|593083281|FG001|Overall Study|Physician Decision|3|||
164195215|NCT00126594|593083280|FG000|Overall Study|Adverse Event|7|||
164195216|NCT00126594|593083281|FG001|Overall Study|Adverse Event|5|||
164195217|NCT00126594|593083280|FG000|Overall Study|Non-compliance|0|||
164195218|NCT00126594|593083281|FG001|Overall Study|Non-compliance|1|||
164195219|NCT00126594|593083280|FG000|Overall Study|Disease Progression|29|||
164195220|NCT00126594|593083281|FG001|Overall Study|Disease Progression|24|||
164195221|NCT00243919|593083288|FG000|Overall Study|Death|3|||
164195222|NCT00243919|593083289|FG001|Overall Study|Death|4|||
164195223|NCT00243919|593083290|FG002|Overall Study|Death|6|||
164195224|NCT00243919|593083288|FG000|Overall Study|Withdrawal by Subject|6|||
164195225|NCT00243919|593083289|FG001|Overall Study|Withdrawal by Subject|6|||
164195226|NCT00243919|593083290|FG002|Overall Study|Withdrawal by Subject|2|||
164195227|NCT00243919|593083288|FG000|Overall Study|Lost to Follow-up|6|||
164195228|NCT00243919|593083289|FG001|Overall Study|Lost to Follow-up|7|||
164195229|NCT00243919|593083290|FG002|Overall Study|Lost to Follow-up|3|||
164195230|NCT00243919|593083288|FG000|Overall Study|Administrative Error|1|||
164195231|NCT00243919|593083289|FG001|Overall Study|Administrative Error|0|||
164195232|NCT00243919|593083290|FG002|Overall Study|Administrative Error|0|||
164195233|NCT00243919|593083288|FG000|Overall Study|Physician Decision|1|||
164195234|NCT00243919|593083289|FG001|Overall Study|Physician Decision|1|||
164195235|NCT00243919|593083290|FG002|Overall Study|Physician Decision|0|||
164653731|NCT01806597|594758935|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
164653732|NCT01806597|594758936|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
164195236|NCT02157519|593083291|FG000|Overall Study|Death|3|||
164195237|NCT02157519|593083292|FG001|Overall Study|Death|1|||
164195238|NCT02157519|593083291|FG000|Overall Study|Withdrawal by Subject|7|||
164195239|NCT02157519|593083292|FG001|Overall Study|Withdrawal by Subject|0|||
164195240|NCT02157519|593083291|FG000|Overall Study|Lost to Follow-up|1|||
164195241|NCT02157519|593083292|FG001|Overall Study|Lost to Follow-up|0|||
164195242|NCT01656395|593083293|FG000|Overall Study|Adverse Event|1|||
164195243|NCT01656395|593083294|FG001|Overall Study|Adverse Event|14|||
164195244|NCT01656395|593083295|FG002|Overall Study|Adverse Event|5|||
164195245|NCT01656395|593083296|FG003|Overall Study|Adverse Event|4|||
164195246|NCT01656395|593083297|FG004|Overall Study|Adverse Event|5|||
164195247|NCT01656395|593083298|FG005|Overall Study|Adverse Event|7|||
164195248|NCT01656395|593083299|FG006|Overall Study|Adverse Event|0|||
164195249|NCT01656395|593083300|FG007|Overall Study|Adverse Event|0|||
164195250|NCT01656395|593083293|FG000|Overall Study|Lack of Efficacy|1|||
164195251|NCT01656395|593083294|FG001|Overall Study|Lack of Efficacy|8|||
164195252|NCT01656395|593083295|FG002|Overall Study|Lack of Efficacy|6|||
164195253|NCT01656395|593083296|FG003|Overall Study|Lack of Efficacy|1|||
164195254|NCT01656395|593083297|FG004|Overall Study|Lack of Efficacy|1|||
164195255|NCT01656395|593083298|FG005|Overall Study|Lack of Efficacy|6|||
164195256|NCT01656395|593083299|FG006|Overall Study|Lack of Efficacy|0|||
164195257|NCT01656395|593083300|FG007|Overall Study|Lack of Efficacy|0|||
164195258|NCT01656395|593083293|FG000|Overall Study|Lost to Follow-up|1|||
164195259|NCT01656395|593083294|FG001|Overall Study|Lost to Follow-up|0|||
164195260|NCT01656395|593083295|FG002|Overall Study|Lost to Follow-up|0|||
164195261|NCT01656395|593083296|FG003|Overall Study|Lost to Follow-up|0|||
164195262|NCT01656395|593083297|FG004|Overall Study|Lost to Follow-up|0|||
164195263|NCT01656395|593083298|FG005|Overall Study|Lost to Follow-up|0|||
164195264|NCT01656395|593083299|FG006|Overall Study|Lost to Follow-up|0|||
164195265|NCT01656395|593083300|FG007|Overall Study|Lost to Follow-up|0|||
164195266|NCT01656395|593083293|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164195267|NCT01656395|593083294|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164195268|NCT01656395|593083295|FG002|Overall Study|Non-Compliance with Study Drug|0|||
164195269|NCT01656395|593083296|FG003|Overall Study|Non-Compliance with Study Drug|0|||
164195270|NCT01656395|593083297|FG004|Overall Study|Non-Compliance with Study Drug|1|||
164195271|NCT01656395|593083298|FG005|Overall Study|Non-Compliance with Study Drug|1|||
164195272|NCT01656395|593083299|FG006|Overall Study|Non-Compliance with Study Drug|0|||
164195273|NCT01656395|593083300|FG007|Overall Study|Non-Compliance with Study Drug|0|||
164195274|NCT01656395|593083293|FG000|Overall Study|Other|0|||
164195275|NCT01656395|593083294|FG001|Overall Study|Other|0|||
164195276|NCT01656395|593083295|FG002|Overall Study|Other|1|||
164195277|NCT01656395|593083296|FG003|Overall Study|Other|0|||
164195278|NCT01656395|593083297|FG004|Overall Study|Other|0|||
164195279|NCT01656395|593083298|FG005|Overall Study|Other|1|||
164195280|NCT01656395|593083299|FG006|Overall Study|Other|0|||
164195281|NCT01656395|593083300|FG007|Overall Study|Other|0|||
164195282|NCT01656395|593083293|FG000|Overall Study|Physician Decision|2|||
164195283|NCT01656395|593083294|FG001|Overall Study|Physician Decision|3|||
164195284|NCT01656395|593083295|FG002|Overall Study|Physician Decision|3|||
164195285|NCT01656395|593083296|FG003|Overall Study|Physician Decision|2|||
164195286|NCT01656395|593083297|FG004|Overall Study|Physician Decision|3|||
164195287|NCT01656395|593083298|FG005|Overall Study|Physician Decision|3|||
164195288|NCT01656395|593083299|FG006|Overall Study|Physician Decision|0|||
164195289|NCT01656395|593083300|FG007|Overall Study|Physician Decision|0|||
164195290|NCT01656395|593083293|FG000|Overall Study|Pregnancy|0|||
164195291|NCT01656395|593083294|FG001|Overall Study|Pregnancy|0|||
164195292|NCT01656395|593083295|FG002|Overall Study|Pregnancy|1|||
164195293|NCT01656395|593083296|FG003|Overall Study|Pregnancy|0|||
164195294|NCT01656395|593083297|FG004|Overall Study|Pregnancy|0|||
164195295|NCT01656395|593083298|FG005|Overall Study|Pregnancy|0|||
164195296|NCT01656395|593083299|FG006|Overall Study|Pregnancy|0|||
164195297|NCT01656395|593083300|FG007|Overall Study|Pregnancy|0|||
164195298|NCT01656395|593083293|FG000|Overall Study|Progressive Disease|0|||
164195299|NCT01656395|593083294|FG001|Overall Study|Progressive Disease|0|||
164195300|NCT01656395|593083295|FG002|Overall Study|Progressive Disease|0|||
164195301|NCT01656395|593083296|FG003|Overall Study|Progressive Disease|0|||
164195302|NCT01656395|593083297|FG004|Overall Study|Progressive Disease|0|||
164195303|NCT01656395|593083298|FG005|Overall Study|Progressive Disease|1|||
164195304|NCT01656395|593083299|FG006|Overall Study|Progressive Disease|0|||
164195305|NCT01656395|593083300|FG007|Overall Study|Progressive Disease|0|||
164195306|NCT01656395|593083293|FG000|Overall Study|Protocol Violation|6|||
164195307|NCT01656395|593083294|FG001|Overall Study|Protocol Violation|6|||
164195308|NCT01656395|593083295|FG002|Overall Study|Protocol Violation|9|||
164195309|NCT01656395|593083296|FG003|Overall Study|Protocol Violation|2|||
164195310|NCT01656395|593083297|FG004|Overall Study|Protocol Violation|4|||
164195311|NCT01656395|593083298|FG005|Overall Study|Protocol Violation|10|||
164195312|NCT01656395|593083299|FG006|Overall Study|Protocol Violation|0|||
164195313|NCT01656395|593083300|FG007|Overall Study|Protocol Violation|0|||
164547768|NCT00388973|594378194|FG001|Overall Study|Lack of Efficacy|12|||
164547769|NCT00388973|594378193|FG000|Overall Study|Protocol Violation|3|||
164547770|NCT00388973|594378194|FG001|Overall Study|Protocol Violation|0|||
164547771|NCT00388973|594378193|FG000|Overall Study|Withdrawal by Subject|14|||
164547772|NCT00388973|594378194|FG001|Overall Study|Withdrawal by Subject|17|||
164547773|NCT00388973|594378193|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
164195314|NCT01656395|593083293|FG000|Overall Study|Screen Failure|2|||
164195315|NCT01656395|593083294|FG001|Overall Study|Screen Failure|1|||
164195316|NCT01656395|593083295|FG002|Overall Study|Screen Failure|7|||
164195317|NCT01656395|593083296|FG003|Overall Study|Screen Failure|1|||
164195318|NCT01656395|593083297|FG004|Overall Study|Screen Failure|0|||
164195319|NCT01656395|593083298|FG005|Overall Study|Screen Failure|8|||
164195320|NCT01656395|593083299|FG006|Overall Study|Screen Failure|0|||
164195321|NCT01656395|593083300|FG007|Overall Study|Screen Failure|0|||
164195322|NCT01656395|593083293|FG000|Overall Study|Withdrawal by Subject|3|||
164195323|NCT01656395|593083294|FG001|Overall Study|Withdrawal by Subject|1|||
164302202|NCT01134055|593482559|FG003|Overall Study|Lost to Follow-up|1|||
164195324|NCT01656395|593083295|FG002|Overall Study|Withdrawal by Subject|4|||
164195325|NCT01656395|593083296|FG003|Overall Study|Withdrawal by Subject|2|||
164195326|NCT01656395|593083297|FG004|Overall Study|Withdrawal by Subject|0|||
164195327|NCT01656395|593083298|FG005|Overall Study|Withdrawal by Subject|3|||
164195328|NCT01656395|593083299|FG006|Overall Study|Withdrawal by Subject|0|||
164195329|NCT01656395|593083300|FG007|Overall Study|Withdrawal by Subject|0|||
164195330|NCT03225170|593083302|FG000|Overall Study|Lost to Follow-up|4|||
164195331|NCT03225170|593083303|FG001|Overall Study|Lost to Follow-up|4|||
164195332|NCT03225170|593083304|FG002|Overall Study|Lost to Follow-up|0|||
164195333|NCT03225170|593083302|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
164195334|NCT03225170|593083303|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
164195335|NCT03225170|593083304|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
164195336|NCT01272908|593083307|FG000|Initial Treatment Period|Adverse Event|1|||
164195337|NCT01272908|593083307|FG000|Initial Treatment Period|Lack of Efficacy|5|||
164195338|NCT01272908|593083307|FG000|Initial Treatment Period|Protocol Violation|1|||
164195339|NCT01272908|593083307|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
164195340|NCT01272908|593083307|FG000|Re-Treatment Period|Adverse Event|2|||
164195341|NCT01272908|593083307|FG000|Re-Treatment Period|Lack of Efficacy|3|||
164195342|NCT01272908|593083307|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
164195343|NCT02716779|593083313|FG000|Monotherapy|Adverse Event|0|||
164195344|NCT02716779|593083314|FG001|Monotherapy|Adverse Event|1|||
164195345|NCT02716779|593083315|FG002|Monotherapy|Adverse Event|1|||
164195346|NCT02716779|593083313|FG000|Combination Therapy|Adverse Event|0|||
164195347|NCT02716779|593083314|FG001|Combination Therapy|Adverse Event|2|||
164195348|NCT02716779|593083315|FG002|Combination Therapy|Adverse Event|1|||
164195349|NCT02600923|593083316|FG000|Overall Study|Death|10|||
164195350|NCT02600923|593083316|FG000|Overall Study|Adverse Event|3|||
164195351|NCT02600923|593083316|FG000|Overall Study|Global deterioration of health status|2|||
164195352|NCT02600923|593083316|FG000|Overall Study|Insufficient clinical response|6|||
164195353|NCT02600923|593083316|FG000|Overall Study|Lost to Follow-up|1|||
164195354|NCT02600923|593083316|FG000|Overall Study|Withdrawal by Subject|5|||
164195355|NCT02600923|593083316|FG000|Overall Study|Objective progression or relapse|50|||
164195356|NCT02600923|593083316|FG000|Overall Study|Study terminated by Sponsor|53|||
164195357|NCT02600923|593083316|FG000|Overall Study|Not treated|1|||
164195358|NCT01497067|593083322|FG000|Overall Study|Lost to Follow-up|56|||
164195359|NCT01497067|593083322|FG000|Overall Study|Adverse Event|3|||
164195360|NCT01497067|593083322|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
164195361|NCT01497067|593083322|FG000|Overall Study|Other|13|||
164195362|NCT04058028|593083323|FG000|Overall Study|Withdrawal of Consent from Study|12|||
164195363|NCT04058028|593083324|FG001|Overall Study|Withdrawal of Consent from Study|8|||
164547774|NCT00388973|594378194|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
164547775|NCT00388973|594378193|FG000|Overall Study|Did not complete 61 days of treatment|5|||
164195364|NCT04058028|593083325|FG002|Overall Study|Withdrawal of Consent from Study|6|||
164195365|NCT04058028|593083326|FG003|Overall Study|Withdrawal of Consent from Study|7|||
164195366|NCT04058028|593083323|FG000|Overall Study|Decision by Sponsor|13|||
164195367|NCT04058028|593083324|FG001|Overall Study|Decision by Sponsor|4|||
164195368|NCT04058028|593083325|FG002|Overall Study|Decision by Sponsor|1|||
164195369|NCT04058028|593083326|FG003|Overall Study|Decision by Sponsor|35|||
164195370|NCT04058028|593083323|FG000|Overall Study|Lost to Follow-up|1|||
164195371|NCT04058028|593083324|FG001|Overall Study|Lost to Follow-up|1|||
164195372|NCT04058028|593083325|FG002|Overall Study|Lost to Follow-up|1|||
164195373|NCT04058028|593083326|FG003|Overall Study|Lost to Follow-up|0|||
164195374|NCT04058028|593083323|FG000|Overall Study|Death|0|||
164195375|NCT04058028|593083324|FG001|Overall Study|Death|1|||
164195376|NCT04058028|593083325|FG002|Overall Study|Death|0|||
164195377|NCT04058028|593083326|FG003|Overall Study|Death|0|||
164195378|NCT02227784|593083327|FG000|Double-Blind Phase|Adverse Event|3|||
164195379|NCT02227784|593083328|FG001|Double-Blind Phase|Adverse Event|2|||
164195380|NCT02227784|593083329|FG002|Double-Blind Phase|Adverse Event|1|||
164195381|NCT02227784|593083330|FG003|Double-Blind Phase|Adverse Event|3|||
164195382|NCT02227784|593083331|FG004|Double-Blind Phase|Adverse Event|0|||
164195383|NCT02227784|593083327|FG000|Double-Blind Phase|Physician Decision|1|||
164195384|NCT02227784|593083328|FG001|Double-Blind Phase|Physician Decision|0|||
164195385|NCT02227784|593083329|FG002|Double-Blind Phase|Physician Decision|0|||
164195386|NCT02227784|593083330|FG003|Double-Blind Phase|Physician Decision|1|||
164195387|NCT02227784|593083331|FG004|Double-Blind Phase|Physician Decision|0|||
164195388|NCT02227784|593083327|FG000|Double-Blind Phase|Protocol Violation|0|||
164195389|NCT02227784|593083328|FG001|Double-Blind Phase|Protocol Violation|0|||
164195390|NCT02227784|593083329|FG002|Double-Blind Phase|Protocol Violation|1|||
164195391|NCT02227784|593083330|FG003|Double-Blind Phase|Protocol Violation|1|||
164195392|NCT02227784|593083331|FG004|Double-Blind Phase|Protocol Violation|0|||
164195393|NCT02227784|593083327|FG000|Double-Blind Phase|Sponsor Decision|34|||
164195394|NCT02227784|593083328|FG001|Double-Blind Phase|Sponsor Decision|15|||
164195395|NCT02227784|593083329|FG002|Double-Blind Phase|Sponsor Decision|14|||
164195396|NCT02227784|593083330|FG003|Double-Blind Phase|Sponsor Decision|32|||
164195397|NCT02227784|593083331|FG004|Double-Blind Phase|Sponsor Decision|0|||
164195398|NCT02227784|593083327|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
164195399|NCT02227784|593083328|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
164195400|NCT02227784|593083329|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
164195401|NCT02227784|593083330|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
164195402|NCT02227784|593083331|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
164195403|NCT02227784|593083327|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
164195404|NCT02227784|593083328|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
164195405|NCT02227784|593083329|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
164195406|NCT02227784|593083330|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
164195407|NCT02227784|593083331|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
164195408|NCT02227784|593083327|FG000|Open-Label Extension Phase (OLE)|Death|0|||
164195409|NCT02227784|593083328|FG001|Open-Label Extension Phase (OLE)|Death|0|||
164195410|NCT02227784|593083329|FG002|Open-Label Extension Phase (OLE)|Death|0|||
164195411|NCT02227784|593083330|FG003|Open-Label Extension Phase (OLE)|Death|0|||
164195412|NCT02227784|593083331|FG004|Open-Label Extension Phase (OLE)|Death|1|||
164547776|NCT00388973|594378194|FG001|Overall Study|Did not complete 61 days of treatment|4|||
164547777|NCT00388973|594378193|FG000|Overall Study|Left region|0|||
164547778|NCT00388973|594378194|FG001|Overall Study|Left region|1|||
164195413|NCT02227784|593083327|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
164195414|NCT02227784|593083328|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
164195415|NCT02227784|593083329|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
164195416|NCT02227784|593083330|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
164195417|NCT02227784|593083331|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
164195418|NCT02227784|593083327|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
164547779|NCT00388973|594378193|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
164547780|NCT00388973|594378194|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
164547781|NCT00666458|594378209|FG000|Overall Study|Adverse Event|8|||
164547782|NCT00666458|594378210|FG001|Overall Study|Adverse Event|7|||
164547783|NCT00666458|594378209|FG000|Overall Study|Withdrawal by Subject|5|||
164195419|NCT02227784|593083328|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
164195420|NCT02227784|593083329|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
164195421|NCT02227784|593083330|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
164195422|NCT02227784|593083331|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
164195423|NCT01705977|593083332|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
164195424|NCT01705977|593083333|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
164195425|NCT01705977|593083332|FG000|Treatment Period (Year 1)|Adverse Event|57|||
164195426|NCT01705977|593083333|FG001|Treatment Period (Year 1)|Adverse Event|49|||
164195427|NCT01705977|593083332|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
164195428|NCT01705977|593083333|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
164195429|NCT01705977|593083332|FG000|Treatment Period (Year 1)|Site closure|3|||
164195430|NCT01705977|593083333|FG001|Treatment Period (Year 1)|Site closure|2|||
164195431|NCT01705977|593083332|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
164195432|NCT01705977|593083333|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
164195433|NCT01705977|593083332|FG000|Treatment Period (Year 1)|Physician Decision|48|||
164195434|NCT01705977|593083333|FG001|Treatment Period (Year 1)|Physician Decision|38|||
164195435|NCT01705977|593083332|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
164195436|NCT01705977|593083333|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
164195437|NCT01705977|593083332|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
164195438|NCT01705977|593083333|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
164195439|NCT01705977|593083332|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
164195440|NCT01705977|593083333|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
164195441|NCT01705977|593083332|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
164195442|NCT01705977|593083333|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
164195443|NCT01705977|593083332|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
164195444|NCT01705977|593083333|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
164195445|NCT01705977|593083332|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
164195446|NCT01705977|593083333|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
164195447|NCT01275144|593083334|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
164195448|NCT01275144|593083335|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
164195449|NCT00828113|593083336|FG000|Overall Study|Withdrawal by Subject|27|||
164195450|NCT00828113|593083337|FG001|Overall Study|Withdrawal by Subject|26|||
164195451|NCT00828113|593083336|FG000|Overall Study|Lost to Follow-up|3|||
164195452|NCT00828113|593083337|FG001|Overall Study|Lost to Follow-up|5|||
164195453|NCT02864407|593083348|FG000|Overall Study|Protocol Violation|3|||
164195454|NCT02864407|593083348|FG000|Overall Study|Lost to Follow-up|115|||
164195455|NCT02864407|593083348|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
164195456|NCT02864407|593083348|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
164195457|NCT02864407|593083348|FG000|Overall Study|Consent prior to the contract date|1|||
164195458|NCT00096538|593083349|FG000|Overall Study|Withdrawal by Subject|1|||
164195459|NCT00003471|593083369|FG000|Overall Study|Not evaluable|4|||
164195460|NCT00715403|593083374|FG000|Overall Study|Progressive disease|0|||
164195461|NCT00715403|593083375|FG001|Overall Study|Progressive disease|1|||
164195462|NCT00715403|593083376|FG002|Overall Study|Progressive disease|3|||
164195463|NCT00715403|593083377|FG003|Overall Study|Progressive disease|9|||
164195464|NCT00715403|593083378|FG004|Overall Study|Progressive disease|5|||
164195465|NCT00715403|593083379|FG005|Overall Study|Progressive disease|14|||
164195466|NCT00715403|593083380|FG006|Overall Study|Progressive disease|1|||
164195467|NCT00715403|593083374|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
164195468|NCT00715403|593083375|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
164195469|NCT00715403|593083376|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
164195470|NCT00715403|593083377|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
164195471|NCT00715403|593083378|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
164195472|NCT00715403|593083379|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
164195473|NCT00715403|593083380|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
164195474|NCT00715403|593083374|FG000|Overall Study|Other Adverse Event than DLT|1|||
164195475|NCT00715403|593083375|FG001|Overall Study|Other Adverse Event than DLT|0|||
164195476|NCT00715403|593083376|FG002|Overall Study|Other Adverse Event than DLT|0|||
164195477|NCT00715403|593083377|FG003|Overall Study|Other Adverse Event than DLT|0|||
164195478|NCT00715403|593083378|FG004|Overall Study|Other Adverse Event than DLT|0|||
164195479|NCT00715403|593083379|FG005|Overall Study|Other Adverse Event than DLT|2|||
164195480|NCT00715403|593083380|FG006|Overall Study|Other Adverse Event than DLT|0|||
164195481|NCT00715403|593083374|FG000|Overall Study|Protocol Violation|0|||
164195482|NCT00715403|593083375|FG001|Overall Study|Protocol Violation|0|||
164195483|NCT00715403|593083376|FG002|Overall Study|Protocol Violation|0|||
164195484|NCT00715403|593083377|FG003|Overall Study|Protocol Violation|0|||
164195485|NCT00715403|593083378|FG004|Overall Study|Protocol Violation|0|||
164195486|NCT00715403|593083379|FG005|Overall Study|Protocol Violation|1|||
164195487|NCT00715403|593083380|FG006|Overall Study|Protocol Violation|0|||
164195488|NCT00715403|593083374|FG000|Overall Study|Other reason not defined above|0|||
164195489|NCT00715403|593083375|FG001|Overall Study|Other reason not defined above|0|||
164195490|NCT00715403|593083376|FG002|Overall Study|Other reason not defined above|1|||
164195491|NCT00715403|593083377|FG003|Overall Study|Other reason not defined above|0|||
164195492|NCT00715403|593083378|FG004|Overall Study|Other reason not defined above|1|||
164195493|NCT00715403|593083379|FG005|Overall Study|Other reason not defined above|1|||
164195494|NCT00715403|593083380|FG006|Overall Study|Other reason not defined above|0|||
164195495|NCT00101868|593083381|FG000|Overall Study|Death|10|||
164195496|NCT00101868|593083382|FG001|Overall Study|Death|10|||
164195497|NCT00101868|593083381|FG000|Overall Study|Withdrawal by Subject|8|||
164195498|NCT00101868|593083382|FG001|Overall Study|Withdrawal by Subject|9|||
164195499|NCT00101868|593083381|FG000|Overall Study|Protocol Violation|3|||
164195500|NCT00101868|593083382|FG001|Overall Study|Protocol Violation|0|||
164195501|NCT00101868|593083381|FG000|Overall Study|Lost to Follow-up|8|||
164195502|NCT00101868|593083382|FG001|Overall Study|Lost to Follow-up|13|||
164195503|NCT04001803|593083383|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
164195504|NCT04001803|593083383|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
164195505|NCT04001803|593083383|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
164195506|NCT04001803|593083383|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
164195507|NCT04001803|593083383|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
164195508|NCT04001803|593083383|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
164195509|NCT04001803|593083383|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
164195510|NCT04001803|593083383|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
164195511|NCT04001803|593083383|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
164195512|NCT04001803|593083383|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
164195513|NCT01931397|593083386|FG000|Overall Study|Physician Decision|2|||
164195514|NCT01931397|593083386|FG000|Overall Study|Withdrawal by Subject|8|||
164195515|NCT01931397|593083386|FG000|Overall Study|moved out of state|1|||
164195516|NCT00520039|593083387|FG000|Overall Study|Exclusion criteria met at first visit|7|||
164195517|NCT00520039|593083388|FG001|Overall Study|Exclusion criteria met at first visit|5|||
164195518|NCT02493517|593083392|FG000|Overall Study|Protocol Violation|1|||
164195519|NCT02493517|593083393|FG001|Overall Study|Protocol Violation|2|||
164195520|NCT02493517|593083392|FG000|Overall Study|Withdrawal by Subject|1|||
164195521|NCT02493517|593083393|FG001|Overall Study|Withdrawal by Subject|2|||
164195522|NCT02493517|593083392|FG000|Overall Study|Adverse Event|0|||
164195523|NCT02493517|593083393|FG001|Overall Study|Adverse Event|2|||
164195524|NCT02493517|593083392|FG000|Overall Study|Missed study visit|0|||
164195525|NCT02493517|593083393|FG001|Overall Study|Missed study visit|1|||
164195526|NCT01367249|593083394|FG000|Overall Study|Withdrawal by Subject|6|||
164195527|NCT01367249|593083395|FG001|Overall Study|Withdrawal by Subject|6|||
164195528|NCT01367249|593083394|FG000|Overall Study|Other|3|||
164195529|NCT01367249|593083395|FG001|Overall Study|Other|10|||
164195530|NCT05404711|593083396|FG000|Completed Study Visit|Withdrawal by Subject|1|||
164195531|NCT05404711|593083396|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
164195532|NCT05404711|593083396|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
164195533|NCT05404711|593083396|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
164195534|NCT05404711|593083396|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
164195535|NCT05404711|593083396|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
164195536|NCT00325819|593083397|FG000|Overall Study|Study product lost in mail|2|||
164195537|NCT00325819|593083398|FG001|Overall Study|Study product lost in mail|1|||
164547784|NCT00666458|594378210|FG001|Overall Study|Withdrawal by Subject|4|||
164547785|NCT00666458|594378209|FG000|Overall Study|Lost to Follow-up|0|||
164547786|NCT00666458|594378210|FG001|Overall Study|Lost to Follow-up|3|||
164547787|NCT00666458|594378209|FG000|Overall Study|Administrative reason by sponsor|1|||
164547788|NCT00666458|594378210|FG001|Overall Study|Administrative reason by sponsor|1|||
164547789|NCT00666458|594378209|FG000|Overall Study|Incorrect enrollment|7|||
164547790|NCT00666458|594378210|FG001|Overall Study|Incorrect enrollment|1|||
164195538|NCT00325819|593083397|FG000|Overall Study|Did not take a dose of study product|4|||
164195539|NCT00325819|593083398|FG001|Overall Study|Did not take a dose of study product|9|||
164195540|NCT00325819|593083397|FG000|Overall Study|Lost to Follow-up|3|||
164195541|NCT00325819|593083398|FG001|Overall Study|Lost to Follow-up|3|||
164195542|NCT01683604|593083399|FG000|Overall Study|Adverse Event|2|||
164195543|NCT01683604|593083399|FG000|Overall Study|Lack of Efficacy|1|||
164195544|NCT01683604|593083399|FG000|Overall Study|Other|2|||
164195545|NCT01548599|593085425|FG000|Overall Study|Lost to Follow-up|0|||
164195546|NCT01548599|593085426|FG001|Overall Study|Lost to Follow-up|1|||
164195547|NCT01548599|593085425|FG000|Overall Study|Withdrawal by Subject|4|||
164195548|NCT01548599|593085426|FG001|Overall Study|Withdrawal by Subject|0|||
164195549|NCT01548599|593085425|FG000|Overall Study|Death|2|||
164195550|NCT01548599|593085426|FG001|Overall Study|Death|1|||
164195551|NCT02188160|593085427|FG000|Overall Study|Adverse Event|1|||
164195552|NCT02188160|593085428|FG001|Overall Study|Adverse Event|0|||
164195553|NCT02188160|593085427|FG000|Overall Study|Use of an excluded medication|0|||
164195554|NCT02188160|593085428|FG001|Overall Study|Use of an excluded medication|1|||
164195555|NCT00916578|593085429|FG000|Overall Study|Physician Decision|2|||
164195556|NCT00916578|593085429|FG000|Overall Study|Withdrawal by Subject|3|||
164195557|NCT00916578|593085429|FG000|Overall Study|Insurance Denial|2|||
164195558|NCT00945243|593085434|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
164195559|NCT02371616|593085435|FG000|Overall Study|Protocol Violation|2|||
164195560|NCT02371616|593085436|FG001|Overall Study|Protocol Violation|1|||
164195561|NCT02371616|593085435|FG000|Overall Study|Adverse Event|0|||
164195562|NCT02371616|593085436|FG001|Overall Study|Adverse Event|1|||
164195563|NCT02371616|593085435|FG000|Overall Study|Withdrawal of Consent|1|||
164195564|NCT02371616|593085436|FG001|Overall Study|Withdrawal of Consent|0|||
164195565|NCT02371616|593085435|FG000|Overall Study|Other (Not specified)|1|||
164195566|NCT02371616|593085436|FG001|Overall Study|Other (Not specified)|5|||
164195567|NCT00754741|593085439|FG000|Overall Study|Died or disenrolled|57|||
164195568|NCT00754741|593085440|FG001|Overall Study|Died or disenrolled|69|||
164195569|NCT00754741|593085441|FG002|Overall Study|Died or disenrolled|54|||
164195570|NCT04152200|593085442|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
164195571|NCT04152200|593085443|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
164195572|NCT04969289|593085444|FG000|Overall Study|Lost to Follow-up|13|||
164195573|NCT04969289|593085445|FG001|Overall Study|Lost to Follow-up|9|||
164195574|NCT02699996|593085446|FG000|Overall Study|Withdrawal by Subject|5|||
164195575|NCT02699996|593085447|FG001|Overall Study|Withdrawal by Subject|2|||
164195576|NCT04069715|593085448|FG000|Overall Study|Lost to Follow-up|1|||
164195577|NCT04069715|593085449|FG001|Overall Study|Lost to Follow-up|1|||
164195578|NCT04069715|593085448|FG000|Overall Study|Physician Decision|1|||
164195579|NCT04069715|593085449|FG001|Overall Study|Physician Decision|1|||
164195580|NCT04069715|593085448|FG000|Overall Study|Withdrawal by Subject|3|||
164195581|NCT04069715|593085449|FG001|Overall Study|Withdrawal by Subject|3|||
164195582|NCT01198002|593085450|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
164195583|NCT01198002|593085451|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
164195584|NCT01198002|593085452|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
164195585|NCT01198002|593085450|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
164195586|NCT01198002|593085451|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
164195587|NCT01198002|593085452|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
164195588|NCT01198002|593085450|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
164195589|NCT01198002|593085451|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
164195590|NCT01198002|593085452|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
164195591|NCT01198002|593085450|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
164195592|NCT01198002|593085451|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
164195593|NCT01198002|593085452|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
164195594|NCT01198002|593085450|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
164195595|NCT01198002|593085451|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
164195596|NCT01198002|593085452|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
164195597|NCT01198002|593085450|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
164195598|NCT01198002|593085451|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
164195599|NCT01198002|593085452|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
164195600|NCT01198002|593085450|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
164195601|NCT01198002|593085451|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
164195602|NCT01198002|593085452|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
164195603|NCT01198002|593085450|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
164195604|NCT01198002|593085451|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
164195605|NCT01198002|593085452|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
164195606|NCT01198002|593085450|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
164195607|NCT01198002|593085451|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
164195608|NCT01198002|593085452|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
164195609|NCT01198002|593085450|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
164195610|NCT01198002|593085451|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
164195611|NCT01198002|593085452|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
164195612|NCT01198002|593085450|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
164195613|NCT01198002|593085451|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
164195614|NCT01198002|593085452|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
164195615|NCT01198002|593085450|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
164195616|NCT01198002|593085451|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
164195617|NCT01198002|593085452|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
164195618|NCT01198002|593085450|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
164195619|NCT01198002|593085451|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
164195620|NCT01198002|593085452|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
164195621|NCT01198002|593085450|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
164195622|NCT01198002|593085451|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
164195623|NCT01198002|593085452|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
164195624|NCT01198002|593085450|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
164195625|NCT01198002|593085451|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
164195626|NCT01198002|593085452|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
164195627|NCT02063672|593085453|FG000|Overall Study|Ongoing Follow-up|27|||
164195628|NCT02063672|593085454|FG001|Overall Study|Ongoing Follow-up|14|||
164195629|NCT02063672|593085453|FG000|Overall Study|Death|5|||
164195630|NCT02063672|593085454|FG001|Overall Study|Death|3|||
164195631|NCT02063672|593085453|FG000|Overall Study|Lost to Follow-up|1|||
164195632|NCT02063672|593085454|FG001|Overall Study|Lost to Follow-up|3|||
164195633|NCT02063672|593085453|FG000|Overall Study|Withdrawal by Subject|2|||
164195634|NCT02063672|593085454|FG001|Overall Study|Withdrawal by Subject|2|||
164195635|NCT01307787|593085456|FG000|Overall Study|Withdrawal by Subject|2|||
164195636|NCT01307787|593085457|FG001|Overall Study|Withdrawal by Subject|0|||
164195637|NCT03353792|593085461|FG000|Overall Study|Lost to Follow-up|1|||
164195638|NCT03353792|593085462|FG001|Overall Study|Lost to Follow-up|0|||
164195639|NCT03353792|593085461|FG000|Overall Study|Participant Unable to Manage Device|1|||
164195640|NCT03353792|593085462|FG001|Overall Study|Participant Unable to Manage Device|0|||
164195641|NCT01965327|593085463|FG000|Overall Study|Physician Decision|2|||
164653733|NCT01806597|594758937|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
164653734|NCT01806597|594758938|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
164653735|NCT01806597|594758939|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
164653736|NCT01806597|594758940|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
164653737|NCT01806597|594758935|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
164653738|NCT01806597|594758936|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
164653739|NCT01806597|594758937|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
164653740|NCT01806597|594758938|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
164195642|NCT01294423|593085464|FG000|Overall Study|Adverse Event|1|||
164195643|NCT01294423|593085465|FG001|Overall Study|Adverse Event|2|||
164195644|NCT01294423|593085466|FG002|Overall Study|Adverse Event|3|||
164195645|NCT01294423|593085464|FG000|Overall Study|Withdrawal by Subject|1|||
164195646|NCT01294423|593085465|FG001|Overall Study|Withdrawal by Subject|2|||
164195647|NCT01294423|593085466|FG002|Overall Study|Withdrawal by Subject|2|||
164195648|NCT01294423|593085464|FG000|Overall Study|subject no longer meets study criteria|2|||
164195649|NCT01294423|593085465|FG001|Overall Study|subject no longer meets study criteria|5|||
164195650|NCT01294423|593085466|FG002|Overall Study|subject no longer meets study criteria|2|||
164195651|NCT01294423|593085464|FG000|Overall Study|poor/non-compliance|1|||
164195652|NCT01294423|593085465|FG001|Overall Study|poor/non-compliance|0|||
164195653|NCT01294423|593085466|FG002|Overall Study|poor/non-compliance|1|||
164195654|NCT01241279|593085467|FG000|Overall Study|Lost to Follow-up|0|||
164195655|NCT01241279|593085468|FG001|Overall Study|Lost to Follow-up|1|||
164195656|NCT01484951|593085470|FG000|Overall Study|Adverse Event|3|||
164195657|NCT01484951|593085470|FG000|Overall Study|Personal Reasons|1|||
164195658|NCT01484951|593085470|FG000|Overall Study|Non-Compliance|1|||
164195659|NCT02452047|593085471|FG000|Overall Study|Adverse Event|0|||
164195660|NCT02452047|593085472|FG001|Overall Study|Adverse Event|1|||
164195661|NCT02452047|593085473|FG002|Overall Study|Adverse Event|1|||
164195662|NCT02452047|593085471|FG000|Overall Study|Death|1|||
164195663|NCT02452047|593085472|FG001|Overall Study|Death|3|||
164195664|NCT02452047|593085473|FG002|Overall Study|Death|1|||
164195665|NCT02452047|593085471|FG000|Overall Study|Physician Decision|1|||
164195666|NCT02452047|593085472|FG001|Overall Study|Physician Decision|0|||
164195667|NCT02452047|593085473|FG002|Overall Study|Physician Decision|0|||
164195668|NCT02452047|593085471|FG000|Overall Study|Lost to Follow-up|1|||
164195669|NCT02452047|593085472|FG001|Overall Study|Lost to Follow-up|1|||
164195670|NCT02452047|593085473|FG002|Overall Study|Lost to Follow-up|0|||
164195671|NCT02452047|593085471|FG000|Overall Study|Withdrawal by Subject|1|||
164195672|NCT02452047|593085472|FG001|Overall Study|Withdrawal by Subject|0|||
164195673|NCT02452047|593085473|FG002|Overall Study|Withdrawal by Subject|0|||
164195674|NCT01248455|593085475|FG000|Overall Study|switched to alternate treatment|1|||
164195675|NCT02631941|593085491|FG000|Overall Study|Physician Decision|0|||
164195676|NCT02631941|593085492|FG001|Overall Study|Physician Decision|1|||
164195677|NCT02631941|593085493|FG002|Overall Study|Physician Decision|0|||
164195678|NCT02631941|593085494|FG003|Overall Study|Physician Decision|0|||
164195679|NCT02631941|593085495|FG004|Overall Study|Physician Decision|0|||
164195680|NCT02631941|593085496|FG005|Overall Study|Physician Decision|0|||
164195681|NCT02631941|593085497|FG006|Overall Study|Physician Decision|0|||
164195682|NCT02631941|593085498|FG007|Overall Study|Physician Decision|0|||
164195683|NCT02631941|593085499|FG008|Overall Study|Physician Decision|0|||
164195684|NCT02631941|593085500|FG009|Overall Study|Physician Decision|0|||
164195685|NCT02631941|593085491|FG000|Overall Study|Adverse Event|0|||
164195686|NCT02631941|593085492|FG001|Overall Study|Adverse Event|1|||
164195687|NCT02631941|593085493|FG002|Overall Study|Adverse Event|0|||
164195688|NCT02631941|593085494|FG003|Overall Study|Adverse Event|0|||
164195689|NCT02631941|593085495|FG004|Overall Study|Adverse Event|0|||
164195690|NCT02631941|593085496|FG005|Overall Study|Adverse Event|0|||
164195691|NCT02631941|593085497|FG006|Overall Study|Adverse Event|0|||
164195692|NCT02631941|593085498|FG007|Overall Study|Adverse Event|0|||
164195693|NCT02631941|593085499|FG008|Overall Study|Adverse Event|0|||
164195694|NCT02631941|593085500|FG009|Overall Study|Adverse Event|0|||
164195695|NCT02631941|593085491|FG000|Overall Study|Withdrawal by Subject|0|||
164195696|NCT02631941|593085492|FG001|Overall Study|Withdrawal by Subject|0|||
164195697|NCT02631941|593085493|FG002|Overall Study|Withdrawal by Subject|0|||
164195698|NCT02631941|593085494|FG003|Overall Study|Withdrawal by Subject|0|||
164195699|NCT02631941|593085495|FG004|Overall Study|Withdrawal by Subject|1|||
164195700|NCT02631941|593085496|FG005|Overall Study|Withdrawal by Subject|0|||
164195701|NCT02631941|593085497|FG006|Overall Study|Withdrawal by Subject|0|||
164195702|NCT02631941|593085498|FG007|Overall Study|Withdrawal by Subject|1|||
164195703|NCT02631941|593085499|FG008|Overall Study|Withdrawal by Subject|0|||
164195704|NCT02631941|593085500|FG009|Overall Study|Withdrawal by Subject|0|||
164195705|NCT02631941|593085491|FG000|Overall Study|Lost to Follow-up|0|||
164195706|NCT02631941|593085492|FG001|Overall Study|Lost to Follow-up|0|||
164195707|NCT02631941|593085493|FG002|Overall Study|Lost to Follow-up|0|||
164195708|NCT02631941|593085494|FG003|Overall Study|Lost to Follow-up|0|||
164195709|NCT02631941|593085495|FG004|Overall Study|Lost to Follow-up|0|||
164195710|NCT02631941|593085496|FG005|Overall Study|Lost to Follow-up|0|||
164195711|NCT02631941|593085497|FG006|Overall Study|Lost to Follow-up|0|||
164195712|NCT02631941|593085498|FG007|Overall Study|Lost to Follow-up|0|||
164195713|NCT02631941|593085499|FG008|Overall Study|Lost to Follow-up|1|||
164195714|NCT02631941|593085500|FG009|Overall Study|Lost to Follow-up|0|||
164195715|NCT04176939|593085505|FG000|Overall Study|Withdrawal by Subject|5|||
164195716|NCT04176939|593085505|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
164195717|NCT04176939|593085505|FG000|Overall Study|Lost to Follow-up|2|||
164195718|NCT04176939|593085505|FG000|Overall Study|Unspecified reason|4|||
164195719|NCT04176939|593085505|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
164195720|NCT00230048|593085509|FG000|Overall Study|Lost to Follow-up|13|||
164195721|NCT00230048|593085510|FG001|Overall Study|Lost to Follow-up|18|||
164195722|NCT00676403|593085511|FG000|Overall Study|Adverse Event|1|||
164195723|NCT00676403|593085512|FG001|Overall Study|Adverse Event|2|||
164195724|NCT00676403|593085513|FG002|Overall Study|Adverse Event|0|||
164195725|NCT00676403|593085514|FG003|Overall Study|Adverse Event|5|||
164195726|NCT00676403|593085515|FG004|Overall Study|Adverse Event|1|||
164195727|NCT00676403|593085516|FG005|Overall Study|Adverse Event|2|||
164195728|NCT00676403|593085511|FG000|Overall Study|Lost to Follow-up|0|||
164195729|NCT00676403|593085512|FG001|Overall Study|Lost to Follow-up|0|||
164195730|NCT00676403|593085513|FG002|Overall Study|Lost to Follow-up|0|||
164195731|NCT00676403|593085514|FG003|Overall Study|Lost to Follow-up|0|||
164195732|NCT00676403|593085515|FG004|Overall Study|Lost to Follow-up|0|||
164195733|NCT00676403|593085516|FG005|Overall Study|Lost to Follow-up|1|||
164195734|NCT00676403|593085511|FG000|Overall Study|Reason Unspecified|1|||
164195735|NCT00676403|593085512|FG001|Overall Study|Reason Unspecified|0|||
164195736|NCT00676403|593085513|FG002|Overall Study|Reason Unspecified|1|||
164195737|NCT00676403|593085514|FG003|Overall Study|Reason Unspecified|0|||
164195738|NCT00676403|593085515|FG004|Overall Study|Reason Unspecified|0|||
164195739|NCT00676403|593085516|FG005|Overall Study|Reason Unspecified|1|||
164195740|NCT00676403|593085511|FG000|Overall Study|Withdrawal by Subject|0|||
164195741|NCT00676403|593085512|FG001|Overall Study|Withdrawal by Subject|0|||
164195742|NCT00676403|593085513|FG002|Overall Study|Withdrawal by Subject|0|||
164195743|NCT00676403|593085514|FG003|Overall Study|Withdrawal by Subject|0|||
164195744|NCT00676403|593085515|FG004|Overall Study|Withdrawal by Subject|0|||
164195745|NCT00676403|593085516|FG005|Overall Study|Withdrawal by Subject|1|||
164195746|NCT00661089|593085518|FG000|Overall Study|1 subject withdrawal|0|||
164195747|NCT00661089|593085519|FG001|Overall Study|1 subject withdrawal|1|||
164195748|NCT00661089|593085518|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
164195749|NCT00661089|593085519|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
164195750|NCT00983372|593085520|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
164195751|NCT00983372|593085520|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
164195752|NCT00983372|593085520|FG000|Diltiazem ER Alone|Adverse Event|1|||
164195753|NCT05635045|593085521|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
164195754|NCT05635045|593085522|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
164195755|NCT05635045|593085523|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
164195756|NCT05635045|593085524|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
164195757|NCT00971867|593085530|FG000|Overall Study|Adverse Event|4|||
164195758|NCT00971867|593085530|FG000|Overall Study|Participant Withdrew Consent|1|||
164195759|NCT00971867|593085530|FG000|Overall Study|Disease Progression|6|||
164195760|NCT03727841|593085533|FG000|Overall Study|Physician Decision|3|||
164195761|NCT03727841|593085534|FG001|Overall Study|Physician Decision|1|||
164195762|NCT00905424|593085543|FG000|Overall Study|Lost to Follow-up|3|||
164195763|NCT00905424|593085544|FG001|Overall Study|Lost to Follow-up|3|||
164195764|NCT00905424|593085543|FG000|Overall Study|Withdrawal by Subject|1|||
164195765|NCT00905424|593085544|FG001|Overall Study|Withdrawal by Subject|2|||
164195766|NCT00905424|593085543|FG000|Overall Study|Adverse Event|4|||
164195767|NCT00905424|593085544|FG001|Overall Study|Adverse Event|2|||
164195768|NCT00905424|593085543|FG000|Overall Study|Non-compliance with study medication|2|||
164195769|NCT00905424|593085544|FG001|Overall Study|Non-compliance with study medication|0|||
164195770|NCT00905424|593085543|FG000|Overall Study|Sponsor decision|1|||
164195771|NCT00905424|593085544|FG001|Overall Study|Sponsor decision|0|||
164195772|NCT00905424|593085543|FG000|Overall Study|Positive urine drug screen|0|||
164195773|NCT00905424|593085544|FG001|Overall Study|Positive urine drug screen|1|||
164195774|NCT00905424|593085543|FG000|Overall Study|Non-adherence to visit schedule|0|||
164195775|NCT00905424|593085544|FG001|Overall Study|Non-adherence to visit schedule|1|||
164195776|NCT00379899|593085546|FG000|Overall Study|Adverse Event|7|||
164195777|NCT00379899|593085547|FG001|Overall Study|Adverse Event|3|||
164195778|NCT00379899|593085546|FG000|Overall Study|Death|10|||
164195779|NCT00379899|593085547|FG001|Overall Study|Death|10|||
164195780|NCT00379899|593085546|FG000|Overall Study|Lost to Follow-up|2|||
164195781|NCT00379899|593085547|FG001|Overall Study|Lost to Follow-up|4|||
164195782|NCT00379899|593085546|FG000|Overall Study|Physician Decision|3|||
164195783|NCT00379899|593085547|FG001|Overall Study|Physician Decision|4|||
164195784|NCT00379899|593085546|FG000|Overall Study|Withdrawal by Subject|5|||
164195785|NCT00379899|593085547|FG001|Overall Study|Withdrawal by Subject|5|||
164195786|NCT00379899|593085546|FG000|Overall Study|Ineligibility determined|0|||
164195787|NCT00379899|593085547|FG001|Overall Study|Ineligibility determined|1|||
164195788|NCT00379899|593085546|FG000|Overall Study|Noncompliance|1|||
164195789|NCT00379899|593085547|FG001|Overall Study|Noncompliance|1|||
164195790|NCT00379899|593085546|FG000|Overall Study|Parathyroidectomy|0|||
164195791|NCT00379899|593085547|FG001|Overall Study|Parathyroidectomy|2|||
164195792|NCT00379899|593085546|FG000|Overall Study|Renal transplantation|5|||
164195793|NCT00379899|593085547|FG001|Overall Study|Renal transplantation|4|||
164547791|NCT00666458|594378209|FG000|Overall Study|Study specific discontinuation criteria|14|||
164547792|NCT00666458|594378210|FG001|Overall Study|Study specific discontinuation criteria|7|||
164547793|NCT00666458|594378209|FG000|Overall Study|Severe non-compliance to the protocol|1|||
164547794|NCT00666458|594378210|FG001|Overall Study|Severe non-compliance to the protocol|1|||
164547795|NCT00666458|594378209|FG000|Overall Study|Safety reasons|1|||
164547796|NCT00666458|594378210|FG001|Overall Study|Safety reasons|0|||
164547797|NCT00666458|594378209|FG000|Overall Study|Medical history of anemia|1|||
164547798|NCT00666458|594378210|FG001|Overall Study|Medical history of anemia|0|||
164547799|NCT01999465|594378211|FG000|Overall Study|Lost to Follow-up|0|||
164547800|NCT01999465|594378212|FG001|Overall Study|Lost to Follow-up|2|||
164547801|NCT01999465|594378211|FG000|Overall Study|Protocol Violation|0|||
164547802|NCT01999465|594378212|FG001|Overall Study|Protocol Violation|1|||
164547803|NCT02325219|594378213|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
164547804|NCT02325219|594378214|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
164547805|NCT02325219|594378215|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
164547806|NCT02325219|594378216|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
164547807|NCT02325219|594378217|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
164547808|NCT02325219|594378213|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
164547809|NCT02325219|594378214|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
164547810|NCT02325219|594378215|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
164547811|NCT02325219|594378216|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
164547812|NCT02325219|594378217|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
164653741|NCT01806597|594758939|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
164195794|NCT00379899|593085546|FG000|Overall Study|Coronary artery bypass graft|1|||
164195795|NCT00379899|593085547|FG001|Overall Study|Coronary artery bypass graft|1|||
164195796|NCT00379899|593085546|FG000|Overall Study|Other protocol-specified criteria|3|||
164547813|NCT02325219|594378213|FG000|Controlled Period (Week 0 - 16)|Other|0|||
164195797|NCT00379899|593085547|FG001|Overall Study|Other protocol-specified criteria|4|||
164195798|NCT00379899|593085546|FG000|Overall Study|Other|3|||
164195799|NCT00379899|593085547|FG001|Overall Study|Other|1|||
164195800|NCT01585246|593085554|FG000|Overall Study|Lost to Follow-up|0|||
164195801|NCT01585246|593085555|FG001|Overall Study|Lost to Follow-up|0|||
164195802|NCT01585246|593085556|FG002|Overall Study|Lost to Follow-up|2|||
164195803|NCT01585246|593085557|FG003|Overall Study|Lost to Follow-up|1|||
164195804|NCT01585246|593085558|FG004|Overall Study|Lost to Follow-up|0|||
164195805|NCT01585246|593085554|FG000|Overall Study|Protocol Violation|0|||
164195806|NCT01585246|593085555|FG001|Overall Study|Protocol Violation|0|||
164195807|NCT01585246|593085556|FG002|Overall Study|Protocol Violation|0|||
164195808|NCT01585246|593085557|FG003|Overall Study|Protocol Violation|0|||
164195809|NCT01585246|593085558|FG004|Overall Study|Protocol Violation|1|||
164195810|NCT01585246|593085554|FG000|Overall Study|Withdrawal by Subject|0|||
164195811|NCT01585246|593085555|FG001|Overall Study|Withdrawal by Subject|0|||
164195812|NCT01585246|593085556|FG002|Overall Study|Withdrawal by Subject|1|||
164195813|NCT01585246|593085557|FG003|Overall Study|Withdrawal by Subject|2|||
164195814|NCT01585246|593085558|FG004|Overall Study|Withdrawal by Subject|1|||
164195815|NCT01585246|593085554|FG000|Overall Study|Other|0|||
164195816|NCT01585246|593085555|FG001|Overall Study|Other|1|||
164195817|NCT01585246|593085556|FG002|Overall Study|Other|1|||
164195818|NCT01585246|593085557|FG003|Overall Study|Other|1|||
164195819|NCT01585246|593085558|FG004|Overall Study|Other|0|||
164195820|NCT04396626|593085559|FG000|Overall Study|Premature termination of study|975|||
164195821|NCT02111174|593085560|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
164195822|NCT02111174|593085561|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
164195823|NCT02111174|593085560|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
164195824|NCT02111174|593085561|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
164195825|NCT02111174|593085560|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
164195826|NCT02111174|593085561|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
164195827|NCT02111174|593085560|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
164195828|NCT02111174|593085561|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
164195829|NCT04552132|593085562|FG000|Overall Study|Lost to Follow-up|4|||
164195830|NCT04552132|593085563|FG001|Overall Study|Lost to Follow-up|3|||
164195831|NCT04552132|593085562|FG000|Overall Study|Protocol Violation|1|||
164195832|NCT04552132|593085563|FG001|Overall Study|Protocol Violation|0|||
164195833|NCT01657162|593085564|FG000|Overall Study|Adverse Event|26|||
164195834|NCT01657162|593085565|FG001|Overall Study|Adverse Event|36|||
164195835|NCT01657162|593085564|FG000|Overall Study|Withdrawal by Subject|13|||
164195836|NCT01657162|593085565|FG001|Overall Study|Withdrawal by Subject|13|||
164195837|NCT01657162|593085564|FG000|Overall Study|Continuing Significant Deterioration|9|||
164195838|NCT01657162|593085565|FG001|Overall Study|Continuing Significant Deterioration|3|||
164195839|NCT01657162|593085564|FG000|Overall Study|Refusal of Treatment|4|||
164195840|NCT01657162|593085565|FG001|Overall Study|Refusal of Treatment|6|||
164195841|NCT01657162|593085564|FG000|Overall Study|Lost to Follow-up|3|||
164195842|NCT01657162|593085565|FG001|Overall Study|Lost to Follow-up|4|||
164195843|NCT01657162|593085564|FG000|Overall Study|Death|2|||
164195844|NCT01657162|593085565|FG001|Overall Study|Death|3|||
164195845|NCT01657162|593085564|FG000|Overall Study|Inability to Complete Study Procedures|1|||
164195846|NCT01657162|593085565|FG001|Overall Study|Inability to Complete Study Procedures|7|||
164195847|NCT01657162|593085564|FG000|Overall Study|Protocol Violation|1|||
164195848|NCT01657162|593085565|FG001|Overall Study|Protocol Violation|0|||
164195849|NCT01657162|593085564|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
164195850|NCT01657162|593085565|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
164547814|NCT02325219|594378214|FG001|Controlled Period (Week 0 - 16)|Other|0|||
164547815|NCT02325219|594378215|FG002|Controlled Period (Week 0 - 16)|Other|1|||
164195851|NCT01657162|593085564|FG000|Overall Study|Other than Specified|0|||
164195852|NCT01657162|593085565|FG001|Overall Study|Other than Specified|2|||
164195853|NCT02421419|593085569|FG000|Overall Study|Physician Decision|0|||
164195854|NCT02421419|593085570|FG001|Overall Study|Physician Decision|0|||
164195855|NCT02421419|593085571|FG002|Overall Study|Physician Decision|1|||
164195856|NCT01747499|593085573|FG000|Overall Study|Steroid refractory aGvHD|1|||
164195857|NCT01747499|593085574|FG001|Overall Study|Steroid refractory aGvHD|0|||
164195858|NCT01747499|593085575|FG002|Overall Study|Steroid refractory aGvHD|0|||
164195859|NCT01747499|593085576|FG003|Overall Study|Steroid refractory aGvHD|1|||
164195860|NCT01747499|593085577|FG004|Overall Study|Steroid refractory aGvHD|4|||
164195861|NCT01747499|593085573|FG000|Overall Study|Physician Decision|0|||
164195862|NCT01747499|593085574|FG001|Overall Study|Physician Decision|1|||
164195863|NCT01747499|593085575|FG002|Overall Study|Physician Decision|0|||
164195864|NCT01747499|593085576|FG003|Overall Study|Physician Decision|0|||
164195865|NCT01747499|593085577|FG004|Overall Study|Physician Decision|2|||
164195866|NCT01747499|593085573|FG000|Overall Study|Death|0|||
164195867|NCT01747499|593085574|FG001|Overall Study|Death|0|||
164195868|NCT01747499|593085575|FG002|Overall Study|Death|0|||
164195869|NCT01747499|593085576|FG003|Overall Study|Death|1|||
164195870|NCT01747499|593085577|FG004|Overall Study|Death|1|||
164195871|NCT01747499|593085573|FG000|Overall Study|Withdrawal by Subject|0|||
164195872|NCT01747499|593085574|FG001|Overall Study|Withdrawal by Subject|0|||
164195873|NCT01747499|593085575|FG002|Overall Study|Withdrawal by Subject|0|||
164195874|NCT01747499|593085576|FG003|Overall Study|Withdrawal by Subject|0|||
164195875|NCT01747499|593085577|FG004|Overall Study|Withdrawal by Subject|6|||
164195876|NCT01747499|593085573|FG000|Overall Study|Developed AML and death|0|||
164195877|NCT01747499|593085574|FG001|Overall Study|Developed AML and death|0|||
164195878|NCT01747499|593085575|FG002|Overall Study|Developed AML and death|0|||
164195879|NCT01747499|593085576|FG003|Overall Study|Developed AML and death|0|||
164195880|NCT01747499|593085577|FG004|Overall Study|Developed AML and death|1|||
164195881|NCT01747499|593085573|FG000|Overall Study|Determined not to be eligible|0|||
164195882|NCT01747499|593085574|FG001|Overall Study|Determined not to be eligible|0|||
164195883|NCT01747499|593085575|FG002|Overall Study|Determined not to be eligible|0|||
164195884|NCT01747499|593085576|FG003|Overall Study|Determined not to be eligible|0|||
164195885|NCT01747499|593085577|FG004|Overall Study|Determined not to be eligible|1|||
164195886|NCT01676701|593085578|FG000|Overall Study|Protocol Violation|1|||
164195887|NCT01676701|593085579|FG001|Overall Study|Protocol Violation|0|||
164195888|NCT01676701|593085578|FG000|Overall Study|Sponsor Decision|3|||
164195889|NCT01676701|593085579|FG001|Overall Study|Sponsor Decision|4|||
164195890|NCT00196105|593085580|FG000|Overall Study|Lost to Follow-up|4|||
164195891|NCT00196105|593085581|FG001|Overall Study|Lost to Follow-up|5|||
164195892|NCT00196105|593085582|FG002|Overall Study|Lost to Follow-up|7|||
164195893|NCT00248651|593085586|FG000|Overall Study|Withdrawal by Subject|28|||
164195894|NCT00248651|593085587|FG001|Overall Study|Withdrawal by Subject|40|||
164195895|NCT00248651|593085588|FG002|Overall Study|Withdrawal by Subject|32|||
164195896|NCT01365130|593085591|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
164195897|NCT05607576|593085593|FG000|Overall Study|immediate sensor error|2|||
164195898|NCT05607576|593085593|FG000|Overall Study|Physician Decision|2|||
164195899|NCT05616013|593085594|FG000|Overall Study|Adverse Event|6|||
164195900|NCT05616013|593085595|FG001|Overall Study|Adverse Event|12|||
164195901|NCT05616013|593085596|FG002|Overall Study|Adverse Event|8|||
164195902|NCT05616013|593085597|FG003|Overall Study|Adverse Event|4|||
164195903|NCT05616013|593085598|FG004|Overall Study|Adverse Event|6|||
164195904|NCT05616013|593085599|FG005|Overall Study|Adverse Event|8|||
164195905|NCT05616013|593085600|FG006|Overall Study|Adverse Event|3|||
164195906|NCT05616013|593085601|FG007|Overall Study|Adverse Event|6|||
164195907|NCT05616013|593085602|FG008|Overall Study|Adverse Event|1|||
164195908|NCT05616013|593085594|FG000|Overall Study|Lost to Follow-up|5|||
164195909|NCT05616013|593085595|FG001|Overall Study|Lost to Follow-up|4|||
164195910|NCT05616013|593085596|FG002|Overall Study|Lost to Follow-up|3|||
164195911|NCT05616013|593085597|FG003|Overall Study|Lost to Follow-up|2|||
164195912|NCT05616013|593085598|FG004|Overall Study|Lost to Follow-up|0|||
164195913|NCT05616013|593085599|FG005|Overall Study|Lost to Follow-up|5|||
164195914|NCT05616013|593085600|FG006|Overall Study|Lost to Follow-up|2|||
164195915|NCT05616013|593085601|FG007|Overall Study|Lost to Follow-up|1|||
164195916|NCT05616013|593085602|FG008|Overall Study|Lost to Follow-up|2|||
164195917|NCT05616013|593085594|FG000|Overall Study|Non-compliance with study requirements|2|||
164195918|NCT05616013|593085595|FG001|Overall Study|Non-compliance with study requirements|2|||
164195919|NCT05616013|593085596|FG002|Overall Study|Non-compliance with study requirements|2|||
164195920|NCT05616013|593085597|FG003|Overall Study|Non-compliance with study requirements|3|||
164195921|NCT05616013|593085598|FG004|Overall Study|Non-compliance with study requirements|0|||
164195922|NCT05616013|593085599|FG005|Overall Study|Non-compliance with study requirements|2|||
164195923|NCT05616013|593085600|FG006|Overall Study|Non-compliance with study requirements|1|||
164195924|NCT05616013|593085601|FG007|Overall Study|Non-compliance with study requirements|1|||
164653742|NCT01806597|594758940|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
164653743|NCT01806597|594758935|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
164195925|NCT05616013|593085602|FG008|Overall Study|Non-compliance with study requirements|4|||
164653744|NCT01806597|594758936|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
164653745|NCT01806597|594758937|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
164653746|NCT01806597|594758938|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
164653747|NCT01806597|594758939|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
164195926|NCT05616013|593085594|FG000|Overall Study|Withdrawal by Subject|11|||
164653748|NCT01806597|594758940|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
164653749|NCT01806597|594758935|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
164195927|NCT05616013|593085595|FG001|Overall Study|Withdrawal by Subject|9|||
164195928|NCT05616013|593085596|FG002|Overall Study|Withdrawal by Subject|8|||
164195929|NCT05616013|593085597|FG003|Overall Study|Withdrawal by Subject|6|||
164195930|NCT05616013|593085598|FG004|Overall Study|Withdrawal by Subject|3|||
164195931|NCT05616013|593085599|FG005|Overall Study|Withdrawal by Subject|4|||
164195932|NCT05616013|593085600|FG006|Overall Study|Withdrawal by Subject|6|||
164195933|NCT05616013|593085601|FG007|Overall Study|Withdrawal by Subject|5|||
164195934|NCT05616013|593085602|FG008|Overall Study|Withdrawal by Subject|4|||
164195935|NCT05616013|593085594|FG000|Overall Study|Physician Decision|0|||
164195936|NCT05616013|593085595|FG001|Overall Study|Physician Decision|0|||
164195937|NCT05616013|593085596|FG002|Overall Study|Physician Decision|1|||
164195938|NCT05616013|593085597|FG003|Overall Study|Physician Decision|0|||
164195939|NCT05616013|593085598|FG004|Overall Study|Physician Decision|0|||
164195940|NCT05616013|593085599|FG005|Overall Study|Physician Decision|1|||
164195941|NCT05616013|593085600|FG006|Overall Study|Physician Decision|3|||
164195942|NCT05616013|593085601|FG007|Overall Study|Physician Decision|0|||
164195943|NCT05616013|593085602|FG008|Overall Study|Physician Decision|0|||
164195944|NCT05616013|593085594|FG000|Overall Study|Protocol Violation|0|||
164195945|NCT05616013|593085595|FG001|Overall Study|Protocol Violation|0|||
164195946|NCT05616013|593085596|FG002|Overall Study|Protocol Violation|0|||
164195947|NCT05616013|593085597|FG003|Overall Study|Protocol Violation|0|||
164195948|NCT05616013|593085598|FG004|Overall Study|Protocol Violation|0|||
164195949|NCT05616013|593085599|FG005|Overall Study|Protocol Violation|0|||
164195950|NCT05616013|593085600|FG006|Overall Study|Protocol Violation|1|||
164195951|NCT05616013|593085601|FG007|Overall Study|Protocol Violation|0|||
164195952|NCT05616013|593085602|FG008|Overall Study|Protocol Violation|2|||
164195953|NCT05616013|593085594|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
164195954|NCT05616013|593085595|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
164195955|NCT05616013|593085596|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
164195956|NCT05616013|593085597|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
164195957|NCT05616013|593085598|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
164195958|NCT05616013|593085599|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
164195959|NCT05616013|593085600|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
164195960|NCT05616013|593085601|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
164195961|NCT05616013|593085602|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
164195962|NCT05616013|593085594|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
164195963|NCT05616013|593085595|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
164195964|NCT05616013|593085596|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
164195965|NCT05616013|593085597|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
164195966|NCT05616013|593085598|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
164195967|NCT05616013|593085599|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
164195968|NCT05616013|593085600|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
164195969|NCT05616013|593085601|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
164195970|NCT05616013|593085602|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
164195971|NCT05616013|593085594|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
164195972|NCT05616013|593085595|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
164195973|NCT05616013|593085596|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
164195974|NCT05616013|593085597|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
164195975|NCT05616013|593085598|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
164195976|NCT05616013|593085599|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
164195977|NCT05616013|593085600|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
164195978|NCT05616013|593085601|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
164195979|NCT05616013|593085602|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
164195980|NCT05616013|593085594|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
164195981|NCT05616013|593085595|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
164195982|NCT05616013|593085596|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
164195983|NCT05616013|593085597|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
164195984|NCT05616013|593085598|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
164195985|NCT05616013|593085599|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
164195986|NCT05616013|593085600|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
164195987|NCT05616013|593085601|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
164195988|NCT05616013|593085602|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
164195989|NCT05616013|593085594|FG000|Overall Study|Participant Decision, Time Constraints|0|||
164195990|NCT05616013|593085595|FG001|Overall Study|Participant Decision, Time Constraints|1|||
164195991|NCT05616013|593085596|FG002|Overall Study|Participant Decision, Time Constraints|0|||
164195992|NCT05616013|593085597|FG003|Overall Study|Participant Decision, Time Constraints|0|||
164195993|NCT05616013|593085598|FG004|Overall Study|Participant Decision, Time Constraints|0|||
164195994|NCT05616013|593085599|FG005|Overall Study|Participant Decision, Time Constraints|0|||
164195995|NCT05616013|593085600|FG006|Overall Study|Participant Decision, Time Constraints|0|||
164195996|NCT05616013|593085601|FG007|Overall Study|Participant Decision, Time Constraints|0|||
164195997|NCT05616013|593085602|FG008|Overall Study|Participant Decision, Time Constraints|0|||
164195998|NCT05616013|593085594|FG000|Overall Study|Prohibited Concomitant Medication|0|||
164195999|NCT05616013|593085595|FG001|Overall Study|Prohibited Concomitant Medication|0|||
164196000|NCT05616013|593085596|FG002|Overall Study|Prohibited Concomitant Medication|1|||
164196001|NCT05616013|593085597|FG003|Overall Study|Prohibited Concomitant Medication|0|||
164196002|NCT05616013|593085598|FG004|Overall Study|Prohibited Concomitant Medication|0|||
164196003|NCT05616013|593085599|FG005|Overall Study|Prohibited Concomitant Medication|0|||
164196004|NCT05616013|593085600|FG006|Overall Study|Prohibited Concomitant Medication|0|||
164196005|NCT05616013|593085601|FG007|Overall Study|Prohibited Concomitant Medication|0|||
164196006|NCT05616013|593085602|FG008|Overall Study|Prohibited Concomitant Medication|0|||
164547816|NCT02325219|594378216|FG003|Controlled Period (Week 0 - 16)|Other|0|||
164547817|NCT02325219|594378217|FG004|Controlled Period (Week 0 - 16)|Other|0|||
164547818|NCT02325219|594378213|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
164547819|NCT02325219|594378214|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
164547820|NCT02325219|594378215|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
164547821|NCT02325219|594378216|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
164547822|NCT02325219|594378217|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
164547823|NCT02325219|594378213|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
164547824|NCT02325219|594378214|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
164547825|NCT02325219|594378215|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
164547826|NCT02325219|594378216|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
164547827|NCT02325219|594378217|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
164547828|NCT02325219|594378213|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
164547829|NCT02325219|594378214|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
164547830|NCT02325219|594378215|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
164547831|NCT02325219|594378216|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
164547832|NCT02325219|594378217|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
164547833|NCT00880399|594378220|FG000|Overall Study|Adverse Event|4|||
164547834|NCT00880399|594378221|FG001|Overall Study|Adverse Event|6|||
164547835|NCT00880399|594378222|FG002|Overall Study|Adverse Event|5|||
164547836|NCT00880399|594378220|FG000|Overall Study|Lack of Efficacy|1|||
164547837|NCT00880399|594378221|FG001|Overall Study|Lack of Efficacy|4|||
164547838|NCT00880399|594378222|FG002|Overall Study|Lack of Efficacy|2|||
164547839|NCT00880399|594378220|FG000|Overall Study|Protocol Violation|4|||
164547840|NCT00880399|594378221|FG001|Overall Study|Protocol Violation|4|||
164547841|NCT00880399|594378222|FG002|Overall Study|Protocol Violation|6|||
164547842|NCT00880399|594378220|FG000|Overall Study|Study closed/terminated|3|||
164547843|NCT00880399|594378221|FG001|Overall Study|Study closed/terminated|7|||
164547844|NCT00880399|594378222|FG002|Overall Study|Study closed/terminated|4|||
164547845|NCT00880399|594378220|FG000|Overall Study|Lost to Follow-up|8|||
164547846|NCT00880399|594378221|FG001|Overall Study|Lost to Follow-up|5|||
164547847|NCT00880399|594378222|FG002|Overall Study|Lost to Follow-up|3|||
164547848|NCT00880399|594378220|FG000|Overall Study|Physician Decision|5|||
164547849|NCT00880399|594378221|FG001|Overall Study|Physician Decision|0|||
164547850|NCT00880399|594378222|FG002|Overall Study|Physician Decision|3|||
164547851|NCT00880399|594378220|FG000|Overall Study|Withdrawal by Subject|6|||
164547852|NCT00880399|594378221|FG001|Overall Study|Withdrawal by Subject|3|||
164547853|NCT00880399|594378222|FG002|Overall Study|Withdrawal by Subject|3|||
164547854|NCT02181816|594378223|FG000|Overall Study|Case Report Forms Uncollected|38|||
164547855|NCT02181816|594378223|FG000|Overall Study|Protocol Deviation|21|||
164547856|NCT00909181|594378224|FG000|Overall Study|Lost to Follow-up|39|||
164547857|NCT00909181|594378225|FG001|Overall Study|Lost to Follow-up|18|||
164547858|NCT00909181|594378226|FG002|Overall Study|Lost to Follow-up|33|||
164547859|NCT02830880|594378227|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
164547860|NCT02830880|594378227|FG000|Overall Study|Death|1|||
164547861|NCT02830880|594378227|FG000|Overall Study|Physician Decision|1|||
164547862|NCT02969187|594378232|FG000|Overall Study|Physician Decision|12|||
164547863|NCT02969187|594378233|FG001|Overall Study|Physician Decision|13|||
164547864|NCT01278745|594378234|FG000|Overall Study|Death|2|||
164547865|NCT01278745|594378235|FG001|Overall Study|Death|5|||
164547866|NCT01278745|594378236|FG002|Overall Study|Death|7|||
164547867|NCT01278745|594378237|FG003|Overall Study|Death|0|||
164547868|NCT01278745|594378234|FG000|Overall Study|Physician Decision|1|||
164547869|NCT01278745|594378235|FG001|Overall Study|Physician Decision|0|||
164547870|NCT01278745|594378236|FG002|Overall Study|Physician Decision|0|||
164547871|NCT01278745|594378237|FG003|Overall Study|Physician Decision|9|||
164547872|NCT01278745|594378234|FG000|Overall Study|Withdrawal by Subject|1|||
164547873|NCT01278745|594378235|FG001|Overall Study|Withdrawal by Subject|1|||
164547874|NCT01278745|594378236|FG002|Overall Study|Withdrawal by Subject|5|||
164547875|NCT01278745|594378237|FG003|Overall Study|Withdrawal by Subject|1|||
164547876|NCT01278745|594378234|FG000|Overall Study|Sponsor Decision|1|||
164547877|NCT01278745|594378235|FG001|Overall Study|Sponsor Decision|0|||
164547878|NCT01278745|594378236|FG002|Overall Study|Sponsor Decision|62|||
164547879|NCT01278745|594378237|FG003|Overall Study|Sponsor Decision|6|||
164547880|NCT01278745|594378234|FG000|Overall Study|Ineligible|0|||
164547881|NCT01278745|594378235|FG001|Overall Study|Ineligible|0|||
164547882|NCT01278745|594378236|FG002|Overall Study|Ineligible|42|||
164547883|NCT01278745|594378237|FG003|Overall Study|Ineligible|61|||
164653750|NCT01806597|594758936|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
164653751|NCT01806597|594758937|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
164653752|NCT01806597|594758938|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
164653753|NCT01806597|594758939|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
164653754|NCT01806597|594758940|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
164653755|NCT01806597|594758935|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
164653756|NCT01806597|594758936|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
164653757|NCT01806597|594758937|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
164653758|NCT01806597|594758938|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
164653759|NCT01806597|594758939|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
164653760|NCT01806597|594758940|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
164653761|NCT01806597|594758935|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
164653762|NCT01806597|594758936|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
164196007|NCT05616013|593085594|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
164196008|NCT05616013|593085595|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
164196009|NCT05616013|593085596|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
164196010|NCT05616013|593085597|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
164196011|NCT05616013|593085598|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
164196012|NCT05616013|593085599|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
164196013|NCT05616013|593085600|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
164196014|NCT05616013|593085601|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
164196015|NCT05616013|593085602|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
164196016|NCT05616013|593085594|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
164196017|NCT05616013|593085595|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
164196018|NCT05616013|593085596|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
164196019|NCT05616013|593085597|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
164196020|NCT05616013|593085598|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
164196021|NCT05616013|593085599|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
164196022|NCT05616013|593085600|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
164196023|NCT05616013|593085601|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
164196024|NCT05616013|593085602|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
164196025|NCT05616013|593085594|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
164196026|NCT05616013|593085595|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
164196027|NCT05616013|593085596|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
164196028|NCT05616013|593085597|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
164196029|NCT05616013|593085598|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
164196030|NCT05616013|593085599|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
164196031|NCT05616013|593085600|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
164196032|NCT05616013|593085601|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
164196033|NCT05616013|593085602|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
164196034|NCT05616013|593085594|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
164196035|NCT05616013|593085595|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
164196036|NCT05616013|593085596|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
164196037|NCT05616013|593085597|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
164196038|NCT05616013|593085598|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
164196039|NCT05616013|593085599|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
164196040|NCT05616013|593085600|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
164196041|NCT05616013|593085601|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
164196042|NCT05616013|593085602|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
164196043|NCT05616013|593085594|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
164196044|NCT05616013|593085595|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
164196045|NCT05616013|593085596|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
164196046|NCT05616013|593085597|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
164196047|NCT05616013|593085598|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
164196048|NCT05616013|593085599|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
164196049|NCT05616013|593085600|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
164196050|NCT05616013|593085601|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
164307249|NCT02023697|593499224|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
164420582|NCT02718417|593910945|FG002|Long-term Follow-up Phase|Other|0|||
164653763|NCT01806597|594758937|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
164653764|NCT01806597|594758938|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
164653765|NCT01806597|594758939|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
164653766|NCT01806597|594758940|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
164653767|NCT01806597|594758935|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
164653768|NCT01806597|594758936|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
164653769|NCT01806597|594758937|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
164653770|NCT01806597|594758938|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
164653771|NCT01806597|594758939|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
164653772|NCT01806597|594758940|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
164653773|NCT01806597|594758935|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
164653774|NCT01806597|594758936|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
164653775|NCT01806597|594758937|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
164653776|NCT01806597|594758938|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
164653777|NCT01806597|594758939|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
164653778|NCT01806597|594758940|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
164653779|NCT01806597|594758935|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
164653780|NCT01806597|594758936|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
164653781|NCT01806597|594758937|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
164653782|NCT01806597|594758938|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
164653783|NCT01806597|594758939|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
164653784|NCT01806597|594758940|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
164653785|NCT01806597|594758935|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
164653786|NCT01806597|594758936|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
164653787|NCT01806597|594758937|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
164653788|NCT01806597|594758938|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
164653789|NCT01806597|594758939|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
164653790|NCT01806597|594758940|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
164196051|NCT05616013|593085602|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
164196052|NCT03430856|593085609|FG000|Overall Study|Adverse Event|0|||
164196053|NCT03430856|593085610|FG001|Overall Study|Adverse Event|1|||
164196054|NCT03430856|593085611|FG002|Overall Study|Adverse Event|0|||
164196055|NCT03430856|593085609|FG000|Overall Study|Rescue criteria|1|||
164196056|NCT03430856|593085610|FG001|Overall Study|Rescue criteria|1|||
164196057|NCT03430856|593085611|FG002|Overall Study|Rescue criteria|0|||
164196058|NCT03430856|593085609|FG000|Overall Study|Voluntary withdrawal of consent|1|||
164196059|NCT03430856|593085610|FG001|Overall Study|Voluntary withdrawal of consent|1|||
164196060|NCT03430856|593085611|FG002|Overall Study|Voluntary withdrawal of consent|1|||
164196061|NCT02481050|593087435|FG000|Overall Study|Adverse Event|1|||
164196062|NCT02481050|593087435|FG000|Overall Study|Disease Progression|47|||
164196063|NCT02481050|593087435|FG000|Overall Study|Withdrawal by Subject|7|||
164196064|NCT02481050|593087435|FG000|Overall Study|Other|3|||
164196065|NCT02357459|593087438|FG000|Overall Study|Adverse Event|0|||
164196066|NCT02357459|593087439|FG001|Overall Study|Adverse Event|1|||
164196067|NCT02357459|593087440|FG002|Overall Study|Adverse Event|1|||
164196068|NCT02357459|593087438|FG000|Overall Study|Withdrawal by Subject|5|||
164196069|NCT02357459|593087439|FG001|Overall Study|Withdrawal by Subject|3|||
164653791|NCT01806597|594758935|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
164196070|NCT02357459|593087440|FG002|Overall Study|Withdrawal by Subject|3|||
164196071|NCT02357459|593087438|FG000|Overall Study|Physician Decision|0|||
164196072|NCT02357459|593087439|FG001|Overall Study|Physician Decision|2|||
164196073|NCT02357459|593087440|FG002|Overall Study|Physician Decision|0|||
164196074|NCT02357459|593087438|FG000|Overall Study|Protocol Violation|1|||
164196075|NCT02357459|593087439|FG001|Overall Study|Protocol Violation|1|||
164196076|NCT02357459|593087440|FG002|Overall Study|Protocol Violation|0|||
164196077|NCT02357459|593087438|FG000|Overall Study|Lost to Follow-up|1|||
164196078|NCT02357459|593087439|FG001|Overall Study|Lost to Follow-up|3|||
164196079|NCT02357459|593087440|FG002|Overall Study|Lost to Follow-up|0|||
164196080|NCT02357459|593087438|FG000|Overall Study|Lack of Efficacy|7|||
164196081|NCT02357459|593087439|FG001|Overall Study|Lack of Efficacy|4|||
164196082|NCT02357459|593087440|FG002|Overall Study|Lack of Efficacy|4|||
164196083|NCT02357459|593087438|FG000|Overall Study|Patient Relocated|2|||
164196084|NCT02357459|593087439|FG001|Overall Study|Patient Relocated|0|||
164196085|NCT02357459|593087440|FG002|Overall Study|Patient Relocated|0|||
164196086|NCT02357459|593087438|FG000|Overall Study|Instruction from PCP|1|||
164196087|NCT02357459|593087439|FG001|Overall Study|Instruction from PCP|0|||
164196088|NCT02357459|593087440|FG002|Overall Study|Instruction from PCP|0|||
164196089|NCT02357459|593087438|FG000|Overall Study|Incarceration|0|||
164196090|NCT02357459|593087439|FG001|Overall Study|Incarceration|0|||
164196091|NCT02357459|593087440|FG002|Overall Study|Incarceration|1|||
164196092|NCT02357459|593087438|FG000|Overall Study|Pre-planned Knee surgery|0|||
164196093|NCT02357459|593087439|FG001|Overall Study|Pre-planned Knee surgery|0|||
164196094|NCT02357459|593087440|FG002|Overall Study|Pre-planned Knee surgery|2|||
164196095|NCT02357459|593087438|FG000|Overall Study|Job Commitments|0|||
164196096|NCT02357459|593087439|FG001|Overall Study|Job Commitments|0|||
164196097|NCT02357459|593087440|FG002|Overall Study|Job Commitments|1|||
164196098|NCT01022203|593087441|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
164196099|NCT01022203|593087442|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
164196100|NCT01022203|593087441|FG000|Post Treatment Assessment|Physician Decision|2|||
164196101|NCT01022203|593087442|FG001|Post Treatment Assessment|Physician Decision|0|||
164196102|NCT01022203|593087441|FG000|Post Treatment Assessment|Adverse Event|0|||
164196103|NCT01022203|593087442|FG001|Post Treatment Assessment|Adverse Event|2|||
164196104|NCT01022203|593087441|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
164196105|NCT01022203|593087442|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
164196106|NCT03638128|593087445|FG000|Overall Study|Withdrawal by Subject|1|||
164196107|NCT03638128|593087446|FG001|Overall Study|Withdrawal by Subject|7|||
164196108|NCT03638128|593087447|FG002|Overall Study|Withdrawal by Subject|6|||
164196109|NCT03638128|593087445|FG000|Overall Study|Sponsor Decision|15|||
164196110|NCT03638128|593087446|FG001|Overall Study|Sponsor Decision|12|||
164196111|NCT03638128|593087447|FG002|Overall Study|Sponsor Decision|19|||
164196112|NCT03638128|593087445|FG000|Overall Study|Lost to Follow-up|0|||
164196113|NCT03638128|593087446|FG001|Overall Study|Lost to Follow-up|0|||
164196114|NCT03638128|593087447|FG002|Overall Study|Lost to Follow-up|1|||
164196115|NCT03163446|593087448|FG000|Overall Study|Unable to return for Day 180 visit|2|||
164196116|NCT03163446|593087449|FG001|Overall Study|Unable to return for Day 180 visit|0|||
164196117|NCT03163446|593087448|FG000|Overall Study|Withdrawal by Subject|2|||
164196118|NCT03163446|593087449|FG001|Overall Study|Withdrawal by Subject|6|||
164196119|NCT03163446|593087448|FG000|Overall Study|Death|16|||
164196120|NCT03163446|593087449|FG001|Overall Study|Death|5|||
164196121|NCT03163446|593087448|FG000|Overall Study|Lost to Follow-up|6|||
164653792|NCT01806597|594758936|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
164196122|NCT03163446|593087449|FG001|Overall Study|Lost to Follow-up|5|||
164196123|NCT03163446|593087448|FG000|Overall Study|Physician Decision|1|||
164196124|NCT03163446|593087449|FG001|Overall Study|Physician Decision|1|||
164196125|NCT03163446|593087448|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
164653793|NCT01806597|594758937|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
164653794|NCT01806597|594758938|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
164653795|NCT01806597|594758939|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
164653796|NCT01806597|594758940|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
164653797|NCT01806597|594758935|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
164653798|NCT01806597|594758936|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
164653799|NCT01806597|594758937|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
164653800|NCT01806597|594758938|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
164653801|NCT01806597|594758939|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
164653802|NCT01806597|594758940|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
164653803|NCT01144663|594758941|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
164653804|NCT01144663|594758942|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
164653805|NCT01144663|594758943|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
164653806|NCT01144663|594758944|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
164653807|NCT01144663|594758941|FG000|Primary Vaccination Phase|Adverse Event|1|||
164653808|NCT01144663|594758942|FG001|Primary Vaccination Phase|Adverse Event|0|||
164653809|NCT01144663|594758943|FG002|Primary Vaccination Phase|Adverse Event|0|||
164653810|NCT01144663|594758944|FG003|Primary Vaccination Phase|Adverse Event|1|||
164653811|NCT01144663|594758941|FG000|Primary Vaccination Phase|Protocol Violation|2|||
164653812|NCT01144663|594758942|FG001|Primary Vaccination Phase|Protocol Violation|0|||
164653813|NCT01144663|594758943|FG002|Primary Vaccination Phase|Protocol Violation|1|||
164653814|NCT01144663|594758944|FG003|Primary Vaccination Phase|Protocol Violation|0|||
164653815|NCT01144663|594758941|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
164653816|NCT01144663|594758942|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
164653817|NCT01144663|594758943|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
164653818|NCT01144663|594758944|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
164653819|NCT01144663|594758941|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
164653820|NCT01144663|594758942|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
164653821|NCT01144663|594758943|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
164653822|NCT01144663|594758944|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
164653823|NCT01144663|594758941|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
164653824|NCT01144663|594758942|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
164653825|NCT01144663|594758943|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
164653826|NCT01144663|594758944|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
164653827|NCT01144663|594758941|FG000|Primary Vaccination Phase|Other|0|||
164653828|NCT01144663|594758942|FG001|Primary Vaccination Phase|Other|1|||
164653829|NCT01144663|594758943|FG002|Primary Vaccination Phase|Other|0|||
164653830|NCT01144663|594758944|FG003|Primary Vaccination Phase|Other|2|||
164653831|NCT01144663|594758941|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
164653832|NCT01144663|594758942|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
164653833|NCT01144663|594758943|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
164653834|NCT01144663|594758944|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
164653835|NCT01144663|594758941|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
164653836|NCT01144663|594758942|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
164653837|NCT01144663|594758943|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
164653838|NCT01144663|594758944|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
164653839|NCT01144663|594758941|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
164653840|NCT01144663|594758942|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
164653841|NCT01144663|594758943|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
164653842|NCT01144663|594758944|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
164653843|NCT01144663|594758941|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
164653844|NCT01144663|594758942|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
164653845|NCT01144663|594758943|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
164196126|NCT03163446|593087449|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
164653846|NCT01144663|594758944|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
164653847|NCT01144663|594758941|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
164653848|NCT01144663|594758942|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
164653849|NCT01144663|594758943|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
164196127|NCT00611806|593087450|FG000|Overall Study|Withdrawal by Subject|8|||
164196128|NCT00611806|593087451|FG001|Overall Study|Withdrawal by Subject|2|||
164196129|NCT00611806|593087450|FG000|Overall Study|Adverse Event|2|||
164196130|NCT00611806|593087451|FG001|Overall Study|Adverse Event|1|||
164196131|NCT00611806|593087450|FG000|Overall Study|Lost to Follow-up|6|||
164196132|NCT00611806|593087451|FG001|Overall Study|Lost to Follow-up|0|||
164196133|NCT00903201|593087453|FG000|Overall Study|Adverse Event|1|||
164307250|NCT02023697|593499225|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
164653850|NCT01144663|594758944|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
164653851|NCT01144663|594758941|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
164653852|NCT01144663|594758942|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
164653853|NCT01144663|594758943|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
164653854|NCT01144663|594758944|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
164653855|NCT01473758|594758949|FG000|Cycle 1|Adverse Event|10|||
164653856|NCT01473758|594758950|FG001|Cycle 1|Adverse Event|2|||
164653857|NCT01473758|594758951|FG002|Cycle 1|Adverse Event|0|||
164653858|NCT01473758|594758952|FG003|Cycle 1|Adverse Event|0|||
164653859|NCT01473758|594758949|FG000|Cycle 1|Withdrawal by Subject|1|||
164653860|NCT01473758|594758950|FG001|Cycle 1|Withdrawal by Subject|1|||
164653861|NCT01473758|594758951|FG002|Cycle 1|Withdrawal by Subject|0|||
164653862|NCT01473758|594758952|FG003|Cycle 1|Withdrawal by Subject|0|||
164653863|NCT01473758|594758949|FG000|Cycle 2|Adverse Event|0|||
164653864|NCT01473758|594758950|FG001|Cycle 2|Adverse Event|0|||
164653865|NCT01473758|594758951|FG002|Cycle 2|Adverse Event|5|||
164653866|NCT01473758|594758952|FG003|Cycle 2|Adverse Event|0|||
164653867|NCT02763579|594758953|FG000|Global Period|Death|167|||
164653868|NCT02763579|594758954|FG001|Global Period|Death|151|||
164653869|NCT02763579|594758955|FG002|Global Period|Death|0|||
164653870|NCT02763579|594758956|FG003|Global Period|Death|0|||
164653871|NCT02763579|594758953|FG000|Global Period|Lost to Follow-up|2|||
164653872|NCT02763579|594758954|FG001|Global Period|Lost to Follow-up|4|||
164653873|NCT02763579|594758955|FG002|Global Period|Lost to Follow-up|0|||
164653874|NCT02763579|594758956|FG003|Global Period|Lost to Follow-up|0|||
164653875|NCT02763579|594758953|FG000|Global Period|Physician Decision|0|||
164653876|NCT02763579|594758954|FG001|Global Period|Physician Decision|2|||
164653877|NCT02763579|594758955|FG002|Global Period|Physician Decision|0|||
164653878|NCT02763579|594758956|FG003|Global Period|Physician Decision|0|||
164653879|NCT02763579|594758953|FG000|Global Period|Study Terminated By Sponsor|21|||
164653880|NCT02763579|594758954|FG001|Global Period|Study Terminated By Sponsor|26|||
164653881|NCT02763579|594758955|FG002|Global Period|Study Terminated By Sponsor|0|||
164653882|NCT02763579|594758956|FG003|Global Period|Study Terminated By Sponsor|0|||
164653883|NCT02763579|594758953|FG000|Global Period|Withdrawal by Subject|12|||
164653884|NCT02763579|594758954|FG001|Global Period|Withdrawal by Subject|18|||
164653885|NCT02763579|594758955|FG002|Global Period|Withdrawal by Subject|0|||
164653886|NCT02763579|594758956|FG003|Global Period|Withdrawal by Subject|0|||
164653887|NCT02763579|594758953|FG000|China Period|Death|0|||
164653888|NCT02763579|594758954|FG001|China Period|Death|0|||
164653889|NCT02763579|594758955|FG002|China Period|Death|46|||
164653890|NCT02763579|594758956|FG003|China Period|Death|48|||
164653891|NCT02763579|594758953|FG000|China Period|Lost to Follow-up|0|||
164653892|NCT02763579|594758954|FG001|China Period|Lost to Follow-up|0|||
164653893|NCT02763579|594758955|FG002|China Period|Lost to Follow-up|1|||
164653894|NCT02763579|594758956|FG003|China Period|Lost to Follow-up|1|||
164653895|NCT02763579|594758953|FG000|China Period|Physician Decision|0|||
164653896|NCT02763579|594758954|FG001|China Period|Physician Decision|0|||
164653897|NCT02763579|594758955|FG002|China Period|Physician Decision|0|||
164653898|NCT02763579|594758956|FG003|China Period|Physician Decision|1|||
164196134|NCT00903201|593087454|FG001|Overall Study|Adverse Event|4|||
164653899|NCT02763579|594758953|FG000|China Period|Study Terminated By Sponsor|0|||
164653900|NCT02763579|594758954|FG001|China Period|Study Terminated By Sponsor|0|||
164653901|NCT02763579|594758955|FG002|China Period|Study Terminated By Sponsor|3|||
164653902|NCT02763579|594758956|FG003|China Period|Study Terminated By Sponsor|4|||
164653903|NCT02763579|594758953|FG000|China Period|Withdrawal by Subject|0|||
164653904|NCT02763579|594758954|FG001|China Period|Withdrawal by Subject|0|||
164653905|NCT02763579|594758955|FG002|China Period|Withdrawal by Subject|3|||
164653906|NCT02763579|594758956|FG003|China Period|Withdrawal by Subject|3|||
164653907|NCT01003886|594758962|FG000|Overall Study|Lack of Efficacy|5|||
164653908|NCT01003886|594758962|FG000|Overall Study|Lost to Follow-up|169|||
164653909|NCT01003886|594758962|FG000|Overall Study|Withdrawal by Subject|39|||
164653910|NCT01003886|594758962|FG000|Overall Study|Other|14|||
164196135|NCT00903201|593087455|FG002|Overall Study|Adverse Event|0|||
164196136|NCT00903201|593087453|FG000|Overall Study|Protocol Violation|2|||
164196137|NCT00903201|593087454|FG001|Overall Study|Protocol Violation|1|||
164196138|NCT00903201|593087455|FG002|Overall Study|Protocol Violation|0|||
164196139|NCT00903201|593087453|FG000|Overall Study|Lost to Follow-up|0|||
164196140|NCT00903201|593087454|FG001|Overall Study|Lost to Follow-up|1|||
164196141|NCT00903201|593087455|FG002|Overall Study|Lost to Follow-up|0|||
164196142|NCT00903201|593087453|FG000|Overall Study|Physician Decision|1|||
164196143|NCT00903201|593087454|FG001|Overall Study|Physician Decision|0|||
164196144|NCT00903201|593087455|FG002|Overall Study|Physician Decision|1|||
164196145|NCT00903201|593087453|FG000|Overall Study|Withdrawal by Subject|1|||
164653911|NCT01003886|594758962|FG000|Overall Study|Adverse Event|3|||
164653912|NCT00909727|594758963|FG000|Overall Study|Adverse Event|1|||
164653913|NCT00909727|594758964|FG001|Overall Study|Adverse Event|0|||
164653914|NCT00909727|594758963|FG000|Overall Study|Wrong Genotype|1|||
164653915|NCT00909727|594758964|FG001|Overall Study|Wrong Genotype|0|||
164653916|NCT00909727|594758963|FG000|Overall Study|Withdrawal of Consent|1|||
164653917|NCT00909727|594758964|FG001|Overall Study|Withdrawal of Consent|0|||
164653918|NCT00909727|594758963|FG000|Overall Study|Prohibited Medication|1|||
164653919|NCT00909727|594758964|FG001|Overall Study|Prohibited Medication|0|||
164653920|NCT01567306|594758968|FG000|Overall Study|Protocol Violation|2|||
164653921|NCT01567306|594758969|FG001|Overall Study|Protocol Violation|2|||
164653922|NCT01567306|594758970|FG002|Overall Study|Protocol Violation|0|||
164653923|NCT01567306|594758971|FG003|Overall Study|Protocol Violation|3|||
164653924|NCT01567306|594758972|FG004|Overall Study|Protocol Violation|1|||
164653925|NCT01567306|594758973|FG005|Overall Study|Protocol Violation|1|||
164653926|NCT01567306|594758968|FG000|Overall Study|Change site living|1|||
164653927|NCT01567306|594758969|FG001|Overall Study|Change site living|0|||
164653928|NCT01567306|594758970|FG002|Overall Study|Change site living|0|||
164653929|NCT01567306|594758971|FG003|Overall Study|Change site living|0|||
164653930|NCT01567306|594758972|FG004|Overall Study|Change site living|0|||
164653931|NCT01567306|594758973|FG005|Overall Study|Change site living|0|||
164653932|NCT01567306|594758968|FG000|Overall Study|Adverse Event|0|||
164653933|NCT01567306|594758969|FG001|Overall Study|Adverse Event|0|||
164653934|NCT01567306|594758970|FG002|Overall Study|Adverse Event|0|||
164653935|NCT01567306|594758971|FG003|Overall Study|Adverse Event|2|||
164653936|NCT01567306|594758972|FG004|Overall Study|Adverse Event|4|||
164653937|NCT01567306|594758973|FG005|Overall Study|Adverse Event|1|||
164653938|NCT01567306|594758968|FG000|Overall Study|Lost to Follow-up|0|||
164653939|NCT01567306|594758969|FG001|Overall Study|Lost to Follow-up|0|||
164653940|NCT01567306|594758970|FG002|Overall Study|Lost to Follow-up|0|||
164653941|NCT01567306|594758971|FG003|Overall Study|Lost to Follow-up|0|||
164653942|NCT01567306|594758972|FG004|Overall Study|Lost to Follow-up|2|||
164653943|NCT01567306|594758973|FG005|Overall Study|Lost to Follow-up|0|||
164653944|NCT01567306|594758968|FG000|Overall Study|Withdrawal by Subject|0|||
164653945|NCT01567306|594758969|FG001|Overall Study|Withdrawal by Subject|0|||
164653946|NCT01567306|594758970|FG002|Overall Study|Withdrawal by Subject|0|||
164653947|NCT01567306|594758971|FG003|Overall Study|Withdrawal by Subject|0|||
164653948|NCT01567306|594758972|FG004|Overall Study|Withdrawal by Subject|0|||
164653949|NCT01567306|594758973|FG005|Overall Study|Withdrawal by Subject|1|||
164653950|NCT00829413|594758976|FG000|Overall Study|No study drug admimnistered|13|||
164653951|NCT00829413|594758976|FG000|Overall Study|Training Patients|67|||
164653952|NCT00829413|594758976|FG000|Overall Study|No truth standard procedure available|9|||
164653953|NCT00829413|594758976|FG000|Overall Study|Technically inadequate truth standard|2|||
164653954|NCT00829413|594758976|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
164653955|NCT00294723|594758977|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
164653956|NCT00294723|594758978|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
164653957|NCT00294723|594758979|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
164653958|NCT00294723|594758977|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
164653959|NCT00294723|594758978|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
164653960|NCT00294723|594758979|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
164653961|NCT00294723|594758977|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
164653962|NCT00294723|594758978|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
164653963|NCT00294723|594758979|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
164653964|NCT00294723|594758977|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
164653965|NCT00294723|594758978|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
164653966|NCT00294723|594758979|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
164653967|NCT00294723|594758977|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
164653968|NCT00294723|594758978|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
164653969|NCT00294723|594758979|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
164653970|NCT00294723|594758977|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
164653971|NCT00294723|594758978|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
164653972|NCT00294723|594758979|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
164653973|NCT00294723|594758977|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
164653974|NCT00294723|594758978|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
164653975|NCT00294723|594758979|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
164653976|NCT00294723|594758977|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
164653977|NCT00294723|594758978|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
164653978|NCT00294723|594758979|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
164653979|NCT00294723|594758977|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
164653980|NCT00294723|594758978|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
164653981|NCT00294723|594758979|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
164653982|NCT00294723|594758977|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
164653983|NCT00294723|594758978|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
164653984|NCT00294723|594758979|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
164653985|NCT00294723|594758977|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
164653986|NCT00294723|594758978|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
164653987|NCT00294723|594758979|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
164653988|NCT00294723|594758977|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
164653989|NCT00294723|594758978|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
164653990|NCT00294723|594758979|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
164653991|NCT00891774|594758984|FG000|Overall Study|Lost to Follow-up|5|||
164196146|NCT00903201|593087454|FG001|Overall Study|Withdrawal by Subject|0|||
164196147|NCT00903201|593087455|FG002|Overall Study|Withdrawal by Subject|1|||
164196148|NCT01094288|593087456|FG000|Overall Study|Adverse Event|0|||
164196149|NCT01094288|593087457|FG001|Overall Study|Adverse Event|3|||
164196150|NCT01094288|593087458|FG002|Overall Study|Adverse Event|1|||
164196151|NCT01094288|593087459|FG003|Overall Study|Adverse Event|1|||
164196152|NCT01094288|593087460|FG004|Overall Study|Adverse Event|0|||
164196153|NCT01094288|593087461|FG005|Overall Study|Adverse Event|0|||
164196154|NCT01094288|593087462|FG006|Overall Study|Adverse Event|0|||
164196155|NCT01094288|593087463|FG007|Overall Study|Adverse Event|0|||
164196156|NCT01094288|593087456|FG000|Overall Study|Withdrawal by Subject|0|||
164196157|NCT01094288|593087457|FG001|Overall Study|Withdrawal by Subject|1|||
164196158|NCT01094288|593087458|FG002|Overall Study|Withdrawal by Subject|2|||
164196159|NCT01094288|593087459|FG003|Overall Study|Withdrawal by Subject|0|||
164196160|NCT01094288|593087460|FG004|Overall Study|Withdrawal by Subject|0|||
164196161|NCT01094288|593087461|FG005|Overall Study|Withdrawal by Subject|0|||
164196162|NCT01094288|593087462|FG006|Overall Study|Withdrawal by Subject|0|||
164196163|NCT01094288|593087463|FG007|Overall Study|Withdrawal by Subject|2|||
164196164|NCT01094288|593087456|FG000|Overall Study|Initiation of Alternative Therapy|0|||
164196165|NCT01094288|593087457|FG001|Overall Study|Initiation of Alternative Therapy|0|||
164196166|NCT01094288|593087458|FG002|Overall Study|Initiation of Alternative Therapy|1|||
164196167|NCT01094288|593087459|FG003|Overall Study|Initiation of Alternative Therapy|0|||
164196168|NCT01094288|593087460|FG004|Overall Study|Initiation of Alternative Therapy|0|||
164196169|NCT01094288|593087461|FG005|Overall Study|Initiation of Alternative Therapy|0|||
164196170|NCT01094288|593087462|FG006|Overall Study|Initiation of Alternative Therapy|0|||
164196171|NCT01094288|593087463|FG007|Overall Study|Initiation of Alternative Therapy|0|||
164196172|NCT01094288|593087456|FG000|Overall Study|Reason not Specified|2|||
164196173|NCT01094288|593087457|FG001|Overall Study|Reason not Specified|3|||
164196174|NCT01094288|593087458|FG002|Overall Study|Reason not Specified|0|||
164196175|NCT01094288|593087459|FG003|Overall Study|Reason not Specified|1|||
164196176|NCT01094288|593087460|FG004|Overall Study|Reason not Specified|0|||
164196177|NCT01094288|593087461|FG005|Overall Study|Reason not Specified|0|||
164196178|NCT01094288|593087462|FG006|Overall Study|Reason not Specified|0|||
164196179|NCT01094288|593087463|FG007|Overall Study|Reason not Specified|0|||
164196180|NCT01094288|593087456|FG000|Overall Study|Ongoing Participants|0|||
164196181|NCT01094288|593087457|FG001|Overall Study|Ongoing Participants|3|||
164196182|NCT01094288|593087458|FG002|Overall Study|Ongoing Participants|0|||
164196183|NCT01094288|593087459|FG003|Overall Study|Ongoing Participants|0|||
164196184|NCT01094288|593087460|FG004|Overall Study|Ongoing Participants|0|||
164196185|NCT01094288|593087461|FG005|Overall Study|Ongoing Participants|0|||
164196186|NCT01094288|593087462|FG006|Overall Study|Ongoing Participants|0|||
164196187|NCT01094288|593087463|FG007|Overall Study|Ongoing Participants|0|||
164196188|NCT02611882|593087466|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
164196189|NCT02611882|593087467|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
164196190|NCT02611882|593087468|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
164196191|NCT01228591|593087469|FG000|Baseline|Lack of Efficacy|1|||
164196192|NCT01228591|593087470|FG001|Baseline|Lack of Efficacy|2|||
164196193|NCT01389232|593087471|FG000|Overall Study|Had scaffold removed|15|||
164196194|NCT01389232|593087471|FG000|Overall Study|Personal reasons|2|||
164196195|NCT01389232|593087471|FG000|Overall Study|Adverse Event|1|||
164196196|NCT01389232|593087471|FG000|Overall Study|Death|1|||
164196197|NCT01317940|593087472|FG000|Overall Study|Death|1|||
164196198|NCT01317940|593087473|FG001|Overall Study|Death|0|||
164196199|NCT01317940|593087474|FG002|Overall Study|Death|1|||
164196200|NCT01317940|593087475|FG003|Overall Study|Death|0|||
164196201|NCT01317940|593087476|FG004|Overall Study|Death|0|||
164196202|NCT01317940|593087477|FG005|Overall Study|Death|0|||
164196203|NCT01317940|593087472|FG000|Overall Study|Lost to Follow-up|0|||
164196204|NCT01317940|593087473|FG001|Overall Study|Lost to Follow-up|0|||
164196205|NCT01317940|593087474|FG002|Overall Study|Lost to Follow-up|1|||
164196206|NCT01317940|593087475|FG003|Overall Study|Lost to Follow-up|1|||
164196207|NCT01317940|593087476|FG004|Overall Study|Lost to Follow-up|1|||
164196208|NCT01317940|593087477|FG005|Overall Study|Lost to Follow-up|0|||
164196209|NCT01317940|593087472|FG000|Overall Study|Change in therapy plan|0|||
164196210|NCT01317940|593087473|FG001|Overall Study|Change in therapy plan|0|||
164196211|NCT01317940|593087474|FG002|Overall Study|Change in therapy plan|3|||
164196212|NCT01317940|593087475|FG003|Overall Study|Change in therapy plan|0|||
164196213|NCT01317940|593087476|FG004|Overall Study|Change in therapy plan|0|||
164196214|NCT01317940|593087477|FG005|Overall Study|Change in therapy plan|0|||
164196215|NCT01921517|593087479|FG000|Overall Study|Lost to Follow-up|5|||
164196216|NCT01921517|593087480|FG001|Overall Study|Lost to Follow-up|0|||
164196217|NCT01921517|593087479|FG000|Overall Study|Newly diagnosed health concern|2|||
164196218|NCT01921517|593087480|FG001|Overall Study|Newly diagnosed health concern|0|||
164196219|NCT01921517|593087479|FG000|Overall Study|Physician Decision|0|||
164196220|NCT01921517|593087480|FG001|Overall Study|Physician Decision|2|||
164196221|NCT01921517|593087479|FG000|Overall Study|Withdrawal by Subject|7|||
164653992|NCT00891774|594758984|FG000|Overall Study|Illness (Self/Mother)|3|||
164653993|NCT00891774|594758984|FG000|Overall Study|Withdrawal by Subject|2|||
164653994|NCT00891774|594758984|FG000|Overall Study|Protocol Violation|4|||
164653995|NCT03255031|594758989|FG000|Overall Study|Adverse Event|5|||
164653996|NCT03255031|594758990|FG001|Overall Study|Adverse Event|3|||
164653997|NCT03255031|594758989|FG000|Overall Study|Physician Decision|2|||
164653998|NCT03255031|594758990|FG001|Overall Study|Physician Decision|1|||
164653999|NCT03255031|594758989|FG000|Overall Study|Withdrawal by Subject|9|||
164654000|NCT03255031|594758990|FG001|Overall Study|Withdrawal by Subject|3|||
164654001|NCT01809314|594758991|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
164654002|NCT01809314|594758991|FG000|Overall Study|Adverse Event|6|||
164654003|NCT01809314|594758991|FG000|Overall Study|Insufficient Therapeutic Response|14|||
164654004|NCT01809314|594758991|FG000|Overall Study|Lost to Follow-up|724|||
164654005|NCT00863057|594758994|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
164654006|NCT00863057|594758995|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
164654007|NCT00863057|594758996|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
164654008|NCT00863057|594758997|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
164654009|NCT00863057|594758994|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
164654010|NCT00863057|594758995|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
164654011|NCT00863057|594758996|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
164654012|NCT00863057|594758997|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
164654013|NCT00863057|594758994|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
164654014|NCT00863057|594758995|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
164654015|NCT00863057|594758996|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
164654016|NCT00863057|594758997|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
164654017|NCT00863057|594758994|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
164654018|NCT00863057|594758995|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
164654019|NCT00863057|594758996|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
164654020|NCT00863057|594758997|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
164654021|NCT02087046|594759001|FG000|Overall Study|Adverse Event|4|||
164654022|NCT02087046|594759001|FG000|Overall Study|Death|1|||
164654023|NCT02087046|594759001|FG000|Overall Study|Lost to Follow-up|3|||
164654024|NCT02087046|594759001|FG000|Overall Study|Withdrawal by Subject|2|||
164654025|NCT02087046|594759001|FG000|Overall Study|Physician Decision|1|||
164654026|NCT02444533|594759002|FG000|Overall Study|Not able to complete forms|0|||
164654027|NCT02444533|594759003|FG001|Overall Study|Not able to complete forms|2|||
164654028|NCT02444533|594759002|FG000|Overall Study|Only gave post-procedure complications|2|||
164654029|NCT02444533|594759003|FG001|Overall Study|Only gave post-procedure complications|2|||
164654030|NCT02974114|594759006|FG000|Overall Study|Other (Not specified)|0|||
164654031|NCT02974114|594759007|FG001|Overall Study|Other (Not specified)|1|||
164654032|NCT02974114|594759008|FG002|Overall Study|Other (Not specified)|2|||
164654033|NCT00545233|594759011|FG000|Overall Study|Adverse Event|10|||
164654034|NCT00545233|594759012|FG001|Overall Study|Adverse Event|5|||
164654035|NCT00545233|594759011|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
164654036|NCT00545233|594759012|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
164654037|NCT00545233|594759011|FG000|Overall Study|Protocol Violation|2|||
164654038|NCT00545233|594759012|FG001|Overall Study|Protocol Violation|0|||
164654039|NCT00545233|594759011|FG000|Overall Study|Refused Treatment|9|||
164654040|NCT00545233|594759012|FG001|Overall Study|Refused Treatment|7|||
164654041|NCT00545233|594759011|FG000|Overall Study|Failure to Return|4|||
164654042|NCT00545233|594759012|FG001|Overall Study|Failure to Return|6|||
164654043|NCT00545233|594759011|FG000|Overall Study|Insufficient response|14|||
164654044|NCT00545233|594759012|FG001|Overall Study|Insufficient response|15|||
164654045|NCT00545233|594759011|FG000|Overall Study|Physician Decision|2|||
164654046|NCT00545233|594759012|FG001|Overall Study|Physician Decision|1|||
164654047|NCT06371079|594759013|FG000|Overall Study|Missing data|88|||
164654048|NCT06371079|594759014|FG001|Overall Study|Missing data|247|||
164654049|NCT01238211|594759015|FG000|Overall Study|Continues active treatment|31|||
164654050|NCT01238211|594759015|FG000|Overall Study|Adverse Event|7|||
164654051|NCT01238211|594759015|FG000|Overall Study|Death|4|||
164654052|NCT01238211|594759015|FG000|Overall Study|Relapse/Progression|2|||
164654053|NCT01238211|594759015|FG000|Overall Study|Withdrawal by Subject|7|||
164654054|NCT01238211|594759015|FG000|Overall Study|Non-protocol treatment|4|||
164654055|NCT01238211|594759015|FG000|Overall Study|Investigator/Patient Decision|3|||
164654056|NCT02868281|594759016|FG000|Overall Study|Adverse Event|2|||
164654057|NCT02868281|594759017|FG001|Overall Study|Adverse Event|2|||
164654058|NCT02868281|594759016|FG000|Overall Study|Protocol Violation|13|||
164654059|NCT02868281|594759017|FG001|Overall Study|Protocol Violation|10|||
164654060|NCT02868281|594759016|FG000|Overall Study|Lost to Follow-up|3|||
164654061|NCT02868281|594759017|FG001|Overall Study|Lost to Follow-up|6|||
164654062|NCT02868281|594759016|FG000|Overall Study|Withdrawal by Subject|11|||
164654063|NCT02868281|594759017|FG001|Overall Study|Withdrawal by Subject|15|||
164654064|NCT02868281|594759016|FG000|Overall Study|Physician Decision|2|||
164654065|NCT02868281|594759017|FG001|Overall Study|Physician Decision|0|||
164654066|NCT02868281|594759016|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
164654067|NCT02868281|594759017|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
164196222|NCT01921517|593087480|FG001|Overall Study|Withdrawal by Subject|3|||
164654068|NCT02868281|594759016|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
164654069|NCT02868281|594759017|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
164654070|NCT02868281|594759016|FG000|Overall Study|Long journey/moving away|1|||
164654071|NCT02868281|594759017|FG001|Overall Study|Long journey/moving away|1|||
164654072|NCT01335464|594759018|FG000|Overall Study|Adverse Event|15|||
164654073|NCT01335464|594759019|FG001|Overall Study|Adverse Event|25|||
164654074|NCT01335464|594759018|FG000|Overall Study|Non compliant with protocol|2|||
164654075|NCT01335464|594759019|FG001|Overall Study|Non compliant with protocol|0|||
164654076|NCT01335464|594759018|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
164654077|NCT01335464|594759019|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
164654078|NCT01335464|594759018|FG000|Overall Study|Not treated|2|||
164654079|NCT01335464|594759019|FG001|Overall Study|Not treated|0|||
164654080|NCT01335464|594759018|FG000|Overall Study|Reason other than those stated above|1|||
164654081|NCT01335464|594759019|FG001|Overall Study|Reason other than those stated above|1|||
164654082|NCT02533999|594759020|FG000|Overall Study|Lost to Follow-up|3|||
164654083|NCT02533999|594759021|FG001|Overall Study|Lost to Follow-up|5|||
164654084|NCT02533999|594759020|FG000|Overall Study|Protocol Violation|3|||
164654085|NCT02533999|594759021|FG001|Overall Study|Protocol Violation|0|||
164654086|NCT02533999|594759020|FG000|Overall Study|Adverse Event|0|||
164654087|NCT02533999|594759021|FG001|Overall Study|Adverse Event|1|||
164654088|NCT02533999|594759020|FG000|Overall Study|Randomized but intervention not received|0|||
164654089|NCT02533999|594759021|FG001|Overall Study|Randomized but intervention not received|1|||
164654090|NCT04304950|594759025|FG000|Overall Study|Lost to Follow-up|1|||
164654091|NCT04304950|594759026|FG001|Overall Study|Lost to Follow-up|1|||
164654092|NCT02006147|594759027|FG000|Overall Study|Protocol Violation|1|||
164654093|NCT02006147|594759028|FG001|Overall Study|Protocol Violation|1|||
164654094|NCT02006147|594759029|FG002|Overall Study|Protocol Violation|0|||
164654095|NCT02006147|594759030|FG003|Overall Study|Protocol Violation|0|||
164654096|NCT02006147|594759027|FG000|Overall Study|Withdrawal by Subject|0|||
164654097|NCT02006147|594759028|FG001|Overall Study|Withdrawal by Subject|1|||
164654098|NCT02006147|594759029|FG002|Overall Study|Withdrawal by Subject|0|||
164654099|NCT02006147|594759030|FG003|Overall Study|Withdrawal by Subject|0|||
164654100|NCT02006147|594759027|FG000|Overall Study|Withdrawal by Sponsor|1|||
164654101|NCT02006147|594759028|FG001|Overall Study|Withdrawal by Sponsor|0|||
164654102|NCT02006147|594759029|FG002|Overall Study|Withdrawal by Sponsor|0|||
164654103|NCT02006147|594759030|FG003|Overall Study|Withdrawal by Sponsor|0|||
164654104|NCT03182686|594759035|FG000|Overall Study|Lost to Follow-up|2|||
164654105|NCT03182686|594759036|FG001|Overall Study|Lost to Follow-up|0|||
164654106|NCT03182686|594759035|FG000|Overall Study|Adverse Event|2|||
164654107|NCT03182686|594759036|FG001|Overall Study|Adverse Event|0|||
164654108|NCT03182686|594759035|FG000|Overall Study|Withdrawal by Subject|3|||
164654109|NCT03182686|594759036|FG001|Overall Study|Withdrawal by Subject|0|||
164654110|NCT01154127|594759037|FG000|Period 1 (21 Days)|Adverse Event|3|||
164654111|NCT01154127|594759038|FG001|Period 1 (21 Days)|Adverse Event|4|||
164654112|NCT01154127|594759037|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
164654113|NCT01154127|594759038|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
164654114|NCT01154127|594759037|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
164654115|NCT01154127|594759038|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
164654116|NCT01154127|594759037|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
164654117|NCT01154127|594759038|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
164654118|NCT01154127|594759037|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
164654119|NCT01154127|594759038|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
164196223|NCT01921517|593087479|FG000|Overall Study|Subject missed final imaging|1|||
164196224|NCT01921517|593087480|FG001|Overall Study|Subject missed final imaging|4|||
164196225|NCT03205150|593087481|FG000|Overall Study|Protocol deviation|1|||
164196226|NCT03205150|593087482|FG001|Overall Study|Protocol deviation|3|||
164196227|NCT03205150|593087483|FG002|Overall Study|Protocol deviation|0|||
164196228|NCT03205150|593087481|FG000|Overall Study|Patient/guardian decision|0|||
164196229|NCT03205150|593087482|FG001|Overall Study|Patient/guardian decision|3|||
164196230|NCT03205150|593087483|FG002|Overall Study|Patient/guardian decision|0|||
164196231|NCT03205150|593087481|FG000|Overall Study|Adverse Event|1|||
164654120|NCT01697449|594759039|FG000|Overall Study|Disease progression|47|||
164654121|NCT01697449|594759039|FG000|Overall Study|Adverse Event|7|||
164654122|NCT01697449|594759039|FG000|Overall Study|Lost to Follow-up|5|||
164196232|NCT03205150|593087482|FG001|Overall Study|Adverse Event|1|||
164196233|NCT03205150|593087483|FG002|Overall Study|Adverse Event|1|||
164654123|NCT01697449|594759039|FG000|Overall Study|Withdrawal by Subject|2|||
164654124|NCT01697449|594759039|FG000|Overall Study|Physician Decision|1|||
164654125|NCT01697449|594759039|FG000|Overall Study|Death|2|||
164654126|NCT01697449|594759039|FG000|Overall Study|Other|1|||
164654127|NCT01697449|594759039|FG000|Overall Study|Missing|25|||
164654128|NCT00003102|594759040|FG000|Overall Study|Physician Decision|1|||
164654129|NCT00003102|594759041|FG001|Overall Study|Physician Decision|1|||
164654130|NCT00003102|594759042|FG002|Overall Study|Physician Decision|0|||
164654131|NCT00003102|594759040|FG000|Overall Study|Progressive Disease|0|||
164196234|NCT03205150|593087481|FG000|Overall Study|Lost to Follow-up|0|||
164654132|NCT00003102|594759041|FG001|Overall Study|Progressive Disease|1|||
164654133|NCT00003102|594759042|FG002|Overall Study|Progressive Disease|0|||
164654134|NCT00003102|594759040|FG000|Overall Study|Adverse Event|0|||
164654135|NCT00003102|594759041|FG001|Overall Study|Adverse Event|1|||
164196235|NCT03205150|593087482|FG001|Overall Study|Lost to Follow-up|0|||
164196236|NCT03205150|593087483|FG002|Overall Study|Lost to Follow-up|1|||
164196237|NCT01095835|593087484|FG000|Overall Study|Adverse Event|8|||
164654136|NCT00003102|594759042|FG002|Overall Study|Adverse Event|1|||
164654137|NCT00003102|594759040|FG000|Overall Study|Death|0|||
164654138|NCT00003102|594759041|FG001|Overall Study|Death|0|||
164654139|NCT00003102|594759042|FG002|Overall Study|Death|1|||
164654140|NCT05037409|594759043|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
164654141|NCT05037409|594759044|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
164654142|NCT05037409|594759045|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
164654143|NCT01559818|594759049|FG000|Overall Study|Physician Decision|1|||
164654144|NCT01559818|594759049|FG000|Overall Study|Pregnancy|1|||
164654145|NCT01559818|594759049|FG000|Overall Study|Study terminated by Sponsor|4|||
164654146|NCT01559818|594759049|FG000|Overall Study|Withdrawal by Subject|1|||
164654147|NCT01512979|594759050|FG000|Overall Study|Adverse Event|2|||
164654148|NCT01512979|594759051|FG001|Overall Study|Adverse Event|2|||
164654149|NCT01512979|594759050|FG000|Overall Study|Protocol Violation|1|||
164654150|NCT01512979|594759051|FG001|Overall Study|Protocol Violation|4|||
164654151|NCT01512979|594759050|FG000|Overall Study|Lost to Follow-up|2|||
164654152|NCT01512979|594759051|FG001|Overall Study|Lost to Follow-up|5|||
164654153|NCT01512979|594759050|FG000|Overall Study|Withdrawal by Subject|1|||
164654154|NCT01512979|594759051|FG001|Overall Study|Withdrawal by Subject|2|||
164654155|NCT01512979|594759050|FG000|Overall Study|Reason other than stated above|13|||
164654156|NCT01512979|594759051|FG001|Overall Study|Reason other than stated above|9|||
164654157|NCT00529568|594759052|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
164654158|NCT00529568|594759053|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
164654159|NCT00529568|594759054|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
164654160|NCT00529568|594759052|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
164654161|NCT00529568|594759053|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
164654162|NCT00529568|594759054|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
164654163|NCT00529568|594759052|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
164654164|NCT00529568|594759053|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
164654165|NCT00529568|594759054|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
164654166|NCT00529568|594759052|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
164654167|NCT00529568|594759053|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
164654168|NCT00529568|594759054|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
164654169|NCT00529568|594759052|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
164654170|NCT00529568|594759053|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
164654171|NCT00529568|594759054|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
164196238|NCT01095835|593087485|FG001|Overall Study|Adverse Event|6|||
164196239|NCT01095835|593087486|FG002|Overall Study|Adverse Event|6|||
164196240|NCT01095835|593087484|FG000|Overall Study|Lack of Efficacy|0|||
164196241|NCT01095835|593087485|FG001|Overall Study|Lack of Efficacy|1|||
164196242|NCT01095835|593087486|FG002|Overall Study|Lack of Efficacy|0|||
164196243|NCT01095835|593087484|FG000|Overall Study|Physician Decision|0|||
164196244|NCT01095835|593087485|FG001|Overall Study|Physician Decision|0|||
164196245|NCT01095835|593087486|FG002|Overall Study|Physician Decision|1|||
164196246|NCT01095835|593087484|FG000|Overall Study|Withdrawal by Subject|1|||
164196247|NCT01095835|593087485|FG001|Overall Study|Withdrawal by Subject|3|||
164196248|NCT01095835|593087486|FG002|Overall Study|Withdrawal by Subject|0|||
164196249|NCT01095835|593087484|FG000|Overall Study|Non study compliance|0|||
164196250|NCT01095835|593087485|FG001|Overall Study|Non study compliance|0|||
164196251|NCT01095835|593087486|FG002|Overall Study|Non study compliance|1|||
164196252|NCT01095835|593087484|FG000|Overall Study|Protocol Violation|1|||
164196253|NCT01095835|593087485|FG001|Overall Study|Protocol Violation|2|||
164196254|NCT01095835|593087486|FG002|Overall Study|Protocol Violation|0|||
164196255|NCT02486692|593087489|FG000|Overall Study|did not login for randomization|4|||
164196256|NCT02486692|593087490|FG001|Overall Study|did not login for randomization|7|||
164196257|NCT03028142|593087491|FG000|Overall Study|Adverse Event|1|||
164196258|NCT03028142|593087492|FG001|Overall Study|Adverse Event|1|||
164196259|NCT03028142|593087493|FG002|Overall Study|Adverse Event|0|||
164654172|NCT00529568|594759052|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
164654173|NCT00529568|594759053|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
164654174|NCT00529568|594759054|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
164654175|NCT00529568|594759052|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
164654176|NCT00529568|594759053|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
164196260|NCT03028142|593087494|FG003|Overall Study|Adverse Event|0|||
164196261|NCT03028142|593087495|FG004|Overall Study|Adverse Event|0|||
164654177|NCT00529568|594759054|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
164654178|NCT00529568|594759052|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
164654179|NCT00529568|594759053|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
164654180|NCT00529568|594759054|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
164654181|NCT00529568|594759052|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
164654182|NCT00529568|594759053|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
164654183|NCT00529568|594759054|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
164654184|NCT00529568|594759052|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
164654185|NCT00529568|594759053|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
164654186|NCT00529568|594759054|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
164654187|NCT00529568|594759052|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
164654188|NCT00529568|594759053|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
164654189|NCT00529568|594759054|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
164654190|NCT04049552|594759055|FG000|Overall Study|Lost to Follow-up|1|||
164654191|NCT00738920|594759057|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
164654192|NCT00738920|594759058|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
164654193|NCT00738920|594759059|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
164654194|NCT00738920|594759057|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
164654195|NCT00738920|594759058|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
164196262|NCT03028142|593087496|FG005|Overall Study|Adverse Event|1|||
164196263|NCT03028142|593087491|FG000|Overall Study|Withdrawal by Subject|0|||
164196264|NCT03028142|593087492|FG001|Overall Study|Withdrawal by Subject|0|||
164196265|NCT03028142|593087493|FG002|Overall Study|Withdrawal by Subject|0|||
164196266|NCT03028142|593087494|FG003|Overall Study|Withdrawal by Subject|0|||
164196267|NCT03028142|593087495|FG004|Overall Study|Withdrawal by Subject|1|||
164196268|NCT03028142|593087496|FG005|Overall Study|Withdrawal by Subject|0|||
164196269|NCT00116688|593087501|FG000|Overall Study|Protocol deviation|1|||
164196270|NCT00116688|593087502|FG001|Overall Study|Protocol deviation|0|||
164196271|NCT00116688|593087501|FG000|Overall Study|Noncompliance|3|||
164196272|NCT00116688|593087502|FG001|Overall Study|Noncompliance|1|||
164196273|NCT00116688|593087501|FG000|Overall Study|Adverse Event|11|||
164196274|NCT00116688|593087502|FG001|Overall Study|Adverse Event|0|||
164196275|NCT00116688|593087501|FG000|Overall Study|Withdrawal by Subject|26|||
164196276|NCT00116688|593087502|FG001|Overall Study|Withdrawal by Subject|2|||
164196277|NCT00116688|593087501|FG000|Overall Study|Requirement for alternative therapy|11|||
164196278|NCT00116688|593087502|FG001|Overall Study|Requirement for alternative therapy|1|||
164196279|NCT00116688|593087501|FG000|Overall Study|Physician Decision|7|||
164196280|NCT00116688|593087502|FG001|Overall Study|Physician Decision|0|||
164196281|NCT00116688|593087501|FG000|Overall Study|Lost to Follow-up|3|||
164196282|NCT00116688|593087502|FG001|Overall Study|Lost to Follow-up|0|||
164196283|NCT00116688|593087501|FG000|Overall Study|Death|15|||
164196284|NCT00116688|593087502|FG001|Overall Study|Death|0|||
164196285|NCT00116688|593087501|FG000|Overall Study|Protocol-specified criteria|3|||
164196286|NCT00116688|593087502|FG001|Overall Study|Protocol-specified criteria|0|||
164196287|NCT00116688|593087501|FG000|Overall Study|Pregnancy|1|||
164196288|NCT00116688|593087502|FG001|Overall Study|Pregnancy|0|||
164196289|NCT00116688|593087501|FG000|Overall Study|Other|11|||
164654196|NCT00738920|594759059|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
164654197|NCT00738920|594759057|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
164654198|NCT00738920|594759058|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
164654199|NCT00738920|594759059|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
164654200|NCT00738920|594759057|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
164654201|NCT00738920|594759058|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
164654202|NCT00738920|594759059|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
164196290|NCT00116688|593087502|FG001|Overall Study|Other|0|||
164196291|NCT01775670|593087507|FG000|Overall Study|Lost to Follow-up|1|||
164196292|NCT01775670|593087508|FG001|Overall Study|Lost to Follow-up|1|||
164196293|NCT01298700|593087509|FG000|Overall Study|Adverse Event|50|||
164196294|NCT01298700|593087510|FG001|Overall Study|Adverse Event|51|||
164196295|NCT01298700|593087509|FG000|Overall Study|Lack of Efficacy|9|||
164196296|NCT01298700|593087510|FG001|Overall Study|Lack of Efficacy|14|||
164654203|NCT00738920|594759057|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
164654204|NCT00738920|594759058|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
164196297|NCT01298700|593087509|FG000|Overall Study|Lost to Follow-up|5|||
164196298|NCT01298700|593087510|FG001|Overall Study|Lost to Follow-up|2|||
164196299|NCT01298700|593087509|FG000|Overall Study|Withdrawal by Subject|12|||
164196300|NCT01298700|593087510|FG001|Overall Study|Withdrawal by Subject|9|||
164196301|NCT01298700|593087509|FG000|Overall Study|Protocol Violation|6|||
164196302|NCT01298700|593087510|FG001|Overall Study|Protocol Violation|4|||
164196303|NCT01298700|593087509|FG000|Overall Study|Other Miscellaneous Reasons|16|||
164196304|NCT01298700|593087510|FG001|Overall Study|Other Miscellaneous Reasons|15|||
164196305|NCT01298700|593087509|FG000|Overall Study|Did not Receive Study Drug|3|||
164196306|NCT01298700|593087510|FG001|Overall Study|Did not Receive Study Drug|5|||
164654205|NCT00738920|594759059|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
164654206|NCT00738920|594759057|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
164654207|NCT00738920|594759058|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
164547884|NCT01278745|594378234|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
164547885|NCT01278745|594378235|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
164547886|NCT01278745|594378236|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
164547887|NCT01278745|594378237|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
164547888|NCT01843842|594378240|FG000|Overall Study|Do not meet inclusion criteria|1|||
164547889|NCT01843842|594378241|FG001|Overall Study|Do not meet inclusion criteria|1|||
164547890|NCT01376778|594378242|FG000|Overall Study|Lost to Follow-up|3|||
164547891|NCT01376778|594378243|FG001|Overall Study|Lost to Follow-up|2|||
164547892|NCT02700412|594378244|FG000|Overall Study|Adverse Event|6|||
164547893|NCT02700412|594378244|FG000|Overall Study|Death|1|||
164547894|NCT02700412|594378244|FG000|Overall Study|Lack of Efficacy|19|||
164547895|NCT02700412|594378244|FG000|Overall Study|Protocol Violation|5|||
164547896|NCT02700412|594378244|FG000|Overall Study|Withdrawal by Subject|2|||
164547897|NCT00632099|594378245|FG000|Overall Study|Lost to Follow-up|3|||
164547898|NCT00632099|594378246|FG001|Overall Study|Lost to Follow-up|3|||
164547899|NCT01517893|594378247|FG000|Overall Study|Withdrawal by Subject|3|||
164547900|NCT01517893|594378248|FG001|Overall Study|Withdrawal by Subject|0|||
164547901|NCT03201458|594378249|FG000|Overall Study|No longer eligible|2|||
164547902|NCT03201458|594378250|FG001|Overall Study|No longer eligible|5|||
164547903|NCT03201458|594378249|FG000|Overall Study|Health event before starting|1|||
164547904|NCT03201458|594378250|FG001|Overall Study|Health event before starting|0|||
164547905|NCT03201458|594378249|FG000|Overall Study|Physician Decision|1|||
164547906|NCT03201458|594378250|FG001|Overall Study|Physician Decision|0|||
164547907|NCT00711425|594378254|FG000|Overall Study|Protocol Violation|1|||
164547908|NCT00711425|594378254|FG000|Overall Study|Death|2|||
164547909|NCT00711425|594378254|FG000|Overall Study|Lost to Follow-up|1|||
164547910|NCT00916149|594378255|FG000|Overall Study|Lost to Follow-up|3|||
164547911|NCT00916149|594378256|FG001|Overall Study|Lost to Follow-up|2|||
164547912|NCT00916149|594378257|FG002|Overall Study|Lost to Follow-up|0|||
164547913|NCT00916149|594378255|FG000|Overall Study|Unable to place scalp EEG leads|1|||
164547914|NCT00916149|594378256|FG001|Overall Study|Unable to place scalp EEG leads|0|||
164547915|NCT00916149|594378257|FG002|Overall Study|Unable to place scalp EEG leads|0|||
164547916|NCT00589420|594378260|FG000|Overall Study|screen failure|1|||
164547917|NCT00841568|594378261|FG000|Overall Study|Adverse Event|1|||
164547918|NCT00841568|594378261|FG000|Overall Study|Death|1|||
164547919|NCT00841568|594378261|FG000|Overall Study|Withdrawal by Subject|2|||
164547920|NCT00841568|594378261|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
164547921|NCT03002155|594378262|FG000|Overall Study|Lost to Follow-up|1|||
164547922|NCT03002155|594378263|FG001|Overall Study|Lost to Follow-up|2|||
164547923|NCT03002155|594378262|FG000|Overall Study|Withdrawal by Subject|1|||
164547924|NCT03002155|594378263|FG001|Overall Study|Withdrawal by Subject|0|||
164547925|NCT03002155|594378262|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
164547926|NCT03002155|594378263|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
164547927|NCT00545298|594378264|FG000|Overall Study|Issues with Standard of Care|2|||
164547928|NCT00545298|594378265|FG001|Overall Study|Issues with Standard of Care|0|||
164547929|NCT00545298|594378266|FG002|Overall Study|Issues with Standard of Care|1|||
164547930|NCT00978029|594378267|FG000|Overall Study|Adverse Event|1|||
164547931|NCT00978029|594378268|FG001|Overall Study|Adverse Event|2|||
164547932|NCT00978029|594378269|FG002|Overall Study|Adverse Event|5|||
164547933|NCT00978029|594378267|FG000|Overall Study|Withdrawal by Subject|0|||
164547934|NCT00978029|594378268|FG001|Overall Study|Withdrawal by Subject|0|||
164547935|NCT00978029|594378269|FG002|Overall Study|Withdrawal by Subject|1|||
164547936|NCT00978029|594378267|FG000|Overall Study|Protocol Violation|0|||
164547937|NCT00978029|594378268|FG001|Overall Study|Protocol Violation|1|||
164547938|NCT00978029|594378269|FG002|Overall Study|Protocol Violation|0|||
164547939|NCT01087775|594378274|FG000|Overall Study|failed inclusion criteria|2|||
164547940|NCT01147744|594378277|FG000|Overall Study|Protocol Violation|1|||
164547941|NCT01147744|594378278|FG001|Overall Study|Protocol Violation|0|||
164547942|NCT01147744|594378279|FG002|Overall Study|Protocol Violation|1|||
164547943|NCT01147744|594378280|FG003|Overall Study|Protocol Violation|0|||
164547944|NCT01147744|594378281|FG004|Overall Study|Protocol Violation|1|||
164547945|NCT01147744|594378282|FG005|Overall Study|Protocol Violation|3|||
164547946|NCT01147744|594378283|FG006|Overall Study|Protocol Violation|1|||
164547947|NCT01147744|594378277|FG000|Overall Study|Physician Decision|0|||
164547948|NCT01147744|594378278|FG001|Overall Study|Physician Decision|1|||
164547949|NCT01147744|594378279|FG002|Overall Study|Physician Decision|1|||
164547950|NCT01147744|594378280|FG003|Overall Study|Physician Decision|0|||
164547951|NCT01147744|594378281|FG004|Overall Study|Physician Decision|0|||
164547952|NCT01147744|594378282|FG005|Overall Study|Physician Decision|0|||
164547953|NCT01147744|594378283|FG006|Overall Study|Physician Decision|1|||
164547954|NCT01147744|594378277|FG000|Overall Study|Lack of Efficacy|11|||
164547955|NCT01147744|594378278|FG001|Overall Study|Lack of Efficacy|11|||
164547956|NCT01147744|594378279|FG002|Overall Study|Lack of Efficacy|9|||
164196307|NCT04006145|593087513|FG000|Overall Study|Lost to Follow-up|0|||
164196308|NCT04006145|593087514|FG001|Overall Study|Lost to Follow-up|1|||
164196309|NCT04006145|593087513|FG000|Overall Study|Other|1|||
164196310|NCT04006145|593087514|FG001|Overall Study|Other|2|||
164654208|NCT00738920|594759059|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
164654209|NCT00738920|594759057|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
164654210|NCT00738920|594759058|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
164654211|NCT00738920|594759059|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
164654212|NCT00738920|594759057|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
164654213|NCT00738920|594759058|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
164654214|NCT00738920|594759059|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
164654215|NCT00738920|594759057|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
164654216|NCT00738920|594759058|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
164654217|NCT00738920|594759059|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
164654218|NCT00738920|594759057|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
164654219|NCT00738920|594759058|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
164654220|NCT00738920|594759059|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
164654221|NCT04385199|594759063|FG000|Overall Study|Withdrawal by Subject|1|||
164654222|NCT04385199|594759064|FG001|Overall Study|Withdrawal by Subject|0|||
164654223|NCT00458302|594760642|FG000|Overall Study|Adverse Event|4|||
164654224|NCT00458302|594760643|FG001|Overall Study|Adverse Event|14|||
164654225|NCT00458302|594760642|FG000|Overall Study|Pregnancy|2|||
164654226|NCT00458302|594760643|FG001|Overall Study|Pregnancy|1|||
164654227|NCT00458302|594760642|FG000|Overall Study|Protocol Violation|0|||
164654228|NCT00458302|594760643|FG001|Overall Study|Protocol Violation|2|||
164654229|NCT00458302|594760642|FG000|Overall Study|Withdrawal by Subject|6|||
164654230|NCT00458302|594760643|FG001|Overall Study|Withdrawal by Subject|4|||
164654231|NCT00458302|594760642|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
164654232|NCT00458302|594760643|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
164654233|NCT00458302|594760642|FG000|Overall Study|Study Termination By Sponsor|1|||
164654234|NCT00458302|594760643|FG001|Overall Study|Study Termination By Sponsor|0|||
164654235|NCT00458302|594760642|FG000|Overall Study|Lost to Follow-up|2|||
164654236|NCT00458302|594760643|FG001|Overall Study|Lost to Follow-up|0|||
164654237|NCT00458302|594760642|FG000|Overall Study|Other|4|||
164654238|NCT00458302|594760643|FG001|Overall Study|Other|2|||
164654239|NCT01513551|594760646|FG000|Overall Study|Death|0|||
164654240|NCT01513551|594760647|FG001|Overall Study|Death|1|||
164654241|NCT01513551|594760648|FG002|Overall Study|Death|0|||
164654242|NCT01513551|594760646|FG000|Overall Study|Lost to Follow-up|3|||
164654243|NCT01513551|594760647|FG001|Overall Study|Lost to Follow-up|5|||
164654244|NCT01513551|594760648|FG002|Overall Study|Lost to Follow-up|2|||
164654245|NCT01513551|594760646|FG000|Overall Study|Withdrawal by Subject|1|||
164654246|NCT01513551|594760647|FG001|Overall Study|Withdrawal by Subject|0|||
164654247|NCT01513551|594760648|FG002|Overall Study|Withdrawal by Subject|2|||
164654248|NCT01513551|594760646|FG000|Overall Study|Randomized but not vaccinated|0|||
164654249|NCT01513551|594760647|FG001|Overall Study|Randomized but not vaccinated|0|||
164654250|NCT01513551|594760648|FG002|Overall Study|Randomized but not vaccinated|1|||
164654251|NCT01706198|594760651|FG000|Overall Study|Adverse Event|12|||
164654252|NCT01706198|594760652|FG001|Overall Study|Adverse Event|15|||
164654253|NCT01706198|594760651|FG000|Overall Study|Protocol Violation|7|||
164654254|NCT01706198|594760652|FG001|Overall Study|Protocol Violation|5|||
164654255|NCT01706198|594760651|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
164654256|NCT01706198|594760652|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
164654257|NCT01706198|594760651|FG000|Overall Study|Lost to Follow-up|97|||
164654258|NCT01706198|594760652|FG001|Overall Study|Lost to Follow-up|93|||
164654259|NCT01706198|594760651|FG000|Overall Study|Physician Decision|23|||
164654260|NCT01706198|594760652|FG001|Overall Study|Physician Decision|37|||
164654261|NCT01706198|594760651|FG000|Overall Study|Withdrawal by Subject|23|||
164654262|NCT01706198|594760652|FG001|Overall Study|Withdrawal by Subject|31|||
164654263|NCT00549198|594760653|FG000|Overall Study|Adverse Event|28|||
164654264|NCT00549198|594760654|FG001|Overall Study|Adverse Event|26|||
164654265|NCT00549198|594760653|FG000|Overall Study|Insufficient Viral Load Response|4|||
164196311|NCT01001429|593087517|FG000|Overall Study|surgery cancelled|0|||
164196312|NCT01001429|593087518|FG001|Overall Study|surgery cancelled|1|||
164196313|NCT00010257|593087519|FG000|Overall Study|Withdrawal by Subject|1|||
164196314|NCT00010257|593087520|FG001|Overall Study|Withdrawal by Subject|0|||
164654266|NCT00549198|594760654|FG001|Overall Study|Insufficient Viral Load Response|2|||
164654267|NCT00549198|594760653|FG000|Overall Study|Protocol-defined Virological Failure|7|||
164654268|NCT00549198|594760654|FG001|Overall Study|Protocol-defined Virological Failure|0|||
164654269|NCT00549198|594760653|FG000|Overall Study|Non-compliance|2|||
164654270|NCT00549198|594760654|FG001|Overall Study|Non-compliance|4|||
164654271|NCT00549198|594760653|FG000|Overall Study|Lost to Follow-up|7|||
164654272|NCT00549198|594760654|FG001|Overall Study|Lost to Follow-up|8|||
164654273|NCT00549198|594760653|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
164654274|NCT00549198|594760654|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
164196315|NCT02812186|593087521|FG000|Period 1|Post randomization screen failure|5|||
164196316|NCT02812186|593087522|FG001|Period 1|Post randomization screen failure|9|||
164196317|NCT02812186|593087521|FG000|Period 1|nonevaluable data sets|6|||
164196318|NCT02812186|593087522|FG001|Period 1|nonevaluable data sets|6|||
164196319|NCT00643760|593087525|FG000|Overall Study|Adverse Event|11|||
164196320|NCT00643760|593087526|FG001|Overall Study|Adverse Event|5|||
164196321|NCT00643760|593087527|FG002|Overall Study|Adverse Event|12|||
164196322|NCT00643760|593087528|FG003|Overall Study|Adverse Event|21|||
164196323|NCT00643760|593087529|FG004|Overall Study|Adverse Event|6|||
164196324|NCT00643760|593087525|FG000|Overall Study|Lack of Efficacy|3|||
164196325|NCT00643760|593087526|FG001|Overall Study|Lack of Efficacy|1|||
164196326|NCT00643760|593087527|FG002|Overall Study|Lack of Efficacy|0|||
164196327|NCT00643760|593087528|FG003|Overall Study|Lack of Efficacy|4|||
164196328|NCT00643760|593087529|FG004|Overall Study|Lack of Efficacy|3|||
164196329|NCT00643760|593087525|FG000|Overall Study|Protocol Violation|7|||
164196330|NCT00643760|593087526|FG001|Overall Study|Protocol Violation|6|||
164196331|NCT00643760|593087527|FG002|Overall Study|Protocol Violation|4|||
164196332|NCT00643760|593087528|FG003|Overall Study|Protocol Violation|4|||
164196333|NCT00643760|593087529|FG004|Overall Study|Protocol Violation|6|||
164196334|NCT00643760|593087525|FG000|Overall Study|Lost to Follow-up|6|||
164196335|NCT00643760|593087526|FG001|Overall Study|Lost to Follow-up|2|||
164196336|NCT00643760|593087527|FG002|Overall Study|Lost to Follow-up|1|||
164196337|NCT00643760|593087528|FG003|Overall Study|Lost to Follow-up|3|||
164196338|NCT00643760|593087529|FG004|Overall Study|Lost to Follow-up|3|||
164196339|NCT00643760|593087525|FG000|Overall Study|Investigator Discretion|0|||
164196340|NCT00643760|593087526|FG001|Overall Study|Investigator Discretion|0|||
164196341|NCT00643760|593087527|FG002|Overall Study|Investigator Discretion|0|||
164196342|NCT00643760|593087528|FG003|Overall Study|Investigator Discretion|2|||
164196343|NCT00643760|593087529|FG004|Overall Study|Investigator Discretion|0|||
164196344|NCT00643760|593087525|FG000|Overall Study|Withdrawal by Subject|3|||
164196345|NCT00643760|593087526|FG001|Overall Study|Withdrawal by Subject|1|||
164196346|NCT00643760|593087527|FG002|Overall Study|Withdrawal by Subject|2|||
164196347|NCT00643760|593087528|FG003|Overall Study|Withdrawal by Subject|4|||
164196348|NCT00643760|593087529|FG004|Overall Study|Withdrawal by Subject|1|||
164196349|NCT00789321|593087533|FG000|Overall Study|Adverse Event|0|||
164196350|NCT00789321|593087534|FG001|Overall Study|Adverse Event|1|||
164196351|NCT00104052|593087535|FG000|Overall Study|Adverse Event|1|||
164196352|NCT00104052|593087535|FG000|Overall Study|Lack of Efficacy|26|||
164196353|NCT00104052|593087535|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
164196354|NCT01162343|593087536|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
164196355|NCT01162343|593087536|FG000|Overall Study|Refused psychiatrist assessment|12|||
164196356|NCT03652818|593087537|FG000|Overall Study|Adverse Event|1|||
164196357|NCT03652818|593087538|FG001|Overall Study|Adverse Event|0|||
164196358|NCT03652818|593087539|FG002|Overall Study|Adverse Event|0|||
164196359|NCT03652818|593087540|FG003|Overall Study|Adverse Event|0|||
164196360|NCT03652818|593087541|FG004|Overall Study|Adverse Event|0|||
164196361|NCT03652818|593087537|FG000|Overall Study|Physician Decision|1|||
164196362|NCT03652818|593087538|FG001|Overall Study|Physician Decision|0|||
164196363|NCT03652818|593087539|FG002|Overall Study|Physician Decision|0|||
164196364|NCT03652818|593087540|FG003|Overall Study|Physician Decision|0|||
164196365|NCT03652818|593087541|FG004|Overall Study|Physician Decision|0|||
164196366|NCT03652818|593087537|FG000|Overall Study|Lost to Follow-up|0|||
164196367|NCT03652818|593087538|FG001|Overall Study|Lost to Follow-up|1|||
164196368|NCT03652818|593087539|FG002|Overall Study|Lost to Follow-up|2|||
164196369|NCT03652818|593087540|FG003|Overall Study|Lost to Follow-up|1|||
164196370|NCT03652818|593087541|FG004|Overall Study|Lost to Follow-up|1|||
164196371|NCT01783743|593087546|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
164196372|NCT01783743|593087547|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
164196373|NCT01783743|593087546|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
164196374|NCT01783743|593087547|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
164196375|NCT01783743|593087546|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
164196376|NCT01783743|593087547|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
164196377|NCT02771275|593087548|FG000|Overall Study|Reoperation|3|||
164196378|NCT02771275|593087548|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
164654275|NCT00549198|594760653|FG000|Overall Study|Protocol Violation|7|||
164196379|NCT03322293|593087549|FG000|Overall Study|Lost to Follow-up|0|||
164196380|NCT03322293|593087550|FG001|Overall Study|Lost to Follow-up|0|||
164196381|NCT03322293|593087551|FG002|Overall Study|Lost to Follow-up|1|||
164196382|NCT01239797|593087554|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
164196383|NCT01239797|593087555|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
164196384|NCT01239797|593087554|FG000|Randomized Participants|Participant withdrew consent|1|||
164196385|NCT01239797|593087555|FG001|Randomized Participants|Participant withdrew consent|7|||
164196386|NCT01239797|593087554|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
164196387|NCT01239797|593087555|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
164196388|NCT01239797|593087554|FG000|Treated Participants|Disease progression|185|||
164654276|NCT00549198|594760654|FG001|Overall Study|Protocol Violation|2|||
164654277|NCT00549198|594760653|FG000|Overall Study|Investigator Decision|4|||
164654278|NCT00549198|594760654|FG001|Overall Study|Investigator Decision|3|||
164654279|NCT00549198|594760653|FG000|Overall Study|Withdrawal by Subject|7|||
164654280|NCT00549198|594760654|FG001|Overall Study|Withdrawal by Subject|7|||
164654281|NCT00549198|594760653|FG000|Overall Study|Disease Progression|1|||
164654282|NCT00549198|594760654|FG001|Overall Study|Disease Progression|0|||
164654283|NCT00549198|594760653|FG000|Overall Study|Participant Moved|2|||
164654284|NCT00549198|594760654|FG001|Overall Study|Participant Moved|0|||
164654285|NCT00549198|594760653|FG000|Overall Study|Participant not able to perform Week 96|1|||
164654286|NCT00549198|594760654|FG001|Overall Study|Participant not able to perform Week 96|0|||
164654287|NCT00549198|594760653|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
164654288|NCT00549198|594760654|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
164654289|NCT00549198|594760653|FG000|Overall Study|Prohibited Medication|1|||
164654290|NCT00549198|594760654|FG001|Overall Study|Prohibited Medication|2|||
164654291|NCT00549198|594760653|FG000|Overall Study|Participant planning pregnancy|1|||
164654292|NCT00549198|594760654|FG001|Overall Study|Participant planning pregnancy|0|||
164654293|NCT00549198|594760653|FG000|Overall Study|Participant overweight, no scan possible|1|||
164654294|NCT00549198|594760654|FG001|Overall Study|Participant overweight, no scan possible|0|||
164654295|NCT00549198|594760653|FG000|Overall Study|No scan facilities|0|||
164654296|NCT00549198|594760654|FG001|Overall Study|No scan facilities|2|||
164654297|NCT00549198|594760653|FG000|Overall Study|Pregnancy|0|||
164654298|NCT00549198|594760654|FG001|Overall Study|Pregnancy|3|||
164654299|NCT00549198|594760653|FG000|Overall Study|Not Exposed to Study Drug|3|||
164654300|NCT00549198|594760654|FG001|Overall Study|Not Exposed to Study Drug|4|||
164654301|NCT03273387|594760655|FG000|Overall Study|Death|2|||
164654302|NCT03273387|594760656|FG001|Overall Study|Death|2|||
164654303|NCT03273387|594760655|FG000|Overall Study|Withdrawal by Subject|1|||
164654304|NCT03273387|594760656|FG001|Overall Study|Withdrawal by Subject|1|||
164654305|NCT02668783|594760657|FG000|Overall Study|Pregnancy|0|||
164654306|NCT02668783|594760658|FG001|Overall Study|Pregnancy|1|||
164654307|NCT02668783|594760657|FG000|Overall Study|Protocol Violation|2|||
164654308|NCT02668783|594760658|FG001|Overall Study|Protocol Violation|1|||
164654309|NCT02668783|594760657|FG000|Overall Study|Study terminated by sponsor|9|||
164654310|NCT02668783|594760658|FG001|Overall Study|Study terminated by sponsor|10|||
164654311|NCT02668783|594760657|FG000|Overall Study|Subject moved|1|||
164654312|NCT02668783|594760658|FG001|Overall Study|Subject moved|0|||
164654313|NCT02668783|594760657|FG000|Overall Study|Withdrawal by Subject|1|||
164654314|NCT02668783|594760658|FG001|Overall Study|Withdrawal by Subject|0|||
164654315|NCT01399723|594760659|FG000|Overall Study|Lost to Follow-up|0|||
164654316|NCT01399723|594760660|FG001|Overall Study|Lost to Follow-up|1|||
164654317|NCT00673361|594760661|FG000|Overall Study|Screen Failure|2|||
164654318|NCT01769378|594760665|FG000|Overall Study|Adverse Event|10|||
164654319|NCT01769378|594760666|FG001|Overall Study|Adverse Event|0|||
164654320|NCT01769378|594760665|FG000|Overall Study|Entry criteria not met|1|||
164654321|NCT01769378|594760666|FG001|Overall Study|Entry criteria not met|0|||
164654322|NCT01769378|594760665|FG000|Overall Study|Protocol Violation|1|||
164654323|NCT01769378|594760666|FG001|Overall Study|Protocol Violation|1|||
164654324|NCT01769378|594760665|FG000|Overall Study|Withdrawal by Subject|10|||
164654325|NCT01769378|594760666|FG001|Overall Study|Withdrawal by Subject|3|||
164654326|NCT01769378|594760665|FG000|Overall Study|Sponsor Decision|1|||
164654327|NCT01769378|594760666|FG001|Overall Study|Sponsor Decision|0|||
164654328|NCT01769378|594760665|FG000|Overall Study|Lost to Follow-up|2|||
164654329|NCT01769378|594760666|FG001|Overall Study|Lost to Follow-up|0|||
164654330|NCT01958281|594760667|FG000|Overall Study|Lack of Efficacy|5|||
164654331|NCT01958281|594760668|FG001|Overall Study|Lack of Efficacy|2|||
164654332|NCT01958281|594760669|FG002|Overall Study|Lack of Efficacy|0|||
164654333|NCT01958281|594760667|FG000|Overall Study|Adverse Event|0|||
164654334|NCT01958281|594760668|FG001|Overall Study|Adverse Event|2|||
164654335|NCT01958281|594760669|FG002|Overall Study|Adverse Event|0|||
164654336|NCT01958281|594760667|FG000|Overall Study|Withdrew Consent|1|||
164654337|NCT01958281|594760668|FG001|Overall Study|Withdrew Consent|0|||
164654338|NCT01958281|594760669|FG002|Overall Study|Withdrew Consent|0|||
164654339|NCT02784106|594760670|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
164654340|NCT02784106|594760671|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
164654341|NCT02784106|594760672|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
164654342|NCT02784106|594760673|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
164654343|NCT02784106|594760670|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
164654344|NCT02784106|594760671|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
164654345|NCT02784106|594760672|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164654346|NCT02784106|594760673|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164654347|NCT02784106|594760670|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
164654348|NCT02784106|594760671|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
164654349|NCT02784106|594760672|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
164196389|NCT01239797|593087555|FG001|Treated Participants|Disease progression|185|||
164547957|NCT01147744|594378280|FG003|Overall Study|Lack of Efficacy|11|||
164547958|NCT01147744|594378281|FG004|Overall Study|Lack of Efficacy|13|||
164547959|NCT01147744|594378282|FG005|Overall Study|Lack of Efficacy|8|||
164547960|NCT01147744|594378283|FG006|Overall Study|Lack of Efficacy|7|||
164547961|NCT01147744|594378277|FG000|Overall Study|Adverse Event|1|||
164196390|NCT01239797|593087554|FG000|Treated Participants|Study drug toxicity|39|||
164196391|NCT01239797|593087555|FG001|Treated Participants|Study drug toxicity|45|||
164196392|NCT01239797|593087554|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
164196393|NCT01239797|593087555|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
164196394|NCT01239797|593087554|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
164196395|NCT01239797|593087555|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
164196396|NCT01239797|593087554|FG000|Treated Participants|Administrative reason by sponsor|13|||
164196397|NCT01239797|593087555|FG001|Treated Participants|Administrative reason by sponsor|4|||
164196398|NCT01239797|593087554|FG000|Treated Participants|Other reasons|14|||
164196399|NCT01239797|593087555|FG001|Treated Participants|Other reasons|14|||
164196400|NCT01239797|593087554|FG000|Treated Participants|Participant withdrew consent|6|||
164196401|NCT01239797|593087555|FG001|Treated Participants|Participant withdrew consent|11|||
164196402|NCT01239797|593087554|FG000|Treated Participants|Death|1|||
164196403|NCT01239797|593087555|FG001|Treated Participants|Death|1|||
164196404|NCT01239797|593087554|FG000|Treated Participants|Participant no longer meets study criteria|1|||
164196405|NCT01239797|593087555|FG001|Treated Participants|Participant no longer meets study criteria|1|||
164196406|NCT01239797|593087554|FG000|Treated Participants|Poor/non-compliance|0|||
164196407|NCT01239797|593087555|FG001|Treated Participants|Poor/non-compliance|1|||
164196408|NCT00853762|593087556|FG000|Overall Study|Premature Termination|16|||
164196409|NCT00853762|593087557|FG001|Overall Study|Premature Termination|15|||
164196410|NCT00853762|593087558|FG002|Overall Study|Premature Termination|14|||
164196411|NCT00853762|593087559|FG003|Overall Study|Premature Termination|21|||
164196412|NCT00853762|593087556|FG000|Overall Study|Protocol Violation|0|||
164196413|NCT00853762|593087557|FG001|Overall Study|Protocol Violation|0|||
164196414|NCT00853762|593087558|FG002|Overall Study|Protocol Violation|0|||
164196415|NCT00853762|593087559|FG003|Overall Study|Protocol Violation|1|||
164196416|NCT00853762|593087556|FG000|Overall Study|Withdrawal by Subject|0|||
164196417|NCT00853762|593087557|FG001|Overall Study|Withdrawal by Subject|0|||
164196418|NCT00853762|593087558|FG002|Overall Study|Withdrawal by Subject|1|||
164196419|NCT00853762|593087559|FG003|Overall Study|Withdrawal by Subject|0|||
164196420|NCT00853762|593087556|FG000|Overall Study|Other|0|||
164196421|NCT00853762|593087557|FG001|Overall Study|Other|2|||
164196422|NCT00853762|593087558|FG002|Overall Study|Other|0|||
164196423|NCT00853762|593087559|FG003|Overall Study|Other|0|||
164196424|NCT00853762|593087556|FG000|Overall Study|Randomised but not Treated|0|||
164196425|NCT00853762|593087557|FG001|Overall Study|Randomised but not Treated|2|||
164196426|NCT00853762|593087558|FG002|Overall Study|Randomised but not Treated|2|||
164196427|NCT00853762|593087559|FG003|Overall Study|Randomised but not Treated|0|||
164196428|NCT01418339|593087562|FG000|Overall Study|Adverse Event|5|||
164196429|NCT01418339|593087563|FG001|Overall Study|Adverse Event|2|||
164196430|NCT01418339|593087562|FG000|Overall Study|Subject Withdrew Consent|1|||
164196431|NCT01418339|593087563|FG001|Overall Study|Subject Withdrew Consent|2|||
164196432|NCT01418339|593087562|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
164196433|NCT01418339|593087563|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
164196434|NCT02219685|593087564|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
164196435|NCT02219685|593087565|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
164196436|NCT02219685|593087564|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
164196437|NCT02219685|593087565|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
164196438|NCT02869789|593087566|FG000|Overall Study|Disease progression|184|||
164196439|NCT02869789|593087567|FG001|Overall Study|Disease progression|109|||
164196440|NCT02869789|593087568|FG002|Overall Study|Disease progression|260|||
164196441|NCT02869789|593087569|FG003|Overall Study|Disease progression|19|||
164196442|NCT02869789|593087566|FG000|Overall Study|Study drug toxicity|90|||
164196443|NCT02869789|593087567|FG001|Overall Study|Study drug toxicity|32|||
164196444|NCT02869789|593087568|FG002|Overall Study|Study drug toxicity|55|||
164196445|NCT02869789|593087569|FG003|Overall Study|Study drug toxicity|14|||
164196446|NCT02869789|593087566|FG000|Overall Study|Death|7|||
164196447|NCT02869789|593087567|FG001|Overall Study|Death|3|||
164196448|NCT02869789|593087568|FG002|Overall Study|Death|5|||
164196449|NCT02869789|593087569|FG003|Overall Study|Death|1|||
164196450|NCT02869789|593087566|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
164196451|NCT02869789|593087567|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
164196452|NCT02869789|593087568|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
164196453|NCT02869789|593087569|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
164196454|NCT02869789|593087566|FG000|Overall Study|Participant request to discontinue study treatment|10|||
164196455|NCT02869789|593087567|FG001|Overall Study|Participant request to discontinue study treatment|5|||
164196456|NCT02869789|593087568|FG002|Overall Study|Participant request to discontinue study treatment|5|||
164547962|NCT01147744|594378278|FG001|Overall Study|Adverse Event|2|||
164196457|NCT02869789|593087569|FG003|Overall Study|Participant request to discontinue study treatment|3|||
164196458|NCT02869789|593087566|FG000|Overall Study|Withdrawal by Subject|5|||
164196459|NCT02869789|593087567|FG001|Overall Study|Withdrawal by Subject|2|||
164196460|NCT02869789|593087568|FG002|Overall Study|Withdrawal by Subject|7|||
164196461|NCT02869789|593087569|FG003|Overall Study|Withdrawal by Subject|2|||
164196462|NCT02869789|593087566|FG000|Overall Study|Lost to Follow-up|0|||
164196463|NCT02869789|593087567|FG001|Overall Study|Lost to Follow-up|0|||
164196464|NCT02869789|593087568|FG002|Overall Study|Lost to Follow-up|2|||
164196465|NCT02869789|593087569|FG003|Overall Study|Lost to Follow-up|0|||
164196466|NCT02869789|593087566|FG000|Overall Study|Maximum clinical benefit|5|||
164196467|NCT02869789|593087567|FG001|Overall Study|Maximum clinical benefit|2|||
164196468|NCT02869789|593087568|FG002|Overall Study|Maximum clinical benefit|1|||
164196469|NCT02869789|593087569|FG003|Overall Study|Maximum clinical benefit|0|||
164196470|NCT02869789|593087566|FG000|Overall Study|Poor/Non-compliance|0|||
164196471|NCT02869789|593087567|FG001|Overall Study|Poor/Non-compliance|2|||
164196472|NCT02869789|593087568|FG002|Overall Study|Poor/Non-compliance|1|||
164196473|NCT02869789|593087569|FG003|Overall Study|Poor/Non-compliance|0|||
164196474|NCT02869789|593087566|FG000|Overall Study|Participant no longer meets study criteria|0|||
164196475|NCT02869789|593087567|FG001|Overall Study|Participant no longer meets study criteria|1|||
164196476|NCT02869789|593087568|FG002|Overall Study|Participant no longer meets study criteria|1|||
164196477|NCT02869789|593087569|FG003|Overall Study|Participant no longer meets study criteria|0|||
164196478|NCT02869789|593087566|FG000|Overall Study|Administrative reason by sponsor|0|||
164196479|NCT02869789|593087567|FG001|Overall Study|Administrative reason by sponsor|0|||
164196480|NCT02869789|593087568|FG002|Overall Study|Administrative reason by sponsor|1|||
164547963|NCT01147744|594378279|FG002|Overall Study|Adverse Event|3|||
164547964|NCT01147744|594378280|FG003|Overall Study|Adverse Event|0|||
164547965|NCT01147744|594378281|FG004|Overall Study|Adverse Event|2|||
164547966|NCT01147744|594378282|FG005|Overall Study|Adverse Event|1|||
164547967|NCT01147744|594378283|FG006|Overall Study|Adverse Event|2|||
164547968|NCT01147744|594378277|FG000|Overall Study|Withdrawal by Subject|8|||
164547969|NCT01147744|594378278|FG001|Overall Study|Withdrawal by Subject|4|||
164547970|NCT01147744|594378279|FG002|Overall Study|Withdrawal by Subject|2|||
164547971|NCT01147744|594378280|FG003|Overall Study|Withdrawal by Subject|2|||
164547972|NCT01147744|594378281|FG004|Overall Study|Withdrawal by Subject|2|||
164547973|NCT01147744|594378282|FG005|Overall Study|Withdrawal by Subject|5|||
164547974|NCT01147744|594378283|FG006|Overall Study|Withdrawal by Subject|2|||
164547975|NCT01147744|594378277|FG000|Overall Study|Lost to Follow-up|0|||
164547976|NCT01147744|594378278|FG001|Overall Study|Lost to Follow-up|1|||
164547977|NCT01147744|594378279|FG002|Overall Study|Lost to Follow-up|0|||
164547978|NCT01147744|594378280|FG003|Overall Study|Lost to Follow-up|0|||
164547979|NCT01147744|594378281|FG004|Overall Study|Lost to Follow-up|0|||
164547980|NCT01147744|594378282|FG005|Overall Study|Lost to Follow-up|0|||
164547981|NCT01147744|594378283|FG006|Overall Study|Lost to Follow-up|0|||
164547982|NCT01147744|594378277|FG000|Overall Study|Sponsor decision to amend protocol|7|||
164547983|NCT01147744|594378278|FG001|Overall Study|Sponsor decision to amend protocol|4|||
164547984|NCT01147744|594378279|FG002|Overall Study|Sponsor decision to amend protocol|2|||
164547985|NCT01147744|594378280|FG003|Overall Study|Sponsor decision to amend protocol|5|||
164547986|NCT01147744|594378281|FG004|Overall Study|Sponsor decision to amend protocol|7|||
164547987|NCT01147744|594378282|FG005|Overall Study|Sponsor decision to amend protocol|2|||
164547988|NCT01147744|594378283|FG006|Overall Study|Sponsor decision to amend protocol|6|||
164547989|NCT01147744|594378277|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
164547990|NCT01147744|594378278|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
164547991|NCT01147744|594378279|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
164547992|NCT01147744|594378280|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
164547993|NCT01147744|594378281|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
164547994|NCT01147744|594378282|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
164547995|NCT01147744|594378283|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
164547996|NCT01342484|594378285|FG000|Overall Study|Other Reasons|1|||
164547997|NCT01342484|594378286|FG001|Overall Study|Other Reasons|0|||
164547998|NCT01342484|594378287|FG002|Overall Study|Other Reasons|0|||
164547999|NCT01342484|594378285|FG000|Overall Study|Protocol Violation|0|||
164196481|NCT02869789|593087569|FG003|Overall Study|Administrative reason by sponsor|0|||
164196482|NCT02869789|593087566|FG000|Overall Study|Other reasons|4|||
164196483|NCT02869789|593087567|FG001|Overall Study|Other reasons|8|||
164196484|NCT02869789|593087568|FG002|Overall Study|Other reasons|6|||
164548000|NCT01342484|594378286|FG001|Overall Study|Protocol Violation|0|||
164548001|NCT01342484|594378287|FG002|Overall Study|Protocol Violation|1|||
164548002|NCT01342484|594378285|FG000|Overall Study|Withdrawal by Subject|1|||
164548003|NCT01342484|594378286|FG001|Overall Study|Withdrawal by Subject|0|||
164548004|NCT01342484|594378287|FG002|Overall Study|Withdrawal by Subject|0|||
164548005|NCT01744665|594378288|FG000|Monitoring Phase|Adverse Event|4|||
164548006|NCT01744665|594378288|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
164548007|NCT01744665|594378288|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
164548008|NCT01744665|594378288|FG000|Monitoring Phase|Withdrawal by Subject|5|||
164548009|NCT01744665|594378288|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
164548010|NCT01744665|594378288|FG000|Consolidation Phase|Adverse Event|2|||
164548011|NCT01744665|594378288|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
164548012|NCT01744665|594378288|FG000|Consolidation Phase|Withdrawal by Subject|4|||
164548013|NCT01744665|594378288|FG000|Consolidation Phase|Administrative problems|9|||
164548014|NCT01744665|594378288|FG000|Re-initiation Phase|Administrative problems|10|||
164548015|NCT01744665|594378288|FG000|Re-initiation Phase|Adverse Event|1|||
164548016|NCT01744665|594378288|FG000|Re-initiation Phase|No longer required treatment|1|||
164548017|NCT01744665|594378288|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
164548018|NCT05998148|594378289|FG000|Allocation|Did not attend any appointments|1|||
164548019|NCT05998148|594378290|FG001|Allocation|Did not attend any appointments|4|||
164548020|NCT05998148|594378289|FG000|Follow-Up|Lost to Follow-up|1|||
164548021|NCT05998148|594378290|FG001|Follow-Up|Lost to Follow-up|2|||
164548022|NCT05998148|594378289|FG000|Follow-Up|Change in insurance|1|||
164548023|NCT05998148|594378290|FG001|Follow-Up|Change in insurance|1|||
164548024|NCT02090413|594378292|FG000|Overall Study|Adverse Event|11|||
164548025|NCT02090413|594378293|FG001|Overall Study|Adverse Event|15|||
164548026|NCT02090413|594378294|FG002|Overall Study|Adverse Event|20|||
164548027|NCT02090413|594378292|FG000|Overall Study|Flushing event|2|||
164548028|NCT02090413|594378293|FG001|Overall Study|Flushing event|0|||
164548029|NCT02090413|594378294|FG002|Overall Study|Flushing event|1|||
164548030|NCT02090413|594378292|FG000|Overall Study|Withdrawal by Subject|2|||
164548031|NCT02090413|594378293|FG001|Overall Study|Withdrawal by Subject|2|||
164548032|NCT02090413|594378294|FG002|Overall Study|Withdrawal by Subject|2|||
164548033|NCT02090413|594378292|FG000|Overall Study|Investigator Decision|1|||
164548034|NCT02090413|594378293|FG001|Overall Study|Investigator Decision|1|||
164548035|NCT02090413|594378294|FG002|Overall Study|Investigator Decision|0|||
164548036|NCT02090413|594378292|FG000|Overall Study|Other|2|||
164548037|NCT02090413|594378293|FG001|Overall Study|Other|1|||
164548038|NCT02090413|594378294|FG002|Overall Study|Other|0|||
164548039|NCT02090413|594378292|FG000|Overall Study|Lost to Follow-up|1|||
164548040|NCT02090413|594378293|FG001|Overall Study|Lost to Follow-up|1|||
164548041|NCT02090413|594378294|FG002|Overall Study|Lost to Follow-up|0|||
164548042|NCT03834519|594378296|FG000|Overall Study|Lost to Follow-up|2|||
164548043|NCT03834519|594378297|FG001|Overall Study|Lost to Follow-up|1|||
164548044|NCT03834519|594378296|FG000|Overall Study|Withdrawal by Subject|5|||
164548045|NCT03834519|594378297|FG001|Overall Study|Withdrawal by Subject|8|||
164548046|NCT03834519|594378296|FG000|Overall Study|Death|368|||
164548047|NCT03834519|594378297|FG001|Overall Study|Death|174|||
164548048|NCT03834519|594378296|FG000|Overall Study|Physician Decision|5|||
164548049|NCT03834519|594378297|FG001|Overall Study|Physician Decision|1|||
164548050|NCT03834519|594378296|FG000|Overall Study|Sponsor decision|149|||
164548051|NCT03834519|594378297|FG001|Overall Study|Sponsor decision|80|||
164548052|NCT05248295|594378298|FG000|Overall Study|found ineligible|4|||
164548053|NCT05248295|594378299|FG001|Overall Study|found ineligible|1|||
164548054|NCT05248295|594378298|FG000|Overall Study|Withdrawal by Subject|0|||
164548055|NCT05248295|594378299|FG001|Overall Study|Withdrawal by Subject|1|||
164548056|NCT05248295|594378298|FG000|Overall Study|Data loss: audio recording error|1|||
164548057|NCT05248295|594378299|FG001|Overall Study|Data loss: audio recording error|1|||
164548058|NCT01293968|594378302|FG000|Overall Study|non-cooperation|3|||
164548059|NCT01293968|594378303|FG001|Overall Study|non-cooperation|3|||
164548060|NCT01133379|594378304|FG000|Overall Study|Withdrawal by Subject|0|||
164548061|NCT01133379|594378305|FG001|Overall Study|Withdrawal by Subject|1|||
164548062|NCT01133379|594378306|FG002|Overall Study|Withdrawal by Subject|1|||
164548063|NCT01133379|594378304|FG000|Overall Study|Lost to Follow-up|1|||
164548064|NCT01133379|594378305|FG001|Overall Study|Lost to Follow-up|1|||
164548065|NCT01133379|594378306|FG002|Overall Study|Lost to Follow-up|1|||
164548066|NCT00597753|594378313|FG000|Overall Study|Adverse Event|6|||
164548067|NCT00597753|594378314|FG001|Overall Study|Adverse Event|2|||
164548068|NCT00597753|594378313|FG000|Overall Study|Death|55|||
164548069|NCT00597753|594378314|FG001|Overall Study|Death|29|||
164548070|NCT00597753|594378313|FG000|Overall Study|Lack of Efficacy|2|||
164548071|NCT00597753|594378314|FG001|Overall Study|Lack of Efficacy|0|||
164548072|NCT00597753|594378313|FG000|Overall Study|Lost to Follow-up|10|||
164548073|NCT00597753|594378314|FG001|Overall Study|Lost to Follow-up|3|||
164548074|NCT00597753|594378313|FG000|Overall Study|Physician Decision|5|||
164548075|NCT00597753|594378314|FG001|Overall Study|Physician Decision|1|||
164548076|NCT00597753|594378313|FG000|Overall Study|Pregnancy|1|||
164548077|NCT00597753|594378314|FG001|Overall Study|Pregnancy|0|||
164548078|NCT00597753|594378313|FG000|Overall Study|Withdrawal by Subject|35|||
164548079|NCT00597753|594378314|FG001|Overall Study|Withdrawal by Subject|12|||
164548080|NCT00597753|594378313|FG000|Overall Study|Discontinued Dialysis|0|||
164548081|NCT00597753|594378314|FG001|Overall Study|Discontinued Dialysis|1|||
164548082|NCT00597753|594378313|FG000|Overall Study|Never dosed|2|||
164548083|NCT00597753|594378314|FG001|Overall Study|Never dosed|0|||
164548084|NCT00597753|594378313|FG000|Overall Study|Noncompliance|2|||
164548085|NCT00597753|594378314|FG001|Overall Study|Noncompliance|1|||
164548086|NCT00597753|594378313|FG000|Overall Study|Relocation|17|||
164548087|NCT00597753|594378314|FG001|Overall Study|Relocation|6|||
164548088|NCT00597753|594378313|FG000|Overall Study|Renal transplant|10|||
164548089|NCT00597753|594378314|FG001|Overall Study|Renal transplant|3|||
164548090|NCT00597753|594378313|FG000|Overall Study|Site closed by sponsor|19|||
164548091|NCT00597753|594378314|FG001|Overall Study|Site closed by sponsor|7|||
164548092|NCT00597753|594378313|FG000|Overall Study|Site elected to close|2|||
164548093|NCT00597753|594378314|FG001|Overall Study|Site elected to close|4|||
164548094|NCT04682405|594379656|FG000|Overall Study|Adverse Event|0|||
164548095|NCT04682405|594379657|FG001|Overall Study|Adverse Event|1|||
164548096|NCT00750698|594379661|FG000|Overall Study|Withdrawal by Subject|1|||
164548097|NCT00750698|594379662|FG001|Overall Study|Withdrawal by Subject|0|||
164548098|NCT00750698|594379661|FG000|Overall Study|Progressive disease|5|||
164548099|NCT00750698|594379662|FG001|Overall Study|Progressive disease|2|||
164548100|NCT03357731|594379665|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
164654350|NCT02784106|594760673|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
164548101|NCT03357731|594379666|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
164548102|NCT03357731|594379667|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
164548103|NCT03357731|594379668|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
164548104|NCT03357731|594379669|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
164654351|NCT02784106|594760670|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
164654352|NCT02784106|594760671|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
164548105|NCT03357731|594379670|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
164548106|NCT03357731|594379665|FG000|Overall Study|Acute bradycardia and hypotension|0|||
164548107|NCT03357731|594379666|FG001|Overall Study|Acute bradycardia and hypotension|0|||
164654353|NCT02784106|594760672|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
164654354|NCT02784106|594760673|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
164654355|NCT02784106|594760670|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
164654356|NCT02784106|594760671|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
164654357|NCT02784106|594760672|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
164654358|NCT02784106|594760673|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
164654359|NCT02784106|594760670|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
164654360|NCT02784106|594760671|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
164654361|NCT02784106|594760672|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
164654362|NCT02784106|594760673|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
164654363|NCT01755858|594760676|FG000|Overall Study|Adverse Event|1|||
164654364|NCT01755858|594760677|FG001|Overall Study|Adverse Event|1|||
164654365|NCT00175019|594760678|FG000|Overall Study|Adverse Event|54|||
164654366|NCT00175019|594760679|FG001|Overall Study|Adverse Event|22|||
164654367|NCT00175019|594760680|FG002|Overall Study|Adverse Event|2|||
164654368|NCT00175019|594760678|FG000|Overall Study|Protocol Violation|6|||
164654369|NCT00175019|594760679|FG001|Overall Study|Protocol Violation|3|||
164654370|NCT00175019|594760680|FG002|Overall Study|Protocol Violation|3|||
164654371|NCT00175019|594760678|FG000|Overall Study|Lost to Follow-up|42|||
164654372|NCT00175019|594760679|FG001|Overall Study|Lost to Follow-up|39|||
164654373|NCT00175019|594760680|FG002|Overall Study|Lost to Follow-up|9|||
164654374|NCT00175019|594760678|FG000|Overall Study|Did not continue under Amendment 4|1|||
164654375|NCT00175019|594760679|FG001|Overall Study|Did not continue under Amendment 4|1|||
164654376|NCT00175019|594760680|FG002|Overall Study|Did not continue under Amendment 4|2|||
164654377|NCT00175019|594760678|FG000|Overall Study|Personal Reason(s)|39|||
164654378|NCT00175019|594760679|FG001|Overall Study|Personal Reason(s)|31|||
164654379|NCT00175019|594760680|FG002|Overall Study|Personal Reason(s)|8|||
164654380|NCT00175019|594760678|FG000|Overall Study|Therapeutic Failure|10|||
164654381|NCT00175019|594760679|FG001|Overall Study|Therapeutic Failure|38|||
164654382|NCT00175019|594760680|FG002|Overall Study|Therapeutic Failure|22|||
164654383|NCT00175019|594760678|FG000|Overall Study|Gout Flare|2|||
164654384|NCT00175019|594760679|FG001|Overall Study|Gout Flare|3|||
164654385|NCT00175019|594760680|FG002|Overall Study|Gout Flare|0|||
164654386|NCT00175019|594760678|FG000|Overall Study|Reason Not Specified|40|||
164654387|NCT00175019|594760679|FG001|Overall Study|Reason Not Specified|34|||
164654388|NCT00175019|594760680|FG002|Overall Study|Reason Not Specified|11|||
164654389|NCT00475852|594760684|FG000|Overall Study|Death|444|||
164654390|NCT00475852|594760685|FG001|Overall Study|Death|456|||
164654391|NCT00475852|594760684|FG000|Overall Study|Withdrawal by Subject|19|||
164548108|NCT03357731|594379667|FG002|Overall Study|Acute bradycardia and hypotension|0|||
164548109|NCT03357731|594379668|FG003|Overall Study|Acute bradycardia and hypotension|1|||
164548110|NCT03357731|594379669|FG004|Overall Study|Acute bradycardia and hypotension|0|||
164548111|NCT03357731|594379670|FG005|Overall Study|Acute bradycardia and hypotension|0|||
164548112|NCT03357731|594379665|FG000|Overall Study|Adverse Event|0|||
164548113|NCT03357731|594379666|FG001|Overall Study|Adverse Event|0|||
164548114|NCT03357731|594379667|FG002|Overall Study|Adverse Event|0|||
164548115|NCT03357731|594379668|FG003|Overall Study|Adverse Event|0|||
164548116|NCT03357731|594379669|FG004|Overall Study|Adverse Event|0|||
164654392|NCT00475852|594760685|FG001|Overall Study|Withdrawal by Subject|24|||
164654393|NCT00475852|594760684|FG000|Overall Study|Lost to Follow-up|54|||
164654394|NCT00475852|594760685|FG001|Overall Study|Lost to Follow-up|68|||
164654395|NCT00297479|594760686|FG000|Overall Study|Lost to Follow-up|37|||
164548117|NCT03357731|594379670|FG005|Overall Study|Adverse Event|1|||
164548118|NCT03357731|594379665|FG000|Overall Study|Hypotension|0|||
164548119|NCT03357731|594379666|FG001|Overall Study|Hypotension|0|||
164548120|NCT03357731|594379667|FG002|Overall Study|Hypotension|1|||
164548121|NCT03357731|594379668|FG003|Overall Study|Hypotension|1|||
164548122|NCT03357731|594379669|FG004|Overall Study|Hypotension|0|||
164548123|NCT03357731|594379670|FG005|Overall Study|Hypotension|0|||
164548124|NCT03357731|594379665|FG000|Overall Study|Lost to Follow-up|0|||
164548125|NCT03357731|594379666|FG001|Overall Study|Lost to Follow-up|0|||
164548126|NCT03357731|594379667|FG002|Overall Study|Lost to Follow-up|0|||
164548127|NCT03357731|594379668|FG003|Overall Study|Lost to Follow-up|1|||
164548128|NCT03357731|594379669|FG004|Overall Study|Lost to Follow-up|0|||
164548129|NCT03357731|594379670|FG005|Overall Study|Lost to Follow-up|0|||
164548130|NCT01417195|594379671|FG000|Overall Study|Stimulation failure|1|||
164548131|NCT01417195|594379672|FG001|Overall Study|Stimulation failure|0|||
164548132|NCT01417195|594379671|FG000|Overall Study|No embryos for transfer|0|||
164548133|NCT01417195|594379672|FG001|Overall Study|No embryos for transfer|1|||
164548134|NCT01417195|594379671|FG000|Overall Study|No transfer due to risk of OHSS|1|||
164548135|NCT01417195|594379672|FG001|Overall Study|No transfer due to risk of OHSS|0|||
164548136|NCT01417195|594379671|FG000|Overall Study|No transfer due to elevated progesterone|1|||
164548137|NCT01417195|594379672|FG001|Overall Study|No transfer due to elevated progesterone|0|||
164548138|NCT02349048|594379673|FG000|Overall Study|Withdrawal by Subject|4|||
164548139|NCT02349048|594379674|FG001|Overall Study|Withdrawal by Subject|0|||
164196485|NCT02869789|593087569|FG003|Overall Study|Other reasons|0|||
164548140|NCT02349048|594379673|FG000|Overall Study|Lost to Follow-up|1|||
164548141|NCT02349048|594379674|FG001|Overall Study|Lost to Follow-up|0|||
164548142|NCT03709654|594379675|FG000|Overall Study|Lost to Follow-up|1|||
164196486|NCT00297648|593087571|FG000|Overall Study|Adverse Event|13|||
164196487|NCT00297648|593087571|FG000|Overall Study|Lack of Efficacy|18|||
164196488|NCT00297648|593087571|FG000|Overall Study|Lost to Follow-up|1|||
164196489|NCT00297648|593087571|FG000|Overall Study|Withdrawal by Subject|3|||
164196490|NCT00297648|593087571|FG000|Overall Study|Other: Incompliance|1|||
164196491|NCT01746862|593087572|FG000|Overall Study|Withdrawal by Subject|1|||
164196492|NCT01746862|593087573|FG001|Overall Study|Withdrawal by Subject|1|||
164196493|NCT01746862|593087572|FG000|Overall Study|Protocol Violation|1|||
164196494|NCT01746862|593087573|FG001|Overall Study|Protocol Violation|0|||
164196495|NCT01746862|593087572|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
164196496|NCT01746862|593087573|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
164196497|NCT01746862|593087572|FG000|Overall Study|Entered puberty during the study|1|||
164196498|NCT01746862|593087573|FG001|Overall Study|Entered puberty during the study|0|||
164196499|NCT04742673|593087574|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
164196500|NCT04742673|593087575|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
164196501|NCT03243305|593087576|FG000|Overall Study|Lost to Follow-up|250|||
164196502|NCT03243305|593087576|FG000|Overall Study|Withdrawal by Subject|170|||
164196503|NCT03243305|593087576|FG000|Overall Study|Pregnancy|104|||
164196504|NCT03243305|593087576|FG000|Overall Study|Non-Compliance with Study Drug|38|||
164196505|NCT03243305|593087576|FG000|Overall Study|Adverse Event|23|||
164196506|NCT03243305|593087576|FG000|Overall Study|No sexually active|26|||
164196507|NCT03243305|593087576|FG000|Overall Study|Physician Decision|22|||
164196508|NCT03243305|593087576|FG000|Overall Study|Protocol Violation|22|||
164196509|NCT03243305|593087576|FG000|Overall Study|Study method no longer primary method|12|||
164196510|NCT03243305|593087576|FG000|Overall Study|Study Terminated by Sponsor|1|||
164196511|NCT03243305|593087576|FG000|Overall Study|Early terminations|267|||
164196512|NCT02689804|593087577|FG000|Overall Study|Withdrawal by Subject|2|||
164196513|NCT02689804|593087578|FG001|Overall Study|Withdrawal by Subject|0|||
164196514|NCT00227539|593087579|FG000|Overall Study|Protocol Violation|1|||
164196515|NCT00673257|593087580|FG000|Overall Study|Withdrawal by Subject|4|||
164196516|NCT00673257|593087580|FG000|Overall Study|Unable to obtain specimen|1|||
164196517|NCT00570401|593087581|FG000|Overall Study|Adverse Event|2|||
164196518|NCT00792909|593087584|FG000|Overall Study|Withdrawal by Subject|0|||
164196519|NCT00792909|593087585|FG001|Overall Study|Withdrawal by Subject|1|||
164196520|NCT00792909|593087586|FG002|Overall Study|Withdrawal by Subject|0|||
164196521|NCT04157088|593087587|FG000|Overall Study|Study terminated by sponsor|23|||
164196522|NCT04157088|593087587|FG000|Overall Study|Withdrawal by Subject|4|||
164196523|NCT04157088|593087587|FG000|Overall Study|Lost to Follow-up|2|||
164196524|NCT04157088|593087587|FG000|Overall Study|Death|1|||
164196525|NCT00810199|593087588|FG000|Overall Study|Adverse Event|24|||
164196526|NCT00810199|593087589|FG001|Overall Study|Adverse Event|26|||
164196527|NCT00810199|593087588|FG000|Overall Study|Death|4|||
164196528|NCT00810199|593087589|FG001|Overall Study|Death|6|||
164196529|NCT00810199|593087588|FG000|Overall Study|Withdrew consent|9|||
164196530|NCT00810199|593087589|FG001|Overall Study|Withdrew consent|12|||
164548143|NCT03709654|594379676|FG001|Overall Study|Lost to Follow-up|1|||
164548144|NCT03709654|594379675|FG000|Overall Study|Withdrawal by Subject|1|||
164548145|NCT03709654|594379676|FG001|Overall Study|Withdrawal by Subject|1|||
164548146|NCT03709654|594379675|FG000|Overall Study|Adverse Event|1|||
164196531|NCT00810199|593087588|FG000|Overall Study|Insufficient therapeutic response|5|||
164548147|NCT03709654|594379676|FG001|Overall Study|Adverse Event|0|||
164548148|NCT01040351|594379677|FG000|Overall Study|poor ovarian response|1|||
164548149|NCT01040351|594379678|FG001|Overall Study|poor ovarian response|2|||
164548150|NCT00530894|594379683|FG000|Overall Study|Death|84|||
164548151|NCT00530894|594379684|FG001|Overall Study|Death|89|||
164548152|NCT00530894|594379685|FG002|Overall Study|Death|55|||
164548153|NCT00530894|594379686|FG003|Overall Study|Death|89|||
164548154|NCT00530894|594379683|FG000|Overall Study|Lost to Follow-up|1|||
164548155|NCT00530894|594379684|FG001|Overall Study|Lost to Follow-up|3|||
164548156|NCT00530894|594379685|FG002|Overall Study|Lost to Follow-up|0|||
164548157|NCT00530894|594379686|FG003|Overall Study|Lost to Follow-up|0|||
164548158|NCT00530894|594379683|FG000|Overall Study|Withdrawal by Subject|1|||
164548159|NCT00530894|594379684|FG001|Overall Study|Withdrawal by Subject|23|||
164548160|NCT00530894|594379685|FG002|Overall Study|Withdrawal by Subject|0|||
164548161|NCT00530894|594379686|FG003|Overall Study|Withdrawal by Subject|5|||
164548162|NCT00530894|594379683|FG000|Overall Study|Alive and censored prior to 1 year|2|||
164548163|NCT00530894|594379684|FG001|Overall Study|Alive and censored prior to 1 year|0|||
164548164|NCT00530894|594379685|FG002|Overall Study|Alive and censored prior to 1 year|0|||
164548165|NCT00530894|594379686|FG003|Overall Study|Alive and censored prior to 1 year|0|||
164548166|NCT01230242|594379687|FG000|Overall Study|Physician Decision|2|||
164548167|NCT01230242|594379687|FG000|Overall Study|Withdrawal by Subject|1|||
164548168|NCT02256540|594379688|FG000|Overall Study|Withdrawal by Subject|0|||
164548169|NCT02256540|594379689|FG001|Overall Study|Withdrawal by Subject|1|||
164548170|NCT02256540|594379690|FG002|Overall Study|Withdrawal by Subject|1|||
164548171|NCT02256540|594379688|FG000|Overall Study|Back pain preventing exercise|0|||
164548172|NCT02256540|594379689|FG001|Overall Study|Back pain preventing exercise|0|||
164548173|NCT02256540|594379690|FG002|Overall Study|Back pain preventing exercise|1|||
164548174|NCT01438489|594379691|FG000|Overall Study|Lost to Follow-up|4|||
164548175|NCT01438489|594379692|FG001|Overall Study|Lost to Follow-up|2|||
164548176|NCT01438489|594379693|FG002|Overall Study|Lost to Follow-up|2|||
164548177|NCT01438489|594379691|FG000|Overall Study|Withdrawal by Subject|11|||
164548178|NCT01438489|594379692|FG001|Overall Study|Withdrawal by Subject|3|||
164548179|NCT01438489|594379693|FG002|Overall Study|Withdrawal by Subject|8|||
164548180|NCT01438489|594379691|FG000|Overall Study|Death|0|||
164548181|NCT01438489|594379692|FG001|Overall Study|Death|0|||
164548182|NCT01438489|594379693|FG002|Overall Study|Death|1|||
164548183|NCT01438489|594379691|FG000|Overall Study|Sponsor decision|4|||
164548184|NCT01438489|594379692|FG001|Overall Study|Sponsor decision|1|||
164548185|NCT01438489|594379693|FG002|Overall Study|Sponsor decision|4|||
164548186|NCT01438489|594379691|FG000|Overall Study|Subject choice/Subject moved|2|||
164548187|NCT01438489|594379692|FG001|Overall Study|Subject choice/Subject moved|1|||
164548188|NCT01438489|594379693|FG002|Overall Study|Subject choice/Subject moved|1|||
164548189|NCT01438489|594379691|FG000|Overall Study|Investigator decision|0|||
164548190|NCT01438489|594379692|FG001|Overall Study|Investigator decision|1|||
164548191|NCT01438489|594379693|FG002|Overall Study|Investigator decision|0|||
164548192|NCT01438489|594379691|FG000|Overall Study|AE/SAEs|2|||
164548193|NCT01438489|594379692|FG001|Overall Study|AE/SAEs|1|||
164548194|NCT01438489|594379693|FG002|Overall Study|AE/SAEs|1|||
164548195|NCT01438489|594379691|FG000|Overall Study|Received prohibited medication|1|||
164548196|NCT01438489|594379692|FG001|Overall Study|Received prohibited medication|0|||
164548197|NCT01438489|594379693|FG002|Overall Study|Received prohibited medication|0|||
164548198|NCT01438489|594379691|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
164548199|NCT01438489|594379692|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
164548200|NCT01438489|594379693|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
164548201|NCT01438489|594379691|FG000|Overall Study|Inadequate venous access|0|||
164548202|NCT01438489|594379692|FG001|Overall Study|Inadequate venous access|2|||
164548203|NCT01438489|594379693|FG002|Overall Study|Inadequate venous access|0|||
164548204|NCT03923426|594379694|FG000|Overall Study|Other|19|||
164548205|NCT03923426|594379694|FG000|Overall Study|Lost to Follow-up|16|||
164548206|NCT03923426|594379694|FG000|Overall Study|Death|107|||
164548207|NCT03923426|594379694|FG000|Overall Study|Incomplete response to question|13|||
164548208|NCT00766532|594379695|FG000|Overall Study|Protocol Violation|2|||
164548209|NCT03719690|594379701|FG000|Overall Study|Withdrawal by Subject|5|||
164548210|NCT03719690|594379702|FG001|Overall Study|Withdrawal by Subject|10|||
164548211|NCT03719690|594379701|FG000|Overall Study|Death|40|||
164548212|NCT03719690|594379702|FG001|Overall Study|Death|149|||
164548213|NCT03719690|594379701|FG000|Overall Study|Miscellaneous|12|||
164548214|NCT03719690|594379702|FG001|Overall Study|Miscellaneous|56|||
164548215|NCT03719690|594379701|FG000|Overall Study|Lost to Follow-up|2|||
164548216|NCT03719690|594379702|FG001|Overall Study|Lost to Follow-up|18|||
164548217|NCT03719690|594379701|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
164548218|NCT03719690|594379702|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
164548219|NCT02953340|594379712|FG000|Overall Study|Death|0|||
164548220|NCT02953340|594379713|FG001|Overall Study|Death|1|||
164548221|NCT02953340|594379712|FG000|Overall Study|Investigator Decision|3|||
164548222|NCT02953340|594379713|FG001|Overall Study|Investigator Decision|3|||
164548223|NCT02953340|594379712|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
164548224|NCT02953340|594379713|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
164548225|NCT02953340|594379712|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
164548226|NCT02953340|594379713|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
164548227|NCT02953340|594379712|FG000|Overall Study|Withdrawal by Subject|9|||
164548228|NCT02953340|594379713|FG001|Overall Study|Withdrawal by Subject|9|||
164548229|NCT02953340|594379712|FG000|Overall Study|Sponsor decision|0|||
164548230|NCT02953340|594379713|FG001|Overall Study|Sponsor decision|2|||
164548231|NCT02953340|594379712|FG000|Overall Study|Lost to Follow-up|3|||
164548232|NCT02953340|594379713|FG001|Overall Study|Lost to Follow-up|2|||
164548233|NCT02953340|594379712|FG000|Overall Study|Reason not specified|2|||
164548234|NCT02953340|594379713|FG001|Overall Study|Reason not specified|2|||
164548235|NCT04416555|594379717|FG000|Overall Study|Withdrawal by Subject|0|||
164548236|NCT04416555|594379718|FG001|Overall Study|Withdrawal by Subject|3|||
164548237|NCT00530270|594379719|FG000|Overall Study|Protocol Violation|1|||
164548238|NCT00530270|594379720|FG001|Overall Study|Protocol Violation|0|||
164548239|NCT01923285|594379729|FG000|Overall Study|Withdrawal by Subject|7|||
164548240|NCT01923285|594379730|FG001|Overall Study|Withdrawal by Subject|6|||
164548241|NCT01309659|594379733|FG000|Overall Study|Protocol Violation|0|||
164548242|NCT01309659|594379734|FG001|Overall Study|Protocol Violation|1|||
164548243|NCT03462576|594379735|FG000|Overall Study|Protocol Violation|5|||
164548244|NCT03462576|594379736|FG001|Overall Study|Protocol Violation|11|||
164548245|NCT03462576|594379737|FG002|Overall Study|Protocol Violation|7|||
164548246|NCT03462576|594379735|FG000|Overall Study|Device Malfunction|0|||
164548247|NCT03462576|594379736|FG001|Overall Study|Device Malfunction|0|||
164548248|NCT03462576|594379737|FG002|Overall Study|Device Malfunction|1|||
164548249|NCT03962101|594379738|FG000|Overall Study|Adverse Event|1|||
164548250|NCT03962101|594379738|FG000|Overall Study|Physician Decision|2|||
164548251|NCT03962101|594379738|FG000|Overall Study|Not related to medical events|1|||
164548252|NCT00750737|594379745|FG000|Overall Study|Withdrawal by Subject|3|||
164548253|NCT00750737|594379746|FG001|Overall Study|Withdrawal by Subject|3|||
164548254|NCT00865904|594379748|FG000|Overall Study|Randomized but not Treated|2|||
164548255|NCT00865904|594379749|FG001|Overall Study|Randomized but not Treated|0|||
164548256|NCT00865904|594379750|FG002|Overall Study|Randomized but not Treated|0|||
164548257|NCT00865904|594379751|FG003|Overall Study|Randomized but not Treated|1|||
164548258|NCT00865904|594379752|FG004|Overall Study|Randomized but not Treated|1|||
164548259|NCT01543828|594379753|FG000|Treatment 2|Lost to Follow-up|1|||
164548260|NCT01543828|594379754|FG001|Treatment 2|Lost to Follow-up|0|||
164548261|NCT00825162|594379762|FG000|Overall Study|Withdrawal by Subject|11|||
164548262|NCT00825162|594379763|FG001|Overall Study|Withdrawal by Subject|13|||
164548263|NCT00825162|594379764|FG002|Overall Study|Withdrawal by Subject|3|||
164548264|NCT00825162|594379762|FG000|Overall Study|Lost to Follow-up|9|||
164548265|NCT00825162|594379763|FG001|Overall Study|Lost to Follow-up|6|||
164548266|NCT00825162|594379764|FG002|Overall Study|Lost to Follow-up|3|||
164548267|NCT00825162|594379762|FG000|Overall Study|Physician Decision|2|||
164548268|NCT00825162|594379763|FG001|Overall Study|Physician Decision|0|||
164548269|NCT00825162|594379764|FG002|Overall Study|Physician Decision|0|||
164548270|NCT00825162|594379762|FG000|Overall Study|Move away from the study area|1|||
164548271|NCT00825162|594379763|FG001|Overall Study|Move away from the study area|0|||
164548272|NCT00825162|594379764|FG002|Overall Study|Move away from the study area|0|||
164548273|NCT00825162|594379762|FG000|Overall Study|Unable to attend the study visit|5|||
164548274|NCT00825162|594379763|FG001|Overall Study|Unable to attend the study visit|2|||
164548275|NCT00825162|594379764|FG002|Overall Study|Unable to attend the study visit|0|||
164548276|NCT02016820|594379772|FG000|Overall Study|Lost to Follow-up|2|||
164548277|NCT02016820|594379773|FG001|Overall Study|Lost to Follow-up|4|||
164548278|NCT00884273|594379774|FG000|Overall Study|Adverse Event|0|||
164654396|NCT00297479|594760687|FG001|Overall Study|Lost to Follow-up|54|||
164654397|NCT00297479|594760688|FG002|Overall Study|Lost to Follow-up|51|||
164654398|NCT03263819|594760689|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
164654399|NCT03263819|594760690|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
164654400|NCT00686920|594760695|FG000|Overall Study|Death|45|||
164654401|NCT00686920|594760696|FG001|Overall Study|Death|14|||
164654402|NCT00686920|594760695|FG000|Overall Study|Liver Transplant|23|||
164654403|NCT00686920|594760696|FG001|Overall Study|Liver Transplant|8|||
164654404|NCT00686920|594760695|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
164654405|NCT00686920|594760696|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
164654406|NCT00686920|594760695|FG000|Overall Study|Withdrawal by Subject|23|||
164654407|NCT00686920|594760696|FG001|Overall Study|Withdrawal by Subject|5|||
164548279|NCT00884273|594379775|FG001|Overall Study|Adverse Event|2|||
164548280|NCT00884273|594379774|FG000|Overall Study|Protocol Violation|1|||
164548281|NCT00884273|594379775|FG001|Overall Study|Protocol Violation|3|||
164548282|NCT00884273|594379774|FG000|Overall Study|Practical reasons|1|||
164654408|NCT00686920|594760695|FG000|Overall Study|Protocol Violation|2|||
164548283|NCT00884273|594379775|FG001|Overall Study|Practical reasons|0|||
164548284|NCT00258674|594379776|FG000|Overall Study|Death|32|||
164548285|NCT00258674|594379777|FG001|Overall Study|Death|53|||
164548286|NCT00258674|594379778|FG002|Overall Study|Death|34|||
164654409|NCT00686920|594760696|FG001|Overall Study|Protocol Violation|1|||
164654410|NCT00686920|594760695|FG000|Overall Study|Adverse Event|10|||
164654411|NCT00686920|594760696|FG001|Overall Study|Adverse Event|2|||
164548287|NCT03710486|594379779|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
164548288|NCT03710486|594379780|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
164548289|NCT03710486|594379779|FG000|Overall Study|Missing|0|||
164548290|NCT03710486|594379780|FG001|Overall Study|Missing|2|||
164548291|NCT01279850|594379781|FG000|Overall Study|Protocol Violation|50|||
164548292|NCT01279850|594379781|FG000|Overall Study|No Drug Administration Information|7|||
164548293|NCT01279850|594379781|FG000|Overall Study|No Visit After Treatment|34|||
164548294|NCT00432042|594379789|FG000|Overall Study|Protocol Violation|2|||
164548295|NCT00432042|594379790|FG001|Overall Study|Protocol Violation|0|||
164548296|NCT00432042|594379791|FG002|Overall Study|Protocol Violation|0|||
164548297|NCT00432042|594379789|FG000|Overall Study|Withdrawal by Subject|0|||
164548298|NCT00432042|594379790|FG001|Overall Study|Withdrawal by Subject|0|||
164548299|NCT00432042|594379791|FG002|Overall Study|Withdrawal by Subject|2|||
164548300|NCT00432042|594379789|FG000|Overall Study|Lost to Follow-up|5|||
164548301|NCT00432042|594379790|FG001|Overall Study|Lost to Follow-up|1|||
164548302|NCT00432042|594379791|FG002|Overall Study|Lost to Follow-up|0|||
164548303|NCT00492752|594379792|FG000|Double Blind Treatment|Death|13|||
164548304|NCT00492752|594379793|FG001|Double Blind Treatment|Death|0|||
164548305|NCT00492752|594379794|FG002|Double Blind Treatment|Death|2|||
164548306|NCT00492752|594379795|FG003|Double Blind Treatment|Death|0|||
164548307|NCT00492752|594379792|FG000|Double Blind Treatment|Adverse Event|1|||
164548308|NCT00492752|594379793|FG001|Double Blind Treatment|Adverse Event|0|||
164548309|NCT00492752|594379794|FG002|Double Blind Treatment|Adverse Event|0|||
164548310|NCT00492752|594379795|FG003|Double Blind Treatment|Adverse Event|0|||
164548311|NCT00492752|594379792|FG000|Double Blind Treatment|Protocol Violation|0|||
164548312|NCT00492752|594379793|FG001|Double Blind Treatment|Protocol Violation|0|||
164548313|NCT00492752|594379794|FG002|Double Blind Treatment|Protocol Violation|1|||
164548314|NCT00492752|594379795|FG003|Double Blind Treatment|Protocol Violation|0|||
164548315|NCT00492752|594379792|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
164548316|NCT00492752|594379793|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
164548317|NCT00492752|594379794|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
164548318|NCT00492752|594379795|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
164548319|NCT00492752|594379792|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
164548320|NCT00492752|594379793|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
164654412|NCT00686920|594760695|FG000|Overall Study|Personal Reason|0|||
164654413|NCT00686920|594760696|FG001|Overall Study|Personal Reason|1|||
164654414|NCT00686920|594760695|FG000|Overall Study|Lost to Follow-up|15|||
164654415|NCT00686920|594760696|FG001|Overall Study|Lost to Follow-up|3|||
164654416|NCT00686920|594760695|FG000|Overall Study|Moved to Another State|1|||
164654417|NCT00686920|594760696|FG001|Overall Study|Moved to Another State|0|||
164654418|NCT00686920|594760695|FG000|Overall Study|Transferred to Nursing Home|1|||
164654419|NCT00686920|594760696|FG001|Overall Study|Transferred to Nursing Home|0|||
164654420|NCT00686920|594760695|FG000|Overall Study|Noncompliance|9|||
164654421|NCT00686920|594760696|FG001|Overall Study|Noncompliance|0|||
164654422|NCT00686920|594760695|FG000|Overall Study|Principal Investigator Decision|2|||
164654423|NCT00686920|594760696|FG001|Overall Study|Principal Investigator Decision|0|||
164654424|NCT00814658|594760700|FG000|Overall Study|Lost to Follow-up|0|||
164654425|NCT00814658|594760701|FG001|Overall Study|Lost to Follow-up|1|||
164654426|NCT00814658|594760700|FG000|Overall Study|Physician Decision|1|||
164654427|NCT00814658|594760701|FG001|Overall Study|Physician Decision|0|||
164654428|NCT00814658|594760700|FG000|Overall Study|Adverse Event|3|||
164654429|NCT00814658|594760701|FG001|Overall Study|Adverse Event|3|||
164654430|NCT01141283|594760702|FG000|Overall Study|Adverse Event|56|||
164654431|NCT01141283|594760702|FG000|Overall Study|Lost to Follow-up|4|||
164654432|NCT01141283|594760702|FG000|Overall Study|Withdrawal by Subject|14|||
164654433|NCT01141283|594760702|FG000|Overall Study|Administrative|4|||
164654434|NCT01141283|594760702|FG000|Overall Study|Lack of Efficacy|10|||
164654435|NCT01208402|594760704|FG000|Overall Study|Withdrawal by Subject|1|||
164654436|NCT01208402|594760705|FG001|Overall Study|Withdrawal by Subject|0|||
164654437|NCT01571635|594760707|FG000|Overall Study|Adverse Event|3|||
164654438|NCT01571635|594760708|FG001|Overall Study|Adverse Event|0|||
164548321|NCT00492752|594379794|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
164548322|NCT00492752|594379795|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
164548323|NCT00492752|594379792|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
164654439|NCT01571635|594760709|FG002|Overall Study|Adverse Event|2|||
164654440|NCT01571635|594760710|FG003|Overall Study|Adverse Event|3|||
164548324|NCT00492752|594379793|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
164548325|NCT00492752|594379794|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
164654441|NCT01571635|594760711|FG004|Overall Study|Adverse Event|5|||
164548326|NCT00492752|594379795|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
164548327|NCT00492752|594379792|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
164654442|NCT01571635|594760707|FG000|Overall Study|Other reasons|2|||
164654443|NCT01571635|594760708|FG001|Overall Study|Other reasons|1|||
164654444|NCT01571635|594760709|FG002|Overall Study|Other reasons|2|||
164654445|NCT01571635|594760710|FG003|Overall Study|Other reasons|2|||
164654446|NCT01571635|594760711|FG004|Overall Study|Other reasons|1|||
164654447|NCT01571635|594760707|FG000|Overall Study|Study terminated by sponsor|0|||
164654448|NCT01571635|594760708|FG001|Overall Study|Study terminated by sponsor|4|||
164654449|NCT01571635|594760709|FG002|Overall Study|Study terminated by sponsor|1|||
164654450|NCT01571635|594760710|FG003|Overall Study|Study terminated by sponsor|3|||
164654451|NCT01571635|594760711|FG004|Overall Study|Study terminated by sponsor|1|||
164654452|NCT01571635|594760707|FG000|Overall Study|Withdrew consent|1|||
164654453|NCT01571635|594760708|FG001|Overall Study|Withdrew consent|1|||
164654454|NCT01571635|594760709|FG002|Overall Study|Withdrew consent|2|||
164654455|NCT01571635|594760710|FG003|Overall Study|Withdrew consent|3|||
164654456|NCT01571635|594760711|FG004|Overall Study|Withdrew consent|0|||
164654457|NCT01571635|594760707|FG000|Overall Study|Lack of Efficacy|0|||
164654458|NCT01571635|594760708|FG001|Overall Study|Lack of Efficacy|2|||
164654459|NCT01571635|594760709|FG002|Overall Study|Lack of Efficacy|0|||
164654460|NCT01571635|594760710|FG003|Overall Study|Lack of Efficacy|1|||
164654461|NCT01571635|594760711|FG004|Overall Study|Lack of Efficacy|2|||
164654462|NCT03210259|594760720|FG000|12-Week Run-in Period|Adverse Event|1|||
164654463|NCT03210259|594760721|FG001|12-Week Run-in Period|Adverse Event|0|||
164654464|NCT03210259|594760722|FG002|12-Week Run-in Period|Adverse Event|0|||
164654465|NCT03210259|594760720|FG000|12-Week Run-in Period|Death|1|||
164654466|NCT03210259|594760721|FG001|12-Week Run-in Period|Death|0|||
164654467|NCT03210259|594760722|FG002|12-Week Run-in Period|Death|0|||
164654468|NCT03210259|594760720|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
164654469|NCT03210259|594760721|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
164654470|NCT03210259|594760722|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
164654471|NCT03210259|594760720|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
164654472|NCT03210259|594760721|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
164654473|NCT03210259|594760722|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
164654474|NCT03210259|594760720|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
164654475|NCT03210259|594760721|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
164654476|NCT03210259|594760722|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
164654477|NCT03210259|594760720|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
164654478|NCT03210259|594760721|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
164654479|NCT03210259|594760722|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
164654480|NCT03210259|594760720|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
164654481|NCT03210259|594760721|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
164654482|NCT03210259|594760722|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
164654483|NCT03210259|594760720|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
164654484|NCT03210259|594760721|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
164654485|NCT03210259|594760722|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
164654486|NCT03210259|594760720|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
164654487|NCT03210259|594760721|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
164654488|NCT03210259|594760722|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
164654489|NCT03210259|594760720|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
164654490|NCT03210259|594760721|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
164654491|NCT03210259|594760722|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
164654492|NCT03210259|594760720|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
164654493|NCT03210259|594760721|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
164654494|NCT03210259|594760722|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
164654495|NCT05017493|594760723|FG000|Overall Study|Withdrawal by Subject|26|||
164654496|NCT05017493|594760724|FG001|Overall Study|Withdrawal by Subject|0|||
164654497|NCT05017493|594760723|FG000|Overall Study|Physician Decision|15|||
164654498|NCT05017493|594760724|FG001|Overall Study|Physician Decision|0|||
164654499|NCT05017493|594760723|FG000|Overall Study|Protocol Violation|81|||
164654500|NCT05017493|594760724|FG001|Overall Study|Protocol Violation|0|||
164654501|NCT03940586|594760725|FG000|Overall Study|Death|3|||
164654502|NCT03940586|594760726|FG001|Overall Study|Death|2|||
164654503|NCT03940586|594760727|FG002|Overall Study|Death|0|||
164654504|NCT03940586|594760725|FG000|Overall Study|Physician Decision|1|||
164654505|NCT03940586|594760726|FG001|Overall Study|Physician Decision|0|||
164654506|NCT03940586|594760727|FG002|Overall Study|Physician Decision|1|||
164654507|NCT03940586|594760725|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
164654508|NCT03940586|594760726|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
164654509|NCT03940586|594760727|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
164654510|NCT03940586|594760725|FG000|Overall Study|Not Treated|0|||
164654511|NCT03940586|594760726|FG001|Overall Study|Not Treated|2|||
164654512|NCT03940586|594760727|FG002|Overall Study|Not Treated|0|||
164654513|NCT00345683|594760730|FG000|Overall Study|Lost to Follow-up|19|||
164654514|NCT00345683|594760731|FG001|Overall Study|Lost to Follow-up|7|||
164654515|NCT00345683|594760730|FG000|Overall Study|Other|6|||
164654516|NCT00345683|594760731|FG001|Overall Study|Other|2|||
164654517|NCT01337050|594760732|FG000|Overall Study|Death|0|||
164654518|NCT01337050|594760733|FG001|Overall Study|Death|0|||
164654519|NCT01337050|594760734|FG002|Overall Study|Death|4|||
164654520|NCT01337050|594760732|FG000|Overall Study|Other|4|||
164654521|NCT01337050|594760733|FG001|Overall Study|Other|6|||
164654522|NCT01337050|594760734|FG002|Overall Study|Other|8|||
164654523|NCT01337050|594760732|FG000|Overall Study|Participants refused further follow-up|0|||
164654524|NCT01337050|594760733|FG001|Overall Study|Participants refused further follow-up|7|||
164654525|NCT01337050|594760734|FG002|Overall Study|Participants refused further follow-up|7|||
164654526|NCT00096486|594760735|FG000|Overall Study|Withdrawal by Subject|0|||
164654527|NCT00096486|594760736|FG001|Overall Study|Withdrawal by Subject|0|||
164654528|NCT00096486|594760737|FG002|Overall Study|Withdrawal by Subject|1|||
164654529|NCT00096486|594760738|FG003|Overall Study|Withdrawal by Subject|1|||
164654530|NCT00096486|594760735|FG000|Overall Study|Not Treated|0|||
164654531|NCT00096486|594760736|FG001|Overall Study|Not Treated|0|||
164654532|NCT00096486|594760737|FG002|Overall Study|Not Treated|1|||
164654533|NCT00096486|594760738|FG003|Overall Study|Not Treated|1|||
164654534|NCT04071626|594760739|FG000|Overall Study|Withdrawal by Subject|1|||
164654535|NCT04071626|594760740|FG001|Overall Study|Withdrawal by Subject|1|||
164654536|NCT04071626|594760739|FG000|Overall Study|Protocol Violation|0|||
164654537|NCT04071626|594760740|FG001|Overall Study|Protocol Violation|1|||
164654538|NCT00125359|594760741|FG000|Overall Study|Death|4|||
164654539|NCT00125359|594760741|FG000|Overall Study|Adverse Event|5|||
164654540|NCT00125359|594760741|FG000|Overall Study|Physician Decision|14|||
164654541|NCT01201356|594760742|FG000|Overall Study|Adverse Event|170|||
164654542|NCT01201356|594760742|FG000|Overall Study|Abnormal laboratory value(s)|51|||
164654543|NCT01201356|594760742|FG000|Overall Study|Abnormal test procedure result(s)|3|||
164654544|NCT01201356|594760742|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
164654545|NCT01201356|594760742|FG000|Overall Study|Condition no longer requires study drug|12|||
164654546|NCT01201356|594760742|FG000|Overall Study|Withdrawal by Subject|144|||
164654547|NCT01201356|594760742|FG000|Overall Study|Lost to Follow-up|50|||
164654548|NCT01201356|594760742|FG000|Overall Study|administrative problems|74|||
164654549|NCT01201356|594760742|FG000|Overall Study|Death|16|||
164654550|NCT01201356|594760742|FG000|Overall Study|Protocol Violation|12|||
164654551|NCT00585039|594760745|FG000|Overall Study|medication spilled|2|||
164654552|NCT00585039|594760746|FG001|Overall Study|medication spilled|0|||
164654553|NCT02173301|594760747|FG000|Overall Study|Adverse Event|7|||
164654554|NCT02173301|594760748|FG001|Overall Study|Adverse Event|8|||
164654555|NCT02173301|594760749|FG002|Overall Study|Adverse Event|13|||
164654556|NCT02173301|594760750|FG003|Overall Study|Adverse Event|5|||
164654557|NCT02173301|594760747|FG000|Overall Study|Withdrawal by Subject|8|||
164654558|NCT02173301|594760748|FG001|Overall Study|Withdrawal by Subject|10|||
164654559|NCT02173301|594760749|FG002|Overall Study|Withdrawal by Subject|4|||
164654560|NCT02173301|594760750|FG003|Overall Study|Withdrawal by Subject|8|||
164654561|NCT02173301|594760747|FG000|Overall Study|Lost to Follow-up|4|||
164654562|NCT02173301|594760748|FG001|Overall Study|Lost to Follow-up|4|||
164654563|NCT02173301|594760749|FG002|Overall Study|Lost to Follow-up|2|||
164654564|NCT02173301|594760750|FG003|Overall Study|Lost to Follow-up|2|||
164654565|NCT02173301|594760747|FG000|Overall Study|Protocol Violation|0|||
164654566|NCT02173301|594760748|FG001|Overall Study|Protocol Violation|1|||
164654567|NCT02173301|594760749|FG002|Overall Study|Protocol Violation|0|||
164654568|NCT02173301|594760750|FG003|Overall Study|Protocol Violation|0|||
164196532|NCT00810199|593087589|FG001|Overall Study|Insufficient therapeutic response|14|||
164196533|NCT00810199|593087588|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
164196534|NCT00810199|593087589|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
164196535|NCT00810199|593087588|FG000|Overall Study|Administrative/Other|5|||
164196536|NCT00810199|593087589|FG001|Overall Study|Administrative/Other|6|||
164196537|NCT00810199|593087588|FG000|Overall Study|Protocol Violation|2|||
164196538|NCT00810199|593087589|FG001|Overall Study|Protocol Violation|6|||
164196539|NCT00810199|593087588|FG000|Overall Study|Failure to return|1|||
164196540|NCT00810199|593087589|FG001|Overall Study|Failure to return|4|||
164196541|NCT00810199|593087588|FG000|Overall Study|Did not receive study drug|2|||
164196542|NCT00810199|593087589|FG001|Overall Study|Did not receive study drug|1|||
164196543|NCT00992017|593087590|FG000|Overall Study|Lost to Follow-up|2|||
164196544|NCT00992017|593087590|FG000|Overall Study|Withdrawal by Subject|2|||
164196545|NCT00992017|593087590|FG000|Overall Study|Unable to get to clinic|5|||
164196546|NCT00992017|593087590|FG000|Overall Study|Not adhere to study requirements|1|||
164196547|NCT01691378|593087591|FG000|Overall Study|Withdrawal by Subject|2|||
164654569|NCT02173301|594760747|FG000|Overall Study|Physician Decision|0|||
164654570|NCT02173301|594760748|FG001|Overall Study|Physician Decision|0|||
164654571|NCT02173301|594760749|FG002|Overall Study|Physician Decision|1|||
164654572|NCT02173301|594760750|FG003|Overall Study|Physician Decision|0|||
164654573|NCT02173301|594760747|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
164654574|NCT02173301|594760748|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
164654575|NCT02173301|594760749|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
164654576|NCT02173301|594760750|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
164307251|NCT02023697|593499223|FG000|Long-term Follow-up Period|Technical problems|0|||
164654577|NCT04147611|594760751|FG000|Overall Study|Physician Decision|0|||
164654578|NCT04147611|594760752|FG001|Overall Study|Physician Decision|1|||
164654579|NCT01585831|594760755|FG000|Overall Study|Physician Decision|0|||
164654580|NCT01585831|594760756|FG001|Overall Study|Physician Decision|1|||
164654581|NCT01585831|594760755|FG000|Overall Study|Withdrawal by Subject|2|||
164654582|NCT01585831|594760756|FG001|Overall Study|Withdrawal by Subject|1|||
164654583|NCT01123980|594760757|FG000|Overall Study|Adverse Event|1|||
164654584|NCT01123980|594760758|FG001|Overall Study|Adverse Event|1|||
164654585|NCT01123980|594760757|FG000|Overall Study|Lack of Efficacy|1|||
164654586|NCT01123980|594760758|FG001|Overall Study|Lack of Efficacy|0|||
164654587|NCT01123980|594760757|FG000|Overall Study|Physician Decision|0|||
164654588|NCT01123980|594760758|FG001|Overall Study|Physician Decision|1|||
164654589|NCT01123980|594760757|FG000|Overall Study|Lost to Follow-up|0|||
164654590|NCT01123980|594760758|FG001|Overall Study|Lost to Follow-up|6|||
164654591|NCT01123980|594760757|FG000|Overall Study|Protocol Violation|6|||
164654592|NCT01123980|594760758|FG001|Overall Study|Protocol Violation|6|||
164654593|NCT01123980|594760757|FG000|Overall Study|Withdrawal by Subject|5|||
164548328|NCT00492752|594379793|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
164548329|NCT00492752|594379794|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
164548330|NCT00492752|594379795|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
164548331|NCT00492752|594379792|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
164548332|NCT00492752|594379793|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
164548333|NCT00492752|594379794|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
164548334|NCT00492752|594379795|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
164548335|NCT00492752|594379792|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
164548336|NCT00492752|594379793|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
164548337|NCT00492752|594379794|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
164548338|NCT00492752|594379795|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
164548339|NCT00492752|594379792|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
164548340|NCT00492752|594379793|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
164548341|NCT00492752|594379794|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
164548342|NCT00492752|594379795|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
164548343|NCT00492752|594379792|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
164548344|NCT00492752|594379793|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
164548345|NCT00492752|594379794|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
164548346|NCT00492752|594379795|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
164548347|NCT02321930|594379799|FG000|Overall Study|Lost to Follow-up|1|||
164548348|NCT04649255|594381284|FG000|Overall Study|Death|9|||
164548349|NCT04649255|594381284|FG000|Overall Study|Withdrawal by Subject|1|||
164548350|NCT01652885|594381285|FG000|Overall Study|Adverse Event|1|||
164548351|NCT03723707|594381286|FG000|Overall Study|Death|32|||
164548352|NCT03723707|594381287|FG001|Overall Study|Death|32|||
164548353|NCT03723707|594381286|FG000|Overall Study|Admitted to long term care|12|||
164548354|NCT03723707|594381287|FG001|Overall Study|Admitted to long term care|12|||
164548355|NCT03723707|594381286|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
164548356|NCT03723707|594381287|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
164548357|NCT03723707|594381286|FG000|Overall Study|Lost to Follow-up|40|||
164548358|NCT03723707|594381287|FG001|Overall Study|Lost to Follow-up|22|||
164548359|NCT03723707|594381286|FG000|Overall Study|Discontinued after study closure|24|||
164548360|NCT03723707|594381287|FG001|Overall Study|Discontinued after study closure|12|||
164548361|NCT00075023|594381288|FG000|Pilot Study|Physician Decision|1|||
164654594|NCT01123980|594760758|FG001|Overall Study|Withdrawal by Subject|3|||
164654595|NCT01123980|594760757|FG000|Overall Study|Unclassified|6|||
164654596|NCT01123980|594760758|FG001|Overall Study|Unclassified|7|||
164654597|NCT01225991|594760759|FG000|Overall Study|Withdrawal by Subject|6|||
164654598|NCT04079842|594760760|FG000|Overall Study|Request of subject|2|||
164654599|NCT04079842|594760760|FG000|Overall Study|Unable to draw Arterial samples|1|||
164654600|NCT02904200|594760761|FG000|Overall Study|Withdrawal by Subject|1|||
164654601|NCT02904200|594760762|FG001|Overall Study|Withdrawal by Subject|0|||
164307252|NCT02023697|593499224|FG001|Long-term Follow-up Period|Technical problems|0|||
164548362|NCT00075023|594381289|FG001|Pilot Study|Physician Decision|2|||
164548363|NCT00075023|594381288|FG000|Pilot Study|Withdrawal by Subject|1|||
164548364|NCT00075023|594381289|FG001|Pilot Study|Withdrawal by Subject|0|||
164548365|NCT04342871|594381290|FG000|Overall Study|Death|4|||
164548366|NCT04342871|594381290|FG000|Overall Study|Clinical deterioration/illness progression|2|||
164548367|NCT04342871|594381290|FG000|Overall Study|Did not complete baseline assessments|5|||
164548368|NCT04342871|594381290|FG000|Overall Study|Lost to Follow-up|13|||
164654602|NCT02133352|594760763|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
164654603|NCT04444752|594760764|FG000|Overall Study|Adverse Event|1|||
164654604|NCT04444752|594760765|FG001|Overall Study|Adverse Event|0|||
164654605|NCT04444752|594760766|FG002|Overall Study|Adverse Event|0|||
164654606|NCT04444752|594760767|FG003|Overall Study|Adverse Event|2|||
164196548|NCT01691378|593087592|FG001|Overall Study|Withdrawal by Subject|0|||
164548369|NCT01429584|594381292|FG000|Overall Study|Withdrawal by Subject|1|||
164548370|NCT01429584|594381293|FG001|Overall Study|Withdrawal by Subject|0|||
164548371|NCT01429584|594381292|FG000|Overall Study|Protocol Violation|0|||
164548372|NCT01429584|594381293|FG001|Overall Study|Protocol Violation|1|||
164548373|NCT01773109|594381294|FG000|Overall Study|Symptomatic Progression|2|||
164548374|NCT01773109|594381294|FG000|Overall Study|Death|1|||
164548375|NCT01239342|594381295|FG000|Overall Study|Adverse Event|1|||
164548376|NCT01239342|594381296|FG001|Overall Study|Adverse Event|0|||
164548377|NCT01239342|594381295|FG000|Overall Study|Withdrawal by Subject|1|||
164548378|NCT01239342|594381296|FG001|Overall Study|Withdrawal by Subject|5|||
164548379|NCT01239342|594381295|FG000|Overall Study|Reason Unknown|1|||
164548380|NCT01239342|594381296|FG001|Overall Study|Reason Unknown|1|||
164548381|NCT04766021|594381297|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
164548382|NCT04766021|594381297|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
164548383|NCT02634151|594381298|FG000|Overall Study|Withdrawal by Subject|1|||
164548384|NCT02634151|594381299|FG001|Overall Study|Withdrawal by Subject|0|||
164548385|NCT02634151|594381298|FG000|Overall Study|Non-Compliance|0|||
164548386|NCT02634151|594381299|FG001|Overall Study|Non-Compliance|1|||
164196549|NCT01691378|593087591|FG000|Overall Study|Lost to Follow-up|5|||
164196550|NCT01691378|593087592|FG001|Overall Study|Lost to Follow-up|2|||
164196551|NCT01107925|593087597|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
164196552|NCT01107925|593087598|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
164196553|NCT01107925|593087599|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
164196554|NCT01107925|593087600|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
164196555|NCT01107925|593087601|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
164196556|NCT01107925|593087602|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
164196557|NCT01107925|593087597|FG000|Period 2|Withdrawal by Subject|0|||
164196558|NCT01107925|593087598|FG001|Period 2|Withdrawal by Subject|1|||
164196559|NCT01107925|593087599|FG002|Period 2|Withdrawal by Subject|0|||
164196560|NCT01107925|593087600|FG003|Period 2|Withdrawal by Subject|0|||
164196561|NCT01107925|593087601|FG004|Period 2|Withdrawal by Subject|0|||
164196562|NCT01107925|593087602|FG005|Period 2|Withdrawal by Subject|1|||
164196563|NCT04235504|593087603|FG000|Study Phase|Withdrawal by Subject|5|||
164196564|NCT04235504|593087604|FG001|Study Phase|Withdrawal by Subject|2|||
164196565|NCT04235504|593087605|FG002|Study Phase|Withdrawal by Subject|0|||
164196566|NCT04235504|593087606|FG003|Study Phase|Withdrawal by Subject|0|||
164196567|NCT04235504|593087603|FG000|Continuation Phase|Withdrawal by Subject|0|||
164196568|NCT04235504|593087604|FG001|Continuation Phase|Withdrawal by Subject|4|||
164196569|NCT04235504|593087605|FG002|Continuation Phase|Withdrawal by Subject|0|||
164196570|NCT04235504|593087606|FG003|Continuation Phase|Withdrawal by Subject|0|||
164196571|NCT04235504|593087603|FG000|Continuation Phase|Adverse Event|0|||
164196572|NCT04235504|593087604|FG001|Continuation Phase|Adverse Event|1|||
164196573|NCT04235504|593087605|FG002|Continuation Phase|Adverse Event|0|||
164196574|NCT04235504|593087606|FG003|Continuation Phase|Adverse Event|0|||
164196575|NCT04235504|593087603|FG000|Continuation Phase|Physician Decision|1|||
164548387|NCT02634151|594381298|FG000|Overall Study|Other|0|||
164548388|NCT02634151|594381299|FG001|Overall Study|Other|1|||
164548389|NCT00003535|594381300|FG000|Overall Study|Not evaluable|5|||
164548390|NCT01849874|594381301|FG000|Overall Study|Death|89|||
164548391|NCT01849874|594381302|FG001|Overall Study|Death|42|||
164548392|NCT01849874|594381301|FG000|Overall Study|Withdrawal by Subject|17|||
164548393|NCT01849874|594381302|FG001|Overall Study|Withdrawal by Subject|16|||
164548394|NCT01849874|594381301|FG000|Overall Study|Lost to Follow-up|3|||
164548395|NCT01849874|594381302|FG001|Overall Study|Lost to Follow-up|2|||
164548396|NCT01849874|594381301|FG000|Overall Study|Study Termination By Sponsor|93|||
164548397|NCT01849874|594381302|FG001|Overall Study|Study Termination By Sponsor|48|||
164548398|NCT01849874|594381301|FG000|Overall Study|Completed as per protocol amendment 6|3|||
164548399|NCT01849874|594381302|FG001|Overall Study|Completed as per protocol amendment 6|0|||
164548400|NCT01849874|594381301|FG000|Overall Study|Physician Decision|7|||
164548401|NCT01849874|594381302|FG001|Overall Study|Physician Decision|1|||
164548402|NCT01849874|594381301|FG000|Overall Study|Other|16|||
164548403|NCT01849874|594381302|FG001|Overall Study|Other|4|||
164548404|NCT02104583|594381303|FG000|Overall Study|New ICD or CRT-D implanted|2|||
164548405|NCT02104583|594381304|FG001|Overall Study|New ICD or CRT-D implanted|0|||
164548406|NCT02104583|594381305|FG002|Overall Study|New ICD or CRT-D implanted|1|||
164654607|NCT04444752|594760764|FG000|Overall Study|Lost to Follow-up|2|||
164196576|NCT04235504|593087604|FG001|Continuation Phase|Physician Decision|2|||
164196577|NCT04235504|593087605|FG002|Continuation Phase|Physician Decision|1|||
164196578|NCT04235504|593087606|FG003|Continuation Phase|Physician Decision|0|||
164196579|NCT04877990|593087607|FG000|Treatment|Other reasons|3|||
164196580|NCT04877990|593087608|FG001|Treatment|Other reasons|1|||
164548407|NCT02104583|594381306|FG003|Overall Study|New ICD or CRT-D implanted|0|||
164548408|NCT02104583|594381307|FG004|Overall Study|New ICD or CRT-D implanted|0|||
164548409|NCT02104583|594381303|FG000|Overall Study|Death|2|||
164548410|NCT02104583|594381304|FG001|Overall Study|Death|1|||
164548411|NCT02104583|594381305|FG002|Overall Study|Death|3|||
164196581|NCT04877990|593087607|FG000|Treatment|Administrative reasons by sponsor|17|||
164196582|NCT04877990|593087608|FG001|Treatment|Administrative reasons by sponsor|33|||
164196583|NCT04877990|593087607|FG000|Treatment|Withdrawal by Subject|2|||
164196584|NCT04877990|593087608|FG001|Treatment|Withdrawal by Subject|6|||
164196585|NCT04877990|593087607|FG000|Treatment|Adverse Event|2|||
164196586|NCT04877990|593087608|FG001|Treatment|Adverse Event|1|||
164196587|NCT01817075|593087610|FG000|Overall Study|Adverse Event|7|||
164196588|NCT01817075|593087611|FG001|Overall Study|Adverse Event|5|||
164196589|NCT01817075|593087610|FG000|Overall Study|Physician Decision|9|||
164196590|NCT01817075|593087611|FG001|Overall Study|Physician Decision|12|||
164548412|NCT02104583|594381306|FG003|Overall Study|Death|3|||
164548413|NCT02104583|594381307|FG004|Overall Study|Death|5|||
164548414|NCT02104583|594381303|FG000|Overall Study|Subject required cardiac ablation|6|||
164548415|NCT02104583|594381304|FG001|Overall Study|Subject required cardiac ablation|4|||
164548416|NCT02104583|594381305|FG002|Overall Study|Subject required cardiac ablation|4|||
164548417|NCT02104583|594381306|FG003|Overall Study|Subject required cardiac ablation|5|||
164548418|NCT02104583|594381307|FG004|Overall Study|Subject required cardiac ablation|4|||
164548419|NCT02104583|594381303|FG000|Overall Study|Subject required prohibited medication|0|||
164548420|NCT02104583|594381304|FG001|Overall Study|Subject required prohibited medication|1|||
164548421|NCT02104583|594381305|FG002|Overall Study|Subject required prohibited medication|1|||
164548422|NCT02104583|594381306|FG003|Overall Study|Subject required prohibited medication|0|||
164548423|NCT02104583|594381307|FG004|Overall Study|Subject required prohibited medication|1|||
164548424|NCT02104583|594381303|FG000|Overall Study|Withdrew Consent|3|||
164548425|NCT02104583|594381304|FG001|Overall Study|Withdrew Consent|2|||
164548426|NCT02104583|594381305|FG002|Overall Study|Withdrew Consent|0|||
164548427|NCT02104583|594381306|FG003|Overall Study|Withdrew Consent|2|||
164548428|NCT02104583|594381307|FG004|Overall Study|Withdrew Consent|1|||
164548429|NCT02104583|594381303|FG000|Overall Study|Investigator's Discretion|1|||
164548430|NCT02104583|594381304|FG001|Overall Study|Investigator's Discretion|0|||
164548431|NCT02104583|594381305|FG002|Overall Study|Investigator's Discretion|0|||
164548432|NCT02104583|594381306|FG003|Overall Study|Investigator's Discretion|0|||
164548433|NCT02104583|594381307|FG004|Overall Study|Investigator's Discretion|0|||
164548434|NCT02104583|594381303|FG000|Overall Study|Protocol Violation|0|||
164548435|NCT02104583|594381304|FG001|Overall Study|Protocol Violation|0|||
164548436|NCT02104583|594381305|FG002|Overall Study|Protocol Violation|1|||
164548437|NCT02104583|594381306|FG003|Overall Study|Protocol Violation|0|||
164548438|NCT02104583|594381307|FG004|Overall Study|Protocol Violation|0|||
164548439|NCT02104583|594381303|FG000|Overall Study|Adverse Event|3|||
164548440|NCT02104583|594381304|FG001|Overall Study|Adverse Event|3|||
164548441|NCT02104583|594381305|FG002|Overall Study|Adverse Event|6|||
164548442|NCT02104583|594381306|FG003|Overall Study|Adverse Event|6|||
164548443|NCT02104583|594381307|FG004|Overall Study|Adverse Event|1|||
164548444|NCT02104583|594381303|FG000|Overall Study|Lost to Follow-up|1|||
164548445|NCT02104583|594381304|FG001|Overall Study|Lost to Follow-up|0|||
164548446|NCT02104583|594381305|FG002|Overall Study|Lost to Follow-up|0|||
164548447|NCT02104583|594381306|FG003|Overall Study|Lost to Follow-up|0|||
164548448|NCT02104583|594381307|FG004|Overall Study|Lost to Follow-up|0|||
164548449|NCT02104583|594381303|FG000|Overall Study|Randomized but Never Treated|0|||
164548450|NCT02104583|594381304|FG001|Overall Study|Randomized but Never Treated|0|||
164548451|NCT02104583|594381305|FG002|Overall Study|Randomized but Never Treated|0|||
164548452|NCT02104583|594381306|FG003|Overall Study|Randomized but Never Treated|1|||
164548453|NCT02104583|594381307|FG004|Overall Study|Randomized but Never Treated|0|||
164548454|NCT02347098|594381309|FG000|Overall Study|Death|1|||
164548455|NCT02347098|594381310|FG001|Overall Study|Death|0|||
164548456|NCT02347098|594381309|FG000|Overall Study|Withdrawal by Subject|1|||
164548457|NCT02347098|594381310|FG001|Overall Study|Withdrawal by Subject|0|||
164548458|NCT02347098|594381309|FG000|Overall Study|Lost to Follow-up|2|||
164548459|NCT02347098|594381310|FG001|Overall Study|Lost to Follow-up|2|||
164548460|NCT02347098|594381309|FG000|Overall Study|Refuse Follow-up Visit|1|||
164548461|NCT02347098|594381310|FG001|Overall Study|Refuse Follow-up Visit|5|||
164548462|NCT02347098|594381309|FG000|Overall Study|no visit due to illness|2|||
164548463|NCT02347098|594381310|FG001|Overall Study|no visit due to illness|1|||
164548464|NCT04640272|594381311|FG000|Overall Study|Subject moved out of area|1|||
164548465|NCT02535715|594381315|FG000|Overall Study|Withdrawal by Subject|0|||
164548466|NCT02535715|594381316|FG001|Overall Study|Withdrawal by Subject|0|||
164548467|NCT02535715|594381317|FG002|Overall Study|Withdrawal by Subject|1|||
164548468|NCT04353284|594381318|FG000|Overall Study|Adverse Event|1|||
164548469|NCT04353284|594381319|FG001|Overall Study|Adverse Event|1|||
164196591|NCT01817075|593087610|FG000|Overall Study|Withdrawal by Subject|31|||
164548470|NCT04353284|594381318|FG000|Overall Study|Lost to Follow-up|1|||
164548471|NCT04353284|594381319|FG001|Overall Study|Lost to Follow-up|0|||
164548472|NCT01476475|594381321|FG000|Overall Study|Adverse Event|6|||
164548473|NCT01476475|594381322|FG001|Overall Study|Adverse Event|0|||
164548474|NCT01476475|594381321|FG000|Overall Study|Poor compliance to protocol|1|||
164548475|NCT01476475|594381322|FG001|Overall Study|Poor compliance to protocol|1|||
164548476|NCT01476475|594381321|FG000|Overall Study|Other reasons|4|||
164654608|NCT04444752|594760765|FG001|Overall Study|Lost to Follow-up|6|||
164548477|NCT01476475|594381322|FG001|Overall Study|Other reasons|2|||
164548478|NCT01372384|594381324|FG000|Overall Study|Progression of disease|3|||
164548479|NCT00441974|594381328|FG000|Overall Study|Adverse Event|6|||
164548480|NCT00441974|594381328|FG000|Overall Study|Consent Withdrawn|35|||
164548481|NCT00441974|594381328|FG000|Overall Study|Lost to Follow-up|80|||
164548482|NCT00441974|594381328|FG000|Overall Study|Protocol Violation|7|||
164548483|NCT02576444|594381329|FG000|Overall Study|Death|1|||
164548484|NCT02576444|594381330|FG001|Overall Study|Death|1|||
164548485|NCT02576444|594381331|FG002|Overall Study|Death|0|||
164548486|NCT02576444|594381332|FG003|Overall Study|Death|0|||
164548487|NCT02576444|594381329|FG000|Overall Study|Withdrawal by Subject|0|||
164548488|NCT02576444|594381330|FG001|Overall Study|Withdrawal by Subject|0|||
164548489|NCT02576444|594381331|FG002|Overall Study|Withdrawal by Subject|2|||
164548490|NCT02576444|594381332|FG003|Overall Study|Withdrawal by Subject|0|||
164548491|NCT02576444|594381329|FG000|Overall Study|Adverse Event|0|||
164548492|NCT02576444|594381330|FG001|Overall Study|Adverse Event|0|||
164548493|NCT02576444|594381331|FG002|Overall Study|Adverse Event|1|||
164548494|NCT02576444|594381332|FG003|Overall Study|Adverse Event|0|||
164548495|NCT02576444|594381329|FG000|Overall Study|Physician Decision|0|||
164548496|NCT02576444|594381330|FG001|Overall Study|Physician Decision|0|||
164548497|NCT02576444|594381331|FG002|Overall Study|Physician Decision|1|||
164548498|NCT02576444|594381332|FG003|Overall Study|Physician Decision|0|||
164548499|NCT03370120|594381338|FG000|Overall Study|Adverse event, non-fatal|24|||
164548500|NCT03370120|594381338|FG000|Overall Study|Withdrawal by Subject|6|||
164548501|NCT03370120|594381338|FG000|Overall Study|Lost to Follow-up|1|||
164548502|NCT03370120|594381338|FG000|Overall Study|Lack of Efficacy|37|||
164548503|NCT03370120|594381338|FG000|Overall Study|Per sponsor's instructions|1|||
164548504|NCT03370120|594381338|FG000|Overall Study|Study was terminated by parent company UCB|2|||
164548505|NCT03370120|594381338|FG000|Overall Study|The study was ended by the promoter|3|||
164548506|NCT03370120|594381338|FG000|Overall Study|Discontinuation of drug development|3|||
164548507|NCT03370120|594381338|FG000|Overall Study|End of project|2|||
164548508|NCT03370120|594381338|FG000|Overall Study|Premature study closure|2|||
164548509|NCT03370120|594381338|FG000|Overall Study|Premature program termination|1|||
164548510|NCT03370120|594381338|FG000|Overall Study|Premature study termination|7|||
164548511|NCT03370120|594381338|FG000|Overall Study|Trial terminated by sponsor|2|||
164548512|NCT03370120|594381338|FG000|Overall Study|Trial discontinued by sponsor|2|||
164548513|NCT03370120|594381338|FG000|Overall Study|Study ended|15|||
164548514|NCT03370120|594381338|FG000|Overall Study|Clinical trial has been cancelled|1|||
164548515|NCT03370120|594381338|FG000|Overall Study|End of study per sponsor decision|2|||
164548516|NCT03370120|594381338|FG000|Overall Study|Promoter's decision|2|||
164548517|NCT03370120|594381338|FG000|Overall Study|The trial has been suspended|3|||
164548518|NCT03370120|594381338|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
164548519|NCT03370120|594381338|FG000|Overall Study|Early termination by order of sponsor|2|||
164548520|NCT03370120|594381338|FG000|Overall Study|Discontinuation of the study|5|||
164548521|NCT03370120|594381338|FG000|Overall Study|End of clinical trial discontinuation|1|||
164548522|NCT03370120|594381338|FG000|Overall Study|Because the clinical trial ended halfway|4|||
164196592|NCT01817075|593087611|FG001|Overall Study|Withdrawal by Subject|15|||
164196593|NCT01817075|593087610|FG000|Overall Study|Received Sorafenib after enrollment|0|||
164196594|NCT01817075|593087611|FG001|Overall Study|Received Sorafenib after enrollment|1|||
164196595|NCT01817075|593087610|FG000|Overall Study|Ineligible|0|||
164196596|NCT01817075|593087611|FG001|Overall Study|Ineligible|2|||
164196597|NCT04888494|593087612|FG000|Overall Study|Lost to Follow-up|2|||
164196598|NCT04888494|593087613|FG001|Overall Study|Lost to Follow-up|3|||
164196599|NCT04888494|593087612|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
164196600|NCT04888494|593087613|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
164196601|NCT01699750|593089833|FG000|Overall Study|Withdrew Consent|0|||
164196602|NCT01699750|593089834|FG001|Overall Study|Withdrew Consent|1|||
164196603|NCT01699750|593089833|FG000|Overall Study|Other|0|||
164196604|NCT01699750|593089834|FG001|Overall Study|Other|2|||
164196605|NCT01868646|593089837|FG000|Overall Study|Do not meet inclusion criteria|3|||
164196606|NCT01868646|593089838|FG001|Overall Study|Do not meet inclusion criteria|5|||
164196607|NCT01831427|593089839|FG000|Overall Study|Adverse Event|0|||
164196608|NCT01831427|593089840|FG001|Overall Study|Adverse Event|1|||
164196609|NCT01831427|593089841|FG002|Overall Study|Adverse Event|0|||
164548523|NCT03370120|594381338|FG000|Overall Study|Development discontinued|5|||
164548524|NCT03370120|594381338|FG000|Overall Study|Padsenovil program closed|3|||
164548525|NCT03370120|594381338|FG000|Overall Study|End of project|2|||
164548526|NCT03370120|594381338|FG000|Overall Study|Termination of project|1|||
164548527|NCT03370120|594381338|FG000|Overall Study|The study was interrupted by sponsor|4|||
164548528|NCT03370120|594381338|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
164196610|NCT01831427|593089842|FG003|Overall Study|Adverse Event|0|||
164196611|NCT01831427|593089843|FG004|Overall Study|Adverse Event|0|||
164196612|NCT01831427|593089844|FG005|Overall Study|Adverse Event|1|||
164548529|NCT03370120|594381338|FG000|Overall Study|End of sponsor decision|1|||
164548530|NCT03370120|594381338|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
164548531|NCT03370120|594381338|FG000|Overall Study|Early termination of studies|5|||
164654609|NCT04444752|594760766|FG002|Overall Study|Lost to Follow-up|2|||
164654610|NCT04444752|594760767|FG003|Overall Study|Lost to Follow-up|5|||
164654611|NCT04444752|594760764|FG000|Overall Study|Physician Decision|0|||
164654612|NCT04444752|594760765|FG001|Overall Study|Physician Decision|0|||
164654613|NCT04444752|594760766|FG002|Overall Study|Physician Decision|0|||
164654614|NCT04444752|594760767|FG003|Overall Study|Physician Decision|2|||
164654615|NCT04444752|594760764|FG000|Overall Study|Pregnancy|0|||
164654616|NCT04444752|594760765|FG001|Overall Study|Pregnancy|0|||
164654617|NCT04444752|594760766|FG002|Overall Study|Pregnancy|0|||
164654618|NCT04444752|594760767|FG003|Overall Study|Pregnancy|1|||
164654619|NCT04444752|594760764|FG000|Overall Study|Withdrawal by Subject|6|||
164654620|NCT04444752|594760765|FG001|Overall Study|Withdrawal by Subject|5|||
164654621|NCT04444752|594760766|FG002|Overall Study|Withdrawal by Subject|3|||
164654622|NCT04444752|594760767|FG003|Overall Study|Withdrawal by Subject|4|||
164654623|NCT04444752|594760764|FG000|Overall Study|Protocol Violation|1|||
164654624|NCT04444752|594760765|FG001|Overall Study|Protocol Violation|1|||
164654625|NCT04444752|594760766|FG002|Overall Study|Protocol Violation|0|||
164654626|NCT04444752|594760767|FG003|Overall Study|Protocol Violation|0|||
164654627|NCT04444752|594760764|FG000|Overall Study|Patient moving out of town|1|||
164654628|NCT04444752|594760765|FG001|Overall Study|Patient moving out of town|0|||
164654629|NCT04444752|594760766|FG002|Overall Study|Patient moving out of town|0|||
164654630|NCT04444752|594760767|FG003|Overall Study|Patient moving out of town|1|||
164654631|NCT04444752|594760764|FG000|Overall Study|Lack of Efficacy|0|||
164654632|NCT04444752|594760765|FG001|Overall Study|Lack of Efficacy|0|||
164654633|NCT04444752|594760766|FG002|Overall Study|Lack of Efficacy|0|||
164654634|NCT04444752|594760767|FG003|Overall Study|Lack of Efficacy|1|||
164654635|NCT04444752|594760764|FG000|Overall Study|Death|0|||
164654636|NCT04444752|594760765|FG001|Overall Study|Death|0|||
164654637|NCT04444752|594760766|FG002|Overall Study|Death|1|||
164654638|NCT04444752|594760767|FG003|Overall Study|Death|0|||
164654639|NCT00579254|594760768|FG000|Overall Study|Lost to Follow-up|39|||
164654640|NCT00579254|594760768|FG000|Overall Study|Discontinued when study terminated|73|||
164654641|NCT02557672|594760769|FG000|Overall Study|Withdrawal by Subject|4|||
164654642|NCT02557672|594760770|FG001|Overall Study|Withdrawal by Subject|2|||
164654643|NCT03705169|594760771|FG000|Overall Study|Lost to Follow-up|0|||
164654644|NCT03705169|594760772|FG001|Overall Study|Lost to Follow-up|0|||
164654645|NCT03705169|594760773|FG002|Overall Study|Lost to Follow-up|0|||
164654646|NCT03705169|594760774|FG003|Overall Study|Lost to Follow-up|2|||
164654647|NCT03705169|594760775|FG004|Overall Study|Lost to Follow-up|0|||
164654648|NCT03705169|594760776|FG005|Overall Study|Lost to Follow-up|2|||
164654649|NCT03705169|594760777|FG006|Overall Study|Lost to Follow-up|1|||
164654650|NCT03705169|594760778|FG007|Overall Study|Lost to Follow-up|0|||
164654651|NCT03705169|594760779|FG008|Overall Study|Lost to Follow-up|0|||
164654652|NCT03705169|594760780|FG009|Overall Study|Lost to Follow-up|1|||
164654653|NCT03705169|594760771|FG000|Overall Study|Adverse Event|0|||
164654654|NCT03705169|594760772|FG001|Overall Study|Adverse Event|0|||
164654655|NCT03705169|594760773|FG002|Overall Study|Adverse Event|0|||
164654656|NCT03705169|594760774|FG003|Overall Study|Adverse Event|1|||
164654657|NCT03705169|594760775|FG004|Overall Study|Adverse Event|0|||
164654658|NCT03705169|594760776|FG005|Overall Study|Adverse Event|0|||
164654659|NCT03705169|594760777|FG006|Overall Study|Adverse Event|0|||
164654660|NCT03705169|594760778|FG007|Overall Study|Adverse Event|0|||
164654661|NCT03705169|594760779|FG008|Overall Study|Adverse Event|0|||
164654662|NCT03705169|594760780|FG009|Overall Study|Adverse Event|0|||
164654663|NCT03705169|594760771|FG000|Overall Study|Site Closure|0|||
164654664|NCT03705169|594760772|FG001|Overall Study|Site Closure|0|||
164654665|NCT03705169|594760773|FG002|Overall Study|Site Closure|0|||
164654666|NCT03705169|594760774|FG003|Overall Study|Site Closure|1|||
164654667|NCT03705169|594760775|FG004|Overall Study|Site Closure|0|||
164654668|NCT03705169|594760776|FG005|Overall Study|Site Closure|0|||
164654669|NCT03705169|594760777|FG006|Overall Study|Site Closure|0|||
164654670|NCT03705169|594760778|FG007|Overall Study|Site Closure|0|||
164654671|NCT03705169|594760779|FG008|Overall Study|Site Closure|0|||
164654672|NCT03705169|594760780|FG009|Overall Study|Site Closure|0|||
164654673|NCT03705169|594760771|FG000|Overall Study|Did not receive study treatment|0|||
164654674|NCT03705169|594760772|FG001|Overall Study|Did not receive study treatment|0|||
164307253|NCT02023697|593499225|FG002|Long-term Follow-up Period|Technical problems|1|||
164654675|NCT03705169|594760773|FG002|Overall Study|Did not receive study treatment|0|||
164654676|NCT03705169|594760774|FG003|Overall Study|Did not receive study treatment|1|||
164654677|NCT03705169|594760775|FG004|Overall Study|Did not receive study treatment|0|||
164654678|NCT03705169|594760776|FG005|Overall Study|Did not receive study treatment|0|||
164654679|NCT03705169|594760777|FG006|Overall Study|Did not receive study treatment|0|||
164654680|NCT03705169|594760778|FG007|Overall Study|Did not receive study treatment|0|||
164654681|NCT03705169|594760779|FG008|Overall Study|Did not receive study treatment|0|||
164654682|NCT03705169|594760780|FG009|Overall Study|Did not receive study treatment|0|||
164654683|NCT03705169|594760771|FG000|Overall Study|Concerns about study visit compliance|0|||
164654684|NCT03705169|594760772|FG001|Overall Study|Concerns about study visit compliance|0|||
164654685|NCT03705169|594760773|FG002|Overall Study|Concerns about study visit compliance|0|||
164654686|NCT03705169|594760774|FG003|Overall Study|Concerns about study visit compliance|1|||
164654687|NCT03705169|594760775|FG004|Overall Study|Concerns about study visit compliance|0|||
164654688|NCT03705169|594760776|FG005|Overall Study|Concerns about study visit compliance|0|||
164654689|NCT03705169|594760777|FG006|Overall Study|Concerns about study visit compliance|0|||
164654690|NCT03705169|594760778|FG007|Overall Study|Concerns about study visit compliance|0|||
164654691|NCT03705169|594760779|FG008|Overall Study|Concerns about study visit compliance|0|||
164654692|NCT03705169|594760780|FG009|Overall Study|Concerns about study visit compliance|0|||
164654693|NCT02038634|594762934|FG000|Overall Study|Lost to Follow-up|0|||
164654694|NCT02038634|594762935|FG001|Overall Study|Lost to Follow-up|1|||
164654695|NCT01764854|594762946|FG000|Overall Study|Adverse Event|0|||
164654696|NCT01764854|594762947|FG001|Overall Study|Adverse Event|0|||
164654697|NCT01764854|594762948|FG002|Overall Study|Adverse Event|2|||
164654698|NCT01764854|594762949|FG003|Overall Study|Adverse Event|0|||
164654699|NCT01764854|594762946|FG000|Overall Study|Withdrawal by Subject|0|||
164654700|NCT01764854|594762947|FG001|Overall Study|Withdrawal by Subject|0|||
164654701|NCT01764854|594762948|FG002|Overall Study|Withdrawal by Subject|1|||
164654702|NCT01764854|594762949|FG003|Overall Study|Withdrawal by Subject|0|||
164654703|NCT01764854|594762946|FG000|Overall Study|relocation|0|||
164654704|NCT01764854|594762947|FG001|Overall Study|relocation|0|||
164654705|NCT01764854|594762948|FG002|Overall Study|relocation|2|||
164654706|NCT01764854|594762949|FG003|Overall Study|relocation|0|||
164654707|NCT01764854|594762946|FG000|Overall Study|Protocol Violation|0|||
164654708|NCT01764854|594762947|FG001|Overall Study|Protocol Violation|0|||
164654709|NCT01764854|594762948|FG002|Overall Study|Protocol Violation|1|||
164654710|NCT01764854|594762949|FG003|Overall Study|Protocol Violation|2|||
164654711|NCT01381900|594762950|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
164654712|NCT01381900|594762951|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
164654713|NCT01381900|594762952|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
164654714|NCT01381900|594762950|FG000|Overall Study|Adverse Event|4|||
164654715|NCT01381900|594762951|FG001|Overall Study|Adverse Event|6|||
164548532|NCT03370120|594381338|FG000|Overall Study|This study is ended early|1|||
164548533|NCT03370120|594381338|FG000|Overall Study|End of padsevonil program|2|||
164548534|NCT03370120|594381338|FG000|Overall Study|Decision of sponsor|6|||
164548535|NCT03370120|594381338|FG000|Overall Study|Asked by the sponsor|3|||
164548536|NCT03370120|594381338|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
164548537|NCT03370120|594381338|FG000|Overall Study|PI decision poor compliance from participant|1|||
164548538|NCT03370120|594381338|FG000|Overall Study|Promoter ended the study|3|||
164548539|NCT03370120|594381338|FG000|Overall Study|Premature study close by sponsor's decision|4|||
164548540|NCT03370120|594381338|FG000|Overall Study|Study terminated by sponsor|33|||
164548541|NCT03370120|594381338|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
164548542|NCT03370120|594381338|FG000|Overall Study|Sponsor decision to terminate study|63|||
164548543|NCT03370120|594381338|FG000|Overall Study|Program closure|3|||
164548544|NCT03370120|594381338|FG000|Overall Study|Study ended prematurely|1|||
164548545|NCT03370120|594381338|FG000|Overall Study|Study stopped by sponsor|2|||
164548546|NCT03370120|594381338|FG000|Overall Study|Program termination|55|||
164548547|NCT03370120|594381338|FG000|Overall Study|Sponsor decision|62|||
164548548|NCT03370120|594381338|FG000|Overall Study|Sponsor study closure|10|||
164548549|NCT00928889|594381340|FG000|Overall Study|Lost to Follow-up|3|||
164548550|NCT00928889|594381341|FG001|Overall Study|Lost to Follow-up|1|||
164548551|NCT00928889|594381340|FG000|Overall Study|Protocol Violation|0|||
164548552|NCT00928889|594381341|FG001|Overall Study|Protocol Violation|1|||
164548553|NCT00928889|594381340|FG000|Overall Study|Adverse Event|1|||
164548554|NCT00928889|594381341|FG001|Overall Study|Adverse Event|0|||
164548555|NCT00928889|594381340|FG000|Overall Study|Other|1|||
164548556|NCT00928889|594381341|FG001|Overall Study|Other|0|||
164548557|NCT04712110|594381342|FG000|Overall Study|Lost to Follow-up|0|||
164548558|NCT04712110|594381343|FG001|Overall Study|Lost to Follow-up|1|||
164548559|NCT04712110|594381342|FG000|Overall Study|Withdrawal by Subject|0|||
164548560|NCT04712110|594381343|FG001|Overall Study|Withdrawal by Subject|4|||
164548561|NCT04712110|594381342|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
164548562|NCT04712110|594381343|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
164654716|NCT01381900|594762952|FG002|Overall Study|Adverse Event|7|||
164654717|NCT01381900|594762950|FG000|Overall Study|Noncompliance with study drug|0|||
164654718|NCT01381900|594762951|FG001|Overall Study|Noncompliance with study drug|0|||
164654719|NCT01381900|594762952|FG002|Overall Study|Noncompliance with study drug|1|||
164654720|NCT01381900|594762950|FG000|Overall Study|Physician Decision|0|||
164654721|NCT01381900|594762951|FG001|Overall Study|Physician Decision|1|||
164548563|NCT01356407|594381344|FG000|Overall Study|Lost to Follow-up|2|||
164548564|NCT01356407|594381345|FG001|Overall Study|Lost to Follow-up|0|||
164654722|NCT01381900|594762952|FG002|Overall Study|Physician Decision|1|||
164654723|NCT01381900|594762950|FG000|Overall Study|Protocol Violation|0|||
164654724|NCT01381900|594762951|FG001|Overall Study|Protocol Violation|1|||
164654725|NCT01381900|594762952|FG002|Overall Study|Protocol Violation|1|||
164654726|NCT01381900|594762950|FG000|Overall Study|Withdrawal by Subject|0|||
164654727|NCT01381900|594762951|FG001|Overall Study|Withdrawal by Subject|0|||
164548565|NCT01356407|594381344|FG000|Overall Study|Patient Withdrew Consent|2|||
164548566|NCT01356407|594381345|FG001|Overall Study|Patient Withdrew Consent|1|||
164548567|NCT01356407|594381344|FG000|Overall Study|Could not afford IMP administration|0|||
164548568|NCT01356407|594381345|FG001|Overall Study|Could not afford IMP administration|1|||
164548569|NCT01356407|594381344|FG000|Overall Study|Not complete Endoscopy|2|||
164548570|NCT01356407|594381345|FG001|Overall Study|Not complete Endoscopy|2|||
164548571|NCT01197521|594381346|FG000|Overall Study|Not reported|24|||
164548572|NCT01197521|594381347|FG001|Overall Study|Not reported|25|||
164548573|NCT01197521|594381348|FG002|Overall Study|Not reported|21|||
164548574|NCT01197521|594381346|FG000|Overall Study|Enrolment in long term extension|42|||
164548575|NCT01197521|594381347|FG001|Overall Study|Enrolment in long term extension|36|||
164548576|NCT01197521|594381348|FG002|Overall Study|Enrolment in long term extension|87|||
164548577|NCT01197521|594381346|FG000|Overall Study|Severe non-compliance to protocol|1|||
164548578|NCT01197521|594381347|FG001|Overall Study|Severe non-compliance to protocol|3|||
164548579|NCT01197521|594381348|FG002|Overall Study|Severe non-compliance to protocol|3|||
164548580|NCT01197521|594381346|FG000|Overall Study|Lack of therapeutic response|2|||
164548581|NCT01197521|594381347|FG001|Overall Study|Lack of therapeutic response|3|||
164548582|NCT01197521|594381348|FG002|Overall Study|Lack of therapeutic response|4|||
164548583|NCT01197521|594381346|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
164548584|NCT01197521|594381347|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
164548585|NCT01197521|594381348|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
164548586|NCT01197521|594381346|FG000|Overall Study|Lost to Follow-up|3|||
164548587|NCT01197521|594381347|FG001|Overall Study|Lost to Follow-up|2|||
164548588|NCT01197521|594381348|FG002|Overall Study|Lost to Follow-up|2|||
164548589|NCT01197521|594381346|FG000|Overall Study|Adverse Event|25|||
164548590|NCT01197521|594381347|FG001|Overall Study|Adverse Event|28|||
164548591|NCT01197521|594381348|FG002|Overall Study|Adverse Event|24|||
164548592|NCT03901079|594381349|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
164548593|NCT04607148|594381350|FG000|Overall Study|Withdrawal by Subject|0|||
164548594|NCT04607148|594381351|FG001|Overall Study|Withdrawal by Subject|4|||
164548595|NCT04607148|594381352|FG002|Overall Study|Withdrawal by Subject|2|||
164548596|NCT04607148|594381353|FG003|Overall Study|Withdrawal by Subject|8|||
164548597|NCT04607148|594381350|FG000|Overall Study|Study Terminated by Sponsor|14|||
164548598|NCT04607148|594381351|FG001|Overall Study|Study Terminated by Sponsor|59|||
164548599|NCT04607148|594381352|FG002|Overall Study|Study Terminated by Sponsor|9|||
164548600|NCT04607148|594381353|FG003|Overall Study|Study Terminated by Sponsor|39|||
164548601|NCT04607148|594381350|FG000|Overall Study|Sponsor Decision|0|||
164548602|NCT04607148|594381351|FG001|Overall Study|Sponsor Decision|0|||
164548603|NCT04607148|594381352|FG002|Overall Study|Sponsor Decision|1|||
164548604|NCT04607148|594381353|FG003|Overall Study|Sponsor Decision|0|||
164548605|NCT04607148|594381350|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164548606|NCT04607148|594381351|FG001|Overall Study|Non-Compliance With Study Drug|1|||
164548607|NCT04607148|594381352|FG002|Overall Study|Non-Compliance With Study Drug|0|||
164548608|NCT04607148|594381353|FG003|Overall Study|Non-Compliance With Study Drug|0|||
164548609|NCT04607148|594381350|FG000|Overall Study|Lost to Follow-up|0|||
164548610|NCT04607148|594381351|FG001|Overall Study|Lost to Follow-up|2|||
164548611|NCT04607148|594381352|FG002|Overall Study|Lost to Follow-up|0|||
164548612|NCT04607148|594381353|FG003|Overall Study|Lost to Follow-up|0|||
164548613|NCT04607148|594381350|FG000|Overall Study|Death|0|||
164548614|NCT04607148|594381351|FG001|Overall Study|Death|3|||
164548615|NCT04607148|594381352|FG002|Overall Study|Death|0|||
164548616|NCT04607148|594381353|FG003|Overall Study|Death|1|||
164548617|NCT04607148|594381350|FG000|Overall Study|Adverse Event|0|||
164548618|NCT04607148|594381351|FG001|Overall Study|Adverse Event|1|||
164548619|NCT04607148|594381352|FG002|Overall Study|Adverse Event|0|||
164548620|NCT04607148|594381353|FG003|Overall Study|Adverse Event|0|||
164548621|NCT00912028|594381354|FG000|Overall Study|Lost to Follow-up|2|||
164548622|NCT00912028|594381355|FG001|Overall Study|Lost to Follow-up|3|||
164548623|NCT00912028|594381356|FG002|Overall Study|Lost to Follow-up|0|||
164548624|NCT00912028|594381357|FG003|Overall Study|Lost to Follow-up|1|||
164548625|NCT00912028|594381358|FG004|Overall Study|Lost to Follow-up|3|||
164548626|NCT00912028|594381354|FG000|Overall Study|Withdrawal by Subject|3|||
164548627|NCT00912028|594381355|FG001|Overall Study|Withdrawal by Subject|0|||
164548628|NCT00912028|594381356|FG002|Overall Study|Withdrawal by Subject|0|||
164548629|NCT00912028|594381357|FG003|Overall Study|Withdrawal by Subject|0|||
164548630|NCT00912028|594381358|FG004|Overall Study|Withdrawal by Subject|0|||
164548631|NCT01820364|594381359|FG000|Part I: LGX818|Death|1|||
164548632|NCT01820364|594381360|FG001|Part I: LGX818|Death|0|||
164548633|NCT01820364|594381359|FG000|Part I: LGX818|Administrative Problems|3|||
164548634|NCT01820364|594381360|FG001|Part I: LGX818|Administrative Problems|0|||
164548635|NCT01820364|594381359|FG000|Part I: LGX818|Adverse Event|6|||
164548636|NCT01820364|594381360|FG001|Part I: LGX818|Adverse Event|0|||
164548637|NCT01820364|594381359|FG000|Part I: LGX818|Disease Progression|4|||
164548638|NCT01820364|594381360|FG001|Part I: LGX818|Disease Progression|0|||
164548639|NCT01820364|594381359|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
164548640|NCT01820364|594381360|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
164654728|NCT01381900|594762952|FG002|Overall Study|Withdrawal by Subject|1|||
164654729|NCT01381900|594762950|FG000|Overall Study|Early withdraw|3|||
164654730|NCT01381900|594762951|FG001|Overall Study|Early withdraw|1|||
164654731|NCT01381900|594762952|FG002|Overall Study|Early withdraw|1|||
164654732|NCT01772368|594762953|FG000|Overall Study|Adverse Event|1|||
164654733|NCT01772368|594762953|FG000|Overall Study|Withdrawal by Subject|3|||
164654734|NCT01772368|594762953|FG000|Overall Study|Protocol Violation|2|||
164654735|NCT01772368|594762953|FG000|Overall Study|Other|1|||
164654736|NCT02891200|594762961|FG000|Overall Study|Lost to Follow-up|31|||
164654737|NCT02891200|594762962|FG001|Overall Study|Lost to Follow-up|36|||
164654738|NCT02891200|594762961|FG000|Overall Study|Death|10|||
164654739|NCT02891200|594762962|FG001|Overall Study|Death|9|||
164654740|NCT02891200|594762961|FG000|Overall Study|Withdrawal by Subject|1|||
164654741|NCT02891200|594762962|FG001|Overall Study|Withdrawal by Subject|4|||
164654742|NCT04480463|594762963|FG000|Overall Study|Death|0|||
164654743|NCT04480463|594762964|FG001|Overall Study|Death|1|||
164654744|NCT04480463|594762963|FG000|Overall Study|Adverse Event|6|||
164654745|NCT04480463|594762964|FG001|Overall Study|Adverse Event|8|||
164654746|NCT04480463|594762963|FG000|Overall Study|Lost to Follow-up|3|||
164654747|NCT04480463|594762964|FG001|Overall Study|Lost to Follow-up|2|||
164654748|NCT04480463|594762963|FG000|Overall Study|Physician Decision|2|||
164654749|NCT04480463|594762964|FG001|Overall Study|Physician Decision|5|||
164654750|NCT04480463|594762963|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
164654751|NCT04480463|594762964|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
164654752|NCT04480463|594762963|FG000|Overall Study|Protocol Violation|2|||
164654753|NCT04480463|594762964|FG001|Overall Study|Protocol Violation|1|||
164654754|NCT04480463|594762963|FG000|Overall Study|Withdrawal by Subject|6|||
164654755|NCT04480463|594762964|FG001|Overall Study|Withdrawal by Subject|7|||
164654756|NCT04480463|594762963|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
164654757|NCT04480463|594762964|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
164654758|NCT04480463|594762963|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
164654759|NCT04480463|594762964|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
164654760|NCT04480463|594762963|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
164654761|NCT04480463|594762964|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
164654762|NCT04480463|594762963|FG000|Overall Study|Other|6|||
164654763|NCT04480463|594762964|FG001|Overall Study|Other|4|||
164654764|NCT02231710|594762965|FG000|Overall Study|Physician Decision|1|||
164548641|NCT03029143|594381361|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
164548642|NCT03029143|594381362|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
164548643|NCT03029143|594381363|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
164548644|NCT03029143|594381361|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
164548645|NCT03029143|594381362|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
164548646|NCT03029143|594381363|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
164548647|NCT03029143|594381361|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
164548648|NCT03029143|594381362|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
164548649|NCT03029143|594381363|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
164548650|NCT03029143|594381361|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
164548651|NCT03029143|594381362|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
164548652|NCT03029143|594381363|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
164548653|NCT03029143|594381361|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
164548654|NCT03029143|594381362|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
164548655|NCT03029143|594381363|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
164548656|NCT03029143|594381361|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
164548657|NCT03029143|594381362|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
164548658|NCT03029143|594381363|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
164548659|NCT03029143|594381361|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
164548660|NCT03029143|594381362|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
164548661|NCT03029143|594381363|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
164548662|NCT03029143|594381361|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164548663|NCT03029143|594381362|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
164548664|NCT03029143|594381363|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
164654765|NCT01339910|594762966|FG000|Overall Study|Withdrawal by Subject|1|||
164654766|NCT01339910|594762967|FG001|Overall Study|Withdrawal by Subject|0|||
164654767|NCT01339910|594762966|FG000|Overall Study|Physician Decision|1|||
164654768|NCT01339910|594762967|FG001|Overall Study|Physician Decision|0|||
164654769|NCT01339910|594762966|FG000|Overall Study|Disease relapse|1|||
164548665|NCT03029143|594381361|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
164548666|NCT03029143|594381362|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
164548667|NCT03029143|594381363|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
164548668|NCT03029143|594381361|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
164548669|NCT03029143|594381362|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
164548670|NCT03029143|594381363|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
164654770|NCT01339910|594762967|FG001|Overall Study|Disease relapse|4|||
164654771|NCT02322879|594762968|FG000|First Intervention|Physician Decision|1|||
164654772|NCT02322879|594762969|FG001|First Intervention|Physician Decision|0|||
164196613|NCT01831427|593089845|FG006|Overall Study|Adverse Event|0|||
164196614|NCT01831427|593089846|FG007|Overall Study|Adverse Event|1|||
164196615|NCT01831427|593089847|FG008|Overall Study|Adverse Event|0|||
164548671|NCT03029143|594381361|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
164548672|NCT03029143|594381362|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
164548673|NCT03029143|594381363|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
164548674|NCT00961220|594381365|FG000|Overall Study|Adverse Event|3|||
164548675|NCT00961220|594381365|FG000|Overall Study|Lack of Efficacy|1|||
164548676|NCT00961220|594381365|FG000|Overall Study|No IV access for O6BG|1|||
164548677|NCT00961220|594381365|FG000|Overall Study|O6BG no longer supplied|1|||
164548678|NCT00961220|594381365|FG000|Overall Study|Complete Response prior to 12 courses|1|||
164548679|NCT05376215|594381366|FG000|Overall Study|Withdrawal by Subject|2|||
164548680|NCT05376215|594381367|FG001|Overall Study|Withdrawal by Subject|1|||
164548681|NCT05376215|594381366|FG000|Overall Study|Lost to Follow-up|0|||
164548682|NCT05376215|594381367|FG001|Overall Study|Lost to Follow-up|1|||
164548683|NCT00942175|594381368|FG000|Overall Study|Adverse Event|2|||
164548684|NCT00942175|594381369|FG001|Overall Study|Adverse Event|1|||
164548685|NCT00942175|594381370|FG002|Overall Study|Adverse Event|0|||
164548686|NCT00942175|594381371|FG003|Overall Study|Adverse Event|0|||
164548687|NCT00942175|594381368|FG000|Overall Study|Protocol Violation|0|||
164548688|NCT00942175|594381369|FG001|Overall Study|Protocol Violation|1|||
164548689|NCT00942175|594381370|FG002|Overall Study|Protocol Violation|2|||
164548690|NCT00942175|594381371|FG003|Overall Study|Protocol Violation|0|||
164548691|NCT00942175|594381368|FG000|Overall Study|Pregnancy|0|||
164548692|NCT00942175|594381369|FG001|Overall Study|Pregnancy|0|||
164548693|NCT00942175|594381370|FG002|Overall Study|Pregnancy|0|||
164548694|NCT00942175|594381371|FG003|Overall Study|Pregnancy|1|||
164548695|NCT00942175|594381368|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
164548696|NCT00942175|594381369|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
164548697|NCT00942175|594381370|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
164654773|NCT00124020|594762976|FG000|Overall Study|Death|67|||
164654774|NCT00124020|594762977|FG001|Overall Study|Death|71|||
164196616|NCT01831427|593089848|FG009|Overall Study|Adverse Event|0|||
164196617|NCT01831427|593089849|FG010|Overall Study|Adverse Event|2|||
164196618|NCT01831427|593089839|FG000|Overall Study|Investigator's Discretion|0|||
164196619|NCT01831427|593089840|FG001|Overall Study|Investigator's Discretion|0|||
164196620|NCT01831427|593089841|FG002|Overall Study|Investigator's Discretion|0|||
164196621|NCT01831427|593089842|FG003|Overall Study|Investigator's Discretion|1|||
164196622|NCT01831427|593089843|FG004|Overall Study|Investigator's Discretion|0|||
164196623|NCT01831427|593089844|FG005|Overall Study|Investigator's Discretion|0|||
164196624|NCT01831427|593089845|FG006|Overall Study|Investigator's Discretion|0|||
164196625|NCT01831427|593089846|FG007|Overall Study|Investigator's Discretion|0|||
164196626|NCT01831427|593089847|FG008|Overall Study|Investigator's Discretion|0|||
164196627|NCT01831427|593089848|FG009|Overall Study|Investigator's Discretion|0|||
164196628|NCT01831427|593089849|FG010|Overall Study|Investigator's Discretion|0|||
164196629|NCT01831427|593089839|FG000|Overall Study|Withdrew Consent|0|||
164196630|NCT01831427|593089840|FG001|Overall Study|Withdrew Consent|0|||
164196631|NCT01831427|593089841|FG002|Overall Study|Withdrew Consent|0|||
164196632|NCT01831427|593089842|FG003|Overall Study|Withdrew Consent|0|||
164196633|NCT01831427|593089843|FG004|Overall Study|Withdrew Consent|0|||
164196634|NCT01831427|593089844|FG005|Overall Study|Withdrew Consent|0|||
164196635|NCT01831427|593089845|FG006|Overall Study|Withdrew Consent|2|||
164196636|NCT01831427|593089846|FG007|Overall Study|Withdrew Consent|0|||
164196637|NCT01831427|593089847|FG008|Overall Study|Withdrew Consent|0|||
164196638|NCT01831427|593089848|FG009|Overall Study|Withdrew Consent|1|||
164196639|NCT01831427|593089849|FG010|Overall Study|Withdrew Consent|1|||
164196640|NCT01249417|593089852|FG000|Randomised Population|Study treatment not received|0|||
164196641|NCT01249417|593089853|FG001|Randomised Population|Study treatment not received|0|||
164196642|NCT01249417|593089854|FG002|Randomised Population|Study treatment not received|2|||
164196643|NCT01249417|593089852|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
164548698|NCT00942175|594381371|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
164548699|NCT00942175|594381368|FG000|Overall Study|Low Platelet Count|0|||
164548700|NCT00942175|594381369|FG001|Overall Study|Low Platelet Count|2|||
164548701|NCT00942175|594381370|FG002|Overall Study|Low Platelet Count|0|||
164548702|NCT00942175|594381371|FG003|Overall Study|Low Platelet Count|0|||
164548703|NCT04041284|594381372|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
164548704|NCT04041284|594381373|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
164548705|NCT04041284|594381372|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
164548706|NCT04041284|594381373|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
164548707|NCT04041284|594381372|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
164548708|NCT04041284|594381373|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
164548709|NCT04041284|594381372|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
164548710|NCT04041284|594381373|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
164548711|NCT04041284|594381372|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
164548712|NCT04041284|594381373|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
164548713|NCT04041284|594381372|FG000|DB Phase (12 Weeks)|Other than specified|1|||
164548714|NCT04041284|594381373|FG001|DB Phase (12 Weeks)|Other than specified|0|||
164548715|NCT04041284|594381372|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
164548716|NCT04041284|594381373|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
164548717|NCT04041284|594381372|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
164548718|NCT04041284|594381373|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
164548719|NCT04041284|594381372|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
164548720|NCT04041284|594381373|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
164548721|NCT04041284|594381372|FG000|OL Phase (12 Weeks)|Other than specified|6|||
164548722|NCT04041284|594381373|FG001|OL Phase (12 Weeks)|Other than specified|2|||
164548723|NCT02973087|594381376|FG000|Overall Study|Withdrawal by Subject|2|||
164548724|NCT02973087|594381377|FG001|Overall Study|Withdrawal by Subject|1|||
164548725|NCT02973087|594381376|FG000|Overall Study|Adverse Event|1|||
164548726|NCT02973087|594381377|FG001|Overall Study|Adverse Event|0|||
164548727|NCT02973087|594381376|FG000|Overall Study|other|1|||
164548728|NCT02973087|594381377|FG001|Overall Study|other|1|||
164548729|NCT01840579|594381378|FG000|Overall Study|Status not recorded|0|||
164548730|NCT01840579|594381379|FG001|Overall Study|Status not recorded|0|||
164548731|NCT01840579|594381380|FG002|Overall Study|Status not recorded|2|||
164548732|NCT01840579|594381381|FG003|Overall Study|Status not recorded|3|||
164548733|NCT01840579|594381382|FG004|Overall Study|Status not recorded|4|||
164548734|NCT01840579|594381383|FG005|Overall Study|Status not recorded|3|||
164548735|NCT01840579|594381384|FG006|Overall Study|Status not recorded|0|||
164548736|NCT01840579|594381385|FG007|Overall Study|Status not recorded|3|||
164548737|NCT01840579|594381386|FG008|Overall Study|Status not recorded|3|||
164548738|NCT01840579|594381387|FG009|Overall Study|Status not recorded|3|||
164548739|NCT01840579|594381378|FG000|Overall Study|Progressive disease|3|||
164548740|NCT01840579|594381379|FG001|Overall Study|Progressive disease|5|||
164548741|NCT01840579|594381380|FG002|Overall Study|Progressive disease|0|||
164548742|NCT01840579|594381381|FG003|Overall Study|Progressive disease|0|||
164548743|NCT01840579|594381382|FG004|Overall Study|Progressive disease|0|||
164548744|NCT01840579|594381383|FG005|Overall Study|Progressive disease|0|||
164548745|NCT01840579|594381384|FG006|Overall Study|Progressive disease|0|||
164548746|NCT01840579|594381385|FG007|Overall Study|Progressive disease|0|||
164548747|NCT01840579|594381386|FG008|Overall Study|Progressive disease|0|||
164548748|NCT01840579|594381387|FG009|Overall Study|Progressive disease|0|||
164548749|NCT01840579|594381378|FG000|Overall Study|Ongoing in study|0|||
164548750|NCT01840579|594381379|FG001|Overall Study|Ongoing in study|1|||
164548751|NCT01840579|594381380|FG002|Overall Study|Ongoing in study|0|||
164548752|NCT01840579|594381381|FG003|Overall Study|Ongoing in study|0|||
164548753|NCT01840579|594381382|FG004|Overall Study|Ongoing in study|0|||
164548754|NCT01840579|594381383|FG005|Overall Study|Ongoing in study|0|||
164548755|NCT01840579|594381384|FG006|Overall Study|Ongoing in study|0|||
164548756|NCT01840579|594381385|FG007|Overall Study|Ongoing in study|0|||
164548757|NCT01840579|594381386|FG008|Overall Study|Ongoing in study|0|||
164548758|NCT01840579|594381387|FG009|Overall Study|Ongoing in study|0|||
164548759|NCT01840579|594381378|FG000|Overall Study|Death|0|||
164548760|NCT01840579|594381379|FG001|Overall Study|Death|0|||
164548761|NCT01840579|594381380|FG002|Overall Study|Death|0|||
164548762|NCT01840579|594381381|FG003|Overall Study|Death|0|||
164548763|NCT01840579|594381382|FG004|Overall Study|Death|0|||
164548764|NCT01840579|594381383|FG005|Overall Study|Death|1|||
164548765|NCT01840579|594381384|FG006|Overall Study|Death|0|||
164548766|NCT01840579|594381385|FG007|Overall Study|Death|0|||
164548767|NCT01840579|594381386|FG008|Overall Study|Death|0|||
164548768|NCT01840579|594381387|FG009|Overall Study|Death|0|||
164548769|NCT01840579|594381378|FG000|Overall Study|Adverse Event|0|||
164548770|NCT01840579|594381379|FG001|Overall Study|Adverse Event|1|||
164548771|NCT01840579|594381380|FG002|Overall Study|Adverse Event|0|||
164548772|NCT01840579|594381381|FG003|Overall Study|Adverse Event|0|||
164548773|NCT01840579|594381382|FG004|Overall Study|Adverse Event|0|||
164548774|NCT01840579|594381383|FG005|Overall Study|Adverse Event|0|||
164548775|NCT01840579|594381384|FG006|Overall Study|Adverse Event|0|||
164548776|NCT01840579|594381385|FG007|Overall Study|Adverse Event|0|||
164548777|NCT01840579|594381386|FG008|Overall Study|Adverse Event|0|||
164548778|NCT01840579|594381387|FG009|Overall Study|Adverse Event|0|||
164548779|NCT01840579|594381378|FG000|Overall Study|Follow-up ended by Sponsor|0|||
164548780|NCT01840579|594381379|FG001|Overall Study|Follow-up ended by Sponsor|0|||
164548781|NCT01840579|594381380|FG002|Overall Study|Follow-up ended by Sponsor|0|||
164548782|NCT01840579|594381381|FG003|Overall Study|Follow-up ended by Sponsor|0|||
164548783|NCT01840579|594381382|FG004|Overall Study|Follow-up ended by Sponsor|0|||
164548784|NCT01840579|594381383|FG005|Overall Study|Follow-up ended by Sponsor|0|||
164548785|NCT01840579|594381384|FG006|Overall Study|Follow-up ended by Sponsor|2|||
164548786|NCT01840579|594381385|FG007|Overall Study|Follow-up ended by Sponsor|0|||
164196644|NCT01249417|593089853|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
164196645|NCT01249417|593089854|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
164196646|NCT01249417|593089852|FG000|Treatment Phase - ITT Population|Other|0|||
164196647|NCT01249417|593089853|FG001|Treatment Phase - ITT Population|Other|0|||
164196648|NCT01249417|593089854|FG002|Treatment Phase - ITT Population|Other|1|||
164196649|NCT01249417|593089852|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
164196650|NCT01249417|593089853|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
164196651|NCT01249417|593089854|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
164196652|NCT01249417|593089852|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
164196653|NCT01249417|593089853|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
164196654|NCT01249417|593089854|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
164196655|NCT01249417|593089852|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
164196656|NCT01249417|593089853|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
164196657|NCT01249417|593089854|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
164196658|NCT01854697|593089855|FG000|Overall Study|Adverse Event|1|||
164196659|NCT01854697|593089856|FG001|Overall Study|Adverse Event|0|||
164196660|NCT01854697|593089857|FG002|Overall Study|Adverse Event|0|||
164196661|NCT01854697|593089858|FG003|Overall Study|Adverse Event|0|||
164196662|NCT01854697|593089859|FG004|Overall Study|Adverse Event|1|||
164196663|NCT01854697|593089855|FG000|Overall Study|Lost to Follow-up|4|||
164196664|NCT01854697|593089856|FG001|Overall Study|Lost to Follow-up|1|||
164196665|NCT01854697|593089857|FG002|Overall Study|Lost to Follow-up|1|||
164196666|NCT01854697|593089858|FG003|Overall Study|Lost to Follow-up|2|||
164548787|NCT01840579|594381386|FG008|Overall Study|Follow-up ended by Sponsor|0|||
164548788|NCT01840579|594381387|FG009|Overall Study|Follow-up ended by Sponsor|0|||
164548789|NCT02437864|594381390|FG000|Overall Study|Protocol Violation|4|||
164196667|NCT01854697|593089859|FG004|Overall Study|Lost to Follow-up|0|||
164196668|NCT01854697|593089855|FG000|Overall Study|To enter another AbbVie study|1|||
164196669|NCT01854697|593089856|FG001|Overall Study|To enter another AbbVie study|0|||
164196670|NCT01854697|593089857|FG002|Overall Study|To enter another AbbVie study|0|||
164196671|NCT01854697|593089858|FG003|Overall Study|To enter another AbbVie study|0|||
164196672|NCT01854697|593089859|FG004|Overall Study|To enter another AbbVie study|1|||
164196673|NCT01854697|593089855|FG000|Overall Study|Withdrew Consent|0|||
164196674|NCT01854697|593089856|FG001|Overall Study|Withdrew Consent|1|||
164196675|NCT01854697|593089857|FG002|Overall Study|Withdrew Consent|0|||
164196676|NCT01854697|593089858|FG003|Overall Study|Withdrew Consent|1|||
164196677|NCT01854697|593089859|FG004|Overall Study|Withdrew Consent|0|||
164196678|NCT01854697|593089855|FG000|Overall Study|Other|0|||
164196679|NCT01854697|593089856|FG001|Overall Study|Other|1|||
164196680|NCT01854697|593089857|FG002|Overall Study|Other|1|||
164196681|NCT01854697|593089858|FG003|Overall Study|Other|0|||
164196682|NCT01854697|593089859|FG004|Overall Study|Other|0|||
164196683|NCT05556148|593089864|FG000|Overall Study|Early Termination|29|||
164420583|NCT01890967|593910946|FG000|Overall Study|Adverse Event|3|||
164548790|NCT02437864|594381391|FG001|Overall Study|Protocol Violation|0|||
164548791|NCT00645593|594381393|FG000|Overall Study|Later found to be ineligible|1|||
164548792|NCT00645593|594381394|FG001|Overall Study|Later found to be ineligible|0|||
164548793|NCT03803059|594381396|FG000|Overall Study|Protocol Violation|2|||
164548794|NCT03803059|594381396|FG000|Overall Study|Lost to Follow-up|1|||
164548795|NCT04013529|594381397|FG000|Overall Study|Withdrawal by Subject|1|||
164548796|NCT04013529|594381398|FG001|Overall Study|Withdrawal by Subject|1|||
164548797|NCT01484977|594381399|FG000|Overall Study|Adverse Event|8|||
164548798|NCT01484977|594381399|FG000|Overall Study|Lack of Efficacy|4|||
164548799|NCT01484977|594381399|FG000|Overall Study|Protocol Violation|6|||
164548800|NCT01484977|594381399|FG000|Overall Study|Lost to Follow-up|1|||
164548801|NCT01484977|594381399|FG000|Overall Study|Withdrawal by Subject|4|||
164548802|NCT01484977|594381399|FG000|Overall Study|Subject Protocol Non-compliant|1|||
164548803|NCT01484977|594381399|FG000|Overall Study|Moving Overseas|1|||
164548804|NCT01484977|594381399|FG000|Overall Study|Low White Blood Cell Count|1|||
164548805|NCT01484977|594381399|FG000|Overall Study|Lack of Compliance|1|||
164548806|NCT04857996|594381400|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
164548807|NCT04857996|594381401|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
164548808|NCT04857996|594381400|FG000|Overall Study|Lost to Follow-up|1|||
164548809|NCT04857996|594381401|FG001|Overall Study|Lost to Follow-up|3|||
164196684|NCT05556148|593089864|FG000|Overall Study|Baseline Tasks Expired|4|||
164548810|NCT04857996|594381400|FG000|Overall Study|Site Closure|1|||
164548811|NCT04857996|594381401|FG001|Overall Study|Site Closure|0|||
164548812|NCT04857996|594381400|FG000|Overall Study|Withdrawal by Subject|1|||
164548813|NCT04857996|594381401|FG001|Overall Study|Withdrawal by Subject|0|||
164548814|NCT01129921|594381402|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
164196685|NCT05556148|593089864|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
164196686|NCT05556148|593089864|FG000|Overall Study|No Longer Wished to Participate|1|||
164196687|NCT05556148|593089864|FG000|Overall Study|Bacterial Conjunctivitis|1|||
164196688|NCT01171898|593089865|FG000|Overall Study|Death|0|||
164196689|NCT01171898|593089866|FG001|Overall Study|Death|0|||
164548815|NCT01129921|594381403|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
164548816|NCT01129921|594381402|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
164548817|NCT01129921|594381403|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
164548818|NCT01129921|594381402|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
164548819|NCT01129921|594381403|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
164548820|NCT01129921|594381402|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
164548821|NCT01129921|594381403|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
164548822|NCT02988661|594381404|FG000|Overall Study|Death|2|||
164548823|NCT02988661|594381405|FG001|Overall Study|Death|18|||
164548824|NCT02988661|594381404|FG000|Overall Study|Lost to Follow-up|0|||
164548825|NCT02988661|594381405|FG001|Overall Study|Lost to Follow-up|33|||
164548826|NCT02988661|594381404|FG000|Overall Study|Withdrawal by Subject|0|||
164548827|NCT02988661|594381405|FG001|Overall Study|Withdrawal by Subject|6|||
164548828|NCT02988661|594381404|FG000|Overall Study|Unable to complete the 18-month survey|1|||
164548829|NCT02988661|594381405|FG001|Overall Study|Unable to complete the 18-month survey|27|||
164548830|NCT02484911|594383047|FG000|Overall Study|Withdrawal by Subject|2|||
164548831|NCT02484911|594383048|FG001|Overall Study|Withdrawal by Subject|1|||
164548832|NCT02484911|594383047|FG000|Overall Study|Protocol Violation|2|||
164548833|NCT02484911|594383048|FG001|Overall Study|Protocol Violation|1|||
164548834|NCT02222207|594383055|FG000|Overall Study|Death|1|||
164548835|NCT02222207|594383055|FG000|Overall Study|Other reasons|2|||
164548836|NCT02222207|594383055|FG000|Overall Study|Adverse Event|1|||
164548837|NCT00747643|594383056|FG000|Overall Study|Withdrawal by Subject|36|||
164548838|NCT00747643|594383057|FG001|Overall Study|Withdrawal by Subject|27|||
164548839|NCT03557281|594383058|FG000|Overall Study|Investigator discretion|0|||
164548840|NCT03557281|594383059|FG001|Overall Study|Investigator discretion|0|||
164548841|NCT03557281|594383060|FG002|Overall Study|Investigator discretion|1|||
164548842|NCT03557281|594383061|FG003|Overall Study|Investigator discretion|0|||
164548843|NCT03557281|594383062|FG004|Overall Study|Investigator discretion|0|||
164548844|NCT03557281|594383058|FG000|Overall Study|Withdrawal by Subject|0|||
164548845|NCT03557281|594383059|FG001|Overall Study|Withdrawal by Subject|1|||
164548846|NCT03557281|594383060|FG002|Overall Study|Withdrawal by Subject|1|||
164548847|NCT03557281|594383061|FG003|Overall Study|Withdrawal by Subject|1|||
164548848|NCT03557281|594383062|FG004|Overall Study|Withdrawal by Subject|2|||
164548849|NCT03557281|594383058|FG000|Overall Study|Randomized, but did not receive treatment|0|||
164548850|NCT03557281|594383059|FG001|Overall Study|Randomized, but did not receive treatment|0|||
164548851|NCT03557281|594383060|FG002|Overall Study|Randomized, but did not receive treatment|0|||
164548852|NCT03557281|594383061|FG003|Overall Study|Randomized, but did not receive treatment|0|||
164548853|NCT03557281|594383062|FG004|Overall Study|Randomized, but did not receive treatment|1|||
164548854|NCT01199042|594383063|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
164548855|NCT01199042|594383063|FG000|At Home (3 Months)|Lost to Follow-up|1|||
164548856|NCT04036708|594383066|FG000|Overall Study|Lost to Follow-up|14|||
164548857|NCT04036708|594383067|FG001|Overall Study|Lost to Follow-up|4|||
164548858|NCT04036708|594383068|FG002|Overall Study|Lost to Follow-up|14|||
164548859|NCT04036708|594383069|FG003|Overall Study|Lost to Follow-up|4|||
164548860|NCT02918864|594383070|FG000|Overall Study|Withdrawal by Subject|1|||
164548861|NCT02918864|594383071|FG001|Overall Study|Withdrawal by Subject|1|||
164548862|NCT02918864|594383070|FG000|Overall Study|Lost to Follow-up|3|||
164548863|NCT02918864|594383071|FG001|Overall Study|Lost to Follow-up|2|||
164548864|NCT02257372|594383075|FG000|Overall Study|Adverse Event|3|||
164548865|NCT02257372|594383076|FG001|Overall Study|Adverse Event|7|||
164548866|NCT02257372|594383075|FG000|Overall Study|Lack of Efficacy|2|||
164548867|NCT02257372|594383076|FG001|Overall Study|Lack of Efficacy|1|||
164548868|NCT02257372|594383075|FG000|Overall Study|Protocol Violation|1|||
164548869|NCT02257372|594383076|FG001|Overall Study|Protocol Violation|1|||
164548870|NCT02257372|594383075|FG000|Overall Study|Lost to Follow-up|0|||
164548871|NCT02257372|594383076|FG001|Overall Study|Lost to Follow-up|1|||
164548872|NCT02257372|594383075|FG000|Overall Study|Withdrew consent|1|||
164548873|NCT02257372|594383076|FG001|Overall Study|Withdrew consent|0|||
164548874|NCT00129766|594383078|FG000|Overall Study|Death|3|||
164548875|NCT00129766|594383079|FG001|Overall Study|Death|8|||
164548876|NCT00129766|594383078|FG000|Overall Study|Withdrawal of consent|31|||
164548877|NCT00129766|594383079|FG001|Overall Study|Withdrawal of consent|30|||
164548878|NCT00129766|594383078|FG000|Overall Study|Lost to Follow-up|26|||
164548879|NCT00129766|594383079|FG001|Overall Study|Lost to Follow-up|21|||
164548880|NCT01230307|594383080|FG000|Overall Study|LVAD Placement|0|||
164548881|NCT01230307|594383081|FG001|Overall Study|LVAD Placement|2|||
164548882|NCT04773106|594383084|FG000|Overall Study|Withdrawal by Subject|3|||
164548883|NCT04773106|594383084|FG000|Overall Study|Death|1|||
164548884|NCT01349465|594383093|FG000|Overall Study|Adverse Event|1|||
164548885|NCT01349465|594383094|FG001|Overall Study|Adverse Event|0|||
164548886|NCT01349465|594383093|FG000|Overall Study|Death|3|||
164548887|NCT01349465|594383094|FG001|Overall Study|Death|0|||
164548888|NCT01349465|594383093|FG000|Overall Study|Lost to Follow-up|10|||
164548889|NCT01349465|594383094|FG001|Overall Study|Lost to Follow-up|1|||
164548890|NCT01349465|594383093|FG000|Overall Study|Withdrawal by Subject|4|||
164548891|NCT01349465|594383094|FG001|Overall Study|Withdrawal by Subject|2|||
164548892|NCT01349465|594383093|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
164548893|NCT01349465|594383094|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
164548894|NCT04329702|594383097|FG000|Overall Study|illness|3|||
164548895|NCT04329702|594383098|FG001|Overall Study|illness|4|||
164548896|NCT04329702|594383099|FG002|Overall Study|illness|0|||
164548897|NCT04329702|594383097|FG000|Overall Study|Lost to Follow-up|0|||
164548898|NCT04329702|594383098|FG001|Overall Study|Lost to Follow-up|0|||
164548899|NCT04329702|594383099|FG002|Overall Study|Lost to Follow-up|2|||
164548900|NCT04329702|594383097|FG000|Overall Study|Death|0|||
164548901|NCT04329702|594383098|FG001|Overall Study|Death|2|||
164548902|NCT04329702|594383099|FG002|Overall Study|Death|0|||
164548903|NCT00751400|594383102|FG000|Overall Study|Lost to Follow-up|10|||
164548904|NCT01918007|594383103|FG000|Overall Study|Baseline oximetry not acceptable|11|||
164548905|NCT01918007|594383104|FG001|Overall Study|Baseline oximetry not acceptable|7|||
164548906|NCT01918007|594383103|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
164548907|NCT01918007|594383104|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
164548908|NCT01918007|594383103|FG000|Overall Study|Lost to Follow-up|4|||
164548909|NCT01918007|594383104|FG001|Overall Study|Lost to Follow-up|7|||
164548910|NCT01140451|594383105|FG000|Overall Study|Withdrawal by Subject|26|||
164548911|NCT01140451|594383106|FG001|Overall Study|Withdrawal by Subject|33|||
164548912|NCT01140451|594383105|FG000|Overall Study|Adverse Event|2|||
164548913|NCT01140451|594383106|FG001|Overall Study|Adverse Event|6|||
164548914|NCT01140451|594383105|FG000|Overall Study|Physician Decision|5|||
164548915|NCT01140451|594383106|FG001|Overall Study|Physician Decision|3|||
164548916|NCT01140451|594383105|FG000|Overall Study|Lost to Follow-up|2|||
164548917|NCT01140451|594383106|FG001|Overall Study|Lost to Follow-up|0|||
164548918|NCT01140451|594383105|FG000|Overall Study|Participants Planning Pregnancy|3|||
164548919|NCT01140451|594383106|FG001|Overall Study|Participants Planning Pregnancy|0|||
164548920|NCT04206020|594383107|FG000|Overall Study|Adverse Event|1|||
164548921|NCT04206020|594383108|FG001|Overall Study|Adverse Event|4|||
164548922|NCT04206020|594383107|FG000|Overall Study|Protocol Violation|2|||
164548923|NCT04206020|594383108|FG001|Overall Study|Protocol Violation|0|||
164548924|NCT04206020|594383107|FG000|Overall Study|Withdrawal by Subject|2|||
164548925|NCT04206020|594383108|FG001|Overall Study|Withdrawal by Subject|0|||
164548926|NCT04206020|594383107|FG000|Overall Study|Lost to Follow-up|2|||
164548927|NCT04206020|594383108|FG001|Overall Study|Lost to Follow-up|0|||
164548928|NCT04206020|594383107|FG000|Overall Study|Pregnancy|0|||
164548929|NCT04206020|594383108|FG001|Overall Study|Pregnancy|1|||
164548930|NCT04206020|594383107|FG000|Overall Study|Unable to attend visits|1|||
164548931|NCT04206020|594383108|FG001|Overall Study|Unable to attend visits|2|||
164548932|NCT04962022|594383111|FG000|Period 1|Withdrawal by Subject|1|||
164548933|NCT04962022|594383112|FG001|Period 1|Withdrawal by Subject|0|||
164548934|NCT02375724|594383113|FG000|Overall Study|Lack of Efficacy|1|||
164548935|NCT02375724|594383114|FG001|Overall Study|Lack of Efficacy|1|||
164548936|NCT02375724|594383113|FG000|Overall Study|Withdrawal by Subject|1|||
164548937|NCT02375724|594383114|FG001|Overall Study|Withdrawal by Subject|1|||
164548938|NCT02375724|594383113|FG000|Overall Study|Lost to Follow-up|1|||
164548939|NCT02375724|594383114|FG001|Overall Study|Lost to Follow-up|0|||
164548940|NCT02375724|594383113|FG000|Overall Study|Protocol Violation|1|||
164548941|NCT02375724|594383114|FG001|Overall Study|Protocol Violation|0|||
164548942|NCT02375724|594383113|FG000|Overall Study|Adverse Event|2|||
164548943|NCT02375724|594383114|FG001|Overall Study|Adverse Event|4|||
164548944|NCT00631020|594383115|FG000|Overall Study|Lost to Follow-up|7|||
164548945|NCT00631020|594383115|FG000|Overall Study|Incarcerated|1|||
164548946|NCT02614859|594383116|FG000|Overall Study|Physician Decision|0|||
164548947|NCT02614859|594383117|FG001|Overall Study|Physician Decision|1|||
164548948|NCT03548935|594383118|FG000|Overall Study|Withdrawal by Subject|26|||
164548949|NCT03548935|594383119|FG001|Overall Study|Withdrawal by Subject|17|||
164548950|NCT03548935|594383118|FG000|Overall Study|Lost to Follow-up|39|||
164548951|NCT03548935|594383119|FG001|Overall Study|Lost to Follow-up|28|||
164548952|NCT03548935|594383118|FG000|Overall Study|Death|1|||
164548953|NCT03548935|594383119|FG001|Overall Study|Death|1|||
164548954|NCT01074190|594383126|FG000|Overall Study|Emergency Cesarean Delivery|1|||
164196690|NCT01171898|593089867|FG002|Overall Study|Death|2|||
164196691|NCT01171898|593089868|FG003|Overall Study|Death|0|||
164196692|NCT01171898|593089865|FG000|Overall Study|Lost to Follow-up|0|||
164196693|NCT01171898|593089866|FG001|Overall Study|Lost to Follow-up|1|||
164196694|NCT01171898|593089867|FG002|Overall Study|Lost to Follow-up|1|||
164548955|NCT01074190|594383127|FG001|Overall Study|Emergency Cesarean Delivery|2|||
164548956|NCT01074190|594383128|FG002|Overall Study|Emergency Cesarean Delivery|1|||
164548957|NCT01074190|594383126|FG000|Overall Study|Protocol Violation|2|||
164548958|NCT01074190|594383127|FG001|Overall Study|Protocol Violation|1|||
164548959|NCT01074190|594383128|FG002|Overall Study|Protocol Violation|0|||
164548960|NCT01074190|594383126|FG000|Overall Study|Delivered in under 90 minutes|0|||
164548961|NCT01074190|594383127|FG001|Overall Study|Delivered in under 90 minutes|2|||
164196695|NCT01171898|593089868|FG003|Overall Study|Lost to Follow-up|1|||
164548962|NCT01074190|594383128|FG002|Overall Study|Delivered in under 90 minutes|1|||
164302203|NCT01134055|593482560|FG004|Overall Study|Lost to Follow-up|0|||
164196696|NCT01171898|593089865|FG000|Overall Study|Withdrawal by Subject|1|||
164196697|NCT01171898|593089866|FG001|Overall Study|Withdrawal by Subject|4|||
164196698|NCT01171898|593089867|FG002|Overall Study|Withdrawal by Subject|6|||
164196699|NCT01171898|593089868|FG003|Overall Study|Withdrawal by Subject|3|||
164196700|NCT01171898|593089865|FG000|Overall Study|Terminated by Sponsor|1|||
164548963|NCT01074190|594383126|FG000|Overall Study|Subject withdrew consent|1|||
164548964|NCT01074190|594383127|FG001|Overall Study|Subject withdrew consent|1|||
164548965|NCT01074190|594383128|FG002|Overall Study|Subject withdrew consent|1|||
164548966|NCT00732303|594383129|FG000|Overall Study|Study Terminated|2|||
164548967|NCT01576549|594383140|FG000|Overall Study|Sponsor Decision|2|||
164548968|NCT00053417|594383141|FG000|Overall Study|Adverse Event|1|||
164548969|NCT00053417|594383142|FG001|Overall Study|Adverse Event|0|||
164548970|NCT00053417|594383143|FG002|Overall Study|Adverse Event|1|||
164548971|NCT00053417|594383144|FG003|Overall Study|Adverse Event|5|||
164548972|NCT00053417|594383141|FG000|Overall Study|Non-Compliance|0|||
164548973|NCT00053417|594383142|FG001|Overall Study|Non-Compliance|0|||
164548974|NCT00053417|594383143|FG002|Overall Study|Non-Compliance|0|||
164548975|NCT00053417|594383144|FG003|Overall Study|Non-Compliance|1|||
164548976|NCT00053417|594383141|FG000|Overall Study|Withdrawal by Subject|0|||
164548977|NCT00053417|594383142|FG001|Overall Study|Withdrawal by Subject|1|||
164548978|NCT00053417|594383143|FG002|Overall Study|Withdrawal by Subject|0|||
164548979|NCT00053417|594383144|FG003|Overall Study|Withdrawal by Subject|0|||
164548980|NCT00053417|594383141|FG000|Overall Study|Lost to Follow-up|1|||
164548981|NCT00053417|594383142|FG001|Overall Study|Lost to Follow-up|1|||
164548982|NCT00053417|594383143|FG002|Overall Study|Lost to Follow-up|0|||
164548983|NCT00053417|594383144|FG003|Overall Study|Lost to Follow-up|0|||
164548984|NCT05879107|594383145|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
164548985|NCT05879107|594383146|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
164548986|NCT05879107|594383145|FG000|Overall Study|Migrated / moved from the study area|1|||
164548987|NCT05879107|594383146|FG001|Overall Study|Migrated / moved from the study area|1|||
164548988|NCT05879107|594383145|FG000|Overall Study|Lost to Follow-up|8|||
164548989|NCT05879107|594383146|FG001|Overall Study|Lost to Follow-up|13|||
164548990|NCT05879107|594383145|FG000|Overall Study|Death|0|||
164548991|NCT05879107|594383146|FG001|Overall Study|Death|2|||
164548992|NCT05879107|594383145|FG000|Overall Study|Other|0|||
164548993|NCT05879107|594383146|FG001|Overall Study|Other|3|||
164548994|NCT00804570|594383147|FG000|Overall Study|Adverse Event|14|||
164548995|NCT00804570|594383148|FG001|Overall Study|Adverse Event|7|||
164548996|NCT00804570|594383147|FG000|Overall Study|Lack of Efficacy|0|||
164548997|NCT00804570|594383148|FG001|Overall Study|Lack of Efficacy|1|||
164548998|NCT00804570|594383147|FG000|Overall Study|Lost to Follow-up|18|||
164548999|NCT00804570|594383148|FG001|Overall Study|Lost to Follow-up|21|||
164549000|NCT00804570|594383147|FG000|Overall Study|Entry criteria not met|5|||
164549001|NCT00804570|594383148|FG001|Overall Study|Entry criteria not met|5|||
164549002|NCT00804570|594383147|FG000|Overall Study|Protocol Violation|12|||
164549003|NCT00804570|594383148|FG001|Overall Study|Protocol Violation|16|||
164549004|NCT00804570|594383147|FG000|Overall Study|Physician Decision|1|||
164549005|NCT00804570|594383148|FG001|Overall Study|Physician Decision|2|||
164549006|NCT00804570|594383147|FG000|Overall Study|Sponsor decision|1|||
164549007|NCT00804570|594383148|FG001|Overall Study|Sponsor decision|4|||
164549008|NCT00804570|594383147|FG000|Overall Study|Withdrawal by Subject|21|||
164549009|NCT00804570|594383148|FG001|Overall Study|Withdrawal by Subject|38|||
164549010|NCT00290342|594383149|FG000|Overall Study|Other|0|||
164549011|NCT00290342|594383150|FG001|Overall Study|Other|1|||
164549012|NCT00290342|594383149|FG000|Overall Study|Withdrawal by Subject|6|||
164549013|NCT00290342|594383150|FG001|Overall Study|Withdrawal by Subject|4|||
164549014|NCT00290342|594383149|FG000|Overall Study|Lost to Follow-up|1|||
164549015|NCT00290342|594383150|FG001|Overall Study|Lost to Follow-up|0|||
164549016|NCT01056510|594383153|FG000|Overall Study|Dropout Before Start of Treatment|1|||
164549017|NCT01056510|594383154|FG001|Overall Study|Dropout Before Start of Treatment|1|||
164549018|NCT01056510|594383153|FG000|Overall Study|Withdrawal by Subject|4|||
164549019|NCT01056510|594383154|FG001|Overall Study|Withdrawal by Subject|2|||
164549020|NCT01056510|594383153|FG000|Overall Study|Death|29|||
164549021|NCT01056510|594383154|FG001|Overall Study|Death|34|||
164549022|NCT01056510|594383153|FG000|Overall Study|Noncompliance|1|||
164549023|NCT01056510|594383154|FG001|Overall Study|Noncompliance|3|||
164549024|NCT01056510|594383153|FG000|Overall Study|Physician Decision|4|||
164549025|NCT01056510|594383154|FG001|Overall Study|Physician Decision|5|||
164654775|NCT00124020|594762976|FG000|Overall Study|Withdrawal by Subject|13|||
164654776|NCT00124020|594762977|FG001|Overall Study|Withdrawal by Subject|11|||
164549026|NCT01056510|594383153|FG000|Overall Study|Lost to Follow-up|5|||
164549027|NCT01056510|594383154|FG001|Overall Study|Lost to Follow-up|6|||
164654777|NCT00124020|594762976|FG000|Overall Study|Lost to Follow-up|5|||
164654778|NCT00124020|594762977|FG001|Overall Study|Lost to Follow-up|8|||
164196701|NCT01171898|593089866|FG001|Overall Study|Terminated by Sponsor|0|||
164549028|NCT01056510|594383153|FG000|Overall Study|Other|10|||
164549029|NCT01056510|594383154|FG001|Overall Study|Other|12|||
164549030|NCT01056510|594383153|FG000|Overall Study|Missing|0|||
164549031|NCT01056510|594383154|FG001|Overall Study|Missing|1|||
164654779|NCT00124020|594762976|FG000|Overall Study|Other|1|||
164654780|NCT00124020|594762977|FG001|Overall Study|Other|1|||
164654781|NCT00124020|594762976|FG000|Overall Study|Transfer to another hospital|2|||
164654782|NCT00124020|594762977|FG001|Overall Study|Transfer to another hospital|0|||
164654783|NCT01799590|594762978|FG000|Overall Study|Adverse Event|13|||
164654784|NCT01799590|594762979|FG001|Overall Study|Adverse Event|7|||
164654785|NCT01799590|594762980|FG002|Overall Study|Adverse Event|5|||
164654786|NCT01799590|594762978|FG000|Overall Study|Pregnancy|2|||
164654787|NCT01799590|594762979|FG001|Overall Study|Pregnancy|0|||
164654788|NCT01799590|594762980|FG002|Overall Study|Pregnancy|0|||
164654789|NCT01799590|594762978|FG000|Overall Study|Lack of Efficacy|3|||
164654790|NCT01799590|594762979|FG001|Overall Study|Lack of Efficacy|1|||
164654791|NCT01799590|594762980|FG002|Overall Study|Lack of Efficacy|3|||
164654792|NCT01799590|594762978|FG000|Overall Study|Participants convenience|4|||
164654793|NCT01799590|594762979|FG001|Overall Study|Participants convenience|4|||
164654794|NCT01799590|594762980|FG002|Overall Study|Participants convenience|2|||
164654795|NCT01799590|594762978|FG000|Overall Study|Aggravation of complications|0|||
164654796|NCT01799590|594762979|FG001|Overall Study|Aggravation of complications|1|||
164654797|NCT01799590|594762980|FG002|Overall Study|Aggravation of complications|1|||
164654798|NCT01799590|594762978|FG000|Overall Study|Using drugs with restricted days of use|0|||
164654799|NCT01799590|594762979|FG001|Overall Study|Using drugs with restricted days of use|3|||
164654800|NCT01799590|594762980|FG002|Overall Study|Using drugs with restricted days of use|2|||
164654801|NCT01799590|594762978|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
164654802|NCT01799590|594762979|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
164654803|NCT01799590|594762980|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
164654804|NCT01799590|594762978|FG000|Overall Study|Other|3|||
164654805|NCT01799590|594762979|FG001|Overall Study|Other|0|||
164654806|NCT01799590|594762980|FG002|Overall Study|Other|1|||
164654807|NCT00752791|594762981|FG000|Overall Study|Adverse Event|7|||
164654808|NCT00752791|594762981|FG000|Overall Study|Withdrawal by Subject|1|||
164654809|NCT00752791|594762981|FG000|Overall Study|Physician Decision|1|||
164654810|NCT00752791|594762981|FG000|Overall Study|Death|1|||
164654811|NCT00752791|594762981|FG000|Overall Study|Renal transplant|3|||
164654812|NCT00752791|594762981|FG000|Overall Study|Switched to hemodialysis|2|||
164654813|NCT00752791|594762981|FG000|Overall Study|Protocol deviation|1|||
164654814|NCT01977092|594762986|FG000|Overall Study|Death|3|||
164654815|NCT01977092|594762987|FG001|Overall Study|Death|4|||
164654816|NCT01977092|594762986|FG000|Overall Study|Lost to Follow-up|23|||
164654817|NCT01977092|594762987|FG001|Overall Study|Lost to Follow-up|14|||
164654818|NCT01977092|594762986|FG000|Overall Study|Withdrawal by Subject|2|||
164654819|NCT01977092|594762987|FG001|Overall Study|Withdrawal by Subject|1|||
164654820|NCT01977092|594762986|FG000|Overall Study|In prison|3|||
164654821|NCT01977092|594762987|FG001|Overall Study|In prison|11|||
164654822|NCT03038113|594762988|FG000|Overall Study|Withdrawal by Subject|0|||
164654823|NCT03038113|594762989|FG001|Overall Study|Withdrawal by Subject|0|||
164654824|NCT03038113|594762990|FG002|Overall Study|Withdrawal by Subject|1|||
164654825|NCT03038113|594762991|FG003|Overall Study|Withdrawal by Subject|0|||
164654826|NCT03038113|594762992|FG004|Overall Study|Withdrawal by Subject|0|||
164654827|NCT03038113|594762993|FG005|Overall Study|Withdrawal by Subject|0|||
164654828|NCT03038113|594762994|FG006|Overall Study|Withdrawal by Subject|0|||
164654829|NCT03038113|594762995|FG007|Overall Study|Withdrawal by Subject|0|||
164654830|NCT03038113|594762996|FG008|Overall Study|Withdrawal by Subject|0|||
164654831|NCT03038113|594762997|FG009|Overall Study|Withdrawal by Subject|0|||
164654832|NCT03038113|594762998|FG010|Overall Study|Withdrawal by Subject|0|||
164654833|NCT03038113|594762999|FG011|Overall Study|Withdrawal by Subject|0|||
164654834|NCT03038113|594763000|FG012|Overall Study|Withdrawal by Subject|0|||
164654835|NCT03038113|594763001|FG013|Overall Study|Withdrawal by Subject|1|||
164654836|NCT03038113|594762988|FG000|Overall Study|Lost to Follow-up|0|||
164654837|NCT03038113|594762989|FG001|Overall Study|Lost to Follow-up|0|||
164654838|NCT03038113|594762990|FG002|Overall Study|Lost to Follow-up|0|||
164654839|NCT03038113|594762991|FG003|Overall Study|Lost to Follow-up|0|||
164654840|NCT03038113|594762992|FG004|Overall Study|Lost to Follow-up|0|||
164654841|NCT03038113|594762993|FG005|Overall Study|Lost to Follow-up|0|||
164654842|NCT03038113|594762994|FG006|Overall Study|Lost to Follow-up|1|||
164654843|NCT03038113|594762995|FG007|Overall Study|Lost to Follow-up|0|||
164654844|NCT03038113|594762996|FG008|Overall Study|Lost to Follow-up|0|||
164654845|NCT03038113|594762997|FG009|Overall Study|Lost to Follow-up|0|||
164654846|NCT03038113|594762998|FG010|Overall Study|Lost to Follow-up|0|||
164654847|NCT03038113|594762999|FG011|Overall Study|Lost to Follow-up|0|||
164654848|NCT03038113|594763000|FG012|Overall Study|Lost to Follow-up|0|||
164654849|NCT03038113|594763001|FG013|Overall Study|Lost to Follow-up|0|||
164654850|NCT02927847|594763005|FG000|Overall Study|Lost to Follow-up|1|||
164654851|NCT02927847|594763006|FG001|Overall Study|Lost to Follow-up|0|||
164654852|NCT02927847|594763005|FG000|Overall Study|Withdrawal by Subject|4|||
164196702|NCT01171898|593089867|FG002|Overall Study|Terminated by Sponsor|0|||
164654853|NCT02927847|594763006|FG001|Overall Study|Withdrawal by Subject|2|||
164654854|NCT02927847|594763005|FG000|Overall Study|PI withdrawn due to missed visits|1|||
164654855|NCT02927847|594763006|FG001|Overall Study|PI withdrawn due to missed visits|1|||
164549032|NCT02285998|594383155|FG000|Overall Study|Adverse Event|9|||
164549033|NCT02285998|594383156|FG001|Overall Study|Adverse Event|8|||
164549034|NCT02285998|594383155|FG000|Overall Study|Physician Decision|1|||
164549035|NCT02285998|594383156|FG001|Overall Study|Physician Decision|2|||
164549036|NCT02285998|594383155|FG000|Overall Study|Lost to Follow-up|176|||
164549037|NCT02285998|594383156|FG001|Overall Study|Lost to Follow-up|172|||
164549038|NCT02285998|594383155|FG000|Overall Study|Withdrawal by Subject|53|||
164549039|NCT02285998|594383156|FG001|Overall Study|Withdrawal by Subject|61|||
164549040|NCT02285998|594383155|FG000|Overall Study|Other Reasons|7|||
164549041|NCT02285998|594383156|FG001|Overall Study|Other Reasons|10|||
164549042|NCT04744207|594383157|FG000|Treatment|Withdrawal by Subject|2|||
164549043|NCT04744207|594383158|FG001|Treatment|Withdrawal by Subject|0|||
164549044|NCT04744207|594383157|FG000|Treatment|Adverse Event|1|||
164549045|NCT04744207|594383158|FG001|Treatment|Adverse Event|2|||
164549046|NCT02230384|594383159|FG000|Phase 1|Lost to Follow-up|1|||
164549047|NCT02230384|594383160|FG001|Phase 1|Lost to Follow-up|0|||
164549048|NCT02230384|594383159|FG000|Phase 1|Physician Decision|0|||
164549049|NCT02230384|594383160|FG001|Phase 1|Physician Decision|1|||
164549050|NCT02230384|594383159|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
164549051|NCT02230384|594383160|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
164549052|NCT02230384|594383159|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
164549053|NCT02230384|594383160|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
164549054|NCT02230384|594383159|FG000|Phase 2 - Switch|Adverse Event|2|||
164549055|NCT02230384|594383160|FG001|Phase 2 - Switch|Adverse Event|0|||
164549056|NCT01301950|594383161|FG000|Overall Study|Surgery was cancelled by patient|0|||
164549057|NCT01301950|594383162|FG001|Overall Study|Surgery was cancelled by patient|1|||
164549058|NCT00964743|594383165|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
164549059|NCT03317795|594383166|FG000|Overall Study|IUD Expulsion|1|||
164549060|NCT03317795|594383167|FG001|Overall Study|IUD Expulsion|0|||
164549061|NCT03317795|594383166|FG000|Overall Study|Lost to Follow-up|1|||
164549062|NCT03317795|594383167|FG001|Overall Study|Lost to Follow-up|3|||
164549063|NCT03317795|594383166|FG000|Overall Study|Treatment change|0|||
164549064|NCT03317795|594383167|FG001|Overall Study|Treatment change|3|||
164549065|NCT03317795|594383166|FG000|Overall Study|Intolerance of medication|0|||
164549066|NCT03317795|594383167|FG001|Overall Study|Intolerance of medication|1|||
164549067|NCT00886600|594383170|FG000|Double-blind Monotherapy|Adverse Event|1|||
164549068|NCT00886600|594383171|FG001|Double-blind Monotherapy|Adverse Event|1|||
164549069|NCT00886600|594383172|FG002|Double-blind Monotherapy|Adverse Event|1|||
164549070|NCT00886600|594383173|FG003|Double-blind Monotherapy|Adverse Event|1|||
164549071|NCT00886600|594383170|FG000|Double-blind Monotherapy|Protocol Violation|0|||
164549072|NCT00886600|594383171|FG001|Double-blind Monotherapy|Protocol Violation|0|||
164549073|NCT00886600|594383172|FG002|Double-blind Monotherapy|Protocol Violation|0|||
164549074|NCT00886600|594383173|FG003|Double-blind Monotherapy|Protocol Violation|1|||
164549075|NCT00886600|594383170|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
164549076|NCT00886600|594383171|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
164549077|NCT00886600|594383172|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
164549078|NCT00886600|594383173|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
164549079|NCT00886600|594383170|FG000|Combination Therapy Period|Adverse Event|0|||
164549080|NCT00886600|594383171|FG001|Combination Therapy Period|Adverse Event|0|||
164549081|NCT00886600|594383172|FG002|Combination Therapy Period|Adverse Event|1|||
164549082|NCT00886600|594383173|FG003|Combination Therapy Period|Adverse Event|0|||
164549083|NCT00886600|594383170|FG000|Combination Therapy Period|Protocol Violation|0|||
164549084|NCT00886600|594383171|FG001|Combination Therapy Period|Protocol Violation|0|||
164549085|NCT00886600|594383172|FG002|Combination Therapy Period|Protocol Violation|1|||
164549086|NCT00886600|594383173|FG003|Combination Therapy Period|Protocol Violation|0|||
164549087|NCT00501007|594383174|FG000|Overall Study|Inclusion criteria not met.|29|||
164549088|NCT00501007|594383175|FG001|Overall Study|Inclusion criteria not met.|25|||
164549089|NCT02424253|594383177|FG000|Overall Study|Other, unspecified|1|||
164549090|NCT02424253|594383178|FG001|Overall Study|Other, unspecified|0|||
164549091|NCT02424253|594383177|FG000|Overall Study|Compliance problems|1|||
164549092|NCT02424253|594383178|FG001|Overall Study|Compliance problems|0|||
164549093|NCT02424253|594383177|FG000|Overall Study|Physician Decision|2|||
164549094|NCT02424253|594383178|FG001|Overall Study|Physician Decision|0|||
164549095|NCT02424253|594383177|FG000|Overall Study|Lack of Efficacy|0|||
164549096|NCT02424253|594383178|FG001|Overall Study|Lack of Efficacy|7|||
164549097|NCT02424253|594383177|FG000|Overall Study|Adverse Event|2|||
164549098|NCT02424253|594383178|FG001|Overall Study|Adverse Event|0|||
164549099|NCT02424253|594383177|FG000|Overall Study|Consent withdrawn by subject|4|||
164549100|NCT02424253|594383178|FG001|Overall Study|Consent withdrawn by subject|1|||
164549101|NCT02424253|594383177|FG000|Overall Study|Lost to Follow-up|1|||
164549102|NCT02424253|594383178|FG001|Overall Study|Lost to Follow-up|1|||
164549103|NCT00578136|594383181|FG000|Overall Study|Not given intervention|1|||
164549104|NCT00578136|594383182|FG001|Overall Study|Not given intervention|1|||
164549105|NCT01585272|594383192|FG000|Overall Study|Adverse Event|22|||
164549106|NCT01585272|594383192|FG000|Overall Study|Protocol Violation|7|||
164549107|NCT01585272|594383192|FG000|Overall Study|Withdrawal by Subject|10|||
164549108|NCT00517751|594383197|FG000|Overall Study|Death|3|||
164654856|NCT00553540|594763007|FG000|Overall Study|discharged after first visit|2|||
164654857|NCT00553540|594763008|FG001|Overall Study|discharged after first visit|5|||
164654858|NCT03882047|594763009|FG000|Overall Study|Adverse Event|0|||
164654859|NCT03882047|594763010|FG001|Overall Study|Adverse Event|2|||
164654860|NCT03882047|594763011|FG002|Overall Study|Adverse Event|2|||
164654861|NCT03882047|594763009|FG000|Overall Study|Treatment Failure|3|||
164654862|NCT03882047|594763010|FG001|Overall Study|Treatment Failure|3|||
164654863|NCT03882047|594763011|FG002|Overall Study|Treatment Failure|12|||
164654864|NCT03882047|594763009|FG000|Overall Study|Lost to Follow-up|0|||
164654865|NCT03882047|594763010|FG001|Overall Study|Lost to Follow-up|1|||
164654866|NCT03882047|594763011|FG002|Overall Study|Lost to Follow-up|0|||
164654867|NCT03882047|594763009|FG000|Overall Study|Did Not Wish to Continue|1|||
164654868|NCT03882047|594763010|FG001|Overall Study|Did Not Wish to Continue|4|||
164654869|NCT03882047|594763011|FG002|Overall Study|Did Not Wish to Continue|1|||
164654870|NCT03882047|594763009|FG000|Overall Study|Noncompliance With Protocol|2|||
164654871|NCT03882047|594763010|FG001|Overall Study|Noncompliance With Protocol|0|||
164654872|NCT03882047|594763011|FG002|Overall Study|Noncompliance With Protocol|0|||
164654873|NCT03882047|594763009|FG000|Overall Study|Did Not Meet Eligibility|0|||
164654874|NCT03882047|594763010|FG001|Overall Study|Did Not Meet Eligibility|0|||
164654875|NCT03882047|594763011|FG002|Overall Study|Did Not Meet Eligibility|1|||
164654876|NCT01155583|594763013|FG000|Phase I|Screen failure - did not start treatment|0|||
164654877|NCT01155583|594763014|FG001|Phase I|Screen failure - did not start treatment|0|||
164654878|NCT01155583|594763015|FG002|Phase I|Screen failure - did not start treatment|0|||
164654879|NCT01155583|594763016|FG003|Phase I|Screen failure - did not start treatment|0|||
164654880|NCT01155583|594763017|FG004|Phase I|Screen failure - did not start treatment|1|||
164654881|NCT01155583|594763018|FG005|Phase I|Screen failure - did not start treatment|0|||
164654882|NCT01155583|594763019|FG006|Phase I|Screen failure - did not start treatment|0|||
164654883|NCT01155583|594763020|FG007|Phase I|Screen failure - did not start treatment|2|||
164654884|NCT01155583|594763021|FG008|Phase I|Screen failure - did not start treatment|0|||
164654885|NCT01155583|594763013|FG000|Phase I|Withdrawal by Subject|0|||
164654886|NCT01155583|594763014|FG001|Phase I|Withdrawal by Subject|0|||
164654887|NCT01155583|594763015|FG002|Phase I|Withdrawal by Subject|0|||
164654888|NCT01155583|594763016|FG003|Phase I|Withdrawal by Subject|0|||
164654889|NCT01155583|594763017|FG004|Phase I|Withdrawal by Subject|0|||
164654890|NCT01155583|594763018|FG005|Phase I|Withdrawal by Subject|0|||
164654891|NCT01155583|594763019|FG006|Phase I|Withdrawal by Subject|0|||
164654892|NCT01155583|594763020|FG007|Phase I|Withdrawal by Subject|1|||
164654893|NCT01155583|594763021|FG008|Phase I|Withdrawal by Subject|0|||
164654894|NCT00886483|594763028|FG000|Overall Study|Lost to Follow-up|0|||
164654895|NCT00886483|594763029|FG001|Overall Study|Lost to Follow-up|1|||
164654896|NCT00886483|594763028|FG000|Overall Study|Pursue medications|1|||
164654897|NCT00886483|594763029|FG001|Overall Study|Pursue medications|2|||
164654898|NCT00886483|594763028|FG000|Overall Study|Distance to center, poor grades|1|||
164654899|NCT00886483|594763029|FG001|Overall Study|Distance to center, poor grades|0|||
164654900|NCT01001169|594763030|FG000|Overall Study|Withdrawal by Subject|2|||
164654901|NCT01001169|594763031|FG001|Overall Study|Withdrawal by Subject|1|||
164549109|NCT00517751|594383197|FG000|Overall Study|Withdrawal by Subject|37|||
164549110|NCT00517751|594383197|FG000|Overall Study|Lost to Follow-up|4|||
164549111|NCT00517751|594383197|FG000|Overall Study|patient not over due|6|||
164549112|NCT00517751|594383197|FG000|Overall Study|Patient not due for visit|76|||
164549113|NCT00517751|594383197|FG000|Overall Study|Missing|3|||
164549114|NCT02581202|594383200|FG000|Overall Study|Lack of Efficacy|2|||
164549115|NCT02581202|594383200|FG000|Overall Study|Withdrawal by Subject|4|||
164549116|NCT02581202|594383200|FG000|Overall Study|Lost to Follow-up|5|||
164549117|NCT02581202|594383200|FG000|Overall Study|Pregnancy|3|||
164549118|NCT04050982|594383201|FG000|Overall Study|Did not meet eligibility criteria|0|||
164549119|NCT04050982|594383202|FG001|Overall Study|Did not meet eligibility criteria|1|||
164549120|NCT04050982|594383203|FG002|Overall Study|Did not meet eligibility criteria|0|||
164549121|NCT04050982|594383201|FG000|Overall Study|Withdrawal by Subject|1|||
164654902|NCT00602030|594763032|FG000|Lead-in Phase|Disease Progression|2|||
164654903|NCT00602030|594763033|FG001|Lead-in Phase|Disease Progression|3|||
164654904|NCT00602030|594763034|FG002|Lead-in Phase|Disease Progression|0|||
164654905|NCT00602030|594763035|FG003|Lead-in Phase|Disease Progression|0|||
164654906|NCT00602030|594763036|FG004|Lead-in Phase|Disease Progression|0|||
164654907|NCT00602030|594763032|FG000|Lead-in Phase|Adverse Event|0|||
164654908|NCT00602030|594763033|FG001|Lead-in Phase|Adverse Event|2|||
164654909|NCT00602030|594763034|FG002|Lead-in Phase|Adverse Event|0|||
164654910|NCT00602030|594763035|FG003|Lead-in Phase|Adverse Event|0|||
164196703|NCT01171898|593089868|FG003|Overall Study|Terminated by Sponsor|0|||
164654911|NCT00602030|594763036|FG004|Lead-in Phase|Adverse Event|0|||
164654912|NCT00602030|594763032|FG000|Double-blind Phase|Disease progression|0|||
164654913|NCT00602030|594763033|FG001|Double-blind Phase|Disease progression|0|||
164196704|NCT01171898|593089865|FG000|Overall Study|Ongoing|1|||
164549122|NCT04050982|594383202|FG001|Overall Study|Withdrawal by Subject|0|||
164196705|NCT01171898|593089866|FG001|Overall Study|Ongoing|9|||
164549123|NCT04050982|594383203|FG002|Overall Study|Withdrawal by Subject|0|||
164654914|NCT00602030|594763034|FG002|Double-blind Phase|Disease progression|33|||
164549124|NCT04050982|594383201|FG000|Overall Study|Unable to enroll on platform|1|||
164549125|NCT04050982|594383202|FG001|Overall Study|Unable to enroll on platform|0|||
164549126|NCT04050982|594383203|FG002|Overall Study|Unable to enroll on platform|0|||
164549127|NCT05885737|594383204|FG000|DB Period|Adverse Event|4|||
164549128|NCT05885737|594383205|FG001|DB Period|Adverse Event|4|||
164549129|NCT05885737|594383204|FG000|DB Period|Lost to Follow-up|0|||
164549130|NCT05885737|594383205|FG001|DB Period|Lost to Follow-up|1|||
164549131|NCT05885737|594383204|FG000|DB Period|Physician Decision|2|||
164549132|NCT05885737|594383205|FG001|DB Period|Physician Decision|0|||
164549133|NCT05885737|594383204|FG000|DB Period|Withdrawal by Subject|12|||
164549134|NCT05885737|594383205|FG001|DB Period|Withdrawal by Subject|6|||
164549135|NCT05885737|594383204|FG000|DB Period|Other: Unspecified|2|||
164549136|NCT05885737|594383205|FG001|DB Period|Other: Unspecified|2|||
164549137|NCT05885737|594383204|FG000|OLE Period|Adverse Event|3|||
164549138|NCT05885737|594383205|FG001|OLE Period|Adverse Event|2|||
164549139|NCT05885737|594383204|FG000|OLE Period|Physician Decision|1|||
164549140|NCT05885737|594383205|FG001|OLE Period|Physician Decision|0|||
164196706|NCT01171898|593089867|FG002|Overall Study|Ongoing|3|||
164196707|NCT01171898|593089868|FG003|Overall Study|Ongoing|0|||
164196708|NCT01171898|593089865|FG000|Overall Study|Other|1|||
164549141|NCT05885737|594383204|FG000|OLE Period|Withdrawal by Subject|5|||
164549142|NCT05885737|594383205|FG001|OLE Period|Withdrawal by Subject|5|||
164549143|NCT05885737|594383204|FG000|OLE Period|Other: Unspecified|2|||
164549144|NCT05885737|594383205|FG001|OLE Period|Other: Unspecified|1|||
164549145|NCT02819635|594384905|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
164654915|NCT00602030|594763035|FG003|Double-blind Phase|Disease progression|30|||
164654916|NCT00602030|594763036|FG004|Double-blind Phase|Disease progression|0|||
164654917|NCT00602030|594763032|FG000|Double-blind Phase|Adverse Event|0|||
164654918|NCT00602030|594763033|FG001|Double-blind Phase|Adverse Event|0|||
164654919|NCT00602030|594763034|FG002|Double-blind Phase|Adverse Event|9|||
164654920|NCT00602030|594763035|FG003|Double-blind Phase|Adverse Event|18|||
164654921|NCT00602030|594763036|FG004|Double-blind Phase|Adverse Event|0|||
164654922|NCT00602030|594763032|FG000|Double-blind Phase|Consent withdrawal|0|||
164654923|NCT00602030|594763033|FG001|Double-blind Phase|Consent withdrawal|0|||
164654924|NCT00602030|594763034|FG002|Double-blind Phase|Consent withdrawal|4|||
164654925|NCT00602030|594763035|FG003|Double-blind Phase|Consent withdrawal|3|||
164654926|NCT00602030|594763036|FG004|Double-blind Phase|Consent withdrawal|0|||
164654927|NCT00602030|594763032|FG000|Double-blind Phase|Death|0|||
164654928|NCT00602030|594763033|FG001|Double-blind Phase|Death|0|||
164654929|NCT00602030|594763034|FG002|Double-blind Phase|Death|3|||
164654930|NCT00602030|594763035|FG003|Double-blind Phase|Death|3|||
164654931|NCT00602030|594763036|FG004|Double-blind Phase|Death|0|||
164654932|NCT00602030|594763032|FG000|Double-blind Phase|Administrative decision|0|||
164549146|NCT02819635|594384906|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
164549147|NCT02819635|594384907|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
164549148|NCT02819635|594384908|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
164549149|NCT02819635|594384909|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
164654933|NCT00602030|594763033|FG001|Double-blind Phase|Administrative decision|0|||
164654934|NCT00602030|594763034|FG002|Double-blind Phase|Administrative decision|0|||
164196709|NCT01171898|593089866|FG001|Overall Study|Other|5|||
164654935|NCT00602030|594763035|FG003|Double-blind Phase|Administrative decision|2|||
164654936|NCT00602030|594763036|FG004|Double-blind Phase|Administrative decision|0|||
164654937|NCT00602030|594763032|FG000|Double-blind Phase|Ineligibility|0|||
164654938|NCT00602030|594763033|FG001|Double-blind Phase|Ineligibility|0|||
164654939|NCT00602030|594763034|FG002|Double-blind Phase|Ineligibility|0|||
164654940|NCT00602030|594763035|FG003|Double-blind Phase|Ineligibility|1|||
164196710|NCT01171898|593089867|FG002|Overall Study|Other|0|||
164196711|NCT01171898|593089868|FG003|Overall Study|Other|2|||
164196712|NCT03191799|593089869|FG000|Overall Study|Withdrawal by Subject|4|||
164196713|NCT03191799|593089869|FG000|Overall Study|Physician Decision|2|||
164196714|NCT03191799|593089869|FG000|Overall Study|Lost to Follow-up|1|||
164196715|NCT03191799|593089869|FG000|Overall Study|Death|2|||
164549150|NCT02819635|594384910|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
164654941|NCT00602030|594763036|FG004|Double-blind Phase|Ineligibility|0|||
164654942|NCT00602030|594763032|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
164196716|NCT00468585|593089870|FG000|Overall Study|Patient not treated|1|||
164196717|NCT00468585|593089871|FG001|Overall Study|Patient not treated|0|||
164196718|NCT00468585|593089872|FG002|Overall Study|Patient not treated|1|||
164196719|NCT00468585|593089873|FG003|Overall Study|Patient not treated|0|||
164196720|NCT00468585|593089870|FG000|Overall Study|Patient found to be ineligible|0|||
164196721|NCT00468585|593089871|FG001|Overall Study|Patient found to be ineligible|0|||
164302204|NCT01134055|593482561|FG005|Overall Study|Lost to Follow-up|0|||
164549151|NCT02819635|594384911|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
164549152|NCT02819635|594384912|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
164549153|NCT02819635|594384913|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
164549154|NCT02819635|594384914|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
164549155|NCT02819635|594384915|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
164654943|NCT00602030|594763033|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
164654944|NCT00602030|594763034|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
164654945|NCT00602030|594763035|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
164654946|NCT00602030|594763036|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
164654947|NCT00602030|594763032|FG000|Double-blind Phase|Reason not specified|0|||
164654948|NCT00602030|594763033|FG001|Double-blind Phase|Reason not specified|0|||
164654949|NCT00602030|594763034|FG002|Double-blind Phase|Reason not specified|4|||
164654950|NCT00602030|594763035|FG003|Double-blind Phase|Reason not specified|2|||
164654951|NCT00602030|594763036|FG004|Double-blind Phase|Reason not specified|0|||
164654952|NCT00602030|594763032|FG000|Crossover Phase|Disease Progression|0|||
164654953|NCT00602030|594763033|FG001|Crossover Phase|Disease Progression|0|||
164654954|NCT00602030|594763034|FG002|Crossover Phase|Disease Progression|0|||
164654955|NCT00602030|594763035|FG003|Crossover Phase|Disease Progression|0|||
164654956|NCT00602030|594763036|FG004|Crossover Phase|Disease Progression|11|||
164654957|NCT00602030|594763032|FG000|Crossover Phase|Adverse Event|0|||
164654958|NCT00602030|594763033|FG001|Crossover Phase|Adverse Event|0|||
164654959|NCT00602030|594763034|FG002|Crossover Phase|Adverse Event|0|||
164654960|NCT00602030|594763035|FG003|Crossover Phase|Adverse Event|0|||
164654961|NCT00602030|594763036|FG004|Crossover Phase|Adverse Event|3|||
164654962|NCT00602030|594763032|FG000|Crossover Phase|Consent withdrawal|0|||
164654963|NCT00602030|594763033|FG001|Crossover Phase|Consent withdrawal|0|||
164654964|NCT00602030|594763034|FG002|Crossover Phase|Consent withdrawal|0|||
164654965|NCT00602030|594763035|FG003|Crossover Phase|Consent withdrawal|0|||
164654966|NCT00602030|594763036|FG004|Crossover Phase|Consent withdrawal|2|||
164654967|NCT01138150|594763037|FG000|Overall Study|blood unable to be processed|0|||
164654968|NCT01138150|594763038|FG001|Overall Study|blood unable to be processed|1|||
164654969|NCT01138150|594763037|FG000|Overall Study|Physician Decision|1|||
164654970|NCT01138150|594763038|FG001|Overall Study|Physician Decision|0|||
164654971|NCT01580020|594763039|FG000|Overall Study|Lack of Efficacy|0|||
164654972|NCT01580020|594763040|FG001|Overall Study|Lack of Efficacy|5|||
164654973|NCT01580020|594763041|FG002|Overall Study|Lack of Efficacy|0|||
164654974|NCT01580020|594763042|FG003|Overall Study|Lack of Efficacy|1|||
164654975|NCT01580020|594763039|FG000|Overall Study|Withdrawal by Subject|0|||
164654976|NCT01580020|594763040|FG001|Overall Study|Withdrawal by Subject|1|||
164654977|NCT01580020|594763041|FG002|Overall Study|Withdrawal by Subject|1|||
164654978|NCT01580020|594763042|FG003|Overall Study|Withdrawal by Subject|0|||
164654979|NCT01580020|594763039|FG000|Overall Study|Adverse Event|1|||
164654980|NCT01580020|594763040|FG001|Overall Study|Adverse Event|1|||
164654981|NCT01580020|594763041|FG002|Overall Study|Adverse Event|1|||
164654982|NCT01580020|594763042|FG003|Overall Study|Adverse Event|1|||
164654983|NCT01580020|594763039|FG000|Overall Study|Administrative Problems|0|||
164654984|NCT01580020|594763040|FG001|Overall Study|Administrative Problems|0|||
164654985|NCT01580020|594763041|FG002|Overall Study|Administrative Problems|1|||
164654986|NCT01580020|594763042|FG003|Overall Study|Administrative Problems|0|||
164654987|NCT01580020|594763039|FG000|Overall Study|Lost to Follow-up|0|||
164654988|NCT01580020|594763040|FG001|Overall Study|Lost to Follow-up|0|||
164654989|NCT01580020|594763041|FG002|Overall Study|Lost to Follow-up|1|||
164654990|NCT01580020|594763042|FG003|Overall Study|Lost to Follow-up|0|||
164654991|NCT01724359|594763043|FG000|Overall Study|Adverse Event|10|||
164654992|NCT01724359|594763043|FG000|Overall Study|Death|1|||
164654993|NCT01724359|594763043|FG000|Overall Study|Other|20|||
164654994|NCT02151461|594763050|FG000|Overall Study|Adverse Event|5|||
164654995|NCT02151461|594763051|FG001|Overall Study|Adverse Event|1|||
164654996|NCT02151461|594763052|FG002|Overall Study|Adverse Event|0|||
164654997|NCT02151461|594763053|FG003|Overall Study|Adverse Event|2|||
164654998|NCT02151461|594763050|FG000|Overall Study|Lost to Follow-up|0|||
164654999|NCT02151461|594763051|FG001|Overall Study|Lost to Follow-up|0|||
164655000|NCT02151461|594763052|FG002|Overall Study|Lost to Follow-up|1|||
164655001|NCT02151461|594763053|FG003|Overall Study|Lost to Follow-up|1|||
164655002|NCT02151461|594763050|FG000|Overall Study|Withdrawal by Subject|1|||
164655003|NCT02151461|594763051|FG001|Overall Study|Withdrawal by Subject|0|||
164655004|NCT02151461|594763052|FG002|Overall Study|Withdrawal by Subject|1|||
164655005|NCT02151461|594763053|FG003|Overall Study|Withdrawal by Subject|1|||
164196722|NCT00468585|593089872|FG002|Overall Study|Patient found to be ineligible|1|||
164196723|NCT00468585|593089873|FG003|Overall Study|Patient found to be ineligible|0|||
164196724|NCT00468585|593089870|FG000|Overall Study|Adverse Event|0|||
164655006|NCT02151461|594763050|FG000|Overall Study|Treatment discontinuation|0|||
164655007|NCT02151461|594763051|FG001|Overall Study|Treatment discontinuation|0|||
164196725|NCT00468585|593089871|FG001|Overall Study|Adverse Event|0|||
164655008|NCT02151461|594763052|FG002|Overall Study|Treatment discontinuation|1|||
164655009|NCT02151461|594763053|FG003|Overall Study|Treatment discontinuation|0|||
164655010|NCT02168270|594763054|FG000|Overall Study|Lack of Efficacy|4|||
164655011|NCT00252187|594763055|FG000|Overall Study|Adverse Event|3|||
164655012|NCT00252187|594763056|FG001|Overall Study|Adverse Event|1|||
164655013|NCT00252187|594763055|FG000|Overall Study|Withdrawal by Subject|1|||
164655014|NCT00252187|594763056|FG001|Overall Study|Withdrawal by Subject|0|||
164655015|NCT00593333|594763057|FG000|Overall Study|Lost to Follow-up|10|||
164655016|NCT00593333|594763058|FG001|Overall Study|Lost to Follow-up|11|||
164549156|NCT02819635|594384916|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
164549157|NCT02819635|594384905|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
164549158|NCT02819635|594384906|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
164549159|NCT02819635|594384907|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
164549160|NCT02819635|594384908|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
164549161|NCT02819635|594384909|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
164549162|NCT02819635|594384910|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
164549163|NCT02819635|594384911|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
164549164|NCT02819635|594384912|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
164549165|NCT02819635|594384913|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
164549166|NCT02819635|594384914|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
164549167|NCT02819635|594384915|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
164549168|NCT02819635|594384916|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
164549169|NCT02819635|594384905|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
164549170|NCT02819635|594384906|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
164549171|NCT02819635|594384907|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
164549172|NCT02819635|594384908|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
164549173|NCT02819635|594384909|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
164549174|NCT02819635|594384910|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
164549175|NCT02819635|594384911|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
164549176|NCT02819635|594384912|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
164549177|NCT02819635|594384913|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
164549178|NCT02819635|594384914|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
164549179|NCT02819635|594384915|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
164549180|NCT02819635|594384916|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
164549181|NCT02819635|594384905|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
164549182|NCT02819635|594384906|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
164549183|NCT02819635|594384907|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
164549184|NCT02819635|594384908|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
164549185|NCT02819635|594384909|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
164549186|NCT02819635|594384910|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
164549187|NCT02819635|594384911|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
164549188|NCT02819635|594384912|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
164549189|NCT02819635|594384913|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
164549190|NCT02819635|594384914|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
164549191|NCT02819635|594384915|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
164549192|NCT02819635|594384916|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
164549193|NCT02819635|594384905|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
164549194|NCT02819635|594384906|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
164549195|NCT02819635|594384907|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
164549196|NCT02819635|594384908|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
164549197|NCT02819635|594384909|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
164549198|NCT02819635|594384910|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
164549199|NCT02819635|594384911|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
164549200|NCT02819635|594384912|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
164549201|NCT02819635|594384913|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
164549202|NCT02819635|594384914|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
164549203|NCT02819635|594384915|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
164549204|NCT02819635|594384916|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
164549205|NCT02819635|594384905|FG000|Substudy 2, Part 2|Adverse Event|0|||
164549206|NCT02819635|594384906|FG001|Substudy 2, Part 2|Adverse Event|0|||
164549207|NCT02819635|594384907|FG002|Substudy 2, Part 2|Adverse Event|0|||
164549208|NCT02819635|594384908|FG003|Substudy 2, Part 2|Adverse Event|0|||
164549209|NCT02819635|594384909|FG004|Substudy 2, Part 2|Adverse Event|0|||
164549210|NCT02819635|594384910|FG005|Substudy 2, Part 2|Adverse Event|4|||
164549211|NCT02819635|594384911|FG006|Substudy 2, Part 2|Adverse Event|0|||
164549212|NCT02819635|594384912|FG007|Substudy 2, Part 2|Adverse Event|0|||
164549213|NCT02819635|594384913|FG008|Substudy 2, Part 2|Adverse Event|0|||
164549214|NCT02819635|594384914|FG009|Substudy 2, Part 2|Adverse Event|0|||
164549215|NCT02819635|594384915|FG010|Substudy 2, Part 2|Adverse Event|0|||
164549216|NCT02819635|594384916|FG011|Substudy 2, Part 2|Adverse Event|0|||
164549217|NCT02819635|594384905|FG000|Substudy 2, Part 2|Withdrew consent|0|||
164549218|NCT02819635|594384906|FG001|Substudy 2, Part 2|Withdrew consent|0|||
164549219|NCT02819635|594384907|FG002|Substudy 2, Part 2|Withdrew consent|0|||
164549220|NCT02819635|594384908|FG003|Substudy 2, Part 2|Withdrew consent|0|||
164549221|NCT02819635|594384909|FG004|Substudy 2, Part 2|Withdrew consent|0|||
164655017|NCT01738581|594763059|FG000|Overall Study|Lost to Follow-up|1|||
164655018|NCT01738581|594763060|FG001|Overall Study|Lost to Follow-up|0|||
164655019|NCT02191579|594763067|FG000|Treatment 1|Multiple Reasons Specified|27|||
164655020|NCT02191579|594763068|FG001|Treatment 1|Multiple Reasons Specified|58|||
164655021|NCT02191579|594763067|FG000|Treatment 2|Multiple Reasons Specified|0|||
164655022|NCT02191579|594763068|FG001|Treatment 2|Multiple Reasons Specified|25|||
164655023|NCT02862535|594763069|FG000|Overall Study|Death|7|||
164655024|NCT02862535|594763070|FG001|Overall Study|Death|3|||
164655025|NCT02862535|594763071|FG002|Overall Study|Death|2|||
164655026|NCT02862535|594763072|FG003|Overall Study|Death|5|||
164655027|NCT02862535|594763069|FG000|Overall Study|Study Terminated by Sponsor|1|||
164655028|NCT02862535|594763070|FG001|Overall Study|Study Terminated by Sponsor|3|||
164655029|NCT02862535|594763071|FG002|Overall Study|Study Terminated by Sponsor|8|||
164655030|NCT02862535|594763072|FG003|Overall Study|Study Terminated by Sponsor|5|||
164655031|NCT02862535|594763069|FG000|Overall Study|Enrolled, not Treated|1|||
164655032|NCT02862535|594763070|FG001|Overall Study|Enrolled, not Treated|0|||
164655033|NCT02862535|594763071|FG002|Overall Study|Enrolled, not Treated|0|||
164655034|NCT02862535|594763072|FG003|Overall Study|Enrolled, not Treated|1|||
164655035|NCT02280356|594763076|FG000|Overall Study|Not Treated|2|||
164655036|NCT02280356|594763076|FG000|Overall Study|Withdrawal by Subject|1|||
164655037|NCT02280356|594763076|FG000|Overall Study|Not evaluable|2|||
164655038|NCT01086215|594763077|FG000|Overall Study|Death|14|||
164655039|NCT01086215|594763078|FG001|Overall Study|Death|8|||
164655040|NCT01086215|594763079|FG002|Overall Study|Death|8|||
164655041|NCT01086215|594763080|FG003|Overall Study|Death|1|||
164655042|NCT01086215|594763077|FG000|Overall Study|Lost to Follow-up|22|||
164655043|NCT01086215|594763078|FG001|Overall Study|Lost to Follow-up|39|||
164655044|NCT01086215|594763079|FG002|Overall Study|Lost to Follow-up|18|||
164655045|NCT01086215|594763080|FG003|Overall Study|Lost to Follow-up|2|||
164655046|NCT01965652|594763081|FG000|Overall Study|Adverse Event|40|||
164655047|NCT01965652|594763082|FG001|Overall Study|Adverse Event|37|||
164655048|NCT01965652|594763081|FG000|Overall Study|Withdrawal by Subject|62|||
164655049|NCT01965652|594763082|FG001|Overall Study|Withdrawal by Subject|69|||
164655050|NCT01965652|594763081|FG000|Overall Study|Lost to Follow-up|53|||
164655051|NCT01965652|594763082|FG001|Overall Study|Lost to Follow-up|40|||
164655052|NCT01965652|594763081|FG000|Overall Study|Protocol Violation|34|||
164655053|NCT01965652|594763082|FG001|Overall Study|Protocol Violation|38|||
164655054|NCT01965652|594763081|FG000|Overall Study|Death|3|||
164655055|NCT01965652|594763082|FG001|Overall Study|Death|4|||
164655056|NCT01965652|594763081|FG000|Overall Study|Other - Miscellaneous|18|||
164655057|NCT01965652|594763082|FG001|Overall Study|Other - Miscellaneous|21|||
164655058|NCT01965652|594763081|FG000|Overall Study|Pregnancy|0|||
164655059|NCT01965652|594763082|FG001|Overall Study|Pregnancy|1|||
164655060|NCT01121900|594763087|FG000|First Intervention Period|Adverse Event|1|||
164655061|NCT01121900|594763088|FG001|First Intervention Period|Adverse Event|1|||
164655062|NCT01121900|594763087|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
164655063|NCT01121900|594763088|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
164655064|NCT03493698|594763089|FG000|Treatment Period C|Adverse Event|1|||
164655065|NCT03493698|594763089|FG000|Treatment Period C|Withdrawal by Subject|1|||
164655066|NCT00408876|594763090|FG000|Overall Study|Adverse Event|9|||
164655067|NCT00408876|594763091|FG001|Overall Study|Adverse Event|17|||
164655068|NCT00408876|594763092|FG002|Overall Study|Adverse Event|27|||
164655069|NCT00408876|594763093|FG003|Overall Study|Adverse Event|10|||
164655070|NCT00408876|594763090|FG000|Overall Study|Withdrawal by Subject|3|||
164655071|NCT00408876|594763091|FG001|Overall Study|Withdrawal by Subject|6|||
164655072|NCT00408876|594763092|FG002|Overall Study|Withdrawal by Subject|6|||
164655073|NCT00408876|594763093|FG003|Overall Study|Withdrawal by Subject|14|||
164655074|NCT00408876|594763090|FG000|Overall Study|Lack of Efficacy|2|||
164655075|NCT00408876|594763091|FG001|Overall Study|Lack of Efficacy|4|||
164655076|NCT00408876|594763092|FG002|Overall Study|Lack of Efficacy|5|||
164655077|NCT00408876|594763093|FG003|Overall Study|Lack of Efficacy|6|||
164655078|NCT00408876|594763090|FG000|Overall Study|Lost to Follow-up|1|||
164655079|NCT00408876|594763091|FG001|Overall Study|Lost to Follow-up|6|||
164196726|NCT00468585|593089872|FG002|Overall Study|Adverse Event|1|||
164196727|NCT00468585|593089873|FG003|Overall Study|Adverse Event|0|||
164196728|NCT00468585|593089870|FG000|Overall Study|Withdrawal by Subject|0|||
164655080|NCT00408876|594763092|FG002|Overall Study|Lost to Follow-up|5|||
164655081|NCT00408876|594763093|FG003|Overall Study|Lost to Follow-up|2|||
164655082|NCT00408876|594763090|FG000|Overall Study|Protocol Violation|0|||
164655083|NCT00408876|594763091|FG001|Overall Study|Protocol Violation|3|||
164655084|NCT00408876|594763092|FG002|Overall Study|Protocol Violation|4|||
164655085|NCT00408876|594763093|FG003|Overall Study|Protocol Violation|3|||
164655086|NCT00408876|594763090|FG000|Overall Study|Physician Decision|1|||
164655087|NCT00408876|594763091|FG001|Overall Study|Physician Decision|0|||
164655088|NCT00408876|594763092|FG002|Overall Study|Physician Decision|3|||
164655089|NCT00408876|594763093|FG003|Overall Study|Physician Decision|0|||
164655090|NCT00291330|594763094|FG000|Overall Study|Adverse Event|47|||
164196729|NCT00468585|593089871|FG001|Overall Study|Withdrawal by Subject|0|||
164655091|NCT00291330|594763095|FG001|Overall Study|Adverse Event|40|||
164655092|NCT00291330|594763094|FG000|Overall Study|Protocol Violation|13|||
164655093|NCT00291330|594763095|FG001|Overall Study|Protocol Violation|20|||
164655094|NCT00291330|594763094|FG000|Overall Study|Lost to Follow-up|16|||
164196730|NCT00468585|593089872|FG002|Overall Study|Withdrawal by Subject|2|||
164196731|NCT00468585|593089873|FG003|Overall Study|Withdrawal by Subject|1|||
164196732|NCT03769649|593089874|FG000|Overall Study|Lost to Follow-up|4|||
164196733|NCT02000921|593089879|FG000|Overall Study|Withdrawal by Subject|3|||
164196734|NCT02000921|593089880|FG001|Overall Study|Withdrawal by Subject|10|||
164196735|NCT02000921|593089881|FG002|Overall Study|Withdrawal by Subject|5|||
164196736|NCT02000921|593089879|FG000|Overall Study|Lost to Follow-up|2|||
164196737|NCT02000921|593089880|FG001|Overall Study|Lost to Follow-up|4|||
164196738|NCT02000921|593089881|FG002|Overall Study|Lost to Follow-up|5|||
164196739|NCT02000921|593089879|FG000|Overall Study|Physician Decision|0|||
164196740|NCT02000921|593089880|FG001|Overall Study|Physician Decision|2|||
164196741|NCT02000921|593089881|FG002|Overall Study|Physician Decision|0|||
164196742|NCT03933449|593089884|FG000|Overall Study|Adverse Event|6|||
164196743|NCT03933449|593089885|FG001|Overall Study|Adverse Event|4|||
164196744|NCT03933449|593089884|FG000|Overall Study|Death|55|||
164196745|NCT03933449|593089885|FG001|Overall Study|Death|57|||
164196746|NCT03933449|593089884|FG000|Overall Study|Sponsor Decision|1|||
164196747|NCT03933449|593089885|FG001|Overall Study|Sponsor Decision|0|||
164196748|NCT02087774|593089888|FG000|Overall Study|Were absent day of data collection|8|||
164196749|NCT02087774|593089889|FG001|Overall Study|Were absent day of data collection|20|||
164196750|NCT00719901|593089890|FG000|Overall Study|Adverse Event|5|||
164196751|NCT00719901|593089890|FG000|Overall Study|Withdrawal by Subject|1|||
164196752|NCT00719901|593089890|FG000|Overall Study|Alternate Treatment|1|||
164196753|NCT00719901|593089890|FG000|Overall Study|Disease Progression|3|||
164196754|NCT00719901|593089890|FG000|Overall Study|Availability of Study Drug|1|||
164196755|NCT02858401|593089891|FG000|Overall Study|Withdrew Consent|0|||
164196756|NCT02858401|593089892|FG001|Overall Study|Withdrew Consent|0|||
164196757|NCT02858401|593089893|FG002|Overall Study|Withdrew Consent|0|||
164196758|NCT02858401|593089894|FG003|Overall Study|Withdrew Consent|0|||
164196759|NCT02858401|593089895|FG004|Overall Study|Withdrew Consent|0|||
164196760|NCT02858401|593089896|FG005|Overall Study|Withdrew Consent|1|||
164196761|NCT02858401|593089897|FG006|Overall Study|Withdrew Consent|0|||
164196762|NCT02858401|593089891|FG000|Overall Study|Lost to Follow-up|0|||
164196763|NCT02858401|593089892|FG001|Overall Study|Lost to Follow-up|1|||
164196764|NCT02858401|593089893|FG002|Overall Study|Lost to Follow-up|0|||
164196765|NCT02858401|593089894|FG003|Overall Study|Lost to Follow-up|0|||
164196766|NCT02858401|593089895|FG004|Overall Study|Lost to Follow-up|0|||
164196767|NCT02858401|593089896|FG005|Overall Study|Lost to Follow-up|0|||
164196768|NCT02858401|593089897|FG006|Overall Study|Lost to Follow-up|0|||
164196769|NCT02059239|593089898|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
164196770|NCT02059239|593089899|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
164196771|NCT02059239|593089898|FG000|Overall Study|Physician Decision|1|||
164196772|NCT02059239|593089899|FG001|Overall Study|Physician Decision|0|||
164196773|NCT01408706|593089901|FG000|Overall Study|Physician Decision|1|||
164196774|NCT01408706|593089902|FG001|Overall Study|Physician Decision|0|||
164196775|NCT01268267|593089903|FG000|Overall Study|Protocol Violation|1|||
164196776|NCT02204917|593089905|FG000|Overall Study|Protocol Violation|1|||
164196777|NCT01529606|593089907|FG000|Overall Study|Lost to Follow-up|21|||
164196778|NCT01529606|593089908|FG001|Overall Study|Lost to Follow-up|18|||
164196779|NCT00490035|593089910|FG000|Overall Study|AE, non-serious non-fatal|3|||
164196780|NCT00490035|593089911|FG001|Overall Study|AE, non-serious non-fatal|4|||
164196781|NCT00490035|593089912|FG002|Overall Study|AE, non-serious non-fatal|4|||
164196782|NCT00490035|593089913|FG003|Overall Study|AE, non-serious non-fatal|5|||
164196783|NCT00490035|593089910|FG000|Overall Study|Lost to Follow-up|2|||
164196784|NCT00490035|593089911|FG001|Overall Study|Lost to Follow-up|0|||
164196785|NCT00490035|593089912|FG002|Overall Study|Lost to Follow-up|1|||
164196786|NCT00490035|593089913|FG003|Overall Study|Lost to Follow-up|0|||
164196787|NCT00490035|593089910|FG000|Overall Study|Withdrawal by Subject|2|||
164196788|NCT00490035|593089911|FG001|Overall Study|Withdrawal by Subject|1|||
164196789|NCT00490035|593089912|FG002|Overall Study|Withdrawal by Subject|1|||
164196790|NCT00490035|593089913|FG003|Overall Study|Withdrawal by Subject|0|||
164196791|NCT00490035|593089910|FG000|Overall Study|Other reason|0|||
164196792|NCT00490035|593089911|FG001|Overall Study|Other reason|1|||
164196793|NCT00490035|593089912|FG002|Overall Study|Other reason|3|||
164196794|NCT00490035|593089913|FG003|Overall Study|Other reason|1|||
164196795|NCT00490035|593089910|FG000|Overall Study|AE, serious fatal|1|||
164655095|NCT00291330|594763095|FG001|Overall Study|Lost to Follow-up|11|||
164655096|NCT00291330|594763094|FG000|Overall Study|Withdrawal by Subject|22|||
164196796|NCT00490035|593089911|FG001|Overall Study|AE, serious fatal|0|||
164196797|NCT00490035|593089912|FG002|Overall Study|AE, serious fatal|0|||
164196798|NCT00490035|593089913|FG003|Overall Study|AE, serious fatal|0|||
164196799|NCT00490035|593089910|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
164196800|NCT00490035|593089911|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
164196801|NCT00490035|593089912|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
164196802|NCT00490035|593089913|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
164196803|NCT00490035|593089910|FG000|Overall Study|AE of unknown type|0|||
164196804|NCT00490035|593089911|FG001|Overall Study|AE of unknown type|0|||
164196805|NCT00490035|593089912|FG002|Overall Study|AE of unknown type|2|||
164196806|NCT00490035|593089913|FG003|Overall Study|AE of unknown type|0|||
164196807|NCT00731822|593089918|FG000|Overall Study|Adverse Event|2|||
164196808|NCT00731822|593089919|FG001|Overall Study|Adverse Event|1|||
164196809|NCT00731822|593089918|FG000|Overall Study|Protocol Violation|1|||
164196810|NCT00731822|593089919|FG001|Overall Study|Protocol Violation|0|||
164196811|NCT00731822|593089918|FG000|Overall Study|Lost to Follow-up|1|||
164196812|NCT00731822|593089919|FG001|Overall Study|Lost to Follow-up|0|||
164196813|NCT05209880|593089921|FG000|1-Month Follow-up|Spoke with Doctor|5|||
164196814|NCT05209880|593089922|FG001|1-Month Follow-up|Spoke with Doctor|5|||
164196815|NCT05209880|593089921|FG000|1-Month Follow-up|Lost to Follow-up|7|||
164196816|NCT05209880|593089922|FG001|1-Month Follow-up|Lost to Follow-up|9|||
164196817|NCT05209880|593089921|FG000|1-Month Follow-up|Discontinued|0|||
164196818|NCT05209880|593089922|FG001|1-Month Follow-up|Discontinued|1|||
164196819|NCT05209880|593089921|FG000|3-Month Follow-up|Spoke with Doctor|17|||
164196820|NCT05209880|593089922|FG001|3-Month Follow-up|Spoke with Doctor|7|||
164196821|NCT05209880|593089921|FG000|3-Month Follow-up|Lost to Follow-up|8|||
164196822|NCT05209880|593089922|FG001|3-Month Follow-up|Lost to Follow-up|10|||
164196823|NCT05209880|593089921|FG000|3-Month Follow-up|Discontinued|1|||
164196824|NCT05209880|593089922|FG001|3-Month Follow-up|Discontinued|3|||
164196825|NCT05209880|593089921|FG000|6-Month Follow-up|Spoke with Doctor|25|||
164196826|NCT05209880|593089922|FG001|6-Month Follow-up|Spoke with Doctor|14|||
164196827|NCT05209880|593089921|FG000|6-Month Follow-up|Lost to Follow-up|9|||
164196828|NCT05209880|593089922|FG001|6-Month Follow-up|Lost to Follow-up|14|||
164196829|NCT05209880|593089921|FG000|6-Month Follow-up|Discontinued|1|||
164196830|NCT05209880|593089922|FG001|6-Month Follow-up|Discontinued|3|||
164196831|NCT03834493|593089923|FG000|Overall Study|Participants Ongoing|311|||
164196832|NCT03834493|593089924|FG001|Overall Study|Participants Ongoing|324|||
164196833|NCT03834493|593089923|FG000|Overall Study|Withdrawal by Subject|20|||
164196834|NCT03834493|593089924|FG001|Overall Study|Withdrawal by Subject|17|||
164196835|NCT03834493|593089923|FG000|Overall Study|Physician Decision|1|||
164196836|NCT03834493|593089924|FG001|Overall Study|Physician Decision|0|||
164196837|NCT03834493|593089923|FG000|Overall Study|Death|289|||
164196838|NCT03834493|593089924|FG001|Overall Study|Death|282|||
164196839|NCT05276973|593089929|FG000|Overall Study|Treated and DLT unevaluable|1|||
164196840|NCT05276973|593089930|FG001|Overall Study|Treated and DLT unevaluable|1|||
164196841|NCT05276973|593089931|FG002|Overall Study|Treated and DLT unevaluable|0|||
164196842|NCT03180736|593089932|FG000|Overall Study|Adverse Event|3|||
164196843|NCT03180736|593089933|FG001|Overall Study|Adverse Event|4|||
164196844|NCT03180736|593089932|FG000|Overall Study|Death|10|||
164196845|NCT03180736|593089933|FG001|Overall Study|Death|7|||
164196846|NCT03180736|593089932|FG000|Overall Study|Withdrawal by Subject|5|||
164196847|NCT03180736|593089933|FG001|Overall Study|Withdrawal by Subject|12|||
164196848|NCT03180736|593089932|FG000|Overall Study|Lost to Follow-up|1|||
164196849|NCT03180736|593089933|FG001|Overall Study|Lost to Follow-up|0|||
164196850|NCT03180736|593089932|FG000|Overall Study|Lack of Efficacy|66|||
164196851|NCT03180736|593089933|FG001|Overall Study|Lack of Efficacy|87|||
164196852|NCT03180736|593089932|FG000|Overall Study|Physician Decision|4|||
164196853|NCT03180736|593089933|FG001|Overall Study|Physician Decision|7|||
164196854|NCT03180736|593089932|FG000|Overall Study|randomized but not treated|2|||
164196855|NCT03180736|593089933|FG001|Overall Study|randomized but not treated|3|||
164196856|NCT04073303|593089934|FG000|Overall Study|Adverse Event|0|||
164196857|NCT04073303|593089935|FG001|Overall Study|Adverse Event|2|||
164196858|NCT04073303|593089934|FG000|Overall Study|Withdrawal by Subject|16|||
164196859|NCT04073303|593089935|FG001|Overall Study|Withdrawal by Subject|36|||
164196860|NCT04073303|593089934|FG000|Overall Study|Lost to Follow-up|6|||
164196861|NCT04073303|593089935|FG001|Overall Study|Lost to Follow-up|1|||
164196862|NCT04073303|593089934|FG000|Overall Study|Protocol Deviation|0|||
164196863|NCT04073303|593089935|FG001|Overall Study|Protocol Deviation|4|||
164196864|NCT04073303|593089934|FG000|Overall Study|Other|1|||
164196865|NCT04073303|593089935|FG001|Overall Study|Other|1|||
164196866|NCT03258593|593089936|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
164196867|NCT03258593|593089937|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
164196868|NCT03258593|593089938|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
164196869|NCT03258593|593089939|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
164196870|NCT03258593|593089936|FG000|Run-In Maintenance Phase|Disease progression|3|||
164196871|NCT03258593|593089937|FG001|Run-In Maintenance Phase|Disease progression|0|||
164196872|NCT03258593|593089938|FG002|Run-In Maintenance Phase|Disease progression|0|||
164196873|NCT03258593|593089939|FG003|Run-In Maintenance Phase|Disease progression|0|||
164196874|NCT03258593|593089936|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
164196875|NCT03258593|593089937|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
164196876|NCT03258593|593089938|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
164196877|NCT03258593|593089939|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
164196878|NCT03258593|593089936|FG000|Expansion Maintenance Phase|Physician Decision|0|||
164196879|NCT03258593|593089937|FG001|Expansion Maintenance Phase|Physician Decision|1|||
164196880|NCT03258593|593089938|FG002|Expansion Maintenance Phase|Physician Decision|0|||
164196881|NCT03258593|593089939|FG003|Expansion Maintenance Phase|Physician Decision|0|||
164196882|NCT04144322|593089943|FG000|Overall Study|Lack of Efficacy|2|||
164196883|NCT04144322|593089944|FG001|Overall Study|Lack of Efficacy|2|||
164196884|NCT02277028|593089945|FG000|Overall Study|Lost to Follow-up|1|||
164196885|NCT02277028|593089946|FG001|Overall Study|Lost to Follow-up|0|||
164196886|NCT02277028|593089945|FG000|Overall Study|Withdrawal by Subject|0|||
164196887|NCT02277028|593089946|FG001|Overall Study|Withdrawal by Subject|1|||
164196888|NCT02718911|593089947|FG000|Overall Study|Adverse Event|0|||
164196889|NCT02718911|593089948|FG001|Overall Study|Adverse Event|0|||
164196890|NCT02718911|593089949|FG002|Overall Study|Adverse Event|0|||
164196891|NCT02718911|593089950|FG003|Overall Study|Adverse Event|0|||
164196892|NCT02718911|593089951|FG004|Overall Study|Adverse Event|0|||
164196893|NCT02718911|593089952|FG005|Overall Study|Adverse Event|0|||
164196894|NCT02718911|593089953|FG006|Overall Study|Adverse Event|0|||
164196895|NCT02718911|593089954|FG007|Overall Study|Adverse Event|0|||
164196896|NCT02718911|593089955|FG008|Overall Study|Adverse Event|0|||
164196897|NCT02718911|593089956|FG009|Overall Study|Adverse Event|2|||
164196898|NCT02718911|593089947|FG000|Overall Study|Death|2|||
164196899|NCT02718911|593089948|FG001|Overall Study|Death|3|||
164196900|NCT02718911|593089949|FG002|Overall Study|Death|1|||
164196901|NCT02718911|593089950|FG003|Overall Study|Death|0|||
164196902|NCT02718911|593089951|FG004|Overall Study|Death|1|||
164196903|NCT02718911|593089952|FG005|Overall Study|Death|3|||
164196904|NCT02718911|593089953|FG006|Overall Study|Death|1|||
164196905|NCT02718911|593089954|FG007|Overall Study|Death|1|||
164196906|NCT02718911|593089955|FG008|Overall Study|Death|4|||
164196907|NCT02718911|593089956|FG009|Overall Study|Death|3|||
164196908|NCT02718911|593089947|FG000|Overall Study|Lost to Follow-up|0|||
164196909|NCT02718911|593089948|FG001|Overall Study|Lost to Follow-up|0|||
164196910|NCT02718911|593089949|FG002|Overall Study|Lost to Follow-up|0|||
164196911|NCT02718911|593089950|FG003|Overall Study|Lost to Follow-up|0|||
164196912|NCT02718911|593089951|FG004|Overall Study|Lost to Follow-up|0|||
164196913|NCT02718911|593089952|FG005|Overall Study|Lost to Follow-up|0|||
164196914|NCT02718911|593089953|FG006|Overall Study|Lost to Follow-up|0|||
164196915|NCT02718911|593089954|FG007|Overall Study|Lost to Follow-up|0|||
164196916|NCT02718911|593089955|FG008|Overall Study|Lost to Follow-up|1|||
164196917|NCT02718911|593089956|FG009|Overall Study|Lost to Follow-up|0|||
164196918|NCT02718911|593089947|FG000|Overall Study|Physician Decision|2|||
164196919|NCT02718911|593089948|FG001|Overall Study|Physician Decision|0|||
164196920|NCT02718911|593089949|FG002|Overall Study|Physician Decision|1|||
164196921|NCT02718911|593089950|FG003|Overall Study|Physician Decision|1|||
164196922|NCT02718911|593089951|FG004|Overall Study|Physician Decision|0|||
164196923|NCT02718911|593089952|FG005|Overall Study|Physician Decision|0|||
164196924|NCT02718911|593089953|FG006|Overall Study|Physician Decision|0|||
164196925|NCT02718911|593089954|FG007|Overall Study|Physician Decision|1|||
164196926|NCT02718911|593089955|FG008|Overall Study|Physician Decision|2|||
164196927|NCT02718911|593089956|FG009|Overall Study|Physician Decision|1|||
164196928|NCT02718911|593089947|FG000|Overall Study|Withdrawal by Subject|0|||
164196929|NCT02718911|593089948|FG001|Overall Study|Withdrawal by Subject|0|||
164196930|NCT02718911|593089949|FG002|Overall Study|Withdrawal by Subject|0|||
164196931|NCT02718911|593089950|FG003|Overall Study|Withdrawal by Subject|0|||
164196932|NCT02718911|593089951|FG004|Overall Study|Withdrawal by Subject|1|||
164196933|NCT02718911|593089952|FG005|Overall Study|Withdrawal by Subject|0|||
164196934|NCT02718911|593089953|FG006|Overall Study|Withdrawal by Subject|0|||
164196935|NCT02718911|593089954|FG007|Overall Study|Withdrawal by Subject|0|||
164196936|NCT02718911|593089955|FG008|Overall Study|Withdrawal by Subject|1|||
164196937|NCT02718911|593089956|FG009|Overall Study|Withdrawal by Subject|4|||
164196938|NCT02718911|593089947|FG000|Overall Study|Reason Not Collected|0|||
164196939|NCT02718911|593089948|FG001|Overall Study|Reason Not Collected|0|||
164196940|NCT02718911|593089949|FG002|Overall Study|Reason Not Collected|1|||
164196941|NCT02718911|593089950|FG003|Overall Study|Reason Not Collected|0|||
164196942|NCT02718911|593089951|FG004|Overall Study|Reason Not Collected|0|||
164196943|NCT02718911|593089952|FG005|Overall Study|Reason Not Collected|0|||
164196944|NCT02718911|593089953|FG006|Overall Study|Reason Not Collected|2|||
164196945|NCT02718911|593089954|FG007|Overall Study|Reason Not Collected|1|||
164196946|NCT02718911|593089955|FG008|Overall Study|Reason Not Collected|4|||
164196947|NCT02718911|593089956|FG009|Overall Study|Reason Not Collected|9|||
164196948|NCT04817332|593089957|FG000|Overall Study|Lost to Follow-up|3|||
164196949|NCT04817332|593089958|FG001|Overall Study|Lost to Follow-up|3|||
164196950|NCT04817332|593089957|FG000|Overall Study|Protocol Violation|2|||
164655097|NCT00291330|594763095|FG001|Overall Study|Withdrawal by Subject|25|||
164196951|NCT04817332|593089958|FG001|Overall Study|Protocol Violation|0|||
164196952|NCT01867008|593089964|FG000|Overall Study|Withdrawal by Subject|1|||
164196953|NCT05457257|593089971|FG000|Overall Study|Withdrawal by Subject|0|||
164196954|NCT05457257|593089972|FG001|Overall Study|Withdrawal by Subject|2|||
164196955|NCT05457257|593089971|FG000|Overall Study|Death|10|||
164196956|NCT05457257|593089972|FG001|Overall Study|Death|3|||
164196957|NCT05457257|593089971|FG000|Overall Study|Ongoing|19|||
164196958|NCT05457257|593089972|FG001|Overall Study|Ongoing|9|||
164196959|NCT01158261|593089973|FG000|Overall Study|Lost to Follow-up|9|||
164196960|NCT01158261|593089973|FG000|Overall Study|Death|7|||
164196961|NCT01158261|593089973|FG000|Overall Study|Withdrawal by Subject|1|||
164196962|NCT03143101|593089974|FG000|Overall Study|Withdrawal by Subject|0|||
164196963|NCT03143101|593089975|FG001|Overall Study|Withdrawal by Subject|1|||
164196964|NCT03143101|593089976|FG002|Overall Study|Withdrawal by Subject|0|||
164196965|NCT03143101|593089974|FG000|Overall Study|Lost to Follow-up|2|||
164196966|NCT03143101|593089975|FG001|Overall Study|Lost to Follow-up|2|||
164196967|NCT03143101|593089976|FG002|Overall Study|Lost to Follow-up|0|||
164196968|NCT05227118|593089977|FG000|Overall Study|Adverse Event|0|||
164196969|NCT05227118|593089978|FG001|Overall Study|Adverse Event|0|||
164196970|NCT05227118|593089979|FG002|Overall Study|Adverse Event|1|||
164196971|NCT05227118|593089980|FG003|Overall Study|Adverse Event|0|||
164196972|NCT05227118|593089977|FG000|Overall Study|Withdrawal by Subject|0|||
164196973|NCT05227118|593089978|FG001|Overall Study|Withdrawal by Subject|0|||
164196974|NCT05227118|593089979|FG002|Overall Study|Withdrawal by Subject|2|||
164196975|NCT05227118|593089980|FG003|Overall Study|Withdrawal by Subject|0|||
164196976|NCT01435759|593089981|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
164196977|NCT01435759|593089982|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
164196978|NCT01435759|593089983|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
164196979|NCT01435759|593089984|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
164196980|NCT01435759|593089985|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
164196981|NCT01435759|593089986|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
164196982|NCT01435759|593089981|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
164196983|NCT01435759|593089982|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
164196984|NCT01435759|593089983|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
164196985|NCT01435759|593089984|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
164196986|NCT01435759|593089985|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
164196987|NCT01435759|593089986|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
164196988|NCT01435759|593089981|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
164196989|NCT01435759|593089982|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
164196990|NCT01435759|593089983|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
164196991|NCT01435759|593089984|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
164196992|NCT01435759|593089985|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
164196993|NCT01435759|593089986|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
164196994|NCT01435759|593089981|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
164196995|NCT01435759|593089982|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
164196996|NCT01435759|593089983|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
164196997|NCT01435759|593089984|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
164196998|NCT01435759|593089985|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
164196999|NCT01435759|593089986|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
164197000|NCT01435759|593089981|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
164197001|NCT01435759|593089982|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
164197002|NCT01435759|593089983|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
164197003|NCT01435759|593089984|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
164197004|NCT01435759|593089985|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
164197005|NCT01435759|593089986|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
164197006|NCT01435759|593089981|FG000|Antidepressant Lead-in Phase|Other|119|||
164197007|NCT01435759|593089982|FG001|Antidepressant Lead-in Phase|Other|0|||
164197008|NCT01435759|593089983|FG002|Antidepressant Lead-in Phase|Other|0|||
164197009|NCT01435759|593089984|FG003|Antidepressant Lead-in Phase|Other|0|||
164197010|NCT01435759|593089985|FG004|Antidepressant Lead-in Phase|Other|0|||
164197011|NCT01435759|593089986|FG005|Antidepressant Lead-in Phase|Other|0|||
164197012|NCT01435759|593089981|FG000|Double-blind Phase|Adverse Event|7|||
164197013|NCT01435759|593089982|FG001|Double-blind Phase|Adverse Event|0|||
164197014|NCT01435759|593089983|FG002|Double-blind Phase|Adverse Event|1|||
164197015|NCT01435759|593089984|FG003|Double-blind Phase|Adverse Event|1|||
164197016|NCT01435759|593089985|FG004|Double-blind Phase|Adverse Event|1|||
164197017|NCT01435759|593089986|FG005|Double-blind Phase|Adverse Event|3|||
164197018|NCT01435759|593089981|FG000|Double-blind Phase|Protocol Violation|2|||
164197019|NCT01435759|593089982|FG001|Double-blind Phase|Protocol Violation|0|||
164197020|NCT01435759|593089983|FG002|Double-blind Phase|Protocol Violation|1|||
164197021|NCT01435759|593089984|FG003|Double-blind Phase|Protocol Violation|2|||
164197022|NCT01435759|593089985|FG004|Double-blind Phase|Protocol Violation|0|||
164197023|NCT01435759|593089986|FG005|Double-blind Phase|Protocol Violation|1|||
164197024|NCT01435759|593089981|FG000|Double-blind Phase|Withdrawal by Subject|17|||
164197025|NCT01435759|593089982|FG001|Double-blind Phase|Withdrawal by Subject|4|||
164197026|NCT01435759|593089983|FG002|Double-blind Phase|Withdrawal by Subject|3|||
164197027|NCT01435759|593089984|FG003|Double-blind Phase|Withdrawal by Subject|4|||
164197028|NCT01435759|593089985|FG004|Double-blind Phase|Withdrawal by Subject|2|||
164197029|NCT01435759|593089986|FG005|Double-blind Phase|Withdrawal by Subject|2|||
164197030|NCT01435759|593089981|FG000|Double-blind Phase|Lost to Follow-up|31|||
164197031|NCT01435759|593089982|FG001|Double-blind Phase|Lost to Follow-up|1|||
164197032|NCT01435759|593089983|FG002|Double-blind Phase|Lost to Follow-up|2|||
164197033|NCT01435759|593089984|FG003|Double-blind Phase|Lost to Follow-up|0|||
164197034|NCT01435759|593089985|FG004|Double-blind Phase|Lost to Follow-up|3|||
164197035|NCT01435759|593089986|FG005|Double-blind Phase|Lost to Follow-up|3|||
164197036|NCT01435759|593089981|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
164197037|NCT01435759|593089982|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
164197038|NCT01435759|593089983|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
164197039|NCT01435759|593089984|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
164197040|NCT01435759|593089985|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
164197041|NCT01435759|593089986|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
164197042|NCT01435759|593089981|FG000|Double-blind Phase|Other|8|||
164197043|NCT01435759|593089982|FG001|Double-blind Phase|Other|2|||
164197044|NCT01435759|593089983|FG002|Double-blind Phase|Other|0|||
164197045|NCT01435759|593089984|FG003|Double-blind Phase|Other|2|||
164197046|NCT01435759|593089985|FG004|Double-blind Phase|Other|0|||
164197047|NCT01435759|593089986|FG005|Double-blind Phase|Other|0|||
164197048|NCT01601496|593089987|FG000|Overall Study|Physician Decision|1|||
164197049|NCT01601496|593089987|FG000|Overall Study|Withdrawal by Subject|1|||
164197050|NCT01601496|593089987|FG000|Overall Study|Lost to Follow-up|6|||
164197051|NCT01601496|593089987|FG000|Overall Study|Death|4|||
164197052|NCT01601496|593089987|FG000|Overall Study|Other: patient refusal to continue|3|||
164197053|NCT03126786|593089988|FG000|Overall Study|Adverse Event|3|||
164197054|NCT03126786|593089989|FG001|Overall Study|Adverse Event|0|||
164197055|NCT03126786|593089988|FG000|Overall Study|Lost to Follow-up|0|||
164197056|NCT03126786|593089989|FG001|Overall Study|Lost to Follow-up|1|||
164197057|NCT03126786|593089988|FG000|Overall Study|Withdrawal by Subject|3|||
164197058|NCT03126786|593089989|FG001|Overall Study|Withdrawal by Subject|1|||
164197059|NCT01710020|593089992|FG000|Period 1|Protocol Violation|1|||
164197060|NCT00427908|593089993|FG000|Primary Phase|Lost to Follow-up|4|||
164197061|NCT00427908|593089994|FG001|Primary Phase|Lost to Follow-up|0|||
164197062|NCT00427908|593089995|FG002|Primary Phase|Lost to Follow-up|2|||
164197063|NCT00427908|593089996|FG003|Primary Phase|Lost to Follow-up|0|||
164197064|NCT00427908|593089993|FG000|Primary Phase|Withdrawal by Subject|1|||
164197065|NCT00427908|593089994|FG001|Primary Phase|Withdrawal by Subject|2|||
164197066|NCT00427908|593089995|FG002|Primary Phase|Withdrawal by Subject|1|||
164197067|NCT00427908|593089996|FG003|Primary Phase|Withdrawal by Subject|0|||
164197068|NCT00427908|593089993|FG000|Primary Phase|Adverse Event|0|||
164197069|NCT00427908|593089994|FG001|Primary Phase|Adverse Event|1|||
164197070|NCT00427908|593089995|FG002|Primary Phase|Adverse Event|0|||
164197071|NCT00427908|593089996|FG003|Primary Phase|Adverse Event|0|||
164197072|NCT05067972|593090001|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
164197073|NCT05067972|593090002|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
164197074|NCT05067972|593090003|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
164197075|NCT05067972|593090004|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
164197076|NCT05067972|593090005|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
164197077|NCT05067972|593090006|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
164197078|NCT05067972|593090007|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
164197079|NCT05067972|593090001|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
164197080|NCT05067972|593090002|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
164197081|NCT05067972|593090003|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
164197082|NCT05067972|593090004|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
164197083|NCT05067972|593090005|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
164197084|NCT05067972|593090006|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
164197085|NCT05067972|593090007|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
164197086|NCT05067972|593090001|FG000|Part 1: Treatment|Progressive Disease|3|||
164197087|NCT05067972|593090002|FG001|Part 1: Treatment|Progressive Disease|3|||
164197088|NCT05067972|593090003|FG002|Part 1: Treatment|Progressive Disease|4|||
164197089|NCT05067972|593090004|FG003|Part 1: Treatment|Progressive Disease|2|||
164197090|NCT05067972|593090005|FG004|Part 1: Treatment|Progressive Disease|3|||
164197091|NCT05067972|593090006|FG005|Part 1: Treatment|Progressive Disease|0|||
164197092|NCT05067972|593090007|FG006|Part 1: Treatment|Progressive Disease|2|||
164197093|NCT05067972|593090001|FG000|Part 1: Treatment|Physician Decision|0|||
164197094|NCT05067972|593090002|FG001|Part 1: Treatment|Physician Decision|0|||
164197095|NCT05067972|593090003|FG002|Part 1: Treatment|Physician Decision|0|||
164197096|NCT05067972|593090004|FG003|Part 1: Treatment|Physician Decision|1|||
164197097|NCT05067972|593090005|FG004|Part 1: Treatment|Physician Decision|0|||
164197098|NCT05067972|593090006|FG005|Part 1: Treatment|Physician Decision|0|||
164197099|NCT05067972|593090007|FG006|Part 1: Treatment|Physician Decision|0|||
164197100|NCT05067972|593090001|FG000|Part 1: Treatment|Death|0|||
164197101|NCT05067972|593090002|FG001|Part 1: Treatment|Death|0|||
164197102|NCT05067972|593090003|FG002|Part 1: Treatment|Death|0|||
164197103|NCT05067972|593090004|FG003|Part 1: Treatment|Death|2|||
164197104|NCT05067972|593090005|FG004|Part 1: Treatment|Death|0|||
164197105|NCT05067972|593090006|FG005|Part 1: Treatment|Death|0|||
164197106|NCT05067972|593090007|FG006|Part 1: Treatment|Death|0|||
164197107|NCT05067972|593090001|FG000|Part 1: Treatment|Adverse Event|0|||
164197108|NCT05067972|593090002|FG001|Part 1: Treatment|Adverse Event|0|||
164197109|NCT05067972|593090003|FG002|Part 1: Treatment|Adverse Event|0|||
164197110|NCT05067972|593090004|FG003|Part 1: Treatment|Adverse Event|0|||
164549222|NCT02819635|594384910|FG005|Substudy 2, Part 2|Withdrew consent|3|||
164549223|NCT02819635|594384911|FG006|Substudy 2, Part 2|Withdrew consent|1|||
164549224|NCT02819635|594384912|FG007|Substudy 2, Part 2|Withdrew consent|0|||
164549225|NCT02819635|594384913|FG008|Substudy 2, Part 2|Withdrew consent|0|||
164549226|NCT02819635|594384914|FG009|Substudy 2, Part 2|Withdrew consent|0|||
164549227|NCT02819635|594384915|FG010|Substudy 2, Part 2|Withdrew consent|0|||
164549228|NCT02819635|594384916|FG011|Substudy 2, Part 2|Withdrew consent|0|||
164549229|NCT02819635|594384905|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
164549230|NCT02819635|594384906|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
164549231|NCT02819635|594384907|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
164549232|NCT02819635|594384908|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
164549233|NCT02819635|594384909|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
164549234|NCT02819635|594384910|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
164197111|NCT05067972|593090005|FG004|Part 1: Treatment|Adverse Event|0|||
164197112|NCT05067972|593090006|FG005|Part 1: Treatment|Adverse Event|2|||
164197113|NCT05067972|593090007|FG006|Part 1: Treatment|Adverse Event|1|||
164197114|NCT05067972|593090001|FG000|Part 1: Follow-up|Adverse Event|0|||
164197115|NCT05067972|593090002|FG001|Part 1: Follow-up|Adverse Event|0|||
164197116|NCT05067972|593090003|FG002|Part 1: Follow-up|Adverse Event|0|||
164197117|NCT05067972|593090004|FG003|Part 1: Follow-up|Adverse Event|0|||
164197118|NCT05067972|593090005|FG004|Part 1: Follow-up|Adverse Event|0|||
164197119|NCT05067972|593090006|FG005|Part 1: Follow-up|Adverse Event|1|||
164197120|NCT05067972|593090007|FG006|Part 1: Follow-up|Adverse Event|0|||
164197121|NCT05067972|593090001|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
164197122|NCT05067972|593090002|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
164197123|NCT05067972|593090003|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
164197124|NCT05067972|593090004|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
164655098|NCT00291330|594763094|FG000|Overall Study|Other|3|||
164655099|NCT00291330|594763095|FG001|Overall Study|Other|1|||
164655100|NCT00566709|594763096|FG000|Overall Study|Protocol Violation|5|||
164655101|NCT00566709|594763097|FG001|Overall Study|Protocol Violation|0|||
164655102|NCT00299728|594763098|FG000|Overall Study|Lost to Follow-up|0|||
164655103|NCT00299728|594763099|FG001|Overall Study|Lost to Follow-up|1|||
164655104|NCT00299728|594763098|FG000|Overall Study|Withdrawal by Subject|0|||
164655105|NCT00299728|594763099|FG001|Overall Study|Withdrawal by Subject|1|||
164655106|NCT00299728|594763098|FG000|Overall Study|Progressive disease|0|||
164655107|NCT00299728|594763099|FG001|Overall Study|Progressive disease|1|||
164655108|NCT02230085|594763103|FG000|Overall Study|Physician Decision|1|||
164655109|NCT02230085|594763103|FG000|Overall Study|Withdrawal by Subject|3|||
164655110|NCT01360632|594763104|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
164655111|NCT01360632|594763105|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
164655112|NCT01360632|594763106|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
164655113|NCT01360632|594763107|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
164655114|NCT01360632|594763108|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
164655115|NCT01360632|594763104|FG000|Phase A (8 Weeks)|Adverse Event|60|||
164655116|NCT01360632|594763105|FG001|Phase A (8 Weeks)|Adverse Event|0|||
164655117|NCT01360632|594763106|FG002|Phase A (8 Weeks)|Adverse Event|0|||
164655118|NCT01360632|594763107|FG003|Phase A (8 Weeks)|Adverse Event|0|||
164655119|NCT01360632|594763108|FG004|Phase A (8 Weeks)|Adverse Event|0|||
164197125|NCT05067972|593090005|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
164197126|NCT05067972|593090006|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
164197127|NCT05067972|593090007|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
164197128|NCT05067972|593090001|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
164197129|NCT05067972|593090002|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
164197130|NCT05067972|593090003|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
164197131|NCT05067972|593090004|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
164197132|NCT05067972|593090005|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
164197133|NCT05067972|593090006|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
164197134|NCT05067972|593090007|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
164197135|NCT05067972|593090001|FG000|Part 1: Follow-up|Physician Decision|0|||
164197136|NCT05067972|593090002|FG001|Part 1: Follow-up|Physician Decision|0|||
164197137|NCT05067972|593090003|FG002|Part 1: Follow-up|Physician Decision|0|||
164197138|NCT05067972|593090004|FG003|Part 1: Follow-up|Physician Decision|1|||
164197139|NCT05067972|593090005|FG004|Part 1: Follow-up|Physician Decision|0|||
164197140|NCT05067972|593090006|FG005|Part 1: Follow-up|Physician Decision|0|||
164197141|NCT05067972|593090007|FG006|Part 1: Follow-up|Physician Decision|0|||
164197142|NCT05067972|593090001|FG000|Part 1: Follow-up|Death|1|||
164197143|NCT05067972|593090002|FG001|Part 1: Follow-up|Death|2|||
164197144|NCT05067972|593090003|FG002|Part 1: Follow-up|Death|1|||
164197145|NCT05067972|593090004|FG003|Part 1: Follow-up|Death|0|||
164197146|NCT05067972|593090005|FG004|Part 1: Follow-up|Death|1|||
164197147|NCT05067972|593090006|FG005|Part 1: Follow-up|Death|0|||
164197148|NCT05067972|593090007|FG006|Part 1: Follow-up|Death|1|||
164197149|NCT04391842|593090009|FG000|Overall Study|Withdrawal by Subject|2|||
164197150|NCT00808067|593090010|FG000|Overall Study|Major/minor bleed|30|||
164655120|NCT01360632|594763104|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
164655121|NCT01360632|594763105|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
164197151|NCT00808067|593090011|FG001|Overall Study|Major/minor bleed|44|||
164197152|NCT00808067|593090010|FG000|Overall Study|Outcome event - other|33|||
164197153|NCT00808067|593090011|FG001|Overall Study|Outcome event - other|25|||
164197154|NCT00808067|593090010|FG000|Overall Study|Adverse Event|111|||
164197155|NCT00808067|593090011|FG001|Overall Study|Adverse Event|121|||
164655122|NCT01360632|594763106|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
164655123|NCT01360632|594763107|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
164655124|NCT01360632|594763108|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
164197156|NCT00808067|593090010|FG000|Overall Study|Hospitalization (not including surgery)|18|||
164197157|NCT00808067|593090011|FG001|Overall Study|Hospitalization (not including surgery)|17|||
164197158|NCT00808067|593090010|FG000|Overall Study|Hospitalization due to surgery|37|||
164197159|NCT00808067|593090011|FG001|Overall Study|Hospitalization due to surgery|40|||
164655125|NCT01360632|594763104|FG000|Phase A (8 Weeks)|Physician Decision|10|||
164655126|NCT01360632|594763105|FG001|Phase A (8 Weeks)|Physician Decision|0|||
164655127|NCT01360632|594763106|FG002|Phase A (8 Weeks)|Physician Decision|0|||
164655128|NCT01360632|594763107|FG003|Phase A (8 Weeks)|Physician Decision|0|||
164655129|NCT01360632|594763108|FG004|Phase A (8 Weeks)|Physician Decision|0|||
164655130|NCT01360632|594763104|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
164655131|NCT01360632|594763105|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
164655132|NCT01360632|594763106|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
164197160|NCT00808067|593090010|FG000|Overall Study|Reduced creatinine clearance|53|||
164197161|NCT00808067|593090011|FG001|Overall Study|Reduced creatinine clearance|55|||
164197162|NCT00808067|593090010|FG000|Overall Study|Elevated LFT results|7|||
164197163|NCT00808067|593090011|FG001|Overall Study|Elevated LFT results|3|||
164197164|NCT00808067|593090010|FG000|Overall Study|Patient refused to take study medication|65|||
164197165|NCT00808067|593090011|FG001|Overall Study|Patient refused to take study medication|76|||
164197166|NCT00808067|593090010|FG000|Overall Study|Missing|1|||
164197167|NCT00808067|593090011|FG001|Overall Study|Missing|0|||
164197168|NCT00808067|593090010|FG000|Overall Study|Death|1|||
164197169|NCT00808067|593090011|FG001|Overall Study|Death|1|||
164197170|NCT00808067|593090010|FG000|Overall Study|Procedure|6|||
164197171|NCT00808067|593090011|FG001|Overall Study|Procedure|7|||
164197172|NCT00808067|593090010|FG000|Overall Study|Withdrawal by Subject|21|||
164197173|NCT00808067|593090011|FG001|Overall Study|Withdrawal by Subject|25|||
164197174|NCT00808067|593090010|FG000|Overall Study|Site closed|4|||
164197175|NCT00808067|593090011|FG001|Overall Study|Site closed|3|||
164197176|NCT00808067|593090010|FG000|Overall Study|Physician Decision|47|||
164197177|NCT00808067|593090011|FG001|Overall Study|Physician Decision|38|||
164197178|NCT00808067|593090010|FG000|Overall Study|Protocol Violation|3|||
164197179|NCT00808067|593090011|FG001|Overall Study|Protocol Violation|11|||
164197180|NCT00808067|593090010|FG000|Overall Study|Patient elected|7|||
164197181|NCT00808067|593090011|FG001|Overall Study|Patient elected|9|||
164197182|NCT00808067|593090010|FG000|Overall Study|Site closed for cause|19|||
164197183|NCT00808067|593090011|FG001|Overall Study|Site closed for cause|19|||
164197184|NCT00808067|593090010|FG000|Overall Study|Other reason not defined above|5|||
164197185|NCT00808067|593090011|FG001|Overall Study|Other reason not defined above|5|||
164197186|NCT00808067|593090010|FG000|Overall Study|Excluded from analysis|13|||
164197187|NCT00808067|593090011|FG001|Overall Study|Excluded from analysis|19|||
164197188|NCT04157517|593090012|FG000|Overall Study|Death|1|||
164197189|NCT04157517|593090013|FG001|Overall Study|Death|2|||
164197190|NCT04157517|593090014|FG002|Overall Study|Death|2|||
164197191|NCT04157517|593090015|FG003|Overall Study|Death|3|||
164197192|NCT04157517|593090016|FG004|Overall Study|Death|3|||
164197193|NCT04157517|593090017|FG005|Overall Study|Death|4|||
164197194|NCT04157517|593090018|FG006|Overall Study|Death|1|||
164197195|NCT04157517|593090019|FG007|Overall Study|Death|2|||
164197196|NCT04157517|593090020|FG008|Overall Study|Death|4|||
164197197|NCT04157517|593090021|FG009|Overall Study|Death|0|||
164197198|NCT04157517|593090012|FG000|Overall Study|Withdrawal by Subject|1|||
164197199|NCT04157517|593090013|FG001|Overall Study|Withdrawal by Subject|1|||
164197200|NCT04157517|593090014|FG002|Overall Study|Withdrawal by Subject|1|||
164197201|NCT04157517|593090015|FG003|Overall Study|Withdrawal by Subject|0|||
164197202|NCT04157517|593090016|FG004|Overall Study|Withdrawal by Subject|0|||
164197203|NCT04157517|593090017|FG005|Overall Study|Withdrawal by Subject|1|||
164197204|NCT04157517|593090018|FG006|Overall Study|Withdrawal by Subject|0|||
164197205|NCT04157517|593090019|FG007|Overall Study|Withdrawal by Subject|0|||
164197206|NCT04157517|593090020|FG008|Overall Study|Withdrawal by Subject|1|||
164197207|NCT04157517|593090021|FG009|Overall Study|Withdrawal by Subject|0|||
164197208|NCT04157517|593090012|FG000|Overall Study|Other|1|||
164197209|NCT04157517|593090013|FG001|Overall Study|Other|0|||
164197210|NCT04157517|593090014|FG002|Overall Study|Other|0|||
164197211|NCT04157517|593090015|FG003|Overall Study|Other|0|||
164197212|NCT04157517|593090016|FG004|Overall Study|Other|0|||
164197213|NCT04157517|593090017|FG005|Overall Study|Other|1|||
164655133|NCT01360632|594763107|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
164655134|NCT01360632|594763108|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
164655135|NCT01360632|594763104|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
164197214|NCT04157517|593090018|FG006|Overall Study|Other|2|||
164197215|NCT04157517|593090019|FG007|Overall Study|Other|7|||
164197216|NCT04157517|593090020|FG008|Overall Study|Other|7|||
164197217|NCT04157517|593090021|FG009|Overall Study|Other|0|||
164197218|NCT00565604|593090025|FG000|Overall Study|Failure to treat|2|||
164197219|NCT00565604|593090025|FG000|Overall Study|Lost to Follow-up|2|||
164197220|NCT04579380|593092221|FG000|Overall Study|Death|9|||
164655136|NCT01360632|594763105|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
164197221|NCT04579380|593092222|FG001|Overall Study|Death|22|||
164197222|NCT04579380|593092223|FG002|Overall Study|Death|22|||
164197223|NCT04579380|593092224|FG003|Overall Study|Death|17|||
164197224|NCT04579380|593092225|FG004|Overall Study|Death|6|||
164197225|NCT04579380|593092226|FG005|Overall Study|Death|21|||
164197226|NCT04579380|593092227|FG006|Overall Study|Death|10|||
164197227|NCT04579380|593092228|FG007|Overall Study|Death|11|||
164655137|NCT01360632|594763106|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
164197228|NCT04579380|593092229|FG008|Overall Study|Death|25|||
164197229|NCT04579380|593092221|FG000|Overall Study|Withdrawal by Subject|0|||
164197230|NCT04579380|593092222|FG001|Overall Study|Withdrawal by Subject|3|||
164197231|NCT04579380|593092223|FG002|Overall Study|Withdrawal by Subject|4|||
164197232|NCT04579380|593092224|FG003|Overall Study|Withdrawal by Subject|0|||
164549235|NCT02819635|594384911|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
164549236|NCT02819635|594384912|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
164549237|NCT02819635|594384913|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
164549238|NCT02819635|594384914|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
164549239|NCT02819635|594384915|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
164549240|NCT02819635|594384916|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
164549241|NCT02819635|594384905|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
164549242|NCT02819635|594384906|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
164549243|NCT02819635|594384907|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
164549244|NCT02819635|594384908|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
164549245|NCT02819635|594384909|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
164549246|NCT02819635|594384910|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
164549247|NCT02819635|594384911|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
164549248|NCT02819635|594384912|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
164549249|NCT02819635|594384913|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
164549250|NCT02819635|594384914|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
164549251|NCT02819635|594384915|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
164549252|NCT02819635|594384916|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
164549253|NCT02819635|594384905|FG000|Substudy 2, Part 2|Other, not specified|0|||
164549254|NCT02819635|594384906|FG001|Substudy 2, Part 2|Other, not specified|0|||
164549255|NCT02819635|594384907|FG002|Substudy 2, Part 2|Other, not specified|0|||
164549256|NCT02819635|594384908|FG003|Substudy 2, Part 2|Other, not specified|0|||
164549257|NCT02819635|594384909|FG004|Substudy 2, Part 2|Other, not specified|0|||
164549258|NCT02819635|594384910|FG005|Substudy 2, Part 2|Other, not specified|4|||
164549259|NCT02819635|594384911|FG006|Substudy 2, Part 2|Other, not specified|8|||
164549260|NCT02819635|594384912|FG007|Substudy 2, Part 2|Other, not specified|0|||
164549261|NCT02819635|594384913|FG008|Substudy 2, Part 2|Other, not specified|0|||
164549262|NCT02819635|594384914|FG009|Substudy 2, Part 2|Other, not specified|0|||
164549263|NCT02819635|594384915|FG010|Substudy 2, Part 2|Other, not specified|0|||
164549264|NCT02819635|594384916|FG011|Substudy 2, Part 2|Other, not specified|0|||
164549265|NCT02819635|594384905|FG000|Substudy 3|Adverse Event|0|||
164549266|NCT02819635|594384906|FG001|Substudy 3|Adverse Event|0|||
164549267|NCT02819635|594384907|FG002|Substudy 3|Adverse Event|0|||
164549268|NCT02819635|594384908|FG003|Substudy 3|Adverse Event|0|||
164549269|NCT02819635|594384909|FG004|Substudy 3|Adverse Event|0|||
164549270|NCT02819635|594384910|FG005|Substudy 3|Adverse Event|0|||
164549271|NCT02819635|594384911|FG006|Substudy 3|Adverse Event|0|||
164549272|NCT02819635|594384912|FG007|Substudy 3|Adverse Event|0|||
164549273|NCT02819635|594384913|FG008|Substudy 3|Adverse Event|32|||
164549274|NCT02819635|594384914|FG009|Substudy 3|Adverse Event|3|||
164549275|NCT02819635|594384915|FG010|Substudy 3|Adverse Event|12|||
164549276|NCT02819635|594384916|FG011|Substudy 3|Adverse Event|18|||
164549277|NCT02819635|594384905|FG000|Substudy 3|Withdrew consent|0|||
164549278|NCT02819635|594384906|FG001|Substudy 3|Withdrew consent|0|||
164549279|NCT02819635|594384907|FG002|Substudy 3|Withdrew consent|0|||
164549280|NCT02819635|594384908|FG003|Substudy 3|Withdrew consent|0|||
164549281|NCT02819635|594384909|FG004|Substudy 3|Withdrew consent|0|||
164549282|NCT02819635|594384910|FG005|Substudy 3|Withdrew consent|0|||
164549283|NCT02819635|594384911|FG006|Substudy 3|Withdrew consent|0|||
164549284|NCT02819635|594384912|FG007|Substudy 3|Withdrew consent|0|||
164549285|NCT02819635|594384913|FG008|Substudy 3|Withdrew consent|11|||
164549286|NCT02819635|594384914|FG009|Substudy 3|Withdrew consent|1|||
164549287|NCT02819635|594384915|FG010|Substudy 3|Withdrew consent|4|||
164549288|NCT02819635|594384916|FG011|Substudy 3|Withdrew consent|9|||
164549289|NCT02819635|594384905|FG000|Substudy 3|Lost to Follow-up|0|||
164549290|NCT02819635|594384906|FG001|Substudy 3|Lost to Follow-up|0|||
164549291|NCT02819635|594384907|FG002|Substudy 3|Lost to Follow-up|0|||
164549292|NCT02819635|594384908|FG003|Substudy 3|Lost to Follow-up|0|||
164549293|NCT02819635|594384909|FG004|Substudy 3|Lost to Follow-up|0|||
164549294|NCT02819635|594384910|FG005|Substudy 3|Lost to Follow-up|0|||
164549295|NCT02819635|594384911|FG006|Substudy 3|Lost to Follow-up|0|||
164549296|NCT02819635|594384912|FG007|Substudy 3|Lost to Follow-up|0|||
164549297|NCT02819635|594384913|FG008|Substudy 3|Lost to Follow-up|1|||
164655138|NCT01360632|594763107|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
164549298|NCT02819635|594384914|FG009|Substudy 3|Lost to Follow-up|0|||
164549299|NCT02819635|594384915|FG010|Substudy 3|Lost to Follow-up|1|||
164549300|NCT02819635|594384916|FG011|Substudy 3|Lost to Follow-up|1|||
164197233|NCT04579380|593092225|FG004|Overall Study|Withdrawal by Subject|1|||
164549301|NCT02819635|594384905|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
164549302|NCT02819635|594384906|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
164549303|NCT02819635|594384907|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
164549304|NCT02819635|594384908|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
164655139|NCT01360632|594763108|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
164655140|NCT01360632|594763104|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
164655141|NCT01360632|594763105|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
164655142|NCT01360632|594763106|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
164655143|NCT01360632|594763107|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
164655144|NCT01360632|594763108|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
164655145|NCT01360632|594763104|FG000|Phase B (6 Weeks)|Adverse Event|0|||
164655146|NCT01360632|594763105|FG001|Phase B (6 Weeks)|Adverse Event|3|||
164655147|NCT01360632|594763106|FG002|Phase B (6 Weeks)|Adverse Event|9|||
164655148|NCT01360632|594763107|FG003|Phase B (6 Weeks)|Adverse Event|3|||
164655149|NCT01360632|594763108|FG004|Phase B (6 Weeks)|Adverse Event|0|||
164655150|NCT01360632|594763104|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
164655151|NCT01360632|594763105|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
164655152|NCT01360632|594763106|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
164655153|NCT01360632|594763107|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
164655154|NCT01360632|594763108|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
164655155|NCT01360632|594763104|FG000|Phase B (6 Weeks)|Physician Decision|0|||
164655156|NCT01360632|594763105|FG001|Phase B (6 Weeks)|Physician Decision|0|||
164655157|NCT01360632|594763106|FG002|Phase B (6 Weeks)|Physician Decision|0|||
164655158|NCT01360632|594763107|FG003|Phase B (6 Weeks)|Physician Decision|1|||
164655159|NCT01360632|594763108|FG004|Phase B (6 Weeks)|Physician Decision|0|||
164655160|NCT01360632|594763104|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
164655161|NCT01360632|594763105|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
164655162|NCT01360632|594763106|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
164655163|NCT01360632|594763107|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
164655164|NCT01360632|594763108|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
164655165|NCT01360632|594763104|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
164655166|NCT01360632|594763105|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
164655167|NCT01360632|594763106|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
164655168|NCT01360632|594763107|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
164655169|NCT01360632|594763108|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
164655170|NCT01360632|594763104|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
164655171|NCT01360632|594763105|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
164655172|NCT01360632|594763106|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
164655173|NCT01360632|594763107|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
164655174|NCT01360632|594763108|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
164655175|NCT01360632|594763104|FG000|Phase A+|Lost to Follow-up|0|||
164655176|NCT01360632|594763105|FG001|Phase A+|Lost to Follow-up|0|||
164655177|NCT01360632|594763106|FG002|Phase A+|Lost to Follow-up|0|||
164655178|NCT01360632|594763107|FG003|Phase A+|Lost to Follow-up|0|||
164655179|NCT01360632|594763108|FG004|Phase A+|Lost to Follow-up|2|||
164655180|NCT01360632|594763104|FG000|Phase A+|Adverse Event|0|||
164655181|NCT01360632|594763105|FG001|Phase A+|Adverse Event|0|||
164655182|NCT01360632|594763106|FG002|Phase A+|Adverse Event|0|||
164655183|NCT01360632|594763107|FG003|Phase A+|Adverse Event|0|||
164655184|NCT01360632|594763108|FG004|Phase A+|Adverse Event|2|||
164655185|NCT01360632|594763104|FG000|Phase A+|Met Withdrawal Criteria|0|||
164655186|NCT01360632|594763105|FG001|Phase A+|Met Withdrawal Criteria|0|||
164655187|NCT01360632|594763106|FG002|Phase A+|Met Withdrawal Criteria|0|||
164655188|NCT01360632|594763107|FG003|Phase A+|Met Withdrawal Criteria|0|||
164655189|NCT01360632|594763108|FG004|Phase A+|Met Withdrawal Criteria|7|||
164655190|NCT01360632|594763104|FG000|Phase A+|Physician Decision|0|||
164655191|NCT01360632|594763105|FG001|Phase A+|Physician Decision|0|||
164655192|NCT01360632|594763106|FG002|Phase A+|Physician Decision|0|||
164655193|NCT01360632|594763107|FG003|Phase A+|Physician Decision|0|||
164655194|NCT01360632|594763108|FG004|Phase A+|Physician Decision|3|||
164655195|NCT01360632|594763104|FG000|Phase A+|Withdrawal by Subject|0|||
164655196|NCT01360632|594763105|FG001|Phase A+|Withdrawal by Subject|0|||
164655197|NCT01360632|594763106|FG002|Phase A+|Withdrawal by Subject|0|||
164655198|NCT01360632|594763107|FG003|Phase A+|Withdrawal by Subject|0|||
164655199|NCT01360632|594763108|FG004|Phase A+|Withdrawal by Subject|8|||
164655200|NCT01360632|594763104|FG000|Phase A+|Protocol Deviation|0|||
164655201|NCT01360632|594763105|FG001|Phase A+|Protocol Deviation|0|||
164655202|NCT01360632|594763106|FG002|Phase A+|Protocol Deviation|0|||
164655203|NCT01360632|594763107|FG003|Phase A+|Protocol Deviation|0|||
164655204|NCT01360632|594763108|FG004|Phase A+|Protocol Deviation|3|||
164655205|NCT00811070|594763109|FG000|Overall Study|Death|0|||
164655206|NCT00811070|594763110|FG001|Overall Study|Death|0|||
164655207|NCT00811070|594763111|FG002|Overall Study|Death|0|||
164655208|NCT00811070|594763112|FG003|Overall Study|Death|2|||
164655209|NCT00811070|594763113|FG004|Overall Study|Death|5|||
164655210|NCT00811070|594763114|FG005|Overall Study|Death|0|||
164655211|NCT00811070|594763109|FG000|Overall Study|Other|1|||
164655212|NCT00811070|594763110|FG001|Overall Study|Other|0|||
164655213|NCT00811070|594763111|FG002|Overall Study|Other|0|||
164655214|NCT00811070|594763112|FG003|Overall Study|Other|0|||
164655215|NCT00811070|594763113|FG004|Overall Study|Other|0|||
164655216|NCT00811070|594763114|FG005|Overall Study|Other|0|||
164655217|NCT00811070|594763109|FG000|Overall Study|Withdrawal by Subject|0|||
164655218|NCT00811070|594763110|FG001|Overall Study|Withdrawal by Subject|1|||
164197234|NCT04579380|593092226|FG005|Overall Study|Withdrawal by Subject|2|||
164197235|NCT04579380|593092227|FG006|Overall Study|Withdrawal by Subject|0|||
164197236|NCT04579380|593092228|FG007|Overall Study|Withdrawal by Subject|1|||
164197237|NCT04579380|593092229|FG008|Overall Study|Withdrawal by Subject|2|||
164197238|NCT04579380|593092221|FG000|Overall Study|Ongoing|2|||
164197239|NCT04579380|593092222|FG001|Overall Study|Ongoing|6|||
164197240|NCT04579380|593092223|FG002|Overall Study|Ongoing|4|||
164197241|NCT04579380|593092224|FG003|Overall Study|Ongoing|8|||
164197242|NCT04579380|593092225|FG004|Overall Study|Ongoing|5|||
164197243|NCT04579380|593092226|FG005|Overall Study|Ongoing|8|||
164197244|NCT04579380|593092227|FG006|Overall Study|Ongoing|3|||
164197245|NCT04579380|593092228|FG007|Overall Study|Ongoing|19|||
164197246|NCT04579380|593092229|FG008|Overall Study|Ongoing|6|||
164197247|NCT04113694|593092231|FG000|Overall Study|Adverse Event|2|||
164197248|NCT04113694|593092231|FG000|Overall Study|Lost to Follow-up|2|||
164197249|NCT04113694|593092231|FG000|Overall Study|Withdrawal by Subject|6|||
164197250|NCT04113694|593092231|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
164197251|NCT05630196|593092234|FG000|Overall Study|Adverse Event|2|||
164197252|NCT05630196|593092235|FG001|Overall Study|Adverse Event|1|||
164197253|NCT05630196|593092234|FG000|Overall Study|Lost to Follow-up|1|||
164197254|NCT05630196|593092235|FG001|Overall Study|Lost to Follow-up|1|||
164197255|NCT05630196|593092234|FG000|Overall Study|Protocol Violation|2|||
164197256|NCT05630196|593092235|FG001|Overall Study|Protocol Violation|3|||
164197257|NCT05630196|593092234|FG000|Overall Study|Physician Decision|1|||
164197258|NCT05630196|593092235|FG001|Overall Study|Physician Decision|0|||
164197259|NCT05630196|593092234|FG000|Overall Study|Withdrawal by Subject|3|||
164197260|NCT05630196|593092235|FG001|Overall Study|Withdrawal by Subject|4|||
164197261|NCT03973996|593092237|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
164197262|NCT03973996|593092238|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
164197263|NCT03973996|593092239|FG002|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
164197264|NCT03973996|593092240|FG003|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
164197265|NCT04070989|593092241|FG000|Overall Study|Death|1|||
164197266|NCT04070989|593092242|FG001|Overall Study|Death|0|||
164197267|NCT04070989|593092243|FG002|Overall Study|Death|0|||
164197268|NCT04070989|593092241|FG000|Overall Study|Study Terminated by Sponsor|7|||
164197269|NCT04070989|593092242|FG001|Overall Study|Study Terminated by Sponsor|8|||
164197270|NCT04070989|593092243|FG002|Overall Study|Study Terminated by Sponsor|23|||
164197271|NCT04070989|593092241|FG000|Overall Study|Withdrawal by Subject|0|||
164197272|NCT04070989|593092242|FG001|Overall Study|Withdrawal by Subject|1|||
164197273|NCT04070989|593092243|FG002|Overall Study|Withdrawal by Subject|0|||
164197274|NCT04070989|593092241|FG000|Overall Study|Inclusion/Exclusion Criteria not met|2|||
164197275|NCT04070989|593092242|FG001|Overall Study|Inclusion/Exclusion Criteria not met|0|||
164197276|NCT04070989|593092243|FG002|Overall Study|Inclusion/Exclusion Criteria not met|1|||
164197277|NCT04070989|593092241|FG000|Overall Study|Other|1|||
164197278|NCT04070989|593092242|FG001|Overall Study|Other|1|||
164197279|NCT04070989|593092243|FG002|Overall Study|Other|0|||
164197280|NCT06088784|593092244|FG000|Overall Study|Adverse Event|0|||
164197281|NCT06088784|593092245|FG001|Overall Study|Adverse Event|0|||
164197282|NCT06088784|593092246|FG002|Overall Study|Adverse Event|0|||
164197283|NCT06088784|593092247|FG003|Overall Study|Adverse Event|0|||
164197284|NCT06088784|593092248|FG004|Overall Study|Adverse Event|0|||
164197285|NCT06088784|593092249|FG005|Overall Study|Adverse Event|0|||
164197286|NCT06088784|593092250|FG006|Overall Study|Adverse Event|3|||
164197287|NCT06088784|593092251|FG007|Overall Study|Adverse Event|0|||
164197288|NCT06088784|593092252|FG008|Overall Study|Adverse Event|0|||
164197289|NCT06088784|593092253|FG009|Overall Study|Adverse Event|0|||
164549305|NCT02819635|594384909|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
164549306|NCT02819635|594384910|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
164549307|NCT02819635|594384911|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
164549308|NCT02819635|594384912|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
164549309|NCT02819635|594384913|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
164549310|NCT02819635|594384914|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
164549311|NCT02819635|594384915|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
164549312|NCT02819635|594384916|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
164549313|NCT02819635|594384905|FG000|Substudy 3|Other, not specified|0|||
164549314|NCT02819635|594384906|FG001|Substudy 3|Other, not specified|0|||
164197290|NCT06088784|593092254|FG010|Overall Study|Adverse Event|0|||
164197291|NCT06088784|593092255|FG011|Overall Study|Adverse Event|0|||
164197292|NCT06088784|593092244|FG000|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
164197293|NCT06088784|593092245|FG001|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
164197294|NCT06088784|593092246|FG002|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
164197295|NCT06088784|593092247|FG003|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
164197296|NCT06088784|593092248|FG004|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
164197297|NCT06088784|593092249|FG005|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
164197298|NCT06088784|593092250|FG006|Overall Study|Exclusion criterion: QTcF >450 msec|1|||
164549315|NCT02819635|594384907|FG002|Substudy 3|Other, not specified|0|||
164549316|NCT02819635|594384908|FG003|Substudy 3|Other, not specified|0|||
164197299|NCT06088784|593092251|FG007|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
164197300|NCT06088784|593092252|FG008|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
164197301|NCT06088784|593092253|FG009|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
164197302|NCT06088784|593092254|FG010|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
164197303|NCT06088784|593092255|FG011|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
164197304|NCT00830219|593092258|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
164197305|NCT00830219|593092259|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
164197306|NCT01130272|593092260|FG000|Overall Study|Adverse Event|2|||
164197307|NCT01130272|593092261|FG001|Overall Study|Adverse Event|5|||
164197308|NCT01130272|593092262|FG002|Overall Study|Adverse Event|6|||
164197309|NCT01130272|593092263|FG003|Overall Study|Adverse Event|22|||
164197310|NCT01130272|593092264|FG004|Overall Study|Adverse Event|7|||
164197311|NCT01130272|593092260|FG000|Overall Study|IVRS-confirmed constipation|0|||
164197312|NCT01130272|593092261|FG001|Overall Study|IVRS-confirmed constipation|1|||
164197313|NCT01130272|593092262|FG002|Overall Study|IVRS-confirmed constipation|1|||
164197314|NCT01130272|593092263|FG003|Overall Study|IVRS-confirmed constipation|2|||
164197315|NCT01130272|593092264|FG004|Overall Study|IVRS-confirmed constipation|0|||
164197316|NCT01130272|593092260|FG000|Overall Study|Rescue medications due to diarrhea|3|||
164197317|NCT01130272|593092261|FG001|Overall Study|Rescue medications due to diarrhea|5|||
164197318|NCT01130272|593092262|FG002|Overall Study|Rescue medications due to diarrhea|8|||
164197319|NCT01130272|593092263|FG003|Overall Study|Rescue medications due to diarrhea|8|||
164197320|NCT01130272|593092264|FG004|Overall Study|Rescue medications due to diarrhea|6|||
164197321|NCT01130272|593092260|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
164197322|NCT01130272|593092261|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
164197323|NCT01130272|593092262|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
164197324|NCT01130272|593092263|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
164197325|NCT01130272|593092264|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
164549317|NCT02819635|594384909|FG004|Substudy 3|Other, not specified|0|||
164549318|NCT02819635|594384910|FG005|Substudy 3|Other, not specified|0|||
164549319|NCT02819635|594384911|FG006|Substudy 3|Other, not specified|0|||
164549320|NCT02819635|594384912|FG007|Substudy 3|Other, not specified|0|||
164549321|NCT02819635|594384913|FG008|Substudy 3|Other, not specified|202|||
164549322|NCT02819635|594384914|FG009|Substudy 3|Other, not specified|5|||
164549323|NCT02819635|594384915|FG010|Substudy 3|Other, not specified|89|||
164549324|NCT02819635|594384916|FG011|Substudy 3|Other, not specified|39|||
164549325|NCT00783094|594384923|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
164549326|NCT00783094|594384924|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
164549327|NCT00783094|594384925|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
164549328|NCT00783094|594384923|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
164549329|NCT00783094|594384924|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
164549330|NCT00783094|594384925|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
164549331|NCT00783094|594384923|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
164549332|NCT00783094|594384924|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
164549333|NCT00783094|594384925|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
164549334|NCT00783094|594384923|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
164549335|NCT00783094|594384924|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
164549336|NCT00783094|594384925|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
164549337|NCT00783094|594384923|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
164549338|NCT00783094|594384924|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
164549339|NCT00783094|594384925|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
164549340|NCT00783094|594384923|FG000|Open-Label Extension Period|Adverse Event|12|||
164549341|NCT00783094|594384924|FG001|Open-Label Extension Period|Adverse Event|7|||
164549342|NCT00783094|594384925|FG002|Open-Label Extension Period|Adverse Event|16|||
164549343|NCT00783094|594384923|FG000|Open-Label Extension Period|Death|0|||
164549344|NCT00783094|594384924|FG001|Open-Label Extension Period|Death|0|||
164549345|NCT00783094|594384925|FG002|Open-Label Extension Period|Death|1|||
164549346|NCT00783094|594384923|FG000|Open-Label Extension Period|Protocol Violation|4|||
164549347|NCT00783094|594384924|FG001|Open-Label Extension Period|Protocol Violation|5|||
164549348|NCT00783094|594384925|FG002|Open-Label Extension Period|Protocol Violation|7|||
164549349|NCT00783094|594384923|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
164549350|NCT00783094|594384924|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
164549351|NCT00783094|594384925|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
164549352|NCT00783094|594384923|FG000|Open-Label Extension Period|Physician Decision|4|||
164197326|NCT01130272|593092260|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
164197327|NCT01130272|593092261|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
164549353|NCT00783094|594384924|FG001|Open-Label Extension Period|Physician Decision|2|||
164549354|NCT00783094|594384925|FG002|Open-Label Extension Period|Physician Decision|3|||
164549355|NCT00783094|594384923|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
164549356|NCT00783094|594384924|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
164549357|NCT00783094|594384925|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
164549358|NCT01324232|594384926|FG000|Overall Study|Protocol Violation|0|||
164197328|NCT01130272|593092262|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
164197329|NCT01130272|593092263|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
164197330|NCT01130272|593092264|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
164197331|NCT01130272|593092260|FG000|Overall Study|Protocol Violation|0|||
164197332|NCT01130272|593092261|FG001|Overall Study|Protocol Violation|0|||
164197333|NCT01130272|593092262|FG002|Overall Study|Protocol Violation|3|||
164197334|NCT01130272|593092263|FG003|Overall Study|Protocol Violation|5|||
164197335|NCT01130272|593092264|FG004|Overall Study|Protocol Violation|5|||
164197336|NCT01130272|593092260|FG000|Overall Study|Lost to Follow-up|4|||
164197337|NCT01130272|593092261|FG001|Overall Study|Lost to Follow-up|3|||
164197338|NCT01130272|593092262|FG002|Overall Study|Lost to Follow-up|4|||
164197339|NCT01130272|593092263|FG003|Overall Study|Lost to Follow-up|7|||
164197340|NCT01130272|593092264|FG004|Overall Study|Lost to Follow-up|6|||
164197341|NCT01130272|593092260|FG000|Overall Study|Withdrawal by Subject|4|||
164197342|NCT01130272|593092261|FG001|Overall Study|Withdrawal by Subject|11|||
164197343|NCT01130272|593092262|FG002|Overall Study|Withdrawal by Subject|10|||
164197344|NCT01130272|593092263|FG003|Overall Study|Withdrawal by Subject|9|||
164197345|NCT01130272|593092264|FG004|Overall Study|Withdrawal by Subject|8|||
164197346|NCT01130272|593092260|FG000|Overall Study|Physician Decision|1|||
164197347|NCT01130272|593092261|FG001|Overall Study|Physician Decision|1|||
164197348|NCT01130272|593092262|FG002|Overall Study|Physician Decision|0|||
164197349|NCT01130272|593092263|FG003|Overall Study|Physician Decision|1|||
164197350|NCT01130272|593092264|FG004|Overall Study|Physician Decision|2|||
164197351|NCT01130272|593092260|FG000|Overall Study|Sponsor decision|6|||
164197352|NCT01130272|593092261|FG001|Overall Study|Sponsor decision|15|||
164197353|NCT01130272|593092262|FG002|Overall Study|Sponsor decision|16|||
164197354|NCT01130272|593092263|FG003|Overall Study|Sponsor decision|13|||
164197355|NCT01130272|593092264|FG004|Overall Study|Sponsor decision|16|||
164197356|NCT01130272|593092260|FG000|Overall Study|Study arm discontinued|38|||
164197357|NCT01130272|593092261|FG001|Overall Study|Study arm discontinued|0|||
164197358|NCT01130272|593092262|FG002|Overall Study|Study arm discontinued|0|||
164197359|NCT01130272|593092263|FG003|Overall Study|Study arm discontinued|0|||
164197360|NCT01130272|593092264|FG004|Overall Study|Study arm discontinued|0|||
164197361|NCT00641056|593092265|FG000|Overall Study|Adverse Event|12|||
164197362|NCT00641056|593092266|FG001|Overall Study|Adverse Event|2|||
164197363|NCT00641056|593092265|FG000|Overall Study|Lost to Follow-up|2|||
164197364|NCT00641056|593092266|FG001|Overall Study|Lost to Follow-up|1|||
164197365|NCT00641056|593092265|FG000|Overall Study|Physician Decision|3|||
164197366|NCT00641056|593092266|FG001|Overall Study|Physician Decision|1|||
164197367|NCT00641056|593092265|FG000|Overall Study|Protocol Violation|2|||
164197368|NCT00641056|593092266|FG001|Overall Study|Protocol Violation|0|||
164197369|NCT00641056|593092265|FG000|Overall Study|Entry Criteria Not Met|3|||
164197370|NCT00641056|593092266|FG001|Overall Study|Entry Criteria Not Met|0|||
164197371|NCT00641056|593092265|FG000|Overall Study|Subject Decision|6|||
164197372|NCT00641056|593092266|FG001|Overall Study|Subject Decision|19|||
164197373|NCT00641056|593092265|FG000|Overall Study|Sponsor Decision|1|||
164197374|NCT00641056|593092266|FG001|Overall Study|Sponsor Decision|2|||
164197375|NCT00239720|593092268|FG000|Overall Study|Adverse Event|1|||
164197376|NCT00239720|593092269|FG001|Overall Study|Adverse Event|0|||
164197377|NCT00239720|593092268|FG000|Overall Study|Lost to Follow-up|0|||
164197378|NCT00239720|593092269|FG001|Overall Study|Lost to Follow-up|1|||
164197379|NCT01811732|593092270|FG000|Overall Study|Lost to Follow-up|24|||
164197380|NCT01811732|593092271|FG001|Overall Study|Lost to Follow-up|30|||
164197381|NCT01811732|593092270|FG000|Overall Study|Withdrawal by Subject|16|||
164197382|NCT01811732|593092271|FG001|Overall Study|Withdrawal by Subject|10|||
164197383|NCT01811732|593092270|FG000|Overall Study|Adverse Event|3|||
164197384|NCT01811732|593092271|FG001|Overall Study|Adverse Event|9|||
164197385|NCT01811732|593092270|FG000|Overall Study|Lack of Efficacy|3|||
164197386|NCT01811732|593092271|FG001|Overall Study|Lack of Efficacy|1|||
164197387|NCT01811732|593092270|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
164197388|NCT01811732|593092271|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
164197389|NCT01811732|593092270|FG000|Overall Study|Physician Decision|2|||
164197390|NCT01811732|593092271|FG001|Overall Study|Physician Decision|0|||
164197391|NCT01811732|593092270|FG000|Overall Study|Death|1|||
164197392|NCT01811732|593092271|FG001|Overall Study|Death|1|||
164197393|NCT01811732|593092270|FG000|Overall Study|Insufficient venous access|0|||
164197394|NCT01811732|593092271|FG001|Overall Study|Insufficient venous access|1|||
164197395|NCT01811732|593092270|FG000|Overall Study|Protocol Violation|0|||
164197396|NCT01811732|593092271|FG001|Overall Study|Protocol Violation|1|||
164197397|NCT01811732|593092270|FG000|Overall Study|Subject incarcerated|1|||
164197398|NCT01811732|593092271|FG001|Overall Study|Subject incarcerated|2|||
164197399|NCT01811732|593092270|FG000|Overall Study|Admitted to another facility|1|||
164197400|NCT01811732|593092271|FG001|Overall Study|Admitted to another facility|0|||
164197401|NCT01811732|593092270|FG000|Overall Study|Correct study drug not available on site|1|||
164197402|NCT01811732|593092271|FG001|Overall Study|Correct study drug not available on site|0|||
164197403|NCT01405560|593092272|FG000|Overall Study|Physician Decision|1|||
164197404|NCT00896493|593092275|FG000|Overall Study|Early disease relapse|3|||
164197405|NCT00536510|593092276|FG000|Overall Study|Adverse Event|27|||
164197406|NCT00536510|593092277|FG001|Overall Study|Adverse Event|4|||
164197407|NCT00536510|593092276|FG000|Overall Study|Lost to Follow-up|11|||
164197408|NCT00536510|593092277|FG001|Overall Study|Lost to Follow-up|8|||
164197409|NCT00536510|593092276|FG000|Overall Study|Protocol Violation|4|||
164197410|NCT00536510|593092277|FG001|Overall Study|Protocol Violation|5|||
164197411|NCT00536510|593092276|FG000|Overall Study|Withdrawal by Subject|16|||
164197412|NCT00536510|593092277|FG001|Overall Study|Withdrawal by Subject|9|||
164197413|NCT00536510|593092276|FG000|Overall Study|Flushing with Product|20|||
164197414|NCT00536510|593092277|FG001|Overall Study|Flushing with Product|0|||
164197415|NCT00536510|593092276|FG000|Overall Study|Laboratory Adverse Event|2|||
164197416|NCT00536510|593092277|FG001|Overall Study|Laboratory Adverse Event|1|||
164197417|NCT00536510|593092276|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
164197418|NCT00536510|593092277|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
164197419|NCT02035553|593092278|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
164549359|NCT01324232|594384927|FG001|Overall Study|Protocol Violation|0|||
164549360|NCT01324232|594384928|FG002|Overall Study|Protocol Violation|0|||
164549361|NCT01324232|594384929|FG003|Overall Study|Protocol Violation|2|||
164549362|NCT01324232|594384926|FG000|Overall Study|Missing|0|||
164549363|NCT01324232|594384927|FG001|Overall Study|Missing|0|||
164549364|NCT01324232|594384928|FG002|Overall Study|Missing|1|||
164549365|NCT01324232|594384929|FG003|Overall Study|Missing|0|||
164549366|NCT01324232|594384926|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
164549367|NCT01324232|594384927|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
164549368|NCT01324232|594384928|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
164549369|NCT01324232|594384929|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
164549370|NCT01324232|594384926|FG000|Overall Study|Lack of Efficacy|2|||
164549371|NCT01324232|594384927|FG001|Overall Study|Lack of Efficacy|1|||
164549372|NCT01324232|594384928|FG002|Overall Study|Lack of Efficacy|2|||
164549373|NCT01324232|594384929|FG003|Overall Study|Lack of Efficacy|2|||
164549374|NCT01324232|594384926|FG000|Overall Study|Participant Refused Medication|0|||
164549375|NCT01324232|594384927|FG001|Overall Study|Participant Refused Medication|1|||
164549376|NCT01324232|594384928|FG002|Overall Study|Participant Refused Medication|0|||
164549377|NCT01324232|594384929|FG003|Overall Study|Participant Refused Medication|0|||
164549378|NCT01324232|594384926|FG000|Overall Study|Intercurrent illness|0|||
164549379|NCT01324232|594384927|FG001|Overall Study|Intercurrent illness|0|||
164549380|NCT01324232|594384928|FG002|Overall Study|Intercurrent illness|0|||
164549381|NCT01324232|594384929|FG003|Overall Study|Intercurrent illness|1|||
164549382|NCT01324232|594384926|FG000|Overall Study|Adverse Event|2|||
164549383|NCT01324232|594384927|FG001|Overall Study|Adverse Event|5|||
164549384|NCT01324232|594384928|FG002|Overall Study|Adverse Event|6|||
164549385|NCT01324232|594384929|FG003|Overall Study|Adverse Event|6|||
164549386|NCT01324232|594384926|FG000|Overall Study|Withdrawal by Subject|0|||
164549387|NCT01324232|594384927|FG001|Overall Study|Withdrawal by Subject|3|||
164549388|NCT01324232|594384928|FG002|Overall Study|Withdrawal by Subject|4|||
164549389|NCT01324232|594384929|FG003|Overall Study|Withdrawal by Subject|0|||
164549390|NCT01324232|594384926|FG000|Overall Study|Lost to Follow-up|1|||
164549391|NCT01324232|594384927|FG001|Overall Study|Lost to Follow-up|0|||
164549392|NCT01324232|594384928|FG002|Overall Study|Lost to Follow-up|0|||
164549393|NCT01324232|594384929|FG003|Overall Study|Lost to Follow-up|0|||
164549394|NCT02513329|594384930|FG000|Overall Study|Lost to Follow-up|5|||
164549395|NCT02513329|594384931|FG001|Overall Study|Lost to Follow-up|2|||
164549396|NCT05440539|594384932|FG000|Overall Study|Lost to Follow-up|4|||
164549397|NCT05440539|594384933|FG001|Overall Study|Lost to Follow-up|4|||
164549398|NCT05440539|594384932|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
164549399|NCT05440539|594384933|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
164549400|NCT01265615|594384934|FG000|Overall Study|Protocol Violation|2|||
164549401|NCT01265615|594384935|FG001|Overall Study|Protocol Violation|2|||
164549402|NCT01265615|594384936|FG002|Overall Study|Protocol Violation|4|||
164549403|NCT01265615|594384937|FG003|Overall Study|Protocol Violation|3|||
164549404|NCT01471015|594384938|FG000|Overall Study|Death|0|||
164197420|NCT02035553|593092279|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
164197421|NCT02035553|593092278|FG000|Overall Study|Adverse Event|10|||
164197422|NCT02035553|593092279|FG001|Overall Study|Adverse Event|6|||
164549405|NCT01471015|594384939|FG001|Overall Study|Death|1|||
164549406|NCT01471015|594384940|FG002|Overall Study|Death|1|||
164549407|NCT01732796|594384941|FG000|Overall Study|Adverse Event|16|||
164549408|NCT01732796|594384942|FG001|Overall Study|Adverse Event|16|||
164549409|NCT01732796|594384943|FG002|Overall Study|Adverse Event|4|||
164549410|NCT01732796|594384941|FG000|Overall Study|Lack of Efficacy|21|||
164549411|NCT01732796|594384942|FG001|Overall Study|Lack of Efficacy|18|||
164549412|NCT01732796|594384943|FG002|Overall Study|Lack of Efficacy|5|||
164549413|NCT01732796|594384941|FG000|Overall Study|Lost to Follow-up|2|||
164549414|NCT01732796|594384942|FG001|Overall Study|Lost to Follow-up|0|||
164549415|NCT01732796|594384943|FG002|Overall Study|Lost to Follow-up|0|||
164549416|NCT01732796|594384941|FG000|Overall Study|Withdrawal by Subject|6|||
164549417|NCT01732796|594384942|FG001|Overall Study|Withdrawal by Subject|8|||
164549418|NCT01732796|594384943|FG002|Overall Study|Withdrawal by Subject|2|||
164655219|NCT00811070|594763111|FG002|Overall Study|Withdrawal by Subject|0|||
164197423|NCT02035553|593092278|FG000|Overall Study|Physician Decision|3|||
164197424|NCT02035553|593092279|FG001|Overall Study|Physician Decision|2|||
164197425|NCT02035553|593092278|FG000|Overall Study|Lack of Efficacy|1|||
164197426|NCT02035553|593092279|FG001|Overall Study|Lack of Efficacy|1|||
164197427|NCT02035553|593092278|FG000|Overall Study|Withdrawal by Subject|4|||
164197428|NCT02035553|593092279|FG001|Overall Study|Withdrawal by Subject|7|||
164197429|NCT02035553|593092278|FG000|Overall Study|Non-compliance with Study Drug|0|||
164197430|NCT02035553|593092279|FG001|Overall Study|Non-compliance with Study Drug|1|||
164197431|NCT02035553|593092278|FG000|Overall Study|Lost to Follow-up|0|||
164197432|NCT02035553|593092279|FG001|Overall Study|Lost to Follow-up|1|||
164197433|NCT02035553|593092278|FG000|Overall Study|Other Reason|0|||
164197434|NCT02035553|593092279|FG001|Overall Study|Other Reason|4|||
164549419|NCT01732796|594384941|FG000|Overall Study|Other reason not defined above|1|||
164549420|NCT01732796|594384942|FG001|Overall Study|Other reason not defined above|0|||
164549421|NCT01732796|594384943|FG002|Overall Study|Other reason not defined above|2|||
164549422|NCT03200366|594384946|FG000|Patient Navigation Intervention Given|Death|0|||
164549423|NCT03200366|594384947|FG001|Patient Navigation Intervention Given|Death|2|||
164549424|NCT03200366|594384948|FG002|Patient Navigation Intervention Given|Death|0|||
164549425|NCT03200366|594384946|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
164549426|NCT03200366|594384947|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
164549427|NCT03200366|594384948|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
164549428|NCT03200366|594384946|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
164549429|NCT03200366|594384947|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
164549430|NCT03200366|594384948|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
164549431|NCT03200366|594384946|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
164549432|NCT03200366|594384947|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
164549433|NCT03200366|594384948|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
164549434|NCT03200366|594384946|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
164549435|NCT03200366|594384947|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
164549436|NCT03200366|594384948|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
164549437|NCT03200366|594384946|FG000|6 Month Post-Baseline Interview|Death|1|||
164549438|NCT03200366|594384947|FG001|6 Month Post-Baseline Interview|Death|1|||
164549439|NCT03200366|594384948|FG002|6 Month Post-Baseline Interview|Death|1|||
164549440|NCT03200366|594384946|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
164549441|NCT03200366|594384947|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
164549442|NCT03200366|594384948|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
164549443|NCT03200366|594384946|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
164549444|NCT03200366|594384947|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
164549445|NCT03200366|594384948|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
164549446|NCT03200366|594384946|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
164549447|NCT03200366|594384947|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
164549448|NCT03200366|594384948|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
164549449|NCT03200366|594384946|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
164549450|NCT03200366|594384947|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
164549451|NCT03200366|594384948|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
164549452|NCT03200366|594384946|FG000|9 Month Post-Baseline Interview|Death|1|||
164549453|NCT03200366|594384947|FG001|9 Month Post-Baseline Interview|Death|1|||
164549454|NCT03200366|594384948|FG002|9 Month Post-Baseline Interview|Death|1|||
164549455|NCT03200366|594384946|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
164549456|NCT03200366|594384947|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
164549457|NCT03200366|594384948|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
164549458|NCT03200366|594384946|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
164549459|NCT03200366|594384947|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
164549460|NCT03200366|594384948|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
164549461|NCT03200366|594384946|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
164549462|NCT03200366|594384947|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
164655220|NCT00811070|594763112|FG003|Overall Study|Withdrawal by Subject|0|||
164197435|NCT04539964|593092280|FG000|Overall Study|device malfunction|1|||
164197436|NCT04539964|593092281|FG001|Overall Study|device malfunction|0|||
164197437|NCT04539964|593092280|FG000|Overall Study|Withdrawal by Subject|1|||
164549463|NCT03200366|594384948|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
164549464|NCT00405067|594384949|FG000|Overall Study|Adverse Event|4|||
164549465|NCT00405067|594384950|FG001|Overall Study|Adverse Event|9|||
164549466|NCT00405067|594384951|FG002|Overall Study|Adverse Event|4|||
164549467|NCT00405067|594384949|FG000|Overall Study|Lost to Follow-up|0|||
164549468|NCT00405067|594384950|FG001|Overall Study|Lost to Follow-up|0|||
164655221|NCT00811070|594763113|FG004|Overall Study|Withdrawal by Subject|0|||
164197438|NCT04539964|593092281|FG001|Overall Study|Withdrawal by Subject|2|||
164197439|NCT04539964|593092280|FG000|Overall Study|Adverse Event|0|||
164549469|NCT00405067|594384951|FG002|Overall Study|Lost to Follow-up|1|||
164549470|NCT02055820|594384952|FG000|Phase I: Dose-Finding|Death|1|||
164549471|NCT02055820|594384953|FG001|Phase I: Dose-Finding|Death|0|||
164549472|NCT02055820|594384954|FG002|Phase I: Dose-Finding|Death|1|||
164549473|NCT02055820|594384955|FG003|Phase I: Dose-Finding|Death|2|||
164549474|NCT02055820|594384956|FG004|Phase I: Dose-Finding|Death|0|||
164549475|NCT02055820|594384957|FG005|Phase I: Dose-Finding|Death|1|||
164549476|NCT02055820|594384958|FG006|Phase I: Dose-Finding|Death|1|||
164549477|NCT02055820|594384959|FG007|Phase I: Dose-Finding|Death|0|||
164549478|NCT02055820|594384960|FG008|Phase I: Dose-Finding|Death|0|||
164549479|NCT02055820|594384961|FG009|Phase I: Dose-Finding|Death|0|||
164655222|NCT00811070|594763114|FG005|Overall Study|Withdrawal by Subject|0|||
164197440|NCT04539964|593092281|FG001|Overall Study|Adverse Event|2|||
164197441|NCT01674725|593092282|FG000|Overall Study|Adverse Event|1|||
164197442|NCT01674725|593092283|FG001|Overall Study|Adverse Event|0|||
164197443|NCT01674725|593092282|FG000|Overall Study|Did not receive study drug|1|||
164197444|NCT01674725|593092283|FG001|Overall Study|Did not receive study drug|0|||
164197445|NCT01674725|593092282|FG000|Overall Study|Withdrawal by Subject|1|||
164197446|NCT01674725|593092283|FG001|Overall Study|Withdrawal by Subject|0|||
164197447|NCT01674725|593092282|FG000|Overall Study|Lost to Follow-up|0|||
164197448|NCT01674725|593092283|FG001|Overall Study|Lost to Follow-up|1|||
164197449|NCT03102762|593092284|FG000|Overall Study|Lost to Follow-up|1|||
164197450|NCT03102762|593092285|FG001|Overall Study|Lost to Follow-up|0|||
164197451|NCT02709746|593092286|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
164197452|NCT02709746|593092287|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
164197453|NCT02709746|593092288|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
164197454|NCT02709746|593092289|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
164197455|NCT02709746|593092290|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
164197456|NCT02709746|593092286|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
164197457|NCT02709746|593092287|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
164197458|NCT02709746|593092288|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
164197459|NCT02709746|593092289|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
164197460|NCT02709746|593092290|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
164197461|NCT02709746|593092286|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
164197462|NCT02709746|593092287|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
164197463|NCT02709746|593092288|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
164197464|NCT02709746|593092289|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
164197465|NCT02709746|593092290|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
164197466|NCT02709746|593092286|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
164197467|NCT02709746|593092287|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
164197468|NCT02709746|593092288|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
164197469|NCT02709746|593092289|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
164197470|NCT02709746|593092290|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
164197471|NCT02709746|593092286|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
164197472|NCT02709746|593092287|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
164197473|NCT02709746|593092288|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
164197474|NCT02709746|593092289|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
164197475|NCT02709746|593092290|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
164197476|NCT02709746|593092286|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
164197477|NCT02709746|593092287|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
164197478|NCT02709746|593092288|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
164197479|NCT02709746|593092289|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
164197480|NCT02709746|593092290|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
164197481|NCT02709746|593092286|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
164197482|NCT02709746|593092287|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
164197483|NCT02709746|593092288|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
164197484|NCT02709746|593092289|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
164197485|NCT02709746|593092290|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
164197486|NCT02709746|593092286|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
164197487|NCT02709746|593092287|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
164197488|NCT02709746|593092288|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
164197489|NCT02709746|593092289|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
164549480|NCT02055820|594384952|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
164549481|NCT02055820|594384953|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
164549482|NCT02055820|594384954|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
164549483|NCT02055820|594384955|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
164655223|NCT00811070|594763109|FG000|Overall Study|Physician Decision|0|||
164655224|NCT00811070|594763110|FG001|Overall Study|Physician Decision|0|||
164197490|NCT02709746|593092290|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
164197491|NCT02709746|593092286|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
164197492|NCT02709746|593092287|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
164197493|NCT02709746|593092288|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
164197494|NCT02709746|593092289|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
164197495|NCT02709746|593092290|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
164197496|NCT02709746|593092286|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
164197497|NCT02709746|593092287|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
164197498|NCT02709746|593092288|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
164197499|NCT02709746|593092289|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
164197500|NCT02709746|593092290|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
164197501|NCT02709746|593092286|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
164197502|NCT02709746|593092287|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
164197503|NCT02709746|593092288|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
164197504|NCT02709746|593092289|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
164197505|NCT02709746|593092290|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
164197506|NCT02709746|593092286|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
164197507|NCT02709746|593092287|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
164197508|NCT02709746|593092288|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
164197509|NCT02709746|593092289|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
164197510|NCT02709746|593092290|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
164197511|NCT02709746|593092286|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
164197512|NCT02709746|593092287|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
164197513|NCT02709746|593092288|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
164197514|NCT02709746|593092289|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
164197515|NCT02709746|593092290|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
164197516|NCT02709746|593092286|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
164197517|NCT02709746|593092287|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
164197518|NCT02709746|593092288|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
164197519|NCT02709746|593092289|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
164197520|NCT02709746|593092290|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
164197521|NCT02709746|593092286|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
164197522|NCT02709746|593092287|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
164197523|NCT02709746|593092288|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
164197524|NCT02709746|593092289|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
164197525|NCT02709746|593092290|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
164197526|NCT02709746|593092286|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
164197527|NCT02709746|593092287|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
164197528|NCT02709746|593092288|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
164197529|NCT02709746|593092289|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
164197530|NCT02709746|593092290|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
164197531|NCT02709746|593092286|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
164197532|NCT02709746|593092287|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
164197533|NCT02709746|593092288|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
164197534|NCT02709746|593092289|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
164197535|NCT02709746|593092290|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
164197536|NCT03074695|593092291|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
164197537|NCT03074695|593092292|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
164197538|NCT03074695|593092291|FG000|Overall Study|Research staff not available|1|||
164197539|NCT03074695|593092292|FG001|Overall Study|Research staff not available|2|||
164197540|NCT03074695|593092291|FG000|Overall Study|Did not receive neuraxial block|2|||
164197541|NCT03074695|593092292|FG001|Overall Study|Did not receive neuraxial block|2|||
164197542|NCT00902577|593092293|FG000|Overall Study|Withdrawal by Subject|6|||
164197543|NCT00902577|593092293|FG000|Overall Study|FMISO production failure|2|||
164197544|NCT01232790|593092294|FG000|Randomization|Withdrawal by Subject|2|||
164197545|NCT01232790|593092295|FG001|Randomization|Withdrawal by Subject|0|||
164197546|NCT01232790|593092294|FG000|Randomization|Protocol Violation|0|||
164197547|NCT01232790|593092295|FG001|Randomization|Protocol Violation|1|||
164197548|NCT01232790|593092294|FG000|Randomization|Physician Decision|0|||
164197549|NCT01232790|593092295|FG001|Randomization|Physician Decision|1|||
164197550|NCT01232790|593092294|FG000|Initial Assessment|Withdrawal by Subject|0|||
164197551|NCT01232790|593092295|FG001|Initial Assessment|Withdrawal by Subject|1|||
164197552|NCT01232790|593092294|FG000|First Crossover|Withdrawal by Subject|1|||
164197553|NCT01232790|593092295|FG001|First Crossover|Withdrawal by Subject|0|||
164197554|NCT01232790|593092294|FG000|Second Crossover|Withdrawal by Subject|1|||
164197555|NCT01232790|593092295|FG001|Second Crossover|Withdrawal by Subject|2|||
164197556|NCT00083915|593092296|FG000|Overall Study|Death|6|||
164197557|NCT00083915|593092297|FG001|Overall Study|Death|3|||
164197558|NCT00083915|593092296|FG000|Overall Study|Physician Decision|11|||
164197559|NCT00083915|593092297|FG001|Overall Study|Physician Decision|6|||
164197560|NCT00083915|593092296|FG000|Overall Study|Withdrawal by Subject|8|||
164197561|NCT00083915|593092297|FG001|Overall Study|Withdrawal by Subject|3|||
164197562|NCT00083915|593092296|FG000|Overall Study|disease progression|18|||
164197563|NCT00083915|593092297|FG001|Overall Study|disease progression|23|||
164197564|NCT00083915|593092296|FG000|Overall Study|Failure to collect|3|||
164197565|NCT00083915|593092297|FG001|Overall Study|Failure to collect|0|||
164197566|NCT00083915|593092296|FG000|Overall Study|No response|3|||
164197567|NCT00083915|593092297|FG001|Overall Study|No response|1|||
164197568|NCT00083915|593092296|FG000|Overall Study|Insurance issues|1|||
164197569|NCT00083915|593092297|FG001|Overall Study|Insurance issues|1|||
164197570|NCT04456686|593092301|FG000|Overall Study|Adverse Event|2|||
164197571|NCT04456686|593092302|FG001|Overall Study|Adverse Event|1|||
164197572|NCT04456686|593092301|FG000|Overall Study|Lack of Efficacy|3|||
164197573|NCT04456686|593092302|FG001|Overall Study|Lack of Efficacy|1|||
164197574|NCT04456686|593092301|FG000|Overall Study|Withdrew consent|3|||
164197575|NCT04456686|593092302|FG001|Overall Study|Withdrew consent|1|||
164197576|NCT04456686|593092301|FG000|Overall Study|Physician Decision|2|||
164197577|NCT04456686|593092302|FG001|Overall Study|Physician Decision|2|||
164197578|NCT04456686|593092301|FG000|Overall Study|Withdrawal by Subject|5|||
164197579|NCT04456686|593092302|FG001|Overall Study|Withdrawal by Subject|1|||
164197580|NCT04456686|593092301|FG000|Overall Study|Protocol Violation|0|||
164197581|NCT04456686|593092302|FG001|Overall Study|Protocol Violation|1|||
164197582|NCT03722576|593092305|FG000|Overall Study|Withdrawal by Subject|3|||
164197583|NCT03722576|593092305|FG000|Overall Study|Adverse Event|2|||
164197584|NCT03722576|593092305|FG000|Overall Study|Physician Decision|1|||
164197585|NCT03722576|593092305|FG000|Overall Study|Lost to Follow-up|1|||
164197586|NCT02048722|593092311|FG000|2 Cycles of Treatment|Adverse Event|2|||
164197587|NCT02048722|593092311|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
164197588|NCT02048722|593092311|FG000|2 Cycles of Treatment|Progressive Disease|2|||
164197589|NCT02048722|593092311|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
164197590|NCT02048722|593092311|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
164197591|NCT02048722|593092311|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
164197592|NCT03575702|593092312|FG000|Overall Study|Withdrawal by Subject|1|||
164197593|NCT03575702|593092313|FG001|Overall Study|Withdrawal by Subject|1|||
164197594|NCT03575702|593092312|FG000|Overall Study|Lost to Follow-up|1|||
164197595|NCT03575702|593092313|FG001|Overall Study|Lost to Follow-up|2|||
164197596|NCT03575702|593092312|FG000|Overall Study|Protocol Violation|0|||
164197597|NCT03575702|593092313|FG001|Overall Study|Protocol Violation|1|||
164197598|NCT03575702|593092312|FG000|Overall Study|Patient non compliance|4|||
164197599|NCT03575702|593092313|FG001|Overall Study|Patient non compliance|0|||
164197600|NCT02127658|593092323|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
164197601|NCT02127658|593092324|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
164197602|NCT02127658|593092323|FG000|Overall Study|Withdrawal by Subject|0|||
164197603|NCT02127658|593092324|FG001|Overall Study|Withdrawal by Subject|2|||
164197604|NCT02127658|593092323|FG000|Overall Study|Physician Decision|0|||
164197605|NCT02127658|593092324|FG001|Overall Study|Physician Decision|1|||
164197606|NCT05559905|593092325|FG000|Overall Study|Withdrawal by Subject|1|||
164549484|NCT02055820|594384956|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
164549485|NCT02055820|594384957|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
164549486|NCT02055820|594384958|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
164549487|NCT02055820|594384959|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
164549488|NCT02055820|594384960|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
164549489|NCT02055820|594384961|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
164549490|NCT02055820|594384952|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
164549491|NCT02055820|594384953|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
164549492|NCT02055820|594384954|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
164549493|NCT02055820|594384955|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
164549494|NCT02055820|594384956|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
164549495|NCT02055820|594384957|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
164549496|NCT02055820|594384958|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
164549497|NCT02055820|594384959|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
164549498|NCT02055820|594384960|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
164197607|NCT05559905|593092326|FG001|Overall Study|Withdrawal by Subject|0|||
164197608|NCT05559905|593092327|FG002|Overall Study|Withdrawal by Subject|0|||
164197609|NCT05559905|593092325|FG000|Overall Study|Not Reported|1|||
164197610|NCT05559905|593092326|FG001|Overall Study|Not Reported|0|||
164197611|NCT05559905|593092327|FG002|Overall Study|Not Reported|0|||
164197612|NCT04003103|593092328|FG000|Overall Study|Death|1|||
164197613|NCT04003103|593092329|FG001|Overall Study|Death|0|||
164197614|NCT04003103|593092330|FG002|Overall Study|Death|0|||
164197615|NCT04003103|593092328|FG000|Overall Study|Lost to Follow-up|4|||
164197616|NCT04003103|593092329|FG001|Overall Study|Lost to Follow-up|3|||
164655225|NCT00811070|594763111|FG002|Overall Study|Physician Decision|0|||
164197617|NCT04003103|593092330|FG002|Overall Study|Lost to Follow-up|2|||
164655226|NCT00811070|594763112|FG003|Overall Study|Physician Decision|0|||
164655227|NCT00811070|594763113|FG004|Overall Study|Physician Decision|0|||
164655228|NCT00811070|594763114|FG005|Overall Study|Physician Decision|1|||
164655229|NCT00665626|594763117|FG000|Overall Study|Lack of Efficacy|8|||
164655230|NCT00665626|594763118|FG001|Overall Study|Lack of Efficacy|5|||
164655231|NCT00665626|594763117|FG000|Overall Study|Lost to Follow-up|0|||
164655232|NCT00665626|594763118|FG001|Overall Study|Lost to Follow-up|2|||
164655233|NCT00665626|594763117|FG000|Overall Study|Withdrawal by Subject|0|||
164655234|NCT00665626|594763118|FG001|Overall Study|Withdrawal by Subject|1|||
164655235|NCT00665626|594763117|FG000|Overall Study|Protocol Violation|0|||
164655236|NCT00665626|594763118|FG001|Overall Study|Protocol Violation|2|||
164655237|NCT00665626|594763117|FG000|Overall Study|Adverse Event|1|||
164655238|NCT00665626|594763118|FG001|Overall Study|Adverse Event|9|||
164655239|NCT00665626|594763117|FG000|Overall Study|Due to exclusion criteria|0|||
164655240|NCT00665626|594763118|FG001|Overall Study|Due to exclusion criteria|1|||
164655241|NCT00665626|594763117|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
164655242|NCT00665626|594763118|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
164655243|NCT00665626|594763117|FG000|Overall Study|Unably to comply with dosing regimen|0|||
164655244|NCT00665626|594763118|FG001|Overall Study|Unably to comply with dosing regimen|1|||
164655245|NCT00665626|594763117|FG000|Overall Study|Death|1|||
164655246|NCT00665626|594763118|FG001|Overall Study|Death|0|||
164655247|NCT02046369|594763119|FG000|Overall Study|Adverse Event|3|||
164655248|NCT02046369|594763120|FG001|Overall Study|Adverse Event|3|||
164655249|NCT02046369|594763119|FG000|Overall Study|Lack of Efficacy|3|||
164655250|NCT02046369|594763120|FG001|Overall Study|Lack of Efficacy|3|||
164655251|NCT02046369|594763119|FG000|Overall Study|Lost to Follow-up|3|||
164655252|NCT02046369|594763120|FG001|Overall Study|Lost to Follow-up|3|||
164655253|NCT02046369|594763119|FG000|Overall Study|Protocol Violation|1|||
164655254|NCT02046369|594763120|FG001|Overall Study|Protocol Violation|2|||
164197618|NCT04003103|593092328|FG000|Overall Study|Withdrawal by Subject|10|||
164197619|NCT04003103|593092329|FG001|Overall Study|Withdrawal by Subject|1|||
164197620|NCT04003103|593092330|FG002|Overall Study|Withdrawal by Subject|1|||
164197621|NCT04003103|593092328|FG000|Overall Study|Status not recorded|0|||
164197622|NCT04003103|593092329|FG001|Overall Study|Status not recorded|2|||
164197623|NCT04003103|593092330|FG002|Overall Study|Status not recorded|0|||
164197624|NCT01764841|593092331|FG000|Overall Study|Logistical Difficulties|0|||
164197625|NCT01764841|593092332|FG001|Overall Study|Logistical Difficulties|1|||
164197626|NCT01764841|593092333|FG002|Overall Study|Logistical Difficulties|0|||
164197627|NCT01764841|593092334|FG003|Overall Study|Logistical Difficulties|0|||
164197628|NCT01764841|593092331|FG000|Overall Study|Death|3|||
164197629|NCT01764841|593092332|FG001|Overall Study|Death|0|||
164197630|NCT01764841|593092333|FG002|Overall Study|Death|1|||
164197631|NCT01764841|593092334|FG003|Overall Study|Death|4|||
164197632|NCT01764841|593092331|FG000|Overall Study|No Follow Up|1|||
164197633|NCT01764841|593092332|FG001|Overall Study|No Follow Up|0|||
164197634|NCT01764841|593092333|FG002|Overall Study|No Follow Up|1|||
164197635|NCT01764841|593092334|FG003|Overall Study|No Follow Up|0|||
164197636|NCT01764841|593092331|FG000|Overall Study|Protocol Violation|0|||
164197637|NCT01764841|593092332|FG001|Overall Study|Protocol Violation|1|||
164197638|NCT01764841|593092333|FG002|Overall Study|Protocol Violation|0|||
164197639|NCT01764841|593092334|FG003|Overall Study|Protocol Violation|0|||
164197640|NCT01764841|593092331|FG000|Overall Study|Withdrawal by Subject|16|||
164197641|NCT01764841|593092332|FG001|Overall Study|Withdrawal by Subject|24|||
164197642|NCT01764841|593092333|FG002|Overall Study|Withdrawal by Subject|11|||
164197643|NCT01764841|593092334|FG003|Overall Study|Withdrawal by Subject|15|||
164197644|NCT01764841|593092331|FG000|Overall Study|Lost to Follow-up|3|||
164197645|NCT01764841|593092332|FG001|Overall Study|Lost to Follow-up|0|||
164197646|NCT01764841|593092333|FG002|Overall Study|Lost to Follow-up|1|||
164655255|NCT02046369|594763119|FG000|Overall Study|Withdrawal by Subject|3|||
164655256|NCT02046369|594763120|FG001|Overall Study|Withdrawal by Subject|6|||
164655257|NCT02046369|594763119|FG000|Overall Study|never received study drug|0|||
164655258|NCT02046369|594763120|FG001|Overall Study|never received study drug|1|||
164655259|NCT02046369|594763119|FG000|Overall Study|non compliance|1|||
164655260|NCT02046369|594763120|FG001|Overall Study|non compliance|0|||
164655261|NCT03120520|594763121|FG000|Overall Study|Lost to Follow-up|1|||
164655262|NCT03120520|594763122|FG001|Overall Study|Lost to Follow-up|1|||
164197647|NCT01764841|593092334|FG003|Overall Study|Lost to Follow-up|0|||
164197648|NCT02115607|593092335|FG000|Overall Study|Withdrawal by Subject|1|||
164197649|NCT04863872|593092336|FG000|Overall Study|Withdrawal by Subject|4|||
164197650|NCT04863872|593092337|FG001|Overall Study|Withdrawal by Subject|15|||
164197651|NCT04863872|593092336|FG000|Overall Study|Death|5|||
164197652|NCT04863872|593092337|FG001|Overall Study|Death|2|||
164197653|NCT04863872|593092336|FG000|Overall Study|Lost to Follow-up|2|||
164197654|NCT04863872|593092337|FG001|Overall Study|Lost to Follow-up|1|||
164197655|NCT00549549|593092338|FG000|Overall Study|Adverse Event|5|||
164655263|NCT03120520|594763123|FG002|Overall Study|Lost to Follow-up|1|||
164655264|NCT03120520|594763124|FG003|Overall Study|Lost to Follow-up|1|||
164549499|NCT02055820|594384961|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
164549500|NCT02055820|594384952|FG000|Phase II: Expansion|Death|0|||
164549501|NCT02055820|594384953|FG001|Phase II: Expansion|Death|0|||
164549502|NCT02055820|594384954|FG002|Phase II: Expansion|Death|0|||
164549503|NCT02055820|594384955|FG003|Phase II: Expansion|Death|0|||
164549504|NCT02055820|594384956|FG004|Phase II: Expansion|Death|33|||
164549505|NCT02055820|594384957|FG005|Phase II: Expansion|Death|0|||
164549506|NCT02055820|594384958|FG006|Phase II: Expansion|Death|0|||
164549507|NCT02055820|594384959|FG007|Phase II: Expansion|Death|0|||
164549508|NCT02055820|594384960|FG008|Phase II: Expansion|Death|0|||
164549509|NCT02055820|594384961|FG009|Phase II: Expansion|Death|0|||
164549510|NCT02055820|594384952|FG000|Phase II: Expansion|Lost to Follow-up|0|||
164549511|NCT02055820|594384953|FG001|Phase II: Expansion|Lost to Follow-up|0|||
164549512|NCT02055820|594384954|FG002|Phase II: Expansion|Lost to Follow-up|0|||
164549513|NCT02055820|594384955|FG003|Phase II: Expansion|Lost to Follow-up|0|||
164549514|NCT02055820|594384956|FG004|Phase II: Expansion|Lost to Follow-up|4|||
164549515|NCT02055820|594384957|FG005|Phase II: Expansion|Lost to Follow-up|0|||
164549516|NCT02055820|594384958|FG006|Phase II: Expansion|Lost to Follow-up|0|||
164549517|NCT02055820|594384959|FG007|Phase II: Expansion|Lost to Follow-up|0|||
164549518|NCT02055820|594384960|FG008|Phase II: Expansion|Lost to Follow-up|0|||
164549519|NCT02055820|594384961|FG009|Phase II: Expansion|Lost to Follow-up|0|||
164549520|NCT02055820|594384952|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
164549521|NCT02055820|594384953|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
164549522|NCT02055820|594384954|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
164549523|NCT02055820|594384955|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
164549524|NCT02055820|594384956|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
164655265|NCT03120520|594763121|FG000|Overall Study|Withdrawal by Subject|3|||
164197656|NCT00549549|593092339|FG001|Overall Study|Adverse Event|3|||
164197657|NCT00549549|593092340|FG002|Overall Study|Adverse Event|1|||
164197658|NCT00549549|593092341|FG003|Overall Study|Adverse Event|9|||
164197659|NCT00549549|593092338|FG000|Overall Study|Lack of Efficacy|9|||
164197660|NCT00549549|593092339|FG001|Overall Study|Lack of Efficacy|6|||
164197661|NCT00549549|593092340|FG002|Overall Study|Lack of Efficacy|4|||
164197662|NCT00549549|593092341|FG003|Overall Study|Lack of Efficacy|2|||
164197663|NCT00549549|593092338|FG000|Overall Study|Lost to Follow-up|1|||
164197664|NCT00549549|593092339|FG001|Overall Study|Lost to Follow-up|0|||
164197665|NCT00549549|593092340|FG002|Overall Study|Lost to Follow-up|1|||
164197666|NCT00549549|593092341|FG003|Overall Study|Lost to Follow-up|2|||
164197667|NCT00549549|593092338|FG000|Overall Study|Withdrawal by Subject|0|||
164197668|NCT00549549|593092339|FG001|Overall Study|Withdrawal by Subject|4|||
164197669|NCT00549549|593092340|FG002|Overall Study|Withdrawal by Subject|1|||
164197670|NCT00549549|593092341|FG003|Overall Study|Withdrawal by Subject|0|||
164197671|NCT00549549|593092338|FG000|Overall Study|Other|9|||
164197672|NCT00549549|593092339|FG001|Overall Study|Other|9|||
164197673|NCT00549549|593092340|FG002|Overall Study|Other|9|||
164197674|NCT00549549|593092341|FG003|Overall Study|Other|11|||
164197675|NCT00549549|593092338|FG000|Overall Study|Randomized but not treated|0|||
164197676|NCT00549549|593092339|FG001|Overall Study|Randomized but not treated|0|||
164197677|NCT00549549|593092340|FG002|Overall Study|Randomized but not treated|1|||
164197678|NCT00549549|593092341|FG003|Overall Study|Randomized but not treated|1|||
164197679|NCT02155699|593092342|FG000|Overall Study|Withdrawal by Subject|0|||
164197680|NCT02155699|593092343|FG001|Overall Study|Withdrawal by Subject|3|||
164197681|NCT02155699|593092344|FG002|Overall Study|Withdrawal by Subject|6|||
164197682|NCT02155699|593092345|FG003|Overall Study|Withdrawal by Subject|1|||
164197683|NCT02155699|593092342|FG000|Overall Study|Lost to Follow-up|0|||
164197684|NCT02155699|593092343|FG001|Overall Study|Lost to Follow-up|0|||
164197685|NCT02155699|593092344|FG002|Overall Study|Lost to Follow-up|0|||
164197686|NCT02155699|593092345|FG003|Overall Study|Lost to Follow-up|3|||
164197687|NCT02155699|593092342|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
164197688|NCT02155699|593092343|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
164197689|NCT02155699|593092344|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
164197690|NCT02155699|593092345|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
164197691|NCT05547386|593092346|FG000|Overall Study|Withdrawal by Subject|7|||
164197692|NCT02573259|593092352|FG000|Overall Study|Death|1|||
164549525|NCT02055820|594384957|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
164549526|NCT02055820|594384958|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
164549527|NCT02055820|594384959|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
164549528|NCT02055820|594384960|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
164549529|NCT02055820|594384961|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
164655266|NCT03120520|594763122|FG001|Overall Study|Withdrawal by Subject|2|||
164549530|NCT02285777|594384962|FG000|Overall Study|Withdrawal by Subject|1|||
164549531|NCT02285777|594384963|FG001|Overall Study|Withdrawal by Subject|1|||
164549532|NCT02285777|594384962|FG000|Overall Study|Lost to Follow-up|4|||
164549533|NCT02285777|594384963|FG001|Overall Study|Lost to Follow-up|2|||
164655267|NCT03120520|594763123|FG002|Overall Study|Withdrawal by Subject|3|||
164197693|NCT02573259|593092353|FG001|Overall Study|Death|6|||
164197694|NCT02573259|593092354|FG002|Overall Study|Death|5|||
164197695|NCT02573259|593092355|FG003|Overall Study|Death|6|||
164549534|NCT01399788|594384964|FG000|First Intervention Period|Adverse Event|1|||
164549535|NCT01399788|594384965|FG001|First Intervention Period|Adverse Event|0|||
164549536|NCT02919436|594384966|FG000|Overall Study|Did not undergo surgery|16|||
164549537|NCT02919436|594384967|FG001|Overall Study|Did not undergo surgery|20|||
164549538|NCT02919436|594384966|FG000|Overall Study|Enrolled before trial registration|44|||
164549539|NCT02919436|594384967|FG001|Overall Study|Enrolled before trial registration|33|||
164549540|NCT04718974|594384968|FG000|Overall Study|Death|0|||
164549541|NCT04718974|594384969|FG001|Overall Study|Death|2|||
164549542|NCT04718974|594384968|FG000|Overall Study|Lost to Follow-up|10|||
164549543|NCT04718974|594384969|FG001|Overall Study|Lost to Follow-up|20|||
164549544|NCT04718974|594384968|FG000|Overall Study|Transferred out|2|||
164549545|NCT04718974|594384969|FG001|Overall Study|Transferred out|4|||
164549546|NCT02409290|594384970|FG000|Overall Study|Protocol Violation|3|||
164549547|NCT02409290|594384971|FG001|Overall Study|Protocol Violation|6|||
164549548|NCT02409290|594384972|FG002|Overall Study|Protocol Violation|9|||
164549549|NCT02409290|594384973|FG003|Overall Study|Protocol Violation|4|||
164549550|NCT02409290|594384970|FG000|Overall Study|No positive culture/no baseline sample|3|||
164549551|NCT02409290|594384971|FG001|Overall Study|No positive culture/no baseline sample|9|||
164549552|NCT02409290|594384972|FG002|Overall Study|No positive culture/no baseline sample|6|||
164549553|NCT02409290|594384973|FG003|Overall Study|No positive culture/no baseline sample|5|||
164549554|NCT02409290|594384970|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
164549555|NCT02409290|594384971|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
164549556|NCT02409290|594384972|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
164549557|NCT02409290|594384973|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
164549558|NCT02830776|594384974|FG000|Overall Study|Lost to Follow-up|1|||
164549559|NCT01793142|594384975|FG000|Overall Study|Randomized not treated|7|||
164549560|NCT02121262|594384985|FG000|Overall Study|Adverse Event|6|||
164549561|NCT02121262|594384986|FG001|Overall Study|Adverse Event|3|||
164549562|NCT02121262|594384985|FG000|Overall Study|Lack of Efficacy|3|||
164549563|NCT02121262|594384986|FG001|Overall Study|Lack of Efficacy|0|||
164549564|NCT02121262|594384985|FG000|Overall Study|Personal Reasons|19|||
164549565|NCT02121262|594384986|FG001|Overall Study|Personal Reasons|5|||
164549566|NCT02121262|594384985|FG000|Overall Study|Protocol Violation|1|||
164549567|NCT02121262|594384986|FG001|Overall Study|Protocol Violation|1|||
164549568|NCT02121262|594384985|FG000|Overall Study|Participant Dropped-out|0|||
164549569|NCT02121262|594384986|FG001|Overall Study|Participant Dropped-out|1|||
164549570|NCT02121262|594384985|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
164549571|NCT02121262|594384986|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
164549572|NCT02121262|594384985|FG000|Overall Study|Consent Withdrawn|1|||
164197696|NCT02573259|593092356|FG004|Overall Study|Death|9|||
164197697|NCT02573259|593092357|FG005|Overall Study|Death|32|||
164197698|NCT02573259|593092358|FG006|Overall Study|Death|21|||
164197699|NCT02573259|593092352|FG000|Overall Study|Lost to Follow-up|0|||
164197700|NCT02573259|593092353|FG001|Overall Study|Lost to Follow-up|0|||
164197701|NCT02573259|593092354|FG002|Overall Study|Lost to Follow-up|0|||
164197702|NCT02573259|593092355|FG003|Overall Study|Lost to Follow-up|0|||
164197703|NCT02573259|593092356|FG004|Overall Study|Lost to Follow-up|0|||
164197704|NCT02573259|593092357|FG005|Overall Study|Lost to Follow-up|2|||
164197705|NCT02573259|593092358|FG006|Overall Study|Lost to Follow-up|1|||
164197706|NCT02573259|593092352|FG000|Overall Study|Participant refused further follow-up|0|||
164197707|NCT02573259|593092353|FG001|Overall Study|Participant refused further follow-up|2|||
164197708|NCT02573259|593092354|FG002|Overall Study|Participant refused further follow-up|1|||
164197709|NCT02573259|593092355|FG003|Overall Study|Participant refused further follow-up|0|||
164197710|NCT02573259|593092356|FG004|Overall Study|Participant refused further follow-up|3|||
164197711|NCT02573259|593092357|FG005|Overall Study|Participant refused further follow-up|20|||
164197712|NCT02573259|593092358|FG006|Overall Study|Participant refused further follow-up|7|||
164197713|NCT02573259|593092352|FG000|Overall Study|Other|0|||
164197714|NCT02573259|593092353|FG001|Overall Study|Other|0|||
164197715|NCT02573259|593092354|FG002|Overall Study|Other|0|||
164197716|NCT02573259|593092355|FG003|Overall Study|Other|0|||
164197717|NCT02573259|593092356|FG004|Overall Study|Other|1|||
164197718|NCT02573259|593092357|FG005|Overall Study|Other|4|||
164549573|NCT02121262|594384986|FG001|Overall Study|Consent Withdrawn|0|||
164549574|NCT02716987|594384989|FG000|Overall Study|Ligand synthesis failure|0|||
164549575|NCT02716987|594384990|FG001|Overall Study|Ligand synthesis failure|0|||
164549576|NCT02716987|594384991|FG002|Overall Study|Ligand synthesis failure|1|||
164549577|NCT02716987|594384992|FG003|Overall Study|Ligand synthesis failure|0|||
164549578|NCT02716987|594384993|FG004|Overall Study|Ligand synthesis failure|0|||
164655268|NCT03120520|594763124|FG003|Overall Study|Withdrawal by Subject|2|||
164197719|NCT02573259|593092358|FG006|Overall Study|Other|5|||
164197720|NCT00751140|593092362|FG000|Overall Study|benign angioma excluded from analysis|1|||
164197721|NCT02895295|593092365|FG000|Overall Study|Survey Non-response|71|||
164549579|NCT02716987|594384994|FG005|Overall Study|Ligand synthesis failure|0|||
164549580|NCT02716987|594384989|FG000|Overall Study|Withdrawal by Subject|0|||
164197722|NCT02895295|593092366|FG001|Overall Study|Survey Non-response|94|||
164197723|NCT02895295|593092367|FG002|Overall Study|Survey Non-response|92|||
164197724|NCT01945944|593092377|FG000|Overall Study|Adverse Event|0|||
164197725|NCT01945944|593092378|FG001|Overall Study|Adverse Event|2|||
164197726|NCT01945944|593092377|FG000|Overall Study|Physician Decision|1|||
164197727|NCT01945944|593092378|FG001|Overall Study|Physician Decision|0|||
164197728|NCT01945944|593092377|FG000|Overall Study|Withdrawal by Subject|0|||
164197729|NCT01945944|593092378|FG001|Overall Study|Withdrawal by Subject|1|||
164549581|NCT02716987|594384990|FG001|Overall Study|Withdrawal by Subject|0|||
164549582|NCT02716987|594384991|FG002|Overall Study|Withdrawal by Subject|0|||
164549583|NCT02716987|594384992|FG003|Overall Study|Withdrawal by Subject|0|||
164549584|NCT02716987|594384993|FG004|Overall Study|Withdrawal by Subject|1|||
164549585|NCT02716987|594384994|FG005|Overall Study|Withdrawal by Subject|1|||
164549586|NCT01553188|594384995|FG000|Overall Study|Patient choice|1|||
164549587|NCT01553188|594384996|FG001|Overall Study|Patient choice|0|||
164549588|NCT01553188|594384997|FG002|Overall Study|Patient choice|0|||
164549589|NCT01553188|594384998|FG003|Overall Study|Patient choice|0|||
164549590|NCT01553188|594384995|FG000|Overall Study|Intercurrent illness and adverse event|0|||
164549591|NCT01553188|594384996|FG001|Overall Study|Intercurrent illness and adverse event|1|||
164549592|NCT01553188|594384997|FG002|Overall Study|Intercurrent illness and adverse event|2|||
164549593|NCT01553188|594384998|FG003|Overall Study|Intercurrent illness and adverse event|0|||
164549594|NCT02829138|594384999|FG000|Overall Study|Withdrawal by Subject|1|||
164549595|NCT02829138|594385000|FG001|Overall Study|Withdrawal by Subject|0|||
164549596|NCT01394627|594385002|FG000|First Intervention (1 Day)|poor intravenous access|0|||
164549597|NCT01394627|594385003|FG001|First Intervention (1 Day)|poor intravenous access|1|||
164549598|NCT01394627|594385002|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
164549599|NCT01394627|594385003|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
164549600|NCT05289570|594385005|FG000|Overall Study|Physician Decision|1|||
164549601|NCT01617070|594385006|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
164549602|NCT00808236|594385008|FG000|Overall Study|Was not resuscitated|50|||
164549603|NCT00808236|594385009|FG001|Overall Study|Was not resuscitated|56|||
164549604|NCT00808236|594385008|FG000|Overall Study|Pre-defined exclusion|13|||
164549605|NCT00808236|594385009|FG001|Overall Study|Pre-defined exclusion|3|||
164549606|NCT00808236|594385008|FG000|Overall Study|Lost to Follow-up|1|||
164549607|NCT00808236|594385009|FG001|Overall Study|Lost to Follow-up|1|||
164549608|NCT00808236|594385008|FG000|Overall Study|Physician Decision|0|||
164549609|NCT00808236|594385009|FG001|Overall Study|Physician Decision|1|||
164549610|NCT00808236|594385008|FG000|Overall Study|Death|18|||
164549611|NCT00808236|594385009|FG001|Overall Study|Death|30|||
164549612|NCT01066585|594385010|FG000|Overall Study|Protocol Violation|1|||
164549613|NCT01066585|594385011|FG001|Overall Study|Protocol Violation|0|||
164549614|NCT01066585|594385010|FG000|Overall Study|Withdrawal by Subject|0|||
164549615|NCT01066585|594385011|FG001|Overall Study|Withdrawal by Subject|3|||
164549616|NCT03631732|594385021|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
164549617|NCT03631732|594385022|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
164549618|NCT03631732|594385021|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
164549619|NCT03631732|594385022|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
164549620|NCT03631732|594385021|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
164549621|NCT03631732|594385022|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
164549622|NCT03631732|594385021|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
164549623|NCT03631732|594385022|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
164549624|NCT03631732|594385021|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
164549625|NCT03631732|594385022|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
164549626|NCT03631732|594385021|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
164549627|NCT03631732|594385022|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
164549628|NCT03631732|594385021|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
164549629|NCT03631732|594385022|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
164549630|NCT03631732|594385021|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
164549631|NCT03631732|594385022|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
164549632|NCT03631732|594385021|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
164549633|NCT03631732|594385022|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
164549634|NCT03631732|594385021|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
164549635|NCT03631732|594385022|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
164549636|NCT01439204|594385023|FG000|Overall Study|Withdrawal by Subject|0|||
164549637|NCT01439204|594385024|FG001|Overall Study|Withdrawal by Subject|1|||
164549638|NCT01439204|594385023|FG000|Overall Study|Lost to Follow-up|0|||
164549639|NCT01439204|594385024|FG001|Overall Study|Lost to Follow-up|2|||
164549640|NCT01439204|594385023|FG000|Overall Study|No longer meets study criteria|1|||
164549641|NCT01439204|594385024|FG001|Overall Study|No longer meets study criteria|0|||
164549642|NCT01439204|594385023|FG000|Overall Study|poor/non-compliance|3|||
164549643|NCT01439204|594385024|FG001|Overall Study|poor/non-compliance|0|||
164197730|NCT04376515|593092381|FG000|Overall Study|Found to have been vaccinated before study start|6|||
164197731|NCT04376515|593092382|FG001|Overall Study|Found to have been vaccinated before study start|6|||
164655269|NCT03120520|594763121|FG000|Overall Study|Other|0|||
164655270|NCT03120520|594763122|FG001|Overall Study|Other|1|||
164655271|NCT03120520|594763123|FG002|Overall Study|Other|0|||
164655272|NCT03120520|594763124|FG003|Overall Study|Other|0|||
164549644|NCT02255409|594385025|FG000|Overall Study|Administrative Reason|3|||
164549645|NCT02255409|594385026|FG001|Overall Study|Administrative Reason|7|||
164655273|NCT04345471|594763126|FG000|Overall Study|Adverse Event|8|||
164655274|NCT04345471|594763127|FG001|Overall Study|Adverse Event|5|||
164655275|NCT04345471|594763128|FG002|Overall Study|Adverse Event|6|||
164655276|NCT04345471|594763126|FG000|Overall Study|Lack of Efficacy|1|||
164655277|NCT04345471|594763127|FG001|Overall Study|Lack of Efficacy|1|||
164655278|NCT04345471|594763128|FG002|Overall Study|Lack of Efficacy|0|||
164655279|NCT04345471|594763126|FG000|Overall Study|Protocol Violation|0|||
164655280|NCT04345471|594763127|FG001|Overall Study|Protocol Violation|1|||
164655281|NCT04345471|594763128|FG002|Overall Study|Protocol Violation|2|||
164655282|NCT04345471|594763126|FG000|Overall Study|Withdrawal by Subject|10|||
164655283|NCT04345471|594763127|FG001|Overall Study|Withdrawal by Subject|5|||
164655284|NCT04345471|594763128|FG002|Overall Study|Withdrawal by Subject|10|||
164655285|NCT01025193|594763129|FG000|Overall Study|Protocol Violation|1|||
164655286|NCT01025193|594763129|FG000|Overall Study|Adverse Event|3|||
164655287|NCT02378506|594763134|FG000|Overall Study|Lack of Efficacy|3|||
164655288|NCT02378506|594763134|FG000|Overall Study|Withdrawal by Subject|4|||
164655289|NCT02378506|594763134|FG000|Overall Study|Protocol Violation|2|||
164655290|NCT02378506|594763134|FG000|Overall Study|Death|1|||
164655291|NCT02378506|594763134|FG000|Overall Study|Adverse Event|14|||
164655292|NCT02378506|594763134|FG000|Overall Study|Randomized But Not Treated|1|||
164655293|NCT00433381|594764760|FG000|Overall Study|Ineligible / no protocol treatment|3|||
164655294|NCT00433381|594764761|FG001|Overall Study|Ineligible / no protocol treatment|3|||
164655295|NCT01387282|594764762|FG000|Overall Study|Death|47|||
164655296|NCT01387282|594764763|FG001|Overall Study|Death|16|||
164655297|NCT01387282|594764762|FG000|Overall Study|Other|5|||
164655298|NCT01387282|594764763|FG001|Overall Study|Other|1|||
164655299|NCT01387282|594764762|FG000|Overall Study|Unrelated AE|6|||
164655300|NCT01387282|594764763|FG001|Overall Study|Unrelated AE|4|||
164655301|NCT01387282|594764762|FG000|Overall Study|Withdrawal by patient|33|||
164655302|NCT01387282|594764763|FG001|Overall Study|Withdrawal by patient|23|||
164655303|NCT01387282|594764762|FG000|Overall Study|Study drug-related AE|2|||
164655304|NCT01387282|594764763|FG001|Overall Study|Study drug-related AE|2|||
164655305|NCT01387282|594764762|FG000|Overall Study|Lost to Follow-up|4|||
164655306|NCT01387282|594764763|FG001|Overall Study|Lost to Follow-up|1|||
164655307|NCT04582266|594764764|FG000|Overall Study|Lost to Follow-up|7|||
164655308|NCT04582266|594764765|FG001|Overall Study|Lost to Follow-up|5|||
164655309|NCT04582266|594764764|FG000|Overall Study|Withdrawal by Subject|1|||
164655310|NCT04582266|594764765|FG001|Overall Study|Withdrawal by Subject|0|||
164655311|NCT04582266|594764764|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
164655312|NCT04582266|594764765|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
164655313|NCT01034137|594764773|FG000|Overall Study|Adverse Event|9|||
164655314|NCT01034137|594764774|FG001|Overall Study|Adverse Event|10|||
164655315|NCT01034137|594764775|FG002|Overall Study|Adverse Event|8|||
164655316|NCT01034137|594764773|FG000|Overall Study|Withdrawal by Subject|4|||
164655317|NCT01034137|594764774|FG001|Overall Study|Withdrawal by Subject|3|||
164655318|NCT01034137|594764775|FG002|Overall Study|Withdrawal by Subject|3|||
164655319|NCT01034137|594764773|FG000|Overall Study|Lack of Efficacy|9|||
164655320|NCT01034137|594764774|FG001|Overall Study|Lack of Efficacy|4|||
164655321|NCT01034137|594764775|FG002|Overall Study|Lack of Efficacy|13|||
164549646|NCT02255409|594385025|FG000|Overall Study|Withdrawal by Subject|1|||
164549647|NCT02255409|594385026|FG001|Overall Study|Withdrawal by Subject|5|||
164549648|NCT02255409|594385025|FG000|Overall Study|Lost to Follow-up|10|||
164549649|NCT02255409|594385026|FG001|Overall Study|Lost to Follow-up|19|||
164549650|NCT01251367|594385027|FG000|Overall Study|Protocol Violation|1|||
164549651|NCT01251367|594385027|FG000|Overall Study|Lack of Efficacy|2|||
164549652|NCT01251367|594385027|FG000|Overall Study|Adverse Event|19|||
164549653|NCT01251367|594385027|FG000|Overall Study|Withdrawal by Subject|36|||
164549654|NCT01251367|594385027|FG000|Overall Study|Lost to Follow-up|5|||
164549655|NCT01251367|594385027|FG000|Overall Study|Subject Required Alternative Treatment|7|||
164655322|NCT01034137|594764773|FG000|Overall Study|Protocol Violation|2|||
164655323|NCT01034137|594764774|FG001|Overall Study|Protocol Violation|2|||
164655324|NCT01034137|594764775|FG002|Overall Study|Protocol Violation|1|||
164655325|NCT01034137|594764773|FG000|Overall Study|Refused treatment or did not cooperate|2|||
164655326|NCT01034137|594764774|FG001|Overall Study|Refused treatment or did not cooperate|0|||
164655327|NCT01034137|594764775|FG002|Overall Study|Refused treatment or did not cooperate|1|||
164655328|NCT01034137|594764773|FG000|Overall Study|Administrative or other|2|||
164655329|NCT01034137|594764774|FG001|Overall Study|Administrative or other|3|||
164655330|NCT01034137|594764775|FG002|Overall Study|Administrative or other|4|||
164549656|NCT01251367|594385027|FG000|Overall Study|No Study Drug Available|1|||
164549657|NCT01251367|594385027|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
164549658|NCT01251367|594385027|FG000|Overall Study|End of Study Visit Performed in Error|1|||
164655331|NCT03572933|594764776|FG000|Overall Study|Adverse Event|4|||
164655332|NCT03572933|594764777|FG001|Overall Study|Adverse Event|1|||
164549659|NCT03917823|594385028|FG000|Overall Study|Lost to Follow-up|1|||
164549660|NCT03917823|594385029|FG001|Overall Study|Lost to Follow-up|1|||
164549661|NCT03917823|594385028|FG000|Overall Study|Withdrawal by Subject|0|||
164549662|NCT03917823|594385029|FG001|Overall Study|Withdrawal by Subject|1|||
164549663|NCT00135668|594385030|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
164549664|NCT00135668|594385031|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
164549665|NCT00135668|594385032|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
164549666|NCT00135668|594385033|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
164549667|NCT00473343|594385036|FG000|Overall Study|Adverse Event|9|||
164549668|NCT00473343|594385036|FG000|Overall Study|Lost to Follow-up|8|||
164549669|NCT00473343|594385036|FG000|Overall Study|Treatment failure|27|||
164549670|NCT00473343|594385036|FG000|Overall Study|Withdrew consent|3|||
164549671|NCT00473343|594385036|FG000|Overall Study|Other un-specified reason|3|||
164549672|NCT02290873|594385039|FG000|Overall Study|Withdrawal by Subject|0|||
164549673|NCT02290873|594385040|FG001|Overall Study|Withdrawal by Subject|1|||
164549674|NCT02290873|594385041|FG002|Overall Study|Withdrawal by Subject|1|||
164549675|NCT02290873|594385039|FG000|Overall Study|Nellcor device error|1|||
164549676|NCT02290873|594385040|FG001|Overall Study|Nellcor device error|0|||
164549677|NCT02290873|594385041|FG002|Overall Study|Nellcor device error|0|||
164549678|NCT02290873|594385039|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
164549679|NCT02290873|594385040|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
164549680|NCT02290873|594385041|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
164549681|NCT02290873|594385039|FG000|Overall Study|Protocol Violation|0|||
164549682|NCT02290873|594385040|FG001|Overall Study|Protocol Violation|0|||
164549683|NCT02290873|594385041|FG002|Overall Study|Protocol Violation|1|||
164549684|NCT02370615|594385042|FG000|Overall Study|Adverse Event|1|||
164549685|NCT02370615|594385043|FG001|Overall Study|Adverse Event|0|||
164549686|NCT03715153|594385044|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
164549687|NCT03715153|594385045|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
164549688|NCT03715153|594385044|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
164549689|NCT03715153|594385045|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
164549690|NCT03715153|594385044|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
164549691|NCT03715153|594385045|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
164549692|NCT03715153|594385044|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
164549693|NCT03715153|594385045|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
164549694|NCT03715153|594385044|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
164655333|NCT03572933|594764776|FG000|Overall Study|Withdrawal by Subject|0|||
164655334|NCT03572933|594764777|FG001|Overall Study|Withdrawal by Subject|1|||
164197732|NCT03811821|593092383|FG000|Overall Study|Adverse Event|1|||
164197733|NCT03811821|593092384|FG001|Overall Study|Adverse Event|1|||
164197734|NCT03811821|593092383|FG000|Overall Study|Withdrawal by Subject|5|||
164197735|NCT03811821|593092384|FG001|Overall Study|Withdrawal by Subject|4|||
164197736|NCT03811821|593092383|FG000|Overall Study|Lost to Follow-up|2|||
164197737|NCT03811821|593092384|FG001|Overall Study|Lost to Follow-up|2|||
164197738|NCT03811821|593092383|FG000|Overall Study|Contraindication for treatment|0|||
164197739|NCT03811821|593092384|FG001|Overall Study|Contraindication for treatment|1|||
164197740|NCT03811821|593092383|FG000|Overall Study|Tolerability|0|||
164197741|NCT03811821|593092384|FG001|Overall Study|Tolerability|3|||
164197742|NCT03811821|593092383|FG000|Overall Study|Comorbidities|0|||
164197743|NCT03811821|593092384|FG001|Overall Study|Comorbidities|2|||
164197744|NCT03433898|593092387|FG000|Overall Study|Progressive disease|6|||
164197745|NCT03433898|593092388|FG001|Overall Study|Progressive disease|3|||
164197746|NCT03433898|593092389|FG002|Overall Study|Progressive disease|3|||
164197747|NCT03433898|593092390|FG003|Overall Study|Progressive disease|2|||
164197748|NCT03433898|593092391|FG004|Overall Study|Progressive disease|30|||
164197749|NCT03433898|593092392|FG005|Overall Study|Progressive disease|29|||
164197750|NCT03433898|593092393|FG006|Overall Study|Progressive disease|17|||
164197751|NCT03433898|593092394|FG007|Overall Study|Progressive disease|30|||
164197752|NCT03433898|593092387|FG000|Overall Study|Not treated|1|||
164197753|NCT03433898|593092388|FG001|Overall Study|Not treated|0|||
164549695|NCT03715153|594385045|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
164549696|NCT03715153|594385044|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
164549697|NCT03715153|594385045|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
164549698|NCT04126083|594385046|FG000|Overall Study|Withdrawal by Subject|1|||
164549699|NCT01892163|594385049|FG000|Overall Study|Death|1|||
164655335|NCT01466686|594764778|FG000|Overall Study|Withdrawal by Subject|1|||
164655336|NCT02049359|594764779|FG000|Overall Study|Lost to Follow-up|26|||
164197754|NCT03433898|593092389|FG002|Overall Study|Not treated|0|||
164197755|NCT03433898|593092390|FG003|Overall Study|Not treated|0|||
164197756|NCT03433898|593092391|FG004|Overall Study|Not treated|1|||
164307254|NCT02023697|593499223|FG000|Long-term Follow-up Period|Other unspecified|6|||
164197757|NCT03433898|593092392|FG005|Overall Study|Not treated|0|||
164197758|NCT03433898|593092393|FG006|Overall Study|Not treated|0|||
164197759|NCT03433898|593092394|FG007|Overall Study|Not treated|0|||
164197760|NCT03433898|593092387|FG000|Overall Study|Death|0|||
164197761|NCT03433898|593092388|FG001|Overall Study|Death|0|||
164197762|NCT03433898|593092389|FG002|Overall Study|Death|0|||
164197763|NCT03433898|593092390|FG003|Overall Study|Death|0|||
164197764|NCT03433898|593092391|FG004|Overall Study|Death|0|||
164197765|NCT03433898|593092392|FG005|Overall Study|Death|0|||
164197766|NCT03433898|593092393|FG006|Overall Study|Death|1|||
164197767|NCT03433898|593092394|FG007|Overall Study|Death|1|||
164549700|NCT01892163|594385050|FG001|Overall Study|Death|1|||
164549701|NCT01892163|594385049|FG000|Overall Study|Lost to Follow-up|1|||
164549702|NCT01892163|594385050|FG001|Overall Study|Lost to Follow-up|0|||
164549703|NCT02577146|594385051|FG000|Overall Study|Lost to Follow-up|8|||
164549704|NCT02577146|594385051|FG000|Overall Study|Physician Decision|3|||
164549705|NCT02577146|594385051|FG000|Overall Study|Screen Failure|17|||
164549706|NCT03116698|594385052|FG000|Overall Study|Adverse Event|1|||
164549707|NCT03116698|594385053|FG001|Overall Study|Adverse Event|1|||
164549708|NCT03116698|594385054|FG002|Overall Study|Adverse Event|1|||
164549709|NCT03116698|594385055|FG003|Overall Study|Adverse Event|0|||
164549710|NCT03116698|594385052|FG000|Overall Study|Withdrawal by Subject|1|||
164549711|NCT03116698|594385053|FG001|Overall Study|Withdrawal by Subject|4|||
164549712|NCT03116698|594385054|FG002|Overall Study|Withdrawal by Subject|5|||
164549713|NCT03116698|594385055|FG003|Overall Study|Withdrawal by Subject|2|||
164549714|NCT03116698|594385052|FG000|Overall Study|Lost to Follow-up|2|||
164549715|NCT03116698|594385053|FG001|Overall Study|Lost to Follow-up|0|||
164549716|NCT03116698|594385054|FG002|Overall Study|Lost to Follow-up|0|||
164549717|NCT03116698|594385055|FG003|Overall Study|Lost to Follow-up|0|||
164549718|NCT03116698|594385052|FG000|Overall Study|Physician Decision|1|||
164549719|NCT03116698|594385053|FG001|Overall Study|Physician Decision|1|||
164549720|NCT03116698|594385054|FG002|Overall Study|Physician Decision|0|||
164549721|NCT03116698|594385055|FG003|Overall Study|Physician Decision|0|||
164549722|NCT03116698|594385052|FG000|Overall Study|Protocol Violation|1|||
164549723|NCT03116698|594385053|FG001|Overall Study|Protocol Violation|0|||
164549724|NCT03116698|594385054|FG002|Overall Study|Protocol Violation|0|||
164549725|NCT03116698|594385055|FG003|Overall Study|Protocol Violation|0|||
164549726|NCT03116698|594385052|FG000|Overall Study|Death|0|||
164549727|NCT03116698|594385053|FG001|Overall Study|Death|0|||
164549728|NCT03116698|594385054|FG002|Overall Study|Death|2|||
164549729|NCT03116698|594385055|FG003|Overall Study|Death|0|||
164549730|NCT02258451|594385056|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
164549731|NCT02258451|594385057|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
164549732|NCT02258451|594385056|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
164549733|NCT02258451|594385057|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
164549734|NCT02258451|594385056|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
164549735|NCT02258451|594385057|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
164549736|NCT02258451|594385056|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
164549737|NCT02258451|594385057|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
164549738|NCT02258451|594385056|FG000|Overall Study|Discontinuation all treatment due to death|4|||
164549739|NCT02258451|594385057|FG001|Overall Study|Discontinuation all treatment due to death|3|||
164549740|NCT02258451|594385056|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
164549741|NCT02258451|594385057|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
164549742|NCT02258451|594385056|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
164549743|NCT02258451|594385057|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
164549744|NCT02258451|594385056|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
164549745|NCT02258451|594385057|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
164549746|NCT02258451|594385056|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
164549747|NCT02258451|594385057|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
164549748|NCT02258451|594385056|FG000|Overall Study|Other reason|1|||
164549749|NCT02258451|594385057|FG001|Overall Study|Other reason|1|||
164549750|NCT02258451|594385056|FG000|Overall Study|Never treated|2|||
164197768|NCT03433898|593092387|FG000|Overall Study|Withdrawal by Subject|0|||
164197769|NCT03433898|593092388|FG001|Overall Study|Withdrawal by Subject|0|||
164549751|NCT02258451|594385057|FG001|Overall Study|Never treated|3|||
164549752|NCT05419128|594385060|FG000|Overall Study|Withdrawal by Subject|1|||
164549753|NCT05419128|594385061|FG001|Overall Study|Withdrawal by Subject|1|||
164549754|NCT05419128|594385062|FG002|Overall Study|Withdrawal by Subject|0|||
164549755|NCT05419128|594385063|FG003|Overall Study|Withdrawal by Subject|1|||
164549756|NCT05419128|594385064|FG004|Overall Study|Withdrawal by Subject|1|||
164549757|NCT05419128|594385065|FG005|Overall Study|Withdrawal by Subject|0|||
164549758|NCT05419128|594385060|FG000|Overall Study|Lost to Follow-up|0|||
164197770|NCT03433898|593092389|FG002|Overall Study|Withdrawal by Subject|0|||
164655337|NCT02049359|594764780|FG001|Overall Study|Lost to Follow-up|19|||
164655338|NCT00658320|594764781|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
164655339|NCT00658320|594764782|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
164655340|NCT00658320|594764781|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
164655341|NCT00658320|594764782|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
164655342|NCT00658320|594764781|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
164655343|NCT00658320|594764782|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
164655344|NCT00658320|594764781|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
164655345|NCT00658320|594764782|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
164655346|NCT01405950|594764783|FG000|Overall Study|Withdrawal by Subject|1|||
164655347|NCT01405950|594764784|FG001|Overall Study|Withdrawal by Subject|0|||
164655348|NCT01405950|594764785|FG002|Overall Study|Withdrawal by Subject|0|||
164655349|NCT01405950|594764786|FG003|Overall Study|Withdrawal by Subject|0|||
164655350|NCT02410252|594764788|FG000|Overall Study|Withdrawal by Subject|4|||
164655351|NCT02410252|594764788|FG000|Overall Study|Physician Decision|2|||
164655352|NCT01007916|594764792|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
164655353|NCT01007916|594764793|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
164655354|NCT01007916|594764792|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
164655355|NCT01007916|594764793|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
164655356|NCT00387712|594764796|FG000|Overall Study|Physician Decision|6|||
164655357|NCT00387712|594764797|FG001|Overall Study|Physician Decision|4|||
164655358|NCT00387712|594764796|FG000|Overall Study|Lost to Follow-up|17|||
164655359|NCT00387712|594764797|FG001|Overall Study|Lost to Follow-up|20|||
164655360|NCT00387712|594764796|FG000|Overall Study|Withdrawal by Subject|6|||
164655361|NCT00387712|594764797|FG001|Overall Study|Withdrawal by Subject|12|||
164655362|NCT00112489|594764808|FG000|Overall Study|Refused further treatment|8|||
164655363|NCT00112489|594764808|FG000|Overall Study|Adverse Event|12|||
164655364|NCT00112489|594764808|FG000|Overall Study|Death|2|||
164655365|NCT00112489|594764808|FG000|Overall Study|Other, Not Specified|9|||
164197771|NCT03433898|593092390|FG003|Overall Study|Withdrawal by Subject|0|||
164197772|NCT03433898|593092391|FG004|Overall Study|Withdrawal by Subject|2|||
164197773|NCT03433898|593092392|FG005|Overall Study|Withdrawal by Subject|0|||
164197774|NCT03433898|593092393|FG006|Overall Study|Withdrawal by Subject|0|||
164197775|NCT03433898|593092394|FG007|Overall Study|Withdrawal by Subject|0|||
164197776|NCT03433898|593092387|FG000|Overall Study|Adverse Event|0|||
164197777|NCT03433898|593092388|FG001|Overall Study|Adverse Event|0|||
164197778|NCT03433898|593092389|FG002|Overall Study|Adverse Event|0|||
164197779|NCT03433898|593092390|FG003|Overall Study|Adverse Event|0|||
164197780|NCT03433898|593092391|FG004|Overall Study|Adverse Event|0|||
164197781|NCT03433898|593092392|FG005|Overall Study|Adverse Event|5|||
164197782|NCT03433898|593092393|FG006|Overall Study|Adverse Event|2|||
164197783|NCT03433898|593092394|FG007|Overall Study|Adverse Event|2|||
164197784|NCT03433898|593092387|FG000|Overall Study|Fatal adverse event: Acute kidney injury|0|||
164197785|NCT03433898|593092388|FG001|Overall Study|Fatal adverse event: Acute kidney injury|0|||
164197786|NCT03433898|593092389|FG002|Overall Study|Fatal adverse event: Acute kidney injury|0|||
164197787|NCT03433898|593092390|FG003|Overall Study|Fatal adverse event: Acute kidney injury|0|||
164197788|NCT03433898|593092391|FG004|Overall Study|Fatal adverse event: Acute kidney injury|1|||
164197789|NCT03433898|593092392|FG005|Overall Study|Fatal adverse event: Acute kidney injury|0|||
164197790|NCT03433898|593092393|FG006|Overall Study|Fatal adverse event: Acute kidney injury|0|||
164197791|NCT03433898|593092394|FG007|Overall Study|Fatal adverse event: Acute kidney injury|0|||
164197792|NCT01395810|593092397|FG000|Overall Study|Adverse Event|0|||
164197793|NCT01395810|593092398|FG001|Overall Study|Adverse Event|1|||
164197794|NCT01395810|593092399|FG002|Overall Study|Adverse Event|0|||
164197795|NCT01395810|593092400|FG003|Overall Study|Adverse Event|0|||
164197796|NCT01395810|593092397|FG000|Overall Study|Lack of Efficacy|0|||
164197797|NCT01395810|593092398|FG001|Overall Study|Lack of Efficacy|1|||
164197798|NCT01395810|593092399|FG002|Overall Study|Lack of Efficacy|0|||
164197799|NCT01395810|593092400|FG003|Overall Study|Lack of Efficacy|0|||
164197800|NCT01395810|593092397|FG000|Overall Study|Withdrawal criteria|0|||
164197801|NCT01395810|593092398|FG001|Overall Study|Withdrawal criteria|2|||
164655366|NCT00112489|594764808|FG000|Overall Study|Patient never treated|2|||
164655367|NCT00112489|594764808|FG000|Overall Study|Ineligible|7|||
164655368|NCT04467697|594764810|FG000|Overall Study|Adverse Event|2|||
164655369|NCT04467697|594764810|FG000|Overall Study|Lost to Follow-up|6|||
164197802|NCT01395810|593092399|FG002|Overall Study|Withdrawal criteria|0|||
164197803|NCT01395810|593092400|FG003|Overall Study|Withdrawal criteria|0|||
164197804|NCT01395810|593092397|FG000|Overall Study|Unclassified|2|||
164655370|NCT04467697|594764810|FG000|Overall Study|Withdrawal by Subject|9|||
164197805|NCT01395810|593092398|FG001|Overall Study|Unclassified|0|||
164655371|NCT04467697|594764810|FG000|Overall Study|Protocol Violation|3|||
164197806|NCT01395810|593092399|FG002|Overall Study|Unclassified|0|||
164197807|NCT01395810|593092400|FG003|Overall Study|Unclassified|0|||
164197808|NCT05069259|593092404|FG000|Overall Study|Withdrawal by Subject|1|||
164197809|NCT05069259|593092404|FG000|Overall Study|Sponsor decision|1|||
164655372|NCT00268346|594764811|FG000|Overall Study|Adverse Event|0|||
164655373|NCT00268346|594764812|FG001|Overall Study|Adverse Event|1|||
164197810|NCT01496976|593093676|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
164197811|NCT05556616|593093677|FG000|Overall Study|Withdrawal by Subject|1|||
164197812|NCT05556616|593093678|FG001|Overall Study|Withdrawal by Subject|0|||
164197813|NCT05556616|593093679|FG002|Overall Study|Withdrawal by Subject|0|||
164197814|NCT05556616|593093680|FG003|Overall Study|Withdrawal by Subject|0|||
164197815|NCT05556616|593093681|FG004|Overall Study|Withdrawal by Subject|0|||
164197816|NCT05556616|593093682|FG005|Overall Study|Withdrawal by Subject|0|||
164197817|NCT05556616|593093683|FG006|Overall Study|Withdrawal by Subject|0|||
164197818|NCT05556616|593093677|FG000|Overall Study|Death|0|||
164197819|NCT05556616|593093678|FG001|Overall Study|Death|0|||
164197820|NCT05556616|593093679|FG002|Overall Study|Death|2|||
164197821|NCT05556616|593093680|FG003|Overall Study|Death|1|||
164197822|NCT05556616|593093681|FG004|Overall Study|Death|0|||
164197823|NCT05556616|593093682|FG005|Overall Study|Death|0|||
164197824|NCT05556616|593093683|FG006|Overall Study|Death|0|||
164197825|NCT05556616|593093677|FG000|Overall Study|Study Terminated by Sponsor|0|||
164197826|NCT05556616|593093678|FG001|Overall Study|Study Terminated by Sponsor|3|||
164197827|NCT05556616|593093679|FG002|Overall Study|Study Terminated by Sponsor|0|||
164197828|NCT05556616|593093680|FG003|Overall Study|Study Terminated by Sponsor|0|||
164197829|NCT05556616|593093681|FG004|Overall Study|Study Terminated by Sponsor|0|||
164197830|NCT05556616|593093682|FG005|Overall Study|Study Terminated by Sponsor|0|||
164197831|NCT05556616|593093683|FG006|Overall Study|Study Terminated by Sponsor|0|||
164197832|NCT03256578|593093684|FG000|Overall Study|Excluded Post Randomization|66|||
164197833|NCT03256578|593093685|FG001|Overall Study|Excluded Post Randomization|56|||
164197834|NCT05428436|593093686|FG000|Period 1 - 2 washout|Adverse Event|1|||
164197835|NCT05428436|593093687|FG001|Period 1 - 2 washout|Adverse Event|0|||
164197836|NCT05428436|593093688|FG002|Period 1 - 2 washout|Adverse Event|0|||
164197837|NCT03964207|593093689|FG000|First Treatment|Withdrawal by Subject|1|||
164197838|NCT03964207|593093690|FG001|First Treatment|Withdrawal by Subject|2|||
164197839|NCT03964207|593093689|FG000|First Treatment|Protocol Violation|1|||
164197840|NCT03964207|593093690|FG001|First Treatment|Protocol Violation|0|||
164197841|NCT03964207|593093689|FG000|First Treatment|Lost to Follow-up|1|||
164197842|NCT03964207|593093690|FG001|First Treatment|Lost to Follow-up|0|||
164197843|NCT03964207|593093689|FG000|Second Treatment|Lost to Follow-up|0|||
164197844|NCT03964207|593093690|FG001|Second Treatment|Lost to Follow-up|1|||
164197845|NCT03964207|593093689|FG000|Second Treatment|Adverse Event|1|||
164197846|NCT03964207|593093690|FG001|Second Treatment|Adverse Event|2|||
164197847|NCT00001566|593093695|FG000|Overall Study|patients' choice to discontinue protocol|3|||
164197848|NCT00001566|593093695|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
164197849|NCT00001566|593093695|FG000|Overall Study|Death|13|||
164197850|NCT00001566|593093695|FG000|Overall Study|Lost to Follow-up|1|||
164197851|NCT00001566|593093695|FG000|Overall Study|unable to complete initial apheresis|1|||
164197852|NCT01290718|593093696|FG000|Overall Study|Early termination of the study|4|||
164197853|NCT01222104|593093698|FG000|Overall Study|Lost to Follow-up|37|||
164197854|NCT01222104|593093698|FG000|Overall Study|Death|10|||
164197855|NCT00888654|593093699|FG000|Overall Study|Problems swallowing oral meds.|1|||
164197856|NCT00888654|593093699|FG000|Overall Study|Not enough oral meds before surgery|3|||
164197857|NCT00888654|593093699|FG000|Overall Study|Surgery aborted|2|||
164197858|NCT00888654|593093699|FG000|Overall Study|Withdrawal by Subject|1|||
164197859|NCT00888654|593093699|FG000|Overall Study|Inelig. due to contraindication of med|1|||
164197860|NCT00888654|593093699|FG000|Overall Study|Change in surg date|1|||
164197861|NCT00888654|593093699|FG000|Overall Study|Stopped meds due to headaches|1|||
164197862|NCT03669549|593093702|FG000|Overall Study|Adverse Event|4|||
164197863|NCT03669549|593093702|FG000|Overall Study|Withdrawal by Subject|1|||
164197864|NCT03669549|593093702|FG000|Overall Study|Study terminated by the Sponsor|1|||
164197865|NCT00705757|593093704|FG000|Overall Study|Lack of Efficacy|5|||
164197866|NCT00705757|593093705|FG001|Overall Study|Lack of Efficacy|1|||
164197867|NCT00705757|593093706|FG002|Overall Study|Lack of Efficacy|3|||
164197868|NCT00705757|593093704|FG000|Overall Study|Lost to Follow-up|7|||
164197869|NCT00705757|593093705|FG001|Overall Study|Lost to Follow-up|6|||
164197870|NCT00705757|593093706|FG002|Overall Study|Lost to Follow-up|6|||
164197871|NCT00705757|593093704|FG000|Overall Study|Withdrawal by Subject|1|||
164197872|NCT00705757|593093705|FG001|Overall Study|Withdrawal by Subject|1|||
164197873|NCT00705757|593093706|FG002|Overall Study|Withdrawal by Subject|2|||
164197874|NCT05953363|593093713|FG000|Overall Study|Screen Failure|2|||
164197875|NCT05953363|593093713|FG000|Overall Study|Withdrawal by Subject|3|||
164197876|NCT05953363|593093713|FG000|Overall Study|Surgery cancelled|2|||
164197877|NCT05953363|593093713|FG000|Overall Study|Adverse Event|1|||
164197878|NCT01701674|593093714|FG000|Overall Study|Unable to safely complete treatment|1|||
164197879|NCT05696392|593093716|FG000|Overall Study|Lost to Follow-up|3|||
164197880|NCT05696392|593093716|FG000|Overall Study|Protocol Violation|1|||
164197881|NCT05696392|593093716|FG000|Overall Study|Withdrawal by Subject|1|||
164197882|NCT04464707|593093721|FG000|Overall Study|Adverse Event|1|||
164197883|NCT04464707|593093722|FG001|Overall Study|Adverse Event|0|||
164197884|NCT04464707|593093723|FG002|Overall Study|Adverse Event|0|||
164197885|NCT04464707|593093721|FG000|Overall Study|Withdrawal by Subject|0|||
164549759|NCT05419128|594385061|FG001|Overall Study|Lost to Follow-up|0|||
164549760|NCT05419128|594385062|FG002|Overall Study|Lost to Follow-up|1|||
164549761|NCT05419128|594385063|FG003|Overall Study|Lost to Follow-up|0|||
164549762|NCT05419128|594385064|FG004|Overall Study|Lost to Follow-up|0|||
164549763|NCT05419128|594385065|FG005|Overall Study|Lost to Follow-up|1|||
164549764|NCT03021499|594385068|FG000|Overall Study|Adverse Event|1|||
164549765|NCT03021499|594385069|FG001|Overall Study|Adverse Event|0|||
164549766|NCT03021499|594385068|FG000|Overall Study|Death|1|||
164549767|NCT03021499|594385069|FG001|Overall Study|Death|5|||
164549768|NCT03021499|594385068|FG000|Overall Study|Lack of Efficacy|0|||
164549769|NCT03021499|594385069|FG001|Overall Study|Lack of Efficacy|1|||
164549770|NCT03021499|594385068|FG000|Overall Study|Lost to Follow-up|1|||
164549771|NCT03021499|594385069|FG001|Overall Study|Lost to Follow-up|3|||
164549772|NCT03021499|594385068|FG000|Overall Study|Physician Decision|2|||
164549773|NCT03021499|594385069|FG001|Overall Study|Physician Decision|3|||
164549774|NCT03021499|594385068|FG000|Overall Study|Pregnancy|1|||
164549775|NCT03021499|594385069|FG001|Overall Study|Pregnancy|0|||
164549776|NCT03021499|594385068|FG000|Overall Study|Withdrawal by Subject|7|||
164549777|NCT03021499|594385069|FG001|Overall Study|Withdrawal by Subject|14|||
164549778|NCT03021499|594385068|FG000|Overall Study|Prohibited medication required|1|||
164549779|NCT03021499|594385069|FG001|Overall Study|Prohibited medication required|0|||
164549780|NCT03021499|594385068|FG000|Overall Study|Protocol non-compliance|1|||
164549781|NCT03021499|594385069|FG001|Overall Study|Protocol non-compliance|1|||
164549782|NCT03021499|594385068|FG000|Overall Study|None of the above|0|||
164549783|NCT03021499|594385069|FG001|Overall Study|None of the above|4|||
164549784|NCT03021499|594385068|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
164549785|NCT03021499|594385069|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
164549786|NCT00495820|594385070|FG000|Overall Study|Adverse Event|1|||
164549787|NCT00495820|594385071|FG001|Overall Study|Adverse Event|1|||
164549788|NCT00820950|594385072|FG000|Overall Study|Scheduling Conflict|0|||
164549789|NCT00820950|594385073|FG001|Overall Study|Scheduling Conflict|0|||
164549790|NCT00820950|594385074|FG002|Overall Study|Scheduling Conflict|0|||
164549791|NCT00820950|594385075|FG003|Overall Study|Scheduling Conflict|0|||
164549792|NCT00820950|594385076|FG004|Overall Study|Scheduling Conflict|0|||
164549793|NCT00820950|594385077|FG005|Overall Study|Scheduling Conflict|0|||
164549794|NCT00820950|594385078|FG006|Overall Study|Scheduling Conflict|1|||
164549795|NCT00820950|594385079|FG007|Overall Study|Scheduling Conflict|1|||
164549796|NCT00820950|594385080|FG008|Overall Study|Scheduling Conflict|0|||
164549797|NCT00820950|594385081|FG009|Overall Study|Scheduling Conflict|0|||
164549798|NCT00820950|594385072|FG000|Overall Study|Protocol Violation|1|||
164549799|NCT00820950|594385073|FG001|Overall Study|Protocol Violation|1|||
164549800|NCT00820950|594385074|FG002|Overall Study|Protocol Violation|0|||
164549801|NCT00820950|594385075|FG003|Overall Study|Protocol Violation|0|||
164549802|NCT00820950|594385076|FG004|Overall Study|Protocol Violation|0|||
164549803|NCT00820950|594385077|FG005|Overall Study|Protocol Violation|0|||
164549804|NCT00820950|594385078|FG006|Overall Study|Protocol Violation|0|||
164549805|NCT00820950|594385079|FG007|Overall Study|Protocol Violation|0|||
164549806|NCT00820950|594385080|FG008|Overall Study|Protocol Violation|0|||
164549807|NCT00820950|594385081|FG009|Overall Study|Protocol Violation|0|||
164549808|NCT00609791|594387094|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
164549809|NCT04218201|594387095|FG000|Overall Study|Death|0|||
164549810|NCT04218201|594387096|FG001|Overall Study|Death|0|||
164549811|NCT04218201|594387097|FG002|Overall Study|Death|2|||
164549812|NCT04218201|594387098|FG003|Overall Study|Death|0|||
164197886|NCT04464707|593093722|FG001|Overall Study|Withdrawal by Subject|0|||
164197887|NCT04464707|593093723|FG002|Overall Study|Withdrawal by Subject|2|||
164197888|NCT04464707|593093721|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164197889|NCT04464707|593093722|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
164197890|NCT04464707|593093723|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
164197891|NCT04464707|593093721|FG000|Overall Study|Protocol Deviation|1|||
164197892|NCT04464707|593093722|FG001|Overall Study|Protocol Deviation|0|||
164197893|NCT04464707|593093723|FG002|Overall Study|Protocol Deviation|0|||
164197894|NCT04464707|593093721|FG000|Overall Study|Lost to Follow-up|2|||
164197895|NCT04464707|593093722|FG001|Overall Study|Lost to Follow-up|0|||
164549813|NCT04218201|594387095|FG000|Overall Study|Unable to contact participant|4|||
164549814|NCT04218201|594387096|FG001|Overall Study|Unable to contact participant|0|||
164549815|NCT04218201|594387097|FG002|Overall Study|Unable to contact participant|3|||
164549816|NCT04218201|594387098|FG003|Overall Study|Unable to contact participant|0|||
164549817|NCT04218201|594387095|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
164549818|NCT04218201|594387096|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
164549819|NCT04218201|594387097|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
164549820|NCT04218201|594387098|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
164549821|NCT04218201|594387095|FG000|Overall Study|Withdrawal by Subject|2|||
164549822|NCT04218201|594387096|FG001|Overall Study|Withdrawal by Subject|0|||
164197896|NCT04464707|593093723|FG002|Overall Study|Lost to Follow-up|1|||
164197897|NCT02131064|593093724|FG000|Overall Study|Death|5|||
164549823|NCT04218201|594387097|FG002|Overall Study|Withdrawal by Subject|0|||
164655374|NCT00268346|594764811|FG000|Overall Study|Death|0|||
164655375|NCT00268346|594764812|FG001|Overall Study|Death|1|||
164197898|NCT02131064|593093725|FG001|Overall Study|Death|6|||
164197899|NCT02131064|593093724|FG000|Overall Study|Lost to Follow-up|4|||
164197900|NCT02131064|593093725|FG001|Overall Study|Lost to Follow-up|8|||
164655376|NCT00268346|594764811|FG000|Overall Study|Withdrawal by Subject|0|||
164655377|NCT00268346|594764812|FG001|Overall Study|Withdrawal by Subject|1|||
164197901|NCT02131064|593093724|FG000|Overall Study|Withdrawal by Subject|14|||
164197902|NCT02131064|593093725|FG001|Overall Study|Withdrawal by Subject|18|||
164197903|NCT02131064|593093724|FG000|Overall Study|Other|2|||
164197904|NCT02131064|593093725|FG001|Overall Study|Other|2|||
164197905|NCT00593918|593093730|FG000|Overall Study|Withdrawal by Subject|5|||
164197906|NCT00593918|593093731|FG001|Overall Study|Withdrawal by Subject|24|||
164197907|NCT00871234|593093745|FG000|Overall Study|Adverse Event|2|||
164197908|NCT00871234|593093745|FG000|Overall Study|Lost to Follow-up|3|||
164197909|NCT04202497|593093747|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
164197910|NCT04202497|593093748|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
164197911|NCT04202497|593093749|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
164197912|NCT04202497|593093750|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
164197913|NCT04344301|593093751|FG000|Overall Study|Withdrawal by Subject|1|||
164197914|NCT04344301|593093752|FG001|Overall Study|Withdrawal by Subject|0|||
164197915|NCT04344301|593093751|FG000|Overall Study|Death|0|||
164197916|NCT04344301|593093752|FG001|Overall Study|Death|1|||
164197917|NCT00072410|593093753|FG000|Overall Study|Progressive disease|0|||
164197918|NCT00072410|593093754|FG001|Overall Study|Progressive disease|3|||
164197919|NCT05590377|593093757|FG000|Overall Study|Death|1|||
164197920|NCT05590377|593093758|FG001|Overall Study|Death|1|||
164197921|NCT05590377|593093759|FG002|Overall Study|Death|2|||
164197922|NCT05590377|593093760|FG003|Overall Study|Death|0|||
164197923|NCT05590377|593093761|FG004|Overall Study|Death|0|||
164197924|NCT05590377|593093757|FG000|Overall Study|Study Terminated by Sponsor|1|||
164197925|NCT05590377|593093758|FG001|Overall Study|Study Terminated by Sponsor|5|||
164197926|NCT05590377|593093759|FG002|Overall Study|Study Terminated by Sponsor|4|||
164197927|NCT05590377|593093760|FG003|Overall Study|Study Terminated by Sponsor|0|||
164197928|NCT05590377|593093761|FG004|Overall Study|Study Terminated by Sponsor|0|||
164197929|NCT05590377|593093757|FG000|Overall Study|Withdrawal by Subject|1|||
164197930|NCT05590377|593093758|FG001|Overall Study|Withdrawal by Subject|0|||
164197931|NCT05590377|593093759|FG002|Overall Study|Withdrawal by Subject|0|||
164197932|NCT05590377|593093760|FG003|Overall Study|Withdrawal by Subject|0|||
164655378|NCT02043366|594764815|FG000|Overall Study|Lost to Follow-up|2|||
164655379|NCT02043366|594764816|FG001|Overall Study|Lost to Follow-up|2|||
164655380|NCT02043366|594764817|FG002|Overall Study|Lost to Follow-up|2|||
164655381|NCT02043366|594764818|FG003|Overall Study|Lost to Follow-up|2|||
164197933|NCT05590377|593093761|FG004|Overall Study|Withdrawal by Subject|0|||
164655382|NCT02043366|594764819|FG004|Overall Study|Lost to Follow-up|2|||
164655383|NCT02043366|594764820|FG005|Overall Study|Lost to Follow-up|2|||
164197934|NCT03389620|593093762|FG000|Overall Study|Lost to Follow-up|5|||
164655384|NCT01489956|594764821|FG000|Overall Study|Lost to Follow-up|1|||
164655385|NCT01489956|594764822|FG001|Overall Study|Lost to Follow-up|0|||
164655386|NCT01489956|594764823|FG002|Overall Study|Lost to Follow-up|0|||
164655387|NCT01489956|594764821|FG000|Overall Study|Withdrawal by Subject|0|||
164655388|NCT01489956|594764822|FG001|Overall Study|Withdrawal by Subject|0|||
164655389|NCT01489956|594764823|FG002|Overall Study|Withdrawal by Subject|1|||
164655390|NCT00723554|594764825|FG000|Overall Study|Adverse Event|12|||
164655391|NCT00723554|594764825|FG000|Overall Study|Investigator's judgement|5|||
164197935|NCT03389620|593093763|FG001|Overall Study|Lost to Follow-up|1|||
164197936|NCT04782180|593093770|FG000|Overall Study|Withdrawal by Subject|2|||
164197937|NCT04782180|593093770|FG000|Overall Study|Lost to Follow-up|2|||
164197938|NCT05852353|593093771|FG000|Overall Study|Family (dyad with LUTS) who consented but withdrew|2|||
164197939|NCT05852353|593093771|FG000|Overall Study|Family (dyad did not have LUTS) who consented but withdrew|1|||
164197940|NCT05852353|593093771|FG000|Overall Study|Family (dyad) who consented but did not complete intervention|24|||
164197941|NCT05852353|593093771|FG000|Overall Study|Family (dyad) who completed intervention but was lost to follow-up|7|||
164197942|NCT01005745|593093772|FG000|Overall Study|No TIL growth|1|||
164197943|NCT01005745|593093772|FG000|Overall Study|Disease progressed during TIL growth|3|||
164197944|NCT01005745|593093772|FG000|Overall Study|Death prior to treatment|1|||
164197945|NCT01005745|593093772|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
164197946|NCT06077773|593093773|FG000|Overall Study|Withdrawal by Subject|1|||
164197947|NCT06077773|593093774|FG001|Overall Study|Withdrawal by Subject|0|||
164197948|NCT06077773|593093775|FG002|Overall Study|Withdrawal by Subject|1|||
164197949|NCT06077773|593093773|FG000|Overall Study|Lost to Follow-up|0|||
164197950|NCT06077773|593093774|FG001|Overall Study|Lost to Follow-up|1|||
164197951|NCT06077773|593093775|FG002|Overall Study|Lost to Follow-up|0|||
164197952|NCT06077773|593093773|FG000|Overall Study|Adverse Event|0|||
164197953|NCT06077773|593093774|FG001|Overall Study|Adverse Event|0|||
164197954|NCT06077773|593093775|FG002|Overall Study|Adverse Event|2|||
164197955|NCT03834506|593093776|FG000|Overall Study|Death|336|||
164197956|NCT03834506|593093777|FG001|Overall Study|Death|326|||
164197957|NCT03834506|593093776|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
164197958|NCT03834506|593093777|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
164197959|NCT03834506|593093776|FG000|Overall Study|Withdrawal by Subject|10|||
164197960|NCT03834506|593093777|FG001|Overall Study|Withdrawal by Subject|8|||
164197961|NCT03834506|593093776|FG000|Overall Study|Sponsor decision|165|||
164197962|NCT03834506|593093777|FG001|Overall Study|Sponsor decision|178|||
164197963|NCT03834506|593093776|FG000|Overall Study|Physician Decision|3|||
164197964|NCT03834506|593093777|FG001|Overall Study|Physician Decision|1|||
164197965|NCT03834506|593093776|FG000|Overall Study|Lost to Follow-up|0|||
164197966|NCT03834506|593093777|FG001|Overall Study|Lost to Follow-up|1|||
164197967|NCT02499146|593093778|FG000|Overall Study|Global deterioration of health status|1|||
164197968|NCT02499146|593093778|FG000|Overall Study|Objective progression or relapse|20|||
164197969|NCT02499146|593093778|FG000|Overall Study|Other|2|||
164197970|NCT02499146|593093778|FG000|Overall Study|Participant refused continued treatment for reason other than adverse event|3|||
164197971|NCT04325828|593093779|FG000|Overall Study|Ongoing|26|||
164197972|NCT05115630|593093780|FG000|Overall Study|Due to COVID19|1|||
164197973|NCT05115630|593093780|FG000|Overall Study|Due to Bacteremia|1|||
164197974|NCT05115630|593093780|FG000|Overall Study|Due to viral infection|1|||
164197975|NCT02287038|593093781|FG000|Overall Study|Stopped attending appointments|3|||
164197976|NCT02287038|593093782|FG001|Overall Study|Stopped attending appointments|2|||
164197977|NCT02287038|593093781|FG000|Overall Study|Anxiety after starting medication|0|||
164197978|NCT02287038|593093782|FG001|Overall Study|Anxiety after starting medication|1|||
164197979|NCT02287038|593093781|FG000|Overall Study|Nausea after starting medication|1|||
164197980|NCT02287038|593093782|FG001|Overall Study|Nausea after starting medication|0|||
164197981|NCT02287038|593093781|FG000|Overall Study|Abnormal ECG after starting medication|1|||
164197982|NCT02287038|593093782|FG001|Overall Study|Abnormal ECG after starting medication|0|||
164197983|NCT03160716|593093783|FG000|Overall Study|Lost to Follow-up|1|||
164197984|NCT01628848|593093784|FG000|Overall Study|Adverse Event|9|||
164197985|NCT01628848|593093785|FG001|Overall Study|Adverse Event|7|||
164197986|NCT01628848|593093784|FG000|Overall Study|Lack of Efficacy|0|||
164197987|NCT01628848|593093785|FG001|Overall Study|Lack of Efficacy|4|||
164197988|NCT01628848|593093784|FG000|Overall Study|Withdrawal by Subject|0|||
164197989|NCT01628848|593093785|FG001|Overall Study|Withdrawal by Subject|2|||
164197990|NCT01628848|593093784|FG000|Overall Study|Physician Decision|3|||
164197991|NCT01628848|593093785|FG001|Overall Study|Physician Decision|1|||
164197992|NCT00689338|593093787|FG000|Overall Study|Death|65|||
164197993|NCT00689338|593093787|FG000|Overall Study|Adverse Event|13|||
164655392|NCT00723554|594764825|FG000|Overall Study|Inhaled medication other than iloprost|4|||
164197994|NCT00689338|593093787|FG000|Overall Study|Insufficient Clinical Response|1|||
164197995|NCT00689338|593093787|FG000|Overall Study|Lack of Efficacy|6|||
164197996|NCT00689338|593093787|FG000|Overall Study|Other|8|||
164197997|NCT00689338|593093787|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
164655393|NCT00723554|594764825|FG000|Overall Study|Withdrawal of consent|3|||
164655394|NCT00723554|594764825|FG000|Overall Study|Other|3|||
164549824|NCT04218201|594387098|FG003|Overall Study|Withdrawal by Subject|0|||
164549825|NCT04218201|594387095|FG000|Overall Study|PCP plans to leave practice|0|||
164549826|NCT04218201|594387096|FG001|Overall Study|PCP plans to leave practice|8|||
164549827|NCT04218201|594387097|FG002|Overall Study|PCP plans to leave practice|0|||
164549828|NCT04218201|594387098|FG003|Overall Study|PCP plans to leave practice|5|||
164549829|NCT04218201|594387095|FG000|Overall Study|Reduced panel|0|||
164549830|NCT04218201|594387096|FG001|Overall Study|Reduced panel|0|||
164549831|NCT04218201|594387097|FG002|Overall Study|Reduced panel|0|||
164549832|NCT04218201|594387098|FG003|Overall Study|Reduced panel|1|||
164549833|NCT04218201|594387095|FG000|Overall Study|No longer interested in participating|0|||
164549834|NCT04218201|594387096|FG001|Overall Study|No longer interested in participating|1|||
164549835|NCT04218201|594387097|FG002|Overall Study|No longer interested in participating|0|||
164549836|NCT04218201|594387098|FG003|Overall Study|No longer interested in participating|0|||
164549837|NCT04129528|594387099|FG000|Overall Study|Adverse Event|1|||
164549838|NCT04129528|594387100|FG001|Overall Study|Adverse Event|0|||
164549839|NCT04129528|594387099|FG000|Overall Study|Physician Decision|1|||
164549840|NCT04129528|594387100|FG001|Overall Study|Physician Decision|1|||
164549841|NCT04129528|594387099|FG000|Overall Study|Withdrawal by Subject|1|||
164549842|NCT04129528|594387100|FG001|Overall Study|Withdrawal by Subject|1|||
164549843|NCT00490568|594387106|FG000|Overall Study|Adverse Event|116|||
164549844|NCT00490568|594387106|FG000|Overall Study|Lost to Follow-up|13|||
164655395|NCT00723554|594764825|FG000|Overall Study|Lost to Follow-up|1|||
164655396|NCT00723554|594764825|FG000|Overall Study|Non-compliance|1|||
164197998|NCT00689338|593093787|FG000|Overall Study|Lost to Follow-up|5|||
164197999|NCT00689338|593093787|FG000|Overall Study|Withdrawal by Subject|3|||
164198000|NCT00689338|593093787|FG000|Overall Study|Protocol Violation|15|||
164198001|NCT01939314|593093788|FG000|Overall Study|Withdrawal by Subject|3|||
164198002|NCT01939314|593093789|FG001|Overall Study|Withdrawal by Subject|1|||
164198003|NCT01939314|593093788|FG000|Overall Study|Protocol Violation|1|||
164198004|NCT01939314|593093789|FG001|Overall Study|Protocol Violation|0|||
164198005|NCT01939314|593093788|FG000|Overall Study|Pregnancy|0|||
164198006|NCT01939314|593093789|FG001|Overall Study|Pregnancy|1|||
164198007|NCT01939314|593093788|FG000|Overall Study|Lost to Follow-up|5|||
164198008|NCT01939314|593093789|FG001|Overall Study|Lost to Follow-up|6|||
164198009|NCT00735007|593093790|FG000|Overall Study|Adverse Event|4|||
164198010|NCT00735007|593093790|FG000|Overall Study|Protocol Violation|1|||
164198011|NCT00969228|593093793|FG000|Overall Study|Adverse Event|1|||
164198012|NCT00969228|593093794|FG001|Overall Study|Adverse Event|0|||
164198013|NCT00969228|593093793|FG000|Overall Study|Withdrawal by Subject|4|||
164198014|NCT00969228|593093794|FG001|Overall Study|Withdrawal by Subject|0|||
164198015|NCT00969228|593093793|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
164198016|NCT00969228|593093794|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
164198017|NCT03311945|593093797|FG000|Overall Study|Adverse Event|2|||
164198018|NCT03311945|593093797|FG000|Overall Study|Lack of Efficacy|1|||
164198019|NCT01619878|593093798|FG000|6 Week Follow-up Phase|Adverse Event|1|||
164198020|NCT01619878|593093798|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
164198021|NCT01619878|593093798|FG000|Follow-up at 12 Months of Age|Death|2|||
164198022|NCT03839394|593093799|FG000|Overall Study|Lost to Follow-up|6|||
164198023|NCT03839394|593093800|FG001|Overall Study|Lost to Follow-up|8|||
164198024|NCT03839394|593093799|FG000|Overall Study|Withdrawal by Subject|0|||
164198025|NCT03839394|593093800|FG001|Overall Study|Withdrawal by Subject|2|||
164198026|NCT00922636|593095539|FG000|Overall Study|Adverse Event|3|||
164198027|NCT00922636|593095540|FG001|Overall Study|Adverse Event|3|||
164198028|NCT00922636|593095541|FG002|Overall Study|Adverse Event|2|||
164198029|NCT00922636|593095542|FG003|Overall Study|Adverse Event|3|||
164198030|NCT00922636|593095543|FG004|Overall Study|Adverse Event|2|||
164198031|NCT00922636|593095539|FG000|Overall Study|Lack of Efficacy|1|||
164198032|NCT00922636|593095540|FG001|Overall Study|Lack of Efficacy|7|||
164198033|NCT00922636|593095541|FG002|Overall Study|Lack of Efficacy|3|||
164198034|NCT00922636|593095542|FG003|Overall Study|Lack of Efficacy|2|||
164198035|NCT00922636|593095543|FG004|Overall Study|Lack of Efficacy|4|||
164198036|NCT00922636|593095539|FG000|Overall Study|Sponsor Decision|0|||
164198037|NCT00922636|593095540|FG001|Overall Study|Sponsor Decision|0|||
164198038|NCT00922636|593095541|FG002|Overall Study|Sponsor Decision|2|||
164198039|NCT00922636|593095542|FG003|Overall Study|Sponsor Decision|0|||
164198040|NCT00922636|593095543|FG004|Overall Study|Sponsor Decision|0|||
164198041|NCT00922636|593095539|FG000|Overall Study|Withdrawal by Subject|0|||
164198042|NCT00922636|593095540|FG001|Overall Study|Withdrawal by Subject|0|||
164198043|NCT00922636|593095541|FG002|Overall Study|Withdrawal by Subject|5|||
164198044|NCT00922636|593095542|FG003|Overall Study|Withdrawal by Subject|2|||
164198045|NCT00922636|593095543|FG004|Overall Study|Withdrawal by Subject|4|||
164198046|NCT00922636|593095539|FG000|Overall Study|Protocol Violation|0|||
164198047|NCT00922636|593095540|FG001|Overall Study|Protocol Violation|0|||
164198048|NCT00922636|593095541|FG002|Overall Study|Protocol Violation|2|||
164549845|NCT00490568|594387106|FG000|Overall Study|Protocol Violation|45|||
164549846|NCT00490568|594387106|FG000|Overall Study|Withdrawal by Subject|135|||
164549847|NCT00490568|594387106|FG000|Overall Study|Still in the study at termination|974|||
164549848|NCT00490568|594387106|FG000|Overall Study|Other|1|||
164198049|NCT00922636|593095542|FG003|Overall Study|Protocol Violation|2|||
164198050|NCT00922636|593095543|FG004|Overall Study|Protocol Violation|0|||
164198051|NCT00922636|593095539|FG000|Overall Study|Entry Criteria Not Met|0|||
164198052|NCT00922636|593095540|FG001|Overall Study|Entry Criteria Not Met|0|||
164198053|NCT00922636|593095541|FG002|Overall Study|Entry Criteria Not Met|1|||
164198054|NCT00922636|593095542|FG003|Overall Study|Entry Criteria Not Met|1|||
164198055|NCT00922636|593095543|FG004|Overall Study|Entry Criteria Not Met|0|||
164198056|NCT00922636|593095539|FG000|Overall Study|Parent/Caregiver Decision|2|||
164198057|NCT00922636|593095540|FG001|Overall Study|Parent/Caregiver Decision|4|||
164198058|NCT00922636|593095541|FG002|Overall Study|Parent/Caregiver Decision|3|||
164198059|NCT00922636|593095542|FG003|Overall Study|Parent/Caregiver Decision|5|||
164198060|NCT00922636|593095543|FG004|Overall Study|Parent/Caregiver Decision|2|||
164198061|NCT00922636|593095539|FG000|Overall Study|Lost to Follow-up|1|||
164198062|NCT00922636|593095540|FG001|Overall Study|Lost to Follow-up|2|||
164198063|NCT00922636|593095541|FG002|Overall Study|Lost to Follow-up|2|||
164198064|NCT00922636|593095542|FG003|Overall Study|Lost to Follow-up|2|||
164198065|NCT00922636|593095543|FG004|Overall Study|Lost to Follow-up|4|||
164198066|NCT00870727|593095544|FG000|Overall Study|Lost to Follow-up|0|||
164198067|NCT00870727|593095545|FG001|Overall Study|Lost to Follow-up|1|||
164198068|NCT00870727|593095544|FG000|Overall Study|Lack of Efficacy|1|||
164198069|NCT00870727|593095545|FG001|Overall Study|Lack of Efficacy|3|||
164198070|NCT00870727|593095544|FG000|Overall Study|Adverse Event|0|||
164198071|NCT00870727|593095545|FG001|Overall Study|Adverse Event|1|||
164198072|NCT00557466|593095546|FG000|Overall Study|Adverse Event|3|||
164198073|NCT00557466|593095547|FG001|Overall Study|Adverse Event|1|||
164198074|NCT00557466|593095548|FG002|Overall Study|Adverse Event|4|||
164198075|NCT00557466|593095549|FG003|Overall Study|Adverse Event|1|||
164198076|NCT00557466|593095550|FG004|Overall Study|Adverse Event|2|||
164198077|NCT00557466|593095551|FG005|Overall Study|Adverse Event|4|||
164198078|NCT00557466|593095546|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164198079|NCT00557466|593095547|FG001|Overall Study|Abnormal laboratory value(s)|2|||
164198080|NCT00557466|593095548|FG002|Overall Study|Abnormal laboratory value(s)|0|||
164198081|NCT00557466|593095549|FG003|Overall Study|Abnormal laboratory value(s)|0|||
164198082|NCT00557466|593095550|FG004|Overall Study|Abnormal laboratory value(s)|0|||
164198083|NCT00557466|593095551|FG005|Overall Study|Abnormal laboratory value(s)|0|||
164198084|NCT00557466|593095546|FG000|Overall Study|Protocol deviation|0|||
164198085|NCT00557466|593095547|FG001|Overall Study|Protocol deviation|1|||
164198086|NCT00557466|593095548|FG002|Overall Study|Protocol deviation|0|||
164198087|NCT00557466|593095549|FG003|Overall Study|Protocol deviation|2|||
164198088|NCT00557466|593095550|FG004|Overall Study|Protocol deviation|0|||
164198089|NCT00557466|593095551|FG005|Overall Study|Protocol deviation|0|||
164198090|NCT00557466|593095546|FG000|Overall Study|Subject withdrew consent|0|||
164198091|NCT00557466|593095547|FG001|Overall Study|Subject withdrew consent|0|||
164198092|NCT00557466|593095548|FG002|Overall Study|Subject withdrew consent|0|||
164549849|NCT00490568|594387106|FG000|Overall Study|Exclusion criteria met|1|||
164549850|NCT00490568|594387106|FG000|Overall Study|Caregiver related|20|||
164549851|NCT00490568|594387106|FG000|Overall Study|Abnormal ECG|25|||
164549852|NCT00490568|594387106|FG000|Overall Study|Participant refused follow-up|9|||
164549853|NCT00490568|594387106|FG000|Overall Study|Legal representative withdrew consent|1|||
164549854|NCT00490568|594387106|FG000|Overall Study|Disease progression|4|||
164549855|NCT00490568|594387106|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
164549856|NCT00490568|594387106|FG000|Overall Study|Investigator decision|3|||
164549857|NCT00490568|594387106|FG000|Overall Study|Non-Compliance|7|||
164549858|NCT00490568|594387106|FG000|Overall Study|Efficacy related|3|||
164549859|NCT00490568|594387106|FG000|Overall Study|Participant died|1|||
164549860|NCT00490568|594387106|FG000|Overall Study|Participant withdrawal due to surgery|1|||
164549861|NCT03927105|594387109|FG000|Overall Study|Death|1|||
164549862|NCT03927105|594387109|FG000|Overall Study|In observation for potential re-treatment|2|||
164549863|NCT03927105|594387109|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
164549864|NCT00789529|594387111|FG000|Overall Study|Withdrawal by Subject|0|||
164549865|NCT00789529|594387112|FG001|Overall Study|Withdrawal by Subject|1|||
164549866|NCT00789529|594387111|FG000|Overall Study|Other Reason|1|||
164198093|NCT00557466|593095549|FG003|Overall Study|Subject withdrew consent|0|||
164198094|NCT00557466|593095550|FG004|Overall Study|Subject withdrew consent|1|||
164198095|NCT00557466|593095551|FG005|Overall Study|Subject withdrew consent|2|||
164549867|NCT00789529|594387112|FG001|Overall Study|Other Reason|0|||
164198096|NCT00557466|593095546|FG000|Overall Study|Administrative problems|0|||
164549868|NCT01870401|594387113|FG000|Overall Study|Death|48|||
164198097|NCT00557466|593095547|FG001|Overall Study|Administrative problems|1|||
164198098|NCT00557466|593095548|FG002|Overall Study|Administrative problems|1|||
164198099|NCT00557466|593095549|FG003|Overall Study|Administrative problems|0|||
164198100|NCT00557466|593095550|FG004|Overall Study|Administrative problems|0|||
164549869|NCT01870401|594387114|FG001|Overall Study|Death|24|||
164549870|NCT01870401|594387113|FG000|Overall Study|Withdrawal by Subject|39|||
164549871|NCT01870401|594387114|FG001|Overall Study|Withdrawal by Subject|26|||
164549872|NCT01870401|594387113|FG000|Overall Study|Lost to Follow-up|19|||
164198101|NCT00557466|593095551|FG005|Overall Study|Administrative problems|0|||
164198102|NCT00557466|593095546|FG000|Overall Study|Abnormal test procedure results|0|||
164198103|NCT00557466|593095547|FG001|Overall Study|Abnormal test procedure results|0|||
164198104|NCT00557466|593095548|FG002|Overall Study|Abnormal test procedure results|1|||
164549873|NCT01870401|594387114|FG001|Overall Study|Lost to Follow-up|14|||
164549874|NCT01870401|594387113|FG000|Overall Study|Other|9|||
164549875|NCT01870401|594387114|FG001|Overall Study|Other|7|||
164549876|NCT01870401|594387113|FG000|Overall Study|On-going in the Study|35|||
164549877|NCT01870401|594387114|FG001|Overall Study|On-going in the Study|25|||
164549878|NCT01135498|594387116|FG000|Overall Study|Adverse Event|20|||
164549879|NCT01135498|594387116|FG000|Overall Study|Progressive disease|38|||
164549880|NCT01135498|594387116|FG000|Overall Study|Investigator judgement|25|||
164549881|NCT01135498|594387116|FG000|Overall Study|Withdrawal by Subject|4|||
164549882|NCT01135498|594387116|FG000|Overall Study|Death|1|||
164549883|NCT01135498|594387116|FG000|Overall Study|Ongoing at time of analysis|2|||
164549884|NCT01192022|594387117|FG000|Overall Study|Withdrawal of Consent|3|||
164655397|NCT01405820|594764826|FG000|Randomized Treatment Period|Adverse Event|3|||
164198105|NCT00557466|593095549|FG003|Overall Study|Abnormal test procedure results|0|||
164198106|NCT00557466|593095550|FG004|Overall Study|Abnormal test procedure results|0|||
164198107|NCT00557466|593095551|FG005|Overall Study|Abnormal test procedure results|0|||
164198108|NCT00557466|593095546|FG000|Overall Study|Lost to Follow-up|0|||
164198109|NCT00557466|593095547|FG001|Overall Study|Lost to Follow-up|0|||
164198110|NCT00557466|593095548|FG002|Overall Study|Lost to Follow-up|0|||
164198111|NCT00557466|593095549|FG003|Overall Study|Lost to Follow-up|1|||
164198112|NCT00557466|593095550|FG004|Overall Study|Lost to Follow-up|0|||
164198113|NCT00557466|593095551|FG005|Overall Study|Lost to Follow-up|0|||
164198114|NCT01712516|593095552|FG000|Overall Study|Technical problems|0|||
164198115|NCT01712516|593095553|FG001|Overall Study|Technical problems|0|||
164198116|NCT01712516|593095554|FG002|Overall Study|Technical problems|0|||
164198117|NCT01712516|593095555|FG003|Overall Study|Technical problems|2|||
164198118|NCT01712516|593095552|FG000|Overall Study|Lost to Follow-up|0|||
164198119|NCT01712516|593095553|FG001|Overall Study|Lost to Follow-up|0|||
164198120|NCT01712516|593095554|FG002|Overall Study|Lost to Follow-up|2|||
164198121|NCT01712516|593095555|FG003|Overall Study|Lost to Follow-up|1|||
164198122|NCT01712516|593095552|FG000|Overall Study|Death|0|||
164198123|NCT01712516|593095553|FG001|Overall Study|Death|1|||
164198124|NCT01712516|593095554|FG002|Overall Study|Death|0|||
164198125|NCT01712516|593095555|FG003|Overall Study|Death|0|||
164198126|NCT01712516|593095552|FG000|Overall Study|Protocol deviation|1|||
164198127|NCT01712516|593095553|FG001|Overall Study|Protocol deviation|0|||
164198128|NCT01712516|593095554|FG002|Overall Study|Protocol deviation|1|||
164198129|NCT01712516|593095555|FG003|Overall Study|Protocol deviation|0|||
164198130|NCT01712516|593095552|FG000|Overall Study|Physician Decision|2|||
164198131|NCT01712516|593095553|FG001|Overall Study|Physician Decision|0|||
164198132|NCT01712516|593095554|FG002|Overall Study|Physician Decision|0|||
164198133|NCT01712516|593095555|FG003|Overall Study|Physician Decision|1|||
164198134|NCT01712516|593095552|FG000|Overall Study|Withdrawal by Subject|3|||
164198135|NCT01712516|593095553|FG001|Overall Study|Withdrawal by Subject|9|||
164198136|NCT01712516|593095554|FG002|Overall Study|Withdrawal by Subject|3|||
164198137|NCT01712516|593095555|FG003|Overall Study|Withdrawal by Subject|9|||
164198138|NCT01251952|593095556|FG000|Overall Study|Adverse Event|1|||
164198139|NCT00496769|593095557|FG000|Double Blind|>=1 reason assigned per patient|558|||
164198140|NCT00496769|593095558|FG001|Double Blind|>=1 reason assigned per patient|649|||
164198141|NCT00496769|593095559|FG002|Double Blind|>=1 reason assigned per patient|0|||
164198142|NCT00496769|593095557|FG000|Open Label|>=1 reason assigned per patient|0|||
164198143|NCT00496769|593095558|FG001|Open Label|>=1 reason assigned per patient|0|||
164198144|NCT00496769|593095559|FG002|Open Label|>=1 reason assigned per patient|1011|||
164198145|NCT02308046|593095560|FG000|Overall Study|Negative yeast culture at Baseline|32|||
164198146|NCT02308046|593095561|FG001|Overall Study|Negative yeast culture at Baseline|33|||
164198147|NCT02308046|593095560|FG000|Overall Study|Positive for STD at Baseline|1|||
164198148|NCT02308046|593095561|FG001|Overall Study|Positive for STD at Baseline|2|||
164198149|NCT02308046|593095560|FG000|Overall Study|Lost to Follow-up|1|||
164198150|NCT02308046|593095561|FG001|Overall Study|Lost to Follow-up|3|||
164198151|NCT02224625|593095567|FG000|Irritation|Adverse Event|6|||
164198152|NCT02224625|593095567|FG000|Sensitization|Adverse Event|55|||
164198153|NCT01181167|593095568|FG000|Overall Study|Adverse Event|11|||
164198154|NCT01181167|593095569|FG001|Overall Study|Adverse Event|21|||
164198155|NCT01181167|593095568|FG000|Overall Study|Lost to Follow-up|1|||
164198156|NCT01181167|593095569|FG001|Overall Study|Lost to Follow-up|0|||
164198157|NCT01181167|593095568|FG000|Overall Study|Physician Decision|2|||
164198158|NCT01181167|593095569|FG001|Overall Study|Physician Decision|3|||
164198159|NCT01181167|593095568|FG000|Overall Study|Protocol Violation|3|||
164549885|NCT01192022|594387118|FG001|Overall Study|Withdrawal of Consent|1|||
164549886|NCT01192022|594387119|FG002|Overall Study|Withdrawal of Consent|0|||
164549887|NCT01192022|594387120|FG003|Overall Study|Withdrawal of Consent|0|||
164549888|NCT01192022|594387121|FG004|Overall Study|Withdrawal of Consent|0|||
164549889|NCT01192022|594387117|FG000|Overall Study|Lost to Follow-up|4|||
164549890|NCT01192022|594387118|FG001|Overall Study|Lost to Follow-up|2|||
164198160|NCT01181167|593095569|FG001|Overall Study|Protocol Violation|0|||
164198161|NCT01181167|593095568|FG000|Overall Study|Withdrawal by Subject|6|||
164198162|NCT01181167|593095569|FG001|Overall Study|Withdrawal by Subject|8|||
164198163|NCT01573000|593095573|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
164198164|NCT01573000|593095574|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
164198165|NCT01573000|593095573|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
164198166|NCT01573000|593095574|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
164198167|NCT01573000|593095573|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
164198168|NCT01573000|593095574|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
164198169|NCT01573000|593095573|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
164198170|NCT01573000|593095574|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
164198171|NCT01573000|593095573|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
164198172|NCT01573000|593095574|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
164198173|NCT01573000|593095573|FG000|Crossover Phase|Lack of Efficacy|0|||
164198174|NCT01573000|593095574|FG001|Crossover Phase|Lack of Efficacy|13|||
164198175|NCT01573000|593095573|FG000|Crossover Phase|Lost to Follow-up|0|||
164198176|NCT01573000|593095574|FG001|Crossover Phase|Lost to Follow-up|2|||
164198177|NCT01573000|593095573|FG000|Crossover Phase|Death|0|||
164198178|NCT01573000|593095574|FG001|Crossover Phase|Death|3|||
164198179|NCT01573000|593095573|FG000|Long-Term Follow-Up|Death|3|||
164198180|NCT01573000|593095574|FG001|Long-Term Follow-Up|Death|0|||
164549891|NCT01192022|594387119|FG002|Overall Study|Lost to Follow-up|1|||
164549892|NCT01192022|594387120|FG003|Overall Study|Lost to Follow-up|1|||
164198181|NCT01573000|593095573|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
164198182|NCT01573000|593095574|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
164198183|NCT03342001|593095577|FG000|Overall Study|Adverse Event|1|||
164198184|NCT03342001|593095577|FG000|Overall Study|Lost to Follow-up|1|||
164549893|NCT01192022|594387121|FG004|Overall Study|Lost to Follow-up|0|||
164549894|NCT01192022|594387117|FG000|Overall Study|Adverse Event|1|||
164549895|NCT01192022|594387118|FG001|Overall Study|Adverse Event|0|||
164549896|NCT01192022|594387119|FG002|Overall Study|Adverse Event|0|||
164549897|NCT01192022|594387120|FG003|Overall Study|Adverse Event|0|||
164549898|NCT01192022|594387121|FG004|Overall Study|Adverse Event|0|||
164549899|NCT01192022|594387117|FG000|Overall Study|Fatal Adverse Event|4|||
164549900|NCT01192022|594387118|FG001|Overall Study|Fatal Adverse Event|6|||
164549901|NCT01192022|594387119|FG002|Overall Study|Fatal Adverse Event|0|||
164549902|NCT01192022|594387120|FG003|Overall Study|Fatal Adverse Event|0|||
164549903|NCT01192022|594387121|FG004|Overall Study|Fatal Adverse Event|1|||
164549904|NCT01192022|594387117|FG000|Overall Study|Physician withdrew-patient hardship|1|||
164549905|NCT01192022|594387118|FG001|Overall Study|Physician withdrew-patient hardship|0|||
164549906|NCT01192022|594387119|FG002|Overall Study|Physician withdrew-patient hardship|0|||
164549907|NCT01192022|594387120|FG003|Overall Study|Physician withdrew-patient hardship|0|||
164549908|NCT01192022|594387121|FG004|Overall Study|Physician withdrew-patient hardship|0|||
164549909|NCT01192022|594387117|FG000|Overall Study|Patient too sick from chemotherapy|0|||
164549910|NCT01192022|594387118|FG001|Overall Study|Patient too sick from chemotherapy|1|||
164549911|NCT01192022|594387119|FG002|Overall Study|Patient too sick from chemotherapy|0|||
164549912|NCT01192022|594387120|FG003|Overall Study|Patient too sick from chemotherapy|0|||
164549913|NCT01192022|594387121|FG004|Overall Study|Patient too sick from chemotherapy|0|||
164549914|NCT01192022|594387117|FG000|Overall Study|Patient needed surgery|0|||
164549915|NCT01192022|594387118|FG001|Overall Study|Patient needed surgery|1|||
164549916|NCT01192022|594387119|FG002|Overall Study|Patient needed surgery|0|||
164549917|NCT01192022|594387120|FG003|Overall Study|Patient needed surgery|0|||
164549918|NCT01192022|594387121|FG004|Overall Study|Patient needed surgery|0|||
164549919|NCT01192022|594387117|FG000|Overall Study|Parents did not allow all follow up|0|||
164549920|NCT01192022|594387118|FG001|Overall Study|Parents did not allow all follow up|0|||
164549921|NCT01192022|594387119|FG002|Overall Study|Parents did not allow all follow up|0|||
164549922|NCT01192022|594387120|FG003|Overall Study|Parents did not allow all follow up|1|||
164549923|NCT01192022|594387121|FG004|Overall Study|Parents did not allow all follow up|0|||
164549924|NCT01351389|594387122|FG000|Overall Study|Withdrawal by Subject|7|||
164549925|NCT01351389|594387123|FG001|Overall Study|Withdrawal by Subject|0|||
164549926|NCT01351389|594387122|FG000|Overall Study|did not complete intervention|23|||
164549927|NCT01351389|594387123|FG001|Overall Study|did not complete intervention|15|||
164549928|NCT04839978|594387124|FG000|Overall Study|Lost to Follow-up|135|||
164655398|NCT01405820|594764827|FG001|Randomized Treatment Period|Adverse Event|3|||
164198185|NCT01384877|593095581|FG000|Treatment 2|Lost to Follow-up|2|||
164198186|NCT01384877|593095582|FG001|Treatment 2|Lost to Follow-up|2|||
164198187|NCT01930539|593095593|FG000|Overall Study|Withdrawal by Subject|2|||
164198188|NCT01930539|593095594|FG001|Overall Study|Withdrawal by Subject|2|||
164549929|NCT04839978|594387125|FG001|Overall Study|Lost to Follow-up|147|||
164655399|NCT01405820|594764828|FG002|Randomized Treatment Period|Adverse Event|3|||
164198189|NCT01548404|593095595|FG000|Overall Study|Adverse Event|3|||
164549930|NCT03551509|594387130|FG000|Overall Study|Lost to Follow-up|0|||
164549931|NCT03551509|594387131|FG001|Overall Study|Lost to Follow-up|1|||
164549932|NCT03551509|594387132|FG002|Overall Study|Lost to Follow-up|0|||
164549933|NCT01902966|594387133|FG000|Overall Study|Death|1|||
164198190|NCT01548404|593095596|FG001|Overall Study|Adverse Event|1|||
164198191|NCT01548404|593095595|FG000|Overall Study|Physician Decision|2|||
164198192|NCT01548404|593095596|FG001|Overall Study|Physician Decision|1|||
164198193|NCT01548404|593095595|FG000|Overall Study|Inadequate response to study treatment|23|||
164198194|NCT01548404|593095596|FG001|Overall Study|Inadequate response to study treatment|7|||
164198195|NCT01548404|593095595|FG000|Overall Study|Lost to Follow-up|2|||
164198196|NCT01548404|593095596|FG001|Overall Study|Lost to Follow-up|0|||
164198197|NCT01548404|593095595|FG000|Overall Study|Withdrawal by Subject|0|||
164198198|NCT01548404|593095596|FG001|Overall Study|Withdrawal by Subject|3|||
164198199|NCT01548404|593095595|FG000|Overall Study|Other than specified above|0|||
164198200|NCT01548404|593095596|FG001|Overall Study|Other than specified above|2|||
164198201|NCT04040439|593095599|FG000|Overall Study|Invalid registration|11|||
164198202|NCT04040439|593095599|FG000|Overall Study|No IC* on publication of study results|2|||
164198203|NCT00426270|593095600|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
164198204|NCT00426270|593095600|FG000|Overall Study|Adverse Event|5|||
164198205|NCT01117870|593095601|FG000|Overall Study|Inability to place needle|1|||
164198206|NCT01117870|593095602|FG001|Overall Study|Inability to place needle|0|||
164198207|NCT01450813|593095603|FG000|Overall Study|Physician Decision|1|||
164198208|NCT01450813|593095604|FG001|Overall Study|Physician Decision|1|||
164198209|NCT01450813|593095605|FG002|Overall Study|Physician Decision|0|||
164198210|NCT01450813|593095606|FG003|Overall Study|Physician Decision|3|||
164198211|NCT01309386|593095609|FG000|Overall Study|Other|2|||
164198212|NCT01309386|593095610|FG001|Overall Study|Other|0|||
164198213|NCT01309386|593095609|FG000|Overall Study|Withdrawal by Subject|2|||
164198214|NCT01309386|593095610|FG001|Overall Study|Withdrawal by Subject|0|||
164198215|NCT01309386|593095609|FG000|Overall Study|Progressive disease|9|||
164198216|NCT01309386|593095610|FG001|Overall Study|Progressive disease|11|||
164198217|NCT01309386|593095609|FG000|Overall Study|Physician Decision|1|||
164198218|NCT01309386|593095610|FG001|Overall Study|Physician Decision|1|||
164198219|NCT01309386|593095609|FG000|Overall Study|Lack of Efficacy|3|||
164198220|NCT01309386|593095610|FG001|Overall Study|Lack of Efficacy|1|||
164198221|NCT01309386|593095609|FG000|Overall Study|Adverse Event|5|||
164198222|NCT01309386|593095610|FG001|Overall Study|Adverse Event|8|||
164198223|NCT02062437|593095611|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
164198224|NCT02062437|593095611|FG000|Overall Study|Patient not available for the 2y visit|18|||
164198225|NCT02062437|593095611|FG000|Overall Study|Death|2|||
164198226|NCT02062437|593095611|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
164198227|NCT00752089|593095616|FG000|Overall Study|Adverse Event|1|||
164198228|NCT00752089|593095616|FG000|Overall Study|Protocol Deviation|2|||
164198229|NCT00752089|593095616|FG000|Overall Study|Could not attend visit 9|1|||
164198230|NCT00752089|593095616|FG000|Overall Study|Not capable of wearing partial denture|1|||
164198231|NCT00752089|593095616|FG000|Overall Study|Cannot continue the study|1|||
164549934|NCT01902966|594387133|FG000|Overall Study|Physician Decision|1|||
164549935|NCT01902966|594387133|FG000|Overall Study|Withdrawal by Subject|1|||
164549936|NCT01549275|594387134|FG000|Overall Study|Lost to Follow-up|1|||
164549937|NCT01549275|594387135|FG001|Overall Study|Lost to Follow-up|0|||
164549938|NCT00122681|594387136|FG000|Overall Study|Adverse Event|20|||
164549939|NCT00122681|594387137|FG001|Overall Study|Adverse Event|16|||
164549940|NCT00122681|594387136|FG000|Overall Study|Lost to Follow-up|1080|||
164549941|NCT00122681|594387137|FG001|Overall Study|Lost to Follow-up|1097|||
164549942|NCT00122681|594387136|FG000|Overall Study|Protocol Violation|7|||
164549943|NCT00122681|594387137|FG001|Overall Study|Protocol Violation|10|||
164549944|NCT00122681|594387136|FG000|Overall Study|Withdrawal by Subject|257|||
164549945|NCT00122681|594387137|FG001|Overall Study|Withdrawal by Subject|251|||
164549946|NCT00122681|594387136|FG000|Overall Study|Personal reasons|150|||
164549947|NCT00122681|594387137|FG001|Overall Study|Personal reasons|147|||
164549948|NCT01081912|594387138|FG000|Conversion/Titration|Adverse Event|47|||
164549949|NCT01081912|594387139|FG001|Conversion/Titration|Adverse Event|0|||
164549950|NCT01081912|594387140|FG002|Conversion/Titration|Adverse Event|0|||
164549951|NCT01081912|594387138|FG000|Conversion/Titration|Lack of Efficacy|17|||
164549952|NCT01081912|594387139|FG001|Conversion/Titration|Lack of Efficacy|0|||
164655400|NCT01405820|594764829|FG003|Randomized Treatment Period|Adverse Event|0|||
164198232|NCT01774981|593095617|FG000|Overall Study|Adverse Event|0|||
164198233|NCT01774981|593095618|FG001|Overall Study|Adverse Event|0|||
164198234|NCT01774981|593095619|FG002|Overall Study|Adverse Event|0|||
164198235|NCT01774981|593095620|FG003|Overall Study|Adverse Event|0|||
164198236|NCT01774981|593095621|FG004|Overall Study|Adverse Event|0|||
164198237|NCT01774981|593095622|FG005|Overall Study|Adverse Event|1|||
164198238|NCT01774981|593095623|FG006|Overall Study|Adverse Event|0|||
164198239|NCT01774981|593095624|FG007|Overall Study|Adverse Event|0|||
164549953|NCT01081912|594387140|FG002|Conversion/Titration|Lack of Efficacy|0|||
164198240|NCT01774981|593095617|FG000|Overall Study|Withdrawal by Subject|0|||
164198241|NCT01774981|593095618|FG001|Overall Study|Withdrawal by Subject|0|||
164198242|NCT01774981|593095619|FG002|Overall Study|Withdrawal by Subject|0|||
164549954|NCT01081912|594387138|FG000|Conversion/Titration|Lost to Follow-up|5|||
164549955|NCT01081912|594387139|FG001|Conversion/Titration|Lost to Follow-up|0|||
164549956|NCT01081912|594387140|FG002|Conversion/Titration|Lost to Follow-up|0|||
164198243|NCT01774981|593095620|FG003|Overall Study|Withdrawal by Subject|0|||
164198244|NCT01774981|593095621|FG004|Overall Study|Withdrawal by Subject|0|||
164198245|NCT01774981|593095622|FG005|Overall Study|Withdrawal by Subject|0|||
164198246|NCT01774981|593095623|FG006|Overall Study|Withdrawal by Subject|0|||
164198247|NCT01774981|593095624|FG007|Overall Study|Withdrawal by Subject|1|||
164198248|NCT01774981|593095617|FG000|Overall Study|Death|0|||
164198249|NCT01774981|593095618|FG001|Overall Study|Death|0|||
164198250|NCT01774981|593095619|FG002|Overall Study|Death|0|||
164198251|NCT01774981|593095620|FG003|Overall Study|Death|0|||
164198252|NCT01774981|593095621|FG004|Overall Study|Death|1|||
164198253|NCT01774981|593095622|FG005|Overall Study|Death|0|||
164198254|NCT01774981|593095623|FG006|Overall Study|Death|0|||
164198255|NCT01774981|593095624|FG007|Overall Study|Death|0|||
164198256|NCT01324102|593095625|FG000|Overall Study|illness|1|||
164198257|NCT01324102|593095626|FG001|Overall Study|illness|6|||
164198258|NCT00728494|593095631|FG000|Overall Study|Adverse Event|7|||
164198259|NCT00728494|593095632|FG001|Overall Study|Adverse Event|0|||
164198260|NCT00728494|593095631|FG000|Overall Study|Withdrawal by Subject|0|||
164198261|NCT00728494|593095632|FG001|Overall Study|Withdrawal by Subject|2|||
164198262|NCT00728494|593095631|FG000|Overall Study|Lack of Efficacy|2|||
164198263|NCT00728494|593095632|FG001|Overall Study|Lack of Efficacy|4|||
164198264|NCT00728494|593095631|FG000|Overall Study|No data available|0|||
164198265|NCT00728494|593095632|FG001|Overall Study|No data available|1|||
164198266|NCT00975416|593095633|FG000|Overall Study|early discharge from tx|3|||
164198267|NCT00975416|593095634|FG001|Overall Study|early discharge from tx|5|||
164198268|NCT02915835|593095635|FG000|Overall Study|Physician Decision|1|||
164198269|NCT02915835|593095636|FG001|Overall Study|Physician Decision|0|||
164198270|NCT02915835|593095635|FG000|Overall Study|Withdrawal by Subject|0|||
164198271|NCT02915835|593095636|FG001|Overall Study|Withdrawal by Subject|1|||
164198272|NCT00433836|593095637|FG000|Overall Study|Adverse Event|7|||
164198273|NCT00433836|593095638|FG001|Overall Study|Adverse Event|0|||
164198274|NCT00433836|593095637|FG000|Overall Study|Lost to Follow-up|3|||
164198275|NCT00433836|593095638|FG001|Overall Study|Lost to Follow-up|0|||
164198276|NCT00433836|593095637|FG000|Overall Study|Withdrawal by Subject|2|||
164198277|NCT00433836|593095638|FG001|Overall Study|Withdrawal by Subject|1|||
164198278|NCT00433836|593095637|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164198279|NCT00433836|593095638|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
164198280|NCT00433836|593095637|FG000|Overall Study|Protocol Violation|0|||
164198281|NCT00433836|593095638|FG001|Overall Study|Protocol Violation|2|||
164198282|NCT00433836|593095637|FG000|Overall Study|Condition no longer requires study drug|0|||
164198283|NCT00433836|593095638|FG001|Overall Study|Condition no longer requires study drug|1|||
164198284|NCT00433836|593095637|FG000|Overall Study|Abnormal laboratory values|0|||
164198285|NCT00433836|593095638|FG001|Overall Study|Abnormal laboratory values|1|||
164198286|NCT00748241|593095639|FG000|Overall Study|Implant failure|1|||
164198287|NCT00748241|593095639|FG000|Overall Study|Lost to Follow-up|5|||
164198288|NCT00748241|593095639|FG000|Overall Study|Death|2|||
164198289|NCT01240382|593095640|FG000|Overall Study|Adverse Event|2|||
164549957|NCT01081912|594387138|FG000|Conversion/Titration|Physician Decision|2|||
164549958|NCT01081912|594387139|FG001|Conversion/Titration|Physician Decision|0|||
164549959|NCT01081912|594387140|FG002|Conversion/Titration|Physician Decision|0|||
164549960|NCT01081912|594387138|FG000|Conversion/Titration|Protocol Violation|67|||
164549961|NCT01081912|594387139|FG001|Conversion/Titration|Protocol Violation|0|||
164549962|NCT01081912|594387140|FG002|Conversion/Titration|Protocol Violation|0|||
164549963|NCT01081912|594387138|FG000|Conversion/Titration|Withdrawal by Subject|23|||
164549964|NCT01081912|594387139|FG001|Conversion/Titration|Withdrawal by Subject|0|||
164549965|NCT01081912|594387140|FG002|Conversion/Titration|Withdrawal by Subject|0|||
164549966|NCT01081912|594387138|FG000|Conversion/Titration|Non-Compliance|47|||
164549967|NCT01081912|594387139|FG001|Conversion/Titration|Non-Compliance|0|||
164549968|NCT01081912|594387140|FG002|Conversion/Titration|Non-Compliance|0|||
164549969|NCT01081912|594387138|FG000|Maintenance Treatment|Adverse Event|0|||
164549970|NCT01081912|594387139|FG001|Maintenance Treatment|Adverse Event|2|||
164549971|NCT01081912|594387140|FG002|Maintenance Treatment|Adverse Event|12|||
164198290|NCT01240382|593095641|FG001|Overall Study|Adverse Event|1|||
164198291|NCT01240382|593095640|FG000|Overall Study|Lack of Efficacy|0|||
164198292|NCT01240382|593095641|FG001|Overall Study|Lack of Efficacy|2|||
164198293|NCT01240382|593095640|FG000|Overall Study|Fear of adverse events|0|||
164198294|NCT01240382|593095641|FG001|Overall Study|Fear of adverse events|1|||
164198295|NCT02456727|593095642|FG000|Overall Study|Lost to Follow-up|63|||
164198296|NCT02456727|593095643|FG001|Overall Study|Lost to Follow-up|65|||
164198297|NCT02456727|593095642|FG000|Overall Study|Death|2|||
164198298|NCT02456727|593095643|FG001|Overall Study|Death|1|||
164198299|NCT02456727|593095642|FG000|Overall Study|Withdrawal by Subject|1|||
164549972|NCT01081912|594387138|FG000|Maintenance Treatment|Lack of Efficacy|0|||
164549973|NCT01081912|594387139|FG001|Maintenance Treatment|Lack of Efficacy|14|||
164198300|NCT02456727|593095643|FG001|Overall Study|Withdrawal by Subject|10|||
164198301|NCT02456727|593095642|FG000|Overall Study|Never Initiated Treatment|43|||
164549974|NCT01081912|594387140|FG002|Maintenance Treatment|Lack of Efficacy|64|||
164549975|NCT01081912|594387138|FG000|Maintenance Treatment|Lost to Follow-up|0|||
164198302|NCT02456727|593095643|FG001|Overall Study|Never Initiated Treatment|30|||
164198303|NCT02643693|593095644|FG000|Overall Study|Physician Decision|0|||
164198304|NCT02643693|593095645|FG001|Overall Study|Physician Decision|1|||
164198305|NCT02643693|593095646|FG002|Overall Study|Physician Decision|0|||
164198306|NCT02643693|593095647|FG003|Overall Study|Physician Decision|0|||
164198307|NCT02643693|593095648|FG004|Overall Study|Physician Decision|0|||
164198308|NCT02643693|593095649|FG005|Overall Study|Physician Decision|0|||
164655401|NCT01405820|594764830|FG004|Randomized Treatment Period|Adverse Event|2|||
164655402|NCT01405820|594764831|FG005|Randomized Treatment Period|Adverse Event|1|||
164655403|NCT01405820|594764826|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
164655404|NCT01405820|594764827|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
164655405|NCT01405820|594764828|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
164655406|NCT01405820|594764829|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
164655407|NCT01405820|594764830|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
164655408|NCT01405820|594764831|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
164655409|NCT01405820|594764826|FG000|Randomized Treatment Period|Other|2|||
164655410|NCT01405820|594764827|FG001|Randomized Treatment Period|Other|2|||
164655411|NCT01405820|594764828|FG002|Randomized Treatment Period|Other|1|||
164655412|NCT01405820|594764829|FG003|Randomized Treatment Period|Other|1|||
164655413|NCT01405820|594764830|FG004|Randomized Treatment Period|Other|0|||
164655414|NCT01405820|594764831|FG005|Randomized Treatment Period|Other|0|||
164655415|NCT01405820|594764826|FG000|Randomized Treatment Period|Physician Decision|0|||
164655416|NCT01405820|594764827|FG001|Randomized Treatment Period|Physician Decision|2|||
164655417|NCT01405820|594764828|FG002|Randomized Treatment Period|Physician Decision|1|||
164655418|NCT01405820|594764829|FG003|Randomized Treatment Period|Physician Decision|0|||
164655419|NCT01405820|594764830|FG004|Randomized Treatment Period|Physician Decision|0|||
164655420|NCT01405820|594764831|FG005|Randomized Treatment Period|Physician Decision|0|||
164655421|NCT01405820|594764826|FG000|Randomized Treatment Period|Rescue|0|||
164655422|NCT01405820|594764827|FG001|Randomized Treatment Period|Rescue|1|||
164655423|NCT01405820|594764828|FG002|Randomized Treatment Period|Rescue|13|||
164655424|NCT01405820|594764829|FG003|Randomized Treatment Period|Rescue|10|||
164655425|NCT01405820|594764830|FG004|Randomized Treatment Period|Rescue|8|||
164655426|NCT01405820|594764831|FG005|Randomized Treatment Period|Rescue|8|||
164655427|NCT01405820|594764826|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
164655428|NCT01405820|594764827|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
164655429|NCT01405820|594764828|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
164655430|NCT01405820|594764829|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
164655431|NCT01405820|594764830|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
164655432|NCT01405820|594764831|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
164655433|NCT01405820|594764826|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
164655434|NCT01405820|594764827|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
164655435|NCT01405820|594764828|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
164655436|NCT01405820|594764829|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
164655437|NCT01405820|594764830|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
164655438|NCT01405820|594764831|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
164655439|NCT01405820|594764826|FG000|Randomized Treatment Period|Death|0|||
164655440|NCT01405820|594764827|FG001|Randomized Treatment Period|Death|0|||
164655441|NCT01405820|594764828|FG002|Randomized Treatment Period|Death|0|||
164198309|NCT02643693|593095644|FG000|Overall Study|Withdrawal by Subject|0|||
164198310|NCT02643693|593095645|FG001|Overall Study|Withdrawal by Subject|1|||
164198311|NCT02643693|593095646|FG002|Overall Study|Withdrawal by Subject|0|||
164198312|NCT02643693|593095647|FG003|Overall Study|Withdrawal by Subject|0|||
164655442|NCT01405820|594764829|FG003|Randomized Treatment Period|Death|1|||
164198313|NCT02643693|593095648|FG004|Overall Study|Withdrawal by Subject|0|||
164198314|NCT02643693|593095649|FG005|Overall Study|Withdrawal by Subject|0|||
164198315|NCT02643693|593095644|FG000|Overall Study|Protocol Adherence Issues|2|||
164198316|NCT02643693|593095645|FG001|Overall Study|Protocol Adherence Issues|0|||
164198317|NCT02643693|593095646|FG002|Overall Study|Protocol Adherence Issues|1|||
164198318|NCT02643693|593095647|FG003|Overall Study|Protocol Adherence Issues|0|||
164198319|NCT02643693|593095648|FG004|Overall Study|Protocol Adherence Issues|0|||
164198320|NCT02643693|593095649|FG005|Overall Study|Protocol Adherence Issues|1|||
164198321|NCT01319565|593095650|FG000|Overall Study|Not treated: Rapid disease progression prior to start|0|||
164198322|NCT01319565|593095651|FG001|Overall Study|Not treated: Rapid disease progression prior to start|2|||
164198323|NCT01319565|593095652|FG002|Overall Study|Not treated: Rapid disease progression prior to start|0|||
164198324|NCT00113607|593095653|FG000|Overall Study|Adverse Event|40|||
164655443|NCT01405820|594764830|FG004|Randomized Treatment Period|Death|0|||
164655444|NCT01405820|594764831|FG005|Randomized Treatment Period|Death|0|||
164655445|NCT01405820|594764826|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
164655446|NCT01405820|594764827|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
164198325|NCT00113607|593095654|FG001|Overall Study|Adverse Event|71|||
164198326|NCT00113607|593095653|FG000|Overall Study|Death|8|||
164198327|NCT00113607|593095654|FG001|Overall Study|Death|8|||
164655447|NCT01405820|594764828|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
164549976|NCT01081912|594387139|FG001|Maintenance Treatment|Lost to Follow-up|1|||
164549977|NCT01081912|594387140|FG002|Maintenance Treatment|Lost to Follow-up|0|||
164549978|NCT01081912|594387138|FG000|Maintenance Treatment|Physician Decision|0|||
164549979|NCT01081912|594387139|FG001|Maintenance Treatment|Physician Decision|0|||
164549980|NCT01081912|594387140|FG002|Maintenance Treatment|Physician Decision|1|||
164549981|NCT01081912|594387138|FG000|Maintenance Treatment|Protocol Violation|0|||
164549982|NCT01081912|594387139|FG001|Maintenance Treatment|Protocol Violation|1|||
164549983|NCT01081912|594387140|FG002|Maintenance Treatment|Protocol Violation|2|||
164549984|NCT01081912|594387138|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
164549985|NCT01081912|594387139|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
164549986|NCT01081912|594387140|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
164549987|NCT01081912|594387138|FG000|Maintenance Treatment|Non-Compliance|0|||
164549988|NCT01081912|594387139|FG001|Maintenance Treatment|Non-Compliance|4|||
164549989|NCT01081912|594387140|FG002|Maintenance Treatment|Non-Compliance|7|||
164549990|NCT01081912|594387138|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
164549991|NCT01081912|594387139|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
164549992|NCT01081912|594387140|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
164549993|NCT02004262|594387150|FG000|Overall Study|Death|67|||
164549994|NCT02004262|594387151|FG001|Overall Study|Death|64|||
164549995|NCT02004262|594387152|FG002|Overall Study|Death|66|||
164549996|NCT02004262|594387153|FG003|Overall Study|Death|28|||
164549997|NCT02004262|594387154|FG004|Overall Study|Death|29|||
164549998|NCT02004262|594387155|FG005|Overall Study|Death|22|||
164549999|NCT02004262|594387150|FG000|Overall Study|Withdrawal by Subject|1|||
164550000|NCT02004262|594387151|FG001|Overall Study|Withdrawal by Subject|0|||
164198328|NCT00113607|593095653|FG000|Overall Study|Withdrawal by Subject|50|||
164198329|NCT00113607|593095654|FG001|Overall Study|Withdrawal by Subject|58|||
164198330|NCT00113607|593095653|FG000|Overall Study|Lost to Follow-up|0|||
164198331|NCT00113607|593095654|FG001|Overall Study|Lost to Follow-up|2|||
164198332|NCT00113607|593095653|FG000|Overall Study|Disease Progression|180|||
164198333|NCT00113607|593095654|FG001|Overall Study|Disease Progression|142|||
164198334|NCT00113607|593095653|FG000|Overall Study|Complete Response (Confirmed)|14|||
164198335|NCT00113607|593095654|FG001|Overall Study|Complete Response (Confirmed)|24|||
164198336|NCT00113607|593095653|FG000|Overall Study|Other|43|||
164198337|NCT00113607|593095654|FG001|Overall Study|Other|32|||
164198338|NCT00909844|593095657|FG000|Overall Study|Adverse Event|1|||
164198339|NCT00909844|593095657|FG000|Overall Study|Withdrawal by Subject|1|||
164198340|NCT00909844|593095657|FG000|Overall Study|Lost to Follow-up|2|||
164198341|NCT00698815|593095658|FG000|Overall Study|Death|1|||
164198342|NCT00698815|593095659|FG001|Overall Study|Death|2|||
164198343|NCT00698815|593095660|FG002|Overall Study|Death|4|||
164198344|NCT00698815|593095658|FG000|Overall Study|Withdrawal by Subject|6|||
164198345|NCT00698815|593095659|FG001|Overall Study|Withdrawal by Subject|3|||
164198346|NCT00698815|593095660|FG002|Overall Study|Withdrawal by Subject|2|||
164198347|NCT00698815|593095658|FG000|Overall Study|MD discretion|2|||
164198348|NCT00698815|593095659|FG001|Overall Study|MD discretion|7|||
164198349|NCT00698815|593095660|FG002|Overall Study|MD discretion|2|||
164198350|NCT00698815|593095658|FG000|Overall Study|Did not receive protocol treatment|1|||
164198351|NCT00698815|593095659|FG001|Overall Study|Did not receive protocol treatment|2|||
164198352|NCT00698815|593095660|FG002|Overall Study|Did not receive protocol treatment|2|||
164198353|NCT02974868|593095661|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
164198354|NCT02974868|593095662|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
164198355|NCT02974868|593095663|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
164198356|NCT02974868|593095664|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
164198357|NCT02974868|593095661|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
164198358|NCT02974868|593095662|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
164198359|NCT02974868|593095663|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
164198360|NCT02974868|593095664|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
164198361|NCT02974868|593095661|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
164198362|NCT02974868|593095662|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
164198363|NCT02974868|593095663|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
164198364|NCT02974868|593095664|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
164198365|NCT02974868|593095661|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
164198366|NCT02974868|593095662|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
164198367|NCT02974868|593095663|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
164198368|NCT02974868|593095664|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
164198369|NCT00706004|593095665|FG000|Overall Study|Did not meet eligibility criteria|2|||
164198370|NCT02674516|593095666|FG000|Overall Study|Lost to Follow-up|3|||
164198371|NCT02674516|593095667|FG001|Overall Study|Lost to Follow-up|0|||
164198372|NCT02674516|593095666|FG000|Overall Study|Protocol Violation|0|||
164198373|NCT02674516|593095667|FG001|Overall Study|Protocol Violation|4|||
164198374|NCT02674516|593095666|FG000|Overall Study|Knowledge of study hypothesis|1|||
164198375|NCT02674516|593095667|FG001|Overall Study|Knowledge of study hypothesis|0|||
164550001|NCT02004262|594387152|FG002|Overall Study|Withdrawal by Subject|4|||
164655448|NCT01405820|594764829|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
164655449|NCT01405820|594764830|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
164655450|NCT01405820|594764831|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
164655451|NCT01405820|594764826|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
164655452|NCT01405820|594764827|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
164655453|NCT01405820|594764828|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
164655454|NCT01405820|594764829|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
164655455|NCT01405820|594764830|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
164655456|NCT01405820|594764831|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
164655457|NCT01405820|594764826|FG000|Open-Label Treatment Period|Other|1|||
164655458|NCT01405820|594764827|FG001|Open-Label Treatment Period|Other|1|||
164655459|NCT01405820|594764828|FG002|Open-Label Treatment Period|Other|1|||
164655460|NCT01405820|594764829|FG003|Open-Label Treatment Period|Other|1|||
164655461|NCT01405820|594764830|FG004|Open-Label Treatment Period|Other|1|||
164655462|NCT01405820|594764831|FG005|Open-Label Treatment Period|Other|1|||
164655463|NCT01405820|594764826|FG000|Open-Label Treatment Period|Physician Decision|0|||
164655464|NCT01405820|594764827|FG001|Open-Label Treatment Period|Physician Decision|0|||
164655465|NCT01405820|594764828|FG002|Open-Label Treatment Period|Physician Decision|1|||
164655466|NCT01405820|594764829|FG003|Open-Label Treatment Period|Physician Decision|2|||
164655467|NCT01405820|594764830|FG004|Open-Label Treatment Period|Physician Decision|1|||
164655468|NCT01405820|594764831|FG005|Open-Label Treatment Period|Physician Decision|0|||
164655469|NCT01405820|594764826|FG000|Open-Label Treatment Period|Adverse Event|0|||
164655470|NCT01405820|594764827|FG001|Open-Label Treatment Period|Adverse Event|0|||
164655471|NCT01405820|594764828|FG002|Open-Label Treatment Period|Adverse Event|0|||
164655472|NCT01405820|594764829|FG003|Open-Label Treatment Period|Adverse Event|1|||
164655473|NCT01405820|594764830|FG004|Open-Label Treatment Period|Adverse Event|0|||
164655474|NCT01405820|594764831|FG005|Open-Label Treatment Period|Adverse Event|0|||
164655475|NCT03222141|594764834|FG000|Overall Study|Death|15|||
164655476|NCT03222141|594764834|FG000|Overall Study|Lost to Follow-up|3|||
164655477|NCT00827359|594764837|FG000|Overall Study|Progressive Diseas|19|||
164655478|NCT00827359|594764837|FG000|Overall Study|Unacceptable Toxicity|5|||
164655479|NCT00827359|594764837|FG000|Overall Study|Ineligible|1|||
164655480|NCT02436135|594764838|FG000|Overall Study|Progressive Disease|3|||
164655481|NCT02436135|594764839|FG001|Overall Study|Progressive Disease|1|||
164655482|NCT02436135|594764838|FG000|Overall Study|Investigator Discretion|1|||
164655483|NCT02436135|594764839|FG001|Overall Study|Investigator Discretion|2|||
164655484|NCT02436135|594764838|FG000|Overall Study|Adverse Event|1|||
164655485|NCT02436135|594764839|FG001|Overall Study|Adverse Event|0|||
164655486|NCT02436135|594764838|FG000|Overall Study|Withdrawal by Participant|1|||
164655487|NCT02436135|594764839|FG001|Overall Study|Withdrawal by Participant|0|||
164655488|NCT02436135|594764838|FG000|Overall Study|Study Terminated By Sponsor|0|||
164655489|NCT02436135|594764839|FG001|Overall Study|Study Terminated By Sponsor|1|||
164655490|NCT00415532|594764842|FG000|Treatment Period|Adverse Event|2|||
164655491|NCT00415532|594764843|FG001|Treatment Period|Adverse Event|3|||
164655492|NCT00415532|594764842|FG000|Treatment Period|Death|2|||
164550002|NCT02004262|594387153|FG003|Overall Study|Withdrawal by Subject|0|||
164550003|NCT02004262|594387154|FG004|Overall Study|Withdrawal by Subject|1|||
164550004|NCT02004262|594387155|FG005|Overall Study|Withdrawal by Subject|3|||
164550005|NCT02004262|594387150|FG000|Overall Study|Lost to Follow-up|1|||
164550006|NCT02004262|594387151|FG001|Overall Study|Lost to Follow-up|1|||
164550007|NCT02004262|594387152|FG002|Overall Study|Lost to Follow-up|0|||
164550008|NCT02004262|594387153|FG003|Overall Study|Lost to Follow-up|0|||
164550009|NCT02004262|594387154|FG004|Overall Study|Lost to Follow-up|0|||
164550010|NCT02004262|594387155|FG005|Overall Study|Lost to Follow-up|0|||
164550011|NCT02004262|594387150|FG000|Overall Study|Study Terminated by Sponsor|4|||
164550012|NCT02004262|594387151|FG001|Overall Study|Study Terminated by Sponsor|3|||
164550013|NCT02004262|594387152|FG002|Overall Study|Study Terminated by Sponsor|2|||
164550014|NCT02004262|594387153|FG003|Overall Study|Study Terminated by Sponsor|1|||
164550015|NCT02004262|594387154|FG004|Overall Study|Study Terminated by Sponsor|1|||
164550016|NCT02004262|594387155|FG005|Overall Study|Study Terminated by Sponsor|5|||
164550017|NCT01146873|594387156|FG000|Overall Study|Transfer out|0|||
164550018|NCT01146873|594387157|FG001|Overall Study|Transfer out|6|||
164550019|NCT03703102|594387158|FG000|Overall Study|Adverse Event|4|||
164550020|NCT03703102|594387159|FG001|Overall Study|Adverse Event|3|||
164550021|NCT03703102|594387160|FG002|Overall Study|Adverse Event|7|||
164550022|NCT03703102|594387161|FG003|Overall Study|Adverse Event|3|||
164550023|NCT03703102|594387162|FG004|Overall Study|Adverse Event|13|||
164550024|NCT03703102|594387158|FG000|Overall Study|Lack of Efficacy|4|||
164550025|NCT03703102|594387159|FG001|Overall Study|Lack of Efficacy|0|||
164550026|NCT03703102|594387160|FG002|Overall Study|Lack of Efficacy|1|||
164550027|NCT03703102|594387161|FG003|Overall Study|Lack of Efficacy|4|||
164550028|NCT03703102|594387162|FG004|Overall Study|Lack of Efficacy|1|||
164550029|NCT03703102|594387158|FG000|Overall Study|Lost to Follow-up|0|||
164550030|NCT03703102|594387159|FG001|Overall Study|Lost to Follow-up|0|||
164550031|NCT03703102|594387160|FG002|Overall Study|Lost to Follow-up|1|||
164550032|NCT03703102|594387161|FG003|Overall Study|Lost to Follow-up|2|||
164550033|NCT03703102|594387162|FG004|Overall Study|Lost to Follow-up|2|||
164550034|NCT03703102|594387158|FG000|Overall Study|Physician Decision|2|||
164550035|NCT03703102|594387159|FG001|Overall Study|Physician Decision|2|||
164550036|NCT03703102|594387160|FG002|Overall Study|Physician Decision|2|||
164550037|NCT03703102|594387161|FG003|Overall Study|Physician Decision|2|||
164655493|NCT00415532|594764843|FG001|Treatment Period|Death|1|||
164655494|NCT00415532|594764842|FG000|Treatment Period|Lost to Follow-up|1|||
164655495|NCT00415532|594764843|FG001|Treatment Period|Lost to Follow-up|1|||
164655496|NCT00415532|594764842|FG000|Treatment Period|Protocol Violation|1|||
164655497|NCT00415532|594764843|FG001|Treatment Period|Protocol Violation|0|||
164655498|NCT00415532|594764842|FG000|Treatment Period|Withdrawal by Subject|6|||
164655499|NCT00415532|594764843|FG001|Treatment Period|Withdrawal by Subject|6|||
164655500|NCT00415532|594764842|FG000|Treatment Period|Other|2|||
164655501|NCT00415532|594764843|FG001|Treatment Period|Other|2|||
164550038|NCT03703102|594387162|FG004|Overall Study|Physician Decision|4|||
164550039|NCT03703102|594387158|FG000|Overall Study|Withdrawal by Subject|7|||
164550040|NCT03703102|594387159|FG001|Overall Study|Withdrawal by Subject|5|||
164550041|NCT03703102|594387160|FG002|Overall Study|Withdrawal by Subject|5|||
164550042|NCT03703102|594387161|FG003|Overall Study|Withdrawal by Subject|5|||
164655502|NCT00415532|594764842|FG000|Treatment Period|Ineligibility determined|1|||
164655503|NCT00415532|594764843|FG001|Treatment Period|Ineligibility determined|1|||
164655504|NCT00415532|594764842|FG000|Treatment Period|Noncompliance|1|||
164655505|NCT00415532|594764843|FG001|Treatment Period|Noncompliance|1|||
164655506|NCT00415532|594764842|FG000|Treatment Period|Requirement for alternative therapy|1|||
164550043|NCT03703102|594387162|FG004|Overall Study|Withdrawal by Subject|9|||
164550044|NCT03703102|594387158|FG000|Overall Study|Ineligibility|0|||
164550045|NCT03703102|594387159|FG001|Overall Study|Ineligibility|0|||
164550046|NCT03703102|594387160|FG002|Overall Study|Ineligibility|1|||
164550047|NCT03703102|594387161|FG003|Overall Study|Ineligibility|0|||
164550048|NCT03703102|594387162|FG004|Overall Study|Ineligibility|0|||
164550049|NCT03703102|594387158|FG000|Overall Study|Protocol Deviation|4|||
164550050|NCT03703102|594387159|FG001|Overall Study|Protocol Deviation|4|||
164550051|NCT03703102|594387160|FG002|Overall Study|Protocol Deviation|3|||
164550052|NCT03703102|594387161|FG003|Overall Study|Protocol Deviation|0|||
164550053|NCT03703102|594387162|FG004|Overall Study|Protocol Deviation|0|||
164550054|NCT03703102|594387158|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164550055|NCT03703102|594387159|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164550056|NCT03703102|594387160|FG002|Overall Study|Non-Compliance with Study Drug|2|||
164550057|NCT03703102|594387161|FG003|Overall Study|Non-Compliance with Study Drug|1|||
164550058|NCT03703102|594387162|FG004|Overall Study|Non-Compliance with Study Drug|4|||
164550059|NCT00552175|594387168|FG000|Overall Study|Lack of Efficacy|2|||
164550060|NCT00552175|594387169|FG001|Overall Study|Lack of Efficacy|0|||
164550061|NCT00552175|594387170|FG002|Overall Study|Lack of Efficacy|1|||
164550062|NCT00552175|594387168|FG000|Overall Study|Adverse Event|9|||
164550063|NCT00552175|594387169|FG001|Overall Study|Adverse Event|9|||
164550064|NCT00552175|594387170|FG002|Overall Study|Adverse Event|10|||
164550065|NCT00552175|594387168|FG000|Overall Study|Withdrawal by Subject|2|||
164550066|NCT00552175|594387169|FG001|Overall Study|Withdrawal by Subject|2|||
164550067|NCT00552175|594387170|FG002|Overall Study|Withdrawal by Subject|1|||
164550068|NCT00552175|594387168|FG000|Overall Study|Lost to Follow-up|0|||
164550069|NCT00552175|594387169|FG001|Overall Study|Lost to Follow-up|0|||
164550070|NCT00552175|594387170|FG002|Overall Study|Lost to Follow-up|1|||
164550071|NCT00552175|594387168|FG000|Overall Study|Entry Criteria Not Met|1|||
164550072|NCT00552175|594387169|FG001|Overall Study|Entry Criteria Not Met|1|||
164550073|NCT00552175|594387170|FG002|Overall Study|Entry Criteria Not Met|0|||
164550074|NCT00552175|594387168|FG000|Overall Study|Reason Not Specified|3|||
164550075|NCT00552175|594387169|FG001|Overall Study|Reason Not Specified|1|||
164550076|NCT00552175|594387170|FG002|Overall Study|Reason Not Specified|1|||
164550077|NCT00811135|594387171|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
164550078|NCT00811135|594387171|FG000|Overall Study|Death|3|||
164550079|NCT00811135|594387171|FG000|Overall Study|Protocol Violation|2|||
164550080|NCT00811135|594387171|FG000|Overall Study|Violation of Selection Criteria|1|||
164550081|NCT00811135|594387171|FG000|Overall Study|Refused Treatment|1|||
164550082|NCT00811135|594387171|FG000|Overall Study|Withdrawal by Subject|3|||
164550083|NCT00811135|594387171|FG000|Overall Study|Administrative/Other Unspecified|11|||
164550084|NCT00811135|594387171|FG000|Overall Study|Ongoing|59|||
164550085|NCT01118351|594387172|FG000|Overall Study|Adverse Event|3|||
164550086|NCT01118351|594387172|FG000|Overall Study|Withdrawal by Subject|1|||
164550087|NCT02192827|594387173|FG000|Overall Study|Lost to Follow-up|25|||
164550088|NCT02192827|594387174|FG001|Overall Study|Lost to Follow-up|27|||
164550089|NCT02192827|594387173|FG000|Overall Study|Given additional steroids with admission|13|||
164550090|NCT02192827|594387174|FG001|Overall Study|Given additional steroids with admission|11|||
164550091|NCT03972969|594387176|FG000|3-month Follow-up|Death|1|||
164550092|NCT03972969|594387177|FG001|3-month Follow-up|Death|1|||
164550093|NCT03972969|594387178|FG002|3-month Follow-up|Death|0|||
164550094|NCT03972969|594387176|FG000|6-month Follow-up|Death|1|||
164550095|NCT03972969|594387177|FG001|6-month Follow-up|Death|1|||
164550096|NCT03972969|594387178|FG002|6-month Follow-up|Death|1|||
164550097|NCT03972969|594387176|FG000|6-month Follow-up|Lost to Follow-up|2|||
164550098|NCT03972969|594387177|FG001|6-month Follow-up|Lost to Follow-up|2|||
164550099|NCT03972969|594387178|FG002|6-month Follow-up|Lost to Follow-up|2|||
164655507|NCT00415532|594764843|FG001|Treatment Period|Requirement for alternative therapy|0|||
164655508|NCT00415532|594764842|FG000|Safety Follow Up Period|Adverse Event|1|||
164550100|NCT04677959|594387179|FG000|Overall Study|Adverse Event|1|||
164550101|NCT04677959|594387180|FG001|Overall Study|Adverse Event|9|||
164550102|NCT04677959|594387179|FG000|Overall Study|Withdrawal by Subject|2|||
164550103|NCT04677959|594387180|FG001|Overall Study|Withdrawal by Subject|15|||
164550104|NCT04677959|594387179|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164550105|NCT04677959|594387180|FG001|Overall Study|Withdrawal by parent/guardian|1|||
164550106|NCT04677959|594387179|FG000|Overall Study|Non-compliance with study drug|0|||
164550107|NCT04677959|594387180|FG001|Overall Study|Non-compliance with study drug|2|||
164550108|NCT04677959|594387179|FG000|Overall Study|Protocol deviation|0|||
164550109|NCT04677959|594387180|FG001|Overall Study|Protocol deviation|11|||
164550110|NCT04677959|594387179|FG000|Overall Study|Lost to Follow-up|9|||
164550111|NCT04677959|594387180|FG001|Overall Study|Lost to Follow-up|13|||
164550112|NCT04677959|594387179|FG000|Overall Study|Other than specified|0|||
164550113|NCT04677959|594387180|FG001|Overall Study|Other than specified|8|||
164550114|NCT00845728|594387184|FG000|Overall Study|Abnormal laboratory value (s)|2|||
164550115|NCT00845728|594387185|FG001|Overall Study|Abnormal laboratory value (s)|2|||
164550116|NCT00845728|594387184|FG000|Overall Study|Patient's inability to use the device|4|||
164550117|NCT00845728|594387185|FG001|Overall Study|Patient's inability to use the device|6|||
164550118|NCT00845728|594387184|FG000|Overall Study|Abnormal test procedure result (s)|7|||
164550119|NCT00845728|594387185|FG001|Overall Study|Abnormal test procedure result (s)|2|||
164550120|NCT00845728|594387184|FG000|Overall Study|Lost to Follow-up|22|||
164550121|NCT00845728|594387185|FG001|Overall Study|Lost to Follow-up|13|||
164550122|NCT00845728|594387184|FG000|Overall Study|Death|24|||
164550123|NCT00845728|594387185|FG001|Overall Study|Death|26|||
164550124|NCT00845728|594387184|FG000|Overall Study|Administrative Problems|34|||
164550125|NCT00845728|594387185|FG001|Overall Study|Administrative Problems|26|||
164550126|NCT00845728|594387184|FG000|Overall Study|Protocol Violation|36|||
164550127|NCT00845728|594387185|FG001|Overall Study|Protocol Violation|24|||
164550128|NCT00845728|594387184|FG000|Overall Study|Lack of Efficacy|51|||
164550129|NCT00845728|594387185|FG001|Overall Study|Lack of Efficacy|39|||
164550130|NCT00845728|594387184|FG000|Overall Study|Adverse Event|101|||
164550131|NCT00845728|594387185|FG001|Overall Study|Adverse Event|96|||
164550132|NCT00845728|594387184|FG000|Overall Study|Withdrawal by Subject|105|||
164550133|NCT00845728|594387185|FG001|Overall Study|Withdrawal by Subject|108|||
164550134|NCT01389752|594387186|FG000|Study Period 1|Sponsor decision|0|||
164550135|NCT01389752|594387187|FG001|Study Period 1|Sponsor decision|2|||
164550136|NCT01389752|594387186|FG000|Study Period 2|Sponsor decision|1|||
164550137|NCT01389752|594387187|FG001|Study Period 2|Sponsor decision|0|||
164550138|NCT03259074|594387188|FG000|Overall Study|Adverse Event|9|||
164198376|NCT01064479|593095668|FG000|Overall Study|Death|10|||
164198377|NCT01064479|593095669|FG001|Overall Study|Death|11|||
164198378|NCT01064479|593095668|FG000|Overall Study|Withdrawal by Subject|2|||
164198379|NCT01064479|593095669|FG001|Overall Study|Withdrawal by Subject|2|||
164198380|NCT01064479|593095668|FG000|Overall Study|Disease progression|1|||
164198381|NCT01064479|593095669|FG001|Overall Study|Disease progression|1|||
164198382|NCT01064479|593095668|FG000|Overall Study|Toxicity|1|||
164198383|NCT01064479|593095669|FG001|Overall Study|Toxicity|1|||
164198384|NCT01064479|593095668|FG000|Overall Study|Other|1|||
164198385|NCT01064479|593095669|FG001|Overall Study|Other|2|||
164198386|NCT00749398|593095671|FG000|Overall Study|Lack of Efficacy|7|||
164198387|NCT00749398|593095671|FG000|Overall Study|Adverse Event|4|||
164198388|NCT00749398|593095671|FG000|Overall Study|Serious adverse event|11|||
164198389|NCT00749398|593095671|FG000|Overall Study|Withdrawal by Subject|17|||
164198390|NCT00749398|593095671|FG000|Overall Study|Lost to Follow-up|11|||
164198391|NCT00749398|593095671|FG000|Overall Study|Reason not specified|2|||
164198392|NCT00749398|593095671|FG000|Overall Study|Unknown reason|1|||
164198393|NCT01663402|593095677|FG000|Overall Study|Randomized but not treated|19|||
164198394|NCT01663402|593095678|FG001|Overall Study|Randomized but not treated|11|||
164198395|NCT01663402|593095677|FG000|Overall Study|Adverse Event|347|||
164198396|NCT01663402|593095678|FG001|Overall Study|Adverse Event|362|||
164198397|NCT01663402|593095677|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
164198398|NCT01663402|593095678|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
164198399|NCT01663402|593095677|FG000|Overall Study|Poor compliance to protocol|529|||
164198400|NCT01663402|593095678|FG001|Overall Study|Poor compliance to protocol|454|||
164198401|NCT01663402|593095677|FG000|Overall Study|Physician Decision|77|||
164198402|NCT01663402|593095678|FG001|Overall Study|Physician Decision|62|||
164198403|NCT01663402|593095677|FG000|Overall Study|Site terminated by sponsor|1|||
164198404|NCT01663402|593095678|FG001|Overall Study|Site terminated by sponsor|3|||
164198405|NCT01663402|593095677|FG000|Overall Study|Participant moved|139|||
164198406|NCT01663402|593095678|FG001|Overall Study|Participant moved|104|||
164198407|NCT01663402|593095677|FG000|Overall Study|Withdrawal by Subject|118|||
164198408|NCT01663402|593095678|FG001|Overall Study|Withdrawal by Subject|91|||
164198409|NCT01663402|593095677|FG000|Overall Study|Related to study drug administration|96|||
164198410|NCT01663402|593095678|FG001|Overall Study|Related to study drug administration|105|||
164198411|NCT01663402|593095677|FG000|Overall Study|Lost to Follow-up|17|||
164198412|NCT01663402|593095678|FG001|Overall Study|Lost to Follow-up|15|||
164198413|NCT01663402|593095677|FG000|Overall Study|Other than specified above|172|||
164198414|NCT01663402|593095678|FG001|Overall Study|Other than specified above|147|||
164198415|NCT01211145|593095679|FG000|Overall Study|Reason not specified|3|||
164198416|NCT01211145|593095680|FG001|Overall Study|Reason not specified|2|||
164198417|NCT01211145|593095681|FG002|Overall Study|Reason not specified|2|||
164198418|NCT01211145|593095682|FG003|Overall Study|Reason not specified|1|||
164198419|NCT01211145|593095679|FG000|Overall Study|Lost to Follow-up|3|||
164198420|NCT01211145|593095680|FG001|Overall Study|Lost to Follow-up|2|||
164198421|NCT01211145|593095681|FG002|Overall Study|Lost to Follow-up|1|||
164550139|NCT03259074|594387189|FG001|Overall Study|Adverse Event|12|||
164550140|NCT03259074|594387190|FG002|Overall Study|Adverse Event|8|||
164550141|NCT03259074|594387188|FG000|Overall Study|Death|1|||
164550142|NCT03259074|594387189|FG001|Overall Study|Death|1|||
164550143|NCT03259074|594387190|FG002|Overall Study|Death|3|||
164550144|NCT03259074|594387188|FG000|Overall Study|Lost to Follow-up|2|||
164655509|NCT00415532|594764843|FG001|Safety Follow Up Period|Adverse Event|3|||
164655510|NCT00415532|594764842|FG000|Safety Follow Up Period|Death|3|||
164655511|NCT00415532|594764843|FG001|Safety Follow Up Period|Death|0|||
164655512|NCT00415532|594764842|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
164655513|NCT00415532|594764843|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
164655514|NCT00415532|594764842|FG000|Safety Follow Up Period|Other|1|||
164655515|NCT00415532|594764843|FG001|Safety Follow Up Period|Other|4|||
164655516|NCT00415532|594764842|FG000|Safety Follow Up Period|Ineligibility determined|1|||
164655517|NCT00415532|594764843|FG001|Safety Follow Up Period|Ineligibility determined|1|||
164655518|NCT00415532|594764842|FG000|Safety Follow Up Period|Noncompliance|1|||
164655519|NCT00415532|594764843|FG001|Safety Follow Up Period|Noncompliance|0|||
164655520|NCT00415532|594764842|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
164655521|NCT00415532|594764843|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
164655522|NCT01698320|594764844|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
164655523|NCT01698320|594764845|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
164198422|NCT01211145|593095682|FG003|Overall Study|Lost to Follow-up|2|||
164198423|NCT01211145|593095679|FG000|Overall Study|Study-specific withdrawal criteria|1|||
164198424|NCT01211145|593095680|FG001|Overall Study|Study-specific withdrawal criteria|0|||
164198425|NCT01211145|593095681|FG002|Overall Study|Study-specific withdrawal criteria|0|||
164198426|NCT01211145|593095682|FG003|Overall Study|Study-specific withdrawal criteria|0|||
164198427|NCT01211145|593095679|FG000|Overall Study|Severe noncompliance to protocol|1|||
164198428|NCT01211145|593095680|FG001|Overall Study|Severe noncompliance to protocol|0|||
164198429|NCT01211145|593095681|FG002|Overall Study|Severe noncompliance to protocol|0|||
164198430|NCT01211145|593095682|FG003|Overall Study|Severe noncompliance to protocol|0|||
164198431|NCT01211145|593095679|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
164198432|NCT01211145|593095680|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
164198433|NCT01211145|593095681|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
164198434|NCT01211145|593095682|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
164198435|NCT01211145|593095679|FG000|Overall Study|Patient decision|2|||
164198436|NCT01211145|593095680|FG001|Overall Study|Patient decision|1|||
164198437|NCT01211145|593095681|FG002|Overall Study|Patient decision|0|||
164198438|NCT01211145|593095682|FG003|Overall Study|Patient decision|2|||
164198439|NCT04577794|593095689|FG000|Overall Study|Adverse Event|1|||
164198440|NCT04577794|593095690|FG001|Overall Study|Adverse Event|1|||
164198441|NCT02667301|593095698|FG000|Overall Study|Adverse Event|1|||
164198442|NCT02667301|593095698|FG000|Overall Study|Lack of Efficacy|1|||
164198443|NCT00846586|593095700|FG000|Overall Study|Adverse Event|20|||
164198444|NCT00846586|593095701|FG001|Overall Study|Adverse Event|10|||
164198445|NCT00846586|593095700|FG000|Overall Study|Subject withdrew consent|8|||
164198446|NCT00846586|593095701|FG001|Overall Study|Subject withdrew consent|10|||
164198447|NCT00846586|593095700|FG000|Overall Study|Administrative problems|5|||
164198448|NCT00846586|593095701|FG001|Overall Study|Administrative problems|4|||
164198449|NCT00846586|593095700|FG000|Overall Study|Death|2|||
164198450|NCT00846586|593095701|FG001|Overall Study|Death|0|||
164198451|NCT00846586|593095700|FG000|Overall Study|Protocol deviation|2|||
164198452|NCT00846586|593095701|FG001|Overall Study|Protocol deviation|6|||
164198453|NCT00846586|593095700|FG000|Overall Study|Abnormal test procedure result(s)|1|||
164198454|NCT00846586|593095701|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164198455|NCT00846586|593095700|FG000|Overall Study|Lost to Follow-up|1|||
164198456|NCT00846586|593095701|FG001|Overall Study|Lost to Follow-up|4|||
164198457|NCT00846586|593095700|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164198458|NCT00846586|593095701|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
164198459|NCT02104895|593095702|FG000|Overall Study|Withdrawal by Subject|0|||
164198460|NCT02104895|593095703|FG001|Overall Study|Withdrawal by Subject|14|||
164198461|NCT01883895|593095705|FG000|Overall Study|Lost to Follow-up|2|||
164198462|NCT04414787|593095706|FG000|Overall Study|Patient Death|18|||
164198463|NCT04414787|593095707|FG001|Overall Study|Patient Death|18|||
164198464|NCT04414787|593095708|FG002|Overall Study|Patient Death|15|||
164198465|NCT04414787|593095709|FG003|Overall Study|Patient Death|15|||
164198466|NCT04414787|593095706|FG000|Overall Study|Patient Hospitalization|1|||
164198467|NCT04414787|593095707|FG001|Overall Study|Patient Hospitalization|1|||
164198468|NCT04414787|593095708|FG002|Overall Study|Patient Hospitalization|2|||
164655524|NCT01698320|594764846|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
164198469|NCT04414787|593095709|FG003|Overall Study|Patient Hospitalization|2|||
164198470|NCT04414787|593095706|FG000|Overall Study|Lost to Follow-up|7|||
164198471|NCT04414787|593095707|FG001|Overall Study|Lost to Follow-up|7|||
164198472|NCT04414787|593095708|FG002|Overall Study|Lost to Follow-up|5|||
164198473|NCT04414787|593095709|FG003|Overall Study|Lost to Follow-up|5|||
164198474|NCT04414787|593095706|FG000|Overall Study|Residence in post-acute care facility|3|||
164198475|NCT04414787|593095707|FG001|Overall Study|Residence in post-acute care facility|3|||
164655525|NCT01698320|594764844|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
164198476|NCT04414787|593095708|FG002|Overall Study|Residence in post-acute care facility|5|||
164655526|NCT01698320|594764845|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
164655527|NCT01698320|594764846|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
164655528|NCT01698320|594764844|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
164655529|NCT01698320|594764845|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
164655530|NCT01698320|594764846|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
164655531|NCT01698320|594764844|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
164655532|NCT01698320|594764845|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
164655533|NCT01698320|594764846|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
164655534|NCT01698320|594764844|FG000|12-Week Double-Blind Period|Adverse Event|0|||
164655535|NCT01698320|594764845|FG001|12-Week Double-Blind Period|Adverse Event|1|||
164655536|NCT01698320|594764846|FG002|12-Week Double-Blind Period|Adverse Event|1|||
164655537|NCT01698320|594764844|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
164655538|NCT01698320|594764845|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
164655539|NCT01698320|594764846|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
164655540|NCT01698320|594764844|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
164655541|NCT01698320|594764845|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
164655542|NCT01698320|594764846|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
164655543|NCT01698320|594764844|FG000|12-Week Double-Blind Period|Pregnancy|0|||
164655544|NCT01698320|594764845|FG001|12-Week Double-Blind Period|Pregnancy|1|||
164655545|NCT01698320|594764846|FG002|12-Week Double-Blind Period|Pregnancy|1|||
164655546|NCT01698320|594764844|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
164550145|NCT03259074|594387189|FG001|Overall Study|Lost to Follow-up|4|||
164550146|NCT03259074|594387190|FG002|Overall Study|Lost to Follow-up|3|||
164550147|NCT03259074|594387188|FG000|Overall Study|New Therapy For Study Indication|1|||
164550148|NCT03259074|594387189|FG001|Overall Study|New Therapy For Study Indication|2|||
164550149|NCT03259074|594387190|FG002|Overall Study|New Therapy For Study Indication|2|||
164550150|NCT03259074|594387188|FG000|Overall Study|Physician Decision|4|||
164550151|NCT03259074|594387189|FG001|Overall Study|Physician Decision|12|||
164550152|NCT03259074|594387190|FG002|Overall Study|Physician Decision|10|||
164550153|NCT03259074|594387188|FG000|Overall Study|Pregnancy|1|||
164655547|NCT01698320|594764845|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
164198477|NCT04414787|593095709|FG003|Overall Study|Residence in post-acute care facility|5|||
164198478|NCT05093933|593095710|FG000|Overall Study|Death|372|||
164198479|NCT05093933|593095711|FG001|Overall Study|Death|434|||
164198480|NCT05093933|593095710|FG000|Overall Study|Lost to Follow-up|13|||
164198481|NCT05093933|593095711|FG001|Overall Study|Lost to Follow-up|16|||
164198482|NCT05093933|593095710|FG000|Overall Study|Physician Decision|0|||
164198483|NCT05093933|593095711|FG001|Overall Study|Physician Decision|2|||
164198484|NCT05093933|593095710|FG000|Overall Study|Sponsor Decision|1|||
164198485|NCT05093933|593095711|FG001|Overall Study|Sponsor Decision|3|||
164198486|NCT05093933|593095710|FG000|Overall Study|Withdrawal by Guardian|1|||
164198487|NCT05093933|593095711|FG001|Overall Study|Withdrawal by Guardian|1|||
164198488|NCT05093933|593095710|FG000|Overall Study|Withdrawal by Subject|18|||
164198489|NCT05093933|593095711|FG001|Overall Study|Withdrawal by Subject|25|||
164198490|NCT02532283|593095712|FG000|Overall Study|Adverse Event|0|||
164198491|NCT02532283|593095713|FG001|Overall Study|Adverse Event|1|||
164198492|NCT02532283|593095712|FG000|Overall Study|Death|1|||
164198493|NCT02532283|593095713|FG001|Overall Study|Death|0|||
164198494|NCT02532283|593095712|FG000|Overall Study|Lost to Follow-up|0|||
164198495|NCT02532283|593095713|FG001|Overall Study|Lost to Follow-up|1|||
164198496|NCT02532283|593095712|FG000|Overall Study|Withdrawal by Subject|8|||
164198497|NCT02532283|593095713|FG001|Overall Study|Withdrawal by Subject|3|||
164198498|NCT01249131|593097620|FG000|Washout Period of 10 Days|Adverse Event|0|||
164655548|NCT01698320|594764846|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
164655549|NCT01698320|594764844|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
164655550|NCT01698320|594764845|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
164655551|NCT01698320|594764846|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
164655552|NCT01698320|594764844|FG000|40-Week Open-Label Period|Adverse Event|0|||
164198499|NCT01249131|593097621|FG001|Washout Period of 10 Days|Adverse Event|0|||
164198500|NCT01249131|593097622|FG002|Washout Period of 10 Days|Adverse Event|0|||
164198501|NCT01249131|593097623|FG003|Washout Period of 10 Days|Adverse Event|0|||
164198502|NCT01249131|593097624|FG004|Washout Period of 10 Days|Adverse Event|1|||
164198503|NCT01249131|593097625|FG005|Washout Period of 10 Days|Adverse Event|0|||
164198504|NCT00473083|593097626|FG000|Overall Study|Adverse Event|1|||
164198505|NCT00473083|593097627|FG001|Overall Study|Adverse Event|0|||
164198506|NCT00473083|593097628|FG002|Overall Study|Adverse Event|0|||
164198507|NCT01184872|593097629|FG000|Overall Study|Adverse Event|3|||
164198508|NCT01184872|593097630|FG001|Overall Study|Adverse Event|4|||
164198509|NCT01184872|593097629|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
164198510|NCT01184872|593097630|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164198511|NCT01184872|593097629|FG000|Overall Study|Withdrawal by Subject|2|||
164198512|NCT01184872|593097630|FG001|Overall Study|Withdrawal by Subject|0|||
164198513|NCT01184872|593097629|FG000|Overall Study|Lost to Follow-up|0|||
164550154|NCT03259074|594387189|FG001|Overall Study|Pregnancy|1|||
164550155|NCT03259074|594387190|FG002|Overall Study|Pregnancy|0|||
164550156|NCT03259074|594387188|FG000|Overall Study|Progressive Disease|1|||
164550157|NCT03259074|594387189|FG001|Overall Study|Progressive Disease|0|||
164198514|NCT01184872|593097630|FG001|Overall Study|Lost to Follow-up|1|||
164198515|NCT01184872|593097629|FG000|Overall Study|Administrative problems|1|||
164198516|NCT01184872|593097630|FG001|Overall Study|Administrative problems|1|||
164198517|NCT01184872|593097629|FG000|Overall Study|Protocol deviation|1|||
164198518|NCT01184872|593097630|FG001|Overall Study|Protocol deviation|0|||
164198519|NCT03426345|593097631|FG000|Overall Study|Adverse Event|4|||
164198520|NCT03426345|593097632|FG001|Overall Study|Adverse Event|4|||
164198521|NCT03426345|593097631|FG000|Overall Study|Lack of Efficacy|1|||
164198522|NCT03426345|593097632|FG001|Overall Study|Lack of Efficacy|0|||
164198523|NCT03426345|593097631|FG000|Overall Study|Withdrawal by Subject|5|||
164198524|NCT03426345|593097632|FG001|Overall Study|Withdrawal by Subject|6|||
164198525|NCT03426345|593097631|FG000|Overall Study|Lost to Follow-up|3|||
164198526|NCT03426345|593097632|FG001|Overall Study|Lost to Follow-up|1|||
164198527|NCT03426345|593097631|FG000|Overall Study|Protocol Deviation|3|||
164198528|NCT03426345|593097632|FG001|Overall Study|Protocol Deviation|4|||
164198529|NCT03426345|593097631|FG000|Overall Study|Reason Not Specified|1|||
164198530|NCT03426345|593097632|FG001|Overall Study|Reason Not Specified|2|||
164198531|NCT03426345|593097631|FG000|Overall Study|Missing Completion Status|1|||
164198532|NCT03426345|593097632|FG001|Overall Study|Missing Completion Status|0|||
164198533|NCT02446691|593097639|FG000|Overall Study|Withdrawal by Subject|2|||
164198534|NCT02446691|593097639|FG000|Overall Study|Lost to Follow-up|8|||
164198535|NCT02446691|593097639|FG000|Overall Study|Protocol Violation|1|||
164198536|NCT00192114|593097640|FG000|Overall Study|Objective Tumor Progression|19|||
164198537|NCT00192114|593097640|FG000|Overall Study|Adverse Event|2|||
164198538|NCT00192114|593097640|FG000|Overall Study|Clinical Progression|2|||
164198539|NCT00192114|593097640|FG000|Overall Study|Death|1|||
164198540|NCT00492297|593097641|FG000|Treatment|Death|2|||
164198541|NCT00492297|593097641|FG000|Treatment|Study terminated by sponsor|3|||
164198542|NCT00492297|593097641|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
164198543|NCT00492297|593097641|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
164198544|NCT00492297|593097641|FG000|Survival Only Follow-up|Death|46|||
164198545|NCT00492297|593097641|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
164198546|NCT00492297|593097641|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
164198547|NCT03885908|593097642|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
164198548|NCT03885908|593097643|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
164198549|NCT03885908|593097642|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
164198550|NCT03885908|593097643|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
164198551|NCT03885908|593097642|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
164550158|NCT03259074|594387190|FG002|Overall Study|Progressive Disease|0|||
164550159|NCT03259074|594387188|FG000|Overall Study|Protocol Deviation|1|||
164550160|NCT03259074|594387189|FG001|Overall Study|Protocol Deviation|1|||
164550161|NCT03259074|594387190|FG002|Overall Study|Protocol Deviation|3|||
164550162|NCT03259074|594387188|FG000|Overall Study|Subject/Guardian Decision|13|||
164550163|NCT03259074|594387189|FG001|Overall Study|Subject/Guardian Decision|16|||
164550164|NCT03259074|594387190|FG002|Overall Study|Subject/Guardian Decision|14|||
164550165|NCT00705783|594387193|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
164550166|NCT00705783|594387194|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
164550167|NCT00705783|594387195|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
164550168|NCT00705783|594387193|FG000|Conversion Phase|Lost to Follow-up|13|||
164550169|NCT00705783|594387194|FG001|Conversion Phase|Lost to Follow-up|0|||
164550170|NCT00705783|594387195|FG002|Conversion Phase|Lost to Follow-up|0|||
164550171|NCT00705783|594387193|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
164550172|NCT00705783|594387194|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
164550173|NCT00705783|594387195|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
164550174|NCT00705783|594387193|FG000|Conversion Phase|Withdrawn by Investigator|4|||
164550175|NCT00705783|594387194|FG001|Conversion Phase|Withdrawn by Investigator|0|||
164550176|NCT00705783|594387195|FG002|Conversion Phase|Withdrawn by Investigator|0|||
164550177|NCT00705783|594387193|FG000|Conversion Phase|Withdrew Consent|24|||
164550178|NCT00705783|594387194|FG001|Conversion Phase|Withdrew Consent|0|||
164550179|NCT00705783|594387195|FG002|Conversion Phase|Withdrew Consent|0|||
164550180|NCT00705783|594387193|FG000|Conversion Phase|Protocol Deviation|2|||
164550181|NCT00705783|594387194|FG001|Conversion Phase|Protocol Deviation|0|||
164550182|NCT00705783|594387195|FG002|Conversion Phase|Protocol Deviation|0|||
164550183|NCT00705783|594387193|FG000|Conversion Phase|Adverse Event|11|||
164550184|NCT00705783|594387194|FG001|Conversion Phase|Adverse Event|0|||
164550185|NCT00705783|594387195|FG002|Conversion Phase|Adverse Event|0|||
164198552|NCT03885908|593097643|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
164302205|NCT01134055|593482562|FG006|Overall Study|Lost to Follow-up|0|||
164550186|NCT00705783|594387193|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
164550187|NCT00705783|594387194|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
164550188|NCT00705783|594387195|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
164550189|NCT00705783|594387193|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
164550190|NCT00705783|594387194|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
164198553|NCT03885908|593097642|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
164198554|NCT03885908|593097643|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
164198555|NCT03903172|593097655|FG000|Overall Study|screen fail|4|||
164198556|NCT03903172|593097656|FG001|Overall Study|screen fail|1|||
164198557|NCT01545388|593097657|FG000|Overall Study|Adverse Event|2|||
164198558|NCT01545388|593097658|FG001|Overall Study|Adverse Event|4|||
164198559|NCT01545388|593097659|FG002|Overall Study|Adverse Event|1|||
164198560|NCT01545388|593097657|FG000|Overall Study|Lack of Efficacy|3|||
164198561|NCT01545388|593097658|FG001|Overall Study|Lack of Efficacy|2|||
164198562|NCT01545388|593097659|FG002|Overall Study|Lack of Efficacy|5|||
164198563|NCT01545388|593097657|FG000|Overall Study|Participant moved or relocated|1|||
164198564|NCT01545388|593097658|FG001|Overall Study|Participant moved or relocated|0|||
164198565|NCT01545388|593097659|FG002|Overall Study|Participant moved or relocated|0|||
164198566|NCT01545388|593097657|FG000|Overall Study|Withdrawal by Subject|1|||
164198567|NCT01545388|593097658|FG001|Overall Study|Withdrawal by Subject|4|||
164198568|NCT01545388|593097659|FG002|Overall Study|Withdrawal by Subject|2|||
164198569|NCT01545388|593097657|FG000|Overall Study|Other|1|||
164198570|NCT01545388|593097658|FG001|Overall Study|Other|1|||
164198571|NCT01545388|593097659|FG002|Overall Study|Other|0|||
164198572|NCT01900444|593097660|FG000|Overall Study|Protocol Violation|2|||
164198573|NCT01900444|593097660|FG000|Overall Study|Lost to Follow-up|1|||
164198574|NCT00072384|593097661|FG000|Overall Study|Physician Decision|1|||
164198575|NCT00072384|593097661|FG000|Overall Study|Ineligible|8|||
164198576|NCT06058390|593097663|FG000|Overall Study|Lost to Follow-up|0|||
164198577|NCT06058390|593097664|FG001|Overall Study|Lost to Follow-up|0|||
164198578|NCT06058390|593097665|FG002|Overall Study|Lost to Follow-up|2|||
164198579|NCT06058390|593097666|FG003|Overall Study|Lost to Follow-up|1|||
164198580|NCT06058390|593097663|FG000|Overall Study|Physician Decision|0|||
164198581|NCT06058390|593097664|FG001|Overall Study|Physician Decision|0|||
164198582|NCT06058390|593097665|FG002|Overall Study|Physician Decision|0|||
164198583|NCT06058390|593097666|FG003|Overall Study|Physician Decision|1|||
164198584|NCT06058390|593097663|FG000|Overall Study|Participants did not receive any study intervention|0|||
164198585|NCT06058390|593097664|FG001|Overall Study|Participants did not receive any study intervention|0|||
164198586|NCT06058390|593097665|FG002|Overall Study|Participants did not receive any study intervention|0|||
164198587|NCT06058390|593097666|FG003|Overall Study|Participants did not receive any study intervention|1|||
164198588|NCT02495389|593097667|FG000|Overall Study|Withdrawal by Subject|40|||
164198589|NCT03585270|593097668|FG000|Overall Study|Withdrawal by Subject|2|||
164198590|NCT03585270|593097669|FG001|Overall Study|Withdrawal by Subject|6|||
164198591|NCT03585270|593097668|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
164198592|NCT03585270|593097669|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
164198593|NCT03585270|593097668|FG000|Overall Study|Adverse Event|5|||
164198594|NCT03585270|593097669|FG001|Overall Study|Adverse Event|2|||
164198595|NCT03585270|593097668|FG000|Overall Study|Lost to Follow-up|1|||
164198596|NCT03585270|593097669|FG001|Overall Study|Lost to Follow-up|4|||
164198597|NCT03585270|593097668|FG000|Overall Study|Death|5|||
164198598|NCT03585270|593097669|FG001|Overall Study|Death|3|||
164198599|NCT03585270|593097668|FG000|Overall Study|Other reasons|2|||
164198600|NCT03585270|593097669|FG001|Overall Study|Other reasons|2|||
164198601|NCT03292016|593097670|FG000|Second Washout|Adverse Event|0|||
164198602|NCT03292016|593097671|FG001|Second Washout|Adverse Event|1|||
164198603|NCT03292016|593097672|FG002|Second Washout|Adverse Event|0|||
164198604|NCT03292016|593097673|FG003|Second Washout|Adverse Event|0|||
164198605|NCT03292016|593097674|FG004|Second Washout|Adverse Event|0|||
164198606|NCT03292016|593097675|FG005|Second Washout|Adverse Event|0|||
164198607|NCT01802385|593097677|FG000|Overall Study|Death|106|||
164198608|NCT01802385|593097678|FG001|Overall Study|Death|120|||
164198609|NCT00323063|593097680|FG000|Overall Study|Adverse Event|1|||
164198610|NCT00323063|593097681|FG001|Overall Study|Adverse Event|0|||
164198611|NCT00323063|593097680|FG000|Overall Study|brain mets discovered prior to treatment|1|||
164198612|NCT00323063|593097681|FG001|Overall Study|brain mets discovered prior to treatment|0|||
164198613|NCT03904693|593097682|FG000|DB Treatment Period (Week 1 to Week 16)|Death|0|||
164198614|NCT03904693|593097683|FG001|DB Treatment Period (Week 1 to Week 16)|Death|0|||
164198615|NCT03904693|593097684|FG002|DB Treatment Period (Week 1 to Week 16)|Death|3|||
164550191|NCT00705783|594387195|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
164550192|NCT00705783|594387193|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
164550193|NCT00705783|594387194|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
164550194|NCT00705783|594387195|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
164550195|NCT00705783|594387193|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
164550196|NCT00705783|594387194|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
164550197|NCT00705783|594387195|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
164550198|NCT00705783|594387193|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
164550199|NCT00705783|594387194|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
164198616|NCT03904693|593097685|FG003|DB Treatment Period (Week 1 to Week 16)|Death|0|||
164198617|NCT03904693|593097686|FG004|DB Treatment Period (Week 1 to Week 16)|Death|0|||
164550200|NCT00705783|594387195|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
164550201|NCT00705783|594387193|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
164550202|NCT00705783|594387194|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
164550203|NCT00705783|594387195|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
164550204|NCT00705783|594387193|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
164550205|NCT00705783|594387194|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
164550206|NCT00705783|594387195|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
164550207|NCT00705783|594387193|FG000|Oral Stabilization Phase|Adverse Event|14|||
164550208|NCT00705783|594387194|FG001|Oral Stabilization Phase|Adverse Event|0|||
164550209|NCT00705783|594387195|FG002|Oral Stabilization Phase|Adverse Event|0|||
164550210|NCT00705783|594387193|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
164550211|NCT00705783|594387194|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
164655553|NCT01698320|594764845|FG001|40-Week Open-Label Period|Adverse Event|3|||
164655554|NCT01698320|594764846|FG002|40-Week Open-Label Period|Adverse Event|2|||
164655555|NCT01698320|594764844|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
164198618|NCT03904693|593097687|FG005|DB Treatment Period (Week 1 to Week 16)|Death|0|||
164198619|NCT03904693|593097682|FG000|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
164198620|NCT03904693|593097683|FG001|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
164198621|NCT03904693|593097684|FG002|DB Treatment Period (Week 1 to Week 16)|Physician Decision|2|||
164198622|NCT03904693|593097685|FG003|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
164198623|NCT03904693|593097686|FG004|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
164198624|NCT03904693|593097687|FG005|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
164198625|NCT03904693|593097682|FG000|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
164198626|NCT03904693|593097683|FG001|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|1|||
164198627|NCT03904693|593097684|FG002|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|4|||
164198628|NCT03904693|593097685|FG003|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
164198629|NCT03904693|593097686|FG004|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
164198630|NCT03904693|593097687|FG005|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
164198631|NCT03904693|593097682|FG000|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
164198632|NCT03904693|593097683|FG001|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
164655556|NCT01698320|594764845|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
164655557|NCT01698320|594764846|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
164655558|NCT01698320|594764844|FG000|40-Week Open-Label Period|Pregnancy|0|||
164655559|NCT01698320|594764845|FG001|40-Week Open-Label Period|Pregnancy|2|||
164655560|NCT01698320|594764846|FG002|40-Week Open-Label Period|Pregnancy|1|||
164655561|NCT01698320|594764844|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
164655562|NCT01698320|594764845|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
164655563|NCT01698320|594764846|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
164655564|NCT01698320|594764844|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
164655565|NCT01698320|594764845|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
164655566|NCT01698320|594764846|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
164655567|NCT03567057|594764847|FG000|Overall Study|Adverse Event|56|||
164655568|NCT03567057|594764848|FG001|Overall Study|Adverse Event|53|||
164655569|NCT03567057|594764849|FG002|Overall Study|Adverse Event|28|||
164655570|NCT03567057|594764847|FG000|Overall Study|Withdrawal by Subject|22|||
164655571|NCT03567057|594764848|FG001|Overall Study|Withdrawal by Subject|24|||
164655572|NCT03567057|594764849|FG002|Overall Study|Withdrawal by Subject|13|||
164655573|NCT03567057|594764847|FG000|Overall Study|Lost to Follow-up|3|||
164655574|NCT03567057|594764848|FG001|Overall Study|Lost to Follow-up|5|||
164655575|NCT03567057|594764849|FG002|Overall Study|Lost to Follow-up|2|||
164655576|NCT03567057|594764847|FG000|Overall Study|COVID-19 pandemic|4|||
164655577|NCT03567057|594764848|FG001|Overall Study|COVID-19 pandemic|3|||
164655578|NCT03567057|594764849|FG002|Overall Study|COVID-19 pandemic|0|||
164655579|NCT03567057|594764847|FG000|Overall Study|Non-compliance with study drug|4|||
164655580|NCT03567057|594764848|FG001|Overall Study|Non-compliance with study drug|2|||
164655581|NCT03567057|594764849|FG002|Overall Study|Non-compliance with study drug|0|||
164655582|NCT03567057|594764847|FG000|Overall Study|Lack of Efficacy|3|||
164655583|NCT03567057|594764848|FG001|Overall Study|Lack of Efficacy|0|||
164655584|NCT03567057|594764849|FG002|Overall Study|Lack of Efficacy|1|||
164655585|NCT03567057|594764847|FG000|Overall Study|Death|1|||
164655586|NCT03567057|594764848|FG001|Overall Study|Death|0|||
164655587|NCT03567057|594764849|FG002|Overall Study|Death|0|||
164655588|NCT03567057|594764847|FG000|Overall Study|Physician Decision|1|||
164655589|NCT03567057|594764848|FG001|Overall Study|Physician Decision|0|||
164655590|NCT03567057|594764849|FG002|Overall Study|Physician Decision|0|||
164655591|NCT03567057|594764847|FG000|Overall Study|Unstable medical condition|1|||
164198633|NCT03904693|593097684|FG002|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
164655592|NCT03567057|594764848|FG001|Overall Study|Unstable medical condition|0|||
164655593|NCT03567057|594764849|FG002|Overall Study|Unstable medical condition|0|||
164655594|NCT03567057|594764847|FG000|Overall Study|Medical history event|0|||
164655595|NCT03567057|594764848|FG001|Overall Study|Medical history event|0|||
164198634|NCT03904693|593097685|FG003|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|2|||
164198635|NCT03904693|593097686|FG004|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|4|||
164198636|NCT03904693|593097687|FG005|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|7|||
164198637|NCT03904693|593097682|FG000|OL Treatment Period (Week 17 to Week189)|Death|0|||
164198638|NCT03904693|593097683|FG001|OL Treatment Period (Week 17 to Week189)|Death|0|||
164198639|NCT03904693|593097684|FG002|OL Treatment Period (Week 17 to Week189)|Death|0|||
164198640|NCT03904693|593097685|FG003|OL Treatment Period (Week 17 to Week189)|Death|0|||
164198641|NCT03904693|593097686|FG004|OL Treatment Period (Week 17 to Week189)|Death|0|||
164198642|NCT03904693|593097687|FG005|OL Treatment Period (Week 17 to Week189)|Death|5|||
164198643|NCT03904693|593097682|FG000|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
164198644|NCT03904693|593097683|FG001|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
164198645|NCT03904693|593097684|FG002|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
164198646|NCT03904693|593097685|FG003|OL Treatment Period (Week 17 to Week189)|Adverse Event|2|||
164198647|NCT03904693|593097686|FG004|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
164198648|NCT03904693|593097687|FG005|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
164198649|NCT03904693|593097682|FG000|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
164198650|NCT03904693|593097683|FG001|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
164198651|NCT03904693|593097684|FG002|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
164198652|NCT03904693|593097685|FG003|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|1|||
164198653|NCT03904693|593097686|FG004|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
164198654|NCT03904693|593097687|FG005|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
164198655|NCT03904693|593097682|FG000|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
164198656|NCT03904693|593097683|FG001|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
164198657|NCT03904693|593097684|FG002|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
164198658|NCT03904693|593097685|FG003|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
164198659|NCT03904693|593097686|FG004|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
164198660|NCT03904693|593097687|FG005|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|1|||
164198661|NCT03904693|593097682|FG000|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
164198662|NCT03904693|593097683|FG001|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
164198663|NCT03904693|593097684|FG002|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
164198664|NCT03904693|593097685|FG003|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
164198665|NCT03904693|593097686|FG004|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|1|||
164198666|NCT03904693|593097687|FG005|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
164198667|NCT03904693|593097682|FG000|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
164198668|NCT03904693|593097683|FG001|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
164198669|NCT03904693|593097684|FG002|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
164198670|NCT03904693|593097685|FG003|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
164198671|NCT03904693|593097686|FG004|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
164198672|NCT03904693|593097687|FG005|OL Treatment Period (Week 17 to Week189)|Technical problems|1|||
164198673|NCT03904693|593097682|FG000|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
164198674|NCT03904693|593097683|FG001|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
164198675|NCT03904693|593097684|FG002|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
164198676|NCT03904693|593097685|FG003|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
164198677|NCT03904693|593097686|FG004|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
164198678|NCT03904693|593097687|FG005|OL Treatment Period (Week 17 to Week189)|Family problems|1|||
164198679|NCT01172873|593097689|FG000|Overall Study|Withdrawal by Subject|3|||
164198680|NCT01172873|593097690|FG001|Overall Study|Withdrawal by Subject|2|||
164198681|NCT05518539|593097691|FG000|Overall Study|Lost to Follow-up|6|||
164198682|NCT04613518|593097697|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
164198683|NCT04613518|593097698|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
164198684|NCT04613518|593097699|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
164198685|NCT04613518|593097697|FG000|Double-Blind Treatment Period|Adverse Event|2|||
164198686|NCT04613518|593097698|FG001|Double-Blind Treatment Period|Adverse Event|0|||
164198687|NCT04613518|593097699|FG002|Double-Blind Treatment Period|Adverse Event|1|||
164198688|NCT04613518|593097697|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
164198689|NCT04613518|593097698|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
164198690|NCT04613518|593097699|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
164198691|NCT04613518|593097697|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
164198692|NCT04613518|593097698|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
164198693|NCT04613518|593097699|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
164198694|NCT04613518|593097697|FG000|Double-Blind Treatment Period|Other Reasons|2|||
164198695|NCT04613518|593097698|FG001|Double-Blind Treatment Period|Other Reasons|0|||
164198696|NCT04613518|593097699|FG002|Double-Blind Treatment Period|Other Reasons|0|||
164655596|NCT03567057|594764849|FG002|Overall Study|Medical history event|1|||
164655597|NCT03567057|594764847|FG000|Overall Study|Other|0|||
164655598|NCT03567057|594764848|FG001|Overall Study|Other|0|||
164655599|NCT03567057|594764849|FG002|Overall Study|Other|1|||
164655600|NCT01271933|594764850|FG000|Single-Blind Phase|Lack of Efficacy|37|||
164655601|NCT01271933|594764851|FG001|Single-Blind Phase|Lack of Efficacy|0|||
164655602|NCT01271933|594764852|FG002|Single-Blind Phase|Lack of Efficacy|0|||
164655603|NCT01271933|594764850|FG000|Single-Blind Phase|Lost to Follow-up|10|||
164655604|NCT01271933|594764851|FG001|Single-Blind Phase|Lost to Follow-up|0|||
164655605|NCT01271933|594764852|FG002|Single-Blind Phase|Lost to Follow-up|0|||
164655606|NCT01271933|594764850|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
164655607|NCT01271933|594764851|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
164655608|NCT01271933|594764852|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
164655609|NCT01271933|594764850|FG000|Single-Blind Phase|Protocol Violation|3|||
164655610|NCT01271933|594764851|FG001|Single-Blind Phase|Protocol Violation|0|||
164655611|NCT01271933|594764852|FG002|Single-Blind Phase|Protocol Violation|0|||
164655612|NCT01271933|594764850|FG000|Single-Blind Phase|Adverse Event|52|||
164655613|NCT01271933|594764851|FG001|Single-Blind Phase|Adverse Event|0|||
164655614|NCT01271933|594764852|FG002|Single-Blind Phase|Adverse Event|0|||
164655615|NCT01271933|594764850|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
164655616|NCT01271933|594764851|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
164655617|NCT01271933|594764852|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
164655618|NCT01271933|594764850|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
164655619|NCT01271933|594764851|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
164655620|NCT01271933|594764852|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
164655621|NCT01271933|594764850|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
164655622|NCT01271933|594764851|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
164655623|NCT01271933|594764852|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
164655624|NCT01271933|594764850|FG000|Double-Blind Phase|Randomized but not treated|0|||
164550212|NCT00705783|594387195|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
164550213|NCT00705783|594387193|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
164550214|NCT00705783|594387194|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
164550215|NCT00705783|594387195|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
164550216|NCT00705783|594387193|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
164550217|NCT00705783|594387194|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
164550218|NCT00705783|594387195|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
164550219|NCT00705783|594387193|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
164550220|NCT00705783|594387194|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
164550221|NCT00705783|594387195|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
164550222|NCT00705783|594387193|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
164550223|NCT00705783|594387194|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
164550224|NCT00705783|594387195|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
164550225|NCT00705783|594387193|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
164550226|NCT00705783|594387194|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
164550227|NCT00705783|594387195|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
164550228|NCT00705783|594387193|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
164550229|NCT00705783|594387194|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
164550230|NCT00705783|594387195|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
164550231|NCT00705783|594387193|FG000|Depot Stabilization Phase|Adverse Event|17|||
164550232|NCT00705783|594387194|FG001|Depot Stabilization Phase|Adverse Event|0|||
164550233|NCT00705783|594387195|FG002|Depot Stabilization Phase|Adverse Event|0|||
164550234|NCT00705783|594387193|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
164550235|NCT00705783|594387194|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
164550236|NCT00705783|594387195|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
164550237|NCT00705783|594387193|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
164550238|NCT00705783|594387194|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
164550239|NCT00705783|594387195|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
164550240|NCT00705783|594387193|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
164550241|NCT00705783|594387194|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
164550242|NCT00705783|594387195|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
164550243|NCT00705783|594387193|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
164550244|NCT00705783|594387194|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
164655625|NCT01271933|594764851|FG001|Double-Blind Phase|Randomized but not treated|0|||
164655626|NCT01271933|594764852|FG002|Double-Blind Phase|Randomized but not treated|1|||
164655627|NCT01271933|594764850|FG000|Double-Blind Phase|Lack of Efficacy|0|||
164655628|NCT01271933|594764851|FG001|Double-Blind Phase|Lack of Efficacy|6|||
164655629|NCT01271933|594764852|FG002|Double-Blind Phase|Lack of Efficacy|9|||
164655630|NCT01271933|594764850|FG000|Double-Blind Phase|Lost to Follow-up|0|||
164655631|NCT01271933|594764851|FG001|Double-Blind Phase|Lost to Follow-up|1|||
164655632|NCT01271933|594764852|FG002|Double-Blind Phase|Lost to Follow-up|1|||
164550245|NCT00705783|594387195|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
164550246|NCT00705783|594387193|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
164550247|NCT00705783|594387194|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
164550248|NCT00705783|594387195|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
164550249|NCT00705783|594387193|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
164550250|NCT00705783|594387194|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
164550251|NCT00705783|594387195|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
164550252|NCT00705783|594387193|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
164550253|NCT00705783|594387194|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
164550254|NCT00705783|594387195|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
164550255|NCT00705783|594387193|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
164550256|NCT00705783|594387194|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
164550257|NCT00705783|594387195|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
164550258|NCT00705783|594387193|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
164550259|NCT00705783|594387194|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
164550260|NCT00705783|594387195|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
164198697|NCT04613518|593097697|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
164198698|NCT04613518|593097698|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
164198699|NCT04613518|593097699|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
164198700|NCT04613518|593097697|FG000|Open-Label Treatment Period|Adverse Event|1|||
164198701|NCT04613518|593097698|FG001|Open-Label Treatment Period|Adverse Event|0|||
164198702|NCT04613518|593097699|FG002|Open-Label Treatment Period|Adverse Event|3|||
164198703|NCT04613518|593097697|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
164198704|NCT04613518|593097698|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
164198705|NCT04613518|593097699|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
164198706|NCT04613518|593097697|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
164198707|NCT04613518|593097698|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
164198708|NCT04613518|593097699|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
164198709|NCT04613518|593097697|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
164198710|NCT04613518|593097698|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
164198711|NCT04613518|593097699|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
164198712|NCT04613518|593097697|FG000|Open-Label Treatment Period|Other reasons|1|||
164198713|NCT04613518|593097698|FG001|Open-Label Treatment Period|Other reasons|0|||
164198714|NCT04613518|593097699|FG002|Open-Label Treatment Period|Other reasons|0|||
164198715|NCT03589807|593097700|FG000|Overall Study|Lost to Follow-up|0|||
164198716|NCT03589807|593097701|FG001|Overall Study|Lost to Follow-up|2|||
164198717|NCT03589807|593097702|FG002|Overall Study|Lost to Follow-up|2|||
164198718|NCT03589807|593097703|FG003|Overall Study|Lost to Follow-up|3|||
164198719|NCT03589807|593097704|FG004|Overall Study|Lost to Follow-up|1|||
164198720|NCT03589807|593097705|FG005|Overall Study|Lost to Follow-up|1|||
164198721|NCT03589807|593097700|FG000|Overall Study|Withdrawal by Subject|0|||
164198722|NCT03589807|593097701|FG001|Overall Study|Withdrawal by Subject|5|||
164198723|NCT03589807|593097702|FG002|Overall Study|Withdrawal by Subject|0|||
164198724|NCT03589807|593097703|FG003|Overall Study|Withdrawal by Subject|0|||
164198725|NCT03589807|593097704|FG004|Overall Study|Withdrawal by Subject|0|||
164198726|NCT03589807|593097705|FG005|Overall Study|Withdrawal by Subject|0|||
164198727|NCT03589807|593097700|FG000|Overall Study|Protocol Violation|0|||
164198728|NCT03589807|593097701|FG001|Overall Study|Protocol Violation|0|||
164198729|NCT03589807|593097702|FG002|Overall Study|Protocol Violation|0|||
164198730|NCT03589807|593097703|FG003|Overall Study|Protocol Violation|1|||
164198731|NCT03589807|593097704|FG004|Overall Study|Protocol Violation|0|||
164198732|NCT03589807|593097705|FG005|Overall Study|Protocol Violation|0|||
164198733|NCT03589807|593097700|FG000|Overall Study|Enrolled but treatment not administered|0|||
164198734|NCT03589807|593097701|FG001|Overall Study|Enrolled but treatment not administered|0|||
164198735|NCT03589807|593097702|FG002|Overall Study|Enrolled but treatment not administered|0|||
164198736|NCT03589807|593097703|FG003|Overall Study|Enrolled but treatment not administered|0|||
164198737|NCT03589807|593097704|FG004|Overall Study|Enrolled but treatment not administered|1|||
164198738|NCT03589807|593097705|FG005|Overall Study|Enrolled but treatment not administered|0|||
164198739|NCT01076543|593097706|FG000|Overall Study|Withdrawal by Subject|2|||
164198740|NCT01076543|593097707|FG001|Overall Study|Withdrawal by Subject|0|||
164198741|NCT01076543|593097708|FG002|Overall Study|Withdrawal by Subject|0|||
164198742|NCT01076543|593097709|FG003|Overall Study|Withdrawal by Subject|0|||
164198743|NCT01076543|593097710|FG004|Overall Study|Withdrawal by Subject|0|||
164198744|NCT01076543|593097711|FG005|Overall Study|Withdrawal by Subject|0|||
164198745|NCT00338741|593097712|FG000|Overall Study|Lost to Follow-up|2|||
164198746|NCT00338741|593097713|FG001|Overall Study|Lost to Follow-up|0|||
164198747|NCT01534273|593097714|FG000|Period 1|Physician Decision|0|||
164198748|NCT01534273|593097715|FG001|Period 1|Physician Decision|0|||
164550261|NCT00705783|594387193|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
164550262|NCT00705783|594387194|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
164198749|NCT01534273|593097716|FG002|Period 1|Physician Decision|0|||
164198750|NCT01534273|593097717|FG003|Period 1|Physician Decision|1|||
164198751|NCT01534273|593097718|FG004|Period 1|Physician Decision|0|||
164198752|NCT01534273|593097719|FG005|Period 1|Physician Decision|0|||
164198753|NCT01534273|593097720|FG006|Period 1|Physician Decision|0|||
164198754|NCT01619865|593097721|FG000|Overall Study|Adverse Event|1|||
164198755|NCT01619865|593097721|FG000|Overall Study|Death|2|||
164198756|NCT01619865|593097721|FG000|Overall Study|subject not able to comply|1|||
164198757|NCT03586050|593097722|FG000|Overall Study|Death|3|||
164198758|NCT03586050|593097722|FG000|Overall Study|Withdrawal by Subject|2|||
164198759|NCT01494818|593097723|FG000|Overall Study|Relocation|1|||
164198760|NCT01494818|593097724|FG001|Overall Study|Relocation|2|||
164198761|NCT01494818|593097723|FG000|Overall Study|Lost to Follow-up|1|||
164198762|NCT01494818|593097724|FG001|Overall Study|Lost to Follow-up|0|||
164198763|NCT04831138|593097725|FG000|Overall Study|Lost to Follow-up|2|||
164198764|NCT04831138|593097726|FG001|Overall Study|Lost to Follow-up|0|||
164198765|NCT00791999|593097727|FG000|Overall Study|Protocol planed withdrawal|14|||
164198766|NCT00791999|593097728|FG001|Overall Study|Protocol planed withdrawal|11|||
164198767|NCT00791999|593097729|FG002|Overall Study|Protocol planed withdrawal|11|||
164198768|NCT00791999|593097730|FG003|Overall Study|Protocol planed withdrawal|45|||
164198769|NCT00791999|593097727|FG000|Overall Study|Withdrawal by Subject|0|||
164307255|NCT02023697|593499224|FG001|Long-term Follow-up Period|Other unspecified|3|||
164550263|NCT00705783|594387195|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
164550264|NCT00705783|594387193|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
164550265|NCT00705783|594387194|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
164550266|NCT00705783|594387195|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
164550267|NCT02182687|594387196|FG000|Overall Study|Withdrawal by Subject|4|||
164550268|NCT02182687|594387197|FG001|Overall Study|Withdrawal by Subject|0|||
164550269|NCT02182687|594387196|FG000|Overall Study|Adverse Event|1|||
164550270|NCT02182687|594387197|FG001|Overall Study|Adverse Event|0|||
164550271|NCT02182687|594387196|FG000|Overall Study|Lost to Follow-up|0|||
164550272|NCT02182687|594387197|FG001|Overall Study|Lost to Follow-up|1|||
164550273|NCT04251910|594387201|FG000|Overall Study|Covid 19 lockdown|0|||
164550274|NCT04251910|594387202|FG001|Overall Study|Covid 19 lockdown|5|||
164550275|NCT04251910|594387203|FG002|Overall Study|Covid 19 lockdown|0|||
164550276|NCT04251910|594387204|FG003|Overall Study|Covid 19 lockdown|4|||
164550277|NCT04251910|594387205|FG004|Overall Study|Covid 19 lockdown|0|||
164550278|NCT04251910|594387206|FG005|Overall Study|Covid 19 lockdown|0|||
164550279|NCT04251910|594387201|FG000|Overall Study|Assisted living facility was closed|0|||
164550280|NCT04251910|594387202|FG001|Overall Study|Assisted living facility was closed|0|||
164550281|NCT04251910|594387203|FG002|Overall Study|Assisted living facility was closed|0|||
164550282|NCT04251910|594387204|FG003|Overall Study|Assisted living facility was closed|0|||
164550283|NCT04251910|594387205|FG004|Overall Study|Assisted living facility was closed|1|||
164550284|NCT04251910|594387206|FG005|Overall Study|Assisted living facility was closed|0|||
164550285|NCT03451084|594387214|FG000|Overall Study|Withdrawal by Subject|2|||
164550286|NCT03451084|594387215|FG001|Overall Study|Withdrawal by Subject|1|||
164550287|NCT03451084|594387216|FG002|Overall Study|Withdrawal by Subject|2|||
164550288|NCT03451084|594387217|FG003|Overall Study|Withdrawal by Subject|1|||
164550289|NCT03451084|594387214|FG000|Overall Study|Disease recurrence|0|||
164550290|NCT03451084|594387215|FG001|Overall Study|Disease recurrence|2|||
164550291|NCT03451084|594387216|FG002|Overall Study|Disease recurrence|0|||
164550292|NCT03451084|594387217|FG003|Overall Study|Disease recurrence|0|||
164550293|NCT03451084|594387214|FG000|Overall Study|Lack of Efficacy|0|||
164550294|NCT03451084|594387215|FG001|Overall Study|Lack of Efficacy|3|||
164550295|NCT03451084|594387216|FG002|Overall Study|Lack of Efficacy|0|||
164550296|NCT03451084|594387217|FG003|Overall Study|Lack of Efficacy|1|||
164550297|NCT03451084|594387214|FG000|Overall Study|Death|1|||
164550298|NCT03451084|594387215|FG001|Overall Study|Death|0|||
164550299|NCT03451084|594387216|FG002|Overall Study|Death|2|||
164550300|NCT03451084|594387217|FG003|Overall Study|Death|0|||
164550301|NCT03451084|594387214|FG000|Overall Study|Physician Decision|0|||
164550302|NCT03451084|594387215|FG001|Overall Study|Physician Decision|0|||
164550303|NCT03451084|594387216|FG002|Overall Study|Physician Decision|2|||
164550304|NCT03451084|594387217|FG003|Overall Study|Physician Decision|2|||
164550305|NCT03451084|594387214|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
164550306|NCT03451084|594387215|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
164550307|NCT03451084|594387216|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
164550308|NCT03451084|594387217|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
164550309|NCT04544475|594387222|FG000|Overall Study|Withdrawal by Subject|1|||
164550310|NCT04544475|594387223|FG001|Overall Study|Withdrawal by Subject|3|||
164550311|NCT01765920|594387224|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
164550312|NCT01765920|594387225|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
164550313|NCT01765920|594387224|FG000|Overall Study|Patient code disclosure|0|||
164550314|NCT01765920|594387225|FG001|Overall Study|Patient code disclosure|1|||
164550315|NCT03223428|594387226|FG000|Overall Study|No longer taking Xermelo|27|||
164550316|NCT03223428|594387226|FG000|Overall Study|Declined Consent|1|||
164198770|NCT00791999|593097728|FG001|Overall Study|Withdrawal by Subject|1|||
164655633|NCT01271933|594764850|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
164655634|NCT01271933|594764851|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
164655635|NCT01271933|594764852|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
164655636|NCT01271933|594764850|FG000|Double-Blind Phase|Adverse Event|0|||
164655637|NCT01271933|594764851|FG001|Double-Blind Phase|Adverse Event|3|||
164655638|NCT01271933|594764852|FG002|Double-Blind Phase|Adverse Event|0|||
164655639|NCT01271933|594764850|FG000|Double-Blind Phase|Participant request-personal reason|0|||
164655640|NCT01271933|594764851|FG001|Double-Blind Phase|Participant request-personal reason|1|||
164655641|NCT01271933|594764852|FG002|Double-Blind Phase|Participant request-personal reason|0|||
164307256|NCT02023697|593499225|FG002|Long-term Follow-up Period|Other unspecified|5|||
164307257|NCT00541385|593499226|FG000|Overall Study|Adverse Event|6|||
164307258|NCT00541385|593499227|FG001|Overall Study|Adverse Event|3|||
164307259|NCT00541385|593499226|FG000|Overall Study|Withdrawal by Subject|2|||
164307260|NCT00541385|593499227|FG001|Overall Study|Withdrawal by Subject|2|||
164307261|NCT00541385|593499226|FG000|Overall Study|Lost to Follow-up|6|||
164307262|NCT00541385|593499227|FG001|Overall Study|Lost to Follow-up|1|||
164307263|NCT00541385|593499226|FG000|Overall Study|Parasite reappearance/malaria|67|||
164655642|NCT00591253|594764855|FG000|Overall Study|Adverse Event|3|||
164655643|NCT00591253|594764856|FG001|Overall Study|Adverse Event|3|||
164655644|NCT00591253|594764857|FG002|Overall Study|Adverse Event|1|||
164655645|NCT00591253|594764855|FG000|Overall Study|Protocol Violation|2|||
164655646|NCT00591253|594764856|FG001|Overall Study|Protocol Violation|2|||
164655647|NCT00591253|594764857|FG002|Overall Study|Protocol Violation|2|||
164655648|NCT00591253|594764855|FG000|Overall Study|Lost to Follow-up|2|||
164655649|NCT00591253|594764856|FG001|Overall Study|Lost to Follow-up|4|||
164655650|NCT00591253|594764857|FG002|Overall Study|Lost to Follow-up|0|||
164655651|NCT00591253|594764855|FG000|Overall Study|Withdrawal by Subject|1|||
164655652|NCT00591253|594764856|FG001|Overall Study|Withdrawal by Subject|7|||
164655653|NCT00591253|594764857|FG002|Overall Study|Withdrawal by Subject|6|||
164655654|NCT00591253|594764855|FG000|Overall Study|Lack of Efficacy|1|||
164655655|NCT00591253|594764856|FG001|Overall Study|Lack of Efficacy|0|||
164655656|NCT00591253|594764857|FG002|Overall Study|Lack of Efficacy|3|||
164655657|NCT00591253|594764855|FG000|Overall Study|Other|5|||
164655658|NCT00591253|594764856|FG001|Overall Study|Other|5|||
164655659|NCT00591253|594764857|FG002|Overall Study|Other|3|||
164655660|NCT01783730|594764861|FG000|Overall Study|Failed to meet inclusion criteria|6|||
164655661|NCT01841359|594764862|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
164655662|NCT01841359|594764862|FG000|Overall Study|Concommitant medical issues|2|||
164655663|NCT01841359|594764862|FG000|Overall Study|Adverse Event|3|||
164655664|NCT01841359|594764862|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
164655665|NCT00871169|594764863|FG000|Overall Study|Protocol Violation|1|||
164655666|NCT00871169|594764863|FG000|Overall Study|Patient did not receive study treatment|2|||
164655667|NCT01752920|594764866|FG000|Overall Study|Adverse Event|1|||
164655668|NCT01752920|594764867|FG001|Overall Study|Adverse Event|0|||
164655669|NCT01752920|594764868|FG002|Overall Study|Adverse Event|5|||
164655670|NCT01752920|594764869|FG003|Overall Study|Adverse Event|10|||
164655671|NCT01752920|594764866|FG000|Overall Study|Clinical Disease Progression|6|||
164655672|NCT01752920|594764867|FG001|Overall Study|Clinical Disease Progression|4|||
164655673|NCT01752920|594764868|FG002|Overall Study|Clinical Disease Progression|1|||
164655674|NCT01752920|594764869|FG003|Overall Study|Clinical Disease Progression|13|||
164655675|NCT01752920|594764866|FG000|Overall Study|Physician Decision|1|||
164655676|NCT01752920|594764867|FG001|Overall Study|Physician Decision|0|||
164655677|NCT01752920|594764868|FG002|Overall Study|Physician Decision|0|||
164655678|NCT01752920|594764869|FG003|Overall Study|Physician Decision|3|||
164655679|NCT01752920|594764866|FG000|Overall Study|Radiographic Disease Progression|20|||
164655680|NCT01752920|594764867|FG001|Overall Study|Radiographic Disease Progression|7|||
164655681|NCT01752920|594764868|FG002|Overall Study|Radiographic Disease Progression|12|||
164655682|NCT01752920|594764869|FG003|Overall Study|Radiographic Disease Progression|29|||
164655683|NCT01752920|594764866|FG000|Overall Study|Study Terminated by Sponsor|0|||
164655684|NCT01752920|594764867|FG001|Overall Study|Study Terminated by Sponsor|0|||
164655685|NCT01752920|594764868|FG002|Overall Study|Study Terminated by Sponsor|0|||
164655686|NCT01752920|594764869|FG003|Overall Study|Study Terminated by Sponsor|1|||
164655687|NCT01752920|594764866|FG000|Overall Study|Withdrawal by Subject|0|||
164655688|NCT01752920|594764867|FG001|Overall Study|Withdrawal by Subject|1|||
164307264|NCT00541385|593499227|FG001|Overall Study|Parasite reappearance/malaria|32|||
164307265|NCT01469377|593499228|FG000|Overall Study|Protocol Deviation|7|||
164307266|NCT01469377|593499229|FG001|Overall Study|Protocol Deviation|10|||
164307267|NCT01469377|593499230|FG002|Overall Study|Protocol Deviation|10|||
164307268|NCT01469377|593499228|FG000|Overall Study|Lost to Follow-up|3|||
164307269|NCT01469377|593499229|FG001|Overall Study|Lost to Follow-up|2|||
164307270|NCT01469377|593499230|FG002|Overall Study|Lost to Follow-up|5|||
164307271|NCT01469377|593499228|FG000|Overall Study|Withdrawal of Consent|12|||
164307272|NCT01469377|593499229|FG001|Overall Study|Withdrawal of Consent|14|||
164307273|NCT01469377|593499230|FG002|Overall Study|Withdrawal of Consent|15|||
164307274|NCT01469377|593499228|FG000|Overall Study|Adverse Event|8|||
164307275|NCT01469377|593499229|FG001|Overall Study|Adverse Event|18|||
164655689|NCT01752920|594764868|FG002|Overall Study|Withdrawal by Subject|0|||
164655690|NCT01752920|594764869|FG003|Overall Study|Withdrawal by Subject|1|||
164655691|NCT01752920|594764866|FG000|Overall Study|Lack of clinical benefit|1|||
164655692|NCT01752920|594764867|FG001|Overall Study|Lack of clinical benefit|1|||
164655693|NCT01752920|594764868|FG002|Overall Study|Lack of clinical benefit|1|||
164655694|NCT01752920|594764869|FG003|Overall Study|Lack of clinical benefit|1|||
164655695|NCT00771901|594764872|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
164655696|NCT00771901|594764873|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
164655697|NCT00771901|594764874|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
164655698|NCT01328054|594764877|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
164655699|NCT01328054|594764878|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
164655700|NCT01328054|594764877|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
164655701|NCT01328054|594764878|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
164655702|NCT01328054|594764877|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
164655703|NCT01328054|594764878|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
164655704|NCT03443869|594764879|FG000|Overall Study|Death|3|||
164198771|NCT00791999|593097729|FG002|Overall Study|Withdrawal by Subject|0|||
164198772|NCT00791999|593097730|FG003|Overall Study|Withdrawal by Subject|2|||
164198773|NCT00791999|593097727|FG000|Overall Study|Protocol Violation|3|||
164198774|NCT00791999|593097728|FG001|Overall Study|Protocol Violation|0|||
164198775|NCT00791999|593097729|FG002|Overall Study|Protocol Violation|1|||
164198776|NCT00791999|593097730|FG003|Overall Study|Protocol Violation|0|||
164198777|NCT00791999|593097727|FG000|Overall Study|Adverse Event|3|||
164198778|NCT00791999|593097728|FG001|Overall Study|Adverse Event|3|||
164198779|NCT00791999|593097729|FG002|Overall Study|Adverse Event|7|||
164198780|NCT00791999|593097730|FG003|Overall Study|Adverse Event|3|||
164198781|NCT00791999|593097727|FG000|Overall Study|Lack of Efficacy|0|||
164198782|NCT00791999|593097728|FG001|Overall Study|Lack of Efficacy|1|||
164198783|NCT00791999|593097729|FG002|Overall Study|Lack of Efficacy|0|||
164198784|NCT00791999|593097730|FG003|Overall Study|Lack of Efficacy|2|||
164198785|NCT00791999|593097727|FG000|Overall Study|Reason other than those above|1|||
164198786|NCT00791999|593097728|FG001|Overall Study|Reason other than those above|0|||
164198787|NCT00791999|593097729|FG002|Overall Study|Reason other than those above|1|||
164198788|NCT00791999|593097730|FG003|Overall Study|Reason other than those above|0|||
164198789|NCT02688933|593097733|FG000|Overall Study|Adverse Event|3|||
164198790|NCT02688933|593097734|FG001|Overall Study|Adverse Event|1|||
164198791|NCT02688933|593097733|FG000|Overall Study|Lack of Efficacy|2|||
164198792|NCT02688933|593097734|FG001|Overall Study|Lack of Efficacy|2|||
164198793|NCT02688933|593097733|FG000|Overall Study|Poor compliance to protocol|7|||
164198794|NCT02688933|593097734|FG001|Overall Study|Poor compliance to protocol|4|||
164198795|NCT02688933|593097733|FG000|Overall Study|Hypoglycemia|2|||
164198796|NCT02688933|593097734|FG001|Overall Study|Hypoglycemia|0|||
164198797|NCT02688933|593097733|FG000|Overall Study|Other than Specified|14|||
164198798|NCT02688933|593097734|FG001|Overall Study|Other than Specified|25|||
164198799|NCT02688933|593097733|FG000|Overall Study|Lost to Follow-up|1|||
164198800|NCT02688933|593097734|FG001|Overall Study|Lost to Follow-up|5|||
164198801|NCT03509467|593097735|FG000|Overall Study|Withdrawal by Subject|5|||
164198802|NCT03509467|593097736|FG001|Overall Study|Withdrawal by Subject|1|||
164198803|NCT03509467|593097737|FG002|Overall Study|Withdrawal by Subject|6|||
164198804|NCT03509467|593097738|FG003|Overall Study|Withdrawal by Subject|7|||
164198805|NCT03509467|593097739|FG004|Overall Study|Withdrawal by Subject|10|||
164198806|NCT03509467|593097740|FG005|Overall Study|Withdrawal by Subject|10|||
164198807|NCT03509467|593097741|FG006|Overall Study|Withdrawal by Subject|10|||
164198808|NCT03509467|593097742|FG007|Overall Study|Withdrawal by Subject|10|||
164198809|NCT03509467|593097735|FG000|Overall Study|Death|0|||
164198810|NCT03509467|593097736|FG001|Overall Study|Death|0|||
164198811|NCT03509467|593097737|FG002|Overall Study|Death|2|||
164198812|NCT03509467|593097738|FG003|Overall Study|Death|2|||
164198813|NCT03509467|593097739|FG004|Overall Study|Death|1|||
164198814|NCT03509467|593097740|FG005|Overall Study|Death|0|||
164198815|NCT03509467|593097741|FG006|Overall Study|Death|1|||
164198816|NCT03509467|593097742|FG007|Overall Study|Death|0|||
164198817|NCT03509467|593097735|FG000|Overall Study|Proxy Withdrawal|0|||
164198818|NCT03509467|593097736|FG001|Overall Study|Proxy Withdrawal|0|||
164198819|NCT03509467|593097737|FG002|Overall Study|Proxy Withdrawal|0|||
164655705|NCT03443869|594764880|FG001|Overall Study|Death|3|||
164198820|NCT03509467|593097738|FG003|Overall Study|Proxy Withdrawal|0|||
164198821|NCT03509467|593097739|FG004|Overall Study|Proxy Withdrawal|0|||
164198822|NCT03509467|593097740|FG005|Overall Study|Proxy Withdrawal|0|||
164198823|NCT03509467|593097741|FG006|Overall Study|Proxy Withdrawal|0|||
164198824|NCT03509467|593097742|FG007|Overall Study|Proxy Withdrawal|1|||
164198825|NCT04275973|593097745|FG000|Overall Study|Withdrawal by Subject|2|||
164198826|NCT04275973|593097746|FG001|Overall Study|Withdrawal by Subject|1|||
164198827|NCT06110754|593097747|FG000|Overall Study|Withdrawal by Subject|0|||
164198828|NCT06110754|593097748|FG001|Overall Study|Withdrawal by Subject|0|||
164198829|NCT06110754|593097749|FG002|Overall Study|Withdrawal by Subject|1|||
164198830|NCT06110754|593097750|FG003|Overall Study|Withdrawal by Subject|0|||
164307276|NCT01469377|593499230|FG002|Overall Study|Adverse Event|36|||
164307277|NCT01469377|593499228|FG000|Overall Study|Insufficient Therapeutic Response|3|||
164307278|NCT01469377|593499229|FG001|Overall Study|Insufficient Therapeutic Response|4|||
164307279|NCT01469377|593499230|FG002|Overall Study|Insufficient Therapeutic Response|0|||
164307280|NCT01469377|593499228|FG000|Overall Study|Other Miscellaneous Reasons|2|||
164307281|NCT01469377|593499229|FG001|Overall Study|Other Miscellaneous Reasons|0|||
164307282|NCT01469377|593499230|FG002|Overall Study|Other Miscellaneous Reasons|0|||
164307283|NCT01733680|593499231|FG000|Overall Study|Withdrawal by Subject|0|||
164307284|NCT01733680|593499232|FG001|Overall Study|Withdrawal by Subject|1|||
164307285|NCT04139798|593499235|FG000|Overall Study|Withdrawal by Subject|6|||
164307286|NCT04139798|593499236|FG001|Overall Study|Withdrawal by Subject|5|||
164307287|NCT04139798|593499235|FG000|Overall Study|Lost to Follow-up|2|||
164307288|NCT04139798|593499236|FG001|Overall Study|Lost to Follow-up|5|||
164307289|NCT04139798|593499235|FG000|Overall Study|Discontinued|4|||
164655706|NCT03443869|594764879|FG000|Overall Study|Withdrawal by Subject|34|||
164655707|NCT03443869|594764880|FG001|Overall Study|Withdrawal by Subject|22|||
164655708|NCT03443869|594764879|FG000|Overall Study|Lost to Follow-up|1|||
164655709|NCT03443869|594764880|FG001|Overall Study|Lost to Follow-up|2|||
164655710|NCT03443869|594764879|FG000|Overall Study|Physician Decision|3|||
164655711|NCT03443869|594764880|FG001|Overall Study|Physician Decision|3|||
164655712|NCT03443869|594764879|FG000|Overall Study|Other|4|||
164655713|NCT03443869|594764880|FG001|Overall Study|Other|4|||
164655714|NCT02390219|594764881|FG000|Overall Study|Death|1|||
164307290|NCT04139798|593499236|FG001|Overall Study|Discontinued|2|||
164307291|NCT04139798|593499235|FG000|Overall Study|Adverse Event|1|||
164307292|NCT04139798|593499236|FG001|Overall Study|Adverse Event|3|||
164307293|NCT04139798|593499235|FG000|Overall Study|Protocol Violation|1|||
164307294|NCT04139798|593499236|FG001|Overall Study|Protocol Violation|0|||
164307295|NCT02839200|593499237|FG000|Overall Study|Withdrawal by Subject|2|||
164307296|NCT02839200|593499238|FG001|Overall Study|Withdrawal by Subject|0|||
164307297|NCT02839200|593499239|FG002|Overall Study|Withdrawal by Subject|1|||
164307298|NCT02839200|593499240|FG003|Overall Study|Withdrawal by Subject|0|||
164550317|NCT03223428|594387226|FG000|Overall Study|Non-responders|56|||
164655715|NCT02390219|594764881|FG000|Overall Study|Physician Decision|1|||
164655716|NCT02390219|594764881|FG000|Overall Study|Adverse Event|6|||
164655717|NCT02390219|594764881|FG000|Overall Study|Withdrawal by Subject|1|||
164655718|NCT02390219|594764881|FG000|Overall Study|Lost to Follow-up|2|||
164655719|NCT02390219|594764881|FG000|Overall Study|Other|2|||
164655720|NCT01855126|594764882|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
164655721|NCT01855126|594764883|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
164655722|NCT01855126|594764882|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
164655723|NCT01855126|594764883|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
164655724|NCT00931385|594764884|FG000|Overall Study|Adverse Event|2|||
164655725|NCT00931385|594764885|FG001|Overall Study|Adverse Event|1|||
164550318|NCT03223428|594387226|FG000|Overall Study|Withdrawal by Subject|14|||
164550319|NCT00777101|594387230|FG000|Overall Study|Death|48|||
164550320|NCT00777101|594387231|FG001|Overall Study|Death|43|||
164550321|NCT00777101|594387230|FG000|Overall Study|Withdrawal by Subject|11|||
164550322|NCT00777101|594387231|FG001|Overall Study|Withdrawal by Subject|6|||
164550323|NCT00777101|594387230|FG000|Overall Study|Lost to Follow-up|2|||
164550324|NCT00777101|594387231|FG001|Overall Study|Lost to Follow-up|1|||
164550325|NCT00777101|594387230|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
164550326|NCT00777101|594387231|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
164550327|NCT00777101|594387230|FG000|Overall Study|Failed to Return|0|||
164550328|NCT00777101|594387231|FG001|Overall Study|Failed to Return|1|||
164550329|NCT02411539|594387232|FG000|Overall Study|Lost to Follow-up|2|||
164550330|NCT02411539|594387233|FG001|Overall Study|Lost to Follow-up|0|||
164550331|NCT02411539|594387232|FG000|Overall Study|Confounding medical condition|0|||
164550332|NCT02411539|594387233|FG001|Overall Study|Confounding medical condition|1|||
164550333|NCT00282334|594387236|FG000|Overall Study|Withdrawal by Subject|8|||
164550334|NCT00282334|594387237|FG001|Overall Study|Withdrawal by Subject|5|||
164550335|NCT01422915|594387241|FG000|Overall Study|Adverse Event|1|||
164550336|NCT01265797|594387242|FG000|Run-in Month|Withdrawal by Subject|0|||
164550337|NCT01265797|594387243|FG001|Run-in Month|Withdrawal by Subject|4|||
164655726|NCT00931385|594764886|FG002|Overall Study|Adverse Event|0|||
164655727|NCT00931385|594764887|FG003|Overall Study|Adverse Event|3|||
164655728|NCT00931385|594764884|FG000|Overall Study|Protocol Violation|0|||
164655729|NCT00931385|594764885|FG001|Overall Study|Protocol Violation|0|||
164655730|NCT00931385|594764886|FG002|Overall Study|Protocol Violation|1|||
164655731|NCT00931385|594764887|FG003|Overall Study|Protocol Violation|0|||
164655732|NCT00931385|594764884|FG000|Overall Study|Withdrawal by Subject|0|||
164307299|NCT02839200|593499241|FG004|Overall Study|Withdrawal by Subject|0|||
164550338|NCT01265797|594387242|FG000|Run-in Month|1st seizure during run-in month|0|||
164550339|NCT01265797|594387243|FG001|Run-in Month|1st seizure during run-in month|1|||
164307300|NCT02839200|593499242|FG005|Overall Study|Withdrawal by Subject|1|||
164655733|NCT00931385|594764885|FG001|Overall Study|Withdrawal by Subject|1|||
164655734|NCT00931385|594764886|FG002|Overall Study|Withdrawal by Subject|0|||
164655735|NCT00931385|594764887|FG003|Overall Study|Withdrawal by Subject|1|||
164655736|NCT00931385|594764884|FG000|Overall Study|Lost to Follow-up|0|||
164655737|NCT00931385|594764885|FG001|Overall Study|Lost to Follow-up|0|||
164655738|NCT00931385|594764886|FG002|Overall Study|Lost to Follow-up|0|||
164655739|NCT00931385|594764887|FG003|Overall Study|Lost to Follow-up|1|||
164655740|NCT00580983|594764890|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
164655741|NCT01298596|594764893|FG000|Overall Study|Withdrawal by Subject|1|||
164655742|NCT01298596|594764894|FG001|Overall Study|Withdrawal by Subject|1|||
164655743|NCT01298596|594764893|FG000|Overall Study|Death|5|||
164655744|NCT01298596|594764894|FG001|Overall Study|Death|3|||
164655745|NCT01298596|594764893|FG000|Overall Study|Lost to Follow-up|6|||
164655746|NCT01298596|594764894|FG001|Overall Study|Lost to Follow-up|14|||
164655747|NCT01298596|594764893|FG000|Overall Study|Referred for further management|16|||
164655748|NCT01298596|594764894|FG001|Overall Study|Referred for further management|15|||
164655749|NCT01629693|594764895|FG000|Overall Study|Lost to Follow-up|2|||
164655750|NCT01629693|594764896|FG001|Overall Study|Lost to Follow-up|4|||
164655751|NCT01629693|594764895|FG000|Overall Study|Withdrawal by Subject|2|||
164655752|NCT01629693|594764896|FG001|Overall Study|Withdrawal by Subject|2|||
164655753|NCT01629693|594764895|FG000|Overall Study|Adverse Event|1|||
164655754|NCT01629693|594764896|FG001|Overall Study|Adverse Event|0|||
164655755|NCT01629693|594764895|FG000|Overall Study|Investigator decision|0|||
164655756|NCT01629693|594764896|FG001|Overall Study|Investigator decision|1|||
164655757|NCT01629693|594764895|FG000|Overall Study|Poor comfort of study lenses|0|||
164655758|NCT01629693|594764896|FG001|Overall Study|Poor comfort of study lenses|2|||
164655759|NCT01629693|594764895|FG000|Overall Study|Subject decision unrelated to AE|0|||
164655760|NCT01629693|594764896|FG001|Overall Study|Subject decision unrelated to AE|1|||
164655761|NCT03740100|594764897|FG000|Overall Study|Adverse Event|1|||
164655762|NCT03740100|594764897|FG000|Overall Study|Death|1|||
164307301|NCT02839200|593499237|FG000|Overall Study|Lost to Follow-up|2|||
164307302|NCT02839200|593499238|FG001|Overall Study|Lost to Follow-up|0|||
164655763|NCT00185211|594764903|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
164655764|NCT00185211|594764904|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
164655765|NCT00185211|594764903|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
164655766|NCT00185211|594764904|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
164655767|NCT00185211|594764903|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
164655768|NCT00185211|594764904|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
164655769|NCT00185211|594764903|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
164655770|NCT00185211|594764904|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
164655771|NCT00185211|594764903|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
164655772|NCT00185211|594764904|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
164655773|NCT00185211|594764903|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
164655774|NCT00185211|594764904|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
164655775|NCT00185211|594764903|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
164655776|NCT00185211|594764904|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
164655777|NCT00185211|594764903|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
164655778|NCT00185211|594764904|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
164655779|NCT00185211|594764903|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
164655780|NCT00185211|594764904|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
164655781|NCT00185211|594764903|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
164655782|NCT00185211|594764904|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
164655783|NCT00185211|594764903|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
164655784|NCT00185211|594764904|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
164655785|NCT00185211|594764903|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
164655786|NCT00185211|594764904|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
164655787|NCT00254397|594764905|FG000|Overall Study|Disease Progression|4|||
164655788|NCT00254397|594764906|FG001|Overall Study|Disease Progression|1|||
164655789|NCT00254397|594764907|FG002|Overall Study|Disease Progression|16|||
164655790|NCT00254397|594764908|FG003|Overall Study|Disease Progression|23|||
164655791|NCT00254397|594764905|FG000|Overall Study|Non-Compliant|0|||
164655792|NCT00254397|594764906|FG001|Overall Study|Non-Compliant|0|||
164655793|NCT00254397|594764907|FG002|Overall Study|Non-Compliant|0|||
164655794|NCT00254397|594764908|FG003|Overall Study|Non-Compliant|1|||
164655795|NCT00254397|594764905|FG000|Overall Study|Adverse Event|2|||
164655796|NCT00254397|594764906|FG001|Overall Study|Adverse Event|0|||
164655797|NCT00254397|594764907|FG002|Overall Study|Adverse Event|3|||
164655798|NCT00254397|594764908|FG003|Overall Study|Adverse Event|1|||
164655799|NCT01759537|594764909|FG000|Overall Study|Death|1|||
164655800|NCT01759537|594764910|FG001|Overall Study|Death|1|||
164655801|NCT01759537|594764909|FG000|Overall Study|Pregnancy|1|||
164655802|NCT01759537|594764910|FG001|Overall Study|Pregnancy|1|||
164655803|NCT01759537|594764909|FG000|Overall Study|Lost to Follow-up|9|||
164655804|NCT01759537|594764910|FG001|Overall Study|Lost to Follow-up|9|||
164655805|NCT01759537|594764909|FG000|Overall Study|Accident involving jaw fracture|1|||
164550340|NCT01265797|594387242|FG000|Blinded Month|Lack of Efficacy|5|||
164550341|NCT01265797|594387243|FG001|Blinded Month|Lack of Efficacy|0|||
164550342|NCT01265797|594387242|FG000|Blinded Month|Lost to Follow-up|1|||
164550343|NCT01265797|594387243|FG001|Blinded Month|Lost to Follow-up|0|||
164550344|NCT01265797|594387242|FG000|Blinded Month|Protocol Violation|2|||
164550345|NCT01265797|594387243|FG001|Blinded Month|Protocol Violation|1|||
164550346|NCT01265797|594387242|FG000|Blinded Month|Adverse Event|2|||
164550347|NCT01265797|594387243|FG001|Blinded Month|Adverse Event|0|||
164550348|NCT01265797|594387242|FG000|Blinded Month|Diary data incomplete|0|||
164550349|NCT01265797|594387243|FG001|Blinded Month|Diary data incomplete|1|||
164550350|NCT01265797|594387242|FG000|Open Label Month|Lost to Follow-up|0|||
164550351|NCT01265797|594387243|FG001|Open Label Month|Lost to Follow-up|1|||
164550352|NCT00506883|594387246|FG000|Overall Study|Lost to Follow-up|1|||
164550353|NCT00506883|594387247|FG001|Overall Study|Lost to Follow-up|1|||
164550354|NCT00506883|594387248|FG002|Overall Study|Lost to Follow-up|1|||
164550355|NCT00506883|594387246|FG000|Overall Study|Withdrawal by Subject|1|||
164550356|NCT00506883|594387247|FG001|Overall Study|Withdrawal by Subject|0|||
164550357|NCT00506883|594387248|FG002|Overall Study|Withdrawal by Subject|1|||
164550358|NCT00506883|594387246|FG000|Overall Study|Lack of Efficacy|0|||
164550359|NCT00506883|594387247|FG001|Overall Study|Lack of Efficacy|1|||
164550360|NCT00506883|594387248|FG002|Overall Study|Lack of Efficacy|1|||
164550361|NCT00506883|594387246|FG000|Overall Study|Other|5|||
164550362|NCT00506883|594387247|FG001|Overall Study|Other|1|||
164550363|NCT00506883|594387248|FG002|Overall Study|Other|1|||
164550364|NCT00455013|594387249|FG000|Short Term Period|Adverse Event|2|||
164550365|NCT00455013|594387250|FG001|Short Term Period|Adverse Event|5|||
164550366|NCT00455013|594387251|FG002|Short Term Period|Adverse Event|0|||
164550367|NCT00455013|594387249|FG000|Short Term Period|Withdrawal by Subject|0|||
164550368|NCT00455013|594387250|FG001|Short Term Period|Withdrawal by Subject|0|||
164550369|NCT00455013|594387251|FG002|Short Term Period|Withdrawal by Subject|1|||
164550370|NCT00455013|594387249|FG000|Short Term Period|Lack of Efficacy|4|||
164550371|NCT00455013|594387250|FG001|Short Term Period|Lack of Efficacy|0|||
164550372|NCT00455013|594387251|FG002|Short Term Period|Lack of Efficacy|0|||
164550373|NCT00455013|594387249|FG000|Short Term Period|Other|0|||
164550374|NCT00455013|594387250|FG001|Short Term Period|Other|0|||
164550375|NCT00455013|594387251|FG002|Short Term Period|Other|1|||
164550376|NCT00455013|594387249|FG000|Long Term Extension (LTE)|Adverse Event|0|||
164550377|NCT00455013|594387250|FG001|Long Term Extension (LTE)|Adverse Event|1|||
164550378|NCT00455013|594387251|FG002|Long Term Extension (LTE)|Adverse Event|1|||
164550379|NCT00455013|594387249|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
164550380|NCT00455013|594387250|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
164550381|NCT00455013|594387251|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
164550382|NCT00455013|594387249|FG000|Long Term Extension (LTE)|Death|1|||
164550383|NCT00455013|594387250|FG001|Long Term Extension (LTE)|Death|1|||
164550384|NCT00455013|594387251|FG002|Long Term Extension (LTE)|Death|0|||
164550385|NCT00455013|594387249|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
164550386|NCT00455013|594387250|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
164550387|NCT00455013|594387251|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
164550388|NCT00455013|594387249|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
164550389|NCT00455013|594387250|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
164550390|NCT00455013|594387251|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
164550391|NCT00455013|594387249|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
164550392|NCT00455013|594387250|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
164550393|NCT00455013|594387251|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
164550394|NCT00455013|594387249|FG000|Long Term Extension (LTE)|non-specified|0|||
164550395|NCT00455013|594387250|FG001|Long Term Extension (LTE)|non-specified|0|||
164550396|NCT00455013|594387251|FG002|Long Term Extension (LTE)|non-specified|1|||
164550397|NCT01519765|594387252|FG000|Overall Study|Adverse Event|0|||
164550398|NCT01519765|594387253|FG001|Overall Study|Adverse Event|1|||
164550399|NCT01519765|594387252|FG000|Overall Study|Lack of Efficacy|2|||
164550400|NCT01519765|594387253|FG001|Overall Study|Lack of Efficacy|0|||
164550401|NCT01519765|594387252|FG000|Overall Study|Protocol Violation|1|||
164550402|NCT01519765|594387253|FG001|Overall Study|Protocol Violation|0|||
164550403|NCT01519765|594387252|FG000|Overall Study|Withdrawal by Subject|0|||
164550404|NCT01519765|594387253|FG001|Overall Study|Withdrawal by Subject|1|||
164550405|NCT05513625|594387259|FG000|Overall Study|Withdrawal by Subject|1|||
164550406|NCT00754793|594387260|FG000|Overall Study|voluntary withdrawn from study|0|||
164550407|NCT00754793|594387261|FG001|Overall Study|voluntary withdrawn from study|1|||
164655806|NCT01759537|594764910|FG001|Overall Study|Accident involving jaw fracture|1|||
164655807|NCT01759537|594764909|FG000|Overall Study|Subcrestal implant too coronal|1|||
164550408|NCT02943564|594387262|FG000|Overall Study|Miscellaneous Reasons|0|||
164550409|NCT02943564|594387263|FG001|Overall Study|Miscellaneous Reasons|0|||
164550410|NCT02943564|594387264|FG002|Overall Study|Miscellaneous Reasons|3|||
164550411|NCT02943564|594387262|FG000|Overall Study|Site terminated by sponsor|0|||
164550412|NCT02943564|594387263|FG001|Overall Study|Site terminated by sponsor|1|||
164550413|NCT02943564|594387264|FG002|Overall Study|Site terminated by sponsor|0|||
164655808|NCT01759537|594764910|FG001|Overall Study|Subcrestal implant too coronal|1|||
164655809|NCT01715415|594764914|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
164655810|NCT01715415|594764915|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
164655811|NCT01715415|594764914|FG000|Double-blind Treatment|Adverse Event|3|||
164655812|NCT01715415|594764915|FG001|Double-blind Treatment|Adverse Event|0|||
164655813|NCT01715415|594764914|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
164655814|NCT01715415|594764915|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
164655815|NCT01715415|594764914|FG000|Double-blind Treatment|Other|1|||
164655816|NCT01715415|594764915|FG001|Double-blind Treatment|Other|0|||
164655817|NCT01715415|594764914|FG000|Open-label Treatment|Adverse Event|0|||
164655818|NCT01715415|594764915|FG001|Open-label Treatment|Adverse Event|1|||
164655819|NCT01715415|594764914|FG000|Open-label Treatment|Subject Noncompliant|0|||
164655820|NCT01715415|594764915|FG001|Open-label Treatment|Subject Noncompliant|1|||
164655821|NCT01015612|594764916|FG000|Overall Study|Death|113|||
164655822|NCT01015612|594764916|FG000|Overall Study|Withdrawal by Subject|40|||
164655823|NCT00420290|594764917|FG000|Overall Study|Adverse Event|3|||
164655824|NCT00420290|594764918|FG001|Overall Study|Adverse Event|1|||
164655825|NCT00420290|594764917|FG000|Overall Study|Withdrawal by Subject|0|||
164655826|NCT00420290|594764918|FG001|Overall Study|Withdrawal by Subject|2|||
164655827|NCT00420290|594764917|FG000|Overall Study|did not meet inclusion/exclusion|1|||
164655828|NCT00420290|594764918|FG001|Overall Study|did not meet inclusion/exclusion|1|||
164655829|NCT05028751|594764919|FG000|Overall Study|Study Terminated by Sponsor|3|||
164655830|NCT05028751|594764920|FG001|Overall Study|Study Terminated by Sponsor|0|||
164655831|NCT05028751|594764921|FG002|Overall Study|Study Terminated by Sponsor|0|||
164655832|NCT05028751|594764922|FG003|Overall Study|Study Terminated by Sponsor|0|||
164655833|NCT05028751|594764919|FG000|Overall Study|Death|9|||
164655834|NCT05028751|594764920|FG001|Overall Study|Death|3|||
164655835|NCT05028751|594764921|FG002|Overall Study|Death|2|||
164655836|NCT05028751|594764922|FG003|Overall Study|Death|4|||
164655837|NCT05028751|594764919|FG000|Overall Study|Withdrawal by Subject|0|||
164655838|NCT05028751|594764920|FG001|Overall Study|Withdrawal by Subject|0|||
164655839|NCT05028751|594764921|FG002|Overall Study|Withdrawal by Subject|1|||
164655840|NCT05028751|594764922|FG003|Overall Study|Withdrawal by Subject|0|||
164655841|NCT05028751|594764919|FG000|Overall Study|Miscellaneous|2|||
164655842|NCT05028751|594764920|FG001|Overall Study|Miscellaneous|0|||
164655843|NCT05028751|594764921|FG002|Overall Study|Miscellaneous|0|||
164655844|NCT05028751|594764922|FG003|Overall Study|Miscellaneous|0|||
164655845|NCT04578548|594764923|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
164655846|NCT04578548|594764924|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
164655847|NCT04578548|594764923|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
164307303|NCT02839200|593499239|FG002|Overall Study|Lost to Follow-up|0|||
164307304|NCT02839200|593499240|FG003|Overall Study|Lost to Follow-up|0|||
164307305|NCT02839200|593499241|FG004|Overall Study|Lost to Follow-up|1|||
164307306|NCT02839200|593499242|FG005|Overall Study|Lost to Follow-up|0|||
164307307|NCT02839200|593499237|FG000|Overall Study|Adverse Event|0|||
164307308|NCT02839200|593499238|FG001|Overall Study|Adverse Event|0|||
164307309|NCT02839200|593499239|FG002|Overall Study|Adverse Event|0|||
164307310|NCT02839200|593499240|FG003|Overall Study|Adverse Event|0|||
164307311|NCT02839200|593499241|FG004|Overall Study|Adverse Event|1|||
164307312|NCT02839200|593499242|FG005|Overall Study|Adverse Event|0|||
164655848|NCT04578548|594764924|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
164655849|NCT04578548|594764923|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
164307313|NCT02839200|593499237|FG000|Overall Study|Randomized in error|0|||
164307314|NCT02839200|593499238|FG001|Overall Study|Randomized in error|1|||
164307315|NCT02839200|593499239|FG002|Overall Study|Randomized in error|0|||
164307316|NCT02839200|593499240|FG003|Overall Study|Randomized in error|0|||
164307317|NCT02839200|593499241|FG004|Overall Study|Randomized in error|0|||
164307318|NCT02839200|593499242|FG005|Overall Study|Randomized in error|0|||
164307319|NCT02952820|593499243|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
164307320|NCT02952820|593499244|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
164307321|NCT02952820|593499245|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
164307322|NCT02952820|593499243|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
164307323|NCT02952820|593499244|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
164307324|NCT02952820|593499245|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
164307325|NCT02952820|593499243|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
164307326|NCT02952820|593499244|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
164307327|NCT02952820|593499245|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
164307328|NCT02952820|593499243|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
164307329|NCT02952820|593499244|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
164307330|NCT02952820|593499245|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
164307331|NCT02952820|593499243|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
164307332|NCT02952820|593499244|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
164307333|NCT02952820|593499245|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
164655850|NCT04578548|594764924|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
164655851|NCT04578548|594764923|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
164655852|NCT04578548|594764924|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
164655853|NCT04578548|594764923|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
164655854|NCT04578548|594764924|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
164655855|NCT04578548|594764923|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
164655856|NCT04578548|594764924|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
164655857|NCT00972153|594764927|FG000|Overall Study|Equipment malfunction during case|0|||
164655858|NCT00972153|594764928|FG001|Overall Study|Equipment malfunction during case|1|||
164655859|NCT00972153|594764929|FG002|Overall Study|Equipment malfunction during case|0|||
164655860|NCT01077713|594764934|FG000|Overall Study|Withdrawal by Subject|1|||
164655861|NCT01077713|594764935|FG001|Overall Study|Withdrawal by Subject|2|||
164307334|NCT02952820|593499243|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
164307335|NCT02952820|593499244|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
164307336|NCT02952820|593499245|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
164307337|NCT02952820|593499243|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
164307338|NCT02952820|593499244|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
164307339|NCT02952820|593499245|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
164307340|NCT02952820|593499243|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
164307341|NCT02952820|593499244|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
164307342|NCT02952820|593499245|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
164307343|NCT02952820|593499243|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
164307344|NCT02952820|593499244|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
164307345|NCT02952820|593499245|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
164307346|NCT02952820|593499243|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
164307347|NCT02952820|593499244|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
164307348|NCT02952820|593499245|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
164655862|NCT01077713|594764934|FG000|Overall Study|Progressive Disease (PD)|0|||
164655863|NCT01077713|594764935|FG001|Overall Study|Progressive Disease (PD)|1|||
164655864|NCT01077713|594764934|FG000|Overall Study|Death|28|||
164655865|NCT01077713|594764935|FG001|Overall Study|Death|29|||
164655866|NCT01077713|594764934|FG000|Overall Study|Lost to Follow-up|1|||
164655867|NCT01077713|594764935|FG001|Overall Study|Lost to Follow-up|1|||
164655868|NCT01077713|594764934|FG000|Overall Study|Adverse Event|2|||
164655869|NCT01077713|594764935|FG001|Overall Study|Adverse Event|1|||
164655870|NCT01077713|594764934|FG000|Overall Study|Other|4|||
164655871|NCT01077713|594764935|FG001|Overall Study|Other|2|||
164655872|NCT04136626|594764936|FG000|Treatment Phase|Withdrawal by Subject|1|||
164655873|NCT04136626|594764937|FG001|Treatment Phase|Withdrawal by Subject|9|||
164655874|NCT04136626|594764936|FG000|Treatment Phase|Adverse Event|1|||
164655875|NCT04136626|594764937|FG001|Treatment Phase|Adverse Event|0|||
164655876|NCT04136626|594764936|FG000|Treatment Phase|Lost to Follow-up|1|||
164655877|NCT04136626|594764937|FG001|Treatment Phase|Lost to Follow-up|5|||
164655878|NCT04136626|594764936|FG000|12-month Follow-up|Lost to Follow-up|8|||
164655879|NCT04136626|594764937|FG001|12-month Follow-up|Lost to Follow-up|7|||
164655880|NCT02224456|594766327|FG000|Overall Study|Lack of Efficacy|1|||
164655881|NCT02224456|594766327|FG000|Overall Study|Lost to Follow-up|15|||
164655882|NCT02224456|594766327|FG000|Overall Study|Withdrawal by Subject|9|||
164655883|NCT02224456|594766327|FG000|Overall Study|Physician Decision|3|||
164655884|NCT02224456|594766327|FG000|Overall Study|Death|2|||
164655885|NCT02224456|594766327|FG000|Overall Study|Pregnancy|4|||
164655886|NCT02224456|594766327|FG000|Overall Study|Protocol Violation|1|||
164655887|NCT02224456|594766327|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
164655888|NCT01241461|594766328|FG000|Overall Study|Progressive Disease|3|||
164655889|NCT01241461|594766329|FG001|Overall Study|Progressive Disease|6|||
164655890|NCT01379781|594766330|FG000|Overall Study|Lost to Follow-up|11|||
164655891|NCT01379781|594766331|FG001|Overall Study|Lost to Follow-up|8|||
164655892|NCT02247479|594766332|FG000|Overall Study|Adverse Event|8|||
164655893|NCT02247479|594766333|FG001|Overall Study|Adverse Event|9|||
164655894|NCT02247479|594766334|FG002|Overall Study|Adverse Event|8|||
164655895|NCT02247479|594766332|FG000|Overall Study|Death|5|||
164655896|NCT02247479|594766333|FG001|Overall Study|Death|4|||
164655897|NCT02247479|594766334|FG002|Overall Study|Death|6|||
164655898|NCT02247479|594766332|FG000|Overall Study|Lost to Follow-up|3|||
164655899|NCT02247479|594766333|FG001|Overall Study|Lost to Follow-up|3|||
164655900|NCT02247479|594766334|FG002|Overall Study|Lost to Follow-up|1|||
164655901|NCT02247479|594766332|FG000|Overall Study|Non-compliance|0|||
164655902|NCT02247479|594766333|FG001|Overall Study|Non-compliance|0|||
164655903|NCT02247479|594766334|FG002|Overall Study|Non-compliance|1|||
164655904|NCT02247479|594766332|FG000|Overall Study|Withdrawal by Subject|25|||
164655905|NCT02247479|594766333|FG001|Overall Study|Withdrawal by Subject|29|||
164655906|NCT02247479|594766334|FG002|Overall Study|Withdrawal by Subject|24|||
164655907|NCT02247479|594766332|FG000|Overall Study|Study Terminated by Sponsor|98|||
164655908|NCT02247479|594766333|FG001|Overall Study|Study Terminated by Sponsor|88|||
164550414|NCT02943564|594387262|FG000|Overall Study|Non-compliance with study drug|0|||
164550415|NCT02943564|594387263|FG001|Overall Study|Non-compliance with study drug|1|||
164550416|NCT02943564|594387264|FG002|Overall Study|Non-compliance with study drug|0|||
164550417|NCT02943564|594387262|FG000|Overall Study|Pregnancy|0|||
164550418|NCT02943564|594387263|FG001|Overall Study|Pregnancy|1|||
164550419|NCT02943564|594387264|FG002|Overall Study|Pregnancy|1|||
164550420|NCT02943564|594387262|FG000|Overall Study|Protocol Violation|2|||
164550421|NCT02943564|594387263|FG001|Overall Study|Protocol Violation|2|||
164550422|NCT02943564|594387264|FG002|Overall Study|Protocol Violation|2|||
164550423|NCT02943564|594387262|FG000|Overall Study|Lost to Follow-up|1|||
164550424|NCT02943564|594387263|FG001|Overall Study|Lost to Follow-up|0|||
164550425|NCT02943564|594387264|FG002|Overall Study|Lost to Follow-up|0|||
164550426|NCT02943564|594387262|FG000|Overall Study|Withdrawal by Subject|6|||
164550427|NCT02943564|594387263|FG001|Overall Study|Withdrawal by Subject|5|||
164550428|NCT02943564|594387264|FG002|Overall Study|Withdrawal by Subject|2|||
164550429|NCT02943564|594387262|FG000|Overall Study|Adverse Event|1|||
164550430|NCT02943564|594387263|FG001|Overall Study|Adverse Event|2|||
164550431|NCT02943564|594387264|FG002|Overall Study|Adverse Event|1|||
164550432|NCT02943564|594387262|FG000|Overall Study|Lack of Efficacy|0|||
164550433|NCT02943564|594387263|FG001|Overall Study|Lack of Efficacy|1|||
164550434|NCT02943564|594387264|FG002|Overall Study|Lack of Efficacy|0|||
164550435|NCT00932360|594387265|FG000|Washout (One Week)|Withdrawal by Subject|0|||
164550436|NCT00932360|594387266|FG001|Washout (One Week)|Withdrawal by Subject|0|||
164550437|NCT00932360|594387267|FG002|Washout (One Week)|Withdrawal by Subject|0|||
164550438|NCT00932360|594387268|FG003|Washout (One Week)|Withdrawal by Subject|0|||
164550439|NCT00932360|594387269|FG004|Washout (One Week)|Withdrawal by Subject|2|||
164550440|NCT00932360|594387270|FG005|Washout (One Week)|Withdrawal by Subject|0|||
164550441|NCT02536313|594387271|FG000|Overall Study|Lack of Efficacy|0|||
164550442|NCT02536313|594387272|FG001|Overall Study|Lack of Efficacy|1|||
164550443|NCT00917150|594387273|FG000|Overall Study|Adverse Event|12|||
164550444|NCT00917150|594387274|FG001|Overall Study|Adverse Event|7|||
164550445|NCT00917150|594387275|FG002|Overall Study|Adverse Event|12|||
164550446|NCT00917150|594387276|FG003|Overall Study|Adverse Event|11|||
164550447|NCT00917150|594387273|FG000|Overall Study|Death|1|||
164550448|NCT00917150|594387274|FG001|Overall Study|Death|4|||
164550449|NCT00917150|594387275|FG002|Overall Study|Death|3|||
164550450|NCT00917150|594387276|FG003|Overall Study|Death|2|||
164550451|NCT00917150|594387273|FG000|Overall Study|Lost to Follow-up|1|||
164550452|NCT00917150|594387274|FG001|Overall Study|Lost to Follow-up|0|||
164550453|NCT00917150|594387275|FG002|Overall Study|Lost to Follow-up|4|||
164550454|NCT00917150|594387276|FG003|Overall Study|Lost to Follow-up|2|||
164550455|NCT00917150|594387273|FG000|Overall Study|Physician Decision|0|||
164550456|NCT00917150|594387274|FG001|Overall Study|Physician Decision|2|||
164550457|NCT00917150|594387275|FG002|Overall Study|Physician Decision|0|||
164550458|NCT00917150|594387276|FG003|Overall Study|Physician Decision|1|||
164550459|NCT00917150|594387273|FG000|Overall Study|Protocol Violation|5|||
164550460|NCT00917150|594387274|FG001|Overall Study|Protocol Violation|5|||
164550461|NCT00917150|594387275|FG002|Overall Study|Protocol Violation|3|||
164550462|NCT00917150|594387276|FG003|Overall Study|Protocol Violation|5|||
164550463|NCT00917150|594387273|FG000|Overall Study|Withdrawal by Subject|15|||
164550464|NCT00917150|594387274|FG001|Overall Study|Withdrawal by Subject|16|||
164550465|NCT00917150|594387275|FG002|Overall Study|Withdrawal by Subject|18|||
164550466|NCT00917150|594387276|FG003|Overall Study|Withdrawal by Subject|11|||
164550467|NCT00917150|594387273|FG000|Overall Study|Other than specified|3|||
164550468|NCT00917150|594387274|FG001|Overall Study|Other than specified|3|||
164550469|NCT00917150|594387275|FG002|Overall Study|Other than specified|2|||
164550470|NCT00917150|594387276|FG003|Overall Study|Other than specified|2|||
164655909|NCT02247479|594766334|FG002|Overall Study|Study Terminated by Sponsor|94|||
164655910|NCT02247479|594766332|FG000|Overall Study|Physician Decision|1|||
164655911|NCT02247479|594766333|FG001|Overall Study|Physician Decision|0|||
164655912|NCT02247479|594766334|FG002|Overall Study|Physician Decision|2|||
164550471|NCT04143009|594387278|FG000|Pilot Trial|Lost to Follow-up|0|||
164550472|NCT04143009|594387279|FG001|Pilot Trial|Lost to Follow-up|1|||
164550473|NCT04143009|594387280|FG002|Pilot Trial|Lost to Follow-up|1|||
164550474|NCT00874120|594388692|FG000|First Intervention|Adverse Event|0|||
164550475|NCT00874120|594388693|FG001|First Intervention|Adverse Event|1|||
164550476|NCT00874120|594388692|FG000|First Intervention|Withdrawal by Subject|2|||
164550477|NCT00874120|594388693|FG001|First Intervention|Withdrawal by Subject|0|||
164550478|NCT00874120|594388692|FG000|First Intervention|Lost to Follow-up|0|||
164550479|NCT00874120|594388693|FG001|First Intervention|Lost to Follow-up|1|||
164550480|NCT00874120|594388692|FG000|First Intervention|Protocol Violation|3|||
164550481|NCT00874120|594388693|FG001|First Intervention|Protocol Violation|0|||
164550482|NCT00874120|594388692|FG000|First Intervention|positive drug test|1|||
164550483|NCT00874120|594388693|FG001|First Intervention|positive drug test|0|||
164550484|NCT00874120|594388692|FG000|Second Intervention|Withdrawal by Subject|1|||
164550485|NCT00874120|594388693|FG001|Second Intervention|Withdrawal by Subject|0|||
164550486|NCT00874120|594388692|FG000|Second Intervention|Protocol Violation|1|||
164550487|NCT00874120|594388693|FG001|Second Intervention|Protocol Violation|0|||
164550488|NCT00105443|594388699|FG000|Double-Blind Treatment|Adverse Event|1|||
164307349|NCT02952820|593499243|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
164307350|NCT02952820|593499244|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
164307351|NCT02952820|593499245|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
164307352|NCT02952820|593499243|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
164307353|NCT02952820|593499244|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
164307354|NCT02952820|593499245|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
164307355|NCT02952820|593499243|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
164307356|NCT02952820|593499244|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
164307357|NCT02952820|593499245|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
164307358|NCT02952820|593499243|FG000|Active Treatment Period (6 Months)|Not treated|0|||
164307359|NCT02952820|593499244|FG001|Active Treatment Period (6 Months)|Not treated|0|||
164307360|NCT02952820|593499245|FG002|Active Treatment Period (6 Months)|Not treated|1|||
164307361|NCT03857867|593499247|FG000|Overall Study|Physician Decision|1|||
164307362|NCT03070964|593499248|FG000|Overall Study|Progressive disease|8|||
164307363|NCT03070964|593499248|FG000|Overall Study|Treatment-unrelated adverse event|2|||
164307364|NCT03070964|593499248|FG000|Overall Study|Never treated|1|||
164307365|NCT03070964|593499248|FG000|Overall Study|Physician Decision|1|||
164307366|NCT03070964|593499248|FG000|Overall Study|Withdrawal by Subject|1|||
164307367|NCT03070964|593499248|FG000|Overall Study|Adverse Event|1|||
164307368|NCT01286480|593499249|FG000|Overall Study|Withdrawal by Subject|5|||
164307369|NCT01286480|593499250|FG001|Overall Study|Withdrawal by Subject|3|||
164307370|NCT00834093|593499251|FG000|Overall Study|Progressive Disease|3|||
164307371|NCT00834093|593499251|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
164307372|NCT00885534|593499252|FG000|Overall Study|Patient deemed ineligible|1|||
164307373|NCT02453711|593499253|FG000|Overall Study|Withdrawal by Subject|5|||
164307374|NCT02453711|593499254|FG001|Overall Study|Withdrawal by Subject|4|||
164307375|NCT02453711|593499255|FG002|Overall Study|Withdrawal by Subject|6|||
164307376|NCT02453711|593499256|FG003|Overall Study|Withdrawal by Subject|4|||
164307377|NCT02453711|593499257|FG004|Overall Study|Withdrawal by Subject|1|||
164307378|NCT02453711|593499258|FG005|Overall Study|Withdrawal by Subject|1|||
164307379|NCT02453711|593499259|FG006|Overall Study|Withdrawal by Subject|0|||
164307380|NCT02453711|593499260|FG007|Overall Study|Withdrawal by Subject|1|||
164307381|NCT02453711|593499261|FG008|Overall Study|Withdrawal by Subject|7|||
164307382|NCT02453711|593499253|FG000|Overall Study|Lost to Follow-up|5|||
164307383|NCT02453711|593499254|FG001|Overall Study|Lost to Follow-up|3|||
164307384|NCT02453711|593499255|FG002|Overall Study|Lost to Follow-up|2|||
164307385|NCT02453711|593499256|FG003|Overall Study|Lost to Follow-up|3|||
164307386|NCT02453711|593499257|FG004|Overall Study|Lost to Follow-up|1|||
164307387|NCT02453711|593499258|FG005|Overall Study|Lost to Follow-up|5|||
164307388|NCT02453711|593499259|FG006|Overall Study|Lost to Follow-up|2|||
164307389|NCT02453711|593499260|FG007|Overall Study|Lost to Follow-up|6|||
164307390|NCT02453711|593499261|FG008|Overall Study|Lost to Follow-up|6|||
164307391|NCT02453711|593499253|FG000|Overall Study|Death|0|||
164307392|NCT02453711|593499254|FG001|Overall Study|Death|0|||
164307393|NCT02453711|593499255|FG002|Overall Study|Death|0|||
164307394|NCT02453711|593499256|FG003|Overall Study|Death|0|||
164307395|NCT02453711|593499257|FG004|Overall Study|Death|0|||
164307396|NCT02453711|593499258|FG005|Overall Study|Death|0|||
164307397|NCT02453711|593499259|FG006|Overall Study|Death|1|||
164307398|NCT02453711|593499260|FG007|Overall Study|Death|0|||
164307399|NCT02453711|593499261|FG008|Overall Study|Death|0|||
164307400|NCT02453711|593499253|FG000|Overall Study|Unclassified|1|||
164307401|NCT02453711|593499254|FG001|Overall Study|Unclassified|0|||
164307402|NCT02453711|593499255|FG002|Overall Study|Unclassified|1|||
164307403|NCT02453711|593499256|FG003|Overall Study|Unclassified|0|||
164307404|NCT02453711|593499257|FG004|Overall Study|Unclassified|0|||
164307405|NCT02453711|593499258|FG005|Overall Study|Unclassified|0|||
164307406|NCT02453711|593499259|FG006|Overall Study|Unclassified|0|||
164307407|NCT02453711|593499260|FG007|Overall Study|Unclassified|0|||
164307408|NCT02453711|593499261|FG008|Overall Study|Unclassified|0|||
164307409|NCT01587924|593499262|FG000|Overall Study|Adverse Event|0|||
164307410|NCT01587924|593499263|FG001|Overall Study|Adverse Event|2|||
164307411|NCT01587924|593499264|FG002|Overall Study|Adverse Event|0|||
164307412|NCT01587924|593499265|FG003|Overall Study|Adverse Event|0|||
164307413|NCT01587924|593499262|FG000|Overall Study|Protocol Violation|2|||
164307414|NCT01587924|593499263|FG001|Overall Study|Protocol Violation|1|||
164307415|NCT01587924|593499264|FG002|Overall Study|Protocol Violation|2|||
164307416|NCT01587924|593499265|FG003|Overall Study|Protocol Violation|1|||
164307417|NCT01587924|593499262|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
164307418|NCT01587924|593499263|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
164307419|NCT01587924|593499264|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
164655913|NCT02247479|594766332|FG000|Overall Study|Unspecified Reason|2|||
164655914|NCT02247479|594766333|FG001|Overall Study|Unspecified Reason|5|||
164307420|NCT01587924|593499265|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
164307421|NCT01587924|593499262|FG000|Overall Study|Withdrawal by Subject|0|||
164307422|NCT01587924|593499263|FG001|Overall Study|Withdrawal by Subject|1|||
164307423|NCT01587924|593499264|FG002|Overall Study|Withdrawal by Subject|1|||
164550489|NCT00105443|594388700|FG001|Double-Blind Treatment|Adverse Event|0|||
164550490|NCT00105443|594388701|FG002|Double-Blind Treatment|Adverse Event|0|||
164550491|NCT00105443|594388702|FG003|Double-Blind Treatment|Adverse Event|0|||
164550492|NCT00105443|594388699|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
164550493|NCT00105443|594388700|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
164550494|NCT00105443|594388701|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
164550495|NCT00105443|594388702|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
164550496|NCT00105443|594388699|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
164550497|NCT00105443|594388700|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
164550498|NCT00105443|594388701|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
164550499|NCT00105443|594388702|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
164550500|NCT00105443|594388699|FG000|Double-Blind Treatment|Physician Decision|1|||
164550501|NCT00105443|594388700|FG001|Double-Blind Treatment|Physician Decision|0|||
164550502|NCT00105443|594388701|FG002|Double-Blind Treatment|Physician Decision|2|||
164550503|NCT00105443|594388702|FG003|Double-Blind Treatment|Physician Decision|0|||
164550504|NCT00105443|594388699|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
164550505|NCT00105443|594388700|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
164550506|NCT00105443|594388701|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
164550507|NCT00105443|594388702|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
164550508|NCT00105443|594388699|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
164550509|NCT00105443|594388700|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
164550510|NCT00105443|594388701|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
164550511|NCT00105443|594388702|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
164550512|NCT00105443|594388699|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
164550513|NCT00105443|594388700|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
164550514|NCT00105443|594388701|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
164550515|NCT00105443|594388702|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
164550516|NCT00105443|594388699|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
164550517|NCT00105443|594388700|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
164550518|NCT00105443|594388701|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
164550519|NCT00105443|594388702|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
164550520|NCT00105443|594388699|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
164550521|NCT00105443|594388700|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
164550522|NCT00105443|594388701|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
164550523|NCT00105443|594388702|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
164550524|NCT00105443|594388699|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
164550525|NCT00105443|594388700|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
164550526|NCT00105443|594388701|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
164550527|NCT00105443|594388702|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
164550528|NCT00105443|594388699|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
164550529|NCT00105443|594388700|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
164550530|NCT00105443|594388701|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
164550531|NCT00105443|594388702|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
164550532|NCT00105443|594388699|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
164550533|NCT00105443|594388700|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
164550534|NCT00105443|594388701|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
164550535|NCT00105443|594388702|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
164198831|NCT04037358|593097757|FG000|Overall Study|Patient withdrew before intervention|1|||
164198832|NCT04037358|593097758|FG001|Overall Study|Patient withdrew before intervention|0|||
164198833|NCT01949142|593097761|FG000|Overall Study|Withdrawal of consent|1|||
164198834|NCT01949142|593097762|FG001|Overall Study|Withdrawal of consent|0|||
164198835|NCT01949142|593097761|FG000|Overall Study|Lost to Follow-up|1|||
164198836|NCT01949142|593097762|FG001|Overall Study|Lost to Follow-up|1|||
164198837|NCT01949142|593097761|FG000|Overall Study|Parent changed their mind|1|||
164198838|NCT01949142|593097762|FG001|Overall Study|Parent changed their mind|0|||
164198839|NCT05027815|593097763|FG000|Overall Study|Death|2|||
164198840|NCT05027815|593097764|FG001|Overall Study|Death|1|||
164198841|NCT04802161|593097766|FG000|Overall Study|Alternate Therapy prior to Day 21|1|||
164198842|NCT04802161|593097767|FG001|Overall Study|Alternate Therapy prior to Day 21|0|||
164198843|NCT04802161|593097768|FG002|Overall Study|Alternate Therapy prior to Day 21|1|||
164198844|NCT04802161|593097769|FG003|Overall Study|Alternate Therapy prior to Day 21|1|||
164198845|NCT04802161|593097766|FG000|Overall Study|Clinical Instability|0|||
164198846|NCT04802161|593097767|FG001|Overall Study|Clinical Instability|0|||
164198847|NCT04802161|593097768|FG002|Overall Study|Clinical Instability|1|||
164550536|NCT00105443|594388699|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
164550537|NCT00105443|594388700|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
164550538|NCT00105443|594388701|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
164198848|NCT04802161|593097769|FG003|Overall Study|Clinical Instability|0|||
164198849|NCT04802161|593097766|FG000|Overall Study|Adverse Event|0|||
164307424|NCT01587924|593499265|FG003|Overall Study|Withdrawal by Subject|0|||
164655915|NCT02247479|594766334|FG002|Overall Study|Unspecified Reason|2|||
164655916|NCT03740698|594766335|FG000|Overall Study|Physician Decision|0|||
164655917|NCT03740698|594766336|FG001|Overall Study|Physician Decision|1|||
164655918|NCT03740698|594766337|FG002|Overall Study|Physician Decision|1|||
164655919|NCT05216978|594766347|FG000|Overall Study|Withdrawal by Subject|3|||
164655920|NCT05216978|594766347|FG000|Overall Study|Lost to Follow-up|5|||
164655921|NCT03433001|594766364|FG000|Overall Study|Lack of Efficacy|109|||
164655922|NCT03433001|594766364|FG000|Overall Study|Adverse Event|69|||
164655923|NCT03433001|594766364|FG000|Overall Study|Withdrawal by Subject|10|||
164655924|NCT03433001|594766364|FG000|Overall Study|Death|12|||
164655925|NCT03433001|594766364|FG000|Overall Study|Lost to Follow-up|4|||
164655926|NCT03433001|594766364|FG000|Overall Study|Other|25|||
164655927|NCT01299038|594766367|FG000|Overall Study|Withdrawal by Subject|1|||
164655928|NCT01299038|594766368|FG001|Overall Study|Withdrawal by Subject|0|||
164655929|NCT01162499|594766373|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
164655930|NCT01162499|594766374|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
164307425|NCT01578486|593499266|FG000|Overall Study|Physician Decision|3|||
164307426|NCT01578486|593499266|FG000|Overall Study|Withdrawal by Subject|2|||
164307427|NCT03181529|593499267|FG000|Overall Study|Withdrawal by Subject|1|||
164307428|NCT03181529|593499268|FG001|Overall Study|Withdrawal by Subject|1|||
164307429|NCT03181529|593499267|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
164307430|NCT03181529|593499268|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
164307431|NCT00607373|593499269|FG000|Treatment Period|Adverse Event|0|||
164307432|NCT00607373|593499270|FG001|Treatment Period|Adverse Event|4|||
164307433|NCT00607373|593499269|FG000|Treatment Period|Physician Decision|0|||
164307434|NCT00607373|593499270|FG001|Treatment Period|Physician Decision|1|||
164307435|NCT00607373|593499269|FG000|Treatment Period|Withdrawal by Subject|0|||
164307436|NCT00607373|593499270|FG001|Treatment Period|Withdrawal by Subject|1|||
164307437|NCT00607373|593499269|FG000|Follow-up Period|Other|0|||
164307438|NCT00607373|593499270|FG001|Follow-up Period|Other|1|||
164307439|NCT00607373|593499269|FG000|Follow-up Period|Protocol Violation|0|||
164307440|NCT00607373|593499270|FG001|Follow-up Period|Protocol Violation|1|||
164307441|NCT00607373|593499269|FG000|Follow-up Period|Withdrawal by Subject|1|||
164307442|NCT00607373|593499270|FG001|Follow-up Period|Withdrawal by Subject|3|||
164307443|NCT01918306|593499271|FG000|Overall Study|progresive disease|4|||
164307444|NCT01918306|593499272|FG001|Overall Study|progresive disease|0|||
164307445|NCT01918306|593499273|FG002|Overall Study|progresive disease|1|||
164307446|NCT01918306|593499274|FG003|Overall Study|progresive disease|1|||
164307447|NCT01918306|593499271|FG000|Overall Study|Withdrawal by Subject|0|||
164655931|NCT00322556|594766375|FG000|Overall Study|Adverse Event|1|||
164655932|NCT00322556|594766375|FG000|Overall Study|Withdrawal by Subject|1|||
164655933|NCT00322556|594766375|FG000|Overall Study|Lost to Follow-up|3|||
164655934|NCT00322556|594766375|FG000|Overall Study|Other Reason|7|||
164655935|NCT01506323|594766377|FG000|Overall Study|Lost to Follow-up|5|||
164655936|NCT01506323|594766378|FG001|Overall Study|Lost to Follow-up|4|||
164655937|NCT01506323|594766377|FG000|Overall Study|Withdrawal by Subject|4|||
164655938|NCT01506323|594766378|FG001|Overall Study|Withdrawal by Subject|4|||
164655939|NCT01506323|594766377|FG000|Overall Study|Lack of Efficacy|1|||
164655940|NCT01506323|594766378|FG001|Overall Study|Lack of Efficacy|3|||
164655941|NCT01506323|594766377|FG000|Overall Study|Moved out of area|5|||
164655942|NCT01506323|594766378|FG001|Overall Study|Moved out of area|2|||
164655943|NCT01506323|594766377|FG000|Overall Study|Schedule or Transportation conflict|8|||
164655944|NCT01506323|594766378|FG001|Overall Study|Schedule or Transportation conflict|0|||
164655945|NCT01506323|594766377|FG000|Overall Study|Started another treatment|1|||
164655946|NCT01506323|594766378|FG001|Overall Study|Started another treatment|0|||
164655947|NCT03907280|594766379|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
164655948|NCT03907280|594766380|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
164655949|NCT03907280|594766381|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
164655950|NCT02637076|594766385|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
164655951|NCT02637076|594766386|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
164655952|NCT02637076|594766385|FG000|Overall Study|Withdrawal by Subject|0|||
164655953|NCT02637076|594766386|FG001|Overall Study|Withdrawal by Subject|4|||
164655954|NCT00130520|594766387|FG000|Overall Study|Adverse Event|11|||
164655955|NCT00130520|594766387|FG000|Overall Study|Death|1|||
164655956|NCT00130520|594766387|FG000|Overall Study|Physician Decision|1|||
164655957|NCT00130520|594766387|FG000|Overall Study|Withdrawal by Subject|1|||
164655958|NCT00130520|594766387|FG000|Overall Study|Disease Progression|23|||
164655959|NCT00130520|594766387|FG000|Overall Study|Protocol non-compliance|1|||
164655960|NCT00130520|594766387|FG000|Overall Study|Did not meet re-treatment criteria|1|||
164655961|NCT03487796|594766388|FG000|Overall Study|Lost to Follow-up|18|||
164655962|NCT03487796|594766389|FG001|Overall Study|Lost to Follow-up|6|||
164655963|NCT00613574|594766393|FG000|Overall Study|Adverse Event|3|||
164655964|NCT00613574|594766393|FG000|Overall Study|Lost to Follow-up|2|||
164655965|NCT00613574|594766393|FG000|Overall Study|Other|1|||
164655966|NCT04604184|594766397|FG000|Overall Study|Adverse Event|5|||
164655967|NCT04604184|594766398|FG001|Overall Study|Adverse Event|5|||
164655968|NCT04604184|594766397|FG000|Overall Study|Death|2|||
164655969|NCT04604184|594766398|FG001|Overall Study|Death|1|||
164655970|NCT04604184|594766397|FG000|Overall Study|Withdrawal by Subject|1|||
164655971|NCT04604184|594766398|FG001|Overall Study|Withdrawal by Subject|3|||
164655972|NCT04604184|594766397|FG000|Overall Study|Not treated|2|||
164655973|NCT04604184|594766398|FG001|Overall Study|Not treated|2|||
164655974|NCT04604184|594766397|FG000|Overall Study|Due to sponsor decision|9|||
164655975|NCT04604184|594766398|FG001|Overall Study|Due to sponsor decision|7|||
164655976|NCT04604184|594766397|FG000|Overall Study|Physician Decision|0|||
164655977|NCT04604184|594766398|FG001|Overall Study|Physician Decision|1|||
164655978|NCT04604184|594766397|FG000|Overall Study|Transfer to healthcare|1|||
164655979|NCT04604184|594766398|FG001|Overall Study|Transfer to healthcare|0|||
164655980|NCT01751412|594766399|FG000|Overall Study|Disease Progression Before Treatment|1|||
164655981|NCT00582036|594766400|FG000|Overall Study|Withdrawal by Subject|0|||
164655982|NCT00582036|594766401|FG001|Overall Study|Withdrawal by Subject|1|||
164655983|NCT03734237|594766402|FG000|Overall Study|Lost to Follow-up|1|||
164655984|NCT03734237|594766403|FG001|Overall Study|Lost to Follow-up|3|||
164655985|NCT03734237|594766404|FG002|Overall Study|Lost to Follow-up|0|||
164655986|NCT03734237|594766402|FG000|Overall Study|Withdrawal by Subject|7|||
164655987|NCT03734237|594766403|FG001|Overall Study|Withdrawal by Subject|9|||
164655988|NCT03734237|594766404|FG002|Overall Study|Withdrawal by Subject|10|||
164655989|NCT02711956|594766405|FG000|Overall Study|Adverse Event|0|||
164655990|NCT02711956|594766406|FG001|Overall Study|Adverse Event|0|||
164655991|NCT02711956|594766407|FG002|Overall Study|Adverse Event|0|||
164655992|NCT02711956|594766408|FG003|Overall Study|Adverse Event|1|||
164655993|NCT02711956|594766409|FG004|Overall Study|Adverse Event|2|||
164655994|NCT02711956|594766410|FG005|Overall Study|Adverse Event|0|||
164655995|NCT02711956|594766411|FG006|Overall Study|Adverse Event|0|||
164655996|NCT02711956|594766412|FG007|Overall Study|Adverse Event|1|||
164307448|NCT01918306|593499272|FG001|Overall Study|Withdrawal by Subject|0|||
164307449|NCT01918306|593499273|FG002|Overall Study|Withdrawal by Subject|0|||
164307450|NCT01918306|593499274|FG003|Overall Study|Withdrawal by Subject|2|||
164307451|NCT01918306|593499271|FG000|Overall Study|neutropenia|1|||
164307452|NCT01918306|593499272|FG001|Overall Study|neutropenia|0|||
164307453|NCT01918306|593499273|FG002|Overall Study|neutropenia|0|||
164307454|NCT01918306|593499274|FG003|Overall Study|neutropenia|0|||
164307455|NCT01918306|593499271|FG000|Overall Study|Lack of Efficacy|1|||
164307456|NCT01918306|593499272|FG001|Overall Study|Lack of Efficacy|0|||
164307457|NCT01918306|593499273|FG002|Overall Study|Lack of Efficacy|0|||
164307458|NCT01918306|593499274|FG003|Overall Study|Lack of Efficacy|0|||
164307459|NCT01918306|593499271|FG000|Overall Study|progress disease, crossover|0|||
164307460|NCT01918306|593499272|FG001|Overall Study|progress disease, crossover|0|||
164307461|NCT01918306|593499273|FG002|Overall Study|progress disease, crossover|1|||
164307462|NCT01918306|593499274|FG003|Overall Study|progress disease, crossover|0|||
164655997|NCT02711956|594766413|FG008|Overall Study|Adverse Event|1|||
164655998|NCT02711956|594766414|FG009|Overall Study|Adverse Event|1|||
164655999|NCT02711956|594766415|FG010|Overall Study|Adverse Event|1|||
164656000|NCT02711956|594766416|FG011|Overall Study|Adverse Event|0|||
164656001|NCT02711956|594766417|FG012|Overall Study|Adverse Event|0|||
164656002|NCT02711956|594766418|FG013|Overall Study|Adverse Event|0|||
164656003|NCT02711956|594766419|FG014|Overall Study|Adverse Event|2|||
164656004|NCT02711956|594766405|FG000|Overall Study|Physician Decision|0|||
164656005|NCT02711956|594766406|FG001|Overall Study|Physician Decision|0|||
164656006|NCT02711956|594766407|FG002|Overall Study|Physician Decision|0|||
164656007|NCT02711956|594766408|FG003|Overall Study|Physician Decision|2|||
164656008|NCT02711956|594766409|FG004|Overall Study|Physician Decision|0|||
164656009|NCT02711956|594766410|FG005|Overall Study|Physician Decision|0|||
164656010|NCT02711956|594766411|FG006|Overall Study|Physician Decision|0|||
164656011|NCT02711956|594766412|FG007|Overall Study|Physician Decision|0|||
164656012|NCT02711956|594766413|FG008|Overall Study|Physician Decision|0|||
164656013|NCT02711956|594766414|FG009|Overall Study|Physician Decision|0|||
164656014|NCT02711956|594766415|FG010|Overall Study|Physician Decision|0|||
164656015|NCT02711956|594766416|FG011|Overall Study|Physician Decision|0|||
164656016|NCT02711956|594766417|FG012|Overall Study|Physician Decision|0|||
164656017|NCT02711956|594766418|FG013|Overall Study|Physician Decision|0|||
164307463|NCT00314795|593499282|FG000|Overall Study|Adverse Event|8|||
164656018|NCT02711956|594766419|FG014|Overall Study|Physician Decision|0|||
164656019|NCT02711956|594766405|FG000|Overall Study|Withdrawal by Subject|0|||
164656020|NCT02711956|594766406|FG001|Overall Study|Withdrawal by Subject|0|||
164656021|NCT02711956|594766407|FG002|Overall Study|Withdrawal by Subject|0|||
164307464|NCT00314795|593499282|FG000|Overall Study|Death|4|||
164307465|NCT00314795|593499282|FG000|Overall Study|Reason not Specified|3|||
164656022|NCT02711956|594766408|FG003|Overall Study|Withdrawal by Subject|0|||
164656023|NCT02711956|594766409|FG004|Overall Study|Withdrawal by Subject|0|||
164656024|NCT02711956|594766410|FG005|Overall Study|Withdrawal by Subject|0|||
164656025|NCT02711956|594766411|FG006|Overall Study|Withdrawal by Subject|1|||
164656026|NCT02711956|594766412|FG007|Overall Study|Withdrawal by Subject|0|||
164656027|NCT02711956|594766413|FG008|Overall Study|Withdrawal by Subject|0|||
164656028|NCT02711956|594766414|FG009|Overall Study|Withdrawal by Subject|0|||
164656029|NCT02711956|594766415|FG010|Overall Study|Withdrawal by Subject|0|||
164656030|NCT02711956|594766416|FG011|Overall Study|Withdrawal by Subject|1|||
164656031|NCT02711956|594766417|FG012|Overall Study|Withdrawal by Subject|6|||
164656032|NCT02711956|594766418|FG013|Overall Study|Withdrawal by Subject|0|||
164656033|NCT02711956|594766419|FG014|Overall Study|Withdrawal by Subject|1|||
164656034|NCT02711956|594766405|FG000|Overall Study|Clinical progression|1|||
164656035|NCT02711956|594766406|FG001|Overall Study|Clinical progression|0|||
164656036|NCT02711956|594766407|FG002|Overall Study|Clinical progression|0|||
164656037|NCT02711956|594766408|FG003|Overall Study|Clinical progression|0|||
164656038|NCT02711956|594766409|FG004|Overall Study|Clinical progression|0|||
164656039|NCT02711956|594766410|FG005|Overall Study|Clinical progression|0|||
164656040|NCT02711956|594766411|FG006|Overall Study|Clinical progression|1|||
164656041|NCT02711956|594766412|FG007|Overall Study|Clinical progression|0|||
164656042|NCT02711956|594766413|FG008|Overall Study|Clinical progression|1|||
164656043|NCT02711956|594766414|FG009|Overall Study|Clinical progression|0|||
164656044|NCT02711956|594766415|FG010|Overall Study|Clinical progression|0|||
164656045|NCT02711956|594766416|FG011|Overall Study|Clinical progression|2|||
164656046|NCT02711956|594766417|FG012|Overall Study|Clinical progression|4|||
164656047|NCT02711956|594766418|FG013|Overall Study|Clinical progression|1|||
164656048|NCT02711956|594766419|FG014|Overall Study|Clinical progression|1|||
164656049|NCT02711956|594766405|FG000|Overall Study|Radiographic progression|1|||
164656050|NCT02711956|594766406|FG001|Overall Study|Radiographic progression|1|||
164656051|NCT02711956|594766407|FG002|Overall Study|Radiographic progression|2|||
164656052|NCT02711956|594766408|FG003|Overall Study|Radiographic progression|0|||
164656053|NCT02711956|594766409|FG004|Overall Study|Radiographic progression|1|||
164656054|NCT02711956|594766410|FG005|Overall Study|Radiographic progression|0|||
164656055|NCT02711956|594766411|FG006|Overall Study|Radiographic progression|0|||
164656056|NCT02711956|594766412|FG007|Overall Study|Radiographic progression|0|||
164656057|NCT02711956|594766413|FG008|Overall Study|Radiographic progression|2|||
164656058|NCT02711956|594766414|FG009|Overall Study|Radiographic progression|1|||
164656059|NCT02711956|594766415|FG010|Overall Study|Radiographic progression|0|||
164656060|NCT02711956|594766416|FG011|Overall Study|Radiographic progression|5|||
164550539|NCT00105443|594388702|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
164550540|NCT00105443|594388699|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
164550541|NCT00105443|594388700|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
164550542|NCT00105443|594388701|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
164550543|NCT00105443|594388702|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
164550544|NCT00105443|594388699|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
164550545|NCT00105443|594388700|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
164550546|NCT00105443|594388701|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
164550547|NCT00105443|594388702|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
164550548|NCT00105443|594388699|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
164550549|NCT00105443|594388700|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
164550550|NCT00105443|594388701|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
164550551|NCT00105443|594388702|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
164550552|NCT00105443|594388699|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
164550553|NCT00105443|594388700|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
164550554|NCT00105443|594388701|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
164550555|NCT00105443|594388702|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
164550556|NCT00105443|594388699|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
164550557|NCT00105443|594388700|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
164550558|NCT00105443|594388701|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
164550559|NCT00105443|594388702|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
164550560|NCT00105443|594388699|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
164550561|NCT00105443|594388700|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
164550562|NCT00105443|594388701|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
164550563|NCT00105443|594388702|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
164550564|NCT01623271|594388705|FG000|Overall Study|Withdrawal by Subject|2|||
164550565|NCT00876187|594388709|FG000|Overall Study|Adverse Event|14|||
164550566|NCT00876187|594388710|FG001|Overall Study|Adverse Event|12|||
164656061|NCT02711956|594766417|FG012|Overall Study|Radiographic progression|3|||
164656062|NCT02711956|594766418|FG013|Overall Study|Radiographic progression|0|||
164656063|NCT02711956|594766419|FG014|Overall Study|Radiographic progression|1|||
164656064|NCT02711956|594766405|FG000|Overall Study|PSA progression with clinical progression|0|||
164656065|NCT02711956|594766406|FG001|Overall Study|PSA progression with clinical progression|0|||
164198850|NCT04802161|593097767|FG001|Overall Study|Adverse Event|0|||
164198851|NCT04802161|593097768|FG002|Overall Study|Adverse Event|1|||
164198852|NCT04802161|593097769|FG003|Overall Study|Adverse Event|0|||
164198853|NCT04802161|593097766|FG000|Overall Study|Death|0|||
164198854|NCT04802161|593097767|FG001|Overall Study|Death|0|||
164198855|NCT04802161|593097768|FG002|Overall Study|Death|1|||
164198856|NCT04802161|593097769|FG003|Overall Study|Death|0|||
164198857|NCT00447902|593097775|FG000|Overall Study|Adverse Event|0|||
164198858|NCT00447902|593097776|FG001|Overall Study|Adverse Event|3|||
164198859|NCT00447902|593097775|FG000|Overall Study|Protocol Violation|1|||
164198860|NCT00447902|593097776|FG001|Overall Study|Protocol Violation|0|||
164198861|NCT00447902|593097775|FG000|Overall Study|Withdrawal by Subject|0|||
164198862|NCT00447902|593097776|FG001|Overall Study|Withdrawal by Subject|1|||
164198863|NCT00447902|593097775|FG000|Overall Study|included patients who discontinued|1|||
164198864|NCT00447902|593097776|FG001|Overall Study|included patients who discontinued|1|||
164198865|NCT00447902|593097775|FG000|Overall Study|Lack of Efficacy|2|||
164198866|NCT00447902|593097776|FG001|Overall Study|Lack of Efficacy|1|||
164198867|NCT02873689|593099583|FG000|Overall Study|Lack of Efficacy|1|||
164198868|NCT02873689|593099584|FG001|Overall Study|Lack of Efficacy|0|||
164198869|NCT02873689|593099583|FG000|Overall Study|Withdrawal by Subject|2|||
164198870|NCT02873689|593099584|FG001|Overall Study|Withdrawal by Subject|2|||
164198871|NCT02873689|593099583|FG000|Overall Study|Protocol Violation|1|||
164198872|NCT02873689|593099584|FG001|Overall Study|Protocol Violation|0|||
164198873|NCT02873689|593099583|FG000|Overall Study|Adverse Event|2|||
164198874|NCT02873689|593099584|FG001|Overall Study|Adverse Event|2|||
164198875|NCT02873689|593099583|FG000|Overall Study|Randomized but not Treated|1|||
164198876|NCT02873689|593099584|FG001|Overall Study|Randomized but not Treated|1|||
164198877|NCT00350545|593099585|FG000|Overall Study|Withdrawal by Subject|2|||
164198878|NCT00434252|593099589|FG000|Overall Study|Lack of Efficacy|50|||
164198879|NCT00434252|593099590|FG001|Overall Study|Lack of Efficacy|100|||
164198880|NCT00434252|593099589|FG000|Overall Study|Adverse Event|6|||
164198881|NCT00434252|593099590|FG001|Overall Study|Adverse Event|13|||
164198882|NCT00434252|593099589|FG000|Overall Study|Death|1|||
164198883|NCT00434252|593099590|FG001|Overall Study|Death|2|||
164198884|NCT00434252|593099589|FG000|Overall Study|Lost to Follow-up|0|||
164198885|NCT00434252|593099590|FG001|Overall Study|Lost to Follow-up|1|||
164198886|NCT00434252|593099589|FG000|Overall Study|Physician Decision|4|||
164198887|NCT00434252|593099590|FG001|Overall Study|Physician Decision|8|||
164198888|NCT00434252|593099589|FG000|Overall Study|Withdrawal by Subject|3|||
164198889|NCT00434252|593099590|FG001|Overall Study|Withdrawal by Subject|7|||
164198890|NCT00352118|593099593|FG000|Overall Study|Physician Decision|4|||
164198891|NCT02997163|593099594|FG000|Overall Study|Adverse Event|1|||
164198892|NCT02997163|593099595|FG001|Overall Study|Adverse Event|0|||
164198893|NCT02997163|593099596|FG002|Overall Study|Adverse Event|0|||
164198894|NCT02997163|593099597|FG003|Overall Study|Adverse Event|1|||
164198895|NCT02337764|593099598|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
164198896|NCT02337764|593099598|FG000|Overall Study|Voluntary Withdrawal|12|||
164198897|NCT02337764|593099598|FG000|Overall Study|Lack of Efficacy|2|||
164198898|NCT02990000|593099599|FG000|Overall Study|Failed to provide data beyond baseline|36|||
164198899|NCT02990000|593099600|FG001|Overall Study|Failed to provide data beyond baseline|34|||
164198900|NCT02810418|593099614|FG000|Arm A Dose Escalation|Adverse Event|2|||
164198901|NCT02810418|593099615|FG001|Arm A Dose Escalation|Adverse Event|1|||
164198902|NCT02810418|593099616|FG002|Arm A Dose Escalation|Adverse Event|0|||
164198903|NCT02810418|593099617|FG003|Arm A Dose Escalation|Adverse Event|0|||
164198904|NCT02810418|593099618|FG004|Arm A Dose Escalation|Adverse Event|0|||
164198905|NCT02810418|593099619|FG005|Arm A Dose Escalation|Adverse Event|0|||
164198906|NCT02810418|593099620|FG006|Arm A Dose Escalation|Adverse Event|0|||
164198907|NCT02810418|593099614|FG000|Dose Expansion|Adverse Event|0|||
164198908|NCT02810418|593099615|FG001|Dose Expansion|Adverse Event|1|||
164198909|NCT02810418|593099616|FG002|Dose Expansion|Adverse Event|1|||
164198910|NCT02810418|593099617|FG003|Dose Expansion|Adverse Event|0|||
164198911|NCT02810418|593099618|FG004|Dose Expansion|Adverse Event|0|||
164198912|NCT02810418|593099619|FG005|Dose Expansion|Adverse Event|0|||
164198913|NCT02810418|593099620|FG006|Dose Expansion|Adverse Event|0|||
164198914|NCT02810418|593099614|FG000|Dose Expansion|Physician Decision|0|||
164198915|NCT02810418|593099615|FG001|Dose Expansion|Physician Decision|0|||
164198916|NCT02810418|593099616|FG002|Dose Expansion|Physician Decision|2|||
164198917|NCT02810418|593099617|FG003|Dose Expansion|Physician Decision|0|||
164198918|NCT02810418|593099618|FG004|Dose Expansion|Physician Decision|0|||
164198919|NCT02810418|593099619|FG005|Dose Expansion|Physician Decision|0|||
164198920|NCT02810418|593099620|FG006|Dose Expansion|Physician Decision|0|||
164198921|NCT02810418|593099614|FG000|Arm B Dose Escalation|Adverse Event|0|||
164198922|NCT02810418|593099615|FG001|Arm B Dose Escalation|Adverse Event|0|||
164198923|NCT02810418|593099616|FG002|Arm B Dose Escalation|Adverse Event|0|||
164198924|NCT02810418|593099617|FG003|Arm B Dose Escalation|Adverse Event|0|||
164198925|NCT02810418|593099618|FG004|Arm B Dose Escalation|Adverse Event|1|||
164198926|NCT02810418|593099619|FG005|Arm B Dose Escalation|Adverse Event|2|||
164198927|NCT02810418|593099620|FG006|Arm B Dose Escalation|Adverse Event|0|||
164198928|NCT03103503|593099621|FG000|Overall Study|Death|64|||
164198929|NCT03103503|593099621|FG000|Overall Study|Physician Decision|57|||
164198930|NCT03103503|593099621|FG000|Overall Study|Withdrawal by Subject|10|||
164198931|NCT03103503|593099621|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
164198932|NCT03103503|593099621|FG000|Overall Study|Lost to Follow-up|3|||
164198933|NCT03103503|593099621|FG000|Overall Study|Study Closure|757|||
164198934|NCT01433159|593099624|FG000|Overall Study|Adverse Event|1|||
164198935|NCT01433159|593099625|FG001|Overall Study|Adverse Event|0|||
164198936|NCT01433159|593099624|FG000|Overall Study|Physician Decision|1|||
164198937|NCT01433159|593099625|FG001|Overall Study|Physician Decision|0|||
164198938|NCT01433159|593099624|FG000|Overall Study|Protocol Violation|0|||
164198939|NCT01433159|593099625|FG001|Overall Study|Protocol Violation|1|||
164198940|NCT01100853|593099626|FG000|Overall Study|Lost to Follow-up|11|||
164198941|NCT01100853|593099627|FG001|Overall Study|Lost to Follow-up|6|||
164198942|NCT01100853|593099626|FG000|Overall Study|Received <4 study injections|10|||
164198943|NCT01100853|593099627|FG001|Overall Study|Received <4 study injections|13|||
164198944|NCT01100853|593099626|FG000|Overall Study|Withdrawal by Subject|6|||
164198945|NCT01100853|593099627|FG001|Overall Study|Withdrawal by Subject|4|||
164198946|NCT04161391|593099628|FG000|Overall Study|Adverse Event|0|||
164198947|NCT04161391|593099629|FG001|Overall Study|Adverse Event|1|||
164198948|NCT04161391|593099630|FG002|Overall Study|Adverse Event|0|||
164198949|NCT04161391|593099631|FG003|Overall Study|Adverse Event|1|||
164198950|NCT04161391|593099632|FG004|Overall Study|Adverse Event|0|||
164198951|NCT04161391|593099633|FG005|Overall Study|Adverse Event|0|||
164198952|NCT04161391|593099634|FG006|Overall Study|Adverse Event|0|||
164198953|NCT04161391|593099635|FG007|Overall Study|Adverse Event|3|||
164198954|NCT04161391|593099636|FG008|Overall Study|Adverse Event|0|||
164198955|NCT04161391|593099628|FG000|Overall Study|Death|0|||
164198956|NCT04161391|593099629|FG001|Overall Study|Death|0|||
164198957|NCT04161391|593099630|FG002|Overall Study|Death|0|||
164198958|NCT04161391|593099631|FG003|Overall Study|Death|0|||
164198959|NCT04161391|593099632|FG004|Overall Study|Death|0|||
164198960|NCT04161391|593099633|FG005|Overall Study|Death|0|||
164198961|NCT04161391|593099634|FG006|Overall Study|Death|0|||
164198962|NCT04161391|593099635|FG007|Overall Study|Death|1|||
164198963|NCT04161391|593099636|FG008|Overall Study|Death|0|||
164198964|NCT04161391|593099628|FG000|Overall Study|Physician Decision|0|||
164198965|NCT04161391|593099629|FG001|Overall Study|Physician Decision|0|||
164198966|NCT04161391|593099630|FG002|Overall Study|Physician Decision|1|||
164198967|NCT04161391|593099631|FG003|Overall Study|Physician Decision|2|||
164198968|NCT04161391|593099632|FG004|Overall Study|Physician Decision|0|||
164198969|NCT04161391|593099633|FG005|Overall Study|Physician Decision|0|||
164198970|NCT04161391|593099634|FG006|Overall Study|Physician Decision|2|||
164198971|NCT04161391|593099635|FG007|Overall Study|Physician Decision|0|||
164198972|NCT04161391|593099636|FG008|Overall Study|Physician Decision|0|||
164198973|NCT04161391|593099628|FG000|Overall Study|Progressive Disease|4|||
164198974|NCT04161391|593099629|FG001|Overall Study|Progressive Disease|3|||
164198975|NCT04161391|593099630|FG002|Overall Study|Progressive Disease|3|||
164198976|NCT04161391|593099631|FG003|Overall Study|Progressive Disease|5|||
164198977|NCT04161391|593099632|FG004|Overall Study|Progressive Disease|3|||
164198978|NCT04161391|593099633|FG005|Overall Study|Progressive Disease|3|||
164198979|NCT04161391|593099634|FG006|Overall Study|Progressive Disease|5|||
164198980|NCT04161391|593099635|FG007|Overall Study|Progressive Disease|2|||
164198981|NCT04161391|593099636|FG008|Overall Study|Progressive Disease|2|||
164198982|NCT01863771|593099641|FG000|Induction Phase|Adverse Event|9|||
164198983|NCT01863771|593099642|FG001|Induction Phase|Adverse Event|0|||
164198984|NCT01863771|593099643|FG002|Induction Phase|Adverse Event|0|||
164198985|NCT01863771|593099644|FG003|Induction Phase|Adverse Event|0|||
164198986|NCT01863771|593099641|FG000|Induction Phase|Lack of Efficacy|10|||
164198987|NCT01863771|593099642|FG001|Induction Phase|Lack of Efficacy|0|||
164198988|NCT01863771|593099643|FG002|Induction Phase|Lack of Efficacy|0|||
164198989|NCT01863771|593099644|FG003|Induction Phase|Lack of Efficacy|0|||
164198990|NCT01863771|593099641|FG000|Induction Phase|Withdrawal by Subject|2|||
164198991|NCT01863771|593099642|FG001|Induction Phase|Withdrawal by Subject|0|||
164198992|NCT01863771|593099643|FG002|Induction Phase|Withdrawal by Subject|0|||
164198993|NCT01863771|593099644|FG003|Induction Phase|Withdrawal by Subject|0|||
164198994|NCT01863771|593099641|FG000|Maintenance Phase|Adverse Event|0|||
164198995|NCT01863771|593099642|FG001|Maintenance Phase|Adverse Event|0|||
164198996|NCT01863771|593099643|FG002|Maintenance Phase|Adverse Event|1|||
164198997|NCT01863771|593099644|FG003|Maintenance Phase|Adverse Event|1|||
164198998|NCT01863771|593099641|FG000|Maintenance Phase|Lack of Efficacy|0|||
164198999|NCT01863771|593099642|FG001|Maintenance Phase|Lack of Efficacy|3|||
164199000|NCT01863771|593099643|FG002|Maintenance Phase|Lack of Efficacy|7|||
164199001|NCT01863771|593099644|FG003|Maintenance Phase|Lack of Efficacy|38|||
164199002|NCT01863771|593099641|FG000|Maintenance Phase|Physician Decision|0|||
164199003|NCT01863771|593099642|FG001|Maintenance Phase|Physician Decision|0|||
164199004|NCT01863771|593099643|FG002|Maintenance Phase|Physician Decision|2|||
164199005|NCT01863771|593099644|FG003|Maintenance Phase|Physician Decision|1|||
164199006|NCT01863771|593099641|FG000|Maintenance Phase|Pregnancy|0|||
164199007|NCT01863771|593099642|FG001|Maintenance Phase|Pregnancy|1|||
164199008|NCT01863771|593099643|FG002|Maintenance Phase|Pregnancy|0|||
164656066|NCT02711956|594766407|FG002|Overall Study|PSA progression with clinical progression|0|||
164656067|NCT02711956|594766408|FG003|Overall Study|PSA progression with clinical progression|0|||
164656068|NCT02711956|594766409|FG004|Overall Study|PSA progression with clinical progression|1|||
164656069|NCT02711956|594766410|FG005|Overall Study|PSA progression with clinical progression|0|||
164199009|NCT01863771|593099644|FG003|Maintenance Phase|Pregnancy|0|||
164199010|NCT01863771|593099641|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164199011|NCT01863771|593099642|FG001|Maintenance Phase|Withdrawal by Subject|1|||
164199012|NCT01863771|593099643|FG002|Maintenance Phase|Withdrawal by Subject|2|||
164199013|NCT01863771|593099644|FG003|Maintenance Phase|Withdrawal by Subject|3|||
164199014|NCT00386334|593099645|FG000|Double Blind Period|Adverse Event|9|||
164199015|NCT00386334|593099646|FG001|Double Blind Period|Adverse Event|14|||
164199016|NCT00386334|593099645|FG000|Double Blind Period|Protocol Violation|1|||
164199017|NCT00386334|593099646|FG001|Double Blind Period|Protocol Violation|1|||
164199018|NCT00386334|593099645|FG000|Double Blind Period|Withdrawal by Subject|9|||
164199019|NCT00386334|593099646|FG001|Double Blind Period|Withdrawal by Subject|13|||
164199020|NCT00386334|593099645|FG000|Double Blind Period|Lack of Efficacy|20|||
164199021|NCT00386334|593099646|FG001|Double Blind Period|Lack of Efficacy|11|||
164199022|NCT00386334|593099645|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
164199023|NCT00386334|593099646|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
164199024|NCT00386334|593099645|FG000|Double Blind Period|Other|3|||
164199025|NCT00386334|593099646|FG001|Double Blind Period|Other|3|||
164199026|NCT00386334|593099645|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
164199027|NCT00386334|593099646|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
164199028|NCT02089347|593099647|FG000|Overall Study|Protocol Violation|1|||
164199029|NCT02089347|593099648|FG001|Overall Study|Protocol Violation|0|||
164199030|NCT02914834|593099652|FG000|Overall Study|Study halted due to COVID|1|||
164199031|NCT02914834|593099653|FG001|Overall Study|Study halted due to COVID|1|||
164199032|NCT02914834|593099652|FG000|Overall Study|1 subject withdrew|0|||
164199033|NCT02914834|593099653|FG001|Overall Study|1 subject withdrew|1|||
164199034|NCT01225549|593099656|FG000|Period 4 - Washout|Disallowed medication|0|||
164199035|NCT01225549|593099657|FG001|Period 4 - Washout|Disallowed medication|1|||
164199036|NCT01225549|593099658|FG002|Period 4 - Washout|Disallowed medication|0|||
164199037|NCT01225549|593099659|FG003|Period 4 - Washout|Disallowed medication|0|||
164199038|NCT01225549|593099660|FG004|Period 4 - Washout|Disallowed medication|0|||
164199039|NCT01225549|593099661|FG005|Period 4 - Washout|Disallowed medication|0|||
164199040|NCT01225549|593099662|FG006|Period 4 - Washout|Disallowed medication|0|||
164199041|NCT01225549|593099663|FG007|Period 4 - Washout|Disallowed medication|0|||
164199042|NCT01225549|593099664|FG008|Period 4 - Washout|Disallowed medication|0|||
164199043|NCT01225549|593099665|FG009|Period 4 - Washout|Disallowed medication|0|||
164199044|NCT01225549|593099656|FG000|Period 6 - Washout|Disallowed medication|0|||
164199045|NCT01225549|593099657|FG001|Period 6 - Washout|Disallowed medication|0|||
164199046|NCT01225549|593099658|FG002|Period 6 - Washout|Disallowed medication|0|||
164199047|NCT01225549|593099659|FG003|Period 6 - Washout|Disallowed medication|1|||
164199048|NCT01225549|593099660|FG004|Period 6 - Washout|Disallowed medication|0|||
164199049|NCT01225549|593099661|FG005|Period 6 - Washout|Disallowed medication|0|||
164199050|NCT01225549|593099662|FG006|Period 6 - Washout|Disallowed medication|0|||
164199051|NCT01225549|593099663|FG007|Period 6 - Washout|Disallowed medication|0|||
164199052|NCT01225549|593099664|FG008|Period 6 - Washout|Disallowed medication|0|||
164199053|NCT01225549|593099665|FG009|Period 6 - Washout|Disallowed medication|0|||
164199054|NCT02666222|593099673|FG000|Overall Study|Death|2|||
164199055|NCT01825200|593099674|FG000|Overall Study|Lost to Follow-up|5|||
164199056|NCT01825200|593099675|FG001|Overall Study|Lost to Follow-up|6|||
164199057|NCT01825200|593099674|FG000|Overall Study|Withdrawal by Subject|0|||
164199058|NCT01825200|593099675|FG001|Overall Study|Withdrawal by Subject|1|||
164199059|NCT01474486|593099676|FG000|Overall Study|Death|2|||
164199060|NCT01474486|593099676|FG000|Overall Study|Withdrawal by Subject|4|||
164199061|NCT01474486|593099676|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
164199062|NCT01255163|593099677|FG000|Overall Study|Withdrawal by Subject|1|||
164199063|NCT01255163|593099678|FG001|Overall Study|Withdrawal by Subject|0|||
164199064|NCT01255163|593099677|FG000|Overall Study|Lost to Follow-up|2|||
164199065|NCT01255163|593099678|FG001|Overall Study|Lost to Follow-up|0|||
164199066|NCT01255163|593099677|FG000|Overall Study|Adverse Event|0|||
164199067|NCT01255163|593099678|FG001|Overall Study|Adverse Event|2|||
164199068|NCT01255163|593099677|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
164199069|NCT01255163|593099678|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
164199070|NCT04219189|593099682|FG000|Overall Study|Withdrawal by Subject|1|||
164199071|NCT04219189|593099683|FG001|Overall Study|Withdrawal by Subject|2|||
164199072|NCT04219189|593099682|FG000|Overall Study|Protocol Violation|0|||
164199073|NCT04219189|593099683|FG001|Overall Study|Protocol Violation|1|||
164656070|NCT02711956|594766411|FG006|Overall Study|PSA progression with clinical progression|0|||
164656071|NCT02711956|594766412|FG007|Overall Study|PSA progression with clinical progression|0|||
164199074|NCT04219189|593099682|FG000|Overall Study|Lost to Follow-up|0|||
164199075|NCT04219189|593099683|FG001|Overall Study|Lost to Follow-up|1|||
164199076|NCT04219189|593099682|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
164656072|NCT02711956|594766413|FG008|Overall Study|PSA progression with clinical progression|0|||
164656073|NCT02711956|594766414|FG009|Overall Study|PSA progression with clinical progression|0|||
164656074|NCT02711956|594766415|FG010|Overall Study|PSA progression with clinical progression|0|||
164656075|NCT02711956|594766416|FG011|Overall Study|PSA progression with clinical progression|0|||
164656076|NCT02711956|594766417|FG012|Overall Study|PSA progression with clinical progression|1|||
164656077|NCT02711956|594766418|FG013|Overall Study|PSA progression with clinical progression|1|||
164656078|NCT02711956|594766419|FG014|Overall Study|PSA progression with clinical progression|0|||
164656079|NCT02711956|594766405|FG000|Overall Study|PSA progression with radiographic progression|0|||
164656080|NCT02711956|594766406|FG001|Overall Study|PSA progression with radiographic progression|1|||
164656081|NCT02711956|594766407|FG002|Overall Study|PSA progression with radiographic progression|0|||
164656082|NCT02711956|594766408|FG003|Overall Study|PSA progression with radiographic progression|0|||
164656083|NCT02711956|594766409|FG004|Overall Study|PSA progression with radiographic progression|0|||
164656084|NCT02711956|594766410|FG005|Overall Study|PSA progression with radiographic progression|2|||
164656085|NCT02711956|594766411|FG006|Overall Study|PSA progression with radiographic progression|2|||
164656086|NCT02711956|594766412|FG007|Overall Study|PSA progression with radiographic progression|1|||
164656087|NCT02711956|594766413|FG008|Overall Study|PSA progression with radiographic progression|0|||
164656088|NCT02711956|594766414|FG009|Overall Study|PSA progression with radiographic progression|1|||
164307466|NCT00314795|593499282|FG000|Overall Study|Renal Transplant|3|||
164307467|NCT00314795|593499282|FG000|Overall Study|Participants Withdrew Consent|2|||
164307468|NCT02908672|593499289|FG000|Run-in Period|Death|12|||
164307469|NCT02908672|593499290|FG001|Run-in Period|Death|10|||
164307470|NCT02908672|593499291|FG002|Run-in Period|Death|0|||
164307471|NCT02908672|593499292|FG003|Run-in Period|Death|0|||
164307472|NCT02908672|593499289|FG000|Run-in Period|Lost to Follow-up|1|||
164307473|NCT02908672|593499290|FG001|Run-in Period|Lost to Follow-up|1|||
164307474|NCT02908672|593499291|FG002|Run-in Period|Lost to Follow-up|0|||
164307475|NCT02908672|593499292|FG003|Run-in Period|Lost to Follow-up|0|||
164307476|NCT02908672|593499289|FG000|Run-in Period|Reason Not Specified|2|||
164307477|NCT02908672|593499290|FG001|Run-in Period|Reason Not Specified|0|||
164307478|NCT02908672|593499291|FG002|Run-in Period|Reason Not Specified|0|||
164307479|NCT02908672|593499292|FG003|Run-in Period|Reason Not Specified|0|||
164307480|NCT02908672|593499289|FG000|Run-in Period|Protocol Violation|1|||
164307481|NCT02908672|593499290|FG001|Run-in Period|Protocol Violation|1|||
164307482|NCT02908672|593499291|FG002|Run-in Period|Protocol Violation|0|||
164656089|NCT02711956|594766415|FG010|Overall Study|PSA progression with radiographic progression|0|||
164307483|NCT02908672|593499292|FG003|Run-in Period|Protocol Violation|0|||
164307484|NCT02908672|593499289|FG000|Run-in Period|Study Ended by Sponsor|5|||
164307485|NCT02908672|593499290|FG001|Run-in Period|Study Ended by Sponsor|1|||
164307486|NCT02908672|593499291|FG002|Run-in Period|Study Ended by Sponsor|0|||
164307487|NCT02908672|593499292|FG003|Run-in Period|Study Ended by Sponsor|0|||
164307488|NCT02908672|593499289|FG000|Run-in Period|Withdrawal by Subject|3|||
164307489|NCT02908672|593499290|FG001|Run-in Period|Withdrawal by Subject|9|||
164307490|NCT02908672|593499291|FG002|Run-in Period|Withdrawal by Subject|0|||
164307491|NCT02908672|593499292|FG003|Run-in Period|Withdrawal by Subject|0|||
164307492|NCT02908672|593499289|FG000|Triple Combination Period|Death|0|||
164307493|NCT02908672|593499290|FG001|Triple Combination Period|Death|0|||
164307494|NCT02908672|593499291|FG002|Triple Combination Period|Death|150|||
164307495|NCT02908672|593499292|FG003|Triple Combination Period|Death|127|||
164307496|NCT02908672|593499289|FG000|Triple Combination Period|Lost to Follow-up|0|||
164307497|NCT02908672|593499290|FG001|Triple Combination Period|Lost to Follow-up|0|||
164307498|NCT02908672|593499291|FG002|Triple Combination Period|Lost to Follow-up|6|||
164307499|NCT02908672|593499292|FG003|Triple Combination Period|Lost to Follow-up|8|||
164307500|NCT02908672|593499289|FG000|Triple Combination Period|Reason Not Specified|0|||
164307501|NCT02908672|593499290|FG001|Triple Combination Period|Reason Not Specified|0|||
164307502|NCT02908672|593499291|FG002|Triple Combination Period|Reason Not Specified|0|||
164307503|NCT02908672|593499292|FG003|Triple Combination Period|Reason Not Specified|1|||
164307504|NCT02908672|593499289|FG000|Triple Combination Period|Physician Decision|0|||
164307505|NCT02908672|593499290|FG001|Triple Combination Period|Physician Decision|0|||
164307506|NCT02908672|593499291|FG002|Triple Combination Period|Physician Decision|1|||
164307507|NCT02908672|593499292|FG003|Triple Combination Period|Physician Decision|1|||
164307508|NCT02908672|593499289|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
164307509|NCT02908672|593499290|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
164307510|NCT02908672|593499291|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
164307511|NCT02908672|593499292|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
164307512|NCT02908672|593499289|FG000|Triple Combination Period|Withdrawal by Subject|0|||
164307513|NCT02908672|593499290|FG001|Triple Combination Period|Withdrawal by Subject|0|||
164307514|NCT02908672|593499291|FG002|Triple Combination Period|Withdrawal by Subject|13|||
164307515|NCT02908672|593499292|FG003|Triple Combination Period|Withdrawal by Subject|16|||
164307516|NCT02876601|593499296|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
164307517|NCT02876601|593499297|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
164307518|NCT02876601|593499298|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
164307519|NCT02876601|593499299|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
164307520|NCT00802945|593499301|FG000|Overall Study|Death|27|||
164307521|NCT00802945|593499302|FG001|Overall Study|Death|23|||
164307522|NCT00802945|593499301|FG000|Overall Study|Terminated by sponsor|8|||
164307523|NCT00802945|593499302|FG001|Overall Study|Terminated by sponsor|12|||
164307524|NCT05307692|593499303|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
164307525|NCT05307692|593499304|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
164307526|NCT05307692|593499305|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
164307527|NCT05307692|593499306|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
164307528|NCT05307692|593499303|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
164307529|NCT05307692|593499304|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
164307530|NCT05307692|593499305|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
164307531|NCT05307692|593499306|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
164307532|NCT05307692|593499303|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
164307533|NCT05307692|593499304|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
164307534|NCT05307692|593499305|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
164199077|NCT04219189|593099683|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
164199078|NCT03863353|593099684|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
164199079|NCT03863353|593099685|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
164199080|NCT04079790|593099689|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
164199081|NCT04079790|593099690|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
164199082|NCT04079790|593099691|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
164199083|NCT04079790|593099692|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
164199084|NCT04079790|593099689|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
164199085|NCT04079790|593099690|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
164199086|NCT04079790|593099691|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
164199087|NCT04079790|593099692|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
164199088|NCT04079790|593099689|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
164199089|NCT04079790|593099690|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
164199090|NCT04079790|593099691|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
164199091|NCT04079790|593099692|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
164199092|NCT01924533|593099694|FG000|Overall Study|Death|181|||
164199093|NCT01924533|593099695|FG001|Overall Study|Death|200|||
164199094|NCT01924533|593099694|FG000|Overall Study|Lost to Follow-up|0|||
164199095|NCT01924533|593099695|FG001|Overall Study|Lost to Follow-up|1|||
164199096|NCT01924533|593099694|FG000|Overall Study|Withdrawal by Subject|7|||
164199097|NCT01924533|593099695|FG001|Overall Study|Withdrawal by Subject|3|||
164199098|NCT01924533|593099694|FG000|Overall Study|Other Eligibility criteria|1|||
164199099|NCT01924533|593099695|FG001|Overall Study|Other Eligibility criteria|1|||
164199100|NCT05817669|593099696|FG000|Overall Study|Prohibited medication used|1|||
164199101|NCT05817669|593099697|FG001|Overall Study|Prohibited medication used|2|||
164199102|NCT05817669|593099696|FG000|Overall Study|Adverse Event|1|||
164199103|NCT05817669|593099697|FG001|Overall Study|Adverse Event|0|||
164199104|NCT05817669|593099696|FG000|Overall Study|Withdrawal by Subject|1|||
164199105|NCT05817669|593099697|FG001|Overall Study|Withdrawal by Subject|2|||
164199106|NCT04233879|593099698|FG000|Overall Study|Death|2|||
164199107|NCT04233879|593099699|FG001|Overall Study|Death|0|||
164199108|NCT04233879|593099698|FG000|Overall Study|Lost to Follow-up|3|||
164199109|NCT04233879|593099699|FG001|Overall Study|Lost to Follow-up|8|||
164199110|NCT04233879|593099698|FG000|Overall Study|Physician Decision|4|||
164199111|NCT04233879|593099699|FG001|Overall Study|Physician Decision|4|||
164199112|NCT04233879|593099698|FG000|Overall Study|Withdrawal by Subject|7|||
164199113|NCT04233879|593099699|FG001|Overall Study|Withdrawal by Subject|10|||
164199114|NCT04233879|593099698|FG000|Overall Study|Other|281|||
164199115|NCT04233879|593099699|FG001|Overall Study|Other|279|||
164199116|NCT03055936|593099702|FG000|Overall Study|Adverse Event|0|||
164199117|NCT03055936|593099703|FG001|Overall Study|Adverse Event|1|||
164199118|NCT03055936|593099704|FG002|Overall Study|Adverse Event|1|||
164199119|NCT03055936|593099705|FG003|Overall Study|Adverse Event|1|||
164199120|NCT03055936|593099702|FG000|Overall Study|Personal reason|2|||
164199121|NCT03055936|593099703|FG001|Overall Study|Personal reason|0|||
164199122|NCT03055936|593099704|FG002|Overall Study|Personal reason|1|||
164199123|NCT03055936|593099705|FG003|Overall Study|Personal reason|0|||
164199124|NCT05002972|593099709|FG000|Overall Study|Withdrawal by Subject|2|||
164199125|NCT01664091|593099710|FG000|Overall Study|Death|1|||
164199126|NCT01664091|593099710|FG000|Overall Study|Disease Progression|2|||
164199127|NCT01664091|593099710|FG000|Overall Study|Lost to Follow-up|2|||
164420584|NCT01890967|593910947|FG001|Overall Study|Adverse Event|3|||
164656090|NCT02711956|594766416|FG011|Overall Study|PSA progression with radiographic progression|1|||
164199128|NCT01664091|593099710|FG000|Overall Study|Withdrawal by Subject|1|||
164199129|NCT00086190|593099714|FG000|Overall Study|Adverse Event|6|||
164199130|NCT00086190|593099715|FG001|Overall Study|Adverse Event|2|||
164307535|NCT05307692|593499306|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
164307536|NCT05307692|593499303|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
164307537|NCT05307692|593499304|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
164307538|NCT05307692|593499305|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
164307539|NCT05307692|593499306|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
164307540|NCT05307692|593499303|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
164307541|NCT05307692|593499304|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
164307542|NCT05307692|593499305|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
164307543|NCT05307692|593499306|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
164307544|NCT05307692|593499303|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
164307545|NCT05307692|593499304|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
164307546|NCT05307692|593499305|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
164307547|NCT05307692|593499306|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
164307548|NCT05307692|593499303|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
164307549|NCT05307692|593499304|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
164307550|NCT05307692|593499305|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
164307551|NCT05307692|593499306|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
164307552|NCT05307692|593499303|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
164550567|NCT00876187|594388711|FG002|Overall Study|Adverse Event|19|||
164550568|NCT00876187|594388712|FG003|Overall Study|Adverse Event|29|||
164550569|NCT00876187|594388713|FG004|Overall Study|Adverse Event|10|||
164550570|NCT00876187|594388709|FG000|Overall Study|Lack of Efficacy|59|||
164550571|NCT00876187|594388710|FG001|Overall Study|Lack of Efficacy|34|||
164550572|NCT00876187|594388711|FG002|Overall Study|Lack of Efficacy|45|||
164550573|NCT00876187|594388712|FG003|Overall Study|Lack of Efficacy|34|||
164550574|NCT00876187|594388713|FG004|Overall Study|Lack of Efficacy|59|||
164199131|NCT00086190|593099716|FG002|Overall Study|Adverse Event|2|||
164199132|NCT00086190|593099714|FG000|Overall Study|Withdrawal by Subject|0|||
164199133|NCT00086190|593099715|FG001|Overall Study|Withdrawal by Subject|2|||
164199134|NCT00086190|593099716|FG002|Overall Study|Withdrawal by Subject|2|||
164199135|NCT00086190|593099714|FG000|Overall Study|Protocol Violation|1|||
164199136|NCT00086190|593099715|FG001|Overall Study|Protocol Violation|0|||
164199137|NCT00086190|593099716|FG002|Overall Study|Protocol Violation|0|||
164199138|NCT00086190|593099714|FG000|Overall Study|Moved|1|||
164199139|NCT00086190|593099715|FG001|Overall Study|Moved|0|||
164199140|NCT00086190|593099716|FG002|Overall Study|Moved|0|||
164199141|NCT00086190|593099714|FG000|Overall Study|Worsening depression|0|||
164199142|NCT00086190|593099715|FG001|Overall Study|Worsening depression|0|||
164199143|NCT00086190|593099716|FG002|Overall Study|Worsening depression|2|||
164199144|NCT00249834|593099717|FG000|Overall Study|Ovarian stimulation failed|1|||
164199145|NCT00249834|593099718|FG001|Overall Study|Ovarian stimulation failed|0|||
164199146|NCT00249834|593099719|FG002|Overall Study|Ovarian stimulation failed|0|||
164199147|NCT00249834|593099720|FG003|Overall Study|Ovarian stimulation failed|0|||
164199148|NCT00249834|593099721|FG004|Overall Study|Ovarian stimulation failed|0|||
164199149|NCT00249834|593099722|FG005|Overall Study|Ovarian stimulation failed|0|||
164199150|NCT00249834|593099723|FG006|Overall Study|Ovarian stimulation failed|0|||
164199151|NCT00249834|593099724|FG007|Overall Study|Ovarian stimulation failed|0|||
164199152|NCT00249834|593099717|FG000|Overall Study|Failure of down-regulation|0|||
164199153|NCT00249834|593099718|FG001|Overall Study|Failure of down-regulation|0|||
164199154|NCT00249834|593099719|FG002|Overall Study|Failure of down-regulation|0|||
164199155|NCT00249834|593099720|FG003|Overall Study|Failure of down-regulation|0|||
164199156|NCT00249834|593099721|FG004|Overall Study|Failure of down-regulation|0|||
164199157|NCT00249834|593099722|FG005|Overall Study|Failure of down-regulation|0|||
164199158|NCT00249834|593099723|FG006|Overall Study|Failure of down-regulation|1|||
164199159|NCT00249834|593099724|FG007|Overall Study|Failure of down-regulation|0|||
164199160|NCT00249834|593099717|FG000|Overall Study|Protocol Violation|0|||
164199161|NCT00249834|593099718|FG001|Overall Study|Protocol Violation|19|||
164199162|NCT00249834|593099719|FG002|Overall Study|Protocol Violation|14|||
164199163|NCT00249834|593099720|FG003|Overall Study|Protocol Violation|8|||
164199164|NCT00249834|593099721|FG004|Overall Study|Protocol Violation|5|||
164199165|NCT00249834|593099722|FG005|Overall Study|Protocol Violation|2|||
164199166|NCT00249834|593099723|FG006|Overall Study|Protocol Violation|0|||
164199167|NCT00249834|593099724|FG007|Overall Study|Protocol Violation|0|||
164199168|NCT05502302|593099727|FG000|Overall Study|Lost to Follow-up|6|||
164199169|NCT05502302|593099727|FG000|Overall Study|Death|2|||
164199170|NCT02998151|593099728|FG000|Overall Study|Withdrawal by Subject|3|||
164550575|NCT00876187|594388709|FG000|Overall Study|Lost to Follow-up|9|||
164550576|NCT00876187|594388710|FG001|Overall Study|Lost to Follow-up|10|||
164199171|NCT02998151|593099728|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
164199172|NCT02998151|593099728|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
164199173|NCT01204671|593099734|FG000|Overall Study|Adverse Event|4|||
164199174|NCT01204671|593099735|FG001|Overall Study|Adverse Event|3|||
164199175|NCT01204671|593099736|FG002|Overall Study|Adverse Event|3|||
164199176|NCT01204671|593099737|FG003|Overall Study|Adverse Event|3|||
164307553|NCT05307692|593499304|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
164307554|NCT05307692|593499305|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
164307555|NCT05307692|593499306|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
164307556|NCT01648751|593499307|FG000|Overall Study|Withdrawal by Subject|2|||
164307557|NCT01648751|593499308|FG001|Overall Study|Withdrawal by Subject|3|||
164307558|NCT03467750|593499309|FG000|Overall Study|Surgery canceled|1|||
164307559|NCT03467750|593499310|FG001|Overall Study|Surgery canceled|0|||
164307560|NCT03467750|593499309|FG000|Overall Study|Protocol Violation|1|||
164307561|NCT03467750|593499310|FG001|Overall Study|Protocol Violation|1|||
164307562|NCT03467750|593499309|FG000|Overall Study|Withdrawal by Subject|0|||
164307563|NCT03467750|593499310|FG001|Overall Study|Withdrawal by Subject|1|||
164307564|NCT05673876|593499311|FG000|Overall Study|Death|3|||
164307565|NCT05673876|593499312|FG001|Overall Study|Death|1|||
164307566|NCT05673876|593499311|FG000|Overall Study|Study Terminated by Sponsor|0|||
164307567|NCT05673876|593499312|FG001|Overall Study|Study Terminated by Sponsor|1|||
164307568|NCT05673876|593499311|FG000|Overall Study|Physician Decision|0|||
164307569|NCT05673876|593499312|FG001|Overall Study|Physician Decision|1|||
164307570|NCT05006573|593499315|FG000|Double-blind Treatment Period|Physician Decision|2|||
164307571|NCT05006573|593499316|FG001|Double-blind Treatment Period|Physician Decision|0|||
164307572|NCT05006573|593499315|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
164307573|NCT05006573|593499316|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
164307574|NCT05006573|593499315|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
164307575|NCT05006573|593499316|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
164307576|NCT05006573|593499315|FG000|Double-blind Treatment Period|Protocol Violation|2|||
164307577|NCT05006573|593499316|FG001|Double-blind Treatment Period|Protocol Violation|0|||
164307578|NCT05006573|593499315|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
164307579|NCT05006573|593499316|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
164307580|NCT05006573|593499315|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
164307581|NCT05006573|593499316|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
164307582|NCT01077050|593500965|FG000|Overall Study|Subjects signed ICF could not be located|1|||
164307583|NCT01077050|593500965|FG000|Overall Study|Screen failure|8|||
164307584|NCT00684060|593500966|FG000|Overall Study|Lost to Follow-up|1|||
164307585|NCT00684060|593500967|FG001|Overall Study|Lost to Follow-up|0|||
164307586|NCT00684060|593500966|FG000|Overall Study|New stenosis identified|1|||
164307587|NCT00684060|593500967|FG001|Overall Study|New stenosis identified|0|||
164307588|NCT00684060|593500966|FG000|Overall Study|Unable to collect MRI|1|||
164307589|NCT00684060|593500967|FG001|Overall Study|Unable to collect MRI|2|||
164307590|NCT00684060|593500966|FG000|Overall Study|Death|0|||
164307591|NCT00684060|593500967|FG001|Overall Study|Death|1|||
164307592|NCT00702715|593500968|FG000|Overall Study|Lost to Follow-up|1|||
164307593|NCT00702715|593500969|FG001|Overall Study|Lost to Follow-up|0|||
164307594|NCT03126344|593500984|FG000|Overall Study|Lost to Follow-up|0|||
164307595|NCT03126344|593500985|FG001|Overall Study|Lost to Follow-up|0|||
164307596|NCT03126344|593500986|FG002|Overall Study|Lost to Follow-up|5|||
164307597|NCT01715857|593500987|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
164307598|NCT02563067|593500988|FG000|Overall Study|Subject/guardian decision|14|||
164307599|NCT02563067|593500989|FG001|Overall Study|Subject/guardian decision|20|||
164307600|NCT02563067|593500990|FG002|Overall Study|Subject/guardian decision|16|||
164307601|NCT02563067|593500988|FG000|Overall Study|Physician Decision|0|||
164307602|NCT02563067|593500989|FG001|Overall Study|Physician Decision|1|||
164307603|NCT02563067|593500990|FG002|Overall Study|Physician Decision|3|||
164307604|NCT02563067|593500988|FG000|Overall Study|Lost to Follow-up|1|||
164307605|NCT02563067|593500989|FG001|Overall Study|Lost to Follow-up|2|||
164307606|NCT02563067|593500990|FG002|Overall Study|Lost to Follow-up|0|||
164307607|NCT02563067|593500988|FG000|Overall Study|Technical problems|0|||
164307608|NCT02563067|593500989|FG001|Overall Study|Technical problems|1|||
164307609|NCT02563067|593500990|FG002|Overall Study|Technical problems|0|||
164307610|NCT02563067|593500988|FG000|Overall Study|Lack of Efficacy|1|||
164307611|NCT02563067|593500989|FG001|Overall Study|Lack of Efficacy|0|||
164307612|NCT02563067|593500990|FG002|Overall Study|Lack of Efficacy|0|||
164307613|NCT02563067|593500988|FG000|Overall Study|Death|0|||
164307614|NCT02563067|593500989|FG001|Overall Study|Death|1|||
164307615|NCT02563067|593500990|FG002|Overall Study|Death|1|||
164307616|NCT02563067|593500988|FG000|Overall Study|Adverse Event|2|||
164307617|NCT02563067|593500989|FG001|Overall Study|Adverse Event|1|||
164307618|NCT02563067|593500990|FG002|Overall Study|Adverse Event|0|||
164307619|NCT02563067|593500988|FG000|Overall Study|Death post Treatment/safety period|1|||
164307620|NCT02563067|593500989|FG001|Overall Study|Death post Treatment/safety period|0|||
164307621|NCT02563067|593500990|FG002|Overall Study|Death post Treatment/safety period|0|||
164307622|NCT03544333|593500991|FG000|Overall Study|Withdrawal by Subject|1|||
164656091|NCT02711956|594766417|FG012|Overall Study|PSA progression with radiographic progression|2|||
164307623|NCT03544333|593500992|FG001|Overall Study|Withdrawal by Subject|0|||
164307624|NCT00475306|593501000|FG000|Overall Study|Protocol Violation|1|||
164307625|NCT00475306|593501001|FG001|Overall Study|Protocol Violation|1|||
164307626|NCT00475306|593501002|FG002|Overall Study|Protocol Violation|0|||
164307627|NCT00475306|593501003|FG003|Overall Study|Protocol Violation|1|||
164199177|NCT01204671|593099738|FG004|Overall Study|Adverse Event|1|||
164199178|NCT01204671|593099734|FG000|Overall Study|Withdrawal by Subject|2|||
164199179|NCT01204671|593099735|FG001|Overall Study|Withdrawal by Subject|3|||
164199180|NCT01204671|593099736|FG002|Overall Study|Withdrawal by Subject|4|||
164199181|NCT01204671|593099737|FG003|Overall Study|Withdrawal by Subject|5|||
164199182|NCT01204671|593099738|FG004|Overall Study|Withdrawal by Subject|3|||
164199183|NCT01204671|593099734|FG000|Overall Study|Lost to Follow-up|7|||
164199184|NCT01204671|593099735|FG001|Overall Study|Lost to Follow-up|8|||
164199185|NCT01204671|593099736|FG002|Overall Study|Lost to Follow-up|6|||
164199186|NCT01204671|593099737|FG003|Overall Study|Lost to Follow-up|4|||
164199187|NCT01204671|593099738|FG004|Overall Study|Lost to Follow-up|0|||
164199188|NCT01204671|593099734|FG000|Overall Study|Unknown Completion Status|1|||
164199189|NCT01204671|593099735|FG001|Overall Study|Unknown Completion Status|1|||
164199190|NCT01204671|593099736|FG002|Overall Study|Unknown Completion Status|0|||
164199191|NCT01204671|593099737|FG003|Overall Study|Unknown Completion Status|0|||
164199192|NCT01204671|593099738|FG004|Overall Study|Unknown Completion Status|0|||
164199193|NCT01204671|593099734|FG000|Overall Study|Physician Decision|0|||
164199194|NCT01204671|593099735|FG001|Overall Study|Physician Decision|0|||
164199195|NCT01204671|593099736|FG002|Overall Study|Physician Decision|0|||
164199196|NCT01204671|593099737|FG003|Overall Study|Physician Decision|1|||
164199197|NCT01204671|593099738|FG004|Overall Study|Physician Decision|0|||
164199198|NCT02700048|593099739|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
164199199|NCT02700048|593099740|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
164199200|NCT01121263|593099753|FG000|Overall Study|Death|3|||
164199201|NCT01121263|593099754|FG001|Overall Study|Death|2|||
164199202|NCT01121263|593099753|FG000|Overall Study|Lost to Follow-up|22|||
164199203|NCT01121263|593099754|FG001|Overall Study|Lost to Follow-up|12|||
164199204|NCT01121263|593099753|FG000|Overall Study|Withdrawal by Subject|0|||
164199205|NCT01121263|593099754|FG001|Overall Study|Withdrawal by Subject|1|||
164199206|NCT01655901|593101659|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
164199207|NCT01655901|593101660|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
164199208|NCT01655901|593101661|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
164199209|NCT01655901|593101662|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
164199210|NCT01655901|593101663|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
164199211|NCT01655901|593101664|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
164199212|NCT02579629|593101674|FG000|Overall Study|Withdrawal by Subject|0|||
164199213|NCT02579629|593101675|FG001|Overall Study|Withdrawal by Subject|1|||
164199214|NCT02579629|593101676|FG002|Overall Study|Withdrawal by Subject|0|||
164199215|NCT02579629|593101674|FG000|Overall Study|Screen Failure|2|||
164199216|NCT02579629|593101675|FG001|Overall Study|Screen Failure|0|||
164199217|NCT02579629|593101676|FG002|Overall Study|Screen Failure|2|||
164199218|NCT01190891|593101677|FG000|Overall Study|Protocol Violation|1|||
164199219|NCT01190891|593101678|FG001|Overall Study|Protocol Violation|0|||
164199220|NCT01190891|593101677|FG000|Overall Study|Withdrawal by Subject|5|||
164199221|NCT01190891|593101678|FG001|Overall Study|Withdrawal by Subject|0|||
164199222|NCT00737048|593101679|FG000|Overall Study|Physician Decision|0|||
164199223|NCT00737048|593101680|FG001|Overall Study|Physician Decision|0|||
164199224|NCT00737048|593101681|FG002|Overall Study|Physician Decision|1|||
164199225|NCT00737048|593101679|FG000|Overall Study|Adverse Event|0|||
164199226|NCT00737048|593101680|FG001|Overall Study|Adverse Event|1|||
164199227|NCT00737048|593101681|FG002|Overall Study|Adverse Event|0|||
164199228|NCT00737048|593101679|FG000|Overall Study|Worsening of the symptoms|3|||
164199229|NCT00737048|593101680|FG001|Overall Study|Worsening of the symptoms|5|||
164199230|NCT00737048|593101681|FG002|Overall Study|Worsening of the symptoms|3|||
164199231|NCT00301834|593101682|FG000|Overall Study|Death|1|||
164199232|NCT02737358|593101683|FG000|Overall Study|Withdrawal by Subject|7|||
164199233|NCT02737358|593101684|FG001|Overall Study|Withdrawal by Subject|12|||
164199234|NCT02737358|593101683|FG000|Overall Study|Lost to Follow-up|2|||
164199235|NCT02737358|593101684|FG001|Overall Study|Lost to Follow-up|3|||
164199236|NCT00744939|593101685|FG000|Overall Study|Withdrawal by Subject|9|||
164199237|NCT00744939|593101685|FG000|Overall Study|Protocol Violation|13|||
164199238|NCT00744939|593101685|FG000|Overall Study|Death|24|||
164199239|NCT00744939|593101685|FG000|Overall Study|distance|4|||
164199240|NCT00744939|593101685|FG000|Overall Study|Lost to Follow-up|12|||
164199241|NCT00744939|593101685|FG000|Overall Study|Medical history exclusionary|1|||
164199242|NCT00744939|593101685|FG000|Overall Study|Did not receive Magnevist|7|||
164199243|NCT00744939|593101685|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
164199244|NCT00744939|593101685|FG000|Overall Study|coma|1|||
164199245|NCT00744939|593101685|FG000|Overall Study|incorrect race|1|||
164199246|NCT01739335|593101686|FG000|Overall Study|Lost to Follow-up|7|||
164199247|NCT01739335|593101687|FG001|Overall Study|Lost to Follow-up|4|||
164550577|NCT00876187|594388711|FG002|Overall Study|Lost to Follow-up|8|||
164199248|NCT01739335|593101686|FG000|Overall Study|Ineligible patient randomized|0|||
164550578|NCT00876187|594388712|FG003|Overall Study|Lost to Follow-up|8|||
164550579|NCT00876187|594388713|FG004|Overall Study|Lost to Follow-up|11|||
164550580|NCT00876187|594388709|FG000|Overall Study|Protocol Violation|6|||
164199249|NCT01739335|593101687|FG001|Overall Study|Ineligible patient randomized|1|||
164307628|NCT01237899|593501004|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
164307629|NCT01237899|593501005|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
164307630|NCT01237899|593501006|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
164307631|NCT01237899|593501007|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
164307632|NCT01237899|593501008|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
164307633|NCT01237899|593501009|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
164307634|NCT01237899|593501010|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
164307635|NCT01237899|593501011|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
164307636|NCT01237899|593501012|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
164307637|NCT01237899|593501013|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
164307638|NCT01237899|593501014|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
164307639|NCT00790088|593501015|FG000|Overall Study|Protocol Violation|11|||
164307640|NCT00790088|593501015|FG000|Overall Study|Withdrawal by Subject|17|||
164307641|NCT00790088|593501015|FG000|Overall Study|Lost to Follow-up|7|||
164307642|NCT00790088|593501015|FG000|Overall Study|Physician Decision|4|||
164307643|NCT02910986|593501016|FG000|Overall Study|non-Latina|14|||
164307644|NCT02910986|593501017|FG001|Overall Study|non-Latina|13|||
164307645|NCT02910986|593501018|FG002|Overall Study|non-Latina|12|||
164307646|NCT02910986|593501016|FG000|Overall Study|Failure to return T! survey|72|||
164307647|NCT02910986|593501017|FG001|Overall Study|Failure to return T! survey|84|||
164307648|NCT02910986|593501018|FG002|Overall Study|Failure to return T! survey|72|||
164307649|NCT02910986|593501016|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
164307650|NCT02910986|593501017|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
164307651|NCT02910986|593501018|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
164307652|NCT02910986|593501016|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
164307653|NCT02910986|593501017|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
164307654|NCT02910986|593501018|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
164307655|NCT03682770|593501023|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
164307656|NCT03682770|593501024|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
164307657|NCT03682770|593501025|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
164307658|NCT03682770|593501026|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
164307659|NCT03682770|593501027|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
164307660|NCT03682770|593501028|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
164307661|NCT03682770|593501029|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
164307662|NCT03682770|593501023|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
164307663|NCT03682770|593501024|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
164307664|NCT03682770|593501025|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
164307665|NCT03682770|593501026|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
164307666|NCT03682770|593501027|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
164307667|NCT03682770|593501028|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
164307668|NCT03682770|593501029|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
164307669|NCT03682770|593501023|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
164307670|NCT03682770|593501024|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
164307671|NCT03682770|593501025|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
164307672|NCT03682770|593501026|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
164550581|NCT00876187|594388710|FG001|Overall Study|Protocol Violation|7|||
164550582|NCT00876187|594388711|FG002|Overall Study|Protocol Violation|7|||
164550583|NCT00876187|594388712|FG003|Overall Study|Protocol Violation|6|||
164199250|NCT00183430|593101689|FG000|Overall Study|Adverse Event|1|||
164199251|NCT00183430|593101690|FG001|Overall Study|Adverse Event|0|||
164199252|NCT00183430|593101689|FG000|Overall Study|Lost to Follow-up|3|||
164199253|NCT00183430|593101690|FG001|Overall Study|Lost to Follow-up|0|||
164199254|NCT00183430|593101689|FG000|Overall Study|did not meet inclusion criteria|1|||
164199255|NCT00183430|593101690|FG001|Overall Study|did not meet inclusion criteria|0|||
164199256|NCT00183430|593101689|FG000|Overall Study|Withdrawal by Subject|1|||
164199257|NCT00183430|593101690|FG001|Overall Study|Withdrawal by Subject|0|||
164199258|NCT00883181|593101695|FG000|Overall Study|Hematological Adverse Event|26|||
164199259|NCT00883181|593101695|FG000|Overall Study|Non-hematological Adverse Event|55|||
164199260|NCT00883181|593101695|FG000|Overall Study|Disease Progression|94|||
164199261|NCT00883181|593101695|FG000|Overall Study|Administrative Reason|24|||
164199262|NCT00883181|593101695|FG000|Overall Study|Withdrawal by Subject|4|||
164199263|NCT00883181|593101695|FG000|Overall Study|Death|31|||
164199264|NCT00883181|593101695|FG000|Overall Study|Other|38|||
164199265|NCT00883181|593101695|FG000|Overall Study|Protocol Deviation|3|||
164199266|NCT00883181|593101695|FG000|Overall Study|Noncompliance|3|||
164199267|NCT01218308|593101696|FG000|Overall Study|Adverse Event|1|||
164199268|NCT01218308|593101697|FG001|Overall Study|Adverse Event|2|||
164199269|NCT01218308|593101696|FG000|Overall Study|Protocol Violation|0|||
164307673|NCT03682770|593501027|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
164307674|NCT03682770|593501028|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
164199270|NCT01218308|593101697|FG001|Overall Study|Protocol Violation|2|||
164307675|NCT03682770|593501029|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
164307676|NCT03682770|593501023|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
164307677|NCT03682770|593501024|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
164307678|NCT03682770|593501025|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
164307679|NCT03682770|593501026|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
164307680|NCT03682770|593501027|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
164307681|NCT03682770|593501028|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
164307682|NCT03682770|593501029|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
164307683|NCT03682770|593501023|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
164307684|NCT03682770|593501024|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
164307685|NCT03682770|593501025|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
164307686|NCT03682770|593501026|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
164307687|NCT03682770|593501027|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
164307688|NCT03682770|593501028|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
164307689|NCT03682770|593501029|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
164307690|NCT03682770|593501023|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
164307691|NCT03682770|593501024|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
164307692|NCT03682770|593501025|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
164307693|NCT03682770|593501026|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
164307694|NCT03682770|593501027|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
164199271|NCT01218308|593101696|FG000|Overall Study|Withdrawal by Subject|61|||
164199272|NCT01218308|593101697|FG001|Overall Study|Withdrawal by Subject|64|||
164199273|NCT01218308|593101696|FG000|Overall Study|Lost to Follow-up|27|||
164199274|NCT01218308|593101697|FG001|Overall Study|Lost to Follow-up|31|||
164199275|NCT01218308|593101696|FG000|Overall Study|Other|14|||
164199276|NCT01218308|593101697|FG001|Overall Study|Other|21|||
164199277|NCT03238417|593101702|FG000|Overall|non-response|955|||
164199278|NCT03238417|593101703|FG001|Overall|non-response|1920|||
164199279|NCT03238417|593101702|FG000|Overall|partial completion|48|||
164199280|NCT03238417|593101703|FG001|Overall|partial completion|68|||
164199281|NCT03238417|593101702|FG000|Baseline|Partial completion|17|||
164199282|NCT03238417|593101703|FG001|Baseline|Partial completion|48|||
164199283|NCT03238417|593101702|FG000|Baseline|non-response|372|||
164199284|NCT03238417|593101703|FG001|Baseline|non-response|669|||
164199285|NCT03238417|593101702|FG000|12-month|non-response|296|||
164199286|NCT03238417|593101703|FG001|12-month|non-response|669|||
164199287|NCT03238417|593101702|FG000|12-month|partial completion|23|||
164199288|NCT03238417|593101703|FG001|12-month|partial completion|37|||
164199289|NCT03238417|593101702|FG000|24-month|non-response|287|||
164199290|NCT03238417|593101703|FG001|24-month|non-response|594|||
164199291|NCT03238417|593101702|FG000|24-month|partial completion|8|||
164199292|NCT03238417|593101703|FG001|24-month|partial completion|31|||
164199293|NCT00106002|593101708|FG000|Overall Study|Did not take any study drug|1|||
164199294|NCT00106002|593101708|FG000|Overall Study|Ineligible after Registration|1|||
164199295|NCT01122173|593101713|FG000|Overall Study|Lost to Follow-up|3|||
164199296|NCT01122173|593101713|FG000|Overall Study|Withdrawal by Subject|3|||
164199297|NCT01122173|593101713|FG000|Overall Study|Left study for other reasons|3|||
164199298|NCT04210986|593101715|FG000|Overall Study|Lost to Follow-up|5|||
164199299|NCT04210986|593101716|FG001|Overall Study|Lost to Follow-up|2|||
164199300|NCT04210986|593101715|FG000|Overall Study|Withdrawal by Subject|3|||
164199301|NCT04210986|593101716|FG001|Overall Study|Withdrawal by Subject|1|||
164199302|NCT04210986|593101715|FG000|Overall Study|Protocol Violation|1|||
164199303|NCT04210986|593101716|FG001|Overall Study|Protocol Violation|1|||
164199304|NCT04210986|593101715|FG000|Overall Study|Physician Decision|0|||
164199305|NCT04210986|593101716|FG001|Overall Study|Physician Decision|1|||
164199306|NCT01774591|593101717|FG000|Overall Study|Physician Decision|1|||
164199307|NCT01774591|593101718|FG001|Overall Study|Physician Decision|1|||
164199308|NCT01774591|593101717|FG000|Overall Study|Withdrawal by Subject|0|||
164199309|NCT01774591|593101718|FG001|Overall Study|Withdrawal by Subject|1|||
164199310|NCT01774591|593101717|FG000|Overall Study|Adverse Event|0|||
164199311|NCT01774591|593101718|FG001|Overall Study|Adverse Event|2|||
164199312|NCT03504917|593101719|FG000|Blinded Treatment Period|Protocol Violation|1|||
164199313|NCT03504917|593101720|FG001|Blinded Treatment Period|Protocol Violation|0|||
164199314|NCT03504917|593101719|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
164199315|NCT03504917|593101720|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
164199316|NCT03504917|593101719|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
164199317|NCT03504917|593101720|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
164199318|NCT03504917|593101719|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
164307695|NCT03682770|593501028|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
164307696|NCT03682770|593501029|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
164307697|NCT03682770|593501023|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
164307698|NCT03682770|593501024|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
164199319|NCT03504917|593101720|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
164199320|NCT03504917|593101719|FG000|Blinded Treatment Period|Adverse Event|4|||
164550584|NCT00876187|594388713|FG004|Overall Study|Protocol Violation|3|||
164550585|NCT00876187|594388709|FG000|Overall Study|Withdrawal by Subject|16|||
164550586|NCT00876187|594388710|FG001|Overall Study|Withdrawal by Subject|26|||
164550587|NCT00876187|594388711|FG002|Overall Study|Withdrawal by Subject|32|||
164550588|NCT00876187|594388712|FG003|Overall Study|Withdrawal by Subject|38|||
164550589|NCT00876187|594388713|FG004|Overall Study|Withdrawal by Subject|37|||
164550590|NCT00876187|594388709|FG000|Overall Study|Entered extension study|101|||
164550591|NCT00876187|594388710|FG001|Overall Study|Entered extension study|120|||
164550592|NCT00876187|594388711|FG002|Overall Study|Entered extension study|156|||
164550593|NCT00876187|594388712|FG003|Overall Study|Entered extension study|151|||
164550594|NCT00876187|594388713|FG004|Overall Study|Entered extension study|144|||
164550595|NCT00876187|594388709|FG000|Overall Study|Randomized but not treated|3|||
164550596|NCT00876187|594388710|FG001|Overall Study|Randomized but not treated|1|||
164550597|NCT00876187|594388711|FG002|Overall Study|Randomized but not treated|3|||
164550598|NCT00876187|594388712|FG003|Overall Study|Randomized but not treated|2|||
164550599|NCT00876187|594388713|FG004|Overall Study|Randomized but not treated|3|||
164550600|NCT00876187|594388709|FG000|Overall Study|Other|2|||
164550601|NCT00876187|594388710|FG001|Overall Study|Other|5|||
164550602|NCT00876187|594388711|FG002|Overall Study|Other|9|||
164550603|NCT00876187|594388712|FG003|Overall Study|Other|7|||
164550604|NCT00876187|594388713|FG004|Overall Study|Other|4|||
164550605|NCT01379274|594388714|FG000|Overall Study|funding withdrawn|1|||
164550606|NCT03287219|594388717|FG000|Overall Study|Protocol Violation|0|||
164550607|NCT03287219|594388718|FG001|Overall Study|Protocol Violation|2|||
164199321|NCT03504917|593101720|FG001|Blinded Treatment Period|Adverse Event|4|||
164199322|NCT03504917|593101719|FG000|Blinded Treatment Period|Physician Decision|1|||
164199323|NCT03504917|593101720|FG001|Blinded Treatment Period|Physician Decision|0|||
164199324|NCT03504917|593101719|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
164199325|NCT03504917|593101720|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
164199326|NCT03504917|593101719|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
164199327|NCT03504917|593101720|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
164199328|NCT03504917|593101719|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
164199329|NCT03504917|593101720|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
164199330|NCT03504917|593101719|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
164199331|NCT03504917|593101720|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
164199332|NCT03504917|593101719|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
164199333|NCT03504917|593101720|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
164199334|NCT03504917|593101719|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
164199335|NCT03504917|593101720|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
164199336|NCT03504917|593101719|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
164199337|NCT03504917|593101720|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
164199338|NCT03504917|593101719|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
164199339|NCT03504917|593101720|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
164199340|NCT03504917|593101719|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
164199341|NCT03504917|593101720|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
164199342|NCT03504917|593101719|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
164199343|NCT03504917|593101720|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
164199344|NCT03810183|593101721|FG000|Overall Study|Study terminated by Sponsor|2|||
164199345|NCT03810183|593101722|FG001|Overall Study|Study terminated by Sponsor|1|||
164199346|NCT04275336|593101723|FG000|Overall Study|First venipuncture failed|4|||
164199347|NCT04275336|593101724|FG001|Overall Study|First venipuncture failed|6|||
164199348|NCT04275336|593101725|FG002|Overall Study|First venipuncture failed|5|||
164199349|NCT04275336|593101723|FG000|Overall Study|Unscheduled venipuncture|9|||
164199350|NCT04275336|593101724|FG001|Overall Study|Unscheduled venipuncture|13|||
164199351|NCT04275336|593101725|FG002|Overall Study|Unscheduled venipuncture|7|||
164199352|NCT04275336|593101723|FG000|Overall Study|Failed specimen of saliva|4|||
164199353|NCT04275336|593101724|FG001|Overall Study|Failed specimen of saliva|3|||
164199354|NCT04275336|593101725|FG002|Overall Study|Failed specimen of saliva|4|||
164199355|NCT02053493|593101729|FG000|Overall Study|Withdrawal by Subject|1|||
164199356|NCT02053493|593101730|FG001|Overall Study|Withdrawal by Subject|1|||
164199357|NCT01909804|593101731|FG000|Overall Study|Randomized but Never Treated|0|||
164199358|NCT01909804|593101732|FG001|Overall Study|Randomized but Never Treated|0|||
164199359|NCT01909804|593101733|FG002|Overall Study|Randomized but Never Treated|0|||
164199360|NCT01909804|593101734|FG003|Overall Study|Randomized but Never Treated|0|||
164199361|NCT01909804|593101735|FG004|Overall Study|Randomized but Never Treated|0|||
164199362|NCT01909804|593101736|FG005|Overall Study|Randomized but Never Treated|0|||
164199363|NCT01909804|593101737|FG006|Overall Study|Randomized but Never Treated|1|||
164199364|NCT01909804|593101738|FG007|Overall Study|Randomized but Never Treated|0|||
164199365|NCT01909804|593101739|FG008|Overall Study|Randomized but Never Treated|0|||
164550608|NCT00957008|594388719|FG000|Overall Study|Withdrawal by Subject|13|||
164199366|NCT01909804|593101740|FG009|Overall Study|Randomized but Never Treated|0|||
164199367|NCT01909804|593101741|FG010|Overall Study|Randomized but Never Treated|0|||
164199368|NCT01909804|593101742|FG011|Overall Study|Randomized but Never Treated|1|||
164199369|NCT01909804|593101731|FG000|Overall Study|Death|0|||
164199370|NCT01909804|593101732|FG001|Overall Study|Death|0|||
164199371|NCT01909804|593101733|FG002|Overall Study|Death|0|||
164199372|NCT01909804|593101734|FG003|Overall Study|Death|0|||
164199373|NCT01909804|593101735|FG004|Overall Study|Death|0|||
164199374|NCT01909804|593101736|FG005|Overall Study|Death|0|||
164199375|NCT01909804|593101737|FG006|Overall Study|Death|0|||
164199376|NCT01909804|593101738|FG007|Overall Study|Death|0|||
164199377|NCT01909804|593101739|FG008|Overall Study|Death|0|||
164199378|NCT01909804|593101740|FG009|Overall Study|Death|0|||
164199379|NCT01909804|593101741|FG010|Overall Study|Death|1|||
164199380|NCT01909804|593101742|FG011|Overall Study|Death|0|||
164199381|NCT01909804|593101731|FG000|Overall Study|Lack of Efficacy|4|||
164199382|NCT01909804|593101732|FG001|Overall Study|Lack of Efficacy|1|||
164199383|NCT01909804|593101733|FG002|Overall Study|Lack of Efficacy|0|||
164199384|NCT01909804|593101734|FG003|Overall Study|Lack of Efficacy|0|||
164199385|NCT01909804|593101735|FG004|Overall Study|Lack of Efficacy|7|||
164550609|NCT00957008|594388720|FG001|Overall Study|Withdrawal by Subject|10|||
164550610|NCT00957008|594388721|FG002|Overall Study|Withdrawal by Subject|12|||
164550611|NCT00957008|594388722|FG003|Overall Study|Withdrawal by Subject|16|||
164550612|NCT00957008|594388719|FG000|Overall Study|Lost to Follow-up|3|||
164550613|NCT00957008|594388720|FG001|Overall Study|Lost to Follow-up|1|||
164550614|NCT00957008|594388721|FG002|Overall Study|Lost to Follow-up|3|||
164550615|NCT00957008|594388722|FG003|Overall Study|Lost to Follow-up|4|||
164550616|NCT00957008|594388719|FG000|Overall Study|Physician Decision|1|||
164550617|NCT00957008|594388720|FG001|Overall Study|Physician Decision|0|||
164550618|NCT00957008|594388721|FG002|Overall Study|Physician Decision|1|||
164550619|NCT00957008|594388722|FG003|Overall Study|Physician Decision|1|||
164550620|NCT00957008|594388719|FG000|Overall Study|Relocated; Family conflict|4|||
164550621|NCT00957008|594388720|FG001|Overall Study|Relocated; Family conflict|1|||
164550622|NCT00957008|594388721|FG002|Overall Study|Relocated; Family conflict|1|||
164550623|NCT00957008|594388722|FG003|Overall Study|Relocated; Family conflict|3|||
164550624|NCT03571646|594388731|FG000|Overall Study|Adverse Event|1|||
164550625|NCT03571646|594388732|FG001|Overall Study|Adverse Event|0|||
164550626|NCT03571646|594388731|FG000|Overall Study|Withdrawal by Subject|1|||
164550627|NCT03571646|594388732|FG001|Overall Study|Withdrawal by Subject|1|||
164550628|NCT00283595|594388733|FG000|Overall Study|Withdrawal by Subject|1|||
164550629|NCT00283595|594388734|FG001|Overall Study|Withdrawal by Subject|2|||
164550630|NCT04081363|594388735|FG000|Overall Study|Withdrawal by Subject|1|||
164550631|NCT04081363|594388736|FG001|Overall Study|Withdrawal by Subject|0|||
164550632|NCT02025907|594388738|FG000|Overall Study|Lack of Efficacy|1|||
164550633|NCT02025907|594388739|FG001|Overall Study|Lack of Efficacy|0|||
164550634|NCT02025907|594388738|FG000|Overall Study|Withdrawal by Subject|15|||
164550635|NCT02025907|594388739|FG001|Overall Study|Withdrawal by Subject|8|||
164550636|NCT02025907|594388738|FG000|Overall Study|Protocol Violation|2|||
164550637|NCT02025907|594388739|FG001|Overall Study|Protocol Violation|0|||
164550638|NCT02025907|594388738|FG000|Overall Study|Physician Decision|2|||
164550639|NCT02025907|594388739|FG001|Overall Study|Physician Decision|0|||
164550640|NCT02025907|594388738|FG000|Overall Study|Lost to Follow-up|2|||
164550641|NCT02025907|594388739|FG001|Overall Study|Lost to Follow-up|2|||
164550642|NCT02025907|594388738|FG000|Overall Study|Adverse Event|3|||
164550643|NCT02025907|594388739|FG001|Overall Study|Adverse Event|1|||
164550644|NCT02025907|594388738|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
164550645|NCT02025907|594388739|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
164550646|NCT00583362|594388746|FG000|Overall Study|Adverse Event|44|||
164550647|NCT00583362|594388746|FG000|Overall Study|Lack of Efficacy|22|||
164550648|NCT00583362|594388746|FG000|Overall Study|Lost to Follow-up|4|||
164199386|NCT01909804|593101736|FG005|Overall Study|Lack of Efficacy|3|||
164199387|NCT01909804|593101737|FG006|Overall Study|Lack of Efficacy|1|||
164199388|NCT01909804|593101738|FG007|Overall Study|Lack of Efficacy|1|||
164199389|NCT01909804|593101739|FG008|Overall Study|Lack of Efficacy|0|||
164199390|NCT01909804|593101740|FG009|Overall Study|Lack of Efficacy|1|||
164550649|NCT00583362|594388746|FG000|Overall Study|Non-compliance with study drug|28|||
164199391|NCT01909804|593101741|FG010|Overall Study|Lack of Efficacy|0|||
164199392|NCT01909804|593101742|FG011|Overall Study|Lack of Efficacy|1|||
164550650|NCT00583362|594388746|FG000|Overall Study|Pregnancy|7|||
164550651|NCT00583362|594388746|FG000|Overall Study|Miscommunication of visit window|5|||
164550652|NCT00583362|594388746|FG000|Overall Study|Current site closed|7|||
164550653|NCT00583362|594388746|FG000|Overall Study|Subject not dosed in LBSL99|1|||
164550654|NCT00583362|594388746|FG000|Overall Study|Subject moved out of the country/state|2|||
164550655|NCT00583362|594388746|FG000|Overall Study|Missed visits due to staff changes|1|||
164550656|NCT00583362|594388746|FG000|Overall Study|Misunderstanding of protocol|1|||
164550657|NCT00583362|594388746|FG000|Overall Study|Behavioral problems and non-compliance|1|||
164199393|NCT01909804|593101731|FG000|Overall Study|Withdrew Consent|0|||
164550658|NCT00583362|594388746|FG000|Overall Study|Sponsor request due to missed doses|1|||
164199394|NCT01909804|593101732|FG001|Overall Study|Withdrew Consent|0|||
164307699|NCT03682770|593501025|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
164307700|NCT03682770|593501026|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
164307701|NCT03682770|593501027|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
164307702|NCT03682770|593501028|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
164307703|NCT03682770|593501029|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
164307704|NCT03682770|593501023|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
164307705|NCT03682770|593501024|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
164307706|NCT03682770|593501025|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
164307707|NCT03682770|593501026|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
164307708|NCT03682770|593501027|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
164307709|NCT03682770|593501028|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
164307710|NCT03682770|593501029|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
164307711|NCT03682770|593501023|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
164307712|NCT03682770|593501024|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
164307713|NCT03682770|593501025|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
164307714|NCT03682770|593501026|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
164307715|NCT03682770|593501027|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
164307716|NCT03682770|593501028|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
164307717|NCT03682770|593501029|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
164307718|NCT03682770|593501023|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
164307719|NCT03682770|593501024|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
164307720|NCT03682770|593501025|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
164307721|NCT03682770|593501026|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
164307722|NCT03682770|593501027|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
164307723|NCT03682770|593501028|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
164307724|NCT03682770|593501029|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
164307725|NCT03682770|593501023|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
164307726|NCT03682770|593501024|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
164307727|NCT03682770|593501025|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
164307728|NCT03682770|593501026|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
164307729|NCT03682770|593501027|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
164307730|NCT03682770|593501028|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
164307731|NCT03682770|593501029|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
164307732|NCT03682770|593501023|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
164307733|NCT03682770|593501024|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
164307734|NCT03682770|593501025|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
164307735|NCT03682770|593501026|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
164307736|NCT03682770|593501027|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
164307737|NCT03682770|593501028|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
164307738|NCT03682770|593501029|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
164307739|NCT02304367|593501030|FG000|Overall Study|Lack of Response to Bruosumab|1|||
164307740|NCT02304367|593501030|FG000|Overall Study|Sponsor Decision|3|||
164307741|NCT02304367|593501030|FG000|Overall Study|Death|2|||
164307742|NCT02304367|593501030|FG000|Overall Study|Physician Decision|1|||
164307743|NCT02304367|593501030|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
164307744|NCT01262989|593501031|FG000|Period 1|Lost to Follow-up|1|||
164307745|NCT01262989|593501032|FG001|Period 1|Lost to Follow-up|1|||
164307746|NCT01262989|593501031|FG000|Period 1|Intercurrent disease|0|||
164307747|NCT01262989|593501032|FG001|Period 1|Intercurrent disease|1|||
164307748|NCT01262989|593501031|FG000|Period 1|Positive answer for exclusion criteria|0|||
164307749|NCT01262989|593501032|FG001|Period 1|Positive answer for exclusion criteria|1|||
164307750|NCT01262989|593501031|FG000|Period 2|Intercurrent disease|0|||
164307751|NCT01262989|593501032|FG001|Period 2|Intercurrent disease|1|||
164307752|NCT03599089|593501033|FG000|Overall Study|Lost to Follow-up|1|||
164307753|NCT03599089|593501034|FG001|Overall Study|Lost to Follow-up|0|||
164307754|NCT03599089|593501035|FG002|Overall Study|Lost to Follow-up|0|||
164307755|NCT03599089|593501036|FG003|Overall Study|Lost to Follow-up|0|||
164307756|NCT03599089|593501033|FG000|Overall Study|Withdrawal by Subject|2|||
164307757|NCT03599089|593501034|FG001|Overall Study|Withdrawal by Subject|1|||
164307758|NCT03599089|593501035|FG002|Overall Study|Withdrawal by Subject|0|||
164307759|NCT03599089|593501036|FG003|Overall Study|Withdrawal by Subject|0|||
164307760|NCT03599089|593501033|FG000|Overall Study|Lack of Efficacy|0|||
164307761|NCT03599089|593501034|FG001|Overall Study|Lack of Efficacy|0|||
164307762|NCT03599089|593501035|FG002|Overall Study|Lack of Efficacy|1|||
164307763|NCT03599089|593501036|FG003|Overall Study|Lack of Efficacy|2|||
164307764|NCT00459186|593501042|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
164307765|NCT00459186|593501042|FG000|PET Imaging and Assessment|Adverse Event|3|||
164656092|NCT02711956|594766418|FG013|Overall Study|PSA progression with radiographic progression|3|||
164307766|NCT00573144|593501043|FG000|Overall Study|Withdrawal by Subject|2|||
164307767|NCT00573144|593501044|FG001|Overall Study|Withdrawal by Subject|3|||
164307768|NCT02500797|593501047|FG000|Overall Study|Cancel (rapid disease progression)|0|||
164307769|NCT02500797|593501048|FG001|Overall Study|Cancel (rapid disease progression)|0|||
164307770|NCT02500797|593501049|FG002|Overall Study|Cancel (rapid disease progression)|0|||
164307771|NCT02500797|593501050|FG003|Overall Study|Cancel (rapid disease progression)|0|||
164307772|NCT02500797|593501051|FG004|Overall Study|Cancel (rapid disease progression)|1|||
164307773|NCT02500797|593501052|FG005|Overall Study|Cancel (rapid disease progression)|1|||
164307774|NCT02500797|593501053|FG006|Overall Study|Cancel (rapid disease progression)|0|||
164307775|NCT02500797|593501054|FG007|Overall Study|Cancel (rapid disease progression)|0|||
164307776|NCT02500797|593501047|FG000|Overall Study|Withdrawal by Subject|1|||
164307777|NCT02500797|593501048|FG001|Overall Study|Withdrawal by Subject|0|||
164307778|NCT02500797|593501049|FG002|Overall Study|Withdrawal by Subject|0|||
164307779|NCT02500797|593501050|FG003|Overall Study|Withdrawal by Subject|0|||
164307780|NCT02500797|593501051|FG004|Overall Study|Withdrawal by Subject|0|||
164307781|NCT02500797|593501052|FG005|Overall Study|Withdrawal by Subject|0|||
164307782|NCT02500797|593501053|FG006|Overall Study|Withdrawal by Subject|0|||
164307783|NCT02500797|593501054|FG007|Overall Study|Withdrawal by Subject|0|||
164307784|NCT00357006|593501061|FG000|Overall Study|Lost to Follow-up|1|||
164307785|NCT00357006|593501062|FG001|Overall Study|Lost to Follow-up|2|||
164307786|NCT00357006|593501063|FG002|Overall Study|Lost to Follow-up|1|||
164307787|NCT00357006|593501061|FG000|Overall Study|Withdrawal by Subject|1|||
164307788|NCT00357006|593501062|FG001|Overall Study|Withdrawal by Subject|3|||
164307789|NCT00357006|593501063|FG002|Overall Study|Withdrawal by Subject|2|||
164307790|NCT03710161|593501064|FG000|Overall Study|Study halted due to COVID pandemic|3|||
164307791|NCT03710161|593501065|FG001|Overall Study|Study halted due to COVID pandemic|2|||
164307792|NCT02637037|593501066|FG000|Overall Study|Positive drug screen at admission|1|||
164307793|NCT02637037|593501067|FG001|Overall Study|Positive drug screen at admission|0|||
164307794|NCT02637037|593501066|FG000|Overall Study|Withdrawal by Subject|2|||
164307795|NCT02637037|593501067|FG001|Overall Study|Withdrawal by Subject|1|||
164307796|NCT02637037|593501066|FG000|Overall Study|Adverse Event|1|||
164307797|NCT02637037|593501067|FG001|Overall Study|Adverse Event|0|||
164307798|NCT00074490|593501068|FG000|Overall Study|Progressive malignancy|0|||
164307799|NCT00074490|593501069|FG001|Overall Study|Progressive malignancy|7|||
164307800|NCT00074490|593501070|FG002|Overall Study|Progressive malignancy|0|||
164307801|NCT00074490|593501071|FG003|Overall Study|Progressive malignancy|0|||
164307802|NCT00074490|593501072|FG004|Overall Study|Progressive malignancy|3|||
164307803|NCT00074490|593501073|FG005|Overall Study|Progressive malignancy|0|||
164307804|NCT01526733|593501074|FG000|Phase 1|Protocol Violation|1|||
164307805|NCT01526733|593501075|FG001|Phase 1|Protocol Violation|0|||
164307806|NCT01526733|593501074|FG000|Phase 1|Withdrawal by Subject|1|||
164307807|NCT01526733|593501075|FG001|Phase 1|Withdrawal by Subject|1|||
164307808|NCT01869764|593501081|FG000|Overall Study|Withdrawal by Subject|0|||
164307809|NCT01869764|593501082|FG001|Overall Study|Withdrawal by Subject|2|||
164307810|NCT02175030|593501083|FG000|Overall Study|Failed screen after consent|7|||
164307811|NCT02175030|593501084|FG001|Overall Study|Failed screen after consent|6|||
164307812|NCT02175030|593501083|FG000|Overall Study|Failed IUD Insertion|20|||
164307813|NCT02175030|593501084|FG001|Overall Study|Failed IUD Insertion|21|||
164307814|NCT02175030|593501083|FG000|Overall Study|Physician Decision|1|||
164307815|NCT02175030|593501084|FG001|Overall Study|Physician Decision|1|||
164307816|NCT02175030|593501083|FG000|Overall Study|Lost to Follow-up|6|||
164307817|NCT02175030|593501084|FG001|Overall Study|Lost to Follow-up|6|||
164307818|NCT02175030|593501083|FG000|Overall Study|Withdrawal by Subject|1|||
164307819|NCT02175030|593501084|FG001|Overall Study|Withdrawal by Subject|4|||
164307820|NCT00068419|593501090|FG000|Overall Study|Adverse Event|3|||
164307821|NCT00068419|593501090|FG000|Overall Study|Lack of Efficacy|24|||
164307822|NCT00068419|593501090|FG000|Overall Study|Lost to Follow-up|1|||
164307823|NCT00068419|593501090|FG000|Overall Study|Physician Decision|7|||
164307824|NCT00068419|593501090|FG000|Overall Study|Withdrawal by Subject|14|||
164307825|NCT00068419|593501090|FG000|Overall Study|Ineligible|11|||
164307826|NCT02506244|593501095|FG000|Overall Study|Did not undergo active monitoring|458|||
164307827|NCT02506244|593501096|FG001|Overall Study|Did not undergo active monitoring|459|||
164307828|NCT02506244|593501097|FG002|Overall Study|Did not undergo active monitoring|0|||
164307829|NCT02170077|593501102|FG000|Overall Study|Withdrawal by Subject|3|||
164307830|NCT02170077|593501103|FG001|Overall Study|Withdrawal by Subject|4|||
164307831|NCT02170077|593501104|FG002|Overall Study|Withdrawal by Subject|2|||
164307832|NCT02170077|593501102|FG000|Overall Study|Adverse Event|4|||
164307833|NCT02170077|593501103|FG001|Overall Study|Adverse Event|4|||
164307834|NCT02170077|593501104|FG002|Overall Study|Adverse Event|4|||
164307835|NCT02170077|593501102|FG000|Overall Study|Lost to Follow-up|0|||
164307836|NCT02170077|593501103|FG001|Overall Study|Lost to Follow-up|1|||
164307837|NCT02170077|593501104|FG002|Overall Study|Lost to Follow-up|0|||
164307838|NCT02170077|593501102|FG000|Overall Study|Exclusion criteria|2|||
164307839|NCT02170077|593501103|FG001|Overall Study|Exclusion criteria|2|||
164307840|NCT02170077|593501104|FG002|Overall Study|Exclusion criteria|5|||
164307841|NCT02170077|593501102|FG000|Overall Study|Exacerbation of seizures|0|||
164199395|NCT01909804|593101733|FG002|Overall Study|Withdrew Consent|0|||
164199396|NCT01909804|593101734|FG003|Overall Study|Withdrew Consent|0|||
164199397|NCT01909804|593101735|FG004|Overall Study|Withdrew Consent|1|||
164199398|NCT01909804|593101736|FG005|Overall Study|Withdrew Consent|1|||
164199399|NCT01909804|593101737|FG006|Overall Study|Withdrew Consent|0|||
164199400|NCT01909804|593101738|FG007|Overall Study|Withdrew Consent|0|||
164199401|NCT01909804|593101739|FG008|Overall Study|Withdrew Consent|0|||
164199402|NCT01909804|593101740|FG009|Overall Study|Withdrew Consent|0|||
164199403|NCT01909804|593101741|FG010|Overall Study|Withdrew Consent|0|||
164199404|NCT01909804|593101742|FG011|Overall Study|Withdrew Consent|0|||
164199405|NCT01909804|593101731|FG000|Overall Study|Protocol Violation|0|||
164199406|NCT01909804|593101732|FG001|Overall Study|Protocol Violation|0|||
164199407|NCT01909804|593101733|FG002|Overall Study|Protocol Violation|0|||
164199408|NCT01909804|593101734|FG003|Overall Study|Protocol Violation|0|||
164199409|NCT01909804|593101735|FG004|Overall Study|Protocol Violation|0|||
164199410|NCT01909804|593101736|FG005|Overall Study|Protocol Violation|0|||
164199411|NCT01909804|593101737|FG006|Overall Study|Protocol Violation|0|||
164199412|NCT01909804|593101738|FG007|Overall Study|Protocol Violation|0|||
164199413|NCT01909804|593101739|FG008|Overall Study|Protocol Violation|0|||
164199414|NCT01909804|593101740|FG009|Overall Study|Protocol Violation|0|||
164199415|NCT01909804|593101741|FG010|Overall Study|Protocol Violation|0|||
164199416|NCT01909804|593101742|FG011|Overall Study|Protocol Violation|1|||
164199417|NCT05222880|593101744|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
164199418|NCT05222880|593101744|FG000|Overall Study|Withdrew Consent during Study|1|||
164199419|NCT05222880|593101744|FG000|Overall Study|COVID-19 Related|1|||
164199420|NCT05401565|593101745|FG000|Overall Study|Lost to Follow-up|1|||
164199421|NCT05401565|593101746|FG001|Overall Study|Lost to Follow-up|0|||
164199422|NCT05401565|593101745|FG000|Overall Study|Adverse Event|2|||
164199423|NCT05401565|593101746|FG001|Overall Study|Adverse Event|0|||
164199424|NCT00617357|593101749|FG000|Overall Study|Lost to Follow-up|7|||
164199425|NCT00617357|593101749|FG000|Overall Study|Death|5|||
164199426|NCT00617357|593101749|FG000|Overall Study|insurance concerns|2|||
164199427|NCT00617357|593101749|FG000|Overall Study|Withdrawal by Subject|1|||
164199428|NCT00617357|593101749|FG000|Overall Study|Physician Decision|1|||
164199429|NCT02153918|593101754|FG000|Overall Study|Refused further treatment|1|||
164199430|NCT03327324|593101755|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164199431|NCT03327324|593101756|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
164199432|NCT03327324|593101757|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164199433|NCT03327324|593101758|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
164199434|NCT03327324|593101759|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164199435|NCT03327324|593101760|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
164199436|NCT03327324|593101755|FG000|Baseline (Month 0-Month 3)|Refused|0|||
164199437|NCT03327324|593101756|FG001|Baseline (Month 0-Month 3)|Refused|0|||
164199438|NCT03327324|593101757|FG002|Baseline (Month 0-Month 3)|Refused|0|||
164199439|NCT03327324|593101758|FG003|Baseline (Month 0-Month 3)|Refused|0|||
164199440|NCT03327324|593101759|FG004|Baseline (Month 0-Month 3)|Refused|1|||
164199441|NCT03327324|593101760|FG005|Baseline (Month 0-Month 3)|Refused|0|||
164199442|NCT03327324|593101755|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
164199443|NCT03327324|593101756|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
164199444|NCT03327324|593101757|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
164199445|NCT03327324|593101758|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
164199446|NCT03327324|593101759|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
164199447|NCT03327324|593101760|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
164199448|NCT03327324|593101755|FG000|Baseline (Month 0-Month 3)|Death|0|||
164199449|NCT03327324|593101756|FG001|Baseline (Month 0-Month 3)|Death|0|||
164199450|NCT03327324|593101757|FG002|Baseline (Month 0-Month 3)|Death|0|||
164199451|NCT03327324|593101758|FG003|Baseline (Month 0-Month 3)|Death|0|||
164199452|NCT03327324|593101759|FG004|Baseline (Month 0-Month 3)|Death|1|||
164199453|NCT03327324|593101760|FG005|Baseline (Month 0-Month 3)|Death|0|||
164199454|NCT03327324|593101755|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199455|NCT03327324|593101756|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199456|NCT03327324|593101757|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199457|NCT03327324|593101758|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199458|NCT03327324|593101759|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199459|NCT03327324|593101760|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
164199460|NCT03327324|593101755|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164199461|NCT03327324|593101756|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164307842|NCT02170077|593501103|FG001|Overall Study|Exacerbation of seizures|2|||
164307843|NCT02170077|593501104|FG002|Overall Study|Exacerbation of seizures|1|||
164307844|NCT01780974|593501105|FG000|Overall Study|Death|1|||
164307845|NCT01780974|593501106|FG001|Overall Study|Death|0|||
164307846|NCT01780974|593501105|FG000|Overall Study|Adverse Event|1|||
164307847|NCT01780974|593501106|FG001|Overall Study|Adverse Event|3|||
164307848|NCT02447003|593501109|FG000|Overall Study|Other|0|||
164307849|NCT02447003|593501110|FG001|Overall Study|Other|4|||
164307850|NCT02447003|593501109|FG000|Overall Study|Site discontinued|0|||
164307851|NCT02447003|593501110|FG001|Overall Study|Site discontinued|2|||
164307852|NCT02447003|593501109|FG000|Overall Study|Physician Decision|0|||
164307853|NCT02447003|593501110|FG001|Overall Study|Physician Decision|1|||
164307854|NCT02447003|593501109|FG000|Overall Study|Withdrawal by Subject|4|||
164307855|NCT02447003|593501110|FG001|Overall Study|Withdrawal by Subject|3|||
164307856|NCT02447003|593501109|FG000|Overall Study|Sponsor Decision|6|||
164307857|NCT02447003|593501110|FG001|Overall Study|Sponsor Decision|11|||
164307858|NCT02447003|593501109|FG000|Overall Study|Progressive Disease|1|||
164307859|NCT02447003|593501110|FG001|Overall Study|Progressive Disease|0|||
164307860|NCT02447003|593501109|FG000|Overall Study|Lost to Follow-up|5|||
164307861|NCT02447003|593501110|FG001|Overall Study|Lost to Follow-up|0|||
164307862|NCT02447003|593501109|FG000|Overall Study|Death|154|||
164307863|NCT02447003|593501110|FG001|Overall Study|Death|63|||
164307864|NCT00750438|593501111|FG000|Overall Study|Protocol Violation|4|||
164307865|NCT00750438|593501112|FG001|Overall Study|Protocol Violation|1|||
164307866|NCT00750438|593501111|FG000|Overall Study|Physician Decision|2|||
164307867|NCT00750438|593501112|FG001|Overall Study|Physician Decision|2|||
164307868|NCT00750438|593501111|FG000|Overall Study|Withdrawal by Subject|1|||
164307869|NCT00750438|593501112|FG001|Overall Study|Withdrawal by Subject|1|||
164307870|NCT03848728|593501113|FG000|Overall Study|Death|16|||
164307871|NCT03848728|593501114|FG001|Overall Study|Death|13|||
164307872|NCT03848728|593501113|FG000|Overall Study|Outmigrated to non-study community|98|||
164307873|NCT03848728|593501114|FG001|Overall Study|Outmigrated to non-study community|106|||
164307874|NCT03848728|593501113|FG000|Overall Study|Transfered to non-study clinic|32|||
164307875|NCT03848728|593501114|FG001|Overall Study|Transfered to non-study clinic|48|||
164307876|NCT03848728|593501113|FG000|Overall Study|Withdrawal by Subject|1|||
164307877|NCT03848728|593501114|FG001|Overall Study|Withdrawal by Subject|0|||
164307878|NCT00670748|593501116|FG000|Overall Study|Death during treatment|1|||
164307879|NCT00670748|593501117|FG001|Overall Study|Death during treatment|1|||
164307880|NCT00670748|593501118|FG002|Overall Study|Death during treatment|1|||
164307881|NCT00670748|593501119|FG003|Overall Study|Death during treatment|0|||
164307882|NCT00670748|593501116|FG000|Overall Study|Not off study|2|||
164307883|NCT00670748|593501117|FG001|Overall Study|Not off study|1|||
164307884|NCT00670748|593501118|FG002|Overall Study|Not off study|1|||
164307885|NCT00670748|593501119|FG003|Overall Study|Not off study|1|||
164307886|NCT01185080|593501120|FG000|Overall Study|Adverse Event|1|||
164307887|NCT01185080|593501121|FG001|Overall Study|Adverse Event|1|||
164307888|NCT01185080|593501122|FG002|Overall Study|Adverse Event|0|||
164307889|NCT01185080|593501120|FG000|Overall Study|Personal reasons|0|||
164307890|NCT01185080|593501121|FG001|Overall Study|Personal reasons|0|||
164307891|NCT01185080|593501122|FG002|Overall Study|Personal reasons|1|||
164307892|NCT02736578|593501125|FG000|Overall Study|Adverse Event|1|||
164307893|NCT02736578|593501126|FG001|Overall Study|Adverse Event|0|||
164307894|NCT05615922|593501129|FG000|Overall Study|Lost to Follow-up|1|||
164307895|NCT06083506|593501130|FG000|Overall Study|Physician Decision|2|||
164307896|NCT06083506|593501130|FG000|Overall Study|Lack of Efficacy|1|||
164307897|NCT04500158|593501131|FG000|Overall Study|Physician Decision|17|||
164307898|NCT04500158|593501132|FG001|Overall Study|Physician Decision|11|||
164307899|NCT00905164|593501136|FG000|Period 1|Protocol Violation|0|||
164307900|NCT00905164|593501137|FG001|Period 1|Protocol Violation|1|||
164307901|NCT04730804|593501138|FG000|Overall Study|Physician Decision|0|||
164307902|NCT04730804|593501139|FG001|Overall Study|Physician Decision|0|||
164307903|NCT04730804|593501140|FG002|Overall Study|Physician Decision|0|||
164307904|NCT04730804|593501141|FG003|Overall Study|Physician Decision|0|||
164307905|NCT04730804|593501142|FG004|Overall Study|Physician Decision|0|||
164307906|NCT04730804|593501143|FG005|Overall Study|Physician Decision|1|||
164307907|NCT04730804|593501138|FG000|Overall Study|Withdrawal by Subject|0|||
164307908|NCT04730804|593501139|FG001|Overall Study|Withdrawal by Subject|0|||
164307909|NCT04730804|593501140|FG002|Overall Study|Withdrawal by Subject|0|||
164307910|NCT04730804|593501141|FG003|Overall Study|Withdrawal by Subject|0|||
164307911|NCT04730804|593501142|FG004|Overall Study|Withdrawal by Subject|1|||
164307912|NCT04730804|593501143|FG005|Overall Study|Withdrawal by Subject|2|||
164307913|NCT01193257|593502451|FG000|Overall Study|Death|202|||
164307914|NCT01193257|593502452|FG001|Overall Study|Death|391|||
164307915|NCT01193257|593502451|FG000|Overall Study|Study termination by sponsor|0|||
164307916|NCT01193257|593502452|FG001|Overall Study|Study termination by sponsor|3|||
164307917|NCT01193257|593502451|FG000|Overall Study|Withdrawal by Subject|26|||
164307918|NCT01193257|593502452|FG001|Overall Study|Withdrawal by Subject|86|||
164307919|NCT01193257|593502451|FG000|Overall Study|Lost to Follow-up|2|||
164307920|NCT01193257|593502452|FG001|Overall Study|Lost to Follow-up|3|||
164307921|NCT01193257|593502451|FG000|Overall Study|Unblinded due to futility|135|||
164307922|NCT01193257|593502452|FG001|Overall Study|Unblinded due to futility|251|||
164307923|NCT01330108|593502468|FG000|Overall Study|Withdrawal by Subject|4|||
164307924|NCT00423917|593502471|FG000|Overall Study|Cancel|2|||
164307925|NCT00423917|593502471|FG000|Overall Study|Ineligible|1|||
164307926|NCT00555061|593502472|FG000|Overall Study|Adverse Event|3|||
164307927|NCT00555061|593502472|FG000|Overall Study|Protocol Violation|1|||
164307928|NCT00555061|593502472|FG000|Overall Study|Lost to Follow-up|2|||
164307929|NCT00555061|593502472|FG000|Overall Study|Withdrawal by Subject|2|||
164307930|NCT00555061|593502472|FG000|Overall Study|Participant enrolled, but never treated|1|||
164307931|NCT01175083|593502473|FG000|Primary Epoch|Withdrawal by Subject|0|||
164307932|NCT01175083|593502474|FG001|Primary Epoch|Withdrawal by Subject|0|||
164307933|NCT01175083|593502475|FG002|Primary Epoch|Withdrawal by Subject|0|||
164307934|NCT01175083|593502476|FG003|Primary Epoch|Withdrawal by Subject|0|||
164307935|NCT01175083|593502477|FG004|Primary Epoch|Withdrawal by Subject|0|||
164307936|NCT01175083|593502478|FG005|Primary Epoch|Withdrawal by Subject|2|||
164307937|NCT01175083|593502473|FG000|Primary Epoch|Lost to Follow-up|0|||
164307938|NCT01175083|593502474|FG001|Primary Epoch|Lost to Follow-up|0|||
164307939|NCT01175083|593502475|FG002|Primary Epoch|Lost to Follow-up|0|||
164307940|NCT01175083|593502476|FG003|Primary Epoch|Lost to Follow-up|0|||
164307941|NCT01175083|593502477|FG004|Primary Epoch|Lost to Follow-up|0|||
164307942|NCT01175083|593502478|FG005|Primary Epoch|Lost to Follow-up|1|||
164307943|NCT01175083|593502473|FG000|Booster Epoch|Death|0|||
164307944|NCT01175083|593502474|FG001|Booster Epoch|Death|0|||
164307945|NCT01175083|593502475|FG002|Booster Epoch|Death|1|||
164307946|NCT01175083|593502476|FG003|Booster Epoch|Death|0|||
164307947|NCT01175083|593502477|FG004|Booster Epoch|Death|0|||
164307948|NCT01175083|593502478|FG005|Booster Epoch|Death|0|||
164307949|NCT01175083|593502473|FG000|Booster Epoch|Withdrawal by Subject|0|||
164307950|NCT01175083|593502474|FG001|Booster Epoch|Withdrawal by Subject|0|||
164307951|NCT01175083|593502475|FG002|Booster Epoch|Withdrawal by Subject|0|||
164307952|NCT01175083|593502476|FG003|Booster Epoch|Withdrawal by Subject|1|||
164307953|NCT01175083|593502477|FG004|Booster Epoch|Withdrawal by Subject|0|||
164307954|NCT01175083|593502478|FG005|Booster Epoch|Withdrawal by Subject|0|||
164307955|NCT02881567|593502479|FG000|Overall Study|Adverse Event|1|||
164307956|NCT02881567|593502479|FG000|Overall Study|Lost to Follow-up|3|||
164307957|NCT02881567|593502479|FG000|Overall Study|Consent withdrawn|1|||
164307958|NCT02881567|593502479|FG000|Overall Study|Investigator decision|1|||
164307959|NCT02881567|593502479|FG000|Overall Study|Study terminated by sponsor|9|||
164307960|NCT02881567|593502479|FG000|Overall Study|Reason not Specified|3|||
164307961|NCT00373113|593502481|FG000|Overall Study|Death|1|||
164307962|NCT00373113|593502482|FG001|Overall Study|Death|7|||
164307963|NCT00373113|593502481|FG000|Overall Study|Adverse Event|38|||
164307964|NCT00373113|593502482|FG001|Overall Study|Adverse Event|24|||
164307965|NCT00373113|593502481|FG000|Overall Study|Study terminated by sponsor|9|||
164307966|NCT00373113|593502482|FG001|Overall Study|Study terminated by sponsor|1|||
164307967|NCT00373113|593502481|FG000|Overall Study|Global deterioration of health status|10|||
164307968|NCT00373113|593502482|FG001|Overall Study|Global deterioration of health status|7|||
164307969|NCT00373113|593502481|FG000|Overall Study|Lost to Follow-up|1|||
164307970|NCT00373113|593502482|FG001|Overall Study|Lost to Follow-up|3|||
164307971|NCT00373113|593502481|FG000|Overall Study|Objective progression or relapse|150|||
164307972|NCT00373113|593502482|FG001|Overall Study|Objective progression or relapse|169|||
164307973|NCT00373113|593502481|FG000|Overall Study|Other|14|||
164307974|NCT00373113|593502482|FG001|Overall Study|Other|17|||
164307975|NCT00373113|593502481|FG000|Overall Study|Protocol Violation|5|||
164307976|NCT00373113|593502482|FG001|Overall Study|Protocol Violation|1|||
164307977|NCT00373113|593502481|FG000|Overall Study|Withdrawal by Subject|10|||
164307978|NCT00373113|593502482|FG001|Overall Study|Withdrawal by Subject|15|||
164307979|NCT03830892|593502484|FG000|Overall Study|Physician Decision|2|||
164307980|NCT03830892|593502485|FG001|Overall Study|Physician Decision|3|||
164656093|NCT02711956|594766419|FG014|Overall Study|PSA progression with radiographic progression|3|||
164656094|NCT01844583|594766420|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
164656095|NCT01844583|594766421|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
164656096|NCT01625377|594766422|FG000|Overall Study|Death|1|||
164656097|NCT01625377|594766423|FG001|Overall Study|Death|1|||
164307981|NCT03830892|593502484|FG000|Overall Study|Study terminated due to COVID|4|||
164307982|NCT03830892|593502485|FG001|Overall Study|Study terminated due to COVID|0|||
164307983|NCT03830892|593502484|FG000|Overall Study|Protocol Violation|0|||
164656098|NCT01625377|594766422|FG000|Overall Study|Administrative Problem|1|||
164307984|NCT03830892|593502485|FG001|Overall Study|Protocol Violation|1|||
164307985|NCT03830892|593502484|FG000|Overall Study|Withdrawal by Subject|0|||
164307986|NCT03830892|593502485|FG001|Overall Study|Withdrawal by Subject|2|||
164307987|NCT01499277|593502486|FG000|Overall Study|Adverse Event|3|||
164307988|NCT01499277|593502487|FG001|Overall Study|Adverse Event|6|||
164307989|NCT01499277|593502486|FG000|Overall Study|Death|3|||
164307990|NCT01499277|593502487|FG001|Overall Study|Death|2|||
164307991|NCT01499277|593502486|FG000|Overall Study|Lost to Follow-up|15|||
164307992|NCT01499277|593502487|FG001|Overall Study|Lost to Follow-up|8|||
164307993|NCT01499277|593502486|FG000|Overall Study|Protocol Violation|2|||
164307994|NCT01499277|593502487|FG001|Overall Study|Protocol Violation|3|||
164307995|NCT01499277|593502486|FG000|Overall Study|Withdrawal by Subject|16|||
164307996|NCT01499277|593502487|FG001|Overall Study|Withdrawal by Subject|6|||
164307997|NCT01499277|593502486|FG000|Overall Study|Lack of therapeutic response and other|8|||
164307998|NCT01499277|593502487|FG001|Overall Study|Lack of therapeutic response and other|7|||
164307999|NCT00975689|593502488|FG000|Overall Study|Adverse Event|0|||
164308000|NCT00975689|593502489|FG001|Overall Study|Adverse Event|3|||
164308001|NCT00975689|593502488|FG000|Overall Study|Withdrawal by Subject|1|||
164308002|NCT00975689|593502489|FG001|Overall Study|Withdrawal by Subject|0|||
164308003|NCT00975689|593502488|FG000|Overall Study|Physician Decision|1|||
164308004|NCT00975689|593502489|FG001|Overall Study|Physician Decision|0|||
164308005|NCT00372593|593502492|FG000|Overall Study|Adverse Event|43|||
164308006|NCT00372593|593502493|FG001|Overall Study|Adverse Event|45|||
164308007|NCT00372593|593502494|FG002|Overall Study|Adverse Event|0|||
164308008|NCT00372593|593502492|FG000|Overall Study|Death|16|||
164308009|NCT00372593|593502493|FG001|Overall Study|Death|20|||
164308010|NCT00372593|593502494|FG002|Overall Study|Death|1|||
164308011|NCT00372593|593502492|FG000|Overall Study|Lack of Efficacy|82|||
164308012|NCT00372593|593502493|FG001|Overall Study|Lack of Efficacy|71|||
164308013|NCT00372593|593502494|FG002|Overall Study|Lack of Efficacy|2|||
164308014|NCT00372593|593502492|FG000|Overall Study|Lost to Follow-up|1|||
164308015|NCT00372593|593502493|FG001|Overall Study|Lost to Follow-up|0|||
164308016|NCT00372593|593502494|FG002|Overall Study|Lost to Follow-up|0|||
164308017|NCT00372593|593502492|FG000|Overall Study|Physician Decision|42|||
164308018|NCT00372593|593502493|FG001|Overall Study|Physician Decision|41|||
164308019|NCT00372593|593502494|FG002|Overall Study|Physician Decision|0|||
164308020|NCT00372593|593502492|FG000|Overall Study|Ineligible|20|||
164308021|NCT00372593|593502493|FG001|Overall Study|Ineligible|21|||
164308022|NCT00372593|593502494|FG002|Overall Study|Ineligible|1|||
164308023|NCT02974543|593502495|FG000|Overall Study|Withdrawal by Subject|1|||
164308024|NCT02974543|593502496|FG001|Overall Study|Withdrawal by Subject|0|||
164308025|NCT03534180|593502497|FG000|Overall Study|Withdrawal by Subject|1|||
164308026|NCT00220636|593502498|FG000|Overall Study|Withdrawal by Subject|4|||
164308027|NCT00330967|593502499|FG000|Overall Study|Withdrawal by Subject|0|||
164308028|NCT00330967|593502500|FG001|Overall Study|Withdrawal by Subject|5|||
164308029|NCT00330967|593502499|FG000|Overall Study|Physician Decision|0|||
164308030|NCT00330967|593502500|FG001|Overall Study|Physician Decision|9|||
164308031|NCT01662102|593502506|FG000|Overall Study|Sponsor's decision|1|||
164308032|NCT01662102|593502507|FG001|Overall Study|Sponsor's decision|0|||
164308033|NCT02586207|593502508|FG000|Overall Study|Physician Decision|1|||
164308034|NCT02586207|593502508|FG000|Overall Study|Withdrawal by Subject|1|||
164308035|NCT02362282|593502512|FG000|Overall Study|Withdrawal by Subject|1|||
164308036|NCT02362282|593502513|FG001|Overall Study|Withdrawal by Subject|0|||
164308037|NCT02004093|593502514|FG000|Overall Study|Death|2|||
164308038|NCT02004093|593502515|FG001|Overall Study|Death|1|||
164308039|NCT02004093|593502514|FG000|Overall Study|Lack of Efficacy|66|||
164308040|NCT02004093|593502515|FG001|Overall Study|Lack of Efficacy|62|||
164308041|NCT02004093|593502514|FG000|Overall Study|Protocol Violation|0|||
164308042|NCT02004093|593502515|FG001|Overall Study|Protocol Violation|1|||
164308043|NCT02004093|593502514|FG000|Overall Study|Lost to Follow-up|0|||
164308044|NCT02004093|593502515|FG001|Overall Study|Lost to Follow-up|1|||
164308045|NCT02004093|593502514|FG000|Overall Study|Withdrawal by Subject|3|||
164308046|NCT02004093|593502515|FG001|Overall Study|Withdrawal by Subject|7|||
164308047|NCT02004093|593502514|FG000|Overall Study|Other|3|||
164308048|NCT02004093|593502515|FG001|Overall Study|Other|1|||
164308049|NCT04085289|593502516|FG000|Overall Study|Withdrawal by Subject|0|||
164308050|NCT04085289|593502517|FG001|Overall Study|Withdrawal by Subject|0|||
164308051|NCT04085289|593502518|FG002|Overall Study|Withdrawal by Subject|1|||
164308052|NCT00774566|593502519|FG000|Overall Study|Protocol Violation|18|||
164308053|NCT00774566|593502520|FG001|Overall Study|Protocol Violation|15|||
164308054|NCT04896073|593502521|FG000|Overall Study|Screen failure|0|||
164308055|NCT04896073|593502522|FG001|Overall Study|Screen failure|2|||
164308056|NCT04896073|593502521|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
164308057|NCT04896073|593502522|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
164308058|NCT00439517|593502523|FG000|Overall Study|Subject on treatment|1|||
164308059|NCT00439517|593502524|FG001|Overall Study|Subject on treatment|0|||
164308060|NCT00439517|593502523|FG000|Overall Study|Subject in survival follow-up|1|||
164308061|NCT00439517|593502524|FG001|Overall Study|Subject in survival follow-up|0|||
164308062|NCT03527732|593502527|FG000|Overall Study|Lost to Follow-up|21|||
164308063|NCT03527732|593502528|FG001|Overall Study|Lost to Follow-up|23|||
164308064|NCT03527732|593502529|FG002|Overall Study|Lost to Follow-up|80|||
164308065|NCT03527732|593502530|FG003|Overall Study|Lost to Follow-up|62|||
164308066|NCT03527732|593502531|FG004|Overall Study|Lost to Follow-up|12|||
164308067|NCT03527732|593502532|FG005|Overall Study|Lost to Follow-up|20|||
164308068|NCT00470275|593502533|FG000|Overall Study|Death|1|||
164308069|NCT00470275|593502533|FG000|Overall Study|Lack of Efficacy|7|||
164308070|NCT00470275|593502533|FG000|Overall Study|Withdrawal by Subject|2|||
164308071|NCT02207088|593502534|FG000|Overall Study|Adverse Event|2|||
164308072|NCT04411667|593502544|FG000|Overall Study|Physician Decision|1|||
164308073|NCT04411667|593502545|FG001|Overall Study|Physician Decision|0|||
164308074|NCT03399552|593502547|FG000|Overall Study|No evidence of disease|1|||
164308075|NCT03399552|593502547|FG000|Overall Study|Unevaluable|1|||
164308076|NCT01147874|593502552|FG000|Overall Study|Adverse Event|5|||
164308077|NCT01147874|593502552|FG000|Overall Study|Investigator's Request|1|||
164308078|NCT01147874|593502552|FG000|Overall Study|Lost to Follow-up|25|||
164308079|NCT01147874|593502552|FG000|Overall Study|Other|5|||
164308080|NCT01147874|593502552|FG000|Overall Study|Protocol Violation|5|||
164308081|NCT01147874|593502552|FG000|Overall Study|Sponsor's Decision|2|||
164308082|NCT01147874|593502552|FG000|Overall Study|Withdrawal by Subject|24|||
164308083|NCT02991040|593502553|FG000|Overall Study|Withdrawal by Subject|2|||
164308084|NCT02991040|593502553|FG000|Overall Study|Lost to Follow-up|2|||
164308085|NCT04287517|593502554|FG000|Overall Study|Withdrawal by Subject|1|||
164308086|NCT04287517|593502555|FG001|Overall Study|Withdrawal by Subject|1|||
164308087|NCT02533453|593502559|FG000|Overall Study|Adverse Event|6|||
164308088|NCT02533453|593502559|FG000|Overall Study|Protocol Violation|1|||
164308089|NCT02533453|593502559|FG000|Overall Study|Withdrawal by Subject|2|||
164308090|NCT01273519|593502560|FG000|Overall Study|Adverse Event|3|||
164308091|NCT01273519|593502561|FG001|Overall Study|Adverse Event|0|||
164308092|NCT01273519|593502562|FG002|Overall Study|Adverse Event|0|||
164308093|NCT01273519|593502560|FG000|Overall Study|Lost to Follow-up|2|||
164308094|NCT01273519|593502561|FG001|Overall Study|Lost to Follow-up|1|||
164308095|NCT01273519|593502562|FG002|Overall Study|Lost to Follow-up|3|||
164308096|NCT01273519|593502560|FG000|Overall Study|Lack of Efficacy|8|||
164308097|NCT01273519|593502561|FG001|Overall Study|Lack of Efficacy|3|||
164308098|NCT01273519|593502562|FG002|Overall Study|Lack of Efficacy|4|||
164308099|NCT01273519|593502560|FG000|Overall Study|Other|6|||
164308100|NCT01273519|593502561|FG001|Overall Study|Other|1|||
164308101|NCT01273519|593502562|FG002|Overall Study|Other|1|||
164308102|NCT00396253|593502564|FG000|Overall Study|Protocol Violation|1|||
164308103|NCT00396253|593502564|FG000|Overall Study|Withdrawal by Subject|7|||
164308104|NCT00396253|593502564|FG000|Overall Study|Death|3|||
164308105|NCT00396253|593502564|FG000|Overall Study|Physician Decision|1|||
164308106|NCT00396253|593502564|FG000|Overall Study|Change in eligibility status|1|||
164308107|NCT00092443|593502565|FG000|Overall Study|Adverse Event|9|||
164308108|NCT00092443|593502566|FG001|Overall Study|Adverse Event|13|||
164308109|NCT00092443|593502565|FG000|Overall Study|Lost to Follow-up|7|||
164308110|NCT00092443|593502566|FG001|Overall Study|Lost to Follow-up|3|||
164308111|NCT00092443|593502565|FG000|Overall Study|Protocol Violation|11|||
164308112|NCT00092443|593502566|FG001|Overall Study|Protocol Violation|9|||
164308113|NCT00092443|593502565|FG000|Overall Study|Withdrawal by Subject|9|||
164308114|NCT00092443|593502566|FG001|Overall Study|Withdrawal by Subject|11|||
164308115|NCT00092443|593502565|FG000|Overall Study|Moved|5|||
164308116|NCT00092443|593502566|FG001|Overall Study|Moved|5|||
164308117|NCT00092443|593502565|FG000|Overall Study|Other|17|||
164308118|NCT00092443|593502566|FG001|Overall Study|Other|13|||
164308119|NCT04717336|593502567|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
164308120|NCT04717336|593502568|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
164308121|NCT04717336|593502567|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
164308122|NCT04717336|593502568|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
164308123|NCT01724346|593502572|FG000|Overall Study|Death|42|||
164308124|NCT01724346|593502573|FG001|Overall Study|Death|42|||
164308125|NCT01724346|593502572|FG000|Overall Study|Lost to Follow-up|5|||
164308126|NCT01724346|593502573|FG001|Overall Study|Lost to Follow-up|1|||
164308127|NCT01724346|593502572|FG000|Overall Study|Withdrawal by Subject|27|||
164308128|NCT01724346|593502573|FG001|Overall Study|Withdrawal by Subject|19|||
164308129|NCT01724346|593502572|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
164308130|NCT01724346|593502573|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
164308131|NCT00536744|593502576|FG000|Overall Study|Adverse Event|13|||
164308132|NCT00536744|593502577|FG001|Overall Study|Adverse Event|10|||
164308133|NCT00536744|593502576|FG000|Overall Study|Death|2|||
164656099|NCT01625377|594766423|FG001|Overall Study|Administrative Problem|1|||
164656100|NCT01625377|594766422|FG000|Overall Study|Protocol Violation|0|||
164308134|NCT00536744|593502577|FG001|Overall Study|Death|1|||
164308135|NCT00536744|593502576|FG000|Overall Study|Physician Decision|3|||
164308136|NCT00536744|593502577|FG001|Overall Study|Physician Decision|1|||
164308137|NCT00536744|593502576|FG000|Overall Study|Lost to Follow-up|3|||
164308138|NCT00536744|593502577|FG001|Overall Study|Lost to Follow-up|5|||
164308139|NCT00536744|593502576|FG000|Overall Study|Withdrawal by Subject|7|||
164308140|NCT00536744|593502577|FG001|Overall Study|Withdrawal by Subject|8|||
164308141|NCT00536744|593502576|FG000|Overall Study|PI tried alternative treatment|1|||
164308142|NCT00536744|593502577|FG001|Overall Study|PI tried alternative treatment|3|||
164308143|NCT00787644|593502578|FG000|Overall Study|Lost to Follow-up|1|||
164308144|NCT00787644|593502579|FG001|Overall Study|Lost to Follow-up|1|||
164308145|NCT00787644|593502578|FG000|Overall Study|Withdrawal by Subject|1|||
164308146|NCT00787644|593502579|FG001|Overall Study|Withdrawal by Subject|1|||
164308147|NCT01642589|593502583|FG000|Overall Study|Withdrawal by Subject|1|||
164308148|NCT01642589|593502584|FG001|Overall Study|Withdrawal by Subject|1|||
164199462|NCT03327324|593101757|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
164199463|NCT03327324|593101758|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164199464|NCT03327324|593101759|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164199465|NCT03327324|593101760|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164199466|NCT03327324|593101755|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
164199467|NCT03327324|593101756|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
164199468|NCT03327324|593101757|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
164199469|NCT03327324|593101758|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
164199470|NCT03327324|593101759|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
164199471|NCT03327324|593101760|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
164199472|NCT03327324|593101755|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
164199473|NCT03327324|593101756|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
164199474|NCT03327324|593101757|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
164199475|NCT03327324|593101758|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
164199476|NCT03327324|593101759|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
164199477|NCT03327324|593101760|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
164199478|NCT03327324|593101755|FG000|Intervention (Month 3-Month 6)|Death|1|||
164199479|NCT03327324|593101756|FG001|Intervention (Month 3-Month 6)|Death|0|||
164199480|NCT03327324|593101757|FG002|Intervention (Month 3-Month 6)|Death|1|||
164199481|NCT03327324|593101758|FG003|Intervention (Month 3-Month 6)|Death|1|||
164199482|NCT03327324|593101759|FG004|Intervention (Month 3-Month 6)|Death|1|||
164199483|NCT03327324|593101760|FG005|Intervention (Month 3-Month 6)|Death|0|||
164199484|NCT03327324|593101755|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199485|NCT03327324|593101756|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199486|NCT03327324|593101757|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199487|NCT03327324|593101758|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199488|NCT03327324|593101759|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199489|NCT03327324|593101760|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
164199490|NCT03327324|593101755|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
164199491|NCT03327324|593101756|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164199492|NCT03327324|593101757|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164199493|NCT03327324|593101758|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164199494|NCT03327324|593101759|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164199495|NCT03327324|593101760|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164199496|NCT03327324|593101755|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
164199497|NCT03327324|593101756|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
164199498|NCT03327324|593101757|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
164199499|NCT03327324|593101758|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
164199500|NCT03327324|593101759|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
164199501|NCT03327324|593101760|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
164199502|NCT03327324|593101755|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
164199503|NCT03327324|593101756|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
164199504|NCT03327324|593101757|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
164199505|NCT03327324|593101758|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
164199506|NCT03327324|593101759|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
164199507|NCT03327324|593101760|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
164199508|NCT03327324|593101755|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199509|NCT03327324|593101756|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199510|NCT03327324|593101757|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199511|NCT03327324|593101758|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
164199512|NCT03327324|593101759|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
164199513|NCT03327324|593101760|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199514|NCT03327324|593101755|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
164199515|NCT03327324|593101756|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
164308149|NCT01108185|593502589|FG000|Overall Study|Non-compliance|15|||
164308150|NCT01108185|593502589|FG000|Overall Study|Lost to Follow-up|12|||
164308151|NCT04774094|593502594|FG000|Overall Study|Other|2|||
164308152|NCT04774094|593502594|FG000|Overall Study|Withdrawal by Subject|9|||
164308153|NCT04774094|593502594|FG000|Overall Study|Lost to Follow-up|7|||
164308154|NCT04774094|593502594|FG000|Overall Study|Lack of Efficacy|5|||
164308155|NCT04774094|593502594|FG000|Overall Study|Death|17|||
164308156|NCT04774094|593502594|FG000|Overall Study|Adverse Event|4|||
164308157|NCT02374450|593502595|FG000|Overall Study|Protocol Violation|0|||
164308158|NCT02374450|593502596|FG001|Overall Study|Protocol Violation|1|||
164308159|NCT02374450|593502597|FG002|Overall Study|Protocol Violation|0|||
164308160|NCT02374450|593502595|FG000|Overall Study|Withdrawal by Subject|91|||
164308161|NCT02374450|593502596|FG001|Overall Study|Withdrawal by Subject|110|||
164308162|NCT02374450|593502597|FG002|Overall Study|Withdrawal by Subject|4|||
164308163|NCT02374450|593502595|FG000|Overall Study|Lost to Follow-up|168|||
164308164|NCT02374450|593502596|FG001|Overall Study|Lost to Follow-up|194|||
164308165|NCT02374450|593502597|FG002|Overall Study|Lost to Follow-up|138|||
164308166|NCT02374450|593502595|FG000|Overall Study|Death|173|||
164308167|NCT02374450|593502596|FG001|Overall Study|Death|185|||
164308168|NCT02374450|593502597|FG002|Overall Study|Death|81|||
164308169|NCT02374450|593502595|FG000|Overall Study|Migrated from the study area|538|||
164308170|NCT02374450|593502596|FG001|Overall Study|Migrated from the study area|648|||
164308171|NCT02374450|593502597|FG002|Overall Study|Migrated from the study area|181|||
164308172|NCT02374450|593502595|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
164308173|NCT02374450|593502596|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
164308174|NCT02374450|593502597|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
164308175|NCT02374450|593502595|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
164308176|NCT02374450|593502596|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
164308177|NCT02374450|593502597|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
164308178|NCT02374450|593502595|FG000|Overall Study|Other|0|||
164308179|NCT02374450|593502596|FG001|Overall Study|Other|21|||
164308180|NCT02374450|593502597|FG002|Overall Study|Other|79|||
164308181|NCT01006291|593504415|FG000|Overall Study|Adverse Event|2|||
164308182|NCT01006291|593504416|FG001|Overall Study|Adverse Event|1|||
164308183|NCT01006291|593504417|FG002|Overall Study|Adverse Event|2|||
164308184|NCT01006291|593504415|FG000|Overall Study|Lack of Efficacy|2|||
164308185|NCT01006291|593504416|FG001|Overall Study|Lack of Efficacy|2|||
164308186|NCT01006291|593504417|FG002|Overall Study|Lack of Efficacy|1|||
164308187|NCT01006291|593504415|FG000|Overall Study|Protocol Violation|3|||
164308188|NCT01006291|593504416|FG001|Overall Study|Protocol Violation|3|||
164308189|NCT01006291|593504417|FG002|Overall Study|Protocol Violation|3|||
164308190|NCT01006291|593504415|FG000|Overall Study|Withdrawal criteria|5|||
164308191|NCT01006291|593504416|FG001|Overall Study|Withdrawal criteria|4|||
164308192|NCT01006291|593504417|FG002|Overall Study|Withdrawal criteria|4|||
164308193|NCT01006291|593504415|FG000|Overall Study|Other|14|||
164308194|NCT01006291|593504416|FG001|Overall Study|Other|14|||
164308195|NCT01006291|593504417|FG002|Overall Study|Other|17|||
164308196|NCT01677377|593504418|FG000|Overall Study|Protocol Violation|1|||
164308197|NCT01677377|593504419|FG001|Overall Study|Protocol Violation|0|||
164308198|NCT01677377|593504420|FG002|Overall Study|Protocol Violation|0|||
164308199|NCT01677377|593504418|FG000|Overall Study|Lost to Follow-up|0|||
164308200|NCT01677377|593504419|FG001|Overall Study|Lost to Follow-up|1|||
164308201|NCT01677377|593504420|FG002|Overall Study|Lost to Follow-up|1|||
164308202|NCT01677377|593504418|FG000|Overall Study|Withdrawal by Subject|0|||
164308203|NCT01677377|593504419|FG001|Overall Study|Withdrawal by Subject|0|||
164308204|NCT01677377|593504420|FG002|Overall Study|Withdrawal by Subject|3|||
164308205|NCT01677377|593504418|FG000|Overall Study|Lack of Efficacy|0|||
164308206|NCT01677377|593504419|FG001|Overall Study|Lack of Efficacy|0|||
164308207|NCT01677377|593504420|FG002|Overall Study|Lack of Efficacy|1|||
164308208|NCT01677377|593504418|FG000|Overall Study|Pregnancy|0|||
164308209|NCT01677377|593504419|FG001|Overall Study|Pregnancy|0|||
164656101|NCT01625377|594766423|FG001|Overall Study|Protocol Violation|3|||
164656102|NCT01625377|594766422|FG000|Overall Study|Adverse Event|3|||
164656103|NCT01625377|594766423|FG001|Overall Study|Adverse Event|16|||
164308210|NCT01677377|593504420|FG002|Overall Study|Pregnancy|1|||
164308211|NCT02260180|593504421|FG000|Overall Study|Adverse Event|2|||
164308212|NCT02260180|593504422|FG001|Overall Study|Adverse Event|0|||
164308213|NCT02260180|593504423|FG002|Overall Study|Adverse Event|1|||
164308214|NCT00943072|593504426|FG000|Overall Study|Adverse Event|0|||
164308215|NCT00943072|593504427|FG001|Overall Study|Adverse Event|3|||
164308216|NCT00943072|593504426|FG000|Overall Study|Death|0|||
164308217|NCT00943072|593504427|FG001|Overall Study|Death|2|||
164308218|NCT00943072|593504426|FG000|Overall Study|Withdrawal by Subject|3|||
164308219|NCT00943072|593504427|FG001|Overall Study|Withdrawal by Subject|1|||
164308220|NCT00943072|593504426|FG000|Overall Study|Protocol Violation|0|||
164308221|NCT00943072|593504427|FG001|Overall Study|Protocol Violation|1|||
164308222|NCT00943072|593504426|FG000|Overall Study|Lost to Follow-up|1|||
164308223|NCT00943072|593504427|FG001|Overall Study|Lost to Follow-up|2|||
164308224|NCT00943072|593504426|FG000|Overall Study|Lack of Efficacy|0|||
164308225|NCT00943072|593504427|FG001|Overall Study|Lack of Efficacy|4|||
164308226|NCT00943072|593504426|FG000|Overall Study|Other|1|||
164308227|NCT00943072|593504427|FG001|Overall Study|Other|1|||
164308228|NCT03275350|593504428|FG000|Overall Study|Lost to Follow-up|4|||
164308229|NCT03275350|593504429|FG001|Overall Study|Lost to Follow-up|6|||
164308230|NCT03275350|593504428|FG000|Overall Study|Death|2|||
164308231|NCT03275350|593504429|FG001|Overall Study|Death|1|||
164308232|NCT03275350|593504428|FG000|Overall Study|Physician Decision|1|||
164308233|NCT03275350|593504429|FG001|Overall Study|Physician Decision|0|||
164308234|NCT03275350|593504428|FG000|Overall Study|Incarcerated|1|||
164308235|NCT03275350|593504429|FG001|Overall Study|Incarcerated|1|||
164308236|NCT00905645|593504430|FG000|Overall Study|Death (not device related)|10|||
164308237|NCT00905645|593504431|FG001|Overall Study|Death (not device related)|4|||
164308238|NCT00905645|593504432|FG002|Overall Study|Death (not device related)|15|||
164308239|NCT00905645|593504433|FG003|Overall Study|Death (not device related)|8|||
164308240|NCT00905645|593504430|FG000|Overall Study|Explantation of study device(s)|78|||
164308241|NCT00905645|593504431|FG001|Overall Study|Explantation of study device(s)|47|||
164308242|NCT00905645|593504432|FG002|Overall Study|Explantation of study device(s)|28|||
164308243|NCT00905645|593504433|FG003|Overall Study|Explantation of study device(s)|21|||
164308244|NCT00905645|593504430|FG000|Overall Study|Subject Request|41|||
164308245|NCT00905645|593504431|FG001|Overall Study|Subject Request|17|||
164308246|NCT00905645|593504432|FG002|Overall Study|Subject Request|13|||
164308247|NCT00905645|593504433|FG003|Overall Study|Subject Request|11|||
164308248|NCT00905645|593504430|FG000|Overall Study|Lost to Follow-up|299|||
164308249|NCT00905645|593504431|FG001|Overall Study|Lost to Follow-up|103|||
164308250|NCT00905645|593504432|FG002|Overall Study|Lost to Follow-up|51|||
164308251|NCT00905645|593504433|FG003|Overall Study|Lost to Follow-up|12|||
164308252|NCT01386970|593504434|FG000|Overall Study|Withdrawal by Subject|0|||
164308253|NCT01386970|593504435|FG001|Overall Study|Withdrawal by Subject|1|||
164308254|NCT01386970|593504434|FG000|Overall Study|Adverse Event|4|||
164308255|NCT01386970|593504435|FG001|Overall Study|Adverse Event|1|||
164308256|NCT04439136|593504436|FG000|Overall Study|Ineligible|1|||
164308257|NCT04439136|593504436|FG000|Overall Study|Never Started Treatment|2|||
164308258|NCT04439136|593504436|FG000|Overall Study|Adverse Event|4|||
164308259|NCT04439136|593504436|FG000|Overall Study|Death|3|||
164308260|NCT04439136|593504436|FG000|Overall Study|Disease Progression|27|||
164308261|NCT04439136|593504436|FG000|Overall Study|Alternative Therapy|1|||
164308262|NCT04439136|593504436|FG000|Overall Study|Increased Tumor Burden|1|||
164308263|NCT04439136|593504436|FG000|Overall Study|Symptomatic Detrioration|1|||
164308264|NCT00578292|593504439|FG000|Overall Study|Death|1|||
164308265|NCT00578292|593504439|FG000|Overall Study|Graft failure|2|||
164308266|NCT04849559|593504440|FG000|Overall Study|Withdrawal by Subject|2|||
164308267|NCT04849559|593504441|FG001|Overall Study|Withdrawal by Subject|1|||
164308268|NCT03901469|593504442|FG000|Overall Study|Radiographic Progression|4|||
164308269|NCT03901469|593504443|FG001|Overall Study|Radiographic Progression|6|||
164308270|NCT03901469|593504444|FG002|Overall Study|Radiographic Progression|3|||
164308271|NCT03901469|593504445|FG003|Overall Study|Radiographic Progression|30|||
164308272|NCT03901469|593504446|FG004|Overall Study|Radiographic Progression|7|||
164308273|NCT03901469|593504447|FG005|Overall Study|Radiographic Progression|2|||
164308274|NCT03901469|593504448|FG006|Overall Study|Radiographic Progression|11|||
164308275|NCT03901469|593504442|FG000|Overall Study|Clinical Progression|0|||
164308276|NCT03901469|593504443|FG001|Overall Study|Clinical Progression|2|||
164308277|NCT03901469|593504444|FG002|Overall Study|Clinical Progression|0|||
164308278|NCT03901469|593504445|FG003|Overall Study|Clinical Progression|7|||
164308279|NCT03901469|593504446|FG004|Overall Study|Clinical Progression|6|||
164308280|NCT03901469|593504447|FG005|Overall Study|Clinical Progression|0|||
164308281|NCT03901469|593504448|FG006|Overall Study|Clinical Progression|2|||
164308282|NCT03901469|593504442|FG000|Overall Study|Adverse Event|1|||
164308283|NCT03901469|593504443|FG001|Overall Study|Adverse Event|0|||
164308284|NCT03901469|593504444|FG002|Overall Study|Adverse Event|0|||
164308285|NCT03901469|593504445|FG003|Overall Study|Adverse Event|0|||
164308286|NCT03901469|593504446|FG004|Overall Study|Adverse Event|0|||
164308287|NCT03901469|593504447|FG005|Overall Study|Adverse Event|0|||
164308288|NCT03901469|593504448|FG006|Overall Study|Adverse Event|9|||
164308289|NCT03901469|593504442|FG000|Overall Study|Physician Decision|0|||
164308290|NCT03901469|593504443|FG001|Overall Study|Physician Decision|0|||
164308291|NCT03901469|593504444|FG002|Overall Study|Physician Decision|0|||
164308292|NCT03901469|593504445|FG003|Overall Study|Physician Decision|1|||
164308293|NCT03901469|593504446|FG004|Overall Study|Physician Decision|0|||
164308294|NCT03901469|593504447|FG005|Overall Study|Physician Decision|0|||
164308295|NCT03901469|593504448|FG006|Overall Study|Physician Decision|0|||
164308296|NCT03901469|593504442|FG000|Overall Study|Withdrawal by Subject|0|||
164308297|NCT03901469|593504443|FG001|Overall Study|Withdrawal by Subject|0|||
164308298|NCT03901469|593504444|FG002|Overall Study|Withdrawal by Subject|0|||
164308299|NCT03901469|593504445|FG003|Overall Study|Withdrawal by Subject|0|||
164308300|NCT03901469|593504446|FG004|Overall Study|Withdrawal by Subject|2|||
164308301|NCT03901469|593504447|FG005|Overall Study|Withdrawal by Subject|0|||
164308302|NCT03901469|593504448|FG006|Overall Study|Withdrawal by Subject|8|||
164308303|NCT03901469|593504442|FG000|Overall Study|Death|0|||
164308304|NCT03901469|593504443|FG001|Overall Study|Death|0|||
164308305|NCT03901469|593504444|FG002|Overall Study|Death|0|||
164308306|NCT03901469|593504445|FG003|Overall Study|Death|3|||
164308307|NCT03901469|593504446|FG004|Overall Study|Death|5|||
164308308|NCT03901469|593504447|FG005|Overall Study|Death|0|||
164308309|NCT03901469|593504448|FG006|Overall Study|Death|1|||
164308310|NCT03901469|593504442|FG000|Overall Study|Termination of study by sponsor|0|||
164308311|NCT03901469|593504443|FG001|Overall Study|Termination of study by sponsor|0|||
164308312|NCT03901469|593504444|FG002|Overall Study|Termination of study by sponsor|0|||
164308313|NCT03901469|593504445|FG003|Overall Study|Termination of study by sponsor|0|||
164308314|NCT03901469|593504446|FG004|Overall Study|Termination of study by sponsor|1|||
164308315|NCT03901469|593504447|FG005|Overall Study|Termination of study by sponsor|1|||
164308316|NCT03901469|593504448|FG006|Overall Study|Termination of study by sponsor|0|||
164308317|NCT03901469|593504442|FG000|Overall Study|Not Reported|1|||
164550659|NCT00583362|594388746|FG000|Overall Study|Physician Decision|19|||
164550660|NCT00583362|594388746|FG000|Overall Study|Protocol Violation|2|||
164550661|NCT00583362|594388746|FG000|Overall Study|Withdrawal by Subject|57|||
164199516|NCT03327324|593101757|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
164199517|NCT03327324|593101758|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
164199518|NCT03327324|593101759|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
164199519|NCT03327324|593101760|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
164199520|NCT03327324|593101755|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
164199521|NCT03327324|593101756|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
164199522|NCT03327324|593101757|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
164199523|NCT03327324|593101758|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
164199524|NCT03327324|593101759|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
164199525|NCT03327324|593101760|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
164199526|NCT01791985|593101761|FG000|Overall Study|Adverse Event|7|||
164199527|NCT01791985|593101761|FG000|Overall Study|Withdrawal by Subject|1|||
164199528|NCT01103323|593101762|FG000|Without/Before Drug Switch|Adverse Event|50|||
164199529|NCT01103323|593101763|FG001|Without/Before Drug Switch|Adverse Event|7|||
164199530|NCT01103323|593101762|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
164199531|NCT01103323|593101763|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
164199532|NCT01103323|593101762|FG000|Without/Before Drug Switch|Protocol Violation|2|||
164199533|NCT01103323|593101763|FG001|Without/Before Drug Switch|Protocol Violation|0|||
164199534|NCT01103323|593101762|FG000|Without/Before Drug Switch|Physician Decision|2|||
164199535|NCT01103323|593101763|FG001|Without/Before Drug Switch|Physician Decision|0|||
164199536|NCT01103323|593101762|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
164199537|NCT01103323|593101763|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
164199538|NCT01103323|593101762|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
164199539|NCT01103323|593101763|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
164199540|NCT01103323|593101762|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
164199541|NCT01103323|593101763|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
164199542|NCT01946204|593101769|FG000|Overall Study|Death|38|||
164199543|NCT01946204|593101770|FG001|Overall Study|Death|59|||
164199544|NCT01946204|593101769|FG000|Overall Study|Withdrawal by Subject|37|||
164199545|NCT01946204|593101770|FG001|Overall Study|Withdrawal by Subject|50|||
164199546|NCT01946204|593101769|FG000|Overall Study|Lost to Follow-up|3|||
164199547|NCT01946204|593101770|FG001|Overall Study|Lost to Follow-up|7|||
164199548|NCT01946204|593101769|FG000|Overall Study|Ongoing|316|||
164199549|NCT01946204|593101770|FG001|Overall Study|Ongoing|687|||
164199550|NCT01946204|593101769|FG000|Overall Study|Other|7|||
164199551|NCT01946204|593101770|FG001|Overall Study|Other|3|||
164199552|NCT03797898|593101771|FG000|Overall Study|Lost to Follow-up|60|||
164199553|NCT03797898|593101772|FG001|Overall Study|Lost to Follow-up|69|||
164199554|NCT03797898|593101771|FG000|Overall Study|Withdrawal by Subject|9|||
164199555|NCT03797898|593101772|FG001|Overall Study|Withdrawal by Subject|7|||
164199556|NCT03797898|593101771|FG000|Overall Study|Became ineligible|5|||
164199557|NCT03797898|593101772|FG001|Overall Study|Became ineligible|2|||
164199558|NCT00485069|593101773|FG000|Overall Study|Adverse Event|10|||
164199559|NCT00485069|593101774|FG001|Overall Study|Adverse Event|4|||
164199560|NCT00485069|593101773|FG000|Overall Study|Lack of Efficacy|2|||
164199561|NCT00485069|593101774|FG001|Overall Study|Lack of Efficacy|1|||
164199562|NCT00485069|593101773|FG000|Overall Study|Protocol Violation|0|||
164199563|NCT00485069|593101774|FG001|Overall Study|Protocol Violation|1|||
164199564|NCT00485069|593101773|FG000|Overall Study|Withdrawal by Subject|6|||
164199565|NCT00485069|593101774|FG001|Overall Study|Withdrawal by Subject|6|||
164199566|NCT03217591|593101775|FG000|Overall Study|Adverse Event|1|||
164199567|NCT03217591|593101776|FG001|Overall Study|Adverse Event|2|||
164199568|NCT03217591|593101777|FG002|Overall Study|Adverse Event|6|||
164199569|NCT03217591|593101775|FG000|Overall Study|Withdrawal by Subject|0|||
164199570|NCT03217591|593101776|FG001|Overall Study|Withdrawal by Subject|1|||
164308318|NCT03901469|593504443|FG001|Overall Study|Not Reported|0|||
164308319|NCT03901469|593504444|FG002|Overall Study|Not Reported|0|||
164308320|NCT03901469|593504445|FG003|Overall Study|Not Reported|1|||
164308321|NCT03901469|593504446|FG004|Overall Study|Not Reported|0|||
164308322|NCT03901469|593504447|FG005|Overall Study|Not Reported|0|||
164308323|NCT03901469|593504448|FG006|Overall Study|Not Reported|1|||
164308324|NCT03306173|593504456|FG000|Overall Study|Lost to Follow-up|16|||
164308325|NCT03306173|593504457|FG001|Overall Study|Lost to Follow-up|23|||
164308326|NCT03306173|593504456|FG000|Overall Study|Withdrawal by Subject|4|||
164308327|NCT03306173|593504457|FG001|Overall Study|Withdrawal by Subject|3|||
164308328|NCT03306173|593504456|FG000|Overall Study|Discontinued|4|||
164308329|NCT03306173|593504457|FG001|Overall Study|Discontinued|4|||
164308330|NCT01077076|593504458|FG000|First Intervention|Withdrawal by Subject|1|||
164308331|NCT01077076|593504459|FG001|First Intervention|Withdrawal by Subject|0|||
164308332|NCT01077076|593504460|FG002|First Intervention|Withdrawal by Subject|0|||
164308333|NCT01077076|593504461|FG003|First Intervention|Withdrawal by Subject|0|||
164308334|NCT01077076|593504462|FG004|First Intervention|Withdrawal by Subject|0|||
164656104|NCT01625377|594766422|FG000|Overall Study|Graft loss|1|||
164656105|NCT01625377|594766423|FG001|Overall Study|Graft loss|0|||
164656106|NCT01625377|594766422|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164656107|NCT01625377|594766423|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
164656108|NCT01625377|594766422|FG000|Overall Study|Abnormal laboratory values|1|||
164656109|NCT01625377|594766423|FG001|Overall Study|Abnormal laboratory values|0|||
164308335|NCT01077076|593504463|FG005|First Intervention|Withdrawal by Subject|0|||
164308336|NCT01077076|593504458|FG000|Third Intervention|Death in the participant's family|0|||
164308337|NCT01077076|593504459|FG001|Third Intervention|Death in the participant's family|0|||
164308338|NCT01077076|593504460|FG002|Third Intervention|Death in the participant's family|0|||
164308339|NCT01077076|593504461|FG003|Third Intervention|Death in the participant's family|0|||
164308340|NCT01077076|593504462|FG004|Third Intervention|Death in the participant's family|0|||
164308341|NCT01077076|593504463|FG005|Third Intervention|Death in the participant's family|1|||
164308342|NCT00060840|593504466|FG000|Overall Study|Change in surgical plan|2|||
164308343|NCT00060840|593504467|FG001|Overall Study|Change in surgical plan|6|||
164308344|NCT00060840|593504466|FG000|Overall Study|Death|0|||
164308345|NCT00060840|593504467|FG001|Overall Study|Death|1|||
164308346|NCT00060840|593504466|FG000|Overall Study|Withdrawal by Subject|0|||
164308347|NCT00060840|593504467|FG001|Overall Study|Withdrawal by Subject|1|||
164308348|NCT00060840|593504466|FG000|Overall Study|Subinvestigator unavailable|0|||
164308349|NCT00060840|593504467|FG001|Overall Study|Subinvestigator unavailable|1|||
164308350|NCT00060840|593504466|FG000|Overall Study|Physician Decision|1|||
164308351|NCT00060840|593504467|FG001|Overall Study|Physician Decision|0|||
164308352|NCT00060840|593504466|FG000|Overall Study|Other|1|||
164308353|NCT00060840|593504467|FG001|Overall Study|Other|0|||
164308354|NCT01388335|593504468|FG000|Period 1|Progressive Disease|1|||
164308355|NCT01388335|593504468|FG000|Period 2|Progressive Disease|2|||
164308356|NCT01388335|593504468|FG000|Period 2|Sponsor Decision|1|||
164308357|NCT01388335|593504468|FG000|Safety Extension|Progressive Disease|7|||
164308358|NCT01415882|593504469|FG000|Overall Study|Ineligible|1|||
164308359|NCT01415882|593504470|FG001|Overall Study|Ineligible|0|||
164308360|NCT01415882|593504471|FG002|Overall Study|Ineligible|0|||
164308361|NCT01415882|593504472|FG003|Overall Study|Ineligible|3|||
164308362|NCT01415882|593504473|FG004|Overall Study|Ineligible|0|||
164308363|NCT01415882|593504469|FG000|Overall Study|Withdrawal by Subject|0|||
164308364|NCT01415882|593504470|FG001|Overall Study|Withdrawal by Subject|1|||
164308365|NCT01415882|593504471|FG002|Overall Study|Withdrawal by Subject|0|||
164308366|NCT01415882|593504472|FG003|Overall Study|Withdrawal by Subject|1|||
164308367|NCT01415882|593504473|FG004|Overall Study|Withdrawal by Subject|0|||
164308368|NCT00976560|593504474|FG000|Overall Study|Adverse Event|5|||
164308369|NCT00976560|593504475|FG001|Overall Study|Adverse Event|5|||
164308370|NCT00976560|593504474|FG000|Overall Study|Lack of Efficacy|3|||
164308371|NCT00976560|593504475|FG001|Overall Study|Lack of Efficacy|5|||
164308372|NCT00976560|593504474|FG000|Overall Study|Protocol Violation|1|||
164308373|NCT00976560|593504475|FG001|Overall Study|Protocol Violation|0|||
164308374|NCT00976560|593504474|FG000|Overall Study|Lost to Follow-up|1|||
164308375|NCT00976560|593504475|FG001|Overall Study|Lost to Follow-up|0|||
164308376|NCT00976560|593504474|FG000|Overall Study|Physician Decision|2|||
164308377|NCT00976560|593504475|FG001|Overall Study|Physician Decision|0|||
164656110|NCT01090765|594766429|FG000|Overall Study|Patient withdrew consent|0|||
164656111|NCT01090765|594766430|FG001|Overall Study|Patient withdrew consent|0|||
164656112|NCT01090765|594766431|FG002|Overall Study|Patient withdrew consent|0|||
164656113|NCT01090765|594766432|FG003|Overall Study|Patient withdrew consent|0|||
164308378|NCT00976560|593504474|FG000|Overall Study|Withdrawal by Subject|2|||
164308379|NCT00976560|593504475|FG001|Overall Study|Withdrawal by Subject|3|||
164308380|NCT00125164|593504478|FG000|Overall Study|Adverse Event|0|||
164308381|NCT00125164|593504479|FG001|Overall Study|Adverse Event|0|||
164308382|NCT00125164|593504480|FG002|Overall Study|Adverse Event|2|||
164308383|NCT00125164|593504481|FG003|Overall Study|Adverse Event|4|||
164308384|NCT00125164|593504478|FG000|Overall Study|Lost to Follow-up|0|||
164308385|NCT00125164|593504479|FG001|Overall Study|Lost to Follow-up|0|||
164308386|NCT00125164|593504480|FG002|Overall Study|Lost to Follow-up|1|||
164308387|NCT00125164|593504481|FG003|Overall Study|Lost to Follow-up|1|||
164308388|NCT00125164|593504478|FG000|Overall Study|Withdrawal by Subject|2|||
164308389|NCT00125164|593504479|FG001|Overall Study|Withdrawal by Subject|0|||
164308390|NCT00125164|593504480|FG002|Overall Study|Withdrawal by Subject|1|||
164308391|NCT00125164|593504481|FG003|Overall Study|Withdrawal by Subject|1|||
164308392|NCT00670306|593504482|FG000|Overall Study|Adverse Event|8|||
164308393|NCT00670306|593504482|FG000|Overall Study|Lack of Efficacy|10|||
164199571|NCT03217591|593101777|FG002|Overall Study|Withdrawal by Subject|3|||
164199572|NCT03217591|593101775|FG000|Overall Study|Lost to Follow-up|1|||
164199573|NCT03217591|593101776|FG001|Overall Study|Lost to Follow-up|0|||
164199574|NCT03217591|593101777|FG002|Overall Study|Lost to Follow-up|0|||
164199575|NCT03217591|593101775|FG000|Overall Study|Protocol Violation|1|||
164199576|NCT03217591|593101776|FG001|Overall Study|Protocol Violation|0|||
164199577|NCT03217591|593101777|FG002|Overall Study|Protocol Violation|1|||
164199578|NCT00402727|593101783|FG000|Overall Study|Adverse Event|10|||
164308394|NCT00670306|593504482|FG000|Overall Study|Withdrawal by Subject|9|||
164308395|NCT00670306|593504482|FG000|Overall Study|Physician Decision|1|||
164308396|NCT00670306|593504482|FG000|Overall Study|Lost to Follow-up|8|||
164308397|NCT00670306|593504482|FG000|Overall Study|incl/excl criterias did not meet|19|||
164308398|NCT01339052|593504486|FG000|Overall Study|Disease progression|13|||
164308399|NCT01339052|593504487|FG001|Overall Study|Disease progression|46|||
164308400|NCT01339052|593504486|FG000|Overall Study|Adverse Event|1|||
164308401|NCT01339052|593504487|FG001|Overall Study|Adverse Event|1|||
164308402|NCT01339052|593504486|FG000|Overall Study|Withdrawal by Subject|0|||
164308403|NCT01339052|593504487|FG001|Overall Study|Withdrawal by Subject|3|||
164308404|NCT01339052|593504486|FG000|Overall Study|Physician Decision|1|||
164308405|NCT01339052|593504487|FG001|Overall Study|Physician Decision|0|||
164308406|NCT03339219|593504488|FG000|Overall Study|Death|12|||
164308407|NCT03339219|593504488|FG000|Overall Study|Site Terminated by Sponsor|22|||
164308408|NCT03339219|593504488|FG000|Overall Study|Withdrawal by Subject|1|||
164308409|NCT01301027|593504492|FG000|Overall Study|Physician Decision|2|||
164308410|NCT01301027|593504493|FG001|Overall Study|Physician Decision|0|||
164308411|NCT01301027|593504492|FG000|Overall Study|Withdrawal by Subject|2|||
164308412|NCT01301027|593504493|FG001|Overall Study|Withdrawal by Subject|3|||
164308413|NCT01301027|593504492|FG000|Overall Study|Adverse Event|0|||
164308414|NCT01301027|593504493|FG001|Overall Study|Adverse Event|2|||
164308415|NCT01301027|593504492|FG000|Overall Study|Fracture|1|||
164308416|NCT01301027|593504493|FG001|Overall Study|Fracture|3|||
164308417|NCT01301027|593504492|FG000|Overall Study|Transplant|0|||
164308418|NCT01301027|593504493|FG001|Overall Study|Transplant|2|||
164308419|NCT01301027|593504492|FG000|Overall Study|Volume Overload|3|||
164308420|NCT01301027|593504493|FG001|Overall Study|Volume Overload|0|||
164308421|NCT04939415|593504497|FG000|Overall Study|Withdrawal by Subject|1|||
164308422|NCT04939415|593504498|FG001|Overall Study|Withdrawal by Subject|3|||
164308423|NCT04939415|593504497|FG000|Overall Study|Lost to Follow-up|0|||
164308424|NCT04939415|593504498|FG001|Overall Study|Lost to Follow-up|2|||
164308425|NCT03155841|593504499|FG000|Overall Study|Protocol Violation|3|||
164308426|NCT03155841|593504500|FG001|Overall Study|Protocol Violation|4|||
164308427|NCT04308291|593504501|FG000|Run-In Phase|Withdrawal by Subject|4|||
164308428|NCT04308291|593504501|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
164308429|NCT04308291|593504501|FG000|Study Phase 6-M|Physician Decision|2|||
164308430|NCT04308291|593504501|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
164199579|NCT00402727|593101784|FG001|Overall Study|Adverse Event|6|||
164199580|NCT00402727|593101783|FG000|Overall Study|Death|1|||
164199581|NCT00402727|593101784|FG001|Overall Study|Death|0|||
164199582|NCT00402727|593101783|FG000|Overall Study|Lack of Efficacy|1|||
164308431|NCT04308291|593504501|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
164308432|NCT04308291|593504501|FG000|Study Phase 12-M|Physician Decision|2|||
164308433|NCT04308291|593504501|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
164308434|NCT00714870|593504507|FG000|Overall Study|Lost to Follow-up|22|||
164308435|NCT00714870|593504508|FG001|Overall Study|Lost to Follow-up|5|||
164550662|NCT00078325|594388752|FG000|Overall Study|Adverse Event|15|||
164550663|NCT00078325|594388753|FG001|Overall Study|Adverse Event|10|||
164550664|NCT00078325|594388754|FG002|Overall Study|Adverse Event|5|||
164550665|NCT00078325|594388752|FG000|Overall Study|Protocol Violation|2|||
164550666|NCT00078325|594388753|FG001|Overall Study|Protocol Violation|2|||
164550667|NCT00078325|594388754|FG002|Overall Study|Protocol Violation|0|||
164550668|NCT00078325|594388752|FG000|Overall Study|Withdrawal by Subject|1|||
164199583|NCT00402727|593101784|FG001|Overall Study|Lack of Efficacy|3|||
164308436|NCT00714870|593504507|FG000|Overall Study|patient unable to come b/c back pain|1|||
164308437|NCT00714870|593504508|FG001|Overall Study|patient unable to come b/c back pain|0|||
164308438|NCT00714870|593504507|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
164308439|NCT00714870|593504508|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
164550669|NCT00078325|594388753|FG001|Overall Study|Withdrawal by Subject|5|||
164550670|NCT00078325|594388754|FG002|Overall Study|Withdrawal by Subject|3|||
164550671|NCT00078325|594388752|FG000|Overall Study|Lost to Follow-up|0|||
164550672|NCT00078325|594388753|FG001|Overall Study|Lost to Follow-up|1|||
164550673|NCT00078325|594388754|FG002|Overall Study|Lost to Follow-up|1|||
164550674|NCT00078325|594388752|FG000|Overall Study|Physician Decision|2|||
164550675|NCT00078325|594388753|FG001|Overall Study|Physician Decision|0|||
164550676|NCT00078325|594388754|FG002|Overall Study|Physician Decision|1|||
164550677|NCT00078325|594388752|FG000|Overall Study|Miscellaneous|1|||
164308440|NCT02357368|593504509|FG000|Overall Study|Lost to Follow-up|0|||
164308441|NCT02357368|593504510|FG001|Overall Study|Lost to Follow-up|0|||
164308442|NCT02357368|593504511|FG002|Overall Study|Lost to Follow-up|0|||
164308443|NCT02357368|593504512|FG003|Overall Study|Lost to Follow-up|1|||
164308444|NCT02357368|593504509|FG000|Overall Study|Pregnancy|3|||
164308445|NCT02357368|593504510|FG001|Overall Study|Pregnancy|2|||
164308446|NCT02357368|593504511|FG002|Overall Study|Pregnancy|0|||
164308447|NCT02357368|593504512|FG003|Overall Study|Pregnancy|0|||
164308448|NCT02357368|593504509|FG000|Overall Study|Withdrawal by Subject|3|||
164308449|NCT02357368|593504510|FG001|Overall Study|Withdrawal by Subject|1|||
164308450|NCT02357368|593504511|FG002|Overall Study|Withdrawal by Subject|1|||
164308451|NCT02357368|593504512|FG003|Overall Study|Withdrawal by Subject|2|||
164308452|NCT03895840|593504513|FG000|Overall Study|Withdrawal by Subject|21|||
164199584|NCT00402727|593101783|FG000|Overall Study|Lost to Follow-up|24|||
164199585|NCT00402727|593101784|FG001|Overall Study|Lost to Follow-up|11|||
164199586|NCT00402727|593101783|FG000|Overall Study|Physician Decision|1|||
164199587|NCT00402727|593101784|FG001|Overall Study|Physician Decision|1|||
164199588|NCT00402727|593101783|FG000|Overall Study|Protocol Violation|0|||
164199589|NCT00402727|593101784|FG001|Overall Study|Protocol Violation|4|||
164199590|NCT00402727|593101783|FG000|Overall Study|Withdrawal by Subject|3|||
164199591|NCT00402727|593101784|FG001|Overall Study|Withdrawal by Subject|7|||
164199592|NCT00402727|593101783|FG000|Overall Study|supply problems|2|||
164199593|NCT00402727|593101784|FG001|Overall Study|supply problems|1|||
164199594|NCT00402727|593101783|FG000|Overall Study|non-compliance|0|||
164199595|NCT00402727|593101784|FG001|Overall Study|non-compliance|1|||
164199596|NCT04460326|593101785|FG000|Completed at Least 4 Meals|Early discharge|5|||
164199597|NCT04460326|593101786|FG001|Completed at Least 4 Meals|Early discharge|5|||
164199598|NCT04460326|593101785|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
164199599|NCT04460326|593101786|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
164199600|NCT04460326|593101785|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
164199601|NCT04460326|593101786|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
164199602|NCT04460326|593101785|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
164199603|NCT04460326|593101786|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
164199604|NCT04460326|593101785|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
164199605|NCT04460326|593101786|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
164199606|NCT04460326|593101785|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
164199607|NCT04460326|593101786|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
164199608|NCT00577317|593101787|FG000|Overall Study|Study Terminated|0|||
164199609|NCT00577317|593101788|FG001|Overall Study|Study Terminated|2|||
164199610|NCT03372798|593101789|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
164199611|NCT03372798|593101790|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
164199612|NCT03372798|593101789|FG000|Overall Study|Failure of imaging probe|0|||
164199613|NCT03372798|593101790|FG001|Overall Study|Failure of imaging probe|1|||
164199614|NCT01687218|593101791|FG000|Overall Study|Withdrawal by Subject|2|||
164199615|NCT01687218|593101792|FG001|Overall Study|Withdrawal by Subject|3|||
164199616|NCT01687218|593101793|FG002|Overall Study|Withdrawal by Subject|0|||
164199617|NCT01687218|593101794|FG003|Overall Study|Withdrawal by Subject|1|||
164199618|NCT01687218|593101795|FG004|Overall Study|Withdrawal by Subject|1|||
164199619|NCT01687218|593101796|FG005|Overall Study|Withdrawal by Subject|0|||
164199620|NCT01687218|593101791|FG000|Overall Study|Relocated, no follow-up planned|1|||
164199621|NCT01687218|593101792|FG001|Overall Study|Relocated, no follow-up planned|0|||
164199622|NCT01687218|593101793|FG002|Overall Study|Relocated, no follow-up planned|1|||
164199623|NCT01687218|593101794|FG003|Overall Study|Relocated, no follow-up planned|1|||
164199624|NCT01687218|593101795|FG004|Overall Study|Relocated, no follow-up planned|0|||
164199625|NCT01687218|593101796|FG005|Overall Study|Relocated, no follow-up planned|0|||
164199626|NCT03528551|593101805|FG000|Overall Study|Lost to Follow-up|0|||
164199627|NCT03528551|593101806|FG001|Overall Study|Lost to Follow-up|1|||
164199628|NCT03528551|593101807|FG002|Overall Study|Lost to Follow-up|0|||
164199629|NCT03528551|593101805|FG000|Overall Study|Transferred to other arm/group|2|||
164199630|NCT03528551|593101806|FG001|Overall Study|Transferred to other arm/group|3|||
164199631|NCT03528551|593101807|FG002|Overall Study|Transferred to other arm/group|0|||
164199632|NCT03528551|593101805|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164199633|NCT03528551|593101806|FG001|Overall Study|Withdrawal by parent/guardian|5|||
164199634|NCT03528551|593101807|FG002|Overall Study|Withdrawal by parent/guardian|0|||
164199635|NCT03528551|593101805|FG000|Overall Study|Protocol Violation|0|||
164308453|NCT01931566|593504514|FG000|Overall Study|Randomized But Not Treated|6|||
164308454|NCT01931566|593504515|FG001|Overall Study|Randomized But Not Treated|9|||
164199636|NCT03528551|593101806|FG001|Overall Study|Protocol Violation|3|||
164199637|NCT03528551|593101807|FG002|Overall Study|Protocol Violation|0|||
164199638|NCT03528551|593101805|FG000|Overall Study|Withdrawal by Subject|0|||
164199639|NCT03528551|593101806|FG001|Overall Study|Withdrawal by Subject|7|||
164308455|NCT01931566|593504516|FG002|Overall Study|Randomized But Not Treated|14|||
164308456|NCT01931566|593504514|FG000|Overall Study|Adverse Event|37|||
164308457|NCT01931566|593504515|FG001|Overall Study|Adverse Event|167|||
164550678|NCT00078325|594388753|FG001|Overall Study|Miscellaneous|1|||
164550679|NCT00078325|594388754|FG002|Overall Study|Miscellaneous|1|||
164199640|NCT03528551|593101807|FG002|Overall Study|Withdrawal by Subject|0|||
164199641|NCT00875810|593101815|FG000|Overall Study|Withdrawal by Subject|1|||
164199642|NCT00875810|593101815|FG000|Overall Study|Physician Decision|3|||
164199643|NCT00875810|593101815|FG000|Overall Study|Lost to Follow-up|39|||
164199644|NCT00875810|593101815|FG000|Overall Study|Patient enroled but not implanted|2|||
164199645|NCT00875810|593101815|FG000|Overall Study|Device explanted|1|||
164199646|NCT01789047|593101819|FG000|Overall Study|Adverse Event|3|||
164199647|NCT01789047|593101820|FG001|Overall Study|Adverse Event|2|||
164199648|NCT01789047|593101819|FG000|Overall Study|Withdrawal by Subject|1|||
164199649|NCT01789047|593101820|FG001|Overall Study|Withdrawal by Subject|2|||
164199650|NCT03644017|593101821|FG000|Overall Study|Access Abandonment|5|||
164199651|NCT03644017|593101821|FG000|Overall Study|Kidney Transplant|2|||
164199652|NCT02175225|593101822|FG000|Overall Study|Withdrawal by Subject|1|||
164199653|NCT02175225|593101823|FG001|Overall Study|Withdrawal by Subject|2|||
164199654|NCT02175225|593101822|FG000|Overall Study|Lost to Follow-up|6|||
164199655|NCT02175225|593101823|FG001|Overall Study|Lost to Follow-up|7|||
164199656|NCT02175225|593101822|FG000|Overall Study|Study drug not administered|1|||
164199657|NCT02175225|593101823|FG001|Overall Study|Study drug not administered|2|||
164199658|NCT02340000|593101824|FG000|Time Period 1|Withdrawal by Subject|6|||
164199659|NCT02340000|593101825|FG001|Time Period 1|Withdrawal by Subject|8|||
164199660|NCT02340000|593101824|FG000|Time Period 1|Lost to Follow-up|6|||
164199661|NCT02340000|593101825|FG001|Time Period 1|Lost to Follow-up|7|||
164199662|NCT02340000|593101824|FG000|Time Period 2|Withdrawal by Subject|9|||
164199663|NCT02340000|593101825|FG001|Time Period 2|Withdrawal by Subject|7|||
164199664|NCT02340000|593101824|FG000|Time Period 2|Lost to Follow-up|10|||
164199665|NCT02340000|593101825|FG001|Time Period 2|Lost to Follow-up|8|||
164199666|NCT03106077|593101826|FG000|Overall Study|Screen Failure|94|||
164199667|NCT03106077|593101827|FG001|Overall Study|Screen Failure|0|||
164199668|NCT02668640|593101828|FG000|Overall Study|Lost to Follow-up|13|||
164199669|NCT02668640|593101828|FG000|Overall Study|Other, not specified|1|||
164199670|NCT00919633|593101836|FG000|Overall Study|Adverse Event|1|||
164199671|NCT00919633|593101837|FG001|Overall Study|Adverse Event|9|||
164199672|NCT00919633|593101838|FG002|Overall Study|Adverse Event|12|||
164199673|NCT00919633|593101839|FG003|Overall Study|Adverse Event|10|||
164199674|NCT00919633|593101836|FG000|Overall Study|Death|0|||
164199675|NCT00919633|593101837|FG001|Overall Study|Death|0|||
164199676|NCT00919633|593101838|FG002|Overall Study|Death|2|||
164199677|NCT00919633|593101839|FG003|Overall Study|Death|0|||
164199678|NCT00919633|593101836|FG000|Overall Study|Lack of Efficacy|17|||
164199679|NCT00919633|593101837|FG001|Overall Study|Lack of Efficacy|3|||
164199680|NCT00919633|593101838|FG002|Overall Study|Lack of Efficacy|2|||
164199681|NCT00919633|593101839|FG003|Overall Study|Lack of Efficacy|3|||
164199682|NCT00919633|593101836|FG000|Overall Study|Withdrawal by Subject|1|||
164199683|NCT00919633|593101837|FG001|Overall Study|Withdrawal by Subject|2|||
164199684|NCT00919633|593101838|FG002|Overall Study|Withdrawal by Subject|4|||
164199685|NCT00919633|593101839|FG003|Overall Study|Withdrawal by Subject|3|||
164199686|NCT00919633|593101836|FG000|Overall Study|Lost to Follow-up|3|||
164199687|NCT00919633|593101837|FG001|Overall Study|Lost to Follow-up|1|||
164199688|NCT00919633|593101838|FG002|Overall Study|Lost to Follow-up|0|||
164199689|NCT00919633|593101839|FG003|Overall Study|Lost to Follow-up|2|||
164199690|NCT00919633|593101836|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
164199691|NCT00919633|593101837|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
164199692|NCT00919633|593101838|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
164199693|NCT00919633|593101839|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
164199694|NCT00919633|593101836|FG000|Overall Study|Protocol Violation|0|||
164199695|NCT00919633|593101837|FG001|Overall Study|Protocol Violation|0|||
164199696|NCT00919633|593101838|FG002|Overall Study|Protocol Violation|0|||
164199697|NCT00919633|593101839|FG003|Overall Study|Protocol Violation|1|||
164199698|NCT00919633|593101836|FG000|Overall Study|Physician Decision|0|||
164199699|NCT00919633|593101837|FG001|Overall Study|Physician Decision|0|||
164199700|NCT00919633|593101838|FG002|Overall Study|Physician Decision|0|||
164199701|NCT00919633|593101839|FG003|Overall Study|Physician Decision|1|||
164199702|NCT00919633|593101836|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
164199703|NCT00919633|593101837|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
164199704|NCT00919633|593101838|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
164199705|NCT00919633|593101839|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
164199706|NCT00919633|593101836|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
164199707|NCT00919633|593101837|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
164199708|NCT00919633|593101838|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
164199709|NCT00919633|593101839|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
164199710|NCT01526785|593101840|FG000|Overall Study|Study Terminated by Sponsor|8|||
164199711|NCT01526785|593101840|FG000|Overall Study|Death|2|||
164199712|NCT01526785|593101840|FG000|Overall Study|Physician Decision|1|||
164199713|NCT01526785|593101840|FG000|Overall Study|Withdrawal by Subject|2|||
164550680|NCT01473563|594388755|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
164308458|NCT01931566|593504516|FG002|Overall Study|Adverse Event|132|||
164308459|NCT01931566|593504514|FG000|Overall Study|Major Protocol Deviation|5|||
164656114|NCT01090765|594766433|FG004|Overall Study|Patient withdrew consent|1|||
164656115|NCT01090765|594766434|FG005|Overall Study|Patient withdrew consent|1|||
164656116|NCT01090765|594766429|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
164656117|NCT01090765|594766430|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
164656118|NCT01090765|594766431|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
164199714|NCT03408899|593103470|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
164199715|NCT04745351|593103476|FG000|Overall Study|Death|51|||
164199716|NCT04745351|593103477|FG001|Overall Study|Death|25|||
164199717|NCT04745351|593103476|FG000|Overall Study|Lost to Follow-up|9|||
164199718|NCT04745351|593103477|FG001|Overall Study|Lost to Follow-up|3|||
164199719|NCT04745351|593103476|FG000|Overall Study|Randomized but Never Treated|3|||
164199720|NCT04745351|593103477|FG001|Overall Study|Randomized but Never Treated|3|||
164199721|NCT04745351|593103476|FG000|Overall Study|Adverse Event|4|||
164199722|NCT04745351|593103477|FG001|Overall Study|Adverse Event|0|||
164199723|NCT04745351|593103476|FG000|Overall Study|Withdrew Consent|1|||
164199724|NCT04745351|593103477|FG001|Overall Study|Withdrew Consent|2|||
164199725|NCT04745351|593103476|FG000|Overall Study|Investigator's Discretion|2|||
164199726|NCT04745351|593103477|FG001|Overall Study|Investigator's Discretion|0|||
164199727|NCT04745351|593103476|FG000|Overall Study|Protocol Violation|1|||
164199728|NCT04745351|593103477|FG001|Overall Study|Protocol Violation|0|||
164199729|NCT02014272|593103478|FG000|Intervention Period 1|Withdrawal by Subject|1|||
164199730|NCT02014272|593103479|FG001|Intervention Period 1|Withdrawal by Subject|0|||
164199731|NCT02014272|593103478|FG000|Intervention Period 1|Adverse Event|0|||
164199732|NCT02014272|593103479|FG001|Intervention Period 1|Adverse Event|1|||
164199733|NCT03636256|593103480|FG000|Overall Study|Lost to Follow-up|3|||
164199734|NCT03636256|593103481|FG001|Overall Study|Lost to Follow-up|0|||
164199735|NCT03636256|593103482|FG002|Overall Study|Lost to Follow-up|2|||
164199736|NCT03636256|593103483|FG003|Overall Study|Lost to Follow-up|1|||
164199737|NCT03636256|593103484|FG004|Overall Study|Lost to Follow-up|0|||
164199738|NCT03636256|593103485|FG005|Overall Study|Lost to Follow-up|4|||
164199739|NCT03636256|593103486|FG006|Overall Study|Lost to Follow-up|2|||
164199740|NCT03636256|593103487|FG007|Overall Study|Lost to Follow-up|0|||
164199741|NCT03636256|593103488|FG008|Overall Study|Lost to Follow-up|4|||
164199742|NCT03636256|593103480|FG000|Overall Study|Withdrawal by Subject|0|||
164199743|NCT03636256|593103481|FG001|Overall Study|Withdrawal by Subject|0|||
164199744|NCT03636256|593103482|FG002|Overall Study|Withdrawal by Subject|0|||
164199745|NCT03636256|593103483|FG003|Overall Study|Withdrawal by Subject|0|||
164199746|NCT03636256|593103484|FG004|Overall Study|Withdrawal by Subject|0|||
164199747|NCT03636256|593103485|FG005|Overall Study|Withdrawal by Subject|0|||
164199748|NCT03636256|593103486|FG006|Overall Study|Withdrawal by Subject|0|||
164199749|NCT03636256|593103487|FG007|Overall Study|Withdrawal by Subject|0|||
164199750|NCT03636256|593103488|FG008|Overall Study|Withdrawal by Subject|1|||
164199751|NCT00723229|593103491|FG000|First Intervention|Lost to Follow-up|7|||
164199752|NCT00723229|593103492|FG001|First Intervention|Lost to Follow-up|3|||
164199753|NCT02337491|593103493|FG000|Overall Study|Death|1|||
164199754|NCT02337491|593103494|FG001|Overall Study|Death|1|||
164199755|NCT02337491|593103493|FG000|Overall Study|Adverse Event|0|||
164199756|NCT02337491|593103494|FG001|Overall Study|Adverse Event|1|||
164199757|NCT02337491|593103493|FG000|Overall Study|Withdrawal by Subject|3|||
164199758|NCT02337491|593103494|FG001|Overall Study|Withdrawal by Subject|0|||
164199759|NCT02337491|593103493|FG000|Overall Study|Progressive Disease|44|||
164199760|NCT02337491|593103494|FG001|Overall Study|Progressive Disease|28|||
164199761|NCT02337491|593103493|FG000|Overall Study|On Treatment|2|||
164199762|NCT02337491|593103494|FG001|Overall Study|On Treatment|0|||
164199763|NCT01432951|593103495|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
164199764|NCT02900352|593103496|FG000|Overall Study|Lost to Follow-up|28|||
164199765|NCT02900352|593103497|FG001|Overall Study|Lost to Follow-up|17|||
164199766|NCT00960193|593103498|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
164199767|NCT00785356|593103500|FG000|Overall Study|Study prematurely terminated|8|||
164199768|NCT03712280|593103506|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
164199769|NCT03712280|593103507|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
164199770|NCT03712280|593103508|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
164199771|NCT03712280|593103509|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
164199772|NCT03712280|593103506|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
164199773|NCT03712280|593103507|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
164199774|NCT03712280|593103508|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
164199775|NCT03712280|593103509|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
164199776|NCT03712280|593103506|FG000|Overall Study|Adverse Event|0|||
164199777|NCT03712280|593103507|FG001|Overall Study|Adverse Event|0|||
164199778|NCT03712280|593103508|FG002|Overall Study|Adverse Event|1|||
164308460|NCT01931566|593504515|FG001|Overall Study|Major Protocol Deviation|14|||
164199779|NCT03712280|593103509|FG003|Overall Study|Adverse Event|0|||
164308461|NCT01931566|593504516|FG002|Overall Study|Major Protocol Deviation|21|||
164308462|NCT01931566|593504514|FG000|Overall Study|Lost to Follow-up|3|||
164199780|NCT01245101|593103510|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
164199781|NCT01245101|593103511|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
164199782|NCT01245101|593103510|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
164199783|NCT01245101|593103511|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
164199784|NCT01245101|593103510|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
164199785|NCT01245101|593103511|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
164199786|NCT03093181|593103512|FG000|Overall Study|Withdrawal by Subject|2|||
164199787|NCT03093181|593103513|FG001|Overall Study|Withdrawal by Subject|1|||
164199788|NCT03093181|593103514|FG002|Overall Study|Withdrawal by Subject|2|||
164199789|NCT03093181|593103512|FG000|Overall Study|Other (Not specified)|1|||
164199790|NCT03093181|593103513|FG001|Overall Study|Other (Not specified)|0|||
164199791|NCT03093181|593103514|FG002|Overall Study|Other (Not specified)|0|||
164199792|NCT03093181|593103512|FG000|Overall Study|Adverse Event|0|||
164199793|NCT03093181|593103513|FG001|Overall Study|Adverse Event|1|||
164199794|NCT03093181|593103514|FG002|Overall Study|Adverse Event|0|||
164199795|NCT03093181|593103512|FG000|Overall Study|Other (Protocol violation)|0|||
164199796|NCT03093181|593103513|FG001|Overall Study|Other (Protocol violation)|0|||
164199797|NCT03093181|593103514|FG002|Overall Study|Other (Protocol violation)|1|||
164199798|NCT04076917|593103515|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
164199799|NCT04076917|593103515|FG000|Overall Study|Study closure|13|||
164199800|NCT04076917|593103515|FG000|Overall Study|Physician Decision|3|||
164308463|NCT01931566|593504515|FG001|Overall Study|Lost to Follow-up|26|||
164308464|NCT01931566|593504516|FG002|Overall Study|Lost to Follow-up|23|||
164308465|NCT01931566|593504514|FG000|Overall Study|Voluntary Withdrawal|78|||
164308466|NCT01931566|593504515|FG001|Overall Study|Voluntary Withdrawal|245|||
164308467|NCT01931566|593504516|FG002|Overall Study|Voluntary Withdrawal|225|||
164308468|NCT01931566|593504514|FG000|Overall Study|Study Termination|289|||
164308469|NCT01931566|593504515|FG001|Overall Study|Study Termination|968|||
164308470|NCT01931566|593504516|FG002|Overall Study|Study Termination|1037|||
164308471|NCT01931566|593504514|FG000|Overall Study|Reason Not Specified|11|||
164308472|NCT01931566|593504515|FG001|Overall Study|Reason Not Specified|47|||
164308473|NCT01931566|593504516|FG002|Overall Study|Reason Not Specified|53|||
164308474|NCT01931566|593504514|FG000|Overall Study|Missing|0|||
164308475|NCT01931566|593504515|FG001|Overall Study|Missing|0|||
164308476|NCT01931566|593504516|FG002|Overall Study|Missing|1|||
164308477|NCT01599637|593504517|FG000|Overall Study|administrative problems|0|||
164308478|NCT01599637|593504518|FG001|Overall Study|administrative problems|2|||
164308479|NCT01599637|593504519|FG002|Overall Study|administrative problems|0|||
164308480|NCT01599637|593504517|FG000|Overall Study|Adverse Event|1|||
164308481|NCT01599637|593504518|FG001|Overall Study|Adverse Event|0|||
164308482|NCT01599637|593504519|FG002|Overall Study|Adverse Event|0|||
164308483|NCT00611026|593504520|FG000|Randomized to Double-blind Treatment|Not treated|2|||
164308484|NCT00611026|593504521|FG001|Randomized to Double-blind Treatment|Not treated|1|||
164308485|NCT00611026|593504522|FG002|Randomized to Double-blind Treatment|Not treated|3|||
164308486|NCT00611026|593504520|FG000|Double-blind Treatment Period|Death|1|||
164199801|NCT04076917|593103515|FG000|Overall Study|Death|1|||
164199802|NCT04076917|593103515|FG000|Overall Study|Lost to Follow-up|1|||
164199803|NCT04076917|593103515|FG000|Overall Study|Withdrawal by Subject|1|||
164199804|NCT04076917|593103515|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
164199805|NCT02378662|593103516|FG000|Overall Study|Early Discontinuation|2|||
164199806|NCT02378662|593103517|FG001|Overall Study|Early Discontinuation|0|||
164199807|NCT01159574|593103518|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
164199808|NCT01159574|593103518|FG000|Treatment Phase|Adverse Event|3|||
164199809|NCT01159574|593103518|FG000|Treatment Phase|Death|6|||
164199810|NCT01159574|593103518|FG000|Treatment Phase|Physician Decision|2|||
164199811|NCT01159574|593103518|FG000|Treatment Phase|Withdrawal by Subject|7|||
164199812|NCT01159574|593103518|FG000|Treatment Phase|still on treatment|2|||
164199813|NCT01159574|593103518|FG000|Follow Up Phase|Lost to Follow-up|2|||
164199814|NCT01159574|593103518|FG000|Follow Up Phase|still being followed for overall surviva|18|||
164199815|NCT05412134|593103519|FG000|Overall Study|Lost to Follow-up|2|||
164199816|NCT05412134|593103520|FG001|Overall Study|Lost to Follow-up|0|||
164199817|NCT03167242|593103524|FG000|Overall Study|Patient/Guardian Decision|0|||
164199818|NCT03167242|593103525|FG001|Overall Study|Patient/Guardian Decision|1|||
164199819|NCT03167242|593103526|FG002|Overall Study|Patient/Guardian Decision|2|||
164199820|NCT03167242|593103527|FG003|Overall Study|Patient/Guardian Decision|1|||
164199821|NCT03167242|593103528|FG004|Overall Study|Patient/Guardian Decision|1|||
164199822|NCT03167242|593103529|FG005|Overall Study|Patient/Guardian Decision|1|||
164199823|NCT03167242|593103530|FG006|Overall Study|Patient/Guardian Decision|0|||
164199824|NCT03167242|593103531|FG007|Overall Study|Patient/Guardian Decision|0|||
164199825|NCT03167242|593103532|FG008|Overall Study|Patient/Guardian Decision|0|||
164199826|NCT03167242|593103533|FG009|Overall Study|Patient/Guardian Decision|0|||
164308487|NCT00611026|593504521|FG001|Double-blind Treatment Period|Death|0|||
164308488|NCT00611026|593504522|FG002|Double-blind Treatment Period|Death|0|||
164308489|NCT00611026|593504520|FG000|Double-blind Treatment Period|Adverse Event|9|||
164308490|NCT00611026|593504521|FG001|Double-blind Treatment Period|Adverse Event|28|||
164420585|NCT01890967|593910948|FG002|Overall Study|Adverse Event|3|||
164308491|NCT00611026|593504522|FG002|Double-blind Treatment Period|Adverse Event|46|||
164308492|NCT00611026|593504520|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
164308493|NCT00611026|593504521|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
164308494|NCT00611026|593504522|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
164308495|NCT00611026|593504520|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
164308496|NCT00611026|593504521|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
164308497|NCT00611026|593504522|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
164308498|NCT00611026|593504520|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
164308499|NCT00611026|593504521|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
164308500|NCT00611026|593504522|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
164308501|NCT00611026|593504520|FG000|Double-blind Treatment Period|Other|13|||
164308502|NCT00611026|593504521|FG001|Double-blind Treatment Period|Other|20|||
164308503|NCT00611026|593504522|FG002|Double-blind Treatment Period|Other|18|||
164308504|NCT00760617|593504523|FG000|Overall Study|Adverse Event|5|||
164308505|NCT00760617|593504524|FG001|Overall Study|Adverse Event|2|||
164308506|NCT00760617|593504525|FG002|Overall Study|Adverse Event|0|||
164308507|NCT00760617|593504523|FG000|Overall Study|Lost to Follow-up|0|||
164308508|NCT00760617|593504524|FG001|Overall Study|Lost to Follow-up|0|||
164308509|NCT00760617|593504525|FG002|Overall Study|Lost to Follow-up|5|||
164308510|NCT04625101|593504526|FG000|Overall Study|Withdrawal by Subject|0|||
164308511|NCT04625101|593504527|FG001|Overall Study|Withdrawal by Subject|1|||
164308512|NCT04625101|593504526|FG000|Overall Study|Protocol Deviation|1|||
164308513|NCT04625101|593504527|FG001|Overall Study|Protocol Deviation|0|||
164308514|NCT01192191|593504529|FG000|Overall Study|Adverse Event|7|||
164308515|NCT01192191|593504530|FG001|Overall Study|Adverse Event|12|||
164308516|NCT01192191|593504529|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
164308517|NCT01192191|593504530|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
164308518|NCT01192191|593504529|FG000|Overall Study|Lost to Follow-up|0|||
164308519|NCT01192191|593504530|FG001|Overall Study|Lost to Follow-up|1|||
164308520|NCT01192191|593504529|FG000|Overall Study|Withdrawal by Subject|1|||
164308521|NCT01192191|593504530|FG001|Overall Study|Withdrawal by Subject|6|||
164308522|NCT00467753|593504531|FG000|Overall Study|Lost to Follow-up|1|||
164308523|NCT00467753|593504532|FG001|Overall Study|Lost to Follow-up|2|||
164308524|NCT00467753|593504531|FG000|Overall Study|Adverse Event|2|||
164308525|NCT00467753|593504532|FG001|Overall Study|Adverse Event|0|||
164308526|NCT01047553|593504533|FG000|Overall Study|Adverse Event|10|||
164308527|NCT01047553|593504534|FG001|Overall Study|Adverse Event|5|||
164308528|NCT01047553|593504533|FG000|Overall Study|Withdrawal by Subject|4|||
164308529|NCT01047553|593504534|FG001|Overall Study|Withdrawal by Subject|2|||
164308530|NCT01047553|593504533|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
164308531|NCT01047553|593504534|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
164308532|NCT01047553|593504533|FG000|Overall Study|Lost to Follow-up|1|||
164308533|NCT01047553|593504534|FG001|Overall Study|Lost to Follow-up|0|||
164308534|NCT01047553|593504533|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
164308535|NCT01047553|593504534|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
164308536|NCT01047553|593504533|FG000|Overall Study|PI's decision|0|||
164308537|NCT01047553|593504534|FG001|Overall Study|PI's decision|1|||
164308538|NCT02817464|593504536|FG000|Overall Study|Lost to Follow-up|1|||
164308539|NCT02817464|593504537|FG001|Overall Study|Lost to Follow-up|0|||
164308540|NCT02817464|593504536|FG000|Overall Study|Discontinued early due to personal decision|1|||
164308541|NCT02817464|593504537|FG001|Overall Study|Discontinued early due to personal decision|1|||
164308542|NCT04292899|593504539|FG000|Overall Study|Death|21|||
164308543|NCT04292899|593504540|FG001|Overall Study|Death|28|||
164308544|NCT04292899|593504541|FG002|Overall Study|Death|188|||
164308545|NCT04292899|593504542|FG003|Overall Study|Death|371|||
164308546|NCT04292899|593504539|FG000|Overall Study|Lost to Follow-up|8|||
164308547|NCT04292899|593504540|FG001|Overall Study|Lost to Follow-up|4|||
164308548|NCT04292899|593504541|FG002|Overall Study|Lost to Follow-up|22|||
164308549|NCT04292899|593504542|FG003|Overall Study|Lost to Follow-up|235|||
164308550|NCT04292899|593504539|FG000|Overall Study|Withdrew consent|1|||
164308551|NCT04292899|593504540|FG001|Overall Study|Withdrew consent|0|||
164308552|NCT04292899|593504541|FG002|Overall Study|Withdrew consent|11|||
164308553|NCT04292899|593504542|FG003|Overall Study|Withdrew consent|32|||
164308554|NCT04292899|593504539|FG000|Overall Study|Adverse Event|2|||
164308555|NCT04292899|593504540|FG001|Overall Study|Adverse Event|1|||
164308556|NCT04292899|593504541|FG002|Overall Study|Adverse Event|2|||
164308557|NCT04292899|593504542|FG003|Overall Study|Adverse Event|2|||
164308558|NCT04292899|593504539|FG000|Overall Study|Investigator's Discretion|0|||
164308559|NCT04292899|593504540|FG001|Overall Study|Investigator's Discretion|0|||
164550681|NCT03610724|594388756|FG000|Overall Study|Death|17|||
164550682|NCT03610724|594388756|FG000|Overall Study|Lost to Follow-up|1|||
164308560|NCT04292899|593504541|FG002|Overall Study|Investigator's Discretion|0|||
164308561|NCT04292899|593504542|FG003|Overall Study|Investigator's Discretion|3|||
164308562|NCT04292899|593504539|FG000|Overall Study|Non-compliance With Study Drug|0|||
164308563|NCT04292899|593504540|FG001|Overall Study|Non-compliance With Study Drug|0|||
164308564|NCT04292899|593504541|FG002|Overall Study|Non-compliance With Study Drug|0|||
164199827|NCT03167242|593103534|FG010|Overall Study|Patient/Guardian Decision|1|||
164199828|NCT03167242|593103535|FG011|Overall Study|Patient/Guardian Decision|0|||
164199829|NCT03167242|593103524|FG000|Overall Study|Lost to Follow-up|0|||
164199830|NCT03167242|593103525|FG001|Overall Study|Lost to Follow-up|0|||
164199831|NCT03167242|593103526|FG002|Overall Study|Lost to Follow-up|1|||
164199832|NCT03167242|593103527|FG003|Overall Study|Lost to Follow-up|0|||
164199833|NCT03167242|593103528|FG004|Overall Study|Lost to Follow-up|0|||
164199834|NCT03167242|593103529|FG005|Overall Study|Lost to Follow-up|1|||
164199835|NCT03167242|593103530|FG006|Overall Study|Lost to Follow-up|2|||
164199836|NCT03167242|593103531|FG007|Overall Study|Lost to Follow-up|1|||
164199837|NCT03167242|593103532|FG008|Overall Study|Lost to Follow-up|0|||
164199838|NCT03167242|593103533|FG009|Overall Study|Lost to Follow-up|0|||
164199839|NCT03167242|593103534|FG010|Overall Study|Lost to Follow-up|1|||
164199840|NCT03167242|593103535|FG011|Overall Study|Lost to Follow-up|1|||
164199841|NCT03167242|593103524|FG000|Overall Study|Reason not provided|0|||
164199842|NCT03167242|593103525|FG001|Overall Study|Reason not provided|0|||
164199843|NCT03167242|593103526|FG002|Overall Study|Reason not provided|0|||
164199844|NCT03167242|593103527|FG003|Overall Study|Reason not provided|0|||
164199845|NCT03167242|593103528|FG004|Overall Study|Reason not provided|0|||
164199846|NCT03167242|593103529|FG005|Overall Study|Reason not provided|0|||
164199847|NCT03167242|593103530|FG006|Overall Study|Reason not provided|0|||
164199848|NCT03167242|593103531|FG007|Overall Study|Reason not provided|0|||
164199849|NCT03167242|593103532|FG008|Overall Study|Reason not provided|1|||
164199850|NCT03167242|593103533|FG009|Overall Study|Reason not provided|0|||
164199851|NCT03167242|593103534|FG010|Overall Study|Reason not provided|0|||
164199852|NCT03167242|593103535|FG011|Overall Study|Reason not provided|0|||
164199853|NCT03444584|593103536|FG000|Overall Study|Withdrawal by Subject|0|||
164199854|NCT03444584|593103537|FG001|Overall Study|Withdrawal by Subject|1|||
164199855|NCT03444584|593103536|FG000|Overall Study|Other|0|||
164199856|NCT03444584|593103537|FG001|Overall Study|Other|1|||
164199857|NCT01077323|593103540|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
164199858|NCT01077323|593103541|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
164199859|NCT01077323|593103542|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
164199860|NCT01077323|593103540|FG000|Overall Study|Dispensing of drug in baseline period|0|||
164199861|NCT01077323|593103541|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
164199862|NCT01077323|593103542|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
164199863|NCT01077323|593103540|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
164199864|NCT01077323|593103541|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
164199865|NCT01077323|593103542|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
164199866|NCT00372424|593103543|FG000|Overall Study|Adverse Event|2|||
164199867|NCT00372424|593103543|FG000|Overall Study|Withdrawal by Subject|1|||
164199868|NCT00372424|593103543|FG000|Overall Study|Death|1|||
164199869|NCT00372424|593103543|FG000|Overall Study|Objective Progression or Relapse|14|||
164199870|NCT00372424|593103543|FG000|Overall Study|Other|7|||
164199871|NCT00372424|593103543|FG000|Overall Study|Enrolled, Not Treated|1|||
164199872|NCT03118934|593103552|FG000|Overall Study|Adverse Event|0|||
164199873|NCT03118934|593103553|FG001|Overall Study|Adverse Event|0|||
164199874|NCT03118934|593103554|FG002|Overall Study|Adverse Event|0|||
164199875|NCT03118934|593103555|FG003|Overall Study|Adverse Event|0|||
164199876|NCT03118934|593103556|FG004|Overall Study|Adverse Event|0|||
164199877|NCT03118934|593103557|FG005|Overall Study|Adverse Event|1|||
164199878|NCT03118934|593103552|FG000|Overall Study|Physician Decision|0|||
164199879|NCT03118934|593103553|FG001|Overall Study|Physician Decision|0|||
164199880|NCT03118934|593103554|FG002|Overall Study|Physician Decision|0|||
164199881|NCT03118934|593103555|FG003|Overall Study|Physician Decision|0|||
164199882|NCT03118934|593103556|FG004|Overall Study|Physician Decision|0|||
164199883|NCT03118934|593103557|FG005|Overall Study|Physician Decision|1|||
164199884|NCT03118934|593103552|FG000|Overall Study|Discontinued prior to exposure|0|||
164199885|NCT03118934|593103553|FG001|Overall Study|Discontinued prior to exposure|1|||
164199886|NCT03118934|593103554|FG002|Overall Study|Discontinued prior to exposure|1|||
164199887|NCT03118934|593103555|FG003|Overall Study|Discontinued prior to exposure|1|||
164199888|NCT03118934|593103556|FG004|Overall Study|Discontinued prior to exposure|2|||
164199889|NCT03118934|593103557|FG005|Overall Study|Discontinued prior to exposure|0|||
164199890|NCT02849080|593103568|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
164199891|NCT02849080|593103569|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
164199892|NCT02849080|593103570|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
164199893|NCT02849080|593103571|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
164199894|NCT02849080|593103568|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
164199895|NCT02849080|593103569|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
164199896|NCT02849080|593103570|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
164199897|NCT02849080|593103571|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
164199898|NCT02849080|593103568|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
164199899|NCT02849080|593103569|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
164199900|NCT02849080|593103570|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
164199901|NCT02849080|593103571|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
164199902|NCT02849080|593103568|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
164308565|NCT04292899|593504542|FG003|Overall Study|Non-compliance With Study Drug|1|||
164308566|NCT04292899|593504539|FG000|Overall Study|Protocol Violation|0|||
164308567|NCT04292899|593504540|FG001|Overall Study|Protocol Violation|0|||
164308568|NCT04292899|593504541|FG002|Overall Study|Protocol Violation|0|||
164308569|NCT04292899|593504542|FG003|Overall Study|Protocol Violation|1|||
164308570|NCT00948441|593504543|FG000|Overall Study|no longer meet inclusion criteria|1|||
164308571|NCT00948441|593504544|FG001|Overall Study|no longer meet inclusion criteria|4|||
164308572|NCT03695367|593504545|FG000|Overall Study|Missed the Day 28 visit.|1|||
164308573|NCT03695367|593504546|FG001|Overall Study|Missed the Day 28 visit.|0|||
164308574|NCT03695367|593504545|FG000|Overall Study|Lost to Follow-up|0|||
164308575|NCT03695367|593504546|FG001|Overall Study|Lost to Follow-up|1|||
164308576|NCT03695367|593504545|FG000|Overall Study|Withdrawal by Subject|0|||
164308577|NCT03695367|593504546|FG001|Overall Study|Withdrawal by Subject|1|||
164308578|NCT03695367|593504545|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
164308579|NCT03695367|593504546|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
164308580|NCT02039843|593504548|FG000|Randomization and Observation Period|Adverse Event|2|||
164308581|NCT02039843|593504549|FG001|Randomization and Observation Period|Adverse Event|0|||
164308582|NCT02039843|593504548|FG000|Randomization and Observation Period|Death|1|||
164308583|NCT02039843|593504549|FG001|Randomization and Observation Period|Death|0|||
164308584|NCT02039843|593504548|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
164308585|NCT02039843|593504549|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
164308586|NCT02039843|593504548|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
164308587|NCT02039843|593504549|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
164308588|NCT02039843|593504548|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
164308589|NCT02039843|593504549|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
164308590|NCT02039843|593504548|FG000|Pairing With a Study Dog|Death|1|||
164308591|NCT02039843|593504549|FG001|Pairing With a Study Dog|Death|0|||
164308592|NCT02039843|593504548|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
164308593|NCT02039843|593504549|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
164308594|NCT02039843|593504548|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
164308595|NCT02039843|593504549|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
164308596|NCT02039843|593504548|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
164308597|NCT02039843|593504549|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
164308598|NCT01958164|593504550|FG000|Overall Study|Adverse Event|0|||
164308599|NCT01958164|593504551|FG001|Overall Study|Adverse Event|2|||
164308600|NCT01958164|593504550|FG000|Overall Study|Lost to Follow-up|2|||
164308601|NCT01958164|593504551|FG001|Overall Study|Lost to Follow-up|3|||
164308602|NCT00740857|593504552|FG000|Overall Study|Withdrawal by Subject|1|||
164308603|NCT00740857|593504553|FG001|Overall Study|Withdrawal by Subject|0|||
164308604|NCT00740857|593504554|FG002|Overall Study|Withdrawal by Subject|0|||
164308605|NCT02963506|593504555|FG000|Double-Blind Period|Adverse Event|0|||
164308606|NCT02963506|593504556|FG001|Double-Blind Period|Adverse Event|0|||
164308607|NCT02963506|593504557|FG002|Double-Blind Period|Adverse Event|1|||
164308608|NCT02963506|593504558|FG003|Double-Blind Period|Adverse Event|0|||
164308609|NCT02963506|593504559|FG004|Double-Blind Period|Adverse Event|0|||
164308610|NCT02963506|593504560|FG005|Double-Blind Period|Adverse Event|0|||
164308611|NCT02963506|593504561|FG006|Double-Blind Period|Adverse Event|0|||
164308612|NCT02963506|593504562|FG007|Double-Blind Period|Adverse Event|0|||
164308613|NCT02963506|593504563|FG008|Double-Blind Period|Adverse Event|0|||
164308614|NCT02963506|593504564|FG009|Double-Blind Period|Adverse Event|0|||
164308615|NCT02963506|593504565|FG010|Double-Blind Period|Adverse Event|0|||
164308616|NCT02963506|593504566|FG011|Double-Blind Period|Adverse Event|0|||
164308617|NCT02963506|593504567|FG012|Double-Blind Period|Adverse Event|0|||
164308618|NCT02963506|593504555|FG000|Double-Blind Period|Death|0|||
164308619|NCT02963506|593504556|FG001|Double-Blind Period|Death|0|||
164308620|NCT02963506|593504557|FG002|Double-Blind Period|Death|0|||
164308621|NCT02963506|593504558|FG003|Double-Blind Period|Death|1|||
164308622|NCT02963506|593504559|FG004|Double-Blind Period|Death|0|||
164308623|NCT02963506|593504560|FG005|Double-Blind Period|Death|0|||
164308624|NCT02963506|593504561|FG006|Double-Blind Period|Death|0|||
164308625|NCT02963506|593504562|FG007|Double-Blind Period|Death|0|||
164308626|NCT02963506|593504563|FG008|Double-Blind Period|Death|0|||
164308627|NCT02963506|593504564|FG009|Double-Blind Period|Death|0|||
164308628|NCT02963506|593504565|FG010|Double-Blind Period|Death|0|||
164308629|NCT02963506|593504566|FG011|Double-Blind Period|Death|0|||
164308630|NCT02963506|593504567|FG012|Double-Blind Period|Death|0|||
164308631|NCT02963506|593504555|FG000|Double-Blind Period|Lost to Follow-up|0|||
164308632|NCT02963506|593504556|FG001|Double-Blind Period|Lost to Follow-up|1|||
164308633|NCT02963506|593504557|FG002|Double-Blind Period|Lost to Follow-up|0|||
164308634|NCT02963506|593504558|FG003|Double-Blind Period|Lost to Follow-up|0|||
164308635|NCT02963506|593504559|FG004|Double-Blind Period|Lost to Follow-up|0|||
164308636|NCT02963506|593504560|FG005|Double-Blind Period|Lost to Follow-up|0|||
164308637|NCT02963506|593504561|FG006|Double-Blind Period|Lost to Follow-up|0|||
164308638|NCT02963506|593504562|FG007|Double-Blind Period|Lost to Follow-up|0|||
164308639|NCT02963506|593504563|FG008|Double-Blind Period|Lost to Follow-up|0|||
164308640|NCT02963506|593504564|FG009|Double-Blind Period|Lost to Follow-up|0|||
164308641|NCT02963506|593504565|FG010|Double-Blind Period|Lost to Follow-up|0|||
164308642|NCT02963506|593504566|FG011|Double-Blind Period|Lost to Follow-up|0|||
164308643|NCT02963506|593504567|FG012|Double-Blind Period|Lost to Follow-up|0|||
164308644|NCT02963506|593504555|FG000|Double-Blind Period|Withdrawal by Subject|0|||
164308645|NCT02963506|593504556|FG001|Double-Blind Period|Withdrawal by Subject|0|||
164308646|NCT02963506|593504557|FG002|Double-Blind Period|Withdrawal by Subject|1|||
164308647|NCT02963506|593504558|FG003|Double-Blind Period|Withdrawal by Subject|1|||
164308648|NCT02963506|593504559|FG004|Double-Blind Period|Withdrawal by Subject|0|||
164308649|NCT02963506|593504560|FG005|Double-Blind Period|Withdrawal by Subject|0|||
164308650|NCT02963506|593504561|FG006|Double-Blind Period|Withdrawal by Subject|0|||
164308651|NCT02963506|593504562|FG007|Double-Blind Period|Withdrawal by Subject|0|||
164308652|NCT02963506|593504563|FG008|Double-Blind Period|Withdrawal by Subject|0|||
164308653|NCT02963506|593504564|FG009|Double-Blind Period|Withdrawal by Subject|0|||
164308654|NCT02963506|593504565|FG010|Double-Blind Period|Withdrawal by Subject|0|||
164308655|NCT02963506|593504566|FG011|Double-Blind Period|Withdrawal by Subject|0|||
164308656|NCT02963506|593504567|FG012|Double-Blind Period|Withdrawal by Subject|0|||
164308657|NCT02963506|593504555|FG000|Double-Blind Period|No compliance|0|||
164308658|NCT02963506|593504556|FG001|Double-Blind Period|No compliance|1|||
164308659|NCT02963506|593504557|FG002|Double-Blind Period|No compliance|0|||
164308660|NCT02963506|593504558|FG003|Double-Blind Period|No compliance|0|||
164308661|NCT02963506|593504559|FG004|Double-Blind Period|No compliance|0|||
164308662|NCT02963506|593504560|FG005|Double-Blind Period|No compliance|0|||
164308663|NCT02963506|593504561|FG006|Double-Blind Period|No compliance|0|||
164308664|NCT02963506|593504562|FG007|Double-Blind Period|No compliance|0|||
164308665|NCT02963506|593504563|FG008|Double-Blind Period|No compliance|0|||
164308666|NCT02963506|593504564|FG009|Double-Blind Period|No compliance|0|||
164308667|NCT02963506|593504565|FG010|Double-Blind Period|No compliance|0|||
164308668|NCT02963506|593504566|FG011|Double-Blind Period|No compliance|0|||
164308669|NCT02963506|593504567|FG012|Double-Blind Period|No compliance|0|||
164308670|NCT02963506|593504555|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
164308671|NCT02963506|593504556|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
164308672|NCT02963506|593504557|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
164308673|NCT02963506|593504558|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
164308674|NCT02963506|593504559|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
164308675|NCT02963506|593504560|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
164308676|NCT02963506|593504561|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
164308677|NCT02963506|593504562|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
164308678|NCT02963506|593504563|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
164308679|NCT02963506|593504564|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
164308680|NCT02963506|593504565|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
164308681|NCT02963506|593504566|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
164308682|NCT02963506|593504567|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
164308683|NCT02963506|593504555|FG000|Dose-Blind Period|Adverse Event|0|||
164308684|NCT02963506|593504556|FG001|Dose-Blind Period|Adverse Event|0|||
164308685|NCT02963506|593504557|FG002|Dose-Blind Period|Adverse Event|0|||
164308686|NCT02963506|593504558|FG003|Dose-Blind Period|Adverse Event|0|||
164308687|NCT02963506|593504559|FG004|Dose-Blind Period|Adverse Event|0|||
164308688|NCT02963506|593504560|FG005|Dose-Blind Period|Adverse Event|1|||
164308689|NCT02963506|593504561|FG006|Dose-Blind Period|Adverse Event|3|||
164308690|NCT02963506|593504562|FG007|Dose-Blind Period|Adverse Event|2|||
164308691|NCT02963506|593504563|FG008|Dose-Blind Period|Adverse Event|2|||
164308692|NCT02963506|593504564|FG009|Dose-Blind Period|Adverse Event|2|||
164308693|NCT02963506|593504565|FG010|Dose-Blind Period|Adverse Event|1|||
164308694|NCT02963506|593504566|FG011|Dose-Blind Period|Adverse Event|1|||
164308695|NCT02963506|593504567|FG012|Dose-Blind Period|Adverse Event|6|||
164308696|NCT02963506|593504555|FG000|Dose-Blind Period|Lack of Efficacy|0|||
164308697|NCT02963506|593504556|FG001|Dose-Blind Period|Lack of Efficacy|0|||
164308698|NCT02963506|593504557|FG002|Dose-Blind Period|Lack of Efficacy|0|||
164308699|NCT02963506|593504558|FG003|Dose-Blind Period|Lack of Efficacy|0|||
164308700|NCT02963506|593504559|FG004|Dose-Blind Period|Lack of Efficacy|0|||
164308701|NCT02963506|593504560|FG005|Dose-Blind Period|Lack of Efficacy|0|||
164308702|NCT02963506|593504561|FG006|Dose-Blind Period|Lack of Efficacy|0|||
164308703|NCT02963506|593504562|FG007|Dose-Blind Period|Lack of Efficacy|1|||
164308704|NCT02963506|593504563|FG008|Dose-Blind Period|Lack of Efficacy|0|||
164308705|NCT02963506|593504564|FG009|Dose-Blind Period|Lack of Efficacy|1|||
164308706|NCT02963506|593504565|FG010|Dose-Blind Period|Lack of Efficacy|0|||
164308707|NCT02963506|593504566|FG011|Dose-Blind Period|Lack of Efficacy|0|||
164308708|NCT02963506|593504567|FG012|Dose-Blind Period|Lack of Efficacy|0|||
164308709|NCT02963506|593504555|FG000|Dose-Blind Period|Lost to Follow-up|0|||
164308710|NCT02963506|593504556|FG001|Dose-Blind Period|Lost to Follow-up|0|||
164308711|NCT02963506|593504557|FG002|Dose-Blind Period|Lost to Follow-up|0|||
164308712|NCT02963506|593504558|FG003|Dose-Blind Period|Lost to Follow-up|0|||
164308713|NCT02963506|593504559|FG004|Dose-Blind Period|Lost to Follow-up|0|||
164308714|NCT02963506|593504560|FG005|Dose-Blind Period|Lost to Follow-up|1|||
164199903|NCT02849080|593103569|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
164199904|NCT02849080|593103570|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
164199905|NCT02849080|593103571|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
164199906|NCT02849080|593103568|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
164199907|NCT02849080|593103569|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
164199908|NCT02849080|593103570|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
164199909|NCT02849080|593103571|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
164199910|NCT02849080|593103568|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
164199911|NCT02849080|593103569|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
164199912|NCT02849080|593103570|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
164199913|NCT02849080|593103571|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
164199914|NCT02155985|593103574|FG000|Overall Study|Withdrawal by Subject|0|||
164199915|NCT02155985|593103575|FG001|Overall Study|Withdrawal by Subject|0|||
164199916|NCT02155985|593103576|FG002|Overall Study|Withdrawal by Subject|1|||
164199917|NCT02155985|593103574|FG000|Overall Study|Lost to Follow-up|1|||
164199918|NCT02155985|593103575|FG001|Overall Study|Lost to Follow-up|0|||
164199919|NCT02155985|593103576|FG002|Overall Study|Lost to Follow-up|0|||
164199920|NCT00732069|593103577|FG000|Washout After First Study Drug|Adverse Event|1|||
164199921|NCT00732069|593103578|FG001|Washout After First Study Drug|Adverse Event|0|||
164199922|NCT00732069|593103579|FG002|Washout After First Study Drug|Adverse Event|0|||
164199923|NCT00732069|593103580|FG003|Washout After First Study Drug|Adverse Event|0|||
164199924|NCT00732069|593103581|FG004|Washout After First Study Drug|Adverse Event|0|||
164199925|NCT00732069|593103582|FG005|Washout After First Study Drug|Adverse Event|0|||
164199926|NCT02283658|593103583|FG000|Overall Study|Withdrawal by Subject|1|||
164199927|NCT03608826|593103584|FG000|Overall Study|Death|3|||
164199928|NCT03608826|593103584|FG000|Overall Study|Heart Transplant|3|||
164199929|NCT03608826|593103584|FG000|Overall Study|Physician Decision|4|||
164199930|NCT03139552|593103589|FG000|Overall Study|unable to attend tasting due to schedule|3|||
164199931|NCT00780975|593103597|FG000|Overall Study|Progressive disease|3|||
164199932|NCT00780975|593103597|FG000|Overall Study|Toxicity|5|||
164199933|NCT00887484|593103598|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
164199934|NCT00887484|593103598|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
164199935|NCT00887484|593103598|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
164199936|NCT01061606|593103599|FG000|Overall Study|Adverse Event|1|||
164199937|NCT01061606|593103599|FG000|Overall Study|Death|1|||
164199938|NCT01061606|593103599|FG000|Overall Study|Disease Progression|4|||
164199939|NCT01061606|593103599|FG000|Overall Study|alternative therapy|2|||
164199940|NCT03122171|593103600|FG000|Overall Study|Withdrawal by Subject|1|||
164199941|NCT03044314|593103601|FG000|Overall Study|Physician Decision|2|||
164199942|NCT03044314|593103601|FG000|Overall Study|Withdrawal by Subject|1|||
164199943|NCT03044314|593103601|FG000|Overall Study|Connector tubing not available|1|||
164199944|NCT01316224|593103602|FG000|Overall Study|Protocol Violation|3|||
164199945|NCT01316224|593103602|FG000|Overall Study|Adverse Event|3|||
164199946|NCT01316224|593103602|FG000|Overall Study|Lack of Efficacy|1|||
164199947|NCT01316224|593103602|FG000|Overall Study|Withdrawal by Subject|1|||
164199948|NCT01316224|593103602|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
164199949|NCT01316224|593103602|FG000|Overall Study|Other|1|||
164199950|NCT00264147|593103603|FG000|Treatment I Period|Adverse Event|3|||
164199951|NCT00264147|593103604|FG001|Treatment I Period|Adverse Event|6|||
164199952|NCT00264147|593103605|FG002|Treatment I Period|Adverse Event|3|||
164199953|NCT00264147|593103606|FG003|Treatment I Period|Adverse Event|5|||
164199954|NCT00264147|593103607|FG004|Treatment I Period|Adverse Event|7|||
164199955|NCT00264147|593103608|FG005|Treatment I Period|Adverse Event|0|||
164199956|NCT00264147|593103603|FG000|Treatment I Period|Laboratory Adverse Event|0|||
164199957|NCT00264147|593103604|FG001|Treatment I Period|Laboratory Adverse Event|0|||
164199958|NCT00264147|593103605|FG002|Treatment I Period|Laboratory Adverse Event|0|||
164199959|NCT00264147|593103606|FG003|Treatment I Period|Laboratory Adverse Event|1|||
164199960|NCT00264147|593103607|FG004|Treatment I Period|Laboratory Adverse Event|0|||
164199961|NCT00264147|593103608|FG005|Treatment I Period|Laboratory Adverse Event|0|||
164199962|NCT00264147|593103603|FG000|Treatment I Period|Lack of Efficacy|6|||
164199963|NCT00264147|593103604|FG001|Treatment I Period|Lack of Efficacy|2|||
164199964|NCT00264147|593103605|FG002|Treatment I Period|Lack of Efficacy|8|||
164199965|NCT00264147|593103606|FG003|Treatment I Period|Lack of Efficacy|0|||
164199966|NCT00264147|593103607|FG004|Treatment I Period|Lack of Efficacy|1|||
164199967|NCT00264147|593103608|FG005|Treatment I Period|Lack of Efficacy|0|||
164199968|NCT00264147|593103603|FG000|Treatment I Period|Lost to Follow-up|1|||
164199969|NCT00264147|593103604|FG001|Treatment I Period|Lost to Follow-up|0|||
164199970|NCT00264147|593103605|FG002|Treatment I Period|Lost to Follow-up|0|||
164199971|NCT00264147|593103606|FG003|Treatment I Period|Lost to Follow-up|1|||
164199972|NCT00264147|593103607|FG004|Treatment I Period|Lost to Follow-up|1|||
164199973|NCT00264147|593103608|FG005|Treatment I Period|Lost to Follow-up|0|||
164199974|NCT00264147|593103603|FG000|Treatment I Period|Protocol Violation|2|||
164199975|NCT00264147|593103604|FG001|Treatment I Period|Protocol Violation|2|||
164199976|NCT00264147|593103605|FG002|Treatment I Period|Protocol Violation|0|||
164199977|NCT00264147|593103606|FG003|Treatment I Period|Protocol Violation|0|||
164550683|NCT03610724|594388756|FG000|Overall Study|Physician Decision|1|||
164550684|NCT03610724|594388756|FG000|Overall Study|Died prior to infusion|1|||
164550685|NCT00786565|594388757|FG000|Enrollment Prior to Surgery|Site Closed|3|||
164550686|NCT00786565|594388757|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
164550687|NCT00786565|594388757|FG000|Post Surgery|Abnormal macular pucker|1|||
164550688|NCT00786565|594388757|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
164199978|NCT00264147|593103607|FG004|Treatment I Period|Protocol Violation|0|||
164199979|NCT00264147|593103608|FG005|Treatment I Period|Protocol Violation|0|||
164199980|NCT00264147|593103603|FG000|Treatment I Period|Withdrawal by Subject|2|||
164199981|NCT00264147|593103604|FG001|Treatment I Period|Withdrawal by Subject|0|||
164199982|NCT00264147|593103605|FG002|Treatment I Period|Withdrawal by Subject|0|||
164199983|NCT00264147|593103606|FG003|Treatment I Period|Withdrawal by Subject|2|||
164199984|NCT00264147|593103607|FG004|Treatment I Period|Withdrawal by Subject|2|||
164199985|NCT00264147|593103608|FG005|Treatment I Period|Withdrawal by Subject|0|||
164199986|NCT00264147|593103603|FG000|Treatment I Period|Patient out of town for an extended time|0|||
164199987|NCT00264147|593103604|FG001|Treatment I Period|Patient out of town for an extended time|1|||
164199988|NCT00264147|593103605|FG002|Treatment I Period|Patient out of town for an extended time|0|||
164199989|NCT00264147|593103606|FG003|Treatment I Period|Patient out of town for an extended time|0|||
164199990|NCT00264147|593103607|FG004|Treatment I Period|Patient out of town for an extended time|0|||
164199991|NCT00264147|593103608|FG005|Treatment I Period|Patient out of town for an extended time|0|||
164199992|NCT00264147|593103603|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
164199993|NCT00264147|593103604|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
164199994|NCT00264147|593103605|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
164199995|NCT00264147|593103606|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
164199996|NCT00264147|593103607|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
164199997|NCT00264147|593103608|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
164199998|NCT00264147|593103603|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
164199999|NCT00264147|593103604|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
164200000|NCT00264147|593103605|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
164200001|NCT00264147|593103606|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
164200002|NCT00264147|593103607|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
164200003|NCT00264147|593103608|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
164200004|NCT00264147|593103603|FG000|Treatment II Period|Adverse Event|0|||
164200005|NCT00264147|593103604|FG001|Treatment II Period|Adverse Event|0|||
164200006|NCT00264147|593103605|FG002|Treatment II Period|Adverse Event|0|||
164200007|NCT00264147|593103606|FG003|Treatment II Period|Adverse Event|0|||
164200008|NCT00264147|593103607|FG004|Treatment II Period|Adverse Event|9|||
164200009|NCT00264147|593103608|FG005|Treatment II Period|Adverse Event|9|||
164200010|NCT00264147|593103603|FG000|Treatment II Period|Laboratory Adverse Event|0|||
164200011|NCT00264147|593103604|FG001|Treatment II Period|Laboratory Adverse Event|0|||
164200012|NCT00264147|593103605|FG002|Treatment II Period|Laboratory Adverse Event|0|||
164200013|NCT00264147|593103606|FG003|Treatment II Period|Laboratory Adverse Event|0|||
164200014|NCT00264147|593103607|FG004|Treatment II Period|Laboratory Adverse Event|0|||
164200015|NCT00264147|593103608|FG005|Treatment II Period|Laboratory Adverse Event|1|||
164200016|NCT00264147|593103603|FG000|Treatment II Period|Lack of Efficacy|0|||
164200017|NCT00264147|593103604|FG001|Treatment II Period|Lack of Efficacy|0|||
164200018|NCT00264147|593103605|FG002|Treatment II Period|Lack of Efficacy|0|||
164200019|NCT00264147|593103606|FG003|Treatment II Period|Lack of Efficacy|0|||
164200020|NCT00264147|593103607|FG004|Treatment II Period|Lack of Efficacy|20|||
164200021|NCT00264147|593103608|FG005|Treatment II Period|Lack of Efficacy|19|||
164200022|NCT00264147|593103603|FG000|Treatment II Period|Lost to Follow-up|0|||
164200023|NCT00264147|593103604|FG001|Treatment II Period|Lost to Follow-up|0|||
164200024|NCT00264147|593103605|FG002|Treatment II Period|Lost to Follow-up|0|||
164200025|NCT00264147|593103606|FG003|Treatment II Period|Lost to Follow-up|0|||
164200026|NCT00264147|593103607|FG004|Treatment II Period|Lost to Follow-up|1|||
164200027|NCT00264147|593103608|FG005|Treatment II Period|Lost to Follow-up|1|||
164200028|NCT00264147|593103603|FG000|Treatment II Period|Withdrawal by Subject|0|||
164200029|NCT00264147|593103604|FG001|Treatment II Period|Withdrawal by Subject|0|||
164200030|NCT00264147|593103605|FG002|Treatment II Period|Withdrawal by Subject|0|||
164200031|NCT00264147|593103606|FG003|Treatment II Period|Withdrawal by Subject|0|||
164200032|NCT00264147|593103607|FG004|Treatment II Period|Withdrawal by Subject|3|||
164200033|NCT00264147|593103608|FG005|Treatment II Period|Withdrawal by Subject|2|||
164200034|NCT00264147|593103603|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
164200035|NCT00264147|593103604|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
164200036|NCT00264147|593103605|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
164200037|NCT00264147|593103606|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
164200038|NCT00264147|593103607|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
164200039|NCT00264147|593103608|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
164200040|NCT03234465|593103609|FG000|Overall Study|Adverse Event|4|||
164200041|NCT03234465|593103610|FG001|Overall Study|Adverse Event|2|||
164200042|NCT03234465|593103609|FG000|Overall Study|Death|0|||
164308715|NCT02963506|593504561|FG006|Dose-Blind Period|Lost to Follow-up|0|||
164308716|NCT02963506|593504562|FG007|Dose-Blind Period|Lost to Follow-up|0|||
164308717|NCT02963506|593504563|FG008|Dose-Blind Period|Lost to Follow-up|1|||
164308718|NCT02963506|593504564|FG009|Dose-Blind Period|Lost to Follow-up|0|||
164308719|NCT02963506|593504565|FG010|Dose-Blind Period|Lost to Follow-up|0|||
164308720|NCT02963506|593504566|FG011|Dose-Blind Period|Lost to Follow-up|1|||
164308721|NCT02963506|593504567|FG012|Dose-Blind Period|Lost to Follow-up|0|||
164308722|NCT02963506|593504555|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
164308723|NCT02963506|593504556|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
164308724|NCT02963506|593504557|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
164308725|NCT02963506|593504558|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
164308726|NCT02963506|593504559|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
164308727|NCT02963506|593504560|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
164308728|NCT02963506|593504561|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
164308729|NCT02963506|593504562|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
164308730|NCT02963506|593504563|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
164308731|NCT02963506|593504564|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
164308732|NCT02963506|593504565|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
164308733|NCT02963506|593504566|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
164308734|NCT02963506|593504567|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
164308735|NCT02963506|593504555|FG000|Dose-Blind Period|Sponsor decision|0|||
164308736|NCT02963506|593504556|FG001|Dose-Blind Period|Sponsor decision|0|||
164308737|NCT02963506|593504557|FG002|Dose-Blind Period|Sponsor decision|0|||
164308738|NCT02963506|593504558|FG003|Dose-Blind Period|Sponsor decision|0|||
164308739|NCT02963506|593504559|FG004|Dose-Blind Period|Sponsor decision|0|||
164308740|NCT02963506|593504560|FG005|Dose-Blind Period|Sponsor decision|1|||
164308741|NCT02963506|593504561|FG006|Dose-Blind Period|Sponsor decision|0|||
164308742|NCT02963506|593504562|FG007|Dose-Blind Period|Sponsor decision|0|||
164308743|NCT02963506|593504563|FG008|Dose-Blind Period|Sponsor decision|0|||
164308744|NCT02963506|593504564|FG009|Dose-Blind Period|Sponsor decision|0|||
164308745|NCT02963506|593504565|FG010|Dose-Blind Period|Sponsor decision|0|||
164308746|NCT02963506|593504566|FG011|Dose-Blind Period|Sponsor decision|0|||
164308747|NCT02963506|593504567|FG012|Dose-Blind Period|Sponsor decision|0|||
164308748|NCT02963506|593504555|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
164308749|NCT02963506|593504556|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
164308750|NCT02963506|593504557|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
164308751|NCT02963506|593504558|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
164308752|NCT02963506|593504559|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
164308753|NCT02963506|593504560|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
164308754|NCT02963506|593504561|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
164308755|NCT02963506|593504562|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
164308756|NCT02963506|593504563|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
164308757|NCT02963506|593504564|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
164308758|NCT02963506|593504565|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
164308759|NCT02963506|593504566|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
164308760|NCT02963506|593504567|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
164308761|NCT02581410|593504568|FG000|Vaccination Phase|Adverse Event|2|||
164308762|NCT02581410|593504569|FG001|Vaccination Phase|Adverse Event|1|||
164308763|NCT02581410|593504568|FG000|Vaccination Phase|Withdrawal by Subject|0|||
164308764|NCT02581410|593504569|FG001|Vaccination Phase|Withdrawal by Subject|1|||
164308765|NCT02581410|593504568|FG000|Vaccination Phase|Migrated/moved from study area|0|||
164308766|NCT02581410|593504569|FG001|Vaccination Phase|Migrated/moved from study area|1|||
164308767|NCT02581410|593504568|FG000|End of Study Phase|Adverse Event|4|||
164308768|NCT02581410|593504569|FG001|End of Study Phase|Adverse Event|3|||
164308769|NCT02581410|593504568|FG000|End of Study Phase|Withdrawal by Subject|1|||
164308770|NCT02581410|593504569|FG001|End of Study Phase|Withdrawal by Subject|2|||
164308771|NCT02581410|593504568|FG000|End of Study Phase|Migrated/moved from study area|0|||
164308772|NCT02581410|593504569|FG001|End of Study Phase|Migrated/moved from study area|3|||
164308773|NCT02581410|593504568|FG000|End of Study Phase|Lost to Follow-up|0|||
164308774|NCT02581410|593504569|FG001|End of Study Phase|Lost to Follow-up|2|||
164308775|NCT02581410|593504568|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
164308776|NCT02581410|593504569|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
164308777|NCT02807402|593504571|FG000|Overall Study|Failure to Return|1|||
164308778|NCT02807402|593504571|FG000|Overall Study|Death|3|||
164308779|NCT02807402|593504571|FG000|Overall Study|Other|2|||
164308780|NCT01865552|593506489|FG000|Period 1|Adverse Event|1|||
164308781|NCT01865552|593506490|FG001|Period 1|Adverse Event|0|||
164308782|NCT01865552|593506491|FG002|Period 1|Adverse Event|0|||
164308783|NCT01865552|593506492|FG003|Period 1|Adverse Event|1|||
164550689|NCT00219284|594388758|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
164308784|NCT01865552|593506493|FG004|Period 1|Adverse Event|1|||
164308785|NCT01865552|593506494|FG005|Period 1|Adverse Event|1|||
164308786|NCT01865552|593506489|FG000|Period 1|Pathological lab|0|||
164308787|NCT01865552|593506490|FG001|Period 1|Pathological lab|0|||
164550690|NCT00219284|594388759|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
164308788|NCT01865552|593506491|FG002|Period 1|Pathological lab|0|||
164308789|NCT01865552|593506492|FG003|Period 1|Pathological lab|0|||
164308790|NCT01865552|593506493|FG004|Period 1|Pathological lab|1|||
164308791|NCT01865552|593506494|FG005|Period 1|Pathological lab|0|||
164308792|NCT01865552|593506489|FG000|Period 1|Other|0|||
164308793|NCT01865552|593506490|FG001|Period 1|Other|0|||
164308794|NCT01865552|593506491|FG002|Period 1|Other|0|||
164308795|NCT01865552|593506492|FG003|Period 1|Other|0|||
164308796|NCT01865552|593506493|FG004|Period 1|Other|1|||
164308797|NCT01865552|593506494|FG005|Period 1|Other|0|||
164308798|NCT03079102|593506497|FG000|Overall Study|Physician Decision|0|||
164308799|NCT03079102|593506498|FG001|Overall Study|Physician Decision|1|||
164308800|NCT02923921|593506499|FG000|Overall Study|Sponsor Decision|39|||
164308801|NCT02923921|593506500|FG001|Overall Study|Sponsor Decision|38|||
164308802|NCT02923921|593506499|FG000|Overall Study|Lost to Follow-up|1|||
164308803|NCT02923921|593506500|FG001|Overall Study|Lost to Follow-up|0|||
164308804|NCT02923921|593506499|FG000|Overall Study|Withdrawal by Subject|6|||
164308805|NCT02923921|593506500|FG001|Overall Study|Withdrawal by Subject|13|||
164308806|NCT02923921|593506499|FG000|Overall Study|Unknown, Not Collected|7|||
164308807|NCT02923921|593506500|FG001|Overall Study|Unknown, Not Collected|6|||
164308808|NCT03083873|593506501|FG000|Overall Study|Death|6|||
164308809|NCT03083873|593506502|FG001|Overall Study|Death|15|||
164308810|NCT03083873|593506503|FG002|Overall Study|Death|13|||
164308811|NCT03083873|593506504|FG003|Overall Study|Death|9|||
164308812|NCT03083873|593506505|FG004|Overall Study|Death|0|||
164308813|NCT03083873|593506501|FG000|Overall Study|Sponsor Terminated Study|0|||
164308814|NCT03083873|593506502|FG001|Overall Study|Sponsor Terminated Study|1|||
164308815|NCT03083873|593506503|FG002|Overall Study|Sponsor Terminated Study|2|||
164308816|NCT03083873|593506504|FG003|Overall Study|Sponsor Terminated Study|3|||
164308817|NCT03083873|593506505|FG004|Overall Study|Sponsor Terminated Study|0|||
164308818|NCT03083873|593506501|FG000|Overall Study|Lost to Follow-up|0|||
164308819|NCT03083873|593506502|FG001|Overall Study|Lost to Follow-up|1|||
164308820|NCT03083873|593506503|FG002|Overall Study|Lost to Follow-up|1|||
164308821|NCT03083873|593506504|FG003|Overall Study|Lost to Follow-up|0|||
164308822|NCT03083873|593506505|FG004|Overall Study|Lost to Follow-up|0|||
164308823|NCT03083873|593506501|FG000|Overall Study|Withdrawal by Subject|2|||
164308824|NCT03083873|593506502|FG001|Overall Study|Withdrawal by Subject|0|||
164308825|NCT03083873|593506503|FG002|Overall Study|Withdrawal by Subject|0|||
164308826|NCT03083873|593506504|FG003|Overall Study|Withdrawal by Subject|0|||
164308827|NCT03083873|593506505|FG004|Overall Study|Withdrawal by Subject|0|||
164308828|NCT03083873|593506501|FG000|Overall Study|Did Not Receive TIL|2|||
164308829|NCT03083873|593506502|FG001|Overall Study|Did Not Receive TIL|5|||
164308830|NCT03083873|593506503|FG002|Overall Study|Did Not Receive TIL|3|||
164308831|NCT03083873|593506504|FG003|Overall Study|Did Not Receive TIL|1|||
164308832|NCT03083873|593506505|FG004|Overall Study|Did Not Receive TIL|0|||
164308833|NCT00479687|593506506|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
164308834|NCT00479687|593506507|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
164308835|NCT00479687|593506508|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
164308836|NCT00479687|593506506|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
164308837|NCT00479687|593506507|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
164308838|NCT00479687|593506508|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
164308839|NCT00479687|593506506|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
164308840|NCT00479687|593506507|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
164308841|NCT00479687|593506508|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
164308842|NCT00479687|593506506|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
164308843|NCT00479687|593506507|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
164308844|NCT00479687|593506508|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
164308845|NCT00479687|593506506|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
164308846|NCT00479687|593506507|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
164308847|NCT00479687|593506508|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
164308848|NCT00479687|593506506|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
164308849|NCT00479687|593506507|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
164308850|NCT00479687|593506508|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
164308851|NCT00479687|593506506|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
164308852|NCT00479687|593506507|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
164308853|NCT00479687|593506508|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
164308854|NCT00479687|593506506|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
164308855|NCT00479687|593506507|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
164308856|NCT00479687|593506508|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
164308857|NCT00479687|593506506|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
164308858|NCT00479687|593506507|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
164308859|NCT00479687|593506508|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
164308860|NCT00854113|593506512|FG000|Overall Study|Adverse Event|0|||
164308861|NCT00854113|593506513|FG001|Overall Study|Adverse Event|0|||
164308862|NCT00854113|593506514|FG002|Overall Study|Adverse Event|0|||
164200043|NCT03234465|593103610|FG001|Overall Study|Death|1|||
164200044|NCT03234465|593103609|FG000|Overall Study|Lost to Follow-up|1|||
164200045|NCT03234465|593103610|FG001|Overall Study|Lost to Follow-up|1|||
164200046|NCT03234465|593103609|FG000|Overall Study|Withdrawal by Subject|12|||
164200047|NCT03234465|593103610|FG001|Overall Study|Withdrawal by Subject|27|||
164200048|NCT03234465|593103609|FG000|Overall Study|Symptomatic deterioration|0|||
164200049|NCT03234465|593103610|FG001|Overall Study|Symptomatic deterioration|1|||
164200050|NCT03234465|593103609|FG000|Overall Study|Non-compliance|2|||
164200051|NCT03234465|593103610|FG001|Overall Study|Non-compliance|0|||
164200052|NCT03234465|593103609|FG000|Overall Study|Other|14|||
164200053|NCT03234465|593103610|FG001|Overall Study|Other|8|||
164200054|NCT01274533|593103615|FG000|Overall Study|Withdrawal by Subject|1|||
164200055|NCT01274533|593103615|FG000|Overall Study|Non-compliance|1|||
164200056|NCT01274533|593103615|FG000|Overall Study|Disease progression|2|||
164200057|NCT02563899|593103616|FG000|Overall Study|Protocol Violation|1|||
164200058|NCT02563899|593103617|FG001|Overall Study|Protocol Violation|0|||
164200059|NCT02563899|593103618|FG002|Overall Study|Protocol Violation|0|||
164200060|NCT02563899|593103619|FG003|Overall Study|Protocol Violation|0|||
164200061|NCT02563899|593103616|FG000|Overall Study|Withdrawal by Subject|0|||
164200062|NCT02563899|593103617|FG001|Overall Study|Withdrawal by Subject|0|||
164200063|NCT02563899|593103618|FG002|Overall Study|Withdrawal by Subject|1|||
164200064|NCT02563899|593103619|FG003|Overall Study|Withdrawal by Subject|0|||
164200065|NCT02008526|593103620|FG000|Overall Study|Death|0|||
164200066|NCT02008526|593103621|FG001|Overall Study|Death|2|||
164200067|NCT02008526|593103622|FG002|Overall Study|Death|1|||
164200068|NCT02008526|593103620|FG000|Overall Study|Withdrawal by Subject|3|||
164200069|NCT02008526|593103621|FG001|Overall Study|Withdrawal by Subject|3|||
164200070|NCT02008526|593103622|FG002|Overall Study|Withdrawal by Subject|2|||
164200071|NCT02008526|593103620|FG000|Overall Study|Lost to Follow-up|5|||
164200072|NCT02008526|593103621|FG001|Overall Study|Lost to Follow-up|9|||
164200073|NCT02008526|593103622|FG002|Overall Study|Lost to Follow-up|6|||
164200074|NCT01305564|593103625|FG000|Overall Study|Death|21|||
164200075|NCT01305564|593103625|FG000|Overall Study|Lost to Follow-up|12|||
164200076|NCT01305564|593103625|FG000|Overall Study|Withdrawal by Subject|1|||
164200077|NCT01305564|593103625|FG000|Overall Study|Physician Decision|3|||
164200078|NCT01190813|593103626|FG000|Overall Study|Lost to Follow-up|1|||
164200079|NCT01190813|593103627|FG001|Overall Study|Lost to Follow-up|2|||
164200080|NCT01190813|593103626|FG000|Overall Study|Withdrawal by Subject|2|||
164200081|NCT01190813|593103627|FG001|Overall Study|Withdrawal by Subject|1|||
164200082|NCT01190813|593103626|FG000|Overall Study|Refused study treatment after randomized|1|||
164200083|NCT01190813|593103627|FG001|Overall Study|Refused study treatment after randomized|0|||
164200084|NCT01190813|593103626|FG000|Overall Study|Adverse Event|0|||
164200085|NCT01190813|593103627|FG001|Overall Study|Adverse Event|1|||
164200086|NCT03810456|593103630|FG000|Treatment|Urgent Family Matters|3|||
164200087|NCT03810456|593103631|FG001|Treatment|Urgent Family Matters|0|||
164200088|NCT03810456|593103632|FG002|Treatment|Urgent Family Matters|0|||
164200089|NCT03810456|593103630|FG000|Treatment|Scheduling Conflicts|0|||
164200090|NCT03810456|593103631|FG001|Treatment|Scheduling Conflicts|11|||
164200091|NCT03810456|593103632|FG002|Treatment|Scheduling Conflicts|0|||
164200092|NCT03810456|593103630|FG000|Treatment|No Longer Interested|0|||
164200093|NCT03810456|593103631|FG001|Treatment|No Longer Interested|12|||
164200094|NCT03810456|593103632|FG002|Treatment|No Longer Interested|0|||
164200095|NCT03810456|593103630|FG000|Treatment|Transportation Issues|0|||
164200096|NCT03810456|593103631|FG001|Treatment|Transportation Issues|1|||
164200097|NCT03810456|593103632|FG002|Treatment|Transportation Issues|0|||
164200098|NCT03810456|593103630|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
164200099|NCT03810456|593103631|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
164200100|NCT03810456|593103632|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
164200101|NCT03810456|593103630|FG000|1 Month Follow-Up|Relocated to Different State|1|||
164200102|NCT03810456|593103631|FG001|1 Month Follow-Up|Relocated to Different State|0|||
164200103|NCT03810456|593103632|FG002|1 Month Follow-Up|Relocated to Different State|1|||
164200104|NCT03810456|593103630|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
164200105|NCT03810456|593103631|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
164200106|NCT03810456|593103632|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
164200107|NCT03810456|593103630|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
164200108|NCT03810456|593103631|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
164200109|NCT03810456|593103632|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
164200110|NCT03810456|593103630|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
164200111|NCT03810456|593103631|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
164200112|NCT03810456|593103632|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
164200113|NCT03810456|593103630|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
164200114|NCT03810456|593103631|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
164200115|NCT03810456|593103632|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
164200116|NCT03810456|593103630|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
164200117|NCT03810456|593103631|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
164200118|NCT03810456|593103632|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
164200119|NCT03499795|593105030|FG000|Overall Study|Adverse Event|1|||
164200120|NCT03499795|593105030|FG000|Overall Study|Lost to Follow-up|1|||
164308863|NCT00854113|593506515|FG003|Overall Study|Adverse Event|0|||
164308864|NCT00854113|593506516|FG004|Overall Study|Adverse Event|0|||
164308865|NCT00854113|593506517|FG005|Overall Study|Adverse Event|0|||
164308866|NCT00854113|593506518|FG006|Overall Study|Adverse Event|0|||
164308867|NCT00854113|593506519|FG007|Overall Study|Adverse Event|2|||
164308868|NCT00854113|593506520|FG008|Overall Study|Adverse Event|0|||
164308869|NCT00854113|593506521|FG009|Overall Study|Adverse Event|0|||
164308870|NCT00854113|593506522|FG010|Overall Study|Adverse Event|0|||
164308871|NCT00854113|593506512|FG000|Overall Study|Withdrawal by Subject|0|||
164308872|NCT00854113|593506513|FG001|Overall Study|Withdrawal by Subject|0|||
164308873|NCT00854113|593506514|FG002|Overall Study|Withdrawal by Subject|0|||
164308874|NCT00854113|593506515|FG003|Overall Study|Withdrawal by Subject|0|||
164308875|NCT00854113|593506516|FG004|Overall Study|Withdrawal by Subject|0|||
164308876|NCT00854113|593506517|FG005|Overall Study|Withdrawal by Subject|0|||
164308877|NCT00854113|593506518|FG006|Overall Study|Withdrawal by Subject|0|||
164308878|NCT00854113|593506519|FG007|Overall Study|Withdrawal by Subject|1|||
164308879|NCT00854113|593506520|FG008|Overall Study|Withdrawal by Subject|1|||
164308880|NCT00854113|593506521|FG009|Overall Study|Withdrawal by Subject|0|||
164308881|NCT00854113|593506522|FG010|Overall Study|Withdrawal by Subject|0|||
164308882|NCT00796419|593506523|FG000|Overall Study|Death|0|||
164308883|NCT00796419|593506524|FG001|Overall Study|Death|1|||
164308884|NCT00539864|593506527|FG000|Overall Study|Lost to Follow-up|0|||
164308885|NCT00539864|593506528|FG001|Overall Study|Lost to Follow-up|1|||
164308886|NCT00539864|593506527|FG000|Overall Study|Withdrawal by Subject|1|||
164308887|NCT00539864|593506528|FG001|Overall Study|Withdrawal by Subject|1|||
164308888|NCT01250145|593506529|FG000|Overall Study|Adverse Event|2|||
164308889|NCT01250145|593506530|FG001|Overall Study|Adverse Event|1|||
164308890|NCT01250145|593506529|FG000|Overall Study|Withdrawal by Subject|0|||
164308891|NCT01250145|593506530|FG001|Overall Study|Withdrawal by Subject|4|||
164308892|NCT02840799|593506533|FG000|Phase 1|Physician Decision|1|||
164308893|NCT02840799|593506534|FG001|Phase 1|Physician Decision|3|||
164308894|NCT02840799|593506533|FG000|Phase 1|Withdrawal by Subject|4|||
164308895|NCT02840799|593506534|FG001|Phase 1|Withdrawal by Subject|0|||
164308896|NCT02840799|593506533|FG000|Phase 2 (Crossover)|Adverse Event|0|||
164308897|NCT02840799|593506534|FG001|Phase 2 (Crossover)|Adverse Event|1|||
164308898|NCT02840799|593506533|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
164308899|NCT02840799|593506534|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
164308900|NCT02687191|593506541|FG000|Overall Study|Death|0|||
164308901|NCT02687191|593506542|FG001|Overall Study|Death|1|||
164308902|NCT02687191|593506543|FG002|Overall Study|Death|1|||
164308903|NCT02687191|593506544|FG003|Overall Study|Death|0|||
164308904|NCT02687191|593506545|FG004|Overall Study|Death|1|||
164308905|NCT02687191|593506546|FG005|Overall Study|Death|1|||
164308906|NCT02687191|593506541|FG000|Overall Study|Withdrawal by Subject|0|||
164308907|NCT02687191|593506542|FG001|Overall Study|Withdrawal by Subject|0|||
164308908|NCT02687191|593506543|FG002|Overall Study|Withdrawal by Subject|0|||
164308909|NCT02687191|593506544|FG003|Overall Study|Withdrawal by Subject|1|||
164308910|NCT02687191|593506545|FG004|Overall Study|Withdrawal by Subject|0|||
164308911|NCT02687191|593506546|FG005|Overall Study|Withdrawal by Subject|0|||
164308912|NCT01349049|593506547|FG000|Overall Study|Disease progression|3|||
164308913|NCT01349049|593506548|FG001|Overall Study|Disease progression|5|||
164308914|NCT01349049|593506549|FG002|Overall Study|Disease progression|3|||
164308915|NCT01349049|593506550|FG003|Overall Study|Disease progression|2|||
164308916|NCT01349049|593506551|FG004|Overall Study|Disease progression|2|||
164308917|NCT01349049|593506552|FG005|Overall Study|Disease progression|2|||
164308918|NCT01349049|593506553|FG006|Overall Study|Disease progression|3|||
164308919|NCT01349049|593506554|FG007|Overall Study|Disease progression|2|||
164656119|NCT01090765|594766432|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
164308920|NCT01349049|593506555|FG008|Overall Study|Disease progression|33|||
164308921|NCT01349049|593506547|FG000|Overall Study|Adverse Event|0|||
164308922|NCT01349049|593506548|FG001|Overall Study|Adverse Event|1|||
164308923|NCT01349049|593506549|FG002|Overall Study|Adverse Event|0|||
164308924|NCT01349049|593506550|FG003|Overall Study|Adverse Event|0|||
164308925|NCT01349049|593506551|FG004|Overall Study|Adverse Event|0|||
164308926|NCT01349049|593506552|FG005|Overall Study|Adverse Event|3|||
164308927|NCT01349049|593506553|FG006|Overall Study|Adverse Event|1|||
164308928|NCT01349049|593506554|FG007|Overall Study|Adverse Event|0|||
164308929|NCT01349049|593506555|FG008|Overall Study|Adverse Event|4|||
164308930|NCT01349049|593506547|FG000|Overall Study|Physician Decision|0|||
164308931|NCT01349049|593506548|FG001|Overall Study|Physician Decision|1|||
164308932|NCT01349049|593506549|FG002|Overall Study|Physician Decision|0|||
164308933|NCT01349049|593506550|FG003|Overall Study|Physician Decision|0|||
164308934|NCT01349049|593506551|FG004|Overall Study|Physician Decision|0|||
164308935|NCT01349049|593506552|FG005|Overall Study|Physician Decision|0|||
164308936|NCT01349049|593506553|FG006|Overall Study|Physician Decision|0|||
164308937|NCT01349049|593506554|FG007|Overall Study|Physician Decision|0|||
164308938|NCT01349049|593506555|FG008|Overall Study|Physician Decision|2|||
164308939|NCT01349049|593506547|FG000|Overall Study|Protocol Violation|0|||
164308940|NCT01349049|593506548|FG001|Overall Study|Protocol Violation|0|||
164200121|NCT02265510|593105031|FG000|Overall Study|Withdrawal by Subject|1|||
164200122|NCT02265510|593105032|FG001|Overall Study|Withdrawal by Subject|1|||
164200123|NCT02265510|593105033|FG002|Overall Study|Withdrawal by Subject|2|||
164200124|NCT02265510|593105034|FG003|Overall Study|Withdrawal by Subject|1|||
164200125|NCT02265510|593105035|FG004|Overall Study|Withdrawal by Subject|0|||
164200126|NCT02265510|593105036|FG005|Overall Study|Withdrawal by Subject|2|||
164200127|NCT02265510|593105037|FG006|Overall Study|Withdrawal by Subject|0|||
164200128|NCT02265510|593105038|FG007|Overall Study|Withdrawal by Subject|2|||
164200129|NCT02265510|593105039|FG008|Overall Study|Withdrawal by Subject|0|||
164200130|NCT02265510|593105040|FG009|Overall Study|Withdrawal by Subject|0|||
164200131|NCT02265510|593105041|FG010|Overall Study|Withdrawal by Subject|0|||
164200132|NCT02265510|593105042|FG011|Overall Study|Withdrawal by Subject|0|||
164200133|NCT02265510|593105043|FG012|Overall Study|Withdrawal by Subject|1|||
164200134|NCT02265510|593105044|FG013|Overall Study|Withdrawal by Subject|0|||
164200135|NCT02265510|593105031|FG000|Overall Study|Disease Progression|0|||
164200136|NCT02265510|593105032|FG001|Overall Study|Disease Progression|1|||
164200137|NCT02265510|593105033|FG002|Overall Study|Disease Progression|2|||
164200138|NCT02265510|593105034|FG003|Overall Study|Disease Progression|1|||
164200139|NCT02265510|593105035|FG004|Overall Study|Disease Progression|1|||
164200140|NCT02265510|593105036|FG005|Overall Study|Disease Progression|0|||
164200141|NCT02265510|593105037|FG006|Overall Study|Disease Progression|0|||
164200142|NCT02265510|593105038|FG007|Overall Study|Disease Progression|0|||
164200143|NCT02265510|593105039|FG008|Overall Study|Disease Progression|0|||
164200144|NCT02265510|593105040|FG009|Overall Study|Disease Progression|0|||
164200145|NCT02265510|593105041|FG010|Overall Study|Disease Progression|0|||
164200146|NCT02265510|593105042|FG011|Overall Study|Disease Progression|0|||
164200147|NCT02265510|593105043|FG012|Overall Study|Disease Progression|0|||
164200148|NCT02265510|593105044|FG013|Overall Study|Disease Progression|0|||
164200149|NCT02265510|593105031|FG000|Overall Study|Death|2|||
164200150|NCT02265510|593105032|FG001|Overall Study|Death|0|||
164200151|NCT02265510|593105033|FG002|Overall Study|Death|2|||
164200152|NCT02265510|593105034|FG003|Overall Study|Death|2|||
164200153|NCT02265510|593105035|FG004|Overall Study|Death|1|||
164200154|NCT02265510|593105036|FG005|Overall Study|Death|3|||
164200155|NCT02265510|593105037|FG006|Overall Study|Death|2|||
164200156|NCT02265510|593105038|FG007|Overall Study|Death|1|||
164200157|NCT02265510|593105039|FG008|Overall Study|Death|3|||
164200158|NCT02265510|593105040|FG009|Overall Study|Death|3|||
164200159|NCT02265510|593105041|FG010|Overall Study|Death|4|||
164200160|NCT02265510|593105042|FG011|Overall Study|Death|12|||
164200161|NCT02265510|593105043|FG012|Overall Study|Death|7|||
164200162|NCT02265510|593105044|FG013|Overall Study|Death|6|||
164200163|NCT02265510|593105031|FG000|Overall Study|Lost to Follow-up|0|||
164200164|NCT02265510|593105032|FG001|Overall Study|Lost to Follow-up|0|||
164200165|NCT02265510|593105033|FG002|Overall Study|Lost to Follow-up|0|||
164200166|NCT02265510|593105034|FG003|Overall Study|Lost to Follow-up|0|||
164200167|NCT02265510|593105035|FG004|Overall Study|Lost to Follow-up|1|||
164200168|NCT02265510|593105036|FG005|Overall Study|Lost to Follow-up|0|||
164200169|NCT02265510|593105037|FG006|Overall Study|Lost to Follow-up|0|||
164200170|NCT02265510|593105038|FG007|Overall Study|Lost to Follow-up|0|||
164200171|NCT02265510|593105039|FG008|Overall Study|Lost to Follow-up|0|||
164200172|NCT02265510|593105040|FG009|Overall Study|Lost to Follow-up|2|||
164200173|NCT02265510|593105041|FG010|Overall Study|Lost to Follow-up|0|||
164200174|NCT02265510|593105042|FG011|Overall Study|Lost to Follow-up|0|||
164200175|NCT02265510|593105043|FG012|Overall Study|Lost to Follow-up|0|||
164200176|NCT02265510|593105044|FG013|Overall Study|Lost to Follow-up|2|||
164200177|NCT02265510|593105031|FG000|Overall Study|Other|0|||
164200178|NCT02265510|593105032|FG001|Overall Study|Other|1|||
164200179|NCT02265510|593105033|FG002|Overall Study|Other|0|||
164200180|NCT02265510|593105034|FG003|Overall Study|Other|0|||
164200181|NCT02265510|593105035|FG004|Overall Study|Other|0|||
164200182|NCT02265510|593105036|FG005|Overall Study|Other|0|||
164200183|NCT02265510|593105037|FG006|Overall Study|Other|0|||
164200184|NCT02265510|593105038|FG007|Overall Study|Other|0|||
164550691|NCT00219284|594388758|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
164200185|NCT02265510|593105039|FG008|Overall Study|Other|0|||
164200186|NCT02265510|593105040|FG009|Overall Study|Other|0|||
164200187|NCT02265510|593105041|FG010|Overall Study|Other|0|||
164200188|NCT02265510|593105042|FG011|Overall Study|Other|0|||
164550692|NCT00219284|594388759|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
164200189|NCT02265510|593105043|FG012|Overall Study|Other|0|||
164200190|NCT02265510|593105044|FG013|Overall Study|Other|0|||
164200191|NCT02265510|593105031|FG000|Overall Study|Study Terminated by Sponsor|0|||
164200192|NCT02265510|593105032|FG001|Overall Study|Study Terminated by Sponsor|0|||
164200193|NCT02265510|593105033|FG002|Overall Study|Study Terminated by Sponsor|0|||
164200194|NCT02265510|593105034|FG003|Overall Study|Study Terminated by Sponsor|0|||
164200195|NCT02265510|593105035|FG004|Overall Study|Study Terminated by Sponsor|0|||
164200196|NCT02265510|593105036|FG005|Overall Study|Study Terminated by Sponsor|1|||
164200197|NCT02265510|593105037|FG006|Overall Study|Study Terminated by Sponsor|1|||
164200198|NCT02265510|593105038|FG007|Overall Study|Study Terminated by Sponsor|1|||
164200199|NCT02265510|593105039|FG008|Overall Study|Study Terminated by Sponsor|1|||
164200200|NCT02265510|593105040|FG009|Overall Study|Study Terminated by Sponsor|2|||
164200201|NCT02265510|593105041|FG010|Overall Study|Study Terminated by Sponsor|1|||
164200202|NCT02265510|593105042|FG011|Overall Study|Study Terminated by Sponsor|4|||
164200203|NCT02265510|593105043|FG012|Overall Study|Study Terminated by Sponsor|1|||
164200204|NCT02265510|593105044|FG013|Overall Study|Study Terminated by Sponsor|2|||
164200205|NCT00630916|593105045|FG000|Overall Study|Death|110|||
164200206|NCT00630916|593105045|FG000|Overall Study|Explant|8|||
164200207|NCT00630916|593105045|FG000|Overall Study|Lost to Follow-up|5|||
164200208|NCT00630916|593105045|FG000|Overall Study|Withdrawal by Subject|30|||
164200209|NCT00630916|593105045|FG000|Overall Study|Protocol Violation|7|||
164200210|NCT00630916|593105045|FG000|Overall Study|Physician Decision|47|||
164200211|NCT00630916|593105045|FG000|Overall Study|Lack of Efficacy|3|||
164200212|NCT00324155|593105046|FG000|Enrolled and Randomized|No longer met study criteria|3|||
164200213|NCT00324155|593105047|FG001|Enrolled and Randomized|No longer met study criteria|0|||
164200214|NCT00324155|593105046|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
164200215|NCT00324155|593105047|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
164200216|NCT00324155|593105046|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
164200217|NCT00324155|593105047|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
164200218|NCT00324155|593105046|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
164200219|NCT00324155|593105047|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
164200220|NCT00324155|593105046|FG000|Received Treatment in Induction Phase|Death|8|||
164200221|NCT00324155|593105047|FG001|Received Treatment in Induction Phase|Death|15|||
164200222|NCT00324155|593105046|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
164200223|NCT00324155|593105047|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
164200224|NCT00324155|593105046|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
164200225|NCT00324155|593105047|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
164200226|NCT00324155|593105046|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
164200227|NCT00324155|593105047|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
164200228|NCT00324155|593105046|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
164200229|NCT00324155|593105047|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
164200230|NCT00324155|593105046|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
164200231|NCT00324155|593105047|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
164200232|NCT00324155|593105046|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
164200233|NCT00324155|593105047|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
164200234|NCT00324155|593105046|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
164200235|NCT00324155|593105047|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
164200236|NCT00324155|593105046|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
164200237|NCT00324155|593105047|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
164200238|NCT00324155|593105046|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
164200239|NCT00324155|593105047|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
164200240|NCT00324155|593105046|FG000|Follow-up Phase|On-going participants still on drug|11|||
164200241|NCT00324155|593105047|FG001|Follow-up Phase|On-going participants still on drug|6|||
164200242|NCT00390689|593105048|FG000|Overall Study|Adverse Event|2|||
164200243|NCT00390689|593105049|FG001|Overall Study|Adverse Event|5|||
164200244|NCT00390689|593105050|FG002|Overall Study|Adverse Event|2|||
164200245|NCT00390689|593105048|FG000|Overall Study|Lack of Efficacy|0|||
164200246|NCT00390689|593105049|FG001|Overall Study|Lack of Efficacy|0|||
164200247|NCT00390689|593105050|FG002|Overall Study|Lack of Efficacy|1|||
164200248|NCT00390689|593105048|FG000|Overall Study|Protocol Violation|1|||
164200249|NCT00390689|593105049|FG001|Overall Study|Protocol Violation|0|||
164200250|NCT00390689|593105050|FG002|Overall Study|Protocol Violation|0|||
164200251|NCT00390689|593105048|FG000|Overall Study|Investigator's judgement|2|||
164200252|NCT00390689|593105049|FG001|Overall Study|Investigator's judgement|0|||
164200253|NCT00390689|593105050|FG002|Overall Study|Investigator's judgement|0|||
164200254|NCT01253161|593105051|FG000|Overall Study|Adverse Event|1|||
164200255|NCT03786380|593105053|FG000|Overall Study|Adverse Event|1|||
164200256|NCT03786380|593105054|FG001|Overall Study|Adverse Event|0|||
164200257|NCT03786380|593105055|FG002|Overall Study|Adverse Event|0|||
164200258|NCT03786380|593105056|FG003|Overall Study|Adverse Event|3|||
164200259|NCT03786380|593105057|FG004|Overall Study|Adverse Event|1|||
164200260|NCT03786380|593105053|FG000|Overall Study|Lack of Efficacy|0|||
164200261|NCT03786380|593105054|FG001|Overall Study|Lack of Efficacy|0|||
164200262|NCT03786380|593105055|FG002|Overall Study|Lack of Efficacy|0|||
164200263|NCT03786380|593105056|FG003|Overall Study|Lack of Efficacy|0|||
164200264|NCT03786380|593105057|FG004|Overall Study|Lack of Efficacy|1|||
164200265|NCT03786380|593105053|FG000|Overall Study|Withdrawal by Subject|1|||
164200266|NCT03786380|593105054|FG001|Overall Study|Withdrawal by Subject|2|||
164200267|NCT03786380|593105055|FG002|Overall Study|Withdrawal by Subject|2|||
164200268|NCT03786380|593105056|FG003|Overall Study|Withdrawal by Subject|1|||
164200269|NCT03786380|593105057|FG004|Overall Study|Withdrawal by Subject|2|||
164200270|NCT03786380|593105053|FG000|Overall Study|Lost to Follow-up|3|||
164200271|NCT03786380|593105054|FG001|Overall Study|Lost to Follow-up|0|||
164200272|NCT03786380|593105055|FG002|Overall Study|Lost to Follow-up|1|||
164200273|NCT03786380|593105056|FG003|Overall Study|Lost to Follow-up|2|||
164200274|NCT03786380|593105057|FG004|Overall Study|Lost to Follow-up|0|||
164200275|NCT03786380|593105053|FG000|Overall Study|Physician Decision|0|||
164200276|NCT03786380|593105054|FG001|Overall Study|Physician Decision|0|||
164200277|NCT03786380|593105055|FG002|Overall Study|Physician Decision|1|||
164200278|NCT03786380|593105056|FG003|Overall Study|Physician Decision|0|||
164200279|NCT03786380|593105057|FG004|Overall Study|Physician Decision|0|||
164200280|NCT03786380|593105053|FG000|Overall Study|Study Terminated by the Sponsor|30|||
164200281|NCT03786380|593105054|FG001|Overall Study|Study Terminated by the Sponsor|20|||
164200282|NCT03786380|593105055|FG002|Overall Study|Study Terminated by the Sponsor|50|||
164200283|NCT03786380|593105056|FG003|Overall Study|Study Terminated by the Sponsor|57|||
164200284|NCT03786380|593105057|FG004|Overall Study|Study Terminated by the Sponsor|23|||
164200285|NCT03786380|593105053|FG000|Overall Study|Reason Not Specified|0|||
164200286|NCT03786380|593105054|FG001|Overall Study|Reason Not Specified|0|||
164200287|NCT03786380|593105055|FG002|Overall Study|Reason Not Specified|0|||
164200288|NCT03786380|593105056|FG003|Overall Study|Reason Not Specified|0|||
164200289|NCT03786380|593105057|FG004|Overall Study|Reason Not Specified|1|||
164200290|NCT02984982|593105058|FG000|Overall Study|Adverse Event|2|||
164200291|NCT02984982|593105059|FG001|Overall Study|Adverse Event|5|||
164200292|NCT02984982|593105058|FG000|Overall Study|Poor Compliance to Protocol|4|||
164200293|NCT02984982|593105059|FG001|Overall Study|Poor Compliance to Protocol|4|||
164200294|NCT02984982|593105058|FG000|Overall Study|Withdrawal by Subject|2|||
164200295|NCT02984982|593105059|FG001|Overall Study|Withdrawal by Subject|0|||
164200296|NCT02984982|593105058|FG000|Overall Study|Randomized but not treated|0|||
164200297|NCT02984982|593105059|FG001|Overall Study|Randomized but not treated|1|||
164200298|NCT02144701|593105060|FG000|Overall Study|development of relapse, GVHD or death|9|||
164200299|NCT02144701|593105061|FG001|Overall Study|development of relapse, GVHD or death|3|||
164200300|NCT00467519|593105062|FG000|Overall Study|Protocol Violation|8|||
164200301|NCT00467519|593105063|FG001|Overall Study|Protocol Violation|4|||
164200302|NCT00467519|593105062|FG000|Overall Study|Lost to Follow-up|2|||
164200303|NCT00467519|593105063|FG001|Overall Study|Lost to Follow-up|9|||
164200304|NCT00467519|593105062|FG000|Overall Study|Withdrawal by Subject|4|||
164200305|NCT00467519|593105063|FG001|Overall Study|Withdrawal by Subject|10|||
164200306|NCT02314728|593105064|FG000|Overall Study|Protocol Violation|1|||
164200307|NCT02314728|593105065|FG001|Overall Study|Protocol Violation|0|||
164200308|NCT02314728|593105064|FG000|Overall Study|Lost to Follow-up|0|||
164200309|NCT02314728|593105065|FG001|Overall Study|Lost to Follow-up|1|||
164656120|NCT01090765|594766433|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
164656121|NCT01090765|594766434|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
164656122|NCT01090765|594766429|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
164656123|NCT01090765|594766430|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
164656124|NCT01090765|594766431|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
164656125|NCT01090765|594766432|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
164656126|NCT01090765|594766433|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
164656127|NCT01090765|594766434|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
164656128|NCT01787825|594766435|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
164656129|NCT01787825|594766436|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
164656130|NCT01787825|594766435|FG000|Overall Study|Data Not Analyzable|5|||
164656131|NCT01787825|594766436|FG001|Overall Study|Data Not Analyzable|1|||
164656132|NCT00718159|594766441|FG000|Overall Study|Progressive Disease|3|||
164656133|NCT00718159|594766442|FG001|Overall Study|Progressive Disease|3|||
164656134|NCT00718159|594766443|FG002|Overall Study|Progressive Disease|2|||
164656135|NCT00718159|594766444|FG003|Overall Study|Progressive Disease|0|||
164656136|NCT00718159|594766445|FG004|Overall Study|Progressive Disease|6|||
164656137|NCT00718159|594766446|FG005|Overall Study|Progressive Disease|0|||
164656138|NCT00718159|594766447|FG006|Overall Study|Progressive Disease|0|||
164656139|NCT00718159|594766441|FG000|Overall Study|Death due to Adverse Event|0|||
164656140|NCT00718159|594766442|FG001|Overall Study|Death due to Adverse Event|0|||
164656141|NCT00718159|594766443|FG002|Overall Study|Death due to Adverse Event|0|||
164656142|NCT00718159|594766444|FG003|Overall Study|Death due to Adverse Event|2|||
164656143|NCT00718159|594766445|FG004|Overall Study|Death due to Adverse Event|2|||
164656144|NCT00718159|594766446|FG005|Overall Study|Death due to Adverse Event|0|||
164656145|NCT00718159|594766447|FG006|Overall Study|Death due to Adverse Event|0|||
164656146|NCT00718159|594766441|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
164656147|NCT00718159|594766442|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
164656148|NCT00718159|594766443|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
164656149|NCT00718159|594766444|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
164656150|NCT00718159|594766445|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
164656151|NCT00718159|594766446|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
164656152|NCT00718159|594766447|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
164656153|NCT00718159|594766441|FG000|Overall Study|Investigator Decision|0|||
164656154|NCT00718159|594766442|FG001|Overall Study|Investigator Decision|0|||
164656155|NCT00718159|594766443|FG002|Overall Study|Investigator Decision|0|||
164656156|NCT00718159|594766444|FG003|Overall Study|Investigator Decision|0|||
164656157|NCT00718159|594766445|FG004|Overall Study|Investigator Decision|0|||
164656158|NCT00718159|594766446|FG005|Overall Study|Investigator Decision|1|||
164656159|NCT00718159|594766447|FG006|Overall Study|Investigator Decision|1|||
164656160|NCT01238848|594766448|FG000|Overall Study|Physician Decision|13|||
164656161|NCT01238848|594766449|FG001|Overall Study|Physician Decision|5|||
164656162|NCT01894984|594766452|FG000|Overall Study|Other|314|||
164656163|NCT01894984|594766453|FG001|Overall Study|Other|175|||
164656164|NCT01427803|594766454|FG000|Overall Study|Lost to Follow-up|32|||
164656165|NCT01427803|594766455|FG001|Overall Study|Lost to Follow-up|26|||
164656166|NCT01427803|594766454|FG000|Overall Study|Withdrawal by Subject|20|||
164656167|NCT01427803|594766455|FG001|Overall Study|Withdrawal by Subject|0|||
164656168|NCT01427803|594766454|FG000|Overall Study|Unable to complete full treatment period|6|||
164656169|NCT01427803|594766455|FG001|Overall Study|Unable to complete full treatment period|0|||
164656170|NCT01427803|594766454|FG000|Overall Study|Protocol Violation|1|||
164656171|NCT01427803|594766455|FG001|Overall Study|Protocol Violation|0|||
164656172|NCT01427803|594766454|FG000|Overall Study|Physician Decision|3|||
164656173|NCT01427803|594766455|FG001|Overall Study|Physician Decision|0|||
164656174|NCT01427803|594766454|FG000|Overall Study|did not take product|1|||
164656175|NCT01427803|594766455|FG001|Overall Study|did not take product|0|||
164656176|NCT03412019|594766456|FG000|Overall Study|Withdrawal by Subject|1|||
164656177|NCT03412019|594766457|FG001|Overall Study|Withdrawal by Subject|1|||
164656178|NCT01952574|594766458|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
164656179|NCT01952574|594766459|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
164656180|NCT01952574|594766460|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
164656181|NCT01952574|594766461|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
164656182|NCT01952574|594766462|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
164656183|NCT01952574|594766463|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
164656184|NCT01952574|594766464|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
164656185|NCT01952574|594766458|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
164656186|NCT01952574|594766459|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
164656187|NCT01952574|594766460|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
164656188|NCT01952574|594766461|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
164656189|NCT01952574|594766462|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
164656190|NCT01952574|594766463|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
164656191|NCT01952574|594766464|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
164656192|NCT01952574|594766458|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
164200310|NCT03902613|593105069|FG000|Overall Study|Physician Decision|1|||
164200311|NCT04622969|593105070|FG000|Overall Study|Withdrawal by Subject|2|||
164200312|NCT04622969|593105071|FG001|Overall Study|Withdrawal by Subject|3|||
164200313|NCT04467515|593105072|FG000|Overall Study|Lost to Follow-up|1|||
164200314|NCT04467515|593105073|FG001|Overall Study|Lost to Follow-up|0|||
164200315|NCT04467515|593105074|FG002|Overall Study|Lost to Follow-up|0|||
164200316|NCT04467515|593105072|FG000|Overall Study|Withdrawal by Subject|1|||
164200317|NCT04467515|593105073|FG001|Overall Study|Withdrawal by Subject|0|||
164200318|NCT04467515|593105074|FG002|Overall Study|Withdrawal by Subject|1|||
164200319|NCT04467515|593105072|FG000|Overall Study|Progressive Disease|0|||
164200320|NCT04467515|593105073|FG001|Overall Study|Progressive Disease|1|||
164200321|NCT04467515|593105074|FG002|Overall Study|Progressive Disease|3|||
164200322|NCT04467515|593105072|FG000|Overall Study|Death|0|||
164200323|NCT04467515|593105073|FG001|Overall Study|Death|1|||
164200324|NCT04467515|593105074|FG002|Overall Study|Death|0|||
164200325|NCT04249427|593105077|FG000|Overall Study|Adverse Event|3|||
164200326|NCT04249427|593105078|FG001|Overall Study|Adverse Event|1|||
164200327|NCT04249427|593105077|FG000|Overall Study|Lack of Efficacy|0|||
164200328|NCT04249427|593105078|FG001|Overall Study|Lack of Efficacy|1|||
164200329|NCT04249427|593105077|FG000|Overall Study|Withdrawal by Subject|1|||
164200330|NCT04249427|593105078|FG001|Overall Study|Withdrawal by Subject|2|||
164200331|NCT03886272|593105079|FG000|Period 1|Withdrawal by Subject|0|||
164200332|NCT03886272|593105080|FG001|Period 1|Withdrawal by Subject|0|||
164200333|NCT03886272|593105081|FG002|Period 1|Withdrawal by Subject|0|||
164200334|NCT03886272|593105082|FG003|Period 1|Withdrawal by Subject|0|||
164200335|NCT03886272|593105083|FG004|Period 1|Withdrawal by Subject|0|||
164200336|NCT03886272|593105084|FG005|Period 1|Withdrawal by Subject|1|||
164200337|NCT03886272|593105085|FG006|Period 1|Withdrawal by Subject|0|||
164200338|NCT01091246|593105086|FG000|Overall Study|Lost to Follow-up|23|||
164200339|NCT01091246|593105087|FG001|Overall Study|Lost to Follow-up|11|||
164200340|NCT01091246|593105088|FG002|Overall Study|Lost to Follow-up|7|||
164200341|NCT01091246|593105086|FG000|Overall Study|Adverse Event|1|||
164200342|NCT01091246|593105087|FG001|Overall Study|Adverse Event|0|||
164200343|NCT01091246|593105088|FG002|Overall Study|Adverse Event|1|||
164200344|NCT01091246|593105086|FG000|Overall Study|Withdrawal by Subject|9|||
164200345|NCT01091246|593105087|FG001|Overall Study|Withdrawal by Subject|5|||
164200346|NCT01091246|593105088|FG002|Overall Study|Withdrawal by Subject|4|||
164200347|NCT01091246|593105086|FG000|Overall Study|Subject not dosed|2|||
164200348|NCT01091246|593105087|FG001|Overall Study|Subject not dosed|0|||
164200349|NCT01091246|593105088|FG002|Overall Study|Subject not dosed|1|||
164200350|NCT01673178|593105092|FG000|Overall Study|Lost to Follow-up|0|||
164200351|NCT01673178|593105093|FG001|Overall Study|Lost to Follow-up|1|||
164200352|NCT01673178|593105094|FG002|Overall Study|Lost to Follow-up|0|||
164200353|NCT01673178|593105095|FG003|Overall Study|Lost to Follow-up|0|||
164200354|NCT01673178|593105096|FG004|Overall Study|Lost to Follow-up|0|||
164200355|NCT01673178|593105092|FG000|Overall Study|Withdrawal by Subject|0|||
164200356|NCT01673178|593105093|FG001|Overall Study|Withdrawal by Subject|0|||
164200357|NCT01673178|593105094|FG002|Overall Study|Withdrawal by Subject|1|||
164200358|NCT01673178|593105095|FG003|Overall Study|Withdrawal by Subject|4|||
164200359|NCT01673178|593105096|FG004|Overall Study|Withdrawal by Subject|2|||
164200360|NCT01673178|593105092|FG000|Overall Study|Protocol Violation|1|||
164200361|NCT01673178|593105093|FG001|Overall Study|Protocol Violation|1|||
164200362|NCT01673178|593105094|FG002|Overall Study|Protocol Violation|0|||
164308941|NCT01349049|593506549|FG002|Overall Study|Protocol Violation|0|||
164656193|NCT01952574|594766459|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
164656194|NCT01952574|594766460|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
164656195|NCT01952574|594766461|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
164656196|NCT01952574|594766462|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
164656197|NCT01952574|594766463|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
164656198|NCT01952574|594766464|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
164656199|NCT01952574|594766458|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
164656200|NCT01952574|594766459|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
164200363|NCT01673178|593105095|FG003|Overall Study|Protocol Violation|1|||
164200364|NCT01673178|593105096|FG004|Overall Study|Protocol Violation|0|||
164200365|NCT01673178|593105092|FG000|Overall Study|Adverse Event|1|||
164200366|NCT01673178|593105093|FG001|Overall Study|Adverse Event|0|||
164200367|NCT01673178|593105094|FG002|Overall Study|Adverse Event|0|||
164200368|NCT01673178|593105095|FG003|Overall Study|Adverse Event|2|||
164200369|NCT01673178|593105096|FG004|Overall Study|Adverse Event|0|||
164200370|NCT01673178|593105092|FG000|Overall Study|Other|1|||
164200371|NCT01673178|593105093|FG001|Overall Study|Other|0|||
164200372|NCT01673178|593105094|FG002|Overall Study|Other|2|||
164200373|NCT01673178|593105095|FG003|Overall Study|Other|1|||
164200374|NCT01673178|593105096|FG004|Overall Study|Other|0|||
164200375|NCT03177148|593105097|FG000|Overall Study|Lost to Follow-up|50|||
164200376|NCT03177148|593105098|FG001|Overall Study|Lost to Follow-up|1|||
164200377|NCT03177148|593105097|FG000|Overall Study|Death|1|||
164200378|NCT03177148|593105098|FG001|Overall Study|Death|0|||
164200379|NCT01676012|593105100|FG000|Overall Study|Adverse Event|2|||
164308942|NCT01349049|593506550|FG003|Overall Study|Protocol Violation|0|||
164308943|NCT01349049|593506551|FG004|Overall Study|Protocol Violation|0|||
164308944|NCT01349049|593506552|FG005|Overall Study|Protocol Violation|0|||
164308945|NCT01349049|593506553|FG006|Overall Study|Protocol Violation|0|||
164550693|NCT00219284|594388758|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
164550694|NCT00219284|594388759|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
164550695|NCT00219284|594388758|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
164550696|NCT00219284|594388759|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
164200380|NCT01676012|593105100|FG000|Overall Study|incomplete set of videos|1|||
164200381|NCT02848664|593105102|FG000|Overall Study|Withdrawal by Subject|2|||
164200382|NCT02848664|593105102|FG000|Overall Study|Adverse Event|1|||
164200383|NCT02848664|593105102|FG000|Overall Study|no assistance for device training|1|||
164200384|NCT01819727|593105108|FG000|Overall Study|Adverse Event|8|||
164200385|NCT01819727|593105109|FG001|Overall Study|Adverse Event|9|||
164200386|NCT01819727|593105108|FG000|Overall Study|Death|1|||
164200387|NCT01819727|593105109|FG001|Overall Study|Death|0|||
164200388|NCT01819727|593105108|FG000|Overall Study|Lost to Follow-up|1|||
164200389|NCT01819727|593105109|FG001|Overall Study|Lost to Follow-up|1|||
164200390|NCT01819727|593105108|FG000|Overall Study|Physician Decision|3|||
164200391|NCT01819727|593105109|FG001|Overall Study|Physician Decision|2|||
164200392|NCT01819727|593105108|FG000|Overall Study|Pregnancy|1|||
164200393|NCT01819727|593105109|FG001|Overall Study|Pregnancy|0|||
164200394|NCT01819727|593105108|FG000|Overall Study|Protocol Violation|0|||
164200395|NCT01819727|593105109|FG001|Overall Study|Protocol Violation|2|||
164200396|NCT01819727|593105108|FG000|Overall Study|Study Terminated by Sponsor|0|||
164200397|NCT01819727|593105109|FG001|Overall Study|Study Terminated by Sponsor|1|||
164200398|NCT01819727|593105108|FG000|Overall Study|Withdrawal by Subject|6|||
164200399|NCT01819727|593105109|FG001|Overall Study|Withdrawal by Subject|11|||
164200400|NCT01819727|593105108|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
164200401|NCT01819727|593105109|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
164200402|NCT01819727|593105108|FG000|Overall Study|Quit due to lack of health benifits|0|||
164200403|NCT01819727|593105109|FG001|Overall Study|Quit due to lack of health benifits|1|||
164200404|NCT04794751|593105115|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
164200405|NCT04794751|593105116|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
164200406|NCT04794751|593105115|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
164200407|NCT04794751|593105116|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
164200408|NCT04794751|593105115|FG000|Period 1|Protocol Violation|0|||
164200409|NCT04794751|593105116|FG001|Period 1|Protocol Violation|2|||
164200410|NCT04794751|593105115|FG000|Period 1|Withdrawal by Subject|0|||
164200411|NCT04794751|593105116|FG001|Period 1|Withdrawal by Subject|1|||
164200412|NCT04794751|593105115|FG000|Period 2|Withdrawal by Subject|0|||
164200413|NCT04794751|593105116|FG001|Period 2|Withdrawal by Subject|1|||
164200414|NCT04794751|593105115|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
164200415|NCT04794751|593105116|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
164200416|NCT04794751|593105115|FG000|Period 2|Protocol Violation|1|||
164200417|NCT04794751|593105116|FG001|Period 2|Protocol Violation|0|||
164200418|NCT01405898|593105119|FG000|Overall Study|Withdrawal by Subject|2|||
164200419|NCT01405898|593105120|FG001|Overall Study|Withdrawal by Subject|2|||
164200420|NCT00369343|593105136|FG000|Double-blind Phase|Adverse Event|19|||
164200421|NCT00369343|593105137|FG001|Double-blind Phase|Adverse Event|4|||
164200422|NCT00369343|593105136|FG000|Double-blind Phase|Failed to return|2|||
164200423|NCT00369343|593105137|FG001|Double-blind Phase|Failed to return|0|||
164200424|NCT00369343|593105136|FG000|Double-blind Phase|Lost to Follow-up|9|||
164200425|NCT00369343|593105137|FG001|Double-blind Phase|Lost to Follow-up|2|||
164200426|NCT00369343|593105136|FG000|Double-blind Phase|Protocol Violation|2|||
164200427|NCT00369343|593105137|FG001|Double-blind Phase|Protocol Violation|0|||
164200428|NCT00369343|593105136|FG000|Double-blind Phase|Withdrawal by Subject|8|||
164200429|NCT00369343|593105137|FG001|Double-blind Phase|Withdrawal by Subject|6|||
164200430|NCT00369343|593105136|FG000|Double-blind Phase|Lack of Efficacy|0|||
164200431|NCT00369343|593105137|FG001|Double-blind Phase|Lack of Efficacy|4|||
164200432|NCT00369343|593105136|FG000|Double-blind Phase|Protocol deviation|4|||
164200433|NCT00369343|593105137|FG001|Double-blind Phase|Protocol deviation|0|||
164200434|NCT00369343|593105136|FG000|Open-label Phase|Adverse Event|19|||
164200435|NCT00369343|593105137|FG001|Open-label Phase|Adverse Event|7|||
164200436|NCT00369343|593105136|FG000|Open-label Phase|Failed to return|4|||
164200437|NCT00369343|593105137|FG001|Open-label Phase|Failed to return|0|||
164200438|NCT00369343|593105136|FG000|Open-label Phase|Physician Decision|2|||
164200439|NCT00369343|593105137|FG001|Open-label Phase|Physician Decision|0|||
164200440|NCT00369343|593105136|FG000|Open-label Phase|Lost to Follow-up|5|||
164200441|NCT00369343|593105137|FG001|Open-label Phase|Lost to Follow-up|3|||
164200442|NCT00369343|593105136|FG000|Open-label Phase|inadvertently reported study completers|3|||
164200443|NCT00369343|593105137|FG001|Open-label Phase|inadvertently reported study completers|2|||
164200444|NCT00369343|593105136|FG000|Open-label Phase|Protocol Violation|1|||
164200445|NCT00369343|593105137|FG001|Open-label Phase|Protocol Violation|3|||
164200446|NCT00369343|593105136|FG000|Open-label Phase|Withdrawal by Subject|15|||
164200447|NCT00369343|593105137|FG001|Open-label Phase|Withdrawal by Subject|6|||
164200448|NCT00369343|593105136|FG000|Open-label Phase|Lack of Efficacy|4|||
164200449|NCT00369343|593105137|FG001|Open-label Phase|Lack of Efficacy|3|||
164200450|NCT00369343|593105136|FG000|Open-label Phase|Lack of continuance tolerability|3|||
164308946|NCT01349049|593506554|FG007|Overall Study|Protocol Violation|0|||
164308947|NCT01349049|593506555|FG008|Overall Study|Protocol Violation|1|||
164308948|NCT01349049|593506547|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
164308949|NCT01349049|593506548|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
164308950|NCT01349049|593506549|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
164308951|NCT01349049|593506550|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
164308952|NCT01349049|593506551|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
164308953|NCT01349049|593506552|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
164308954|NCT01349049|593506553|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
164308955|NCT01349049|593506554|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
164308956|NCT01349049|593506555|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
164308957|NCT01349049|593506547|FG000|Overall Study|Other|0|||
164656201|NCT01952574|594766460|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
164200451|NCT00369343|593105137|FG001|Open-label Phase|Lack of continuance tolerability|4|||
164200452|NCT00369343|593105136|FG000|Open-label Phase|did not take study drug|1|||
164200453|NCT00369343|593105137|FG001|Open-label Phase|did not take study drug|2|||
164200454|NCT01973218|593105138|FG000|Overall Study|Adverse Event|1|||
164200455|NCT01973218|593105139|FG001|Overall Study|Adverse Event|0|||
164200456|NCT01973218|593105138|FG000|Overall Study|Withdrawal by Subject|1|||
164200457|NCT01973218|593105139|FG001|Overall Study|Withdrawal by Subject|0|||
164200458|NCT02247466|593105140|FG000|Overall Study|Procedure changed to open surgery|0|||
164200459|NCT02247466|593105141|FG001|Overall Study|Procedure changed to open surgery|3|||
164200460|NCT02322749|593105146|FG000|Period 2|Adverse Event|0|||
164200461|NCT02322749|593105147|FG001|Period 2|Adverse Event|0|||
164200462|NCT02322749|593105148|FG002|Period 2|Adverse Event|0|||
164200463|NCT02322749|593105149|FG003|Period 2|Adverse Event|1|||
164200464|NCT02322749|593105150|FG004|Period 2|Adverse Event|0|||
164200465|NCT02322749|593105151|FG005|Period 2|Adverse Event|0|||
164200466|NCT02322749|593105146|FG000|Period 2|Withdrawal by Subject|0|||
164200467|NCT02322749|593105147|FG001|Period 2|Withdrawal by Subject|0|||
164200468|NCT02322749|593105148|FG002|Period 2|Withdrawal by Subject|0|||
164200469|NCT02322749|593105149|FG003|Period 2|Withdrawal by Subject|1|||
164200470|NCT02322749|593105150|FG004|Period 2|Withdrawal by Subject|0|||
164200471|NCT02322749|593105151|FG005|Period 2|Withdrawal by Subject|0|||
164200472|NCT02322749|593105146|FG000|Period 3|Withdrawal by Subject|0|||
164200473|NCT02322749|593105147|FG001|Period 3|Withdrawal by Subject|0|||
164200474|NCT02322749|593105148|FG002|Period 3|Withdrawal by Subject|1|||
164200475|NCT02322749|593105149|FG003|Period 3|Withdrawal by Subject|0|||
164200476|NCT02322749|593105150|FG004|Period 3|Withdrawal by Subject|0|||
164200477|NCT02322749|593105151|FG005|Period 3|Withdrawal by Subject|0|||
164200478|NCT00073918|593105152|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
164200479|NCT00073918|593105152|FG000|Overall Study|Rapid disease progression|2|||
164200480|NCT00073918|593105152|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
164200481|NCT02033759|593105155|FG000|Overall Study|Withdrawal by Subject|2|||
164200482|NCT02033759|593105156|FG001|Overall Study|Withdrawal by Subject|1|||
164200483|NCT02033759|593105155|FG000|Overall Study|Protocol Violation|1|||
164200484|NCT02033759|593105156|FG001|Overall Study|Protocol Violation|1|||
164200485|NCT02007720|593105163|FG000|Overall Study|Withdrawal by Subject|9|||
164200486|NCT02007720|593105164|FG001|Overall Study|Withdrawal by Subject|11|||
164200487|NCT02007720|593105163|FG000|Overall Study|study terminated by sponsor|58|||
164200488|NCT02007720|593105164|FG001|Overall Study|study terminated by sponsor|54|||
164200489|NCT02007720|593105163|FG000|Overall Study|technical problem|4|||
164200490|NCT02007720|593105164|FG001|Overall Study|technical problem|2|||
164200491|NCT02007720|593105163|FG000|Overall Study|patient followd less than 165 days|11|||
164200492|NCT02007720|593105164|FG001|Overall Study|patient followd less than 165 days|5|||
164200493|NCT00490919|593105166|FG000|Open-label Run-in Period|Adverse Event|239|||
164200494|NCT00490919|593105167|FG001|Open-label Run-in Period|Adverse Event|0|||
164200495|NCT00490919|593105168|FG002|Open-label Run-in Period|Adverse Event|0|||
164200496|NCT00490919|593105166|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
164200497|NCT00490919|593105167|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
164200498|NCT00490919|593105168|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
164200499|NCT00490919|593105166|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
164200500|NCT00490919|593105167|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
164200501|NCT00490919|593105168|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
164200502|NCT00490919|593105166|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
164200503|NCT00490919|593105167|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
164200504|NCT00490919|593105168|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
164200505|NCT00490919|593105166|FG000|Open-label Run-in Period|Administrative|40|||
164200506|NCT00490919|593105167|FG001|Open-label Run-in Period|Administrative|0|||
164200507|NCT00490919|593105168|FG002|Open-label Run-in Period|Administrative|0|||
164308958|NCT01349049|593506548|FG001|Overall Study|Other|0|||
164656202|NCT01952574|594766461|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
164200508|NCT00490919|593105166|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
164200509|NCT00490919|593105167|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
164200510|NCT00490919|593105168|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
164308959|NCT01349049|593506549|FG002|Overall Study|Other|0|||
164308960|NCT01349049|593506550|FG003|Overall Study|Other|0|||
164308961|NCT01349049|593506551|FG004|Overall Study|Other|0|||
164308962|NCT01349049|593506552|FG005|Overall Study|Other|1|||
164308963|NCT01349049|593506553|FG006|Overall Study|Other|0|||
164308964|NCT01349049|593506554|FG007|Overall Study|Other|0|||
164308965|NCT01349049|593506555|FG008|Overall Study|Other|4|||
164308966|NCT01349049|593506547|FG000|Overall Study|Death|0|||
164308967|NCT01349049|593506548|FG001|Overall Study|Death|0|||
164308968|NCT01349049|593506549|FG002|Overall Study|Death|0|||
164308969|NCT01349049|593506550|FG003|Overall Study|Death|0|||
164308970|NCT01349049|593506551|FG004|Overall Study|Death|0|||
164308971|NCT01349049|593506552|FG005|Overall Study|Death|0|||
164308972|NCT01349049|593506553|FG006|Overall Study|Death|0|||
164308973|NCT01349049|593506554|FG007|Overall Study|Death|1|||
164308974|NCT01349049|593506555|FG008|Overall Study|Death|5|||
164308975|NCT01349049|593506547|FG000|Overall Study|Non-compliance|0|||
164308976|NCT01349049|593506548|FG001|Overall Study|Non-compliance|0|||
164308977|NCT01349049|593506549|FG002|Overall Study|Non-compliance|0|||
164308978|NCT01349049|593506550|FG003|Overall Study|Non-compliance|1|||
164308979|NCT01349049|593506551|FG004|Overall Study|Non-compliance|0|||
164308980|NCT01349049|593506552|FG005|Overall Study|Non-compliance|0|||
164308981|NCT01349049|593506553|FG006|Overall Study|Non-compliance|0|||
164308982|NCT01349049|593506554|FG007|Overall Study|Non-compliance|0|||
164308983|NCT01349049|593506555|FG008|Overall Study|Non-compliance|0|||
164308984|NCT01349049|593506547|FG000|Overall Study|Withdrawal by Subject|0|||
164308985|NCT01349049|593506548|FG001|Overall Study|Withdrawal by Subject|0|||
164308986|NCT01349049|593506549|FG002|Overall Study|Withdrawal by Subject|0|||
164308987|NCT01349049|593506550|FG003|Overall Study|Withdrawal by Subject|0|||
164308988|NCT01349049|593506551|FG004|Overall Study|Withdrawal by Subject|0|||
164308989|NCT01349049|593506552|FG005|Overall Study|Withdrawal by Subject|0|||
164308990|NCT01349049|593506553|FG006|Overall Study|Withdrawal by Subject|0|||
164308991|NCT01349049|593506554|FG007|Overall Study|Withdrawal by Subject|0|||
164308992|NCT01349049|593506555|FG008|Overall Study|Withdrawal by Subject|6|||
164308993|NCT03887702|593506556|FG000|Overall Study|Study terminated|0|||
164308994|NCT03887702|593506557|FG001|Overall Study|Study terminated|0|||
164308995|NCT03887702|593506558|FG002|Overall Study|Study terminated|2|||
164308996|NCT03887702|593506559|FG003|Overall Study|Study terminated|2|||
164308997|NCT01643772|593506560|FG000|Overall Study|Protocol Violation|0|||
164308998|NCT01643772|593506561|FG001|Overall Study|Protocol Violation|0|||
164308999|NCT01643772|593506562|FG002|Overall Study|Protocol Violation|0|||
164309000|NCT01643772|593506563|FG003|Overall Study|Protocol Violation|1|||
164309001|NCT01643772|593506560|FG000|Overall Study|Adverse Event|0|||
164309002|NCT01643772|593506561|FG001|Overall Study|Adverse Event|0|||
164309003|NCT01643772|593506562|FG002|Overall Study|Adverse Event|0|||
164309004|NCT01643772|593506563|FG003|Overall Study|Adverse Event|1|||
164309005|NCT03860818|593506564|FG000|Overall Study|Death|144|||
164309006|NCT03860818|593506565|FG001|Overall Study|Death|195|||
164309007|NCT03860818|593506564|FG000|Overall Study|Graft Loss|32|||
164309008|NCT03860818|593506565|FG001|Overall Study|Graft Loss|45|||
164309009|NCT00505778|593506566|FG000|Overall Study|Adverse Event|2|||
164309010|NCT00505778|593506567|FG001|Overall Study|Adverse Event|7|||
164309011|NCT00505778|593506566|FG000|Overall Study|Physician Decision|8|||
164309012|NCT00505778|593506567|FG001|Overall Study|Physician Decision|14|||
164309013|NCT00505778|593506566|FG000|Overall Study|Lost to Follow-up|17|||
164309014|NCT00505778|593506567|FG001|Overall Study|Lost to Follow-up|23|||
164309015|NCT00505778|593506566|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
164309016|NCT00505778|593506567|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
164309017|NCT00505778|593506566|FG000|Overall Study|Protocol Violation|7|||
164309018|NCT00505778|593506567|FG001|Overall Study|Protocol Violation|9|||
164420586|NCT01890967|593910949|FG003|Overall Study|Adverse Event|2|||
164420587|NCT01890967|593910950|FG004|Overall Study|Adverse Event|1|||
164309019|NCT00505778|593506566|FG000|Overall Study|Withdrawal by Subject|29|||
164309020|NCT00505778|593506567|FG001|Overall Study|Withdrawal by Subject|14|||
164309021|NCT00505778|593506566|FG000|Overall Study|Relapse|65|||
164309022|NCT00505778|593506567|FG001|Overall Study|Relapse|65|||
164309023|NCT00505778|593506566|FG000|Overall Study|Took No Study Drug|2|||
164309024|NCT00505778|593506567|FG001|Overall Study|Took No Study Drug|2|||
164309025|NCT03436082|593506568|FG000|Overall Study|Did not undergo procedure|1|||
164309026|NCT03436082|593506569|FG001|Overall Study|Did not undergo procedure|0|||
164309027|NCT01864603|593506572|FG000|Stage 2|DSMB design modification|86056|||
164309028|NCT01864603|593506573|FG001|Stage 2|DSMB design modification|92558|||
164309029|NCT04661579|593506576|FG000|Overall Study|Lost to Follow-up|19|||
164309030|NCT04661579|593506577|FG001|Overall Study|Lost to Follow-up|10|||
164309031|NCT04661579|593506578|FG002|Overall Study|Lost to Follow-up|2|||
164309032|NCT04661579|593506579|FG003|Overall Study|Lost to Follow-up|7|||
164309033|NCT04661579|593506580|FG004|Overall Study|Lost to Follow-up|11|||
164309034|NCT04661579|593506576|FG000|Overall Study|Physician Decision|2|||
164309035|NCT04661579|593506577|FG001|Overall Study|Physician Decision|0|||
164309036|NCT04661579|593506578|FG002|Overall Study|Physician Decision|0|||
164420588|NCT01890967|593910951|FG005|Overall Study|Adverse Event|7|||
164309037|NCT04661579|593506579|FG003|Overall Study|Physician Decision|1|||
164309038|NCT04661579|593506580|FG004|Overall Study|Physician Decision|0|||
164309039|NCT04661579|593506576|FG000|Overall Study|Withdrawal by Subject|1|||
164309040|NCT04661579|593506577|FG001|Overall Study|Withdrawal by Subject|4|||
164309041|NCT04661579|593506578|FG002|Overall Study|Withdrawal by Subject|0|||
164309042|NCT04661579|593506579|FG003|Overall Study|Withdrawal by Subject|2|||
164309043|NCT04661579|593506580|FG004|Overall Study|Withdrawal by Subject|0|||
164309044|NCT04661579|593506576|FG000|Overall Study|Death|1|||
164309045|NCT04661579|593506577|FG001|Overall Study|Death|0|||
164309046|NCT04661579|593506578|FG002|Overall Study|Death|0|||
164309047|NCT04661579|593506579|FG003|Overall Study|Death|0|||
164309048|NCT04661579|593506580|FG004|Overall Study|Death|0|||
164309049|NCT04661579|593506576|FG000|Overall Study|Other|1|||
164309050|NCT04661579|593506577|FG001|Overall Study|Other|2|||
164309051|NCT04661579|593506578|FG002|Overall Study|Other|1|||
164309052|NCT04661579|593506579|FG003|Overall Study|Other|1|||
164309053|NCT04661579|593506580|FG004|Overall Study|Other|1|||
164309054|NCT04661579|593506576|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
164309055|NCT04661579|593506577|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
164309056|NCT04661579|593506578|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
164309057|NCT04661579|593506579|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
164309058|NCT04661579|593506580|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
164309059|NCT03656562|593506581|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
164309060|NCT03656562|593506582|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
164309061|NCT03656562|593506583|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
164309062|NCT03656562|593506584|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
164550697|NCT00219284|594388758|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
164550698|NCT00219284|594388759|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
164550699|NCT00219284|594388758|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
164550700|NCT00219284|594388759|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
164550701|NCT00219284|594388758|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
164550702|NCT00219284|594388759|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
164550703|NCT00219284|594388758|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
164550704|NCT00219284|594388759|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
164200511|NCT00490919|593105166|FG000|Double-blind Phase|Adverse Event|0|||
164200512|NCT00490919|593105167|FG001|Double-blind Phase|Adverse Event|40|||
164200513|NCT00490919|593105168|FG002|Double-blind Phase|Adverse Event|20|||
164200514|NCT00490919|593105166|FG000|Double-blind Phase|Withdrawal by Subject|0|||
164200515|NCT00490919|593105167|FG001|Double-blind Phase|Withdrawal by Subject|10|||
164200516|NCT00490919|593105168|FG002|Double-blind Phase|Withdrawal by Subject|11|||
164200517|NCT00490919|593105166|FG000|Double-blind Phase|Lost to Follow-up|0|||
164200518|NCT00490919|593105167|FG001|Double-blind Phase|Lost to Follow-up|8|||
164200519|NCT00490919|593105168|FG002|Double-blind Phase|Lost to Follow-up|11|||
164200520|NCT00490919|593105166|FG000|Double-blind Phase|Lack of Efficacy|0|||
164200521|NCT00490919|593105167|FG001|Double-blind Phase|Lack of Efficacy|22|||
164200522|NCT00490919|593105168|FG002|Double-blind Phase|Lack of Efficacy|36|||
164200523|NCT00490919|593105166|FG000|Double-blind Phase|Administrative|0|||
164200524|NCT00490919|593105167|FG001|Double-blind Phase|Administrative|6|||
164200525|NCT00490919|593105168|FG002|Double-blind Phase|Administrative|6|||
164200526|NCT04265261|593105175|FG000|Overall Study|Adverse Event|2|||
164200527|NCT04265261|593105176|FG001|Overall Study|Adverse Event|0|||
164200528|NCT04265261|593105177|FG002|Overall Study|Adverse Event|0|||
164200529|NCT04265261|593105175|FG000|Overall Study|Death|1|||
164200530|NCT04265261|593105176|FG001|Overall Study|Death|0|||
164200531|NCT04265261|593105177|FG002|Overall Study|Death|0|||
164200532|NCT04265261|593105175|FG000|Overall Study|Lost to Follow-up|4|||
164200533|NCT04265261|593105176|FG001|Overall Study|Lost to Follow-up|1|||
164200534|NCT04265261|593105177|FG002|Overall Study|Lost to Follow-up|3|||
164200535|NCT04265261|593105175|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164200536|NCT04265261|593105176|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164200537|NCT04265261|593105177|FG002|Overall Study|Non-Compliance with Study Drug|0|||
164200538|NCT04265261|593105175|FG000|Overall Study|Physician Decision|0|||
164200539|NCT04265261|593105176|FG001|Overall Study|Physician Decision|0|||
164656203|NCT01952574|594766462|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
164200540|NCT04265261|593105177|FG002|Overall Study|Physician Decision|1|||
164200541|NCT04265261|593105175|FG000|Overall Study|Protocol Deviation|0|||
164200542|NCT04265261|593105176|FG001|Overall Study|Protocol Deviation|2|||
164200543|NCT04265261|593105177|FG002|Overall Study|Protocol Deviation|0|||
164309063|NCT03656562|593506581|FG000|Overall Study|Physician Decision|1|||
164309064|NCT03656562|593506582|FG001|Overall Study|Physician Decision|2|||
164309065|NCT03656562|593506583|FG002|Overall Study|Physician Decision|0|||
164550705|NCT00219284|594388758|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
164656204|NCT01952574|594766463|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
164200544|NCT04265261|593105175|FG000|Overall Study|Withdrawal by Subject|2|||
164309066|NCT03656562|593506584|FG003|Overall Study|Physician Decision|0|||
164309067|NCT03656562|593506581|FG000|Overall Study|Subject Decision|3|||
164309068|NCT03656562|593506582|FG001|Overall Study|Subject Decision|5|||
164309069|NCT03656562|593506583|FG002|Overall Study|Subject Decision|0|||
164309070|NCT03656562|593506584|FG003|Overall Study|Subject Decision|2|||
164309071|NCT04335136|593506585|FG000|Overall Study|Death|8|||
164309072|NCT04335136|593506586|FG001|Overall Study|Death|4|||
164309073|NCT04335136|593506585|FG000|Overall Study|Lost to Follow-up|2|||
164309074|NCT04335136|593506586|FG001|Overall Study|Lost to Follow-up|0|||
164309075|NCT04335136|593506585|FG000|Overall Study|Protocol Violation|1|||
164309076|NCT04335136|593506586|FG001|Overall Study|Protocol Violation|0|||
164309077|NCT04335136|593506585|FG000|Overall Study|Withdrawal by Subject|1|||
164309078|NCT04335136|593506586|FG001|Overall Study|Withdrawal by Subject|1|||
164309079|NCT04335136|593506585|FG000|Overall Study|Health-threatening condition|0|||
164309080|NCT04335136|593506586|FG001|Overall Study|Health-threatening condition|1|||
164309081|NCT04335136|593506585|FG000|Overall Study|Adverse Event|0|||
164309082|NCT04335136|593506586|FG001|Overall Study|Adverse Event|1|||
164309083|NCT04335136|593506585|FG000|Overall Study|Erroneously randomized|2|||
164309084|NCT04335136|593506586|FG001|Overall Study|Erroneously randomized|0|||
164309085|NCT01396447|593506587|FG000|Overall Study|Did Not Receive Treatment|3|||
164309086|NCT01396447|593506588|FG001|Overall Study|Did Not Receive Treatment|2|||
164309087|NCT01396447|593506589|FG002|Overall Study|Did Not Receive Treatment|1|||
164309088|NCT01396447|593506590|FG003|Overall Study|Did Not Receive Treatment|0|||
164309089|NCT01396447|593506587|FG000|Overall Study|Adverse Event|15|||
164309090|NCT01396447|593506588|FG001|Overall Study|Adverse Event|12|||
164309091|NCT01396447|593506589|FG002|Overall Study|Adverse Event|12|||
164309092|NCT01396447|593506590|FG003|Overall Study|Adverse Event|17|||
164309093|NCT01396447|593506587|FG000|Overall Study|Insufficient Therapeutic Response|5|||
164309094|NCT01396447|593506588|FG001|Overall Study|Insufficient Therapeutic Response|5|||
164309095|NCT01396447|593506589|FG002|Overall Study|Insufficient Therapeutic Response|2|||
164309096|NCT01396447|593506590|FG003|Overall Study|Insufficient Therapeutic Response|4|||
164309097|NCT01396447|593506587|FG000|Overall Study|Protocol Violation|5|||
164309098|NCT01396447|593506588|FG001|Overall Study|Protocol Violation|2|||
164309099|NCT01396447|593506589|FG002|Overall Study|Protocol Violation|3|||
164309100|NCT01396447|593506590|FG003|Overall Study|Protocol Violation|7|||
164309101|NCT01396447|593506587|FG000|Overall Study|Withdrawal of Consent|11|||
164309102|NCT01396447|593506588|FG001|Overall Study|Withdrawal of Consent|9|||
164309103|NCT01396447|593506589|FG002|Overall Study|Withdrawal of Consent|4|||
164309104|NCT01396447|593506590|FG003|Overall Study|Withdrawal of Consent|15|||
164309105|NCT01396447|593506587|FG000|Overall Study|Lost to Follow-up|4|||
164309106|NCT01396447|593506588|FG001|Overall Study|Lost to Follow-up|8|||
164309107|NCT01396447|593506589|FG002|Overall Study|Lost to Follow-up|7|||
164309108|NCT01396447|593506590|FG003|Overall Study|Lost to Follow-up|9|||
164309109|NCT01396447|593506587|FG000|Overall Study|Other Miscellaneous Reasons|0|||
164309110|NCT01396447|593506588|FG001|Overall Study|Other Miscellaneous Reasons|2|||
164309111|NCT01396447|593506589|FG002|Overall Study|Other Miscellaneous Reasons|1|||
164309112|NCT01396447|593506590|FG003|Overall Study|Other Miscellaneous Reasons|0|||
164309113|NCT01402102|593506591|FG000|Overall Study|Protocol Violation|1|||
164309114|NCT01402102|593506592|FG001|Overall Study|Protocol Violation|0|||
164309115|NCT01402102|593506591|FG000|Overall Study|Insufficiency of compliance|1|||
164309116|NCT01402102|593506592|FG001|Overall Study|Insufficiency of compliance|1|||
164309117|NCT01402102|593506591|FG000|Overall Study|Withdrawal by Subject|0|||
164309118|NCT01402102|593506592|FG001|Overall Study|Withdrawal by Subject|2|||
164309119|NCT02423902|593506593|FG000|Overall Study|Disease progression|1|||
164309120|NCT02423902|593506594|FG001|Overall Study|Disease progression|4|||
164309121|NCT02136069|593506595|FG000|Overall Study|UC flare-up|1|||
164309122|NCT02136069|593506596|FG001|Overall Study|UC flare-up|0|||
164309123|NCT02136069|593506595|FG000|Overall Study|Adverse Event|6|||
164309124|NCT02136069|593506596|FG001|Overall Study|Adverse Event|8|||
164309125|NCT02136069|593506595|FG000|Overall Study|Death|0|||
164309126|NCT02136069|593506596|FG001|Overall Study|Death|1|||
164309127|NCT02136069|593506595|FG000|Overall Study|Lack of Efficacy|10|||
164309128|NCT02136069|593506596|FG001|Overall Study|Lack of Efficacy|4|||
164309129|NCT02136069|593506595|FG000|Overall Study|Lost to Follow-up|1|||
164309130|NCT02136069|593506596|FG001|Overall Study|Lost to Follow-up|0|||
164309131|NCT02136069|593506595|FG000|Overall Study|Non-Compliance|1|||
164309132|NCT02136069|593506596|FG001|Overall Study|Non-Compliance|0|||
164309133|NCT02136069|593506595|FG000|Overall Study|Physician Decision|5|||
164309134|NCT02136069|593506596|FG001|Overall Study|Physician Decision|4|||
164309135|NCT02136069|593506595|FG000|Overall Study|Withdrawal by Subject|10|||
164309136|NCT02136069|593506596|FG001|Overall Study|Withdrawal by Subject|11|||
164309137|NCT04269265|593506597|FG000|Overall Study|Physician Decision|1|||
164309138|NCT04269265|593506597|FG000|Overall Study|Withdrawal by Subject|1|||
164309139|NCT04269265|593506597|FG000|Overall Study|Overenrolled (sample size reached)|4|||
164309140|NCT04693234|593506598|FG000|Overall Study|Death|79|||
164309141|NCT04693234|593506599|FG001|Overall Study|Death|19|||
164309142|NCT04693234|593506598|FG000|Overall Study|Sponsor Ended Study|47|||
164309143|NCT04693234|593506599|FG001|Overall Study|Sponsor Ended Study|18|||
164309144|NCT04693234|593506598|FG000|Overall Study|Withdrawal by Subject|10|||
164309145|NCT04693234|593506599|FG001|Overall Study|Withdrawal by Subject|2|||
164309146|NCT04693234|593506598|FG000|Overall Study|Lost to Follow-up|2|||
164309147|NCT04693234|593506599|FG001|Overall Study|Lost to Follow-up|1|||
164309148|NCT04838626|593506602|FG000|Overall Study|Adverse Event|2|||
164309149|NCT04838626|593506602|FG000|Overall Study|Physician Decision|6|||
164309150|NCT04838626|593506602|FG000|Overall Study|Protocol Violation|3|||
164309151|NCT04838626|593506602|FG000|Overall Study|Withdrawal by Subject|9|||
164309152|NCT04838626|593506602|FG000|Overall Study|Technical Problems|2|||
164309153|NCT02578706|593506603|FG000|Overall Study|Withdrawal by Subject|1|||
164309154|NCT02578706|593506604|FG001|Overall Study|Withdrawal by Subject|0|||
164309155|NCT02578706|593506605|FG002|Overall Study|Withdrawal by Subject|0|||
164309156|NCT02578706|593506603|FG000|Overall Study|Lost to Follow-up|0|||
164309157|NCT02578706|593506604|FG001|Overall Study|Lost to Follow-up|4|||
164309158|NCT02578706|593506605|FG002|Overall Study|Lost to Follow-up|0|||
164309159|NCT02578706|593506603|FG000|Overall Study|Physician Decision|0|||
164309160|NCT02578706|593506604|FG001|Overall Study|Physician Decision|1|||
164309161|NCT02578706|593506605|FG002|Overall Study|Physician Decision|0|||
164309162|NCT00811018|593506607|FG000|Overall Study|Additional Chronic Treatment|31|||
164309163|NCT00811018|593506607|FG000|Overall Study|Adverse Event|79|||
164309164|NCT00811018|593506607|FG000|Overall Study|Death|147|||
164309165|NCT00811018|593506607|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
164309166|NCT00811018|593506607|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
164309167|NCT00811018|593506607|FG000|Overall Study|Investigator Decision|57|||
164309168|NCT00811018|593506607|FG000|Overall Study|Lost to Follow-up|19|||
164309169|NCT00811018|593506607|FG000|Overall Study|Pregnancy|6|||
164309170|NCT00811018|593506607|FG000|Overall Study|Sponsor Decision|450|||
164309171|NCT00811018|593506607|FG000|Overall Study|Withdrawal by Subject|70|||
164309172|NCT00811018|593506607|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
164309173|NCT00811018|593506607|FG000|Overall Study|Other|26|||
164309174|NCT00392769|593506608|FG000|Overall Study|Clinical Deterioration|9|||
164309175|NCT00392769|593506608|FG000|Overall Study|Adverse Event|1|||
164309176|NCT04154189|593506609|FG000|Overall Study|Withdrawal by Subject|4|||
164309177|NCT04154189|593506610|FG001|Overall Study|Withdrawal by Subject|6|||
164309178|NCT04154189|593506609|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
164309179|NCT04154189|593506610|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
164309180|NCT04154189|593506609|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
164309181|NCT04154189|593506610|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
164309182|NCT04154189|593506609|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
164309183|NCT04154189|593506610|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
164309184|NCT04154189|593506609|FG000|Overall Study|Death|25|||
164309185|NCT04154189|593506610|FG001|Overall Study|Death|25|||
164309186|NCT00067002|593506613|FG000|Overall Study|Early Death|1|||
164309187|NCT00067002|593506614|FG001|Overall Study|Early Death|2|||
164309188|NCT00067002|593506613|FG000|Overall Study|Delayed|1|||
164309189|NCT00067002|593506614|FG001|Overall Study|Delayed|1|||
164309190|NCT00067002|593506613|FG000|Overall Study|Graft Failure|5|||
164309191|NCT00067002|593506614|FG001|Overall Study|Graft Failure|6|||
164309192|NCT03350672|593506615|FG000|Overall Study|Withdrawal by Subject|7|||
164309193|NCT03350672|593506616|FG001|Overall Study|Withdrawal by Subject|0|||
164309194|NCT03350672|593506617|FG002|Overall Study|Withdrawal by Subject|0|||
164309195|NCT00478023|593506618|FG000|Overall Study|Adverse Event|11|||
164309196|NCT00478023|593506619|FG001|Overall Study|Adverse Event|7|||
164309197|NCT00478023|593506620|FG002|Overall Study|Adverse Event|8|||
164309198|NCT00478023|593506621|FG003|Overall Study|Adverse Event|14|||
164309199|NCT00478023|593506622|FG004|Overall Study|Adverse Event|6|||
164309200|NCT00478023|593506618|FG000|Overall Study|Death|1|||
164309201|NCT00478023|593506619|FG001|Overall Study|Death|0|||
164309202|NCT00478023|593506620|FG002|Overall Study|Death|0|||
164309203|NCT00478023|593506621|FG003|Overall Study|Death|0|||
164309204|NCT00478023|593506622|FG004|Overall Study|Death|0|||
164309205|NCT00478023|593506618|FG000|Overall Study|Lack of Efficacy|11|||
164309206|NCT00478023|593506619|FG001|Overall Study|Lack of Efficacy|10|||
164309207|NCT00478023|593506620|FG002|Overall Study|Lack of Efficacy|4|||
164656205|NCT01952574|594766464|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
164309208|NCT00478023|593506621|FG003|Overall Study|Lack of Efficacy|5|||
164309209|NCT00478023|593506622|FG004|Overall Study|Lack of Efficacy|41|||
164309210|NCT00478023|593506618|FG000|Overall Study|Lost to Follow-up|3|||
164309211|NCT00478023|593506619|FG001|Overall Study|Lost to Follow-up|1|||
164309212|NCT00478023|593506620|FG002|Overall Study|Lost to Follow-up|1|||
164309213|NCT00478023|593506621|FG003|Overall Study|Lost to Follow-up|1|||
164309214|NCT00478023|593506622|FG004|Overall Study|Lost to Follow-up|0|||
164309215|NCT00478023|593506618|FG000|Overall Study|Withdrawal by Subject|2|||
164309216|NCT00478023|593506619|FG001|Overall Study|Withdrawal by Subject|3|||
164309217|NCT00478023|593506620|FG002|Overall Study|Withdrawal by Subject|2|||
164309218|NCT00478023|593506621|FG003|Overall Study|Withdrawal by Subject|4|||
164309219|NCT00478023|593506622|FG004|Overall Study|Withdrawal by Subject|5|||
164309220|NCT00478023|593506618|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
164309221|NCT00478023|593506619|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
164309222|NCT00478023|593506620|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
164550706|NCT00219284|594388759|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
164550707|NCT01357655|594388760|FG000|Overall Study|Administrative Reason by Sponsor|45|||
164550708|NCT01357655|594388761|FG001|Overall Study|Administrative Reason by Sponsor|0|||
164550709|NCT01357655|594388760|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
164550710|NCT01357655|594388761|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
164550711|NCT01357655|594388760|FG000|Overall Study|Disease Progression|1|||
164550712|NCT01357655|594388761|FG001|Overall Study|Disease Progression|0|||
164550713|NCT01357655|594388760|FG000|Overall Study|Lost to Follow-up|2|||
164550714|NCT01357655|594388761|FG001|Overall Study|Lost to Follow-up|0|||
164550715|NCT01357655|594388760|FG000|Overall Study|Maximum Clinical Benefit|2|||
164550716|NCT01357655|594388761|FG001|Overall Study|Maximum Clinical Benefit|0|||
164550717|NCT01357655|594388760|FG000|Overall Study|Reason Unspecified|1|||
164550718|NCT01357655|594388761|FG001|Overall Study|Reason Unspecified|0|||
164550719|NCT01357655|594388760|FG000|Overall Study|Study Drug Toxicity|11|||
164550720|NCT01357655|594388761|FG001|Overall Study|Study Drug Toxicity|0|||
164550721|NCT01357655|594388760|FG000|Overall Study|Subject Withdrew Consent|1|||
164550722|NCT01357655|594388761|FG001|Overall Study|Subject Withdrew Consent|0|||
164550723|NCT05003622|594388762|FG000|Overall Study|Progressive disease|2|||
164200545|NCT04265261|593105176|FG001|Overall Study|Withdrawal by Subject|1|||
164550724|NCT05003622|594388762|FG000|Overall Study|Withdrawal by Subject|1|||
164550725|NCT01692275|594388764|FG000|Overall Study|Lost to Follow-up|57|||
164550726|NCT01692275|594388765|FG001|Overall Study|Lost to Follow-up|48|||
164550727|NCT01692275|594388764|FG000|Overall Study|Withdrawal by Subject|9|||
164550728|NCT01692275|594388765|FG001|Overall Study|Withdrawal by Subject|11|||
164550729|NCT01624662|594388770|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
164550730|NCT01624662|594388771|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
164550731|NCT01624662|594388772|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
164550732|NCT01624662|594388773|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
164550733|NCT01624662|594388770|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
164550734|NCT01624662|594388771|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
164550735|NCT01624662|594388772|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
164550736|NCT01624662|594388773|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
164200546|NCT04265261|593105177|FG002|Overall Study|Withdrawal by Subject|4|||
164200547|NCT07116759|593105178|FG000|Overall Study|Incompatibility with the RHMC device|2|||
164200548|NCT01898078|593106799|FG000|Overall Study|Progressive Disease|1|||
164200549|NCT01898078|593106800|FG001|Overall Study|Progressive Disease|5|||
164200550|NCT01898078|593106799|FG000|Overall Study|Adverse Event|2|||
164200551|NCT01898078|593106800|FG001|Overall Study|Adverse Event|1|||
164200552|NCT01898078|593106799|FG000|Overall Study|Withdrawal by Subject|1|||
164200553|NCT01898078|593106800|FG001|Overall Study|Withdrawal by Subject|1|||
164200554|NCT01898078|593106799|FG000|Overall Study|Symptomatic Deterioration|2|||
164200555|NCT01898078|593106800|FG001|Overall Study|Symptomatic Deterioration|0|||
164200556|NCT01898078|593106799|FG000|Overall Study|Reason not Specified|0|||
164200557|NCT01898078|593106800|FG001|Overall Study|Reason not Specified|1|||
164200558|NCT04635839|593106807|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
164200559|NCT04635839|593106808|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
164200560|NCT02870868|593106809|FG000|Overall Study|Withdrawal by Subject|2|||
164200561|NCT02870868|593106810|FG001|Overall Study|Withdrawal by Subject|1|||
164200562|NCT00499122|593106812|FG000|Overall Study|Withdrawal by Subject|2|||
164200563|NCT00288912|593106813|FG000|Overall Study|Developed exclusion criterion|4|||
164200564|NCT00288912|593106814|FG001|Overall Study|Developed exclusion criterion|6|||
164200565|NCT00288912|593106815|FG002|Overall Study|Developed exclusion criterion|7|||
164200566|NCT00288912|593106813|FG000|Overall Study|Lost to Follow-up|9|||
164200567|NCT00288912|593106814|FG001|Overall Study|Lost to Follow-up|6|||
164200568|NCT00288912|593106815|FG002|Overall Study|Lost to Follow-up|9|||
164200569|NCT00288912|593106813|FG000|Overall Study|Withdrawal by Subject|4|||
164200570|NCT00288912|593106814|FG001|Overall Study|Withdrawal by Subject|5|||
164200571|NCT00288912|593106815|FG002|Overall Study|Withdrawal by Subject|12|||
164200572|NCT03312738|593106816|FG000|Overall Study|Progressive disease|58|||
164200573|NCT03312738|593106817|FG001|Overall Study|Progressive disease|67|||
164200574|NCT03312738|593106816|FG000|Overall Study|Patient/guardian decision|13|||
164200575|NCT03312738|593106817|FG001|Overall Study|Patient/guardian decision|5|||
164200576|NCT03312738|593106816|FG000|Overall Study|Adverse Event|5|||
164200577|NCT03312738|593106817|FG001|Overall Study|Adverse Event|3|||
164200578|NCT03312738|593106816|FG000|Overall Study|Protocol deviation|2|||
164550737|NCT01624662|594388770|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
164550738|NCT01624662|594388771|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
164550739|NCT01624662|594388772|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
164550740|NCT01624662|594388773|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
164200579|NCT03312738|593106817|FG001|Overall Study|Protocol deviation|0|||
164200580|NCT03312738|593106816|FG000|Overall Study|Technical problems|0|||
164200581|NCT03312738|593106817|FG001|Overall Study|Technical problems|1|||
164200582|NCT03312738|593106816|FG000|Overall Study|Physician Decision|2|||
164309223|NCT00478023|593506621|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
164309224|NCT00478023|593506622|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
164309225|NCT01026324|593506626|FG000|Follow up/Survival|Withdrawal by Subject|1|||
164309226|NCT01026324|593506627|FG001|Follow up/Survival|Withdrawal by Subject|0|||
164309227|NCT01026324|593506628|FG002|Follow up/Survival|Withdrawal by Subject|0|||
164309228|NCT05340478|593506637|FG000|Overall Study|Scheduling Issues|10|||
164309229|NCT05340478|593506638|FG001|Overall Study|Scheduling Issues|4|||
164309230|NCT05340478|593506637|FG000|Overall Study|Neither member of dyad started treatment|2|||
164309231|NCT05340478|593506638|FG001|Overall Study|Neither member of dyad started treatment|2|||
164309232|NCT05340478|593506637|FG000|Overall Study|Withdrawn from study|2|||
164309233|NCT05340478|593506638|FG001|Overall Study|Withdrawn from study|2|||
164309234|NCT05340478|593506637|FG000|Overall Study|Lost to Follow-up|1|||
164309235|NCT05340478|593506638|FG001|Overall Study|Lost to Follow-up|4|||
164309236|NCT01032889|593506641|FG000|Overall Study|Adverse Event|2|||
164309237|NCT01032889|593506642|FG001|Overall Study|Adverse Event|2|||
164309238|NCT01032889|593506643|FG002|Overall Study|Adverse Event|0|||
164309239|NCT01032889|593506641|FG000|Overall Study|Withdrawal of Consent|1|||
164309240|NCT01032889|593506642|FG001|Overall Study|Withdrawal of Consent|2|||
164309241|NCT01032889|593506643|FG002|Overall Study|Withdrawal of Consent|1|||
164309242|NCT01032889|593506641|FG000|Overall Study|Patient Request|0|||
164309243|NCT01032889|593506642|FG001|Overall Study|Patient Request|1|||
164309244|NCT01032889|593506643|FG002|Overall Study|Patient Request|0|||
164309245|NCT01032889|593506641|FG000|Overall Study|Lost to Follow-up|1|||
164309246|NCT01032889|593506642|FG001|Overall Study|Lost to Follow-up|1|||
164309247|NCT01032889|593506643|FG002|Overall Study|Lost to Follow-up|0|||
164309248|NCT01032889|593506641|FG000|Overall Study|Lack of Submental Fat|2|||
164309249|NCT01032889|593506642|FG001|Overall Study|Lack of Submental Fat|8|||
164309250|NCT01032889|593506643|FG002|Overall Study|Lack of Submental Fat|1|||
164309251|NCT01032889|593506641|FG000|Overall Study|Miscellaneous Reasons|2|||
164309252|NCT01032889|593506642|FG001|Overall Study|Miscellaneous Reasons|1|||
164309253|NCT01032889|593506643|FG002|Overall Study|Miscellaneous Reasons|1|||
164309254|NCT01500720|593506644|FG000|Overall Study|Randomized But Not Treated|1|||
164309255|NCT01500720|593506645|FG001|Overall Study|Randomized But Not Treated|1|||
164309256|NCT01500720|593506644|FG000|Overall Study|Other|4|||
164309257|NCT01500720|593506645|FG001|Overall Study|Other|8|||
164309258|NCT02624986|593506646|FG000|Overall Study|Death|0|||
164309259|NCT02624986|593506647|FG001|Overall Study|Death|1|||
164309260|NCT02624986|593506648|FG002|Overall Study|Death|2|||
164309261|NCT02624986|593506649|FG003|Overall Study|Death|2|||
164309262|NCT02624986|593506650|FG004|Overall Study|Death|2|||
164309263|NCT02624986|593506651|FG005|Overall Study|Death|0|||
164309264|NCT02624986|593506652|FG006|Overall Study|Death|0|||
164309265|NCT02624986|593506653|FG007|Overall Study|Death|1|||
164309266|NCT02624986|593506646|FG000|Overall Study|Study Terminated by Sponsor|1|||
164309267|NCT02624986|593506647|FG001|Overall Study|Study Terminated by Sponsor|1|||
164309268|NCT02624986|593506648|FG002|Overall Study|Study Terminated by Sponsor|0|||
164309269|NCT02624986|593506649|FG003|Overall Study|Study Terminated by Sponsor|1|||
164309270|NCT02624986|593506650|FG004|Overall Study|Study Terminated by Sponsor|2|||
164309271|NCT02624986|593506651|FG005|Overall Study|Study Terminated by Sponsor|2|||
164309272|NCT02624986|593506652|FG006|Overall Study|Study Terminated by Sponsor|4|||
164309273|NCT02624986|593506653|FG007|Overall Study|Study Terminated by Sponsor|3|||
164309274|NCT02624986|593506646|FG000|Overall Study|Progressive Disease|0|||
164309275|NCT02624986|593506647|FG001|Overall Study|Progressive Disease|1|||
164309276|NCT02624986|593506648|FG002|Overall Study|Progressive Disease|0|||
164309277|NCT02624986|593506649|FG003|Overall Study|Progressive Disease|0|||
164309278|NCT02624986|593506650|FG004|Overall Study|Progressive Disease|0|||
164309279|NCT02624986|593506651|FG005|Overall Study|Progressive Disease|0|||
164309280|NCT02624986|593506652|FG006|Overall Study|Progressive Disease|0|||
164309281|NCT02624986|593506653|FG007|Overall Study|Progressive Disease|0|||
164656206|NCT01952574|594766458|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
164309282|NCT02624986|593506646|FG000|Overall Study|Protocol Violation|1|||
164309283|NCT02624986|593506647|FG001|Overall Study|Protocol Violation|0|||
164309284|NCT02624986|593506648|FG002|Overall Study|Protocol Violation|0|||
164309285|NCT02624986|593506649|FG003|Overall Study|Protocol Violation|0|||
164309286|NCT02624986|593506650|FG004|Overall Study|Protocol Violation|0|||
164309287|NCT02624986|593506651|FG005|Overall Study|Protocol Violation|0|||
164309288|NCT02624986|593506652|FG006|Overall Study|Protocol Violation|0|||
164309289|NCT02624986|593506653|FG007|Overall Study|Protocol Violation|0|||
164309290|NCT02624986|593506646|FG000|Overall Study|Withdrawal by Subject|0|||
164309291|NCT02624986|593506647|FG001|Overall Study|Withdrawal by Subject|0|||
164309292|NCT02624986|593506648|FG002|Overall Study|Withdrawal by Subject|0|||
164309293|NCT02624986|593506649|FG003|Overall Study|Withdrawal by Subject|0|||
164309294|NCT02624986|593506650|FG004|Overall Study|Withdrawal by Subject|0|||
164309295|NCT02624986|593506651|FG005|Overall Study|Withdrawal by Subject|0|||
164309296|NCT02624986|593506652|FG006|Overall Study|Withdrawal by Subject|0|||
164309297|NCT02624986|593506653|FG007|Overall Study|Withdrawal by Subject|1|||
164309298|NCT03532451|593506655|FG000|Overall Study|Withdrawal by Subject|0|||
164309299|NCT03532451|593506656|FG001|Overall Study|Withdrawal by Subject|1|||
164309300|NCT03532451|593506655|FG000|Overall Study|Did not undergo surgery|1|||
164309301|NCT03532451|593506656|FG001|Overall Study|Did not undergo surgery|1|||
164309302|NCT02116205|593506657|FG000|Overall Study|Withdrawal by Subject|2|||
164309303|NCT02116205|593506658|FG001|Overall Study|Withdrawal by Subject|4|||
164309304|NCT02116205|593506659|FG002|Overall Study|Withdrawal by Subject|1|||
164309305|NCT02116205|593506660|FG003|Overall Study|Withdrawal by Subject|3|||
164309306|NCT02116205|593506657|FG000|Overall Study|Lost to Follow-up|0|||
164309307|NCT02116205|593506658|FG001|Overall Study|Lost to Follow-up|2|||
164309308|NCT02116205|593506659|FG002|Overall Study|Lost to Follow-up|1|||
164309309|NCT02116205|593506660|FG003|Overall Study|Lost to Follow-up|2|||
164309310|NCT02116205|593506657|FG000|Overall Study|Physician Decision|0|||
164309311|NCT02116205|593506658|FG001|Overall Study|Physician Decision|1|||
164309312|NCT02116205|593506659|FG002|Overall Study|Physician Decision|1|||
164309313|NCT02116205|593506660|FG003|Overall Study|Physician Decision|1|||
164309314|NCT02116205|593506657|FG000|Overall Study|Exclusion criteria|0|||
164309315|NCT02116205|593506658|FG001|Overall Study|Exclusion criteria|0|||
164309316|NCT02116205|593506659|FG002|Overall Study|Exclusion criteria|1|||
164309317|NCT02116205|593506660|FG003|Overall Study|Exclusion criteria|0|||
164309318|NCT00525161|593506663|FG000|Overall Study|Adverse Event|1|||
164309319|NCT01076361|593506664|FG000|Overall Study|22 leads were excluded from analysis|21|||
164309320|NCT00630838|593506674|FG000|Overall Study|Death|0|||
164309321|NCT00630838|593506675|FG001|Overall Study|Death|1|||
164309322|NCT00630838|593506674|FG000|Overall Study|Lost to Follow-up|0|||
164309323|NCT00630838|593506675|FG001|Overall Study|Lost to Follow-up|1|||
164309324|NCT00928408|593506676|FG000|Overall Study|Other|2|||
164309325|NCT00928408|593506676|FG000|Overall Study|Withdrawal by Subject|4|||
164309326|NCT00928408|593506676|FG000|Overall Study|Death|5|||
164309327|NCT00928408|593506676|FG000|Overall Study|Lost to Follow-up|12|||
164309328|NCT00256997|593506681|FG000|Overall Study|Protocol Violation|1|||
164309329|NCT00256997|593506682|FG001|Overall Study|Protocol Violation|4|||
164309330|NCT00256997|593506681|FG000|Overall Study|Lack of Efficacy|1|||
164309331|NCT00256997|593506682|FG001|Overall Study|Lack of Efficacy|4|||
164309332|NCT00256997|593506681|FG000|Overall Study|Death|2|||
164309333|NCT00256997|593506682|FG001|Overall Study|Death|0|||
164309334|NCT00256997|593506681|FG000|Overall Study|Adverse Event|4|||
164309335|NCT00256997|593506682|FG001|Overall Study|Adverse Event|0|||
164309336|NCT00256997|593506681|FG000|Overall Study|Lost to Follow-up|3|||
164309337|NCT00256997|593506682|FG001|Overall Study|Lost to Follow-up|5|||
164309338|NCT00256997|593506681|FG000|Overall Study|Withdrawal by Subject|13|||
164309339|NCT00256997|593506682|FG001|Overall Study|Withdrawal by Subject|3|||
164309340|NCT00256997|593506681|FG000|Overall Study|Started but not treated|2|||
164309341|NCT00256997|593506682|FG001|Overall Study|Started but not treated|0|||
164656207|NCT01952574|594766459|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
164656208|NCT01952574|594766460|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
164656209|NCT01952574|594766461|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
164656210|NCT01952574|594766462|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
164656211|NCT01952574|594766463|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
164656212|NCT01952574|594766464|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
164656213|NCT01952574|594766458|FG000|Open-label Treatment Phase|Missing|0|||
164656214|NCT01952574|594766459|FG001|Open-label Treatment Phase|Missing|0|||
164656215|NCT01952574|594766460|FG002|Open-label Treatment Phase|Missing|0|||
164656216|NCT01952574|594766461|FG003|Open-label Treatment Phase|Missing|0|||
164656217|NCT01952574|594766462|FG004|Open-label Treatment Phase|Missing|4|||
164656218|NCT01952574|594766463|FG005|Open-label Treatment Phase|Missing|0|||
164656219|NCT01952574|594766464|FG006|Open-label Treatment Phase|Missing|0|||
164656220|NCT01952574|594766458|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
164656221|NCT01952574|594766459|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
164656222|NCT01952574|594766460|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
164656223|NCT01952574|594766461|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
164656224|NCT01952574|594766462|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
164656225|NCT01952574|594766463|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
164309342|NCT00256997|593506681|FG000|Overall Study|Other|5|||
164309343|NCT00256997|593506682|FG001|Overall Study|Other|8|||
164656226|NCT01952574|594766464|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
164309344|NCT00256997|593506681|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
164309345|NCT00256997|593506682|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
164656227|NCT01952574|594766458|FG000|Open-label Treatment Phase|Death|0|||
164656228|NCT01952574|594766459|FG001|Open-label Treatment Phase|Death|0|||
164309346|NCT00256997|593506681|FG000|Overall Study|Participant Non-compliant|3|||
164309347|NCT00256997|593506682|FG001|Overall Study|Participant Non-compliant|6|||
164309348|NCT00256997|593506681|FG000|Overall Study|Investigator Withdrew Participant|2|||
164309349|NCT00256997|593506682|FG001|Overall Study|Investigator Withdrew Participant|1|||
164309350|NCT04672655|593506687|FG000|Overall Study|Lost to Follow-up|12|||
164309351|NCT04672655|593506688|FG001|Overall Study|Lost to Follow-up|17|||
164309352|NCT04672655|593506687|FG000|Overall Study|Withdrawal by Subject|1|||
164309353|NCT04672655|593506688|FG001|Overall Study|Withdrawal by Subject|0|||
164309354|NCT04672655|593506687|FG000|Overall Study|Withdrawal by Study|1|||
164309355|NCT04672655|593506688|FG001|Overall Study|Withdrawal by Study|0|||
164309356|NCT01326104|593506689|FG000|Overall Study|progressed prior to vaccine|0|||
164309357|NCT01326104|593506690|FG001|Overall Study|progressed prior to vaccine|2|||
164309358|NCT01326104|593506689|FG000|Overall Study|unable to make vaccine|0|||
164309359|NCT01326104|593506690|FG001|Overall Study|unable to make vaccine|2|||
164309360|NCT01287741|593506691|FG000|Overall Study|Withdrawal by Subject|35|||
164309361|NCT01287741|593506692|FG001|Overall Study|Withdrawal by Subject|38|||
164309362|NCT01287741|593506691|FG000|Overall Study|Protocol Violation|2|||
164309363|NCT01287741|593506692|FG001|Overall Study|Protocol Violation|0|||
164309364|NCT01287741|593506691|FG000|Overall Study|Physician Decision|15|||
164309365|NCT01287741|593506692|FG001|Overall Study|Physician Decision|23|||
164309366|NCT01287741|593506691|FG000|Overall Study|Non-compliance|8|||
164309367|NCT01287741|593506692|FG001|Overall Study|Non-compliance|6|||
164309368|NCT01287741|593506691|FG000|Overall Study|Lost to Follow-up|10|||
164309369|NCT01287741|593506692|FG001|Overall Study|Lost to Follow-up|8|||
164309370|NCT01287741|593506691|FG000|Overall Study|Death|32|||
164309371|NCT01287741|593506692|FG001|Overall Study|Death|44|||
164309372|NCT01287741|593506691|FG000|Overall Study|Adverse Event|4|||
164309373|NCT01287741|593506692|FG001|Overall Study|Adverse Event|6|||
164309374|NCT01287741|593506691|FG000|Overall Study|Study terminated by Sponsor|307|||
164309375|NCT01287741|593506692|FG001|Overall Study|Study terminated by Sponsor|315|||
164309376|NCT01287741|593506691|FG000|Overall Study|Progressive disease|190|||
164309377|NCT01287741|593506692|FG001|Overall Study|Progressive disease|166|||
164309378|NCT01287741|593506691|FG000|Overall Study|Reason not specified|23|||
164309379|NCT01287741|593506692|FG001|Overall Study|Reason not specified|9|||
164309380|NCT02930018|593506693|FG000|Overall Study|Lost to Follow-up|1|||
164309381|NCT02930018|593506694|FG001|Overall Study|Lost to Follow-up|1|||
164309382|NCT02930018|593506693|FG000|Overall Study|Withdrawal by Subject|5|||
164309383|NCT02930018|593506694|FG001|Overall Study|Withdrawal by Subject|2|||
164309384|NCT01256294|593508069|FG000|Overall Study|Adverse Event|1|||
164309385|NCT01256294|593508070|FG001|Overall Study|Adverse Event|0|||
164309386|NCT01256294|593508069|FG000|Overall Study|Withdrawal by Subject|1|||
164309387|NCT01256294|593508070|FG001|Overall Study|Withdrawal by Subject|1|||
164309388|NCT01256294|593508069|FG000|Overall Study|Protocol deviation|2|||
164309389|NCT01256294|593508070|FG001|Overall Study|Protocol deviation|1|||
164309390|NCT04681352|593508071|FG000|Overall Study|Lost to Follow-up|2|||
164309391|NCT04681352|593508071|FG000|Overall Study|Withdrawal by Subject|22|||
164309392|NCT01675544|593508074|FG000|Overall Study|Withdrawal by Subject|2|||
164309393|NCT02600819|593508075|FG000|GEN Phase|Adverse Event|2|||
164309394|NCT02600819|593508076|FG001|GEN Phase|Adverse Event|0|||
164309395|NCT02600819|593508075|FG000|GEN Phase|Death|2|||
164309396|NCT02600819|593508076|FG001|GEN Phase|Death|0|||
164309397|NCT02600819|593508075|FG000|GEN Phase|Investigator's Discretion|4|||
164309398|NCT02600819|593508076|FG001|GEN Phase|Investigator's Discretion|0|||
164309399|NCT02600819|593508075|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
164309400|NCT02600819|593508076|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
164309401|NCT02600819|593508075|FG000|GEN Phase|Withdrew Consent|5|||
164309402|NCT02600819|593508076|FG001|GEN Phase|Withdrew Consent|0|||
164309403|NCT02600819|593508075|FG000|GEN Phase|Lost to Follow-up|2|||
164309404|NCT02600819|593508076|FG001|GEN Phase|Lost to Follow-up|0|||
164309405|NCT01621802|593508078|FG000|Overall Study|Protocol Violation|0|||
164309406|NCT01621802|593508079|FG001|Overall Study|Protocol Violation|0|||
164309407|NCT01621802|593508080|FG002|Overall Study|Protocol Violation|0|||
164309408|NCT01621802|593508081|FG003|Overall Study|Protocol Violation|0|||
164550741|NCT01624662|594388770|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
164550742|NCT01624662|594388771|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
164550743|NCT01624662|594388772|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
164550744|NCT01624662|594388773|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
164550745|NCT01624662|594388770|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
164550746|NCT01624662|594388771|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
164550747|NCT01624662|594388772|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
164550748|NCT01624662|594388773|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
164550749|NCT01624662|594388770|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
164550750|NCT01624662|594388771|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
164550751|NCT01624662|594388772|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
164309409|NCT01621802|593508082|FG004|Overall Study|Protocol Violation|0|||
164309410|NCT01621802|593508083|FG005|Overall Study|Protocol Violation|1|||
164309411|NCT01621802|593508078|FG000|Overall Study|Withdrawal by Subject|8|||
164309412|NCT01621802|593508079|FG001|Overall Study|Withdrawal by Subject|4|||
164309413|NCT01621802|593508080|FG002|Overall Study|Withdrawal by Subject|4|||
164309414|NCT01621802|593508081|FG003|Overall Study|Withdrawal by Subject|2|||
164309415|NCT01621802|593508082|FG004|Overall Study|Withdrawal by Subject|2|||
164309416|NCT01621802|593508083|FG005|Overall Study|Withdrawal by Subject|0|||
164309417|NCT01621802|593508078|FG000|Overall Study|Migrated/moved from study area|0|||
164309418|NCT01621802|593508079|FG001|Overall Study|Migrated/moved from study area|0|||
164200583|NCT03312738|593106817|FG001|Overall Study|Physician Decision|3|||
164200584|NCT02466399|593106824|FG000|Overall Study|Adverse Event|1|||
164200585|NCT02466399|593106825|FG001|Overall Study|Adverse Event|0|||
164200586|NCT02466399|593106824|FG000|Overall Study|Early exit due to family emergency|1|||
164200587|NCT02466399|593106825|FG001|Overall Study|Early exit due to family emergency|0|||
164200588|NCT00607893|593106830|FG000|Overall Study|Lost to Follow-up|4|||
164200589|NCT00607893|593106831|FG001|Overall Study|Lost to Follow-up|0|||
164200590|NCT00607893|593106830|FG000|Overall Study|withdrew due to loss of interest|0|||
164200591|NCT00607893|593106831|FG001|Overall Study|withdrew due to loss of interest|1|||
164200592|NCT00607893|593106830|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
164200593|NCT00607893|593106831|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
164200594|NCT00607893|593106830|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
164200595|NCT00607893|593106831|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
164200596|NCT00607893|593106830|FG000|Overall Study|Declined to be treated|1|||
164200597|NCT00607893|593106831|FG001|Overall Study|Declined to be treated|0|||
164200598|NCT00607893|593106830|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
164200599|NCT00607893|593106831|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
164200600|NCT02669849|593106832|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
164200601|NCT02669849|593106833|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
164200602|NCT02669849|593106834|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
164200603|NCT02669849|593106832|FG000|Overall Study|Lost to Follow-up|1|||
164200604|NCT02669849|593106833|FG001|Overall Study|Lost to Follow-up|0|||
164200605|NCT02669849|593106834|FG002|Overall Study|Lost to Follow-up|3|||
164200606|NCT02669849|593106832|FG000|Overall Study|Death|1|||
164200607|NCT02669849|593106833|FG001|Overall Study|Death|1|||
164200608|NCT02669849|593106834|FG002|Overall Study|Death|2|||
164200609|NCT02669849|593106832|FG000|Overall Study|Study terminated by sponsor|16|||
164200610|NCT02669849|593106833|FG001|Overall Study|Study terminated by sponsor|1|||
164200611|NCT02669849|593106834|FG002|Overall Study|Study terminated by sponsor|14|||
164200612|NCT02669849|593106832|FG000|Overall Study|Other|0|||
164550752|NCT01624662|594388773|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
164550753|NCT01624662|594388770|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
164550754|NCT01624662|594388771|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
164550755|NCT01624662|594388772|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
164550756|NCT01624662|594388773|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
164550757|NCT00361270|594388774|FG000|Overall Study|Death|0|||
164550758|NCT00361270|594388775|FG001|Overall Study|Death|0|||
164550759|NCT00361270|594388776|FG002|Overall Study|Death|0|||
164550760|NCT00361270|594388777|FG003|Overall Study|Death|2|||
164550761|NCT00361270|594388774|FG000|Overall Study|Lost to Follow-up|4|||
164550762|NCT00361270|594388775|FG001|Overall Study|Lost to Follow-up|1|||
164550763|NCT00361270|594388776|FG002|Overall Study|Lost to Follow-up|0|||
164550764|NCT00361270|594388777|FG003|Overall Study|Lost to Follow-up|0|||
164550765|NCT00361270|594388774|FG000|Overall Study|Physician Decision|0|||
164550766|NCT00361270|594388775|FG001|Overall Study|Physician Decision|0|||
164550767|NCT00361270|594388776|FG002|Overall Study|Physician Decision|1|||
164550768|NCT00361270|594388777|FG003|Overall Study|Physician Decision|0|||
164550769|NCT00361270|594388774|FG000|Overall Study|Protocol Violation|9|||
164550770|NCT00361270|594388775|FG001|Overall Study|Protocol Violation|4|||
164550771|NCT00361270|594388776|FG002|Overall Study|Protocol Violation|5|||
164550772|NCT00361270|594388777|FG003|Overall Study|Protocol Violation|4|||
164550773|NCT00361270|594388774|FG000|Overall Study|Withdrawal by Subject|6|||
164550774|NCT00361270|594388775|FG001|Overall Study|Withdrawal by Subject|6|||
164550775|NCT00361270|594388776|FG002|Overall Study|Withdrawal by Subject|3|||
164550776|NCT00361270|594388777|FG003|Overall Study|Withdrawal by Subject|7|||
164550777|NCT00361270|594388774|FG000|Overall Study|Afraid of Hypnosis|1|||
164550778|NCT00361270|594388775|FG001|Overall Study|Afraid of Hypnosis|2|||
164550779|NCT00361270|594388776|FG002|Overall Study|Afraid of Hypnosis|0|||
164550780|NCT00361270|594388777|FG003|Overall Study|Afraid of Hypnosis|0|||
164550781|NCT00361270|594388774|FG000|Overall Study|Problems with Transportation|4|||
164550782|NCT00361270|594388775|FG001|Overall Study|Problems with Transportation|0|||
164550783|NCT00361270|594388776|FG002|Overall Study|Problems with Transportation|0|||
164550784|NCT00361270|594388777|FG003|Overall Study|Problems with Transportation|0|||
164656229|NCT01952574|594766460|FG002|Open-label Treatment Phase|Death|0|||
164200613|NCT02669849|593106833|FG001|Overall Study|Other|0|||
164200614|NCT02669849|593106834|FG002|Overall Study|Other|2|||
164200615|NCT00606008|593106835|FG000|Overall Study|Adverse Event|1|||
164200616|NCT00606008|593106835|FG000|Overall Study|Withdrawal by Subject|4|||
164200617|NCT03736967|593106836|FG000|Overall Study|Withdrawal by Subject|26|||
164309419|NCT01621802|593508080|FG002|Overall Study|Migrated/moved from study area|2|||
164420589|NCT01890967|593910946|FG000|Overall Study|Death|1|||
164550785|NCT00361270|594388774|FG000|Overall Study|Adverse Event|0|||
164550786|NCT00361270|594388775|FG001|Overall Study|Adverse Event|1|||
164550787|NCT00361270|594388776|FG002|Overall Study|Adverse Event|1|||
164550788|NCT00361270|594388777|FG003|Overall Study|Adverse Event|0|||
164550789|NCT00278993|594388785|FG000|Overall Study|Adverse Event|24|||
164309420|NCT01621802|593508081|FG003|Overall Study|Migrated/moved from study area|0|||
164309421|NCT01621802|593508082|FG004|Overall Study|Migrated/moved from study area|1|||
164309422|NCT01621802|593508083|FG005|Overall Study|Migrated/moved from study area|0|||
164309423|NCT01621802|593508078|FG000|Overall Study|Others|3|||
164309424|NCT01621802|593508079|FG001|Overall Study|Others|3|||
164309425|NCT01621802|593508080|FG002|Overall Study|Others|3|||
164309426|NCT01621802|593508081|FG003|Overall Study|Others|2|||
164309427|NCT01621802|593508082|FG004|Overall Study|Others|1|||
164309428|NCT01621802|593508083|FG005|Overall Study|Others|0|||
164309429|NCT01621802|593508078|FG000|Overall Study|Lost to Follow-up|36|||
164309430|NCT01621802|593508079|FG001|Overall Study|Lost to Follow-up|16|||
164309431|NCT01621802|593508080|FG002|Overall Study|Lost to Follow-up|24|||
164309432|NCT01621802|593508081|FG003|Overall Study|Lost to Follow-up|7|||
164550790|NCT00278993|594388785|FG000|Overall Study|Withdrawal by Subject|5|||
164550791|NCT00278993|594388785|FG000|Overall Study|Progressive Disease|65|||
164550792|NCT00278993|594388785|FG000|Overall Study|Physician Decision|9|||
164550793|NCT00278993|594388785|FG000|Overall Study|Not Otherwise Specified|4|||
164550794|NCT00470054|594388786|FG000|Overall Study|Ineligible|1|||
164550795|NCT01439555|594388787|FG000|Overall Study|Protocol Violation|1|||
164550796|NCT04194528|594388792|FG000|Overall Study|Adverse Event|1|||
164550797|NCT03921424|594388799|FG000|Overall Study|Lost to Follow-up|0|||
164550798|NCT03921424|594388800|FG001|Overall Study|Lost to Follow-up|1|||
164550799|NCT03921424|594388799|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
164550800|NCT03921424|594388800|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
164550801|NCT01246583|594388803|FG000|Overall Study|Lost to Follow-up|0|||
164550802|NCT01246583|594388804|FG001|Overall Study|Lost to Follow-up|0|||
164550803|NCT01246583|594388805|FG002|Overall Study|Lost to Follow-up|0|||
164550804|NCT01246583|594388806|FG003|Overall Study|Lost to Follow-up|1|||
164550805|NCT01246583|594388803|FG000|Overall Study|Protocol Violation|0|||
164550806|NCT01246583|594388804|FG001|Overall Study|Protocol Violation|0|||
164550807|NCT01246583|594388805|FG002|Overall Study|Protocol Violation|1|||
164550808|NCT01246583|594388806|FG003|Overall Study|Protocol Violation|0|||
164550809|NCT01246583|594388803|FG000|Overall Study|Withdrawal by Subject|1|||
164550810|NCT01246583|594388804|FG001|Overall Study|Withdrawal by Subject|0|||
164550811|NCT01246583|594388805|FG002|Overall Study|Withdrawal by Subject|0|||
164550812|NCT01246583|594388806|FG003|Overall Study|Withdrawal by Subject|0|||
164550813|NCT02595450|594388807|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
164550814|NCT02595450|594388807|FG000|Overall Study|Enrolled, but not treated|8|||
164550815|NCT05264740|594388809|FG000|Baseline|Withdrawal by Subject|0|||
164550816|NCT05264740|594388810|FG001|Baseline|Withdrawal by Subject|1|||
164550817|NCT05264740|594388809|FG000|Follow Up 1|Lost to Follow-up|1|||
164550818|NCT05264740|594388810|FG001|Follow Up 1|Lost to Follow-up|1|||
164550819|NCT05264740|594388809|FG000|Follow Up 1|Withdrawal by Subject|0|||
164550820|NCT05264740|594388810|FG001|Follow Up 1|Withdrawal by Subject|1|||
164550821|NCT05264740|594388809|FG000|Follow Up 2|Lost to Follow-up|1|||
164550822|NCT05264740|594388810|FG001|Follow Up 2|Lost to Follow-up|4|||
164550823|NCT05264740|594388809|FG000|Follow Up 3|Lost to Follow-up|7|||
164550824|NCT05264740|594388810|FG001|Follow Up 3|Lost to Follow-up|4|||
164550825|NCT00102960|594388813|FG000|Overall Study|Death|23|||
164550826|NCT00102960|594388814|FG001|Overall Study|Death|11|||
164550827|NCT00102960|594388815|FG002|Overall Study|Death|11|||
164550828|NCT00102960|594388813|FG000|Overall Study|Lost to Follow-up|6|||
164550829|NCT00102960|594388814|FG001|Overall Study|Lost to Follow-up|12|||
164550830|NCT00102960|594388815|FG002|Overall Study|Lost to Follow-up|16|||
164550831|NCT00102960|594388813|FG000|Overall Study|Withdrawal by Subject|1|||
164550832|NCT00102960|594388814|FG001|Overall Study|Withdrawal by Subject|0|||
164550833|NCT00102960|594388815|FG002|Overall Study|Withdrawal by Subject|1|||
164550834|NCT01423851|594388816|FG000|Whole Study|Disease progression|2|||
164550835|NCT01423851|594388817|FG001|Whole Study|Disease progression|1|||
164550836|NCT01423851|594388818|FG002|Whole Study|Disease progression|1|||
164309433|NCT01621802|593508082|FG004|Overall Study|Lost to Follow-up|31|||
164309434|NCT01621802|593508083|FG005|Overall Study|Lost to Follow-up|11|||
164309435|NCT01149148|593508084|FG000|Overall Study|Lost to Follow-up|1|||
164550837|NCT01423851|594388819|FG003|Whole Study|Disease progression|4|||
164550838|NCT01423851|594388820|FG004|Whole Study|Disease progression|1|||
164656230|NCT01952574|594766461|FG003|Open-label Treatment Phase|Death|0|||
164309436|NCT01149148|593508085|FG001|Overall Study|Lost to Follow-up|2|||
164309437|NCT01149148|593508084|FG000|Overall Study|Death|1|||
164309438|NCT01149148|593508085|FG001|Overall Study|Death|0|||
164309439|NCT04605991|593508087|FG000|Overall Study|Adverse Event|5|||
164550839|NCT01423851|594388821|FG005|Whole Study|Disease progression|3|||
164550840|NCT01423851|594388822|FG006|Whole Study|Disease progression|1|||
164550841|NCT01423851|594388823|FG007|Whole Study|Disease progression|4|||
164550842|NCT01423851|594388824|FG008|Whole Study|Disease progression|0|||
164550843|NCT01423851|594388825|FG009|Whole Study|Disease progression|2|||
164550844|NCT01423851|594388826|FG010|Whole Study|Disease progression|10|||
164550845|NCT01423851|594388816|FG000|Whole Study|Physician Decision|0|||
164550846|NCT01423851|594388817|FG001|Whole Study|Physician Decision|1|||
164550847|NCT01423851|594388818|FG002|Whole Study|Physician Decision|2|||
164550848|NCT01423851|594388819|FG003|Whole Study|Physician Decision|0|||
164420590|NCT01890967|593910947|FG001|Overall Study|Death|0|||
164143314|NCT05246670|592886588|FG002|Overall Study|Protocol Violation|0|||
164143315|NCT05246670|592886589|FG003|Overall Study|Protocol Violation|0|||
164143316|NCT00356525|592886595|FG000|Overall Study|Progressive Disease|8|||
164143317|NCT00356525|592886596|FG001|Overall Study|Progressive Disease|5|||
164143318|NCT00356525|592886597|FG002|Overall Study|Progressive Disease|4|||
164143319|NCT00356525|592886598|FG003|Overall Study|Progressive Disease|2|||
164143320|NCT00356525|592886595|FG000|Overall Study|Adverse Event|1|||
164143321|NCT00356525|592886596|FG001|Overall Study|Adverse Event|3|||
164143322|NCT00356525|592886597|FG002|Overall Study|Adverse Event|1|||
164143323|NCT00356525|592886598|FG003|Overall Study|Adverse Event|1|||
164143324|NCT00356525|592886595|FG000|Overall Study|Lost to Follow-up|1|||
164143325|NCT00356525|592886596|FG001|Overall Study|Lost to Follow-up|0|||
164143326|NCT00356525|592886597|FG002|Overall Study|Lost to Follow-up|0|||
164143327|NCT00356525|592886598|FG003|Overall Study|Lost to Follow-up|0|||
164143328|NCT00356525|592886595|FG000|Overall Study|Physician Decision|2|||
164143329|NCT00356525|592886596|FG001|Overall Study|Physician Decision|2|||
164143330|NCT00356525|592886597|FG002|Overall Study|Physician Decision|2|||
164143331|NCT00356525|592886598|FG003|Overall Study|Physician Decision|1|||
164143332|NCT00356525|592886595|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
164143333|NCT00356525|592886596|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
164143334|NCT00356525|592886597|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
164143335|NCT00356525|592886598|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
164143336|NCT00356525|592886595|FG000|Overall Study|Withdrawal by Subject|1|||
164143337|NCT00356525|592886596|FG001|Overall Study|Withdrawal by Subject|1|||
164143338|NCT00356525|592886597|FG002|Overall Study|Withdrawal by Subject|0|||
164143339|NCT00356525|592886598|FG003|Overall Study|Withdrawal by Subject|3|||
164143340|NCT00356525|592886595|FG000|Overall Study|Death|0|||
164143341|NCT00356525|592886596|FG001|Overall Study|Death|0|||
164143342|NCT00356525|592886597|FG002|Overall Study|Death|0|||
164143343|NCT00356525|592886598|FG003|Overall Study|Death|1|||
164143344|NCT00356525|592886595|FG000|Overall Study|Sponsor Decision|0|||
164143345|NCT00356525|592886596|FG001|Overall Study|Sponsor Decision|0|||
164143346|NCT00356525|592886597|FG002|Overall Study|Sponsor Decision|0|||
164143347|NCT00356525|592886598|FG003|Overall Study|Sponsor Decision|1|||
164143348|NCT00652340|592886599|FG000|Overall Study|Had not progressed.|4|||
164143349|NCT00652340|592886600|FG001|Overall Study|Had not progressed.|3|||
164143350|NCT04152291|592886601|FG000|Overall Study|Covid-19 restrictions|27|||
164143351|NCT04152291|592886601|FG000|Overall Study|Withdrawal by Subject|3|||
164143352|NCT03597295|592886602|FG000|Overall Study|Death|70|||
164309440|NCT04605991|593508087|FG000|Overall Study|Lack of Efficacy|1|||
164309441|NCT04605991|593508087|FG000|Overall Study|Lost to Follow-up|8|||
164309442|NCT04605991|593508087|FG000|Overall Study|Physician Decision|4|||
164309443|NCT04605991|593508087|FG000|Overall Study|Withdrawal by Subject|14|||
164309444|NCT04605991|593508087|FG000|Overall Study|Non-compliance with study|1|||
164309445|NCT01727024|593508089|FG000|Period 1|Lost to Follow-up|1|||
164309446|NCT01727024|593508090|FG001|Period 1|Lost to Follow-up|1|||
164309447|NCT01727024|593508089|FG000|Period 1|Withdrawal by Subject|2|||
164309448|NCT01727024|593508090|FG001|Period 1|Withdrawal by Subject|3|||
164309449|NCT02920242|593508091|FG000|Overall Study|Withdrawal by Subject|1|||
164309450|NCT02920242|593508092|FG001|Overall Study|Withdrawal by Subject|0|||
164309451|NCT02920242|593508093|FG002|Overall Study|Withdrawal by Subject|1|||
164309452|NCT02920242|593508091|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
164309453|NCT02920242|593508092|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
164309454|NCT02920242|593508093|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
164309455|NCT04995419|593508099|FG000|Overall Study|Withdrawal by Subject|3|||
164309456|NCT04995419|593508099|FG000|Overall Study|Progressive Disease|19|||
164309457|NCT04995419|593508099|FG000|Overall Study|Adverse Event|2|||
164309458|NCT04995419|593508099|FG000|Overall Study|Ongoing|16|||
164309459|NCT02948088|593508100|FG000|Overall Study|Lost to Follow-up|8|||
164309460|NCT02948088|593508100|FG000|Overall Study|Death|1|||
164309461|NCT02948088|593508100|FG000|Overall Study|Withdrawal by Subject|4|||
164309462|NCT02948088|593508100|FG000|Overall Study|Other|2|||
164309463|NCT00634101|593508101|FG000|Overall Study|Study Terminated|3|||
164309464|NCT00634101|593508102|FG001|Overall Study|Study Terminated|3|||
164309465|NCT00634101|593508101|FG000|Overall Study|Lost to Follow-up|2|||
164309466|NCT00634101|593508102|FG001|Overall Study|Lost to Follow-up|0|||
164309467|NCT00139477|593508103|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
164309468|NCT00139477|593508104|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
164309469|NCT00139477|593508103|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
164309470|NCT00139477|593508104|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
164309471|NCT00139477|593508103|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
164309472|NCT00139477|593508104|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
164309473|NCT00139477|593508103|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
164309474|NCT00139477|593508104|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
164309475|NCT00139477|593508103|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
164309476|NCT00139477|593508104|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
164309477|NCT00139477|593508103|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
164309478|NCT00139477|593508104|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
164309479|NCT00139477|593508103|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
164309480|NCT00139477|593508104|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
164309481|NCT00845897|593508105|FG000|Overall Study|Lost to Follow-up|1|||
164309482|NCT00845897|593508106|FG001|Overall Study|Lost to Follow-up|1|||
164309483|NCT00845897|593508107|FG002|Overall Study|Lost to Follow-up|0|||
164309484|NCT00845897|593508105|FG000|Overall Study|Withdrawal by Subject|0|||
164309485|NCT00845897|593508106|FG001|Overall Study|Withdrawal by Subject|3|||
164309486|NCT00845897|593508107|FG002|Overall Study|Withdrawal by Subject|2|||
164309487|NCT00845897|593508105|FG000|Overall Study|Ulcer did not heal|1|||
164309488|NCT00845897|593508106|FG001|Overall Study|Ulcer did not heal|0|||
164309489|NCT00845897|593508107|FG002|Overall Study|Ulcer did not heal|1|||
164309490|NCT00845897|593508105|FG000|Overall Study|Too ill to participate|0|||
164309491|NCT00845897|593508106|FG001|Overall Study|Too ill to participate|1|||
164309492|NCT00845897|593508107|FG002|Overall Study|Too ill to participate|0|||
164309493|NCT02722499|593508109|FG000|Overall Study|Lost to Follow-up|2|||
164309494|NCT02722499|593508110|FG001|Overall Study|Lost to Follow-up|0|||
164309495|NCT02722499|593508111|FG002|Overall Study|Lost to Follow-up|1|||
164309496|NCT04999852|593508112|FG000|Overall Study|Withdrawal by Subject|11|||
164309497|NCT04999852|593508113|FG001|Overall Study|Withdrawal by Subject|1|||
164309498|NCT04999852|593508112|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
164656231|NCT01952574|594766462|FG004|Open-label Treatment Phase|Death|1|||
164656232|NCT01952574|594766463|FG005|Open-label Treatment Phase|Death|0|||
164309499|NCT04999852|593508113|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
164309500|NCT05626322|593508114|FG000|Overall Study|Death|2|||
164309501|NCT05626322|593508115|FG001|Overall Study|Death|0|||
164309502|NCT05626322|593508116|FG002|Overall Study|Death|0|||
164309503|NCT05626322|593508114|FG000|Overall Study|Physician Decision|1|||
164656233|NCT01952574|594766464|FG006|Open-label Treatment Phase|Death|0|||
164309504|NCT05626322|593508115|FG001|Overall Study|Physician Decision|0|||
164309505|NCT05626322|593508116|FG002|Overall Study|Physician Decision|0|||
164309506|NCT05626322|593508114|FG000|Overall Study|Progressive Disease|0|||
164309507|NCT05626322|593508115|FG001|Overall Study|Progressive Disease|1|||
164309508|NCT05626322|593508116|FG002|Overall Study|Progressive Disease|1|||
164656234|NCT01952574|594766458|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
164420591|NCT01890967|593910948|FG002|Overall Study|Death|0|||
164309509|NCT05626322|593508114|FG000|Overall Study|Study terminated by sponsor|0|||
164309510|NCT05626322|593508115|FG001|Overall Study|Study terminated by sponsor|1|||
164309511|NCT05626322|593508116|FG002|Overall Study|Study terminated by sponsor|0|||
164309512|NCT03776812|593508117|FG000|Overall Study|Death|53|||
164309513|NCT03776812|593508118|FG001|Overall Study|Death|49|||
164309514|NCT03776812|593508119|FG002|Overall Study|Death|56|||
164309515|NCT03776812|593508117|FG000|Overall Study|Withdrawal by Subject|1|||
164309516|NCT03776812|593508118|FG001|Overall Study|Withdrawal by Subject|7|||
164309517|NCT03776812|593508119|FG002|Overall Study|Withdrawal by Subject|2|||
164309518|NCT03776812|593508117|FG000|Overall Study|Lost to Follow-up|1|||
164309519|NCT03776812|593508118|FG001|Overall Study|Lost to Follow-up|1|||
164309520|NCT03776812|593508119|FG002|Overall Study|Lost to Follow-up|0|||
164309521|NCT03776812|593508117|FG000|Overall Study|Did not enter long-term follow-up|3|||
164309522|NCT03776812|593508118|FG001|Overall Study|Did not enter long-term follow-up|3|||
164309523|NCT03776812|593508119|FG002|Overall Study|Did not enter long-term follow-up|2|||
164309524|NCT04758637|593508120|FG000|Overall Study|Lost to Follow-up|0|||
164309525|NCT04758637|593508121|FG001|Overall Study|Lost to Follow-up|1|||
164309526|NCT04758637|593508122|FG002|Overall Study|Lost to Follow-up|0|||
164309527|NCT04758637|593508123|FG003|Overall Study|Lost to Follow-up|0|||
164309528|NCT03610269|593508124|FG000|Overall Study|Physician Decision|10|||
164309529|NCT03610269|593508124|FG000|Overall Study|Protocol Violation|1|||
164309530|NCT03610269|593508124|FG000|Overall Study|Unable to draw blood|1|||
164309531|NCT03610269|593508124|FG000|Overall Study|Screen fail|4|||
164309532|NCT01354314|593508125|FG000|Overall Study|Lost to Follow-up|1|||
164309533|NCT01354314|593508126|FG001|Overall Study|Lost to Follow-up|0|||
164309534|NCT01354314|593508127|FG002|Overall Study|Lost to Follow-up|1|||
164309535|NCT01354314|593508128|FG003|Overall Study|Lost to Follow-up|1|||
164309536|NCT01354314|593508125|FG000|Overall Study|Withdrawal by Subject|0|||
164309537|NCT01354314|593508126|FG001|Overall Study|Withdrawal by Subject|0|||
164309538|NCT01354314|593508127|FG002|Overall Study|Withdrawal by Subject|1|||
164309539|NCT01354314|593508128|FG003|Overall Study|Withdrawal by Subject|0|||
164309540|NCT01354314|593508125|FG000|Overall Study|Adverse Event|0|||
164309541|NCT01354314|593508126|FG001|Overall Study|Adverse Event|0|||
164309542|NCT01354314|593508127|FG002|Overall Study|Adverse Event|0|||
164309543|NCT01354314|593508128|FG003|Overall Study|Adverse Event|1|||
164309544|NCT01354314|593508125|FG000|Overall Study|Protocol Violation|1|||
164309545|NCT01354314|593508126|FG001|Overall Study|Protocol Violation|1|||
164309546|NCT01354314|593508127|FG002|Overall Study|Protocol Violation|0|||
164309547|NCT01354314|593508128|FG003|Overall Study|Protocol Violation|0|||
164309548|NCT01354314|593508125|FG000|Overall Study|Less than 90% Adherence|4|||
164309549|NCT01354314|593508126|FG001|Overall Study|Less than 90% Adherence|2|||
164309550|NCT01354314|593508127|FG002|Overall Study|Less than 90% Adherence|6|||
164309551|NCT01354314|593508128|FG003|Overall Study|Less than 90% Adherence|4|||
164309552|NCT00369265|593508129|FG000|Overall Study|Study terminated|4|||
164309553|NCT00369265|593508130|FG001|Overall Study|Study terminated|7|||
164309554|NCT05019521|593508131|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
164309555|NCT05019521|593508132|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
164309556|NCT05019521|593508133|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
164309557|NCT05019521|593508134|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
164309558|NCT05019521|593508135|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
164309559|NCT05019521|593508136|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
164309560|NCT05019521|593508137|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
164309561|NCT05019521|593508131|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
164309562|NCT05019521|593508132|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
164309563|NCT05019521|593508133|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
164309564|NCT05019521|593508134|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
164309565|NCT05019521|593508135|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
164309566|NCT05019521|593508136|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
164309567|NCT05019521|593508137|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
164309568|NCT05019521|593508131|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
164309569|NCT05019521|593508132|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
164309570|NCT05019521|593508133|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
164309571|NCT05019521|593508134|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
164550849|NCT01423851|594388820|FG004|Whole Study|Physician Decision|2|||
164550850|NCT01423851|594388821|FG005|Whole Study|Physician Decision|0|||
164309572|NCT05019521|593508135|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
164309573|NCT05019521|593508136|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
164309574|NCT05019521|593508137|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
164309575|NCT05019521|593508131|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
164309576|NCT05019521|593508132|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
164309577|NCT05019521|593508133|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
164550851|NCT01423851|594388822|FG006|Whole Study|Physician Decision|2|||
164550852|NCT01423851|594388823|FG007|Whole Study|Physician Decision|1|||
164656235|NCT01952574|594766459|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
164656236|NCT01952574|594766460|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
164656237|NCT01952574|594766461|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
164656238|NCT01952574|594766462|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
164656239|NCT01952574|594766463|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
164656240|NCT01952574|594766464|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
164656241|NCT01952574|594766458|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
164656242|NCT01952574|594766459|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
164200618|NCT03736967|593106837|FG001|Overall Study|Withdrawal by Subject|25|||
164200619|NCT03736967|593106838|FG002|Overall Study|Withdrawal by Subject|23|||
164200620|NCT03736967|593106839|FG003|Overall Study|Withdrawal by Subject|26|||
164200621|NCT03736967|593106836|FG000|Overall Study|Lost to Follow-up|3|||
164200622|NCT03736967|593106837|FG001|Overall Study|Lost to Follow-up|2|||
164200623|NCT03736967|593106838|FG002|Overall Study|Lost to Follow-up|1|||
164200624|NCT03736967|593106839|FG003|Overall Study|Lost to Follow-up|1|||
164200625|NCT03736967|593106836|FG000|Overall Study|Physician Decision|1|||
164200626|NCT03736967|593106837|FG001|Overall Study|Physician Decision|0|||
164200627|NCT03736967|593106838|FG002|Overall Study|Physician Decision|0|||
164200628|NCT03736967|593106839|FG003|Overall Study|Physician Decision|1|||
164200629|NCT03736967|593106836|FG000|Overall Study|Adverse Event|0|||
164200630|NCT03736967|593106837|FG001|Overall Study|Adverse Event|1|||
164200631|NCT03736967|593106838|FG002|Overall Study|Adverse Event|0|||
164200632|NCT03736967|593106839|FG003|Overall Study|Adverse Event|1|||
164200633|NCT03736967|593106836|FG000|Overall Study|Death|0|||
164200634|NCT03736967|593106837|FG001|Overall Study|Death|0|||
164200635|NCT03736967|593106838|FG002|Overall Study|Death|0|||
164200636|NCT03736967|593106839|FG003|Overall Study|Death|1|||
164200637|NCT03736967|593106836|FG000|Overall Study|Randomized but never treated|1|||
164200638|NCT03736967|593106837|FG001|Overall Study|Randomized but never treated|0|||
164200639|NCT03736967|593106838|FG002|Overall Study|Randomized but never treated|0|||
164200640|NCT03736967|593106839|FG003|Overall Study|Randomized but never treated|0|||
164200641|NCT02369653|593106840|FG000|Overall Study|Lost to Follow-up|0|||
164200642|NCT02369653|593106841|FG001|Overall Study|Lost to Follow-up|1|||
164200643|NCT02369653|593106840|FG000|Overall Study|Administrative reason by sponsor|0|||
164200644|NCT02369653|593106841|FG001|Overall Study|Administrative reason by sponsor|1|||
164200645|NCT02369653|593106840|FG000|Overall Study|Death|1|||
164200646|NCT02369653|593106841|FG001|Overall Study|Death|2|||
164200647|NCT02369653|593106840|FG000|Overall Study|Participant withdrew consent|13|||
164200648|NCT02369653|593106841|FG001|Overall Study|Participant withdrew consent|3|||
164200649|NCT01587885|593106842|FG000|Treatment Period 1|Failure to Return|0|||
164200650|NCT01587885|593106843|FG001|Treatment Period 1|Failure to Return|1|||
164200651|NCT01587885|593106842|FG000|Treatment Period 1|Protocol Violation|0|||
164200652|NCT01587885|593106843|FG001|Treatment Period 1|Protocol Violation|2|||
164200653|NCT01458587|593106844|FG000|Overall Study|Withdrawal by Subject|1|||
164200654|NCT01458587|593106845|FG001|Overall Study|Withdrawal by Subject|0|||
164200655|NCT01603602|593106846|FG000|Overall Study|Adverse Event|1|||
164200656|NCT01603602|593106847|FG001|Overall Study|Adverse Event|0|||
164200657|NCT01603602|593106848|FG002|Overall Study|Adverse Event|0|||
164200658|NCT01603602|593106846|FG000|Overall Study|Personal Reasons|1|||
164200659|NCT01603602|593106847|FG001|Overall Study|Personal Reasons|0|||
164200660|NCT01603602|593106848|FG002|Overall Study|Personal Reasons|1|||
164200661|NCT04748718|593106852|FG000|Overall Study|Lost to Follow-up|50|||
164200662|NCT00316004|593106853|FG000|Overall Study|Subject was not given study fluid.|14|||
164200663|NCT00316004|593106854|FG001|Overall Study|Subject was not given study fluid.|14|||
164200664|NCT00316004|593106855|FG002|Overall Study|Subject was not given study fluid.|21|||
164200665|NCT01118299|593106856|FG000|Overall Study|Death|7|||
164200666|NCT01118299|593106857|FG001|Overall Study|Death|5|||
164200667|NCT01118299|593106856|FG000|Overall Study|Withdrawal by Subject|8|||
164200668|NCT01118299|593106857|FG001|Overall Study|Withdrawal by Subject|8|||
164200669|NCT01118299|593106856|FG000|Overall Study|Lost to Follow-up|2|||
164200670|NCT01118299|593106857|FG001|Overall Study|Lost to Follow-up|1|||
164200671|NCT01118299|593106856|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
164200672|NCT01118299|593106857|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
164200673|NCT01935089|593106859|FG000|Overall Study|Adverse Event|2|||
164200674|NCT01935089|593106859|FG000|Overall Study|Withdrawal by Subject|1|||
164200675|NCT02932943|593106860|FG000|Overall Study|Lost to Follow-up|0|||
164200676|NCT02932943|593106861|FG001|Overall Study|Lost to Follow-up|2|||
164200677|NCT02932943|593106860|FG000|Overall Study|Adverse Event|2|||
164200678|NCT02932943|593106861|FG001|Overall Study|Adverse Event|2|||
164200679|NCT02932943|593106860|FG000|Overall Study|Withdrawal by Subject|3|||
164200680|NCT02932943|593106861|FG001|Overall Study|Withdrawal by Subject|3|||
164200681|NCT02665117|593106864|FG000|Overall Study|Physician Decision|1|||
164200682|NCT02665117|593106865|FG001|Overall Study|Physician Decision|0|||
164656243|NCT01952574|594766460|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
164200683|NCT00977197|593106869|FG000|Overall Study|Withdrawal by Subject|3|||
164200684|NCT00977197|593106870|FG001|Overall Study|Withdrawal by Subject|4|||
164200685|NCT00977197|593106869|FG000|Overall Study|Adverse Event|3|||
164550853|NCT01423851|594388824|FG008|Whole Study|Physician Decision|3|||
164550854|NCT01423851|594388825|FG009|Whole Study|Physician Decision|4|||
164550855|NCT01423851|594388826|FG010|Whole Study|Physician Decision|12|||
164550856|NCT01423851|594388816|FG000|Whole Study|Withdrawal by Subject|1|||
164550857|NCT01423851|594388817|FG001|Whole Study|Withdrawal by Subject|1|||
164550858|NCT01423851|594388818|FG002|Whole Study|Withdrawal by Subject|0|||
164550859|NCT01423851|594388819|FG003|Whole Study|Withdrawal by Subject|0|||
164550860|NCT01423851|594388820|FG004|Whole Study|Withdrawal by Subject|0|||
164550861|NCT01423851|594388821|FG005|Whole Study|Withdrawal by Subject|0|||
164550862|NCT01423851|594388822|FG006|Whole Study|Withdrawal by Subject|0|||
164550863|NCT01423851|594388823|FG007|Whole Study|Withdrawal by Subject|0|||
164550864|NCT01423851|594388824|FG008|Whole Study|Withdrawal by Subject|2|||
164550865|NCT01423851|594388825|FG009|Whole Study|Withdrawal by Subject|0|||
164550866|NCT01423851|594388826|FG010|Whole Study|Withdrawal by Subject|4|||
164550867|NCT01423851|594388816|FG000|Whole Study|Adverse Event|0|||
164550868|NCT01423851|594388817|FG001|Whole Study|Adverse Event|0|||
164550869|NCT01423851|594388818|FG002|Whole Study|Adverse Event|0|||
164550870|NCT01423851|594388819|FG003|Whole Study|Adverse Event|2|||
164550871|NCT01423851|594388820|FG004|Whole Study|Adverse Event|0|||
164550872|NCT01423851|594388821|FG005|Whole Study|Adverse Event|0|||
164550873|NCT01423851|594388822|FG006|Whole Study|Adverse Event|0|||
164550874|NCT01423851|594388823|FG007|Whole Study|Adverse Event|3|||
164550875|NCT01423851|594388824|FG008|Whole Study|Adverse Event|3|||
164550876|NCT01423851|594388825|FG009|Whole Study|Adverse Event|2|||
164550877|NCT01423851|594388826|FG010|Whole Study|Adverse Event|3|||
164550878|NCT01395394|594389993|FG000|Baseline Study Visit|Protocol Violation|1|||
164200686|NCT00977197|593106870|FG001|Overall Study|Adverse Event|1|||
164200687|NCT00977197|593106869|FG000|Overall Study|Lack of Efficacy|1|||
164200688|NCT00977197|593106870|FG001|Overall Study|Lack of Efficacy|0|||
164200689|NCT00977197|593106869|FG000|Overall Study|Lost to Follow-up|1|||
164200690|NCT00977197|593106870|FG001|Overall Study|Lost to Follow-up|3|||
164200691|NCT00977197|593106869|FG000|Overall Study|Nonadherence|1|||
164200692|NCT00977197|593106870|FG001|Overall Study|Nonadherence|1|||
164200693|NCT05379920|593106871|FG000|Overall Study|Lost to Follow-up|0|||
164200694|NCT05379920|593106872|FG001|Overall Study|Lost to Follow-up|5|||
164200695|NCT05379920|593106873|FG002|Overall Study|Lost to Follow-up|0|||
164200696|NCT05379920|593106874|FG003|Overall Study|Lost to Follow-up|0|||
164200697|NCT03530293|593106877|FG000|Pre-randomization|Adverse Event|12|||
164200698|NCT03530293|593106878|FG001|Pre-randomization|Adverse Event|0|||
164200699|NCT03530293|593106879|FG002|Pre-randomization|Adverse Event|0|||
164200700|NCT03530293|593106877|FG000|Pre-randomization|Protocol Violation|2|||
164200701|NCT03530293|593106878|FG001|Pre-randomization|Protocol Violation|0|||
164200702|NCT03530293|593106879|FG002|Pre-randomization|Protocol Violation|0|||
164200703|NCT03530293|593106877|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
164200704|NCT03530293|593106878|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
164200705|NCT03530293|593106879|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
164200706|NCT03530293|593106877|FG000|Pre-randomization|Withdrawal by Subject|5|||
164200707|NCT03530293|593106878|FG001|Pre-randomization|Withdrawal by Subject|0|||
164200708|NCT03530293|593106879|FG002|Pre-randomization|Withdrawal by Subject|0|||
164200709|NCT03530293|593106877|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
164200710|NCT03530293|593106878|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
164200711|NCT03530293|593106879|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
164200712|NCT03530293|593106877|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
164200713|NCT03530293|593106878|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
164200714|NCT03530293|593106879|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
164200715|NCT03530293|593106877|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
164200716|NCT03530293|593106878|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
164200717|NCT03530293|593106879|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
164200718|NCT03530293|593106877|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
164200719|NCT03530293|593106878|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
164200720|NCT03530293|593106879|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
164200721|NCT03530293|593106877|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
164200722|NCT03530293|593106878|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
164200723|NCT03530293|593106879|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
164200724|NCT02530385|593106881|FG000|Overall Study|Withdrawal by Subject|0|||
164550879|NCT01395394|594389994|FG001|Baseline Study Visit|Protocol Violation|0|||
164550880|NCT01395394|594389995|FG002|Baseline Study Visit|Protocol Violation|0|||
164550881|NCT02356562|594389996|FG000|Overall Study|Withdrawal by Subject|0|||
164200725|NCT02530385|593106882|FG001|Overall Study|Withdrawal by Subject|1|||
164550882|NCT02356562|594389997|FG001|Overall Study|Withdrawal by Subject|1|||
164550883|NCT02356562|594389996|FG000|Overall Study|Re-entered treatment in a previous study|1|||
164550884|NCT02356562|594389997|FG001|Overall Study|Re-entered treatment in a previous study|0|||
164550885|NCT02356562|594389996|FG000|Overall Study|site closure|1|||
164550886|NCT02356562|594389997|FG001|Overall Study|site closure|0|||
164550887|NCT00150592|594389998|FG000|Overall Study|Adverse Event|4|||
164656244|NCT01952574|594766461|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
164656245|NCT01952574|594766462|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
164656246|NCT01952574|594766463|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
164200726|NCT00116142|593106883|FG000|Overall Study|Adverse Event|8|||
164200727|NCT00116142|593106884|FG001|Overall Study|Adverse Event|7|||
164200728|NCT00116142|593106883|FG000|Overall Study|Protocol Violation|2|||
164200729|NCT00116142|593106884|FG001|Overall Study|Protocol Violation|1|||
164200730|NCT00116142|593106883|FG000|Overall Study|Withdrawal by Subject|5|||
164200731|NCT00116142|593106884|FG001|Overall Study|Withdrawal by Subject|5|||
164200732|NCT00116142|593106883|FG000|Overall Study|Physician Decision|3|||
164200733|NCT00116142|593106884|FG001|Overall Study|Physician Decision|1|||
164200734|NCT00116142|593106883|FG000|Overall Study|Delayed Radiation Therapy|1|||
164200735|NCT00116142|593106884|FG001|Overall Study|Delayed Radiation Therapy|0|||
164200736|NCT00116142|593106883|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
164200737|NCT00116142|593106884|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
164200738|NCT00116142|593106883|FG000|Overall Study|Patient stopped due to depression|0|||
164200739|NCT00116142|593106884|FG001|Overall Study|Patient stopped due to depression|1|||
164200740|NCT00116142|593106883|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
164200741|NCT00116142|593106884|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
164200742|NCT00116142|593106883|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
164200743|NCT00116142|593106884|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
164200744|NCT00116142|593106883|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
164200745|NCT00116142|593106884|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
164200746|NCT03482024|593106885|FG000|Overall Study|Physician Decision|1|||
164200747|NCT03482024|593106886|FG001|Overall Study|Physician Decision|0|||
164200748|NCT03482024|593106887|FG002|Overall Study|Physician Decision|0|||
164200749|NCT03482024|593106888|FG003|Overall Study|Physician Decision|0|||
164200750|NCT03482024|593106889|FG004|Overall Study|Physician Decision|0|||
164200751|NCT02295644|593106890|FG000|Overall Study|Did not meet inclusion criterion|0|||
164200752|NCT02295644|593106891|FG001|Overall Study|Did not meet inclusion criterion|0|||
164200753|NCT02295644|593106892|FG002|Overall Study|Did not meet inclusion criterion|1|||
164200754|NCT02295644|593106893|FG003|Overall Study|Did not meet inclusion criterion|2|||
164200755|NCT02147626|593106894|FG000|Overall Study|Lost to Follow-up|4|||
164200756|NCT02147626|593106895|FG001|Overall Study|Lost to Follow-up|4|||
164200757|NCT02147626|593106894|FG000|Overall Study|Pregnancy|1|||
164200758|NCT02147626|593106895|FG001|Overall Study|Pregnancy|2|||
164200759|NCT02147626|593106894|FG000|Overall Study|Withdrawal by Subject|0|||
164200760|NCT02147626|593106895|FG001|Overall Study|Withdrawal by Subject|1|||
164200761|NCT03101020|593106896|FG000|Overall Study|Lack of time to participate|1|||
164200762|NCT03101020|593106897|FG001|Overall Study|Lack of time to participate|0|||
164200763|NCT03101020|593106896|FG000|Overall Study|Ran over by a car|0|||
164200764|NCT03101020|593106897|FG001|Overall Study|Ran over by a car|1|||
164200765|NCT03101020|593106896|FG000|Overall Study|Withdrawal by Subject|0|||
164200766|NCT03101020|593106897|FG001|Overall Study|Withdrawal by Subject|2|||
164200767|NCT00423046|593106901|FG000|Overall Study|Other|340|||
164200768|NCT00423046|593106902|FG001|Overall Study|Other|345|||
164200769|NCT01038687|593106903|FG000|Overall Study|Adverse Event|0|||
164200770|NCT01038687|593106904|FG001|Overall Study|Adverse Event|2|||
164200771|NCT01038687|593106905|FG002|Overall Study|Adverse Event|1|||
164200772|NCT02783911|593106906|FG000|Overall Study|Lost to Follow-up|3|||
164200773|NCT02783911|593106907|FG001|Overall Study|Lost to Follow-up|32|||
164200774|NCT02616783|593106908|FG000|Overall Study|Randomized but Not Treated|1|||
164200775|NCT02616783|593106909|FG001|Overall Study|Randomized but Not Treated|0|||
164200776|NCT02616783|593106908|FG000|Overall Study|Adverse Event|1|||
164200777|NCT02616783|593106909|FG001|Overall Study|Adverse Event|0|||
164200778|NCT02616783|593106908|FG000|Overall Study|Death|1|||
164200779|NCT02616783|593106909|FG001|Overall Study|Death|0|||
164200780|NCT02616783|593106908|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164200781|NCT02616783|593106909|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164200782|NCT02616783|593106908|FG000|Overall Study|Protocol Violation|1|||
164200783|NCT02616783|593106909|FG001|Overall Study|Protocol Violation|1|||
164309578|NCT05019521|593508134|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
164200784|NCT02616783|593106908|FG000|Overall Study|Withdrew Consent|1|||
164200785|NCT02616783|593106909|FG001|Overall Study|Withdrew Consent|1|||
164200786|NCT03080935|593106913|FG000|Overall Study|Death|34|||
164200787|NCT03080935|593106914|FG001|Overall Study|Death|50|||
164309579|NCT05019521|593508135|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
164309580|NCT05019521|593508136|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
164656247|NCT01952574|594766464|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
164200788|NCT03080935|593106913|FG000|Overall Study|Lost to Follow-up|5|||
164200789|NCT03080935|593106914|FG001|Overall Study|Lost to Follow-up|4|||
164200790|NCT03080935|593106913|FG000|Overall Study|Withdrawal by Subject|11|||
164200791|NCT03080935|593106914|FG001|Overall Study|Withdrawal by Subject|15|||
164200792|NCT01614470|593106915|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
164309581|NCT05019521|593508137|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
164656248|NCT01107535|594766465|FG000|Overall Study|Death|5|||
164656249|NCT02040766|594766466|FG000|Overall Study|Adverse Event|1|||
164656250|NCT02040766|594766467|FG001|Overall Study|Adverse Event|1|||
164656251|NCT02040766|594766468|FG002|Overall Study|Adverse Event|1|||
164656252|NCT02040766|594766469|FG003|Overall Study|Adverse Event|0|||
164656253|NCT02040766|594766470|FG004|Overall Study|Adverse Event|2|||
164200793|NCT01614470|593106916|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
164200794|NCT01614470|593106917|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
164200795|NCT01614470|593106915|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
164200796|NCT01614470|593106916|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
164200797|NCT01614470|593106917|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
164200798|NCT00069264|593106920|FG000|Overall Study|Adverse Event|3|||
164200799|NCT00069264|593106920|FG000|Overall Study|Progressive Disease|23|||
164200800|NCT00069264|593106920|FG000|Overall Study|Withdrawal by Subject|3|||
164200801|NCT00069264|593106920|FG000|Overall Study|Discon Therapy|3|||
164200802|NCT03014206|593106921|FG000|Overall Study|Registration Violation|12|||
164200803|NCT02895347|593106924|FG000|Overall Study|Withdrawal by Subject|3|||
164200804|NCT02895347|593106925|FG001|Overall Study|Withdrawal by Subject|1|||
164200805|NCT00606307|593106930|FG000|Overall Study|Adverse Event|2|||
164200806|NCT00606307|593106930|FG000|Overall Study|Withdrawal by Subject|2|||
164200807|NCT00606307|593106930|FG000|Overall Study|Disease progression|6|||
164200808|NCT00606307|593106930|FG000|Overall Study|QTc prolongation|1|||
164200809|NCT03669588|593106940|FG000|Overall Study|Adverse Event|1|||
164200810|NCT03669588|593106941|FG001|Overall Study|Adverse Event|0|||
164200811|NCT03669588|593106940|FG000|Overall Study|Physician Decision|0|||
164200812|NCT03669588|593106941|FG001|Overall Study|Physician Decision|1|||
164200813|NCT03669588|593106940|FG000|Overall Study|Protocol Violation|1|||
164200814|NCT03669588|593106941|FG001|Overall Study|Protocol Violation|0|||
164200815|NCT03669588|593106940|FG000|Overall Study|Sponsor Decision|1|||
164200816|NCT03669588|593106941|FG001|Overall Study|Sponsor Decision|1|||
164200817|NCT03669588|593106940|FG000|Overall Study|Withdrawal by Subject|1|||
164200818|NCT03669588|593106941|FG001|Overall Study|Withdrawal by Subject|4|||
164200819|NCT03669588|593106940|FG000|Overall Study|Rescue Therapy Needed|0|||
164200820|NCT03669588|593106941|FG001|Overall Study|Rescue Therapy Needed|1|||
164200821|NCT00492726|593106946|FG000|Overall Study|Adverse Event|10|||
164200822|NCT00492726|593106947|FG001|Overall Study|Adverse Event|6|||
164200823|NCT00492726|593106946|FG000|Overall Study|Death|7|||
164200824|NCT00492726|593106947|FG001|Overall Study|Death|2|||
164200825|NCT00492726|593106946|FG000|Overall Study|Lack of Efficacy|0|||
164200826|NCT00492726|593106947|FG001|Overall Study|Lack of Efficacy|2|||
164200827|NCT00492726|593106946|FG000|Overall Study|Lost to Follow-up|27|||
164200828|NCT00492726|593106947|FG001|Overall Study|Lost to Follow-up|19|||
164200829|NCT00492726|593106946|FG000|Overall Study|Physician Decision|0|||
164200830|NCT00492726|593106947|FG001|Overall Study|Physician Decision|1|||
164200831|NCT00492726|593106946|FG000|Overall Study|Withdrawal by Subject|6|||
164200832|NCT00492726|593106947|FG001|Overall Study|Withdrawal by Subject|3|||
164200833|NCT00492726|593106946|FG000|Overall Study|Non compliant with study medication|0|||
164200834|NCT00492726|593106947|FG001|Overall Study|Non compliant with study medication|3|||
164200835|NCT04386902|593106948|FG000|Overall Study|Withdrawal by Subject|5|||
164200836|NCT04386902|593106948|FG000|Overall Study|Technical problems in the recording|5|||
164200837|NCT02557399|593106949|FG000|Overall Study|Adverse Event|6|||
164550888|NCT00150592|594389999|FG001|Overall Study|Adverse Event|1|||
164550889|NCT00150592|594389998|FG000|Overall Study|Protocol Violation|1|||
164550890|NCT00150592|594389999|FG001|Overall Study|Protocol Violation|0|||
164550891|NCT00150592|594389998|FG000|Overall Study|Withdrawal by Subject|1|||
164550892|NCT00150592|594389999|FG001|Overall Study|Withdrawal by Subject|2|||
164550893|NCT00150592|594389998|FG000|Overall Study|Non-compliance|1|||
164550894|NCT00150592|594389999|FG001|Overall Study|Non-compliance|0|||
164550895|NCT00412750|594390000|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164550896|NCT00412750|594390001|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164550897|NCT00412750|594390002|FG002|Overall Study|Abnormal laboratory value(s)|0|||
164550898|NCT00412750|594390000|FG000|Overall Study|Administrative problems|21|||
164550899|NCT00412750|594390001|FG001|Overall Study|Administrative problems|17|||
164550900|NCT00412750|594390002|FG002|Overall Study|Administrative problems|14|||
164550901|NCT00412750|594390000|FG000|Overall Study|Adverse Event|8|||
164550902|NCT00412750|594390001|FG001|Overall Study|Adverse Event|3|||
164200838|NCT02557399|593106950|FG001|Overall Study|Adverse Event|5|||
164200839|NCT02557399|593106949|FG000|Overall Study|Protocol Violation|0|||
164550903|NCT00412750|594390002|FG002|Overall Study|Adverse Event|3|||
164656254|NCT02040766|594766466|FG000|Overall Study|Withdrawal by Subject|4|||
164200840|NCT02557399|593106950|FG001|Overall Study|Protocol Violation|1|||
164200841|NCT02557399|593106949|FG000|Overall Study|Protocol-defined stopping criteria|0|||
164550904|NCT00412750|594390000|FG000|Overall Study|Lost to Follow-up|1|||
164550905|NCT00412750|594390001|FG001|Overall Study|Lost to Follow-up|0|||
164550906|NCT00412750|594390002|FG002|Overall Study|Lost to Follow-up|1|||
164550907|NCT00412750|594390000|FG000|Overall Study|Withdrawal by Subject|0|||
164656255|NCT02040766|594766467|FG001|Overall Study|Withdrawal by Subject|3|||
164309582|NCT05019521|593508131|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
164309583|NCT05019521|593508132|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
164309584|NCT05019521|593508133|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
164309585|NCT05019521|593508134|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
164309586|NCT05019521|593508135|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
164309587|NCT05019521|593508136|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
164309588|NCT05019521|593508137|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
164309589|NCT05019521|593508131|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
164309590|NCT05019521|593508132|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
164309591|NCT05019521|593508133|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
164309592|NCT05019521|593508134|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
164309593|NCT05019521|593508135|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
164309594|NCT05019521|593508136|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
164309595|NCT05019521|593508137|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
164309596|NCT05019521|593508131|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
164309597|NCT05019521|593508132|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
164309598|NCT05019521|593508133|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
164309599|NCT05019521|593508134|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
164309600|NCT05019521|593508135|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
164309601|NCT05019521|593508136|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
164309602|NCT05019521|593508137|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
164309603|NCT05019521|593508131|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
164309604|NCT05019521|593508132|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
164309605|NCT05019521|593508133|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
164309606|NCT05019521|593508134|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
164309607|NCT05019521|593508135|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
164309608|NCT05019521|593508136|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
164309609|NCT05019521|593508137|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
164309610|NCT05019521|593508131|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
164550908|NCT00412750|594390001|FG001|Overall Study|Withdrawal by Subject|1|||
164550909|NCT00412750|594390002|FG002|Overall Study|Withdrawal by Subject|2|||
164550910|NCT00412750|594390000|FG000|Overall Study|Lack of Efficacy|0|||
164550911|NCT00412750|594390001|FG001|Overall Study|Lack of Efficacy|0|||
164550912|NCT00412750|594390002|FG002|Overall Study|Lack of Efficacy|3|||
164550913|NCT01823679|594390009|FG000|Overall Study|Death|1|||
164550914|NCT01157078|594390010|FG000|Overall Study|Withdrawal by Subject|12|||
164550915|NCT01157078|594390011|FG001|Overall Study|Withdrawal by Subject|14|||
164550916|NCT01157078|594390010|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
164550917|NCT01157078|594390011|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164550918|NCT01157078|594390010|FG000|Overall Study|Adverse Event|6|||
164550919|NCT01157078|594390011|FG001|Overall Study|Adverse Event|6|||
164550920|NCT01157078|594390010|FG000|Overall Study|Severe non-compliance to protocol|2|||
164550921|NCT01157078|594390011|FG001|Overall Study|Severe non-compliance to protocol|4|||
164550922|NCT01157078|594390010|FG000|Overall Study|Condition under investigation worsened|0|||
164550923|NCT01157078|594390011|FG001|Overall Study|Condition under investigation worsened|1|||
164550924|NCT01157078|594390010|FG000|Overall Study|Lack of Efficacy|2|||
164550925|NCT01157078|594390011|FG001|Overall Study|Lack of Efficacy|0|||
164550926|NCT01157078|594390010|FG000|Overall Study|Study-specific withdrawal criteria|2|||
164550927|NCT01157078|594390011|FG001|Overall Study|Study-specific withdrawal criteria|2|||
164550928|NCT01157078|594390010|FG000|Overall Study|Lost to Follow-up|7|||
164550929|NCT01157078|594390011|FG001|Overall Study|Lost to Follow-up|5|||
164550930|NCT01157078|594390010|FG000|Overall Study|Other|2|||
164550931|NCT01157078|594390011|FG001|Overall Study|Other|4|||
164550932|NCT01611974|594390012|FG000|Overall Study|Death|10|||
164550933|NCT01611974|594390013|FG001|Overall Study|Death|12|||
164550934|NCT01611974|594390014|FG002|Overall Study|Death|10|||
164550935|NCT01611974|594390012|FG000|Overall Study|Lost to Follow-up|0|||
164550936|NCT01611974|594390013|FG001|Overall Study|Lost to Follow-up|1|||
164550937|NCT01611974|594390014|FG002|Overall Study|Lost to Follow-up|0|||
164550938|NCT01611974|594390012|FG000|Overall Study|Physician Decision|5|||
164550939|NCT01611974|594390013|FG001|Overall Study|Physician Decision|1|||
164550940|NCT01611974|594390014|FG002|Overall Study|Physician Decision|2|||
164550941|NCT01611974|594390012|FG000|Overall Study|Withdrawal by Subject|0|||
164550942|NCT01611974|594390013|FG001|Overall Study|Withdrawal by Subject|1|||
164550943|NCT01611974|594390014|FG002|Overall Study|Withdrawal by Subject|4|||
164550944|NCT00522431|594390015|FG000|Overall Study|Adverse Event|5|||
164550945|NCT00522431|594390015|FG000|Overall Study|Protocol Violation|2|||
164550946|NCT00522431|594390015|FG000|Overall Study|Withdrawal by Subject|2|||
164550947|NCT00522431|594390015|FG000|Overall Study|Subject non-compliance|1|||
164550948|NCT00522431|594390015|FG000|Overall Study|Other/unknown|1|||
164309611|NCT05019521|593508132|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
164309612|NCT05019521|593508133|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
164309613|NCT05019521|593508134|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
164309614|NCT05019521|593508135|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
164309615|NCT05019521|593508136|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
164309616|NCT05019521|593508137|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
164309617|NCT05019521|593508131|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
164309618|NCT05019521|593508132|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
164309619|NCT05019521|593508133|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
164309620|NCT05019521|593508134|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
164309621|NCT05019521|593508135|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
164309622|NCT05019521|593508136|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
164309623|NCT05019521|593508137|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
164309624|NCT05019521|593508131|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
164309625|NCT05019521|593508132|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
164309626|NCT05019521|593508133|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
164309627|NCT05019521|593508134|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
164309628|NCT05019521|593508135|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
164309629|NCT05019521|593508136|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
164309630|NCT05019521|593508137|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
164309631|NCT05019521|593508131|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
164309632|NCT05019521|593508132|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
164309633|NCT05019521|593508133|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
164309634|NCT05019521|593508134|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
164309635|NCT05019521|593508135|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
164309636|NCT05019521|593508136|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
164309637|NCT05019521|593508137|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
164309638|NCT05019521|593508131|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
164309639|NCT05019521|593508132|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
164309640|NCT05019521|593508133|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
164309641|NCT05019521|593508134|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
164309642|NCT05019521|593508135|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
164309643|NCT05019521|593508136|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
164309644|NCT05019521|593508137|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
164309645|NCT05019521|593508131|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
164309646|NCT05019521|593508132|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
164309647|NCT05019521|593508133|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
164309648|NCT05019521|593508134|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
164309649|NCT05019521|593508135|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
164309650|NCT05019521|593508136|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
164309651|NCT05019521|593508137|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
164309652|NCT05019521|593508131|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
164309653|NCT05019521|593508132|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
164309654|NCT05019521|593508133|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
164309655|NCT05019521|593508134|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
164309656|NCT05019521|593508135|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
164309657|NCT05019521|593508136|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
164309658|NCT05019521|593508137|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
164309659|NCT02721966|593508138|FG000|Overall Study|Protocol Violation|1|||
164309660|NCT02721966|593508139|FG001|Overall Study|Protocol Violation|0|||
164309661|NCT02721966|593508140|FG002|Overall Study|Protocol Violation|0|||
164309662|NCT02721966|593508141|FG003|Overall Study|Protocol Violation|0|||
164309663|NCT02721966|593508142|FG004|Overall Study|Protocol Violation|0|||
164309664|NCT02721966|593508138|FG000|Overall Study|Withdrawal by Subject|9|||
164309665|NCT02721966|593508139|FG001|Overall Study|Withdrawal by Subject|2|||
164309666|NCT02721966|593508140|FG002|Overall Study|Withdrawal by Subject|3|||
164309667|NCT02721966|593508141|FG003|Overall Study|Withdrawal by Subject|7|||
164309668|NCT02721966|593508142|FG004|Overall Study|Withdrawal by Subject|0|||
164309669|NCT02721966|593508138|FG000|Overall Study|Adverse Event|4|||
164309670|NCT02721966|593508139|FG001|Overall Study|Adverse Event|4|||
164309671|NCT02721966|593508140|FG002|Overall Study|Adverse Event|3|||
164309672|NCT02721966|593508141|FG003|Overall Study|Adverse Event|0|||
164656256|NCT02040766|594766468|FG002|Overall Study|Withdrawal by Subject|2|||
164656257|NCT02040766|594766469|FG003|Overall Study|Withdrawal by Subject|3|||
164656258|NCT02040766|594766470|FG004|Overall Study|Withdrawal by Subject|2|||
164309673|NCT02721966|593508142|FG004|Overall Study|Adverse Event|0|||
164309674|NCT02721966|593508138|FG000|Overall Study|Death|1|||
164309675|NCT02721966|593508139|FG001|Overall Study|Death|0|||
164309676|NCT02721966|593508140|FG002|Overall Study|Death|0|||
164309677|NCT02721966|593508141|FG003|Overall Study|Death|0|||
164309678|NCT02721966|593508142|FG004|Overall Study|Death|0|||
164309679|NCT02721966|593508138|FG000|Overall Study|Lack of Efficacy|7|||
164309680|NCT02721966|593508139|FG001|Overall Study|Lack of Efficacy|4|||
164550949|NCT00132132|594390017|FG000|Overall Study|Lost to Follow-up|7|||
164550950|NCT00132132|594390018|FG001|Overall Study|Lost to Follow-up|2|||
164550951|NCT02145741|594390019|FG000|Overall Study|Progressive disease|3|||
164550952|NCT02145741|594390020|FG001|Overall Study|Progressive disease|6|||
164550953|NCT02145741|594390021|FG002|Overall Study|Progressive disease|6|||
164550954|NCT02145741|594390019|FG000|Overall Study|quality issue with the administered drug|3|||
164550955|NCT02145741|594390020|FG001|Overall Study|quality issue with the administered drug|0|||
164550956|NCT02145741|594390021|FG002|Overall Study|quality issue with the administered drug|0|||
164550957|NCT02037295|594390022|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
164550958|NCT02037295|594390023|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
164550959|NCT02037295|594390024|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
164550960|NCT02037295|594390025|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
164550961|NCT03776175|594390026|FG000|Treatment Period (42 Days)|Adverse Event|0|||
164550962|NCT03776175|594390027|FG001|Treatment Period (42 Days)|Adverse Event|1|||
164550963|NCT03776175|594390028|FG002|Treatment Period (42 Days)|Adverse Event|1|||
164550964|NCT03776175|594390029|FG003|Treatment Period (42 Days)|Adverse Event|0|||
164550965|NCT03776175|594390026|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
164550966|NCT03776175|594390027|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
164550967|NCT03776175|594390028|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
164550968|NCT03776175|594390029|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
164550969|NCT03776175|594390026|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
164550970|NCT03776175|594390027|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
164550971|NCT03776175|594390028|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
164550972|NCT03776175|594390029|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
164550973|NCT03776175|594390026|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
164550974|NCT03776175|594390027|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
164550975|NCT03776175|594390028|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
164550976|NCT03776175|594390029|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
164550977|NCT03776175|594390026|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
164550978|NCT03776175|594390027|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
164550979|NCT03776175|594390028|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
164550980|NCT03776175|594390029|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
164550981|NCT03776175|594390026|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
164550982|NCT03776175|594390027|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
164550983|NCT03776175|594390028|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
164550984|NCT03776175|594390029|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
164550985|NCT02770547|594390033|FG000|Overall Study|Patient non-compliant|1|||
164550986|NCT02770547|594390034|FG001|Overall Study|Patient non-compliant|0|||
164550987|NCT02770547|594390033|FG000|Overall Study|Adverse Event|0|||
164550988|NCT02770547|594390034|FG001|Overall Study|Adverse Event|1|||
164550989|NCT01496885|594390035|FG000|Overall Study|Lost to Follow-up|13|||
164550990|NCT01496885|594390035|FG000|Overall Study|Withdrawal by Subject|7|||
164550991|NCT01496885|594390035|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
164550992|NCT01496885|594390035|FG000|Overall Study|Death|1|||
164550993|NCT03273166|594390036|FG000|Overall Study|Withdrawn prior to Completion|31|||
164550994|NCT01294670|594390037|FG000|Overall Study|Not treated|1|||
164550995|NCT01294670|594390038|FG001|Overall Study|Not treated|0|||
164550996|NCT01294670|594390039|FG002|Overall Study|Not treated|0|||
164550997|NCT01294670|594390040|FG003|Overall Study|Not treated|0|||
164550998|NCT01294670|594390041|FG004|Overall Study|Not treated|0|||
164550999|NCT00661531|594390042|FG000|Overall Study|Withdrawal by Subject|3|||
164551000|NCT03134599|594390044|FG000|Week 1|Lost to Follow-up|0|||
164551001|NCT03134599|594390045|FG001|Week 1|Lost to Follow-up|0|||
164551002|NCT03134599|594390046|FG002|Week 1|Lost to Follow-up|0|||
164551003|NCT03134599|594390047|FG003|Week 1|Lost to Follow-up|0|||
164551004|NCT03134599|594390048|FG004|Week 1|Lost to Follow-up|1|||
164551005|NCT03134599|594390049|FG005|Week 1|Lost to Follow-up|0|||
164551006|NCT03134599|594390044|FG000|Week 2|Lost to Follow-up|1|||
164551007|NCT03134599|594390045|FG001|Week 2|Lost to Follow-up|0|||
164551008|NCT03134599|594390046|FG002|Week 2|Lost to Follow-up|0|||
164551009|NCT03134599|594390047|FG003|Week 2|Lost to Follow-up|1|||
164551010|NCT03134599|594390048|FG004|Week 2|Lost to Follow-up|1|||
164551011|NCT03134599|594390049|FG005|Week 2|Lost to Follow-up|0|||
164551012|NCT03134599|594390044|FG000|Week 3|Lost to Follow-up|0|||
164551013|NCT03134599|594390045|FG001|Week 3|Lost to Follow-up|0|||
164551014|NCT03134599|594390046|FG002|Week 3|Lost to Follow-up|0|||
164309681|NCT02721966|593508140|FG002|Overall Study|Lack of Efficacy|0|||
164309682|NCT02721966|593508141|FG003|Overall Study|Lack of Efficacy|0|||
164551015|NCT03134599|594390047|FG003|Week 3|Lost to Follow-up|1|||
164551016|NCT03134599|594390048|FG004|Week 3|Lost to Follow-up|0|||
164551017|NCT03134599|594390049|FG005|Week 3|Lost to Follow-up|1|||
164551018|NCT03808077|594390050|FG000|Overall Study|Physician Decision|2|||
164200842|NCT02557399|593106950|FG001|Overall Study|Protocol-defined stopping criteria|1|||
164200843|NCT02557399|593106949|FG000|Overall Study|Withdrawal by Subject|1|||
164200844|NCT02557399|593106950|FG001|Overall Study|Withdrawal by Subject|1|||
164200845|NCT00960804|593106951|FG000|Overall Study|Adverse Event|1|||
164200846|NCT00960804|593106952|FG001|Overall Study|Adverse Event|0|||
164200847|NCT00960804|593106953|FG002|Overall Study|Adverse Event|0|||
164200848|NCT00960804|593106951|FG000|Overall Study|Withdrawal by Subject|1|||
164200849|NCT00960804|593106952|FG001|Overall Study|Withdrawal by Subject|0|||
164200850|NCT00960804|593106953|FG002|Overall Study|Withdrawal by Subject|0|||
164200851|NCT00960804|593106951|FG000|Overall Study|Study terminated by the sponsor|5|||
164200852|NCT00960804|593106952|FG001|Overall Study|Study terminated by the sponsor|4|||
164200853|NCT00960804|593106953|FG002|Overall Study|Study terminated by the sponsor|10|||
164200854|NCT02100124|593106954|FG000|Overall Study|Lost to Follow-up|5|||
164200855|NCT02100124|593106955|FG001|Overall Study|Lost to Follow-up|11|||
164200856|NCT02100124|593106956|FG002|Overall Study|Lost to Follow-up|3|||
164200857|NCT02100124|593106954|FG000|Overall Study|Withdrawal by Subject|1|||
164200858|NCT02100124|593106955|FG001|Overall Study|Withdrawal by Subject|0|||
164200859|NCT02100124|593106956|FG002|Overall Study|Withdrawal by Subject|0|||
164200860|NCT04350827|593106957|FG000|Overall Study|Lost to Follow-up|1|||
164200861|NCT04350827|593106958|FG001|Overall Study|Lost to Follow-up|2|||
164200862|NCT02034006|593108347|FG000|Overall Study|Withdrawal by Subject|7|||
164200863|NCT02034006|593108347|FG000|Overall Study|Lost to Follow-up|5|||
164200864|NCT02034006|593108347|FG000|Overall Study|Death|1|||
164200865|NCT02034006|593108347|FG000|Overall Study|Pregnancy|1|||
164200866|NCT00750269|593108360|FG000|Overall Study|Protocol Violation|0|||
164200867|NCT00750269|593108361|FG001|Overall Study|Protocol Violation|1|||
164200868|NCT00750269|593108362|FG002|Overall Study|Protocol Violation|1|||
164200869|NCT00750269|593108363|FG003|Overall Study|Protocol Violation|2|||
164200870|NCT00750269|593108364|FG004|Overall Study|Protocol Violation|4|||
164200871|NCT00750269|593108360|FG000|Overall Study|Withdrawal by Subject|0|||
164200872|NCT00750269|593108361|FG001|Overall Study|Withdrawal by Subject|0|||
164200873|NCT00750269|593108362|FG002|Overall Study|Withdrawal by Subject|2|||
164200874|NCT00750269|593108363|FG003|Overall Study|Withdrawal by Subject|2|||
164200875|NCT00750269|593108364|FG004|Overall Study|Withdrawal by Subject|2|||
164200876|NCT00750269|593108360|FG000|Overall Study|Physician Decision|0|||
164200877|NCT00750269|593108361|FG001|Overall Study|Physician Decision|0|||
164200878|NCT00750269|593108362|FG002|Overall Study|Physician Decision|0|||
164200879|NCT00750269|593108363|FG003|Overall Study|Physician Decision|0|||
164200880|NCT00750269|593108364|FG004|Overall Study|Physician Decision|2|||
164200881|NCT00750269|593108360|FG000|Overall Study|Patient too large for positioning|0|||
164200882|NCT00750269|593108361|FG001|Overall Study|Patient too large for positioning|0|||
164200883|NCT00750269|593108362|FG002|Overall Study|Patient too large for positioning|1|||
164200884|NCT00750269|593108363|FG003|Overall Study|Patient too large for positioning|0|||
164200885|NCT00750269|593108364|FG004|Overall Study|Patient too large for positioning|0|||
164200886|NCT00750269|593108360|FG000|Overall Study|Site error|0|||
164200887|NCT00750269|593108361|FG001|Overall Study|Site error|0|||
164200888|NCT00750269|593108362|FG002|Overall Study|Site error|0|||
164200889|NCT00750269|593108363|FG003|Overall Study|Site error|1|||
164200890|NCT00750269|593108364|FG004|Overall Study|Site error|0|||
164200891|NCT00750269|593108360|FG000|Overall Study|SBRT plan could not be drawn|0|||
164200892|NCT00750269|593108361|FG001|Overall Study|SBRT plan could not be drawn|0|||
164200893|NCT00750269|593108362|FG002|Overall Study|SBRT plan could not be drawn|0|||
164200894|NCT00750269|593108363|FG003|Overall Study|SBRT plan could not be drawn|0|||
164200895|NCT00750269|593108364|FG004|Overall Study|SBRT plan could not be drawn|1|||
164200896|NCT00750269|593108360|FG000|Overall Study|Fiducials could not be placed|0|||
164200897|NCT00750269|593108361|FG001|Overall Study|Fiducials could not be placed|0|||
164200898|NCT00750269|593108362|FG002|Overall Study|Fiducials could not be placed|0|||
164200899|NCT00750269|593108363|FG003|Overall Study|Fiducials could not be placed|0|||
164200900|NCT00750269|593108364|FG004|Overall Study|Fiducials could not be placed|1|||
164200901|NCT00161213|593108365|FG000|Overall Study|Withdrawal by Subject|1|||
164200902|NCT00161213|593108365|FG000|Overall Study|Evaluable for toxicity but not response|1|||
164200903|NCT03630393|593108366|FG000|Overall Study|Death|1|||
164200904|NCT03630393|593108367|FG001|Overall Study|Death|0|||
164200905|NCT02351934|593108368|FG000|Allocation|POD weight<pre-op weight|3|||
164200906|NCT02351934|593108369|FG001|Allocation|POD weight<pre-op weight|0|||
164200907|NCT02351934|593108368|FG000|Allocation|Hypotension preventing administration|2|||
164200908|NCT02351934|593108369|FG001|Allocation|Hypotension preventing administration|0|||
164200909|NCT02351934|593108368|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
164200910|NCT02351934|593108369|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
164200911|NCT02351934|593108368|FG000|Follow-Up|POD weight<pre-op weight|3|||
164200912|NCT02351934|593108369|FG001|Follow-Up|POD weight<pre-op weight|0|||
164200913|NCT02351934|593108368|FG000|Follow-Up|Acute Kidney Injury|1|||
164551019|NCT03808077|594390051|FG001|Overall Study|Physician Decision|3|||
164309683|NCT02721966|593508142|FG004|Overall Study|Lack of Efficacy|0|||
164309684|NCT02721966|593508138|FG000|Overall Study|Lost to Follow-up|0|||
164309685|NCT02721966|593508139|FG001|Overall Study|Lost to Follow-up|0|||
164309686|NCT02721966|593508140|FG002|Overall Study|Lost to Follow-up|3|||
164309687|NCT02721966|593508141|FG003|Overall Study|Lost to Follow-up|0|||
164309688|NCT02721966|593508142|FG004|Overall Study|Lost to Follow-up|0|||
164309689|NCT02721966|593508138|FG000|Overall Study|Physician Decision|1|||
164309690|NCT02721966|593508139|FG001|Overall Study|Physician Decision|1|||
164309691|NCT02721966|593508140|FG002|Overall Study|Physician Decision|0|||
164309692|NCT02721966|593508141|FG003|Overall Study|Physician Decision|0|||
164309693|NCT02721966|593508142|FG004|Overall Study|Physician Decision|0|||
164309694|NCT02721966|593508138|FG000|Overall Study|Pregnancy|1|||
164309695|NCT02721966|593508139|FG001|Overall Study|Pregnancy|0|||
164309696|NCT02721966|593508140|FG002|Overall Study|Pregnancy|0|||
164309697|NCT02721966|593508141|FG003|Overall Study|Pregnancy|0|||
164309698|NCT02721966|593508142|FG004|Overall Study|Pregnancy|0|||
164309699|NCT02721966|593508138|FG000|Overall Study|Did not continue to period 2|5|||
164309700|NCT02721966|593508139|FG001|Overall Study|Did not continue to period 2|12|||
164309701|NCT02721966|593508140|FG002|Overall Study|Did not continue to period 2|0|||
164309702|NCT02721966|593508141|FG003|Overall Study|Did not continue to period 2|0|||
164309703|NCT02721966|593508142|FG004|Overall Study|Did not continue to period 2|5|||
164309704|NCT00828204|593508143|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
164309705|NCT00828204|593508144|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
164309706|NCT00828204|593508143|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
164309707|NCT00828204|593508144|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
164309708|NCT00828204|593508143|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
164309709|NCT00828204|593508144|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
164309710|NCT00828204|593508143|FG000|Main Study: After Study Restart|Adverse Event|0|||
164309711|NCT00828204|593508144|FG001|Main Study: After Study Restart|Adverse Event|2|||
164309712|NCT00828204|593508143|FG000|Main Study: After Study Restart|Noncompliance|0|||
164309713|NCT00828204|593508144|FG001|Main Study: After Study Restart|Noncompliance|1|||
164309714|NCT00828204|593508143|FG000|Extension Study|Lost to Follow-up|0|||
164309715|NCT00828204|593508144|FG001|Extension Study|Lost to Follow-up|1|||
164309716|NCT00828204|593508143|FG000|Extension Study|Physician Decision|0|||
164309717|NCT00828204|593508144|FG001|Extension Study|Physician Decision|2|||
164309718|NCT02840461|593508145|FG000|Overall Study|Adverse Event|1|||
164309719|NCT02840461|593508146|FG001|Overall Study|Adverse Event|5|||
164309720|NCT02840461|593508147|FG002|Overall Study|Adverse Event|3|||
164309721|NCT02840461|593508145|FG000|Overall Study|Lost to Follow-up|10|||
164309722|NCT02840461|593508146|FG001|Overall Study|Lost to Follow-up|7|||
164309723|NCT02840461|593508147|FG002|Overall Study|Lost to Follow-up|6|||
164309724|NCT02840461|593508145|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
164309725|NCT02840461|593508146|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
164309726|NCT02840461|593508147|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
164309727|NCT02840461|593508145|FG000|Overall Study|Protocol Violation|2|||
164551020|NCT03808077|594390050|FG000|Overall Study|Withdrawal by Subject|1|||
164551021|NCT03808077|594390051|FG001|Overall Study|Withdrawal by Subject|0|||
164551022|NCT03808077|594390050|FG000|Overall Study|Equipment Issues|2|||
164551023|NCT03808077|594390051|FG001|Overall Study|Equipment Issues|1|||
164551024|NCT02412787|594390052|FG000|Overall Study|Withdrawal by Subject|9|||
164551025|NCT02412787|594390052|FG000|Overall Study|Participation Terminated by Investigator|1|||
164551026|NCT02412787|594390052|FG000|Overall Study|Site Terminated by Sponsor|21|||
164551027|NCT02412787|594390052|FG000|Overall Study|Technical Problems|1|||
164551028|NCT02412787|594390052|FG000|Overall Study|Reason Not Specified|1|||
164551029|NCT00393887|594390053|FG000|Overall Study|Physician Decision|5|||
164551030|NCT00393887|594390054|FG001|Overall Study|Physician Decision|0|||
164551031|NCT00393887|594390053|FG000|Overall Study|Lost to Follow-up|11|||
164551032|NCT00393887|594390054|FG001|Overall Study|Lost to Follow-up|9|||
164551033|NCT03246958|594390055|FG000|Overall Study|Withdrawal by Subject|0|||
164551034|NCT03246958|594390056|FG001|Overall Study|Withdrawal by Subject|1|||
164551035|NCT03246958|594390057|FG002|Overall Study|Withdrawal by Subject|0|||
164551036|NCT03246958|594390058|FG003|Overall Study|Withdrawal by Subject|0|||
164551037|NCT03246958|594390059|FG004|Overall Study|Withdrawal by Subject|0|||
164551038|NCT03246958|594390060|FG005|Overall Study|Withdrawal by Subject|1|||
164551039|NCT03246958|594390061|FG006|Overall Study|Withdrawal by Subject|0|||
164551040|NCT03246958|594390055|FG000|Overall Study|Progression|13|||
164551041|NCT03246958|594390056|FG001|Overall Study|Progression|9|||
164551042|NCT03246958|594390057|FG002|Overall Study|Progression|3|||
164551043|NCT03246958|594390058|FG003|Overall Study|Progression|2|||
164551044|NCT03246958|594390059|FG004|Overall Study|Progression|1|||
164551045|NCT03246958|594390060|FG005|Overall Study|Progression|2|||
164551046|NCT03246958|594390061|FG006|Overall Study|Progression|1|||
164551047|NCT03246958|594390055|FG000|Overall Study|Adverse Event|2|||
164551048|NCT03246958|594390056|FG001|Overall Study|Adverse Event|2|||
164551049|NCT03246958|594390057|FG002|Overall Study|Adverse Event|0|||
164551050|NCT03246958|594390058|FG003|Overall Study|Adverse Event|1|||
164551051|NCT03246958|594390059|FG004|Overall Study|Adverse Event|1|||
164551052|NCT03246958|594390060|FG005|Overall Study|Adverse Event|0|||
164551053|NCT03246958|594390061|FG006|Overall Study|Adverse Event|2|||
164551054|NCT03246958|594390055|FG000|Overall Study|Death|0|||
164551055|NCT03246958|594390056|FG001|Overall Study|Death|1|||
164551056|NCT03246958|594390057|FG002|Overall Study|Death|0|||
164551057|NCT03246958|594390058|FG003|Overall Study|Death|0|||
164551058|NCT03246958|594390059|FG004|Overall Study|Death|0|||
164656259|NCT02040766|594766466|FG000|Overall Study|Non-compliance|0|||
164656260|NCT02040766|594766467|FG001|Overall Study|Non-compliance|1|||
164656261|NCT02040766|594766468|FG002|Overall Study|Non-compliance|0|||
164656262|NCT02040766|594766469|FG003|Overall Study|Non-compliance|0|||
164309728|NCT02840461|593508146|FG001|Overall Study|Protocol Violation|3|||
164309729|NCT02840461|593508147|FG002|Overall Study|Protocol Violation|1|||
164309730|NCT02840461|593508145|FG000|Overall Study|Withdrawal by Subject|10|||
164309731|NCT02840461|593508146|FG001|Overall Study|Withdrawal by Subject|6|||
164309732|NCT02840461|593508147|FG002|Overall Study|Withdrawal by Subject|2|||
164309733|NCT02840461|593508145|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
164309734|NCT02840461|593508146|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
164309735|NCT02840461|593508147|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
164309736|NCT03843541|593508148|FG000|Overall Study|Adverse Event|4|||
164309737|NCT03843541|593508149|FG001|Overall Study|Adverse Event|2|||
164309738|NCT03843541|593508150|FG002|Overall Study|Adverse Event|3|||
164309739|NCT03843541|593508148|FG000|Overall Study|Death|1|||
164309740|NCT03843541|593508149|FG001|Overall Study|Death|0|||
164309741|NCT03843541|593508150|FG002|Overall Study|Death|0|||
164309742|NCT03843541|593508148|FG000|Overall Study|Lack of adherence to study medication|0|||
164309743|NCT03843541|593508149|FG001|Overall Study|Lack of adherence to study medication|0|||
164309744|NCT03843541|593508150|FG002|Overall Study|Lack of adherence to study medication|1|||
164309745|NCT03843541|593508148|FG000|Overall Study|Physician Decision|1|||
164309746|NCT03843541|593508149|FG001|Overall Study|Physician Decision|2|||
164309747|NCT03843541|593508150|FG002|Overall Study|Physician Decision|2|||
164309748|NCT03843541|593508148|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
164309749|NCT03843541|593508149|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
164309750|NCT03843541|593508150|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
164309751|NCT03843541|593508148|FG000|Overall Study|Withdrawal by Subject|6|||
164309752|NCT03843541|593508149|FG001|Overall Study|Withdrawal by Subject|9|||
164309753|NCT03843541|593508150|FG002|Overall Study|Withdrawal by Subject|7|||
164309754|NCT03843541|593508148|FG000|Overall Study|Administration of rescue mucolytic|0|||
164309755|NCT03843541|593508149|FG001|Overall Study|Administration of rescue mucolytic|0|||
164309756|NCT03843541|593508150|FG002|Overall Study|Administration of rescue mucolytic|1|||
164309757|NCT03843541|593508148|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
164309758|NCT03843541|593508149|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
164309759|NCT03843541|593508150|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
164309760|NCT04163016|593508153|FG000|Enrollment|Adverse Event|1|||
164309761|NCT04163016|593508154|FG001|Enrollment|Adverse Event|0|||
164309762|NCT04163016|593508155|FG002|Enrollment|Adverse Event|0|||
164309763|NCT04163016|593508156|FG003|Enrollment|Adverse Event|0|||
164309764|NCT04163016|593508153|FG000|Treatment|Adverse Event|0|||
164309765|NCT04163016|593508154|FG001|Treatment|Adverse Event|1|||
164309766|NCT04163016|593508155|FG002|Treatment|Adverse Event|0|||
164309767|NCT04163016|593508156|FG003|Treatment|Adverse Event|0|||
164309768|NCT04163016|593508153|FG000|Treatment|Withdrawal by Subject|0|||
164309769|NCT04163016|593508154|FG001|Treatment|Withdrawal by Subject|2|||
164551059|NCT03246958|594390060|FG005|Overall Study|Death|0|||
164551060|NCT03246958|594390061|FG006|Overall Study|Death|0|||
164551061|NCT03246958|594390055|FG000|Overall Study|Physician Decision|0|||
164551062|NCT03246958|594390056|FG001|Overall Study|Physician Decision|0|||
164551063|NCT03246958|594390057|FG002|Overall Study|Physician Decision|0|||
164551064|NCT03246958|594390058|FG003|Overall Study|Physician Decision|1|||
164551065|NCT03246958|594390059|FG004|Overall Study|Physician Decision|0|||
164551066|NCT03246958|594390060|FG005|Overall Study|Physician Decision|0|||
164551067|NCT03246958|594390061|FG006|Overall Study|Physician Decision|0|||
164551068|NCT03246958|594390055|FG000|Overall Study|Never start treatment|1|||
164551069|NCT03246958|594390056|FG001|Overall Study|Never start treatment|0|||
164551070|NCT03246958|594390057|FG002|Overall Study|Never start treatment|0|||
164551071|NCT03246958|594390058|FG003|Overall Study|Never start treatment|0|||
164656263|NCT02040766|594766470|FG004|Overall Study|Non-compliance|0|||
164656264|NCT02040766|594766466|FG000|Overall Study|Protocol Violation|2|||
164551072|NCT03246958|594390059|FG004|Overall Study|Never start treatment|0|||
164656265|NCT02040766|594766467|FG001|Overall Study|Protocol Violation|1|||
164309770|NCT04163016|593508155|FG002|Treatment|Withdrawal by Subject|0|||
164309771|NCT04163016|593508156|FG003|Treatment|Withdrawal by Subject|0|||
164309772|NCT04163016|593508153|FG000|Treatment|Indeterminate TB-test|0|||
164309773|NCT04163016|593508154|FG001|Treatment|Indeterminate TB-test|0|||
164551073|NCT03246958|594390060|FG005|Overall Study|Never start treatment|0|||
164656266|NCT02040766|594766468|FG002|Overall Study|Protocol Violation|2|||
164551074|NCT03246958|594390061|FG006|Overall Study|Never start treatment|0|||
164551075|NCT03246958|594390055|FG000|Overall Study|Over enrollment|0|||
164551076|NCT03246958|594390056|FG001|Overall Study|Over enrollment|2|||
164551077|NCT03246958|594390057|FG002|Overall Study|Over enrollment|0|||
164551078|NCT03246958|594390058|FG003|Overall Study|Over enrollment|0|||
164551079|NCT03246958|594390059|FG004|Overall Study|Over enrollment|0|||
164551080|NCT03246958|594390060|FG005|Overall Study|Over enrollment|0|||
164551081|NCT03246958|594390061|FG006|Overall Study|Over enrollment|0|||
164551082|NCT02311153|594390064|FG000|Overall Study|Lost to Follow-up|5|||
164551083|NCT02311153|594390065|FG001|Overall Study|Lost to Follow-up|7|||
164551084|NCT01967628|594390066|FG000|Overall Study|Withdrawal by Subject|2|||
164551085|NCT01967628|594390067|FG001|Overall Study|Withdrawal by Subject|0|||
164551086|NCT01967628|594390066|FG000|Overall Study|Unable to complete bronchoscopy|4|||
164551087|NCT01967628|594390067|FG001|Overall Study|Unable to complete bronchoscopy|6|||
164551088|NCT01967628|594390066|FG000|Overall Study|Lost to Follow-up|1|||
164551089|NCT01967628|594390067|FG001|Overall Study|Lost to Follow-up|0|||
164551090|NCT01967628|594390066|FG000|Overall Study|Low protein concentration in sample|20|||
164551091|NCT01967628|594390067|FG001|Overall Study|Low protein concentration in sample|25|||
164551092|NCT00838331|594390068|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
164551093|NCT01650636|594390073|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
164551094|NCT01650636|594390074|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
164551095|NCT01650636|594390073|FG000|Washout up to 5 Months|Physician Decision|2|||
164551096|NCT01650636|594390074|FG001|Washout up to 5 Months|Physician Decision|2|||
164551097|NCT01650636|594390073|FG000|Washout up to 5 Months|Death|1|||
164551098|NCT01650636|594390074|FG001|Washout up to 5 Months|Death|0|||
164551099|NCT01650636|594390073|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
164551100|NCT01650636|594390074|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
164551101|NCT01650636|594390073|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
164551102|NCT01650636|594390074|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
164551103|NCT01650636|594390073|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
164551104|NCT01650636|594390074|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
164551105|NCT01560780|594390075|FG000|Overall Study|Death|2|||
164551106|NCT01560780|594390076|FG001|Overall Study|Death|1|||
164551107|NCT01560780|594390075|FG000|Overall Study|Patient Preference|11|||
164551108|NCT01560780|594390076|FG001|Overall Study|Patient Preference|11|||
164551109|NCT00930761|594390077|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
164551110|NCT00930761|594390078|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
164551111|NCT00930761|594390077|FG000|Overall Study|less than 3 music therapy sessions|0|||
164551112|NCT00930761|594390078|FG001|Overall Study|less than 3 music therapy sessions|3|||
164551113|NCT01970995|594390080|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
164551114|NCT01970995|594390081|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
164551115|NCT01970995|594390082|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
164551116|NCT01970995|594390080|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
164551117|NCT01970995|594390081|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
164551118|NCT01970995|594390082|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
164551119|NCT00414453|594390083|FG000|Overall Study|Abnormal lab work|16|||
164551120|NCT01780662|594390084|FG000|Overall Study|Adverse Event|1|||
164551121|NCT01780662|594390085|FG001|Overall Study|Adverse Event|0|||
164551122|NCT01780662|594390086|FG002|Overall Study|Adverse Event|2|||
164551123|NCT01780662|594390084|FG000|Overall Study|Physician Decision|0|||
164551124|NCT01780662|594390085|FG001|Overall Study|Physician Decision|5|||
164551125|NCT01780662|594390086|FG002|Overall Study|Physician Decision|7|||
164551126|NCT01780662|594390084|FG000|Overall Study|Protocol Violation|0|||
164551127|NCT01780662|594390085|FG001|Overall Study|Protocol Violation|1|||
164551128|NCT01780662|594390086|FG002|Overall Study|Protocol Violation|0|||
164551129|NCT01780662|594390084|FG000|Overall Study|Ineligible|0|||
164551130|NCT01780662|594390085|FG001|Overall Study|Ineligible|0|||
164551131|NCT01780662|594390086|FG002|Overall Study|Ineligible|1|||
164656267|NCT02040766|594766469|FG003|Overall Study|Protocol Violation|3|||
164551132|NCT01081249|594390089|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
164551133|NCT01081249|594390090|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
164551134|NCT02813694|594390093|FG000|Overall Study|Physician Decision|0|||
164551135|NCT02813694|594390094|FG001|Overall Study|Physician Decision|1|||
164551136|NCT02813694|594390093|FG000|Overall Study|Withdrawal by Subject|10|||
164551137|NCT02813694|594390094|FG001|Overall Study|Withdrawal by Subject|9|||
164551138|NCT02813694|594390093|FG000|Overall Study|Lost to Follow-up|1|||
164551139|NCT02813694|594390094|FG001|Overall Study|Lost to Follow-up|1|||
164551140|NCT02813694|594390093|FG000|Overall Study|Death|3|||
164551141|NCT02813694|594390094|FG001|Overall Study|Death|3|||
164551142|NCT02813694|594390093|FG000|Overall Study|Randomized- did not receive study drug|2|||
164551143|NCT02813694|594390094|FG001|Overall Study|Randomized- did not receive study drug|0|||
164551144|NCT02813694|594390093|FG000|Overall Study|Patient hospitalized|1|||
164551145|NCT02813694|594390094|FG001|Overall Study|Patient hospitalized|0|||
164551146|NCT00606320|594390095|FG000|Overall Study|Adverse Event|3|||
164551147|NCT00606320|594390095|FG000|Overall Study|Lack of Efficacy|5|||
164200914|NCT02351934|593108369|FG001|Follow-Up|Acute Kidney Injury|0|||
164200915|NCT02351934|593108368|FG000|Follow-Up|Early dismissal|3|||
164200916|NCT02351934|593108369|FG001|Follow-Up|Early dismissal|0|||
164200917|NCT02351934|593108368|FG000|Follow-Up|Hypotension|3|||
164200918|NCT02351934|593108369|FG001|Follow-Up|Hypotension|0|||
164200919|NCT02351934|593108368|FG000|Follow-Up|No documentation|2|||
164200920|NCT02351934|593108369|FG001|Follow-Up|No documentation|0|||
164200921|NCT02351934|593108368|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
164200922|NCT02351934|593108369|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
164200923|NCT02351934|593108368|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
164200924|NCT02351934|593108369|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
164200925|NCT02426684|593108372|FG000|Overall Study|Physician Decision|1|||
164200926|NCT00095979|593108379|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
164200927|NCT01483118|593108380|FG000|Overall Study|Lost to Follow-up|12|||
164200928|NCT01483118|593108381|FG001|Overall Study|Lost to Follow-up|16|||
164200929|NCT02783066|593108383|FG000|Overall Study|Withdrawal by Subject|13|||
164200930|NCT01004614|593108389|FG000|Washout|Withdrawal by Subject|0|||
164200931|NCT01004614|593108390|FG001|Washout|Withdrawal by Subject|1|||
164200932|NCT01004614|593108391|FG002|Washout|Withdrawal by Subject|0|||
164200933|NCT01004614|593108392|FG003|Washout|Withdrawal by Subject|0|||
164200934|NCT01569022|593108394|FG000|First Intervention|Lost to Follow-up|2|||
164200935|NCT01569022|593108395|FG001|First Intervention|Lost to Follow-up|1|||
164200936|NCT01569022|593108394|FG000|Second Intervention|Lost to Follow-up|2|||
164200937|NCT01569022|593108395|FG001|Second Intervention|Lost to Follow-up|2|||
164200938|NCT00644059|593108400|FG000|Overall Study|Lost to Follow-up|37|||
164200939|NCT00644059|593108401|FG001|Overall Study|Lost to Follow-up|34|||
164200940|NCT00644059|593108402|FG002|Overall Study|Lost to Follow-up|16|||
164200941|NCT00644059|593108400|FG000|Overall Study|Withdrawal by Subject|52|||
164200942|NCT00644059|593108401|FG001|Overall Study|Withdrawal by Subject|60|||
164200943|NCT00644059|593108402|FG002|Overall Study|Withdrawal by Subject|30|||
164200944|NCT00644059|593108400|FG000|Overall Study|Adverse Event|8|||
164200945|NCT00644059|593108401|FG001|Overall Study|Adverse Event|5|||
164200946|NCT00644059|593108402|FG002|Overall Study|Adverse Event|1|||
164200947|NCT00644059|593108400|FG000|Overall Study|Inappropriate Enrollment|1|||
164200948|NCT00644059|593108401|FG001|Overall Study|Inappropriate Enrollment|3|||
164200949|NCT00644059|593108402|FG002|Overall Study|Inappropriate Enrollment|0|||
164200950|NCT00644059|593108400|FG000|Overall Study|Protocol Deviation/violation|20|||
164200951|NCT00644059|593108401|FG001|Overall Study|Protocol Deviation/violation|19|||
164200952|NCT00644059|593108402|FG002|Overall Study|Protocol Deviation/violation|15|||
164200953|NCT00644059|593108400|FG000|Overall Study|Unable to classify|6|||
164200954|NCT00644059|593108401|FG001|Overall Study|Unable to classify|2|||
164200955|NCT00644059|593108402|FG002|Overall Study|Unable to classify|3|||
164200956|NCT02497469|593108403|FG000|Overall Study|Randomized but not Treated|0|||
164200957|NCT02497469|593108404|FG001|Overall Study|Randomized but not Treated|2|||
164200958|NCT02497469|593108403|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
164200959|NCT02497469|593108404|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
164200960|NCT02497469|593108403|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
164200961|NCT02497469|593108404|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
164200962|NCT02497469|593108403|FG000|Overall Study|Significant Protocol Deviation|4|||
164200963|NCT02497469|593108404|FG001|Overall Study|Significant Protocol Deviation|5|||
164200964|NCT02497469|593108403|FG000|Overall Study|Lost to Follow-up|14|||
164200965|NCT02497469|593108404|FG001|Overall Study|Lost to Follow-up|4|||
164200966|NCT02497469|593108403|FG000|Overall Study|Voluntary Withdrawal|39|||
164200967|NCT02497469|593108404|FG001|Overall Study|Voluntary Withdrawal|41|||
164200968|NCT02497469|593108403|FG000|Overall Study|Pregnancy|1|||
164200969|NCT02497469|593108404|FG001|Overall Study|Pregnancy|1|||
164200970|NCT02497469|593108403|FG000|Overall Study|Lack of Efficacy|86|||
164200971|NCT02497469|593108404|FG001|Overall Study|Lack of Efficacy|40|||
164200972|NCT02497469|593108403|FG000|Overall Study|Reason not Specified|6|||
164309774|NCT04163016|593508155|FG002|Treatment|Indeterminate TB-test|0|||
164309775|NCT04163016|593508156|FG003|Treatment|Indeterminate TB-test|1|||
164309776|NCT04163016|593508153|FG000|Treatment|Participant did not want to continue in study|0|||
164309777|NCT04163016|593508154|FG001|Treatment|Participant did not want to continue in study|0|||
164200973|NCT02497469|593108404|FG001|Overall Study|Reason not Specified|6|||
164200974|NCT03558516|593108405|FG000|Overall Study|Protocol Violation|2|||
164200975|NCT03558516|593108406|FG001|Overall Study|Protocol Violation|2|||
164200976|NCT01462942|593108410|FG000|Overall Study|Adverse Event|7|||
164200977|NCT01462942|593108411|FG001|Overall Study|Adverse Event|12|||
164200978|NCT01462942|593108412|FG002|Overall Study|Adverse Event|10|||
164200979|NCT01462942|593108413|FG003|Overall Study|Adverse Event|11|||
164200980|NCT01462942|593108414|FG004|Overall Study|Adverse Event|11|||
164200981|NCT01462942|593108410|FG000|Overall Study|Other, including COPD exacerbation|3|||
164200982|NCT01462942|593108411|FG001|Overall Study|Other, including COPD exacerbation|5|||
164200983|NCT01462942|593108412|FG002|Overall Study|Other, including COPD exacerbation|2|||
164200984|NCT01462942|593108413|FG003|Overall Study|Other, including COPD exacerbation|8|||
164200985|NCT01462942|593108414|FG004|Overall Study|Other, including COPD exacerbation|5|||
164200986|NCT01462942|593108410|FG000|Overall Study|Withdrawal by Subject|14|||
164309778|NCT04163016|593508155|FG002|Treatment|Participant did not want to continue in study|0|||
164309779|NCT04163016|593508156|FG003|Treatment|Participant did not want to continue in study|1|||
164309780|NCT01104311|593508158|FG000|Overall Study|Withdrawal by Subject|6|||
164309781|NCT01104311|593508159|FG001|Overall Study|Withdrawal by Subject|6|||
164309782|NCT01104311|593508158|FG000|Overall Study|Protocol Violation|0|||
164309783|NCT01104311|593508159|FG001|Overall Study|Protocol Violation|1|||
164309784|NCT01104311|593508158|FG000|Overall Study|Physician Decision|2|||
164309785|NCT01104311|593508159|FG001|Overall Study|Physician Decision|2|||
164309786|NCT01104311|593508158|FG000|Overall Study|low compliance|1|||
164309787|NCT01104311|593508159|FG001|Overall Study|low compliance|1|||
164309788|NCT01104311|593508158|FG000|Overall Study|Adverse Event|1|||
164309789|NCT01104311|593508159|FG001|Overall Study|Adverse Event|2|||
164309790|NCT04434937|593508161|FG000|Overall Study|Death|4|||
164309791|NCT04434937|593508161|FG000|Overall Study|Withdrawal by Subject|1|||
164309792|NCT04434937|593508161|FG000|Overall Study|Transitioned to Rollover Study|19|||
164309793|NCT04434937|593508161|FG000|Overall Study|Progressive Disease|18|||
164309794|NCT04193189|593508166|FG000|Overall Study|Lost to Follow-up|9|||
164309795|NCT04193189|593508167|FG001|Overall Study|Lost to Follow-up|7|||
164309796|NCT04193189|593508168|FG002|Overall Study|Lost to Follow-up|9|||
164309797|NCT04193189|593508169|FG003|Overall Study|Lost to Follow-up|0|||
164309798|NCT04193189|593508166|FG000|Overall Study|Withdrawal by Subject|1|||
164309799|NCT04193189|593508167|FG001|Overall Study|Withdrawal by Subject|2|||
164309800|NCT04193189|593508168|FG002|Overall Study|Withdrawal by Subject|2|||
164309801|NCT04193189|593508169|FG003|Overall Study|Withdrawal by Subject|0|||
164309802|NCT04193189|593508166|FG000|Overall Study|Death|1|||
164309803|NCT04193189|593508167|FG001|Overall Study|Death|1|||
164309804|NCT04193189|593508168|FG002|Overall Study|Death|0|||
164309805|NCT04193189|593508169|FG003|Overall Study|Death|0|||
164309806|NCT04193189|593508166|FG000|Overall Study|Protocol Violation|0|||
164309807|NCT04193189|593508167|FG001|Overall Study|Protocol Violation|0|||
164309808|NCT04193189|593508168|FG002|Overall Study|Protocol Violation|0|||
164309809|NCT04193189|593508169|FG003|Overall Study|Protocol Violation|1|||
164309810|NCT04549545|593509504|FG000|Initial Period|Withdrawal by Subject|4|||
164309811|NCT04549545|593509505|FG001|Initial Period|Withdrawal by Subject|0|||
164309812|NCT04549545|593509504|FG000|Initial Period|Additional ENT Procedure|3|||
164309813|NCT04549545|593509505|FG001|Initial Period|Additional ENT Procedure|0|||
164309814|NCT04549545|593509504|FG000|Initial Period|Lost to Follow-up|3|||
164309815|NCT04549545|593509505|FG001|Initial Period|Lost to Follow-up|1|||
164309816|NCT04549545|593509504|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
164309817|NCT04549545|593509505|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
164309818|NCT04549545|593509504|FG000|Crossover Period|Additional ENT Procedure|0|||
164309819|NCT04549545|593509505|FG001|Crossover Period|Additional ENT Procedure|6|||
164309820|NCT04549545|593509504|FG000|Crossover Period|Lost to Follow-up|0|||
164309821|NCT04549545|593509505|FG001|Crossover Period|Lost to Follow-up|1|||
164309822|NCT04549545|593509504|FG000|Crossover Period|Withdrawal by Subject|0|||
164309823|NCT04549545|593509505|FG001|Crossover Period|Withdrawal by Subject|4|||
164309824|NCT00295880|593509509|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
164309825|NCT00295880|593509509|FG000|Overall Study|Unit randomization did not occur|1|||
164309826|NCT01474239|593509510|FG000|Overall Study|Disease Progression|37|||
164309827|NCT01474239|593509511|FG001|Overall Study|Disease Progression|25|||
164309828|NCT01474239|593509510|FG000|Overall Study|Adverse Event|12|||
164309829|NCT01474239|593509511|FG001|Overall Study|Adverse Event|3|||
164309830|NCT01474239|593509510|FG000|Overall Study|Withdrawal by Subject|1|||
164309831|NCT01474239|593509511|FG001|Overall Study|Withdrawal by Subject|2|||
164309832|NCT01474239|593509510|FG000|Overall Study|Death|1|||
164309833|NCT01474239|593509511|FG001|Overall Study|Death|1|||
164309834|NCT01474239|593509510|FG000|Overall Study|Clinical Disease Progression|7|||
164309835|NCT01474239|593509511|FG001|Overall Study|Clinical Disease Progression|1|||
164309836|NCT01474239|593509510|FG000|Overall Study|Withdrawal for Economic Reason|1|||
164309837|NCT01474239|593509511|FG001|Overall Study|Withdrawal for Economic Reason|0|||
164309838|NCT01243242|593509512|FG000|Overall Study|Adverse Event|1|||
164309839|NCT01243242|593509513|FG001|Overall Study|Adverse Event|1|||
164309840|NCT01243242|593509512|FG000|Overall Study|Withdrawal by Subject|1|||
164309841|NCT01243242|593509513|FG001|Overall Study|Withdrawal by Subject|1|||
164309842|NCT01243242|593509512|FG000|Overall Study|Physician Decision|0|||
164309843|NCT01243242|593509513|FG001|Overall Study|Physician Decision|1|||
164309844|NCT01243242|593509512|FG000|Overall Study|sponsor decision|0|||
164309845|NCT01243242|593509513|FG001|Overall Study|sponsor decision|1|||
164309846|NCT01243242|593509512|FG000|Overall Study|non compliance|1|||
164309847|NCT01243242|593509513|FG001|Overall Study|non compliance|0|||
164309848|NCT03983317|593509514|FG000|Overall Study|Physician Decision|5|||
164309849|NCT00792571|593509515|FG000|Overall Study|Death|1|||
164309850|NCT00792571|593509515|FG000|Overall Study|Adverse Event|4|||
164309851|NCT00792571|593509515|FG000|Overall Study|Withdrawal by Subject|1|||
164309852|NCT00792571|593509515|FG000|Overall Study|Other|4|||
164309853|NCT03790696|593509517|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
164309854|NCT03790696|593509518|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
164309855|NCT04896086|593509519|FG000|Overall Study|Lost to Follow-up|0|||
164309856|NCT04896086|593509520|FG001|Overall Study|Lost to Follow-up|2|||
164309857|NCT04896086|593509521|FG002|Overall Study|Lost to Follow-up|1|||
164309858|NCT04896086|593509522|FG003|Overall Study|Lost to Follow-up|0|||
164309859|NCT04896086|593509523|FG004|Overall Study|Lost to Follow-up|0|||
164309860|NCT04896086|593509519|FG000|Overall Study|Physician Decision|0|||
164309861|NCT04896086|593509520|FG001|Overall Study|Physician Decision|1|||
164309862|NCT04896086|593509521|FG002|Overall Study|Physician Decision|0|||
164309863|NCT04896086|593509522|FG003|Overall Study|Physician Decision|0|||
164309864|NCT04896086|593509523|FG004|Overall Study|Physician Decision|0|||
164309865|NCT04896086|593509519|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
164309866|NCT04896086|593509520|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
164309867|NCT04896086|593509521|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
164309868|NCT04896086|593509522|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
164309869|NCT04896086|593509523|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
164309870|NCT04896086|593509519|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
164309871|NCT04896086|593509520|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
164309872|NCT04896086|593509521|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
164309873|NCT04896086|593509522|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
164309874|NCT04896086|593509523|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
164309875|NCT02249832|593509524|FG000|Overall Study|Withdrawal by Subject|3|||
164309876|NCT02249832|593509524|FG000|Overall Study|Lost to Follow-up|10|||
164309877|NCT00485134|593509530|FG000|Overall Study|Lost to Follow-up|1|||
164309878|NCT00485134|593509531|FG001|Overall Study|Lost to Follow-up|0|||
164309879|NCT00485134|593509532|FG002|Overall Study|Lost to Follow-up|0|||
164309880|NCT00485134|593509533|FG003|Overall Study|Lost to Follow-up|0|||
164309881|NCT00485134|593509534|FG004|Overall Study|Lost to Follow-up|0|||
164309882|NCT00485134|593509535|FG005|Overall Study|Lost to Follow-up|0|||
164309883|NCT00485134|593509536|FG006|Overall Study|Lost to Follow-up|0|||
164309884|NCT00485134|593509537|FG007|Overall Study|Lost to Follow-up|0|||
164309885|NCT00485134|593509530|FG000|Overall Study|Withdrawal by Subject|0|||
164309886|NCT00485134|593509531|FG001|Overall Study|Withdrawal by Subject|1|||
164309887|NCT00485134|593509532|FG002|Overall Study|Withdrawal by Subject|0|||
164309888|NCT00485134|593509533|FG003|Overall Study|Withdrawal by Subject|0|||
164309889|NCT00485134|593509534|FG004|Overall Study|Withdrawal by Subject|0|||
164309890|NCT00485134|593509535|FG005|Overall Study|Withdrawal by Subject|0|||
164309891|NCT00485134|593509536|FG006|Overall Study|Withdrawal by Subject|0|||
164309892|NCT00485134|593509537|FG007|Overall Study|Withdrawal by Subject|0|||
164309893|NCT00485134|593509530|FG000|Overall Study|Change in health status|0|||
164309894|NCT00485134|593509531|FG001|Overall Study|Change in health status|1|||
164309895|NCT00485134|593509532|FG002|Overall Study|Change in health status|2|||
164309896|NCT00485134|593509533|FG003|Overall Study|Change in health status|1|||
164309897|NCT00485134|593509534|FG004|Overall Study|Change in health status|0|||
164309898|NCT00485134|593509535|FG005|Overall Study|Change in health status|1|||
164309899|NCT00485134|593509536|FG006|Overall Study|Change in health status|0|||
164309900|NCT00485134|593509537|FG007|Overall Study|Change in health status|0|||
164309901|NCT00485134|593509530|FG000|Overall Study|Withdrew for adverse event|0|||
164309902|NCT00485134|593509531|FG001|Overall Study|Withdrew for adverse event|0|||
164309903|NCT00485134|593509532|FG002|Overall Study|Withdrew for adverse event|1|||
164309904|NCT00485134|593509533|FG003|Overall Study|Withdrew for adverse event|0|||
164309905|NCT00485134|593509534|FG004|Overall Study|Withdrew for adverse event|0|||
164309906|NCT00485134|593509535|FG005|Overall Study|Withdrew for adverse event|0|||
164309907|NCT00485134|593509536|FG006|Overall Study|Withdrew for adverse event|0|||
164309908|NCT00485134|593509537|FG007|Overall Study|Withdrew for adverse event|0|||
164309909|NCT00485134|593509530|FG000|Overall Study|Positive drug test|0|||
164309910|NCT00485134|593509531|FG001|Overall Study|Positive drug test|0|||
164309911|NCT00485134|593509532|FG002|Overall Study|Positive drug test|0|||
164309912|NCT00485134|593509533|FG003|Overall Study|Positive drug test|0|||
164309913|NCT00485134|593509534|FG004|Overall Study|Positive drug test|2|||
164309914|NCT00485134|593509535|FG005|Overall Study|Positive drug test|1|||
164309915|NCT00485134|593509536|FG006|Overall Study|Positive drug test|0|||
164309916|NCT00485134|593509537|FG007|Overall Study|Positive drug test|0|||
164309917|NCT00485134|593509530|FG000|Overall Study|Non-compliance|0|||
164309918|NCT00485134|593509531|FG001|Overall Study|Non-compliance|0|||
164309919|NCT00485134|593509532|FG002|Overall Study|Non-compliance|0|||
164309920|NCT00485134|593509533|FG003|Overall Study|Non-compliance|0|||
164309921|NCT00485134|593509534|FG004|Overall Study|Non-compliance|1|||
164309922|NCT00485134|593509535|FG005|Overall Study|Non-compliance|2|||
164551148|NCT00606320|594390095|FG000|Overall Study|Physician Decision|7|||
164551149|NCT00606320|594390095|FG000|Overall Study|Protocol Violation|8|||
164309923|NCT00485134|593509536|FG006|Overall Study|Non-compliance|2|||
164309924|NCT00485134|593509537|FG007|Overall Study|Non-compliance|0|||
164309925|NCT00485134|593509530|FG000|Overall Study|Unable to comply with study schedule|0|||
164551150|NCT00606320|594390095|FG000|Overall Study|Withdrawal by Subject|10|||
164656268|NCT02040766|594766470|FG004|Overall Study|Protocol Violation|0|||
164656269|NCT02040766|594766466|FG000|Overall Study|Lost to Follow-up|4|||
164656270|NCT02040766|594766467|FG001|Overall Study|Lost to Follow-up|1|||
164656271|NCT02040766|594766468|FG002|Overall Study|Lost to Follow-up|3|||
164656272|NCT02040766|594766469|FG003|Overall Study|Lost to Follow-up|1|||
164656273|NCT02040766|594766470|FG004|Overall Study|Lost to Follow-up|4|||
164656274|NCT02040766|594766466|FG000|Overall Study|Not reported|1|||
164656275|NCT02040766|594766467|FG001|Overall Study|Not reported|0|||
164200987|NCT01462942|593108411|FG001|Overall Study|Withdrawal by Subject|10|||
164200988|NCT01462942|593108412|FG002|Overall Study|Withdrawal by Subject|14|||
164200989|NCT01462942|593108413|FG003|Overall Study|Withdrawal by Subject|16|||
164200990|NCT01462942|593108414|FG004|Overall Study|Withdrawal by Subject|19|||
164200991|NCT01462942|593108410|FG000|Overall Study|Lack of Efficacy|6|||
164200992|NCT01462942|593108411|FG001|Overall Study|Lack of Efficacy|0|||
164200993|NCT01462942|593108412|FG002|Overall Study|Lack of Efficacy|4|||
164200994|NCT01462942|593108413|FG003|Overall Study|Lack of Efficacy|5|||
164200995|NCT01462942|593108414|FG004|Overall Study|Lack of Efficacy|3|||
164200996|NCT01462942|593108410|FG000|Overall Study|Lost to Follow-up|0|||
164200997|NCT01462942|593108411|FG001|Overall Study|Lost to Follow-up|1|||
164200998|NCT01462942|593108412|FG002|Overall Study|Lost to Follow-up|1|||
164200999|NCT01462942|593108413|FG003|Overall Study|Lost to Follow-up|1|||
164201000|NCT01462942|593108414|FG004|Overall Study|Lost to Follow-up|1|||
164201001|NCT01462942|593108410|FG000|Overall Study|Protocol Violation|4|||
164201002|NCT01462942|593108411|FG001|Overall Study|Protocol Violation|6|||
164201003|NCT01462942|593108412|FG002|Overall Study|Protocol Violation|9|||
164201004|NCT01462942|593108413|FG003|Overall Study|Protocol Violation|9|||
164201005|NCT01462942|593108414|FG004|Overall Study|Protocol Violation|6|||
164201006|NCT00572832|593108436|FG000|Overall Study|Lost to Follow-up|0|||
164201007|NCT00572832|593108437|FG001|Overall Study|Lost to Follow-up|11|||
164201008|NCT00572832|593108436|FG000|Overall Study|Pregnancy|0|||
164201009|NCT00572832|593108437|FG001|Overall Study|Pregnancy|1|||
164201010|NCT01604785|593108442|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
164201011|NCT01604785|593108443|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
164201012|NCT05214118|593108444|FG000|Overall Study|Lost to Follow-up|0|||
164201013|NCT05214118|593108445|FG001|Overall Study|Lost to Follow-up|2|||
164201014|NCT05214118|593108444|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
164201015|NCT05214118|593108445|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
164201016|NCT05214118|593108444|FG000|Overall Study|moved|1|||
164201017|NCT05214118|593108445|FG001|Overall Study|moved|0|||
164201018|NCT00931632|593108446|FG000|Overall Study|Withdrawal by Subject|2|||
164201019|NCT00931632|593108447|FG001|Overall Study|Withdrawal by Subject|3|||
164201020|NCT00931632|593108446|FG000|Overall Study|Adverse Event|19|||
164201021|NCT00931632|593108447|FG001|Overall Study|Adverse Event|15|||
164201022|NCT01419314|593108449|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
164201023|NCT01419314|593108450|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
164201024|NCT01419314|593108449|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
164201025|NCT01419314|593108450|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
164201026|NCT01419314|593108449|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
164201027|NCT01419314|593108450|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
164201028|NCT00449163|593108451|FG000|Overall Study|Physician Decision|3|||
164201029|NCT03368807|593108454|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
164201030|NCT03368807|593108454|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
164201031|NCT03368807|593108454|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
164201032|NCT03368807|593108454|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
164201033|NCT01118052|593108455|FG000|Overall Study|Never treated|2|||
164201034|NCT00843492|593108457|FG000|Overall Study|Adverse Event|0|||
164201035|NCT00843492|593108458|FG001|Overall Study|Adverse Event|3|||
164201036|NCT00843492|593108457|FG000|Overall Study|Lost to Follow-up|4|||
164201037|NCT00843492|593108458|FG001|Overall Study|Lost to Follow-up|4|||
164201038|NCT00843492|593108457|FG000|Overall Study|Withdrawal by Subject|0|||
164201039|NCT00843492|593108458|FG001|Overall Study|Withdrawal by Subject|4|||
164201040|NCT00843492|593108457|FG000|Overall Study|Immobilization Stopped|1|||
164201041|NCT00843492|593108458|FG001|Overall Study|Immobilization Stopped|0|||
164656276|NCT02040766|594766468|FG002|Overall Study|Not reported|0|||
164656277|NCT02040766|594766469|FG003|Overall Study|Not reported|0|||
164656278|NCT02040766|594766470|FG004|Overall Study|Not reported|0|||
164201042|NCT00843492|593108457|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
164201043|NCT00843492|593108458|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
164201044|NCT00843492|593108457|FG000|Overall Study|Orthopedic Surgery|0|||
164201045|NCT00843492|593108458|FG001|Overall Study|Orthopedic Surgery|2|||
164201046|NCT00843492|593108457|FG000|Overall Study|Visit Not Performed|1|||
164201047|NCT00843492|593108458|FG001|Overall Study|Visit Not Performed|0|||
164201048|NCT00843492|593108457|FG000|Overall Study|Deep-vein Thrombosis|1|||
164201049|NCT00843492|593108458|FG001|Overall Study|Deep-vein Thrombosis|0|||
164201050|NCT01677741|593108460|FG000|Overall Study|Death|0|||
164201051|NCT01677741|593108461|FG001|Overall Study|Death|0|||
164656279|NCT02040766|594766466|FG000|Overall Study|Lack of Efficacy|6|||
164656280|NCT02040766|594766467|FG001|Overall Study|Lack of Efficacy|3|||
164656281|NCT02040766|594766468|FG002|Overall Study|Lack of Efficacy|4|||
164656282|NCT02040766|594766469|FG003|Overall Study|Lack of Efficacy|6|||
164656283|NCT02040766|594766470|FG004|Overall Study|Lack of Efficacy|5|||
164656284|NCT01620983|594766475|FG000|Overall Study|Lost to Follow-up|8|||
164656285|NCT01620983|594766476|FG001|Overall Study|Lost to Follow-up|4|||
164656286|NCT01620983|594766477|FG002|Overall Study|Lost to Follow-up|9|||
164656287|NCT01620983|594766475|FG000|Overall Study|Withdrawal by Subject|6|||
164656288|NCT01620983|594766476|FG001|Overall Study|Withdrawal by Subject|8|||
164656289|NCT01620983|594766477|FG002|Overall Study|Withdrawal by Subject|1|||
164656290|NCT01620983|594766475|FG000|Overall Study|Death|2|||
164656291|NCT01620983|594766476|FG001|Overall Study|Death|0|||
164656292|NCT01620983|594766477|FG002|Overall Study|Death|0|||
164656293|NCT01620983|594766475|FG000|Overall Study|Physician Decision|3|||
164656294|NCT01620983|594766476|FG001|Overall Study|Physician Decision|10|||
164656295|NCT01620983|594766477|FG002|Overall Study|Physician Decision|5|||
164656296|NCT00798889|594766479|FG000|Overall Study|Adverse Event|53|||
164656297|NCT00798889|594766479|FG000|Overall Study|Protocol Violation|2|||
164656298|NCT00798889|594766479|FG000|Overall Study|Withdrawal by Subject|31|||
164551151|NCT00606320|594390095|FG000|Overall Study|Progression to depressive phase|4|||
164551152|NCT00939783|594390097|FG000|Overall Study|Death|6|||
164656299|NCT00798889|594766479|FG000|Overall Study|Lost to Follow-up|1|||
164656300|NCT00798889|594766479|FG000|Overall Study|Lack of Efficacy|213|||
164656301|NCT00798889|594766479|FG000|Overall Study|Decision of Sponsor|11|||
164656302|NCT00798889|594766479|FG000|Overall Study|Enrolled, Not treated|3|||
164656303|NCT00617461|594766480|FG000|First Treatment Intervention Period|Adverse Event|2|||
164656304|NCT00617461|594766481|FG001|First Treatment Intervention Period|Adverse Event|0|||
164656305|NCT00617461|594766480|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
164656306|NCT00617461|594766481|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
164656307|NCT00617461|594766480|FG000|First Treatment Intervention Period|Protocol Violation|2|||
164656308|NCT00617461|594766481|FG001|First Treatment Intervention Period|Protocol Violation|1|||
164656309|NCT00617461|594766480|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
164656310|NCT00617461|594766481|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
164656311|NCT00617461|594766480|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
164656312|NCT00617461|594766481|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
164656313|NCT00617461|594766480|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
164656314|NCT00617461|594766481|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
164656315|NCT00617461|594766480|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
164656316|NCT00617461|594766481|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
164656317|NCT00617461|594766480|FG000|Second Treatment Intervention Period|Adverse Event|0|||
164656318|NCT00617461|594766481|FG001|Second Treatment Intervention Period|Adverse Event|1|||
164656319|NCT00617461|594766480|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
164656320|NCT00617461|594766481|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
164201052|NCT01677741|593108462|FG002|Overall Study|Death|0|||
164201053|NCT01677741|593108463|FG003|Overall Study|Death|1|||
164201054|NCT01677741|593108464|FG004|Overall Study|Death|0|||
164551153|NCT00939783|594390097|FG000|Overall Study|Adverse Event|39|||
164551154|NCT00939783|594390097|FG000|Overall Study|Study Terminated by Sponsor|498|||
164551155|NCT00939783|594390097|FG000|Overall Study|Withdrawal by Subject|78|||
164551156|NCT00939783|594390097|FG000|Overall Study|Other|16|||
164551157|NCT00939783|594390097|FG000|Overall Study|Lost to Follow-up|8|||
164551158|NCT00939783|594390097|FG000|Overall Study|Protocol Violation|3|||
164551159|NCT00939783|594390097|FG000|Overall Study|Enrolled but not treated|1|||
164551160|NCT04839380|594390098|FG000|Overall Study|Withdrawal by Subject|2|||
164551161|NCT04839380|594390098|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
164551162|NCT01549002|594390102|FG000|Overall Study|Excessive pain|0|||
164551163|NCT01549002|594390103|FG001|Overall Study|Excessive pain|2|||
164551164|NCT01549002|594390102|FG000|Overall Study|Moderate sedation required|0|||
164551165|NCT01549002|594390103|FG001|Overall Study|Moderate sedation required|2|||
164551166|NCT00749996|594390104|FG000|Overall Study|Lost to Follow-up|7|||
164551167|NCT00749996|594390105|FG001|Overall Study|Lost to Follow-up|4|||
164551168|NCT00749996|594390104|FG000|Overall Study|Withdrawal by Subject|5|||
164551169|NCT00749996|594390105|FG001|Overall Study|Withdrawal by Subject|4|||
164656321|NCT00617461|594766480|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
164656322|NCT00617461|594766481|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
164656323|NCT00617461|594766480|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
164656324|NCT00617461|594766481|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
164656325|NCT05085964|594766482|FG000|Overall Study|Premature termination of study|21|||
164656326|NCT05085964|594766483|FG001|Overall Study|Premature termination of study|0|||
164656327|NCT01821625|594766484|FG000|Overall Study|Withdrawal by Subject|2|||
164656328|NCT01821625|594766484|FG000|Overall Study|Lack of Efficacy|2|||
164201055|NCT01677741|593108465|FG005|Overall Study|Death|1|||
164201056|NCT01677741|593108466|FG006|Overall Study|Death|0|||
164551170|NCT00749996|594390104|FG000|Overall Study|Protocol Violation|2|||
164551171|NCT00749996|594390105|FG001|Overall Study|Protocol Violation|3|||
164656329|NCT01821625|594766484|FG000|Overall Study|Adverse Event|1|||
164656330|NCT01821625|594766484|FG000|Overall Study|Medical contraindication|1|||
164656331|NCT03156270|594766486|FG000|Overall Study|Failed pre-treatment screening|1|||
164656332|NCT03156270|594766486|FG000|Overall Study|Lost to Follow-up|1|||
164656333|NCT01620489|594766487|FG000|Overall Study|Adverse Event|17|||
164656334|NCT01620489|594766488|FG001|Overall Study|Adverse Event|4|||
164656335|NCT01620489|594766487|FG000|Overall Study|Protocol Violation|0|||
164656336|NCT01620489|594766488|FG001|Overall Study|Protocol Violation|3|||
164656337|NCT01620489|594766487|FG000|Overall Study|Withdrawal Criteria|17|||
164656338|NCT01620489|594766488|FG001|Overall Study|Withdrawal Criteria|25|||
164656339|NCT01620489|594766487|FG000|Overall Study|Unclassified|1|||
164656340|NCT01620489|594766488|FG001|Overall Study|Unclassified|2|||
164656341|NCT00982410|594768311|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
164656342|NCT00982410|594768312|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
164656343|NCT00982410|594768311|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
164656344|NCT00982410|594768312|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
164656345|NCT00982410|594768311|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
164656346|NCT00982410|594768312|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
164656347|NCT00982410|594768311|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
164656348|NCT00982410|594768312|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
164656349|NCT00982410|594768311|FG000|6-month Follow-up Assessment|participant no transportation|1|||
164656350|NCT00982410|594768312|FG001|6-month Follow-up Assessment|participant no transportation|0|||
164656351|NCT00982410|594768311|FG000|6-month Follow-up Assessment|incarceration|0|||
164656352|NCT00982410|594768312|FG001|6-month Follow-up Assessment|incarceration|2|||
164656353|NCT00982410|594768311|FG000|6-month Follow-up Assessment|patent surgery|0|||
164656354|NCT00982410|594768312|FG001|6-month Follow-up Assessment|patent surgery|1|||
164656355|NCT00982410|594768311|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
164656356|NCT00982410|594768312|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
164656357|NCT00982410|594768311|FG000|12-month Follow-up Assessment|Death|0|||
164656358|NCT00982410|594768312|FG001|12-month Follow-up Assessment|Death|2|||
164656359|NCT00982410|594768311|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
164656360|NCT00982410|594768312|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
164656361|NCT00982410|594768311|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
164656362|NCT00982410|594768312|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
164656363|NCT00982410|594768311|FG000|12-month Follow-up Assessment|incarceration|2|||
164656364|NCT00982410|594768312|FG001|12-month Follow-up Assessment|incarceration|1|||
164656365|NCT00982410|594768311|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
164656366|NCT00982410|594768312|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
164656367|NCT02034799|594768315|FG000|Overall Study|Withdrawal by Subject|0|||
164656368|NCT02034799|594768316|FG001|Overall Study|Withdrawal by Subject|2|||
164656369|NCT02034799|594768315|FG000|Overall Study|Lost to Follow-up|0|||
164656370|NCT02034799|594768316|FG001|Overall Study|Lost to Follow-up|1|||
164656371|NCT02034799|594768315|FG000|Overall Study|Death|2|||
164656372|NCT02034799|594768316|FG001|Overall Study|Death|1|||
164656373|NCT03381248|594768319|FG000|0-6 Months|Withdrawal by Subject|4|||
164656374|NCT03381248|594768320|FG001|0-6 Months|Withdrawal by Subject|1|||
164656375|NCT03381248|594768319|FG000|0-6 Months|Lost to Follow-up|3|||
164656376|NCT03381248|594768320|FG001|0-6 Months|Lost to Follow-up|2|||
164656377|NCT03381248|594768319|FG000|0-6 Months|Lack of Efficacy|1|||
164656378|NCT03381248|594768320|FG001|0-6 Months|Lack of Efficacy|0|||
164656379|NCT03381248|594768319|FG000|0-6 Months|Adverse Event|1|||
164656380|NCT03381248|594768320|FG001|0-6 Months|Adverse Event|0|||
164656381|NCT03381248|594768319|FG000|0-6 Months|Protocol Violation|2|||
164656382|NCT03381248|594768320|FG001|0-6 Months|Protocol Violation|1|||
164656383|NCT03381248|594768319|FG000|0-6 Months|Physician Decision|1|||
164656384|NCT03381248|594768320|FG001|0-6 Months|Physician Decision|0|||
164656385|NCT03381248|594768319|FG000|0-6 Months|Planning another procedure|1|||
164656386|NCT03381248|594768320|FG001|0-6 Months|Planning another procedure|2|||
164656387|NCT03381248|594768319|FG000|6-12 Months|Withdrawal by Subject|1|||
164656388|NCT03381248|594768320|FG001|6-12 Months|Withdrawal by Subject|3|||
164656389|NCT03381248|594768319|FG000|6-12 Months|Lost to Follow-up|0|||
164656390|NCT03381248|594768320|FG001|6-12 Months|Lost to Follow-up|2|||
164309926|NCT00485134|593509531|FG001|Overall Study|Unable to comply with study schedule|0|||
164656391|NCT03381248|594768319|FG000|6-12 Months|Protocol Violation|3|||
164656392|NCT03381248|594768320|FG001|6-12 Months|Protocol Violation|2|||
164656393|NCT03381248|594768319|FG000|6-12 Months|Planning another procedure|6|||
164656394|NCT03381248|594768320|FG001|6-12 Months|Planning another procedure|2|||
164656395|NCT03381248|594768319|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
164656396|NCT03381248|594768320|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
164656397|NCT03381248|594768319|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
164656398|NCT03381248|594768320|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
164656399|NCT03381248|594768319|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
164656400|NCT03381248|594768320|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
164656401|NCT01341639|594768325|FG000|Infant Series|Protocol Violation|1|||
164551172|NCT00749996|594390104|FG000|Overall Study|Physician Decision|2|||
164551173|NCT00749996|594390105|FG001|Overall Study|Physician Decision|0|||
164551174|NCT00749996|594390104|FG000|Overall Study|Pregnancy|0|||
164551175|NCT00749996|594390105|FG001|Overall Study|Pregnancy|2|||
164551176|NCT00749996|594390104|FG000|Overall Study|Adverse Event|1|||
164551177|NCT00749996|594390105|FG001|Overall Study|Adverse Event|0|||
164551178|NCT00749996|594390104|FG000|Overall Study|Death|1|||
164551179|NCT00749996|594390105|FG001|Overall Study|Death|0|||
164551180|NCT00996944|594390106|FG000|Double-blind Treatment Period|Adverse Event|2|||
164551181|NCT00996944|594390107|FG001|Double-blind Treatment Period|Adverse Event|1|||
164551182|NCT00996944|594390106|FG000|Double-blind Treatment Period|Protocol Violation|1|||
164551183|NCT00996944|594390107|FG001|Double-blind Treatment Period|Protocol Violation|0|||
164551184|NCT00996944|594390106|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
164551185|NCT00996944|594390107|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
164551186|NCT00996944|594390106|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
164551187|NCT00996944|594390107|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
164551188|NCT00996944|594390106|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
164551189|NCT00996944|594390107|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
164551190|NCT03775421|594390110|FG000|Overall Study|Lost to Follow-up|2|||
164551191|NCT03775421|594390110|FG000|Overall Study|Withdrawal by Subject|10|||
164551192|NCT03775421|594390110|FG000|Overall Study|Physician Decision|3|||
164551193|NCT03775421|594390110|FG000|Overall Study|Death|1|||
164551194|NCT03775421|594390110|FG000|Overall Study|Study Terminated by Sponsor|94|||
164551195|NCT04247061|594390113|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
164551196|NCT04247061|594390113|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
164551197|NCT04247061|594390113|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
164551198|NCT01378104|594390114|FG000|Overall Study|Adverse Event|8|||
164551199|NCT01378104|594390115|FG001|Overall Study|Adverse Event|8|||
164551200|NCT01378104|594390114|FG000|Overall Study|Lack of Efficacy|7|||
164551201|NCT01378104|594390115|FG001|Overall Study|Lack of Efficacy|5|||
164551202|NCT01378104|594390114|FG000|Overall Study|Withdrawal by Subject|12|||
164551203|NCT01378104|594390115|FG001|Overall Study|Withdrawal by Subject|13|||
164551204|NCT02287623|594390116|FG000|Overall Study|Protocol Violation|0|||
164551205|NCT02287623|594390117|FG001|Overall Study|Protocol Violation|1|||
164551206|NCT00205855|594390118|FG000|Overall Study|Only received temporary implants|16|||
164551207|NCT00205855|594390118|FG000|Overall Study|Withdrawal by Subject|5|||
164551208|NCT01445951|594390122|FG000|Overall Study|Adverse Event|16|||
164551209|NCT01445951|594390123|FG001|Overall Study|Adverse Event|9|||
164551210|NCT01445951|594390124|FG002|Overall Study|Adverse Event|0|||
164551211|NCT01445951|594390122|FG000|Overall Study|Protocol Violation|2|||
164551212|NCT01445951|594390123|FG001|Overall Study|Protocol Violation|2|||
164551213|NCT01445951|594390124|FG002|Overall Study|Protocol Violation|2|||
164551214|NCT01445951|594390122|FG000|Overall Study|Withdrawal by Subject|21|||
164551215|NCT01445951|594390123|FG001|Overall Study|Withdrawal by Subject|16|||
164551216|NCT01445951|594390124|FG002|Overall Study|Withdrawal by Subject|8|||
164551217|NCT01445951|594390122|FG000|Overall Study|Physician Decision|3|||
164551218|NCT01445951|594390123|FG001|Overall Study|Physician Decision|1|||
164551219|NCT01445951|594390124|FG002|Overall Study|Physician Decision|0|||
164551220|NCT01445951|594390122|FG000|Overall Study|Lost to Follow-up|1|||
164551221|NCT01445951|594390123|FG001|Overall Study|Lost to Follow-up|2|||
164551222|NCT01445951|594390124|FG002|Overall Study|Lost to Follow-up|4|||
164551223|NCT01445951|594390122|FG000|Overall Study|Pregnancy|0|||
164551224|NCT01445951|594390123|FG001|Overall Study|Pregnancy|1|||
164551225|NCT01445951|594390124|FG002|Overall Study|Pregnancy|4|||
164551226|NCT01445951|594390122|FG000|Overall Study|Death|0|||
164551227|NCT01445951|594390123|FG001|Overall Study|Death|0|||
164551228|NCT01445951|594390124|FG002|Overall Study|Death|1|||
164551229|NCT01445951|594390122|FG000|Overall Study|Non-compliance with study drug|1|||
164551230|NCT01445951|594390123|FG001|Overall Study|Non-compliance with study drug|2|||
164551231|NCT01445951|594390124|FG002|Overall Study|Non-compliance with study drug|0|||
164551232|NCT01445951|594390122|FG000|Overall Study|Non-compliance with protocol|0|||
164551233|NCT01445951|594390123|FG001|Overall Study|Non-compliance with protocol|1|||
164551234|NCT01445951|594390124|FG002|Overall Study|Non-compliance with protocol|0|||
164551235|NCT01445951|594390122|FG000|Overall Study|Sponsor decision - subject travel|0|||
164551236|NCT01445951|594390123|FG001|Overall Study|Sponsor decision - subject travel|1|||
164551237|NCT01445951|594390124|FG002|Overall Study|Sponsor decision - subject travel|0|||
164551238|NCT01445951|594390122|FG000|Overall Study|Cough|0|||
164551239|NCT01445951|594390123|FG001|Overall Study|Cough|1|||
164551240|NCT01445951|594390124|FG002|Overall Study|Cough|0|||
164551241|NCT02739620|594390127|FG000|Overall Study|Lost to Follow-up|3|||
164551242|NCT02739620|594390128|FG001|Overall Study|Lost to Follow-up|1|||
164656402|NCT01341639|594768326|FG001|Infant Series|Protocol Violation|0|||
164551243|NCT02739620|594390127|FG000|Overall Study|Adverse Event|0|||
164551244|NCT02739620|594390128|FG001|Overall Study|Adverse Event|1|||
164551245|NCT02039375|594390137|FG000|Overall Study|Lost to Follow-up|2|||
164551246|NCT03891264|594390139|FG000|Overall Study|Adverse Event|1|||
164656403|NCT01341639|594768325|FG000|Infant Series|Not Vaccinated|0|||
164656404|NCT01341639|594768326|FG001|Infant Series|Not Vaccinated|1|||
164656405|NCT01341639|594768325|FG000|Infant Series|Adverse Event|0|||
164656406|NCT01341639|594768326|FG001|Infant Series|Adverse Event|5|||
164656407|NCT01341639|594768325|FG000|Infant Series|Withdrawal by Subject|11|||
164656408|NCT01341639|594768326|FG001|Infant Series|Withdrawal by Subject|8|||
164656409|NCT01341639|594768325|FG000|Infant Series|Lost to Follow-up|0|||
164656410|NCT01341639|594768326|FG001|Infant Series|Lost to Follow-up|2|||
164656411|NCT01341639|594768325|FG000|Infant Series|Site 0048 Participants|17|||
164656412|NCT01341639|594768326|FG001|Infant Series|Site 0048 Participants|16|||
164656413|NCT01341639|594768325|FG000|Interim Period|Withdrawal by Subject|6|||
164656414|NCT01341639|594768326|FG001|Interim Period|Withdrawal by Subject|7|||
164656415|NCT01341639|594768325|FG000|Interim Period|Lost to Follow-up|2|||
164656416|NCT01341639|594768326|FG001|Interim Period|Lost to Follow-up|0|||
164656417|NCT01341639|594768325|FG000|Interim Period|Physician Decision|0|||
164656418|NCT01341639|594768326|FG001|Interim Period|Physician Decision|1|||
164656419|NCT01341639|594768325|FG000|Interim Period|Protocol Violation|0|||
164656420|NCT01341639|594768326|FG001|Interim Period|Protocol Violation|1|||
164656421|NCT01341639|594768325|FG000|Post-Treatment|Withdrawal by Subject|0|||
164656422|NCT01341639|594768326|FG001|Post-Treatment|Withdrawal by Subject|1|||
164656423|NCT01341639|594768325|FG000|Post-Treatment|Adverse Event|0|||
164656424|NCT01341639|594768326|FG001|Post-Treatment|Adverse Event|2|||
164656425|NCT01590433|594768327|FG000|Overall Study|Lost to Follow-up|20|||
164656426|NCT01590433|594768328|FG001|Overall Study|Lost to Follow-up|8|||
164656427|NCT01590433|594768327|FG000|Overall Study|Withdrawal by Subject|21|||
164656428|NCT01590433|594768328|FG001|Overall Study|Withdrawal by Subject|11|||
164656429|NCT01590433|594768327|FG000|Overall Study|Adverse Event|11|||
164656430|NCT01590433|594768328|FG001|Overall Study|Adverse Event|3|||
164656431|NCT00555009|594768329|FG000|Overall Study|Withdrawal by Subject|0|||
164656432|NCT00555009|594768330|FG001|Overall Study|Withdrawal by Subject|1|||
164656433|NCT00555009|594768329|FG000|Overall Study|Terminated by Sponsor|2|||
164656434|NCT00555009|594768330|FG001|Overall Study|Terminated by Sponsor|5|||
164656435|NCT02040428|594768331|FG000|Overall Study|Death|4|||
164656436|NCT02040428|594768332|FG001|Overall Study|Death|3|||
164656437|NCT02040428|594768331|FG000|Overall Study|Withdrawal by Subject|1|||
164656438|NCT02040428|594768332|FG001|Overall Study|Withdrawal by Subject|1|||
164656439|NCT02058628|594768333|FG000|Overall Study|Adverse Event|1|||
164656440|NCT02058628|594768334|FG001|Overall Study|Adverse Event|0|||
164656441|NCT02058628|594768333|FG000|Overall Study|Withdrawal by Subject|2|||
164656442|NCT02058628|594768334|FG001|Overall Study|Withdrawal by Subject|2|||
164656443|NCT02058628|594768333|FG000|Overall Study|Lost to Follow-up|2|||
164656444|NCT02058628|594768334|FG001|Overall Study|Lost to Follow-up|4|||
164656445|NCT02058628|594768333|FG000|Overall Study|Not in time schedule|0|||
164656446|NCT02058628|594768334|FG001|Overall Study|Not in time schedule|1|||
164656447|NCT02058628|594768333|FG000|Overall Study|The visit date was not in timeline|0|||
164656448|NCT02058628|594768334|FG001|Overall Study|The visit date was not in timeline|1|||
164656449|NCT02058628|594768333|FG000|Overall Study|A lot of time for study for participant|1|||
164656450|NCT02058628|594768334|FG001|Overall Study|A lot of time for study for participant|0|||
164656451|NCT02058628|594768333|FG000|Overall Study|Non compliance|1|||
164656452|NCT02058628|594768334|FG001|Overall Study|Non compliance|0|||
164656453|NCT00832078|594768335|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
164656454|NCT00832078|594768336|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
164656455|NCT00832078|594768335|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
164656456|NCT00832078|594768336|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
164656457|NCT02961920|594768337|FG000|Overall Study|did not achive stydy protocol schedule|1|||
164656458|NCT02961920|594768338|FG001|Overall Study|did not achive stydy protocol schedule|1|||
164201057|NCT01677741|593108467|FG007|Overall Study|Death|0|||
164656459|NCT03551730|594768339|FG000|Overall Study|Adverse Event|1|||
164656460|NCT03551730|594768340|FG001|Overall Study|Adverse Event|0|||
164201058|NCT01677741|593108460|FG000|Overall Study|Withdrawal by Subject|2|||
164201059|NCT01677741|593108461|FG001|Overall Study|Withdrawal by Subject|7|||
164656461|NCT03551730|594768341|FG002|Overall Study|Adverse Event|0|||
164656462|NCT03551730|594768342|FG003|Overall Study|Adverse Event|0|||
164656463|NCT03347695|594768349|FG000|Overall Study|Death|0|||
164656464|NCT03347695|594768350|FG001|Overall Study|Death|4|||
164656465|NCT03347695|594768349|FG000|Overall Study|Lost to Follow-up|0|||
164656466|NCT03347695|594768350|FG001|Overall Study|Lost to Follow-up|1|||
164656467|NCT00671879|594768353|FG000|Overall Study|Withdrawal by Subject|0|||
164656468|NCT00671879|594768354|FG001|Overall Study|Withdrawal by Subject|4|||
164656469|NCT00671879|594768355|FG002|Overall Study|Withdrawal by Subject|6|||
164656470|NCT04633837|594768356|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
164656471|NCT04633837|594768357|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
164656472|NCT04527471|594768360|FG000|Overall Study|Adverse Event|1|||
164656473|NCT04527471|594768361|FG001|Overall Study|Adverse Event|0|||
164656474|NCT04527471|594768360|FG000|Overall Study|Lost to Follow-up|1|||
164656475|NCT04527471|594768361|FG001|Overall Study|Lost to Follow-up|0|||
164656476|NCT01628120|594768374|FG000|Overall Study|Withdrawal by Subject|7|||
164656477|NCT01628120|594768374|FG000|Overall Study|Adverse Event|12|||
164656478|NCT01628120|594768374|FG000|Overall Study|Lost to Follow-up|1|||
164656479|NCT01628120|594768374|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
164656480|NCT01628120|594768374|FG000|Overall Study|Non-compliant with Study Procedures|1|||
164656481|NCT01628120|594768374|FG000|Overall Study|Not Treated|3|||
164656482|NCT01628120|594768374|FG000|Overall Study|Sponsor Decision|5|||
164656483|NCT01628120|594768374|FG000|Overall Study|Switched Dialysis Method|2|||
164656484|NCT01628120|594768374|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
164656485|NCT01628120|594768374|FG000|Overall Study|Moved or Relocated|5|||
164656486|NCT01628120|594768374|FG000|Overall Study|Kidney Transplant|2|||
164656487|NCT01628120|594768374|FG000|Overall Study|Use of Standard of Care|1|||
164656488|NCT01165996|594768375|FG000|Overall Study|Death|1|||
164656489|NCT01165996|594768375|FG000|Overall Study|Physician Decision|1|||
164656490|NCT00096265|594768376|FG000|Overall Study|Ineligible|1|||
164656491|NCT00096265|594768377|FG001|Overall Study|Ineligible|0|||
164656492|NCT00096265|594768378|FG002|Overall Study|Ineligible|0|||
164656493|NCT02232074|594768381|FG000|Overall Study|Withdrawal by Subject|5|||
164656494|NCT02232074|594768382|FG001|Overall Study|Withdrawal by Subject|3|||
164656495|NCT02232074|594768381|FG000|Overall Study|No legal concerns at baseline|36|||
164656496|NCT02232074|594768382|FG001|Overall Study|No legal concerns at baseline|41|||
164656497|NCT02232074|594768381|FG000|Overall Study|deemed ineligible|0|||
164656498|NCT02232074|594768382|FG001|Overall Study|deemed ineligible|1|||
164656499|NCT01927757|594768383|FG000|Overall Study|Withdrawal by Subject|14|||
164656500|NCT01927757|594768383|FG000|Overall Study|Lost to Follow-up|2|||
164656501|NCT01927757|594768383|FG000|Overall Study|Decision by Sponsor|2|||
164656502|NCT01927757|594768383|FG000|Overall Study|Other|1|||
164656503|NCT01927757|594768383|FG000|Overall Study|Ethical Reasons|4|||
164656504|NCT00444795|594768385|FG000|Overall Study|Not Treated|1|||
164656505|NCT00444795|594768385|FG000|Overall Study|Treated Prior to the Contract Date|2|||
164656506|NCT00988169|594768386|FG000|Overall Study|Withdrawal by Subject|1|||
164656507|NCT00704418|594768387|FG000|Overall Study|Withdrawal by Subject|2|||
164656508|NCT00704418|594768388|FG001|Overall Study|Withdrawal by Subject|0|||
164656509|NCT00704418|594768387|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
164656510|NCT00704418|594768388|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
164656511|NCT01464827|594768389|FG000|Overall Study|Adverse Event|0|||
164656512|NCT01464827|594768390|FG001|Overall Study|Adverse Event|0|||
164656513|NCT01464827|594768391|FG002|Overall Study|Adverse Event|0|||
164656514|NCT01464827|594768392|FG003|Overall Study|Adverse Event|0|||
164656515|NCT01464827|594768393|FG004|Overall Study|Adverse Event|0|||
164656516|NCT01464827|594768394|FG005|Overall Study|Adverse Event|0|||
164656517|NCT01464827|594768395|FG006|Overall Study|Adverse Event|0|||
164656518|NCT01464827|594768396|FG007|Overall Study|Adverse Event|0|||
164656519|NCT01464827|594768397|FG008|Overall Study|Adverse Event|0|||
164656520|NCT01464827|594768398|FG009|Overall Study|Adverse Event|0|||
164656521|NCT01464827|594768399|FG010|Overall Study|Adverse Event|0|||
164656522|NCT01464827|594768400|FG011|Overall Study|Adverse Event|0|||
164656523|NCT01464827|594768401|FG012|Overall Study|Adverse Event|1|||
164656524|NCT01464827|594768402|FG013|Overall Study|Adverse Event|0|||
164656525|NCT01464827|594768389|FG000|Overall Study|Withdrawal by Subject|1|||
164656526|NCT01464827|594768390|FG001|Overall Study|Withdrawal by Subject|0|||
164656527|NCT01464827|594768391|FG002|Overall Study|Withdrawal by Subject|0|||
164656528|NCT01464827|594768392|FG003|Overall Study|Withdrawal by Subject|0|||
164656529|NCT01464827|594768393|FG004|Overall Study|Withdrawal by Subject|1|||
164656530|NCT01464827|594768394|FG005|Overall Study|Withdrawal by Subject|0|||
164656531|NCT01464827|594768395|FG006|Overall Study|Withdrawal by Subject|0|||
164656532|NCT01464827|594768396|FG007|Overall Study|Withdrawal by Subject|1|||
164656533|NCT01464827|594768397|FG008|Overall Study|Withdrawal by Subject|0|||
164656534|NCT01464827|594768398|FG009|Overall Study|Withdrawal by Subject|0|||
164656535|NCT01464827|594768399|FG010|Overall Study|Withdrawal by Subject|0|||
164656536|NCT01464827|594768400|FG011|Overall Study|Withdrawal by Subject|0|||
164656537|NCT01464827|594768401|FG012|Overall Study|Withdrawal by Subject|0|||
164420592|NCT01890967|593910949|FG003|Overall Study|Death|0|||
164656538|NCT01464827|594768402|FG013|Overall Study|Withdrawal by Subject|0|||
164656539|NCT01464827|594768389|FG000|Overall Study|Lost to Follow-up|0|||
164656540|NCT01464827|594768390|FG001|Overall Study|Lost to Follow-up|2|||
164656541|NCT01464827|594768391|FG002|Overall Study|Lost to Follow-up|0|||
164656542|NCT01464827|594768392|FG003|Overall Study|Lost to Follow-up|2|||
164656543|NCT01464827|594768393|FG004|Overall Study|Lost to Follow-up|3|||
164656544|NCT01464827|594768394|FG005|Overall Study|Lost to Follow-up|1|||
164656545|NCT01464827|594768395|FG006|Overall Study|Lost to Follow-up|2|||
164656546|NCT01464827|594768396|FG007|Overall Study|Lost to Follow-up|2|||
164656547|NCT01464827|594768397|FG008|Overall Study|Lost to Follow-up|0|||
164656548|NCT01464827|594768398|FG009|Overall Study|Lost to Follow-up|0|||
164656549|NCT01464827|594768399|FG010|Overall Study|Lost to Follow-up|0|||
164656550|NCT01464827|594768400|FG011|Overall Study|Lost to Follow-up|1|||
164656551|NCT01464827|594768401|FG012|Overall Study|Lost to Follow-up|0|||
164656552|NCT01464827|594768402|FG013|Overall Study|Lost to Follow-up|1|||
164656553|NCT01464827|594768389|FG000|Overall Study|Other|2|||
164656554|NCT01464827|594768390|FG001|Overall Study|Other|3|||
164656555|NCT01464827|594768391|FG002|Overall Study|Other|0|||
164656556|NCT01464827|594768392|FG003|Overall Study|Other|2|||
164656557|NCT01464827|594768393|FG004|Overall Study|Other|3|||
164656558|NCT01464827|594768394|FG005|Overall Study|Other|0|||
164656559|NCT01464827|594768395|FG006|Overall Study|Other|1|||
164656560|NCT01464827|594768396|FG007|Overall Study|Other|0|||
164656561|NCT01464827|594768397|FG008|Overall Study|Other|3|||
164656562|NCT01464827|594768398|FG009|Overall Study|Other|1|||
164656563|NCT01464827|594768399|FG010|Overall Study|Other|2|||
164656564|NCT01464827|594768400|FG011|Overall Study|Other|0|||
164551247|NCT03891264|594390139|FG000|Overall Study|Withdrawal by Subject|2|||
164551248|NCT03891264|594390139|FG000|Overall Study|Physician Decision|2|||
164551249|NCT01924182|594390140|FG000|Overall Study|Withdrawal by Subject|1|||
164551250|NCT01924182|594390141|FG001|Overall Study|Withdrawal by Subject|0|||
164551251|NCT00993265|594390142|FG000|Overall Study|Adverse Event|1|||
164551252|NCT00993265|594390143|FG001|Overall Study|Adverse Event|0|||
164551253|NCT00993265|594390142|FG000|Overall Study|Changed dose of concomitant drug|2|||
164551254|NCT00993265|594390143|FG001|Overall Study|Changed dose of concomitant drug|0|||
164551255|NCT00993265|594390142|FG000|Overall Study|Non-compliant with study medication|1|||
164551256|NCT00993265|594390143|FG001|Overall Study|Non-compliant with study medication|0|||
164551257|NCT03765138|594390144|FG000|Overall Study|Lost to Follow-up|1|||
164551258|NCT00781911|594390145|FG000|Overall Study|Adverse Event|4|||
164551259|NCT00781911|594390146|FG001|Overall Study|Adverse Event|4|||
164551260|NCT00781911|594390145|FG000|Overall Study|Withdrawal by Subject|1|||
164551261|NCT00781911|594390146|FG001|Overall Study|Withdrawal by Subject|2|||
164551262|NCT00781911|594390145|FG000|Overall Study|Physician Decision|0|||
164551263|NCT00781911|594390146|FG001|Overall Study|Physician Decision|2|||
164551264|NCT00781911|594390145|FG000|Overall Study|Sponsor Decision|1|||
164551265|NCT00781911|594390146|FG001|Overall Study|Sponsor Decision|0|||
164551266|NCT03040999|594392300|FG000|Overall Study|Lost to Follow-up|2|||
164551267|NCT03040999|594392301|FG001|Overall Study|Lost to Follow-up|2|||
164551268|NCT03040999|594392300|FG000|Overall Study|Withdrawal by Subject|12|||
164551269|NCT03040999|594392301|FG001|Overall Study|Withdrawal by Subject|13|||
164551270|NCT03040999|594392300|FG000|Overall Study|Death|155|||
164551271|NCT03040999|594392301|FG001|Overall Study|Death|171|||
164551272|NCT03040999|594392300|FG000|Overall Study|Physician Decision|0|||
164551273|NCT03040999|594392301|FG001|Overall Study|Physician Decision|3|||
164551274|NCT05121480|594392302|FG000|Overall Study|Lack of Efficacy|2|||
164551275|NCT05121480|594392303|FG001|Overall Study|Lack of Efficacy|2|||
164551276|NCT05121480|594392304|FG002|Overall Study|Lack of Efficacy|1|||
164551277|NCT05121480|594392305|FG003|Overall Study|Lack of Efficacy|4|||
164551278|NCT05121480|594392306|FG004|Overall Study|Lack of Efficacy|0|||
164551279|NCT05121480|594392307|FG005|Overall Study|Lack of Efficacy|1|||
164551280|NCT05121480|594392308|FG006|Overall Study|Lack of Efficacy|0|||
164551281|NCT05121480|594392309|FG007|Overall Study|Lack of Efficacy|2|||
164551282|NCT05121480|594392302|FG000|Overall Study|Treatment Failure|0|||
164551283|NCT05121480|594392303|FG001|Overall Study|Treatment Failure|2|||
164551284|NCT05121480|594392304|FG002|Overall Study|Treatment Failure|0|||
164551285|NCT05121480|594392305|FG003|Overall Study|Treatment Failure|1|||
164551286|NCT05121480|594392306|FG004|Overall Study|Treatment Failure|0|||
164551287|NCT05121480|594392307|FG005|Overall Study|Treatment Failure|0|||
164551288|NCT05121480|594392308|FG006|Overall Study|Treatment Failure|0|||
164551289|NCT05121480|594392309|FG007|Overall Study|Treatment Failure|0|||
164551290|NCT05121480|594392302|FG000|Overall Study|Adverse Event|0|||
164551291|NCT05121480|594392303|FG001|Overall Study|Adverse Event|1|||
164551292|NCT05121480|594392304|FG002|Overall Study|Adverse Event|0|||
164551293|NCT05121480|594392305|FG003|Overall Study|Adverse Event|5|||
164551294|NCT05121480|594392306|FG004|Overall Study|Adverse Event|3|||
164551295|NCT05121480|594392307|FG005|Overall Study|Adverse Event|2|||
164551296|NCT05121480|594392308|FG006|Overall Study|Adverse Event|0|||
164551297|NCT05121480|594392309|FG007|Overall Study|Adverse Event|4|||
164551298|NCT05121480|594392302|FG000|Overall Study|Withdrawal by Subject|4|||
164551299|NCT05121480|594392303|FG001|Overall Study|Withdrawal by Subject|9|||
164551300|NCT05121480|594392304|FG002|Overall Study|Withdrawal by Subject|1|||
164551301|NCT05121480|594392305|FG003|Overall Study|Withdrawal by Subject|8|||
164551302|NCT05121480|594392306|FG004|Overall Study|Withdrawal by Subject|0|||
164551303|NCT05121480|594392307|FG005|Overall Study|Withdrawal by Subject|9|||
164551304|NCT05121480|594392308|FG006|Overall Study|Withdrawal by Subject|0|||
164551305|NCT05121480|594392309|FG007|Overall Study|Withdrawal by Subject|4|||
164551306|NCT05121480|594392302|FG000|Overall Study|Non-compliance with the protocol|0|||
164551307|NCT05121480|594392303|FG001|Overall Study|Non-compliance with the protocol|0|||
164551308|NCT05121480|594392304|FG002|Overall Study|Non-compliance with the protocol|0|||
164656565|NCT01464827|594768401|FG012|Overall Study|Other|1|||
164551309|NCT05121480|594392305|FG003|Overall Study|Non-compliance with the protocol|0|||
164551310|NCT05121480|594392306|FG004|Overall Study|Non-compliance with the protocol|1|||
164551311|NCT05121480|594392307|FG005|Overall Study|Non-compliance with the protocol|6|||
164551312|NCT05121480|594392308|FG006|Overall Study|Non-compliance with the protocol|0|||
164551313|NCT05121480|594392309|FG007|Overall Study|Non-compliance with the protocol|1|||
164656566|NCT01464827|594768402|FG013|Overall Study|Other|0|||
164309927|NCT00485134|593509532|FG002|Overall Study|Unable to comply with study schedule|0|||
164309928|NCT00485134|593509533|FG003|Overall Study|Unable to comply with study schedule|0|||
164309929|NCT00485134|593509534|FG004|Overall Study|Unable to comply with study schedule|0|||
164309930|NCT00485134|593509535|FG005|Overall Study|Unable to comply with study schedule|0|||
164551314|NCT05121480|594392302|FG000|Overall Study|Lost to Follow-up|0|||
164551315|NCT05121480|594392303|FG001|Overall Study|Lost to Follow-up|4|||
164551316|NCT05121480|594392304|FG002|Overall Study|Lost to Follow-up|1|||
164551317|NCT05121480|594392305|FG003|Overall Study|Lost to Follow-up|3|||
164551318|NCT05121480|594392306|FG004|Overall Study|Lost to Follow-up|1|||
164551319|NCT05121480|594392307|FG005|Overall Study|Lost to Follow-up|1|||
164551320|NCT05121480|594392308|FG006|Overall Study|Lost to Follow-up|1|||
164551321|NCT05121480|594392309|FG007|Overall Study|Lost to Follow-up|4|||
164551322|NCT05121480|594392302|FG000|Overall Study|Physician Decision|0|||
164551323|NCT05121480|594392303|FG001|Overall Study|Physician Decision|0|||
164551324|NCT05121480|594392304|FG002|Overall Study|Physician Decision|0|||
164551325|NCT05121480|594392305|FG003|Overall Study|Physician Decision|0|||
164551326|NCT05121480|594392306|FG004|Overall Study|Physician Decision|0|||
164551327|NCT05121480|594392307|FG005|Overall Study|Physician Decision|1|||
164551328|NCT05121480|594392308|FG006|Overall Study|Physician Decision|0|||
164551329|NCT05121480|594392309|FG007|Overall Study|Physician Decision|1|||
164551330|NCT05121480|594392302|FG000|Overall Study|Other Reason|0|||
164551331|NCT05121480|594392303|FG001|Overall Study|Other Reason|0|||
164551332|NCT05121480|594392304|FG002|Overall Study|Other Reason|0|||
164551333|NCT05121480|594392305|FG003|Overall Study|Other Reason|0|||
164551334|NCT05121480|594392306|FG004|Overall Study|Other Reason|0|||
164551335|NCT05121480|594392307|FG005|Overall Study|Other Reason|1|||
164551336|NCT05121480|594392308|FG006|Overall Study|Other Reason|1|||
164551337|NCT05121480|594392309|FG007|Overall Study|Other Reason|1|||
164551338|NCT01964352|594392316|FG000|Overall Study|Adverse Event|13|||
164551339|NCT01964352|594392317|FG001|Overall Study|Adverse Event|3|||
164551340|NCT01964352|594392318|FG002|Overall Study|Adverse Event|4|||
164551341|NCT01964352|594392319|FG003|Overall Study|Adverse Event|3|||
164551342|NCT01964352|594392316|FG000|Overall Study|Lack of Efficacy|6|||
164551343|NCT01964352|594392317|FG001|Overall Study|Lack of Efficacy|0|||
164551344|NCT01964352|594392318|FG002|Overall Study|Lack of Efficacy|0|||
164551345|NCT01964352|594392319|FG003|Overall Study|Lack of Efficacy|0|||
164551346|NCT01964352|594392316|FG000|Overall Study|Protocol Violation|2|||
164551347|NCT01964352|594392317|FG001|Overall Study|Protocol Violation|4|||
164551348|NCT01964352|594392318|FG002|Overall Study|Protocol Violation|0|||
164551349|NCT01964352|594392319|FG003|Overall Study|Protocol Violation|2|||
164551350|NCT01964352|594392316|FG000|Overall Study|Lost to Follow-up|1|||
164551351|NCT01964352|594392317|FG001|Overall Study|Lost to Follow-up|0|||
164551352|NCT01964352|594392318|FG002|Overall Study|Lost to Follow-up|0|||
164551353|NCT01964352|594392319|FG003|Overall Study|Lost to Follow-up|1|||
164551354|NCT01964352|594392316|FG000|Overall Study|Withdrawal by Subject|4|||
164551355|NCT01964352|594392317|FG001|Overall Study|Withdrawal by Subject|2|||
164551356|NCT01964352|594392318|FG002|Overall Study|Withdrawal by Subject|1|||
164551357|NCT01964352|594392319|FG003|Overall Study|Withdrawal by Subject|0|||
164551358|NCT01964352|594392316|FG000|Overall Study|Other than stated above|0|||
164551359|NCT01964352|594392317|FG001|Overall Study|Other than stated above|2|||
164551360|NCT01964352|594392318|FG002|Overall Study|Other than stated above|1|||
164551361|NCT01964352|594392319|FG003|Overall Study|Other than stated above|2|||
164551362|NCT02831673|594392320|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
164551363|NCT02831673|594392321|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
164551364|NCT02831673|594392322|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
164551365|NCT02831673|594392323|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
164551366|NCT02831673|594392324|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
164551367|NCT02831673|594392320|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
164551368|NCT02831673|594392321|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
164551369|NCT02831673|594392322|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
164551370|NCT02831673|594392323|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
164309931|NCT00485134|593509536|FG006|Overall Study|Unable to comply with study schedule|0|||
164551371|NCT02831673|594392324|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
164420593|NCT01890967|593910950|FG004|Overall Study|Death|0|||
164551372|NCT02831673|594392320|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
164551373|NCT02831673|594392321|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
164551374|NCT02831673|594392322|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
164551375|NCT02831673|594392323|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
164551376|NCT02831673|594392324|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
164551377|NCT02831673|594392320|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
164551378|NCT02831673|594392321|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
164551379|NCT02831673|594392322|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
164551380|NCT02831673|594392323|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
164551381|NCT02831673|594392324|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
164551382|NCT02831673|594392320|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
164551383|NCT02831673|594392321|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
164551384|NCT02831673|594392322|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
164551385|NCT02831673|594392323|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
164551386|NCT02831673|594392324|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
164551387|NCT02831673|594392320|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
164551388|NCT02831673|594392321|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
164551389|NCT02831673|594392322|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
164551390|NCT02831673|594392323|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
164551391|NCT02831673|594392324|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
164551392|NCT02831673|594392320|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
164551393|NCT02831673|594392321|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
164551394|NCT02831673|594392322|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
164551395|NCT02831673|594392323|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
164551396|NCT02831673|594392324|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
164551397|NCT02831673|594392320|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
164551398|NCT02831673|594392321|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
164551399|NCT02831673|594392322|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
164551400|NCT02831673|594392323|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
164551401|NCT02831673|594392324|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
164551402|NCT02831673|594392320|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
164551403|NCT02831673|594392321|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
164551404|NCT02831673|594392322|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
164551405|NCT02831673|594392323|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
164551406|NCT02831673|594392324|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
164551407|NCT02831673|594392320|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
164551408|NCT02831673|594392321|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
164551409|NCT02831673|594392322|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
164551410|NCT02831673|594392323|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
164551411|NCT02831673|594392324|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
164551412|NCT02831673|594392320|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
164551413|NCT02831673|594392321|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
164551414|NCT02831673|594392322|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
164551415|NCT02831673|594392323|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
164551416|NCT02831673|594392324|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
164551417|NCT02831673|594392320|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
164551418|NCT02831673|594392321|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
164551419|NCT02831673|594392322|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
164551420|NCT02831673|594392323|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
164551421|NCT02831673|594392324|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
164551422|NCT02831673|594392320|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
164551423|NCT02831673|594392321|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
164551424|NCT02831673|594392322|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
164551425|NCT02831673|594392323|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
164551426|NCT02831673|594392324|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
164551427|NCT02831673|594392320|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
164551428|NCT02831673|594392321|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
164551429|NCT02831673|594392322|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
164551430|NCT02831673|594392323|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
164551431|NCT02831673|594392324|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
164551432|NCT02831673|594392320|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
164551433|NCT02831673|594392321|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
164551434|NCT02831673|594392322|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
164551435|NCT02831673|594392323|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
164551436|NCT02831673|594392324|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
164551437|NCT02831673|594392320|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
164551438|NCT02831673|594392321|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
164551439|NCT02831673|594392322|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
164551440|NCT02831673|594392323|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
164551441|NCT02831673|594392324|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
164551442|NCT02831673|594392320|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
164551443|NCT02831673|594392321|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
164551444|NCT02831673|594392322|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
164551445|NCT02831673|594392323|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
164656567|NCT01464827|594768389|FG000|Overall Study|Not Treated|0|||
164551446|NCT02831673|594392324|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
164551447|NCT02831673|594392320|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
164551448|NCT02831673|594392321|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
164551449|NCT02831673|594392322|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
164551450|NCT02831673|594392323|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
164551451|NCT02831673|594392324|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
164551452|NCT02831673|594392320|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
164551453|NCT02831673|594392321|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
164551454|NCT02831673|594392322|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
164551455|NCT02831673|594392323|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
164551456|NCT02831673|594392324|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
164551457|NCT02831673|594392320|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
164551458|NCT02831673|594392321|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
164551459|NCT02831673|594392322|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
164551460|NCT02831673|594392323|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
164551461|NCT02831673|594392324|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
164551462|NCT00001379|594392325|FG000|Initial Treatment|Disease progression|21|||
164551463|NCT00001379|594392326|FG001|Initial Treatment|Disease progression|3|||
164551464|NCT00001379|594392327|FG002|Initial Treatment|Disease progression|0|||
164551465|NCT00001379|594392328|FG003|Initial Treatment|Disease progression|0|||
164551466|NCT00001379|594392325|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
164551467|NCT00001379|594392326|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
164551468|NCT00001379|594392327|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
164551469|NCT00001379|594392328|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
164551470|NCT00001379|594392325|FG000|Initial Treatment|Received alternative treatment|2|||
164551471|NCT00001379|594392326|FG001|Initial Treatment|Received alternative treatment|1|||
164551472|NCT00001379|594392327|FG002|Initial Treatment|Received alternative treatment|0|||
164551473|NCT00001379|594392328|FG003|Initial Treatment|Received alternative treatment|0|||
164551474|NCT00001379|594392325|FG000|Initial Treatment|Refused further treatment|2|||
164551475|NCT00001379|594392326|FG001|Initial Treatment|Refused further treatment|0|||
164551476|NCT00001379|594392327|FG002|Initial Treatment|Refused further treatment|0|||
164551477|NCT00001379|594392328|FG003|Initial Treatment|Refused further treatment|0|||
164551478|NCT00001379|594392325|FG000|Initial Treatment|Did not receive protocol treatment|0|||
164551479|NCT00001379|594392326|FG001|Initial Treatment|Did not receive protocol treatment|0|||
164551480|NCT00001379|594392327|FG002|Initial Treatment|Did not receive protocol treatment|5|||
164551481|NCT00001379|594392328|FG003|Initial Treatment|Did not receive protocol treatment|0|||
164551482|NCT00001379|594392325|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
164551483|NCT00001379|594392326|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
164551484|NCT00001379|594392327|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
164551485|NCT00001379|594392328|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
164551486|NCT00001379|594392325|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
164551487|NCT00001379|594392326|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
164551488|NCT00001379|594392327|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
164551489|NCT00001379|594392328|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
164551490|NCT00001379|594392325|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
164551491|NCT00001379|594392326|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
164551492|NCT00001379|594392327|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
164551493|NCT00001379|594392328|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
164551494|NCT00001379|594392325|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
164551495|NCT00001379|594392326|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
164551496|NCT00001379|594392327|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
164551497|NCT00001379|594392328|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
164551498|NCT00001379|594392325|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
164551499|NCT00001379|594392326|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
164551500|NCT00001379|594392327|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
164551501|NCT00001379|594392328|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
164551502|NCT00264875|594392329|FG000|Overall Study|Adverse Event|6|||
164551503|NCT00264875|594392329|FG000|Overall Study|Lost to Follow-up|6|||
164551504|NCT00264875|594392329|FG000|Overall Study|Protocol Violation|11|||
164551505|NCT00264875|594392329|FG000|Overall Study|Withdrawal by Subject|7|||
164551506|NCT01500278|594392331|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
164551507|NCT01500278|594392332|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
164551508|NCT01500278|594392331|FG000|Week 0 - Week 12|Protocol Violation|10|||
164551509|NCT01500278|594392332|FG001|Week 0 - Week 12|Protocol Violation|16|||
164656568|NCT01464827|594768390|FG001|Overall Study|Not Treated|2|||
164656569|NCT01464827|594768391|FG002|Overall Study|Not Treated|0|||
164551510|NCT01500278|594392331|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
164551511|NCT01500278|594392332|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
164551512|NCT01500278|594392331|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
164551513|NCT01500278|594392332|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
164551514|NCT01500278|594392331|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
164551515|NCT01500278|594392332|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
164551516|NCT01500278|594392331|FG000|Week 0 - Week 12|Patient decision|1|||
164551517|NCT01500278|594392332|FG001|Week 0 - Week 12|Patient decision|0|||
164551518|NCT01500278|594392331|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
164551519|NCT01500278|594392332|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
164551520|NCT01500278|594392331|FG000|Week 0 - Week 12|Investigator decision|1|||
164551521|NCT01500278|594392332|FG001|Week 0 - Week 12|Investigator decision|0|||
164551522|NCT01500278|594392331|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
164551523|NCT01500278|594392332|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
164551524|NCT01500278|594392331|FG000|Week 0 - Week 12|Sponsor decision|1|||
164551525|NCT01500278|594392332|FG001|Week 0 - Week 12|Sponsor decision|0|||
164551526|NCT01500278|594392331|FG000|Week 0 - Week 12|Personal reason|0|||
164551527|NCT01500278|594392332|FG001|Week 0 - Week 12|Personal reason|1|||
164551528|NCT01500278|594392331|FG000|Week 0 - Week 12|Other serious disease|0|||
164551529|NCT01500278|594392332|FG001|Week 0 - Week 12|Other serious disease|1|||
164551530|NCT01500278|594392331|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
164551531|NCT01500278|594392332|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
164551532|NCT01500278|594392331|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
164551533|NCT01500278|594392332|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
164551534|NCT01500278|594392331|FG000|Week 13 - Week 104|Protocol Violation|6|||
164551535|NCT01500278|594392332|FG001|Week 13 - Week 104|Protocol Violation|6|||
164551536|NCT01500278|594392331|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
164551537|NCT01500278|594392332|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
164551538|NCT01500278|594392331|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
164551539|NCT01500278|594392332|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
164551540|NCT01500278|594392331|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
164551541|NCT01500278|594392332|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
164551542|NCT01500278|594392331|FG000|Week 13 - Week 104|Non/bad compliance|7|||
164551543|NCT01500278|594392332|FG001|Week 13 - Week 104|Non/bad compliance|5|||
164551544|NCT01500278|594392331|FG000|Week 13 - Week 104|Recurrent infections|1|||
164551545|NCT01500278|594392332|FG001|Week 13 - Week 104|Recurrent infections|0|||
164551546|NCT01500278|594392331|FG000|Week 13 - Week 104|False positive test|1|||
164551547|NCT01500278|594392332|FG001|Week 13 - Week 104|False positive test|2|||
164551548|NCT01500278|594392331|FG000|Week 13 - Week 104|Sponsor request|4|||
164551549|NCT01500278|594392332|FG001|Week 13 - Week 104|Sponsor request|0|||
164551550|NCT01500278|594392331|FG000|Week 13 - Week 104|Withdrawn in error|1|||
164551551|NCT01500278|594392332|FG001|Week 13 - Week 104|Withdrawn in error|0|||
164551552|NCT01500278|594392331|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
164551553|NCT01500278|594392332|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
164551554|NCT01500278|594392331|FG000|Week 13 - Week 104|Protocol deviation|1|||
164551555|NCT01500278|594392332|FG001|Week 13 - Week 104|Protocol deviation|0|||
164551556|NCT01500278|594392331|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
164551557|NCT01500278|594392332|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
164551558|NCT01500278|594392331|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
164551559|NCT01500278|594392332|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
164551560|NCT01500278|594392331|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
164551561|NCT01500278|594392332|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
164551562|NCT01500278|594392331|FG000|Week 13 - Week 104|Relocation|0|||
164551563|NCT01500278|594392332|FG001|Week 13 - Week 104|Relocation|1|||
164551564|NCT01500278|594392331|FG000|Week 13 - Week 104|Sponsor decision|0|||
164551565|NCT01500278|594392332|FG001|Week 13 - Week 104|Sponsor decision|2|||
164656570|NCT01464827|594768392|FG003|Overall Study|Not Treated|0|||
164656571|NCT01464827|594768393|FG004|Overall Study|Not Treated|1|||
164656572|NCT01464827|594768394|FG005|Overall Study|Not Treated|0|||
164656573|NCT01464827|594768395|FG006|Overall Study|Not Treated|1|||
164656574|NCT01464827|594768396|FG007|Overall Study|Not Treated|0|||
164656575|NCT01464827|594768397|FG008|Overall Study|Not Treated|0|||
164656576|NCT01464827|594768398|FG009|Overall Study|Not Treated|2|||
164551566|NCT01500278|594392331|FG000|Week 13 - Week 104|Medical monitor decision|0|||
164551567|NCT01500278|594392332|FG001|Week 13 - Week 104|Medical monitor decision|2|||
164551568|NCT01500278|594392331|FG000|Week 13 - Week 104|Personal reason|0|||
164656577|NCT01464827|594768399|FG010|Overall Study|Not Treated|0|||
164656578|NCT01464827|594768400|FG011|Overall Study|Not Treated|1|||
164551569|NCT01500278|594392332|FG001|Week 13 - Week 104|Personal reason|1|||
164551570|NCT01500278|594392331|FG000|Week 13 - Week 104|Not completed|0|||
164551571|NCT01500278|594392332|FG001|Week 13 - Week 104|Not completed|1|||
164551572|NCT01500278|594392331|FG000|Week 13 - Week 104|Death|2|||
164551573|NCT01500278|594392332|FG001|Week 13 - Week 104|Death|4|||
164656579|NCT01464827|594768401|FG012|Overall Study|Not Treated|0|||
164551574|NCT01500278|594392331|FG000|Week 13 - Week 104|Adverse Event|54|||
164551575|NCT01500278|594392332|FG001|Week 13 - Week 104|Adverse Event|54|||
164551576|NCT03699007|594392333|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
164551577|NCT03699007|594392334|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
164551578|NCT03699007|594392333|FG000|6-month Follow Up|Lost to Follow-up|2|||
164551579|NCT03699007|594392334|FG001|6-month Follow Up|Lost to Follow-up|3|||
164551580|NCT01709435|594392335|FG000|Overall Study|Adverse Event|1|||
164551581|NCT01709435|594392336|FG001|Overall Study|Adverse Event|1|||
164551582|NCT01709435|594392337|FG002|Overall Study|Adverse Event|1|||
164551583|NCT01709435|594392338|FG003|Overall Study|Adverse Event|0|||
164551584|NCT01709435|594392339|FG004|Overall Study|Adverse Event|0|||
164551585|NCT01709435|594392340|FG005|Overall Study|Adverse Event|1|||
164551586|NCT01709435|594392335|FG000|Overall Study|Lack of Efficacy|5|||
164551587|NCT01709435|594392336|FG001|Overall Study|Lack of Efficacy|7|||
164551588|NCT01709435|594392337|FG002|Overall Study|Lack of Efficacy|2|||
164551589|NCT01709435|594392338|FG003|Overall Study|Lack of Efficacy|2|||
164551590|NCT01709435|594392339|FG004|Overall Study|Lack of Efficacy|6|||
164551591|NCT01709435|594392340|FG005|Overall Study|Lack of Efficacy|3|||
164551592|NCT01709435|594392335|FG000|Overall Study|Physician Decision|0|||
164551593|NCT01709435|594392336|FG001|Overall Study|Physician Decision|1|||
164551594|NCT01709435|594392337|FG002|Overall Study|Physician Decision|0|||
164551595|NCT01709435|594392338|FG003|Overall Study|Physician Decision|1|||
164551596|NCT01709435|594392339|FG004|Overall Study|Physician Decision|2|||
164551597|NCT01709435|594392340|FG005|Overall Study|Physician Decision|0|||
164551598|NCT01709435|594392335|FG000|Overall Study|Withdrawal by Subject|0|||
164551599|NCT01709435|594392336|FG001|Overall Study|Withdrawal by Subject|0|||
164551600|NCT01709435|594392337|FG002|Overall Study|Withdrawal by Subject|3|||
164551601|NCT01709435|594392338|FG003|Overall Study|Withdrawal by Subject|0|||
164551602|NCT01709435|594392339|FG004|Overall Study|Withdrawal by Subject|2|||
164551603|NCT01709435|594392340|FG005|Overall Study|Withdrawal by Subject|2|||
164551604|NCT01157364|594392341|FG000|Overall Study|Other Reasons|1|||
164551605|NCT01157364|594392342|FG001|Overall Study|Other Reasons|1|||
164551606|NCT01157364|594392343|FG002|Overall Study|Other Reasons|2|||
164551607|NCT01157364|594392344|FG003|Overall Study|Other Reasons|1|||
164551608|NCT01157364|594392345|FG004|Overall Study|Other Reasons|0|||
164551609|NCT01157364|594392346|FG005|Overall Study|Other Reasons|0|||
164551610|NCT01157364|594392341|FG000|Overall Study|Personal Reasons|0|||
164551611|NCT01157364|594392342|FG001|Overall Study|Personal Reasons|2|||
164551612|NCT01157364|594392343|FG002|Overall Study|Personal Reasons|0|||
164551613|NCT01157364|594392344|FG003|Overall Study|Personal Reasons|0|||
164551614|NCT01157364|594392345|FG004|Overall Study|Personal Reasons|1|||
164551615|NCT01157364|594392346|FG005|Overall Study|Personal Reasons|1|||
164551616|NCT01157364|594392341|FG000|Overall Study|Lost to Follow-up|1|||
164551617|NCT01157364|594392342|FG001|Overall Study|Lost to Follow-up|0|||
164551618|NCT01157364|594392343|FG002|Overall Study|Lost to Follow-up|1|||
164551619|NCT01157364|594392344|FG003|Overall Study|Lost to Follow-up|0|||
164551620|NCT01157364|594392345|FG004|Overall Study|Lost to Follow-up|0|||
164551621|NCT01157364|594392346|FG005|Overall Study|Lost to Follow-up|0|||
164551622|NCT01157364|594392341|FG000|Overall Study|Lack of Efficacy|0|||
164551623|NCT01157364|594392342|FG001|Overall Study|Lack of Efficacy|0|||
164551624|NCT01157364|594392343|FG002|Overall Study|Lack of Efficacy|0|||
164551625|NCT01157364|594392344|FG003|Overall Study|Lack of Efficacy|1|||
164551626|NCT01157364|594392345|FG004|Overall Study|Lack of Efficacy|0|||
164551627|NCT01157364|594392346|FG005|Overall Study|Lack of Efficacy|0|||
164551628|NCT01157364|594392341|FG000|Overall Study|Adverse Event|0|||
164551629|NCT01157364|594392342|FG001|Overall Study|Adverse Event|1|||
164551630|NCT01157364|594392343|FG002|Overall Study|Adverse Event|1|||
164551631|NCT01157364|594392344|FG003|Overall Study|Adverse Event|0|||
164551632|NCT01157364|594392345|FG004|Overall Study|Adverse Event|1|||
164551633|NCT01157364|594392346|FG005|Overall Study|Adverse Event|0|||
164551634|NCT01263639|594392349|FG000|Overall Study|Lost to Follow-up|66|||
164551635|NCT01263639|594392350|FG001|Overall Study|Lost to Follow-up|70|||
164551636|NCT01263639|594392349|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
164551637|NCT01263639|594392350|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
164551638|NCT00183274|594392351|FG000|Phase 1: Open-Label|Adverse Event|31|||
164551639|NCT00183274|594392352|FG001|Phase 1: Open-Label|Adverse Event|0|||
164551640|NCT00183274|594392353|FG002|Phase 1: Open-Label|Adverse Event|0|||
164551641|NCT00183274|594392354|FG003|Phase 1: Open-Label|Adverse Event|0|||
164551642|NCT00183274|594392355|FG004|Phase 1: Open-Label|Adverse Event|0|||
164551643|NCT00183274|594392356|FG005|Phase 1: Open-Label|Adverse Event|0|||
164551644|NCT00183274|594392351|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
164551645|NCT00183274|594392352|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
164551646|NCT00183274|594392353|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
164551647|NCT00183274|594392354|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
164551648|NCT00183274|594392355|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
164551649|NCT00183274|594392356|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
164551650|NCT00183274|594392351|FG000|Phase 1: Open-Label|Protocol Violation|11|||
164551651|NCT00183274|594392352|FG001|Phase 1: Open-Label|Protocol Violation|0|||
164551652|NCT00183274|594392353|FG002|Phase 1: Open-Label|Protocol Violation|0|||
164309932|NCT00485134|593509537|FG007|Overall Study|Unable to comply with study schedule|1|||
164309933|NCT00485134|593509530|FG000|Overall Study|Pregnancy|0|||
164309934|NCT00485134|593509531|FG001|Overall Study|Pregnancy|0|||
164309935|NCT00485134|593509532|FG002|Overall Study|Pregnancy|0|||
164309936|NCT00485134|593509533|FG003|Overall Study|Pregnancy|0|||
164309937|NCT00485134|593509534|FG004|Overall Study|Pregnancy|0|||
164309938|NCT00485134|593509535|FG005|Overall Study|Pregnancy|0|||
164309939|NCT00485134|593509536|FG006|Overall Study|Pregnancy|1|||
164309940|NCT00485134|593509537|FG007|Overall Study|Pregnancy|0|||
164309941|NCT00970684|593509538|FG000|Overall Study|Lack of Efficacy|5|||
164309942|NCT00970684|593509538|FG000|Overall Study|Adverse Event|4|||
164551653|NCT00183274|594392354|FG003|Phase 1: Open-Label|Protocol Violation|0|||
164551654|NCT00183274|594392355|FG004|Phase 1: Open-Label|Protocol Violation|0|||
164551655|NCT00183274|594392356|FG005|Phase 1: Open-Label|Protocol Violation|0|||
164551656|NCT00183274|594392351|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
164551657|NCT00183274|594392352|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
164551658|NCT00183274|594392353|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
164551659|NCT00183274|594392354|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
164551660|NCT00183274|594392355|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
164551661|NCT00183274|594392356|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
164551662|NCT00183274|594392351|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
164551663|NCT00183274|594392352|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
164551664|NCT00183274|594392353|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
164551665|NCT00183274|594392354|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
164551666|NCT00183274|594392355|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
164551667|NCT00183274|594392356|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
164551668|NCT00183274|594392351|FG000|Phase 1: Open-Label|Other|9|||
164551669|NCT00183274|594392352|FG001|Phase 1: Open-Label|Other|0|||
164551670|NCT00183274|594392353|FG002|Phase 1: Open-Label|Other|0|||
164551671|NCT00183274|594392354|FG003|Phase 1: Open-Label|Other|0|||
164551672|NCT00183274|594392355|FG004|Phase 1: Open-Label|Other|0|||
164551673|NCT00183274|594392356|FG005|Phase 1: Open-Label|Other|0|||
164551674|NCT00183274|594392351|FG000|Phase 2: Double-Blind|Relapsed|0|||
164551675|NCT00183274|594392352|FG001|Phase 2: Double-Blind|Relapsed|8|||
164551676|NCT00183274|594392353|FG002|Phase 2: Double-Blind|Relapsed|29|||
164551677|NCT00183274|594392354|FG003|Phase 2: Double-Blind|Relapsed|0|||
164551678|NCT00183274|594392355|FG004|Phase 2: Double-Blind|Relapsed|0|||
164551679|NCT00183274|594392356|FG005|Phase 2: Double-Blind|Relapsed|0|||
164551680|NCT00183274|594392351|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
164551681|NCT00183274|594392352|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
164551682|NCT00183274|594392353|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
164551683|NCT00183274|594392354|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
164551684|NCT00183274|594392355|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
164551685|NCT00183274|594392356|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
164551686|NCT00183274|594392351|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
164551687|NCT00183274|594392352|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
164551688|NCT00183274|594392353|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
164551689|NCT00183274|594392354|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
164551690|NCT00183274|594392355|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
164551691|NCT00183274|594392356|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
164551692|NCT00183274|594392351|FG000|Phase 3: Double-Blind|Relapsed|0|||
164551693|NCT00183274|594392352|FG001|Phase 3: Double-Blind|Relapsed|0|||
164551694|NCT00183274|594392353|FG002|Phase 3: Double-Blind|Relapsed|0|||
164551695|NCT00183274|594392354|FG003|Phase 3: Double-Blind|Relapsed|1|||
164551696|NCT00183274|594392355|FG004|Phase 3: Double-Blind|Relapsed|11|||
164551697|NCT00183274|594392356|FG005|Phase 3: Double-Blind|Relapsed|2|||
164551698|NCT03975920|594392359|FG000|Overall Study|Lost to Follow-up|1|||
164551699|NCT03975920|594392360|FG001|Overall Study|Lost to Follow-up|2|||
164551700|NCT03975920|594392359|FG000|Overall Study|Protocol Violation|1|||
164551701|NCT03975920|594392360|FG001|Overall Study|Protocol Violation|1|||
164551702|NCT03975920|594392359|FG000|Overall Study|Did not complete survey|2|||
164551703|NCT03975920|594392360|FG001|Overall Study|Did not complete survey|1|||
164551704|NCT00586495|594392363|FG000|Treatment Period|Adverse Event|11|||
164551705|NCT00586495|594392363|FG000|Treatment Period|Death|1|||
164551706|NCT00586495|594392363|FG000|Treatment Period|Protocol Violation|1|||
164551707|NCT00586495|594392363|FG000|Treatment Period|Withdrawal by Subject|1|||
164551708|NCT00586495|594392363|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
164551709|NCT00586495|594392363|FG000|Treatment Period|Switch to commercial drug|10|||
164551710|NCT00586495|594392363|FG000|Follow-up|Death|40|||
164551711|NCT00586495|594392363|FG000|Follow-up|Lost to Follow-up|1|||
164656580|NCT01464827|594768402|FG013|Overall Study|Not Treated|2|||
164309943|NCT00970684|593509538|FG000|Overall Study|Withdrawal by Subject|1|||
164309944|NCT00481091|593509539|FG000|Overall Study|Withdrawal by Subject|0|||
164309945|NCT00481091|593509540|FG001|Overall Study|Withdrawal by Subject|1|||
164551712|NCT00586495|594392363|FG000|Follow-up|Withdrawal by Subject|4|||
164551713|NCT00586495|594392363|FG000|Follow-up|Protocol driven decision point|37|||
164551714|NCT00586495|594392363|FG000|Follow-up|Switch to commercial drug|10|||
164551715|NCT03882970|594392366|FG000|Overall Study|Adverse Event|5|||
164551716|NCT03882970|594392367|FG001|Overall Study|Adverse Event|7|||
164551717|NCT03882970|594392368|FG002|Overall Study|Adverse Event|3|||
164551718|NCT03882970|594392369|FG003|Overall Study|Adverse Event|1|||
164551719|NCT03882970|594392366|FG000|Overall Study|Death|1|||
164551720|NCT03882970|594392367|FG001|Overall Study|Death|2|||
164551721|NCT03882970|594392368|FG002|Overall Study|Death|1|||
164551722|NCT03882970|594392369|FG003|Overall Study|Death|1|||
164551723|NCT03882970|594392366|FG000|Overall Study|Lost to Follow-up|8|||
164551724|NCT03882970|594392367|FG001|Overall Study|Lost to Follow-up|9|||
164551725|NCT03882970|594392368|FG002|Overall Study|Lost to Follow-up|5|||
164551726|NCT03882970|594392369|FG003|Overall Study|Lost to Follow-up|5|||
164551727|NCT03882970|594392366|FG000|Overall Study|Physician Decision|0|||
164551728|NCT03882970|594392367|FG001|Overall Study|Physician Decision|2|||
164551729|NCT03882970|594392368|FG002|Overall Study|Physician Decision|2|||
164551730|NCT03882970|594392369|FG003|Overall Study|Physician Decision|2|||
164551731|NCT03882970|594392366|FG000|Overall Study|Protocol Violation|2|||
164551732|NCT03882970|594392367|FG001|Overall Study|Protocol Violation|0|||
164551733|NCT03882970|594392368|FG002|Overall Study|Protocol Violation|0|||
164551734|NCT03882970|594392369|FG003|Overall Study|Protocol Violation|0|||
164551735|NCT03882970|594392366|FG000|Overall Study|Withdrawal by Subject|8|||
164551736|NCT03882970|594392367|FG001|Overall Study|Withdrawal by Subject|17|||
164551737|NCT03882970|594392368|FG002|Overall Study|Withdrawal by Subject|7|||
164551738|NCT03882970|594392369|FG003|Overall Study|Withdrawal by Subject|22|||
164551739|NCT03882970|594392366|FG000|Overall Study|Personal Reason|2|||
164551740|NCT03882970|594392367|FG001|Overall Study|Personal Reason|3|||
164551741|NCT03882970|594392368|FG002|Overall Study|Personal Reason|1|||
164551742|NCT03882970|594392369|FG003|Overall Study|Personal Reason|3|||
164551743|NCT02863809|594392370|FG000|Overall Study|Adverse Event|8|||
164551744|NCT02863809|594392371|FG001|Overall Study|Adverse Event|8|||
164551745|NCT02863809|594392370|FG000|Overall Study|Withdrawal by Subject|0|||
164551746|NCT02863809|594392371|FG001|Overall Study|Withdrawal by Subject|1|||
164551747|NCT02863809|594392370|FG000|Overall Study|Lost to Follow-up|1|||
164551748|NCT02863809|594392371|FG001|Overall Study|Lost to Follow-up|1|||
164551749|NCT02863809|594392370|FG000|Overall Study|Death|1|||
164551750|NCT02863809|594392371|FG001|Overall Study|Death|0|||
164551751|NCT01046877|594392374|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
164551752|NCT01046877|594392374|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
164551753|NCT02980224|594392378|FG000|Overall Study|Adverse Event|4|||
164551754|NCT02980224|594392379|FG001|Overall Study|Adverse Event|1|||
164551755|NCT02980224|594392378|FG000|Overall Study|Withdrawal by Subject|0|||
164551756|NCT02980224|594392379|FG001|Overall Study|Withdrawal by Subject|2|||
164551757|NCT00879645|594392382|FG000|Overall Study|Adverse Event|1|||
164551758|NCT00879645|594392383|FG001|Overall Study|Adverse Event|0|||
164551759|NCT00879645|594392384|FG002|Overall Study|Adverse Event|0|||
164551760|NCT00879645|594392385|FG003|Overall Study|Adverse Event|0|||
164551761|NCT01227044|594392386|FG000|Overall Study|Lost to Follow-up|5|||
164551762|NCT01227044|594392387|FG001|Overall Study|Lost to Follow-up|7|||
164551763|NCT01227044|594392386|FG000|Overall Study|Discontinued Intervention|1|||
164551764|NCT01227044|594392387|FG001|Overall Study|Discontinued Intervention|2|||
164551765|NCT02250274|594392389|FG000|Overall Study|Insufficient blood draw amount|7|||
164551766|NCT02250274|594392390|FG001|Overall Study|Insufficient blood draw amount|6|||
164551767|NCT04770389|594392403|FG000|Overall Study|Adverse Event|1|||
164551768|NCT04770389|594392404|FG001|Overall Study|Adverse Event|2|||
164551769|NCT04770389|594392405|FG002|Overall Study|Adverse Event|0|||
164551770|NCT04770389|594392406|FG003|Overall Study|Adverse Event|1|||
164551771|NCT04770389|594392403|FG000|Overall Study|Withdrawal by Subject|0|||
164551772|NCT04770389|594392404|FG001|Overall Study|Withdrawal by Subject|2|||
164551773|NCT04770389|594392405|FG002|Overall Study|Withdrawal by Subject|1|||
164551774|NCT04770389|594392406|FG003|Overall Study|Withdrawal by Subject|0|||
164551775|NCT04770389|594392403|FG000|Overall Study|Failed attempt to draw blood|1|||
164551776|NCT04770389|594392404|FG001|Overall Study|Failed attempt to draw blood|0|||
164201060|NCT01677741|593108462|FG002|Overall Study|Withdrawal by Subject|5|||
164551777|NCT04770389|594392405|FG002|Overall Study|Failed attempt to draw blood|0|||
164201061|NCT01677741|593108463|FG003|Overall Study|Withdrawal by Subject|4|||
164302359|NCT00001959|593482599|FG000|Overall Study|non-compliance|1|||
164551778|NCT04770389|594392406|FG003|Overall Study|Failed attempt to draw blood|0|||
164551779|NCT04770389|594392403|FG000|Overall Study|Left the country|0|||
164551780|NCT04770389|594392404|FG001|Overall Study|Left the country|0|||
164551781|NCT04770389|594392405|FG002|Overall Study|Left the country|1|||
164551782|NCT04770389|594392406|FG003|Overall Study|Left the country|2|||
164551783|NCT04770389|594392403|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
164551784|NCT04770389|594392404|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
164551785|NCT04770389|594392405|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
164551786|NCT04770389|594392406|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
164551787|NCT04770389|594392403|FG000|Overall Study|Lost to Follow-up|0|||
164551788|NCT04770389|594392404|FG001|Overall Study|Lost to Follow-up|0|||
164551789|NCT04770389|594392405|FG002|Overall Study|Lost to Follow-up|0|||
164551790|NCT04770389|594392406|FG003|Overall Study|Lost to Follow-up|1|||
164309946|NCT00481091|593509541|FG002|Overall Study|Withdrawal by Subject|1|||
164309947|NCT00481091|593509542|FG003|Overall Study|Withdrawal by Subject|0|||
164309948|NCT00481091|593509543|FG004|Overall Study|Withdrawal by Subject|0|||
164309949|NCT00481091|593509544|FG005|Overall Study|Withdrawal by Subject|0|||
164309950|NCT00481091|593509545|FG006|Overall Study|Withdrawal by Subject|0|||
164309951|NCT00481091|593509546|FG007|Overall Study|Withdrawal by Subject|0|||
164309952|NCT00481091|593509547|FG008|Overall Study|Withdrawal by Subject|1|||
164309953|NCT00481091|593509548|FG009|Overall Study|Withdrawal by Subject|6|||
164309954|NCT00481091|593509539|FG000|Overall Study|Other, Not Specified|0|||
164309955|NCT00481091|593509540|FG001|Overall Study|Other, Not Specified|1|||
164309956|NCT00481091|593509541|FG002|Overall Study|Other, Not Specified|1|||
164309957|NCT00481091|593509542|FG003|Overall Study|Other, Not Specified|0|||
164551791|NCT04770389|594392403|FG000|Overall Study|Moved away from study site|0|||
164551792|NCT04770389|594392404|FG001|Overall Study|Moved away from study site|1|||
164551793|NCT04770389|594392405|FG002|Overall Study|Moved away from study site|0|||
164551794|NCT04770389|594392406|FG003|Overall Study|Moved away from study site|0|||
164551795|NCT00794157|594392407|FG000|Overall Study|Adverse Event|4|||
164551796|NCT00794157|594392408|FG001|Overall Study|Adverse Event|1|||
164551797|NCT00794157|594392409|FG002|Overall Study|Adverse Event|8|||
164551798|NCT00794157|594392407|FG000|Overall Study|Subject withdrew consent|2|||
164551799|NCT00794157|594392408|FG001|Overall Study|Subject withdrew consent|0|||
164551800|NCT00794157|594392409|FG002|Overall Study|Subject withdrew consent|3|||
164551801|NCT00794157|594392407|FG000|Overall Study|Lost to Follow-up|2|||
164551802|NCT00794157|594392408|FG001|Overall Study|Lost to Follow-up|0|||
164551803|NCT00794157|594392409|FG002|Overall Study|Lost to Follow-up|1|||
164551804|NCT00794157|594392407|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164551805|NCT00794157|594392408|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164551806|NCT00794157|594392409|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
164551807|NCT00794157|594392407|FG000|Overall Study|Administrative problems|1|||
164551808|NCT00794157|594392408|FG001|Overall Study|Administrative problems|7|||
164551809|NCT00794157|594392409|FG002|Overall Study|Administrative problems|4|||
164551810|NCT00794157|594392407|FG000|Overall Study|Abnormal test procedure result(s)|0|||
164551811|NCT00794157|594392408|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164551812|NCT00794157|594392409|FG002|Overall Study|Abnormal test procedure result(s)|0|||
164551813|NCT00794157|594392407|FG000|Overall Study|Protocol deviation|0|||
164551814|NCT00794157|594392408|FG001|Overall Study|Protocol deviation|1|||
164551815|NCT00794157|594392409|FG002|Overall Study|Protocol deviation|1|||
164551816|NCT02970292|594392414|FG000|Overall Study|Physician Decision|1|||
164551817|NCT02970292|594392415|FG001|Overall Study|Physician Decision|1|||
164551818|NCT02970292|594392414|FG000|Overall Study|Withdrawal by Subject|11|||
164551819|NCT02970292|594392415|FG001|Overall Study|Withdrawal by Subject|5|||
164551820|NCT02970292|594392414|FG000|Overall Study|Noncompliance with study drug|2|||
164551821|NCT02970292|594392415|FG001|Overall Study|Noncompliance with study drug|2|||
164551822|NCT02970292|594392414|FG000|Overall Study|Adverse Event|5|||
164551823|NCT02970292|594392415|FG001|Overall Study|Adverse Event|0|||
164551824|NCT02970292|594392414|FG000|Overall Study|Lack of Efficacy|1|||
164551825|NCT02970292|594392415|FG001|Overall Study|Lack of Efficacy|0|||
164551826|NCT02970292|594392414|FG000|Overall Study|Lost to Follow-up|1|||
164551827|NCT02970292|594392415|FG001|Overall Study|Lost to Follow-up|0|||
164551828|NCT02970292|594392414|FG000|Overall Study|Protocol Violation|2|||
164551829|NCT02970292|594392415|FG001|Overall Study|Protocol Violation|0|||
164551830|NCT02970292|594392414|FG000|Overall Study|Other|1|||
164551831|NCT02970292|594392415|FG001|Overall Study|Other|0|||
164551832|NCT00814892|594392416|FG000|Overall Study|Disease Progression|1|||
164551833|NCT00814892|594392416|FG000|Overall Study|Study Termination|1|||
164551834|NCT00531752|594392417|FG000|First Double-blind Intervention Period|Adverse Event|2|||
164551835|NCT00531752|594392418|FG001|First Double-blind Intervention Period|Adverse Event|0|||
164551836|NCT00531752|594392419|FG002|First Double-blind Intervention Period|Adverse Event|1|||
164551837|NCT00531752|594392420|FG003|First Double-blind Intervention Period|Adverse Event|1|||
164309958|NCT00481091|593509543|FG004|Overall Study|Other, Not Specified|0|||
164309959|NCT00481091|593509544|FG005|Overall Study|Other, Not Specified|1|||
164309960|NCT00481091|593509545|FG006|Overall Study|Other, Not Specified|0|||
164309961|NCT00481091|593509546|FG007|Overall Study|Other, Not Specified|0|||
164551838|NCT00531752|594392417|FG000|First Double-blind Intervention Period|Other|1|||
164551839|NCT00531752|594392418|FG001|First Double-blind Intervention Period|Other|4|||
164551840|NCT00531752|594392419|FG002|First Double-blind Intervention Period|Other|4|||
164309962|NCT00481091|593509547|FG008|Overall Study|Other, Not Specified|0|||
164309963|NCT00481091|593509548|FG009|Overall Study|Other, Not Specified|4|||
164551841|NCT00531752|594392420|FG003|First Double-blind Intervention Period|Other|0|||
164551842|NCT00531752|594392417|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
164551843|NCT00531752|594392418|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
164551844|NCT00531752|594392419|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
164551845|NCT00531752|594392420|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
164551846|NCT00531752|594392417|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
164656581|NCT01075763|594768403|FG000|Overall Study|Lost to Follow-up|2|||
164656582|NCT01075763|594768404|FG001|Overall Study|Lost to Follow-up|1|||
164656583|NCT01075763|594768403|FG000|Overall Study|Lack of Efficacy|0|||
164656584|NCT01075763|594768404|FG001|Overall Study|Lack of Efficacy|1|||
164656585|NCT01075763|594768403|FG000|Overall Study|Withdrawal by Subject|2|||
164656586|NCT01075763|594768404|FG001|Overall Study|Withdrawal by Subject|2|||
164656587|NCT00586521|594768405|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
164656588|NCT03083483|594768409|FG000|Overall Study|Adverse Event|1|||
164656589|NCT03083483|594768410|FG001|Overall Study|Adverse Event|1|||
164656590|NCT03083483|594768411|FG002|Overall Study|Adverse Event|1|||
164656591|NCT03083483|594768409|FG000|Overall Study|Lost to Follow-up|2|||
164656592|NCT03083483|594768410|FG001|Overall Study|Lost to Follow-up|1|||
164656593|NCT03083483|594768411|FG002|Overall Study|Lost to Follow-up|1|||
164656594|NCT03083483|594768409|FG000|Overall Study|technological issues|1|||
164656595|NCT03083483|594768410|FG001|Overall Study|technological issues|0|||
164656596|NCT03083483|594768411|FG002|Overall Study|technological issues|1|||
164656597|NCT02710071|594768412|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
164656598|NCT02710071|594768413|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
164656599|NCT02710071|594768412|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
164656600|NCT02710071|594768413|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
164656601|NCT05487456|594768416|FG000|Overall Study|Withdrawal by Subject|0|||
164656602|NCT05487456|594768417|FG001|Overall Study|Withdrawal by Subject|0|||
164656603|NCT05487456|594768418|FG002|Overall Study|Withdrawal by Subject|1|||
164656604|NCT05487456|594768419|FG003|Overall Study|Withdrawal by Subject|0|||
164656605|NCT03294538|594768420|FG000|Overall Study|Adverse Event|0|||
164656606|NCT03294538|594768421|FG001|Overall Study|Adverse Event|1|||
164656607|NCT03294538|594768422|FG002|Overall Study|Adverse Event|1|||
164656608|NCT03294538|594768420|FG000|Overall Study|Lost to Follow-up|1|||
164656609|NCT03294538|594768421|FG001|Overall Study|Lost to Follow-up|0|||
164656610|NCT03294538|594768422|FG002|Overall Study|Lost to Follow-up|0|||
164656611|NCT03294538|594768420|FG000|Overall Study|Outside of Visit Window|4|||
164656612|NCT03294538|594768421|FG001|Overall Study|Outside of Visit Window|4|||
164656613|NCT03294538|594768422|FG002|Overall Study|Outside of Visit Window|1|||
164656614|NCT00958256|594768424|FG000|Overall Study|Adverse Event|3|||
164656615|NCT05431153|594768425|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164656616|NCT05431153|594768426|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164656617|NCT05431153|594768427|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164656618|NCT05431153|594768428|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164656619|NCT05431153|594768429|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
164656620|NCT05431153|594768430|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164656621|NCT00678392|594768431|FG000|Overall Study|Adverse Event|0|||
164656622|NCT00678392|594768432|FG001|Overall Study|Adverse Event|6|||
164656623|NCT00678392|594768431|FG000|Overall Study|Death|280|||
164656624|NCT00678392|594768432|FG001|Overall Study|Death|269|||
164656625|NCT00678392|594768431|FG000|Overall Study|Lost to Follow-up|15|||
164656626|NCT00678392|594768432|FG001|Overall Study|Lost to Follow-up|13|||
164656627|NCT00678392|594768431|FG000|Overall Study|Objective Progression or Relapse|3|||
164656628|NCT00678392|594768432|FG001|Overall Study|Objective Progression or Relapse|8|||
164656629|NCT00678392|594768431|FG000|Overall Study|Sponsor's Decision|1|||
164656630|NCT00678392|594768432|FG001|Overall Study|Sponsor's Decision|2|||
164656631|NCT00678392|594768431|FG000|Overall Study|Withdrawal by Subject|4|||
164656632|NCT00678392|594768432|FG001|Overall Study|Withdrawal by Subject|4|||
164656633|NCT00678392|594768431|FG000|Overall Study|Randomized But Not Treated|2|||
164656634|NCT00678392|594768432|FG001|Overall Study|Randomized But Not Treated|7|||
164656635|NCT00678392|594768431|FG000|Overall Study|Other|56|||
164656636|NCT00678392|594768432|FG001|Overall Study|Other|53|||
164656637|NCT03341507|594768433|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
164656638|NCT00989261|594768435|FG000|Overall Study|Still in follow up|12|||
164656639|NCT00989261|594768436|FG001|Overall Study|Still in follow up|21|||
164656640|NCT00989261|594768435|FG000|Overall Study|Withdrawal by Subject|0|||
164656641|NCT00989261|594768436|FG001|Overall Study|Withdrawal by Subject|1|||
164656642|NCT00989261|594768435|FG000|Overall Study|Lost to Follow-up|3|||
164656643|NCT00989261|594768436|FG001|Overall Study|Lost to Follow-up|0|||
164656644|NCT00782509|594768437|FG000|Overall Study|Adverse Event|20|||
164656645|NCT00782509|594768438|FG001|Overall Study|Adverse Event|10|||
164656646|NCT00782509|594768439|FG002|Overall Study|Adverse Event|20|||
164656647|NCT00782509|594768437|FG000|Overall Study|Lost to Follow-up|1|||
164656648|NCT00782509|594768438|FG001|Overall Study|Lost to Follow-up|2|||
164656649|NCT00782509|594768439|FG002|Overall Study|Lost to Follow-up|3|||
164656650|NCT00782509|594768437|FG000|Overall Study|Withdrawal by Subject|3|||
164656651|NCT00782509|594768438|FG001|Overall Study|Withdrawal by Subject|5|||
164656652|NCT00782509|594768439|FG002|Overall Study|Withdrawal by Subject|8|||
164656653|NCT00782509|594768437|FG000|Overall Study|Non compliance with protocol|2|||
164656654|NCT00782509|594768438|FG001|Overall Study|Non compliance with protocol|0|||
164656655|NCT00782509|594768439|FG002|Overall Study|Non compliance with protocol|0|||
164656656|NCT00782509|594768437|FG000|Overall Study|Other reasons not stated above|5|||
164656657|NCT00782509|594768438|FG001|Overall Study|Other reasons not stated above|2|||
164656658|NCT00782509|594768439|FG002|Overall Study|Other reasons not stated above|3|||
164656659|NCT00782509|594768437|FG000|Overall Study|Lack of Efficacy|10|||
164656660|NCT00782509|594768438|FG001|Overall Study|Lack of Efficacy|5|||
164656661|NCT00782509|594768439|FG002|Overall Study|Lack of Efficacy|2|||
164656662|NCT01401478|594768450|FG000|Overall Study|Study drug not available|6|||
164656663|NCT01401478|594768450|FG000|Overall Study|Adverse Event|5|||
164656664|NCT01401478|594768450|FG000|Overall Study|Hyperphosphatemia|5|||
164656665|NCT01401478|594768450|FG000|Overall Study|Lost to Follow-up|5|||
164656666|NCT01401478|594768450|FG000|Overall Study|Kidney transplantation|3|||
164656667|NCT01401478|594768450|FG000|Overall Study|Withdrawal by Subject|3|||
164656668|NCT01401478|594768450|FG000|Overall Study|Blood samples not available|1|||
164656669|NCT01401478|594768450|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
164656670|NCT01401478|594768450|FG000|Overall Study|Low intact parathyroid hormone|1|||
164656671|NCT01401478|594768450|FG000|Overall Study|Serious adverse event|1|||
164656672|NCT01814137|594768452|FG000|Overall Study|Adverse Event|0|||
164656673|NCT01814137|594768453|FG001|Overall Study|Adverse Event|1|||
164656674|NCT01814137|594768452|FG000|Overall Study|Withdrawal by Subject|2|||
164656675|NCT01814137|594768453|FG001|Overall Study|Withdrawal by Subject|2|||
164656676|NCT01814137|594768452|FG000|Overall Study|Physician Decision|1|||
164656677|NCT01814137|594768453|FG001|Overall Study|Physician Decision|1|||
164656678|NCT01814137|594768452|FG000|Overall Study|Unclassified|2|||
164656679|NCT01814137|594768453|FG001|Overall Study|Unclassified|1|||
164656680|NCT02536378|594768462|FG000|Overall Study|Physician Decision|0|||
164656681|NCT02536378|594768463|FG001|Overall Study|Physician Decision|2|||
164656682|NCT02536378|594768462|FG000|Overall Study|Withdrawal by Subject|0|||
164656683|NCT02536378|594768463|FG001|Overall Study|Withdrawal by Subject|1|||
164656684|NCT02536378|594768462|FG000|Overall Study|Death|1|||
164656685|NCT02536378|594768463|FG001|Overall Study|Death|2|||
164656686|NCT02536378|594768462|FG000|Overall Study|Patient refused further follow up|6|||
164656687|NCT02536378|594768463|FG001|Overall Study|Patient refused further follow up|2|||
164656688|NCT00947856|594768464|FG000|Treatment Period|Progressive Disease|33|||
164309964|NCT00481091|593509539|FG000|Overall Study|Adverse Event|1|||
164309965|NCT00481091|593509540|FG001|Overall Study|Adverse Event|2|||
164551847|NCT00531752|594392418|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
164551848|NCT00531752|594392419|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
164551849|NCT00531752|594392420|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
164551850|NCT00531752|594392417|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
164551851|NCT00531752|594392418|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
164551852|NCT00531752|594392419|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
164551853|NCT00531752|594392420|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
164551854|NCT00531752|594392417|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
164551855|NCT00531752|594392418|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
164551856|NCT00531752|594392419|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
164551857|NCT00531752|594392420|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
164551858|NCT00531752|594392417|FG000|Second Double-blind Intervention Period|Other|1|||
164551859|NCT00531752|594392418|FG001|Second Double-blind Intervention Period|Other|1|||
164551860|NCT00531752|594392419|FG002|Second Double-blind Intervention Period|Other|0|||
164551861|NCT00531752|594392420|FG003|Second Double-blind Intervention Period|Other|0|||
164551862|NCT00531752|594392417|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
164551863|NCT00531752|594392418|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
164551864|NCT00531752|594392419|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
164551865|NCT00531752|594392420|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
164551866|NCT00531752|594392417|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
164551867|NCT00531752|594392418|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
164551868|NCT00531752|594392419|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
164551869|NCT00531752|594392420|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
164551870|NCT04486950|594392422|FG000|Overall Study|Lost to Follow-up|0|||
164551871|NCT04486950|594392423|FG001|Overall Study|Lost to Follow-up|0|||
164551872|NCT04486950|594392424|FG002|Overall Study|Lost to Follow-up|0|||
164551873|NCT04486950|594392425|FG003|Overall Study|Lost to Follow-up|0|||
164551874|NCT04486950|594392426|FG004|Overall Study|Lost to Follow-up|0|||
164551875|NCT04486950|594392427|FG005|Overall Study|Lost to Follow-up|1|||
164551876|NCT04486950|594392428|FG006|Overall Study|Lost to Follow-up|0|||
164551877|NCT02821715|594392429|FG000|Overall Study|Protocol Violation|1|||
164551878|NCT02821715|594392430|FG001|Overall Study|Protocol Violation|0|||
164551879|NCT02821715|594392431|FG002|Overall Study|Protocol Violation|0|||
164551880|NCT02821715|594392432|FG003|Overall Study|Protocol Violation|0|||
164656689|NCT00947856|594768465|FG001|Treatment Period|Progressive Disease|12|||
164656690|NCT00947856|594768464|FG000|Treatment Period|Adverse Event|15|||
164656691|NCT00947856|594768465|FG001|Treatment Period|Adverse Event|9|||
164656692|NCT00947856|594768464|FG000|Treatment Period|Physician Decision|14|||
164656693|NCT00947856|594768465|FG001|Treatment Period|Physician Decision|6|||
164656694|NCT00947856|594768464|FG000|Treatment Period|Study Stopped by Sponsor|4|||
164656695|NCT00947856|594768465|FG001|Treatment Period|Study Stopped by Sponsor|4|||
164551881|NCT02821715|594392433|FG004|Overall Study|Protocol Violation|0|||
164551882|NCT02821715|594392434|FG005|Overall Study|Protocol Violation|0|||
164551883|NCT00640328|594392435|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
164551884|NCT00640328|594392436|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
164551885|NCT00640328|594392437|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
164551886|NCT00640328|594392438|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
164551887|NCT00640328|594392439|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
164551888|NCT00640328|594392440|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
164551889|NCT00640328|594392435|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
164551890|NCT00640328|594392436|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
164551891|NCT00640328|594392437|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
164551892|NCT00640328|594392438|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
164551893|NCT00640328|594392439|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
164551894|NCT00640328|594392440|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
164551895|NCT00640328|594392435|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
164551896|NCT00640328|594392436|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
164551897|NCT00640328|594392437|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
164551898|NCT00640328|594392438|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
164551899|NCT00640328|594392439|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
164551900|NCT00640328|594392440|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
164551901|NCT00640328|594392435|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
164551902|NCT00640328|594392436|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
164551903|NCT00640328|594392437|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
164551904|NCT00640328|594392438|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
164551905|NCT00640328|594392439|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
164551906|NCT00640328|594392440|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
164551907|NCT02374099|594392443|FG000|Overall Study|Adverse Event|1|||
164551908|NCT02374099|594392444|FG001|Overall Study|Adverse Event|0|||
164551909|NCT02374099|594392443|FG000|Overall Study|Progressive Disease|35|||
164551910|NCT02374099|594392444|FG001|Overall Study|Progressive Disease|40|||
164551911|NCT02374099|594392443|FG000|Overall Study|Withdrawal by Subject|5|||
164551912|NCT02374099|594392444|FG001|Overall Study|Withdrawal by Subject|1|||
164551913|NCT02374099|594392443|FG000|Overall Study|Miscellaneous|2|||
164551914|NCT02374099|594392444|FG001|Overall Study|Miscellaneous|3|||
164551915|NCT02374099|594392443|FG000|Overall Study|Randomized, but not treated|2|||
164551916|NCT02374099|594392444|FG001|Overall Study|Randomized, but not treated|1|||
164551917|NCT02374099|594392443|FG000|Overall Study|Study Terminated by Sponsor|3|||
164551918|NCT02374099|594392444|FG001|Overall Study|Study Terminated by Sponsor|4|||
164551919|NCT01033825|594392445|FG000|Overall Study|Withdrawal by Subject|2|||
164551920|NCT01033825|594392446|FG001|Overall Study|Withdrawal by Subject|3|||
164551921|NCT01033825|594392447|FG002|Overall Study|Withdrawal by Subject|2|||
164551922|NCT01033825|594392448|FG003|Overall Study|Withdrawal by Subject|1|||
164551923|NCT01033825|594392449|FG004|Overall Study|Withdrawal by Subject|1|||
164551924|NCT01033825|594392450|FG005|Overall Study|Withdrawal by Subject|0|||
164551925|NCT01033825|594392451|FG006|Overall Study|Withdrawal by Subject|0|||
164551926|NCT01033825|594392445|FG000|Overall Study|Adverse Event|0|||
164551927|NCT01033825|594392446|FG001|Overall Study|Adverse Event|0|||
164551928|NCT01033825|594392447|FG002|Overall Study|Adverse Event|0|||
164551929|NCT01033825|594392448|FG003|Overall Study|Adverse Event|1|||
164551930|NCT01033825|594392449|FG004|Overall Study|Adverse Event|0|||
164551931|NCT01033825|594392450|FG005|Overall Study|Adverse Event|0|||
164551932|NCT01033825|594392451|FG006|Overall Study|Adverse Event|0|||
164551933|NCT01033825|594392445|FG000|Overall Study|Protocol Violation|1|||
164551934|NCT01033825|594392446|FG001|Overall Study|Protocol Violation|0|||
164551935|NCT01033825|594392447|FG002|Overall Study|Protocol Violation|0|||
164551936|NCT01033825|594392448|FG003|Overall Study|Protocol Violation|0|||
164551937|NCT01033825|594392449|FG004|Overall Study|Protocol Violation|0|||
164551938|NCT01033825|594392450|FG005|Overall Study|Protocol Violation|0|||
164551939|NCT01033825|594392451|FG006|Overall Study|Protocol Violation|0|||
164551940|NCT01033825|594392445|FG000|Overall Study|Other|0|||
164551941|NCT01033825|594392446|FG001|Overall Study|Other|0|||
164551942|NCT01033825|594392447|FG002|Overall Study|Other|0|||
164201062|NCT01677741|593108464|FG004|Overall Study|Withdrawal by Subject|11|||
164201063|NCT01677741|593108465|FG005|Overall Study|Withdrawal by Subject|20|||
164201064|NCT01677741|593108466|FG006|Overall Study|Withdrawal by Subject|4|||
164201065|NCT01677741|593108467|FG007|Overall Study|Withdrawal by Subject|2|||
164201066|NCT01677741|593108460|FG000|Overall Study|Enrolled in a rollover study|0|||
164551943|NCT01033825|594392448|FG003|Overall Study|Other|0|||
164551944|NCT01033825|594392449|FG004|Overall Study|Other|1|||
164551945|NCT01033825|594392450|FG005|Overall Study|Other|0|||
164551946|NCT01033825|594392451|FG006|Overall Study|Other|0|||
164201067|NCT01677741|593108461|FG001|Overall Study|Enrolled in a rollover study|3|||
164201068|NCT01677741|593108462|FG002|Overall Study|Enrolled in a rollover study|2|||
164551947|NCT04294719|594392452|FG000|Overall Study|Withdrawal by Subject|1|||
164551948|NCT01883635|594392453|FG000|Overall Study|Withdrawal by Subject|4|||
164551949|NCT01883635|594392454|FG001|Overall Study|Withdrawal by Subject|0|||
164551950|NCT01464307|594392458|FG000|Main Period|Death|0|||
164551951|NCT01464307|594392459|FG001|Main Period|Death|1|||
164551952|NCT01464307|594392458|FG000|Main Period|Adverse Event|6|||
164551953|NCT01464307|594392459|FG001|Main Period|Adverse Event|1|||
164551954|NCT01464307|594392458|FG000|Main Period|Lack of Efficacy|2|||
164551955|NCT01464307|594392459|FG001|Main Period|Lack of Efficacy|0|||
164551956|NCT01464307|594392458|FG000|Main Period|Withdrawal by Subject|5|||
164551957|NCT01464307|594392459|FG001|Main Period|Withdrawal by Subject|2|||
164551958|NCT01464307|594392458|FG000|Main Period|Predefined discontinuation criteria|2|||
164551959|NCT01464307|594392459|FG001|Main Period|Predefined discontinuation criteria|1|||
164551960|NCT01464307|594392458|FG000|Open-Label Extension Period|Adverse Event|15|||
164551961|NCT01464307|594392459|FG001|Open-Label Extension Period|Adverse Event|0|||
164551962|NCT01464307|594392458|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
164551963|NCT01464307|594392459|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
164551964|NCT01464307|594392458|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
164551965|NCT01464307|594392459|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
164551966|NCT01464307|594392458|FG000|Open-Label Extension Period|Death|1|||
164551967|NCT01464307|594392459|FG001|Open-Label Extension Period|Death|0|||
164551968|NCT01464307|594392458|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
164551969|NCT01464307|594392459|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
164551970|NCT01464307|594392458|FG000|Open-Label Extension Period|Non-compliance|9|||
164551971|NCT01464307|594392459|FG001|Open-Label Extension Period|Non-compliance|0|||
164551972|NCT01464307|594392458|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
164551973|NCT01464307|594392459|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
164551974|NCT04869345|594392460|FG000|Overall Study|Lost to Follow-up|8|||
164551975|NCT04869345|594392461|FG001|Overall Study|Lost to Follow-up|3|||
164551976|NCT00528021|594392469|FG000|Overall Study|Lack of Efficacy|17|||
164551977|NCT00528021|594392470|FG001|Overall Study|Lack of Efficacy|13|||
164551978|NCT00528021|594392471|FG002|Overall Study|Lack of Efficacy|7|||
164551979|NCT00528021|594392472|FG003|Overall Study|Lack of Efficacy|9|||
164551980|NCT05054114|594392482|FG000|Overall Study|Protocol Violation|13|||
164551981|NCT05054114|594392483|FG001|Overall Study|Protocol Violation|1|||
164551982|NCT05054114|594392482|FG000|Overall Study|Pregnancy|0|||
164551983|NCT05054114|594392483|FG001|Overall Study|Pregnancy|1|||
164551984|NCT04294901|594392486|FG000|Overall Study|Death|86|||
164551985|NCT04294901|594392487|FG001|Overall Study|Death|110|||
164551986|NCT04294901|594392486|FG000|Overall Study|Provider did not have historical control patients|581|||
164201069|NCT01677741|593108463|FG003|Overall Study|Enrolled in a rollover study|1|||
164201070|NCT01677741|593108464|FG004|Overall Study|Enrolled in a rollover study|6|||
164201071|NCT01677741|593108465|FG005|Overall Study|Enrolled in a rollover study|6|||
164201072|NCT01677741|593108466|FG006|Overall Study|Enrolled in a rollover study|7|||
164201073|NCT01677741|593108467|FG007|Overall Study|Enrolled in a rollover study|0|||
164551987|NCT04294901|594392487|FG001|Overall Study|Provider did not have historical control patients|0|||
164551988|NCT04294901|594392486|FG000|Overall Study|Provider did not have intervention patients|0|||
164551989|NCT04294901|594392487|FG001|Overall Study|Provider did not have intervention patients|98|||
164551990|NCT03077685|594392488|FG000|Overall Study|Lost to Follow-up|0|||
164551991|NCT03077685|594392489|FG001|Overall Study|Lost to Follow-up|0|||
164551992|NCT03077685|594392490|FG002|Overall Study|Lost to Follow-up|0|||
164551993|NCT03077685|594392491|FG003|Overall Study|Lost to Follow-up|0|||
164551994|NCT03077685|594392492|FG004|Overall Study|Lost to Follow-up|1|||
164551995|NCT03077685|594392488|FG000|Overall Study|Death|0|||
164201074|NCT01677741|593108460|FG000|Overall Study|Progressive disease|1|||
164201075|NCT01677741|593108461|FG001|Overall Study|Progressive disease|0|||
164201076|NCT01677741|593108462|FG002|Overall Study|Progressive disease|1|||
164201077|NCT01677741|593108463|FG003|Overall Study|Progressive disease|0|||
164201078|NCT01677741|593108464|FG004|Overall Study|Progressive disease|0|||
164201079|NCT01677741|593108465|FG005|Overall Study|Progressive disease|1|||
164201080|NCT01677741|593108466|FG006|Overall Study|Progressive disease|0|||
164201081|NCT01677741|593108467|FG007|Overall Study|Progressive disease|0|||
164201082|NCT00794664|593108468|FG000|Treatment Period|Withdrawal by Subject|0|||
164201083|NCT00794664|593108469|FG001|Treatment Period|Withdrawal by Subject|2|||
164201084|NCT00794664|593108468|FG000|Treatment Period|Protocol non-compliance|0|||
164309966|NCT00481091|593509541|FG002|Overall Study|Adverse Event|0|||
164551996|NCT03077685|594392489|FG001|Overall Study|Death|0|||
164551997|NCT03077685|594392490|FG002|Overall Study|Death|1|||
164551998|NCT03077685|594392491|FG003|Overall Study|Death|1|||
164551999|NCT03077685|594392492|FG004|Overall Study|Death|3|||
164552000|NCT03077685|594392488|FG000|Overall Study|Withdrawal by Subject|0|||
164552001|NCT03077685|594392489|FG001|Overall Study|Withdrawal by Subject|0|||
164552002|NCT03077685|594392490|FG002|Overall Study|Withdrawal by Subject|0|||
164552003|NCT03077685|594392491|FG003|Overall Study|Withdrawal by Subject|2|||
164552004|NCT03077685|594392492|FG004|Overall Study|Withdrawal by Subject|1|||
164201085|NCT00794664|593108469|FG001|Treatment Period|Protocol non-compliance|1|||
164201086|NCT00794664|593108468|FG000|Treatment Period|Other|0|||
164309967|NCT00481091|593509542|FG003|Overall Study|Adverse Event|1|||
164309968|NCT00481091|593509543|FG004|Overall Study|Adverse Event|1|||
164309969|NCT00481091|593509544|FG005|Overall Study|Adverse Event|1|||
164309970|NCT00481091|593509545|FG006|Overall Study|Adverse Event|2|||
164309971|NCT00481091|593509546|FG007|Overall Study|Adverse Event|1|||
164309972|NCT00481091|593509547|FG008|Overall Study|Adverse Event|1|||
164309973|NCT00481091|593509548|FG009|Overall Study|Adverse Event|6|||
164309974|NCT00481091|593509539|FG000|Overall Study|Progressive disease clinical|0|||
164309975|NCT00481091|593509540|FG001|Overall Study|Progressive disease clinical|0|||
164309976|NCT00481091|593509541|FG002|Overall Study|Progressive disease clinical|0|||
164309977|NCT00481091|593509542|FG003|Overall Study|Progressive disease clinical|0|||
164309978|NCT00481091|593509543|FG004|Overall Study|Progressive disease clinical|0|||
164309979|NCT00481091|593509544|FG005|Overall Study|Progressive disease clinical|0|||
164309980|NCT00481091|593509545|FG006|Overall Study|Progressive disease clinical|0|||
164309981|NCT00481091|593509546|FG007|Overall Study|Progressive disease clinical|0|||
164309982|NCT00481091|593509547|FG008|Overall Study|Progressive disease clinical|1|||
164309983|NCT00481091|593509548|FG009|Overall Study|Progressive disease clinical|7|||
164309984|NCT00481091|593509539|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
164309985|NCT00481091|593509540|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
164309986|NCT00481091|593509541|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
164309987|NCT00481091|593509542|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
164309988|NCT00481091|593509543|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
164309989|NCT00481091|593509544|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
164309990|NCT00481091|593509545|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
164309991|NCT00481091|593509546|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
164309992|NCT00481091|593509547|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
164309993|NCT00481091|593509548|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
164309994|NCT00481091|593509539|FG000|Overall Study|Progressive disease other|1|||
164309995|NCT00481091|593509540|FG001|Overall Study|Progressive disease other|1|||
164309996|NCT00481091|593509541|FG002|Overall Study|Progressive disease other|0|||
164309997|NCT00481091|593509542|FG003|Overall Study|Progressive disease other|1|||
164309998|NCT00481091|593509543|FG004|Overall Study|Progressive disease other|1|||
164309999|NCT00481091|593509544|FG005|Overall Study|Progressive disease other|1|||
164310000|NCT00481091|593509545|FG006|Overall Study|Progressive disease other|0|||
164310001|NCT00481091|593509546|FG007|Overall Study|Progressive disease other|2|||
164310002|NCT00481091|593509547|FG008|Overall Study|Progressive disease other|0|||
164310003|NCT00481091|593509548|FG009|Overall Study|Progressive disease other|0|||
164310004|NCT00481091|593509539|FG000|Overall Study|No reason given|0|||
164310005|NCT00481091|593509540|FG001|Overall Study|No reason given|0|||
164310006|NCT00481091|593509541|FG002|Overall Study|No reason given|1|||
164310007|NCT00481091|593509542|FG003|Overall Study|No reason given|1|||
164310008|NCT00481091|593509543|FG004|Overall Study|No reason given|1|||
164310009|NCT00481091|593509544|FG005|Overall Study|No reason given|0|||
164310010|NCT00481091|593509545|FG006|Overall Study|No reason given|1|||
164310011|NCT00481091|593509546|FG007|Overall Study|No reason given|1|||
164310012|NCT00481091|593509547|FG008|Overall Study|No reason given|1|||
164310013|NCT00481091|593509548|FG009|Overall Study|No reason given|4|||
164310014|NCT04294680|593509549|FG000|Overall Study|Withdrawal by Subject|2|||
164310015|NCT04294680|593509550|FG001|Overall Study|Withdrawal by Subject|1|||
164310016|NCT04294680|593509549|FG000|Overall Study|Follow-up visits completed outside of window|1|||
164310017|NCT04294680|593509550|FG001|Overall Study|Follow-up visits completed outside of window|0|||
164310018|NCT02078960|593509553|FG000|Treatment Period|Other|0|||
164310019|NCT02078960|593509554|FG001|Treatment Period|Other|0|||
164310020|NCT02078960|593509555|FG002|Treatment Period|Other|1|||
164310021|NCT02078960|593509553|FG000|Treatment Period|Lack of Efficacy|0|||
164310022|NCT02078960|593509554|FG001|Treatment Period|Lack of Efficacy|1|||
164310023|NCT02078960|593509555|FG002|Treatment Period|Lack of Efficacy|0|||
164310024|NCT02078960|593509553|FG000|Treatment Period|Disease progression - accelerated phase|0|||
164310025|NCT02078960|593509554|FG001|Treatment Period|Disease progression - accelerated phase|1|||
164552005|NCT03077685|594392488|FG000|Overall Study|Physician Decision|0|||
164552006|NCT03077685|594392489|FG001|Overall Study|Physician Decision|0|||
164552007|NCT03077685|594392490|FG002|Overall Study|Physician Decision|1|||
164552008|NCT03077685|594392491|FG003|Overall Study|Physician Decision|0|||
164310026|NCT02078960|593509555|FG002|Treatment Period|Disease progression - accelerated phase|0|||
164310027|NCT02078960|593509553|FG000|Treatment Period|Disease progression - blast phase|1|||
164310028|NCT02078960|593509554|FG001|Treatment Period|Disease progression - blast phase|0|||
164310029|NCT02078960|593509555|FG002|Treatment Period|Disease progression - blast phase|0|||
164310030|NCT02078960|593509553|FG000|Treatment Period|Withdrawal by Subject|0|||
164552009|NCT03077685|594392492|FG004|Overall Study|Physician Decision|3|||
164310031|NCT02078960|593509554|FG001|Treatment Period|Withdrawal by Subject|1|||
164420594|NCT01890967|593910951|FG005|Overall Study|Death|0|||
164552010|NCT03077685|594392488|FG000|Overall Study|Disease Progression|1|||
164310032|NCT02078960|593509555|FG002|Treatment Period|Withdrawal by Subject|1|||
164656696|NCT00947856|594768464|FG000|Treatment Period|Withdrawal by Subject|12|||
164656697|NCT00947856|594768465|FG001|Treatment Period|Withdrawal by Subject|1|||
164656698|NCT00947856|594768464|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
164656699|NCT00947856|594768465|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
164656700|NCT00947856|594768464|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
164656701|NCT00947856|594768465|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
164656702|NCT00947856|594768464|FG000|Follow-up Period|Lost to Follow-up|7|||
164656703|NCT00947856|594768465|FG001|Follow-up Period|Lost to Follow-up|0|||
164656704|NCT00947856|594768464|FG000|Follow-up Period|Patient unavailable for site visits|1|||
164656705|NCT00947856|594768465|FG001|Follow-up Period|Patient unavailable for site visits|0|||
164656706|NCT00947856|594768464|FG000|Follow-up Period|Withdrawal by Subject|1|||
164656707|NCT00947856|594768465|FG001|Follow-up Period|Withdrawal by Subject|0|||
164656708|NCT02418910|594768466|FG000|Overall Study|Lost to Follow-up|3|||
164656709|NCT02418910|594768466|FG000|Overall Study|Withdrawal by Subject|4|||
164656710|NCT02472977|594768467|FG000|Overall Study|Disease progression|4|||
164656711|NCT02472977|594768468|FG001|Overall Study|Disease progression|25|||
164656712|NCT02472977|594768469|FG002|Overall Study|Disease progression|6|||
164552011|NCT03077685|594392489|FG001|Overall Study|Disease Progression|0|||
164552012|NCT03077685|594392490|FG002|Overall Study|Disease Progression|0|||
164552013|NCT03077685|594392491|FG003|Overall Study|Disease Progression|2|||
164552014|NCT03077685|594392492|FG004|Overall Study|Disease Progression|1|||
164552015|NCT03077685|594392488|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
164552016|NCT03077685|594392489|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
164552017|NCT03077685|594392490|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
164552018|NCT03077685|594392491|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
164552019|NCT03077685|594392492|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
164552020|NCT03077685|594392488|FG000|Overall Study|Subject entered hospice care|0|||
164552021|NCT03077685|594392489|FG001|Overall Study|Subject entered hospice care|0|||
164552022|NCT03077685|594392490|FG002|Overall Study|Subject entered hospice care|0|||
164552023|NCT03077685|594392491|FG003|Overall Study|Subject entered hospice care|0|||
164552024|NCT03077685|594392492|FG004|Overall Study|Subject entered hospice care|1|||
164552025|NCT01934556|594392495|FG000|Overall Study|Withdrawal by Subject|0|||
164552026|NCT01934556|594392496|FG001|Overall Study|Withdrawal by Subject|1|||
164552027|NCT01934556|594392497|FG002|Overall Study|Withdrawal by Subject|1|||
164552028|NCT01934556|594392495|FG000|Overall Study|Lost to Follow-up|4|||
164552029|NCT01934556|594392496|FG001|Overall Study|Lost to Follow-up|10|||
164552030|NCT01934556|594392497|FG002|Overall Study|Lost to Follow-up|7|||
164552031|NCT01934556|594392495|FG000|Overall Study|Death|1|||
164552032|NCT01934556|594392496|FG001|Overall Study|Death|5|||
164552033|NCT01934556|594392497|FG002|Overall Study|Death|2|||
164552034|NCT03770260|594393385|FG000|Overall Study|Disease progression|0|||
164552035|NCT03770260|594393386|FG001|Overall Study|Disease progression|1|||
164552036|NCT03770260|594393387|FG002|Overall Study|Disease progression|0|||
164552037|NCT03770260|594393388|FG003|Overall Study|Disease progression|0|||
164552038|NCT00477165|594393391|FG000|Overall Study|Adverse Event|7|||
164552039|NCT00477165|594393392|FG001|Overall Study|Adverse Event|2|||
164552040|NCT02135692|594393396|FG000|Overall Study|Adverse Event|3|||
164552041|NCT02135692|594393396|FG000|Overall Study|Lack of Efficacy|2|||
164552042|NCT02135692|594393396|FG000|Overall Study|Protocol Violation|2|||
164552043|NCT02135692|594393396|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
164552044|NCT02135692|594393396|FG000|Overall Study|Product commercially available|159|||
164552045|NCT02135692|594393396|FG000|Overall Study|Study closed/terminated|153|||
164552046|NCT02135692|594393396|FG000|Overall Study|Lost to Follow-up|4|||
164552047|NCT02135692|594393396|FG000|Overall Study|Withdrawal by Subject|15|||
164552048|NCT01097746|594393398|FG000|Overall Study|Adverse Event|4|||
164552049|NCT01097746|594393398|FG000|Overall Study|taken off study before any treatment given|1|||
164552050|NCT01514682|594393399|FG000|Overall Study|Withdrawal by Subject|2|||
164552051|NCT01514682|594393400|FG001|Overall Study|Withdrawal by Subject|3|||
164552052|NCT01514682|594393399|FG000|Overall Study|Physician Decision|4|||
164552053|NCT01514682|594393400|FG001|Overall Study|Physician Decision|3|||
164552054|NCT00143312|594393401|FG000|Overall Study|Death|11|||
164552055|NCT00143312|594393401|FG000|Overall Study|Adverse Event|2|||
164552056|NCT00143312|594393401|FG000|Overall Study|Lost to Follow-up|1|||
164552057|NCT00143312|594393401|FG000|Overall Study|Other|1|||
164552058|NCT00143312|594393401|FG000|Overall Study|Withdrawal by Subject|1|||
164552059|NCT00607386|594393402|FG000|Overall Study|Physician Decision|1|||
164656713|NCT02472977|594768467|FG000|Overall Study|Withdrawal by Subject|0|||
164656714|NCT02472977|594768468|FG001|Overall Study|Withdrawal by Subject|1|||
164656715|NCT02472977|594768469|FG002|Overall Study|Withdrawal by Subject|0|||
164656716|NCT02472977|594768467|FG000|Overall Study|Study drug toxicity|2|||
164656717|NCT02472977|594768468|FG001|Overall Study|Study drug toxicity|0|||
164656718|NCT02472977|594768469|FG002|Overall Study|Study drug toxicity|2|||
164552060|NCT00446511|594393405|FG000|Overall Study|Adverse Event|7|||
164552061|NCT00446511|594393406|FG001|Overall Study|Adverse Event|2|||
164552062|NCT00446511|594393407|FG002|Overall Study|Adverse Event|3|||
164656719|NCT02472977|594768467|FG000|Overall Study|Subject request to discontinue treatment|0|||
164656720|NCT02472977|594768468|FG001|Overall Study|Subject request to discontinue treatment|1|||
164310033|NCT02078960|593509553|FG000|Treatment Period|Adverse Event|1|||
164310034|NCT02078960|593509554|FG001|Treatment Period|Adverse Event|0|||
164552063|NCT00446511|594393408|FG003|Overall Study|Adverse Event|1|||
164552064|NCT00446511|594393405|FG000|Overall Study|Protocol Violation|0|||
164552065|NCT00446511|594393406|FG001|Overall Study|Protocol Violation|0|||
164552066|NCT00446511|594393407|FG002|Overall Study|Protocol Violation|0|||
164552067|NCT00446511|594393408|FG003|Overall Study|Protocol Violation|1|||
164552068|NCT00446511|594393405|FG000|Overall Study|Withdrawal by Subject|0|||
164552069|NCT00446511|594393406|FG001|Overall Study|Withdrawal by Subject|0|||
164552070|NCT00446511|594393407|FG002|Overall Study|Withdrawal by Subject|0|||
164552071|NCT00446511|594393408|FG003|Overall Study|Withdrawal by Subject|3|||
164552072|NCT00446511|594393405|FG000|Overall Study|Administrative Problems|3|||
164552073|NCT00446511|594393406|FG001|Overall Study|Administrative Problems|0|||
164552074|NCT00446511|594393407|FG002|Overall Study|Administrative Problems|4|||
164552075|NCT00446511|594393408|FG003|Overall Study|Administrative Problems|1|||
164552076|NCT02700997|594393409|FG000|Overall Study|Did not undergo CT imaging|1|||
164552077|NCT02700997|594393409|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
164552078|NCT01073267|594393410|FG000|Overall Study|Disease Progression|3|||
164552079|NCT00708123|594393411|FG000|Period 1|Protocol Violation|0|||
164552080|NCT00708123|594393412|FG001|Period 1|Protocol Violation|1|||
164552081|NCT00708123|594393413|FG002|Period 1|Protocol Violation|0|||
164552082|NCT00708123|594393414|FG003|Period 1|Protocol Violation|1|||
164552083|NCT00708123|594393415|FG004|Period 1|Protocol Violation|0|||
164552084|NCT00708123|594393411|FG000|Period 1|Adverse Event|0|||
164552085|NCT00708123|594393412|FG001|Period 1|Adverse Event|0|||
164552086|NCT00708123|594393413|FG002|Period 1|Adverse Event|1|||
164552087|NCT00708123|594393414|FG003|Period 1|Adverse Event|0|||
164552088|NCT00708123|594393415|FG004|Period 1|Adverse Event|0|||
164552089|NCT00708123|594393411|FG000|Period 2|Protocol Violation|0|||
164552090|NCT00708123|594393412|FG001|Period 2|Protocol Violation|0|||
164552091|NCT00708123|594393413|FG002|Period 2|Protocol Violation|0|||
164552092|NCT00708123|594393414|FG003|Period 2|Protocol Violation|1|||
164552093|NCT00708123|594393415|FG004|Period 2|Protocol Violation|0|||
164552094|NCT00708123|594393411|FG000|Period 2|Other Reason|1|||
164552095|NCT00708123|594393412|FG001|Period 2|Other Reason|0|||
164552096|NCT00708123|594393413|FG002|Period 2|Other Reason|0|||
164552097|NCT00708123|594393414|FG003|Period 2|Other Reason|0|||
164552098|NCT00708123|594393415|FG004|Period 2|Other Reason|0|||
164552099|NCT00708123|594393411|FG000|Period 3|Lost to Follow-up|0|||
164552100|NCT00708123|594393412|FG001|Period 3|Lost to Follow-up|0|||
164552101|NCT00708123|594393413|FG002|Period 3|Lost to Follow-up|1|||
164552102|NCT00708123|594393414|FG003|Period 3|Lost to Follow-up|1|||
164552103|NCT00708123|594393415|FG004|Period 3|Lost to Follow-up|0|||
164552104|NCT00708123|594393411|FG000|Period 4|Protocol Violation|0|||
164552105|NCT00708123|594393412|FG001|Period 4|Protocol Violation|1|||
164552106|NCT00708123|594393413|FG002|Period 4|Protocol Violation|0|||
164552107|NCT00708123|594393414|FG003|Period 4|Protocol Violation|0|||
164552108|NCT00708123|594393415|FG004|Period 4|Protocol Violation|0|||
164552109|NCT00845650|594393416|FG000|Overall Study|Withdrawal by Subject|0|||
164201087|NCT00794664|593108469|FG001|Treatment Period|Other|1|||
164201088|NCT00794664|593108468|FG000|Treatment Period|Adverse Event|1|||
164201089|NCT00794664|593108469|FG001|Treatment Period|Adverse Event|8|||
164201090|NCT00794664|593108468|FG000|Follow-up Period|Other|1|||
164201091|NCT00794664|593108469|FG001|Follow-up Period|Other|2|||
164201092|NCT00794664|593108468|FG000|Follow-up Period|Withdrawal by Subject|0|||
164201093|NCT00794664|593108469|FG001|Follow-up Period|Withdrawal by Subject|2|||
164201094|NCT00794664|593108468|FG000|Follow-up Period|Protocol non-compliance|0|||
164201095|NCT00794664|593108469|FG001|Follow-up Period|Protocol non-compliance|1|||
164201096|NCT02949947|593108470|FG000|Overall Study|Non Compliance|0|||
164201097|NCT02949947|593108471|FG001|Overall Study|Non Compliance|1|||
164310035|NCT02078960|593509555|FG002|Treatment Period|Adverse Event|0|||
164310036|NCT02078960|593509553|FG000|Treatment Period|Death|0|||
164552110|NCT00845650|594393417|FG001|Overall Study|Withdrawal by Subject|0|||
164552111|NCT00845650|594393418|FG002|Overall Study|Withdrawal by Subject|0|||
164552112|NCT00845650|594393419|FG003|Overall Study|Withdrawal by Subject|0|||
164552113|NCT00845650|594393420|FG004|Overall Study|Withdrawal by Subject|2|||
164552114|NCT00845650|594393421|FG005|Overall Study|Withdrawal by Subject|0|||
164552115|NCT00845650|594393416|FG000|Overall Study|Lost to Follow-up|0|||
164552116|NCT00845650|594393417|FG001|Overall Study|Lost to Follow-up|0|||
164552117|NCT00845650|594393418|FG002|Overall Study|Lost to Follow-up|3|||
164552118|NCT00845650|594393419|FG003|Overall Study|Lost to Follow-up|1|||
164552119|NCT00845650|594393420|FG004|Overall Study|Lost to Follow-up|0|||
164552120|NCT00845650|594393421|FG005|Overall Study|Lost to Follow-up|1|||
164201098|NCT02949947|593108470|FG000|Overall Study|Insurance change|1|||
164201099|NCT02949947|593108471|FG001|Overall Study|Insurance change|0|||
164552121|NCT00845650|594393416|FG000|Overall Study|Sponsor hold on dosing|0|||
164552122|NCT00845650|594393417|FG001|Overall Study|Sponsor hold on dosing|0|||
164552123|NCT00845650|594393418|FG002|Overall Study|Sponsor hold on dosing|0|||
164552124|NCT00845650|594393419|FG003|Overall Study|Sponsor hold on dosing|0|||
164552125|NCT00845650|594393420|FG004|Overall Study|Sponsor hold on dosing|1|||
164310037|NCT02078960|593509554|FG001|Treatment Period|Death|0|||
164310038|NCT02078960|593509555|FG002|Treatment Period|Death|1|||
164310039|NCT02078960|593509553|FG000|Follow-up Period|Death|2|||
164310040|NCT02078960|593509554|FG001|Follow-up Period|Death|0|||
164310041|NCT02078960|593509555|FG002|Follow-up Period|Death|0|||
164310042|NCT02078960|593509553|FG000|Follow-up Period|Lost to Follow-up|0|||
164310043|NCT02078960|593509554|FG001|Follow-up Period|Lost to Follow-up|1|||
164310044|NCT02078960|593509555|FG002|Follow-up Period|Lost to Follow-up|0|||
164310045|NCT04881942|593509557|FG000|Overall Study|Adverse Event|0|||
164310046|NCT04881942|593509558|FG001|Overall Study|Adverse Event|0|||
164310047|NCT04881942|593509559|FG002|Overall Study|Adverse Event|0|||
164310048|NCT04881942|593509560|FG003|Overall Study|Adverse Event|0|||
164310049|NCT04881942|593509561|FG004|Overall Study|Adverse Event|1|||
164552126|NCT00845650|594393421|FG005|Overall Study|Sponsor hold on dosing|1|||
164552127|NCT00845650|594393416|FG000|Overall Study|Unable to access IV line|1|||
164552128|NCT00845650|594393417|FG001|Overall Study|Unable to access IV line|0|||
164552129|NCT00845650|594393418|FG002|Overall Study|Unable to access IV line|0|||
164552130|NCT00845650|594393419|FG003|Overall Study|Unable to access IV line|0|||
164552131|NCT00845650|594393420|FG004|Overall Study|Unable to access IV line|0|||
164552132|NCT00845650|594393421|FG005|Overall Study|Unable to access IV line|0|||
164552133|NCT00677014|594393422|FG000|Overall Study|Lost to Follow-up|20|||
164552134|NCT00677014|594393423|FG001|Overall Study|Lost to Follow-up|12|||
164552135|NCT00677014|594393424|FG002|Overall Study|Lost to Follow-up|24|||
164552136|NCT00677014|594393422|FG000|Overall Study|Death|6|||
164552137|NCT00677014|594393423|FG001|Overall Study|Death|15|||
164552138|NCT00677014|594393424|FG002|Overall Study|Death|7|||
164552139|NCT00677014|594393422|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
164552140|NCT00677014|594393423|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
164552141|NCT00677014|594393424|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
164552142|NCT00081159|594393426|FG000|Overall Study|Withdrawal by Subject|0|||
164552143|NCT00081159|594393427|FG001|Overall Study|Withdrawal by Subject|3|||
164552144|NCT00081159|594393426|FG000|Overall Study|Myelosuppression prior to treatment|0|||
164552145|NCT00081159|594393427|FG001|Overall Study|Myelosuppression prior to treatment|1|||
164552146|NCT00081159|594393426|FG000|Overall Study|Lost to Follow-up|2|||
164552147|NCT00081159|594393427|FG001|Overall Study|Lost to Follow-up|1|||
164552148|NCT01714687|594393428|FG000|Overall Study|Withdrawal by Subject|1|||
164552149|NCT01714687|594393429|FG001|Overall Study|Withdrawal by Subject|0|||
164552150|NCT01714687|594393428|FG000|Overall Study|Lost to Follow-up|2|||
164552151|NCT01714687|594393429|FG001|Overall Study|Lost to Follow-up|4|||
164552152|NCT00923130|594393432|FG000|Overall Study|Stopped treatment due to progression|17|||
164552153|NCT00923130|594393432|FG000|Overall Study|Death|1|||
164552154|NCT00923130|594393432|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
164552155|NCT00923130|594393432|FG000|Overall Study|Switched to alternative treatment|2|||
164552156|NCT00923130|594393432|FG000|Overall Study|Refused further treatment|2|||
164552157|NCT00788372|594393433|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
164552158|NCT00788372|594393433|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
164552159|NCT00788372|594393433|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
164552160|NCT00788372|594393433|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
164552161|NCT00788372|594393433|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
164552162|NCT00788372|594393433|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
164552163|NCT00788372|594393433|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
164552164|NCT03693625|594393434|FG000|Overall Study|Adverse Event|2|||
164552165|NCT03693625|594393435|FG001|Overall Study|Adverse Event|0|||
164552166|NCT03693625|594393434|FG000|Overall Study|Study Terminated By Sponsor|20|||
164552167|NCT03693625|594393435|FG001|Overall Study|Study Terminated By Sponsor|7|||
164552168|NCT03693625|594393434|FG000|Overall Study|Withdrawal by Subject|1|||
164552169|NCT03693625|594393435|FG001|Overall Study|Withdrawal by Subject|1|||
164552170|NCT00761514|594393439|FG000|Overall Study|Adverse Event|1|||
164552171|NCT00761514|594393439|FG000|Overall Study|Withdrawal by Subject|2|||
164552172|NCT00761514|594393439|FG000|Overall Study|Lost to Follow-up|1|||
164552173|NCT00761514|594393439|FG000|Overall Study|Health insurance didn't cover study drug|1|||
164552174|NCT00761514|594393439|FG000|Overall Study|Problem complying with study visit|1|||
164552175|NCT00761514|594393439|FG000|Overall Study|Unable to pay for medications|1|||
164552176|NCT02457637|594393440|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
164552177|NCT01035905|594393441|FG000|Overall Study|Lack of Efficacy|1|||
164552178|NCT01035905|594393442|FG001|Overall Study|Lack of Efficacy|1|||
164552179|NCT00159861|594393443|FG000|Core Study - 16 Weeks|Death|3|||
164552180|NCT00159861|594393444|FG001|Core Study - 16 Weeks|Death|0|||
164552181|NCT00159861|594393443|FG000|Core Study - 16 Weeks|Adverse Event|12|||
164552182|NCT00159861|594393444|FG001|Core Study - 16 Weeks|Adverse Event|6|||
164552183|NCT00159861|594393443|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
164552184|NCT00159861|594393444|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
164310050|NCT04881942|593509557|FG000|Overall Study|Alternates|0|||
164310051|NCT04881942|593509558|FG001|Overall Study|Alternates|0|||
164310052|NCT04881942|593509559|FG002|Overall Study|Alternates|0|||
164310053|NCT04881942|593509560|FG003|Overall Study|Alternates|0|||
164310054|NCT04881942|593509561|FG004|Overall Study|Alternates|2|||
164310055|NCT00859638|593509562|FG000|Overall Study|Lost to Follow-up|6|||
164310056|NCT00859638|593509563|FG001|Overall Study|Lost to Follow-up|1|||
164310057|NCT00859638|593509562|FG000|Overall Study|Withdrawal by Subject|3|||
164310058|NCT00859638|593509563|FG001|Overall Study|Withdrawal by Subject|2|||
164310059|NCT00859638|593509562|FG000|Overall Study|Ill health|1|||
164310060|NCT00859638|593509563|FG001|Overall Study|Ill health|1|||
164310061|NCT00771953|593509567|FG000|Overall Study|Adverse Event|5|||
164552185|NCT00159861|594393443|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
164552186|NCT00159861|594393444|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
164552187|NCT00159861|594393443|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
164552188|NCT00159861|594393444|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
164552189|NCT00159861|594393443|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
164552190|NCT00159861|594393444|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
164552191|NCT00159861|594393443|FG000|Extension Study - up to 3 Years|Death|24|||
164552192|NCT00159861|594393444|FG001|Extension Study - up to 3 Years|Death|28|||
164552193|NCT00159861|594393443|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
164552194|NCT00159861|594393444|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
164552195|NCT00159861|594393443|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
164552196|NCT00159861|594393444|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
164552197|NCT00159861|594393443|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
164552198|NCT00159861|594393444|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
164552199|NCT00159861|594393443|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
164552200|NCT00159861|594393444|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
164552201|NCT03099187|594393449|FG000|Double-blind Treatment|Adverse Event|19|||
164552202|NCT03099187|594393450|FG001|Double-blind Treatment|Adverse Event|1|||
164552203|NCT03099187|594393451|FG002|Double-blind Treatment|Adverse Event|0|||
164552204|NCT03099187|594393452|FG003|Double-blind Treatment|Adverse Event|0|||
164552205|NCT03099187|594393449|FG000|Double-blind Treatment|Death|1|||
164552206|NCT03099187|594393450|FG001|Double-blind Treatment|Death|3|||
164552207|NCT03099187|594393451|FG002|Double-blind Treatment|Death|0|||
164552208|NCT03099187|594393452|FG003|Double-blind Treatment|Death|0|||
164552209|NCT03099187|594393449|FG000|Double-blind Treatment|Lack of Efficacy|1|||
164552210|NCT03099187|594393450|FG001|Double-blind Treatment|Lack of Efficacy|0|||
164552211|NCT03099187|594393451|FG002|Double-blind Treatment|Lack of Efficacy|0|||
164552212|NCT03099187|594393452|FG003|Double-blind Treatment|Lack of Efficacy|0|||
164552213|NCT03099187|594393449|FG000|Double-blind Treatment|Physician Decision|2|||
164552214|NCT03099187|594393450|FG001|Double-blind Treatment|Physician Decision|1|||
164552215|NCT03099187|594393451|FG002|Double-blind Treatment|Physician Decision|0|||
164552216|NCT03099187|594393452|FG003|Double-blind Treatment|Physician Decision|0|||
164552217|NCT03099187|594393449|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
164552218|NCT03099187|594393450|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
164552219|NCT03099187|594393451|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
164552220|NCT03099187|594393452|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
164552221|NCT03099187|594393449|FG000|Double-blind Treatment|Lung transplantation|0|||
164552222|NCT03099187|594393450|FG001|Double-blind Treatment|Lung transplantation|1|||
164552223|NCT03099187|594393451|FG002|Double-blind Treatment|Lung transplantation|0|||
164552224|NCT03099187|594393452|FG003|Double-blind Treatment|Lung transplantation|0|||
164552225|NCT03099187|594393449|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
164552226|NCT03099187|594393450|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
164552227|NCT03099187|594393451|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
164552228|NCT03099187|594393452|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
164552229|NCT03099187|594393449|FG000|Double-blind Treatment|Disease progression|0|||
164552230|NCT03099187|594393450|FG001|Double-blind Treatment|Disease progression|1|||
164552231|NCT03099187|594393451|FG002|Double-blind Treatment|Disease progression|0|||
164552232|NCT03099187|594393452|FG003|Double-blind Treatment|Disease progression|0|||
164552233|NCT03099187|594393449|FG000|Double-blind Treatment|Randomization error|0|||
164552234|NCT03099187|594393450|FG001|Double-blind Treatment|Randomization error|2|||
164552235|NCT03099187|594393451|FG002|Double-blind Treatment|Randomization error|0|||
164552236|NCT03099187|594393452|FG003|Double-blind Treatment|Randomization error|0|||
164552237|NCT03099187|594393449|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
164552238|NCT03099187|594393450|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
164552239|NCT03099187|594393451|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
164552240|NCT03099187|594393452|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
164552241|NCT03099187|594393449|FG000|12-month Safety Follow-up|Adverse Event|0|||
164552242|NCT03099187|594393450|FG001|12-month Safety Follow-up|Adverse Event|0|||
164552243|NCT03099187|594393451|FG002|12-month Safety Follow-up|Adverse Event|5|||
164552244|NCT03099187|594393452|FG003|12-month Safety Follow-up|Adverse Event|12|||
164552245|NCT03099187|594393449|FG000|12-month Safety Follow-up|Death|0|||
164552246|NCT03099187|594393450|FG001|12-month Safety Follow-up|Death|0|||
164310062|NCT00771953|593509568|FG001|Overall Study|Adverse Event|3|||
164552247|NCT03099187|594393451|FG002|12-month Safety Follow-up|Death|7|||
164656721|NCT02472977|594768469|FG002|Overall Study|Subject request to discontinue treatment|0|||
164656722|NCT01829295|594768470|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
164656723|NCT01829295|594768471|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
164656724|NCT01829295|594768472|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
164656725|NCT01829295|594768473|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
164656726|NCT01829295|594768470|FG000|6-12 Months|Adverse Event|0|||
164656727|NCT01829295|594768471|FG001|6-12 Months|Adverse Event|0|||
164656728|NCT01829295|594768472|FG002|6-12 Months|Adverse Event|3|||
164656729|NCT01829295|594768473|FG003|6-12 Months|Adverse Event|2|||
164656730|NCT01829295|594768470|FG000|6-12 Months|Lost to Follow-up|2|||
164656731|NCT01829295|594768471|FG001|6-12 Months|Lost to Follow-up|0|||
164656732|NCT01829295|594768472|FG002|6-12 Months|Lost to Follow-up|0|||
164656733|NCT01829295|594768473|FG003|6-12 Months|Lost to Follow-up|0|||
164656734|NCT01829295|594768470|FG000|6-12 Months|Withdrawal by Subject|2|||
164656735|NCT01829295|594768471|FG001|6-12 Months|Withdrawal by Subject|2|||
164656736|NCT01829295|594768472|FG002|6-12 Months|Withdrawal by Subject|0|||
164656737|NCT01829295|594768473|FG003|6-12 Months|Withdrawal by Subject|0|||
164656738|NCT02629965|594768476|FG000|Period 1|Adverse Event|1|||
164656739|NCT02629965|594768477|FG001|Period 1|Adverse Event|0|||
164656740|NCT02629965|594768476|FG000|Period 1|Unexpected worsening of disease|2|||
164656741|NCT02629965|594768477|FG001|Period 1|Unexpected worsening of disease|0|||
164656742|NCT02629965|594768476|FG000|Period 1|Other than listed above|1|||
164656743|NCT02629965|594768477|FG001|Period 1|Other than listed above|2|||
164656744|NCT02629965|594768476|FG000|Period 2|Adverse Event|1|||
164656745|NCT02629965|594768477|FG001|Period 2|Adverse Event|0|||
164656746|NCT01606137|594768481|FG000|Overall Study|Adverse Event|85|||
164656747|NCT01606137|594768481|FG000|Overall Study|Withdrawal by Subject|74|||
164656748|NCT01606137|594768481|FG000|Overall Study|Lack of Efficacy|56|||
164656749|NCT01606137|594768481|FG000|Overall Study|Lost to Follow-up|15|||
164656750|NCT01606137|594768481|FG000|Overall Study|Protocol Violation|1|||
164656751|NCT01606137|594768481|FG000|Overall Study|Patient non-compliance|9|||
164656752|NCT01606137|594768481|FG000|Overall Study|Death|1|||
164656753|NCT01606137|594768481|FG000|Overall Study|Decreased/no pain|4|||
164656754|NCT01606137|594768481|FG000|Overall Study|Issues with driving|4|||
164656755|NCT01606137|594768481|FG000|Overall Study|multiple sclerosis less stable|1|||
164656756|NCT01606137|594768481|FG000|Overall Study|Increased bilirubin|1|||
164656757|NCT01606137|594768481|FG000|Overall Study|Spray causes nausea|1|||
164656758|NCT01606137|594768481|FG000|Overall Study|Not enough improvement|4|||
164656759|NCT01606137|594768481|FG000|Overall Study|Wanted to try another treatment|1|||
164656760|NCT01606137|594768481|FG000|Overall Study|Patient leaving country|1|||
164656761|NCT01606137|594768481|FG000|Overall Study|Personal reasons|1|||
164656762|NCT01606137|594768481|FG000|Overall Study|Unable to tolerate study med. taste|1|||
164656763|NCT01606137|594768481|FG000|Overall Study|Patient moving|1|||
164656764|NCT01606137|594768481|FG000|Overall Study|Unable to collect consistent data|1|||
164656765|NCT03586830|594768492|FG000|Overall Study|Site terminated by Sponsor|1|||
164656766|NCT03586830|594768493|FG001|Overall Study|Site terminated by Sponsor|4|||
164656767|NCT03586830|594768494|FG002|Overall Study|Site terminated by Sponsor|3|||
164656768|NCT03586830|594768495|FG003|Overall Study|Site terminated by Sponsor|3|||
164656769|NCT03586830|594768492|FG000|Overall Study|Lost to Follow-up|0|||
164656770|NCT03586830|594768493|FG001|Overall Study|Lost to Follow-up|2|||
164656771|NCT03586830|594768494|FG002|Overall Study|Lost to Follow-up|2|||
164656772|NCT03586830|594768495|FG003|Overall Study|Lost to Follow-up|1|||
164656773|NCT03586830|594768492|FG000|Overall Study|Withdrawal by Subject|1|||
164656774|NCT03586830|594768493|FG001|Overall Study|Withdrawal by Subject|0|||
164656775|NCT03586830|594768494|FG002|Overall Study|Withdrawal by Subject|3|||
164656776|NCT03586830|594768495|FG003|Overall Study|Withdrawal by Subject|1|||
164656777|NCT00395083|594768496|FG000|Overall Study|Withdrawal by Subject|6|||
164656778|NCT00395083|594768497|FG001|Overall Study|Withdrawal by Subject|5|||
164656779|NCT00395083|594768496|FG000|Overall Study|Developed another disease|4|||
164656780|NCT00395083|594768497|FG001|Overall Study|Developed another disease|3|||
164656781|NCT05188521|594770032|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
164656782|NCT05188521|594770033|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
164656783|NCT01132118|594770034|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
164656784|NCT01132118|594770035|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
164656785|NCT01132118|594770034|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
164656786|NCT01132118|594770035|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
164656787|NCT01132118|594770034|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
164656788|NCT01132118|594770035|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
164656789|NCT01644890|594770036|FG000|Overall Study|Adverse Event|7|||
164656790|NCT01644890|594770037|FG001|Overall Study|Adverse Event|20|||
164656791|NCT01644890|594770036|FG000|Overall Study|Death|1|||
164656792|NCT01644890|594770037|FG001|Overall Study|Death|3|||
164656793|NCT01644890|594770036|FG000|Overall Study|Physician Decision|3|||
164656794|NCT01644890|594770037|FG001|Overall Study|Physician Decision|9|||
164656795|NCT01644890|594770036|FG000|Overall Study|Protocol Violation|6|||
164656796|NCT01644890|594770037|FG001|Overall Study|Protocol Violation|7|||
164656797|NCT01644890|594770036|FG000|Overall Study|Withdrawal by Subject|19|||
164201100|NCT00720499|593108474|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
164201101|NCT00720499|593108475|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
164201102|NCT00720499|593108474|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
164201103|NCT00720499|593108475|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
164201104|NCT00720499|593108474|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
164201105|NCT00720499|593108475|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
164201106|NCT01100502|593108476|FG000|Overall Study|Withdrawal by Subject|18|||
164201107|NCT01100502|593108477|FG001|Overall Study|Withdrawal by Subject|25|||
164201108|NCT01100502|593108476|FG000|Overall Study|Lost to Follow-up|13|||
164201109|NCT01100502|593108477|FG001|Overall Study|Lost to Follow-up|28|||
164201110|NCT01100502|593108476|FG000|Overall Study|Site request to end participation in study|0|||
164201111|NCT01100502|593108477|FG001|Overall Study|Site request to end participation in study|1|||
164201112|NCT01100502|593108476|FG000|Overall Study|Death|45|||
164201113|NCT01100502|593108477|FG001|Overall Study|Death|40|||
164201114|NCT00721799|593108485|FG000|Overall Study|Withdrawal by Subject|7|||
164201115|NCT00721799|593108485|FG000|Overall Study|withdraw by subject after scan 1|1|||
164201116|NCT01441973|593108487|FG000|Overall Study|Disease progression|8|||
164201117|NCT01441973|593108488|FG001|Overall Study|Disease progression|6|||
164201118|NCT01441973|593108487|FG000|Overall Study|Adverse event unrelated to study drug|3|||
164201119|NCT01441973|593108488|FG001|Overall Study|Adverse event unrelated to study drug|2|||
164201120|NCT01441973|593108487|FG000|Overall Study|Participant request to discontinue|1|||
164201121|NCT01441973|593108488|FG001|Overall Study|Participant request to discontinue|1|||
164201122|NCT01441973|593108487|FG000|Overall Study|Poor compliance/noncompliance|0|||
164201123|NCT01441973|593108488|FG001|Overall Study|Poor compliance/noncompliance|1|||
164201124|NCT01441973|593108487|FG000|Overall Study|Administrative reason by sponsor|3|||
164201125|NCT01441973|593108488|FG001|Overall Study|Administrative reason by sponsor|5|||
164201126|NCT01441973|593108487|FG000|Overall Study|Participant withdrew consent|0|||
164201127|NCT01441973|593108488|FG001|Overall Study|Participant withdrew consent|1|||
164552248|NCT03099187|594393452|FG003|12-month Safety Follow-up|Death|9|||
164552249|NCT03099187|594393449|FG000|12-month Safety Follow-up|Lung transplantation|0|||
164552250|NCT03099187|594393450|FG001|12-month Safety Follow-up|Lung transplantation|0|||
164552251|NCT03099187|594393451|FG002|12-month Safety Follow-up|Lung transplantation|2|||
164552252|NCT03099187|594393452|FG003|12-month Safety Follow-up|Lung transplantation|1|||
164552253|NCT03099187|594393449|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
164552254|NCT03099187|594393450|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
164552255|NCT03099187|594393451|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
164552256|NCT03099187|594393452|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
164552257|NCT03099187|594393449|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
164552258|NCT03099187|594393450|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
164552259|NCT03099187|594393451|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
164552260|NCT03099187|594393452|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
164552261|NCT03099187|594393449|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
164552262|NCT03099187|594393450|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
164552263|NCT03099187|594393451|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
164552264|NCT03099187|594393452|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
164552265|NCT03099187|594393449|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
164552266|NCT03099187|594393450|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
164552267|NCT03099187|594393451|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
164552268|NCT03099187|594393452|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
164552269|NCT03885089|594393453|FG000|Overall Study|No informed consent for publication of study results|2|||
164552270|NCT03349099|594393456|FG000|Overall Study|Physician Decision|3|||
164552271|NCT03349099|594393457|FG001|Overall Study|Physician Decision|4|||
164552272|NCT03349099|594393456|FG000|Overall Study|Stone migrated from the kidney|1|||
164552273|NCT03349099|594393457|FG001|Overall Study|Stone migrated from the kidney|0|||
164552274|NCT01210690|594393459|FG000|Overall Study|Adverse Event|7|||
164552275|NCT01210690|594393459|FG000|Overall Study|Lack of Efficacy|12|||
164552276|NCT01210690|594393459|FG000|Overall Study|Lost to Follow-up|3|||
164552277|NCT01210690|594393459|FG000|Overall Study|Disease Remission|1|||
164552278|NCT01210690|594393459|FG000|Overall Study|Withdrawal by Subject|1|||
164552279|NCT01210690|594393459|FG000|Overall Study|Patient refused to swallow|1|||
164552280|NCT01210690|594393459|FG000|Overall Study|Patient could not take glucose|1|||
164552281|NCT00894556|594393460|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
164552282|NCT00894556|594393461|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
164552283|NCT00894556|594393462|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
164552284|NCT00894556|594393463|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
164552285|NCT00894556|594393460|FG000|Treatment Phase|Lost to Follow-up|2|||
164552286|NCT00894556|594393461|FG001|Treatment Phase|Lost to Follow-up|3|||
164201128|NCT04356937|593108489|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
164201129|NCT04356937|593108490|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
164201130|NCT00807365|593108491|FG000|Overall Study|Study Terminated|5|||
164201131|NCT04821830|593108492|FG000|Overall Study|Withdrawal by Subject|1|||
164552287|NCT00894556|594393462|FG002|Treatment Phase|Lost to Follow-up|1|||
164552288|NCT00894556|594393463|FG003|Treatment Phase|Lost to Follow-up|0|||
164552289|NCT00894556|594393460|FG000|Treatment Phase|Lack of Qualifying Event|2|||
164552290|NCT00894556|594393461|FG001|Treatment Phase|Lack of Qualifying Event|1|||
164552291|NCT00894556|594393462|FG002|Treatment Phase|Lack of Qualifying Event|0|||
164552292|NCT00894556|594393463|FG003|Treatment Phase|Lack of Qualifying Event|0|||
164552293|NCT01979536|594393464|FG000|Overall Study|Physician Decision|2|||
164552294|NCT01979536|594393465|FG001|Overall Study|Physician Decision|3|||
164552295|NCT01979536|594393464|FG000|Overall Study|Withdrawal by Subject|0|||
164201132|NCT04821830|593108493|FG001|Overall Study|Withdrawal by Subject|0|||
164201133|NCT02934178|593110639|FG000|Received Vaccination 2|Death|0|||
164201134|NCT02934178|593110640|FG001|Received Vaccination 2|Death|1|||
164201135|NCT02934178|593110639|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
164201136|NCT02934178|593110640|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
164201137|NCT03944616|593110645|FG000|Overall Study|Lost to Follow-up|0|||
164201138|NCT03944616|593110646|FG001|Overall Study|Lost to Follow-up|2|||
164201139|NCT01926028|593110647|FG000|Overall Study|Lost to Follow-up|7|||
164201140|NCT01926028|593110648|FG001|Overall Study|Lost to Follow-up|6|||
164201141|NCT01926028|593110649|FG002|Overall Study|Lost to Follow-up|0|||
164201142|NCT01926028|593110647|FG000|Overall Study|Physician Decision|1|||
164201143|NCT01926028|593110648|FG001|Overall Study|Physician Decision|5|||
164201144|NCT01926028|593110649|FG002|Overall Study|Physician Decision|0|||
164201145|NCT01926028|593110647|FG000|Overall Study|Withdrawal by Subject|9|||
164201146|NCT01926028|593110648|FG001|Overall Study|Withdrawal by Subject|9|||
164201147|NCT01926028|593110649|FG002|Overall Study|Withdrawal by Subject|2|||
164201148|NCT01926028|593110647|FG000|Overall Study|Non compliance or other reasons|4|||
164201149|NCT01926028|593110648|FG001|Overall Study|Non compliance or other reasons|2|||
164201150|NCT01926028|593110649|FG002|Overall Study|Non compliance or other reasons|0|||
164201151|NCT04539275|593110650|FG000|Overall Study|Death|2|||
164201152|NCT04539275|593110651|FG001|Overall Study|Death|4|||
164201153|NCT04539275|593110650|FG000|Overall Study|Lost to Follow-up|1|||
164201154|NCT04539275|593110651|FG001|Overall Study|Lost to Follow-up|1|||
164201155|NCT04539275|593110650|FG000|Overall Study|Withdrawal by Subject|3|||
164201156|NCT04539275|593110651|FG001|Overall Study|Withdrawal by Subject|0|||
164201157|NCT01799941|593110652|FG000|Overall Study|Adverse Event|34|||
164201158|NCT01799941|593110652|FG000|Overall Study|Withdrawal by Subject|21|||
164201159|NCT01799941|593110652|FG000|Overall Study|Death|2|||
164201160|NCT01799941|593110652|FG000|Overall Study|Investigator Decision|4|||
164201161|NCT01799941|593110652|FG000|Overall Study|Lack of Efficacy|3|||
164201162|NCT01799941|593110652|FG000|Overall Study|Lost to Follow-up|17|||
164201163|NCT01799941|593110652|FG000|Overall Study|Other|15|||
164201164|NCT00547339|593110653|FG000|Overall Study|Physician Decision|0|||
164201165|NCT00547339|593110654|FG001|Overall Study|Physician Decision|0|||
164201166|NCT00547339|593110655|FG002|Overall Study|Physician Decision|1|||
164201167|NCT00547339|593110656|FG003|Overall Study|Physician Decision|0|||
164201168|NCT03587636|593110657|FG000|Overall Study|Lost to Follow-up|2|||
164201169|NCT03587636|593110658|FG001|Overall Study|Lost to Follow-up|5|||
164201170|NCT01079780|593110661|FG000|Overall Study|Disease progression|43|||
164201171|NCT01079780|593110662|FG001|Overall Study|Disease progression|7|||
164201172|NCT01079780|593110663|FG002|Overall Study|Disease progression|31|||
164201173|NCT01079780|593110661|FG000|Overall Study|Adverse Event|13|||
164201174|NCT01079780|593110662|FG001|Overall Study|Adverse Event|5|||
164201175|NCT01079780|593110663|FG002|Overall Study|Adverse Event|7|||
164201176|NCT01079780|593110661|FG000|Overall Study|Death|2|||
164201177|NCT01079780|593110662|FG001|Overall Study|Death|0|||
164201178|NCT01079780|593110663|FG002|Overall Study|Death|2|||
164201179|NCT01079780|593110661|FG000|Overall Study|Withdrawal by Subject|6|||
164201180|NCT01079780|593110662|FG001|Overall Study|Withdrawal by Subject|4|||
164201181|NCT01079780|593110663|FG002|Overall Study|Withdrawal by Subject|4|||
164201182|NCT01079780|593110661|FG000|Overall Study|Alternative therapy|2|||
164201183|NCT01079780|593110662|FG001|Overall Study|Alternative therapy|0|||
164201184|NCT01079780|593110663|FG002|Overall Study|Alternative therapy|2|||
164201185|NCT01079780|593110661|FG000|Overall Study|Physician Decision|1|||
164201186|NCT01079780|593110662|FG001|Overall Study|Physician Decision|0|||
164201187|NCT01079780|593110663|FG002|Overall Study|Physician Decision|1|||
164201188|NCT01079780|593110661|FG000|Overall Study|Error made in lesion measurement|1|||
164201189|NCT01079780|593110662|FG001|Overall Study|Error made in lesion measurement|0|||
164201190|NCT01079780|593110663|FG002|Overall Study|Error made in lesion measurement|0|||
164201191|NCT01079780|593110661|FG000|Overall Study|Patient had surgery|1|||
164201192|NCT01079780|593110662|FG001|Overall Study|Patient had surgery|0|||
164201193|NCT01079780|593110663|FG002|Overall Study|Patient had surgery|0|||
164201194|NCT01079780|593110661|FG000|Overall Study|Treatment cycle delay|0|||
164552296|NCT01979536|594393465|FG001|Overall Study|Withdrawal by Subject|1|||
164552297|NCT01979536|594393464|FG000|Overall Study|Refusal|0|||
164201195|NCT01079780|593110662|FG001|Overall Study|Treatment cycle delay|0|||
164201196|NCT01079780|593110663|FG002|Overall Study|Treatment cycle delay|1|||
164201197|NCT01079780|593110661|FG000|Overall Study|Never started treatment|1|||
164302360|NCT03755934|593482602|FG000|Overall Study|Adverse Event|4|||
164552298|NCT01979536|594393465|FG001|Overall Study|Refusal|1|||
164656798|NCT01644890|594770037|FG001|Overall Study|Withdrawal by Subject|27|||
164656799|NCT01644890|594770036|FG000|Overall Study|Progression Disease|160|||
164656800|NCT01644890|594770037|FG001|Overall Study|Progression Disease|131|||
164656801|NCT01644890|594770036|FG000|Overall Study|Clinical Progression|6|||
164656802|NCT01644890|594770037|FG001|Overall Study|Clinical Progression|6|||
164656803|NCT01644890|594770036|FG000|Overall Study|> 28 days since last dose of study drug|6|||
164656804|NCT01644890|594770037|FG001|Overall Study|> 28 days since last dose of study drug|3|||
164656805|NCT01644890|594770036|FG000|Overall Study|Other|8|||
164656806|NCT01644890|594770037|FG001|Overall Study|Other|9|||
164656807|NCT01413204|594770040|FG000|Overall Study|Adverse Event|1|||
164656808|NCT01413204|594770041|FG001|Overall Study|Adverse Event|2|||
164656809|NCT01413204|594770042|FG002|Overall Study|Adverse Event|2|||
164656810|NCT01413204|594770040|FG000|Overall Study|Physician Decision|3|||
164656811|NCT01413204|594770041|FG001|Overall Study|Physician Decision|0|||
164656812|NCT01413204|594770042|FG002|Overall Study|Physician Decision|2|||
164656813|NCT01413204|594770040|FG000|Overall Study|Withdrawal by Subject|1|||
164656814|NCT01413204|594770041|FG001|Overall Study|Withdrawal by Subject|4|||
164656815|NCT01413204|594770042|FG002|Overall Study|Withdrawal by Subject|4|||
164656816|NCT01413204|594770040|FG000|Overall Study|Clearly not eligible for the study|0|||
164656817|NCT01413204|594770041|FG001|Overall Study|Clearly not eligible for the study|0|||
164656818|NCT01413204|594770042|FG002|Overall Study|Clearly not eligible for the study|1|||
164656819|NCT01413204|594770040|FG000|Overall Study|Fasting plasma glucose level increased|1|||
164656820|NCT01413204|594770041|FG001|Overall Study|Fasting plasma glucose level increased|0|||
164656821|NCT01413204|594770042|FG002|Overall Study|Fasting plasma glucose level increased|10|||
164656822|NCT00313703|594770044|FG000|Overall Study|Lost to Follow-up|11|||
164656823|NCT00313703|594770045|FG001|Overall Study|Lost to Follow-up|2|||
164656824|NCT00313703|594770046|FG002|Overall Study|Lost to Follow-up|5|||
164656825|NCT00313703|594770047|FG003|Overall Study|Lost to Follow-up|12|||
164656826|NCT02497391|594770048|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
164656827|NCT02497391|594770049|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
164656828|NCT02497391|594770050|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
164656829|NCT02497391|594770051|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
164656830|NCT02497391|594770052|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
164656831|NCT02497391|594770053|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
164201198|NCT01079780|593110662|FG001|Overall Study|Never started treatment|0|||
164201199|NCT01079780|593110663|FG002|Overall Study|Never started treatment|2|||
164201200|NCT01178294|593110664|FG000|Overall Study|Adverse Event|4|||
164201201|NCT01178294|593110664|FG000|Overall Study|Lost to Follow-up|2|||
164201202|NCT01178294|593110664|FG000|Overall Study|Lack of Efficacy|1|||
164201203|NCT01178294|593110664|FG000|Overall Study|Death|1|||
164201204|NCT01178294|593110664|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
164201205|NCT01178294|593110664|FG000|Overall Study|Subject status is terminal|1|||
164201206|NCT01178294|593110664|FG000|Overall Study|Completion status could not be verified|1|||
164201207|NCT00551369|593110665|FG000|Overall Study|Protocol Violation|5|||
164201208|NCT00551369|593110665|FG000|Overall Study|Withdrawal by Subject|1|||
164201209|NCT00551369|593110665|FG000|Overall Study|Not treated per protocol and re|1|||
164201210|NCT02051296|593110670|FG000|Overall Study|Lost to Follow-up|1|||
164201211|NCT02051296|593110671|FG001|Overall Study|Lost to Follow-up|2|||
164201212|NCT02051296|593110670|FG000|Overall Study|withdraw prior to treatment|7|||
164201213|NCT02051296|593110671|FG001|Overall Study|withdraw prior to treatment|7|||
164201214|NCT01663623|593110672|FG000|Overall Study|Adverse Event|3|||
164201215|NCT01663623|593110673|FG001|Overall Study|Adverse Event|7|||
164201216|NCT01663623|593110672|FG000|Overall Study|Lack of Efficacy|5|||
164201217|NCT01663623|593110673|FG001|Overall Study|Lack of Efficacy|6|||
164201218|NCT01663623|593110672|FG000|Overall Study|Protocol Violation|0|||
164201219|NCT01663623|593110673|FG001|Overall Study|Protocol Violation|1|||
164201220|NCT01663623|593110672|FG000|Overall Study|Other-Study closed/terminated|1|||
164201221|NCT01663623|593110673|FG001|Overall Study|Other-Study closed/terminated|1|||
164201222|NCT01663623|593110672|FG000|Overall Study|Physician Decision|1|||
164656832|NCT02497391|594770048|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
164656833|NCT02497391|594770049|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
164656834|NCT02497391|594770050|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
164656835|NCT02497391|594770051|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
164656836|NCT02497391|594770052|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
164656837|NCT02497391|594770053|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
164656838|NCT02497391|594770048|FG000|Period 3 (14 Days)|Adverse Event|0|||
164201223|NCT01663623|593110673|FG001|Overall Study|Physician Decision|4|||
164201224|NCT01663623|593110672|FG000|Overall Study|Withdrawal by Subject|2|||
164201225|NCT01663623|593110673|FG001|Overall Study|Withdrawal by Subject|1|||
164201226|NCT02251275|593110674|FG000|Overall Study|Adverse Event|23|||
164201227|NCT02251275|593110675|FG001|Overall Study|Adverse Event|60|||
164201228|NCT02251275|593110676|FG002|Overall Study|Adverse Event|28|||
164201229|NCT02251275|593110677|FG003|Overall Study|Adverse Event|0|||
164201230|NCT02251275|593110678|FG004|Overall Study|Adverse Event|0|||
164656839|NCT02497391|594770049|FG001|Period 3 (14 Days)|Adverse Event|1|||
164656840|NCT02497391|594770050|FG002|Period 3 (14 Days)|Adverse Event|0|||
164656841|NCT02497391|594770051|FG003|Period 3 (14 Days)|Adverse Event|0|||
164552299|NCT01979536|594393464|FG000|Overall Study|Relapse|0|||
164552300|NCT01979536|594393465|FG001|Overall Study|Relapse|1|||
164552301|NCT01979536|594393464|FG000|Overall Study|Study terminated by Sponsor|0|||
164552302|NCT01979536|594393465|FG001|Overall Study|Study terminated by Sponsor|1|||
164552303|NCT01979536|594393464|FG000|Overall Study|Did not start treatment|0|||
164552304|NCT01979536|594393465|FG001|Overall Study|Did not start treatment|1|||
164552305|NCT01806779|594393467|FG000|Overall Study|Physician Decision|2|||
164552306|NCT01806779|594393468|FG001|Overall Study|Physician Decision|0|||
164552307|NCT01806779|594393469|FG002|Overall Study|Physician Decision|1|||
164552308|NCT01806779|594393467|FG000|Overall Study|Lack of Efficacy|1|||
164552309|NCT01806779|594393468|FG001|Overall Study|Lack of Efficacy|1|||
164552310|NCT01806779|594393469|FG002|Overall Study|Lack of Efficacy|0|||
164552311|NCT01806779|594393467|FG000|Overall Study|Lost to Follow-up|19|||
164552312|NCT01806779|594393468|FG001|Overall Study|Lost to Follow-up|20|||
164552313|NCT01806779|594393469|FG002|Overall Study|Lost to Follow-up|0|||
164552314|NCT01806779|594393467|FG000|Overall Study|Withdrawal by Subject|20|||
164552315|NCT01806779|594393468|FG001|Overall Study|Withdrawal by Subject|23|||
164552316|NCT01806779|594393469|FG002|Overall Study|Withdrawal by Subject|22|||
164552317|NCT00805480|594393470|FG000|Overall Study|Withdrawal by Subject|13|||
164552318|NCT00805480|594393471|FG001|Overall Study|Withdrawal by Subject|5|||
164552319|NCT00805480|594393472|FG002|Overall Study|Withdrawal by Subject|11|||
164552320|NCT00805480|594393473|FG003|Overall Study|Withdrawal by Subject|5|||
164552321|NCT00805480|594393470|FG000|Overall Study|Lost to Follow-up|1|||
164552322|NCT00805480|594393471|FG001|Overall Study|Lost to Follow-up|2|||
164552323|NCT00805480|594393472|FG002|Overall Study|Lost to Follow-up|0|||
164552324|NCT00805480|594393473|FG003|Overall Study|Lost to Follow-up|0|||
164552325|NCT00805480|594393470|FG000|Overall Study|Adverse Event|0|||
164552326|NCT00805480|594393471|FG001|Overall Study|Adverse Event|0|||
164552327|NCT00805480|594393472|FG002|Overall Study|Adverse Event|1|||
164552328|NCT00805480|594393473|FG003|Overall Study|Adverse Event|0|||
164552329|NCT02116777|594393476|FG000|Overall Study|Adverse Event|0|||
164552330|NCT02116777|594393477|FG001|Overall Study|Adverse Event|0|||
164552331|NCT02116777|594393478|FG002|Overall Study|Adverse Event|0|||
164552332|NCT02116777|594393479|FG003|Overall Study|Adverse Event|0|||
164552333|NCT02116777|594393480|FG004|Overall Study|Adverse Event|2|||
164552334|NCT02116777|594393481|FG005|Overall Study|Adverse Event|2|||
164552335|NCT02116777|594393482|FG006|Overall Study|Adverse Event|0|||
164552336|NCT02116777|594393476|FG000|Overall Study|Death|0|||
164552337|NCT02116777|594393477|FG001|Overall Study|Death|0|||
164552338|NCT02116777|594393478|FG002|Overall Study|Death|0|||
164552339|NCT02116777|594393479|FG003|Overall Study|Death|1|||
164552340|NCT02116777|594393480|FG004|Overall Study|Death|0|||
164552341|NCT02116777|594393481|FG005|Overall Study|Death|0|||
164552342|NCT02116777|594393482|FG006|Overall Study|Death|0|||
164552343|NCT02116777|594393476|FG000|Overall Study|Lack of Efficacy|3|||
164552344|NCT02116777|594393477|FG001|Overall Study|Lack of Efficacy|3|||
164552345|NCT02116777|594393478|FG002|Overall Study|Lack of Efficacy|3|||
164552346|NCT02116777|594393479|FG003|Overall Study|Lack of Efficacy|8|||
164552347|NCT02116777|594393480|FG004|Overall Study|Lack of Efficacy|4|||
164552348|NCT02116777|594393481|FG005|Overall Study|Lack of Efficacy|1|||
164552349|NCT02116777|594393482|FG006|Overall Study|Lack of Efficacy|9|||
164552350|NCT02116777|594393476|FG000|Overall Study|Physician Decision|0|||
164552351|NCT02116777|594393477|FG001|Overall Study|Physician Decision|0|||
164552352|NCT02116777|594393478|FG002|Overall Study|Physician Decision|0|||
164552353|NCT02116777|594393479|FG003|Overall Study|Physician Decision|2|||
164552354|NCT02116777|594393480|FG004|Overall Study|Physician Decision|0|||
164552355|NCT02116777|594393481|FG005|Overall Study|Physician Decision|0|||
164552356|NCT02116777|594393482|FG006|Overall Study|Physician Decision|0|||
164552357|NCT02116777|594393476|FG000|Overall Study|Protocol Violation|0|||
164552358|NCT02116777|594393477|FG001|Overall Study|Protocol Violation|0|||
164552359|NCT02116777|594393478|FG002|Overall Study|Protocol Violation|0|||
164552360|NCT02116777|594393479|FG003|Overall Study|Protocol Violation|1|||
164552361|NCT02116777|594393480|FG004|Overall Study|Protocol Violation|0|||
164552362|NCT02116777|594393481|FG005|Overall Study|Protocol Violation|0|||
164552363|NCT02116777|594393482|FG006|Overall Study|Protocol Violation|0|||
164552364|NCT02116777|594393476|FG000|Overall Study|Withdrawal by Subject|0|||
164552365|NCT02116777|594393477|FG001|Overall Study|Withdrawal by Subject|0|||
164552366|NCT02116777|594393478|FG002|Overall Study|Withdrawal by Subject|0|||
164552367|NCT02116777|594393479|FG003|Overall Study|Withdrawal by Subject|1|||
164552368|NCT02116777|594393480|FG004|Overall Study|Withdrawal by Subject|0|||
164552369|NCT02116777|594393481|FG005|Overall Study|Withdrawal by Subject|0|||
164552370|NCT02116777|594393482|FG006|Overall Study|Withdrawal by Subject|0|||
164552371|NCT05038020|594393483|FG000|Overall Study|Early Termination|3|||
164552372|NCT05038020|594393484|FG001|Overall Study|Early Termination|0|||
164552373|NCT00733954|594393487|FG000|Overall Study|Lost to Follow-up|5|||
164552374|NCT00733954|594393488|FG001|Overall Study|Lost to Follow-up|2|||
164552375|NCT00733954|594393487|FG000|Overall Study|Protocol Violation|1|||
164552376|NCT00733954|594393488|FG001|Overall Study|Protocol Violation|0|||
164552377|NCT00733954|594393487|FG000|Overall Study|Withdrawal by Subject|2|||
164552378|NCT00733954|594393488|FG001|Overall Study|Withdrawal by Subject|0|||
164552379|NCT02663453|594393489|FG000|Overall Study|Death|4|||
164552380|NCT02663453|594393490|FG001|Overall Study|Death|4|||
164552381|NCT02663453|594393489|FG000|Overall Study|Withdrawal by Subject|1|||
164552382|NCT02663453|594393490|FG001|Overall Study|Withdrawal by Subject|0|||
164552383|NCT03416153|594393491|FG000|Overall Study|Physician Decision|1|||
164552384|NCT03416153|594393492|FG001|Overall Study|Physician Decision|1|||
164552385|NCT03416153|594393491|FG000|Overall Study|Withdrawal by Subject|1|||
164552386|NCT03416153|594393492|FG001|Overall Study|Withdrawal by Subject|0|||
164552387|NCT03468855|594394903|FG000|Overall Study|Adverse Event|2|||
164552388|NCT03468855|594394903|FG000|Overall Study|Lost to Follow-up|5|||
164552389|NCT03468855|594394903|FG000|Overall Study|Withdrawal by Subject|3|||
164552390|NCT03468855|594394903|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
164552391|NCT01908101|594394904|FG000|Overall Study|Physician Decision|1|||
164552392|NCT01908101|594394904|FG000|Overall Study|Withdrawal by Subject|1|||
164552393|NCT01908101|594394904|FG000|Overall Study|Incorrect Diagnosis|2|||
164552394|NCT01908101|594394904|FG000|Overall Study|Incorrect Starting Dose|1|||
164552395|NCT01908101|594394904|FG000|Overall Study|Did not complete the first cycle|4|||
164552396|NCT01394939|594394905|FG000|Overall Study|Adverse Event|1|||
164552397|NCT01394939|594394906|FG001|Overall Study|Adverse Event|3|||
164552398|NCT01394939|594394907|FG002|Overall Study|Adverse Event|0|||
164552399|NCT01394939|594394908|FG003|Overall Study|Adverse Event|2|||
164552400|NCT01394939|594394905|FG000|Overall Study|Death|0|||
164552401|NCT01394939|594394906|FG001|Overall Study|Death|2|||
164552402|NCT01394939|594394907|FG002|Overall Study|Death|0|||
164552403|NCT01394939|594394908|FG003|Overall Study|Death|0|||
164552404|NCT01394939|594394905|FG000|Overall Study|Physician Decision|0|||
164552405|NCT01394939|594394906|FG001|Overall Study|Physician Decision|1|||
164552406|NCT01394939|594394907|FG002|Overall Study|Physician Decision|0|||
164552407|NCT01394939|594394908|FG003|Overall Study|Physician Decision|0|||
164552408|NCT01394939|594394905|FG000|Overall Study|Withdrawal by Subject|0|||
164552409|NCT01394939|594394906|FG001|Overall Study|Withdrawal by Subject|2|||
164552410|NCT01394939|594394907|FG002|Overall Study|Withdrawal by Subject|0|||
164552411|NCT01394939|594394908|FG003|Overall Study|Withdrawal by Subject|2|||
164552412|NCT01394939|594394905|FG000|Overall Study|Others|0|||
164552413|NCT01394939|594394906|FG001|Overall Study|Others|2|||
164552414|NCT01394939|594394907|FG002|Overall Study|Others|0|||
164552415|NCT01394939|594394908|FG003|Overall Study|Others|3|||
164552416|NCT02068547|594394911|FG000|Overall Study|Lost to Follow-up|3|||
164552417|NCT02068547|594394912|FG001|Overall Study|Lost to Follow-up|3|||
164552418|NCT02068547|594394911|FG000|Overall Study|Physician Decision|1|||
164552419|NCT02068547|594394912|FG001|Overall Study|Physician Decision|0|||
164552420|NCT03657043|594394914|FG000|Overall Study|Withdrawal by Subject|1|||
164552421|NCT03657043|594394915|FG001|Overall Study|Withdrawal by Subject|1|||
164552422|NCT03657043|594394916|FG002|Overall Study|Withdrawal by Subject|0|||
164552423|NCT03657043|594394917|FG003|Overall Study|Withdrawal by Subject|0|||
164552424|NCT03657043|594394918|FG004|Overall Study|Withdrawal by Subject|4|||
164552425|NCT03657043|594394914|FG000|Overall Study|Study closure by Sponsor|0|||
164552426|NCT03657043|594394915|FG001|Overall Study|Study closure by Sponsor|2|||
164552427|NCT03657043|594394916|FG002|Overall Study|Study closure by Sponsor|0|||
164552428|NCT03657043|594394917|FG003|Overall Study|Study closure by Sponsor|0|||
164552429|NCT03657043|594394918|FG004|Overall Study|Study closure by Sponsor|17|||
164552430|NCT03657043|594394914|FG000|Overall Study|Lost to Follow-up|0|||
164552431|NCT03657043|594394915|FG001|Overall Study|Lost to Follow-up|0|||
164552432|NCT03657043|594394916|FG002|Overall Study|Lost to Follow-up|0|||
164201231|NCT02251275|593110674|FG000|Overall Study|Lost to Follow-up|5|||
164201232|NCT02251275|593110675|FG001|Overall Study|Lost to Follow-up|6|||
164201233|NCT02251275|593110676|FG002|Overall Study|Lost to Follow-up|4|||
164201234|NCT02251275|593110677|FG003|Overall Study|Lost to Follow-up|0|||
164201235|NCT02251275|593110678|FG004|Overall Study|Lost to Follow-up|0|||
164201236|NCT02251275|593110674|FG000|Overall Study|Physician Decision|19|||
164552433|NCT03657043|594394917|FG003|Overall Study|Lost to Follow-up|0|||
164552434|NCT03657043|594394918|FG004|Overall Study|Lost to Follow-up|4|||
164552435|NCT03657043|594394914|FG000|Overall Study|Death|6|||
164552436|NCT03657043|594394915|FG001|Overall Study|Death|5|||
164552437|NCT03657043|594394916|FG002|Overall Study|Death|0|||
164552438|NCT03657043|594394917|FG003|Overall Study|Death|0|||
164552439|NCT03657043|594394918|FG004|Overall Study|Death|53|||
164552440|NCT03657043|594394914|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
164552441|NCT03657043|594394915|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
164552442|NCT03657043|594394916|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
164552443|NCT03657043|594394917|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
164552444|NCT03657043|594394918|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
164552445|NCT03657043|594394914|FG000|Overall Study|Adverse Event|0|||
164201237|NCT02251275|593110675|FG001|Overall Study|Physician Decision|30|||
164552446|NCT03657043|594394915|FG001|Overall Study|Adverse Event|0|||
164552447|NCT03657043|594394916|FG002|Overall Study|Adverse Event|0|||
164552448|NCT03657043|594394917|FG003|Overall Study|Adverse Event|0|||
164552449|NCT03657043|594394918|FG004|Overall Study|Adverse Event|2|||
164552450|NCT03657043|594394914|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
164656842|NCT02497391|594770052|FG004|Period 3 (14 Days)|Adverse Event|0|||
164656843|NCT02497391|594770053|FG005|Period 3 (14 Days)|Adverse Event|0|||
164656844|NCT02497391|594770048|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
164656845|NCT02497391|594770049|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
164656846|NCT02497391|594770050|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
164656847|NCT02497391|594770051|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
164656848|NCT02497391|594770052|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
164656849|NCT02497391|594770053|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
164656850|NCT02497391|594770048|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
164656851|NCT02497391|594770049|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
164656852|NCT02497391|594770050|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
164656853|NCT02497391|594770051|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
164656854|NCT02497391|594770052|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
164656855|NCT02497391|594770053|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
164656856|NCT03031899|594770056|FG000|Overall Study|Protocol Violation|1|||
164656857|NCT03031899|594770056|FG000|Overall Study|lesion disappeared after stopping habit|1|||
164656858|NCT01664052|594770057|FG000|Phase 1|No device placement|6|||
164310063|NCT00771953|593509567|FG000|Overall Study|Death|2|||
164310064|NCT00771953|593509568|FG001|Overall Study|Death|2|||
164310065|NCT00771953|593509567|FG000|Overall Study|Progression before active Tx|1|||
164310066|NCT00771953|593509568|FG001|Overall Study|Progression before active Tx|2|||
164310067|NCT00771953|593509567|FG000|Overall Study|Sponsor decision|1|||
164310068|NCT00771953|593509568|FG001|Overall Study|Sponsor decision|0|||
164310069|NCT00771953|593509567|FG000|Overall Study|Other complicating disease|1|||
164310070|NCT00771953|593509568|FG001|Overall Study|Other complicating disease|0|||
164310071|NCT00771953|593509567|FG000|Overall Study|Withdrawal by Subject|0|||
164310072|NCT00771953|593509568|FG001|Overall Study|Withdrawal by Subject|3|||
164310073|NCT00947193|593509571|FG000|Overall Study|Lost to Follow-up|1|||
164310074|NCT00947193|593509572|FG001|Overall Study|Lost to Follow-up|0|||
164310075|NCT00947193|593509571|FG000|Overall Study|Withdrawal by Subject|1|||
164310076|NCT00947193|593509572|FG001|Overall Study|Withdrawal by Subject|0|||
164310077|NCT00947193|593509571|FG000|Overall Study|Factor VIII >1%|1|||
164310078|NCT00947193|593509572|FG001|Overall Study|Factor VIII >1%|0|||
164310079|NCT04364984|593509573|FG000|Overall Study|Death|2|||
164310080|NCT04364984|593509574|FG001|Overall Study|Death|2|||
164310081|NCT04364984|593509575|FG002|Overall Study|Death|0|||
164310082|NCT01349959|593509576|FG000|Overall Study|Adverse Event|7|||
164310083|NCT02675634|593509577|FG000|Test Period 1|Adverse Event|0|||
164310084|NCT02675634|593509578|FG001|Test Period 1|Adverse Event|1|||
164310085|NCT02675634|593509579|FG002|Test Period 1|Adverse Event|0|||
164310086|NCT02675634|593509580|FG003|Test Period 1|Adverse Event|1|||
164656859|NCT01664052|594770058|FG001|Phase 1|No device placement|0|||
164656860|NCT01664052|594770057|FG000|Phase 1|No HSG 1 hr post placement|1|||
164656861|NCT01664052|594770058|FG001|Phase 1|No HSG 1 hr post placement|0|||
164201238|NCT02251275|593110676|FG002|Overall Study|Physician Decision|26|||
164201239|NCT02251275|593110677|FG003|Overall Study|Physician Decision|0|||
164201240|NCT02251275|593110678|FG004|Overall Study|Physician Decision|1|||
164201241|NCT02251275|593110674|FG000|Overall Study|Protocol Deviation|0|||
164201242|NCT02251275|593110675|FG001|Overall Study|Protocol Deviation|0|||
164201243|NCT02251275|593110676|FG002|Overall Study|Protocol Deviation|1|||
164201244|NCT02251275|593110677|FG003|Overall Study|Protocol Deviation|0|||
164201245|NCT02251275|593110678|FG004|Overall Study|Protocol Deviation|0|||
164201246|NCT02251275|593110674|FG000|Overall Study|Withdrawal by Subject|25|||
164201247|NCT02251275|593110675|FG001|Overall Study|Withdrawal by Subject|51|||
164201248|NCT02251275|593110676|FG002|Overall Study|Withdrawal by Subject|35|||
164201249|NCT02251275|593110677|FG003|Overall Study|Withdrawal by Subject|1|||
164201250|NCT02251275|593110678|FG004|Overall Study|Withdrawal by Subject|0|||
164201251|NCT02133508|593110680|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
164201252|NCT02133508|593110680|FG000|Overall Study|Death|12|||
164201253|NCT02133508|593110680|FG000|Overall Study|Lost to Follow-up|2|||
164201254|NCT01302899|593110685|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
164201255|NCT01302899|593110686|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
164201256|NCT01302899|593110685|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
164201257|NCT01302899|593110686|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
164201258|NCT03451071|593110687|FG000|First Vaccine|Withdrawal by Subject|1|||
164310087|NCT02675634|593509581|FG004|Test Period 1|Adverse Event|0|||
164201259|NCT03451071|593110687|FG000|Second Vaccine|Lost to Follow-up|19|||
164310088|NCT02675634|593509582|FG005|Test Period 1|Adverse Event|0|||
164310089|NCT02675634|593509577|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
164310090|NCT02675634|593509578|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
164310091|NCT02675634|593509579|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
164310092|NCT02675634|593509580|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
164656862|NCT01664052|594770057|FG000|Phase 2|No device placement|0|||
164656863|NCT01664052|594770058|FG001|Phase 2|No device placement|4|||
164656864|NCT01060670|594770059|FG000|Run In|screen failure|0|||
164656865|NCT01060670|594770060|FG001|Run In|screen failure|238|||
164656866|NCT03705351|594770063|FG000|Overall Study|Study termination|3|||
164552451|NCT03657043|594394915|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
164552452|NCT03657043|594394916|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
164552453|NCT03657043|594394917|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
164552454|NCT03657043|594394918|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
164552455|NCT03657043|594394914|FG000|Overall Study|Withdrawal - declined follow-up|0|||
164552456|NCT03657043|594394915|FG001|Overall Study|Withdrawal - declined follow-up|0|||
164552457|NCT03657043|594394916|FG002|Overall Study|Withdrawal - declined follow-up|0|||
164552458|NCT03657043|594394917|FG003|Overall Study|Withdrawal - declined follow-up|0|||
164552459|NCT03657043|594394918|FG004|Overall Study|Withdrawal - declined follow-up|1|||
164552460|NCT00880893|594394919|FG000|Overall Study|Protocol Violation|13|||
164552461|NCT00880893|594394920|FG001|Overall Study|Protocol Violation|1|||
164552462|NCT00880893|594394919|FG000|Overall Study|Withdrawal by Subject|15|||
164552463|NCT00880893|594394920|FG001|Overall Study|Withdrawal by Subject|11|||
164552464|NCT00880893|594394919|FG000|Overall Study|Lost to Follow-up|76|||
164552465|NCT00880893|594394920|FG001|Overall Study|Lost to Follow-up|33|||
164552466|NCT00880893|594394919|FG000|Overall Study|Serious adverse event|3|||
164552467|NCT00880893|594394920|FG001|Overall Study|Serious adverse event|0|||
164552468|NCT01736579|594394924|FG000|Overall Study|Termination of Study by Sponsor|2|||
164552469|NCT01736579|594394925|FG001|Overall Study|Termination of Study by Sponsor|2|||
164552470|NCT01995071|594394926|FG000|Overall Study|Adverse Event|0|||
164552471|NCT01995071|594394927|FG001|Overall Study|Adverse Event|0|||
164552472|NCT01995071|594394928|FG002|Overall Study|Adverse Event|0|||
164552473|NCT01995071|594394929|FG003|Overall Study|Adverse Event|0|||
164552474|NCT01995071|594394930|FG004|Overall Study|Adverse Event|0|||
164552475|NCT01995071|594394931|FG005|Overall Study|Adverse Event|0|||
164552476|NCT01995071|594394932|FG006|Overall Study|Adverse Event|1|||
164552477|NCT01995071|594394933|FG007|Overall Study|Adverse Event|0|||
164552478|NCT01995071|594394934|FG008|Overall Study|Adverse Event|0|||
164552479|NCT01995071|594394935|FG009|Overall Study|Adverse Event|0|||
164552480|NCT01995071|594394936|FG010|Overall Study|Adverse Event|0|||
164552481|NCT01995071|594394937|FG011|Overall Study|Adverse Event|0|||
164552482|NCT01995071|594394926|FG000|Overall Study|Moved|0|||
164552483|NCT01995071|594394927|FG001|Overall Study|Moved|0|||
164552484|NCT01995071|594394928|FG002|Overall Study|Moved|1|||
164552485|NCT01995071|594394929|FG003|Overall Study|Moved|0|||
164552486|NCT01995071|594394930|FG004|Overall Study|Moved|1|||
164552487|NCT01995071|594394931|FG005|Overall Study|Moved|0|||
164552488|NCT01995071|594394932|FG006|Overall Study|Moved|0|||
164552489|NCT01995071|594394933|FG007|Overall Study|Moved|0|||
164552490|NCT01995071|594394934|FG008|Overall Study|Moved|0|||
164552491|NCT01995071|594394935|FG009|Overall Study|Moved|0|||
164552492|NCT01995071|594394936|FG010|Overall Study|Moved|1|||
164552493|NCT01995071|594394937|FG011|Overall Study|Moved|0|||
164552494|NCT01995071|594394926|FG000|Overall Study|Lost to Follow-up|1|||
164552495|NCT01995071|594394927|FG001|Overall Study|Lost to Follow-up|0|||
164552496|NCT01995071|594394928|FG002|Overall Study|Lost to Follow-up|0|||
164552497|NCT01995071|594394929|FG003|Overall Study|Lost to Follow-up|0|||
164552498|NCT01995071|594394930|FG004|Overall Study|Lost to Follow-up|0|||
164552499|NCT01995071|594394931|FG005|Overall Study|Lost to Follow-up|0|||
164552500|NCT01995071|594394932|FG006|Overall Study|Lost to Follow-up|0|||
164552501|NCT01995071|594394933|FG007|Overall Study|Lost to Follow-up|1|||
164552502|NCT01995071|594394934|FG008|Overall Study|Lost to Follow-up|1|||
164552503|NCT01995071|594394935|FG009|Overall Study|Lost to Follow-up|0|||
164552504|NCT01995071|594394936|FG010|Overall Study|Lost to Follow-up|0|||
164552505|NCT01995071|594394937|FG011|Overall Study|Lost to Follow-up|0|||
164552506|NCT01995071|594394926|FG000|Overall Study|Incarcerated|0|||
164552507|NCT01995071|594394927|FG001|Overall Study|Incarcerated|0|||
164552508|NCT01995071|594394928|FG002|Overall Study|Incarcerated|0|||
164552509|NCT01995071|594394929|FG003|Overall Study|Incarcerated|0|||
164552510|NCT01995071|594394930|FG004|Overall Study|Incarcerated|0|||
164552511|NCT01995071|594394931|FG005|Overall Study|Incarcerated|0|||
164552512|NCT01995071|594394932|FG006|Overall Study|Incarcerated|0|||
164552513|NCT01995071|594394933|FG007|Overall Study|Incarcerated|1|||
164656867|NCT03705351|594770063|FG000|Overall Study|Death|1|||
164552514|NCT01995071|594394934|FG008|Overall Study|Incarcerated|0|||
164552515|NCT01995071|594394935|FG009|Overall Study|Incarcerated|0|||
164656868|NCT03705351|594770063|FG000|Overall Study|Lack of Efficacy|2|||
164552516|NCT01995071|594394936|FG010|Overall Study|Incarcerated|0|||
164552517|NCT01995071|594394937|FG011|Overall Study|Incarcerated|0|||
164552518|NCT01979523|594394939|FG000|Overall Study|Withdrawal by Subject|1|||
164552519|NCT01979523|594394940|FG001|Overall Study|Withdrawal by Subject|0|||
164552520|NCT02495844|594394947|FG000|Overall Study|Lack of Efficacy|1|||
164552521|NCT02495844|594394948|FG001|Overall Study|Lack of Efficacy|2|||
164552522|NCT02495844|594394947|FG000|Overall Study|AE, non-fatal|0|||
164552523|NCT02495844|594394948|FG001|Overall Study|AE, non-fatal|1|||
164552524|NCT02495844|594394947|FG000|Overall Study|Hepatitis Positivity|0|||
164552525|NCT02495844|594394948|FG001|Overall Study|Hepatitis Positivity|1|||
164552526|NCT00493870|594394953|FG000|Overall Study|Lost to Follow-up|12|||
164552527|NCT00493870|594394954|FG001|Overall Study|Lost to Follow-up|15|||
164656869|NCT03705351|594770063|FG000|Overall Study|Withdrawal by Subject|1|||
164656870|NCT00633152|594770066|FG000|Overall Study|Adverse Event|1|||
164656871|NCT00633152|594770067|FG001|Overall Study|Adverse Event|0|||
164656872|NCT00633152|594770066|FG000|Overall Study|Randomized, did not receive study drug|5|||
164656873|NCT00633152|594770067|FG001|Overall Study|Randomized, did not receive study drug|2|||
164656874|NCT00633152|594770066|FG000|Overall Study|Withdrawal by Subject|1|||
164656875|NCT00633152|594770067|FG001|Overall Study|Withdrawal by Subject|1|||
164656876|NCT00633152|594770066|FG000|Overall Study|Lost to Follow-up|4|||
164656877|NCT00633152|594770067|FG001|Overall Study|Lost to Follow-up|1|||
164656878|NCT00633152|594770066|FG000|Overall Study|Miscellaneous Other|3|||
164656879|NCT00633152|594770067|FG001|Overall Study|Miscellaneous Other|2|||
164656880|NCT02180061|594770068|FG000|Overall Study|Adverse Event|4|||
164656881|NCT02180061|594770069|FG001|Overall Study|Adverse Event|2|||
164656882|NCT02180061|594770068|FG000|Overall Study|Clinical Progression|5|||
164656883|NCT02180061|594770069|FG001|Overall Study|Clinical Progression|1|||
164656884|NCT02180061|594770068|FG000|Overall Study|Progressive Disease|15|||
164656885|NCT02180061|594770069|FG001|Overall Study|Progressive Disease|5|||
164656886|NCT02180061|594770068|FG000|Overall Study|Physician Decision|1|||
164656887|NCT02180061|594770069|FG001|Overall Study|Physician Decision|0|||
164656888|NCT00056160|594770072|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
164656889|NCT00056160|594770073|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
164656890|NCT00056160|594770072|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
164656891|NCT00056160|594770073|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
164656892|NCT00056160|594770072|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
164656893|NCT00056160|594770073|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
164656894|NCT00056160|594770072|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
164656895|NCT00056160|594770073|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
164656896|NCT00056160|594770072|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
164656897|NCT00056160|594770073|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
164656898|NCT00056160|594770072|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
164656899|NCT00056160|594770073|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
164656900|NCT00056160|594770072|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
164656901|NCT00056160|594770073|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
164656902|NCT00056160|594770072|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
164656903|NCT00056160|594770073|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
164656904|NCT00056160|594770072|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
164656905|NCT00056160|594770073|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
164656906|NCT00056160|594770072|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
164656907|NCT00056160|594770073|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
164656908|NCT00056160|594770072|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
164656909|NCT00056160|594770073|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
164656910|NCT00056160|594770072|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
164656911|NCT00056160|594770073|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
164656912|NCT00056160|594770072|FG000|Final Follow-up|Transferred into expanded access study.|3|||
164656913|NCT00056160|594770073|FG001|Final Follow-up|Transferred into expanded access study.|0|||
164656914|NCT00056160|594770072|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
164656915|NCT00056160|594770073|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
164656916|NCT00056160|594770072|FG000|Final Follow-up|Adverse Event|1|||
164656917|NCT00056160|594770073|FG001|Final Follow-up|Adverse Event|0|||
164656918|NCT01469364|594770074|FG000|Overall Study|Adverse Event|1|||
164656919|NCT01469364|594770074|FG000|Overall Study|Withdrawal by Subject|1|||
164656920|NCT01452529|594770077|FG000|Run-in Period|Adverse Event|96|||
164656921|NCT01452529|594770078|FG001|Run-in Period|Adverse Event|0|||
164656922|NCT01452529|594770079|FG002|Run-in Period|Adverse Event|0|||
164656923|NCT01452529|594770077|FG000|Run-in Period|Withdrawal by Subject|49|||
164656924|NCT01452529|594770078|FG001|Run-in Period|Withdrawal by Subject|0|||
164656925|NCT01452529|594770079|FG002|Run-in Period|Withdrawal by Subject|0|||
164201260|NCT03451071|593110687|FG000|Third Vaccine|Lost to Follow-up|22|||
164201261|NCT03451071|593110687|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
164201262|NCT02834975|593110688|FG000|Overall Study|Physician Decision|2|||
164201263|NCT02834975|593110688|FG000|Overall Study|Adverse Event|1|||
164656926|NCT01452529|594770077|FG000|Run-in Period|Lost to Follow-up|19|||
164656927|NCT01452529|594770078|FG001|Run-in Period|Lost to Follow-up|0|||
164656928|NCT01452529|594770079|FG002|Run-in Period|Lost to Follow-up|0|||
164656929|NCT01452529|594770077|FG000|Run-in Period|Lack of Efficacy|46|||
164656930|NCT01452529|594770078|FG001|Run-in Period|Lack of Efficacy|0|||
164656931|NCT01452529|594770079|FG002|Run-in Period|Lack of Efficacy|0|||
164656932|NCT01452529|594770077|FG000|Run-in Period|Confirmed or suspected diversion|23|||
164656933|NCT01452529|594770078|FG001|Run-in Period|Confirmed or suspected diversion|0|||
164656934|NCT01452529|594770079|FG002|Run-in Period|Confirmed or suspected diversion|0|||
164656935|NCT01452529|594770077|FG000|Run-in Period|Administrative|21|||
164656936|NCT01452529|594770078|FG001|Run-in Period|Administrative|0|||
164656937|NCT01452529|594770079|FG002|Run-in Period|Administrative|0|||
164201264|NCT02834975|593110688|FG000|Overall Study|Withdrawal by Subject|1|||
164656938|NCT01452529|594770077|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
164656939|NCT01452529|594770078|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
164656940|NCT01452529|594770079|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
164656941|NCT01452529|594770077|FG000|Double-blind (DB) Period|Adverse Event|0|||
164656942|NCT01452529|594770078|FG001|Double-blind (DB) Period|Adverse Event|18|||
164656943|NCT01452529|594770079|FG002|Double-blind (DB) Period|Adverse Event|11|||
164656944|NCT01452529|594770077|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
164656945|NCT01452529|594770078|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
164656946|NCT01452529|594770079|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
164656947|NCT01452529|594770077|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
164656948|NCT01452529|594770078|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
164656949|NCT01452529|594770079|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
164656950|NCT01452529|594770077|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
164656951|NCT01452529|594770078|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
164656952|NCT01452529|594770079|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
164656953|NCT01452529|594770077|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
164656954|NCT01452529|594770078|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
164552528|NCT00647556|594394955|FG000|Overall Study|Adverse Event|0|||
164552529|NCT00647556|594394956|FG001|Overall Study|Adverse Event|1|||
164552530|NCT00647556|594394955|FG000|Overall Study|Lost to Follow-up|1|||
164552531|NCT00647556|594394956|FG001|Overall Study|Lost to Follow-up|0|||
164552532|NCT00647556|594394955|FG000|Overall Study|Protocol Violation|0|||
164552533|NCT00647556|594394956|FG001|Overall Study|Protocol Violation|1|||
164552534|NCT00647556|594394955|FG000|Overall Study|Withdrawal by Subject|1|||
164552535|NCT00647556|594394956|FG001|Overall Study|Withdrawal by Subject|0|||
164552536|NCT00647556|594394955|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
164552537|NCT00647556|594394956|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
164552538|NCT02646982|594394957|FG000|Overall Study|Adverse Event|1|||
164552539|NCT02646982|594394958|FG001|Overall Study|Adverse Event|1|||
164552540|NCT02646982|594394957|FG000|Overall Study|Withdrawal by Subject|2|||
164552541|NCT02646982|594394958|FG001|Overall Study|Withdrawal by Subject|1|||
164552542|NCT00623480|594394959|FG000|Overall Study|Lost to Follow-up|0|||
164552543|NCT00623480|594394960|FG001|Overall Study|Lost to Follow-up|1|||
164552544|NCT00623480|594394959|FG000|Overall Study|Withdrawal by Subject|2|||
164552545|NCT00623480|594394960|FG001|Overall Study|Withdrawal by Subject|4|||
164552546|NCT00623480|594394959|FG000|Overall Study|Lack of Efficacy|1|||
164552547|NCT00623480|594394960|FG001|Overall Study|Lack of Efficacy|0|||
164552548|NCT00623480|594394959|FG000|Overall Study|Non-compliant with study medication|4|||
164552549|NCT00623480|594394960|FG001|Overall Study|Non-compliant with study medication|0|||
164552550|NCT00623480|594394959|FG000|Overall Study|Protocol Violation|0|||
164656955|NCT01452529|594770079|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
164656956|NCT01452529|594770077|FG000|Double-blind (DB) Period|Administrative|0|||
164656957|NCT01452529|594770078|FG001|Double-blind (DB) Period|Administrative|11|||
164201265|NCT02834975|593110688|FG000|Overall Study|Lack of Efficacy|1|||
164201266|NCT02714153|593110694|FG000|Overall Study|Death|1|||
164201267|NCT00686972|593110695|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
164201268|NCT01901185|593110696|FG000|Overall Study|Withdrawal by Subject|2|||
164201269|NCT02065557|593110697|FG000|Induction Period|Withdrawal by Subject|2|||
164201270|NCT02065557|593110698|FG001|Induction Period|Withdrawal by Subject|1|||
164201271|NCT02065557|593110699|FG002|Induction Period|Withdrawal by Subject|0|||
164201272|NCT02065557|593110700|FG003|Induction Period|Withdrawal by Subject|0|||
164201273|NCT02065557|593110701|FG004|Induction Period|Withdrawal by Subject|0|||
164201274|NCT02065557|593110702|FG005|Induction Period|Withdrawal by Subject|0|||
164201275|NCT02065557|593110697|FG000|Induction Period|Lack of Efficacy|2|||
164201276|NCT02065557|593110698|FG001|Induction Period|Lack of Efficacy|1|||
164201277|NCT02065557|593110699|FG002|Induction Period|Lack of Efficacy|1|||
164201278|NCT02065557|593110700|FG003|Induction Period|Lack of Efficacy|0|||
164201279|NCT02065557|593110701|FG004|Induction Period|Lack of Efficacy|0|||
164201280|NCT02065557|593110702|FG005|Induction Period|Lack of Efficacy|0|||
164201281|NCT02065557|593110697|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
164201282|NCT02065557|593110698|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
164201283|NCT02065557|593110699|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
164201284|NCT02065557|593110700|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
164201285|NCT02065557|593110701|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
164201286|NCT02065557|593110702|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
164656958|NCT01452529|594770079|FG002|Double-blind (DB) Period|Administrative|7|||
164656959|NCT02884206|594770080|FG000|Valsartan Run-in Period|Death|1|||
164656960|NCT02884206|594770081|FG001|Valsartan Run-in Period|Death|0|||
164201287|NCT02065557|593110697|FG000|Induction Period|Non-Responder at Week 8|4|||
164201288|NCT02065557|593110698|FG001|Induction Period|Non-Responder at Week 8|4|||
164201289|NCT02065557|593110699|FG002|Induction Period|Non-Responder at Week 8|0|||
164310093|NCT02675634|593509581|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
164201290|NCT02065557|593110700|FG003|Induction Period|Non-Responder at Week 8|0|||
164552551|NCT00623480|594394960|FG001|Overall Study|Protocol Violation|1|||
164656961|NCT02884206|594770082|FG002|Valsartan Run-in Period|Death|0|||
164656962|NCT02884206|594770080|FG000|Valsartan Run-in Period|Adverse Event|31|||
164656963|NCT02884206|594770081|FG001|Valsartan Run-in Period|Adverse Event|0|||
164656964|NCT02884206|594770082|FG002|Valsartan Run-in Period|Adverse Event|0|||
164656965|NCT02884206|594770080|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
164656966|NCT02884206|594770081|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
164656967|NCT02884206|594770082|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
164656968|NCT02884206|594770080|FG000|Valsartan Run-in Period|Protocol deviation|4|||
164656969|NCT02884206|594770081|FG001|Valsartan Run-in Period|Protocol deviation|0|||
164656970|NCT02884206|594770082|FG002|Valsartan Run-in Period|Protocol deviation|0|||
164656971|NCT02884206|594770080|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
164656972|NCT02884206|594770081|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
164656973|NCT02884206|594770082|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
164656974|NCT02884206|594770080|FG000|Valsartan Run-in Period|Physician Decision|1|||
164656975|NCT02884206|594770081|FG001|Valsartan Run-in Period|Physician Decision|0|||
164656976|NCT02884206|594770082|FG002|Valsartan Run-in Period|Physician Decision|0|||
164656977|NCT02884206|594770080|FG000|LCZ696 Run-in Period|Adverse Event|38|||
164656978|NCT02884206|594770081|FG001|LCZ696 Run-in Period|Adverse Event|0|||
164656979|NCT02884206|594770082|FG002|LCZ696 Run-in Period|Adverse Event|0|||
164656980|NCT02884206|594770080|FG000|LCZ696 Run-in Period|Death|2|||
164656981|NCT02884206|594770081|FG001|LCZ696 Run-in Period|Death|0|||
164656982|NCT02884206|594770082|FG002|LCZ696 Run-in Period|Death|0|||
164656983|NCT02884206|594770080|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
164656984|NCT02884206|594770081|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
164656985|NCT02884206|594770082|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
164656986|NCT02884206|594770080|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
164656987|NCT02884206|594770081|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
164656988|NCT02884206|594770082|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
164656989|NCT02884206|594770080|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
164656990|NCT02884206|594770081|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
164656991|NCT02884206|594770082|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
164656992|NCT02884206|594770080|FG000|LCZ696 Run-in Period|Physician Decision|1|||
164656993|NCT02884206|594770081|FG001|LCZ696 Run-in Period|Physician Decision|0|||
164656994|NCT02884206|594770082|FG002|LCZ696 Run-in Period|Physician Decision|0|||
164656995|NCT02884206|594770080|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
164656996|NCT02884206|594770081|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
164656997|NCT02884206|594770082|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
164656998|NCT02884206|594770080|FG000|Double-Blind Period|Death|0|||
164656999|NCT02884206|594770081|FG001|Double-Blind Period|Death|28|||
164657000|NCT02884206|594770082|FG002|Double-Blind Period|Death|39|||
164657001|NCT02884206|594770080|FG000|Double-Blind Period|Patient/guardian decision|0|||
164657002|NCT02884206|594770081|FG001|Double-Blind Period|Patient/guardian decision|10|||
164657003|NCT02884206|594770082|FG002|Double-Blind Period|Patient/guardian decision|13|||
164657004|NCT02884206|594770080|FG000|Double-Blind Period|Lost to Follow-up|0|||
164657005|NCT02884206|594770081|FG001|Double-Blind Period|Lost to Follow-up|4|||
164657006|NCT02884206|594770082|FG002|Double-Blind Period|Lost to Follow-up|4|||
164657007|NCT02884206|594770080|FG000|Double-Blind Period|Physician Decision|0|||
164657008|NCT02884206|594770081|FG001|Double-Blind Period|Physician Decision|2|||
164657009|NCT02884206|594770082|FG002|Double-Blind Period|Physician Decision|0|||
164657010|NCT02884206|594770080|FG000|Double-Blind Period|Adverse Event|0|||
164657011|NCT02884206|594770081|FG001|Double-Blind Period|Adverse Event|0|||
164657012|NCT02884206|594770082|FG002|Double-Blind Period|Adverse Event|3|||
164657013|NCT02884206|594770080|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
164657014|NCT02884206|594770081|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
164657015|NCT02884206|594770082|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
164657016|NCT01579474|594770083|FG000|Overall Study|Adverse Event|1|||
164657017|NCT01579474|594770084|FG001|Overall Study|Adverse Event|13|||
164657018|NCT01579474|594770085|FG002|Overall Study|Adverse Event|2|||
164201291|NCT02065557|593110701|FG004|Induction Period|Non-Responder at Week 8|0|||
164201292|NCT02065557|593110702|FG005|Induction Period|Non-Responder at Week 8|0|||
164201293|NCT02065557|593110697|FG000|Induction Period|Adverse Event|1|||
164201294|NCT02065557|593110698|FG001|Induction Period|Adverse Event|1|||
164201295|NCT02065557|593110699|FG002|Induction Period|Adverse Event|0|||
164201296|NCT02065557|593110700|FG003|Induction Period|Adverse Event|0|||
164201297|NCT02065557|593110701|FG004|Induction Period|Adverse Event|0|||
164201298|NCT02065557|593110702|FG005|Induction Period|Adverse Event|0|||
164201299|NCT02065557|593110697|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
164310094|NCT02675634|593509582|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
164657019|NCT01579474|594770086|FG003|Overall Study|Adverse Event|0|||
164657020|NCT01579474|594770087|FG004|Overall Study|Adverse Event|0|||
164657021|NCT01579474|594770088|FG005|Overall Study|Adverse Event|1|||
164657022|NCT01579474|594770083|FG000|Overall Study|Lack of Efficacy|1|||
164657023|NCT01579474|594770084|FG001|Overall Study|Lack of Efficacy|0|||
164310095|NCT02675634|593509577|FG000|Test Period 2|Lack of Efficacy|1|||
164657024|NCT01579474|594770085|FG002|Overall Study|Lack of Efficacy|0|||
164657025|NCT01579474|594770086|FG003|Overall Study|Lack of Efficacy|0|||
164657026|NCT01579474|594770087|FG004|Overall Study|Lack of Efficacy|1|||
164657027|NCT01579474|594770088|FG005|Overall Study|Lack of Efficacy|0|||
164657028|NCT01579474|594770083|FG000|Overall Study|Withdrawal by Subject|1|||
164657029|NCT01579474|594770084|FG001|Overall Study|Withdrawal by Subject|0|||
164657030|NCT01579474|594770085|FG002|Overall Study|Withdrawal by Subject|0|||
164657031|NCT01579474|594770086|FG003|Overall Study|Withdrawal by Subject|0|||
164657032|NCT01579474|594770087|FG004|Overall Study|Withdrawal by Subject|0|||
164657033|NCT01579474|594770088|FG005|Overall Study|Withdrawal by Subject|0|||
164657034|NCT02295774|594770089|FG000|Overall Study|Physician Decision|1|||
164657035|NCT02295774|594770089|FG000|Overall Study|Withdrawal by Subject|2|||
164657036|NCT03532009|594770093|FG000|Overall Study|Other|1|||
164657037|NCT03532009|594770094|FG001|Overall Study|Other|1|||
164657038|NCT03532009|594770093|FG000|Overall Study|Death|1|||
164657039|NCT03532009|594770094|FG001|Overall Study|Death|1|||
164657040|NCT03532009|594770093|FG000|Overall Study|Withdrawal by Patient|0|||
164657041|NCT03532009|594770094|FG001|Overall Study|Withdrawal by Patient|2|||
164657042|NCT00368966|594770095|FG000|Infant Series|Withdrawal by Subject|11|||
164657043|NCT00368966|594770096|FG001|Infant Series|Withdrawal by Subject|6|||
164657044|NCT00368966|594770095|FG000|Infant Series|Protocol Violation|2|||
164657045|NCT00368966|594770096|FG001|Infant Series|Protocol Violation|1|||
164657046|NCT00368966|594770095|FG000|Infant Series|Lost to Follow-up|2|||
164657047|NCT00368966|594770096|FG001|Infant Series|Lost to Follow-up|0|||
164657048|NCT00368966|594770095|FG000|Infant Series|Randomization error|0|||
164657049|NCT00368966|594770096|FG001|Infant Series|Randomization error|1|||
164657050|NCT00368966|594770095|FG000|Infant Series|Failed to meet eligibility criteria|0|||
164657051|NCT00368966|594770096|FG001|Infant Series|Failed to meet eligibility criteria|1|||
164657052|NCT00368966|594770095|FG000|Infant Series|Adverse Event|0|||
164657053|NCT00368966|594770096|FG001|Infant Series|Adverse Event|1|||
164657054|NCT00368966|594770095|FG000|Infant Series|Failed to return|1|||
164657055|NCT00368966|594770096|FG001|Infant Series|Failed to return|0|||
164657056|NCT00368966|594770095|FG000|After Infant|Failed to return|3|||
164657057|NCT00368966|594770096|FG001|After Infant|Failed to return|1|||
164657058|NCT00368966|594770095|FG000|After Infant|Adverse Event|1|||
164657059|NCT00368966|594770096|FG001|After Infant|Adverse Event|2|||
164657060|NCT00368966|594770095|FG000|After Infant|Withdrawal by Subject|1|||
164657061|NCT00368966|594770096|FG001|After Infant|Withdrawal by Subject|1|||
164657062|NCT00368966|594770095|FG000|After Infant|Death|1|||
164657063|NCT00368966|594770096|FG001|After Infant|Death|0|||
164657064|NCT00368966|594770095|FG000|After Infant|Lost to Follow-up|0|||
164657065|NCT00368966|594770096|FG001|After Infant|Lost to Follow-up|1|||
164657066|NCT00368966|594770095|FG000|Toddler Dose|Withdrawal by Subject|1|||
164657067|NCT00368966|594770096|FG001|Toddler Dose|Withdrawal by Subject|1|||
164657068|NCT00368966|594770095|FG000|Toddler Dose|Lost to Follow-up|0|||
164657069|NCT00368966|594770096|FG001|Toddler Dose|Lost to Follow-up|2|||
164657070|NCT02866175|594770101|FG000|Overall Study|Adverse Event|56|||
164657071|NCT02866175|594770102|FG001|Overall Study|Adverse Event|54|||
164657072|NCT02866175|594770101|FG000|Overall Study|Withdrawal by Subject|31|||
164657073|NCT02866175|594770102|FG001|Overall Study|Withdrawal by Subject|52|||
164657074|NCT02866175|594770101|FG000|Overall Study|Death|30|||
164657075|NCT02866175|594770102|FG001|Overall Study|Death|23|||
164657076|NCT02866175|594770101|FG000|Overall Study|Other|7|||
164657077|NCT02866175|594770102|FG001|Overall Study|Other|14|||
164657078|NCT02866175|594770101|FG000|Overall Study|Progressive disease|1|||
164657079|NCT02866175|594770102|FG001|Overall Study|Progressive disease|1|||
164657080|NCT02866175|594770101|FG000|Overall Study|Lost to Follow-up|2|||
164657081|NCT02866175|594770102|FG001|Overall Study|Lost to Follow-up|0|||
164657082|NCT02866175|594770101|FG000|Overall Study|Lack of Efficacy|0|||
164657083|NCT02866175|594770102|FG001|Overall Study|Lack of Efficacy|1|||
164657084|NCT02866175|594770101|FG000|Overall Study|Physician Decision|3|||
164657085|NCT02866175|594770102|FG001|Overall Study|Physician Decision|15|||
164201300|NCT02065557|593110698|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
164201301|NCT02065557|593110699|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
164201302|NCT02065557|593110700|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
164657086|NCT02866175|594770101|FG000|Overall Study|Did not receive treatment|5|||
164657087|NCT02866175|594770102|FG001|Overall Study|Did not receive treatment|15|||
164657088|NCT01694485|594770105|FG000|Overall Study|Withdrawal by Subject|20|||
164657089|NCT01694485|594770106|FG001|Overall Study|Withdrawal by Subject|6|||
164657090|NCT01694485|594770107|FG002|Overall Study|Withdrawal by Subject|7|||
164657091|NCT01694485|594770108|FG003|Overall Study|Withdrawal by Subject|25|||
164657092|NCT01694485|594770109|FG004|Overall Study|Withdrawal by Subject|18|||
164657093|NCT01694485|594770105|FG000|Overall Study|Sponsor Decision|3|||
164657094|NCT01694485|594770106|FG001|Overall Study|Sponsor Decision|0|||
164657095|NCT01694485|594770107|FG002|Overall Study|Sponsor Decision|0|||
164657096|NCT01694485|594770108|FG003|Overall Study|Sponsor Decision|2|||
164657097|NCT01694485|594770109|FG004|Overall Study|Sponsor Decision|0|||
164657098|NCT01694485|594770105|FG000|Overall Study|Lost to Follow-up|9|||
164657099|NCT01694485|594770106|FG001|Overall Study|Lost to Follow-up|1|||
164310096|NCT02675634|593509578|FG001|Test Period 2|Lack of Efficacy|0|||
164310097|NCT02675634|593509579|FG002|Test Period 2|Lack of Efficacy|0|||
164310098|NCT02675634|593509580|FG003|Test Period 2|Lack of Efficacy|0|||
164310099|NCT02675634|593509581|FG004|Test Period 2|Lack of Efficacy|0|||
164310100|NCT02675634|593509582|FG005|Test Period 2|Lack of Efficacy|0|||
164310101|NCT02675634|593509577|FG000|Test Period 2|Adverse Event|0|||
164310102|NCT02675634|593509578|FG001|Test Period 2|Adverse Event|0|||
164310103|NCT02675634|593509579|FG002|Test Period 2|Adverse Event|0|||
164310104|NCT02675634|593509580|FG003|Test Period 2|Adverse Event|0|||
164657100|NCT01694485|594770107|FG002|Overall Study|Lost to Follow-up|6|||
164657101|NCT01694485|594770108|FG003|Overall Study|Lost to Follow-up|10|||
164657102|NCT01694485|594770109|FG004|Overall Study|Lost to Follow-up|7|||
164657103|NCT01694485|594770105|FG000|Overall Study|Death|1|||
164657104|NCT01694485|594770106|FG001|Overall Study|Death|0|||
164657105|NCT01694485|594770107|FG002|Overall Study|Death|0|||
164657106|NCT01694485|594770108|FG003|Overall Study|Death|1|||
164657107|NCT01694485|594770109|FG004|Overall Study|Death|0|||
164657108|NCT02907203|594770110|FG000|Overall Study|Death|1|||
164657109|NCT02907203|594770110|FG000|Overall Study|Lost to Follow-up|3|||
164657110|NCT02907203|594770110|FG000|Overall Study|Withdrawal by Subject|3|||
164657111|NCT02907203|594770110|FG000|Overall Study|Surgical bypass|1|||
164657112|NCT01798485|594770111|FG000|Overall Study|Adverse Event|32|||
164657113|NCT01798485|594770112|FG001|Overall Study|Adverse Event|40|||
164310105|NCT02675634|593509581|FG004|Test Period 2|Adverse Event|0|||
164552552|NCT00623480|594394959|FG000|Overall Study|Site closed by sponsor|0|||
164552553|NCT00623480|594394960|FG001|Overall Study|Site closed by sponsor|1|||
164552554|NCT01594853|594394961|FG000|Overall Study|Withdrawal by Subject|1|||
164552555|NCT01594853|594394962|FG001|Overall Study|Withdrawal by Subject|1|||
164552556|NCT01594853|594394961|FG000|Overall Study|Lost to Follow-up|1|||
164552557|NCT01594853|594394962|FG001|Overall Study|Lost to Follow-up|1|||
164552558|NCT01594853|594394961|FG000|Overall Study|noncompliance with exercise|0|||
164552559|NCT01594853|594394962|FG001|Overall Study|noncompliance with exercise|1|||
164552560|NCT00769002|594394963|FG000|Overall Study|Study was not completed, no data|9|||
164552561|NCT00769002|594394964|FG001|Overall Study|Study was not completed, no data|9|||
164552562|NCT00960661|594394966|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
164552563|NCT00960661|594394967|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
164552564|NCT00960661|594394968|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
164552565|NCT00960661|594394966|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
164552566|NCT00960661|594394967|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
164552567|NCT00960661|594394968|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
164552568|NCT00960661|594394966|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
164552569|NCT00960661|594394967|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
164552570|NCT00960661|594394968|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
164552571|NCT00960661|594394966|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
164552572|NCT00960661|594394967|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
164552573|NCT00960661|594394968|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
164552574|NCT00960661|594394966|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
164552575|NCT00960661|594394967|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
164552576|NCT00960661|594394968|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
164552577|NCT00960661|594394966|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
164552578|NCT00960661|594394967|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
164552579|NCT00960661|594394968|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
164552580|NCT00960661|594394966|FG000|Interventional Phase|Adverse Event|0|||
164552581|NCT00960661|594394967|FG001|Interventional Phase|Adverse Event|17|||
164552582|NCT00960661|594394968|FG002|Interventional Phase|Adverse Event|8|||
164552583|NCT00960661|594394966|FG000|Interventional Phase|Death|0|||
164552584|NCT00960661|594394967|FG001|Interventional Phase|Death|1|||
164552585|NCT00960661|594394968|FG002|Interventional Phase|Death|0|||
164552586|NCT00960661|594394966|FG000|Interventional Phase|Lost to Follow-up|0|||
164552587|NCT00960661|594394967|FG001|Interventional Phase|Lost to Follow-up|0|||
164552588|NCT00960661|594394968|FG002|Interventional Phase|Lost to Follow-up|2|||
164657114|NCT01798485|594770111|FG000|Overall Study|Withdrawal by Subject|27|||
164657115|NCT01798485|594770112|FG001|Overall Study|Withdrawal by Subject|31|||
164310106|NCT02675634|593509582|FG005|Test Period 2|Adverse Event|1|||
164657116|NCT01798485|594770111|FG000|Overall Study|Lost to Follow-up|0|||
164657117|NCT01798485|594770112|FG001|Overall Study|Lost to Follow-up|3|||
164657118|NCT01798485|594770111|FG000|Overall Study|Physician Decision|14|||
164657119|NCT01798485|594770112|FG001|Overall Study|Physician Decision|10|||
164310107|NCT01652534|593509583|FG000|Overall Study|Lack of Efficacy|1|||
164310108|NCT01652534|593509584|FG001|Overall Study|Lack of Efficacy|0|||
164310109|NCT02722304|593509585|FG000|Overall Study|Study Terminated by Sponsor|1|||
164552589|NCT00960661|594394966|FG000|Interventional Phase|entry criteria not met|0|||
164552590|NCT00960661|594394967|FG001|Interventional Phase|entry criteria not met|3|||
164552591|NCT00960661|594394968|FG002|Interventional Phase|entry criteria not met|0|||
164657120|NCT01798485|594770111|FG000|Overall Study|Objective Disease Progression|152|||
164657121|NCT01798485|594770112|FG001|Overall Study|Objective Disease Progression|106|||
164657122|NCT01798485|594770111|FG000|Overall Study|Death|25|||
164657123|NCT01798485|594770112|FG001|Overall Study|Death|22|||
164657124|NCT01798485|594770111|FG000|Overall Study|Sponsor Decision|61|||
164657125|NCT01798485|594770112|FG001|Overall Study|Sponsor Decision|54|||
164657126|NCT01798485|594770111|FG000|Overall Study|Clinical Progression|35|||
164657127|NCT01798485|594770112|FG001|Overall Study|Clinical Progression|24|||
164657128|NCT00770991|594770113|FG000|Overall Study|Physician Decision|2|||
164657129|NCT00770991|594770114|FG001|Overall Study|Physician Decision|0|||
164657130|NCT00770991|594770113|FG000|Overall Study|Withdrawal by Subject|1|||
164657131|NCT00770991|594770114|FG001|Overall Study|Withdrawal by Subject|0|||
164657132|NCT00770991|594770113|FG000|Overall Study|Adverse Event|1|||
164657133|NCT00770991|594770114|FG001|Overall Study|Adverse Event|5|||
164657134|NCT00770991|594770113|FG000|Overall Study|Pregnancy|1|||
164657135|NCT00770991|594770114|FG001|Overall Study|Pregnancy|0|||
164657136|NCT03687125|594770115|FG000|Overall Study|Progressive Disease|2|||
164657137|NCT03687125|594770116|FG001|Overall Study|Progressive Disease|1|||
164657138|NCT03687125|594770115|FG000|Overall Study|Protocol Violation|1|||
164657139|NCT03687125|594770116|FG001|Overall Study|Protocol Violation|0|||
164657140|NCT00490061|594770118|FG000|Overall Study|Physician Decision|1|||
164657141|NCT00952484|594770119|FG000|Overall Study|Withdrawal by Subject|0|||
164657142|NCT00952484|594770120|FG001|Overall Study|Withdrawal by Subject|1|||
164657143|NCT00952484|594770121|FG002|Overall Study|Withdrawal by Subject|0|||
164657144|NCT02750306|594770122|FG000|Overall Study|Withdrawal by Subject|5|||
164657145|NCT02750306|594770123|FG001|Overall Study|Withdrawal by Subject|2|||
164657146|NCT02750306|594770122|FG000|Overall Study|Protocol Violation|1|||
164657147|NCT02750306|594770123|FG001|Overall Study|Protocol Violation|0|||
164657148|NCT00585351|594770127|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
164657149|NCT00585351|594770128|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
164657150|NCT00585351|594770129|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
164657151|NCT00585351|594770130|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
164657152|NCT00585351|594770131|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
164657153|NCT00585351|594770132|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
164657154|NCT00585351|594770133|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
164657155|NCT00585351|594770134|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
164657156|NCT00585351|594770127|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
164657157|NCT00585351|594770128|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
164657158|NCT00585351|594770129|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
164657159|NCT00585351|594770130|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
164657160|NCT00585351|594770131|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
164657161|NCT00585351|594770132|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
164657162|NCT00585351|594770133|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
164657163|NCT00585351|594770134|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
164657164|NCT00585351|594770127|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
164657165|NCT00585351|594770128|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
164657166|NCT00585351|594770129|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
164657167|NCT00585351|594770130|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
164657168|NCT00585351|594770131|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
164657169|NCT00585351|594770132|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
164657170|NCT00585351|594770133|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
164657171|NCT00585351|594770134|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
164657172|NCT00585351|594770127|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
164657173|NCT00585351|594770128|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
164657174|NCT00585351|594770129|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
164657175|NCT00585351|594770130|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
164657176|NCT00585351|594770131|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
164201303|NCT02065557|593110701|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
164201304|NCT02065557|593110702|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
164201305|NCT02065557|593110697|FG000|Maintenance Period|Withdrawal by Subject|0|||
164201306|NCT02065557|593110698|FG001|Maintenance Period|Withdrawal by Subject|0|||
164201307|NCT02065557|593110699|FG002|Maintenance Period|Withdrawal by Subject|0|||
164657177|NCT00585351|594770132|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
164657178|NCT00585351|594770133|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
164657179|NCT00585351|594770134|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
164657180|NCT00585351|594770127|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
164657181|NCT00585351|594770128|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
164201308|NCT02065557|593110700|FG003|Maintenance Period|Withdrawal by Subject|0|||
164201309|NCT02065557|593110701|FG004|Maintenance Period|Withdrawal by Subject|2|||
164201310|NCT02065557|593110702|FG005|Maintenance Period|Withdrawal by Subject|1|||
164657182|NCT00585351|594770129|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
164657183|NCT00585351|594770130|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
164657184|NCT00585351|594770131|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
164657185|NCT00585351|594770132|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
164657186|NCT00585351|594770133|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
164657187|NCT00585351|594770134|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
164657188|NCT00585351|594770127|FG000|Enrollment Period (Intervention)|Death|0|||
164657189|NCT00585351|594770128|FG001|Enrollment Period (Intervention)|Death|0|||
164657190|NCT00585351|594770129|FG002|Enrollment Period (Intervention)|Death|0|||
164657191|NCT00585351|594770130|FG003|Enrollment Period (Intervention)|Death|0|||
164657192|NCT00585351|594770131|FG004|Enrollment Period (Intervention)|Death|1|||
164657193|NCT00585351|594770132|FG005|Enrollment Period (Intervention)|Death|0|||
164657194|NCT00585351|594770133|FG006|Enrollment Period (Intervention)|Death|1|||
164657195|NCT00585351|594770134|FG007|Enrollment Period (Intervention)|Death|0|||
164657196|NCT00585351|594770127|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
164657197|NCT00585351|594770128|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
164657198|NCT00585351|594770129|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
164657199|NCT00585351|594770130|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
164657200|NCT00585351|594770131|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
164657201|NCT00585351|594770132|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
164657202|NCT00585351|594770133|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
164657203|NCT00585351|594770134|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
164657204|NCT00192296|594770135|FG000|Overall Study|Withdrawal by Subject|0|||
164657205|NCT00192296|594770136|FG001|Overall Study|Withdrawal by Subject|1|||
164657206|NCT00192296|594770137|FG002|Overall Study|Withdrawal by Subject|0|||
164657207|NCT00192296|594770138|FG003|Overall Study|Withdrawal by Subject|0|||
164657208|NCT02227849|594770143|FG000|Overall Study|Adverse Event|4|||
164657209|NCT02227849|594770143|FG000|Overall Study|Physician Decision|1|||
164657210|NCT02227849|594770143|FG000|Overall Study|Withdrawal by Subject|3|||
164657211|NCT00457665|594770146|FG000|12 Months|Drug allergy|1|||
164657212|NCT00457665|594770147|FG001|12 Months|Drug allergy|1|||
164657213|NCT00457665|594770146|FG000|12 Months|High HIV viral load|5|||
164657214|NCT00457665|594770147|FG001|12 Months|High HIV viral load|1|||
164657215|NCT00457665|594770146|FG000|12 Months|Lipodystrophy|2|||
164657216|NCT00457665|594770147|FG001|12 Months|Lipodystrophy|0|||
164657217|NCT00457665|594770146|FG000|12 Months|Withdrawal by Subject|0|||
164657218|NCT00457665|594770147|FG001|12 Months|Withdrawal by Subject|2|||
164657219|NCT00457665|594770146|FG000|12 Months|Abnormal Liver function tests|0|||
164657220|NCT00457665|594770147|FG001|12 Months|Abnormal Liver function tests|5|||
164657221|NCT00457665|594770146|FG000|24 Months|Withdrawal by Subject|3|||
164657222|NCT00457665|594770147|FG001|24 Months|Withdrawal by Subject|2|||
164657223|NCT00457665|594770146|FG000|24 Months|Lipodystrophy|1|||
164657224|NCT00457665|594770147|FG001|24 Months|Lipodystrophy|1|||
164657225|NCT00457665|594770146|FG000|24 Months|Abnormal liver function tests|1|||
164657226|NCT00457665|594770147|FG001|24 Months|Abnormal liver function tests|5|||
164657227|NCT02535000|594770148|FG000|Overall Study|Cancellation of surgery.|1|||
164657228|NCT02535000|594770149|FG001|Overall Study|Cancellation of surgery.|2|||
164657229|NCT04317781|594770151|FG000|Overall Study|Adverse Event|1|||
164657230|NCT04317781|594770151|FG000|Overall Study|Disease relapse|1|||
164657231|NCT04317781|594770151|FG000|Overall Study|Withdrawal by Subject|1|||
164552592|NCT00960661|594394966|FG000|Interventional Phase|Protocol Violation|0|||
164552593|NCT00960661|594394967|FG001|Interventional Phase|Protocol Violation|7|||
164552594|NCT00960661|594394968|FG002|Interventional Phase|Protocol Violation|2|||
164552595|NCT00960661|594394966|FG000|Interventional Phase|Withdrawal by Subject|0|||
164552596|NCT00960661|594394967|FG001|Interventional Phase|Withdrawal by Subject|18|||
164552597|NCT00960661|594394968|FG002|Interventional Phase|Withdrawal by Subject|29|||
164552598|NCT00960661|594394966|FG000|Interventional Phase|Physician Decision|0|||
164552599|NCT00960661|594394967|FG001|Interventional Phase|Physician Decision|3|||
164552600|NCT00960661|594394968|FG002|Interventional Phase|Physician Decision|5|||
164552601|NCT00960661|594394966|FG000|Interventional Phase|sponsor decision|0|||
164552602|NCT00960661|594394967|FG001|Interventional Phase|sponsor decision|1|||
164657232|NCT00706706|594770154|FG000|Overall Study|Death|53|||
164657233|NCT00706706|594770154|FG000|Overall Study|Lost to Follow-up|7|||
164657234|NCT00706706|594770154|FG000|Overall Study|Study endpoint had reached|45|||
164302361|NCT03755934|593482603|FG001|Overall Study|Adverse Event|1|||
164657235|NCT02175966|594770159|FG000|Follow-up Period|Lack of Efficacy|10|||
164657236|NCT02175966|594770160|FG001|Follow-up Period|Lack of Efficacy|6|||
164552603|NCT00960661|594394968|FG002|Interventional Phase|sponsor decision|0|||
164552604|NCT00960661|594394966|FG000|Interventional Phase|Lack of Efficacy|0|||
164657237|NCT00210626|594770161|FG000|Overall Study|Adverse Event|1|||
164657238|NCT00210626|594770162|FG001|Overall Study|Adverse Event|2|||
164657239|NCT00210626|594770161|FG000|Overall Study|Protocol Violation|1|||
164657240|NCT00210626|594770162|FG001|Overall Study|Protocol Violation|5|||
164552605|NCT00960661|594394967|FG001|Interventional Phase|Lack of Efficacy|2|||
164552606|NCT00960661|594394968|FG002|Interventional Phase|Lack of Efficacy|0|||
164657241|NCT00210626|594770161|FG000|Overall Study|Lost to Follow-up|11|||
164657242|NCT00210626|594770162|FG001|Overall Study|Lost to Follow-up|11|||
164657243|NCT00210626|594770161|FG000|Overall Study|Death|1|||
164657244|NCT00210626|594770162|FG001|Overall Study|Death|0|||
164657245|NCT00210626|594770161|FG000|Overall Study|Withdrawal by Subject|29|||
164657246|NCT00210626|594770162|FG001|Overall Study|Withdrawal by Subject|20|||
164657247|NCT00210626|594770161|FG000|Overall Study|Physician Decision|0|||
164657248|NCT00210626|594770162|FG001|Overall Study|Physician Decision|2|||
164657249|NCT00210626|594770161|FG000|Overall Study|Sponser Request|1|||
164657250|NCT00210626|594770162|FG001|Overall Study|Sponser Request|0|||
164657251|NCT00210626|594770161|FG000|Overall Study|Other|4|||
164657252|NCT00210626|594770162|FG001|Overall Study|Other|5|||
164657253|NCT03361956|594770163|FG000|Overall Study|Adverse Event|1|||
164657254|NCT03361956|594770164|FG001|Overall Study|Adverse Event|0|||
164657255|NCT03361956|594770165|FG002|Overall Study|Adverse Event|1|||
164657256|NCT03361956|594770166|FG003|Overall Study|Adverse Event|1|||
164657257|NCT03361956|594770167|FG004|Overall Study|Adverse Event|0|||
164657258|NCT03361956|594770163|FG000|Overall Study|Other|0|||
164657259|NCT03361956|594770164|FG001|Overall Study|Other|0|||
164657260|NCT03361956|594770165|FG002|Overall Study|Other|0|||
164657261|NCT03361956|594770166|FG003|Overall Study|Other|1|||
164657262|NCT03361956|594770167|FG004|Overall Study|Other|0|||
164657263|NCT03361956|594770163|FG000|Overall Study|Withdrawal by Subject|2|||
164657264|NCT03361956|594770164|FG001|Overall Study|Withdrawal by Subject|2|||
164657265|NCT03361956|594770165|FG002|Overall Study|Withdrawal by Subject|2|||
164657266|NCT03361956|594770166|FG003|Overall Study|Withdrawal by Subject|0|||
164657267|NCT03361956|594770167|FG004|Overall Study|Withdrawal by Subject|3|||
164657268|NCT03361956|594770163|FG000|Overall Study|Disease Relapse|0|||
164657269|NCT03361956|594770164|FG001|Overall Study|Disease Relapse|0|||
164657270|NCT03361956|594770165|FG002|Overall Study|Disease Relapse|1|||
164657271|NCT03361956|594770166|FG003|Overall Study|Disease Relapse|0|||
164657272|NCT03361956|594770167|FG004|Overall Study|Disease Relapse|0|||
164657273|NCT03361956|594770163|FG000|Overall Study|Physician Decision|0|||
164657274|NCT03361956|594770164|FG001|Overall Study|Physician Decision|2|||
164657275|NCT03361956|594770165|FG002|Overall Study|Physician Decision|0|||
164657276|NCT03361956|594770166|FG003|Overall Study|Physician Decision|1|||
164657277|NCT03361956|594770167|FG004|Overall Study|Physician Decision|0|||
164657278|NCT03361956|594770163|FG000|Overall Study|Lost to Follow-up|0|||
164657279|NCT03361956|594770164|FG001|Overall Study|Lost to Follow-up|0|||
164657280|NCT03361956|594770165|FG002|Overall Study|Lost to Follow-up|1|||
164657281|NCT03361956|594770166|FG003|Overall Study|Lost to Follow-up|1|||
164657282|NCT03361956|594770167|FG004|Overall Study|Lost to Follow-up|2|||
164657283|NCT02330081|594770170|FG000|Overall Study|Adverse Event|1|||
164657284|NCT02330081|594770170|FG000|Overall Study|Donation did not meet criteria|1|||
164657285|NCT02330081|594770170|FG000|Overall Study|Protocol Violation|6|||
164657286|NCT02277769|594770171|FG000|Overall Study|Protocol Violation|3|||
164657287|NCT02277769|594770172|FG001|Overall Study|Protocol Violation|3|||
164657288|NCT02277769|594770173|FG002|Overall Study|Protocol Violation|5|||
164657289|NCT02277769|594770171|FG000|Overall Study|Lack of Efficacy|17|||
164657290|NCT02277769|594770172|FG001|Overall Study|Lack of Efficacy|0|||
164657291|NCT02277769|594770173|FG002|Overall Study|Lack of Efficacy|4|||
164657292|NCT02277769|594770171|FG000|Overall Study|Adverse Event|14|||
164657293|NCT02277769|594770172|FG001|Overall Study|Adverse Event|2|||
164657294|NCT02277769|594770173|FG002|Overall Study|Adverse Event|4|||
164657295|NCT02277769|594770171|FG000|Overall Study|Other than specified above|12|||
164657296|NCT02277769|594770172|FG001|Overall Study|Other than specified above|8|||
164657297|NCT02277769|594770173|FG002|Overall Study|Other than specified above|5|||
164657298|NCT03775681|594770177|FG000|Overall Study|Physician Decision|3|||
164657299|NCT02123459|594770180|FG000|Washout Period (1 Day)|Adverse Event|1|||
164657300|NCT02123459|594770181|FG001|Washout Period (1 Day)|Adverse Event|0|||
164657301|NCT02196506|594770182|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
164657302|NCT02196506|594770183|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
164657303|NCT02196506|594770184|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
164657304|NCT02196506|594770185|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
164657305|NCT02196506|594770182|FG000|Phase A|Withdrawal by Subject|34|||
164657306|NCT02196506|594770183|FG001|Phase A|Withdrawal by Subject|0|||
164657307|NCT02196506|594770184|FG002|Phase A|Withdrawal by Subject|0|||
164201311|NCT02065557|593110697|FG000|Maintenance Period|Lack of Efficacy|0|||
164201312|NCT02065557|593110698|FG001|Maintenance Period|Lack of Efficacy|0|||
164657308|NCT02196506|594770185|FG003|Phase A|Withdrawal by Subject|0|||
164657309|NCT02196506|594770182|FG000|Phase A|Adverse Event|22|||
164657310|NCT02196506|594770183|FG001|Phase A|Adverse Event|0|||
164657311|NCT02196506|594770184|FG002|Phase A|Adverse Event|0|||
164657312|NCT02196506|594770185|FG003|Phase A|Adverse Event|0|||
164657313|NCT02196506|594770182|FG000|Phase A|Lost to Follow-up|9|||
164657314|NCT02196506|594770183|FG001|Phase A|Lost to Follow-up|0|||
164657315|NCT02196506|594770184|FG002|Phase A|Lost to Follow-up|0|||
164657316|NCT02196506|594770185|FG003|Phase A|Lost to Follow-up|0|||
164657317|NCT02196506|594770182|FG000|Phase A|Protocol deviation|12|||
164657318|NCT02196506|594770183|FG001|Phase A|Protocol deviation|0|||
164657319|NCT02196506|594770184|FG002|Phase A|Protocol deviation|0|||
164420595|NCT01890967|593910946|FG000|Overall Study|Lost to Follow-up|1|||
164552607|NCT02699892|594394969|FG000|Overall Study|Other|36|||
164552608|NCT04677712|594394975|FG000|Overall Study|Lost to Follow-up|0|||
164552609|NCT04677712|594394976|FG001|Overall Study|Lost to Follow-up|1|||
164552610|NCT04677712|594394977|FG002|Overall Study|Lost to Follow-up|0|||
164552611|NCT04677712|594394978|FG003|Overall Study|Lost to Follow-up|0|||
164552612|NCT04677712|594394979|FG004|Overall Study|Lost to Follow-up|0|||
164552613|NCT04677712|594394980|FG005|Overall Study|Lost to Follow-up|0|||
164552614|NCT00711100|594394981|FG000|Overall Study|Lack of Efficacy|5|||
164552615|NCT00711100|594394981|FG000|Overall Study|Withdrawal by Subject|8|||
164552616|NCT00847912|594394982|FG000|Overall Study|Protocol Violation|6|||
164552617|NCT00847912|594394983|FG001|Overall Study|Protocol Violation|7|||
164552618|NCT00847912|594394982|FG000|Overall Study|Withdrawal by Subject|3|||
164552619|NCT00847912|594394983|FG001|Overall Study|Withdrawal by Subject|6|||
164552620|NCT02083380|594394985|FG000|Overall Study|Lack of Efficacy|68|||
164552621|NCT02083380|594394986|FG001|Overall Study|Lack of Efficacy|79|||
164552622|NCT02083380|594394987|FG002|Overall Study|Lack of Efficacy|64|||
164552623|NCT02083380|594394985|FG000|Overall Study|Withdrawal by Subject|9|||
164552624|NCT02083380|594394986|FG001|Overall Study|Withdrawal by Subject|3|||
164552625|NCT02083380|594394987|FG002|Overall Study|Withdrawal by Subject|7|||
164552626|NCT02083380|594394985|FG000|Overall Study|Physician Decision|1|||
164552627|NCT02083380|594394986|FG001|Overall Study|Physician Decision|6|||
164552628|NCT02083380|594394987|FG002|Overall Study|Physician Decision|3|||
164552629|NCT02083380|594394985|FG000|Overall Study|Adverse Event|0|||
164552630|NCT02083380|594394986|FG001|Overall Study|Adverse Event|0|||
164552631|NCT02083380|594394987|FG002|Overall Study|Adverse Event|1|||
164552632|NCT02083380|594394985|FG000|Overall Study|Lost to Follow-up|5|||
164552633|NCT02083380|594394986|FG001|Overall Study|Lost to Follow-up|3|||
164552634|NCT02083380|594394987|FG002|Overall Study|Lost to Follow-up|3|||
164552635|NCT02083380|594394985|FG000|Overall Study|Other|8|||
164552636|NCT02083380|594394986|FG001|Overall Study|Other|4|||
164552637|NCT02083380|594394987|FG002|Overall Study|Other|6|||
164552638|NCT01577186|594394993|FG000|Overall Study|Adverse Event|23|||
164552639|NCT01577186|594394993|FG000|Overall Study|Death|1|||
164552640|NCT01577186|594394993|FG000|Overall Study|Lost to Follow-up|28|||
164552641|NCT01577186|594394993|FG000|Overall Study|Withdrawal by Subject|35|||
164552642|NCT01577186|594394993|FG000|Overall Study|Insufficient Response|18|||
164552643|NCT01577186|594394993|FG000|Overall Study|Ineligible to Continue|15|||
164552644|NCT01577186|594394993|FG000|Overall Study|Non-Compliant|8|||
164552645|NCT01577186|594394993|FG000|Overall Study|Other|2|||
164552646|NCT01032915|594394994|FG000|Overall Study|Adverse Event|2|||
164552647|NCT01032915|594394995|FG001|Overall Study|Adverse Event|2|||
164552648|NCT01032915|594394996|FG002|Overall Study|Adverse Event|1|||
164552649|NCT01032915|594394997|FG003|Overall Study|Adverse Event|1|||
164552650|NCT01032915|594394994|FG000|Overall Study|Abnormal test procedure result|0|||
164552651|NCT01032915|594394995|FG001|Overall Study|Abnormal test procedure result|0|||
164552652|NCT01032915|594394996|FG002|Overall Study|Abnormal test procedure result|1|||
164552653|NCT01032915|594394997|FG003|Overall Study|Abnormal test procedure result|0|||
164552654|NCT01032915|594394994|FG000|Overall Study|Withdrawal by Subject|0|||
164552655|NCT01032915|594394995|FG001|Overall Study|Withdrawal by Subject|3|||
164552656|NCT01032915|594394996|FG002|Overall Study|Withdrawal by Subject|1|||
164552657|NCT01032915|594394997|FG003|Overall Study|Withdrawal by Subject|1|||
164552658|NCT01032915|594394994|FG000|Overall Study|Administrative reasons|5|||
164552659|NCT01032915|594394995|FG001|Overall Study|Administrative reasons|6|||
164552660|NCT01032915|594394996|FG002|Overall Study|Administrative reasons|4|||
164552661|NCT01032915|594394997|FG003|Overall Study|Administrative reasons|4|||
164552662|NCT01032915|594394994|FG000|Overall Study|Protocol Violation|1|||
164552663|NCT01032915|594394995|FG001|Overall Study|Protocol Violation|0|||
164552664|NCT01032915|594394996|FG002|Overall Study|Protocol Violation|0|||
164552665|NCT01032915|594394997|FG003|Overall Study|Protocol Violation|1|||
164552666|NCT02915523|594394999|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
164657320|NCT02196506|594770185|FG003|Phase A|Protocol deviation|0|||
164657321|NCT02196506|594770182|FG000|Phase A|Participant withdrawn by investigator|10|||
164657322|NCT02196506|594770183|FG001|Phase A|Participant withdrawn by investigator|0|||
164657323|NCT02196506|594770184|FG002|Phase A|Participant withdrawn by investigator|0|||
164552667|NCT02915523|594395000|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
164552668|NCT02915523|594395001|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
164552669|NCT02915523|594395002|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
164552670|NCT02915523|594394999|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
164552671|NCT02915523|594395000|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
164552672|NCT02915523|594395001|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
164552673|NCT02915523|594395002|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
164552674|NCT02915523|594394999|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
164552675|NCT02915523|594395000|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
164552676|NCT02915523|594395001|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
164552677|NCT02915523|594395002|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
164552678|NCT02915523|594394999|FG000|Expansion Phase (Phase 2)|Death|0|||
164552679|NCT02915523|594395000|FG001|Expansion Phase (Phase 2)|Death|0|||
164552680|NCT02915523|594395001|FG002|Expansion Phase (Phase 2)|Death|26|||
164552681|NCT02915523|594395002|FG003|Expansion Phase (Phase 2)|Death|53|||
164552682|NCT02915523|594394999|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
164552683|NCT02915523|594395000|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
164552684|NCT02915523|594395001|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
164552685|NCT02915523|594395002|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
164552686|NCT02915523|594394999|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
164552687|NCT02915523|594395000|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
164552688|NCT02915523|594395001|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
164552689|NCT02915523|594395002|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
164552690|NCT02915523|594394999|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
164552691|NCT02915523|594395000|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
164552692|NCT02915523|594395001|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
164552693|NCT02915523|594395002|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
164552694|NCT02797808|594395003|FG000|Overall Study|Withdrawal by Subject|1|||
164552695|NCT02797808|594395004|FG001|Overall Study|Withdrawal by Subject|1|||
164552696|NCT02797808|594395003|FG000|Overall Study|Physician Decision|6|||
164552697|NCT02797808|594395004|FG001|Overall Study|Physician Decision|2|||
164552698|NCT03221751|594395005|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
164552699|NCT03221751|594395006|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
164552700|NCT00535132|594395009|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
164552701|NCT00535132|594395010|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
164552702|NCT00535132|594395009|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
164552703|NCT00535132|594395010|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
164552704|NCT00708500|594395022|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
164552705|NCT00708500|594395023|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
164552706|NCT00708500|594395024|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
164552707|NCT00708500|594395022|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
164552708|NCT00708500|594395023|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
164552709|NCT00708500|594395024|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
164552710|NCT00708500|594395022|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
164552711|NCT00708500|594395023|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
164552712|NCT00708500|594395024|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
164552713|NCT00708500|594395022|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
164552714|NCT00708500|594395023|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
164552715|NCT00708500|594395024|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
164552716|NCT00708500|594395022|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
164552717|NCT00708500|594395023|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
164552718|NCT00708500|594395024|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
164552719|NCT00708500|594395022|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
164552720|NCT00708500|594395023|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
164552721|NCT00708500|594395024|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
164552722|NCT00708500|594395022|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
164552723|NCT00708500|594395023|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
164552724|NCT00708500|594395024|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
164552725|NCT00708500|594395022|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
164552726|NCT00708500|594395023|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
164552727|NCT00708500|594395024|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
164552728|NCT00708500|594395022|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
164552729|NCT00708500|594395023|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
164552730|NCT00708500|594395024|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
164552731|NCT00708500|594395022|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
164552732|NCT00708500|594395023|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
164552733|NCT00708500|594395024|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
164552734|NCT00708500|594395022|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
164552735|NCT00708500|594395023|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
164552736|NCT00708500|594395024|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
164552737|NCT00708500|594395022|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
164552738|NCT00708500|594395023|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
164552739|NCT00708500|594395024|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
164552740|NCT00708500|594395022|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
164552741|NCT00708500|594395023|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
164552742|NCT00708500|594395024|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
164552743|NCT00708500|594395022|FG000|FOLLOWUP|Adverse Event|0|||
164657324|NCT02196506|594770185|FG003|Phase A|Participant withdrawn by investigator|0|||
164552744|NCT00708500|594395023|FG001|FOLLOWUP|Adverse Event|1|||
164552745|NCT00708500|594395024|FG002|FOLLOWUP|Adverse Event|0|||
164552746|NCT00708500|594395022|FG000|FOLLOWUP|Lost to Follow-up|1|||
164552747|NCT00708500|594395023|FG001|FOLLOWUP|Lost to Follow-up|6|||
164552748|NCT00708500|594395024|FG002|FOLLOWUP|Lost to Follow-up|4|||
164552749|NCT00708500|594395022|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
164552750|NCT00708500|594395023|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
164552751|NCT00708500|594395024|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
164552752|NCT00708500|594395022|FG000|FOLLOWUP|Subject withdrew consent|31|||
164552753|NCT00708500|594395023|FG001|FOLLOWUP|Subject withdrew consent|4|||
164552754|NCT00708500|594395024|FG002|FOLLOWUP|Subject withdrew consent|5|||
164552755|NCT00708500|594395022|FG000|FOLLOWUP|Non-compliance with protocol|5|||
164552756|NCT00708500|594395023|FG001|FOLLOWUP|Non-compliance with protocol|0|||
164552757|NCT00708500|594395024|FG002|FOLLOWUP|Non-compliance with protocol|1|||
164552758|NCT00794677|594395038|FG000|First Intervention|Withdrawal by Subject|2|||
164552759|NCT00794677|594395039|FG001|First Intervention|Withdrawal by Subject|0|||
164552760|NCT01929408|594395040|FG000|Overall Study|received HCT as initial treatment|8|||
164552761|NCT00652366|594395050|FG000|Overall Study|Adverse Event|8|||
164552762|NCT00652366|594395051|FG001|Overall Study|Adverse Event|4|||
164552763|NCT00652366|594395052|FG002|Overall Study|Adverse Event|7|||
164552764|NCT00652366|594395053|FG003|Overall Study|Adverse Event|17|||
164552765|NCT00652366|594395054|FG004|Overall Study|Adverse Event|13|||
164552766|NCT00652366|594395050|FG000|Overall Study|Death|5|||
164552767|NCT00652366|594395051|FG001|Overall Study|Death|4|||
164552768|NCT00652366|594395052|FG002|Overall Study|Death|1|||
164552769|NCT00652366|594395053|FG003|Overall Study|Death|8|||
164552770|NCT00652366|594395054|FG004|Overall Study|Death|5|||
164552771|NCT00652366|594395050|FG000|Overall Study|Lack of Efficacy|84|||
164552772|NCT00652366|594395051|FG001|Overall Study|Lack of Efficacy|58|||
164552773|NCT00652366|594395052|FG002|Overall Study|Lack of Efficacy|53|||
164552774|NCT00652366|594395053|FG003|Overall Study|Lack of Efficacy|133|||
164552775|NCT00652366|594395054|FG004|Overall Study|Lack of Efficacy|13|||
164552776|NCT00652366|594395050|FG000|Overall Study|Violation of Selection Criteria|0|||
164552777|NCT00652366|594395051|FG001|Overall Study|Violation of Selection Criteria|0|||
164552778|NCT00652366|594395052|FG002|Overall Study|Violation of Selection Criteria|1|||
164552779|NCT00652366|594395053|FG003|Overall Study|Violation of Selection Criteria|0|||
164552780|NCT00652366|594395054|FG004|Overall Study|Violation of Selection Criteria|0|||
164552781|NCT00652366|594395050|FG000|Overall Study|Protocol Violation|1|||
164552782|NCT00652366|594395051|FG001|Overall Study|Protocol Violation|0|||
164552783|NCT00652366|594395052|FG002|Overall Study|Protocol Violation|0|||
164552784|NCT00652366|594395053|FG003|Overall Study|Protocol Violation|0|||
164552785|NCT00652366|594395054|FG004|Overall Study|Protocol Violation|0|||
164552786|NCT00652366|594395050|FG000|Overall Study|Refused treatment|3|||
164552787|NCT00652366|594395051|FG001|Overall Study|Refused treatment|7|||
164552788|NCT00652366|594395052|FG002|Overall Study|Refused treatment|6|||
164552789|NCT00652366|594395053|FG003|Overall Study|Refused treatment|17|||
164552790|NCT00652366|594395054|FG004|Overall Study|Refused treatment|5|||
164552791|NCT00652366|594395050|FG000|Overall Study|Other|5|||
164552792|NCT00652366|594395051|FG001|Overall Study|Other|2|||
164552793|NCT00652366|594395052|FG002|Overall Study|Other|3|||
164552794|NCT00652366|594395053|FG003|Overall Study|Other|4|||
164552795|NCT00652366|594395054|FG004|Overall Study|Other|0|||
164552796|NCT03873714|594395055|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
164552797|NCT01970501|594395056|FG000|Overall Study|Discontinuation of study by sponsor|16|||
164552798|NCT01970501|594395057|FG001|Overall Study|Discontinuation of study by sponsor|14|||
164552799|NCT01970501|594395056|FG000|Overall Study|Withdrawal by Subject|6|||
164552800|NCT01970501|594395057|FG001|Overall Study|Withdrawal by Subject|7|||
164552801|NCT01970501|594395056|FG000|Overall Study|Adverse Event|2|||
164552802|NCT01970501|594395057|FG001|Overall Study|Adverse Event|4|||
164552803|NCT01970501|594395056|FG000|Overall Study|Death|1|||
164552804|NCT01970501|594395057|FG001|Overall Study|Death|3|||
164552805|NCT01970501|594395056|FG000|Overall Study|Physician Decision|2|||
164552806|NCT01970501|594395057|FG001|Overall Study|Physician Decision|0|||
164552807|NCT01181011|594395061|FG000|Overall Study|Adverse Event|2|||
164552808|NCT01181011|594395061|FG000|Overall Study|Lost to Follow-up|1|||
164552809|NCT00401375|594395062|FG000|Overall Study|Protocol Violation|2|||
164657325|NCT02196506|594770182|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
164657326|NCT02196506|594770183|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
164552810|NCT00401375|594395063|FG001|Overall Study|Protocol Violation|2|||
164552811|NCT00401375|594395064|FG002|Overall Study|Protocol Violation|1|||
164552812|NCT00401375|594395062|FG000|Overall Study|Adverse Event|6|||
164552813|NCT00401375|594395063|FG001|Overall Study|Adverse Event|11|||
164552814|NCT00401375|594395064|FG002|Overall Study|Adverse Event|10|||
164552815|NCT00401375|594395062|FG000|Overall Study|Withdrawal by Subject|9|||
164552816|NCT00401375|594395063|FG001|Overall Study|Withdrawal by Subject|7|||
164552817|NCT00401375|594395064|FG002|Overall Study|Withdrawal by Subject|7|||
164552818|NCT00401375|594395062|FG000|Overall Study|Lost to Follow-up|0|||
164552819|NCT00401375|594395063|FG001|Overall Study|Lost to Follow-up|1|||
164552820|NCT00401375|594395064|FG002|Overall Study|Lost to Follow-up|1|||
164657327|NCT02196506|594770184|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
164657328|NCT02196506|594770185|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
164657329|NCT02196506|594770182|FG000|Phase B|Lack of Efficacy|0|||
164657330|NCT02196506|594770183|FG001|Phase B|Lack of Efficacy|1|||
164657331|NCT02196506|594770184|FG002|Phase B|Lack of Efficacy|2|||
164657332|NCT02196506|594770185|FG003|Phase B|Lack of Efficacy|0|||
164657333|NCT02196506|594770182|FG000|Phase B|Withdrawal by Participant|0|||
164657334|NCT02196506|594770183|FG001|Phase B|Withdrawal by Participant|8|||
164657335|NCT02196506|594770184|FG002|Phase B|Withdrawal by Participant|1|||
164657336|NCT02196506|594770185|FG003|Phase B|Withdrawal by Participant|0|||
164657337|NCT02196506|594770182|FG000|Phase B|Adverse Event|0|||
164657338|NCT02196506|594770183|FG001|Phase B|Adverse Event|4|||
164657339|NCT02196506|594770184|FG002|Phase B|Adverse Event|1|||
164657340|NCT02196506|594770185|FG003|Phase B|Adverse Event|0|||
164657341|NCT02196506|594770182|FG000|Phase B|Lost to Follow-up|0|||
164657342|NCT02196506|594770183|FG001|Phase B|Lost to Follow-up|2|||
164657343|NCT02196506|594770184|FG002|Phase B|Lost to Follow-up|1|||
164657344|NCT02196506|594770185|FG003|Phase B|Lost to Follow-up|0|||
164657345|NCT02196506|594770182|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
164657346|NCT02196506|594770183|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
164657347|NCT02196506|594770184|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
164657348|NCT02196506|594770185|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
164657349|NCT02196506|594770182|FG000|Phase A+|Withdrawal by Participant|0|||
164657350|NCT02196506|594770183|FG001|Phase A+|Withdrawal by Participant|0|||
164657351|NCT02196506|594770184|FG002|Phase A+|Withdrawal by Participant|0|||
164657352|NCT02196506|594770185|FG003|Phase A+|Withdrawal by Participant|5|||
164657353|NCT02196506|594770182|FG000|Phase A+|Adverse Event|0|||
164657354|NCT02196506|594770183|FG001|Phase A+|Adverse Event|0|||
164657355|NCT02196506|594770184|FG002|Phase A+|Adverse Event|0|||
164657356|NCT02196506|594770185|FG003|Phase A+|Adverse Event|1|||
164657357|NCT02196506|594770182|FG000|Phase A+|Lost to Follow-up|0|||
164657358|NCT02196506|594770183|FG001|Phase A+|Lost to Follow-up|0|||
164657359|NCT02196506|594770184|FG002|Phase A+|Lost to Follow-up|0|||
164657360|NCT02196506|594770185|FG003|Phase A+|Lost to Follow-up|6|||
164657361|NCT02196506|594770182|FG000|Phase A+|Participant withdrawn by investigator|0|||
164657362|NCT02196506|594770183|FG001|Phase A+|Participant withdrawn by investigator|0|||
164657363|NCT02196506|594770184|FG002|Phase A+|Participant withdrawn by investigator|0|||
164657364|NCT02196506|594770185|FG003|Phase A+|Participant withdrawn by investigator|1|||
164657365|NCT03387059|594770186|FG000|Overall Study|Study termination|5|||
164657366|NCT03387059|594770187|FG001|Overall Study|Study termination|4|||
164657367|NCT01098240|594770188|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
164657368|NCT01098240|594770189|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
164657369|NCT01098240|594770190|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
164657370|NCT01098240|594770188|FG000|Open-Label Phase|Protocol Violation|4|||
164657371|NCT01098240|594770189|FG001|Open-Label Phase|Protocol Violation|0|||
164657372|NCT01098240|594770190|FG002|Open-Label Phase|Protocol Violation|0|||
164657373|NCT01098240|594770188|FG000|Open-Label Phase|Lost to Follow-up|13|||
164657374|NCT01098240|594770189|FG001|Open-Label Phase|Lost to Follow-up|0|||
164657375|NCT01098240|594770190|FG002|Open-Label Phase|Lost to Follow-up|0|||
164657376|NCT01098240|594770188|FG000|Open-Label Phase|Other|19|||
164657377|NCT01098240|594770189|FG001|Open-Label Phase|Other|0|||
164657378|NCT01098240|594770190|FG002|Open-Label Phase|Other|0|||
164657379|NCT01098240|594770188|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
164657380|NCT01098240|594770189|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
164657381|NCT01098240|594770190|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
164657382|NCT01098240|594770188|FG000|Open-Label Phase|Pregnancy|1|||
164657383|NCT01098240|594770189|FG001|Open-Label Phase|Pregnancy|0|||
164657384|NCT01098240|594770190|FG002|Open-Label Phase|Pregnancy|0|||
164657385|NCT01098240|594770188|FG000|Open-Label Phase|Withdrawal by Subject|9|||
164657386|NCT01098240|594770189|FG001|Open-Label Phase|Withdrawal by Subject|0|||
164657387|NCT01098240|594770190|FG002|Open-Label Phase|Withdrawal by Subject|0|||
164657388|NCT01098240|594770188|FG000|Open-Label Phase|Adverse Event|12|||
164657389|NCT01098240|594770189|FG001|Open-Label Phase|Adverse Event|0|||
164657390|NCT01098240|594770190|FG002|Open-Label Phase|Adverse Event|0|||
164657391|NCT01098240|594770188|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
164657392|NCT01098240|594770189|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
164657393|NCT01098240|594770190|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
164657394|NCT01098240|594770188|FG000|Double-Blind Phase|Protocol Violation|0|||
164657395|NCT01098240|594770189|FG001|Double-Blind Phase|Protocol Violation|2|||
164657396|NCT01098240|594770190|FG002|Double-Blind Phase|Protocol Violation|4|||
164657397|NCT01098240|594770188|FG000|Double-Blind Phase|Lost to Follow-up|0|||
164310110|NCT02722304|593509586|FG001|Overall Study|Study Terminated by Sponsor|0|||
164657398|NCT01098240|594770189|FG001|Double-Blind Phase|Lost to Follow-up|2|||
164657399|NCT01098240|594770190|FG002|Double-Blind Phase|Lost to Follow-up|0|||
164657400|NCT01098240|594770188|FG000|Double-Blind Phase|Other|0|||
164657401|NCT01098240|594770189|FG001|Double-Blind Phase|Other|2|||
164657402|NCT01098240|594770190|FG002|Double-Blind Phase|Other|2|||
164657403|NCT01098240|594770188|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
164657404|NCT01098240|594770189|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
164552821|NCT00401375|594395062|FG000|Overall Study|Other than specified|2|||
164552822|NCT00401375|594395063|FG001|Overall Study|Other than specified|1|||
164552823|NCT00401375|594395064|FG002|Overall Study|Other than specified|3|||
164552824|NCT00401375|594395062|FG000|Overall Study|Randomized but not treated|3|||
164552825|NCT00401375|594395063|FG001|Overall Study|Randomized but not treated|3|||
164552826|NCT00401375|594395064|FG002|Overall Study|Randomized but not treated|3|||
164552827|NCT00950664|594395065|FG000|First Intervention|Lost to Follow-up|1|||
164552828|NCT00950664|594395066|FG001|First Intervention|Lost to Follow-up|3|||
164552829|NCT00950664|594395065|FG000|First Intervention|Withdrawal by Subject|2|||
164552830|NCT00950664|594395066|FG001|First Intervention|Withdrawal by Subject|2|||
164552831|NCT01326546|594395069|FG000|Overall Study|Lost to Follow-up|8|||
164552832|NCT01326546|594395070|FG001|Overall Study|Lost to Follow-up|7|||
164552833|NCT01326546|594395069|FG000|Overall Study|Protocol Violation|3|||
164552834|NCT01326546|594395070|FG001|Overall Study|Protocol Violation|4|||
164552835|NCT01326546|594395069|FG000|Overall Study|Pregnancy|0|||
164552836|NCT01326546|594395070|FG001|Overall Study|Pregnancy|1|||
164552837|NCT01326546|594395069|FG000|Overall Study|Adverse Event|1|||
164552838|NCT01326546|594395070|FG001|Overall Study|Adverse Event|0|||
164552839|NCT01326546|594395069|FG000|Overall Study|Withdrawal by Subject|5|||
164552840|NCT01326546|594395070|FG001|Overall Study|Withdrawal by Subject|1|||
164552841|NCT03152019|594395071|FG000|Overall Study|Adverse Event|0|||
164552842|NCT03152019|594395072|FG001|Overall Study|Adverse Event|1|||
164552843|NCT04703075|594395073|FG000|Overall Study|Adverse Event|11|||
164552844|NCT04703075|594395074|FG001|Overall Study|Adverse Event|7|||
164552845|NCT04703075|594395073|FG000|Overall Study|Lost to Follow-up|6|||
164552846|NCT04703075|594395074|FG001|Overall Study|Lost to Follow-up|12|||
164552847|NCT04703075|594395073|FG000|Overall Study|Physician Decision|3|||
164552848|NCT04703075|594395074|FG001|Overall Study|Physician Decision|0|||
164552849|NCT04703075|594395073|FG000|Overall Study|Moved|0|||
164552850|NCT04703075|594395074|FG001|Overall Study|Moved|2|||
164552851|NCT04703075|594395073|FG000|Overall Study|Index INH Resistant|0|||
164552852|NCT04703075|594395074|FG001|Overall Study|Index INH Resistant|1|||
164552853|NCT04703075|594395073|FG000|Overall Study|Lack of Efficacy|6|||
164552854|NCT04703075|594395074|FG001|Overall Study|Lack of Efficacy|18|||
164552855|NCT01187953|594395077|FG000|Overall Study|Death|11|||
164552856|NCT01187953|594395078|FG001|Overall Study|Death|13|||
164552857|NCT01187953|594395077|FG000|Overall Study|Adverse Event|1|||
164552858|NCT01187953|594395078|FG001|Overall Study|Adverse Event|2|||
164552859|NCT01187953|594395077|FG000|Overall Study|Lost to Follow-up|0|||
164552860|NCT01187953|594395078|FG001|Overall Study|Lost to Follow-up|3|||
164552861|NCT01187953|594395077|FG000|Overall Study|Withdrawal by Subject|3|||
164201313|NCT02065557|593110699|FG002|Maintenance Period|Lack of Efficacy|0|||
164201314|NCT02065557|593110700|FG003|Maintenance Period|Lack of Efficacy|0|||
164201315|NCT02065557|593110701|FG004|Maintenance Period|Lack of Efficacy|5|||
164201316|NCT02065557|593110702|FG005|Maintenance Period|Lack of Efficacy|2|||
164201317|NCT02065557|593110697|FG000|Maintenance Period|Subject Non-Compliance|0|||
164201318|NCT02065557|593110698|FG001|Maintenance Period|Subject Non-Compliance|0|||
164201319|NCT02065557|593110699|FG002|Maintenance Period|Subject Non-Compliance|0|||
164201320|NCT02065557|593110700|FG003|Maintenance Period|Subject Non-Compliance|0|||
164201321|NCT02065557|593110701|FG004|Maintenance Period|Subject Non-Compliance|0|||
164201322|NCT02065557|593110702|FG005|Maintenance Period|Subject Non-Compliance|1|||
164201323|NCT00250588|593110703|FG000|Overall Study|Withdrawal by Subject|3|||
164201324|NCT00250588|593110704|FG001|Overall Study|Withdrawal by Subject|6|||
164201325|NCT00250588|593110705|FG002|Overall Study|Withdrawal by Subject|0|||
164201326|NCT00250588|593110703|FG000|Overall Study|Lost to Follow-up|6|||
164201327|NCT00250588|593110704|FG001|Overall Study|Lost to Follow-up|13|||
164201328|NCT00250588|593110705|FG002|Overall Study|Lost to Follow-up|13|||
164201329|NCT02737722|593110706|FG000|Overall Study|Physician Decision|0|||
164201330|NCT02737722|593110707|FG001|Overall Study|Physician Decision|0|||
164201331|NCT02737722|593110708|FG002|Overall Study|Physician Decision|1|||
164201332|NCT02737722|593110709|FG003|Overall Study|Physician Decision|0|||
164201333|NCT01026493|593110712|FG000|Overall Study|Protocol Violation|0|||
164201334|NCT01026493|593110713|FG001|Overall Study|Protocol Violation|1|||
164201335|NCT01026493|593110714|FG002|Overall Study|Protocol Violation|0|||
164552862|NCT01187953|594395078|FG001|Overall Study|Withdrawal by Subject|3|||
164552863|NCT01783678|594396788|FG000|Overall Study|Randomized but Not Treated|0|||
164552864|NCT01783678|594396789|FG001|Overall Study|Randomized but Not Treated|0|||
164657405|NCT01098240|594770190|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
164657406|NCT01098240|594770188|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
164201336|NCT01026493|593110715|FG003|Overall Study|Protocol Violation|0|||
164201337|NCT01026493|593110716|FG004|Overall Study|Protocol Violation|2|||
164201338|NCT01026493|593110717|FG005|Overall Study|Protocol Violation|3|||
164552865|NCT01783678|594396790|FG002|Overall Study|Randomized but Not Treated|0|||
164552866|NCT01783678|594396791|FG003|Overall Study|Randomized but Not Treated|1|||
164552867|NCT01783678|594396792|FG004|Overall Study|Randomized but Not Treated|0|||
164552868|NCT01783678|594396793|FG005|Overall Study|Randomized but Not Treated|0|||
164552869|NCT01783678|594396788|FG000|Overall Study|Lack of Efficacy|1|||
164552870|NCT01783678|594396789|FG001|Overall Study|Lack of Efficacy|13|||
164657407|NCT01098240|594770189|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
164657408|NCT01098240|594770190|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
164657409|NCT01098240|594770188|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
164657410|NCT01098240|594770189|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
164657411|NCT01098240|594770190|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
164657412|NCT01098240|594770188|FG000|Double-Blind Phase|Adverse Event|0|||
164657413|NCT01098240|594770189|FG001|Double-Blind Phase|Adverse Event|3|||
164657414|NCT01098240|594770190|FG002|Double-Blind Phase|Adverse Event|3|||
164657415|NCT00628745|594770191|FG000|Overall Study|Withdrawal by Subject|63|||
164657416|NCT00628745|594770192|FG001|Overall Study|Withdrawal by Subject|3|||
164657417|NCT00628745|594770193|FG002|Overall Study|Withdrawal by Subject|9|||
164657418|NCT00628745|594770194|FG003|Overall Study|Withdrawal by Subject|2|||
164657419|NCT00628745|594770195|FG004|Overall Study|Withdrawal by Subject|69|||
164657420|NCT00628745|594770191|FG000|Overall Study|Does not meet inclusion criteria|0|||
164657421|NCT00628745|594770192|FG001|Overall Study|Does not meet inclusion criteria|12|||
164657422|NCT00628745|594770193|FG002|Overall Study|Does not meet inclusion criteria|0|||
164657423|NCT00628745|594770194|FG003|Overall Study|Does not meet inclusion criteria|0|||
164657424|NCT00628745|594770195|FG004|Overall Study|Does not meet inclusion criteria|18|||
164657425|NCT00628745|594770191|FG000|Overall Study|Participation in an interventional clinical trial|81|||
164657426|NCT00628745|594770192|FG001|Overall Study|Participation in an interventional clinical trial|4|||
164657427|NCT00628745|594770193|FG002|Overall Study|Participation in an interventional clinical trial|7|||
164657428|NCT00628745|594770194|FG003|Overall Study|Participation in an interventional clinical trial|0|||
164657429|NCT00628745|594770195|FG004|Overall Study|Participation in an interventional clinical trial|63|||
164657430|NCT00628745|594770191|FG000|Overall Study|Physician Decision|8|||
164657431|NCT00628745|594770192|FG001|Overall Study|Physician Decision|4|||
164657432|NCT00628745|594770193|FG002|Overall Study|Physician Decision|3|||
164657433|NCT00628745|594770194|FG003|Overall Study|Physician Decision|0|||
164657434|NCT00628745|594770195|FG004|Overall Study|Physician Decision|30|||
164657435|NCT00628745|594770191|FG000|Overall Study|Lost to Follow-up|109|||
164657436|NCT00628745|594770192|FG001|Overall Study|Lost to Follow-up|7|||
164657437|NCT00628745|594770193|FG002|Overall Study|Lost to Follow-up|7|||
164657438|NCT00628745|594770194|FG003|Overall Study|Lost to Follow-up|0|||
164657439|NCT00628745|594770195|FG004|Overall Study|Lost to Follow-up|498|||
164657440|NCT00628745|594770191|FG000|Overall Study|Death|197|||
164657441|NCT00628745|594770192|FG001|Overall Study|Death|81|||
164657442|NCT00628745|594770193|FG002|Overall Study|Death|12|||
164657443|NCT00628745|594770194|FG003|Overall Study|Death|4|||
164657444|NCT00628745|594770195|FG004|Overall Study|Death|939|||
164657445|NCT00628745|594770191|FG000|Overall Study|Participant transferred to another THAOS site|6|||
164657446|NCT00628745|594770192|FG001|Overall Study|Participant transferred to another THAOS site|0|||
164657447|NCT00628745|594770193|FG002|Overall Study|Participant transferred to another THAOS site|0|||
164657448|NCT00628745|594770194|FG003|Overall Study|Participant transferred to another THAOS site|0|||
164657449|NCT00628745|594770195|FG004|Overall Study|Participant transferred to another THAOS site|7|||
164657450|NCT00628745|594770191|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
164657451|NCT00628745|594770192|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
164657452|NCT00628745|594770193|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
164657453|NCT00628745|594770194|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
164657454|NCT00628745|594770195|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
164657455|NCT00628745|594770191|FG000|Overall Study|Site closure|152|||
164657456|NCT00628745|594770192|FG001|Overall Study|Site closure|146|||
164657457|NCT00628745|594770193|FG002|Overall Study|Site closure|6|||
164657458|NCT00628745|594770194|FG003|Overall Study|Site closure|8|||
164657459|NCT00628745|594770195|FG004|Overall Study|Site closure|691|||
164657460|NCT00628745|594770191|FG000|Overall Study|Duplicate participant|0|||
164657461|NCT00628745|594770192|FG001|Overall Study|Duplicate participant|0|||
164657462|NCT00628745|594770193|FG002|Overall Study|Duplicate participant|0|||
164657463|NCT00628745|594770194|FG003|Overall Study|Duplicate participant|0|||
164657464|NCT00628745|594770195|FG004|Overall Study|Duplicate participant|1|||
164657465|NCT00628745|594770191|FG000|Overall Study|Missing|4|||
164657466|NCT00628745|594770192|FG001|Overall Study|Missing|3|||
164657467|NCT00628745|594770193|FG002|Overall Study|Missing|0|||
164657468|NCT00628745|594770194|FG003|Overall Study|Missing|0|||
164657469|NCT00628745|594770195|FG004|Overall Study|Missing|10|||
164657470|NCT00628745|594770191|FG000|Overall Study|Othe reasons|987|||
164657471|NCT00628745|594770192|FG001|Overall Study|Othe reasons|373|||
164657472|NCT00628745|594770193|FG002|Overall Study|Othe reasons|105|||
164310111|NCT02722304|593509587|FG002|Overall Study|Study Terminated by Sponsor|2|||
164657473|NCT00628745|594770194|FG003|Overall Study|Othe reasons|1|||
164657474|NCT00628745|594770195|FG004|Overall Study|Othe reasons|1772|||
164657475|NCT03346538|594771966|FG000|Overall Study|Physician Decision|0|||
164657476|NCT03346538|594771967|FG001|Overall Study|Physician Decision|1|||
164657477|NCT03346538|594771968|FG002|Overall Study|Physician Decision|0|||
164657478|NCT03346538|594771966|FG000|Overall Study|Withdrawal by Subject|3|||
164657479|NCT03346538|594771967|FG001|Overall Study|Withdrawal by Subject|2|||
164657480|NCT03346538|594771968|FG002|Overall Study|Withdrawal by Subject|0|||
164657481|NCT03346538|594771966|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
164657482|NCT03346538|594771967|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
164657483|NCT03346538|594771968|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
164657484|NCT04014959|594771970|FG000|Baseline MRI and Assessments|Physician Decision|2|||
164657485|NCT04014959|594771970|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
164657486|NCT04014959|594771970|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
164657487|NCT02004847|594771972|FG000|Overall Study|Protocol Violation|1|||
164657488|NCT02004847|594771973|FG001|Overall Study|Protocol Violation|1|||
164657489|NCT02220920|594771974|FG000|Overall Study|Adverse Event|1|||
164657490|NCT02220920|594771975|FG001|Overall Study|Adverse Event|0|||
164657491|NCT02220920|594771974|FG000|Overall Study|Lack of Efficacy|0|||
164657492|NCT02220920|594771975|FG001|Overall Study|Lack of Efficacy|1|||
164657493|NCT02220920|594771974|FG000|Overall Study|Withdrawal by Subject|1|||
164657494|NCT02220920|594771975|FG001|Overall Study|Withdrawal by Subject|0|||
164657495|NCT02220920|594771974|FG000|Overall Study|Conflict with the stopping criteria|1|||
164657496|NCT02220920|594771975|FG001|Overall Study|Conflict with the stopping criteria|2|||
164657497|NCT02811861|594771989|FG000|Overall Study|Radiological Disease Progression|123|||
164657498|NCT02811861|594771990|FG001|Overall Study|Radiological Disease Progression|97|||
164657499|NCT02811861|594771991|FG002|Overall Study|Radiological Disease Progression|174|||
164657500|NCT02811861|594771989|FG000|Overall Study|Clinical Disease Progression|20|||
164657501|NCT02811861|594771990|FG001|Overall Study|Clinical Disease Progression|19|||
164657502|NCT02811861|594771991|FG002|Overall Study|Clinical Disease Progression|22|||
164657503|NCT02811861|594771989|FG000|Overall Study|Adverse Event|63|||
164657504|NCT02811861|594771990|FG001|Overall Study|Adverse Event|60|||
164657505|NCT02811861|594771991|FG002|Overall Study|Adverse Event|41|||
164657506|NCT02811861|594771989|FG000|Overall Study|Lost to Follow-up|0|||
164657507|NCT02811861|594771990|FG001|Overall Study|Lost to Follow-up|0|||
164657508|NCT02811861|594771991|FG002|Overall Study|Lost to Follow-up|1|||
164657509|NCT02811861|594771989|FG000|Overall Study|Subject Choice|29|||
164657510|NCT02811861|594771990|FG001|Overall Study|Subject Choice|17|||
164657511|NCT02811861|594771991|FG002|Overall Study|Subject Choice|23|||
164657512|NCT02811861|594771989|FG000|Overall Study|Withdrawal by Subject|4|||
164657513|NCT02811861|594771990|FG001|Overall Study|Withdrawal by Subject|4|||
164657514|NCT02811861|594771991|FG002|Overall Study|Withdrawal by Subject|9|||
164657515|NCT02811861|594771989|FG000|Overall Study|Other|4|||
164657516|NCT02811861|594771990|FG001|Overall Study|Other|13|||
164657517|NCT02811861|594771991|FG002|Overall Study|Other|3|||
164657518|NCT02811861|594771989|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
164657519|NCT02811861|594771990|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
164657520|NCT02811861|594771991|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
164657521|NCT02811861|594771989|FG000|Overall Study|Randomized but not treated|2|||
164657522|NCT02811861|594771990|FG001|Overall Study|Randomized but not treated|3|||
164657523|NCT02811861|594771991|FG002|Overall Study|Randomized but not treated|17|||
164657524|NCT04081337|594771995|FG000|Overall Study|Adverse Event|0|||
164657525|NCT04081337|594771996|FG001|Overall Study|Adverse Event|1|||
164657526|NCT04081337|594771995|FG000|Overall Study|Withdrawal by Subject|2|||
164657527|NCT04081337|594771996|FG001|Overall Study|Withdrawal by Subject|0|||
164657528|NCT04081337|594771995|FG000|Overall Study|Physician Decision|1|||
164657529|NCT04081337|594771996|FG001|Overall Study|Physician Decision|2|||
164657530|NCT04081337|594771995|FG000|Overall Study|Lost to Follow-up|1|||
164657531|NCT04081337|594771996|FG001|Overall Study|Lost to Follow-up|0|||
164657532|NCT06624072|594771997|FG000|Washout Period 1 (7 days)|Adverse Event|0|||
164657533|NCT06624072|594771998|FG001|Washout Period 1 (7 days)|Adverse Event|0|||
164657534|NCT06624072|594771999|FG002|Washout Period 1 (7 days)|Adverse Event|1|||
164657535|NCT01387737|594772012|FG000|Overall Study|Adverse Event|20|||
164657536|NCT01387737|594772013|FG001|Overall Study|Adverse Event|30|||
164657537|NCT01387737|594772012|FG000|Overall Study|Lack of Efficacy|1|||
164657538|NCT01387737|594772013|FG001|Overall Study|Lack of Efficacy|0|||
164657539|NCT01387737|594772012|FG000|Overall Study|Physician Decision|3|||
164657540|NCT01387737|594772013|FG001|Overall Study|Physician Decision|10|||
164657541|NCT01387737|594772012|FG000|Overall Study|Withdrawal by Subject|27|||
164657542|NCT01387737|594772013|FG001|Overall Study|Withdrawal by Subject|31|||
164657543|NCT01387737|594772012|FG000|Overall Study|Clearly not eligible for the study|1|||
164657544|NCT01387737|594772013|FG001|Overall Study|Clearly not eligible for the study|3|||
164657545|NCT00707954|594772015|FG000|Overall Study|Physician Decision|0|||
164657546|NCT00707954|594772016|FG001|Overall Study|Physician Decision|0|||
164657547|NCT00707954|594772017|FG002|Overall Study|Physician Decision|0|||
164657548|NCT00707954|594772018|FG003|Overall Study|Physician Decision|0|||
164657549|NCT00707954|594772019|FG004|Overall Study|Physician Decision|1|||
164657550|NCT05002569|594772022|FG000|Randomized|Withdrew Consent|3|||
164657551|NCT05002569|594772023|FG001|Randomized|Withdrew Consent|0|||
164657552|NCT05002569|594772022|FG000|Randomized|No longer meets study criteria|0|||
164657553|NCT05002569|594772023|FG001|Randomized|No longer meets study criteria|1|||
164657554|NCT05002569|594772022|FG000|Randomized|AE unrelated to study drug|1|||
164657555|NCT05002569|594772023|FG001|Randomized|AE unrelated to study drug|0|||
164657556|NCT05002569|594772022|FG000|Treatment Period|Requested to Discontinue|26|||
164657557|NCT05002569|594772023|FG001|Treatment Period|Requested to Discontinue|5|||
164657558|NCT05002569|594772022|FG000|Treatment Period|Withdrew Consent|7|||
164657559|NCT05002569|594772023|FG001|Treatment Period|Withdrew Consent|1|||
164657560|NCT05002569|594772022|FG000|Treatment Period|Study Drug Toxicity|114|||
164657561|NCT05002569|594772023|FG001|Treatment Period|Study Drug Toxicity|64|||
164657562|NCT05002569|594772022|FG000|Treatment Period|AE unrelated to study drug|6|||
164657563|NCT05002569|594772023|FG001|Treatment Period|AE unrelated to study drug|12|||
164657564|NCT05002569|594772022|FG000|Treatment Period|Disease Recurrence|102|||
164657565|NCT05002569|594772023|FG001|Treatment Period|Disease Recurrence|128|||
164657566|NCT05002569|594772022|FG000|Treatment Period|Other Reasons|4|||
164657567|NCT05002569|594772023|FG001|Treatment Period|Other Reasons|7|||
164657568|NCT05002569|594772022|FG000|Treatment Period|Death|1|||
164657569|NCT05002569|594772023|FG001|Treatment Period|Death|1|||
164657570|NCT05002569|594772022|FG000|Follow Up|Death|78|||
164657571|NCT05002569|594772023|FG001|Follow Up|Death|69|||
164657572|NCT05002569|594772022|FG000|Follow Up|Lost to Follow-up|3|||
164657573|NCT05002569|594772023|FG001|Follow Up|Lost to Follow-up|3|||
164657574|NCT05002569|594772022|FG000|Follow Up|Withdrew consent|17|||
164657575|NCT05002569|594772023|FG001|Follow Up|Withdrew consent|16|||
164657576|NCT05002569|594772022|FG000|Follow Up|Other Reasons|444|||
164657577|NCT05002569|594772023|FG001|Follow Up|Other Reasons|452|||
164657578|NCT00220701|594772029|FG000|Overall Study|Lost to Follow-up|5|||
164657579|NCT00220701|594772030|FG001|Overall Study|Lost to Follow-up|4|||
164657580|NCT04041570|594772032|FG000|Overall Study|Moved from Area|0|||
164657581|NCT04041570|594772033|FG001|Overall Study|Moved from Area|2|||
164657582|NCT05211336|594772034|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
164657583|NCT05211336|594772035|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
164657584|NCT05211336|594772034|FG000|Overall Study|Progressive disease|0|||
164657585|NCT05211336|594772035|FG001|Overall Study|Progressive disease|4|||
164201339|NCT01026493|593110718|FG006|Overall Study|Protocol Violation|4|||
164201340|NCT01026493|593110719|FG007|Overall Study|Protocol Violation|1|||
164201341|NCT02662569|593110721|FG000|Overall Study|Withdrawal by Subject|6|||
164552871|NCT01783678|594396790|FG002|Overall Study|Lack of Efficacy|1|||
164552872|NCT01783678|594396791|FG003|Overall Study|Lack of Efficacy|3|||
164552873|NCT01783678|594396792|FG004|Overall Study|Lack of Efficacy|6|||
164552874|NCT01783678|594396793|FG005|Overall Study|Lack of Efficacy|5|||
164552875|NCT01783678|594396788|FG000|Overall Study|Lost to Follow-up|0|||
164552876|NCT01783678|594396789|FG001|Overall Study|Lost to Follow-up|4|||
164552877|NCT01783678|594396790|FG002|Overall Study|Lost to Follow-up|0|||
164552878|NCT01783678|594396791|FG003|Overall Study|Lost to Follow-up|2|||
164552879|NCT01783678|594396792|FG004|Overall Study|Lost to Follow-up|1|||
164552880|NCT01783678|594396793|FG005|Overall Study|Lost to Follow-up|0|||
164552881|NCT01783678|594396788|FG000|Overall Study|Withdrew Consent|1|||
164552882|NCT01783678|594396789|FG001|Overall Study|Withdrew Consent|1|||
164552883|NCT01783678|594396790|FG002|Overall Study|Withdrew Consent|0|||
164552884|NCT01783678|594396791|FG003|Overall Study|Withdrew Consent|2|||
164552885|NCT01783678|594396792|FG004|Overall Study|Withdrew Consent|0|||
164552886|NCT01783678|594396793|FG005|Overall Study|Withdrew Consent|0|||
164552887|NCT02404103|594396794|FG000|Overall Study|Adverse Event|1|||
164552888|NCT02404103|594396795|FG001|Overall Study|Adverse Event|0|||
164552889|NCT02404103|594396794|FG000|Overall Study|Lost to Follow-up|3|||
164552890|NCT02404103|594396795|FG001|Overall Study|Lost to Follow-up|3|||
164552891|NCT01408147|594396796|FG000|Overall Study|Withdrawal by Subject|0|||
164552892|NCT01408147|594396797|FG001|Overall Study|Withdrawal by Subject|1|||
164552893|NCT00621504|594396798|FG000|Overall Study|Adverse Event|1|||
164552894|NCT00621504|594396799|FG001|Overall Study|Adverse Event|3|||
164552895|NCT00621504|594396798|FG000|Overall Study|At the request of sponsor/investigator|1|||
164552896|NCT00621504|594396799|FG001|Overall Study|At the request of sponsor/investigator|0|||
164552897|NCT00621504|594396798|FG000|Overall Study|Withdrew consent|9|||
164552898|NCT00621504|594396799|FG001|Overall Study|Withdrew consent|6|||
164552899|NCT00621504|594396798|FG000|Overall Study|Lost to Follow-up|8|||
164552900|NCT00621504|594396799|FG001|Overall Study|Lost to Follow-up|10|||
164552901|NCT00621504|594396798|FG000|Overall Study|Other|1|||
164552902|NCT00621504|594396799|FG001|Overall Study|Other|0|||
164552903|NCT00621504|594396798|FG000|Overall Study|Death|6|||
164552904|NCT00621504|594396799|FG001|Overall Study|Death|6|||
164552905|NCT03311711|594396802|FG000|Overall Study|Death|1|||
164552906|NCT03311711|594396803|FG001|Overall Study|Death|0|||
164552907|NCT03311711|594396804|FG002|Overall Study|Death|0|||
164552908|NCT03311711|594396805|FG003|Overall Study|Death|0|||
164657586|NCT05211336|594772034|FG000|Overall Study|Death due to myocardial infarction|0|||
164657587|NCT05211336|594772035|FG001|Overall Study|Death due to myocardial infarction|1|||
164657588|NCT05211336|594772034|FG000|Overall Study|Death due to unknown cause|0|||
164657589|NCT05211336|594772035|FG001|Overall Study|Death due to unknown cause|1|||
164657590|NCT05211336|594772034|FG000|Overall Study|Worsening kidney function and quality of response|0|||
164657591|NCT05211336|594772035|FG001|Overall Study|Worsening kidney function and quality of response|1|||
164552909|NCT03311711|594396806|FG004|Overall Study|Death|0|||
164552910|NCT03311711|594396807|FG005|Overall Study|Death|0|||
164552911|NCT03311711|594396808|FG006|Overall Study|Death|1|||
164552912|NCT03311711|594396809|FG007|Overall Study|Death|0|||
164552913|NCT03311711|594396810|FG008|Overall Study|Death|1|||
164552914|NCT03311711|594396811|FG009|Overall Study|Death|0|||
164552915|NCT03311711|594396802|FG000|Overall Study|Death of dyad partner|0|||
164552916|NCT03311711|594396803|FG001|Overall Study|Death of dyad partner|1|||
164552917|NCT03311711|594396804|FG002|Overall Study|Death of dyad partner|0|||
164552918|NCT03311711|594396805|FG003|Overall Study|Death of dyad partner|0|||
164552919|NCT03311711|594396806|FG004|Overall Study|Death of dyad partner|0|||
164552920|NCT03311711|594396807|FG005|Overall Study|Death of dyad partner|0|||
164552921|NCT03311711|594396808|FG006|Overall Study|Death of dyad partner|0|||
164552922|NCT03311711|594396809|FG007|Overall Study|Death of dyad partner|1|||
164552923|NCT03311711|594396810|FG008|Overall Study|Death of dyad partner|0|||
164552924|NCT03311711|594396811|FG009|Overall Study|Death of dyad partner|1|||
164552925|NCT03311711|594396802|FG000|Overall Study|Lost to Follow-up|2|||
164552926|NCT03311711|594396803|FG001|Overall Study|Lost to Follow-up|2|||
164552927|NCT03311711|594396804|FG002|Overall Study|Lost to Follow-up|0|||
164552928|NCT03311711|594396805|FG003|Overall Study|Lost to Follow-up|0|||
164552929|NCT03311711|594396806|FG004|Overall Study|Lost to Follow-up|0|||
164552930|NCT03311711|594396807|FG005|Overall Study|Lost to Follow-up|0|||
164552931|NCT03311711|594396808|FG006|Overall Study|Lost to Follow-up|1|||
164552932|NCT03311711|594396809|FG007|Overall Study|Lost to Follow-up|1|||
164552933|NCT03311711|594396810|FG008|Overall Study|Lost to Follow-up|0|||
164552934|NCT03311711|594396811|FG009|Overall Study|Lost to Follow-up|0|||
164552935|NCT03311711|594396802|FG000|Overall Study|Withdrawal by Subject|1|||
164552936|NCT03311711|594396803|FG001|Overall Study|Withdrawal by Subject|1|||
164552937|NCT03311711|594396804|FG002|Overall Study|Withdrawal by Subject|0|||
164552938|NCT03311711|594396805|FG003|Overall Study|Withdrawal by Subject|0|||
164552939|NCT03311711|594396806|FG004|Overall Study|Withdrawal by Subject|0|||
164552940|NCT03311711|594396807|FG005|Overall Study|Withdrawal by Subject|0|||
164552941|NCT03311711|594396808|FG006|Overall Study|Withdrawal by Subject|3|||
164552942|NCT03311711|594396809|FG007|Overall Study|Withdrawal by Subject|3|||
164552943|NCT03311711|594396810|FG008|Overall Study|Withdrawal by Subject|0|||
164552944|NCT03311711|594396811|FG009|Overall Study|Withdrawal by Subject|0|||
164552945|NCT02229552|594396812|FG000|Baseline|Withdrawal by Subject|6|||
164552946|NCT02229552|594396812|FG000|1-year Follow up|Withdrawal by Subject|7|||
164552947|NCT02229552|594396812|FG000|1-year Follow up|Lost to Follow-up|18|||
164552948|NCT02229552|594396812|FG000|2-Year Follow up|Withdrawal by Subject|9|||
164552949|NCT02229552|594396812|FG000|2-Year Follow up|Lost to Follow-up|17|||
164552950|NCT00706134|594396817|FG000|Overall Study|Adverse Event|8|||
164552951|NCT00706134|594396818|FG001|Overall Study|Adverse Event|7|||
164552952|NCT00706134|594396819|FG002|Overall Study|Adverse Event|2|||
164552953|NCT00706134|594396820|FG003|Overall Study|Adverse Event|3|||
164552954|NCT00706134|594396817|FG000|Overall Study|Lost to Follow-up|0|||
164552955|NCT00706134|594396818|FG001|Overall Study|Lost to Follow-up|1|||
164552956|NCT00706134|594396819|FG002|Overall Study|Lost to Follow-up|0|||
164552957|NCT00706134|594396820|FG003|Overall Study|Lost to Follow-up|0|||
164552958|NCT00706134|594396817|FG000|Overall Study|Protocol Violation|0|||
164552959|NCT00706134|594396818|FG001|Overall Study|Protocol Violation|6|||
164552960|NCT00706134|594396819|FG002|Overall Study|Protocol Violation|0|||
164552961|NCT00706134|594396820|FG003|Overall Study|Protocol Violation|3|||
164552962|NCT00706134|594396817|FG000|Overall Study|Withdrawal by Subject|1|||
164552963|NCT00706134|594396818|FG001|Overall Study|Withdrawal by Subject|2|||
164552964|NCT00706134|594396819|FG002|Overall Study|Withdrawal by Subject|1|||
164552965|NCT00706134|594396820|FG003|Overall Study|Withdrawal by Subject|0|||
164552966|NCT00706134|594396817|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
164552967|NCT00706134|594396818|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
164552968|NCT00706134|594396819|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
164552969|NCT00706134|594396820|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
164552970|NCT00706134|594396817|FG000|Overall Study|Did not meet study criteria|2|||
164552971|NCT00706134|594396818|FG001|Overall Study|Did not meet study criteria|0|||
164552972|NCT00706134|594396819|FG002|Overall Study|Did not meet study criteria|0|||
164552973|NCT00706134|594396820|FG003|Overall Study|Did not meet study criteria|0|||
164552974|NCT00772954|594396830|FG000|Overall Study|Adverse Event|0|||
164552975|NCT00772954|594396831|FG001|Overall Study|Adverse Event|0|||
164552976|NCT00772954|594396832|FG002|Overall Study|Adverse Event|1|||
164552977|NCT01661140|594396835|FG000|Open-Label Period|Adverse Event|44|||
164552978|NCT01661140|594396836|FG001|Open-Label Period|Adverse Event|0|||
164552979|NCT01661140|594396837|FG002|Open-Label Period|Adverse Event|0|||
164552980|NCT01661140|594396835|FG000|Open-Label Period|Protocol Violation|3|||
164552981|NCT01661140|594396836|FG001|Open-Label Period|Protocol Violation|0|||
164552982|NCT01661140|594396837|FG002|Open-Label Period|Protocol Violation|0|||
164552983|NCT01661140|594396835|FG000|Open-Label Period|Withdrawal by Subject|5|||
164552984|NCT01661140|594396836|FG001|Open-Label Period|Withdrawal by Subject|0|||
164552985|NCT01661140|594396837|FG002|Open-Label Period|Withdrawal by Subject|0|||
164552986|NCT01661140|594396835|FG000|Open-Label Period|Investigator Decision|3|||
164657592|NCT02337829|594772036|FG000|Overall Study|Death|0|||
164657593|NCT02337829|594772037|FG001|Overall Study|Death|1|||
164657594|NCT02337829|594772038|FG002|Overall Study|Death|0|||
164657595|NCT02337829|594772039|FG003|Overall Study|Death|0|||
164657596|NCT02337829|594772036|FG000|Overall Study|Study terminated by sponsor|12|||
164657597|NCT02337829|594772037|FG001|Overall Study|Study terminated by sponsor|10|||
164657598|NCT02337829|594772038|FG002|Overall Study|Study terminated by sponsor|5|||
164657599|NCT02337829|594772039|FG003|Overall Study|Study terminated by sponsor|6|||
164657600|NCT02337829|594772036|FG000|Overall Study|discontinued for other reasons|6|||
164657601|NCT02337829|594772037|FG001|Overall Study|discontinued for other reasons|3|||
164657602|NCT02337829|594772038|FG002|Overall Study|discontinued for other reasons|1|||
164657603|NCT02337829|594772039|FG003|Overall Study|discontinued for other reasons|4|||
164657604|NCT01418352|594772040|FG000|Overall Study|Lost to Follow-up|2|||
164657605|NCT01418352|594772041|FG001|Overall Study|Lost to Follow-up|0|||
164657606|NCT01418352|594772042|FG002|Overall Study|Lost to Follow-up|0|||
164657607|NCT01418352|594772043|FG003|Overall Study|Lost to Follow-up|0|||
164657608|NCT01418352|594772040|FG000|Overall Study|Adverse Event|0|||
164657609|NCT01418352|594772041|FG001|Overall Study|Adverse Event|1|||
164657610|NCT01418352|594772042|FG002|Overall Study|Adverse Event|0|||
164657611|NCT01418352|594772043|FG003|Overall Study|Adverse Event|0|||
164657612|NCT01418352|594772040|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
164657613|NCT01418352|594772041|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
164657614|NCT01418352|594772042|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
164657615|NCT01418352|594772043|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
164552987|NCT01661140|594396836|FG001|Open-Label Period|Investigator Decision|0|||
164552988|NCT01661140|594396837|FG002|Open-Label Period|Investigator Decision|0|||
164552989|NCT01661140|594396835|FG000|Open-Label Period|Death|1|||
164552990|NCT01661140|594396836|FG001|Open-Label Period|Death|0|||
164552991|NCT01661140|594396837|FG002|Open-Label Period|Death|0|||
164552992|NCT01661140|594396835|FG000|Open-Label Period|Administrative/Other|1|||
164552993|NCT01661140|594396836|FG001|Open-Label Period|Administrative/Other|0|||
164552994|NCT01661140|594396837|FG002|Open-Label Period|Administrative/Other|0|||
164552995|NCT01661140|594396835|FG000|Open-Label Period|Sponsor termination|16|||
164552996|NCT01661140|594396836|FG001|Open-Label Period|Sponsor termination|0|||
164552997|NCT01661140|594396837|FG002|Open-Label Period|Sponsor termination|0|||
164552998|NCT01661140|594396835|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
164552999|NCT01661140|594396836|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
164553000|NCT01661140|594396837|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
164553001|NCT01661140|594396835|FG000|Open-Label Period|Lost to Follow-up|2|||
164553002|NCT01661140|594396836|FG001|Open-Label Period|Lost to Follow-up|0|||
164553003|NCT01661140|594396837|FG002|Open-Label Period|Lost to Follow-up|0|||
164553004|NCT01661140|594396835|FG000|Double-Blind Period|Refused Treatment|0|||
164553005|NCT01661140|594396836|FG001|Double-Blind Period|Refused Treatment|0|||
164553006|NCT01661140|594396837|FG002|Double-Blind Period|Refused Treatment|1|||
164553007|NCT01661140|594396835|FG000|Double-Blind Period|Adverse Event|0|||
164553008|NCT01661140|594396836|FG001|Double-Blind Period|Adverse Event|16|||
164553009|NCT01661140|594396837|FG002|Double-Blind Period|Adverse Event|18|||
164553010|NCT01661140|594396835|FG000|Double-Blind Period|Protocol Violation|0|||
164553011|NCT01661140|594396836|FG001|Double-Blind Period|Protocol Violation|2|||
164553012|NCT01661140|594396837|FG002|Double-Blind Period|Protocol Violation|3|||
164553013|NCT01661140|594396835|FG000|Double-Blind Period|Withdrawal by Subject|0|||
164553014|NCT01661140|594396836|FG001|Double-Blind Period|Withdrawal by Subject|1|||
164553015|NCT01661140|594396837|FG002|Double-Blind Period|Withdrawal by Subject|3|||
164553016|NCT01661140|594396835|FG000|Double-Blind Period|Investigator's Decision|0|||
164553017|NCT01661140|594396836|FG001|Double-Blind Period|Investigator's Decision|1|||
164553018|NCT01661140|594396837|FG002|Double-Blind Period|Investigator's Decision|2|||
164553019|NCT01661140|594396835|FG000|Double-Blind Period|Sponsor Termination|0|||
164553020|NCT01661140|594396836|FG001|Double-Blind Period|Sponsor Termination|14|||
164553021|NCT01661140|594396837|FG002|Double-Blind Period|Sponsor Termination|17|||
164553022|NCT01661140|594396835|FG000|Double-Blind Period|Administrative/Other|0|||
164553023|NCT01661140|594396836|FG001|Double-Blind Period|Administrative/Other|7|||
164553024|NCT01661140|594396837|FG002|Double-Blind Period|Administrative/Other|6|||
164553025|NCT01391000|594396838|FG000|Overall Study|Lost to Follow-up|2|||
164657616|NCT01418352|594772040|FG000|Overall Study|Subject Withdrew Consent|0|||
164657617|NCT01418352|594772041|FG001|Overall Study|Subject Withdrew Consent|1|||
164657618|NCT01418352|594772042|FG002|Overall Study|Subject Withdrew Consent|2|||
164657619|NCT01418352|594772043|FG003|Overall Study|Subject Withdrew Consent|1|||
164310112|NCT02722304|593509588|FG003|Overall Study|Study Terminated by Sponsor|1|||
164310113|NCT02722304|593509589|FG004|Overall Study|Study Terminated by Sponsor|1|||
164553026|NCT01391000|594396839|FG001|Overall Study|Lost to Follow-up|0|||
164553027|NCT02239939|594396840|FG000|Overall Study|Adverse Event|1|||
164553028|NCT02239939|594396841|FG001|Overall Study|Adverse Event|0|||
164553029|NCT02239939|594396840|FG000|Overall Study|Withdrawal by Subject|1|||
164553030|NCT02239939|594396841|FG001|Overall Study|Withdrawal by Subject|1|||
164553031|NCT02239939|594396840|FG000|Overall Study|Lost to Follow-up|0|||
164657620|NCT01418352|594772040|FG000|Overall Study|Protocol Deviation|0|||
164657621|NCT01418352|594772041|FG001|Overall Study|Protocol Deviation|0|||
164657622|NCT01418352|594772042|FG002|Overall Study|Protocol Deviation|1|||
164657623|NCT01418352|594772043|FG003|Overall Study|Protocol Deviation|0|||
164657624|NCT01418352|594772040|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
164657625|NCT01418352|594772041|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
164657626|NCT01418352|594772042|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
164657627|NCT01418352|594772043|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
164657628|NCT00619619|594772044|FG000|Overall Study|Physician Decision|0|||
164657629|NCT00619619|594772045|FG001|Overall Study|Physician Decision|0|||
164657630|NCT00619619|594772046|FG002|Overall Study|Physician Decision|1|||
164657631|NCT00619619|594772047|FG003|Overall Study|Physician Decision|0|||
164657632|NCT00619619|594772048|FG004|Overall Study|Physician Decision|0|||
164657633|NCT00619619|594772049|FG005|Overall Study|Physician Decision|0|||
164657634|NCT00619619|594772050|FG006|Overall Study|Physician Decision|0|||
164657635|NCT00619619|594772051|FG007|Overall Study|Physician Decision|0|||
164657636|NCT00619619|594772044|FG000|Overall Study|Protocol Violation|0|||
164657637|NCT00619619|594772045|FG001|Overall Study|Protocol Violation|0|||
164657638|NCT00619619|594772046|FG002|Overall Study|Protocol Violation|0|||
164657639|NCT00619619|594772047|FG003|Overall Study|Protocol Violation|1|||
164657640|NCT00619619|594772048|FG004|Overall Study|Protocol Violation|0|||
164657641|NCT00619619|594772049|FG005|Overall Study|Protocol Violation|0|||
164657642|NCT00619619|594772050|FG006|Overall Study|Protocol Violation|1|||
164657643|NCT00619619|594772051|FG007|Overall Study|Protocol Violation|1|||
164657644|NCT00619619|594772044|FG000|Overall Study|Adverse Event|0|||
164657645|NCT00619619|594772045|FG001|Overall Study|Adverse Event|0|||
164657646|NCT00619619|594772046|FG002|Overall Study|Adverse Event|0|||
164657647|NCT00619619|594772047|FG003|Overall Study|Adverse Event|0|||
164657648|NCT00619619|594772048|FG004|Overall Study|Adverse Event|2|||
164657649|NCT00619619|594772049|FG005|Overall Study|Adverse Event|0|||
164657650|NCT00619619|594772050|FG006|Overall Study|Adverse Event|0|||
164657651|NCT00619619|594772051|FG007|Overall Study|Adverse Event|2|||
164657652|NCT01992107|594772054|FG000|Overall Study|Administrative reasons|2|||
164201342|NCT02662569|593110722|FG001|Overall Study|Withdrawal by Subject|1|||
164201343|NCT02662569|593110723|FG002|Overall Study|Withdrawal by Subject|6|||
164201344|NCT02662569|593110724|FG003|Overall Study|Withdrawal by Subject|4|||
164201345|NCT02662569|593110721|FG000|Overall Study|Lost to Follow-up|1|||
164201346|NCT02662569|593110722|FG001|Overall Study|Lost to Follow-up|0|||
164201347|NCT02662569|593110723|FG002|Overall Study|Lost to Follow-up|0|||
164201348|NCT02662569|593110724|FG003|Overall Study|Lost to Follow-up|0|||
164201349|NCT03154086|593110727|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164657653|NCT01992107|594772055|FG001|Overall Study|Administrative reasons|0|||
164657654|NCT01992107|594772056|FG002|Overall Study|Administrative reasons|0|||
164657655|NCT01992107|594772054|FG000|Overall Study|Adverse Event|0|||
164657656|NCT01992107|594772055|FG001|Overall Study|Adverse Event|1|||
164657657|NCT01992107|594772056|FG002|Overall Study|Adverse Event|0|||
164657658|NCT01992107|594772054|FG000|Overall Study|Lost to Follow-up|46|||
164657659|NCT01992107|594772055|FG001|Overall Study|Lost to Follow-up|22|||
164657660|NCT01992107|594772056|FG002|Overall Study|Lost to Follow-up|26|||
164657661|NCT01992107|594772054|FG000|Overall Study|noncompliance and were unavailable|7|||
164657662|NCT01992107|594772055|FG001|Overall Study|noncompliance and were unavailable|3|||
164657663|NCT01992107|594772056|FG002|Overall Study|noncompliance and were unavailable|2|||
164657664|NCT01992107|594772054|FG000|Overall Study|Withdrawal by Subject|13|||
164657665|NCT01992107|594772055|FG001|Overall Study|Withdrawal by Subject|7|||
164201350|NCT03154086|593110728|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164201351|NCT03154086|593110729|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164201352|NCT03154086|593110730|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
164657666|NCT01992107|594772056|FG002|Overall Study|Withdrawal by Subject|8|||
164657667|NCT02022007|594772057|FG000|Overall Study|Withdrawal by Subject|1|||
164657668|NCT02022007|594772058|FG001|Overall Study|Withdrawal by Subject|1|||
164657669|NCT02022007|594772059|FG002|Overall Study|Withdrawal by Subject|1|||
164657670|NCT02022007|594772057|FG000|Overall Study|Noncompliant|0|||
164657671|NCT02022007|594772058|FG001|Overall Study|Noncompliant|0|||
164657672|NCT02022007|594772059|FG002|Overall Study|Noncompliant|1|||
164201353|NCT03154086|593110731|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164201354|NCT03154086|593110732|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164657673|NCT01214603|594772060|FG000|Overall Study|Adverse Event|0|||
164657674|NCT01214603|594772061|FG001|Overall Study|Adverse Event|0|||
164657675|NCT01214603|594772062|FG002|Overall Study|Adverse Event|1|||
164657676|NCT01214603|594772060|FG000|Overall Study|Death|1|||
164657677|NCT01214603|594772061|FG001|Overall Study|Death|0|||
164201355|NCT03154086|593110733|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164657678|NCT01214603|594772062|FG002|Overall Study|Death|0|||
164657679|NCT01214603|594772060|FG000|Overall Study|Progressive Disease|4|||
164657680|NCT01214603|594772061|FG001|Overall Study|Progressive Disease|1|||
164657681|NCT01214603|594772062|FG002|Overall Study|Progressive Disease|3|||
164657682|NCT01507896|594772063|FG000|Overall Study|Withdrawal by Subject|1|||
164657683|NCT01507896|594772063|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
164657684|NCT00446654|594772071|FG000|Overall Study|Withdrawal by Subject|1|||
164657685|NCT00446654|594772072|FG001|Overall Study|Withdrawal by Subject|0|||
164657686|NCT00446654|594772071|FG000|Overall Study|Adverse Event|1|||
164657687|NCT00446654|594772072|FG001|Overall Study|Adverse Event|0|||
164657688|NCT01875445|594772076|FG000|Overall Study|Lost to Follow-up|5|||
164657689|NCT01875445|594772077|FG001|Overall Study|Lost to Follow-up|0|||
164657690|NCT01875445|594772076|FG000|Overall Study|Withdrawal by Subject|2|||
164657691|NCT01875445|594772077|FG001|Overall Study|Withdrawal by Subject|0|||
164657692|NCT01102777|594772078|FG000|Overall Study|Death|2|||
164657693|NCT01102777|594772079|FG001|Overall Study|Death|6|||
164657694|NCT01102777|594772078|FG000|Overall Study|Lost to Follow-up|7|||
164657695|NCT01102777|594772079|FG001|Overall Study|Lost to Follow-up|10|||
164657696|NCT04029090|594772080|FG000|Overall Study|Protocol Violation|1|||
164657697|NCT04029090|594772081|FG001|Overall Study|Protocol Violation|0|||
164657698|NCT04029090|594772082|FG002|Overall Study|Protocol Violation|0|||
164657699|NCT04029090|594772080|FG000|Overall Study|Withdrawal by Subject|0|||
164657700|NCT04029090|594772081|FG001|Overall Study|Withdrawal by Subject|1|||
164657701|NCT04029090|594772082|FG002|Overall Study|Withdrawal by Subject|0|||
164657702|NCT00501046|594772083|FG000|Overall Study|Adverse Event|21|||
164657703|NCT00501046|594772084|FG001|Overall Study|Adverse Event|25|||
164657704|NCT00501046|594772083|FG000|Overall Study|Death|23|||
164657705|NCT00501046|594772084|FG001|Overall Study|Death|30|||
164657706|NCT00501046|594772083|FG000|Overall Study|Lost to Follow-up|14|||
164657707|NCT00501046|594772084|FG001|Overall Study|Lost to Follow-up|13|||
164657708|NCT00501046|594772083|FG000|Overall Study|Physician Decision|7|||
164657709|NCT00501046|594772084|FG001|Overall Study|Physician Decision|2|||
164657710|NCT00501046|594772083|FG000|Overall Study|Pregnancy|0|||
164657711|NCT00501046|594772084|FG001|Overall Study|Pregnancy|3|||
164657712|NCT00501046|594772083|FG000|Overall Study|Protocol Violation|2|||
164657713|NCT00501046|594772084|FG001|Overall Study|Protocol Violation|1|||
164657714|NCT00501046|594772083|FG000|Overall Study|Withdrawal by Subject|84|||
164657715|NCT00501046|594772084|FG001|Overall Study|Withdrawal by Subject|83|||
164657716|NCT00501046|594772083|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
164657717|NCT00501046|594772084|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
164657718|NCT05056727|594772085|FG000|Initiation Phase|Lost to Follow-up|1|||
164657719|NCT05056727|594772086|FG001|Initiation Phase|Lost to Follow-up|0|||
164201356|NCT03154086|593110734|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164201357|NCT03154086|593110735|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164201358|NCT03154086|593110736|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164201359|NCT03154086|593110737|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164201360|NCT03154086|593110738|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164201361|NCT03154086|593110739|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164201362|NCT03154086|593110740|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164201363|NCT03154086|593110741|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164201364|NCT03154086|593110727|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201365|NCT03154086|593110728|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
164201366|NCT03154086|593110729|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201367|NCT03154086|593110730|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201368|NCT03154086|593110731|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201369|NCT03154086|593110732|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201370|NCT03154086|593110733|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201371|NCT03154086|593110734|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201372|NCT03154086|593110735|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201373|NCT03154086|593110736|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164302362|NCT03755934|593482604|FG002|Overall Study|Adverse Event|1|||
164657720|NCT05056727|594772087|FG002|Initiation Phase|Lost to Follow-up|0|||
164657721|NCT05056727|594772088|FG003|Initiation Phase|Lost to Follow-up|0|||
164657722|NCT05056727|594772085|FG000|Initiation Phase|Study-specific; Study terminated; Other|20|||
164657723|NCT05056727|594772086|FG001|Initiation Phase|Study-specific; Study terminated; Other|0|||
164657724|NCT05056727|594772087|FG002|Initiation Phase|Study-specific; Study terminated; Other|0|||
164657725|NCT05056727|594772088|FG003|Initiation Phase|Study-specific; Study terminated; Other|0|||
164657726|NCT05056727|594772085|FG000|Initiation Phase|Withdrawal by Subject|9|||
164657727|NCT05056727|594772086|FG001|Initiation Phase|Withdrawal by Subject|0|||
164657728|NCT05056727|594772087|FG002|Initiation Phase|Withdrawal by Subject|0|||
164657729|NCT05056727|594772088|FG003|Initiation Phase|Withdrawal by Subject|0|||
164657730|NCT05056727|594772085|FG000|Initiation Phase|Physician Decision|4|||
164657731|NCT05056727|594772086|FG001|Initiation Phase|Physician Decision|0|||
164657732|NCT05056727|594772087|FG002|Initiation Phase|Physician Decision|0|||
164657733|NCT05056727|594772088|FG003|Initiation Phase|Physician Decision|0|||
164657734|NCT05056727|594772085|FG000|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
164657735|NCT05056727|594772086|FG001|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|237|||
164657736|NCT05056727|594772087|FG002|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
164657737|NCT05056727|594772088|FG003|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
164657738|NCT05056727|594772085|FG000|Run-in Phase|Death|0|||
164657739|NCT05056727|594772086|FG001|Run-in Phase|Death|3|||
164657740|NCT05056727|594772087|FG002|Run-in Phase|Death|0|||
164657741|NCT05056727|594772088|FG003|Run-in Phase|Death|0|||
164657742|NCT05056727|594772085|FG000|Run-in Phase|Withdrawal by Subject|0|||
164657743|NCT05056727|594772086|FG001|Run-in Phase|Withdrawal by Subject|25|||
164657744|NCT05056727|594772087|FG002|Run-in Phase|Withdrawal by Subject|0|||
164657745|NCT05056727|594772088|FG003|Run-in Phase|Withdrawal by Subject|0|||
164657746|NCT05056727|594772085|FG000|Run-in Phase|Physician Decision|0|||
164657747|NCT05056727|594772086|FG001|Run-in Phase|Physician Decision|20|||
164657748|NCT05056727|594772087|FG002|Run-in Phase|Physician Decision|0|||
164657749|NCT05056727|594772088|FG003|Run-in Phase|Physician Decision|0|||
164657750|NCT05056727|594772085|FG000|Run-in Phase|Lost to Follow-up|0|||
164657751|NCT05056727|594772086|FG001|Run-in Phase|Lost to Follow-up|1|||
164657752|NCT05056727|594772087|FG002|Run-in Phase|Lost to Follow-up|0|||
164657753|NCT05056727|594772088|FG003|Run-in Phase|Lost to Follow-up|0|||
164657754|NCT05056727|594772085|FG000|Maintenance Phase|Site terminated; Study terminated; Other|0|||
164657755|NCT05056727|594772086|FG001|Maintenance Phase|Site terminated; Study terminated; Other|0|||
164657756|NCT05056727|594772087|FG002|Maintenance Phase|Site terminated; Study terminated; Other|332|||
164657757|NCT05056727|594772088|FG003|Maintenance Phase|Site terminated; Study terminated; Other|314|||
164657758|NCT05056727|594772085|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164657759|NCT05056727|594772086|FG001|Maintenance Phase|Withdrawal by Subject|0|||
164657760|NCT05056727|594772087|FG002|Maintenance Phase|Withdrawal by Subject|19|||
164657761|NCT05056727|594772088|FG003|Maintenance Phase|Withdrawal by Subject|21|||
164657762|NCT05056727|594772085|FG000|Maintenance Phase|Physician Decision|0|||
164657763|NCT05056727|594772086|FG001|Maintenance Phase|Physician Decision|0|||
164657764|NCT05056727|594772087|FG002|Maintenance Phase|Physician Decision|4|||
164657765|NCT05056727|594772088|FG003|Maintenance Phase|Physician Decision|16|||
164657766|NCT05056727|594772085|FG000|Maintenance Phase|Lost to Follow-up|0|||
164657767|NCT05056727|594772086|FG001|Maintenance Phase|Lost to Follow-up|0|||
164657768|NCT05056727|594772087|FG002|Maintenance Phase|Lost to Follow-up|2|||
164657769|NCT05056727|594772088|FG003|Maintenance Phase|Lost to Follow-up|2|||
164657770|NCT05056727|594772085|FG000|Maintenance Phase|Death|0|||
164657771|NCT05056727|594772086|FG001|Maintenance Phase|Death|0|||
164657772|NCT05056727|594772087|FG002|Maintenance Phase|Death|4|||
164657773|NCT05056727|594772088|FG003|Maintenance Phase|Death|2|||
164657774|NCT02622113|594772089|FG000|Overall Study|Adverse Event|4|||
164657775|NCT02622113|594772090|FG001|Overall Study|Adverse Event|4|||
164657776|NCT02622113|594772089|FG000|Overall Study|Physician Decision|0|||
164657777|NCT02622113|594772090|FG001|Overall Study|Physician Decision|1|||
164657778|NCT02622113|594772089|FG000|Overall Study|Withdrawal by Subject|0|||
164657779|NCT02622113|594772090|FG001|Overall Study|Withdrawal by Subject|2|||
164657780|NCT02622113|594772089|FG000|Overall Study|Stopping Criteria|1|||
164657781|NCT02622113|594772090|FG001|Overall Study|Stopping Criteria|3|||
164657782|NCT03289208|594772092|FG000|Overall Study|Adverse Event|1|||
164657783|NCT03289208|594772093|FG001|Overall Study|Adverse Event|0|||
164657784|NCT03289208|594772094|FG002|Overall Study|Adverse Event|0|||
164657785|NCT01840605|594772096|FG000|Overall Study|Adverse Event|0|||
164657786|NCT01840605|594772097|FG001|Overall Study|Adverse Event|1|||
164657787|NCT01840605|594772096|FG000|Overall Study|Physician Decision|2|||
164553032|NCT02239939|594396841|FG001|Overall Study|Lost to Follow-up|1|||
164553033|NCT05594173|594396843|FG000|Overall Study|Adverse Event|1|||
164553034|NCT05594173|594396843|FG000|Overall Study|COVID-19 Pandemic|2|||
164553035|NCT00763139|594396844|FG000|Overall Study|Adverse Event|4|||
164553036|NCT00763139|594396845|FG001|Overall Study|Adverse Event|2|||
164553037|NCT00763139|594396844|FG000|Overall Study|Withdrawal by Subject|0|||
164553038|NCT00763139|594396845|FG001|Overall Study|Withdrawal by Subject|1|||
164553039|NCT00763139|594396844|FG000|Overall Study|med change not allowed by protocol|1|||
164553040|NCT00763139|594396845|FG001|Overall Study|med change not allowed by protocol|0|||
164553041|NCT05634577|594396846|FG000|Overall Study|Lost to Follow-up|1|||
164657788|NCT01840605|594772097|FG001|Overall Study|Physician Decision|1|||
164657789|NCT05308472|594772098|FG000|Overall Study|Adverse Event|0|||
164657790|NCT05308472|594772099|FG001|Overall Study|Adverse Event|0|||
164657791|NCT05308472|594772100|FG002|Overall Study|Adverse Event|3|||
164657792|NCT03469271|594772101|FG000|Overall Study|Withdrawal by Subject|2|||
164657793|NCT03469271|594772102|FG001|Overall Study|Withdrawal by Subject|0|||
164657794|NCT03469271|594772103|FG002|Overall Study|Withdrawal by Subject|0|||
164657795|NCT03469271|594772104|FG003|Overall Study|Withdrawal by Subject|1|||
164553042|NCT05634577|594396846|FG000|Overall Study|Withdrawal by Subject|1|||
164657796|NCT03760510|594772106|FG000|Overall Study|Not ventilated for 24 hours|105|||
164657797|NCT03760510|594772107|FG001|Overall Study|Not ventilated for 24 hours|97|||
164657798|NCT04147715|594772109|FG000|Overall Study|Adverse Event|0|||
164657799|NCT04147715|594772110|FG001|Overall Study|Adverse Event|0|||
164657800|NCT04147715|594772111|FG002|Overall Study|Adverse Event|0|||
164553043|NCT02095535|594396847|FG000|Recruitment|Protocol Violation|2|||
164657801|NCT04147715|594772112|FG003|Overall Study|Adverse Event|0|||
164657802|NCT04147715|594772113|FG004|Overall Study|Adverse Event|0|||
164657803|NCT04147715|594772114|FG005|Overall Study|Adverse Event|0|||
164657804|NCT04147715|594772115|FG006|Overall Study|Adverse Event|0|||
164657805|NCT04147715|594772116|FG007|Overall Study|Adverse Event|2|||
164657806|NCT04147715|594772117|FG008|Overall Study|Adverse Event|1|||
164657807|NCT04147715|594772118|FG009|Overall Study|Adverse Event|0|||
164657808|NCT04147715|594772119|FG010|Overall Study|Adverse Event|0|||
164657809|NCT04147715|594772120|FG011|Overall Study|Adverse Event|0|||
164657810|NCT00895583|594772125|FG000|Overall Study|Adverse Event|28|||
164657811|NCT00895583|594772126|FG001|Overall Study|Adverse Event|4|||
164657812|NCT00895583|594772125|FG000|Overall Study|Death|2|||
164657813|NCT00895583|594772126|FG001|Overall Study|Death|1|||
164657814|NCT00895583|594772125|FG000|Overall Study|Physician Decision|3|||
164657815|NCT00895583|594772126|FG001|Overall Study|Physician Decision|1|||
164657816|NCT00895583|594772125|FG000|Overall Study|Lost to Follow-up|1|||
164657817|NCT00895583|594772126|FG001|Overall Study|Lost to Follow-up|3|||
164657818|NCT00895583|594772125|FG000|Overall Study|Protocol Violation|1|||
164657819|NCT00895583|594772126|FG001|Overall Study|Protocol Violation|0|||
164657820|NCT00895583|594772125|FG000|Overall Study|Withdrawal by Subject|4|||
164657821|NCT00895583|594772126|FG001|Overall Study|Withdrawal by Subject|2|||
164657822|NCT00895583|594772125|FG000|Overall Study|Lack of Efficacy|5|||
164657823|NCT00895583|594772126|FG001|Overall Study|Lack of Efficacy|0|||
164657824|NCT00895583|594772125|FG000|Overall Study|Other|0|||
164310114|NCT02722304|593509585|FG000|Overall Study|Other|0|||
164310115|NCT02722304|593509586|FG001|Overall Study|Other|0|||
164310116|NCT02722304|593509587|FG002|Overall Study|Other|0|||
164310117|NCT02722304|593509588|FG003|Overall Study|Other|1|||
164310118|NCT02722304|593509589|FG004|Overall Study|Other|1|||
164310119|NCT00393861|593509592|FG000|Overall Study|Adverse Event|2|||
164310120|NCT00393861|593509592|FG000|Overall Study|Disease Progression|24|||
164310121|NCT05300763|593509593|FG000|Overall Study|Adverse Event|0|||
164310122|NCT05300763|593509594|FG001|Overall Study|Adverse Event|1|||
164310123|NCT05300763|593509593|FG000|Overall Study|Major Protocol Deviation|1|||
164310124|NCT05300763|593509594|FG001|Overall Study|Major Protocol Deviation|0|||
164310125|NCT05300763|593509593|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
164657825|NCT00895583|594772126|FG001|Overall Study|Other|1|||
164657826|NCT01078090|594772127|FG000|Overall Study|Lost to Follow-up|2363|||
164657827|NCT01078090|594772127|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
164657828|NCT01078090|594772127|FG000|Overall Study|Lack of Efficacy|1193|||
164657829|NCT01078090|594772127|FG000|Overall Study|ADR and lack of efficacy|61|||
164657830|NCT01078090|594772127|FG000|Overall Study|Other|523|||
164310126|NCT05300763|593509594|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
164310127|NCT01485172|593509595|FG000|Overall Study|Adverse Event|2|||
164310128|NCT01485172|593509596|FG001|Overall Study|Adverse Event|1|||
164553044|NCT02631200|594396850|FG000|First Period|Death|1|||
164553045|NCT02631200|594396851|FG001|First Period|Death|2|||
164553046|NCT02631200|594396850|FG000|First Period|Patient ill-health|2|||
164553047|NCT02631200|594396851|FG001|First Period|Patient ill-health|4|||
164553048|NCT02631200|594396850|FG000|First Period|Withdrawal by Subject|4|||
164553049|NCT02631200|594396851|FG001|First Period|Withdrawal by Subject|1|||
164553050|NCT02631200|594396850|FG000|Deferred Period|Death|0|||
164553051|NCT02631200|594396851|FG001|Deferred Period|Death|1|||
164553052|NCT02631200|594396850|FG000|Deferred Period|Received kidney transplant|0|||
164553053|NCT02631200|594396851|FG001|Deferred Period|Received kidney transplant|1|||
164553054|NCT02631200|594396850|FG000|Deferred Period|Withdrawal by Subject|0|||
164553055|NCT02631200|594396851|FG001|Deferred Period|Withdrawal by Subject|2|||
164553056|NCT02631200|594396850|FG000|Deferred Period|Lost to Follow-up|0|||
164553057|NCT02631200|594396851|FG001|Deferred Period|Lost to Follow-up|1|||
164553058|NCT01877187|594396853|FG000|Overall Study|Death|2|||
164553059|NCT01877187|594396853|FG000|Overall Study|Withdrawal by Subject|4|||
164553060|NCT01877187|594396853|FG000|Overall Study|Lost to Follow-up|3|||
164553061|NCT01877187|594396853|FG000|Overall Study|Declining clinical status|11|||
164553062|NCT01877187|594396853|FG000|Overall Study|Liver transplant|2|||
164657831|NCT03035227|594772128|FG000|Overall Study|study stopped due to PI leaving institut|1|||
164310129|NCT01485172|593509597|FG002|Overall Study|Adverse Event|2|||
164310130|NCT01485172|593509598|FG003|Overall Study|Adverse Event|2|||
164657832|NCT03035227|594772129|FG001|Overall Study|study stopped due to PI leaving institut|1|||
164657833|NCT02100956|594772130|FG000|At Least One Week Between Injections|Adverse Event|0|||
164310131|NCT01485172|593509599|FG004|Overall Study|Adverse Event|1|||
164310132|NCT01485172|593509600|FG005|Overall Study|Adverse Event|2|||
164553063|NCT02669017|594396855|FG000|Overall Study|Death|1|||
164553064|NCT02669017|594396856|FG001|Overall Study|Death|2|||
164553065|NCT02669017|594396857|FG002|Overall Study|Death|2|||
164310133|NCT01485172|593509595|FG000|Overall Study|Lack of Efficacy|2|||
164553066|NCT02669017|594396858|FG003|Overall Study|Death|3|||
164657834|NCT02100956|594772131|FG001|At Least One Week Between Injections|Adverse Event|1|||
164657835|NCT03529955|594772132|FG000|Overall Study|Adverse Event|1|||
164657836|NCT03529955|594772132|FG000|Overall Study|Lack of Efficacy|1|||
164657837|NCT03016078|594772139|FG000|Overall Study|Protocol Violation|1|||
164657838|NCT03016078|594772139|FG000|Overall Study|Protocol Violation|1|||
164657839|NCT01070394|594772140|FG000|Overall Study|Adverse Event|6|||
164657840|NCT01070394|594772140|FG000|Overall Study|Withdrawal by Subject|1|||
164657841|NCT00066807|594772141|FG000|Overall Study|Study was terminated early|14|||
164657842|NCT00066807|594772142|FG001|Overall Study|Study was terminated early|15|||
164657843|NCT04526899|594772143|FG000|Overall Study|Withdrawal by Subject|3|||
164657844|NCT04526899|594772144|FG001|Overall Study|Withdrawal by Subject|2|||
164310134|NCT01485172|593509596|FG001|Overall Study|Lack of Efficacy|0|||
164657845|NCT04526899|594772145|FG002|Overall Study|Withdrawal by Subject|2|||
164657846|NCT04526899|594772143|FG000|Overall Study|Lost to Follow-up|3|||
164657847|NCT04526899|594772144|FG001|Overall Study|Lost to Follow-up|3|||
164657848|NCT04526899|594772145|FG002|Overall Study|Lost to Follow-up|1|||
164657849|NCT04526899|594772143|FG000|Overall Study|Investigator's decision|1|||
164657850|NCT04526899|594772144|FG001|Overall Study|Investigator's decision|0|||
164657851|NCT04526899|594772145|FG002|Overall Study|Investigator's decision|0|||
164657852|NCT04526899|594772143|FG000|Overall Study|Death|33|||
164657853|NCT04526899|594772144|FG001|Overall Study|Death|17|||
164657854|NCT04526899|594772145|FG002|Overall Study|Death|13|||
164657855|NCT04526899|594772143|FG000|Overall Study|Other|1|||
164657856|NCT04526899|594772144|FG001|Overall Study|Other|0|||
164657857|NCT04526899|594772145|FG002|Overall Study|Other|0|||
164657858|NCT04526899|594772143|FG000|Overall Study|On-Treatment|19|||
164657859|NCT04526899|594772144|FG001|Overall Study|On-Treatment|10|||
164657860|NCT04526899|594772145|FG002|Overall Study|On-Treatment|12|||
164657861|NCT04526899|594772143|FG000|Overall Study|Survival Follow-up|34|||
164657862|NCT04526899|594772144|FG001|Overall Study|Survival Follow-up|14|||
164657863|NCT04526899|594772145|FG002|Overall Study|Survival Follow-up|16|||
164657864|NCT03507439|594772146|FG000|Overall Study|Other|2|||
164657865|NCT03507439|594772147|FG001|Overall Study|Other|1|||
164657866|NCT03507439|594772146|FG000|Overall Study|Withdrawal by Subject|1|||
164657867|NCT03507439|594772147|FG001|Overall Study|Withdrawal by Subject|0|||
164657868|NCT03507439|594772146|FG000|Overall Study|Death|1|||
164657869|NCT03507439|594772147|FG001|Overall Study|Death|1|||
164657870|NCT00874757|594772148|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
164657871|NCT00416520|594773385|FG000|Open-label Period|Adverse Event|28|||
164657872|NCT00416520|594773386|FG001|Open-label Period|Adverse Event|10|||
164657873|NCT00416520|594773387|FG002|Open-label Period|Adverse Event|0|||
164657874|NCT00416520|594773388|FG003|Open-label Period|Adverse Event|0|||
164657875|NCT00416520|594773385|FG000|Open-label Period|Death|2|||
164657876|NCT00416520|594773386|FG001|Open-label Period|Death|1|||
164657877|NCT00416520|594773387|FG002|Open-label Period|Death|0|||
164657878|NCT00416520|594773388|FG003|Open-label Period|Death|0|||
164657879|NCT00416520|594773385|FG000|Open-label Period|Lack of Efficacy|8|||
164657880|NCT00416520|594773386|FG001|Open-label Period|Lack of Efficacy|1|||
164657881|NCT00416520|594773387|FG002|Open-label Period|Lack of Efficacy|0|||
164657882|NCT00416520|594773388|FG003|Open-label Period|Lack of Efficacy|0|||
164657883|NCT00416520|594773385|FG000|Open-label Period|Protocol Violation|3|||
164657884|NCT00416520|594773386|FG001|Open-label Period|Protocol Violation|3|||
164657885|NCT00416520|594773387|FG002|Open-label Period|Protocol Violation|0|||
164657886|NCT00416520|594773388|FG003|Open-label Period|Protocol Violation|0|||
164310135|NCT01485172|593509597|FG002|Overall Study|Lack of Efficacy|0|||
164310136|NCT01485172|593509598|FG003|Overall Study|Lack of Efficacy|0|||
164310137|NCT01485172|593509599|FG004|Overall Study|Lack of Efficacy|0|||
164310138|NCT01485172|593509600|FG005|Overall Study|Lack of Efficacy|0|||
164310139|NCT01485172|593509595|FG000|Overall Study|Protocol Violation|0|||
164310140|NCT01485172|593509596|FG001|Overall Study|Protocol Violation|0|||
164310141|NCT01485172|593509597|FG002|Overall Study|Protocol Violation|4|||
164310142|NCT01485172|593509598|FG003|Overall Study|Protocol Violation|5|||
164310143|NCT01485172|593509599|FG004|Overall Study|Protocol Violation|1|||
164310144|NCT01485172|593509600|FG005|Overall Study|Protocol Violation|0|||
164310145|NCT01485172|593509595|FG000|Overall Study|Protocol defined stopping criteria|1|||
164657887|NCT00416520|594773385|FG000|Open-label Period|Withdrawal by Subject|16|||
164657888|NCT00416520|594773386|FG001|Open-label Period|Withdrawal by Subject|5|||
164657889|NCT00416520|594773387|FG002|Open-label Period|Withdrawal by Subject|0|||
164310146|NCT01485172|593509596|FG001|Overall Study|Protocol defined stopping criteria|0|||
164310147|NCT01485172|593509597|FG002|Overall Study|Protocol defined stopping criteria|0|||
164310148|NCT01485172|593509598|FG003|Overall Study|Protocol defined stopping criteria|0|||
164657890|NCT00416520|594773388|FG003|Open-label Period|Withdrawal by Subject|0|||
164657891|NCT00416520|594773385|FG000|Open-label Period|Other Reasons|3|||
164310149|NCT01485172|593509599|FG004|Overall Study|Protocol defined stopping criteria|1|||
164657892|NCT00416520|594773386|FG001|Open-label Period|Other Reasons|12|||
164657893|NCT00416520|594773387|FG002|Open-label Period|Other Reasons|0|||
164657894|NCT00416520|594773388|FG003|Open-label Period|Other Reasons|0|||
164657895|NCT00416520|594773385|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
164657896|NCT00416520|594773386|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
164657897|NCT00416520|594773387|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
164657898|NCT00416520|594773388|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
164657899|NCT00416520|594773385|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
164657900|NCT00416520|594773386|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
164657901|NCT00416520|594773387|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
164657902|NCT00416520|594773388|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
164657903|NCT00416520|594773385|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
164657904|NCT00416520|594773386|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
164657905|NCT00416520|594773387|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
164657906|NCT00416520|594773388|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
164657907|NCT06509100|594773391|FG000|Overall Study|Withdrawal by Subject|1|||
164657908|NCT06509100|594773391|FG000|Overall Study|Lost to Follow-up|1|||
164657909|NCT01612000|594773397|FG000|Overall Study|Lost to Follow-up|6|||
164657910|NCT01612000|594773398|FG001|Overall Study|Lost to Follow-up|4|||
164657911|NCT01612000|594773399|FG002|Overall Study|Lost to Follow-up|4|||
164657912|NCT01612000|594773400|FG003|Overall Study|Lost to Follow-up|8|||
164657913|NCT01612000|594773397|FG000|Overall Study|Physician Decision|0|||
164657914|NCT01612000|594773398|FG001|Overall Study|Physician Decision|0|||
164657915|NCT01612000|594773399|FG002|Overall Study|Physician Decision|1|||
164657916|NCT01612000|594773400|FG003|Overall Study|Physician Decision|0|||
164657917|NCT01612000|594773397|FG000|Overall Study|Withdrawal by Subject|3|||
164657918|NCT01612000|594773398|FG001|Overall Study|Withdrawal by Subject|1|||
164657919|NCT01612000|594773399|FG002|Overall Study|Withdrawal by Subject|2|||
164657920|NCT01612000|594773400|FG003|Overall Study|Withdrawal by Subject|2|||
164657921|NCT03425331|594773401|FG000|Overall Study|Withdrawal by Subject|1|||
164657922|NCT03425331|594773401|FG000|Overall Study|Death|1|||
164657923|NCT03425331|594773401|FG000|Overall Study|Adverse Event|1|||
164657924|NCT03425331|594773401|FG000|Overall Study|Disease Progression|2|||
164657925|NCT03433274|594773402|FG000|Overall Study|Withdrawal by Subject|2|||
164657926|NCT03433274|594773402|FG000|Overall Study|Missed visit|5|||
164657927|NCT03433274|594773402|FG000|Overall Study|Death|23|||
164657928|NCT00441584|594773403|FG000|Overall Study|Lack of Efficacy|79|||
164657929|NCT00441584|594773403|FG000|Overall Study|Withdrawal by Subject|8|||
164657930|NCT00441584|594773403|FG000|Overall Study|Adverse Event|6|||
164657931|NCT00441584|594773403|FG000|Overall Study|Protocol Violation|5|||
164657932|NCT00441584|594773403|FG000|Overall Study|Lost to Follow-up|4|||
164657933|NCT00441584|594773403|FG000|Overall Study|Failure to meet eligibility criteria|3|||
164657934|NCT00542386|594773404|FG000|Overall Study|Adverse Event|1|||
164657935|NCT00542386|594773405|FG001|Overall Study|Adverse Event|7|||
164657936|NCT00542386|594773406|FG002|Overall Study|Adverse Event|7|||
164657937|NCT00542386|594773407|FG003|Overall Study|Adverse Event|8|||
164657938|NCT00542386|594773408|FG004|Overall Study|Adverse Event|13|||
164657939|NCT00542386|594773409|FG005|Overall Study|Adverse Event|4|||
164657940|NCT00542386|594773404|FG000|Overall Study|Death|0|||
164657941|NCT00542386|594773405|FG001|Overall Study|Death|0|||
164657942|NCT00542386|594773406|FG002|Overall Study|Death|1|||
164657943|NCT00542386|594773407|FG003|Overall Study|Death|2|||
164657944|NCT00542386|594773408|FG004|Overall Study|Death|1|||
164657945|NCT00542386|594773409|FG005|Overall Study|Death|2|||
164657946|NCT00542386|594773404|FG000|Overall Study|Lack of Efficacy|32|||
164657947|NCT00542386|594773405|FG001|Overall Study|Lack of Efficacy|12|||
164657948|NCT00542386|594773406|FG002|Overall Study|Lack of Efficacy|10|||
164657949|NCT00542386|594773407|FG003|Overall Study|Lack of Efficacy|13|||
164657950|NCT00542386|594773408|FG004|Overall Study|Lack of Efficacy|7|||
164657951|NCT00542386|594773409|FG005|Overall Study|Lack of Efficacy|31|||
164657952|NCT00542386|594773404|FG000|Overall Study|Physician Decision|1|||
164657953|NCT00542386|594773405|FG001|Overall Study|Physician Decision|0|||
164657954|NCT00542386|594773406|FG002|Overall Study|Physician Decision|0|||
164657955|NCT00542386|594773407|FG003|Overall Study|Physician Decision|1|||
164657956|NCT00542386|594773408|FG004|Overall Study|Physician Decision|0|||
164657957|NCT00542386|594773409|FG005|Overall Study|Physician Decision|0|||
164657958|NCT00542386|594773404|FG000|Overall Study|Protocol Violation|0|||
164657959|NCT00542386|594773405|FG001|Overall Study|Protocol Violation|0|||
164657960|NCT00542386|594773406|FG002|Overall Study|Protocol Violation|1|||
164657961|NCT00542386|594773407|FG003|Overall Study|Protocol Violation|0|||
164657962|NCT00542386|594773408|FG004|Overall Study|Protocol Violation|0|||
164657963|NCT00542386|594773409|FG005|Overall Study|Protocol Violation|4|||
164657964|NCT00542386|594773404|FG000|Overall Study|Withdrawal by Subject|5|||
164657965|NCT00542386|594773405|FG001|Overall Study|Withdrawal by Subject|8|||
164657966|NCT00542386|594773406|FG002|Overall Study|Withdrawal by Subject|10|||
164657967|NCT00542386|594773407|FG003|Overall Study|Withdrawal by Subject|11|||
164657968|NCT00542386|594773408|FG004|Overall Study|Withdrawal by Subject|15|||
164657969|NCT00542386|594773409|FG005|Overall Study|Withdrawal by Subject|7|||
164657970|NCT00542386|594773404|FG000|Overall Study|Other Reasons|4|||
164657971|NCT00542386|594773405|FG001|Overall Study|Other Reasons|1|||
164657972|NCT00542386|594773406|FG002|Overall Study|Other Reasons|4|||
164657973|NCT00542386|594773407|FG003|Overall Study|Other Reasons|3|||
164657974|NCT00542386|594773408|FG004|Overall Study|Other Reasons|4|||
164657975|NCT00542386|594773409|FG005|Overall Study|Other Reasons|2|||
164657976|NCT04864405|594773410|FG000|Overall Study|Withdrawal by Subject|4|||
164657977|NCT04864405|594773411|FG001|Overall Study|Withdrawal by Subject|6|||
164657978|NCT04864405|594773410|FG000|Overall Study|Did not want endocrine therapy|3|||
164657979|NCT04864405|594773411|FG001|Overall Study|Did not want endocrine therapy|5|||
164657980|NCT00506441|594773412|FG000|Period 1; Open-label Period|Adverse Event|21|||
164657981|NCT00506441|594773413|FG001|Period 1; Open-label Period|Adverse Event|0|||
164657982|NCT00506441|594773412|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
164657983|NCT00506441|594773413|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
164657984|NCT00506441|594773412|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
164657985|NCT00506441|594773413|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
164657986|NCT00506441|594773412|FG000|Period 1; Open-label Period|Physician Decision|5|||
164657987|NCT00506441|594773413|FG001|Period 1; Open-label Period|Physician Decision|0|||
164657988|NCT00506441|594773412|FG000|Period 1; Open-label Period|Protocol Violation|9|||
164657989|NCT00506441|594773413|FG001|Period 1; Open-label Period|Protocol Violation|0|||
164657990|NCT00506441|594773412|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
164657991|NCT00506441|594773413|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
164657992|NCT00506441|594773412|FG000|Period 1; Open-label Period|Other Reasons|13|||
164657993|NCT00506441|594773413|FG001|Period 1; Open-label Period|Other Reasons|0|||
164657994|NCT00506441|594773412|FG000|Period 2; Double-blind Period|Adverse Event|0|||
164657995|NCT00506441|594773413|FG001|Period 2; Double-blind Period|Adverse Event|1|||
164657996|NCT00506441|594773412|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
164657997|NCT00506441|594773413|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
164657998|NCT00506441|594773412|FG000|Period 2; Double-blind Period|Physician Decision|1|||
164657999|NCT00506441|594773413|FG001|Period 2; Double-blind Period|Physician Decision|1|||
164658000|NCT00506441|594773412|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
164658001|NCT00506441|594773413|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
164658002|NCT00506441|594773412|FG000|Period 2; Double-blind Period|Other Reason|1|||
164658003|NCT00506441|594773413|FG001|Period 2; Double-blind Period|Other Reason|1|||
164658004|NCT04969939|594773414|FG000|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
164658005|NCT04969939|594773415|FG001|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
164658006|NCT04969939|594773416|FG002|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
164658007|NCT04969939|594773417|FG003|Part 2a: Run in Period (32 Weeks)|Adverse Event|4|||
164658008|NCT04969939|594773418|FG004|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
164658009|NCT04969939|594773419|FG005|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
164658010|NCT04969939|594773420|FG006|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
164658011|NCT04969939|594773414|FG000|Part 2a: Run in Period (32 Weeks)|Other|0|||
164658012|NCT04969939|594773415|FG001|Part 2a: Run in Period (32 Weeks)|Other|0|||
164658013|NCT04969939|594773416|FG002|Part 2a: Run in Period (32 Weeks)|Other|0|||
164658014|NCT04969939|594773417|FG003|Part 2a: Run in Period (32 Weeks)|Other|5|||
164658015|NCT04969939|594773418|FG004|Part 2a: Run in Period (32 Weeks)|Other|0|||
164658016|NCT04969939|594773419|FG005|Part 2a: Run in Period (32 Weeks)|Other|0|||
164658017|NCT04969939|594773420|FG006|Part 2a: Run in Period (32 Weeks)|Other|0|||
164658018|NCT04969939|594773414|FG000|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
164658019|NCT04969939|594773415|FG001|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
164658020|NCT04969939|594773416|FG002|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
164658021|NCT04969939|594773417|FG003|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|2|||
164658022|NCT04969939|594773418|FG004|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
164658023|NCT04969939|594773419|FG005|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
164658024|NCT04969939|594773420|FG006|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
164658025|NCT04969939|594773414|FG000|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
164658026|NCT04969939|594773415|FG001|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
164658027|NCT04969939|594773416|FG002|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
164658028|NCT04969939|594773417|FG003|Part 2a: Run in Period (32 Weeks)|Pregnancy|1|||
164658029|NCT04969939|594773418|FG004|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
164658030|NCT04969939|594773419|FG005|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
164658031|NCT04969939|594773420|FG006|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
164658032|NCT04969939|594773414|FG000|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
164658033|NCT04969939|594773415|FG001|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
164658034|NCT04969939|594773416|FG002|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
164658035|NCT04969939|594773417|FG003|Part 2a: Run in Period (32 Weeks)|Protocol Violation|1|||
164658036|NCT04969939|594773418|FG004|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
164658037|NCT04969939|594773419|FG005|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
164658038|NCT04969939|594773420|FG006|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
164658039|NCT04969939|594773414|FG000|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
164658040|NCT04969939|594773415|FG001|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
164658041|NCT04969939|594773416|FG002|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
164658042|NCT04969939|594773417|FG003|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
164658043|NCT04969939|594773418|FG004|Part 2b (16 Weeks)|Withdrawal by Subject|3|||
164658044|NCT04969939|594773419|FG005|Part 2b (16 Weeks)|Withdrawal by Subject|1|||
164658045|NCT04969939|594773420|FG006|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
164658046|NCT03843359|594773421|FG000|Escalation Phase|Lost to Follow-up|0|||
164658047|NCT03843359|594773422|FG001|Escalation Phase|Lost to Follow-up|0|||
164658048|NCT03843359|594773423|FG002|Escalation Phase|Lost to Follow-up|0|||
164658049|NCT03843359|594773424|FG003|Escalation Phase|Lost to Follow-up|0|||
164658050|NCT03843359|594773425|FG004|Escalation Phase|Lost to Follow-up|0|||
164658051|NCT03843359|594773426|FG005|Escalation Phase|Lost to Follow-up|0|||
164658052|NCT03843359|594773427|FG006|Escalation Phase|Lost to Follow-up|0|||
164658053|NCT03843359|594773428|FG007|Escalation Phase|Lost to Follow-up|0|||
164658054|NCT03843359|594773429|FG008|Escalation Phase|Lost to Follow-up|1|||
164658055|NCT03843359|594773430|FG009|Escalation Phase|Lost to Follow-up|0|||
164658056|NCT03843359|594773431|FG010|Escalation Phase|Lost to Follow-up|0|||
164658057|NCT03843359|594773432|FG011|Escalation Phase|Lost to Follow-up|0|||
164658058|NCT03843359|594773433|FG012|Escalation Phase|Lost to Follow-up|0|||
164658059|NCT03843359|594773434|FG013|Escalation Phase|Lost to Follow-up|0|||
164658060|NCT03843359|594773435|FG014|Escalation Phase|Lost to Follow-up|0|||
164658061|NCT03843359|594773436|FG015|Escalation Phase|Lost to Follow-up|0|||
164658062|NCT03843359|594773421|FG000|Escalation Phase|Physician Decision|0|||
164658063|NCT03843359|594773422|FG001|Escalation Phase|Physician Decision|0|||
164658064|NCT03843359|594773423|FG002|Escalation Phase|Physician Decision|1|||
164658065|NCT03843359|594773424|FG003|Escalation Phase|Physician Decision|0|||
164658066|NCT03843359|594773425|FG004|Escalation Phase|Physician Decision|0|||
164658067|NCT03843359|594773426|FG005|Escalation Phase|Physician Decision|1|||
164658068|NCT03843359|594773427|FG006|Escalation Phase|Physician Decision|0|||
164658069|NCT03843359|594773428|FG007|Escalation Phase|Physician Decision|0|||
164658070|NCT03843359|594773429|FG008|Escalation Phase|Physician Decision|0|||
164658071|NCT03843359|594773430|FG009|Escalation Phase|Physician Decision|0|||
164658072|NCT03843359|594773431|FG010|Escalation Phase|Physician Decision|0|||
164658073|NCT03843359|594773432|FG011|Escalation Phase|Physician Decision|0|||
164658074|NCT03843359|594773433|FG012|Escalation Phase|Physician Decision|0|||
164658075|NCT03843359|594773434|FG013|Escalation Phase|Physician Decision|0|||
164658076|NCT03843359|594773435|FG014|Escalation Phase|Physician Decision|0|||
164658077|NCT03843359|594773436|FG015|Escalation Phase|Physician Decision|0|||
164658078|NCT03843359|594773421|FG000|Escalation Phase|Investigator site closed|0|||
164658079|NCT03843359|594773422|FG001|Escalation Phase|Investigator site closed|1|||
164658080|NCT03843359|594773423|FG002|Escalation Phase|Investigator site closed|0|||
164658081|NCT03843359|594773424|FG003|Escalation Phase|Investigator site closed|1|||
164658082|NCT03843359|594773425|FG004|Escalation Phase|Investigator site closed|1|||
164658083|NCT03843359|594773426|FG005|Escalation Phase|Investigator site closed|0|||
164658084|NCT03843359|594773427|FG006|Escalation Phase|Investigator site closed|1|||
164658085|NCT03843359|594773428|FG007|Escalation Phase|Investigator site closed|0|||
164658086|NCT03843359|594773429|FG008|Escalation Phase|Investigator site closed|2|||
164658087|NCT03843359|594773430|FG009|Escalation Phase|Investigator site closed|0|||
164658088|NCT03843359|594773431|FG010|Escalation Phase|Investigator site closed|0|||
164658089|NCT03843359|594773432|FG011|Escalation Phase|Investigator site closed|0|||
164658090|NCT03843359|594773433|FG012|Escalation Phase|Investigator site closed|0|||
164658091|NCT03843359|594773434|FG013|Escalation Phase|Investigator site closed|0|||
164658092|NCT03843359|594773435|FG014|Escalation Phase|Investigator site closed|0|||
164658093|NCT03843359|594773436|FG015|Escalation Phase|Investigator site closed|0|||
164658094|NCT03843359|594773421|FG000|Escalation Phase|Ongoing at the time of analysis|0|||
164658095|NCT03843359|594773422|FG001|Escalation Phase|Ongoing at the time of analysis|0|||
164658096|NCT03843359|594773423|FG002|Escalation Phase|Ongoing at the time of analysis|0|||
164658097|NCT03843359|594773424|FG003|Escalation Phase|Ongoing at the time of analysis|0|||
164658098|NCT03843359|594773425|FG004|Escalation Phase|Ongoing at the time of analysis|0|||
164658099|NCT03843359|594773426|FG005|Escalation Phase|Ongoing at the time of analysis|0|||
164658100|NCT03843359|594773427|FG006|Escalation Phase|Ongoing at the time of analysis|0|||
164658101|NCT03843359|594773428|FG007|Escalation Phase|Ongoing at the time of analysis|0|||
164658102|NCT03843359|594773429|FG008|Escalation Phase|Ongoing at the time of analysis|1|||
164658103|NCT03843359|594773430|FG009|Escalation Phase|Ongoing at the time of analysis|0|||
164201374|NCT03154086|593110737|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201375|NCT03154086|593110738|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201376|NCT03154086|593110739|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201377|NCT03154086|593110740|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201378|NCT03154086|593110741|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201379|NCT03154086|593110727|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164201380|NCT03154086|593110728|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164310150|NCT01485172|593509600|FG005|Overall Study|Protocol defined stopping criteria|0|||
164310151|NCT01485172|593509595|FG000|Overall Study|Lost to Follow-up|0|||
164658104|NCT03843359|594773431|FG010|Escalation Phase|Ongoing at the time of analysis|0|||
164658105|NCT03843359|594773432|FG011|Escalation Phase|Ongoing at the time of analysis|1|||
164658106|NCT03843359|594773433|FG012|Escalation Phase|Ongoing at the time of analysis|1|||
164658107|NCT03843359|594773434|FG013|Escalation Phase|Ongoing at the time of analysis|0|||
164658108|NCT03843359|594773435|FG014|Escalation Phase|Ongoing at the time of analysis|0|||
164658109|NCT03843359|594773436|FG015|Escalation Phase|Ongoing at the time of analysis|0|||
164658110|NCT03843359|594773421|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164201381|NCT03154086|593110729|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
164201382|NCT03154086|593110730|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164201383|NCT03154086|593110731|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164201384|NCT03154086|593110732|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164658111|NCT03843359|594773422|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164658112|NCT03843359|594773423|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|7|||
164658113|NCT03843359|594773424|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164658114|NCT03843359|594773425|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
164658115|NCT03843359|594773426|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164658116|NCT03843359|594773427|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164658117|NCT03843359|594773428|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164658118|NCT03843359|594773429|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164658119|NCT03843359|594773430|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164658120|NCT03843359|594773431|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164658121|NCT03843359|594773432|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164658122|NCT03843359|594773433|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164658123|NCT03843359|594773434|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164658124|NCT03843359|594773435|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164658125|NCT03843359|594773436|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164658126|NCT03843359|594773421|FG000|Crossover|Withdrawal by Subject|0|||
164658127|NCT03843359|594773422|FG001|Crossover|Withdrawal by Subject|0|||
164658128|NCT03843359|594773423|FG002|Crossover|Withdrawal by Subject|0|||
164658129|NCT03843359|594773424|FG003|Crossover|Withdrawal by Subject|0|||
164658130|NCT03843359|594773425|FG004|Crossover|Withdrawal by Subject|0|||
164658131|NCT03843359|594773426|FG005|Crossover|Withdrawal by Subject|0|||
164658132|NCT03843359|594773427|FG006|Crossover|Withdrawal by Subject|0|||
164658133|NCT03843359|594773428|FG007|Crossover|Withdrawal by Subject|0|||
164658134|NCT03843359|594773429|FG008|Crossover|Withdrawal by Subject|0|||
164658135|NCT03843359|594773430|FG009|Crossover|Withdrawal by Subject|0|||
164658136|NCT03843359|594773431|FG010|Crossover|Withdrawal by Subject|0|||
164658137|NCT03843359|594773432|FG011|Crossover|Withdrawal by Subject|0|||
164658138|NCT03843359|594773433|FG012|Crossover|Withdrawal by Subject|0|||
164658139|NCT03843359|594773434|FG013|Crossover|Withdrawal by Subject|0|||
164658140|NCT03843359|594773435|FG014|Crossover|Withdrawal by Subject|0|||
164658141|NCT03843359|594773436|FG015|Crossover|Withdrawal by Subject|1|||
164658142|NCT03843359|594773421|FG000|Crossover|Investigator site closed|0|||
164658143|NCT03843359|594773422|FG001|Crossover|Investigator site closed|0|||
164658144|NCT03843359|594773423|FG002|Crossover|Investigator site closed|0|||
164658145|NCT03843359|594773424|FG003|Crossover|Investigator site closed|0|||
164658146|NCT03843359|594773425|FG004|Crossover|Investigator site closed|0|||
164658147|NCT03843359|594773426|FG005|Crossover|Investigator site closed|0|||
164658148|NCT03843359|594773427|FG006|Crossover|Investigator site closed|0|||
164658149|NCT03843359|594773428|FG007|Crossover|Investigator site closed|0|||
164658150|NCT03843359|594773429|FG008|Crossover|Investigator site closed|0|||
164658151|NCT03843359|594773430|FG009|Crossover|Investigator site closed|0|||
164658152|NCT03843359|594773431|FG010|Crossover|Investigator site closed|0|||
164658153|NCT03843359|594773432|FG011|Crossover|Investigator site closed|0|||
164658154|NCT03843359|594773433|FG012|Crossover|Investigator site closed|0|||
164658155|NCT03843359|594773434|FG013|Crossover|Investigator site closed|0|||
164658156|NCT03843359|594773435|FG014|Crossover|Investigator site closed|2|||
164658157|NCT03843359|594773436|FG015|Crossover|Investigator site closed|2|||
164658158|NCT03843359|594773421|FG000|Crossover|Ongoing at the time of analysis|0|||
164658159|NCT03843359|594773422|FG001|Crossover|Ongoing at the time of analysis|0|||
164658160|NCT03843359|594773423|FG002|Crossover|Ongoing at the time of analysis|0|||
164658161|NCT03843359|594773424|FG003|Crossover|Ongoing at the time of analysis|0|||
164658162|NCT03843359|594773425|FG004|Crossover|Ongoing at the time of analysis|0|||
164658163|NCT03843359|594773426|FG005|Crossover|Ongoing at the time of analysis|0|||
164658164|NCT03843359|594773427|FG006|Crossover|Ongoing at the time of analysis|0|||
164658165|NCT03843359|594773428|FG007|Crossover|Ongoing at the time of analysis|0|||
164658166|NCT03843359|594773429|FG008|Crossover|Ongoing at the time of analysis|0|||
164658167|NCT03843359|594773430|FG009|Crossover|Ongoing at the time of analysis|0|||
164658168|NCT03843359|594773431|FG010|Crossover|Ongoing at the time of analysis|0|||
164658169|NCT03843359|594773432|FG011|Crossover|Ongoing at the time of analysis|0|||
164658170|NCT03843359|594773433|FG012|Crossover|Ongoing at the time of analysis|0|||
164658171|NCT03843359|594773434|FG013|Crossover|Ongoing at the time of analysis|1|||
164302363|NCT03755934|593482605|FG003|Overall Study|Adverse Event|3|||
164658172|NCT03843359|594773435|FG014|Crossover|Ongoing at the time of analysis|0|||
164658173|NCT03843359|594773436|FG015|Crossover|Ongoing at the time of analysis|0|||
164658174|NCT03075527|594773437|FG000|Overall Study|Death|1|||
164658175|NCT03075527|594773437|FG000|Overall Study|Withdrawal by Subject|1|||
164658176|NCT03075527|594773437|FG000|Overall Study|Physician Decision|3|||
164658177|NCT03075527|594773437|FG000|Overall Study|Progression/Relapse|14|||
164658178|NCT05359003|594773442|FG000|Overall Study|Withdrawal by Subject|1|||
164658179|NCT05359003|594773443|FG001|Overall Study|Withdrawal by Subject|3|||
164658180|NCT06202521|594773444|FG000|Overall Study|Withdrawal by Subject|0|||
164658181|NCT06202521|594773445|FG001|Overall Study|Withdrawal by Subject|1|||
164658182|NCT06202521|594773446|FG002|Overall Study|Withdrawal by Subject|0|||
164658183|NCT06202521|594773447|FG003|Overall Study|Withdrawal by Subject|1|||
164310152|NCT01485172|593509596|FG001|Overall Study|Lost to Follow-up|0|||
164310153|NCT01485172|593509597|FG002|Overall Study|Lost to Follow-up|1|||
164310154|NCT01485172|593509598|FG003|Overall Study|Lost to Follow-up|0|||
164310155|NCT01485172|593509599|FG004|Overall Study|Lost to Follow-up|0|||
164310156|NCT01485172|593509600|FG005|Overall Study|Lost to Follow-up|1|||
164310157|NCT01485172|593509595|FG000|Overall Study|Physician Decision|0|||
164310158|NCT01485172|593509596|FG001|Overall Study|Physician Decision|0|||
164310159|NCT01485172|593509597|FG002|Overall Study|Physician Decision|0|||
164310160|NCT01485172|593509598|FG003|Overall Study|Physician Decision|0|||
164310161|NCT01485172|593509599|FG004|Overall Study|Physician Decision|1|||
164310162|NCT01485172|593509600|FG005|Overall Study|Physician Decision|0|||
164310163|NCT01485172|593509595|FG000|Overall Study|Withdrawal by Subject|2|||
164310164|NCT01485172|593509596|FG001|Overall Study|Withdrawal by Subject|0|||
164310165|NCT01485172|593509597|FG002|Overall Study|Withdrawal by Subject|0|||
164310166|NCT01485172|593509598|FG003|Overall Study|Withdrawal by Subject|1|||
164310167|NCT01485172|593509599|FG004|Overall Study|Withdrawal by Subject|1|||
164310168|NCT01485172|593509600|FG005|Overall Study|Withdrawal by Subject|1|||
164310169|NCT01587014|593509601|FG000|Overall Study|Death|2|||
164310170|NCT01409811|593509602|FG000|Overall Study|Insurance denial|1|||
164310171|NCT00441064|593509603|FG000|Overall Study|Adverse Event|1|||
164310172|NCT00441064|593509604|FG001|Overall Study|Adverse Event|0|||
164310173|NCT00441064|593509603|FG000|Overall Study|Abnormal laboratory values|0|||
164310174|NCT00441064|593509604|FG001|Overall Study|Abnormal laboratory values|2|||
164310175|NCT00441064|593509603|FG000|Overall Study|Abnormal test procedure results|0|||
164310176|NCT00441064|593509604|FG001|Overall Study|Abnormal test procedure results|1|||
164310177|NCT00441064|593509603|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164310178|NCT00441064|593509604|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164310179|NCT00441064|593509603|FG000|Overall Study|Protocol Deviation|3|||
164310180|NCT00441064|593509604|FG001|Overall Study|Protocol Deviation|2|||
164310181|NCT00441064|593509603|FG000|Overall Study|Patient withdrew consent|5|||
164310182|NCT00441064|593509604|FG001|Overall Study|Patient withdrew consent|2|||
164310183|NCT03051178|593509605|FG000|Overall Study|Withdrawal by Subject|5|||
164310184|NCT00953056|593509606|FG000|Overall Study|Withdrew Consent|0|||
164310185|NCT00953056|593509607|FG001|Overall Study|Withdrew Consent|0|||
164310186|NCT00953056|593509608|FG002|Overall Study|Withdrew Consent|0|||
164310187|NCT00953056|593509609|FG003|Overall Study|Withdrew Consent|0|||
164310188|NCT00953056|593509610|FG004|Overall Study|Withdrew Consent|2|||
164310189|NCT00953056|593509611|FG005|Overall Study|Withdrew Consent|3|||
164310190|NCT00953056|593509606|FG000|Overall Study|Serious Adverse Event|0|||
164310191|NCT00953056|593509607|FG001|Overall Study|Serious Adverse Event|0|||
164310192|NCT00953056|593509608|FG002|Overall Study|Serious Adverse Event|0|||
164310193|NCT00953056|593509609|FG003|Overall Study|Serious Adverse Event|0|||
164310194|NCT00953056|593509610|FG004|Overall Study|Serious Adverse Event|0|||
164310195|NCT00953056|593509611|FG005|Overall Study|Serious Adverse Event|1|||
164310196|NCT02442804|593509615|FG000|Overall Study|Withdrawal by Subject|0|||
164310197|NCT02442804|593509616|FG001|Overall Study|Withdrawal by Subject|1|||
164310198|NCT02442804|593509615|FG000|Overall Study|Adverse Event|1|||
164310199|NCT02442804|593509616|FG001|Overall Study|Adverse Event|0|||
164310200|NCT02527421|593509623|FG000|Overall Study|Withdrawal by Subject|1|||
164310201|NCT02527421|593509624|FG001|Overall Study|Withdrawal by Subject|0|||
164310202|NCT04200352|593509625|FG000|Overall Study|Death|1|||
164658184|NCT06202521|594773444|FG000|Overall Study|Adverse Event|0|||
164658185|NCT06202521|594773445|FG001|Overall Study|Adverse Event|0|||
164658186|NCT06202521|594773446|FG002|Overall Study|Adverse Event|1|||
164310203|NCT04200352|593509625|FG000|Overall Study|Adverse Event|6|||
164310204|NCT04200352|593509625|FG000|Overall Study|Withdrawal by parent/guardian|6|||
164310205|NCT04200352|593509625|FG000|Overall Study|Lack of Efficacy|1|||
164310206|NCT04200352|593509625|FG000|Overall Study|Other than specified|6|||
164310207|NCT02541604|593509626|FG000|Overall Study|Death|6|||
164310208|NCT02541604|593509627|FG001|Overall Study|Death|5|||
164310209|NCT02541604|593509628|FG002|Overall Study|Death|7|||
164310210|NCT02541604|593509629|FG003|Overall Study|Death|2|||
164310211|NCT02541604|593509630|FG004|Overall Study|Death|9|||
164310212|NCT02541604|593509631|FG005|Overall Study|Death|8|||
164310213|NCT02541604|593509632|FG006|Overall Study|Death|9|||
164310214|NCT02541604|593509633|FG007|Overall Study|Death|9|||
164310215|NCT02541604|593509634|FG008|Overall Study|Death|3|||
164310216|NCT02541604|593509635|FG009|Overall Study|Death|4|||
164310217|NCT02541604|593509636|FG010|Overall Study|Death|2|||
164310218|NCT02541604|593509637|FG011|Overall Study|Death|3|||
164310219|NCT02541604|593509626|FG000|Overall Study|Lost to Follow-up|2|||
164310220|NCT02541604|593509627|FG001|Overall Study|Lost to Follow-up|0|||
164310221|NCT02541604|593509628|FG002|Overall Study|Lost to Follow-up|1|||
164310222|NCT02541604|593509629|FG003|Overall Study|Lost to Follow-up|0|||
164310223|NCT02541604|593509630|FG004|Overall Study|Lost to Follow-up|0|||
164310224|NCT02541604|593509631|FG005|Overall Study|Lost to Follow-up|1|||
164310225|NCT02541604|593509632|FG006|Overall Study|Lost to Follow-up|1|||
164310226|NCT02541604|593509633|FG007|Overall Study|Lost to Follow-up|0|||
164553067|NCT02669017|594396859|FG004|Overall Study|Death|8|||
164553068|NCT02669017|594396860|FG005|Overall Study|Death|18|||
164553069|NCT02669017|594396861|FG006|Overall Study|Death|10|||
164553070|NCT02669017|594396862|FG007|Overall Study|Death|47|||
164553071|NCT02669017|594396863|FG008|Overall Study|Death|20|||
164553072|NCT02669017|594396855|FG000|Overall Study|Withdrawal by Subject|0|||
164553073|NCT02669017|594396856|FG001|Overall Study|Withdrawal by Subject|0|||
164553074|NCT02669017|594396857|FG002|Overall Study|Withdrawal by Subject|0|||
164553075|NCT02669017|594396858|FG003|Overall Study|Withdrawal by Subject|1|||
164553076|NCT02669017|594396859|FG004|Overall Study|Withdrawal by Subject|2|||
164553077|NCT02669017|594396860|FG005|Overall Study|Withdrawal by Subject|0|||
164553078|NCT02669017|594396861|FG006|Overall Study|Withdrawal by Subject|0|||
164553079|NCT02669017|594396862|FG007|Overall Study|Withdrawal by Subject|2|||
164553080|NCT02669017|594396863|FG008|Overall Study|Withdrawal by Subject|2|||
164553081|NCT02669017|594396855|FG000|Overall Study|Lost to Follow-up|0|||
164553082|NCT02669017|594396856|FG001|Overall Study|Lost to Follow-up|0|||
164553083|NCT02669017|594396857|FG002|Overall Study|Lost to Follow-up|0|||
164553084|NCT02669017|594396858|FG003|Overall Study|Lost to Follow-up|0|||
164553085|NCT02669017|594396859|FG004|Overall Study|Lost to Follow-up|0|||
164553086|NCT02669017|594396860|FG005|Overall Study|Lost to Follow-up|0|||
164553087|NCT02669017|594396861|FG006|Overall Study|Lost to Follow-up|0|||
164553088|NCT02669017|594396862|FG007|Overall Study|Lost to Follow-up|0|||
164553089|NCT02669017|594396863|FG008|Overall Study|Lost to Follow-up|1|||
164553090|NCT02669017|594396855|FG000|Overall Study|Miscellaneous|0|||
164553091|NCT02669017|594396856|FG001|Overall Study|Miscellaneous|0|||
164553092|NCT02669017|594396857|FG002|Overall Study|Miscellaneous|0|||
164553093|NCT02669017|594396858|FG003|Overall Study|Miscellaneous|0|||
164553094|NCT02669017|594396859|FG004|Overall Study|Miscellaneous|2|||
164553095|NCT02669017|594396860|FG005|Overall Study|Miscellaneous|1|||
164553096|NCT02669017|594396861|FG006|Overall Study|Miscellaneous|1|||
164553097|NCT02669017|594396862|FG007|Overall Study|Miscellaneous|13|||
164553098|NCT02669017|594396863|FG008|Overall Study|Miscellaneous|2|||
164553099|NCT04091087|594396864|FG000|Overall Study|Not treated|1|||
164553100|NCT04091087|594396865|FG001|Overall Study|Not treated|0|||
164553101|NCT04091087|594396864|FG000|Overall Study|Adverse Event|4|||
164553102|NCT04091087|594396865|FG001|Overall Study|Adverse Event|4|||
164553103|NCT04091087|594396864|FG000|Overall Study|Protocol Violation|0|||
164553104|NCT04091087|594396865|FG001|Overall Study|Protocol Violation|1|||
164553105|NCT04091087|594396864|FG000|Overall Study|Withdrawal by Subject|5|||
164553106|NCT04091087|594396865|FG001|Overall Study|Withdrawal by Subject|2|||
164553107|NCT04152161|594396866|FG000|Overall Study|Death|0|||
164553108|NCT04152161|594396867|FG001|Overall Study|Death|1|||
164553109|NCT04152161|594396866|FG000|Overall Study|Physician Decision|0|||
164553110|NCT04152161|594396867|FG001|Overall Study|Physician Decision|1|||
164553111|NCT04152161|594396866|FG000|Overall Study|Lost to Follow-up|9|||
164553112|NCT04152161|594396867|FG001|Overall Study|Lost to Follow-up|3|||
164553113|NCT04152161|594396866|FG000|Overall Study|Protocol Violation|1|||
164553114|NCT04152161|594396867|FG001|Overall Study|Protocol Violation|0|||
164553115|NCT04152161|594396866|FG000|Overall Study|Withdrawal by Subject|29|||
164553116|NCT04152161|594396867|FG001|Overall Study|Withdrawal by Subject|28|||
164553117|NCT04152161|594396866|FG000|Overall Study|Sponsor termination of study|750|||
164553118|NCT04152161|594396867|FG001|Overall Study|Sponsor termination of study|755|||
164553119|NCT04152161|594396866|FG000|Overall Study|Other|20|||
164553120|NCT04152161|594396867|FG001|Overall Study|Other|18|||
164553121|NCT00915681|594396868|FG000|Overall Study|Screening failures|46|||
164553122|NCT01098071|594396875|FG000|Overall Study|Surgery (adenoidectomy)|2|||
164553123|NCT01098071|594396875|FG000|Overall Study|Lost to Follow-up|13|||
164553124|NCT00382993|594396878|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
164553125|NCT00382993|594396879|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
164553126|NCT00382993|594396878|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
164553127|NCT00382993|594396879|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
164553128|NCT00382993|594396878|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
164658187|NCT06202521|594773447|FG003|Overall Study|Adverse Event|0|||
164310227|NCT02541604|593509634|FG008|Overall Study|Lost to Follow-up|0|||
164553129|NCT00382993|594396879|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
164553130|NCT00382993|594396878|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
164553131|NCT00382993|594396879|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
164553132|NCT00382993|594396878|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
164553133|NCT00382993|594396879|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
164658188|NCT00871728|594773450|FG000|Overall Study|Adverse Event|1|||
164553134|NCT00382993|594396878|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
164553135|NCT00382993|594396879|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
164553136|NCT00382993|594396878|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
164553137|NCT00382993|594396879|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
164553138|NCT00382993|594396878|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
164553139|NCT00382993|594396879|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
164553140|NCT00382993|594396878|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
164553141|NCT00382993|594396879|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
164553142|NCT00382993|594396878|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
164553143|NCT00382993|594396879|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
164553144|NCT01965262|594396897|FG000|Second Intervention (7 Days)|Discontinued|0|||
164553145|NCT01965262|594396898|FG001|Second Intervention (7 Days)|Discontinued|1|||
164553146|NCT01965262|594396897|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
164553147|NCT01965262|594396898|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
164553148|NCT01965262|594396897|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
164553149|NCT01965262|594396898|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
164553150|NCT01029366|594396899|FG000|Overall Study|Withdrawal by Subject|1|||
164553151|NCT01029366|594396900|FG001|Overall Study|Withdrawal by Subject|0|||
164553152|NCT01029366|594396899|FG000|Overall Study|Death|1|||
164553153|NCT01029366|594396900|FG001|Overall Study|Death|1|||
164553154|NCT01029366|594396899|FG000|Overall Study|disease progression|2|||
164553155|NCT01029366|594396900|FG001|Overall Study|disease progression|0|||
164553156|NCT01029366|594396899|FG000|Overall Study|manufacturing failure|0|||
164553157|NCT01029366|594396900|FG001|Overall Study|manufacturing failure|1|||
164553158|NCT00906087|594396906|FG000|Initial Washout|Withdrawal by Subject|1|||
164553159|NCT00906087|594396906|FG000|Initial Washout|Physician Decision|1|||
164553160|NCT00440947|594396907|FG000|36-Week Induction Phase|Adverse Event|16|||
164553161|NCT00440947|594396908|FG001|36-Week Induction Phase|Adverse Event|0|||
164553162|NCT00440947|594396909|FG002|36-Week Induction Phase|Adverse Event|0|||
164553163|NCT00440947|594396910|FG003|36-Week Induction Phase|Adverse Event|0|||
164553164|NCT00440947|594396911|FG004|36-Week Induction Phase|Adverse Event|0|||
164553165|NCT00440947|594396907|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
164553166|NCT00440947|594396908|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
164553167|NCT00440947|594396909|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
164553168|NCT00440947|594396910|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
164553169|NCT00440947|594396911|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
164553170|NCT00440947|594396907|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
164553171|NCT00440947|594396908|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
164553172|NCT00440947|594396909|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
164553173|NCT00440947|594396910|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
164553174|NCT00440947|594396911|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
164553175|NCT00440947|594396907|FG000|36-Week Induction Phase|Non-compliance|10|||
164553176|NCT00440947|594396908|FG001|36-Week Induction Phase|Non-compliance|0|||
164553177|NCT00440947|594396909|FG002|36-Week Induction Phase|Non-compliance|0|||
164553178|NCT00440947|594396910|FG003|36-Week Induction Phase|Non-compliance|0|||
164553179|NCT00440947|594396911|FG004|36-Week Induction Phase|Non-compliance|0|||
164553180|NCT00440947|594396907|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
164553181|NCT00440947|594396908|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
164553182|NCT00440947|594396909|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
164553183|NCT00440947|594396910|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
164553184|NCT00440947|594396911|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
164553185|NCT00440947|594396907|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
164553186|NCT00440947|594396908|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
164553187|NCT00440947|594396909|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
164553188|NCT00440947|594396910|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
164553189|NCT00440947|594396911|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
164553190|NCT00440947|594396907|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
164553191|NCT00440947|594396908|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
164553192|NCT00440947|594396909|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
164553193|NCT00440947|594396910|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
164553194|NCT00440947|594396911|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
164201385|NCT03154086|593110733|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164553195|NCT00440947|594396907|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
164553196|NCT00440947|594396908|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
164201386|NCT03154086|593110734|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164201387|NCT03154086|593110735|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164201388|NCT03154086|593110736|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164201389|NCT03154086|593110737|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164420596|NCT01890967|593910947|FG001|Overall Study|Lost to Follow-up|1|||
164658189|NCT00871728|594773450|FG000|Overall Study|Protocol Violation|7|||
164658190|NCT00871728|594773450|FG000|Overall Study|Lost to Follow-up|2|||
164658191|NCT00871728|594773450|FG000|Overall Study|Failed to Visit Hospital|4|||
164658192|NCT00871728|594773450|FG000|Overall Study|Participant Non-compliance|1|||
164658193|NCT00871728|594773450|FG000|Overall Study|Withdrawal of Informed Consent|5|||
164658194|NCT02717611|594773454|FG000|Overall Study|Death|13|||
164658195|NCT02717611|594773454|FG000|Overall Study|Withdrawal by Subject|6|||
164658196|NCT02717611|594773454|FG000|Overall Study|Active, not recruiting|40|||
164658197|NCT02717611|594773454|FG000|Overall Study|Complicating disease|1|||
164658198|NCT00616928|594773457|FG000|Overall Study|Adverse Event|6|||
164658199|NCT00616928|594773458|FG001|Overall Study|Adverse Event|3|||
164658200|NCT00616928|594773459|FG002|Overall Study|Adverse Event|2|||
164658201|NCT00616928|594773460|FG003|Overall Study|Adverse Event|2|||
164658202|NCT00616928|594773457|FG000|Overall Study|Other|51|||
164658203|NCT00616928|594773458|FG001|Overall Study|Other|8|||
164658204|NCT00616928|594773459|FG002|Overall Study|Other|15|||
164658205|NCT00616928|594773460|FG003|Overall Study|Other|5|||
164658206|NCT00616928|594773457|FG000|Overall Study|Lost to Follow-up|5|||
164658207|NCT00616928|594773458|FG001|Overall Study|Lost to Follow-up|7|||
164658208|NCT00616928|594773459|FG002|Overall Study|Lost to Follow-up|0|||
164658209|NCT00616928|594773460|FG003|Overall Study|Lost to Follow-up|0|||
164658210|NCT05182606|594773465|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|29|||
164658211|NCT04535583|594773470|FG000|Overall Study|Lost to Follow-up|1|||
164658212|NCT04535583|594773470|FG000|Overall Study|Physician Decision|1|||
164658213|NCT04535583|594773470|FG000|Overall Study|Withdrawal by Subject|1|||
164658214|NCT01748890|594773472|FG000|Overall Study|Insufficient recruitment for analysis|4|||
164658215|NCT02669264|594773473|FG000|Overall Study|Death|5|||
164658216|NCT02669264|594773474|FG001|Overall Study|Death|5|||
164658217|NCT02669264|594773475|FG002|Overall Study|Death|3|||
164658218|NCT02669264|594773476|FG003|Overall Study|Death|3|||
164658219|NCT02669264|594773477|FG004|Overall Study|Death|3|||
164658220|NCT02669264|594773478|FG005|Overall Study|Death|6|||
164658221|NCT02669264|594773479|FG006|Overall Study|Death|3|||
164658222|NCT02669264|594773473|FG000|Overall Study|Withdrawal by Subject|0|||
164658223|NCT02669264|594773474|FG001|Overall Study|Withdrawal by Subject|1|||
164658224|NCT02669264|594773475|FG002|Overall Study|Withdrawal by Subject|0|||
164658225|NCT02669264|594773476|FG003|Overall Study|Withdrawal by Subject|0|||
164658226|NCT02669264|594773477|FG004|Overall Study|Withdrawal by Subject|1|||
164658227|NCT02669264|594773478|FG005|Overall Study|Withdrawal by Subject|0|||
164658228|NCT02669264|594773479|FG006|Overall Study|Withdrawal by Subject|0|||
164658229|NCT02669264|594773473|FG000|Overall Study|Lost to Follow-up|0|||
164658230|NCT02669264|594773474|FG001|Overall Study|Lost to Follow-up|0|||
164658231|NCT02669264|594773475|FG002|Overall Study|Lost to Follow-up|0|||
164658232|NCT02669264|594773476|FG003|Overall Study|Lost to Follow-up|0|||
164658233|NCT02669264|594773477|FG004|Overall Study|Lost to Follow-up|1|||
164658234|NCT02669264|594773478|FG005|Overall Study|Lost to Follow-up|0|||
164658235|NCT02669264|594773479|FG006|Overall Study|Lost to Follow-up|0|||
164658236|NCT02669264|594773473|FG000|Overall Study|Miscellaneous|0|||
164658237|NCT02669264|594773474|FG001|Overall Study|Miscellaneous|0|||
164658238|NCT02669264|594773475|FG002|Overall Study|Miscellaneous|0|||
164658239|NCT02669264|594773476|FG003|Overall Study|Miscellaneous|0|||
164658240|NCT02669264|594773477|FG004|Overall Study|Miscellaneous|0|||
164658241|NCT02669264|594773478|FG005|Overall Study|Miscellaneous|0|||
164658242|NCT02669264|594773479|FG006|Overall Study|Miscellaneous|2|||
164658243|NCT01680159|594773480|FG000|Screening Period|Not meet criteria for dose-up period|7|||
164658244|NCT01680159|594773480|FG000|Increased Dose Period|Adverse Event|6|||
164658245|NCT01680159|594773480|FG000|Increased Dose Period|Withdrawal by Subject|2|||
164658246|NCT04128696|594773481|FG000|Overall Study|Lost to Follow-up|3|||
164658247|NCT04128696|594773482|FG001|Overall Study|Lost to Follow-up|7|||
164658248|NCT04128696|594773481|FG000|Overall Study|Withdrawal by Subject|12|||
164658249|NCT04128696|594773482|FG001|Overall Study|Withdrawal by Subject|11|||
164658250|NCT04128696|594773481|FG000|Overall Study|Study Closed/Terminated|26|||
164658251|NCT04128696|594773482|FG001|Overall Study|Study Closed/Terminated|38|||
164658252|NCT04128696|594773481|FG000|Overall Study|Physician Decision|2|||
164658253|NCT04128696|594773482|FG001|Overall Study|Physician Decision|3|||
164658254|NCT00772382|594773483|FG000|Overall Study|Adverse Event|19|||
164658255|NCT00772382|594773483|FG000|Overall Study|Death|6|||
164658256|NCT00772382|594773483|FG000|Overall Study|Lack of Efficacy|4|||
164310228|NCT02541604|593509635|FG009|Overall Study|Lost to Follow-up|0|||
164658257|NCT00772382|594773483|FG000|Overall Study|Physician Decision|5|||
164658258|NCT00772382|594773483|FG000|Overall Study|Protocol Violation|1|||
164658259|NCT00772382|594773483|FG000|Overall Study|Withdrawal by Subject|10|||
164658260|NCT00772382|594773483|FG000|Overall Study|Other Reasons|10|||
164658261|NCT05576012|594773488|FG000|Overall Study|Physician Decision|0|||
164658262|NCT05576012|594773489|FG001|Overall Study|Physician Decision|0|||
164310229|NCT02541604|593509636|FG010|Overall Study|Lost to Follow-up|0|||
164658263|NCT05576012|594773490|FG002|Overall Study|Physician Decision|0|||
164658264|NCT05576012|594773491|FG003|Overall Study|Physician Decision|0|||
164658265|NCT05576012|594773492|FG004|Overall Study|Physician Decision|0|||
164201390|NCT03154086|593110738|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164201391|NCT03154086|593110739|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164201392|NCT03154086|593110740|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164201393|NCT03154086|593110741|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164201394|NCT03154086|593110727|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
164201395|NCT03154086|593110728|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201396|NCT03154086|593110729|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201397|NCT03154086|593110730|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201398|NCT03154086|593110731|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201399|NCT03154086|593110732|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201400|NCT03154086|593110733|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201401|NCT03154086|593110734|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201402|NCT03154086|593110735|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201403|NCT03154086|593110736|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201404|NCT03154086|593110737|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201405|NCT03154086|593110738|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201406|NCT03154086|593110739|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201407|NCT03154086|593110740|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201408|NCT03154086|593110741|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201409|NCT03154086|593110727|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201410|NCT03154086|593110728|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201411|NCT03154086|593110729|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201412|NCT03154086|593110730|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201413|NCT03154086|593110731|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201414|NCT03154086|593110732|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201415|NCT03154086|593110733|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201416|NCT03154086|593110734|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201417|NCT03154086|593110735|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
164201418|NCT03154086|593110736|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201419|NCT03154086|593110737|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201420|NCT03154086|593110738|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201421|NCT03154086|593110739|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201422|NCT03154086|593110740|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201423|NCT03154086|593110741|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201424|NCT03154086|593110727|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201425|NCT03154086|593110728|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201426|NCT03154086|593110729|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201427|NCT03154086|593110730|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201428|NCT03154086|593110731|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201429|NCT03154086|593110732|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201430|NCT03154086|593110733|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201431|NCT03154086|593110734|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
164201432|NCT03154086|593110735|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164553197|NCT00440947|594396909|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
164553198|NCT00440947|594396910|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
164553199|NCT00440947|594396911|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
164553200|NCT00440947|594396907|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
164553201|NCT00440947|594396908|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
164553202|NCT00440947|594396909|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
164553203|NCT00440947|594396910|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
164553204|NCT00440947|594396911|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
164553205|NCT00440947|594396907|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
164553206|NCT00440947|594396908|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
164553207|NCT00440947|594396909|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
164553208|NCT00440947|594396910|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
164553209|NCT00440947|594396911|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
164553210|NCT00440947|594396907|FG000|36-Week Induction Phase|Incarceration|3|||
164553211|NCT00440947|594396908|FG001|36-Week Induction Phase|Incarceration|0|||
164553212|NCT00440947|594396909|FG002|36-Week Induction Phase|Incarceration|0|||
164553213|NCT00440947|594396910|FG003|36-Week Induction Phase|Incarceration|0|||
164553214|NCT00440947|594396911|FG004|36-Week Induction Phase|Incarceration|0|||
164553215|NCT00440947|594396907|FG000|36-Week Induction Phase|Pregnancy|1|||
164553216|NCT00440947|594396908|FG001|36-Week Induction Phase|Pregnancy|0|||
164553217|NCT00440947|594396909|FG002|36-Week Induction Phase|Pregnancy|0|||
164553218|NCT00440947|594396910|FG003|36-Week Induction Phase|Pregnancy|0|||
164201433|NCT03154086|593110736|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201434|NCT03154086|593110737|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201435|NCT03154086|593110738|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201436|NCT03154086|593110739|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201437|NCT03154086|593110740|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201438|NCT03154086|593110741|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201439|NCT03154086|593110727|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
164201440|NCT03154086|593110728|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
164201441|NCT03154086|593110729|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
164201442|NCT03154086|593110730|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
164201443|NCT03154086|593110731|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
164201444|NCT03154086|593110732|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
164201445|NCT03154086|593110733|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
164201446|NCT03154086|593110734|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
164201447|NCT03154086|593110735|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
164201448|NCT03154086|593110736|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
164201449|NCT03154086|593110737|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
164201450|NCT03154086|593110738|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
164201451|NCT03154086|593110739|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
164201452|NCT03154086|593110740|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
164201453|NCT03154086|593110741|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
164201454|NCT01603277|593110742|FG000|Overall Study|Adverse Event|1|||
164201455|NCT01603277|593110743|FG001|Overall Study|Adverse Event|2|||
164201456|NCT01603277|593110742|FG000|Overall Study|Physician Decision|0|||
164553219|NCT00440947|594396911|FG004|36-Week Induction Phase|Pregnancy|0|||
164553220|NCT00440947|594396907|FG000|48-Week Randomization Phase|Adverse Event|0|||
164553221|NCT00440947|594396908|FG001|48-Week Randomization Phase|Adverse Event|2|||
164553222|NCT00440947|594396909|FG002|48-Week Randomization Phase|Adverse Event|5|||
164553223|NCT00440947|594396910|FG003|48-Week Randomization Phase|Adverse Event|0|||
164553224|NCT00440947|594396911|FG004|48-Week Randomization Phase|Adverse Event|0|||
164553225|NCT00440947|594396907|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
164553226|NCT00440947|594396908|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
164553227|NCT00440947|594396909|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
164553228|NCT00440947|594396910|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
164553229|NCT00440947|594396911|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
164553230|NCT00440947|594396907|FG000|48-Week Randomization Phase|Non-compliance|0|||
164553231|NCT00440947|594396908|FG001|48-Week Randomization Phase|Non-compliance|3|||
164553232|NCT00440947|594396909|FG002|48-Week Randomization Phase|Non-compliance|4|||
164553233|NCT00440947|594396910|FG003|48-Week Randomization Phase|Non-compliance|0|||
164553234|NCT00440947|594396911|FG004|48-Week Randomization Phase|Non-compliance|0|||
164553235|NCT00440947|594396907|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
164553236|NCT00440947|594396908|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
164553237|NCT00440947|594396909|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
164553238|NCT00440947|594396910|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
164553239|NCT00440947|594396911|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
164553240|NCT00440947|594396907|FG000|48-Week Randomization Phase|Protocol Violation|0|||
164553241|NCT00440947|594396908|FG001|48-Week Randomization Phase|Protocol Violation|0|||
164553242|NCT00440947|594396909|FG002|48-Week Randomization Phase|Protocol Violation|1|||
164553243|NCT00440947|594396910|FG003|48-Week Randomization Phase|Protocol Violation|0|||
164553244|NCT00440947|594396911|FG004|48-Week Randomization Phase|Protocol Violation|0|||
164553245|NCT00440947|594396907|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
164553246|NCT00440947|594396908|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
164553247|NCT00440947|594396909|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
164553248|NCT00440947|594396910|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
164553249|NCT00440947|594396911|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
164553250|NCT00440947|594396907|FG000|48-Week Randomization Phase|Pregnancy|0|||
164553251|NCT00440947|594396908|FG001|48-Week Randomization Phase|Pregnancy|0|||
164553252|NCT00440947|594396909|FG002|48-Week Randomization Phase|Pregnancy|1|||
164553253|NCT00440947|594396910|FG003|48-Week Randomization Phase|Pregnancy|0|||
164553254|NCT00440947|594396911|FG004|48-Week Randomization Phase|Pregnancy|0|||
164553255|NCT00440947|594396907|FG000|48-Week Randomization Phase|Incarceration|0|||
164553256|NCT00440947|594396908|FG001|48-Week Randomization Phase|Incarceration|3|||
164553257|NCT00440947|594396909|FG002|48-Week Randomization Phase|Incarceration|0|||
164553258|NCT00440947|594396910|FG003|48-Week Randomization Phase|Incarceration|0|||
164553259|NCT00440947|594396911|FG004|48-Week Randomization Phase|Incarceration|0|||
164553260|NCT00440947|594396907|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
164553261|NCT00440947|594396908|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
164553262|NCT00440947|594396909|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
164553263|NCT00440947|594396910|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
164553264|NCT00440947|594396911|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
164553265|NCT00440947|594396907|FG000|48-Week Randomization Phase|Physician Decision|0|||
164658266|NCT05576012|594773493|FG005|Overall Study|Physician Decision|0|||
164658267|NCT05576012|594773494|FG006|Overall Study|Physician Decision|0|||
164658268|NCT05576012|594773495|FG007|Overall Study|Physician Decision|0|||
164658269|NCT05576012|594773496|FG008|Overall Study|Physician Decision|1|||
164658270|NCT05576012|594773497|FG009|Overall Study|Physician Decision|0|||
164658271|NCT03731182|594774780|FG000|Overall Study|Lost to Follow-up|2|||
164658272|NCT03731182|594774781|FG001|Overall Study|Lost to Follow-up|0|||
164658273|NCT03731182|594774780|FG000|Overall Study|Physician Decision|1|||
164658274|NCT03731182|594774781|FG001|Overall Study|Physician Decision|0|||
164658275|NCT03731182|594774780|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
164658276|NCT03731182|594774781|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
164658277|NCT00449072|594774788|FG000|Overall Study|Adverse Event|3|||
164658278|NCT00449072|594774789|FG001|Overall Study|Adverse Event|1|||
164658279|NCT00449072|594774788|FG000|Overall Study|Protocol Violation|14|||
164658280|NCT00449072|594774789|FG001|Overall Study|Protocol Violation|12|||
164658281|NCT00449072|594774788|FG000|Overall Study|Lost to Follow-up|5|||
164658282|NCT00449072|594774789|FG001|Overall Study|Lost to Follow-up|7|||
164658283|NCT00449072|594774788|FG000|Overall Study|Withdrawal by Subject|11|||
164658284|NCT00449072|594774789|FG001|Overall Study|Withdrawal by Subject|8|||
164658285|NCT00449072|594774788|FG000|Overall Study|Lack of Efficacy|1|||
164658286|NCT00449072|594774789|FG001|Overall Study|Lack of Efficacy|1|||
164658287|NCT00449072|594774788|FG000|Overall Study|Physician Decision|1|||
164658288|NCT00449072|594774789|FG001|Overall Study|Physician Decision|0|||
164658289|NCT00449072|594774788|FG000|Overall Study|Not treated|0|||
164658290|NCT00449072|594774789|FG001|Overall Study|Not treated|1|||
164658291|NCT00449072|594774788|FG000|Overall Study|Excluded medication|0|||
164658292|NCT00449072|594774789|FG001|Overall Study|Excluded medication|2|||
164658293|NCT00449072|594774788|FG000|Overall Study|Non-compliance|2|||
164658294|NCT00449072|594774789|FG001|Overall Study|Non-compliance|5|||
164658295|NCT00449072|594774788|FG000|Overall Study|Sponsor decision|1|||
164658296|NCT00449072|594774789|FG001|Overall Study|Sponsor decision|3|||
164658297|NCT00449072|594774788|FG000|Overall Study|Relocation|3|||
164658298|NCT00449072|594774789|FG001|Overall Study|Relocation|2|||
164658299|NCT03036579|594774790|FG000|2 Years|Lost to Follow-up|1|||
164658300|NCT03036579|594774791|FG001|2 Years|Lost to Follow-up|0|||
164658301|NCT03036579|594774790|FG000|3 Years|Lost to Follow-up|0|||
164658302|NCT03036579|594774791|FG001|3 Years|Lost to Follow-up|1|||
164658303|NCT02352337|594774792|FG000|Overall Study|Patients never treated|4|||
164658304|NCT02352337|594774793|FG001|Overall Study|Patients never treated|1|||
164658305|NCT02352337|594774794|FG002|Overall Study|Patients never treated|2|||
164658306|NCT02458638|594774797|FG000|Overall Study|Death|309|||
164658307|NCT02458638|594774797|FG000|Overall Study|End of Cohort/End of Study|67|||
164658308|NCT02458638|594774797|FG000|Overall Study|Lost to Follow-up|31|||
164658309|NCT02458638|594774797|FG000|Overall Study|Other Reasons|4|||
164658310|NCT02458638|594774797|FG000|Overall Study|Physician Decision|1|||
164658311|NCT02458638|594774797|FG000|Overall Study|Withdrawal by Subject|47|||
164658312|NCT00576901|594774809|FG000|Overall Study|Withdrawal by Subject|1|||
164658313|NCT00576901|594774809|FG000|Overall Study|Disease course|1|||
164658314|NCT00576901|594774809|FG000|Overall Study|Protocol Violation|1|||
164658315|NCT02398188|594774810|FG000|Overall Study|Adverse Event|2|||
164658316|NCT02398188|594774811|FG001|Overall Study|Adverse Event|3|||
164658317|NCT02398188|594774810|FG000|Overall Study|Lost to Follow-up|5|||
164658318|NCT02398188|594774811|FG001|Overall Study|Lost to Follow-up|0|||
164658319|NCT02398188|594774810|FG000|Overall Study|Non-compliance|4|||
164658320|NCT02398188|594774811|FG001|Overall Study|Non-compliance|4|||
164658321|NCT02398188|594774810|FG000|Overall Study|Protocol Violation|6|||
164658322|NCT02398188|594774811|FG001|Overall Study|Protocol Violation|10|||
164658323|NCT02398188|594774810|FG000|Overall Study|Sponsor Decision|2|||
164658324|NCT02398188|594774811|FG001|Overall Study|Sponsor Decision|1|||
164658325|NCT02398188|594774810|FG000|Overall Study|Pregnancy|1|||
164658326|NCT02398188|594774811|FG001|Overall Study|Pregnancy|0|||
164658327|NCT02398188|594774810|FG000|Overall Study|Withdrawal by Subject|7|||
164658328|NCT02398188|594774811|FG001|Overall Study|Withdrawal by Subject|16|||
164658329|NCT01259869|594774812|FG000|Overall Study|Duplicated registration|1|||
164658330|NCT05245617|594774813|FG000|Overall Study|Withdrawal by Subject|1|||
164658331|NCT00620763|594774814|FG000|Period: First Intervention|Withdrawal by Subject|0|||
164658332|NCT00620763|594774815|FG001|Period: First Intervention|Withdrawal by Subject|2|||
164658333|NCT00620763|594774814|FG000|Period: First Intervention|Protocol Violation|0|||
164658334|NCT00620763|594774815|FG001|Period: First Intervention|Protocol Violation|3|||
164658335|NCT00620763|594774814|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
164658336|NCT00620763|594774815|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
164658337|NCT00729859|594774816|FG000|Overall Study|Adverse Event|0|||
164658338|NCT00729859|594774817|FG001|Overall Study|Adverse Event|1|||
164658339|NCT00729859|594774818|FG002|Overall Study|Adverse Event|0|||
164658340|NCT00729859|594774816|FG000|Overall Study|Withdrawal by Subject|0|||
164658341|NCT00729859|594774817|FG001|Overall Study|Withdrawal by Subject|1|||
164658342|NCT00729859|594774818|FG002|Overall Study|Withdrawal by Subject|0|||
164658343|NCT00760383|594774819|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
164658344|NCT00760383|594774820|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
164553266|NCT00440947|594396908|FG001|48-Week Randomization Phase|Physician Decision|2|||
164553267|NCT00440947|594396909|FG002|48-Week Randomization Phase|Physician Decision|0|||
164553268|NCT00440947|594396910|FG003|48-Week Randomization Phase|Physician Decision|0|||
164553269|NCT00440947|594396911|FG004|48-Week Randomization Phase|Physician Decision|0|||
164553270|NCT00440947|594396907|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
164553271|NCT00440947|594396908|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
164553272|NCT00440947|594396909|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
164553273|NCT00440947|594396910|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
164553274|NCT00440947|594396911|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
164553275|NCT00440947|594396907|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
164553276|NCT00440947|594396908|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
164553277|NCT00440947|594396909|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
164553278|NCT00440947|594396910|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
164553279|NCT00440947|594396911|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
164553280|NCT00440947|594396907|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
164553281|NCT00440947|594396908|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
164553282|NCT00440947|594396909|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
164553283|NCT00440947|594396910|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
164553284|NCT00440947|594396911|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
164553285|NCT00440947|594396907|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
164553286|NCT00440947|594396908|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
164553287|NCT00440947|594396909|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
164553288|NCT00440947|594396910|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
164553289|NCT00440947|594396911|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
164553290|NCT00440947|594396907|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
164553291|NCT00440947|594396908|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
164553292|NCT00440947|594396909|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
164553293|NCT00440947|594396910|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
164553294|NCT00440947|594396911|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
164553295|NCT00440947|594396907|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
164553296|NCT00440947|594396908|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
164553297|NCT00440947|594396909|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
164553298|NCT00440947|594396910|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
164553299|NCT00440947|594396911|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
164553300|NCT00440947|594396907|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
164553301|NCT00440947|594396908|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
164553302|NCT00440947|594396909|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
164553303|NCT00440947|594396910|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
164553304|NCT00440947|594396911|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
164553305|NCT00440947|594396907|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
164553306|NCT00440947|594396908|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
164553307|NCT00440947|594396909|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
164553308|NCT00440947|594396910|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
164553309|NCT00440947|594396911|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
164553310|NCT00440947|594396907|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
164553311|NCT00440947|594396908|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
164553312|NCT00440947|594396909|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
164553313|NCT00440947|594396910|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
164553314|NCT00440947|594396911|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
164553315|NCT00440947|594396907|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
164553316|NCT00440947|594396908|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
164553317|NCT00440947|594396909|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
164553318|NCT00440947|594396910|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
164553319|NCT00440947|594396911|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
164553320|NCT00440947|594396907|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
164658345|NCT01336894|594774821|FG000|Follow-up|Study terminated prematurely|2|||
164201457|NCT01603277|593110743|FG001|Overall Study|Physician Decision|1|||
164201458|NCT01603277|593110742|FG000|Overall Study|Protocol Violation|6|||
164201459|NCT01603277|593110743|FG001|Overall Study|Protocol Violation|10|||
164201460|NCT01603277|593110742|FG000|Overall Study|Withdrawal by Subject|5|||
164201461|NCT01603277|593110743|FG001|Overall Study|Withdrawal by Subject|4|||
164201462|NCT01603277|593110742|FG000|Overall Study|Non-Compliance|2|||
164201463|NCT01603277|593110743|FG001|Overall Study|Non-Compliance|1|||
164201464|NCT01701245|593110748|FG000|Overall Study|Protocol Violation|1|||
164201465|NCT01701245|593110749|FG001|Overall Study|Protocol Violation|3|||
164658346|NCT01336894|594774822|FG001|Follow-up|Study terminated prematurely|7|||
164658347|NCT05034731|594774823|FG000|Overall Study|Screen fail|1|||
164201466|NCT01701245|593110748|FG000|Overall Study|Did not complete the open label period|11|||
164310230|NCT02541604|593509637|FG011|Overall Study|Lost to Follow-up|0|||
164310231|NCT02541604|593509626|FG000|Overall Study|Withdrawal by Subject|2|||
164310232|NCT02541604|593509627|FG001|Overall Study|Withdrawal by Subject|0|||
164310233|NCT02541604|593509628|FG002|Overall Study|Withdrawal by Subject|1|||
164310234|NCT02541604|593509629|FG003|Overall Study|Withdrawal by Subject|0|||
164310235|NCT02541604|593509630|FG004|Overall Study|Withdrawal by Subject|1|||
164310236|NCT02541604|593509631|FG005|Overall Study|Withdrawal by Subject|1|||
164553321|NCT00440947|594396908|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
164553322|NCT00440947|594396909|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
164553323|NCT00440947|594396910|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
164553324|NCT00440947|594396911|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
164553325|NCT00440947|594396907|FG000|Optional 60-Week Extension Phase|Other|0|||
164553326|NCT00440947|594396908|FG001|Optional 60-Week Extension Phase|Other|0|||
164553327|NCT00440947|594396909|FG002|Optional 60-Week Extension Phase|Other|0|||
164553328|NCT00440947|594396910|FG003|Optional 60-Week Extension Phase|Other|1|||
164553329|NCT00440947|594396911|FG004|Optional 60-Week Extension Phase|Other|0|||
164553330|NCT00440947|594396907|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
164553331|NCT00440947|594396908|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
164553332|NCT00440947|594396909|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
164553333|NCT00440947|594396910|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
164553334|NCT00440947|594396911|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
164553335|NCT00440947|594396907|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
164553336|NCT00440947|594396908|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
164553337|NCT00440947|594396909|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
164553338|NCT00440947|594396910|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
164553339|NCT00440947|594396911|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
164553340|NCT02898259|594396912|FG000|Overall Study|Adverse Event|0|||
164553341|NCT02898259|594396913|FG001|Overall Study|Adverse Event|0|||
164553342|NCT02898259|594396914|FG002|Overall Study|Adverse Event|1|||
164553343|NCT02898259|594396915|FG003|Overall Study|Adverse Event|0|||
164553344|NCT02898259|594396916|FG004|Overall Study|Adverse Event|0|||
164553345|NCT02898259|594396912|FG000|Overall Study|Lack of Efficacy|1|||
164553346|NCT02898259|594396913|FG001|Overall Study|Lack of Efficacy|1|||
164553347|NCT02898259|594396914|FG002|Overall Study|Lack of Efficacy|3|||
164553348|NCT02898259|594396915|FG003|Overall Study|Lack of Efficacy|0|||
164553349|NCT02898259|594396916|FG004|Overall Study|Lack of Efficacy|0|||
164553350|NCT02898259|594396912|FG000|Overall Study|Lost to Follow-up|0|||
164553351|NCT02898259|594396913|FG001|Overall Study|Lost to Follow-up|0|||
164553352|NCT02898259|594396914|FG002|Overall Study|Lost to Follow-up|1|||
164553353|NCT02898259|594396915|FG003|Overall Study|Lost to Follow-up|0|||
164553354|NCT02898259|594396916|FG004|Overall Study|Lost to Follow-up|0|||
164553355|NCT02898259|594396912|FG000|Overall Study|Transformation before study began|0|||
164553356|NCT02898259|594396913|FG001|Overall Study|Transformation before study began|0|||
164553357|NCT02898259|594396914|FG002|Overall Study|Transformation before study began|0|||
164553358|NCT02898259|594396915|FG003|Overall Study|Transformation before study began|1|||
164553359|NCT02898259|594396916|FG004|Overall Study|Transformation before study began|0|||
164553360|NCT01834274|594396922|FG000|Overall Study|Study Termination|41|||
164553361|NCT01834274|594396923|FG001|Overall Study|Study Termination|38|||
164553362|NCT01834274|594396922|FG000|Overall Study|Withdrawal by Subject|1|||
164658348|NCT05034731|594774824|FG001|Overall Study|Screen fail|1|||
164658349|NCT01725451|594774832|FG000|Period 1|Withdrawal by Subject|1|||
164658350|NCT01725451|594774833|FG001|Period 1|Withdrawal by Subject|0|||
164310237|NCT02541604|593509632|FG006|Overall Study|Withdrawal by Subject|0|||
164310238|NCT02541604|593509633|FG007|Overall Study|Withdrawal by Subject|0|||
164310239|NCT02541604|593509634|FG008|Overall Study|Withdrawal by Subject|1|||
164310240|NCT02541604|593509635|FG009|Overall Study|Withdrawal by Subject|0|||
164310241|NCT02541604|593509636|FG010|Overall Study|Withdrawal by Subject|0|||
164310242|NCT02541604|593509637|FG011|Overall Study|Withdrawal by Subject|0|||
164310243|NCT02541604|593509626|FG000|Overall Study|Study Terminated by Sponsor|1|||
164310244|NCT02541604|593509627|FG001|Overall Study|Study Terminated by Sponsor|4|||
164310245|NCT02541604|593509628|FG002|Overall Study|Study Terminated by Sponsor|2|||
164310246|NCT02541604|593509629|FG003|Overall Study|Study Terminated by Sponsor|1|||
164310247|NCT02541604|593509630|FG004|Overall Study|Study Terminated by Sponsor|0|||
164310248|NCT02541604|593509631|FG005|Overall Study|Study Terminated by Sponsor|0|||
164310249|NCT02541604|593509632|FG006|Overall Study|Study Terminated by Sponsor|0|||
164553363|NCT01834274|594396923|FG001|Overall Study|Withdrawal by Subject|1|||
164553364|NCT01834274|594396922|FG000|Overall Study|Lost to Follow-up|3|||
164553365|NCT01834274|594396923|FG001|Overall Study|Lost to Follow-up|1|||
164553366|NCT01834274|594396922|FG000|Overall Study|Other|2|||
164553367|NCT01834274|594396923|FG001|Overall Study|Other|1|||
164658351|NCT01725451|594774834|FG002|Period 1|Withdrawal by Subject|0|||
164658352|NCT01725451|594774835|FG003|Period 1|Withdrawal by Subject|0|||
164310250|NCT02541604|593509633|FG007|Overall Study|Study Terminated by Sponsor|0|||
164310251|NCT02541604|593509634|FG008|Overall Study|Study Terminated by Sponsor|0|||
164310252|NCT02541604|593509635|FG009|Overall Study|Study Terminated by Sponsor|0|||
164553368|NCT01827670|594396924|FG000|Overall Study|Withdrawal of Consent|3|||
164553369|NCT01827670|594396925|FG001|Overall Study|Withdrawal of Consent|2|||
164553370|NCT01827670|594396924|FG000|Overall Study|Lost to Follow-up|0|||
164553371|NCT01827670|594396925|FG001|Overall Study|Lost to Follow-up|1|||
164553372|NCT03681119|594396932|FG000|Overall Study|No specific reason|4|||
164553373|NCT03681119|594396933|FG001|Overall Study|No specific reason|0|||
164553374|NCT03681119|594396932|FG000|Overall Study|Sickness|2|||
164553375|NCT03681119|594396933|FG001|Overall Study|Sickness|0|||
164553376|NCT02941627|594396943|FG000|Overall Study|Death|1|||
164553377|NCT02941627|594396943|FG000|Overall Study|Surgical failure|1|||
164553378|NCT02941627|594396943|FG000|Overall Study|cholesteatoma prevented implantation|1|||
164553379|NCT00563186|594396944|FG000|Overall Study|LOS<48 hours|97|||
164553380|NCT00563186|594396945|FG001|Overall Study|LOS<48 hours|74|||
164553381|NCT00563186|594396944|FG000|Overall Study|Incomplete data|1|||
164553382|NCT00563186|594396945|FG001|Overall Study|Incomplete data|1|||
164553383|NCT02595723|594396946|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
164553384|NCT02595723|594396947|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
164553385|NCT02595723|594396948|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
164553386|NCT02595723|594396946|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
164553387|NCT02595723|594396947|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
164553388|NCT02595723|594396948|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
164553389|NCT00769184|594396950|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
164553390|NCT00769184|594396951|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
164553391|NCT00769184|594396950|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
164553392|NCT00769184|594396951|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
164553393|NCT00769184|594396950|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
164553394|NCT00769184|594396951|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
164553395|NCT00517829|594396952|FG000|Overall Study|Adverse Event|22|||
164553396|NCT00517829|594396953|FG001|Overall Study|Adverse Event|34|||
164553397|NCT00517829|594396952|FG000|Overall Study|Disease Progression|39|||
164553398|NCT00517829|594396953|FG001|Overall Study|Disease Progression|32|||
164553399|NCT00517829|594396952|FG000|Overall Study|Patient Request|6|||
164553400|NCT00517829|594396953|FG001|Overall Study|Patient Request|5|||
164553401|NCT00517829|594396952|FG000|Overall Study|Investigator Request|5|||
164553402|NCT00517829|594396953|FG001|Overall Study|Investigator Request|3|||
164553403|NCT00517829|594396952|FG000|Overall Study|Other|3|||
164553404|NCT00517829|594396953|FG001|Overall Study|Other|1|||
164553405|NCT00385255|594396954|FG000|Overall Study|Serious Adverse Event|1|||
164553406|NCT00385255|594396955|FG001|Overall Study|Serious Adverse Event|2|||
164553407|NCT00385255|594396954|FG000|Overall Study|Protocol Violation|0|||
164553408|NCT00385255|594396955|FG001|Overall Study|Protocol Violation|4|||
164553409|NCT00385255|594396954|FG000|Overall Study|Withdrawal by Subject|0|||
164553410|NCT00385255|594396955|FG001|Overall Study|Withdrawal by Subject|8|||
164553411|NCT00385255|594396954|FG000|Overall Study|Migrated/moved from study area|0|||
164553412|NCT00385255|594396955|FG001|Overall Study|Migrated/moved from study area|1|||
164553413|NCT00385255|594396954|FG000|Overall Study|Lost to Follow-up|20|||
164553414|NCT00385255|594396955|FG001|Overall Study|Lost to Follow-up|58|||
164553415|NCT00835237|594396960|FG000|Overall Study|Lost to Follow-up|4|||
164553416|NCT00835237|594396961|FG001|Overall Study|Lost to Follow-up|0|||
164553417|NCT00835237|594396960|FG000|Overall Study|Withdrawal by Subject|2|||
164553418|NCT00835237|594396961|FG001|Overall Study|Withdrawal by Subject|0|||
164553419|NCT01136655|594396962|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
164553420|NCT01136655|594396962|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
164553421|NCT01136655|594396962|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
164553422|NCT01136655|594396962|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
164553423|NCT01265550|594396963|FG000|Pre Randomization|Withdrawal by Subject|0|||
164553424|NCT01265550|594396964|FG001|Pre Randomization|Withdrawal by Subject|0|||
164553425|NCT01265550|594396965|FG002|Pre Randomization|Withdrawal by Subject|0|||
164553426|NCT01265550|594396966|FG003|Pre Randomization|Withdrawal by Subject|70|||
164553427|NCT01265550|594396963|FG000|Pre Randomization|Technical Exclusions|0|||
164553428|NCT01265550|594396964|FG001|Pre Randomization|Technical Exclusions|0|||
164553429|NCT01265550|594396965|FG002|Pre Randomization|Technical Exclusions|0|||
164553430|NCT01265550|594396966|FG003|Pre Randomization|Technical Exclusions|54|||
164553431|NCT01265550|594396963|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
164553432|NCT01265550|594396964|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
164553433|NCT01265550|594396965|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
164553434|NCT01265550|594396966|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
164553435|NCT01265550|594396963|FG000|Pre Randomization|Non-GERD organic disorders|0|||
164553436|NCT01265550|594396964|FG001|Pre Randomization|Non-GERD organic disorders|0|||
164553437|NCT01265550|594396965|FG002|Pre Randomization|Non-GERD organic disorders|0|||
164553438|NCT01265550|594396966|FG003|Pre Randomization|Non-GERD organic disorders|23|||
164553439|NCT01265550|594396963|FG000|Pre Randomization|Functional heartburn|0|||
164553440|NCT01265550|594396964|FG001|Pre Randomization|Functional heartburn|0|||
164553441|NCT01265550|594396965|FG002|Pre Randomization|Functional heartburn|0|||
164553442|NCT01265550|594396966|FG003|Pre Randomization|Functional heartburn|99|||
164553443|NCT00606086|594396967|FG000|Overall Study|Adverse Event|1|||
164553444|NCT00606086|594396968|FG001|Overall Study|Adverse Event|1|||
164553445|NCT00606086|594396967|FG000|Overall Study|Lost to Follow-up|4|||
164553446|NCT00606086|594396968|FG001|Overall Study|Lost to Follow-up|8|||
164553447|NCT00606086|594396967|FG000|Overall Study|Protocol Violation|1|||
164553448|NCT00606086|594396968|FG001|Overall Study|Protocol Violation|0|||
164553449|NCT00606086|594396967|FG000|Overall Study|Withdrawal by Subject|5|||
164658353|NCT01725451|594774832|FG000|Washout From Period 3|Protocol Violation|0|||
164658354|NCT01725451|594774833|FG001|Washout From Period 3|Protocol Violation|0|||
164658355|NCT01725451|594774834|FG002|Washout From Period 3|Protocol Violation|1|||
164658356|NCT01725451|594774835|FG003|Washout From Period 3|Protocol Violation|0|||
164658357|NCT01725451|594774832|FG000|Washout From Period 3|Adverse Event|0|||
164658358|NCT01725451|594774833|FG001|Washout From Period 3|Adverse Event|1|||
164658359|NCT01725451|594774834|FG002|Washout From Period 3|Adverse Event|0|||
164658360|NCT01725451|594774835|FG003|Washout From Period 3|Adverse Event|0|||
164658361|NCT01725451|594774832|FG000|Period 4|Adverse Event|0|||
164658362|NCT01725451|594774833|FG001|Period 4|Adverse Event|0|||
164658363|NCT01725451|594774834|FG002|Period 4|Adverse Event|1|||
164658364|NCT01725451|594774835|FG003|Period 4|Adverse Event|0|||
164658365|NCT00358826|594774836|FG000|Core Study|Adverse Event|1|||
164658366|NCT00358826|594774837|FG001|Core Study|Adverse Event|3|||
164658367|NCT00358826|594774838|FG002|Core Study|Adverse Event|1|||
164658368|NCT00358826|594774839|FG003|Core Study|Adverse Event|1|||
164658369|NCT00358826|594774840|FG004|Core Study|Adverse Event|0|||
164201467|NCT01701245|593110749|FG001|Overall Study|Did not complete the open label period|12|||
164201468|NCT03555149|593110756|FG000|Overall Study|Death|18|||
164201469|NCT03555149|593110757|FG001|Overall Study|Death|15|||
164201470|NCT03555149|593110758|FG002|Overall Study|Death|15|||
164201471|NCT03555149|593110759|FG003|Overall Study|Death|4|||
164201472|NCT03555149|593110760|FG004|Overall Study|Death|4|||
164201473|NCT03555149|593110761|FG005|Overall Study|Death|11|||
164201474|NCT03555149|593110762|FG006|Overall Study|Death|12|||
164201475|NCT03555149|593110763|FG007|Overall Study|Death|1|||
164201476|NCT03555149|593110756|FG000|Overall Study|Lost to Follow-up|1|||
164201477|NCT03555149|593110757|FG001|Overall Study|Lost to Follow-up|0|||
164201478|NCT03555149|593110758|FG002|Overall Study|Lost to Follow-up|0|||
164201479|NCT03555149|593110759|FG003|Overall Study|Lost to Follow-up|0|||
164201480|NCT03555149|593110760|FG004|Overall Study|Lost to Follow-up|0|||
164201481|NCT03555149|593110761|FG005|Overall Study|Lost to Follow-up|1|||
164201482|NCT03555149|593110762|FG006|Overall Study|Lost to Follow-up|0|||
164201483|NCT03555149|593110763|FG007|Overall Study|Lost to Follow-up|0|||
164201484|NCT03555149|593110756|FG000|Overall Study|Physician Decision|1|||
164201485|NCT03555149|593110757|FG001|Overall Study|Physician Decision|0|||
164201486|NCT03555149|593110758|FG002|Overall Study|Physician Decision|0|||
164201487|NCT03555149|593110759|FG003|Overall Study|Physician Decision|0|||
164201488|NCT03555149|593110760|FG004|Overall Study|Physician Decision|0|||
164201489|NCT03555149|593110761|FG005|Overall Study|Physician Decision|0|||
164201490|NCT03555149|593110762|FG006|Overall Study|Physician Decision|0|||
164201491|NCT03555149|593110763|FG007|Overall Study|Physician Decision|0|||
164201492|NCT03555149|593110756|FG000|Overall Study|Study Terminated By Sponsor|1|||
164201493|NCT03555149|593110757|FG001|Overall Study|Study Terminated By Sponsor|0|||
164201494|NCT03555149|593110758|FG002|Overall Study|Study Terminated By Sponsor|0|||
164201495|NCT03555149|593110759|FG003|Overall Study|Study Terminated By Sponsor|0|||
164201496|NCT03555149|593110760|FG004|Overall Study|Study Terminated By Sponsor|0|||
164201497|NCT03555149|593110761|FG005|Overall Study|Study Terminated By Sponsor|2|||
164201498|NCT03555149|593110762|FG006|Overall Study|Study Terminated By Sponsor|3|||
164201499|NCT03555149|593110763|FG007|Overall Study|Study Terminated By Sponsor|1|||
164201500|NCT03555149|593110756|FG000|Overall Study|Withdrawal by Subject|3|||
164201501|NCT03555149|593110757|FG001|Overall Study|Withdrawal by Subject|0|||
164201502|NCT03555149|593110758|FG002|Overall Study|Withdrawal by Subject|0|||
164201503|NCT03555149|593110759|FG003|Overall Study|Withdrawal by Subject|2|||
164201504|NCT03555149|593110760|FG004|Overall Study|Withdrawal by Subject|0|||
164201505|NCT03555149|593110761|FG005|Overall Study|Withdrawal by Subject|1|||
164201506|NCT03555149|593110762|FG006|Overall Study|Withdrawal by Subject|0|||
164201507|NCT03555149|593110763|FG007|Overall Study|Withdrawal by Subject|0|||
164201508|NCT02785939|593110765|FG000|Overall Study|Progression|25|||
164201509|NCT02785939|593110766|FG001|Overall Study|Progression|8|||
164201510|NCT02785939|593110765|FG000|Overall Study|Adverse Event|3|||
164420597|NCT01890967|593910948|FG002|Overall Study|Lost to Follow-up|1|||
164553450|NCT00606086|594396968|FG001|Overall Study|Withdrawal by Subject|3|||
164553451|NCT00606086|594396967|FG000|Overall Study|Non-compliance|0|||
164553452|NCT00606086|594396968|FG001|Overall Study|Non-compliance|1|||
164553453|NCT00606086|594396967|FG000|Overall Study|Randomized, not treated|1|||
164201511|NCT02785939|593110766|FG001|Overall Study|Adverse Event|1|||
164201512|NCT02785939|593110765|FG000|Overall Study|Death|1|||
164553454|NCT00606086|594396968|FG001|Overall Study|Randomized, not treated|2|||
164658370|NCT00358826|594774841|FG005|Core Study|Adverse Event|0|||
164658371|NCT00358826|594774842|FG006|Core Study|Adverse Event|0|||
164658372|NCT00358826|594774843|FG007|Core Study|Adverse Event|0|||
164658373|NCT00358826|594774836|FG000|Core Study|Withdrawal by Subject|2|||
164658374|NCT00358826|594774837|FG001|Core Study|Withdrawal by Subject|2|||
164553455|NCT00391222|594396971|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
164553456|NCT00391222|594396972|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
164553457|NCT00391222|594396973|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
164553458|NCT00391222|594396974|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
164553459|NCT00391222|594396971|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
164553460|NCT00391222|594396972|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
164553461|NCT00391222|594396973|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
164553462|NCT00391222|594396974|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
164553463|NCT00391222|594396971|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
164553464|NCT00391222|594396972|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
164553465|NCT00391222|594396973|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
164553466|NCT00391222|594396974|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
164553467|NCT00391222|594396971|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
164553468|NCT00391222|594396972|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
164553469|NCT00391222|594396973|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
164553470|NCT00391222|594396974|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
164553471|NCT00391222|594396971|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
164553472|NCT00391222|594396972|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
164553473|NCT00391222|594396973|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
164553474|NCT00391222|594396974|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
164553475|NCT00391222|594396971|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
164553476|NCT00391222|594396972|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
164553477|NCT00391222|594396973|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
164553478|NCT00391222|594396974|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
164553479|NCT00391222|594396971|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
164553480|NCT00391222|594396972|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
164553481|NCT00391222|594396973|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
164553482|NCT00391222|594396974|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
164553483|NCT00391222|594396971|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
164553484|NCT00391222|594396972|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
164553485|NCT00391222|594396973|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
164553486|NCT00391222|594396974|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
164553487|NCT00391222|594396971|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
164553488|NCT00391222|594396972|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
164553489|NCT00391222|594396973|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
164553490|NCT00391222|594396974|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
164553491|NCT00391222|594396971|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
164553492|NCT00391222|594396972|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
164553493|NCT00391222|594396973|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
164553494|NCT00391222|594396974|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
164553495|NCT00391222|594396971|FG000|Period III (Double-Blind Treatment)|Other|6|||
164553496|NCT00391222|594396972|FG001|Period III (Double-Blind Treatment)|Other|1|||
164553497|NCT00391222|594396973|FG002|Period III (Double-Blind Treatment)|Other|6|||
164553498|NCT00391222|594396974|FG003|Period III (Double-Blind Treatment)|Other|0|||
164553499|NCT00550680|594396977|FG000|Overall Study|Administrative Reasons|1|||
164553500|NCT00550680|594396977|FG000|Overall Study|Adverse Event|5|||
164553501|NCT00550680|594396977|FG000|Overall Study|Death|3|||
164553502|NCT00550680|594396977|FG000|Overall Study|Early Improvement|1|||
164553503|NCT00550680|594396977|FG000|Overall Study|Lost to Follow-up|3|||
164553504|NCT00550680|594396977|FG000|Overall Study|Lack of Efficacy|1|||
164553505|NCT00550680|594396977|FG000|Overall Study|Other|10|||
164553506|NCT00550680|594396977|FG000|Overall Study|Protocol Violation|7|||
164553507|NCT00550680|594396977|FG000|Overall Study|Refused Treatment|19|||
164553508|NCT00550680|594396977|FG000|Overall Study|Screen Failure|6|||
164553509|NCT05032157|594398705|FG000|Overall Study|Adverse Event|12|||
164553510|NCT05032157|594398706|FG001|Overall Study|Adverse Event|7|||
164553511|NCT05032157|594398705|FG000|Overall Study|Pregnancy|0|||
164553512|NCT05032157|594398706|FG001|Overall Study|Pregnancy|2|||
164553513|NCT05032157|594398705|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
164553514|NCT05032157|594398706|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
164553515|NCT05032157|594398705|FG000|Overall Study|Protocol Deviation|8|||
164553516|NCT05032157|594398706|FG001|Overall Study|Protocol Deviation|4|||
164553517|NCT05032157|594398705|FG000|Overall Study|Lost to Follow-up|1|||
164553518|NCT05032157|594398706|FG001|Overall Study|Lost to Follow-up|3|||
164553519|NCT05032157|594398705|FG000|Overall Study|Physician Decision|7|||
164553520|NCT05032157|594398706|FG001|Overall Study|Physician Decision|2|||
164553521|NCT05032157|594398705|FG000|Overall Study|Patient Decision|38|||
164658375|NCT00358826|594774838|FG002|Core Study|Withdrawal by Subject|0|||
164658376|NCT00358826|594774839|FG003|Core Study|Withdrawal by Subject|0|||
164553522|NCT05032157|594398706|FG001|Overall Study|Patient Decision|19|||
164553523|NCT02627495|594398707|FG000|Overall Study|Withdrawal by Subject|4|||
164658377|NCT00358826|594774840|FG004|Core Study|Withdrawal by Subject|0|||
164658378|NCT00358826|594774841|FG005|Core Study|Withdrawal by Subject|0|||
164658379|NCT00358826|594774842|FG006|Core Study|Withdrawal by Subject|0|||
164658380|NCT00358826|594774843|FG007|Core Study|Withdrawal by Subject|0|||
164658381|NCT00358826|594774836|FG000|Core Study|Lost to Follow-up|0|||
164658382|NCT00358826|594774837|FG001|Core Study|Lost to Follow-up|0|||
164658383|NCT00358826|594774838|FG002|Core Study|Lost to Follow-up|0|||
164658384|NCT00358826|594774839|FG003|Core Study|Lost to Follow-up|1|||
164658385|NCT00358826|594774840|FG004|Core Study|Lost to Follow-up|0|||
164658386|NCT00358826|594774841|FG005|Core Study|Lost to Follow-up|0|||
164658387|NCT00358826|594774842|FG006|Core Study|Lost to Follow-up|0|||
164658388|NCT00358826|594774843|FG007|Core Study|Lost to Follow-up|0|||
164658389|NCT00358826|594774836|FG000|Core Study|Physician Decision|0|||
164658390|NCT00358826|594774837|FG001|Core Study|Physician Decision|0|||
164658391|NCT00358826|594774838|FG002|Core Study|Physician Decision|1|||
164658392|NCT00358826|594774839|FG003|Core Study|Physician Decision|0|||
164658393|NCT00358826|594774840|FG004|Core Study|Physician Decision|0|||
164658394|NCT00358826|594774841|FG005|Core Study|Physician Decision|0|||
164658395|NCT00358826|594774842|FG006|Core Study|Physician Decision|0|||
164658396|NCT00358826|594774843|FG007|Core Study|Physician Decision|0|||
164658397|NCT00358826|594774836|FG000|MDCT Substudy|Adverse Event|0|||
164658398|NCT00358826|594774837|FG001|MDCT Substudy|Adverse Event|0|||
164658399|NCT00358826|594774838|FG002|MDCT Substudy|Adverse Event|0|||
164658400|NCT00358826|594774839|FG003|MDCT Substudy|Adverse Event|0|||
164658401|NCT00358826|594774840|FG004|MDCT Substudy|Adverse Event|1|||
164658402|NCT00358826|594774841|FG005|MDCT Substudy|Adverse Event|0|||
164658403|NCT00358826|594774842|FG006|MDCT Substudy|Adverse Event|0|||
164658404|NCT00358826|594774843|FG007|MDCT Substudy|Adverse Event|0|||
164658405|NCT00358826|594774836|FG000|MDCT Substudy|Lost to Follow-up|0|||
164658406|NCT00358826|594774837|FG001|MDCT Substudy|Lost to Follow-up|0|||
164658407|NCT00358826|594774838|FG002|MDCT Substudy|Lost to Follow-up|0|||
164658408|NCT00358826|594774839|FG003|MDCT Substudy|Lost to Follow-up|0|||
164658409|NCT00358826|594774840|FG004|MDCT Substudy|Lost to Follow-up|0|||
164658410|NCT00358826|594774841|FG005|MDCT Substudy|Lost to Follow-up|1|||
164658411|NCT00358826|594774842|FG006|MDCT Substudy|Lost to Follow-up|0|||
164658412|NCT00358826|594774843|FG007|MDCT Substudy|Lost to Follow-up|0|||
164658413|NCT00358826|594774836|FG000|MDCT Substudy|Withdrawal by Subject|0|||
164658414|NCT00358826|594774837|FG001|MDCT Substudy|Withdrawal by Subject|0|||
164658415|NCT00358826|594774838|FG002|MDCT Substudy|Withdrawal by Subject|0|||
164658416|NCT00358826|594774839|FG003|MDCT Substudy|Withdrawal by Subject|0|||
164658417|NCT00358826|594774840|FG004|MDCT Substudy|Withdrawal by Subject|0|||
164658418|NCT00358826|594774841|FG005|MDCT Substudy|Withdrawal by Subject|1|||
164658419|NCT00358826|594774842|FG006|MDCT Substudy|Withdrawal by Subject|0|||
164658420|NCT00358826|594774843|FG007|MDCT Substudy|Withdrawal by Subject|0|||
164658421|NCT00283686|594774844|FG000|Overall Study|Death|1|||
164658422|NCT00283686|594774845|FG001|Overall Study|Death|1|||
164658423|NCT00283686|594774846|FG002|Overall Study|Death|1|||
164658424|NCT00283686|594774847|FG003|Overall Study|Death|0|||
164658425|NCT00283686|594774844|FG000|Overall Study|Lost to Follow-up|21|||
164658426|NCT00283686|594774845|FG001|Overall Study|Lost to Follow-up|31|||
164658427|NCT00283686|594774846|FG002|Overall Study|Lost to Follow-up|26|||
164658428|NCT00283686|594774847|FG003|Overall Study|Lost to Follow-up|20|||
164658429|NCT00283686|594774844|FG000|Overall Study|Less than full participation|7|||
164658430|NCT00283686|594774845|FG001|Overall Study|Less than full participation|9|||
164658431|NCT00283686|594774846|FG002|Overall Study|Less than full participation|6|||
164658432|NCT00283686|594774847|FG003|Overall Study|Less than full participation|12|||
164658433|NCT00696709|594774849|FG000|Overall Study|Withdrawal by Subject|1|||
164658434|NCT00696709|594774850|FG001|Overall Study|Withdrawal by Subject|2|||
164658435|NCT00696709|594774851|FG002|Overall Study|Withdrawal by Subject|1|||
164658436|NCT00696709|594774852|FG003|Overall Study|Withdrawal by Subject|4|||
164658437|NCT00696709|594774853|FG004|Overall Study|Withdrawal by Subject|3|||
164658438|NCT00696709|594774849|FG000|Overall Study|Protocol Violation|1|||
164658439|NCT00696709|594774850|FG001|Overall Study|Protocol Violation|0|||
164658440|NCT00696709|594774851|FG002|Overall Study|Protocol Violation|0|||
164658441|NCT00696709|594774852|FG003|Overall Study|Protocol Violation|0|||
164658442|NCT00696709|594774853|FG004|Overall Study|Protocol Violation|0|||
164658443|NCT00696709|594774849|FG000|Overall Study|Lost to Follow-up|1|||
164658444|NCT00696709|594774850|FG001|Overall Study|Lost to Follow-up|1|||
164658445|NCT00696709|594774851|FG002|Overall Study|Lost to Follow-up|0|||
164658446|NCT00696709|594774852|FG003|Overall Study|Lost to Follow-up|0|||
164658447|NCT00696709|594774853|FG004|Overall Study|Lost to Follow-up|0|||
164658448|NCT00696709|594774849|FG000|Overall Study|Adverse Event|0|||
164658449|NCT00696709|594774850|FG001|Overall Study|Adverse Event|0|||
164658450|NCT00696709|594774851|FG002|Overall Study|Adverse Event|0|||
164658451|NCT00696709|594774852|FG003|Overall Study|Adverse Event|1|||
164658452|NCT00696709|594774853|FG004|Overall Study|Adverse Event|0|||
164658453|NCT00310856|594774854|FG000|Overall Study|Withdrawal by Subject|2|||
164658454|NCT00310856|594774855|FG001|Overall Study|Withdrawal by Subject|2|||
164658455|NCT00310856|594774856|FG002|Overall Study|Withdrawal by Subject|2|||
164658456|NCT00310856|594774854|FG000|Overall Study|Lost to Follow-up|1|||
164310253|NCT02541604|593509636|FG010|Overall Study|Study Terminated by Sponsor|0|||
164310254|NCT02541604|593509637|FG011|Overall Study|Study Terminated by Sponsor|0|||
164310255|NCT02541604|593509626|FG000|Overall Study|Medical condition may jeopardize safety|0|||
164310256|NCT02541604|593509627|FG001|Overall Study|Medical condition may jeopardize safety|0|||
164310257|NCT02541604|593509628|FG002|Overall Study|Medical condition may jeopardize safety|0|||
164310258|NCT02541604|593509629|FG003|Overall Study|Medical condition may jeopardize safety|0|||
164310259|NCT02541604|593509630|FG004|Overall Study|Medical condition may jeopardize safety|0|||
164310260|NCT02541604|593509631|FG005|Overall Study|Medical condition may jeopardize safety|0|||
164310261|NCT02541604|593509632|FG006|Overall Study|Medical condition may jeopardize safety|0|||
164310262|NCT02541604|593509633|FG007|Overall Study|Medical condition may jeopardize safety|1|||
164310263|NCT02541604|593509634|FG008|Overall Study|Medical condition may jeopardize safety|0|||
164310264|NCT02541604|593509635|FG009|Overall Study|Medical condition may jeopardize safety|0|||
164310265|NCT02541604|593509636|FG010|Overall Study|Medical condition may jeopardize safety|0|||
164310266|NCT02541604|593509637|FG011|Overall Study|Medical condition may jeopardize safety|0|||
164310267|NCT00993148|593509638|FG000|Overall Study|Lost to Follow-up|2|||
164310268|NCT00993148|593509638|FG000|Overall Study|never initiated treatment|1|||
164310269|NCT00806819|593509639|FG000|Overall Study|progressive disease (modified RECIST )|217|||
164310270|NCT00806819|593509640|FG001|Overall Study|progressive disease (modified RECIST )|216|||
164553524|NCT02543528|594398712|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
164553525|NCT02543528|594398713|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
164553526|NCT02543528|594398714|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
164553527|NCT02543528|594398715|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
164553528|NCT02543528|594398716|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
164553529|NCT02543528|594398712|FG000|Adaptation Period|Lens Handling Difficultes|0|||
164553530|NCT02543528|594398713|FG001|Adaptation Period|Lens Handling Difficultes|0|||
164553531|NCT02543528|594398714|FG002|Adaptation Period|Lens Handling Difficultes|0|||
164553532|NCT02543528|594398715|FG003|Adaptation Period|Lens Handling Difficultes|0|||
164553533|NCT02543528|594398716|FG004|Adaptation Period|Lens Handling Difficultes|8|||
164553534|NCT02543528|594398712|FG000|Adaptation Period|Lost to Follow-up|0|||
164553535|NCT02543528|594398713|FG001|Adaptation Period|Lost to Follow-up|0|||
164553536|NCT02543528|594398714|FG002|Adaptation Period|Lost to Follow-up|0|||
164553537|NCT02543528|594398715|FG003|Adaptation Period|Lost to Follow-up|0|||
164553538|NCT02543528|594398716|FG004|Adaptation Period|Lost to Follow-up|14|||
164553539|NCT02543528|594398712|FG000|Adaptation Period|Adverse Event|0|||
164553540|NCT02543528|594398713|FG001|Adaptation Period|Adverse Event|0|||
164553541|NCT02543528|594398714|FG002|Adaptation Period|Adverse Event|0|||
164553542|NCT02543528|594398715|FG003|Adaptation Period|Adverse Event|0|||
164553543|NCT02543528|594398716|FG004|Adaptation Period|Adverse Event|2|||
164553544|NCT02543528|594398712|FG000|Extended Wear Period|Adverse Event|17|||
164553545|NCT02543528|594398713|FG001|Extended Wear Period|Adverse Event|11|||
164553546|NCT02543528|594398714|FG002|Extended Wear Period|Adverse Event|16|||
164553547|NCT02543528|594398715|FG003|Extended Wear Period|Adverse Event|3|||
164553548|NCT02543528|594398716|FG004|Extended Wear Period|Adverse Event|0|||
164553549|NCT02543528|594398712|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
164553550|NCT02543528|594398713|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
164553551|NCT02543528|594398714|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
164553552|NCT02543528|594398715|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
164553553|NCT02543528|594398716|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
164553554|NCT02543528|594398712|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
164553555|NCT02543528|594398713|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
164553556|NCT02543528|594398714|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
164553557|NCT02543528|594398715|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
164553558|NCT02543528|594398716|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
164553559|NCT02543528|594398712|FG000|Extended Wear Period|Lost to Follow-up|0|||
164553560|NCT02543528|594398713|FG001|Extended Wear Period|Lost to Follow-up|1|||
164553561|NCT02543528|594398714|FG002|Extended Wear Period|Lost to Follow-up|2|||
164553562|NCT02543528|594398715|FG003|Extended Wear Period|Lost to Follow-up|1|||
164553563|NCT02543528|594398716|FG004|Extended Wear Period|Lost to Follow-up|0|||
164553564|NCT02543528|594398712|FG000|Extended Wear Period|Withdrawal by Subject|10|||
164553565|NCT02543528|594398713|FG001|Extended Wear Period|Withdrawal by Subject|9|||
164553566|NCT02543528|594398714|FG002|Extended Wear Period|Withdrawal by Subject|4|||
164553567|NCT02543528|594398715|FG003|Extended Wear Period|Withdrawal by Subject|5|||
164553568|NCT02543528|594398716|FG004|Extended Wear Period|Withdrawal by Subject|0|||
164553569|NCT02049944|594398717|FG000|Overall Study|Protocol Violation|2|||
164553570|NCT01042600|594398718|FG000|Overall Study|Ineligible|1|||
164553571|NCT01042600|594398719|FG001|Overall Study|Ineligible|0|||
164553572|NCT00631371|594398722|FG000|Overall Study|Lost to Follow-up|24|||
164553573|NCT00631371|594398723|FG001|Overall Study|Lost to Follow-up|19|||
164553574|NCT00631371|594398722|FG000|Overall Study|Other reason|5|||
164658457|NCT00310856|594774855|FG001|Overall Study|Lost to Follow-up|2|||
164310271|NCT00806819|593509639|FG000|Overall Study|Worsening or AE of underlying disease|18|||
164553575|NCT00631371|594398723|FG001|Overall Study|Other reason|12|||
164553576|NCT00631371|594398722|FG000|Overall Study|subject request|38|||
164553577|NCT00631371|594398723|FG001|Overall Study|subject request|45|||
164553578|NCT00631371|594398722|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
164553579|NCT00631371|594398723|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
164553580|NCT00631371|594398722|FG000|Overall Study|Death|263|||
164553581|NCT00631371|594398723|FG001|Overall Study|Death|239|||
164553582|NCT03860961|594398729|FG000|Overall Study|Withdrawal by Subject|6|||
164553583|NCT03860961|594398730|FG001|Overall Study|Withdrawal by Subject|11|||
164553584|NCT03860961|594398729|FG000|Overall Study|Death|10|||
164553585|NCT03860961|594398730|FG001|Overall Study|Death|6|||
164553586|NCT03860961|594398729|FG000|Overall Study|Incomplete two-year data|4|||
164553587|NCT03860961|594398730|FG001|Overall Study|Incomplete two-year data|0|||
164553588|NCT03325673|594398731|FG000|Overall Study|Adverse Event|4|||
164553589|NCT03325673|594398732|FG001|Overall Study|Adverse Event|0|||
164553590|NCT01659320|594398733|FG000|Overall Study|Withdrawal by Subject|2|||
164553591|NCT01659320|594398733|FG000|Overall Study|Physician Decision|1|||
164553592|NCT00590590|594398734|FG000|Overall Study|Lack of Efficacy|1|||
164553593|NCT00590590|594398735|FG001|Overall Study|Lack of Efficacy|2|||
164201513|NCT02785939|593110766|FG001|Overall Study|Death|0|||
164201514|NCT02785939|593110765|FG000|Overall Study|Refusal|1|||
164201515|NCT02785939|593110766|FG001|Overall Study|Refusal|0|||
164201516|NCT02785939|593110765|FG000|Overall Study|Deteriorating health|1|||
164201517|NCT02785939|593110766|FG001|Overall Study|Deteriorating health|0|||
164201518|NCT02785939|593110765|FG000|Overall Study|Not protocol specified|0|||
164201519|NCT02785939|593110766|FG001|Overall Study|Not protocol specified|1|||
164201520|NCT04465422|593110767|FG000|Overall Study|Lost to Follow-up|0|||
164201521|NCT04465422|593110768|FG001|Overall Study|Lost to Follow-up|2|||
164201522|NCT01787552|593110771|FG000|Overall Study|Withdrawal by Subject|2|||
164201523|NCT01787552|593110772|FG001|Overall Study|Withdrawal by Subject|0|||
164201524|NCT01787552|593110773|FG002|Overall Study|Withdrawal by Subject|0|||
164201525|NCT01787552|593110774|FG003|Overall Study|Withdrawal by Subject|4|||
164201526|NCT01787552|593110771|FG000|Overall Study|Physician Decision|2|||
164201527|NCT01787552|593110772|FG001|Overall Study|Physician Decision|2|||
164201528|NCT01787552|593110773|FG002|Overall Study|Physician Decision|1|||
164201529|NCT01787552|593110774|FG003|Overall Study|Physician Decision|2|||
164201530|NCT01787552|593110771|FG000|Overall Study|Death|0|||
164201531|NCT01787552|593110772|FG001|Overall Study|Death|0|||
164201532|NCT01787552|593110773|FG002|Overall Study|Death|0|||
164201533|NCT01787552|593110774|FG003|Overall Study|Death|1|||
164201534|NCT01787552|593110771|FG000|Overall Study|Adverse Event|2|||
164201535|NCT01787552|593110772|FG001|Overall Study|Adverse Event|5|||
164201536|NCT01787552|593110773|FG002|Overall Study|Adverse Event|2|||
164201537|NCT01787552|593110774|FG003|Overall Study|Adverse Event|16|||
164201538|NCT01787552|593110771|FG000|Overall Study|Study terminated by Sponsor|0|||
164201539|NCT01787552|593110772|FG001|Overall Study|Study terminated by Sponsor|0|||
164201540|NCT01787552|593110773|FG002|Overall Study|Study terminated by Sponsor|1|||
164201541|NCT01787552|593110774|FG003|Overall Study|Study terminated by Sponsor|3|||
164201542|NCT01787552|593110771|FG000|Overall Study|Progressive Disease|2|||
164201543|NCT01787552|593110772|FG001|Overall Study|Progressive Disease|2|||
164201544|NCT01787552|593110773|FG002|Overall Study|Progressive Disease|1|||
164201545|NCT01787552|593110774|FG003|Overall Study|Progressive Disease|1|||
164201546|NCT01299584|593110779|FG000|Overall Study|Protocol Violation|9|||
164201547|NCT02175121|593110787|FG000|Overall Study|Lack of Efficacy|1|||
164201548|NCT02175121|593110788|FG001|Overall Study|Lack of Efficacy|0|||
164201549|NCT02175121|593110789|FG002|Overall Study|Lack of Efficacy|0|||
164201550|NCT02175121|593110790|FG003|Overall Study|Lack of Efficacy|0|||
164201551|NCT02175121|593110791|FG004|Overall Study|Lack of Efficacy|0|||
164201552|NCT02175121|593110787|FG000|Overall Study|Lost to Follow-up|0|||
164201553|NCT02175121|593110788|FG001|Overall Study|Lost to Follow-up|1|||
164201554|NCT02175121|593110789|FG002|Overall Study|Lost to Follow-up|0|||
164201555|NCT02175121|593110790|FG003|Overall Study|Lost to Follow-up|1|||
164201556|NCT02175121|593110791|FG004|Overall Study|Lost to Follow-up|0|||
164201557|NCT02175121|593110787|FG000|Overall Study|Personal emergency|0|||
164201558|NCT02175121|593110788|FG001|Overall Study|Personal emergency|0|||
164201559|NCT02175121|593110789|FG002|Overall Study|Personal emergency|0|||
164201560|NCT02175121|593110790|FG003|Overall Study|Personal emergency|0|||
164201561|NCT02175121|593110791|FG004|Overall Study|Personal emergency|1|||
164553594|NCT00590590|594398736|FG002|Overall Study|Lack of Efficacy|0|||
164553595|NCT00590590|594398734|FG000|Overall Study|Adverse Event|1|||
164553596|NCT00590590|594398735|FG001|Overall Study|Adverse Event|0|||
164553597|NCT00590590|594398736|FG002|Overall Study|Adverse Event|0|||
164553598|NCT00590590|594398734|FG000|Overall Study|Protocol Violation|0|||
164201562|NCT02175121|593110787|FG000|Overall Study|Schedule conflict|0|||
164201563|NCT02175121|593110788|FG001|Overall Study|Schedule conflict|0|||
164553599|NCT00590590|594398735|FG001|Overall Study|Protocol Violation|0|||
164201564|NCT02175121|593110789|FG002|Overall Study|Schedule conflict|1|||
164201565|NCT02175121|593110790|FG003|Overall Study|Schedule conflict|0|||
164201566|NCT02175121|593110791|FG004|Overall Study|Schedule conflict|0|||
164201567|NCT02175121|593110787|FG000|Overall Study|Time issues|0|||
164553600|NCT00590590|594398736|FG002|Overall Study|Protocol Violation|2|||
164658458|NCT00310856|594774856|FG002|Overall Study|Lost to Follow-up|6|||
164658459|NCT00310856|594774854|FG000|Overall Study|Inappropriate enrollment|1|||
164658460|NCT00310856|594774855|FG001|Overall Study|Inappropriate enrollment|1|||
164658461|NCT00310856|594774856|FG002|Overall Study|Inappropriate enrollment|0|||
164658462|NCT00310856|594774854|FG000|Overall Study|Unable to classify|1|||
164658463|NCT00310856|594774855|FG001|Overall Study|Unable to classify|0|||
164658464|NCT00310856|594774856|FG002|Overall Study|Unable to classify|0|||
164658465|NCT01306253|594774857|FG000|Overall Study|Lost to Follow-up|1|||
164658466|NCT01306253|594774858|FG001|Overall Study|Lost to Follow-up|1|||
164658467|NCT01261325|594774859|FG000|Overall Study|Lack of Efficacy|1|||
164658468|NCT01261325|594774860|FG001|Overall Study|Lack of Efficacy|1|||
164658469|NCT01261325|594774861|FG002|Overall Study|Lack of Efficacy|0|||
164658470|NCT01261325|594774859|FG000|Overall Study|Withdrawal by Subject|2|||
164658471|NCT01261325|594774860|FG001|Overall Study|Withdrawal by Subject|2|||
164658472|NCT01261325|594774861|FG002|Overall Study|Withdrawal by Subject|4|||
164658473|NCT01261325|594774859|FG000|Overall Study|SAE, non-fatal|1|||
164658474|NCT01261325|594774860|FG001|Overall Study|SAE, non-fatal|5|||
164658475|NCT01261325|594774861|FG002|Overall Study|SAE, non-fatal|1|||
164658476|NCT01261325|594774859|FG000|Overall Study|AE, non-serious non-fatal|9|||
164658477|NCT01261325|594774860|FG001|Overall Study|AE, non-serious non-fatal|15|||
164658478|NCT01261325|594774861|FG002|Overall Study|AE, non-serious non-fatal|13|||
164658479|NCT01261325|594774859|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
164658480|NCT01261325|594774860|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
164658481|NCT01261325|594774861|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
164658482|NCT01261325|594774859|FG000|Overall Study|Non Compliance|2|||
164658483|NCT01261325|594774860|FG001|Overall Study|Non Compliance|0|||
164658484|NCT01261325|594774861|FG002|Overall Study|Non Compliance|0|||
164658485|NCT01261325|594774859|FG000|Overall Study|Patient Randomized by Mistake|0|||
164658486|NCT01261325|594774860|FG001|Overall Study|Patient Randomized by Mistake|1|||
164658487|NCT01261325|594774861|FG002|Overall Study|Patient Randomized by Mistake|0|||
164658488|NCT01261325|594774859|FG000|Overall Study|Erroneously Randomized|1|||
164658489|NCT01261325|594774860|FG001|Overall Study|Erroneously Randomized|0|||
164658490|NCT01261325|594774861|FG002|Overall Study|Erroneously Randomized|0|||
164658491|NCT01261325|594774859|FG000|Overall Study|Screen Failure|1|||
164658492|NCT01261325|594774860|FG001|Overall Study|Screen Failure|0|||
164658493|NCT01261325|594774861|FG002|Overall Study|Screen Failure|0|||
164658494|NCT01261325|594774859|FG000|Overall Study|Randomized in Error|0|||
164658495|NCT01261325|594774860|FG001|Overall Study|Randomized in Error|0|||
164658496|NCT01261325|594774861|FG002|Overall Study|Randomized in Error|1|||
164658497|NCT01261325|594774859|FG000|Overall Study|Protocol Violation|0|||
164658498|NCT01261325|594774860|FG001|Overall Study|Protocol Violation|3|||
164658499|NCT01261325|594774861|FG002|Overall Study|Protocol Violation|1|||
164658500|NCT01261325|594774859|FG000|Overall Study|Lost to Follow-up|0|||
164658501|NCT01261325|594774860|FG001|Overall Study|Lost to Follow-up|1|||
164658502|NCT01261325|594774861|FG002|Overall Study|Lost to Follow-up|3|||
164658503|NCT01261325|594774859|FG000|Overall Study|AE, serious fatal|0|||
164658504|NCT01261325|594774860|FG001|Overall Study|AE, serious fatal|0|||
164658505|NCT01261325|594774861|FG002|Overall Study|AE, serious fatal|2|||
164658506|NCT00500682|594774872|FG000|Overall Study|Adverse Event|37|||
164658507|NCT00500682|594774873|FG001|Overall Study|Adverse Event|29|||
164658508|NCT00500682|594774872|FG000|Overall Study|Death|25|||
164658509|NCT00500682|594774873|FG001|Overall Study|Death|16|||
164658510|NCT00500682|594774872|FG000|Overall Study|Lost to Follow-up|11|||
164658511|NCT00500682|594774873|FG001|Overall Study|Lost to Follow-up|11|||
164658512|NCT00500682|594774872|FG000|Overall Study|Physician Decision|6|||
164658513|NCT00500682|594774873|FG001|Overall Study|Physician Decision|10|||
164658514|NCT00500682|594774872|FG000|Overall Study|Pregnancy|2|||
164201568|NCT02175121|593110788|FG001|Overall Study|Time issues|0|||
164201569|NCT02175121|593110789|FG002|Overall Study|Time issues|1|||
164201570|NCT02175121|593110790|FG003|Overall Study|Time issues|0|||
164201571|NCT02175121|593110791|FG004|Overall Study|Time issues|0|||
164201572|NCT04798027|593110796|FG000|Overall Study|Protocol Violation|0|||
164201573|NCT04798027|593110797|FG001|Overall Study|Protocol Violation|0|||
164201574|NCT04798027|593110798|FG002|Overall Study|Protocol Violation|0|||
164658515|NCT00500682|594774873|FG001|Overall Study|Pregnancy|0|||
164658516|NCT00500682|594774872|FG000|Overall Study|Protocol Violation|1|||
164658517|NCT00500682|594774873|FG001|Overall Study|Protocol Violation|3|||
164658518|NCT00500682|594774872|FG000|Overall Study|Withdrawal by Subject|80|||
164658519|NCT00500682|594774873|FG001|Overall Study|Withdrawal by Subject|74|||
164658520|NCT00500682|594774872|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
164658521|NCT00500682|594774873|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
164658522|NCT01995058|594774874|FG000|Overall Study|Sponsor Decision to terminate study|14|||
164658523|NCT01995058|594774875|FG001|Overall Study|Sponsor Decision to terminate study|12|||
164658524|NCT01995058|594774876|FG002|Overall Study|Sponsor Decision to terminate study|12|||
164658525|NCT01995058|594774877|FG003|Overall Study|Sponsor Decision to terminate study|10|||
164201575|NCT04798027|593110799|FG003|Overall Study|Protocol Violation|0|||
164201576|NCT04798027|593110800|FG004|Overall Study|Protocol Violation|1|||
164201577|NCT04798027|593110801|FG005|Overall Study|Protocol Violation|0|||
164310272|NCT00806819|593509640|FG001|Overall Study|Worsening or AE of underlying disease|25|||
164310273|NCT00806819|593509639|FG000|Overall Study|Other AE|38|||
164310274|NCT00806819|593509640|FG001|Overall Study|Other AE|40|||
164310275|NCT00806819|593509639|FG000|Overall Study|Protocol Violation|9|||
164310276|NCT00806819|593509640|FG001|Overall Study|Protocol Violation|4|||
164310277|NCT00806819|593509639|FG000|Overall Study|Lost to Follow-up|1|||
164310278|NCT00806819|593509640|FG001|Overall Study|Lost to Follow-up|0|||
164310279|NCT00806819|593509639|FG000|Overall Study|Withdrawal by Subject|32|||
164310280|NCT00806819|593509640|FG001|Overall Study|Withdrawal by Subject|29|||
164310281|NCT00806819|593509639|FG000|Overall Study|Not treated|6|||
164310282|NCT00806819|593509640|FG001|Overall Study|Not treated|3|||
164310283|NCT00806819|593509639|FG000|Overall Study|Reasons other than stated above|25|||
164310284|NCT00806819|593509640|FG001|Overall Study|Reasons other than stated above|41|||
164310285|NCT00912197|593509643|FG000|Overall Study|Withdrawal by Subject|3|||
164310286|NCT00912197|593509644|FG001|Overall Study|Withdrawal by Subject|3|||
164310287|NCT03304249|593509649|FG000|Overall Study|Lost to Follow-up|8|||
164553601|NCT00590590|594398734|FG000|Overall Study|Lost to Follow-up|4|||
164553602|NCT00590590|594398735|FG001|Overall Study|Lost to Follow-up|1|||
164553603|NCT00590590|594398736|FG002|Overall Study|Lost to Follow-up|2|||
164553604|NCT00590590|594398734|FG000|Overall Study|Withdrawal by Subject|0|||
164553605|NCT00590590|594398735|FG001|Overall Study|Withdrawal by Subject|1|||
164553606|NCT00590590|594398736|FG002|Overall Study|Withdrawal by Subject|1|||
164553607|NCT00590590|594398734|FG000|Overall Study|Did not complete due to study closure|1|||
164553608|NCT00590590|594398735|FG001|Overall Study|Did not complete due to study closure|1|||
164553609|NCT00590590|594398736|FG002|Overall Study|Did not complete due to study closure|1|||
164553610|NCT00590590|594398734|FG000|Overall Study|Did not complete study|0|||
164553611|NCT00590590|594398735|FG001|Overall Study|Did not complete study|1|||
164553612|NCT00590590|594398736|FG002|Overall Study|Did not complete study|0|||
164553613|NCT00272038|594398737|FG000|Overall Study|withdrew before they received 2 cycles|7|||
164553614|NCT03605680|594398738|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
164553615|NCT03605680|594398739|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
164553616|NCT03605680|594398740|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
164553617|NCT03605680|594398741|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
164553618|NCT03605680|594398738|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
164553619|NCT03605680|594398739|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
164553620|NCT03605680|594398740|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
164553621|NCT03605680|594398741|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
164553622|NCT03605680|594398738|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
164553623|NCT03605680|594398739|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
164553624|NCT03605680|594398740|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
164553625|NCT03605680|594398741|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
164553626|NCT03605680|594398738|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
164553627|NCT03605680|594398739|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
164553628|NCT03605680|594398740|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
164553629|NCT03605680|594398741|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
164553630|NCT03605680|594398738|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
164553631|NCT03605680|594398739|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
164553632|NCT03605680|594398740|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
164553633|NCT03605680|594398741|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
164553634|NCT03605680|594398738|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
164553635|NCT03605680|594398739|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
164553636|NCT03605680|594398740|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
164553637|NCT03605680|594398741|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
164553638|NCT03605680|594398738|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
164553639|NCT03605680|594398739|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
164553640|NCT03605680|594398740|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
164553641|NCT03605680|594398741|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
164553642|NCT03605680|594398738|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
164553643|NCT03605680|594398739|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
164553644|NCT03605680|594398740|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
164553645|NCT03605680|594398741|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
164553646|NCT03605680|594398738|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
164553647|NCT03605680|594398739|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
164310288|NCT03304249|593509650|FG001|Overall Study|Lost to Follow-up|10|||
164310289|NCT03304249|593509649|FG000|Overall Study|Withdrawal by Subject|12|||
164310290|NCT03304249|593509650|FG001|Overall Study|Withdrawal by Subject|2|||
164310291|NCT03304249|593509649|FG000|Overall Study|Moved Out of District|4|||
164310292|NCT03304249|593509650|FG001|Overall Study|Moved Out of District|2|||
164310293|NCT00552188|593510799|FG000|Overall Study|Adverse Event|0|||
164658526|NCT01995058|594774874|FG000|Overall Study|Progressive Disease|0|||
164658527|NCT01995058|594774875|FG001|Overall Study|Progressive Disease|1|||
164658528|NCT01995058|594774876|FG002|Overall Study|Progressive Disease|1|||
164658529|NCT01995058|594774877|FG003|Overall Study|Progressive Disease|1|||
164658530|NCT01995058|594774874|FG000|Overall Study|Adverse Event|0|||
164658531|NCT01995058|594774875|FG001|Overall Study|Adverse Event|0|||
164658532|NCT01995058|594774876|FG002|Overall Study|Adverse Event|0|||
164658533|NCT01995058|594774877|FG003|Overall Study|Adverse Event|1|||
164658534|NCT01995058|594774874|FG000|Overall Study|Lack of Efficacy|0|||
164658535|NCT01995058|594774875|FG001|Overall Study|Lack of Efficacy|0|||
164658536|NCT01995058|594774876|FG002|Overall Study|Lack of Efficacy|0|||
164658537|NCT01995058|594774877|FG003|Overall Study|Lack of Efficacy|1|||
164658538|NCT01995058|594774874|FG000|Overall Study|No Treatment Given|0|||
164658539|NCT01995058|594774875|FG001|Overall Study|No Treatment Given|0|||
164658540|NCT01995058|594774876|FG002|Overall Study|No Treatment Given|0|||
164658541|NCT01995058|594774877|FG003|Overall Study|No Treatment Given|1|||
164658542|NCT03611309|594774880|FG000|Overall Study|Lost to Follow-up|16|||
164658543|NCT03611309|594774881|FG001|Overall Study|Lost to Follow-up|8|||
164658544|NCT03611309|594774880|FG000|Overall Study|Withdrawal by Subject|5|||
164658545|NCT03611309|594774881|FG001|Overall Study|Withdrawal by Subject|5|||
164658546|NCT03611309|594774880|FG000|Overall Study|Physician Decision|0|||
164658547|NCT03611309|594774881|FG001|Overall Study|Physician Decision|2|||
164658548|NCT03280537|594774886|FG000|Overall Study|Withdrawal by Subject|2|||
164658549|NCT03280537|594774887|FG001|Overall Study|Withdrawal by Subject|4|||
164658550|NCT01588106|594774888|FG000|Overall Study|Withdrawal by Subject|5|||
164658551|NCT01588106|594774889|FG001|Overall Study|Withdrawal by Subject|4|||
164658552|NCT03083132|594774890|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
164658553|NCT03083132|594774891|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
164658554|NCT03083132|594774890|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
164658555|NCT03083132|594774891|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
164658556|NCT03083132|594774890|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
164658557|NCT03083132|594774891|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
164658558|NCT02995837|594774892|FG000|Overall Study|Lost to Follow-up|9|||
164658559|NCT02995837|594774893|FG001|Overall Study|Lost to Follow-up|8|||
164658560|NCT03118739|594774894|FG000|Overall Study|Physician Decision|0|||
164658561|NCT03118739|594774895|FG001|Overall Study|Physician Decision|1|||
164658562|NCT03118739|594774894|FG000|Overall Study|Withdrawal by Subject|5|||
164658563|NCT03118739|594774895|FG001|Overall Study|Withdrawal by Subject|3|||
164658564|NCT03118739|594774894|FG000|Overall Study|Lost to Follow-up|2|||
164658565|NCT03118739|594774895|FG001|Overall Study|Lost to Follow-up|0|||
164201578|NCT04798027|593110802|FG006|Overall Study|Protocol Violation|0|||
164201579|NCT04798027|593110803|FG007|Overall Study|Protocol Violation|1|||
164201580|NCT04798027|593110804|FG008|Overall Study|Protocol Violation|0|||
164201581|NCT04798027|593110796|FG000|Overall Study|Withdrawal by Subject|1|||
164201582|NCT04798027|593110797|FG001|Overall Study|Withdrawal by Subject|0|||
164201583|NCT04798027|593110798|FG002|Overall Study|Withdrawal by Subject|1|||
164201584|NCT04798027|593110799|FG003|Overall Study|Withdrawal by Subject|1|||
164201585|NCT04798027|593110800|FG004|Overall Study|Withdrawal by Subject|1|||
164201586|NCT04798027|593110801|FG005|Overall Study|Withdrawal by Subject|1|||
164201587|NCT04798027|593110802|FG006|Overall Study|Withdrawal by Subject|3|||
164201588|NCT04798027|593110803|FG007|Overall Study|Withdrawal by Subject|2|||
164201589|NCT04798027|593110804|FG008|Overall Study|Withdrawal by Subject|2|||
164201590|NCT04798027|593110796|FG000|Overall Study|Lost to Follow-up|1|||
164201591|NCT04798027|593110797|FG001|Overall Study|Lost to Follow-up|3|||
164201592|NCT04798027|593110798|FG002|Overall Study|Lost to Follow-up|0|||
164201593|NCT04798027|593110799|FG003|Overall Study|Lost to Follow-up|0|||
164201594|NCT04798027|593110800|FG004|Overall Study|Lost to Follow-up|0|||
164201595|NCT04798027|593110801|FG005|Overall Study|Lost to Follow-up|1|||
164201596|NCT04798027|593110802|FG006|Overall Study|Lost to Follow-up|0|||
164201597|NCT04798027|593110803|FG007|Overall Study|Lost to Follow-up|0|||
164201598|NCT04798027|593110804|FG008|Overall Study|Lost to Follow-up|1|||
164201599|NCT04798027|593110796|FG000|Overall Study|Withdrawal by Sponsor|8|||
164201600|NCT04798027|593110797|FG001|Overall Study|Withdrawal by Sponsor|22|||
164201601|NCT04798027|593110798|FG002|Overall Study|Withdrawal by Sponsor|9|||
164201602|NCT04798027|593110799|FG003|Overall Study|Withdrawal by Sponsor|26|||
164201603|NCT04798027|593110800|FG004|Overall Study|Withdrawal by Sponsor|24|||
164201604|NCT04798027|593110801|FG005|Overall Study|Withdrawal by Sponsor|11|||
164201605|NCT04798027|593110802|FG006|Overall Study|Withdrawal by Sponsor|25|||
164201606|NCT04798027|593110803|FG007|Overall Study|Withdrawal by Sponsor|26|||
164201607|NCT04798027|593110804|FG008|Overall Study|Withdrawal by Sponsor|11|||
164201608|NCT01814007|593110810|FG000|Overall Study|Withdrawal by Subject|1|||
164658566|NCT03996005|594774898|FG000|Overall Study|Withdrawal by Subject|1|||
164658567|NCT01022112|594774900|FG000|Overall Study|Adverse Event|1|||
164201609|NCT01274351|593110811|FG000|Overall Study|Lost to Follow-up|1|||
164201610|NCT01274351|593110811|FG000|Overall Study|patient not compliant with the protocol|1|||
164201611|NCT01274351|593110811|FG000|Overall Study|Pregnancy|1|||
164201612|NCT01274351|593110811|FG000|Overall Study|Death|2|||
164201613|NCT01274351|593110811|FG000|Overall Study|Withdrawal by Subject|3|||
164201614|NCT01274351|593110811|FG000|Overall Study|Adverse Event|8|||
164201615|NCT01274351|593110811|FG000|Overall Study|progression of disease|3|||
164201616|NCT01274351|593110811|FG000|Overall Study|hospitalization|1|||
164201617|NCT03861039|593112528|FG000|Overall Study|Adverse Event|2|||
164201618|NCT03861039|593112529|FG001|Overall Study|Adverse Event|5|||
164201619|NCT03861039|593112530|FG002|Overall Study|Adverse Event|11|||
164201620|NCT03861039|593112528|FG000|Overall Study|Withdrawal by Subject|1|||
164201621|NCT03861039|593112529|FG001|Overall Study|Withdrawal by Subject|3|||
164201622|NCT03861039|593112530|FG002|Overall Study|Withdrawal by Subject|4|||
164201623|NCT01113749|593112531|FG000|Overall Study|Lost to Follow-up|1|||
164201624|NCT01113749|593112532|FG001|Overall Study|Lost to Follow-up|2|||
164201625|NCT03427892|593112533|FG000|Overall Study|Lost to Follow-up|2|||
164201626|NCT00997334|593112535|FG000|Overall Study|still on therapy|12|||
164201627|NCT00997334|593112535|FG000|Overall Study|Adverse Event|3|||
164201628|NCT00997334|593112535|FG000|Overall Study|Patient non-compliance|1|||
164201629|NCT00997334|593112535|FG000|Overall Study|Withdrawal by Subject|3|||
164201630|NCT00997334|593112535|FG000|Overall Study|Death|2|||
164201631|NCT00997334|593112535|FG000|Overall Study|Urgent Palliative Care|2|||
164201632|NCT00997334|593112535|FG000|Overall Study|No lesion amenable|1|||
164553648|NCT03605680|594398740|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
164553649|NCT03605680|594398741|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
164553650|NCT03605680|594398738|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
164553651|NCT03605680|594398739|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
164553652|NCT03605680|594398740|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
164553653|NCT03605680|594398741|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
164553654|NCT03605680|594398738|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
164553655|NCT03605680|594398739|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
164553656|NCT03605680|594398740|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
164553657|NCT03605680|594398741|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
164553658|NCT03605680|594398738|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
164553659|NCT03605680|594398739|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
164553660|NCT03605680|594398740|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
164553661|NCT03605680|594398741|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
164553662|NCT03605680|594398738|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
164553663|NCT03605680|594398739|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
164553664|NCT03605680|594398740|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
164553665|NCT03605680|594398741|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
164553666|NCT03605680|594398738|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
164553667|NCT03605680|594398739|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
164553668|NCT03605680|594398740|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
164553669|NCT03605680|594398741|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
164553670|NCT03605680|594398738|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
164553671|NCT03605680|594398739|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
164553672|NCT03605680|594398740|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
164553673|NCT03605680|594398741|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
164553674|NCT03605680|594398738|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
164553675|NCT03605680|594398739|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
164553676|NCT03605680|594398740|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
164553677|NCT03605680|594398741|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
164553678|NCT03605680|594398738|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
164553679|NCT03605680|594398739|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
164553680|NCT03605680|594398740|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
164553681|NCT03605680|594398741|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
164553682|NCT03605680|594398738|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
164553683|NCT03605680|594398739|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
164553684|NCT03605680|594398740|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
164553685|NCT03605680|594398741|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
164553686|NCT03605680|594398738|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
164553687|NCT03605680|594398739|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
164553688|NCT03605680|594398740|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
164553689|NCT03605680|594398741|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
164553690|NCT03189446|594398742|FG000|Overall Study|Adverse Event|2|||
164553691|NCT03189446|594398742|FG000|Overall Study|Withdrawal by Subject|2|||
164553692|NCT03189446|594398742|FG000|Overall Study|Physician Decision|1|||
164201633|NCT00997334|593112535|FG000|Overall Study|Ineligible|1|||
164658568|NCT01022112|594774901|FG001|Overall Study|Adverse Event|2|||
164658569|NCT01022112|594774902|FG002|Overall Study|Adverse Event|0|||
164658570|NCT01022112|594774903|FG003|Overall Study|Adverse Event|1|||
164658571|NCT01022112|594774904|FG004|Overall Study|Adverse Event|0|||
164658572|NCT01022112|594774900|FG000|Overall Study|Lack of Efficacy|1|||
164658573|NCT01022112|594774901|FG001|Overall Study|Lack of Efficacy|0|||
164658574|NCT01022112|594774902|FG002|Overall Study|Lack of Efficacy|0|||
164658575|NCT01022112|594774903|FG003|Overall Study|Lack of Efficacy|0|||
164658576|NCT01022112|594774904|FG004|Overall Study|Lack of Efficacy|1|||
164658577|NCT01022112|594774900|FG000|Overall Study|Physician Decision|0|||
164658578|NCT01022112|594774901|FG001|Overall Study|Physician Decision|0|||
164658579|NCT01022112|594774902|FG002|Overall Study|Physician Decision|1|||
164658580|NCT01022112|594774903|FG003|Overall Study|Physician Decision|0|||
164658581|NCT01022112|594774904|FG004|Overall Study|Physician Decision|1|||
164658582|NCT01022112|594774900|FG000|Overall Study|Withdrawal by Subject|0|||
164658583|NCT01022112|594774901|FG001|Overall Study|Withdrawal by Subject|1|||
164658584|NCT01022112|594774902|FG002|Overall Study|Withdrawal by Subject|2|||
164658585|NCT01022112|594774903|FG003|Overall Study|Withdrawal by Subject|2|||
164658586|NCT01022112|594774904|FG004|Overall Study|Withdrawal by Subject|1|||
164658587|NCT01022112|594774900|FG000|Overall Study|Fasting plasma glucose level increased|1|||
164658588|NCT01022112|594774901|FG001|Overall Study|Fasting plasma glucose level increased|0|||
164658589|NCT01022112|594774902|FG002|Overall Study|Fasting plasma glucose level increased|0|||
164658590|NCT01022112|594774903|FG003|Overall Study|Fasting plasma glucose level increased|0|||
164658591|NCT01022112|594774904|FG004|Overall Study|Fasting plasma glucose level increased|7|||
164658592|NCT00289458|594774905|FG000|Overall Study|Death|1|||
164658593|NCT00289458|594774906|FG001|Overall Study|Death|0|||
164658594|NCT00289458|594774907|FG002|Overall Study|Death|0|||
164658595|NCT00289458|594774905|FG000|Overall Study|Physician Decision|3|||
164658596|NCT00289458|594774906|FG001|Overall Study|Physician Decision|4|||
164658597|NCT00289458|594774907|FG002|Overall Study|Physician Decision|2|||
164658598|NCT00289458|594774905|FG000|Overall Study|Withdrawal by Subject|2|||
164658599|NCT00289458|594774906|FG001|Overall Study|Withdrawal by Subject|2|||
164658600|NCT00289458|594774907|FG002|Overall Study|Withdrawal by Subject|4|||
164658601|NCT04274192|594774908|FG000|Overall Study|Protocol Violation|1|||
164658602|NCT04274192|594774909|FG001|Overall Study|Protocol Violation|0|||
164658603|NCT07174544|594774910|FG000|Overall Study|Lost to Follow-up|43|||
164658604|NCT07174544|594774911|FG001|Overall Study|Lost to Follow-up|15|||
164658605|NCT03419234|594774912|FG000|Overall Study|Disease progression|37|||
164658606|NCT03419234|594774913|FG001|Overall Study|Disease progression|36|||
164658607|NCT03419234|594774912|FG000|Overall Study|Adverse Event|6|||
164201634|NCT01586195|593112536|FG000|Overall Study|Death|11|||
164201635|NCT01586195|593112536|FG000|Overall Study|Withdrawal of Consent|5|||
164201636|NCT01586195|593112536|FG000|Overall Study|Started new anti-melanoma therapy|1|||
164201637|NCT01586195|593112536|FG000|Overall Study|Reason not specified|9|||
164201638|NCT01287936|593112541|FG000|Overall Study|Lost to Follow-up|0|||
164201639|NCT01287936|593112542|FG001|Overall Study|Lost to Follow-up|1|||
164201640|NCT01287936|593112543|FG002|Overall Study|Lost to Follow-up|1|||
164201641|NCT01855958|593112544|FG000|Overall Study|Withdrawal by Subject|1|||
164201642|NCT01855958|593112545|FG001|Overall Study|Withdrawal by Subject|0|||
164201643|NCT00296244|593112546|FG000|Overall Study|Underwent retransplant|0|||
164201644|NCT00296244|593112547|FG001|Overall Study|Underwent retransplant|1|||
164201645|NCT00266708|593112552|FG000|Overall Study|No renal function|1|||
164201646|NCT00266708|593112553|FG001|Overall Study|No renal function|1|||
164201647|NCT00266708|593112552|FG000|Overall Study|Refused biopsy|3|||
164201648|NCT00266708|593112553|FG001|Overall Study|Refused biopsy|6|||
164201649|NCT00266708|593112552|FG000|Overall Study|Asthma|0|||
164201650|NCT00266708|593112553|FG001|Overall Study|Asthma|2|||
164201651|NCT00703534|593112554|FG000|Overall Study|Adverse Event|14|||
164201652|NCT00703534|593112555|FG001|Overall Study|Adverse Event|3|||
164201653|NCT00703534|593112554|FG000|Overall Study|Withdrawal by Subject|8|||
164201654|NCT00703534|593112555|FG001|Overall Study|Withdrawal by Subject|7|||
164201655|NCT00703534|593112554|FG000|Overall Study|Incorrect Enrollment|6|||
164658608|NCT03419234|594774913|FG001|Overall Study|Adverse Event|9|||
164658609|NCT03419234|594774912|FG000|Overall Study|Withdrawal by Subject|9|||
164658610|NCT03419234|594774913|FG001|Overall Study|Withdrawal by Subject|7|||
164658611|NCT03419234|594774912|FG000|Overall Study|Death|5|||
164658612|NCT03419234|594774913|FG001|Overall Study|Death|1|||
164658613|NCT03419234|594774912|FG000|Overall Study|Alternative therapy|4|||
164658614|NCT03419234|594774913|FG001|Overall Study|Alternative therapy|2|||
164658615|NCT03419234|594774912|FG000|Overall Study|PSA progression|8|||
164658616|NCT03419234|594774913|FG001|Overall Study|PSA progression|10|||
164658617|NCT03419234|594774912|FG000|Overall Study|Rising PSA and bone issues|3|||
164658618|NCT03419234|594774913|FG001|Overall Study|Rising PSA and bone issues|2|||
164658619|NCT03419234|594774912|FG000|Overall Study|Clinical deterioration/clinical progression/symptomatic progression|10|||
164658620|NCT03419234|594774913|FG001|Overall Study|Clinical deterioration/clinical progression/symptomatic progression|16|||
164658621|NCT03419234|594774912|FG000|Overall Study|Physician Decision|12|||
164201656|NCT00703534|593112555|FG001|Overall Study|Incorrect Enrollment|6|||
164201657|NCT00703534|593112554|FG000|Overall Study|Lost to Follow-up|1|||
164201658|NCT00703534|593112555|FG001|Overall Study|Lost to Follow-up|4|||
164553693|NCT00883337|594398743|FG000|Core Treatment Period|Adverse Event|9|||
164553694|NCT00883337|594398744|FG001|Core Treatment Period|Adverse Event|12|||
164553695|NCT00883337|594398745|FG002|Core Treatment Period|Adverse Event|22|||
164553696|NCT00883337|594398743|FG000|Core Treatment Period|Lack of Efficacy|7|||
164553697|NCT00883337|594398744|FG001|Core Treatment Period|Lack of Efficacy|4|||
164553698|NCT00883337|594398745|FG002|Core Treatment Period|Lack of Efficacy|2|||
164553699|NCT00883337|594398743|FG000|Core Treatment Period|Lost to Follow-up|1|||
164553700|NCT00883337|594398744|FG001|Core Treatment Period|Lost to Follow-up|1|||
164553701|NCT00883337|594398745|FG002|Core Treatment Period|Lost to Follow-up|0|||
164553702|NCT00883337|594398743|FG000|Core Treatment Period|Withdrawal by Subject|2|||
164553703|NCT00883337|594398744|FG001|Core Treatment Period|Withdrawal by Subject|2|||
164553704|NCT00883337|594398745|FG002|Core Treatment Period|Withdrawal by Subject|6|||
164553705|NCT00883337|594398743|FG000|Core Treatment Period|Wish to be pregnant|1|||
164553706|NCT00883337|594398744|FG001|Core Treatment Period|Wish to be pregnant|2|||
164553707|NCT00883337|594398745|FG002|Core Treatment Period|Wish to be pregnant|1|||
164553708|NCT00883337|594398743|FG000|Core Treatment Period|Poor compliance to protocol|0|||
164553709|NCT00883337|594398744|FG001|Core Treatment Period|Poor compliance to protocol|0|||
164553710|NCT00883337|594398745|FG002|Core Treatment Period|Poor compliance to protocol|1|||
164553711|NCT00883337|594398743|FG000|Core Treatment Period|Other than above|0|||
164553712|NCT00883337|594398744|FG001|Core Treatment Period|Other than above|1|||
164553713|NCT00883337|594398745|FG002|Core Treatment Period|Other than above|1|||
164553714|NCT00883337|594398743|FG000|Extension Treatment Period|Adverse Event|8|||
164553715|NCT00883337|594398744|FG001|Extension Treatment Period|Adverse Event|5|||
164553716|NCT00883337|594398745|FG002|Extension Treatment Period|Adverse Event|5|||
164553717|NCT00883337|594398743|FG000|Extension Treatment Period|Lack of Efficacy|8|||
164553718|NCT00883337|594398744|FG001|Extension Treatment Period|Lack of Efficacy|8|||
164553719|NCT00883337|594398745|FG002|Extension Treatment Period|Lack of Efficacy|8|||
164553720|NCT00883337|594398743|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
164553721|NCT00883337|594398744|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
164553722|NCT00883337|594398745|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
164553723|NCT00883337|594398743|FG000|Extension Treatment Period|Lost to Follow-up|1|||
164553724|NCT00883337|594398744|FG001|Extension Treatment Period|Lost to Follow-up|0|||
164553725|NCT00883337|594398745|FG002|Extension Treatment Period|Lost to Follow-up|0|||
164553726|NCT00883337|594398743|FG000|Extension Treatment Period|Other than above|10|||
164553727|NCT00883337|594398744|FG001|Extension Treatment Period|Other than above|9|||
164553728|NCT00883337|594398745|FG002|Extension Treatment Period|Other than above|5|||
164553729|NCT03468309|594398746|FG000|Overall Study|Lost to Follow-up|4|||
164553730|NCT03468309|594398746|FG000|Overall Study|Withdrawal by Subject|2|||
164553731|NCT03865706|594398750|FG000|Overall Study|Death|0|||
164553732|NCT03865706|594398751|FG001|Overall Study|Death|3|||
164553733|NCT03865706|594398752|FG002|Overall Study|Death|1|||
164553734|NCT03363321|594398755|FG000|Overall Study|Withdrawal by Subject|0|||
164553735|NCT03363321|594398756|FG001|Overall Study|Withdrawal by Subject|1|||
164553736|NCT03363321|594398757|FG002|Overall Study|Withdrawal by Subject|0|||
164553737|NCT03363321|594398758|FG003|Overall Study|Withdrawal by Subject|1|||
164553738|NCT03363321|594398759|FG004|Overall Study|Withdrawal by Subject|0|||
164553739|NCT02590588|594398762|FG000|Overall Study|Adverse Event|1|||
164553740|NCT01780831|594398763|FG000|Overall Study|Withdrawal by Subject|0|||
164553741|NCT01780831|594398764|FG001|Overall Study|Withdrawal by Subject|0|||
164201659|NCT00703534|593112554|FG000|Overall Study|Severe Non Compliance|1|||
164201660|NCT00703534|593112555|FG001|Overall Study|Severe Non Compliance|5|||
164201661|NCT00427934|593112556|FG000|Overall Study|Adverse Event|1|||
164201662|NCT00427934|593112557|FG001|Overall Study|Adverse Event|0|||
164201663|NCT00427934|593112558|FG002|Overall Study|Adverse Event|5|||
164201664|NCT00427934|593112559|FG003|Overall Study|Adverse Event|4|||
164201665|NCT00427934|593112556|FG000|Overall Study|Lack of Efficacy|0|||
164201666|NCT00427934|593112557|FG001|Overall Study|Lack of Efficacy|0|||
164201667|NCT00427934|593112558|FG002|Overall Study|Lack of Efficacy|5|||
164201668|NCT00427934|593112559|FG003|Overall Study|Lack of Efficacy|2|||
164201669|NCT00427934|593112556|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
164201670|NCT00427934|593112557|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
164201671|NCT00427934|593112558|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
164201672|NCT00427934|593112559|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
164553742|NCT01780831|594398765|FG002|Overall Study|Withdrawal by Subject|4|||
164553743|NCT01780831|594398766|FG003|Overall Study|Withdrawal by Subject|0|||
164553744|NCT01780831|594398763|FG000|Overall Study|Lost to Follow-up|0|||
164553745|NCT01780831|594398764|FG001|Overall Study|Lost to Follow-up|0|||
164553746|NCT01780831|594398765|FG002|Overall Study|Lost to Follow-up|0|||
164553747|NCT01780831|594398766|FG003|Overall Study|Lost to Follow-up|1|||
164201673|NCT00427934|593112556|FG000|Overall Study|Other|0|||
164201674|NCT00427934|593112557|FG001|Overall Study|Other|0|||
164201675|NCT00427934|593112558|FG002|Overall Study|Other|11|||
164201676|NCT00427934|593112559|FG003|Overall Study|Other|5|||
164201677|NCT00427934|593112556|FG000|Overall Study|Withdrawal by Subject|0|||
164658622|NCT03419234|594774913|FG001|Overall Study|Physician Decision|11|||
164658623|NCT03419234|594774912|FG000|Overall Study|Second malignancy|1|||
164658624|NCT03419234|594774913|FG001|Overall Study|Second malignancy|0|||
164658625|NCT03419234|594774912|FG000|Overall Study|Insurance status change/patient could not afford|2|||
164658626|NCT03419234|594774913|FG001|Overall Study|Insurance status change/patient could not afford|1|||
164658627|NCT03419234|594774912|FG000|Overall Study|Non-compliance|1|||
164658628|NCT03419234|594774913|FG001|Overall Study|Non-compliance|3|||
164658629|NCT03419234|594774912|FG000|Overall Study|Mistakenly off treatment|1|||
164658630|NCT03419234|594774913|FG001|Overall Study|Mistakenly off treatment|0|||
164658631|NCT03419234|594774912|FG000|Overall Study|Transition to hospice|1|||
164658632|NCT03419234|594774913|FG001|Overall Study|Transition to hospice|0|||
164658633|NCT03419234|594774912|FG000|Overall Study|Still on treatment|9|||
164658634|NCT03419234|594774913|FG001|Overall Study|Still on treatment|8|||
164658635|NCT03419234|594774912|FG000|Overall Study|Never received protocol therapy|2|||
164658636|NCT03419234|594774913|FG001|Overall Study|Never received protocol therapy|4|||
164658637|NCT03419234|594774912|FG000|Overall Study|Other complicating disease|0|||
164658638|NCT03419234|594774913|FG001|Overall Study|Other complicating disease|1|||
164658639|NCT03419234|594774912|FG000|Overall Study|patient switched from prednisone to another steroid|0|||
164658640|NCT03419234|594774913|FG001|Overall Study|patient switched from prednisone to another steroid|1|||
164658641|NCT03355742|594776028|FG000|Overall Study|Lost to Follow-up|4|||
164658642|NCT03355742|594776028|FG000|Overall Study|Withdrawal by Subject|29|||
164658643|NCT03355742|594776028|FG000|Overall Study|Physician Decision|6|||
164658644|NCT03355742|594776028|FG000|Overall Study|Death|55|||
164658645|NCT03355742|594776028|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
164658646|NCT02207621|594776029|FG000|Overall Study|Adverse Event|71|||
164658647|NCT02207621|594776030|FG001|Overall Study|Adverse Event|15|||
164658648|NCT02207621|594776031|FG002|Overall Study|Adverse Event|132|||
164658649|NCT02207621|594776029|FG000|Overall Study|Withdrawal by Subject|9|||
164658650|NCT02207621|594776030|FG001|Overall Study|Withdrawal by Subject|9|||
164658651|NCT02207621|594776031|FG002|Overall Study|Withdrawal by Subject|13|||
164658652|NCT02207621|594776029|FG000|Overall Study|Non-Compliant|3|||
164658653|NCT02207621|594776030|FG001|Overall Study|Non-Compliant|3|||
164658654|NCT02207621|594776031|FG002|Overall Study|Non-Compliant|1|||
164658655|NCT02207621|594776029|FG000|Overall Study|Lost to Follow-up|1|||
164658656|NCT02207621|594776030|FG001|Overall Study|Lost to Follow-up|0|||
164658657|NCT02207621|594776031|FG002|Overall Study|Lost to Follow-up|3|||
164658658|NCT02207621|594776029|FG000|Overall Study|Lack of Efficacy|10|||
164658659|NCT02207621|594776030|FG001|Overall Study|Lack of Efficacy|2|||
164658660|NCT02207621|594776031|FG002|Overall Study|Lack of Efficacy|4|||
164658661|NCT02207621|594776029|FG000|Overall Study|Disallowed Concurrent Medication|2|||
164658662|NCT02207621|594776030|FG001|Overall Study|Disallowed Concurrent Medication|5|||
164658663|NCT02207621|594776031|FG002|Overall Study|Disallowed Concurrent Medication|2|||
164658664|NCT02207621|594776029|FG000|Overall Study|Physician Decision|1|||
164658665|NCT02207621|594776030|FG001|Overall Study|Physician Decision|2|||
164658666|NCT02207621|594776031|FG002|Overall Study|Physician Decision|2|||
164658667|NCT02207621|594776029|FG000|Overall Study|Protocol Violation|4|||
164658668|NCT02207621|594776030|FG001|Overall Study|Protocol Violation|10|||
164658669|NCT02207621|594776031|FG002|Overall Study|Protocol Violation|6|||
164658670|NCT02207621|594776029|FG000|Overall Study|Death|2|||
164658671|NCT02207621|594776030|FG001|Overall Study|Death|0|||
164658672|NCT02207621|594776031|FG002|Overall Study|Death|0|||
164658673|NCT02207621|594776029|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
164658674|NCT02207621|594776030|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
164658675|NCT02207621|594776031|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
164658676|NCT02623959|594776032|FG000|Overall Study|Progression|0|||
164658677|NCT02623959|594776033|FG001|Overall Study|Progression|1|||
164658678|NCT04903288|594776037|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
164658679|NCT04903288|594776037|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
164658680|NCT04903288|594776037|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
164658681|NCT04903288|594776037|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
164658682|NCT00634907|594776045|FG000|Overall Study|Withdrawal by Subject|3|||
164658683|NCT00634907|594776046|FG001|Overall Study|Withdrawal by Subject|0|||
164658684|NCT00634907|594776045|FG000|Overall Study|Physician Decision|3|||
164658685|NCT00634907|594776046|FG001|Overall Study|Physician Decision|9|||
164658686|NCT00634907|594776045|FG000|Overall Study|Withdrawal by Subject|11|||
164658687|NCT00634907|594776046|FG001|Overall Study|Withdrawal by Subject|8|||
164658688|NCT01180244|594776052|FG000|Overall Study|Lack of Efficacy|0|||
164658689|NCT01180244|594776053|FG001|Overall Study|Lack of Efficacy|7|||
164658690|NCT01180244|594776052|FG000|Overall Study|Physician Decision|3|||
164658691|NCT01180244|594776053|FG001|Overall Study|Physician Decision|0|||
164658692|NCT01180244|594776052|FG000|Overall Study|Adverse Event|1|||
164658693|NCT01180244|594776053|FG001|Overall Study|Adverse Event|0|||
164658694|NCT01180244|594776052|FG000|Overall Study|Withdrawal by Subject|0|||
164658695|NCT01180244|594776053|FG001|Overall Study|Withdrawal by Subject|1|||
164658696|NCT01180244|594776052|FG000|Overall Study|Protocol Violation|1|||
164658697|NCT01180244|594776053|FG001|Overall Study|Protocol Violation|0|||
164658698|NCT01180244|594776052|FG000|Overall Study|Lost to Follow-up|1|||
164658699|NCT01180244|594776053|FG001|Overall Study|Lost to Follow-up|0|||
164658700|NCT01595009|594776058|FG000|Core|Patients completed per protocol|85|||
164658701|NCT01595009|594776059|FG001|Core|Patients completed per protocol|44|||
164658702|NCT01595009|594776060|FG002|Core|Patients completed per protocol|0|||
164658703|NCT01595009|594776061|FG003|Core|Patients completed per protocol|0|||
164658704|NCT01595009|594776058|FG000|Core|Adverse Event|19|||
164658705|NCT01595009|594776059|FG001|Core|Adverse Event|23|||
164658706|NCT01595009|594776060|FG002|Core|Adverse Event|0|||
164658707|NCT01595009|594776061|FG003|Core|Adverse Event|0|||
164658708|NCT01595009|594776058|FG000|Core|Disease progression|14|||
164658709|NCT01595009|594776059|FG001|Core|Disease progression|26|||
164658710|NCT01595009|594776060|FG002|Core|Disease progression|0|||
164658711|NCT01595009|594776061|FG003|Core|Disease progression|0|||
164658712|NCT01595009|594776058|FG000|Core|Withdrawal by Subject|4|||
164658713|NCT01595009|594776059|FG001|Core|Withdrawal by Subject|17|||
164658714|NCT01595009|594776060|FG002|Core|Withdrawal by Subject|0|||
164658715|NCT01595009|594776061|FG003|Core|Withdrawal by Subject|0|||
164658716|NCT01595009|594776058|FG000|Core|Death|3|||
164658717|NCT01595009|594776059|FG001|Core|Death|6|||
164658718|NCT01595009|594776060|FG002|Core|Death|0|||
164658719|NCT01595009|594776061|FG003|Core|Death|0|||
164658720|NCT01595009|594776058|FG000|Core|Lost to Follow-up|1|||
164658721|NCT01595009|594776059|FG001|Core|Lost to Follow-up|2|||
164658722|NCT01595009|594776060|FG002|Core|Lost to Follow-up|0|||
164658723|NCT01595009|594776061|FG003|Core|Lost to Follow-up|0|||
164658724|NCT01595009|594776058|FG000|Core|Protocol deviation|0|||
164658725|NCT01595009|594776059|FG001|Core|Protocol deviation|1|||
164658726|NCT01595009|594776060|FG002|Core|Protocol deviation|0|||
164658727|NCT01595009|594776061|FG003|Core|Protocol deviation|0|||
164658728|NCT01595009|594776058|FG000|Core|Administrative problems|0|||
164658729|NCT01595009|594776059|FG001|Core|Administrative problems|1|||
164658730|NCT01595009|594776060|FG002|Core|Administrative problems|0|||
164658731|NCT01595009|594776061|FG003|Core|Administrative problems|0|||
164658732|NCT01595009|594776058|FG000|Extension|Administrative problems|0|||
164658733|NCT01595009|594776059|FG001|Extension|Administrative problems|0|||
164658734|NCT01595009|594776060|FG002|Extension|Administrative problems|0|||
164658735|NCT01595009|594776061|FG003|Extension|Administrative problems|1|||
164658736|NCT01595009|594776058|FG000|Extension|Patients completed per protocol|0|||
164658737|NCT01595009|594776059|FG001|Extension|Patients completed per protocol|0|||
164658738|NCT01595009|594776060|FG002|Extension|Patients completed per protocol|0|||
164658739|NCT01595009|594776061|FG003|Extension|Patients completed per protocol|2|||
164658740|NCT01595009|594776058|FG000|Extension|Disease progression|0|||
164658741|NCT01595009|594776059|FG001|Extension|Disease progression|0|||
164658742|NCT01595009|594776060|FG002|Extension|Disease progression|4|||
164658743|NCT01595009|594776061|FG003|Extension|Disease progression|7|||
164658744|NCT01595009|594776058|FG000|Extension|Adverse Event|0|||
164658745|NCT01595009|594776059|FG001|Extension|Adverse Event|0|||
164658746|NCT01595009|594776060|FG002|Extension|Adverse Event|0|||
164658747|NCT01595009|594776061|FG003|Extension|Adverse Event|1|||
164658748|NCT02623829|594776068|FG000|Overall Study|Lost to Follow-up|1|||
164658749|NCT02623829|594776069|FG001|Overall Study|Lost to Follow-up|1|||
164658750|NCT00681863|594776070|FG000|Overall Study|Adverse Event|1|||
164658751|NCT00681863|594776070|FG000|Overall Study|Lost to Follow-up|2|||
164658752|NCT00681863|594776070|FG000|Overall Study|Lack of Efficacy|2|||
164658753|NCT00681863|594776070|FG000|Overall Study|Other|18|||
164658754|NCT01388647|594776076|FG000|Overall Study|Adverse Event|1|||
164658755|NCT01388647|594776077|FG001|Overall Study|Adverse Event|2|||
164658756|NCT01006707|594776078|FG000|Study Session 1|Lost to Follow-up|2|||
164658757|NCT01006707|594776079|FG001|Study Session 1|Lost to Follow-up|0|||
164658758|NCT01006707|594776080|FG002|Study Session 1|Lost to Follow-up|0|||
164201678|NCT00427934|593112557|FG001|Overall Study|Withdrawal by Subject|0|||
164201679|NCT00427934|593112558|FG002|Overall Study|Withdrawal by Subject|1|||
164201680|NCT00427934|593112559|FG003|Overall Study|Withdrawal by Subject|3|||
164658759|NCT01006707|594776078|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
164658760|NCT01006707|594776079|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
164658761|NCT01006707|594776080|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
164658762|NCT00622908|594776081|FG000|Overall Study|Protocol Violation|1|||
164658763|NCT00622908|594776082|FG001|Overall Study|Protocol Violation|0|||
164658764|NCT00622908|594776081|FG000|Overall Study|Adverse Event|0|||
164658765|NCT00622908|594776082|FG001|Overall Study|Adverse Event|1|||
164658766|NCT00622908|594776081|FG000|Overall Study|Lack of Efficacy|1|||
164658767|NCT00622908|594776082|FG001|Overall Study|Lack of Efficacy|7|||
164658768|NCT00622908|594776081|FG000|Overall Study|Lost to Follow-up|1|||
164658769|NCT00622908|594776082|FG001|Overall Study|Lost to Follow-up|0|||
164658770|NCT00622908|594776081|FG000|Overall Study|Refusal|0|||
164201681|NCT02791269|593112560|FG000|Overall Study|Lost to Follow-up|0|||
164658771|NCT00622908|594776082|FG001|Overall Study|Refusal|1|||
164658772|NCT00622908|594776081|FG000|Overall Study|Termination by study sponser|0|||
164658773|NCT00622908|594776082|FG001|Overall Study|Termination by study sponser|1|||
164658774|NCT03937466|594776083|FG000|Overall Study|not eligbile after the 2-week diary|9|||
164658775|NCT03937466|594776083|FG000|Overall Study|never returned their diary|6|||
164310294|NCT00552188|593510800|FG001|Overall Study|Adverse Event|2|||
164310295|NCT00552188|593510799|FG000|Overall Study|Lost to Follow-up|2|||
164310296|NCT00552188|593510800|FG001|Overall Study|Lost to Follow-up|1|||
164310297|NCT00552188|593510799|FG000|Overall Study|Withdrawal of consent|0|||
164310298|NCT00552188|593510800|FG001|Overall Study|Withdrawal of consent|1|||
164310299|NCT00552188|593510799|FG000|Overall Study|Subject returned to home country|0|||
164310300|NCT00552188|593510800|FG001|Overall Study|Subject returned to home country|1|||
164310301|NCT01368562|593510803|FG000|Overall Study|Adverse Event|1|||
164310302|NCT01368562|593510803|FG000|Overall Study|Disease progression|1|||
164310303|NCT01368562|593510803|FG000|Overall Study|Lost to Follow-up|1|||
164310304|NCT01368562|593510803|FG000|Overall Study|Death|6|||
164310305|NCT01368562|593510803|FG000|Overall Study|Unresponsive to treatment|5|||
164310306|NCT01368562|593510803|FG000|Overall Study|Other|3|||
164310307|NCT01368562|593510803|FG000|Overall Study|Other than specified|2|||
164310308|NCT00727441|593510805|FG000|Overall Study|Disease Progression|11|||
164310309|NCT00727441|593510806|FG001|Overall Study|Disease Progression|14|||
164310310|NCT00727441|593510807|FG002|Overall Study|Disease Progression|17|||
164310311|NCT00727441|593510805|FG000|Overall Study|Eligibility|7|||
164310312|NCT00727441|593510806|FG001|Overall Study|Eligibility|5|||
164310313|NCT00727441|593510807|FG002|Overall Study|Eligibility|7|||
164310314|NCT00727441|593510805|FG000|Overall Study|Death|0|||
164310315|NCT00727441|593510806|FG001|Overall Study|Death|1|||
164310316|NCT00727441|593510807|FG002|Overall Study|Death|1|||
164310317|NCT00727441|593510805|FG000|Overall Study|Physician Decision|0|||
164310318|NCT00727441|593510806|FG001|Overall Study|Physician Decision|1|||
164310319|NCT00727441|593510807|FG002|Overall Study|Physician Decision|0|||
164310320|NCT00727441|593510805|FG000|Overall Study|Withdrawal by Subject|0|||
164310321|NCT00727441|593510806|FG001|Overall Study|Withdrawal by Subject|1|||
164310322|NCT00727441|593510807|FG002|Overall Study|Withdrawal by Subject|0|||
164310323|NCT00243269|593510812|FG000|Overall Study|Protocol Violation|2|||
164310324|NCT00243269|593510813|FG001|Overall Study|Protocol Violation|1|||
164310325|NCT00243269|593510814|FG002|Overall Study|Protocol Violation|0|||
164310326|NCT00243269|593510815|FG003|Overall Study|Protocol Violation|1|||
164310327|NCT00243269|593510812|FG000|Overall Study|Lost to Follow-up|1|||
164310328|NCT00243269|593510813|FG001|Overall Study|Lost to Follow-up|0|||
164310329|NCT00243269|593510814|FG002|Overall Study|Lost to Follow-up|1|||
164553748|NCT01784861|594398768|FG000|Overall Study|Adverse Event|0|||
164553749|NCT01784861|594398769|FG001|Overall Study|Adverse Event|0|||
164553750|NCT01784861|594398770|FG002|Overall Study|Adverse Event|1|||
164553751|NCT01784861|594398771|FG003|Overall Study|Adverse Event|2|||
164553752|NCT01784861|594398772|FG004|Overall Study|Adverse Event|1|||
164553753|NCT01784861|594398773|FG005|Overall Study|Adverse Event|0|||
164553754|NCT01784861|594398768|FG000|Overall Study|Withdrawal by Subject|0|||
164553755|NCT01784861|594398769|FG001|Overall Study|Withdrawal by Subject|0|||
164553756|NCT01784861|594398770|FG002|Overall Study|Withdrawal by Subject|0|||
164553757|NCT01784861|594398771|FG003|Overall Study|Withdrawal by Subject|1|||
164553758|NCT01784861|594398772|FG004|Overall Study|Withdrawal by Subject|0|||
164553759|NCT01784861|594398773|FG005|Overall Study|Withdrawal by Subject|0|||
164553760|NCT01784861|594398768|FG000|Overall Study|Physician Decision|0|||
164553761|NCT01784861|594398769|FG001|Overall Study|Physician Decision|0|||
164553762|NCT01784861|594398770|FG002|Overall Study|Physician Decision|0|||
164553763|NCT01784861|594398771|FG003|Overall Study|Physician Decision|2|||
164553764|NCT01784861|594398772|FG004|Overall Study|Physician Decision|0|||
164553765|NCT01784861|594398773|FG005|Overall Study|Physician Decision|1|||
164553766|NCT02599961|594398776|FG000|Overall Study|Withdrawal by Subject|1|||
164553767|NCT02599961|594398776|FG000|Overall Study|Subject Non-Compliance|2|||
164553768|NCT02599961|594398776|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
164553769|NCT02599961|594398776|FG000|Overall Study|Other, Not Specified|3|||
164553770|NCT01857869|594398777|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
164553771|NCT01857869|594398778|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
164553772|NCT01857869|594398779|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
164310330|NCT00243269|593510815|FG003|Overall Study|Lost to Follow-up|3|||
164310331|NCT01296672|593510820|FG000|Overall Study|Lost to Follow-up|73|||
164310332|NCT01296672|593510821|FG001|Overall Study|Lost to Follow-up|18|||
164553773|NCT01857869|594398780|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
164553774|NCT01857869|594398781|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
164553775|NCT01857869|594398782|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
164553776|NCT01857869|594398783|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
164310333|NCT01311024|593510822|FG000|Overall Study|Protocol Violation|35|||
164553777|NCT01857869|594398784|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
164553778|NCT01857869|594398785|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
164553779|NCT01857869|594398786|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
164553780|NCT01857869|594398777|FG000|Primary/Challenge Phase|Pregnancy|1|||
164553781|NCT01857869|594398778|FG001|Primary/Challenge Phase|Pregnancy|0|||
164310334|NCT01311024|593510823|FG001|Overall Study|Protocol Violation|22|||
164310335|NCT00856518|593510824|FG000|Overall Study|Lost to Follow-up|4|||
164310336|NCT00856518|593510825|FG001|Overall Study|Lost to Follow-up|2|||
164310337|NCT02867384|593510826|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
164310338|NCT02867384|593510827|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
164658776|NCT03937466|594776083|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
164658777|NCT03937466|594776083|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
164658778|NCT01851590|594776087|FG000|Overall Study|Withdrawal by Subject|0|||
164658779|NCT01851590|594776088|FG001|Overall Study|Withdrawal by Subject|0|||
164658780|NCT01851590|594776089|FG002|Overall Study|Withdrawal by Subject|1|||
164658781|NCT01851590|594776087|FG000|Overall Study|Adverse Event|0|||
164658782|NCT01851590|594776088|FG001|Overall Study|Adverse Event|0|||
164658783|NCT01851590|594776089|FG002|Overall Study|Adverse Event|2|||
164658784|NCT01851590|594776087|FG000|Overall Study|Lack of Efficacy|0|||
164658785|NCT01851590|594776088|FG001|Overall Study|Lack of Efficacy|1|||
164658786|NCT01851590|594776089|FG002|Overall Study|Lack of Efficacy|0|||
164658787|NCT00321711|594776092|FG000|Part A|Adverse Event|3|||
164658788|NCT00321711|594776093|FG001|Part A|Adverse Event|3|||
164658789|NCT00321711|594776094|FG002|Part A|Adverse Event|2|||
164658790|NCT00321711|594776095|FG003|Part A|Adverse Event|0|||
164658791|NCT00321711|594776096|FG004|Part A|Adverse Event|0|||
164658792|NCT00321711|594776092|FG000|Part A|Withdrawal by Subject|1|||
164658793|NCT00321711|594776093|FG001|Part A|Withdrawal by Subject|1|||
164658794|NCT00321711|594776094|FG002|Part A|Withdrawal by Subject|1|||
164658795|NCT00321711|594776095|FG003|Part A|Withdrawal by Subject|0|||
164658796|NCT00321711|594776096|FG004|Part A|Withdrawal by Subject|0|||
164658797|NCT00321711|594776092|FG000|Part A|Disease progression|0|||
164658798|NCT00321711|594776093|FG001|Part A|Disease progression|1|||
164658799|NCT00321711|594776094|FG002|Part A|Disease progression|0|||
164658800|NCT00321711|594776095|FG003|Part A|Disease progression|0|||
164658801|NCT00321711|594776096|FG004|Part A|Disease progression|0|||
164658802|NCT00321711|594776092|FG000|Part A|Requirement for alternative therapy|0|||
164658803|NCT00321711|594776093|FG001|Part A|Requirement for alternative therapy|2|||
164658804|NCT00321711|594776094|FG002|Part A|Requirement for alternative therapy|1|||
164658805|NCT00321711|594776095|FG003|Part A|Requirement for alternative therapy|0|||
164658806|NCT00321711|594776096|FG004|Part A|Requirement for alternative therapy|0|||
164658807|NCT00321711|594776092|FG000|Part A|Physician Decision|0|||
164658808|NCT00321711|594776093|FG001|Part A|Physician Decision|1|||
164658809|NCT00321711|594776094|FG002|Part A|Physician Decision|3|||
164658810|NCT00321711|594776095|FG003|Part A|Physician Decision|0|||
164658811|NCT00321711|594776096|FG004|Part A|Physician Decision|0|||
164658812|NCT00321711|594776092|FG000|Part A|Other|1|||
164658813|NCT00321711|594776093|FG001|Part A|Other|2|||
164658814|NCT00321711|594776094|FG002|Part A|Other|3|||
164658815|NCT00321711|594776095|FG003|Part A|Other|0|||
164658816|NCT00321711|594776096|FG004|Part A|Other|0|||
164658817|NCT00321711|594776092|FG000|Part A|Protocol deviation|0|||
164658818|NCT00321711|594776093|FG001|Part A|Protocol deviation|0|||
164658819|NCT00321711|594776094|FG002|Part A|Protocol deviation|1|||
164658820|NCT00321711|594776095|FG003|Part A|Protocol deviation|0|||
164658821|NCT00321711|594776096|FG004|Part A|Protocol deviation|0|||
164658822|NCT00321711|594776092|FG000|Part B|Noncompliance|0|||
164658823|NCT00321711|594776093|FG001|Part B|Noncompliance|0|||
164658824|NCT00321711|594776094|FG002|Part B|Noncompliance|0|||
164658825|NCT00321711|594776095|FG003|Part B|Noncompliance|0|||
164658826|NCT00321711|594776096|FG004|Part B|Noncompliance|1|||
164658827|NCT00321711|594776092|FG000|Part B|Adverse Event|0|||
164658828|NCT00321711|594776093|FG001|Part B|Adverse Event|0|||
164658829|NCT00321711|594776094|FG002|Part B|Adverse Event|0|||
164658830|NCT00321711|594776095|FG003|Part B|Adverse Event|2|||
164658831|NCT00321711|594776096|FG004|Part B|Adverse Event|1|||
164658832|NCT00321711|594776092|FG000|Part B|Disease progression|0|||
164658833|NCT00321711|594776093|FG001|Part B|Disease progression|0|||
164658834|NCT00321711|594776094|FG002|Part B|Disease progression|0|||
164658835|NCT00321711|594776095|FG003|Part B|Disease progression|1|||
164658836|NCT00321711|594776096|FG004|Part B|Disease progression|0|||
164658837|NCT00321711|594776092|FG000|Part B|Physician Decision|0|||
164201682|NCT02791269|593112561|FG001|Overall Study|Lost to Follow-up|1|||
164201683|NCT02683109|593112562|FG000|Overall Study|Adverse Event|1|||
164201684|NCT02683109|593112563|FG001|Overall Study|Adverse Event|0|||
164658838|NCT00321711|594776093|FG001|Part B|Physician Decision|0|||
164658839|NCT00321711|594776094|FG002|Part B|Physician Decision|0|||
164658840|NCT00321711|594776095|FG003|Part B|Physician Decision|1|||
164658841|NCT00321711|594776096|FG004|Part B|Physician Decision|2|||
164658842|NCT00321711|594776092|FG000|Part B|Death|0|||
164658843|NCT00321711|594776093|FG001|Part B|Death|0|||
164658844|NCT00321711|594776094|FG002|Part B|Death|0|||
164658845|NCT00321711|594776095|FG003|Part B|Death|2|||
164658846|NCT00321711|594776096|FG004|Part B|Death|1|||
164658847|NCT00543439|594776097|FG000|Period 1|Adverse Event|0|||
164658848|NCT00543439|594776098|FG001|Period 1|Adverse Event|2|||
164658849|NCT00543439|594776099|FG002|Period 1|Adverse Event|1|||
164658850|NCT00543439|594776097|FG000|Period 1|Withdrawal by Subject|1|||
164658851|NCT00543439|594776098|FG001|Period 1|Withdrawal by Subject|1|||
164201685|NCT00368251|593112564|FG000|Overall Study|SAE, non-fatal|1|||
164658852|NCT00543439|594776099|FG002|Period 1|Withdrawal by Subject|0|||
164658853|NCT00543439|594776097|FG000|Period 1|Physician Decision|0|||
164658854|NCT00543439|594776098|FG001|Period 1|Physician Decision|0|||
164658855|NCT00543439|594776099|FG002|Period 1|Physician Decision|1|||
164310339|NCT02867384|593510828|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
164310340|NCT02867384|593510826|FG000|Overall Study|Progression/ Relapse|15|||
164310341|NCT02867384|593510827|FG001|Overall Study|Progression/ Relapse|19|||
164310342|NCT02867384|593510828|FG002|Overall Study|Progression/ Relapse|0|||
164310343|NCT02867384|593510826|FG000|Overall Study|Adverse Event|13|||
164310344|NCT02867384|593510827|FG001|Overall Study|Adverse Event|1|||
164310345|NCT02867384|593510828|FG002|Overall Study|Adverse Event|0|||
164310346|NCT02867384|593510826|FG000|Overall Study|Withdrawal by Subject|6|||
164310347|NCT02867384|593510827|FG001|Overall Study|Withdrawal by Subject|5|||
164310348|NCT02867384|593510828|FG002|Overall Study|Withdrawal by Subject|0|||
164310349|NCT02867384|593510826|FG000|Overall Study|Physician Decision|1|||
164310350|NCT02867384|593510827|FG001|Overall Study|Physician Decision|2|||
164310351|NCT02867384|593510828|FG002|Overall Study|Physician Decision|0|||
164310352|NCT02867384|593510826|FG000|Overall Study|Patient compliance|1|||
164310353|NCT02867384|593510827|FG001|Overall Study|Patient compliance|0|||
164310354|NCT02867384|593510828|FG002|Overall Study|Patient compliance|0|||
164310355|NCT02867384|593510826|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
164310356|NCT02867384|593510827|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
164310357|NCT02867384|593510828|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
164310358|NCT02867384|593510826|FG000|Overall Study|Never start treatment|3|||
164310359|NCT02867384|593510827|FG001|Overall Study|Never start treatment|0|||
164310360|NCT02867384|593510828|FG002|Overall Study|Never start treatment|0|||
164310361|NCT01941186|593510829|FG000|Follow-up|Lost to Follow-up|1|||
164310362|NCT01941186|593510830|FG001|Follow-up|Lost to Follow-up|0|||
164310363|NCT02105961|593510831|FG000|Overall Study|Adverse Event|18|||
164310364|NCT02105961|593510832|FG001|Overall Study|Adverse Event|7|||
164310365|NCT02105961|593510833|FG002|Overall Study|Adverse Event|13|||
164310366|NCT02105961|593510831|FG000|Overall Study|Lack of Efficacy|3|||
164310367|NCT02105961|593510832|FG001|Overall Study|Lack of Efficacy|0|||
164310368|NCT02105961|593510833|FG002|Overall Study|Lack of Efficacy|3|||
164553782|NCT01857869|594398779|FG002|Primary/Challenge Phase|Pregnancy|0|||
164553783|NCT01857869|594398780|FG003|Primary/Challenge Phase|Pregnancy|0|||
164553784|NCT01857869|594398781|FG004|Primary/Challenge Phase|Pregnancy|0|||
164553785|NCT01857869|594398782|FG005|Primary/Challenge Phase|Pregnancy|0|||
164553786|NCT01857869|594398783|FG006|Primary/Challenge Phase|Pregnancy|0|||
164553787|NCT01857869|594398784|FG007|Primary/Challenge Phase|Pregnancy|0|||
164553788|NCT01857869|594398785|FG008|Primary/Challenge Phase|Pregnancy|0|||
164553789|NCT01857869|594398786|FG009|Primary/Challenge Phase|Pregnancy|0|||
164553790|NCT01857869|594398777|FG000|Primary/Challenge Phase|Protocol Violation|1|||
164553791|NCT01857869|594398778|FG001|Primary/Challenge Phase|Protocol Violation|0|||
164553792|NCT01857869|594398779|FG002|Primary/Challenge Phase|Protocol Violation|0|||
164553793|NCT01857869|594398780|FG003|Primary/Challenge Phase|Protocol Violation|0|||
164553794|NCT01857869|594398781|FG004|Primary/Challenge Phase|Protocol Violation|0|||
164553795|NCT01857869|594398782|FG005|Primary/Challenge Phase|Protocol Violation|0|||
164553796|NCT01857869|594398783|FG006|Primary/Challenge Phase|Protocol Violation|0|||
164553797|NCT01857869|594398784|FG007|Primary/Challenge Phase|Protocol Violation|0|||
164553798|NCT01857869|594398785|FG008|Primary/Challenge Phase|Protocol Violation|0|||
164553799|NCT01857869|594398786|FG009|Primary/Challenge Phase|Protocol Violation|0|||
164553800|NCT01857869|594398777|FG000|Primary/Challenge Phase|Other|1|||
164553801|NCT01857869|594398778|FG001|Primary/Challenge Phase|Other|1|||
164553802|NCT01857869|594398779|FG002|Primary/Challenge Phase|Other|0|||
164553803|NCT01857869|594398780|FG003|Primary/Challenge Phase|Other|0|||
164553804|NCT01857869|594398781|FG004|Primary/Challenge Phase|Other|0|||
164553805|NCT01857869|594398782|FG005|Primary/Challenge Phase|Other|0|||
164553806|NCT01857869|594398783|FG006|Primary/Challenge Phase|Other|0|||
164553807|NCT01857869|594398784|FG007|Primary/Challenge Phase|Other|0|||
164553808|NCT01857869|594398785|FG008|Primary/Challenge Phase|Other|0|||
164553809|NCT01857869|594398786|FG009|Primary/Challenge Phase|Other|0|||
164553810|NCT01857869|594398777|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
164553811|NCT01857869|594398778|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
164553812|NCT01857869|594398779|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
164553813|NCT01857869|594398780|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
164553814|NCT01857869|594398781|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
164553815|NCT01857869|594398782|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
164553816|NCT01857869|594398783|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
164553817|NCT01857869|594398784|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
164553818|NCT01857869|594398785|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
164553819|NCT01857869|594398786|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
164658856|NCT00543439|594776097|FG000|Period 2|Protocol Violation|1|||
164658857|NCT00543439|594776098|FG001|Period 2|Protocol Violation|0|||
164658858|NCT00543439|594776099|FG002|Period 2|Protocol Violation|1|||
164310369|NCT02105961|593510831|FG000|Overall Study|Lost to Follow-up|2|||
164310370|NCT02105961|593510832|FG001|Overall Study|Lost to Follow-up|0|||
164310371|NCT02105961|593510833|FG002|Overall Study|Lost to Follow-up|1|||
164310372|NCT02105961|593510831|FG000|Overall Study|Physician Decision|3|||
164310373|NCT02105961|593510832|FG001|Overall Study|Physician Decision|3|||
164310374|NCT02105961|593510833|FG002|Overall Study|Physician Decision|2|||
164310375|NCT02105961|593510831|FG000|Overall Study|Withdrawal by Subject|15|||
164310376|NCT02105961|593510832|FG001|Overall Study|Withdrawal by Subject|7|||
164310377|NCT02105961|593510833|FG002|Overall Study|Withdrawal by Subject|11|||
164310378|NCT00934362|593510837|FG000|Overall Study|Adverse Event|1|||
164310379|NCT00934362|593510838|FG001|Overall Study|Adverse Event|0|||
164310380|NCT01092117|593510841|FG000|Index Procedure to 1 Month|Death|1|||
164310381|NCT01092117|593510841|FG000|1 Month|Death|1|||
164310382|NCT01092117|593510841|FG000|1 Month|Withdrawal by Subject|1|||
164310383|NCT01092117|593510841|FG000|1 Month|Lost to Follow-up|1|||
164310384|NCT01092117|593510841|FG000|6 Months|Death|2|||
164310385|NCT01092117|593510841|FG000|6 Months|Withdrawal by Subject|3|||
164310386|NCT01092117|593510841|FG000|12 Month|Death|11|||
164310387|NCT01092117|593510841|FG000|12 Month|Withdrawal by Subject|2|||
164310388|NCT01092117|593510841|FG000|12 Month|Lost to Follow-up|1|||
164310389|NCT01092117|593510841|FG000|Year 2|Death|5|||
164310390|NCT01092117|593510841|FG000|Year 2|Withdrawal by Subject|4|||
164310391|NCT01092117|593510841|FG000|Year 2|Lost to Follow-up|1|||
164310392|NCT01092117|593510841|FG000|Year 3|Death|7|||
164310393|NCT01092117|593510841|FG000|Year 3|Withdrawal by Subject|9|||
164310394|NCT01092117|593510841|FG000|Year 3|Lost to Follow-up|3|||
164310395|NCT01092117|593510841|FG000|Year 4|Death|8|||
164310396|NCT01092117|593510841|FG000|Year 4|Withdrawal by Subject|4|||
164310397|NCT01092117|593510841|FG000|Year 4|Lost to Follow-up|4|||
164310398|NCT04380519|593510842|FG000|Overall Study|Withdrawal by Subject|4|||
164310399|NCT04380519|593510843|FG001|Overall Study|Withdrawal by Subject|0|||
164310400|NCT04380519|593510844|FG002|Overall Study|Withdrawal by Subject|1|||
164310401|NCT04380519|593510842|FG000|Overall Study|Death|14|||
164310402|NCT04380519|593510843|FG001|Overall Study|Death|9|||
164310403|NCT04380519|593510844|FG002|Overall Study|Death|6|||
164310404|NCT04380519|593510842|FG000|Overall Study|Adverse Event|0|||
164310405|NCT04380519|593510843|FG001|Overall Study|Adverse Event|1|||
164310406|NCT04380519|593510844|FG002|Overall Study|Adverse Event|0|||
164310407|NCT04380519|593510842|FG000|Overall Study|relatives' decision|0|||
164310408|NCT04380519|593510843|FG001|Overall Study|relatives' decision|1|||
164201686|NCT00368251|593112565|FG001|Overall Study|SAE, non-fatal|0|||
164310409|NCT04380519|593510844|FG002|Overall Study|relatives' decision|0|||
164310410|NCT04173494|593510845|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
164310411|NCT04173494|593510846|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
164310412|NCT04173494|593510845|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
164310413|NCT04173494|593510846|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
164310414|NCT04173494|593510845|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
164310415|NCT04173494|593510846|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
164310416|NCT04173494|593510845|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
164310417|NCT04173494|593510846|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
164310418|NCT04173494|593510845|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
164310419|NCT04173494|593510846|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
164310420|NCT04173494|593510845|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
164310421|NCT04173494|593510846|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
164310422|NCT04173494|593510845|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
164310423|NCT04173494|593510846|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
164310424|NCT04173494|593510845|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
164310425|NCT04173494|593510846|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
164310426|NCT04173494|593510845|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
164310427|NCT04173494|593510846|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
164310428|NCT04173494|593510845|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
164310429|NCT04173494|593510846|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
164310430|NCT04173494|593510845|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
164310431|NCT04173494|593510846|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
164310432|NCT04173494|593510845|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
164310433|NCT04173494|593510846|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
164310434|NCT04173494|593510845|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
164310435|NCT04173494|593510846|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
164201687|NCT00368251|593112566|FG002|Overall Study|SAE, non-fatal|0|||
164201688|NCT00368251|593112564|FG000|Overall Study|AE, non-serious non-fatal|0|||
164201689|NCT00368251|593112565|FG001|Overall Study|AE, non-serious non-fatal|0|||
164201690|NCT00368251|593112566|FG002|Overall Study|AE, non-serious non-fatal|1|||
164201691|NCT01125930|593112574|FG000|Overall Study|Adverse Event|0|||
164201692|NCT01125930|593112575|FG001|Overall Study|Adverse Event|1|||
164201693|NCT01125930|593112574|FG000|Overall Study|Withdrawal by Subject|1|||
164201694|NCT01125930|593112575|FG001|Overall Study|Withdrawal by Subject|6|||
164201695|NCT01125930|593112574|FG000|Overall Study|Protocol Violation|0|||
164201696|NCT01125930|593112575|FG001|Overall Study|Protocol Violation|1|||
164201697|NCT01125930|593112574|FG000|Overall Study|Lost to Follow-up|0|||
164201698|NCT01125930|593112575|FG001|Overall Study|Lost to Follow-up|2|||
164658859|NCT00543439|594776097|FG000|Period 2|Adverse Event|0|||
164658860|NCT00543439|594776098|FG001|Period 2|Adverse Event|1|||
164658861|NCT00543439|594776099|FG002|Period 2|Adverse Event|1|||
164658862|NCT03264066|594776102|FG000|Overall Study|Adverse Event|1|||
164658863|NCT03264066|594776103|FG001|Overall Study|Adverse Event|1|||
164658864|NCT03264066|594776104|FG002|Overall Study|Adverse Event|0|||
164658865|NCT03264066|594776105|FG003|Overall Study|Adverse Event|0|||
164658866|NCT03264066|594776106|FG004|Overall Study|Adverse Event|0|||
164658867|NCT03264066|594776107|FG005|Overall Study|Adverse Event|0|||
164658868|NCT03264066|594776102|FG000|Overall Study|Death|12|||
164658869|NCT03264066|594776103|FG001|Overall Study|Death|12|||
164658870|NCT03264066|594776104|FG002|Overall Study|Death|8|||
164658871|NCT03264066|594776105|FG003|Overall Study|Death|10|||
164658872|NCT03264066|594776106|FG004|Overall Study|Death|6|||
164658873|NCT03264066|594776107|FG005|Overall Study|Death|1|||
164658874|NCT03264066|594776102|FG000|Overall Study|Lost to Follow-up|1|||
164658875|NCT03264066|594776103|FG001|Overall Study|Lost to Follow-up|0|||
164658876|NCT03264066|594776104|FG002|Overall Study|Lost to Follow-up|0|||
164658877|NCT03264066|594776105|FG003|Overall Study|Lost to Follow-up|0|||
164658878|NCT03264066|594776106|FG004|Overall Study|Lost to Follow-up|0|||
164658879|NCT03264066|594776107|FG005|Overall Study|Lost to Follow-up|0|||
164658880|NCT03264066|594776102|FG000|Overall Study|Progressive Disease|0|||
164658881|NCT03264066|594776103|FG001|Overall Study|Progressive Disease|2|||
164658882|NCT03264066|594776104|FG002|Overall Study|Progressive Disease|1|||
164658883|NCT03264066|594776105|FG003|Overall Study|Progressive Disease|0|||
164658884|NCT03264066|594776106|FG004|Overall Study|Progressive Disease|0|||
164658885|NCT03264066|594776107|FG005|Overall Study|Progressive Disease|0|||
164658886|NCT03264066|594776102|FG000|Overall Study|Study Terminated by Sponsor|5|||
164658887|NCT03264066|594776103|FG001|Overall Study|Study Terminated by Sponsor|5|||
164658888|NCT03264066|594776104|FG002|Overall Study|Study Terminated by Sponsor|8|||
164310436|NCT04173494|593510845|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
164310437|NCT04173494|593510846|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
164310438|NCT04173494|593510845|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
164310439|NCT04173494|593510846|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
164310440|NCT04173494|593510845|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
164310441|NCT04173494|593510846|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
164310442|NCT01623050|593510847|FG000|Overall Study|Lost to Follow-up|9|||
164310443|NCT02147561|593510850|FG000|Overall Study|Lost to Follow-up|3|||
164310444|NCT02147561|593510850|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
164310445|NCT00526071|593510851|FG000|Overall Study|Adverse Event|1|||
164310446|NCT00526071|593510851|FG000|Overall Study|Withdrawal by Subject|1|||
164310447|NCT00526071|593510851|FG000|Overall Study|Lack of Response to Study Drug|4|||
164310448|NCT01191762|593510852|FG000|Overall Study|Adverse Event|1|||
164310449|NCT01191762|593510853|FG001|Overall Study|Adverse Event|0|||
164310450|NCT00048074|593510863|FG000|Overall Study|Adverse Event|46|||
164310451|NCT00048074|593510864|FG001|Overall Study|Adverse Event|41|||
164310452|NCT00048074|593510865|FG002|Overall Study|Adverse Event|53|||
164310453|NCT00048074|593510863|FG000|Overall Study|Death|3|||
164310454|NCT00048074|593510864|FG001|Overall Study|Death|3|||
164310455|NCT00048074|593510865|FG002|Overall Study|Death|2|||
164310456|NCT00048074|593510863|FG000|Overall Study|Lost to Follow-up|2|||
164310457|NCT00048074|593510864|FG001|Overall Study|Lost to Follow-up|6|||
164310458|NCT00048074|593510865|FG002|Overall Study|Lost to Follow-up|6|||
164310459|NCT00048074|593510863|FG000|Overall Study|Withdrawal by Subject|28|||
164310460|NCT00048074|593510864|FG001|Overall Study|Withdrawal by Subject|30|||
164310461|NCT00048074|593510865|FG002|Overall Study|Withdrawal by Subject|35|||
164310462|NCT00048074|593510863|FG000|Overall Study|Protocol Violation|1|||
164310463|NCT00048074|593510864|FG001|Overall Study|Protocol Violation|3|||
164310464|NCT00048074|593510865|FG002|Overall Study|Protocol Violation|0|||
164310465|NCT00048074|593510863|FG000|Overall Study|Study participation was terminated|0|||
164310466|NCT00048074|593510864|FG001|Overall Study|Study participation was terminated|1|||
164310467|NCT00048074|593510865|FG002|Overall Study|Study participation was terminated|0|||
164310468|NCT00048074|593510863|FG000|Overall Study|Husband ill|0|||
164310469|NCT00048074|593510864|FG001|Overall Study|Husband ill|1|||
164310470|NCT00048074|593510865|FG002|Overall Study|Husband ill|0|||
164310471|NCT00048074|593510863|FG000|Overall Study|Poor compliance|0|||
164658889|NCT03264066|594776105|FG003|Overall Study|Study Terminated by Sponsor|5|||
164658890|NCT03264066|594776106|FG004|Overall Study|Study Terminated by Sponsor|1|||
164658891|NCT03264066|594776107|FG005|Overall Study|Study Terminated by Sponsor|2|||
164658892|NCT03264066|594776102|FG000|Overall Study|Withdrawal by Subject|1|||
164658893|NCT03264066|594776103|FG001|Overall Study|Withdrawal by Subject|0|||
164658894|NCT03264066|594776104|FG002|Overall Study|Withdrawal by Subject|0|||
164658895|NCT03264066|594776105|FG003|Overall Study|Withdrawal by Subject|5|||
164658896|NCT03264066|594776106|FG004|Overall Study|Withdrawal by Subject|0|||
164658897|NCT03264066|594776107|FG005|Overall Study|Withdrawal by Subject|0|||
164658898|NCT01484028|594776108|FG000|Period 1|Lost to Follow-up|0|||
164658899|NCT01484028|594776109|FG001|Period 1|Lost to Follow-up|1|||
164658900|NCT01484028|594776110|FG002|Period 1|Lost to Follow-up|0|||
164553820|NCT01857869|594398777|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
164553821|NCT01857869|594398778|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
164553822|NCT01857869|594398779|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
164553823|NCT01857869|594398780|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
164553824|NCT01857869|594398781|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
164553825|NCT01857869|594398782|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
164553826|NCT01857869|594398783|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
164553827|NCT01857869|594398784|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
164553828|NCT01857869|594398785|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
164553829|NCT01857869|594398786|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
164553830|NCT03016325|594398804|FG000|Treatment Period|Participant withdrew consent|0|||
164553831|NCT03016325|594398805|FG001|Treatment Period|Participant withdrew consent|1|||
164553832|NCT03016325|594398806|FG002|Treatment Period|Participant withdrew consent|0|||
164553833|NCT03016325|594398807|FG003|Treatment Period|Participant withdrew consent|0|||
164553834|NCT03016325|594398808|FG004|Treatment Period|Participant withdrew consent|0|||
164553835|NCT03016325|594398809|FG005|Treatment Period|Participant withdrew consent|0|||
164553836|NCT03016325|594398810|FG006|Treatment Period|Participant withdrew consent|0|||
164553837|NCT03016325|594398811|FG007|Treatment Period|Participant withdrew consent|0|||
164553838|NCT03016325|594398804|FG000|Treatment Period|Death|0|||
164553839|NCT03016325|594398805|FG001|Treatment Period|Death|0|||
164553840|NCT03016325|594398806|FG002|Treatment Period|Death|0|||
164553841|NCT03016325|594398807|FG003|Treatment Period|Death|0|||
164553842|NCT03016325|594398808|FG004|Treatment Period|Death|2|||
164553843|NCT03016325|594398809|FG005|Treatment Period|Death|0|||
164553844|NCT03016325|594398810|FG006|Treatment Period|Death|0|||
164553845|NCT03016325|594398811|FG007|Treatment Period|Death|0|||
164553846|NCT03016325|594398804|FG000|Treatment Period|Participant refuses assessments|0|||
164553847|NCT03016325|594398805|FG001|Treatment Period|Participant refuses assessments|0|||
164553848|NCT03016325|594398806|FG002|Treatment Period|Participant refuses assessments|1|||
164553849|NCT03016325|594398807|FG003|Treatment Period|Participant refuses assessments|0|||
164553850|NCT03016325|594398808|FG004|Treatment Period|Participant refuses assessments|0|||
164553851|NCT03016325|594398809|FG005|Treatment Period|Participant refuses assessments|0|||
164553852|NCT03016325|594398810|FG006|Treatment Period|Participant refuses assessments|0|||
164553853|NCT03016325|594398811|FG007|Treatment Period|Participant refuses assessments|0|||
164553854|NCT03016325|594398804|FG000|32-Day Follow-Up Period|Death|2|||
164553855|NCT03016325|594398805|FG001|32-Day Follow-Up Period|Death|0|||
164553856|NCT03016325|594398806|FG002|32-Day Follow-Up Period|Death|5|||
164553857|NCT03016325|594398807|FG003|32-Day Follow-Up Period|Death|6|||
164553858|NCT03016325|594398808|FG004|32-Day Follow-Up Period|Death|3|||
164553859|NCT03016325|594398809|FG005|32-Day Follow-Up Period|Death|0|||
164553860|NCT03016325|594398810|FG006|32-Day Follow-Up Period|Death|0|||
164553861|NCT03016325|594398811|FG007|32-Day Follow-Up Period|Death|0|||
164553862|NCT03016325|594398804|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
164553863|NCT03016325|594398805|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
164553864|NCT03016325|594398806|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
164553865|NCT03016325|594398807|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
164553866|NCT03016325|594398808|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
164553867|NCT03016325|594398809|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
164553868|NCT03016325|594398810|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
164553869|NCT03016325|594398811|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
164553870|NCT03016325|594398804|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
164553871|NCT03016325|594398805|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
164553872|NCT03016325|594398806|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
164553873|NCT03016325|594398807|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
164553874|NCT03016325|594398808|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
164553875|NCT03016325|594398809|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
164553876|NCT03016325|594398810|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
164553877|NCT03016325|594398811|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
164553878|NCT03016325|594398804|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
164553879|NCT03016325|594398805|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
164553880|NCT03016325|594398806|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
164553881|NCT03016325|594398807|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
164553882|NCT03016325|594398808|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
164553883|NCT03016325|594398809|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
164658901|NCT01484028|594776111|FG003|Period 1|Lost to Follow-up|0|||
164658902|NCT01484028|594776108|FG000|Period 1|Non-Compliance to Protocol|0|||
164658903|NCT01484028|594776109|FG001|Period 1|Non-Compliance to Protocol|1|||
164658904|NCT01484028|594776110|FG002|Period 1|Non-Compliance to Protocol|0|||
164658905|NCT01484028|594776111|FG003|Period 1|Non-Compliance to Protocol|1|||
164658906|NCT01484028|594776108|FG000|Period 1|Lens Discomfort|0|||
164658907|NCT01484028|594776109|FG001|Period 1|Lens Discomfort|1|||
164658908|NCT01484028|594776110|FG002|Period 1|Lens Discomfort|0|||
164658909|NCT01484028|594776111|FG003|Period 1|Lens Discomfort|0|||
164201699|NCT00900562|593112578|FG000|Overall Study|Progressive disease|9|||
164201700|NCT00900562|593112579|FG001|Overall Study|Progressive disease|5|||
164201701|NCT00900562|593112578|FG000|Overall Study|Toxicity|1|||
164201702|NCT00900562|593112579|FG001|Overall Study|Toxicity|0|||
164201703|NCT00900562|593112578|FG000|Overall Study|Death|1|||
164201704|NCT00900562|593112579|FG001|Overall Study|Death|1|||
164201705|NCT00900562|593112578|FG000|Overall Study|Withdrawal by Subject|0|||
164201706|NCT00900562|593112579|FG001|Overall Study|Withdrawal by Subject|1|||
164201707|NCT00900562|593112578|FG000|Overall Study|Unrelated adverse event|1|||
164201708|NCT00900562|593112579|FG001|Overall Study|Unrelated adverse event|0|||
164201709|NCT02300610|593112580|FG000|Overall Study|Withdrawal by Subject|1|||
164201710|NCT02300610|593112581|FG001|Overall Study|Withdrawal by Subject|0|||
164201711|NCT02300610|593112582|FG002|Overall Study|Withdrawal by Subject|1|||
164201712|NCT02152007|593112583|FG000|Overall Study|Withdrawal by Subject|1|||
164201713|NCT03363906|593112590|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
164201714|NCT03363906|593112591|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
164201715|NCT03363906|593112590|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
164201716|NCT03363906|593112591|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
164201717|NCT03363906|593112590|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
164201718|NCT03363906|593112591|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
164201719|NCT03363906|593112590|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
164201720|NCT03363906|593112591|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
164201721|NCT00676143|593112592|FG000|Overall Study|Adverse Event|34|||
164201722|NCT00676143|593112593|FG001|Overall Study|Adverse Event|60|||
164201723|NCT00676143|593112592|FG000|Overall Study|Death|4|||
164201724|NCT00676143|593112593|FG001|Overall Study|Death|4|||
164201725|NCT00676143|593112592|FG000|Overall Study|Lack of Efficacy|0|||
164201726|NCT00676143|593112593|FG001|Overall Study|Lack of Efficacy|6|||
164201727|NCT00676143|593112592|FG000|Overall Study|Lost to Follow-up|0|||
164201728|NCT00676143|593112593|FG001|Overall Study|Lost to Follow-up|13|||
164201729|NCT00676143|593112592|FG000|Overall Study|Physician Decision|5|||
164201730|NCT00676143|593112593|FG001|Overall Study|Physician Decision|8|||
164201731|NCT00676143|593112592|FG000|Overall Study|Protocol Violation|4|||
164201732|NCT00676143|593112593|FG001|Overall Study|Protocol Violation|8|||
164201733|NCT00676143|593112592|FG000|Overall Study|Withdrawal by Subject|24|||
164201734|NCT00676143|593112593|FG001|Overall Study|Withdrawal by Subject|42|||
164201735|NCT00676143|593112592|FG000|Overall Study|Discontinuation of study by sponsor|65|||
164201736|NCT00676143|593112593|FG001|Overall Study|Discontinuation of study by sponsor|88|||
164201737|NCT00676143|593112592|FG000|Overall Study|Failed to return|2|||
164201738|NCT00676143|593112593|FG001|Overall Study|Failed to return|1|||
164201739|NCT00676143|593112592|FG000|Overall Study|Loss of caregiver|5|||
164201740|NCT00676143|593112593|FG001|Overall Study|Loss of caregiver|3|||
164201741|NCT00676143|593112592|FG000|Overall Study|Other|11|||
164201742|NCT00676143|593112593|FG001|Overall Study|Other|20|||
164201743|NCT00676143|593112592|FG000|Overall Study|Participant participation unknown|1|||
164553884|NCT03016325|594398810|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
164553885|NCT03016325|594398811|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
164553886|NCT03016325|594398804|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
164553887|NCT03016325|594398805|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
164553888|NCT03016325|594398806|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
164553889|NCT03016325|594398807|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
164553890|NCT03016325|594398808|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
164553891|NCT03016325|594398809|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
164553892|NCT03016325|594398810|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
164553893|NCT03016325|594398811|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
164553894|NCT03016325|594398804|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
164553895|NCT03016325|594398805|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
164553896|NCT03016325|594398806|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
164553897|NCT03016325|594398807|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
164553898|NCT03016325|594398808|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
164553899|NCT03016325|594398809|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
164553900|NCT03016325|594398810|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
164553901|NCT03016325|594398811|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
164553902|NCT03016325|594398804|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
164553903|NCT03016325|594398805|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
164553904|NCT03016325|594398806|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
164553905|NCT03016325|594398807|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
164553906|NCT03016325|594398808|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
164553907|NCT03016325|594398809|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
164553908|NCT03016325|594398810|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
164553909|NCT03016325|594398811|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
164553910|NCT03016325|594398804|FG000|182-Day Follow-Up Period|Death|3|||
164310472|NCT00048074|593510864|FG001|Overall Study|Poor compliance|1|||
164310473|NCT00048074|593510865|FG002|Overall Study|Poor compliance|0|||
164310474|NCT00048074|593510863|FG000|Overall Study|Out of station|0|||
164310475|NCT00048074|593510864|FG001|Overall Study|Out of station|1|||
164310476|NCT00048074|593510865|FG002|Overall Study|Out of station|1|||
164310477|NCT00048074|593510863|FG000|Overall Study|Social reasons|1|||
164310478|NCT00048074|593510864|FG001|Overall Study|Social reasons|0|||
164310479|NCT00048074|593510865|FG002|Overall Study|Social reasons|0|||
164310480|NCT04476797|593510866|FG000|Overall Study|Withdrawal by Subject|1|||
164310481|NCT04476797|593510867|FG001|Overall Study|Withdrawal by Subject|0|||
164310482|NCT04476797|593510868|FG002|Overall Study|Withdrawal by Subject|0|||
164310483|NCT04476797|593510866|FG000|Overall Study|Death|0|||
164310484|NCT04476797|593510867|FG001|Overall Study|Death|1|||
164310485|NCT04476797|593510868|FG002|Overall Study|Death|2|||
164310486|NCT04476797|593510866|FG000|Overall Study|Sponsor Terminated Study|0|||
164310487|NCT04476797|593510867|FG001|Overall Study|Sponsor Terminated Study|18|||
164310488|NCT04476797|593510868|FG002|Overall Study|Sponsor Terminated Study|17|||
164553911|NCT03016325|594398805|FG001|182-Day Follow-Up Period|Death|3|||
164553912|NCT03016325|594398806|FG002|182-Day Follow-Up Period|Death|11|||
164553913|NCT03016325|594398807|FG003|182-Day Follow-Up Period|Death|12|||
164553914|NCT03016325|594398808|FG004|182-Day Follow-Up Period|Death|9|||
164553915|NCT03016325|594398809|FG005|182-Day Follow-Up Period|Death|0|||
164553916|NCT03016325|594398810|FG006|182-Day Follow-Up Period|Death|0|||
164553917|NCT03016325|594398811|FG007|182-Day Follow-Up Period|Death|1|||
164553918|NCT03016325|594398804|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
164553919|NCT03016325|594398805|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
164553920|NCT03016325|594398806|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
164553921|NCT03016325|594398807|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
164553922|NCT03016325|594398808|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
164553923|NCT03016325|594398809|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
164553924|NCT03016325|594398810|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
164553925|NCT03016325|594398811|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
164553926|NCT03016325|594398804|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
164553927|NCT03016325|594398805|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
164553928|NCT03016325|594398806|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
164553929|NCT03016325|594398807|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
164553930|NCT03016325|594398808|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
164553931|NCT03016325|594398809|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
164553932|NCT03016325|594398810|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
164553933|NCT03016325|594398811|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
164553934|NCT03016325|594398804|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
164553935|NCT03016325|594398805|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
164553936|NCT03016325|594398806|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
164553937|NCT03016325|594398807|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
164553938|NCT03016325|594398808|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
164553939|NCT03016325|594398809|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
164553940|NCT03016325|594398810|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
164553941|NCT03016325|594398811|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
164553942|NCT03016325|594398804|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
164553943|NCT03016325|594398805|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
164553944|NCT03016325|594398806|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
164553945|NCT03016325|594398807|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
164553946|NCT03016325|594398808|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
164553947|NCT03016325|594398809|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
164553948|NCT03016325|594398810|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
164553949|NCT03016325|594398811|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
164553950|NCT03016325|594398804|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
164553951|NCT03016325|594398805|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
164553952|NCT03016325|594398806|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
164553953|NCT03016325|594398807|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
164553954|NCT03016325|594398808|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
164553955|NCT03016325|594398809|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
164553956|NCT03016325|594398810|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
164553957|NCT03016325|594398811|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
164553958|NCT03016325|594398804|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
164553959|NCT03016325|594398805|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
164553960|NCT03016325|594398806|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
164553961|NCT03016325|594398807|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
164310489|NCT02395081|593510869|FG000|Overall Study|Withdrawal by Subject|1|||
164310490|NCT02395081|593510870|FG001|Overall Study|Withdrawal by Subject|1|||
164658910|NCT00146770|594776127|FG000|Overall Study|Adverse Event|2|||
164658911|NCT00146770|594776128|FG001|Overall Study|Adverse Event|0|||
164658912|NCT00146770|594776127|FG000|Overall Study|Pregnancy|1|||
164658913|NCT00146770|594776128|FG001|Overall Study|Pregnancy|0|||
164658914|NCT00146770|594776127|FG000|Overall Study|Withdrawal by Subject|2|||
164658915|NCT00146770|594776128|FG001|Overall Study|Withdrawal by Subject|0|||
164658916|NCT02826603|594776131|FG000|Overall Study|Adverse Event|17|||
164658917|NCT02826603|594776132|FG001|Overall Study|Adverse Event|9|||
164658918|NCT02826603|594776131|FG000|Overall Study|Lack of Efficacy|4|||
164658919|NCT02826603|594776132|FG001|Overall Study|Lack of Efficacy|9|||
164658920|NCT02826603|594776131|FG000|Overall Study|Lost to Follow-up|13|||
164658921|NCT02826603|594776132|FG001|Overall Study|Lost to Follow-up|12|||
164658922|NCT02826603|594776131|FG000|Overall Study|Noncompliance with treatment|0|||
164658923|NCT02826603|594776132|FG001|Overall Study|Noncompliance with treatment|2|||
164658924|NCT02826603|594776131|FG000|Overall Study|Physician Decision|1|||
164658925|NCT02826603|594776132|FG001|Overall Study|Physician Decision|7|||
164658926|NCT02826603|594776131|FG000|Overall Study|Pregnancy|1|||
164658927|NCT02826603|594776132|FG001|Overall Study|Pregnancy|2|||
164658928|NCT02826603|594776131|FG000|Overall Study|Protocol Violation|3|||
164658929|NCT02826603|594776132|FG001|Overall Study|Protocol Violation|3|||
164658930|NCT02826603|594776131|FG000|Overall Study|Withdrawal by Subject|20|||
164658931|NCT02826603|594776132|FG001|Overall Study|Withdrawal by Subject|19|||
164658932|NCT02826603|594776131|FG000|Overall Study|Death|2|||
164658933|NCT02826603|594776132|FG001|Overall Study|Death|0|||
164658934|NCT02826603|594776131|FG000|Overall Study|New therapy for study indication|0|||
164658935|NCT02826603|594776132|FG001|Overall Study|New therapy for study indication|1|||
164658936|NCT00905489|594776133|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
164658937|NCT00905489|594776133|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
164658938|NCT00905489|594776133|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
164658939|NCT00583596|594776134|FG000|Overall Study|Lost to Follow-up|110|||
164658940|NCT00583596|594776134|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
164201744|NCT00676143|593112593|FG001|Overall Study|Participant participation unknown|4|||
164201745|NCT00676143|593112592|FG000|Overall Study|Vasogenic edema recurrence|1|||
164201746|NCT00676143|593112593|FG001|Overall Study|Vasogenic edema recurrence|3|||
164201747|NCT00929669|593112594|FG000|Overall Study|elevated glucose levels|1|||
164201748|NCT00472420|593112595|FG000|Induction Treatment Period|Physician Decision|9|||
164201749|NCT00472420|593112595|FG000|Induction Treatment Period|Adverse Event|3|||
164201750|NCT00472420|593112595|FG000|Induction Treatment Period|Non-compliance|1|||
164201751|NCT00472420|593112595|FG000|Induction Treatment Period|Death|3|||
164201752|NCT00472420|593112595|FG000|Follow-up Period|Death|5|||
164201753|NCT00472420|593112595|FG000|Follow-up Period|Physician Decision|9|||
164201754|NCT00472420|593112595|FG000|Follow-up Period|Lost to Follow-up|2|||
164201755|NCT00472420|593112595|FG000|Follow-up Period|Protocol Violation|1|||
164201756|NCT04656652|593112597|FG000|Overall Study|Lost to Follow-up|2|||
164201757|NCT04656652|593112598|FG001|Overall Study|Lost to Follow-up|2|||
164201758|NCT04656652|593112597|FG000|Overall Study|Death|213|||
164201759|NCT04656652|593112598|FG001|Overall Study|Death|212|||
164201760|NCT04656652|593112597|FG000|Overall Study|Other|1|||
164201761|NCT04656652|593112598|FG001|Overall Study|Other|0|||
164201762|NCT04656652|593112597|FG000|Overall Study|Withdrawal by Subject|15|||
164201763|NCT04656652|593112598|FG001|Overall Study|Withdrawal by Subject|29|||
164201764|NCT02722967|593112599|FG000|Overall Study|Adverse Event|1|||
164201765|NCT02722967|593112600|FG001|Overall Study|Adverse Event|0|||
164201766|NCT02722967|593112601|FG002|Overall Study|Adverse Event|0|||
164201767|NCT02722967|593112599|FG000|Overall Study|Lost to Follow-up|0|||
164201768|NCT02722967|593112600|FG001|Overall Study|Lost to Follow-up|1|||
164201769|NCT02722967|593112601|FG002|Overall Study|Lost to Follow-up|0|||
164201770|NCT02722967|593112599|FG000|Overall Study|Non-compliance with patch wearing|2|||
164201771|NCT02722967|593112600|FG001|Overall Study|Non-compliance with patch wearing|1|||
164201772|NCT02722967|593112601|FG002|Overall Study|Non-compliance with patch wearing|1|||
164201773|NCT02722967|593112599|FG000|Overall Study|Withdrawal by Subject|1|||
164201774|NCT02722967|593112600|FG001|Overall Study|Withdrawal by Subject|0|||
164201775|NCT02722967|593112601|FG002|Overall Study|Withdrawal by Subject|1|||
164658941|NCT00583596|594776134|FG000|Overall Study|Death|2|||
164658942|NCT00583596|594776134|FG000|Overall Study|Withdrawal by Subject|6|||
164658943|NCT00583596|594776134|FG000|Overall Study|Lost to Follow-up|94|||
164658944|NCT00583596|594776134|FG000|Overall Study|Data not complete|1|||
164658945|NCT00583596|594776134|FG000|Overall Study|Not consented|15|||
164658946|NCT00583596|594776134|FG000|Overall Study|Outside f-up window|26|||
164658947|NCT02668302|594776135|FG000|Overall Study|Withdrawal by Subject|1|||
164658948|NCT02668302|594776136|FG001|Overall Study|Withdrawal by Subject|0|||
164201776|NCT02722967|593112599|FG000|Overall Study|Physician Decision|1|||
164201777|NCT02722967|593112600|FG001|Overall Study|Physician Decision|0|||
164201778|NCT02722967|593112601|FG002|Overall Study|Physician Decision|0|||
164201779|NCT02722967|593112599|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
164201780|NCT02722967|593112600|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
164201781|NCT02722967|593112601|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
164310491|NCT02395081|593510871|FG002|Overall Study|Withdrawal by Subject|0|||
164310492|NCT02395081|593510869|FG000|Overall Study|Moved where blood couldn't be collected|4|||
164310493|NCT02395081|593510870|FG001|Overall Study|Moved where blood couldn't be collected|1|||
164310494|NCT02395081|593510871|FG002|Overall Study|Moved where blood couldn't be collected|3|||
164310495|NCT02395081|593510869|FG000|Overall Study|Fetal Loss|2|||
164310496|NCT02395081|593510870|FG001|Overall Study|Fetal Loss|3|||
164310497|NCT02395081|593510871|FG002|Overall Study|Fetal Loss|1|||
164310498|NCT01583296|593510872|FG000|Overall Study|Withdrawal by Subject|11|||
164310499|NCT01583296|593510873|FG001|Overall Study|Withdrawal by Subject|10|||
164310500|NCT01063283|593510874|FG000|Cycle 1|Adverse Event|2|||
164310501|NCT01063283|593510875|FG001|Cycle 1|Adverse Event|0|||
164310502|NCT01063283|593510876|FG002|Cycle 1|Adverse Event|0|||
164310503|NCT01063283|593510874|FG000|Cycle 1|Technical failure in data collection|1|||
164310504|NCT01063283|593510875|FG001|Cycle 1|Technical failure in data collection|0|||
164310505|NCT01063283|593510876|FG002|Cycle 1|Technical failure in data collection|0|||
164310506|NCT02504216|593510879|FG000|Overall Study|Lost to Follow-up|3|||
164310507|NCT02504216|593510880|FG001|Overall Study|Lost to Follow-up|3|||
164310508|NCT02504216|593510879|FG000|Overall Study|Withdrawal by Subject|8|||
164310509|NCT02504216|593510880|FG001|Overall Study|Withdrawal by Subject|12|||
164310510|NCT00223080|593510881|FG000|Overall Study|Withdrawal by Subject|253|||
164310511|NCT00223080|593510882|FG001|Overall Study|Withdrawal by Subject|232|||
164310512|NCT00223080|593510881|FG000|Overall Study|Required contraindicated med|0|||
164310513|NCT00223080|593510882|FG001|Overall Study|Required contraindicated med|1|||
164310514|NCT00223080|593510881|FG000|Overall Study|Non-compliant|7|||
164310515|NCT00223080|593510882|FG001|Overall Study|Non-compliant|7|||
164310516|NCT00223080|593510881|FG000|Overall Study|Moved from study area|37|||
164310517|NCT00223080|593510882|FG001|Overall Study|Moved from study area|47|||
164310518|NCT00223080|593510881|FG000|Overall Study|Lost to Follow-up|259|||
164310519|NCT00223080|593510882|FG001|Overall Study|Lost to Follow-up|284|||
164310520|NCT00223080|593510881|FG000|Overall Study|Death|85|||
164310521|NCT00223080|593510882|FG001|Overall Study|Death|74|||
164310522|NCT00223080|593510881|FG000|Overall Study|Other|14|||
164310523|NCT00223080|593510882|FG001|Overall Study|Other|11|||
164310524|NCT00223080|593510881|FG000|Overall Study|Reason not provided|141|||
164310525|NCT00223080|593510882|FG001|Overall Study|Reason not provided|140|||
164310526|NCT00223080|593510881|FG000|Overall Study|Adverse Event|0|||
164310527|NCT00223080|593510882|FG001|Overall Study|Adverse Event|1|||
164310528|NCT02598583|593510883|FG000|Extension Period|Withdrawal by Subject|1|||
164553962|NCT03016325|594398808|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
164553963|NCT03016325|594398809|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
164553964|NCT03016325|594398810|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
164553965|NCT03016325|594398811|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
164553966|NCT03016325|594398804|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
164553967|NCT03016325|594398805|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
164553968|NCT03016325|594398806|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
164553969|NCT03016325|594398807|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
164553970|NCT03016325|594398808|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
164553971|NCT03016325|594398809|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
164553972|NCT03016325|594398810|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
164553973|NCT03016325|594398811|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
164553974|NCT01087905|594398812|FG000|Overall Study|Lost to Follow-up|24|||
164553975|NCT01087905|594398813|FG001|Overall Study|Lost to Follow-up|28|||
164553976|NCT01087905|594398814|FG002|Overall Study|Lost to Follow-up|18|||
164553977|NCT01087905|594398815|FG003|Overall Study|Lost to Follow-up|31|||
164553978|NCT01087905|594398816|FG004|Overall Study|Lost to Follow-up|27|||
164553979|NCT01087905|594398817|FG005|Overall Study|Lost to Follow-up|25|||
164553980|NCT01087905|594398818|FG006|Overall Study|Lost to Follow-up|20|||
164553981|NCT01087905|594398819|FG007|Overall Study|Lost to Follow-up|24|||
164310529|NCT02598583|593510884|FG001|Extension Period|Withdrawal by Subject|0|||
164310530|NCT03237286|593510885|FG000|Overall Study|Withdrawal by Subject|1|||
164310531|NCT03237286|593510886|FG001|Overall Study|Withdrawal by Subject|0|||
164310532|NCT03237286|593510887|FG002|Overall Study|Withdrawal by Subject|2|||
164310533|NCT03237286|593510885|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
164310534|NCT03237286|593510886|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
164310535|NCT03237286|593510887|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
164310536|NCT02792829|593510895|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
164310537|NCT02792829|593510896|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
164553982|NCT01087905|594398812|FG000|Overall Study|Withdrawal by Subject|5|||
164310538|NCT02792829|593510897|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
164310539|NCT02792829|593510898|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
164310540|NCT02792829|593510899|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
164310541|NCT02792829|593510900|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
164310542|NCT02792829|593510901|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
164310543|NCT02792829|593510902|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
164310544|NCT02792829|593510895|FG000|Treatment Period 2|Adverse Event|0|||
164310545|NCT02792829|593510896|FG001|Treatment Period 2|Adverse Event|0|||
164310546|NCT02792829|593510897|FG002|Treatment Period 2|Adverse Event|0|||
164310547|NCT02792829|593510898|FG003|Treatment Period 2|Adverse Event|0|||
164310548|NCT02792829|593510899|FG004|Treatment Period 2|Adverse Event|1|||
164310549|NCT02792829|593510900|FG005|Treatment Period 2|Adverse Event|0|||
164310550|NCT02792829|593510901|FG006|Treatment Period 2|Adverse Event|1|||
164310551|NCT02792829|593510902|FG007|Treatment Period 2|Adverse Event|1|||
164310552|NCT02792829|593510895|FG000|Treatment Period 2|Use of proscribed medications|0|||
164310553|NCT02792829|593510896|FG001|Treatment Period 2|Use of proscribed medications|0|||
164310554|NCT02792829|593510897|FG002|Treatment Period 2|Use of proscribed medications|0|||
164310555|NCT02792829|593510898|FG003|Treatment Period 2|Use of proscribed medications|0|||
164310556|NCT02792829|593510899|FG004|Treatment Period 2|Use of proscribed medications|0|||
164310557|NCT02792829|593510900|FG005|Treatment Period 2|Use of proscribed medications|0|||
164310558|NCT02792829|593510901|FG006|Treatment Period 2|Use of proscribed medications|0|||
164310559|NCT02792829|593510902|FG007|Treatment Period 2|Use of proscribed medications|1|||
164310560|NCT01262820|593510903|FG000|Overall Study|Adverse Event|5|||
164310561|NCT01262820|593510903|FG000|Overall Study|Lack of Efficacy|9|||
164310562|NCT01262820|593510903|FG000|Overall Study|Drug held for 21+ days|1|||
164310563|NCT01737502|593510907|FG000|Phase I|Disease progression|2|||
164310564|NCT01737502|593510908|FG001|Phase I|Disease progression|3|||
164310565|NCT01737502|593510907|FG000|Phase I|Complicating disease|1|||
164310566|NCT01737502|593510908|FG001|Phase I|Complicating disease|0|||
164310567|NCT01737502|593510907|FG000|Phase II|Adverse Event|0|||
164310568|NCT01737502|593510908|FG001|Phase II|Adverse Event|3|||
164310569|NCT01737502|593510907|FG000|Phase II|Disease progression|0|||
164310570|NCT01737502|593510908|FG001|Phase II|Disease progression|18|||
164310571|NCT01737502|593510907|FG000|Phase II|Death|0|||
164310572|NCT01737502|593510908|FG001|Phase II|Death|1|||
164310573|NCT01737502|593510907|FG000|Phase II|Transition to hospice care|0|||
164310574|NCT01737502|593510908|FG001|Phase II|Transition to hospice care|1|||
164310575|NCT04421027|593510912|FG000|Treatment Period|Adverse Event|5|||
164310576|NCT04421027|593510913|FG001|Treatment Period|Adverse Event|3|||
164310577|NCT04421027|593510914|FG002|Treatment Period|Adverse Event|0|||
164310578|NCT04421027|593510915|FG003|Treatment Period|Adverse Event|0|||
164310579|NCT04421027|593510912|FG000|Treatment Period|Death|98|||
164310580|NCT04421027|593510913|FG001|Treatment Period|Death|61|||
164310581|NCT04421027|593510914|FG002|Treatment Period|Death|0|||
164310582|NCT04421027|593510915|FG003|Treatment Period|Death|0|||
164310583|NCT04421027|593510912|FG000|Treatment Period|Lost to Follow-up|22|||
164310584|NCT04421027|593510913|FG001|Treatment Period|Lost to Follow-up|20|||
164310585|NCT04421027|593510914|FG002|Treatment Period|Lost to Follow-up|0|||
164310586|NCT04421027|593510915|FG003|Treatment Period|Lost to Follow-up|0|||
164310587|NCT04421027|593510912|FG000|Treatment Period|Other-Unknown|15|||
164310588|NCT04421027|593510913|FG001|Treatment Period|Other-Unknown|9|||
164310589|NCT04421027|593510914|FG002|Treatment Period|Other-Unknown|0|||
164310590|NCT04421027|593510915|FG003|Treatment Period|Other-Unknown|0|||
164310591|NCT04421027|593510912|FG000|Treatment Period|Physician Decision|1|||
164310592|NCT04421027|593510913|FG001|Treatment Period|Physician Decision|1|||
164553983|NCT01087905|594398813|FG001|Overall Study|Withdrawal by Subject|4|||
164553984|NCT01087905|594398814|FG002|Overall Study|Withdrawal by Subject|4|||
164553985|NCT01087905|594398815|FG003|Overall Study|Withdrawal by Subject|5|||
164553986|NCT01087905|594398816|FG004|Overall Study|Withdrawal by Subject|4|||
164553987|NCT01087905|594398817|FG005|Overall Study|Withdrawal by Subject|3|||
164553988|NCT01087905|594398818|FG006|Overall Study|Withdrawal by Subject|3|||
164553989|NCT01087905|594398819|FG007|Overall Study|Withdrawal by Subject|5|||
164553990|NCT00513500|594398820|FG000|Overall Study|Lost to Follow-up|35|||
164553991|NCT00513500|594398821|FG001|Overall Study|Lost to Follow-up|39|||
164553992|NCT00513500|594398820|FG000|Overall Study|Death|2|||
164553993|NCT00513500|594398821|FG001|Overall Study|Death|1|||
164553994|NCT00513500|594398820|FG000|Overall Study|Hospitalized|4|||
164553995|NCT00513500|594398821|FG001|Overall Study|Hospitalized|14|||
164658949|NCT02619682|594776137|FG000|Overall Study|Withdrawal by Subject|3|||
164310593|NCT04421027|593510914|FG002|Treatment Period|Physician Decision|0|||
164310594|NCT04421027|593510915|FG003|Treatment Period|Physician Decision|0|||
164310595|NCT04421027|593510912|FG000|Treatment Period|Withdrawal by Subject|7|||
164310596|NCT04421027|593510913|FG001|Treatment Period|Withdrawal by Subject|12|||
164310597|NCT04421027|593510914|FG002|Treatment Period|Withdrawal by Subject|0|||
164310598|NCT04421027|593510915|FG003|Treatment Period|Withdrawal by Subject|0|||
164553996|NCT04288154|594398822|FG000|Overall Study|Withdrawal by Subject|9|||
164553997|NCT04288154|594398823|FG001|Overall Study|Withdrawal by Subject|9|||
164553998|NCT00790907|594398828|FG000|Overall Study|Adverse Event|9|||
164658950|NCT02619682|594776137|FG000|Overall Study|Lack of Efficacy|8|||
164310599|NCT04421027|593510912|FG000|Treatment Period|Randomized Not Dosed|9|||
164310600|NCT04421027|593510913|FG001|Treatment Period|Randomized Not Dosed|14|||
164310601|NCT04421027|593510914|FG002|Treatment Period|Randomized Not Dosed|0|||
164553999|NCT00790907|594398829|FG001|Overall Study|Adverse Event|7|||
164554000|NCT00790907|594398830|FG002|Overall Study|Adverse Event|6|||
164554001|NCT00790907|594398828|FG000|Overall Study|Physician Decision|304|||
164554002|NCT00790907|594398829|FG001|Overall Study|Physician Decision|271|||
164554003|NCT00790907|594398830|FG002|Overall Study|Physician Decision|255|||
164554004|NCT00790907|594398828|FG000|Overall Study|Withdrawal by Subject|1|||
164554005|NCT00790907|594398829|FG001|Overall Study|Withdrawal by Subject|7|||
164554006|NCT00790907|594398830|FG002|Overall Study|Withdrawal by Subject|5|||
164554007|NCT00790907|594398828|FG000|Overall Study|Bleeding Event|11|||
164554008|NCT00790907|594398829|FG001|Overall Study|Bleeding Event|16|||
164554009|NCT00790907|594398830|FG002|Overall Study|Bleeding Event|21|||
164554010|NCT00790907|594398828|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
164554011|NCT00790907|594398829|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
164554012|NCT00790907|594398830|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
164554013|NCT00790907|594398828|FG000|Overall Study|Qualifying Condition Not Present|29|||
164554014|NCT00790907|594398829|FG001|Overall Study|Qualifying Condition Not Present|14|||
164554015|NCT00790907|594398830|FG002|Overall Study|Qualifying Condition Not Present|16|||
164554016|NCT00790907|594398828|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
164554017|NCT00790907|594398829|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
164554018|NCT00790907|594398830|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
164554019|NCT00790907|594398828|FG000|Overall Study|Did Not Receive Study Drug|10|||
164554020|NCT00790907|594398829|FG001|Overall Study|Did Not Receive Study Drug|0|||
164554021|NCT00790907|594398830|FG002|Overall Study|Did Not Receive Study Drug|0|||
164554022|NCT01902290|594398831|FG000|Overall Study|Withdrawal by Subject|19|||
164554023|NCT01902290|594398832|FG001|Overall Study|Withdrawal by Subject|27|||
164554024|NCT01902290|594398831|FG000|Overall Study|Lost to Follow-up|2|||
164554025|NCT01902290|594398832|FG001|Overall Study|Lost to Follow-up|2|||
164554026|NCT01902290|594398831|FG000|Overall Study|Death|1|||
164554027|NCT01902290|594398832|FG001|Overall Study|Death|0|||
164554028|NCT01902290|594398831|FG000|Overall Study|Sponsor Decision|26|||
164554029|NCT01902290|594398832|FG001|Overall Study|Sponsor Decision|24|||
164554030|NCT00774345|594398833|FG000|Pre-treatment|Other reasons|2|||
164554031|NCT00774345|594398834|FG001|Pre-treatment|Other reasons|0|||
164554032|NCT00774345|594398833|FG000|Treatment|Adverse Event|61|||
164554033|NCT00774345|594398834|FG001|Treatment|Adverse Event|15|||
164554034|NCT00774345|594398833|FG000|Treatment|Progressive Disease without histologic transformation|51|||
164554035|NCT00774345|594398834|FG001|Treatment|Progressive Disease without histologic transformation|111|||
164554036|NCT00774345|594398833|FG000|Treatment|Progressive Disease with histologic transformation|4|||
164554037|NCT00774345|594398834|FG001|Treatment|Progressive Disease with histologic transformation|2|||
164554038|NCT00774345|594398833|FG000|Treatment|Withdrawal by Subject|5|||
164554039|NCT00774345|594398834|FG001|Treatment|Withdrawal by Subject|2|||
164554040|NCT00774345|594398833|FG000|Treatment|Lost to Follow-up|1|||
164554041|NCT00774345|594398834|FG001|Treatment|Lost to Follow-up|1|||
164554042|NCT00774345|594398833|FG000|Treatment|Death|4|||
164554043|NCT00774345|594398834|FG001|Treatment|Death|0|||
164554044|NCT00774345|594398833|FG000|Treatment|Other Reasons|32|||
164554045|NCT00774345|594398834|FG001|Treatment|Other Reasons|26|||
164554046|NCT03436862|594398838|FG000|Overall Study|Adverse Event|4|||
164554047|NCT03436862|594398838|FG000|Overall Study|Progressive Disease|2|||
164554048|NCT02873936|594398839|FG000|Overall Study|Withdrew Consent|4|||
164554049|NCT02873936|594398840|FG001|Overall Study|Withdrew Consent|11|||
164554050|NCT02873936|594398841|FG002|Overall Study|Withdrew Consent|20|||
164554051|NCT02873936|594398839|FG000|Overall Study|Investigator's Discretion|3|||
164554052|NCT02873936|594398840|FG001|Overall Study|Investigator's Discretion|5|||
164554053|NCT02873936|594398841|FG002|Overall Study|Investigator's Discretion|4|||
164554054|NCT02873936|594398839|FG000|Overall Study|Adverse Event|3|||
164554055|NCT02873936|594398840|FG001|Overall Study|Adverse Event|5|||
164554056|NCT02873936|594398841|FG002|Overall Study|Adverse Event|3|||
164554057|NCT02873936|594398839|FG000|Overall Study|Protocol Violation|0|||
164554058|NCT02873936|594398840|FG001|Overall Study|Protocol Violation|1|||
164554059|NCT02873936|594398841|FG002|Overall Study|Protocol Violation|3|||
164554060|NCT02873936|594398839|FG000|Overall Study|Lost to Follow-up|1|||
164554061|NCT02873936|594398840|FG001|Overall Study|Lost to Follow-up|1|||
164554062|NCT02873936|594398841|FG002|Overall Study|Lost to Follow-up|1|||
164554063|NCT02873936|594398839|FG000|Overall Study|Non-compliance With Study Drug|1|||
164554064|NCT02873936|594398840|FG001|Overall Study|Non-compliance With Study Drug|0|||
164554065|NCT02873936|594398841|FG002|Overall Study|Non-compliance With Study Drug|1|||
164554066|NCT02873936|594398839|FG000|Overall Study|Randomized but not Dosed|1|||
164554067|NCT02873936|594398840|FG001|Overall Study|Randomized but not Dosed|0|||
164554068|NCT02873936|594398841|FG002|Overall Study|Randomized but not Dosed|0|||
164554069|NCT01015768|594398842|FG000|Overall Study|Some subject data unuseable|4|||
164554070|NCT01015768|594398843|FG001|Overall Study|Some subject data unuseable|4|||
164554071|NCT01627860|594398844|FG000|Overall Study|Adverse Event|9|||
164554072|NCT01627860|594398845|FG001|Overall Study|Adverse Event|4|||
164658951|NCT02619682|594776137|FG000|Overall Study|new secondary cancer|1|||
164554073|NCT01627860|594398844|FG000|Overall Study|Withdrawal by Subject|2|||
164554074|NCT01627860|594398845|FG001|Overall Study|Withdrawal by Subject|1|||
164658952|NCT02619682|594776137|FG000|Overall Study|post surgery complications|2|||
164658953|NCT01861522|594776141|FG000|Overall Study|Adverse Event|1|||
164658954|NCT01861522|594776142|FG001|Overall Study|Adverse Event|0|||
164658955|NCT01861522|594776141|FG000|Overall Study|Withdrawal by Subject|2|||
164658956|NCT01861522|594776142|FG001|Overall Study|Withdrawal by Subject|0|||
164658957|NCT00526890|594776143|FG000|Overall Study|Adverse Event|2|||
164658958|NCT01859702|594776145|FG000|Overall Study|Protocol deviation|3|||
164658959|NCT01859702|594776145|FG000|Overall Study|Adverse Event|2|||
164658960|NCT01893138|594776146|FG000|Double-Blind Period|Withdrawal by Subject|1|||
164658961|NCT01893138|594776147|FG001|Double-Blind Period|Withdrawal by Subject|1|||
164658962|NCT01893138|594776146|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
164658963|NCT01893138|594776147|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
164658964|NCT01893138|594776146|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
164658965|NCT01893138|594776147|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
164658966|NCT01893138|594776146|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
164658967|NCT01893138|594776147|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
164658968|NCT01893138|594776146|FG000|Open Label - Unblinded Period|Adverse Event|1|||
164658969|NCT01893138|594776147|FG001|Open Label - Unblinded Period|Adverse Event|0|||
164658970|NCT01326026|594776150|FG000|Overall Study|Adverse Event|4|||
164658971|NCT01326026|594776151|FG001|Overall Study|Adverse Event|3|||
164658972|NCT01326026|594776150|FG000|Overall Study|Withdrawal Criteria|5|||
164658973|NCT01326026|594776151|FG001|Overall Study|Withdrawal Criteria|7|||
164658974|NCT01326026|594776150|FG000|Overall Study|Other|3|||
164658975|NCT01326026|594776151|FG001|Overall Study|Other|3|||
164658976|NCT04567615|594776155|FG000|Randomization|Participant withdrew consent|1|||
164310602|NCT04421027|593510915|FG003|Treatment Period|Randomized Not Dosed|0|||
164310603|NCT04421027|593510912|FG000|Follow-Up Period|Adverse Event|0|||
164310604|NCT04421027|593510913|FG001|Follow-Up Period|Adverse Event|0|||
164310605|NCT04421027|593510914|FG002|Follow-Up Period|Adverse Event|0|||
164310606|NCT04421027|593510915|FG003|Follow-Up Period|Adverse Event|3|||
164554075|NCT01627860|594398844|FG000|Overall Study|Seizure frequency doubled|0|||
164554076|NCT01627860|594398845|FG001|Overall Study|Seizure frequency doubled|1|||
164554077|NCT01627860|594398844|FG000|Overall Study|Protocol Violation|1|||
164554078|NCT01627860|594398845|FG001|Overall Study|Protocol Violation|0|||
164554079|NCT01225731|594398846|FG000|Part 1|Did not meet eligibility criteria|1|||
164554080|NCT01225731|594398847|FG001|Part 1|Did not meet eligibility criteria|0|||
164554081|NCT01225731|594398848|FG002|Part 1|Did not meet eligibility criteria|0|||
164554082|NCT01225731|594398849|FG003|Part 1|Did not meet eligibility criteria|0|||
164554083|NCT01225731|594398850|FG004|Part 1|Did not meet eligibility criteria|1|||
164554084|NCT01225731|594398851|FG005|Part 1|Did not meet eligibility criteria|0|||
164554085|NCT01225731|594398852|FG006|Part 1|Did not meet eligibility criteria|0|||
164554086|NCT01225731|594398853|FG007|Part 1|Did not meet eligibility criteria|0|||
164554087|NCT01225731|594398854|FG008|Part 1|Did not meet eligibility criteria|0|||
164554088|NCT01225731|594398855|FG009|Part 1|Did not meet eligibility criteria|0|||
164554089|NCT01225731|594398856|FG010|Part 1|Did not meet eligibility criteria|0|||
164554090|NCT01225731|594398857|FG011|Part 1|Did not meet eligibility criteria|0|||
164554091|NCT01225731|594398858|FG012|Part 1|Did not meet eligibility criteria|0|||
164554092|NCT01225731|594398846|FG000|Part 1|Adverse Event|1|||
164554093|NCT01225731|594398847|FG001|Part 1|Adverse Event|2|||
164554094|NCT01225731|594398848|FG002|Part 1|Adverse Event|1|||
164554095|NCT01225731|594398849|FG003|Part 1|Adverse Event|1|||
164554096|NCT01225731|594398850|FG004|Part 1|Adverse Event|1|||
164554097|NCT01225731|594398851|FG005|Part 1|Adverse Event|0|||
164554098|NCT01225731|594398852|FG006|Part 1|Adverse Event|0|||
164554099|NCT01225731|594398853|FG007|Part 1|Adverse Event|0|||
164554100|NCT01225731|594398854|FG008|Part 1|Adverse Event|0|||
164554101|NCT01225731|594398855|FG009|Part 1|Adverse Event|0|||
164554102|NCT01225731|594398856|FG010|Part 1|Adverse Event|0|||
164554103|NCT01225731|594398857|FG011|Part 1|Adverse Event|0|||
164554104|NCT01225731|594398858|FG012|Part 1|Adverse Event|0|||
164554105|NCT01225731|594398846|FG000|Part 1|Withdrawal by Subject|0|||
164554106|NCT01225731|594398847|FG001|Part 1|Withdrawal by Subject|3|||
164554107|NCT01225731|594398848|FG002|Part 1|Withdrawal by Subject|0|||
164554108|NCT01225731|594398849|FG003|Part 1|Withdrawal by Subject|0|||
164554109|NCT01225731|594398850|FG004|Part 1|Withdrawal by Subject|4|||
164310607|NCT04421027|593510912|FG000|Follow-Up Period|Death|0|||
164310608|NCT04421027|593510913|FG001|Follow-Up Period|Death|0|||
164554110|NCT01225731|594398851|FG005|Part 1|Withdrawal by Subject|0|||
164554111|NCT01225731|594398852|FG006|Part 1|Withdrawal by Subject|0|||
164554112|NCT01225731|594398853|FG007|Part 1|Withdrawal by Subject|0|||
164658977|NCT04567615|594776156|FG001|Randomization|Participant withdrew consent|0|||
164658978|NCT04567615|594776157|FG002|Randomization|Participant withdrew consent|0|||
164658979|NCT04567615|594776155|FG000|Randomization|Adverse event unrelated to study drug|0|||
164554113|NCT01225731|594398854|FG008|Part 1|Withdrawal by Subject|0|||
164554114|NCT01225731|594398855|FG009|Part 1|Withdrawal by Subject|0|||
164554115|NCT01225731|594398856|FG010|Part 1|Withdrawal by Subject|0|||
164554116|NCT01225731|594398857|FG011|Part 1|Withdrawal by Subject|0|||
164554117|NCT01225731|594398858|FG012|Part 1|Withdrawal by Subject|0|||
164554118|NCT01225731|594398846|FG000|Part 1|Protocol Violation|0|||
164554119|NCT01225731|594398847|FG001|Part 1|Protocol Violation|0|||
164554120|NCT01225731|594398848|FG002|Part 1|Protocol Violation|0|||
164554121|NCT01225731|594398849|FG003|Part 1|Protocol Violation|1|||
164554122|NCT01225731|594398850|FG004|Part 1|Protocol Violation|0|||
164554123|NCT01225731|594398851|FG005|Part 1|Protocol Violation|0|||
164554124|NCT01225731|594398852|FG006|Part 1|Protocol Violation|0|||
164554125|NCT01225731|594398853|FG007|Part 1|Protocol Violation|0|||
164554126|NCT01225731|594398854|FG008|Part 1|Protocol Violation|0|||
164554127|NCT01225731|594398855|FG009|Part 1|Protocol Violation|0|||
164554128|NCT01225731|594398856|FG010|Part 1|Protocol Violation|0|||
164554129|NCT01225731|594398857|FG011|Part 1|Protocol Violation|0|||
164554130|NCT01225731|594398858|FG012|Part 1|Protocol Violation|0|||
164554131|NCT01225731|594398846|FG000|Part 2|Protocol Violation|0|||
164554132|NCT01225731|594398847|FG001|Part 2|Protocol Violation|0|||
164554133|NCT01225731|594398848|FG002|Part 2|Protocol Violation|0|||
164554134|NCT01225731|594398849|FG003|Part 2|Protocol Violation|0|||
164554135|NCT01225731|594398850|FG004|Part 2|Protocol Violation|0|||
164554136|NCT01225731|594398851|FG005|Part 2|Protocol Violation|1|||
164554137|NCT01225731|594398852|FG006|Part 2|Protocol Violation|0|||
164554138|NCT01225731|594398853|FG007|Part 2|Protocol Violation|0|||
164554139|NCT01225731|594398854|FG008|Part 2|Protocol Violation|1|||
164554140|NCT01225731|594398855|FG009|Part 2|Protocol Violation|0|||
164554141|NCT01225731|594398856|FG010|Part 2|Protocol Violation|0|||
164554142|NCT01225731|594398857|FG011|Part 2|Protocol Violation|0|||
164554143|NCT01225731|594398858|FG012|Part 2|Protocol Violation|0|||
164554144|NCT01225731|594398846|FG000|Part 2|Adverse Event|0|||
164554145|NCT01225731|594398847|FG001|Part 2|Adverse Event|0|||
164554146|NCT01225731|594398848|FG002|Part 2|Adverse Event|0|||
164554147|NCT01225731|594398849|FG003|Part 2|Adverse Event|0|||
164554148|NCT01225731|594398850|FG004|Part 2|Adverse Event|0|||
164554149|NCT01225731|594398851|FG005|Part 2|Adverse Event|0|||
164554150|NCT01225731|594398852|FG006|Part 2|Adverse Event|4|||
164554151|NCT01225731|594398853|FG007|Part 2|Adverse Event|4|||
164554152|NCT01225731|594398854|FG008|Part 2|Adverse Event|2|||
164554153|NCT01225731|594398855|FG009|Part 2|Adverse Event|0|||
164554154|NCT01225731|594398856|FG010|Part 2|Adverse Event|0|||
164554155|NCT01225731|594398857|FG011|Part 2|Adverse Event|0|||
164554156|NCT01225731|594398858|FG012|Part 2|Adverse Event|0|||
164554157|NCT01225731|594398846|FG000|Part 2|Lack of Efficacy|0|||
164554158|NCT01225731|594398847|FG001|Part 2|Lack of Efficacy|0|||
164554159|NCT01225731|594398848|FG002|Part 2|Lack of Efficacy|0|||
164554160|NCT01225731|594398849|FG003|Part 2|Lack of Efficacy|0|||
164554161|NCT01225731|594398850|FG004|Part 2|Lack of Efficacy|0|||
164554162|NCT01225731|594398851|FG005|Part 2|Lack of Efficacy|1|||
164554163|NCT01225731|594398852|FG006|Part 2|Lack of Efficacy|0|||
164554164|NCT01225731|594398853|FG007|Part 2|Lack of Efficacy|12|||
164554165|NCT01225731|594398854|FG008|Part 2|Lack of Efficacy|3|||
164554166|NCT01225731|594398855|FG009|Part 2|Lack of Efficacy|0|||
164201782|NCT04142242|593112602|FG000|Stage I|Non-compliance with the protocol|1|||
164201783|NCT04142242|593112603|FG001|Stage I|Non-compliance with the protocol|0|||
164201784|NCT04142242|593112604|FG002|Stage I|Non-compliance with the protocol|0|||
164201785|NCT04142242|593112605|FG003|Stage I|Non-compliance with the protocol|0|||
164201786|NCT04142242|593112606|FG004|Stage I|Non-compliance with the protocol|0|||
164201787|NCT04142242|593112607|FG005|Stage I|Non-compliance with the protocol|1|||
164201788|NCT04142242|593112602|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
164201789|NCT04142242|593112603|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
164201790|NCT04142242|593112604|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
164201791|NCT04142242|593112605|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
164201792|NCT04142242|593112606|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
164201793|NCT04142242|593112607|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
164201794|NCT04142242|593112602|FG000|Stage II|Non-compliance with the protocol|0|||
164201795|NCT04142242|593112603|FG001|Stage II|Non-compliance with the protocol|0|||
164310609|NCT04421027|593510914|FG002|Follow-Up Period|Death|16|||
164554167|NCT01225731|594398856|FG010|Part 2|Lack of Efficacy|0|||
164554168|NCT01225731|594398857|FG011|Part 2|Lack of Efficacy|0|||
164554169|NCT01225731|594398858|FG012|Part 2|Lack of Efficacy|0|||
164554170|NCT01225731|594398846|FG000|Part 2|Pregnancy|0|||
164554171|NCT01225731|594398847|FG001|Part 2|Pregnancy|0|||
164554172|NCT01225731|594398848|FG002|Part 2|Pregnancy|0|||
164554173|NCT01225731|594398849|FG003|Part 2|Pregnancy|0|||
164554174|NCT01225731|594398850|FG004|Part 2|Pregnancy|0|||
164554175|NCT01225731|594398851|FG005|Part 2|Pregnancy|0|||
164554176|NCT01225731|594398852|FG006|Part 2|Pregnancy|1|||
164554177|NCT01225731|594398853|FG007|Part 2|Pregnancy|0|||
164554178|NCT01225731|594398854|FG008|Part 2|Pregnancy|1|||
164201796|NCT04142242|593112604|FG002|Stage II|Non-compliance with the protocol|0|||
164554179|NCT01225731|594398855|FG009|Part 2|Pregnancy|0|||
164554180|NCT01225731|594398856|FG010|Part 2|Pregnancy|0|||
164554181|NCT01225731|594398857|FG011|Part 2|Pregnancy|0|||
164554182|NCT01225731|594398858|FG012|Part 2|Pregnancy|0|||
164554183|NCT01225731|594398846|FG000|Part 2|Lost to Follow-up|0|||
164554184|NCT01225731|594398847|FG001|Part 2|Lost to Follow-up|0|||
164554185|NCT01225731|594398848|FG002|Part 2|Lost to Follow-up|0|||
164554186|NCT01225731|594398849|FG003|Part 2|Lost to Follow-up|0|||
164658980|NCT04567615|594776156|FG001|Randomization|Adverse event unrelated to study drug|1|||
164658981|NCT04567615|594776157|FG002|Randomization|Adverse event unrelated to study drug|0|||
164658982|NCT04567615|594776155|FG000|Treatment Period|Participant Withdrew Consent|2|||
164658983|NCT04567615|594776156|FG001|Treatment Period|Participant Withdrew Consent|5|||
164658984|NCT04567615|594776157|FG002|Treatment Period|Participant Withdrew Consent|1|||
164658985|NCT04567615|594776155|FG000|Treatment Period|Death|1|||
164658986|NCT04567615|594776156|FG001|Treatment Period|Death|2|||
164658987|NCT04567615|594776157|FG002|Treatment Period|Death|0|||
164658988|NCT04567615|594776155|FG000|Treatment Period|Lost to Follow-up|0|||
164658989|NCT04567615|594776156|FG001|Treatment Period|Lost to Follow-up|1|||
164658990|NCT04567615|594776157|FG002|Treatment Period|Lost to Follow-up|0|||
164658991|NCT04567615|594776155|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164658992|NCT04567615|594776156|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
164658993|NCT04567615|594776157|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164658994|NCT04567615|594776155|FG000|Treatment Period|Disease Progression|85|||
164658995|NCT04567615|594776156|FG001|Treatment Period|Disease Progression|63|||
164658996|NCT04567615|594776157|FG002|Treatment Period|Disease Progression|16|||
164658997|NCT04567615|594776155|FG000|Treatment Period|Study Drug Toxicity|3|||
164658998|NCT04567615|594776156|FG001|Treatment Period|Study Drug Toxicity|10|||
164658999|NCT04567615|594776157|FG002|Treatment Period|Study Drug Toxicity|4|||
164659000|NCT04567615|594776155|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
164659001|NCT04567615|594776156|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
164659002|NCT04567615|594776157|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
164659003|NCT04567615|594776155|FG000|Treatment Period|Other Reasons|1|||
164659004|NCT04567615|594776156|FG001|Treatment Period|Other Reasons|2|||
164659005|NCT04567615|594776157|FG002|Treatment Period|Other Reasons|0|||
164659006|NCT04567615|594776155|FG000|Treatment Period|Still On-going Treatment|21|||
164659007|NCT04567615|594776156|FG001|Treatment Period|Still On-going Treatment|22|||
164659008|NCT04567615|594776157|FG002|Treatment Period|Still On-going Treatment|2|||
164659009|NCT04317053|594776158|FG000|Overall Study|Withdrawn (screen failure)|4|||
164659010|NCT04317053|594776159|FG001|Overall Study|Withdrawn (screen failure)|2|||
164659011|NCT04680052|594777607|FG000|Overall Study|Ongoing|244|||
164659012|NCT04680052|594777608|FG001|Overall Study|Ongoing|229|||
164659013|NCT04680052|594777609|FG002|Overall Study|Ongoing|39|||
164659014|NCT04680052|594777610|FG003|Overall Study|Ongoing|46|||
164659015|NCT04680052|594777607|FG000|Overall Study|Death|15|||
164659016|NCT04680052|594777608|FG001|Overall Study|Death|22|||
164659017|NCT04680052|594777609|FG002|Overall Study|Death|7|||
164659018|NCT04680052|594777610|FG003|Overall Study|Death|1|||
164659019|NCT04680052|594777607|FG000|Overall Study|Lost to Follow-up|3|||
164659020|NCT04680052|594777608|FG001|Overall Study|Lost to Follow-up|2|||
164659021|NCT04680052|594777609|FG002|Overall Study|Lost to Follow-up|0|||
164659022|NCT04680052|594777610|FG003|Overall Study|Lost to Follow-up|1|||
164659023|NCT04680052|594777607|FG000|Overall Study|Withdrawal by Subject|11|||
164659024|NCT04680052|594777608|FG001|Overall Study|Withdrawal by Subject|19|||
164659025|NCT04680052|594777609|FG002|Overall Study|Withdrawal by Subject|7|||
164659026|NCT04680052|594777610|FG003|Overall Study|Withdrawal by Subject|5|||
164659027|NCT04680052|594777607|FG000|Overall Study|Missing|0|||
164659028|NCT04680052|594777608|FG001|Overall Study|Missing|1|||
164659029|NCT04680052|594777609|FG002|Overall Study|Missing|0|||
164659030|NCT04680052|594777610|FG003|Overall Study|Missing|0|||
164659031|NCT04680052|594777607|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
164659032|NCT04680052|594777608|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
164659033|NCT04680052|594777609|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
164659034|NCT04680052|594777610|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
164659035|NCT04680052|594777607|FG000|Overall Study|Physician Decision|0|||
164659036|NCT04680052|594777608|FG001|Overall Study|Physician Decision|1|||
164659037|NCT04680052|594777609|FG002|Overall Study|Physician Decision|0|||
164659038|NCT04680052|594777610|FG003|Overall Study|Physician Decision|0|||
164659039|NCT00759148|594777612|FG000|Overall Study|Adverse Event|1|||
164659040|NCT00759148|594777613|FG001|Overall Study|Adverse Event|6|||
164659041|NCT00759148|594777612|FG000|Overall Study|Withdrawal by Subject|3|||
164659042|NCT00759148|594777613|FG001|Overall Study|Withdrawal by Subject|7|||
164659043|NCT00759148|594777612|FG000|Overall Study|Lost to Follow-up|3|||
164659044|NCT00759148|594777613|FG001|Overall Study|Lost to Follow-up|9|||
164659045|NCT00759148|594777612|FG000|Overall Study|Treatment Failure|6|||
164201797|NCT04142242|593112605|FG003|Stage II|Non-compliance with the protocol|2|||
164201798|NCT04142242|593112606|FG004|Stage II|Non-compliance with the protocol|0|||
164201799|NCT04142242|593112607|FG005|Stage II|Non-compliance with the protocol|0|||
164201800|NCT04142242|593112602|FG000|Stage II|Lost to Follow-up|0|||
164201801|NCT04142242|593112603|FG001|Stage II|Lost to Follow-up|0|||
164201802|NCT04142242|593112604|FG002|Stage II|Lost to Follow-up|1|||
164201803|NCT04142242|593112605|FG003|Stage II|Lost to Follow-up|2|||
164659046|NCT00759148|594777613|FG001|Overall Study|Treatment Failure|10|||
164659047|NCT00759148|594777612|FG000|Overall Study|Reason not given|1|||
164201804|NCT04142242|593112606|FG004|Stage II|Lost to Follow-up|0|||
164310610|NCT04421027|593510915|FG003|Follow-Up Period|Death|17|||
164310611|NCT04421027|593510912|FG000|Follow-Up Period|Lost to Follow-up|0|||
164310612|NCT04421027|593510913|FG001|Follow-Up Period|Lost to Follow-up|0|||
164310613|NCT04421027|593510914|FG002|Follow-Up Period|Lost to Follow-up|7|||
164310614|NCT04421027|593510915|FG003|Follow-Up Period|Lost to Follow-up|7|||
164310615|NCT04421027|593510912|FG000|Follow-Up Period|Protocol Deviation|0|||
164554187|NCT01225731|594398850|FG004|Part 2|Lost to Follow-up|0|||
164554188|NCT01225731|594398851|FG005|Part 2|Lost to Follow-up|0|||
164554189|NCT01225731|594398852|FG006|Part 2|Lost to Follow-up|0|||
164554190|NCT01225731|594398853|FG007|Part 2|Lost to Follow-up|3|||
164554191|NCT01225731|594398854|FG008|Part 2|Lost to Follow-up|1|||
164554192|NCT01225731|594398855|FG009|Part 2|Lost to Follow-up|0|||
164554193|NCT01225731|594398856|FG010|Part 2|Lost to Follow-up|0|||
164554194|NCT01225731|594398857|FG011|Part 2|Lost to Follow-up|0|||
164554195|NCT01225731|594398858|FG012|Part 2|Lost to Follow-up|0|||
164554196|NCT01225731|594398846|FG000|Part 2|Physician Decision|0|||
164554197|NCT01225731|594398847|FG001|Part 2|Physician Decision|0|||
164554198|NCT01225731|594398848|FG002|Part 2|Physician Decision|0|||
164554199|NCT01225731|594398849|FG003|Part 2|Physician Decision|0|||
164554200|NCT01225731|594398850|FG004|Part 2|Physician Decision|0|||
164554201|NCT01225731|594398851|FG005|Part 2|Physician Decision|0|||
164554202|NCT01225731|594398852|FG006|Part 2|Physician Decision|0|||
164554203|NCT01225731|594398853|FG007|Part 2|Physician Decision|2|||
164554204|NCT01225731|594398854|FG008|Part 2|Physician Decision|2|||
164554205|NCT01225731|594398855|FG009|Part 2|Physician Decision|0|||
164554206|NCT01225731|594398856|FG010|Part 2|Physician Decision|0|||
164554207|NCT01225731|594398857|FG011|Part 2|Physician Decision|0|||
164554208|NCT01225731|594398858|FG012|Part 2|Physician Decision|0|||
164554209|NCT01225731|594398846|FG000|Part 2|Withdrawal by Subject|0|||
164554210|NCT01225731|594398847|FG001|Part 2|Withdrawal by Subject|0|||
164554211|NCT01225731|594398848|FG002|Part 2|Withdrawal by Subject|0|||
164554212|NCT01225731|594398849|FG003|Part 2|Withdrawal by Subject|0|||
164554213|NCT01225731|594398850|FG004|Part 2|Withdrawal by Subject|0|||
164554214|NCT01225731|594398851|FG005|Part 2|Withdrawal by Subject|1|||
164554215|NCT01225731|594398852|FG006|Part 2|Withdrawal by Subject|3|||
164554216|NCT01225731|594398853|FG007|Part 2|Withdrawal by Subject|4|||
164554217|NCT01225731|594398854|FG008|Part 2|Withdrawal by Subject|1|||
164554218|NCT01225731|594398855|FG009|Part 2|Withdrawal by Subject|0|||
164554219|NCT01225731|594398856|FG010|Part 2|Withdrawal by Subject|0|||
164554220|NCT01225731|594398857|FG011|Part 2|Withdrawal by Subject|0|||
164554221|NCT01225731|594398858|FG012|Part 2|Withdrawal by Subject|0|||
164554222|NCT01225731|594398846|FG000|Part 3|Adverse Event|0|||
164554223|NCT01225731|594398847|FG001|Part 3|Adverse Event|0|||
164554224|NCT01225731|594398848|FG002|Part 3|Adverse Event|0|||
164554225|NCT01225731|594398849|FG003|Part 3|Adverse Event|0|||
164554226|NCT01225731|594398850|FG004|Part 3|Adverse Event|0|||
164554227|NCT01225731|594398851|FG005|Part 3|Adverse Event|0|||
164554228|NCT01225731|594398852|FG006|Part 3|Adverse Event|0|||
164554229|NCT01225731|594398853|FG007|Part 3|Adverse Event|0|||
164554230|NCT01225731|594398854|FG008|Part 3|Adverse Event|0|||
164554231|NCT01225731|594398855|FG009|Part 3|Adverse Event|0|||
164554232|NCT01225731|594398856|FG010|Part 3|Adverse Event|1|||
164554233|NCT01225731|594398857|FG011|Part 3|Adverse Event|1|||
164554234|NCT01225731|594398858|FG012|Part 3|Adverse Event|0|||
164554235|NCT01225731|594398846|FG000|Part 3|Lost to Follow-up|0|||
164554236|NCT01225731|594398847|FG001|Part 3|Lost to Follow-up|0|||
164554237|NCT01225731|594398848|FG002|Part 3|Lost to Follow-up|0|||
164554238|NCT01225731|594398849|FG003|Part 3|Lost to Follow-up|0|||
164554239|NCT01225731|594398850|FG004|Part 3|Lost to Follow-up|0|||
164554240|NCT01225731|594398851|FG005|Part 3|Lost to Follow-up|0|||
164554241|NCT01225731|594398852|FG006|Part 3|Lost to Follow-up|0|||
164659048|NCT00759148|594777613|FG001|Overall Study|Reason not given|0|||
164310616|NCT04421027|593510913|FG001|Follow-Up Period|Protocol Deviation|0|||
164310617|NCT04421027|593510914|FG002|Follow-Up Period|Protocol Deviation|1|||
164310618|NCT04421027|593510915|FG003|Follow-Up Period|Protocol Deviation|0|||
164554242|NCT01225731|594398853|FG007|Part 3|Lost to Follow-up|0|||
164554243|NCT01225731|594398854|FG008|Part 3|Lost to Follow-up|0|||
164554244|NCT01225731|594398855|FG009|Part 3|Lost to Follow-up|0|||
164554245|NCT01225731|594398856|FG010|Part 3|Lost to Follow-up|1|||
164554246|NCT01225731|594398857|FG011|Part 3|Lost to Follow-up|2|||
164554247|NCT01225731|594398858|FG012|Part 3|Lost to Follow-up|1|||
164554248|NCT01225731|594398846|FG000|Part 3|Physician Decision|0|||
164554249|NCT01225731|594398847|FG001|Part 3|Physician Decision|0|||
164554250|NCT01225731|594398848|FG002|Part 3|Physician Decision|0|||
164554251|NCT01225731|594398849|FG003|Part 3|Physician Decision|0|||
164554252|NCT01225731|594398850|FG004|Part 3|Physician Decision|0|||
164554253|NCT01225731|594398851|FG005|Part 3|Physician Decision|0|||
164554254|NCT01225731|594398852|FG006|Part 3|Physician Decision|0|||
164554255|NCT01225731|594398853|FG007|Part 3|Physician Decision|0|||
164554256|NCT01225731|594398854|FG008|Part 3|Physician Decision|0|||
164554257|NCT01225731|594398855|FG009|Part 3|Physician Decision|0|||
164554258|NCT01225731|594398856|FG010|Part 3|Physician Decision|0|||
164554259|NCT01225731|594398857|FG011|Part 3|Physician Decision|1|||
164554260|NCT01225731|594398858|FG012|Part 3|Physician Decision|2|||
164554261|NCT01225731|594398846|FG000|Part 3|Withdrawal by Subject|0|||
164659049|NCT01073020|594777614|FG000|Overall Study|Withdrawal by Subject|6|||
164659050|NCT01073020|594777615|FG001|Overall Study|Withdrawal by Subject|4|||
164659051|NCT01073020|594777616|FG002|Overall Study|Withdrawal by Subject|1|||
164659052|NCT01073020|594777617|FG003|Overall Study|Withdrawal by Subject|2|||
164659053|NCT01073020|594777614|FG000|Overall Study|Physician Decision|1|||
164659054|NCT01073020|594777615|FG001|Overall Study|Physician Decision|0|||
164659055|NCT01073020|594777616|FG002|Overall Study|Physician Decision|2|||
164659056|NCT01073020|594777617|FG003|Overall Study|Physician Decision|0|||
164659057|NCT01073020|594777614|FG000|Overall Study|Death|0|||
164659058|NCT01073020|594777615|FG001|Overall Study|Death|1|||
164659059|NCT01073020|594777616|FG002|Overall Study|Death|0|||
164659060|NCT01073020|594777617|FG003|Overall Study|Death|0|||
164659061|NCT00094302|594777620|FG000|Overall Study|Lost to Follow-up|43|||
164659062|NCT00094302|594777621|FG001|Overall Study|Lost to Follow-up|41|||
164659063|NCT00094302|594777620|FG000|Overall Study|Physician Decision|5|||
164659064|NCT00094302|594777621|FG001|Overall Study|Physician Decision|8|||
164659065|NCT00094302|594777620|FG000|Overall Study|Withdrawal by Subject|103|||
164659066|NCT00094302|594777621|FG001|Overall Study|Withdrawal by Subject|111|||
164659067|NCT00094302|594777620|FG000|Overall Study|Death|266|||
164659068|NCT00094302|594777621|FG001|Overall Study|Death|246|||
164659069|NCT03329027|594777622|FG000|Overall Study|Lost to Follow-up|1|||
164659070|NCT03329027|594777623|FG001|Overall Study|Lost to Follow-up|0|||
164659071|NCT03329027|594777624|FG002|Overall Study|Lost to Follow-up|1|||
164659072|NCT03329027|594777622|FG000|Overall Study|Protocol Violation|9|||
164659073|NCT03329027|594777623|FG001|Overall Study|Protocol Violation|5|||
164659074|NCT03329027|594777624|FG002|Overall Study|Protocol Violation|7|||
164659075|NCT02761980|594777629|FG000|Overall Study|Adverse Event|4|||
164659076|NCT02761980|594777630|FG001|Overall Study|Adverse Event|6|||
164659077|NCT02761980|594777631|FG002|Overall Study|Adverse Event|5|||
164659078|NCT02761980|594777632|FG003|Overall Study|Adverse Event|6|||
164659079|NCT02761980|594777629|FG000|Overall Study|Withdrawal by Subject|0|||
164659080|NCT02761980|594777630|FG001|Overall Study|Withdrawal by Subject|1|||
164659081|NCT02761980|594777631|FG002|Overall Study|Withdrawal by Subject|0|||
164659082|NCT02761980|594777632|FG003|Overall Study|Withdrawal by Subject|0|||
164659083|NCT02761980|594777629|FG000|Overall Study|Other|0|||
164659084|NCT02761980|594777630|FG001|Overall Study|Other|0|||
164659085|NCT02761980|594777631|FG002|Overall Study|Other|1|||
164659086|NCT02761980|594777632|FG003|Overall Study|Other|0|||
164659087|NCT00101582|594777633|FG000|Overall Study|Ineligibility determined|0|||
164659088|NCT00101582|594777634|FG001|Overall Study|Ineligibility determined|1|||
164659089|NCT00101582|594777633|FG000|Overall Study|Adverse Event|1|||
164659090|NCT00101582|594777634|FG001|Overall Study|Adverse Event|4|||
164659091|NCT00101582|594777633|FG000|Overall Study|Withdrawal by Subject|6|||
164659092|NCT00101582|594777634|FG001|Overall Study|Withdrawal by Subject|4|||
164659093|NCT00101582|594777633|FG000|Overall Study|Physician Decision|1|||
164659094|NCT00101582|594777634|FG001|Overall Study|Physician Decision|0|||
164659095|NCT00101582|594777633|FG000|Overall Study|Death|3|||
164659096|NCT00101582|594777634|FG001|Overall Study|Death|5|||
164659097|NCT00101582|594777633|FG000|Overall Study|Other|0|||
164659098|NCT00101582|594777634|FG001|Overall Study|Other|1|||
164659099|NCT01907087|594777635|FG000|Overall Study|Withdrawal by Subject|1|||
164659100|NCT01919190|594777636|FG000|Overall Study|Intra-op findings, etc.|3|||
164659101|NCT01919190|594777637|FG001|Overall Study|Intra-op findings, etc.|0|||
164659102|NCT00135707|594777641|FG000|Overall Study|Lost to Follow-up|94|||
164659103|NCT00135707|594777642|FG001|Overall Study|Lost to Follow-up|89|||
164659104|NCT00135707|594777641|FG000|Overall Study|Withdrawal by Subject|0|||
164659105|NCT00135707|594777642|FG001|Overall Study|Withdrawal by Subject|1|||
164659106|NCT00135707|594777641|FG000|Overall Study|Institutional review board request|1|||
164659107|NCT00135707|594777642|FG001|Overall Study|Institutional review board request|0|||
164659108|NCT01829464|594777649|FG000|Overall Study|Adverse Event|1|||
164659109|NCT01829464|594777650|FG001|Overall Study|Adverse Event|0|||
164659110|NCT01829464|594777651|FG002|Overall Study|Adverse Event|0|||
164659111|NCT01829464|594777649|FG000|Overall Study|Lost to Follow-up|0|||
164659112|NCT01829464|594777650|FG001|Overall Study|Lost to Follow-up|0|||
164659113|NCT01829464|594777651|FG002|Overall Study|Lost to Follow-up|1|||
164659114|NCT01829464|594777649|FG000|Overall Study|Withdrawal by Subject|2|||
164659115|NCT01829464|594777650|FG001|Overall Study|Withdrawal by Subject|0|||
164659116|NCT01829464|594777651|FG002|Overall Study|Withdrawal by Subject|0|||
164659117|NCT01829464|594777649|FG000|Overall Study|Study terminated by sponsor|25|||
164659118|NCT01829464|594777650|FG001|Overall Study|Study terminated by sponsor|28|||
164659119|NCT01829464|594777651|FG002|Overall Study|Study terminated by sponsor|25|||
164659120|NCT01829464|594777649|FG000|Overall Study|Lack of Efficacy|0|||
164659121|NCT01829464|594777650|FG001|Overall Study|Lack of Efficacy|1|||
164659122|NCT01829464|594777651|FG002|Overall Study|Lack of Efficacy|0|||
164659123|NCT00635778|594777656|FG000|Overall Study|Adverse Event|1|||
164659124|NCT00635778|594777657|FG001|Overall Study|Adverse Event|0|||
164659125|NCT00635778|594777658|FG002|Overall Study|Adverse Event|0|||
164659126|NCT00635778|594777659|FG003|Overall Study|Adverse Event|3|||
164659127|NCT00635778|594777660|FG004|Overall Study|Adverse Event|3|||
164659128|NCT00635778|594777661|FG005|Overall Study|Adverse Event|6|||
164310619|NCT04421027|593510912|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
164310620|NCT04421027|593510913|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
164310621|NCT04421027|593510914|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
164310622|NCT04421027|593510915|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
164659129|NCT00635778|594777662|FG006|Overall Study|Adverse Event|1|||
164659130|NCT00635778|594777656|FG000|Overall Study|Withdrawal by Subject|0|||
164659131|NCT00635778|594777657|FG001|Overall Study|Withdrawal by Subject|0|||
164659132|NCT00635778|594777658|FG002|Overall Study|Withdrawal by Subject|0|||
164659133|NCT00635778|594777659|FG003|Overall Study|Withdrawal by Subject|1|||
164659134|NCT00635778|594777660|FG004|Overall Study|Withdrawal by Subject|0|||
164659135|NCT00635778|594777661|FG005|Overall Study|Withdrawal by Subject|1|||
164659136|NCT00635778|594777662|FG006|Overall Study|Withdrawal by Subject|1|||
164659137|NCT00635778|594777656|FG000|Overall Study|Progressive disease|0|||
164659138|NCT00635778|594777657|FG001|Overall Study|Progressive disease|3|||
164659139|NCT00635778|594777658|FG002|Overall Study|Progressive disease|3|||
164659140|NCT00635778|594777659|FG003|Overall Study|Progressive disease|4|||
164659141|NCT00635778|594777660|FG004|Overall Study|Progressive disease|5|||
164659142|NCT00635778|594777661|FG005|Overall Study|Progressive disease|14|||
164659143|NCT00635778|594777662|FG006|Overall Study|Progressive disease|4|||
164659144|NCT00812253|594777663|FG000|Overall Study|Withdrawal by Subject|3|||
164659145|NCT00812253|594777664|FG001|Overall Study|Withdrawal by Subject|2|||
164659146|NCT00812253|594777663|FG000|Overall Study|Protocol Violation|1|||
164659147|NCT00812253|594777664|FG001|Overall Study|Protocol Violation|1|||
164659148|NCT00812253|594777663|FG000|Overall Study|Lost to Follow-up|2|||
164659149|NCT00812253|594777664|FG001|Overall Study|Lost to Follow-up|0|||
164659150|NCT02385526|594777668|FG000|Overall Study|Withdrawal by Subject|0|||
164659151|NCT02385526|594777669|FG001|Overall Study|Withdrawal by Subject|2|||
164659152|NCT02385526|594777670|FG002|Overall Study|Withdrawal by Subject|0|||
164659153|NCT02385526|594777668|FG000|Overall Study|Lost to Follow-up|0|||
164659154|NCT02385526|594777669|FG001|Overall Study|Lost to Follow-up|1|||
164659155|NCT02385526|594777670|FG002|Overall Study|Lost to Follow-up|0|||
164659156|NCT02385526|594777668|FG000|Overall Study|Physician Decision|1|||
164659157|NCT02385526|594777669|FG001|Overall Study|Physician Decision|0|||
164659158|NCT02385526|594777670|FG002|Overall Study|Physician Decision|0|||
164659159|NCT02385526|594777668|FG000|Overall Study|Protocol Violation|1|||
164659160|NCT02385526|594777669|FG001|Overall Study|Protocol Violation|0|||
164659161|NCT02385526|594777670|FG002|Overall Study|Protocol Violation|0|||
164659162|NCT01689974|594777671|FG000|Overall Study|Termination of Study|5|||
164659163|NCT01689974|594777672|FG001|Overall Study|Termination of Study|5|||
164659164|NCT01333033|594777673|FG000|Overall Study|Ineligible|0|||
164659165|NCT01333033|594777674|FG001|Overall Study|Ineligible|0|||
164659166|NCT01333033|594777675|FG002|Overall Study|Ineligible|0|||
164659167|NCT01333033|594777676|FG003|Overall Study|Ineligible|0|||
164659168|NCT01333033|594777677|FG004|Overall Study|Ineligible|6|||
164659169|NCT01333033|594777678|FG005|Overall Study|Ineligible|8|||
164659170|NCT01333033|594777673|FG000|Overall Study|Withdrawal by Subject|0|||
164659171|NCT01333033|594777674|FG001|Overall Study|Withdrawal by Subject|0|||
164659172|NCT01333033|594777675|FG002|Overall Study|Withdrawal by Subject|0|||
164659173|NCT01333033|594777676|FG003|Overall Study|Withdrawal by Subject|0|||
164659174|NCT01333033|594777677|FG004|Overall Study|Withdrawal by Subject|4|||
164659175|NCT01333033|594777678|FG005|Overall Study|Withdrawal by Subject|2|||
164659176|NCT01333033|594777673|FG000|Overall Study|PET inevaluable|0|||
164659177|NCT01333033|594777674|FG001|Overall Study|PET inevaluable|0|||
164659178|NCT01333033|594777675|FG002|Overall Study|PET inevaluable|0|||
164659179|NCT01333033|594777676|FG003|Overall Study|PET inevaluable|0|||
164659180|NCT01333033|594777677|FG004|Overall Study|PET inevaluable|2|||
164659181|NCT01333033|594777678|FG005|Overall Study|PET inevaluable|4|||
164659182|NCT01333033|594777673|FG000|Overall Study|Adverse Event|0|||
164310623|NCT04421027|593510912|FG000|Follow-Up Period|Left message, participant did not call back|0|||
164310624|NCT04421027|593510913|FG001|Follow-Up Period|Left message, participant did not call back|0|||
164310625|NCT04421027|593510914|FG002|Follow-Up Period|Left message, participant did not call back|0|||
164310626|NCT04421027|593510915|FG003|Follow-Up Period|Left message, participant did not call back|1|||
164310627|NCT04421027|593510912|FG000|Follow-Up Period|Participant died|0|||
164310628|NCT04421027|593510913|FG001|Follow-Up Period|Participant died|0|||
164310629|NCT04421027|593510914|FG002|Follow-Up Period|Participant died|0|||
164310630|NCT04421027|593510915|FG003|Follow-Up Period|Participant died|1|||
164659183|NCT01333033|594777674|FG001|Overall Study|Adverse Event|0|||
164659184|NCT01333033|594777675|FG002|Overall Study|Adverse Event|0|||
164659185|NCT01333033|594777676|FG003|Overall Study|Adverse Event|0|||
164659186|NCT01333033|594777677|FG004|Overall Study|Adverse Event|2|||
164659187|NCT01333033|594777678|FG005|Overall Study|Adverse Event|1|||
164659188|NCT01333033|594777673|FG000|Overall Study|Progression|0|||
164659189|NCT01333033|594777674|FG001|Overall Study|Progression|0|||
164659190|NCT01333033|594777675|FG002|Overall Study|Progression|0|||
164659191|NCT01333033|594777676|FG003|Overall Study|Progression|0|||
164659192|NCT01333033|594777677|FG004|Overall Study|Progression|0|||
164659193|NCT01333033|594777678|FG005|Overall Study|Progression|1|||
164659194|NCT01333033|594777673|FG000|Overall Study|MD Decision|0|||
164659195|NCT01333033|594777674|FG001|Overall Study|MD Decision|0|||
164659196|NCT01333033|594777675|FG002|Overall Study|MD Decision|0|||
164659197|NCT01333033|594777676|FG003|Overall Study|MD Decision|0|||
164659198|NCT01333033|594777677|FG004|Overall Study|MD Decision|0|||
164659199|NCT01333033|594777678|FG005|Overall Study|MD Decision|2|||
164659200|NCT00384033|594777688|FG000|Overall Study|Adverse Event|10|||
164659201|NCT00384033|594777689|FG001|Overall Study|Adverse Event|8|||
164659202|NCT00384033|594777690|FG002|Overall Study|Adverse Event|11|||
164659203|NCT00384033|594777691|FG003|Overall Study|Adverse Event|20|||
164659204|NCT00384033|594777688|FG000|Overall Study|Failed to return|1|||
164659205|NCT00384033|594777689|FG001|Overall Study|Failed to return|3|||
164659206|NCT00384033|594777690|FG002|Overall Study|Failed to return|2|||
164659207|NCT00384033|594777691|FG003|Overall Study|Failed to return|2|||
164659208|NCT00384033|594777688|FG000|Overall Study|Physician Decision|1|||
164659209|NCT00384033|594777689|FG001|Overall Study|Physician Decision|0|||
164659210|NCT00384033|594777690|FG002|Overall Study|Physician Decision|0|||
164659211|NCT00384033|594777691|FG003|Overall Study|Physician Decision|0|||
164659212|NCT00384033|594777688|FG000|Overall Study|Lost to Follow-up|6|||
164659213|NCT00384033|594777689|FG001|Overall Study|Lost to Follow-up|12|||
164659214|NCT00384033|594777690|FG002|Overall Study|Lost to Follow-up|7|||
164659215|NCT00384033|594777691|FG003|Overall Study|Lost to Follow-up|7|||
164659216|NCT00384033|594777688|FG000|Overall Study|Other|2|||
164659217|NCT00384033|594777689|FG001|Overall Study|Other|0|||
164659218|NCT00384033|594777690|FG002|Overall Study|Other|0|||
164659219|NCT00384033|594777691|FG003|Overall Study|Other|0|||
164659220|NCT00384033|594777688|FG000|Overall Study|Protocol Violation|5|||
164659221|NCT00384033|594777689|FG001|Overall Study|Protocol Violation|0|||
164659222|NCT00384033|594777690|FG002|Overall Study|Protocol Violation|5|||
164659223|NCT00384033|594777691|FG003|Overall Study|Protocol Violation|6|||
164659224|NCT00384033|594777688|FG000|Overall Study|Withdrawal by Subject|6|||
164659225|NCT00384033|594777689|FG001|Overall Study|Withdrawal by Subject|2|||
164659226|NCT00384033|594777690|FG002|Overall Study|Withdrawal by Subject|5|||
164659227|NCT00384033|594777691|FG003|Overall Study|Withdrawal by Subject|2|||
164659228|NCT00384033|594777688|FG000|Overall Study|Lack of Efficacy|7|||
164659229|NCT00384033|594777689|FG001|Overall Study|Lack of Efficacy|3|||
164659230|NCT00384033|594777690|FG002|Overall Study|Lack of Efficacy|3|||
164659231|NCT00384033|594777691|FG003|Overall Study|Lack of Efficacy|1|||
164659232|NCT00384033|594777688|FG000|Overall Study|Randomized but not treated|3|||
164659233|NCT00384033|594777689|FG001|Overall Study|Randomized but not treated|7|||
164659234|NCT00384033|594777690|FG002|Overall Study|Randomized but not treated|10|||
164659235|NCT00384033|594777691|FG003|Overall Study|Randomized but not treated|2|||
164659236|NCT01842958|594777694|FG000|Overall Study|Lost to Follow-up|1|||
164659237|NCT01842958|594777695|FG001|Overall Study|Lost to Follow-up|1|||
164659238|NCT01829477|594777696|FG000|Overall Study|Study Terminated by Sponsor|15|||
164659239|NCT01829477|594777697|FG001|Overall Study|Study Terminated by Sponsor|15|||
164659240|NCT01829477|594777696|FG000|Overall Study|Withdrawal by Subject|1|||
164659241|NCT01829477|594777697|FG001|Overall Study|Withdrawal by Subject|0|||
164659242|NCT03465891|594777699|FG000|Overall Study|Withdrawal by Subject|0|||
164659243|NCT03465891|594777700|FG001|Overall Study|Withdrawal by Subject|1|||
164659244|NCT03465891|594777699|FG000|Overall Study|Disease progression|1|||
164659245|NCT03465891|594777700|FG001|Overall Study|Disease progression|0|||
164659246|NCT02737306|594777702|FG000|Overall Study|Adverse Event|3|||
164659247|NCT02737306|594777703|FG001|Overall Study|Adverse Event|0|||
164659248|NCT02737306|594777702|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
164659249|NCT02737306|594777703|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
164659250|NCT03361423|594777704|FG000|Overall Study|Withdrawal by Subject|4|||
164659251|NCT03361423|594777705|FG001|Overall Study|Withdrawal by Subject|3|||
164659252|NCT03361423|594777704|FG000|Overall Study|Did not treat|19|||
164659253|NCT03361423|594777705|FG001|Overall Study|Did not treat|18|||
164659254|NCT03361423|594777704|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
164659255|NCT03361423|594777705|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
164659256|NCT03361423|594777704|FG000|Overall Study|Missing data|4|||
164659257|NCT03361423|594777705|FG001|Overall Study|Missing data|1|||
164659258|NCT00818623|594777706|FG000|Overall Study|Adverse Event|1|||
164659259|NCT00818623|594777707|FG001|Overall Study|Adverse Event|0|||
164659260|NCT00818623|594777708|FG002|Overall Study|Adverse Event|1|||
164659261|NCT00818623|594777709|FG003|Overall Study|Adverse Event|0|||
164659262|NCT00818623|594777710|FG004|Overall Study|Adverse Event|0|||
164659263|NCT00818623|594777711|FG005|Overall Study|Adverse Event|1|||
164659264|NCT00818623|594777712|FG006|Overall Study|Adverse Event|0|||
164659265|NCT00818623|594777713|FG007|Overall Study|Adverse Event|0|||
164659266|NCT00818623|594777706|FG000|Overall Study|Bad prostate specific antigen response|0|||
164659267|NCT00818623|594777707|FG001|Overall Study|Bad prostate specific antigen response|3|||
164659268|NCT00818623|594777708|FG002|Overall Study|Bad prostate specific antigen response|2|||
164659269|NCT00818623|594777709|FG003|Overall Study|Bad prostate specific antigen response|5|||
164659270|NCT00818623|594777710|FG004|Overall Study|Bad prostate specific antigen response|0|||
164659271|NCT00818623|594777711|FG005|Overall Study|Bad prostate specific antigen response|1|||
164659272|NCT00818623|594777712|FG006|Overall Study|Bad prostate specific antigen response|0|||
164310631|NCT04421027|593510912|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
164310632|NCT04421027|593510913|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
164554262|NCT01225731|594398847|FG001|Part 3|Withdrawal by Subject|0|||
164554263|NCT01225731|594398848|FG002|Part 3|Withdrawal by Subject|0|||
164554264|NCT01225731|594398849|FG003|Part 3|Withdrawal by Subject|0|||
164554265|NCT01225731|594398850|FG004|Part 3|Withdrawal by Subject|0|||
164554266|NCT01225731|594398851|FG005|Part 3|Withdrawal by Subject|0|||
164554267|NCT01225731|594398852|FG006|Part 3|Withdrawal by Subject|0|||
164554268|NCT01225731|594398853|FG007|Part 3|Withdrawal by Subject|0|||
164554269|NCT01225731|594398854|FG008|Part 3|Withdrawal by Subject|0|||
164554270|NCT01225731|594398855|FG009|Part 3|Withdrawal by Subject|0|||
164554271|NCT01225731|594398856|FG010|Part 3|Withdrawal by Subject|4|||
164554272|NCT01225731|594398857|FG011|Part 3|Withdrawal by Subject|6|||
164554273|NCT01225731|594398858|FG012|Part 3|Withdrawal by Subject|4|||
164554274|NCT00577642|594398859|FG000|Overall Study|Clinical Disease Progression|1|||
164554275|NCT02069899|594398864|FG000|Overall Study|Adverse Event|6|||
164554276|NCT02069899|594398865|FG001|Overall Study|Adverse Event|0|||
164554277|NCT02069899|594398866|FG002|Overall Study|Adverse Event|1|||
164554278|NCT02069899|594398864|FG000|Overall Study|Withdrawal by Participant|2|||
164554279|NCT02069899|594398865|FG001|Overall Study|Withdrawal by Participant|0|||
164554280|NCT02069899|594398866|FG002|Overall Study|Withdrawal by Participant|0|||
164554281|NCT02069899|594398864|FG000|Overall Study|Lost to Follow-up|1|||
164554282|NCT02069899|594398865|FG001|Overall Study|Lost to Follow-up|0|||
164554283|NCT02069899|594398866|FG002|Overall Study|Lost to Follow-up|1|||
164554284|NCT02069899|594398864|FG000|Overall Study|Other|4|||
164554285|NCT02069899|594398865|FG001|Overall Study|Other|0|||
164554286|NCT02069899|594398866|FG002|Overall Study|Other|0|||
164554287|NCT02069899|594398864|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
164554288|NCT02069899|594398865|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
164554289|NCT02069899|594398866|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
164554290|NCT02069899|594398864|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
164554291|NCT02069899|594398865|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
164554292|NCT02069899|594398866|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
164554293|NCT01119248|594398867|FG000|Overall Study|Physician Decision|5|||
164554294|NCT01273883|594398869|FG000|First Intervention|Adverse Event|2|||
164554295|NCT01273883|594398870|FG001|First Intervention|Adverse Event|1|||
164554296|NCT01273883|594398869|FG000|Second Intervention|Lost to Follow-up|1|||
164554297|NCT01273883|594398870|FG001|Second Intervention|Lost to Follow-up|1|||
164554298|NCT01273883|594398869|FG000|Second Intervention|Lack of Efficacy|1|||
164554299|NCT01273883|594398870|FG001|Second Intervention|Lack of Efficacy|0|||
164554300|NCT01553136|594398871|FG000|Overall Study|Adverse Event|3|||
164554301|NCT01553136|594398872|FG001|Overall Study|Adverse Event|2|||
164554302|NCT01553136|594398871|FG000|Overall Study|Withdrawal by Subject|2|||
164554303|NCT01553136|594398872|FG001|Overall Study|Withdrawal by Subject|3|||
164554304|NCT01553136|594398871|FG000|Overall Study|Lost to Follow-up|4|||
164554305|NCT01553136|594398872|FG001|Overall Study|Lost to Follow-up|10|||
164554306|NCT01553136|594398871|FG000|Overall Study|Physician Decision|2|||
164554307|NCT01553136|594398872|FG001|Overall Study|Physician Decision|3|||
164554308|NCT01553136|594398871|FG000|Overall Study|Scheduling Difficulties|5|||
164554309|NCT01553136|594398872|FG001|Overall Study|Scheduling Difficulties|4|||
164554310|NCT01452152|594398873|FG000|Overall Study|Study termination by sponsor|5|||
164554311|NCT01452152|594398874|FG001|Overall Study|Study termination by sponsor|0|||
164554312|NCT01452152|594398875|FG002|Overall Study|Study termination by sponsor|4|||
164554313|NCT04311502|594400687|FG000|Overall Study|Death|1|||
164554314|NCT04311502|594400688|FG001|Overall Study|Death|1|||
164554315|NCT04311502|594400689|FG002|Overall Study|Death|1|||
164554316|NCT04311502|594400687|FG000|Overall Study|Lost to Follow-up|2|||
164554317|NCT04311502|594400688|FG001|Overall Study|Lost to Follow-up|3|||
164554318|NCT04311502|594400689|FG002|Overall Study|Lost to Follow-up|0|||
164554319|NCT04311502|594400687|FG000|Overall Study|Participant is in prison|1|||
164659273|NCT00818623|594777713|FG007|Overall Study|Bad prostate specific antigen response|0|||
164554320|NCT04311502|594400688|FG001|Overall Study|Participant is in prison|0|||
164554321|NCT04311502|594400689|FG002|Overall Study|Participant is in prison|0|||
164554322|NCT04311502|594400687|FG000|Overall Study|Participant moved out of country|1|||
164554323|NCT04311502|594400688|FG001|Overall Study|Participant moved out of country|0|||
164554324|NCT04311502|594400689|FG002|Overall Study|Participant moved out of country|0|||
164554325|NCT04311502|594400687|FG000|Overall Study|Withdrawal by Subject|2|||
164554326|NCT04311502|594400688|FG001|Overall Study|Withdrawal by Subject|0|||
164554327|NCT04311502|594400689|FG002|Overall Study|Withdrawal by Subject|0|||
164554328|NCT04311502|594400687|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
164554329|NCT04311502|594400688|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
164554330|NCT04311502|594400689|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
164554331|NCT03451773|594400690|FG000|Overall Study|Death on study|1|||
164659274|NCT00818623|594777706|FG000|Overall Study|Withdrawal by Subject|0|||
164659275|NCT00818623|594777707|FG001|Overall Study|Withdrawal by Subject|1|||
164659276|NCT00818623|594777708|FG002|Overall Study|Withdrawal by Subject|1|||
164659277|NCT00818623|594777709|FG003|Overall Study|Withdrawal by Subject|0|||
164659278|NCT00818623|594777710|FG004|Overall Study|Withdrawal by Subject|0|||
164659279|NCT00818623|594777711|FG005|Overall Study|Withdrawal by Subject|1|||
164659280|NCT00818623|594777712|FG006|Overall Study|Withdrawal by Subject|1|||
164659281|NCT00818623|594777713|FG007|Overall Study|Withdrawal by Subject|1|||
164659282|NCT00818623|594777706|FG000|Overall Study|Protocol Violation|1|||
164659283|NCT00818623|594777707|FG001|Overall Study|Protocol Violation|0|||
164659284|NCT00818623|594777708|FG002|Overall Study|Protocol Violation|0|||
164659285|NCT00818623|594777709|FG003|Overall Study|Protocol Violation|0|||
164659286|NCT00818623|594777710|FG004|Overall Study|Protocol Violation|1|||
164659287|NCT00818623|594777711|FG005|Overall Study|Protocol Violation|0|||
164659288|NCT00818623|594777712|FG006|Overall Study|Protocol Violation|1|||
164659289|NCT00818623|594777713|FG007|Overall Study|Protocol Violation|0|||
164659290|NCT00818623|594777706|FG000|Overall Study|Need of additional treatment|0|||
164659291|NCT00818623|594777707|FG001|Overall Study|Need of additional treatment|0|||
164659292|NCT00818623|594777708|FG002|Overall Study|Need of additional treatment|0|||
164659293|NCT00818623|594777709|FG003|Overall Study|Need of additional treatment|0|||
164659294|NCT00818623|594777710|FG004|Overall Study|Need of additional treatment|1|||
164659295|NCT00818623|594777711|FG005|Overall Study|Need of additional treatment|0|||
164659296|NCT00818623|594777712|FG006|Overall Study|Need of additional treatment|0|||
164659297|NCT00818623|594777713|FG007|Overall Study|Need of additional treatment|0|||
164659298|NCT00818623|594777706|FG000|Overall Study|Lack of trial drug at site|0|||
164659299|NCT00818623|594777707|FG001|Overall Study|Lack of trial drug at site|0|||
164659300|NCT00818623|594777708|FG002|Overall Study|Lack of trial drug at site|0|||
164659301|NCT00818623|594777709|FG003|Overall Study|Lack of trial drug at site|0|||
164659302|NCT00818623|594777710|FG004|Overall Study|Lack of trial drug at site|2|||
164659303|NCT00818623|594777711|FG005|Overall Study|Lack of trial drug at site|0|||
164659304|NCT00818623|594777712|FG006|Overall Study|Lack of trial drug at site|1|||
164659305|NCT00818623|594777713|FG007|Overall Study|Lack of trial drug at site|0|||
164659306|NCT00818623|594777706|FG000|Overall Study|Disease progression|0|||
164659307|NCT00818623|594777707|FG001|Overall Study|Disease progression|0|||
164659308|NCT00818623|594777708|FG002|Overall Study|Disease progression|0|||
164659309|NCT00818623|594777709|FG003|Overall Study|Disease progression|0|||
164659310|NCT00818623|594777710|FG004|Overall Study|Disease progression|0|||
164659311|NCT00818623|594777711|FG005|Overall Study|Disease progression|0|||
164659312|NCT00818623|594777712|FG006|Overall Study|Disease progression|1|||
164659313|NCT00818623|594777713|FG007|Overall Study|Disease progression|0|||
164659314|NCT00299156|594777714|FG000|Period 2 (Randomized)|Screen Failure|0|||
164659315|NCT00299156|594777715|FG001|Period 2 (Randomized)|Screen Failure|1|||
164659316|NCT00299156|594777716|FG002|Period 2 (Randomized)|Screen Failure|0|||
164659317|NCT01166568|594777717|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
164659318|NCT01166568|594777718|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
164659319|NCT01166568|594777719|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
164659320|NCT01166568|594777717|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
164659321|NCT01166568|594777718|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
164659322|NCT01166568|594777719|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
164659323|NCT01166568|594777717|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
164659324|NCT01166568|594777718|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
164659325|NCT01166568|594777719|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
164659326|NCT00903383|594777720|FG000|Overall Study|Adverse Event|1|||
164659327|NCT00903383|594777721|FG001|Overall Study|Adverse Event|2|||
164659328|NCT00903383|594777722|FG002|Overall Study|Adverse Event|3|||
164659329|NCT00903383|594777723|FG003|Overall Study|Adverse Event|1|||
164554332|NCT03451773|594400691|FG001|Overall Study|Death on study|5|||
164554333|NCT03451773|594400690|FG000|Overall Study|Death during follow-up period|0|||
164554334|NCT03451773|594400691|FG001|Overall Study|Death during follow-up period|1|||
164554335|NCT01049035|594400693|FG000|Overall Study|Serious adverse event|0|||
164554336|NCT01049035|594400694|FG001|Overall Study|Serious adverse event|1|||
164554337|NCT01049035|594400695|FG002|Overall Study|Serious adverse event|1|||
164554338|NCT01049035|594400696|FG003|Overall Study|Serious adverse event|2|||
164554339|NCT01049035|594400697|FG004|Overall Study|Serious adverse event|0|||
164554340|NCT01049035|594400698|FG005|Overall Study|Serious adverse event|0|||
164554341|NCT01049035|594400699|FG006|Overall Study|Serious adverse event|0|||
164554342|NCT01049035|594400693|FG000|Overall Study|Other adverse event (AE)|0|||
164554343|NCT01049035|594400694|FG001|Overall Study|Other adverse event (AE)|0|||
164554344|NCT01049035|594400695|FG002|Overall Study|Other adverse event (AE)|0|||
164554345|NCT01049035|594400696|FG003|Overall Study|Other adverse event (AE)|1|||
164554346|NCT01049035|594400697|FG004|Overall Study|Other adverse event (AE)|0|||
164659330|NCT00903383|594777720|FG000|Overall Study|Physician Decision|1|||
164659331|NCT00903383|594777721|FG001|Overall Study|Physician Decision|2|||
164659332|NCT00903383|594777722|FG002|Overall Study|Physician Decision|0|||
164310633|NCT04421027|593510914|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
164310634|NCT04421027|593510915|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
164310635|NCT00560352|593510920|FG000|Overall Study|Adverse event unrelated to study drug|2|||
164310636|NCT00560352|593510921|FG001|Overall Study|Adverse event unrelated to study drug|1|||
164310637|NCT00560352|593510922|FG002|Overall Study|Adverse event unrelated to study drug|1|||
164310638|NCT00560352|593510920|FG000|Overall Study|Study drug toxicity|3|||
164310639|NCT00560352|593510921|FG001|Overall Study|Study drug toxicity|0|||
164310640|NCT00560352|593510922|FG002|Overall Study|Study drug toxicity|1|||
164310641|NCT00560352|593510920|FG000|Overall Study|Disease progression|0|||
164310642|NCT00560352|593510921|FG001|Overall Study|Disease progression|1|||
164310643|NCT00560352|593510922|FG002|Overall Study|Disease progression|1|||
164310644|NCT00560352|593510920|FG000|Overall Study|Withdrawal by Subject|1|||
164310645|NCT00560352|593510921|FG001|Overall Study|Withdrawal by Subject|1|||
164310646|NCT00560352|593510922|FG002|Overall Study|Withdrawal by Subject|1|||
164310647|NCT00560352|593510920|FG000|Overall Study|Maximum clinical benefit|1|||
164310648|NCT00560352|593510921|FG001|Overall Study|Maximum clinical benefit|0|||
164310649|NCT00560352|593510922|FG002|Overall Study|Maximum clinical benefit|0|||
164310650|NCT03568461|593510926|FG000|Overall Study|Death|7|||
164310651|NCT03568461|593510926|FG000|Overall Study|Physician Decision|5|||
164310652|NCT03568461|593510926|FG000|Overall Study|Subject decision|5|||
164310653|NCT03568461|593510926|FG000|Overall Study|Lost to Follow-up|1|||
164310654|NCT03387085|593510927|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
164310655|NCT01395524|593512901|FG000|Overall Study|Non-compliance with study schedule|1|||
164310656|NCT01395524|593512902|FG001|Overall Study|Non-compliance with study schedule|0|||
164310657|NCT01395524|593512903|FG002|Overall Study|Non-compliance with study schedule|1|||
164310658|NCT01395524|593512901|FG000|Overall Study|Lost to Follow-up|3|||
164310659|NCT01395524|593512902|FG001|Overall Study|Lost to Follow-up|1|||
164310660|NCT01395524|593512903|FG002|Overall Study|Lost to Follow-up|1|||
164310661|NCT01395524|593512901|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
164310662|NCT01395524|593512902|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
164310663|NCT01395524|593512903|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
164310664|NCT01395524|593512901|FG000|Overall Study|Severe noncompliance with protocol|1|||
164310665|NCT01395524|593512902|FG001|Overall Study|Severe noncompliance with protocol|0|||
164310666|NCT01395524|593512903|FG002|Overall Study|Severe noncompliance with protocol|0|||
164310667|NCT01395524|593512901|FG000|Overall Study|Adverse Event|4|||
164310668|NCT01395524|593512902|FG001|Overall Study|Adverse Event|4|||
164310669|NCT01395524|593512903|FG002|Overall Study|Adverse Event|3|||
164310670|NCT01395524|593512901|FG000|Overall Study|Death|1|||
164554347|NCT01049035|594400698|FG005|Overall Study|Other adverse event (AE)|0|||
164554348|NCT01049035|594400699|FG006|Overall Study|Other adverse event (AE)|0|||
164554349|NCT01049035|594400693|FG000|Overall Study|Non-compliance with the protocol|12|||
164554350|NCT01049035|594400694|FG001|Overall Study|Non-compliance with the protocol|6|||
164554351|NCT01049035|594400695|FG002|Overall Study|Non-compliance with the protocol|14|||
164554352|NCT01049035|594400696|FG003|Overall Study|Non-compliance with the protocol|5|||
164554353|NCT01049035|594400697|FG004|Overall Study|Non-compliance with the protocol|3|||
164554354|NCT01049035|594400698|FG005|Overall Study|Non-compliance with the protocol|4|||
164554355|NCT01049035|594400699|FG006|Overall Study|Non-compliance with the protocol|10|||
164554356|NCT01049035|594400693|FG000|Overall Study|Lost to Follow-up|5|||
164554357|NCT01049035|594400694|FG001|Overall Study|Lost to Follow-up|4|||
164554358|NCT01049035|594400695|FG002|Overall Study|Lost to Follow-up|4|||
164554359|NCT01049035|594400696|FG003|Overall Study|Lost to Follow-up|1|||
164554360|NCT01049035|594400697|FG004|Overall Study|Lost to Follow-up|0|||
164554361|NCT01049035|594400698|FG005|Overall Study|Lost to Follow-up|3|||
164554362|NCT01049035|594400699|FG006|Overall Study|Lost to Follow-up|3|||
164554363|NCT01049035|594400693|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
164554364|NCT01049035|594400694|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
164554365|NCT01049035|594400695|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
164554366|NCT01049035|594400696|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
164554367|NCT01049035|594400697|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
164554368|NCT01049035|594400698|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
164554369|NCT01049035|594400699|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
164554370|NCT00746252|594400700|FG000|Overall Study|weight gain >7.5 %|1|||
164554371|NCT00746252|594400701|FG001|Overall Study|weight gain >7.5 %|2|||
164554372|NCT01137773|594400702|FG000|Overall Study|Death|3|||
164554373|NCT01137773|594400703|FG001|Overall Study|Death|3|||
164554374|NCT01137773|594400702|FG000|Overall Study|Lost to Follow-up|6|||
164554375|NCT01137773|594400703|FG001|Overall Study|Lost to Follow-up|0|||
164554376|NCT03548051|594400705|FG000|Overall Study|Death|1|||
164554377|NCT03548051|594400706|FG001|Overall Study|Death|1|||
164554378|NCT03548051|594400705|FG000|Overall Study|Withdrawal by Subject|1|||
164554379|NCT03548051|594400706|FG001|Overall Study|Withdrawal by Subject|0|||
164554380|NCT00082888|594400707|FG000|Overall Study|Ineligible|1|||
164554381|NCT00082888|594400708|FG001|Overall Study|Ineligible|0|||
164554382|NCT00082888|594400709|FG002|Overall Study|Ineligible|0|||
164554383|NCT00817531|594400711|FG000|Overall Study|Adverse Event|1|||
164554384|NCT00817531|594400711|FG000|Overall Study|Lack of Efficacy|1|||
164554385|NCT00812214|594400712|FG000|Overall Study|Lost to Follow-up|3|||
164554386|NCT00812214|594400713|FG001|Overall Study|Lost to Follow-up|1|||
164554387|NCT02684981|594400716|FG000|Overall Study|Permanently discontinued the treatment|157|||
164554388|NCT02684981|594400717|FG001|Overall Study|Permanently discontinued the treatment|161|||
164554389|NCT02684981|594400718|FG002|Overall Study|Permanently discontinued the treatment|110|||
164554390|NCT02684981|594400716|FG000|Overall Study|Other|83|||
164554391|NCT02684981|594400717|FG001|Overall Study|Other|49|||
164554392|NCT02684981|594400718|FG002|Overall Study|Other|17|||
164554393|NCT00820898|594400721|FG000|Overall Study|Inelgible - wrong primary site|1|||
164554394|NCT00452699|594400724|FG000|Overall Study|Adverse Event|10|||
164554395|NCT00452699|594400725|FG001|Overall Study|Adverse Event|3|||
164554396|NCT00452699|594400724|FG000|Overall Study|Lack of Efficacy|6|||
164554397|NCT00452699|594400725|FG001|Overall Study|Lack of Efficacy|4|||
164554398|NCT00452699|594400724|FG000|Overall Study|Lost to Follow-up|6|||
164554399|NCT00452699|594400725|FG001|Overall Study|Lost to Follow-up|9|||
164554400|NCT00452699|594400724|FG000|Overall Study|Protocol Violation|21|||
164554401|NCT00452699|594400725|FG001|Overall Study|Protocol Violation|25|||
164554402|NCT00452699|594400724|FG000|Overall Study|Withdrawal by Subject|26|||
164554403|NCT00452699|594400725|FG001|Overall Study|Withdrawal by Subject|25|||
164554404|NCT00452699|594400724|FG000|Overall Study|Other|12|||
164554405|NCT00452699|594400725|FG001|Overall Study|Other|7|||
164554406|NCT02921971|594400726|FG000|Overall Study|Adverse Event|1|||
164554407|NCT02921971|594400727|FG001|Overall Study|Adverse Event|2|||
164554408|NCT02921971|594400726|FG000|Overall Study|Lack of Efficacy|3|||
164201805|NCT04142242|593112607|FG005|Stage II|Lost to Follow-up|0|||
164201806|NCT04142242|593112602|FG000|Stage II|Withdrawal by Subject|0|||
164201807|NCT04142242|593112603|FG001|Stage II|Withdrawal by Subject|0|||
164201808|NCT04142242|593112604|FG002|Stage II|Withdrawal by Subject|5|||
164201809|NCT04142242|593112605|FG003|Stage II|Withdrawal by Subject|9|||
164201810|NCT04142242|593112606|FG004|Stage II|Withdrawal by Subject|0|||
164201811|NCT04142242|593112607|FG005|Stage II|Withdrawal by Subject|0|||
164201812|NCT00846053|593112610|FG000|Overall Study|Physician Decision|3|||
164201813|NCT00846053|593112611|FG001|Overall Study|Physician Decision|0|||
164201814|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
164201815|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
164201816|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
164201817|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
164201818|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
164201819|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
164201820|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
164201821|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
164201822|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
164201823|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
164201824|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
164201825|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
164201826|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
164201827|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
164201828|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
164201829|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
164201830|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
164201831|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
164201832|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
164201833|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
164201834|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
164201835|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
164201836|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
164201837|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
164201838|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
164310671|NCT01395524|593512902|FG001|Overall Study|Death|0|||
164310672|NCT01395524|593512903|FG002|Overall Study|Death|0|||
164310673|NCT01395524|593512901|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
164554409|NCT02921971|594400727|FG001|Overall Study|Lack of Efficacy|1|||
164310674|NCT01395524|593512902|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
164554410|NCT02921971|594400726|FG000|Overall Study|Other than specified above|2|||
164554411|NCT02921971|594400727|FG001|Overall Study|Other than specified above|1|||
164554412|NCT00326898|594400730|FG000|Overall Study|Disease progression|52|||
164554413|NCT00326898|594400731|FG001|Overall Study|Disease progression|54|||
164554414|NCT00326898|594400732|FG002|Overall Study|Disease progression|102|||
164554415|NCT00326898|594400730|FG000|Overall Study|Adverse Event|124|||
164554416|NCT00326898|594400731|FG001|Overall Study|Adverse Event|128|||
164554417|NCT00326898|594400732|FG002|Overall Study|Adverse Event|33|||
164201839|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
164201840|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
164659333|NCT00903383|594777723|FG003|Overall Study|Physician Decision|0|||
164659334|NCT00903383|594777720|FG000|Overall Study|Lost to Follow-up|0|||
164659335|NCT00903383|594777721|FG001|Overall Study|Lost to Follow-up|0|||
164659336|NCT00903383|594777722|FG002|Overall Study|Lost to Follow-up|0|||
164659337|NCT00903383|594777723|FG003|Overall Study|Lost to Follow-up|1|||
164659338|NCT00903383|594777720|FG000|Overall Study|Decision of Sponsor|1|||
164659339|NCT00903383|594777721|FG001|Overall Study|Decision of Sponsor|0|||
164659340|NCT00903383|594777722|FG002|Overall Study|Decision of Sponsor|0|||
164659341|NCT00903383|594777723|FG003|Overall Study|Decision of Sponsor|0|||
164659342|NCT00903383|594777720|FG000|Overall Study|Withdrawal by Subject|4|||
164659343|NCT00903383|594777721|FG001|Overall Study|Withdrawal by Subject|1|||
164659344|NCT00903383|594777722|FG002|Overall Study|Withdrawal by Subject|0|||
164659345|NCT00903383|594777723|FG003|Overall Study|Withdrawal by Subject|2|||
164659346|NCT00903383|594777720|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
164659347|NCT00903383|594777721|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
164659348|NCT00903383|594777722|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
164659349|NCT00903383|594777723|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
164659350|NCT00903383|594777720|FG000|Overall Study|Patient Decision|0|||
164659351|NCT00903383|594777721|FG001|Overall Study|Patient Decision|0|||
164659352|NCT00903383|594777722|FG002|Overall Study|Patient Decision|0|||
164659353|NCT00903383|594777723|FG003|Overall Study|Patient Decision|1|||
164659354|NCT02015793|594777731|FG000|Overall Study|Adverse Event|3|||
164659355|NCT02015793|594777732|FG001|Overall Study|Adverse Event|3|||
164659356|NCT02015793|594777731|FG000|Overall Study|Withdrawal by Subject|1|||
164659357|NCT02015793|594777732|FG001|Overall Study|Withdrawal by Subject|1|||
164659358|NCT00320593|594777733|FG000|Overall Study|Lost to Follow-up|3|||
164659359|NCT00320593|594777734|FG001|Overall Study|Lost to Follow-up|0|||
164659360|NCT00320593|594777733|FG000|Overall Study|Moved to another state|1|||
164659361|NCT00320593|594777734|FG001|Overall Study|Moved to another state|0|||
164659362|NCT00320593|594777733|FG000|Overall Study|Withdrawal by Subject|2|||
164659363|NCT00320593|594777734|FG001|Overall Study|Withdrawal by Subject|1|||
164659364|NCT00320593|594777733|FG000|Overall Study|Withdrawal by clinical center|1|||
164659365|NCT00320593|594777734|FG001|Overall Study|Withdrawal by clinical center|0|||
164659366|NCT01076166|594777735|FG000|Overall Study|Adverse Event|3|||
164659367|NCT01076166|594777735|FG000|Overall Study|Symptoms improved/resolved|6|||
164659368|NCT02087059|594777736|FG000|Overall Study|Disease Progression|1|||
164659369|NCT02087059|594777736|FG000|Overall Study|Adverse Event|5|||
164659370|NCT02087059|594777736|FG000|Overall Study|Lost to Follow-up|1|||
164659371|NCT04281485|594777740|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
164659372|NCT04281485|594777741|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
164659373|NCT04281485|594777740|FG000|Overall Study|Ongoing (Safety data collection)|10|||
164659374|NCT04281485|594777741|FG001|Overall Study|Ongoing (Safety data collection)|5|||
164659375|NCT01211769|594777744|FG000|Overall Study|Lost to Follow-up|7|||
164659376|NCT01211769|594777745|FG001|Overall Study|Lost to Follow-up|9|||
164659377|NCT01211769|594777746|FG002|Overall Study|Lost to Follow-up|5|||
164659378|NCT01211769|594777747|FG003|Overall Study|Lost to Follow-up|9|||
164659379|NCT01211769|594777744|FG000|Overall Study|Physician Decision|2|||
164659380|NCT01211769|594777745|FG001|Overall Study|Physician Decision|0|||
164659381|NCT01211769|594777746|FG002|Overall Study|Physician Decision|2|||
164659382|NCT01211769|594777747|FG003|Overall Study|Physician Decision|1|||
164659383|NCT01211769|594777744|FG000|Overall Study|Adverse Event|0|||
164659384|NCT01211769|594777745|FG001|Overall Study|Adverse Event|1|||
164659385|NCT01211769|594777746|FG002|Overall Study|Adverse Event|1|||
164659386|NCT01211769|594777747|FG003|Overall Study|Adverse Event|1|||
164659387|NCT01709383|594777752|FG000|Overall Study|Lost to Follow-up|1|||
164659388|NCT01709383|594777753|FG001|Overall Study|Lost to Follow-up|0|||
164659389|NCT01193517|594777754|FG000|Overall Study|Early Progression|1|||
164659390|NCT01193517|594777755|FG001|Overall Study|Early Progression|0|||
164659391|NCT01193517|594777756|FG002|Overall Study|Early Progression|0|||
164659392|NCT03558997|594777757|FG000|Overall Study|Adverse Event|0|||
164659393|NCT03558997|594777758|FG001|Overall Study|Adverse Event|2|||
164659394|NCT03558997|594777759|FG002|Overall Study|Adverse Event|5|||
164659395|NCT03558997|594777760|FG003|Overall Study|Adverse Event|1|||
164659396|NCT03558997|594777757|FG000|Overall Study|Physician Decision|0|||
164659397|NCT03558997|594777758|FG001|Overall Study|Physician Decision|0|||
164659398|NCT03558997|594777759|FG002|Overall Study|Physician Decision|1|||
164659399|NCT03558997|594777760|FG003|Overall Study|Physician Decision|0|||
164659400|NCT03558997|594777757|FG000|Overall Study|Withdrawal by Subject|1|||
164659401|NCT03558997|594777758|FG001|Overall Study|Withdrawal by Subject|0|||
164659402|NCT03558997|594777759|FG002|Overall Study|Withdrawal by Subject|1|||
164659403|NCT03558997|594777760|FG003|Overall Study|Withdrawal by Subject|1|||
164659404|NCT03558997|594777757|FG000|Overall Study|Lost to Follow-up|0|||
164659405|NCT03558997|594777758|FG001|Overall Study|Lost to Follow-up|0|||
164659406|NCT03558997|594777759|FG002|Overall Study|Lost to Follow-up|1|||
164659407|NCT03558997|594777760|FG003|Overall Study|Lost to Follow-up|0|||
164659408|NCT01673009|594778642|FG000|Overall Study|Physician Decision|5|||
164659409|NCT01673009|594778642|FG000|Overall Study|Withdrawal by Subject|8|||
164659410|NCT03093454|594778643|FG000|Overall Study|Withdrawal by Subject|1|||
164659411|NCT03093454|594778644|FG001|Overall Study|Withdrawal by Subject|1|||
164659412|NCT03093454|594778643|FG000|Overall Study|Scheduling conflict|3|||
164659413|NCT03093454|594778644|FG001|Overall Study|Scheduling conflict|1|||
164659414|NCT03093454|594778643|FG000|Overall Study|Physician Decision|2|||
164659415|NCT03093454|594778644|FG001|Overall Study|Physician Decision|1|||
164659416|NCT02524379|594778645|FG000|Overall Study|Death|1|||
164659417|NCT01884025|594778646|FG000|Overall Study|Lost to Follow-up|3|||
164659418|NCT01884025|594778647|FG001|Overall Study|Lost to Follow-up|4|||
164659419|NCT00755326|594778649|FG000|Overall Study|Lost to Follow-up|2|||
164659420|NCT00755326|594778650|FG001|Overall Study|Lost to Follow-up|3|||
164659421|NCT01338636|594778653|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
164659422|NCT02854436|594778654|FG000|Overall Study|Adverse Event|1|||
164659423|NCT02854436|594778654|FG000|Overall Study|Death|208|||
164659424|NCT02854436|594778654|FG000|Overall Study|Lost to Follow-up|5|||
164659425|NCT02854436|594778654|FG000|Overall Study|Withdrawal by Subject|24|||
164659426|NCT02854436|594778654|FG000|Overall Study|Other|45|||
164659427|NCT02854436|594778654|FG000|Overall Study|Physician Decision|6|||
164659428|NCT00662025|594778657|FG000|Overall Study|Objective progression or relapse|51|||
164659429|NCT00662025|594778657|FG000|Overall Study|Adverse Event|7|||
164659430|NCT00662025|594778657|FG000|Overall Study|Withdrawal by Subject|1|||
164659431|NCT00662025|594778657|FG000|Overall Study|Results of other clinical study|2|||
164659432|NCT00662025|594778657|FG000|Overall Study|Target lesion cannot be evaluated|1|||
164659433|NCT00662025|594778657|FG000|Overall Study|Domestic circumstances|1|||
164659434|NCT02985151|594778658|FG000|Original Randomization|Withdrawal by Subject|0|||
164659435|NCT02985151|594778659|FG001|Original Randomization|Withdrawal by Subject|1|||
164659436|NCT02843074|594778669|FG000|Overall Study|Withdrawal by Subject|5|||
164659437|NCT02843074|594778669|FG000|Overall Study|Progressive disease|1|||
164659438|NCT02843074|594778669|FG000|Overall Study|Physician Decision|1|||
164659439|NCT02843074|594778669|FG000|Overall Study|Lost to Follow-up|1|||
164659440|NCT02843074|594778669|FG000|Overall Study|Death|9|||
164659441|NCT01564758|594778670|FG000|Overall Study|Death|8|||
164659442|NCT01564758|594778670|FG000|Overall Study|Adverse Event|3|||
164310675|NCT01395524|593512903|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
164310676|NCT01395524|593512901|FG000|Overall Study|Withdrawal by Subject|4|||
164310677|NCT01395524|593512902|FG001|Overall Study|Withdrawal by Subject|8|||
164310678|NCT01395524|593512903|FG002|Overall Study|Withdrawal by Subject|8|||
164310679|NCT01395524|593512901|FG000|Overall Study|Did not receive treatment|1|||
164310680|NCT01395524|593512902|FG001|Overall Study|Did not receive treatment|1|||
164310681|NCT01395524|593512903|FG002|Overall Study|Did not receive treatment|3|||
164310682|NCT01395524|593512901|FG000|Overall Study|Subject had spinal surgery|0|||
164310683|NCT01395524|593512902|FG001|Overall Study|Subject had spinal surgery|0|||
164310684|NCT01395524|593512903|FG002|Overall Study|Subject had spinal surgery|1|||
164310685|NCT02175199|593512910|FG000|Overall Study|Withdrawal by Subject|1|||
164310686|NCT02175199|593512911|FG001|Overall Study|Withdrawal by Subject|5|||
164310687|NCT02175199|593512910|FG000|Overall Study|Randomized in Error|1|||
164310688|NCT02175199|593512911|FG001|Overall Study|Randomized in Error|0|||
164310689|NCT02175199|593512910|FG000|Overall Study|Sponsor Decision|1|||
164310690|NCT02175199|593512911|FG001|Overall Study|Sponsor Decision|0|||
164310691|NCT00122980|593512912|FG000|Overall Study|Death|0|||
164310692|NCT00122980|593512913|FG001|Overall Study|Death|1|||
164310693|NCT00122980|593512912|FG000|Overall Study|Physician Decision|2|||
164310694|NCT00122980|593512913|FG001|Overall Study|Physician Decision|0|||
164310695|NCT00122980|593512912|FG000|Overall Study|Protocol Violation|5|||
164310696|NCT00122980|593512913|FG001|Overall Study|Protocol Violation|1|||
164310697|NCT00122980|593512912|FG000|Overall Study|Withdrawal by Subject|2|||
164310698|NCT00122980|593512913|FG001|Overall Study|Withdrawal by Subject|3|||
164310699|NCT00122980|593512912|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
164310700|NCT00122980|593512913|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
164310701|NCT00122980|593512912|FG000|Overall Study|Study termination|27|||
164659443|NCT01564758|594778670|FG000|Overall Study|Other|3|||
164659444|NCT01186978|594778671|FG000|Overall Study|Withdrawal by Subject|1|||
164310702|NCT00122980|593512913|FG001|Overall Study|Study termination|35|||
164310703|NCT01124864|593512914|FG000|Overall Study|Follow up phase competed as per protocol|18|||
164310704|NCT01124864|593512915|FG001|Overall Study|Follow up phase competed as per protocol|22|||
164310705|NCT01124864|593512916|FG002|Overall Study|Follow up phase competed as per protocol|24|||
164310706|NCT01124864|593512917|FG003|Overall Study|Follow up phase competed as per protocol|18|||
164310707|NCT01124864|593512918|FG004|Overall Study|Follow up phase competed as per protocol|26|||
164310708|NCT01124864|593512919|FG005|Overall Study|Follow up phase competed as per protocol|2|||
164310709|NCT01124864|593512914|FG000|Overall Study|Death|6|||
164310710|NCT01124864|593512915|FG001|Overall Study|Death|9|||
164310711|NCT01124864|593512916|FG002|Overall Study|Death|6|||
164310712|NCT01124864|593512917|FG003|Overall Study|Death|2|||
164310713|NCT01124864|593512918|FG004|Overall Study|Death|1|||
164659445|NCT01227668|594778672|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
164659446|NCT01227668|594778673|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
164659447|NCT01227668|594778672|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
164659448|NCT01227668|594778673|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
164554418|NCT00326898|594400730|FG000|Overall Study|Death|2|||
164554419|NCT00326898|594400731|FG001|Overall Study|Death|0|||
164554420|NCT00326898|594400732|FG002|Overall Study|Death|0|||
164554421|NCT00326898|594400730|FG000|Overall Study|Withdrawal by Subject|134|||
164554422|NCT00326898|594400731|FG001|Overall Study|Withdrawal by Subject|128|||
164554423|NCT00326898|594400732|FG002|Overall Study|Withdrawal by Subject|32|||
164554424|NCT00326898|594400730|FG000|Overall Study|Alternative therapy|1|||
164554425|NCT00326898|594400731|FG001|Overall Study|Alternative therapy|0|||
164554426|NCT00326898|594400732|FG002|Overall Study|Alternative therapy|0|||
164554427|NCT00326898|594400730|FG000|Overall Study|Other complicating disease|5|||
164554428|NCT00326898|594400731|FG001|Overall Study|Other complicating disease|5|||
164554429|NCT00326898|594400732|FG002|Overall Study|Other complicating disease|4|||
164554430|NCT00326898|594400730|FG000|Overall Study|Other/Missing/Unknown|33|||
164554431|NCT00326898|594400731|FG001|Overall Study|Other/Missing/Unknown|28|||
164554432|NCT00326898|594400732|FG002|Overall Study|Other/Missing/Unknown|32|||
164554433|NCT03847987|594400733|FG000|Overall Study|Lost to Follow-up|1|||
164554434|NCT03847987|594400734|FG001|Overall Study|Lost to Follow-up|0|||
164554435|NCT03847987|594400733|FG000|Overall Study|Adverse Event|2|||
164554436|NCT03847987|594400734|FG001|Overall Study|Adverse Event|0|||
164554437|NCT02721355|594400737|FG000|Overall Study|Lost to Follow-up|6|||
164554438|NCT02721355|594400738|FG001|Overall Study|Lost to Follow-up|1|||
164554439|NCT00356278|594400739|FG000|Overall Study|Withdrawal by Subject|25|||
164554440|NCT00356278|594400740|FG001|Overall Study|Withdrawal by Subject|15|||
164554441|NCT00356278|594400741|FG002|Overall Study|Withdrawal by Subject|19|||
164554442|NCT01268293|594400749|FG000|Overall Study|Disease progression|7|||
164554443|NCT01268293|594400749|FG000|Overall Study|Adverse Event|1|||
164554444|NCT01268293|594400749|FG000|Overall Study|Subject choice|1|||
164554445|NCT02597855|594400750|FG000|Overall Study|Lost to Follow-up|2|||
164554446|NCT02597855|594400751|FG001|Overall Study|Lost to Follow-up|1|||
164554447|NCT00713700|594400756|FG000|Overall Study|Lost to Follow-up|3|||
164554448|NCT00713700|594400756|FG000|Overall Study|Withdrawal by Subject|1|||
164554449|NCT00781456|594400757|FG000|Overall Study|Adverse Event|3|||
164554450|NCT00781456|594400758|FG001|Overall Study|Adverse Event|3|||
164554451|NCT00781456|594400757|FG000|Overall Study|Withdrawal by Subject|3|||
164554452|NCT00781456|594400758|FG001|Overall Study|Withdrawal by Subject|5|||
164554453|NCT00781456|594400757|FG000|Overall Study|Protocol Violation|4|||
164554454|NCT00781456|594400758|FG001|Overall Study|Protocol Violation|1|||
164554455|NCT00781456|594400757|FG000|Overall Study|Noncompliance With Protocol|1|||
164554456|NCT00781456|594400758|FG001|Overall Study|Noncompliance With Protocol|1|||
164554457|NCT00781456|594400757|FG000|Overall Study|Lost to Follow-up|10|||
164554458|NCT00781456|594400758|FG001|Overall Study|Lost to Follow-up|5|||
164554459|NCT00781456|594400757|FG000|Overall Study|Other Reason, Unknown|0|||
164554460|NCT00781456|594400758|FG001|Overall Study|Other Reason, Unknown|1|||
164554461|NCT01777152|594400760|FG000|Overall Study|Withdrawal by Subject|22|||
164554462|NCT01777152|594400761|FG001|Overall Study|Withdrawal by Subject|16|||
164554463|NCT01777152|594400760|FG000|Overall Study|Lost to Follow-up|3|||
164554464|NCT01777152|594400761|FG001|Overall Study|Lost to Follow-up|5|||
164554465|NCT01777152|594400760|FG000|Overall Study|Death|68|||
164554466|NCT01777152|594400761|FG001|Overall Study|Death|89|||
164554467|NCT01777152|594400760|FG000|Overall Study|Not eligible, no study drug received|1|||
164554468|NCT01777152|594400761|FG001|Overall Study|Not eligible, no study drug received|0|||
164554469|NCT01777152|594400760|FG000|Overall Study|Change of diagnosis|1|||
164554470|NCT01777152|594400761|FG001|Overall Study|Change of diagnosis|0|||
164201841|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
164201842|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
164201843|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
164201844|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
164201845|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
164201846|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
164201847|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
164201848|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
164201849|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
164201850|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
164201851|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
164554471|NCT03548558|594400762|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
164554472|NCT03548558|594400763|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
164554473|NCT03548558|594400764|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
164554474|NCT03548558|594400765|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
164554475|NCT03548558|594400766|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
164554476|NCT03548558|594400767|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
164554477|NCT03548558|594400768|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
164554478|NCT03548558|594400762|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
164554479|NCT03548558|594400763|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
164554480|NCT03548558|594400764|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
164310714|NCT01124864|593512919|FG005|Overall Study|Death|0|||
164310715|NCT01124864|593512914|FG000|Overall Study|Withdrawal by Subject|2|||
164310716|NCT01124864|593512915|FG001|Overall Study|Withdrawal by Subject|3|||
164310717|NCT01124864|593512916|FG002|Overall Study|Withdrawal by Subject|4|||
164310718|NCT01124864|593512917|FG003|Overall Study|Withdrawal by Subject|0|||
164310719|NCT01124864|593512918|FG004|Overall Study|Withdrawal by Subject|2|||
164310720|NCT01124864|593512919|FG005|Overall Study|Withdrawal by Subject|1|||
164310721|NCT01124864|593512914|FG000|Overall Study|Lost to Follow-up|1|||
164310722|NCT01124864|593512915|FG001|Overall Study|Lost to Follow-up|1|||
164310723|NCT01124864|593512916|FG002|Overall Study|Lost to Follow-up|0|||
164310724|NCT01124864|593512917|FG003|Overall Study|Lost to Follow-up|1|||
164310725|NCT01124864|593512918|FG004|Overall Study|Lost to Follow-up|0|||
164310726|NCT01124864|593512919|FG005|Overall Study|Lost to Follow-up|0|||
164310727|NCT01124864|593512914|FG000|Overall Study|Protocol Violation|1|||
164310728|NCT01124864|593512915|FG001|Overall Study|Protocol Violation|0|||
164310729|NCT01124864|593512916|FG002|Overall Study|Protocol Violation|0|||
164310730|NCT01124864|593512917|FG003|Overall Study|Protocol Violation|0|||
164310731|NCT01124864|593512918|FG004|Overall Study|Protocol Violation|1|||
164310732|NCT01124864|593512919|FG005|Overall Study|Protocol Violation|0|||
164310733|NCT00798759|593512922|FG000|Overall Study|Adverse Event|3|||
164310734|NCT00798759|593512923|FG001|Overall Study|Adverse Event|3|||
164310735|NCT00798759|593512922|FG000|Overall Study|Lost to Follow-up|1|||
164310736|NCT00798759|593512923|FG001|Overall Study|Lost to Follow-up|1|||
164310737|NCT00798759|593512922|FG000|Overall Study|Protocol Violation|4|||
164310738|NCT00798759|593512923|FG001|Overall Study|Protocol Violation|8|||
164310739|NCT00798759|593512922|FG000|Overall Study|Other|0|||
164310740|NCT00798759|593512923|FG001|Overall Study|Other|1|||
164310741|NCT00724711|593512924|FG000|Overall Study|Adverse Event|7|||
164310742|NCT00724711|593512925|FG001|Overall Study|Adverse Event|3|||
164310743|NCT00724711|593512924|FG000|Overall Study|Pregnancy|0|||
164310744|NCT00724711|593512925|FG001|Overall Study|Pregnancy|1|||
164310745|NCT00724711|593512924|FG000|Overall Study|Lack of Efficacy|0|||
164310746|NCT00724711|593512925|FG001|Overall Study|Lack of Efficacy|1|||
164310747|NCT00724711|593512924|FG000|Overall Study|Physician Decision|0|||
164310748|NCT00724711|593512925|FG001|Overall Study|Physician Decision|3|||
164554481|NCT03548558|594400765|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
164554482|NCT03548558|594400766|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
164554483|NCT03548558|594400767|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
164554484|NCT03548558|594400768|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
164554485|NCT03548558|594400762|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
164554486|NCT03548558|594400763|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
164554487|NCT03548558|594400764|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
164554488|NCT03548558|594400765|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
164554489|NCT03548558|594400766|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
164554490|NCT03548558|594400767|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
164554491|NCT03548558|594400768|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
164554492|NCT03548558|594400762|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
164554493|NCT03548558|594400763|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
164554494|NCT03548558|594400764|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
164554495|NCT03548558|594400765|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
164554496|NCT03548558|594400766|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
164554497|NCT03548558|594400767|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
164554498|NCT03548558|594400768|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
164554499|NCT03548558|594400762|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
164554500|NCT03548558|594400763|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
164554501|NCT03548558|594400764|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
164554502|NCT03548558|594400765|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
164554503|NCT03548558|594400766|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
164554504|NCT03548558|594400767|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
164554505|NCT03548558|594400768|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
164554506|NCT03548558|594400762|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
164554507|NCT03548558|594400763|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
164554508|NCT03548558|594400764|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
164554509|NCT03548558|594400765|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
164554510|NCT03548558|594400766|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
164554511|NCT03548558|594400767|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
164310749|NCT00724711|593512924|FG000|Overall Study|Withdrawal by Subject|5|||
164310750|NCT00724711|593512925|FG001|Overall Study|Withdrawal by Subject|4|||
164310751|NCT00724711|593512924|FG000|Overall Study|Lost to Follow-up|4|||
164310752|NCT00724711|593512925|FG001|Overall Study|Lost to Follow-up|5|||
164310753|NCT00724711|593512924|FG000|Overall Study|Protocol Violation|1|||
164310754|NCT00724711|593512925|FG001|Overall Study|Protocol Violation|0|||
164659449|NCT01227668|594778672|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
164659450|NCT01227668|594778673|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
164659451|NCT01227668|594778672|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
164659452|NCT01227668|594778673|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
164659453|NCT01227668|594778672|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
164659454|NCT01227668|594778673|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
164659455|NCT01227668|594778672|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
164659456|NCT01227668|594778673|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
164659457|NCT01227668|594778672|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
164659458|NCT01227668|594778673|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
164659459|NCT01227668|594778672|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
164659460|NCT01227668|594778673|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
164659461|NCT01227668|594778672|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
164659462|NCT01227668|594778673|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
164659463|NCT01227668|594778672|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
164659464|NCT01227668|594778673|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
164659465|NCT01227668|594778672|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
164659466|NCT01227668|594778673|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
164659467|NCT01227668|594778672|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
164659468|NCT01227668|594778673|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
164659469|NCT04317599|594778674|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
164659470|NCT04317599|594778674|FG000|Overall Study|treatment outside standard of care|4|||
164659471|NCT02115256|594778684|FG000|Overall Study|Withdrawal by Subject|0|||
164659472|NCT02115256|594778685|FG001|Overall Study|Withdrawal by Subject|1|||
164659473|NCT02427607|594778688|FG000|Overall Study|Withdrawal by Subject|1|||
164659474|NCT03211416|594778689|FG000|Overall Study|Adverse Event|7|||
164659475|NCT03211416|594778689|FG000|Overall Study|Lack of Efficacy|2|||
164659476|NCT03211416|594778689|FG000|Overall Study|Physician Decision|1|||
164659477|NCT01789320|594778690|FG000|Overall Study|Re-enrolled into study|1|||
164659478|NCT01789320|594778690|FG000|Overall Study|Lost to Follow-up|1|||
164659479|NCT03199274|594778693|FG000|Overall Study|Withdrawal by Subject|4|||
164659480|NCT03199274|594778694|FG001|Overall Study|Withdrawal by Subject|0|||
164659481|NCT03199274|594778693|FG000|Overall Study|Lost to Follow-up|0|||
164659482|NCT03199274|594778694|FG001|Overall Study|Lost to Follow-up|1|||
164659483|NCT03199274|594778693|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
164659484|NCT03199274|594778694|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
164659485|NCT01688037|594778707|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
164659486|NCT01688037|594778708|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
164659487|NCT01688037|594778709|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
164659488|NCT01688037|594778707|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
164659489|NCT01688037|594778708|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
164659490|NCT01688037|594778709|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
164659491|NCT01688037|594778707|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
164659492|NCT01688037|594778708|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
164659493|NCT01688037|594778709|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
164659494|NCT01688037|594778707|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
164659495|NCT01688037|594778708|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
164659496|NCT01688037|594778709|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
164659497|NCT01688037|594778707|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
164659498|NCT01688037|594778708|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
164659499|NCT01688037|594778709|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
164659500|NCT01688037|594778707|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
164659501|NCT01688037|594778708|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
164659502|NCT01688037|594778709|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
164659503|NCT01688037|594778707|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
164659504|NCT01688037|594778708|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
164659505|NCT01688037|594778709|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
164659506|NCT01688037|594778707|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
164659507|NCT01688037|594778708|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
164659508|NCT01688037|594778709|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
164659509|NCT01688037|594778707|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
164659510|NCT01688037|594778708|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
164659511|NCT01688037|594778709|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
164659512|NCT01688037|594778707|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
164659513|NCT01688037|594778708|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
164659514|NCT01688037|594778709|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
164659515|NCT04071769|594778710|FG000|Overall Study|Lost to Follow-up|3|||
164659516|NCT04071769|594778710|FG000|Overall Study|Physician Decision|2|||
164659517|NCT04071769|594778710|FG000|Overall Study|Withdrawal by Subject|8|||
164659518|NCT00385541|594778713|FG000|Overall Study|severe pain, clinician requested unblind|0|||
164659519|NCT00385541|594778714|FG001|Overall Study|severe pain, clinician requested unblind|1|||
164659520|NCT00929708|594778715|FG000|Overall Study|Protocol Violation|2|||
164659521|NCT00929708|594778716|FG001|Overall Study|Protocol Violation|1|||
164659522|NCT00929708|594778717|FG002|Overall Study|Protocol Violation|1|||
164659523|NCT00929708|594778718|FG003|Overall Study|Protocol Violation|1|||
164659524|NCT00929708|594778719|FG004|Overall Study|Protocol Violation|1|||
164659525|NCT00929708|594778715|FG000|Overall Study|Withdrawal by Subject|2|||
164659526|NCT00929708|594778716|FG001|Overall Study|Withdrawal by Subject|0|||
164659527|NCT00929708|594778717|FG002|Overall Study|Withdrawal by Subject|0|||
164659528|NCT00929708|594778718|FG003|Overall Study|Withdrawal by Subject|2|||
164659529|NCT00929708|594778719|FG004|Overall Study|Withdrawal by Subject|1|||
164659530|NCT00929708|594778715|FG000|Overall Study|Adverse Event|0|||
164659531|NCT00929708|594778716|FG001|Overall Study|Adverse Event|0|||
164659532|NCT00929708|594778717|FG002|Overall Study|Adverse Event|0|||
164659533|NCT00929708|594778718|FG003|Overall Study|Adverse Event|0|||
164659534|NCT00929708|594778719|FG004|Overall Study|Adverse Event|3|||
164659535|NCT00929708|594778715|FG000|Overall Study|Physician Decision|0|||
164659536|NCT00929708|594778716|FG001|Overall Study|Physician Decision|2|||
164659537|NCT00929708|594778717|FG002|Overall Study|Physician Decision|2|||
164659538|NCT00929708|594778718|FG003|Overall Study|Physician Decision|2|||
164659539|NCT00929708|594778719|FG004|Overall Study|Physician Decision|1|||
164659540|NCT00929708|594778715|FG000|Overall Study|Lost to Follow-up|0|||
164659541|NCT00929708|594778716|FG001|Overall Study|Lost to Follow-up|0|||
164659542|NCT00929708|594778717|FG002|Overall Study|Lost to Follow-up|0|||
164659543|NCT00929708|594778718|FG003|Overall Study|Lost to Follow-up|1|||
164659544|NCT00929708|594778719|FG004|Overall Study|Lost to Follow-up|0|||
164659545|NCT02154529|594778720|FG000|Overall Study|Death|1|||
164659546|NCT02154529|594778721|FG001|Overall Study|Death|1|||
164659547|NCT02154529|594778722|FG002|Overall Study|Death|5|||
164659548|NCT02154529|594778723|FG003|Overall Study|Death|1|||
164659549|NCT02154529|594778720|FG000|Overall Study|Termination of study by sponsor|2|||
164659550|NCT02154529|594778721|FG001|Overall Study|Termination of study by sponsor|2|||
164659551|NCT02154529|594778722|FG002|Overall Study|Termination of study by sponsor|3|||
164659552|NCT02154529|594778723|FG003|Overall Study|Termination of study by sponsor|1|||
164659553|NCT02154529|594778720|FG000|Overall Study|Lost to Follow-up|1|||
164659554|NCT02154529|594778721|FG001|Overall Study|Lost to Follow-up|0|||
164659555|NCT02154529|594778722|FG002|Overall Study|Lost to Follow-up|0|||
164659556|NCT02154529|594778723|FG003|Overall Study|Lost to Follow-up|0|||
164659557|NCT05440097|594780313|FG000|Overall Study|Withdrawal by Subject|154|||
164659558|NCT05440097|594780313|FG000|Overall Study|Death|2|||
164659559|NCT05440097|594780313|FG000|Overall Study|Physician Decision|2|||
164201852|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
164201853|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
164201854|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
164201855|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
164201856|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
164201857|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
164201858|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
164201859|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
164201860|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
164201861|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
164201862|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
164201863|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
164201864|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
164201865|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
164201866|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
164201867|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
164201868|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
164201869|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
164201870|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
164659560|NCT05440097|594780313|FG000|Overall Study|Lost to Follow-up|56|||
164659561|NCT05440097|594780313|FG000|Overall Study|"Include enrolled by mistake and withdrawed by mistake."|15|||
164659562|NCT02081599|594780314|FG000|Period 1：Double-blind Period|Adverse Event|3|||
164659563|NCT02081599|594780315|FG001|Period 1：Double-blind Period|Adverse Event|0|||
164659564|NCT02081599|594780314|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
164659565|NCT02081599|594780315|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
164659566|NCT02081599|594780314|FG000|Period 1：Double-blind Period|Physician Decision|1|||
164659567|NCT02081599|594780315|FG001|Period 1：Double-blind Period|Physician Decision|0|||
164659568|NCT02081599|594780314|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
164659569|NCT02081599|594780315|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
164659570|NCT02081599|594780314|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
164310755|NCT03387111|593512926|FG000|Overall Study|Progressive Disease|3|||
164310756|NCT03387111|593512926|FG000|Overall Study|Other|1|||
164310757|NCT01239992|593512927|FG000|Overall Study|Withdrawal by Subject|2|||
164310758|NCT00535288|593512928|FG000|Overall Study|Adverse Event|20|||
164310759|NCT00535288|593512929|FG001|Overall Study|Adverse Event|19|||
164310760|NCT00535288|593512930|FG002|Overall Study|Adverse Event|25|||
164554512|NCT03548558|594400768|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
164554513|NCT03446885|594400771|FG000|Overall Study|Lost to Follow-up|1|||
164554514|NCT03446885|594400772|FG001|Overall Study|Lost to Follow-up|0|||
164554515|NCT03446885|594400771|FG000|Overall Study|Did not complete entire visit|1|||
164554516|NCT03446885|594400772|FG001|Overall Study|Did not complete entire visit|0|||
164554517|NCT01709149|594400780|FG000|Open-label Lead-in Phase|Adverse Event|109|||
164554518|NCT01709149|594400781|FG001|Open-label Lead-in Phase|Adverse Event|0|||
164554519|NCT01709149|594400782|FG002|Open-label Lead-in Phase|Adverse Event|0|||
164554520|NCT01709149|594400780|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
164554521|NCT01709149|594400781|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
164554522|NCT01709149|594400782|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
164554523|NCT01709149|594400780|FG000|Open-label Lead-in Phase|Death|1|||
164554524|NCT01709149|594400781|FG001|Open-label Lead-in Phase|Death|0|||
164554525|NCT01709149|594400782|FG002|Open-label Lead-in Phase|Death|0|||
164554526|NCT01709149|594400780|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
164554527|NCT01709149|594400781|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
164554528|NCT01709149|594400782|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
164554529|NCT01709149|594400780|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
164554530|NCT01709149|594400781|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
164554531|NCT01709149|594400782|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
164554532|NCT01709149|594400780|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
164554533|NCT01709149|594400781|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
164554534|NCT01709149|594400782|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
164554535|NCT01709149|594400780|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
164554536|NCT01709149|594400781|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
164554537|NCT01709149|594400782|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
164554538|NCT01709149|594400780|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
164554539|NCT01709149|594400781|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
164554540|NCT01709149|594400782|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
164554541|NCT01709149|594400780|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
164554542|NCT01709149|594400781|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
164554543|NCT01709149|594400782|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
164554544|NCT01709149|594400780|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
164554545|NCT01709149|594400781|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
164554546|NCT01709149|594400782|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
164554547|NCT03509350|594400783|FG000|Overall Study|Withdrawal by Subject|0|||
164554548|NCT03509350|594400784|FG001|Overall Study|Withdrawal by Subject|2|||
164554549|NCT00763815|594400785|FG000|Overall Study|Adverse Event|14|||
164554550|NCT00763815|594400786|FG001|Overall Study|Adverse Event|29|||
164554551|NCT00763815|594400785|FG000|Overall Study|Lack of Efficacy|10|||
164554552|NCT00763815|594400786|FG001|Overall Study|Lack of Efficacy|11|||
164554553|NCT00763815|594400785|FG000|Overall Study|Poor Compliance to Protocol|6|||
164554554|NCT00763815|594400786|FG001|Overall Study|Poor Compliance to Protocol|6|||
164554555|NCT00763815|594400785|FG000|Overall Study|Lost to Follow-up|2|||
164554556|NCT00763815|594400786|FG001|Overall Study|Lost to Follow-up|4|||
164554557|NCT00763815|594400785|FG000|Overall Study|Early Termination|1|||
164554558|NCT00763815|594400786|FG001|Overall Study|Early Termination|0|||
164554559|NCT00763815|594400785|FG000|Overall Study|Familial and Personal Reasons|9|||
164554560|NCT00763815|594400786|FG001|Overall Study|Familial and Personal Reasons|16|||
164554561|NCT00763815|594400785|FG000|Overall Study|Physician Decision|1|||
164554562|NCT00763815|594400786|FG001|Overall Study|Physician Decision|0|||
164554563|NCT00763815|594400785|FG000|Overall Study|Withdrawal by Subject|7|||
164554564|NCT00763815|594400786|FG001|Overall Study|Withdrawal by Subject|12|||
164554565|NCT00763815|594400785|FG000|Overall Study|Protocol Violation|2|||
164554566|NCT00763815|594400786|FG001|Overall Study|Protocol Violation|5|||
164554567|NCT00763815|594400785|FG000|Overall Study|Sponsor's Decision|0|||
164554568|NCT00763815|594400786|FG001|Overall Study|Sponsor's Decision|1|||
164554569|NCT02559687|594400787|FG000|Overall Study|Death|112|||
164554570|NCT02559687|594400787|FG000|Overall Study|Sponsor Decision|5|||
164554571|NCT02559687|594400787|FG000|Overall Study|Withdrawal by Subject|4|||
164554572|NCT04951037|594400788|FG000|Overall Study|Lost to Follow-up|16|||
164554573|NCT04951037|594400788|FG000|Overall Study|Withdrawal by Subject|5|||
164554574|NCT04951037|594400788|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
164310761|NCT00535288|593512931|FG003|Overall Study|Adverse Event|20|||
164310762|NCT00535288|593512932|FG004|Overall Study|Adverse Event|30|||
164310763|NCT00535288|593512928|FG000|Overall Study|Lost to Follow-up|0|||
164310764|NCT00535288|593512929|FG001|Overall Study|Lost to Follow-up|3|||
164554575|NCT05630937|594400789|FG000|Overall Study|Study terminated by sponsor|1|||
164554576|NCT05630937|594400790|FG001|Overall Study|Study terminated by sponsor|1|||
164554577|NCT05630937|594400791|FG002|Overall Study|Study terminated by sponsor|8|||
164554578|NCT05630937|594400792|FG003|Overall Study|Study terminated by sponsor|0|||
164554579|NCT05630937|594400789|FG000|Overall Study|Lost to Follow-up|0|||
164554580|NCT05630937|594400790|FG001|Overall Study|Lost to Follow-up|0|||
164554581|NCT05630937|594400791|FG002|Overall Study|Lost to Follow-up|1|||
164554582|NCT05630937|594400792|FG003|Overall Study|Lost to Follow-up|0|||
164554583|NCT05630937|594400789|FG000|Overall Study|Enrolled but not treated|0|||
164554584|NCT05630937|594400790|FG001|Overall Study|Enrolled but not treated|0|||
164554585|NCT05630937|594400791|FG002|Overall Study|Enrolled but not treated|0|||
164554586|NCT05630937|594400792|FG003|Overall Study|Enrolled but not treated|1|||
164554587|NCT03245450|594400793|FG000|Overall Study|Radiological disease progression|3|||
164554588|NCT03245450|594400794|FG001|Overall Study|Radiological disease progression|3|||
164554589|NCT03245450|594400795|FG002|Overall Study|Radiological disease progression|2|||
164554590|NCT03245450|594400796|FG003|Overall Study|Radiological disease progression|2|||
164554591|NCT03245450|594400797|FG004|Overall Study|Radiological disease progression|7|||
164554592|NCT03245450|594400798|FG005|Overall Study|Radiological disease progression|6|||
164554593|NCT03245450|594400799|FG006|Overall Study|Radiological disease progression|6|||
164554594|NCT03245450|594400793|FG000|Overall Study|Clinical disease progression|0|||
164554595|NCT03245450|594400794|FG001|Overall Study|Clinical disease progression|0|||
164554596|NCT03245450|594400795|FG002|Overall Study|Clinical disease progression|1|||
164554597|NCT03245450|594400796|FG003|Overall Study|Clinical disease progression|0|||
164554598|NCT03245450|594400797|FG004|Overall Study|Clinical disease progression|0|||
164554599|NCT03245450|594400798|FG005|Overall Study|Clinical disease progression|2|||
164554600|NCT03245450|594400799|FG006|Overall Study|Clinical disease progression|0|||
164554601|NCT03245450|594400793|FG000|Overall Study|Other|0|||
164554602|NCT03245450|594400794|FG001|Overall Study|Other|0|||
164554603|NCT03245450|594400795|FG002|Overall Study|Other|0|||
164554604|NCT03245450|594400796|FG003|Overall Study|Other|1|||
164554605|NCT03245450|594400797|FG004|Overall Study|Other|1|||
164554606|NCT03245450|594400798|FG005|Overall Study|Other|1|||
164554607|NCT03245450|594400799|FG006|Overall Study|Other|1|||
164554608|NCT03245450|594400793|FG000|Overall Study|Withdrawal by Subject|0|||
164554609|NCT03245450|594400794|FG001|Overall Study|Withdrawal by Subject|1|||
164554610|NCT03245450|594400795|FG002|Overall Study|Withdrawal by Subject|0|||
164554611|NCT03245450|594400796|FG003|Overall Study|Withdrawal by Subject|0|||
164554612|NCT03245450|594400797|FG004|Overall Study|Withdrawal by Subject|0|||
164554613|NCT03245450|594400798|FG005|Overall Study|Withdrawal by Subject|0|||
164554614|NCT03245450|594400799|FG006|Overall Study|Withdrawal by Subject|0|||
164554615|NCT03245450|594400793|FG000|Overall Study|Adverse Event|0|||
164554616|NCT03245450|594400794|FG001|Overall Study|Adverse Event|0|||
164554617|NCT03245450|594400795|FG002|Overall Study|Adverse Event|0|||
164554618|NCT03245450|594400796|FG003|Overall Study|Adverse Event|0|||
164554619|NCT03245450|594400797|FG004|Overall Study|Adverse Event|1|||
164554620|NCT03245450|594400798|FG005|Overall Study|Adverse Event|0|||
164554621|NCT03245450|594400799|FG006|Overall Study|Adverse Event|2|||
164554622|NCT02429414|594400800|FG000|Overall Study|Physician Decision|0|||
164554623|NCT02429414|594400801|FG001|Overall Study|Physician Decision|1|||
164554624|NCT01604265|594400814|FG000|Overall Study|Adverse Event|1|||
164554625|NCT01604265|594400815|FG001|Overall Study|Adverse Event|0|||
164554626|NCT01604265|594400814|FG000|Overall Study|Withdrawal by Subject|1|||
164554627|NCT01604265|594400815|FG001|Overall Study|Withdrawal by Subject|0|||
164554628|NCT01903837|594400818|FG000|Part A|Withdrawal by Subject|4|||
164554629|NCT01903837|594400819|FG001|Part A|Withdrawal by Subject|9|||
164554630|NCT01903837|594400820|FG002|Part A|Withdrawal by Subject|8|||
164554631|NCT01903837|594400821|FG003|Part A|Withdrawal by Subject|5|||
164554632|NCT01903837|594400818|FG000|Part A|Adverse Event|3|||
164554633|NCT01903837|594400819|FG001|Part A|Adverse Event|6|||
164554634|NCT01903837|594400820|FG002|Part A|Adverse Event|9|||
164554635|NCT01903837|594400821|FG003|Part A|Adverse Event|6|||
164554636|NCT01903837|594400818|FG000|Part A|Lost to Follow-up|9|||
164554637|NCT01903837|594400819|FG001|Part A|Lost to Follow-up|7|||
164554638|NCT01903837|594400820|FG002|Part A|Lost to Follow-up|7|||
164554639|NCT01903837|594400821|FG003|Part A|Lost to Follow-up|2|||
164554640|NCT01903837|594400818|FG000|Part A|Non-compliance with study drug|1|||
164554641|NCT01903837|594400819|FG001|Part A|Non-compliance with study drug|4|||
164554642|NCT01903837|594400820|FG002|Part A|Non-compliance with study drug|4|||
164554643|NCT01903837|594400821|FG003|Part A|Non-compliance with study drug|0|||
164554644|NCT01903837|594400818|FG000|Part A|Physician Decision|1|||
164554645|NCT01903837|594400819|FG001|Part A|Physician Decision|1|||
164554646|NCT01903837|594400820|FG002|Part A|Physician Decision|0|||
164554647|NCT01903837|594400821|FG003|Part A|Physician Decision|0|||
164554648|NCT01903837|594400818|FG000|Part A|Protocol Violation|1|||
164554649|NCT01903837|594400819|FG001|Part A|Protocol Violation|1|||
164554650|NCT01903837|594400820|FG002|Part A|Protocol Violation|0|||
164554651|NCT01903837|594400821|FG003|Part A|Protocol Violation|0|||
164554652|NCT01903837|594400818|FG000|Part B|Lost to Follow-up|0|||
164554653|NCT01903837|594400819|FG001|Part B|Lost to Follow-up|3|||
164659571|NCT02081599|594780315|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
164659572|NCT02081599|594780314|FG000|Period 1：Double-blind Period|stopping criteria|1|||
164659573|NCT02081599|594780315|FG001|Period 1：Double-blind Period|stopping criteria|0|||
164659574|NCT02081599|594780314|FG000|Period 2：Open-label Period|Adverse Event|1|||
164659575|NCT02081599|594780315|FG001|Period 2：Open-label Period|Adverse Event|0|||
164659576|NCT02081599|594780314|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
164659577|NCT02081599|594780315|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
164659578|NCT02081599|594780314|FG000|Period 2：Open-label Period|Physician Decision|1|||
164659579|NCT02081599|594780315|FG001|Period 2：Open-label Period|Physician Decision|0|||
164659580|NCT02081599|594780314|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
164659581|NCT02081599|594780315|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
164659582|NCT02146430|594780324|FG000|Overall Study|Protocol Violation|5|||
164659583|NCT02146430|594780325|FG001|Overall Study|Protocol Violation|4|||
164659584|NCT02146430|594780326|FG002|Overall Study|Protocol Violation|8|||
164659585|NCT02146430|594780327|FG003|Overall Study|Protocol Violation|6|||
164659586|NCT02146430|594780324|FG000|Overall Study|Lack of Efficacy|13|||
164659587|NCT02146430|594780325|FG001|Overall Study|Lack of Efficacy|11|||
164659588|NCT02146430|594780326|FG002|Overall Study|Lack of Efficacy|8|||
164659589|NCT02146430|594780327|FG003|Overall Study|Lack of Efficacy|5|||
164659590|NCT02146430|594780324|FG000|Overall Study|Adverse Event|20|||
164659591|NCT02146430|594780325|FG001|Overall Study|Adverse Event|40|||
164659592|NCT02146430|594780326|FG002|Overall Study|Adverse Event|32|||
164659593|NCT02146430|594780327|FG003|Overall Study|Adverse Event|49|||
164659594|NCT02146430|594780324|FG000|Overall Study|Reason missing or not reported|2|||
164659595|NCT02146430|594780325|FG001|Overall Study|Reason missing or not reported|3|||
164659596|NCT02146430|594780326|FG002|Overall Study|Reason missing or not reported|4|||
164659597|NCT02146430|594780327|FG003|Overall Study|Reason missing or not reported|5|||
164659598|NCT02146430|594780324|FG000|Overall Study|Withdrawal by Subject|27|||
164659599|NCT02146430|594780325|FG001|Overall Study|Withdrawal by Subject|29|||
164659600|NCT02146430|594780326|FG002|Overall Study|Withdrawal by Subject|30|||
164659601|NCT02146430|594780327|FG003|Overall Study|Withdrawal by Subject|34|||
164659602|NCT03093324|594780328|FG000|Overall Study|Adverse Event|4|||
164659603|NCT03093324|594780329|FG001|Overall Study|Adverse Event|15|||
164659604|NCT03093324|594780328|FG000|Overall Study|Lost to Follow-up|1|||
164659605|NCT03093324|594780329|FG001|Overall Study|Lost to Follow-up|0|||
164659606|NCT03093324|594780328|FG000|Overall Study|Protocol Deviation|2|||
164659607|NCT03093324|594780329|FG001|Overall Study|Protocol Deviation|2|||
164659608|NCT03093324|594780328|FG000|Overall Study|Withdrawal by Subject|2|||
164659609|NCT03093324|594780329|FG001|Overall Study|Withdrawal by Subject|2|||
164659610|NCT01767597|594780330|FG000|Overall Study|Incomplete intervention|3|||
164659611|NCT01767597|594780331|FG001|Overall Study|Incomplete intervention|1|||
164659612|NCT01767597|594780330|FG000|Overall Study|Withdrawal by Subject|1|||
164659613|NCT01767597|594780331|FG001|Overall Study|Withdrawal by Subject|0|||
164310765|NCT00535288|593512930|FG002|Overall Study|Lost to Follow-up|0|||
164310766|NCT00535288|593512931|FG003|Overall Study|Lost to Follow-up|0|||
164310767|NCT00535288|593512932|FG004|Overall Study|Lost to Follow-up|0|||
164310768|NCT00535288|593512928|FG000|Overall Study|Lack of Efficacy|26|||
164310769|NCT00535288|593512929|FG001|Overall Study|Lack of Efficacy|3|||
164310770|NCT00535288|593512930|FG002|Overall Study|Lack of Efficacy|4|||
164310771|NCT00535288|593512931|FG003|Overall Study|Lack of Efficacy|4|||
164310772|NCT00535288|593512932|FG004|Overall Study|Lack of Efficacy|7|||
164310773|NCT00535288|593512928|FG000|Overall Study|Unwilling to cooperate|6|||
164310774|NCT00535288|593512929|FG001|Overall Study|Unwilling to cooperate|6|||
164310775|NCT00535288|593512930|FG002|Overall Study|Unwilling to cooperate|3|||
164310776|NCT00535288|593512931|FG003|Overall Study|Unwilling to cooperate|3|||
164310777|NCT00535288|593512932|FG004|Overall Study|Unwilling to cooperate|4|||
164310778|NCT00535288|593512928|FG000|Overall Study|Other|2|||
164310779|NCT00535288|593512929|FG001|Overall Study|Other|1|||
164310780|NCT00535288|593512930|FG002|Overall Study|Other|1|||
164310781|NCT00535288|593512931|FG003|Overall Study|Other|2|||
164310782|NCT00535288|593512932|FG004|Overall Study|Other|1|||
164310783|NCT02810444|593512933|FG000|Overall Study|Screen Failures|14|||
164310784|NCT02810444|593512933|FG000|Overall Study|Withdrawal by Subject|4|||
164310785|NCT02810444|593512933|FG000|Overall Study|Adverse Event|3|||
164310786|NCT03390101|593512934|FG000|Weeks 0-12|Withdrawal by Subject|0|||
164310787|NCT03390101|593512935|FG001|Weeks 0-12|Withdrawal by Subject|1|||
164659614|NCT05342753|594780332|FG000|Overall Study|Withdrawal by Subject|6|||
164659615|NCT05342753|594780332|FG000|Overall Study|Lost to Follow-up|1|||
164659616|NCT00836927|594780333|FG000|Overall Study|Progressive disease|2|||
164659617|NCT00836927|594780334|FG001|Overall Study|Progressive disease|0|||
164659618|NCT00836927|594780335|FG002|Overall Study|Progressive disease|0|||
164310788|NCT03390101|593512936|FG002|Weeks 0-12|Withdrawal by Subject|1|||
164310789|NCT03390101|593512934|FG000|Weeks 0-12|Lost to Follow-up|0|||
164310790|NCT03390101|593512935|FG001|Weeks 0-12|Lost to Follow-up|1|||
164310791|NCT03390101|593512936|FG002|Weeks 0-12|Lost to Follow-up|0|||
164310792|NCT03390101|593512934|FG000|Weeks 12-54|Withdrawal by Subject|0|||
164310793|NCT03390101|593512935|FG001|Weeks 12-54|Withdrawal by Subject|3|||
164310794|NCT03390101|593512936|FG002|Weeks 12-54|Withdrawal by Subject|1|||
164310795|NCT03390101|593512934|FG000|Weeks 12-54|Pregnancy|1|||
164310796|NCT03390101|593512935|FG001|Weeks 12-54|Pregnancy|0|||
164310797|NCT03390101|593512936|FG002|Weeks 12-54|Pregnancy|0|||
164659619|NCT00836927|594780336|FG003|Overall Study|Progressive disease|1|||
164554654|NCT01903837|594400820|FG002|Part B|Lost to Follow-up|3|||
164554655|NCT01903837|594400821|FG003|Part B|Lost to Follow-up|4|||
164554656|NCT01903837|594400818|FG000|Part B|Withdrawal by Subject|1|||
164554657|NCT01903837|594400819|FG001|Part B|Withdrawal by Subject|2|||
164554658|NCT01903837|594400820|FG002|Part B|Withdrawal by Subject|0|||
164554659|NCT01903837|594400821|FG003|Part B|Withdrawal by Subject|3|||
164554660|NCT01903837|594400818|FG000|Part B|Adverse Event|3|||
164554661|NCT01903837|594400819|FG001|Part B|Adverse Event|0|||
164554662|NCT01903837|594400820|FG002|Part B|Adverse Event|2|||
164554663|NCT01903837|594400821|FG003|Part B|Adverse Event|0|||
164554664|NCT01903837|594400818|FG000|Part B|Non-compliance with study drug|2|||
164554665|NCT01903837|594400819|FG001|Part B|Non-compliance with study drug|0|||
164554666|NCT01903837|594400820|FG002|Part B|Non-compliance with study drug|0|||
164554667|NCT01903837|594400821|FG003|Part B|Non-compliance with study drug|1|||
164554668|NCT01903837|594400818|FG000|Part B|Incarceration|2|||
164554669|NCT01903837|594400819|FG001|Part B|Incarceration|0|||
164554670|NCT01903837|594400820|FG002|Part B|Incarceration|0|||
164554671|NCT01903837|594400821|FG003|Part B|Incarceration|1|||
164554672|NCT01903837|594400818|FG000|Part B|Physician Decision|1|||
164554673|NCT01903837|594400819|FG001|Part B|Physician Decision|0|||
164554674|NCT01903837|594400820|FG002|Part B|Physician Decision|0|||
164554675|NCT01903837|594400821|FG003|Part B|Physician Decision|2|||
164554676|NCT01903837|594400818|FG000|Part B|Lack of Efficacy|0|||
164554677|NCT01903837|594400819|FG001|Part B|Lack of Efficacy|1|||
164554678|NCT01903837|594400820|FG002|Part B|Lack of Efficacy|0|||
164554679|NCT01903837|594400821|FG003|Part B|Lack of Efficacy|0|||
164554680|NCT02706873|594400822|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
164554681|NCT02706873|594400823|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
164554682|NCT02706873|594400824|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
164554683|NCT02706873|594400825|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
164554684|NCT02706873|594400822|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
164554685|NCT02706873|594400823|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
164554686|NCT02706873|594400824|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
164554687|NCT02706873|594400825|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
164554688|NCT02706873|594400822|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
164554689|NCT02706873|594400823|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
164554690|NCT02706873|594400824|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
164554691|NCT02706873|594400825|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
164554692|NCT02706873|594400822|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
164554693|NCT02706873|594400823|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
164554694|NCT02706873|594400824|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
164554695|NCT02706873|594400825|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
164554696|NCT02706873|594400822|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
164554697|NCT02706873|594400823|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
164554698|NCT02706873|594400824|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
164554699|NCT02706873|594400825|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
164554700|NCT02706873|594400822|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
164554701|NCT02706873|594400823|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
164554702|NCT02706873|594400824|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
164554703|NCT02706873|594400825|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
164554704|NCT02706873|594400822|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
164554705|NCT02706873|594400823|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
164554706|NCT02706873|594400824|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
164554707|NCT02706873|594400825|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
164554708|NCT02706873|594400822|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
164554709|NCT02706873|594400823|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
164554710|NCT02706873|594400824|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
164554711|NCT02706873|594400825|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
164554712|NCT02706873|594400822|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
164554713|NCT02706873|594400823|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
164554714|NCT02706873|594400824|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
164554715|NCT02706873|594400825|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
164554716|NCT02706873|594400822|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
164554717|NCT02706873|594400823|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
164554718|NCT02706873|594400824|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
164554719|NCT02706873|594400825|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
164554720|NCT02706873|594400822|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
164554721|NCT02706873|594400823|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
164554722|NCT02706873|594400824|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
164659620|NCT00836927|594780337|FG004|Overall Study|Progressive disease|1|||
164310798|NCT03390101|593512934|FG000|Weeks 12-54|Adverse Event|2|||
164554723|NCT02706873|594400825|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
164554724|NCT02706873|594400822|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
164554725|NCT02706873|594400823|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
164554726|NCT02706873|594400824|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
164554727|NCT02706873|594400825|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
164554728|NCT02706873|594400822|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
164554729|NCT02706873|594400823|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
164554730|NCT02706873|594400824|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
164554731|NCT02706873|594400825|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
164554732|NCT05098041|594400828|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
164554733|NCT00705939|594400829|FG000|Overall Study|Protocol Violation|0|||
164554734|NCT00705939|594400830|FG001|Overall Study|Protocol Violation|0|||
164554735|NCT00705939|594400831|FG002|Overall Study|Protocol Violation|1|||
164554736|NCT00705939|594400829|FG000|Overall Study|Withdrawal by Subject|0|||
164554737|NCT00705939|594400830|FG001|Overall Study|Withdrawal by Subject|1|||
164554738|NCT00705939|594400831|FG002|Overall Study|Withdrawal by Subject|3|||
164554739|NCT00705939|594400829|FG000|Overall Study|Physician Decision|0|||
164554740|NCT00705939|594400830|FG001|Overall Study|Physician Decision|1|||
164554741|NCT00705939|594400831|FG002|Overall Study|Physician Decision|0|||
164554742|NCT01895322|594400832|FG000|Overall Study|Adverse Event|1|||
164554743|NCT01895322|594400832|FG000|Overall Study|Withdrawal by Subject|2|||
164554744|NCT01895322|594400832|FG000|Overall Study|Protocol Violation|10|||
164554745|NCT02728830|594400840|FG000|Overall Study|Exclusionary Surgery|9|||
164554746|NCT02728830|594400840|FG000|Overall Study|Exclusionary Pathology|6|||
164554747|NCT02728830|594400840|FG000|Overall Study|Physician Decision|3|||
164554748|NCT02728830|594400840|FG000|Overall Study|Withdrawal by Subject|2|||
164554749|NCT02728830|594400840|FG000|Overall Study|Lost to Follow-up|1|||
164554750|NCT02728830|594400840|FG000|Overall Study|Exclusionary Lab Values|1|||
164554751|NCT02728830|594400840|FG000|Overall Study|Contraindicated Illness|1|||
164554752|NCT02728830|594400840|FG000|Overall Study|Language Barrier|1|||
164554753|NCT01152021|594400841|FG000|Overall Study|Adverse Event|4|||
164554754|NCT01152021|594400842|FG001|Overall Study|Adverse Event|4|||
164554755|NCT01152021|594400841|FG000|Overall Study|Study drug had expired|1|||
164554756|NCT01152021|594400842|FG001|Overall Study|Study drug had expired|0|||
164554757|NCT01152021|594400841|FG000|Overall Study|Physician Decision|1|||
164554758|NCT01152021|594400842|FG001|Overall Study|Physician Decision|1|||
164554759|NCT01152021|594400841|FG000|Overall Study|No access to study drug in Pharmacy|0|||
164554760|NCT01152021|594400842|FG001|Overall Study|No access to study drug in Pharmacy|1|||
164554761|NCT01347554|594400843|FG000|Overall Study|Lack of Efficacy|7|||
164554762|NCT01347554|594400844|FG001|Overall Study|Lack of Efficacy|11|||
164554763|NCT02228590|594400848|FG000|Overall Study|Withdrawal by Subject|1|||
164554764|NCT02054897|594400849|FG000|Overall Study|Withdrawal by Subject|2|||
164554765|NCT02054897|594400850|FG001|Overall Study|Withdrawal by Subject|0|||
164554766|NCT02054897|594400851|FG002|Overall Study|Withdrawal by Subject|2|||
164554767|NCT02054897|594400849|FG000|Overall Study|Missing follow-up information|3|||
164554768|NCT02054897|594400850|FG001|Overall Study|Missing follow-up information|5|||
164554769|NCT02054897|594400851|FG002|Overall Study|Missing follow-up information|3|||
164554770|NCT02054897|594400849|FG000|Overall Study|Lost to Follow-up|4|||
164554771|NCT02054897|594400850|FG001|Overall Study|Lost to Follow-up|2|||
164554772|NCT02054897|594400851|FG002|Overall Study|Lost to Follow-up|7|||
164554773|NCT02054897|594400849|FG000|Overall Study|Randomized but not exposed|1|||
164554774|NCT02054897|594400850|FG001|Overall Study|Randomized but not exposed|0|||
164554775|NCT02054897|594400851|FG002|Overall Study|Randomized but not exposed|0|||
164554776|NCT00542269|594400852|FG000|Overall Study|Adverse Event|10|||
164554777|NCT00542269|594400853|FG001|Overall Study|Adverse Event|4|||
164554778|NCT00542269|594400854|FG002|Overall Study|Adverse Event|5|||
164554779|NCT00542269|594400852|FG000|Overall Study|Protocol Violation|1|||
164554780|NCT00542269|594400853|FG001|Overall Study|Protocol Violation|1|||
164554781|NCT00542269|594400854|FG002|Overall Study|Protocol Violation|0|||
164554782|NCT00542269|594400852|FG000|Overall Study|Withdrawal by Subject|1|||
164554783|NCT00542269|594400853|FG001|Overall Study|Withdrawal by Subject|0|||
164554784|NCT00542269|594400854|FG002|Overall Study|Withdrawal by Subject|0|||
164201871|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
164554785|NCT00542269|594400852|FG000|Overall Study|Administrative problems|1|||
164554786|NCT00542269|594400853|FG001|Overall Study|Administrative problems|1|||
164554787|NCT00542269|594400854|FG002|Overall Study|Administrative problems|1|||
164554788|NCT00490451|594400855|FG000|Overall Study|Adverse Event|3|||
164554789|NCT00490451|594400856|FG001|Overall Study|Adverse Event|3|||
164554790|NCT00490451|594400855|FG000|Overall Study|Death|3|||
164554791|NCT00490451|594400856|FG001|Overall Study|Death|1|||
164554792|NCT00490451|594400855|FG000|Overall Study|Withdrawal by Subject|2|||
164554793|NCT00490451|594400856|FG001|Overall Study|Withdrawal by Subject|0|||
164554794|NCT00490451|594400855|FG000|Overall Study|Investigator Decision|1|||
164554795|NCT00490451|594400856|FG001|Overall Study|Investigator Decision|0|||
164659621|NCT00836927|594780333|FG000|Overall Study|Withdrawal by Subject|1|||
164554796|NCT00490451|594400855|FG000|Overall Study|Protocol Violation|1|||
164310799|NCT03390101|593512935|FG001|Weeks 12-54|Adverse Event|1|||
164310800|NCT03390101|593512936|FG002|Weeks 12-54|Adverse Event|1|||
164310801|NCT00545272|593512938|FG000|Overall Study|Protocol deviation|0|||
164310802|NCT00545272|593512939|FG001|Overall Study|Protocol deviation|1|||
164310803|NCT00545272|593512940|FG002|Overall Study|Protocol deviation|0|||
164310804|NCT00545272|593512941|FG003|Overall Study|Protocol deviation|1|||
164310805|NCT00545272|593512942|FG004|Overall Study|Protocol deviation|0|||
164554797|NCT00490451|594400856|FG001|Overall Study|Protocol Violation|0|||
164554798|NCT00490451|594400855|FG000|Overall Study|Progressive Disease|53|||
164554799|NCT00490451|594400856|FG001|Overall Study|Progressive Disease|34|||
164554800|NCT01967550|594400859|FG000|Overall Study|Withdrawal by Subject|1|||
164554801|NCT01967550|594400860|FG001|Overall Study|Withdrawal by Subject|0|||
164554802|NCT01967550|594400859|FG000|Overall Study|Adverse Event|2|||
164554803|NCT01967550|594400860|FG001|Overall Study|Adverse Event|0|||
164554804|NCT01967550|594400859|FG000|Overall Study|Protocol Violation|2|||
164554805|NCT01967550|594400860|FG001|Overall Study|Protocol Violation|1|||
164554806|NCT01967550|594400859|FG000|Overall Study|Non Compliance|0|||
164554807|NCT01967550|594400860|FG001|Overall Study|Non Compliance|1|||
164554808|NCT02500121|594400862|FG000|Overall Study|Lost to Follow-up|0|||
164554809|NCT02500121|594400863|FG001|Overall Study|Lost to Follow-up|1|||
164554810|NCT02500121|594400862|FG000|Overall Study|Withdrawal by Subject|1|||
164554811|NCT02500121|594400863|FG001|Overall Study|Withdrawal by Subject|1|||
164554812|NCT02500121|594400862|FG000|Overall Study|Death|26|||
164554813|NCT02500121|594400863|FG001|Overall Study|Death|24|||
164554814|NCT00333359|594400868|FG000|Overall Study|Adverse Event|29|||
164554815|NCT00333359|594400869|FG001|Overall Study|Adverse Event|35|||
164554816|NCT00333359|594400868|FG000|Overall Study|Withdrawal by Subject|19|||
164554817|NCT00333359|594400869|FG001|Overall Study|Withdrawal by Subject|37|||
164554818|NCT00333359|594400868|FG000|Overall Study|Physician Decision|2|||
164554819|NCT00333359|594400869|FG001|Overall Study|Physician Decision|2|||
164554820|NCT00333359|594400868|FG000|Overall Study|Protocol Non-compliance|2|||
164554821|NCT00333359|594400869|FG001|Overall Study|Protocol Non-compliance|8|||
164554822|NCT00333359|594400868|FG000|Overall Study|Lost to Follow-up|15|||
164554823|NCT00333359|594400869|FG001|Overall Study|Lost to Follow-up|25|||
164554824|NCT00333359|594400868|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
164554825|NCT00333359|594400869|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
164554826|NCT00333359|594400868|FG000|Overall Study|Treatment Failure|3|||
164554827|NCT00333359|594400869|FG001|Overall Study|Treatment Failure|8|||
164554828|NCT00333359|594400868|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
164554829|NCT00333359|594400869|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
164554830|NCT03315871|594400874|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
164554831|NCT03315871|594400875|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
164554832|NCT03315871|594400876|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
164554833|NCT03315871|594400874|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
164554834|NCT03315871|594400875|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
164554835|NCT03315871|594400876|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
164554836|NCT03315871|594400874|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
164554837|NCT03315871|594400875|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
164554838|NCT03315871|594400876|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
164554839|NCT03315871|594400874|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
164554840|NCT03315871|594400875|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
164554841|NCT03315871|594400876|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
164554842|NCT03315871|594400874|FG000|PROSTVAC + CV301|Progressive disease|0|||
164554843|NCT03315871|594400875|FG001|PROSTVAC + CV301|Progressive disease|0|||
164554844|NCT03315871|594400876|FG002|PROSTVAC + CV301|Progressive disease|1|||
164554845|NCT03315871|594400874|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
164554846|NCT03315871|594400875|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
164554847|NCT03315871|594400876|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
164554848|NCT04099251|594404132|FG000|Pre-Treatment|Other reasons|1|||
164554849|NCT04099251|594404133|FG001|Pre-Treatment|Other reasons|0|||
164554850|NCT04099251|594404132|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
164554851|NCT04099251|594404133|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
164554852|NCT04099251|594404132|FG000|Blinded Treatment Phase|Other reasons|16|||
164554853|NCT04099251|594404133|FG001|Blinded Treatment Phase|Other reasons|7|||
164554854|NCT04099251|594404132|FG000|Blinded Treatment Phase|Disease recurrence|26|||
164554855|NCT04099251|594404133|FG001|Blinded Treatment Phase|Disease recurrence|41|||
164554856|NCT04099251|594404132|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
164554857|NCT04099251|594404133|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
164554858|NCT04099251|594404132|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
164554859|NCT04099251|594404133|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
164554860|NCT04099251|594404132|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
164310806|NCT00545272|593512943|FG005|Overall Study|Protocol deviation|1|||
164659622|NCT00836927|594780334|FG001|Overall Study|Withdrawal by Subject|0|||
164659623|NCT00836927|594780335|FG002|Overall Study|Withdrawal by Subject|0|||
164659624|NCT00836927|594780336|FG003|Overall Study|Withdrawal by Subject|0|||
164659625|NCT00836927|594780337|FG004|Overall Study|Withdrawal by Subject|0|||
164659626|NCT05590585|594780341|FG000|Overall Study|Lost to Follow-up|3|||
164659627|NCT05590585|594780341|FG000|Overall Study|Withdrawal by Subject|1|||
164659628|NCT04161144|594780343|FG000|Overall Study|Withdrawal by Subject|0|||
164659629|NCT04161144|594780344|FG001|Overall Study|Withdrawal by Subject|1|||
164659630|NCT04161144|594780343|FG000|Overall Study|Protocol Violation|1|||
164659631|NCT04161144|594780344|FG001|Overall Study|Protocol Violation|0|||
164659632|NCT02848599|594780345|FG000|Overall Study|Protocol Violation|7|||
164659633|NCT02848599|594780346|FG001|Overall Study|Protocol Violation|9|||
164659634|NCT04828161|594780347|FG000|Overall Study|Withdrawal by Subject|0|||
164554861|NCT04099251|594404133|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
164554862|NCT04099251|594404132|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
164554863|NCT04099251|594404133|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
164554864|NCT04099251|594404132|FG000|Blinded Treatment Phase|Death|6|||
164554865|NCT04099251|594404133|FG001|Blinded Treatment Phase|Death|2|||
164554866|NCT04099251|594404132|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
164554867|NCT04099251|594404133|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
164554868|NCT04099251|594404132|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
164554869|NCT04099251|594404133|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
164554870|NCT04099251|594404132|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
164554871|NCT04099251|594404133|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
164554872|NCT04099251|594404132|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
164554873|NCT04099251|594404133|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
164554874|NCT04099251|594404132|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
164554875|NCT04099251|594404133|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
164554876|NCT04099251|594404132|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
164554877|NCT04099251|594404133|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
164554878|NCT04099251|594404132|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
164554879|NCT04099251|594404133|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
164554880|NCT04099251|594404132|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
164554881|NCT04099251|594404133|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
164554882|NCT04099251|594404132|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
164554883|NCT04099251|594404133|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
164554884|NCT00328627|594404134|FG000|Overall Study|Hyperglycemic Rescue|41|||
164554885|NCT00328627|594404135|FG001|Overall Study|Hyperglycemic Rescue|18|||
164554886|NCT00328627|594404136|FG002|Overall Study|Hyperglycemic Rescue|16|||
164554887|NCT00328627|594404137|FG003|Overall Study|Hyperglycemic Rescue|13|||
164554888|NCT00328627|594404138|FG004|Overall Study|Hyperglycemic Rescue|6|||
164554889|NCT00328627|594404139|FG005|Overall Study|Hyperglycemic Rescue|5|||
164554890|NCT00328627|594404140|FG006|Overall Study|Hyperglycemic Rescue|19|||
164554891|NCT00328627|594404141|FG007|Overall Study|Hyperglycemic Rescue|6|||
164554892|NCT00328627|594404142|FG008|Overall Study|Hyperglycemic Rescue|6|||
164554893|NCT00328627|594404143|FG009|Overall Study|Hyperglycemic Rescue|11|||
164554894|NCT00328627|594404144|FG010|Overall Study|Hyperglycemic Rescue|3|||
164554895|NCT00328627|594404145|FG011|Overall Study|Hyperglycemic Rescue|2|||
164554896|NCT00328627|594404134|FG000|Overall Study|Adverse Event|3|||
164554897|NCT00328627|594404135|FG001|Overall Study|Adverse Event|1|||
164554898|NCT00328627|594404136|FG002|Overall Study|Adverse Event|2|||
164554899|NCT00328627|594404137|FG003|Overall Study|Adverse Event|3|||
164554900|NCT00328627|594404138|FG004|Overall Study|Adverse Event|1|||
164554901|NCT00328627|594404139|FG005|Overall Study|Adverse Event|2|||
164554902|NCT00328627|594404140|FG006|Overall Study|Adverse Event|1|||
164554903|NCT00328627|594404141|FG007|Overall Study|Adverse Event|2|||
164554904|NCT00328627|594404142|FG008|Overall Study|Adverse Event|0|||
164554905|NCT00328627|594404143|FG009|Overall Study|Adverse Event|7|||
164554906|NCT00328627|594404144|FG010|Overall Study|Adverse Event|5|||
164554907|NCT00328627|594404145|FG011|Overall Study|Adverse Event|4|||
164554908|NCT00328627|594404134|FG000|Overall Study|Protocol Violation|2|||
164554909|NCT00328627|594404135|FG001|Overall Study|Protocol Violation|2|||
164554910|NCT00328627|594404136|FG002|Overall Study|Protocol Violation|2|||
164554911|NCT00328627|594404137|FG003|Overall Study|Protocol Violation|8|||
164554912|NCT00328627|594404138|FG004|Overall Study|Protocol Violation|5|||
164554913|NCT00328627|594404139|FG005|Overall Study|Protocol Violation|5|||
164554914|NCT00328627|594404140|FG006|Overall Study|Protocol Violation|6|||
164554915|NCT00328627|594404141|FG007|Overall Study|Protocol Violation|2|||
164554916|NCT00328627|594404142|FG008|Overall Study|Protocol Violation|1|||
164659635|NCT04828161|594780348|FG001|Overall Study|Withdrawal by Subject|3|||
164659636|NCT04828161|594780349|FG002|Overall Study|Withdrawal by Subject|3|||
164659637|NCT04828161|594780350|FG003|Overall Study|Withdrawal by Subject|4|||
164659638|NCT04828161|594780347|FG000|Overall Study|Lost to Follow-up|1|||
164310807|NCT00545272|593512938|FG000|Overall Study|Adverse Event|0|||
164310808|NCT00545272|593512939|FG001|Overall Study|Adverse Event|0|||
164310809|NCT00545272|593512940|FG002|Overall Study|Adverse Event|1|||
164310810|NCT00545272|593512941|FG003|Overall Study|Adverse Event|0|||
164554917|NCT00328627|594404143|FG009|Overall Study|Protocol Violation|4|||
164554918|NCT00328627|594404144|FG010|Overall Study|Protocol Violation|6|||
164554919|NCT00328627|594404145|FG011|Overall Study|Protocol Violation|2|||
164554920|NCT00328627|594404134|FG000|Overall Study|Lost to Follow-up|4|||
164554921|NCT00328627|594404135|FG001|Overall Study|Lost to Follow-up|2|||
164554922|NCT00328627|594404136|FG002|Overall Study|Lost to Follow-up|2|||
164554923|NCT00328627|594404137|FG003|Overall Study|Lost to Follow-up|4|||
164554924|NCT00328627|594404138|FG004|Overall Study|Lost to Follow-up|0|||
164554925|NCT00328627|594404139|FG005|Overall Study|Lost to Follow-up|2|||
164554926|NCT00328627|594404140|FG006|Overall Study|Lost to Follow-up|3|||
164554927|NCT00328627|594404141|FG007|Overall Study|Lost to Follow-up|0|||
164554928|NCT00328627|594404142|FG008|Overall Study|Lost to Follow-up|3|||
164554929|NCT00328627|594404143|FG009|Overall Study|Lost to Follow-up|2|||
164554930|NCT00328627|594404144|FG010|Overall Study|Lost to Follow-up|0|||
164554931|NCT00328627|594404145|FG011|Overall Study|Lost to Follow-up|1|||
164554932|NCT00328627|594404134|FG000|Overall Study|Withdrawal by Subject|5|||
164554933|NCT00328627|594404135|FG001|Overall Study|Withdrawal by Subject|4|||
164554934|NCT00328627|594404136|FG002|Overall Study|Withdrawal by Subject|5|||
164554935|NCT00328627|594404137|FG003|Overall Study|Withdrawal by Subject|6|||
164554936|NCT00328627|594404138|FG004|Overall Study|Withdrawal by Subject|2|||
164554937|NCT00328627|594404139|FG005|Overall Study|Withdrawal by Subject|5|||
164554938|NCT00328627|594404140|FG006|Overall Study|Withdrawal by Subject|4|||
164554939|NCT00328627|594404141|FG007|Overall Study|Withdrawal by Subject|4|||
164554940|NCT00328627|594404142|FG008|Overall Study|Withdrawal by Subject|4|||
164554941|NCT00328627|594404143|FG009|Overall Study|Withdrawal by Subject|5|||
164554942|NCT00328627|594404144|FG010|Overall Study|Withdrawal by Subject|2|||
164554943|NCT00328627|594404145|FG011|Overall Study|Withdrawal by Subject|7|||
164554944|NCT00328627|594404134|FG000|Overall Study|Pregnancy|0|||
164554945|NCT00328627|594404135|FG001|Overall Study|Pregnancy|1|||
164554946|NCT00328627|594404136|FG002|Overall Study|Pregnancy|0|||
164554947|NCT00328627|594404137|FG003|Overall Study|Pregnancy|0|||
164554948|NCT00328627|594404138|FG004|Overall Study|Pregnancy|0|||
164554949|NCT00328627|594404139|FG005|Overall Study|Pregnancy|0|||
164554950|NCT00328627|594404140|FG006|Overall Study|Pregnancy|0|||
164554951|NCT00328627|594404141|FG007|Overall Study|Pregnancy|0|||
164554952|NCT00328627|594404142|FG008|Overall Study|Pregnancy|0|||
164554953|NCT00328627|594404143|FG009|Overall Study|Pregnancy|0|||
164554954|NCT00328627|594404144|FG010|Overall Study|Pregnancy|0|||
164554955|NCT00328627|594404145|FG011|Overall Study|Pregnancy|0|||
164554956|NCT00328627|594404134|FG000|Overall Study|Physician Decision|4|||
164554957|NCT00328627|594404135|FG001|Overall Study|Physician Decision|3|||
164554958|NCT00328627|594404136|FG002|Overall Study|Physician Decision|1|||
164554959|NCT00328627|594404137|FG003|Overall Study|Physician Decision|2|||
164554960|NCT00328627|594404138|FG004|Overall Study|Physician Decision|1|||
164554961|NCT00328627|594404139|FG005|Overall Study|Physician Decision|1|||
164554962|NCT00328627|594404140|FG006|Overall Study|Physician Decision|1|||
164554963|NCT00328627|594404141|FG007|Overall Study|Physician Decision|0|||
164554964|NCT00328627|594404142|FG008|Overall Study|Physician Decision|3|||
164554965|NCT00328627|594404143|FG009|Overall Study|Physician Decision|2|||
164554966|NCT00328627|594404144|FG010|Overall Study|Physician Decision|1|||
164554967|NCT00328627|594404145|FG011|Overall Study|Physician Decision|0|||
164554968|NCT00328627|594404134|FG000|Overall Study|Other|0|||
164554969|NCT00328627|594404135|FG001|Overall Study|Other|0|||
164554970|NCT00328627|594404136|FG002|Overall Study|Other|0|||
164554971|NCT00328627|594404137|FG003|Overall Study|Other|1|||
164554972|NCT00328627|594404138|FG004|Overall Study|Other|0|||
164554973|NCT00328627|594404139|FG005|Overall Study|Other|0|||
164554974|NCT00328627|594404140|FG006|Overall Study|Other|1|||
164554975|NCT00328627|594404141|FG007|Overall Study|Other|0|||
164554976|NCT00328627|594404142|FG008|Overall Study|Other|0|||
164554977|NCT00328627|594404143|FG009|Overall Study|Other|1|||
164554978|NCT00328627|594404144|FG010|Overall Study|Other|1|||
164554979|NCT00328627|594404145|FG011|Overall Study|Other|0|||
164554980|NCT01339559|594404147|FG000|Overall Study|Adverse Event|92|||
164310811|NCT00545272|593512942|FG004|Overall Study|Adverse Event|0|||
164554981|NCT01339559|594404147|FG000|Overall Study|Death|5|||
164554982|NCT01339559|594404147|FG000|Overall Study|Lack of Efficacy|164|||
164554983|NCT01339559|594404147|FG000|Overall Study|Lost to Follow-up|22|||
164554984|NCT01339559|594404147|FG000|Overall Study|Subject choice|89|||
164554985|NCT01339559|594404147|FG000|Overall Study|Protocol Violation|15|||
164554986|NCT01339559|594404147|FG000|Overall Study|Study closure at site|1|||
164554987|NCT01339559|594404147|FG000|Overall Study|Incarcerated|2|||
164554988|NCT01339559|594404147|FG000|Overall Study|Epilepsy surgery|1|||
164554989|NCT01339559|594404147|FG000|Overall Study|Pregnancy planned|2|||
164554990|NCT01339559|594404147|FG000|Overall Study|Left the country|1|||
164554991|NCT01339559|594404147|FG000|Overall Study|Investigator decision|2|||
164554992|NCT01339559|594404147|FG000|Overall Study|Patient didn't wish to continue|1|||
164554993|NCT01339559|594404147|FG000|Overall Study|PI decision|1|||
164310812|NCT00545272|593512943|FG005|Overall Study|Adverse Event|1|||
164310813|NCT00545272|593512938|FG000|Overall Study|Abnormal laboratory value(s)|0|||
164310814|NCT00545272|593512939|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164310815|NCT00545272|593512940|FG002|Overall Study|Abnormal laboratory value(s)|0|||
164310816|NCT00545272|593512941|FG003|Overall Study|Abnormal laboratory value(s)|0|||
164310817|NCT00545272|593512942|FG004|Overall Study|Abnormal laboratory value(s)|0|||
164310818|NCT00545272|593512943|FG005|Overall Study|Abnormal laboratory value(s)|1|||
164310819|NCT00545272|593512938|FG000|Overall Study|Abnormal test procedure result(s)|0|||
164310820|NCT00545272|593512939|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164310821|NCT00545272|593512940|FG002|Overall Study|Abnormal test procedure result(s)|0|||
164310822|NCT00545272|593512941|FG003|Overall Study|Abnormal test procedure result(s)|0|||
164310823|NCT00545272|593512942|FG004|Overall Study|Abnormal test procedure result(s)|1|||
164310824|NCT00545272|593512943|FG005|Overall Study|Abnormal test procedure result(s)|0|||
164310825|NCT00545272|593512938|FG000|Overall Study|Lost to Follow-up|0|||
164310826|NCT00545272|593512939|FG001|Overall Study|Lost to Follow-up|0|||
164310827|NCT00545272|593512940|FG002|Overall Study|Lost to Follow-up|0|||
164310828|NCT00545272|593512941|FG003|Overall Study|Lost to Follow-up|0|||
164310829|NCT00545272|593512942|FG004|Overall Study|Lost to Follow-up|1|||
164310830|NCT00545272|593512943|FG005|Overall Study|Lost to Follow-up|0|||
164554994|NCT00971945|594404148|FG000|Overall Study|Progressive Disease|3|||
164554995|NCT00971945|594404148|FG000|Overall Study|Change in treatment policy|1|||
164554996|NCT00971945|594404148|FG000|Overall Study|Other reasons|2|||
164554997|NCT03354663|594404149|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
164554998|NCT03354663|594404149|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
164554999|NCT03354663|594404149|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
164555000|NCT03354663|594404149|FG000|Completed 30-day Visit|Missed Visit|1|||
164555001|NCT03691974|594404150|FG000|Overall Study|Physician Decision|1|||
164555002|NCT03691974|594404151|FG001|Overall Study|Physician Decision|0|||
164555003|NCT03691974|594404150|FG000|Overall Study|Adverse Event|1|||
164555004|NCT03691974|594404151|FG001|Overall Study|Adverse Event|0|||
164555005|NCT03691974|594404150|FG000|Overall Study|Withdrawal by Subject|11|||
164555006|NCT03691974|594404151|FG001|Overall Study|Withdrawal by Subject|9|||
164555007|NCT03691974|594404150|FG000|Overall Study|Protocol Violation|1|||
164555008|NCT03691974|594404151|FG001|Overall Study|Protocol Violation|0|||
164555009|NCT03691974|594404150|FG000|Overall Study|Lost to Follow-up|8|||
164555010|NCT03691974|594404151|FG001|Overall Study|Lost to Follow-up|7|||
164555011|NCT00513409|594404155|FG000|Overall Study|Adverse Event|0|||
164555012|NCT00513409|594404156|FG001|Overall Study|Adverse Event|1|||
164555013|NCT00513409|594404155|FG000|Overall Study|Withdrawal by Subject|0|||
164555014|NCT00513409|594404156|FG001|Overall Study|Withdrawal by Subject|2|||
164555015|NCT00513409|594404155|FG000|Overall Study|Lost to Follow-up|0|||
164555016|NCT00513409|594404156|FG001|Overall Study|Lost to Follow-up|1|||
164555017|NCT00513409|594404155|FG000|Overall Study|Physician Decision|1|||
164555018|NCT00513409|594404156|FG001|Overall Study|Physician Decision|0|||
164555019|NCT00513409|594404155|FG000|Overall Study|Visit 3 not done|1|||
164555020|NCT00513409|594404156|FG001|Overall Study|Visit 3 not done|2|||
164555021|NCT00691483|594404157|FG000|Overall Study|Adverse Event|14|||
164555022|NCT00691483|594404158|FG001|Overall Study|Adverse Event|6|||
164555023|NCT00691483|594404157|FG000|Overall Study|Lost to Follow-up|17|||
164555024|NCT00691483|594404158|FG001|Overall Study|Lost to Follow-up|10|||
164555025|NCT00691483|594404157|FG000|Overall Study|Withdrawal by Subject|24|||
164555026|NCT00691483|594404158|FG001|Overall Study|Withdrawal by Subject|7|||
164555027|NCT00691483|594404157|FG000|Overall Study|Other known cause|6|||
164555028|NCT00691483|594404158|FG001|Overall Study|Other known cause|1|||
164555029|NCT00691483|594404157|FG000|Overall Study|Randomized by not treated|7|||
164555030|NCT00691483|594404158|FG001|Overall Study|Randomized by not treated|1|||
164555031|NCT04623242|594404160|FG000|Overall Study|Withdrawal by Subject|7|||
164555032|NCT04623242|594404161|FG001|Overall Study|Withdrawal by Subject|12|||
164555033|NCT04623242|594404162|FG002|Overall Study|Withdrawal by Subject|5|||
164555034|NCT04623242|594404163|FG003|Overall Study|Withdrawal by Subject|7|||
164555035|NCT04623242|594404164|FG004|Overall Study|Withdrawal by Subject|0|||
164555036|NCT04623242|594404160|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
164555037|NCT04623242|594404161|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
164555038|NCT04623242|594404162|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
164555039|NCT04623242|594404163|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
164555040|NCT04623242|594404164|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
164310831|NCT02934503|593512944|FG000|Overall Study|progression of disease|3|||
164310832|NCT02934503|593512944|FG000|Overall Study|Withdrawal by Subject|1|||
164555041|NCT04623242|594404160|FG000|Overall Study|Subject unblinded to mutation status|0|||
164555042|NCT04623242|594404161|FG001|Overall Study|Subject unblinded to mutation status|0|||
164555043|NCT04623242|594404162|FG002|Overall Study|Subject unblinded to mutation status|0|||
164555044|NCT04623242|594404163|FG003|Overall Study|Subject unblinded to mutation status|13|||
164555045|NCT04623242|594404164|FG004|Overall Study|Subject unblinded to mutation status|0|||
164555046|NCT02105454|594404167|FG000|Overall Study|Withdrawal by Subject|1|||
164555047|NCT05131204|594404168|FG000|Overall Study|Sponsor request|2|||
164555048|NCT05131204|594404169|FG001|Overall Study|Sponsor request|1|||
164555049|NCT02469090|594404171|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
164555050|NCT02469090|594404172|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
164555051|NCT02469090|594404173|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
164555052|NCT02469090|594404171|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
164555053|NCT02469090|594404172|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
164555054|NCT02469090|594404173|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
164555055|NCT02469090|594404171|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
164555056|NCT02469090|594404172|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
164555057|NCT02469090|594404173|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
164555058|NCT02469090|594404171|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
164555059|NCT02469090|594404172|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
164555060|NCT02469090|594404173|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
164555061|NCT02469090|594404171|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
164555062|NCT02469090|594404172|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
164555063|NCT02469090|594404173|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
164555064|NCT02469090|594404171|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
164555065|NCT02469090|594404172|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
164555066|NCT02469090|594404173|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
164555067|NCT02469090|594404171|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
164555068|NCT02469090|594404172|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
164555069|NCT02469090|594404173|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
164555070|NCT02469090|594404171|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
164555071|NCT02469090|594404172|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
164555072|NCT02469090|594404173|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
164555073|NCT01485627|594404174|FG000|Overall Study|Patient withdrew|6|||
164555074|NCT01485627|594404175|FG001|Overall Study|Patient withdrew|5|||
164555075|NCT01485627|594404174|FG000|Overall Study|Patient died|3|||
164555076|NCT01485627|594404175|FG001|Overall Study|Patient died|1|||
164555077|NCT01485627|594404174|FG000|Overall Study|Patient lost to followup|0|||
164555078|NCT01485627|594404175|FG001|Overall Study|Patient lost to followup|1|||
164555079|NCT01485627|594404174|FG000|Overall Study|Caregiver withdrew|3|||
164555080|NCT01485627|594404175|FG001|Overall Study|Caregiver withdrew|3|||
164555081|NCT01485627|594404174|FG000|Overall Study|Caregiver lost to follow up|11|||
164555082|NCT01485627|594404175|FG001|Overall Study|Caregiver lost to follow up|12|||
164555083|NCT01485627|594404174|FG000|Overall Study|Caregiver died|1|||
164555084|NCT01485627|594404175|FG001|Overall Study|Caregiver died|0|||
164555085|NCT01485627|594404174|FG000|Overall Study|caregiver was not bereaved|42|||
164555086|NCT01485627|594404175|FG001|Overall Study|caregiver was not bereaved|35|||
164555087|NCT01425203|594404176|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
164555088|NCT01425203|594404177|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
164555089|NCT01425203|594404178|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
164555090|NCT01425203|594404176|FG000|Treatment Phase|Failure at futility timepoint|8|||
164555091|NCT01425203|594404177|FG001|Treatment Phase|Failure at futility timepoint|27|||
164555092|NCT01425203|594404178|FG002|Treatment Phase|Failure at futility timepoint|0|||
164555093|NCT01425203|594404176|FG000|Treatment Phase|Other virologic failure criteria|5|||
164555094|NCT01425203|594404177|FG001|Treatment Phase|Other virologic failure criteria|3|||
164555095|NCT01425203|594404178|FG002|Treatment Phase|Other virologic failure criteria|0|||
164555096|NCT01425203|594404176|FG000|Treatment Phase|Unidentified reasons|11|||
164555097|NCT01425203|594404177|FG001|Treatment Phase|Unidentified reasons|5|||
164555098|NCT01425203|594404178|FG002|Treatment Phase|Unidentified reasons|0|||
164555099|NCT01425203|594404176|FG000|Treatment Phase|Did not receive treatment|0|||
164555100|NCT01425203|594404177|FG001|Treatment Phase|Did not receive treatment|1|||
164555101|NCT01425203|594404178|FG002|Treatment Phase|Did not receive treatment|0|||
164555102|NCT01425203|594404176|FG000|Crossover Phase|Failure at futility timepoint|0|||
164555103|NCT01425203|594404177|FG001|Crossover Phase|Failure at futility timepoint|0|||
164555104|NCT01425203|594404178|FG002|Crossover Phase|Failure at futility timepoint|3|||
164555105|NCT01425203|594404176|FG000|Crossover Phase|Other virologic failure criteria|0|||
164555106|NCT01425203|594404177|FG001|Crossover Phase|Other virologic failure criteria|0|||
164555107|NCT01425203|594404178|FG002|Crossover Phase|Other virologic failure criteria|3|||
164555108|NCT00290433|594404181|FG000|Overall Study|Disease Progression|13|||
164555109|NCT00290433|594404181|FG000|Overall Study|Adverse Event|14|||
164555110|NCT00290433|594404181|FG000|Overall Study|Withdrawal by Subject|1|||
164555111|NCT00290433|594404181|FG000|Overall Study|Non-Compliance|1|||
164555112|NCT00290433|594404181|FG000|Overall Study|Congestive Heart Failure|1|||
164555113|NCT00290433|594404181|FG000|Overall Study|Transplant in CR|5|||
164555114|NCT00290433|594404181|FG000|Overall Study|Unrelated Infection/Death|1|||
164659639|NCT04828161|594780348|FG001|Overall Study|Lost to Follow-up|4|||
164555115|NCT00618410|594404184|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
164659640|NCT04828161|594780349|FG002|Overall Study|Lost to Follow-up|2|||
164659641|NCT04828161|594780350|FG003|Overall Study|Lost to Follow-up|2|||
164310833|NCT00724867|593512945|FG000|Overall Study|Adverse Event|25|||
164310834|NCT00724867|593512945|FG000|Overall Study|Lack of Efficacy|14|||
164310835|NCT00724867|593512945|FG000|Overall Study|Lost to Follow-up|12|||
164310836|NCT00724867|593512945|FG000|Overall Study|Non-compliance with study drug|6|||
164310837|NCT00724867|593512945|FG000|Overall Study|Physician Decision|17|||
164310838|NCT00724867|593512945|FG000|Overall Study|Protocol Violation|1|||
164310839|NCT00724867|593512945|FG000|Overall Study|Withdrawal by Subject|31|||
164310840|NCT00724867|593512945|FG000|Overall Study|Sponsor decision to end study|14|||
164310841|NCT00724867|593512945|FG000|Overall Study|Subject incarcerated|1|||
164310842|NCT00724867|593512945|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
164310843|NCT00724867|593512945|FG000|Overall Study|Subject moved out of state|1|||
164310844|NCT00724867|593512945|FG000|Overall Study|Elected to exit due to site closure|2|||
164310845|NCT00436345|593512946|FG000|Overall Study|ICU resident beyond follow-up period|3|||
164310846|NCT00436345|593512947|FG001|Overall Study|ICU resident beyond follow-up period|0|||
164310847|NCT04027608|593512948|FG000|Overall Study|Withdrawal by Subject|13|||
164310848|NCT04027608|593512949|FG001|Overall Study|Withdrawal by Subject|2|||
164310849|NCT04027608|593512948|FG000|Overall Study|Protocol Violation|2|||
164310850|NCT04027608|593512949|FG001|Overall Study|Protocol Violation|1|||
164310851|NCT04027608|593512948|FG000|Overall Study|Physician Decision|1|||
164310852|NCT04027608|593512949|FG001|Overall Study|Physician Decision|0|||
164310853|NCT04027608|593512948|FG000|Overall Study|Lost to Follow-up|20|||
164310854|NCT04027608|593512949|FG001|Overall Study|Lost to Follow-up|4|||
164310855|NCT04248491|593512953|FG000|Overall Study|Lost to Follow-up|1|||
164310856|NCT04248491|593512954|FG001|Overall Study|Lost to Follow-up|0|||
164310857|NCT04643158|593512964|FG000|Overall Study|Study terminated by sponsor|0|||
164310858|NCT04643158|593512965|FG001|Overall Study|Study terminated by sponsor|0|||
164310859|NCT04643158|593512966|FG002|Overall Study|Study terminated by sponsor|1|||
164310860|NCT04643158|593512967|FG003|Overall Study|Study terminated by sponsor|0|||
164310861|NCT04643158|593512968|FG004|Overall Study|Study terminated by sponsor|0|||
164310862|NCT04643158|593512969|FG005|Overall Study|Study terminated by sponsor|1|||
164310863|NCT04643158|593512970|FG006|Overall Study|Study terminated by sponsor|0|||
164310864|NCT04643158|593512964|FG000|Overall Study|Global/country situation|0|||
164310865|NCT04643158|593512965|FG001|Overall Study|Global/country situation|0|||
164310866|NCT04643158|593512966|FG002|Overall Study|Global/country situation|1|||
164310867|NCT04643158|593512967|FG003|Overall Study|Global/country situation|0|||
164310868|NCT04643158|593512968|FG004|Overall Study|Global/country situation|0|||
164310869|NCT04643158|593512969|FG005|Overall Study|Global/country situation|0|||
164310870|NCT04643158|593512970|FG006|Overall Study|Global/country situation|0|||
164310871|NCT04643158|593512964|FG000|Overall Study|Withdrawal by Subject|0|||
164310872|NCT04643158|593512965|FG001|Overall Study|Withdrawal by Subject|0|||
164555116|NCT00618410|594404185|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
164555117|NCT00464334|594404189|FG000|Overall Study|Adverse Event|0|||
164555118|NCT00464334|594404190|FG001|Overall Study|Adverse Event|0|||
164555119|NCT00464334|594404191|FG002|Overall Study|Adverse Event|0|||
164555120|NCT00464334|594404192|FG003|Overall Study|Adverse Event|1|||
164555121|NCT00464334|594404193|FG004|Overall Study|Adverse Event|1|||
164555122|NCT00464334|594404194|FG005|Overall Study|Adverse Event|1|||
164555123|NCT00464334|594404195|FG006|Overall Study|Adverse Event|0|||
164555124|NCT00464334|594404196|FG007|Overall Study|Adverse Event|0|||
164555125|NCT00464334|594404197|FG008|Overall Study|Adverse Event|2|||
164555126|NCT00464334|594404198|FG009|Overall Study|Adverse Event|1|||
164555127|NCT00464334|594404199|FG010|Overall Study|Adverse Event|2|||
164555128|NCT00464334|594404189|FG000|Overall Study|Lack of Efficacy|0|||
164555129|NCT00464334|594404190|FG001|Overall Study|Lack of Efficacy|1|||
164555130|NCT00464334|594404191|FG002|Overall Study|Lack of Efficacy|0|||
164555131|NCT00464334|594404192|FG003|Overall Study|Lack of Efficacy|0|||
164555132|NCT00464334|594404193|FG004|Overall Study|Lack of Efficacy|0|||
164555133|NCT00464334|594404194|FG005|Overall Study|Lack of Efficacy|0|||
164555134|NCT00464334|594404195|FG006|Overall Study|Lack of Efficacy|0|||
164659642|NCT04828161|594780347|FG000|Overall Study|Other|2|||
164310873|NCT04643158|593512966|FG002|Overall Study|Withdrawal by Subject|0|||
164310874|NCT04643158|593512967|FG003|Overall Study|Withdrawal by Subject|0|||
164555135|NCT00464334|594404196|FG007|Overall Study|Lack of Efficacy|0|||
164310875|NCT04643158|593512968|FG004|Overall Study|Withdrawal by Subject|0|||
164310876|NCT04643158|593512969|FG005|Overall Study|Withdrawal by Subject|1|||
164310877|NCT04643158|593512970|FG006|Overall Study|Withdrawal by Subject|0|||
164310878|NCT04329806|593512971|FG000|Overall Study|Physician Decision|3|||
164310879|NCT04329806|593512972|FG001|Overall Study|Physician Decision|4|||
164310880|NCT00622440|593512985|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
164310881|NCT00622440|593512986|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
164310882|NCT00622440|593512985|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
164310883|NCT00622440|593512986|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
164310884|NCT00622440|593512985|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
164555136|NCT00464334|594404197|FG008|Overall Study|Lack of Efficacy|0|||
164555137|NCT00464334|594404198|FG009|Overall Study|Lack of Efficacy|0|||
164555138|NCT00464334|594404199|FG010|Overall Study|Lack of Efficacy|0|||
164659643|NCT04828161|594780348|FG001|Overall Study|Other|0|||
164555139|NCT00464334|594404189|FG000|Overall Study|Lost to Follow-up|0|||
164555140|NCT00464334|594404190|FG001|Overall Study|Lost to Follow-up|0|||
164555141|NCT00464334|594404191|FG002|Overall Study|Lost to Follow-up|1|||
164555142|NCT00464334|594404192|FG003|Overall Study|Lost to Follow-up|0|||
164555143|NCT00464334|594404193|FG004|Overall Study|Lost to Follow-up|1|||
164555144|NCT00464334|594404194|FG005|Overall Study|Lost to Follow-up|0|||
164555145|NCT00464334|594404195|FG006|Overall Study|Lost to Follow-up|1|||
164555146|NCT00464334|594404196|FG007|Overall Study|Lost to Follow-up|0|||
164555147|NCT00464334|594404197|FG008|Overall Study|Lost to Follow-up|0|||
164555148|NCT00464334|594404198|FG009|Overall Study|Lost to Follow-up|0|||
164555149|NCT00464334|594404199|FG010|Overall Study|Lost to Follow-up|2|||
164555150|NCT00464334|594404189|FG000|Overall Study|Progressive Disease|0|||
164555151|NCT00464334|594404190|FG001|Overall Study|Progressive Disease|0|||
164555152|NCT00464334|594404191|FG002|Overall Study|Progressive Disease|0|||
164555153|NCT00464334|594404192|FG003|Overall Study|Progressive Disease|0|||
164555154|NCT00464334|594404193|FG004|Overall Study|Progressive Disease|0|||
164555155|NCT00464334|594404194|FG005|Overall Study|Progressive Disease|1|||
164555156|NCT00464334|594404195|FG006|Overall Study|Progressive Disease|0|||
164555157|NCT00464334|594404196|FG007|Overall Study|Progressive Disease|0|||
164555158|NCT00464334|594404197|FG008|Overall Study|Progressive Disease|1|||
164555159|NCT00464334|594404198|FG009|Overall Study|Progressive Disease|0|||
164555160|NCT00464334|594404199|FG010|Overall Study|Progressive Disease|0|||
164555161|NCT00464334|594404189|FG000|Overall Study|Study Terminated by Sponsor|0|||
164555162|NCT00464334|594404190|FG001|Overall Study|Study Terminated by Sponsor|0|||
164555163|NCT00464334|594404191|FG002|Overall Study|Study Terminated by Sponsor|0|||
164555164|NCT00464334|594404192|FG003|Overall Study|Study Terminated by Sponsor|1|||
164555165|NCT00464334|594404193|FG004|Overall Study|Study Terminated by Sponsor|0|||
164555166|NCT00464334|594404194|FG005|Overall Study|Study Terminated by Sponsor|0|||
164555167|NCT00464334|594404195|FG006|Overall Study|Study Terminated by Sponsor|0|||
164555168|NCT00464334|594404196|FG007|Overall Study|Study Terminated by Sponsor|0|||
164555169|NCT00464334|594404197|FG008|Overall Study|Study Terminated by Sponsor|0|||
164555170|NCT00464334|594404198|FG009|Overall Study|Study Terminated by Sponsor|0|||
164555171|NCT00464334|594404199|FG010|Overall Study|Study Terminated by Sponsor|0|||
164555172|NCT00464334|594404189|FG000|Overall Study|Withdrawal by Subject|1|||
164555173|NCT00464334|594404190|FG001|Overall Study|Withdrawal by Subject|7|||
164555174|NCT00464334|594404191|FG002|Overall Study|Withdrawal by Subject|4|||
164555175|NCT00464334|594404192|FG003|Overall Study|Withdrawal by Subject|2|||
164555176|NCT00464334|594404193|FG004|Overall Study|Withdrawal by Subject|2|||
164555177|NCT00464334|594404194|FG005|Overall Study|Withdrawal by Subject|2|||
164555178|NCT00464334|594404195|FG006|Overall Study|Withdrawal by Subject|2|||
164555179|NCT00464334|594404196|FG007|Overall Study|Withdrawal by Subject|1|||
164555180|NCT00464334|594404197|FG008|Overall Study|Withdrawal by Subject|3|||
164555181|NCT00464334|594404198|FG009|Overall Study|Withdrawal by Subject|0|||
164555182|NCT00464334|594404199|FG010|Overall Study|Withdrawal by Subject|0|||
164555183|NCT00797732|594404200|FG000|Overall Study|Withdrawal by Subject|3|||
164555184|NCT00797732|594404201|FG001|Overall Study|Withdrawal by Subject|3|||
164555185|NCT00797732|594404202|FG002|Overall Study|Withdrawal by Subject|0|||
164555186|NCT00797732|594404200|FG000|Overall Study|Lost to Follow-up|1|||
164555187|NCT00797732|594404201|FG001|Overall Study|Lost to Follow-up|0|||
164201872|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
164201873|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
164201874|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
164201875|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
164201876|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
164201877|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
164201878|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
164201879|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
164201880|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
164201881|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
164201882|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
164201883|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
164201884|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
164555188|NCT00797732|594404202|FG002|Overall Study|Lost to Follow-up|0|||
164555189|NCT00797732|594404200|FG000|Overall Study|Death|1|||
164555190|NCT00797732|594404201|FG001|Overall Study|Death|0|||
164201885|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
164555191|NCT00797732|594404202|FG002|Overall Study|Death|0|||
164555192|NCT00797732|594404200|FG000|Overall Study|Not meet inclusion criteria|0|||
164555193|NCT00797732|594404201|FG001|Overall Study|Not meet inclusion criteria|0|||
164555194|NCT00797732|594404202|FG002|Overall Study|Not meet inclusion criteria|7|||
164555195|NCT00797732|594404200|FG000|Overall Study|Excluded due to time constraints|0|||
164555196|NCT00797732|594404201|FG001|Overall Study|Excluded due to time constraints|0|||
164555197|NCT00797732|594404202|FG002|Overall Study|Excluded due to time constraints|24|||
164555198|NCT00797732|594404200|FG000|Overall Study|Refused to Participate|0|||
164659644|NCT04828161|594780349|FG002|Overall Study|Other|2|||
164659645|NCT04828161|594780350|FG003|Overall Study|Other|0|||
164659646|NCT04828161|594780347|FG000|Overall Study|Death|0|||
164659647|NCT04828161|594780348|FG001|Overall Study|Death|0|||
164659648|NCT04828161|594780349|FG002|Overall Study|Death|0|||
164659649|NCT04828161|594780350|FG003|Overall Study|Death|2|||
164659650|NCT04700449|594780351|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
164659651|NCT04700449|594780352|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
164659652|NCT04700449|594780353|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
164659653|NCT04700449|594780354|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
164659654|NCT04700449|594780351|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
164659655|NCT04700449|594780352|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
164659656|NCT04700449|594780353|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
164659657|NCT04700449|594780354|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
164659658|NCT04700449|594780351|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
164659659|NCT04700449|594780352|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
164659660|NCT04700449|594780353|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
164659661|NCT04700449|594780354|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
164659662|NCT04700449|594780351|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
164659663|NCT04700449|594780352|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
164659664|NCT04700449|594780353|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
164659665|NCT04700449|594780354|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
164659666|NCT04700449|594780351|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
164659667|NCT04700449|594780352|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
164659668|NCT04700449|594780353|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
164659669|NCT04700449|594780354|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
164659670|NCT04700449|594780351|FG000|Stage 1: Double-Blind Period|Other|0|||
164659671|NCT04700449|594780352|FG001|Stage 1: Double-Blind Period|Other|0|||
164659672|NCT04700449|594780353|FG002|Stage 1: Double-Blind Period|Other|1|||
164659673|NCT04700449|594780354|FG003|Stage 1: Double-Blind Period|Other|0|||
164659674|NCT04700449|594780351|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
164659675|NCT04700449|594780352|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
164659676|NCT04700449|594780353|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
164659677|NCT04700449|594780354|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
164659678|NCT04700449|594780351|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
164659679|NCT04700449|594780352|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
164659680|NCT04700449|594780353|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
164659681|NCT04700449|594780354|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
164659682|NCT04700449|594780351|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
164659683|NCT04700449|594780352|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
164659684|NCT04700449|594780353|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
164659685|NCT04700449|594780354|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
164659686|NCT04700449|594780351|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
164659687|NCT04700449|594780352|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
164659688|NCT04700449|594780353|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
164659689|NCT04700449|594780354|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
164659690|NCT04700449|594780351|FG000|Stage 2 Sub-study 1|Other|1|||
164659691|NCT04700449|594780352|FG001|Stage 2 Sub-study 1|Other|2|||
164659692|NCT04700449|594780353|FG002|Stage 2 Sub-study 1|Other|0|||
164659693|NCT04700449|594780354|FG003|Stage 2 Sub-study 1|Other|0|||
164659694|NCT04700449|594780351|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
164659695|NCT04700449|594780352|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
164659696|NCT04700449|594780353|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
164659697|NCT04700449|594780354|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
164659698|NCT04700449|594780351|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
164659699|NCT04700449|594780352|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
164659700|NCT04700449|594780353|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
164310885|NCT00622440|593512986|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
164310886|NCT00622440|593512985|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
164310887|NCT00622440|593512986|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
164310888|NCT02474069|593512992|FG000|Selection Phase (SP)|Adverse Event|8|||
164310889|NCT02474069|593512993|FG001|Selection Phase (SP)|Adverse Event|0|||
164659701|NCT04700449|594780354|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
164659702|NCT04700449|594780351|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
164659703|NCT04700449|594780352|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
164659704|NCT04700449|594780353|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
164659705|NCT04700449|594780354|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
164659706|NCT04700449|594780351|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
164659707|NCT04700449|594780352|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
164659708|NCT04700449|594780353|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
164659709|NCT04700449|594780354|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
164659710|NCT04700449|594780351|FG000|Stage 2 Sub-study 2|Other|0|||
164659711|NCT04700449|594780352|FG001|Stage 2 Sub-study 2|Other|0|||
164659712|NCT04700449|594780353|FG002|Stage 2 Sub-study 2|Other|0|||
164659713|NCT04700449|594780354|FG003|Stage 2 Sub-study 2|Other|5|||
164659714|NCT01000337|594780355|FG000|Overall Study|Lost to Follow-up|4|||
164659715|NCT01000337|594780356|FG001|Overall Study|Lost to Follow-up|3|||
164659716|NCT02173704|594780357|FG000|Overall Study|Adverse Event|1|||
164659717|NCT02173704|594780358|FG001|Overall Study|Adverse Event|0|||
164201886|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
164201887|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
164555199|NCT00797732|594404201|FG001|Overall Study|Refused to Participate|0|||
164555200|NCT00797732|594404202|FG002|Overall Study|Refused to Participate|123|||
164555201|NCT03948178|594404203|FG000|Overall Study|Protocol Violation|1|||
164555202|NCT03948178|594404203|FG000|Overall Study|Lost to Follow-up|2|||
164555203|NCT03948178|594404203|FG000|Overall Study|Withdrawal by Subject|2|||
164555204|NCT03948178|594404203|FG000|Overall Study|Reason not known|2|||
164555205|NCT03948178|594404203|FG000|Overall Study|Personal reason|14|||
164555206|NCT03948178|594404203|FG000|Overall Study|Disease progression|30|||
164555207|NCT03948178|594404203|FG000|Overall Study|Adverse Event|12|||
164555208|NCT03948178|594404203|FG000|Overall Study|Sponsor terminated study|164|||
164555209|NCT01297270|594404204|FG000|Overall Study|Adverse Event|19|||
164555210|NCT01297270|594404205|FG001|Overall Study|Adverse Event|32|||
164555211|NCT01297270|594404206|FG002|Overall Study|Adverse Event|5|||
164555212|NCT01297270|594404204|FG000|Overall Study|Lack of Efficacy|15|||
164555213|NCT01297270|594404205|FG001|Overall Study|Lack of Efficacy|17|||
164555214|NCT01297270|594404206|FG002|Overall Study|Lack of Efficacy|15|||
164555215|NCT01297270|594404204|FG000|Overall Study|Lost to Follow-up|1|||
164555216|NCT01297270|594404205|FG001|Overall Study|Lost to Follow-up|2|||
164555217|NCT01297270|594404206|FG002|Overall Study|Lost to Follow-up|1|||
164555218|NCT01297270|594404204|FG000|Overall Study|Protocol Violation|0|||
164555219|NCT01297270|594404205|FG001|Overall Study|Protocol Violation|2|||
164555220|NCT01297270|594404206|FG002|Overall Study|Protocol Violation|0|||
164555221|NCT01297270|594404204|FG000|Overall Study|Withdrawal by Subject|7|||
164555222|NCT01297270|594404205|FG001|Overall Study|Withdrawal by Subject|15|||
164555223|NCT01297270|594404206|FG002|Overall Study|Withdrawal by Subject|7|||
164555224|NCT01297270|594404204|FG000|Overall Study|Other reason not defined above|3|||
164555225|NCT01297270|594404205|FG001|Overall Study|Other reason not defined above|3|||
164555226|NCT01297270|594404206|FG002|Overall Study|Other reason not defined above|1|||
164555227|NCT01297270|594404204|FG000|Overall Study|Not treated|0|||
164555228|NCT01297270|594404205|FG001|Overall Study|Not treated|1|||
164555229|NCT01297270|594404206|FG002|Overall Study|Not treated|0|||
164555230|NCT00401752|594404209|FG000|Overall Study|Adverse Event|2|||
164555231|NCT00401752|594404210|FG001|Overall Study|Adverse Event|5|||
164555232|NCT00401752|594404209|FG000|Overall Study|Withdrawal by Subject|2|||
164555233|NCT00401752|594404210|FG001|Overall Study|Withdrawal by Subject|6|||
164555234|NCT00401752|594404209|FG000|Overall Study|Lost to Follow-up|1|||
164555235|NCT00401752|594404210|FG001|Overall Study|Lost to Follow-up|4|||
164555236|NCT00401752|594404209|FG000|Overall Study|Development of any exclusion criteria|4|||
164555237|NCT00401752|594404210|FG001|Overall Study|Development of any exclusion criteria|2|||
164555238|NCT00401752|594404209|FG000|Overall Study|Physician Decision|1|||
164555239|NCT00401752|594404210|FG001|Overall Study|Physician Decision|1|||
164555240|NCT02432235|594404211|FG000|Overall Study|Death|1|||
164555241|NCT02432235|594404212|FG001|Overall Study|Death|1|||
164555242|NCT02432235|594404213|FG002|Overall Study|Death|2|||
164555243|NCT02432235|594404214|FG003|Overall Study|Death|2|||
164555244|NCT02432235|594404215|FG004|Overall Study|Death|1|||
164555245|NCT02432235|594404216|FG005|Overall Study|Death|3|||
164555246|NCT02432235|594404217|FG006|Overall Study|Death|11|||
164555247|NCT02432235|594404218|FG007|Overall Study|Death|15|||
164555248|NCT02432235|594404219|FG008|Overall Study|Death|15|||
164555249|NCT02432235|594404220|FG009|Overall Study|Death|3|||
164555250|NCT02432235|594404221|FG010|Overall Study|Death|1|||
164555251|NCT02432235|594404222|FG011|Overall Study|Death|0|||
164555252|NCT02432235|594404211|FG000|Overall Study|Withdrawal by Subject|0|||
164555253|NCT02432235|594404212|FG001|Overall Study|Withdrawal by Subject|1|||
164555254|NCT02432235|594404213|FG002|Overall Study|Withdrawal by Subject|0|||
164555255|NCT02432235|594404214|FG003|Overall Study|Withdrawal by Subject|0|||
164555256|NCT02432235|594404215|FG004|Overall Study|Withdrawal by Subject|0|||
164555257|NCT02432235|594404216|FG005|Overall Study|Withdrawal by Subject|2|||
164555258|NCT02432235|594404217|FG006|Overall Study|Withdrawal by Subject|5|||
164555259|NCT02432235|594404218|FG007|Overall Study|Withdrawal by Subject|3|||
164659718|NCT02173704|594780357|FG000|Overall Study|Lost to Follow-up|1|||
164302364|NCT03755934|593482602|FG000|Overall Study|Physician Decision|2|||
164555260|NCT02432235|594404219|FG008|Overall Study|Withdrawal by Subject|1|||
164555261|NCT02432235|594404220|FG009|Overall Study|Withdrawal by Subject|0|||
164555262|NCT02432235|594404221|FG010|Overall Study|Withdrawal by Subject|0|||
164555263|NCT02432235|594404222|FG011|Overall Study|Withdrawal by Subject|0|||
164555264|NCT02432235|594404211|FG000|Overall Study|Lost to Follow-up|0|||
164555265|NCT02432235|594404212|FG001|Overall Study|Lost to Follow-up|0|||
164555266|NCT02432235|594404213|FG002|Overall Study|Lost to Follow-up|0|||
164555267|NCT02432235|594404214|FG003|Overall Study|Lost to Follow-up|0|||
164555268|NCT02432235|594404215|FG004|Overall Study|Lost to Follow-up|0|||
164555269|NCT02432235|594404216|FG005|Overall Study|Lost to Follow-up|1|||
164555270|NCT02432235|594404217|FG006|Overall Study|Lost to Follow-up|0|||
164310890|NCT02474069|593512994|FG002|Selection Phase (SP)|Adverse Event|0|||
164310891|NCT02474069|593512992|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
164310892|NCT02474069|593512993|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
164310893|NCT02474069|593512994|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
164310894|NCT02474069|593512992|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
164310895|NCT02474069|593512993|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
164310896|NCT02474069|593512994|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
164310897|NCT02474069|593512992|FG000|Selection Phase (SP)|Physician Decision|1|||
164310898|NCT02474069|593512993|FG001|Selection Phase (SP)|Physician Decision|0|||
164310899|NCT02474069|593512994|FG002|Selection Phase (SP)|Physician Decision|0|||
164310900|NCT02474069|593512992|FG000|Selection Phase (SP)|Protocol Violation|1|||
164310901|NCT02474069|593512993|FG001|Selection Phase (SP)|Protocol Violation|0|||
164310902|NCT02474069|593512994|FG002|Selection Phase (SP)|Protocol Violation|0|||
164310903|NCT02474069|593512992|FG000|Selection Phase (SP)|No longer requires treatment|1|||
164310904|NCT02474069|593512993|FG001|Selection Phase (SP)|No longer requires treatment|0|||
164310905|NCT02474069|593512994|FG002|Selection Phase (SP)|No longer requires treatment|0|||
164310906|NCT02474069|593512992|FG000|Selection Phase (SP)|Technical Problem|1|||
164310907|NCT02474069|593512993|FG001|Selection Phase (SP)|Technical Problem|0|||
164310908|NCT02474069|593512994|FG002|Selection Phase (SP)|Technical Problem|0|||
164310909|NCT02474069|593512992|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
164310910|NCT02474069|593512993|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
164555271|NCT02432235|594404218|FG007|Overall Study|Lost to Follow-up|0|||
164555272|NCT02432235|594404219|FG008|Overall Study|Lost to Follow-up|1|||
164555273|NCT02432235|594404220|FG009|Overall Study|Lost to Follow-up|0|||
164555274|NCT02432235|594404221|FG010|Overall Study|Lost to Follow-up|0|||
164555275|NCT02432235|594404222|FG011|Overall Study|Lost to Follow-up|0|||
164555276|NCT02432235|594404211|FG000|Overall Study|Miscellaneous|0|||
164555277|NCT02432235|594404212|FG001|Overall Study|Miscellaneous|0|||
164555278|NCT02432235|594404213|FG002|Overall Study|Miscellaneous|0|||
164555279|NCT02432235|594404214|FG003|Overall Study|Miscellaneous|0|||
164555280|NCT02432235|594404215|FG004|Overall Study|Miscellaneous|1|||
164555281|NCT02432235|594404216|FG005|Overall Study|Miscellaneous|6|||
164555282|NCT02432235|594404217|FG006|Overall Study|Miscellaneous|2|||
164555283|NCT02432235|594404218|FG007|Overall Study|Miscellaneous|2|||
164555284|NCT02432235|594404219|FG008|Overall Study|Miscellaneous|4|||
164555285|NCT02432235|594404220|FG009|Overall Study|Miscellaneous|0|||
164555286|NCT02432235|594404221|FG010|Overall Study|Miscellaneous|0|||
164555287|NCT02432235|594404222|FG011|Overall Study|Miscellaneous|1|||
164555288|NCT03603496|594404223|FG000|Overall Study|Death|19|||
164555289|NCT03603496|594404224|FG001|Overall Study|Death|24|||
164555290|NCT03603496|594404223|FG000|Overall Study|Lost to Follow-up|141|||
164555291|NCT03603496|594404224|FG001|Overall Study|Lost to Follow-up|141|||
164555292|NCT03603496|594404223|FG000|Overall Study|Withdrawal by Subject|26|||
164555293|NCT03603496|594404224|FG001|Overall Study|Withdrawal by Subject|20|||
164555294|NCT00004259|594404227|FG000|Overall Study|Protocol Violation|1|||
164555295|NCT00004259|594404228|FG001|Overall Study|Protocol Violation|2|||
164555296|NCT00004259|594404229|FG002|Overall Study|Protocol Violation|0|||
164555297|NCT00004259|594404230|FG003|Overall Study|Protocol Violation|0|||
164555298|NCT00004259|594404227|FG000|Overall Study|Withdrawal by Subject|0|||
164555299|NCT00004259|594404228|FG001|Overall Study|Withdrawal by Subject|2|||
164555300|NCT00004259|594404229|FG002|Overall Study|Withdrawal by Subject|0|||
164555301|NCT00004259|594404230|FG003|Overall Study|Withdrawal by Subject|0|||
164555302|NCT03594227|594404231|FG000|Overall Study|Adverse Event|2|||
164555303|NCT03594227|594404232|FG001|Overall Study|Adverse Event|1|||
164555304|NCT03594227|594404233|FG002|Overall Study|Adverse Event|0|||
164555305|NCT03594227|594404234|FG003|Overall Study|Adverse Event|2|||
164555306|NCT03594227|594404231|FG000|Overall Study|Lost to Follow-up|1|||
164555307|NCT03594227|594404232|FG001|Overall Study|Lost to Follow-up|1|||
164555308|NCT03594227|594404233|FG002|Overall Study|Lost to Follow-up|1|||
164555309|NCT03594227|594404234|FG003|Overall Study|Lost to Follow-up|0|||
164555310|NCT03594227|594404231|FG000|Overall Study|Withdrawal by Subject|1|||
164555311|NCT03594227|594404232|FG001|Overall Study|Withdrawal by Subject|1|||
164555312|NCT03594227|594404233|FG002|Overall Study|Withdrawal by Subject|1|||
164555313|NCT03594227|594404234|FG003|Overall Study|Withdrawal by Subject|1|||
164555314|NCT03594227|594404231|FG000|Overall Study|Pregnancy|0|||
164555315|NCT03594227|594404232|FG001|Overall Study|Pregnancy|1|||
164310911|NCT02474069|593512994|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
164310912|NCT02474069|593512992|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
164310913|NCT02474069|593512993|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
164310914|NCT02474069|593512994|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
164310915|NCT02474069|593512992|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
164420598|NCT01890967|593910949|FG003|Overall Study|Lost to Follow-up|1|||
164555316|NCT03594227|594404233|FG002|Overall Study|Pregnancy|0|||
164555317|NCT03594227|594404234|FG003|Overall Study|Pregnancy|0|||
164555318|NCT03594227|594404231|FG000|Overall Study|Sponsor Decision|0|||
164555319|NCT03594227|594404232|FG001|Overall Study|Sponsor Decision|0|||
164555320|NCT03594227|594404233|FG002|Overall Study|Sponsor Decision|0|||
164555321|NCT03594227|594404234|FG003|Overall Study|Sponsor Decision|1|||
164555322|NCT03594227|594404231|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
164555323|NCT03594227|594404232|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
164555324|NCT03594227|594404233|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
164555325|NCT03594227|594404234|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
164555326|NCT00109707|594404240|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
164555327|NCT00109707|594404241|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
164555328|NCT00109707|594404242|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
164555329|NCT00109707|594404240|FG000|Overall Study|Abnormal laboratory values|1|||
164555330|NCT00109707|594404241|FG001|Overall Study|Abnormal laboratory values|0|||
164555331|NCT00109707|594404242|FG002|Overall Study|Abnormal laboratory values|0|||
164555332|NCT00109707|594404240|FG000|Overall Study|Administrative problems|2|||
164555333|NCT00109707|594404241|FG001|Overall Study|Administrative problems|0|||
164555334|NCT00109707|594404242|FG002|Overall Study|Administrative problems|1|||
164555335|NCT00109707|594404240|FG000|Overall Study|Adverse Event|10|||
164555336|NCT00109707|594404241|FG001|Overall Study|Adverse Event|2|||
164555337|NCT00109707|594404242|FG002|Overall Study|Adverse Event|3|||
164555338|NCT00109707|594404240|FG000|Overall Study|Death|4|||
164555339|NCT00109707|594404241|FG001|Overall Study|Death|0|||
164555340|NCT00109707|594404242|FG002|Overall Study|Death|0|||
164555341|NCT00109707|594404240|FG000|Overall Study|Disease progression|12|||
164555342|NCT00109707|594404241|FG001|Overall Study|Disease progression|4|||
164555343|NCT00109707|594404242|FG002|Overall Study|Disease progression|3|||
164555344|NCT00109707|594404240|FG000|Overall Study|Lost to Follow-up|3|||
164555345|NCT00109707|594404241|FG001|Overall Study|Lost to Follow-up|0|||
164555346|NCT00109707|594404242|FG002|Overall Study|Lost to Follow-up|0|||
164555347|NCT00109707|594404240|FG000|Overall Study|Protocol Violation|1|||
164555348|NCT00109707|594404241|FG001|Overall Study|Protocol Violation|0|||
164555349|NCT00109707|594404242|FG002|Overall Study|Protocol Violation|0|||
164555350|NCT00109707|594404240|FG000|Overall Study|Patient withdrew consent|6|||
164555351|NCT00109707|594404241|FG001|Overall Study|Patient withdrew consent|1|||
164555352|NCT00109707|594404242|FG002|Overall Study|Patient withdrew consent|0|||
164555353|NCT00960843|594404257|FG000|Overall Study|Lost to Follow-up|2|||
164555354|NCT00960843|594404258|FG001|Overall Study|Lost to Follow-up|0|||
164555355|NCT00960843|594404257|FG000|Overall Study|Protocol Violation|0|||
164555356|NCT00960843|594404258|FG001|Overall Study|Protocol Violation|4|||
164555357|NCT00960843|594404257|FG000|Overall Study|Repeated needle dislodgment|0|||
164555358|NCT00960843|594404258|FG001|Overall Study|Repeated needle dislodgment|1|||
164555359|NCT01967537|594404259|FG000|Overall Study|Withdrawal by Subject|52|||
164555360|NCT01967537|594404259|FG000|Overall Study|Refuse treatment|2|||
164555361|NCT01967537|594404259|FG000|Overall Study|Lost to Follow-up|6|||
164555362|NCT00254501|594404262|FG000|Overall Study|Lost to Follow-up|1|||
164555363|NCT00254501|594404263|FG001|Overall Study|Lost to Follow-up|1|||
164555364|NCT00317109|594404264|FG000|Overall Study|Withdrawal by Subject|2|||
164555365|NCT00317109|594404265|FG001|Overall Study|Withdrawal by Subject|0|||
164555366|NCT00317109|594404264|FG000|Overall Study|Migated/moved from study area|1|||
164555367|NCT00317109|594404265|FG001|Overall Study|Migated/moved from study area|0|||
164555368|NCT01508702|594404269|FG000|Overall Study|Adverse Event|7|||
164555369|NCT01508702|594404270|FG001|Overall Study|Adverse Event|3|||
164555370|NCT01508702|594404269|FG000|Overall Study|Gout flare|2|||
164555371|NCT01508702|594404270|FG001|Overall Study|Gout flare|0|||
164555372|NCT01508702|594404269|FG000|Overall Study|Protocol Violation|2|||
164555373|NCT01508702|594404270|FG001|Overall Study|Protocol Violation|1|||
164555374|NCT01508702|594404269|FG000|Overall Study|Lost to Follow-up|1|||
164555375|NCT01508702|594404270|FG001|Overall Study|Lost to Follow-up|2|||
164555376|NCT01508702|594404269|FG000|Overall Study|Withdrawal by Subject|11|||
164555377|NCT01508702|594404270|FG001|Overall Study|Withdrawal by Subject|7|||
164555378|NCT04472429|594404271|FG000|Randomized Period|Ongoing|90|||
164555379|NCT04472429|594404272|FG001|Randomized Period|Ongoing|40|||
164555380|NCT04472429|594404273|FG002|Randomized Period|Ongoing|0|||
164555381|NCT04472429|594404271|FG000|Randomized Period|Death|52|||
164555382|NCT04472429|594404272|FG001|Randomized Period|Death|37|||
164555383|NCT04472429|594404273|FG002|Randomized Period|Death|0|||
164555384|NCT04472429|594404271|FG000|Randomized Period|Lost to Follow-up|4|||
164555385|NCT04472429|594404272|FG001|Randomized Period|Lost to Follow-up|0|||
164555386|NCT04472429|594404273|FG002|Randomized Period|Lost to Follow-up|0|||
164555387|NCT04472429|594404271|FG000|Randomized Period|Physician Decision|1|||
164555388|NCT04472429|594404272|FG001|Randomized Period|Physician Decision|2|||
164555389|NCT04472429|594404273|FG002|Randomized Period|Physician Decision|0|||
164555390|NCT04472429|594404271|FG000|Randomized Period|Withdrawal by Subject|6|||
164555391|NCT04472429|594404272|FG001|Randomized Period|Withdrawal by Subject|5|||
164555392|NCT04472429|594404273|FG002|Randomized Period|Withdrawal by Subject|0|||
164555393|NCT04472429|594404271|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
164555394|NCT04472429|594404272|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
164555395|NCT04472429|594404273|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
164659719|NCT02173704|594780358|FG001|Overall Study|Lost to Follow-up|0|||
164659720|NCT02173704|594780357|FG000|Overall Study|Other|1|||
164659721|NCT02173704|594780358|FG001|Overall Study|Other|0|||
164659722|NCT02173704|594780357|FG000|Overall Study|Protocol Violation|1|||
164659723|NCT02173704|594780358|FG001|Overall Study|Protocol Violation|0|||
164659724|NCT02173704|594780357|FG000|Overall Study|Withdrawal by Subject|9|||
164659725|NCT02173704|594780358|FG001|Overall Study|Withdrawal by Subject|4|||
164659726|NCT03901963|594780359|FG000|Overall Study|Lost to Follow-up|1|||
164659727|NCT03901963|594780360|FG001|Overall Study|Lost to Follow-up|1|||
164659728|NCT03901963|594780359|FG000|Overall Study|Physician Decision|1|||
164659729|NCT03901963|594780360|FG001|Overall Study|Physician Decision|2|||
164659730|NCT03901963|594780359|FG000|Overall Study|Protocol Violation|1|||
164659731|NCT03901963|594780360|FG001|Overall Study|Protocol Violation|1|||
164659732|NCT03901963|594780359|FG000|Overall Study|Withdrawal by Subject|4|||
164659733|NCT03901963|594780360|FG001|Overall Study|Withdrawal by Subject|11|||
164659734|NCT03901963|594780359|FG000|Overall Study|Ongoing|84|||
164659735|NCT03901963|594780360|FG001|Overall Study|Ongoing|73|||
164659736|NCT03901963|594780359|FG000|Overall Study|Randomized but not treated|3|||
164659737|NCT03901963|594780360|FG001|Overall Study|Randomized but not treated|3|||
164659738|NCT04956666|594780361|FG000|Overall Study|Adverse Event|18|||
164659739|NCT04956666|594780361|FG000|Overall Study|Physician Decision|5|||
164659740|NCT01700621|594780362|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
164659741|NCT01700621|594780363|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
164659742|NCT01700621|594780362|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
164659743|NCT01700621|594780363|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
164659744|NCT01700621|594780362|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
164659745|NCT01700621|594780363|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
164659746|NCT02909673|594780364|FG000|Overall Study|Did not meet inclusion criteria|129|||
164659747|NCT02909673|594780365|FG001|Overall Study|Did not meet inclusion criteria|29|||
164659748|NCT02909673|594780364|FG000|Overall Study|Surveys lost by scanner|95|||
164659749|NCT02909673|594780365|FG001|Overall Study|Surveys lost by scanner|2|||
164659750|NCT02909673|594780364|FG000|Overall Study|Tracking info missing|0|||
164659751|NCT02909673|594780365|FG001|Overall Study|Tracking info missing|5|||
164659752|NCT02035137|594780368|FG000|Overall Study|Physician Decision|0|||
164659753|NCT02035137|594780369|FG001|Overall Study|Physician Decision|0|||
164659754|NCT02035137|594780370|FG002|Overall Study|Physician Decision|1|||
164659755|NCT02035137|594780368|FG000|Overall Study|Withdrawal by Subject|0|||
164659756|NCT02035137|594780369|FG001|Overall Study|Withdrawal by Subject|1|||
164659757|NCT02035137|594780370|FG002|Overall Study|Withdrawal by Subject|2|||
164659758|NCT02035137|594780368|FG000|Overall Study|Ineligible|0|||
164659759|NCT02035137|594780369|FG001|Overall Study|Ineligible|1|||
164659760|NCT02035137|594780370|FG002|Overall Study|Ineligible|2|||
164659761|NCT02035137|594780368|FG000|Overall Study|Disease progression prior to treatment start|2|||
164659762|NCT02035137|594780369|FG001|Overall Study|Disease progression prior to treatment start|0|||
164659763|NCT02035137|594780370|FG002|Overall Study|Disease progression prior to treatment start|0|||
164659764|NCT03349333|594780377|FG000|Overall Study|Progression of Disease|36|||
164659765|NCT03349333|594780377|FG000|Overall Study|Adverse Event|11|||
164659766|NCT03349333|594780377|FG000|Overall Study|Other|6|||
164659767|NCT03349333|594780377|FG000|Overall Study|Withdrawal by Subject|5|||
164659768|NCT03349333|594780377|FG000|Overall Study|Conditions interfere with participation|2|||
164659769|NCT03349333|594780377|FG000|Overall Study|Physician Decision|2|||
164659770|NCT03349333|594780377|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
164659771|NCT03349333|594780377|FG000|Overall Study|Patients in treatment less than 24 month|8|||
164659772|NCT00783796|594780378|FG000|Overall Study|Did not receive any stent|4|||
164659773|NCT00783796|594780378|FG000|Overall Study|Received non-XIENCE V stent|1|||
164659774|NCT00783796|594780378|FG000|Overall Study|Received commercial XIENCE V stent|1|||
164659775|NCT01215942|594780381|FG000|Treatment Period|Adverse Event|15|||
164659776|NCT01215942|594780382|FG001|Treatment Period|Adverse Event|26|||
164659777|NCT01215942|594780381|FG000|Treatment Period|Death|2|||
164659778|NCT01215942|594780382|FG001|Treatment Period|Death|4|||
164659779|NCT01215942|594780381|FG000|Treatment Period|Lack of Efficacy|23|||
164659780|NCT01215942|594780382|FG001|Treatment Period|Lack of Efficacy|62|||
164659781|NCT01215942|594780381|FG000|Treatment Period|Lost to Follow-up|3|||
164659782|NCT01215942|594780382|FG001|Treatment Period|Lost to Follow-up|4|||
164659783|NCT01215942|594780381|FG000|Treatment Period|Withdrawal by Subject|17|||
164659784|NCT01215942|594780382|FG001|Treatment Period|Withdrawal by Subject|40|||
164659785|NCT01215942|594780381|FG000|Treatment Period|Physician Decision|5|||
164659786|NCT01215942|594780382|FG001|Treatment Period|Physician Decision|5|||
164659787|NCT01215942|594780381|FG000|Treatment Period|Protocol Violation|0|||
164659788|NCT01215942|594780382|FG001|Treatment Period|Protocol Violation|1|||
164659789|NCT01215942|594780381|FG000|Treatment Period|Sponsor Decision|349|||
164659790|NCT01215942|594780382|FG001|Treatment Period|Sponsor Decision|530|||
164659791|NCT01215942|594780381|FG000|Post-Treatment Follow-Up Period|Death|0|||
164659792|NCT01215942|594780382|FG001|Post-Treatment Follow-Up Period|Death|1|||
164659793|NCT01215942|594780381|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
164420599|NCT01890967|593910950|FG004|Overall Study|Lost to Follow-up|0|||
164555396|NCT04472429|594404271|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
164555397|NCT04472429|594404272|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
164555398|NCT04472429|594404273|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
164555399|NCT04472429|594404271|FG000|Open-label Monotherapy Period|Ongoing|0|||
164555400|NCT04472429|594404272|FG001|Open-label Monotherapy Period|Ongoing|0|||
164555401|NCT04472429|594404273|FG002|Open-label Monotherapy Period|Ongoing|32|||
164555402|NCT04472429|594404271|FG000|Open-label Monotherapy Period|Death|0|||
164555403|NCT04472429|594404272|FG001|Open-label Monotherapy Period|Death|0|||
164555404|NCT04472429|594404273|FG002|Open-label Monotherapy Period|Death|35|||
164555405|NCT04472429|594404271|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
164555406|NCT04472429|594404272|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
164555407|NCT04472429|594404273|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
164555408|NCT01180660|594404274|FG000|Overall Study|Changed to open surgery|1|||
164555409|NCT01180660|594404275|FG001|Overall Study|Changed to open surgery|0|||
164555410|NCT00250835|594404276|FG000|Overall Study|Withdrawal by Subject|1|||
164555411|NCT03461757|594404277|FG000|Overall Study|Adverse Event|1|||
164555412|NCT03461757|594404278|FG001|Overall Study|Adverse Event|0|||
164555413|NCT03461757|594404277|FG000|Overall Study|Lost to Follow-up|13|||
164555414|NCT03461757|594404278|FG001|Overall Study|Lost to Follow-up|7|||
164659794|NCT01215942|594780382|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
164659795|NCT01215942|594780381|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
164659796|NCT01215942|594780382|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
164659797|NCT01215942|594780381|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
164659798|NCT01215942|594780382|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
164659799|NCT01215942|594780381|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
164201888|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
164201889|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
164201890|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
164201891|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
164201892|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
164201893|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
164201894|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
164201895|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
164201896|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
164201897|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
164201898|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
164201899|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
164201900|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
164201901|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
164201902|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
164201903|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
164201904|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
164302365|NCT03755934|593482603|FG001|Overall Study|Physician Decision|0|||
164302366|NCT03755934|593482604|FG002|Overall Study|Physician Decision|0|||
164302367|NCT03755934|593482605|FG003|Overall Study|Physician Decision|1|||
164302368|NCT03755934|593482602|FG000|Overall Study|Withdrawal by Subject|5|||
164302369|NCT03755934|593482603|FG001|Overall Study|Withdrawal by Subject|0|||
164302370|NCT03755934|593482604|FG002|Overall Study|Withdrawal by Subject|0|||
164302371|NCT03755934|593482605|FG003|Overall Study|Withdrawal by Subject|1|||
164302372|NCT03755934|593482602|FG000|Overall Study|Other|3|||
164302373|NCT03755934|593482603|FG001|Overall Study|Other|1|||
164302374|NCT03755934|593482604|FG002|Overall Study|Other|3|||
164302375|NCT03755934|593482605|FG003|Overall Study|Other|1|||
164302376|NCT00904982|593482607|FG000|Overall Study|Withdrawal by Subject|2|||
164302377|NCT00904982|593482608|FG001|Overall Study|Withdrawal by Subject|0|||
164302378|NCT00904982|593482609|FG002|Overall Study|Withdrawal by Subject|0|||
164302379|NCT00904982|593482610|FG003|Overall Study|Withdrawal by Subject|0|||
164302380|NCT02594124|593482613|FG000|Overall Study|Adverse Event|0|||
164302381|NCT02594124|593482614|FG001|Overall Study|Adverse Event|5|||
164302382|NCT02594124|593482615|FG002|Overall Study|Adverse Event|8|||
164302383|NCT02594124|593482616|FG003|Overall Study|Adverse Event|1|||
164302384|NCT02594124|593482617|FG004|Overall Study|Adverse Event|0|||
164302385|NCT02594124|593482618|FG005|Overall Study|Adverse Event|0|||
164302386|NCT02594124|593482619|FG006|Overall Study|Adverse Event|2|||
164302387|NCT02594124|593482620|FG007|Overall Study|Adverse Event|2|||
164302388|NCT02594124|593482621|FG008|Overall Study|Adverse Event|0|||
164302389|NCT02594124|593482613|FG000|Overall Study|Withdrawal by Subject|2|||
164302390|NCT02594124|593482614|FG001|Overall Study|Withdrawal by Subject|3|||
164302391|NCT02594124|593482615|FG002|Overall Study|Withdrawal by Subject|5|||
164302392|NCT02594124|593482616|FG003|Overall Study|Withdrawal by Subject|1|||
164302393|NCT02594124|593482617|FG004|Overall Study|Withdrawal by Subject|8|||
164302394|NCT02594124|593482618|FG005|Overall Study|Withdrawal by Subject|4|||
164201905|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
164555415|NCT03461757|594404277|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
164555416|NCT03461757|594404278|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
164555417|NCT03461757|594404277|FG000|Overall Study|Non-compliance with study treatment|0|||
164555418|NCT03461757|594404278|FG001|Overall Study|Non-compliance with study treatment|1|||
164555419|NCT03461757|594404277|FG000|Overall Study|Pregnancy|2|||
164555420|NCT03461757|594404278|FG001|Overall Study|Pregnancy|0|||
164555421|NCT03461757|594404277|FG000|Overall Study|Protocol Violation|1|||
164555422|NCT03461757|594404278|FG001|Overall Study|Protocol Violation|1|||
164555423|NCT03461757|594404277|FG000|Overall Study|Withdrawal by Subject|7|||
164555424|NCT03461757|594404278|FG001|Overall Study|Withdrawal by Subject|7|||
164555425|NCT03461757|594404277|FG000|Overall Study|Other Reasons|1|||
164555426|NCT03461757|594404278|FG001|Overall Study|Other Reasons|4|||
164555427|NCT02425826|594404279|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
164555428|NCT02425826|594404280|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
164555429|NCT02425826|594404281|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
164555430|NCT02425826|594404279|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
164555431|NCT02425826|594404280|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
164555432|NCT02425826|594404281|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
164555433|NCT02425826|594404279|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
164555434|NCT02425826|594404280|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
164555435|NCT02425826|594404281|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
164555436|NCT02425826|594404279|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
164555437|NCT02425826|594404280|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
164555438|NCT02425826|594404281|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
164555439|NCT02425826|594404279|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
164555440|NCT02425826|594404280|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
164555441|NCT02425826|594404281|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
164555442|NCT02425826|594404279|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
164555443|NCT02425826|594404280|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
164555444|NCT02425826|594404281|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
164555445|NCT02425826|594404279|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
164555446|NCT02425826|594404280|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
164555447|NCT02425826|594404281|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
164555448|NCT02425826|594404279|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
164555449|NCT02425826|594404280|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
164201906|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
164201907|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
164201908|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
164201909|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
164201910|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
164201911|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
164201912|NCT01791595|593112614|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
164201913|NCT01791595|593112615|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
164201914|NCT01791595|593112616|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
164201915|NCT01791595|593112617|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
164201916|NCT01791595|593112618|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
164201917|NCT01791595|593112619|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
164201918|NCT01791595|593112620|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
164201919|NCT01791595|593112614|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
164201920|NCT01791595|593112615|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
164201921|NCT01791595|593112616|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
164201922|NCT01791595|593112617|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
164201923|NCT01791595|593112618|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
164201924|NCT01791595|593112619|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
164201925|NCT01791595|593112620|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
164201926|NCT01791595|593112614|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
164201927|NCT01791595|593112615|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
164201928|NCT01791595|593112616|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
164201929|NCT01791595|593112617|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
164201930|NCT01791595|593112618|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
164201931|NCT01791595|593112619|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
164201932|NCT01791595|593112620|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
164201933|NCT01791595|593112614|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
164201934|NCT01791595|593112615|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
164302984|NCT02760498|593484678|FG005|Overall Study|Not treated|2|||
164555450|NCT02425826|594404281|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
164555451|NCT02425826|594404279|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
164555452|NCT02425826|594404280|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
164555453|NCT02425826|594404281|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
164555454|NCT02425826|594404279|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
164555455|NCT02425826|594404280|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
164555456|NCT02425826|594404281|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
164555457|NCT03861559|594404282|FG000|Overall Study|Adverse Event|0|||
164555458|NCT03861559|594404283|FG001|Overall Study|Adverse Event|2|||
164555459|NCT03861559|594404282|FG000|Overall Study|Treatment failure|0|||
164555460|NCT03861559|594404283|FG001|Overall Study|Treatment failure|2|||
164555461|NCT03861559|594404282|FG000|Overall Study|Noncompliance|1|||
164555462|NCT03861559|594404283|FG001|Overall Study|Noncompliance|1|||
164555463|NCT03861559|594404282|FG000|Overall Study|Did not meet eligibility requirements|1|||
164555464|NCT03861559|594404283|FG001|Overall Study|Did not meet eligibility requirements|0|||
164555465|NCT01100437|594404289|FG000|Titration/Stabilization|Adverse Event|0|||
164555466|NCT01100437|594404290|FG001|Titration/Stabilization|Adverse Event|0|||
164555467|NCT01100437|594404291|FG002|Titration/Stabilization|Adverse Event|4|||
164555468|NCT01100437|594404289|FG000|Titration/Stabilization|Non-compliance|0|||
164555469|NCT01100437|594404290|FG001|Titration/Stabilization|Non-compliance|0|||
164555470|NCT01100437|594404291|FG002|Titration/Stabilization|Non-compliance|1|||
164555471|NCT01100437|594404289|FG000|Titration/Stabilization|Sponsor canceled study|0|||
164555472|NCT01100437|594404290|FG001|Titration/Stabilization|Sponsor canceled study|0|||
164555473|NCT01100437|594404291|FG002|Titration/Stabilization|Sponsor canceled study|1|||
164555474|NCT01100437|594404289|FG000|Maintenance|Withdrawal by Subject|0|||
164555475|NCT01100437|594404290|FG001|Maintenance|Withdrawal by Subject|0|||
164555476|NCT01100437|594404291|FG002|Maintenance|Withdrawal by Subject|1|||
164555477|NCT01100437|594404289|FG000|Maintenance|Sponsor termination of study|0|||
164555478|NCT01100437|594404290|FG001|Maintenance|Sponsor termination of study|0|||
164555479|NCT01100437|594404291|FG002|Maintenance|Sponsor termination of study|1|||
164555480|NCT04489888|594404292|FG000|Overall Study|Death|75|||
164555481|NCT04489888|594404292|FG000|Overall Study|Sponsor Decision|26|||
164555482|NCT03829657|594404302|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
164555483|NCT03829657|594404303|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
164555484|NCT03829657|594404304|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
164555485|NCT03829657|594404305|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
164555486|NCT03829657|594404306|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
164555487|NCT03829657|594404302|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
164555488|NCT03829657|594404303|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
164555489|NCT03829657|594404304|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
164555490|NCT03829657|594404305|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
164555491|NCT03829657|594404306|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
164555492|NCT03829657|594404302|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
164555493|NCT03829657|594404303|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
164555494|NCT03829657|594404304|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
164555495|NCT03829657|594404305|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
164555496|NCT03829657|594404306|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
164555497|NCT03829657|594404302|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
164555498|NCT03829657|594404303|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
164555499|NCT03829657|594404304|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
164555500|NCT03829657|594404305|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
164555501|NCT03829657|594404306|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
164555502|NCT03829657|594404302|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
164555503|NCT03829657|594404303|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
164555504|NCT03829657|594404304|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
164555505|NCT03829657|594404305|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
164555506|NCT03829657|594404306|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
164555507|NCT03829657|594404302|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
164555508|NCT03829657|594404303|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
164555509|NCT03829657|594404304|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
164555510|NCT03829657|594404305|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
164555511|NCT03829657|594404306|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
164555512|NCT03829657|594404302|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
164555513|NCT03829657|594404303|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
164555514|NCT03829657|594404304|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
164555515|NCT03829657|594404305|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
164310916|NCT02474069|593512993|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
164310917|NCT02474069|593512994|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
164310918|NCT02474069|593512992|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
164310919|NCT02474069|593512993|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
164310920|NCT02474069|593512994|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
164310921|NCT02474069|593512992|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
164310922|NCT02474069|593512993|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
164555516|NCT03829657|594404306|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
164555517|NCT03829657|594404302|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
164555518|NCT03829657|594404303|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
164555519|NCT03829657|594404304|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
164555520|NCT03829657|594404305|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
164555521|NCT03829657|594404306|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
164555522|NCT03829657|594404302|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
164555523|NCT03829657|594404303|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
164555524|NCT03829657|594404304|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
164555525|NCT03829657|594404305|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
164555526|NCT03829657|594404306|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
164555527|NCT03829657|594404302|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
164555528|NCT03829657|594404303|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
164555529|NCT03829657|594404304|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
164555530|NCT03829657|594404305|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
164555531|NCT03829657|594404306|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
164555532|NCT02867995|594404308|FG000|Overall Study|Withdrawal by Subject|0|||
164555533|NCT02867995|594404309|FG001|Overall Study|Withdrawal by Subject|1|||
164555534|NCT02867995|594404308|FG000|Overall Study|Lost to Follow-up|0|||
164555535|NCT02867995|594404309|FG001|Overall Study|Lost to Follow-up|2|||
164555536|NCT01534533|594404310|FG000|Overall Study|Lost to Follow-up|3|||
164555537|NCT01534533|594404311|FG001|Overall Study|Lost to Follow-up|0|||
164555538|NCT01534533|594404312|FG002|Overall Study|Lost to Follow-up|4|||
164555539|NCT01534533|594404313|FG003|Overall Study|Lost to Follow-up|3|||
164555540|NCT01534533|594404310|FG000|Overall Study|Withdrawal by Subject|5|||
164555541|NCT01534533|594404311|FG001|Overall Study|Withdrawal by Subject|3|||
164555542|NCT01534533|594404312|FG002|Overall Study|Withdrawal by Subject|4|||
164555543|NCT01534533|594404313|FG003|Overall Study|Withdrawal by Subject|1|||
164555544|NCT03368170|594405869|FG000|Overall Study|Adverse Event|2|||
164555545|NCT03368170|594405870|FG001|Overall Study|Adverse Event|1|||
164555546|NCT03704194|594405878|FG000|Overall Study|Withdrawal by Subject|0|||
164555547|NCT03704194|594405879|FG001|Overall Study|Withdrawal by Subject|1|||
164555548|NCT00925015|594405880|FG000|Overall Study|Adverse Event|1|||
164555549|NCT00925015|594405881|FG001|Overall Study|Adverse Event|2|||
164555550|NCT00925015|594405882|FG002|Overall Study|Adverse Event|1|||
164555551|NCT00925015|594405880|FG000|Overall Study|Physician Decision|0|||
164555552|NCT00925015|594405881|FG001|Overall Study|Physician Decision|1|||
164555553|NCT00925015|594405882|FG002|Overall Study|Physician Decision|0|||
164555554|NCT00925015|594405880|FG000|Overall Study|Progressive Disease|7|||
164555555|NCT00925015|594405881|FG001|Overall Study|Progressive Disease|3|||
164555556|NCT00925015|594405882|FG002|Overall Study|Progressive Disease|4|||
164555557|NCT00925015|594405880|FG000|Overall Study|Withdrawal by Subject|0|||
164555558|NCT00925015|594405881|FG001|Overall Study|Withdrawal by Subject|0|||
164555559|NCT00925015|594405882|FG002|Overall Study|Withdrawal by Subject|1|||
164555560|NCT04986202|594405883|FG000|Overall Study|Death|10|||
164555561|NCT04986202|594405884|FG001|Overall Study|Death|3|||
164555562|NCT04986202|594405885|FG002|Overall Study|Death|10|||
164555563|NCT04986202|594405883|FG000|Overall Study|Physician Decision|3|||
164555564|NCT04986202|594405884|FG001|Overall Study|Physician Decision|1|||
164555565|NCT04986202|594405885|FG002|Overall Study|Physician Decision|2|||
164555566|NCT04986202|594405883|FG000|Overall Study|Withdrawal by Subject|4|||
164555567|NCT04986202|594405884|FG001|Overall Study|Withdrawal by Subject|2|||
164310923|NCT02474069|593512994|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
164310924|NCT02474069|593512992|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
164310925|NCT02474069|593512993|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
164310926|NCT02474069|593512994|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
164555568|NCT04986202|594405885|FG002|Overall Study|Withdrawal by Subject|4|||
164555569|NCT03806127|594405891|FG000|Overall Study|Withdrawal by Subject|4|||
164555570|NCT03806127|594405892|FG001|Overall Study|Withdrawal by Subject|5|||
164555571|NCT03806127|594405891|FG000|Overall Study|Protocol Violation|3|||
164555572|NCT03806127|594405892|FG001|Overall Study|Protocol Violation|1|||
164555573|NCT03806127|594405891|FG000|Overall Study|Adverse Event|3|||
164555574|NCT03806127|594405892|FG001|Overall Study|Adverse Event|0|||
164555575|NCT03806127|594405891|FG000|Overall Study|Unable to Complete Procedures|0|||
164555576|NCT03806127|594405892|FG001|Overall Study|Unable to Complete Procedures|1|||
164555577|NCT03806127|594405891|FG000|Overall Study|Pregnancy|0|||
164555578|NCT03806127|594405892|FG001|Overall Study|Pregnancy|1|||
164201935|NCT01791595|593112616|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
164555579|NCT03806127|594405891|FG000|Overall Study|Lost to Follow-up|5|||
164555580|NCT03806127|594405892|FG001|Overall Study|Lost to Follow-up|1|||
164555581|NCT03806127|594405891|FG000|Overall Study|Physician Decision|1|||
164555582|NCT03806127|594405892|FG001|Overall Study|Physician Decision|1|||
164555583|NCT03806127|594405891|FG000|Overall Study|Could Not Come Due to Covid|1|||
164555584|NCT03806127|594405892|FG001|Overall Study|Could Not Come Due to Covid|0|||
164555585|NCT03806127|594405891|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
164555586|NCT03806127|594405892|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
164555587|NCT03806127|594405891|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
164555588|NCT03806127|594405892|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
164555589|NCT03806127|594405891|FG000|Overall Study|Covid 19 Restrictions|2|||
164555590|NCT03806127|594405892|FG001|Overall Study|Covid 19 Restrictions|0|||
164555591|NCT03806127|594405891|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
164555592|NCT03806127|594405892|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
164555593|NCT03806127|594405891|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
164555594|NCT03806127|594405892|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
164555595|NCT03823391|594405896|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
164555596|NCT03823391|594405897|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
164555597|NCT03823391|594405896|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
164555598|NCT03823391|594405897|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
164555599|NCT05882318|594405903|FG000|Overall Study|Withdrawal by Subject|1|||
164555600|NCT05882318|594405904|FG001|Overall Study|Withdrawal by Subject|0|||
164659800|NCT01215942|594780382|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
164659801|NCT02752776|594780383|FG000|Overall Study|Adverse Event|15|||
164201936|NCT01791595|593112617|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
164201937|NCT01791595|593112618|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
164201938|NCT01791595|593112619|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
164201939|NCT01791595|593112620|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
164201940|NCT01776554|593112621|FG000|Overall Study|Adverse Event|1|||
164201941|NCT01776554|593112622|FG001|Overall Study|Adverse Event|0|||
164201942|NCT01776554|593112621|FG000|Overall Study|Withdrawal by Subject|3|||
164201943|NCT01776554|593112622|FG001|Overall Study|Withdrawal by Subject|8|||
164201944|NCT01776554|593112621|FG000|Overall Study|Lost to Follow-up|6|||
164201945|NCT01776554|593112622|FG001|Overall Study|Lost to Follow-up|9|||
164201946|NCT01776554|593112621|FG000|Overall Study|Administrative Reason|2|||
164201947|NCT01776554|593112622|FG001|Overall Study|Administrative Reason|5|||
164201948|NCT01776554|593112621|FG000|Overall Study|Protocol Violation|1|||
164201949|NCT01776554|593112622|FG001|Overall Study|Protocol Violation|0|||
164201950|NCT01776554|593112621|FG000|Overall Study|Unclassified|4|||
164201951|NCT01776554|593112622|FG001|Overall Study|Unclassified|1|||
164201952|NCT01041859|593112623|FG000|Open-Label Titration|Adverse Event|69|||
164201953|NCT01041859|593112624|FG001|Open-Label Titration|Adverse Event|0|||
164201954|NCT01041859|593112625|FG002|Open-Label Titration|Adverse Event|0|||
164201955|NCT01041859|593112623|FG000|Open-Label Titration|Lack of Efficacy|3|||
164201956|NCT01041859|593112624|FG001|Open-Label Titration|Lack of Efficacy|0|||
164201957|NCT01041859|593112625|FG002|Open-Label Titration|Lack of Efficacy|0|||
164201958|NCT01041859|593112623|FG000|Open-Label Titration|Lost to Follow-up|1|||
164201959|NCT01041859|593112624|FG001|Open-Label Titration|Lost to Follow-up|0|||
164201960|NCT01041859|593112625|FG002|Open-Label Titration|Lost to Follow-up|0|||
164201961|NCT01041859|593112623|FG000|Open-Label Titration|Physician Decision|1|||
164201962|NCT01041859|593112624|FG001|Open-Label Titration|Physician Decision|0|||
164201963|NCT01041859|593112625|FG002|Open-Label Titration|Physician Decision|0|||
164201964|NCT01041859|593112623|FG000|Open-Label Titration|Protocol Violation|1|||
164201965|NCT01041859|593112624|FG001|Open-Label Titration|Protocol Violation|0|||
164201966|NCT01041859|593112625|FG002|Open-Label Titration|Protocol Violation|0|||
164201967|NCT01041859|593112623|FG000|Open-Label Titration|Other|7|||
164201968|NCT01041859|593112624|FG001|Open-Label Titration|Other|0|||
164201969|NCT01041859|593112625|FG002|Open-Label Titration|Other|0|||
164201970|NCT01041859|593112623|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
164201971|NCT01041859|593112624|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
164310927|NCT03023813|593512997|FG000|Overall Study|Lost to Follow-up|1|||
164555601|NCT05882318|594405903|FG000|Overall Study|Protocol Violation|0|||
164555602|NCT05882318|594405904|FG001|Overall Study|Protocol Violation|1|||
164201972|NCT01041859|593112625|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
164201973|NCT01041859|593112623|FG000|Open-Label Titration|Withdrawal by Subject|11|||
164201974|NCT01041859|593112624|FG001|Open-Label Titration|Withdrawal by Subject|0|||
164201975|NCT01041859|593112625|FG002|Open-Label Titration|Withdrawal by Subject|0|||
164201976|NCT01041859|593112623|FG000|Double-Blind Maintenance|Adverse Event|0|||
164201977|NCT01041859|593112624|FG001|Double-Blind Maintenance|Adverse Event|23|||
164201978|NCT01041859|593112625|FG002|Double-Blind Maintenance|Adverse Event|13|||
164201979|NCT01041859|593112623|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
164659802|NCT02752776|594780384|FG001|Overall Study|Adverse Event|23|||
164659803|NCT02752776|594780385|FG002|Overall Study|Adverse Event|11|||
164659804|NCT02752776|594780383|FG000|Overall Study|Lack of Efficacy|2|||
164659805|NCT02752776|594780384|FG001|Overall Study|Lack of Efficacy|6|||
164659806|NCT02752776|594780385|FG002|Overall Study|Lack of Efficacy|14|||
164659807|NCT02752776|594780383|FG000|Overall Study|Lost to Follow-up|11|||
164659808|NCT02752776|594780384|FG001|Overall Study|Lost to Follow-up|12|||
164659809|NCT02752776|594780385|FG002|Overall Study|Lost to Follow-up|4|||
164659810|NCT02752776|594780383|FG000|Overall Study|Non-compliance with study treatment|0|||
164659811|NCT02752776|594780384|FG001|Overall Study|Non-compliance with study treatment|0|||
164659812|NCT02752776|594780385|FG002|Overall Study|Non-compliance with study treatment|1|||
164659813|NCT02752776|594780383|FG000|Overall Study|Physician Decision|2|||
164659814|NCT02752776|594780384|FG001|Overall Study|Physician Decision|6|||
164659815|NCT02752776|594780385|FG002|Overall Study|Physician Decision|2|||
164659816|NCT02752776|594780383|FG000|Overall Study|Pregnancy|1|||
164659817|NCT02752776|594780384|FG001|Overall Study|Pregnancy|6|||
164659818|NCT02752776|594780385|FG002|Overall Study|Pregnancy|3|||
164659819|NCT02752776|594780383|FG000|Overall Study|Protocol Violation|10|||
164659820|NCT02752776|594780384|FG001|Overall Study|Protocol Violation|13|||
164659821|NCT02752776|594780385|FG002|Overall Study|Protocol Violation|6|||
164659822|NCT02752776|594780383|FG000|Overall Study|Subject/guardian decision|8|||
164659823|NCT02752776|594780384|FG001|Overall Study|Subject/guardian decision|6|||
164659824|NCT02752776|594780385|FG002|Overall Study|Subject/guardian decision|4|||
164659825|NCT02752776|594780383|FG000|Overall Study|Death|0|||
164659826|NCT02752776|594780384|FG001|Overall Study|Death|0|||
164659827|NCT02752776|594780385|FG002|Overall Study|Death|1|||
164659828|NCT02752776|594780383|FG000|Overall Study|Withdrawal by Subject|3|||
164659829|NCT02752776|594780384|FG001|Overall Study|Withdrawal by Subject|4|||
164659830|NCT02752776|594780385|FG002|Overall Study|Withdrawal by Subject|2|||
164659831|NCT01816477|594780386|FG000|Overall Study|Withdrawal by Subject|13|||
164659832|NCT01816477|594780387|FG001|Overall Study|Withdrawal by Subject|1|||
164659833|NCT01816477|594780386|FG000|Overall Study|Unable to tolerate catheter placement|3|||
164659834|NCT01816477|594780387|FG001|Overall Study|Unable to tolerate catheter placement|0|||
164659835|NCT02162758|594780388|FG000|Overall Study|Study termination|0|||
164659836|NCT02162758|594780389|FG001|Overall Study|Study termination|1|||
164659837|NCT04471935|594780390|FG000|Overall Study|Withdrawal by Subject|1|||
164659838|NCT04471935|594780390|FG000|Overall Study|Deemed ineligible to participate|1|||
164659839|NCT02116803|594780391|FG000|Overall Study|Adverse Event|2|||
164659840|NCT02116803|594780392|FG001|Overall Study|Adverse Event|1|||
164659841|NCT02116803|594780391|FG000|Overall Study|Physician Decision|1|||
164659842|NCT02116803|594780392|FG001|Overall Study|Physician Decision|0|||
164659843|NCT02116803|594780391|FG000|Overall Study|Progressive disease|4|||
164659844|NCT02116803|594780392|FG001|Overall Study|Progressive disease|0|||
164659845|NCT02116803|594780391|FG000|Overall Study|Study terminated by sponsor|2|||
164659846|NCT02116803|594780392|FG001|Overall Study|Study terminated by sponsor|1|||
164659847|NCT02116803|594780391|FG000|Overall Study|Death|1|||
164659848|NCT02116803|594780392|FG001|Overall Study|Death|0|||
164659849|NCT03213210|594780393|FG000|Overall Study|Lost to Follow-up|2|||
164659850|NCT03213210|594780393|FG000|Overall Study|Study termination|3|||
164659851|NCT01399736|594780394|FG000|Overall Study|Withdrawal by Subject|4|||
164659852|NCT01399736|594780395|FG001|Overall Study|Withdrawal by Subject|2|||
164659853|NCT01399736|594780394|FG000|Overall Study|Lost to Follow-up|0|||
164659854|NCT01399736|594780395|FG001|Overall Study|Lost to Follow-up|2|||
164659855|NCT03500484|594780396|FG000|Overall Study|Adverse Event|2|||
164659856|NCT03500484|594780397|FG001|Overall Study|Adverse Event|0|||
164659857|NCT03500484|594780396|FG000|Overall Study|Physician Decision|1|||
164659858|NCT03500484|594780397|FG001|Overall Study|Physician Decision|0|||
164659859|NCT03500484|594780396|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
164659860|NCT03500484|594780397|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
164659861|NCT02795104|594780398|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
164659862|NCT02795104|594780399|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
164659863|NCT02795104|594780400|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
164659864|NCT02795104|594780398|FG000|Overall Study|Withdrawal by Subject|0|||
164659865|NCT02795104|594780399|FG001|Overall Study|Withdrawal by Subject|2|||
164201980|NCT01041859|593112624|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
164201981|NCT01041859|593112625|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
164201982|NCT01041859|593112623|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
164201983|NCT01041859|593112624|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
164201984|NCT01041859|593112625|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
164659866|NCT02795104|594780400|FG002|Overall Study|Withdrawal by Subject|0|||
164659867|NCT02795104|594780398|FG000|Overall Study|Lost to Follow-up|0|||
164659868|NCT02795104|594780399|FG001|Overall Study|Lost to Follow-up|0|||
164659869|NCT02795104|594780400|FG002|Overall Study|Lost to Follow-up|1|||
164659870|NCT00948675|594780401|FG000|Overall Study|Lost to Follow-up|1|||
164659871|NCT00948675|594780402|FG001|Overall Study|Lost to Follow-up|0|||
164659872|NCT00684671|594780403|FG000|Overall Study|Adverse Event|1|||
164201985|NCT01041859|593112623|FG000|Double-Blind Maintenance|Physician Decision|0|||
164310928|NCT03023813|593512998|FG001|Overall Study|Lost to Follow-up|2|||
164310929|NCT03023813|593512999|FG002|Overall Study|Lost to Follow-up|0|||
164310930|NCT03710083|593513000|FG000|Overall Study|Withdrawal by Subject|2|||
164310931|NCT03710083|593513000|FG000|Overall Study|Unsuccessful Procedure|1|||
164310932|NCT02283762|593513001|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
164310933|NCT02283762|593513002|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
164310934|NCT02283762|593513001|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
164310935|NCT02283762|593513002|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
164310936|NCT02283762|593513001|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
164310937|NCT02283762|593513002|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
164310938|NCT02283762|593513001|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
164310939|NCT02283762|593513002|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
164310940|NCT02283762|593513001|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
164310941|NCT02283762|593513002|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
164310942|NCT02283762|593513001|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
164310943|NCT02283762|593513002|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
164310944|NCT02283762|593513001|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
164310945|NCT02283762|593513002|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
164310946|NCT02283762|593513001|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
164310947|NCT02283762|593513002|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
164310948|NCT02283762|593513001|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
164310949|NCT02283762|593513002|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
164310950|NCT02283762|593513001|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
164310951|NCT02283762|593513002|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
164310952|NCT02283762|593513001|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
164310953|NCT02283762|593513002|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
164310954|NCT02283762|593513001|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
164310955|NCT02283762|593513002|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
164310956|NCT00202878|593513006|FG000|Overall Study|Death|964|||
164310957|NCT00202878|593513007|FG001|Overall Study|Death|968|||
164310958|NCT00202878|593513006|FG000|Overall Study|Only Vital Status Known|357|||
164310959|NCT00202878|593513007|FG001|Overall Study|Only Vital Status Known|356|||
164310960|NCT00202878|593513006|FG000|Overall Study|Lost to Follow-up|44|||
164310961|NCT00202878|593513007|FG001|Overall Study|Lost to Follow-up|49|||
164310962|NCT00202878|593513006|FG000|Overall Study|Site Closure|39|||
164310963|NCT00202878|593513007|FG001|Overall Study|Site Closure|36|||
164310964|NCT00202878|593513006|FG000|Overall Study|Withdrawal by Subject|795|||
164310965|NCT00202878|593513007|FG001|Overall Study|Withdrawal by Subject|808|||
164310966|NCT00975780|593513016|FG000|Follow Up|Death|88|||
164310967|NCT00975780|593513017|FG001|Follow Up|Death|122|||
164310968|NCT00975780|593513016|FG000|Follow Up|Facility Withdrawal|7|||
164310969|NCT00975780|593513017|FG001|Follow Up|Facility Withdrawal|23|||
164310970|NCT00975780|593513016|FG000|Follow Up|Discharged from Facility|7|||
164310971|NCT00975780|593513017|FG001|Follow Up|Discharged from Facility|12|||
164310972|NCT02813577|593513018|FG000|Overall Study|Study terminated|4|||
164310973|NCT00035932|593513019|FG000|Overall Study|Adverse Event|10|||
164310974|NCT00035932|593513020|FG001|Overall Study|Adverse Event|9|||
164310975|NCT00035932|593513021|FG002|Overall Study|Adverse Event|9|||
164310976|NCT00035932|593513019|FG000|Overall Study|Death|0|||
164310977|NCT00035932|593513020|FG001|Overall Study|Death|0|||
164310978|NCT00035932|593513021|FG002|Overall Study|Death|1|||
164310979|NCT00035932|593513019|FG000|Overall Study|Disease Progression / Relapse|1|||
164310980|NCT00035932|593513020|FG001|Overall Study|Disease Progression / Relapse|1|||
164555603|NCT05030311|594405905|FG000|Overall Study|Technical problems|0|||
164555604|NCT05030311|594405906|FG001|Overall Study|Technical problems|1|||
164555605|NCT05030311|594405905|FG000|Overall Study|Withdrawal by Subject|31|||
164555606|NCT05030311|594405906|FG001|Overall Study|Withdrawal by Subject|17|||
164555607|NCT05030311|594405905|FG000|Overall Study|Adverse Event|13|||
164555608|NCT05030311|594405906|FG001|Overall Study|Adverse Event|5|||
164555609|NCT05030311|594405905|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
164659873|NCT00684671|594780404|FG001|Overall Study|Adverse Event|0|||
164659874|NCT00684671|594780405|FG002|Overall Study|Adverse Event|0|||
164659875|NCT00684671|594780403|FG000|Overall Study|Lost to Follow-up|1|||
164659876|NCT00684671|594780404|FG001|Overall Study|Lost to Follow-up|0|||
164310981|NCT00035932|593513021|FG002|Overall Study|Disease Progression / Relapse|0|||
164310982|NCT00035932|593513019|FG000|Overall Study|Lost to Follow-up|4|||
164310983|NCT00035932|593513020|FG001|Overall Study|Lost to Follow-up|4|||
164310984|NCT00035932|593513021|FG002|Overall Study|Lost to Follow-up|3|||
164310985|NCT00035932|593513019|FG000|Overall Study|Noncompliance|6|||
164310986|NCT00035932|593513020|FG001|Overall Study|Noncompliance|7|||
164310987|NCT00035932|593513021|FG002|Overall Study|Noncompliance|6|||
164310988|NCT00035932|593513019|FG000|Overall Study|Protocol Violation While on Study|0|||
164310989|NCT00035932|593513020|FG001|Overall Study|Protocol Violation While on Study|1|||
164555610|NCT05030311|594405906|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
164555611|NCT05030311|594405905|FG000|Overall Study|Physician Decision|5|||
164659877|NCT00684671|594780405|FG002|Overall Study|Lost to Follow-up|0|||
164659878|NCT00684671|594780403|FG000|Overall Study|Alcoholic dependance|1|||
164659879|NCT00684671|594780404|FG001|Overall Study|Alcoholic dependance|0|||
164659880|NCT00684671|594780405|FG002|Overall Study|Alcoholic dependance|0|||
164659881|NCT04128007|594780406|FG000|Overall Study|Withdrawal by Subject|9|||
164659882|NCT04128007|594780407|FG001|Overall Study|Withdrawal by Subject|6|||
164659883|NCT04128007|594780406|FG000|Overall Study|Protocol Violation|1|||
164659884|NCT04128007|594780407|FG001|Overall Study|Protocol Violation|0|||
164659885|NCT04128007|594780406|FG000|Overall Study|Lost to Follow-up|8|||
164310990|NCT00035932|593513021|FG002|Overall Study|Protocol Violation While on Study|2|||
164310991|NCT00035932|593513019|FG000|Overall Study|Withdrawal by Subject|1|||
164310992|NCT00035932|593513020|FG001|Overall Study|Withdrawal by Subject|5|||
164659886|NCT04128007|594780407|FG001|Overall Study|Lost to Follow-up|7|||
164659887|NCT04128007|594780406|FG000|Overall Study|Adverse Event|5|||
164659888|NCT04128007|594780407|FG001|Overall Study|Adverse Event|2|||
164659889|NCT04128007|594780406|FG000|Overall Study|Not reported|0|||
164659890|NCT04128007|594780407|FG001|Overall Study|Not reported|2|||
164659891|NCT00481247|594780412|FG000|Overall Study|Death|0|||
164659892|NCT00481247|594780413|FG001|Overall Study|Death|1|||
164659893|NCT00481247|594780412|FG000|Overall Study|Disease progression|18|||
164659894|NCT00481247|594780413|FG001|Overall Study|Disease progression|22|||
164659895|NCT00481247|594780412|FG000|Overall Study|Intolerance|42|||
164659896|NCT00481247|594780413|FG001|Overall Study|Intolerance|17|||
164659897|NCT00481247|594780412|FG000|Overall Study|Treatment failure|10|||
164659898|NCT00481247|594780413|FG001|Overall Study|Treatment failure|14|||
164659899|NCT00481247|594780412|FG000|Overall Study|AE unrelated to study drug|13|||
164310993|NCT00035932|593513021|FG002|Overall Study|Withdrawal by Subject|0|||
164310994|NCT00035932|593513019|FG000|Overall Study|Study Termination by Sponsor|1|||
164310995|NCT00035932|593513020|FG001|Overall Study|Study Termination by Sponsor|0|||
164310996|NCT00035932|593513021|FG002|Overall Study|Study Termination by Sponsor|0|||
164310997|NCT00035932|593513019|FG000|Overall Study|Lack of Efficacy|33|||
164310998|NCT00035932|593513020|FG001|Overall Study|Lack of Efficacy|33|||
164310999|NCT00035932|593513021|FG002|Overall Study|Lack of Efficacy|28|||
164311000|NCT01976741|593513022|FG000|Overall Study|Withdrawal by Subject|1|||
164311001|NCT01976741|593513023|FG001|Overall Study|Withdrawal by Subject|0|||
164311002|NCT01976741|593513024|FG002|Overall Study|Withdrawal by Subject|1|||
164311003|NCT01976741|593513025|FG003|Overall Study|Withdrawal by Subject|1|||
164311004|NCT01976741|593513026|FG004|Overall Study|Withdrawal by Subject|0|||
164311005|NCT01976741|593513027|FG005|Overall Study|Withdrawal by Subject|0|||
164311006|NCT01976741|593513028|FG006|Overall Study|Withdrawal by Subject|1|||
164311007|NCT01976741|593513029|FG007|Overall Study|Withdrawal by Subject|4|||
164311008|NCT01976741|593513030|FG008|Overall Study|Withdrawal by Subject|0|||
164311009|NCT01976741|593513031|FG009|Overall Study|Withdrawal by Subject|0|||
164311010|NCT01976741|593513022|FG000|Overall Study|Adverse Event|0|||
164311011|NCT01976741|593513023|FG001|Overall Study|Adverse Event|0|||
164311012|NCT01976741|593513024|FG002|Overall Study|Adverse Event|2|||
164311013|NCT01976741|593513025|FG003|Overall Study|Adverse Event|0|||
164311014|NCT01976741|593513026|FG004|Overall Study|Adverse Event|0|||
164311015|NCT01976741|593513027|FG005|Overall Study|Adverse Event|0|||
164311016|NCT01976741|593513028|FG006|Overall Study|Adverse Event|3|||
164311017|NCT01976741|593513029|FG007|Overall Study|Adverse Event|8|||
164311018|NCT01976741|593513030|FG008|Overall Study|Adverse Event|1|||
164311019|NCT01976741|593513031|FG009|Overall Study|Adverse Event|4|||
164311020|NCT00889720|593513032|FG000|Overall Study|Withdrawal by Subject|4|||
164311021|NCT00889720|593513032|FG000|Overall Study|Other|4|||
164311022|NCT03865381|593513040|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
164311023|NCT03865381|593513040|FG000|Overall Study|Withdrawal by Subject|2|||
164311024|NCT02873377|593513041|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
164311025|NCT02873377|593513042|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
164311026|NCT02873377|593513041|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
164311027|NCT02873377|593513042|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
164311028|NCT00104520|593513043|FG000|Overall Study|Unrelated adverse event|34|||
164311029|NCT00104520|593513044|FG001|Overall Study|Unrelated adverse event|47|||
164311030|NCT00104520|593513043|FG000|Overall Study|Study drug intolerance|0|||
164659900|NCT00481247|594780413|FG001|Overall Study|AE unrelated to study drug|4|||
164659901|NCT00481247|594780412|FG000|Overall Study|Withdrawal by Subject|8|||
164659902|NCT00481247|594780413|FG001|Overall Study|Withdrawal by Subject|13|||
164659903|NCT00481247|594780412|FG000|Overall Study|Pregnancy|2|||
164659904|NCT00481247|594780413|FG001|Overall Study|Pregnancy|1|||
164311031|NCT00104520|593513044|FG001|Overall Study|Study drug intolerance|1|||
164311032|NCT00104520|593513043|FG000|Overall Study|Related adverse event|13|||
164311033|NCT00104520|593513044|FG001|Overall Study|Related adverse event|15|||
164311034|NCT00104520|593513043|FG000|Overall Study|Lost to Follow-up|1|||
164311035|NCT00104520|593513044|FG001|Overall Study|Lost to Follow-up|0|||
164311036|NCT00104520|593513043|FG000|Overall Study|Noncompliance|0|||
164311037|NCT00104520|593513044|FG001|Overall Study|Noncompliance|2|||
164420600|NCT01890967|593910951|FG005|Overall Study|Lost to Follow-up|1|||
164659905|NCT00481247|594780412|FG000|Overall Study|Lost to Follow-up|1|||
164659906|NCT00481247|594780413|FG001|Overall Study|Lost to Follow-up|2|||
164311038|NCT00104520|593513043|FG000|Overall Study|Personal/administrative|1|||
164311039|NCT00104520|593513044|FG001|Overall Study|Personal/administrative|1|||
164311040|NCT00104520|593513043|FG000|Overall Study|Other|1|||
164311041|NCT00104520|593513044|FG001|Overall Study|Other|5|||
164311042|NCT00452361|593513045|FG000|Overall Study|Adverse Event|8|||
164311043|NCT00452361|593513046|FG001|Overall Study|Adverse Event|0|||
164311044|NCT00452361|593513045|FG000|Overall Study|Withdrawal by Subject|0|||
164311045|NCT00452361|593513046|FG001|Overall Study|Withdrawal by Subject|1|||
164311046|NCT00452361|593513045|FG000|Overall Study|Premature termination|13|||
164311047|NCT00452361|593513046|FG001|Overall Study|Premature termination|9|||
164311048|NCT00233064|593513049|FG000|Overall Study|Lost to Follow-up|7|||
164311049|NCT00233064|593513050|FG001|Overall Study|Lost to Follow-up|7|||
164311050|NCT00233064|593513049|FG000|Overall Study|Withdrawal by Subject|5|||
164311051|NCT00233064|593513050|FG001|Overall Study|Withdrawal by Subject|3|||
164311052|NCT00233064|593513049|FG000|Overall Study|Death|0|||
164311053|NCT00233064|593513050|FG001|Overall Study|Death|1|||
164311054|NCT00233064|593513049|FG000|Overall Study|Relocation|0|||
164311055|NCT00233064|593513050|FG001|Overall Study|Relocation|1|||
164311056|NCT00233064|593513049|FG000|Overall Study|Protocol Violation|1|||
164311057|NCT00233064|593513050|FG001|Overall Study|Protocol Violation|0|||
164311058|NCT00233064|593513049|FG000|Overall Study|Moved to Dom. Republic|1|||
164311059|NCT00233064|593513050|FG001|Overall Study|Moved to Dom. Republic|0|||
164311060|NCT02302339|593513051|FG000|Overall Study|Lost to Follow-up|1|||
164311061|NCT02302339|593513052|FG001|Overall Study|Lost to Follow-up|0|||
164311062|NCT02302339|593513053|FG002|Overall Study|Lost to Follow-up|0|||
164311063|NCT02302339|593513054|FG003|Overall Study|Lost to Follow-up|0|||
164311064|NCT02302339|593513051|FG000|Overall Study|Withdrawal by Subject|0|||
164311065|NCT02302339|593513052|FG001|Overall Study|Withdrawal by Subject|2|||
164311066|NCT02302339|593513053|FG002|Overall Study|Withdrawal by Subject|1|||
164311067|NCT02302339|593513054|FG003|Overall Study|Withdrawal by Subject|0|||
164311068|NCT00494676|593513058|FG000|Allocation|Withdrawal by Subject|2|||
164311069|NCT00494676|593513059|FG001|Allocation|Withdrawal by Subject|4|||
164311070|NCT00494676|593513058|FG000|First Intervention|Withdrawal by Subject|1|||
164311071|NCT00494676|593513059|FG001|First Intervention|Withdrawal by Subject|3|||
164311072|NCT00494676|593513058|FG000|Second Intervention|Withdrawal by Subject|1|||
164311073|NCT00494676|593513059|FG001|Second Intervention|Withdrawal by Subject|1|||
164311074|NCT04073225|593513060|FG000|Overall Study|Lost to Follow-up|4|||
164311075|NCT04073225|593513061|FG001|Overall Study|Lost to Follow-up|3|||
164311076|NCT04238819|593513063|FG000|Overall Study|Ongoing Treatment|0|||
164311077|NCT04238819|593513064|FG001|Overall Study|Ongoing Treatment|0|||
164311078|NCT04238819|593513065|FG002|Overall Study|Ongoing Treatment|0|||
164311079|NCT04238819|593513066|FG003|Overall Study|Ongoing Treatment|0|||
164311080|NCT04238819|593513067|FG004|Overall Study|Ongoing Treatment|1|||
164311081|NCT04238819|593513068|FG005|Overall Study|Ongoing Treatment|4|||
164311082|NCT04238819|593513069|FG006|Overall Study|Ongoing Treatment|0|||
164311083|NCT04238819|593513063|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
164311084|NCT04238819|593513064|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
164311085|NCT04238819|593513065|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
164311086|NCT04238819|593513066|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
164311087|NCT04238819|593513067|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
164311088|NCT04238819|593513068|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
164311089|NCT04238819|593513069|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
164311090|NCT03892967|593513070|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
164311091|NCT03892967|593513071|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
164311092|NCT03892967|593513072|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
164311093|NCT03892967|593513073|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
164659907|NCT00481247|594780412|FG000|Overall Study|Poor compliance/noncompliance|1|||
164659908|NCT00481247|594780413|FG001|Overall Study|Poor compliance/noncompliance|7|||
164659909|NCT00481247|594780412|FG000|Overall Study|Administrative reason by sponsor|157|||
164659910|NCT00481247|594780413|FG001|Overall Study|Administrative reason by sponsor|162|||
164659911|NCT00481247|594780412|FG000|Overall Study|Varied|6|||
164659912|NCT00481247|594780413|FG001|Overall Study|Varied|15|||
164659913|NCT00481247|594780412|FG000|Overall Study|Did not receive treatment|1|||
164659914|NCT00481247|594780413|FG001|Overall Study|Did not receive treatment|2|||
164659915|NCT01716754|594780414|FG000|Overall Study|Death|0|||
164311094|NCT03892967|593513074|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
164311095|NCT03892967|593513070|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
164311096|NCT03892967|593513071|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
164311097|NCT03892967|593513072|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
164659916|NCT01716754|594780415|FG001|Overall Study|Death|0|||
164659917|NCT01716754|594780416|FG002|Overall Study|Death|0|||
164659918|NCT01716754|594780417|FG003|Overall Study|Death|1|||
164659919|NCT01716754|594780414|FG000|Overall Study|Protocol deviation|0|||
164659920|NCT01716754|594780415|FG001|Overall Study|Protocol deviation|2|||
164659921|NCT01716754|594780416|FG002|Overall Study|Protocol deviation|7|||
164659922|NCT01716754|594780417|FG003|Overall Study|Protocol deviation|2|||
164659923|NCT01716754|594780414|FG000|Overall Study|Non-compliance with study treatment|0|||
164659924|NCT01716754|594780415|FG001|Overall Study|Non-compliance with study treatment|0|||
164659925|NCT01716754|594780416|FG002|Overall Study|Non-compliance with study treatment|1|||
164659926|NCT01716754|594780417|FG003|Overall Study|Non-compliance with study treatment|0|||
164659927|NCT01716754|594780414|FG000|Overall Study|Physician Decision|1|||
164659928|NCT01716754|594780415|FG001|Overall Study|Physician Decision|0|||
164659929|NCT01716754|594780416|FG002|Overall Study|Physician Decision|0|||
164659930|NCT01716754|594780417|FG003|Overall Study|Physician Decision|0|||
164659931|NCT01716754|594780414|FG000|Overall Study|Lost to Follow-up|1|||
164659932|NCT01716754|594780415|FG001|Overall Study|Lost to Follow-up|0|||
164659933|NCT01716754|594780416|FG002|Overall Study|Lost to Follow-up|0|||
164659934|NCT01716754|594780417|FG003|Overall Study|Lost to Follow-up|1|||
164659935|NCT01716754|594780414|FG000|Overall Study|Adverse Event|4|||
164659936|NCT01716754|594780415|FG001|Overall Study|Adverse Event|2|||
164659937|NCT01716754|594780416|FG002|Overall Study|Adverse Event|2|||
164659938|NCT01716754|594780417|FG003|Overall Study|Adverse Event|1|||
164659939|NCT01716754|594780414|FG000|Overall Study|Withdrawal by Subject|5|||
164659940|NCT01716754|594780415|FG001|Overall Study|Withdrawal by Subject|0|||
164659941|NCT01716754|594780416|FG002|Overall Study|Withdrawal by Subject|4|||
164659942|NCT01716754|594780417|FG003|Overall Study|Withdrawal by Subject|3|||
164659943|NCT02110706|594780437|FG000|Overall Study|Adverse Event|2|||
164659944|NCT02110706|594780438|FG001|Overall Study|Adverse Event|3|||
164659945|NCT02110706|594780437|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
164659946|NCT02110706|594780438|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
164659947|NCT03521999|594780440|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
164659948|NCT03521999|594780441|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
164659949|NCT03521999|594780440|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
164659950|NCT03521999|594780441|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
164659951|NCT03521999|594780440|FG000|Completed 3 Month Follow up|Death|0|||
164659952|NCT03521999|594780441|FG001|Completed 3 Month Follow up|Death|1|||
164659953|NCT03521999|594780440|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
164659954|NCT03521999|594780441|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
164659955|NCT04182204|594780444|FG000|Safety Run-in|Lost to Follow-up|1|||
164659956|NCT04182204|594780445|FG001|Safety Run-in|Lost to Follow-up|0|||
164659957|NCT04182204|594780446|FG002|Safety Run-in|Lost to Follow-up|0|||
164659958|NCT04182204|594780444|FG000|Safety Run-in|Withdrawal by Subject|2|||
164659959|NCT04182204|594780445|FG001|Safety Run-in|Withdrawal by Subject|0|||
164659960|NCT04182204|594780446|FG002|Safety Run-in|Withdrawal by Subject|0|||
164659961|NCT04182204|594780444|FG000|Safety Run-in|Death|7|||
164659962|NCT04182204|594780445|FG001|Safety Run-in|Death|0|||
164659963|NCT04182204|594780446|FG002|Safety Run-in|Death|0|||
164659964|NCT04182204|594780444|FG000|Randomized Controlled Trial|Lost to Follow-up|0|||
164659965|NCT04182204|594780445|FG001|Randomized Controlled Trial|Lost to Follow-up|1|||
164659966|NCT04182204|594780446|FG002|Randomized Controlled Trial|Lost to Follow-up|2|||
164659967|NCT04182204|594780444|FG000|Randomized Controlled Trial|Withdrawal by Subject|0|||
164659968|NCT04182204|594780445|FG001|Randomized Controlled Trial|Withdrawal by Subject|10|||
164659969|NCT04182204|594780446|FG002|Randomized Controlled Trial|Withdrawal by Subject|6|||
164659970|NCT04182204|594780444|FG000|Randomized Controlled Trial|Death|0|||
164659971|NCT04182204|594780445|FG001|Randomized Controlled Trial|Death|83|||
164659972|NCT04182204|594780446|FG002|Randomized Controlled Trial|Death|66|||
164659973|NCT03933202|594780447|FG000|Overall Study|Participant withdrawn by Principal Investigator|1|||
164659974|NCT03933202|594780448|FG001|Overall Study|Participant withdrawn by Principal Investigator|0|||
164659975|NCT03933202|594780447|FG000|Overall Study|Participant transferred care|1|||
164659976|NCT03933202|594780448|FG001|Overall Study|Participant transferred care|0|||
164659977|NCT03933202|594780447|FG000|Overall Study|Site research department closing|1|||
164659978|NCT03933202|594780448|FG001|Overall Study|Site research department closing|0|||
164659979|NCT03933202|594780447|FG000|Overall Study|Site closed prematurely due to unexpected circumstances|0|||
164659980|NCT03933202|594780448|FG001|Overall Study|Site closed prematurely due to unexpected circumstances|1|||
164659981|NCT03933202|594780447|FG000|Overall Study|Participant discontinuation due to Sponsor decision to close study|0|||
164659982|NCT03933202|594780448|FG001|Overall Study|Participant discontinuation due to Sponsor decision to close study|2|||
164659983|NCT03933202|594780447|FG000|Overall Study|Participant changed primary neurology provider|1|||
164201986|NCT01041859|593112624|FG001|Double-Blind Maintenance|Physician Decision|2|||
164201987|NCT01041859|593112625|FG002|Double-Blind Maintenance|Physician Decision|1|||
164302985|NCT02205736|593484679|FG000|Overall Study|Lost to Follow-up|106|||
164659984|NCT03933202|594780448|FG001|Overall Study|Participant changed primary neurology provider|0|||
164659985|NCT03933202|594780447|FG000|Overall Study|Participant could not be entered as a follow-up|0|||
164659986|NCT03933202|594780448|FG001|Overall Study|Participant could not be entered as a follow-up|1|||
164659987|NCT03933202|594780447|FG000|Overall Study|Participant non-compliant, therefore, has been discontinued|1|||
164659988|NCT03933202|594780448|FG001|Overall Study|Participant non-compliant, therefore, has been discontinued|0|||
164311098|NCT03892967|593513073|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
164311099|NCT03892967|593513074|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
164311100|NCT03892967|593513070|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
164659989|NCT03933202|594780447|FG000|Overall Study|Participant delayed year 2 due to subject fear of COVID-19|1|||
164659990|NCT03933202|594780448|FG001|Overall Study|Participant delayed year 2 due to subject fear of COVID-19|0|||
164659991|NCT03933202|594780447|FG000|Overall Study|Missed visit|0|||
164659992|NCT03933202|594780448|FG001|Overall Study|Missed visit|1|||
164659993|NCT03933202|594780447|FG000|Overall Study|Investigator decision|4|||
164659994|NCT03933202|594780448|FG001|Overall Study|Investigator decision|0|||
164659995|NCT03933202|594780447|FG000|Overall Study|Discontinuation due to safety extension removal by Sponsor|0|||
164659996|NCT03933202|594780448|FG001|Overall Study|Discontinuation due to safety extension removal by Sponsor|1|||
164659997|NCT03933202|594780447|FG000|Overall Study|Withdrawal by Subject|10|||
164659998|NCT03933202|594780448|FG001|Overall Study|Withdrawal by Subject|8|||
164659999|NCT03933202|594780447|FG000|Overall Study|Death|2|||
164660000|NCT03933202|594780448|FG001|Overall Study|Death|0|||
164660001|NCT03933202|594780447|FG000|Overall Study|Progressive disease|0|||
164660002|NCT03933202|594780448|FG001|Overall Study|Progressive disease|3|||
164660003|NCT03933202|594780447|FG000|Overall Study|Protocol non-compliance|6|||
164660004|NCT03933202|594780448|FG001|Overall Study|Protocol non-compliance|3|||
164660005|NCT03933202|594780447|FG000|Overall Study|Lost to Follow-up|16|||
164660006|NCT03933202|594780448|FG001|Overall Study|Lost to Follow-up|8|||
164660007|NCT03933202|594780447|FG000|Overall Study|Adverse Event|3|||
164660008|NCT03933202|594780448|FG001|Overall Study|Adverse Event|0|||
164660009|NCT00947427|594780449|FG000|Overall Study|Withdrawal by Subject|1|||
164660010|NCT00947427|594780450|FG001|Overall Study|Withdrawal by Subject|3|||
164660011|NCT00947427|594780449|FG000|Overall Study|Protocol Violation|0|||
164660012|NCT00947427|594780450|FG001|Overall Study|Protocol Violation|1|||
164660013|NCT01348542|594780452|FG000|Overall Study|Withdrawal by Subject|3|||
164660014|NCT01348542|594780453|FG001|Overall Study|Withdrawal by Subject|0|||
164660015|NCT00686036|594780456|FG000|Overall Study|Adverse Event|3|||
164660016|NCT00686036|594780457|FG001|Overall Study|Adverse Event|0|||
164660017|NCT00686036|594780456|FG000|Overall Study|Withdrawal by Subject|3|||
164660018|NCT00686036|594780457|FG001|Overall Study|Withdrawal by Subject|1|||
164660019|NCT00686036|594780456|FG000|Overall Study|Study terminated by AstraZeneca|2|||
164660020|NCT00686036|594780457|FG001|Overall Study|Study terminated by AstraZeneca|1|||
164660021|NCT00686036|594780456|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
164660022|NCT00686036|594780457|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
164660023|NCT00686036|594780456|FG000|Overall Study|Other reasons not identified|0|||
164660024|NCT00686036|594780457|FG001|Overall Study|Other reasons not identified|4|||
164660025|NCT01411995|594780458|FG000|Overall Study|Failed IUD insertion|0|||
164660026|NCT01411995|594780459|FG001|Overall Study|Failed IUD insertion|1|||
164660027|NCT05658523|594780460|FG000|Baseline|No blood draw|1|||
164660028|NCT05658523|594780461|FG001|Baseline|No blood draw|0|||
164660029|NCT05658523|594780462|FG002|Baseline|No blood draw|0|||
164660030|NCT05658523|594780460|FG000|28 Days|Lost to Follow-up|1|||
164660031|NCT05658523|594780461|FG001|28 Days|Lost to Follow-up|0|||
164660032|NCT05658523|594780462|FG002|28 Days|Lost to Follow-up|0|||
164660033|NCT05658523|594780460|FG000|28 Days|Withdrawal by Subject|1|||
164660034|NCT05658523|594780461|FG001|28 Days|Withdrawal by Subject|1|||
164660035|NCT05658523|594780462|FG002|28 Days|Withdrawal by Subject|0|||
164660036|NCT05658523|594780460|FG000|28 Days|Visit missed|0|||
164660037|NCT05658523|594780461|FG001|28 Days|Visit missed|4|||
164660038|NCT05658523|594780462|FG002|28 Days|Visit missed|0|||
164660039|NCT05658523|594780460|FG000|6 Months|Lost to Follow-up|1|||
164660040|NCT05658523|594780461|FG001|6 Months|Lost to Follow-up|7|||
164660041|NCT05658523|594780462|FG002|6 Months|Lost to Follow-up|2|||
164660042|NCT05658523|594780460|FG000|6 Months|Withdrawal by Subject|1|||
164660043|NCT05658523|594780461|FG001|6 Months|Withdrawal by Subject|3|||
164660044|NCT05658523|594780462|FG002|6 Months|Withdrawal by Subject|4|||
164660045|NCT05658523|594780460|FG000|6 Months|Visit missed|5|||
164660046|NCT05658523|594780461|FG001|6 Months|Visit missed|7|||
164660047|NCT05658523|594780462|FG002|6 Months|Visit missed|0|||
164660048|NCT05658523|594780460|FG000|6 Months|No blood draw|0|||
164660049|NCT05658523|594780461|FG001|6 Months|No blood draw|0|||
164660050|NCT05658523|594780462|FG002|6 Months|No blood draw|1|||
164660051|NCT05658523|594780460|FG000|12 Months|Lost to Follow-up|2|||
164660052|NCT05658523|594780461|FG001|12 Months|Lost to Follow-up|6|||
164660053|NCT05658523|594780462|FG002|12 Months|Lost to Follow-up|3|||
164660054|NCT05658523|594780460|FG000|12 Months|Withdrawal by Subject|4|||
164660055|NCT05658523|594780461|FG001|12 Months|Withdrawal by Subject|4|||
164660056|NCT05658523|594780462|FG002|12 Months|Withdrawal by Subject|2|||
164660057|NCT05658523|594780460|FG000|12 Months|Visit missed|4|||
164660058|NCT05658523|594780461|FG001|12 Months|Visit missed|8|||
164660059|NCT05658523|594780462|FG002|12 Months|Visit missed|8|||
164660060|NCT05658523|594780460|FG000|18 Months|Lost to Follow-up|5|||
164660061|NCT05658523|594780461|FG001|18 Months|Lost to Follow-up|8|||
164660062|NCT05658523|594780462|FG002|18 Months|Lost to Follow-up|2|||
164660063|NCT05658523|594780460|FG000|18 Months|Withdrawal by Subject|17|||
164660064|NCT05658523|594780461|FG001|18 Months|Withdrawal by Subject|9|||
164660065|NCT05658523|594780462|FG002|18 Months|Withdrawal by Subject|16|||
164660066|NCT05658523|594780460|FG000|18 Months|Visit missed|12|||
164660067|NCT05658523|594780461|FG001|18 Months|Visit missed|14|||
164660068|NCT05658523|594780462|FG002|18 Months|Visit missed|6|||
164660069|NCT03212170|594780463|FG000|Overall Study|Withdrawal by Subject|1|||
164660070|NCT01937364|594780464|FG000|Overall Study|Adverse Event|2|||
164660071|NCT01937364|594780465|FG001|Overall Study|Adverse Event|1|||
164660072|NCT00628212|594780468|FG000|Overall Study|Adverse Event|2|||
164660073|NCT00628212|594780469|FG001|Overall Study|Adverse Event|0|||
164660074|NCT00628212|594780470|FG002|Overall Study|Adverse Event|1|||
164660075|NCT00628212|594780471|FG003|Overall Study|Adverse Event|2|||
164660076|NCT00628212|594780468|FG000|Overall Study|Physician Decision|1|||
164660077|NCT00628212|594780469|FG001|Overall Study|Physician Decision|1|||
164660078|NCT00628212|594780470|FG002|Overall Study|Physician Decision|2|||
164660079|NCT00628212|594780471|FG003|Overall Study|Physician Decision|3|||
164660080|NCT02482571|594780472|FG000|Overall Study|Adverse Event|1|||
164660081|NCT02482571|594780472|FG000|Overall Study|Scanner or Respiract failure|3|||
164660082|NCT02482571|594780472|FG000|Overall Study|Withdrawal by Subject|4|||
164660083|NCT01533428|594780473|FG000|Overall Study|Adverse Event|0|||
164660084|NCT01533428|594780474|FG001|Overall Study|Adverse Event|1|||
164660085|NCT01533428|594780473|FG000|Overall Study|Lost to Follow-up|2|||
164660086|NCT01533428|594780474|FG001|Overall Study|Lost to Follow-up|1|||
164660087|NCT01533428|594780473|FG000|Overall Study|Withdrawal by Subject|7|||
164660088|NCT01533428|594780474|FG001|Overall Study|Withdrawal by Subject|6|||
164660089|NCT02102490|594780475|FG000|Overall Study|Death|6|||
164660090|NCT02102490|594780475|FG000|Overall Study|Lost to Follow-up|1|||
164660091|NCT00095199|594780476|FG000|Overall Study|Adverse Event|40|||
164660092|NCT00095199|594780477|FG001|Overall Study|Adverse Event|22|||
164660093|NCT00095199|594780478|FG002|Overall Study|Adverse Event|26|||
164660094|NCT00095199|594780479|FG003|Overall Study|Adverse Event|11|||
164660095|NCT00095199|594780476|FG000|Overall Study|Progressive disease|213|||
164660096|NCT00095199|594780477|FG001|Overall Study|Progressive disease|179|||
164660097|NCT00095199|594780478|FG002|Overall Study|Progressive disease|105|||
164660098|NCT00095199|594780479|FG003|Overall Study|Progressive disease|98|||
164660099|NCT00095199|594780476|FG000|Overall Study|Death|10|||
164660100|NCT00095199|594780477|FG001|Overall Study|Death|6|||
164660101|NCT00095199|594780478|FG002|Overall Study|Death|11|||
164660102|NCT00095199|594780479|FG003|Overall Study|Death|9|||
164660103|NCT00095199|594780476|FG000|Overall Study|Withdrawal by Subject|21|||
164660104|NCT00095199|594780477|FG001|Overall Study|Withdrawal by Subject|16|||
164660105|NCT00095199|594780478|FG002|Overall Study|Withdrawal by Subject|13|||
164660106|NCT00095199|594780479|FG003|Overall Study|Withdrawal by Subject|22|||
164660107|NCT00095199|594780476|FG000|Overall Study|Protocol Violation|4|||
164660108|NCT00095199|594780477|FG001|Overall Study|Protocol Violation|4|||
164660109|NCT00095199|594780478|FG002|Overall Study|Protocol Violation|2|||
164660110|NCT00095199|594780479|FG003|Overall Study|Protocol Violation|0|||
164660111|NCT00095199|594780476|FG000|Overall Study|Liver function test results elevated|0|||
164660112|NCT00095199|594780477|FG001|Overall Study|Liver function test results elevated|0|||
164660113|NCT00095199|594780478|FG002|Overall Study|Liver function test results elevated|1|||
164660114|NCT00095199|594780479|FG003|Overall Study|Liver function test results elevated|1|||
164660115|NCT00095199|594780476|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
164660116|NCT00095199|594780477|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
164660117|NCT00095199|594780478|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
164660118|NCT00095199|594780479|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
164660119|NCT00095199|594780476|FG000|Overall Study|Physician Decision|5|||
164660120|NCT00095199|594780477|FG001|Overall Study|Physician Decision|6|||
164660121|NCT00095199|594780478|FG002|Overall Study|Physician Decision|1|||
164311101|NCT03892967|593513071|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
164311102|NCT03892967|593513072|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
164311103|NCT03892967|593513073|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
164355613|NCT01962207|593676478|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
164660122|NCT00095199|594780479|FG003|Overall Study|Physician Decision|1|||
164660123|NCT00095199|594780476|FG000|Overall Study|Not eligible|1|||
164660124|NCT00095199|594780477|FG001|Overall Study|Not eligible|7|||
164660125|NCT00095199|594780478|FG002|Overall Study|Not eligible|0|||
164660126|NCT00095199|594780479|FG003|Overall Study|Not eligible|1|||
164660127|NCT00095199|594780476|FG000|Overall Study|Started Palliative Radiotherapy|1|||
164660128|NCT00095199|594780477|FG001|Overall Study|Started Palliative Radiotherapy|0|||
164660129|NCT00095199|594780478|FG002|Overall Study|Started Palliative Radiotherapy|0|||
164660130|NCT00095199|594780479|FG003|Overall Study|Started Palliative Radiotherapy|0|||
164660131|NCT00095199|594780476|FG000|Overall Study|Started radiotherapy regimen|0|||
164660132|NCT00095199|594780477|FG001|Overall Study|Started radiotherapy regimen|1|||
164660133|NCT00095199|594780478|FG002|Overall Study|Started radiotherapy regimen|0|||
164311104|NCT03892967|593513074|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
164311105|NCT03892967|593513070|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
164311106|NCT03892967|593513071|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
164311107|NCT03892967|593513072|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
164311108|NCT03892967|593513073|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
164311109|NCT03892967|593513074|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
164311110|NCT03892967|593513070|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
164311111|NCT03892967|593513071|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
164311112|NCT03892967|593513072|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
164311113|NCT03892967|593513073|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
164311114|NCT03892967|593513074|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
164311115|NCT03892967|593513070|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
164311116|NCT03892967|593513071|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
164311117|NCT03892967|593513072|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
164311118|NCT03892967|593513073|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
164311119|NCT03892967|593513074|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
164311120|NCT05767749|593513078|FG000|Overall Study|Withdrawal by Subject|0|||
164311121|NCT05767749|593513079|FG001|Overall Study|Withdrawal by Subject|0|||
164311122|NCT05767749|593513080|FG002|Overall Study|Withdrawal by Subject|2|||
164311123|NCT05767749|593513081|FG003|Overall Study|Withdrawal by Subject|2|||
164311124|NCT05767749|593513082|FG004|Overall Study|Withdrawal by Subject|2|||
164311125|NCT05767749|593513083|FG005|Overall Study|Withdrawal by Subject|2|||
164311126|NCT04236141|593515206|FG000|Overall Study|Death|18|||
164311127|NCT04236141|593515207|FG001|Overall Study|Death|10|||
164311128|NCT04236141|593515206|FG000|Overall Study|Withdrawal by Participant|1|||
164311129|NCT04236141|593515207|FG001|Overall Study|Withdrawal by Participant|0|||
164311130|NCT04236141|593515206|FG000|Overall Study|Reason not Specified|1|||
164311131|NCT04236141|593515207|FG001|Overall Study|Reason not Specified|0|||
164311132|NCT04236141|593515206|FG000|Overall Study|Study terminated by Sponsor|8|||
164311133|NCT04236141|593515207|FG001|Overall Study|Study terminated by Sponsor|4|||
164311134|NCT01657461|593515208|FG000|Overall Study|Death|9|||
164311135|NCT01657461|593515209|FG001|Overall Study|Death|12|||
164311136|NCT01657461|593515208|FG000|Overall Study|Lost to Follow-up|0|||
164311137|NCT01657461|593515209|FG001|Overall Study|Lost to Follow-up|3|||
164311138|NCT01657461|593515208|FG000|Overall Study|Physician Decision|0|||
164311139|NCT01657461|593515209|FG001|Overall Study|Physician Decision|2|||
164311140|NCT01657461|593515208|FG000|Overall Study|Withdrawal by Subject|1|||
164311141|NCT01657461|593515209|FG001|Overall Study|Withdrawal by Subject|3|||
164311142|NCT01754727|593515214|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
164311143|NCT02848729|593515217|FG000|Overall Study|Withdrawal by Subject|1|||
164660134|NCT00095199|594780479|FG003|Overall Study|Started radiotherapy regimen|0|||
164660135|NCT00095199|594780476|FG000|Overall Study|Primary tumor removed in other surgery|0|||
164660136|NCT00095199|594780477|FG001|Overall Study|Primary tumor removed in other surgery|1|||
164660137|NCT00095199|594780478|FG002|Overall Study|Primary tumor removed in other surgery|0|||
164660138|NCT00095199|594780479|FG003|Overall Study|Primary tumor removed in other surgery|0|||
164660139|NCT00095199|594780476|FG000|Overall Study|Data inadvertently lost by site|1|||
164660140|NCT00095199|594780477|FG001|Overall Study|Data inadvertently lost by site|0|||
164660141|NCT00095199|594780478|FG002|Overall Study|Data inadvertently lost by site|0|||
164660142|NCT00095199|594780479|FG003|Overall Study|Data inadvertently lost by site|0|||
164660143|NCT03896490|594780480|FG000|Overall Study|Withdrawal by Subject|1|||
164660144|NCT03896490|594780481|FG001|Overall Study|Withdrawal by Subject|1|||
164660145|NCT03312530|594781835|FG000|Overall Study|Death|5|||
164660146|NCT03312530|594781836|FG001|Overall Study|Death|5|||
164660147|NCT03312530|594781837|FG002|Overall Study|Death|4|||
164660148|NCT03312530|594781838|FG003|Overall Study|Death|10|||
164660149|NCT03312530|594781839|FG004|Overall Study|Death|8|||
164660150|NCT03312530|594781835|FG000|Overall Study|Lost to Follow-up|0|||
164660151|NCT03312530|594781836|FG001|Overall Study|Lost to Follow-up|0|||
164660152|NCT03312530|594781837|FG002|Overall Study|Lost to Follow-up|0|||
164660153|NCT03312530|594781838|FG003|Overall Study|Lost to Follow-up|1|||
164660154|NCT03312530|594781839|FG004|Overall Study|Lost to Follow-up|0|||
164660155|NCT03312530|594781835|FG000|Overall Study|Participant in another sponsor study.|0|||
164660156|NCT03312530|594781836|FG001|Overall Study|Participant in another sponsor study.|0|||
164660157|NCT03312530|594781837|FG002|Overall Study|Participant in another sponsor study.|0|||
164311144|NCT02848729|593515218|FG001|Overall Study|Withdrawal by Subject|0|||
164311145|NCT02848729|593515217|FG000|Overall Study|Emesis|15|||
164311146|NCT02848729|593515218|FG001|Overall Study|Emesis|11|||
164311147|NCT04838977|593515219|FG000|Overall Study|Lost to Follow-up|2|||
164311148|NCT04838977|593515220|FG001|Overall Study|Lost to Follow-up|3|||
164311149|NCT04838977|593515219|FG000|Overall Study|Withdrawal by Subject|1|||
164311150|NCT04838977|593515220|FG001|Overall Study|Withdrawal by Subject|1|||
164311151|NCT05367492|593515221|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
164311152|NCT05367492|593515222|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
164311153|NCT05367492|593515223|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
164311154|NCT05367492|593515221|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
164311155|NCT05367492|593515222|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
164311156|NCT05367492|593515223|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
164311157|NCT05367492|593515221|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
164311158|NCT05367492|593515222|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
164311159|NCT05367492|593515223|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
164311160|NCT05367492|593515221|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
164311161|NCT05367492|593515222|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
164311162|NCT05367492|593515223|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
164311163|NCT00950859|593515227|FG000|Overall Study|Adverse Event|3|||
164311164|NCT00950859|593515228|FG001|Overall Study|Adverse Event|3|||
164311165|NCT00950859|593515227|FG000|Overall Study|Insufficient Viral Load Response|12|||
164311166|NCT00950859|593515228|FG001|Overall Study|Insufficient Viral Load Response|3|||
164311167|NCT00950859|593515227|FG000|Overall Study|Protocol Violation|1|||
164311168|NCT00950859|593515228|FG001|Overall Study|Protocol Violation|1|||
164311169|NCT00950859|593515227|FG000|Overall Study|Lost to Follow-up|0|||
164311170|NCT00950859|593515228|FG001|Overall Study|Lost to Follow-up|3|||
164311171|NCT00265148|593515229|FG000|Overall Study|Adverse Event|2|||
164311172|NCT00265148|593515230|FG001|Overall Study|Adverse Event|2|||
164555612|NCT05030311|594405906|FG001|Overall Study|Physician Decision|2|||
164555613|NCT05030311|594405905|FG000|Overall Study|Lost to Follow-up|5|||
164555614|NCT05030311|594405906|FG001|Overall Study|Lost to Follow-up|1|||
164555615|NCT05030311|594405905|FG000|Overall Study|Protocol Violation|4|||
164555616|NCT05030311|594405906|FG001|Overall Study|Protocol Violation|4|||
164555617|NCT03042468|594405907|FG000|Overall Study|Death|0|||
164555618|NCT03042468|594405908|FG001|Overall Study|Death|1|||
164555619|NCT03042468|594405909|FG002|Overall Study|Death|1|||
164555620|NCT03042468|594405910|FG003|Overall Study|Death|0|||
164555621|NCT03042468|594405911|FG004|Overall Study|Death|0|||
164555622|NCT03042468|594405912|FG005|Overall Study|Death|0|||
164555623|NCT03042468|594405907|FG000|Overall Study|Withdrawal by Subject|0|||
164555624|NCT03042468|594405908|FG001|Overall Study|Withdrawal by Subject|0|||
164555625|NCT03042468|594405909|FG002|Overall Study|Withdrawal by Subject|0|||
164555626|NCT03042468|594405910|FG003|Overall Study|Withdrawal by Subject|0|||
164555627|NCT03042468|594405911|FG004|Overall Study|Withdrawal by Subject|0|||
164555628|NCT03042468|594405912|FG005|Overall Study|Withdrawal by Subject|1|||
164555629|NCT03042468|594405907|FG000|Overall Study|Lost to Follow-up|0|||
164555630|NCT03042468|594405908|FG001|Overall Study|Lost to Follow-up|0|||
164555631|NCT03042468|594405909|FG002|Overall Study|Lost to Follow-up|0|||
164555632|NCT03042468|594405910|FG003|Overall Study|Lost to Follow-up|0|||
164555633|NCT03042468|594405911|FG004|Overall Study|Lost to Follow-up|1|||
164555634|NCT03042468|594405912|FG005|Overall Study|Lost to Follow-up|1|||
164555635|NCT02264990|594405915|FG000|Overall Study|Death|255|||
164555636|NCT02264990|594405916|FG001|Overall Study|Death|250|||
164555637|NCT02264990|594405915|FG000|Overall Study|Withdrawal by Subject|4|||
164555638|NCT02264990|594405916|FG001|Overall Study|Withdrawal by Subject|5|||
164555639|NCT02264990|594405915|FG000|Overall Study|Lost to Follow-up|1|||
164555640|NCT02264990|594405916|FG001|Overall Study|Lost to Follow-up|3|||
164555641|NCT02264990|594405915|FG000|Overall Study|Other|0|||
164555642|NCT02264990|594405916|FG001|Overall Study|Other|1|||
164555643|NCT03031301|594405917|FG000|Overall Study|Protocol Violation|4|||
164555644|NCT03031301|594405918|FG001|Overall Study|Protocol Violation|8|||
164555645|NCT03031301|594405917|FG000|Overall Study|Withdrawal by Subject|7|||
164555646|NCT03031301|594405918|FG001|Overall Study|Withdrawal by Subject|4|||
164555647|NCT03031301|594405917|FG000|Overall Study|Lost to Follow-up|4|||
164555648|NCT03031301|594405918|FG001|Overall Study|Lost to Follow-up|12|||
164555649|NCT03031301|594405917|FG000|Overall Study|Noncompliance|1|||
164311173|NCT00265148|593515229|FG000|Overall Study|Lack of Efficacy|0|||
164311174|NCT00265148|593515230|FG001|Overall Study|Lack of Efficacy|2|||
164311175|NCT00265148|593515229|FG000|Overall Study|Protocol Violation|3|||
164311176|NCT00265148|593515230|FG001|Overall Study|Protocol Violation|2|||
164311177|NCT00265148|593515229|FG000|Overall Study|Lost to Follow-up|0|||
164311178|NCT00265148|593515230|FG001|Overall Study|Lost to Follow-up|1|||
164555650|NCT03031301|594405918|FG001|Overall Study|Noncompliance|3|||
164555651|NCT03031301|594405917|FG000|Overall Study|Technical issue|1|||
164555652|NCT03031301|594405918|FG001|Overall Study|Technical issue|1|||
164555653|NCT03031301|594405917|FG000|Overall Study|Adverse Event|1|||
164555654|NCT03031301|594405918|FG001|Overall Study|Adverse Event|0|||
164555655|NCT00267748|594405919|FG000|Non-randomized Period|Progressive disease|10|||
164311179|NCT00265148|593515229|FG000|Overall Study|Withdrawal by Subject|2|||
164660158|NCT03312530|594781838|FG003|Overall Study|Participant in another sponsor study.|1|||
164660159|NCT03312530|594781839|FG004|Overall Study|Participant in another sponsor study.|0|||
164660160|NCT03312530|594781835|FG000|Overall Study|Study terminated by sponsor|1|||
164660161|NCT03312530|594781836|FG001|Overall Study|Study terminated by sponsor|0|||
164311180|NCT00265148|593515230|FG001|Overall Study|Withdrawal by Subject|1|||
164311181|NCT00265148|593515229|FG000|Overall Study|Physician Decision|1|||
164311182|NCT00265148|593515230|FG001|Overall Study|Physician Decision|0|||
164311183|NCT00265148|593515229|FG000|Overall Study|Increasing frailty|0|||
164311184|NCT00265148|593515230|FG001|Overall Study|Increasing frailty|1|||
164311185|NCT00265148|593515229|FG000|Overall Study|Subject chose to change of the dose|1|||
164311186|NCT00265148|593515230|FG001|Overall Study|Subject chose to change of the dose|0|||
164311187|NCT01463007|593515231|FG000|Overall Study|Physician Decision|1|||
164311188|NCT03583385|593515232|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164311189|NCT03583385|593515233|FG001|Treatment Period 1|Withdrawal by Subject|1|||
164311190|NCT03583385|593515232|FG000|Treatment Period 2|Adverse Event|1|||
164311191|NCT03583385|593515233|FG001|Treatment Period 2|Adverse Event|0|||
164311192|NCT03539549|593515236|FG000|Overall Study|Adverse Event|12|||
164311193|NCT03539549|593515236|FG000|Overall Study|Lost to Follow-up|1|||
164311194|NCT03539549|593515236|FG000|Overall Study|Death|2|||
164311195|NCT03539549|593515236|FG000|Overall Study|Progressive Disease|1|||
164311196|NCT03539549|593515236|FG000|Overall Study|Reason not Specified|1|||
164311197|NCT01652469|593515240|FG000|Overall Study|Withdrawal by Subject|1|||
164311198|NCT01652469|593515241|FG001|Overall Study|Withdrawal by Subject|4|||
164311199|NCT01652469|593515240|FG000|Overall Study|Lost to Follow-up|0|||
164311200|NCT01652469|593515241|FG001|Overall Study|Lost to Follow-up|2|||
164311201|NCT02123472|593515242|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
164311202|NCT02123472|593515243|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
164311203|NCT00918736|593515244|FG000|Overall Study|Withdrawal by Subject|4|||
164311204|NCT01474018|593515245|FG000|Overall Study|Lost to Follow-up|0|||
164311205|NCT01474018|593515246|FG001|Overall Study|Lost to Follow-up|1|||
164660162|NCT03312530|594781837|FG002|Overall Study|Study terminated by sponsor|2|||
164660163|NCT03312530|594781838|FG003|Overall Study|Study terminated by sponsor|3|||
164660164|NCT03312530|594781839|FG004|Overall Study|Study terminated by sponsor|7|||
164660165|NCT03312530|594781835|FG000|Overall Study|Withdrawal by Subject|0|||
164660166|NCT03312530|594781836|FG001|Overall Study|Withdrawal by Subject|1|||
164660167|NCT03312530|594781837|FG002|Overall Study|Withdrawal by Subject|0|||
164660168|NCT03312530|594781838|FG003|Overall Study|Withdrawal by Subject|0|||
164660169|NCT03312530|594781839|FG004|Overall Study|Withdrawal by Subject|0|||
164660170|NCT03312530|594781835|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
164660171|NCT03312530|594781836|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
164660172|NCT03312530|594781837|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
164660173|NCT03312530|594781838|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
164660174|NCT03312530|594781839|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
164660175|NCT00614055|594781840|FG000|Overall Study|Adverse Event|1|||
164660176|NCT00614055|594781841|FG001|Overall Study|Adverse Event|0|||
164660177|NCT00614055|594781842|FG002|Overall Study|Adverse Event|0|||
164660178|NCT00614055|594781840|FG000|Overall Study|Protocol Violation|2|||
164660179|NCT00614055|594781841|FG001|Overall Study|Protocol Violation|2|||
164660180|NCT00614055|594781842|FG002|Overall Study|Protocol Violation|1|||
164660181|NCT00614055|594781840|FG000|Overall Study|Lack of Efficacy|0|||
164660182|NCT00614055|594781841|FG001|Overall Study|Lack of Efficacy|0|||
164660183|NCT00614055|594781842|FG002|Overall Study|Lack of Efficacy|2|||
164660184|NCT00614055|594781840|FG000|Overall Study|Unclassified|1|||
164660185|NCT00614055|594781841|FG001|Overall Study|Unclassified|4|||
164660186|NCT00614055|594781842|FG002|Overall Study|Unclassified|2|||
164311206|NCT01474018|593515245|FG000|Overall Study|Withdrawal by Subject|0|||
164311207|NCT01474018|593515246|FG001|Overall Study|Withdrawal by Subject|2|||
164311208|NCT03801031|593515247|FG000|Overall Study|Lost to Follow-up|1|||
164311209|NCT03801031|593515248|FG001|Overall Study|Lost to Follow-up|0|||
164311210|NCT03801031|593515247|FG000|Overall Study|Unable to comply|1|||
164311211|NCT03801031|593515248|FG001|Overall Study|Unable to comply|0|||
164311212|NCT03801031|593515247|FG000|Overall Study|Withdrawal by Subject|0|||
164311213|NCT03801031|593515248|FG001|Overall Study|Withdrawal by Subject|1|||
164660187|NCT04583579|594781843|FG000|Overall Study|Lost to Follow-up|4|||
164660188|NCT02489318|594781846|FG000|Randomized|Withdrawal by Subject|0|||
164660189|NCT02489318|594781847|FG001|Randomized|Withdrawal by Subject|1|||
164660190|NCT02489318|594781846|FG000|Treated|Adverse Event|19|||
164311214|NCT01942733|593515249|FG000|Overall Study|Lost to Follow-up|1|||
164311215|NCT01942733|593515249|FG000|Overall Study|Non-compliance with IMP|1|||
164311216|NCT01942733|593515249|FG000|Overall Study|Administrative|1|||
164311217|NCT00838513|593515250|FG000|Screening Period|Screen Failure|3|||
164311218|NCT00838513|593515250|FG000|Extension Treatment Period|Death|1|||
164311219|NCT00838513|593515250|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
164660191|NCT02489318|594781847|FG001|Treated|Adverse Event|62|||
164660192|NCT02489318|594781846|FG000|Treated|Death|13|||
164660193|NCT02489318|594781847|FG001|Treated|Death|11|||
164660194|NCT02489318|594781846|FG000|Treated|Physician Decision|4|||
164660195|NCT02489318|594781847|FG001|Treated|Physician Decision|6|||
164660196|NCT02489318|594781846|FG000|Treated|Protocol Violation|1|||
164660197|NCT02489318|594781847|FG001|Treated|Protocol Violation|2|||
164660198|NCT02489318|594781846|FG000|Treated|Withdrawal by Subject|37|||
164660199|NCT02489318|594781847|FG001|Treated|Withdrawal by Subject|36|||
164660200|NCT02489318|594781846|FG000|Treated|Other: Progressive Disease|245|||
164660201|NCT02489318|594781847|FG001|Treated|Other: Progressive Disease|138|||
164311220|NCT00126490|593515251|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
164311221|NCT03462511|593515253|FG000|Overall Study|Withdrawal by Subject|2|||
164311222|NCT03462511|593515254|FG001|Overall Study|Withdrawal by Subject|3|||
164311223|NCT02925416|593515255|FG000|Overall Study|Adverse Event|2|||
164311224|NCT02925416|593515256|FG001|Overall Study|Adverse Event|0|||
164311225|NCT02625909|593515257|FG000|Overall Study|Death|2|||
164311226|NCT02625909|593515258|FG001|Overall Study|Death|0|||
164311227|NCT02625909|593515257|FG000|Overall Study|Lost to Follow-up|3|||
164311228|NCT02625909|593515258|FG001|Overall Study|Lost to Follow-up|5|||
164311229|NCT02625909|593515257|FG000|Overall Study|Lack of Efficacy|9|||
164311230|NCT02625909|593515258|FG001|Overall Study|Lack of Efficacy|2|||
164311231|NCT02625909|593515257|FG000|Overall Study|Reinfection|3|||
164311232|NCT02625909|593515258|FG001|Overall Study|Reinfection|2|||
164311233|NCT01598506|593515259|FG000|Overall Study|Withdrawal by Subject|2|||
164311234|NCT03962504|593515260|FG000|Overall Study|Other|11|||
164311235|NCT03962504|593515261|FG001|Overall Study|Other|32|||
164311236|NCT02367833|593515262|FG000|Overall Study|Withdrawal by Subject|1|||
164311237|NCT02367833|593515263|FG001|Overall Study|Withdrawal by Subject|1|||
164311238|NCT02367833|593515264|FG002|Overall Study|Withdrawal by Subject|0|||
164660202|NCT02489318|594781846|FG000|Treated|Other|0|||
164660203|NCT02489318|594781847|FG001|Treated|Other|2|||
164660204|NCT02489318|594781846|FG000|Treated|Ongoing|0|||
164660205|NCT02489318|594781847|FG001|Treated|Ongoing|267|||
164660206|NCT02006706|594781850|FG000|Overall Study|Lost to Follow-up|1|||
164660207|NCT06041646|594781853|FG000|Overall Study|Withdrawal by Subject|1|||
164660208|NCT00356200|594781854|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
164660209|NCT00356200|594781855|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
164660210|NCT00356200|594781854|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
164660211|NCT00356200|594781855|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
164660212|NCT03209570|594781856|FG000|Overall Study|Death|1|||
164660213|NCT03209570|594781857|FG001|Overall Study|Death|0|||
164660214|NCT03209570|594781856|FG000|Overall Study|Incomplete Data|8|||
164660215|NCT03209570|594781857|FG001|Overall Study|Incomplete Data|10|||
164660216|NCT03209570|594781856|FG000|Overall Study|Protocol Violation|1|||
164660217|NCT03209570|594781857|FG001|Overall Study|Protocol Violation|0|||
164660218|NCT03209570|594781856|FG000|Overall Study|Withdrawal by Subject|0|||
164660219|NCT03209570|594781857|FG001|Overall Study|Withdrawal by Subject|3|||
164660220|NCT03679741|594781858|FG000|Period 1|No longer meet eligibility criteria|1|||
164660221|NCT03679741|594781859|FG001|Period 1|No longer meet eligibility criteria|0|||
164660222|NCT03679741|594781858|FG000|Period 1|Lost to Follow-up|0|||
164660223|NCT03679741|594781859|FG001|Period 1|Lost to Follow-up|1|||
164660224|NCT03679741|594781858|FG000|Period 1|Adverse Event|1|||
164660225|NCT03679741|594781859|FG001|Period 1|Adverse Event|1|||
164660226|NCT03679741|594781858|FG000|Period 1|Withdrawal by Subject|0|||
164660227|NCT03679741|594781859|FG001|Period 1|Withdrawal by Subject|1|||
164660228|NCT03679741|594781858|FG000|Period 2|Adverse Event|2|||
164660229|NCT03679741|594781859|FG001|Period 2|Adverse Event|1|||
164660230|NCT03679741|594781858|FG000|Period 2|Withdrawal by Subject|1|||
164311239|NCT02167139|593515267|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
164311240|NCT02167139|593515268|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
164311241|NCT02167139|593515269|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
164311242|NCT02167139|593515270|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
164311243|NCT02167139|593515267|FG000|Randomised, Double-blind|Adverse Event|2|||
164311244|NCT02167139|593515268|FG001|Randomised, Double-blind|Adverse Event|9|||
164660231|NCT03679741|594781859|FG001|Period 2|Withdrawal by Subject|1|||
164660232|NCT03305055|594781861|FG000|Overall Study|Withdrawal by Subject|0|||
164660233|NCT03305055|594781862|FG001|Overall Study|Withdrawal by Subject|1|||
164311245|NCT02167139|593515269|FG002|Randomised, Double-blind|Adverse Event|0|||
164311246|NCT02167139|593515270|FG003|Randomised, Double-blind|Adverse Event|0|||
164311247|NCT02167139|593515267|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
164660234|NCT03305055|594781861|FG000|Overall Study|Adverse Event|1|||
164660235|NCT03305055|594781862|FG001|Overall Study|Adverse Event|1|||
164660236|NCT02540356|594781863|FG000|Overall Study|Terminated due to disease progression|1|||
164660237|NCT02540356|594781864|FG001|Overall Study|Terminated due to disease progression|0|||
164660238|NCT01654380|594781868|FG000|Part B, Period 1|Physician Decision|0|||
164660239|NCT01654380|594781869|FG001|Part B, Period 1|Physician Decision|0|||
164660240|NCT01654380|594781870|FG002|Part B, Period 1|Physician Decision|1|||
164660241|NCT01654380|594781871|FG003|Part B, Period 1|Physician Decision|0|||
164311248|NCT02167139|593515268|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
164311249|NCT02167139|593515269|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
164311250|NCT02167139|593515270|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
164311251|NCT02167139|593515267|FG000|Randomised, Double-blind|Other|3|||
164311252|NCT02167139|593515268|FG001|Randomised, Double-blind|Other|0|||
164311253|NCT02167139|593515269|FG002|Randomised, Double-blind|Other|0|||
164660242|NCT03335371|594781872|FG000|Overall Study|Lost to Follow-up|0|||
164660243|NCT03335371|594781873|FG001|Overall Study|Lost to Follow-up|0|||
164311254|NCT02167139|593515270|FG003|Randomised, Double-blind|Other|0|||
164311255|NCT02167139|593515267|FG000|Transition-extension|Adverse Event|2|||
164311256|NCT02167139|593515268|FG001|Transition-extension|Adverse Event|0|||
164311257|NCT02167139|593515269|FG002|Transition-extension|Adverse Event|2|||
164311258|NCT02167139|593515270|FG003|Transition-extension|Adverse Event|3|||
164660244|NCT03335371|594781874|FG002|Overall Study|Lost to Follow-up|0|||
164660245|NCT03335371|594781875|FG003|Overall Study|Lost to Follow-up|0|||
164660246|NCT03335371|594781876|FG004|Overall Study|Lost to Follow-up|1|||
164660247|NCT03335371|594781872|FG000|Overall Study|Withdrawal by Subject|0|||
164660248|NCT03335371|594781873|FG001|Overall Study|Withdrawal by Subject|0|||
164660249|NCT03335371|594781874|FG002|Overall Study|Withdrawal by Subject|0|||
164660250|NCT03335371|594781875|FG003|Overall Study|Withdrawal by Subject|0|||
164660251|NCT03335371|594781876|FG004|Overall Study|Withdrawal by Subject|1|||
164660252|NCT03335371|594781872|FG000|Overall Study|Randomization Error|0|||
164660253|NCT03335371|594781873|FG001|Overall Study|Randomization Error|0|||
164660254|NCT03335371|594781874|FG002|Overall Study|Randomization Error|1|||
164660255|NCT03335371|594781875|FG003|Overall Study|Randomization Error|0|||
164660256|NCT03335371|594781876|FG004|Overall Study|Randomization Error|0|||
164660257|NCT05845645|594781878|FG000|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
164660258|NCT05845645|594781879|FG001|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
164660259|NCT05845645|594781880|FG002|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|1|||
164660260|NCT05845645|594781881|FG003|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
164660261|NCT05845645|594781882|FG004|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
164660262|NCT05845645|594781883|FG005|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
164660263|NCT05845645|594781884|FG006|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
164660264|NCT05845645|594781885|FG007|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
164660265|NCT05845645|594781886|FG008|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
164660266|NCT05845645|594781887|FG009|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
164660267|NCT05845645|594781888|FG010|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
164660268|NCT05845645|594781889|FG011|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
164660269|NCT05845645|594781878|FG000|Part B- Period 1 (Day 1)|Adverse Event|0|||
164660270|NCT05845645|594781879|FG001|Part B- Period 1 (Day 1)|Adverse Event|0|||
164660271|NCT05845645|594781880|FG002|Part B- Period 1 (Day 1)|Adverse Event|0|||
164660272|NCT05845645|594781881|FG003|Part B- Period 1 (Day 1)|Adverse Event|0|||
164660273|NCT05845645|594781882|FG004|Part B- Period 1 (Day 1)|Adverse Event|0|||
164660274|NCT05845645|594781883|FG005|Part B- Period 1 (Day 1)|Adverse Event|0|||
164660275|NCT05845645|594781884|FG006|Part B- Period 1 (Day 1)|Adverse Event|0|||
164660276|NCT05845645|594781885|FG007|Part B- Period 1 (Day 1)|Adverse Event|0|||
164311259|NCT02167139|593515267|FG000|Transition-extension|Withdrawal by Subject|2|||
164311260|NCT02167139|593515268|FG001|Transition-extension|Withdrawal by Subject|0|||
164311261|NCT02167139|593515269|FG002|Transition-extension|Withdrawal by Subject|4|||
164311262|NCT02167139|593515270|FG003|Transition-extension|Withdrawal by Subject|1|||
164311263|NCT02167139|593515267|FG000|Transition-extension|Lack of Efficacy|0|||
164311264|NCT02167139|593515268|FG001|Transition-extension|Lack of Efficacy|0|||
164311265|NCT02167139|593515269|FG002|Transition-extension|Lack of Efficacy|1|||
164311266|NCT02167139|593515270|FG003|Transition-extension|Lack of Efficacy|1|||
164311267|NCT02167139|593515267|FG000|Transition-extension|Other|1|||
164311268|NCT02167139|593515268|FG001|Transition-extension|Other|0|||
164311269|NCT02167139|593515269|FG002|Transition-extension|Other|1|||
164311270|NCT02167139|593515270|FG003|Transition-extension|Other|0|||
164660277|NCT05845645|594781886|FG008|Part B- Period 1 (Day 1)|Adverse Event|0|||
164660278|NCT05845645|594781887|FG009|Part B- Period 1 (Day 1)|Adverse Event|1|||
164660279|NCT05845645|594781888|FG010|Part B- Period 1 (Day 1)|Adverse Event|0|||
164660280|NCT05845645|594781889|FG011|Part B- Period 1 (Day 1)|Adverse Event|0|||
164660281|NCT00998881|594781892|FG000|Overall Study|Adverse Event|2|||
164311271|NCT02167139|593515267|FG000|Transition-extension|Lost to Follow-up|1|||
164311272|NCT02167139|593515268|FG001|Transition-extension|Lost to Follow-up|0|||
164311273|NCT02167139|593515269|FG002|Transition-extension|Lost to Follow-up|0|||
164311274|NCT02167139|593515270|FG003|Transition-extension|Lost to Follow-up|0|||
164311275|NCT02067676|593515271|FG000|Overall Study|Withdrawal by Subject|1|||
164660282|NCT00998881|594781893|FG001|Overall Study|Adverse Event|2|||
164660283|NCT00998881|594781892|FG000|Overall Study|Lack of Efficacy|1|||
164660284|NCT00998881|594781893|FG001|Overall Study|Lack of Efficacy|0|||
164555656|NCT00267748|594405920|FG001|Non-randomized Period|Progressive disease|0|||
164555657|NCT00267748|594405921|FG002|Non-randomized Period|Progressive disease|0|||
164555658|NCT00267748|594405919|FG000|Non-randomized Period|Adverse Event|8|||
164555659|NCT00267748|594405920|FG001|Non-randomized Period|Adverse Event|0|||
164555660|NCT00267748|594405921|FG002|Non-randomized Period|Adverse Event|0|||
164555661|NCT00267748|594405919|FG000|Non-randomized Period|Death|1|||
164555662|NCT00267748|594405920|FG001|Non-randomized Period|Death|0|||
164555663|NCT00267748|594405921|FG002|Non-randomized Period|Death|0|||
164555664|NCT00267748|594405919|FG000|Non-randomized Period|Participant not willing to participate|1|||
164555665|NCT00267748|594405920|FG001|Non-randomized Period|Participant not willing to participate|0|||
164555666|NCT00267748|594405921|FG002|Non-randomized Period|Participant not willing to participate|0|||
164555667|NCT00267748|594405919|FG000|Non-randomized Period|Other|3|||
164555668|NCT00267748|594405920|FG001|Non-randomized Period|Other|0|||
164555669|NCT00267748|594405921|FG002|Non-randomized Period|Other|0|||
164555670|NCT00267748|594405919|FG000|Randomized Period|Death|0|||
164555671|NCT00267748|594405920|FG001|Randomized Period|Death|2|||
164555672|NCT00267748|594405921|FG002|Randomized Period|Death|3|||
164555673|NCT00267748|594405919|FG000|Randomized Period|Adverse Event|0|||
164555674|NCT00267748|594405920|FG001|Randomized Period|Adverse Event|23|||
164555675|NCT00267748|594405921|FG002|Randomized Period|Adverse Event|25|||
164555676|NCT00267748|594405919|FG000|Randomized Period|Global deterioration of health status|0|||
164555677|NCT00267748|594405920|FG001|Randomized Period|Global deterioration of health status|6|||
164555678|NCT00267748|594405921|FG002|Randomized Period|Global deterioration of health status|7|||
164555679|NCT00267748|594405919|FG000|Randomized Period|Lost to Follow-up|0|||
164555680|NCT00267748|594405920|FG001|Randomized Period|Lost to Follow-up|1|||
164555681|NCT00267748|594405921|FG002|Randomized Period|Lost to Follow-up|0|||
164555682|NCT00267748|594405919|FG000|Randomized Period|Objective progression or relapse|0|||
164555683|NCT00267748|594405920|FG001|Randomized Period|Objective progression or relapse|77|||
164555684|NCT00267748|594405921|FG002|Randomized Period|Objective progression or relapse|86|||
164555685|NCT00267748|594405919|FG000|Randomized Period|Withdrawal by Subject|0|||
164555686|NCT00267748|594405920|FG001|Randomized Period|Withdrawal by Subject|9|||
164555687|NCT00267748|594405921|FG002|Randomized Period|Withdrawal by Subject|2|||
164555688|NCT00267748|594405919|FG000|Randomized Period|Other|0|||
164555689|NCT00267748|594405920|FG001|Randomized Period|Other|9|||
164555690|NCT00267748|594405921|FG002|Randomized Period|Other|6|||
164555691|NCT00267748|594405919|FG000|Randomized Period|randomized but not treated|0|||
164555692|NCT00267748|594405920|FG001|Randomized Period|randomized but not treated|0|||
164555693|NCT00267748|594405921|FG002|Randomized Period|randomized but not treated|3|||
164555694|NCT01294800|594405922|FG000|Overall Study|Adverse Event|7|||
164555695|NCT01294800|594405923|FG001|Overall Study|Adverse Event|6|||
164555696|NCT01294800|594405924|FG002|Overall Study|Adverse Event|12|||
164555697|NCT01294800|594405925|FG003|Overall Study|Adverse Event|5|||
164555698|NCT01294800|594405922|FG000|Overall Study|Subject Withdrew Consent|2|||
164555699|NCT01294800|594405923|FG001|Overall Study|Subject Withdrew Consent|2|||
164555700|NCT01294800|594405924|FG002|Overall Study|Subject Withdrew Consent|2|||
164555701|NCT01294800|594405925|FG003|Overall Study|Subject Withdrew Consent|11|||
164555702|NCT01294800|594405922|FG000|Overall Study|Lost to Follow-up|0|||
164555703|NCT01294800|594405923|FG001|Overall Study|Lost to Follow-up|0|||
164555704|NCT01294800|594405924|FG002|Overall Study|Lost to Follow-up|1|||
164555705|NCT01294800|594405925|FG003|Overall Study|Lost to Follow-up|0|||
164555706|NCT01294800|594405922|FG000|Overall Study|Non-compliance With Protocol|0|||
164555707|NCT01294800|594405923|FG001|Overall Study|Non-compliance With Protocol|1|||
164555708|NCT01294800|594405924|FG002|Overall Study|Non-compliance With Protocol|1|||
164555709|NCT01294800|594405925|FG003|Overall Study|Non-compliance With Protocol|0|||
164555710|NCT01294800|594405922|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
164555711|NCT01294800|594405923|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
164555712|NCT01294800|594405924|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
164555713|NCT01294800|594405925|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
164555714|NCT01662895|594405927|FG000|Overall Study|Lost to Follow-up|0|||
164555715|NCT01662895|594405928|FG001|Overall Study|Lost to Follow-up|1|||
164555716|NCT00493038|594405929|FG000|Treatment|Adverse Event|8|||
164555717|NCT00493038|594405930|FG001|Treatment|Adverse Event|4|||
164555718|NCT00493038|594405929|FG000|Treatment|Lost to Follow-up|5|||
164555719|NCT00493038|594405930|FG001|Treatment|Lost to Follow-up|3|||
164555720|NCT00493038|594405929|FG000|Treatment|Withdrawal by Subject|11|||
164660285|NCT00998881|594781892|FG000|Overall Study|Physician Decision|3|||
164555721|NCT00493038|594405930|FG001|Treatment|Withdrawal by Subject|12|||
164660286|NCT00998881|594781893|FG001|Overall Study|Physician Decision|0|||
164555722|NCT00493038|594405929|FG000|Treatment|Other|0|||
164555723|NCT00493038|594405930|FG001|Treatment|Other|1|||
164555724|NCT00493038|594405929|FG000|Follow-up|Lost to Follow-up|1|||
164555725|NCT00493038|594405930|FG001|Follow-up|Lost to Follow-up|0|||
164555726|NCT02275338|594405933|FG000|Overall Study|Adverse Event|15|||
164555727|NCT02275338|594405933|FG000|Overall Study|Lack of Efficacy|3|||
164555728|NCT02275338|594405933|FG000|Overall Study|Withdrawal by Subject|4|||
164555729|NCT02275338|594405933|FG000|Overall Study|Disease progression (death)|1|||
164660287|NCT00998881|594781892|FG000|Overall Study|Withdrawal by Subject|1|||
164311276|NCT02067676|593515272|FG001|Overall Study|Withdrawal by Subject|0|||
164311277|NCT02067676|593515273|FG002|Overall Study|Withdrawal by Subject|0|||
164311278|NCT02067676|593515274|FG003|Overall Study|Withdrawal by Subject|0|||
164555730|NCT02275338|594405933|FG000|Overall Study|Ineligible to start Phase 2|4|||
164555731|NCT02275338|594405933|FG000|Overall Study|Reason not specified|5|||
164555732|NCT02275338|594405933|FG000|Overall Study|Does not meet entry criteria|1|||
164555733|NCT01100944|594405934|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
164555734|NCT01100944|594405935|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
164555735|NCT01100944|594405936|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
164555736|NCT01100944|594405934|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
164555737|NCT01100944|594405935|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
164555738|NCT01100944|594405936|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
164555739|NCT01100944|594405934|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
164555740|NCT01100944|594405935|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
164555741|NCT01100944|594405936|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
164555742|NCT01100944|594405934|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
164555743|NCT01100944|594405935|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
164555744|NCT01100944|594405936|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
164555745|NCT01665807|594405940|FG000|Overall Study|Withdrawal by Subject|2|||
164555746|NCT01665807|594405941|FG001|Overall Study|Withdrawal by Subject|0|||
164555747|NCT01665807|594405942|FG002|Overall Study|Withdrawal by Subject|1|||
164555748|NCT01618214|594405944|FG000|Overall Study|Adverse Event|3|||
164555749|NCT01618214|594405945|FG001|Overall Study|Adverse Event|1|||
164555750|NCT01618214|594405944|FG000|Overall Study|Lack of Efficacy|1|||
164555751|NCT01618214|594405945|FG001|Overall Study|Lack of Efficacy|1|||
164555752|NCT01618214|594405944|FG000|Overall Study|Protocol Violation|1|||
164555753|NCT01618214|594405945|FG001|Overall Study|Protocol Violation|4|||
164555754|NCT01618214|594405944|FG000|Overall Study|Withdrawal Criteria|1|||
164555755|NCT01618214|594405945|FG001|Overall Study|Withdrawal Criteria|2|||
164555756|NCT01618214|594405944|FG000|Overall Study|Unclassified|4|||
164555757|NCT01618214|594405945|FG001|Overall Study|Unclassified|5|||
164555758|NCT01692301|594405946|FG000|Overall Study|Adverse Event|15|||
164555759|NCT01692301|594405947|FG001|Overall Study|Adverse Event|12|||
164555760|NCT01692301|594405946|FG000|Overall Study|Death|1|||
164555761|NCT01692301|594405947|FG001|Overall Study|Death|2|||
164555762|NCT01692301|594405946|FG000|Overall Study|Lack of Efficacy|0|||
164555763|NCT01692301|594405947|FG001|Overall Study|Lack of Efficacy|5|||
164555764|NCT01692301|594405946|FG000|Overall Study|Non-compliance with study treatment|1|||
164555765|NCT01692301|594405947|FG001|Overall Study|Non-compliance with study treatment|2|||
164555766|NCT01692301|594405946|FG000|Overall Study|Protocol deviation|9|||
164555767|NCT01692301|594405947|FG001|Overall Study|Protocol deviation|2|||
164555768|NCT01692301|594405946|FG000|Overall Study|Patient/guardian decision|16|||
164555769|NCT01692301|594405947|FG001|Overall Study|Patient/guardian decision|15|||
164555770|NCT01692301|594405946|FG000|Overall Study|Technical problems|0|||
164555771|NCT01692301|594405947|FG001|Overall Study|Technical problems|1|||
164555772|NCT01692301|594405946|FG000|Overall Study|Physician Decision|2|||
164555773|NCT01692301|594405947|FG001|Overall Study|Physician Decision|2|||
164555774|NCT01692301|594405946|FG000|Overall Study|Lost to Follow-up|1|||
164555775|NCT01692301|594405947|FG001|Overall Study|Lost to Follow-up|1|||
164555776|NCT01142726|594405948|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
164555777|NCT01142726|594405949|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
164555778|NCT01142726|594405950|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
164555779|NCT01142726|594405948|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
164555780|NCT01142726|594405949|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
164555781|NCT01142726|594405950|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
164555782|NCT01142726|594405948|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
164555783|NCT01142726|594405949|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
164555784|NCT01142726|594405950|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
164555785|NCT01142726|594405948|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
164555786|NCT01142726|594405949|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
164311279|NCT02067676|593515275|FG004|Overall Study|Withdrawal by Subject|0|||
164311280|NCT02067676|593515276|FG005|Overall Study|Withdrawal by Subject|0|||
164555787|NCT01142726|594405950|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
164555788|NCT01142726|594405948|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
164555789|NCT01142726|594405949|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
164555790|NCT01142726|594405950|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
164555791|NCT01142726|594405948|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
164555792|NCT01142726|594405949|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
164660288|NCT00998881|594781893|FG001|Overall Study|Withdrawal by Subject|0|||
164311281|NCT00996333|593515277|FG000|Overall Study|Screen failure|1|||
164311282|NCT00996333|593515277|FG000|Overall Study|Withdrawal by Subject|1|||
164311283|NCT00996333|593515277|FG000|Overall Study|Death|4|||
164311284|NCT00996333|593515277|FG000|Overall Study|Adverse Event|1|||
164555793|NCT01142726|594405950|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
164555794|NCT01142726|594405948|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
164555795|NCT01142726|594405949|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
164555796|NCT01142726|594405950|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
164555797|NCT01142726|594405948|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
164555798|NCT01142726|594405949|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
164555799|NCT01142726|594405950|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
164555800|NCT01142726|594405948|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
164555801|NCT01142726|594405949|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
164555802|NCT01142726|594405950|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
164555803|NCT01142726|594405948|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
164555804|NCT01142726|594405949|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
164555805|NCT01142726|594405950|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
164555806|NCT01142726|594405948|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
164555807|NCT01142726|594405949|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
164555808|NCT01142726|594405950|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
164555809|NCT01142726|594405948|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
164555810|NCT01142726|594405949|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
164555811|NCT01142726|594405950|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
164555812|NCT01142726|594405948|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
164555813|NCT01142726|594405949|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
164555814|NCT01142726|594405950|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
164555815|NCT01142726|594405948|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
164555816|NCT01142726|594405949|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
164555817|NCT01142726|594405950|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
164555818|NCT01142726|594405948|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
164555819|NCT01142726|594405949|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
164555820|NCT01142726|594405950|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
164555821|NCT01142726|594405948|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
164555822|NCT01142726|594405949|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
164555823|NCT01142726|594405950|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
164555824|NCT01568593|594405951|FG000|Overall Study|Lack of Efficacy|4|||
164555825|NCT01568593|594405952|FG001|Overall Study|Lack of Efficacy|1|||
164555826|NCT01568593|594405951|FG000|Overall Study|Adverse Event|3|||
164555827|NCT01568593|594405952|FG001|Overall Study|Adverse Event|2|||
164555828|NCT02109484|594405953|FG000|Overall Study|Lost to Follow-up|0|||
164555829|NCT02109484|594405954|FG001|Overall Study|Lost to Follow-up|0|||
164555830|NCT02109484|594405955|FG002|Overall Study|Lost to Follow-up|0|||
164555831|NCT02109484|594405956|FG003|Overall Study|Lost to Follow-up|1|||
164555832|NCT02109484|594405957|FG004|Overall Study|Lost to Follow-up|1|||
164555833|NCT02109484|594405958|FG005|Overall Study|Lost to Follow-up|0|||
164555834|NCT02109484|594405959|FG006|Overall Study|Lost to Follow-up|1|||
164555835|NCT02109484|594405960|FG007|Overall Study|Lost to Follow-up|0|||
164555836|NCT02109484|594405953|FG000|Overall Study|Withdrawal by Subject|0|||
164555837|NCT02109484|594405954|FG001|Overall Study|Withdrawal by Subject|0|||
164555838|NCT02109484|594405955|FG002|Overall Study|Withdrawal by Subject|0|||
164555839|NCT02109484|594405956|FG003|Overall Study|Withdrawal by Subject|0|||
164555840|NCT02109484|594405957|FG004|Overall Study|Withdrawal by Subject|1|||
164555841|NCT02109484|594405958|FG005|Overall Study|Withdrawal by Subject|1|||
164555842|NCT02109484|594405959|FG006|Overall Study|Withdrawal by Subject|1|||
164555843|NCT02109484|594405960|FG007|Overall Study|Withdrawal by Subject|0|||
164555844|NCT02109484|594405953|FG000|Overall Study|Physician Decision|0|||
164555845|NCT02109484|594405954|FG001|Overall Study|Physician Decision|0|||
164555846|NCT02109484|594405955|FG002|Overall Study|Physician Decision|0|||
164555847|NCT02109484|594405956|FG003|Overall Study|Physician Decision|0|||
164555848|NCT02109484|594405957|FG004|Overall Study|Physician Decision|2|||
164555849|NCT02109484|594405958|FG005|Overall Study|Physician Decision|0|||
164555850|NCT02109484|594405959|FG006|Overall Study|Physician Decision|0|||
164555851|NCT02109484|594405960|FG007|Overall Study|Physician Decision|0|||
164555852|NCT02109484|594405953|FG000|Overall Study|Death|0|||
164555853|NCT02109484|594405954|FG001|Overall Study|Death|0|||
164555854|NCT02109484|594405955|FG002|Overall Study|Death|0|||
164555855|NCT02109484|594405956|FG003|Overall Study|Death|0|||
164555856|NCT02109484|594405957|FG004|Overall Study|Death|0|||
164555857|NCT02109484|594405958|FG005|Overall Study|Death|0|||
164555858|NCT02109484|594405959|FG006|Overall Study|Death|0|||
164555859|NCT02109484|594405960|FG007|Overall Study|Death|2|||
164555860|NCT02109484|594405953|FG000|Overall Study|Moved away from study area|0|||
164555861|NCT02109484|594405954|FG001|Overall Study|Moved away from study area|0|||
164555862|NCT02109484|594405955|FG002|Overall Study|Moved away from study area|0|||
164311285|NCT00996333|593515277|FG000|Overall Study|Physician Decision|1|||
164311286|NCT00996333|593515277|FG000|Overall Study|Other|5|||
164311287|NCT00476229|593515278|FG000|Overall Study|Progressive shortness of breath|1|||
164311288|NCT02100696|593515281|FG000|Induction Phase|Adverse Event|0|||
164311289|NCT02100696|593515282|FG001|Induction Phase|Adverse Event|0|||
164311290|NCT02100696|593515283|FG002|Induction Phase|Adverse Event|1|||
164660289|NCT00998881|594781892|FG000|Overall Study|Personal matter|1|||
164660290|NCT00998881|594781893|FG001|Overall Study|Personal matter|0|||
164660291|NCT02649231|594781894|FG000|Overall Study|Adverse Event|0|||
164660292|NCT02649231|594781895|FG001|Overall Study|Adverse Event|0|||
164660293|NCT02649231|594781896|FG002|Overall Study|Adverse Event|0|||
164660294|NCT02649231|594781897|FG003|Overall Study|Adverse Event|1|||
164660295|NCT02649231|594781894|FG000|Overall Study|Lost to Follow-up|2|||
164660296|NCT02649231|594781895|FG001|Overall Study|Lost to Follow-up|1|||
164660297|NCT02649231|594781896|FG002|Overall Study|Lost to Follow-up|1|||
164660298|NCT02649231|594781897|FG003|Overall Study|Lost to Follow-up|0|||
164660299|NCT02649231|594781894|FG000|Overall Study|Withdrawal by Subject|0|||
164660300|NCT02649231|594781895|FG001|Overall Study|Withdrawal by Subject|1|||
164660301|NCT02649231|594781896|FG002|Overall Study|Withdrawal by Subject|0|||
164660302|NCT02649231|594781897|FG003|Overall Study|Withdrawal by Subject|1|||
164660303|NCT02649231|594781894|FG000|Overall Study|Protocol Violation|2|||
164660304|NCT02649231|594781895|FG001|Overall Study|Protocol Violation|1|||
164660305|NCT02649231|594781896|FG002|Overall Study|Protocol Violation|1|||
164660306|NCT02649231|594781897|FG003|Overall Study|Protocol Violation|0|||
164660307|NCT00876733|594781900|FG000|Overall Study|Adverse Event|34|||
164660308|NCT00876733|594781901|FG001|Overall Study|Adverse Event|20|||
164660309|NCT00876733|594781902|FG002|Overall Study|Adverse Event|10|||
164660310|NCT00876733|594781903|FG003|Overall Study|Adverse Event|3|||
164660311|NCT00876733|594781900|FG000|Overall Study|Lack of Efficacy|17|||
164660312|NCT00876733|594781901|FG001|Overall Study|Lack of Efficacy|9|||
164660313|NCT00876733|594781902|FG002|Overall Study|Lack of Efficacy|10|||
164660314|NCT00876733|594781903|FG003|Overall Study|Lack of Efficacy|1|||
164660315|NCT00876733|594781900|FG000|Overall Study|Lost to Follow-up|26|||
164660316|NCT00876733|594781901|FG001|Overall Study|Lost to Follow-up|10|||
164660317|NCT00876733|594781902|FG002|Overall Study|Lost to Follow-up|3|||
164660318|NCT00876733|594781903|FG003|Overall Study|Lost to Follow-up|2|||
164660319|NCT00876733|594781900|FG000|Overall Study|Data not available|14|||
164660320|NCT00876733|594781901|FG001|Overall Study|Data not available|3|||
164660321|NCT00876733|594781902|FG002|Overall Study|Data not available|7|||
164660322|NCT00876733|594781903|FG003|Overall Study|Data not available|1|||
164660323|NCT02611752|594781906|FG000|Overall Study|Adverse Event|0|||
164660324|NCT02611752|594781907|FG001|Overall Study|Adverse Event|1|||
164660325|NCT00249821|594781908|FG000|Overall Study|Technical problem|0|||
164660326|NCT00249821|594781909|FG001|Overall Study|Technical problem|1|||
164660327|NCT00423800|594781913|FG000|Overall Study|Protocol Violation|0|||
164660328|NCT00423800|594781914|FG001|Overall Study|Protocol Violation|1|||
164660329|NCT00814320|594781915|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
164660330|NCT00814320|594781916|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
164660331|NCT00814320|594781915|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
164660332|NCT00814320|594781916|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
164660333|NCT00814320|594781915|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
164660334|NCT00814320|594781916|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
164660335|NCT00814320|594781915|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
164660336|NCT00814320|594781916|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
164660337|NCT00814320|594781915|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
164660338|NCT00814320|594781916|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
164660339|NCT00814320|594781915|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
164660340|NCT00814320|594781916|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
164660341|NCT00814320|594781915|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
164660342|NCT00814320|594781916|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
164660343|NCT00814320|594781915|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
164660344|NCT00814320|594781916|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
164660345|NCT00814320|594781915|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
164311291|NCT02100696|593515284|FG003|Induction Phase|Adverse Event|0|||
164660346|NCT00814320|594781916|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
164660347|NCT00814320|594781915|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
164660348|NCT00814320|594781916|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
164660349|NCT00619385|594781917|FG000|Overall Study|Adverse Event|0|||
164660350|NCT00619385|594781918|FG001|Overall Study|Adverse Event|0|||
164660351|NCT00619385|594781919|FG002|Overall Study|Adverse Event|3|||
164660352|NCT00619385|594781917|FG000|Overall Study|Other|1|||
164660353|NCT00619385|594781918|FG001|Overall Study|Other|2|||
164660354|NCT00619385|594781919|FG002|Overall Study|Other|1|||
164660355|NCT00656019|594781923|FG000|Overall Study|Not Eligible|10|||
164660356|NCT00656019|594781924|FG001|Overall Study|Not Eligible|0|||
164660357|NCT00656019|594781925|FG002|Overall Study|Not Eligible|0|||
164311292|NCT02100696|593515285|FG004|Induction Phase|Adverse Event|0|||
164311293|NCT02100696|593515286|FG005|Induction Phase|Adverse Event|0|||
164311294|NCT02100696|593515281|FG000|Induction Phase|Lost to Follow-up|1|||
164311295|NCT02100696|593515282|FG001|Induction Phase|Lost to Follow-up|0|||
164311296|NCT02100696|593515283|FG002|Induction Phase|Lost to Follow-up|1|||
164311297|NCT02100696|593515284|FG003|Induction Phase|Lost to Follow-up|0|||
164311298|NCT02100696|593515285|FG004|Induction Phase|Lost to Follow-up|0|||
164311299|NCT02100696|593515286|FG005|Induction Phase|Lost to Follow-up|0|||
164311300|NCT02100696|593515281|FG000|Induction Phase|Protocol Violation|0|||
164311301|NCT02100696|593515282|FG001|Induction Phase|Protocol Violation|1|||
164311302|NCT02100696|593515283|FG002|Induction Phase|Protocol Violation|1|||
164311303|NCT02100696|593515284|FG003|Induction Phase|Protocol Violation|0|||
164311304|NCT02100696|593515285|FG004|Induction Phase|Protocol Violation|0|||
164311305|NCT02100696|593515286|FG005|Induction Phase|Protocol Violation|0|||
164311306|NCT02100696|593515281|FG000|Induction Phase|Withdrawal by Subject|8|||
164311307|NCT02100696|593515282|FG001|Induction Phase|Withdrawal by Subject|2|||
164311308|NCT02100696|593515283|FG002|Induction Phase|Withdrawal by Subject|13|||
164311309|NCT02100696|593515284|FG003|Induction Phase|Withdrawal by Subject|0|||
164311310|NCT02100696|593515285|FG004|Induction Phase|Withdrawal by Subject|0|||
164311311|NCT02100696|593515286|FG005|Induction Phase|Withdrawal by Subject|0|||
164311312|NCT02100696|593515281|FG000|Induction Phase|Physician Decision|1|||
164311313|NCT02100696|593515282|FG001|Induction Phase|Physician Decision|0|||
164311314|NCT02100696|593515283|FG002|Induction Phase|Physician Decision|2|||
164311315|NCT02100696|593515284|FG003|Induction Phase|Physician Decision|0|||
164311316|NCT02100696|593515285|FG004|Induction Phase|Physician Decision|0|||
164311317|NCT02100696|593515286|FG005|Induction Phase|Physician Decision|0|||
164311318|NCT02100696|593515281|FG000|Induction Phase|Multiple Reasons|5|||
164311319|NCT02100696|593515282|FG001|Induction Phase|Multiple Reasons|2|||
164311320|NCT02100696|593515283|FG002|Induction Phase|Multiple Reasons|8|||
164311321|NCT02100696|593515284|FG003|Induction Phase|Multiple Reasons|0|||
164311322|NCT02100696|593515285|FG004|Induction Phase|Multiple Reasons|0|||
164311323|NCT02100696|593515286|FG005|Induction Phase|Multiple Reasons|0|||
164311324|NCT02100696|593515281|FG000|Maintenance Phase|Adverse Event|0|||
164311325|NCT02100696|593515282|FG001|Maintenance Phase|Adverse Event|0|||
164311326|NCT02100696|593515283|FG002|Maintenance Phase|Adverse Event|0|||
164311327|NCT02100696|593515284|FG003|Maintenance Phase|Adverse Event|0|||
164311328|NCT02100696|593515285|FG004|Maintenance Phase|Adverse Event|0|||
164311329|NCT02100696|593515286|FG005|Maintenance Phase|Adverse Event|2|||
164311330|NCT02100696|593515281|FG000|Maintenance Phase|Lost to Follow-up|0|||
164311331|NCT02100696|593515282|FG001|Maintenance Phase|Lost to Follow-up|0|||
164311332|NCT02100696|593515283|FG002|Maintenance Phase|Lost to Follow-up|0|||
164311333|NCT02100696|593515284|FG003|Maintenance Phase|Lost to Follow-up|0|||
164311334|NCT02100696|593515285|FG004|Maintenance Phase|Lost to Follow-up|1|||
164311335|NCT02100696|593515286|FG005|Maintenance Phase|Lost to Follow-up|0|||
164311336|NCT02100696|593515281|FG000|Maintenance Phase|Protocol Violation|0|||
164311337|NCT02100696|593515282|FG001|Maintenance Phase|Protocol Violation|0|||
164311338|NCT02100696|593515283|FG002|Maintenance Phase|Protocol Violation|0|||
164311339|NCT02100696|593515284|FG003|Maintenance Phase|Protocol Violation|0|||
164311340|NCT02100696|593515285|FG004|Maintenance Phase|Protocol Violation|1|||
164311341|NCT02100696|593515286|FG005|Maintenance Phase|Protocol Violation|0|||
164311342|NCT02100696|593515281|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164311343|NCT02100696|593515282|FG001|Maintenance Phase|Withdrawal by Subject|0|||
164311344|NCT02100696|593515283|FG002|Maintenance Phase|Withdrawal by Subject|0|||
164555863|NCT02109484|594405956|FG003|Overall Study|Moved away from study area|0|||
164555864|NCT02109484|594405957|FG004|Overall Study|Moved away from study area|0|||
164555865|NCT02109484|594405958|FG005|Overall Study|Moved away from study area|0|||
164555866|NCT02109484|594405959|FG006|Overall Study|Moved away from study area|1|||
164555867|NCT02109484|594405960|FG007|Overall Study|Moved away from study area|1|||
164555868|NCT02111993|594405961|FG000|Overall Study|Physician Decision|5|||
164555869|NCT02111993|594405962|FG001|Overall Study|Physician Decision|4|||
164555870|NCT00796315|594405963|FG000|Overall Study|Protocol Violation|0|||
164555871|NCT00796315|594405964|FG001|Overall Study|Protocol Violation|1|||
164555872|NCT00796315|594405965|FG002|Overall Study|Protocol Violation|0|||
164555873|NCT01400451|594405970|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
164555874|NCT01400451|594405971|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
164555875|NCT01400451|594405972|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
164555876|NCT01400451|594405970|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
164555877|NCT01400451|594405971|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
164555878|NCT01400451|594405972|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
164555879|NCT01400451|594405970|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
164555880|NCT01400451|594405971|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
164311345|NCT02100696|593515284|FG003|Maintenance Phase|Withdrawal by Subject|1|||
164311346|NCT02100696|593515285|FG004|Maintenance Phase|Withdrawal by Subject|4|||
164311347|NCT02100696|593515286|FG005|Maintenance Phase|Withdrawal by Subject|2|||
164311348|NCT02100696|593515281|FG000|Maintenance Phase|Physician Decision|0|||
164555881|NCT01400451|594405972|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
164660358|NCT00656019|594781926|FG003|Overall Study|Not Eligible|0|||
164660359|NCT00656019|594781923|FG000|Overall Study|Withdrawal by Subject|2|||
164660360|NCT00656019|594781924|FG001|Overall Study|Withdrawal by Subject|0|||
164660361|NCT00656019|594781925|FG002|Overall Study|Withdrawal by Subject|0|||
164660362|NCT00656019|594781926|FG003|Overall Study|Withdrawal by Subject|0|||
164660363|NCT00656019|594781923|FG000|Overall Study|Lost to Follow-up|2|||
164660364|NCT00656019|594781924|FG001|Overall Study|Lost to Follow-up|1|||
164660365|NCT00656019|594781925|FG002|Overall Study|Lost to Follow-up|0|||
164660366|NCT00656019|594781926|FG003|Overall Study|Lost to Follow-up|0|||
164660367|NCT01488578|594781927|FG000|Overall Study|Protocol Violation|1836|||
164660368|NCT05550532|594781932|FG000|Overall Study|Withdrawal by Subject|8|||
164660369|NCT05550532|594781933|FG001|Overall Study|Withdrawal by Subject|3|||
164660370|NCT05550532|594781932|FG000|Overall Study|Adverse Event|2|||
164660371|NCT05550532|594781933|FG001|Overall Study|Adverse Event|3|||
164660372|NCT05550532|594781932|FG000|Overall Study|Lost to Follow-up|4|||
164660373|NCT05550532|594781933|FG001|Overall Study|Lost to Follow-up|0|||
164660374|NCT05550532|594781932|FG000|Overall Study|Other|0|||
164660375|NCT05550532|594781933|FG001|Overall Study|Other|4|||
164660376|NCT03390504|594781941|FG000|Overall Study|Lost to Follow-up|2|||
164660377|NCT03390504|594781942|FG001|Overall Study|Lost to Follow-up|4|||
164660378|NCT03390504|594781943|FG002|Overall Study|Lost to Follow-up|0|||
164660379|NCT03390504|594781944|FG003|Overall Study|Lost to Follow-up|1|||
164660380|NCT03390504|594781941|FG000|Overall Study|Withdrawal by Subject|3|||
164660381|NCT03390504|594781942|FG001|Overall Study|Withdrawal by Subject|15|||
164660382|NCT03390504|594781943|FG002|Overall Study|Withdrawal by Subject|5|||
164660383|NCT03390504|594781944|FG003|Overall Study|Withdrawal by Subject|2|||
164660384|NCT03390504|594781941|FG000|Overall Study|Other|1|||
164660385|NCT03390504|594781942|FG001|Overall Study|Other|2|||
164660386|NCT03390504|594781943|FG002|Overall Study|Other|2|||
164660387|NCT03390504|594781944|FG003|Overall Study|Other|6|||
164660388|NCT00859469|594781945|FG000|Overall Study|Adverse Event|2|||
164660389|NCT00859469|594781945|FG000|Overall Study|Lack of Efficacy|9|||
164660390|NCT00859469|594781945|FG000|Overall Study|Withdrawal by Subject|1|||
164660391|NCT00859469|594781945|FG000|Overall Study|Death|16|||
164660392|NCT05431686|594781946|FG000|Overall Study|unable to schedule|10|||
164660393|NCT01736553|594781953|FG000|Overall Study|Death|12|||
164660394|NCT01736553|594781954|FG001|Overall Study|Death|0|||
164660395|NCT01736553|594781953|FG000|Overall Study|Withdrawal by Subject|5|||
164660396|NCT01736553|594781954|FG001|Overall Study|Withdrawal by Subject|2|||
164660397|NCT01736553|594781953|FG000|Overall Study|Lost to Follow-up|2|||
164660398|NCT01736553|594781954|FG001|Overall Study|Lost to Follow-up|2|||
164660399|NCT01890707|594781955|FG000|Overall Study|Lost to Follow-up|1|||
164660400|NCT01890707|594781956|FG001|Overall Study|Lost to Follow-up|1|||
164660401|NCT00669955|594781957|FG000|Overall Study|Adverse Event|3|||
164660402|NCT00669955|594781958|FG001|Overall Study|Adverse Event|5|||
164660403|NCT00669955|594781957|FG000|Overall Study|Death|0|||
164660404|NCT00669955|594781958|FG001|Overall Study|Death|1|||
164660405|NCT00669955|594781957|FG000|Overall Study|Withdrawal by Subject|2|||
164660406|NCT00669955|594781958|FG001|Overall Study|Withdrawal by Subject|3|||
164660407|NCT00669955|594781957|FG000|Overall Study|Lost to Follow-up|5|||
164660408|NCT00669955|594781958|FG001|Overall Study|Lost to Follow-up|7|||
164660409|NCT00669955|594781957|FG000|Overall Study|Protocol Violation|2|||
164660410|NCT00669955|594781958|FG001|Overall Study|Protocol Violation|7|||
164660411|NCT00669955|594781957|FG000|Overall Study|Investigator Sponsor Judgement|0|||
164660412|NCT00669955|594781958|FG001|Overall Study|Investigator Sponsor Judgement|1|||
164660413|NCT00669955|594781957|FG000|Overall Study|not compliant with study drug/visit|2|||
164660414|NCT00669955|594781958|FG001|Overall Study|not compliant with study drug/visit|3|||
164660415|NCT03495869|594781959|FG000|Overall Study|Lost to Follow-up|4|||
164660416|NCT03495869|594781960|FG001|Overall Study|Lost to Follow-up|17|||
164660417|NCT03495869|594781961|FG002|Overall Study|Lost to Follow-up|8|||
164660418|NCT03495869|594781962|FG003|Overall Study|Lost to Follow-up|14|||
164660419|NCT03495869|594781959|FG000|Overall Study|Withdrawal by Subject|0|||
164660420|NCT03495869|594781960|FG001|Overall Study|Withdrawal by Subject|3|||
164660421|NCT03495869|594781961|FG002|Overall Study|Withdrawal by Subject|0|||
164660422|NCT03495869|594781962|FG003|Overall Study|Withdrawal by Subject|3|||
164660423|NCT03495869|594781959|FG000|Overall Study|Dropped from study|0|||
164660424|NCT03495869|594781960|FG001|Overall Study|Dropped from study|7|||
164660425|NCT03495869|594781961|FG002|Overall Study|Dropped from study|2|||
164660426|NCT03495869|594781962|FG003|Overall Study|Dropped from study|4|||
164660427|NCT02918162|594783385|FG000|Overall Study|Withdrawal by Subject|1|||
164660428|NCT02918162|594783385|FG000|Overall Study|Omental Disease|1|||
164660429|NCT00395226|594783386|FG000|Overall Study|Adverse Event|4|||
164660430|NCT00395226|594783387|FG001|Overall Study|Adverse Event|3|||
164660431|NCT00395226|594783386|FG000|Overall Study|Withdrawal by Subject|0|||
164660432|NCT00395226|594783387|FG001|Overall Study|Withdrawal by Subject|1|||
164660433|NCT00395226|594783386|FG000|Overall Study|Lost to Follow-up|0|||
164660434|NCT00395226|594783387|FG001|Overall Study|Lost to Follow-up|1|||
164660435|NCT02655237|594783390|FG000|Overall Study|Adverse Event|10|||
164660436|NCT02655237|594783391|FG001|Overall Study|Adverse Event|7|||
164660437|NCT02655237|594783390|FG000|Overall Study|Protocol Deviation|2|||
164311349|NCT02100696|593515282|FG001|Maintenance Phase|Physician Decision|0|||
164311350|NCT02100696|593515283|FG002|Maintenance Phase|Physician Decision|0|||
164311351|NCT02100696|593515284|FG003|Maintenance Phase|Physician Decision|0|||
164311352|NCT02100696|593515285|FG004|Maintenance Phase|Physician Decision|1|||
164311353|NCT02100696|593515286|FG005|Maintenance Phase|Physician Decision|0|||
164311354|NCT02100696|593515281|FG000|Maintenance Phase|Multiple Reasons|0|||
164311355|NCT02100696|593515282|FG001|Maintenance Phase|Multiple Reasons|0|||
164311356|NCT02100696|593515283|FG002|Maintenance Phase|Multiple Reasons|0|||
164311357|NCT02100696|593515284|FG003|Maintenance Phase|Multiple Reasons|0|||
164311358|NCT02100696|593515285|FG004|Maintenance Phase|Multiple Reasons|2|||
164311359|NCT02100696|593515286|FG005|Maintenance Phase|Multiple Reasons|1|||
164311360|NCT03566485|593515290|FG000|Overall Study|Disease progression|5|||
164311361|NCT03566485|593515291|FG001|Overall Study|Disease progression|4|||
164311362|NCT03566485|593515290|FG000|Overall Study|Clinical progression|0|||
164311363|NCT03566485|593515291|FG001|Overall Study|Clinical progression|1|||
164311364|NCT03566485|593515290|FG000|Overall Study|Toxicity|0|||
164311365|NCT03566485|593515291|FG001|Overall Study|Toxicity|2|||
164311366|NCT01387542|593515303|FG000|Overall Study|Adverse Event|3|||
164311367|NCT01387542|593515303|FG000|Overall Study|Withdrawal by Subject|1|||
164311368|NCT01387542|593515303|FG000|Overall Study|Changed diagnosis|1|||
164311369|NCT01387542|593515303|FG000|Overall Study|Insufficient response|1|||
164311370|NCT01387542|593515303|FG000|Overall Study|Non-compliant|1|||
164311371|NCT01387542|593515303|FG000|Overall Study|Lost to Follow-up|1|||
164311372|NCT01010867|593515304|FG000|Overall Study|< 50% adherence to probiotic|1|||
164311373|NCT01668589|593515307|FG000|Overall Study|Lost to Follow-up|29|||
164311374|NCT01668589|593515308|FG001|Overall Study|Lost to Follow-up|37|||
164311375|NCT01668589|593515309|FG002|Overall Study|Lost to Follow-up|15|||
164311376|NCT01668589|593515310|FG003|Overall Study|Lost to Follow-up|5|||
164311377|NCT01668589|593515307|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
164311378|NCT01668589|593515308|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
164311379|NCT01668589|593515309|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
164311380|NCT01668589|593515310|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
164311381|NCT01668589|593515307|FG000|Overall Study|Death|12|||
164311382|NCT01668589|593515308|FG001|Overall Study|Death|3|||
164311383|NCT01668589|593515309|FG002|Overall Study|Death|2|||
164311384|NCT01668589|593515310|FG003|Overall Study|Death|11|||
164311385|NCT01668589|593515307|FG000|Overall Study|Other|44|||
164311386|NCT01668589|593515308|FG001|Overall Study|Other|10|||
164311387|NCT01668589|593515309|FG002|Overall Study|Other|7|||
164311388|NCT01668589|593515310|FG003|Overall Study|Other|15|||
164311389|NCT02954172|593515311|FG000|Overall Study|Protocol Violation|3|||
164311390|NCT02954172|593515312|FG001|Overall Study|Protocol Violation|0|||
164311391|NCT02954172|593515311|FG000|Overall Study|allergic reaction|2|||
164311392|NCT02954172|593515312|FG001|Overall Study|allergic reaction|1|||
164311393|NCT02954172|593515311|FG000|Overall Study|non-measurable lesions at baseline|1|||
164311394|NCT02954172|593515312|FG001|Overall Study|non-measurable lesions at baseline|2|||
164311395|NCT01827956|593515314|FG000|Overall Study|Protocol Violation|3|||
164311396|NCT04393454|593515315|FG000|Overall Study|Death|1|||
164311397|NCT04393454|593515315|FG000|Overall Study|Lost to Follow-up|1|||
164311398|NCT02752165|593515316|FG000|Overall Study|Withdrawal by Subject|6|||
164311399|NCT02752165|593515317|FG001|Overall Study|Withdrawal by Subject|6|||
164311400|NCT02752165|593515316|FG000|Overall Study|Protocol Violation|6|||
164311401|NCT02752165|593515317|FG001|Overall Study|Protocol Violation|5|||
164311402|NCT02752165|593515316|FG000|Overall Study|Lost to Follow-up|33|||
164311403|NCT02752165|593515317|FG001|Overall Study|Lost to Follow-up|38|||
164311404|NCT01120964|593515318|FG000|Overall Study|Did not receive full treatment|1|||
164311405|NCT01120964|593515319|FG001|Overall Study|Did not receive full treatment|0|||
164311406|NCT01704599|593515321|FG000|Overall Study|Adverse Event|1|||
164311407|NCT05064358|593515322|FG000|Overall Study|Death|23|||
164311408|NCT05064358|593515323|FG001|Overall Study|Death|23|||
164311409|NCT05064358|593515324|FG002|Overall Study|Death|25|||
164311410|NCT05064358|593515325|FG003|Overall Study|Death|21|||
164311411|NCT05064358|593515326|FG004|Overall Study|Death|5|||
164311412|NCT05064358|593515322|FG000|Overall Study|Lost to Follow-up|1|||
164311413|NCT05064358|593515323|FG001|Overall Study|Lost to Follow-up|2|||
164311414|NCT05064358|593515324|FG002|Overall Study|Lost to Follow-up|0|||
164311415|NCT05064358|593515325|FG003|Overall Study|Lost to Follow-up|2|||
164311416|NCT05064358|593515326|FG004|Overall Study|Lost to Follow-up|0|||
164311417|NCT05064358|593515322|FG000|Overall Study|Physician Decision|1|||
164311418|NCT05064358|593515323|FG001|Overall Study|Physician Decision|1|||
164311419|NCT05064358|593515324|FG002|Overall Study|Physician Decision|2|||
164311420|NCT05064358|593515325|FG003|Overall Study|Physician Decision|0|||
164311421|NCT05064358|593515326|FG004|Overall Study|Physician Decision|0|||
164311422|NCT05064358|593515322|FG000|Overall Study|Withdrawal by Subject|4|||
164311423|NCT05064358|593515323|FG001|Overall Study|Withdrawal by Subject|5|||
164311424|NCT05064358|593515324|FG002|Overall Study|Withdrawal by Subject|3|||
164311425|NCT05064358|593515325|FG003|Overall Study|Withdrawal by Subject|6|||
164311426|NCT05064358|593515326|FG004|Overall Study|Withdrawal by Subject|3|||
164311427|NCT05064358|593515322|FG000|Overall Study|Ongoing at the time of analysis|1|||
164311428|NCT05064358|593515323|FG001|Overall Study|Ongoing at the time of analysis|2|||
164311429|NCT05064358|593515324|FG002|Overall Study|Ongoing at the time of analysis|2|||
164311430|NCT05064358|593515325|FG003|Overall Study|Ongoing at the time of analysis|2|||
164311431|NCT05064358|593515326|FG004|Overall Study|Ongoing at the time of analysis|2|||
164311432|NCT04976192|593515329|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
164311433|NCT04976192|593515330|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
164311434|NCT04976192|593515331|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
164311435|NCT04976192|593515332|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
164311436|NCT04976192|593515333|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
164311437|NCT04976192|593515334|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
164311438|NCT04976192|593515335|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
164311439|NCT04976192|593515336|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
164311440|NCT04976192|593515337|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
164311441|NCT04976192|593515338|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
164311442|NCT04976192|593515329|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
164311443|NCT04976192|593515330|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
164311444|NCT04976192|593515331|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
164311445|NCT04976192|593515332|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
164311446|NCT04976192|593515333|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164311447|NCT04976192|593515334|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164311448|NCT04976192|593515335|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164311449|NCT04976192|593515336|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164311450|NCT04976192|593515337|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164311451|NCT04976192|593515338|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164311452|NCT04976192|593515329|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
164311453|NCT04976192|593515330|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
164311454|NCT04976192|593515331|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
164311455|NCT04976192|593515332|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
164311456|NCT04976192|593515333|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
164311457|NCT04976192|593515334|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
164311458|NCT04976192|593515335|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
164311459|NCT04976192|593515336|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
164311460|NCT04976192|593515337|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
164311461|NCT04976192|593515338|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
164311462|NCT04976192|593515329|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164311463|NCT04976192|593515330|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164311464|NCT04976192|593515331|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164311465|NCT04976192|593515332|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164311466|NCT04976192|593515333|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
164311467|NCT04976192|593515334|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
164311468|NCT04976192|593515335|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
164311469|NCT04976192|593515336|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
164311470|NCT04976192|593515337|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
164311471|NCT04976192|593515338|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
164311472|NCT04976192|593515329|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
164311473|NCT04976192|593515330|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
164311474|NCT04976192|593515331|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
164311475|NCT04976192|593515332|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
164311476|NCT04976192|593515333|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
164311477|NCT04976192|593515334|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
164311478|NCT04976192|593515335|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
164311479|NCT04976192|593515336|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
164555882|NCT01400451|594405970|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
164555883|NCT01400451|594405971|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
164555884|NCT01400451|594405972|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
164555885|NCT01400451|594405970|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
164555886|NCT01400451|594405971|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
164555887|NCT01400451|594405972|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
164555888|NCT00574275|594405973|FG000|Overall Study|Randomized but not treated|2|||
164555889|NCT00574275|594405974|FG001|Overall Study|Randomized but not treated|3|||
164555890|NCT00574275|594405973|FG000|Overall Study|Adverse Event|32|||
164555891|NCT00574275|594405974|FG001|Overall Study|Adverse Event|76|||
164311480|NCT04976192|593515337|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
164555892|NCT00574275|594405973|FG000|Overall Study|Disease progression|160|||
164311481|NCT04976192|593515338|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
164311482|NCT04976192|593515329|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164311483|NCT04976192|593515330|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164311484|NCT04976192|593515331|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164311485|NCT04976192|593515332|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164311486|NCT04976192|593515333|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164311487|NCT04976192|593515334|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
164311488|NCT04976192|593515335|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164311489|NCT04976192|593515336|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164311490|NCT04976192|593515337|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164311491|NCT04976192|593515338|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164311492|NCT02621151|593515339|FG000|Overall Study|Not eligible for trial|6|||
164311493|NCT00924027|593515345|FG000|Overall Study|Lost to Further Follow-Up|4|||
164311494|NCT00924027|593515346|FG001|Overall Study|Lost to Further Follow-Up|0|||
164311495|NCT00924027|593515347|FG002|Overall Study|Lost to Further Follow-Up|0|||
164311496|NCT00924027|593515348|FG003|Overall Study|Lost to Further Follow-Up|0|||
164311497|NCT00924027|593515345|FG000|Overall Study|Physician Decision|1|||
164311498|NCT00924027|593515346|FG001|Overall Study|Physician Decision|0|||
164311499|NCT00924027|593515347|FG002|Overall Study|Physician Decision|0|||
164311500|NCT00924027|593515348|FG003|Overall Study|Physician Decision|1|||
164311501|NCT00924027|593515345|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
164311502|NCT00924027|593515346|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
164311503|NCT00924027|593515347|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
164311504|NCT00924027|593515348|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
164311505|NCT00924027|593515345|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
164311506|NCT00924027|593515346|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
164311507|NCT00924027|593515347|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
164311508|NCT00924027|593515348|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
164311509|NCT00924027|593515345|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
164311510|NCT00924027|593515346|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
164311511|NCT00924027|593515347|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
164311512|NCT00924027|593515348|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
164311513|NCT01761162|593516609|FG000|Overall Study|Withdrawal by Subject|3|||
164311514|NCT02160899|593516614|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
164311515|NCT02160899|593516615|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
164311516|NCT02160899|593516616|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
164311517|NCT02160899|593516617|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
164311518|NCT02160899|593516618|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
164311519|NCT02160899|593516619|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
164311520|NCT04129151|593516620|FG000|Overall Study|Adverse Event|1|||
164311521|NCT04129151|593516620|FG000|Overall Study|Disease Progression|7|||
164311522|NCT04129151|593516620|FG000|Overall Study|Study closure|1|||
164311523|NCT04473235|593516621|FG000|Overall Study|Lost to Follow-up|6|||
164311524|NCT04473235|593516622|FG001|Overall Study|Lost to Follow-up|5|||
164311525|NCT04473235|593516621|FG000|Overall Study|Declined continuation|2|||
164311526|NCT04473235|593516622|FG001|Overall Study|Declined continuation|0|||
164311527|NCT04473235|593516621|FG000|Overall Study|Physician Decision|1|||
164311528|NCT04473235|593516622|FG001|Overall Study|Physician Decision|1|||
164311529|NCT04473235|593516621|FG000|Overall Study|Protocol Violation|10|||
164311530|NCT04473235|593516622|FG001|Overall Study|Protocol Violation|6|||
164311531|NCT01945710|593516625|FG000|Overall Study|Progressive Disease|5|||
164311532|NCT01945710|593516626|FG001|Overall Study|Progressive Disease|4|||
164311533|NCT01945710|593516627|FG002|Overall Study|Progressive Disease|3|||
164311534|NCT01945710|593516628|FG003|Overall Study|Progressive Disease|2|||
164311535|NCT01945710|593516629|FG004|Overall Study|Progressive Disease|7|||
164311536|NCT01945710|593516630|FG005|Overall Study|Progressive Disease|3|||
164311537|NCT01945710|593516631|FG006|Overall Study|Progressive Disease|19|||
164311538|NCT01945710|593516625|FG000|Overall Study|Adverse Event|0|||
164311539|NCT01945710|593516626|FG001|Overall Study|Adverse Event|1|||
164311540|NCT01945710|593516627|FG002|Overall Study|Adverse Event|0|||
164311541|NCT01945710|593516628|FG003|Overall Study|Adverse Event|0|||
164311542|NCT01945710|593516629|FG004|Overall Study|Adverse Event|0|||
164311543|NCT01945710|593516630|FG005|Overall Study|Adverse Event|0|||
164555893|NCT00574275|594405974|FG001|Overall Study|Disease progression|146|||
164311544|NCT01945710|593516631|FG006|Overall Study|Adverse Event|0|||
164311545|NCT01945710|593516625|FG000|Overall Study|Other|2|||
164311546|NCT01945710|593516626|FG001|Overall Study|Other|0|||
164555894|NCT00574275|594405973|FG000|Overall Study|Lost to Follow-up|2|||
164555895|NCT00574275|594405974|FG001|Overall Study|Lost to Follow-up|1|||
164311547|NCT01945710|593516627|FG002|Overall Study|Other|3|||
164311548|NCT01945710|593516628|FG003|Overall Study|Other|1|||
164311549|NCT01945710|593516629|FG004|Overall Study|Other|1|||
164311550|NCT01945710|593516630|FG005|Overall Study|Other|0|||
164311551|NCT01945710|593516631|FG006|Overall Study|Other|4|||
164311552|NCT01945710|593516625|FG000|Overall Study|Withdrawal by Subject|0|||
164311553|NCT01945710|593516626|FG001|Overall Study|Withdrawal by Subject|1|||
164311554|NCT01945710|593516627|FG002|Overall Study|Withdrawal by Subject|1|||
164311555|NCT01945710|593516628|FG003|Overall Study|Withdrawal by Subject|0|||
164311556|NCT01945710|593516629|FG004|Overall Study|Withdrawal by Subject|1|||
164311557|NCT01945710|593516630|FG005|Overall Study|Withdrawal by Subject|0|||
164311558|NCT01945710|593516631|FG006|Overall Study|Withdrawal by Subject|0|||
164311559|NCT02730195|593516632|FG000|Overall Study|Withdrawal by Subject|1|||
164311560|NCT00745849|593516633|FG000|First Intervention|Withdrawal by Subject|0|||
164311561|NCT00745849|593516634|FG001|First Intervention|Withdrawal by Subject|1|||
164311562|NCT00745849|593516633|FG000|First Intervention|Lost to Follow-up|1|||
164311563|NCT00745849|593516634|FG001|First Intervention|Lost to Follow-up|1|||
164311564|NCT00745849|593516633|FG000|Second Intervention|Lost to Follow-up|2|||
164311565|NCT00745849|593516634|FG001|Second Intervention|Lost to Follow-up|1|||
164311566|NCT01139008|593516635|FG000|Overall Study|Withdrawal by Subject|5|||
164311567|NCT01139008|593516635|FG000|Overall Study|Non-compliant, lost product|1|||
164311568|NCT02785770|593516636|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
164311569|NCT02785770|593516637|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
164311570|NCT02785770|593516638|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
164311571|NCT02785770|593516639|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
164311572|NCT02785770|593516636|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
164311573|NCT02785770|593516637|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
164311574|NCT02785770|593516638|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
164311575|NCT02785770|593516639|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
164311576|NCT02785770|593516636|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
164311577|NCT02785770|593516637|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
164311578|NCT02785770|593516638|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
164311579|NCT02785770|593516639|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
164311580|NCT00813943|593516645|FG000|Overall Study|Ongoing at cut-off date|5|||
164311581|NCT00813943|593516646|FG001|Overall Study|Ongoing at cut-off date|5|||
164311582|NCT00813943|593516647|FG002|Overall Study|Ongoing at cut-off date|3|||
164311583|NCT01088048|593516648|FG000|Overall Study|Adverse Event|7|||
164311584|NCT01088048|593516649|FG001|Overall Study|Adverse Event|9|||
164311585|NCT01088048|593516650|FG002|Overall Study|Adverse Event|7|||
164311586|NCT01088048|593516651|FG003|Overall Study|Adverse Event|5|||
164311587|NCT01088048|593516652|FG004|Overall Study|Adverse Event|6|||
164311588|NCT01088048|593516653|FG005|Overall Study|Adverse Event|3|||
164311589|NCT01088048|593516654|FG006|Overall Study|Adverse Event|3|||
164311590|NCT01088048|593516655|FG007|Overall Study|Adverse Event|0|||
164311591|NCT01088048|593516656|FG008|Overall Study|Adverse Event|2|||
164311592|NCT01088048|593516657|FG009|Overall Study|Adverse Event|2|||
164311593|NCT01088048|593516648|FG000|Overall Study|Withdrew Consent|1|||
164311594|NCT01088048|593516649|FG001|Overall Study|Withdrew Consent|1|||
164311595|NCT01088048|593516650|FG002|Overall Study|Withdrew Consent|1|||
164311596|NCT01088048|593516651|FG003|Overall Study|Withdrew Consent|1|||
164311597|NCT01088048|593516652|FG004|Overall Study|Withdrew Consent|2|||
164311598|NCT01088048|593516653|FG005|Overall Study|Withdrew Consent|1|||
164311599|NCT01088048|593516654|FG006|Overall Study|Withdrew Consent|0|||
164311600|NCT01088048|593516655|FG007|Overall Study|Withdrew Consent|2|||
164311601|NCT01088048|593516656|FG008|Overall Study|Withdrew Consent|2|||
164311602|NCT01088048|593516657|FG009|Overall Study|Withdrew Consent|1|||
164311603|NCT01088048|593516648|FG000|Overall Study|Concomitant Medication Prohibited|1|||
164311604|NCT01088048|593516649|FG001|Overall Study|Concomitant Medication Prohibited|0|||
164311605|NCT01088048|593516650|FG002|Overall Study|Concomitant Medication Prohibited|0|||
164311606|NCT01088048|593516651|FG003|Overall Study|Concomitant Medication Prohibited|0|||
164311607|NCT01088048|593516652|FG004|Overall Study|Concomitant Medication Prohibited|0|||
164311608|NCT01088048|593516653|FG005|Overall Study|Concomitant Medication Prohibited|0|||
164311609|NCT01088048|593516654|FG006|Overall Study|Concomitant Medication Prohibited|0|||
164311610|NCT01088048|593516655|FG007|Overall Study|Concomitant Medication Prohibited|0|||
164311611|NCT01088048|593516656|FG008|Overall Study|Concomitant Medication Prohibited|0|||
164311612|NCT01088048|593516657|FG009|Overall Study|Concomitant Medication Prohibited|0|||
164311613|NCT01088048|593516648|FG000|Overall Study|Investigator Request|2|||
164311614|NCT01088048|593516649|FG001|Overall Study|Investigator Request|2|||
164311615|NCT01088048|593516650|FG002|Overall Study|Investigator Request|0|||
164311616|NCT01088048|593516651|FG003|Overall Study|Investigator Request|0|||
164311617|NCT01088048|593516652|FG004|Overall Study|Investigator Request|3|||
164311618|NCT01088048|593516653|FG005|Overall Study|Investigator Request|1|||
164311619|NCT01088048|593516654|FG006|Overall Study|Investigator Request|1|||
164311620|NCT01088048|593516655|FG007|Overall Study|Investigator Request|0|||
164311621|NCT01088048|593516656|FG008|Overall Study|Investigator Request|0|||
164311622|NCT01088048|593516657|FG009|Overall Study|Investigator Request|0|||
164311623|NCT01088048|593516648|FG000|Overall Study|Patient Non-compliance|0|||
164311624|NCT01088048|593516649|FG001|Overall Study|Patient Non-compliance|1|||
164311625|NCT01088048|593516650|FG002|Overall Study|Patient Non-compliance|0|||
164311626|NCT01088048|593516651|FG003|Overall Study|Patient Non-compliance|0|||
164311627|NCT01088048|593516652|FG004|Overall Study|Patient Non-compliance|0|||
164311628|NCT01088048|593516653|FG005|Overall Study|Patient Non-compliance|0|||
164311629|NCT01088048|593516654|FG006|Overall Study|Patient Non-compliance|0|||
164311630|NCT01088048|593516655|FG007|Overall Study|Patient Non-compliance|0|||
164311631|NCT01088048|593516656|FG008|Overall Study|Patient Non-compliance|0|||
164311632|NCT01088048|593516657|FG009|Overall Study|Patient Non-compliance|0|||
164311633|NCT01088048|593516648|FG000|Overall Study|Disease Progression|7|||
164311634|NCT01088048|593516649|FG001|Overall Study|Disease Progression|4|||
164311635|NCT01088048|593516650|FG002|Overall Study|Disease Progression|3|||
164311636|NCT01088048|593516651|FG003|Overall Study|Disease Progression|5|||
164311637|NCT01088048|593516652|FG004|Overall Study|Disease Progression|3|||
164311638|NCT01088048|593516653|FG005|Overall Study|Disease Progression|3|||
164311639|NCT01088048|593516654|FG006|Overall Study|Disease Progression|2|||
164311640|NCT01088048|593516655|FG007|Overall Study|Disease Progression|1|||
164311641|NCT01088048|593516656|FG008|Overall Study|Disease Progression|0|||
164311642|NCT01088048|593516657|FG009|Overall Study|Disease Progression|0|||
164311643|NCT01088048|593516648|FG000|Overall Study|Death|1|||
164311644|NCT01088048|593516649|FG001|Overall Study|Death|5|||
164311645|NCT01088048|593516650|FG002|Overall Study|Death|3|||
164311646|NCT01088048|593516651|FG003|Overall Study|Death|3|||
164311647|NCT01088048|593516652|FG004|Overall Study|Death|1|||
164311648|NCT01088048|593516653|FG005|Overall Study|Death|3|||
164311649|NCT01088048|593516654|FG006|Overall Study|Death|0|||
164311650|NCT01088048|593516655|FG007|Overall Study|Death|0|||
164311651|NCT01088048|593516656|FG008|Overall Study|Death|3|||
164311652|NCT01088048|593516657|FG009|Overall Study|Death|1|||
164311653|NCT01088048|593516648|FG000|Overall Study|Other|3|||
164311654|NCT01088048|593516649|FG001|Overall Study|Other|5|||
164311655|NCT01088048|593516650|FG002|Overall Study|Other|0|||
164311656|NCT01088048|593516651|FG003|Overall Study|Other|0|||
164311657|NCT01088048|593516652|FG004|Overall Study|Other|2|||
164311658|NCT01088048|593516653|FG005|Overall Study|Other|0|||
164311659|NCT01088048|593516654|FG006|Overall Study|Other|0|||
164311660|NCT01088048|593516655|FG007|Overall Study|Other|2|||
164311661|NCT01088048|593516656|FG008|Overall Study|Other|0|||
164311662|NCT01088048|593516657|FG009|Overall Study|Other|0|||
164311663|NCT01049009|593516664|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
164311664|NCT01049009|593516665|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
164311665|NCT01049009|593516664|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164311666|NCT01049009|593516665|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
164311667|NCT01049009|593516664|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
164311668|NCT01049009|593516665|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
164311669|NCT01049009|593516664|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
164311670|NCT01049009|593516665|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
164311671|NCT03760731|593516666|FG000|Pre-Treatment and Randomization|Withdrawal by Subject|1|||
164311672|NCT03760731|593516667|FG001|Pre-Treatment and Randomization|Withdrawal by Subject|0|||
164311673|NCT03760731|593516666|FG000|Treatment|Attended less than 70% of sessions|10|||
164311674|NCT03760731|593516667|FG001|Treatment|Attended less than 70% of sessions|15|||
164311675|NCT01092546|593516668|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
164311676|NCT01970358|593516669|FG000|Overall Study|Unable to make NeoVax or NeoVax not viable|3|||
164311677|NCT01970358|593516669|FG000|Overall Study|Ineligible at time of second consent|4|||
164311678|NCT02644109|593516670|FG000|Overall Study|Adverse Event|0|||
164311679|NCT02644109|593516671|FG001|Overall Study|Adverse Event|4|||
164311680|NCT01519869|593516674|FG000|Overall Study|Lost to Follow-up|1|||
164311681|NCT04075734|593516677|FG000|Overall Study|Lost to Follow-up|1|||
164311682|NCT04075734|593516678|FG001|Overall Study|Lost to Follow-up|1|||
164311683|NCT04075734|593516679|FG002|Overall Study|Lost to Follow-up|0|||
164311684|NCT04075734|593516677|FG000|Overall Study|Withdrawal by Subject|3|||
164311685|NCT04075734|593516678|FG001|Overall Study|Withdrawal by Subject|0|||
164311686|NCT04075734|593516679|FG002|Overall Study|Withdrawal by Subject|0|||
164311687|NCT02433080|593516681|FG000|Overall Study|Lost to Follow-up|1|||
164311688|NCT02433080|593516682|FG001|Overall Study|Lost to Follow-up|2|||
164311689|NCT02433080|593516681|FG000|Overall Study|Withdrawal by Subject|0|||
164311690|NCT02433080|593516682|FG001|Overall Study|Withdrawal by Subject|2|||
164311691|NCT04080167|593516688|FG000|Overall Study|Lost to Follow-up-Patients|7|||
164311692|NCT04080167|593516689|FG001|Overall Study|Lost to Follow-up-Patients|14|||
164311693|NCT04080167|593516690|FG002|Overall Study|Lost to Follow-up-Patients|0|||
164311694|NCT04080167|593516688|FG000|Overall Study|Lost to Follow-up-Providers|2|||
164311695|NCT04080167|593516689|FG001|Overall Study|Lost to Follow-up-Providers|2|||
164311696|NCT04080167|593516690|FG002|Overall Study|Lost to Follow-up-Providers|0|||
164311697|NCT04080167|593516688|FG000|Overall Study|Withdrawal by Subject|1|||
164311698|NCT04080167|593516689|FG001|Overall Study|Withdrawal by Subject|2|||
164311699|NCT04080167|593516690|FG002|Overall Study|Withdrawal by Subject|0|||
164311700|NCT04080167|593516688|FG000|Overall Study|Withdrawal by Provider|0|||
164311701|NCT04080167|593516689|FG001|Overall Study|Withdrawal by Provider|0|||
164311702|NCT04080167|593516690|FG002|Overall Study|Withdrawal by Provider|4|||
164311703|NCT04080167|593516688|FG000|Overall Study|Death-Patient|2|||
164311704|NCT04080167|593516689|FG001|Overall Study|Death-Patient|1|||
164311705|NCT04080167|593516690|FG002|Overall Study|Death-Patient|0|||
164311706|NCT04080167|593516688|FG000|Overall Study|Hydroxyurea New Starts|0|||
164555896|NCT00574275|594405973|FG000|Overall Study|Study stopped based on DMC decision|62|||
164555897|NCT00574275|594405974|FG001|Overall Study|Study stopped based on DMC decision|23|||
164555898|NCT00574275|594405973|FG000|Overall Study|Withdrawal by Subject|15|||
164555899|NCT00574275|594405974|FG001|Overall Study|Withdrawal by Subject|17|||
164555900|NCT00574275|594405973|FG000|Overall Study|Error calculating tumor measurement|1|||
164555901|NCT00574275|594405974|FG001|Overall Study|Error calculating tumor measurement|0|||
164555902|NCT00574275|594405973|FG000|Overall Study|Physician Decision|1|||
164555903|NCT00574275|594405974|FG001|Overall Study|Physician Decision|1|||
164555904|NCT00574275|594405973|FG000|Overall Study|Protocol Violation|0|||
164660438|NCT02655237|594783391|FG001|Overall Study|Protocol Deviation|0|||
164201988|NCT01041859|593112623|FG000|Double-Blind Maintenance|Protocol Violation|0|||
164201989|NCT01041859|593112624|FG001|Double-Blind Maintenance|Protocol Violation|1|||
164201990|NCT01041859|593112625|FG002|Double-Blind Maintenance|Protocol Violation|3|||
164201991|NCT01041859|593112623|FG000|Double-Blind Maintenance|Other|0|||
164201992|NCT01041859|593112624|FG001|Double-Blind Maintenance|Other|6|||
164201993|NCT01041859|593112625|FG002|Double-Blind Maintenance|Other|2|||
164201994|NCT01041859|593112623|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
164201995|NCT01041859|593112624|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
164201996|NCT01041859|593112625|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
164201997|NCT01041859|593112623|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
164201998|NCT01041859|593112624|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
164201999|NCT01041859|593112625|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
164202000|NCT02027025|593112626|FG000|Overall Study|Adverse Event|0|||
164202001|NCT02027025|593112627|FG001|Overall Study|Adverse Event|1|||
164202002|NCT02027025|593112628|FG002|Overall Study|Adverse Event|1|||
164202003|NCT02027025|593112626|FG000|Overall Study|Protocol Violation|1|||
164202004|NCT02027025|593112627|FG001|Overall Study|Protocol Violation|0|||
164202005|NCT02027025|593112628|FG002|Overall Study|Protocol Violation|0|||
164202006|NCT02027025|593112626|FG000|Overall Study|Lost to Follow-up|0|||
164202007|NCT02027025|593112627|FG001|Overall Study|Lost to Follow-up|2|||
164202008|NCT02027025|593112628|FG002|Overall Study|Lost to Follow-up|0|||
164202009|NCT02027025|593112626|FG000|Overall Study|Withdrawal by Subject|0|||
164202010|NCT02027025|593112627|FG001|Overall Study|Withdrawal by Subject|1|||
164202011|NCT02027025|593112628|FG002|Overall Study|Withdrawal by Subject|0|||
164202012|NCT02027025|593112626|FG000|Overall Study|Sponsor's decision|0|||
164202013|NCT02027025|593112627|FG001|Overall Study|Sponsor's decision|1|||
164202014|NCT02027025|593112628|FG002|Overall Study|Sponsor's decision|0|||
164202015|NCT03210714|593112629|FG000|Overall Study|Adverse Event|6|||
164202016|NCT03210714|593112629|FG000|Overall Study|Physician Decision|1|||
164202017|NCT03210714|593112629|FG000|Overall Study|Progressive disease|11|||
164202018|NCT03210714|593112629|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
164202019|NCT04609514|593112630|FG000|Overall Study|Lost to Follow-up|5|||
164202020|NCT04609514|593112631|FG001|Overall Study|Lost to Follow-up|4|||
164202021|NCT04609514|593112630|FG000|Overall Study|Withdrawal by PI|0|||
164202022|NCT04609514|593112631|FG001|Overall Study|Withdrawal by PI|2|||
164202023|NCT00828711|593112634|FG000|Overall Study|Lost to Follow-up|1|||
164202024|NCT00828711|593112635|FG001|Overall Study|Lost to Follow-up|0|||
164202025|NCT00828711|593112636|FG002|Overall Study|Lost to Follow-up|0|||
164202026|NCT03883386|593112637|FG000|First Assignment|Lost to Follow-up|1|||
164202027|NCT03883386|593112638|FG001|First Assignment|Lost to Follow-up|0|||
164202028|NCT03883386|593112637|FG000|First Assignment|Withdrawal by Subject|1|||
164202029|NCT03883386|593112638|FG001|First Assignment|Withdrawal by Subject|1|||
164202030|NCT01618968|593112639|FG000|Overall Study|Adverse Event|1|||
164202031|NCT01618968|593112640|FG001|Overall Study|Adverse Event|0|||
164202032|NCT01618968|593112641|FG002|Overall Study|Adverse Event|0|||
164202033|NCT01618968|593112642|FG003|Overall Study|Adverse Event|0|||
164202034|NCT01618968|593112639|FG000|Overall Study|Death|0|||
164202035|NCT01618968|593112640|FG001|Overall Study|Death|0|||
164202036|NCT01618968|593112641|FG002|Overall Study|Death|0|||
164202037|NCT01618968|593112642|FG003|Overall Study|Death|1|||
164202038|NCT01326871|593112643|FG000|Overall Study|Major surgery|0|||
164202039|NCT01326871|593112644|FG001|Overall Study|Major surgery|1|||
164202040|NCT01326871|593112645|FG002|Overall Study|Major surgery|0|||
164202041|NCT01326871|593112643|FG000|Overall Study|SAE and death|0|||
164202042|NCT01326871|593112644|FG001|Overall Study|SAE and death|2|||
164202043|NCT01326871|593112645|FG002|Overall Study|SAE and death|0|||
164202044|NCT01326871|593112643|FG000|Overall Study|Physician decision and decreased performance status|0|||
164202045|NCT01326871|593112644|FG001|Overall Study|Physician decision and decreased performance status|1|||
164660439|NCT02655237|594783390|FG000|Overall Study|Withdrawal by Participant|1|||
164202046|NCT01326871|593112645|FG002|Overall Study|Physician decision and decreased performance status|0|||
164202047|NCT01326871|593112643|FG000|Overall Study|Disease progression|0|||
164202048|NCT01326871|593112644|FG001|Overall Study|Disease progression|11|||
164202049|NCT01326871|593112645|FG002|Overall Study|Disease progression|5|||
164202050|NCT01326871|593112643|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
164202051|NCT01326871|593112644|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
164202052|NCT01326871|593112645|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
164660440|NCT02655237|594783391|FG001|Overall Study|Withdrawal by Participant|2|||
164660441|NCT02655237|594783390|FG000|Overall Study|Lack of Efficacy|0|||
164660442|NCT02655237|594783391|FG001|Overall Study|Lack of Efficacy|1|||
164660443|NCT02655237|594783390|FG000|Overall Study|Recovery Leading to Surgery|2|||
164660444|NCT02655237|594783391|FG001|Overall Study|Recovery Leading to Surgery|1|||
164660445|NCT02655237|594783390|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
164660446|NCT02655237|594783391|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
164660447|NCT02655237|594783390|FG000|Overall Study|Randomized but Not Treated|1|||
164660448|NCT02655237|594783391|FG001|Overall Study|Randomized but Not Treated|0|||
164660449|NCT02227862|594783392|FG000|Overall Study|Protocol Violation|7|||
164660450|NCT02227862|594783393|FG001|Overall Study|Protocol Violation|9|||
164660451|NCT02227862|594783392|FG000|Overall Study|Other|0|||
164660452|NCT02227862|594783393|FG001|Overall Study|Other|2|||
164660453|NCT02227862|594783392|FG000|Overall Study|Adverse Event|4|||
164660454|NCT02227862|594783393|FG001|Overall Study|Adverse Event|3|||
164202053|NCT01326871|593112643|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
164202054|NCT01326871|593112644|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
164202055|NCT01326871|593112645|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
164202056|NCT01326871|593112643|FG000|Overall Study|Withdrawal by Subject|0|||
164202057|NCT01326871|593112644|FG001|Overall Study|Withdrawal by Subject|1|||
164202058|NCT01326871|593112645|FG002|Overall Study|Withdrawal by Subject|0|||
164202059|NCT01326871|593112643|FG000|Overall Study|DLT|0|||
164202060|NCT01326871|593112644|FG001|Overall Study|DLT|2|||
164202061|NCT01326871|593112645|FG002|Overall Study|DLT|0|||
164202062|NCT01326871|593112643|FG000|Overall Study|SAE, disease progression and subject decision|0|||
164202063|NCT01326871|593112644|FG001|Overall Study|SAE, disease progression and subject decision|1|||
164202064|NCT01326871|593112645|FG002|Overall Study|SAE, disease progression and subject decision|0|||
164202065|NCT01326871|593112643|FG000|Overall Study|Death|0|||
164202066|NCT01326871|593112644|FG001|Overall Study|Death|1|||
164202067|NCT01326871|593112645|FG002|Overall Study|Death|0|||
164202068|NCT01326871|593112643|FG000|Overall Study|Other|0|||
164202069|NCT01326871|593112644|FG001|Overall Study|Other|3|||
164202070|NCT01326871|593112645|FG002|Overall Study|Other|0|||
164202071|NCT01326871|593112643|FG000|Overall Study|SAE and disease progression|0|||
164202072|NCT01326871|593112644|FG001|Overall Study|SAE and disease progression|0|||
164202073|NCT01326871|593112645|FG002|Overall Study|SAE and disease progression|1|||
164202074|NCT01326871|593112643|FG000|Overall Study|SAE and physician decision|0|||
164202075|NCT01326871|593112644|FG001|Overall Study|SAE and physician decision|0|||
164202076|NCT01326871|593112645|FG002|Overall Study|SAE and physician decision|1|||
164202077|NCT01326871|593112643|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
164202078|NCT01326871|593112644|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
164202079|NCT01326871|593112645|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
164202080|NCT01326871|593112643|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
164202081|NCT01326871|593112644|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
164202082|NCT01326871|593112645|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
164202083|NCT01326871|593112643|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
164202084|NCT01326871|593112644|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
164202085|NCT01326871|593112645|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
164202086|NCT01326871|593112643|FG000|Overall Study|Physician Decision|0|||
164202087|NCT01326871|593112644|FG001|Overall Study|Physician Decision|0|||
164202088|NCT01326871|593112645|FG002|Overall Study|Physician Decision|1|||
164202089|NCT01326871|593112643|FG000|Overall Study|SAE|0|||
164202090|NCT01326871|593112644|FG001|Overall Study|SAE|0|||
164202091|NCT01326871|593112645|FG002|Overall Study|SAE|1|||
164202092|NCT01326871|593112643|FG000|Overall Study|Disease progression and death|0|||
164202093|NCT01326871|593112644|FG001|Overall Study|Disease progression and death|0|||
164202094|NCT01326871|593112645|FG002|Overall Study|Disease progression and death|1|||
164202095|NCT01326871|593112643|FG000|Overall Study|Subject decision|0|||
164202096|NCT01326871|593112644|FG001|Overall Study|Subject decision|0|||
164202097|NCT01326871|593112645|FG002|Overall Study|Subject decision|1|||
164202098|NCT00251758|593112647|FG000|Overall Study|Adverse Event|7|||
164202099|NCT00251758|593112648|FG001|Overall Study|Adverse Event|9|||
164202100|NCT00251758|593112649|FG002|Overall Study|Adverse Event|11|||
164202101|NCT00251758|593112647|FG000|Overall Study|Lost to Follow-up|4|||
164202102|NCT00251758|593112648|FG001|Overall Study|Lost to Follow-up|2|||
164202103|NCT00251758|593112649|FG002|Overall Study|Lost to Follow-up|5|||
164202104|NCT00251758|593112647|FG000|Overall Study|Withdrawal by Subject|13|||
164202105|NCT00251758|593112648|FG001|Overall Study|Withdrawal by Subject|7|||
164202106|NCT00251758|593112649|FG002|Overall Study|Withdrawal by Subject|3|||
164202107|NCT00251758|593112647|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
164202108|NCT00251758|593112648|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
164202109|NCT00251758|593112649|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
164660455|NCT02227862|594783392|FG000|Overall Study|Withdrawal by Subject|7|||
164311707|NCT04080167|593516689|FG001|Overall Study|Hydroxyurea New Starts|0|||
164311708|NCT04080167|593516690|FG002|Overall Study|Hydroxyurea New Starts|1|||
164311709|NCT04080167|593516688|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
164311710|NCT04080167|593516689|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
164311711|NCT04080167|593516690|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
164311712|NCT04927364|593516691|FG000|Overall Study|Withdrawal by Subject|3|||
164311713|NCT04927364|593516691|FG000|Overall Study|Unable to complete preassessment MRI|1|||
164311714|NCT05188053|593516695|FG000|Overall Study|Lost to Follow-up|23|||
164311715|NCT05188053|593516696|FG001|Overall Study|Lost to Follow-up|30|||
164311716|NCT05188053|593516695|FG000|Overall Study|Protocol Violation|16|||
164311717|NCT05188053|593516696|FG001|Overall Study|Protocol Violation|16|||
164311718|NCT05188053|593516695|FG000|Overall Study|Physician Decision|3|||
164311719|NCT05188053|593516696|FG001|Overall Study|Physician Decision|0|||
164311720|NCT05188053|593516695|FG000|Overall Study|Withdrawal by Subject|0|||
164311721|NCT05188053|593516696|FG001|Overall Study|Withdrawal by Subject|1|||
164311722|NCT01761240|593516700|FG000|Overall Study|Progressive disease:radiology assessment|3|||
164311723|NCT01761240|593516701|FG001|Overall Study|Progressive disease:radiology assessment|3|||
164311724|NCT01761240|593516702|FG002|Overall Study|Progressive disease:radiology assessment|0|||
164311725|NCT01761240|593516703|FG003|Overall Study|Progressive disease:radiology assessment|0|||
164311726|NCT01761240|593516704|FG004|Overall Study|Progressive disease:radiology assessment|0|||
164311727|NCT01761240|593516700|FG000|Overall Study|Progressive disease:clinical assessment|0|||
164311728|NCT01761240|593516701|FG001|Overall Study|Progressive disease:clinical assessment|0|||
164311729|NCT01761240|593516702|FG002|Overall Study|Progressive disease:clinical assessment|3|||
164311730|NCT01761240|593516703|FG003|Overall Study|Progressive disease:clinical assessment|1|||
164311731|NCT01761240|593516704|FG004|Overall Study|Progressive disease:clinical assessment|0|||
164311732|NCT01761240|593516700|FG000|Overall Study|Withdrawal by Subject|0|||
164311733|NCT01761240|593516701|FG001|Overall Study|Withdrawal by Subject|0|||
164311734|NCT01761240|593516702|FG002|Overall Study|Withdrawal by Subject|0|||
164311735|NCT01761240|593516703|FG003|Overall Study|Withdrawal by Subject|3|||
164311736|NCT01761240|593516704|FG004|Overall Study|Withdrawal by Subject|1|||
164311737|NCT01761240|593516700|FG000|Overall Study|Adverse Event|0|||
164311738|NCT01761240|593516701|FG001|Overall Study|Adverse Event|0|||
164311739|NCT01761240|593516702|FG002|Overall Study|Adverse Event|0|||
164311740|NCT01761240|593516703|FG003|Overall Study|Adverse Event|1|||
164311741|NCT01761240|593516704|FG004|Overall Study|Adverse Event|6|||
164311742|NCT01761240|593516700|FG000|Overall Study|Death|0|||
164311743|NCT01761240|593516701|FG001|Overall Study|Death|1|||
164311744|NCT01761240|593516702|FG002|Overall Study|Death|1|||
164311745|NCT01761240|593516703|FG003|Overall Study|Death|2|||
164311746|NCT01761240|593516704|FG004|Overall Study|Death|1|||
164311747|NCT01761240|593516700|FG000|Overall Study|Non-compliance|0|||
164311748|NCT01761240|593516701|FG001|Overall Study|Non-compliance|0|||
164311749|NCT01761240|593516702|FG002|Overall Study|Non-compliance|1|||
164311750|NCT01761240|593516703|FG003|Overall Study|Non-compliance|0|||
164311751|NCT01761240|593516704|FG004|Overall Study|Non-compliance|0|||
164555905|NCT00574275|594405974|FG001|Overall Study|Protocol Violation|1|||
164555906|NCT00574275|594405973|FG000|Overall Study|Patient and Investigator decision|0|||
164555907|NCT00574275|594405974|FG001|Overall Study|Patient and Investigator decision|1|||
164555908|NCT00574275|594405973|FG000|Overall Study|Insurance change|0|||
164555909|NCT00574275|594405974|FG001|Overall Study|Insurance change|1|||
164555910|NCT00574275|594405973|FG000|Overall Study|Operation for curative intent|0|||
164555911|NCT00574275|594405974|FG001|Overall Study|Operation for curative intent|1|||
164555912|NCT01505634|594405978|FG000|Overall Study|Withdrawal by Subject|2|||
164555913|NCT01505634|594405979|FG001|Overall Study|Withdrawal by Subject|5|||
164555914|NCT01505634|594405980|FG002|Overall Study|Withdrawal by Subject|1|||
164555915|NCT01505634|594405978|FG000|Overall Study|Physician Decision|1|||
164555916|NCT01505634|594405979|FG001|Overall Study|Physician Decision|1|||
164555917|NCT01505634|594405980|FG002|Overall Study|Physician Decision|0|||
164555918|NCT01505634|594405978|FG000|Overall Study|Adverse Event|1|||
164555919|NCT01505634|594405979|FG001|Overall Study|Adverse Event|0|||
164555920|NCT01505634|594405980|FG002|Overall Study|Adverse Event|0|||
164555921|NCT01505634|594405978|FG000|Overall Study|Insufficient supply of drug at site|1|||
164555922|NCT01505634|594405979|FG001|Overall Study|Insufficient supply of drug at site|0|||
164311752|NCT05422638|593516705|FG000|Overall Study|Withdrawal by Subject|8|||
164555923|NCT01505634|594405980|FG002|Overall Study|Insufficient supply of drug at site|0|||
164311753|NCT05422638|593516706|FG001|Overall Study|Withdrawal by Subject|2|||
164311754|NCT02529553|593516708|FG000|Overall Study|Progressive Disease|1|||
164311755|NCT02529553|593516709|FG001|Overall Study|Progressive Disease|0|||
164311756|NCT02529553|593516710|FG002|Overall Study|Progressive Disease|1|||
164311757|NCT02529553|593516711|FG003|Overall Study|Progressive Disease|3|||
164311758|NCT02529553|593516712|FG004|Overall Study|Progressive Disease|2|||
164311759|NCT02529553|593516713|FG005|Overall Study|Progressive Disease|3|||
164555924|NCT01505634|594405978|FG000|Overall Study|Protocol Violation|2|||
164555925|NCT01505634|594405979|FG001|Overall Study|Protocol Violation|0|||
164555926|NCT01505634|594405980|FG002|Overall Study|Protocol Violation|0|||
164555927|NCT01505634|594405978|FG000|Overall Study|Lost to Follow-up|1|||
164660456|NCT02227862|594783393|FG001|Overall Study|Withdrawal by Subject|6|||
164660457|NCT02227862|594783392|FG000|Overall Study|Lost to Follow-up|1|||
164660458|NCT02227862|594783393|FG001|Overall Study|Lost to Follow-up|2|||
164660459|NCT06331156|594783394|FG000|Overall Study|Adverse Event|1|||
164660460|NCT06331156|594783395|FG001|Overall Study|Adverse Event|0|||
164660461|NCT06331156|594783394|FG000|Overall Study|Lost to Follow-up|1|||
164660462|NCT06331156|594783395|FG001|Overall Study|Lost to Follow-up|0|||
164660463|NCT06331156|594783394|FG000|Overall Study|Migrated / Moved from the study area|4|||
164660464|NCT06331156|594783395|FG001|Overall Study|Migrated / Moved from the study area|3|||
164660465|NCT06331156|594783394|FG000|Overall Study|Other|7|||
164660466|NCT06331156|594783395|FG001|Overall Study|Other|0|||
164660467|NCT06331156|594783394|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
164660468|NCT06331156|594783395|FG001|Overall Study|Adverse event requiring expedited reporting|1|||
164311760|NCT02529553|593516714|FG006|Overall Study|Progressive Disease|3|||
164311761|NCT02529553|593516715|FG007|Overall Study|Progressive Disease|5|||
164311762|NCT02529553|593516716|FG008|Overall Study|Progressive Disease|3|||
164311763|NCT02529553|593516708|FG000|Overall Study|Physician Decision|0|||
164311764|NCT02529553|593516709|FG001|Overall Study|Physician Decision|1|||
164311765|NCT02529553|593516710|FG002|Overall Study|Physician Decision|0|||
164311766|NCT02529553|593516711|FG003|Overall Study|Physician Decision|0|||
164311767|NCT02529553|593516712|FG004|Overall Study|Physician Decision|1|||
164311768|NCT02529553|593516713|FG005|Overall Study|Physician Decision|0|||
164311769|NCT02529553|593516714|FG006|Overall Study|Physician Decision|0|||
164311770|NCT02529553|593516715|FG007|Overall Study|Physician Decision|0|||
164311771|NCT02529553|593516716|FG008|Overall Study|Physician Decision|0|||
164311772|NCT02529553|593516708|FG000|Overall Study|Withdrawal by Subject|0|||
164311773|NCT02529553|593516709|FG001|Overall Study|Withdrawal by Subject|0|||
164311774|NCT02529553|593516710|FG002|Overall Study|Withdrawal by Subject|0|||
164311775|NCT02529553|593516711|FG003|Overall Study|Withdrawal by Subject|0|||
164311776|NCT02529553|593516712|FG004|Overall Study|Withdrawal by Subject|0|||
164311777|NCT02529553|593516713|FG005|Overall Study|Withdrawal by Subject|1|||
164311778|NCT02529553|593516714|FG006|Overall Study|Withdrawal by Subject|0|||
164311779|NCT02529553|593516715|FG007|Overall Study|Withdrawal by Subject|1|||
164311780|NCT02529553|593516716|FG008|Overall Study|Withdrawal by Subject|0|||
164311781|NCT00114517|593516723|FG000|Overall Study|Adverse Event|6|||
164311782|NCT00114517|593516724|FG001|Overall Study|Adverse Event|1|||
164311783|NCT00114517|593516725|FG002|Overall Study|Adverse Event|6|||
164311784|NCT00114517|593516726|FG003|Overall Study|Adverse Event|3|||
164311785|NCT00114517|593516723|FG000|Overall Study|Lost to Follow-up|2|||
164311786|NCT00114517|593516724|FG001|Overall Study|Lost to Follow-up|2|||
164311787|NCT00114517|593516725|FG002|Overall Study|Lost to Follow-up|2|||
164311788|NCT00114517|593516726|FG003|Overall Study|Lost to Follow-up|1|||
164311789|NCT00114517|593516723|FG000|Overall Study|Too busy|3|||
164311790|NCT00114517|593516724|FG001|Overall Study|Too busy|1|||
164311791|NCT00114517|593516725|FG002|Overall Study|Too busy|1|||
164311792|NCT00114517|593516726|FG003|Overall Study|Too busy|2|||
164311793|NCT00114517|593516723|FG000|Overall Study|Moved from area|0|||
164311794|NCT00114517|593516724|FG001|Overall Study|Moved from area|3|||
164311795|NCT00114517|593516725|FG002|Overall Study|Moved from area|2|||
164311796|NCT00114517|593516726|FG003|Overall Study|Moved from area|1|||
164311797|NCT00114517|593516723|FG000|Overall Study|Did not want estradiol|1|||
164311798|NCT00114517|593516724|FG001|Overall Study|Did not want estradiol|1|||
164311799|NCT00114517|593516725|FG002|Overall Study|Did not want estradiol|0|||
164311800|NCT00114517|593516726|FG003|Overall Study|Did not want estradiol|0|||
164311801|NCT00114517|593516723|FG000|Overall Study|Armed-services duty|0|||
164311802|NCT00114517|593516724|FG001|Overall Study|Armed-services duty|1|||
164311803|NCT00114517|593516725|FG002|Overall Study|Armed-services duty|0|||
164311804|NCT00114517|593516726|FG003|Overall Study|Armed-services duty|1|||
164660469|NCT00437281|594783399|FG000|Overall Study|Adverse Event|0|||
164660470|NCT00437281|594783400|FG001|Overall Study|Adverse Event|0|||
164311805|NCT00114517|593516723|FG000|Overall Study|Competing family issue|0|||
164311806|NCT00114517|593516724|FG001|Overall Study|Competing family issue|1|||
164420601|NCT01890967|593910946|FG000|Overall Study|Protocol Violation|0|||
164660471|NCT00437281|594783401|FG002|Overall Study|Adverse Event|0|||
164660472|NCT00437281|594783402|FG003|Overall Study|Adverse Event|1|||
164311807|NCT00114517|593516725|FG002|Overall Study|Competing family issue|0|||
164311808|NCT00114517|593516726|FG003|Overall Study|Competing family issue|1|||
164311809|NCT00114517|593516723|FG000|Overall Study|Physician Decision|0|||
164311810|NCT00114517|593516724|FG001|Overall Study|Physician Decision|1|||
164311811|NCT00114517|593516725|FG002|Overall Study|Physician Decision|0|||
164311812|NCT00114517|593516726|FG003|Overall Study|Physician Decision|0|||
164311813|NCT00114517|593516723|FG000|Overall Study|Lost interest|0|||
164311814|NCT00114517|593516724|FG001|Overall Study|Lost interest|0|||
164311815|NCT00114517|593516725|FG002|Overall Study|Lost interest|1|||
164311816|NCT00114517|593516726|FG003|Overall Study|Lost interest|0|||
164660473|NCT00437281|594783403|FG004|Overall Study|Adverse Event|0|||
164311817|NCT00114517|593516723|FG000|Overall Study|Weight increase|0|||
164311818|NCT00114517|593516724|FG001|Overall Study|Weight increase|0|||
164311819|NCT00114517|593516725|FG002|Overall Study|Weight increase|1|||
164311820|NCT00114517|593516726|FG003|Overall Study|Weight increase|0|||
164311821|NCT00114517|593516723|FG000|Overall Study|Concern about blood clots|0|||
164311822|NCT00114517|593516724|FG001|Overall Study|Concern about blood clots|0|||
164311823|NCT00114517|593516725|FG002|Overall Study|Concern about blood clots|1|||
164311824|NCT00114517|593516726|FG003|Overall Study|Concern about blood clots|0|||
164311825|NCT00114517|593516723|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
164311826|NCT00114517|593516724|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
164311827|NCT00114517|593516725|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
164311828|NCT00114517|593516726|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
164311829|NCT04695977|593516727|FG000|Overall Study|Sponsor Decision|9|||
164311830|NCT04695977|593516728|FG001|Overall Study|Sponsor Decision|4|||
164311831|NCT04695977|593516727|FG000|Overall Study|Death|2|||
164311832|NCT04695977|593516728|FG001|Overall Study|Death|5|||
164311833|NCT01868542|593518034|FG000|Overall Study|Protocol Violation|0|||
164311834|NCT01868542|593518035|FG001|Overall Study|Protocol Violation|1|||
164311835|NCT01868542|593518034|FG000|Overall Study|Unclassified|0|||
164311836|NCT01868542|593518035|FG001|Overall Study|Unclassified|1|||
164311837|NCT00130247|593518036|FG000|Overall Study|Pregnancy|1|||
164311838|NCT00130247|593518037|FG001|Overall Study|Pregnancy|0|||
164311839|NCT00130247|593518036|FG000|Overall Study|Post-randomization exclusion|1|||
164311840|NCT00130247|593518037|FG001|Overall Study|Post-randomization exclusion|2|||
164311841|NCT00130247|593518036|FG000|Overall Study|Not compliant with DOT|0|||
164311842|NCT00130247|593518037|FG001|Overall Study|Not compliant with DOT|2|||
164311843|NCT03844945|593518038|FG000|Overall Study|Adverse Event|1|||
164311844|NCT03844945|593518039|FG001|Overall Study|Adverse Event|1|||
164311845|NCT03844945|593518040|FG002|Overall Study|Adverse Event|4|||
164311846|NCT03844945|593518041|FG003|Overall Study|Adverse Event|0|||
164311847|NCT03844945|593518038|FG000|Overall Study|Withdrawal by Subject|0|||
164311848|NCT03844945|593518039|FG001|Overall Study|Withdrawal by Subject|0|||
164311849|NCT03844945|593518040|FG002|Overall Study|Withdrawal by Subject|1|||
164311850|NCT03844945|593518041|FG003|Overall Study|Withdrawal by Subject|0|||
164311851|NCT03844945|593518038|FG000|Overall Study|Lack of Efficacy|0|||
164311852|NCT03844945|593518039|FG001|Overall Study|Lack of Efficacy|0|||
164311853|NCT03844945|593518040|FG002|Overall Study|Lack of Efficacy|0|||
164311854|NCT03844945|593518041|FG003|Overall Study|Lack of Efficacy|1|||
164311855|NCT00220779|593518044|FG000|Overall Study|Adverse Event|1|||
164311856|NCT00220779|593518045|FG001|Overall Study|Adverse Event|0|||
164311857|NCT00220779|593518046|FG002|Overall Study|Adverse Event|0|||
164311858|NCT00220779|593518044|FG000|Overall Study|Withdrawal by Subject|1|||
164311859|NCT00220779|593518045|FG001|Overall Study|Withdrawal by Subject|4|||
164311860|NCT00220779|593518046|FG002|Overall Study|Withdrawal by Subject|1|||
164311861|NCT00220779|593518044|FG000|Overall Study|Non-compliance|1|||
164311862|NCT00220779|593518045|FG001|Overall Study|Non-compliance|0|||
164311863|NCT00220779|593518046|FG002|Overall Study|Non-compliance|0|||
164311864|NCT00220779|593518044|FG000|Overall Study|Too time consuming|1|||
164311865|NCT00220779|593518045|FG001|Overall Study|Too time consuming|0|||
164311866|NCT00220779|593518046|FG002|Overall Study|Too time consuming|0|||
164311867|NCT00220779|593518044|FG000|Overall Study|Pregnancy|0|||
164311868|NCT00220779|593518045|FG001|Overall Study|Pregnancy|0|||
164311869|NCT00220779|593518046|FG002|Overall Study|Pregnancy|2|||
164311870|NCT00220779|593518044|FG000|Overall Study|Lack of Efficacy|3|||
164660474|NCT00437281|594783404|FG005|Overall Study|Adverse Event|1|||
164660475|NCT00437281|594783405|FG006|Overall Study|Adverse Event|0|||
164660476|NCT00437281|594783406|FG007|Overall Study|Adverse Event|0|||
164660477|NCT00437281|594783407|FG008|Overall Study|Adverse Event|0|||
164660478|NCT00437281|594783408|FG009|Overall Study|Adverse Event|1|||
164660479|NCT00437281|594783409|FG010|Overall Study|Adverse Event|0|||
164660480|NCT00437281|594783410|FG011|Overall Study|Adverse Event|0|||
164660481|NCT00437281|594783411|FG012|Overall Study|Adverse Event|0|||
164660482|NCT00437281|594783412|FG013|Overall Study|Adverse Event|1|||
164660483|NCT00437281|594783413|FG014|Overall Study|Adverse Event|1|||
164311871|NCT00220779|593518045|FG001|Overall Study|Lack of Efficacy|0|||
164311872|NCT00220779|593518046|FG002|Overall Study|Lack of Efficacy|1|||
164311873|NCT04518995|593518047|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
164311874|NCT04518995|593518048|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
164311875|NCT04518995|593518049|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
164311876|NCT04518995|593518047|FG000|Overall Study|Lack of Efficacy|2|||
164311877|NCT04518995|593518048|FG001|Overall Study|Lack of Efficacy|1|||
164311878|NCT04518995|593518049|FG002|Overall Study|Lack of Efficacy|0|||
164311879|NCT04518995|593518047|FG000|Overall Study|Non-compliance With Study Drug|0|||
164311880|NCT04518995|593518048|FG001|Overall Study|Non-compliance With Study Drug|3|||
164311881|NCT04518995|593518049|FG002|Overall Study|Non-compliance With Study Drug|2|||
164311882|NCT04518995|593518047|FG000|Overall Study|Pregnancy|0|||
164311883|NCT04518995|593518048|FG001|Overall Study|Pregnancy|0|||
164311884|NCT04518995|593518049|FG002|Overall Study|Pregnancy|1|||
164311885|NCT04518995|593518047|FG000|Overall Study|Protocol Violation|2|||
164660484|NCT00437281|594783414|FG015|Overall Study|Adverse Event|0|||
164660485|NCT00437281|594783415|FG016|Overall Study|Adverse Event|0|||
164311886|NCT04518995|593518048|FG001|Overall Study|Protocol Violation|0|||
164311887|NCT04518995|593518049|FG002|Overall Study|Protocol Violation|1|||
164311888|NCT04518995|593518047|FG000|Overall Study|Reason not Specified|4|||
164311889|NCT04518995|593518048|FG001|Overall Study|Reason not Specified|11|||
164311890|NCT04518995|593518049|FG002|Overall Study|Reason not Specified|2|||
164311891|NCT04518995|593518047|FG000|Overall Study|Lost to Follow-up|1|||
164311892|NCT04518995|593518048|FG001|Overall Study|Lost to Follow-up|10|||
164311893|NCT04518995|593518049|FG002|Overall Study|Lost to Follow-up|6|||
164555928|NCT01505634|594405979|FG001|Overall Study|Lost to Follow-up|4|||
164555929|NCT01505634|594405980|FG002|Overall Study|Lost to Follow-up|4|||
164555930|NCT01505634|594405978|FG000|Overall Study|Death|1|||
164555931|NCT01505634|594405979|FG001|Overall Study|Death|0|||
164555932|NCT01505634|594405980|FG002|Overall Study|Death|0|||
164555933|NCT01505634|594405978|FG000|Overall Study|In a conflict zone|0|||
164555934|NCT01505634|594405979|FG001|Overall Study|In a conflict zone|0|||
164555935|NCT01505634|594405980|FG002|Overall Study|In a conflict zone|1|||
164555936|NCT00889265|594405981|FG000|Overall Study|Adverse Event|1|||
164555937|NCT00889265|594405981|FG000|Overall Study|Lost to Follow-up|5|||
164555938|NCT00889265|594405981|FG000|Overall Study|Protocol Violation|1|||
164555939|NCT03028870|594405982|FG000|Overall Study|Adverse Event|7|||
164555940|NCT03028870|594405983|FG001|Overall Study|Adverse Event|4|||
164555941|NCT03028870|594405984|FG002|Overall Study|Adverse Event|3|||
164555942|NCT03028870|594405985|FG003|Overall Study|Adverse Event|3|||
164555943|NCT03028870|594405982|FG000|Overall Study|Withdrawal by Subject|1|||
164555944|NCT03028870|594405983|FG001|Overall Study|Withdrawal by Subject|1|||
164555945|NCT03028870|594405984|FG002|Overall Study|Withdrawal by Subject|1|||
164555946|NCT03028870|594405985|FG003|Overall Study|Withdrawal by Subject|2|||
164555947|NCT03028870|594405982|FG000|Overall Study|Lost to Follow-up|1|||
164555948|NCT03028870|594405983|FG001|Overall Study|Lost to Follow-up|0|||
164555949|NCT03028870|594405984|FG002|Overall Study|Lost to Follow-up|0|||
164555950|NCT03028870|594405985|FG003|Overall Study|Lost to Follow-up|0|||
164555951|NCT03028870|594405982|FG000|Overall Study|Lack of Efficacy|3|||
164555952|NCT03028870|594405983|FG001|Overall Study|Lack of Efficacy|0|||
164555953|NCT03028870|594405984|FG002|Overall Study|Lack of Efficacy|0|||
164555954|NCT03028870|594405985|FG003|Overall Study|Lack of Efficacy|0|||
164555955|NCT03028870|594405982|FG000|Overall Study|Administrative|5|||
164555956|NCT03028870|594405983|FG001|Overall Study|Administrative|5|||
164555957|NCT03028870|594405984|FG002|Overall Study|Administrative|12|||
164555958|NCT03028870|594405985|FG003|Overall Study|Administrative|4|||
164555959|NCT01294579|594405988|FG000|Overall Study|Disease progression|12|||
164555960|NCT01294579|594405988|FG000|Overall Study|Adverse Event|11|||
164555961|NCT01294579|594405988|FG000|Overall Study|Study closed/terminated|3|||
164555962|NCT01294579|594405988|FG000|Overall Study|Lost to Follow-up|1|||
164555963|NCT01294579|594405988|FG000|Overall Study|Physician Decision|3|||
164555964|NCT01294579|594405988|FG000|Overall Study|Withdrawal by Subject|5|||
164555965|NCT02788747|594405989|FG000|Overall Study|Adverse Event|1|||
164555966|NCT02788747|594405990|FG001|Overall Study|Adverse Event|0|||
164555967|NCT02788747|594405991|FG002|Overall Study|Adverse Event|0|||
164555968|NCT00562354|594405994|FG000|Overall Study|Physician Decision|0|||
164555969|NCT00562354|594405995|FG001|Overall Study|Physician Decision|1|||
164555970|NCT00562354|594405994|FG000|Overall Study|Lost to Follow-up|0|||
164555971|NCT00562354|594405995|FG001|Overall Study|Lost to Follow-up|1|||
164555972|NCT00784654|594405996|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
164555973|NCT00784654|594405997|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
164555974|NCT00784654|594405998|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
164555975|NCT00784654|594405996|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
164555976|NCT00784654|594405997|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
164555977|NCT00784654|594405998|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
164555978|NCT00784654|594405996|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
164555979|NCT00784654|594405997|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
164660486|NCT00437281|594783416|FG017|Overall Study|Adverse Event|0|||
164555980|NCT00784654|594405998|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
164555981|NCT00784654|594405996|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
164555982|NCT00784654|594405997|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
164555983|NCT00784654|594405998|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
164660487|NCT00437281|594783417|FG018|Overall Study|Adverse Event|1|||
164660488|NCT00437281|594783418|FG019|Overall Study|Adverse Event|0|||
164660489|NCT00437281|594783399|FG000|Overall Study|Lost to Follow-up|0|||
164311894|NCT04590248|593518050|FG000|Overall Study|Lost to Follow-up|1|||
164311895|NCT04590248|593518050|FG000|Overall Study|Withdrawal by Subject|16|||
164555984|NCT00784654|594405996|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
164555985|NCT00784654|594405997|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
164555986|NCT00784654|594405998|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
164555987|NCT00784654|594405996|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
164555988|NCT00784654|594405997|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
164555989|NCT00784654|594405998|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
164311896|NCT04590248|593518050|FG000|Overall Study|Other|2|||
164311897|NCT02052414|593518051|FG000|Overall Study|Adverse Event|12|||
164311898|NCT02052414|593518051|FG000|Overall Study|Lack of Efficacy|2|||
164311899|NCT02052414|593518051|FG000|Overall Study|Withdrawal by Subject|3|||
164311900|NCT01343693|593518056|FG000|Overall Study|Lost to Follow-up|9|||
164311901|NCT01235598|593518057|FG000|Overall Study|Adverse Event|0|||
164311902|NCT01235598|593518058|FG001|Overall Study|Adverse Event|3|||
164311903|NCT01235598|593518057|FG000|Overall Study|Lack of Efficacy|0|||
164311904|NCT01235598|593518058|FG001|Overall Study|Lack of Efficacy|1|||
164311905|NCT01235598|593518057|FG000|Overall Study|Withdrawal by Subject|1|||
164311906|NCT01235598|593518058|FG001|Overall Study|Withdrawal by Subject|0|||
164311907|NCT00395343|593518059|FG000|Overall Study|Adverse Event|13|||
164311908|NCT00395343|593518060|FG001|Overall Study|Adverse Event|5|||
164311909|NCT00395343|593518059|FG000|Overall Study|Lack of Efficacy|0|||
164311910|NCT00395343|593518060|FG001|Overall Study|Lack of Efficacy|1|||
164311911|NCT00395343|593518059|FG000|Overall Study|Lost to Follow-up|4|||
164311912|NCT00395343|593518060|FG001|Overall Study|Lost to Follow-up|4|||
164311913|NCT00395343|593518059|FG000|Overall Study|Physician Decision|2|||
164311914|NCT00395343|593518060|FG001|Overall Study|Physician Decision|4|||
164311915|NCT00395343|593518059|FG000|Overall Study|Protocol Violation|6|||
164311916|NCT00395343|593518060|FG001|Overall Study|Protocol Violation|8|||
164311917|NCT00395343|593518059|FG000|Overall Study|Withdrawal by Subject|11|||
164311918|NCT00395343|593518060|FG001|Overall Study|Withdrawal by Subject|12|||
164311919|NCT00395343|593518059|FG000|Overall Study|Other|5|||
164311920|NCT00395343|593518060|FG001|Overall Study|Other|2|||
164311921|NCT01536067|593518061|FG000|Overall Study|Disease Progression|1|||
164311922|NCT00606905|593518062|FG000|Overall Study|No Pregnancy|9|||
164311923|NCT00606905|593518063|FG001|Overall Study|No Pregnancy|6|||
164311924|NCT00606905|593518062|FG000|Overall Study|Non-Index Pregnancy|1|||
164311925|NCT00606905|593518063|FG001|Overall Study|Non-Index Pregnancy|4|||
164311926|NCT00606905|593518062|FG000|Overall Study|Withdrew|5|||
164311927|NCT00606905|593518063|FG001|Overall Study|Withdrew|5|||
164311928|NCT04657666|593518064|FG000|Period 1|Withdrawal of participant consent|2|||
164311929|NCT04657666|593518065|FG001|Period 1|Withdrawal of participant consent|1|||
164311930|NCT04657666|593518064|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
164311931|NCT04657666|593518065|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
164311932|NCT04657666|593518064|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
164311933|NCT04657666|593518065|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
164311934|NCT04657666|593518064|FG000|Period 2|Other|2|||
164311935|NCT04657666|593518065|FG001|Period 2|Other|0|||
164311936|NCT04657666|593518064|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
164311937|NCT04657666|593518065|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
164311938|NCT02386189|593518067|FG000|Overall Study|Lost to Follow-up|2|||
164311939|NCT02386189|593518068|FG001|Overall Study|Lost to Follow-up|3|||
164311940|NCT02386189|593518067|FG000|Overall Study|Withdrawal by Subject|1|||
164311941|NCT02386189|593518068|FG001|Overall Study|Withdrawal by Subject|0|||
164311942|NCT02386189|593518067|FG000|Overall Study|Death|1|||
164311943|NCT02386189|593518068|FG001|Overall Study|Death|0|||
164311944|NCT03120351|593518069|FG000|Overall Study|Physician Decision|1|||
164311945|NCT03120351|593518070|FG001|Overall Study|Physician Decision|1|||
164311946|NCT04931888|593518072|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
164311947|NCT04931888|593518073|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
164311948|NCT04931888|593518074|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
164311949|NCT04931888|593518075|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
164311950|NCT02969408|593518077|FG000|Overall Study|Adverse Event|2|||
164311951|NCT02969408|593518077|FG000|Overall Study|Withdrawal by Subject|8|||
164311952|NCT02969408|593518077|FG000|Overall Study|Lost to Follow-up|4|||
164311953|NCT02969408|593518077|FG000|Overall Study|Protocol Violation|1|||
164311954|NCT02969408|593518077|FG000|Overall Study|Other than specified|1|||
164311955|NCT02350478|593518078|FG000|Overall Study|Lost to Follow-up|5|||
164311956|NCT02350478|593518079|FG001|Overall Study|Lost to Follow-up|1|||
164555990|NCT00784654|594405996|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
164311957|NCT01667419|593518080|FG000|Overall Study|Reason Not Specified|1|||
164311958|NCT01667419|593518081|FG001|Overall Study|Reason Not Specified|0|||
164311959|NCT01667419|593518082|FG002|Overall Study|Reason Not Specified|0|||
164311960|NCT01667419|593518083|FG003|Overall Study|Reason Not Specified|0|||
164311961|NCT01667419|593518080|FG000|Overall Study|Withdrawal by Subject|16|||
164311962|NCT01667419|593518081|FG001|Overall Study|Withdrawal by Subject|8|||
164311963|NCT01667419|593518082|FG002|Overall Study|Withdrawal by Subject|9|||
164311964|NCT01667419|593518083|FG003|Overall Study|Withdrawal by Subject|8|||
164311965|NCT01667419|593518080|FG000|Overall Study|Non-compliance|0|||
164555991|NCT00784654|594405997|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
164311966|NCT01667419|593518081|FG001|Overall Study|Non-compliance|0|||
164311967|NCT01667419|593518082|FG002|Overall Study|Non-compliance|0|||
164311968|NCT01667419|593518083|FG003|Overall Study|Non-compliance|1|||
164311969|NCT01667419|593518080|FG000|Overall Study|Protocol Violation|1|||
164311970|NCT01667419|593518081|FG001|Overall Study|Protocol Violation|0|||
164311971|NCT01667419|593518082|FG002|Overall Study|Protocol Violation|0|||
164311972|NCT01667419|593518083|FG003|Overall Study|Protocol Violation|0|||
164311973|NCT01667419|593518080|FG000|Overall Study|Lost to Follow-up|7|||
164311974|NCT01667419|593518081|FG001|Overall Study|Lost to Follow-up|6|||
164311975|NCT01667419|593518082|FG002|Overall Study|Lost to Follow-up|2|||
164311976|NCT01667419|593518083|FG003|Overall Study|Lost to Follow-up|4|||
164311977|NCT01667419|593518080|FG000|Overall Study|Death|18|||
164311978|NCT01667419|593518081|FG001|Overall Study|Death|33|||
164311979|NCT01667419|593518082|FG002|Overall Study|Death|25|||
164311980|NCT01667419|593518083|FG003|Overall Study|Death|26|||
164311981|NCT03330002|593518084|FG000|Overall Study|Lost to Follow-up|15|||
164311982|NCT03330002|593518084|FG000|Overall Study|Death|7|||
164311983|NCT03869216|593518085|FG000|Overall Study|prostate removed during the study|1|||
164311984|NCT03869216|593518086|FG001|Overall Study|prostate removed during the study|1|||
164311985|NCT03869216|593518085|FG000|Overall Study|Withdrawal by Subject|0|||
164311986|NCT03869216|593518086|FG001|Overall Study|Withdrawal by Subject|1|||
164311987|NCT03869216|593518085|FG000|Overall Study|Lost to Follow-up|3|||
164311988|NCT03869216|593518086|FG001|Overall Study|Lost to Follow-up|12|||
164311989|NCT03869216|593518085|FG000|Overall Study|Changed clinical site or moved out of city|5|||
164311990|NCT03869216|593518086|FG001|Overall Study|Changed clinical site or moved out of city|9|||
164311991|NCT03869216|593518085|FG000|Overall Study|No primary care appointment scheduled|10|||
164311992|NCT03869216|593518086|FG001|Overall Study|No primary care appointment scheduled|4|||
164311993|NCT03869216|593518085|FG000|Overall Study|Death|1|||
164311994|NCT03869216|593518086|FG001|Overall Study|Death|1|||
164311995|NCT03860259|593518093|FG000|Overall Study|Lost to Follow-up|5|||
164311996|NCT03860259|593518094|FG001|Overall Study|Lost to Follow-up|5|||
164311997|NCT03860259|593518093|FG000|Overall Study|Protocol Violation|1|||
164311998|NCT03860259|593518094|FG001|Overall Study|Protocol Violation|0|||
164311999|NCT01068600|593518095|FG000|Overall Study|Withdrawal by Subject|5|||
164312000|NCT01068600|593518096|FG001|Overall Study|Withdrawal by Subject|6|||
164312001|NCT01068600|593518095|FG000|Overall Study|Adverse Event|3|||
164312002|NCT01068600|593518096|FG001|Overall Study|Adverse Event|3|||
164312003|NCT01068600|593518095|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164312004|NCT01068600|593518096|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164312005|NCT01068600|593518095|FG000|Overall Study|Lost to Follow-up|1|||
164312006|NCT01068600|593518096|FG001|Overall Study|Lost to Follow-up|2|||
164202110|NCT00251758|593112647|FG000|Overall Study|Lack of Efficacy|3|||
164202111|NCT00251758|593112648|FG001|Overall Study|Lack of Efficacy|0|||
164202112|NCT00251758|593112649|FG002|Overall Study|Lack of Efficacy|0|||
164202113|NCT00251758|593112647|FG000|Overall Study|Noncompliant|0|||
164202114|NCT00251758|593112648|FG001|Overall Study|Noncompliant|2|||
164202115|NCT00251758|593112649|FG002|Overall Study|Noncompliant|2|||
164202116|NCT00251758|593112647|FG000|Overall Study|Pregnancy|0|||
164202117|NCT00251758|593112648|FG001|Overall Study|Pregnancy|1|||
164202118|NCT00251758|593112649|FG002|Overall Study|Pregnancy|0|||
164202119|NCT00251758|593112647|FG000|Overall Study|Per Subject Request|0|||
164660490|NCT00437281|594783400|FG001|Overall Study|Lost to Follow-up|0|||
164660491|NCT00437281|594783401|FG002|Overall Study|Lost to Follow-up|0|||
164660492|NCT00437281|594783402|FG003|Overall Study|Lost to Follow-up|0|||
164660493|NCT00437281|594783403|FG004|Overall Study|Lost to Follow-up|0|||
164660494|NCT00437281|594783404|FG005|Overall Study|Lost to Follow-up|0|||
164660495|NCT00437281|594783405|FG006|Overall Study|Lost to Follow-up|0|||
164660496|NCT00437281|594783406|FG007|Overall Study|Lost to Follow-up|0|||
164660497|NCT00437281|594783407|FG008|Overall Study|Lost to Follow-up|0|||
164660498|NCT00437281|594783408|FG009|Overall Study|Lost to Follow-up|0|||
164660499|NCT00437281|594783409|FG010|Overall Study|Lost to Follow-up|0|||
164660500|NCT00437281|594783410|FG011|Overall Study|Lost to Follow-up|0|||
164660501|NCT00437281|594783411|FG012|Overall Study|Lost to Follow-up|0|||
164312007|NCT01068600|593518095|FG000|Overall Study|Protocol deviation|1|||
164312008|NCT01068600|593518096|FG001|Overall Study|Protocol deviation|1|||
164660502|NCT00437281|594783412|FG013|Overall Study|Lost to Follow-up|0|||
164660503|NCT00437281|594783413|FG014|Overall Study|Lost to Follow-up|0|||
164660504|NCT00437281|594783414|FG015|Overall Study|Lost to Follow-up|0|||
164660505|NCT00437281|594783415|FG016|Overall Study|Lost to Follow-up|0|||
164660506|NCT00437281|594783416|FG017|Overall Study|Lost to Follow-up|0|||
164660507|NCT00437281|594783417|FG018|Overall Study|Lost to Follow-up|0|||
164660508|NCT00437281|594783418|FG019|Overall Study|Lost to Follow-up|1|||
164202120|NCT00251758|593112648|FG001|Overall Study|Per Subject Request|0|||
164202121|NCT00251758|593112649|FG002|Overall Study|Per Subject Request|1|||
164312009|NCT01068600|593518095|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164660509|NCT02970669|594783419|FG000|Double-blind Period|Adverse Event|4|||
164660510|NCT02970669|594783420|FG001|Double-blind Period|Adverse Event|0|||
164660511|NCT02970669|594783419|FG000|Double-blind Period|Death|1|||
164660512|NCT02970669|594783420|FG001|Double-blind Period|Death|0|||
164202122|NCT00251758|593112647|FG000|Overall Study|Per Investigator Request|1|||
164312010|NCT01068600|593518096|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
164312011|NCT01068600|593518095|FG000|Overall Study|Administrative problems|0|||
164312012|NCT01068600|593518096|FG001|Overall Study|Administrative problems|1|||
164312013|NCT00486291|593518103|FG000|Overall Study|Adverse Event|3|||
164660513|NCT02970669|594783419|FG000|Double-blind Period|Study terminated by sponsor|1|||
164202123|NCT00251758|593112648|FG001|Overall Study|Per Investigator Request|0|||
164202124|NCT00251758|593112649|FG002|Overall Study|Per Investigator Request|0|||
164202125|NCT01387269|593112653|FG000|Overall Study|Death|38|||
164202126|NCT01387269|593112654|FG001|Overall Study|Death|20|||
164202127|NCT01387269|593112653|FG000|Overall Study|Other|8|||
164202128|NCT01387269|593112654|FG001|Overall Study|Other|7|||
164202129|NCT01387269|593112653|FG000|Overall Study|Unrelated AE|12|||
164202130|NCT01387269|593112654|FG001|Overall Study|Unrelated AE|3|||
164202131|NCT01387269|593112653|FG000|Overall Study|Withdrawal by patient|32|||
164202132|NCT01387269|593112654|FG001|Overall Study|Withdrawal by patient|10|||
164202133|NCT01387269|593112653|FG000|Overall Study|Study drug-related AE|1|||
164202134|NCT01387269|593112654|FG001|Overall Study|Study drug-related AE|0|||
164202135|NCT01387269|593112653|FG000|Overall Study|Lost to Follow-up|1|||
164202136|NCT01387269|593112654|FG001|Overall Study|Lost to Follow-up|0|||
164202137|NCT01200329|593112655|FG000|Overall Study|Lack of financial coverage|2|||
164202138|NCT01200329|593112655|FG000|Overall Study|Progressive disease|1|||
164202139|NCT02230891|593112658|FG000|Baseline|Did not meet inclusion|0|||
164202140|NCT02230891|593112659|FG001|Baseline|Did not meet inclusion|1|||
164202141|NCT02230891|593112660|FG002|Baseline|Did not meet inclusion|1|||
164202142|NCT02230891|593112658|FG000|2 Week|Withdrawal by Subject|2|||
164202143|NCT02230891|593112659|FG001|2 Week|Withdrawal by Subject|2|||
164202144|NCT02230891|593112660|FG002|2 Week|Withdrawal by Subject|0|||
164202145|NCT02230891|593112658|FG000|2 Week|Consent withdrawn|1|||
164202146|NCT02230891|593112659|FG001|2 Week|Consent withdrawn|0|||
164202147|NCT02230891|593112660|FG002|2 Week|Consent withdrawn|0|||
164202148|NCT02230891|593112658|FG000|6 Month|Withdrawal by Subject|1|||
164202149|NCT02230891|593112659|FG001|6 Month|Withdrawal by Subject|1|||
164202150|NCT02230891|593112660|FG002|6 Month|Withdrawal by Subject|1|||
164202151|NCT02230891|593112658|FG000|6 Month|Physician Decision|0|||
164202152|NCT02230891|593112659|FG001|6 Month|Physician Decision|2|||
164202153|NCT02230891|593112660|FG002|6 Month|Physician Decision|0|||
164202154|NCT02230891|593112658|FG000|12 Month|Death|1|||
164202155|NCT02230891|593112659|FG001|12 Month|Death|0|||
164202156|NCT02230891|593112660|FG002|12 Month|Death|0|||
164202157|NCT02230891|593112658|FG000|12 Month|Lost to Follow-up|0|||
164202158|NCT02230891|593112659|FG001|12 Month|Lost to Follow-up|1|||
164202159|NCT02230891|593112660|FG002|12 Month|Lost to Follow-up|0|||
164202160|NCT02230891|593112658|FG000|12 Month|Withdrawal by Subject|0|||
164202161|NCT02230891|593112659|FG001|12 Month|Withdrawal by Subject|2|||
164202162|NCT02230891|593112660|FG002|12 Month|Withdrawal by Subject|0|||
164202163|NCT02230891|593112658|FG000|18 Month End of Study|Death|0|||
164202164|NCT02230891|593112659|FG001|18 Month End of Study|Death|0|||
164202165|NCT02230891|593112660|FG002|18 Month End of Study|Death|1|||
164202166|NCT02230891|593112658|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
164202167|NCT02230891|593112659|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
164202168|NCT02230891|593112660|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
164202169|NCT03642990|593112663|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
164555992|NCT00784654|594405998|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
164555993|NCT00784654|594405996|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
164555994|NCT00784654|594405997|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
164555995|NCT00784654|594405998|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
164555996|NCT00784654|594405996|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
164555997|NCT00784654|594405997|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
164555998|NCT00784654|594405998|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
164555999|NCT00784654|594405996|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
164556000|NCT00784654|594405997|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
164556001|NCT00784654|594405998|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
164556002|NCT00784654|594405996|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
164556003|NCT00784654|594405997|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
164556004|NCT00784654|594405998|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
164556005|NCT00784654|594405996|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
164556006|NCT00784654|594405997|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
164556007|NCT00784654|594405998|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
164556008|NCT00784654|594405996|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
164556009|NCT00784654|594405997|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
164556010|NCT00784654|594405998|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
164202170|NCT03642990|593112663|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
164202171|NCT03087058|593112664|FG000|Overall Study|Withdrawal by Subject|2|||
164202172|NCT03087058|593112665|FG001|Overall Study|Withdrawal by Subject|0|||
164202173|NCT03087058|593112666|FG002|Overall Study|Withdrawal by Subject|0|||
164202174|NCT05158140|593112669|FG000|Overall Study|Death|0|||
164202175|NCT05158140|593112670|FG001|Overall Study|Death|0|||
164202176|NCT05158140|593112671|FG002|Overall Study|Death|0|||
164312014|NCT00486291|593518104|FG001|Overall Study|Adverse Event|4|||
164312015|NCT00486291|593518103|FG000|Overall Study|Lost to Follow-up|3|||
164312016|NCT00486291|593518104|FG001|Overall Study|Lost to Follow-up|7|||
164312017|NCT00486291|593518103|FG000|Overall Study|protocol non-compliance|10|||
164312018|NCT00486291|593518104|FG001|Overall Study|protocol non-compliance|15|||
164312019|NCT00486291|593518103|FG000|Overall Study|requirement for restricted medication|0|||
164312020|NCT00486291|593518104|FG001|Overall Study|requirement for restricted medication|3|||
164312021|NCT01015638|593518109|FG000|Overall Study|Withdrawal by Subject|1|||
164312022|NCT01015638|593518110|FG001|Overall Study|Withdrawal by Subject|0|||
164312023|NCT00984620|593518111|FG000|Overall Study|Adverse Event|5|||
164312024|NCT00984620|593518112|FG001|Overall Study|Adverse Event|5|||
164312025|NCT00984620|593518111|FG000|Overall Study|Lost to Follow-up|1|||
164312026|NCT00984620|593518112|FG001|Overall Study|Lost to Follow-up|1|||
164312027|NCT00984620|593518111|FG000|Overall Study|Withdrawal by Subject|0|||
164312028|NCT00984620|593518112|FG001|Overall Study|Withdrawal by Subject|2|||
164312029|NCT00984620|593518111|FG000|Overall Study|reason other than listed above|0|||
164312030|NCT00984620|593518112|FG001|Overall Study|reason other than listed above|4|||
164312031|NCT02164461|593518113|FG000|Overall Study|Adverse Event|0|||
164312032|NCT02164461|593518114|FG001|Overall Study|Adverse Event|0|||
164312033|NCT02164461|593518115|FG002|Overall Study|Adverse Event|1|||
164312034|NCT02164461|593518113|FG000|Overall Study|Disease Progression|1|||
164312035|NCT02164461|593518114|FG001|Overall Study|Disease Progression|3|||
164312036|NCT02164461|593518115|FG002|Overall Study|Disease Progression|4|||
164312037|NCT02164461|593518113|FG000|Overall Study|Withdrawal by Subject|0|||
164312038|NCT02164461|593518114|FG001|Overall Study|Withdrawal by Subject|3|||
164312039|NCT02164461|593518115|FG002|Overall Study|Withdrawal by Subject|0|||
164556011|NCT00784654|594405996|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164556012|NCT00784654|594405997|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
164556013|NCT00784654|594405998|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
164556014|NCT00784654|594405996|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
164556015|NCT00784654|594405997|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
164556016|NCT00784654|594405998|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
164556017|NCT00784654|594405996|FG000|Randomized Withdrawal Period|Adverse Event|0|||
164556018|NCT00784654|594405997|FG001|Randomized Withdrawal Period|Adverse Event|1|||
164556019|NCT00784654|594405998|FG002|Randomized Withdrawal Period|Adverse Event|1|||
164556020|NCT00784654|594405996|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
164556021|NCT00784654|594405997|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
164556022|NCT00784654|594405998|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
164556023|NCT00784654|594405996|FG000|Randomized Withdrawal Period|Family reasons|0|||
164556024|NCT00784654|594405997|FG001|Randomized Withdrawal Period|Family reasons|0|||
164556025|NCT00784654|594405998|FG002|Randomized Withdrawal Period|Family reasons|1|||
164556026|NCT00879697|594406004|FG000|Overall Study|Physician Decision|2|||
164556027|NCT00879697|594406005|FG001|Overall Study|Physician Decision|2|||
164556028|NCT01836783|594406008|FG000|Overall Study|Withdrawal by Subject|0|||
164556029|NCT01836783|594406009|FG001|Overall Study|Withdrawal by Subject|2|||
164556030|NCT04942925|594406019|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
164556031|NCT04942925|594406020|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
164556032|NCT04942925|594406019|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
164556033|NCT04942925|594406020|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
164556034|NCT02124564|594406022|FG000|Treatment Period|Adverse Event|2|||
164556035|NCT02124564|594406022|FG000|Treatment Period|Lack of Efficacy|3|||
164556036|NCT02124564|594406022|FG000|Treatment Period|Withdrawal by Subject|2|||
164556037|NCT01014689|594406026|FG000|Overall Study|Lack of Efficacy|0|||
164556038|NCT01014689|594406027|FG001|Overall Study|Lack of Efficacy|1|||
164556039|NCT01014689|594406026|FG000|Overall Study|Adverse Event|3|||
164556040|NCT01014689|594406027|FG001|Overall Study|Adverse Event|0|||
164556041|NCT01014689|594406026|FG000|Overall Study|Withdrawal by Subject|5|||
164556042|NCT01014689|594406027|FG001|Overall Study|Withdrawal by Subject|4|||
164660514|NCT02970669|594783420|FG001|Double-blind Period|Study terminated by sponsor|2|||
164660515|NCT02970669|594783419|FG000|Double-blind Period|Physician Decision|0|||
164660516|NCT02970669|594783420|FG001|Double-blind Period|Physician Decision|2|||
164660517|NCT02970669|594783419|FG000|Double-blind Period|Withdrawal by Subject|2|||
164660518|NCT02970669|594783420|FG001|Double-blind Period|Withdrawal by Subject|2|||
164660519|NCT02970669|594783419|FG000|Open-label Period|Withdrawal by Subject|2|||
164312040|NCT00324961|593518117|FG000|Overall Study|Adverse Event|5|||
164312041|NCT00324961|593518117|FG000|Overall Study|Consent Withdrawn|11|||
164312042|NCT00324961|593518117|FG000|Overall Study|Lost to Follow-up|22|||
164312043|NCT00324961|593518117|FG000|Overall Study|Protocol Violation|3|||
164312044|NCT00324961|593518117|FG000|Overall Study|Other|2|||
164312045|NCT00344487|593518118|FG000|Overall Study|immunologic failure|1|||
164312046|NCT02355184|593518122|FG000|Overall Study|Lost to Follow-up|2|||
164312047|NCT02355184|593518122|FG000|Overall Study|Study Terminated|10|||
164312048|NCT06173063|593518123|FG000|Overall Study|Withdrawal by Subject|2|||
164312049|NCT01925131|593520209|FG000|Overall Study|Death|0|||
164556043|NCT01014689|594406026|FG000|Overall Study|Protocol Violation|1|||
164660520|NCT02970669|594783420|FG001|Open-label Period|Withdrawal by Subject|2|||
164312050|NCT01925131|593520210|FG001|Overall Study|Death|0|||
164312051|NCT01925131|593520211|FG002|Overall Study|Death|1|||
164312052|NCT01925131|593520212|FG003|Overall Study|Death|0|||
164312053|NCT01925131|593520213|FG004|Overall Study|Death|0|||
164312054|NCT01925131|593520214|FG005|Overall Study|Death|0|||
164312055|NCT01925131|593520209|FG000|Overall Study|Progression/Relapse|1|||
164312056|NCT01925131|593520210|FG001|Overall Study|Progression/Relapse|1|||
164312057|NCT01925131|593520211|FG002|Overall Study|Progression/Relapse|4|||
164312058|NCT01925131|593520212|FG003|Overall Study|Progression/Relapse|0|||
164312059|NCT01925131|593520213|FG004|Overall Study|Progression/Relapse|0|||
164312060|NCT01925131|593520214|FG005|Overall Study|Progression/Relapse|1|||
164312061|NCT01925131|593520209|FG000|Overall Study|Patient Refusal|1|||
164312062|NCT01925131|593520210|FG001|Overall Study|Patient Refusal|0|||
164312063|NCT01925131|593520211|FG002|Overall Study|Patient Refusal|0|||
164312064|NCT01925131|593520212|FG003|Overall Study|Patient Refusal|0|||
164312065|NCT01925131|593520213|FG004|Overall Study|Patient Refusal|0|||
164312066|NCT01925131|593520214|FG005|Overall Study|Patient Refusal|0|||
164312067|NCT01925131|593520209|FG000|Overall Study|Adverse Event|0|||
164312068|NCT01925131|593520210|FG001|Overall Study|Adverse Event|0|||
164312069|NCT01925131|593520211|FG002|Overall Study|Adverse Event|2|||
164312070|NCT01925131|593520212|FG003|Overall Study|Adverse Event|0|||
164312071|NCT01925131|593520213|FG004|Overall Study|Adverse Event|1|||
164312072|NCT01925131|593520214|FG005|Overall Study|Adverse Event|3|||
164312073|NCT01925131|593520209|FG000|Overall Study|Other - Not Protocol Specified|3|||
164312074|NCT01925131|593520210|FG001|Overall Study|Other - Not Protocol Specified|1|||
164312075|NCT01925131|593520211|FG002|Overall Study|Other - Not Protocol Specified|2|||
164312076|NCT01925131|593520212|FG003|Overall Study|Other - Not Protocol Specified|5|||
164312077|NCT01925131|593520213|FG004|Overall Study|Other - Not Protocol Specified|10|||
164312078|NCT01925131|593520214|FG005|Overall Study|Other - Not Protocol Specified|6|||
164312079|NCT03320824|593520215|FG000|Overall Study|Withdrawal by Subject|8|||
164312080|NCT03320824|593520216|FG001|Overall Study|Withdrawal by Subject|1|||
164312081|NCT03320824|593520215|FG000|Overall Study|Lost to Follow-up|10|||
164312082|NCT03320824|593520216|FG001|Overall Study|Lost to Follow-up|1|||
164312083|NCT03320824|593520215|FG000|Overall Study|moved out of state|0|||
164312084|NCT03320824|593520216|FG001|Overall Study|moved out of state|1|||
164312085|NCT03320824|593520215|FG000|Overall Study|could not complete final visit|0|||
164312086|NCT03320824|593520216|FG001|Overall Study|could not complete final visit|1|||
164312087|NCT00109590|593520217|FG000|Overall Study|Lost to Follow-up|1|||
164312088|NCT00109590|593520218|FG001|Overall Study|Lost to Follow-up|0|||
164312089|NCT00109590|593520219|FG002|Overall Study|Lost to Follow-up|1|||
164312090|NCT00109590|593520217|FG000|Overall Study|Never Started Treatment|1|||
164312091|NCT00109590|593520218|FG001|Overall Study|Never Started Treatment|2|||
164312092|NCT00109590|593520219|FG002|Overall Study|Never Started Treatment|3|||
164312093|NCT00588861|593520220|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
164312094|NCT00588861|593520221|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
164312095|NCT00588861|593520220|FG000|6 Months|Patients did not return for follow-up|98|||
164660521|NCT02970669|594783419|FG000|Open-label Period|Adverse Event|1|||
164660522|NCT02970669|594783420|FG001|Open-label Period|Adverse Event|0|||
164660523|NCT02970669|594783419|FG000|Open-label Period|Physician Decision|1|||
164660524|NCT02970669|594783420|FG001|Open-label Period|Physician Decision|0|||
164660525|NCT05476679|594783421|FG000|Overall Study|Withdrawal by Subject|0|||
164660526|NCT05476679|594783422|FG001|Overall Study|Withdrawal by Subject|0|||
164660527|NCT05476679|594783423|FG002|Overall Study|Withdrawal by Subject|0|||
164660528|NCT05476679|594783424|FG003|Overall Study|Withdrawal by Subject|1|||
164660529|NCT05476679|594783425|FG004|Overall Study|Withdrawal by Subject|0|||
164660530|NCT05476679|594783421|FG000|Overall Study|Lost to Follow-up|0|||
164660531|NCT05476679|594783422|FG001|Overall Study|Lost to Follow-up|0|||
164660532|NCT05476679|594783423|FG002|Overall Study|Lost to Follow-up|0|||
164312096|NCT00588861|593520221|FG001|6 Months|Patients did not return for follow-up|73|||
164312097|NCT00588861|593520220|FG000|1 Year|Patients did not return for follow-up|89|||
164660533|NCT05476679|594783424|FG003|Overall Study|Lost to Follow-up|1|||
164660534|NCT05476679|594783425|FG004|Overall Study|Lost to Follow-up|0|||
164660535|NCT01214330|594783426|FG000|Overall Study|Withdrawal by Subject|2|||
164660536|NCT01214330|594783426|FG000|Overall Study|Withdrawal by Subject|2|||
164660537|NCT00467584|594783427|FG000|Overall Study|Withdrawal by Subject|4|||
164312098|NCT00588861|593520221|FG001|1 Year|Patients did not return for follow-up|82|||
164312099|NCT00588861|593520220|FG000|2 Years|Patients did not return for follow-up|92|||
164660538|NCT00467584|594783428|FG001|Overall Study|Withdrawal by Subject|5|||
164312100|NCT00588861|593520221|FG001|2 Years|Patients did not return for follow-up|87|||
164312101|NCT00588861|593520220|FG000|4 Years|Patients did not return for follow-up|91|||
164312102|NCT00588861|593520221|FG001|4 Years|Patients did not return for follow-up|103|||
164312103|NCT00588861|593520220|FG000|6 Years|Patients did not return for follow-up|104|||
164312104|NCT00588861|593520221|FG001|6 Years|Patients did not return for follow-up|109|||
164312105|NCT00588861|593520220|FG000|8 Years|Patients did not return for follow-up|105|||
164312106|NCT00588861|593520221|FG001|8 Years|Patients did not return for follow-up|114|||
164202177|NCT05158140|593112672|FG003|Overall Study|Death|1|||
164202178|NCT05158140|593112669|FG000|Overall Study|Lost to Follow-up|3|||
164202179|NCT05158140|593112670|FG001|Overall Study|Lost to Follow-up|6|||
164202180|NCT05158140|593112671|FG002|Overall Study|Lost to Follow-up|4|||
164202181|NCT05158140|593112672|FG003|Overall Study|Lost to Follow-up|3|||
164202182|NCT05158140|593112669|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164202183|NCT05158140|593112670|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164202184|NCT05158140|593112671|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
164202185|NCT05158140|593112672|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
164202186|NCT05158140|593112669|FG000|Overall Study|Withdrawal by Subject|3|||
164202187|NCT05158140|593112670|FG001|Overall Study|Withdrawal by Subject|7|||
164202188|NCT05158140|593112671|FG002|Overall Study|Withdrawal by Subject|3|||
164202189|NCT05158140|593112672|FG003|Overall Study|Withdrawal by Subject|7|||
164202190|NCT01265498|593112675|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
164202191|NCT01265498|593112676|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
164202192|NCT00617279|593112678|FG000|Overall Study|Study terminated by Sponsor|10|||
164202193|NCT00617279|593112679|FG001|Overall Study|Study terminated by Sponsor|15|||
164202194|NCT00617279|593112678|FG000|Overall Study|Graft abandonment|2|||
164202195|NCT00617279|593112679|FG001|Overall Study|Graft abandonment|0|||
164202196|NCT00617279|593112678|FG000|Overall Study|Lost to Follow-up|1|||
164202197|NCT00617279|593112679|FG001|Overall Study|Lost to Follow-up|0|||
164202198|NCT00617279|593112678|FG000|Overall Study|Death|1|||
164202199|NCT00617279|593112679|FG001|Overall Study|Death|2|||
164202200|NCT04158219|593112685|FG000|Overall Study|Lost to Follow-up|1|||
164202201|NCT01324947|593112691|FG000|Overall Study|Adverse Event|7|||
164202202|NCT01324947|593112691|FG000|Overall Study|Death|10|||
164202203|NCT01324947|593112691|FG000|Overall Study|Other|3|||
164202204|NCT01324947|593112691|FG000|Overall Study|Progressive Disease|50|||
164202205|NCT01324947|593112691|FG000|Overall Study|Withdrawal by Subject|3|||
164202206|NCT01324947|593112691|FG000|Overall Study|1 discontinued before starting drug|1|||
164202207|NCT01296412|593112692|FG000|Overall Study|Adverse Event|8|||
164202208|NCT01296412|593112693|FG001|Overall Study|Adverse Event|29|||
164202209|NCT01296412|593112692|FG000|Overall Study|Lack of Efficacy|1|||
164202210|NCT01296412|593112693|FG001|Overall Study|Lack of Efficacy|0|||
164202211|NCT01296412|593112692|FG000|Overall Study|Lost to Follow-up|10|||
164202212|NCT01296412|593112693|FG001|Overall Study|Lost to Follow-up|7|||
164202213|NCT01296412|593112692|FG000|Overall Study|Non-compliance with study drug|1|||
164202214|NCT01296412|593112693|FG001|Overall Study|Non-compliance with study drug|2|||
164202215|NCT01296412|593112692|FG000|Overall Study|Other reason not specified|20|||
164202216|NCT01296412|593112693|FG001|Overall Study|Other reason not specified|15|||
164202217|NCT01296412|593112692|FG000|Overall Study|Physician Decision|1|||
164202218|NCT01296412|593112693|FG001|Overall Study|Physician Decision|3|||
164202219|NCT01296412|593112692|FG000|Overall Study|Pregnancy|0|||
164202220|NCT01296412|593112693|FG001|Overall Study|Pregnancy|1|||
164202221|NCT01296412|593112692|FG000|Overall Study|Withdrawal by Subject|10|||
164202222|NCT01296412|593112693|FG001|Overall Study|Withdrawal by Subject|13|||
164202223|NCT02160626|593112694|FG000|Overall Study|Adverse Event|1|||
164202224|NCT02160626|593112695|FG001|Overall Study|Adverse Event|0|||
164202225|NCT02160626|593112696|FG002|Overall Study|Adverse Event|0|||
164202226|NCT02160626|593112694|FG000|Overall Study|Schedule not conducive to study visits|0|||
164202227|NCT02160626|593112695|FG001|Overall Study|Schedule not conducive to study visits|0|||
164202228|NCT02160626|593112696|FG002|Overall Study|Schedule not conducive to study visits|1|||
164202229|NCT02160626|593112694|FG000|Overall Study|Withdrawal by Subject|0|||
164202230|NCT02160626|593112695|FG001|Overall Study|Withdrawal by Subject|1|||
164202231|NCT02160626|593112696|FG002|Overall Study|Withdrawal by Subject|0|||
164202232|NCT04239924|593112699|FG000|Overall Study|Lost to Follow-up|2|||
164202233|NCT05399680|593115049|FG000|Overall Study|Lost to Follow-up|1|||
164202234|NCT05399680|593115050|FG001|Overall Study|Lost to Follow-up|0|||
164202235|NCT05399680|593115049|FG000|Overall Study|Death|0|||
164202236|NCT05399680|593115050|FG001|Overall Study|Death|1|||
164202237|NCT03737994|593115052|FG000|Overall Study|Withdrawal by Subject|0|||
164202238|NCT03737994|593115053|FG001|Overall Study|Withdrawal by Subject|0|||
164202239|NCT03737994|593115054|FG002|Overall Study|Withdrawal by Subject|0|||
164202240|NCT03737994|593115055|FG003|Overall Study|Withdrawal by Subject|0|||
164660539|NCT00467584|594783429|FG002|Overall Study|Withdrawal by Subject|1|||
164202241|NCT03737994|593115056|FG004|Overall Study|Withdrawal by Subject|0|||
164202242|NCT03737994|593115057|FG005|Overall Study|Withdrawal by Subject|0|||
164202243|NCT03737994|593115058|FG006|Overall Study|Withdrawal by Subject|1|||
164202244|NCT03255187|593115059|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
164202245|NCT03255187|593115060|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
164202246|NCT03255187|593115059|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
164202247|NCT03255187|593115060|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
164202248|NCT00720278|593115061|FG000|Overall Study|Adverse Event|5|||
164202249|NCT00720278|593115062|FG001|Overall Study|Adverse Event|3|||
164202250|NCT00720278|593115063|FG002|Overall Study|Adverse Event|4|||
164202251|NCT00720278|593115061|FG000|Overall Study|Withdrawal by Subject|0|||
164312107|NCT00588861|593520220|FG000|10 Years|Incomplete due to study termination|107|||
164312108|NCT00588861|593520221|FG001|10 Years|Incomplete due to study termination|114|||
164312109|NCT00490529|593520227|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
164312110|NCT00490529|593520227|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
164312111|NCT00490529|593520227|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
164312112|NCT00490529|593520227|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
164312113|NCT00490529|593520227|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
164312114|NCT00490529|593520227|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
164312115|NCT03254459|593520228|FG000|Overall Study|Adverse Event|7|||
164312116|NCT03254459|593520229|FG001|Overall Study|Adverse Event|20|||
164312117|NCT03254459|593520228|FG000|Overall Study|Withdrawal by Subject Consent|3|||
164312118|NCT03254459|593520229|FG001|Overall Study|Withdrawal by Subject Consent|1|||
164312119|NCT03254459|593520228|FG000|Overall Study|Lost to Follow-up|0|||
164312120|NCT03254459|593520229|FG001|Overall Study|Lost to Follow-up|1|||
164312121|NCT03254459|593520228|FG000|Overall Study|Miscellaneous|0|||
164312122|NCT03254459|593520229|FG001|Overall Study|Miscellaneous|1|||
164312123|NCT01129583|593520230|FG000|Overall Study|Death|1|||
164312124|NCT01129583|593520231|FG001|Overall Study|Death|0|||
164312125|NCT01129583|593520230|FG000|Overall Study|Lost to Follow-up|1|||
164312126|NCT01129583|593520231|FG001|Overall Study|Lost to Follow-up|1|||
164312127|NCT01129583|593520230|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
164312128|NCT01129583|593520231|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
164312129|NCT01904773|593520241|FG000|Screen|Screen failure|3|||
164312130|NCT01904773|593520242|FG001|Screen|Screen failure|0|||
164312131|NCT01904773|593520243|FG002|Screen|Screen failure|0|||
164312132|NCT01904773|593520244|FG003|Screen|Screen failure|0|||
164312133|NCT01904773|593520245|FG004|Screen|Screen failure|0|||
164312134|NCT01904773|593520246|FG005|Screen|Screen failure|0|||
164312135|NCT01904773|593520247|FG006|Screen|Screen failure|0|||
164312136|NCT01904773|593520248|FG007|Screen|Screen failure|0|||
164312137|NCT01904773|593520249|FG008|Screen|Screen failure|0|||
164312138|NCT01904773|593520241|FG000|Screen|Withdrawal by Subject|1|||
164312139|NCT01904773|593520242|FG001|Screen|Withdrawal by Subject|0|||
164312140|NCT01904773|593520243|FG002|Screen|Withdrawal by Subject|0|||
164312141|NCT01904773|593520244|FG003|Screen|Withdrawal by Subject|0|||
164312142|NCT01904773|593520245|FG004|Screen|Withdrawal by Subject|0|||
164312143|NCT01904773|593520246|FG005|Screen|Withdrawal by Subject|0|||
164312144|NCT01904773|593520247|FG006|Screen|Withdrawal by Subject|0|||
164312145|NCT01904773|593520248|FG007|Screen|Withdrawal by Subject|0|||
164312146|NCT01904773|593520249|FG008|Screen|Withdrawal by Subject|0|||
164312147|NCT01904773|593520241|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
164312148|NCT01904773|593520242|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
164312149|NCT01904773|593520243|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
164312150|NCT01904773|593520244|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
164312151|NCT01904773|593520245|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
164312152|NCT01904773|593520246|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
164312153|NCT01904773|593520247|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
164312154|NCT01904773|593520248|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
164312155|NCT01904773|593520249|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
164312156|NCT01904773|593520241|FG000|First Intervention|Adverse Event|0|||
164312157|NCT01904773|593520242|FG001|First Intervention|Adverse Event|0|||
164312158|NCT01904773|593520243|FG002|First Intervention|Adverse Event|0|||
164312159|NCT01904773|593520244|FG003|First Intervention|Adverse Event|0|||
164312160|NCT01904773|593520245|FG004|First Intervention|Adverse Event|0|||
164312161|NCT01904773|593520246|FG005|First Intervention|Adverse Event|0|||
164312162|NCT01904773|593520247|FG006|First Intervention|Adverse Event|1|||
164312163|NCT01904773|593520248|FG007|First Intervention|Adverse Event|0|||
164312164|NCT01904773|593520249|FG008|First Intervention|Adverse Event|0|||
164312165|NCT01904773|593520241|FG000|Placebo Washout First Intervention|Condition worsened|0|||
164556044|NCT01014689|594406027|FG001|Overall Study|Protocol Violation|1|||
164556045|NCT01014689|594406026|FG000|Overall Study|Lost to Follow-up|3|||
164556046|NCT01014689|594406027|FG001|Overall Study|Lost to Follow-up|7|||
164556047|NCT01014689|594406026|FG000|Overall Study|Pregnancy|1|||
164312166|NCT01904773|593520242|FG001|Placebo Washout First Intervention|Condition worsened|1|||
164312167|NCT01904773|593520243|FG002|Placebo Washout First Intervention|Condition worsened|0|||
164312168|NCT01904773|593520244|FG003|Placebo Washout First Intervention|Condition worsened|0|||
164312169|NCT01904773|593520245|FG004|Placebo Washout First Intervention|Condition worsened|0|||
164312170|NCT01904773|593520246|FG005|Placebo Washout First Intervention|Condition worsened|0|||
164312171|NCT01904773|593520247|FG006|Placebo Washout First Intervention|Condition worsened|0|||
164312172|NCT01904773|593520248|FG007|Placebo Washout First Intervention|Condition worsened|0|||
164312173|NCT01904773|593520249|FG008|Placebo Washout First Intervention|Condition worsened|0|||
164312174|NCT01904773|593520241|FG000|Fifth Intervention|Adverse Event|0|||
164556048|NCT01014689|594406027|FG001|Overall Study|Pregnancy|0|||
164556049|NCT04418076|594406029|FG000|Overall Study|Death|1|||
164556050|NCT04418076|594406030|FG001|Overall Study|Death|0|||
164660540|NCT03387098|594783430|FG000|Overall Study|progressive disease|1|||
164660541|NCT03387098|594783430|FG000|Overall Study|Withdrawal by Subject|2|||
164660542|NCT03387098|594783430|FG000|Overall Study|study terminated by sponsor|1|||
164660543|NCT00278512|594783431|FG000|Overall Study|Death|1|||
164660544|NCT00278512|594783432|FG001|Overall Study|Death|0|||
164660545|NCT01620177|594783433|FG000|Overall Study|Failure at Screening Visit|43|||
164660546|NCT01620177|594783433|FG000|Overall Study|Withdrawal by Subject|26|||
164660547|NCT01620177|594783433|FG000|Overall Study|Lost to Follow-up|7|||
164660548|NCT01620177|594783433|FG000|Overall Study|Physician Decision|2|||
164660549|NCT01620177|594783433|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
164660550|NCT02292238|594783434|FG000|Overall Study|Protocol Violation|1|||
164660551|NCT02292238|594783435|FG001|Overall Study|Protocol Violation|2|||
164660552|NCT02292238|594783434|FG000|Overall Study|Withdrawal by Subject|2|||
164660553|NCT02292238|594783435|FG001|Overall Study|Withdrawal by Subject|1|||
164660554|NCT02292238|594783434|FG000|Overall Study|Lost to Follow-up|1|||
164660555|NCT02292238|594783435|FG001|Overall Study|Lost to Follow-up|0|||
164660556|NCT02292238|594783434|FG000|Overall Study|Physician Decision|0|||
164660557|NCT02292238|594783435|FG001|Overall Study|Physician Decision|1|||
164660558|NCT04000009|594783436|FG000|Overall Study|Adverse Event|13|||
164660559|NCT04000009|594783436|FG000|Overall Study|Lack of Efficacy|7|||
164660560|NCT04000009|594783436|FG000|Overall Study|Lost to Follow-up|8|||
164660561|NCT04000009|594783436|FG000|Overall Study|Noncompliance with study drug|4|||
164660562|NCT04000009|594783436|FG000|Overall Study|Physician Decision|1|||
164660563|NCT04000009|594783436|FG000|Overall Study|Use of prohibited medication|3|||
164660564|NCT04000009|594783436|FG000|Overall Study|Pregnancy|1|||
164660565|NCT04000009|594783436|FG000|Overall Study|Withdrawal by Subject|22|||
164660566|NCT04000009|594783436|FG000|Overall Study|Study terminated by sponsor|98|||
164660567|NCT04000009|594783436|FG000|Overall Study|Not further specified|8|||
164660568|NCT01754259|594783439|FG000|Overall Study|Withdrawal by Subject|2|||
164660569|NCT01754259|594783440|FG001|Overall Study|Withdrawal by Subject|4|||
164202252|NCT00720278|593115062|FG001|Overall Study|Withdrawal by Subject|1|||
164202253|NCT00720278|593115063|FG002|Overall Study|Withdrawal by Subject|0|||
164202254|NCT00720278|593115061|FG000|Overall Study|Lost to Follow-up|0|||
164202255|NCT00720278|593115062|FG001|Overall Study|Lost to Follow-up|0|||
164202256|NCT00720278|593115063|FG002|Overall Study|Lost to Follow-up|1|||
164202257|NCT00720278|593115061|FG000|Overall Study|Non-compliance|1|||
164202258|NCT00720278|593115062|FG001|Overall Study|Non-compliance|0|||
164202259|NCT00720278|593115063|FG002|Overall Study|Non-compliance|0|||
164202260|NCT00720278|593115061|FG000|Overall Study|eligibility criteria violation|1|||
164202261|NCT00720278|593115062|FG001|Overall Study|eligibility criteria violation|0|||
164202262|NCT00720278|593115063|FG002|Overall Study|eligibility criteria violation|1|||
164202263|NCT01075048|593115064|FG000|Overall Study|Death|4|||
164202264|NCT01075048|593115065|FG001|Overall Study|Death|17|||
164202265|NCT01075048|593115066|FG002|Overall Study|Death|12|||
164202266|NCT01075048|593115064|FG000|Overall Study|Start of other or new therapy|4|||
164202267|NCT01075048|593115065|FG001|Overall Study|Start of other or new therapy|36|||
164202268|NCT01075048|593115066|FG002|Overall Study|Start of other or new therapy|46|||
164202269|NCT01075048|593115064|FG000|Overall Study|Withdrawal by Subject|1|||
164202270|NCT01075048|593115065|FG001|Overall Study|Withdrawal by Subject|6|||
164202271|NCT01075048|593115066|FG002|Overall Study|Withdrawal by Subject|3|||
164202272|NCT01075048|593115064|FG000|Overall Study|Lost to Follow-up|0|||
164202273|NCT01075048|593115065|FG001|Overall Study|Lost to Follow-up|1|||
164202274|NCT01075048|593115066|FG002|Overall Study|Lost to Follow-up|1|||
164202275|NCT00408499|593115068|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
164202276|NCT00408499|593115069|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
164202277|NCT00408499|593115070|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
164202278|NCT00408499|593115071|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
164202279|NCT00408499|593115072|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
164202280|NCT00408499|593115068|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
164202281|NCT00408499|593115069|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
164202282|NCT00408499|593115070|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
164202283|NCT00408499|593115071|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
164202284|NCT00408499|593115072|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
164202285|NCT00408499|593115068|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
164202286|NCT00408499|593115069|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
164312175|NCT01904773|593520242|FG001|Fifth Intervention|Adverse Event|0|||
164312176|NCT01904773|593520243|FG002|Fifth Intervention|Adverse Event|0|||
164660570|NCT01754259|594783439|FG000|Overall Study|Adverse Event|3|||
164660571|NCT01754259|594783440|FG001|Overall Study|Adverse Event|1|||
164660572|NCT01754259|594783439|FG000|Overall Study|Lost to Follow-up|0|||
164660573|NCT01754259|594783440|FG001|Overall Study|Lost to Follow-up|1|||
164202287|NCT00408499|593115070|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
164202288|NCT00408499|593115071|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
164202289|NCT00408499|593115072|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
164202290|NCT00408499|593115068|FG000|Phase II- MTD Expansion|Adverse Event|0|||
164202291|NCT00408499|593115069|FG001|Phase II- MTD Expansion|Adverse Event|0|||
164202292|NCT00408499|593115070|FG002|Phase II- MTD Expansion|Adverse Event|0|||
164556051|NCT04418076|594406031|FG002|Overall Study|Death|0|||
164556052|NCT04418076|594406032|FG003|Overall Study|Death|0|||
164556053|NCT04418076|594406029|FG000|Overall Study|Lost to Follow-up|2|||
164556054|NCT04418076|594406030|FG001|Overall Study|Lost to Follow-up|5|||
164556055|NCT04418076|594406031|FG002|Overall Study|Lost to Follow-up|1|||
164556056|NCT04418076|594406032|FG003|Overall Study|Lost to Follow-up|2|||
164556057|NCT04418076|594406029|FG000|Overall Study|Withdrawal by Subject|1|||
164556058|NCT04418076|594406030|FG001|Overall Study|Withdrawal by Subject|0|||
164556059|NCT04418076|594406031|FG002|Overall Study|Withdrawal by Subject|1|||
164556060|NCT04418076|594406032|FG003|Overall Study|Withdrawal by Subject|1|||
164556061|NCT04418076|594406029|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
164556062|NCT04418076|594406030|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
164556063|NCT04418076|594406031|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
164556064|NCT04418076|594406032|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
164556065|NCT01344876|594406034|FG000|Overall Study|Adverse Event|0|||
164556066|NCT01344876|594406035|FG001|Overall Study|Adverse Event|0|||
164556067|NCT01344876|594406036|FG002|Overall Study|Adverse Event|0|||
164556068|NCT01344876|594406037|FG003|Overall Study|Adverse Event|0|||
164556069|NCT01344876|594406038|FG004|Overall Study|Adverse Event|1|||
164556070|NCT01344876|594406034|FG000|Overall Study|Withdrawal by Subject|0|||
164556071|NCT01344876|594406035|FG001|Overall Study|Withdrawal by Subject|0|||
164556072|NCT01344876|594406036|FG002|Overall Study|Withdrawal by Subject|1|||
164556073|NCT01344876|594406037|FG003|Overall Study|Withdrawal by Subject|0|||
164556074|NCT01344876|594406038|FG004|Overall Study|Withdrawal by Subject|0|||
164556075|NCT01344876|594406034|FG000|Overall Study|Definite progression of primary disease|1|||
164556076|NCT01344876|594406035|FG001|Overall Study|Definite progression of primary disease|0|||
164556077|NCT01344876|594406036|FG002|Overall Study|Definite progression of primary disease|0|||
164556078|NCT01344876|594406037|FG003|Overall Study|Definite progression of primary disease|3|||
164556079|NCT01344876|594406038|FG004|Overall Study|Definite progression of primary disease|0|||
164556080|NCT00562588|594406039|FG000|Overall Study|Adverse Event|40|||
164556081|NCT00562588|594406040|FG001|Overall Study|Adverse Event|58|||
164556082|NCT00562588|594406039|FG000|Overall Study|Protocol Violation|30|||
164556083|NCT00562588|594406040|FG001|Overall Study|Protocol Violation|26|||
164556084|NCT00562588|594406039|FG000|Overall Study|Lost to Follow-up|12|||
164556085|NCT00562588|594406040|FG001|Overall Study|Lost to Follow-up|4|||
164556086|NCT00562588|594406039|FG000|Overall Study|Withdrawal by Subject|10|||
164556087|NCT00562588|594406040|FG001|Overall Study|Withdrawal by Subject|9|||
164556088|NCT00562588|594406039|FG000|Overall Study|Other|0|||
164556089|NCT00562588|594406040|FG001|Overall Study|Other|2|||
164556090|NCT03047980|594407998|FG000|Overall Study|Adverse Event|1|||
164556091|NCT02164981|594407999|FG000|Started|Withdrawal by Subject|2|||
164556092|NCT02164981|594408000|FG001|Started|Withdrawal by Subject|1|||
164556093|NCT02164981|594408001|FG002|Started|Withdrawal by Subject|0|||
164556094|NCT02164981|594407999|FG000|Started|Protocol Violation|2|||
164556095|NCT02164981|594408000|FG001|Started|Protocol Violation|0|||
164556096|NCT02164981|594408001|FG002|Started|Protocol Violation|0|||
164556097|NCT02164981|594407999|FG000|Started|Adverse Event|1|||
164556098|NCT02164981|594408000|FG001|Started|Adverse Event|2|||
164556099|NCT02164981|594408001|FG002|Started|Adverse Event|0|||
164556100|NCT02164981|594407999|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
164556101|NCT02164981|594408000|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
164556102|NCT02164981|594408001|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
164556103|NCT02164981|594407999|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
164556104|NCT02164981|594408000|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
164660574|NCT02829918|594783441|FG000|Overall Study|Death|2|||
164202293|NCT00408499|593115071|FG003|Phase II- MTD Expansion|Adverse Event|0|||
164202294|NCT00408499|593115072|FG004|Phase II- MTD Expansion|Adverse Event|9|||
164202295|NCT00408499|593115068|FG000|Phase II- MTD Expansion|Death|0|||
164202296|NCT00408499|593115069|FG001|Phase II- MTD Expansion|Death|0|||
164202297|NCT00408499|593115070|FG002|Phase II- MTD Expansion|Death|0|||
164202298|NCT00408499|593115071|FG003|Phase II- MTD Expansion|Death|0|||
164202299|NCT00408499|593115072|FG004|Phase II- MTD Expansion|Death|2|||
164202300|NCT00408499|593115068|FG000|Phase II- MTD Expansion|Physician Decision|0|||
164556105|NCT02164981|594408001|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
164556106|NCT02164981|594407999|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
164556107|NCT02164981|594408000|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
164556108|NCT02164981|594408001|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
164556109|NCT01761266|594408007|FG000|Overall Study|Death|415|||
164660575|NCT02829918|594783441|FG000|Overall Study|Withdrawal by Subject|4|||
164202301|NCT00408499|593115069|FG001|Phase II- MTD Expansion|Physician Decision|0|||
164556110|NCT01761266|594408008|FG001|Overall Study|Death|402|||
164556111|NCT01761266|594408007|FG000|Overall Study|Lost to Follow-up|8|||
164556112|NCT01761266|594408008|FG001|Overall Study|Lost to Follow-up|12|||
164556113|NCT01761266|594408007|FG000|Overall Study|Withdrawal by Subject|14|||
164556114|NCT01761266|594408008|FG001|Overall Study|Withdrawal by Subject|10|||
164556115|NCT01761266|594408007|FG000|Overall Study|Sponsor Decision|41|||
164556116|NCT01761266|594408008|FG001|Overall Study|Sponsor Decision|52|||
164312177|NCT01904773|593520244|FG003|Fifth Intervention|Adverse Event|0|||
164312178|NCT01904773|593520245|FG004|Fifth Intervention|Adverse Event|0|||
164312179|NCT01904773|593520246|FG005|Fifth Intervention|Adverse Event|0|||
164312180|NCT01904773|593520247|FG006|Fifth Intervention|Adverse Event|0|||
164312181|NCT01904773|593520248|FG007|Fifth Intervention|Adverse Event|1|||
164312182|NCT01904773|593520249|FG008|Fifth Intervention|Adverse Event|0|||
164312183|NCT01904773|593520241|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
164312184|NCT01904773|593520242|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
164312185|NCT01904773|593520243|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
164312186|NCT01904773|593520244|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
164312187|NCT01904773|593520245|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
164312188|NCT01904773|593520246|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
164312189|NCT01904773|593520247|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
164312190|NCT01904773|593520248|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
164312191|NCT01904773|593520249|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
164312192|NCT01511055|593520252|FG000|Overall Study|Withdrawal by Subject|6|||
164312193|NCT02891070|593520259|FG000|Overall Study|Adverse Event|1|||
164312194|NCT02891070|593520260|FG001|Overall Study|Adverse Event|0|||
164312195|NCT02891070|593520259|FG000|Overall Study|Physician Decision|0|||
164312196|NCT02891070|593520260|FG001|Overall Study|Physician Decision|1|||
164312197|NCT02891070|593520259|FG000|Overall Study|Lost to Follow-up|4|||
164312198|NCT02891070|593520260|FG001|Overall Study|Lost to Follow-up|4|||
164312199|NCT02891070|593520259|FG000|Overall Study|Other|1|||
164312200|NCT02891070|593520260|FG001|Overall Study|Other|0|||
164312201|NCT02891070|593520259|FG000|Overall Study|Protocol Violation|0|||
164312202|NCT02891070|593520260|FG001|Overall Study|Protocol Violation|1|||
164312203|NCT02891070|593520259|FG000|Overall Study|Withdrawal by Subject|1|||
164312204|NCT02891070|593520260|FG001|Overall Study|Withdrawal by Subject|2|||
164312205|NCT02891070|593520259|FG000|Overall Study|Death|3|||
164312206|NCT02891070|593520260|FG001|Overall Study|Death|0|||
164312207|NCT02704143|593520263|FG000|Overall Study|disease progression|10|||
164312208|NCT02551991|593520266|FG000|Overall Study|Death|5|||
164312209|NCT02551991|593520267|FG001|Overall Study|Death|7|||
164312210|NCT02551991|593520268|FG002|Overall Study|Death|8|||
164312211|NCT02551991|593520269|FG003|Overall Study|Death|7|||
164312212|NCT02551991|593520270|FG004|Overall Study|Death|17|||
164312213|NCT02551991|593520266|FG000|Overall Study|Withdrawal by Subject|1|||
164312214|NCT02551991|593520267|FG001|Overall Study|Withdrawal by Subject|0|||
164312215|NCT02551991|593520268|FG002|Overall Study|Withdrawal by Subject|0|||
164312216|NCT02551991|593520269|FG003|Overall Study|Withdrawal by Subject|0|||
164312217|NCT02551991|593520270|FG004|Overall Study|Withdrawal by Subject|2|||
164312218|NCT02551991|593520266|FG000|Overall Study|Lost to Follow-up|0|||
164312219|NCT02551991|593520267|FG001|Overall Study|Lost to Follow-up|0|||
164312220|NCT02551991|593520268|FG002|Overall Study|Lost to Follow-up|1|||
164312221|NCT02551991|593520269|FG003|Overall Study|Lost to Follow-up|0|||
164312222|NCT02551991|593520270|FG004|Overall Study|Lost to Follow-up|0|||
164312223|NCT02551991|593520266|FG000|Overall Study|Sponsor Decision|1|||
164312224|NCT02551991|593520267|FG001|Overall Study|Sponsor Decision|0|||
164312225|NCT02551991|593520268|FG002|Overall Study|Sponsor Decision|1|||
164312226|NCT02551991|593520269|FG003|Overall Study|Sponsor Decision|0|||
164312227|NCT02551991|593520270|FG004|Overall Study|Sponsor Decision|5|||
164312228|NCT02551991|593520266|FG000|Overall Study|Other|0|||
164312229|NCT02551991|593520267|FG001|Overall Study|Other|0|||
164312230|NCT02551991|593520268|FG002|Overall Study|Other|0|||
164312231|NCT02551991|593520269|FG003|Overall Study|Other|0|||
164312232|NCT02551991|593520270|FG004|Overall Study|Other|1|||
164312233|NCT00942994|593520274|FG000|Overall Study|Adverse Event|7|||
164312234|NCT00942994|593520275|FG001|Overall Study|Adverse Event|4|||
164312235|NCT00942994|593520274|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164312236|NCT00942994|593520275|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164312237|NCT00942994|593520274|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164312238|NCT00942994|593520275|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
164556117|NCT01662440|594408009|FG000|Overall Study|Adverse Event|1|||
164556118|NCT01662440|594408010|FG001|Overall Study|Adverse Event|0|||
164556119|NCT01662440|594408011|FG002|Overall Study|Adverse Event|0|||
164556120|NCT01662440|594408012|FG003|Overall Study|Adverse Event|1|||
164556121|NCT01662440|594408009|FG000|Overall Study|Death|0|||
164312239|NCT00942994|593520274|FG000|Overall Study|Patient withdrew consent|5|||
164312240|NCT00942994|593520275|FG001|Overall Study|Patient withdrew consent|8|||
164312241|NCT00942994|593520274|FG000|Overall Study|Lost to Follow-up|1|||
164312242|NCT00942994|593520275|FG001|Overall Study|Lost to Follow-up|4|||
164312243|NCT00942994|593520274|FG000|Overall Study|Protocol deviation|1|||
164312244|NCT00942994|593520275|FG001|Overall Study|Protocol deviation|2|||
164312245|NCT00387790|593520276|FG000|Overall Study|Adverse Event|5|||
164312246|NCT00387790|593520276|FG000|Overall Study|Lack of Efficacy|2|||
164312247|NCT00387790|593520276|FG000|Overall Study|Physician Decision|2|||
164312248|NCT00387790|593520276|FG000|Overall Study|Withdrawal by Subject|3|||
164202302|NCT00408499|593115070|FG002|Phase II- MTD Expansion|Physician Decision|0|||
164202303|NCT00408499|593115071|FG003|Phase II- MTD Expansion|Physician Decision|0|||
164202304|NCT00408499|593115072|FG004|Phase II- MTD Expansion|Physician Decision|1|||
164202305|NCT00408499|593115068|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
164202306|NCT00408499|593115069|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
164202307|NCT00408499|593115070|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
164202308|NCT00408499|593115071|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
164202309|NCT00408499|593115072|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
164202310|NCT00408499|593115068|FG000|Phase II- MTD Expansion|treatment delay|0|||
164202311|NCT00408499|593115069|FG001|Phase II- MTD Expansion|treatment delay|0|||
164202312|NCT00408499|593115070|FG002|Phase II- MTD Expansion|treatment delay|0|||
164202313|NCT00408499|593115071|FG003|Phase II- MTD Expansion|treatment delay|0|||
164202314|NCT00408499|593115072|FG004|Phase II- MTD Expansion|treatment delay|3|||
164202315|NCT03617588|593115076|FG000|Overall Study|Withdrawal by Subject|1|||
164202316|NCT03617588|593115077|FG001|Overall Study|Withdrawal by Subject|0|||
164202317|NCT01715831|593115080|FG000|Overall Study|Adverse Event|1|||
164202318|NCT03261401|593115081|FG000|Overall Study|Withdrawal by Subject|0|||
164202319|NCT03261401|593115082|FG001|Overall Study|Withdrawal by Subject|0|||
164202320|NCT03261401|593115083|FG002|Overall Study|Withdrawal by Subject|0|||
164202321|NCT03261401|593115084|FG003|Overall Study|Withdrawal by Subject|0|||
164202322|NCT03261401|593115085|FG004|Overall Study|Withdrawal by Subject|0|||
164556122|NCT01662440|594408010|FG001|Overall Study|Death|1|||
164556123|NCT01662440|594408011|FG002|Overall Study|Death|0|||
164556124|NCT01662440|594408012|FG003|Overall Study|Death|0|||
164556125|NCT01662440|594408009|FG000|Overall Study|Lost to Follow-up|2|||
164556126|NCT01662440|594408010|FG001|Overall Study|Lost to Follow-up|2|||
164556127|NCT01662440|594408011|FG002|Overall Study|Lost to Follow-up|4|||
164556128|NCT01662440|594408012|FG003|Overall Study|Lost to Follow-up|1|||
164556129|NCT01662440|594408009|FG000|Overall Study|Subject moved to another country.|0|||
164556130|NCT01662440|594408010|FG001|Overall Study|Subject moved to another country.|1|||
164556131|NCT01662440|594408011|FG002|Overall Study|Subject moved to another country.|0|||
164556132|NCT01662440|594408012|FG003|Overall Study|Subject moved to another country.|0|||
164556133|NCT01662440|594408009|FG000|Overall Study|Protocol Violation|1|||
164556134|NCT01662440|594408010|FG001|Overall Study|Protocol Violation|0|||
164556135|NCT01662440|594408011|FG002|Overall Study|Protocol Violation|0|||
164556136|NCT01662440|594408012|FG003|Overall Study|Protocol Violation|0|||
164556137|NCT01662440|594408009|FG000|Overall Study|Withdrawal by Subject|5|||
164556138|NCT01662440|594408010|FG001|Overall Study|Withdrawal by Subject|2|||
164556139|NCT01662440|594408011|FG002|Overall Study|Withdrawal by Subject|2|||
164556140|NCT01662440|594408012|FG003|Overall Study|Withdrawal by Subject|2|||
164556141|NCT00112905|594408013|FG000|Overall Study|Adverse Event|4|||
164556142|NCT00112905|594408013|FG000|Overall Study|Death|1|||
164556143|NCT00112905|594408013|FG000|Overall Study|Ineligibility|5|||
164556144|NCT00112905|594408013|FG000|Overall Study|Alternative treatment|1|||
164202323|NCT03261401|593115086|FG005|Overall Study|Withdrawal by Subject|1|||
164202324|NCT03261401|593115087|FG006|Overall Study|Withdrawal by Subject|0|||
164202325|NCT03261401|593115088|FG007|Overall Study|Withdrawal by Subject|0|||
164202326|NCT03261401|593115089|FG008|Overall Study|Withdrawal by Subject|0|||
164202327|NCT03261401|593115090|FG009|Overall Study|Withdrawal by Subject|0|||
164202328|NCT03261401|593115091|FG010|Overall Study|Withdrawal by Subject|0|||
164202329|NCT03261401|593115092|FG011|Overall Study|Withdrawal by Subject|0|||
164202330|NCT03261401|593115093|FG012|Overall Study|Withdrawal by Subject|0|||
164202331|NCT03261401|593115081|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
164202332|NCT03261401|593115082|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
164202333|NCT03261401|593115083|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
164202334|NCT03261401|593115084|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
164202335|NCT03261401|593115085|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
164202336|NCT03261401|593115086|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
164202337|NCT03261401|593115087|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
164202338|NCT03261401|593115088|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
164202339|NCT03261401|593115089|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
164312249|NCT00387790|593520276|FG000|Overall Study|Ineligible for study|2|||
164312250|NCT01874340|593520277|FG000|Overall Study|Study terminated by Sponsor|6|||
164556145|NCT00112905|594408013|FG000|Overall Study|performance status was deteiorating|1|||
164202340|NCT03261401|593115090|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
164202341|NCT03261401|593115091|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
164202342|NCT03261401|593115092|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
164202343|NCT03261401|593115093|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
164202344|NCT01516216|593115096|FG000|Overall Study|Adverse Event|2|||
164202345|NCT01516216|593115097|FG001|Overall Study|Adverse Event|4|||
164202346|NCT01516216|593115096|FG000|Overall Study|Disease Progression|38|||
164202347|NCT01516216|593115097|FG001|Overall Study|Disease Progression|34|||
164556146|NCT01765673|594408014|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
164556147|NCT02600507|594408015|FG000|Overall Study|Adverse Event|3|||
164312251|NCT01874340|593520278|FG001|Overall Study|Study terminated by Sponsor|8|||
164312252|NCT01874340|593520279|FG002|Overall Study|Study terminated by Sponsor|8|||
164312253|NCT01874340|593520280|FG003|Overall Study|Study terminated by Sponsor|4|||
164312254|NCT01874340|593520277|FG000|Overall Study|Withdrawal by Subject|0|||
164312255|NCT01874340|593520278|FG001|Overall Study|Withdrawal by Subject|0|||
164312256|NCT01874340|593520279|FG002|Overall Study|Withdrawal by Subject|0|||
164660576|NCT02829918|594783441|FG000|Overall Study|Adverse Event|1|||
164660577|NCT02829918|594783441|FG000|Overall Study|Progression|1|||
164660578|NCT00491504|594783444|FG000|Overall Study|Adverse Event|0|||
164660579|NCT00491504|594783445|FG001|Overall Study|Adverse Event|1|||
164660580|NCT00491504|594783446|FG002|Overall Study|Adverse Event|0|||
164660581|NCT00491504|594783447|FG003|Overall Study|Adverse Event|0|||
164660582|NCT00491504|594783444|FG000|Overall Study|Withdrawal by Subject|0|||
164660583|NCT00491504|594783445|FG001|Overall Study|Withdrawal by Subject|0|||
164660584|NCT00491504|594783446|FG002|Overall Study|Withdrawal by Subject|1|||
164660585|NCT00491504|594783447|FG003|Overall Study|Withdrawal by Subject|2|||
164660586|NCT00491504|594783444|FG000|Overall Study|Protocol Violation|0|||
164660587|NCT00491504|594783445|FG001|Overall Study|Protocol Violation|0|||
164660588|NCT00491504|594783446|FG002|Overall Study|Protocol Violation|3|||
164660589|NCT00491504|594783447|FG003|Overall Study|Protocol Violation|2|||
164660590|NCT00203307|594783452|FG000|First Intervention|Adverse Event|2|||
164660591|NCT00203307|594783453|FG001|First Intervention|Adverse Event|0|||
164660592|NCT03730103|594783454|FG000|Overall Study|Did not meet inclusion criteria|0|||
164660593|NCT03730103|594783455|FG001|Overall Study|Did not meet inclusion criteria|5|||
164660594|NCT02789111|594783456|FG000|Overall Study|Withdrawal by Subject|1|||
164660595|NCT02789111|594783457|FG001|Overall Study|Withdrawal by Subject|4|||
164312257|NCT01874340|593520280|FG003|Overall Study|Withdrawal by Subject|1|||
164312258|NCT01716052|593520284|FG000|Overall Study|Withdrawal of funding|1|||
164312259|NCT01716052|593520285|FG001|Overall Study|Withdrawal of funding|1|||
164312260|NCT02864862|593520288|FG000|Overall Study|Lost to Follow-up|1|||
164312261|NCT02864862|593520289|FG001|Overall Study|Lost to Follow-up|0|||
164312262|NCT02864862|593520290|FG002|Overall Study|Lost to Follow-up|1|||
164312263|NCT02864862|593520288|FG000|Overall Study|Protocol Violation|0|||
164312264|NCT02864862|593520289|FG001|Overall Study|Protocol Violation|0|||
164312265|NCT02864862|593520290|FG002|Overall Study|Protocol Violation|1|||
164312266|NCT01523275|593520294|FG000|Overall Study|Lost to Follow-up|1|||
164312267|NCT01523275|593520295|FG001|Overall Study|Lost to Follow-up|2|||
164312268|NCT01523275|593520294|FG000|Overall Study|Withdrawal by Subject|1|||
164312269|NCT01523275|593520295|FG001|Overall Study|Withdrawal by Subject|0|||
164312270|NCT03598114|593520296|FG000|Overall Study|Staff turnover/left the program|3|||
164312271|NCT03598114|593520297|FG001|Overall Study|Staff turnover/left the program|39|||
164312272|NCT02527200|593520298|FG000|Overall Study|Withdrawal by Subject|3|||
164312273|NCT02527200|593520299|FG001|Overall Study|Withdrawal by Subject|2|||
164312274|NCT02527200|593520300|FG002|Overall Study|Withdrawal by Subject|1|||
164312275|NCT02527200|593520301|FG003|Overall Study|Withdrawal by Subject|0|||
164312276|NCT02527200|593520298|FG000|Overall Study|Unclassified|0|||
164312277|NCT02527200|593520299|FG001|Overall Study|Unclassified|1|||
164312278|NCT02527200|593520300|FG002|Overall Study|Unclassified|0|||
164312279|NCT02527200|593520301|FG003|Overall Study|Unclassified|0|||
164312280|NCT02527200|593520298|FG000|Overall Study|Lost to Follow-up|0|||
164312281|NCT02527200|593520299|FG001|Overall Study|Lost to Follow-up|0|||
164312282|NCT02527200|593520300|FG002|Overall Study|Lost to Follow-up|1|||
164312283|NCT02527200|593520301|FG003|Overall Study|Lost to Follow-up|0|||
164312284|NCT00689117|593520302|FG000|Overall Study|Adverse Event|6|||
164312285|NCT00689117|593520303|FG001|Overall Study|Adverse Event|0|||
164312286|NCT00689117|593520304|FG002|Overall Study|Adverse Event|5|||
164312287|NCT00689117|593520305|FG003|Overall Study|Adverse Event|0|||
164312288|NCT00689117|593520302|FG000|Overall Study|Lost to Follow-up|26|||
164312289|NCT00689117|593520303|FG001|Overall Study|Lost to Follow-up|19|||
164312290|NCT00689117|593520304|FG002|Overall Study|Lost to Follow-up|17|||
164312291|NCT00689117|593520305|FG003|Overall Study|Lost to Follow-up|11|||
164660596|NCT02308111|594783458|FG000|Overall Study|Adverse Event|31|||
164312292|NCT00689117|593520302|FG000|Overall Study|Lack of Efficacy|1|||
164312293|NCT00689117|593520303|FG001|Overall Study|Lack of Efficacy|2|||
164312294|NCT00689117|593520304|FG002|Overall Study|Lack of Efficacy|2|||
164312295|NCT00689117|593520305|FG003|Overall Study|Lack of Efficacy|2|||
164660597|NCT02308111|594783459|FG001|Overall Study|Adverse Event|19|||
164660598|NCT02308111|594783458|FG000|Overall Study|Death|9|||
164660599|NCT02308111|594783459|FG001|Overall Study|Death|6|||
164660600|NCT02308111|594783458|FG000|Overall Study|Lost to Follow-up|2|||
164312296|NCT00689117|593520302|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
164312297|NCT00689117|593520303|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
164312298|NCT00689117|593520304|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
164660601|NCT02308111|594783459|FG001|Overall Study|Lost to Follow-up|7|||
164660602|NCT02308111|594783458|FG000|Overall Study|Physician Decision|6|||
164660603|NCT02308111|594783459|FG001|Overall Study|Physician Decision|17|||
164312299|NCT00689117|593520305|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
164660604|NCT02308111|594783458|FG000|Overall Study|Protocol Violation|0|||
164556148|NCT02600507|594408016|FG001|Overall Study|Adverse Event|15|||
164556149|NCT02600507|594408017|FG002|Overall Study|Adverse Event|5|||
164556150|NCT02600507|594408015|FG000|Overall Study|Lack of Efficacy|3|||
164556151|NCT02600507|594408016|FG001|Overall Study|Lack of Efficacy|8|||
164556152|NCT02600507|594408017|FG002|Overall Study|Lack of Efficacy|5|||
164202348|NCT01516216|593115096|FG000|Overall Study|Withdrawal by Subject|9|||
164202349|NCT01516216|593115097|FG001|Overall Study|Withdrawal by Subject|11|||
164202350|NCT01516216|593115096|FG000|Overall Study|Potentially Curative Resection|6|||
164202351|NCT01516216|593115097|FG001|Overall Study|Potentially Curative Resection|12|||
164202352|NCT01516216|593115096|FG000|Overall Study|Nonadherence|2|||
164202353|NCT01516216|593115097|FG001|Overall Study|Nonadherence|3|||
164202354|NCT01516216|593115096|FG000|Overall Study|Physician Decision|6|||
164202355|NCT01516216|593115097|FG001|Overall Study|Physician Decision|3|||
164202356|NCT01516216|593115096|FG000|Overall Study|Prolonged Treatment Delay|5|||
164202357|NCT01516216|593115097|FG001|Overall Study|Prolonged Treatment Delay|1|||
164202358|NCT01516216|593115096|FG000|Overall Study|Intercurrent Illness|1|||
164202359|NCT01516216|593115097|FG001|Overall Study|Intercurrent Illness|0|||
164202360|NCT01516216|593115096|FG000|Overall Study|Death|1|||
164202361|NCT01516216|593115097|FG001|Overall Study|Death|1|||
164202362|NCT03098979|593115098|FG000|Overall Study|Adverse Event|1|||
164202363|NCT03098979|593115099|FG001|Overall Study|Adverse Event|0|||
164202364|NCT03098979|593115100|FG002|Overall Study|Adverse Event|1|||
164202365|NCT03098979|593115101|FG003|Overall Study|Adverse Event|4|||
164202366|NCT03098979|593115102|FG004|Overall Study|Adverse Event|6|||
164202367|NCT03098979|593115103|FG005|Overall Study|Adverse Event|1|||
164202368|NCT03098979|593115098|FG000|Overall Study|Withdrawal by Subject|2|||
164202369|NCT03098979|593115099|FG001|Overall Study|Withdrawal by Subject|1|||
164202370|NCT03098979|593115100|FG002|Overall Study|Withdrawal by Subject|1|||
164202371|NCT03098979|593115101|FG003|Overall Study|Withdrawal by Subject|1|||
164202372|NCT03098979|593115102|FG004|Overall Study|Withdrawal by Subject|2|||
164202373|NCT03098979|593115103|FG005|Overall Study|Withdrawal by Subject|1|||
164202374|NCT03098979|593115098|FG000|Overall Study|Death|1|||
164202375|NCT03098979|593115099|FG001|Overall Study|Death|0|||
164202376|NCT03098979|593115100|FG002|Overall Study|Death|2|||
164202377|NCT03098979|593115101|FG003|Overall Study|Death|0|||
164202378|NCT03098979|593115102|FG004|Overall Study|Death|1|||
164202379|NCT03098979|593115103|FG005|Overall Study|Death|0|||
164202380|NCT03098979|593115098|FG000|Overall Study|Physician Decision|2|||
164202381|NCT03098979|593115099|FG001|Overall Study|Physician Decision|1|||
164202382|NCT03098979|593115100|FG002|Overall Study|Physician Decision|0|||
164202383|NCT03098979|593115101|FG003|Overall Study|Physician Decision|0|||
164202384|NCT03098979|593115102|FG004|Overall Study|Physician Decision|0|||
164202385|NCT03098979|593115103|FG005|Overall Study|Physician Decision|0|||
164202386|NCT03098979|593115098|FG000|Overall Study|Non-compliance|0|||
164202387|NCT03098979|593115099|FG001|Overall Study|Non-compliance|0|||
164202388|NCT03098979|593115100|FG002|Overall Study|Non-compliance|0|||
164202389|NCT03098979|593115101|FG003|Overall Study|Non-compliance|0|||
164202390|NCT03098979|593115102|FG004|Overall Study|Non-compliance|0|||
164202391|NCT03098979|593115103|FG005|Overall Study|Non-compliance|1|||
164202392|NCT03098979|593115098|FG000|Overall Study|Protocol Violation|0|||
164202393|NCT03098979|593115099|FG001|Overall Study|Protocol Violation|0|||
164202394|NCT03098979|593115100|FG002|Overall Study|Protocol Violation|0|||
164202395|NCT03098979|593115101|FG003|Overall Study|Protocol Violation|0|||
164202396|NCT03098979|593115102|FG004|Overall Study|Protocol Violation|0|||
164202397|NCT03098979|593115103|FG005|Overall Study|Protocol Violation|1|||
164202398|NCT01715298|593115104|FG000|Overall Study|Lost to Follow-up|0|||
164202399|NCT01715298|593115105|FG001|Overall Study|Lost to Follow-up|2|||
164202400|NCT01715298|593115104|FG000|Overall Study|Patient/guardian decision|7|||
164202401|NCT01715298|593115105|FG001|Overall Study|Patient/guardian decision|9|||
164202402|NCT02419807|593115106|FG000|Overall Study|Withdrawal by Subject|4|||
164202403|NCT02419807|593115106|FG000|Overall Study|Physician Decision|1|||
164556153|NCT02600507|594408015|FG000|Overall Study|Lost to Follow-up|3|||
164202404|NCT02419807|593115106|FG000|Overall Study|Protocol Violation|5|||
164202405|NCT01006629|593115109|FG000|Overall Study|Adverse Event|1|||
164202406|NCT01006629|593115109|FG000|Overall Study|Parent refused to continue participation|1|||
164202407|NCT01006629|593115109|FG000|Overall Study|Parent unable to perform site visit|4|||
164202408|NCT01499511|593115110|FG000|Overall Study|Death|1|||
164202409|NCT01499511|593115111|FG001|Overall Study|Death|0|||
164202410|NCT00998946|593115113|FG000|Overall Study|Lost to Follow-up|1|||
164202411|NCT00998946|593115113|FG000|Overall Study|Withdrawal by Subject|1|||
164202412|NCT00998946|593115113|FG000|Overall Study|Death|2|||
164202413|NCT00998946|593115113|FG000|Overall Study|Reason Unspecified|3|||
164202414|NCT00998946|593115113|FG000|Overall Study|Enrolled but not Dosed|2|||
164202415|NCT01065818|593115115|FG000|Overall Study|Withdrawal by Subject|1|||
164202416|NCT01065818|593115115|FG000|Overall Study|Not a candidate for surgery|1|||
164202417|NCT04459338|593115118|FG000|Overall Study|Loss of IV during study|1|||
164202418|NCT04459338|593115119|FG001|Overall Study|Loss of IV during study|0|||
164202419|NCT00958074|593115120|FG000|Overall Study|Withdrawal by Subject|0|||
164556154|NCT02600507|594408016|FG001|Overall Study|Lost to Follow-up|5|||
164556155|NCT02600507|594408017|FG002|Overall Study|Lost to Follow-up|2|||
164312300|NCT00689117|593520302|FG000|Overall Study|Withdrawal by Subject|19|||
164312301|NCT00689117|593520303|FG001|Overall Study|Withdrawal by Subject|18|||
164312302|NCT00689117|593520304|FG002|Overall Study|Withdrawal by Subject|26|||
164312303|NCT00689117|593520305|FG003|Overall Study|Withdrawal by Subject|13|||
164312304|NCT00689117|593520302|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
164312305|NCT00689117|593520303|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
164312306|NCT00689117|593520304|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
164312307|NCT00689117|593520305|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
164312308|NCT00689117|593520302|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
164312309|NCT00689117|593520303|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
164312310|NCT00689117|593520304|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
164312311|NCT00689117|593520305|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
164312312|NCT00689117|593520302|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
164312313|NCT00689117|593520303|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
164312314|NCT00689117|593520304|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
164312315|NCT00689117|593520305|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
164312316|NCT00689117|593520302|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
164312317|NCT00689117|593520303|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
164312318|NCT00689117|593520304|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
164312319|NCT00689117|593520305|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
164312320|NCT00689117|593520302|FG000|Overall Study|Use of Prohibitive Medication|2|||
164312321|NCT00689117|593520303|FG001|Overall Study|Use of Prohibitive Medication|1|||
164312322|NCT00689117|593520304|FG002|Overall Study|Use of Prohibitive Medication|3|||
164312323|NCT00689117|593520305|FG003|Overall Study|Use of Prohibitive Medication|0|||
164312324|NCT00689117|593520302|FG000|Overall Study|Pregnancy|0|||
164312325|NCT00689117|593520303|FG001|Overall Study|Pregnancy|2|||
164312326|NCT00689117|593520304|FG002|Overall Study|Pregnancy|0|||
164312327|NCT00689117|593520305|FG003|Overall Study|Pregnancy|2|||
164312328|NCT00689117|593520302|FG000|Overall Study|Incarceration|2|||
164312329|NCT00689117|593520303|FG001|Overall Study|Incarceration|0|||
164312330|NCT00689117|593520304|FG002|Overall Study|Incarceration|0|||
164312331|NCT00689117|593520305|FG003|Overall Study|Incarceration|0|||
164312332|NCT00689117|593520302|FG000|Overall Study|Fear of Birth Defects|0|||
164312333|NCT00689117|593520303|FG001|Overall Study|Fear of Birth Defects|0|||
164312334|NCT00689117|593520304|FG002|Overall Study|Fear of Birth Defects|1|||
164312335|NCT00689117|593520305|FG003|Overall Study|Fear of Birth Defects|0|||
164312336|NCT00689117|593520302|FG000|Overall Study|Transportation|1|||
164312337|NCT00689117|593520303|FG001|Overall Study|Transportation|0|||
164312338|NCT00689117|593520304|FG002|Overall Study|Transportation|0|||
164312339|NCT00689117|593520305|FG003|Overall Study|Transportation|0|||
164312340|NCT00689117|593520302|FG000|Overall Study|Patient Withdrew from Study|0|||
164312341|NCT00689117|593520303|FG001|Overall Study|Patient Withdrew from Study|0|||
164312342|NCT00689117|593520304|FG002|Overall Study|Patient Withdrew from Study|0|||
164312343|NCT00689117|593520305|FG003|Overall Study|Patient Withdrew from Study|1|||
164312344|NCT00689117|593520302|FG000|Overall Study|Personal Reason|0|||
164312345|NCT00689117|593520303|FG001|Overall Study|Personal Reason|1|||
164312346|NCT00689117|593520304|FG002|Overall Study|Personal Reason|0|||
164312347|NCT00689117|593520305|FG003|Overall Study|Personal Reason|0|||
164312348|NCT00689117|593520302|FG000|Overall Study|Dispensing Error|0|||
164312349|NCT00689117|593520303|FG001|Overall Study|Dispensing Error|1|||
164312350|NCT00689117|593520304|FG002|Overall Study|Dispensing Error|0|||
164312351|NCT00689117|593520305|FG003|Overall Study|Dispensing Error|0|||
164312352|NCT00444678|593520308|FG000|Overall Study|Toxicity|11|||
164312353|NCT00444678|593520308|FG000|Overall Study|Disease Progression|12|||
164556156|NCT02600507|594408015|FG000|Overall Study|Protocol Violation|12|||
164556157|NCT02600507|594408016|FG001|Overall Study|Protocol Violation|4|||
164556158|NCT02600507|594408017|FG002|Overall Study|Protocol Violation|4|||
164556159|NCT02600507|594408015|FG000|Overall Study|Physician Decision|1|||
164556160|NCT02600507|594408016|FG001|Overall Study|Physician Decision|0|||
164556161|NCT02600507|594408017|FG002|Overall Study|Physician Decision|1|||
164556162|NCT02600507|594408015|FG000|Overall Study|Withdrawal by Subject|7|||
164556163|NCT02600507|594408016|FG001|Overall Study|Withdrawal by Subject|11|||
164556164|NCT02600507|594408017|FG002|Overall Study|Withdrawal by Subject|7|||
164556165|NCT02600507|594408015|FG000|Overall Study|Other|0|||
164556166|NCT02600507|594408016|FG001|Overall Study|Other|1|||
164420602|NCT01890967|593910947|FG001|Overall Study|Protocol Violation|3|||
164420603|NCT01890967|593910948|FG002|Overall Study|Protocol Violation|3|||
164420604|NCT01890967|593910949|FG003|Overall Study|Protocol Violation|2|||
164556167|NCT02600507|594408017|FG002|Overall Study|Other|1|||
164556168|NCT04541004|594408022|FG000|Overall Study|Adverse Event|2|||
164312354|NCT00444678|593520308|FG000|Overall Study|Death|3|||
164312355|NCT00444678|593520308|FG000|Overall Study|Physician Decision|3|||
164312356|NCT00444678|593520308|FG000|Overall Study|Withdrawal by Subject|2|||
164312357|NCT01022398|593520309|FG000|Overall Study|Study terminated|2|||
164556169|NCT05048719|594408023|FG000|Overall Study|Withdrawal by Subject|2|||
164556170|NCT05048719|594408024|FG001|Overall Study|Withdrawal by Subject|1|||
164312358|NCT01022398|593520310|FG001|Overall Study|Study terminated|2|||
164312359|NCT01317550|593520311|FG000|Overall Study|Withdrawal by Subject|1|||
164312360|NCT01317550|593520312|FG001|Overall Study|Withdrawal by Subject|0|||
164312361|NCT01317550|593520313|FG002|Overall Study|Withdrawal by Subject|0|||
164312362|NCT01317550|593520314|FG003|Overall Study|Withdrawal by Subject|0|||
164312363|NCT01317550|593520311|FG000|Overall Study|Lack of compliance study med|1|||
164312364|NCT01317550|593520312|FG001|Overall Study|Lack of compliance study med|0|||
164312365|NCT01317550|593520313|FG002|Overall Study|Lack of compliance study med|0|||
164312366|NCT01317550|593520314|FG003|Overall Study|Lack of compliance study med|0|||
164312367|NCT02888119|593520315|FG000|Overall Study|Lost to Follow-up|5|||
164312368|NCT02888119|593520316|FG001|Overall Study|Lost to Follow-up|4|||
164312369|NCT02888119|593520317|FG002|Overall Study|Lost to Follow-up|0|||
164312370|NCT03646123|593520319|FG000|Overall Study|Withdrawal by Subject|2|||
164312371|NCT03646123|593520320|FG001|Overall Study|Withdrawal by Subject|2|||
164312372|NCT03646123|593520321|FG002|Overall Study|Withdrawal by Subject|3|||
164312373|NCT03646123|593520319|FG000|Overall Study|Study termination by sponsor|0|||
164312374|NCT03646123|593520320|FG001|Overall Study|Study termination by sponsor|45|||
164312375|NCT03646123|593520321|FG002|Overall Study|Study termination by sponsor|139|||
164312376|NCT03646123|593520319|FG000|Overall Study|Lost to Follow-up|4|||
164312377|NCT03646123|593520320|FG001|Overall Study|Lost to Follow-up|10|||
164312378|NCT03646123|593520321|FG002|Overall Study|Lost to Follow-up|10|||
164312379|NCT03646123|593520319|FG000|Overall Study|Death|2|||
164312380|NCT03646123|593520320|FG001|Overall Study|Death|1|||
164312381|NCT03646123|593520321|FG002|Overall Study|Death|1|||
164312382|NCT03646123|593520319|FG000|Overall Study|Other|2|||
164312383|NCT03646123|593520320|FG001|Overall Study|Other|0|||
164312384|NCT03646123|593520321|FG002|Overall Study|Other|2|||
164312385|NCT02280408|593520322|FG000|Overall Study|Lost to Follow-up|0|||
164312386|NCT02280408|593520323|FG001|Overall Study|Lost to Follow-up|2|||
164312387|NCT02280408|593520324|FG002|Overall Study|Lost to Follow-up|0|||
164312388|NCT02280408|593520325|FG003|Overall Study|Lost to Follow-up|0|||
164312389|NCT02745145|593520331|FG000|Overall Study|Adverse Event|1|||
164312390|NCT02745145|593520332|FG001|Overall Study|Adverse Event|0|||
164556171|NCT05048719|594408025|FG002|Overall Study|Withdrawal by Subject|3|||
164556172|NCT05048719|594408026|FG003|Overall Study|Withdrawal by Subject|1|||
164556173|NCT05048719|594408027|FG004|Overall Study|Withdrawal by Subject|0|||
164556174|NCT05048719|594408028|FG005|Overall Study|Withdrawal by Subject|2|||
164556175|NCT05048719|594408029|FG006|Overall Study|Withdrawal by Subject|1|||
164556176|NCT05048719|594408030|FG007|Overall Study|Withdrawal by Subject|1|||
164556177|NCT05048719|594408031|FG008|Overall Study|Withdrawal by Subject|0|||
164556178|NCT05048719|594408023|FG000|Overall Study|Death|1|||
164556179|NCT05048719|594408024|FG001|Overall Study|Death|0|||
164556180|NCT05048719|594408025|FG002|Overall Study|Death|0|||
164556181|NCT05048719|594408026|FG003|Overall Study|Death|0|||
164556182|NCT05048719|594408027|FG004|Overall Study|Death|0|||
164556183|NCT05048719|594408028|FG005|Overall Study|Death|0|||
164556184|NCT05048719|594408029|FG006|Overall Study|Death|0|||
164556185|NCT05048719|594408030|FG007|Overall Study|Death|0|||
164556186|NCT05048719|594408031|FG008|Overall Study|Death|0|||
164556187|NCT05048719|594408023|FG000|Overall Study|Adverse Event|0|||
164556188|NCT05048719|594408024|FG001|Overall Study|Adverse Event|1|||
164556189|NCT05048719|594408025|FG002|Overall Study|Adverse Event|2|||
164556190|NCT05048719|594408026|FG003|Overall Study|Adverse Event|0|||
164556191|NCT05048719|594408027|FG004|Overall Study|Adverse Event|1|||
164556192|NCT05048719|594408028|FG005|Overall Study|Adverse Event|0|||
164556193|NCT05048719|594408029|FG006|Overall Study|Adverse Event|0|||
164556194|NCT05048719|594408030|FG007|Overall Study|Adverse Event|0|||
164556195|NCT05048719|594408031|FG008|Overall Study|Adverse Event|0|||
164312391|NCT02745145|593520333|FG002|Overall Study|Adverse Event|0|||
164556196|NCT05048719|594408023|FG000|Overall Study|Lost to Follow-up|0|||
164556197|NCT05048719|594408024|FG001|Overall Study|Lost to Follow-up|0|||
164556198|NCT05048719|594408025|FG002|Overall Study|Lost to Follow-up|1|||
164556199|NCT05048719|594408026|FG003|Overall Study|Lost to Follow-up|3|||
164556200|NCT05048719|594408027|FG004|Overall Study|Lost to Follow-up|1|||
164556201|NCT05048719|594408028|FG005|Overall Study|Lost to Follow-up|1|||
164556202|NCT05048719|594408029|FG006|Overall Study|Lost to Follow-up|1|||
164660605|NCT02308111|594783459|FG001|Overall Study|Protocol Violation|1|||
164312392|NCT02745145|593520331|FG000|Overall Study|Death|0|||
164312393|NCT02745145|593520332|FG001|Overall Study|Death|1|||
164312394|NCT02745145|593520333|FG002|Overall Study|Death|0|||
164312395|NCT02745145|593520331|FG000|Overall Study|Progressive disease|0|||
164312396|NCT02745145|593520332|FG001|Overall Study|Progressive disease|0|||
164556203|NCT05048719|594408030|FG007|Overall Study|Lost to Follow-up|1|||
164556204|NCT05048719|594408031|FG008|Overall Study|Lost to Follow-up|0|||
164556205|NCT05048719|594408023|FG000|Overall Study|Physician Decision|0|||
164556206|NCT05048719|594408024|FG001|Overall Study|Physician Decision|0|||
164556207|NCT05048719|594408025|FG002|Overall Study|Physician Decision|0|||
164556208|NCT05048719|594408026|FG003|Overall Study|Physician Decision|0|||
164556209|NCT05048719|594408027|FG004|Overall Study|Physician Decision|0|||
164556210|NCT05048719|594408028|FG005|Overall Study|Physician Decision|0|||
164660606|NCT02308111|594783458|FG000|Overall Study|Withdrawal by Subject|28|||
164660607|NCT02308111|594783459|FG001|Overall Study|Withdrawal by Subject|38|||
164660608|NCT02308111|594783458|FG000|Overall Study|Study Terminated by Sponsor|72|||
164660609|NCT02308111|594783459|FG001|Overall Study|Study Terminated by Sponsor|61|||
164660610|NCT02308111|594783458|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
164660611|NCT02308111|594783459|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
164660612|NCT02308111|594783458|FG000|Overall Study|Site Closure|3|||
164660613|NCT02308111|594783459|FG001|Overall Study|Site Closure|3|||
164660614|NCT02308111|594783458|FG000|Overall Study|Non-compliance with Study Drug|3|||
164660615|NCT02308111|594783459|FG001|Overall Study|Non-compliance with Study Drug|1|||
164660616|NCT02308111|594783458|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
164660617|NCT02308111|594783459|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
164660618|NCT02308111|594783458|FG000|Overall Study|Liver Transplant|3|||
164660619|NCT02308111|594783459|FG001|Overall Study|Liver Transplant|3|||
164660620|NCT02308111|594783458|FG000|Overall Study|Liver Transplant Waitlist|2|||
164660621|NCT02308111|594783459|FG001|Overall Study|Liver Transplant Waitlist|2|||
164660622|NCT02308111|594783458|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
164660623|NCT02308111|594783459|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
164660624|NCT03271528|594783461|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
164660625|NCT03271528|594783462|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
164312397|NCT02745145|593520333|FG002|Overall Study|Progressive disease|1|||
164312398|NCT02745145|593520331|FG000|Overall Study|Withdrew consent|1|||
164312399|NCT02745145|593520332|FG001|Overall Study|Withdrew consent|1|||
164312400|NCT02745145|593520333|FG002|Overall Study|Withdrew consent|1|||
164312401|NCT02745145|593520331|FG000|Overall Study|Study Termination|8|||
164312402|NCT02745145|593520332|FG001|Overall Study|Study Termination|3|||
164312403|NCT02745145|593520333|FG002|Overall Study|Study Termination|7|||
164312404|NCT01297491|593520339|FG000|Overall Study|Adverse Event|11|||
164312405|NCT01297491|593520340|FG001|Overall Study|Adverse Event|6|||
164312406|NCT01297491|593520339|FG000|Overall Study|Physician Decision|3|||
164312407|NCT01297491|593520340|FG001|Overall Study|Physician Decision|2|||
164312408|NCT01297491|593520339|FG000|Overall Study|Progressive disease|11|||
164312409|NCT01297491|593520340|FG001|Overall Study|Progressive disease|20|||
164312410|NCT01297491|593520339|FG000|Overall Study|Patient/Guardian decision|3|||
164312411|NCT01297491|593520340|FG001|Overall Study|Patient/Guardian decision|4|||
164312412|NCT01297491|593520339|FG000|Overall Study|Death|2|||
164312413|NCT01297491|593520340|FG001|Overall Study|Death|1|||
164312414|NCT04413617|593520343|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
164312415|NCT04413617|593520344|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
164312416|NCT04413617|593520345|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
164312417|NCT04413617|593520346|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
164312418|NCT04413617|593520347|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
164312419|NCT04413617|593520343|FG000|Overall Study|Protocol Violation|0|||
164312420|NCT04413617|593520344|FG001|Overall Study|Protocol Violation|1|||
164312421|NCT04413617|593520345|FG002|Overall Study|Protocol Violation|0|||
164312422|NCT04413617|593520346|FG003|Overall Study|Protocol Violation|0|||
164312423|NCT04413617|593520347|FG004|Overall Study|Protocol Violation|1|||
164312424|NCT04413617|593520343|FG000|Overall Study|Lack of Efficacy|2|||
164312425|NCT04413617|593520344|FG001|Overall Study|Lack of Efficacy|0|||
164312426|NCT04413617|593520345|FG002|Overall Study|Lack of Efficacy|2|||
164312427|NCT04413617|593520346|FG003|Overall Study|Lack of Efficacy|1|||
164312428|NCT04413617|593520347|FG004|Overall Study|Lack of Efficacy|0|||
164312429|NCT04413617|593520343|FG000|Overall Study|Withdrawal by Subject|3|||
164312430|NCT04413617|593520344|FG001|Overall Study|Withdrawal by Subject|4|||
164312431|NCT04413617|593520345|FG002|Overall Study|Withdrawal by Subject|2|||
164312432|NCT04413617|593520346|FG003|Overall Study|Withdrawal by Subject|5|||
164312433|NCT04413617|593520347|FG004|Overall Study|Withdrawal by Subject|3|||
164312434|NCT04413617|593520343|FG000|Overall Study|Death|1|||
164312435|NCT04413617|593520344|FG001|Overall Study|Death|0|||
164312436|NCT04413617|593520345|FG002|Overall Study|Death|0|||
164312437|NCT04413617|593520346|FG003|Overall Study|Death|0|||
164660626|NCT03271528|594783461|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
164660627|NCT03271528|594783462|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
164312438|NCT04413617|593520347|FG004|Overall Study|Death|0|||
164660628|NCT03271528|594783461|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
164660629|NCT03271528|594783462|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
164694663|NCT03250299|594905311|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
164312439|NCT04413617|593520343|FG000|Overall Study|Adverse Event|1|||
164312440|NCT04413617|593520344|FG001|Overall Study|Adverse Event|0|||
164420605|NCT01890967|593910950|FG004|Overall Study|Protocol Violation|4|||
164312441|NCT04413617|593520345|FG002|Overall Study|Adverse Event|0|||
164312442|NCT04413617|593520346|FG003|Overall Study|Adverse Event|1|||
164312443|NCT04413617|593520347|FG004|Overall Study|Adverse Event|1|||
164312444|NCT04413617|593520343|FG000|Overall Study|COVID-19|0|||
164312445|NCT04413617|593520344|FG001|Overall Study|COVID-19|1|||
164202420|NCT00958074|593115121|FG001|Overall Study|Withdrawal by Subject|1|||
164202421|NCT00784875|593115122|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
164202422|NCT00784875|593115123|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
164202423|NCT00784875|593115124|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
164202424|NCT00784875|593115125|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
164202425|NCT00784875|593115122|FG000|Period A - Baseline|Adverse Event|0|||
164202426|NCT00784875|593115123|FG001|Period A - Baseline|Adverse Event|0|||
164202427|NCT00784875|593115124|FG002|Period A - Baseline|Adverse Event|0|||
164202428|NCT00784875|593115125|FG003|Period A - Baseline|Adverse Event|8|||
164556211|NCT05048719|594408029|FG006|Overall Study|Physician Decision|0|||
164556212|NCT05048719|594408030|FG007|Overall Study|Physician Decision|1|||
164556213|NCT05048719|594408031|FG008|Overall Study|Physician Decision|1|||
164556214|NCT05048719|594408023|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
164202429|NCT00784875|593115122|FG000|Period A - Baseline|Protocol Violation|0|||
164202430|NCT00784875|593115123|FG001|Period A - Baseline|Protocol Violation|0|||
164202431|NCT00784875|593115124|FG002|Period A - Baseline|Protocol Violation|0|||
164202432|NCT00784875|593115125|FG003|Period A - Baseline|Protocol Violation|25|||
164202433|NCT00784875|593115122|FG000|Period A - Baseline|Withdrawal by Subject|0|||
164202434|NCT00784875|593115123|FG001|Period A - Baseline|Withdrawal by Subject|0|||
164202435|NCT00784875|593115124|FG002|Period A - Baseline|Withdrawal by Subject|0|||
164202436|NCT00784875|593115125|FG003|Period A - Baseline|Withdrawal by Subject|27|||
164556215|NCT05048719|594408024|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
164556216|NCT05048719|594408025|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
164556217|NCT05048719|594408026|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
164556218|NCT05048719|594408027|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
164556219|NCT05048719|594408028|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
164556220|NCT05048719|594408029|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
164556221|NCT05048719|594408030|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
164556222|NCT05048719|594408031|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
164556223|NCT05048719|594408023|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
164202437|NCT00784875|593115122|FG000|Period A - Baseline|Physician Decision|0|||
164202438|NCT00784875|593115123|FG001|Period A - Baseline|Physician Decision|0|||
164202439|NCT00784875|593115124|FG002|Period A - Baseline|Physician Decision|0|||
164202440|NCT00784875|593115125|FG003|Period A - Baseline|Physician Decision|2|||
164312446|NCT04413617|593520345|FG002|Overall Study|COVID-19|0|||
164312447|NCT04413617|593520346|FG003|Overall Study|COVID-19|0|||
164312448|NCT04413617|593520347|FG004|Overall Study|COVID-19|0|||
164312449|NCT00775593|593520348|FG000|Overall Study|Unmet eligibility criteria|6|||
164312450|NCT00775593|593520348|FG000|Overall Study|Death|1|||
164312451|NCT00312195|593520349|FG000|Overall Study|Adverse Event|4|||
164312452|NCT00312195|593520350|FG001|Overall Study|Adverse Event|6|||
164312453|NCT00312195|593520349|FG000|Overall Study|Lost to Follow-up|1|||
164312454|NCT00312195|593520350|FG001|Overall Study|Lost to Follow-up|0|||
164312455|NCT00312195|593520349|FG000|Overall Study|Protocol Violation|1|||
164312456|NCT00312195|593520350|FG001|Overall Study|Protocol Violation|0|||
164312457|NCT04145219|593520353|FG000|Overall Study|Adverse Event|18|||
164312458|NCT04145219|593520354|FG001|Overall Study|Adverse Event|6|||
164312459|NCT04145219|593520353|FG000|Overall Study|Lost to Follow-up|2|||
164556224|NCT05048719|594408024|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
164556225|NCT05048719|594408025|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
164556226|NCT05048719|594408026|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
164556227|NCT05048719|594408027|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
164556228|NCT05048719|594408028|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
164556229|NCT05048719|594408029|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
164556230|NCT05048719|594408030|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
164556231|NCT05048719|594408031|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
164556232|NCT05048719|594408023|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
164556233|NCT05048719|594408024|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
164556234|NCT05048719|594408025|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
164556235|NCT05048719|594408026|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
164556236|NCT05048719|594408027|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
164556237|NCT05048719|594408028|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
164312460|NCT04145219|593520354|FG001|Overall Study|Lost to Follow-up|3|||
164202441|NCT00784875|593115122|FG000|Period A - Baseline|Sponsor Decision|0|||
164202442|NCT00784875|593115123|FG001|Period A - Baseline|Sponsor Decision|0|||
164202443|NCT00784875|593115124|FG002|Period A - Baseline|Sponsor Decision|0|||
164202444|NCT00784875|593115125|FG003|Period A - Baseline|Sponsor Decision|113|||
164312461|NCT04145219|593520353|FG000|Overall Study|Physician Decision|0|||
164312462|NCT04145219|593520354|FG001|Overall Study|Physician Decision|2|||
164312463|NCT04145219|593520353|FG000|Overall Study|Withdrawal by Subject|12|||
164312464|NCT04145219|593520354|FG001|Overall Study|Withdrawal by Subject|8|||
164312465|NCT04145219|593520353|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
164312466|NCT04145219|593520354|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
164312467|NCT01703754|593520360|FG000|Overall Study|Clinically significant disease progression|2|||
164312468|NCT01703754|593520361|FG001|Overall Study|Clinically significant disease progression|2|||
164312469|NCT01703754|593520362|FG002|Overall Study|Clinically significant disease progression|1|||
164312470|NCT01703754|593520360|FG000|Overall Study|Adverse Event|1|||
164312471|NCT01703754|593520361|FG001|Overall Study|Adverse Event|1|||
164312472|NCT01703754|593520362|FG002|Overall Study|Adverse Event|0|||
164312473|NCT01703754|593520360|FG000|Overall Study|Withdrawal by Subject|2|||
164312474|NCT01703754|593520361|FG001|Overall Study|Withdrawal by Subject|0|||
164312475|NCT01703754|593520362|FG002|Overall Study|Withdrawal by Subject|0|||
164312476|NCT00947882|593520365|FG000|Overall Study|Adverse Event|0|||
164312477|NCT00947882|593520366|FG001|Overall Study|Adverse Event|1|||
164312478|NCT00947882|593520367|FG002|Overall Study|Adverse Event|4|||
164312479|NCT00947882|593520368|FG003|Overall Study|Adverse Event|4|||
164312480|NCT00947882|593520365|FG000|Overall Study|Withdrawal by Subject|2|||
164312481|NCT00947882|593520366|FG001|Overall Study|Withdrawal by Subject|0|||
164312482|NCT00947882|593520367|FG002|Overall Study|Withdrawal by Subject|8|||
164312483|NCT00947882|593520368|FG003|Overall Study|Withdrawal by Subject|2|||
164312484|NCT00947882|593520365|FG000|Overall Study|Protocol Violation|0|||
164312485|NCT00947882|593520366|FG001|Overall Study|Protocol Violation|0|||
164312486|NCT00947882|593520367|FG002|Overall Study|Protocol Violation|1|||
164312487|NCT00947882|593520368|FG003|Overall Study|Protocol Violation|0|||
164312488|NCT00947882|593520365|FG000|Overall Study|Lost to Follow-up|0|||
164312489|NCT00947882|593520366|FG001|Overall Study|Lost to Follow-up|2|||
164312490|NCT00947882|593520367|FG002|Overall Study|Lost to Follow-up|1|||
164312491|NCT00947882|593520368|FG003|Overall Study|Lost to Follow-up|0|||
164312492|NCT00947882|593520365|FG000|Overall Study|Other/Unknown|10|||
164312493|NCT00947882|593520366|FG001|Overall Study|Other/Unknown|13|||
164312494|NCT00947882|593520367|FG002|Overall Study|Other/Unknown|3|||
164312495|NCT00947882|593520368|FG003|Overall Study|Other/Unknown|6|||
164312496|NCT00947882|593520365|FG000|Overall Study|Trial Terminated by Sponsor|62|||
164312497|NCT00947882|593520366|FG001|Overall Study|Trial Terminated by Sponsor|61|||
164312498|NCT00947882|593520367|FG002|Overall Study|Trial Terminated by Sponsor|62|||
164312499|NCT00947882|593520368|FG003|Overall Study|Trial Terminated by Sponsor|70|||
164312500|NCT02379637|593520369|FG000|Overall Study|Protocol Violation|0|||
164312501|NCT02379637|593520370|FG001|Overall Study|Protocol Violation|1|||
164312502|NCT02379637|593520369|FG000|Overall Study|Adverse Event|1|||
164312503|NCT02379637|593520370|FG001|Overall Study|Adverse Event|0|||
164312504|NCT02379637|593520369|FG000|Overall Study|Withdrawal by Subject|1|||
164312505|NCT02379637|593520370|FG001|Overall Study|Withdrawal by Subject|0|||
164312506|NCT02447302|593520371|FG000|Overall Study|Physician Decision|1|||
164312507|NCT02447302|593520372|FG001|Overall Study|Physician Decision|0|||
164312508|NCT02447302|593520373|FG002|Overall Study|Physician Decision|0|||
164312509|NCT02447302|593520371|FG000|Overall Study|Adverse Event|4|||
164312510|NCT02447302|593520372|FG001|Overall Study|Adverse Event|3|||
164312511|NCT02447302|593520373|FG002|Overall Study|Adverse Event|0|||
164312512|NCT02447302|593520371|FG000|Overall Study|Withdrawal by Subject|0|||
164312513|NCT02447302|593520372|FG001|Overall Study|Withdrawal by Subject|1|||
164312514|NCT02447302|593520373|FG002|Overall Study|Withdrawal by Subject|5|||
164312515|NCT02447302|593520371|FG000|Overall Study|Sponsor Decision|0|||
164312516|NCT02447302|593520372|FG001|Overall Study|Sponsor Decision|0|||
164312517|NCT02447302|593520373|FG002|Overall Study|Sponsor Decision|1|||
164312518|NCT01561313|593520381|FG000|Overall Study|Withdrawal by Subject|1|||
164312519|NCT01561313|593520382|FG001|Overall Study|Withdrawal by Subject|0|||
164312520|NCT01561313|593520381|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
164312521|NCT01561313|593520382|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
164312522|NCT01742286|593520385|FG000|Escalation Phase|Administrative problems|1|||
164312523|NCT01742286|593520386|FG001|Escalation Phase|Administrative problems|1|||
164312524|NCT01742286|593520387|FG002|Escalation Phase|Administrative problems|0|||
164312525|NCT01742286|593520388|FG003|Escalation Phase|Administrative problems|0|||
164660630|NCT03271528|594783461|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
164660631|NCT03271528|594783462|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
164312526|NCT01742286|593520389|FG004|Escalation Phase|Administrative problems|0|||
164312527|NCT01742286|593520390|FG005|Escalation Phase|Administrative problems|0|||
164312528|NCT01742286|593520391|FG006|Escalation Phase|Administrative problems|2|||
164312529|NCT01742286|593520385|FG000|Escalation Phase|Adverse Event|0|||
164312530|NCT01742286|593520386|FG001|Escalation Phase|Adverse Event|1|||
164312531|NCT01742286|593520387|FG002|Escalation Phase|Adverse Event|2|||
164312532|NCT01742286|593520388|FG003|Escalation Phase|Adverse Event|0|||
164312533|NCT01742286|593520389|FG004|Escalation Phase|Adverse Event|0|||
164312534|NCT01742286|593520390|FG005|Escalation Phase|Adverse Event|1|||
164312535|NCT01742286|593520391|FG006|Escalation Phase|Adverse Event|0|||
164312536|NCT01742286|593520385|FG000|Escalation Phase|Disease progression|3|||
164312537|NCT01742286|593520386|FG001|Escalation Phase|Disease progression|7|||
164312538|NCT01742286|593520387|FG002|Escalation Phase|Disease progression|4|||
164312539|NCT01742286|593520388|FG003|Escalation Phase|Disease progression|1|||
164312540|NCT01742286|593520389|FG004|Escalation Phase|Disease progression|4|||
164312541|NCT01742286|593520390|FG005|Escalation Phase|Disease progression|3|||
164312542|NCT01742286|593520391|FG006|Escalation Phase|Disease progression|2|||
164312543|NCT01742286|593520385|FG000|Escalation Phase|Death|0|||
164312544|NCT01742286|593520386|FG001|Escalation Phase|Death|0|||
164312545|NCT01742286|593520387|FG002|Escalation Phase|Death|0|||
164312546|NCT01742286|593520388|FG003|Escalation Phase|Death|0|||
164312547|NCT01742286|593520389|FG004|Escalation Phase|Death|0|||
164312548|NCT01742286|593520390|FG005|Escalation Phase|Death|1|||
164312549|NCT01742286|593520391|FG006|Escalation Phase|Death|0|||
164312550|NCT01742286|593520385|FG000|Escalation Phase|Physician Decision|0|||
164312551|NCT01742286|593520386|FG001|Escalation Phase|Physician Decision|3|||
164312552|NCT01742286|593520387|FG002|Escalation Phase|Physician Decision|0|||
164312553|NCT01742286|593520388|FG003|Escalation Phase|Physician Decision|1|||
164312554|NCT01742286|593520389|FG004|Escalation Phase|Physician Decision|0|||
164312555|NCT01742286|593520390|FG005|Escalation Phase|Physician Decision|0|||
164312556|NCT01742286|593520391|FG006|Escalation Phase|Physician Decision|2|||
164312557|NCT01742286|593520385|FG000|Escalation Phase|Subject/guardian decision|1|||
164312558|NCT01742286|593520386|FG001|Escalation Phase|Subject/guardian decision|0|||
164312559|NCT01742286|593520387|FG002|Escalation Phase|Subject/guardian decision|0|||
164312560|NCT01742286|593520388|FG003|Escalation Phase|Subject/guardian decision|0|||
164312561|NCT01742286|593520389|FG004|Escalation Phase|Subject/guardian decision|0|||
164312562|NCT01742286|593520390|FG005|Escalation Phase|Subject/guardian decision|0|||
164312563|NCT01742286|593520391|FG006|Escalation Phase|Subject/guardian decision|0|||
164312564|NCT01742286|593520385|FG000|Expansion Phase|Administrative problems|0|||
164312565|NCT01742286|593520386|FG001|Expansion Phase|Administrative problems|0|||
164312566|NCT01742286|593520387|FG002|Expansion Phase|Administrative problems|0|||
164312567|NCT01742286|593520388|FG003|Expansion Phase|Administrative problems|0|||
164312568|NCT01742286|593520389|FG004|Expansion Phase|Administrative problems|0|||
164312569|NCT01742286|593520390|FG005|Expansion Phase|Administrative problems|0|||
164312570|NCT01742286|593520391|FG006|Expansion Phase|Administrative problems|5|||
164312571|NCT01742286|593520385|FG000|Expansion Phase|Physician Decision|0|||
164312572|NCT01742286|593520386|FG001|Expansion Phase|Physician Decision|0|||
164312573|NCT01742286|593520387|FG002|Expansion Phase|Physician Decision|4|||
164312574|NCT01742286|593520388|FG003|Expansion Phase|Physician Decision|0|||
164312575|NCT01742286|593520389|FG004|Expansion Phase|Physician Decision|0|||
164312576|NCT01742286|593520390|FG005|Expansion Phase|Physician Decision|0|||
164312577|NCT01742286|593520391|FG006|Expansion Phase|Physician Decision|9|||
164312578|NCT01742286|593520385|FG000|Expansion Phase|Adverse Event|0|||
164312579|NCT01742286|593520386|FG001|Expansion Phase|Adverse Event|0|||
164312580|NCT01742286|593520387|FG002|Expansion Phase|Adverse Event|0|||
164312581|NCT01742286|593520388|FG003|Expansion Phase|Adverse Event|0|||
164312582|NCT01742286|593520389|FG004|Expansion Phase|Adverse Event|0|||
164312583|NCT01742286|593520390|FG005|Expansion Phase|Adverse Event|0|||
164312584|NCT01742286|593520391|FG006|Expansion Phase|Adverse Event|6|||
164312585|NCT01742286|593520385|FG000|Expansion Phase|Disease progression|0|||
164312586|NCT01742286|593520386|FG001|Expansion Phase|Disease progression|0|||
164312587|NCT01742286|593520387|FG002|Expansion Phase|Disease progression|3|||
164312588|NCT01742286|593520388|FG003|Expansion Phase|Disease progression|0|||
164312589|NCT01742286|593520389|FG004|Expansion Phase|Disease progression|0|||
164312590|NCT01742286|593520390|FG005|Expansion Phase|Disease progression|0|||
164312591|NCT01742286|593520391|FG006|Expansion Phase|Disease progression|15|||
164312592|NCT01742286|593520385|FG000|Expansion Phase|Withdrawal by Subject|0|||
164312593|NCT01742286|593520386|FG001|Expansion Phase|Withdrawal by Subject|0|||
164312594|NCT01742286|593520387|FG002|Expansion Phase|Withdrawal by Subject|0|||
164312595|NCT01742286|593520388|FG003|Expansion Phase|Withdrawal by Subject|0|||
164312596|NCT01742286|593520389|FG004|Expansion Phase|Withdrawal by Subject|0|||
164312597|NCT01742286|593520390|FG005|Expansion Phase|Withdrawal by Subject|0|||
164312598|NCT01742286|593520391|FG006|Expansion Phase|Withdrawal by Subject|1|||
164312599|NCT01233232|593520392|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
164312600|NCT01233232|593520393|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
164312601|NCT01233232|593520394|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
164312602|NCT04198714|593520395|FG000|Overall Study|Physician Decision|0|||
164312603|NCT04198714|593520396|FG001|Overall Study|Physician Decision|1|||
164312604|NCT01031836|593522573|FG000|Stage I|Adverse Event|1|||
164312605|NCT01031836|593522574|FG001|Stage I|Adverse Event|1|||
164312606|NCT01031836|593522575|FG002|Stage I|Adverse Event|0|||
164312607|NCT01031836|593522576|FG003|Stage I|Adverse Event|0|||
164312608|NCT01031836|593522577|FG004|Stage I|Adverse Event|0|||
164312609|NCT01031836|593522578|FG005|Stage I|Adverse Event|0|||
164312610|NCT01031836|593522573|FG000|Stage I|Other|0|||
164312611|NCT01031836|593522574|FG001|Stage I|Other|1|||
164312612|NCT01031836|593522575|FG002|Stage I|Other|0|||
164312613|NCT01031836|593522576|FG003|Stage I|Other|0|||
164312614|NCT01031836|593522577|FG004|Stage I|Other|0|||
164312615|NCT01031836|593522578|FG005|Stage I|Other|1|||
164312616|NCT01031836|593522573|FG000|Stage II|Adverse Event|0|||
164312617|NCT01031836|593522574|FG001|Stage II|Adverse Event|0|||
164312618|NCT01031836|593522575|FG002|Stage II|Adverse Event|2|||
164312619|NCT01031836|593522576|FG003|Stage II|Adverse Event|2|||
164312620|NCT01031836|593522577|FG004|Stage II|Adverse Event|1|||
164312621|NCT01031836|593522578|FG005|Stage II|Adverse Event|1|||
164312622|NCT01031836|593522573|FG000|Stage II|Other|2|||
164312623|NCT01031836|593522574|FG001|Stage II|Other|0|||
164312624|NCT01031836|593522575|FG002|Stage II|Other|0|||
164312625|NCT01031836|593522576|FG003|Stage II|Other|1|||
164312626|NCT01031836|593522577|FG004|Stage II|Other|1|||
164312627|NCT01031836|593522578|FG005|Stage II|Other|0|||
164312628|NCT05091567|593522579|FG000|Enrollment Phase|Death|37|||
164312629|NCT05091567|593522580|FG001|Enrollment Phase|Death|0|||
164312630|NCT05091567|593522581|FG002|Enrollment Phase|Death|0|||
164312631|NCT05091567|593522579|FG000|Enrollment Phase|Adverse Event|21|||
164312632|NCT05091567|593522580|FG001|Enrollment Phase|Adverse Event|0|||
164312633|NCT05091567|593522581|FG002|Enrollment Phase|Adverse Event|0|||
164312634|NCT05091567|593522579|FG000|Enrollment Phase|Progressive Disease|10|||
164312635|NCT05091567|593522580|FG001|Enrollment Phase|Progressive Disease|0|||
164312636|NCT05091567|593522581|FG002|Enrollment Phase|Progressive Disease|0|||
164312637|NCT05091567|593522579|FG000|Enrollment Phase|Withdrawal by Subject|8|||
164312638|NCT05091567|593522580|FG001|Enrollment Phase|Withdrawal by Subject|0|||
164312639|NCT05091567|593522581|FG002|Enrollment Phase|Withdrawal by Subject|0|||
164312640|NCT05091567|593522579|FG000|Enrollment Phase|Symptomatic Deterioration|7|||
164312641|NCT05091567|593522580|FG001|Enrollment Phase|Symptomatic Deterioration|0|||
164312642|NCT05091567|593522581|FG002|Enrollment Phase|Symptomatic Deterioration|0|||
164312643|NCT05091567|593522579|FG000|Enrollment Phase|Physician Decision|3|||
164312644|NCT05091567|593522580|FG001|Enrollment Phase|Physician Decision|0|||
164312645|NCT05091567|593522581|FG002|Enrollment Phase|Physician Decision|0|||
164312646|NCT05091567|593522579|FG000|Enrollment Phase|Protocol Violation|2|||
164312647|NCT05091567|593522580|FG001|Enrollment Phase|Protocol Violation|0|||
164312648|NCT05091567|593522581|FG002|Enrollment Phase|Protocol Violation|0|||
164312649|NCT05091567|593522579|FG000|Enrollment Phase|Reason not Specified|1|||
164312650|NCT05091567|593522580|FG001|Enrollment Phase|Reason not Specified|0|||
164312651|NCT05091567|593522581|FG002|Enrollment Phase|Reason not Specified|0|||
164312652|NCT05091567|593522579|FG000|Randomized Phase|Death|0|||
164312653|NCT05091567|593522580|FG001|Randomized Phase|Death|135|||
164312654|NCT05091567|593522581|FG002|Randomized Phase|Death|112|||
164312655|NCT05091567|593522579|FG000|Randomized Phase|Progressive Disease|0|||
164312656|NCT05091567|593522580|FG001|Randomized Phase|Progressive Disease|2|||
164312657|NCT05091567|593522581|FG002|Randomized Phase|Progressive Disease|0|||
164312658|NCT05091567|593522579|FG000|Randomized Phase|Withdrawal by Subject|0|||
164312659|NCT05091567|593522580|FG001|Randomized Phase|Withdrawal by Subject|1|||
164312660|NCT05091567|593522581|FG002|Randomized Phase|Withdrawal by Subject|3|||
164312661|NCT05091567|593522579|FG000|Randomized Phase|Lost to Follow-up|0|||
164312662|NCT05091567|593522580|FG001|Randomized Phase|Lost to Follow-up|1|||
164312663|NCT05091567|593522581|FG002|Randomized Phase|Lost to Follow-up|1|||
164312664|NCT05091567|593522579|FG000|Randomized Phase|Ongoing in Study|0|||
164312665|NCT05091567|593522580|FG001|Randomized Phase|Ongoing in Study|102|||
164556238|NCT05048719|594408029|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
164556239|NCT05048719|594408030|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
164556240|NCT05048719|594408031|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
164556241|NCT05048719|594408023|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
164556242|NCT05048719|594408024|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
164556243|NCT05048719|594408025|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
164556244|NCT05048719|594408026|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
164556245|NCT05048719|594408027|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
164660632|NCT03271528|594783461|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
164312666|NCT05091567|593522581|FG002|Randomized Phase|Ongoing in Study|126|||
164312667|NCT01217307|593522582|FG000|Overall Study|Withdrawal by Subject|0|||
164312668|NCT01217307|593522583|FG001|Overall Study|Withdrawal by Subject|1|||
164312669|NCT00843284|593522586|FG000|Overall Study|Adverse Event|39|||
164312670|NCT00843284|593522586|FG000|Overall Study|Lack of Efficacy|5|||
164312671|NCT00843284|593522586|FG000|Overall Study|Lost to Follow-up|11|||
164312672|NCT00843284|593522586|FG000|Overall Study|Other|10|||
164312673|NCT00843284|593522586|FG000|Overall Study|Withdrawal by Subject|4|||
164312674|NCT00843284|593522586|FG000|Overall Study|Death|3|||
164312675|NCT01696929|593522587|FG000|Overall Study|Physician Decision|1|||
164312676|NCT01794338|593522589|FG000|Overall Study|Death|2|||
164312677|NCT01794338|593522590|FG001|Overall Study|Death|0|||
164312678|NCT01794338|593522589|FG000|Overall Study|Lost to Follow-up|6|||
164312679|NCT01794338|593522590|FG001|Overall Study|Lost to Follow-up|9|||
164556246|NCT05048719|594408028|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
164556247|NCT05048719|594408029|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
164556248|NCT05048719|594408030|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
164556249|NCT05048719|594408031|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
164556250|NCT05048719|594408023|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
164556251|NCT05048719|594408024|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
164556252|NCT05048719|594408025|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
164556253|NCT05048719|594408026|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
164556254|NCT05048719|594408027|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
164556255|NCT05048719|594408028|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
164556256|NCT05048719|594408029|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
164556257|NCT05048719|594408030|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
164556258|NCT05048719|594408031|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
164556259|NCT00605085|594408032|FG000|Overall Study|Withdrawal by Subject|8|||
164556260|NCT00605085|594408033|FG001|Overall Study|Withdrawal by Subject|5|||
164556261|NCT00605085|594408032|FG000|Overall Study|Adverse Event|9|||
164556262|NCT00605085|594408033|FG001|Overall Study|Adverse Event|5|||
164556263|NCT00605085|594408032|FG000|Overall Study|Pregnancy|2|||
164556264|NCT00605085|594408033|FG001|Overall Study|Pregnancy|0|||
164556265|NCT00605085|594408032|FG000|Overall Study|Protocol Violation|3|||
164556266|NCT00605085|594408033|FG001|Overall Study|Protocol Violation|2|||
164556267|NCT00605085|594408032|FG000|Overall Study|Lost to Follow-up|10|||
164556268|NCT00605085|594408033|FG001|Overall Study|Lost to Follow-up|5|||
164556269|NCT00605085|594408032|FG000|Overall Study|administrative reasons|18|||
164556270|NCT00605085|594408033|FG001|Overall Study|administrative reasons|8|||
164556271|NCT03257267|594408034|FG000|Overall Study|Adverse Event|17|||
164202445|NCT00784875|593115122|FG000|Period A - Baseline|Lost to Follow-up|0|||
164202446|NCT00784875|593115123|FG001|Period A - Baseline|Lost to Follow-up|0|||
164202447|NCT00784875|593115124|FG002|Period A - Baseline|Lost to Follow-up|0|||
164202448|NCT00784875|593115125|FG003|Period A - Baseline|Lost to Follow-up|2|||
164202449|NCT00784875|593115122|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
164202450|NCT00784875|593115123|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
164202451|NCT00784875|593115124|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
164202452|NCT00784875|593115125|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
164202453|NCT00784875|593115122|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
164202454|NCT00784875|593115123|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
164202455|NCT00784875|593115124|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
164202456|NCT00784875|593115125|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
164202457|NCT00784875|593115122|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
164202458|NCT00784875|593115123|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
164202459|NCT00784875|593115124|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
164202460|NCT00784875|593115125|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
164202461|NCT00784875|593115122|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
164202462|NCT00784875|593115123|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
164202463|NCT00784875|593115124|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
164202464|NCT00784875|593115125|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
164202465|NCT00784875|593115122|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
164202466|NCT00784875|593115123|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
164202467|NCT00784875|593115124|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
164202468|NCT00784875|593115125|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
164202469|NCT00784875|593115122|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
164202470|NCT00784875|593115123|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
164202471|NCT00784875|593115124|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
164202472|NCT00784875|593115125|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
164202473|NCT00784875|593115122|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
164202474|NCT00784875|593115123|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
164202475|NCT00784875|593115124|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
164202476|NCT00784875|593115125|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
164202477|NCT00784875|593115122|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
164202478|NCT00784875|593115123|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
164202479|NCT00784875|593115124|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
164202480|NCT00784875|593115125|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
164202481|NCT00784875|593115122|FG000|Period C|Adverse Event|1|||
164202482|NCT00784875|593115123|FG001|Period C|Adverse Event|0|||
164202483|NCT00784875|593115124|FG002|Period C|Adverse Event|4|||
164202484|NCT00784875|593115125|FG003|Period C|Adverse Event|2|||
164202485|NCT00784875|593115122|FG000|Period C|Protocol Violation|0|||
164202486|NCT00784875|593115123|FG001|Period C|Protocol Violation|0|||
164202487|NCT00784875|593115124|FG002|Period C|Protocol Violation|1|||
164312680|NCT01282463|593522591|FG000|Overall Study|Lost to Follow-up|1|||
164312681|NCT01282463|593522592|FG001|Overall Study|Lost to Follow-up|0|||
164312682|NCT01282463|593522593|FG002|Overall Study|Lost to Follow-up|0|||
164312683|NCT01282463|593522591|FG000|Overall Study|Withdrawal by Subject|6|||
164312684|NCT01282463|593522592|FG001|Overall Study|Withdrawal by Subject|2|||
164312685|NCT01282463|593522593|FG002|Overall Study|Withdrawal by Subject|3|||
164312686|NCT01282463|593522591|FG000|Overall Study|"Never Treated Death"|0|||
164312687|NCT01282463|593522592|FG001|Overall Study|"Never Treated Death"|1|||
164312688|NCT01282463|593522593|FG002|Overall Study|"Never Treated Death"|0|||
164312689|NCT01282463|593522591|FG000|Overall Study|"Never Treated PD"|0|||
164312690|NCT01282463|593522592|FG001|Overall Study|"Never Treated PD"|1|||
164312691|NCT01282463|593522593|FG002|Overall Study|"Never Treated PD"|0|||
164312692|NCT01282463|593522591|FG000|Overall Study|Protocol Violation|0|||
164312693|NCT01282463|593522592|FG001|Overall Study|Protocol Violation|0|||
164312694|NCT01282463|593522593|FG002|Overall Study|Protocol Violation|1|||
164312695|NCT01282463|593522591|FG000|Overall Study|Physician Decision|1|||
164312696|NCT01282463|593522592|FG001|Overall Study|Physician Decision|0|||
164312697|NCT01282463|593522593|FG002|Overall Study|Physician Decision|0|||
164312698|NCT02051933|593522594|FG000|Overall Study|Physician Decision|0|||
164312699|NCT02051933|593522595|FG001|Overall Study|Physician Decision|1|||
164312700|NCT01954927|593522596|FG000|Overall Study|Withdrawal by Subject|3|||
164312701|NCT01954927|593522597|FG001|Overall Study|Withdrawal by Subject|1|||
164312702|NCT02156271|593522598|FG000|Overall Study|Physician Decision|4|||
164312703|NCT02156271|593522599|FG001|Overall Study|Physician Decision|3|||
164312704|NCT02617485|593522600|FG000|Treatment and Observation Period|Adverse Event|9|||
164312705|NCT02617485|593522601|FG001|Treatment and Observation Period|Adverse Event|1|||
164312706|NCT02617485|593522600|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
164312707|NCT02617485|593522601|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
164556272|NCT03257267|594408035|FG001|Overall Study|Adverse Event|7|||
164556273|NCT03257267|594408034|FG000|Overall Study|Death|96|||
164556274|NCT03257267|594408035|FG001|Overall Study|Death|98|||
164556275|NCT03257267|594408034|FG000|Overall Study|Lost to Follow-up|2|||
164556276|NCT03257267|594408035|FG001|Overall Study|Lost to Follow-up|2|||
164556277|NCT03257267|594408034|FG000|Overall Study|Non-compliance with Study Drug|0|||
164556278|NCT03257267|594408035|FG001|Overall Study|Non-compliance with Study Drug|2|||
164556279|NCT03257267|594408034|FG000|Overall Study|Participant Decision|35|||
164556280|NCT03257267|594408035|FG001|Overall Study|Participant Decision|43|||
164556281|NCT03257267|594408034|FG000|Overall Study|Sponsor Decision|1|||
164556282|NCT03257267|594408035|FG001|Overall Study|Sponsor Decision|0|||
164556283|NCT03257267|594408034|FG000|Overall Study|Physician Decision|1|||
164556284|NCT03257267|594408035|FG001|Overall Study|Physician Decision|3|||
164556285|NCT03257267|594408034|FG000|Overall Study|Disease Progression|109|||
164556286|NCT03257267|594408035|FG001|Overall Study|Disease Progression|121|||
164556287|NCT03257267|594408034|FG000|Overall Study|Withdrawal by Subject|8|||
164202488|NCT00784875|593115125|FG003|Period C|Protocol Violation|2|||
164202489|NCT00784875|593115122|FG000|Period C|Lack of Efficacy|0|||
164556288|NCT03257267|594408035|FG001|Overall Study|Withdrawal by Subject|26|||
164556289|NCT03257267|594408034|FG000|Overall Study|Other|0|||
164556290|NCT03257267|594408035|FG001|Overall Study|Other|2|||
164556291|NCT03445000|594408036|FG000|Overall Study|Disease progression|8|||
164202490|NCT00784875|593115123|FG001|Period C|Lack of Efficacy|0|||
164202491|NCT00784875|593115124|FG002|Period C|Lack of Efficacy|1|||
164202492|NCT00784875|593115125|FG003|Period C|Lack of Efficacy|0|||
164202493|NCT00784875|593115122|FG000|Period C|Withdrawal by Subject|1|||
164202494|NCT00784875|593115123|FG001|Period C|Withdrawal by Subject|1|||
164202495|NCT00784875|593115124|FG002|Period C|Withdrawal by Subject|2|||
164202496|NCT00784875|593115125|FG003|Period C|Withdrawal by Subject|0|||
164202497|NCT00784875|593115122|FG000|Period C|Physician Decision|0|||
164202498|NCT00784875|593115123|FG001|Period C|Physician Decision|0|||
164202499|NCT00784875|593115124|FG002|Period C|Physician Decision|1|||
164202500|NCT00784875|593115125|FG003|Period C|Physician Decision|1|||
164202501|NCT00784875|593115122|FG000|Period C|Sponsor Decision|5|||
164202502|NCT00784875|593115123|FG001|Period C|Sponsor Decision|5|||
164202503|NCT00784875|593115124|FG002|Period C|Sponsor Decision|4|||
164202504|NCT00784875|593115125|FG003|Period C|Sponsor Decision|2|||
164202505|NCT00784875|593115122|FG000|Period D|Adverse Event|0|||
164202506|NCT00784875|593115123|FG001|Period D|Adverse Event|2|||
164312708|NCT02617485|593522600|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
164202507|NCT00784875|593115124|FG002|Period D|Adverse Event|2|||
164202508|NCT00784875|593115125|FG003|Period D|Adverse Event|0|||
164202509|NCT00784875|593115122|FG000|Period D|Protocol Violation|1|||
164202510|NCT00784875|593115123|FG001|Period D|Protocol Violation|0|||
164202511|NCT00784875|593115124|FG002|Period D|Protocol Violation|0|||
164202512|NCT00784875|593115125|FG003|Period D|Protocol Violation|0|||
164202513|NCT00784875|593115122|FG000|Period D|Withdrawal by Subject|2|||
164556292|NCT03445000|594408036|FG000|Overall Study|Adverse Event|3|||
164202514|NCT00784875|593115123|FG001|Period D|Withdrawal by Subject|0|||
164202515|NCT00784875|593115124|FG002|Period D|Withdrawal by Subject|2|||
164202516|NCT00784875|593115125|FG003|Period D|Withdrawal by Subject|0|||
164556293|NCT03445000|594408036|FG000|Overall Study|Death|2|||
164556294|NCT03445000|594408036|FG000|Overall Study|Physician Decision|1|||
164556295|NCT03409744|594408037|FG000|Overall Study|Death|2|||
164202517|NCT00784875|593115122|FG000|Period D|Physician Decision|0|||
164202518|NCT00784875|593115123|FG001|Period D|Physician Decision|1|||
164202519|NCT00784875|593115124|FG002|Period D|Physician Decision|0|||
164202520|NCT00784875|593115125|FG003|Period D|Physician Decision|0|||
164202521|NCT00784875|593115122|FG000|Period D|Sponsor Decision|1|||
164202522|NCT00784875|593115123|FG001|Period D|Sponsor Decision|1|||
164202523|NCT00784875|593115124|FG002|Period D|Sponsor Decision|1|||
164202524|NCT00784875|593115125|FG003|Period D|Sponsor Decision|0|||
164202525|NCT00784875|593115122|FG000|Period D|Lost to Follow-up|1|||
164202526|NCT00784875|593115123|FG001|Period D|Lost to Follow-up|0|||
164202527|NCT00784875|593115124|FG002|Period D|Lost to Follow-up|1|||
164202528|NCT00784875|593115125|FG003|Period D|Lost to Follow-up|1|||
164556296|NCT03409744|594408037|FG000|Overall Study|Physician Decision|5|||
164556297|NCT03409744|594408037|FG000|Overall Study|Pregnancy|1|||
164556298|NCT03409744|594408037|FG000|Overall Study|Lost to Follow-up|1|||
164556299|NCT03409744|594408037|FG000|Overall Study|Protocol Violation|1|||
164556300|NCT05804877|594408038|FG000|Overall Study|Lost to Follow-up|1|||
164556301|NCT05804877|594408039|FG001|Overall Study|Lost to Follow-up|3|||
164556302|NCT05804877|594408038|FG000|Overall Study|Withdrawal by Subject|1|||
164556303|NCT05804877|594408039|FG001|Overall Study|Withdrawal by Subject|0|||
164556304|NCT05804877|594408038|FG000|Overall Study|Withdrawal by Subject|1|||
164556305|NCT05804877|594408039|FG001|Overall Study|Withdrawal by Subject|0|||
164556306|NCT00264004|594408040|FG000|Overall Study|Adverse Event|2|||
164556307|NCT00264004|594408041|FG001|Overall Study|Adverse Event|3|||
164202529|NCT00915525|593115126|FG000|Overall Study|Protocol Violation|9|||
164202530|NCT00915525|593115127|FG001|Overall Study|Protocol Violation|4|||
164202531|NCT00915525|593115126|FG000|Overall Study|Withdrawal by Subject|59|||
164202532|NCT00915525|593115127|FG001|Overall Study|Withdrawal by Subject|21|||
164202533|NCT00915525|593115126|FG000|Overall Study|Lost to Follow-up|27|||
164202534|NCT00915525|593115127|FG001|Overall Study|Lost to Follow-up|16|||
164202535|NCT00915525|593115126|FG000|Overall Study|Pregnancy|2|||
164202536|NCT00915525|593115127|FG001|Overall Study|Pregnancy|0|||
164202537|NCT00915525|593115126|FG000|Overall Study|Lack of Efficacy|15|||
164556308|NCT00264004|594408042|FG002|Overall Study|Adverse Event|6|||
164556309|NCT00264004|594408043|FG003|Overall Study|Adverse Event|4|||
164556310|NCT00264004|594408040|FG000|Overall Study|Withdrawal by Subject|0|||
164556311|NCT00264004|594408041|FG001|Overall Study|Withdrawal by Subject|1|||
164556312|NCT00264004|594408042|FG002|Overall Study|Withdrawal by Subject|2|||
164556313|NCT00264004|594408043|FG003|Overall Study|Withdrawal by Subject|2|||
164556314|NCT00264004|594408040|FG000|Overall Study|Other|2|||
164556315|NCT00264004|594408041|FG001|Overall Study|Other|2|||
164556316|NCT00264004|594408042|FG002|Overall Study|Other|0|||
164556317|NCT00264004|594408043|FG003|Overall Study|Other|3|||
164556318|NCT00264004|594408040|FG000|Overall Study|Development study specific disc. crit.|1|||
164556319|NCT00264004|594408041|FG001|Overall Study|Development study specific disc. crit.|0|||
164556320|NCT00264004|594408042|FG002|Overall Study|Development study specific disc. crit.|1|||
164556321|NCT00264004|594408043|FG003|Overall Study|Development study specific disc. crit.|0|||
164556322|NCT00264004|594408040|FG000|Overall Study|Cond. under inv. worsened|9|||
164556323|NCT00264004|594408041|FG001|Overall Study|Cond. under inv. worsened|5|||
164556324|NCT00264004|594408042|FG002|Overall Study|Cond. under inv. worsened|3|||
164556325|NCT00264004|594408043|FG003|Overall Study|Cond. under inv. worsened|4|||
164556326|NCT00264004|594408040|FG000|Overall Study|Not treated|3|||
164556327|NCT00264004|594408041|FG001|Overall Study|Not treated|0|||
164202538|NCT00915525|593115127|FG001|Overall Study|Lack of Efficacy|32|||
164202539|NCT00915525|593115126|FG000|Overall Study|Adverse Event|29|||
164202540|NCT00915525|593115127|FG001|Overall Study|Adverse Event|13|||
164202541|NCT00915525|593115126|FG000|Overall Study|Missing|12|||
164660633|NCT03271528|594783462|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
164312709|NCT02617485|593522601|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
164312710|NCT02617485|593522600|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
164312711|NCT02617485|593522601|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
164202542|NCT00915525|593115127|FG001|Overall Study|Missing|1|||
164202543|NCT00915525|593115126|FG000|Overall Study|Other Reason|35|||
164202544|NCT00915525|593115127|FG001|Overall Study|Other Reason|12|||
164202545|NCT00915525|593115126|FG000|Overall Study|Site Closed|27|||
164202546|NCT00915525|593115127|FG001|Overall Study|Site Closed|9|||
164202547|NCT00915525|593115126|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
164202548|NCT00915525|593115127|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
164202549|NCT00915525|593115126|FG000|Overall Study|Study Burden|28|||
164202550|NCT00915525|593115127|FG001|Overall Study|Study Burden|12|||
164202551|NCT00915525|593115126|FG000|Overall Study|Non-Compliance|3|||
164202552|NCT00915525|593115127|FG001|Overall Study|Non-Compliance|1|||
164202553|NCT00915525|593115126|FG000|Overall Study|Patient Moved|15|||
164202554|NCT00915525|593115127|FG001|Overall Study|Patient Moved|9|||
164202555|NCT00941928|593115132|FG000|Overall Study|Withdrawal by Subject|1|||
164202556|NCT00941928|593115132|FG000|Overall Study|Disease Progression|1|||
164556328|NCT00264004|594408042|FG002|Overall Study|Not treated|2|||
164312712|NCT02617485|593522600|FG000|Treatment and Observation Period|Physician Decision|0|||
164312713|NCT02617485|593522601|FG001|Treatment and Observation Period|Physician Decision|1|||
164312714|NCT02617485|593522600|FG000|Follow-up Period|Adverse Event|1|||
164312715|NCT02617485|593522601|FG001|Follow-up Period|Adverse Event|0|||
164312716|NCT02617485|593522600|FG000|Follow-up Period|Withdrawal by Subject|1|||
164312717|NCT02617485|593522601|FG001|Follow-up Period|Withdrawal by Subject|0|||
164312718|NCT02617485|593522600|FG000|Follow-up Period|Disease progression|2|||
164312719|NCT02617485|593522601|FG001|Follow-up Period|Disease progression|1|||
164312720|NCT02617485|593522600|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
164312721|NCT02617485|593522601|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
164312722|NCT02617485|593522600|FG000|Follow-up Period|Patient needed radiotherapy|9|||
164312723|NCT02617485|593522601|FG001|Follow-up Period|Patient needed radiotherapy|5|||
164312724|NCT02617485|593522600|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
164312725|NCT02617485|593522601|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
164312726|NCT00791076|593522605|FG000|Overall Study|Study was terminated,PI left institution|8|||
164312727|NCT00669409|593522607|FG000|Part 2|Withdrawal by Subject|0|||
164312728|NCT00669409|593522608|FG001|Part 2|Withdrawal by Subject|0|||
164312729|NCT00669409|593522609|FG002|Part 2|Withdrawal by Subject|0|||
164312730|NCT00669409|593522610|FG003|Part 2|Withdrawal by Subject|0|||
164312731|NCT00669409|593522611|FG004|Part 2|Withdrawal by Subject|0|||
164312732|NCT00669409|593522612|FG005|Part 2|Withdrawal by Subject|0|||
164312733|NCT00669409|593522613|FG006|Part 2|Withdrawal by Subject|0|||
164312734|NCT00669409|593522614|FG007|Part 2|Withdrawal by Subject|0|||
164312735|NCT00669409|593522615|FG008|Part 2|Withdrawal by Subject|0|||
164312736|NCT00669409|593522616|FG009|Part 2|Withdrawal by Subject|1|||
164312737|NCT00669409|593522617|FG010|Part 2|Withdrawal by Subject|0|||
164312738|NCT00095940|593522620|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
164312739|NCT00095940|593522621|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
164312740|NCT00095940|593522622|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
164312741|NCT00095940|593522623|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
164312742|NCT00095940|593522624|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
164312743|NCT00095940|593522625|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
164312744|NCT00095940|593522626|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
164312745|NCT00095940|593522627|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
164312746|NCT00095940|593522628|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
164312747|NCT00095940|593522620|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
164312748|NCT00095940|593522621|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
164312749|NCT00095940|593522622|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
164312750|NCT00095940|593522623|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
164312751|NCT00095940|593522624|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
164312752|NCT00095940|593522625|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
164312753|NCT00095940|593522626|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
164312754|NCT00095940|593522627|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
164312755|NCT00095940|593522628|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
164312756|NCT00095940|593522620|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
164312757|NCT00095940|593522621|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
164312758|NCT00095940|593522622|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
164312759|NCT00095940|593522623|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
164312760|NCT00095940|593522624|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
164312761|NCT00095940|593522625|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
164312762|NCT00095940|593522626|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
164312763|NCT00095940|593522627|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
164312764|NCT00095940|593522628|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
164312765|NCT04491604|593522629|FG000|Overall Study|Withdrawal by Subject|3|||
164312766|NCT03263702|593522635|FG000|Overall Study|Lost to Follow-up|2|||
164312767|NCT03263702|593522636|FG001|Overall Study|Lost to Follow-up|2|||
164660634|NCT03271528|594783461|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
164660635|NCT03271528|594783462|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
164660636|NCT03271528|594783461|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
164312768|NCT03263702|593522635|FG000|Overall Study|Withdrawal by Subject|1|||
164312769|NCT03263702|593522636|FG001|Overall Study|Withdrawal by Subject|2|||
164312770|NCT00966875|593522637|FG000|Part A|Adverse Event|2|||
164312771|NCT00966875|593522638|FG001|Part A|Adverse Event|1|||
164312772|NCT00966875|593522639|FG002|Part A|Adverse Event|0|||
164312773|NCT00966875|593522640|FG003|Part A|Adverse Event|1|||
164312774|NCT00966875|593522641|FG004|Part A|Adverse Event|0|||
164312775|NCT00966875|593522642|FG005|Part A|Adverse Event|1|||
164312776|NCT00966875|593522643|FG006|Part A|Adverse Event|0|||
164660637|NCT03271528|594783462|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
164312777|NCT00966875|593522644|FG007|Part A|Adverse Event|3|||
164312778|NCT00966875|593522645|FG008|Part A|Adverse Event|3|||
164312779|NCT00966875|593522637|FG000|Part A|Entry Criteria|0|||
164202557|NCT02732639|593115144|FG000|Overall Study|Lost to Follow-up|1|||
164202558|NCT01668797|593115145|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
164202559|NCT01668797|593115146|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
164202560|NCT01668797|593115147|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
164202561|NCT01668797|593115148|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
164202562|NCT01668797|593115145|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
164202563|NCT01668797|593115146|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
164202564|NCT01668797|593115147|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
164202565|NCT01668797|593115148|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
164202566|NCT01668797|593115145|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
164202567|NCT01668797|593115146|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
164202568|NCT01668797|593115147|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
164202569|NCT01668797|593115148|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
164202570|NCT01668797|593115145|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
164202571|NCT01668797|593115146|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
164202572|NCT01668797|593115147|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
164202573|NCT01668797|593115148|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
164202574|NCT01668797|593115145|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
164202575|NCT01668797|593115146|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
164202576|NCT01668797|593115147|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
164202577|NCT01668797|593115148|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
164202578|NCT01668797|593115145|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
164202579|NCT01668797|593115146|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
164202580|NCT01668797|593115147|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
164202581|NCT01668797|593115148|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
164202582|NCT01668797|593115145|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
164202583|NCT01668797|593115146|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
164202584|NCT01668797|593115147|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
164202585|NCT01668797|593115148|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
164202586|NCT01668797|593115145|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
164202587|NCT01668797|593115146|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
164202588|NCT01668797|593115147|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
164202589|NCT01668797|593115148|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
164202590|NCT01668797|593115145|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
164202591|NCT01668797|593115146|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
164202592|NCT01668797|593115147|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
164202593|NCT01668797|593115148|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
164202594|NCT01668797|593115145|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
164202595|NCT01668797|593115146|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
164202596|NCT01668797|593115147|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
164202597|NCT01668797|593115148|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
164202598|NCT01668797|593115145|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
164202599|NCT01668797|593115146|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
164202600|NCT01668797|593115147|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
164202601|NCT01668797|593115148|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
164202602|NCT01668797|593115145|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
164202603|NCT01668797|593115146|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
164202604|NCT01668797|593115147|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
164202605|NCT01668797|593115148|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
164202606|NCT01668797|593115145|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
164202607|NCT01668797|593115146|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
164202608|NCT01668797|593115147|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
164202609|NCT01668797|593115148|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
164202610|NCT01668797|593115145|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
164202611|NCT01668797|593115146|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
164202612|NCT01668797|593115147|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
164202613|NCT01668797|593115148|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
164202614|NCT01668797|593115145|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
164202615|NCT01668797|593115146|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
164202616|NCT01668797|593115147|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
164202617|NCT01668797|593115148|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
164202618|NCT01668797|593115145|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
164202619|NCT01668797|593115146|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
164202620|NCT01668797|593115147|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
164202621|NCT01668797|593115148|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
164202622|NCT01668797|593115145|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
164312780|NCT00966875|593522638|FG001|Part A|Entry Criteria|0|||
164312781|NCT00966875|593522639|FG002|Part A|Entry Criteria|0|||
164312782|NCT00966875|593522640|FG003|Part A|Entry Criteria|0|||
164312783|NCT00966875|593522641|FG004|Part A|Entry Criteria|0|||
164312784|NCT00966875|593522642|FG005|Part A|Entry Criteria|2|||
164312785|NCT00966875|593522643|FG006|Part A|Entry Criteria|0|||
164202623|NCT01668797|593115146|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
164202624|NCT01668797|593115147|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
164202625|NCT01668797|593115148|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
164202626|NCT01668797|593115145|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
164202627|NCT01668797|593115146|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
164202628|NCT01668797|593115147|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
164202629|NCT01668797|593115148|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
164202630|NCT01668797|593115145|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
164202631|NCT01668797|593115146|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
164202632|NCT01668797|593115147|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
164202633|NCT01668797|593115148|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
164202634|NCT01668797|593115145|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
164202635|NCT01668797|593115146|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
164202636|NCT01668797|593115147|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
164202637|NCT01668797|593115148|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
164202638|NCT01668797|593115145|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
164202639|NCT01668797|593115146|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
164202640|NCT01668797|593115147|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
164202641|NCT01668797|593115148|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
164202642|NCT01668797|593115145|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
164202643|NCT01668797|593115146|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
164202644|NCT01668797|593115147|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
164202645|NCT01668797|593115148|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
164202646|NCT01668797|593115145|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
164202647|NCT01668797|593115146|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
164202648|NCT01668797|593115147|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
164202649|NCT01668797|593115148|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
164202650|NCT01668797|593115145|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
164202651|NCT01668797|593115146|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
164202652|NCT01668797|593115147|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
164202653|NCT01668797|593115148|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
164202654|NCT01668797|593115145|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
164202655|NCT01668797|593115146|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
164202656|NCT01668797|593115147|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
164202657|NCT01668797|593115148|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
164202658|NCT02515227|593115149|FG000|Overall Study|Adverse Event|0|||
164202659|NCT02515227|593115150|FG001|Overall Study|Adverse Event|2|||
164202660|NCT02515227|593115149|FG000|Overall Study|Progressive disease|2|||
164202661|NCT02515227|593115150|FG001|Overall Study|Progressive disease|9|||
164202662|NCT02111083|593115151|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
164202663|NCT02111083|593115152|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
164202664|NCT00827567|593115153|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
164202665|NCT01259245|593115161|FG000|Overall Study|Withdrawal by Subject|27|||
164202666|NCT01259245|593115162|FG001|Overall Study|Withdrawal by Subject|24|||
164202667|NCT01259245|593115161|FG000|Overall Study|Death|1|||
164202668|NCT01259245|593115162|FG001|Overall Study|Death|2|||
164202669|NCT03937778|593115163|FG000|Overall Study|Withdrawal by Subject|1|||
164202670|NCT03937778|593115163|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
164202671|NCT01200355|593115167|FG000|Overall Study|Death|7|||
164202672|NCT01200355|593115168|FG001|Overall Study|Death|2|||
164202673|NCT00706797|593115171|FG000|Overall Study|Lack of Efficacy|3|||
164312786|NCT00966875|593522644|FG007|Part A|Entry Criteria|0|||
164312787|NCT00966875|593522645|FG008|Part A|Entry Criteria|0|||
164312788|NCT00966875|593522637|FG000|Part A|Lack of Efficacy|0|||
164312789|NCT00966875|593522638|FG001|Part A|Lack of Efficacy|1|||
164312790|NCT00966875|593522639|FG002|Part A|Lack of Efficacy|0|||
164312791|NCT00966875|593522640|FG003|Part A|Lack of Efficacy|0|||
164312792|NCT00966875|593522641|FG004|Part A|Lack of Efficacy|0|||
164202674|NCT00706797|593115172|FG001|Overall Study|Lack of Efficacy|0|||
164202675|NCT00706797|593115171|FG000|Overall Study|Adverse Event|0|||
164312793|NCT00966875|593522642|FG005|Part A|Lack of Efficacy|0|||
164312794|NCT00966875|593522643|FG006|Part A|Lack of Efficacy|4|||
164312795|NCT00966875|593522644|FG007|Part A|Lack of Efficacy|0|||
164312796|NCT00966875|593522645|FG008|Part A|Lack of Efficacy|0|||
164312797|NCT00966875|593522637|FG000|Part A|Lost to Follow-up|2|||
164312798|NCT00966875|593522638|FG001|Part A|Lost to Follow-up|0|||
164312799|NCT00966875|593522639|FG002|Part A|Lost to Follow-up|0|||
164312800|NCT00966875|593522640|FG003|Part A|Lost to Follow-up|0|||
164312801|NCT00966875|593522641|FG004|Part A|Lost to Follow-up|0|||
164312802|NCT00966875|593522642|FG005|Part A|Lost to Follow-up|1|||
164312803|NCT00966875|593522643|FG006|Part A|Lost to Follow-up|0|||
164312804|NCT00966875|593522644|FG007|Part A|Lost to Follow-up|0|||
164312805|NCT00966875|593522645|FG008|Part A|Lost to Follow-up|0|||
164312806|NCT00966875|593522637|FG000|Part A|Parent/Caregiver Decision|0|||
164312807|NCT00966875|593522638|FG001|Part A|Parent/Caregiver Decision|0|||
164312808|NCT00966875|593522639|FG002|Part A|Parent/Caregiver Decision|0|||
164312809|NCT00966875|593522640|FG003|Part A|Parent/Caregiver Decision|1|||
164312810|NCT00966875|593522641|FG004|Part A|Parent/Caregiver Decision|0|||
164312811|NCT00966875|593522642|FG005|Part A|Parent/Caregiver Decision|0|||
164312812|NCT00966875|593522643|FG006|Part A|Parent/Caregiver Decision|0|||
164312813|NCT00966875|593522644|FG007|Part A|Parent/Caregiver Decision|0|||
164312814|NCT00966875|593522645|FG008|Part A|Parent/Caregiver Decision|0|||
164312815|NCT00966875|593522637|FG000|Part A|Physician Decision|0|||
164312816|NCT00966875|593522638|FG001|Part A|Physician Decision|0|||
164312817|NCT00966875|593522639|FG002|Part A|Physician Decision|0|||
164312818|NCT00966875|593522640|FG003|Part A|Physician Decision|0|||
164312819|NCT00966875|593522641|FG004|Part A|Physician Decision|1|||
164312820|NCT00966875|593522642|FG005|Part A|Physician Decision|0|||
164312821|NCT00966875|593522643|FG006|Part A|Physician Decision|1|||
164312822|NCT00966875|593522644|FG007|Part A|Physician Decision|0|||
164312823|NCT00966875|593522645|FG008|Part A|Physician Decision|2|||
164312824|NCT00966875|593522637|FG000|Part A|Sponsor Decision|0|||
164312825|NCT00966875|593522638|FG001|Part A|Sponsor Decision|0|||
164312826|NCT00966875|593522639|FG002|Part A|Sponsor Decision|1|||
164312827|NCT00966875|593522640|FG003|Part A|Sponsor Decision|0|||
164312828|NCT00966875|593522641|FG004|Part A|Sponsor Decision|1|||
164312829|NCT00966875|593522642|FG005|Part A|Sponsor Decision|0|||
164312830|NCT00966875|593522643|FG006|Part A|Sponsor Decision|0|||
164312831|NCT00966875|593522644|FG007|Part A|Sponsor Decision|2|||
164312832|NCT00966875|593522645|FG008|Part A|Sponsor Decision|1|||
164312833|NCT00966875|593522637|FG000|Part A|Withdrawal by Subject|2|||
164312834|NCT00966875|593522638|FG001|Part A|Withdrawal by Subject|2|||
164312835|NCT00966875|593522639|FG002|Part A|Withdrawal by Subject|1|||
164312836|NCT00966875|593522640|FG003|Part A|Withdrawal by Subject|1|||
164312837|NCT00966875|593522641|FG004|Part A|Withdrawal by Subject|3|||
164312838|NCT00966875|593522642|FG005|Part A|Withdrawal by Subject|0|||
164312839|NCT00966875|593522643|FG006|Part A|Withdrawal by Subject|5|||
164312840|NCT00966875|593522644|FG007|Part A|Withdrawal by Subject|1|||
164312841|NCT00966875|593522645|FG008|Part A|Withdrawal by Subject|1|||
164312842|NCT00966875|593522637|FG000|Part A|Protocol Violation|0|||
164312843|NCT00966875|593522638|FG001|Part A|Protocol Violation|0|||
164312844|NCT00966875|593522639|FG002|Part A|Protocol Violation|0|||
164312845|NCT00966875|593522640|FG003|Part A|Protocol Violation|0|||
164312846|NCT00966875|593522641|FG004|Part A|Protocol Violation|0|||
164312847|NCT00966875|593522642|FG005|Part A|Protocol Violation|0|||
164312848|NCT00966875|593522643|FG006|Part A|Protocol Violation|2|||
164312849|NCT00966875|593522644|FG007|Part A|Protocol Violation|1|||
164312850|NCT00966875|593522645|FG008|Part A|Protocol Violation|1|||
164312851|NCT00966875|593522637|FG000|Part B|Adverse Event|0|||
164312852|NCT00966875|593522638|FG001|Part B|Adverse Event|1|||
164312853|NCT00966875|593522639|FG002|Part B|Adverse Event|1|||
164312854|NCT00966875|593522640|FG003|Part B|Adverse Event|0|||
164312855|NCT00966875|593522641|FG004|Part B|Adverse Event|1|||
164312856|NCT00966875|593522642|FG005|Part B|Adverse Event|0|||
164312857|NCT00966875|593522643|FG006|Part B|Adverse Event|5|||
164312858|NCT00966875|593522644|FG007|Part B|Adverse Event|2|||
164312859|NCT00966875|593522645|FG008|Part B|Adverse Event|2|||
164312860|NCT00966875|593522637|FG000|Part B|Death|0|||
164312861|NCT00966875|593522638|FG001|Part B|Death|0|||
164312862|NCT00966875|593522639|FG002|Part B|Death|1|||
164312863|NCT00966875|593522640|FG003|Part B|Death|0|||
164312864|NCT00966875|593522641|FG004|Part B|Death|0|||
164312865|NCT00966875|593522642|FG005|Part B|Death|0|||
164312866|NCT00966875|593522643|FG006|Part B|Death|0|||
164312867|NCT00966875|593522644|FG007|Part B|Death|1|||
164312868|NCT00966875|593522645|FG008|Part B|Death|0|||
164312869|NCT00966875|593522637|FG000|Part B|Lack of Efficacy|2|||
164312870|NCT00966875|593522638|FG001|Part B|Lack of Efficacy|1|||
164312871|NCT00966875|593522639|FG002|Part B|Lack of Efficacy|1|||
164312872|NCT00966875|593522640|FG003|Part B|Lack of Efficacy|1|||
164312873|NCT00966875|593522641|FG004|Part B|Lack of Efficacy|2|||
164312874|NCT00966875|593522642|FG005|Part B|Lack of Efficacy|3|||
164312875|NCT00966875|593522643|FG006|Part B|Lack of Efficacy|12|||
164312876|NCT00966875|593522644|FG007|Part B|Lack of Efficacy|9|||
164312877|NCT00966875|593522645|FG008|Part B|Lack of Efficacy|6|||
164312878|NCT00966875|593522637|FG000|Part B|Lost to Follow-up|0|||
164312879|NCT00966875|593522638|FG001|Part B|Lost to Follow-up|0|||
164312880|NCT00966875|593522639|FG002|Part B|Lost to Follow-up|0|||
164312881|NCT00966875|593522640|FG003|Part B|Lost to Follow-up|1|||
164312882|NCT00966875|593522641|FG004|Part B|Lost to Follow-up|0|||
164312883|NCT00966875|593522642|FG005|Part B|Lost to Follow-up|0|||
164312884|NCT00966875|593522643|FG006|Part B|Lost to Follow-up|0|||
164312885|NCT00966875|593522644|FG007|Part B|Lost to Follow-up|0|||
164312886|NCT00966875|593522645|FG008|Part B|Lost to Follow-up|1|||
164312887|NCT00966875|593522637|FG000|Part B|Physician Decision|0|||
164312888|NCT00966875|593522638|FG001|Part B|Physician Decision|0|||
164660638|NCT03977584|594783465|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
164660639|NCT03977584|594783466|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
164660640|NCT03977584|594783467|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
164660641|NCT02257736|594783471|FG000|Overall Study|Progressive disease|365|||
164660642|NCT02257736|594783472|FG001|Overall Study|Progressive disease|327|||
164660643|NCT02257736|594783471|FG000|Overall Study|Adverse Event|45|||
164660644|NCT02257736|594783472|FG001|Overall Study|Adverse Event|56|||
164660645|NCT02257736|594783471|FG000|Overall Study|Withdrawal by Subject|21|||
164660646|NCT02257736|594783472|FG001|Overall Study|Withdrawal by Subject|38|||
164660647|NCT02257736|594783471|FG000|Overall Study|Death|11|||
164660648|NCT02257736|594783472|FG001|Overall Study|Death|6|||
164660649|NCT02257736|594783471|FG000|Overall Study|Physician Decision|5|||
164660650|NCT02257736|594783472|FG001|Overall Study|Physician Decision|9|||
164660651|NCT02257736|594783471|FG000|Overall Study|Non-Compliance with study drug|1|||
164660652|NCT02257736|594783472|FG001|Overall Study|Non-Compliance with study drug|2|||
164660653|NCT02257736|594783471|FG000|Overall Study|Protocol Violation|1|||
164660654|NCT02257736|594783472|FG001|Overall Study|Protocol Violation|0|||
164660655|NCT02257736|594783471|FG000|Overall Study|Other|1|||
164660656|NCT02257736|594783472|FG001|Overall Study|Other|7|||
164660657|NCT02257736|594783471|FG000|Overall Study|Randomized, not treated|1|||
164660658|NCT02257736|594783472|FG001|Overall Study|Randomized, not treated|2|||
164660659|NCT00745251|594783473|FG000|Overall Study|Adverse Event|1|||
164660660|NCT00745251|594783474|FG001|Overall Study|Adverse Event|2|||
164660661|NCT00745251|594783473|FG000|Overall Study|Withdrawal by Subject|1|||
164660662|NCT00745251|594783474|FG001|Overall Study|Withdrawal by Subject|1|||
164660663|NCT01618305|594783475|FG000|Overall Study|Death|0|||
164660664|NCT01618305|594783476|FG001|Overall Study|Death|1|||
164660665|NCT01618305|594783475|FG000|Overall Study|Lost to Follow-up|11|||
164660666|NCT01618305|594783476|FG001|Overall Study|Lost to Follow-up|7|||
164660667|NCT01618305|594783475|FG000|Overall Study|Protocol Violation|1|||
164660668|NCT01618305|594783476|FG001|Overall Study|Protocol Violation|0|||
164660669|NCT01618305|594783475|FG000|Overall Study|Withdrawal by Subject|3|||
164660670|NCT01618305|594783476|FG001|Overall Study|Withdrawal by Subject|2|||
164660671|NCT01565083|594783477|FG000|Overall Study|Withdrawal by Subject|6|||
164660672|NCT01565083|594783478|FG001|Overall Study|Withdrawal by Subject|4|||
164660673|NCT01565083|594783477|FG000|Overall Study|Lost to Follow-up|2|||
164312889|NCT00966875|593522639|FG002|Part B|Physician Decision|1|||
164660674|NCT01565083|594783478|FG001|Overall Study|Lost to Follow-up|7|||
164660675|NCT01565083|594783477|FG000|Overall Study|Death|22|||
164660676|NCT01565083|594783478|FG001|Overall Study|Death|23|||
164660677|NCT01565083|594783477|FG000|Overall Study|Other|3|||
164660678|NCT01565083|594783478|FG001|Overall Study|Other|5|||
164660679|NCT01118728|594783479|FG000|Overall Study|Adverse Event|17|||
164660680|NCT01118728|594783479|FG000|Overall Study|Lack of Efficacy|27|||
164660681|NCT01118728|594783479|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
164660682|NCT01118728|594783479|FG000|Overall Study|Withdrawal by Subject|3|||
164660683|NCT01118728|594783479|FG000|Overall Study|Lost to Follow-up|4|||
164660684|NCT01309919|594783497|FG000|Overall Study|Did not receive a postpartum IUD|17|||
164660685|NCT01309919|594783498|FG001|Overall Study|Did not receive a postpartum IUD|48|||
164660686|NCT00455533|594783499|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
164660687|NCT00455533|594783500|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
164660688|NCT00455533|594783501|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
164312890|NCT00966875|593522640|FG003|Part B|Physician Decision|0|||
164312891|NCT00966875|593522641|FG004|Part B|Physician Decision|2|||
164312892|NCT00966875|593522642|FG005|Part B|Physician Decision|1|||
164312893|NCT00966875|593522643|FG006|Part B|Physician Decision|0|||
164312894|NCT00966875|593522644|FG007|Part B|Physician Decision|0|||
164312895|NCT00966875|593522645|FG008|Part B|Physician Decision|2|||
164312896|NCT00966875|593522637|FG000|Part B|Sponsor Decision|1|||
164312897|NCT00966875|593522638|FG001|Part B|Sponsor Decision|0|||
164660689|NCT00455533|594783499|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
164660690|NCT00455533|594783500|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
164660691|NCT00455533|594783501|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
164660692|NCT00455533|594783499|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
164660693|NCT00455533|594783500|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
164660694|NCT00455533|594783501|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
164660695|NCT00455533|594783499|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
164660696|NCT00455533|594783500|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
164660697|NCT00455533|594783501|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
164660698|NCT00455533|594783499|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
164660699|NCT00455533|594783500|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
164660700|NCT00455533|594783501|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
164312898|NCT00966875|593522639|FG002|Part B|Sponsor Decision|0|||
164312899|NCT00966875|593522640|FG003|Part B|Sponsor Decision|0|||
164312900|NCT00966875|593522641|FG004|Part B|Sponsor Decision|0|||
164312901|NCT00966875|593522642|FG005|Part B|Sponsor Decision|1|||
164312902|NCT00966875|593522643|FG006|Part B|Sponsor Decision|0|||
164312903|NCT00966875|593522644|FG007|Part B|Sponsor Decision|2|||
164312904|NCT00966875|593522645|FG008|Part B|Sponsor Decision|1|||
164312905|NCT00966875|593522637|FG000|Part B|Withdrawal by Subject|2|||
164312906|NCT00966875|593522638|FG001|Part B|Withdrawal by Subject|1|||
164312907|NCT00966875|593522639|FG002|Part B|Withdrawal by Subject|2|||
164312908|NCT00966875|593522640|FG003|Part B|Withdrawal by Subject|1|||
164312909|NCT00966875|593522641|FG004|Part B|Withdrawal by Subject|2|||
164312910|NCT00966875|593522642|FG005|Part B|Withdrawal by Subject|1|||
164312911|NCT00966875|593522643|FG006|Part B|Withdrawal by Subject|4|||
164312912|NCT00966875|593522644|FG007|Part B|Withdrawal by Subject|5|||
164312913|NCT00966875|593522645|FG008|Part B|Withdrawal by Subject|5|||
164312914|NCT00966875|593522637|FG000|Part B|Entry Criteria|0|||
164312915|NCT00966875|593522638|FG001|Part B|Entry Criteria|0|||
164312916|NCT00966875|593522639|FG002|Part B|Entry Criteria|0|||
164312917|NCT00966875|593522640|FG003|Part B|Entry Criteria|0|||
164312918|NCT00966875|593522641|FG004|Part B|Entry Criteria|0|||
164312919|NCT00966875|593522642|FG005|Part B|Entry Criteria|0|||
164312920|NCT00966875|593522643|FG006|Part B|Entry Criteria|1|||
164312921|NCT00966875|593522644|FG007|Part B|Entry Criteria|0|||
164312922|NCT00966875|593522645|FG008|Part B|Entry Criteria|1|||
164312923|NCT02597478|593522647|FG000|Overall Study|Withdrawal by Subject|2|||
164312924|NCT02597478|593522648|FG001|Overall Study|Withdrawal by Subject|0|||
164312925|NCT02597478|593522647|FG000|Overall Study|Change of opioid dose|1|||
164312926|NCT02597478|593522648|FG001|Overall Study|Change of opioid dose|0|||
164312927|NCT02597478|593522647|FG000|Overall Study|Insufficient exertional dyspnea|0|||
164312928|NCT02597478|593522648|FG001|Overall Study|Insufficient exertional dyspnea|1|||
164312929|NCT01305577|593522651|FG000|Overall Study|Adverse Event|2|||
164312930|NCT01305577|593522652|FG001|Overall Study|Adverse Event|2|||
164312931|NCT01305577|593522653|FG002|Overall Study|Adverse Event|1|||
164312932|NCT01305577|593522651|FG000|Overall Study|Withdrawal by Subject|7|||
164312933|NCT01305577|593522652|FG001|Overall Study|Withdrawal by Subject|5|||
164312934|NCT01305577|593522653|FG002|Overall Study|Withdrawal by Subject|6|||
164312935|NCT01305577|593522651|FG000|Overall Study|Lost to Follow-up|4|||
164312936|NCT01305577|593522652|FG001|Overall Study|Lost to Follow-up|3|||
164312937|NCT01305577|593522653|FG002|Overall Study|Lost to Follow-up|2|||
164312938|NCT01305577|593522651|FG000|Overall Study|Protocol Deviation|0|||
164312939|NCT01305577|593522652|FG001|Overall Study|Protocol Deviation|1|||
164312940|NCT01305577|593522653|FG002|Overall Study|Protocol Deviation|1|||
164312941|NCT00796978|593522654|FG000|Overall Study|Cardiac adverse event|5|||
164312942|NCT00796978|593522654|FG000|Overall Study|Adverse Event|4|||
164312943|NCT00796978|593522654|FG000|Overall Study|Withdrawal by Subject|3|||
164312944|NCT01256190|593522655|FG000|Overall Study|Lost to Follow-up|2|||
164312945|NCT01256190|593522656|FG001|Overall Study|Lost to Follow-up|0|||
164312946|NCT02834793|593522657|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
164312947|NCT02834793|593522658|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
164202676|NCT00706797|593115172|FG001|Overall Study|Adverse Event|3|||
164202677|NCT00706797|593115171|FG000|Overall Study|Withdrawal by Subject|8|||
164202678|NCT00706797|593115172|FG001|Overall Study|Withdrawal by Subject|1|||
164202679|NCT00706797|593115171|FG000|Overall Study|Death|1|||
164202680|NCT00706797|593115172|FG001|Overall Study|Death|0|||
164202681|NCT00706797|593115171|FG000|Overall Study|Discontinuation of study by sponsor|52|||
164660701|NCT00455533|594783499|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
164660702|NCT00455533|594783500|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
164660703|NCT00455533|594783501|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
164660704|NCT00455533|594783499|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
164202682|NCT00706797|593115172|FG001|Overall Study|Discontinuation of study by sponsor|63|||
164312948|NCT02834793|593522659|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
164312949|NCT02834793|593522660|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
164312950|NCT02834793|593522657|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
164312951|NCT02834793|593522658|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
164312952|NCT02834793|593522659|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
164312953|NCT02834793|593522660|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
164312954|NCT02834793|593522657|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
164312955|NCT02834793|593522658|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
164312956|NCT02834793|593522659|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
164312957|NCT02834793|593522660|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
164312958|NCT02834793|593522657|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
164312959|NCT02834793|593522658|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
164202683|NCT00706797|593115171|FG000|Overall Study|Protocol Violation|3|||
164312960|NCT02834793|593522659|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
164312961|NCT02834793|593522660|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
164312962|NCT02834793|593522657|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
164312963|NCT02834793|593522658|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
164312964|NCT02834793|593522659|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
164312965|NCT02834793|593522660|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
164312966|NCT02834793|593522657|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
164312967|NCT02834793|593522658|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
164312968|NCT02834793|593522659|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
164312969|NCT02834793|593522660|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
164312970|NCT02834793|593522657|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
164312971|NCT02834793|593522658|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
164312972|NCT02834793|593522659|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
164312973|NCT02834793|593522660|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
164312974|NCT02834793|593522657|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
164312975|NCT02834793|593522658|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
164312976|NCT02834793|593522659|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
164312977|NCT02834793|593522660|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
164312978|NCT02834793|593522657|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
164312979|NCT02834793|593522658|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
164312980|NCT02834793|593522659|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
164312981|NCT02834793|593522660|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
164312982|NCT02834793|593522657|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
164312983|NCT02834793|593522658|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
164312984|NCT02834793|593522659|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
164312985|NCT02834793|593522660|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
164312986|NCT02834793|593522657|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
164312987|NCT02834793|593522658|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
164312988|NCT02834793|593522659|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
164312989|NCT02834793|593522660|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
164312990|NCT02834793|593522657|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
164312991|NCT02834793|593522658|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
164312992|NCT02834793|593522659|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
164312993|NCT02834793|593522660|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
164312994|NCT02834793|593522657|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
164312995|NCT02834793|593522658|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
164312996|NCT02834793|593522659|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
164312997|NCT02834793|593522660|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
164312998|NCT02834793|593522657|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
164312999|NCT02834793|593522658|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
164313000|NCT02834793|593522659|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
164313001|NCT02834793|593522660|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
164313002|NCT02834793|593522657|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
164313003|NCT02834793|593522658|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
164313004|NCT02834793|593522659|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
164313005|NCT02834793|593522660|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
164313006|NCT02364336|593522661|FG000|Overall Study|Adverse Event|0|||
164313007|NCT02364336|593522662|FG001|Overall Study|Adverse Event|1|||
164313008|NCT01731938|593522663|FG000|Preliminary Part I|Withdrawal by Subject|2|||
164313009|NCT01731938|593522664|FG001|Preliminary Part I|Withdrawal by Subject|2|||
164313010|NCT01731938|593522663|FG000|Preliminary Part I|Physician Decision|1|||
164313011|NCT01731938|593522664|FG001|Preliminary Part I|Physician Decision|0|||
164313012|NCT01731938|593522663|FG000|Preliminary Part I|Lost to Follow-up|0|||
164313013|NCT01731938|593522664|FG001|Preliminary Part I|Lost to Follow-up|3|||
164313014|NCT01731938|593522663|FG000|Preliminary Part I|Missed Week 6 visit|0|||
164313015|NCT01731938|593522664|FG001|Preliminary Part I|Missed Week 6 visit|3|||
164313016|NCT01731938|593522663|FG000|Primary Part II|Withdrawal by Subject|5|||
164313017|NCT01731938|593522664|FG001|Primary Part II|Withdrawal by Subject|4|||
164313018|NCT01731938|593522663|FG000|Primary Part II|Lost to Follow-up|4|||
164313019|NCT01731938|593522664|FG001|Primary Part II|Lost to Follow-up|5|||
164313020|NCT01731938|593522663|FG000|Primary Part II|Death|2|||
164313021|NCT01731938|593522664|FG001|Primary Part II|Death|1|||
164313022|NCT01731938|593522663|FG000|Primary Part II|Missed Week 6 visit|2|||
164313023|NCT01731938|593522664|FG001|Primary Part II|Missed Week 6 visit|3|||
164313024|NCT03319745|593522665|FG000|Overall Study|Death|1|||
164313025|NCT03319745|593522665|FG000|Overall Study|Toxicity Precluding Surgery|1|||
164694664|NCT03250299|594905307|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
164313026|NCT00870103|593522666|FG000|Overall Study|Physician Decision|2|||
164313027|NCT00870103|593522666|FG000|Overall Study|Lost to Follow-up|2|||
164313028|NCT03179202|593522667|FG000|Overall Study|Screen Failure|67|||
164313029|NCT03179202|593522667|FG000|Overall Study|Subject Lost to Follow Up|12|||
164313030|NCT03179202|593522667|FG000|Overall Study|Withdrawal by Subject|7|||
164313031|NCT03179202|593522667|FG000|Overall Study|Adverse Event|3|||
164556329|NCT00264004|594408043|FG003|Overall Study|Not treated|2|||
164556330|NCT02475681|594408044|FG000|Overall Study|Death|16|||
164556331|NCT02475681|594408045|FG001|Overall Study|Death|6|||
164556332|NCT02475681|594408046|FG002|Overall Study|Death|9|||
164556333|NCT02475681|594408044|FG000|Overall Study|Physician Decision|0|||
164556334|NCT02475681|594408045|FG001|Overall Study|Physician Decision|3|||
164556335|NCT02475681|594408046|FG002|Overall Study|Physician Decision|1|||
164556336|NCT02475681|594408044|FG000|Overall Study|Withdrawal by Subject|12|||
164556337|NCT02475681|594408045|FG001|Overall Study|Withdrawal by Subject|6|||
164556338|NCT02475681|594408046|FG002|Overall Study|Withdrawal by Subject|9|||
164556339|NCT02475681|594408044|FG000|Overall Study|Lost to Follow-up|2|||
164556340|NCT02475681|594408045|FG001|Overall Study|Lost to Follow-up|1|||
164556341|NCT02475681|594408046|FG002|Overall Study|Lost to Follow-up|3|||
164556342|NCT02475681|594408044|FG000|Overall Study|Ongoing in Study|0|||
164556343|NCT02475681|594408045|FG001|Overall Study|Ongoing in Study|163|||
164556344|NCT02475681|594408046|FG002|Overall Study|Ongoing in Study|157|||
164556345|NCT02475681|594408044|FG000|Overall Study|Reasons other than above listed|2|||
164556346|NCT02475681|594408045|FG001|Overall Study|Reasons other than above listed|0|||
164556347|NCT02475681|594408046|FG002|Overall Study|Reasons other than above listed|0|||
164556348|NCT01262365|594408053|FG000|Overall Study|Lack of Efficacy|35|||
164556349|NCT01262365|594408054|FG001|Overall Study|Lack of Efficacy|30|||
164556350|NCT01262365|594408055|FG002|Overall Study|Lack of Efficacy|47|||
164556351|NCT01262365|594408053|FG000|Overall Study|Protocol Violation|3|||
164556352|NCT01262365|594408054|FG001|Overall Study|Protocol Violation|1|||
164556353|NCT01262365|594408055|FG002|Overall Study|Protocol Violation|1|||
164556354|NCT01262365|594408053|FG000|Overall Study|Lost to Follow-up|3|||
164556355|NCT01262365|594408054|FG001|Overall Study|Lost to Follow-up|7|||
164556356|NCT01262365|594408055|FG002|Overall Study|Lost to Follow-up|6|||
164556357|NCT01262365|594408053|FG000|Overall Study|Withdrawal by Subject|17|||
164556358|NCT01262365|594408054|FG001|Overall Study|Withdrawal by Subject|22|||
164556359|NCT01262365|594408055|FG002|Overall Study|Withdrawal by Subject|22|||
164556360|NCT01262365|594408053|FG000|Overall Study|Death|1|||
164556361|NCT01262365|594408054|FG001|Overall Study|Death|2|||
164556362|NCT01262365|594408055|FG002|Overall Study|Death|1|||
164556363|NCT01262365|594408053|FG000|Overall Study|Adverse Event|26|||
164556364|NCT01262365|594408054|FG001|Overall Study|Adverse Event|16|||
164556365|NCT01262365|594408055|FG002|Overall Study|Adverse Event|11|||
164556366|NCT01262365|594408053|FG000|Overall Study|sponsor decision|1|||
164556367|NCT01262365|594408054|FG001|Overall Study|sponsor decision|1|||
164556368|NCT01262365|594408055|FG002|Overall Study|sponsor decision|0|||
164556369|NCT01262365|594408053|FG000|Overall Study|Randomization error|1|||
164556370|NCT01262365|594408054|FG001|Overall Study|Randomization error|0|||
164556371|NCT01262365|594408055|FG002|Overall Study|Randomization error|2|||
164556372|NCT01262365|594408053|FG000|Overall Study|Non-compliance|1|||
164556373|NCT01262365|594408054|FG001|Overall Study|Non-compliance|0|||
164556374|NCT01262365|594408055|FG002|Overall Study|Non-compliance|2|||
164556375|NCT01262365|594408053|FG000|Overall Study|Suspected pregnancy|1|||
164556376|NCT01262365|594408054|FG001|Overall Study|Suspected pregnancy|0|||
164556377|NCT01262365|594408055|FG002|Overall Study|Suspected pregnancy|0|||
164556378|NCT01262365|594408053|FG000|Overall Study|Patient pregnant|1|||
164556379|NCT01262365|594408054|FG001|Overall Study|Patient pregnant|0|||
164556380|NCT01262365|594408055|FG002|Overall Study|Patient pregnant|1|||
164556381|NCT01262365|594408053|FG000|Overall Study|Toxicity related to study drug|0|||
164556382|NCT01262365|594408054|FG001|Overall Study|Toxicity related to study drug|1|||
164556383|NCT01262365|594408055|FG002|Overall Study|Toxicity related to study drug|0|||
164556384|NCT01262365|594408053|FG000|Overall Study|Cannot tolerate the protocol|0|||
164556385|NCT01262365|594408054|FG001|Overall Study|Cannot tolerate the protocol|1|||
164556386|NCT01262365|594408055|FG002|Overall Study|Cannot tolerate the protocol|0|||
164556387|NCT01262365|594408053|FG000|Overall Study|Patient unavailable|0|||
164556388|NCT01262365|594408054|FG001|Overall Study|Patient unavailable|0|||
164556389|NCT01262365|594408055|FG002|Overall Study|Patient unavailable|1|||
164660705|NCT00455533|594783500|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
164660706|NCT00455533|594783501|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
164660707|NCT00455533|594783499|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
164660708|NCT00455533|594783500|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
164313032|NCT03179202|593522667|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
164313033|NCT03179202|593522667|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
164313034|NCT03255629|593522668|FG000|Overall Study|Adverse Event|1|||
164313035|NCT03255629|593522669|FG001|Overall Study|Adverse Event|0|||
164313036|NCT03255629|593522668|FG000|Overall Study|did not experience hypoglycemia|2|||
164313037|NCT03255629|593522669|FG001|Overall Study|did not experience hypoglycemia|1|||
164313038|NCT04540198|593522670|FG000|Overall Study|Lost to Follow-up|25|||
164313039|NCT04540198|593522671|FG001|Overall Study|Lost to Follow-up|23|||
164313040|NCT04540198|593522670|FG000|Overall Study|Withdrawal by Subject|15|||
164313041|NCT04540198|593522671|FG001|Overall Study|Withdrawal by Subject|9|||
164313042|NCT04540198|593522670|FG000|Overall Study|Discontinued|1|||
164313043|NCT04540198|593522671|FG001|Overall Study|Discontinued|0|||
164313044|NCT02779556|593522672|FG000|Baseline|Partial baseline interview completed|1|||
164313045|NCT02779556|593522673|FG001|Baseline|Partial baseline interview completed|0|||
164313046|NCT02779556|593522672|FG000|3 Months|Lost to Follow-up|40|||
164313047|NCT02779556|593522673|FG001|3 Months|Lost to Follow-up|29|||
164313048|NCT02779556|593522672|FG000|3 Months|Missed 3 month clinic visit|27|||
164313049|NCT02779556|593522673|FG001|3 Months|Missed 3 month clinic visit|19|||
164313050|NCT02779556|593522672|FG000|6 Month|Lost to Follow-up|33|||
164313051|NCT02779556|593522673|FG001|6 Month|Lost to Follow-up|39|||
164313052|NCT02779556|593522672|FG000|6 Month HbA1c|No value collected during window|69|||
164313053|NCT02779556|593522673|FG001|6 Month HbA1c|No value collected during window|50|||
164313054|NCT02779556|593522672|FG000|12 Month HbA1c|No value collected during window|138|||
164313055|NCT02779556|593522673|FG001|12 Month HbA1c|No value collected during window|102|||
164313056|NCT03110770|593522675|FG000|Overall Study|Death|1|||
164313057|NCT03110770|593522676|FG001|Overall Study|Death|0|||
164313058|NCT03110770|593522677|FG002|Overall Study|Death|0|||
164313059|NCT03110770|593522678|FG003|Overall Study|Death|1|||
164313060|NCT03110770|593522679|FG004|Overall Study|Death|0|||
164313061|NCT03110770|593522675|FG000|Overall Study|Enrolled but did not receive product|0|||
164313062|NCT03110770|593522676|FG001|Overall Study|Enrolled but did not receive product|0|||
164313063|NCT03110770|593522677|FG002|Overall Study|Enrolled but did not receive product|0|||
164313064|NCT03110770|593522678|FG003|Overall Study|Enrolled but did not receive product|8|||
164313065|NCT03110770|593522679|FG004|Overall Study|Enrolled but did not receive product|7|||
164313066|NCT03110770|593522675|FG000|Overall Study|Lost to Follow-up|0|||
164313067|NCT03110770|593522676|FG001|Overall Study|Lost to Follow-up|0|||
164313068|NCT03110770|593522677|FG002|Overall Study|Lost to Follow-up|0|||
164313069|NCT03110770|593522678|FG003|Overall Study|Lost to Follow-up|53|||
164313070|NCT03110770|593522679|FG004|Overall Study|Lost to Follow-up|45|||
164313071|NCT03110770|593522675|FG000|Overall Study|Investigator Decision|0|||
164313072|NCT03110770|593522676|FG001|Overall Study|Investigator Decision|0|||
164313073|NCT03110770|593522677|FG002|Overall Study|Investigator Decision|0|||
164313074|NCT03110770|593522678|FG003|Overall Study|Investigator Decision|5|||
164313075|NCT03110770|593522679|FG004|Overall Study|Investigator Decision|3|||
164313076|NCT03110770|593522675|FG000|Overall Study|Withdrawal by Subject|0|||
164313077|NCT03110770|593522676|FG001|Overall Study|Withdrawal by Subject|0|||
164313078|NCT03110770|593522677|FG002|Overall Study|Withdrawal by Subject|0|||
164313079|NCT03110770|593522678|FG003|Overall Study|Withdrawal by Subject|24|||
164313080|NCT03110770|593522679|FG004|Overall Study|Withdrawal by Subject|24|||
164313081|NCT03110770|593522675|FG000|Overall Study|Moved from area|5|||
164313082|NCT03110770|593522676|FG001|Overall Study|Moved from area|0|||
164313083|NCT03110770|593522677|FG002|Overall Study|Moved from area|2|||
164313084|NCT03110770|593522678|FG003|Overall Study|Moved from area|42|||
164313085|NCT03110770|593522679|FG004|Overall Study|Moved from area|43|||
164313086|NCT03110770|593522675|FG000|Overall Study|Illness/Injury unrelated to product|0|||
164313087|NCT03110770|593522676|FG001|Overall Study|Illness/Injury unrelated to product|0|||
164313088|NCT03110770|593522677|FG002|Overall Study|Illness/Injury unrelated to product|0|||
164313089|NCT03110770|593522678|FG003|Overall Study|Illness/Injury unrelated to product|0|||
164313090|NCT03110770|593522679|FG004|Overall Study|Illness/Injury unrelated to product|1|||
164313091|NCT01086358|593522682|FG000|First Intervention|Lost to Follow-up|9|||
164313092|NCT01086358|593522683|FG001|First Intervention|Lost to Follow-up|4|||
164313093|NCT01086358|593522682|FG000|First Intervention|Withdrawal by Subject|0|||
164313094|NCT01086358|593522683|FG001|First Intervention|Withdrawal by Subject|1|||
164313095|NCT01086358|593522682|FG000|Second Intervention|Lost to Follow-up|4|||
164556390|NCT00494091|594408056|FG000|Overall Study|Death|5|||
164556391|NCT00494091|594408057|FG001|Overall Study|Death|54|||
164556392|NCT00494091|594408056|FG000|Overall Study|Lost to Follow-up|0|||
164556393|NCT00494091|594408057|FG001|Overall Study|Lost to Follow-up|4|||
164313096|NCT01086358|593522683|FG001|Second Intervention|Lost to Follow-up|4|||
164313097|NCT03206788|593522689|FG000|Overall Study|Withdrawal by Subject|0|||
164313098|NCT03206788|593522690|FG001|Overall Study|Withdrawal by Subject|1|||
164313099|NCT03206788|593522689|FG000|Overall Study|Adverse Event|0|||
164313100|NCT03206788|593522690|FG001|Overall Study|Adverse Event|1|||
164313101|NCT03206788|593522689|FG000|Overall Study|Physician Decision|0|||
164313102|NCT03206788|593522690|FG001|Overall Study|Physician Decision|1|||
164313103|NCT02082340|593522691|FG000|Overall Study|Lost to Follow-up|1|||
164660709|NCT00455533|594783501|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
164660710|NCT00455533|594783499|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
164660711|NCT00455533|594783500|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
164660712|NCT00455533|594783501|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
164660713|NCT00455533|594783499|FG000|Period Two: Randomized Period|Death|0|||
164660714|NCT00455533|594783500|FG001|Period Two: Randomized Period|Death|0|||
164660715|NCT00455533|594783501|FG002|Period Two: Randomized Period|Death|3|||
164660716|NCT00455533|594783499|FG000|Period Two: Randomized Period|Disease Progression|0|||
164660717|NCT00455533|594783500|FG001|Period Two: Randomized Period|Disease Progression|1|||
164660718|NCT00455533|594783501|FG002|Period Two: Randomized Period|Disease Progression|1|||
164660719|NCT00455533|594783499|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
164660720|NCT00455533|594783500|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
164202684|NCT00706797|593115172|FG001|Overall Study|Protocol Violation|2|||
164202685|NCT00706797|593115171|FG000|Overall Study|Lost to Follow-up|1|||
164202686|NCT00706797|593115172|FG001|Overall Study|Lost to Follow-up|2|||
164202687|NCT00706797|593115171|FG000|Overall Study|Other|1|||
164556394|NCT00494091|594408056|FG000|Overall Study|Other|1|||
164556395|NCT00494091|594408057|FG001|Overall Study|Other|11|||
164556396|NCT00494091|594408056|FG000|Overall Study|Withdrawal by Subject|0|||
164556397|NCT00494091|594408057|FG001|Overall Study|Withdrawal by Subject|7|||
164556398|NCT00527605|594408061|FG000|Overall Study|Adverse Event|3|||
164556399|NCT00527605|594408062|FG001|Overall Study|Adverse Event|0|||
164556400|NCT00527605|594408061|FG000|Overall Study|Withdrawal by Subject|3|||
164556401|NCT00527605|594408062|FG001|Overall Study|Withdrawal by Subject|7|||
164556402|NCT00527605|594408061|FG000|Overall Study|Lost to Follow-up|6|||
164556403|NCT00527605|594408062|FG001|Overall Study|Lost to Follow-up|2|||
164556404|NCT00527605|594408061|FG000|Overall Study|Protocol Violation|1|||
164556405|NCT00527605|594408062|FG001|Overall Study|Protocol Violation|2|||
164556406|NCT04312009|594408068|FG000|Overall Study|Withdrawal by Subject|2|||
164556407|NCT04312009|594408069|FG001|Overall Study|Withdrawal by Subject|1|||
164556408|NCT01363986|594408070|FG000|Overall Study|Disease progression|1|||
164556409|NCT02605642|594408074|FG000|Overall Study|Other|11|||
164556410|NCT02605642|594408075|FG001|Overall Study|Other|1|||
164556411|NCT02605642|594408074|FG000|Overall Study|Participant non-compliance|2|||
164556412|NCT02605642|594408075|FG001|Overall Study|Participant non-compliance|4|||
164556413|NCT02605642|594408074|FG000|Overall Study|Physician Decision|10|||
164556414|NCT02605642|594408075|FG001|Overall Study|Physician Decision|0|||
164556415|NCT02605642|594408074|FG000|Overall Study|Lost to Follow-up|12|||
164556416|NCT02605642|594408075|FG001|Overall Study|Lost to Follow-up|1|||
164556417|NCT02605642|594408074|FG000|Overall Study|Adverse Event|14|||
164556418|NCT02605642|594408075|FG001|Overall Study|Adverse Event|2|||
164556419|NCT02605642|594408074|FG000|Overall Study|Withdrawal by Subject|23|||
164556420|NCT02605642|594408075|FG001|Overall Study|Withdrawal by Subject|2|||
164556421|NCT02605642|594408074|FG000|Overall Study|Lack of response|24|||
164556422|NCT02605642|594408075|FG001|Overall Study|Lack of response|11|||
164556423|NCT02111564|594408084|FG000|Overall Study|Death|109|||
164556424|NCT02111564|594408085|FG001|Overall Study|Death|120|||
164556425|NCT02111564|594408084|FG000|Overall Study|Lost to Follow-up|2|||
164556426|NCT02111564|594408085|FG001|Overall Study|Lost to Follow-up|3|||
164556427|NCT02111564|594408084|FG000|Overall Study|Withdrawal by Subject|20|||
164556428|NCT02111564|594408085|FG001|Overall Study|Withdrawal by Subject|20|||
164556429|NCT00687362|594408086|FG000|Overall Study|Protocol Violation|2|||
164556430|NCT00687362|594408086|FG000|Overall Study|Withdrawal by Subject|1|||
164556431|NCT02354703|594408087|FG000|Overall Study|Withdrawal by Subject|1|||
164556432|NCT02354703|594408088|FG001|Overall Study|Withdrawal by Subject|1|||
164556433|NCT02354703|594408089|FG002|Overall Study|Withdrawal by Subject|1|||
164556434|NCT02354703|594408090|FG003|Overall Study|Withdrawal by Subject|1|||
164556435|NCT02354703|594408087|FG000|Overall Study|Lost to Follow-up|2|||
164556436|NCT02354703|594408088|FG001|Overall Study|Lost to Follow-up|7|||
164556437|NCT02354703|594408089|FG002|Overall Study|Lost to Follow-up|9|||
164202688|NCT00706797|593115172|FG001|Overall Study|Other|0|||
164202689|NCT03502798|593115173|FG000|Overall Study|equipment failure|0|||
164202690|NCT03502798|593115174|FG001|Overall Study|equipment failure|7|||
164202691|NCT01027845|593115178|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
164556438|NCT02354703|594408090|FG003|Overall Study|Lost to Follow-up|2|||
164556439|NCT02354703|594408087|FG000|Overall Study|Adverse Event|0|||
164556440|NCT02354703|594408088|FG001|Overall Study|Adverse Event|0|||
164556441|NCT02354703|594408089|FG002|Overall Study|Adverse Event|1|||
164556442|NCT02354703|594408090|FG003|Overall Study|Adverse Event|0|||
164556443|NCT00699348|594408092|FG000|Overall Study|Death|6|||
164556444|NCT00699348|594408092|FG000|Overall Study|Adverse Event|15|||
164556445|NCT00699348|594408092|FG000|Overall Study|Withdrawal by Subject|11|||
164556446|NCT00699348|594408092|FG000|Overall Study|Protocol Violation|10|||
164556447|NCT00699348|594408092|FG000|Overall Study|Lack of Efficacy|8|||
164556448|NCT00699348|594408092|FG000|Overall Study|Failure to return|1|||
164556449|NCT00699348|594408092|FG000|Overall Study|Blood transfusion|24|||
164660721|NCT00455533|594783501|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
164660722|NCT00455533|594783499|FG000|Period Two: Randomized Period|Other - need reasons|0|||
164660723|NCT00455533|594783500|FG001|Period Two: Randomized Period|Other - need reasons|1|||
164660724|NCT00455533|594783501|FG002|Period Two: Randomized Period|Other - need reasons|0|||
164660725|NCT00455533|594783499|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
164660726|NCT00455533|594783500|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
164660727|NCT00455533|594783501|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
164660728|NCT00455533|594783499|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
164660729|NCT00455533|594783500|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
164660730|NCT00455533|594783501|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
164660731|NCT01896297|594783502|FG000|Overall Study|Died in post treatment phase|1|||
164660732|NCT02415959|594783503|FG000|Overall Study|Adverse Event|0|||
164202692|NCT01027845|593115179|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
164202693|NCT01027845|593115180|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
164202694|NCT01027845|593115181|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
164202695|NCT01027845|593115178|FG000|Primary Vaccination Phase|Adverse Event|1|||
164202696|NCT01027845|593115179|FG001|Primary Vaccination Phase|Adverse Event|0|||
164202697|NCT01027845|593115180|FG002|Primary Vaccination Phase|Adverse Event|0|||
164202698|NCT01027845|593115181|FG003|Primary Vaccination Phase|Adverse Event|0|||
164202699|NCT01027845|593115178|FG000|Primary Vaccination Phase|Protocol Violation|1|||
164202700|NCT01027845|593115179|FG001|Primary Vaccination Phase|Protocol Violation|0|||
164202701|NCT01027845|593115180|FG002|Primary Vaccination Phase|Protocol Violation|0|||
164202702|NCT01027845|593115181|FG003|Primary Vaccination Phase|Protocol Violation|0|||
164202703|NCT01027845|593115178|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
164202704|NCT01027845|593115179|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
164202705|NCT01027845|593115180|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
164556450|NCT00699348|594408092|FG000|Overall Study|Renal transplantation|10|||
164556451|NCT00699348|594408092|FG000|Overall Study|Other|5|||
164660733|NCT02415959|594783504|FG001|Overall Study|Adverse Event|1|||
164660734|NCT02415959|594783505|FG002|Overall Study|Adverse Event|0|||
164660735|NCT02415959|594783506|FG003|Overall Study|Adverse Event|0|||
164660736|NCT02415959|594783507|FG004|Overall Study|Adverse Event|0|||
164660737|NCT02415959|594783503|FG000|Overall Study|Protocol Violation|0|||
164660738|NCT02415959|594783504|FG001|Overall Study|Protocol Violation|0|||
164660739|NCT02415959|594783505|FG002|Overall Study|Protocol Violation|0|||
164660740|NCT02415959|594783506|FG003|Overall Study|Protocol Violation|1|||
164660741|NCT02415959|594783507|FG004|Overall Study|Protocol Violation|0|||
164660742|NCT03626857|594783518|FG000|Overall Study|Adverse Event|9|||
164660743|NCT03626857|594783519|FG001|Overall Study|Adverse Event|7|||
164660744|NCT03626857|594783518|FG000|Overall Study|Lost to Follow-up|8|||
164660745|NCT03626857|594783519|FG001|Overall Study|Lost to Follow-up|8|||
164660746|NCT03626857|594783518|FG000|Overall Study|Withdrawal by Subject|2|||
164660747|NCT03626857|594783519|FG001|Overall Study|Withdrawal by Subject|2|||
164660748|NCT03626857|594783518|FG000|Overall Study|Protocol Violation|1|||
164660749|NCT03626857|594783519|FG001|Overall Study|Protocol Violation|3|||
164660750|NCT01301833|594783520|FG000|Overall Study|Adverse Event|7|||
164660751|NCT01301833|594783521|FG001|Overall Study|Adverse Event|5|||
164660752|NCT01301833|594783522|FG002|Overall Study|Adverse Event|5|||
164660753|NCT01301833|594783523|FG003|Overall Study|Adverse Event|5|||
164660754|NCT01301833|594783520|FG000|Overall Study|Lack of Efficacy|1|||
164660755|NCT01301833|594783521|FG001|Overall Study|Lack of Efficacy|1|||
164660756|NCT01301833|594783522|FG002|Overall Study|Lack of Efficacy|0|||
164202706|NCT01027845|593115181|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
164202707|NCT01027845|593115178|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
164202708|NCT01027845|593115179|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
164202709|NCT01027845|593115180|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
164556452|NCT00122135|594408093|FG000|Overall Study|Withdrawal by Subject|3|||
164556453|NCT00122135|594408094|FG001|Overall Study|Withdrawal by Subject|0|||
164556454|NCT03269344|594408095|FG000|Overall Study|Protocol Violation|4|||
164556455|NCT03269344|594408096|FG001|Overall Study|Protocol Violation|3|||
164556456|NCT04478708|594408099|FG000|Overall Study|Lost to Follow-up|0|||
164556457|NCT04478708|594408100|FG001|Overall Study|Lost to Follow-up|0|||
164556458|NCT04478708|594408101|FG002|Overall Study|Lost to Follow-up|0|||
164556459|NCT04478708|594408102|FG003|Overall Study|Lost to Follow-up|0|||
164556460|NCT04478708|594408103|FG004|Overall Study|Lost to Follow-up|0|||
164202710|NCT01027845|593115181|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
164556461|NCT04478708|594408104|FG005|Overall Study|Lost to Follow-up|0|||
164556462|NCT04478708|594408105|FG006|Overall Study|Lost to Follow-up|0|||
164556463|NCT04478708|594408106|FG007|Overall Study|Lost to Follow-up|0|||
164556464|NCT04478708|594408107|FG008|Overall Study|Lost to Follow-up|1|||
164660757|NCT01301833|594783523|FG003|Overall Study|Lack of Efficacy|0|||
164660758|NCT01301833|594783520|FG000|Overall Study|Physician Decision|3|||
164660759|NCT01301833|594783521|FG001|Overall Study|Physician Decision|1|||
164660760|NCT01301833|594783522|FG002|Overall Study|Physician Decision|1|||
164660761|NCT01301833|594783523|FG003|Overall Study|Physician Decision|0|||
164660762|NCT01301833|594783520|FG000|Overall Study|Withdrawal by Subject|3|||
164660763|NCT01301833|594783521|FG001|Overall Study|Withdrawal by Subject|1|||
164660764|NCT01301833|594783522|FG002|Overall Study|Withdrawal by Subject|1|||
164313104|NCT02082340|593522692|FG001|Overall Study|Lost to Follow-up|1|||
164313105|NCT00833417|593522693|FG000|Overall Study|Adverse Event|5|||
164313106|NCT00833417|593522694|FG001|Overall Study|Adverse Event|16|||
164313107|NCT00833417|593522693|FG000|Overall Study|Death|1|||
164313108|NCT00833417|593522694|FG001|Overall Study|Death|3|||
164313109|NCT00833417|593522693|FG000|Overall Study|Lost to Follow-up|1|||
164313110|NCT00833417|593522694|FG001|Overall Study|Lost to Follow-up|2|||
164420606|NCT01890967|593910951|FG005|Overall Study|Protocol Violation|1|||
164556465|NCT04478708|594408108|FG009|Overall Study|Lost to Follow-up|1|||
164556466|NCT04478708|594408109|FG010|Overall Study|Lost to Follow-up|1|||
164556467|NCT04478708|594408110|FG011|Overall Study|Lost to Follow-up|2|||
164556468|NCT04478708|594408111|FG012|Overall Study|Lost to Follow-up|1|||
164556469|NCT04478708|594408112|FG013|Overall Study|Lost to Follow-up|0|||
164556470|NCT04478708|594408113|FG014|Overall Study|Lost to Follow-up|0|||
164556471|NCT04478708|594408114|FG015|Overall Study|Lost to Follow-up|0|||
164556472|NCT04478708|594408115|FG016|Overall Study|Lost to Follow-up|0|||
164556473|NCT04478708|594408099|FG000|Overall Study|Withdrawal of consent from study|0|||
164556474|NCT04478708|594408100|FG001|Overall Study|Withdrawal of consent from study|1|||
164556475|NCT04478708|594408101|FG002|Overall Study|Withdrawal of consent from study|2|||
164556476|NCT04478708|594408102|FG003|Overall Study|Withdrawal of consent from study|0|||
164556477|NCT04478708|594408103|FG004|Overall Study|Withdrawal of consent from study|1|||
164556478|NCT04478708|594408104|FG005|Overall Study|Withdrawal of consent from study|1|||
164556479|NCT04478708|594408105|FG006|Overall Study|Withdrawal of consent from study|1|||
164556480|NCT04478708|594408106|FG007|Overall Study|Withdrawal of consent from study|0|||
164556481|NCT04478708|594408107|FG008|Overall Study|Withdrawal of consent from study|0|||
164556482|NCT04478708|594408108|FG009|Overall Study|Withdrawal of consent from study|0|||
164556483|NCT04478708|594408109|FG010|Overall Study|Withdrawal of consent from study|4|||
164556484|NCT04478708|594408110|FG011|Overall Study|Withdrawal of consent from study|3|||
164556485|NCT04478708|594408111|FG012|Overall Study|Withdrawal of consent from study|0|||
164556486|NCT04478708|594408112|FG013|Overall Study|Withdrawal of consent from study|0|||
164556487|NCT04478708|594408113|FG014|Overall Study|Withdrawal of consent from study|1|||
164556488|NCT04478708|594408114|FG015|Overall Study|Withdrawal of consent from study|0|||
164556489|NCT04478708|594408115|FG016|Overall Study|Withdrawal of consent from study|4|||
164556490|NCT01869114|594408118|FG000|Overall Study|Death|19|||
164556491|NCT01869114|594408119|FG001|Overall Study|Death|18|||
164556492|NCT01869114|594408120|FG002|Overall Study|Death|8|||
164556493|NCT01869114|594408118|FG000|Overall Study|Adverse Event/Side Effects/Complications|0|||
164556494|NCT01869114|594408119|FG001|Overall Study|Adverse Event/Side Effects/Complications|1|||
164556495|NCT01869114|594408120|FG002|Overall Study|Adverse Event/Side Effects/Complications|0|||
164556496|NCT01869114|594408118|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
164556497|NCT01869114|594408119|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
164556498|NCT01869114|594408120|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
164556499|NCT01869114|594408118|FG000|Overall Study|Withdrawal by Subject|0|||
164556500|NCT01869114|594408119|FG001|Overall Study|Withdrawal by Subject|3|||
164556501|NCT01869114|594408120|FG002|Overall Study|Withdrawal by Subject|0|||
164556502|NCT01869114|594408118|FG000|Overall Study|Disease Progression|0|||
164556503|NCT01869114|594408119|FG001|Overall Study|Disease Progression|1|||
164556504|NCT01869114|594408120|FG002|Overall Study|Disease Progression|0|||
164556505|NCT00179309|594408123|FG000|Treatment|Toxicity|2|||
164556506|NCT00179309|594408124|FG001|Treatment|Toxicity|3|||
164556507|NCT00179309|594408123|FG000|Treatment|Withdrawal by Subject|1|||
164556508|NCT00179309|594408124|FG001|Treatment|Withdrawal by Subject|2|||
164556509|NCT00179309|594408123|FG000|Treatment|Allergy|1|||
164556510|NCT00179309|594408124|FG001|Treatment|Allergy|0|||
164556511|NCT01289015|594408128|FG000|Overall Study|Protocol Violation|12|||
164556512|NCT01289015|594408129|FG001|Overall Study|Protocol Violation|9|||
164556513|NCT01289015|594408128|FG000|Overall Study|Adverse Event|3|||
164556514|NCT01289015|594408129|FG001|Overall Study|Adverse Event|0|||
164556515|NCT01289015|594408128|FG000|Overall Study|Lost to Follow-up|33|||
164556516|NCT01289015|594408129|FG001|Overall Study|Lost to Follow-up|17|||
164556517|NCT01289015|594408128|FG000|Overall Study|Withdrawal by Subject|17|||
164556518|NCT01289015|594408129|FG001|Overall Study|Withdrawal by Subject|8|||
164556519|NCT01289015|594408128|FG000|Overall Study|Disease progression|1|||
164556520|NCT01289015|594408129|FG001|Overall Study|Disease progression|0|||
164313111|NCT00833417|593522693|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
164556521|NCT01289015|594408128|FG000|Overall Study|Negative baseline culture and others|33|||
164556522|NCT01289015|594408129|FG001|Overall Study|Negative baseline culture and others|20|||
164556523|NCT05980299|594408132|FG000|Overall Study|Death|28|||
164556524|NCT05980299|594408133|FG001|Overall Study|Death|0|||
164556525|NCT05980299|594408132|FG000|Overall Study|Discharged from Nursing Home|9|||
164556526|NCT05980299|594408133|FG001|Overall Study|Discharged from Nursing Home|0|||
164556527|NCT05980299|594408132|FG000|Overall Study|Lost to Follow-up|0|||
164556528|NCT05980299|594408133|FG001|Overall Study|Lost to Follow-up|10|||
164556529|NCT05048342|594408142|FG000|Overall Study|Adverse Event|1|||
164556530|NCT05048342|594408142|FG000|Overall Study|Subject decision|2|||
164556531|NCT01441063|594408143|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
164313112|NCT00833417|593522694|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
164313113|NCT00833417|593522693|FG000|Overall Study|Patient Decision to Withdraw|4|||
164313114|NCT00833417|593522694|FG001|Overall Study|Patient Decision to Withdraw|23|||
164313115|NCT00833417|593522693|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
164202711|NCT01027845|593115178|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
164313116|NCT00833417|593522694|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
164313117|NCT00833417|593522693|FG000|Overall Study|Disease Progression|18|||
164556532|NCT01441063|594408143|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
164556533|NCT04418765|594408144|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
164202712|NCT01027845|593115179|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
164202713|NCT01027845|593115180|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
164202714|NCT01027845|593115181|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
164202715|NCT01281306|593115182|FG000|Overall Study|Lack of Efficacy|0|||
164202716|NCT01281306|593115183|FG001|Overall Study|Lack of Efficacy|1|||
164202717|NCT01281306|593115184|FG002|Overall Study|Lack of Efficacy|3|||
164202718|NCT01281306|593115185|FG003|Overall Study|Lack of Efficacy|0|||
164202719|NCT01281306|593115186|FG004|Overall Study|Lack of Efficacy|2|||
164202720|NCT01281306|593115187|FG005|Overall Study|Lack of Efficacy|0|||
164202721|NCT01281306|593115188|FG006|Overall Study|Lack of Efficacy|1|||
164202722|NCT01281306|593115182|FG000|Overall Study|Withdrawal by Subject|1|||
164202723|NCT01281306|593115183|FG001|Overall Study|Withdrawal by Subject|0|||
164202724|NCT01281306|593115184|FG002|Overall Study|Withdrawal by Subject|2|||
164202725|NCT01281306|593115185|FG003|Overall Study|Withdrawal by Subject|4|||
164202726|NCT01281306|593115186|FG004|Overall Study|Withdrawal by Subject|1|||
164202727|NCT01281306|593115187|FG005|Overall Study|Withdrawal by Subject|3|||
164202728|NCT01281306|593115188|FG006|Overall Study|Withdrawal by Subject|1|||
164202729|NCT01281306|593115182|FG000|Overall Study|Protocol deviation|0|||
164202730|NCT01281306|593115183|FG001|Overall Study|Protocol deviation|1|||
164202731|NCT01281306|593115184|FG002|Overall Study|Protocol deviation|1|||
164202732|NCT01281306|593115185|FG003|Overall Study|Protocol deviation|1|||
164202733|NCT01281306|593115186|FG004|Overall Study|Protocol deviation|1|||
164202734|NCT01281306|593115187|FG005|Overall Study|Protocol deviation|0|||
164202735|NCT01281306|593115188|FG006|Overall Study|Protocol deviation|0|||
164202736|NCT01281306|593115182|FG000|Overall Study|Condition no longer requires study drug|1|||
164202737|NCT01281306|593115183|FG001|Overall Study|Condition no longer requires study drug|0|||
164202738|NCT01281306|593115184|FG002|Overall Study|Condition no longer requires study drug|0|||
164202739|NCT01281306|593115185|FG003|Overall Study|Condition no longer requires study drug|0|||
164202740|NCT01281306|593115186|FG004|Overall Study|Condition no longer requires study drug|0|||
164202741|NCT01281306|593115187|FG005|Overall Study|Condition no longer requires study drug|1|||
164202742|NCT01281306|593115188|FG006|Overall Study|Condition no longer requires study drug|1|||
164202743|NCT01281306|593115182|FG000|Overall Study|Lost to Follow-up|1|||
164202744|NCT01281306|593115183|FG001|Overall Study|Lost to Follow-up|0|||
164202745|NCT01281306|593115184|FG002|Overall Study|Lost to Follow-up|0|||
164202746|NCT01281306|593115185|FG003|Overall Study|Lost to Follow-up|2|||
164202747|NCT01281306|593115186|FG004|Overall Study|Lost to Follow-up|0|||
164202748|NCT01281306|593115187|FG005|Overall Study|Lost to Follow-up|0|||
164202749|NCT01281306|593115188|FG006|Overall Study|Lost to Follow-up|1|||
164202750|NCT01281306|593115182|FG000|Overall Study|Death|1|||
164202751|NCT01281306|593115183|FG001|Overall Study|Death|0|||
164202752|NCT01281306|593115184|FG002|Overall Study|Death|0|||
164202753|NCT01281306|593115185|FG003|Overall Study|Death|0|||
164202754|NCT01281306|593115186|FG004|Overall Study|Death|0|||
164202755|NCT01281306|593115187|FG005|Overall Study|Death|0|||
164202756|NCT01281306|593115188|FG006|Overall Study|Death|0|||
164202757|NCT01281306|593115182|FG000|Overall Study|Adverse Event|3|||
164202758|NCT01281306|593115183|FG001|Overall Study|Adverse Event|2|||
164202759|NCT01281306|593115184|FG002|Overall Study|Adverse Event|2|||
164202760|NCT01281306|593115185|FG003|Overall Study|Adverse Event|3|||
164202761|NCT01281306|593115186|FG004|Overall Study|Adverse Event|5|||
164202762|NCT01281306|593115187|FG005|Overall Study|Adverse Event|3|||
164556534|NCT04418765|594408145|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
164556535|NCT04418765|594408146|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
164556536|NCT04418765|594408144|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
164556537|NCT04418765|594408145|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
164556538|NCT04418765|594408146|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
164202763|NCT01281306|593115188|FG006|Overall Study|Adverse Event|3|||
164202764|NCT01281306|593115182|FG000|Overall Study|Randomized in error|1|||
164202765|NCT01281306|593115183|FG001|Overall Study|Randomized in error|0|||
164202766|NCT01281306|593115184|FG002|Overall Study|Randomized in error|0|||
164202767|NCT01281306|593115185|FG003|Overall Study|Randomized in error|1|||
164202768|NCT01281306|593115186|FG004|Overall Study|Randomized in error|0|||
164202769|NCT01281306|593115187|FG005|Overall Study|Randomized in error|0|||
164202770|NCT01281306|593115188|FG006|Overall Study|Randomized in error|0|||
164202771|NCT00368550|593115189|FG000|Overall Study|Adverse Event|7|||
164202772|NCT00368550|593115190|FG001|Overall Study|Adverse Event|4|||
164313118|NCT00833417|593522694|FG001|Overall Study|Disease Progression|17|||
164313119|NCT00833417|593522693|FG000|Overall Study|Reason Not Specified|0|||
164313120|NCT00833417|593522694|FG001|Overall Study|Reason Not Specified|1|||
164313121|NCT01625260|593522695|FG000|Overall Study|Adverse Event|3|||
164313122|NCT01625260|593522696|FG001|Overall Study|Adverse Event|0|||
164313123|NCT01625260|593522695|FG000|Overall Study|Study Terminated by Investigator|2|||
164313124|NCT01625260|593522696|FG001|Overall Study|Study Terminated by Investigator|0|||
164313125|NCT01625260|593522695|FG000|Overall Study|Disease Progression|2|||
164313126|NCT01625260|593522696|FG001|Overall Study|Disease Progression|0|||
164313127|NCT01625260|593522695|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
164313128|NCT01625260|593522696|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
164313129|NCT05573386|593522697|FG000|Overall Study|Withdrawal by Subject|3|||
164313130|NCT05573386|593522698|FG001|Overall Study|Withdrawal by Subject|2|||
164313131|NCT03899805|593522699|FG000|Overall Study|Physician Decision|3|||
164313132|NCT03899805|593522700|FG001|Overall Study|Physician Decision|0|||
164313133|NCT03899805|593522701|FG002|Overall Study|Physician Decision|2|||
164313134|NCT03899805|593522699|FG000|Overall Study|Withdrawal by Subject|1|||
164313135|NCT03899805|593522700|FG001|Overall Study|Withdrawal by Subject|0|||
164313136|NCT03899805|593522701|FG002|Overall Study|Withdrawal by Subject|2|||
164313137|NCT03899805|593522699|FG000|Overall Study|Progressive Disease|10|||
164313138|NCT03899805|593522700|FG001|Overall Study|Progressive Disease|18|||
164313139|NCT03899805|593522701|FG002|Overall Study|Progressive Disease|12|||
164313140|NCT03899805|593522699|FG000|Overall Study|Adverse Event|3|||
164313141|NCT03899805|593522700|FG001|Overall Study|Adverse Event|1|||
164313142|NCT03899805|593522701|FG002|Overall Study|Adverse Event|0|||
164313143|NCT03899805|593522699|FG000|Overall Study|Death|2|||
164556539|NCT04418765|594408144|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
164556540|NCT04418765|594408145|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
164556541|NCT04418765|594408146|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
164556542|NCT04418765|594408144|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
164556543|NCT04418765|594408145|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
164556544|NCT04418765|594408146|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
164556545|NCT04418765|594408144|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
164556546|NCT04418765|594408145|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
164556547|NCT04418765|594408146|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
164556548|NCT04418765|594408144|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
164556549|NCT04418765|594408145|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
164556550|NCT04418765|594408146|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
164556551|NCT04418765|594408144|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
164556552|NCT04418765|594408145|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
164556553|NCT04418765|594408146|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
164556554|NCT04418765|594408144|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
164556555|NCT04418765|594408145|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
164556556|NCT04418765|594408146|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
164556557|NCT04418765|594408144|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
164556558|NCT04418765|594408145|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
164556559|NCT04418765|594408146|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
164556560|NCT04418765|594408144|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
164556561|NCT04418765|594408145|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
164556562|NCT04418765|594408146|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
164556563|NCT04418765|594408144|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
164556564|NCT04418765|594408145|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
164556565|NCT04418765|594408146|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
164556566|NCT04418765|594408144|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
164556567|NCT04418765|594408145|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
164556568|NCT04418765|594408146|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
164556569|NCT04418765|594408144|FG000|Extension Period (48 Weeks)|Other than specified|0|||
164556570|NCT04418765|594408145|FG001|Extension Period (48 Weeks)|Other than specified|5|||
164313144|NCT03899805|593522700|FG001|Overall Study|Death|0|||
164313145|NCT03899805|593522701|FG002|Overall Study|Death|0|||
164313146|NCT03899805|593522699|FG000|Overall Study|Came off for surgery|0|||
164313147|NCT03899805|593522700|FG001|Overall Study|Came off for surgery|0|||
164556571|NCT04418765|594408146|FG002|Extension Period (48 Weeks)|Other than specified|2|||
164556572|NCT03345472|594408151|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
164556573|NCT03345472|594408151|FG000|Implant to 3 Months|Physician Decision|1|||
164556574|NCT03345472|594408151|FG000|Implant to 3 Months|Adverse Event|1|||
164556575|NCT03345472|594408151|FG000|3 Months to 12 Months|Physician Decision|3|||
164556576|NCT03345472|594408151|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
164556577|NCT03345472|594408151|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
164313148|NCT03899805|593522701|FG002|Overall Study|Came off for surgery|1|||
164313149|NCT05246514|593522702|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
164660765|NCT01301833|594783523|FG003|Overall Study|Withdrawal by Subject|2|||
164660766|NCT01301833|594783520|FG000|Overall Study|Personal matter|1|||
164660767|NCT01301833|594783521|FG001|Overall Study|Personal matter|0|||
164660768|NCT01301833|594783522|FG002|Overall Study|Personal matter|0|||
164660769|NCT01301833|594783523|FG003|Overall Study|Personal matter|0|||
164660770|NCT02178709|594784959|FG000|Overall Study|Adverse Event|5|||
164660771|NCT02178709|594784959|FG000|Overall Study|Death|2|||
164660772|NCT02178709|594784959|FG000|Overall Study|Withdrawal by Subject|2|||
164660773|NCT02178709|594784959|FG000|Overall Study|Physician Decision|2|||
164660774|NCT02178709|594784959|FG000|Overall Study|Disease Progression|5|||
164660775|NCT01402908|594784962|FG000|Overall Study|Withdrawal by Subject|30|||
164660776|NCT01402908|594784963|FG001|Overall Study|Withdrawal by Subject|17|||
164660777|NCT01402908|594784962|FG000|Overall Study|Lost to Follow-up|3|||
164660778|NCT01402908|594784963|FG001|Overall Study|Lost to Follow-up|1|||
164660779|NCT01402908|594784962|FG000|Overall Study|Physician Decision|1|||
164660780|NCT01402908|594784963|FG001|Overall Study|Physician Decision|0|||
164660781|NCT01739790|594784964|FG000|Overall Study|Early Trial Termination|2|||
164660782|NCT01739790|594784965|FG001|Overall Study|Early Trial Termination|4|||
164660783|NCT02192905|594784967|FG000|Overall Study|Lost to Follow-up|1|||
164660784|NCT04820842|594784968|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
164660785|NCT04820842|594784969|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
164660786|NCT04820842|594784970|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
164660787|NCT04820842|594784971|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
164660788|NCT04820842|594784972|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
164660789|NCT04820842|594784973|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
164660790|NCT04820842|594784974|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
164660791|NCT04820842|594784968|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
164660792|NCT04820842|594784969|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
164660793|NCT04820842|594784970|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
164660794|NCT04820842|594784971|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
164660795|NCT04820842|594784972|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
164660796|NCT04820842|594784973|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
164660797|NCT04820842|594784974|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
164660798|NCT04820842|594784968|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
164660799|NCT04820842|594784969|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
164660800|NCT04820842|594784970|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
164660801|NCT04820842|594784971|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
164660802|NCT04820842|594784972|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
164660803|NCT04820842|594784973|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
164660804|NCT04820842|594784974|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
164660805|NCT04820842|594784968|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
164660806|NCT04820842|594784969|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
164660807|NCT04820842|594784970|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
164660808|NCT04820842|594784971|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
164660809|NCT04820842|594784972|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
164660810|NCT04820842|594784973|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
164660811|NCT04820842|594784974|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
164660812|NCT01691508|594784975|FG000|Overall Study|Adverse Event|3|||
164660813|NCT01691508|594784976|FG001|Overall Study|Adverse Event|3|||
164660814|NCT01691508|594784975|FG000|Overall Study|Withdrawal by Subject|1|||
164660815|NCT01691508|594784976|FG001|Overall Study|Withdrawal by Subject|0|||
164660816|NCT01296932|594784977|FG000|Overall Study|Dose limiting toxicity|0|||
164660817|NCT01296932|594784978|FG001|Overall Study|Dose limiting toxicity|0|||
164660818|NCT01296932|594784979|FG002|Overall Study|Dose limiting toxicity|0|||
164660819|NCT01296932|594784980|FG003|Overall Study|Dose limiting toxicity|0|||
164660820|NCT01296932|594784981|FG004|Overall Study|Dose limiting toxicity|0|||
164313150|NCT05246514|593522702|FG000|Overall Study|Withdrawal by Subject|1|||
164313151|NCT05246514|593522702|FG000|Overall Study|Death|13|||
164313152|NCT04195893|593522703|FG000|Second Intervention|Withdrawal by Subject|1|||
164313153|NCT04195893|593522704|FG001|Second Intervention|Withdrawal by Subject|0|||
164313154|NCT01802073|593522705|FG000|Overall Study|Lost to Follow-up|0|||
164313155|NCT01802073|593522706|FG001|Overall Study|Lost to Follow-up|1|||
164313156|NCT01802073|593522705|FG000|Overall Study|Non-compliant|4|||
164313157|NCT01802073|593522706|FG001|Overall Study|Non-compliant|2|||
164660821|NCT01296932|594784982|FG005|Overall Study|Dose limiting toxicity|0|||
164313158|NCT01802073|593522705|FG000|Overall Study|Withdrawal by Subject|1|||
164660822|NCT01296932|594784983|FG006|Overall Study|Dose limiting toxicity|1|||
164660823|NCT01296932|594784984|FG007|Overall Study|Dose limiting toxicity|0|||
164660824|NCT01296932|594784985|FG008|Overall Study|Dose limiting toxicity|1|||
164660825|NCT01296932|594784977|FG000|Overall Study|Progressive disease|2|||
164660826|NCT01296932|594784978|FG001|Overall Study|Progressive disease|0|||
164313159|NCT01802073|593522706|FG001|Overall Study|Withdrawal by Subject|1|||
164313160|NCT01802073|593522705|FG000|Overall Study|Physician Decision|0|||
164313161|NCT01802073|593522706|FG001|Overall Study|Physician Decision|7|||
164660827|NCT01296932|594784979|FG002|Overall Study|Progressive disease|1|||
164660828|NCT01296932|594784980|FG003|Overall Study|Progressive disease|1|||
164660829|NCT01296932|594784981|FG004|Overall Study|Progressive disease|2|||
164660830|NCT01296932|594784982|FG005|Overall Study|Progressive disease|3|||
164313162|NCT01327482|593522712|FG000|Overall Study|Adverse Event|1|||
164313163|NCT01018810|593522713|FG000|Overall Study|Withdrawal by Subject|0|||
164313164|NCT01018810|593522714|FG001|Overall Study|Withdrawal by Subject|1|||
164313165|NCT01018810|593522715|FG002|Overall Study|Withdrawal by Subject|0|||
164313166|NCT01018810|593522716|FG003|Overall Study|Withdrawal by Subject|0|||
164313167|NCT01018810|593522717|FG004|Overall Study|Withdrawal by Subject|0|||
164313168|NCT01018810|593522713|FG000|Overall Study|Sponsor Decision|2|||
164313169|NCT01018810|593522714|FG001|Overall Study|Sponsor Decision|0|||
164313170|NCT01018810|593522715|FG002|Overall Study|Sponsor Decision|1|||
164313171|NCT01018810|593522716|FG003|Overall Study|Sponsor Decision|1|||
164313172|NCT01018810|593522717|FG004|Overall Study|Sponsor Decision|1|||
164313173|NCT03672097|593522718|FG000|Period 1|Withdrawal by Subject|2|||
164313174|NCT03672097|593522718|FG000|Period 1|Adverse Event|1|||
164313175|NCT03672097|593522718|FG000|Period 1|Did not receive treatment|1|||
164313176|NCT03672097|593522718|FG000|Period 2|Withdrawal by Subject|3|||
164313177|NCT03672097|593522718|FG000|Period 2|Other|1|||
164313178|NCT00080899|593522719|FG000|Overall Study|Adverse Event|1|||
164313179|NCT02872935|593522720|FG000|Overall Study|Other|0|||
164313180|NCT02872935|593522721|FG001|Overall Study|Other|1|||
164313181|NCT03530124|593522722|FG000|Overall Study|Withdrawal by Subject|0|||
164313182|NCT03530124|593522723|FG001|Overall Study|Withdrawal by Subject|1|||
164313183|NCT03530124|593522722|FG000|Overall Study|Protocol Violation|1|||
164313184|NCT03530124|593522723|FG001|Overall Study|Protocol Violation|0|||
164313185|NCT03530124|593522722|FG000|Overall Study|Discharged prior to study completion|1|||
164313186|NCT03530124|593522723|FG001|Overall Study|Discharged prior to study completion|0|||
164313187|NCT05343624|593522724|FG000|Overall Study|Chart review not completed|1|||
164313188|NCT00530816|593522725|FG000|Overall Study|Progressive Disease|16|||
164313189|NCT00530816|593522726|FG001|Overall Study|Progressive Disease|24|||
164313190|NCT00530816|593522727|FG002|Overall Study|Progressive Disease|24|||
164313191|NCT00530816|593522725|FG000|Overall Study|Adverse Event|6|||
164660831|NCT01296932|594784983|FG006|Overall Study|Progressive disease|1|||
164660832|NCT01296932|594784984|FG007|Overall Study|Progressive disease|0|||
164660833|NCT01296932|594784985|FG008|Overall Study|Progressive disease|0|||
164660834|NCT01296932|594784977|FG000|Overall Study|Withdrawal by Subject|0|||
164660835|NCT01296932|594784978|FG001|Overall Study|Withdrawal by Subject|0|||
164660836|NCT01296932|594784979|FG002|Overall Study|Withdrawal by Subject|1|||
164660837|NCT01296932|594784980|FG003|Overall Study|Withdrawal by Subject|1|||
164660838|NCT01296932|594784981|FG004|Overall Study|Withdrawal by Subject|0|||
164313192|NCT00530816|593522726|FG001|Overall Study|Adverse Event|13|||
164313193|NCT00530816|593522727|FG002|Overall Study|Adverse Event|7|||
164313194|NCT00530816|593522725|FG000|Overall Study|Other|3|||
164313195|NCT00530816|593522726|FG001|Overall Study|Other|3|||
164313196|NCT00530816|593522727|FG002|Overall Study|Other|4|||
164313197|NCT00530816|593522725|FG000|Overall Study|Withdrawal by Subject|1|||
164313198|NCT00530816|593522726|FG001|Overall Study|Withdrawal by Subject|2|||
164313199|NCT00530816|593522727|FG002|Overall Study|Withdrawal by Subject|6|||
164313200|NCT02445794|593522728|FG000|Overall Study|Adverse Event|0|||
164313201|NCT02445794|593522729|FG001|Overall Study|Adverse Event|0|||
164313202|NCT02445794|593522730|FG002|Overall Study|Adverse Event|2|||
164313203|NCT02445794|593522731|FG003|Overall Study|Adverse Event|0|||
164313204|NCT01388985|593522732|FG000|Overall Study|Death|0|||
164313205|NCT01388985|593522733|FG001|Overall Study|Death|1|||
164313206|NCT01388985|593522732|FG000|Overall Study|Lost to Follow-up|30|||
164313207|NCT01388985|593522733|FG001|Overall Study|Lost to Follow-up|30|||
164313208|NCT01388985|593522732|FG000|Overall Study|Withdrawal by Subject|13|||
164313209|NCT01388985|593522733|FG001|Overall Study|Withdrawal by Subject|4|||
164313210|NCT01388985|593522732|FG000|Overall Study|Subject unavailable|1|||
164313211|NCT01388985|593522733|FG001|Overall Study|Subject unavailable|1|||
164313212|NCT01388985|593522732|FG000|Overall Study|Other (no reason)|0|||
164313213|NCT01388985|593522733|FG001|Overall Study|Other (no reason)|1|||
164313214|NCT01388985|593522732|FG000|Overall Study|Error of nurse|5|||
164660839|NCT01296932|594784982|FG005|Overall Study|Withdrawal by Subject|0|||
164660840|NCT01296932|594784983|FG006|Overall Study|Withdrawal by Subject|3|||
164660841|NCT01296932|594784984|FG007|Overall Study|Withdrawal by Subject|0|||
164313215|NCT01388985|593522733|FG001|Overall Study|Error of nurse|1|||
164313216|NCT01057589|593522734|FG000|Overall Study|Disease Progression|35|||
164313217|NCT01057589|593522734|FG000|Overall Study|Adverse Event|10|||
164313218|NCT01057589|593522734|FG000|Overall Study|Physician Decision|8|||
164313219|NCT01057589|593522734|FG000|Overall Study|Withdrawal by Subject|3|||
164313220|NCT01057589|593522734|FG000|Overall Study|Sponsor Decision|1|||
164313221|NCT01057589|593522734|FG000|Overall Study|Death|8|||
164313222|NCT01057589|593522734|FG000|Overall Study|Lost to Follow-up|1|||
164313223|NCT01519167|593522737|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
164313224|NCT01519167|593522738|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
164313225|NCT01519167|593522737|FG000|Overall Study|Adverse Event|0|||
164313226|NCT01519167|593522738|FG001|Overall Study|Adverse Event|1|||
164313227|NCT01519167|593522737|FG000|Overall Study|Lack of Efficacy|0|||
164313228|NCT01519167|593522738|FG001|Overall Study|Lack of Efficacy|1|||
164313229|NCT01519167|593522737|FG000|Overall Study|Medical condition changes&deep sedation|0|||
164313230|NCT01519167|593522738|FG001|Overall Study|Medical condition changes&deep sedation|2|||
164313231|NCT01519167|593522737|FG000|Overall Study|Physician Decision|0|||
164313232|NCT01519167|593522738|FG001|Overall Study|Physician Decision|1|||
164313233|NCT00870584|593522744|FG000|Overall Study|Adverse Event|3|||
164313234|NCT00870584|593522745|FG001|Overall Study|Adverse Event|3|||
164313235|NCT00870584|593522744|FG000|Overall Study|Withdrawal by Subject|6|||
164313236|NCT00870584|593522745|FG001|Overall Study|Withdrawal by Subject|7|||
164313237|NCT00870584|593522744|FG000|Overall Study|Lost to Follow-up|5|||
164313238|NCT00870584|593522745|FG001|Overall Study|Lost to Follow-up|1|||
164313239|NCT00870584|593522744|FG000|Overall Study|Protocol Deviation|2|||
164313240|NCT00870584|593522745|FG001|Overall Study|Protocol Deviation|2|||
164313241|NCT02560025|593522746|FG000|Overall Study|Ineligible after consent/ registration|3|||
164313242|NCT01497366|593522747|FG000|Overall Study|Virologic failure|2|||
164313243|NCT01497366|593522748|FG001|Overall Study|Virologic failure|50|||
164313244|NCT01497366|593522747|FG000|Overall Study|Lost to Follow-up|11|||
164313245|NCT01497366|593522748|FG001|Overall Study|Lost to Follow-up|10|||
164313246|NCT01497366|593522747|FG000|Overall Study|Withdrawal by Subject|6|||
164313247|NCT01497366|593522748|FG001|Overall Study|Withdrawal by Subject|6|||
164313248|NCT01497366|593522747|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
164313249|NCT01497366|593522748|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
164313250|NCT01497366|593522747|FG000|Overall Study|Other|5|||
164313251|NCT01497366|593522748|FG001|Overall Study|Other|0|||
164313252|NCT01497366|593522747|FG000|Overall Study|Death|1|||
164313253|NCT01497366|593522748|FG001|Overall Study|Death|1|||
164313254|NCT01497366|593522747|FG000|Overall Study|Randomized but not treated|7|||
164313255|NCT01497366|593522748|FG001|Overall Study|Randomized but not treated|21|||
164313256|NCT02745080|593522758|FG000|Overall Study|Adverse Event|13|||
164313257|NCT02745080|593522759|FG001|Overall Study|Adverse Event|21|||
164313258|NCT02745080|593522758|FG000|Overall Study|Lack of Efficacy|11|||
164313259|NCT02745080|593522759|FG001|Overall Study|Lack of Efficacy|23|||
164313260|NCT02745080|593522758|FG000|Overall Study|Lost to Follow-up|3|||
164313261|NCT02745080|593522759|FG001|Overall Study|Lost to Follow-up|3|||
164313262|NCT02745080|593522758|FG000|Overall Study|Physician Decision|3|||
164313263|NCT02745080|593522759|FG001|Overall Study|Physician Decision|0|||
164313264|NCT02745080|593522758|FG000|Overall Study|Protocol Violation|3|||
164313265|NCT02745080|593522759|FG001|Overall Study|Protocol Violation|1|||
164313266|NCT02745080|593522758|FG000|Overall Study|Withdrawal by Subject|22|||
164313267|NCT02745080|593522759|FG001|Overall Study|Withdrawal by Subject|41|||
164313268|NCT01888432|593524479|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
164313269|NCT01888432|593524480|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
164313270|NCT01888432|593524479|FG000|12-month Analysis (FAS)|Physician Decision|1|||
164313271|NCT01888432|593524480|FG001|12-month Analysis (FAS)|Physician Decision|1|||
164313272|NCT01888432|593524479|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
164313273|NCT01888432|593524480|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
164313274|NCT01888432|593524479|FG000|12-month Analysis (FAS)|Death|4|||
164313275|NCT01888432|593524480|FG001|12-month Analysis (FAS)|Death|3|||
164313276|NCT01888432|593524479|FG000|24-month Analysis (FAS)|Graft loss|0|||
164313277|NCT01888432|593524480|FG001|24-month Analysis (FAS)|Graft loss|1|||
164313278|NCT01888432|593524479|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
164556578|NCT03345472|594408151|FG000|3 Months to 12 Months|Adverse Event|1|||
164556579|NCT03345472|594408151|FG000|3 Months to 12 Months|Death|1|||
164313279|NCT01888432|593524480|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
164313280|NCT01888432|593524479|FG000|24-month Analysis (FAS)|Physician Decision|2|||
164313281|NCT01888432|593524480|FG001|24-month Analysis (FAS)|Physician Decision|4|||
164313282|NCT01888432|593524479|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
164313283|NCT01888432|593524480|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
164313284|NCT01888432|593524479|FG000|24-month Analysis (FAS)|Death|8|||
164313285|NCT01888432|593524480|FG001|24-month Analysis (FAS)|Death|4|||
164556580|NCT01926782|594408152|FG000|Overall Study|Participant moved|2|||
164313286|NCT01888432|593524479|FG000|36-month Analysis (Extension)|Death|1|||
164313287|NCT01888432|593524480|FG001|36-month Analysis (Extension)|Death|0|||
164556581|NCT01926782|594408153|FG001|Overall Study|Participant moved|0|||
164202773|NCT00368550|593115189|FG000|Overall Study|Lack of Efficacy|4|||
164202774|NCT00368550|593115190|FG001|Overall Study|Lack of Efficacy|9|||
164202775|NCT00368550|593115189|FG000|Overall Study|Withdrawal by Subject|17|||
164202776|NCT00368550|593115190|FG001|Overall Study|Withdrawal by Subject|10|||
164202777|NCT01401322|593115191|FG000|Overall Study|Withdrawal by Subject|1|||
164202778|NCT01401322|593115191|FG000|Overall Study|Physician Decision|1|||
164202779|NCT03466346|593115194|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
164202780|NCT03466346|593115195|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Death|3|||
164202781|NCT03466346|593115196|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
164202782|NCT03466346|593115197|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
164202783|NCT03466346|593115198|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
164202784|NCT03466346|593115194|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|12|||
164202785|NCT03466346|593115195|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|26|||
164202786|NCT03466346|593115196|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
164202787|NCT03466346|593115197|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
164202788|NCT03466346|593115198|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
164202789|NCT03466346|593115194|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|15|||
164202790|NCT03466346|593115195|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|31|||
164202791|NCT03466346|593115196|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
164202792|NCT03466346|593115197|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
164202793|NCT03466346|593115198|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
164202794|NCT03466346|593115194|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|69|||
164202795|NCT03466346|593115195|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|142|||
164202796|NCT03466346|593115196|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
164202797|NCT03466346|593115197|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
164202798|NCT03466346|593115198|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
164202799|NCT03466346|593115194|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
164556582|NCT01926782|594408154|FG002|Overall Study|Participant moved|1|||
164556583|NCT01926782|594408155|FG003|Overall Study|Participant moved|1|||
164556584|NCT01926782|594408156|FG004|Overall Study|Participant moved|0|||
164556585|NCT01926782|594408157|FG005|Overall Study|Participant moved|3|||
164556586|NCT01926782|594408152|FG000|Overall Study|Physician Decision|0|||
164556587|NCT01926782|594408153|FG001|Overall Study|Physician Decision|2|||
164556588|NCT01926782|594408154|FG002|Overall Study|Physician Decision|1|||
164556589|NCT01926782|594408155|FG003|Overall Study|Physician Decision|1|||
164556590|NCT01926782|594408156|FG004|Overall Study|Physician Decision|0|||
164556591|NCT01926782|594408157|FG005|Overall Study|Physician Decision|0|||
164556592|NCT01926782|594408152|FG000|Overall Study|Other than specified|2|||
164556593|NCT01926782|594408153|FG001|Overall Study|Other than specified|3|||
164556594|NCT01926782|594408154|FG002|Overall Study|Other than specified|5|||
164556595|NCT01926782|594408155|FG003|Overall Study|Other than specified|12|||
164556596|NCT01926782|594408156|FG004|Overall Study|Other than specified|4|||
164556597|NCT01926782|594408157|FG005|Overall Study|Other than specified|11|||
164556598|NCT01926782|594408152|FG000|Overall Study|Adverse Event|13|||
164556599|NCT01926782|594408153|FG001|Overall Study|Adverse Event|4|||
164556600|NCT01926782|594408154|FG002|Overall Study|Adverse Event|17|||
164556601|NCT01926782|594408155|FG003|Overall Study|Adverse Event|4|||
164556602|NCT01926782|594408156|FG004|Overall Study|Adverse Event|3|||
164556603|NCT01926782|594408157|FG005|Overall Study|Adverse Event|14|||
164556604|NCT01926782|594408152|FG000|Overall Study|Poor compliance to protocol|5|||
164556605|NCT01926782|594408153|FG001|Overall Study|Poor compliance to protocol|3|||
164556606|NCT01926782|594408154|FG002|Overall Study|Poor compliance to protocol|8|||
164556607|NCT01926782|594408155|FG003|Overall Study|Poor compliance to protocol|0|||
164556608|NCT01926782|594408156|FG004|Overall Study|Poor compliance to protocol|1|||
164556609|NCT01926782|594408157|FG005|Overall Study|Poor compliance to protocol|6|||
164556610|NCT01926782|594408152|FG000|Overall Study|Randomized and not treated|0|||
164556611|NCT01926782|594408153|FG001|Overall Study|Randomized and not treated|0|||
164556612|NCT01926782|594408154|FG002|Overall Study|Randomized and not treated|0|||
164556613|NCT01926782|594408155|FG003|Overall Study|Randomized and not treated|1|||
164556614|NCT01926782|594408156|FG004|Overall Study|Randomized and not treated|0|||
164556615|NCT01926782|594408157|FG005|Overall Study|Randomized and not treated|0|||
164556616|NCT01926782|594408152|FG000|Overall Study|Withdrawal by Subject|6|||
164202800|NCT03466346|593115195|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
164556617|NCT01926782|594408153|FG001|Overall Study|Withdrawal by Subject|1|||
164556618|NCT01926782|594408154|FG002|Overall Study|Withdrawal by Subject|8|||
164556619|NCT01926782|594408155|FG003|Overall Study|Withdrawal by Subject|1|||
164556620|NCT01926782|594408156|FG004|Overall Study|Withdrawal by Subject|0|||
164556621|NCT01926782|594408157|FG005|Overall Study|Withdrawal by Subject|5|||
164556622|NCT01926782|594408152|FG000|Overall Study|Related to study drug administration|0|||
164556623|NCT01926782|594408153|FG001|Overall Study|Related to study drug administration|0|||
164556624|NCT01926782|594408154|FG002|Overall Study|Related to study drug administration|0|||
164556625|NCT01926782|594408155|FG003|Overall Study|Related to study drug administration|0|||
164313288|NCT01754402|593524486|FG000|Overall Study|Death|0|||
164313289|NCT01754402|593524487|FG001|Overall Study|Death|0|||
164313290|NCT01754402|593524488|FG002|Overall Study|Death|1|||
164313291|NCT01754402|593524486|FG000|Overall Study|Adverse Event|2|||
164313292|NCT01754402|593524487|FG001|Overall Study|Adverse Event|2|||
164313293|NCT01754402|593524488|FG002|Overall Study|Adverse Event|1|||
164313294|NCT01754402|593524486|FG000|Overall Study|Withdrawal by Subject|0|||
164313295|NCT01754402|593524487|FG001|Overall Study|Withdrawal by Subject|0|||
164313296|NCT01754402|593524488|FG002|Overall Study|Withdrawal by Subject|1|||
164313297|NCT01754402|593524486|FG000|Overall Study|Lack of Efficacy|0|||
164313298|NCT01754402|593524487|FG001|Overall Study|Lack of Efficacy|0|||
164313299|NCT01754402|593524488|FG002|Overall Study|Lack of Efficacy|1|||
164313300|NCT00955305|593524489|FG000|Overall Study|Disease progression|39|||
164313301|NCT00955305|593524490|FG001|Overall Study|Disease progression|41|||
164313302|NCT00955305|593524489|FG000|Overall Study|Adverse Event|22|||
164313303|NCT00955305|593524490|FG001|Overall Study|Adverse Event|22|||
164313304|NCT00955305|593524489|FG000|Overall Study|Death|2|||
164313305|NCT00955305|593524490|FG001|Overall Study|Death|1|||
164313306|NCT00955305|593524489|FG000|Overall Study|Withdrawal by Subject|5|||
164313307|NCT00955305|593524490|FG001|Overall Study|Withdrawal by Subject|4|||
164313308|NCT00955305|593524489|FG000|Overall Study|Alternative therapy|4|||
164313309|NCT00955305|593524490|FG001|Overall Study|Alternative therapy|0|||
164313310|NCT00955305|593524489|FG000|Overall Study|Other complicating disease|2|||
164313311|NCT00955305|593524490|FG001|Overall Study|Other complicating disease|4|||
164313312|NCT00955305|593524489|FG000|Overall Study|Physician Decision|1|||
164313313|NCT00955305|593524490|FG001|Overall Study|Physician Decision|0|||
164313314|NCT00955305|593524489|FG000|Overall Study|Continued presence of residual disease|0|||
164313315|NCT00955305|593524490|FG001|Overall Study|Continued presence of residual disease|1|||
164313316|NCT00955305|593524489|FG000|Overall Study|Functional decline|2|||
164313317|NCT00955305|593524490|FG001|Overall Study|Functional decline|0|||
164313318|NCT00955305|593524489|FG000|Overall Study|Maximum response achieved|0|||
164313319|NCT00955305|593524490|FG001|Overall Study|Maximum response achieved|1|||
164313320|NCT00955305|593524489|FG000|Overall Study|Lost to Follow-up|0|||
164313321|NCT00955305|593524490|FG001|Overall Study|Lost to Follow-up|1|||
164313322|NCT00955305|593524489|FG000|Overall Study|No off-treatment reason submitted|1|||
164313323|NCT00955305|593524490|FG001|Overall Study|No off-treatment reason submitted|0|||
164313324|NCT00955305|593524489|FG000|Overall Study|Never started protocol treatment|5|||
164313325|NCT00955305|593524490|FG001|Overall Study|Never started protocol treatment|5|||
164313326|NCT00955305|593524489|FG000|Overall Study|Ineligible|5|||
164313327|NCT00955305|593524490|FG001|Overall Study|Ineligible|7|||
164313328|NCT01221285|593524491|FG000|Overall Study|Withdrawal by Subject|1|||
164313329|NCT02123251|593524492|FG000|Overall Study|Death|1|||
164313330|NCT02123251|593524493|FG001|Overall Study|Death|1|||
164313331|NCT02123251|593524492|FG000|Overall Study|Withdrawal by Subject|0|||
164313332|NCT02123251|593524493|FG001|Overall Study|Withdrawal by Subject|3|||
164313333|NCT02123251|593524492|FG000|Overall Study|Lost Medicaid eligibility|29|||
164313334|NCT02123251|593524493|FG001|Overall Study|Lost Medicaid eligibility|22|||
164313335|NCT02123251|593524492|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
164313336|NCT02123251|593524493|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
164313337|NCT00375609|593524500|FG000|Overall Study|Did not receive treatment|1|||
164313338|NCT00375609|593524501|FG001|Overall Study|Did not receive treatment|0|||
164313339|NCT00375609|593524502|FG002|Overall Study|Did not receive treatment|0|||
164313340|NCT00375609|593524500|FG000|Overall Study|Adverse Event|0|||
164556626|NCT01926782|594408156|FG004|Overall Study|Related to study drug administration|0|||
164556627|NCT01926782|594408157|FG005|Overall Study|Related to study drug administration|2|||
164556628|NCT04607733|594408160|FG000|Overall Study|Lost to Follow-up|1|||
164556629|NCT04607733|594408161|FG001|Overall Study|Lost to Follow-up|0|||
164556630|NCT04607733|594408162|FG002|Overall Study|Lost to Follow-up|0|||
164556631|NCT04607733|594408163|FG003|Overall Study|Lost to Follow-up|1|||
164556632|NCT04607733|594408164|FG004|Overall Study|Lost to Follow-up|1|||
164556633|NCT04607733|594408165|FG005|Overall Study|Lost to Follow-up|0|||
164420607|NCT01890967|593910946|FG000|Overall Study|Sponsor Decision|2|||
164556634|NCT04607733|594408160|FG000|Overall Study|Withdrawal by Subject|0|||
164556635|NCT04607733|594408161|FG001|Overall Study|Withdrawal by Subject|0|||
164313341|NCT00375609|593524501|FG001|Overall Study|Adverse Event|3|||
164313342|NCT00375609|593524502|FG002|Overall Study|Adverse Event|0|||
164313343|NCT00375609|593524500|FG000|Overall Study|Lost to Follow-up|1|||
164313344|NCT00375609|593524501|FG001|Overall Study|Lost to Follow-up|0|||
164313345|NCT00375609|593524502|FG002|Overall Study|Lost to Follow-up|0|||
164313346|NCT00375609|593524500|FG000|Overall Study|Physician Decision|0|||
164313347|NCT00375609|593524501|FG001|Overall Study|Physician Decision|0|||
164313348|NCT00375609|593524502|FG002|Overall Study|Physician Decision|1|||
164313349|NCT00375609|593524500|FG000|Overall Study|Withdrawal by Subject|1|||
164313350|NCT00375609|593524501|FG001|Overall Study|Withdrawal by Subject|4|||
164313351|NCT00375609|593524502|FG002|Overall Study|Withdrawal by Subject|0|||
164556636|NCT04607733|594408162|FG002|Overall Study|Withdrawal by Subject|0|||
164556637|NCT04607733|594408163|FG003|Overall Study|Withdrawal by Subject|0|||
164556638|NCT04607733|594408164|FG004|Overall Study|Withdrawal by Subject|1|||
164313352|NCT00375609|593524500|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
164313353|NCT00375609|593524501|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
164313354|NCT00375609|593524502|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
164313355|NCT02338882|593524503|FG000|Overall Study|Death|1|||
164313356|NCT02338882|593524504|FG001|Overall Study|Death|0|||
164313357|NCT02338882|593524503|FG000|Overall Study|Lost to Follow-up|6|||
164313358|NCT02338882|593524504|FG001|Overall Study|Lost to Follow-up|3|||
164313359|NCT02184455|593524505|FG000|Overall Study|Lost to Follow-up|1|||
164313360|NCT02248675|593524512|FG000|Overall Study|Lost to Follow-up|3|||
164313361|NCT02248675|593524513|FG001|Overall Study|Lost to Follow-up|1|||
164313362|NCT00617669|593524514|FG000|Overall Study|Withdrawal by Subject|71|||
164313363|NCT00617669|593524515|FG001|Overall Study|Withdrawal by Subject|77|||
164313364|NCT00617669|593524514|FG000|Overall Study|Lost to Follow-up|3|||
164313365|NCT00617669|593524515|FG001|Overall Study|Lost to Follow-up|2|||
164313366|NCT00617669|593524514|FG000|Overall Study|Adverse Event|87|||
164313367|NCT00617669|593524515|FG001|Overall Study|Adverse Event|76|||
164313368|NCT00617669|593524514|FG000|Overall Study|Protocol Violation|2|||
164313369|NCT00617669|593524515|FG001|Overall Study|Protocol Violation|3|||
164313370|NCT00617669|593524514|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
164313371|NCT00617669|593524515|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
164313372|NCT00617669|593524514|FG000|Overall Study|Patients randomized but not treated|2|||
164313373|NCT00617669|593524515|FG001|Overall Study|Patients randomized but not treated|3|||
164313374|NCT00926029|593524519|FG000|Overall Study|Lost to Follow-up|2|||
164313375|NCT00926029|593524520|FG001|Overall Study|Lost to Follow-up|1|||
164313376|NCT00926029|593524521|FG002|Overall Study|Lost to Follow-up|1|||
164313377|NCT01137604|593524527|FG000|Overall Study|Adverse Event|3|||
164313378|NCT01137604|593524528|FG001|Overall Study|Adverse Event|6|||
164313379|NCT01137604|593524529|FG002|Overall Study|Adverse Event|9|||
164313380|NCT01137604|593524530|FG003|Overall Study|Adverse Event|9|||
164313381|NCT01137604|593524527|FG000|Overall Study|Participant Choice|0|||
164313382|NCT01137604|593524528|FG001|Overall Study|Participant Choice|2|||
164313383|NCT01137604|593524529|FG002|Overall Study|Participant Choice|2|||
164313384|NCT01137604|593524530|FG003|Overall Study|Participant Choice|0|||
164313385|NCT01137604|593524527|FG000|Overall Study|Withdrawal of consent|0|||
164313386|NCT01137604|593524528|FG001|Overall Study|Withdrawal of consent|0|||
164313387|NCT01137604|593524529|FG002|Overall Study|Withdrawal of consent|0|||
164313388|NCT01137604|593524530|FG003|Overall Study|Withdrawal of consent|2|||
164313389|NCT01137604|593524527|FG000|Overall Study|Clinical progression/deterioration|1|||
164313390|NCT01137604|593524528|FG001|Overall Study|Clinical progression/deterioration|2|||
164313391|NCT01137604|593524529|FG002|Overall Study|Clinical progression/deterioration|2|||
164313392|NCT01137604|593524530|FG003|Overall Study|Clinical progression/deterioration|0|||
164313393|NCT00591318|593524531|FG000|Overall Study|Lack of Efficacy|2|||
164313394|NCT00591318|593524532|FG001|Overall Study|Lack of Efficacy|0|||
164313395|NCT00591318|593524531|FG000|Overall Study|Adverse Event|2|||
164313396|NCT00591318|593524532|FG001|Overall Study|Adverse Event|0|||
164313397|NCT01776307|593524533|FG000|Overall Study|Not dosed|0|||
164313398|NCT01776307|593524534|FG001|Overall Study|Not dosed|0|||
164313399|NCT01776307|593524535|FG002|Overall Study|Not dosed|1|||
164313400|NCT00567255|593524536|FG000|Overall Study|Adverse Event|241|||
164313401|NCT00567255|593524537|FG001|Overall Study|Adverse Event|68|||
164313402|NCT00567255|593524536|FG000|Overall Study|Lost to Follow-up|77|||
164313403|NCT00567255|593524537|FG001|Overall Study|Lost to Follow-up|48|||
164313404|NCT00567255|593524536|FG000|Overall Study|Withdrawal by Subject|75|||
164313405|NCT00567255|593524537|FG001|Overall Study|Withdrawal by Subject|56|||
164313406|NCT00567255|593524536|FG000|Overall Study|Lack of Efficacy|19|||
164556639|NCT04607733|594408165|FG005|Overall Study|Withdrawal by Subject|0|||
164556640|NCT01639833|594408191|FG000|Overall Study|Death|4|||
164556641|NCT01639833|594408192|FG001|Overall Study|Death|2|||
164556642|NCT01639833|594408191|FG000|Overall Study|Withdrawal by Subject|2|||
164556643|NCT01639833|594408192|FG001|Overall Study|Withdrawal by Subject|2|||
164556644|NCT03504397|594408193|FG000|Overall Study|Progressive Disease|151|||
164556645|NCT03504397|594408194|FG001|Overall Study|Progressive Disease|199|||
164556646|NCT03504397|594408193|FG000|Overall Study|Withdrawal by Subject|29|||
164556647|NCT03504397|594408194|FG001|Overall Study|Withdrawal by Subject|17|||
164660842|NCT01296932|594784985|FG008|Overall Study|Withdrawal by Subject|0|||
164313407|NCT00567255|593524537|FG001|Overall Study|Lack of Efficacy|33|||
164313408|NCT00567255|593524536|FG000|Overall Study|Protocol Violation|20|||
164313409|NCT00567255|593524537|FG001|Overall Study|Protocol Violation|8|||
164313410|NCT00567255|593524536|FG000|Overall Study|Pregnancy|6|||
164313411|NCT00567255|593524537|FG001|Overall Study|Pregnancy|0|||
164313412|NCT00567255|593524536|FG000|Overall Study|Drug noncompliance,moved,other|25|||
164313413|NCT00567255|593524537|FG001|Overall Study|Drug noncompliance,moved,other|15|||
164313414|NCT02657408|593524540|FG000|Overall Study|Adverse Event|3|||
164313415|NCT02657408|593524541|FG001|Overall Study|Adverse Event|7|||
164556648|NCT03504397|594408193|FG000|Overall Study|Lost to Follow-up|1|||
164556649|NCT03504397|594408194|FG001|Overall Study|Lost to Follow-up|0|||
164556650|NCT03504397|594408193|FG000|Overall Study|Death|14|||
164313416|NCT01403948|593524542|FG000|Overall Study|Progressive disease|0|||
164556651|NCT03504397|594408194|FG001|Overall Study|Death|16|||
164556652|NCT03504397|594408193|FG000|Overall Study|Adverse Event|40|||
164556653|NCT03504397|594408194|FG001|Overall Study|Adverse Event|14|||
164556654|NCT03504397|594408193|FG000|Overall Study|miscellaneous|17|||
164556655|NCT03504397|594408194|FG001|Overall Study|miscellaneous|15|||
164556656|NCT03504397|594408193|FG000|Overall Study|Protocol deviation|1|||
164556657|NCT03504397|594408194|FG001|Overall Study|Protocol deviation|0|||
164556658|NCT03504397|594408193|FG000|Overall Study|Participants who did not take the study drug|4|||
164556659|NCT03504397|594408194|FG001|Overall Study|Participants who did not take the study drug|4|||
164660843|NCT01296932|594784977|FG000|Overall Study|Adverse Event|1|||
164660844|NCT01296932|594784978|FG001|Overall Study|Adverse Event|1|||
164660845|NCT01296932|594784979|FG002|Overall Study|Adverse Event|1|||
164660846|NCT01296932|594784980|FG003|Overall Study|Adverse Event|2|||
164660847|NCT01296932|594784981|FG004|Overall Study|Adverse Event|1|||
164660848|NCT01296932|594784982|FG005|Overall Study|Adverse Event|0|||
164660849|NCT01296932|594784983|FG006|Overall Study|Adverse Event|0|||
164660850|NCT01296932|594784984|FG007|Overall Study|Adverse Event|0|||
164313417|NCT01403948|593524543|FG001|Overall Study|Progressive disease|2|||
164313418|NCT01403948|593524544|FG002|Overall Study|Progressive disease|2|||
164313419|NCT01403948|593524545|FG003|Overall Study|Progressive disease|4|||
164313420|NCT01403948|593524546|FG004|Overall Study|Progressive disease|2|||
164313421|NCT01403948|593524547|FG005|Overall Study|Progressive disease|6|||
164313422|NCT01403948|593524548|FG006|Overall Study|Progressive disease|2|||
164313423|NCT01403948|593524549|FG007|Overall Study|Progressive disease|4|||
164313424|NCT01403948|593524550|FG008|Overall Study|Progressive disease|5|||
164313425|NCT01403948|593524551|FG009|Overall Study|Progressive disease|5|||
164313426|NCT01403948|593524542|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
164313427|NCT01403948|593524543|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
164313428|NCT01403948|593524544|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
164313429|NCT01403948|593524545|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
164313430|NCT01403948|593524546|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
164313431|NCT01403948|593524547|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
164313432|NCT01403948|593524548|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
164313433|NCT01403948|593524549|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
164313434|NCT01403948|593524550|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
164313435|NCT01403948|593524551|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
164313436|NCT01403948|593524542|FG000|Overall Study|Lost to Follow-up|0|||
164313437|NCT01403948|593524543|FG001|Overall Study|Lost to Follow-up|0|||
164313438|NCT01403948|593524544|FG002|Overall Study|Lost to Follow-up|0|||
164313439|NCT01403948|593524545|FG003|Overall Study|Lost to Follow-up|0|||
164313440|NCT01403948|593524546|FG004|Overall Study|Lost to Follow-up|0|||
164313441|NCT01403948|593524547|FG005|Overall Study|Lost to Follow-up|0|||
164313442|NCT01403948|593524548|FG006|Overall Study|Lost to Follow-up|0|||
164313443|NCT01403948|593524549|FG007|Overall Study|Lost to Follow-up|0|||
164313444|NCT01403948|593524550|FG008|Overall Study|Lost to Follow-up|0|||
164313445|NCT01403948|593524551|FG009|Overall Study|Lost to Follow-up|1|||
164313446|NCT01403948|593524542|FG000|Overall Study|Refused cont. medication|0|||
164313447|NCT01403948|593524543|FG001|Overall Study|Refused cont. medication|0|||
164313448|NCT01403948|593524544|FG002|Overall Study|Refused cont. medication|0|||
164313449|NCT01403948|593524545|FG003|Overall Study|Refused cont. medication|0|||
164313450|NCT01403948|593524546|FG004|Overall Study|Refused cont. medication|1|||
164313451|NCT01403948|593524547|FG005|Overall Study|Refused cont. medication|0|||
164313452|NCT01403948|593524548|FG006|Overall Study|Refused cont. medication|0|||
164313453|NCT01403948|593524549|FG007|Overall Study|Refused cont. medication|0|||
164313454|NCT01403948|593524550|FG008|Overall Study|Refused cont. medication|0|||
164313455|NCT01403948|593524551|FG009|Overall Study|Refused cont. medication|1|||
164313456|NCT01403948|593524542|FG000|Overall Study|other than above|1|||
164313457|NCT01403948|593524543|FG001|Overall Study|other than above|2|||
164313458|NCT01403948|593524544|FG002|Overall Study|other than above|1|||
164313459|NCT01403948|593524545|FG003|Overall Study|other than above|0|||
164313460|NCT01403948|593524546|FG004|Overall Study|other than above|1|||
164313461|NCT01403948|593524547|FG005|Overall Study|other than above|1|||
164313462|NCT01403948|593524548|FG006|Overall Study|other than above|2|||
164313463|NCT01403948|593524549|FG007|Overall Study|other than above|0|||
164313464|NCT01403948|593524550|FG008|Overall Study|other than above|0|||
164313465|NCT01403948|593524551|FG009|Overall Study|other than above|0|||
164313466|NCT02184572|593524552|FG000|Overall Study|Lost to Follow-up|29|||
164313467|NCT02184572|593524553|FG001|Overall Study|Lost to Follow-up|21|||
164313468|NCT02184572|593524552|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
164313469|NCT02184572|593524553|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
164660851|NCT01296932|594784985|FG008|Overall Study|Adverse Event|1|||
164660852|NCT01296932|594784977|FG000|Overall Study|Investigator decision|0|||
164660853|NCT01296932|594784978|FG001|Overall Study|Investigator decision|1|||
164660854|NCT01296932|594784979|FG002|Overall Study|Investigator decision|0|||
164313470|NCT02184572|593524552|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
164313471|NCT02184572|593524553|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
164313472|NCT02184572|593524552|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
164313473|NCT02184572|593524553|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
164313474|NCT02184572|593524552|FG000|Overall Study|Traveling Outside The Country|1|||
164313475|NCT02184572|593524553|FG001|Overall Study|Traveling Outside The Country|0|||
164313476|NCT02184572|593524552|FG000|Overall Study|Withdrawal by Subject|14|||
164313477|NCT02184572|593524553|FG001|Overall Study|Withdrawal by Subject|9|||
164313478|NCT00763698|593524556|FG000|Overall Study|Unsuccessful Implant|5|||
164660855|NCT01296932|594784980|FG003|Overall Study|Investigator decision|1|||
164660856|NCT01296932|594784981|FG004|Overall Study|Investigator decision|0|||
164313479|NCT00763698|593524556|FG000|Overall Study|Death|4|||
164313480|NCT00763698|593524556|FG000|Overall Study|Withdrawal by Subject|1|||
164313481|NCT01459497|593524561|FG000|Overall Study|Inability to meet trial constraints.|1|||
164313482|NCT01459497|593524562|FG001|Overall Study|Inability to meet trial constraints.|0|||
164313483|NCT01459497|593524561|FG000|Overall Study|Physician Decision|1|||
164313484|NCT01459497|593524562|FG001|Overall Study|Physician Decision|1|||
164313485|NCT01459497|593524561|FG000|Overall Study|Hospitalization.|0|||
164313486|NCT01459497|593524562|FG001|Overall Study|Hospitalization.|3|||
164313487|NCT01459497|593524561|FG000|Overall Study|Disease progression.|0|||
164313488|NCT01459497|593524562|FG001|Overall Study|Disease progression.|1|||
164313489|NCT01120717|593524563|FG000|Overall Study|Withdrawal by Subject|11|||
164313490|NCT01120717|593524564|FG001|Overall Study|Withdrawal by Subject|6|||
164313491|NCT01120717|593524563|FG000|Overall Study|Adverse Event|10|||
164313492|NCT01120717|593524564|FG001|Overall Study|Adverse Event|6|||
164313493|NCT01120717|593524563|FG000|Overall Study|Protocol Deviation|2|||
164313494|NCT01120717|593524564|FG001|Overall Study|Protocol Deviation|5|||
164313495|NCT01120717|593524563|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
164313496|NCT01120717|593524564|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
164313497|NCT01120717|593524563|FG000|Overall Study|Lost to Follow-up|2|||
164313498|NCT01120717|593524564|FG001|Overall Study|Lost to Follow-up|3|||
164313499|NCT01120717|593524563|FG000|Overall Study|Death|3|||
164313500|NCT01120717|593524564|FG001|Overall Study|Death|1|||
164313501|NCT01120717|593524563|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
164313502|NCT01120717|593524564|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
164313503|NCT02640508|593524569|FG000|Overall Study|Death|19|||
164313504|NCT02640508|593524569|FG000|Overall Study|Withdrawal by Subject|8|||
164313505|NCT02640508|593524569|FG000|Overall Study|Physician Decision|1|||
164313506|NCT02640508|593524569|FG000|Overall Study|Lost to Follow-up|1|||
164313507|NCT00862082|593524570|FG000|Overall Study|Sponsor decision to terminate the study|5|||
164313508|NCT00862082|593524571|FG001|Overall Study|Sponsor decision to terminate the study|0|||
164313509|NCT00862082|593524570|FG000|Overall Study|Withdrawal by Subject|0|||
164313510|NCT00862082|593524571|FG001|Overall Study|Withdrawal by Subject|1|||
164313511|NCT02791763|593524576|FG000|Overall Study|Protocol Violation|0|||
164313512|NCT02791763|593524577|FG001|Overall Study|Protocol Violation|0|||
164313513|NCT02791763|593524578|FG002|Overall Study|Protocol Violation|1|||
164313514|NCT02791763|593524576|FG000|Overall Study|Withdrawal by Subject|5|||
164313515|NCT02791763|593524577|FG001|Overall Study|Withdrawal by Subject|1|||
164313516|NCT02791763|593524578|FG002|Overall Study|Withdrawal by Subject|0|||
164313517|NCT02791763|593524576|FG000|Overall Study|Physician Decision|0|||
164313518|NCT02791763|593524577|FG001|Overall Study|Physician Decision|1|||
164313519|NCT02791763|593524578|FG002|Overall Study|Physician Decision|0|||
164313520|NCT02791763|593524576|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
164313521|NCT02791763|593524577|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
164313522|NCT02791763|593524578|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
164313523|NCT02791763|593524576|FG000|Overall Study|Cancer event|1|||
164313524|NCT02791763|593524577|FG001|Overall Study|Cancer event|3|||
164313525|NCT02791763|593524578|FG002|Overall Study|Cancer event|0|||
164313526|NCT02791763|593524576|FG000|Overall Study|Participant had renal transplant|3|||
164313527|NCT02791763|593524577|FG001|Overall Study|Participant had renal transplant|0|||
164313528|NCT02791763|593524578|FG002|Overall Study|Participant had renal transplant|0|||
164313529|NCT02791763|593524576|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
164313530|NCT02791763|593524577|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
164313531|NCT02791763|593524578|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
164313532|NCT02791763|593524576|FG000|Overall Study|Adverse Event|12|||
164313533|NCT02791763|593524577|FG001|Overall Study|Adverse Event|13|||
164556660|NCT00070941|594408195|FG000|Overall Study|Adverse Event|10|||
164556661|NCT00070941|594408196|FG001|Overall Study|Adverse Event|8|||
164556662|NCT00070941|594408197|FG002|Overall Study|Adverse Event|4|||
164556663|NCT01888640|594408198|FG000|Overall Study|Lost to Follow-up|1|||
164556664|NCT01888640|594408199|FG001|Overall Study|Lost to Follow-up|2|||
164556665|NCT01888640|594408200|FG002|Overall Study|Lost to Follow-up|0|||
164556666|NCT01888640|594408198|FG000|Overall Study|Withdrawal by Subject|15|||
164556667|NCT01888640|594408199|FG001|Overall Study|Withdrawal by Subject|11|||
164313534|NCT02791763|593524578|FG002|Overall Study|Adverse Event|7|||
164313535|NCT05334212|593524579|FG000|Overall Study|Study terminated prematurely|7|||
164313536|NCT04534686|593524580|FG000|Baseline Measurement|Lost to Follow-up|4|||
164313537|NCT04534686|593524581|FG001|Baseline Measurement|Lost to Follow-up|6|||
164313538|NCT04534686|593524580|FG000|Baseline Measurement|Withdrawal by Subject|3|||
164313539|NCT04534686|593524581|FG001|Baseline Measurement|Withdrawal by Subject|1|||
164313540|NCT04534686|593524580|FG000|Intervention|Withdrawal by Subject|2|||
164313541|NCT04534686|593524581|FG001|Intervention|Withdrawal by Subject|2|||
164313542|NCT03179605|593524582|FG000|Overall Study|Withdrawal by Subject|1|||
164313543|NCT00910299|593524583|FG000|Overall Study|Withdrawal by Subject|16|||
164313544|NCT00910299|593524584|FG001|Overall Study|Withdrawal by Subject|13|||
164313545|NCT00910299|593524583|FG000|Overall Study|Sponsor Decision|58|||
164556668|NCT01888640|594408200|FG002|Overall Study|Withdrawal by Subject|4|||
164313546|NCT00910299|593524584|FG001|Overall Study|Sponsor Decision|60|||
164313547|NCT00910299|593524583|FG000|Overall Study|Didn't receive any study drug|2|||
164313548|NCT00910299|593524584|FG001|Overall Study|Didn't receive any study drug|1|||
164313549|NCT01456897|593524585|FG000|Overall Study|Adverse Event|19|||
164313550|NCT01456897|593524586|FG001|Overall Study|Adverse Event|22|||
164313551|NCT01456897|593524585|FG000|Overall Study|Protocol Violation|3|||
164313552|NCT01456897|593524586|FG001|Overall Study|Protocol Violation|4|||
164313553|NCT01456897|593524585|FG000|Overall Study|Physician Decision|5|||
164313554|NCT01456897|593524586|FG001|Overall Study|Physician Decision|3|||
164313555|NCT01456897|593524585|FG000|Overall Study|Withdrawal by Subject|44|||
164313556|NCT01456897|593524586|FG001|Overall Study|Withdrawal by Subject|17|||
164313557|NCT01456897|593524585|FG000|Overall Study|Lack of Efficacy|4|||
164313558|NCT01456897|593524586|FG001|Overall Study|Lack of Efficacy|11|||
164313559|NCT01396070|593524588|FG000|Overall Study|Withdrawal by Subject|2|||
164313560|NCT01396070|593524588|FG000|Overall Study|Death|2|||
164313561|NCT01396070|593524588|FG000|Overall Study|Adverse Event|8|||
164313562|NCT01396070|593524588|FG000|Overall Study|Physician Decision|3|||
164313563|NCT01396070|593524588|FG000|Overall Study|Lack of Efficacy|4|||
164313564|NCT04535453|593524589|FG000|Overall Study|Death|0|||
164313565|NCT04535453|593524590|FG001|Overall Study|Death|1|||
164313566|NCT04535453|593524591|FG002|Overall Study|Death|0|||
164313567|NCT04535453|593524592|FG003|Overall Study|Death|0|||
164313568|NCT04535453|593524593|FG004|Overall Study|Death|0|||
164313569|NCT04535453|593524594|FG005|Overall Study|Death|0|||
164313570|NCT04535453|593524595|FG006|Overall Study|Death|0|||
164313571|NCT04535453|593524596|FG007|Overall Study|Death|0|||
164313572|NCT04535453|593524597|FG008|Overall Study|Death|0|||
164313573|NCT04535453|593524598|FG009|Overall Study|Death|0|||
164313574|NCT04535453|593524599|FG010|Overall Study|Death|0|||
164313575|NCT04535453|593524600|FG011|Overall Study|Death|0|||
164313576|NCT04535453|593524589|FG000|Overall Study|Lost to Follow-up|1|||
164313577|NCT04535453|593524590|FG001|Overall Study|Lost to Follow-up|1|||
164313578|NCT04535453|593524591|FG002|Overall Study|Lost to Follow-up|1|||
164313579|NCT04535453|593524592|FG003|Overall Study|Lost to Follow-up|0|||
164313580|NCT04535453|593524593|FG004|Overall Study|Lost to Follow-up|3|||
164313581|NCT04535453|593524594|FG005|Overall Study|Lost to Follow-up|1|||
164313582|NCT04535453|593524595|FG006|Overall Study|Lost to Follow-up|0|||
164313583|NCT04535453|593524596|FG007|Overall Study|Lost to Follow-up|0|||
164313584|NCT04535453|593524597|FG008|Overall Study|Lost to Follow-up|1|||
164313585|NCT04535453|593524598|FG009|Overall Study|Lost to Follow-up|1|||
164313586|NCT04535453|593524599|FG010|Overall Study|Lost to Follow-up|0|||
164313587|NCT04535453|593524600|FG011|Overall Study|Lost to Follow-up|0|||
164313588|NCT04535453|593524589|FG000|Overall Study|Physician Decision|0|||
164313589|NCT04535453|593524590|FG001|Overall Study|Physician Decision|0|||
164313590|NCT04535453|593524591|FG002|Overall Study|Physician Decision|0|||
164313591|NCT04535453|593524592|FG003|Overall Study|Physician Decision|1|||
164313592|NCT04535453|593524593|FG004|Overall Study|Physician Decision|0|||
164313593|NCT04535453|593524594|FG005|Overall Study|Physician Decision|0|||
164313594|NCT04535453|593524595|FG006|Overall Study|Physician Decision|0|||
164313595|NCT04535453|593524596|FG007|Overall Study|Physician Decision|0|||
164313596|NCT04535453|593524597|FG008|Overall Study|Physician Decision|0|||
164313597|NCT04535453|593524598|FG009|Overall Study|Physician Decision|0|||
164313598|NCT04535453|593524599|FG010|Overall Study|Physician Decision|0|||
164313599|NCT04535453|593524600|FG011|Overall Study|Physician Decision|0|||
164313600|NCT04535453|593524589|FG000|Overall Study|Withdrawal by Subject|3|||
164313601|NCT04535453|593524590|FG001|Overall Study|Withdrawal by Subject|6|||
164313602|NCT04535453|593524591|FG002|Overall Study|Withdrawal by Subject|3|||
164313603|NCT04535453|593524592|FG003|Overall Study|Withdrawal by Subject|3|||
164313604|NCT04535453|593524593|FG004|Overall Study|Withdrawal by Subject|2|||
164313605|NCT04535453|593524594|FG005|Overall Study|Withdrawal by Subject|1|||
164313606|NCT04535453|593524595|FG006|Overall Study|Withdrawal by Subject|1|||
164313607|NCT04535453|593524596|FG007|Overall Study|Withdrawal by Subject|1|||
164313608|NCT04535453|593524597|FG008|Overall Study|Withdrawal by Subject|1|||
164313609|NCT04535453|593524598|FG009|Overall Study|Withdrawal by Subject|1|||
164313610|NCT04535453|593524599|FG010|Overall Study|Withdrawal by Subject|0|||
164313611|NCT04535453|593524600|FG011|Overall Study|Withdrawal by Subject|1|||
164313612|NCT04535453|593524589|FG000|Overall Study|Other|0|||
164313613|NCT04535453|593524590|FG001|Overall Study|Other|0|||
164660857|NCT01296932|594784982|FG005|Overall Study|Investigator decision|0|||
164313614|NCT04535453|593524591|FG002|Overall Study|Other|1|||
164313615|NCT04535453|593524592|FG003|Overall Study|Other|0|||
164313616|NCT04535453|593524593|FG004|Overall Study|Other|1|||
164313617|NCT04535453|593524594|FG005|Overall Study|Other|0|||
164313618|NCT04535453|593524595|FG006|Overall Study|Other|1|||
164313619|NCT04535453|593524596|FG007|Overall Study|Other|1|||
164313620|NCT04535453|593524597|FG008|Overall Study|Other|1|||
164313621|NCT04535453|593524598|FG009|Overall Study|Other|0|||
164313622|NCT04535453|593524599|FG010|Overall Study|Other|0|||
164313623|NCT04535453|593524600|FG011|Overall Study|Other|0|||
164313624|NCT04530136|593524601|FG000|Overall Study|Lost to Follow-up|2|||
164313625|NCT04530136|593524602|FG001|Overall Study|Lost to Follow-up|3|||
164660858|NCT01296932|594784983|FG006|Overall Study|Investigator decision|1|||
164313626|NCT04530136|593524601|FG000|Overall Study|Withdrawal by Subject|1|||
164313627|NCT04530136|593524602|FG001|Overall Study|Withdrawal by Subject|0|||
164313628|NCT04530136|593524601|FG000|Overall Study|Death|0|||
164313629|NCT04530136|593524602|FG001|Overall Study|Death|1|||
164313630|NCT02878798|593524603|FG000|Overall Study|Withdrawal by Subject|5|||
164313631|NCT02878798|593524604|FG001|Overall Study|Withdrawal by Subject|4|||
164313632|NCT02878798|593524603|FG000|Overall Study|Lost to Follow-up|2|||
164313633|NCT02878798|593524604|FG001|Overall Study|Lost to Follow-up|2|||
164313634|NCT02878798|593524603|FG000|Overall Study|Protocol Violation|0|||
164313635|NCT02878798|593524604|FG001|Overall Study|Protocol Violation|1|||
164313636|NCT02762370|593524607|FG000|Overall Study|Protocol Violation|1|||
164313637|NCT02762370|593524608|FG001|Overall Study|Protocol Violation|0|||
164313638|NCT01708902|593524612|FG000|Overall Study|Adverse Event|3|||
164313639|NCT01708902|593524613|FG001|Overall Study|Adverse Event|4|||
164313640|NCT01708902|593524614|FG002|Overall Study|Adverse Event|9|||
164313641|NCT01708902|593524615|FG003|Overall Study|Adverse Event|2|||
164313642|NCT01708902|593524616|FG004|Overall Study|Adverse Event|7|||
164313643|NCT01708902|593524617|FG005|Overall Study|Adverse Event|3|||
164313644|NCT01708902|593524618|FG006|Overall Study|Adverse Event|5|||
164313645|NCT01708902|593524612|FG000|Overall Study|Lack of Efficacy|3|||
164313646|NCT01708902|593524613|FG001|Overall Study|Lack of Efficacy|1|||
164313647|NCT01708902|593524614|FG002|Overall Study|Lack of Efficacy|0|||
164313648|NCT01708902|593524615|FG003|Overall Study|Lack of Efficacy|0|||
164313649|NCT01708902|593524616|FG004|Overall Study|Lack of Efficacy|0|||
164313650|NCT01708902|593524617|FG005|Overall Study|Lack of Efficacy|1|||
164313651|NCT01708902|593524618|FG006|Overall Study|Lack of Efficacy|0|||
164313652|NCT01708902|593524612|FG000|Overall Study|Non compliance with protocol|0|||
164313653|NCT01708902|593524613|FG001|Overall Study|Non compliance with protocol|2|||
164313654|NCT01708902|593524614|FG002|Overall Study|Non compliance with protocol|1|||
164313655|NCT01708902|593524615|FG003|Overall Study|Non compliance with protocol|3|||
164313656|NCT01708902|593524616|FG004|Overall Study|Non compliance with protocol|0|||
164313657|NCT01708902|593524617|FG005|Overall Study|Non compliance with protocol|0|||
164313658|NCT01708902|593524618|FG006|Overall Study|Non compliance with protocol|0|||
164313659|NCT01708902|593524612|FG000|Overall Study|Lost to Follow-up|2|||
164313660|NCT01708902|593524613|FG001|Overall Study|Lost to Follow-up|1|||
164313661|NCT01708902|593524614|FG002|Overall Study|Lost to Follow-up|2|||
164313662|NCT01708902|593524615|FG003|Overall Study|Lost to Follow-up|2|||
164313663|NCT01708902|593524616|FG004|Overall Study|Lost to Follow-up|0|||
164313664|NCT01708902|593524617|FG005|Overall Study|Lost to Follow-up|0|||
164313665|NCT01708902|593524618|FG006|Overall Study|Lost to Follow-up|1|||
164313666|NCT01708902|593524612|FG000|Overall Study|Refused to continue trial medication|8|||
164313667|NCT01708902|593524613|FG001|Overall Study|Refused to continue trial medication|0|||
164313668|NCT01708902|593524614|FG002|Overall Study|Refused to continue trial medication|4|||
164313669|NCT01708902|593524615|FG003|Overall Study|Refused to continue trial medication|2|||
164313670|NCT01708902|593524616|FG004|Overall Study|Refused to continue trial medication|8|||
164313671|NCT01708902|593524617|FG005|Overall Study|Refused to continue trial medication|1|||
164313672|NCT01708902|593524618|FG006|Overall Study|Refused to continue trial medication|1|||
164313673|NCT01708902|593524612|FG000|Overall Study|Other Reason|1|||
164313674|NCT01708902|593524613|FG001|Overall Study|Other Reason|0|||
164313675|NCT01708902|593524614|FG002|Overall Study|Other Reason|1|||
164556669|NCT01888640|594408198|FG000|Overall Study|Minimum dose not met|10|||
164556670|NCT01888640|594408199|FG001|Overall Study|Minimum dose not met|16|||
164556671|NCT01888640|594408200|FG002|Overall Study|Minimum dose not met|0|||
164202801|NCT03466346|593115196|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|2|||
164202802|NCT03466346|593115197|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|1|||
164202803|NCT03466346|593115198|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|4|||
164202804|NCT03466346|593115194|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
164202805|NCT03466346|593115195|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
164202806|NCT03466346|593115196|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
164313676|NCT01708902|593524615|FG003|Overall Study|Other Reason|1|||
164313677|NCT01708902|593524616|FG004|Overall Study|Other Reason|1|||
164313678|NCT01708902|593524617|FG005|Overall Study|Other Reason|2|||
164313679|NCT01708902|593524618|FG006|Overall Study|Other Reason|0|||
164313680|NCT01136785|593524622|FG000|Overall Study|Protocol Violation|2|||
164313681|NCT01136785|593524623|FG001|Overall Study|Protocol Violation|1|||
164313682|NCT02873429|593524624|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
164313683|NCT02873429|593524625|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
164313684|NCT02873429|593524624|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
164313685|NCT02873429|593524625|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
164313686|NCT02873429|593524624|FG000|16 Weeks|Lost to Follow-up|3|||
164313687|NCT02873429|593524625|FG001|16 Weeks|Lost to Follow-up|0|||
164313688|NCT00612807|593524626|FG000|Overall Study|Withdrawal by Subject|2|||
164313689|NCT00612807|593524627|FG001|Overall Study|Withdrawal by Subject|0|||
164556672|NCT01888640|594408198|FG000|Overall Study|Given wrong unit (placebo)|1|||
164556673|NCT01888640|594408199|FG001|Overall Study|Given wrong unit (placebo)|0|||
164313690|NCT01516034|593524628|FG000|Overall Study|Physician Decision|1|||
164313691|NCT01516034|593524628|FG000|Overall Study|Lack of Efficacy|7|||
164313692|NCT00472030|593524632|FG000|Overall Study|Physician Decision|1|||
164313693|NCT00472030|593524633|FG001|Overall Study|Physician Decision|0|||
164313694|NCT00829504|593524634|FG000|First Intervention|Adverse Event|1|||
164313695|NCT00829504|593524635|FG001|First Intervention|Adverse Event|0|||
164313696|NCT00829504|593524634|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
164313697|NCT00829504|593524635|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
164313698|NCT00829504|593524634|FG000|Second Intervention|Physician Decision|1|||
164313699|NCT00829504|593524635|FG001|Second Intervention|Physician Decision|0|||
164313700|NCT05564052|593524636|FG000|Overall Study|Withdrawal by Subject|0|||
164313701|NCT05564052|593524637|FG001|Overall Study|Withdrawal by Subject|0|||
164313702|NCT05564052|593524638|FG002|Overall Study|Withdrawal by Subject|0|||
164313703|NCT05564052|593524639|FG003|Overall Study|Withdrawal by Subject|1|||
164313704|NCT03745820|593525992|FG000|Overall Study|Adverse Event|0|||
164313705|NCT03745820|593525993|FG001|Overall Study|Adverse Event|3|||
164313706|NCT03745820|593525994|FG002|Overall Study|Adverse Event|2|||
164313707|NCT03745820|593525992|FG000|Overall Study|Non-Compliance with Study Drug|4|||
164313708|NCT03745820|593525993|FG001|Overall Study|Non-Compliance with Study Drug|3|||
164313709|NCT03745820|593525994|FG002|Overall Study|Non-Compliance with Study Drug|0|||
164313710|NCT03745820|593525992|FG000|Overall Study|Withdrawal by Subject|4|||
164313711|NCT03745820|593525993|FG001|Overall Study|Withdrawal by Subject|4|||
164313712|NCT03745820|593525994|FG002|Overall Study|Withdrawal by Subject|4|||
164313713|NCT03745820|593525992|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
164313714|NCT03745820|593525993|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
164313715|NCT03745820|593525994|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
164313716|NCT03745820|593525992|FG000|Overall Study|Lost to Follow-up|2|||
164313717|NCT03745820|593525993|FG001|Overall Study|Lost to Follow-up|0|||
164313718|NCT03745820|593525994|FG002|Overall Study|Lost to Follow-up|3|||
164313719|NCT03745820|593525992|FG000|Overall Study|Reason not Specified|2|||
164313720|NCT03745820|593525993|FG001|Overall Study|Reason not Specified|4|||
164313721|NCT03745820|593525994|FG002|Overall Study|Reason not Specified|1|||
164313722|NCT02151773|593525995|FG000|Overall Study|Protocol Deviation|64|||
164313723|NCT03680742|593525996|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
164313724|NCT02894502|593525999|FG000|Baseline|Withdrawal by Subject|24|||
164313725|NCT02894502|593526000|FG001|Baseline|Withdrawal by Subject|31|||
164313726|NCT02894502|593526001|FG002|Baseline|Withdrawal by Subject|36|||
164313727|NCT02894502|593525999|FG000|Baseline|Death|3|||
164313728|NCT02894502|593526000|FG001|Baseline|Death|1|||
164313729|NCT02894502|593526001|FG002|Baseline|Death|9|||
164313730|NCT02894502|593525999|FG000|First Follow up|Withdrawal by Subject|32|||
164313731|NCT02894502|593526000|FG001|First Follow up|Withdrawal by Subject|29|||
164313732|NCT02894502|593526001|FG002|First Follow up|Withdrawal by Subject|37|||
164313733|NCT02894502|593525999|FG000|First Follow up|Death|2|||
164313734|NCT02894502|593526000|FG001|First Follow up|Death|2|||
164313735|NCT02894502|593526001|FG002|First Follow up|Death|3|||
164313736|NCT02894502|593525999|FG000|Second Follow up|Withdrawal by Subject|13|||
164313737|NCT02894502|593526000|FG001|Second Follow up|Withdrawal by Subject|15|||
164313738|NCT02894502|593526001|FG002|Second Follow up|Withdrawal by Subject|13|||
164313739|NCT02894502|593525999|FG000|Second Follow up|Death|2|||
164313740|NCT02894502|593526000|FG001|Second Follow up|Death|3|||
164313741|NCT02894502|593526001|FG002|Second Follow up|Death|1|||
164313742|NCT02894502|593525999|FG000|Third Follow up|Withdrawal by Subject|5|||
164313743|NCT02894502|593526000|FG001|Third Follow up|Withdrawal by Subject|6|||
164313744|NCT02894502|593526001|FG002|Third Follow up|Withdrawal by Subject|3|||
164313745|NCT02894502|593525999|FG000|Third Follow up|Death|1|||
164313746|NCT02894502|593526000|FG001|Third Follow up|Death|1|||
164313747|NCT02894502|593526001|FG002|Third Follow up|Death|0|||
164313748|NCT01410357|593526002|FG000|Overall Study|Death|2|||
164313749|NCT01410357|593526003|FG001|Overall Study|Death|1|||
164313750|NCT01410357|593526002|FG000|Overall Study|Withdrawal by Subject|1|||
164313751|NCT01410357|593526003|FG001|Overall Study|Withdrawal by Subject|2|||
164313752|NCT01410357|593526002|FG000|Overall Study|Lost to Follow-up|23|||
164313753|NCT01410357|593526003|FG001|Overall Study|Lost to Follow-up|21|||
164313754|NCT04250077|593526011|FG000|Overall Study|Withdrawal by Subject|0|||
164660859|NCT01296932|594784984|FG007|Overall Study|Investigator decision|0|||
164660860|NCT01296932|594784985|FG008|Overall Study|Investigator decision|1|||
164313755|NCT04250077|593526012|FG001|Overall Study|Withdrawal by Subject|1|||
164313756|NCT04250077|593526013|FG002|Overall Study|Withdrawal by Subject|0|||
164313757|NCT04250077|593526011|FG000|Overall Study|Lost to Follow-up|2|||
164313758|NCT04250077|593526012|FG001|Overall Study|Lost to Follow-up|3|||
164660861|NCT01296932|594784977|FG000|Overall Study|No clinical benefit anymore|0|||
164313759|NCT04250077|593526013|FG002|Overall Study|Lost to Follow-up|0|||
164313760|NCT03700684|593526014|FG000|Overall Study|COVID-19|0|||
164313761|NCT03700684|593526015|FG001|Overall Study|COVID-19|0|||
164313762|NCT03700684|593526016|FG002|Overall Study|COVID-19|2|||
164313763|NCT02471612|593526017|FG000|Overall Study|Lost to Follow-up|2|||
164313764|NCT01598129|593526020|FG000|Overall Study|Disease progression|6|||
164660862|NCT01296932|594784978|FG001|Overall Study|No clinical benefit anymore|1|||
164660863|NCT01296932|594784979|FG002|Overall Study|No clinical benefit anymore|0|||
164660864|NCT01296932|594784980|FG003|Overall Study|No clinical benefit anymore|0|||
164660865|NCT01296932|594784981|FG004|Overall Study|No clinical benefit anymore|0|||
164660866|NCT01296932|594784982|FG005|Overall Study|No clinical benefit anymore|0|||
164660867|NCT01296932|594784983|FG006|Overall Study|No clinical benefit anymore|0|||
164660868|NCT01296932|594784984|FG007|Overall Study|No clinical benefit anymore|0|||
164660869|NCT01296932|594784985|FG008|Overall Study|No clinical benefit anymore|0|||
164660870|NCT01296932|594784977|FG000|Overall Study|Physician Decision|0|||
164660871|NCT01296932|594784978|FG001|Overall Study|Physician Decision|0|||
164660872|NCT01296932|594784979|FG002|Overall Study|Physician Decision|1|||
164660873|NCT01296932|594784980|FG003|Overall Study|Physician Decision|0|||
164660874|NCT01296932|594784981|FG004|Overall Study|Physician Decision|0|||
164660875|NCT01296932|594784982|FG005|Overall Study|Physician Decision|0|||
164660876|NCT01296932|594784983|FG006|Overall Study|Physician Decision|0|||
164660877|NCT01296932|594784984|FG007|Overall Study|Physician Decision|0|||
164660878|NCT01296932|594784985|FG008|Overall Study|Physician Decision|0|||
164660879|NCT01296932|594784977|FG000|Overall Study|IV problems, administration not possible|0|||
164660880|NCT01296932|594784978|FG001|Overall Study|IV problems, administration not possible|0|||
164660881|NCT01296932|594784979|FG002|Overall Study|IV problems, administration not possible|1|||
164660882|NCT01296932|594784980|FG003|Overall Study|IV problems, administration not possible|0|||
164660883|NCT01296932|594784981|FG004|Overall Study|IV problems, administration not possible|0|||
164660884|NCT01296932|594784982|FG005|Overall Study|IV problems, administration not possible|0|||
164202807|NCT03466346|593115197|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
164202808|NCT03466346|593115198|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
164202809|NCT03466346|593115194|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
164202810|NCT03466346|593115195|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
164202811|NCT03466346|593115196|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|16|||
164202812|NCT03466346|593115197|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|24|||
164202813|NCT03466346|593115198|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|45|||
164202814|NCT02410629|593115200|FG000|Overall Study|Family cannot commit to the study|2|||
164202815|NCT02410629|593115201|FG001|Overall Study|Family cannot commit to the study|1|||
164202816|NCT02410629|593115200|FG000|Overall Study|Subject returned to work|1|||
164202817|NCT02410629|593115201|FG001|Overall Study|Subject returned to work|0|||
164202818|NCT02410629|593115200|FG000|Overall Study|Subject moved back to home country|0|||
164202819|NCT02410629|593115201|FG001|Overall Study|Subject moved back to home country|1|||
164202820|NCT02410629|593115200|FG000|Overall Study|Subject underwent heart surgery|0|||
164202821|NCT02410629|593115201|FG001|Overall Study|Subject underwent heart surgery|1|||
164202822|NCT01670292|593115202|FG000|Overall Study|Lost to Follow-up|14|||
164202823|NCT00087178|593115203|FG000|Overall Study|No follow up data|5|||
164202824|NCT00087178|593115204|FG001|Overall Study|No follow up data|15|||
164202825|NCT00087178|593115203|FG000|Overall Study|No clinical assessment|1|||
164202826|NCT00087178|593115204|FG001|Overall Study|No clinical assessment|2|||
164202827|NCT00087178|593115203|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
164202828|NCT00087178|593115204|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
164202829|NCT01692119|593115209|FG000|Overall Study|Protocol Violation|3|||
164202830|NCT01692119|593115210|FG001|Overall Study|Protocol Violation|1|||
164202831|NCT01692119|593115209|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
164202832|NCT01692119|593115210|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
164202833|NCT03451045|593115211|FG000|Overall Study|Lack of Efficacy|3|||
164202834|NCT03451045|593115212|FG001|Overall Study|Lack of Efficacy|2|||
164202835|NCT03451045|593115213|FG002|Overall Study|Lack of Efficacy|2|||
164202836|NCT03451045|593115211|FG000|Overall Study|Physician Decision|1|||
164202837|NCT03451045|593115212|FG001|Overall Study|Physician Decision|1|||
164202838|NCT03451045|593115213|FG002|Overall Study|Physician Decision|1|||
164202839|NCT03451045|593115211|FG000|Overall Study|Withdrawal by Subject|4|||
164202840|NCT03451045|593115212|FG001|Overall Study|Withdrawal by Subject|0|||
164202841|NCT03451045|593115213|FG002|Overall Study|Withdrawal by Subject|5|||
164202842|NCT03451045|593115211|FG000|Overall Study|Pregnancy|0|||
164202843|NCT03451045|593115212|FG001|Overall Study|Pregnancy|0|||
164202844|NCT03451045|593115213|FG002|Overall Study|Pregnancy|2|||
164313765|NCT01598129|593526020|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
164660885|NCT01296932|594784983|FG006|Overall Study|IV problems, administration not possible|0|||
164202845|NCT03451045|593115211|FG000|Overall Study|Adverse Event|7|||
164202846|NCT03451045|593115212|FG001|Overall Study|Adverse Event|1|||
164202847|NCT03451045|593115213|FG002|Overall Study|Adverse Event|3|||
164202848|NCT03451045|593115211|FG000|Overall Study|Non-compliance with study|2|||
164202849|NCT03451045|593115212|FG001|Overall Study|Non-compliance with study|0|||
164202850|NCT03451045|593115213|FG002|Overall Study|Non-compliance with study|1|||
164202851|NCT03451045|593115211|FG000|Overall Study|any other reason|10|||
164202852|NCT03451045|593115212|FG001|Overall Study|any other reason|2|||
164660886|NCT01296932|594784984|FG007|Overall Study|IV problems, administration not possible|0|||
164660887|NCT01296932|594784985|FG008|Overall Study|IV problems, administration not possible|0|||
164660888|NCT01296932|594784977|FG000|Overall Study|per protocol|0|||
164313766|NCT01598129|593526020|FG000|Overall Study|Withdrawal by Subject|1|||
164313767|NCT00647270|593526021|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
164313768|NCT00647270|593526022|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
164313769|NCT00647270|593526023|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
164313770|NCT00647270|593526021|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
164313771|NCT00647270|593526022|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
164313772|NCT00647270|593526023|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
164313773|NCT00647270|593526021|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
164313774|NCT00647270|593526022|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
164202853|NCT03451045|593115213|FG002|Overall Study|any other reason|13|||
164202854|NCT00863707|593115214|FG000|Overall Study|Randomized, but drug not received|4|||
164202855|NCT00863707|593115215|FG001|Overall Study|Randomized, but drug not received|3|||
164202856|NCT03040726|593115222|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
164556674|NCT01888640|594408200|FG002|Overall Study|Given wrong unit (placebo)|0|||
164556675|NCT01888640|594408198|FG000|Overall Study|Excluded for prior TENS|0|||
164556676|NCT01888640|594408199|FG001|Overall Study|Excluded for prior TENS|1|||
164556677|NCT01888640|594408200|FG002|Overall Study|Excluded for prior TENS|0|||
164556678|NCT01888640|594408198|FG000|Overall Study|Researcher Termination of Participant|0|||
164202857|NCT03040726|593115223|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
164202858|NCT03040726|593115222|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
164202859|NCT03040726|593115223|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
164202860|NCT03040726|593115222|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
164202861|NCT03040726|593115223|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
164202862|NCT03040726|593115222|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
164202863|NCT03040726|593115223|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
164202864|NCT03040726|593115222|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
164202865|NCT03040726|593115223|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
164202866|NCT00062166|593115224|FG000|Overall Study|Withdrawal by Subject|6|||
164202867|NCT05063448|593115225|FG000|Overall Study|Withdrawal by Subject|1|||
164202868|NCT06494761|593115229|FG000|Period 2: (Test Period) (15 days)|Adverse Event|1|||
164202869|NCT06494761|593115229|FG000|Period 2: (Test Period) (15 days)|Physician Decision|1|||
164202870|NCT04865289|593115230|FG000|Overall Study|Death|34|||
164202871|NCT04865289|593115231|FG001|Overall Study|Death|25|||
164202872|NCT04865289|593115230|FG000|Overall Study|Physician Decision|27|||
164202873|NCT04865289|593115231|FG001|Overall Study|Physician Decision|27|||
164202874|NCT04865289|593115230|FG000|Overall Study|Sponsor Decision|11|||
164202875|NCT04865289|593115231|FG001|Overall Study|Sponsor Decision|1|||
164202876|NCT04865289|593115230|FG000|Overall Study|Withdrawal by Subject|2|||
164202877|NCT04865289|593115231|FG001|Overall Study|Withdrawal by Subject|3|||
164202878|NCT03104374|593115232|FG000|Period 1|Adverse Event|7|||
164202879|NCT03104374|593115233|FG001|Period 1|Adverse Event|7|||
164202880|NCT03104374|593115234|FG002|Period 1|Adverse Event|12|||
164202881|NCT03104374|593115235|FG003|Period 1|Adverse Event|14|||
164202882|NCT03104374|593115232|FG000|Period 1|Withdrawal by Subject|18|||
164202883|NCT03104374|593115233|FG001|Period 1|Withdrawal by Subject|9|||
164202884|NCT03104374|593115234|FG002|Period 1|Withdrawal by Subject|10|||
164202885|NCT03104374|593115235|FG003|Period 1|Withdrawal by Subject|17|||
164202886|NCT03104374|593115232|FG000|Period 1|Lost to Follow-up|4|||
164202887|NCT03104374|593115233|FG001|Period 1|Lost to Follow-up|4|||
164202888|NCT03104374|593115234|FG002|Period 1|Lost to Follow-up|6|||
164202889|NCT03104374|593115235|FG003|Period 1|Lost to Follow-up|8|||
164556679|NCT01888640|594408199|FG001|Overall Study|Researcher Termination of Participant|1|||
164556680|NCT01888640|594408200|FG002|Overall Study|Researcher Termination of Participant|1|||
164556681|NCT02199080|594408201|FG000|Overall Study|Protocol Violation|12|||
164556682|NCT02443883|594408202|FG000|Overall Study|Adverse Event|0|||
164556683|NCT02443883|594408203|FG001|Overall Study|Adverse Event|1|||
164556684|NCT02443883|594408204|FG002|Overall Study|Adverse Event|0|||
164556685|NCT02443883|594408205|FG003|Overall Study|Adverse Event|0|||
164556686|NCT02443883|594408202|FG000|Overall Study|Lost to Follow-up|3|||
164556687|NCT02443883|594408203|FG001|Overall Study|Lost to Follow-up|2|||
164556688|NCT02443883|594408204|FG002|Overall Study|Lost to Follow-up|1|||
164556689|NCT02443883|594408205|FG003|Overall Study|Lost to Follow-up|0|||
164556690|NCT02443883|594408202|FG000|Overall Study|Physician Decision|1|||
164660889|NCT01296932|594784978|FG001|Overall Study|per protocol|0|||
164660890|NCT01296932|594784979|FG002|Overall Study|per protocol|1|||
164202890|NCT03104374|593115232|FG000|Period 1|Lack of Efficacy|6|||
164420608|NCT01890967|593910947|FG001|Overall Study|Sponsor Decision|0|||
164556691|NCT02443883|594408203|FG001|Overall Study|Physician Decision|1|||
164556692|NCT02443883|594408204|FG002|Overall Study|Physician Decision|0|||
164556693|NCT02443883|594408205|FG003|Overall Study|Physician Decision|3|||
164202891|NCT03104374|593115233|FG001|Period 1|Lack of Efficacy|7|||
164202892|NCT03104374|593115234|FG002|Period 1|Lack of Efficacy|12|||
164202893|NCT03104374|593115235|FG003|Period 1|Lack of Efficacy|6|||
164556694|NCT02443883|594408202|FG000|Overall Study|Withdrawal by Subject|1|||
164556695|NCT02443883|594408203|FG001|Overall Study|Withdrawal by Subject|0|||
164556696|NCT02443883|594408204|FG002|Overall Study|Withdrawal by Subject|0|||
164556697|NCT02443883|594408205|FG003|Overall Study|Withdrawal by Subject|2|||
164556698|NCT02443883|594408202|FG000|Overall Study|Randomized, but never treated|1|||
164556699|NCT02443883|594408203|FG001|Overall Study|Randomized, but never treated|0|||
164556700|NCT02443883|594408204|FG002|Overall Study|Randomized, but never treated|0|||
164556701|NCT02443883|594408205|FG003|Overall Study|Randomized, but never treated|0|||
164556702|NCT01277549|594408206|FG000|Overall Study|Failed to meet eligibility criteria|13|||
164556703|NCT01277549|594408207|FG001|Overall Study|Failed to meet eligibility criteria|9|||
164660891|NCT01296932|594784980|FG003|Overall Study|per protocol|1|||
164660892|NCT01296932|594784981|FG004|Overall Study|per protocol|0|||
164202894|NCT03104374|593115232|FG000|Period 1|Other|2|||
164202895|NCT03104374|593115233|FG001|Period 1|Other|2|||
164202896|NCT03104374|593115234|FG002|Period 1|Other|4|||
164202897|NCT03104374|593115235|FG003|Period 1|Other|7|||
164202898|NCT03104374|593115232|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
164202899|NCT03104374|593115233|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
164202900|NCT03104374|593115234|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
164202901|NCT03104374|593115235|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
164202902|NCT03104374|593115232|FG000|Period 2|Adverse Event|4|||
164202903|NCT03104374|593115233|FG001|Period 2|Adverse Event|7|||
164202904|NCT03104374|593115234|FG002|Period 2|Adverse Event|10|||
164202905|NCT03104374|593115235|FG003|Period 2|Adverse Event|10|||
164202906|NCT03104374|593115232|FG000|Period 2|Withdrawal by Subject|3|||
164202907|NCT03104374|593115233|FG001|Period 2|Withdrawal by Subject|7|||
164202908|NCT03104374|593115234|FG002|Period 2|Withdrawal by Subject|13|||
164202909|NCT03104374|593115235|FG003|Period 2|Withdrawal by Subject|16|||
164202910|NCT03104374|593115232|FG000|Period 2|Lost to Follow-up|2|||
164202911|NCT03104374|593115233|FG001|Period 2|Lost to Follow-up|2|||
164202912|NCT03104374|593115234|FG002|Period 2|Lost to Follow-up|3|||
164202913|NCT03104374|593115235|FG003|Period 2|Lost to Follow-up|5|||
164202914|NCT03104374|593115232|FG000|Period 2|Lack of Efficacy|2|||
164202915|NCT03104374|593115233|FG001|Period 2|Lack of Efficacy|4|||
164202916|NCT03104374|593115234|FG002|Period 2|Lack of Efficacy|7|||
164202917|NCT03104374|593115235|FG003|Period 2|Lack of Efficacy|4|||
164202918|NCT03104374|593115232|FG000|Period 2|COVID-19 Infection|0|||
164202919|NCT03104374|593115233|FG001|Period 2|COVID-19 Infection|0|||
164202920|NCT03104374|593115234|FG002|Period 2|COVID-19 Infection|1|||
164202921|NCT03104374|593115235|FG003|Period 2|COVID-19 Infection|0|||
164202922|NCT03104374|593115232|FG000|Period 2|Other|3|||
164202923|NCT03104374|593115233|FG001|Period 2|Other|2|||
164202924|NCT03104374|593115234|FG002|Period 2|Other|2|||
164202925|NCT03104374|593115235|FG003|Period 2|Other|4|||
164202926|NCT00803179|593115236|FG000|Overall Study|Lost to Follow-up|3|||
164202927|NCT00885118|593115237|FG000|Overall Study|Adverse Event|1|||
164202928|NCT00885118|593115238|FG001|Overall Study|Adverse Event|0|||
164202929|NCT00885118|593115239|FG002|Overall Study|Adverse Event|0|||
164202930|NCT00885118|593115240|FG003|Overall Study|Adverse Event|0|||
164202931|NCT00885118|593115241|FG004|Overall Study|Adverse Event|0|||
164202932|NCT00885118|593115237|FG000|Overall Study|Withdrawal by Subject|0|||
164202933|NCT00885118|593115238|FG001|Overall Study|Withdrawal by Subject|0|||
164202934|NCT00885118|593115239|FG002|Overall Study|Withdrawal by Subject|0|||
164202935|NCT00885118|593115240|FG003|Overall Study|Withdrawal by Subject|0|||
164202936|NCT00885118|593115241|FG004|Overall Study|Withdrawal by Subject|1|||
164202937|NCT00885118|593115237|FG000|Overall Study|Other reason not defined above|0|||
164202938|NCT00885118|593115238|FG001|Overall Study|Other reason not defined above|0|||
164202939|NCT00885118|593115239|FG002|Overall Study|Other reason not defined above|1|||
164202940|NCT00885118|593115240|FG003|Overall Study|Other reason not defined above|0|||
164202941|NCT00885118|593115241|FG004|Overall Study|Other reason not defined above|0|||
164202942|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
164202943|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
164202944|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
164202945|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
164202946|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
164202947|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
164202948|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
164202949|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
164202950|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
164202951|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
164202952|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
164202953|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
164202954|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
164202955|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
164202956|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
164202957|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
164202958|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
164202959|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
164202960|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
164202961|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
164202962|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
164202963|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
164202964|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
164202965|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
164202966|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
164202967|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
164202968|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
164202969|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
164202970|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
164202971|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
164202972|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
164202973|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
164202974|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
164202975|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
164202976|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
164202977|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
164202978|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
164202979|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
164202980|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
164202981|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
164202982|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
164202983|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
164202984|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
164202985|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
164202986|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
164202987|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
164202988|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
164202989|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
164202990|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
164202991|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
164202992|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
164202993|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
164202994|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
164202995|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
164202996|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
164202997|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
164202998|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
164202999|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
164203000|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
164203001|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
164203002|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
164203003|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
164203004|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
164203005|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
164203006|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
164203007|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
164203008|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
164203009|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
164203010|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
164203011|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
164203012|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
164203013|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
164203014|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
164203015|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
164203016|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
164302986|NCT01198977|593484680|FG000|Overall Study|Lost to Follow-up|1|||
164420609|NCT01890967|593910948|FG002|Overall Study|Sponsor Decision|1|||
164556704|NCT01277549|594408206|FG000|Overall Study|Withdrawal by Subject|1|||
164556705|NCT01277549|594408207|FG001|Overall Study|Withdrawal by Subject|3|||
164556706|NCT01277549|594408206|FG000|Overall Study|Protocol Violation|10|||
164556707|NCT01277549|594408207|FG001|Overall Study|Protocol Violation|1|||
164556708|NCT01277549|594408206|FG000|Overall Study|Physician Decision|2|||
164556709|NCT01277549|594408207|FG001|Overall Study|Physician Decision|1|||
164556710|NCT00999908|594408210|FG000|Treatment Period 1|Subject withdrew consent|2|||
164203017|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
164203018|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
164203019|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
164203020|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
164203021|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
164203022|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
164203023|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
164203024|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
164203025|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
164203026|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
164203027|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
164203028|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
164203029|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
164203030|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
164203031|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
164203032|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
164203033|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
164556711|NCT00999908|594408211|FG001|Treatment Period 1|Subject withdrew consent|0|||
164556712|NCT00999908|594408212|FG002|Treatment Period 1|Subject withdrew consent|0|||
164556713|NCT00999908|594408210|FG000|Treatment Period 2|Protocol Violation|1|||
164203034|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
164203035|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
164203036|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
164203037|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
164203038|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
164203039|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
164203040|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
164203041|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
164556714|NCT00999908|594408211|FG001|Treatment Period 2|Protocol Violation|0|||
164556715|NCT00999908|594408212|FG002|Treatment Period 2|Protocol Violation|0|||
164556716|NCT00623428|594408215|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
164556717|NCT00623428|594408216|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
164556718|NCT00623428|594408215|FG000|Treatment Period|Death|0|||
164556719|NCT00623428|594408216|FG001|Treatment Period|Death|1|||
164556720|NCT00623428|594408215|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
164556721|NCT00623428|594408216|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
164556722|NCT00623428|594408215|FG000|Treatment Period|Insufficient therapeutic response|0|||
164556723|NCT00623428|594408216|FG001|Treatment Period|Insufficient therapeutic response|2|||
164556724|NCT00623428|594408215|FG000|Treatment Period|Other|0|||
164556725|NCT00623428|594408216|FG001|Treatment Period|Other|1|||
164556726|NCT00623428|594408215|FG000|Treatment Period|Withdrawal by Subject|0|||
164556727|NCT00623428|594408216|FG001|Treatment Period|Withdrawal by Subject|1|||
164556728|NCT00623428|594408215|FG000|Follow-up Period|Relapse post-treatment|11|||
164556729|NCT00623428|594408216|FG001|Follow-up Period|Relapse post-treatment|3|||
164556730|NCT00623428|594408215|FG000|Follow-up Period|Failure to return|10|||
164556731|NCT00623428|594408216|FG001|Follow-up Period|Failure to return|2|||
164556732|NCT00623428|594408215|FG000|Follow-up Period|Patient withdrew consent|5|||
164556733|NCT00623428|594408216|FG001|Follow-up Period|Patient withdrew consent|4|||
164556734|NCT00623428|594408215|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
164556735|NCT00623428|594408216|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
164556736|NCT00623428|594408215|FG000|Follow-up Period|Did not cooperate|0|||
164203042|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
164203043|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
164203044|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
164203045|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
164203046|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
164203047|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
164203048|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
164203049|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
164660893|NCT01296932|594784982|FG005|Overall Study|per protocol|0|||
164660894|NCT01296932|594784983|FG006|Overall Study|per protocol|0|||
164660895|NCT01296932|594784984|FG007|Overall Study|per protocol|0|||
164660896|NCT01296932|594784985|FG008|Overall Study|per protocol|0|||
164660897|NCT01296932|594784977|FG000|Overall Study|Low benefit and too many side effects|0|||
164660898|NCT01296932|594784978|FG001|Overall Study|Low benefit and too many side effects|0|||
164660899|NCT01296932|594784979|FG002|Overall Study|Low benefit and too many side effects|0|||
164660900|NCT01296932|594784980|FG003|Overall Study|Low benefit and too many side effects|0|||
164660901|NCT01296932|594784981|FG004|Overall Study|Low benefit and too many side effects|0|||
164660902|NCT01296932|594784982|FG005|Overall Study|Low benefit and too many side effects|0|||
164660903|NCT01296932|594784983|FG006|Overall Study|Low benefit and too many side effects|0|||
164660904|NCT01296932|594784984|FG007|Overall Study|Low benefit and too many side effects|1|||
164660905|NCT01296932|594784985|FG008|Overall Study|Low benefit and too many side effects|0|||
164660906|NCT01296932|594784977|FG000|Overall Study|No adequate treatment response|0|||
164660907|NCT01296932|594784978|FG001|Overall Study|No adequate treatment response|0|||
164660908|NCT01296932|594784979|FG002|Overall Study|No adequate treatment response|0|||
164660909|NCT01296932|594784980|FG003|Overall Study|No adequate treatment response|0|||
164313775|NCT00647270|593526023|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
164313776|NCT00647270|593526021|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
164313777|NCT00647270|593526022|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
164313778|NCT00647270|593526023|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
164313779|NCT00647270|593526021|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
164313780|NCT00647270|593526022|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
164313781|NCT00647270|593526023|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
164313782|NCT00647270|593526021|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
164313783|NCT00647270|593526022|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
164313784|NCT00647270|593526023|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
164313785|NCT00647270|593526021|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
164313786|NCT00647270|593526022|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
164313787|NCT00647270|593526023|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
164313788|NCT03615040|593526024|FG000|Overall Study|Withdrawal by Subject|2|||
164313789|NCT03615040|593526025|FG001|Overall Study|Withdrawal by Subject|1|||
164313790|NCT03615040|593526024|FG000|Overall Study|Physician Decision|2|||
164313791|NCT03615040|593526025|FG001|Overall Study|Physician Decision|2|||
164313792|NCT03615040|593526024|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
164313793|NCT03615040|593526025|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
164313794|NCT03615040|593526024|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
164313795|NCT03615040|593526025|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
164313796|NCT03615040|593526024|FG000|Overall Study|Death|0|||
164313797|NCT03615040|593526025|FG001|Overall Study|Death|2|||
164313798|NCT01024309|593526028|FG000|Overall Study|Physician Decision|4|||
164313799|NCT01024309|593526029|FG001|Overall Study|Physician Decision|0|||
164313800|NCT01024309|593526028|FG000|Overall Study|Withdrawal by Subject|4|||
164313801|NCT01024309|593526029|FG001|Overall Study|Withdrawal by Subject|4|||
164313802|NCT00435045|593526032|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
164313803|NCT00435045|593526033|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
164313804|NCT00435045|593526032|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
164313805|NCT00435045|593526033|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
164313806|NCT00435045|593526032|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
164313807|NCT00435045|593526033|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
164313808|NCT00435045|593526032|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
164313809|NCT00435045|593526033|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
164313810|NCT00435045|593526032|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
164313811|NCT00435045|593526033|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
164313812|NCT00435045|593526032|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
164313813|NCT00435045|593526033|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
164313814|NCT00435045|593526032|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
164313815|NCT00435045|593526033|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
164313816|NCT00435045|593526032|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
164313817|NCT00435045|593526033|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
164660910|NCT01296932|594784981|FG004|Overall Study|No adequate treatment response|0|||
164660911|NCT01296932|594784982|FG005|Overall Study|No adequate treatment response|0|||
164313818|NCT00435045|593526032|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
164313819|NCT00435045|593526033|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
164420610|NCT01890967|593910949|FG003|Overall Study|Sponsor Decision|3|||
164420611|NCT01890967|593910950|FG004|Overall Study|Sponsor Decision|2|||
164660912|NCT01296932|594784983|FG006|Overall Study|No adequate treatment response|0|||
164660913|NCT01296932|594784984|FG007|Overall Study|No adequate treatment response|1|||
164660914|NCT01296932|594784985|FG008|Overall Study|No adequate treatment response|0|||
164313820|NCT00435045|593526032|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
164313821|NCT00435045|593526033|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
164313822|NCT00435045|593526032|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
164313823|NCT00435045|593526033|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
164313824|NCT01743001|593526034|FG000|Overall Study|Physician Decision|1|||
164313825|NCT01743001|593526035|FG001|Overall Study|Physician Decision|0|||
164313826|NCT01743001|593526034|FG000|Overall Study|Pregnancy|1|||
164313827|NCT01743001|593526035|FG001|Overall Study|Pregnancy|0|||
164313828|NCT01743001|593526034|FG000|Overall Study|Death|1|||
164313829|NCT01743001|593526035|FG001|Overall Study|Death|0|||
164313830|NCT03052426|593526036|FG000|Overall Study|Withdrawal by Subject|0|||
164313831|NCT03052426|593526037|FG001|Overall Study|Withdrawal by Subject|1|||
164313832|NCT03052426|593526038|FG002|Overall Study|Withdrawal by Subject|0|||
164313833|NCT03052426|593526036|FG000|Overall Study|Lost to Follow-up|2|||
164313834|NCT03052426|593526037|FG001|Overall Study|Lost to Follow-up|0|||
164313835|NCT03052426|593526038|FG002|Overall Study|Lost to Follow-up|1|||
164313836|NCT01090323|593526041|FG000|Overall Study|Adverse Event|12|||
164313837|NCT01090323|593526042|FG001|Overall Study|Adverse Event|2|||
164313838|NCT01090323|593526041|FG000|Overall Study|Abnormal Lab Values|3|||
164313839|NCT01090323|593526042|FG001|Overall Study|Abnormal Lab Values|1|||
164313840|NCT01090323|593526041|FG000|Overall Study|Abnormal Test Procedure Results|2|||
164313841|NCT01090323|593526042|FG001|Overall Study|Abnormal Test Procedure Results|0|||
164313842|NCT01090323|593526041|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
164313843|NCT01090323|593526042|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164313844|NCT01090323|593526041|FG000|Overall Study|Condition no longer requires drug|5|||
164313845|NCT01090323|593526042|FG001|Overall Study|Condition no longer requires drug|4|||
164313846|NCT01090323|593526041|FG000|Overall Study|Protocol Violation|2|||
164313847|NCT01090323|593526042|FG001|Overall Study|Protocol Violation|1|||
164313848|NCT01090323|593526041|FG000|Overall Study|Withdrew consent|33|||
164313849|NCT01090323|593526042|FG001|Overall Study|Withdrew consent|11|||
164313850|NCT01090323|593526041|FG000|Overall Study|Lost to Follow-up|11|||
164313851|NCT01090323|593526042|FG001|Overall Study|Lost to Follow-up|6|||
164313852|NCT01090323|593526041|FG000|Overall Study|Administrative problems|6|||
164313853|NCT01090323|593526042|FG001|Overall Study|Administrative problems|4|||
164313854|NCT01090323|593526041|FG000|Overall Study|Death|1|||
164313855|NCT01090323|593526042|FG001|Overall Study|Death|2|||
164313856|NCT01090323|593526041|FG000|Overall Study|Stopped end of core|7|||
164313857|NCT01090323|593526042|FG001|Overall Study|Stopped end of core|0|||
164313858|NCT01090323|593526041|FG000|Overall Study|Stopped end of extension 1#|3|||
164313859|NCT01090323|593526042|FG001|Overall Study|Stopped end of extension 1#|1|||
164313860|NCT05498701|593526043|FG000|Period 3|Adverse Event|1|||
164313861|NCT05498701|593526044|FG001|Period 3|Adverse Event|0|||
164313862|NCT01864005|593526045|FG000|Overall Study|Protocol Violation|0|||
164313863|NCT01864005|593526046|FG001|Overall Study|Protocol Violation|1|||
164313864|NCT01864005|593526045|FG000|Overall Study|Withdrawal by Subject|0|||
164313865|NCT01864005|593526046|FG001|Overall Study|Withdrawal by Subject|1|||
164313866|NCT01864005|593526045|FG000|Overall Study|Incorrect enrolment|1|||
164313867|NCT01864005|593526046|FG001|Overall Study|Incorrect enrolment|0|||
164313868|NCT01864005|593526045|FG000|Overall Study|Disease need|1|||
164313869|NCT01864005|593526046|FG001|Overall Study|Disease need|1|||
164313870|NCT01864005|593526045|FG000|Overall Study|Need GP IIb/IIIa|1|||
164313871|NCT01864005|593526046|FG001|Overall Study|Need GP IIb/IIIa|3|||
164313872|NCT02424578|593526047|FG000|Overall Study|Withdrawal by Subject|0|||
164313873|NCT02424578|593526048|FG001|Overall Study|Withdrawal by Subject|1|||
164313874|NCT03679754|593526049|FG000|Overall Study|Investigator request|1|||
164313875|NCT00964171|593526050|FG000|Overall Study|Death|5|||
164313876|NCT03179319|593526054|FG000|Overall Study|Lost to Follow-up|6|||
164313877|NCT03179319|593526055|FG001|Overall Study|Lost to Follow-up|0|||
164313878|NCT00635999|593526056|FG000|Overall Study|Withdrawal by Subject|4|||
164313879|NCT00635999|593526057|FG001|Overall Study|Withdrawal by Subject|2|||
164313880|NCT00635999|593526058|FG002|Overall Study|Withdrawal by Subject|1|||
164313881|NCT00711477|593526059|FG000|Overall Study|Adverse Event|3|||
164313882|NCT00711477|593526060|FG001|Overall Study|Adverse Event|1|||
164556737|NCT00623428|594408216|FG001|Follow-up Period|Did not cooperate|3|||
164556738|NCT00623428|594408215|FG000|Follow-up Period|Reason not specified|1|||
164313883|NCT00711477|593526059|FG000|Overall Study|Lost to Follow-up|0|||
164556739|NCT00623428|594408216|FG001|Follow-up Period|Reason not specified|1|||
164313884|NCT00711477|593526060|FG001|Overall Study|Lost to Follow-up|1|||
164313885|NCT00711477|593526059|FG000|Overall Study|Noncompliance|0|||
164313886|NCT00711477|593526060|FG001|Overall Study|Noncompliance|1|||
164313887|NCT02636361|593526061|FG000|Period 4|Physician Decision|0|||
164313888|NCT02636361|593526062|FG001|Period 4|Physician Decision|0|||
164313889|NCT02636361|593526063|FG002|Period 4|Physician Decision|0|||
164313890|NCT02636361|593526064|FG003|Period 4|Physician Decision|1|||
164313891|NCT02636361|593526065|FG004|Period 4|Physician Decision|0|||
164313892|NCT02695420|593526066|FG000|Overall Study|Death|0|||
164313893|NCT02695420|593526067|FG001|Overall Study|Death|1|||
164313894|NCT02695420|593526068|FG002|Overall Study|Death|0|||
164313895|NCT02695420|593526069|FG003|Overall Study|Death|0|||
164313896|NCT02929407|593526073|FG000|Overall Study|Adverse Event|1|||
164313897|NCT00916929|593526074|FG000|Overall Study|Lost to Follow-up|1|||
164313898|NCT00916929|593526075|FG001|Overall Study|Lost to Follow-up|3|||
164313899|NCT00916929|593526074|FG000|Overall Study|Death|5|||
164313900|NCT00916929|593526075|FG001|Overall Study|Death|10|||
164313901|NCT00916929|593526074|FG000|Overall Study|Withdrawal by Subject|1|||
164313902|NCT00916929|593526075|FG001|Overall Study|Withdrawal by Subject|5|||
164313903|NCT00916929|593526074|FG000|Overall Study|Left ventricular epicardial lead|1|||
164313904|NCT00916929|593526075|FG001|Overall Study|Left ventricular epicardial lead|2|||
164313905|NCT00916929|593526074|FG000|Overall Study|Transferred to hospice care|1|||
164313906|NCT00916929|593526075|FG001|Overall Study|Transferred to hospice care|1|||
164313907|NCT00916929|593526074|FG000|Overall Study|System explant|1|||
164313908|NCT00916929|593526075|FG001|Overall Study|System explant|0|||
164313909|NCT00916929|593526074|FG000|Overall Study|Moved to another state|0|||
164313910|NCT00916929|593526075|FG001|Overall Study|Moved to another state|1|||
164313911|NCT00916929|593526074|FG000|Overall Study|Device unable to process impedance data|0|||
164313912|NCT00916929|593526075|FG001|Overall Study|Device unable to process impedance data|7|||
164313913|NCT03037580|593526077|FG000|Overall Study|Withdrawal by Subject|3|||
164313914|NCT03037580|593526078|FG001|Overall Study|Withdrawal by Subject|0|||
164313915|NCT03037580|593526077|FG000|Overall Study|Adverse Event|1|||
164313916|NCT03037580|593526078|FG001|Overall Study|Adverse Event|0|||
164313917|NCT03037580|593526077|FG000|Overall Study|Study Terminated by Sponsor|12|||
164313918|NCT03037580|593526078|FG001|Overall Study|Study Terminated by Sponsor|15|||
164313919|NCT03037580|593526077|FG000|Overall Study|Death|0|||
164313920|NCT03037580|593526078|FG001|Overall Study|Death|1|||
164313921|NCT02036853|593526079|FG000|Overall Study|Adverse Event|0|||
164313922|NCT02036853|593526080|FG001|Overall Study|Adverse Event|2|||
164313923|NCT02036853|593526079|FG000|Overall Study|Lack of Efficacy|0|||
164313924|NCT02036853|593526080|FG001|Overall Study|Lack of Efficacy|2|||
164313925|NCT02036853|593526079|FG000|Overall Study|Physician Decision|0|||
164313926|NCT02036853|593526080|FG001|Overall Study|Physician Decision|1|||
164313927|NCT02036853|593526079|FG000|Overall Study|Withdrawal by Subject|0|||
164313928|NCT02036853|593526080|FG001|Overall Study|Withdrawal by Subject|1|||
164313929|NCT00228553|593526081|FG000|Overall Study|Adverse Event|112|||
164313930|NCT00228553|593526081|FG000|Overall Study|Lack of Efficacy|34|||
164313931|NCT00228553|593526081|FG000|Overall Study|Lost to Follow-up|67|||
164313932|NCT00228553|593526081|FG000|Overall Study|Physician Decision|48|||
164313933|NCT00228553|593526081|FG000|Overall Study|Protocol Violation|6|||
164313934|NCT00228553|593526081|FG000|Overall Study|Withdrawal by Subject|115|||
164313935|NCT00228553|593526081|FG000|Overall Study|Pregnancy|2|||
164313936|NCT00228553|593526081|FG000|Overall Study|Miscellaneous|46|||
164313937|NCT01309282|593526082|FG000|Overall Study|Lost to Follow-up|1|||
164313938|NCT02087423|593526083|FG000|Overall Study|Withdrawal by Subject|20|||
164313939|NCT02087423|593526084|FG001|Overall Study|Withdrawal by Subject|20|||
164313940|NCT02087423|593526085|FG002|Overall Study|Withdrawal by Subject|3|||
164313941|NCT02087423|593526083|FG000|Overall Study|Death|68|||
164313942|NCT02087423|593526084|FG001|Overall Study|Death|207|||
164313943|NCT02087423|593526085|FG002|Overall Study|Death|40|||
164313944|NCT02087423|593526083|FG000|Overall Study|Lost to Follow-up|0|||
164313945|NCT02087423|593526084|FG001|Overall Study|Lost to Follow-up|2|||
164313946|NCT02087423|593526085|FG002|Overall Study|Lost to Follow-up|0|||
164313947|NCT02087423|593526083|FG000|Overall Study|Terminated from study at final DCO|23|||
164313948|NCT02087423|593526084|FG001|Overall Study|Terminated from study at final DCO|36|||
164313949|NCT02087423|593526085|FG002|Overall Study|Terminated from study at final DCO|25|||
164660915|NCT01296932|594784977|FG000|Overall Study|Dosage already reduced, AE still present|0|||
164313950|NCT00499590|593526088|FG000|Overall Study|Study Terminated|112|||
164313951|NCT00499590|593526089|FG001|Overall Study|Study Terminated|112|||
164313952|NCT00499590|593526090|FG002|Overall Study|Study Terminated|112|||
164313953|NCT00499590|593526088|FG000|Overall Study|Not treated|1|||
164313954|NCT00499590|593526089|FG001|Overall Study|Not treated|0|||
164313955|NCT00499590|593526090|FG002|Overall Study|Not treated|1|||
164313956|NCT02633020|593526094|FG000|Overall Study|Adverse Event|1|||
164313957|NCT02633020|593526095|FG001|Overall Study|Adverse Event|0|||
164313958|NCT00934440|593526096|FG000|Overall Study|Lost to Follow-up|1|||
164313959|NCT02152956|593526097|FG000|Overall Study|Adverse Event|0|||
164313960|NCT02152956|593526098|FG001|Overall Study|Adverse Event|0|||
164313961|NCT02152956|593526099|FG002|Overall Study|Adverse Event|0|||
164313962|NCT02152956|593526100|FG003|Overall Study|Adverse Event|0|||
164313963|NCT02152956|593526101|FG004|Overall Study|Adverse Event|0|||
164313964|NCT02152956|593526102|FG005|Overall Study|Adverse Event|0|||
164313965|NCT02152956|593526103|FG006|Overall Study|Adverse Event|0|||
164313966|NCT02152956|593526104|FG007|Overall Study|Adverse Event|0|||
164313967|NCT02152956|593526105|FG008|Overall Study|Adverse Event|0|||
164313968|NCT02152956|593526106|FG009|Overall Study|Adverse Event|0|||
164313969|NCT02152956|593526107|FG010|Overall Study|Adverse Event|0|||
164313970|NCT02152956|593526108|FG011|Overall Study|Adverse Event|4|||
164313971|NCT02152956|593526109|FG012|Overall Study|Adverse Event|0|||
164313972|NCT02152956|593526097|FG000|Overall Study|Death|0|||
164313973|NCT02152956|593526098|FG001|Overall Study|Death|3|||
164313974|NCT02152956|593526099|FG002|Overall Study|Death|3|||
164313975|NCT02152956|593526100|FG003|Overall Study|Death|4|||
164313976|NCT02152956|593526101|FG004|Overall Study|Death|1|||
164313977|NCT02152956|593526102|FG005|Overall Study|Death|2|||
164313978|NCT02152956|593526103|FG006|Overall Study|Death|6|||
164313979|NCT02152956|593526104|FG007|Overall Study|Death|6|||
164313980|NCT02152956|593526105|FG008|Overall Study|Death|4|||
164313981|NCT02152956|593526106|FG009|Overall Study|Death|5|||
164313982|NCT02152956|593526107|FG010|Overall Study|Death|3|||
164313983|NCT02152956|593526108|FG011|Overall Study|Death|143|||
164313984|NCT02152956|593526109|FG012|Overall Study|Death|12|||
164313985|NCT02152956|593526097|FG000|Overall Study|Lost to Follow-up|0|||
164313986|NCT02152956|593526098|FG001|Overall Study|Lost to Follow-up|1|||
164313987|NCT02152956|593526099|FG002|Overall Study|Lost to Follow-up|0|||
164313988|NCT02152956|593526100|FG003|Overall Study|Lost to Follow-up|0|||
164313989|NCT02152956|593526101|FG004|Overall Study|Lost to Follow-up|0|||
164313990|NCT02152956|593526102|FG005|Overall Study|Lost to Follow-up|0|||
164313991|NCT02152956|593526103|FG006|Overall Study|Lost to Follow-up|0|||
164313992|NCT02152956|593526104|FG007|Overall Study|Lost to Follow-up|0|||
164313993|NCT02152956|593526105|FG008|Overall Study|Lost to Follow-up|0|||
164313994|NCT02152956|593526106|FG009|Overall Study|Lost to Follow-up|0|||
164313995|NCT02152956|593526107|FG010|Overall Study|Lost to Follow-up|0|||
164313996|NCT02152956|593526108|FG011|Overall Study|Lost to Follow-up|3|||
164313997|NCT02152956|593526109|FG012|Overall Study|Lost to Follow-up|0|||
164313998|NCT02152956|593526097|FG000|Overall Study|Withdrawal by Subject|1|||
164313999|NCT02152956|593526098|FG001|Overall Study|Withdrawal by Subject|0|||
164314000|NCT02152956|593526099|FG002|Overall Study|Withdrawal by Subject|1|||
164314001|NCT02152956|593526100|FG003|Overall Study|Withdrawal by Subject|0|||
164314002|NCT02152956|593526101|FG004|Overall Study|Withdrawal by Subject|2|||
164314003|NCT02152956|593526102|FG005|Overall Study|Withdrawal by Subject|2|||
164314004|NCT02152956|593526103|FG006|Overall Study|Withdrawal by Subject|0|||
164314005|NCT02152956|593526104|FG007|Overall Study|Withdrawal by Subject|0|||
164314006|NCT02152956|593526105|FG008|Overall Study|Withdrawal by Subject|1|||
164314007|NCT02152956|593526106|FG009|Overall Study|Withdrawal by Subject|0|||
164314008|NCT02152956|593526107|FG010|Overall Study|Withdrawal by Subject|0|||
164314009|NCT02152956|593526108|FG011|Overall Study|Withdrawal by Subject|4|||
164314010|NCT02152956|593526109|FG012|Overall Study|Withdrawal by Subject|0|||
164314011|NCT02152956|593526097|FG000|Overall Study|Physician Decision|0|||
164314012|NCT02152956|593526098|FG001|Overall Study|Physician Decision|0|||
164314013|NCT02152956|593526099|FG002|Overall Study|Physician Decision|0|||
164314014|NCT02152956|593526100|FG003|Overall Study|Physician Decision|0|||
164314015|NCT02152956|593526101|FG004|Overall Study|Physician Decision|0|||
164314016|NCT02152956|593526102|FG005|Overall Study|Physician Decision|0|||
164314017|NCT02152956|593526103|FG006|Overall Study|Physician Decision|0|||
164314018|NCT02152956|593526104|FG007|Overall Study|Physician Decision|0|||
164314019|NCT02152956|593526105|FG008|Overall Study|Physician Decision|0|||
164314020|NCT02152956|593526106|FG009|Overall Study|Physician Decision|0|||
164314021|NCT02152956|593526107|FG010|Overall Study|Physician Decision|0|||
164314022|NCT02152956|593526108|FG011|Overall Study|Physician Decision|1|||
164314023|NCT02152956|593526109|FG012|Overall Study|Physician Decision|0|||
164314024|NCT02152956|593526097|FG000|Overall Study|Study terminated by sponsor|0|||
164314025|NCT02152956|593526098|FG001|Overall Study|Study terminated by sponsor|0|||
164314026|NCT02152956|593526099|FG002|Overall Study|Study terminated by sponsor|0|||
164314027|NCT02152956|593526100|FG003|Overall Study|Study terminated by sponsor|0|||
164314028|NCT02152956|593526101|FG004|Overall Study|Study terminated by sponsor|0|||
164314029|NCT02152956|593526102|FG005|Overall Study|Study terminated by sponsor|0|||
164314030|NCT02152956|593526103|FG006|Overall Study|Study terminated by sponsor|0|||
164314031|NCT02152956|593526104|FG007|Overall Study|Study terminated by sponsor|0|||
164314032|NCT02152956|593526105|FG008|Overall Study|Study terminated by sponsor|0|||
164314033|NCT02152956|593526106|FG009|Overall Study|Study terminated by sponsor|0|||
164314034|NCT02152956|593526107|FG010|Overall Study|Study terminated by sponsor|0|||
164314035|NCT02152956|593526108|FG011|Overall Study|Study terminated by sponsor|29|||
164314036|NCT02152956|593526109|FG012|Overall Study|Study terminated by sponsor|0|||
164314037|NCT02152956|593526097|FG000|Overall Study|progressive disease|0|||
164314038|NCT02152956|593526098|FG001|Overall Study|progressive disease|0|||
164314039|NCT02152956|593526099|FG002|Overall Study|progressive disease|0|||
164314040|NCT02152956|593526100|FG003|Overall Study|progressive disease|0|||
164314041|NCT02152956|593526101|FG004|Overall Study|progressive disease|0|||
164314042|NCT02152956|593526102|FG005|Overall Study|progressive disease|0|||
164314043|NCT02152956|593526103|FG006|Overall Study|progressive disease|0|||
164314044|NCT02152956|593526104|FG007|Overall Study|progressive disease|0|||
164660916|NCT01296932|594784978|FG001|Overall Study|Dosage already reduced, AE still present|0|||
164314045|NCT02152956|593526105|FG008|Overall Study|progressive disease|1|||
164314046|NCT02152956|593526106|FG009|Overall Study|progressive disease|0|||
164314047|NCT02152956|593526107|FG010|Overall Study|progressive disease|0|||
164314048|NCT02152956|593526108|FG011|Overall Study|progressive disease|1|||
164314049|NCT02152956|593526109|FG012|Overall Study|progressive disease|0|||
164314050|NCT05661851|593526110|FG000|Overall Study|Protocol Violation|1|||
164314051|NCT05661851|593526111|FG001|Overall Study|Protocol Violation|1|||
164314052|NCT05661851|593526110|FG000|Overall Study|Covid-19 Related|3|||
164314053|NCT05661851|593526111|FG001|Overall Study|Covid-19 Related|4|||
164314054|NCT05661851|593526110|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
164314055|NCT05661851|593526111|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
164314056|NCT05661851|593526110|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
164314057|NCT05661851|593526111|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
164314058|NCT01014910|593526112|FG000|Overall Study|Withdrawal by Subject|0|||
164314059|NCT01014910|593526113|FG001|Overall Study|Withdrawal by Subject|2|||
164314060|NCT00744042|593526116|FG000|Overall Study|Withdrawal by Subject|1|||
164314061|NCT00782834|593526117|FG000|Treatment Phase|fibrous tumor not GIST|1|||
164314062|NCT02252939|593526118|FG000|Overall Study|Lost to Follow-up|3|||
164314063|NCT01033448|593526119|FG000|Overall Study|Withdrawal by Subject|4|||
164314064|NCT01033448|593526119|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
164314065|NCT01033448|593526119|FG000|Overall Study|Lost to Follow-up|3|||
164314066|NCT01033448|593526119|FG000|Overall Study|Withdrew due to other reasons|3|||
164314067|NCT01033448|593526119|FG000|Overall Study|Unknown disposition|1|||
164314068|NCT04270370|593526120|FG000|Overall Study|Lost to Follow-up|1|||
164314069|NCT04270370|593526121|FG001|Overall Study|Lost to Follow-up|0|||
164314070|NCT04270370|593526122|FG002|Overall Study|Lost to Follow-up|0|||
164314071|NCT04270370|593526123|FG003|Overall Study|Lost to Follow-up|0|||
164314072|NCT04270370|593526124|FG004|Overall Study|Lost to Follow-up|0|||
164314073|NCT04270370|593526125|FG005|Overall Study|Lost to Follow-up|0|||
164314074|NCT04270370|593526126|FG006|Overall Study|Lost to Follow-up|0|||
164660917|NCT01296932|594784979|FG002|Overall Study|Dosage already reduced, AE still present|0|||
164660918|NCT01296932|594784980|FG003|Overall Study|Dosage already reduced, AE still present|0|||
164660919|NCT01296932|594784981|FG004|Overall Study|Dosage already reduced, AE still present|0|||
164660920|NCT01296932|594784982|FG005|Overall Study|Dosage already reduced, AE still present|0|||
164660921|NCT01296932|594784983|FG006|Overall Study|Dosage already reduced, AE still present|0|||
164660922|NCT01296932|594784984|FG007|Overall Study|Dosage already reduced, AE still present|0|||
164660923|NCT01296932|594784985|FG008|Overall Study|Dosage already reduced, AE still present|1|||
164660924|NCT00862979|594784986|FG000|Overall Study|Adverse Event|6|||
164660925|NCT00862979|594784987|FG001|Overall Study|Adverse Event|3|||
164660926|NCT00862979|594784986|FG000|Overall Study|Protocol Violation|0|||
164660927|NCT00862979|594784987|FG001|Overall Study|Protocol Violation|1|||
164660928|NCT00862979|594784986|FG000|Overall Study|Patient withdrew consent|2|||
164660929|NCT00862979|594784987|FG001|Overall Study|Patient withdrew consent|1|||
164660930|NCT00862979|594784986|FG000|Overall Study|Administrative problems|0|||
164660931|NCT00862979|594784987|FG001|Overall Study|Administrative problems|1|||
164660932|NCT00862979|594784986|FG000|Overall Study|Death|0|||
164660933|NCT00862979|594784987|FG001|Overall Study|Death|1|||
164660934|NCT05568225|594784988|FG000|Primary Treatment Period|Termination of the study by the Sponsor|0|||
164660935|NCT05568225|594784989|FG001|Primary Treatment Period|Termination of the study by the Sponsor|0|||
164660936|NCT05568225|594784990|FG002|Primary Treatment Period|Termination of the study by the Sponsor|1|||
164660937|NCT05568225|594784988|FG000|Primary Treatment Period|Physician Decision|0|||
164660938|NCT05568225|594784989|FG001|Primary Treatment Period|Physician Decision|1|||
164660939|NCT05568225|594784990|FG002|Primary Treatment Period|Physician Decision|0|||
164660940|NCT05568225|594784988|FG000|Primary Treatment Period|Disease progression|0|||
164314075|NCT04270370|593526127|FG007|Overall Study|Lost to Follow-up|0|||
164314076|NCT04270370|593526128|FG008|Overall Study|Lost to Follow-up|1|||
164314077|NCT04270370|593526129|FG009|Overall Study|Lost to Follow-up|0|||
164314078|NCT04270370|593526130|FG010|Overall Study|Lost to Follow-up|0|||
164314079|NCT04270370|593526131|FG011|Overall Study|Lost to Follow-up|0|||
164314080|NCT04189224|593526134|FG000|Period 2|Adverse Event|0|||
164314081|NCT04189224|593526135|FG001|Period 2|Adverse Event|1|||
164314082|NCT03338959|593527548|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
164314083|NCT03338959|593527548|FG000|Overall Study|Physician Decision|1|||
164314084|NCT00409331|593527550|FG000|Overall Study|Physician Decision|1|||
164314085|NCT00281658|593527551|FG000|Randomized Phase|Adverse Event|0|||
164314086|NCT00281658|593527552|FG001|Randomized Phase|Adverse Event|2|||
164314087|NCT00281658|593527553|FG002|Randomized Phase|Adverse Event|0|||
164314088|NCT00281658|593527554|FG003|Randomized Phase|Adverse Event|0|||
164314089|NCT00281658|593527551|FG000|Randomized Phase|Lost to Follow-up|34|||
164314090|NCT00281658|593527552|FG001|Randomized Phase|Lost to Follow-up|27|||
164314091|NCT00281658|593527553|FG002|Randomized Phase|Lost to Follow-up|0|||
164314092|NCT00281658|593527554|FG003|Randomized Phase|Lost to Follow-up|0|||
164660941|NCT05568225|594784989|FG001|Primary Treatment Period|Disease progression|1|||
164660942|NCT05568225|594784990|FG002|Primary Treatment Period|Disease progression|0|||
164314093|NCT00281658|593527551|FG000|Randomized Phase|Withdrawal by Subject|8|||
164314094|NCT00281658|593527552|FG001|Randomized Phase|Withdrawal by Subject|7|||
164314095|NCT00281658|593527553|FG002|Randomized Phase|Withdrawal by Subject|0|||
164314096|NCT00281658|593527554|FG003|Randomized Phase|Withdrawal by Subject|0|||
164314097|NCT00281658|593527551|FG000|Randomized Phase|Study closed/terminated|1|||
164314098|NCT00281658|593527552|FG001|Randomized Phase|Study closed/terminated|1|||
164660943|NCT05568225|594784988|FG000|Primary Treatment Period|Lack of Efficacy|0|||
164314099|NCT00281658|593527553|FG002|Randomized Phase|Study closed/terminated|0|||
164314100|NCT00281658|593527554|FG003|Randomized Phase|Study closed/terminated|0|||
164314101|NCT00281658|593527551|FG000|Randomized Phase|Disease progression|36|||
164314102|NCT00281658|593527552|FG001|Randomized Phase|Disease progression|27|||
164314103|NCT00281658|593527553|FG002|Randomized Phase|Disease progression|0|||
164314104|NCT00281658|593527554|FG003|Randomized Phase|Disease progression|0|||
164314105|NCT00281658|593527551|FG000|Randomized Phase|Physician Decision|1|||
164314106|NCT00281658|593527552|FG001|Randomized Phase|Physician Decision|1|||
164314107|NCT00281658|593527553|FG002|Randomized Phase|Physician Decision|0|||
164314108|NCT00281658|593527554|FG003|Randomized Phase|Physician Decision|0|||
164314109|NCT00281658|593527551|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
164314110|NCT00281658|593527552|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
164314111|NCT00281658|593527553|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
164314112|NCT00281658|593527554|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
164314113|NCT00281658|593527551|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
164314114|NCT00281658|593527552|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
164314115|NCT00281658|593527553|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
164314116|NCT00281658|593527554|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
164314117|NCT00281658|593527551|FG000|Randomized Phase|Treatment ongoing|1|||
164314118|NCT00281658|593527552|FG001|Randomized Phase|Treatment ongoing|0|||
164314119|NCT00281658|593527553|FG002|Randomized Phase|Treatment ongoing|0|||
164314120|NCT00281658|593527554|FG003|Randomized Phase|Treatment ongoing|0|||
164314121|NCT00281658|593527551|FG000|Open Label Phase|Adverse Event|0|||
164314122|NCT00281658|593527552|FG001|Open Label Phase|Adverse Event|0|||
164314123|NCT00281658|593527553|FG002|Open Label Phase|Adverse Event|1|||
164314124|NCT00281658|593527554|FG003|Open Label Phase|Adverse Event|0|||
164314125|NCT00281658|593527551|FG000|Open Label Phase|Lost to Follow-up|0|||
164314126|NCT00281658|593527552|FG001|Open Label Phase|Lost to Follow-up|0|||
164314127|NCT00281658|593527553|FG002|Open Label Phase|Lost to Follow-up|16|||
164314128|NCT00281658|593527554|FG003|Open Label Phase|Lost to Follow-up|2|||
164314129|NCT00281658|593527551|FG000|Open Label Phase|Withdrawal by Subject|0|||
164314130|NCT00281658|593527552|FG001|Open Label Phase|Withdrawal by Subject|0|||
164314131|NCT00281658|593527553|FG002|Open Label Phase|Withdrawal by Subject|3|||
164314132|NCT00281658|593527554|FG003|Open Label Phase|Withdrawal by Subject|2|||
164314133|NCT00281658|593527551|FG000|Open Label Phase|Disease progression|0|||
164314134|NCT00281658|593527552|FG001|Open Label Phase|Disease progression|0|||
164314135|NCT00281658|593527553|FG002|Open Label Phase|Disease progression|18|||
164314136|NCT00281658|593527554|FG003|Open Label Phase|Disease progression|0|||
164314137|NCT00281658|593527551|FG000|Open Label Phase|Physician Decision|0|||
164314138|NCT00281658|593527552|FG001|Open Label Phase|Physician Decision|0|||
164314139|NCT00281658|593527553|FG002|Open Label Phase|Physician Decision|1|||
164314140|NCT00281658|593527554|FG003|Open Label Phase|Physician Decision|0|||
164314141|NCT00281658|593527551|FG000|Open Label Phase|Relocation of patient|0|||
164314142|NCT00281658|593527552|FG001|Open Label Phase|Relocation of patient|0|||
164314143|NCT00281658|593527553|FG002|Open Label Phase|Relocation of patient|1|||
164556740|NCT00623428|594408215|FG000|Follow-up Period|Death|0|||
164556741|NCT00623428|594408216|FG001|Follow-up Period|Death|1|||
164556742|NCT02937818|594408217|FG000|Overall Study|Participants decision|2|||
164556743|NCT02937818|594408218|FG001|Overall Study|Participants decision|1|||
164556744|NCT02937818|594408219|FG002|Overall Study|Participants decision|1|||
164556745|NCT02937818|594408220|FG003|Overall Study|Participants decision|1|||
164556746|NCT02937818|594408217|FG000|Overall Study|Adverse Event|2|||
164556747|NCT02937818|594408218|FG001|Overall Study|Adverse Event|4|||
164556748|NCT02937818|594408219|FG002|Overall Study|Adverse Event|1|||
164556749|NCT02937818|594408220|FG003|Overall Study|Adverse Event|1|||
164556750|NCT02937818|594408217|FG000|Overall Study|Disease progression|17|||
164556751|NCT02937818|594408218|FG001|Overall Study|Disease progression|15|||
164556752|NCT02937818|594408219|FG002|Overall Study|Disease progression|7|||
164556753|NCT02937818|594408220|FG003|Overall Study|Disease progression|19|||
164556754|NCT02937818|594408217|FG000|Overall Study|Condition under investigation worsened|0|||
164556755|NCT02937818|594408218|FG001|Overall Study|Condition under investigation worsened|0|||
164660944|NCT05568225|594784989|FG001|Primary Treatment Period|Lack of Efficacy|1|||
164314144|NCT00281658|593527554|FG003|Open Label Phase|Relocation of patient|0|||
164314145|NCT00281658|593527551|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
164314146|NCT00281658|593527552|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
164314147|NCT00281658|593527553|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
164314148|NCT00281658|593527554|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
164556756|NCT02937818|594408219|FG002|Overall Study|Condition under investigation worsened|1|||
164556757|NCT02937818|594408220|FG003|Overall Study|Condition under investigation worsened|0|||
164314149|NCT00730028|593527555|FG000|Overall Study|Adverse Event|23|||
164314150|NCT00730028|593527556|FG001|Overall Study|Adverse Event|26|||
164314151|NCT00730028|593527557|FG002|Overall Study|Adverse Event|16|||
164556758|NCT01097863|594408221|FG000|Overall Study|Discomfort|1|||
164556759|NCT01097863|594408222|FG001|Overall Study|Discomfort|0|||
164556760|NCT01097863|594408223|FG002|Overall Study|Discomfort|1|||
164203050|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
164203051|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
164203052|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
164203053|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
164203054|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
164203055|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
164203056|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
164203057|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
164203058|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
164203059|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
164203060|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
164203061|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
164203062|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
164203063|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
164203064|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
164203065|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
164203066|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
164203067|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
164203068|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
164203069|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
164203070|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
164203071|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
164203072|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
164203073|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
164203074|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
164203075|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
164203076|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
164203077|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
164203078|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
164203079|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
164203080|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
164203081|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
164203082|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
164203083|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
164203084|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
164203085|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
164203086|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
164203087|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
164203088|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
164203089|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
164203090|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
164203091|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
164203092|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
164203093|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
164203094|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
164203095|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
164203096|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
164203097|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
164203098|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
164203099|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
164203100|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
164203101|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
164203102|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
164203103|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
164203104|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
164203105|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
164203106|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
164203107|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
164203108|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
164203109|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
164203110|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
164420612|NCT01890967|593910951|FG005|Overall Study|Sponsor Decision|3|||
164420613|NCT01890967|593910946|FG000|Overall Study|Withdrawal by Subject|3|||
164420614|NCT01890967|593910947|FG001|Overall Study|Withdrawal by Subject|4|||
164203111|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
164203112|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
164203113|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
164203114|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
164203115|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
164203116|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
164203117|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
164203118|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
164203119|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
164203120|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
164203121|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
164556761|NCT01097863|594408221|FG000|Overall Study|Did not return for final visit|0|||
164556762|NCT01097863|594408222|FG001|Overall Study|Did not return for final visit|0|||
164556763|NCT01097863|594408223|FG002|Overall Study|Did not return for final visit|1|||
164556764|NCT00419380|594408224|FG000|Overall Study|Lack of Efficacy|1|||
164556765|NCT00419380|594408225|FG001|Overall Study|Lack of Efficacy|7|||
164556766|NCT00419380|594408224|FG000|Overall Study|Physician Decision|0|||
164203122|NCT04194814|593115253|FG000|Overall Study|Physician Decision|3|||
164203123|NCT04194814|593115254|FG001|Overall Study|Physician Decision|0|||
164203124|NCT04194814|593115253|FG000|Overall Study|Withdrawal by Subject|0|||
164203125|NCT04194814|593115254|FG001|Overall Study|Withdrawal by Subject|2|||
164203126|NCT02659865|593116456|FG000|Period 1|Withdrawal by Subject|1|||
164203127|NCT02659865|593116457|FG001|Period 1|Withdrawal by Subject|0|||
164203128|NCT02659865|593116458|FG002|Period 1|Withdrawal by Subject|0|||
164203129|NCT02659865|593116459|FG003|Period 1|Withdrawal by Subject|0|||
164203130|NCT02659865|593116460|FG004|Period 1|Withdrawal by Subject|0|||
164203131|NCT02659865|593116456|FG000|Period 1|Adverse Event|0|||
164203132|NCT02659865|593116457|FG001|Period 1|Adverse Event|0|||
164203133|NCT02659865|593116458|FG002|Period 1|Adverse Event|0|||
164203134|NCT02659865|593116459|FG003|Period 1|Adverse Event|0|||
164203135|NCT02659865|593116460|FG004|Period 1|Adverse Event|1|||
164203136|NCT02325414|593116461|FG000|Overall Study|Withdrawal by Subject|3|||
164203137|NCT02325414|593116462|FG001|Overall Study|Withdrawal by Subject|1|||
164203138|NCT02325414|593116461|FG000|Overall Study|Lost to Follow-up|5|||
164203139|NCT02325414|593116462|FG001|Overall Study|Lost to Follow-up|5|||
164203140|NCT00959751|593116465|FG000|Overall Study|Lost to Follow-up|2|||
164203141|NCT00959751|593116466|FG001|Overall Study|Lost to Follow-up|3|||
164203142|NCT00959751|593116465|FG000|Overall Study|Consent Withdrawn|0|||
164203143|NCT00959751|593116466|FG001|Overall Study|Consent Withdrawn|1|||
164203144|NCT00959751|593116465|FG000|Overall Study|Non-compliance to Study Procedures|0|||
164203145|NCT00959751|593116466|FG001|Overall Study|Non-compliance to Study Procedures|1|||
164203146|NCT00959751|593116465|FG000|Overall Study|No migraine headache without aura|7|||
164203147|NCT00959751|593116466|FG001|Overall Study|No migraine headache without aura|7|||
164203148|NCT00761319|593116467|FG000|Overall Study|Protocol Violation|21|||
164203149|NCT00761319|593116468|FG001|Overall Study|Protocol Violation|14|||
164203150|NCT00761319|593116467|FG000|Overall Study|Adverse Event|11|||
164203151|NCT00761319|593116468|FG001|Overall Study|Adverse Event|7|||
164203152|NCT00761319|593116467|FG000|Overall Study|Withdrawal by Subject|8|||
164203153|NCT00761319|593116468|FG001|Overall Study|Withdrawal by Subject|7|||
164203154|NCT00761319|593116467|FG000|Overall Study|Noncompliance|4|||
164203155|NCT00761319|593116468|FG001|Overall Study|Noncompliance|3|||
164203156|NCT00761319|593116467|FG000|Overall Study|Lost to Follow-up|1|||
164203157|NCT00761319|593116468|FG001|Overall Study|Lost to Follow-up|1|||
164203158|NCT00761319|593116467|FG000|Overall Study|Nonspecified|2|||
164203159|NCT00761319|593116468|FG001|Overall Study|Nonspecified|2|||
164203160|NCT00761319|593116467|FG000|Overall Study|Missing|1|||
164203161|NCT00761319|593116468|FG001|Overall Study|Missing|0|||
164203162|NCT03157089|593116471|FG000|Overall Study|Treated only with pembrolizumab|1|||
164203163|NCT03157089|593116472|FG001|Overall Study|Treated only with pembrolizumab|0|||
164203164|NCT03157089|593116471|FG000|Overall Study|Adverse Event|5|||
164203165|NCT03157089|593116472|FG001|Overall Study|Adverse Event|4|||
164203166|NCT03157089|593116471|FG000|Overall Study|Progressive disease|6|||
164203167|NCT03157089|593116472|FG001|Overall Study|Progressive disease|8|||
164556767|NCT00419380|594408225|FG001|Overall Study|Physician Decision|1|||
164556768|NCT00419380|594408224|FG000|Overall Study|Lost to Follow-up|0|||
164556769|NCT00419380|594408225|FG001|Overall Study|Lost to Follow-up|1|||
164556770|NCT00419380|594408224|FG000|Overall Study|Withdrawal by Subject|0|||
164203168|NCT00853385|593116473|FG000|Overall Study|Death|0|||
164203169|NCT00853385|593116474|FG001|Overall Study|Death|0|||
164203170|NCT00853385|593116475|FG002|Overall Study|Death|0|||
164203171|NCT00853385|593116476|FG003|Overall Study|Death|0|||
164556771|NCT00419380|594408225|FG001|Overall Study|Withdrawal by Subject|1|||
164203172|NCT00853385|593116477|FG004|Overall Study|Death|1|||
164203173|NCT00853385|593116473|FG000|Overall Study|Adverse Event|24|||
164203174|NCT00853385|593116474|FG001|Overall Study|Adverse Event|24|||
164556772|NCT03099707|594408226|FG000|Overall Study|Withdrawal by Subject|0|||
164660945|NCT05568225|594784990|FG002|Primary Treatment Period|Lack of Efficacy|0|||
164314152|NCT00730028|593527558|FG003|Overall Study|Adverse Event|20|||
164314153|NCT00730028|593527559|FG004|Overall Study|Adverse Event|43|||
164314154|NCT00730028|593527555|FG000|Overall Study|Lost to Follow-up|13|||
164314155|NCT00730028|593527556|FG001|Overall Study|Lost to Follow-up|26|||
164314156|NCT00730028|593527557|FG002|Overall Study|Lost to Follow-up|22|||
164314157|NCT00730028|593527558|FG003|Overall Study|Lost to Follow-up|26|||
164314158|NCT00730028|593527559|FG004|Overall Study|Lost to Follow-up|25|||
164314159|NCT00730028|593527555|FG000|Overall Study|Protocol Violation|6|||
164314160|NCT00730028|593527556|FG001|Overall Study|Protocol Violation|1|||
164314161|NCT00730028|593527557|FG002|Overall Study|Protocol Violation|1|||
164314162|NCT00730028|593527558|FG003|Overall Study|Protocol Violation|2|||
164314163|NCT00730028|593527559|FG004|Overall Study|Protocol Violation|0|||
164314164|NCT00730028|593527555|FG000|Overall Study|Withdrawal by Subject|9|||
164314165|NCT00730028|593527556|FG001|Overall Study|Withdrawal by Subject|5|||
164314166|NCT00730028|593527557|FG002|Overall Study|Withdrawal by Subject|4|||
164314167|NCT00730028|593527558|FG003|Overall Study|Withdrawal by Subject|5|||
164314168|NCT00730028|593527559|FG004|Overall Study|Withdrawal by Subject|9|||
164314169|NCT00730028|593527555|FG000|Overall Study|Physician Decision|3|||
164314170|NCT00730028|593527556|FG001|Overall Study|Physician Decision|3|||
164314171|NCT00730028|593527557|FG002|Overall Study|Physician Decision|2|||
164314172|NCT00730028|593527558|FG003|Overall Study|Physician Decision|3|||
164314173|NCT00730028|593527559|FG004|Overall Study|Physician Decision|2|||
164314174|NCT00730028|593527555|FG000|Overall Study|Treatment Failure|5|||
164314175|NCT00730028|593527556|FG001|Overall Study|Treatment Failure|5|||
164314176|NCT00730028|593527557|FG002|Overall Study|Treatment Failure|0|||
164314177|NCT00730028|593527558|FG003|Overall Study|Treatment Failure|0|||
164314178|NCT00730028|593527559|FG004|Overall Study|Treatment Failure|1|||
164314179|NCT00730028|593527555|FG000|Overall Study|Randomization Error|1|||
164314180|NCT00730028|593527556|FG001|Overall Study|Randomization Error|0|||
164314181|NCT00730028|593527557|FG002|Overall Study|Randomization Error|0|||
164314182|NCT00730028|593527558|FG003|Overall Study|Randomization Error|0|||
164314183|NCT00730028|593527559|FG004|Overall Study|Randomization Error|2|||
164314184|NCT00615901|593527560|FG000|Overall Study|Withdrawal by Subject|2|||
164314185|NCT00615901|593527560|FG000|Overall Study|Adverse Event|7|||
164314186|NCT01206322|593527564|FG000|Overall Study|Adverse Event|0|||
164314187|NCT01206322|593527565|FG001|Overall Study|Adverse Event|0|||
164314188|NCT01206322|593527566|FG002|Overall Study|Adverse Event|0|||
164314189|NCT01206322|593527567|FG003|Overall Study|Adverse Event|1|||
164314190|NCT01250496|593527571|FG000|Overall Study|Study terminated|124|||
164314191|NCT01250496|593527572|FG001|Overall Study|Study terminated|124|||
164314192|NCT00003590|593527573|FG000|Overall Study|Ineligible Patient|1|||
164314193|NCT00003590|593527573|FG000|Overall Study|Adverse Event|7|||
164314194|NCT00003590|593527573|FG000|Overall Study|Withdrawal by Subject|1|||
164314195|NCT00003590|593527573|FG000|Overall Study|Lack of Efficacy|11|||
164556773|NCT03099707|594408227|FG001|Overall Study|Withdrawal by Subject|3|||
164556774|NCT03099707|594408226|FG000|Overall Study|Lost to Follow-up|0|||
164556775|NCT03099707|594408227|FG001|Overall Study|Lost to Follow-up|1|||
164556776|NCT03167073|594408228|FG000|Overall Study|Stillbirth|1|||
164556777|NCT03167073|594408229|FG001|Overall Study|Stillbirth|0|||
164556778|NCT05107765|594408230|FG000|Overall Study|Lost to Follow-up|4|||
164556779|NCT05107765|594408231|FG001|Overall Study|Lost to Follow-up|1|||
164314196|NCT00003590|593527573|FG000|Overall Study|Death|1|||
164314197|NCT00003590|593527573|FG000|Overall Study|Physician Decision|1|||
164314198|NCT01589653|593527576|FG000|Overall Study|Protocol Violation|3|||
164314199|NCT01589653|593527577|FG001|Overall Study|Protocol Violation|1|||
164314200|NCT01589653|593527576|FG000|Overall Study|Withdrawal criteria|4|||
164314201|NCT01589653|593527577|FG001|Overall Study|Withdrawal criteria|7|||
164314202|NCT01589653|593527576|FG000|Overall Study|Unclassified|0|||
164314203|NCT01589653|593527577|FG001|Overall Study|Unclassified|3|||
164314204|NCT01425463|593527583|FG000|Overall Study|Adverse Event|5|||
164660946|NCT05568225|594784988|FG000|Primary Treatment Period|Withdrawal of conset|1|||
164660947|NCT05568225|594784989|FG001|Primary Treatment Period|Withdrawal of conset|0|||
164660948|NCT05568225|594784990|FG002|Primary Treatment Period|Withdrawal of conset|4|||
164314205|NCT01425463|593527584|FG001|Overall Study|Adverse Event|7|||
164314206|NCT01425463|593527583|FG000|Overall Study|Lack of Efficacy|1|||
164556780|NCT05107765|594408230|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
164556781|NCT05107765|594408231|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
164660949|NCT05568225|594784988|FG000|Primary Treatment Period|Adverse Event|1|||
164314207|NCT01425463|593527584|FG001|Overall Study|Lack of Efficacy|1|||
164314208|NCT01425463|593527583|FG000|Overall Study|Protocol Violation|2|||
164314209|NCT01425463|593527584|FG001|Overall Study|Protocol Violation|2|||
164314210|NCT01425463|593527583|FG000|Overall Study|Lost to Follow-up|5|||
164314211|NCT01425463|593527584|FG001|Overall Study|Lost to Follow-up|2|||
164314212|NCT01425463|593527583|FG000|Overall Study|Withdrawal by Subject|7|||
164314213|NCT01425463|593527584|FG001|Overall Study|Withdrawal by Subject|5|||
164314214|NCT01425463|593527583|FG000|Overall Study|Unknown Reason|4|||
164314215|NCT01425463|593527584|FG001|Overall Study|Unknown Reason|7|||
164314216|NCT01332799|593527587|FG000|Overall Study|Insufficient funding|10|||
164314217|NCT01332799|593527588|FG001|Overall Study|Insufficient funding|10|||
164314218|NCT03467152|593527589|FG000|Overall Study|Adverse Event|4|||
164314219|NCT03467152|593527590|FG001|Overall Study|Adverse Event|5|||
164314220|NCT03467152|593527591|FG002|Overall Study|Adverse Event|0|||
164314221|NCT03467152|593527589|FG000|Overall Study|Subject Choice|1|||
164314222|NCT03467152|593527590|FG001|Overall Study|Subject Choice|3|||
164314223|NCT03467152|593527591|FG002|Overall Study|Subject Choice|0|||
164314224|NCT03467152|593527589|FG000|Overall Study|Lost to Follow-up|1|||
164314225|NCT03467152|593527590|FG001|Overall Study|Lost to Follow-up|0|||
164314226|NCT03467152|593527591|FG002|Overall Study|Lost to Follow-up|0|||
164314227|NCT03467152|593527589|FG000|Overall Study|Withdrawal by Subject|4|||
164314228|NCT03467152|593527590|FG001|Overall Study|Withdrawal by Subject|2|||
164314229|NCT03467152|593527591|FG002|Overall Study|Withdrawal by Subject|0|||
164314230|NCT03467152|593527589|FG000|Overall Study|Others|3|||
164314231|NCT03467152|593527590|FG001|Overall Study|Others|0|||
164314232|NCT03467152|593527591|FG002|Overall Study|Others|0|||
164314233|NCT03467152|593527589|FG000|Overall Study|Not treated|3|||
164314234|NCT03467152|593527590|FG001|Overall Study|Not treated|1|||
164314235|NCT03467152|593527591|FG002|Overall Study|Not treated|6|||
164314236|NCT00945906|593527592|FG000|Overall Study|Withdrawal by Subject|1|||
164314237|NCT00945906|593527592|FG000|Overall Study|Did not want to return for last visit|2|||
164314238|NCT00945906|593527592|FG000|Overall Study|Unable to return for last visit|2|||
164314239|NCT00945906|593527592|FG000|Overall Study|Moved to another country|2|||
164314240|NCT01236547|593527594|FG000|Overall Study|Protocol Violation|0|||
164314241|NCT01236547|593527595|FG001|Overall Study|Protocol Violation|1|||
164314242|NCT01236547|593527596|FG002|Overall Study|Protocol Violation|1|||
164314243|NCT01236547|593527597|FG003|Overall Study|Protocol Violation|6|||
164314244|NCT01236547|593527598|FG004|Overall Study|Protocol Violation|12|||
164314245|NCT01120782|593527599|FG000|Overall Study|Test article shipping error|11|||
164314246|NCT01767142|593527601|FG000|Overall Study|Lost to Follow-up|3|||
164314247|NCT03317405|593527602|FG000|Overall Study|Withdrawal by Subject|1|||
164314248|NCT03317405|593527603|FG001|Overall Study|Withdrawal by Subject|0|||
164314249|NCT03317405|593527604|FG002|Overall Study|Withdrawal by Subject|0|||
164314250|NCT03317405|593527602|FG000|Overall Study|Physician Decision|0|||
164314251|NCT03317405|593527603|FG001|Overall Study|Physician Decision|0|||
164314252|NCT03317405|593527604|FG002|Overall Study|Physician Decision|1|||
164314253|NCT03317405|593527602|FG000|Overall Study|Surgery Rescheduled|0|||
164314254|NCT03317405|593527603|FG001|Overall Study|Surgery Rescheduled|1|||
164314255|NCT03317405|593527604|FG002|Overall Study|Surgery Rescheduled|0|||
164314256|NCT00635219|593527605|FG000|Overall Study|Adverse Event|12|||
164314257|NCT00635219|593527606|FG001|Overall Study|Adverse Event|10|||
164314258|NCT00635219|593527607|FG002|Overall Study|Adverse Event|18|||
164314259|NCT00635219|593527608|FG003|Overall Study|Adverse Event|15|||
164314260|NCT00635219|593527609|FG004|Overall Study|Adverse Event|19|||
164314261|NCT00635219|593527605|FG000|Overall Study|Lack of Efficacy|5|||
164314262|NCT00635219|593527606|FG001|Overall Study|Lack of Efficacy|6|||
164314263|NCT00635219|593527607|FG002|Overall Study|Lack of Efficacy|3|||
164314264|NCT00635219|593527608|FG003|Overall Study|Lack of Efficacy|4|||
164314265|NCT00635219|593527609|FG004|Overall Study|Lack of Efficacy|6|||
164314266|NCT00635219|593527605|FG000|Overall Study|Non-compliance With Study Product|0|||
164314267|NCT00635219|593527606|FG001|Overall Study|Non-compliance With Study Product|0|||
164314268|NCT00635219|593527607|FG002|Overall Study|Non-compliance With Study Product|0|||
164314269|NCT00635219|593527608|FG003|Overall Study|Non-compliance With Study Product|2|||
164556782|NCT05107765|594408230|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
164556783|NCT05107765|594408231|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
164556784|NCT01982292|594409792|FG000|Overall Study|Adverse Event|2|||
164556785|NCT01982292|594409793|FG001|Overall Study|Adverse Event|0|||
164556786|NCT01982292|594409792|FG000|Overall Study|Death|1|||
164556787|NCT01982292|594409793|FG001|Overall Study|Death|0|||
164556788|NCT01982292|594409792|FG000|Overall Study|Lost to Follow-up|2|||
164556789|NCT01982292|594409793|FG001|Overall Study|Lost to Follow-up|0|||
164556790|NCT01982292|594409792|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
164314270|NCT00635219|593527609|FG004|Overall Study|Non-compliance With Study Product|1|||
164314271|NCT00635219|593527605|FG000|Overall Study|Protocol Violation|0|||
164314272|NCT00635219|593527606|FG001|Overall Study|Protocol Violation|2|||
164314273|NCT00635219|593527607|FG002|Overall Study|Protocol Violation|3|||
164314274|NCT00635219|593527608|FG003|Overall Study|Protocol Violation|2|||
164314275|NCT00635219|593527609|FG004|Overall Study|Protocol Violation|4|||
164314276|NCT00635219|593527605|FG000|Overall Study|Withdrawal of Consent|8|||
164314277|NCT00635219|593527606|FG001|Overall Study|Withdrawal of Consent|6|||
164314278|NCT00635219|593527607|FG002|Overall Study|Withdrawal of Consent|8|||
164314279|NCT00635219|593527608|FG003|Overall Study|Withdrawal of Consent|11|||
164314280|NCT00635219|593527609|FG004|Overall Study|Withdrawal of Consent|8|||
164314281|NCT00635219|593527605|FG000|Overall Study|Lost to Follow-up|0|||
164314282|NCT00635219|593527606|FG001|Overall Study|Lost to Follow-up|0|||
164314283|NCT00635219|593527607|FG002|Overall Study|Lost to Follow-up|2|||
164314284|NCT00635219|593527608|FG003|Overall Study|Lost to Follow-up|0|||
164314285|NCT00635219|593527609|FG004|Overall Study|Lost to Follow-up|3|||
164314286|NCT00635219|593527605|FG000|Overall Study|Administrative or Other Reasons|0|||
164314287|NCT00635219|593527606|FG001|Overall Study|Administrative or Other Reasons|1|||
164314288|NCT00635219|593527607|FG002|Overall Study|Administrative or Other Reasons|1|||
164314289|NCT00635219|593527608|FG003|Overall Study|Administrative or Other Reasons|0|||
164314290|NCT00635219|593527609|FG004|Overall Study|Administrative or Other Reasons|1|||
164314291|NCT04093024|593527610|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
164314292|NCT04093024|593527611|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
164314293|NCT04093024|593527610|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
164314294|NCT04093024|593527611|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
164314295|NCT04093024|593527610|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
164314296|NCT04093024|593527611|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
164314297|NCT04093024|593527610|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
164314298|NCT04093024|593527611|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
164314299|NCT01541397|593527616|FG000|Overall Study|Study ended prior to data collection|4|||
164314300|NCT01541397|593527617|FG001|Overall Study|Study ended prior to data collection|2|||
164314301|NCT01290796|593527622|FG000|Overall Study|Lost to Follow-up|21|||
164314302|NCT01290796|593527622|FG000|Overall Study|Withdrawal by Subject|4|||
164314303|NCT01290796|593527622|FG000|Overall Study|Physician Decision|2|||
164314304|NCT01290796|593527622|FG000|Overall Study|Secondary Surgical Intervention|2|||
164314305|NCT01290796|593527622|FG000|Overall Study|Withdrawal by Sponsor|1|||
164314306|NCT00329797|593527623|FG000|Overall Study|Protocol Violation|1|||
164314307|NCT00329797|593527624|FG001|Overall Study|Protocol Violation|0|||
164314308|NCT00329797|593527623|FG000|Overall Study|Withdrawal by Subject|6|||
164314309|NCT00329797|593527624|FG001|Overall Study|Withdrawal by Subject|6|||
164314310|NCT00776919|593527625|FG000|Overall Study|Withdrawal by Subject|16|||
164314311|NCT00776919|593527626|FG001|Overall Study|Withdrawal by Subject|14|||
164314312|NCT00776919|593527627|FG002|Overall Study|Withdrawal by Subject|15|||
164314313|NCT00776919|593527628|FG003|Overall Study|Withdrawal by Subject|26|||
164314314|NCT00776919|593527625|FG000|Overall Study|Lost to Follow-up|8|||
164314315|NCT00776919|593527626|FG001|Overall Study|Lost to Follow-up|12|||
164314316|NCT00776919|593527627|FG002|Overall Study|Lost to Follow-up|11|||
164314317|NCT00776919|593527628|FG003|Overall Study|Lost to Follow-up|8|||
164314318|NCT00776919|593527625|FG000|Overall Study|Adverse Event|1|||
164314319|NCT00776919|593527626|FG001|Overall Study|Adverse Event|0|||
164314320|NCT00776919|593527627|FG002|Overall Study|Adverse Event|2|||
164314321|NCT00776919|593527628|FG003|Overall Study|Adverse Event|2|||
164314322|NCT00776919|593527625|FG000|Overall Study|Protocol Violation|1|||
164314323|NCT00776919|593527626|FG001|Overall Study|Protocol Violation|2|||
164314324|NCT00776919|593527627|FG002|Overall Study|Protocol Violation|0|||
164314325|NCT00776919|593527628|FG003|Overall Study|Protocol Violation|1|||
164314326|NCT00776919|593527625|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
164314327|NCT00776919|593527626|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
164314328|NCT00776919|593527627|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
164314329|NCT00776919|593527628|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
164556791|NCT01982292|594409793|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
164556792|NCT01982292|594409792|FG000|Overall Study|Protocol Deviation|1|||
164556793|NCT01982292|594409793|FG001|Overall Study|Protocol Deviation|0|||
164556794|NCT01982292|594409792|FG000|Overall Study|Patient/Guardian Decision|3|||
164556795|NCT01982292|594409793|FG001|Overall Study|Patient/Guardian Decision|1|||
164556796|NCT01982292|594409792|FG000|Overall Study|Technical Problems|2|||
164556797|NCT01982292|594409793|FG001|Overall Study|Technical Problems|0|||
164556798|NCT04872101|594409794|FG000|Overall Study|Withdrawal by Subject|10|||
164556799|NCT04872101|594409795|FG001|Overall Study|Withdrawal by Subject|16|||
164556800|NCT04872101|594409794|FG000|Overall Study|Lack of Efficacy|6|||
164556801|NCT04872101|594409795|FG001|Overall Study|Lack of Efficacy|14|||
164556802|NCT04872101|594409794|FG000|Overall Study|Adverse Event|1|||
164556803|NCT04872101|594409795|FG001|Overall Study|Adverse Event|6|||
164556804|NCT04872101|594409794|FG000|Overall Study|Lost to Follow-up|2|||
164556805|NCT04872101|594409795|FG001|Overall Study|Lost to Follow-up|1|||
164314330|NCT03091348|593527644|FG000|Overall Study|Lost to Follow-up|2|||
164314331|NCT03091348|593527645|FG001|Overall Study|Lost to Follow-up|1|||
164556806|NCT04872101|594409794|FG000|Overall Study|Pregnancy|2|||
164556807|NCT04872101|594409795|FG001|Overall Study|Pregnancy|0|||
164556808|NCT04872101|594409794|FG000|Overall Study|Prohibited Medication|1|||
164203175|NCT00853385|593116475|FG002|Overall Study|Adverse Event|2|||
164203176|NCT00853385|593116476|FG003|Overall Study|Adverse Event|5|||
164203177|NCT00853385|593116477|FG004|Overall Study|Adverse Event|22|||
164203178|NCT00853385|593116473|FG000|Overall Study|Lack of Efficacy|6|||
164203179|NCT00853385|593116474|FG001|Overall Study|Lack of Efficacy|7|||
164556809|NCT04872101|594409795|FG001|Overall Study|Prohibited Medication|0|||
164556810|NCT04872101|594409794|FG000|Overall Study|Not dosed|1|||
164556811|NCT04872101|594409795|FG001|Overall Study|Not dosed|0|||
164556812|NCT00879229|594409796|FG000|Overall Study|Study terminated by Sponsor|13|||
164556813|NCT00879229|594409797|FG001|Overall Study|Study terminated by Sponsor|12|||
164556814|NCT00879229|594409796|FG000|Overall Study|Death|4|||
164556815|NCT00879229|594409797|FG001|Overall Study|Death|2|||
164556816|NCT00879229|594409796|FG000|Overall Study|Adverse Event|2|||
164556817|NCT00879229|594409797|FG001|Overall Study|Adverse Event|0|||
164556818|NCT00879229|594409796|FG000|Overall Study|Withdrawal by Subject|1|||
164556819|NCT00879229|594409797|FG001|Overall Study|Withdrawal by Subject|0|||
164556820|NCT00879229|594409796|FG000|Overall Study|Clinical status did not improve|1|||
164556821|NCT00879229|594409797|FG001|Overall Study|Clinical status did not improve|0|||
164556822|NCT00879229|594409796|FG000|Overall Study|Other|1|||
164556823|NCT00879229|594409797|FG001|Overall Study|Other|0|||
164556824|NCT01652287|594409801|FG000|Overall Study|Withdrawal by Subject|2|||
164556825|NCT01652287|594409802|FG001|Overall Study|Withdrawal by Subject|0|||
164556826|NCT01592760|594409803|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
164556827|NCT01592760|594409804|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
164556828|NCT01592760|594409805|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
164556829|NCT01637142|594409808|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
164556830|NCT00984204|594409810|FG000|Overall Study|Death|1|||
164556831|NCT00984204|594409810|FG000|Overall Study|Lost to Follow-up|4|||
164556832|NCT00984204|594409810|FG000|Overall Study|Lack of Efficacy|10|||
164203180|NCT00853385|593116475|FG002|Overall Study|Lack of Efficacy|3|||
164203181|NCT00853385|593116476|FG003|Overall Study|Lack of Efficacy|3|||
164203182|NCT00853385|593116477|FG004|Overall Study|Lack of Efficacy|6|||
164203183|NCT00853385|593116473|FG000|Overall Study|Lost to Follow-up|2|||
164203184|NCT00853385|593116474|FG001|Overall Study|Lost to Follow-up|1|||
164203185|NCT00853385|593116475|FG002|Overall Study|Lost to Follow-up|0|||
164203186|NCT00853385|593116476|FG003|Overall Study|Lost to Follow-up|0|||
164203187|NCT00853385|593116477|FG004|Overall Study|Lost to Follow-up|0|||
164203188|NCT00853385|593116473|FG000|Overall Study|Withdrawal by Subject|4|||
164203189|NCT00853385|593116474|FG001|Overall Study|Withdrawal by Subject|2|||
164203190|NCT00853385|593116475|FG002|Overall Study|Withdrawal by Subject|0|||
164203191|NCT00853385|593116476|FG003|Overall Study|Withdrawal by Subject|1|||
164203192|NCT00853385|593116477|FG004|Overall Study|Withdrawal by Subject|1|||
164203193|NCT00853385|593116473|FG000|Overall Study|Other|18|||
164203194|NCT00853385|593116474|FG001|Overall Study|Other|9|||
164203195|NCT00853385|593116475|FG002|Overall Study|Other|4|||
164203196|NCT00853385|593116476|FG003|Overall Study|Other|4|||
164203197|NCT00853385|593116477|FG004|Overall Study|Other|12|||
164203198|NCT00577408|593116478|FG000|Overall Study|Stopped attending study visits|9|||
164203199|NCT00577408|593116479|FG001|Overall Study|Stopped attending study visits|11|||
164203200|NCT00577408|593116478|FG000|Overall Study|Continued opioid use|3|||
164203201|NCT00577408|593116479|FG001|Overall Study|Continued opioid use|2|||
164203202|NCT00577408|593116478|FG000|Overall Study|Non-compliance with study meds|0|||
164203203|NCT00577408|593116479|FG001|Overall Study|Non-compliance with study meds|3|||
164203204|NCT00577408|593116478|FG000|Overall Study|Refused Oral Naltrexone|0|||
164203205|NCT00577408|593116479|FG001|Overall Study|Refused Oral Naltrexone|1|||
164203206|NCT00577408|593116478|FG000|Overall Study|Moved out of state|0|||
164203207|NCT00577408|593116479|FG001|Overall Study|Moved out of state|1|||
164203208|NCT00577408|593116478|FG000|Overall Study|Scheduling Issues|0|||
164203209|NCT00577408|593116479|FG001|Overall Study|Scheduling Issues|3|||
164203210|NCT00577408|593116478|FG000|Overall Study|Death|0|||
164203211|NCT00577408|593116479|FG001|Overall Study|Death|1|||
164203212|NCT00577408|593116478|FG000|Overall Study|Psychiatric hospitalization|0|||
164203213|NCT00577408|593116479|FG001|Overall Study|Psychiatric hospitalization|1|||
164203214|NCT01829347|593116480|FG000|VTI-210|Death|5|||
164203215|NCT01829347|593116481|FG001|VTI-210|Death|3|||
164203216|NCT01829347|593116480|FG000|VTI-210|Withdrawal by Subject|1|||
164203217|NCT01829347|593116481|FG001|VTI-210|Withdrawal by Subject|0|||
164556833|NCT00559507|594409811|FG000|Overall Study|Not treated, patient ineligible|3|||
164203218|NCT01829347|593116480|FG000|VTI-210E|Death|2|||
164203219|NCT01829347|593116481|FG001|VTI-210E|Death|1|||
164203220|NCT01829347|593116480|FG000|VTI-210E|Study terminated prematurely|1|||
164203221|NCT01829347|593116481|FG001|VTI-210E|Study terminated prematurely|5|||
164203222|NCT03055013|593116482|FG000|Overall Study|Adverse Event|78|||
164203223|NCT03055013|593116483|FG001|Overall Study|Adverse Event|0|||
164203224|NCT03055013|593116482|FG000|Overall Study|Death|6|||
164203225|NCT03055013|593116483|FG001|Overall Study|Death|0|||
164203226|NCT03055013|593116482|FG000|Overall Study|Disease relapse|33|||
164203227|NCT03055013|593116483|FG001|Overall Study|Disease relapse|0|||
164203228|NCT03055013|593116482|FG000|Overall Study|Withdrawal by Subject|28|||
164556834|NCT04681170|594409812|FG000|Stratified Enrolment & run-in|Death|1|||
164660950|NCT05568225|594784989|FG001|Primary Treatment Period|Adverse Event|0|||
164660951|NCT05568225|594784990|FG002|Primary Treatment Period|Adverse Event|0|||
164660952|NCT05568225|594784988|FG000|Extension Treatment Period|Termination of the study by the Sponsor|0|||
164660953|NCT05568225|594784989|FG001|Extension Treatment Period|Termination of the study by the Sponsor|0|||
164660954|NCT05568225|594784990|FG002|Extension Treatment Period|Termination of the study by the Sponsor|1|||
164660955|NCT05568225|594784988|FG000|Extension Treatment Period|Protocol Violation|0|||
164660956|NCT05568225|594784989|FG001|Extension Treatment Period|Protocol Violation|0|||
164660957|NCT05568225|594784990|FG002|Extension Treatment Period|Protocol Violation|1|||
164660958|NCT05568225|594784988|FG000|Extension Treatment Period|Lack of Efficacy|0|||
164203229|NCT03055013|593116483|FG001|Overall Study|Withdrawal by Subject|0|||
164203230|NCT03055013|593116482|FG000|Overall Study|Other complicating disease|5|||
164203231|NCT03055013|593116483|FG001|Overall Study|Other complicating disease|0|||
164203232|NCT03055013|593116482|FG000|Overall Study|Physician Decision|1|||
164203233|NCT03055013|593116483|FG001|Overall Study|Physician Decision|0|||
164203234|NCT03055013|593116482|FG000|Overall Study|Benign mass/non-RCC|4|||
164203235|NCT03055013|593116483|FG001|Overall Study|Benign mass/non-RCC|0|||
164203236|NCT03055013|593116482|FG000|Overall Study|Enrolled in another trial|1|||
164203237|NCT03055013|593116483|FG001|Overall Study|Enrolled in another trial|0|||
164203238|NCT03055013|593116482|FG000|Overall Study|Non-protocol therapy|1|||
164203239|NCT03055013|593116483|FG001|Overall Study|Non-protocol therapy|0|||
164203240|NCT03055013|593116482|FG000|Overall Study|Incompliance|1|||
164203241|NCT03055013|593116483|FG001|Overall Study|Incompliance|0|||
164203242|NCT03055013|593116482|FG000|Overall Study|Insurance issues|1|||
164203243|NCT03055013|593116483|FG001|Overall Study|Insurance issues|0|||
164203244|NCT03055013|593116482|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
164203245|NCT03055013|593116483|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
164203246|NCT03055013|593116482|FG000|Overall Study|Did not receive nivolumab|10|||
164203247|NCT03055013|593116483|FG001|Overall Study|Did not receive nivolumab|0|||
164203248|NCT03055013|593116482|FG000|Overall Study|Did not receive surgery|0|||
164203249|NCT03055013|593116483|FG001|Overall Study|Did not receive surgery|28|||
164203250|NCT03435055|593116484|FG000|Screening|Physician Decision|2|||
164203251|NCT03435055|593116484|FG000|Received Intervention|Did not complete nitrous administration|3|||
164203252|NCT03817528|593116487|FG000|Overall Study|Withdrawal by Subject|1|||
164203253|NCT03817528|593116487|FG000|Overall Study|Adverse Event|2|||
164203254|NCT00671749|593116488|FG000|Overall Study|Adverse Event|2|||
164203255|NCT00671749|593116488|FG000|Overall Study|Withdrawal by Subject|4|||
164203256|NCT00671749|593116488|FG000|Overall Study|Protocol Violation|1|||
164203257|NCT00671749|593116488|FG000|Overall Study|Lost to Follow-up|1|||
164203258|NCT00485303|593116489|FG000|Overall Study|Adverse Event|5|||
164203259|NCT00485303|593116489|FG000|Overall Study|Progressive Disease|44|||
164203260|NCT00485303|593116489|FG000|Overall Study|Other|3|||
164203261|NCT00485303|593116489|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
164203262|NCT00485303|593116489|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
164203263|NCT00296335|593116494|FG000|Overall Study|Recurrence|3|||
164203264|NCT00296335|593116495|FG001|Overall Study|Recurrence|51|||
164203265|NCT00296335|593116494|FG000|Overall Study|Adverse Event|17|||
164203266|NCT00296335|593116495|FG001|Overall Study|Adverse Event|27|||
164203267|NCT00296335|593116494|FG000|Overall Study|Lost to Follow-up|7|||
164203268|NCT00296335|593116495|FG001|Overall Study|Lost to Follow-up|33|||
164203269|NCT00296335|593116494|FG000|Overall Study|Physician Decision|3|||
164203270|NCT00296335|593116495|FG001|Overall Study|Physician Decision|11|||
164203271|NCT00830128|593116496|FG000|Overall Study|Adverse Event|5|||
164203272|NCT00830128|593116496|FG000|Overall Study|Lack of Efficacy|7|||
164203273|NCT00830128|593116496|FG000|Overall Study|Protocol Violation|1|||
164203274|NCT00830128|593116496|FG000|Overall Study|Withdrawal by Subject|2|||
164203275|NCT00830128|593116496|FG000|Overall Study|Family obligation|1|||
164203276|NCT00830128|593116496|FG000|Overall Study|Relocation|1|||
164203277|NCT00830128|593116496|FG000|Overall Study|Work obligation|1|||
164203278|NCT00830128|593116496|FG000|Overall Study|Operating a vehicle|1|||
164203279|NCT01123655|593116501|FG000|Overall Study|Medication for RA had to be changed|1|||
164203280|NCT01123655|593116502|FG001|Overall Study|Medication for RA had to be changed|0|||
164203281|NCT01123655|593116503|FG002|Overall Study|Medication for RA had to be changed|0|||
164203282|NCT01123655|593116501|FG000|Overall Study|new illness|0|||
164203283|NCT01123655|593116502|FG001|Overall Study|new illness|1|||
164203284|NCT01123655|593116503|FG002|Overall Study|new illness|0|||
164203285|NCT01123655|593116501|FG000|Overall Study|began prohibitive drug|0|||
164203286|NCT01123655|593116502|FG001|Overall Study|began prohibitive drug|0|||
164203287|NCT01123655|593116503|FG002|Overall Study|began prohibitive drug|1|||
164203288|NCT03329885|593116508|FG000|Overall Study|Sponsor discontinued the study early|0|||
164203289|NCT03329885|593116509|FG001|Overall Study|Sponsor discontinued the study early|0|||
164203290|NCT03329885|593116510|FG002|Overall Study|Sponsor discontinued the study early|0|||
164203291|NCT03329885|593116511|FG003|Overall Study|Sponsor discontinued the study early|0|||
164203292|NCT03329885|593116512|FG004|Overall Study|Sponsor discontinued the study early|0|||
164203293|NCT03329885|593116513|FG005|Overall Study|Sponsor discontinued the study early|0|||
164302987|NCT01198977|593484681|FG001|Overall Study|Lost to Follow-up|0|||
164203294|NCT03329885|593116514|FG006|Overall Study|Sponsor discontinued the study early|1|||
164203295|NCT03329885|593116515|FG007|Overall Study|Sponsor discontinued the study early|1|||
164203296|NCT03329885|593116516|FG008|Overall Study|Sponsor discontinued the study early|0|||
164203297|NCT04004000|593116517|FG000|Extension Phase (Up to 68 Weeks)|Sponsor terminated OLE as REACH (NCT05397470) Phase 3 study in FSHD did not meet primary endpoint.|12|||
164203298|NCT02121210|593116518|FG000|Overall Study|Adverse Event|5|||
164203299|NCT02121210|593116519|FG001|Overall Study|Adverse Event|7|||
164203300|NCT02121210|593116518|FG000|Overall Study|Lack of Efficacy|2|||
164203301|NCT02121210|593116519|FG001|Overall Study|Lack of Efficacy|0|||
164203302|NCT02121210|593116518|FG000|Overall Study|Other than specified above|0|||
164203303|NCT02121210|593116519|FG001|Overall Study|Other than specified above|2|||
164203304|NCT01232283|593116522|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
164203305|NCT01232283|593116523|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
164203306|NCT01232283|593116524|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
164203307|NCT01232283|593116525|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
164203308|NCT01232283|593116526|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
164203309|NCT01232283|593116527|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
164203310|NCT01232283|593116528|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
164203311|NCT01232283|593116529|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
164203312|NCT01232283|593116530|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
164203313|NCT01232283|593116531|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
164203314|NCT01232283|593116522|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
164203315|NCT01232283|593116523|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
164203316|NCT01232283|593116524|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164203317|NCT01232283|593116525|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164203318|NCT01232283|593116526|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164203319|NCT01232283|593116527|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164203320|NCT01232283|593116528|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164203321|NCT01232283|593116529|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164203322|NCT01232283|593116530|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164203323|NCT01232283|593116531|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164203324|NCT01232283|593116522|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
164203325|NCT01232283|593116523|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
164203326|NCT01232283|593116524|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
164203327|NCT01232283|593116525|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
164203328|NCT01232283|593116526|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
164203329|NCT01232283|593116527|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
164203330|NCT01232283|593116528|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
164203331|NCT01232283|593116529|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
164203332|NCT01232283|593116530|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
164203333|NCT01232283|593116531|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
164203334|NCT01232283|593116522|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
164203335|NCT01232283|593116523|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
164203336|NCT01232283|593116524|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
164203337|NCT01232283|593116525|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
164203338|NCT01232283|593116526|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
164203339|NCT01232283|593116527|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
164203340|NCT01232283|593116528|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
164203341|NCT01232283|593116529|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
164203342|NCT01232283|593116530|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
164203343|NCT01232283|593116531|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
164203344|NCT01232283|593116522|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
164203345|NCT01232283|593116523|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
164203346|NCT01232283|593116524|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
164203347|NCT01232283|593116525|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
164203348|NCT01232283|593116526|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
164203349|NCT01232283|593116527|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
164203350|NCT01232283|593116528|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
164203351|NCT01232283|593116529|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
164203352|NCT01232283|593116530|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
164203353|NCT01232283|593116531|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
164203354|NCT01232283|593116522|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
164203355|NCT01232283|593116523|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
164314332|NCT02969655|593527648|FG000|Overall Study|Withdrawal by Subject|3|||
164556835|NCT04681170|594409813|FG001|Stratified Enrolment & run-in|Death|0|||
164556836|NCT04681170|594409812|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
164556837|NCT04681170|594409813|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
164556838|NCT04681170|594409812|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
164556839|NCT04681170|594409813|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
164556840|NCT04681170|594409812|FG000|Open Label Efficacy Phase|Adverse Event|0|||
164556841|NCT04681170|594409813|FG001|Open Label Efficacy Phase|Adverse Event|2|||
164556842|NCT04681170|594409812|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
164556843|NCT04681170|594409813|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
164660959|NCT05568225|594784989|FG001|Extension Treatment Period|Lack of Efficacy|0|||
164660960|NCT05568225|594784990|FG002|Extension Treatment Period|Lack of Efficacy|1|||
164660961|NCT01027143|594784993|FG000|Overall Study|Lost to Follow-up|9|||
164660962|NCT01027143|594784994|FG001|Overall Study|Lost to Follow-up|4|||
164660963|NCT02637557|594784999|FG000|Overall Study|Adverse Event|3|||
164660964|NCT02637557|594785000|FG001|Overall Study|Adverse Event|1|||
164660965|NCT02637557|594785001|FG002|Overall Study|Adverse Event|3|||
164203356|NCT01232283|593116524|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
164203357|NCT01232283|593116525|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
164203358|NCT01232283|593116526|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
164203359|NCT01232283|593116527|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
164203360|NCT01232283|593116528|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
164203361|NCT01232283|593116529|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
164203362|NCT01232283|593116530|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
164203363|NCT01232283|593116531|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
164203364|NCT01232283|593116522|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
164203365|NCT01232283|593116523|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
164203366|NCT01232283|593116524|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
164203367|NCT01232283|593116525|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
164203368|NCT01232283|593116526|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
164203369|NCT01232283|593116527|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
164203370|NCT01232283|593116528|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
164203371|NCT01232283|593116529|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
164203372|NCT01232283|593116530|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
164203373|NCT01232283|593116531|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
164203374|NCT01232283|593116522|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
164203375|NCT01232283|593116523|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
164203376|NCT01232283|593116524|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
164203377|NCT01232283|593116525|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
164203378|NCT01232283|593116526|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
164203379|NCT01232283|593116527|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
164203380|NCT01232283|593116528|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
164203381|NCT01232283|593116529|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
164203382|NCT01232283|593116530|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
164203383|NCT01232283|593116531|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
164203384|NCT01232283|593116522|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
164203385|NCT01232283|593116523|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
164203386|NCT01232283|593116524|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
164203387|NCT01232283|593116525|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
164203388|NCT01232283|593116526|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
164203389|NCT01232283|593116527|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
164203390|NCT01232283|593116528|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
164203391|NCT01232283|593116529|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
164203392|NCT01232283|593116530|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
164203393|NCT01232283|593116531|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
164203394|NCT01232283|593116522|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
164203395|NCT01232283|593116523|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
164203396|NCT01232283|593116524|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
164203397|NCT01232283|593116525|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
164203398|NCT01232283|593116526|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
164203399|NCT01232283|593116527|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
164203400|NCT01232283|593116528|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
164203401|NCT01232283|593116529|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
164556844|NCT04681170|594409812|FG000|Open Label Safety Phase|AEs and none compliance|0|||
164556845|NCT04681170|594409813|FG001|Open Label Safety Phase|AEs and none compliance|1|||
164556846|NCT02468648|594409816|FG000|Overall Study|Death|1|||
164556847|NCT01046825|594409819|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
164660966|NCT02637557|594785002|FG003|Overall Study|Adverse Event|3|||
164660967|NCT02637557|594784999|FG000|Overall Study|Lost to Follow-up|1|||
164660968|NCT02637557|594785000|FG001|Overall Study|Lost to Follow-up|1|||
164660969|NCT02637557|594785001|FG002|Overall Study|Lost to Follow-up|0|||
164302988|NCT03205423|593484682|FG000|Overall Study|Personal|1|||
164314333|NCT02969655|593527649|FG001|Overall Study|Withdrawal by Subject|2|||
164314334|NCT02969655|593527648|FG000|Overall Study|Physician Decision|4|||
164314335|NCT02969655|593527649|FG001|Overall Study|Physician Decision|3|||
164314336|NCT02969655|593527648|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
164314337|NCT02969655|593527649|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
164314338|NCT02969655|593527648|FG000|Overall Study|Adverse Event|10|||
164314339|NCT02969655|593527649|FG001|Overall Study|Adverse Event|8|||
164314340|NCT03753789|593527650|FG000|Overall Study|Withdrawal by Subject|2|||
164314341|NCT00853567|593527653|FG000|Overall Study|Study prematurely terminated|71|||
164314342|NCT02055118|593527657|FG000|Overall Study|Withdrawal by Subject|0|||
164314343|NCT02055118|593527658|FG001|Overall Study|Withdrawal by Subject|2|||
164314344|NCT02055118|593527659|FG002|Overall Study|Withdrawal by Subject|0|||
164314345|NCT02281383|593527661|FG000|Overall Study|Progressive Disease|1|||
164314346|NCT02281383|593527661|FG000|Overall Study|Withdrawal by Subject|6|||
164314347|NCT02281383|593527661|FG000|Overall Study|Protocol Violation|2|||
164314348|NCT02281383|593527661|FG000|Overall Study|Death|1|||
164314349|NCT02281383|593527661|FG000|Overall Study|Adverse Event|2|||
164314350|NCT01324141|593527662|FG000|Overall Study|Declined to participate before treatment started|1|||
164314351|NCT01324141|593527662|FG000|Overall Study|Disease progression on study|1|||
164314352|NCT01001325|593527664|FG000|Overall Study|Lost to Follow-up|16|||
164314353|NCT01001325|593527665|FG001|Overall Study|Lost to Follow-up|10|||
164314354|NCT01001325|593527664|FG000|Overall Study|Protocol Violation|2|||
164314355|NCT01001325|593527665|FG001|Overall Study|Protocol Violation|0|||
164314356|NCT01584440|593527668|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
164556848|NCT01046825|594409820|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
164556849|NCT01046825|594409821|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
164556850|NCT01046825|594409822|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
164556851|NCT01046825|594409823|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
164556852|NCT01046825|594409819|FG000|Overall Study|Physician Decision|0|||
164556853|NCT01046825|594409820|FG001|Overall Study|Physician Decision|1|||
164556854|NCT01046825|594409821|FG002|Overall Study|Physician Decision|2|||
164556855|NCT01046825|594409822|FG003|Overall Study|Physician Decision|0|||
164556856|NCT01046825|594409823|FG004|Overall Study|Physician Decision|0|||
164556857|NCT01046825|594409819|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
164556858|NCT01046825|594409820|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
164556859|NCT01046825|594409821|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
164556860|NCT01046825|594409822|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
164556861|NCT01046825|594409823|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
164556862|NCT01046825|594409819|FG000|Overall Study|Found to be ineligible|0|||
164556863|NCT01046825|594409820|FG001|Overall Study|Found to be ineligible|1|||
164556864|NCT01046825|594409821|FG002|Overall Study|Found to be ineligible|0|||
164556865|NCT01046825|594409822|FG003|Overall Study|Found to be ineligible|0|||
164556866|NCT01046825|594409823|FG004|Overall Study|Found to be ineligible|0|||
164556867|NCT01046825|594409819|FG000|Overall Study|Death|0|||
164556868|NCT01046825|594409820|FG001|Overall Study|Death|0|||
164556869|NCT01046825|594409821|FG002|Overall Study|Death|0|||
164556870|NCT01046825|594409822|FG003|Overall Study|Death|1|||
164556871|NCT01046825|594409823|FG004|Overall Study|Death|0|||
164556872|NCT01046825|594409819|FG000|Overall Study|Did not submit biology samples|0|||
164556873|NCT01046825|594409820|FG001|Overall Study|Did not submit biology samples|0|||
164556874|NCT01046825|594409821|FG002|Overall Study|Did not submit biology samples|0|||
164556875|NCT01046825|594409822|FG003|Overall Study|Did not submit biology samples|0|||
164556876|NCT01046825|594409823|FG004|Overall Study|Did not submit biology samples|13|||
164556877|NCT02872311|594409827|FG000|Overall Study|Death|2|||
164556878|NCT02872311|594409828|FG001|Overall Study|Death|0|||
164556879|NCT02872311|594409829|FG002|Overall Study|Death|0|||
164556880|NCT02872311|594409830|FG003|Overall Study|Death|0|||
164556881|NCT02872311|594409831|FG004|Overall Study|Death|0|||
164556882|NCT02872311|594409827|FG000|Overall Study|Lost to Follow-up|2|||
164660970|NCT02637557|594785002|FG003|Overall Study|Lost to Follow-up|1|||
164660971|NCT02637557|594784999|FG000|Overall Study|Physician Decision|1|||
164660972|NCT02637557|594785000|FG001|Overall Study|Physician Decision|0|||
164314357|NCT01584440|593527669|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
164314358|NCT01584440|593527670|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
164314359|NCT01584440|593527671|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
164314360|NCT01584440|593527672|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
164314361|NCT01584440|593527668|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
164314362|NCT01584440|593527669|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
164314363|NCT01584440|593527670|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
164314364|NCT01584440|593527671|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
164314365|NCT01584440|593527672|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
164314366|NCT01584440|593527668|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
164314367|NCT01584440|593527669|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
164314368|NCT01584440|593527670|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
164314369|NCT01584440|593527671|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
164314370|NCT01584440|593527672|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
164314371|NCT01584440|593527668|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
164314372|NCT01584440|593527669|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
164314373|NCT01584440|593527670|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
164314374|NCT01584440|593527671|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
164314375|NCT01584440|593527672|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
164314376|NCT01584440|593527668|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
164314377|NCT01584440|593527669|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
164314378|NCT01584440|593527670|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
164314379|NCT01584440|593527671|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
164314380|NCT01584440|593527672|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
164314381|NCT01584440|593527668|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
164314382|NCT01584440|593527669|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
164314383|NCT01584440|593527670|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
164314384|NCT01584440|593527671|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
164314385|NCT01584440|593527672|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
164314386|NCT01584440|593527668|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
164314387|NCT01584440|593527669|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
164314388|NCT01584440|593527670|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
164314389|NCT01584440|593527671|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
164314390|NCT01584440|593527672|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
164314391|NCT01584440|593527668|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
164314392|NCT01584440|593527669|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
164314393|NCT01584440|593527670|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
164314394|NCT01584440|593527671|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
164556883|NCT02872311|594409828|FG001|Overall Study|Lost to Follow-up|0|||
164556884|NCT02872311|594409829|FG002|Overall Study|Lost to Follow-up|0|||
164556885|NCT02872311|594409830|FG003|Overall Study|Lost to Follow-up|0|||
164556886|NCT02872311|594409831|FG004|Overall Study|Lost to Follow-up|0|||
164556887|NCT02872311|594409827|FG000|Overall Study|Protocol Violation|0|||
164556888|NCT02872311|594409828|FG001|Overall Study|Protocol Violation|2|||
164556889|NCT02872311|594409829|FG002|Overall Study|Protocol Violation|1|||
164556890|NCT02872311|594409830|FG003|Overall Study|Protocol Violation|0|||
164556891|NCT02872311|594409831|FG004|Overall Study|Protocol Violation|0|||
164556892|NCT05617911|594409832|FG000|Overall Study|Withdrawal by Subject|1|||
164556893|NCT05617911|594409833|FG001|Overall Study|Withdrawal by Subject|0|||
164556894|NCT03557359|594409834|FG000|Dose 1: 240 mg|Adverse Event|1|||
164556895|NCT03557359|594409835|FG001|Dose 1: 240 mg|Adverse Event|0|||
164556896|NCT04868903|594409836|FG000|Overall Study|Adverse Event|0|||
164556897|NCT04868903|594409837|FG001|Overall Study|Adverse Event|0|||
164556898|NCT04868903|594409838|FG002|Overall Study|Adverse Event|0|||
164556899|NCT04868903|594409839|FG003|Overall Study|Adverse Event|1|||
164556900|NCT04868903|594409836|FG000|Overall Study|Withdrawal by Subject|29|||
164556901|NCT04868903|594409837|FG001|Overall Study|Withdrawal by Subject|44|||
164556902|NCT04868903|594409838|FG002|Overall Study|Withdrawal by Subject|17|||
164556903|NCT04868903|594409839|FG003|Overall Study|Withdrawal by Subject|12|||
164556904|NCT04868903|594409836|FG000|Overall Study|Hyperparathyroidism|3|||
164556905|NCT04868903|594409837|FG001|Overall Study|Hyperparathyroidism|5|||
164556906|NCT04868903|594409838|FG002|Overall Study|Hyperparathyroidism|2|||
164556907|NCT04868903|594409839|FG003|Overall Study|Hyperparathyroidism|3|||
164556908|NCT03975647|594409840|FG000|Overall Study|Death|71|||
164556909|NCT03975647|594409841|FG001|Overall Study|Death|63|||
164556910|NCT03975647|594409840|FG000|Overall Study|Lost to Follow-up|2|||
164556911|NCT03975647|594409841|FG001|Overall Study|Lost to Follow-up|2|||
164556912|NCT03975647|594409840|FG000|Overall Study|Subject withdrawal of consent|7|||
164556913|NCT03975647|594409841|FG001|Overall Study|Subject withdrawal of consent|11|||
164556914|NCT03735667|594409842|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
164556915|NCT03735667|594409843|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
164314395|NCT01584440|593527672|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
164314396|NCT01584440|593527668|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
164314397|NCT01584440|593527669|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
164314398|NCT01584440|593527670|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
164314399|NCT01584440|593527671|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
164314400|NCT01584440|593527672|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
164314401|NCT00599339|593527673|FG000|Overall Study|Adverse Event|79|||
164314402|NCT00599339|593527673|FG000|Overall Study|Withdrawal by Subject|137|||
164314403|NCT00599339|593527673|FG000|Overall Study|Other Reason|179|||
164314404|NCT00599339|593527673|FG000|Overall Study|Lost to Follow-up|221|||
164314405|NCT00599339|593527673|FG000|Overall Study|No valid data consent|36|||
164556916|NCT03735667|594409844|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
164556917|NCT03735667|594409842|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
164556918|NCT03735667|594409843|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
164556919|NCT03735667|594409844|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
164556920|NCT03735667|594409842|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
164314406|NCT00599339|593527673|FG000|Overall Study|Study Termination Status Unknown|12|||
164314407|NCT00531427|593527674|FG000|Overall Study|Withdrawal by Subject|7|||
164314408|NCT00531427|593527675|FG001|Overall Study|Withdrawal by Subject|13|||
164314409|NCT00531427|593527674|FG000|Overall Study|Adverse Event|44|||
164314410|NCT00531427|593527675|FG001|Overall Study|Adverse Event|30|||
164314411|NCT00531427|593527674|FG000|Overall Study|Lost to Follow-up|4|||
164314412|NCT00531427|593527675|FG001|Overall Study|Lost to Follow-up|3|||
164314413|NCT00531427|593527674|FG000|Overall Study|Lack of Efficacy|14|||
164314414|NCT00531427|593527675|FG001|Overall Study|Lack of Efficacy|39|||
164314415|NCT00531427|593527674|FG000|Overall Study|Administrative|4|||
164314416|NCT00531427|593527675|FG001|Overall Study|Administrative|9|||
164314417|NCT05688670|593527676|FG000|Overall Study|Change in surgery plan|1|||
164314418|NCT05688670|593527677|FG001|Overall Study|Change in surgery plan|4|||
164314419|NCT05688670|593527676|FG000|Overall Study|Inability to extubate|1|||
164314420|NCT05688670|593527677|FG001|Overall Study|Inability to extubate|2|||
164314421|NCT05688670|593527676|FG000|Overall Study|Day of surgery cancellation|0|||
164314422|NCT05688670|593527677|FG001|Overall Study|Day of surgery cancellation|1|||
164314423|NCT05688670|593527676|FG000|Overall Study|Reintubated on PCICU arrival|0|||
164314424|NCT05688670|593527677|FG001|Overall Study|Reintubated on PCICU arrival|1|||
164314425|NCT00488683|593527678|FG000|Overall Study|Withdrawal by Subject|1|||
164314426|NCT00488683|593527679|FG001|Overall Study|Withdrawal by Subject|2|||
164314427|NCT00488683|593527680|FG002|Overall Study|Withdrawal by Subject|2|||
164314428|NCT00488683|593527678|FG000|Overall Study|Lost to Follow-up|5|||
164314429|NCT00488683|593527679|FG001|Overall Study|Lost to Follow-up|3|||
164314430|NCT00488683|593527680|FG002|Overall Study|Lost to Follow-up|0|||
164314431|NCT00488683|593527678|FG000|Overall Study|Protocol Violation|5|||
164314432|NCT00488683|593527679|FG001|Overall Study|Protocol Violation|1|||
164314433|NCT00488683|593527680|FG002|Overall Study|Protocol Violation|0|||
164314434|NCT00488683|593527678|FG000|Overall Study|Unable to Classify|1|||
164314435|NCT00488683|593527679|FG001|Overall Study|Unable to Classify|0|||
164314436|NCT00488683|593527680|FG002|Overall Study|Unable to Classify|0|||
164314437|NCT00336856|593529651|FG000|Overall Study|Withdrawal by Subject|3|||
164314438|NCT00336856|593529651|FG000|Overall Study|Found ineligible at time of analysis|1|||
164314439|NCT00843778|593529664|FG000|Overall Study|Adverse Event|15|||
164314440|NCT00843778|593529664|FG000|Overall Study|Lack of Efficacy|14|||
164314441|NCT00843778|593529664|FG000|Overall Study|Loss of efficacy|2|||
164314442|NCT00843778|593529664|FG000|Overall Study|Withdrawal by Subject|4|||
164314443|NCT00830869|593529667|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
164314444|NCT00830869|593529668|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
164314445|NCT00830869|593529669|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
164314446|NCT00830869|593529670|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
164314447|NCT00830869|593529671|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
164314448|NCT00830869|593529672|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
164314449|NCT00830869|593529673|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
164314450|NCT00830869|593529674|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
164314451|NCT00830869|593529675|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
164314452|NCT00830869|593529676|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
164314453|NCT00830869|593529677|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
164314454|NCT00830869|593529678|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
164314455|NCT00830869|593529667|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
164314456|NCT00830869|593529668|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
164314457|NCT00830869|593529669|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
164314458|NCT00830869|593529670|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
164314459|NCT00830869|593529671|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
164314460|NCT00830869|593529672|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
164314461|NCT00830869|593529673|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
164314462|NCT00830869|593529674|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
164314463|NCT00830869|593529675|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
164314464|NCT00830869|593529676|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
164314465|NCT00830869|593529677|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
164314466|NCT00830869|593529678|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
164314467|NCT00830869|593529667|FG000|Period 1: Part 1|Adverse Event|0|||
164314468|NCT00830869|593529668|FG001|Period 1: Part 1|Adverse Event|0|||
164314469|NCT00830869|593529669|FG002|Period 1: Part 1|Adverse Event|0|||
164314470|NCT00830869|593529670|FG003|Period 1: Part 1|Adverse Event|0|||
164314471|NCT00830869|593529671|FG004|Period 1: Part 1|Adverse Event|0|||
164314472|NCT00830869|593529672|FG005|Period 1: Part 1|Adverse Event|1|||
164314473|NCT00830869|593529673|FG006|Period 1: Part 1|Adverse Event|1|||
164556921|NCT03735667|594409843|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
164556922|NCT03735667|594409844|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
164556923|NCT03735667|594409842|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
164314474|NCT00830869|593529674|FG007|Period 1: Part 1|Adverse Event|0|||
164314475|NCT00830869|593529675|FG008|Period 1: Part 1|Adverse Event|0|||
164314476|NCT00830869|593529676|FG009|Period 1: Part 1|Adverse Event|0|||
164314477|NCT00830869|593529677|FG010|Period 1: Part 1|Adverse Event|0|||
164314478|NCT00830869|593529678|FG011|Period 1: Part 1|Adverse Event|0|||
164556924|NCT03735667|594409843|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
164556925|NCT03735667|594409844|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
164556926|NCT03735667|594409842|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
164556927|NCT03735667|594409843|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
164203402|NCT01232283|593116530|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
164203403|NCT01232283|593116531|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
164203404|NCT01232283|593116522|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
164203405|NCT01232283|593116523|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
164203406|NCT01232283|593116524|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
164203407|NCT01232283|593116525|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
164203408|NCT01232283|593116526|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
164203409|NCT01232283|593116527|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
164203410|NCT01232283|593116528|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
164203411|NCT01232283|593116529|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
164203412|NCT01232283|593116530|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
164203413|NCT01232283|593116531|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
164203414|NCT01232283|593116522|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
164203415|NCT01232283|593116523|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
164203416|NCT01232283|593116524|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
164203417|NCT01232283|593116525|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
164203418|NCT01232283|593116526|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
164203419|NCT01232283|593116527|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
164203420|NCT01232283|593116528|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
164203421|NCT01232283|593116529|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
164203422|NCT01232283|593116530|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
164203423|NCT01232283|593116531|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
164203424|NCT01232283|593116522|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
164203425|NCT01232283|593116523|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
164203426|NCT01232283|593116524|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
164203427|NCT01232283|593116525|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
164203428|NCT01232283|593116526|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
164203429|NCT01232283|593116527|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
164203430|NCT01232283|593116528|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
164203431|NCT01232283|593116529|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
164203432|NCT01232283|593116530|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
164203433|NCT01232283|593116531|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
164203434|NCT01232283|593116522|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
164203435|NCT01232283|593116523|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
164203436|NCT01232283|593116524|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
164203437|NCT01232283|593116525|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
164556928|NCT03735667|594409844|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
164556929|NCT03735667|594409842|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
164556930|NCT03735667|594409843|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
164660973|NCT02637557|594785001|FG002|Overall Study|Physician Decision|0|||
164660974|NCT02637557|594785002|FG003|Overall Study|Physician Decision|0|||
164660975|NCT02637557|594784999|FG000|Overall Study|Protocol Violation|2|||
164660976|NCT02637557|594785000|FG001|Overall Study|Protocol Violation|0|||
164660977|NCT02637557|594785001|FG002|Overall Study|Protocol Violation|2|||
164660978|NCT02637557|594785002|FG003|Overall Study|Protocol Violation|1|||
164660979|NCT02637557|594784999|FG000|Overall Study|Withdrawal by Subject|1|||
164660980|NCT02637557|594785000|FG001|Overall Study|Withdrawal by Subject|3|||
164660981|NCT02637557|594785001|FG002|Overall Study|Withdrawal by Subject|4|||
164660982|NCT02637557|594785002|FG003|Overall Study|Withdrawal by Subject|2|||
164660983|NCT05218655|594785003|FG000|Overall Study|Adverse Event|6|||
164660984|NCT05218655|594785003|FG000|Overall Study|Sponsor's decision|85|||
164660985|NCT05218655|594785003|FG000|Overall Study|Death|1|||
164660986|NCT05218655|594785003|FG000|Overall Study|Lost to Follow-up|3|||
164660987|NCT05218655|594785003|FG000|Overall Study|Withdrawal by Subject|3|||
164660988|NCT05218655|594785003|FG000|Overall Study|Other than specified|3|||
164660989|NCT02228382|594785004|FG000|Overall Study|Death|5|||
164660990|NCT02228382|594785005|FG001|Overall Study|Death|7|||
164660991|NCT02228382|594785006|FG002|Overall Study|Death|5|||
164660992|NCT02228382|594785007|FG003|Overall Study|Death|0|||
164660993|NCT02228382|594785008|FG004|Overall Study|Death|2|||
164660994|NCT02228382|594785004|FG000|Overall Study|Participant refused further follow-up|0|||
164660995|NCT02228382|594785005|FG001|Overall Study|Participant refused further follow-up|0|||
164660996|NCT02228382|594785006|FG002|Overall Study|Participant refused further follow-up|1|||
164556931|NCT03735667|594409844|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
164660997|NCT02228382|594785007|FG003|Overall Study|Participant refused further follow-up|0|||
164660998|NCT02228382|594785008|FG004|Overall Study|Participant refused further follow-up|0|||
164660999|NCT02228382|594785004|FG000|Overall Study|Study terminated by sponsor|3|||
164314479|NCT00830869|593529667|FG000|Period 1: Part 1|Progressive disease|1|||
164314480|NCT00830869|593529668|FG001|Period 1: Part 1|Progressive disease|0|||
164314481|NCT00830869|593529669|FG002|Period 1: Part 1|Progressive disease|1|||
164314482|NCT00830869|593529670|FG003|Period 1: Part 1|Progressive disease|6|||
164314483|NCT00830869|593529671|FG004|Period 1: Part 1|Progressive disease|4|||
164314484|NCT00830869|593529672|FG005|Period 1: Part 1|Progressive disease|4|||
164314485|NCT00830869|593529673|FG006|Period 1: Part 1|Progressive disease|1|||
164314486|NCT00830869|593529674|FG007|Period 1: Part 1|Progressive disease|0|||
164314487|NCT00830869|593529675|FG008|Period 1: Part 1|Progressive disease|0|||
164314488|NCT00830869|593529676|FG009|Period 1: Part 1|Progressive disease|0|||
164314489|NCT00830869|593529677|FG010|Period 1: Part 1|Progressive disease|0|||
164314490|NCT00830869|593529678|FG011|Period 1: Part 1|Progressive disease|0|||
164314491|NCT00830869|593529667|FG000|Period 2: Part 2|Protocol Violation|0|||
164314492|NCT00830869|593529668|FG001|Period 2: Part 2|Protocol Violation|0|||
164314493|NCT00830869|593529669|FG002|Period 2: Part 2|Protocol Violation|0|||
164314494|NCT00830869|593529670|FG003|Period 2: Part 2|Protocol Violation|0|||
164314495|NCT00830869|593529671|FG004|Period 2: Part 2|Protocol Violation|0|||
164314496|NCT00830869|593529672|FG005|Period 2: Part 2|Protocol Violation|0|||
164314497|NCT00830869|593529673|FG006|Period 2: Part 2|Protocol Violation|0|||
164314498|NCT00830869|593529674|FG007|Period 2: Part 2|Protocol Violation|1|||
164314499|NCT00830869|593529675|FG008|Period 2: Part 2|Protocol Violation|0|||
164314500|NCT00830869|593529676|FG009|Period 2: Part 2|Protocol Violation|1|||
164314501|NCT00830869|593529677|FG010|Period 2: Part 2|Protocol Violation|0|||
164314502|NCT00830869|593529678|FG011|Period 2: Part 2|Protocol Violation|0|||
164314503|NCT00830869|593529667|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
164314504|NCT00830869|593529668|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
164314505|NCT00830869|593529669|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
164314506|NCT00830869|593529670|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
164314507|NCT00830869|593529671|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
164314508|NCT00830869|593529672|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
164314509|NCT00830869|593529673|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
164314510|NCT00830869|593529674|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
164314511|NCT00830869|593529675|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
164314512|NCT00830869|593529676|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
164314513|NCT00830869|593529677|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
164314514|NCT00830869|593529678|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
164314515|NCT00830869|593529667|FG000|Period 2: Part 2|Adverse Event|0|||
164314516|NCT00830869|593529668|FG001|Period 2: Part 2|Adverse Event|0|||
164314517|NCT00830869|593529669|FG002|Period 2: Part 2|Adverse Event|0|||
164314518|NCT00830869|593529670|FG003|Period 2: Part 2|Adverse Event|0|||
164314519|NCT00830869|593529671|FG004|Period 2: Part 2|Adverse Event|0|||
164314520|NCT00830869|593529672|FG005|Period 2: Part 2|Adverse Event|0|||
164314521|NCT00830869|593529673|FG006|Period 2: Part 2|Adverse Event|0|||
164314522|NCT00830869|593529674|FG007|Period 2: Part 2|Adverse Event|4|||
164314523|NCT00830869|593529675|FG008|Period 2: Part 2|Adverse Event|3|||
164314524|NCT00830869|593529676|FG009|Period 2: Part 2|Adverse Event|2|||
164314525|NCT00830869|593529677|FG010|Period 2: Part 2|Adverse Event|2|||
164314526|NCT00830869|593529678|FG011|Period 2: Part 2|Adverse Event|0|||
164314527|NCT00830869|593529667|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
164314528|NCT00830869|593529668|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
164314529|NCT00830869|593529669|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
164314530|NCT00830869|593529670|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
164314531|NCT00830869|593529671|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
164314532|NCT00830869|593529672|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
164314533|NCT00830869|593529673|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
164314534|NCT00830869|593529674|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
164314535|NCT00830869|593529675|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
164314536|NCT00830869|593529676|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
164314537|NCT00830869|593529677|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
164314538|NCT00830869|593529678|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
164556932|NCT03735667|594409842|FG000|4D-CT Substudy (subset of Main RCT)|Death|8|||
164556933|NCT03735667|594409843|FG001|4D-CT Substudy (subset of Main RCT)|Death|5|||
164556934|NCT03735667|594409844|FG002|4D-CT Substudy (subset of Main RCT)|Death|0|||
164556935|NCT03735667|594409842|FG000|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
164556936|NCT03735667|594409843|FG001|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
164556937|NCT03735667|594409844|FG002|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|0|||
164556938|NCT03735667|594409842|FG000|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|1|||
164556939|NCT03735667|594409843|FG001|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
164314539|NCT00830869|593529667|FG000|Period 2: Part 2|Progressive disease|0|||
164314540|NCT00830869|593529668|FG001|Period 2: Part 2|Progressive disease|0|||
164314541|NCT00830869|593529669|FG002|Period 2: Part 2|Progressive disease|0|||
164556940|NCT03735667|594409844|FG002|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
164314542|NCT00830869|593529670|FG003|Period 2: Part 2|Progressive disease|0|||
164314543|NCT00830869|593529671|FG004|Period 2: Part 2|Progressive disease|0|||
164556941|NCT03735667|594409842|FG000|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
164556942|NCT03735667|594409843|FG001|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
164556943|NCT03735667|594409844|FG002|4D-CT Substudy (subset of Main RCT)|Physician Decision|0|||
164556944|NCT03735667|594409842|FG000|4D-CT Substudy (subset of Main RCT)|Other|0|||
164556945|NCT03735667|594409843|FG001|4D-CT Substudy (subset of Main RCT)|Other|1|||
164556946|NCT03735667|594409844|FG002|4D-CT Substudy (subset of Main RCT)|Other|0|||
164203438|NCT01232283|593116526|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
164203439|NCT01232283|593116527|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
164203440|NCT01232283|593116528|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
164203441|NCT01232283|593116529|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
164203442|NCT01232283|593116530|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
164203443|NCT01232283|593116531|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
164203444|NCT01232283|593116522|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
164203445|NCT01232283|593116523|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
164203446|NCT01232283|593116524|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
164203447|NCT01232283|593116525|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
164203448|NCT01232283|593116526|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
164203449|NCT01232283|593116527|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
164203450|NCT01232283|593116528|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
164203451|NCT01232283|593116529|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
164203452|NCT01232283|593116530|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
164203453|NCT01232283|593116531|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
164203454|NCT01232283|593116522|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
164203455|NCT01232283|593116523|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
164203456|NCT01232283|593116524|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
164203457|NCT01232283|593116525|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
164203458|NCT01232283|593116526|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
164203459|NCT01232283|593116527|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
164203460|NCT01232283|593116528|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
164203461|NCT01232283|593116529|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
164203462|NCT01232283|593116530|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
164203463|NCT01232283|593116531|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
164203464|NCT01232283|593116522|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
164203465|NCT01232283|593116523|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
164203466|NCT01232283|593116524|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
164203467|NCT01232283|593116525|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
164203468|NCT01232283|593116526|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
164203469|NCT01232283|593116527|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
164203470|NCT01232283|593116528|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
164203471|NCT01232283|593116529|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
164203472|NCT01232283|593116530|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
164203473|NCT01232283|593116531|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
164203474|NCT01232283|593116522|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
164203475|NCT01232283|593116523|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
164203476|NCT01232283|593116524|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
164203477|NCT01232283|593116525|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
164203478|NCT01232283|593116526|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
164203479|NCT01232283|593116527|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
164203480|NCT01232283|593116528|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
164203481|NCT01232283|593116529|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
164203482|NCT01232283|593116530|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
164203483|NCT01232283|593116531|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
164203484|NCT01232283|593116522|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
164203485|NCT01232283|593116523|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
164203486|NCT01232283|593116524|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
164203487|NCT01232283|593116525|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
164203488|NCT01232283|593116526|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
164203489|NCT01232283|593116527|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
164203490|NCT01232283|593116528|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
164203491|NCT01232283|593116529|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
164203492|NCT01232283|593116530|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
164556947|NCT03735667|594409842|FG000|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
164556948|NCT03735667|594409843|FG001|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
164556949|NCT03735667|594409844|FG002|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|0|||
164556950|NCT03092726|594409845|FG000|Overall Study|Adverse Event|3|||
164203493|NCT01232283|593116531|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
164203494|NCT01232283|593116522|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
164203495|NCT01232283|593116523|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
164203496|NCT01232283|593116524|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
164203497|NCT01232283|593116525|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
164203498|NCT01232283|593116526|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
164203499|NCT01232283|593116527|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
164203500|NCT01232283|593116528|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
164203501|NCT01232283|593116529|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
164203502|NCT01232283|593116530|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
164203503|NCT01232283|593116531|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
164203504|NCT01232283|593116522|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
164203505|NCT01232283|593116523|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
164203506|NCT01232283|593116524|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
164203507|NCT01232283|593116525|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
164203508|NCT01232283|593116526|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
164203509|NCT01232283|593116527|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
164203510|NCT01232283|593116528|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
164203511|NCT01232283|593116529|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
164203512|NCT01232283|593116530|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
164203513|NCT01232283|593116531|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
164203514|NCT01232283|593116522|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
164203515|NCT01232283|593116523|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
164203516|NCT01232283|593116524|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
164203517|NCT01232283|593116525|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
164203518|NCT01232283|593116526|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
164203519|NCT01232283|593116527|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
164203520|NCT01232283|593116528|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
164203521|NCT01232283|593116529|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
164203522|NCT01232283|593116530|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
164203523|NCT01232283|593116531|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
164203524|NCT01232283|593116522|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
164203525|NCT01232283|593116523|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
164203526|NCT01232283|593116524|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
164203527|NCT01232283|593116525|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
164203528|NCT01232283|593116526|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
164203529|NCT01232283|593116527|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
164203530|NCT01232283|593116528|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
164203531|NCT01232283|593116529|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
164203532|NCT01232283|593116530|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
164203533|NCT01232283|593116531|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
164203534|NCT01232283|593116522|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
164203535|NCT01232283|593116523|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
164203536|NCT01232283|593116524|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
164203537|NCT01232283|593116525|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
164203538|NCT01232283|593116526|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
164203539|NCT01232283|593116527|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
164203540|NCT01232283|593116528|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
164203541|NCT01232283|593116529|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
164203542|NCT01232283|593116530|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
164203543|NCT01232283|593116531|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
164203544|NCT01232283|593116522|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
164203545|NCT01232283|593116523|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
164203546|NCT01232283|593116524|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
164203547|NCT01232283|593116525|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
164203548|NCT01232283|593116526|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
164203549|NCT01232283|593116527|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
164203550|NCT01232283|593116528|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
164203551|NCT01232283|593116529|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
164203552|NCT01232283|593116530|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
164203553|NCT01232283|593116531|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
164203554|NCT01232283|593116522|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
164203555|NCT01232283|593116523|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
164203556|NCT01232283|593116524|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
164203557|NCT01232283|593116525|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
164203558|NCT01232283|593116526|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
164203559|NCT01232283|593116527|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
164203560|NCT01232283|593116528|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
164203561|NCT01232283|593116529|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
164203562|NCT01232283|593116530|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
164203563|NCT01232283|593116531|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
164203564|NCT01232283|593116522|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
164203565|NCT01232283|593116523|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
164203566|NCT01232283|593116524|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
164203567|NCT01232283|593116525|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
164203568|NCT01232283|593116526|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
164203569|NCT01232283|593116527|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
164203570|NCT01232283|593116528|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
164203571|NCT01232283|593116529|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
164203572|NCT01232283|593116530|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
164203573|NCT01232283|593116531|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
164203574|NCT01232283|593116522|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
164203575|NCT01232283|593116523|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
164203576|NCT01232283|593116524|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
164203577|NCT01232283|593116525|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
164203578|NCT01232283|593116526|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
164203579|NCT01232283|593116527|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
164203580|NCT01232283|593116528|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
164203581|NCT01232283|593116529|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
164203582|NCT01232283|593116530|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
164203583|NCT01232283|593116531|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
164203584|NCT03641508|593116533|FG000|First Injection|Lost to Follow-up|2|||
164203585|NCT03641508|593116534|FG001|First Injection|Lost to Follow-up|0|||
164203586|NCT00094445|593116535|FG000|Overall Study|Withdrawal by Subject|3|||
164203587|NCT00094445|593116535|FG000|Overall Study|Lost to Follow-up|1|||
164203588|NCT00094445|593116535|FG000|Overall Study|Progressive Disease|2|||
164203589|NCT00855218|593116536|FG000|Overall Study|Adverse Event|43|||
164203590|NCT00855218|593116537|FG001|Overall Study|Adverse Event|27|||
164203591|NCT00855218|593116536|FG000|Overall Study|Withdrawal by Subject|10|||
164203592|NCT00855218|593116537|FG001|Overall Study|Withdrawal by Subject|6|||
164203593|NCT00855218|593116536|FG000|Overall Study|Physician Decision|18|||
164203594|NCT00855218|593116537|FG001|Overall Study|Physician Decision|11|||
164203595|NCT00855218|593116536|FG000|Overall Study|Lost to Follow-up|0|||
164203596|NCT00855218|593116537|FG001|Overall Study|Lost to Follow-up|1|||
164203597|NCT00855218|593116536|FG000|Overall Study|Protocol Violation|5|||
164203598|NCT00855218|593116537|FG001|Overall Study|Protocol Violation|9|||
164203599|NCT00855218|593116536|FG000|Overall Study|non-compliant with study drug|3|||
164203600|NCT00855218|593116537|FG001|Overall Study|non-compliant with study drug|1|||
164203601|NCT00855218|593116536|FG000|Overall Study|patient convenience|2|||
164203602|NCT00855218|593116537|FG001|Overall Study|patient convenience|0|||
164203603|NCT00855218|593116536|FG000|Overall Study|technical problems|2|||
164203604|NCT00855218|593116537|FG001|Overall Study|technical problems|1|||
164203605|NCT00855218|593116536|FG000|Overall Study|Still treated with study medication|0|||
164203606|NCT00855218|593116537|FG001|Overall Study|Still treated with study medication|1|||
164203607|NCT00855218|593116536|FG000|Overall Study|Untreatable disease progression|54|||
164203608|NCT00855218|593116537|FG001|Overall Study|Untreatable disease progression|67|||
164203609|NCT00855218|593116536|FG000|Overall Study|Second malignancy|0|||
164203610|NCT00855218|593116537|FG001|Overall Study|Second malignancy|1|||
164203611|NCT00855218|593116536|FG000|Overall Study|Progression measurement proven|7|||
164203612|NCT00855218|593116537|FG001|Overall Study|Progression measurement proven|15|||
164203613|NCT00855218|593116536|FG000|Overall Study|Clinical endpoint reached|10|||
164203614|NCT00855218|593116537|FG001|Overall Study|Clinical endpoint reached|13|||
164203615|NCT01773928|593116542|FG000|Overall Study|Adverse Event|0|||
164203616|NCT01773928|593116543|FG001|Overall Study|Adverse Event|0|||
164203617|NCT01773928|593116544|FG002|Overall Study|Adverse Event|0|||
164203618|NCT01773928|593116545|FG003|Overall Study|Adverse Event|0|||
164203619|NCT01773928|593116546|FG004|Overall Study|Adverse Event|0|||
164203620|NCT01773928|593116547|FG005|Overall Study|Adverse Event|0|||
164203621|NCT01773928|593116548|FG006|Overall Study|Adverse Event|0|||
164203622|NCT01773928|593116549|FG007|Overall Study|Adverse Event|1|||
164203623|NCT01773928|593116550|FG008|Overall Study|Adverse Event|0|||
164203624|NCT01773928|593116542|FG000|Overall Study|Physician Decision|0|||
164203625|NCT01773928|593116543|FG001|Overall Study|Physician Decision|0|||
164203626|NCT01773928|593116544|FG002|Overall Study|Physician Decision|0|||
164203627|NCT01773928|593116545|FG003|Overall Study|Physician Decision|1|||
164203628|NCT01773928|593116546|FG004|Overall Study|Physician Decision|0|||
164203629|NCT01773928|593116547|FG005|Overall Study|Physician Decision|0|||
164203630|NCT01773928|593116548|FG006|Overall Study|Physician Decision|0|||
164314544|NCT00830869|593529672|FG005|Period 2: Part 2|Progressive disease|0|||
164314545|NCT00830869|593529673|FG006|Period 2: Part 2|Progressive disease|0|||
164314546|NCT00830869|593529674|FG007|Period 2: Part 2|Progressive disease|14|||
164314547|NCT00830869|593529675|FG008|Period 2: Part 2|Progressive disease|11|||
164314548|NCT00830869|593529676|FG009|Period 2: Part 2|Progressive disease|12|||
164314549|NCT00830869|593529677|FG010|Period 2: Part 2|Progressive disease|8|||
164314550|NCT00830869|593529678|FG011|Period 2: Part 2|Progressive disease|15|||
164314551|NCT00830869|593529667|FG000|Period 2: Part 2|Other|0|||
164314552|NCT00830869|593529668|FG001|Period 2: Part 2|Other|0|||
164314553|NCT00830869|593529669|FG002|Period 2: Part 2|Other|0|||
164314554|NCT00830869|593529670|FG003|Period 2: Part 2|Other|0|||
164314555|NCT00830869|593529671|FG004|Period 2: Part 2|Other|0|||
164314556|NCT00830869|593529672|FG005|Period 2: Part 2|Other|0|||
164314557|NCT00830869|593529673|FG006|Period 2: Part 2|Other|0|||
164314558|NCT00830869|593529674|FG007|Period 2: Part 2|Other|0|||
164314559|NCT00830869|593529675|FG008|Period 2: Part 2|Other|0|||
164314560|NCT00830869|593529676|FG009|Period 2: Part 2|Other|1|||
164314561|NCT00830869|593529677|FG010|Period 2: Part 2|Other|0|||
164314562|NCT00830869|593529678|FG011|Period 2: Part 2|Other|0|||
164314563|NCT00507728|593529679|FG000|Randomization to Month 3|Lost to Follow-up|15|||
164314564|NCT00507728|593529680|FG001|Randomization to Month 3|Lost to Follow-up|14|||
164314565|NCT00507728|593529681|FG002|Randomization to Month 3|Lost to Follow-up|20|||
164314566|NCT00507728|593529679|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
164314567|NCT00507728|593529680|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
164314568|NCT00507728|593529681|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
164314569|NCT04140227|593529683|FG000|Overall Study|Withdrawal by Subject|26|||
164314570|NCT04140227|593529683|FG000|Overall Study|Lost to Follow-up|8|||
164314571|NCT04140227|593529683|FG000|Overall Study|Adverse Event|8|||
164314572|NCT04140227|593529683|FG000|Overall Study|Death|1|||
164314573|NCT04140227|593529683|FG000|Overall Study|Other|3|||
164314574|NCT04140227|593529683|FG000|Overall Study|Protocol Violation|2|||
164314575|NCT00538785|593529684|FG000|Overall Study|Death|9|||
164314576|NCT00538785|593529685|FG001|Overall Study|Death|10|||
164314577|NCT00538785|593529684|FG000|Overall Study|Withdrawal of consent|9|||
164314578|NCT00538785|593529685|FG001|Overall Study|Withdrawal of consent|7|||
164314579|NCT00538785|593529684|FG000|Overall Study|Lost to Follow-up|1|||
164314580|NCT00538785|593529685|FG001|Overall Study|Lost to Follow-up|0|||
164314581|NCT04022733|593529686|FG000|Overall Study|conversion to open surgery|3|||
164314582|NCT04022733|593529687|FG001|Overall Study|conversion to open surgery|2|||
164314583|NCT04022733|593529686|FG000|Overall Study|bradycardia|0|||
164661000|NCT02228382|594785005|FG001|Overall Study|Study terminated by sponsor|5|||
164661001|NCT02228382|594785006|FG002|Overall Study|Study terminated by sponsor|7|||
164661002|NCT02228382|594785007|FG003|Overall Study|Study terminated by sponsor|0|||
164661003|NCT02228382|594785008|FG004|Overall Study|Study terminated by sponsor|0|||
164661004|NCT02228382|594785004|FG000|Overall Study|Lost to Follow-up|0|||
164661005|NCT02228382|594785005|FG001|Overall Study|Lost to Follow-up|0|||
164661006|NCT02228382|594785006|FG002|Overall Study|Lost to Follow-up|3|||
164661007|NCT02228382|594785007|FG003|Overall Study|Lost to Follow-up|1|||
164661008|NCT02228382|594785008|FG004|Overall Study|Lost to Follow-up|0|||
164661009|NCT02228382|594785004|FG000|Overall Study|Withdrawal by Subject|0|||
164661010|NCT02228382|594785005|FG001|Overall Study|Withdrawal by Subject|3|||
164661011|NCT02228382|594785006|FG002|Overall Study|Withdrawal by Subject|2|||
164661012|NCT02228382|594785007|FG003|Overall Study|Withdrawal by Subject|1|||
164661013|NCT02228382|594785008|FG004|Overall Study|Withdrawal by Subject|0|||
164661014|NCT02228382|594785004|FG000|Overall Study|Other|2|||
164661015|NCT02228382|594785005|FG001|Overall Study|Other|3|||
164661016|NCT02228382|594785006|FG002|Overall Study|Other|3|||
164661017|NCT02228382|594785007|FG003|Overall Study|Other|0|||
164661018|NCT02228382|594785008|FG004|Overall Study|Other|0|||
164661019|NCT00275002|594785010|FG000|Overall Study|Death|1|||
164661020|NCT00275002|594785011|FG001|Overall Study|Death|0|||
164661021|NCT00275002|594785010|FG000|Overall Study|Disease progression|21|||
164661022|NCT00275002|594785011|FG001|Overall Study|Disease progression|15|||
164661023|NCT00275002|594785010|FG000|Overall Study|Adverse Event|0|||
164314584|NCT04022733|593529687|FG001|Overall Study|bradycardia|1|||
164314585|NCT05315908|593529691|FG000|Overall Study|Lost to Follow-up|4477|||
164314586|NCT05315908|593529692|FG001|Overall Study|Lost to Follow-up|4606|||
164314587|NCT01128621|593529701|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
164661024|NCT00275002|594785011|FG001|Overall Study|Adverse Event|1|||
164661025|NCT05014204|594785012|FG000|Overall Study|Withdrawal by Subject|1|||
164661026|NCT05014204|594785012|FG000|Overall Study|Physician Decision|1|||
164314588|NCT01128621|593529702|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
164314589|NCT00233454|593529705|FG000|Overall Study|Death|6|||
164314590|NCT04224688|593529706|FG000|Overall Study|Withdrawal by Subject|1|||
164314591|NCT04224688|593529707|FG001|Overall Study|Withdrawal by Subject|3|||
164314592|NCT04224688|593529706|FG000|Overall Study|Lack of Efficacy|1|||
164314593|NCT04224688|593529707|FG001|Overall Study|Lack of Efficacy|1|||
164314594|NCT04224688|593529706|FG000|Overall Study|Adverse event, not fatal|0|||
164661027|NCT00113490|594785016|FG000|Overall Study|Withdrawal by Subject|1|||
164203631|NCT01773928|593116549|FG007|Overall Study|Physician Decision|0|||
164203632|NCT01773928|593116550|FG008|Overall Study|Physician Decision|0|||
164203633|NCT01773928|593116542|FG000|Overall Study|Withdrawal by Subject|5|||
164203634|NCT01773928|593116543|FG001|Overall Study|Withdrawal by Subject|4|||
164203635|NCT01773928|593116544|FG002|Overall Study|Withdrawal by Subject|4|||
164203636|NCT01773928|593116545|FG003|Overall Study|Withdrawal by Subject|4|||
164203637|NCT01773928|593116546|FG004|Overall Study|Withdrawal by Subject|7|||
164203638|NCT01773928|593116547|FG005|Overall Study|Withdrawal by Subject|1|||
164203639|NCT01773928|593116548|FG006|Overall Study|Withdrawal by Subject|0|||
164203640|NCT01773928|593116549|FG007|Overall Study|Withdrawal by Subject|0|||
164203641|NCT01773928|593116550|FG008|Overall Study|Withdrawal by Subject|1|||
164203642|NCT01773928|593116542|FG000|Overall Study|Lost to Follow-up|0|||
164203643|NCT01773928|593116543|FG001|Overall Study|Lost to Follow-up|0|||
164203644|NCT01773928|593116544|FG002|Overall Study|Lost to Follow-up|0|||
164203645|NCT01773928|593116545|FG003|Overall Study|Lost to Follow-up|0|||
164203646|NCT01773928|593116546|FG004|Overall Study|Lost to Follow-up|0|||
164203647|NCT01773928|593116547|FG005|Overall Study|Lost to Follow-up|1|||
164203648|NCT01773928|593116548|FG006|Overall Study|Lost to Follow-up|0|||
164203649|NCT01773928|593116549|FG007|Overall Study|Lost to Follow-up|0|||
164203650|NCT01773928|593116550|FG008|Overall Study|Lost to Follow-up|0|||
164203651|NCT01773928|593116542|FG000|Overall Study|Subject misrepresented age|0|||
164203652|NCT01773928|593116543|FG001|Overall Study|Subject misrepresented age|1|||
164203653|NCT01773928|593116544|FG002|Overall Study|Subject misrepresented age|0|||
164203654|NCT01773928|593116545|FG003|Overall Study|Subject misrepresented age|0|||
164203655|NCT01773928|593116546|FG004|Overall Study|Subject misrepresented age|0|||
164203656|NCT01773928|593116547|FG005|Overall Study|Subject misrepresented age|0|||
164203657|NCT01773928|593116548|FG006|Overall Study|Subject misrepresented age|0|||
164203658|NCT01773928|593116549|FG007|Overall Study|Subject misrepresented age|0|||
164203659|NCT01773928|593116550|FG008|Overall Study|Subject misrepresented age|0|||
164203660|NCT01773928|593116542|FG000|Overall Study|Subject met exclusion criteria|0|||
164203661|NCT01773928|593116543|FG001|Overall Study|Subject met exclusion criteria|0|||
164203662|NCT01773928|593116544|FG002|Overall Study|Subject met exclusion criteria|0|||
164203663|NCT01773928|593116545|FG003|Overall Study|Subject met exclusion criteria|0|||
164203664|NCT01773928|593116546|FG004|Overall Study|Subject met exclusion criteria|0|||
164203665|NCT01773928|593116547|FG005|Overall Study|Subject met exclusion criteria|0|||
164203666|NCT01773928|593116548|FG006|Overall Study|Subject met exclusion criteria|0|||
164203667|NCT01773928|593116549|FG007|Overall Study|Subject met exclusion criteria|0|||
164203668|NCT01773928|593116550|FG008|Overall Study|Subject met exclusion criteria|1|||
164203669|NCT01773928|593116542|FG000|Overall Study|Randomized, had to leave, never returned|0|||
164203670|NCT01773928|593116543|FG001|Overall Study|Randomized, had to leave, never returned|0|||
164203671|NCT01773928|593116544|FG002|Overall Study|Randomized, had to leave, never returned|0|||
164203672|NCT01773928|593116545|FG003|Overall Study|Randomized, had to leave, never returned|1|||
164203673|NCT01773928|593116546|FG004|Overall Study|Randomized, had to leave, never returned|0|||
164203674|NCT01773928|593116547|FG005|Overall Study|Randomized, had to leave, never returned|0|||
164203675|NCT01773928|593116548|FG006|Overall Study|Randomized, had to leave, never returned|0|||
164203676|NCT01773928|593116549|FG007|Overall Study|Randomized, had to leave, never returned|0|||
164203677|NCT01773928|593116550|FG008|Overall Study|Randomized, had to leave, never returned|0|||
164203678|NCT01773928|593116542|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
164203679|NCT01773928|593116543|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
164203680|NCT01773928|593116544|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
164203681|NCT01773928|593116545|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
164203682|NCT01773928|593116546|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
164203683|NCT01773928|593116547|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
164203684|NCT01773928|593116548|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
164203685|NCT01773928|593116549|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
164203686|NCT01773928|593116550|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
164203687|NCT02370511|593116551|FG000|Overall Study|Death|10|||
164203688|NCT02370511|593116552|FG001|Overall Study|Death|7|||
164203689|NCT02370511|593116553|FG002|Overall Study|Death|1|||
164203690|NCT02370511|593116551|FG000|Overall Study|Withdrawal by Subject|2|||
164203691|NCT02370511|593116552|FG001|Overall Study|Withdrawal by Subject|0|||
164203692|NCT02370511|593116553|FG002|Overall Study|Withdrawal by Subject|0|||
164203693|NCT02370511|593116551|FG000|Overall Study|Lost to Follow-up|0|||
164203694|NCT02370511|593116552|FG001|Overall Study|Lost to Follow-up|4|||
164203695|NCT02370511|593116553|FG002|Overall Study|Lost to Follow-up|0|||
164203696|NCT01149655|593116554|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
164203697|NCT01149655|593116555|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
164203698|NCT01149655|593116556|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
164203699|NCT01149655|593116557|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
164203700|NCT01149655|593116554|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
164203701|NCT01149655|593116555|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
164203702|NCT01149655|593116556|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
164203703|NCT01149655|593116557|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
164203704|NCT01149655|593116554|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
164203705|NCT01149655|593116555|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
164203706|NCT01149655|593116556|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
164203707|NCT01149655|593116557|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
164203708|NCT01149655|593116554|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
164203709|NCT01149655|593116555|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
164203710|NCT01149655|593116556|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
164203711|NCT01149655|593116557|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
164203712|NCT01149655|593116554|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
164203713|NCT01149655|593116555|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
164203714|NCT01149655|593116556|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
164203715|NCT01149655|593116557|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
164203716|NCT01149655|593116554|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
164203717|NCT01149655|593116555|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
164203718|NCT01149655|593116556|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
164203719|NCT01149655|593116557|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
164203720|NCT01149655|593116554|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
164203721|NCT01149655|593116555|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
164203722|NCT01149655|593116556|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
164203723|NCT01149655|593116557|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
164203724|NCT01149655|593116554|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
164203725|NCT01149655|593116555|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
164203726|NCT01149655|593116556|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
164203727|NCT01149655|593116557|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
164203728|NCT01149655|593116554|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
164203729|NCT01149655|593116555|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
164203730|NCT01149655|593116556|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
164203731|NCT01149655|593116557|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
164203732|NCT01149655|593116554|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
164203733|NCT01149655|593116555|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
164203734|NCT01149655|593116556|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
164203735|NCT01149655|593116557|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
164203736|NCT01149655|593116554|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
164203737|NCT01149655|593116555|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
164203738|NCT01149655|593116556|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
164203739|NCT01149655|593116557|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
164203740|NCT01149655|593116554|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
164203741|NCT01149655|593116555|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
164203742|NCT01149655|593116556|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
164203743|NCT01149655|593116557|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
164203744|NCT01149655|593116554|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
164203745|NCT01149655|593116555|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
164203746|NCT01149655|593116556|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
164203747|NCT01149655|593116557|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
164203748|NCT01149655|593116554|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
164203749|NCT01149655|593116555|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
164203750|NCT01149655|593116556|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
164203751|NCT01149655|593116557|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
164203752|NCT01149655|593116554|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
164203753|NCT01149655|593116555|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
164203754|NCT01149655|593116556|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
164203755|NCT01149655|593116557|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
164203756|NCT01149655|593116554|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
164203757|NCT01149655|593116555|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
164203758|NCT01149655|593116556|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
164203759|NCT01149655|593116557|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
164203760|NCT03882918|593116558|FG000|Overall Study|Study terminated by sponsor|98|||
164203761|NCT03882918|593116558|FG000|Overall Study|Protocol Violation|1|||
164203762|NCT03882918|593116558|FG000|Overall Study|Other|9|||
164203763|NCT03882918|593116558|FG000|Overall Study|Lack of Efficacy|14|||
164203764|NCT03882918|593116558|FG000|Overall Study|Adverse Event|13|||
164203765|NCT03882918|593116558|FG000|Overall Study|Withdrawal by Subject|5|||
164203766|NCT02775851|593117784|FG000|Overall Study|Adverse Event|1|||
164203767|NCT02775851|593117785|FG001|Overall Study|Adverse Event|10|||
164203768|NCT02775851|593117784|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
164203769|NCT02775851|593117785|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
164203770|NCT02775851|593117784|FG000|Overall Study|Progression/Relapse|0|||
164420615|NCT01890967|593910948|FG002|Overall Study|Withdrawal by Subject|2|||
164203771|NCT02775851|593117785|FG001|Overall Study|Progression/Relapse|4|||
164203772|NCT02775851|593117784|FG000|Overall Study|Other - Not Protocol Specified|0|||
164203773|NCT02775851|593117785|FG001|Overall Study|Other - Not Protocol Specified|7|||
164203774|NCT02775851|593117784|FG000|Overall Study|Withdrawal by Subject|1|||
164203775|NCT02775851|593117785|FG001|Overall Study|Withdrawal by Subject|0|||
164203776|NCT06125964|593117786|FG000|Overall Study|Lost to Follow-up|0|||
164203777|NCT06125964|593117787|FG001|Overall Study|Lost to Follow-up|1|||
164203778|NCT06125964|593117788|FG002|Overall Study|Lost to Follow-up|0|||
164203779|NCT06125964|593117789|FG003|Overall Study|Lost to Follow-up|0|||
164203780|NCT03370172|593117790|FG000|Overall Study|Withdrawal by Subject|0|||
164203781|NCT03370172|593117791|FG001|Overall Study|Withdrawal by Subject|1|||
164203782|NCT02194465|593117792|FG000|Overall Study|Adverse Event|6|||
164203783|NCT02194465|593117793|FG001|Overall Study|Adverse Event|1|||
164203784|NCT02194465|593117794|FG002|Overall Study|Adverse Event|4|||
164203785|NCT02194465|593117795|FG003|Overall Study|Adverse Event|4|||
164203786|NCT02194465|593117796|FG004|Overall Study|Adverse Event|4|||
164203787|NCT02194465|593117797|FG005|Overall Study|Adverse Event|2|||
164203788|NCT02194465|593117798|FG006|Overall Study|Adverse Event|0|||
164203789|NCT02194465|593117792|FG000|Overall Study|Lost to Follow-up|0|||
164203790|NCT02194465|593117793|FG001|Overall Study|Lost to Follow-up|0|||
164203791|NCT02194465|593117794|FG002|Overall Study|Lost to Follow-up|0|||
164203792|NCT02194465|593117795|FG003|Overall Study|Lost to Follow-up|1|||
164203793|NCT02194465|593117796|FG004|Overall Study|Lost to Follow-up|0|||
164203794|NCT02194465|593117797|FG005|Overall Study|Lost to Follow-up|1|||
164203795|NCT02194465|593117798|FG006|Overall Study|Lost to Follow-up|0|||
164203796|NCT02194465|593117792|FG000|Overall Study|Physician Decision|1|||
164203797|NCT02194465|593117793|FG001|Overall Study|Physician Decision|0|||
164203798|NCT02194465|593117794|FG002|Overall Study|Physician Decision|0|||
164203799|NCT02194465|593117795|FG003|Overall Study|Physician Decision|0|||
164203800|NCT02194465|593117796|FG004|Overall Study|Physician Decision|0|||
164203801|NCT02194465|593117797|FG005|Overall Study|Physician Decision|0|||
164203802|NCT02194465|593117798|FG006|Overall Study|Physician Decision|0|||
164203803|NCT02194465|593117792|FG000|Overall Study|Protocol Violation|1|||
164203804|NCT02194465|593117793|FG001|Overall Study|Protocol Violation|1|||
164203805|NCT02194465|593117794|FG002|Overall Study|Protocol Violation|2|||
164203806|NCT02194465|593117795|FG003|Overall Study|Protocol Violation|1|||
164203807|NCT02194465|593117796|FG004|Overall Study|Protocol Violation|1|||
164203808|NCT02194465|593117797|FG005|Overall Study|Protocol Violation|0|||
164203809|NCT02194465|593117798|FG006|Overall Study|Protocol Violation|0|||
164203810|NCT02194465|593117792|FG000|Overall Study|Withdrawal by Subject|1|||
164203811|NCT02194465|593117793|FG001|Overall Study|Withdrawal by Subject|3|||
164203812|NCT02194465|593117794|FG002|Overall Study|Withdrawal by Subject|1|||
164203813|NCT02194465|593117795|FG003|Overall Study|Withdrawal by Subject|2|||
164203814|NCT02194465|593117796|FG004|Overall Study|Withdrawal by Subject|2|||
164203815|NCT02194465|593117797|FG005|Overall Study|Withdrawal by Subject|1|||
164203816|NCT02194465|593117798|FG006|Overall Study|Withdrawal by Subject|2|||
164203817|NCT02194465|593117792|FG000|Overall Study|Discontinued follow-up period|0|||
164203818|NCT02194465|593117793|FG001|Overall Study|Discontinued follow-up period|2|||
164203819|NCT02194465|593117794|FG002|Overall Study|Discontinued follow-up period|1|||
164203820|NCT02194465|593117795|FG003|Overall Study|Discontinued follow-up period|0|||
164203821|NCT02194465|593117796|FG004|Overall Study|Discontinued follow-up period|2|||
164203822|NCT02194465|593117797|FG005|Overall Study|Discontinued follow-up period|0|||
164203823|NCT02194465|593117798|FG006|Overall Study|Discontinued follow-up period|0|||
164203824|NCT01316614|593117799|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
164203825|NCT01316614|593117799|FG000|Overall Study|Cytology slides not available for review|4|||
164203826|NCT01316614|593117799|FG000|Overall Study|Cystic lesion|5|||
164203827|NCT01316614|593117799|FG000|Overall Study|Inadequate number of passes|2|||
164203828|NCT01316614|593117799|FG000|Overall Study|Medically unstable|1|||
164203829|NCT00076570|593117800|FG000|Overall Study|Drug intolerance|8|||
164203830|NCT00076570|593117801|FG001|Overall Study|Drug intolerance|8|||
164203831|NCT01373164|593117802|FG000|Overall Study|Lost to Follow-up|0|||
164203832|NCT01373164|593117803|FG001|Overall Study|Lost to Follow-up|0|||
164203833|NCT01373164|593117804|FG002|Overall Study|Lost to Follow-up|1|||
164203834|NCT01373164|593117805|FG003|Overall Study|Lost to Follow-up|2|||
164203835|NCT01373164|593117806|FG004|Overall Study|Lost to Follow-up|0|||
164203836|NCT01373164|593117802|FG000|Overall Study|Withdrawal by Subject|0|||
164203837|NCT01373164|593117803|FG001|Overall Study|Withdrawal by Subject|1|||
164203838|NCT01373164|593117804|FG002|Overall Study|Withdrawal by Subject|0|||
164203839|NCT01373164|593117805|FG003|Overall Study|Withdrawal by Subject|10|||
164203840|NCT01373164|593117806|FG004|Overall Study|Withdrawal by Subject|2|||
164203841|NCT03979313|593117807|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
164203842|NCT03979313|593117808|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
164203843|NCT03979313|593117807|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
164203844|NCT03979313|593117808|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
164203845|NCT03979313|593117807|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
164203846|NCT03979313|593117808|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
164302989|NCT03205423|593484683|FG001|Overall Study|Personal|1|||
164314595|NCT04224688|593529707|FG001|Overall Study|Adverse event, not fatal|2|||
164314596|NCT04224688|593529706|FG000|Overall Study|COVID-19|0|||
164314597|NCT04224688|593529707|FG001|Overall Study|COVID-19|1|||
164314598|NCT04074161|593529708|FG000|Overall Study|Withdrawal by Subject|2|||
164314599|NCT04074161|593529709|FG001|Overall Study|Withdrawal by Subject|4|||
164314600|NCT04074161|593529710|FG002|Overall Study|Withdrawal by Subject|1|||
164314601|NCT04074161|593529708|FG000|Overall Study|Lost to Follow-up|4|||
164314602|NCT04074161|593529709|FG001|Overall Study|Lost to Follow-up|5|||
164314603|NCT04074161|593529710|FG002|Overall Study|Lost to Follow-up|3|||
164314604|NCT03595228|593529713|FG000|Overall Study|Death|2|||
164314605|NCT03595228|593529713|FG000|Overall Study|Lack of Efficacy|13|||
164314606|NCT03595228|593529713|FG000|Overall Study|Withdrawal by Subject|3|||
164314607|NCT03595228|593529713|FG000|Overall Study|Withdrawal by Sponsor|1|||
164314608|NCT01639729|593529714|FG000|Overall Study|Withdrawal by Subject|1|||
164314609|NCT01639729|593529715|FG001|Overall Study|Withdrawal by Subject|0|||
164314610|NCT01639729|593529716|FG002|Overall Study|Withdrawal by Subject|1|||
164314611|NCT01639729|593529717|FG003|Overall Study|Withdrawal by Subject|1|||
164314612|NCT01639729|593529718|FG004|Overall Study|Withdrawal by Subject|0|||
164314613|NCT01639729|593529719|FG005|Overall Study|Withdrawal by Subject|0|||
164314614|NCT03083990|593529720|FG000|Overall Study|Adverse Event|1|||
164314615|NCT03083990|593529721|FG001|Overall Study|Adverse Event|0|||
164314616|NCT01853839|593529722|FG000|Overall Study|Violated inclusion criteria|2|||
164314617|NCT01853839|593529722|FG000|Overall Study|Not meet ITT population definition|58|||
164314618|NCT01853839|593529722|FG000|Overall Study|End of treatment visit too early|33|||
164314619|NCT01853839|593529722|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
164314620|NCT01640314|593529723|FG000|Overall Study|Protocol Violation|0|||
164314621|NCT01640314|593529724|FG001|Overall Study|Protocol Violation|1|||
164314622|NCT02709538|593529726|FG000|Overall Study|Adverse Event|13|||
164314623|NCT02709538|593529727|FG001|Overall Study|Adverse Event|2|||
164314624|NCT02709538|593529728|FG002|Overall Study|Adverse Event|3|||
164314625|NCT02709538|593529726|FG000|Overall Study|Lack of Efficacy|1|||
164314626|NCT02709538|593529727|FG001|Overall Study|Lack of Efficacy|0|||
164314627|NCT02709538|593529728|FG002|Overall Study|Lack of Efficacy|0|||
164314628|NCT02709538|593529726|FG000|Overall Study|Lost to Follow-up|24|||
164314629|NCT02709538|593529727|FG001|Overall Study|Lost to Follow-up|8|||
164556951|NCT03092726|594409846|FG001|Overall Study|Adverse Event|10|||
164556952|NCT03092726|594409845|FG000|Overall Study|Lack of Efficacy|0|||
164314630|NCT02709538|593529728|FG002|Overall Study|Lost to Follow-up|4|||
164556953|NCT03092726|594409846|FG001|Overall Study|Lack of Efficacy|1|||
164556954|NCT03092726|594409845|FG000|Overall Study|Lost to Follow-up|1|||
164556955|NCT03092726|594409846|FG001|Overall Study|Lost to Follow-up|0|||
164556956|NCT03092726|594409845|FG000|Overall Study|Withdrawal by Subject|5|||
164556957|NCT03092726|594409846|FG001|Overall Study|Withdrawal by Subject|3|||
164556958|NCT02296242|594409854|FG000|Overall Study|Death|1|||
164556959|NCT02296242|594409855|FG001|Overall Study|Death|1|||
164556960|NCT02296242|594409856|FG002|Overall Study|Death|1|||
164556961|NCT02296242|594409857|FG003|Overall Study|Death|1|||
164556962|NCT02296242|594409858|FG004|Overall Study|Death|1|||
164556963|NCT02296242|594409854|FG000|Overall Study|Withdrawal by Subject|0|||
164556964|NCT02296242|594409855|FG001|Overall Study|Withdrawal by Subject|0|||
164556965|NCT02296242|594409856|FG002|Overall Study|Withdrawal by Subject|1|||
164556966|NCT02296242|594409857|FG003|Overall Study|Withdrawal by Subject|1|||
164556967|NCT02296242|594409858|FG004|Overall Study|Withdrawal by Subject|3|||
164556968|NCT02296242|594409854|FG000|Overall Study|Disease Progression|1|||
164556969|NCT02296242|594409855|FG001|Overall Study|Disease Progression|3|||
164203847|NCT03979313|593117807|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
164203848|NCT03979313|593117808|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
164203849|NCT03979313|593117807|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
164203850|NCT03979313|593117808|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
164203851|NCT03979313|593117807|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
164203852|NCT03979313|593117808|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
164203853|NCT03979313|593117807|FG000|All Subjects|Any Other Reason|16|||
164203854|NCT03979313|593117808|FG001|All Subjects|Any Other Reason|23|||
164203855|NCT03979313|593117807|FG000|All Subjects|Covid-19|1|||
164203856|NCT03979313|593117808|FG001|All Subjects|Covid-19|3|||
164203857|NCT03979313|593117807|FG000|All Subjects|Withdrawal by Subject|35|||
164203858|NCT03979313|593117808|FG001|All Subjects|Withdrawal by Subject|44|||
164314631|NCT02709538|593529726|FG000|Overall Study|Physician Decision|1|||
164314632|NCT02709538|593529727|FG001|Overall Study|Physician Decision|0|||
164314633|NCT02709538|593529728|FG002|Overall Study|Physician Decision|0|||
164314634|NCT02709538|593529726|FG000|Overall Study|Withdrawal by Subject|40|||
164314635|NCT02709538|593529727|FG001|Overall Study|Withdrawal by Subject|7|||
164314636|NCT02709538|593529728|FG002|Overall Study|Withdrawal by Subject|4|||
164556970|NCT02296242|594409856|FG002|Overall Study|Disease Progression|2|||
164556971|NCT02296242|594409857|FG003|Overall Study|Disease Progression|8|||
164556972|NCT02296242|594409858|FG004|Overall Study|Disease Progression|11|||
164556973|NCT02296242|594409854|FG000|Overall Study|Unacceptable Toxicity|0|||
164556974|NCT02296242|594409855|FG001|Overall Study|Unacceptable Toxicity|0|||
164556975|NCT02296242|594409856|FG002|Overall Study|Unacceptable Toxicity|0|||
164556976|NCT02296242|594409857|FG003|Overall Study|Unacceptable Toxicity|0|||
164556977|NCT02296242|594409858|FG004|Overall Study|Unacceptable Toxicity|1|||
164556978|NCT02296242|594409854|FG000|Overall Study|Patient Condition Changed|0|||
164556979|NCT02296242|594409855|FG001|Overall Study|Patient Condition Changed|0|||
164556980|NCT02296242|594409856|FG002|Overall Study|Patient Condition Changed|2|||
164556981|NCT02296242|594409857|FG003|Overall Study|Patient Condition Changed|0|||
164556982|NCT02296242|594409858|FG004|Overall Study|Patient Condition Changed|1|||
164556983|NCT02296242|594409854|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
164556984|NCT02296242|594409855|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
164556985|NCT02296242|594409856|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
164556986|NCT02296242|594409857|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
164556987|NCT02296242|594409858|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
164556988|NCT02296242|594409854|FG000|Overall Study|Lost to Follow-up|1|||
164556989|NCT02296242|594409855|FG001|Overall Study|Lost to Follow-up|0|||
164556990|NCT02296242|594409856|FG002|Overall Study|Lost to Follow-up|0|||
164556991|NCT02296242|594409857|FG003|Overall Study|Lost to Follow-up|0|||
164556992|NCT02296242|594409858|FG004|Overall Study|Lost to Follow-up|0|||
164556993|NCT02296242|594409854|FG000|Overall Study|Need for Hydroxyurea|2|||
164556994|NCT02296242|594409855|FG001|Overall Study|Need for Hydroxyurea|0|||
164556995|NCT02296242|594409856|FG002|Overall Study|Need for Hydroxyurea|0|||
164556996|NCT02296242|594409857|FG003|Overall Study|Need for Hydroxyurea|0|||
164556997|NCT02296242|594409858|FG004|Overall Study|Need for Hydroxyurea|0|||
164556998|NCT02296242|594409854|FG000|Overall Study|Screened for Other Protocol|0|||
164556999|NCT02296242|594409855|FG001|Overall Study|Screened for Other Protocol|1|||
164557000|NCT02296242|594409856|FG002|Overall Study|Screened for Other Protocol|0|||
164557001|NCT02296242|594409857|FG003|Overall Study|Screened for Other Protocol|0|||
164557002|NCT02296242|594409858|FG004|Overall Study|Screened for Other Protocol|0|||
164557003|NCT02296242|594409854|FG000|Overall Study|Physician Decision|0|||
164557004|NCT02296242|594409855|FG001|Overall Study|Physician Decision|1|||
164557005|NCT02296242|594409856|FG002|Overall Study|Physician Decision|0|||
164557006|NCT02296242|594409857|FG003|Overall Study|Physician Decision|1|||
164557007|NCT02296242|594409858|FG004|Overall Study|Physician Decision|0|||
164557008|NCT02296242|594409854|FG000|Overall Study|Alternative Treatment|0|||
164557009|NCT02296242|594409855|FG001|Overall Study|Alternative Treatment|0|||
164557010|NCT02296242|594409856|FG002|Overall Study|Alternative Treatment|0|||
164557011|NCT02296242|594409857|FG003|Overall Study|Alternative Treatment|1|||
164557012|NCT02296242|594409858|FG004|Overall Study|Alternative Treatment|0|||
164557013|NCT02296242|594409854|FG000|Overall Study|Adverse Event|0|||
164557014|NCT02296242|594409855|FG001|Overall Study|Adverse Event|0|||
164557015|NCT02296242|594409856|FG002|Overall Study|Adverse Event|0|||
164557016|NCT02296242|594409857|FG003|Overall Study|Adverse Event|1|||
164557017|NCT02296242|594409858|FG004|Overall Study|Adverse Event|0|||
164557018|NCT02296242|594409854|FG000|Overall Study|Lack of Efficacy|0|||
164557019|NCT02296242|594409855|FG001|Overall Study|Lack of Efficacy|0|||
164557020|NCT02296242|594409856|FG002|Overall Study|Lack of Efficacy|0|||
164557021|NCT02296242|594409857|FG003|Overall Study|Lack of Efficacy|0|||
164557022|NCT02296242|594409858|FG004|Overall Study|Lack of Efficacy|3|||
164557023|NCT01290692|594409864|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
164557024|NCT02780648|594409865|FG000|Overall Study|Disease Progression|1|||
164557025|NCT02780648|594409866|FG001|Overall Study|Disease Progression|0|||
164557026|NCT01079182|594409881|FG000|Overall Study|Lost to Follow-up|1634|||
164557027|NCT01079182|594409881|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
164557028|NCT01079182|594409881|FG000|Overall Study|Lack of Efficacy|514|||
164557029|NCT01079182|594409881|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
164557030|NCT01079182|594409881|FG000|Overall Study|Reasons not Evaluated|271|||
164557031|NCT01026831|594409882|FG000|Overall Study|Adverse Event|4|||
164557032|NCT01026831|594409883|FG001|Overall Study|Adverse Event|3|||
164557033|NCT01026831|594409882|FG000|Overall Study|Lost to Follow-up|2|||
164557034|NCT01026831|594409883|FG001|Overall Study|Lost to Follow-up|0|||
164557035|NCT01026831|594409882|FG000|Overall Study|Physician Decision|1|||
164557036|NCT01026831|594409883|FG001|Overall Study|Physician Decision|1|||
164557037|NCT01026831|594409882|FG000|Overall Study|Protocol Violation|0|||
164557038|NCT01026831|594409883|FG001|Overall Study|Protocol Violation|2|||
164557039|NCT01026831|594409882|FG000|Overall Study|Withdrawal by Subject|7|||
164557040|NCT01026831|594409883|FG001|Overall Study|Withdrawal by Subject|5|||
164557041|NCT01110200|594409885|FG000|Overall Study|Adverse Event|28|||
164557042|NCT01110200|594409886|FG001|Overall Study|Adverse Event|28|||
164557043|NCT01110200|594409885|FG000|Overall Study|Withdrawal by Subject|25|||
164557044|NCT01110200|594409886|FG001|Overall Study|Withdrawal by Subject|32|||
164557045|NCT01110200|594409885|FG000|Overall Study|Lack of Efficacy|16|||
164557046|NCT01110200|594409886|FG001|Overall Study|Lack of Efficacy|25|||
164557047|NCT01110200|594409885|FG000|Overall Study|Protocol Violation|14|||
164557048|NCT01110200|594409886|FG001|Overall Study|Protocol Violation|12|||
164557049|NCT01110200|594409885|FG000|Overall Study|Physician Decision|13|||
164557050|NCT01110200|594409886|FG001|Overall Study|Physician Decision|17|||
164661028|NCT00113490|594785017|FG001|Overall Study|Withdrawal by Subject|3|||
164661029|NCT00113490|594785016|FG000|Overall Study|Lost to Follow-up|1|||
164661030|NCT00113490|594785017|FG001|Overall Study|Lost to Follow-up|0|||
164661031|NCT00819247|594785018|FG000|Overall Study|Adverse Event|0|||
164661032|NCT00819247|594785019|FG001|Overall Study|Adverse Event|5|||
164661033|NCT00819247|594785020|FG002|Overall Study|Adverse Event|3|||
164661034|NCT00819247|594785018|FG000|Overall Study|Insufficient testosterone response|5|||
164661035|NCT00819247|594785019|FG001|Overall Study|Insufficient testosterone response|8|||
164661036|NCT00819247|594785020|FG002|Overall Study|Insufficient testosterone response|10|||
164661037|NCT00819247|594785018|FG000|Overall Study|Withdrawal by Subject|1|||
164661038|NCT00819247|594785019|FG001|Overall Study|Withdrawal by Subject|0|||
164661039|NCT00819247|594785020|FG002|Overall Study|Withdrawal by Subject|0|||
164661040|NCT00819247|594785018|FG000|Overall Study|Protocol Violation|1|||
164661041|NCT00819247|594785019|FG001|Overall Study|Protocol Violation|0|||
164661042|NCT00819247|594785020|FG002|Overall Study|Protocol Violation|1|||
164661043|NCT00819247|594785018|FG000|Overall Study|Mistakenly withdrawn|0|||
164661044|NCT00819247|594785019|FG001|Overall Study|Mistakenly withdrawn|1|||
164661045|NCT00819247|594785020|FG002|Overall Study|Mistakenly withdrawn|0|||
164661046|NCT00819247|594785018|FG000|Overall Study|Bad prostate-specific antigen response|3|||
164661047|NCT00819247|594785019|FG001|Overall Study|Bad prostate-specific antigen response|2|||
164661048|NCT00819247|594785020|FG002|Overall Study|Bad prostate-specific antigen response|0|||
164661049|NCT00819247|594785018|FG000|Overall Study|Other|1|||
164661050|NCT00819247|594785019|FG001|Overall Study|Other|0|||
164661051|NCT00819247|594785020|FG002|Overall Study|Other|0|||
164661052|NCT04652453|594785022|FG000|Overall Study|Death|8|||
164661053|NCT04652453|594785023|FG001|Overall Study|Death|2|||
164661054|NCT04652453|594785024|FG002|Overall Study|Death|0|||
164661055|NCT04652453|594785022|FG000|Overall Study|Hospice|5|||
164661056|NCT04652453|594785023|FG001|Overall Study|Hospice|5|||
164557051|NCT01110200|594409885|FG000|Overall Study|Lost to Follow-up|10|||
164557052|NCT01110200|594409886|FG001|Overall Study|Lost to Follow-up|7|||
164557053|NCT00903175|594409887|FG000|Period 1 - First Line|Adverse Event|36|||
164557054|NCT00903175|594409888|FG001|Period 1 - First Line|Adverse Event|50|||
164557055|NCT00903175|594409887|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
164557056|NCT00903175|594409888|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
164557057|NCT00903175|594409887|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
164557058|NCT00903175|594409888|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
164557059|NCT00903175|594409887|FG000|Period 1 - First Line|Protocol Violation|3|||
164557060|NCT00903175|594409888|FG001|Period 1 - First Line|Protocol Violation|3|||
164557061|NCT00903175|594409887|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
164557062|NCT00903175|594409888|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
164557063|NCT00903175|594409887|FG000|Period 1 - First Line|Administrative problems|12|||
164557064|NCT00903175|594409888|FG001|Period 1 - First Line|Administrative problems|13|||
164557065|NCT00903175|594409887|FG000|Period 1 - First Line|Death|17|||
164557066|NCT00903175|594409888|FG001|Period 1 - First Line|Death|10|||
164557067|NCT00903175|594409887|FG000|Period 2 - Second Line|Missing|1|||
164557068|NCT00903175|594409888|FG001|Period 2 - Second Line|Missing|0|||
164557069|NCT00903175|594409887|FG000|Period 2 - Second Line|Adverse Event|16|||
164557070|NCT00903175|594409888|FG001|Period 2 - Second Line|Adverse Event|20|||
164557071|NCT00903175|594409887|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
164557072|NCT00903175|594409888|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
164557073|NCT00903175|594409887|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
164557074|NCT00903175|594409888|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
164557075|NCT00903175|594409887|FG000|Period 2 - Second Line|Administrative problems|19|||
164557076|NCT00903175|594409888|FG001|Period 2 - Second Line|Administrative problems|9|||
164557077|NCT00903175|594409887|FG000|Period 2 - Second Line|Death|5|||
164557078|NCT00903175|594409888|FG001|Period 2 - Second Line|Death|2|||
164557079|NCT00371865|594409889|FG000|Overall Study|Lack of Efficacy|0|||
164557080|NCT00371865|594409890|FG001|Overall Study|Lack of Efficacy|2|||
164661057|NCT04652453|594785024|FG002|Overall Study|Hospice|0|||
164661058|NCT04652453|594785022|FG000|Overall Study|Withdrawal by Subject|2|||
164661059|NCT04652453|594785023|FG001|Overall Study|Withdrawal by Subject|0|||
164661060|NCT04652453|594785024|FG002|Overall Study|Withdrawal by Subject|0|||
164661061|NCT04033445|594785026|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
164661062|NCT04033445|594785027|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
164661063|NCT04033445|594785028|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
164661064|NCT04033445|594785029|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
164661065|NCT04033445|594785030|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
164661066|NCT04033445|594785031|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
164557081|NCT00371865|594409889|FG000|Overall Study|Protocol Violation|3|||
164557082|NCT00371865|594409890|FG001|Overall Study|Protocol Violation|2|||
164557083|NCT00371865|594409889|FG000|Overall Study|Withdrawal by Subject|12|||
164557084|NCT00371865|594409890|FG001|Overall Study|Withdrawal by Subject|10|||
164557085|NCT05103332|594409891|FG000|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557086|NCT05103332|594409892|FG001|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
164557087|NCT05103332|594409893|FG002|DB Period (6 Months=168 Days)|Lost to Follow-up|1|||
164661067|NCT04033445|594785032|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
164661068|NCT04033445|594785033|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
164661069|NCT04033445|594785034|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
164661070|NCT04033445|594785035|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
164661071|NCT04033445|594785036|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
164661072|NCT04033445|594785037|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
164661073|NCT04033445|594785038|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
164661074|NCT04033445|594785039|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
164661075|NCT04033445|594785026|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
164661076|NCT04033445|594785027|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
164661077|NCT04033445|594785028|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
164661078|NCT04033445|594785029|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
164661079|NCT04033445|594785030|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
164661080|NCT04033445|594785031|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
164661081|NCT04033445|594785032|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
164661082|NCT04033445|594785033|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
164661083|NCT04033445|594785034|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
164661084|NCT04033445|594785035|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
164661085|NCT04033445|594785036|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
164661086|NCT04033445|594785037|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
164661087|NCT04033445|594785038|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
164661088|NCT04033445|594785039|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
164661089|NCT04033445|594785026|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
164661090|NCT04033445|594785027|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
164661091|NCT04033445|594785028|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
164661092|NCT04033445|594785029|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
164661093|NCT04033445|594785030|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
164661094|NCT04033445|594785031|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
164661095|NCT04033445|594785032|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
164661096|NCT04033445|594785033|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
164661097|NCT04033445|594785034|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
164661098|NCT04033445|594785035|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
164557088|NCT05103332|594409894|FG003|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557089|NCT05103332|594409895|FG004|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557090|NCT05103332|594409896|FG005|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
164557091|NCT05103332|594409897|FG006|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557092|NCT05103332|594409898|FG007|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557093|NCT05103332|594409899|FG008|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557094|NCT05103332|594409900|FG009|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557095|NCT05103332|594409901|FG010|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557096|NCT05103332|594409902|FG011|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557097|NCT05103332|594409903|FG012|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557098|NCT05103332|594409904|FG013|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557099|NCT05103332|594409905|FG014|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557100|NCT05103332|594409906|FG015|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557101|NCT05103332|594409907|FG016|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557102|NCT05103332|594409908|FG017|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557103|NCT05103332|594409891|FG000|DB Period (6 Months=168 Days)|Physician Decision|0|||
164557104|NCT05103332|594409892|FG001|DB Period (6 Months=168 Days)|Physician Decision|1|||
164557105|NCT05103332|594409893|FG002|DB Period (6 Months=168 Days)|Physician Decision|0|||
164557106|NCT05103332|594409894|FG003|DB Period (6 Months=168 Days)|Physician Decision|1|||
164557107|NCT05103332|594409895|FG004|DB Period (6 Months=168 Days)|Physician Decision|0|||
164557108|NCT05103332|594409896|FG005|DB Period (6 Months=168 Days)|Physician Decision|0|||
164557109|NCT05103332|594409897|FG006|DB Period (6 Months=168 Days)|Physician Decision|0|||
164557110|NCT05103332|594409898|FG007|DB Period (6 Months=168 Days)|Physician Decision|0|||
164557111|NCT05103332|594409899|FG008|DB Period (6 Months=168 Days)|Physician Decision|0|||
164557112|NCT05103332|594409900|FG009|DB Period (6 Months=168 Days)|Physician Decision|0|||
164557113|NCT05103332|594409901|FG010|DB Period (6 Months=168 Days)|Physician Decision|0|||
164557114|NCT05103332|594409902|FG011|DB Period (6 Months=168 Days)|Physician Decision|0|||
164661099|NCT04033445|594785036|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
164661100|NCT04033445|594785037|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
164661101|NCT04033445|594785038|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
164661102|NCT04033445|594785039|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
164557115|NCT05103332|594409903|FG012|DB Period (6 Months=168 Days)|Physician Decision|0|||
164557116|NCT05103332|594409904|FG013|DB Period (6 Months=168 Days)|Physician Decision|0|||
164557117|NCT05103332|594409905|FG014|DB Period (6 Months=168 Days)|Physician Decision|0|||
164557118|NCT05103332|594409906|FG015|DB Period (6 Months=168 Days)|Physician Decision|0|||
164661103|NCT04033445|594785026|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
164661104|NCT04033445|594785027|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
164661105|NCT04033445|594785028|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
164661106|NCT04033445|594785029|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
164661107|NCT04033445|594785030|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
164661108|NCT04033445|594785031|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
164661109|NCT04033445|594785032|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
164661110|NCT04033445|594785033|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
164661111|NCT04033445|594785034|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
164661112|NCT04033445|594785035|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
164661113|NCT04033445|594785036|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
164661114|NCT04033445|594785037|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
164661115|NCT04033445|594785038|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
164661116|NCT04033445|594785039|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
164661117|NCT04033445|594785026|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164661118|NCT04033445|594785027|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164661119|NCT04033445|594785028|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164661120|NCT04033445|594785029|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164661121|NCT04033445|594785030|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164661122|NCT04033445|594785031|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164661123|NCT04033445|594785032|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
164661124|NCT04033445|594785033|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164661125|NCT04033445|594785034|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164661126|NCT04033445|594785035|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164661127|NCT04033445|594785036|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164661128|NCT04033445|594785037|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164661129|NCT04033445|594785038|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164661130|NCT04033445|594785039|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164661131|NCT04033445|594785026|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
164661132|NCT04033445|594785027|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
164661133|NCT04033445|594785028|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
164661134|NCT04033445|594785029|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
164661135|NCT04033445|594785030|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
164661136|NCT04033445|594785031|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
164661137|NCT04033445|594785032|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
164661138|NCT04033445|594785033|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
164661139|NCT04033445|594785034|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
164661140|NCT04033445|594785035|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
164661141|NCT04033445|594785036|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
164661142|NCT04033445|594785037|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
164661143|NCT04033445|594785038|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
164661144|NCT04033445|594785039|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
164661145|NCT04033445|594785026|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
164661146|NCT04033445|594785027|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
164661147|NCT04033445|594785028|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
164661148|NCT04033445|594785029|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
164661149|NCT04033445|594785030|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
164661150|NCT04033445|594785031|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
164661151|NCT04033445|594785032|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
164661152|NCT04033445|594785033|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
164661153|NCT04033445|594785034|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
164661154|NCT04033445|594785035|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
164661155|NCT04033445|594785036|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
164661156|NCT04033445|594785037|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
164661157|NCT04033445|594785038|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
164661158|NCT04033445|594785039|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
164661159|NCT04033445|594785026|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
164661160|NCT04033445|594785027|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
164661161|NCT04033445|594785028|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
164661162|NCT04033445|594785029|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
164661163|NCT04033445|594785030|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
164661164|NCT04033445|594785031|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
164661165|NCT04033445|594785032|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
164661166|NCT04033445|594785033|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
164203859|NCT03979313|593117807|FG000|All Subjects|Death|0|||
164203860|NCT03979313|593117808|FG001|All Subjects|Death|5|||
164314637|NCT02709538|593529726|FG000|Overall Study|Non-compliance with study procedures|5|||
164314638|NCT02709538|593529727|FG001|Overall Study|Non-compliance with study procedures|0|||
164314639|NCT02709538|593529728|FG002|Overall Study|Non-compliance with study procedures|0|||
164314640|NCT02709538|593529726|FG000|Overall Study|Non-compliance with study drug|2|||
164314641|NCT02709538|593529727|FG001|Overall Study|Non-compliance with study drug|0|||
164314642|NCT02709538|593529728|FG002|Overall Study|Non-compliance with study drug|0|||
164314643|NCT02709538|593529726|FG000|Overall Study|Protocol deviation|10|||
164314644|NCT02709538|593529727|FG001|Overall Study|Protocol deviation|4|||
164314645|NCT02709538|593529728|FG002|Overall Study|Protocol deviation|4|||
164314646|NCT02709538|593529726|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
164314647|NCT02709538|593529727|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
164314648|NCT02709538|593529728|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
164314649|NCT02709538|593529726|FG000|Overall Study|Other|16|||
164314650|NCT02709538|593529727|FG001|Overall Study|Other|7|||
164314651|NCT02709538|593529728|FG002|Overall Study|Other|5|||
164314652|NCT00835211|593529730|FG000|First Intervention|Withdrawal by Subject|0|||
164314653|NCT00835211|593529731|FG001|First Intervention|Withdrawal by Subject|1|||
164314654|NCT00835211|593529730|FG000|Washout: 7 Days|Adverse Event|2|||
164314655|NCT00835211|593529731|FG001|Washout: 7 Days|Adverse Event|1|||
164314656|NCT00835211|593529730|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
164314657|NCT00835211|593529731|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
164314658|NCT03087617|593529732|FG000|Overall Study|Lost to Follow-up|32|||
164314659|NCT03087617|593529733|FG001|Overall Study|Lost to Follow-up|30|||
164557119|NCT05103332|594409907|FG016|DB Period (6 Months=168 Days)|Physician Decision|0|||
164557120|NCT05103332|594409908|FG017|DB Period (6 Months=168 Days)|Physician Decision|0|||
164557121|NCT05103332|594409891|FG000|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|2|||
164557122|NCT05103332|594409892|FG001|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
164557123|NCT05103332|594409893|FG002|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
164557124|NCT05103332|594409894|FG003|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
164557125|NCT05103332|594409895|FG004|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
164557126|NCT05103332|594409896|FG005|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
164557127|NCT05103332|594409897|FG006|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
164557128|NCT05103332|594409898|FG007|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
164557129|NCT05103332|594409899|FG008|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
164557130|NCT05103332|594409900|FG009|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
164557131|NCT05103332|594409901|FG010|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
164557132|NCT05103332|594409902|FG011|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
164557133|NCT05103332|594409903|FG012|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
164557134|NCT05103332|594409904|FG013|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
164557135|NCT05103332|594409905|FG014|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
164557136|NCT05103332|594409906|FG015|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
164557137|NCT05103332|594409907|FG016|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
164557138|NCT05103332|594409908|FG017|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
164557139|NCT05103332|594409891|FG000|DB Period (6 Months=168 Days)|Other|0|||
164557140|NCT05103332|594409892|FG001|DB Period (6 Months=168 Days)|Other|0|||
164557141|NCT05103332|594409893|FG002|DB Period (6 Months=168 Days)|Other|0|||
164557142|NCT05103332|594409894|FG003|DB Period (6 Months=168 Days)|Other|1|||
164557143|NCT05103332|594409895|FG004|DB Period (6 Months=168 Days)|Other|0|||
164557144|NCT05103332|594409896|FG005|DB Period (6 Months=168 Days)|Other|0|||
164557145|NCT05103332|594409897|FG006|DB Period (6 Months=168 Days)|Other|0|||
164557146|NCT05103332|594409898|FG007|DB Period (6 Months=168 Days)|Other|0|||
164557147|NCT05103332|594409899|FG008|DB Period (6 Months=168 Days)|Other|0|||
164557148|NCT05103332|594409900|FG009|DB Period (6 Months=168 Days)|Other|0|||
164557149|NCT05103332|594409901|FG010|DB Period (6 Months=168 Days)|Other|0|||
164557150|NCT05103332|594409902|FG011|DB Period (6 Months=168 Days)|Other|0|||
164557151|NCT05103332|594409903|FG012|DB Period (6 Months=168 Days)|Other|0|||
164557152|NCT05103332|594409904|FG013|DB Period (6 Months=168 Days)|Other|0|||
164557153|NCT05103332|594409905|FG014|DB Period (6 Months=168 Days)|Other|0|||
164557154|NCT05103332|594409906|FG015|DB Period (6 Months=168 Days)|Other|0|||
164557155|NCT05103332|594409907|FG016|DB Period (6 Months=168 Days)|Other|0|||
164557156|NCT05103332|594409908|FG017|DB Period (6 Months=168 Days)|Other|0|||
164557157|NCT05103332|594409891|FG000|OLE Period (24 Months=672 Days)|Adverse Event|0|||
164557158|NCT05103332|594409892|FG001|OLE Period (24 Months=672 Days)|Adverse Event|0|||
164557159|NCT05103332|594409893|FG002|OLE Period (24 Months=672 Days)|Adverse Event|0|||
164314660|NCT03087617|593529734|FG002|Overall Study|Lost to Follow-up|30|||
164314661|NCT03087617|593529735|FG003|Overall Study|Lost to Follow-up|39|||
164314662|NCT02343549|593529736|FG000|Overall Study|Death|11|||
164314663|NCT02343549|593529736|FG000|Overall Study|Withdrawal by Subject|2|||
164314664|NCT02160041|593529738|FG000|Overall Study|Adverse Event|11|||
164314665|NCT02160041|593529738|FG000|Overall Study|Death|2|||
164314666|NCT02160041|593529738|FG000|Overall Study|disease progression|57|||
164314667|NCT02160041|593529738|FG000|Overall Study|Protocol Violation|1|||
164314668|NCT02160041|593529738|FG000|Overall Study|non-compliance with study|1|||
164314669|NCT02160041|593529738|FG000|Overall Study|Physician Decision|3|||
164314670|NCT02160041|593529738|FG000|Overall Study|Withdrawal by Subject|8|||
164314671|NCT02160041|593529738|FG000|Overall Study|study terminated by by sponsor|1|||
164314672|NCT04450381|593529739|FG000|Overall Study|Protocol Violation|4|||
164314673|NCT04450381|593529739|FG000|Overall Study|Wrong device setting|2|||
164314674|NCT00006409|593529742|FG000|Baseline|Protocol Violation|48|||
164314675|NCT00006409|593529743|FG001|Baseline|Protocol Violation|70|||
164314676|NCT00006409|593529744|FG002|Baseline|Protocol Violation|0|||
164314677|NCT00006409|593529745|FG003|Baseline|Protocol Violation|0|||
164314678|NCT00006409|593529746|FG004|Baseline|Protocol Violation|0|||
164314679|NCT00006409|593529747|FG005|Baseline|Protocol Violation|0|||
164314680|NCT00006409|593529742|FG000|Post-2 Year Intervention|Protocol Violation|0|||
164314681|NCT00006409|593529743|FG001|Post-2 Year Intervention|Protocol Violation|0|||
164314682|NCT00006409|593529744|FG002|Post-2 Year Intervention|Protocol Violation|251|||
164314683|NCT00006409|593529745|FG003|Post-2 Year Intervention|Protocol Violation|168|||
164314684|NCT00006409|593529746|FG004|Post-2 Year Intervention|Protocol Violation|0|||
164314685|NCT00006409|593529747|FG005|Post-2 Year Intervention|Protocol Violation|0|||
164314686|NCT00006409|593529742|FG000|Post-3 Year Intervention|Protocol Violation|0|||
164314687|NCT00006409|593529743|FG001|Post-3 Year Intervention|Protocol Violation|0|||
164314688|NCT00006409|593529744|FG002|Post-3 Year Intervention|Protocol Violation|0|||
164314689|NCT00006409|593529745|FG003|Post-3 Year Intervention|Protocol Violation|0|||
164314690|NCT00006409|593529746|FG004|Post-3 Year Intervention|Protocol Violation|62|||
164314691|NCT00006409|593529747|FG005|Post-3 Year Intervention|Protocol Violation|62|||
164314692|NCT04343235|593529750|FG000|Overall Study|Lost to Follow-up|3|||
164314693|NCT04343235|593529751|FG001|Overall Study|Lost to Follow-up|2|||
164314694|NCT00787267|593529752|FG000|Overall Study|Screen failure/Ineligible|10|||
164314695|NCT00787267|593529752|FG000|Overall Study|No Reason Provided|1|||
164314696|NCT00787267|593529752|FG000|Overall Study|Withdrawal by Subject|1|||
164314697|NCT01763996|593529753|FG000|Treatment Period 2|Adverse Event|0|||
164314698|NCT01763996|593529754|FG001|Treatment Period 2|Adverse Event|1|||
164314699|NCT00865280|593529755|FG000|Overall Study|Withdrawal by Subject|4|||
164314700|NCT00865280|593529756|FG001|Overall Study|Withdrawal by Subject|1|||
164314701|NCT00865280|593529755|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
164314702|NCT00865280|593529756|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
164314703|NCT00865280|593529755|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
164314704|NCT00865280|593529756|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
164314705|NCT00865280|593529755|FG000|Overall Study|Exclusion Condition|1|||
164314706|NCT00865280|593529756|FG001|Overall Study|Exclusion Condition|0|||
164314707|NCT00865280|593529755|FG000|Overall Study|Adverse Event|0|||
164314708|NCT00865280|593529756|FG001|Overall Study|Adverse Event|1|||
164314709|NCT01396057|593529757|FG000|Overall Study|Adverse Event|2|||
164314710|NCT01396057|593529758|FG001|Overall Study|Adverse Event|6|||
164314711|NCT01396057|593529757|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164314712|NCT01396057|593529758|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
164314713|NCT01396057|593529757|FG000|Overall Study|Protocol deviation|4|||
164314714|NCT01396057|593529758|FG001|Overall Study|Protocol deviation|4|||
164314715|NCT01396057|593529757|FG000|Overall Study|Consent withdrawn|3|||
164314716|NCT01396057|593529758|FG001|Overall Study|Consent withdrawn|2|||
164314717|NCT00884741|593529761|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
164314718|NCT00884741|593529762|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
164314719|NCT00884741|593529763|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
164314720|NCT00884741|593529764|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
164314721|NCT00884741|593529761|FG000|Step 1 Registration: Tissue Screening|Death|3|||
164557160|NCT05103332|594409894|FG003|OLE Period (24 Months=672 Days)|Adverse Event|0|||
164557161|NCT05103332|594409895|FG004|OLE Period (24 Months=672 Days)|Adverse Event|0|||
164557162|NCT05103332|594409896|FG005|OLE Period (24 Months=672 Days)|Adverse Event|0|||
164557163|NCT05103332|594409897|FG006|OLE Period (24 Months=672 Days)|Adverse Event|0|||
164557164|NCT05103332|594409898|FG007|OLE Period (24 Months=672 Days)|Adverse Event|0|||
164557165|NCT05103332|594409899|FG008|OLE Period (24 Months=672 Days)|Adverse Event|0|||
164557166|NCT05103332|594409900|FG009|OLE Period (24 Months=672 Days)|Adverse Event|0|||
164557167|NCT05103332|594409901|FG010|OLE Period (24 Months=672 Days)|Adverse Event|1|||
164557168|NCT05103332|594409902|FG011|OLE Period (24 Months=672 Days)|Adverse Event|0|||
164557169|NCT05103332|594409903|FG012|OLE Period (24 Months=672 Days)|Adverse Event|0|||
164557170|NCT05103332|594409904|FG013|OLE Period (24 Months=672 Days)|Adverse Event|0|||
164661167|NCT04033445|594785034|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
164314722|NCT00884741|593529762|FG001|Step 1 Registration: Tissue Screening|Death|0|||
164314723|NCT00884741|593529763|FG002|Step 1 Registration: Tissue Screening|Death|0|||
164314724|NCT00884741|593529764|FG003|Step 1 Registration: Tissue Screening|Death|0|||
164314725|NCT00884741|593529761|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
164314726|NCT00884741|593529762|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
164314727|NCT00884741|593529763|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
164314728|NCT00884741|593529764|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
164557171|NCT05103332|594409905|FG014|OLE Period (24 Months=672 Days)|Adverse Event|0|||
164557172|NCT05103332|594409906|FG015|OLE Period (24 Months=672 Days)|Adverse Event|0|||
164557173|NCT05103332|594409907|FG016|OLE Period (24 Months=672 Days)|Adverse Event|0|||
164557174|NCT05103332|594409908|FG017|OLE Period (24 Months=672 Days)|Adverse Event|0|||
164557175|NCT05103332|594409891|FG000|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
164557176|NCT05103332|594409892|FG001|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
164557177|NCT05103332|594409893|FG002|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
164557178|NCT05103332|594409894|FG003|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
164557179|NCT05103332|594409895|FG004|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
164557180|NCT05103332|594409896|FG005|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
164557181|NCT05103332|594409897|FG006|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
164557182|NCT05103332|594409898|FG007|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
164557183|NCT05103332|594409899|FG008|OLE Period (24 Months=672 Days)|Lost to Follow-up|1|||
164557184|NCT05103332|594409900|FG009|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
164557185|NCT05103332|594409901|FG010|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
164557186|NCT05103332|594409902|FG011|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
164557187|NCT05103332|594409903|FG012|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
164557188|NCT05103332|594409904|FG013|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
164557189|NCT05103332|594409905|FG014|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
164557190|NCT05103332|594409906|FG015|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
164557191|NCT05103332|594409907|FG016|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
164557192|NCT05103332|594409908|FG017|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
164557193|NCT05103332|594409891|FG000|OLE Period (24 Months=672 Days)|Physician Decision|0|||
164557194|NCT05103332|594409892|FG001|OLE Period (24 Months=672 Days)|Physician Decision|0|||
164557195|NCT05103332|594409893|FG002|OLE Period (24 Months=672 Days)|Physician Decision|0|||
164557196|NCT05103332|594409894|FG003|OLE Period (24 Months=672 Days)|Physician Decision|0|||
164557197|NCT05103332|594409895|FG004|OLE Period (24 Months=672 Days)|Physician Decision|0|||
164557198|NCT05103332|594409896|FG005|OLE Period (24 Months=672 Days)|Physician Decision|0|||
164557199|NCT05103332|594409897|FG006|OLE Period (24 Months=672 Days)|Physician Decision|0|||
164557200|NCT05103332|594409898|FG007|OLE Period (24 Months=672 Days)|Physician Decision|0|||
164557201|NCT05103332|594409899|FG008|OLE Period (24 Months=672 Days)|Physician Decision|0|||
164557202|NCT05103332|594409900|FG009|OLE Period (24 Months=672 Days)|Physician Decision|0|||
164557203|NCT05103332|594409901|FG010|OLE Period (24 Months=672 Days)|Physician Decision|0|||
164557204|NCT05103332|594409902|FG011|OLE Period (24 Months=672 Days)|Physician Decision|1|||
164557205|NCT05103332|594409903|FG012|OLE Period (24 Months=672 Days)|Physician Decision|0|||
164557206|NCT05103332|594409904|FG013|OLE Period (24 Months=672 Days)|Physician Decision|0|||
164557207|NCT05103332|594409905|FG014|OLE Period (24 Months=672 Days)|Physician Decision|0|||
164557208|NCT05103332|594409906|FG015|OLE Period (24 Months=672 Days)|Physician Decision|0|||
164557209|NCT05103332|594409907|FG016|OLE Period (24 Months=672 Days)|Physician Decision|0|||
164557210|NCT05103332|594409908|FG017|OLE Period (24 Months=672 Days)|Physician Decision|0|||
164557211|NCT05103332|594409891|FG000|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
164557212|NCT05103332|594409892|FG001|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
164557213|NCT05103332|594409893|FG002|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
164557214|NCT05103332|594409894|FG003|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
164557215|NCT05103332|594409895|FG004|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
164557216|NCT05103332|594409896|FG005|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
164557217|NCT05103332|594409897|FG006|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
164557218|NCT05103332|594409898|FG007|OLE Period (24 Months=672 Days)|Reason Not Specified|1|||
164557219|NCT05103332|594409899|FG008|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
164557220|NCT05103332|594409900|FG009|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
164557221|NCT05103332|594409901|FG010|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
164557222|NCT05103332|594409902|FG011|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
164557223|NCT05103332|594409903|FG012|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
164557224|NCT05103332|594409904|FG013|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
164557225|NCT05103332|594409905|FG014|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
164557226|NCT05103332|594409906|FG015|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
164557227|NCT05103332|594409907|FG016|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
164557228|NCT05103332|594409908|FG017|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
164557229|NCT05103332|594409891|FG000|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557230|NCT05103332|594409892|FG001|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557231|NCT05103332|594409893|FG002|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557232|NCT05103332|594409894|FG003|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557233|NCT05103332|594409895|FG004|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557234|NCT05103332|594409896|FG005|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
164661168|NCT04033445|594785035|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
164661169|NCT04033445|594785036|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
164661170|NCT04033445|594785037|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
164661171|NCT04033445|594785038|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
164661172|NCT04033445|594785039|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
164661173|NCT04033445|594785026|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
164661174|NCT04033445|594785027|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
164661175|NCT04033445|594785028|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
164661176|NCT04033445|594785029|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
164661177|NCT04033445|594785030|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
164661178|NCT04033445|594785031|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
164661179|NCT04033445|594785032|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
164661180|NCT04033445|594785033|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
164661181|NCT04033445|594785034|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
164661182|NCT04033445|594785035|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
164661183|NCT04033445|594785036|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
164661184|NCT04033445|594785037|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
164661185|NCT04033445|594785038|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
164661186|NCT04033445|594785039|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
164661187|NCT04033445|594785026|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
164661188|NCT04033445|594785027|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
164661189|NCT04033445|594785028|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
164661190|NCT04033445|594785029|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
164661191|NCT04033445|594785030|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
164661192|NCT04033445|594785031|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
164661193|NCT04033445|594785032|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
164661194|NCT04033445|594785033|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
164661195|NCT04033445|594785034|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
164661196|NCT04033445|594785035|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
164661197|NCT04033445|594785036|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
164661198|NCT04033445|594785037|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
164661199|NCT04033445|594785038|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
164661200|NCT04033445|594785039|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
164661201|NCT04033445|594785026|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164661202|NCT04033445|594785027|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164661203|NCT04033445|594785028|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164661204|NCT04033445|594785029|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164661205|NCT04033445|594785030|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164661206|NCT04033445|594785031|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164661207|NCT04033445|594785032|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164661208|NCT04033445|594785033|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164661209|NCT04033445|594785034|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
164661210|NCT04033445|594785035|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164661211|NCT04033445|594785036|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164661212|NCT04033445|594785037|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164661213|NCT04033445|594785038|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164661214|NCT04033445|594785039|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164661215|NCT04033445|594785026|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164661216|NCT04033445|594785027|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164661217|NCT04033445|594785028|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164661218|NCT04033445|594785029|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
164661219|NCT04033445|594785030|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164661220|NCT04033445|594785031|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164661221|NCT04033445|594785032|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164661222|NCT04033445|594785033|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164661223|NCT04033445|594785034|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164661224|NCT04033445|594785035|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164661225|NCT04033445|594785036|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164661226|NCT04033445|594785037|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164661227|NCT04033445|594785038|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164661228|NCT04033445|594785039|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164661229|NCT04033445|594785026|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
164661230|NCT04033445|594785027|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
164661231|NCT04033445|594785028|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
164203861|NCT03979313|593117807|FG000|All Subjects|Lost to Follow-up|28|||
164314729|NCT00884741|593529761|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
164314730|NCT00884741|593529762|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
164314731|NCT00884741|593529763|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
164314732|NCT00884741|593529764|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
164314733|NCT00884741|593529761|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
164314734|NCT00884741|593529762|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
164314735|NCT00884741|593529763|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
164314736|NCT00884741|593529764|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
164314737|NCT00884741|593529761|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
164314738|NCT00884741|593529762|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
164314739|NCT00884741|593529763|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
164314740|NCT00884741|593529764|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
164314741|NCT00884741|593529761|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
164314742|NCT00884741|593529762|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
164314743|NCT00884741|593529763|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
164314744|NCT00884741|593529764|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
164314745|NCT00884741|593529761|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
164314746|NCT00884741|593529762|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
164314747|NCT00884741|593529763|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
164557235|NCT05103332|594409897|FG006|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557236|NCT05103332|594409898|FG007|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557237|NCT05103332|594409899|FG008|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557238|NCT05103332|594409900|FG009|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557239|NCT05103332|594409901|FG010|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557240|NCT05103332|594409902|FG011|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
164557241|NCT05103332|594409903|FG012|SFU Period (6 Months=168 Days)|Lost to Follow-up|2|||
164557242|NCT05103332|594409904|FG013|SFU Period (6 Months=168 Days)|Lost to Follow-up|1|||
164557243|NCT05103332|594409905|FG014|SFU Period (6 Months=168 Days)|Lost to Follow-up|5|||
164557244|NCT05103332|594409906|FG015|SFU Period (6 Months=168 Days)|Lost to Follow-up|3|||
164557245|NCT05103332|594409907|FG016|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
164557246|NCT05103332|594409908|FG017|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
164557247|NCT05103332|594409891|FG000|SFU Period (6 Months=168 Days)|Physician Decision|0|||
164557248|NCT05103332|594409892|FG001|SFU Period (6 Months=168 Days)|Physician Decision|0|||
164557249|NCT05103332|594409893|FG002|SFU Period (6 Months=168 Days)|Physician Decision|0|||
164557250|NCT05103332|594409894|FG003|SFU Period (6 Months=168 Days)|Physician Decision|0|||
164557251|NCT05103332|594409895|FG004|SFU Period (6 Months=168 Days)|Physician Decision|0|||
164557252|NCT05103332|594409896|FG005|SFU Period (6 Months=168 Days)|Physician Decision|0|||
164557253|NCT05103332|594409897|FG006|SFU Period (6 Months=168 Days)|Physician Decision|0|||
164557254|NCT05103332|594409898|FG007|SFU Period (6 Months=168 Days)|Physician Decision|0|||
164557255|NCT05103332|594409899|FG008|SFU Period (6 Months=168 Days)|Physician Decision|0|||
164557256|NCT05103332|594409900|FG009|SFU Period (6 Months=168 Days)|Physician Decision|0|||
164557257|NCT05103332|594409901|FG010|SFU Period (6 Months=168 Days)|Physician Decision|0|||
164557258|NCT05103332|594409902|FG011|SFU Period (6 Months=168 Days)|Physician Decision|0|||
164557259|NCT05103332|594409903|FG012|SFU Period (6 Months=168 Days)|Physician Decision|0|||
164557260|NCT05103332|594409904|FG013|SFU Period (6 Months=168 Days)|Physician Decision|0|||
164557261|NCT05103332|594409905|FG014|SFU Period (6 Months=168 Days)|Physician Decision|0|||
164557262|NCT05103332|594409906|FG015|SFU Period (6 Months=168 Days)|Physician Decision|0|||
164557263|NCT05103332|594409907|FG016|SFU Period (6 Months=168 Days)|Physician Decision|0|||
164557264|NCT05103332|594409908|FG017|SFU Period (6 Months=168 Days)|Physician Decision|1|||
164557265|NCT05103332|594409891|FG000|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
164557266|NCT05103332|594409892|FG001|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
164557267|NCT05103332|594409893|FG002|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
164557268|NCT05103332|594409894|FG003|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
164557269|NCT05103332|594409895|FG004|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
164557270|NCT05103332|594409896|FG005|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
164557271|NCT05103332|594409897|FG006|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
164557272|NCT05103332|594409898|FG007|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
164557273|NCT05103332|594409899|FG008|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
164557274|NCT05103332|594409900|FG009|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
164557275|NCT05103332|594409901|FG010|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
164557276|NCT05103332|594409902|FG011|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
164557277|NCT05103332|594409903|FG012|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|4|||
164557278|NCT05103332|594409904|FG013|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
164557279|NCT05103332|594409905|FG014|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|1|||
164589000|NCT02078713|594521335|FG000|Overall Study|Pregnant at baseline|3|||
164661232|NCT04033445|594785029|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
164661233|NCT04033445|594785030|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
164661234|NCT04033445|594785031|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
164661235|NCT04033445|594785032|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
164661236|NCT04033445|594785033|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
164661237|NCT04033445|594785034|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
164661238|NCT04033445|594785035|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
164661239|NCT04033445|594785036|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
164314748|NCT00884741|593529764|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
164661240|NCT04033445|594785037|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
164661241|NCT04033445|594785038|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
164314749|NCT00884741|593529761|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
164661242|NCT04033445|594785039|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
164661243|NCT04033445|594785026|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164661244|NCT04033445|594785027|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164661245|NCT04033445|594785028|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164661246|NCT04033445|594785029|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164661247|NCT04033445|594785030|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164661248|NCT04033445|594785031|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164661249|NCT04033445|594785032|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164661250|NCT04033445|594785033|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
164661251|NCT04033445|594785034|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164661252|NCT04033445|594785035|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164661253|NCT04033445|594785036|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164661254|NCT04033445|594785037|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164661255|NCT04033445|594785038|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164661256|NCT04033445|594785039|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164661257|NCT04033445|594785026|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164661258|NCT04033445|594785027|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164661259|NCT04033445|594785028|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164661260|NCT04033445|594785029|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164661261|NCT04033445|594785030|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164661262|NCT04033445|594785031|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164661263|NCT04033445|594785032|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164661264|NCT04033445|594785033|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
164661265|NCT04033445|594785034|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164661266|NCT04033445|594785035|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164661267|NCT04033445|594785036|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164661268|NCT04033445|594785037|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164661269|NCT04033445|594785038|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164661270|NCT04033445|594785039|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164661271|NCT04033445|594785026|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
164661272|NCT04033445|594785027|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
164661273|NCT04033445|594785028|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
164661274|NCT04033445|594785029|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
164661275|NCT04033445|594785030|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
164661276|NCT04033445|594785031|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
164661277|NCT04033445|594785032|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
164661278|NCT04033445|594785033|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
164661279|NCT04033445|594785034|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
164661280|NCT04033445|594785035|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
164661281|NCT04033445|594785036|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
164661282|NCT04033445|594785037|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
164661283|NCT04033445|594785038|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
164661284|NCT04033445|594785039|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
164661285|NCT04033445|594785026|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
164661286|NCT04033445|594785027|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
164661287|NCT04033445|594785028|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
164661288|NCT04033445|594785029|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
164661289|NCT04033445|594785030|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
164661290|NCT04033445|594785031|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
164661291|NCT04033445|594785032|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
164661292|NCT04033445|594785033|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
164661293|NCT04033445|594785034|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
164557280|NCT05103332|594409906|FG015|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|7|||
164557281|NCT05103332|594409907|FG016|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
164557282|NCT05103332|594409908|FG017|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
164557283|NCT05103332|594409891|FG000|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
164557284|NCT05103332|594409892|FG001|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
164557285|NCT05103332|594409893|FG002|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
164557286|NCT05103332|594409894|FG003|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
164557287|NCT05103332|594409895|FG004|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
164557288|NCT05103332|594409896|FG005|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
164557289|NCT05103332|594409897|FG006|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
164557290|NCT05103332|594409898|FG007|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
164557291|NCT05103332|594409899|FG008|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
164557292|NCT05103332|594409900|FG009|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
164557293|NCT05103332|594409901|FG010|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
164557294|NCT05103332|594409902|FG011|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
164557295|NCT05103332|594409903|FG012|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
164557296|NCT05103332|594409904|FG013|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
164557297|NCT05103332|594409905|FG014|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
164557298|NCT05103332|594409906|FG015|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
164557299|NCT05103332|594409907|FG016|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
164557300|NCT05103332|594409908|FG017|SFU Period (6 Months=168 Days)|Reason Not Specified|2|||
164557301|NCT05103332|594409891|FG000|SFU Period (6 Months=168 Days)|Death|0|||
164557302|NCT05103332|594409892|FG001|SFU Period (6 Months=168 Days)|Death|0|||
164557303|NCT05103332|594409893|FG002|SFU Period (6 Months=168 Days)|Death|0|||
164557304|NCT05103332|594409894|FG003|SFU Period (6 Months=168 Days)|Death|0|||
164557305|NCT05103332|594409895|FG004|SFU Period (6 Months=168 Days)|Death|0|||
164557306|NCT05103332|594409896|FG005|SFU Period (6 Months=168 Days)|Death|0|||
164661294|NCT04033445|594785035|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
164661295|NCT04033445|594785036|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
164661296|NCT04033445|594785037|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
164661297|NCT04033445|594785038|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
164661298|NCT04033445|594785039|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
164661299|NCT04033445|594785026|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
164661300|NCT04033445|594785027|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
164661301|NCT04033445|594785028|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
164661302|NCT04033445|594785029|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
164661303|NCT04033445|594785030|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
164661304|NCT04033445|594785031|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
164661305|NCT04033445|594785032|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
164661306|NCT04033445|594785033|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
164661307|NCT04033445|594785034|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
164661308|NCT04033445|594785035|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
164661309|NCT04033445|594785036|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
164661310|NCT04033445|594785037|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
164661311|NCT04033445|594785038|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
164661312|NCT04033445|594785039|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
164661313|NCT04033445|594785026|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
164661314|NCT04033445|594785027|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
164661315|NCT04033445|594785028|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
164661316|NCT04033445|594785029|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
164661317|NCT04033445|594785030|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
164661318|NCT04033445|594785031|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
164661319|NCT04033445|594785032|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
164661320|NCT04033445|594785033|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
164661321|NCT04033445|594785034|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
164661322|NCT04033445|594785035|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
164661323|NCT04033445|594785036|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
164661324|NCT04033445|594785037|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
164661325|NCT04033445|594785038|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
164661326|NCT04033445|594785039|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
164661327|NCT04033445|594785026|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
164661328|NCT04033445|594785027|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
164661329|NCT04033445|594785028|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
164661330|NCT04033445|594785029|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
164203862|NCT03979313|593117808|FG001|All Subjects|Lost to Follow-up|61|||
164203863|NCT00089648|593117809|FG000|Overall Study|Adverse Event|7|||
164203864|NCT00089648|593117809|FG000|Overall Study|Withdrawal by Subject|1|||
164203865|NCT00089648|593117809|FG000|Overall Study|Lack of Efficacy|33|||
164203866|NCT00420745|593117810|FG000|Overall Study|Adverse Event|2|||
164203867|NCT00420745|593117811|FG001|Overall Study|Adverse Event|2|||
164203868|NCT00420745|593117810|FG000|Overall Study|Lost to Follow-up|10|||
164203869|NCT00420745|593117811|FG001|Overall Study|Lost to Follow-up|2|||
164203870|NCT00420745|593117810|FG000|Overall Study|Protocol Violation|1|||
164203871|NCT00420745|593117811|FG001|Overall Study|Protocol Violation|0|||
164203872|NCT00420745|593117810|FG000|Overall Study|Physician Decision|1|||
164203873|NCT00420745|593117811|FG001|Overall Study|Physician Decision|1|||
164203874|NCT00420745|593117810|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
164203875|NCT00420745|593117811|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
164203876|NCT00420745|593117810|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
164203877|NCT00420745|593117811|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
164203878|NCT00423605|593117812|FG000|Overall Study|Adverse Event|129|||
164203879|NCT00423605|593117812|FG000|Overall Study|Withdrawal by Subject|36|||
164203880|NCT00423605|593117812|FG000|Overall Study|Lost to Follow-up|15|||
164203881|NCT00423605|593117812|FG000|Overall Study|Lack of Efficacy|38|||
164557307|NCT05103332|594409897|FG006|SFU Period (6 Months=168 Days)|Death|0|||
164557308|NCT05103332|594409898|FG007|SFU Period (6 Months=168 Days)|Death|0|||
164557309|NCT05103332|594409899|FG008|SFU Period (6 Months=168 Days)|Death|0|||
164557310|NCT05103332|594409900|FG009|SFU Period (6 Months=168 Days)|Death|0|||
164557311|NCT05103332|594409901|FG010|SFU Period (6 Months=168 Days)|Death|0|||
164557312|NCT05103332|594409902|FG011|SFU Period (6 Months=168 Days)|Death|0|||
164557313|NCT05103332|594409903|FG012|SFU Period (6 Months=168 Days)|Death|0|||
164557314|NCT05103332|594409904|FG013|SFU Period (6 Months=168 Days)|Death|0|||
164557315|NCT05103332|594409905|FG014|SFU Period (6 Months=168 Days)|Death|1|||
164557316|NCT05103332|594409906|FG015|SFU Period (6 Months=168 Days)|Death|0|||
164557317|NCT05103332|594409907|FG016|SFU Period (6 Months=168 Days)|Death|0|||
164557318|NCT05103332|594409908|FG017|SFU Period (6 Months=168 Days)|Death|1|||
164557319|NCT04428476|594409909|FG000|Overall Study|Withdrawal by Subject|1|||
164557320|NCT04428476|594409909|FG000|Overall Study|Still on treatment|12|||
164557321|NCT02043548|594409910|FG000|Overall Study|Lack of Efficacy|1|||
164557322|NCT02043548|594409911|FG001|Overall Study|Lack of Efficacy|0|||
164557323|NCT02043548|594409910|FG000|Overall Study|Adverse Event|0|||
164557324|NCT02043548|594409911|FG001|Overall Study|Adverse Event|1|||
164557325|NCT01430455|594409915|FG000|Overall Study|Withdrawal by Subject|1|||
164557326|NCT01430455|594409915|FG000|Overall Study|Switched to follow-up phase|1|||
164557327|NCT01425008|594409916|FG000|Dose Escalation Phase|Progressive Disease|2|||
164557328|NCT01425008|594409917|FG001|Dose Escalation Phase|Progressive Disease|3|||
164557329|NCT01425008|594409918|FG002|Dose Escalation Phase|Progressive Disease|2|||
164557330|NCT01425008|594409919|FG003|Dose Escalation Phase|Progressive Disease|3|||
164557331|NCT01425008|594409920|FG004|Dose Escalation Phase|Progressive Disease|5|||
164557332|NCT01425008|594409921|FG005|Dose Escalation Phase|Progressive Disease|4|||
164557333|NCT01425008|594409922|FG006|Dose Escalation Phase|Progressive Disease|0|||
164557334|NCT01425008|594409923|FG007|Dose Escalation Phase|Progressive Disease|2|||
164557335|NCT01425008|594409924|FG008|Dose Escalation Phase|Progressive Disease|6|||
164557336|NCT01425008|594409925|FG009|Dose Escalation Phase|Progressive Disease|2|||
164557337|NCT01425008|594409926|FG010|Dose Escalation Phase|Progressive Disease|0|||
164557338|NCT01425008|594409927|FG011|Dose Escalation Phase|Progressive Disease|0|||
164557339|NCT01425008|594409928|FG012|Dose Escalation Phase|Progressive Disease|0|||
164557340|NCT01425008|594409929|FG013|Dose Escalation Phase|Progressive Disease|0|||
164557341|NCT01425008|594409930|FG014|Dose Escalation Phase|Progressive Disease|0|||
164557342|NCT01425008|594409931|FG015|Dose Escalation Phase|Progressive Disease|0|||
164557343|NCT01425008|594409932|FG016|Dose Escalation Phase|Progressive Disease|0|||
164557344|NCT01425008|594409933|FG017|Dose Escalation Phase|Progressive Disease|0|||
164557345|NCT01425008|594409934|FG018|Dose Escalation Phase|Progressive Disease|0|||
164557346|NCT01425008|594409916|FG000|Dose Escalation Phase|Adverse Event|2|||
164557347|NCT01425008|594409917|FG001|Dose Escalation Phase|Adverse Event|0|||
164557348|NCT01425008|594409918|FG002|Dose Escalation Phase|Adverse Event|0|||
164557349|NCT01425008|594409919|FG003|Dose Escalation Phase|Adverse Event|0|||
164557350|NCT01425008|594409920|FG004|Dose Escalation Phase|Adverse Event|0|||
164557351|NCT01425008|594409921|FG005|Dose Escalation Phase|Adverse Event|2|||
164557352|NCT01425008|594409922|FG006|Dose Escalation Phase|Adverse Event|0|||
164557353|NCT01425008|594409923|FG007|Dose Escalation Phase|Adverse Event|0|||
164557354|NCT01425008|594409924|FG008|Dose Escalation Phase|Adverse Event|2|||
164557355|NCT01425008|594409925|FG009|Dose Escalation Phase|Adverse Event|0|||
164557356|NCT01425008|594409926|FG010|Dose Escalation Phase|Adverse Event|0|||
164557357|NCT01425008|594409927|FG011|Dose Escalation Phase|Adverse Event|0|||
164557358|NCT01425008|594409928|FG012|Dose Escalation Phase|Adverse Event|0|||
164203882|NCT00423605|593117812|FG000|Overall Study|Sponsor Decision|3|||
164203883|NCT00423605|593117812|FG000|Overall Study|Physician Decision|8|||
164203884|NCT00423605|593117812|FG000|Overall Study|Protocol Violation|7|||
164557359|NCT01425008|594409929|FG013|Dose Escalation Phase|Adverse Event|0|||
164557360|NCT01425008|594409930|FG014|Dose Escalation Phase|Adverse Event|0|||
164302990|NCT03205423|593484682|FG000|Overall Study|Physician Decision|0|||
164557361|NCT01425008|594409931|FG015|Dose Escalation Phase|Adverse Event|0|||
164557362|NCT01425008|594409932|FG016|Dose Escalation Phase|Adverse Event|0|||
164557363|NCT01425008|594409933|FG017|Dose Escalation Phase|Adverse Event|0|||
164557364|NCT01425008|594409934|FG018|Dose Escalation Phase|Adverse Event|0|||
164557365|NCT01425008|594409916|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164557366|NCT01425008|594409917|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164557367|NCT01425008|594409918|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164557368|NCT01425008|594409919|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164557369|NCT01425008|594409920|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
164557370|NCT01425008|594409921|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164557371|NCT01425008|594409922|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
164557372|NCT01425008|594409923|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
164557373|NCT01425008|594409924|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
164557374|NCT01425008|594409925|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164557375|NCT01425008|594409926|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164557376|NCT01425008|594409927|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164557377|NCT01425008|594409928|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164557378|NCT01425008|594409929|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164557379|NCT01425008|594409930|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164557380|NCT01425008|594409931|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164557381|NCT01425008|594409932|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164557382|NCT01425008|594409933|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164557383|NCT01425008|594409934|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164557384|NCT01425008|594409916|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
164557385|NCT01425008|594409917|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
164557386|NCT01425008|594409918|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
164557387|NCT01425008|594409919|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
164557388|NCT01425008|594409920|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
164557389|NCT01425008|594409921|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
164557390|NCT01425008|594409922|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
164557391|NCT01425008|594409923|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
164557392|NCT01425008|594409924|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
164557393|NCT01425008|594409925|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
164557394|NCT01425008|594409926|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
164557395|NCT01425008|594409927|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
164557396|NCT01425008|594409928|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
164557397|NCT01425008|594409929|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
164557398|NCT01425008|594409930|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
164557399|NCT01425008|594409931|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
164557400|NCT01425008|594409932|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
164557401|NCT01425008|594409933|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
164557402|NCT01425008|594409934|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
164557403|NCT01425008|594409916|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
164557404|NCT01425008|594409917|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
164557405|NCT01425008|594409918|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
164557406|NCT01425008|594409919|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
164203885|NCT00423605|593117812|FG000|Overall Study|Not one of the pre-specified options|5|||
164203886|NCT03183908|593117813|FG000|Overall Study|Missing Symptom Diary Data|0|||
164203887|NCT03183908|593117814|FG001|Overall Study|Missing Symptom Diary Data|2|||
164203888|NCT02058095|593117818|FG000|Overall Study|Adverse Event|1|||
164203889|NCT02058095|593117819|FG001|Overall Study|Adverse Event|0|||
164203890|NCT00726453|593117820|FG000|Primary Enrollment Group|Death|18|||
164203891|NCT00726453|593117821|FG001|Primary Enrollment Group|Death|0|||
164203892|NCT00726453|593117820|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
164203893|NCT00726453|593117821|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
164203894|NCT00726453|593117820|FG000|38 mm Length Group|Death|0|||
164203895|NCT00726453|593117821|FG001|38 mm Length Group|Death|3|||
164203896|NCT01588509|593117825|FG000|Overall Study|Lost to Follow-up|1|||
164661331|NCT04033445|594785030|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
164661332|NCT04033445|594785031|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
164661333|NCT04033445|594785032|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
164661334|NCT04033445|594785033|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
164661335|NCT04033445|594785034|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
164661336|NCT04033445|594785035|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
164661337|NCT04033445|594785036|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
164661338|NCT04033445|594785037|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
164661339|NCT04033445|594785038|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
164661340|NCT04033445|594785039|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
164694665|NCT03250299|594905308|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
164661341|NCT04033445|594785026|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164661342|NCT04033445|594785027|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164661343|NCT04033445|594785028|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164661344|NCT04033445|594785029|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164661345|NCT04033445|594785030|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164661346|NCT04033445|594785031|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164661347|NCT04033445|594785032|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164661348|NCT04033445|594785033|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164661349|NCT04033445|594785034|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164661350|NCT04033445|594785035|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164661351|NCT04033445|594785036|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164661352|NCT04033445|594785037|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164661353|NCT04033445|594785038|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164661354|NCT04033445|594785039|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
164661355|NCT04033445|594785026|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
164661356|NCT04033445|594785027|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
164661357|NCT04033445|594785028|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
164661358|NCT04033445|594785029|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
164661359|NCT04033445|594785030|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
164661360|NCT04033445|594785031|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
164661361|NCT04033445|594785032|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
164661362|NCT04033445|594785033|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
164661363|NCT04033445|594785034|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
164661364|NCT04033445|594785035|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
164661365|NCT04033445|594785036|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
164661366|NCT04033445|594785037|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
164661367|NCT04033445|594785038|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
164661368|NCT04033445|594785039|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
164661369|NCT04033445|594785026|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
164661370|NCT04033445|594785027|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
164661371|NCT04033445|594785028|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
164661372|NCT04033445|594785029|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
164661373|NCT04033445|594785030|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
164661374|NCT04033445|594785031|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
164661375|NCT04033445|594785032|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
164661376|NCT04033445|594785033|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
164661377|NCT04033445|594785034|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
164661378|NCT04033445|594785035|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
164661379|NCT04033445|594785036|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
164661380|NCT04033445|594785037|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
164661381|NCT04033445|594785038|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
164661382|NCT04033445|594785039|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
164661383|NCT02985957|594785044|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164661384|NCT02985957|594785045|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164661385|NCT02985957|594785046|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164661386|NCT02985957|594785047|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164661387|NCT02985957|594785048|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
164661388|NCT02985957|594785049|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164661389|NCT02985957|594785050|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164661390|NCT02985957|594785044|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
164661391|NCT02985957|594785045|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
164661392|NCT02985957|594785046|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
164661393|NCT02985957|594785047|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
164661394|NCT02985957|594785048|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
164661395|NCT02985957|594785049|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
164661396|NCT02985957|594785050|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
164661397|NCT02985957|594785044|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
164661398|NCT02985957|594785045|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
164661399|NCT02985957|594785046|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
164661400|NCT02985957|594785047|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
164661401|NCT02985957|594785048|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
164661402|NCT02985957|594785049|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
164203897|NCT01588509|593117826|FG001|Overall Study|Lost to Follow-up|0|||
164203898|NCT01983930|593117827|FG000|Overall Study|Withdrawal by Subject|9|||
164203899|NCT01983930|593117828|FG001|Overall Study|Withdrawal by Subject|8|||
164203900|NCT01983930|593117827|FG000|Overall Study|Adverse Event|0|||
164203901|NCT01983930|593117828|FG001|Overall Study|Adverse Event|1|||
164203902|NCT01454284|593117829|FG000|Overall Study|Adverse Event|20|||
164203903|NCT01454284|593117830|FG001|Overall Study|Adverse Event|7|||
164203904|NCT01454284|593117829|FG000|Overall Study|Death|0|||
164203905|NCT01454284|593117830|FG001|Overall Study|Death|3|||
164203906|NCT01454284|593117829|FG000|Overall Study|Lost to Follow-up|13|||
164203907|NCT01454284|593117830|FG001|Overall Study|Lost to Follow-up|8|||
164557407|NCT01425008|594409920|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
164557408|NCT01425008|594409921|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
164557409|NCT01425008|594409922|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
164557410|NCT01425008|594409923|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
164557411|NCT01425008|594409924|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
164557412|NCT01425008|594409925|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
164557413|NCT01425008|594409926|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
164557414|NCT01425008|594409927|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
164557415|NCT01425008|594409928|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
164557416|NCT01425008|594409929|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
164557417|NCT01425008|594409930|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
164557418|NCT01425008|594409931|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
164557419|NCT01425008|594409932|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
164557420|NCT01425008|594409933|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
164557421|NCT01425008|594409934|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
164557422|NCT01425008|594409916|FG000|Dose Escalation Phase|Other|0|||
164557423|NCT01425008|594409917|FG001|Dose Escalation Phase|Other|0|||
164557424|NCT01425008|594409918|FG002|Dose Escalation Phase|Other|0|||
164557425|NCT01425008|594409919|FG003|Dose Escalation Phase|Other|0|||
164557426|NCT01425008|594409920|FG004|Dose Escalation Phase|Other|0|||
164557427|NCT01425008|594409921|FG005|Dose Escalation Phase|Other|0|||
164557428|NCT01425008|594409922|FG006|Dose Escalation Phase|Other|0|||
164557429|NCT01425008|594409923|FG007|Dose Escalation Phase|Other|0|||
164557430|NCT01425008|594409924|FG008|Dose Escalation Phase|Other|1|||
164557431|NCT01425008|594409925|FG009|Dose Escalation Phase|Other|0|||
164557432|NCT01425008|594409926|FG010|Dose Escalation Phase|Other|0|||
164557433|NCT01425008|594409927|FG011|Dose Escalation Phase|Other|0|||
164557434|NCT01425008|594409928|FG012|Dose Escalation Phase|Other|0|||
164557435|NCT01425008|594409929|FG013|Dose Escalation Phase|Other|0|||
164557436|NCT01425008|594409930|FG014|Dose Escalation Phase|Other|0|||
164557437|NCT01425008|594409931|FG015|Dose Escalation Phase|Other|0|||
164557438|NCT01425008|594409932|FG016|Dose Escalation Phase|Other|0|||
164557439|NCT01425008|594409933|FG017|Dose Escalation Phase|Other|0|||
164557440|NCT01425008|594409934|FG018|Dose Escalation Phase|Other|0|||
164557441|NCT01425008|594409916|FG000|Dose Expansion Phase|Progressive Disease|0|||
164557442|NCT01425008|594409917|FG001|Dose Expansion Phase|Progressive Disease|0|||
164557443|NCT01425008|594409918|FG002|Dose Expansion Phase|Progressive Disease|0|||
164557444|NCT01425008|594409919|FG003|Dose Expansion Phase|Progressive Disease|0|||
164557445|NCT01425008|594409920|FG004|Dose Expansion Phase|Progressive Disease|0|||
164557446|NCT01425008|594409921|FG005|Dose Expansion Phase|Progressive Disease|0|||
164557447|NCT01425008|594409922|FG006|Dose Expansion Phase|Progressive Disease|0|||
164557448|NCT01425008|594409923|FG007|Dose Expansion Phase|Progressive Disease|0|||
164557449|NCT01425008|594409924|FG008|Dose Expansion Phase|Progressive Disease|0|||
164557450|NCT01425008|594409925|FG009|Dose Expansion Phase|Progressive Disease|0|||
164557451|NCT01425008|594409926|FG010|Dose Expansion Phase|Progressive Disease|10|||
164557452|NCT01425008|594409927|FG011|Dose Expansion Phase|Progressive Disease|4|||
164557453|NCT01425008|594409928|FG012|Dose Expansion Phase|Progressive Disease|12|||
164557454|NCT01425008|594409929|FG013|Dose Expansion Phase|Progressive Disease|1|||
164557455|NCT01425008|594409930|FG014|Dose Expansion Phase|Progressive Disease|5|||
164557456|NCT01425008|594409931|FG015|Dose Expansion Phase|Progressive Disease|8|||
164557457|NCT01425008|594409932|FG016|Dose Expansion Phase|Progressive Disease|9|||
164557458|NCT01425008|594409933|FG017|Dose Expansion Phase|Progressive Disease|2|||
164557459|NCT01425008|594409934|FG018|Dose Expansion Phase|Progressive Disease|10|||
164557460|NCT01425008|594409916|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
164557461|NCT01425008|594409917|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
164557462|NCT01425008|594409918|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
164557463|NCT01425008|594409919|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
164557464|NCT01425008|594409920|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
164557465|NCT01425008|594409921|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
164557466|NCT01425008|594409922|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
164557467|NCT01425008|594409923|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
164557468|NCT01425008|594409924|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
164557469|NCT01425008|594409925|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
164557470|NCT01425008|594409926|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
164661403|NCT02985957|594785050|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
164661404|NCT02985957|594785044|FG000|Treatment Period|Death|0|||
164661405|NCT02985957|594785045|FG001|Treatment Period|Death|0|||
164661406|NCT02985957|594785046|FG002|Treatment Period|Death|0|||
164661407|NCT02985957|594785047|FG003|Treatment Period|Death|0|||
164661408|NCT02985957|594785048|FG004|Treatment Period|Death|1|||
164661409|NCT02985957|594785049|FG005|Treatment Period|Death|0|||
164661410|NCT02985957|594785050|FG006|Treatment Period|Death|0|||
164661411|NCT02985957|594785044|FG000|Treatment Period|Participant withdrew consent|0|||
164661412|NCT02985957|594785045|FG001|Treatment Period|Participant withdrew consent|0|||
164661413|NCT02985957|594785046|FG002|Treatment Period|Participant withdrew consent|0|||
164661414|NCT02985957|594785047|FG003|Treatment Period|Participant withdrew consent|1|||
164661415|NCT02985957|594785048|FG004|Treatment Period|Participant withdrew consent|3|||
164661416|NCT02985957|594785049|FG005|Treatment Period|Participant withdrew consent|0|||
164661417|NCT02985957|594785050|FG006|Treatment Period|Participant withdrew consent|1|||
164661418|NCT02985957|594785044|FG000|Treatment Period|Lost to Follow-up|0|||
164661419|NCT02985957|594785045|FG001|Treatment Period|Lost to Follow-up|0|||
164661420|NCT02985957|594785046|FG002|Treatment Period|Lost to Follow-up|0|||
164661421|NCT02985957|594785047|FG003|Treatment Period|Lost to Follow-up|0|||
164661422|NCT02985957|594785048|FG004|Treatment Period|Lost to Follow-up|1|||
164661423|NCT02985957|594785049|FG005|Treatment Period|Lost to Follow-up|0|||
164661424|NCT02985957|594785050|FG006|Treatment Period|Lost to Follow-up|0|||
164661425|NCT02985957|594785044|FG000|Treatment Period|Other reasons|0|||
164661426|NCT02985957|594785045|FG001|Treatment Period|Other reasons|0|||
164661427|NCT02985957|594785046|FG002|Treatment Period|Other reasons|1|||
164661428|NCT02985957|594785047|FG003|Treatment Period|Other reasons|3|||
164661429|NCT02985957|594785048|FG004|Treatment Period|Other reasons|5|||
164661430|NCT02985957|594785049|FG005|Treatment Period|Other reasons|0|||
164661431|NCT02985957|594785050|FG006|Treatment Period|Other reasons|1|||
164314750|NCT00884741|593529762|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
164314751|NCT00884741|593529763|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
164314752|NCT00884741|593529764|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
164314753|NCT00884741|593529761|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
164661432|NCT02985957|594785044|FG000|Treatment Period|Not reported|0|||
164557471|NCT01425008|594409927|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
164661433|NCT02985957|594785045|FG001|Treatment Period|Not reported|2|||
164661434|NCT02985957|594785046|FG002|Treatment Period|Not reported|2|||
164661435|NCT02985957|594785047|FG003|Treatment Period|Not reported|5|||
164661436|NCT02985957|594785048|FG004|Treatment Period|Not reported|0|||
164661437|NCT02985957|594785049|FG005|Treatment Period|Not reported|0|||
164661438|NCT02985957|594785050|FG006|Treatment Period|Not reported|0|||
164661439|NCT02985957|594785044|FG000|Treatment Period|Maximum clinical benefit|0|||
164557472|NCT01425008|594409928|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
164557473|NCT01425008|594409929|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
164557474|NCT01425008|594409930|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
164557475|NCT01425008|594409931|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
164557476|NCT01425008|594409932|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
164557477|NCT01425008|594409933|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
164557478|NCT01425008|594409934|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
164557479|NCT01425008|594409916|FG000|Dose Expansion Phase|Other|0|||
164557480|NCT01425008|594409917|FG001|Dose Expansion Phase|Other|0|||
164557481|NCT01425008|594409918|FG002|Dose Expansion Phase|Other|0|||
164557482|NCT01425008|594409919|FG003|Dose Expansion Phase|Other|0|||
164557483|NCT01425008|594409920|FG004|Dose Expansion Phase|Other|0|||
164557484|NCT01425008|594409921|FG005|Dose Expansion Phase|Other|0|||
164557485|NCT01425008|594409922|FG006|Dose Expansion Phase|Other|0|||
164557486|NCT01425008|594409923|FG007|Dose Expansion Phase|Other|0|||
164557487|NCT01425008|594409924|FG008|Dose Expansion Phase|Other|0|||
164557488|NCT01425008|594409925|FG009|Dose Expansion Phase|Other|0|||
164557489|NCT01425008|594409926|FG010|Dose Expansion Phase|Other|0|||
164557490|NCT01425008|594409927|FG011|Dose Expansion Phase|Other|0|||
164557491|NCT01425008|594409928|FG012|Dose Expansion Phase|Other|1|||
164557492|NCT01425008|594409929|FG013|Dose Expansion Phase|Other|0|||
164557493|NCT01425008|594409930|FG014|Dose Expansion Phase|Other|0|||
164557494|NCT01425008|594409931|FG015|Dose Expansion Phase|Other|0|||
164557495|NCT01425008|594409932|FG016|Dose Expansion Phase|Other|2|||
164557496|NCT01425008|594409933|FG017|Dose Expansion Phase|Other|0|||
164557497|NCT01425008|594409934|FG018|Dose Expansion Phase|Other|4|||
164557498|NCT01425008|594409916|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
164557499|NCT01425008|594409917|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
164557500|NCT01425008|594409918|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
164661440|NCT02985957|594785045|FG001|Treatment Period|Maximum clinical benefit|0|||
164661441|NCT02985957|594785046|FG002|Treatment Period|Maximum clinical benefit|1|||
164661442|NCT02985957|594785047|FG003|Treatment Period|Maximum clinical benefit|1|||
164661443|NCT02985957|594785048|FG004|Treatment Period|Maximum clinical benefit|0|||
164661444|NCT02985957|594785049|FG005|Treatment Period|Maximum clinical benefit|0|||
164661445|NCT02985957|594785050|FG006|Treatment Period|Maximum clinical benefit|2|||
164661446|NCT02985957|594785044|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
164661447|NCT02985957|594785045|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
164661448|NCT02985957|594785046|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
164661449|NCT02985957|594785047|FG003|Treatment Period|Adverse event unrelated to study drug|2|||
164661450|NCT02985957|594785048|FG004|Treatment Period|Adverse event unrelated to study drug|8|||
164661451|NCT02985957|594785049|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
164661452|NCT02985957|594785050|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
164661453|NCT02985957|594785044|FG000|Treatment Period|Study drug toxicity|1|||
164661454|NCT02985957|594785045|FG001|Treatment Period|Study drug toxicity|23|||
164661455|NCT02985957|594785046|FG002|Treatment Period|Study drug toxicity|20|||
164661456|NCT02985957|594785047|FG003|Treatment Period|Study drug toxicity|12|||
164661457|NCT02985957|594785048|FG004|Treatment Period|Study drug toxicity|20|||
164661458|NCT02985957|594785049|FG005|Treatment Period|Study drug toxicity|3|||
164661459|NCT02985957|594785050|FG006|Treatment Period|Study drug toxicity|5|||
164661460|NCT02985957|594785044|FG000|Treatment Period|Disease progression|0|||
164661461|NCT02985957|594785045|FG001|Treatment Period|Disease progression|16|||
164661462|NCT02985957|594785046|FG002|Treatment Period|Disease progression|20|||
164661463|NCT02985957|594785047|FG003|Treatment Period|Disease progression|40|||
164661464|NCT02985957|594785048|FG004|Treatment Period|Disease progression|29|||
164661465|NCT02985957|594785049|FG005|Treatment Period|Disease progression|11|||
164661466|NCT02985957|594785050|FG006|Treatment Period|Disease progression|28|||
164661467|NCT02985957|594785044|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
164661468|NCT02985957|594785045|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
164661469|NCT02985957|594785046|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
164661470|NCT02985957|594785047|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
164661471|NCT02985957|594785048|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
164661472|NCT02985957|594785049|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
164661473|NCT02985957|594785050|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
164661474|NCT02985957|594785044|FG000|Treatment Period|Poor/Non-Compliance|0|||
164661475|NCT02985957|594785045|FG001|Treatment Period|Poor/Non-Compliance|0|||
164661476|NCT02985957|594785046|FG002|Treatment Period|Poor/Non-Compliance|0|||
164661477|NCT02985957|594785047|FG003|Treatment Period|Poor/Non-Compliance|0|||
164661478|NCT02985957|594785048|FG004|Treatment Period|Poor/Non-Compliance|1|||
164661479|NCT02985957|594785049|FG005|Treatment Period|Poor/Non-Compliance|1|||
164661480|NCT02985957|594785050|FG006|Treatment Period|Poor/Non-Compliance|0|||
164661481|NCT02978326|594785052|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
164661482|NCT02978326|594785053|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
164661483|NCT02978326|594785054|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
164661484|NCT02978326|594785052|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
164661485|NCT02978326|594785053|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
164661486|NCT02978326|594785054|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
164661487|NCT02978326|594785052|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
164661488|NCT02978326|594785053|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
164661489|NCT02978326|594785054|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
164661490|NCT02978326|594785052|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
164661491|NCT02978326|594785053|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
164661492|NCT02978326|594785054|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
164661493|NCT03748641|594785057|FG000|Overall Study|Ongoing|155|||
164661494|NCT03748641|594785058|FG001|Overall Study|Ongoing|148|||
164661495|NCT03748641|594785059|FG002|Overall Study|Ongoing|66|||
164661496|NCT03748641|594785060|FG003|Overall Study|Ongoing|79|||
164661497|NCT03748641|594785061|FG004|Overall Study|Ongoing|84|||
164661498|NCT03748641|594785057|FG000|Overall Study|Death|54|||
164661499|NCT03748641|594785058|FG001|Overall Study|Death|59|||
164661500|NCT03748641|594785059|FG002|Overall Study|Death|51|||
164661501|NCT03748641|594785060|FG003|Overall Study|Death|42|||
164661502|NCT03748641|594785061|FG004|Overall Study|Death|9|||
164661503|NCT03748641|594785057|FG000|Overall Study|Lost to Follow-up|0|||
164661504|NCT03748641|594785058|FG001|Overall Study|Lost to Follow-up|2|||
164661505|NCT03748641|594785059|FG002|Overall Study|Lost to Follow-up|1|||
164661506|NCT03748641|594785060|FG003|Overall Study|Lost to Follow-up|0|||
164661507|NCT03748641|594785061|FG004|Overall Study|Lost to Follow-up|0|||
164661508|NCT03748641|594785057|FG000|Overall Study|Withdrawal by Subject|3|||
164661509|NCT03748641|594785058|FG001|Overall Study|Withdrawal by Subject|2|||
164661510|NCT03748641|594785059|FG002|Overall Study|Withdrawal by Subject|5|||
164661511|NCT03748641|594785060|FG003|Overall Study|Withdrawal by Subject|3|||
164661512|NCT03748641|594785061|FG004|Overall Study|Withdrawal by Subject|2|||
164661513|NCT03495986|594785062|FG000|Overall Study|Physician Decision|1|||
164661514|NCT03495986|594785063|FG001|Overall Study|Physician Decision|0|||
164661515|NCT03495986|594785062|FG000|Overall Study|Withdrawal by Subject|1|||
164661516|NCT03495986|594785063|FG001|Overall Study|Withdrawal by Subject|1|||
164661517|NCT03495986|594785062|FG000|Overall Study|Withdrawal by Subject|1|||
164661518|NCT03495986|594785063|FG001|Overall Study|Withdrawal by Subject|0|||
164661519|NCT02365597|594785064|FG000|Overall Study|Lost to Follow-up|0|||
164661520|NCT02365597|594785065|FG001|Overall Study|Lost to Follow-up|1|||
164661521|NCT02365597|594785066|FG002|Overall Study|Lost to Follow-up|0|||
164661522|NCT02365597|594785067|FG003|Overall Study|Lost to Follow-up|1|||
164661523|NCT02365597|594785064|FG000|Overall Study|Withdrawal by Subject|1|||
164661524|NCT02365597|594785065|FG001|Overall Study|Withdrawal by Subject|8|||
164661525|NCT02365597|594785066|FG002|Overall Study|Withdrawal by Subject|5|||
164661526|NCT02365597|594785067|FG003|Overall Study|Withdrawal by Subject|1|||
164661527|NCT02365597|594785064|FG000|Overall Study|Sponsor's decision|1|||
164661528|NCT02365597|594785065|FG001|Overall Study|Sponsor's decision|3|||
164661529|NCT02365597|594785066|FG002|Overall Study|Sponsor's decision|13|||
164661530|NCT02365597|594785067|FG003|Overall Study|Sponsor's decision|0|||
164661531|NCT02365597|594785064|FG000|Overall Study|Other|0|||
164661532|NCT02365597|594785065|FG001|Overall Study|Other|4|||
164661533|NCT02365597|594785066|FG002|Overall Study|Other|0|||
164661534|NCT02365597|594785067|FG003|Overall Study|Other|0|||
164661535|NCT02365597|594785064|FG000|Overall Study|Enrolled but not treated|0|||
164661536|NCT02365597|594785065|FG001|Overall Study|Enrolled but not treated|1|||
164661537|NCT02365597|594785066|FG002|Overall Study|Enrolled but not treated|1|||
164661538|NCT02365597|594785067|FG003|Overall Study|Enrolled but not treated|0|||
164661539|NCT02365597|594785064|FG000|Overall Study|Ongoing|0|||
164661540|NCT02365597|594785065|FG001|Overall Study|Ongoing|0|||
164661541|NCT02365597|594785066|FG002|Overall Study|Ongoing|0|||
164661542|NCT02365597|594785067|FG003|Overall Study|Ongoing|17|||
164661543|NCT04670068|594785068|FG000|Overall Study|Progressive Disease|1|||
164661544|NCT04670068|594785069|FG001|Overall Study|Progressive Disease|1|||
164661545|NCT04670068|594785068|FG000|Overall Study|Withdrawal by Subject|1|||
164661546|NCT04670068|594785069|FG001|Overall Study|Withdrawal by Subject|0|||
164661547|NCT00926289|594785070|FG000|Overall Study|Adverse Event|9|||
164661548|NCT00926289|594785071|FG001|Overall Study|Adverse Event|11|||
164661549|NCT00926289|594785070|FG000|Overall Study|Protocol Violation|8|||
164661550|NCT00926289|594785071|FG001|Overall Study|Protocol Violation|12|||
164661551|NCT00926289|594785070|FG000|Overall Study|Lost to Follow-up|3|||
164661552|NCT00926289|594785071|FG001|Overall Study|Lost to Follow-up|6|||
164661553|NCT00926289|594785070|FG000|Overall Study|Withdrawal by Subject|4|||
164661554|NCT00926289|594785071|FG001|Overall Study|Withdrawal by Subject|4|||
164661555|NCT00926289|594785070|FG000|Overall Study|Other|1|||
164661556|NCT00926289|594785071|FG001|Overall Study|Other|3|||
164661557|NCT04104646|594785072|FG000|Overall Study|Withdrawal by Subject|1|||
164661558|NCT04104646|594785073|FG001|Overall Study|Withdrawal by Subject|1|||
164661559|NCT04104646|594785072|FG000|Overall Study|Lost to Follow-up|1|||
164661560|NCT04104646|594785073|FG001|Overall Study|Lost to Follow-up|0|||
164661561|NCT04104646|594785072|FG000|Overall Study|Physician Decision|2|||
164661562|NCT04104646|594785073|FG001|Overall Study|Physician Decision|0|||
164661563|NCT01498484|594785074|FG000|Overall Study|Death|6|||
164661564|NCT01498484|594785075|FG001|Overall Study|Death|3|||
164661565|NCT01498484|594785076|FG002|Overall Study|Death|1|||
164661566|NCT01498484|594785077|FG003|Overall Study|Death|1|||
164661567|NCT01498484|594785078|FG004|Overall Study|Death|0|||
164661568|NCT01498484|594785079|FG005|Overall Study|Death|0|||
164661569|NCT01498484|594785080|FG006|Overall Study|Death|10|||
164661570|NCT01498484|594785081|FG007|Overall Study|Death|1|||
164661571|NCT01498484|594785082|FG008|Overall Study|Death|0|||
164661572|NCT01498484|594785074|FG000|Overall Study|Physician Decision|3|||
164661573|NCT01498484|594785075|FG001|Overall Study|Physician Decision|2|||
164661574|NCT01498484|594785076|FG002|Overall Study|Physician Decision|1|||
164661575|NCT01498484|594785077|FG003|Overall Study|Physician Decision|1|||
164661576|NCT01498484|594785078|FG004|Overall Study|Physician Decision|0|||
164661577|NCT01498484|594785079|FG005|Overall Study|Physician Decision|0|||
164661578|NCT01498484|594785080|FG006|Overall Study|Physician Decision|8|||
164661579|NCT01498484|594785081|FG007|Overall Study|Physician Decision|13|||
164661580|NCT01498484|594785082|FG008|Overall Study|Physician Decision|1|||
164661581|NCT01498484|594785074|FG000|Overall Study|Adverse Event|0|||
164661582|NCT01498484|594785075|FG001|Overall Study|Adverse Event|0|||
164661583|NCT01498484|594785076|FG002|Overall Study|Adverse Event|0|||
164661584|NCT01498484|594785077|FG003|Overall Study|Adverse Event|0|||
164661585|NCT01498484|594785078|FG004|Overall Study|Adverse Event|0|||
164661586|NCT01498484|594785079|FG005|Overall Study|Adverse Event|1|||
164661587|NCT01498484|594785080|FG006|Overall Study|Adverse Event|0|||
164661588|NCT01498484|594785081|FG007|Overall Study|Adverse Event|0|||
164661589|NCT01498484|594785082|FG008|Overall Study|Adverse Event|0|||
164661590|NCT01498484|594785074|FG000|Overall Study|Withdrawal by Subject|0|||
164661591|NCT01498484|594785075|FG001|Overall Study|Withdrawal by Subject|0|||
164661592|NCT01498484|594785076|FG002|Overall Study|Withdrawal by Subject|0|||
164661593|NCT01498484|594785077|FG003|Overall Study|Withdrawal by Subject|1|||
164661594|NCT01498484|594785078|FG004|Overall Study|Withdrawal by Subject|0|||
164661595|NCT01498484|594785079|FG005|Overall Study|Withdrawal by Subject|0|||
164661596|NCT01498484|594785080|FG006|Overall Study|Withdrawal by Subject|1|||
164661597|NCT01498484|594785081|FG007|Overall Study|Withdrawal by Subject|0|||
164661598|NCT01498484|594785082|FG008|Overall Study|Withdrawal by Subject|0|||
164661599|NCT01498484|594785074|FG000|Overall Study|Other|5|||
164661600|NCT01498484|594785075|FG001|Overall Study|Other|2|||
164661601|NCT01498484|594785076|FG002|Overall Study|Other|0|||
164661602|NCT01498484|594785077|FG003|Overall Study|Other|0|||
164661603|NCT01498484|594785078|FG004|Overall Study|Other|1|||
164661604|NCT01498484|594785079|FG005|Overall Study|Other|0|||
164661605|NCT01498484|594785080|FG006|Overall Study|Other|3|||
164661606|NCT01498484|594785081|FG007|Overall Study|Other|0|||
164661607|NCT01498484|594785082|FG008|Overall Study|Other|1|||
164661608|NCT01199601|594785083|FG000|Overall Study|Lost to Follow-up|47|||
164661609|NCT01199601|594785084|FG001|Overall Study|Lost to Follow-up|66|||
164661610|NCT01199601|594785083|FG000|Overall Study|Withdrawal by Subject|15|||
164661611|NCT01199601|594785084|FG001|Overall Study|Withdrawal by Subject|3|||
164661612|NCT01199601|594785083|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
164661613|NCT01199601|594785084|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
164661614|NCT00753714|594785085|FG000|Overall Study|Lack of Efficacy|21|||
164661615|NCT00753714|594785086|FG001|Overall Study|Lack of Efficacy|34|||
164661616|NCT00753714|594785085|FG000|Overall Study|Adverse Event|26|||
164661617|NCT00753714|594785086|FG001|Overall Study|Adverse Event|18|||
164661618|NCT00753714|594785085|FG000|Overall Study|Protocol Violation|1|||
164661619|NCT00753714|594785086|FG001|Overall Study|Protocol Violation|0|||
164661620|NCT00753714|594785085|FG000|Overall Study|Lost to Follow-up|0|||
164661621|NCT00753714|594785086|FG001|Overall Study|Lost to Follow-up|1|||
164661622|NCT00753714|594785085|FG000|Overall Study|Withdrawal by Subject|2|||
164661623|NCT00753714|594785086|FG001|Overall Study|Withdrawal by Subject|1|||
164557501|NCT01425008|594409919|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
164557502|NCT01425008|594409920|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
164557503|NCT01425008|594409921|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
164557504|NCT01425008|594409922|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
164557505|NCT01425008|594409923|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
164557506|NCT01425008|594409924|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
164557507|NCT01425008|594409925|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
164557508|NCT01425008|594409926|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
164557509|NCT01425008|594409927|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
164557510|NCT01425008|594409928|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
164557511|NCT01425008|594409929|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
164557512|NCT01425008|594409930|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
164557513|NCT01425008|594409931|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
164557514|NCT01425008|594409932|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
164557515|NCT01425008|594409933|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
164557516|NCT01425008|594409934|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
164557517|NCT01425008|594409916|FG000|Dose Expansion Phase|Adverse Event|0|||
164557518|NCT01425008|594409917|FG001|Dose Expansion Phase|Adverse Event|0|||
164557519|NCT01425008|594409918|FG002|Dose Expansion Phase|Adverse Event|0|||
164557520|NCT01425008|594409919|FG003|Dose Expansion Phase|Adverse Event|0|||
164557521|NCT01425008|594409920|FG004|Dose Expansion Phase|Adverse Event|0|||
164557522|NCT01425008|594409921|FG005|Dose Expansion Phase|Adverse Event|0|||
164557523|NCT01425008|594409922|FG006|Dose Expansion Phase|Adverse Event|0|||
164557524|NCT01425008|594409923|FG007|Dose Expansion Phase|Adverse Event|0|||
164557525|NCT01425008|594409924|FG008|Dose Expansion Phase|Adverse Event|0|||
164557526|NCT01425008|594409925|FG009|Dose Expansion Phase|Adverse Event|0|||
164557527|NCT01425008|594409926|FG010|Dose Expansion Phase|Adverse Event|2|||
164557528|NCT01425008|594409927|FG011|Dose Expansion Phase|Adverse Event|3|||
164557529|NCT01425008|594409928|FG012|Dose Expansion Phase|Adverse Event|3|||
164661624|NCT00753714|594785085|FG000|Overall Study|Death|3|||
164661625|NCT00753714|594785086|FG001|Overall Study|Death|3|||
164661626|NCT00753714|594785085|FG000|Overall Study|Other|7|||
164661627|NCT00753714|594785086|FG001|Overall Study|Other|5|||
164661628|NCT02974153|594785087|FG000|Overall Study|Adverse Event|6|||
164661629|NCT02974153|594785088|FG001|Overall Study|Adverse Event|0|||
164661630|NCT02974153|594785089|FG002|Overall Study|Adverse Event|1|||
164661631|NCT02974153|594785087|FG000|Overall Study|Lack of Efficacy|6|||
164661632|NCT02974153|594785088|FG001|Overall Study|Lack of Efficacy|5|||
164661633|NCT02974153|594785089|FG002|Overall Study|Lack of Efficacy|10|||
164661634|NCT02974153|594785087|FG000|Overall Study|Lost to Follow-up|9|||
164661635|NCT02974153|594785088|FG001|Overall Study|Lost to Follow-up|10|||
164661636|NCT02974153|594785089|FG002|Overall Study|Lost to Follow-up|17|||
164661637|NCT02974153|594785087|FG000|Overall Study|Physician Decision|0|||
164557530|NCT01425008|594409929|FG013|Dose Expansion Phase|Adverse Event|0|||
164557531|NCT01425008|594409930|FG014|Dose Expansion Phase|Adverse Event|1|||
164557532|NCT01425008|594409931|FG015|Dose Expansion Phase|Adverse Event|1|||
164661638|NCT02974153|594785088|FG001|Overall Study|Physician Decision|2|||
164661639|NCT02974153|594785089|FG002|Overall Study|Physician Decision|1|||
164661640|NCT02974153|594785087|FG000|Overall Study|Withdrawal by Subject|9|||
164661641|NCT02974153|594785088|FG001|Overall Study|Withdrawal by Subject|16|||
164661642|NCT02974153|594785089|FG002|Overall Study|Withdrawal by Subject|11|||
164661643|NCT02974153|594785087|FG000|Overall Study|Study Burden|8|||
164661644|NCT02974153|594785088|FG001|Overall Study|Study Burden|7|||
164203908|NCT01454284|593117829|FG000|Overall Study|Protocol Violation|9|||
164203909|NCT01454284|593117830|FG001|Overall Study|Protocol Violation|6|||
164203910|NCT01454284|593117829|FG000|Overall Study|Withdrawal by Subject|58|||
164203911|NCT01454284|593117830|FG001|Overall Study|Withdrawal by Subject|36|||
164203912|NCT01454284|593117829|FG000|Overall Study|Physician Decision|16|||
164203913|NCT01454284|593117830|FG001|Overall Study|Physician Decision|11|||
164203914|NCT01454284|593117829|FG000|Overall Study|Sponsor Decision|0|||
164557533|NCT01425008|594409932|FG016|Dose Expansion Phase|Adverse Event|5|||
164557534|NCT01425008|594409933|FG017|Dose Expansion Phase|Adverse Event|0|||
164557535|NCT01425008|594409934|FG018|Dose Expansion Phase|Adverse Event|3|||
164557536|NCT01425008|594409916|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
164557537|NCT01425008|594409917|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
164557538|NCT01425008|594409918|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
164557539|NCT01425008|594409919|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
164557540|NCT01425008|594409920|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
164557541|NCT01425008|594409921|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
164557542|NCT01425008|594409922|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
164557543|NCT01425008|594409923|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
164557544|NCT01425008|594409924|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
164557545|NCT01425008|594409925|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
164557546|NCT01425008|594409926|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
164557547|NCT01425008|594409927|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
164557548|NCT01425008|594409928|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
164557549|NCT01425008|594409929|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
164557550|NCT01425008|594409930|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
164557551|NCT01425008|594409931|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
164557552|NCT01425008|594409932|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
164557553|NCT01425008|594409933|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
164557554|NCT01425008|594409934|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
164557555|NCT01425008|594409916|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164557556|NCT01425008|594409917|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164557557|NCT01425008|594409918|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164557558|NCT01425008|594409919|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164557559|NCT01425008|594409920|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164557560|NCT01425008|594409921|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164557561|NCT01425008|594409922|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164557562|NCT01425008|594409923|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164557563|NCT01425008|594409924|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164557564|NCT01425008|594409925|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164557565|NCT01425008|594409926|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164557566|NCT01425008|594409927|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164557567|NCT01425008|594409928|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164557568|NCT01425008|594409929|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164557569|NCT01425008|594409930|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164557570|NCT01425008|594409931|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164557571|NCT01425008|594409932|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164557572|NCT01425008|594409933|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164557573|NCT01425008|594409934|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
164557574|NCT05061719|594409935|FG000|Overall Study|Adverse Event|60|||
164557575|NCT05061719|594409935|FG000|Overall Study|Death|1|||
164557576|NCT05061719|594409935|FG000|Overall Study|Lack of Efficacy|7|||
164557577|NCT05061719|594409935|FG000|Overall Study|Lost to Follow-up|5|||
164557578|NCT05061719|594409935|FG000|Overall Study|Pregnancy|1|||
164557579|NCT05061719|594409935|FG000|Overall Study|Protocol Violation|8|||
164557580|NCT05061719|594409935|FG000|Overall Study|Withdrawal by Subject|41|||
164557581|NCT05061719|594409935|FG000|Overall Study|Site Closure|2|||
164557582|NCT04179175|594411645|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
164557583|NCT04179175|594411646|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
164557584|NCT04179175|594411647|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
164557585|NCT04179175|594411648|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
164557586|NCT04179175|594411649|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
164557587|NCT04179175|594411650|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
164557588|NCT04179175|594411645|FG000|Overall Study|Adverse Event|5|||
164557589|NCT04179175|594411646|FG001|Overall Study|Adverse Event|3|||
164557590|NCT04179175|594411647|FG002|Overall Study|Adverse Event|3|||
164557591|NCT04179175|594411648|FG003|Overall Study|Adverse Event|4|||
164557592|NCT04179175|594411649|FG004|Overall Study|Adverse Event|6|||
164557593|NCT04179175|594411650|FG005|Overall Study|Adverse Event|6|||
164557594|NCT04179175|594411645|FG000|Overall Study|Lack of Efficacy|5|||
164557595|NCT04179175|594411646|FG001|Overall Study|Lack of Efficacy|1|||
164557596|NCT04179175|594411647|FG002|Overall Study|Lack of Efficacy|3|||
164557597|NCT04179175|594411648|FG003|Overall Study|Lack of Efficacy|2|||
164557598|NCT04179175|594411649|FG004|Overall Study|Lack of Efficacy|18|||
164314754|NCT00884741|593529762|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
164314755|NCT00884741|593529763|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
164314756|NCT00884741|593529764|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
164314757|NCT00884741|593529761|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
164314758|NCT00884741|593529762|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
164314759|NCT00884741|593529763|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
164314760|NCT00884741|593529764|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
164314761|NCT00884741|593529761|FG000|Randomization|Protocol Violation|0|||
164314762|NCT00884741|593529762|FG001|Randomization|Protocol Violation|0|||
164314763|NCT00884741|593529763|FG002|Randomization|Protocol Violation|8|||
164314764|NCT00884741|593529764|FG003|Randomization|Protocol Violation|8|||
164314765|NCT01324401|593529765|FG000|Overall Study|Withdrawn before any treatment|0|||
164314766|NCT01324401|593529766|FG001|Overall Study|Withdrawn before any treatment|3|||
164314767|NCT01324401|593529765|FG000|Overall Study|Adverse Event|1|||
164314768|NCT01324401|593529766|FG001|Overall Study|Adverse Event|3|||
164314769|NCT01578850|593529767|FG000|Period 1|Insufficient Clinical Response|1|||
164314770|NCT01578850|593529768|FG001|Period 1|Insufficient Clinical Response|0|||
164314771|NCT01578850|593529769|FG002|Period 1|Insufficient Clinical Response|0|||
164314772|NCT01578850|593529767|FG000|Period 1|Adverse Event|11|||
164314773|NCT01578850|593529768|FG001|Period 1|Adverse Event|0|||
164314774|NCT01578850|593529769|FG002|Period 1|Adverse Event|0|||
164314775|NCT01578850|593529767|FG000|Period 1|Death|1|||
164314776|NCT01578850|593529768|FG001|Period 1|Death|0|||
164314777|NCT01578850|593529769|FG002|Period 1|Death|0|||
164314778|NCT01578850|593529767|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
164314779|NCT01578850|593529768|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
164314780|NCT01578850|593529769|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
164314781|NCT01578850|593529767|FG000|Period 1|Withdrawal by Subject|9|||
164314782|NCT01578850|593529768|FG001|Period 1|Withdrawal by Subject|0|||
164314783|NCT01578850|593529769|FG002|Period 1|Withdrawal by Subject|0|||
164314784|NCT01578850|593529767|FG000|Period 1|Study Terminated by Sponsor|3|||
164314785|NCT01578850|593529768|FG001|Period 1|Study Terminated by Sponsor|0|||
164557599|NCT04179175|594411650|FG005|Overall Study|Lack of Efficacy|7|||
164314786|NCT01578850|593529769|FG002|Period 1|Study Terminated by Sponsor|0|||
164314787|NCT01578850|593529767|FG000|Period 2|Insufficient Clinical Response|0|||
164314788|NCT01578850|593529768|FG001|Period 2|Insufficient Clinical Response|1|||
164314789|NCT01578850|593529769|FG002|Period 2|Insufficient Clinical Response|0|||
164314790|NCT01578850|593529767|FG000|Period 2|Adverse Event|0|||
164314791|NCT01578850|593529768|FG001|Period 2|Adverse Event|3|||
164314792|NCT01578850|593529769|FG002|Period 2|Adverse Event|6|||
164314793|NCT01578850|593529767|FG000|Period 2|Lost to Follow-up|0|||
164314794|NCT01578850|593529768|FG001|Period 2|Lost to Follow-up|1|||
164314795|NCT01578850|593529769|FG002|Period 2|Lost to Follow-up|2|||
164314796|NCT01578850|593529767|FG000|Period 2|Withdrawal by Subject|0|||
164314797|NCT01578850|593529768|FG001|Period 2|Withdrawal by Subject|2|||
164314798|NCT01578850|593529769|FG002|Period 2|Withdrawal by Subject|2|||
164314799|NCT01578850|593529767|FG000|Period 2|Study Terminated by Sponsor|0|||
164314800|NCT01578850|593529768|FG001|Period 2|Study Terminated by Sponsor|5|||
164557600|NCT04179175|594411645|FG000|Overall Study|Lost to Follow-up|5|||
164557601|NCT04179175|594411646|FG001|Overall Study|Lost to Follow-up|3|||
164557602|NCT04179175|594411647|FG002|Overall Study|Lost to Follow-up|2|||
164557603|NCT04179175|594411648|FG003|Overall Study|Lost to Follow-up|2|||
164557604|NCT04179175|594411649|FG004|Overall Study|Lost to Follow-up|4|||
164557605|NCT04179175|594411650|FG005|Overall Study|Lost to Follow-up|5|||
164557606|NCT04179175|594411645|FG000|Overall Study|Physician Decision|2|||
164557607|NCT04179175|594411646|FG001|Overall Study|Physician Decision|0|||
164557608|NCT04179175|594411647|FG002|Overall Study|Physician Decision|2|||
164557609|NCT04179175|594411648|FG003|Overall Study|Physician Decision|3|||
164557610|NCT04179175|594411649|FG004|Overall Study|Physician Decision|1|||
164557611|NCT04179175|594411650|FG005|Overall Study|Physician Decision|1|||
164557612|NCT04179175|594411645|FG000|Overall Study|Pregnancy|3|||
164557613|NCT04179175|594411646|FG001|Overall Study|Pregnancy|0|||
164557614|NCT04179175|594411647|FG002|Overall Study|Pregnancy|3|||
164557615|NCT04179175|594411648|FG003|Overall Study|Pregnancy|0|||
164314801|NCT01578850|593529769|FG002|Period 2|Study Terminated by Sponsor|4|||
164314802|NCT01578850|593529767|FG000|Period 2|Unspecified Reasons|0|||
164314803|NCT01578850|593529768|FG001|Period 2|Unspecified Reasons|1|||
164314804|NCT01578850|593529769|FG002|Period 2|Unspecified Reasons|0|||
164314805|NCT01818752|593529773|FG000|Overall Study|Adverse Event|64|||
164557616|NCT04179175|594411649|FG004|Overall Study|Pregnancy|1|||
164557617|NCT04179175|594411650|FG005|Overall Study|Pregnancy|2|||
164557618|NCT04179175|594411645|FG000|Overall Study|Withdrawal by Subject|22|||
164314806|NCT01818752|593529774|FG001|Overall Study|Adverse Event|74|||
164557619|NCT04179175|594411646|FG001|Overall Study|Withdrawal by Subject|10|||
164314807|NCT01818752|593529773|FG000|Overall Study|Death|14|||
164314808|NCT01818752|593529774|FG001|Overall Study|Death|18|||
164314809|NCT01818752|593529773|FG000|Overall Study|Non-compliance|16|||
164557620|NCT04179175|594411647|FG002|Overall Study|Withdrawal by Subject|12|||
164557621|NCT04179175|594411648|FG003|Overall Study|Withdrawal by Subject|8|||
164557622|NCT04179175|594411649|FG004|Overall Study|Withdrawal by Subject|23|||
164557623|NCT04179175|594411650|FG005|Overall Study|Withdrawal by Subject|31|||
164557624|NCT04179175|594411645|FG000|Overall Study|Technical problems|0|||
164557625|NCT04179175|594411646|FG001|Overall Study|Technical problems|0|||
164557626|NCT04179175|594411647|FG002|Overall Study|Technical problems|1|||
164557627|NCT04179175|594411648|FG003|Overall Study|Technical problems|1|||
164557628|NCT04179175|594411649|FG004|Overall Study|Technical problems|0|||
164557629|NCT04179175|594411650|FG005|Overall Study|Technical problems|0|||
164557630|NCT03215030|594411655|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
164557631|NCT03215030|594411656|FG001|Part 1: Dose Escalation|Lost to Follow-up|1|||
164557632|NCT03215030|594411657|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
164557633|NCT03215030|594411658|FG003|Part 1: Dose Escalation|Lost to Follow-up|1|||
164557634|NCT03215030|594411659|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
164557635|NCT03215030|594411660|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
164557636|NCT03215030|594411661|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
164557637|NCT03215030|594411662|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
164557638|NCT03215030|594411663|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
164557639|NCT03215030|594411664|FG009|Part 1: Dose Escalation|Lost to Follow-up|0|||
164203915|NCT01454284|593117830|FG001|Overall Study|Sponsor Decision|2|||
164203916|NCT00393367|593117833|FG000|Overall Study|Protocol Violation|2|||
164557640|NCT03215030|594411665|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
164557641|NCT03215030|594411666|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
164557642|NCT03215030|594411655|FG000|Part 1: Dose Escalation|Withdrawal by Subject|2|||
164557643|NCT03215030|594411656|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164557644|NCT03215030|594411657|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164557645|NCT03215030|594411658|FG003|Part 1: Dose Escalation|Withdrawal by Subject|2|||
164557646|NCT03215030|594411659|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164557647|NCT03215030|594411660|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164661645|NCT02974153|594785089|FG002|Overall Study|Study Burden|3|||
164203917|NCT00393367|593117834|FG001|Overall Study|Protocol Violation|5|||
164203918|NCT00393367|593117833|FG000|Overall Study|Withdrawal by Subject|0|||
164203919|NCT00393367|593117834|FG001|Overall Study|Withdrawal by Subject|2|||
164203920|NCT03248037|593117835|FG000|Overall Study|Withdrawal by Subject|6|||
164203921|NCT03248037|593117836|FG001|Overall Study|Withdrawal by Subject|9|||
164203922|NCT03248037|593117835|FG000|Overall Study|Adverse Event|15|||
164203923|NCT03248037|593117836|FG001|Overall Study|Adverse Event|0|||
164203924|NCT02897349|593117840|FG000|Overall Study|Lost to Follow-up|2|||
164203925|NCT02897349|593117841|FG001|Overall Study|Lost to Follow-up|2|||
164203926|NCT02897349|593117840|FG000|Overall Study|Adverse Event|3|||
164203927|NCT02897349|593117841|FG001|Overall Study|Adverse Event|3|||
164203928|NCT02897349|593117840|FG000|Overall Study|Other than listed above|0|||
164203929|NCT02897349|593117841|FG001|Overall Study|Other than listed above|1|||
164203930|NCT02765035|593117848|FG000|First Intervention (90 Days)|Adverse Event|1|||
164203931|NCT02765035|593117849|FG001|First Intervention (90 Days)|Adverse Event|1|||
164203932|NCT02765035|593117848|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
164203933|NCT02765035|593117849|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
164203934|NCT00856180|593117850|FG000|Overall Study|Adverse Event|4|||
164203935|NCT00856180|593117850|FG000|Overall Study|Progressive Disease|16|||
164203936|NCT03895086|593117853|FG000|Overall Study|Early termination study|1|||
164203937|NCT03895086|593117854|FG001|Overall Study|Early termination study|0|||
164203938|NCT01192815|593117855|FG000|Overall Study|Withdrawal by Subject|1|||
164203939|NCT01192815|593117855|FG000|Overall Study|Lack of Efficacy|1|||
164203940|NCT01142336|593117857|FG000|Overall Study|Adverse Event|1|||
164203941|NCT01142336|593117858|FG001|Overall Study|Adverse Event|1|||
164203942|NCT01142336|593117857|FG000|Overall Study|Lost to Follow-up|0|||
164203943|NCT01142336|593117858|FG001|Overall Study|Lost to Follow-up|1|||
164203944|NCT03025035|593117874|FG000|Overall Study|Death|2|||
164203945|NCT03025035|593117874|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
164203946|NCT01218802|593117875|FG000|Overall Study|Lost to Follow-up|5|||
164203947|NCT01218802|593117876|FG001|Overall Study|Lost to Follow-up|6|||
164203948|NCT01218802|593117875|FG000|Overall Study|Withdrawal by Subject|3|||
164203949|NCT01218802|593117876|FG001|Overall Study|Withdrawal by Subject|10|||
164203950|NCT01218802|593117875|FG000|Overall Study|Adverse Event|0|||
164203951|NCT01218802|593117876|FG001|Overall Study|Adverse Event|2|||
164203952|NCT01218802|593117875|FG000|Overall Study|Incarcerated|2|||
164203953|NCT01218802|593117876|FG001|Overall Study|Incarcerated|0|||
164203954|NCT02475369|593117885|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
164203955|NCT02475369|593117886|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
164203956|NCT00471497|593117887|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
164203957|NCT00471497|593117888|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
164420616|NCT01890967|593910949|FG003|Overall Study|Withdrawal by Subject|3|||
164420617|NCT01890967|593910950|FG004|Overall Study|Withdrawal by Subject|3|||
164557648|NCT03215030|594411661|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164557649|NCT03215030|594411662|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164661646|NCT02974153|594785087|FG000|Overall Study|Other|14|||
164314810|NCT01818752|593529774|FG001|Overall Study|Non-compliance|20|||
164557650|NCT03215030|594411663|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164557651|NCT03215030|594411664|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164557652|NCT03215030|594411665|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164557653|NCT03215030|594411666|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164557654|NCT03215030|594411655|FG000|Part 1: Dose Escalation|Death|15|||
164557655|NCT03215030|594411656|FG001|Part 1: Dose Escalation|Death|6|||
164557656|NCT03215030|594411657|FG002|Part 1: Dose Escalation|Death|6|||
164557657|NCT03215030|594411658|FG003|Part 1: Dose Escalation|Death|8|||
164557658|NCT03215030|594411659|FG004|Part 1: Dose Escalation|Death|0|||
164557659|NCT03215030|594411660|FG005|Part 1: Dose Escalation|Death|0|||
164557660|NCT03215030|594411661|FG006|Part 1: Dose Escalation|Death|0|||
164557661|NCT03215030|594411662|FG007|Part 1: Dose Escalation|Death|0|||
164557662|NCT03215030|594411663|FG008|Part 1: Dose Escalation|Death|0|||
164557663|NCT03215030|594411664|FG009|Part 1: Dose Escalation|Death|0|||
164557664|NCT03215030|594411665|FG010|Part 1: Dose Escalation|Death|0|||
164557665|NCT03215030|594411666|FG011|Part 1: Dose Escalation|Death|0|||
164557666|NCT03215030|594411655|FG000|Part 1: Dose Escalation|Reason Not Specified|0|||
164557667|NCT03215030|594411656|FG001|Part 1: Dose Escalation|Reason Not Specified|0|||
164314811|NCT01818752|593529773|FG000|Overall Study|Withdrawal by Subject|15|||
164314812|NCT01818752|593529774|FG001|Overall Study|Withdrawal by Subject|14|||
164314813|NCT01818752|593529773|FG000|Overall Study|Physician Decision|9|||
164557668|NCT03215030|594411657|FG002|Part 1: Dose Escalation|Reason Not Specified|0|||
164557669|NCT03215030|594411658|FG003|Part 1: Dose Escalation|Reason Not Specified|3|||
164557670|NCT03215030|594411659|FG004|Part 1: Dose Escalation|Reason Not Specified|0|||
164557671|NCT03215030|594411660|FG005|Part 1: Dose Escalation|Reason Not Specified|0|||
164557672|NCT03215030|594411661|FG006|Part 1: Dose Escalation|Reason Not Specified|0|||
164557673|NCT03215030|594411662|FG007|Part 1: Dose Escalation|Reason Not Specified|0|||
164557674|NCT03215030|594411663|FG008|Part 1: Dose Escalation|Reason Not Specified|0|||
164557675|NCT03215030|594411664|FG009|Part 1: Dose Escalation|Reason Not Specified|0|||
164557676|NCT03215030|594411665|FG010|Part 1: Dose Escalation|Reason Not Specified|0|||
164557677|NCT03215030|594411666|FG011|Part 1: Dose Escalation|Reason Not Specified|0|||
164557678|NCT03215030|594411655|FG000|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
164557679|NCT03215030|594411656|FG001|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
164557680|NCT03215030|594411657|FG002|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
164557681|NCT03215030|594411658|FG003|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
164557682|NCT03215030|594411659|FG004|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
164557683|NCT03215030|594411660|FG005|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
164557684|NCT03215030|594411661|FG006|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
164557685|NCT03215030|594411662|FG007|Part 2: Dose Expansion|Study Terminated by Sponsor|1|||
164557686|NCT03215030|594411663|FG008|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
164557687|NCT03215030|594411664|FG009|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
164557688|NCT03215030|594411665|FG010|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
164557689|NCT03215030|594411666|FG011|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
164557690|NCT03215030|594411655|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164557691|NCT03215030|594411656|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164557692|NCT03215030|594411657|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164557693|NCT03215030|594411658|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164557694|NCT03215030|594411659|FG004|Part 2: Dose Expansion|Withdrawal by Subject|1|||
164557695|NCT03215030|594411660|FG005|Part 2: Dose Expansion|Withdrawal by Subject|1|||
164557696|NCT03215030|594411661|FG006|Part 2: Dose Expansion|Withdrawal by Subject|5|||
164557697|NCT03215030|594411662|FG007|Part 2: Dose Expansion|Withdrawal by Subject|2|||
164557698|NCT03215030|594411663|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164557699|NCT03215030|594411664|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164557700|NCT03215030|594411665|FG010|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164557701|NCT03215030|594411666|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164557702|NCT03215030|594411655|FG000|Part 2: Dose Expansion|Death|0|||
164557703|NCT03215030|594411656|FG001|Part 2: Dose Expansion|Death|0|||
164661647|NCT02974153|594785088|FG001|Overall Study|Other|8|||
164661648|NCT02974153|594785089|FG002|Overall Study|Other|7|||
164661649|NCT02521948|594785090|FG000|Overall Study|Adverse Event|2|||
164203958|NCT00471497|593117889|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
164203959|NCT00471497|593117887|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
164203960|NCT00471497|593117888|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
164203961|NCT00471497|593117889|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
164203962|NCT00471497|593117887|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
164203963|NCT00471497|593117888|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
164203964|NCT00471497|593117889|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
164203965|NCT00471497|593117887|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
164203966|NCT00471497|593117888|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
164203967|NCT00471497|593117889|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
164314814|NCT01818752|593529774|FG001|Overall Study|Physician Decision|8|||
164661650|NCT02521948|594785090|FG000|Overall Study|Death|4|||
164661651|NCT02521948|594785090|FG000|Overall Study|Lost to Follow-up|1|||
164661652|NCT02521948|594785090|FG000|Overall Study|Did not attend one or both follow-ups|6|||
164661653|NCT02041702|594785093|FG000|Overall Study|Lost to Follow-up|1|||
164661654|NCT02041702|594785094|FG001|Overall Study|Lost to Follow-up|6|||
164661655|NCT02041702|594785093|FG000|Overall Study|Death|4|||
164661656|NCT02041702|594785094|FG001|Overall Study|Death|0|||
164661657|NCT02041702|594785093|FG000|Overall Study|Withdrawal by Subject|4|||
164661658|NCT02041702|594785094|FG001|Overall Study|Withdrawal by Subject|3|||
164661659|NCT02041702|594785093|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
164661660|NCT02041702|594785094|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
164661661|NCT02041702|594785093|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
164661662|NCT02041702|594785094|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
164661663|NCT00717756|594785095|FG000|Overall Study|Withdrawal by Subject|1|||
164661664|NCT00673790|594785096|FG000|Overall Study|Adverse Event|23|||
164661665|NCT00673790|594785097|FG001|Overall Study|Adverse Event|14|||
164203968|NCT00471497|593117887|FG000|Core Treatment Phase|Lost to Follow-up|6|||
164203969|NCT00471497|593117888|FG001|Core Treatment Phase|Lost to Follow-up|6|||
164203970|NCT00471497|593117889|FG002|Core Treatment Phase|Lost to Follow-up|3|||
164203971|NCT00471497|593117887|FG000|Core Treatment Phase|Death|3|||
164203972|NCT00471497|593117888|FG001|Core Treatment Phase|Death|9|||
164203973|NCT00471497|593117889|FG002|Core Treatment Phase|Death|3|||
164203974|NCT00471497|593117887|FG000|Core Treatment Phase|Disease Progression|10|||
164203975|NCT00471497|593117888|FG001|Core Treatment Phase|Disease Progression|2|||
164203976|NCT00471497|593117889|FG002|Core Treatment Phase|Disease Progression|4|||
164203977|NCT00471497|593117887|FG000|Core Treatment Phase|Protocol Violation|6|||
164203978|NCT00471497|593117888|FG001|Core Treatment Phase|Protocol Violation|15|||
164203979|NCT00471497|593117889|FG002|Core Treatment Phase|Protocol Violation|11|||
164203980|NCT00471497|593117887|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
164203981|NCT00471497|593117888|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
164203982|NCT00471497|593117889|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
164203983|NCT00471497|593117887|FG000|Core Treatment Phase|Administrative problems|14|||
164203984|NCT00471497|593117888|FG001|Core Treatment Phase|Administrative problems|14|||
164203985|NCT00471497|593117889|FG002|Core Treatment Phase|Administrative problems|12|||
164203986|NCT00471497|593117887|FG000|Core Treatment Phase|Adverse Event|43|||
164203987|NCT00471497|593117888|FG001|Core Treatment Phase|Adverse Event|53|||
164203988|NCT00471497|593117889|FG002|Core Treatment Phase|Adverse Event|89|||
164203989|NCT00471497|593117887|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
164203990|NCT00471497|593117888|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
164203991|NCT00471497|593117889|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
164203992|NCT00471497|593117887|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
164203993|NCT00471497|593117888|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
164203994|NCT00471497|593117889|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
164203995|NCT00471497|593117887|FG000|Extension Phase|Adverse Event|9|||
164203996|NCT00471497|593117888|FG001|Extension Phase|Adverse Event|5|||
164203997|NCT00471497|593117889|FG002|Extension Phase|Adverse Event|1|||
164203998|NCT00471497|593117887|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
164203999|NCT00471497|593117888|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
164204000|NCT00471497|593117889|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
164204001|NCT00471497|593117887|FG000|Extension Phase|Withdrawal by Subject|3|||
164204002|NCT00471497|593117888|FG001|Extension Phase|Withdrawal by Subject|1|||
164204003|NCT00471497|593117889|FG002|Extension Phase|Withdrawal by Subject|0|||
164204004|NCT00471497|593117887|FG000|Extension Phase|Lost to Follow-up|2|||
164204005|NCT00471497|593117888|FG001|Extension Phase|Lost to Follow-up|0|||
164204006|NCT00471497|593117889|FG002|Extension Phase|Lost to Follow-up|0|||
164204007|NCT00471497|593117887|FG000|Extension Phase|Death|1|||
164204008|NCT00471497|593117888|FG001|Extension Phase|Death|0|||
164204009|NCT00471497|593117889|FG002|Extension Phase|Death|0|||
164204010|NCT00471497|593117887|FG000|Extension Phase|Disease progression|2|||
164204011|NCT00471497|593117888|FG001|Extension Phase|Disease progression|0|||
164314815|NCT01818752|593529773|FG000|Overall Study|Disease Progression|54|||
164314816|NCT01818752|593529774|FG001|Overall Study|Disease Progression|48|||
164661666|NCT00673790|594785098|FG002|Overall Study|Adverse Event|2|||
164661667|NCT00673790|594785096|FG000|Overall Study|Lack of Efficacy|2|||
164661668|NCT00673790|594785097|FG001|Overall Study|Lack of Efficacy|2|||
164661669|NCT00673790|594785098|FG002|Overall Study|Lack of Efficacy|2|||
164661670|NCT00673790|594785096|FG000|Overall Study|Protocol Violation|6|||
164661671|NCT00673790|594785097|FG001|Overall Study|Protocol Violation|9|||
164204012|NCT00471497|593117889|FG002|Extension Phase|Disease progression|0|||
164204013|NCT00471497|593117887|FG000|Extension Phase|Protocol Violation|2|||
164204014|NCT00471497|593117888|FG001|Extension Phase|Protocol Violation|2|||
164661672|NCT00673790|594785098|FG002|Overall Study|Protocol Violation|1|||
164661673|NCT00673790|594785096|FG000|Overall Study|Withdrawal by Subject|7|||
164204015|NCT00471497|593117889|FG002|Extension Phase|Protocol Violation|0|||
164204016|NCT01991795|593117891|FG000|Overall Study|Lost to Follow-up|6|||
164557704|NCT03215030|594411657|FG002|Part 2: Dose Expansion|Death|0|||
164557705|NCT03215030|594411658|FG003|Part 2: Dose Expansion|Death|0|||
164557706|NCT03215030|594411659|FG004|Part 2: Dose Expansion|Death|3|||
164557707|NCT03215030|594411660|FG005|Part 2: Dose Expansion|Death|1|||
164557708|NCT03215030|594411661|FG006|Part 2: Dose Expansion|Death|5|||
164557709|NCT03215030|594411662|FG007|Part 2: Dose Expansion|Death|4|||
164557710|NCT03215030|594411663|FG008|Part 2: Dose Expansion|Death|0|||
164557711|NCT03215030|594411664|FG009|Part 2: Dose Expansion|Death|0|||
164557712|NCT03215030|594411665|FG010|Part 2: Dose Expansion|Death|0|||
164557713|NCT03215030|594411666|FG011|Part 2: Dose Expansion|Death|0|||
164557714|NCT03215030|594411655|FG000|Part 2: Dose Expansion|Reason Not Specified|0|||
164557715|NCT03215030|594411656|FG001|Part 2: Dose Expansion|Reason Not Specified|0|||
164557716|NCT03215030|594411657|FG002|Part 2: Dose Expansion|Reason Not Specified|0|||
164557717|NCT03215030|594411658|FG003|Part 2: Dose Expansion|Reason Not Specified|0|||
164557718|NCT03215030|594411659|FG004|Part 2: Dose Expansion|Reason Not Specified|0|||
164557719|NCT03215030|594411660|FG005|Part 2: Dose Expansion|Reason Not Specified|0|||
164557720|NCT03215030|594411661|FG006|Part 2: Dose Expansion|Reason Not Specified|4|||
164557721|NCT03215030|594411662|FG007|Part 2: Dose Expansion|Reason Not Specified|2|||
164557722|NCT03215030|594411663|FG008|Part 2: Dose Expansion|Reason Not Specified|0|||
164557723|NCT03215030|594411664|FG009|Part 2: Dose Expansion|Reason Not Specified|0|||
164557724|NCT03215030|594411665|FG010|Part 2: Dose Expansion|Reason Not Specified|0|||
164557725|NCT03215030|594411666|FG011|Part 2: Dose Expansion|Reason Not Specified|0|||
164557726|NCT03215030|594411655|FG000|Part 3: Dose Extension|Lost to Follow-up|0|||
164557727|NCT03215030|594411656|FG001|Part 3: Dose Extension|Lost to Follow-up|0|||
164557728|NCT03215030|594411657|FG002|Part 3: Dose Extension|Lost to Follow-up|0|||
164557729|NCT03215030|594411658|FG003|Part 3: Dose Extension|Lost to Follow-up|0|||
164557730|NCT03215030|594411659|FG004|Part 3: Dose Extension|Lost to Follow-up|0|||
164557731|NCT03215030|594411660|FG005|Part 3: Dose Extension|Lost to Follow-up|0|||
164557732|NCT03215030|594411661|FG006|Part 3: Dose Extension|Lost to Follow-up|0|||
164557733|NCT03215030|594411662|FG007|Part 3: Dose Extension|Lost to Follow-up|0|||
164557734|NCT03215030|594411663|FG008|Part 3: Dose Extension|Lost to Follow-up|0|||
164557735|NCT03215030|594411664|FG009|Part 3: Dose Extension|Lost to Follow-up|2|||
164557736|NCT03215030|594411665|FG010|Part 3: Dose Extension|Lost to Follow-up|0|||
164557737|NCT03215030|594411666|FG011|Part 3: Dose Extension|Lost to Follow-up|0|||
164557738|NCT03215030|594411655|FG000|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
164557739|NCT03215030|594411656|FG001|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
164557740|NCT03215030|594411657|FG002|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
164557741|NCT03215030|594411658|FG003|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
164557742|NCT03215030|594411659|FG004|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
164557743|NCT03215030|594411660|FG005|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
164557744|NCT03215030|594411661|FG006|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
164557745|NCT03215030|594411662|FG007|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
164557746|NCT03215030|594411663|FG008|Part 3: Dose Extension|Study Terminated by Sponsor|38|||
164557747|NCT03215030|594411664|FG009|Part 3: Dose Extension|Study Terminated by Sponsor|39|||
164557748|NCT03215030|594411665|FG010|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
164557749|NCT03215030|594411666|FG011|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
164557750|NCT03215030|594411655|FG000|Part 3: Dose Extension|Withdrawal by Subject|0|||
164557751|NCT03215030|594411656|FG001|Part 3: Dose Extension|Withdrawal by Subject|0|||
164557752|NCT03215030|594411657|FG002|Part 3: Dose Extension|Withdrawal by Subject|0|||
164557753|NCT03215030|594411658|FG003|Part 3: Dose Extension|Withdrawal by Subject|0|||
164557754|NCT03215030|594411659|FG004|Part 3: Dose Extension|Withdrawal by Subject|0|||
164557755|NCT03215030|594411660|FG005|Part 3: Dose Extension|Withdrawal by Subject|0|||
164557756|NCT03215030|594411661|FG006|Part 3: Dose Extension|Withdrawal by Subject|0|||
164557757|NCT03215030|594411662|FG007|Part 3: Dose Extension|Withdrawal by Subject|0|||
164557758|NCT03215030|594411663|FG008|Part 3: Dose Extension|Withdrawal by Subject|6|||
164557759|NCT03215030|594411664|FG009|Part 3: Dose Extension|Withdrawal by Subject|7|||
164557760|NCT03215030|594411665|FG010|Part 3: Dose Extension|Withdrawal by Subject|0|||
164557761|NCT03215030|594411666|FG011|Part 3: Dose Extension|Withdrawal by Subject|0|||
164557762|NCT03215030|594411655|FG000|Part 3: Dose Extension|Death|0|||
164557763|NCT03215030|594411656|FG001|Part 3: Dose Extension|Death|0|||
164557764|NCT03215030|594411657|FG002|Part 3: Dose Extension|Death|0|||
164557765|NCT03215030|594411658|FG003|Part 3: Dose Extension|Death|0|||
164557766|NCT03215030|594411659|FG004|Part 3: Dose Extension|Death|0|||
164557767|NCT03215030|594411660|FG005|Part 3: Dose Extension|Death|0|||
164557768|NCT03215030|594411661|FG006|Part 3: Dose Extension|Death|0|||
164557769|NCT03215030|594411662|FG007|Part 3: Dose Extension|Death|0|||
164557770|NCT03215030|594411663|FG008|Part 3: Dose Extension|Death|19|||
164557771|NCT03215030|594411664|FG009|Part 3: Dose Extension|Death|20|||
164557772|NCT03215030|594411665|FG010|Part 3: Dose Extension|Death|0|||
164557773|NCT03215030|594411666|FG011|Part 3: Dose Extension|Death|0|||
164557774|NCT03215030|594411655|FG000|Part 3: Dose Extension|Reason Not Specified|0|||
164557775|NCT03215030|594411656|FG001|Part 3: Dose Extension|Reason Not Specified|0|||
164557776|NCT03215030|594411657|FG002|Part 3: Dose Extension|Reason Not Specified|0|||
164557777|NCT03215030|594411658|FG003|Part 3: Dose Extension|Reason Not Specified|0|||
164557778|NCT03215030|594411659|FG004|Part 3: Dose Extension|Reason Not Specified|0|||
164557779|NCT03215030|594411660|FG005|Part 3: Dose Extension|Reason Not Specified|0|||
164557780|NCT03215030|594411661|FG006|Part 3: Dose Extension|Reason Not Specified|0|||
164557781|NCT03215030|594411662|FG007|Part 3: Dose Extension|Reason Not Specified|0|||
164557782|NCT03215030|594411663|FG008|Part 3: Dose Extension|Reason Not Specified|3|||
164557783|NCT03215030|594411664|FG009|Part 3: Dose Extension|Reason Not Specified|0|||
164557784|NCT03215030|594411665|FG010|Part 3: Dose Extension|Reason Not Specified|0|||
164557785|NCT03215030|594411666|FG011|Part 3: Dose Extension|Reason Not Specified|0|||
164557786|NCT03215030|594411655|FG000|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
164557787|NCT03215030|594411656|FG001|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
164557788|NCT03215030|594411657|FG002|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
164557789|NCT03215030|594411658|FG003|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
164557790|NCT03215030|594411659|FG004|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
164557791|NCT03215030|594411660|FG005|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
164557792|NCT03215030|594411661|FG006|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
164557793|NCT03215030|594411662|FG007|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
164557794|NCT03215030|594411663|FG008|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
164557795|NCT03215030|594411664|FG009|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
164557796|NCT03215030|594411665|FG010|Japan Safety Lead-In|Study Terminated by Sponsor|3|||
164557797|NCT03215030|594411666|FG011|Japan Safety Lead-In|Study Terminated by Sponsor|2|||
164557798|NCT01745146|594411667|FG000|Overall Study|Withdrawal by Subject|1|||
164557799|NCT01745146|594411668|FG001|Overall Study|Withdrawal by Subject|3|||
164557800|NCT01745146|594411667|FG000|Overall Study|Lost to Follow-up|2|||
164557801|NCT01745146|594411668|FG001|Overall Study|Lost to Follow-up|0|||
164557802|NCT00130832|594411669|FG000|Overall Study|Adverse Event|1|||
164557803|NCT00130832|594411670|FG001|Overall Study|Adverse Event|1|||
164557804|NCT00130832|594411669|FG000|Overall Study|Lost to Follow-up|1|||
164557805|NCT00130832|594411670|FG001|Overall Study|Lost to Follow-up|2|||
164557806|NCT00130832|594411669|FG000|Overall Study|Protocol Violation|6|||
164557807|NCT00130832|594411670|FG001|Overall Study|Protocol Violation|8|||
164557808|NCT00130832|594411669|FG000|Overall Study|Withdrawal by Subject|6|||
164557809|NCT00130832|594411670|FG001|Overall Study|Withdrawal by Subject|1|||
164557810|NCT00130832|594411669|FG000|Overall Study|Moved|2|||
164557811|NCT00130832|594411670|FG001|Overall Study|Moved|2|||
164557812|NCT00130832|594411669|FG000|Overall Study|Other|0|||
164557813|NCT00130832|594411670|FG001|Overall Study|Other|3|||
164557814|NCT02770326|594411672|FG000|Overall Study|Death|3|||
164557815|NCT02770326|594411672|FG000|Overall Study|Lost to Follow-up|1|||
164557816|NCT01407926|594411675|FG000|Overall Study|Lost to Follow-up|55|||
164557817|NCT02118792|594411676|FG000|Overall Study|Withdrawal by Subject|6|||
164557818|NCT02118792|594411677|FG001|Overall Study|Withdrawal by Subject|3|||
164557819|NCT02118792|594411676|FG000|Overall Study|Lost to Follow-up|4|||
164557820|NCT02118792|594411677|FG001|Overall Study|Lost to Follow-up|4|||
164557821|NCT02118792|594411676|FG000|Overall Study|Adverse Event|5|||
164557822|NCT02118792|594411677|FG001|Overall Study|Adverse Event|4|||
164557823|NCT02118792|594411676|FG000|Overall Study|Withdrawal by parent/guardian|14|||
164557824|NCT02118792|594411677|FG001|Overall Study|Withdrawal by parent/guardian|20|||
164557825|NCT02118792|594411676|FG000|Overall Study|Other|1|||
164557826|NCT02118792|594411677|FG001|Overall Study|Other|6|||
164557827|NCT02118792|594411676|FG000|Overall Study|Randomised but not treated|1|||
164557828|NCT02118792|594411677|FG001|Overall Study|Randomised but not treated|0|||
164557829|NCT04232696|594411679|FG000|Overall Study|Implant attempted but not completed|5|||
164557830|NCT04232696|594411680|FG001|Overall Study|Implant attempted but not completed|2|||
164557831|NCT04232696|594411679|FG000|Overall Study|Not satisfied with therapy outcome|0|||
164557832|NCT04232696|594411680|FG001|Overall Study|Not satisfied with therapy outcome|8|||
164557833|NCT04232696|594411679|FG000|Overall Study|Adverse Event|0|||
164557834|NCT04232696|594411680|FG001|Overall Study|Adverse Event|3|||
164557835|NCT04232696|594411679|FG000|Overall Study|Withdrawal by Subject|0|||
164557836|NCT04232696|594411680|FG001|Overall Study|Withdrawal by Subject|3|||
164557837|NCT04232696|594411679|FG000|Overall Study|Missed Visit|0|||
164557838|NCT04232696|594411680|FG001|Overall Study|Missed Visit|2|||
164557839|NCT04232696|594411679|FG000|Overall Study|Other reason|0|||
164557840|NCT04232696|594411680|FG001|Overall Study|Other reason|1|||
164557841|NCT00488982|594411681|FG000|Course 1|Physician Decision|0|||
164557842|NCT00488982|594411682|FG001|Course 1|Physician Decision|2|||
164557843|NCT00488982|594411683|FG002|Course 1|Physician Decision|4|||
164557844|NCT00488982|594411681|FG000|Course 1|Withdrawal by Subject|0|||
164557845|NCT00488982|594411682|FG001|Course 1|Withdrawal by Subject|8|||
164557846|NCT00488982|594411683|FG002|Course 1|Withdrawal by Subject|2|||
164557847|NCT00488982|594411681|FG000|Course 1|nonprotocol therapy|0|||
164557848|NCT00488982|594411682|FG001|Course 1|nonprotocol therapy|2|||
164557849|NCT00488982|594411683|FG002|Course 1|nonprotocol therapy|2|||
164557850|NCT00488982|594411681|FG000|Course 1|Adverse Event|0|||
164557851|NCT00488982|594411682|FG001|Course 1|Adverse Event|0|||
164557852|NCT00488982|594411683|FG002|Course 1|Adverse Event|6|||
164557853|NCT01368835|594411684|FG000|Overall Study|Inclusion criteria/photography quality|22|||
164661674|NCT00673790|594785097|FG001|Overall Study|Withdrawal by Subject|4|||
164661675|NCT00673790|594785098|FG002|Overall Study|Withdrawal by Subject|1|||
164661676|NCT00673790|594785096|FG000|Overall Study|Lost to Follow-up|6|||
164661677|NCT00673790|594785097|FG001|Overall Study|Lost to Follow-up|6|||
164661678|NCT00673790|594785098|FG002|Overall Study|Lost to Follow-up|5|||
164661679|NCT00673790|594785096|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
164661680|NCT00673790|594785097|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
164661681|NCT00673790|594785098|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
164661682|NCT00673790|594785096|FG000|Overall Study|Poor compliance|1|||
164661683|NCT00673790|594785097|FG001|Overall Study|Poor compliance|0|||
164661684|NCT00673790|594785098|FG002|Overall Study|Poor compliance|0|||
164661685|NCT00673790|594785096|FG000|Overall Study|Participated in two Nebivolol studies|0|||
164661686|NCT00673790|594785097|FG001|Overall Study|Participated in two Nebivolol studies|0|||
164661687|NCT00673790|594785098|FG002|Overall Study|Participated in two Nebivolol studies|1|||
164661688|NCT00673790|594785096|FG000|Overall Study|Unconfirmed pregnancy|0|||
164661689|NCT00673790|594785097|FG001|Overall Study|Unconfirmed pregnancy|1|||
164661690|NCT00673790|594785098|FG002|Overall Study|Unconfirmed pregnancy|0|||
164661691|NCT00673790|594785096|FG000|Overall Study|Randomization criteria not met|0|||
164661692|NCT00673790|594785097|FG001|Overall Study|Randomization criteria not met|1|||
164661693|NCT00673790|594785098|FG002|Overall Study|Randomization criteria not met|0|||
164661694|NCT01873859|594785099|FG000|Overall Study|Withdrawal by Subject|0|||
164661695|NCT01873859|594785100|FG001|Overall Study|Withdrawal by Subject|4|||
164661696|NCT01364870|594785101|FG000|Overall Study|Withdrawal by Subject|13|||
164661697|NCT01364870|594785102|FG001|Overall Study|Withdrawal by Subject|24|||
164661698|NCT01364870|594785103|FG002|Overall Study|Withdrawal by Subject|10|||
164661699|NCT01364870|594785101|FG000|Overall Study|Adverse Event|8|||
164661700|NCT01364870|594785102|FG001|Overall Study|Adverse Event|6|||
164661701|NCT01364870|594785103|FG002|Overall Study|Adverse Event|4|||
164661702|NCT01364870|594785101|FG000|Overall Study|Protocol Violation|1|||
164661703|NCT01364870|594785102|FG001|Overall Study|Protocol Violation|0|||
164661704|NCT01364870|594785103|FG002|Overall Study|Protocol Violation|0|||
164661705|NCT04471428|594785104|FG000|Overall Study|Withdrawal by Subject|29|||
164661706|NCT04471428|594785105|FG001|Overall Study|Withdrawal by Subject|4|||
164661707|NCT04471428|594785104|FG000|Overall Study|Physician Decision|0|||
164661708|NCT04471428|594785105|FG001|Overall Study|Physician Decision|1|||
164661709|NCT04471428|594785104|FG000|Overall Study|Reason Not Specified|0|||
164661710|NCT04471428|594785105|FG001|Overall Study|Reason Not Specified|2|||
164661711|NCT04471428|594785104|FG000|Overall Study|Death|131|||
164661712|NCT04471428|594785105|FG001|Overall Study|Death|147|||
164661713|NCT04471428|594785104|FG000|Overall Study|Lost to Follow-up|0|||
164661714|NCT04471428|594785105|FG001|Overall Study|Lost to Follow-up|3|||
164661715|NCT04471428|594785104|FG000|Overall Study|Study Terminated by Sponsor|20|||
164661716|NCT04471428|594785105|FG001|Overall Study|Study Terminated by Sponsor|29|||
164661717|NCT03504852|594785106|FG000|Overall Study|Withdrawal of informed consent|2|||
164661718|NCT03504852|594785107|FG001|Overall Study|Withdrawal of informed consent|1|||
164661719|NCT03504852|594785108|FG002|Overall Study|Withdrawal of informed consent|0|||
164661720|NCT03504852|594785106|FG000|Overall Study|Withdrawal by Subject|5|||
164661721|NCT03504852|594785107|FG001|Overall Study|Withdrawal by Subject|5|||
164661722|NCT03504852|594785108|FG002|Overall Study|Withdrawal by Subject|1|||
164661723|NCT03504852|594785106|FG000|Overall Study|Lost to Follow-up|4|||
164661724|NCT03504852|594785107|FG001|Overall Study|Lost to Follow-up|1|||
164661725|NCT03504852|594785108|FG002|Overall Study|Lost to Follow-up|0|||
164661726|NCT03504852|594785106|FG000|Overall Study|New therapy for study indication|1|||
164661727|NCT03504852|594785107|FG001|Overall Study|New therapy for study indication|0|||
164557854|NCT01368835|594411684|FG000|Overall Study|Lost to Follow-up|11|||
164557855|NCT01678144|594411685|FG000|Stage 1: MAR Classic|Adverse Event|1|||
164557856|NCT02754726|594411686|FG000|Overall Study|Progressive Disease by RECIST|13|||
164557857|NCT02754726|594411686|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
164557858|NCT02754726|594411686|FG000|Overall Study|Clinical Disease Progression|5|||
164557859|NCT02754726|594411686|FG000|Overall Study|Adverse Event|3|||
164557860|NCT02754726|594411686|FG000|Overall Study|Withdrawal by Subject|1|||
164557861|NCT02754726|594411686|FG000|Overall Study|Tolerability|1|||
164661728|NCT03504852|594785108|FG002|Overall Study|New therapy for study indication|0|||
164661729|NCT03504852|594785106|FG000|Overall Study|Lack of Efficacy|1|||
164661730|NCT03504852|594785107|FG001|Overall Study|Lack of Efficacy|2|||
164661731|NCT03504852|594785108|FG002|Overall Study|Lack of Efficacy|0|||
164661732|NCT03504852|594785106|FG000|Overall Study|Death|0|||
164661733|NCT03504852|594785107|FG001|Overall Study|Death|1|||
164204017|NCT01991795|593117892|FG001|Overall Study|Lost to Follow-up|4|||
164557862|NCT01885000|594411687|FG000|Overall Study|Adverse Event|1|||
164557863|NCT01885000|594411688|FG001|Overall Study|Adverse Event|0|||
164557864|NCT01885000|594411687|FG000|Overall Study|Withdrawal by Subject|1|||
164557865|NCT01885000|594411688|FG001|Overall Study|Withdrawal by Subject|1|||
164661734|NCT03504852|594785108|FG002|Overall Study|Death|0|||
164661735|NCT03504852|594785106|FG000|Overall Study|Adverse Event|4|||
164661736|NCT03504852|594785107|FG001|Overall Study|Adverse Event|8|||
164661737|NCT03504852|594785108|FG002|Overall Study|Adverse Event|2|||
164661738|NCT03290079|594785109|FG000|Overall Study|Death|2|||
164661739|NCT03850509|594785110|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
164661740|NCT03850509|594785111|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
164661741|NCT02666430|594785112|FG000|Period 1|Lost to Follow-up|1|||
164661742|NCT02666430|594785113|FG001|Period 1|Lost to Follow-up|0|||
164661743|NCT02666430|594785112|FG000|Period 1|Adverse Event|0|||
164661744|NCT02666430|594785113|FG001|Period 1|Adverse Event|1|||
164661745|NCT02666430|594785112|FG000|Period 2|Withdrawal by Subject|1|||
164661746|NCT02666430|594785113|FG001|Period 2|Withdrawal by Subject|4|||
164661747|NCT02666430|594785112|FG000|Period 3|Lost to Follow-up|1|||
164661748|NCT02666430|594785113|FG001|Period 3|Lost to Follow-up|0|||
164661749|NCT03922477|594785114|FG000|Overall Study|Death|9|||
164661750|NCT03922477|594785114|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
164661751|NCT03922477|594785114|FG000|Overall Study|Physician Decision|1|||
164661752|NCT03922477|594785114|FG000|Overall Study|Withdrawal by Subject|2|||
164661753|NCT01960816|594785118|FG000|Overall Study|Lost to Follow-up|1|||
164661754|NCT00003782|594785119|FG000|Overall Study|No follow up data|30|||
164661755|NCT00003782|594785120|FG001|Overall Study|No follow up data|31|||
164661756|NCT00003782|594785121|FG002|Overall Study|No follow up data|26|||
164661757|NCT04849988|594786491|FG000|Overall Study|Lack of Efficacy|3|||
164661758|NCT04849988|594786492|FG001|Overall Study|Lack of Efficacy|4|||
164661759|NCT04849988|594786493|FG002|Overall Study|Lack of Efficacy|1|||
164661760|NCT04849988|594786494|FG003|Overall Study|Lack of Efficacy|4|||
164661761|NCT04849988|594786491|FG000|Overall Study|Other reasons|1|||
164661762|NCT04849988|594786492|FG001|Overall Study|Other reasons|2|||
164661763|NCT04849988|594786493|FG002|Overall Study|Other reasons|2|||
164661764|NCT04849988|594786494|FG003|Overall Study|Other reasons|1|||
164661765|NCT01893905|594786495|FG000|Overall Study|Withdrawal by Subject|1|||
164661766|NCT01893905|594786496|FG001|Overall Study|Withdrawal by Subject|0|||
164661767|NCT01893905|594786495|FG000|Overall Study|Adverse Event|9|||
164661768|NCT01893905|594786496|FG001|Overall Study|Adverse Event|3|||
164661769|NCT01893905|594786495|FG000|Overall Study|Lack of Efficacy|5|||
164661770|NCT01893905|594786496|FG001|Overall Study|Lack of Efficacy|7|||
164661771|NCT01893905|594786495|FG000|Overall Study|Lost to Follow-up|1|||
164661772|NCT01893905|594786496|FG001|Overall Study|Lost to Follow-up|0|||
164661773|NCT01893905|594786495|FG000|Overall Study|Protocol Violation|6|||
164661774|NCT01893905|594786496|FG001|Overall Study|Protocol Violation|1|||
164661775|NCT01893905|594786495|FG000|Overall Study|Lack of adherence to treatment|2|||
164661776|NCT01893905|594786496|FG001|Overall Study|Lack of adherence to treatment|0|||
164661777|NCT01893905|594786495|FG000|Overall Study|Other reason|1|||
164661778|NCT01893905|594786496|FG001|Overall Study|Other reason|3|||
164661779|NCT01691859|594786497|FG000|Overall Study|Adverse Event|19|||
164661780|NCT01691859|594786497|FG000|Overall Study|Lack of Efficacy|11|||
164661781|NCT01691859|594786497|FG000|Overall Study|Protocol Violation|4|||
164661782|NCT01691859|594786497|FG000|Overall Study|Product commercially available|221|||
164661783|NCT01691859|594786497|FG000|Overall Study|Study closed/terminated|50|||
164557866|NCT01885000|594411687|FG000|Overall Study|Protocol Violation|0|||
164557867|NCT01885000|594411688|FG001|Overall Study|Protocol Violation|1|||
164557868|NCT02792842|594411692|FG000|Overall Study|Adverse Event|4|||
164557869|NCT02792842|594411693|FG001|Overall Study|Adverse Event|2|||
164557870|NCT02792842|594411694|FG002|Overall Study|Adverse Event|3|||
164557871|NCT02792842|594411692|FG000|Overall Study|Withdrawal by Subject|0|||
164557872|NCT02792842|594411693|FG001|Overall Study|Withdrawal by Subject|1|||
164557873|NCT02792842|594411694|FG002|Overall Study|Withdrawal by Subject|2|||
164557874|NCT02792842|594411692|FG000|Overall Study|Lost to Follow-up|0|||
164557875|NCT02792842|594411693|FG001|Overall Study|Lost to Follow-up|0|||
164557876|NCT02792842|594411694|FG002|Overall Study|Lost to Follow-up|1|||
164557877|NCT02792842|594411692|FG000|Overall Study|Schedule delay|0|||
164557878|NCT02792842|594411693|FG001|Overall Study|Schedule delay|1|||
164557879|NCT02792842|594411694|FG002|Overall Study|Schedule delay|1|||
164557880|NCT02363686|594411697|FG000|Overall Study|Withdrawal by Subject|22|||
164557881|NCT02363686|594411697|FG000|Overall Study|incomplete FEES examinations|13|||
164557882|NCT05289830|594411705|FG000|Overall Study|Lost to Follow-up|1|||
164557883|NCT05289830|594411706|FG001|Overall Study|Lost to Follow-up|1|||
164557884|NCT05289830|594411705|FG000|Overall Study|Physician Decision|0|||
164557885|NCT05289830|594411706|FG001|Overall Study|Physician Decision|1|||
164557886|NCT00577993|594411709|FG000|Overall Study|Adverse Event|1|||
164661784|NCT01691859|594786497|FG000|Overall Study|Lost to Follow-up|5|||
164661785|NCT01691859|594786497|FG000|Overall Study|Physician Decision|6|||
164661786|NCT01691859|594786497|FG000|Overall Study|Withdrawal by Subject|31|||
164557887|NCT00577993|594411710|FG001|Overall Study|Adverse Event|0|||
164557888|NCT00577993|594411711|FG002|Overall Study|Adverse Event|0|||
164557889|NCT00577993|594411709|FG000|Overall Study|Death|0|||
164557890|NCT00577993|594411710|FG001|Overall Study|Death|1|||
164661787|NCT00992407|594786498|FG000|Overall Study|Protocol Violation|2|||
164661788|NCT00992407|594786499|FG001|Overall Study|Protocol Violation|1|||
164661789|NCT00992407|594786498|FG000|Overall Study|Lost to Follow-up|3|||
164661790|NCT00992407|594786499|FG001|Overall Study|Lost to Follow-up|3|||
164661791|NCT00992407|594786498|FG000|Overall Study|Adverse Event|3|||
164661792|NCT00992407|594786499|FG001|Overall Study|Adverse Event|2|||
164661793|NCT00992407|594786498|FG000|Overall Study|protocol Violation & Adverse events|2|||
164661794|NCT00992407|594786499|FG001|Overall Study|protocol Violation & Adverse events|4|||
164661795|NCT00992407|594786498|FG000|Overall Study|Other|2|||
164661796|NCT00992407|594786499|FG001|Overall Study|Other|0|||
164661797|NCT00992407|594786498|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
164661798|NCT00992407|594786499|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
164661799|NCT00992407|594786498|FG000|Overall Study|Study medication not administered|17|||
164661800|NCT00992407|594786499|FG001|Overall Study|Study medication not administered|13|||
164661801|NCT03738332|594786502|FG000|Overall Study|Withdrawal by Subject|1|||
164661802|NCT01521559|594786503|FG000|Overall Study|Adverse Event|0|||
164661803|NCT01521559|594786504|FG001|Overall Study|Adverse Event|4|||
164661804|NCT01521559|594786503|FG000|Overall Study|Death|1|||
164661805|NCT01521559|594786504|FG001|Overall Study|Death|0|||
164661806|NCT01521559|594786503|FG000|Overall Study|Withdrawal by Subject|9|||
164661807|NCT01521559|594786504|FG001|Overall Study|Withdrawal by Subject|11|||
164661808|NCT01521559|594786503|FG000|Overall Study|Lost to Follow-up|3|||
164661809|NCT01521559|594786504|FG001|Overall Study|Lost to Follow-up|1|||
164661810|NCT01521559|594786503|FG000|Overall Study|Protocol Violation|1|||
164661811|NCT01521559|594786504|FG001|Overall Study|Protocol Violation|0|||
164661812|NCT01521559|594786503|FG000|Overall Study|Other|1|||
164661813|NCT01521559|594786504|FG001|Overall Study|Other|2|||
164661814|NCT02336737|594786505|FG000|Overall Study|Withdrawal by Subject|5|||
164661815|NCT02336737|594786505|FG000|Overall Study|Physician Decision|8|||
164661816|NCT02396381|594786506|FG000|Overall Study|Adverse Event|3|||
164661817|NCT02396381|594786507|FG001|Overall Study|Adverse Event|2|||
164661818|NCT02396381|594786506|FG000|Overall Study|Withdrawal by Subject|33|||
164661819|NCT02396381|594786507|FG001|Overall Study|Withdrawal by Subject|24|||
164661820|NCT02396381|594786506|FG000|Overall Study|Lost to Follow-up|49|||
164661821|NCT02396381|594786507|FG001|Overall Study|Lost to Follow-up|31|||
164661822|NCT02396381|594786506|FG000|Overall Study|Protocol Violation|1|||
164661823|NCT02396381|594786507|FG001|Overall Study|Protocol Violation|0|||
164661824|NCT02396381|594786506|FG000|Overall Study|Site terminated by sponsor|7|||
164661825|NCT02396381|594786507|FG001|Overall Study|Site terminated by sponsor|8|||
164557891|NCT00577993|594411711|FG002|Overall Study|Death|1|||
164557892|NCT00577993|594411709|FG000|Overall Study|Lack of Efficacy|0|||
164557893|NCT00577993|594411710|FG001|Overall Study|Lack of Efficacy|1|||
164557894|NCT00577993|594411711|FG002|Overall Study|Lack of Efficacy|0|||
164557895|NCT00577993|594411709|FG000|Overall Study|Protocol Violation|2|||
164557896|NCT00577993|594411710|FG001|Overall Study|Protocol Violation|3|||
164557897|NCT00577993|594411711|FG002|Overall Study|Protocol Violation|0|||
164557898|NCT00577993|594411709|FG000|Overall Study|Withdrawal by Subject|1|||
164557899|NCT00577993|594411710|FG001|Overall Study|Withdrawal by Subject|0|||
164557900|NCT00577993|594411711|FG002|Overall Study|Withdrawal by Subject|2|||
164557901|NCT00577993|594411709|FG000|Overall Study|Conversion|2|||
164557902|NCT00577993|594411710|FG001|Overall Study|Conversion|5|||
164557903|NCT00577993|594411711|FG002|Overall Study|Conversion|0|||
164557904|NCT00577993|594411709|FG000|Overall Study|Uninsured|1|||
164557905|NCT00577993|594411710|FG001|Overall Study|Uninsured|0|||
164557906|NCT00577993|594411711|FG002|Overall Study|Uninsured|0|||
164557907|NCT02217566|594411712|FG000|Overall Study|Lost to Follow-up|2|||
164557908|NCT02217566|594411712|FG000|Overall Study|Death|3|||
164557909|NCT02217566|594411712|FG000|Overall Study|Early study termination|6|||
164557910|NCT02064387|594411717|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
164557911|NCT02064387|594411718|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
164557912|NCT02064387|594411719|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
164557913|NCT02064387|594411720|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
164557914|NCT02064387|594411721|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
164557915|NCT02064387|594411722|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
164557916|NCT02064387|594411723|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
164557917|NCT02064387|594411724|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
164557918|NCT02064387|594411725|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
164557919|NCT02064387|594411726|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
164661826|NCT02396381|594786506|FG000|Overall Study|Physician Decision|5|||
164661827|NCT02396381|594786507|FG001|Overall Study|Physician Decision|5|||
164557920|NCT02064387|594411727|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
164557921|NCT02064387|594411728|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
164557922|NCT02064387|594411717|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
164557923|NCT02064387|594411718|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
164557924|NCT02064387|594411719|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
164557925|NCT02064387|594411720|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
164557926|NCT02064387|594411721|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
164661828|NCT02396381|594786506|FG000|Overall Study|Pregnancy|2|||
164661829|NCT02396381|594786507|FG001|Overall Study|Pregnancy|0|||
164661830|NCT02396381|594786506|FG000|Overall Study|Non-compliance with study procedures|1|||
164661831|NCT02396381|594786507|FG001|Overall Study|Non-compliance with study procedures|0|||
164661832|NCT02396381|594786506|FG000|Overall Study|Moved out of town/state|1|||
164661833|NCT02396381|594786507|FG001|Overall Study|Moved out of town/state|3|||
164661834|NCT02396381|594786506|FG000|Overall Study|Could not complete visit|1|||
164661835|NCT02396381|594786507|FG001|Overall Study|Could not complete visit|0|||
164661836|NCT02396381|594786506|FG000|Overall Study|Possible conflict of interest|1|||
164661837|NCT02396381|594786507|FG001|Overall Study|Possible conflict of interest|0|||
164661838|NCT02396381|594786506|FG000|Overall Study|Randomization/Screening Error|3|||
164661839|NCT02396381|594786507|FG001|Overall Study|Randomization/Screening Error|1|||
164661840|NCT00576381|594786512|FG000|Overall Study|Reoperation|3|||
164661841|NCT00576381|594786512|FG000|Overall Study|Adverse Event|4|||
164661842|NCT00287118|594786513|FG000|Overall Study|Adverse Event|30|||
164661843|NCT00287118|594786513|FG000|Overall Study|Death|1|||
164661844|NCT00287118|594786513|FG000|Overall Study|Lack of Efficacy|11|||
164661845|NCT00287118|594786513|FG000|Overall Study|Lost to Follow-up|1|||
164661846|NCT00287118|594786513|FG000|Overall Study|Protocol Violation|2|||
164661847|NCT00287118|594786513|FG000|Overall Study|Other|7|||
164661848|NCT01631864|594786514|FG000|Overall Study|Withdrawal by Subject|0|||
164661849|NCT01631864|594786515|FG001|Overall Study|Withdrawal by Subject|1|||
164661850|NCT01631864|594786514|FG000|Overall Study|Adverse Event|2|||
164661851|NCT01631864|594786515|FG001|Overall Study|Adverse Event|3|||
164661852|NCT04543136|594786528|FG000|Overall Study|Withdrawal by Subject|0|||
164661853|NCT04543136|594786529|FG001|Overall Study|Withdrawal by Subject|1|||
164661854|NCT04543136|594786530|FG002|Overall Study|Withdrawal by Subject|0|||
164661855|NCT04543136|594786531|FG003|Overall Study|Withdrawal by Subject|1|||
164661856|NCT04543136|594786532|FG004|Overall Study|Withdrawal by Subject|0|||
164661857|NCT04543136|594786533|FG005|Overall Study|Withdrawal by Subject|0|||
164661858|NCT00638157|594786536|FG000|Overall Study|Adverse Event|0|||
164661859|NCT00638157|594786537|FG001|Overall Study|Adverse Event|1|||
164661860|NCT00638157|594786536|FG000|Overall Study|Clinical (symptomatic) failure|1|||
164661861|NCT00638157|594786537|FG001|Overall Study|Clinical (symptomatic) failure|1|||
164661862|NCT00638157|594786536|FG000|Overall Study|Microbiological failure|1|||
164661863|NCT00638157|594786537|FG001|Overall Study|Microbiological failure|0|||
164661864|NCT00638157|594786536|FG000|Overall Study|Lost to Follow-up|1|||
164661865|NCT00638157|594786537|FG001|Overall Study|Lost to Follow-up|0|||
164661866|NCT00638157|594786536|FG000|Overall Study|Physician Decision|1|||
164661867|NCT00638157|594786537|FG001|Overall Study|Physician Decision|0|||
164661868|NCT00638157|594786536|FG000|Overall Study|Other|1|||
164661869|NCT00638157|594786537|FG001|Overall Study|Other|2|||
164661870|NCT00638157|594786536|FG000|Overall Study|Randomized, not treated|2|||
164661871|NCT00638157|594786537|FG001|Overall Study|Randomized, not treated|0|||
164661872|NCT04309474|594786538|FG000|Overall Study|Randomized but not treated|0|||
164661873|NCT04309474|594786539|FG001|Overall Study|Randomized but not treated|2|||
164661874|NCT04309474|594786538|FG000|Overall Study|Adverse Event|4|||
164661875|NCT04309474|594786539|FG001|Overall Study|Adverse Event|1|||
164661876|NCT04309474|594786538|FG000|Overall Study|Withdrawal by Subject|6|||
164661877|NCT04309474|594786539|FG001|Overall Study|Withdrawal by Subject|9|||
164661878|NCT04309474|594786538|FG000|Overall Study|Lost to Follow-up|1|||
164661879|NCT04309474|594786539|FG001|Overall Study|Lost to Follow-up|2|||
164661880|NCT04309474|594786538|FG000|Overall Study|Not disclosed|10|||
164661881|NCT04309474|594786539|FG001|Overall Study|Not disclosed|6|||
164661882|NCT04684524|594786540|FG000|Overall Study|Other|2|||
164661883|NCT04684524|594786541|FG001|Overall Study|Other|0|||
164661884|NCT04684524|594786540|FG000|Overall Study|Withdrawal by Subject|5|||
164661885|NCT04684524|594786541|FG001|Overall Study|Withdrawal by Subject|3|||
164661886|NCT04684524|594786540|FG000|Overall Study|Adverse Event|1|||
164661887|NCT04684524|594786541|FG001|Overall Study|Adverse Event|1|||
164661888|NCT00601354|594786545|FG000|Overall Study|Lost to Follow-up|4|||
164661889|NCT00601354|594786546|FG001|Overall Study|Lost to Follow-up|5|||
164661890|NCT05876091|594786547|FG000|Sessions 2-5: Tobacco Flavors|Lost to Follow-up|1|||
164661891|NCT03402893|594786548|FG000|Overall Study|Withdrawal by Subject|1|||
164661892|NCT03466411|594786549|FG000|Overall Study|Lost to Follow-up|0|||
164661893|NCT03466411|594786550|FG001|Overall Study|Lost to Follow-up|1|||
164661894|NCT03466411|594786551|FG002|Overall Study|Lost to Follow-up|1|||
164661895|NCT03466411|594786552|FG003|Overall Study|Lost to Follow-up|0|||
164661896|NCT03466411|594786553|FG004|Overall Study|Lost to Follow-up|0|||
164661897|NCT03466411|594786554|FG005|Overall Study|Lost to Follow-up|0|||
164661898|NCT03466411|594786555|FG006|Overall Study|Lost to Follow-up|1|||
164661899|NCT03466411|594786556|FG007|Overall Study|Lost to Follow-up|1|||
164661900|NCT03466411|594786557|FG008|Overall Study|Lost to Follow-up|0|||
164661901|NCT03466411|594786558|FG009|Overall Study|Lost to Follow-up|1|||
164661902|NCT03466411|594786559|FG010|Overall Study|Lost to Follow-up|1|||
164661903|NCT03466411|594786560|FG011|Overall Study|Lost to Follow-up|1|||
164661904|NCT03466411|594786561|FG012|Overall Study|Lost to Follow-up|0|||
164661905|NCT03466411|594786549|FG000|Overall Study|Withdrawal by Subject|14|||
164661906|NCT03466411|594786550|FG001|Overall Study|Withdrawal by Subject|7|||
164661907|NCT03466411|594786551|FG002|Overall Study|Withdrawal by Subject|8|||
164661908|NCT03466411|594786552|FG003|Overall Study|Withdrawal by Subject|4|||
164661909|NCT03466411|594786553|FG004|Overall Study|Withdrawal by Subject|6|||
164314817|NCT01818752|593529773|FG000|Overall Study|Other|7|||
164557927|NCT02064387|594411722|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
164557928|NCT02064387|594411723|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
164557929|NCT02064387|594411724|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
164557930|NCT02064387|594411725|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
164557931|NCT02064387|594411726|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
164557932|NCT02064387|594411727|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
164557933|NCT02064387|594411728|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
164557934|NCT02064387|594411717|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
164557935|NCT02064387|594411718|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
164557936|NCT02064387|594411719|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
164557937|NCT02064387|594411720|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
164557938|NCT02064387|594411721|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
164557939|NCT02064387|594411722|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
164557940|NCT02064387|594411723|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
164557941|NCT02064387|594411724|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
164557942|NCT02064387|594411725|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
164557943|NCT02064387|594411726|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
164557944|NCT02064387|594411727|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
164557945|NCT02064387|594411728|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
164557946|NCT02064387|594411717|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
164557947|NCT02064387|594411718|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
164557948|NCT02064387|594411719|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
164557949|NCT02064387|594411720|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
164557950|NCT02064387|594411721|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
164557951|NCT02064387|594411722|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
164557952|NCT02064387|594411723|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
164557953|NCT02064387|594411724|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
164557954|NCT02064387|594411725|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
164557955|NCT02064387|594411726|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
164557956|NCT02064387|594411727|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
164557957|NCT02064387|594411728|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
164557958|NCT02064387|594411717|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
164557959|NCT02064387|594411718|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
164557960|NCT02064387|594411719|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
164557961|NCT02064387|594411720|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
164557962|NCT02064387|594411721|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
164557963|NCT02064387|594411722|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
164557964|NCT02064387|594411723|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
164557965|NCT02064387|594411724|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
164557966|NCT02064387|594411725|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
164557967|NCT02064387|594411726|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
164557968|NCT02064387|594411727|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
164557969|NCT02064387|594411728|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
164557970|NCT02436876|594411730|FG000|Overall Study|Lost to Follow-up|0|||
164557971|NCT02436876|594411731|FG001|Overall Study|Lost to Follow-up|1|||
164557972|NCT02436876|594411732|FG002|Overall Study|Lost to Follow-up|1|||
164557973|NCT02436876|594411733|FG003|Overall Study|Lost to Follow-up|1|||
164557974|NCT02436876|594411730|FG000|Overall Study|Withdrawal by Subject|1|||
164557975|NCT02436876|594411731|FG001|Overall Study|Withdrawal by Subject|0|||
164557976|NCT02436876|594411732|FG002|Overall Study|Withdrawal by Subject|0|||
164557977|NCT02436876|594411733|FG003|Overall Study|Withdrawal by Subject|1|||
164557978|NCT02436876|594411730|FG000|Overall Study|Physician Decision|0|||
164557979|NCT02436876|594411731|FG001|Overall Study|Physician Decision|2|||
164557980|NCT02436876|594411732|FG002|Overall Study|Physician Decision|1|||
164557981|NCT02436876|594411733|FG003|Overall Study|Physician Decision|0|||
164557982|NCT02436876|594411730|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
164557983|NCT02436876|594411731|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
164557984|NCT02436876|594411732|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
164557985|NCT02436876|594411733|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
164557986|NCT00075504|594411734|FG000|Overall Study|Withdrawal by Subject|9|||
164557987|NCT00075504|594411735|FG001|Overall Study|Withdrawal by Subject|7|||
164557988|NCT03127384|594411740|FG000|Overall Study|Lost to Follow-up|4|||
164557989|NCT03127384|594411740|FG000|Overall Study|Subject request|2|||
164557990|NCT00689871|594411741|FG000|Overall Study|Lost to Follow-up|123|||
164557991|NCT00689871|594411742|FG001|Overall Study|Lost to Follow-up|13|||
164314818|NCT01818752|593529774|FG001|Overall Study|Other|8|||
164661910|NCT03466411|594786554|FG005|Overall Study|Withdrawal by Subject|3|||
164661911|NCT03466411|594786555|FG006|Overall Study|Withdrawal by Subject|6|||
164661912|NCT03466411|594786556|FG007|Overall Study|Withdrawal by Subject|9|||
164661913|NCT03466411|594786557|FG008|Overall Study|Withdrawal by Subject|6|||
164661914|NCT03466411|594786558|FG009|Overall Study|Withdrawal by Subject|11|||
164661915|NCT03466411|594786559|FG010|Overall Study|Withdrawal by Subject|14|||
164661916|NCT03466411|594786560|FG011|Overall Study|Withdrawal by Subject|12|||
164557992|NCT00689871|594411743|FG002|Overall Study|Lost to Follow-up|37|||
164557993|NCT00689871|594411744|FG003|Overall Study|Lost to Follow-up|1|||
164557994|NCT00689871|594411741|FG000|Overall Study|Explanted of All Study Devices|36|||
164557995|NCT00689871|594411742|FG001|Overall Study|Explanted of All Study Devices|25|||
164557996|NCT00689871|594411743|FG002|Overall Study|Explanted of All Study Devices|29|||
164557997|NCT00689871|594411744|FG003|Overall Study|Explanted of All Study Devices|3|||
164557998|NCT00689871|594411741|FG000|Overall Study|Withdrawal by Subject|13|||
164557999|NCT00689871|594411742|FG001|Overall Study|Withdrawal by Subject|3|||
164558000|NCT00689871|594411743|FG002|Overall Study|Withdrawal by Subject|4|||
164558001|NCT00689871|594411744|FG003|Overall Study|Withdrawal by Subject|1|||
164558002|NCT00689871|594411741|FG000|Overall Study|Death|1|||
164558003|NCT00689871|594411742|FG001|Overall Study|Death|10|||
164558004|NCT00689871|594411743|FG002|Overall Study|Death|2|||
164558005|NCT00689871|594411744|FG003|Overall Study|Death|2|||
164558006|NCT00689871|594411741|FG000|Overall Study|Physician Decision|2|||
164558007|NCT00689871|594411742|FG001|Overall Study|Physician Decision|1|||
164558008|NCT00689871|594411743|FG002|Overall Study|Physician Decision|1|||
164558009|NCT00689871|594411744|FG003|Overall Study|Physician Decision|0|||
164558010|NCT00137111|594411762|FG000|Total Therapy|Death|35|||
164558011|NCT00137111|594411763|FG001|Total Therapy|Death|0|||
164558012|NCT00137111|594411764|FG002|Total Therapy|Death|0|||
164558013|NCT00137111|594411765|FG003|Total Therapy|Death|0|||
164558014|NCT00137111|594411762|FG000|Total Therapy|Non Compliance|5|||
164558015|NCT00137111|594411763|FG001|Total Therapy|Non Compliance|0|||
164558016|NCT00137111|594411764|FG002|Total Therapy|Non Compliance|0|||
164558017|NCT00137111|594411765|FG003|Total Therapy|Non Compliance|0|||
164558018|NCT04417894|594411766|FG000|Overall Study|Lost to Follow-up|3|||
164558019|NCT04417894|594411767|FG001|Overall Study|Lost to Follow-up|0|||
164558020|NCT04417894|594411766|FG000|Overall Study|Withdrawal by Subject|7|||
164558021|NCT04417894|594411767|FG001|Overall Study|Withdrawal by Subject|6|||
164558022|NCT04417894|594411766|FG000|Overall Study|Lack of Efficacy|3|||
164558023|NCT04417894|594411767|FG001|Overall Study|Lack of Efficacy|1|||
164558024|NCT00262873|594411768|FG000|Overall Study|Adverse Event|3|||
164558025|NCT00262873|594411768|FG000|Overall Study|Withdrawal by Subject|5|||
164558026|NCT00844753|594411769|FG000|Overall Study|Lack of Efficacy|1|||
164558027|NCT00844753|594411770|FG001|Overall Study|Lack of Efficacy|0|||
164558028|NCT00844753|594411771|FG002|Overall Study|Lack of Efficacy|2|||
164558029|NCT00844753|594411772|FG003|Overall Study|Lack of Efficacy|2|||
164558030|NCT00844753|594411769|FG000|Overall Study|Adverse Event|3|||
164558031|NCT00844753|594411770|FG001|Overall Study|Adverse Event|2|||
164558032|NCT00844753|594411771|FG002|Overall Study|Adverse Event|5|||
164558033|NCT00844753|594411772|FG003|Overall Study|Adverse Event|5|||
164558034|NCT00844753|594411769|FG000|Overall Study|Lost to Follow-up|1|||
164558035|NCT00844753|594411770|FG001|Overall Study|Lost to Follow-up|1|||
164558036|NCT00844753|594411771|FG002|Overall Study|Lost to Follow-up|0|||
164558037|NCT00844753|594411772|FG003|Overall Study|Lost to Follow-up|1|||
164558038|NCT00844753|594411769|FG000|Overall Study|could not swallow medication|2|||
164558039|NCT00844753|594411770|FG001|Overall Study|could not swallow medication|0|||
164558040|NCT00844753|594411771|FG002|Overall Study|could not swallow medication|0|||
164558041|NCT00844753|594411772|FG003|Overall Study|could not swallow medication|0|||
164558042|NCT00844753|594411769|FG000|Overall Study|Withdrawal by Subject|1|||
164558043|NCT00844753|594411770|FG001|Overall Study|Withdrawal by Subject|0|||
164558044|NCT00844753|594411771|FG002|Overall Study|Withdrawal by Subject|0|||
164558045|NCT00844753|594411772|FG003|Overall Study|Withdrawal by Subject|3|||
164558046|NCT03074474|594411775|FG000|Overall Study|Lost to Follow-up|10|||
164558047|NCT03074474|594411775|FG000|Overall Study|Withdrawal by Subject|10|||
164558048|NCT03074474|594411775|FG000|Overall Study|Death|4|||
164558049|NCT03074474|594411775|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
164558050|NCT02508194|594411784|FG000|Overall Study|Death|5|||
164558051|NCT02508194|594411785|FG001|Overall Study|Death|3|||
164558052|NCT02508194|594411784|FG000|Overall Study|Lost to Follow-up|25|||
164558053|NCT02508194|594411785|FG001|Overall Study|Lost to Follow-up|18|||
164558054|NCT02508194|594411784|FG000|Overall Study|Withdrawal by Subject|20|||
164558055|NCT02508194|594411785|FG001|Overall Study|Withdrawal by Subject|18|||
164558056|NCT02508194|594411784|FG000|Overall Study|Error in Randomization|1|||
164558057|NCT02508194|594411785|FG001|Overall Study|Error in Randomization|3|||
164558058|NCT02508194|594411784|FG000|Overall Study|Principal Investigator Decision|1|||
164558059|NCT02508194|594411785|FG001|Overall Study|Principal Investigator Decision|2|||
164558060|NCT05073458|594411789|FG000|24-week Double-blind Period|Adverse Event|1|||
164558061|NCT05073458|594411790|FG001|24-week Double-blind Period|Adverse Event|0|||
164558062|NCT05073458|594411789|FG000|24-week Double-blind Period|Physician Decision|1|||
164558063|NCT05073458|594411790|FG001|24-week Double-blind Period|Physician Decision|0|||
164558064|NCT05073458|594411789|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
164558065|NCT05073458|594411790|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
164558066|NCT05073458|594411789|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
164558067|NCT05073458|594411790|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
164558068|NCT05073458|594411789|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
164558069|NCT05073458|594411790|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
164558070|NCT05073458|594411789|FG000|24-week Open-label Period|Adverse Event|1|||
164558071|NCT05073458|594411790|FG001|24-week Open-label Period|Adverse Event|2|||
164558072|NCT03892746|594411798|FG000|Overall Study|Withdrawal by Subject|2|||
164558073|NCT03892746|594411799|FG001|Overall Study|Withdrawal by Subject|1|||
164558074|NCT03892746|594411798|FG000|Overall Study|Lost to Follow-up|2|||
164558075|NCT03892746|594411799|FG001|Overall Study|Lost to Follow-up|0|||
164558076|NCT03977467|594411800|FG000|Overall Study|Disease Progression|1|||
164558077|NCT03977467|594411801|FG001|Overall Study|Disease Progression|1|||
164558078|NCT03977467|594411802|FG002|Overall Study|Disease Progression|30|||
164558079|NCT03977467|594411803|FG003|Overall Study|Disease Progression|0|||
164558080|NCT03977467|594411800|FG000|Overall Study|Adverse Event|0|||
164558081|NCT03977467|594411801|FG001|Overall Study|Adverse Event|1|||
164558082|NCT03977467|594411802|FG002|Overall Study|Adverse Event|0|||
164558083|NCT03977467|594411803|FG003|Overall Study|Adverse Event|0|||
164558084|NCT03977467|594411800|FG000|Overall Study|Death|0|||
164558085|NCT03977467|594411801|FG001|Overall Study|Death|0|||
164558086|NCT03977467|594411802|FG002|Overall Study|Death|3|||
164558087|NCT03977467|594411803|FG003|Overall Study|Death|0|||
164558088|NCT03977467|594411800|FG000|Overall Study|Lack of Efficacy|0|||
164558089|NCT03977467|594411801|FG001|Overall Study|Lack of Efficacy|0|||
164558090|NCT03977467|594411802|FG002|Overall Study|Lack of Efficacy|1|||
164558091|NCT03977467|594411803|FG003|Overall Study|Lack of Efficacy|0|||
164558092|NCT03977467|594411800|FG000|Overall Study|Withdrawal by Subject|2|||
164558093|NCT03977467|594411801|FG001|Overall Study|Withdrawal by Subject|1|||
164558094|NCT03977467|594411802|FG002|Overall Study|Withdrawal by Subject|4|||
164558095|NCT03977467|594411803|FG003|Overall Study|Withdrawal by Subject|0|||
164558096|NCT03977467|594411800|FG000|Overall Study|Study Terminated|1|||
164558097|NCT03977467|594411801|FG001|Overall Study|Study Terminated|0|||
164558098|NCT03977467|594411802|FG002|Overall Study|Study Terminated|0|||
164558099|NCT03977467|594411803|FG003|Overall Study|Study Terminated|1|||
164558100|NCT05913232|594411804|FG000|Overall Study|Adverse Event|0|||
164558101|NCT05913232|594411805|FG001|Overall Study|Adverse Event|2|||
164558102|NCT05913232|594411806|FG002|Overall Study|Adverse Event|1|||
164558103|NCT05913232|594411807|FG003|Overall Study|Adverse Event|1|||
164558104|NCT03124563|594411813|FG000|Overall Study|Lost to Follow-up|1|||
164558105|NCT03124563|594411814|FG001|Overall Study|Lost to Follow-up|1|||
164558106|NCT03124563|594411813|FG000|Overall Study|Withdrawal by Subject|1|||
164558107|NCT03124563|594411814|FG001|Overall Study|Withdrawal by Subject|1|||
164558108|NCT04745689|594411817|FG000|Overall Study|Death|9|||
164558109|NCT04745689|594411818|FG001|Overall Study|Death|6|||
164558110|NCT04745689|594411817|FG000|Overall Study|Lost to Follow-up|1|||
164558111|NCT04745689|594411818|FG001|Overall Study|Lost to Follow-up|0|||
164558112|NCT04745689|594411817|FG000|Overall Study|Withdrawal by Subject|2|||
164558113|NCT04745689|594411818|FG001|Overall Study|Withdrawal by Subject|0|||
164558114|NCT04745689|594411817|FG000|Overall Study|Study terminated by sponsor|10|||
164558115|NCT04745689|594411818|FG001|Overall Study|Study terminated by sponsor|3|||
164558116|NCT04316585|594413425|FG000|Overall Study|Adverse Event|2|||
164558117|NCT04316585|594413426|FG001|Overall Study|Adverse Event|1|||
164558118|NCT04316585|594413425|FG000|Overall Study|Lost to Follow-up|1|||
164558119|NCT04316585|594413426|FG001|Overall Study|Lost to Follow-up|0|||
164558120|NCT04316585|594413425|FG000|Overall Study|Withdrawal by Subject|2|||
164558121|NCT04316585|594413426|FG001|Overall Study|Withdrawal by Subject|3|||
164558122|NCT04316585|594413425|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
164558123|NCT04316585|594413426|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
164558124|NCT04316585|594413425|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
164558125|NCT04316585|594413426|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
164558126|NCT03118297|594413427|FG000|Overall Study|Lost to Follow-up|0|||
164558127|NCT03118297|594413428|FG001|Overall Study|Lost to Follow-up|2|||
164558128|NCT01121393|594413429|FG000|Overall Study|Progressive disease|201|||
164558129|NCT01121393|594413430|FG001|Overall Study|Progressive disease|20|||
164558130|NCT01121393|594413429|FG000|Overall Study|Other Adverse events|24|||
164661917|NCT03466411|594786561|FG012|Overall Study|Withdrawal by Subject|7|||
164661918|NCT03466411|594786549|FG000|Overall Study|Other|1|||
164661919|NCT03466411|594786550|FG001|Overall Study|Other|1|||
164661920|NCT03466411|594786551|FG002|Overall Study|Other|0|||
164661921|NCT03466411|594786552|FG003|Overall Study|Other|1|||
164661922|NCT03466411|594786553|FG004|Overall Study|Other|2|||
164661923|NCT03466411|594786554|FG005|Overall Study|Other|0|||
164661924|NCT03466411|594786555|FG006|Overall Study|Other|0|||
164661925|NCT03466411|594786556|FG007|Overall Study|Other|0|||
164661926|NCT03466411|594786557|FG008|Overall Study|Other|0|||
164661927|NCT03466411|594786558|FG009|Overall Study|Other|1|||
164661928|NCT03466411|594786559|FG010|Overall Study|Other|2|||
164661929|NCT03466411|594786560|FG011|Overall Study|Other|0|||
164661930|NCT03466411|594786561|FG012|Overall Study|Other|0|||
164661931|NCT03466411|594786549|FG000|Overall Study|Randomized but not Treated|0|||
164661932|NCT03466411|594786550|FG001|Overall Study|Randomized but not Treated|0|||
164661933|NCT03466411|594786551|FG002|Overall Study|Randomized but not Treated|0|||
164661934|NCT03466411|594786552|FG003|Overall Study|Randomized but not Treated|0|||
164661935|NCT03466411|594786553|FG004|Overall Study|Randomized but not Treated|0|||
164661936|NCT03466411|594786554|FG005|Overall Study|Randomized but not Treated|0|||
164661937|NCT03466411|594786555|FG006|Overall Study|Randomized but not Treated|1|||
164661938|NCT03466411|594786556|FG007|Overall Study|Randomized but not Treated|0|||
164661939|NCT03466411|594786557|FG008|Overall Study|Randomized but not Treated|0|||
164661940|NCT03466411|594786558|FG009|Overall Study|Randomized but not Treated|0|||
164661941|NCT03466411|594786559|FG010|Overall Study|Randomized but not Treated|0|||
164661942|NCT03466411|594786560|FG011|Overall Study|Randomized but not Treated|0|||
164661943|NCT03466411|594786561|FG012|Overall Study|Randomized but not Treated|0|||
164661944|NCT03462719|594786562|FG000|Overall Study|Withdrawal by Subject|4|||
164661945|NCT03462719|594786563|FG001|Overall Study|Withdrawal by Subject|3|||
164661946|NCT03462719|594786562|FG000|Overall Study|Ongoing|87|||
164661947|NCT03462719|594786563|FG001|Overall Study|Ongoing|72|||
164661948|NCT04799158|594786564|FG000|Run-In Period|Adverse Event|6|||
164661949|NCT04799158|594786565|FG001|Run-In Period|Adverse Event|0|||
164661950|NCT04799158|594786566|FG002|Run-In Period|Adverse Event|0|||
164661951|NCT04799158|594786567|FG003|Run-In Period|Adverse Event|0|||
164661952|NCT04799158|594786568|FG004|Run-In Period|Adverse Event|0|||
164661953|NCT04799158|594786564|FG000|Run-In Period|Lost to Follow-up|4|||
164661954|NCT04799158|594786565|FG001|Run-In Period|Lost to Follow-up|0|||
164661955|NCT04799158|594786566|FG002|Run-In Period|Lost to Follow-up|0|||
164558131|NCT01121393|594413430|FG001|Overall Study|Other Adverse events|45|||
164558132|NCT01121393|594413429|FG000|Overall Study|Non-compliant with protocol|0|||
164558133|NCT01121393|594413430|FG001|Overall Study|Non-compliant with protocol|3|||
164558134|NCT01121393|594413429|FG000|Overall Study|Lost to Follow-up|1|||
164558135|NCT01121393|594413430|FG001|Overall Study|Lost to Follow-up|0|||
164558136|NCT01121393|594413429|FG000|Overall Study|Refused cont. medication|7|||
164558137|NCT01121393|594413430|FG001|Overall Study|Refused cont. medication|7|||
164558138|NCT01121393|594413429|FG000|Overall Study|Not treated|3|||
164558139|NCT01121393|594413430|FG001|Overall Study|Not treated|9|||
164558140|NCT01121393|594413429|FG000|Overall Study|Other than listed|6|||
164558141|NCT01121393|594413430|FG001|Overall Study|Other than listed|0|||
164558142|NCT00608985|594413437|FG000|Overall Study|Adverse Event|2|||
164558143|NCT00608985|594413438|FG001|Overall Study|Adverse Event|7|||
164558144|NCT00608985|594413439|FG002|Overall Study|Adverse Event|4|||
164558145|NCT00608985|594413440|FG003|Overall Study|Adverse Event|6|||
164558146|NCT00608985|594413437|FG000|Overall Study|Administrative/Other|7|||
164558147|NCT00608985|594413438|FG001|Overall Study|Administrative/Other|4|||
164558148|NCT00608985|594413439|FG002|Overall Study|Administrative/Other|1|||
164558149|NCT00608985|594413440|FG003|Overall Study|Administrative/Other|2|||
164558150|NCT00608985|594413437|FG000|Overall Study|Withdrawal of Consent|5|||
164661956|NCT04799158|594786567|FG003|Run-In Period|Lost to Follow-up|0|||
164661957|NCT04799158|594786568|FG004|Run-In Period|Lost to Follow-up|0|||
164558151|NCT00608985|594413438|FG001|Overall Study|Withdrawal of Consent|1|||
164558152|NCT00608985|594413439|FG002|Overall Study|Withdrawal of Consent|1|||
164661958|NCT04799158|594786564|FG000|Run-In Period|Significant Protocol Deviation|1|||
164661959|NCT04799158|594786565|FG001|Run-In Period|Significant Protocol Deviation|0|||
164661960|NCT04799158|594786566|FG002|Run-In Period|Significant Protocol Deviation|0|||
164661961|NCT04799158|594786567|FG003|Run-In Period|Significant Protocol Deviation|0|||
164661962|NCT04799158|594786568|FG004|Run-In Period|Significant Protocol Deviation|0|||
164661963|NCT04799158|594786564|FG000|Run-In Period|Withdrawal by Subject|11|||
164661964|NCT04799158|594786565|FG001|Run-In Period|Withdrawal by Subject|0|||
164661965|NCT04799158|594786566|FG002|Run-In Period|Withdrawal by Subject|0|||
164661966|NCT04799158|594786567|FG003|Run-In Period|Withdrawal by Subject|0|||
164661967|NCT04799158|594786568|FG004|Run-In Period|Withdrawal by Subject|0|||
164661968|NCT04799158|594786564|FG000|Run-In Period|Miscellaneous|3|||
164558153|NCT00608985|594413440|FG003|Overall Study|Withdrawal of Consent|1|||
164558154|NCT00608985|594413437|FG000|Overall Study|Lost to Follow-up|2|||
164558155|NCT00608985|594413438|FG001|Overall Study|Lost to Follow-up|1|||
164558156|NCT00608985|594413439|FG002|Overall Study|Lost to Follow-up|0|||
164558157|NCT00608985|594413440|FG003|Overall Study|Lost to Follow-up|0|||
164661969|NCT04799158|594786565|FG001|Run-In Period|Miscellaneous|0|||
164661970|NCT04799158|594786566|FG002|Run-In Period|Miscellaneous|0|||
164661971|NCT04799158|594786567|FG003|Run-In Period|Miscellaneous|0|||
164661972|NCT04799158|594786568|FG004|Run-In Period|Miscellaneous|0|||
164661973|NCT04799158|594786564|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
164661974|NCT04799158|594786565|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
164661975|NCT04799158|594786566|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
164661976|NCT04799158|594786567|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
164661977|NCT04799158|594786568|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
164661978|NCT04799158|594786564|FG000|On-Demand Treatment Period|Adverse Event|0|||
164661979|NCT04799158|594786565|FG001|On-Demand Treatment Period|Adverse Event|1|||
164661980|NCT04799158|594786566|FG002|On-Demand Treatment Period|Adverse Event|0|||
164661981|NCT04799158|594786567|FG003|On-Demand Treatment Period|Adverse Event|0|||
164661982|NCT04799158|594786568|FG004|On-Demand Treatment Period|Adverse Event|1|||
164661983|NCT04799158|594786564|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
164661984|NCT04799158|594786565|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
164661985|NCT04799158|594786566|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
164558158|NCT00661271|594413441|FG000|Overall Study|Lost to Follow-up|28|||
164558159|NCT00661271|594413442|FG001|Overall Study|Lost to Follow-up|25|||
164558160|NCT00953758|594413445|FG000|Overall Study|Death|2|||
164558161|NCT00953758|594413446|FG001|Overall Study|Death|0|||
164558162|NCT00953758|594413447|FG002|Overall Study|Death|1|||
164558163|NCT00953758|594413448|FG003|Overall Study|Death|1|||
164558164|NCT00953758|594413449|FG004|Overall Study|Death|1|||
164558165|NCT00953758|594413450|FG005|Overall Study|Death|1|||
164558166|NCT00953758|594413451|FG006|Overall Study|Death|1|||
164558167|NCT00953758|594413452|FG007|Overall Study|Death|3|||
164558168|NCT00953758|594413453|FG008|Overall Study|Death|1|||
164558169|NCT00953758|594413454|FG009|Overall Study|Death|0|||
164558170|NCT00953758|594413445|FG000|Overall Study|Participant refused further follow-up|0|||
164558171|NCT00953758|594413446|FG001|Overall Study|Participant refused further follow-up|0|||
164558172|NCT00953758|594413447|FG002|Overall Study|Participant refused further follow-up|1|||
164558173|NCT00953758|594413448|FG003|Overall Study|Participant refused further follow-up|0|||
164558174|NCT00953758|594413449|FG004|Overall Study|Participant refused further follow-up|3|||
164558175|NCT00953758|594413450|FG005|Overall Study|Participant refused further follow-up|0|||
164558176|NCT00953758|594413451|FG006|Overall Study|Participant refused further follow-up|0|||
164558177|NCT00953758|594413452|FG007|Overall Study|Participant refused further follow-up|0|||
164558178|NCT00953758|594413453|FG008|Overall Study|Participant refused further follow-up|1|||
164558179|NCT00953758|594413454|FG009|Overall Study|Participant refused further follow-up|0|||
164558180|NCT00953758|594413445|FG000|Overall Study|Lost to Follow-up|0|||
164558181|NCT00953758|594413446|FG001|Overall Study|Lost to Follow-up|0|||
164558182|NCT00953758|594413447|FG002|Overall Study|Lost to Follow-up|0|||
164558183|NCT00953758|594413448|FG003|Overall Study|Lost to Follow-up|1|||
164558184|NCT00953758|594413449|FG004|Overall Study|Lost to Follow-up|0|||
164558185|NCT00953758|594413450|FG005|Overall Study|Lost to Follow-up|0|||
164558186|NCT00953758|594413451|FG006|Overall Study|Lost to Follow-up|0|||
164558187|NCT00953758|594413452|FG007|Overall Study|Lost to Follow-up|1|||
164558188|NCT00953758|594413453|FG008|Overall Study|Lost to Follow-up|0|||
164558189|NCT00953758|594413454|FG009|Overall Study|Lost to Follow-up|1|||
164661986|NCT04799158|594786567|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
164661987|NCT04799158|594786568|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
164661988|NCT04799158|594786564|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
164661989|NCT04799158|594786565|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
164661990|NCT04799158|594786566|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
164661991|NCT04799158|594786567|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
164661992|NCT04799158|594786568|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
164661993|NCT04799158|594786564|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
164661994|NCT04799158|594786565|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
164661995|NCT04799158|594786566|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
164661996|NCT04799158|594786567|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
164558190|NCT00953758|594413445|FG000|Overall Study|Physician Decision|0|||
164558191|NCT00953758|594413446|FG001|Overall Study|Physician Decision|0|||
164558192|NCT00953758|594413447|FG002|Overall Study|Physician Decision|0|||
164558193|NCT00953758|594413448|FG003|Overall Study|Physician Decision|0|||
164558194|NCT00953758|594413449|FG004|Overall Study|Physician Decision|1|||
164558195|NCT00953758|594413450|FG005|Overall Study|Physician Decision|0|||
164558196|NCT00953758|594413451|FG006|Overall Study|Physician Decision|0|||
164558197|NCT00953758|594413452|FG007|Overall Study|Physician Decision|0|||
164558198|NCT00953758|594413453|FG008|Overall Study|Physician Decision|0|||
164661997|NCT04799158|594786568|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
164661998|NCT04799158|594786564|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
164558199|NCT00953758|594413454|FG009|Overall Study|Physician Decision|0|||
164558200|NCT00953758|594413445|FG000|Overall Study|Disease progression|0|||
164558201|NCT00953758|594413446|FG001|Overall Study|Disease progression|0|||
164558202|NCT00953758|594413447|FG002|Overall Study|Disease progression|0|||
164661999|NCT04799158|594786565|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
164662000|NCT04799158|594786566|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
164662001|NCT04799158|594786567|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
164662002|NCT04799158|594786568|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
164662003|NCT04799158|594786564|FG000|On-Demand Treatment Period|Miscellaneous|0|||
164662004|NCT04799158|594786565|FG001|On-Demand Treatment Period|Miscellaneous|0|||
164662005|NCT04799158|594786566|FG002|On-Demand Treatment Period|Miscellaneous|0|||
164662006|NCT04799158|594786567|FG003|On-Demand Treatment Period|Miscellaneous|0|||
164662007|NCT04799158|594786568|FG004|On-Demand Treatment Period|Miscellaneous|1|||
164662008|NCT02607800|594786569|FG000|Overall Study|Lost to Follow-up|7|||
164662009|NCT02607800|594786570|FG001|Overall Study|Lost to Follow-up|10|||
164662010|NCT02607800|594786569|FG000|Overall Study|Withdrew Consent|2|||
164662011|NCT02607800|594786570|FG001|Overall Study|Withdrew Consent|0|||
164662012|NCT02607800|594786569|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
164662013|NCT02607800|594786570|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
164662014|NCT01185288|594786571|FG000|Overall Study|Adverse Event|7|||
164662015|NCT01185288|594786572|FG001|Overall Study|Adverse Event|6|||
164662016|NCT01185288|594786571|FG000|Overall Study|Withdrawal by Subject|6|||
164662017|NCT01185288|594786572|FG001|Overall Study|Withdrawal by Subject|4|||
164662018|NCT01185288|594786571|FG000|Overall Study|Lost to Follow-up|2|||
164662019|NCT01185288|594786572|FG001|Overall Study|Lost to Follow-up|5|||
164662020|NCT01185288|594786571|FG000|Overall Study|Lack of Efficacy|2|||
164662021|NCT01185288|594786572|FG001|Overall Study|Lack of Efficacy|0|||
164662022|NCT01185288|594786571|FG000|Overall Study|Investigator discretion|1|||
164662023|NCT01185288|594786572|FG001|Overall Study|Investigator discretion|0|||
164662024|NCT01185288|594786571|FG000|Overall Study|Did not meet inclusion criteria|1|||
164662025|NCT01185288|594786572|FG001|Overall Study|Did not meet inclusion criteria|0|||
164662026|NCT01185288|594786571|FG000|Overall Study|Noncompliance|0|||
164662027|NCT01185288|594786572|FG001|Overall Study|Noncompliance|1|||
164662028|NCT01202747|594786573|FG000|Overall Study|Withdrawal by Subject|1|||
164662029|NCT01446913|594786574|FG000|Overall Study|Significant illness|1|||
164662030|NCT01446913|594786575|FG001|Overall Study|Significant illness|1|||
164662031|NCT01446913|594786576|FG002|Overall Study|Significant illness|1|||
164662032|NCT01446913|594786574|FG000|Overall Study|Withdrawal by Subject|5|||
164662033|NCT01446913|594786575|FG001|Overall Study|Withdrawal by Subject|3|||
164662034|NCT01446913|594786576|FG002|Overall Study|Withdrawal by Subject|5|||
164662035|NCT01446913|594786574|FG000|Overall Study|Physician Decision|0|||
164662036|NCT01446913|594786575|FG001|Overall Study|Physician Decision|0|||
164662037|NCT01446913|594786576|FG002|Overall Study|Physician Decision|2|||
164558203|NCT00953758|594413448|FG003|Overall Study|Disease progression|0|||
164558204|NCT00953758|594413449|FG004|Overall Study|Disease progression|1|||
164558205|NCT00953758|594413450|FG005|Overall Study|Disease progression|0|||
164558206|NCT00953758|594413451|FG006|Overall Study|Disease progression|0|||
164558207|NCT00953758|594413452|FG007|Overall Study|Disease progression|0|||
164558208|NCT00953758|594413453|FG008|Overall Study|Disease progression|0|||
164558209|NCT00953758|594413454|FG009|Overall Study|Disease progression|0|||
164558210|NCT00953758|594413445|FG000|Overall Study|Participant went for transplant|0|||
164558211|NCT00953758|594413446|FG001|Overall Study|Participant went for transplant|0|||
164558212|NCT00953758|594413447|FG002|Overall Study|Participant went for transplant|0|||
164558213|NCT00953758|594413448|FG003|Overall Study|Participant went for transplant|0|||
164558214|NCT00953758|594413449|FG004|Overall Study|Participant went for transplant|0|||
164558215|NCT00953758|594413450|FG005|Overall Study|Participant went for transplant|0|||
164558216|NCT00953758|594413451|FG006|Overall Study|Participant went for transplant|0|||
164558217|NCT00953758|594413452|FG007|Overall Study|Participant went for transplant|0|||
164558218|NCT00953758|594413453|FG008|Overall Study|Participant went for transplant|1|||
164558219|NCT00953758|594413454|FG009|Overall Study|Participant went for transplant|0|||
164558220|NCT00706030|594413456|FG000|Overall Study|Disease Progression|4|||
164558221|NCT00706030|594413457|FG001|Overall Study|Disease Progression|6|||
164558222|NCT00706030|594413458|FG002|Overall Study|Disease Progression|46|||
164558223|NCT00706030|594413459|FG003|Overall Study|Disease Progression|12|||
164558224|NCT00706030|594413456|FG000|Overall Study|Adverse Event|1|||
164558225|NCT00706030|594413457|FG001|Overall Study|Adverse Event|0|||
164558226|NCT00706030|594413458|FG002|Overall Study|Adverse Event|4|||
164558227|NCT00706030|594413459|FG003|Overall Study|Adverse Event|2|||
164558228|NCT00706030|594413456|FG000|Overall Study|Withdrawal by Subject|1|||
164558229|NCT00706030|594413457|FG001|Overall Study|Withdrawal by Subject|0|||
164314819|NCT01818752|593529773|FG000|Overall Study|Continuing Treatment|1|||
164558230|NCT00706030|594413458|FG002|Overall Study|Withdrawal by Subject|2|||
164558231|NCT00706030|594413459|FG003|Overall Study|Withdrawal by Subject|0|||
164558232|NCT00706030|594413456|FG000|Overall Study|Physician Decision|0|||
164558233|NCT00706030|594413457|FG001|Overall Study|Physician Decision|0|||
164662038|NCT01446913|594786574|FG000|Overall Study|Lost to Follow-up|3|||
164662039|NCT01446913|594786575|FG001|Overall Study|Lost to Follow-up|5|||
164662040|NCT01446913|594786576|FG002|Overall Study|Lost to Follow-up|3|||
164662041|NCT00601484|594786581|FG000|Overall Study|Adverse Event|0|||
164662042|NCT00601484|594786582|FG001|Overall Study|Adverse Event|1|||
164314820|NCT01818752|593529774|FG001|Overall Study|Continuing Treatment|4|||
164662043|NCT00601484|594786581|FG000|Overall Study|Lost to Follow-up|4|||
164662044|NCT00601484|594786582|FG001|Overall Study|Lost to Follow-up|3|||
164662045|NCT00601484|594786581|FG000|Overall Study|Lack of Efficacy|0|||
164662046|NCT00601484|594786582|FG001|Overall Study|Lack of Efficacy|2|||
164662047|NCT00601484|594786581|FG000|Overall Study|Withdrawal by Subject|1|||
164662048|NCT00601484|594786582|FG001|Overall Study|Withdrawal by Subject|1|||
164662049|NCT00601484|594786581|FG000|Overall Study|Randomized, but not treated|0|||
164662050|NCT00601484|594786582|FG001|Overall Study|Randomized, but not treated|1|||
164662051|NCT02928848|594786583|FG000|Arm 2|Withdrawal by Subject|1|||
164662052|NCT02928848|594786584|FG001|Arm 2|Withdrawal by Subject|0|||
164662053|NCT00969332|594786585|FG000|Overall Study|Physician Decision|8|||
164662054|NCT00969332|594786585|FG000|Overall Study|Withdrawal by Subject|3|||
164662055|NCT03828461|594786586|FG000|Overall Study|Lost to Follow-up|1|||
164662056|NCT03828461|594786586|FG000|Overall Study|Withdrawal by Subject|3|||
164662057|NCT00663871|594786588|FG000|Overall Study|Lost to Follow-up|5|||
164662058|NCT00663871|594786589|FG001|Overall Study|Lost to Follow-up|5|||
164662059|NCT00663871|594786588|FG000|Overall Study|Withdrawal by Subject|5|||
164662060|NCT00663871|594786589|FG001|Overall Study|Withdrawal by Subject|2|||
164662061|NCT00582309|594786590|FG000|Overall Study|Protocol Violation|0|||
164662062|NCT00582309|594786591|FG001|Overall Study|Protocol Violation|0|||
164662063|NCT00582309|594786592|FG002|Overall Study|Protocol Violation|2|||
164662064|NCT03095352|594786596|FG000|Treatment assigned at enrollment|Withdrawal by Subject|1|||
164662065|NCT03095352|594786597|FG001|Treatment assigned at enrollment|Withdrawal by Subject|0|||
164558234|NCT00706030|594413458|FG002|Overall Study|Physician Decision|2|||
164558235|NCT00706030|594413459|FG003|Overall Study|Physician Decision|0|||
164558236|NCT00706030|594413456|FG000|Overall Study|Not recorded|0|||
164558237|NCT00706030|594413457|FG001|Overall Study|Not recorded|0|||
164558238|NCT00706030|594413458|FG002|Overall Study|Not recorded|2|||
164558239|NCT00706030|594413459|FG003|Overall Study|Not recorded|0|||
164558240|NCT00706030|594413456|FG000|Overall Study|Protocol Violation|0|||
164558241|NCT00706030|594413457|FG001|Overall Study|Protocol Violation|0|||
164558242|NCT00706030|594413458|FG002|Overall Study|Protocol Violation|1|||
164558243|NCT00706030|594413459|FG003|Overall Study|Protocol Violation|1|||
164558244|NCT00706030|594413456|FG000|Overall Study|Failed to return|0|||
164558245|NCT00706030|594413457|FG001|Overall Study|Failed to return|0|||
164558246|NCT00706030|594413458|FG002|Overall Study|Failed to return|1|||
164558247|NCT00706030|594413459|FG003|Overall Study|Failed to return|0|||
164558248|NCT00706030|594413456|FG000|Overall Study|Symptomatic Deterioration|0|||
164558249|NCT00706030|594413457|FG001|Overall Study|Symptomatic Deterioration|0|||
164558250|NCT00706030|594413458|FG002|Overall Study|Symptomatic Deterioration|1|||
164558251|NCT00706030|594413459|FG003|Overall Study|Symptomatic Deterioration|0|||
164558252|NCT00706030|594413456|FG000|Overall Study|No treatment received|0|||
164558253|NCT00706030|594413457|FG001|Overall Study|No treatment received|0|||
164558254|NCT00706030|594413458|FG002|Overall Study|No treatment received|0|||
164558255|NCT00706030|594413459|FG003|Overall Study|No treatment received|1|||
164558256|NCT00706030|594413456|FG000|Overall Study|Death|0|||
164558257|NCT00706030|594413457|FG001|Overall Study|Death|0|||
164558258|NCT00706030|594413458|FG002|Overall Study|Death|1|||
164558259|NCT00706030|594413459|FG003|Overall Study|Death|0|||
164558260|NCT05779072|594413460|FG000|Overall Study|Lost to Follow-up|0|||
164558261|NCT05779072|594413461|FG001|Overall Study|Lost to Follow-up|1|||
164558262|NCT05779072|594413460|FG000|Overall Study|Withdrawal by Subject|1|||
164558263|NCT05779072|594413461|FG001|Overall Study|Withdrawal by Subject|5|||
164558264|NCT03870555|594413462|FG000|Period 3 (2 Days)|Adverse Event|1|||
164558265|NCT03870555|594413463|FG001|Period 3 (2 Days)|Adverse Event|0|||
164558266|NCT03870555|594413464|FG002|Period 3 (2 Days)|Adverse Event|0|||
164558267|NCT00293579|594413465|FG000|Overall Study|Withdrawal by Subject|1|||
164558268|NCT03215771|594413466|FG000|Overall Study|Withdrawal by Subject|2|||
164558269|NCT03215771|594413466|FG000|Overall Study|Physician Decision|1|||
164662066|NCT02779855|594786598|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
164662067|NCT02779855|594786599|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
164662068|NCT02779855|594786600|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
164662069|NCT00319449|594786609|FG000|Overall Study|Subject did not wish to continue|1|||
164662070|NCT00319449|594786610|FG001|Overall Study|Subject did not wish to continue|0|||
164558270|NCT02703311|594413467|FG000|Overall Study|Death|5|||
164558271|NCT02703311|594413467|FG000|Overall Study|Withdrawal by Subject|3|||
164558272|NCT00343889|594413468|FG000|Overall Study|Lost to Follow-up|2|||
164558273|NCT00343889|594413469|FG001|Overall Study|Lost to Follow-up|0|||
164558274|NCT00343889|594413468|FG000|Overall Study|Withdrawal by Subject|0|||
164558275|NCT00343889|594413469|FG001|Overall Study|Withdrawal by Subject|1|||
164558276|NCT00343889|594413468|FG000|Overall Study|Protocol Violation|1|||
164558277|NCT00343889|594413469|FG001|Overall Study|Protocol Violation|0|||
164662071|NCT00319449|594786609|FG000|Overall Study|Noncompliance with the protocol|1|||
164662072|NCT00319449|594786610|FG001|Overall Study|Noncompliance with the protocol|0|||
164662073|NCT00365352|594786613|FG000|Overall Study|Adverse Event|6|||
164662074|NCT00365352|594786614|FG001|Overall Study|Adverse Event|7|||
164662075|NCT00365352|594786615|FG002|Overall Study|Adverse Event|8|||
164558278|NCT00088374|594413470|FG000|Overall Study|patient did not receive any 17AAG|1|||
164662076|NCT00365352|594786613|FG000|Overall Study|Participant Withdrew Consent|8|||
164662077|NCT00365352|594786614|FG001|Overall Study|Participant Withdrew Consent|3|||
164662078|NCT00365352|594786615|FG002|Overall Study|Participant Withdrew Consent|4|||
164662079|NCT00365352|594786613|FG000|Overall Study|Lack of Efficacy|3|||
164662080|NCT00365352|594786614|FG001|Overall Study|Lack of Efficacy|0|||
164662081|NCT00365352|594786615|FG002|Overall Study|Lack of Efficacy|0|||
164662082|NCT00365352|594786613|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
164662083|NCT00365352|594786614|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
164662084|NCT00365352|594786615|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
164662085|NCT00365352|594786613|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
164662086|NCT00365352|594786614|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
164662087|NCT00365352|594786615|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
164662088|NCT00365352|594786613|FG000|Overall Study|Lost to Follow-up|1|||
164662089|NCT00365352|594786614|FG001|Overall Study|Lost to Follow-up|1|||
164662090|NCT00365352|594786615|FG002|Overall Study|Lost to Follow-up|0|||
164662091|NCT00365352|594786613|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
164662092|NCT00365352|594786614|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
164662093|NCT00365352|594786615|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
164662094|NCT03708211|594786616|FG000|Overall Study|Progressive Disease|10|||
164662095|NCT03708211|594786617|FG001|Overall Study|Progressive Disease|7|||
164662096|NCT03708211|594786616|FG000|Overall Study|Withdrawal by Subject|0|||
164662097|NCT03708211|594786617|FG001|Overall Study|Withdrawal by Subject|1|||
164662098|NCT03708211|594786616|FG000|Overall Study|Other|2|||
164662099|NCT03708211|594786617|FG001|Overall Study|Other|0|||
164662100|NCT05328375|594787597|FG000|Overall Study|Withdrawal by Subject|0|||
164662101|NCT05328375|594787598|FG001|Overall Study|Withdrawal by Subject|1|||
164662102|NCT05514119|594787603|FG000|Overall Study|Ineligible due to disease progression|1|||
164662103|NCT02946385|594787604|FG000|Overall Study|Lost to Follow-up|0|||
164662104|NCT02946385|594787605|FG001|Overall Study|Lost to Follow-up|0|||
164662105|NCT02946385|594787606|FG002|Overall Study|Lost to Follow-up|3|||
164662106|NCT02946385|594787607|FG003|Overall Study|Lost to Follow-up|0|||
164662107|NCT02946385|594787608|FG004|Overall Study|Lost to Follow-up|2|||
164662108|NCT02946385|594787609|FG005|Overall Study|Lost to Follow-up|1|||
164662109|NCT00278200|594787620|FG000|Overall Study|Death|1|||
164662110|NCT00278200|594787621|FG001|Overall Study|Death|3|||
164662111|NCT00278200|594787620|FG000|Overall Study|Physician Decision|0|||
164662112|NCT00278200|594787621|FG001|Overall Study|Physician Decision|1|||
164662113|NCT02688400|594787627|FG000|Overall Study|Protocol Violation|2|||
164662114|NCT02688400|594787628|FG001|Overall Study|Protocol Violation|5|||
164662115|NCT02688400|594787627|FG000|Overall Study|Lack of Efficacy|7|||
164662116|NCT02688400|594787628|FG001|Overall Study|Lack of Efficacy|7|||
164662117|NCT02688400|594787627|FG000|Overall Study|Adverse Event|21|||
164662118|NCT02688400|594787628|FG001|Overall Study|Adverse Event|12|||
164662119|NCT02688400|594787627|FG000|Overall Study|Withdrawal by Subject|15|||
164662120|NCT02688400|594787628|FG001|Overall Study|Withdrawal by Subject|13|||
164662121|NCT02688400|594787627|FG000|Overall Study|No study medication intake|1|||
164662122|NCT02688400|594787628|FG001|Overall Study|No study medication intake|4|||
164662123|NCT02688400|594787627|FG000|Overall Study|Lost to Follow-up|0|||
164662124|NCT02688400|594787628|FG001|Overall Study|Lost to Follow-up|3|||
164662125|NCT03519256|594787641|FG000|Overall Study|Disease recurrence|4|||
164662126|NCT03519256|594787642|FG001|Overall Study|Disease recurrence|4|||
164662127|NCT03519256|594787643|FG002|Overall Study|Disease recurrence|5|||
164662128|NCT03519256|594787644|FG003|Overall Study|Disease recurrence|2|||
164662129|NCT03519256|594787641|FG000|Overall Study|Study drug toxicity|0|||
164662130|NCT03519256|594787642|FG001|Overall Study|Study drug toxicity|2|||
164662131|NCT03519256|594787643|FG002|Overall Study|Study drug toxicity|5|||
164662132|NCT03519256|594787644|FG003|Overall Study|Study drug toxicity|2|||
164662133|NCT03519256|594787641|FG000|Overall Study|Adverse event unrelated to study drug|0|||
164662134|NCT03519256|594787642|FG001|Overall Study|Adverse event unrelated to study drug|1|||
164204018|NCT01991795|593117891|FG000|Overall Study|Withdrawal by Subject|117|||
164204019|NCT01991795|593117892|FG001|Overall Study|Withdrawal by Subject|94|||
164204020|NCT01991795|593117891|FG000|Overall Study|Site prematurely closed by sponsor|26|||
164204021|NCT01991795|593117892|FG001|Overall Study|Site prematurely closed by sponsor|25|||
164204022|NCT02404545|593117893|FG000|Overall Study|Sponsor Termination|6|||
164662135|NCT03519256|594787643|FG002|Overall Study|Adverse event unrelated to study drug|1|||
164662136|NCT03519256|594787644|FG003|Overall Study|Adverse event unrelated to study drug|0|||
164662137|NCT03519256|594787641|FG000|Overall Study|Participant request to discontinue study treatment|0|||
164662138|NCT03519256|594787642|FG001|Overall Study|Participant request to discontinue study treatment|0|||
164662139|NCT03519256|594787643|FG002|Overall Study|Participant request to discontinue study treatment|0|||
164662140|NCT03519256|594787644|FG003|Overall Study|Participant request to discontinue study treatment|2|||
164662141|NCT03519256|594787641|FG000|Overall Study|Other reasons|0|||
164662142|NCT03519256|594787642|FG001|Overall Study|Other reasons|0|||
164204023|NCT02404545|593117894|FG001|Overall Study|Sponsor Termination|6|||
164204024|NCT02078817|593117897|FG000|Overall Study|Withdrawal by Subject|1|||
164204025|NCT00769561|593117899|FG000|Overall Study|Withdrawal by Subject|2|||
164662143|NCT03519256|594787643|FG002|Overall Study|Other reasons|2|||
164662144|NCT03519256|594787644|FG003|Overall Study|Other reasons|0|||
164662145|NCT03519256|594787641|FG000|Overall Study|Disease progression|6|||
164662146|NCT03519256|594787642|FG001|Overall Study|Disease progression|3|||
164662147|NCT03519256|594787643|FG002|Overall Study|Disease progression|2|||
164662148|NCT03519256|594787644|FG003|Overall Study|Disease progression|1|||
164662149|NCT03519256|594787641|FG000|Overall Study|Lost to Follow-up|0|||
164662150|NCT03519256|594787642|FG001|Overall Study|Lost to Follow-up|1|||
164662151|NCT03519256|594787643|FG002|Overall Study|Lost to Follow-up|0|||
164662152|NCT03519256|594787644|FG003|Overall Study|Lost to Follow-up|0|||
164662153|NCT02207231|594787645|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
164662154|NCT02207231|594787646|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
164662155|NCT02207231|594787647|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
164662156|NCT02207231|594787648|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
164662157|NCT02207231|594787645|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
164662158|NCT02207231|594787646|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
164662159|NCT02207231|594787647|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
164662160|NCT02207231|594787648|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
164662161|NCT02207231|594787645|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
164662162|NCT02207231|594787646|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
164662163|NCT02207231|594787647|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
164662164|NCT02207231|594787648|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
164662165|NCT02207231|594787645|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
164662166|NCT02207231|594787646|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
164662167|NCT02207231|594787647|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
164662168|NCT02207231|594787648|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
164662169|NCT02207231|594787645|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
164662170|NCT02207231|594787646|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
164662171|NCT02207231|594787647|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
164662172|NCT02207231|594787648|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
164662173|NCT02207231|594787645|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
164662174|NCT02207231|594787646|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
164662175|NCT02207231|594787647|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
164662176|NCT02207231|594787648|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
164662177|NCT02207231|594787645|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
164662178|NCT02207231|594787646|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
164662179|NCT02207231|594787647|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
164662180|NCT02207231|594787648|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
164662181|NCT02207231|594787645|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
164662182|NCT02207231|594787646|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
164662183|NCT02207231|594787647|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
164662184|NCT02207231|594787648|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
164662185|NCT02207231|594787645|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
164662186|NCT02207231|594787646|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
164662187|NCT02207231|594787647|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
164662188|NCT02207231|594787648|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
164662189|NCT02207231|594787645|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
164662190|NCT02207231|594787646|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
164662191|NCT02207231|594787647|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
164662192|NCT02207231|594787648|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
164662193|NCT02207231|594787645|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
164662194|NCT02207231|594787646|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
164662195|NCT02207231|594787647|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
164204026|NCT00769561|593117900|FG001|Overall Study|Withdrawal by Subject|2|||
164204027|NCT00769561|593117899|FG000|Overall Study|Lost to Follow-up|1|||
164662196|NCT02207231|594787648|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
164662197|NCT02207231|594787645|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
164662198|NCT02207231|594787646|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
164662199|NCT02207231|594787647|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
164204028|NCT00769561|593117900|FG001|Overall Study|Lost to Follow-up|3|||
164204029|NCT03824561|593117903|FG000|Overall Study|Protocol Violation|19|||
164204030|NCT03092752|593117907|FG000|Overall Study|Aged <40 years|14209|||
164204031|NCT03092752|593117907|FG000|Overall Study|At least one claim with T2DM|61299|||
164204032|NCT03092752|593117907|FG000|Overall Study|Having no claim of study drugs|29282|||
164204033|NCT03092752|593117907|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
164314821|NCT01818752|593529773|FG000|Overall Study|Randomized but not Dosed|7|||
164314822|NCT01818752|593529774|FG001|Overall Study|Randomized but not Dosed|4|||
164314823|NCT04629066|593529775|FG000|Overall Study|Lost to Follow-up|3|||
164662200|NCT02207231|594787648|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
164662201|NCT02207231|594787645|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
164662202|NCT02207231|594787646|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
164662203|NCT02207231|594787647|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
164662204|NCT02207231|594787648|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
164662205|NCT02207231|594787645|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
164662206|NCT02207231|594787646|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
164662207|NCT02207231|594787647|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
164662208|NCT02207231|594787648|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
164662209|NCT02207231|594787645|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
164662210|NCT02207231|594787646|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
164662211|NCT02207231|594787647|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
164662212|NCT02207231|594787648|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
164662213|NCT02207231|594787645|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
164662214|NCT02207231|594787646|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
164662215|NCT02207231|594787647|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
164662216|NCT02207231|594787648|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
164662217|NCT02207231|594787645|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
164662218|NCT02207231|594787646|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
164662219|NCT02207231|594787647|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
164662220|NCT02207231|594787648|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
164662221|NCT02207231|594787645|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
164662222|NCT02207231|594787646|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
164662223|NCT02207231|594787647|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
164662224|NCT02207231|594787648|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
164662225|NCT02207231|594787645|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
164662226|NCT02207231|594787646|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
164662227|NCT02207231|594787647|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
164662228|NCT02207231|594787648|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
164662229|NCT02207231|594787645|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
164662230|NCT02207231|594787646|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
164662231|NCT02207231|594787647|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
164662232|NCT02207231|594787648|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
164662233|NCT02207231|594787645|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
164662234|NCT02207231|594787646|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
164662235|NCT02207231|594787647|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
164662236|NCT02207231|594787648|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
164662237|NCT00421174|594787649|FG000|Overall Study|Withdrawal by Subject|0|||
164662238|NCT00421174|594787650|FG001|Overall Study|Withdrawal by Subject|1|||
164662239|NCT00421174|594787649|FG000|Overall Study|Ineligible due to infection|2|||
164662240|NCT00421174|594787650|FG001|Overall Study|Ineligible due to infection|0|||
164662241|NCT01290263|594787653|FG000|Overall Study|Adverse Event|0|||
164662242|NCT01290263|594787654|FG001|Overall Study|Adverse Event|0|||
164662243|NCT01290263|594787655|FG002|Overall Study|Adverse Event|0|||
164662244|NCT01290263|594787656|FG003|Overall Study|Adverse Event|1|||
164662245|NCT01290263|594787657|FG004|Overall Study|Adverse Event|1|||
164662246|NCT01290263|594787653|FG000|Overall Study|Lack of Efficacy|8|||
164662247|NCT01290263|594787654|FG001|Overall Study|Lack of Efficacy|2|||
164662248|NCT01290263|594787655|FG002|Overall Study|Lack of Efficacy|7|||
164662249|NCT01290263|594787656|FG003|Overall Study|Lack of Efficacy|24|||
164662250|NCT01290263|594787657|FG004|Overall Study|Lack of Efficacy|33|||
164662251|NCT01290263|594787653|FG000|Overall Study|Withdrawal by Subject|3|||
164662252|NCT01290263|594787654|FG001|Overall Study|Withdrawal by Subject|1|||
164662253|NCT01290263|594787655|FG002|Overall Study|Withdrawal by Subject|0|||
164662254|NCT01290263|594787656|FG003|Overall Study|Withdrawal by Subject|1|||
164662255|NCT01290263|594787657|FG004|Overall Study|Withdrawal by Subject|2|||
164662256|NCT01290263|594787653|FG000|Overall Study|Participant Non-Compliance|0|||
164662257|NCT01290263|594787654|FG001|Overall Study|Participant Non-Compliance|0|||
164662258|NCT01290263|594787655|FG002|Overall Study|Participant Non-Compliance|0|||
164662259|NCT01290263|594787656|FG003|Overall Study|Participant Non-Compliance|1|||
164662260|NCT01290263|594787657|FG004|Overall Study|Participant Non-Compliance|1|||
164662261|NCT02309099|594787658|FG000|Overall Study|Adverse Event|2|||
164662262|NCT02309099|594787659|FG001|Overall Study|Adverse Event|0|||
164662263|NCT01545076|594787660|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
164662264|NCT01545076|594787661|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
164662265|NCT01545076|594787662|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
164662266|NCT01545076|594787663|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
164662267|NCT01545076|594787664|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
164662268|NCT01545076|594787660|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
164662269|NCT01545076|594787661|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
164662270|NCT01545076|594787662|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
164662271|NCT01545076|594787663|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
164662272|NCT01545076|594787664|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
164662273|NCT01545076|594787660|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
164662274|NCT01545076|594787661|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
164662275|NCT01545076|594787662|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
164662276|NCT01545076|594787663|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
164662277|NCT01545076|594787664|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
164662278|NCT01545076|594787660|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
164662279|NCT01545076|594787661|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
164662280|NCT01545076|594787662|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
164662281|NCT01545076|594787663|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
164662282|NCT01545076|594787664|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
164662283|NCT01545076|594787660|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
164662284|NCT01545076|594787661|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
164662285|NCT01545076|594787662|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
164662286|NCT01545076|594787663|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
164662287|NCT01545076|594787664|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
164662288|NCT01545076|594787660|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
164662289|NCT01545076|594787661|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
164662290|NCT01545076|594787662|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
164662291|NCT01545076|594787663|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
164662292|NCT01545076|594787664|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
164662293|NCT01545076|594787660|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
164662294|NCT01545076|594787661|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
164662295|NCT01545076|594787662|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
164662296|NCT01545076|594787663|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
164662297|NCT01545076|594787664|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
164662298|NCT01545076|594787660|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
164662299|NCT01545076|594787661|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
164662300|NCT01545076|594787662|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
164662301|NCT01545076|594787663|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
164662302|NCT01545076|594787664|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
164662303|NCT01545076|594787660|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
164662304|NCT01545076|594787661|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
164662305|NCT01545076|594787662|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
164662306|NCT01545076|594787663|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
164662307|NCT01545076|594787664|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
164662308|NCT00797108|594787668|FG000|Overall Study|Adverse Event|1|||
164662309|NCT00797108|594787669|FG001|Overall Study|Adverse Event|0|||
164662310|NCT00797108|594787670|FG002|Overall Study|Adverse Event|3|||
164662311|NCT00797108|594787668|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
164662312|NCT00797108|594787669|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
164662313|NCT00797108|594787670|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
164662314|NCT00797108|594787668|FG000|Overall Study|Global Deterioration of Health Status|0|||
164662315|NCT00797108|594787669|FG001|Overall Study|Global Deterioration of Health Status|1|||
164662316|NCT00797108|594787670|FG002|Overall Study|Global Deterioration of Health Status|0|||
164662317|NCT00797108|594787668|FG000|Overall Study|Lack of Efficacy|1|||
164662318|NCT00797108|594787669|FG001|Overall Study|Lack of Efficacy|0|||
164662319|NCT00797108|594787670|FG002|Overall Study|Lack of Efficacy|1|||
164662320|NCT00797108|594787668|FG000|Overall Study|Other|0|||
164662321|NCT00797108|594787669|FG001|Overall Study|Other|0|||
164662322|NCT00797108|594787670|FG002|Overall Study|Other|2|||
164662323|NCT00797108|594787668|FG000|Overall Study|Randomized but not Treated|2|||
164662324|NCT00797108|594787669|FG001|Overall Study|Randomized but not Treated|0|||
164662325|NCT00797108|594787670|FG002|Overall Study|Randomized but not Treated|0|||
164662326|NCT02324465|594787671|FG000|Overall Study|device failure|0|||
164662327|NCT02324465|594787672|FG001|Overall Study|device failure|1|||
164204034|NCT03092752|593117907|FG000|Overall Study|<6 month history|245900|||
164204035|NCT00921024|593117913|FG000|Overall Study|Lost to Follow-up|2|||
164204036|NCT00921024|593117914|FG001|Overall Study|Lost to Follow-up|0|||
164204037|NCT00921024|593117913|FG000|Overall Study|Received concomittant therapy|2|||
164204038|NCT00921024|593117914|FG001|Overall Study|Received concomittant therapy|0|||
164204039|NCT00921024|593117913|FG000|Overall Study|Withdrawal by Subject|0|||
164204040|NCT00921024|593117914|FG001|Overall Study|Withdrawal by Subject|3|||
164204041|NCT06996301|593117918|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
164204042|NCT06996301|593117919|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
164662328|NCT01031537|594787673|FG000|Overall Study|medical reasons not related to study|3|||
164204043|NCT06996301|593117918|FG000|Overall Study|Patients with discordant diagnostic results|107|||
164302991|NCT03205423|593484683|FG001|Overall Study|Physician Decision|2|||
164662329|NCT01031537|594787673|FG000|Overall Study|Lack of Efficacy|1|||
164662330|NCT01031537|594787673|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
164662331|NCT01031537|594787673|FG000|Overall Study|moved, met exclusion criteria|10|||
164662332|NCT01031537|594787673|FG000|Overall Study|Withdrawal by Subject|5|||
164662333|NCT01031537|594787673|FG000|Overall Study|PI removal, no longer met eligibility|12|||
164662334|NCT00561730|594787682|FG000|Overall Study|Adverse Event|2|||
164662335|NCT00561730|594787682|FG000|Overall Study|Handling of the drug|1|||
164662336|NCT00561730|594787682|FG000|Overall Study|Lost to Follow-up|5|||
164662337|NCT00561730|594787682|FG000|Overall Study|Not specified reasons|1|||
164662338|NCT03803943|594787683|FG000|Overall Study|Withdrawal by Subject|2|||
164662339|NCT03803943|594787684|FG001|Overall Study|Withdrawal by Subject|2|||
164662340|NCT03803943|594787685|FG002|Overall Study|Withdrawal by Subject|2|||
164662341|NCT03803943|594787686|FG003|Overall Study|Withdrawal by Subject|2|||
164662342|NCT00995410|594787687|FG000|Overall Study|Adverse Event|51|||
164662343|NCT00995410|594787687|FG000|Overall Study|Withdrawal by Subject|7|||
164662344|NCT00995410|594787687|FG000|Overall Study|Lost to Follow-up|2|||
164662345|NCT00995410|594787687|FG000|Overall Study|Misc|28|||
164558279|NCT00088374|594413470|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
164558280|NCT02573155|594413473|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
164558281|NCT02573155|594413474|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
164558282|NCT02573155|594413473|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
164558283|NCT02573155|594413474|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
164558284|NCT02573155|594413473|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
164558285|NCT02573155|594413474|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
164558286|NCT02573155|594413473|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
164558287|NCT02573155|594413474|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
164558288|NCT02573155|594413473|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
164558289|NCT02573155|594413474|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
164558290|NCT02573155|594413473|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
164558291|NCT02573155|594413474|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
164558292|NCT02573155|594413473|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
164558293|NCT02573155|594413474|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
164558294|NCT02573155|594413473|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
164558295|NCT02573155|594413474|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
164558296|NCT01681433|594413475|FG000|Overall Study|Lack of Efficacy|23|||
164558297|NCT01681433|594413476|FG001|Overall Study|Lack of Efficacy|23|||
164558298|NCT01681433|594413475|FG000|Overall Study|Withdrawal by Subject|5|||
164558299|NCT01681433|594413476|FG001|Overall Study|Withdrawal by Subject|5|||
164558300|NCT01681433|594413475|FG000|Overall Study|Protocol Violation|2|||
164558301|NCT01681433|594413476|FG001|Overall Study|Protocol Violation|0|||
164558302|NCT01681433|594413475|FG000|Overall Study|Adverse Event|2|||
164558303|NCT01681433|594413476|FG001|Overall Study|Adverse Event|4|||
164558304|NCT01681433|594413475|FG000|Overall Study|Lost to Follow-up|0|||
164558305|NCT01681433|594413476|FG001|Overall Study|Lost to Follow-up|1|||
164558306|NCT03208231|594413481|FG000|Overall Study|Death|1|||
164558307|NCT03208231|594413482|FG001|Overall Study|Death|2|||
164558308|NCT03208231|594413481|FG000|Overall Study|Moved and unable to get to clinic|1|||
164558309|NCT03208231|594413482|FG001|Overall Study|Moved and unable to get to clinic|0|||
164558310|NCT03208231|594413481|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
164558311|NCT03208231|594413482|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
164558312|NCT03205995|594413483|FG000|Overall Study|Adverse Event|1|||
164558313|NCT03205995|594413483|FG000|Overall Study|Death|1|||
164558314|NCT03205995|594413483|FG000|Overall Study|Physician Decision|2|||
164558315|NCT03205995|594413483|FG000|Overall Study|Protocol Violation|2|||
164558316|NCT04947800|594413486|FG000|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|8|||
164558317|NCT04947800|594413487|FG001|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
164558318|NCT04947800|594413488|FG002|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
164558319|NCT02158091|594413489|FG000|Overall Study|DLT|2|||
164558320|NCT02158091|594413490|FG001|Overall Study|DLT|1|||
164558321|NCT02158091|594413491|FG002|Overall Study|DLT|0|||
164558322|NCT01328951|594413492|FG000|Overall Study|Disease Progression|17|||
164558323|NCT01328951|594413493|FG001|Overall Study|Disease Progression|14|||
164558324|NCT01328951|594413492|FG000|Overall Study|Adverse Event|2|||
164558325|NCT01328951|594413493|FG001|Overall Study|Adverse Event|0|||
164558326|NCT01328951|594413492|FG000|Overall Study|Death|243|||
164558327|NCT01328951|594413493|FG001|Overall Study|Death|258|||
164558328|NCT01328951|594413492|FG000|Overall Study|Lost to Follow-up|6|||
164558329|NCT01328951|594413493|FG001|Overall Study|Lost to Follow-up|7|||
164558330|NCT01328951|594413492|FG000|Overall Study|Withdrawal by Subject|6|||
164662346|NCT03594123|594787688|FG000|Overall Study|Lost to Follow-up|0|||
164662347|NCT03594123|594787689|FG001|Overall Study|Lost to Follow-up|1|||
164662348|NCT03594123|594787688|FG000|Overall Study|Adverse Event|8|||
164662349|NCT03594123|594787689|FG001|Overall Study|Adverse Event|5|||
164204044|NCT06996301|593117919|FG001|Overall Study|Patients with discordant diagnostic results|90|||
164204045|NCT06996301|593117918|FG000|Overall Study|Lost to Follow-up|31|||
164204046|NCT06996301|593117919|FG001|Overall Study|Lost to Follow-up|56|||
164204047|NCT06996301|593117918|FG000|Overall Study|Withdrawal by Subject|12|||
164204048|NCT06996301|593117919|FG001|Overall Study|Withdrawal by Subject|7|||
164204049|NCT04030598|593117920|FG000|Overall Study|Voluntary Withdrawal|0|||
164558331|NCT01328951|594413493|FG001|Overall Study|Withdrawal by Subject|6|||
164558332|NCT01328951|594413492|FG000|Overall Study|Study Closed by the Sponsor|36|||
164558333|NCT01328951|594413493|FG001|Overall Study|Study Closed by the Sponsor|31|||
164558334|NCT01328951|594413492|FG000|Overall Study|Other|11|||
164558335|NCT01328951|594413493|FG001|Overall Study|Other|6|||
164558336|NCT01358864|594413502|FG000|Overall Study|Adverse Event|0|||
164558337|NCT01358864|594413503|FG001|Overall Study|Adverse Event|6|||
164558338|NCT01358864|594413504|FG002|Overall Study|Adverse Event|9|||
164558339|NCT01358864|594413505|FG003|Overall Study|Adverse Event|0|||
164558340|NCT01358864|594413506|FG004|Overall Study|Adverse Event|4|||
164558341|NCT01358864|594413507|FG005|Overall Study|Adverse Event|8|||
164558342|NCT01358864|594413508|FG006|Overall Study|Adverse Event|12|||
164558343|NCT01358864|594413509|FG007|Overall Study|Adverse Event|7|||
164558344|NCT01358864|594413502|FG000|Overall Study|Lack of Efficacy|26|||
164558345|NCT01358864|594413503|FG001|Overall Study|Lack of Efficacy|3|||
164558346|NCT01358864|594413504|FG002|Overall Study|Lack of Efficacy|4|||
164558347|NCT01358864|594413505|FG003|Overall Study|Lack of Efficacy|19|||
164558348|NCT01358864|594413506|FG004|Overall Study|Lack of Efficacy|7|||
164558349|NCT01358864|594413507|FG005|Overall Study|Lack of Efficacy|4|||
164558350|NCT01358864|594413508|FG006|Overall Study|Lack of Efficacy|49|||
164558351|NCT01358864|594413509|FG007|Overall Study|Lack of Efficacy|44|||
164558352|NCT01358864|594413502|FG000|Overall Study|Lost to Follow-up|0|||
164558353|NCT01358864|594413503|FG001|Overall Study|Lost to Follow-up|0|||
164558354|NCT01358864|594413504|FG002|Overall Study|Lost to Follow-up|1|||
164558355|NCT01358864|594413505|FG003|Overall Study|Lost to Follow-up|0|||
164558356|NCT01358864|594413506|FG004|Overall Study|Lost to Follow-up|0|||
164558357|NCT01358864|594413507|FG005|Overall Study|Lost to Follow-up|0|||
164558358|NCT01358864|594413508|FG006|Overall Study|Lost to Follow-up|0|||
164558359|NCT01358864|594413509|FG007|Overall Study|Lost to Follow-up|1|||
164558360|NCT01358864|594413502|FG000|Overall Study|Withdrawal by Subject|3|||
164558361|NCT01358864|594413503|FG001|Overall Study|Withdrawal by Subject|4|||
164558362|NCT01358864|594413504|FG002|Overall Study|Withdrawal by Subject|2|||
164558363|NCT01358864|594413505|FG003|Overall Study|Withdrawal by Subject|0|||
164558364|NCT01358864|594413506|FG004|Overall Study|Withdrawal by Subject|0|||
164558365|NCT01358864|594413507|FG005|Overall Study|Withdrawal by Subject|1|||
164558366|NCT01358864|594413508|FG006|Overall Study|Withdrawal by Subject|1|||
164558367|NCT01358864|594413509|FG007|Overall Study|Withdrawal by Subject|3|||
164558368|NCT01358864|594413502|FG000|Overall Study|Other reason not defined above|2|||
164558369|NCT01358864|594413503|FG001|Overall Study|Other reason not defined above|0|||
164558370|NCT01358864|594413504|FG002|Overall Study|Other reason not defined above|0|||
164558371|NCT01358864|594413505|FG003|Overall Study|Other reason not defined above|0|||
164558372|NCT01358864|594413506|FG004|Overall Study|Other reason not defined above|0|||
164558373|NCT01358864|594413507|FG005|Overall Study|Other reason not defined above|0|||
164204050|NCT04030598|593117921|FG001|Overall Study|Voluntary Withdrawal|1|||
164204051|NCT04030598|593117922|FG002|Overall Study|Voluntary Withdrawal|0|||
164204052|NCT05117060|593117925|FG000|Overall Study|Adverse Event|3|||
164204053|NCT05117060|593117926|FG001|Overall Study|Adverse Event|5|||
164204054|NCT05117060|593117927|FG002|Overall Study|Adverse Event|6|||
164204055|NCT05117060|593117928|FG003|Overall Study|Adverse Event|1|||
164558374|NCT01358864|594413508|FG006|Overall Study|Other reason not defined above|2|||
164558375|NCT01358864|594413509|FG007|Overall Study|Other reason not defined above|0|||
164558376|NCT01358864|594413502|FG000|Overall Study|Not treated|0|||
164558377|NCT01358864|594413503|FG001|Overall Study|Not treated|0|||
164558378|NCT01358864|594413504|FG002|Overall Study|Not treated|0|||
164558379|NCT01358864|594413505|FG003|Overall Study|Not treated|0|||
164558380|NCT01358864|594413506|FG004|Overall Study|Not treated|0|||
164558381|NCT01358864|594413507|FG005|Overall Study|Not treated|0|||
164558382|NCT01358864|594413508|FG006|Overall Study|Not treated|1|||
164558383|NCT01358864|594413509|FG007|Overall Study|Not treated|0|||
164558384|NCT04042103|594413510|FG000|Overall Study|Lost to Follow-up|1|||
164558385|NCT04042103|594413510|FG000|Overall Study|Withdrawal by Subject|1|||
164558386|NCT04209855|594413511|FG000|Overall Study|Death|161|||
164204056|NCT05117060|593117925|FG000|Overall Study|Lost to Follow-up|0|||
164558387|NCT04209855|594413512|FG001|Overall Study|Death|177|||
164558388|NCT04209855|594413511|FG000|Overall Study|PI Discretion|1|||
164558389|NCT04209855|594413512|FG001|Overall Study|PI Discretion|1|||
164558390|NCT04209855|594413511|FG000|Overall Study|Lost to Follow-up|5|||
164558391|NCT04209855|594413512|FG001|Overall Study|Lost to Follow-up|2|||
164558392|NCT04209855|594413511|FG000|Overall Study|Withdrew consent|10|||
164558393|NCT04209855|594413512|FG001|Overall Study|Withdrew consent|24|||
164558394|NCT04209855|594413511|FG000|Overall Study|Sponsor decision|44|||
164558395|NCT04209855|594413512|FG001|Overall Study|Sponsor decision|18|||
164558396|NCT04209855|594413511|FG000|Overall Study|Other than specified|6|||
164204057|NCT05117060|593117926|FG001|Overall Study|Lost to Follow-up|0|||
164558397|NCT04209855|594413512|FG001|Overall Study|Other than specified|4|||
164558398|NCT02289950|594413514|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
164558399|NCT02289950|594413515|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
164558400|NCT02289950|594413514|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
164558401|NCT02289950|594413515|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
164558402|NCT02289950|594413514|FG000|Overall Study|Lost to Follow-up|1|||
164558403|NCT02289950|594413515|FG001|Overall Study|Lost to Follow-up|0|||
164558404|NCT02289950|594413514|FG000|Overall Study|Physician Decision|9|||
164558405|NCT02289950|594413515|FG001|Overall Study|Physician Decision|3|||
164558406|NCT02289950|594413514|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
164558407|NCT02289950|594413515|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
164558408|NCT02289950|594413514|FG000|Overall Study|Withdrawal by Subject|1|||
164558409|NCT02289950|594413515|FG001|Overall Study|Withdrawal by Subject|3|||
164558410|NCT02289950|594413514|FG000|Overall Study|Test article held for greater than 28 days|0|||
164558411|NCT02289950|594413515|FG001|Overall Study|Test article held for greater than 28 days|1|||
164558412|NCT02289950|594413514|FG000|Overall Study|Adverse Event|11|||
164558413|NCT02289950|594413515|FG001|Overall Study|Adverse Event|3|||
164558414|NCT02289950|594413514|FG000|Overall Study|Death|1|||
164558415|NCT02289950|594413515|FG001|Overall Study|Death|1|||
164558416|NCT02289950|594413514|FG000|Overall Study|Other|5|||
164558417|NCT02289950|594413515|FG001|Overall Study|Other|2|||
164558418|NCT02289950|594413514|FG000|Overall Study|Not Treated|2|||
164558419|NCT02289950|594413515|FG001|Overall Study|Not Treated|1|||
164558420|NCT00271817|594413516|FG000|Part 1|Adverse Event|68|||
164558421|NCT00271817|594413517|FG001|Part 1|Adverse Event|25|||
164558422|NCT00271817|594413518|FG002|Part 1|Adverse Event|156|||
164558423|NCT00271817|594413516|FG000|Part 1|Lost to Follow-up|6|||
164558424|NCT00271817|594413517|FG001|Part 1|Lost to Follow-up|8|||
164558425|NCT00271817|594413518|FG002|Part 1|Lost to Follow-up|24|||
164558426|NCT00271817|594413516|FG000|Part 1|Protocol Violation|5|||
164558427|NCT00271817|594413517|FG001|Part 1|Protocol Violation|4|||
164558428|NCT00271817|594413518|FG002|Part 1|Protocol Violation|7|||
164558429|NCT00271817|594413516|FG000|Part 1|Patient Moved|3|||
164558430|NCT00271817|594413517|FG001|Part 1|Patient Moved|1|||
164558431|NCT00271817|594413518|FG002|Part 1|Patient Moved|5|||
164558432|NCT00271817|594413516|FG000|Part 1|Withdrawal by Subject|23|||
164558433|NCT00271817|594413517|FG001|Part 1|Withdrawal by Subject|17|||
164558434|NCT00271817|594413518|FG002|Part 1|Withdrawal by Subject|45|||
164558435|NCT00271817|594413516|FG000|Part 1|LDL < 50 mg/dL|1|||
164558436|NCT00271817|594413517|FG001|Part 1|LDL < 50 mg/dL|4|||
164558437|NCT00271817|594413518|FG002|Part 1|LDL < 50 mg/dL|48|||
164558438|NCT00271817|594413516|FG000|Part 2|Adverse Event|0|||
164558439|NCT00271817|594413517|FG001|Part 2|Adverse Event|17|||
164558440|NCT00271817|594413518|FG002|Part 2|Adverse Event|33|||
164558441|NCT00271817|594413516|FG000|Part 2|Lack of Efficacy|0|||
164558442|NCT00271817|594413517|FG001|Part 2|Lack of Efficacy|1|||
164558443|NCT00271817|594413518|FG002|Part 2|Lack of Efficacy|6|||
164558444|NCT00271817|594413516|FG000|Part 2|Lost to Follow-up|0|||
164558445|NCT00271817|594413517|FG001|Part 2|Lost to Follow-up|6|||
164558446|NCT00271817|594413518|FG002|Part 2|Lost to Follow-up|18|||
164558447|NCT00271817|594413516|FG000|Part 2|Protocol Violation|0|||
164558448|NCT00271817|594413517|FG001|Part 2|Protocol Violation|3|||
164558449|NCT00271817|594413518|FG002|Part 2|Protocol Violation|5|||
164558450|NCT00271817|594413516|FG000|Part 2|Patient Moved|0|||
164558451|NCT00271817|594413517|FG001|Part 2|Patient Moved|0|||
164558452|NCT00271817|594413518|FG002|Part 2|Patient Moved|5|||
164558453|NCT00271817|594413516|FG000|Part 2|Withdrawal by Subject|0|||
164558454|NCT00271817|594413517|FG001|Part 2|Withdrawal by Subject|2|||
164558455|NCT00271817|594413518|FG002|Part 2|Withdrawal by Subject|13|||
164558456|NCT00271817|594413516|FG000|Part 2|LDL < 50 mg/dL|0|||
164558457|NCT00271817|594413517|FG001|Part 2|LDL < 50 mg/dL|3|||
164558458|NCT00271817|594413518|FG002|Part 2|LDL < 50 mg/dL|4|||
164558459|NCT01471782|594413522|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
164558460|NCT01471782|594413523|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
164558461|NCT01471782|594413524|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
164558462|NCT01471782|594413525|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
164558463|NCT01471782|594413526|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
164558464|NCT01471782|594413527|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
164558465|NCT01471782|594413522|FG000|Overall Study|Lack of Efficacy|1|||
164558466|NCT01471782|594413523|FG001|Overall Study|Lack of Efficacy|2|||
164558467|NCT01471782|594413524|FG002|Overall Study|Lack of Efficacy|1|||
164558468|NCT01471782|594413525|FG003|Overall Study|Lack of Efficacy|1|||
164558469|NCT01471782|594413526|FG004|Overall Study|Lack of Efficacy|5|||
164558470|NCT01471782|594413527|FG005|Overall Study|Lack of Efficacy|18|||
164558471|NCT01471782|594413522|FG000|Overall Study|Adverse Event|1|||
164558472|NCT01471782|594413523|FG001|Overall Study|Adverse Event|1|||
164558473|NCT01471782|594413524|FG002|Overall Study|Adverse Event|2|||
164558474|NCT01471782|594413525|FG003|Overall Study|Adverse Event|2|||
164558475|NCT01471782|594413526|FG004|Overall Study|Adverse Event|3|||
164662350|NCT03594123|594787688|FG000|Overall Study|Site Terminated by Sponsor|4|||
164662351|NCT03594123|594787689|FG001|Overall Study|Site Terminated by Sponsor|1|||
164662352|NCT03594123|594787688|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
164662353|NCT03594123|594787689|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
164662354|NCT03594123|594787688|FG000|Overall Study|Lack of Efficacy|1|||
164662355|NCT03594123|594787689|FG001|Overall Study|Lack of Efficacy|0|||
164662356|NCT03594123|594787688|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
164662357|NCT03594123|594787689|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
164662358|NCT00319956|594787696|FG000|Overall Study|Death|20|||
164662359|NCT00319956|594787697|FG001|Overall Study|Death|24|||
164662360|NCT03276975|594787698|FG000|Overall Study|Withdrawal by Subject|1|||
164662361|NCT03276975|594787699|FG001|Overall Study|Withdrawal by Subject|0|||
164662362|NCT00679783|594787700|FG000|Overall Study|Adverse Event|0|||
164662363|NCT00679783|594787701|FG001|Overall Study|Adverse Event|0|||
164662364|NCT00679783|594787702|FG002|Overall Study|Adverse Event|0|||
164662365|NCT00679783|594787703|FG003|Overall Study|Adverse Event|3|||
164662366|NCT00679783|594787704|FG004|Overall Study|Adverse Event|0|||
164662367|NCT00679783|594787705|FG005|Overall Study|Adverse Event|0|||
164662368|NCT00679783|594787706|FG006|Overall Study|Adverse Event|1|||
164662369|NCT00679783|594787700|FG000|Overall Study|Lack of Efficacy|0|||
164662370|NCT00679783|594787701|FG001|Overall Study|Lack of Efficacy|1|||
164662371|NCT00679783|594787702|FG002|Overall Study|Lack of Efficacy|0|||
164662372|NCT00679783|594787703|FG003|Overall Study|Lack of Efficacy|2|||
164662373|NCT00679783|594787704|FG004|Overall Study|Lack of Efficacy|0|||
164662374|NCT00679783|594787705|FG005|Overall Study|Lack of Efficacy|0|||
164662375|NCT00679783|594787706|FG006|Overall Study|Lack of Efficacy|0|||
164662376|NCT00679783|594787700|FG000|Overall Study|Withdrawal by Subject|0|||
164662377|NCT00679783|594787701|FG001|Overall Study|Withdrawal by Subject|0|||
164662378|NCT00679783|594787702|FG002|Overall Study|Withdrawal by Subject|1|||
164662379|NCT00679783|594787703|FG003|Overall Study|Withdrawal by Subject|1|||
164662380|NCT00679783|594787704|FG004|Overall Study|Withdrawal by Subject|0|||
164662381|NCT00679783|594787705|FG005|Overall Study|Withdrawal by Subject|0|||
164662382|NCT00679783|594787706|FG006|Overall Study|Withdrawal by Subject|0|||
164662383|NCT00679783|594787700|FG000|Overall Study|Not Captured|0|||
164662384|NCT00679783|594787701|FG001|Overall Study|Not Captured|0|||
164662385|NCT00679783|594787702|FG002|Overall Study|Not Captured|0|||
164662386|NCT00679783|594787703|FG003|Overall Study|Not Captured|5|||
164662387|NCT00679783|594787704|FG004|Overall Study|Not Captured|0|||
164662388|NCT00679783|594787705|FG005|Overall Study|Not Captured|0|||
164662389|NCT00679783|594787706|FG006|Overall Study|Not Captured|0|||
164662390|NCT00679783|594787700|FG000|Overall Study|Ongoing at data cut-off|2|||
164662391|NCT00679783|594787701|FG001|Overall Study|Ongoing at data cut-off|2|||
164662392|NCT00679783|594787702|FG002|Overall Study|Ongoing at data cut-off|0|||
164662393|NCT00679783|594787703|FG003|Overall Study|Ongoing at data cut-off|9|||
164662394|NCT00679783|594787704|FG004|Overall Study|Ongoing at data cut-off|1|||
164662395|NCT00679783|594787705|FG005|Overall Study|Ongoing at data cut-off|0|||
164662396|NCT00679783|594787706|FG006|Overall Study|Ongoing at data cut-off|0|||
164662397|NCT01485536|594787707|FG000|Overall Study|Withdrawal by Subject|3|||
164662398|NCT01485536|594787707|FG000|Overall Study|Adverse Event|1|||
164662399|NCT02626949|594787708|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
164662400|NCT02626949|594787709|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
164662401|NCT02626949|594787708|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
164662402|NCT02626949|594787709|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
164662403|NCT02626949|594787708|FG000|Enrolled|Lost to Follow-up|7|||
164662404|NCT02626949|594787709|FG001|Enrolled|Lost to Follow-up|6|||
164662405|NCT02626949|594787708|FG000|Enrolled|Withdrawal by Subject|3|||
164662406|NCT02626949|594787709|FG001|Enrolled|Withdrawal by Subject|2|||
164662407|NCT00576199|594787710|FG000|Overall Study|Adverse Event|12|||
164662408|NCT00576199|594787710|FG000|Overall Study|Insufficient Therapeutic Response|14|||
164662409|NCT00576199|594787710|FG000|Overall Study|Refused Treatment|2|||
164662410|NCT00576199|594787710|FG000|Overall Study|Reason Unspecified|2|||
164662411|NCT03111147|594787711|FG000|Overall Study|Lost to Follow-up|2|||
164662412|NCT03111147|594787712|FG001|Overall Study|Lost to Follow-up|5|||
164662413|NCT03111147|594787711|FG000|Overall Study|Withdrawal by Subject|4|||
164662414|NCT03111147|594787712|FG001|Overall Study|Withdrawal by Subject|3|||
164662415|NCT03111147|594787711|FG000|Overall Study|Protocol Violation|2|||
164662416|NCT03111147|594787712|FG001|Overall Study|Protocol Violation|1|||
164662417|NCT03111147|594787711|FG000|Overall Study|Death|1|||
164662418|NCT03111147|594787712|FG001|Overall Study|Death|1|||
164662419|NCT01463683|594787713|FG000|Overall Study|Adverse Event|2|||
164662420|NCT01463683|594787714|FG001|Overall Study|Adverse Event|0|||
164662421|NCT01463683|594787715|FG002|Overall Study|Adverse Event|0|||
164662422|NCT01463683|594787713|FG000|Overall Study|Lost to Follow-up|10|||
164662423|NCT01463683|594787714|FG001|Overall Study|Lost to Follow-up|9|||
164662424|NCT01463683|594787715|FG002|Overall Study|Lost to Follow-up|7|||
164662425|NCT01463683|594787713|FG000|Overall Study|Physician Decision|0|||
164662426|NCT01463683|594787714|FG001|Overall Study|Physician Decision|3|||
164662427|NCT01463683|594787715|FG002|Overall Study|Physician Decision|1|||
164662428|NCT01463683|594787713|FG000|Overall Study|Pregnancy|2|||
164662429|NCT01463683|594787714|FG001|Overall Study|Pregnancy|2|||
164662430|NCT01463683|594787715|FG002|Overall Study|Pregnancy|1|||
164662431|NCT01463683|594787713|FG000|Overall Study|Withdrawal by Subject|5|||
164662432|NCT01463683|594787714|FG001|Overall Study|Withdrawal by Subject|17|||
164662433|NCT01463683|594787715|FG002|Overall Study|Withdrawal by Subject|2|||
164662434|NCT01058421|594787716|FG000|1 Month Outcomes|Death|10|||
164662435|NCT01058421|594787717|FG001|1 Month Outcomes|Death|6|||
164662436|NCT01058421|594787716|FG000|1 Month Outcomes|Lost to Follow-up|8|||
164662437|NCT01058421|594787717|FG001|1 Month Outcomes|Lost to Follow-up|7|||
164662438|NCT01058421|594787716|FG000|1 Month Outcomes|Remained in Hospital|5|||
164662439|NCT01058421|594787717|FG001|1 Month Outcomes|Remained in Hospital|12|||
164662440|NCT01058421|594787716|FG000|1 Month Outcomes|Remained in Other Facility|16|||
164662441|NCT01058421|594787717|FG001|1 Month Outcomes|Remained in Other Facility|17|||
164662442|NCT01058421|594787716|FG000|3 Month Outcomes|Death|3|||
164662443|NCT01058421|594787717|FG001|3 Month Outcomes|Death|5|||
164662444|NCT01058421|594787716|FG000|3 Month Outcomes|Lost to Follow-up|12|||
164662445|NCT01058421|594787717|FG001|3 Month Outcomes|Lost to Follow-up|11|||
164662446|NCT01058421|594787716|FG000|3 Month Outcomes|Remained in Hospital|0|||
164662447|NCT01058421|594787717|FG001|3 Month Outcomes|Remained in Hospital|2|||
164662448|NCT01058421|594787716|FG000|3 Month Outcomes|Remained in Other Facility|5|||
164662449|NCT01058421|594787717|FG001|3 Month Outcomes|Remained in Other Facility|8|||
164662450|NCT01058421|594787716|FG000|6 Month Outcomes|Death|2|||
164662451|NCT01058421|594787717|FG001|6 Month Outcomes|Death|2|||
164662452|NCT01058421|594787716|FG000|6 Month Outcomes|Lost to Follow-up|16|||
164662453|NCT01058421|594787717|FG001|6 Month Outcomes|Lost to Follow-up|21|||
164662454|NCT01058421|594787716|FG000|6 Month Outcomes|Remained in Other Facility|1|||
164662455|NCT01058421|594787717|FG001|6 Month Outcomes|Remained in Other Facility|3|||
164662456|NCT01497938|594787718|FG000|Overall Study|Adverse Event|0|||
164662457|NCT01497938|594787719|FG001|Overall Study|Adverse Event|1|||
164662458|NCT01497938|594787718|FG000|Overall Study|Physician Decision|0|||
164662459|NCT01497938|594787719|FG001|Overall Study|Physician Decision|1|||
164662460|NCT01497938|594787718|FG000|Overall Study|Withdrawal by Subject|4|||
164662461|NCT01497938|594787719|FG001|Overall Study|Withdrawal by Subject|0|||
164662462|NCT01497938|594787718|FG000|Overall Study|Device Violation|1|||
164662463|NCT01497938|594787719|FG001|Overall Study|Device Violation|0|||
164662464|NCT00462982|594787720|FG000|Overall Study|Adverse Event|1|||
164662465|NCT00462982|594787720|FG000|Overall Study|Patient Not Treated|2|||
164662466|NCT05665595|594789464|FG000|Overall Study|Ongoing|692|||
164662467|NCT05665595|594789465|FG001|Overall Study|Ongoing|698|||
164662468|NCT05665595|594789464|FG000|Overall Study|Withdrawal by Subject|2|||
164662469|NCT05665595|594789465|FG001|Overall Study|Withdrawal by Subject|2|||
164662470|NCT05665595|594789464|FG000|Overall Study|Lost to Follow-up|1|||
164662471|NCT05665595|594789465|FG001|Overall Study|Lost to Follow-up|0|||
164662472|NCT05665595|594789464|FG000|Overall Study|Death|6|||
164662473|NCT05665595|594789465|FG001|Overall Study|Death|1|||
164662474|NCT02581345|594789466|FG000|Part 1: up to Week 16|Adverse Event|3|||
164662475|NCT02581345|594789467|FG001|Part 1: up to Week 16|Adverse Event|8|||
164662476|NCT02581345|594789468|FG002|Part 1: up to Week 16|Adverse Event|0|||
164662477|NCT02581345|594789469|FG003|Part 1: up to Week 16|Adverse Event|0|||
164662478|NCT02581345|594789466|FG000|Part 1: up to Week 16|Physician Decision|2|||
164662479|NCT02581345|594789467|FG001|Part 1: up to Week 16|Physician Decision|4|||
164662480|NCT02581345|594789468|FG002|Part 1: up to Week 16|Physician Decision|0|||
164662481|NCT02581345|594789469|FG003|Part 1: up to Week 16|Physician Decision|0|||
164662482|NCT02581345|594789466|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
164662483|NCT02581345|594789467|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
164662484|NCT02581345|594789468|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
164662485|NCT02581345|594789469|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
164662486|NCT02581345|594789466|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
164662487|NCT02581345|594789467|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
164662488|NCT02581345|594789468|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
164662489|NCT02581345|594789469|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
164662490|NCT02581345|594789466|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
164662491|NCT02581345|594789467|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
164662492|NCT02581345|594789468|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
164662493|NCT02581345|594789469|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
164662494|NCT02581345|594789466|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
164662495|NCT02581345|594789467|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
164662496|NCT02581345|594789468|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
164662497|NCT02581345|594789469|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
164662498|NCT02581345|594789466|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
164662499|NCT02581345|594789467|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
164662500|NCT02581345|594789468|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
164662501|NCT02581345|594789469|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
164662502|NCT02581345|594789466|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
164662503|NCT02581345|594789467|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
164558476|NCT01471782|594413527|FG005|Overall Study|Adverse Event|1|||
164558477|NCT01471782|594413522|FG000|Overall Study|Other|0|||
164558478|NCT01471782|594413523|FG001|Overall Study|Other|0|||
164558479|NCT01471782|594413524|FG002|Overall Study|Other|1|||
164558480|NCT01471782|594413525|FG003|Overall Study|Other|1|||
164558481|NCT01471782|594413526|FG004|Overall Study|Other|6|||
164558482|NCT01471782|594413527|FG005|Overall Study|Other|5|||
164558483|NCT01471782|594413522|FG000|Overall Study|Change of Chemotherapy|1|||
164558484|NCT01471782|594413523|FG001|Overall Study|Change of Chemotherapy|1|||
164558485|NCT01471782|594413524|FG002|Overall Study|Change of Chemotherapy|0|||
164558486|NCT01471782|594413525|FG003|Overall Study|Change of Chemotherapy|0|||
164558487|NCT01471782|594413526|FG004|Overall Study|Change of Chemotherapy|1|||
164558488|NCT01471782|594413527|FG005|Overall Study|Change of Chemotherapy|4|||
164558489|NCT01471782|594413522|FG000|Overall Study|Disease Relapse|0|||
164558490|NCT01471782|594413523|FG001|Overall Study|Disease Relapse|0|||
164558491|NCT01471782|594413524|FG002|Overall Study|Disease Relapse|0|||
164558492|NCT01471782|594413525|FG003|Overall Study|Disease Relapse|1|||
164558493|NCT01471782|594413526|FG004|Overall Study|Disease Relapse|2|||
164558494|NCT01471782|594413527|FG005|Overall Study|Disease Relapse|1|||
164558495|NCT01471782|594413522|FG000|Overall Study|Physician Decision|0|||
164558496|NCT01471782|594413523|FG001|Overall Study|Physician Decision|0|||
164558497|NCT01471782|594413524|FG002|Overall Study|Physician Decision|0|||
164558498|NCT01471782|594413525|FG003|Overall Study|Physician Decision|0|||
164558499|NCT01471782|594413526|FG004|Overall Study|Physician Decision|3|||
164558500|NCT01471782|594413527|FG005|Overall Study|Physician Decision|8|||
164558501|NCT01471782|594413522|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164558502|NCT01471782|594413523|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164558503|NCT01471782|594413524|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
164558504|NCT01471782|594413525|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
164558505|NCT01471782|594413526|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
164558506|NCT01471782|594413527|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
164558507|NCT01471782|594413522|FG000|Overall Study|Death|0|||
164558508|NCT01471782|594413523|FG001|Overall Study|Death|0|||
164558509|NCT01471782|594413524|FG002|Overall Study|Death|0|||
164558510|NCT01471782|594413525|FG003|Overall Study|Death|0|||
164558511|NCT01471782|594413526|FG004|Overall Study|Death|0|||
164558512|NCT01471782|594413527|FG005|Overall Study|Death|1|||
164558513|NCT00936208|594413528|FG000|Overall Study|Protocol Violation|37|||
164558514|NCT00936208|594413529|FG001|Overall Study|Protocol Violation|22|||
164558515|NCT04428424|594413530|FG000|Overall Study|Does not meet entrance criteria|132|||
164558516|NCT04428424|594413530|FG000|Overall Study|Lost to Follow-up|115|||
164558517|NCT03359759|594413531|FG000|Overall Study|Death|3|||
164558518|NCT03359759|594413531|FG000|Overall Study|Lost to Follow-up|2|||
164558519|NCT01411085|594413532|FG000|Overall Study|Physician Decision|1|||
164558520|NCT01411085|594413532|FG000|Overall Study|Protocol Violation|1|||
164558521|NCT01411085|594413532|FG000|Overall Study|Adverse Event|1|||
164558522|NCT05568888|594413533|FG000|Overall Study|Physician Decision|1|||
164558523|NCT05568888|594413534|FG001|Overall Study|Physician Decision|0|||
164558524|NCT05568888|594413533|FG000|Overall Study|Protocol Deviation|2|||
164558525|NCT05568888|594413534|FG001|Overall Study|Protocol Deviation|1|||
164558526|NCT05568888|594413533|FG000|Overall Study|Withdrawal by Subject/Legally Authorized Representative|47|||
164558527|NCT05568888|594413534|FG001|Overall Study|Withdrawal by Subject/Legally Authorized Representative|53|||
164558528|NCT05568888|594413533|FG000|Overall Study|Withdrawal by Parent/Guardian|10|||
164558529|NCT05568888|594413534|FG001|Overall Study|Withdrawal by Parent/Guardian|14|||
164558530|NCT05568888|594413533|FG000|Overall Study|No IP Administered/Subject Excluded|1|||
164558531|NCT05568888|594413534|FG001|Overall Study|No IP Administered/Subject Excluded|4|||
164558532|NCT04818593|594413535|FG000|Overall Study|Low Oocyte Yield|8|||
164558533|NCT04818593|594413536|FG001|Overall Study|Low Oocyte Yield|8|||
164558534|NCT04818593|594413535|FG000|Overall Study|Not ICSI Insemination|7|||
164558535|NCT04818593|594413536|FG001|Overall Study|Not ICSI Insemination|7|||
164558536|NCT04818593|594413535|FG000|Overall Study|Poor Sperm Quality|2|||
164558537|NCT04818593|594413536|FG001|Overall Study|Poor Sperm Quality|2|||
164558538|NCT04818593|594413535|FG000|Overall Study|Withdrawal by Subject|2|||
164558539|NCT04818593|594413536|FG001|Overall Study|Withdrawal by Subject|2|||
164558540|NCT04818593|594413535|FG000|Overall Study|Conversion to IUI due to low response|1|||
164558541|NCT04818593|594413536|FG001|Overall Study|Conversion to IUI due to low response|1|||
164558542|NCT01564862|594413537|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
164558543|NCT01564862|594413538|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
164558544|NCT01564862|594413539|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
164558545|NCT01564862|594413537|FG000|Overall Study|Major Protocol Deviation|3|||
164558546|NCT01564862|594413538|FG001|Overall Study|Major Protocol Deviation|3|||
164558547|NCT01564862|594413539|FG002|Overall Study|Major Protocol Deviation|4|||
164558548|NCT01564862|594413537|FG000|Overall Study|Lost to Follow-up|10|||
164558549|NCT01564862|594413538|FG001|Overall Study|Lost to Follow-up|8|||
164558550|NCT01564862|594413539|FG002|Overall Study|Lost to Follow-up|6|||
164558551|NCT01564862|594413537|FG000|Overall Study|Voluntary Withdrawal|9|||
164558552|NCT01564862|594413538|FG001|Overall Study|Voluntary Withdrawal|6|||
164662504|NCT02581345|594789468|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
164662505|NCT02581345|594789469|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
164662506|NCT02581345|594789466|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
164662507|NCT02581345|594789467|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
164662508|NCT02581345|594789468|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
164662509|NCT02581345|594789469|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
164662510|NCT02581345|594789466|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
164662511|NCT02581345|594789467|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
164662512|NCT02581345|594789468|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
164662513|NCT02581345|594789469|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
164662514|NCT02581345|594789466|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
164662515|NCT02581345|594789467|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
164662516|NCT02581345|594789468|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
164662517|NCT02581345|594789469|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
164662518|NCT02581345|594789466|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
164558553|NCT01564862|594413539|FG002|Overall Study|Voluntary Withdrawal|8|||
164662519|NCT02581345|594789467|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
164662520|NCT02581345|594789468|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
164662521|NCT02581345|594789469|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
164558554|NCT01564862|594413537|FG000|Overall Study|Lack of Efficacy|1|||
164558555|NCT01564862|594413538|FG001|Overall Study|Lack of Efficacy|5|||
164558556|NCT01564862|594413539|FG002|Overall Study|Lack of Efficacy|6|||
164558557|NCT01564862|594413537|FG000|Overall Study|Other reason(s)|1|||
164558558|NCT01564862|594413538|FG001|Overall Study|Other reason(s)|0|||
164558559|NCT01564862|594413539|FG002|Overall Study|Other reason(s)|0|||
164558560|NCT03809611|594413540|FG000|Overall Study|Withdrawal by Subject|1|||
164558561|NCT03809611|594413541|FG001|Overall Study|Withdrawal by Subject|1|||
164558562|NCT02600494|594413542|FG000|Part A (6 Week Double-Blind Treatment)|Adverse Event|13|||
164558563|NCT02600494|594413543|FG001|Part A (6 Week Double-Blind Treatment)|Adverse Event|15|||
164558564|NCT02600494|594413544|FG002|Part A (6 Week Double-Blind Treatment)|Adverse Event|4|||
164558565|NCT02600494|594413542|FG000|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
164558566|NCT02600494|594413543|FG001|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|4|||
164558567|NCT02600494|594413544|FG002|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
164558568|NCT02600494|594413542|FG000|Part A (6 Week Double-Blind Treatment)|Protocol Violation|13|||
164558569|NCT02600494|594413543|FG001|Part A (6 Week Double-Blind Treatment)|Protocol Violation|10|||
164558570|NCT02600494|594413544|FG002|Part A (6 Week Double-Blind Treatment)|Protocol Violation|14|||
164558571|NCT02600494|594413542|FG000|Part A (6 Week Double-Blind Treatment)|Physician Decision|2|||
164558572|NCT02600494|594413543|FG001|Part A (6 Week Double-Blind Treatment)|Physician Decision|3|||
164558573|NCT02600494|594413544|FG002|Part A (6 Week Double-Blind Treatment)|Physician Decision|4|||
164558574|NCT02600494|594413542|FG000|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|15|||
164558575|NCT02600494|594413543|FG001|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|11|||
164558576|NCT02600494|594413544|FG002|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|14|||
164558577|NCT02600494|594413542|FG000|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|12|||
164558578|NCT02600494|594413543|FG001|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|28|||
164558579|NCT02600494|594413544|FG002|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|10|||
164558580|NCT02600494|594413542|FG000|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
164558581|NCT02600494|594413543|FG001|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|1|||
164558582|NCT02600494|594413544|FG002|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
164558583|NCT02600494|594413542|FG000|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
164558584|NCT02600494|594413543|FG001|Part B (6 Month Open-Label Treatment)|Adverse Event|12|||
164558585|NCT02600494|594413544|FG002|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
164558586|NCT02600494|594413542|FG000|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
164558587|NCT02600494|594413543|FG001|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|4|||
164558588|NCT02600494|594413544|FG002|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
164558589|NCT02600494|594413542|FG000|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
164558590|NCT02600494|594413543|FG001|Part B (6 Month Open-Label Treatment)|Protocol Violation|8|||
164558591|NCT02600494|594413544|FG002|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
164558592|NCT02600494|594413542|FG000|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
164662522|NCT03471078|594789470|FG000|Overall Study|Withdrawal by Subject|9|||
164662523|NCT03471078|594789471|FG001|Overall Study|Withdrawal by Subject|1|||
164662524|NCT03471078|594789470|FG000|Overall Study|Adverse Event|4|||
164662525|NCT03471078|594789471|FG001|Overall Study|Adverse Event|1|||
164662526|NCT03471078|594789470|FG000|Overall Study|Physician Decision|3|||
164662527|NCT03471078|594789471|FG001|Overall Study|Physician Decision|2|||
164662528|NCT03471078|594789470|FG000|Overall Study|Death|2|||
164662529|NCT03471078|594789471|FG001|Overall Study|Death|0|||
164662530|NCT03471078|594789470|FG000|Overall Study|Other|3|||
164662531|NCT03471078|594789471|FG001|Overall Study|Other|2|||
164662532|NCT02819362|594789483|FG000|Overall Study|On-site MRI could not be performed|70|||
164662533|NCT05456529|594789484|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
164662534|NCT05456529|594789484|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
164662535|NCT05456529|594789484|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
164662536|NCT05456529|594789484|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
164558593|NCT02600494|594413543|FG001|Part B (6 Month Open-Label Treatment)|Physician Decision|1|||
164558594|NCT02600494|594413544|FG002|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
164558595|NCT02600494|594413542|FG000|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
164558596|NCT02600494|594413543|FG001|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|17|||
164558597|NCT02600494|594413544|FG002|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
164558598|NCT02600494|594413542|FG000|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
164558599|NCT02600494|594413543|FG001|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|11|||
164558600|NCT02600494|594413544|FG002|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
164558601|NCT01844986|594413545|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
164558602|NCT01844986|594413546|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
164558603|NCT01844986|594413545|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
164558604|NCT01844986|594413546|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
164558605|NCT01844986|594413545|FG000|Overall Study (Global Cohort)|Death|55|||
164558606|NCT01844986|594413546|FG001|Overall Study (Global Cohort)|Death|26|||
164558607|NCT01844986|594413545|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
164558608|NCT01844986|594413546|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
164558609|NCT01844986|594413545|FG000|Overall Study (China Cohort)|Death|10|||
164558610|NCT01844986|594413546|FG001|Overall Study (China Cohort)|Death|6|||
164558611|NCT05416138|594415428|FG000|Overall Study|Withdrawal by Subject|2|||
164558612|NCT05416138|594415429|FG001|Overall Study|Withdrawal by Subject|1|||
164558613|NCT04705051|594415430|FG000|Overall Study|Enrolled but not treated|1|||
164558614|NCT04705051|594415430|FG000|Overall Study|Study terminated by sponsor|23|||
164558615|NCT00542997|594415433|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
164558616|NCT00542997|594415433|FG000|Wash in / Wash Out Period|Adverse Event|3|||
164558617|NCT00542997|594415433|FG000|Efficacy Period|Adverse Event|3|||
164558618|NCT00598975|594415434|FG000|Overall Study|Adverse Event|1|||
164558619|NCT00598975|594415435|FG001|Overall Study|Adverse Event|1|||
164558620|NCT00598975|594415434|FG000|Overall Study|Brain metastases|1|||
164558621|NCT00598975|594415435|FG001|Overall Study|Brain metastases|0|||
164558622|NCT00598975|594415434|FG000|Overall Study|Withdrawal by Subject|1|||
164558623|NCT00598975|594415435|FG001|Overall Study|Withdrawal by Subject|1|||
164558624|NCT00598975|594415434|FG000|Overall Study|Withdrawal of consent|0|||
164558625|NCT00598975|594415435|FG001|Overall Study|Withdrawal of consent|1|||
164558626|NCT00598975|594415434|FG000|Overall Study|Disease progression|8|||
164558627|NCT00598975|594415435|FG001|Overall Study|Disease progression|3|||
164558628|NCT00598975|594415434|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
164558629|NCT00598975|594415435|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
164558630|NCT04137887|594415438|FG000|Overall Study|Death|102|||
164558631|NCT04137887|594415439|FG001|Overall Study|Death|92|||
164558632|NCT04137887|594415438|FG000|Overall Study|Withdrawal by Subject|2|||
164558633|NCT04137887|594415439|FG001|Overall Study|Withdrawal by Subject|3|||
164558634|NCT04137887|594415438|FG000|Overall Study|Randomized but not treated|0|||
164558635|NCT04137887|594415439|FG001|Overall Study|Randomized but not treated|1|||
164558636|NCT01790503|594415442|FG000|Overall Study|Adverse Event|1|||
164558637|NCT01790503|594415443|FG001|Overall Study|Adverse Event|0|||
164558638|NCT01790503|594415444|FG002|Overall Study|Adverse Event|0|||
164558639|NCT01790503|594415445|FG003|Overall Study|Adverse Event|0|||
164558640|NCT01790503|594415446|FG004|Overall Study|Adverse Event|0|||
164558641|NCT01790503|594415447|FG005|Overall Study|Adverse Event|2|||
164558642|NCT01790503|594415448|FG006|Overall Study|Adverse Event|0|||
164558643|NCT01790503|594415449|FG007|Overall Study|Adverse Event|0|||
164558644|NCT01790503|594415450|FG008|Overall Study|Adverse Event|2|||
164558645|NCT01790503|594415451|FG009|Overall Study|Adverse Event|4|||
164558646|NCT01790503|594415452|FG010|Overall Study|Adverse Event|7|||
164558647|NCT01790503|594415442|FG000|Overall Study|Withdrawal by Subject|0|||
164558648|NCT01790503|594415443|FG001|Overall Study|Withdrawal by Subject|0|||
164558649|NCT01790503|594415444|FG002|Overall Study|Withdrawal by Subject|1|||
164662537|NCT05456529|594789484|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
164662538|NCT05456529|594789484|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
164662539|NCT05456529|594789484|FG000|44-week Long-term Safety Period|Physician Decision|2|||
164662540|NCT05456529|594789484|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
164662541|NCT05456529|594789484|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
164662542|NCT05456529|594789484|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
164662543|NCT05456529|594789484|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
164662544|NCT02710123|594789485|FG000|Overall Study|Lost to Follow-up|3|||
164662545|NCT02710123|594789486|FG001|Overall Study|Lost to Follow-up|4|||
164662546|NCT02710123|594789485|FG000|Overall Study|Withdrawal by Subject|1|||
164662547|NCT02710123|594789486|FG001|Overall Study|Withdrawal by Subject|1|||
164662548|NCT02710123|594789485|FG000|Overall Study|Illness unrelated to study intervention|1|||
164662549|NCT02710123|594789486|FG001|Overall Study|Illness unrelated to study intervention|0|||
164662550|NCT05381948|594789487|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
164662551|NCT05381948|594789488|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
164662552|NCT05381948|594789489|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
164662553|NCT05381948|594789487|FG000|Overall Study|Adverse Event: Non-ocular|0|||
164662554|NCT05381948|594789488|FG001|Overall Study|Adverse Event: Non-ocular|1|||
164662555|NCT05381948|594789489|FG002|Overall Study|Adverse Event: Non-ocular|0|||
164662556|NCT05381948|594789487|FG000|Overall Study|Lost to Follow-up|1|||
164662557|NCT05381948|594789488|FG001|Overall Study|Lost to Follow-up|0|||
164662558|NCT05381948|594789489|FG002|Overall Study|Lost to Follow-up|0|||
164662559|NCT05381948|594789487|FG000|Overall Study|Protocol Deviation|0|||
164662560|NCT05381948|594789488|FG001|Overall Study|Protocol Deviation|2|||
164662561|NCT05381948|594789489|FG002|Overall Study|Protocol Deviation|0|||
164662562|NCT05381948|594789487|FG000|Overall Study|Withdrawal by Subject|1|||
164662563|NCT05381948|594789488|FG001|Overall Study|Withdrawal by Subject|0|||
164662564|NCT05381948|594789489|FG002|Overall Study|Withdrawal by Subject|1|||
164662565|NCT05381948|594789487|FG000|Overall Study|Death|0|||
164662566|NCT05381948|594789488|FG001|Overall Study|Death|2|||
164662567|NCT05381948|594789489|FG002|Overall Study|Death|0|||
164662568|NCT05381948|594789487|FG000|Overall Study|Discontinued study without receiving study drug|0|||
164662569|NCT05381948|594789488|FG001|Overall Study|Discontinued study without receiving study drug|0|||
164662570|NCT05381948|594789489|FG002|Overall Study|Discontinued study without receiving study drug|1|||
164662571|NCT04471207|594789490|FG000|Overall Study|Lost to Follow-up|4|||
164662572|NCT04471207|594789491|FG001|Overall Study|Lost to Follow-up|1|||
164662573|NCT04471207|594789490|FG000|Overall Study|Medication Contraindication|0|||
164662574|NCT04471207|594789491|FG001|Overall Study|Medication Contraindication|1|||
164662575|NCT04471207|594789490|FG000|Overall Study|Loss of Interest|2|||
164662576|NCT04471207|594789491|FG001|Overall Study|Loss of Interest|1|||
164662577|NCT04471207|594789490|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
164662578|NCT04471207|594789491|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
164662579|NCT04471207|594789490|FG000|Overall Study|Scheduling Conflicts|3|||
164662580|NCT04471207|594789491|FG001|Overall Study|Scheduling Conflicts|1|||
164662581|NCT04471207|594789490|FG000|Overall Study|Physician Decision|1|||
164662582|NCT04471207|594789491|FG001|Overall Study|Physician Decision|0|||
164662583|NCT04471207|594789490|FG000|Overall Study|Unwilling to Use System|0|||
164662584|NCT04471207|594789491|FG001|Overall Study|Unwilling to Use System|1|||
164662585|NCT03194464|594789496|FG000|Overall Study|data not usable|2|||
164662586|NCT02750761|594789500|FG000|Overall Study|Lost to Follow-up|0|||
164662587|NCT02750761|594789501|FG001|Overall Study|Lost to Follow-up|0|||
164662588|NCT02750761|594789502|FG002|Overall Study|Lost to Follow-up|1|||
164662589|NCT02750761|594789503|FG003|Overall Study|Lost to Follow-up|0|||
164662590|NCT02750761|594789504|FG004|Overall Study|Lost to Follow-up|0|||
164662591|NCT02750761|594789505|FG005|Overall Study|Lost to Follow-up|0|||
164662592|NCT01860976|594789506|FG000|Blinded Treatment|Adverse Event|1|||
164662593|NCT01860976|594789507|FG001|Blinded Treatment|Adverse Event|3|||
164662594|NCT01860976|594789506|FG000|Blinded Treatment|Lack of Efficacy|5|||
164662595|NCT01860976|594789507|FG001|Blinded Treatment|Lack of Efficacy|12|||
164662596|NCT01860976|594789506|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
164662597|NCT01860976|594789507|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
164662598|NCT01860976|594789506|FG000|Blinded Treatment|Withdrawal by Subject|3|||
164662599|NCT01860976|594789507|FG001|Blinded Treatment|Withdrawal by Subject|5|||
164662600|NCT01860976|594789506|FG000|Blinded Treatment|Subject no longer met criteria|1|||
164662601|NCT01860976|594789507|FG001|Blinded Treatment|Subject no longer met criteria|0|||
164662602|NCT01860976|594789506|FG000|Blinded Treatment|Entered Open-Label in error|0|||
164204058|NCT05117060|593117927|FG002|Overall Study|Lost to Follow-up|0|||
164204059|NCT05117060|593117928|FG003|Overall Study|Lost to Follow-up|1|||
164662603|NCT01860976|594789507|FG001|Blinded Treatment|Entered Open-Label in error|1|||
164662604|NCT01860976|594789506|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
164662605|NCT01860976|594789507|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
164662606|NCT01860976|594789506|FG000|Open-Label|Adverse Event|2|||
164662607|NCT01860976|594789507|FG001|Open-Label|Adverse Event|4|||
164662608|NCT01860976|594789506|FG000|Open-Label|Lack of Efficacy|16|||
164662609|NCT01860976|594789507|FG001|Open-Label|Lack of Efficacy|8|||
164662610|NCT01860976|594789506|FG000|Open-Label|Lost to Follow-up|1|||
164662611|NCT01860976|594789507|FG001|Open-Label|Lost to Follow-up|2|||
164662612|NCT01860976|594789506|FG000|Open-Label|Subject request discontinue treatment|4|||
164662613|NCT01860976|594789507|FG001|Open-Label|Subject request discontinue treatment|3|||
164558650|NCT01790503|594415445|FG003|Overall Study|Withdrawal by Subject|1|||
164558651|NCT01790503|594415446|FG004|Overall Study|Withdrawal by Subject|1|||
164558652|NCT01790503|594415447|FG005|Overall Study|Withdrawal by Subject|2|||
164558653|NCT01790503|594415448|FG006|Overall Study|Withdrawal by Subject|1|||
164558654|NCT01790503|594415449|FG007|Overall Study|Withdrawal by Subject|0|||
164558655|NCT01790503|594415450|FG008|Overall Study|Withdrawal by Subject|0|||
164558656|NCT01790503|594415451|FG009|Overall Study|Withdrawal by Subject|0|||
164558657|NCT01790503|594415452|FG010|Overall Study|Withdrawal by Subject|1|||
164558658|NCT01790503|594415442|FG000|Overall Study|Disease progression|2|||
164558659|NCT01790503|594415443|FG001|Overall Study|Disease progression|1|||
164558660|NCT01790503|594415444|FG002|Overall Study|Disease progression|0|||
164558661|NCT01790503|594415445|FG003|Overall Study|Disease progression|1|||
164558662|NCT01790503|594415446|FG004|Overall Study|Disease progression|2|||
164558663|NCT01790503|594415447|FG005|Overall Study|Disease progression|1|||
164558664|NCT01790503|594415448|FG006|Overall Study|Disease progression|0|||
164558665|NCT01790503|594415449|FG007|Overall Study|Disease progression|1|||
164558666|NCT01790503|594415450|FG008|Overall Study|Disease progression|0|||
164558667|NCT01790503|594415451|FG009|Overall Study|Disease progression|17|||
164558668|NCT01790503|594415452|FG010|Overall Study|Disease progression|7|||
164558669|NCT01790503|594415442|FG000|Overall Study|Protocol Violation|0|||
164558670|NCT01790503|594415443|FG001|Overall Study|Protocol Violation|0|||
164558671|NCT01790503|594415444|FG002|Overall Study|Protocol Violation|0|||
164558672|NCT01790503|594415445|FG003|Overall Study|Protocol Violation|0|||
164558673|NCT01790503|594415446|FG004|Overall Study|Protocol Violation|0|||
164558674|NCT01790503|594415447|FG005|Overall Study|Protocol Violation|0|||
164558675|NCT01790503|594415448|FG006|Overall Study|Protocol Violation|0|||
164558676|NCT01790503|594415449|FG007|Overall Study|Protocol Violation|0|||
164558677|NCT01790503|594415450|FG008|Overall Study|Protocol Violation|0|||
164558678|NCT01790503|594415451|FG009|Overall Study|Protocol Violation|1|||
164558679|NCT01790503|594415452|FG010|Overall Study|Protocol Violation|0|||
164558680|NCT01790503|594415442|FG000|Overall Study|Physician Decision|0|||
164558681|NCT01790503|594415443|FG001|Overall Study|Physician Decision|0|||
164558682|NCT01790503|594415444|FG002|Overall Study|Physician Decision|0|||
164558683|NCT01790503|594415445|FG003|Overall Study|Physician Decision|0|||
164558684|NCT01790503|594415446|FG004|Overall Study|Physician Decision|0|||
164558685|NCT01790503|594415447|FG005|Overall Study|Physician Decision|0|||
164558686|NCT01790503|594415448|FG006|Overall Study|Physician Decision|0|||
164558687|NCT01790503|594415449|FG007|Overall Study|Physician Decision|0|||
164558688|NCT01790503|594415450|FG008|Overall Study|Physician Decision|0|||
164558689|NCT01790503|594415451|FG009|Overall Study|Physician Decision|1|||
164558690|NCT01790503|594415452|FG010|Overall Study|Physician Decision|1|||
164558691|NCT01790503|594415442|FG000|Overall Study|Death|0|||
164662614|NCT01860976|594789506|FG000|Open-Label|Withdrawal by Subject|4|||
164662615|NCT01860976|594789507|FG001|Open-Label|Withdrawal by Subject|1|||
164662616|NCT01860976|594789506|FG000|Open-Label|Other Reasons|1|||
164662617|NCT01860976|594789507|FG001|Open-Label|Other Reasons|1|||
164662618|NCT01860976|594789506|FG000|Long Term Extension|Adverse Event|4|||
164662619|NCT01860976|594789507|FG001|Long Term Extension|Adverse Event|0|||
164558692|NCT01790503|594415443|FG001|Overall Study|Death|0|||
164558693|NCT01790503|594415444|FG002|Overall Study|Death|0|||
164558694|NCT01790503|594415445|FG003|Overall Study|Death|0|||
164558695|NCT01790503|594415446|FG004|Overall Study|Death|0|||
164558696|NCT01790503|594415447|FG005|Overall Study|Death|0|||
164558697|NCT01790503|594415448|FG006|Overall Study|Death|0|||
164662620|NCT01860976|594789506|FG000|Long Term Extension|Lack of Efficacy|2|||
164662621|NCT01860976|594789507|FG001|Long Term Extension|Lack of Efficacy|0|||
164662622|NCT01860976|594789506|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
164558698|NCT01790503|594415449|FG007|Overall Study|Death|0|||
164558699|NCT01790503|594415450|FG008|Overall Study|Death|0|||
164558700|NCT01790503|594415451|FG009|Overall Study|Death|1|||
164558701|NCT01790503|594415452|FG010|Overall Study|Death|0|||
164558702|NCT01790503|594415442|FG000|Overall Study|Non Compliance|0|||
164558703|NCT01790503|594415443|FG001|Overall Study|Non Compliance|0|||
164558704|NCT01790503|594415444|FG002|Overall Study|Non Compliance|0|||
164558705|NCT01790503|594415445|FG003|Overall Study|Non Compliance|0|||
164558706|NCT01790503|594415446|FG004|Overall Study|Non Compliance|1|||
164558707|NCT01790503|594415447|FG005|Overall Study|Non Compliance|0|||
164558708|NCT01790503|594415448|FG006|Overall Study|Non Compliance|0|||
164558709|NCT01790503|594415449|FG007|Overall Study|Non Compliance|0|||
164558710|NCT01790503|594415450|FG008|Overall Study|Non Compliance|0|||
164558711|NCT01790503|594415451|FG009|Overall Study|Non Compliance|0|||
164558712|NCT01790503|594415452|FG010|Overall Study|Non Compliance|0|||
164558713|NCT01790503|594415442|FG000|Overall Study|Other|0|||
164558714|NCT01790503|594415443|FG001|Overall Study|Other|0|||
164558715|NCT01790503|594415444|FG002|Overall Study|Other|0|||
164558716|NCT01790503|594415445|FG003|Overall Study|Other|0|||
164558717|NCT01790503|594415446|FG004|Overall Study|Other|1|||
164204060|NCT05117060|593117925|FG000|Overall Study|Lack of Efficacy|4|||
164558718|NCT01790503|594415447|FG005|Overall Study|Other|0|||
164558719|NCT01790503|594415448|FG006|Overall Study|Other|0|||
164558720|NCT01790503|594415449|FG007|Overall Study|Other|0|||
164662623|NCT01860976|594789507|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
164662624|NCT01860976|594789506|FG000|Long Term Extension|Lost to Follow-up|2|||
164662625|NCT01860976|594789507|FG001|Long Term Extension|Lost to Follow-up|0|||
164662626|NCT01860976|594789506|FG000|Long Term Extension|subject withdrew consent|7|||
164662627|NCT01860976|594789507|FG001|Long Term Extension|subject withdrew consent|0|||
164662628|NCT02153398|594789509|FG000|Overall Study|Withdrawal by Subject|1|||
164662629|NCT02153398|594789510|FG001|Overall Study|Withdrawal by Subject|0|||
164662630|NCT02153398|594789511|FG002|Overall Study|Withdrawal by Subject|0|||
164662631|NCT02153398|594789512|FG003|Overall Study|Withdrawal by Subject|0|||
164662632|NCT02153398|594789513|FG004|Overall Study|Withdrawal by Subject|0|||
164662633|NCT02153398|594789509|FG000|Overall Study|Adverse Event|0|||
164662634|NCT02153398|594789510|FG001|Overall Study|Adverse Event|0|||
164662635|NCT02153398|594789511|FG002|Overall Study|Adverse Event|1|||
164662636|NCT02153398|594789512|FG003|Overall Study|Adverse Event|1|||
164662637|NCT02153398|594789513|FG004|Overall Study|Adverse Event|0|||
164662638|NCT02204371|594789515|FG000|Overall Study|Adverse Event|1|||
164662639|NCT00810368|594789516|FG000|Overall Study|Lost to Follow-up|4|||
164662640|NCT00810368|594789517|FG001|Overall Study|Lost to Follow-up|2|||
164662641|NCT00810368|594789516|FG000|Overall Study|Lack of Efficacy|2|||
164662642|NCT00810368|594789517|FG001|Overall Study|Lack of Efficacy|0|||
164662643|NCT01506947|594789518|FG000|Overall Study|Lost to Follow-up|7|||
164662644|NCT01506947|594789518|FG000|Overall Study|Adverse Event|5|||
164662645|NCT01506947|594789518|FG000|Overall Study|Death|1|||
164662646|NCT01506947|594789518|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
164662647|NCT01781286|594789523|FG000|Overall Study|Lost to Follow-up|0|||
164662648|NCT01781286|594789524|FG001|Overall Study|Lost to Follow-up|0|||
164662649|NCT01781286|594789525|FG002|Overall Study|Lost to Follow-up|0|||
164662650|NCT01781286|594789526|FG003|Overall Study|Lost to Follow-up|0|||
164662651|NCT01781286|594789527|FG004|Overall Study|Lost to Follow-up|0|||
164662652|NCT01781286|594789528|FG005|Overall Study|Lost to Follow-up|1|||
164662653|NCT01781286|594789523|FG000|Overall Study|Time Constraints|2|||
164662654|NCT01781286|594789524|FG001|Overall Study|Time Constraints|0|||
164662655|NCT01781286|594789525|FG002|Overall Study|Time Constraints|2|||
164662656|NCT01781286|594789526|FG003|Overall Study|Time Constraints|0|||
164662657|NCT01781286|594789527|FG004|Overall Study|Time Constraints|0|||
164662658|NCT01781286|594789528|FG005|Overall Study|Time Constraints|0|||
164662659|NCT01781286|594789523|FG000|Overall Study|Noncompliance|0|||
164662660|NCT01781286|594789524|FG001|Overall Study|Noncompliance|0|||
164662661|NCT01781286|594789525|FG002|Overall Study|Noncompliance|0|||
164662662|NCT01781286|594789526|FG003|Overall Study|Noncompliance|1|||
164662663|NCT01781286|594789527|FG004|Overall Study|Noncompliance|0|||
164662664|NCT01781286|594789528|FG005|Overall Study|Noncompliance|0|||
164662665|NCT03365375|594789529|FG000|Overall Study|Withdrawal by Subject|0|||
164662666|NCT03365375|594789530|FG001|Overall Study|Withdrawal by Subject|1|||
164662667|NCT03365375|594789529|FG000|Overall Study|Lost to Follow-up|0|||
164662668|NCT03365375|594789530|FG001|Overall Study|Lost to Follow-up|4|||
164662669|NCT02187042|594789531|FG000|Overall Study|Death|1|||
164662670|NCT02187042|594789532|FG001|Overall Study|Death|1|||
164662671|NCT02187042|594789531|FG000|Overall Study|Toxicity|6|||
164662672|NCT02187042|594789532|FG001|Overall Study|Toxicity|5|||
164662673|NCT02187042|594789531|FG000|Overall Study|Participant choice|1|||
164662674|NCT02187042|594789532|FG001|Overall Study|Participant choice|0|||
164662675|NCT02187042|594789531|FG000|Overall Study|Doctor choice|1|||
164662676|NCT02187042|594789532|FG001|Overall Study|Doctor choice|0|||
164662677|NCT02187042|594789531|FG000|Overall Study|Progressive disease|4|||
164662678|NCT02187042|594789532|FG001|Overall Study|Progressive disease|8|||
164662679|NCT01766921|594789537|FG000|Overall Study|Administrative Reason|5|||
164662680|NCT01766921|594789538|FG001|Overall Study|Administrative Reason|5|||
164662681|NCT01766921|594789537|FG000|Overall Study|Death|1|||
164662682|NCT01766921|594789538|FG001|Overall Study|Death|1|||
164662683|NCT01766921|594789537|FG000|Overall Study|Lost to Follow-up|1|||
164662684|NCT01766921|594789538|FG001|Overall Study|Lost to Follow-up|3|||
164662685|NCT01766921|594789537|FG000|Overall Study|Unclassified|2|||
164662686|NCT01766921|594789538|FG001|Overall Study|Unclassified|2|||
164662687|NCT01766921|594789537|FG000|Overall Study|Protocol Violation|1|||
164314824|NCT04629066|593529776|FG001|Overall Study|Lost to Follow-up|2|||
164662688|NCT01766921|594789538|FG001|Overall Study|Protocol Violation|1|||
164662689|NCT01766921|594789537|FG000|Overall Study|Withdrawal by Subject|14|||
164662690|NCT01766921|594789538|FG001|Overall Study|Withdrawal by Subject|5|||
164662691|NCT01659567|594789541|FG000|Overall Study|Lack of Efficacy|22|||
164662692|NCT01659567|594789541|FG000|Overall Study|Switched to Pegferon|6|||
164662693|NCT01659567|594789541|FG000|Overall Study|Adverse Event|12|||
164662694|NCT01659567|594789541|FG000|Overall Study|Good result at early stage of treatment|5|||
164662695|NCT01659567|594789541|FG000|Overall Study|Withdrawal by Subject|64|||
164662696|NCT01659567|594789541|FG000|Overall Study|Progression of the main disease|1|||
164662697|NCT01659567|594789541|FG000|Overall Study|Other|13|||
164662698|NCT01179919|594789546|FG000|Overall Study|Protocol Violation|1|||
164662699|NCT01179919|594789546|FG000|Overall Study|Adverse Event|1|||
164662700|NCT01915732|594789555|FG000|Overall Study|Withdrawal by Subject|18|||
164558721|NCT01790503|594415450|FG008|Overall Study|Other|1|||
164558722|NCT01790503|594415451|FG009|Overall Study|Other|2|||
164558723|NCT01790503|594415452|FG010|Overall Study|Other|0|||
164558724|NCT04183335|594415453|FG000|Overall Study|Adverse Event|1|||
164558725|NCT04183335|594415454|FG001|Overall Study|Adverse Event|0|||
164558726|NCT04183335|594415453|FG000|Overall Study|Withdrawal by Subject|12|||
164558727|NCT04183335|594415454|FG001|Overall Study|Withdrawal by Subject|3|||
164558728|NCT00049673|594415455|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
164558729|NCT00049673|594415456|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
164558730|NCT01535729|594415457|FG000|Overall Study|Withdrawal by Subject|2|||
164558731|NCT01535729|594415457|FG000|Overall Study|Disease progression|230|||
164558732|NCT01535729|594415457|FG000|Overall Study|Discontinued treatment|25|||
164558733|NCT01535729|594415457|FG000|Overall Study|Lost to Follow-up|8|||
164558734|NCT01535729|594415457|FG000|Overall Study|Death|52|||
164558735|NCT01535729|594415457|FG000|Overall Study|Other|19|||
164558736|NCT01535729|594415457|FG000|Overall Study|Did not sign informed consent|1|||
164558737|NCT01535729|594415457|FG000|Overall Study|No previous chemotherapy|33|||
164558738|NCT01535729|594415457|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
164558739|NCT01535729|594415457|FG000|Overall Study|Protocol Violation|11|||
164558740|NCT01535729|594415457|FG000|Overall Study|Screening failure|1|||
164558741|NCT01535729|594415457|FG000|Overall Study|Not treated|9|||
164558742|NCT01535729|594415457|FG000|Overall Study|No participant record available|5|||
164558743|NCT01934140|594415460|FG000|Persistence Phase (Year 6-10)|Other|24|||
164558744|NCT01934140|594415461|FG001|Persistence Phase (Year 6-10)|Other|6|||
164558745|NCT01934140|594415460|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
164558746|NCT01934140|594415461|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
164558747|NCT01934140|594415460|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
164558748|NCT01934140|594415461|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
164558749|NCT01934140|594415460|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
164558750|NCT01934140|594415461|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
164558751|NCT01934140|594415460|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
164558752|NCT01934140|594415461|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
164558753|NCT01934140|594415460|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
164558754|NCT01934140|594415461|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
164558755|NCT01934140|594415460|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
164558756|NCT01934140|594415461|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
164558757|NCT01934140|594415460|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
164558758|NCT01934140|594415461|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
164558759|NCT00618748|594415465|FG000|Overall Study|Adverse Event|4|||
164558760|NCT00618748|594415466|FG001|Overall Study|Adverse Event|3|||
164558761|NCT00618748|594415467|FG002|Overall Study|Adverse Event|8|||
164558762|NCT00618748|594415465|FG000|Overall Study|Physician Decision|3|||
164558763|NCT00618748|594415466|FG001|Overall Study|Physician Decision|1|||
164558764|NCT00618748|594415467|FG002|Overall Study|Physician Decision|1|||
164558765|NCT00618748|594415465|FG000|Overall Study|Withdrawal by Subject|4|||
164558766|NCT00618748|594415466|FG001|Overall Study|Withdrawal by Subject|1|||
164558767|NCT00618748|594415467|FG002|Overall Study|Withdrawal by Subject|5|||
164558768|NCT00200850|594415468|FG000|Overall Study|relocation|1|||
164558769|NCT00200850|594415469|FG001|Overall Study|relocation|0|||
164558770|NCT00200850|594415470|FG002|Overall Study|relocation|1|||
164558771|NCT00200850|594415468|FG000|Overall Study|too busy|1|||
164558772|NCT00200850|594415469|FG001|Overall Study|too busy|0|||
164558773|NCT00200850|594415470|FG002|Overall Study|too busy|0|||
164558774|NCT00200850|594415468|FG000|Overall Study|Pregnancy|0|||
164558775|NCT00200850|594415469|FG001|Overall Study|Pregnancy|0|||
164558776|NCT00200850|594415470|FG002|Overall Study|Pregnancy|1|||
164558777|NCT00200850|594415468|FG000|Overall Study|Poor adherence|0|||
164314825|NCT02703337|593529777|FG000|Period One (Part A)|Withdrawal by Subject|0|||
164314826|NCT02703337|593529778|FG001|Period One (Part A)|Withdrawal by Subject|0|||
164314827|NCT02703337|593529779|FG002|Period One (Part A)|Withdrawal by Subject|0|||
164314828|NCT02703337|593529780|FG003|Period One (Part A)|Withdrawal by Subject|0|||
164314829|NCT02703337|593529781|FG004|Period One (Part A)|Withdrawal by Subject|1|||
164558778|NCT00200850|594415469|FG001|Overall Study|Poor adherence|0|||
164558779|NCT00200850|594415470|FG002|Overall Study|Poor adherence|1|||
164558780|NCT00200850|594415468|FG000|Overall Study|optic neuritis|0|||
164558781|NCT00200850|594415469|FG001|Overall Study|optic neuritis|0|||
164558782|NCT00200850|594415470|FG002|Overall Study|optic neuritis|1|||
164558783|NCT00200850|594415468|FG000|Overall Study|Adverse Event|1|||
164558784|NCT00200850|594415469|FG001|Overall Study|Adverse Event|1|||
164558785|NCT00200850|594415470|FG002|Overall Study|Adverse Event|2|||
164558786|NCT01414257|594415476|FG000|Overall Study|No Visit After First Day of Treatment|12|||
164558787|NCT01414257|594415476|FG000|Overall Study|Protocol Violation|10|||
164558788|NCT01978093|594415477|FG000|Overall Study|Death|1|||
164558789|NCT01978093|594415478|FG001|Overall Study|Death|0|||
164558790|NCT01978093|594415477|FG000|Overall Study|Adverse Event|0|||
164558791|NCT01978093|594415478|FG001|Overall Study|Adverse Event|5|||
164558792|NCT01978093|594415477|FG000|Overall Study|Protocol Violation|8|||
164558793|NCT01978093|594415478|FG001|Overall Study|Protocol Violation|2|||
164558794|NCT01978093|594415477|FG000|Overall Study|Withdrawal by Subject|29|||
164558795|NCT01978093|594415478|FG001|Overall Study|Withdrawal by Subject|25|||
164558796|NCT01978093|594415477|FG000|Overall Study|Lost to Follow-up|11|||
164558797|NCT01978093|594415478|FG001|Overall Study|Lost to Follow-up|15|||
164558798|NCT01978093|594415477|FG000|Overall Study|Migrated/moved from study area|11|||
164558799|NCT01978093|594415478|FG001|Overall Study|Migrated/moved from study area|13|||
164558800|NCT01978093|594415477|FG000|Overall Study|Loss of kaiser coverage|4|||
164558801|NCT01978093|594415478|FG001|Overall Study|Loss of kaiser coverage|10|||
164558802|NCT01978093|594415477|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
164558803|NCT01978093|594415478|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
164558804|NCT01978093|594415477|FG000|Overall Study|Mother lost custody of child|0|||
164558805|NCT01978093|594415478|FG001|Overall Study|Mother lost custody of child|1|||
164558806|NCT01978093|594415477|FG000|Overall Study|Child was in care of grandmother|0|||
164558807|NCT01978093|594415478|FG001|Overall Study|Child was in care of grandmother|1|||
164558808|NCT01978093|594415477|FG000|Overall Study|N/A for vaccine administration|0|||
164558809|NCT01978093|594415478|FG001|Overall Study|N/A for vaccine administration|1|||
164558810|NCT03033745|594415486|FG000|Overall Study|Protocol Violation|0|||
164558811|NCT03033745|594415487|FG001|Overall Study|Protocol Violation|0|||
164558812|NCT03033745|594415488|FG002|Overall Study|Protocol Violation|1|||
164558813|NCT03033745|594415486|FG000|Overall Study|Adverse Event|1|||
164558814|NCT03033745|594415487|FG001|Overall Study|Adverse Event|0|||
164558815|NCT03033745|594415488|FG002|Overall Study|Adverse Event|1|||
164558816|NCT03033745|594415486|FG000|Overall Study|Withdrawal by Subject|0|||
164558817|NCT03033745|594415487|FG001|Overall Study|Withdrawal by Subject|1|||
164558818|NCT03033745|594415488|FG002|Overall Study|Withdrawal by Subject|0|||
164558819|NCT03728309|594415492|FG000|Overall Study|Randomized but not Treated|0|||
164558820|NCT03728309|594415493|FG001|Overall Study|Randomized but not Treated|1|||
164558821|NCT03728309|594415492|FG000|Overall Study|Adverse Event|0|||
164558822|NCT03728309|594415493|FG001|Overall Study|Adverse Event|1|||
164558823|NCT03728309|594415492|FG000|Overall Study|Withdrawal by Subject|2|||
164558824|NCT03728309|594415493|FG001|Overall Study|Withdrawal by Subject|8|||
164558825|NCT03728309|594415492|FG000|Overall Study|Lost to Follow-up|9|||
164558826|NCT03728309|594415493|FG001|Overall Study|Lost to Follow-up|10|||
164558827|NCT03728309|594415492|FG000|Overall Study|Protocol Deviation|0|||
164558828|NCT03728309|594415493|FG001|Overall Study|Protocol Deviation|1|||
164558829|NCT03728309|594415492|FG000|Overall Study|Due to COVID|1|||
164558830|NCT03728309|594415493|FG001|Overall Study|Due to COVID|3|||
164558831|NCT03403205|594415494|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
164558832|NCT03403205|594415495|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
164558833|NCT03403205|594415496|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
164558834|NCT03403205|594415497|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
164558835|NCT03403205|594415498|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
164558836|NCT03403205|594415499|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
164558837|NCT03403205|594415494|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
164558838|NCT03403205|594415495|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
164558839|NCT03403205|594415496|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
164558840|NCT03403205|594415497|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
164558841|NCT03403205|594415498|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
164558842|NCT03403205|594415499|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
164558843|NCT03403205|594415494|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
164558844|NCT03403205|594415495|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
164558845|NCT03403205|594415496|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
164558846|NCT03403205|594415497|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
164558847|NCT03403205|594415498|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
164558848|NCT03403205|594415499|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
164558849|NCT03403205|594415494|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
164558850|NCT03403205|594415495|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
164558851|NCT03403205|594415496|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
164558852|NCT03403205|594415497|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
164558853|NCT03403205|594415498|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
164558854|NCT03403205|594415499|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
164558855|NCT03403205|594415494|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
164558856|NCT03403205|594415495|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
164558857|NCT03403205|594415496|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
164558858|NCT03403205|594415497|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
164558859|NCT03403205|594415498|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
164558860|NCT03403205|594415499|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
164558861|NCT03403205|594415494|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
164558862|NCT03403205|594415495|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
164558863|NCT03403205|594415496|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
164558864|NCT03403205|594415497|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
164558865|NCT03403205|594415498|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
164558866|NCT03403205|594415499|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
164558867|NCT03403205|594415494|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
164558868|NCT03403205|594415495|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
164558869|NCT03403205|594415496|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
164558870|NCT03403205|594415497|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
164558871|NCT03403205|594415498|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
164558872|NCT03403205|594415499|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
164558873|NCT03403205|594415494|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
164558874|NCT03403205|594415495|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
164558875|NCT03403205|594415496|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
164558876|NCT03403205|594415497|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
164558877|NCT03403205|594415498|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
164558878|NCT03403205|594415499|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
164558879|NCT03403205|594415494|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
164558880|NCT03403205|594415495|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
164558881|NCT03403205|594415496|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
164558882|NCT03403205|594415497|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
164558883|NCT03403205|594415498|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
164558884|NCT03403205|594415499|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
164558885|NCT03403205|594415494|FG000|Extension Period (Up to 60 Months)|Death|1|||
164558886|NCT03403205|594415495|FG001|Extension Period (Up to 60 Months)|Death|0|||
164558887|NCT03403205|594415496|FG002|Extension Period (Up to 60 Months)|Death|0|||
164558888|NCT03403205|594415497|FG003|Extension Period (Up to 60 Months)|Death|0|||
164558889|NCT03403205|594415498|FG004|Extension Period (Up to 60 Months)|Death|0|||
164558890|NCT03403205|594415499|FG005|Extension Period (Up to 60 Months)|Death|0|||
164558891|NCT03403205|594415494|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
164558892|NCT03403205|594415495|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
164558893|NCT03403205|594415496|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
164558894|NCT03403205|594415497|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
164558895|NCT03403205|594415498|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
164558896|NCT03403205|594415499|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
164558897|NCT03403205|594415494|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
164558898|NCT03403205|594415495|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
164558899|NCT03403205|594415496|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
164558900|NCT03403205|594415497|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
164558901|NCT03403205|594415498|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
164558902|NCT03403205|594415499|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
164558903|NCT03403205|594415494|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
164558904|NCT03403205|594415495|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
164558905|NCT03403205|594415496|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
164558906|NCT03403205|594415497|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
164558907|NCT03403205|594415498|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
164558908|NCT03403205|594415499|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
164662701|NCT01915732|594789556|FG001|Overall Study|Withdrawal by Subject|18|||
164662702|NCT01915732|594789555|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
164662703|NCT01915732|594789556|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
164662704|NCT01915732|594789555|FG000|Overall Study|Adverse Event|12|||
164662705|NCT01915732|594789556|FG001|Overall Study|Adverse Event|4|||
164662706|NCT01915732|594789555|FG000|Overall Study|Protocol Violation|5|||
164558909|NCT03403205|594415494|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
164558910|NCT03403205|594415495|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
164558911|NCT03403205|594415496|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
164662707|NCT01915732|594789556|FG001|Overall Study|Protocol Violation|5|||
164662708|NCT01915732|594789555|FG000|Overall Study|Lack of Efficacy|6|||
164662709|NCT01915732|594789556|FG001|Overall Study|Lack of Efficacy|11|||
164662710|NCT01915732|594789555|FG000|Overall Study|Lost to Follow-up|22|||
164662711|NCT01915732|594789556|FG001|Overall Study|Lost to Follow-up|26|||
164662712|NCT01915732|594789555|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
164662713|NCT01915732|594789556|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
164662714|NCT01915732|594789555|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
164204061|NCT05117060|593117926|FG001|Overall Study|Lack of Efficacy|5|||
164204062|NCT05117060|593117927|FG002|Overall Study|Lack of Efficacy|2|||
164204063|NCT05117060|593117928|FG003|Overall Study|Lack of Efficacy|6|||
164204064|NCT05117060|593117925|FG000|Overall Study|Withdrawal by Subject|8|||
164662715|NCT01915732|594789556|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
164662716|NCT01915732|594789555|FG000|Overall Study|Drug Release Error|1|||
164662717|NCT01915732|594789556|FG001|Overall Study|Drug Release Error|0|||
164662718|NCT01915732|594789555|FG000|Overall Study|Recovered|1|||
164662719|NCT01915732|594789556|FG001|Overall Study|Recovered|0|||
164662720|NCT01915732|594789555|FG000|Overall Study|Pregnancy|1|||
164662721|NCT01915732|594789556|FG001|Overall Study|Pregnancy|0|||
164662722|NCT01915732|594789555|FG000|Overall Study|Poor Perceived Efficacy|1|||
164662723|NCT01915732|594789556|FG001|Overall Study|Poor Perceived Efficacy|0|||
164662724|NCT01915732|594789555|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
164662725|NCT01915732|594789556|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
164662726|NCT01915732|594789555|FG000|Overall Study|Got Well|0|||
164662727|NCT01915732|594789556|FG001|Overall Study|Got Well|1|||
164662728|NCT01915732|594789555|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
164662729|NCT01915732|594789556|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
164662730|NCT01915732|594789555|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
164662731|NCT01915732|594789556|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
164662732|NCT01915732|594789555|FG000|Overall Study|Job Transfer|0|||
164662733|NCT01915732|594789556|FG001|Overall Study|Job Transfer|1|||
164662734|NCT01915732|594789555|FG000|Overall Study|Improper Facial Procedure|0|||
164662735|NCT01915732|594789556|FG001|Overall Study|Improper Facial Procedure|1|||
164662736|NCT01915732|594789555|FG000|Overall Study|Poor Conscious Effect|0|||
164662737|NCT01915732|594789556|FG001|Overall Study|Poor Conscious Effect|1|||
164662738|NCT00698685|594789557|FG000|Overall Study|Sister withdrew as donor|1|||
164662739|NCT00698685|594789557|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
164662740|NCT01325207|594789558|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
164662741|NCT01325207|594789559|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
164662742|NCT01325207|594789560|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
164662743|NCT01325207|594789561|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
164662744|NCT01325207|594789562|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
164662745|NCT01325207|594789563|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
164662746|NCT01325207|594789558|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
164662747|NCT01325207|594789559|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
164662748|NCT01325207|594789560|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
164662749|NCT01325207|594789561|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
164662750|NCT01325207|594789562|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
164662751|NCT01325207|594789563|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
164662752|NCT01325207|594789558|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
164662753|NCT01325207|594789559|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
164662754|NCT01325207|594789560|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
164662755|NCT01325207|594789561|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
164662756|NCT01325207|594789562|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
164662757|NCT01325207|594789563|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
164662758|NCT01325207|594789558|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
164662759|NCT01325207|594789559|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
164662760|NCT01325207|594789560|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
164662761|NCT01325207|594789561|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
164662762|NCT01325207|594789562|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
164662763|NCT01325207|594789563|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
164662764|NCT01325207|594789558|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
164662765|NCT01325207|594789559|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
164662766|NCT01325207|594789560|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
164662767|NCT01325207|594789561|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
164662768|NCT01325207|594789562|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
164662769|NCT01325207|594789563|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
164662770|NCT01325207|594789558|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
164662771|NCT01325207|594789559|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
164662772|NCT01325207|594789560|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
164662773|NCT01325207|594789561|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
164662774|NCT01325207|594789562|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
164662775|NCT01325207|594789563|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
164662776|NCT01325207|594789558|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
164662777|NCT01325207|594789559|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
164662778|NCT01325207|594789560|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
164662779|NCT01325207|594789561|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
164662780|NCT01325207|594789562|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
164662781|NCT01325207|594789563|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
164662782|NCT00337571|594789564|FG000|Overall Study|Lack of Efficacy|3|||
164662783|NCT00337571|594789565|FG001|Overall Study|Lack of Efficacy|0|||
164662784|NCT00337571|594789566|FG002|Overall Study|Lack of Efficacy|0|||
164662785|NCT00337571|594789567|FG003|Overall Study|Lack of Efficacy|0|||
164662786|NCT00337571|594789564|FG000|Overall Study|Adverse Event|4|||
164662787|NCT00337571|594789565|FG001|Overall Study|Adverse Event|5|||
164662788|NCT00337571|594789566|FG002|Overall Study|Adverse Event|8|||
164662789|NCT00337571|594789567|FG003|Overall Study|Adverse Event|4|||
164662790|NCT00337571|594789564|FG000|Overall Study|Withdrawal by Subject|2|||
164662791|NCT00337571|594789565|FG001|Overall Study|Withdrawal by Subject|2|||
164662792|NCT00337571|594789566|FG002|Overall Study|Withdrawal by Subject|1|||
164662793|NCT00337571|594789567|FG003|Overall Study|Withdrawal by Subject|0|||
164662794|NCT00337571|594789564|FG000|Overall Study|Lost to Follow-up|3|||
164662795|NCT00337571|594789565|FG001|Overall Study|Lost to Follow-up|1|||
164662796|NCT00337571|594789566|FG002|Overall Study|Lost to Follow-up|0|||
164662797|NCT00337571|594789567|FG003|Overall Study|Lost to Follow-up|1|||
164662798|NCT00337571|594789564|FG000|Overall Study|Poor/noncompliance|1|||
164662799|NCT00337571|594789565|FG001|Overall Study|Poor/noncompliance|1|||
164662800|NCT00337571|594789566|FG002|Overall Study|Poor/noncompliance|1|||
164662801|NCT00337571|594789567|FG003|Overall Study|Poor/noncompliance|1|||
164662802|NCT00337571|594789564|FG000|Overall Study|No longer met study criteria|1|||
164662803|NCT00337571|594789565|FG001|Overall Study|No longer met study criteria|0|||
164558912|NCT03403205|594415497|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
164558913|NCT03403205|594415498|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
164558914|NCT03403205|594415499|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
164558915|NCT03403205|594415494|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
164558916|NCT03403205|594415495|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
164558917|NCT03403205|594415496|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
164558918|NCT03403205|594415497|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
164558919|NCT03403205|594415498|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
164558920|NCT03403205|594415499|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
164558921|NCT03403205|594415494|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
164558922|NCT03403205|594415495|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
164558923|NCT03403205|594415496|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
164558924|NCT03403205|594415497|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
164558925|NCT03403205|594415498|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
164558926|NCT03403205|594415499|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
164558927|NCT02004873|594415500|FG000|Overall Study|Implant unsuccessful|6|||
164558928|NCT02004873|594415500|FG000|Overall Study|Awaiting 6-month visit|390|||
164558929|NCT02004873|594415500|FG000|Overall Study|Missed 6-month visit|4|||
164558930|NCT02004873|594415500|FG000|Overall Study|Death|23|||
164558931|NCT02004873|594415500|FG000|Overall Study|Withdrawal by Subject|1|||
164558932|NCT01445769|594415502|FG000|Overall Study|Consent Withdrawn|2|||
164558933|NCT01445769|594415502|FG000|Overall Study|Disease Progression|1|||
164558934|NCT01445769|594415502|FG000|Overall Study|Lost to Follow-up|5|||
164558935|NCT01276236|594415503|FG000|Overall Study|Lack of Efficacy|2|||
164558936|NCT01276236|594415503|FG000|Overall Study|Withdrawal by Subject|4|||
164558937|NCT00044512|594415504|FG000|Follow Up|Lost to Follow-up|2|||
164558938|NCT03440814|594415507|FG000|Overall Study|Adverse Event|2|||
164558939|NCT03440814|594415508|FG001|Overall Study|Adverse Event|1|||
164558940|NCT03440814|594415507|FG000|Overall Study|Lost to Follow-up|2|||
164558941|NCT03440814|594415508|FG001|Overall Study|Lost to Follow-up|0|||
164558942|NCT03440814|594415507|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
164558943|NCT03440814|594415508|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
164558944|NCT02695628|594415509|FG000|Overall Study|Withdrawal by Subject|1|||
164558945|NCT02678390|594415510|FG000|AE (1 Day)|Withdrawal by Subject|0|||
164558946|NCT02678390|594415511|FG001|AE (1 Day)|Withdrawal by Subject|1|||
164558947|NCT00852995|594415512|FG000|Overall Study|Adverse Event|1|||
164558948|NCT00852995|594415513|FG001|Overall Study|Adverse Event|0|||
164558949|NCT00852995|594415514|FG002|Overall Study|Adverse Event|4|||
164558950|NCT00852995|594415515|FG003|Overall Study|Adverse Event|0|||
164558951|NCT00852995|594415516|FG004|Overall Study|Adverse Event|0|||
164558952|NCT00852995|594415512|FG000|Overall Study|Lost to Follow-up|0|||
164558953|NCT00852995|594415513|FG001|Overall Study|Lost to Follow-up|1|||
164558954|NCT00852995|594415514|FG002|Overall Study|Lost to Follow-up|1|||
164558955|NCT00852995|594415515|FG003|Overall Study|Lost to Follow-up|0|||
164662804|NCT00337571|594789566|FG002|Overall Study|No longer met study criteria|0|||
164662805|NCT00337571|594789567|FG003|Overall Study|No longer met study criteria|0|||
164662806|NCT00337571|594789564|FG000|Overall Study|High Potassium level|0|||
164302992|NCT04323124|593484686|FG000|Overall Study|Adverse Event|0|||
164558956|NCT00852995|594415516|FG004|Overall Study|Lost to Follow-up|0|||
164558957|NCT00852995|594415512|FG000|Overall Study|Withdrawal by Subject|4|||
164558958|NCT00852995|594415513|FG001|Overall Study|Withdrawal by Subject|0|||
164558959|NCT00852995|594415514|FG002|Overall Study|Withdrawal by Subject|0|||
164662807|NCT00337571|594789565|FG001|Overall Study|High Potassium level|0|||
164662808|NCT00337571|594789566|FG002|Overall Study|High Potassium level|0|||
164662809|NCT00337571|594789567|FG003|Overall Study|High Potassium level|1|||
164662810|NCT01890915|594789568|FG000|Overall Study|Adverse Event|1|||
164662811|NCT01890915|594789569|FG001|Overall Study|Adverse Event|0|||
164662812|NCT01890915|594789568|FG000|Overall Study|Protocol Violation|2|||
164662813|NCT01890915|594789569|FG001|Overall Study|Protocol Violation|0|||
164662814|NCT01890915|594789568|FG000|Overall Study|Equipment Malfunction|0|||
164662815|NCT01890915|594789569|FG001|Overall Study|Equipment Malfunction|1|||
164662816|NCT01974895|594789576|FG000|Overall Study|Protocol Violation|1|||
164662817|NCT01974895|594789577|FG001|Overall Study|Protocol Violation|0|||
164662818|NCT01974895|594789576|FG000|Overall Study|Lost to Follow-up|4|||
164662819|NCT01974895|594789577|FG001|Overall Study|Lost to Follow-up|6|||
164662820|NCT01974895|594789576|FG000|Overall Study|Withdrawal by Subject|0|||
164662821|NCT01974895|594789577|FG001|Overall Study|Withdrawal by Subject|1|||
164662822|NCT01974895|594789576|FG000|Overall Study|Other (Missed Visit)|1|||
164662823|NCT01974895|594789577|FG001|Overall Study|Other (Missed Visit)|0|||
164662824|NCT01974895|594789576|FG000|Overall Study|Other (Reason unknown)|9|||
164662825|NCT01974895|594789577|FG001|Overall Study|Other (Reason unknown)|8|||
164662826|NCT01513148|594789578|FG000|Overall Study|Protocol Violation|2|||
164662827|NCT01513148|594789579|FG001|Overall Study|Protocol Violation|2|||
164662828|NCT03552757|594789580|FG000|Overall Study|Withdrawal by Subject|10|||
164662829|NCT03552757|594789581|FG001|Overall Study|Withdrawal by Subject|5|||
164662830|NCT03552757|594789582|FG002|Overall Study|Withdrawal by Subject|12|||
164662831|NCT03552757|594789580|FG000|Overall Study|Lost to Follow-up|2|||
164204065|NCT05117060|593117926|FG001|Overall Study|Withdrawal by Subject|5|||
164558960|NCT00852995|594415515|FG003|Overall Study|Withdrawal by Subject|1|||
164558961|NCT00852995|594415516|FG004|Overall Study|Withdrawal by Subject|2|||
164558962|NCT00852995|594415512|FG000|Overall Study|Non-Compliance|0|||
164558963|NCT00852995|594415513|FG001|Overall Study|Non-Compliance|0|||
164558964|NCT00852995|594415514|FG002|Overall Study|Non-Compliance|0|||
164558965|NCT00852995|594415515|FG003|Overall Study|Non-Compliance|2|||
164558966|NCT00852995|594415516|FG004|Overall Study|Non-Compliance|0|||
164558967|NCT00852995|594415512|FG000|Overall Study|Progressive Disease|1|||
164558968|NCT00852995|594415513|FG001|Overall Study|Progressive Disease|0|||
164558969|NCT00852995|594415514|FG002|Overall Study|Progressive Disease|0|||
164558970|NCT00852995|594415515|FG003|Overall Study|Progressive Disease|2|||
164558971|NCT00852995|594415516|FG004|Overall Study|Progressive Disease|1|||
164558972|NCT00852995|594415512|FG000|Overall Study|Physician Decision|1|||
164558973|NCT00852995|594415513|FG001|Overall Study|Physician Decision|0|||
164558974|NCT00852995|594415514|FG002|Overall Study|Physician Decision|0|||
164558975|NCT00852995|594415515|FG003|Overall Study|Physician Decision|0|||
164558976|NCT00852995|594415516|FG004|Overall Study|Physician Decision|0|||
164558977|NCT00852995|594415512|FG000|Overall Study|Protocol Violation|0|||
164558978|NCT00852995|594415513|FG001|Overall Study|Protocol Violation|0|||
164558979|NCT00852995|594415514|FG002|Overall Study|Protocol Violation|0|||
164558980|NCT00852995|594415515|FG003|Overall Study|Protocol Violation|0|||
164558981|NCT00852995|594415516|FG004|Overall Study|Protocol Violation|1|||
164558982|NCT00852995|594415512|FG000|Overall Study|Moved Out of Area|1|||
164558983|NCT00852995|594415513|FG001|Overall Study|Moved Out of Area|0|||
164558984|NCT00852995|594415514|FG002|Overall Study|Moved Out of Area|0|||
164558985|NCT00852995|594415515|FG003|Overall Study|Moved Out of Area|0|||
164558986|NCT00852995|594415516|FG004|Overall Study|Moved Out of Area|0|||
164558987|NCT00866307|594415518|FG000|Induction|Adverse Event|5|||
164558988|NCT00866307|594415519|FG001|Induction|Adverse Event|0|||
164558989|NCT00866307|594415520|FG002|Induction|Adverse Event|0|||
164558990|NCT00866307|594415518|FG000|Induction|Death|2|||
164558991|NCT00866307|594415519|FG001|Induction|Death|0|||
164558992|NCT00866307|594415520|FG002|Induction|Death|0|||
164558993|NCT00866307|594415518|FG000|Induction|Physician Decision|5|||
164558994|NCT00866307|594415519|FG001|Induction|Physician Decision|0|||
164558995|NCT00866307|594415520|FG002|Induction|Physician Decision|0|||
164558996|NCT00866307|594415518|FG000|Induction|Progressive Disease|1|||
164558997|NCT00866307|594415519|FG001|Induction|Progressive Disease|0|||
164558998|NCT00866307|594415520|FG002|Induction|Progressive Disease|0|||
164558999|NCT00866307|594415518|FG000|Induction|Identification of Patients with Day 29 M|3|||
164559000|NCT00866307|594415519|FG001|Induction|Identification of Patients with Day 29 M|0|||
164559001|NCT00866307|594415520|FG002|Induction|Identification of Patients with Day 29 M|0|||
164559002|NCT00866307|594415518|FG000|Induction|Inadequate cytognetic samples th|1|||
164559003|NCT00866307|594415519|FG001|Induction|Inadequate cytognetic samples th|0|||
164559004|NCT00866307|594415520|FG002|Induction|Inadequate cytognetic samples th|0|||
164559005|NCT00866307|594415518|FG000|Induction|Improper post-induction consent|2|||
164559006|NCT00866307|594415519|FG001|Induction|Improper post-induction consent|0|||
164559007|NCT00866307|594415520|FG002|Induction|Improper post-induction consent|0|||
164559008|NCT00866307|594415518|FG000|Induction|Study was closed at the time|1|||
164559009|NCT00866307|594415519|FG001|Induction|Study was closed at the time|0|||
164559010|NCT00866307|594415520|FG002|Induction|Study was closed at the time|0|||
164559011|NCT00866307|594415518|FG000|Consolidation/Maintenance|Adverse Event|0|||
164559012|NCT00866307|594415519|FG001|Consolidation/Maintenance|Adverse Event|0|||
164559013|NCT00866307|594415520|FG002|Consolidation/Maintenance|Adverse Event|8|||
164559014|NCT00866307|594415518|FG000|Consolidation/Maintenance|Death|0|||
164662832|NCT03552757|594789581|FG001|Overall Study|Lost to Follow-up|7|||
164662833|NCT03552757|594789582|FG002|Overall Study|Lost to Follow-up|7|||
164559015|NCT00866307|594415519|FG001|Consolidation/Maintenance|Death|0|||
164559016|NCT00866307|594415520|FG002|Consolidation/Maintenance|Death|1|||
164559017|NCT00866307|594415518|FG000|Consolidation/Maintenance|Physician Decision|0|||
164559018|NCT00866307|594415519|FG001|Consolidation/Maintenance|Physician Decision|3|||
164559019|NCT00866307|594415520|FG002|Consolidation/Maintenance|Physician Decision|2|||
164559020|NCT00866307|594415518|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
164559021|NCT00866307|594415519|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
164559022|NCT00866307|594415520|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
164559023|NCT00866307|594415518|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
164559024|NCT00866307|594415519|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
164559025|NCT00866307|594415520|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
164559026|NCT00866307|594415518|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
164559027|NCT00866307|594415519|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
164559028|NCT00866307|594415520|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
164559029|NCT00866307|594415518|FG000|Consolidation/Maintenance|Therapy error|0|||
164559030|NCT00866307|594415519|FG001|Consolidation/Maintenance|Therapy error|1|||
164559031|NCT00866307|594415520|FG002|Consolidation/Maintenance|Therapy error|0|||
164559032|NCT00866307|594415518|FG000|Consolidation/Maintenance|Non-compliance|0|||
164559033|NCT00866307|594415519|FG001|Consolidation/Maintenance|Non-compliance|0|||
164559034|NCT00866307|594415520|FG002|Consolidation/Maintenance|Non-compliance|1|||
164559035|NCT00866307|594415518|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
164559036|NCT00866307|594415519|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
164559037|NCT00866307|594415520|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
164559038|NCT00903929|594415521|FG000|Overall Study|Withdrawal by Subject|0|||
164559039|NCT00903929|594415522|FG001|Overall Study|Withdrawal by Subject|0|||
164559040|NCT00903929|594415523|FG002|Overall Study|Withdrawal by Subject|1|||
164559041|NCT00903929|594415524|FG003|Overall Study|Withdrawal by Subject|2|||
164559042|NCT00903929|594415521|FG000|Overall Study|Adverse Event|0|||
164559043|NCT00903929|594415522|FG001|Overall Study|Adverse Event|0|||
164559044|NCT00903929|594415523|FG002|Overall Study|Adverse Event|0|||
164559045|NCT00903929|594415524|FG003|Overall Study|Adverse Event|1|||
164559046|NCT00626093|594415528|FG000|Overall Study|Lost to Follow-up|5|||
164559047|NCT00626093|594415528|FG000|Overall Study|Death|1|||
164559048|NCT00626093|594415528|FG000|Overall Study|Physician Decision|4|||
164559049|NCT00626093|594415528|FG000|Overall Study|Withdrawal by Subject|6|||
164559050|NCT00626093|594415528|FG000|Overall Study|Protocol Violation|1|||
164559051|NCT00626093|594415528|FG000|Overall Study|One of the required devices not implante|6|||
164559052|NCT00511355|594415529|FG000|Overall Study|Adverse Event|4|||
164559053|NCT00511355|594415530|FG001|Overall Study|Adverse Event|4|||
164559054|NCT00511355|594415529|FG000|Overall Study|Pregnancy Wish|1|||
164559055|NCT00511355|594415530|FG001|Overall Study|Pregnancy Wish|0|||
164559056|NCT00511355|594415529|FG000|Overall Study|Lost to Follow-up|2|||
164559057|NCT00511355|594415530|FG001|Overall Study|Lost to Follow-up|1|||
164559058|NCT00511355|594415529|FG000|Overall Study|Other Reason|0|||
164559059|NCT00511355|594415530|FG001|Overall Study|Other Reason|1|||
164559060|NCT00511355|594415529|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
164559061|NCT00511355|594415530|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
164559062|NCT00511355|594415529|FG000|Overall Study|Withdrawal of informed consent|0|||
164559063|NCT00511355|594415530|FG001|Overall Study|Withdrawal of informed consent|1|||
164559064|NCT00511355|594415529|FG000|Overall Study|Other reason pre-treatment|0|||
164559065|NCT00511355|594415530|FG001|Overall Study|Other reason pre-treatment|1|||
164559066|NCT01632566|594415531|FG000|Overall Study|Withdrawal by Subject|0|||
164559067|NCT01632566|594415532|FG001|Overall Study|Withdrawal by Subject|1|||
164559068|NCT01632566|594415533|FG002|Overall Study|Withdrawal by Subject|0|||
164559069|NCT01632566|594415534|FG003|Overall Study|Withdrawal by Subject|0|||
164559070|NCT01632566|594415535|FG004|Overall Study|Withdrawal by Subject|0|||
164559071|NCT01632566|594415531|FG000|Overall Study|Sponsor Decision|0|||
164559072|NCT01632566|594415532|FG001|Overall Study|Sponsor Decision|2|||
164559073|NCT01632566|594415533|FG002|Overall Study|Sponsor Decision|9|||
164559074|NCT01632566|594415534|FG003|Overall Study|Sponsor Decision|2|||
164559075|NCT01632566|594415535|FG004|Overall Study|Sponsor Decision|2|||
164559076|NCT00454805|594415536|FG000|Overall Study|Withdrawal by Subject|9|||
164559077|NCT00454805|594415537|FG001|Overall Study|Withdrawal by Subject|2|||
164559078|NCT00454805|594415536|FG000|Overall Study|Death|0|||
164559079|NCT00454805|594415537|FG001|Overall Study|Death|2|||
164559080|NCT00454805|594415536|FG000|Overall Study|Disease progression|16|||
164559081|NCT00454805|594415537|FG001|Overall Study|Disease progression|19|||
164559082|NCT00454805|594415536|FG000|Overall Study|In order to begin radiotherapy|1|||
164559083|NCT00454805|594415537|FG001|Overall Study|In order to begin radiotherapy|0|||
164559084|NCT00217087|594415538|FG000|Overall Study|decided to have esophagectomy|1|||
164559085|NCT00217087|594415539|FG001|Overall Study|decided to have esophagectomy|2|||
164559086|NCT00217087|594415538|FG000|Overall Study|completed less than 12 months return|10|||
164559087|NCT00217087|594415539|FG001|Overall Study|completed less than 12 months return|18|||
164559088|NCT01627899|594415540|FG000|Overall Study|Study terminated early by sponsor.|5|||
164559089|NCT04518462|594415546|FG000|Overall Study|Withdrawal by Subject|0|||
164559090|NCT04518462|594415547|FG001|Overall Study|Withdrawal by Subject|0|||
164559091|NCT04518462|594415548|FG002|Overall Study|Withdrawal by Subject|1|||
164559092|NCT04518462|594415546|FG000|Overall Study|Physician Decision|1|||
164559093|NCT04518462|594415547|FG001|Overall Study|Physician Decision|1|||
164559094|NCT04518462|594415548|FG002|Overall Study|Physician Decision|0|||
164559095|NCT01003210|594415549|FG000|Overall Study|Lost to Follow-up|1|||
164559096|NCT01003210|594415550|FG001|Overall Study|Lost to Follow-up|3|||
164559097|NCT00264238|594415553|FG000|Overall Study|Protocol Violation|1|||
164559098|NCT00861744|594415554|FG000|Overall Study|Adverse Event|0|||
164559099|NCT00861744|594415555|FG001|Overall Study|Adverse Event|0|||
164559100|NCT00861744|594415556|FG002|Overall Study|Adverse Event|0|||
164559101|NCT00861744|594415557|FG003|Overall Study|Adverse Event|1|||
164559102|NCT00861744|594415554|FG000|Overall Study|Lost to Follow-up|7|||
164559103|NCT00861744|594415555|FG001|Overall Study|Lost to Follow-up|19|||
164559104|NCT00861744|594415556|FG002|Overall Study|Lost to Follow-up|17|||
164559105|NCT00861744|594415557|FG003|Overall Study|Lost to Follow-up|12|||
164559106|NCT00861744|594415554|FG000|Overall Study|Withdrawal by Subject|10|||
164559107|NCT00861744|594415555|FG001|Overall Study|Withdrawal by Subject|6|||
164559108|NCT00861744|594415556|FG002|Overall Study|Withdrawal by Subject|6|||
164559109|NCT00861744|594415557|FG003|Overall Study|Withdrawal by Subject|19|||
164559110|NCT00861744|594415554|FG000|Overall Study|Protocol Violation|0|||
164559111|NCT00861744|594415555|FG001|Overall Study|Protocol Violation|1|||
164559112|NCT00861744|594415556|FG002|Overall Study|Protocol Violation|0|||
164559113|NCT00861744|594415557|FG003|Overall Study|Protocol Violation|0|||
164559114|NCT00861744|594415554|FG000|Overall Study|Migration from study area|0|||
164559115|NCT00861744|594415555|FG001|Overall Study|Migration from study area|3|||
164559116|NCT00861744|594415556|FG002|Overall Study|Migration from study area|1|||
164559117|NCT00861744|594415557|FG003|Overall Study|Migration from study area|0|||
164559118|NCT00861744|594415554|FG000|Overall Study|Blood draws|0|||
164559119|NCT00861744|594415555|FG001|Overall Study|Blood draws|0|||
164559120|NCT00861744|594415556|FG002|Overall Study|Blood draws|0|||
164559121|NCT00861744|594415557|FG003|Overall Study|Blood draws|1|||
164559122|NCT02193074|594415560|FG000|Overall Study|Withdrawal by Subject|1|||
164559123|NCT02193074|594415561|FG001|Overall Study|Withdrawal by Subject|2|||
164559124|NCT02193074|594415560|FG000|Overall Study|Adverse Event|16|||
164559125|NCT02193074|594415561|FG001|Overall Study|Adverse Event|13|||
164559126|NCT05036083|594415569|FG000|Overall Study|Physician Decision|1|||
164559127|NCT05036083|594415569|FG000|Overall Study|Withdrawal by Subject|1|||
164559128|NCT05036083|594415569|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
164559129|NCT05036083|594415569|FG000|Overall Study|IV not sustainable|1|||
164559130|NCT02396589|594415570|FG000|Intervention|Lost to Follow-up|1|||
164559131|NCT02396589|594415571|FG001|Intervention|Lost to Follow-up|0|||
164559132|NCT02396589|594415570|FG000|6 Month Follow-up|change in health status|0|||
164559133|NCT02396589|594415571|FG001|6 Month Follow-up|change in health status|1|||
164559134|NCT02396589|594415570|FG000|9 Month Follow-up|Death|0|||
164559135|NCT02396589|594415571|FG001|9 Month Follow-up|Death|1|||
164559136|NCT02396589|594415570|FG000|12 Month Follow up|Lost to Follow-up|0|||
164559137|NCT02396589|594415571|FG001|12 Month Follow up|Lost to Follow-up|2|||
164662834|NCT03552757|594789580|FG000|Overall Study|Death|1|||
164662835|NCT03552757|594789581|FG001|Overall Study|Death|1|||
164662836|NCT03552757|594789582|FG002|Overall Study|Death|1|||
164662837|NCT02192099|594789585|FG000|Overall Study|Adverse Event|1|||
164662838|NCT02192099|594789585|FG000|Overall Study|Lost to Follow-up|2|||
164662839|NCT02192099|594789585|FG000|Overall Study|Physician Decision|1|||
164662840|NCT02192099|594789585|FG000|Overall Study|Pregnancy|1|||
164662841|NCT02192099|594789585|FG000|Overall Study|Protocol Violation|8|||
164314830|NCT02703337|593529782|FG005|Period One (Part A)|Withdrawal by Subject|0|||
164559138|NCT04381650|594415572|FG000|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
164559139|NCT04381650|594415573|FG001|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
164559140|NCT04381650|594415574|FG002|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
164559141|NCT04381650|594415575|FG003|Phase 1b (Dose Escalation)|New anti-cancer therapy|1|||
164559142|NCT04381650|594415576|FG004|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
164559143|NCT04381650|594415577|FG005|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
164559144|NCT04381650|594415578|FG006|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
164559145|NCT04381650|594415579|FG007|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
164559146|NCT04381650|594415580|FG008|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
164559147|NCT04381650|594415581|FG009|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
164559148|NCT04381650|594415582|FG010|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
164559149|NCT04381650|594415572|FG000|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
164559150|NCT04381650|594415573|FG001|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
164559151|NCT04381650|594415574|FG002|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
164559152|NCT04381650|594415575|FG003|Phase 1b (Dose Escalation)|Lost to Follow-up|1|||
164559153|NCT04381650|594415576|FG004|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
164559154|NCT04381650|594415577|FG005|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
164662842|NCT02192099|594789585|FG000|Overall Study|Study Terminated by Sponsor|32|||
164559155|NCT04381650|594415578|FG006|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
164559156|NCT04381650|594415579|FG007|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
164559157|NCT04381650|594415580|FG008|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
164559158|NCT04381650|594415581|FG009|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
164559159|NCT04381650|594415582|FG010|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
164559160|NCT04381650|594415572|FG000|Phase 1b (Dose Escalation)|Progressive Disease|1|||
164559161|NCT04381650|594415573|FG001|Phase 1b (Dose Escalation)|Progressive Disease|3|||
164559162|NCT04381650|594415574|FG002|Phase 1b (Dose Escalation)|Progressive Disease|12|||
164559163|NCT04381650|594415575|FG003|Phase 1b (Dose Escalation)|Progressive Disease|8|||
164559164|NCT04381650|594415576|FG004|Phase 1b (Dose Escalation)|Progressive Disease|0|||
164559165|NCT04381650|594415577|FG005|Phase 1b (Dose Escalation)|Progressive Disease|0|||
164559166|NCT04381650|594415578|FG006|Phase 1b (Dose Escalation)|Progressive Disease|0|||
164559167|NCT04381650|594415579|FG007|Phase 1b (Dose Escalation)|Progressive Disease|0|||
164559168|NCT04381650|594415580|FG008|Phase 1b (Dose Escalation)|Progressive Disease|0|||
164559169|NCT04381650|594415581|FG009|Phase 1b (Dose Escalation)|Progressive Disease|0|||
164559170|NCT04381650|594415582|FG010|Phase 1b (Dose Escalation)|Progressive Disease|0|||
164559171|NCT04381650|594415572|FG000|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
164559172|NCT04381650|594415573|FG001|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
164559173|NCT04381650|594415574|FG002|Phase 1b (Dose Escalation)|Withdrawal by Subject|11|||
164559174|NCT04381650|594415575|FG003|Phase 1b (Dose Escalation)|Withdrawal by Subject|4|||
164559175|NCT04381650|594415576|FG004|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
164559176|NCT04381650|594415577|FG005|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
164559177|NCT04381650|594415578|FG006|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
164559178|NCT04381650|594415579|FG007|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
164559179|NCT04381650|594415580|FG008|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
164559180|NCT04381650|594415581|FG009|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
164559181|NCT04381650|594415582|FG010|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
164559182|NCT04381650|594415572|FG000|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
164559183|NCT04381650|594415573|FG001|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
164559184|NCT04381650|594415574|FG002|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
164559185|NCT04381650|594415575|FG003|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
164559186|NCT04381650|594415576|FG004|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
164559187|NCT04381650|594415577|FG005|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
164559188|NCT04381650|594415578|FG006|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
164559189|NCT04381650|594415579|FG007|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
164559190|NCT04381650|594415580|FG008|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
164559191|NCT04381650|594415581|FG009|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
164559192|NCT04381650|594415582|FG010|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
164559193|NCT04381650|594415572|FG000|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
164559194|NCT04381650|594415573|FG001|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
164559195|NCT04381650|594415574|FG002|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
164559196|NCT04381650|594415575|FG003|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
164559197|NCT04381650|594415576|FG004|Phase 2 (Dose Expansion)|New anti-cancer therapy|3|||
164559198|NCT04381650|594415577|FG005|Phase 2 (Dose Expansion)|New anti-cancer therapy|1|||
164559199|NCT04381650|594415578|FG006|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
164559200|NCT04381650|594415579|FG007|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
164559201|NCT04381650|594415580|FG008|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
164559202|NCT04381650|594415581|FG009|Phase 2 (Dose Expansion)|New anti-cancer therapy|2|||
164559203|NCT04381650|594415582|FG010|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
164559204|NCT04381650|594415572|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
164559205|NCT04381650|594415573|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
164559206|NCT04381650|594415574|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
164559207|NCT04381650|594415575|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
164559208|NCT04381650|594415576|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
164559209|NCT04381650|594415577|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
164559210|NCT04381650|594415578|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
164559211|NCT04381650|594415579|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
164559212|NCT04381650|594415580|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
164559213|NCT04381650|594415581|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
164559214|NCT04381650|594415582|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
164559215|NCT04381650|594415572|FG000|Phase 2 (Dose Expansion)|Progressive Disease|0|||
164559216|NCT04381650|594415573|FG001|Phase 2 (Dose Expansion)|Progressive Disease|0|||
164559217|NCT04381650|594415574|FG002|Phase 2 (Dose Expansion)|Progressive Disease|0|||
164559218|NCT04381650|594415575|FG003|Phase 2 (Dose Expansion)|Progressive Disease|0|||
164559219|NCT04381650|594415576|FG004|Phase 2 (Dose Expansion)|Progressive Disease|2|||
164559220|NCT04381650|594415577|FG005|Phase 2 (Dose Expansion)|Progressive Disease|1|||
164559221|NCT04381650|594415578|FG006|Phase 2 (Dose Expansion)|Progressive Disease|0|||
164559222|NCT04381650|594415579|FG007|Phase 2 (Dose Expansion)|Progressive Disease|3|||
164559223|NCT04381650|594415580|FG008|Phase 2 (Dose Expansion)|Progressive Disease|3|||
164662843|NCT02192099|594789585|FG000|Overall Study|Withdrawal by Subject|11|||
164662844|NCT02192099|594789585|FG000|Overall Study|Miscellaneous Reasons|5|||
164662845|NCT00386009|594789586|FG000|Overall Study|Adverse Event|0|||
164662846|NCT00386009|594789587|FG001|Overall Study|Adverse Event|2|||
164662847|NCT00386009|594789586|FG000|Overall Study|Death|1|||
164662848|NCT00386009|594789587|FG001|Overall Study|Death|0|||
164662849|NCT00386009|594789586|FG000|Overall Study|Entry Criteria Not Met|0|||
164662850|NCT00386009|594789587|FG001|Overall Study|Entry Criteria Not Met|2|||
164662851|NCT00386009|594789586|FG000|Overall Study|Lost to Follow-up|1|||
164662852|NCT00386009|594789587|FG001|Overall Study|Lost to Follow-up|1|||
164662853|NCT00386009|594789586|FG000|Overall Study|Protocol Violation|1|||
164662854|NCT00386009|594789587|FG001|Overall Study|Protocol Violation|0|||
164662855|NCT00386009|594789586|FG000|Overall Study|Sponsor Decision|1|||
164662856|NCT00386009|594789587|FG001|Overall Study|Sponsor Decision|1|||
164662857|NCT00386009|594789586|FG000|Overall Study|Withdrawal by Subject|5|||
164662858|NCT00386009|594789587|FG001|Overall Study|Withdrawal by Subject|4|||
164662859|NCT00536575|594789590|FG000|Overall Study|Withdrawal by Subject|1|||
164662860|NCT00536575|594789590|FG000|Overall Study|Death|1|||
164662861|NCT02549495|594789597|FG000|Overall Study|Death|2|||
164662862|NCT02549495|594789597|FG000|Overall Study|Withdrawal by Subject|5|||
164662863|NCT02549495|594789597|FG000|Overall Study|Physician Decision|22|||
164662864|NCT02549495|594789597|FG000|Overall Study|Lost to Follow-up|6|||
164662865|NCT02549495|594789597|FG000|Overall Study|Protocol Violation|6|||
164662866|NCT01862328|594789598|FG000|Overall Study|Progressive Disease|3|||
164662867|NCT01862328|594789599|FG001|Overall Study|Progressive Disease|11|||
164662868|NCT01862328|594789600|FG002|Overall Study|Progressive Disease|5|||
164662869|NCT01862328|594789601|FG003|Overall Study|Progressive Disease|6|||
164662870|NCT01862328|594789602|FG004|Overall Study|Progressive Disease|7|||
164662871|NCT01862328|594789603|FG005|Overall Study|Progressive Disease|4|||
164662872|NCT01862328|594789604|FG006|Overall Study|Progressive Disease|3|||
164662873|NCT01862328|594789598|FG000|Overall Study|Adverse Event|0|||
164662874|NCT01862328|594789599|FG001|Overall Study|Adverse Event|4|||
164662875|NCT01862328|594789600|FG002|Overall Study|Adverse Event|0|||
164662876|NCT01862328|594789601|FG003|Overall Study|Adverse Event|1|||
164662877|NCT01862328|594789602|FG004|Overall Study|Adverse Event|0|||
164662878|NCT01862328|594789603|FG005|Overall Study|Adverse Event|2|||
164662879|NCT01862328|594789604|FG006|Overall Study|Adverse Event|4|||
164662880|NCT01862328|594789598|FG000|Overall Study|Other|0|||
164662881|NCT01862328|594789599|FG001|Overall Study|Other|2|||
164662882|NCT01862328|594789600|FG002|Overall Study|Other|1|||
164662883|NCT01862328|594789601|FG003|Overall Study|Other|0|||
164662884|NCT01862328|594789602|FG004|Overall Study|Other|4|||
164662885|NCT01862328|594789603|FG005|Overall Study|Other|0|||
164662886|NCT01862328|594789604|FG006|Overall Study|Other|1|||
164662887|NCT01862328|594789598|FG000|Overall Study|Withdrawal by Subject|1|||
164662888|NCT01862328|594789599|FG001|Overall Study|Withdrawal by Subject|1|||
164662889|NCT01862328|594789600|FG002|Overall Study|Withdrawal by Subject|0|||
164662890|NCT01862328|594789601|FG003|Overall Study|Withdrawal by Subject|0|||
164662891|NCT01862328|594789602|FG004|Overall Study|Withdrawal by Subject|1|||
164662892|NCT01862328|594789603|FG005|Overall Study|Withdrawal by Subject|1|||
164662893|NCT01862328|594789604|FG006|Overall Study|Withdrawal by Subject|1|||
164662894|NCT01862328|594789598|FG000|Overall Study|Symptomatic Deterioration|0|||
164662895|NCT01862328|594789599|FG001|Overall Study|Symptomatic Deterioration|0|||
164662896|NCT01862328|594789600|FG002|Overall Study|Symptomatic Deterioration|0|||
164662897|NCT01862328|594789601|FG003|Overall Study|Symptomatic Deterioration|0|||
164662898|NCT01862328|594789602|FG004|Overall Study|Symptomatic Deterioration|0|||
164662899|NCT01862328|594789603|FG005|Overall Study|Symptomatic Deterioration|0|||
164662900|NCT01862328|594789604|FG006|Overall Study|Symptomatic Deterioration|1|||
164662901|NCT00936975|594789605|FG000|Overall Study|Withdrawal by Subject|1|||
164662902|NCT00936975|594789605|FG000|Overall Study|Disease progression|3|||
164662903|NCT00936975|594789605|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
164662904|NCT02486796|594789608|FG000|Overall Study|Withdrawal by Subject|1|||
164662905|NCT02486796|594789609|FG001|Overall Study|Withdrawal by Subject|1|||
164662906|NCT02486796|594789608|FG000|Overall Study|Physician Decision|1|||
164662907|NCT02486796|594789609|FG001|Overall Study|Physician Decision|0|||
164662908|NCT00306384|594789612|FG000|Overall Study|Adverse Event|103|||
164662909|NCT00306384|594789613|FG001|Overall Study|Adverse Event|87|||
164662910|NCT00306384|594789614|FG002|Overall Study|Adverse Event|40|||
164662911|NCT00306384|594789612|FG000|Overall Study|Major protocol deviation|43|||
164662912|NCT00306384|594789613|FG001|Overall Study|Major protocol deviation|51|||
164662913|NCT00306384|594789614|FG002|Overall Study|Major protocol deviation|18|||
164662914|NCT00306384|594789612|FG000|Overall Study|Lost to Follow-up|57|||
164662915|NCT00306384|594789613|FG001|Overall Study|Lost to Follow-up|41|||
164662916|NCT00306384|594789614|FG002|Overall Study|Lost to Follow-up|35|||
164662917|NCT00306384|594789612|FG000|Overall Study|Voluntary withdrawal|199|||
164662918|NCT00306384|594789613|FG001|Overall Study|Voluntary withdrawal|187|||
164662919|NCT00306384|594789614|FG002|Overall Study|Voluntary withdrawal|91|||
164662920|NCT00306384|594789612|FG000|Overall Study|Study termination|1|||
164662921|NCT00306384|594789613|FG001|Overall Study|Study termination|0|||
164662922|NCT00306384|594789614|FG002|Overall Study|Study termination|1|||
164662923|NCT00306384|594789612|FG000|Overall Study|Pregnancy|3|||
164662924|NCT00306384|594789613|FG001|Overall Study|Pregnancy|1|||
164662925|NCT00306384|594789614|FG002|Overall Study|Pregnancy|1|||
164662926|NCT00306384|594789612|FG000|Overall Study|Lack of Efficacy|26|||
164662927|NCT00306384|594789613|FG001|Overall Study|Lack of Efficacy|40|||
164662928|NCT00306384|594789614|FG002|Overall Study|Lack of Efficacy|38|||
164662929|NCT00306384|594789612|FG000|Overall Study|Investigator discretion|28|||
164662930|NCT00306384|594789613|FG001|Overall Study|Investigator discretion|31|||
164662931|NCT00306384|594789614|FG002|Overall Study|Investigator discretion|21|||
164662932|NCT00306384|594789612|FG000|Overall Study|Other|80|||
164662933|NCT00306384|594789613|FG001|Overall Study|Other|70|||
164662934|NCT00306384|594789614|FG002|Overall Study|Other|32|||
164662935|NCT00306384|594789612|FG000|Overall Study|Site closure|2|||
164662936|NCT00306384|594789613|FG001|Overall Study|Site closure|0|||
164662937|NCT00306384|594789614|FG002|Overall Study|Site closure|0|||
164662938|NCT02275364|594789615|FG000|Period 1|Withdrawal by Subject|1|||
164662939|NCT02275364|594789616|FG001|Period 1|Withdrawal by Subject|0|||
164662940|NCT02275364|594789615|FG000|Period 1|Other reason|1|||
164662941|NCT02275364|594789616|FG001|Period 1|Other reason|0|||
164662942|NCT03384745|594789621|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
164662943|NCT03384745|594789622|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
164662944|NCT03384745|594789623|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
164662945|NCT03384745|594789624|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
164662946|NCT03384745|594789625|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
164662947|NCT03384745|594789626|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
164662948|NCT03384745|594789621|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
164662949|NCT03384745|594789622|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
164662950|NCT03384745|594789623|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
164662951|NCT03384745|594789624|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
164662952|NCT03384745|594789625|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
164662953|NCT03384745|594789626|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
164662954|NCT03384745|594789621|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
164662955|NCT03384745|594789622|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
164662956|NCT03384745|594789623|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
164662957|NCT03384745|594789624|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
164662958|NCT03384745|594789625|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
164662959|NCT03384745|594789626|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
164662960|NCT03384745|594789621|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
164662961|NCT03384745|594789622|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
164662962|NCT03384745|594789623|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
164662963|NCT03384745|594789624|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
164662964|NCT03384745|594789625|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
164662965|NCT03384745|594789626|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
164662966|NCT03384745|594789621|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
164662967|NCT03384745|594789622|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
164662968|NCT03384745|594789623|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
164662969|NCT03384745|594789624|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
164662970|NCT03384745|594789625|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
164662971|NCT03384745|594789626|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
164662972|NCT03384745|594789621|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
164662973|NCT03384745|594789622|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
164662974|NCT03384745|594789623|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
164662975|NCT03384745|594789624|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
164662976|NCT03384745|594789625|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
164662977|NCT03384745|594789626|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
164662978|NCT03384745|594789621|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
164662979|NCT03384745|594789622|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
164662980|NCT03384745|594789623|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
164662981|NCT03384745|594789624|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
164662982|NCT03384745|594789625|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
164662983|NCT03384745|594789626|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
164662984|NCT03384745|594789621|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
164662985|NCT03384745|594789622|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
164662986|NCT03384745|594789623|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
164662987|NCT03384745|594789624|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
164662988|NCT03384745|594789625|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
164662989|NCT03384745|594789626|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
164662990|NCT03384745|594789621|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
164662991|NCT03384745|594789622|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
164662992|NCT03384745|594789623|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
164662993|NCT03384745|594789624|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
164662994|NCT03384745|594789625|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
164662995|NCT03384745|594789626|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
164662996|NCT03384745|594789621|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
164662997|NCT03384745|594789622|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
164662998|NCT03384745|594789623|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
164662999|NCT03384745|594789624|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
164663000|NCT03384745|594789625|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
164663001|NCT03384745|594789626|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
164663002|NCT03384745|594789621|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
164663003|NCT03384745|594789622|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
164663004|NCT03384745|594789623|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
164663005|NCT03384745|594789624|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
164663006|NCT03384745|594789625|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
164663007|NCT03384745|594789626|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
164663008|NCT02984683|594789627|FG000|Overall Study|Adverse Event|3|||
164663009|NCT02984683|594789628|FG001|Overall Study|Adverse Event|3|||
164663010|NCT02984683|594789627|FG000|Overall Study|Withdrawal by Subject|1|||
164663011|NCT02984683|594789628|FG001|Overall Study|Withdrawal by Subject|0|||
164663012|NCT02984683|594789627|FG000|Overall Study|Disease progression|7|||
164663013|NCT02984683|594789628|FG001|Overall Study|Disease progression|9|||
164663014|NCT03131999|594789629|FG000|Overall Study|Withdrawal by Subject|0|||
164663015|NCT03131999|594789630|FG001|Overall Study|Withdrawal by Subject|1|||
164663016|NCT02260492|594789631|FG000|Overall Study|Adverse Event|6|||
164663017|NCT02260492|594789632|FG001|Overall Study|Adverse Event|1|||
164663018|NCT02260492|594789633|FG002|Overall Study|Adverse Event|2|||
164663019|NCT02260492|594789631|FG000|Overall Study|Death|0|||
164663020|NCT02260492|594789632|FG001|Overall Study|Death|1|||
164663021|NCT02260492|594789633|FG002|Overall Study|Death|0|||
164663022|NCT02260492|594789631|FG000|Overall Study|Lost to Follow-up|12|||
164663023|NCT02260492|594789632|FG001|Overall Study|Lost to Follow-up|9|||
164663024|NCT02260492|594789633|FG002|Overall Study|Lost to Follow-up|0|||
164663025|NCT02260492|594789631|FG000|Overall Study|Physician Decision|2|||
164663026|NCT02260492|594789632|FG001|Overall Study|Physician Decision|0|||
164663027|NCT02260492|594789633|FG002|Overall Study|Physician Decision|1|||
164663028|NCT02260492|594789631|FG000|Overall Study|Withdrawal by Subject|3|||
164663029|NCT02260492|594789632|FG001|Overall Study|Withdrawal by Subject|2|||
164663030|NCT02260492|594789633|FG002|Overall Study|Withdrawal by Subject|2|||
164663031|NCT04634409|594789634|FG000|Overall Study|Death|0|||
164663032|NCT04634409|594789635|FG001|Overall Study|Death|0|||
164663033|NCT04634409|594789636|FG002|Overall Study|Death|0|||
164663034|NCT04634409|594789637|FG003|Overall Study|Death|0|||
164663035|NCT04634409|594789638|FG004|Overall Study|Death|0|||
164663036|NCT04634409|594789639|FG005|Overall Study|Death|0|||
164663037|NCT04634409|594789640|FG006|Overall Study|Death|0|||
164663038|NCT04634409|594789641|FG007|Overall Study|Death|0|||
164663039|NCT04634409|594789642|FG008|Overall Study|Death|0|||
164663040|NCT04634409|594789643|FG009|Overall Study|Death|0|||
164663041|NCT04634409|594789644|FG010|Overall Study|Death|1|||
164663042|NCT04634409|594789645|FG011|Overall Study|Death|0|||
164559224|NCT04381650|594415581|FG009|Phase 2 (Dose Expansion)|Progressive Disease|4|||
164559225|NCT04381650|594415582|FG010|Phase 2 (Dose Expansion)|Progressive Disease|2|||
164559226|NCT04381650|594415572|FG000|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
164559227|NCT04381650|594415573|FG001|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
164559228|NCT04381650|594415574|FG002|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
164559229|NCT04381650|594415575|FG003|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
164559230|NCT04381650|594415576|FG004|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
164559231|NCT04381650|594415577|FG005|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
164559232|NCT04381650|594415578|FG006|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
164559233|NCT04381650|594415579|FG007|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
164559234|NCT04381650|594415580|FG008|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
164559235|NCT04381650|594415581|FG009|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
164559236|NCT04381650|594415582|FG010|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
164559237|NCT04381650|594415572|FG000|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
164559238|NCT04381650|594415573|FG001|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
164559239|NCT04381650|594415574|FG002|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
164663043|NCT04634409|594789646|FG012|Overall Study|Death|1|||
164204066|NCT05117060|593117927|FG002|Overall Study|Withdrawal by Subject|5|||
164559240|NCT04381650|594415575|FG003|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
164559241|NCT04381650|594415576|FG004|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
164663044|NCT04634409|594789647|FG013|Overall Study|Death|0|||
164663045|NCT04634409|594789648|FG014|Overall Study|Death|0|||
164663046|NCT04634409|594789649|FG015|Overall Study|Death|0|||
164663047|NCT04634409|594789650|FG016|Overall Study|Death|0|||
164663048|NCT04634409|594789651|FG017|Overall Study|Death|0|||
164663049|NCT04634409|594789652|FG018|Overall Study|Death|0|||
164663050|NCT04634409|594789653|FG019|Overall Study|Death|0|||
164663051|NCT04634409|594789654|FG020|Overall Study|Death|0|||
164663052|NCT04634409|594789655|FG021|Overall Study|Death|0|||
164663053|NCT04634409|594789656|FG022|Overall Study|Death|0|||
164663054|NCT04634409|594789657|FG023|Overall Study|Death|0|||
164663055|NCT04634409|594789658|FG024|Overall Study|Death|0|||
164663056|NCT04634409|594789659|FG025|Overall Study|Death|0|||
164663057|NCT04634409|594789660|FG026|Overall Study|Death|0|||
164663058|NCT04634409|594789634|FG000|Overall Study|Adverse Event|0|||
164663059|NCT04634409|594789635|FG001|Overall Study|Adverse Event|0|||
164663060|NCT04634409|594789636|FG002|Overall Study|Adverse Event|1|||
164663061|NCT04634409|594789637|FG003|Overall Study|Adverse Event|0|||
164663062|NCT04634409|594789638|FG004|Overall Study|Adverse Event|0|||
164663063|NCT04634409|594789639|FG005|Overall Study|Adverse Event|1|||
164663064|NCT04634409|594789640|FG006|Overall Study|Adverse Event|0|||
164663065|NCT04634409|594789641|FG007|Overall Study|Adverse Event|0|||
164663066|NCT04634409|594789642|FG008|Overall Study|Adverse Event|0|||
164663067|NCT04634409|594789643|FG009|Overall Study|Adverse Event|0|||
164663068|NCT04634409|594789644|FG010|Overall Study|Adverse Event|0|||
164663069|NCT04634409|594789645|FG011|Overall Study|Adverse Event|0|||
164663070|NCT04634409|594789646|FG012|Overall Study|Adverse Event|0|||
164663071|NCT04634409|594789647|FG013|Overall Study|Adverse Event|0|||
164663072|NCT04634409|594789648|FG014|Overall Study|Adverse Event|0|||
164663073|NCT04634409|594789649|FG015|Overall Study|Adverse Event|0|||
164663074|NCT04634409|594789650|FG016|Overall Study|Adverse Event|0|||
164663075|NCT04634409|594789651|FG017|Overall Study|Adverse Event|0|||
164663076|NCT04634409|594789652|FG018|Overall Study|Adverse Event|0|||
164663077|NCT04634409|594789653|FG019|Overall Study|Adverse Event|0|||
164663078|NCT04634409|594789654|FG020|Overall Study|Adverse Event|0|||
164663079|NCT04634409|594789655|FG021|Overall Study|Adverse Event|0|||
164663080|NCT04634409|594789656|FG022|Overall Study|Adverse Event|0|||
164663081|NCT04634409|594789657|FG023|Overall Study|Adverse Event|0|||
164663082|NCT04634409|594789658|FG024|Overall Study|Adverse Event|0|||
164663083|NCT04634409|594789659|FG025|Overall Study|Adverse Event|0|||
164663084|NCT04634409|594789660|FG026|Overall Study|Adverse Event|0|||
164663085|NCT04634409|594789634|FG000|Overall Study|Lost to Follow-up|3|||
164663086|NCT04634409|594789635|FG001|Overall Study|Lost to Follow-up|1|||
164663087|NCT04634409|594789636|FG002|Overall Study|Lost to Follow-up|1|||
164663088|NCT04634409|594789637|FG003|Overall Study|Lost to Follow-up|3|||
164663089|NCT04634409|594789638|FG004|Overall Study|Lost to Follow-up|1|||
164663090|NCT04634409|594789639|FG005|Overall Study|Lost to Follow-up|1|||
164663091|NCT04634409|594789640|FG006|Overall Study|Lost to Follow-up|1|||
164663092|NCT04634409|594789641|FG007|Overall Study|Lost to Follow-up|3|||
164663093|NCT04634409|594789642|FG008|Overall Study|Lost to Follow-up|3|||
164663094|NCT04634409|594789643|FG009|Overall Study|Lost to Follow-up|11|||
164663095|NCT04634409|594789644|FG010|Overall Study|Lost to Follow-up|8|||
164663096|NCT04634409|594789645|FG011|Overall Study|Lost to Follow-up|15|||
164663097|NCT04634409|594789646|FG012|Overall Study|Lost to Follow-up|3|||
164663098|NCT04634409|594789647|FG013|Overall Study|Lost to Follow-up|2|||
164663099|NCT04634409|594789648|FG014|Overall Study|Lost to Follow-up|7|||
164663100|NCT04634409|594789649|FG015|Overall Study|Lost to Follow-up|0|||
164663101|NCT04634409|594789650|FG016|Overall Study|Lost to Follow-up|0|||
164663102|NCT04634409|594789651|FG017|Overall Study|Lost to Follow-up|0|||
164663103|NCT04634409|594789652|FG018|Overall Study|Lost to Follow-up|0|||
164663104|NCT04634409|594789653|FG019|Overall Study|Lost to Follow-up|0|||
164663105|NCT04634409|594789654|FG020|Overall Study|Lost to Follow-up|0|||
164663106|NCT04634409|594789655|FG021|Overall Study|Lost to Follow-up|0|||
164663107|NCT04634409|594789656|FG022|Overall Study|Lost to Follow-up|0|||
164663108|NCT04634409|594789657|FG023|Overall Study|Lost to Follow-up|0|||
164663109|NCT04634409|594789658|FG024|Overall Study|Lost to Follow-up|0|||
164663110|NCT04634409|594789659|FG025|Overall Study|Lost to Follow-up|0|||
164663111|NCT04634409|594789660|FG026|Overall Study|Lost to Follow-up|0|||
164663112|NCT04634409|594789634|FG000|Overall Study|Withdrawal by Subject|3|||
164663113|NCT04634409|594789635|FG001|Overall Study|Withdrawal by Subject|1|||
164663114|NCT04634409|594789636|FG002|Overall Study|Withdrawal by Subject|6|||
164663115|NCT04634409|594789637|FG003|Overall Study|Withdrawal by Subject|4|||
164663116|NCT04634409|594789638|FG004|Overall Study|Withdrawal by Subject|2|||
164663117|NCT04634409|594789639|FG005|Overall Study|Withdrawal by Subject|0|||
164663118|NCT04634409|594789640|FG006|Overall Study|Withdrawal by Subject|0|||
164663119|NCT04634409|594789641|FG007|Overall Study|Withdrawal by Subject|2|||
164663120|NCT04634409|594789642|FG008|Overall Study|Withdrawal by Subject|3|||
164663121|NCT04634409|594789643|FG009|Overall Study|Withdrawal by Subject|2|||
164663122|NCT04634409|594789644|FG010|Overall Study|Withdrawal by Subject|3|||
164663123|NCT04634409|594789645|FG011|Overall Study|Withdrawal by Subject|2|||
164663124|NCT04634409|594789646|FG012|Overall Study|Withdrawal by Subject|2|||
164663125|NCT04634409|594789647|FG013|Overall Study|Withdrawal by Subject|1|||
164663126|NCT04634409|594789648|FG014|Overall Study|Withdrawal by Subject|5|||
164663127|NCT04634409|594789649|FG015|Overall Study|Withdrawal by Subject|0|||
164663128|NCT04634409|594789650|FG016|Overall Study|Withdrawal by Subject|0|||
164663129|NCT04634409|594789651|FG017|Overall Study|Withdrawal by Subject|1|||
164663130|NCT04634409|594789652|FG018|Overall Study|Withdrawal by Subject|0|||
164663131|NCT04634409|594789653|FG019|Overall Study|Withdrawal by Subject|0|||
164663132|NCT04634409|594789654|FG020|Overall Study|Withdrawal by Subject|0|||
164663133|NCT04634409|594789655|FG021|Overall Study|Withdrawal by Subject|0|||
164663134|NCT04634409|594789656|FG022|Overall Study|Withdrawal by Subject|0|||
164663135|NCT04634409|594789657|FG023|Overall Study|Withdrawal by Subject|1|||
164663136|NCT04634409|594789658|FG024|Overall Study|Withdrawal by Subject|0|||
164663137|NCT04634409|594789659|FG025|Overall Study|Withdrawal by Subject|0|||
164663138|NCT04634409|594789660|FG026|Overall Study|Withdrawal by Subject|0|||
164663139|NCT04634409|594789634|FG000|Overall Study|Other - As reported by Investigator|1|||
164663140|NCT04634409|594789635|FG001|Overall Study|Other - As reported by Investigator|0|||
164663141|NCT04634409|594789636|FG002|Overall Study|Other - As reported by Investigator|0|||
164663142|NCT04634409|594789637|FG003|Overall Study|Other - As reported by Investigator|0|||
164663143|NCT04634409|594789638|FG004|Overall Study|Other - As reported by Investigator|0|||
164663144|NCT04634409|594789639|FG005|Overall Study|Other - As reported by Investigator|0|||
164663145|NCT04634409|594789640|FG006|Overall Study|Other - As reported by Investigator|0|||
164663146|NCT04634409|594789641|FG007|Overall Study|Other - As reported by Investigator|6|||
164663147|NCT04634409|594789642|FG008|Overall Study|Other - As reported by Investigator|4|||
164663148|NCT04634409|594789643|FG009|Overall Study|Other - As reported by Investigator|0|||
164663149|NCT04634409|594789644|FG010|Overall Study|Other - As reported by Investigator|1|||
164663150|NCT04634409|594789645|FG011|Overall Study|Other - As reported by Investigator|2|||
164663151|NCT04634409|594789646|FG012|Overall Study|Other - As reported by Investigator|2|||
164663152|NCT04634409|594789647|FG013|Overall Study|Other - As reported by Investigator|1|||
164663153|NCT04634409|594789648|FG014|Overall Study|Other - As reported by Investigator|0|||
164663154|NCT04634409|594789649|FG015|Overall Study|Other - As reported by Investigator|0|||
164663155|NCT04634409|594789650|FG016|Overall Study|Other - As reported by Investigator|0|||
164663156|NCT04634409|594789651|FG017|Overall Study|Other - As reported by Investigator|0|||
164663157|NCT04634409|594789652|FG018|Overall Study|Other - As reported by Investigator|0|||
164663158|NCT04634409|594789653|FG019|Overall Study|Other - As reported by Investigator|0|||
164663159|NCT04634409|594789654|FG020|Overall Study|Other - As reported by Investigator|0|||
164663160|NCT04634409|594789655|FG021|Overall Study|Other - As reported by Investigator|0|||
164663161|NCT04634409|594789656|FG022|Overall Study|Other - As reported by Investigator|0|||
164663162|NCT04634409|594789657|FG023|Overall Study|Other - As reported by Investigator|0|||
164663163|NCT04634409|594789658|FG024|Overall Study|Other - As reported by Investigator|0|||
164663164|NCT04634409|594789659|FG025|Overall Study|Other - As reported by Investigator|0|||
164663165|NCT04634409|594789660|FG026|Overall Study|Other - As reported by Investigator|0|||
164663166|NCT02683187|594789661|FG000|Overall Study|Failed IV access|3|||
164663167|NCT02683187|594789661|FG000|Overall Study|Withdrawal by Subject|5|||
164663168|NCT02785913|594791980|FG000|Overall Study|Adverse Event|5|||
164663169|NCT02785913|594791980|FG000|Overall Study|Death|2|||
164663170|NCT02785913|594791980|FG000|Overall Study|Progression|18|||
164663171|NCT02785913|594791980|FG000|Overall Study|Not protocol specified|1|||
164663172|NCT03717064|594791981|FG000|Period 2|Adverse Event|1|||
164663173|NCT01298570|594791982|FG000|Overall Study|Disease progression, relapse during acti|64|||
164663174|NCT01298570|594791983|FG001|Overall Study|Disease progression, relapse during acti|40|||
164663175|NCT01298570|594791982|FG000|Overall Study|Adverse Event|20|||
164663176|NCT01298570|594791983|FG001|Overall Study|Adverse Event|2|||
164663177|NCT01298570|594791982|FG000|Overall Study|Withdrawal by Subject|21|||
164663178|NCT01298570|594791983|FG001|Overall Study|Withdrawal by Subject|6|||
164663179|NCT01298570|594791982|FG000|Overall Study|Treatment delay > 4 weeks|4|||
164663180|NCT01298570|594791983|FG001|Overall Study|Treatment delay > 4 weeks|5|||
164663181|NCT01298570|594791982|FG000|Overall Study|Physician Decision|4|||
164663182|NCT01298570|594791983|FG001|Overall Study|Physician Decision|2|||
164663183|NCT01298570|594791982|FG000|Overall Study|Other complicating disease|2|||
164663184|NCT01298570|594791983|FG001|Overall Study|Other complicating disease|1|||
164663185|NCT01298570|594791982|FG000|Overall Study|Surgery|2|||
164663186|NCT01298570|594791983|FG001|Overall Study|Surgery|1|||
164663187|NCT01298570|594791982|FG000|Overall Study|Symptomatic progression/deterioration|3|||
164663188|NCT01298570|594791983|FG001|Overall Study|Symptomatic progression/deterioration|2|||
164663189|NCT01298570|594791982|FG000|Overall Study|Death|0|||
164663190|NCT01298570|594791983|FG001|Overall Study|Death|1|||
164663191|NCT01298570|594791982|FG000|Overall Study|Ineligibility|0|||
164663192|NCT01298570|594791983|FG001|Overall Study|Ineligibility|1|||
164663193|NCT01929109|594791984|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
164663194|NCT01929109|594791985|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
164663195|NCT01929109|594791986|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
164663196|NCT01929109|594791987|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
164663197|NCT01929109|594791988|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
164663198|NCT00076102|594791989|FG000|Overall Study|Clinical progression|1|||
164663199|NCT00076102|594791989|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
164663200|NCT00076102|594791989|FG000|Overall Study|plexiform neurofibroma surgery|1|||
164663201|NCT00076102|594791989|FG000|Overall Study|refusal of further therapy|2|||
164663202|NCT01052116|594791990|FG000|Overall Study|Lost to Follow-up|11|||
164663203|NCT01052116|594791991|FG001|Overall Study|Lost to Follow-up|17|||
164559242|NCT04381650|594415577|FG005|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
164559243|NCT04381650|594415578|FG006|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
164559244|NCT04381650|594415579|FG007|Phase 2 (Dose Expansion)|Reason Not Specified|1|||
164559245|NCT04381650|594415580|FG008|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
164559246|NCT04381650|594415581|FG009|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
164559247|NCT04381650|594415582|FG010|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
164559248|NCT05593016|594417605|FG000|Overall Study|Death|1|||
164559249|NCT05593016|594417606|FG001|Overall Study|Death|1|||
164559250|NCT05593016|594417607|FG002|Overall Study|Death|1|||
164559251|NCT05593016|594417608|FG003|Overall Study|Death|0|||
164559252|NCT05593016|594417609|FG004|Overall Study|Death|0|||
164559253|NCT05593016|594417605|FG000|Overall Study|Lost to Follow-up|1|||
164559254|NCT05593016|594417606|FG001|Overall Study|Lost to Follow-up|1|||
164559255|NCT05593016|594417607|FG002|Overall Study|Lost to Follow-up|1|||
164559256|NCT05593016|594417608|FG003|Overall Study|Lost to Follow-up|2|||
164559257|NCT05593016|594417609|FG004|Overall Study|Lost to Follow-up|0|||
164559258|NCT03686397|594417610|FG000|Overall Study|Lack of Efficacy|3|||
164559259|NCT03686397|594417611|FG001|Overall Study|Lack of Efficacy|5|||
164559260|NCT03686397|594417610|FG000|Overall Study|Adverse Event|0|||
164559261|NCT03686397|594417611|FG001|Overall Study|Adverse Event|1|||
164559262|NCT03686397|594417610|FG000|Overall Study|Protocol Violation|0|||
164559263|NCT03686397|594417611|FG001|Overall Study|Protocol Violation|1|||
164559264|NCT03686397|594417610|FG000|Overall Study|Withdrawal by Subject|0|||
164559265|NCT03686397|594417611|FG001|Overall Study|Withdrawal by Subject|1|||
164559266|NCT03686397|594417610|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
164559267|NCT03686397|594417611|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
164559268|NCT01178138|594417612|FG000|Overall Study|Lost to Follow-up|8|||
164559269|NCT01178138|594417612|FG000|Overall Study|Withdrawal by Subject|7|||
164559270|NCT01178138|594417612|FG000|Overall Study|Physician Decision|8|||
164559271|NCT03160560|594417613|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
164559272|NCT03160560|594417614|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
164559273|NCT03160560|594417615|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
164559274|NCT03160560|594417616|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
164559275|NCT03160560|594417613|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
164559276|NCT03160560|594417614|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
164559277|NCT03160560|594417615|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
164559278|NCT03160560|594417616|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
164559279|NCT00403260|594417617|FG000|Overall Study|Adverse Event|5|||
164559280|NCT00403260|594417618|FG001|Overall Study|Adverse Event|4|||
164559281|NCT00403260|594417617|FG000|Overall Study|Withdrawal by Subject|5|||
164559282|NCT00403260|594417618|FG001|Overall Study|Withdrawal by Subject|6|||
164559283|NCT00403260|594417617|FG000|Overall Study|Lost to Follow-up|49|||
164559284|NCT00403260|594417618|FG001|Overall Study|Lost to Follow-up|25|||
164559285|NCT00403260|594417617|FG000|Overall Study|Re-appearance of P. falciparum|34|||
164559286|NCT00403260|594417618|FG001|Overall Study|Re-appearance of P. falciparum|25|||
164559287|NCT00403260|594417617|FG000|Overall Study|P. vivax infection|26|||
164559288|NCT00403260|594417618|FG001|Overall Study|P. vivax infection|4|||
164559289|NCT00403260|594417617|FG000|Overall Study|Mixed infection with P. vivax|2|||
164559290|NCT00403260|594417618|FG001|Overall Study|Mixed infection with P. vivax|0|||
164559291|NCT00403260|594417617|FG000|Overall Study|Mixed infection with P. falciparum|1|||
164559292|NCT00403260|594417618|FG001|Overall Study|Mixed infection with P. falciparum|0|||
164559293|NCT00403260|594417617|FG000|Overall Study|P. vivax infection at screening|1|||
164559294|NCT00403260|594417618|FG001|Overall Study|P. vivax infection at screening|0|||
164559295|NCT00403260|594417617|FG000|Overall Study|P. ovale infection|1|||
164559296|NCT00403260|594417618|FG001|Overall Study|P. ovale infection|0|||
164559297|NCT00403260|594417617|FG000|Overall Study|Gametocyte re-appearance|1|||
164559298|NCT00403260|594417618|FG001|Overall Study|Gametocyte re-appearance|1|||
164559299|NCT00403260|594417617|FG000|Overall Study|Withdrawn from study accidentally|0|||
164559300|NCT00403260|594417618|FG001|Overall Study|Withdrawn from study accidentally|1|||
164559301|NCT01241708|594417625|FG000|Overall Study|Withdrawal by Subject|6|||
164559302|NCT01241708|594417625|FG000|Overall Study|Screen Failure|6|||
164559303|NCT01241708|594417625|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
164204067|NCT05117060|593117928|FG003|Overall Study|Withdrawal by Subject|6|||
164559304|NCT01241708|594417625|FG000|Overall Study|Lost to Follow-up|5|||
164559305|NCT03733392|594417631|FG000|Overall Study|Withdrawal by Subject|11|||
164559306|NCT03733392|594417632|FG001|Overall Study|Withdrawal by Subject|1|||
164559307|NCT03733392|594417631|FG000|Overall Study|Death|1|||
164559308|NCT03733392|594417632|FG001|Overall Study|Death|0|||
164559309|NCT03733392|594417631|FG000|Overall Study|Lost to Follow-up|5|||
164559310|NCT03733392|594417632|FG001|Overall Study|Lost to Follow-up|0|||
164204068|NCT05117060|593117925|FG000|Overall Study|Other|2|||
164204069|NCT05117060|593117926|FG001|Overall Study|Other|1|||
164559311|NCT03733392|594417631|FG000|Overall Study|Protocol Violation|0|||
164559312|NCT03733392|594417632|FG001|Overall Study|Protocol Violation|1|||
164559313|NCT03733392|594417631|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
164663204|NCT01052116|594791990|FG000|Overall Study|Withdrawal by Subject|3|||
164663205|NCT01052116|594791991|FG001|Overall Study|Withdrawal by Subject|6|||
164663206|NCT01052116|594791990|FG000|Overall Study|Spirometry not performed|0|||
164663207|NCT01052116|594791991|FG001|Overall Study|Spirometry not performed|4|||
164663208|NCT02180711|594791992|FG000|Overall Study|Death|0|||
164663209|NCT02180711|594791993|FG001|Overall Study|Death|1|||
164663210|NCT02180711|594791994|FG002|Overall Study|Death|0|||
164663211|NCT02180711|594791995|FG003|Overall Study|Death|0|||
164663212|NCT02180711|594791996|FG004|Overall Study|Death|7|||
164663213|NCT02180711|594791997|FG005|Overall Study|Death|0|||
164663214|NCT02180711|594791998|FG006|Overall Study|Death|1|||
164663215|NCT02180711|594791999|FG007|Overall Study|Death|3|||
164663216|NCT02180711|594791992|FG000|Overall Study|Lost to Follow-up|0|||
164663217|NCT02180711|594791993|FG001|Overall Study|Lost to Follow-up|1|||
164663218|NCT02180711|594791994|FG002|Overall Study|Lost to Follow-up|0|||
164663219|NCT02180711|594791995|FG003|Overall Study|Lost to Follow-up|0|||
164663220|NCT02180711|594791996|FG004|Overall Study|Lost to Follow-up|1|||
164663221|NCT02180711|594791997|FG005|Overall Study|Lost to Follow-up|1|||
164663222|NCT02180711|594791998|FG006|Overall Study|Lost to Follow-up|0|||
164663223|NCT02180711|594791999|FG007|Overall Study|Lost to Follow-up|3|||
164663224|NCT02180711|594791992|FG000|Overall Study|Withdrawal by Subject|2|||
164559314|NCT03733392|594417632|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
164559315|NCT03733392|594417631|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
164559316|NCT03733392|594417632|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
164559317|NCT03733392|594417631|FG000|Overall Study|Patient Non-Compliance|2|||
164559318|NCT03733392|594417632|FG001|Overall Study|Patient Non-Compliance|1|||
164559319|NCT03733392|594417631|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
164559320|NCT03733392|594417632|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
164559321|NCT03733392|594417631|FG000|Overall Study|Withdrawal prior to procedure|5|||
164559322|NCT03733392|594417632|FG001|Overall Study|Withdrawal prior to procedure|2|||
164559323|NCT02740478|594417633|FG000|Overall Study|Withdrawal by Subject|1|||
164559324|NCT02615990|594417634|FG000|Overall Study|study terminated|1|||
164559325|NCT02615990|594417635|FG001|Overall Study|study terminated|1|||
164559326|NCT00808444|594417642|FG000|Overall Study|Withdrawal by Subject|1|||
164559327|NCT00808444|594417643|FG001|Overall Study|Withdrawal by Subject|0|||
164559328|NCT00808444|594417642|FG000|Overall Study|Lost to Follow-up|0|||
164559329|NCT00808444|594417643|FG001|Overall Study|Lost to Follow-up|1|||
164559330|NCT01461044|594417644|FG000|Overall Study|Death|58|||
164559331|NCT01461044|594417645|FG001|Overall Study|Death|35|||
164559332|NCT01461044|594417644|FG000|Overall Study|Lost to Follow-up|12|||
164559333|NCT01461044|594417645|FG001|Overall Study|Lost to Follow-up|5|||
164559334|NCT04401267|594417646|FG000|Overall Study|Death|0|||
164559335|NCT04401267|594417647|FG001|Overall Study|Death|1|||
164559336|NCT04401267|594417646|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
164559337|NCT04401267|594417647|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
164559338|NCT04401267|594417646|FG000|Overall Study|Found to be Ineligible|1|||
164559339|NCT04401267|594417647|FG001|Overall Study|Found to be Ineligible|0|||
164559340|NCT01449708|594417653|FG000|Overall Study|Protocol Violation|0|||
164559341|NCT01449708|594417654|FG001|Overall Study|Protocol Violation|1|||
164559342|NCT01449708|594417653|FG000|Overall Study|surgical complication|1|||
164559343|NCT01449708|594417654|FG001|Overall Study|surgical complication|2|||
164559344|NCT01449708|594417653|FG000|Overall Study|respiratory failure|1|||
164559345|NCT01449708|594417654|FG001|Overall Study|respiratory failure|0|||
164559346|NCT02889796|594417655|FG000|Overall Study|Withdrew Consent|18|||
164559347|NCT02889796|594417656|FG001|Overall Study|Withdrew Consent|29|||
164559348|NCT02889796|594417657|FG002|Overall Study|Withdrew Consent|20|||
164559349|NCT02889796|594417658|FG003|Overall Study|Withdrew Consent|1|||
164559350|NCT02889796|594417659|FG004|Overall Study|Withdrew Consent|2|||
164559351|NCT02889796|594417660|FG005|Overall Study|Withdrew Consent|35|||
164559352|NCT02889796|594417655|FG000|Overall Study|Investigator's Discretion|10|||
164559353|NCT02889796|594417656|FG001|Overall Study|Investigator's Discretion|9|||
164559354|NCT02889796|594417657|FG002|Overall Study|Investigator's Discretion|10|||
164559355|NCT02889796|594417658|FG003|Overall Study|Investigator's Discretion|3|||
164559356|NCT02889796|594417659|FG004|Overall Study|Investigator's Discretion|0|||
164559357|NCT02889796|594417660|FG005|Overall Study|Investigator's Discretion|15|||
164559358|NCT02889796|594417655|FG000|Overall Study|Adverse Event|17|||
164559359|NCT02889796|594417656|FG001|Overall Study|Adverse Event|8|||
164559360|NCT02889796|594417657|FG002|Overall Study|Adverse Event|8|||
164559361|NCT02889796|594417658|FG003|Overall Study|Adverse Event|4|||
164559362|NCT02889796|594417659|FG004|Overall Study|Adverse Event|1|||
164559363|NCT02889796|594417660|FG005|Overall Study|Adverse Event|7|||
164559364|NCT02889796|594417655|FG000|Overall Study|Lost to Follow-up|5|||
164559365|NCT02889796|594417656|FG001|Overall Study|Lost to Follow-up|7|||
164559366|NCT02889796|594417657|FG002|Overall Study|Lost to Follow-up|2|||
164559367|NCT02889796|594417658|FG003|Overall Study|Lost to Follow-up|0|||
164663225|NCT02180711|594791993|FG001|Overall Study|Withdrawal by Subject|1|||
164663226|NCT02180711|594791994|FG002|Overall Study|Withdrawal by Subject|0|||
164663227|NCT02180711|594791995|FG003|Overall Study|Withdrawal by Subject|4|||
164663228|NCT02180711|594791996|FG004|Overall Study|Withdrawal by Subject|3|||
164663229|NCT02180711|594791997|FG005|Overall Study|Withdrawal by Subject|0|||
164663230|NCT02180711|594791998|FG006|Overall Study|Withdrawal by Subject|3|||
164663231|NCT02180711|594791999|FG007|Overall Study|Withdrawal by Subject|2|||
164663232|NCT02180711|594791992|FG000|Overall Study|- Disease Progression|0|||
164663233|NCT02180711|594791993|FG001|Overall Study|- Disease Progression|1|||
164663234|NCT02180711|594791994|FG002|Overall Study|- Disease Progression|0|||
164663235|NCT02180711|594791995|FG003|Overall Study|- Disease Progression|0|||
164663236|NCT02180711|594791996|FG004|Overall Study|- Disease Progression|0|||
164663237|NCT02180711|594791997|FG005|Overall Study|- Disease Progression|0|||
164663238|NCT02180711|594791998|FG006|Overall Study|- Disease Progression|0|||
164663239|NCT02180711|594791999|FG007|Overall Study|- Disease Progression|0|||
164663240|NCT02180711|594791992|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
164663241|NCT02180711|594791993|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
164663242|NCT02180711|594791994|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
164663243|NCT02180711|594791995|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
164663244|NCT02180711|594791996|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
164663245|NCT02180711|594791997|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
164663246|NCT02180711|594791998|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
164663247|NCT02180711|594791999|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
164663248|NCT02180711|594791992|FG000|Overall Study|- Study Terminated by Sponsor|2|||
164663249|NCT02180711|594791993|FG001|Overall Study|- Study Terminated by Sponsor|3|||
164663250|NCT02180711|594791994|FG002|Overall Study|- Study Terminated by Sponsor|0|||
164663251|NCT02180711|594791995|FG003|Overall Study|- Study Terminated by Sponsor|5|||
164663252|NCT02180711|594791996|FG004|Overall Study|- Study Terminated by Sponsor|32|||
164663253|NCT02180711|594791997|FG005|Overall Study|- Study Terminated by Sponsor|0|||
164663254|NCT02180711|594791998|FG006|Overall Study|- Study Terminated by Sponsor|4|||
164663255|NCT02180711|594791999|FG007|Overall Study|- Study Terminated by Sponsor|13|||
164663256|NCT02180711|594791992|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
164663257|NCT02180711|594791993|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
164663258|NCT02180711|594791994|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
164663259|NCT02180711|594791995|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
164663260|NCT02180711|594791996|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
164663261|NCT02180711|594791997|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
164663262|NCT02180711|594791998|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
164663263|NCT02180711|594791999|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
164663264|NCT02180711|594791992|FG000|Overall Study|- Other|1|||
164663265|NCT02180711|594791993|FG001|Overall Study|- Other|0|||
164663266|NCT02180711|594791994|FG002|Overall Study|- Other|0|||
164663267|NCT02180711|594791995|FG003|Overall Study|- Other|1|||
164663268|NCT02180711|594791996|FG004|Overall Study|- Other|0|||
164663269|NCT02180711|594791997|FG005|Overall Study|- Other|0|||
164663270|NCT02180711|594791998|FG006|Overall Study|- Other|0|||
164663271|NCT02180711|594791999|FG007|Overall Study|- Other|0|||
164663272|NCT00444145|594792000|FG000|Overall Study|Withdrawal by Subject|2|||
164663273|NCT00444145|594792000|FG000|Overall Study|Lost to Follow-up|1|||
164663274|NCT00444145|594792000|FG000|Overall Study|non-compliant|11|||
164663275|NCT00444145|594792000|FG000|Overall Study|Screen Failures|5|||
164663276|NCT01768858|594792001|FG000|Overall Study|Lost to Follow-up|9|||
164663277|NCT01768858|594792001|FG000|Overall Study|Lack of Efficacy|8|||
164663278|NCT01768858|594792001|FG000|Overall Study|Serious Adverse Event|1|||
164663279|NCT01768858|594792001|FG000|Overall Study|Participant moved to Germany|1|||
164663280|NCT01768858|594792001|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
164663281|NCT01768858|594792001|FG000|Overall Study|Exanthema|1|||
164663282|NCT01768858|594792001|FG000|Overall Study|Withdrawal by Subject|1|||
164663283|NCT00502775|594792009|FG000|Overall Study|Adverse Event|1|||
164663284|NCT00502775|594792010|FG001|Overall Study|Adverse Event|2|||
164663285|NCT00502775|594792011|FG002|Overall Study|Adverse Event|1|||
164663286|NCT00502775|594792009|FG000|Overall Study|Protocol Violation|1|||
164663287|NCT00502775|594792010|FG001|Overall Study|Protocol Violation|5|||
164663288|NCT00502775|594792011|FG002|Overall Study|Protocol Violation|2|||
164663289|NCT00502775|594792009|FG000|Overall Study|Withdrawal by Subject|1|||
164663290|NCT00502775|594792010|FG001|Overall Study|Withdrawal by Subject|1|||
164663291|NCT00502775|594792011|FG002|Overall Study|Withdrawal by Subject|2|||
164663292|NCT00502775|594792009|FG000|Overall Study|Sponsor Terminated Study|1|||
164663293|NCT00502775|594792010|FG001|Overall Study|Sponsor Terminated Study|0|||
164663294|NCT00502775|594792011|FG002|Overall Study|Sponsor Terminated Study|1|||
164663295|NCT00502775|594792009|FG000|Overall Study|Non-compliance with eDiary|4|||
164663296|NCT00502775|594792010|FG001|Overall Study|Non-compliance with eDiary|1|||
164663297|NCT00502775|594792011|FG002|Overall Study|Non-compliance with eDiary|1|||
164663298|NCT00502775|594792009|FG000|Overall Study|Subject unable to swallow capsule|1|||
164663299|NCT00502775|594792010|FG001|Overall Study|Subject unable to swallow capsule|0|||
164663300|NCT00502775|594792011|FG002|Overall Study|Subject unable to swallow capsule|1|||
164663301|NCT00502775|594792009|FG000|Overall Study|Logpad compliance <80%|1|||
164663302|NCT00502775|594792010|FG001|Overall Study|Logpad compliance <80%|0|||
164663303|NCT00502775|594792011|FG002|Overall Study|Logpad compliance <80%|0|||
164663304|NCT00502775|594792009|FG000|Overall Study|Randomized in error|0|||
164663305|NCT00502775|594792010|FG001|Overall Study|Randomized in error|1|||
164663306|NCT00502775|594792011|FG002|Overall Study|Randomized in error|1|||
164663307|NCT00502775|594792009|FG000|Overall Study|Non-compliance|0|||
164663308|NCT00502775|594792010|FG001|Overall Study|Non-compliance|2|||
164663309|NCT00502775|594792011|FG002|Overall Study|Non-compliance|2|||
164663310|NCT00502775|594792009|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
164663311|NCT00502775|594792010|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
164663312|NCT00502775|594792011|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
164663313|NCT00502775|594792009|FG000|Overall Study|Declining pollen counts|0|||
164663314|NCT00502775|594792010|FG001|Overall Study|Declining pollen counts|1|||
164663315|NCT00502775|594792011|FG002|Overall Study|Declining pollen counts|1|||
164663316|NCT00502775|594792009|FG000|Overall Study|Subject in jail|0|||
164663317|NCT00502775|594792010|FG001|Overall Study|Subject in jail|1|||
164663318|NCT00502775|594792011|FG002|Overall Study|Subject in jail|0|||
164663319|NCT00502775|594792009|FG000|Overall Study|Subject took disallowed drug|0|||
164663320|NCT00502775|594792010|FG001|Overall Study|Subject took disallowed drug|0|||
164663321|NCT00502775|594792011|FG002|Overall Study|Subject took disallowed drug|1|||
164663322|NCT00520741|594792012|FG000|Overall Study|Adverse Event|16|||
164663323|NCT00520741|594792013|FG001|Overall Study|Adverse Event|56|||
164663324|NCT00520741|594792012|FG000|Overall Study|Lack of Efficacy|11|||
164663325|NCT00520741|594792013|FG001|Overall Study|Lack of Efficacy|30|||
164663326|NCT00520741|594792012|FG000|Overall Study|Withdrawal by Subject|0|||
164663327|NCT00520741|594792013|FG001|Overall Study|Withdrawal by Subject|11|||
164663328|NCT00520741|594792012|FG000|Overall Study|Protocol Violation|2|||
164663329|NCT00520741|594792013|FG001|Overall Study|Protocol Violation|15|||
164663330|NCT00520741|594792012|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
164663331|NCT00520741|594792013|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
164663332|NCT00520741|594792012|FG000|Overall Study|Lost to Follow-up|4|||
164663333|NCT00520741|594792013|FG001|Overall Study|Lost to Follow-up|4|||
164663334|NCT00520741|594792012|FG000|Overall Study|Other reasons for premature termination|0|||
164663335|NCT00520741|594792013|FG001|Overall Study|Other reasons for premature termination|6|||
164663336|NCT03702621|594792014|FG000|Overall Study|Physician Decision|6|||
164663337|NCT03702621|594792015|FG001|Overall Study|Physician Decision|6|||
164663338|NCT00419926|594792016|FG000|Overall Study|Withdrawal by Subject|7|||
164663339|NCT00419926|594792017|FG001|Overall Study|Withdrawal by Subject|3|||
164663340|NCT00419926|594792016|FG000|Overall Study|Administrative Problem|4|||
164663341|NCT00419926|594792017|FG001|Overall Study|Administrative Problem|4|||
164663342|NCT00419926|594792016|FG000|Overall Study|Lost to Follow-up|1|||
164663343|NCT00419926|594792017|FG001|Overall Study|Lost to Follow-up|2|||
164663344|NCT00419926|594792016|FG000|Overall Study|Death|2|||
164663345|NCT00419926|594792017|FG001|Overall Study|Death|1|||
164663346|NCT02374918|594792018|FG000|Overall Study|Protocol Violation|2|||
164663347|NCT02374918|594792019|FG001|Overall Study|Protocol Violation|0|||
164663348|NCT02374918|594792020|FG002|Overall Study|Protocol Violation|2|||
164663349|NCT02374918|594792021|FG003|Overall Study|Protocol Violation|1|||
164663350|NCT02374918|594792018|FG000|Overall Study|Withdrawal by Subject|1|||
164663351|NCT02374918|594792019|FG001|Overall Study|Withdrawal by Subject|1|||
164663352|NCT02374918|594792020|FG002|Overall Study|Withdrawal by Subject|1|||
164663353|NCT02374918|594792021|FG003|Overall Study|Withdrawal by Subject|0|||
164663354|NCT02374918|594792018|FG000|Overall Study|Lack of Efficacy|0|||
164663355|NCT02374918|594792019|FG001|Overall Study|Lack of Efficacy|0|||
164663356|NCT02374918|594792020|FG002|Overall Study|Lack of Efficacy|1|||
164663357|NCT02374918|594792021|FG003|Overall Study|Lack of Efficacy|1|||
164663358|NCT02402166|594792022|FG000|Overall Study|Adverse Event|2|||
164663359|NCT02402166|594792022|FG000|Overall Study|Withdrawal by Subject|2|||
164663360|NCT02402166|594792022|FG000|Overall Study|Lost to Follow-up|1|||
164663361|NCT00623103|594792023|FG000|Overall Study|Adverse Event|70|||
164663362|NCT00623103|594792024|FG001|Overall Study|Adverse Event|60|||
164663363|NCT00623103|594792023|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
164663364|NCT00623103|594792024|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
164663365|NCT00623103|594792023|FG000|Overall Study|Withdrawal by Subject|18|||
164663366|NCT00623103|594792024|FG001|Overall Study|Withdrawal by Subject|24|||
164663367|NCT00623103|594792023|FG000|Overall Study|Lost to Follow-up|4|||
164663368|NCT00623103|594792024|FG001|Overall Study|Lost to Follow-up|1|||
164663369|NCT00623103|594792023|FG000|Overall Study|Administrative problems|2|||
164663370|NCT00623103|594792024|FG001|Overall Study|Administrative problems|4|||
164663371|NCT00623103|594792023|FG000|Overall Study|Death|11|||
164663372|NCT00623103|594792024|FG001|Overall Study|Death|11|||
164663373|NCT00623103|594792023|FG000|Overall Study|Protocol deviation|2|||
164663374|NCT00623103|594792024|FG001|Overall Study|Protocol deviation|1|||
164663375|NCT02433678|594792029|FG000|Overall Study|Lost to Follow-up|1|||
164663376|NCT02433678|594792030|FG001|Overall Study|Lost to Follow-up|2|||
164663377|NCT01424722|594792034|FG000|Overall Study|Sponsor terminated investigation|2258|||
164663378|NCT02483975|594792035|FG000|Overall Study|Adverse Event|0|||
164663379|NCT02483975|594792036|FG001|Overall Study|Adverse Event|1|||
164663380|NCT02483975|594792035|FG000|Overall Study|Lost to Follow-up|0|||
164663381|NCT02483975|594792036|FG001|Overall Study|Lost to Follow-up|1|||
164663382|NCT02483975|594792035|FG000|Overall Study|Physician Decision|2|||
164663383|NCT02483975|594792036|FG001|Overall Study|Physician Decision|0|||
164663384|NCT00818883|594792037|FG000|Overall Study|Adverse Event|28|||
164663385|NCT00818883|594792038|FG001|Overall Study|Adverse Event|19|||
164663386|NCT00818883|594792037|FG000|Overall Study|Protocol Violation|2|||
164663387|NCT00818883|594792038|FG001|Overall Study|Protocol Violation|2|||
164663388|NCT00818883|594792037|FG000|Overall Study|Lost to Follow-up|3|||
164663389|NCT00818883|594792038|FG001|Overall Study|Lost to Follow-up|2|||
164663390|NCT00818883|594792037|FG000|Overall Study|Withdrawal by Subject|16|||
164663391|NCT00818883|594792038|FG001|Overall Study|Withdrawal by Subject|14|||
164663392|NCT00818883|594792037|FG000|Overall Study|Lack of Efficacy|0|||
164663393|NCT00818883|594792038|FG001|Overall Study|Lack of Efficacy|2|||
164663394|NCT00818883|594792037|FG000|Overall Study|Other|2|||
164663395|NCT00818883|594792038|FG001|Overall Study|Other|7|||
164663396|NCT02166697|594792039|FG000|Overall Study|Protocol Violation|347|||
164663397|NCT02684578|594792043|FG000|Overall Study|Withdrawal by Subject|10|||
164663398|NCT02684578|594792044|FG001|Overall Study|Withdrawal by Subject|7|||
164663399|NCT02684578|594792043|FG000|Overall Study|Lost to Follow-up|0|||
164663400|NCT02684578|594792044|FG001|Overall Study|Lost to Follow-up|3|||
164663401|NCT02684578|594792043|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
164663402|NCT02684578|594792044|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
164663403|NCT02684578|594792043|FG000|Overall Study|Missing follow-up data|0|||
164663404|NCT02684578|594792044|FG001|Overall Study|Missing follow-up data|1|||
164663405|NCT01505530|594792045|FG000|Overall Study|Progressive Disease|19|||
164663406|NCT01505530|594792046|FG001|Overall Study|Progressive Disease|17|||
164663407|NCT01505530|594792047|FG002|Overall Study|Progressive Disease|18|||
164663408|NCT01505530|594792045|FG000|Overall Study|Adverse Event|1|||
164663409|NCT01505530|594792046|FG001|Overall Study|Adverse Event|1|||
164663410|NCT01505530|594792047|FG002|Overall Study|Adverse Event|0|||
164663411|NCT01505530|594792045|FG000|Overall Study|Withdrawal by Subject|7|||
164663412|NCT01505530|594792046|FG001|Overall Study|Withdrawal by Subject|8|||
164663413|NCT01505530|594792047|FG002|Overall Study|Withdrawal by Subject|6|||
164663414|NCT01505530|594792045|FG000|Overall Study|Physician Decision|6|||
164663415|NCT01505530|594792046|FG001|Overall Study|Physician Decision|2|||
164663416|NCT01505530|594792047|FG002|Overall Study|Physician Decision|5|||
164663417|NCT01505530|594792045|FG000|Overall Study|Sponsor Decision|1|||
164663418|NCT01505530|594792046|FG001|Overall Study|Sponsor Decision|8|||
164663419|NCT01505530|594792047|FG002|Overall Study|Sponsor Decision|7|||
164663420|NCT01505530|594792045|FG000|Overall Study|Death|7|||
164663421|NCT01505530|594792046|FG001|Overall Study|Death|6|||
164663422|NCT01505530|594792047|FG002|Overall Study|Death|5|||
164663423|NCT01505530|594792045|FG000|Overall Study|entry criteria not met|0|||
164663424|NCT01505530|594792046|FG001|Overall Study|entry criteria not met|1|||
164663425|NCT01505530|594792047|FG002|Overall Study|entry criteria not met|0|||
164663426|NCT00625807|594792050|FG000|Overall Study|schedule conflict|2|||
164663427|NCT00625807|594792051|FG001|Overall Study|schedule conflict|8|||
164663428|NCT01966042|594792052|FG000|Overall Study|Death|2|||
164663429|NCT01802879|594792053|FG000|Overall Study|Administrative problems|2|||
164663430|NCT01802879|594792053|FG000|Overall Study|Disease progression|6|||
164663431|NCT00266409|594792054|FG000|Overall Study|Lack of Efficacy|2|||
164663432|NCT00266409|594792055|FG001|Overall Study|Lack of Efficacy|6|||
164663433|NCT00266409|594792056|FG002|Overall Study|Lack of Efficacy|1|||
164663434|NCT00266409|594792057|FG003|Overall Study|Lack of Efficacy|2|||
164663435|NCT00266409|594792054|FG000|Overall Study|Adverse Event|7|||
164663436|NCT00266409|594792055|FG001|Overall Study|Adverse Event|2|||
164663437|NCT00266409|594792056|FG002|Overall Study|Adverse Event|1|||
164663438|NCT00266409|594792057|FG003|Overall Study|Adverse Event|1|||
164663439|NCT00266409|594792054|FG000|Overall Study|Lost to Follow-up|18|||
164663440|NCT00266409|594792055|FG001|Overall Study|Lost to Follow-up|21|||
164663441|NCT00266409|594792056|FG002|Overall Study|Lost to Follow-up|6|||
164663442|NCT00266409|594792057|FG003|Overall Study|Lost to Follow-up|8|||
164663443|NCT00266409|594792054|FG000|Overall Study|Withdrawal by Subject|6|||
164663444|NCT00266409|594792055|FG001|Overall Study|Withdrawal by Subject|10|||
164663445|NCT00266409|594792056|FG002|Overall Study|Withdrawal by Subject|3|||
164663446|NCT00266409|594792057|FG003|Overall Study|Withdrawal by Subject|9|||
164663447|NCT00266409|594792054|FG000|Overall Study|Protocol Violation|5|||
164663448|NCT00266409|594792055|FG001|Overall Study|Protocol Violation|3|||
164663449|NCT00266409|594792056|FG002|Overall Study|Protocol Violation|4|||
164663450|NCT00266409|594792057|FG003|Overall Study|Protocol Violation|2|||
164663451|NCT00266409|594792054|FG000|Overall Study|Other|7|||
164663452|NCT00266409|594792055|FG001|Overall Study|Other|4|||
164663453|NCT00266409|594792056|FG002|Overall Study|Other|2|||
164663454|NCT00266409|594792057|FG003|Overall Study|Other|0|||
164663455|NCT00108732|594792065|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
164663456|NCT00108732|594792065|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
164663457|NCT00108732|594792065|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
164663458|NCT00108732|594792065|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
164663459|NCT00108732|594792065|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
164663460|NCT00108732|594792065|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
164663461|NCT00108732|594792065|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
164663462|NCT01946165|594792067|FG000|Overall Study|Physician Decision|2|||
164663463|NCT01946165|594792068|FG001|Overall Study|Physician Decision|0|||
164663464|NCT01946165|594792067|FG000|Overall Study|Withdrawal by Subject|0|||
164663465|NCT01946165|594792068|FG001|Overall Study|Withdrawal by Subject|2|||
164663466|NCT01901055|594792069|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
164663467|NCT01901055|594792070|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
164663468|NCT01901055|594792069|FG000|Randomization But Not Titrated|Physician Decision|0|||
164663469|NCT01901055|594792070|FG001|Randomization But Not Titrated|Physician Decision|1|||
164663470|NCT01901055|594792069|FG000|Started Protocol to Week 6|Physician Decision|2|||
164663471|NCT01901055|594792070|FG001|Started Protocol to Week 6|Physician Decision|1|||
164663472|NCT01901055|594792069|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
164663473|NCT01901055|594792070|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
164663474|NCT01901055|594792069|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
164663475|NCT01901055|594792070|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
164663476|NCT01901055|594792069|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
164663477|NCT01901055|594792070|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
164663478|NCT01901055|594792069|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
164663479|NCT01901055|594792070|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
164663480|NCT01901055|594792069|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
164663481|NCT01901055|594792070|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
164663482|NCT01901055|594792069|FG000|Week 24|Withdrawal by Subject|13|||
164663483|NCT01901055|594792070|FG001|Week 24|Withdrawal by Subject|19|||
164663484|NCT01901055|594792069|FG000|Week 24|Physician Decision|1|||
164663485|NCT01901055|594792070|FG001|Week 24|Physician Decision|0|||
164663486|NCT01901055|594792069|FG000|Week 36|Withdrawal by Subject|0|||
164663487|NCT01901055|594792070|FG001|Week 36|Withdrawal by Subject|5|||
164663488|NCT03019965|594792071|FG000|Overall Study|Withdrawal by Subject|1|||
164663489|NCT03019965|594792072|FG001|Overall Study|Withdrawal by Subject|0|||
164663490|NCT03019965|594792071|FG000|Overall Study|Protocol Violation|1|||
164663491|NCT03019965|594792072|FG001|Overall Study|Protocol Violation|3|||
164663492|NCT03019965|594792071|FG000|Overall Study|viral or fungal infection|3|||
164663493|NCT03019965|594792072|FG001|Overall Study|viral or fungal infection|4|||
164663494|NCT03019965|594792071|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
164663495|NCT03019965|594792072|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
164663496|NCT03019965|594792071|FG000|Overall Study|Physician Decision|1|||
164663497|NCT03019965|594792072|FG001|Overall Study|Physician Decision|1|||
164663498|NCT00708422|594792073|FG000|Overall Study|Adverse Event|3|||
164663499|NCT00708422|594792074|FG001|Overall Study|Adverse Event|1|||
164663500|NCT00708422|594792073|FG000|Overall Study|Withdrawal by Subject|1|||
164663501|NCT00708422|594792074|FG001|Overall Study|Withdrawal by Subject|0|||
164663502|NCT01254409|594792075|FG000|Overall Study|Adverse Event|0|||
164663503|NCT01254409|594792076|FG001|Overall Study|Adverse Event|1|||
164663504|NCT01254409|594792077|FG002|Overall Study|Adverse Event|0|||
164663505|NCT01254409|594792078|FG003|Overall Study|Adverse Event|0|||
164663506|NCT00635154|594792085|FG000|Overall Study|Alternative Treatment|8|||
164663507|NCT00635154|594792085|FG000|Overall Study|Other|4|||
164663508|NCT00635154|594792085|FG000|Overall Study|Still on treatment|21|||
164663509|NCT02114697|594792086|FG000|Overall Study|Study terminated|5|||
164663510|NCT02114697|594792087|FG001|Overall Study|Study terminated|4|||
164663511|NCT02660242|594792092|FG000|Glucose Tabs|Lost to Follow-up|1|||
164663512|NCT02660242|594792092|FG000|Glucagon Injection|Lost to Follow-up|1|||
164663513|NCT02796664|594792094|FG000|Overall Study|Withdrawal by Subject|0|||
164663514|NCT02796664|594792095|FG001|Overall Study|Withdrawal by Subject|3|||
164663515|NCT02796664|594792094|FG000|Overall Study|Noncompliance|1|||
164663516|NCT02796664|594792095|FG001|Overall Study|Noncompliance|1|||
164663517|NCT02796664|594792094|FG000|Overall Study|Death|0|||
164663518|NCT02796664|594792095|FG001|Overall Study|Death|1|||
164663519|NCT01626079|594792096|FG000|Overall Study|Death|167|||
164663520|NCT01626079|594792097|FG001|Overall Study|Death|192|||
164663521|NCT01626079|594792098|FG002|Overall Study|Death|39|||
164663522|NCT01626079|594792096|FG000|Overall Study|Withdrawal by Subject|23|||
164663523|NCT01626079|594792097|FG001|Overall Study|Withdrawal by Subject|37|||
164663524|NCT01626079|594792098|FG002|Overall Study|Withdrawal by Subject|5|||
164663525|NCT01626079|594792096|FG000|Overall Study|Lost to Follow-up|7|||
164663526|NCT01626079|594792097|FG001|Overall Study|Lost to Follow-up|4|||
164663527|NCT01626079|594792098|FG002|Overall Study|Lost to Follow-up|2|||
164663528|NCT01626079|594792096|FG000|Overall Study|Missed Visits|1|||
164663529|NCT01626079|594792097|FG001|Overall Study|Missed Visits|4|||
164663530|NCT01626079|594792098|FG002|Overall Study|Missed Visits|6|||
164663531|NCT02430870|594792102|FG000|Part 2|Voluntary Withdrawal|0|||
164314831|NCT02703337|593529783|FG006|Period One (Part A)|Withdrawal by Subject|0|||
164314832|NCT02703337|593529784|FG007|Period One (Part A)|Withdrawal by Subject|0|||
164559368|NCT02889796|594417659|FG004|Overall Study|Lost to Follow-up|2|||
164559369|NCT02889796|594417660|FG005|Overall Study|Lost to Follow-up|6|||
164559370|NCT02889796|594417655|FG000|Overall Study|Protocol Violation|0|||
164559371|NCT02889796|594417656|FG001|Overall Study|Protocol Violation|1|||
164559372|NCT02889796|594417657|FG002|Overall Study|Protocol Violation|3|||
164559373|NCT02889796|594417658|FG003|Overall Study|Protocol Violation|0|||
164559374|NCT02889796|594417659|FG004|Overall Study|Protocol Violation|0|||
164559375|NCT02889796|594417660|FG005|Overall Study|Protocol Violation|4|||
164559376|NCT02889796|594417655|FG000|Overall Study|Non-compliance With Study Drug|0|||
164559377|NCT02889796|594417656|FG001|Overall Study|Non-compliance With Study Drug|2|||
164559378|NCT02889796|594417657|FG002|Overall Study|Non-compliance With Study Drug|0|||
164559379|NCT02889796|594417658|FG003|Overall Study|Non-compliance With Study Drug|0|||
164559380|NCT02889796|594417659|FG004|Overall Study|Non-compliance With Study Drug|1|||
164559381|NCT02889796|594417660|FG005|Overall Study|Non-compliance With Study Drug|2|||
164559382|NCT02889796|594417655|FG000|Overall Study|Death|1|||
164559383|NCT02889796|594417656|FG001|Overall Study|Death|1|||
164559384|NCT02889796|594417657|FG002|Overall Study|Death|0|||
164559385|NCT02889796|594417658|FG003|Overall Study|Death|1|||
164559386|NCT02889796|594417659|FG004|Overall Study|Death|0|||
164559387|NCT02889796|594417660|FG005|Overall Study|Death|1|||
164559388|NCT02889796|594417655|FG000|Overall Study|Pregnancy|0|||
164559389|NCT02889796|594417656|FG001|Overall Study|Pregnancy|1|||
164559390|NCT02889796|594417657|FG002|Overall Study|Pregnancy|1|||
164559391|NCT02889796|594417658|FG003|Overall Study|Pregnancy|0|||
164559392|NCT02889796|594417659|FG004|Overall Study|Pregnancy|0|||
164559393|NCT02889796|594417660|FG005|Overall Study|Pregnancy|0|||
164559394|NCT02889796|594417655|FG000|Overall Study|Randomized but not Dosed|2|||
164559395|NCT02889796|594417656|FG001|Overall Study|Randomized but not Dosed|0|||
164559396|NCT02889796|594417657|FG002|Overall Study|Randomized but not Dosed|0|||
164559397|NCT02889796|594417658|FG003|Overall Study|Randomized but not Dosed|0|||
164559398|NCT02889796|594417659|FG004|Overall Study|Randomized but not Dosed|0|||
164559399|NCT02889796|594417660|FG005|Overall Study|Randomized but not Dosed|2|||
164559400|NCT04294459|594417661|FG000|Overall Study|Adverse Event|0|||
164559401|NCT04294459|594417662|FG001|Overall Study|Adverse Event|1|||
164559402|NCT02814565|594417663|FG000|Overall Study|Lack of Efficacy|0|||
164559403|NCT02814565|594417664|FG001|Overall Study|Lack of Efficacy|1|||
164559404|NCT02814565|594417663|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
164559405|NCT02814565|594417664|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
164559406|NCT03757988|594417667|FG000|Overall Study|Withdrawal by Subject|1|||
164559407|NCT02450487|594417670|FG000|Overall Study|Lost to Follow-up|3|||
164559408|NCT04269395|594417671|FG000|Overall Study|Lost to Follow-up|1|||
164559409|NCT04269395|594417672|FG001|Overall Study|Lost to Follow-up|0|||
164559410|NCT04269395|594417671|FG000|Overall Study|Study terminated by Sponsor|13|||
164559411|NCT04269395|594417672|FG001|Overall Study|Study terminated by Sponsor|10|||
164559412|NCT05587296|594417673|FG000|Overall Study|Adverse Event|15|||
164559413|NCT05587296|594417674|FG001|Overall Study|Adverse Event|7|||
164559414|NCT05587296|594417673|FG000|Overall Study|Lack of Efficacy|2|||
164559415|NCT05587296|594417674|FG001|Overall Study|Lack of Efficacy|0|||
164559416|NCT05587296|594417673|FG000|Overall Study|Lost to Follow-up|1|||
164559417|NCT05587296|594417674|FG001|Overall Study|Lost to Follow-up|0|||
164559418|NCT05587296|594417673|FG000|Overall Study|Withdrawal by Subject|14|||
164559419|NCT05587296|594417674|FG001|Overall Study|Withdrawal by Subject|4|||
164559420|NCT05587296|594417673|FG000|Overall Study|miscellaneous|3|||
164559421|NCT05587296|594417674|FG001|Overall Study|miscellaneous|6|||
164559422|NCT05587296|594417673|FG000|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|19|||
164559423|NCT05587296|594417674|FG001|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|8|||
164559424|NCT02847624|594417677|FG000|Overall Study|Lost to Follow-up|28|||
164559425|NCT02847624|594417677|FG000|Overall Study|Protocol Violation|98|||
164559426|NCT02847624|594417677|FG000|Overall Study|Case report failures|4|||
164559427|NCT04735653|594417678|FG000|Overall Study|Lost to Follow-up|17|||
164559428|NCT04735653|594417679|FG001|Overall Study|Lost to Follow-up|7|||
164559429|NCT04735653|594417678|FG000|Overall Study|Withdrawal by Subject|8|||
164559430|NCT04735653|594417679|FG001|Overall Study|Withdrawal by Subject|2|||
164559431|NCT04735653|594417678|FG000|Overall Study|Death|0|||
164559432|NCT04735653|594417679|FG001|Overall Study|Death|2|||
164559433|NCT04735653|594417678|FG000|Overall Study|Removed due to determination of participant noncompliance|2|||
164559434|NCT04735653|594417679|FG001|Overall Study|Removed due to determination of participant noncompliance|0|||
164559435|NCT04161495|594417685|FG000|Overall Study|Withdrawal by Subject|3|||
164559436|NCT04161495|594417686|FG001|Overall Study|Withdrawal by Subject|0|||
164559437|NCT04161495|594417685|FG000|Overall Study|Protocol Violation|1|||
164559438|NCT04161495|594417686|FG001|Overall Study|Protocol Violation|0|||
164559439|NCT04161495|594417685|FG000|Overall Study|Prohibited concomitant medication|3|||
164559440|NCT04161495|594417686|FG001|Overall Study|Prohibited concomitant medication|0|||
164559441|NCT04161495|594417685|FG000|Overall Study|Adverse Event|1|||
164559442|NCT04161495|594417686|FG001|Overall Study|Adverse Event|0|||
164559443|NCT04161495|594417685|FG000|Overall Study|Other - Unspecified|1|||
164559444|NCT04161495|594417686|FG001|Overall Study|Other - Unspecified|0|||
164559445|NCT04161495|594417685|FG000|Overall Study|Death|0|||
164559446|NCT04161495|594417686|FG001|Overall Study|Death|1|||
164559447|NCT00252057|594417689|FG000|Overall Study|Withdrawal by Subject|2|||
164559448|NCT00252057|594417690|FG001|Overall Study|Withdrawal by Subject|5|||
164559449|NCT00252057|594417689|FG000|Overall Study|Death|1|||
164559450|NCT00252057|594417690|FG001|Overall Study|Death|2|||
164559451|NCT00252057|594417689|FG000|Overall Study|Participant previously enrolled|0|||
164559452|NCT00252057|594417690|FG001|Overall Study|Participant previously enrolled|1|||
164559453|NCT02926209|594417691|FG000|Study Cohort|Poor Bowel Preparation|1|||
164559454|NCT02926209|594417692|FG001|Study Cohort|Poor Bowel Preparation|0|||
164559455|NCT00429858|594417693|FG000|Overall Study|Withdrawal by Subject|1|||
164559456|NCT00429858|594417693|FG000|Overall Study|Study Termination|1|||
164559457|NCT01587079|594417694|FG000|Overall Study|Protocol-specified criteria|9|||
164559458|NCT01587079|594417694|FG000|Overall Study|Protocol Violation|5|||
164559459|NCT01587079|594417694|FG000|Overall Study|Lost to Follow-up|2|||
164559460|NCT01587079|594417694|FG000|Overall Study|Physician Decision|2|||
164559461|NCT01587079|594417694|FG000|Overall Study|Withdrawal by Subject|7|||
164559462|NCT01587079|594417694|FG000|Overall Study|Adverse Event|14|||
164559463|NCT01764633|594417695|FG000|Overall Study|Withdrawal by Subject|105|||
164559464|NCT01764633|594417696|FG001|Overall Study|Withdrawal by Subject|88|||
164559465|NCT01764633|594417695|FG000|Overall Study|Lost to Follow-up|13|||
164559466|NCT01764633|594417696|FG001|Overall Study|Lost to Follow-up|5|||
164559467|NCT02268058|594417697|FG000|Overall Study|Protocol Violation|1|||
164559468|NCT02268058|594417698|FG001|Overall Study|Protocol Violation|0|||
164559469|NCT02268058|594417699|FG002|Overall Study|Protocol Violation|0|||
164559470|NCT02268058|594417700|FG003|Overall Study|Protocol Violation|0|||
164559471|NCT04142983|594417701|FG000|Overall Study|Lost to Follow-up|73|||
164559472|NCT04142983|594417701|FG000|Overall Study|Withdrawal by Subject|10|||
164559473|NCT04142983|594417701|FG000|Overall Study|Physician Decision|1|||
164559474|NCT04142983|594417701|FG000|Overall Study|Adverse Event|1|||
164559475|NCT04142983|594417701|FG000|Overall Study|No longer eligible|4|||
164559476|NCT04142983|594417701|FG000|Overall Study|Screen Failure|10|||
164559477|NCT04781816|594417702|FG000|Overall Study|Adverse Event|0|||
164559478|NCT04781816|594417703|FG001|Overall Study|Adverse Event|1|||
164559479|NCT04781816|594417702|FG000|Overall Study|Withdrawal by Subject|1|||
164559480|NCT04781816|594417703|FG001|Overall Study|Withdrawal by Subject|1|||
164559481|NCT04781816|594417702|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
164559482|NCT04781816|594417703|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
164559483|NCT04372927|594417708|FG000|Overall Study|Death|1|||
164559484|NCT01847885|594417711|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
164559485|NCT01847885|594417712|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
164559486|NCT01847885|594417713|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
164559487|NCT01847885|594417711|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
164559488|NCT01847885|594417712|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
164559489|NCT01847885|594417713|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
164559490|NCT01847885|594417711|FG000|Initial Enrollment (Consented)|Screen failure|39|||
164559491|NCT01847885|594417712|FG001|Initial Enrollment (Consented)|Screen failure|0|||
164663532|NCT02430870|594792103|FG001|Part 2|Voluntary Withdrawal|0|||
164663533|NCT02430870|594792104|FG002|Part 2|Voluntary Withdrawal|0|||
164663534|NCT02430870|594792105|FG003|Part 2|Voluntary Withdrawal|0|||
164663535|NCT02430870|594792106|FG004|Part 2|Voluntary Withdrawal|0|||
164663536|NCT02430870|594792107|FG005|Part 2|Voluntary Withdrawal|0|||
164663537|NCT02430870|594792108|FG006|Part 2|Voluntary Withdrawal|1|||
164663538|NCT02430870|594792109|FG007|Part 2|Voluntary Withdrawal|0|||
164663539|NCT02430870|594792102|FG000|Part 2|Other Reason Not Specified|0|||
164663540|NCT02430870|594792103|FG001|Part 2|Other Reason Not Specified|0|||
164663541|NCT02430870|594792104|FG002|Part 2|Other Reason Not Specified|0|||
164663542|NCT02430870|594792105|FG003|Part 2|Other Reason Not Specified|0|||
164663543|NCT02430870|594792106|FG004|Part 2|Other Reason Not Specified|0|||
164663544|NCT02430870|594792107|FG005|Part 2|Other Reason Not Specified|0|||
164663545|NCT02430870|594792108|FG006|Part 2|Other Reason Not Specified|0|||
164663546|NCT02430870|594792109|FG007|Part 2|Other Reason Not Specified|1|||
164559492|NCT01847885|594417713|FG002|Initial Enrollment (Consented)|Screen failure|0|||
164559493|NCT01847885|594417711|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
164559494|NCT01847885|594417712|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
164559495|NCT01847885|594417713|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
164559496|NCT01847885|594417711|FG000|Randomization|Protocol Violation|0|||
164559497|NCT01847885|594417712|FG001|Randomization|Protocol Violation|1|||
164559498|NCT01847885|594417713|FG002|Randomization|Protocol Violation|0|||
164663547|NCT00865709|594792112|FG000|Treatment|Adverse Event|9|||
164663548|NCT00865709|594792113|FG001|Treatment|Adverse Event|6|||
164663549|NCT00865709|594792112|FG000|Treatment|Withdrawal by Subject|10|||
164559499|NCT01847885|594417711|FG000|Randomization|Withdrawal by Subject|0|||
164559500|NCT01847885|594417712|FG001|Randomization|Withdrawal by Subject|0|||
164559501|NCT01847885|594417713|FG002|Randomization|Withdrawal by Subject|2|||
164559502|NCT01847885|594417711|FG000|Randomization|Screen Failure|0|||
164559503|NCT01847885|594417712|FG001|Randomization|Screen Failure|3|||
164559504|NCT01847885|594417713|FG002|Randomization|Screen Failure|0|||
164559505|NCT03847610|594417714|FG000|Overall Study|Withdrawal by Subject|1|||
164559506|NCT02799069|594417717|FG000|Overall Study|Adverse Event|0|||
164559507|NCT02799069|594417718|FG001|Overall Study|Adverse Event|2|||
164559508|NCT02799069|594417719|FG002|Overall Study|Adverse Event|2|||
164559509|NCT02799069|594417717|FG000|Overall Study|Lack of Efficacy|2|||
164559510|NCT02799069|594417718|FG001|Overall Study|Lack of Efficacy|0|||
164559511|NCT02799069|594417719|FG002|Overall Study|Lack of Efficacy|0|||
164559512|NCT02799069|594417717|FG000|Overall Study|Lost to Follow-up|1|||
164559513|NCT02799069|594417718|FG001|Overall Study|Lost to Follow-up|1|||
164559514|NCT02799069|594417719|FG002|Overall Study|Lost to Follow-up|0|||
164559515|NCT02799069|594417717|FG000|Overall Study|Withdrawal by Subject|4|||
164559516|NCT02799069|594417718|FG001|Overall Study|Withdrawal by Subject|4|||
164559517|NCT02799069|594417719|FG002|Overall Study|Withdrawal by Subject|3|||
164559518|NCT02799069|594417717|FG000|Overall Study|Protocol Violation|1|||
164559519|NCT02799069|594417718|FG001|Overall Study|Protocol Violation|0|||
164559520|NCT02799069|594417719|FG002|Overall Study|Protocol Violation|2|||
164559521|NCT05130463|594417722|FG000|Overall Study|Unspecified reasons|2|||
164559522|NCT05130463|594417722|FG000|Overall Study|off-label indication dose|435|||
164559523|NCT03652662|594417724|FG000|Overall Study|Withdrawal by Subject|2|||
164559524|NCT03652662|594417725|FG001|Overall Study|Withdrawal by Subject|1|||
164559525|NCT03652662|594417724|FG000|Overall Study|Lost to Follow-up|1|||
164559526|NCT03652662|594417725|FG001|Overall Study|Lost to Follow-up|0|||
164559527|NCT00487539|594417726|FG000|Overall Study|Adverse Event|3|||
164559528|NCT00487539|594417727|FG001|Overall Study|Adverse Event|2|||
164559529|NCT00487539|594417728|FG002|Overall Study|Adverse Event|1|||
164559530|NCT00487539|594417729|FG003|Overall Study|Adverse Event|1|||
164559531|NCT00487539|594417726|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164559532|NCT00487539|594417727|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164559533|NCT00487539|594417728|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
164559534|NCT00487539|594417729|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
164559535|NCT00487539|594417726|FG000|Overall Study|Other|3|||
164559536|NCT00487539|594417727|FG001|Overall Study|Other|1|||
164559537|NCT00487539|594417728|FG002|Overall Study|Other|2|||
164559538|NCT00487539|594417729|FG003|Overall Study|Other|2|||
164559539|NCT02751502|594417730|FG000|Overall Study|Lack of funding|4|||
164559540|NCT03499028|594417731|FG000|Overall Study|Lost to Follow-up|12|||
164559541|NCT03499028|594417732|FG001|Overall Study|Lost to Follow-up|9|||
164559542|NCT03499028|594417731|FG000|Overall Study|Withdrawal by Subject|5|||
164559543|NCT03499028|594417732|FG001|Overall Study|Withdrawal by Subject|8|||
164559544|NCT03499028|594417731|FG000|Overall Study|Unplanned SNF discharge|5|||
164559545|NCT03499028|594417732|FG001|Overall Study|Unplanned SNF discharge|8|||
164559546|NCT01437397|594417733|FG000|Overall Study|Lost to Follow-up|9|||
164559547|NCT01437397|594417734|FG001|Overall Study|Lost to Follow-up|4|||
164559548|NCT01437397|594417735|FG002|Overall Study|Lost to Follow-up|2|||
164559549|NCT01437397|594417736|FG003|Overall Study|Lost to Follow-up|4|||
164559550|NCT01437397|594417737|FG004|Overall Study|Lost to Follow-up|5|||
164559551|NCT01437397|594417733|FG000|Overall Study|Withdrawal by Subject|11|||
164559552|NCT01437397|594417734|FG001|Overall Study|Withdrawal by Subject|12|||
164559553|NCT01437397|594417735|FG002|Overall Study|Withdrawal by Subject|24|||
164559554|NCT01437397|594417736|FG003|Overall Study|Withdrawal by Subject|11|||
164559555|NCT01437397|594417737|FG004|Overall Study|Withdrawal by Subject|22|||
164559556|NCT01437397|594417733|FG000|Overall Study|Protocol Violation|10|||
164559557|NCT01437397|594417734|FG001|Overall Study|Protocol Violation|12|||
164559558|NCT01437397|594417735|FG002|Overall Study|Protocol Violation|13|||
164559559|NCT01437397|594417736|FG003|Overall Study|Protocol Violation|21|||
164559560|NCT01437397|594417737|FG004|Overall Study|Protocol Violation|19|||
164559561|NCT01437397|594417733|FG000|Overall Study|Lack of Efficacy|5|||
164559562|NCT01437397|594417734|FG001|Overall Study|Lack of Efficacy|4|||
164559563|NCT01437397|594417735|FG002|Overall Study|Lack of Efficacy|8|||
164559564|NCT01437397|594417736|FG003|Overall Study|Lack of Efficacy|10|||
164559565|NCT01437397|594417737|FG004|Overall Study|Lack of Efficacy|20|||
164559566|NCT01437397|594417733|FG000|Overall Study|Adverse Event|21|||
164559567|NCT01437397|594417734|FG001|Overall Study|Adverse Event|22|||
164559568|NCT01437397|594417735|FG002|Overall Study|Adverse Event|16|||
164663550|NCT00865709|594792113|FG001|Treatment|Withdrawal by Subject|7|||
164559569|NCT01437397|594417736|FG003|Overall Study|Adverse Event|14|||
164559570|NCT01437397|594417737|FG004|Overall Study|Adverse Event|21|||
164559571|NCT01437397|594417733|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
164559572|NCT01437397|594417734|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
164559573|NCT01437397|594417735|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
164559574|NCT01437397|594417736|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
164559575|NCT01437397|594417737|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
164559576|NCT01318109|594417738|FG000|Overall Study|Adverse Event|0|||
164559577|NCT01318109|594417739|FG001|Overall Study|Adverse Event|2|||
164559578|NCT01318109|594417740|FG002|Overall Study|Adverse Event|0|||
164559579|NCT01318109|594417738|FG000|Overall Study|Withdrawal by Subject|1|||
164559580|NCT01318109|594417739|FG001|Overall Study|Withdrawal by Subject|0|||
164559581|NCT01318109|594417740|FG002|Overall Study|Withdrawal by Subject|0|||
164559582|NCT01318109|594417738|FG000|Overall Study|Schedule Conflict|0|||
164559583|NCT01318109|594417739|FG001|Overall Study|Schedule Conflict|1|||
164559584|NCT01318109|594417740|FG002|Overall Study|Schedule Conflict|0|||
164559585|NCT04982250|594417748|FG000|Overall Study|Lost to Follow-up|0|||
164559586|NCT04982250|594417749|FG001|Overall Study|Lost to Follow-up|26|||
164559587|NCT04982250|594417750|FG002|Overall Study|Lost to Follow-up|0|||
164559588|NCT04982250|594417751|FG003|Overall Study|Lost to Follow-up|0|||
164559589|NCT04982250|594417752|FG004|Overall Study|Lost to Follow-up|72|||
164559590|NCT04982250|594417753|FG005|Overall Study|Lost to Follow-up|69|||
164559591|NCT04982250|594417748|FG000|Overall Study|Not Eligible to Enroll|0|||
164559592|NCT04982250|594417749|FG001|Overall Study|Not Eligible to Enroll|0|||
164559593|NCT04982250|594417750|FG002|Overall Study|Not Eligible to Enroll|0|||
164559594|NCT04982250|594417751|FG003|Overall Study|Not Eligible to Enroll|0|||
164559595|NCT04982250|594417752|FG004|Overall Study|Not Eligible to Enroll|10|||
164559596|NCT04982250|594417753|FG005|Overall Study|Not Eligible to Enroll|7|||
164559597|NCT02028455|594417759|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
164559598|NCT02028455|594417760|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
164559599|NCT02028455|594417761|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
164559600|NCT02028455|594417762|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
164559601|NCT02028455|594417763|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
164559602|NCT02028455|594417764|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
164559603|NCT02028455|594417765|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
164559604|NCT02028455|594417766|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
164559605|NCT02028455|594417759|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
164559606|NCT02028455|594417760|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
164559607|NCT02028455|594417761|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
164559608|NCT02028455|594417762|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
164559609|NCT02028455|594417763|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
164559610|NCT02028455|594417764|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
164559611|NCT02028455|594417765|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
164559612|NCT02028455|594417766|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
164559613|NCT02028455|594417759|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
164559614|NCT02028455|594417760|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
164559615|NCT02028455|594417761|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
164559616|NCT02028455|594417762|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
164559617|NCT02028455|594417763|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
164559618|NCT02028455|594417764|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
164559619|NCT02028455|594417765|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
164559620|NCT02028455|594417766|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
164559621|NCT02028455|594417759|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
164559622|NCT02028455|594417760|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
164559623|NCT02028455|594417761|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
164559624|NCT02028455|594417762|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
164559625|NCT02028455|594417763|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
164559626|NCT02028455|594417764|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
164559627|NCT02028455|594417765|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
164559628|NCT02028455|594417766|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
164559629|NCT07099521|594417767|FG000|Overall Study|Incompeleted stimulus program|1|||
164559630|NCT07099521|594417768|FG001|Overall Study|Incompeleted stimulus program|0|||
164559631|NCT07099521|594417767|FG000|Overall Study|Non-social anxiety symtpoms|0|||
164559632|NCT07099521|594417768|FG001|Overall Study|Non-social anxiety symtpoms|1|||
164559633|NCT07099521|594417767|FG000|Overall Study|Extreme values|2|||
164559634|NCT07099521|594417768|FG001|Overall Study|Extreme values|4|||
164559635|NCT02392429|594419167|FG000|Screening|Screen failure|15|||
164559636|NCT02392429|594419167|FG000|Enrolled Participants|Ineligible due to disease|3|||
164559637|NCT02392429|594419167|FG000|Enrolled Participants|Withdrawal by Subject|4|||
164559638|NCT02392429|594419167|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
164559639|NCT02392429|594419167|FG000|Evaluable|Death|5|||
164663551|NCT00865709|594792112|FG000|Treatment|Physician Decision|3|||
164559640|NCT02392429|594419167|FG000|Evaluable|Withdrawal by Subject|1|||
164559641|NCT02392429|594419167|FG000|Evaluable|Adverse Event|1|||
164559642|NCT02392429|594419167|FG000|Evaluable|remission bone marrow biopsy|3|||
164559643|NCT03266016|594419168|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
164559644|NCT03266016|594419169|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
164663552|NCT00865709|594792113|FG001|Treatment|Physician Decision|2|||
164663553|NCT00865709|594792112|FG000|Treatment|Surgery|8|||
164663554|NCT00865709|594792113|FG001|Treatment|Surgery|3|||
164663555|NCT00429923|594792114|FG000|Overall Study|Adverse Event|0|||
164663556|NCT00429923|594792115|FG001|Overall Study|Adverse Event|2|||
164663557|NCT00429923|594792116|FG002|Overall Study|Adverse Event|3|||
164663558|NCT00429923|594792114|FG000|Overall Study|Lack of Efficacy|4|||
164663559|NCT00429923|594792115|FG001|Overall Study|Lack of Efficacy|1|||
164663560|NCT00429923|594792116|FG002|Overall Study|Lack of Efficacy|33|||
164663561|NCT00429923|594792114|FG000|Overall Study|Lost to Follow-up|0|||
164663562|NCT00429923|594792115|FG001|Overall Study|Lost to Follow-up|0|||
164663563|NCT00429923|594792116|FG002|Overall Study|Lost to Follow-up|2|||
164663564|NCT00429923|594792114|FG000|Overall Study|Withdrew Consent|1|||
164663565|NCT00429923|594792115|FG001|Overall Study|Withdrew Consent|0|||
164663566|NCT00429923|594792116|FG002|Overall Study|Withdrew Consent|1|||
164663567|NCT00429923|594792114|FG000|Overall Study|Early Termination|0|||
164663568|NCT00429923|594792115|FG001|Overall Study|Early Termination|1|||
164663569|NCT00429923|594792116|FG002|Overall Study|Early Termination|0|||
164663570|NCT01265784|594792117|FG000|Overall Study|Lost to Follow-up|5|||
164663571|NCT01265784|594792118|FG001|Overall Study|Lost to Follow-up|3|||
164663572|NCT01265784|594792119|FG002|Overall Study|Lost to Follow-up|2|||
164663573|NCT01265784|594792117|FG000|Overall Study|Withdrawal by Subject|0|||
164663574|NCT01265784|594792118|FG001|Overall Study|Withdrawal by Subject|5|||
164663575|NCT01265784|594792119|FG002|Overall Study|Withdrawal by Subject|0|||
164663576|NCT01265784|594792117|FG000|Overall Study|Physician Decision|1|||
164663577|NCT01265784|594792118|FG001|Overall Study|Physician Decision|0|||
164663578|NCT01265784|594792119|FG002|Overall Study|Physician Decision|1|||
164663579|NCT01265784|594792117|FG000|Overall Study|Adverse Event|1|||
164663580|NCT01265784|594792118|FG001|Overall Study|Adverse Event|0|||
164663581|NCT01265784|594792119|FG002|Overall Study|Adverse Event|0|||
164663582|NCT01265784|594792117|FG000|Overall Study|Death|3|||
164663583|NCT01265784|594792118|FG001|Overall Study|Death|0|||
164663584|NCT01265784|594792119|FG002|Overall Study|Death|0|||
164663585|NCT01265784|594792117|FG000|Overall Study|Protocol Violation|2|||
164663586|NCT01265784|594792118|FG001|Overall Study|Protocol Violation|0|||
164663587|NCT01265784|594792119|FG002|Overall Study|Protocol Violation|0|||
164663588|NCT01265784|594792117|FG000|Overall Study|Incorrectly Randomized|0|||
164663589|NCT01265784|594792118|FG001|Overall Study|Incorrectly Randomized|0|||
164663590|NCT01265784|594792119|FG002|Overall Study|Incorrectly Randomized|1|||
164663591|NCT03740165|594792122|FG000|Overall Study|Death|232|||
164663592|NCT03740165|594792123|FG001|Overall Study|Death|242|||
164663593|NCT03740165|594792124|FG002|Overall Study|Death|229|||
164663594|NCT03740165|594792122|FG000|Overall Study|Lost to Follow-up|0|||
164663595|NCT03740165|594792123|FG001|Overall Study|Lost to Follow-up|0|||
164663596|NCT03740165|594792124|FG002|Overall Study|Lost to Follow-up|1|||
164663597|NCT03740165|594792122|FG000|Overall Study|Withdrawal by Subject|7|||
164663598|NCT03740165|594792123|FG001|Overall Study|Withdrawal by Subject|4|||
164663599|NCT03740165|594792124|FG002|Overall Study|Withdrawal by Subject|3|||
164663600|NCT03740165|594792122|FG000|Overall Study|Ongoing in Study|216|||
164663601|NCT03740165|594792123|FG001|Overall Study|Ongoing in Study|212|||
164663602|NCT03740165|594792124|FG002|Overall Study|Ongoing in Study|221|||
164663603|NCT03049618|594792125|FG000|Overall Study|Death|1|||
164663604|NCT03049618|594792126|FG001|Overall Study|Death|0|||
164663605|NCT03049618|594792125|FG000|Overall Study|Lack of Efficacy|1|||
164663606|NCT03049618|594792126|FG001|Overall Study|Lack of Efficacy|2|||
164663607|NCT01656889|594792128|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
164663608|NCT01656889|594792129|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
164663609|NCT01656889|594792128|FG000|Treatment Period, 12 Weeks|Death|0|||
164663610|NCT01656889|594792129|FG001|Treatment Period, 12 Weeks|Death|1|||
164663611|NCT01656889|594792128|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
164663612|NCT01656889|594792129|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
164663613|NCT01656889|594792128|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
164663614|NCT01656889|594792129|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
164663615|NCT01656889|594792128|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
164663616|NCT01656889|594792129|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
164663617|NCT01656889|594792128|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
164663618|NCT01656889|594792129|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
164663619|NCT01656889|594792128|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
164663620|NCT01656889|594792129|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
164663621|NCT01656889|594792128|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
164663622|NCT01656889|594792129|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
164663623|NCT01656889|594792128|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
164663624|NCT01656889|594792129|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
164663625|NCT01656889|594792128|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
164663626|NCT01656889|594792129|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
164663627|NCT00788125|594793991|FG000|Overall Study|Death|6|||
164663628|NCT01619800|594793995|FG000|Overall Study|study terminated|2|||
164663629|NCT01619800|594793996|FG001|Overall Study|study terminated|0|||
164663630|NCT03480425|594793998|FG000|Overall Study|Force transducer technical failure|1|||
164663631|NCT02473640|594794005|FG000|Treatment Period 1|Adverse Event|1|||
164663632|NCT02016300|594794010|FG000|Overall Study|Lost to Follow-up|0|||
164663633|NCT02016300|594794011|FG001|Overall Study|Lost to Follow-up|3|||
164663634|NCT05301751|594794012|FG000|Overall Study|Withdrawal by Subject|0|||
164663635|NCT05301751|594794013|FG001|Overall Study|Withdrawal by Subject|0|||
164663636|NCT05301751|594794014|FG002|Overall Study|Withdrawal by Subject|1|||
164663637|NCT05301751|594794015|FG003|Overall Study|Withdrawal by Subject|0|||
164663638|NCT06165744|594794018|FG000|Overall Study|Non device-related adverse event|1|||
164663639|NCT01546987|594794019|FG000|Overall Study|Protocol Violation|3|||
164663640|NCT01546987|594794020|FG001|Overall Study|Protocol Violation|4|||
164663641|NCT02518113|594794021|FG000|Overall Study|Adverse Event|1|||
164663642|NCT02518113|594794022|FG001|Overall Study|Adverse Event|0|||
164663643|NCT02518113|594794023|FG002|Overall Study|Adverse Event|1|||
164663644|NCT02518113|594794024|FG003|Overall Study|Adverse Event|0|||
164663645|NCT02518113|594794021|FG000|Overall Study|Death|1|||
164663646|NCT02518113|594794022|FG001|Overall Study|Death|2|||
164663647|NCT02518113|594794023|FG002|Overall Study|Death|0|||
164663648|NCT02518113|594794024|FG003|Overall Study|Death|0|||
164663649|NCT02518113|594794021|FG000|Overall Study|Physician Decision|0|||
164663650|NCT02518113|594794022|FG001|Overall Study|Physician Decision|1|||
164663651|NCT02518113|594794023|FG002|Overall Study|Physician Decision|0|||
164663652|NCT02518113|594794024|FG003|Overall Study|Physician Decision|0|||
164663653|NCT02518113|594794021|FG000|Overall Study|Progressive Disease|1|||
164663654|NCT02518113|594794022|FG001|Overall Study|Progressive Disease|2|||
164663655|NCT02518113|594794023|FG002|Overall Study|Progressive Disease|3|||
164663656|NCT02518113|594794024|FG003|Overall Study|Progressive Disease|0|||
164663657|NCT02270736|594794025|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
164663658|NCT02270736|594794026|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
164663659|NCT02270736|594794027|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
164663660|NCT02270736|594794028|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
164663661|NCT02270736|594794029|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
164663662|NCT02270736|594794025|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
164663663|NCT02270736|594794026|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
164663664|NCT02270736|594794027|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
164663665|NCT02270736|594794028|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
164663666|NCT02270736|594794029|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
164663667|NCT02270736|594794025|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
164663668|NCT02270736|594794026|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
164663669|NCT02270736|594794027|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
164663670|NCT02270736|594794028|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
164663671|NCT02270736|594794029|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
164663672|NCT02270736|594794025|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
164663673|NCT02270736|594794026|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
164663674|NCT02270736|594794027|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
164663675|NCT02270736|594794028|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
164663676|NCT02270736|594794029|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
164663677|NCT02270736|594794025|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
164663678|NCT02270736|594794026|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
164663679|NCT02270736|594794027|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
164663680|NCT02270736|594794028|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
164663681|NCT02270736|594794029|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
164663682|NCT02270736|594794025|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
164663683|NCT02270736|594794026|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
164663684|NCT02270736|594794027|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
164663685|NCT02270736|594794028|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
164663686|NCT02270736|594794029|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
164663687|NCT02270736|594794025|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
164663688|NCT02270736|594794026|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
164663689|NCT02270736|594794027|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
164663690|NCT02270736|594794028|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
164663691|NCT02270736|594794029|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
164663692|NCT02270736|594794025|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
164663693|NCT02270736|594794026|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
164663694|NCT02270736|594794027|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
164663695|NCT02270736|594794028|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
164663696|NCT02270736|594794029|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
164663697|NCT02270736|594794025|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
164663698|NCT02270736|594794026|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
164663699|NCT02270736|594794027|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
164663700|NCT02270736|594794028|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
164663701|NCT02270736|594794029|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
164663702|NCT00262600|594794030|FG000|Overall Study|Lost to Follow-up|17|||
164663703|NCT00262600|594794031|FG001|Overall Study|Lost to Follow-up|31|||
164663704|NCT00262600|594794032|FG002|Overall Study|Lost to Follow-up|41|||
164663705|NCT00262600|594794030|FG000|Overall Study|Withdrawal by Subject|128|||
164663706|NCT00262600|594794031|FG001|Overall Study|Withdrawal by Subject|145|||
164663707|NCT00262600|594794032|FG002|Overall Study|Withdrawal by Subject|139|||
164663708|NCT00262600|594794030|FG000|Overall Study|Not Treated|32|||
164663709|NCT00262600|594794031|FG001|Overall Study|Not Treated|17|||
164663710|NCT00262600|594794032|FG002|Overall Study|Not Treated|24|||
164663711|NCT00262600|594794030|FG000|Overall Study|Other|58|||
164663712|NCT00262600|594794031|FG001|Overall Study|Other|59|||
164663713|NCT00262600|594794032|FG002|Overall Study|Other|62|||
164663714|NCT02132247|594794039|FG000|Overall Study|Protocol Violation|1|||
164663715|NCT02132247|594794040|FG001|Overall Study|Protocol Violation|0|||
164663716|NCT04373434|594794045|FG000|Overall Study|Lost to Follow-up|37|||
164663717|NCT04373434|594794046|FG001|Overall Study|Lost to Follow-up|32|||
164663718|NCT04373434|594794045|FG000|Overall Study|Refused at 9 months|1|||
164663719|NCT04373434|594794046|FG001|Overall Study|Refused at 9 months|2|||
164663720|NCT04373434|594794045|FG000|Overall Study|Refused at 4 months|7|||
164663721|NCT04373434|594794046|FG001|Overall Study|Refused at 4 months|3|||
164663722|NCT04373434|594794045|FG000|Overall Study|Excluded|2|||
164663723|NCT04373434|594794046|FG001|Overall Study|Excluded|0|||
164663724|NCT00527423|594794047|FG000|Overall Study|Protocol Violation|1|||
164663725|NCT00527423|594794047|FG000|Overall Study|Adverse Event|5|||
164663726|NCT00527423|594794047|FG000|Overall Study|Physician Decision|4|||
164559645|NCT03266016|594419170|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
164559646|NCT03266016|594419171|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
164559647|NCT03266016|594419168|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
164559648|NCT03266016|594419169|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
164559649|NCT03266016|594419170|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
164559650|NCT03266016|594419171|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
164559651|NCT00768898|594419172|FG000|Overall Study|Unrelated injury|1|||
164559652|NCT00768898|594419172|FG000|Overall Study|Headache|1|||
164559653|NCT01777763|594419175|FG000|Overall Study|Adverse Event|2|||
164559654|NCT01777763|594419176|FG001|Overall Study|Adverse Event|32|||
164559655|NCT01777763|594419175|FG000|Overall Study|Protocol Violation|1|||
164559656|NCT01777763|594419176|FG001|Overall Study|Protocol Violation|7|||
164559657|NCT01777763|594419175|FG000|Overall Study|Withdrawal by Subject|0|||
164559658|NCT01777763|594419176|FG001|Overall Study|Withdrawal by Subject|2|||
164559659|NCT01777763|594419175|FG000|Overall Study|Treatment Failure|1|||
164559660|NCT01777763|594419176|FG001|Overall Study|Treatment Failure|6|||
164559661|NCT02787850|594419181|FG000|Overall Study|Withdrawal by Subject|0|||
164559662|NCT02787850|594419182|FG001|Overall Study|Withdrawal by Subject|1|||
164559663|NCT03718143|594419183|FG000|Overall Study|Death|1|||
164559664|NCT03718143|594419184|FG001|Overall Study|Death|0|||
164559665|NCT03718143|594419185|FG002|Overall Study|Death|0|||
164559666|NCT03718143|594419183|FG000|Overall Study|Progression of Disease|1|||
164559667|NCT03718143|594419184|FG001|Overall Study|Progression of Disease|0|||
164559668|NCT03718143|594419185|FG002|Overall Study|Progression of Disease|0|||
164559669|NCT03718143|594419183|FG000|Overall Study|Withdrawal of Informed Consent|1|||
164559670|NCT03718143|594419184|FG001|Overall Study|Withdrawal of Informed Consent|2|||
164559671|NCT03718143|594419185|FG002|Overall Study|Withdrawal of Informed Consent|1|||
164559672|NCT02787863|594419192|FG000|Overall Study|Death|1|||
164559673|NCT02787863|594419193|FG001|Overall Study|Death|0|||
164559674|NCT02787863|594419194|FG002|Overall Study|Death|1|||
164559675|NCT02787863|594419195|FG003|Overall Study|Death|0|||
164559676|NCT02787863|594419196|FG004|Overall Study|Death|0|||
164559677|NCT02787863|594419197|FG005|Overall Study|Death|0|||
164559678|NCT02787863|594419198|FG006|Overall Study|Death|0|||
164559679|NCT02787863|594419199|FG007|Overall Study|Death|0|||
164559680|NCT02787863|594419192|FG000|Overall Study|Withdrawal by Subject|0|||
164559681|NCT02787863|594419193|FG001|Overall Study|Withdrawal by Subject|1|||
164663727|NCT00527423|594794047|FG000|Overall Study|Withdrawal by Subject|10|||
164663728|NCT00527423|594794047|FG000|Overall Study|Lost to Follow-up|4|||
164559682|NCT02787863|594419194|FG002|Overall Study|Withdrawal by Subject|1|||
164663729|NCT00527423|594794047|FG000|Overall Study|OTHER|4|||
164559683|NCT02787863|594419195|FG003|Overall Study|Withdrawal by Subject|0|||
164559684|NCT02787863|594419196|FG004|Overall Study|Withdrawal by Subject|0|||
164663730|NCT00527423|594794047|FG000|Overall Study|Death|9|||
164663731|NCT03103100|594794048|FG000|Overall Study|Adverse Event|1|||
164559685|NCT02787863|594419197|FG005|Overall Study|Withdrawal by Subject|0|||
164559686|NCT02787863|594419198|FG006|Overall Study|Withdrawal by Subject|0|||
164663732|NCT03103100|594794049|FG001|Overall Study|Adverse Event|0|||
164663733|NCT03103100|594794050|FG002|Overall Study|Adverse Event|0|||
164559687|NCT02787863|594419199|FG007|Overall Study|Withdrawal by Subject|0|||
164559688|NCT02479802|594419200|FG000|Overall Study|Lost to Follow-up|1|||
164663734|NCT03103100|594794048|FG000|Overall Study|Physician Decision|1|||
164663735|NCT03103100|594794049|FG001|Overall Study|Physician Decision|0|||
164559689|NCT02479802|594419200|FG000|Overall Study|Adverse Event|1|||
164559690|NCT02421887|594419201|FG000|Overall Study|Lost to Follow-up|5|||
164559691|NCT02421887|594419202|FG001|Overall Study|Lost to Follow-up|0|||
164559692|NCT02421887|594419201|FG000|Overall Study|Withdrawal by Subject|8|||
164559693|NCT02421887|594419202|FG001|Overall Study|Withdrawal by Subject|5|||
164559694|NCT02421887|594419201|FG000|Overall Study|Physician Decision|2|||
164559695|NCT02421887|594419202|FG001|Overall Study|Physician Decision|4|||
164559696|NCT02421887|594419201|FG000|Overall Study|Adverse Event|2|||
164559697|NCT02421887|594419202|FG001|Overall Study|Adverse Event|0|||
164559698|NCT01882907|594419203|FG000|Overall Study|Adverse Event|3|||
164559699|NCT01882907|594419204|FG001|Overall Study|Adverse Event|1|||
164559700|NCT01882907|594419203|FG000|Overall Study|Lack of Efficacy|0|||
164559701|NCT01882907|594419204|FG001|Overall Study|Lack of Efficacy|3|||
164559702|NCT01882907|594419203|FG000|Overall Study|Lost to Follow-up|1|||
164559703|NCT01882907|594419204|FG001|Overall Study|Lost to Follow-up|4|||
164559704|NCT01882907|594419203|FG000|Overall Study|Protocol Violation|10|||
164559705|NCT01882907|594419204|FG001|Overall Study|Protocol Violation|14|||
164559706|NCT01882907|594419203|FG000|Overall Study|Withdrawal by Subject|0|||
164559707|NCT01882907|594419204|FG001|Overall Study|Withdrawal by Subject|6|||
164559708|NCT03124784|594419209|FG000|Overall Study|Adverse Event|1|||
164559709|NCT03124784|594419209|FG000|Overall Study|Computer/Equip Malfunction|1|||
164559710|NCT05702515|594419210|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
164559711|NCT02162732|594419211|FG000|Overall Study|Biopsy not performed.|18|||
164559712|NCT01396005|594419212|FG000|Overall Study|Withdrawal by Subject|0|||
164559713|NCT01396005|594419213|FG001|Overall Study|Withdrawal by Subject|1|||
164559714|NCT01396005|594419212|FG000|Overall Study|Non-compliance with protocol|0|||
164559715|NCT01396005|594419213|FG001|Overall Study|Non-compliance with protocol|1|||
164559716|NCT01784965|594419214|FG000|Overall Study|Withdrawal by Subject|6|||
164559717|NCT01784965|594419215|FG001|Overall Study|Withdrawal by Subject|3|||
164559718|NCT01784965|594419214|FG000|Overall Study|Adverse Event|0|||
164559719|NCT01784965|594419215|FG001|Overall Study|Adverse Event|8|||
164559720|NCT00643994|594419220|FG000|Overall Study|Death|24|||
164559721|NCT00643994|594419220|FG000|Overall Study|Lost to Follow-up|72|||
164559722|NCT00662792|594419223|FG000|Period 1|Personal Reasons|0|||
164559723|NCT00662792|594419224|FG001|Period 1|Personal Reasons|0|||
164559724|NCT00662792|594419225|FG002|Period 1|Personal Reasons|1|||
164559725|NCT00662792|594419226|FG003|Period 1|Personal Reasons|0|||
164559726|NCT00662792|594419223|FG000|Period 1|Refused continuing medication|0|||
164559727|NCT00662792|594419224|FG001|Period 1|Refused continuing medication|1|||
164559728|NCT00662792|594419225|FG002|Period 1|Refused continuing medication|1|||
164559729|NCT00662792|594419226|FG003|Period 1|Refused continuing medication|0|||
164559730|NCT00662792|594419223|FG000|Period 1|Lost to Follow-up|1|||
164559731|NCT00662792|594419224|FG001|Period 1|Lost to Follow-up|0|||
164559732|NCT00662792|594419225|FG002|Period 1|Lost to Follow-up|0|||
164559733|NCT00662792|594419226|FG003|Period 1|Lost to Follow-up|0|||
164559734|NCT00662792|594419223|FG000|Period 1|Other adverse event (AE)|0|||
164559735|NCT00662792|594419224|FG001|Period 1|Other adverse event (AE)|2|||
164559736|NCT00662792|594419225|FG002|Period 1|Other adverse event (AE)|0|||
164559737|NCT00662792|594419226|FG003|Period 1|Other adverse event (AE)|0|||
164559738|NCT00662792|594419223|FG000|Period 1|Worsening of disease under study (AE)|1|||
164559739|NCT00662792|594419224|FG001|Period 1|Worsening of disease under study (AE)|3|||
164559740|NCT00662792|594419225|FG002|Period 1|Worsening of disease under study (AE)|2|||
164559741|NCT00662792|594419226|FG003|Period 1|Worsening of disease under study (AE)|0|||
164559742|NCT00662792|594419223|FG000|Period 1|Not treated|0|||
164559743|NCT00662792|594419224|FG001|Period 1|Not treated|1|||
164559744|NCT00662792|594419225|FG002|Period 1|Not treated|0|||
164559745|NCT00662792|594419226|FG003|Period 1|Not treated|0|||
164559746|NCT00662792|594419223|FG000|Period 2|Worsening of disease under study|1|||
164559747|NCT00662792|594419224|FG001|Period 2|Worsening of disease under study|0|||
164559748|NCT00662792|594419225|FG002|Period 2|Worsening of disease under study|0|||
164559749|NCT00662792|594419226|FG003|Period 2|Worsening of disease under study|3|||
164559750|NCT00662792|594419223|FG000|Period 3|Refused continuing medication|1|||
164559751|NCT00662792|594419224|FG001|Period 3|Refused continuing medication|0|||
164559752|NCT00662792|594419225|FG002|Period 3|Refused continuing medication|1|||
164559753|NCT00662792|594419226|FG003|Period 3|Refused continuing medication|0|||
164559754|NCT00662792|594419223|FG000|Period 3|Other adverse event (AE)|0|||
164559755|NCT00662792|594419224|FG001|Period 3|Other adverse event (AE)|0|||
164559756|NCT00662792|594419225|FG002|Period 3|Other adverse event (AE)|1|||
164663736|NCT03103100|594794050|FG002|Overall Study|Physician Decision|2|||
164663737|NCT02354586|594794052|FG000|Overall Study|Death|230|||
164559757|NCT00662792|594419226|FG003|Period 3|Other adverse event (AE)|1|||
164559758|NCT00662792|594419223|FG000|Period 4|Refused continuing medication|0|||
164559759|NCT00662792|594419224|FG001|Period 4|Refused continuing medication|1|||
164559760|NCT00662792|594419225|FG002|Period 4|Refused continuing medication|0|||
164559761|NCT00662792|594419226|FG003|Period 4|Refused continuing medication|0|||
164559762|NCT00662792|594419223|FG000|Period 4|Other adverse event (AE)|1|||
164559763|NCT00662792|594419224|FG001|Period 4|Other adverse event (AE)|0|||
164559764|NCT00662792|594419225|FG002|Period 4|Other adverse event (AE)|0|||
164559765|NCT00662792|594419226|FG003|Period 4|Other adverse event (AE)|0|||
164559766|NCT00662792|594419223|FG000|Period 4|Worsening of disease under study (AE)|0|||
164663738|NCT02354586|594794052|FG000|Overall Study|Withdrawal by Subject|59|||
164663739|NCT02354586|594794052|FG000|Overall Study|Lost to Follow-up|11|||
164663740|NCT02354586|594794052|FG000|Overall Study|Sponsor decision|51|||
164663741|NCT02354586|594794052|FG000|Overall Study|Site closure|2|||
164663742|NCT02354586|594794052|FG000|Overall Study|Intercurrent illness|1|||
164663743|NCT02354586|594794052|FG000|Overall Study|Protocol Violation|3|||
164663744|NCT02354586|594794052|FG000|Overall Study|Physician Decision|13|||
164663745|NCT02354586|594794052|FG000|Overall Study|Lack of Efficacy|86|||
164663746|NCT02354586|594794052|FG000|Overall Study|Adverse Event|7|||
164663747|NCT00436007|594794053|FG000|Overall Study|Withdrawal by Subject|5|||
164663748|NCT00436007|594794054|FG001|Overall Study|Withdrawal by Subject|3|||
164663749|NCT00436007|594794055|FG002|Overall Study|Withdrawal by Subject|4|||
164663750|NCT00436007|594794053|FG000|Overall Study|Lost to Follow-up|14|||
164663751|NCT00436007|594794054|FG001|Overall Study|Lost to Follow-up|10|||
164663752|NCT00436007|594794055|FG002|Overall Study|Lost to Follow-up|13|||
164663753|NCT00436007|594794053|FG000|Overall Study|Physician Decision|0|||
164663754|NCT00436007|594794054|FG001|Overall Study|Physician Decision|0|||
164663755|NCT00436007|594794055|FG002|Overall Study|Physician Decision|2|||
164663756|NCT00436007|594794053|FG000|Overall Study|Death|0|||
164663757|NCT00436007|594794054|FG001|Overall Study|Death|1|||
164663758|NCT00436007|594794055|FG002|Overall Study|Death|3|||
164663759|NCT00436007|594794053|FG000|Overall Study|Other|0|||
164663760|NCT00436007|594794054|FG001|Overall Study|Other|0|||
164663761|NCT00436007|594794055|FG002|Overall Study|Other|1|||
164663762|NCT00721409|594794056|FG000|Overall Study|Global deterioration of health status|2|||
164663763|NCT00721409|594794057|FG001|Overall Study|Global deterioration of health status|6|||
164559767|NCT00662792|594419224|FG001|Period 4|Worsening of disease under study (AE)|0|||
164559768|NCT00662792|594419225|FG002|Period 4|Worsening of disease under study (AE)|0|||
164559769|NCT00662792|594419226|FG003|Period 4|Worsening of disease under study (AE)|1|||
164559770|NCT02499029|594419227|FG000|Overall Study|Lost to Follow-up|2|||
164559771|NCT02499029|594419228|FG001|Overall Study|Lost to Follow-up|2|||
164559772|NCT02499029|594419227|FG000|Overall Study|Physician Decision|2|||
164559773|NCT02499029|594419228|FG001|Overall Study|Physician Decision|1|||
164559774|NCT02499029|594419227|FG000|Overall Study|Death|1|||
164559775|NCT02499029|594419228|FG001|Overall Study|Death|0|||
164559776|NCT01999582|594419229|FG000|Overall Study|Withdrawal by Subject|0|||
164559777|NCT01999582|594419230|FG001|Overall Study|Withdrawal by Subject|0|||
164559778|NCT01999582|594419231|FG002|Overall Study|Withdrawal by Subject|0|||
164559779|NCT01999582|594419232|FG003|Overall Study|Withdrawal by Subject|1|||
164559780|NCT01999582|594419233|FG004|Overall Study|Withdrawal by Subject|0|||
164559781|NCT01999582|594419234|FG005|Overall Study|Withdrawal by Subject|0|||
164559782|NCT01999582|594419229|FG000|Overall Study|Adverse Event|0|||
164559783|NCT01999582|594419230|FG001|Overall Study|Adverse Event|0|||
164559784|NCT01999582|594419231|FG002|Overall Study|Adverse Event|3|||
164559785|NCT01999582|594419232|FG003|Overall Study|Adverse Event|0|||
164559786|NCT01999582|594419233|FG004|Overall Study|Adverse Event|1|||
164559787|NCT01999582|594419234|FG005|Overall Study|Adverse Event|0|||
164559788|NCT01999582|594419229|FG000|Overall Study|Other Reasons|1|||
164559789|NCT01999582|594419230|FG001|Overall Study|Other Reasons|0|||
164559790|NCT01999582|594419231|FG002|Overall Study|Other Reasons|3|||
164559791|NCT01999582|594419232|FG003|Overall Study|Other Reasons|1|||
164559792|NCT01999582|594419233|FG004|Overall Study|Other Reasons|1|||
164559793|NCT01999582|594419234|FG005|Overall Study|Other Reasons|2|||
164559794|NCT01999582|594419229|FG000|Overall Study|Protocol Violation|1|||
164559795|NCT01999582|594419230|FG001|Overall Study|Protocol Violation|0|||
164559796|NCT01999582|594419231|FG002|Overall Study|Protocol Violation|0|||
164559797|NCT01999582|594419232|FG003|Overall Study|Protocol Violation|0|||
164559798|NCT01999582|594419233|FG004|Overall Study|Protocol Violation|0|||
164559799|NCT01999582|594419234|FG005|Overall Study|Protocol Violation|1|||
164559800|NCT01999582|594419229|FG000|Overall Study|Lack of Efficacy|1|||
164559801|NCT01999582|594419230|FG001|Overall Study|Lack of Efficacy|3|||
164559802|NCT01999582|594419231|FG002|Overall Study|Lack of Efficacy|0|||
164559803|NCT01999582|594419232|FG003|Overall Study|Lack of Efficacy|1|||
164559804|NCT01999582|594419233|FG004|Overall Study|Lack of Efficacy|0|||
164663764|NCT00721409|594794058|FG002|Overall Study|Global deterioration of health status|3|||
164559805|NCT01999582|594419234|FG005|Overall Study|Lack of Efficacy|0|||
164663765|NCT00721409|594794056|FG000|Overall Study|Death|0|||
164663766|NCT00721409|594794057|FG001|Overall Study|Death|1|||
164663767|NCT00721409|594794058|FG002|Overall Study|Death|0|||
164663768|NCT00721409|594794056|FG000|Overall Study|Randomized not Treated|0|||
164663769|NCT00721409|594794057|FG001|Overall Study|Randomized not Treated|1|||
164663770|NCT00721409|594794058|FG002|Overall Study|Randomized not Treated|4|||
164663771|NCT00721409|594794056|FG000|Overall Study|Reason not specified|1|||
164559806|NCT02347176|594419235|FG000|Overall Study|Lost to Follow-up|2|||
164559807|NCT02347176|594419236|FG001|Overall Study|Lost to Follow-up|3|||
164559808|NCT02347176|594419237|FG002|Overall Study|Lost to Follow-up|1|||
164559809|NCT02347176|594419238|FG003|Overall Study|Lost to Follow-up|1|||
164663772|NCT00721409|594794057|FG001|Overall Study|Reason not specified|0|||
164663773|NCT00721409|594794058|FG002|Overall Study|Reason not specified|2|||
164663774|NCT00721409|594794056|FG000|Overall Study|Adverse Event|0|||
164663775|NCT00721409|594794057|FG001|Overall Study|Adverse Event|13|||
164663776|NCT00721409|594794058|FG002|Overall Study|Adverse Event|2|||
164663777|NCT00721409|594794056|FG000|Overall Study|Lost to Follow-up|0|||
164663778|NCT00721409|594794057|FG001|Overall Study|Lost to Follow-up|0|||
164663779|NCT00721409|594794058|FG002|Overall Study|Lost to Follow-up|1|||
164663780|NCT00721409|594794056|FG000|Overall Study|Withdrawal by Subject|1|||
164663781|NCT00721409|594794057|FG001|Overall Study|Withdrawal by Subject|6|||
164663782|NCT00721409|594794058|FG002|Overall Study|Withdrawal by Subject|5|||
164663783|NCT00721409|594794056|FG000|Overall Study|Objective progression or relapse|8|||
164663784|NCT00721409|594794057|FG001|Overall Study|Objective progression or relapse|55|||
164663785|NCT00721409|594794058|FG002|Overall Study|Objective progression or relapse|62|||
164663786|NCT01957488|594794059|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
164663787|NCT01957488|594794060|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
164663788|NCT01957488|594794061|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
164663789|NCT01957488|594794062|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
164663790|NCT01957488|594794063|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
164663791|NCT01957488|594794064|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
164663792|NCT01957488|594794059|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
164663793|NCT01957488|594794060|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
164663794|NCT01957488|594794061|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
164663795|NCT01957488|594794062|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
164663796|NCT01957488|594794063|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
164663797|NCT01957488|594794064|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
164663798|NCT01957488|594794059|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
164663799|NCT01957488|594794060|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
164663800|NCT01957488|594794061|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
164663801|NCT01957488|594794062|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
164663802|NCT01957488|594794063|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
164663803|NCT01957488|594794064|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
164663804|NCT01957488|594794059|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
164663805|NCT01957488|594794060|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
164663806|NCT01957488|594794061|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
164663807|NCT01957488|594794062|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
164663808|NCT01957488|594794063|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
164663809|NCT01957488|594794064|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
164663810|NCT01957488|594794059|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
164314833|NCT00282308|593529793|FG000|Treatment Period|Lost to Follow-up|1|||
164559810|NCT02347176|594419235|FG000|Overall Study|Withdrawal by Subject|9|||
164559811|NCT02347176|594419236|FG001|Overall Study|Withdrawal by Subject|5|||
164663811|NCT01957488|594794060|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
164663812|NCT01957488|594794061|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
164663813|NCT01957488|594794062|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
164559812|NCT02347176|594419237|FG002|Overall Study|Withdrawal by Subject|5|||
164559813|NCT02347176|594419238|FG003|Overall Study|Withdrawal by Subject|3|||
164559814|NCT02347176|594419235|FG000|Overall Study|Other|1|||
164559815|NCT02347176|594419236|FG001|Overall Study|Other|2|||
164559816|NCT02347176|594419237|FG002|Overall Study|Other|2|||
164559817|NCT02347176|594419238|FG003|Overall Study|Other|0|||
164559818|NCT00411554|594419241|FG000|Overall Study|Adverse Event|2|||
164559819|NCT00411554|594419242|FG001|Overall Study|Adverse Event|4|||
164559820|NCT00411554|594419241|FG000|Overall Study|Lack of Efficacy|2|||
164559821|NCT00411554|594419242|FG001|Overall Study|Lack of Efficacy|5|||
164559822|NCT00411554|594419241|FG000|Overall Study|Withdrawal by Subject|3|||
164559823|NCT00411554|594419242|FG001|Overall Study|Withdrawal by Subject|0|||
164559824|NCT00411554|594419241|FG000|Overall Study|Patient Moved|1|||
164559825|NCT00411554|594419242|FG001|Overall Study|Patient Moved|0|||
164559826|NCT02462473|594419245|FG000|Overall Study|Death|1|||
164559827|NCT02462473|594419245|FG000|Overall Study|Other|3|||
164559828|NCT01536860|594419247|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
164559829|NCT01536860|594419248|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
164559830|NCT01536860|594419249|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
164663814|NCT01957488|594794063|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
164663815|NCT01957488|594794064|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
164559831|NCT01707693|594419250|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
164559832|NCT01707693|594419251|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
164663816|NCT01957488|594794059|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
164663817|NCT01957488|594794060|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
164663818|NCT01957488|594794061|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
164663819|NCT01957488|594794062|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
164559833|NCT01707693|594419250|FG000|Overall Study Allocation|Protocol Violation|4|||
164559834|NCT01707693|594419251|FG001|Overall Study Allocation|Protocol Violation|3|||
164559835|NCT01707693|594419250|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
164559836|NCT01707693|594419251|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
164559837|NCT01707693|594419250|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
164559838|NCT01707693|594419251|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
164559839|NCT00927095|594419255|FG000|Overall Study|Adverse Event|3|||
164559840|NCT00927095|594419256|FG001|Overall Study|Adverse Event|1|||
164559841|NCT00927095|594419257|FG002|Overall Study|Adverse Event|0|||
164559842|NCT00927095|594419255|FG000|Overall Study|Withdrawal by Subject|2|||
164559843|NCT00927095|594419256|FG001|Overall Study|Withdrawal by Subject|1|||
164559844|NCT00927095|594419257|FG002|Overall Study|Withdrawal by Subject|1|||
164559845|NCT00927095|594419255|FG000|Overall Study|Physician Decision|1|||
164559846|NCT00927095|594419256|FG001|Overall Study|Physician Decision|2|||
164559847|NCT00927095|594419257|FG002|Overall Study|Physician Decision|1|||
164559848|NCT01543087|594419264|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
164559849|NCT01543087|594419265|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
164559850|NCT01543087|594419266|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
164559851|NCT01543087|594419267|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
164559852|NCT01543087|594419268|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
164559853|NCT01543087|594419269|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
164559854|NCT01543087|594419264|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
164559855|NCT01543087|594419265|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
164559856|NCT01543087|594419266|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
164559857|NCT01543087|594419267|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
164559858|NCT01543087|594419268|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
164559859|NCT01543087|594419269|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
164559860|NCT01543087|594419264|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
164559861|NCT01543087|594419265|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
164559862|NCT01543087|594419266|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
164559863|NCT01543087|594419267|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
164559864|NCT01543087|594419268|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
164559865|NCT01543087|594419269|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
164559866|NCT01543087|594419264|FG000|Stage 1 (48 Months)|Other than specified|5|||
164559867|NCT01543087|594419265|FG001|Stage 1 (48 Months)|Other than specified|0|||
164559868|NCT01543087|594419266|FG002|Stage 1 (48 Months)|Other than specified|9|||
164559869|NCT01543087|594419267|FG003|Stage 1 (48 Months)|Other than specified|0|||
164559870|NCT01543087|594419268|FG004|Stage 1 (48 Months)|Other than specified|0|||
164559871|NCT01543087|594419269|FG005|Stage 1 (48 Months)|Other than specified|0|||
164559872|NCT01543087|594419264|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
164559873|NCT01543087|594419265|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
164559874|NCT01543087|594419266|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
164559875|NCT01543087|594419267|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
164559876|NCT01543087|594419268|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
164559877|NCT01543087|594419269|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
164559878|NCT01543087|594419264|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
164559879|NCT01543087|594419265|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
164559880|NCT01543087|594419266|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
164559881|NCT01543087|594419267|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
164559882|NCT01543087|594419268|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
164559883|NCT01543087|594419269|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
164559884|NCT01543087|594419264|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
164559885|NCT01543087|594419265|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
164559886|NCT01543087|594419266|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
164559887|NCT01543087|594419267|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
164559888|NCT01543087|594419268|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
164559889|NCT01543087|594419269|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
164559890|NCT00720109|594419286|FG000|Induction Period|Did not meet eligibility criteria|3|||
164559891|NCT00720109|594419287|FG001|Induction Period|Did not meet eligibility criteria|0|||
164559892|NCT00720109|594419288|FG002|Induction Period|Did not meet eligibility criteria|0|||
164559893|NCT00720109|594419286|FG000|Induction Period|Bone Marrow Transplant|2|||
164559894|NCT00720109|594419287|FG001|Induction Period|Bone Marrow Transplant|0|||
164559895|NCT00720109|594419288|FG002|Induction Period|Bone Marrow Transplant|0|||
164559896|NCT00720109|594419286|FG000|Induction Period|Physician Decision|1|||
164559897|NCT00720109|594419287|FG001|Induction Period|Physician Decision|0|||
164559898|NCT00720109|594419288|FG002|Induction Period|Physician Decision|0|||
164559899|NCT00720109|594419286|FG000|Risk Stratification Period|Adverse Event|0|||
164559900|NCT00720109|594419287|FG001|Risk Stratification Period|Adverse Event|1|||
164559901|NCT00720109|594419288|FG002|Risk Stratification Period|Adverse Event|0|||
164663820|NCT01957488|594794063|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
164559902|NCT00720109|594419286|FG000|Risk Stratification Period|Physician Decision|0|||
164663821|NCT01957488|594794064|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
164663822|NCT01957488|594794059|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
164663823|NCT01957488|594794060|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
164663824|NCT01957488|594794061|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
164663825|NCT01957488|594794062|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
164663826|NCT01957488|594794063|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
164663827|NCT01957488|594794064|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
164663828|NCT01957488|594794059|FG000|Test Period 2 (2 Weeks)|Other|1|||
164663829|NCT01957488|594794060|FG001|Test Period 2 (2 Weeks)|Other|0|||
164663830|NCT01957488|594794061|FG002|Test Period 2 (2 Weeks)|Other|0|||
164663831|NCT01957488|594794062|FG003|Test Period 2 (2 Weeks)|Other|0|||
164663832|NCT01957488|594794063|FG004|Test Period 2 (2 Weeks)|Other|0|||
164663833|NCT01957488|594794064|FG005|Test Period 2 (2 Weeks)|Other|0|||
164663834|NCT01957488|594794059|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
164663835|NCT01957488|594794060|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
164663836|NCT01957488|594794061|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
164663837|NCT01957488|594794062|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
164663838|NCT01957488|594794063|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
164663839|NCT01957488|594794064|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
164663840|NCT01957488|594794059|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
164663841|NCT01957488|594794060|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
164663842|NCT01957488|594794061|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
164663843|NCT01957488|594794062|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
164663844|NCT01957488|594794063|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
164663845|NCT01957488|594794064|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
164663846|NCT01957488|594794059|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
164663847|NCT01957488|594794060|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
164663848|NCT01957488|594794061|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
164663849|NCT01957488|594794062|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
164663850|NCT01957488|594794063|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
164663851|NCT01957488|594794064|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
164663852|NCT01957488|594794059|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
164663853|NCT01957488|594794060|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
164663854|NCT01957488|594794061|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
164663855|NCT01957488|594794062|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
164663856|NCT01957488|594794063|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
164663857|NCT01957488|594794064|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
164663858|NCT01957488|594794059|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
164663859|NCT01957488|594794060|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
164204070|NCT05117060|593117927|FG002|Overall Study|Other|3|||
164204071|NCT05117060|593117928|FG003|Overall Study|Other|1|||
164204072|NCT03141359|593117929|FG000|Overall Study|Death|32|||
164204073|NCT03141359|593117929|FG000|Overall Study|Still On Study (in follow up)|29|||
164204074|NCT02097823|593117930|FG000|Overall Study|Withdrawal by Subject|1|||
164204075|NCT02097823|593117931|FG001|Overall Study|Withdrawal by Subject|1|||
164204076|NCT01419535|593117932|FG000|Overall Study|could not maintain iv line|1|||
164204077|NCT01419535|593117933|FG001|Overall Study|could not maintain iv line|1|||
164314834|NCT00282308|593529794|FG001|Treatment Period|Lost to Follow-up|0|||
164314835|NCT00282308|593529795|FG002|Treatment Period|Lost to Follow-up|0|||
164314836|NCT00282308|593529793|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
164314837|NCT00282308|593529794|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
164314838|NCT00282308|593529795|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
164314839|NCT00282308|593529793|FG000|Treatment Period|Adverse Event|0|||
164314840|NCT00282308|593529794|FG001|Treatment Period|Adverse Event|2|||
164314841|NCT00282308|593529795|FG002|Treatment Period|Adverse Event|0|||
164314842|NCT00282308|593529793|FG000|Treatment Period|Not Treated with Study Drug|1|||
164314843|NCT00282308|593529794|FG001|Treatment Period|Not Treated with Study Drug|0|||
164314844|NCT00282308|593529795|FG002|Treatment Period|Not Treated with Study Drug|0|||
164314845|NCT00282308|593529793|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
164314846|NCT00282308|593529794|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
164314847|NCT00282308|593529795|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
164314848|NCT00282308|593529793|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
164314849|NCT00282308|593529794|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
164314850|NCT00282308|593529795|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
164314851|NCT00282308|593529793|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
164663860|NCT01957488|594794061|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
164663861|NCT01957488|594794062|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
164663862|NCT01957488|594794063|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
164663863|NCT01957488|594794064|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
164663864|NCT00973700|594794068|FG000|Overall Study|Withdrawal by Subject|2|||
164663865|NCT00973700|594794069|FG001|Overall Study|Withdrawal by Subject|2|||
164204078|NCT01419535|593117932|FG000|Overall Study|Withdrawal by Subject|0|||
164663866|NCT00973700|594794070|FG002|Overall Study|Withdrawal by Subject|8|||
164663867|NCT00973700|594794071|FG003|Overall Study|Withdrawal by Subject|4|||
164663868|NCT00973700|594794072|FG004|Overall Study|Withdrawal by Subject|4|||
164663869|NCT00973700|594794068|FG000|Overall Study|Lost to Follow-up|5|||
164663870|NCT00973700|594794069|FG001|Overall Study|Lost to Follow-up|0|||
164663871|NCT00973700|594794070|FG002|Overall Study|Lost to Follow-up|1|||
164663872|NCT00973700|594794071|FG003|Overall Study|Lost to Follow-up|8|||
164663873|NCT00973700|594794072|FG004|Overall Study|Lost to Follow-up|5|||
164663874|NCT00973700|594794068|FG000|Overall Study|Inappropriate enrolment|0|||
164663875|NCT00973700|594794069|FG001|Overall Study|Inappropriate enrolment|0|||
164663876|NCT00973700|594794070|FG002|Overall Study|Inappropriate enrolment|0|||
164663877|NCT00973700|594794071|FG003|Overall Study|Inappropriate enrolment|4|||
164663878|NCT00973700|594794072|FG004|Overall Study|Inappropriate enrolment|0|||
164663879|NCT00973700|594794068|FG000|Overall Study|Unable to Classify|0|||
164663880|NCT00973700|594794069|FG001|Overall Study|Unable to Classify|0|||
164663881|NCT00973700|594794070|FG002|Overall Study|Unable to Classify|1|||
164663882|NCT00973700|594794071|FG003|Overall Study|Unable to Classify|2|||
164663883|NCT00973700|594794072|FG004|Overall Study|Unable to Classify|1|||
164663884|NCT01618266|594794080|FG000|Overall Study|Lost to Follow-up|9|||
164663885|NCT01618266|594794080|FG000|Overall Study|Treatment satisfaction|10|||
164663886|NCT01618266|594794080|FG000|Overall Study|Other reasons|11|||
164663887|NCT01618266|594794080|FG000|Overall Study|Lack of Efficacy|23|||
164663888|NCT01618266|594794080|FG000|Overall Study|Protocol Violation|43|||
164663889|NCT00290745|594794081|FG000|Overall Study|Withdrawal by Subject|4|||
164663890|NCT00290745|594794081|FG000|Overall Study|Physician Decision|2|||
164663891|NCT00290745|594794081|FG000|Overall Study|Surgery after 3 months for progression|3|||
164663892|NCT00290745|594794081|FG000|Overall Study|Baseline MRI not available|3|||
164663893|NCT00626925|594794082|FG000|Overall Study|Lost to Follow-up|1|||
164663894|NCT00626925|594794083|FG001|Overall Study|Lost to Follow-up|2|||
164663895|NCT00626925|594794082|FG000|Overall Study|relapse|1|||
164663896|NCT00626925|594794083|FG001|Overall Study|relapse|0|||
164663897|NCT00626925|594794082|FG000|Overall Study|Adverse effect|6|||
164663898|NCT00626925|594794083|FG001|Overall Study|Adverse effect|2|||
164663899|NCT00626925|594794082|FG000|Overall Study|Lack of Efficacy|1|||
164663900|NCT00626925|594794083|FG001|Overall Study|Lack of Efficacy|4|||
164663901|NCT00626925|594794082|FG000|Overall Study|Time constraints|3|||
164663902|NCT00626925|594794083|FG001|Overall Study|Time constraints|1|||
164663903|NCT03267264|594794086|FG000|Overall Study|Withdrawal by Subject|1|||
164663904|NCT03267264|594794087|FG001|Overall Study|Withdrawal by Subject|0|||
164663905|NCT03267264|594794088|FG002|Overall Study|Withdrawal by Subject|2|||
164204079|NCT01419535|593117933|FG001|Overall Study|Withdrawal by Subject|1|||
164204080|NCT03675308|593119155|FG000|Overall Study|Adverse Event|3|||
164204081|NCT03675308|593119156|FG001|Overall Study|Adverse Event|2|||
164204082|NCT03675308|593119155|FG000|Overall Study|Withdrawal by Subject|6|||
164204083|NCT03675308|593119156|FG001|Overall Study|Withdrawal by Subject|4|||
164204084|NCT03675308|593119155|FG000|Overall Study|Lost to Follow-up|3|||
164204085|NCT03675308|593119156|FG001|Overall Study|Lost to Follow-up|0|||
164204086|NCT03675308|593119155|FG000|Overall Study|Lack of Efficacy|1|||
164204087|NCT03675308|593119156|FG001|Overall Study|Lack of Efficacy|1|||
164204088|NCT03675308|593119155|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
164204089|NCT03675308|593119156|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
164204090|NCT03675308|593119155|FG000|Overall Study|Other|0|||
164204091|NCT03675308|593119156|FG001|Overall Study|Other|1|||
164204092|NCT05722522|593119157|FG000|Overall Study|Adverse Event|0|||
164204093|NCT05722522|593119158|FG001|Overall Study|Adverse Event|1|||
164204094|NCT04006457|593119159|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
164302993|NCT04323124|593484687|FG001|Overall Study|Adverse Event|0|||
164663906|NCT03267264|594794089|FG003|Overall Study|Withdrawal by Subject|4|||
164663907|NCT02224391|594794090|FG000|Overall Study|Lost to Follow-up|26|||
164663908|NCT02224391|594794091|FG001|Overall Study|Lost to Follow-up|19|||
164663909|NCT02224391|594794090|FG000|Overall Study|Withdrawal by Subject|6|||
164663910|NCT02224391|594794091|FG001|Overall Study|Withdrawal by Subject|5|||
164663911|NCT02492958|594794092|FG000|Overall Study|Withdrawal by Subject|0|||
164663912|NCT02492958|594794093|FG001|Overall Study|Withdrawal by Subject|0|||
164663913|NCT02492958|594794094|FG002|Overall Study|Withdrawal by Subject|1|||
164663914|NCT02492958|594794095|FG003|Overall Study|Withdrawal by Subject|0|||
164663915|NCT02492958|594794092|FG000|Overall Study|Adverse Event|1|||
164663916|NCT02492958|594794093|FG001|Overall Study|Adverse Event|0|||
164663917|NCT02492958|594794094|FG002|Overall Study|Adverse Event|1|||
164663918|NCT02492958|594794095|FG003|Overall Study|Adverse Event|0|||
164663919|NCT03522948|594794096|FG000|Overall Study|Lost to Follow-up|1|||
164663920|NCT02236130|594794098|FG000|Overall Study|Lost to Follow-up|7|||
164663921|NCT02236130|594794099|FG001|Overall Study|Lost to Follow-up|12|||
164663922|NCT00424489|594794102|FG000|Overall Study|Death|3|||
164663923|NCT01984242|594794103|FG000|Overall Study|Death|52|||
164663924|NCT01984242|594794104|FG001|Overall Study|Death|50|||
164663925|NCT01984242|594794105|FG002|Overall Study|Death|52|||
164663926|NCT01984242|594794103|FG000|Overall Study|Withdrawal by Subject|5|||
164663927|NCT01984242|594794104|FG001|Overall Study|Withdrawal by Subject|3|||
164663928|NCT01984242|594794105|FG002|Overall Study|Withdrawal by Subject|10|||
164663929|NCT01984242|594794103|FG000|Overall Study|Physician Decision|0|||
164663930|NCT01984242|594794104|FG001|Overall Study|Physician Decision|0|||
164663931|NCT01984242|594794105|FG002|Overall Study|Physician Decision|1|||
164663932|NCT01984242|594794103|FG000|Overall Study|Lost to Follow-up|4|||
164663933|NCT01984242|594794104|FG001|Overall Study|Lost to Follow-up|0|||
164663934|NCT01984242|594794105|FG002|Overall Study|Lost to Follow-up|3|||
164663935|NCT01984242|594794103|FG000|Overall Study|Sponsor Decision|1|||
164663936|NCT01984242|594794104|FG001|Overall Study|Sponsor Decision|0|||
164663937|NCT01984242|594794105|FG002|Overall Study|Sponsor Decision|0|||
164663938|NCT01984242|594794103|FG000|Overall Study|Non-Compliance|1|||
164663939|NCT01984242|594794104|FG001|Overall Study|Non-Compliance|0|||
164663940|NCT01984242|594794105|FG002|Overall Study|Non-Compliance|0|||
164663941|NCT01984242|594794103|FG000|Overall Study|Study terminated by Sponsor|38|||
164663942|NCT01984242|594794104|FG001|Overall Study|Study terminated by Sponsor|50|||
164663943|NCT01984242|594794105|FG002|Overall Study|Study terminated by Sponsor|34|||
164663944|NCT01984242|594794103|FG000|Overall Study|Disease Progression|0|||
164663945|NCT01984242|594794104|FG001|Overall Study|Disease Progression|0|||
164663946|NCT01984242|594794105|FG002|Overall Study|Disease Progression|1|||
164663947|NCT00449150|594794108|FG000|Overall Study|Adverse Event|11|||
164663948|NCT00449150|594794109|FG001|Overall Study|Adverse Event|18|||
164663949|NCT00449150|594794110|FG002|Overall Study|Adverse Event|9|||
164663950|NCT00449150|594794108|FG000|Overall Study|Lack of Efficacy|1|||
164663951|NCT00449150|594794109|FG001|Overall Study|Lack of Efficacy|2|||
164663952|NCT00449150|594794110|FG002|Overall Study|Lack of Efficacy|2|||
164663953|NCT00449150|594794108|FG000|Overall Study|Other|16|||
164663954|NCT00449150|594794109|FG001|Overall Study|Other|13|||
164663955|NCT00449150|594794110|FG002|Overall Study|Other|14|||
164663956|NCT00449150|594794108|FG000|Overall Study|Withdrawal by Subject|17|||
164663957|NCT00449150|594794109|FG001|Overall Study|Withdrawal by Subject|18|||
164663958|NCT00449150|594794110|FG002|Overall Study|Withdrawal by Subject|21|||
164663959|NCT00449150|594794108|FG000|Overall Study|Protocol Violation|1|||
164663960|NCT00449150|594794109|FG001|Overall Study|Protocol Violation|2|||
164663961|NCT00449150|594794110|FG002|Overall Study|Protocol Violation|1|||
164663962|NCT00770510|594794112|FG000|Overall Study|Lost to Follow-up|2|||
164663963|NCT00770510|594794112|FG000|Overall Study|Pregnancy|1|||
164663964|NCT00770510|594794112|FG000|Overall Study|Withdrawal by Subject|2|||
164663965|NCT02246478|594794115|FG000|Multiple-dose Phase|Protocol Violation|1|||
164663966|NCT02246478|594794116|FG001|Multiple-dose Phase|Protocol Violation|0|||
164663967|NCT02246478|594794117|FG002|Multiple-dose Phase|Protocol Violation|0|||
164663968|NCT02246478|594794118|FG003|Multiple-dose Phase|Protocol Violation|1|||
164663969|NCT01089647|594794122|FG000|Overall Study|Lost to Follow-up|2|||
164663970|NCT01089647|594794123|FG001|Overall Study|Lost to Follow-up|2|||
164663971|NCT01089647|594794122|FG000|Overall Study|Withdrawal by Subject|2|||
164663972|NCT01089647|594794123|FG001|Overall Study|Withdrawal by Subject|1|||
164663973|NCT01089647|594794122|FG000|Overall Study|Adverse Event|0|||
164663974|NCT01089647|594794123|FG001|Overall Study|Adverse Event|1|||
164663975|NCT00198029|594794126|FG000|Overall Study|Withdrawal by Subject|4|||
164663976|NCT02001558|594794127|FG000|Overall Study|Lost to Follow-up|8|||
164663977|NCT02001558|594794128|FG001|Overall Study|Lost to Follow-up|14|||
164204095|NCT04006457|593119160|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
164204096|NCT04006457|593119161|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
164663978|NCT04117607|594794129|FG000|Overall Study|Early Termination|0|||
164663979|NCT04117607|594794130|FG001|Overall Study|Early Termination|1|||
164663980|NCT04117607|594794131|FG002|Overall Study|Early Termination|0|||
164663981|NCT04117607|594794132|FG003|Overall Study|Early Termination|0|||
164663982|NCT04117607|594794133|FG004|Overall Study|Early Termination|0|||
164663983|NCT04117607|594794134|FG005|Overall Study|Early Termination|0|||
164663984|NCT04117607|594794135|FG006|Overall Study|Early Termination|1|||
164663985|NCT04117607|594794136|FG007|Overall Study|Early Termination|0|||
164663986|NCT04117607|594794137|FG008|Overall Study|Early Termination|0|||
164663987|NCT04117607|594794138|FG009|Overall Study|Early Termination|0|||
164663988|NCT04117607|594794139|FG010|Overall Study|Early Termination|0|||
164663989|NCT04117607|594794140|FG011|Overall Study|Early Termination|0|||
164663990|NCT04117607|594794141|FG012|Overall Study|Early Termination|0|||
164663991|NCT04117607|594794142|FG013|Overall Study|Early Termination|0|||
164663992|NCT01457053|594794146|FG000|Overall Study|Unable to undergo selected treatment|1|||
164663993|NCT01457053|594794147|FG001|Overall Study|Unable to undergo selected treatment|1|||
164663994|NCT04333095|594794150|FG000|Overall Study|Protocol Violation|4|||
164559903|NCT00720109|594419287|FG001|Risk Stratification Period|Physician Decision|2|||
164559904|NCT00720109|594419288|FG002|Risk Stratification Period|Physician Decision|1|||
164559905|NCT00720109|594419286|FG000|Risk Stratification Period|Bone marrow transplant|0|||
164559906|NCT00720109|594419287|FG001|Risk Stratification Period|Bone marrow transplant|9|||
164559907|NCT00720109|594419288|FG002|Risk Stratification Period|Bone marrow transplant|7|||
164559908|NCT00720109|594419286|FG000|Risk Stratification Period|Disease progression or relapse|0|||
164559909|NCT00720109|594419287|FG001|Risk Stratification Period|Disease progression or relapse|2|||
164559910|NCT00720109|594419288|FG002|Risk Stratification Period|Disease progression or relapse|0|||
164559911|NCT00720109|594419286|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
164559912|NCT00720109|594419287|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
164559913|NCT00720109|594419288|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
164559914|NCT02925156|594419289|FG000|Overall Study|Lost to Follow-up|27|||
164559915|NCT02925156|594419290|FG001|Overall Study|Lost to Follow-up|53|||
164559916|NCT02925156|594419291|FG002|Overall Study|Lost to Follow-up|51|||
164559917|NCT02925156|594419292|FG003|Overall Study|Lost to Follow-up|59|||
164559918|NCT02925156|594419293|FG004|Overall Study|Lost to Follow-up|89|||
164559919|NCT02925156|594419294|FG005|Overall Study|Lost to Follow-up|107|||
164559920|NCT02925156|594419295|FG006|Overall Study|Lost to Follow-up|34|||
164559921|NCT02925156|594419296|FG007|Overall Study|Lost to Follow-up|36|||
164559922|NCT02925156|594419297|FG008|Overall Study|Lost to Follow-up|73|||
164559923|NCT02925156|594419298|FG009|Overall Study|Lost to Follow-up|34|||
164559924|NCT02665286|594419299|FG000|Overall Study|Lost to Follow-up|3|||
164559925|NCT02665286|594419300|FG001|Overall Study|Lost to Follow-up|2|||
164559926|NCT02665286|594419301|FG002|Overall Study|Lost to Follow-up|1|||
164559927|NCT01844895|594419302|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
164559928|NCT01844895|594419302|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
164559929|NCT01844895|594419302|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
164559930|NCT01844895|594419302|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
164559931|NCT01844895|594419302|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
164559932|NCT01844895|594419302|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
164559933|NCT01844895|594419302|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
164559934|NCT00915343|594419303|FG000|Part B - Open Label Period|Treatment switch|0|||
164559935|NCT00915343|594419304|FG001|Part B - Open Label Period|Treatment switch|0|||
164559936|NCT00915343|594419305|FG002|Part B - Open Label Period|Treatment switch|1|||
164559937|NCT00915343|594419303|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
164559938|NCT00915343|594419304|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
164559939|NCT00915343|594419305|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
164559940|NCT02926950|594419319|FG000|Overall Study|Adverse Event|4|||
164559941|NCT02926950|594419320|FG001|Overall Study|Adverse Event|6|||
164559942|NCT02926950|594419319|FG000|Overall Study|At the participant's own request|21|||
164559943|NCT02926950|594419320|FG001|Overall Study|At the participant's own request|25|||
164559944|NCT02926950|594419319|FG000|Overall Study|Reason not Specified|17|||
164559945|NCT02926950|594419320|FG001|Overall Study|Reason not Specified|9|||
164559946|NCT02926950|594419319|FG000|Overall Study|Lost to Follow-up|7|||
164559947|NCT02926950|594419320|FG001|Overall Study|Lost to Follow-up|8|||
164559948|NCT02553460|594419321|FG000|Overall Study|Death|3|||
164559949|NCT02553460|594419321|FG000|Overall Study|Withdrawal by Subject|1|||
164559950|NCT02553460|594419321|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
164559951|NCT02553460|594419321|FG000|Overall Study|Relapse or Transplant|14|||
164559952|NCT02553460|594419321|FG000|Overall Study|No response to treatment|2|||
164559953|NCT02553460|594419321|FG000|Overall Study|CAR T cells|2|||
164559954|NCT00482014|594421563|FG000|Overall Study|Withdrawal by Subject|1|||
164559955|NCT00482014|594421564|FG001|Overall Study|Withdrawal by Subject|2|||
164559956|NCT00482014|594421565|FG002|Overall Study|Withdrawal by Subject|3|||
164559957|NCT00482014|594421566|FG003|Overall Study|Withdrawal by Subject|4|||
164559958|NCT00482014|594421563|FG000|Overall Study|Adverse Event|3|||
164559959|NCT00482014|594421564|FG001|Overall Study|Adverse Event|0|||
164559960|NCT00482014|594421565|FG002|Overall Study|Adverse Event|2|||
164559961|NCT00482014|594421566|FG003|Overall Study|Adverse Event|8|||
164559962|NCT00482014|594421563|FG000|Overall Study|Death|1|||
164559963|NCT00482014|594421564|FG001|Overall Study|Death|2|||
164559964|NCT00482014|594421565|FG002|Overall Study|Death|1|||
164559965|NCT00482014|594421566|FG003|Overall Study|Death|4|||
164559966|NCT00482014|594421563|FG000|Overall Study|Lack of Efficacy|1|||
164559967|NCT00482014|594421564|FG001|Overall Study|Lack of Efficacy|0|||
164559968|NCT00482014|594421565|FG002|Overall Study|Lack of Efficacy|4|||
164559969|NCT00482014|594421566|FG003|Overall Study|Lack of Efficacy|6|||
164559970|NCT00482014|594421563|FG000|Overall Study|Sponsor Decision|1|||
164559971|NCT00482014|594421564|FG001|Overall Study|Sponsor Decision|2|||
164559972|NCT00482014|594421565|FG002|Overall Study|Sponsor Decision|1|||
164559973|NCT00482014|594421566|FG003|Overall Study|Sponsor Decision|1|||
164559974|NCT01284114|594421569|FG000|Overall Study|viral infection|1|||
164559975|NCT01284114|594421569|FG000|Overall Study|From the results of ALLTITUDE study|1|||
164559976|NCT01284114|594421569|FG000|Overall Study|Symptomatic hypotension|1|||
164559977|NCT01284114|594421569|FG000|Overall Study|dizziness|1|||
164663995|NCT04333095|594794151|FG001|Overall Study|Protocol Violation|0|||
164663996|NCT04333095|594794150|FG000|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|1|||
164663997|NCT04333095|594794151|FG001|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|4|||
164663998|NCT04333095|594794150|FG000|Overall Study|Mini Sternotomy|4|||
164663999|NCT04333095|594794151|FG001|Overall Study|Mini Sternotomy|5|||
164664000|NCT02364557|594794152|FG000|Overall Study|Protocol Violation|3|||
164664001|NCT02364557|594794153|FG001|Overall Study|Protocol Violation|1|||
164664002|NCT04347239|594794154|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
164664003|NCT04347239|594794155|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
164664004|NCT04347239|594794156|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
164664005|NCT04347239|594794154|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
164664006|NCT04347239|594794155|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
164664007|NCT04347239|594794156|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
164664008|NCT04582539|594794157|FG000|Overall Study|Death|1|||
164664009|NCT04582539|594794158|FG001|Overall Study|Death|1|||
164664010|NCT04582539|594794159|FG002|Overall Study|Death|0|||
164664011|NCT04582539|594794160|FG003|Overall Study|Death|1|||
164664012|NCT04582539|594794161|FG004|Overall Study|Death|0|||
164664013|NCT04582539|594794157|FG000|Overall Study|Lost to Follow-up|1|||
164664014|NCT04582539|594794158|FG001|Overall Study|Lost to Follow-up|0|||
164664015|NCT04582539|594794159|FG002|Overall Study|Lost to Follow-up|0|||
164664016|NCT04582539|594794160|FG003|Overall Study|Lost to Follow-up|0|||
164664017|NCT04582539|594794161|FG004|Overall Study|Lost to Follow-up|0|||
164664018|NCT04582539|594794157|FG000|Overall Study|Study Terminated by Sponsor|1|||
164664019|NCT04582539|594794158|FG001|Overall Study|Study Terminated by Sponsor|3|||
164664020|NCT04582539|594794159|FG002|Overall Study|Study Terminated by Sponsor|2|||
164664021|NCT04582539|594794160|FG003|Overall Study|Study Terminated by Sponsor|2|||
164664022|NCT04582539|594794161|FG004|Overall Study|Study Terminated by Sponsor|3|||
164664023|NCT04582539|594794157|FG000|Overall Study|Physician Decision|0|||
164664024|NCT04582539|594794158|FG001|Overall Study|Physician Decision|1|||
164664025|NCT04582539|594794159|FG002|Overall Study|Physician Decision|0|||
164664026|NCT04582539|594794160|FG003|Overall Study|Physician Decision|0|||
164664027|NCT04582539|594794161|FG004|Overall Study|Physician Decision|0|||
164664028|NCT04582539|594794157|FG000|Overall Study|Withdrawal by Subject|1|||
164664029|NCT04582539|594794158|FG001|Overall Study|Withdrawal by Subject|0|||
164664030|NCT04582539|594794159|FG002|Overall Study|Withdrawal by Subject|2|||
164664031|NCT04582539|594794160|FG003|Overall Study|Withdrawal by Subject|1|||
164664032|NCT04582539|594794161|FG004|Overall Study|Withdrawal by Subject|0|||
164664033|NCT04582539|594794157|FG000|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
164664034|NCT04582539|594794158|FG001|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
164664035|NCT04582539|594794159|FG002|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
164664036|NCT04582539|594794160|FG003|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|1|||
164664037|NCT04582539|594794161|FG004|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
164664038|NCT00788957|594794167|FG000|Part 1|Death|8|||
164664039|NCT00788957|594794168|FG001|Part 1|Death|0|||
164664040|NCT00788957|594794169|FG002|Part 1|Death|0|||
164664041|NCT00788957|594794170|FG003|Part 1|Death|0|||
164664042|NCT00788957|594794171|FG004|Part 1|Death|0|||
164664043|NCT00788957|594794172|FG005|Part 1|Death|0|||
164664044|NCT00788957|594794167|FG000|Part 1|Lost to Follow-up|1|||
164664045|NCT00788957|594794168|FG001|Part 1|Lost to Follow-up|0|||
164664046|NCT00788957|594794169|FG002|Part 1|Lost to Follow-up|0|||
164664047|NCT00788957|594794170|FG003|Part 1|Lost to Follow-up|0|||
164664048|NCT00788957|594794171|FG004|Part 1|Lost to Follow-up|0|||
164664049|NCT00788957|594794172|FG005|Part 1|Lost to Follow-up|0|||
164664050|NCT00788957|594794167|FG000|Part 2|Withdrawal by Subject|0|||
164664051|NCT00788957|594794168|FG001|Part 2|Withdrawal by Subject|9|||
164664052|NCT00788957|594794169|FG002|Part 2|Withdrawal by Subject|5|||
164664053|NCT00788957|594794170|FG003|Part 2|Withdrawal by Subject|3|||
164664054|NCT00788957|594794171|FG004|Part 2|Withdrawal by Subject|0|||
164664055|NCT00788957|594794172|FG005|Part 2|Withdrawal by Subject|0|||
164664056|NCT00788957|594794167|FG000|Part 2|Death|0|||
164664057|NCT00788957|594794168|FG001|Part 2|Death|32|||
164664058|NCT00788957|594794169|FG002|Part 2|Death|35|||
164664059|NCT00788957|594794170|FG003|Part 2|Death|37|||
164664060|NCT00788957|594794171|FG004|Part 2|Death|0|||
164664061|NCT00788957|594794172|FG005|Part 2|Death|0|||
164664062|NCT00788957|594794167|FG000|Part 2|Lost to Follow-up|0|||
164664063|NCT00788957|594794168|FG001|Part 2|Lost to Follow-up|0|||
164664064|NCT00788957|594794169|FG002|Part 2|Lost to Follow-up|3|||
164664065|NCT00788957|594794170|FG003|Part 2|Lost to Follow-up|0|||
164664066|NCT00788957|594794171|FG004|Part 2|Lost to Follow-up|0|||
164664067|NCT00788957|594794172|FG005|Part 2|Lost to Follow-up|0|||
164664068|NCT00788957|594794167|FG000|Part 2|On-study at time of data cut-off|0|||
164664069|NCT00788957|594794168|FG001|Part 2|On-study at time of data cut-off|1|||
164664070|NCT00788957|594794169|FG002|Part 2|On-study at time of data cut-off|1|||
164664071|NCT00788957|594794170|FG003|Part 2|On-study at time of data cut-off|1|||
164664072|NCT00788957|594794171|FG004|Part 2|On-study at time of data cut-off|0|||
164664073|NCT00788957|594794172|FG005|Part 2|On-study at time of data cut-off|0|||
164664074|NCT00788957|594794167|FG000|Part 3|Withdrawal by Subject|0|||
164664075|NCT00788957|594794168|FG001|Part 3|Withdrawal by Subject|0|||
164664076|NCT00788957|594794169|FG002|Part 3|Withdrawal by Subject|0|||
164664077|NCT00788957|594794170|FG003|Part 3|Withdrawal by Subject|0|||
164664078|NCT00788957|594794171|FG004|Part 3|Withdrawal by Subject|0|||
164664079|NCT00788957|594794172|FG005|Part 3|Withdrawal by Subject|2|||
164664080|NCT00788957|594794167|FG000|Part 3|Death|0|||
164664081|NCT00788957|594794168|FG001|Part 3|Death|0|||
164664082|NCT00788957|594794169|FG002|Part 3|Death|0|||
164664083|NCT00788957|594794170|FG003|Part 3|Death|0|||
164664084|NCT00788957|594794171|FG004|Part 3|Death|8|||
164664085|NCT00788957|594794172|FG005|Part 3|Death|8|||
164664086|NCT00788957|594794167|FG000|Part 3|On-study at time of data cut-off|0|||
164664087|NCT00788957|594794168|FG001|Part 3|On-study at time of data cut-off|0|||
164664088|NCT00788957|594794169|FG002|Part 3|On-study at time of data cut-off|0|||
164664089|NCT00788957|594794170|FG003|Part 3|On-study at time of data cut-off|0|||
164664090|NCT00788957|594794171|FG004|Part 3|On-study at time of data cut-off|1|||
164664091|NCT00788957|594794172|FG005|Part 3|On-study at time of data cut-off|0|||
164664092|NCT00662129|594794173|FG000|Overall Study|Protocol Violation|1|||
164664093|NCT00662129|594794173|FG000|Overall Study|Cancel prior to beginning treatment|1|||
164664094|NCT00662129|594794173|FG000|Overall Study|Ineligible|1|||
164664095|NCT00796510|594794182|FG000|Overall Study|Death|1|||
164664096|NCT00796510|594794183|FG001|Overall Study|Death|0|||
164664097|NCT00796510|594794182|FG000|Overall Study|Study Terminated|2|||
164664098|NCT00796510|594794183|FG001|Overall Study|Study Terminated|0|||
164664099|NCT03072459|594794184|FG000|Overall Study|Device revised/removed|1|||
164664100|NCT03072459|594794184|FG000|Overall Study|Subject not able to return|1|||
164664101|NCT01210001|594796062|FG000|Overall Study|Not treated|1|||
164664102|NCT01210001|594796063|FG001|Overall Study|Not treated|0|||
164664103|NCT01210001|594796064|FG002|Overall Study|Not treated|0|||
164664104|NCT01210001|594796062|FG000|Overall Study|Adverse Event|4|||
164664105|NCT01210001|594796063|FG001|Overall Study|Adverse Event|2|||
164664106|NCT01210001|594796064|FG002|Overall Study|Adverse Event|5|||
164664107|NCT01210001|594796062|FG000|Overall Study|Non compliant with protocol|2|||
164664108|NCT01210001|594796063|FG001|Overall Study|Non compliant with protocol|2|||
164664109|NCT01210001|594796064|FG002|Overall Study|Non compliant with protocol|3|||
164664110|NCT01210001|594796062|FG000|Overall Study|Lost to Follow-up|4|||
164664111|NCT01210001|594796063|FG001|Overall Study|Lost to Follow-up|3|||
164664112|NCT01210001|594796064|FG002|Overall Study|Lost to Follow-up|2|||
164664113|NCT01210001|594796062|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
164664114|NCT01210001|594796063|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
164664115|NCT01210001|594796064|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
164664116|NCT01210001|594796062|FG000|Overall Study|Other reason not defined above|2|||
164664117|NCT01210001|594796063|FG001|Overall Study|Other reason not defined above|2|||
164664118|NCT01210001|594796064|FG002|Overall Study|Other reason not defined above|1|||
164664119|NCT00414466|594796072|FG000|Overall Study|Adverse Event|0|||
164664120|NCT00414466|594796073|FG001|Overall Study|Adverse Event|0|||
164664121|NCT00414466|594796074|FG002|Overall Study|Adverse Event|1|||
164664122|NCT00414466|594796075|FG003|Overall Study|Adverse Event|1|||
164664123|NCT00414466|594796072|FG000|Overall Study|Lack of Efficacy|1|||
164664124|NCT00414466|594796073|FG001|Overall Study|Lack of Efficacy|0|||
164664125|NCT00414466|594796074|FG002|Overall Study|Lack of Efficacy|0|||
164664126|NCT00414466|594796075|FG003|Overall Study|Lack of Efficacy|0|||
164664127|NCT00414466|594796072|FG000|Overall Study|Withdrawn by Sponsor|1|||
164664128|NCT00414466|594796073|FG001|Overall Study|Withdrawn by Sponsor|0|||
164664129|NCT00414466|594796074|FG002|Overall Study|Withdrawn by Sponsor|0|||
164664130|NCT00414466|594796075|FG003|Overall Study|Withdrawn by Sponsor|0|||
164664131|NCT01781637|594796076|FG000|Overall Study|Adverse Event|1|||
164664132|NCT01781637|594796077|FG001|Overall Study|Adverse Event|0|||
164664133|NCT01781637|594796076|FG000|Overall Study|Lack of Efficacy|2|||
164664134|NCT01781637|594796077|FG001|Overall Study|Lack of Efficacy|6|||
164664135|NCT01781637|594796076|FG000|Overall Study|Withdrawal by Subject|1|||
164664136|NCT01781637|594796077|FG001|Overall Study|Withdrawal by Subject|0|||
164664137|NCT02637232|594796078|FG000|Overall Study|Lost to Follow-up|42|||
164664138|NCT02637232|594796078|FG000|Overall Study|Adverse Event|11|||
164664139|NCT02637232|594796078|FG000|Overall Study|patient 's decision|2|||
164664140|NCT00090857|594796079|FG000|Overall Study|Lost to Follow-up|0|||
164664141|NCT00090857|594796080|FG001|Overall Study|Lost to Follow-up|1|||
164664142|NCT00090857|594796079|FG000|Overall Study|Withdrawal by Subject|2|||
164664143|NCT00090857|594796080|FG001|Overall Study|Withdrawal by Subject|0|||
164664144|NCT00090857|594796079|FG000|Overall Study|Adverse Event|2|||
164664145|NCT00090857|594796080|FG001|Overall Study|Adverse Event|2|||
164664146|NCT02742090|594796082|FG000|Overall Study|Adverse Event|10|||
164664147|NCT02742090|594796082|FG000|Overall Study|Death|3|||
164664148|NCT02742090|594796082|FG000|Overall Study|Disease Progression|25|||
164664149|NCT02742090|594796082|FG000|Overall Study|Investigator's Decision|1|||
164664150|NCT02742090|594796082|FG000|Overall Study|Lost to Follow-up|1|||
164664151|NCT02742090|594796082|FG000|Overall Study|Non-compliance with Study|1|||
164664152|NCT02742090|594796082|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
164664153|NCT02742090|594796082|FG000|Overall Study|Withdrawal by Subject|4|||
164664154|NCT02742090|594796082|FG000|Overall Study|Reason Not Specified|1|||
164664155|NCT00630305|594796083|FG000|Overall Study|Withdrawal by Subject|1|||
164664156|NCT00630305|594796083|FG000|Overall Study|Inability to insert contact lens|1|||
164664157|NCT01085045|594796084|FG000|Part A|Withdrawal by Subject|4|||
164664158|NCT01085045|594796084|FG000|Part A|Adverse Event|6|||
164664159|NCT01085045|594796084|FG000|Part A|Protocol Violation|1|||
164664160|NCT01085045|594796084|FG000|Part A|Protocol Specified Criteria|7|||
164664161|NCT01085045|594796084|FG000|Part B|Withdrawal by Subject|2|||
164664162|NCT01085045|594796084|FG000|Part B|Protocol Specified Criteria|6|||
164664163|NCT01085045|594796084|FG000|Part B|Lost to Follow-up|1|||
164664164|NCT01085045|594796084|FG000|Part B|Adverse Event|6|||
164664165|NCT00863746|594796092|FG000|Treatment|Not treated|4|||
164664166|NCT00863746|594796093|FG001|Treatment|Not treated|2|||
164664167|NCT00863746|594796092|FG000|Treatment|Adverse Event|41|||
164664168|NCT00863746|594796093|FG001|Treatment|Adverse Event|16|||
164664169|NCT00863746|594796092|FG000|Treatment|non-compliant with study medication|4|||
164664170|NCT00863746|594796093|FG001|Treatment|non-compliant with study medication|0|||
164664171|NCT00863746|594796092|FG000|Treatment|Consent withdrawn|15|||
164664172|NCT00863746|594796093|FG001|Treatment|Consent withdrawn|14|||
164664173|NCT00863746|594796092|FG000|Treatment|Lost to Follow-up|1|||
164664174|NCT00863746|594796093|FG001|Treatment|Lost to Follow-up|0|||
164664175|NCT00863746|594796092|FG000|Treatment|Protocol Violation|5|||
164664176|NCT00863746|594796093|FG001|Treatment|Protocol Violation|3|||
164664177|NCT00863746|594796092|FG000|Treatment|Other|1|||
164664178|NCT00863746|594796093|FG001|Treatment|Other|0|||
164664179|NCT00863746|594796092|FG000|Survival Follow up|Death|244|||
164664180|NCT00863746|594796093|FG001|Survival Follow up|Death|271|||
164664181|NCT00863746|594796092|FG000|Survival Follow up|Lost to Follow-up|2|||
164664182|NCT00863746|594796093|FG001|Survival Follow up|Lost to Follow-up|1|||
164664183|NCT00863746|594796092|FG000|Survival Follow up|Consent Withdrawn|7|||
164664184|NCT00863746|594796093|FG001|Survival Follow up|Consent Withdrawn|8|||
164664185|NCT02924038|594796094|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
164664186|NCT02924038|594796095|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
164664187|NCT02395822|594796096|FG000|Overall Study|Withdrawal by Subject|1|||
164664188|NCT02395822|594796096|FG000|Overall Study|Death|1|||
164664189|NCT03292653|594796097|FG000|Overall Study|Adverse Event|0|||
164664190|NCT03292653|594796098|FG001|Overall Study|Adverse Event|0|||
164664191|NCT03292653|594796099|FG002|Overall Study|Adverse Event|1|||
164664192|NCT03292653|594796097|FG000|Overall Study|Did not Receive Treatment|1|||
164664193|NCT03292653|594796098|FG001|Overall Study|Did not Receive Treatment|0|||
164664194|NCT03292653|594796099|FG002|Overall Study|Did not Receive Treatment|0|||
164664195|NCT04720664|594796100|FG000|Overall Study|Adverse Event|2|||
164664196|NCT04720664|594796100|FG000|Overall Study|Lack of Efficacy|9|||
164664197|NCT02446132|594796105|FG000|Overall Study|Adverse Event|10|||
164664198|NCT02446132|594796106|FG001|Overall Study|Adverse Event|27|||
164664199|NCT02446132|594796107|FG002|Overall Study|Adverse Event|27|||
164664200|NCT02446132|594796105|FG000|Overall Study|Death|2|||
164664201|NCT02446132|594796106|FG001|Overall Study|Death|13|||
164664202|NCT02446132|594796107|FG002|Overall Study|Death|10|||
164664203|NCT02446132|594796105|FG000|Overall Study|Lack of Efficacy|1|||
164664204|NCT02446132|594796106|FG001|Overall Study|Lack of Efficacy|10|||
164664205|NCT02446132|594796107|FG002|Overall Study|Lack of Efficacy|6|||
164664206|NCT02446132|594796105|FG000|Overall Study|Lost to Follow-up|2|||
164664207|NCT02446132|594796106|FG001|Overall Study|Lost to Follow-up|4|||
164664208|NCT02446132|594796107|FG002|Overall Study|Lost to Follow-up|5|||
164664209|NCT02446132|594796105|FG000|Overall Study|Non-compliance With Study Drug|2|||
164664210|NCT02446132|594796106|FG001|Overall Study|Non-compliance With Study Drug|2|||
164664211|NCT02446132|594796107|FG002|Overall Study|Non-compliance With Study Drug|3|||
164664212|NCT02446132|594796105|FG000|Overall Study|Physician Decision|1|||
164664213|NCT02446132|594796106|FG001|Overall Study|Physician Decision|8|||
164664214|NCT02446132|594796107|FG002|Overall Study|Physician Decision|13|||
164664215|NCT02446132|594796105|FG000|Overall Study|Protocol Deviation|0|||
164664216|NCT02446132|594796106|FG001|Overall Study|Protocol Deviation|0|||
164664217|NCT02446132|594796107|FG002|Overall Study|Protocol Deviation|1|||
164664218|NCT02446132|594796105|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
164664219|NCT02446132|594796106|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
164664220|NCT02446132|594796107|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
164664221|NCT02446132|594796105|FG000|Overall Study|Study Terminated by Sponsor|4|||
164664222|NCT02446132|594796106|FG001|Overall Study|Study Terminated by Sponsor|35|||
164664223|NCT02446132|594796107|FG002|Overall Study|Study Terminated by Sponsor|58|||
164664224|NCT02446132|594796105|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
164664225|NCT02446132|594796106|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
164664226|NCT02446132|594796107|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
164664227|NCT02446132|594796105|FG000|Overall Study|Withdrawal by Subject|11|||
164664228|NCT02446132|594796106|FG001|Overall Study|Withdrawal by Subject|29|||
164664229|NCT02446132|594796107|FG002|Overall Study|Withdrawal by Subject|25|||
164664230|NCT02446132|594796105|FG000|Overall Study|Reason not Specified|4|||
164664231|NCT02446132|594796106|FG001|Overall Study|Reason not Specified|16|||
164664232|NCT02446132|594796107|FG002|Overall Study|Reason not Specified|10|||
164664233|NCT02446132|594796105|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
164664234|NCT02446132|594796106|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
164664235|NCT02446132|594796107|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
164664236|NCT03444038|594796108|FG000|Overall Study|Adverse Event|12|||
164664237|NCT03444038|594796108|FG000|Overall Study|Withdrawal by Subject|7|||
164664238|NCT03444038|594796108|FG000|Overall Study|Lost to Follow-up|1|||
164664239|NCT03444038|594796108|FG000|Overall Study|Physician Decision|2|||
164664240|NCT03444038|594796108|FG000|Overall Study|Lack of Efficacy|7|||
164664241|NCT02720510|594796120|FG000|Overall Study|Study Terminated by the sponsor|2|||
164664242|NCT02720510|594796121|FG001|Overall Study|Study Terminated by the sponsor|0|||
164664243|NCT02720510|594796120|FG000|Overall Study|Adverse Event|0|||
164664244|NCT02720510|594796121|FG001|Overall Study|Adverse Event|1|||
164664245|NCT02720510|594796120|FG000|Overall Study|Physician Decision|1|||
164664246|NCT02720510|594796121|FG001|Overall Study|Physician Decision|2|||
164664247|NCT01153984|594796122|FG000|Overall Study|Withdrawal by Subject|1|||
164664248|NCT01153984|594796122|FG000|Overall Study|Adverse Event|1|||
164664249|NCT02460159|594796123|FG000|Overall Study|Adverse Event|4|||
164664250|NCT02460159|594796124|FG001|Overall Study|Adverse Event|1|||
164664251|NCT02460159|594796123|FG000|Overall Study|Withdrawal by Subject|2|||
164664252|NCT02460159|594796124|FG001|Overall Study|Withdrawal by Subject|0|||
164664253|NCT00084084|594796129|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
164664254|NCT00084084|594796129|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
164664255|NCT01531205|594796133|FG000|Overall Study|Did not proceed to surgery|1|||
164664256|NCT02465567|594796134|FG000|Overall Study|Adverse Event|118|||
164664257|NCT02465567|594796135|FG001|Overall Study|Adverse Event|113|||
164664258|NCT02465567|594796136|FG002|Overall Study|Adverse Event|147|||
164664259|NCT02465567|594796137|FG003|Overall Study|Adverse Event|138|||
164664260|NCT02465567|594796134|FG000|Overall Study|Lack of Efficacy|103|||
164664261|NCT02465567|594796135|FG001|Overall Study|Lack of Efficacy|102|||
164664262|NCT02465567|594796136|FG002|Overall Study|Lack of Efficacy|171|||
164664263|NCT02465567|594796137|FG003|Overall Study|Lack of Efficacy|135|||
164664264|NCT02465567|594796134|FG000|Overall Study|Withdrawal by Subject|104|||
164664265|NCT02465567|594796135|FG001|Overall Study|Withdrawal by Subject|94|||
164664266|NCT02465567|594796136|FG002|Overall Study|Withdrawal by Subject|123|||
164664267|NCT02465567|594796137|FG003|Overall Study|Withdrawal by Subject|130|||
164664268|NCT02465567|594796134|FG000|Overall Study|Physician Decision|23|||
164664269|NCT02465567|594796135|FG001|Overall Study|Physician Decision|33|||
164664270|NCT02465567|594796136|FG002|Overall Study|Physician Decision|38|||
164664271|NCT02465567|594796137|FG003|Overall Study|Physician Decision|28|||
164664272|NCT02465567|594796134|FG000|Overall Study|Major Protocol Deviation|24|||
164664273|NCT02465567|594796135|FG001|Overall Study|Major Protocol Deviation|26|||
164664274|NCT02465567|594796136|FG002|Overall Study|Major Protocol Deviation|22|||
164664275|NCT02465567|594796137|FG003|Overall Study|Major Protocol Deviation|25|||
164664276|NCT02465567|594796134|FG000|Overall Study|Lost to Follow-up|25|||
164664277|NCT02465567|594796135|FG001|Overall Study|Lost to Follow-up|21|||
164664278|NCT02465567|594796136|FG002|Overall Study|Lost to Follow-up|19|||
164664279|NCT02465567|594796137|FG003|Overall Study|Lost to Follow-up|15|||
164664280|NCT02465567|594796134|FG000|Overall Study|Protocol Specified Criteria|20|||
164664281|NCT02465567|594796135|FG001|Overall Study|Protocol Specified Criteria|10|||
164664282|NCT02465567|594796136|FG002|Overall Study|Protocol Specified Criteria|9|||
164664283|NCT02465567|594796137|FG003|Overall Study|Protocol Specified Criteria|12|||
164664284|NCT02465567|594796134|FG000|Overall Study|Administrative Reasons|12|||
164664285|NCT02465567|594796135|FG001|Overall Study|Administrative Reasons|9|||
164664286|NCT02465567|594796136|FG002|Overall Study|Administrative Reasons|11|||
164664287|NCT02465567|594796137|FG003|Overall Study|Administrative Reasons|5|||
164664288|NCT02465567|594796134|FG000|Overall Study|Randomized but not treated|1|||
164664289|NCT02465567|594796135|FG001|Overall Study|Randomized but not treated|5|||
164664290|NCT02465567|594796136|FG002|Overall Study|Randomized but not treated|4|||
164664291|NCT02465567|594796137|FG003|Overall Study|Randomized but not treated|5|||
164664292|NCT02465567|594796134|FG000|Overall Study|enrolled in >1 studies|18|||
164664293|NCT02465567|594796135|FG001|Overall Study|enrolled in >1 studies|11|||
164664294|NCT02465567|594796136|FG002|Overall Study|enrolled in >1 studies|19|||
164664295|NCT02465567|594796137|FG003|Overall Study|enrolled in >1 studies|15|||
164664296|NCT02465567|594796134|FG000|Overall Study|missing PI Signature|1|||
164664297|NCT02465567|594796135|FG001|Overall Study|missing PI Signature|0|||
164664298|NCT02465567|594796136|FG002|Overall Study|missing PI Signature|0|||
164664299|NCT02465567|594796137|FG003|Overall Study|missing PI Signature|0|||
164664300|NCT00337077|594796141|FG000|Overall Study|Progressive disease|25|||
164664301|NCT00337077|594796142|FG001|Overall Study|Progressive disease|37|||
164664302|NCT00337077|594796143|FG002|Overall Study|Progressive disease|19|||
164664303|NCT00337077|594796141|FG000|Overall Study|Adverse Event|7|||
164664304|NCT00337077|594796142|FG001|Overall Study|Adverse Event|7|||
164664305|NCT00337077|594796143|FG002|Overall Study|Adverse Event|1|||
164664306|NCT00337077|594796141|FG000|Overall Study|Death|0|||
164664307|NCT00337077|594796142|FG001|Overall Study|Death|1|||
164664308|NCT00337077|594796143|FG002|Overall Study|Death|0|||
164664309|NCT00337077|594796141|FG000|Overall Study|Withdrawal by Subject|7|||
164664310|NCT00337077|594796142|FG001|Overall Study|Withdrawal by Subject|2|||
164664311|NCT00337077|594796143|FG002|Overall Study|Withdrawal by Subject|2|||
164664312|NCT00337077|594796141|FG000|Overall Study|Alternative therapy|1|||
164664313|NCT00337077|594796142|FG001|Overall Study|Alternative therapy|0|||
164664314|NCT00337077|594796143|FG002|Overall Study|Alternative therapy|0|||
164664315|NCT00337077|594796141|FG000|Overall Study|Physician Decision|1|||
164664316|NCT00337077|594796142|FG001|Overall Study|Physician Decision|4|||
164664317|NCT00337077|594796143|FG002|Overall Study|Physician Decision|2|||
164664318|NCT00337077|594796141|FG000|Overall Study|Never started treatment|1|||
164664319|NCT00337077|594796142|FG001|Overall Study|Never started treatment|1|||
164664320|NCT00337077|594796143|FG002|Overall Study|Never started treatment|0|||
164664321|NCT00337077|594796141|FG000|Overall Study|Ineligible|1|||
164664322|NCT00337077|594796142|FG001|Overall Study|Ineligible|1|||
164664323|NCT00337077|594796143|FG002|Overall Study|Ineligible|1|||
164664324|NCT02073643|594796144|FG000|Overall Study|Lost to Follow-up|24|||
164664325|NCT00984295|594796146|FG000|Overall Study|Lost to Follow-up|31|||
164664326|NCT00984295|594796147|FG001|Overall Study|Lost to Follow-up|12|||
164664327|NCT00984295|594796148|FG002|Overall Study|Lost to Follow-up|13|||
164664328|NCT00984295|594796146|FG000|Overall Study|Protocol Violation|2|||
164664329|NCT00984295|594796147|FG001|Overall Study|Protocol Violation|1|||
164664330|NCT00984295|594796148|FG002|Overall Study|Protocol Violation|4|||
164664331|NCT00984295|594796146|FG000|Overall Study|Withdrawal by Subject|18|||
164664332|NCT00984295|594796147|FG001|Overall Study|Withdrawal by Subject|9|||
164664333|NCT00984295|594796148|FG002|Overall Study|Withdrawal by Subject|12|||
164664334|NCT00984295|594796146|FG000|Overall Study|CAE - discontinued test vaccine|0|||
164664335|NCT00984295|594796147|FG001|Overall Study|CAE - discontinued test vaccine|1|||
164664336|NCT00984295|594796148|FG002|Overall Study|CAE - discontinued test vaccine|3|||
164664337|NCT00984295|594796146|FG000|Overall Study|Missed one or more blood samplings|3|||
164664338|NCT00984295|594796147|FG001|Overall Study|Missed one or more blood samplings|7|||
164664339|NCT00984295|594796148|FG002|Overall Study|Missed one or more blood samplings|2|||
164664340|NCT00984295|594796146|FG000|Overall Study|Incomplete safety follow-up|11|||
164664341|NCT00984295|594796147|FG001|Overall Study|Incomplete safety follow-up|2|||
164664342|NCT00984295|594796148|FG002|Overall Study|Incomplete safety follow-up|3|||
164664343|NCT05030753|594796156|FG000|9-week|Lost to Follow-up|10|||
164664344|NCT05030753|594796157|FG001|9-week|Lost to Follow-up|7|||
164664345|NCT05030753|594796156|FG000|9-week|Withdrawal by Subject|1|||
164664346|NCT05030753|594796157|FG001|9-week|Withdrawal by Subject|0|||
164664347|NCT05030753|594796156|FG000|9-week|Excluded from analysis due to missing covariates|2|||
164664348|NCT05030753|594796157|FG001|9-week|Excluded from analysis due to missing covariates|1|||
164664349|NCT05030753|594796156|FG000|6-month post intervention|Lost to Follow-up|5|||
164664350|NCT05030753|594796157|FG001|6-month post intervention|Lost to Follow-up|4|||
164664351|NCT05030753|594796156|FG000|6-month post intervention|Withdrawal by Subject|4|||
164664352|NCT05030753|594796157|FG001|6-month post intervention|Withdrawal by Subject|0|||
164664353|NCT05030753|594796156|FG000|18-month post intervention|Lost to Follow-up|3|||
164664354|NCT05030753|594796157|FG001|18-month post intervention|Lost to Follow-up|1|||
164664355|NCT00329602|594796162|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
164664356|NCT00329602|594796163|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
164664357|NCT00329602|594796164|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
164664358|NCT00329602|594796162|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
164664359|NCT00329602|594796163|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
164664360|NCT00329602|594796164|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
164664361|NCT00329602|594796162|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
164664362|NCT00329602|594796163|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
164664363|NCT00329602|594796164|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
164664364|NCT00329602|594796162|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
164664365|NCT00329602|594796163|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
164664366|NCT00329602|594796164|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
164664367|NCT00329602|594796162|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
164664368|NCT00329602|594796163|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
164664369|NCT00329602|594796164|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
164664370|NCT00329602|594796162|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
164664371|NCT00329602|594796163|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
164204097|NCT04006457|593119159|FG000|Main Study: Treatment Period 1|Death|1|||
164664372|NCT00329602|594796164|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
164664373|NCT02579096|594796165|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
164664374|NCT02579096|594796166|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
164664375|NCT02579096|594796165|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
164314852|NCT00282308|593529794|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
164314853|NCT00282308|593529795|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
164314854|NCT00282308|593529793|FG000|Safety Follow-up Period|Adverse Event|0|||
164314855|NCT00282308|593529794|FG001|Safety Follow-up Period|Adverse Event|0|||
164314856|NCT00282308|593529795|FG002|Safety Follow-up Period|Adverse Event|1|||
164559978|NCT03905863|594421570|FG000|Overall Study|Adverse Event|2|||
164559979|NCT03905863|594421571|FG001|Overall Study|Adverse Event|4|||
164559980|NCT03905863|594421570|FG000|Overall Study|Withdrawal by Subject|2|||
164559981|NCT03905863|594421571|FG001|Overall Study|Withdrawal by Subject|2|||
164559982|NCT03905863|594421570|FG000|Overall Study|Physician Decision|0|||
164559983|NCT03905863|594421571|FG001|Overall Study|Physician Decision|3|||
164559984|NCT03905863|594421570|FG000|Overall Study|Lost to Follow-up|1|||
164559985|NCT03905863|594421571|FG001|Overall Study|Lost to Follow-up|0|||
164559986|NCT03905863|594421570|FG000|Overall Study|Protocol Violation|0|||
164559987|NCT03905863|594421571|FG001|Overall Study|Protocol Violation|2|||
164559988|NCT03905863|594421570|FG000|Overall Study|Death|0|||
164559989|NCT03905863|594421571|FG001|Overall Study|Death|1|||
164559990|NCT02944448|594421575|FG000|Overall Study|Adverse Event|37|||
164559991|NCT02944448|594421576|FG001|Overall Study|Adverse Event|6|||
164559992|NCT02944448|594421575|FG000|Overall Study|Lack of Efficacy|8|||
164559993|NCT02944448|594421576|FG001|Overall Study|Lack of Efficacy|5|||
164559994|NCT02944448|594421575|FG000|Overall Study|Lost to Follow-up|3|||
164559995|NCT02944448|594421576|FG001|Overall Study|Lost to Follow-up|1|||
164559996|NCT02944448|594421575|FG000|Overall Study|Protocol Violation|25|||
164559997|NCT02944448|594421576|FG001|Overall Study|Protocol Violation|7|||
164559998|NCT02944448|594421575|FG000|Overall Study|Withdrawal by Subject|14|||
164559999|NCT02944448|594421576|FG001|Overall Study|Withdrawal by Subject|4|||
164560000|NCT02944448|594421575|FG000|Overall Study|Sponsor did not supply drug in time|0|||
164560001|NCT02944448|594421576|FG001|Overall Study|Sponsor did not supply drug in time|1|||
164560002|NCT02944448|594421575|FG000|Overall Study|Noncompliant with dosing|1|||
164560003|NCT02944448|594421576|FG001|Overall Study|Noncompliant with dosing|0|||
164560004|NCT02944448|594421575|FG000|Overall Study|Abnormal laboratory values|1|||
164560005|NCT02944448|594421576|FG001|Overall Study|Abnormal laboratory values|0|||
164560006|NCT00804687|594421577|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
164560007|NCT00804687|594421578|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
164560008|NCT00804687|594421579|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
164560009|NCT00804687|594421580|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
164560010|NCT00804687|594421581|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
164560011|NCT00804687|594421582|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
164560012|NCT00804687|594421577|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
164560013|NCT00804687|594421578|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
164560014|NCT00804687|594421579|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
164560015|NCT00804687|594421580|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
164560016|NCT00804687|594421581|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
164560017|NCT00804687|594421582|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
164560018|NCT00804687|594421577|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
164560019|NCT00804687|594421578|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
164560020|NCT00804687|594421579|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
164560021|NCT00804687|594421580|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
164560022|NCT00804687|594421581|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
164560023|NCT00804687|594421582|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
164560024|NCT00804687|594421577|FG000|Period 5: Treatment Period|Positive drug test|1|||
164560025|NCT00804687|594421578|FG001|Period 5: Treatment Period|Positive drug test|0|||
164560026|NCT00804687|594421579|FG002|Period 5: Treatment Period|Positive drug test|0|||
164560027|NCT00804687|594421580|FG003|Period 5: Treatment Period|Positive drug test|0|||
164560028|NCT00804687|594421581|FG004|Period 5: Treatment Period|Positive drug test|0|||
164560029|NCT00804687|594421582|FG005|Period 5: Treatment Period|Positive drug test|0|||
164560030|NCT05227690|594421592|FG000|Overall Study|Adverse Event|5|||
164560031|NCT05227690|594421593|FG001|Overall Study|Adverse Event|6|||
164560032|NCT05227690|594421594|FG002|Overall Study|Adverse Event|10|||
164560033|NCT05227690|594421592|FG000|Overall Study|Lack of Efficacy|2|||
164560034|NCT05227690|594421593|FG001|Overall Study|Lack of Efficacy|4|||
164560035|NCT05227690|594421594|FG002|Overall Study|Lack of Efficacy|1|||
164560036|NCT05227690|594421592|FG000|Overall Study|Physician Decision|6|||
164560037|NCT05227690|594421593|FG001|Overall Study|Physician Decision|0|||
164560038|NCT05227690|594421594|FG002|Overall Study|Physician Decision|4|||
164560039|NCT05227690|594421592|FG000|Overall Study|Withdrawal of consent|28|||
164560040|NCT05227690|594421593|FG001|Overall Study|Withdrawal of consent|27|||
164560041|NCT05227690|594421594|FG002|Overall Study|Withdrawal of consent|21|||
164560042|NCT05227690|594421592|FG000|Overall Study|Other, not specified|2|||
164560043|NCT05227690|594421593|FG001|Overall Study|Other, not specified|2|||
164560044|NCT05227690|594421594|FG002|Overall Study|Other, not specified|1|||
164560045|NCT00975156|594421595|FG000|Overall Study|Protocol Violation|0|||
164560046|NCT00975156|594421596|FG001|Overall Study|Protocol Violation|1|||
164664376|NCT02579096|594796166|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
164664377|NCT02579096|594796165|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
164664378|NCT02579096|594796166|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
164664379|NCT02579096|594796165|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
164664380|NCT02579096|594796166|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
164664381|NCT02579096|594796165|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
164664382|NCT02579096|594796166|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
164664383|NCT02579096|594796165|FG000|Phase 2, Weeks 25 - 48|Death|2|||
164664384|NCT02579096|594796166|FG001|Phase 2, Weeks 25 - 48|Death|4|||
164664385|NCT02579096|594796165|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
164664386|NCT02579096|594796166|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
164664387|NCT02579096|594796165|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
164664388|NCT02579096|594796166|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
164664389|NCT02579096|594796165|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
164664390|NCT02579096|594796166|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
164664391|NCT02579096|594796165|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
164664392|NCT02579096|594796166|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
164664393|NCT02579096|594796165|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
164664394|NCT02579096|594796166|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
164664395|NCT02579096|594796165|FG000|Phase 3, Weeks 49 - 72|Death|3|||
164664396|NCT02579096|594796166|FG001|Phase 3, Weeks 49 - 72|Death|2|||
164664397|NCT02579096|594796165|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
164664398|NCT02579096|594796166|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
164664399|NCT02579096|594796165|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
164664400|NCT02579096|594796166|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
164664401|NCT02579096|594796165|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
164664402|NCT02579096|594796166|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
164664403|NCT02579096|594796165|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
164664404|NCT02579096|594796166|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
164664405|NCT02579096|594796165|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
164664406|NCT02579096|594796166|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
164664407|NCT02579096|594796165|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
164664408|NCT02579096|594796166|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
164664409|NCT02097121|594796171|FG000|Overall Study|Other, not specified|4|||
164664410|NCT02097121|594796172|FG001|Overall Study|Other, not specified|2|||
164664411|NCT02097121|594796173|FG002|Overall Study|Other, not specified|3|||
164664412|NCT02097121|594796171|FG000|Overall Study|Lack of Efficacy|2|||
164664413|NCT02097121|594796172|FG001|Overall Study|Lack of Efficacy|1|||
164664414|NCT02097121|594796173|FG002|Overall Study|Lack of Efficacy|3|||
164664415|NCT02097121|594796171|FG000|Overall Study|Withdrawal by Subject|0|||
164664416|NCT02097121|594796172|FG001|Overall Study|Withdrawal by Subject|1|||
164664417|NCT02097121|594796173|FG002|Overall Study|Withdrawal by Subject|2|||
164664418|NCT02097121|594796171|FG000|Overall Study|Adverse Event|0|||
164664419|NCT02097121|594796172|FG001|Overall Study|Adverse Event|1|||
164664420|NCT02097121|594796173|FG002|Overall Study|Adverse Event|0|||
164664421|NCT02097121|594796171|FG000|Overall Study|Lost to Follow-up|1|||
164664422|NCT02097121|594796172|FG001|Overall Study|Lost to Follow-up|1|||
164664423|NCT02097121|594796173|FG002|Overall Study|Lost to Follow-up|2|||
164664424|NCT00510510|594796174|FG000|Overall Study|Adverse Event|4|||
164664425|NCT00510510|594796175|FG001|Overall Study|Adverse Event|3|||
164664426|NCT00510510|594796176|FG002|Overall Study|Adverse Event|6|||
164664427|NCT00510510|594796174|FG000|Overall Study|Lack of Efficacy|0|||
164664428|NCT00510510|594796175|FG001|Overall Study|Lack of Efficacy|1|||
164664429|NCT00510510|594796176|FG002|Overall Study|Lack of Efficacy|1|||
164664430|NCT00510510|594796174|FG000|Overall Study|Subjects no longer requires study drug|0|||
164664431|NCT00510510|594796175|FG001|Overall Study|Subjects no longer requires study drug|0|||
164664432|NCT00510510|594796176|FG002|Overall Study|Subjects no longer requires study drug|2|||
164204098|NCT04006457|593119160|FG001|Main Study: Treatment Period 1|Death|1|||
164204099|NCT04006457|593119161|FG002|Main Study: Treatment Period 1|Death|0|||
164204100|NCT04006457|593119159|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
164204101|NCT04006457|593119160|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
164204102|NCT04006457|593119161|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
164204103|NCT04006457|593119159|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
164204104|NCT04006457|593119160|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
164204105|NCT04006457|593119161|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
164204106|NCT04006457|593119159|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
164204107|NCT04006457|593119160|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
164664433|NCT00510510|594796174|FG000|Overall Study|Withdrawal by Subject|1|||
164664434|NCT00510510|594796175|FG001|Overall Study|Withdrawal by Subject|2|||
164664435|NCT00510510|594796176|FG002|Overall Study|Withdrawal by Subject|3|||
164664436|NCT00510510|594796174|FG000|Overall Study|Lost to Follow-up|0|||
164664437|NCT00510510|594796175|FG001|Overall Study|Lost to Follow-up|0|||
164664438|NCT00510510|594796176|FG002|Overall Study|Lost to Follow-up|1|||
164664439|NCT00510510|594796174|FG000|Overall Study|Protocol Violation|0|||
164664440|NCT00510510|594796175|FG001|Overall Study|Protocol Violation|3|||
164664441|NCT00510510|594796176|FG002|Overall Study|Protocol Violation|4|||
164664442|NCT03595657|594796177|FG000|Overall Study|Adverse Event|14|||
164664443|NCT03595657|594796177|FG000|Overall Study|Death|1|||
164664444|NCT03595657|594796177|FG000|Overall Study|Lack of Efficacy|40|||
164664445|NCT03595657|594796177|FG000|Overall Study|Withdrawal by Subject|10|||
164664446|NCT03595657|594796177|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
164664447|NCT03595657|594796177|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
164664448|NCT01066052|594796178|FG000|Overall Study|Enrolled But Not Treated|3|||
164664449|NCT01066052|594796179|FG001|Overall Study|Enrolled But Not Treated|0|||
164664450|NCT03184441|594796180|FG000|Overall Study|Withdrawal by Subject|1|||
164664451|NCT01200394|594796181|FG000|Overall Study|Adverse Event|0|||
164664452|NCT01200394|594796182|FG001|Overall Study|Adverse Event|14|||
164664453|NCT01200394|594796181|FG000|Overall Study|Death|1|||
164664454|NCT01200394|594796182|FG001|Overall Study|Death|0|||
164664455|NCT01200394|594796181|FG000|Overall Study|Lost to Follow-up|0|||
164664456|NCT01200394|594796182|FG001|Overall Study|Lost to Follow-up|1|||
164664457|NCT01200394|594796181|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
164664458|NCT01200394|594796182|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
164664459|NCT01200394|594796181|FG000|Overall Study|Protocol Violation|0|||
164664460|NCT01200394|594796182|FG001|Overall Study|Protocol Violation|3|||
164664461|NCT01200394|594796181|FG000|Overall Study|Withdrawal by Subject|0|||
164664462|NCT01200394|594796182|FG001|Overall Study|Withdrawal by Subject|5|||
164664463|NCT01200394|594796181|FG000|Overall Study|Other|0|||
164664464|NCT01200394|594796182|FG001|Overall Study|Other|1|||
164664465|NCT02729896|594796185|FG000|Overall Study|Death|0|||
164664466|NCT02729896|594796186|FG001|Overall Study|Death|2|||
164664467|NCT02729896|594796187|FG002|Overall Study|Death|13|||
164664468|NCT02729896|594796185|FG000|Overall Study|Lost to Follow-up|0|||
164664469|NCT02729896|594796186|FG001|Overall Study|Lost to Follow-up|2|||
164664470|NCT02729896|594796187|FG002|Overall Study|Lost to Follow-up|3|||
164664471|NCT02729896|594796185|FG000|Overall Study|Other|0|||
164664472|NCT02729896|594796186|FG001|Overall Study|Other|2|||
164664473|NCT02729896|594796187|FG002|Overall Study|Other|0|||
164664474|NCT02729896|594796185|FG000|Overall Study|Physician Decision|1|||
164664475|NCT02729896|594796186|FG001|Overall Study|Physician Decision|2|||
164664476|NCT02729896|594796187|FG002|Overall Study|Physician Decision|3|||
164664477|NCT02729896|594796185|FG000|Overall Study|Progressive Disease|0|||
164664478|NCT02729896|594796186|FG001|Overall Study|Progressive Disease|1|||
164664479|NCT02729896|594796187|FG002|Overall Study|Progressive Disease|0|||
164664480|NCT02729896|594796185|FG000|Overall Study|Withdrawal by Subject|1|||
164664481|NCT02729896|594796186|FG001|Overall Study|Withdrawal by Subject|0|||
164664482|NCT02729896|594796187|FG002|Overall Study|Withdrawal by Subject|3|||
164664483|NCT02199509|594796188|FG000|Overall Study|Suicidal Ideation|0|||
164664484|NCT02199509|594796189|FG001|Overall Study|Suicidal Ideation|1|||
164664485|NCT02199509|594796188|FG000|Overall Study|Misunderstood titration schedule|1|||
164664486|NCT02199509|594796189|FG001|Overall Study|Misunderstood titration schedule|0|||
164664487|NCT04094870|594796190|FG000|Overall Study|Lost to Follow-up|1|||
164664488|NCT04094870|594796191|FG001|Overall Study|Lost to Follow-up|1|||
164664489|NCT02708277|594796193|FG000|Overall Study|Lost to Follow-up|7|||
164664490|NCT02708277|594796194|FG001|Overall Study|Lost to Follow-up|4|||
164664491|NCT02742181|594796195|FG000|Overall Study|Physician Decision|1|||
164664492|NCT02742181|594796196|FG001|Overall Study|Physician Decision|0|||
164664493|NCT02739984|594796197|FG000|Overall Study|Sponsor Decision|1|||
164664494|NCT02739984|594796198|FG001|Overall Study|Sponsor Decision|0|||
164664495|NCT02739984|594796197|FG000|Overall Study|Withdrawal by Subject|1|||
164664496|NCT02739984|594796198|FG001|Overall Study|Withdrawal by Subject|1|||
164664497|NCT02739984|594796197|FG000|Overall Study|Death|0|||
164664498|NCT02739984|594796198|FG001|Overall Study|Death|1|||
164664499|NCT02739984|594796197|FG000|Overall Study|Lost to Follow-up|3|||
164664500|NCT02739984|594796198|FG001|Overall Study|Lost to Follow-up|0|||
164664501|NCT01048333|594796203|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
164664502|NCT01048333|594796204|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
164664503|NCT01048333|594796205|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
164664504|NCT01048333|594796206|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
164664505|NCT01048333|594796207|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
164664506|NCT01048333|594796208|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
164204108|NCT04006457|593119161|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
164664507|NCT00634179|594796210|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
164664508|NCT04947579|594796211|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
164664509|NCT04947579|594796212|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
164664510|NCT04947579|594796213|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
164664511|NCT04947579|594796214|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
164664512|NCT04947579|594796215|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
164664513|NCT04947579|594796216|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
164664514|NCT04947579|594796211|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
164664515|NCT04947579|594796212|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
164664516|NCT04947579|594796213|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
164664517|NCT04947579|594796214|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
164664518|NCT04947579|594796215|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
164664519|NCT04947579|594796216|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
164664520|NCT04947579|594796211|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
164664521|NCT04947579|594796212|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
164664522|NCT04947579|594796213|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
164664523|NCT04947579|594796214|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
164664524|NCT04947579|594796215|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
164664525|NCT04947579|594796216|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
164664526|NCT04947579|594796211|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
164664527|NCT04947579|594796212|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
164664528|NCT04947579|594796213|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
164664529|NCT04947579|594796214|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
164664530|NCT04947579|594796215|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
164664531|NCT04947579|594796216|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
164664532|NCT04947579|594796211|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
164664533|NCT04947579|594796212|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
164664534|NCT04947579|594796213|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
164664535|NCT04947579|594796214|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
164664536|NCT04947579|594796215|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
164664537|NCT04947579|594796216|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
164664538|NCT04947579|594796211|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
164314857|NCT00282308|593529793|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
164314858|NCT00282308|593529794|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
164314859|NCT00282308|593529795|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
164664539|NCT04947579|594796212|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
164664540|NCT04947579|594796213|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
164664541|NCT04947579|594796214|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
164664542|NCT04947579|594796215|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
164664543|NCT04947579|594796216|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
164664544|NCT04947579|594796211|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
164664545|NCT04947579|594796212|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
164664546|NCT04947579|594796213|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
164664547|NCT04947579|594796214|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
164664548|NCT04947579|594796215|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
164664549|NCT04947579|594796216|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
164664550|NCT04947579|594796211|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
164664551|NCT04947579|594796212|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
164664552|NCT04947579|594796213|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
164664553|NCT04947579|594796214|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
164664554|NCT04947579|594796215|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
164314860|NCT00282308|593529793|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
164314861|NCT00282308|593529794|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
164314862|NCT00282308|593529795|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
164314863|NCT00282308|593529793|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
164560047|NCT01191697|594421597|FG000|Overall Study|Death|1|||
164560048|NCT01191697|594421597|FG000|Overall Study|Physician Decision|2|||
164560049|NCT01191697|594421597|FG000|Overall Study|Pursue chemoradiation|2|||
164560050|NCT01191697|594421597|FG000|Overall Study|Break from chemotherapy|2|||
164560051|NCT01191697|594421597|FG000|Overall Study|Withdrawal by Subject|1|||
164560052|NCT01191697|594421597|FG000|Overall Study|Surveillance|1|||
164560053|NCT01191697|594421597|FG000|Overall Study|Adverse Event|2|||
164560054|NCT01191697|594421597|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
164560055|NCT01191697|594421597|FG000|Overall Study|Not completed but analyzed|25|||
164560056|NCT02634580|594421600|FG000|Double-blind Treatment Period|Subject Request|1|||
164560057|NCT02634580|594421601|FG001|Double-blind Treatment Period|Subject Request|0|||
164560058|NCT02634580|594421602|FG002|Double-blind Treatment Period|Subject Request|1|||
164560059|NCT02634580|594421603|FG003|Double-blind Treatment Period|Subject Request|1|||
164560060|NCT02634580|594421600|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
164560061|NCT02634580|594421601|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
164560062|NCT02634580|594421602|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
164560063|NCT02634580|594421603|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
164560064|NCT00424827|594421609|FG000|Overall Study|Adverse Event|1|||
164560065|NCT02397473|594421612|FG000|Treatment Phase|Adverse Event|1|||
164560066|NCT02397473|594421613|FG001|Treatment Phase|Adverse Event|2|||
164560067|NCT02397473|594421612|FG000|Treatment Phase|Lack of Efficacy|8|||
164560068|NCT02397473|594421613|FG001|Treatment Phase|Lack of Efficacy|1|||
164560069|NCT02397473|594421612|FG000|Treatment Phase|Lost to Follow-up|1|||
164560070|NCT02397473|594421613|FG001|Treatment Phase|Lost to Follow-up|0|||
164560071|NCT02397473|594421612|FG000|Treatment Phase|Withdrawal by Subject|2|||
164560072|NCT02397473|594421613|FG001|Treatment Phase|Withdrawal by Subject|1|||
164560073|NCT02397473|594421612|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
164560074|NCT02397473|594421613|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
164560075|NCT02397473|594421612|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
164560076|NCT02397473|594421613|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
164560077|NCT02397473|594421612|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
164560078|NCT02397473|594421613|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
164560079|NCT02397473|594421612|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
164560080|NCT02397473|594421613|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
164560081|NCT02397473|594421612|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
164560082|NCT02397473|594421613|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
164560083|NCT01467492|594421614|FG000|Overall Study|Withdrawal by Subject|6|||
164560084|NCT01467492|594421615|FG001|Overall Study|Withdrawal by Subject|4|||
164560085|NCT01467492|594421614|FG000|Overall Study|Study Terminated by Sponsor|6|||
164560086|NCT01467492|594421615|FG001|Overall Study|Study Terminated by Sponsor|4|||
164560087|NCT01467492|594421614|FG000|Overall Study|Adverse Event|4|||
164560088|NCT01467492|594421615|FG001|Overall Study|Adverse Event|3|||
164560089|NCT01467492|594421614|FG000|Overall Study|Lost to Follow-up|3|||
164560090|NCT01467492|594421615|FG001|Overall Study|Lost to Follow-up|2|||
164560091|NCT01467492|594421614|FG000|Overall Study|Undefined|2|||
164560092|NCT01467492|594421615|FG001|Overall Study|Undefined|0|||
164560093|NCT01467492|594421614|FG000|Overall Study|Enrolled But Not Treated|1|||
164560094|NCT01467492|594421615|FG001|Overall Study|Enrolled But Not Treated|0|||
164560095|NCT00491179|594421616|FG000|Overall Study|Adverse Event|5|||
164560096|NCT00491179|594421617|FG001|Overall Study|Adverse Event|1|||
164560097|NCT00491179|594421616|FG000|Overall Study|Withdrawal by Subject|2|||
164560098|NCT00491179|594421617|FG001|Overall Study|Withdrawal by Subject|1|||
164560099|NCT02009878|594421618|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
164560100|NCT02009878|594421619|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
164560101|NCT02009878|594421620|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
164560102|NCT05689047|594421624|FG000|Overall Study|Lost to Follow-up|0|||
164560103|NCT05689047|594421625|FG001|Overall Study|Lost to Follow-up|1|||
164560104|NCT05689047|594421624|FG000|Overall Study|Protocol Deviation|1|||
164560105|NCT05689047|594421625|FG001|Overall Study|Protocol Deviation|0|||
164560106|NCT01604512|594421626|FG000|Overall Study|Withdrawal by Subject|3|||
164560107|NCT01604512|594421626|FG000|Overall Study|Not treated|4|||
164560108|NCT03132636|594421627|FG000|Overall Study|Adverse Event|1|||
164560109|NCT03132636|594421628|FG001|Overall Study|Adverse Event|2|||
164560110|NCT03132636|594421627|FG000|Overall Study|Death|4|||
164560111|NCT03132636|594421628|FG001|Overall Study|Death|7|||
164560112|NCT03132636|594421627|FG000|Overall Study|Lost to Follow-up|3|||
164560113|NCT03132636|594421628|FG001|Overall Study|Lost to Follow-up|2|||
164560114|NCT03132636|594421627|FG000|Overall Study|Non compliance with protocol by participant|1|||
164560115|NCT03132636|594421628|FG001|Overall Study|Non compliance with protocol by participant|1|||
164560116|NCT03132636|594421627|FG000|Overall Study|Subject decision|1|||
164560117|NCT03132636|594421628|FG001|Overall Study|Subject decision|9|||
164560118|NCT03132636|594421627|FG000|Overall Study|Sponsor decision|0|||
164560119|NCT03132636|594421628|FG001|Overall Study|Sponsor decision|1|||
164560120|NCT03132636|594421627|FG000|Overall Study|Physician Decision|1|||
164560121|NCT03132636|594421628|FG001|Overall Study|Physician Decision|0|||
164560122|NCT03132636|594421627|FG000|Overall Study|Progressive disease|33|||
164560123|NCT03132636|594421628|FG001|Overall Study|Progressive disease|36|||
164560124|NCT03132636|594421627|FG000|Overall Study|Withdrawal of consent|2|||
164560125|NCT03132636|594421628|FG001|Overall Study|Withdrawal of consent|5|||
164560126|NCT03132636|594421627|FG000|Overall Study|Did not re-consent|1|||
164560127|NCT03132636|594421628|FG001|Overall Study|Did not re-consent|0|||
164314864|NCT00282308|593529794|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
164560128|NCT03132636|594421627|FG000|Overall Study|Lost insurance coverage|1|||
164560129|NCT03132636|594421628|FG001|Overall Study|Lost insurance coverage|0|||
164560130|NCT03132636|594421627|FG000|Overall Study|Related to radiological outcomes|0|||
164560131|NCT03132636|594421628|FG001|Overall Study|Related to radiological outcomes|1|||
164560132|NCT03132636|594421627|FG000|Overall Study|Unable to come to site for continued visits|0|||
164560133|NCT03132636|594421628|FG001|Overall Study|Unable to come to site for continued visits|1|||
164560134|NCT01415752|594421629|FG000|Induction (Step 1)|Ineligible|4|||
164560135|NCT01415752|594421630|FG001|Induction (Step 1)|Ineligible|3|||
164560136|NCT01415752|594421631|FG002|Induction (Step 1)|Ineligible|4|||
164560137|NCT01415752|594421632|FG003|Induction (Step 1)|Ineligible|4|||
164560138|NCT01415752|594421629|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
164560139|NCT01415752|594421630|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
164560140|NCT01415752|594421631|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
164560141|NCT01415752|594421632|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
164560142|NCT01415752|594421629|FG000|Maintenance (Step 2)|Adverse Event|3|||
164560143|NCT01415752|594421630|FG001|Maintenance (Step 2)|Adverse Event|4|||
164560144|NCT01415752|594421631|FG002|Maintenance (Step 2)|Adverse Event|9|||
164560145|NCT01415752|594421632|FG003|Maintenance (Step 2)|Adverse Event|6|||
164560146|NCT01415752|594421629|FG000|Maintenance (Step 2)|Death|1|||
164204109|NCT04006457|593119159|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
164204110|NCT04006457|593119160|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
164204111|NCT04006457|593119161|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
164204112|NCT04006457|593119159|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
164204113|NCT04006457|593119160|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
164204114|NCT04006457|593119161|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
164560147|NCT01415752|594421630|FG001|Maintenance (Step 2)|Death|1|||
164560148|NCT01415752|594421631|FG002|Maintenance (Step 2)|Death|2|||
164560149|NCT01415752|594421632|FG003|Maintenance (Step 2)|Death|0|||
164560150|NCT01415752|594421629|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
164560151|NCT01415752|594421630|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
164560152|NCT01415752|594421631|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
164560153|NCT01415752|594421632|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
164560154|NCT01415752|594421629|FG000|Maintenance (Step 2)|Alternative therapy|0|||
164560155|NCT01415752|594421630|FG001|Maintenance (Step 2)|Alternative therapy|1|||
164560156|NCT01415752|594421631|FG002|Maintenance (Step 2)|Alternative therapy|0|||
164560157|NCT01415752|594421632|FG003|Maintenance (Step 2)|Alternative therapy|0|||
164560158|NCT01415752|594421629|FG000|Maintenance (Step 2)|Other reasons|3|||
164560159|NCT01415752|594421630|FG001|Maintenance (Step 2)|Other reasons|6|||
164560160|NCT01415752|594421631|FG002|Maintenance (Step 2)|Other reasons|4|||
164560161|NCT01415752|594421632|FG003|Maintenance (Step 2)|Other reasons|6|||
164560162|NCT01415752|594421629|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
164560163|NCT01415752|594421630|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
164560164|NCT01415752|594421631|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
164560165|NCT01415752|594421632|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
164560166|NCT01415752|594421629|FG000|Maintenance (Step 2)|ineligible|1|||
164560167|NCT01415752|594421630|FG001|Maintenance (Step 2)|ineligible|1|||
164560168|NCT01415752|594421631|FG002|Maintenance (Step 2)|ineligible|1|||
164560169|NCT01415752|594421632|FG003|Maintenance (Step 2)|ineligible|0|||
164560170|NCT01415752|594421629|FG000|Maintenance (Step 2)|Missing|4|||
164560171|NCT01415752|594421630|FG001|Maintenance (Step 2)|Missing|1|||
164560172|NCT01415752|594421631|FG002|Maintenance (Step 2)|Missing|4|||
164560173|NCT01415752|594421632|FG003|Maintenance (Step 2)|Missing|3|||
164560174|NCT03083886|594421633|FG000|Overall Study|Withdrawal by Subject|51|||
164560175|NCT03083886|594421634|FG001|Overall Study|Withdrawal by Subject|73|||
164560176|NCT03083886|594421635|FG002|Overall Study|Withdrawal by Subject|104|||
164560177|NCT03083886|594421633|FG000|Overall Study|Missing Baseline data|43|||
164560178|NCT03083886|594421634|FG001|Overall Study|Missing Baseline data|42|||
164560179|NCT03083886|594421635|FG002|Overall Study|Missing Baseline data|31|||
164560180|NCT03083886|594421633|FG000|Overall Study|Investigator terminated|1|||
164560181|NCT03083886|594421634|FG001|Overall Study|Investigator terminated|6|||
164560182|NCT03083886|594421635|FG002|Overall Study|Investigator terminated|3|||
164560183|NCT01391507|594421636|FG000|Overall Study|Death|0|||
164560184|NCT01391507|594421637|FG001|Overall Study|Death|0|||
164560185|NCT01391507|594421638|FG002|Overall Study|Death|0|||
164560186|NCT01391507|594421639|FG003|Overall Study|Death|1|||
164560187|NCT01391507|594421636|FG000|Overall Study|Adverse Event|1|||
164560188|NCT01391507|594421637|FG001|Overall Study|Adverse Event|1|||
164560189|NCT01391507|594421638|FG002|Overall Study|Adverse Event|2|||
164560190|NCT01391507|594421639|FG003|Overall Study|Adverse Event|2|||
164560191|NCT01391507|594421636|FG000|Overall Study|Withdrawal by Subject|1|||
164560192|NCT01391507|594421637|FG001|Overall Study|Withdrawal by Subject|2|||
164560193|NCT01391507|594421638|FG002|Overall Study|Withdrawal by Subject|1|||
164560194|NCT01391507|594421639|FG003|Overall Study|Withdrawal by Subject|1|||
164560195|NCT01391507|594421636|FG000|Overall Study|Lack of Efficacy|0|||
164560196|NCT01391507|594421637|FG001|Overall Study|Lack of Efficacy|0|||
164560197|NCT01391507|594421638|FG002|Overall Study|Lack of Efficacy|0|||
164204115|NCT04006457|593119159|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
164204116|NCT04006457|593119160|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
164560198|NCT01391507|594421639|FG003|Overall Study|Lack of Efficacy|1|||
164560199|NCT01391507|594421636|FG000|Overall Study|Protocol Violation|2|||
164314865|NCT00282308|593529795|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
164560200|NCT01391507|594421637|FG001|Overall Study|Protocol Violation|1|||
164560201|NCT01391507|594421638|FG002|Overall Study|Protocol Violation|1|||
164560202|NCT01391507|594421639|FG003|Overall Study|Protocol Violation|2|||
164560203|NCT01453855|594421640|FG000|Overall Study|Adverse Event|3|||
164560204|NCT01453855|594421641|FG001|Overall Study|Adverse Event|4|||
164560205|NCT01453855|594421640|FG000|Overall Study|Lost to Follow-up|2|||
164560206|NCT01453855|594421641|FG001|Overall Study|Lost to Follow-up|1|||
164560207|NCT01453855|594421640|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
164560208|NCT01453855|594421641|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
164560209|NCT01453855|594421640|FG000|Overall Study|Noncompliance|1|||
164560210|NCT01453855|594421641|FG001|Overall Study|Noncompliance|0|||
164560211|NCT01453855|594421640|FG000|Overall Study|Inadequate Control of IOP|1|||
164560212|NCT01453855|594421641|FG001|Overall Study|Inadequate Control of IOP|5|||
164560213|NCT01453855|594421640|FG000|Overall Study|Other|0|||
164560214|NCT01453855|594421641|FG001|Overall Study|Other|1|||
164560215|NCT01562548|594421644|FG000|Overall Study|Lost to Follow-up|0|||
164560216|NCT01562548|594421645|FG001|Overall Study|Lost to Follow-up|0|||
164560217|NCT01562548|594421646|FG002|Overall Study|Lost to Follow-up|1|||
164560218|NCT01562548|594421647|FG003|Overall Study|Lost to Follow-up|0|||
164560219|NCT01285908|594421648|FG000|Baseline Measurement|unable to insert catheter|1|||
164560220|NCT01285908|594421649|FG001|Baseline Measurement|unable to insert catheter|0|||
164560221|NCT01285908|594421650|FG002|Baseline Measurement|unable to insert catheter|0|||
164560222|NCT01285908|594421648|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
164560223|NCT01285908|594421649|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
164560224|NCT01285908|594421650|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
164560225|NCT01285908|594421648|FG000|Baseline Measurement|unable to tolerate procedure|1|||
164560226|NCT01285908|594421649|FG001|Baseline Measurement|unable to tolerate procedure|0|||
164560227|NCT01285908|594421650|FG002|Baseline Measurement|unable to tolerate procedure|0|||
164560228|NCT03655756|594421651|FG000|Overall Study|Death|1|||
164560229|NCT03529773|594421652|FG000|Overall Study|Adverse Event|0|||
164560230|NCT03529773|594421653|FG001|Overall Study|Adverse Event|0|||
164560231|NCT03529773|594421654|FG002|Overall Study|Adverse Event|0|||
164560232|NCT03529773|594421655|FG003|Overall Study|Adverse Event|0|||
164560233|NCT03529773|594421656|FG004|Overall Study|Adverse Event|0|||
164560234|NCT03529773|594421657|FG005|Overall Study|Adverse Event|0|||
164560235|NCT03529773|594421658|FG006|Overall Study|Adverse Event|0|||
164560236|NCT03529773|594421659|FG007|Overall Study|Adverse Event|0|||
164560237|NCT03529773|594421660|FG008|Overall Study|Adverse Event|0|||
164560238|NCT03529773|594421661|FG009|Overall Study|Adverse Event|0|||
164560239|NCT03529773|594421662|FG010|Overall Study|Adverse Event|0|||
164560240|NCT03529773|594421663|FG011|Overall Study|Adverse Event|0|||
164560241|NCT03529773|594421664|FG012|Overall Study|Adverse Event|0|||
164560242|NCT03529773|594421665|FG013|Overall Study|Adverse Event|0|||
164560243|NCT03529773|594421666|FG014|Overall Study|Adverse Event|0|||
164560244|NCT03529773|594421667|FG015|Overall Study|Adverse Event|0|||
164560245|NCT03529773|594421668|FG016|Overall Study|Adverse Event|0|||
164560246|NCT03529773|594421669|FG017|Overall Study|Adverse Event|0|||
164560247|NCT03529773|594421670|FG018|Overall Study|Adverse Event|0|||
164560248|NCT03529773|594421671|FG019|Overall Study|Adverse Event|0|||
164560249|NCT03529773|594421672|FG020|Overall Study|Adverse Event|0|||
164560250|NCT03529773|594421673|FG021|Overall Study|Adverse Event|0|||
164560251|NCT03529773|594421674|FG022|Overall Study|Adverse Event|0|||
164560252|NCT03529773|594421675|FG023|Overall Study|Adverse Event|0|||
164560253|NCT03529773|594421676|FG024|Overall Study|Adverse Event|0|||
164560254|NCT03529773|594421677|FG025|Overall Study|Adverse Event|0|||
164560255|NCT03529773|594421678|FG026|Overall Study|Adverse Event|0|||
164560256|NCT03529773|594421679|FG027|Overall Study|Adverse Event|0|||
164560257|NCT03529773|594421680|FG028|Overall Study|Adverse Event|0|||
164560258|NCT03529773|594421681|FG029|Overall Study|Adverse Event|0|||
164560259|NCT03529773|594421682|FG030|Overall Study|Adverse Event|1|||
164560260|NCT03529773|594421683|FG031|Overall Study|Adverse Event|0|||
164560261|NCT03529773|594421684|FG032|Overall Study|Adverse Event|0|||
164560262|NCT03529773|594421685|FG033|Overall Study|Adverse Event|0|||
164560263|NCT03529773|594421686|FG034|Overall Study|Adverse Event|0|||
164560264|NCT03529773|594421687|FG035|Overall Study|Adverse Event|1|||
164560265|NCT03529773|594421688|FG036|Overall Study|Adverse Event|0|||
164560266|NCT03529773|594421689|FG037|Overall Study|Adverse Event|0|||
164560267|NCT03529773|594421690|FG038|Overall Study|Adverse Event|1|||
164560268|NCT03529773|594421691|FG039|Overall Study|Adverse Event|1|||
164560269|NCT03529773|594421652|FG000|Overall Study|Death|0|||
164560270|NCT03529773|594421653|FG001|Overall Study|Death|0|||
164560271|NCT03529773|594421654|FG002|Overall Study|Death|0|||
164560272|NCT03529773|594421655|FG003|Overall Study|Death|0|||
164560273|NCT03529773|594421656|FG004|Overall Study|Death|0|||
164560274|NCT03529773|594421657|FG005|Overall Study|Death|0|||
164560275|NCT03529773|594421658|FG006|Overall Study|Death|0|||
164560276|NCT03529773|594421659|FG007|Overall Study|Death|0|||
164560277|NCT03529773|594421660|FG008|Overall Study|Death|0|||
164560278|NCT03529773|594421661|FG009|Overall Study|Death|0|||
164560279|NCT03529773|594421662|FG010|Overall Study|Death|0|||
164560280|NCT03529773|594421663|FG011|Overall Study|Death|0|||
164560281|NCT03529773|594421664|FG012|Overall Study|Death|1|||
164560282|NCT03529773|594421665|FG013|Overall Study|Death|0|||
164560283|NCT03529773|594421666|FG014|Overall Study|Death|0|||
164560284|NCT03529773|594421667|FG015|Overall Study|Death|0|||
164560285|NCT03529773|594421668|FG016|Overall Study|Death|0|||
164560286|NCT03529773|594421669|FG017|Overall Study|Death|0|||
164560287|NCT03529773|594421670|FG018|Overall Study|Death|0|||
164560288|NCT03529773|594421671|FG019|Overall Study|Death|1|||
164664555|NCT04947579|594796216|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
164664556|NCT04947579|594796211|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
164664557|NCT04947579|594796212|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
164664558|NCT04947579|594796213|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
164664559|NCT04947579|594796214|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
164664560|NCT04947579|594796215|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
164420618|NCT01890967|593910951|FG005|Overall Study|Withdrawal by Subject|1|||
164560289|NCT03529773|594421672|FG020|Overall Study|Death|0|||
164664561|NCT04947579|594796216|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
164664562|NCT04947579|594796211|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
164664563|NCT04947579|594796212|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
164664564|NCT04947579|594796213|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
164664565|NCT04947579|594796214|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
164664566|NCT04947579|594796215|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
164664567|NCT04947579|594796216|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
164664568|NCT04947579|594796211|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
164664569|NCT04947579|594796212|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
164664570|NCT04947579|594796213|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
164664571|NCT04947579|594796214|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
164560290|NCT03529773|594421673|FG021|Overall Study|Death|0|||
164560291|NCT03529773|594421674|FG022|Overall Study|Death|1|||
164560292|NCT03529773|594421675|FG023|Overall Study|Death|0|||
164560293|NCT03529773|594421676|FG024|Overall Study|Death|0|||
164560294|NCT03529773|594421677|FG025|Overall Study|Death|0|||
164560295|NCT03529773|594421678|FG026|Overall Study|Death|0|||
164560296|NCT03529773|594421679|FG027|Overall Study|Death|0|||
164560297|NCT03529773|594421680|FG028|Overall Study|Death|0|||
164560298|NCT03529773|594421681|FG029|Overall Study|Death|0|||
164560299|NCT03529773|594421682|FG030|Overall Study|Death|0|||
164560300|NCT03529773|594421683|FG031|Overall Study|Death|0|||
164560301|NCT03529773|594421684|FG032|Overall Study|Death|0|||
164560302|NCT03529773|594421685|FG033|Overall Study|Death|1|||
164560303|NCT03529773|594421686|FG034|Overall Study|Death|1|||
164560304|NCT03529773|594421687|FG035|Overall Study|Death|0|||
164560305|NCT03529773|594421688|FG036|Overall Study|Death|1|||
164560306|NCT03529773|594421689|FG037|Overall Study|Death|0|||
164560307|NCT03529773|594421690|FG038|Overall Study|Death|0|||
164560308|NCT03529773|594421691|FG039|Overall Study|Death|0|||
164560309|NCT03529773|594421652|FG000|Overall Study|Lost to Follow-up|0|||
164560310|NCT03529773|594421653|FG001|Overall Study|Lost to Follow-up|0|||
164560311|NCT03529773|594421654|FG002|Overall Study|Lost to Follow-up|1|||
164560312|NCT03529773|594421655|FG003|Overall Study|Lost to Follow-up|0|||
164560313|NCT03529773|594421656|FG004|Overall Study|Lost to Follow-up|1|||
164560314|NCT03529773|594421657|FG005|Overall Study|Lost to Follow-up|1|||
164560315|NCT03529773|594421658|FG006|Overall Study|Lost to Follow-up|0|||
164560316|NCT03529773|594421659|FG007|Overall Study|Lost to Follow-up|0|||
164560317|NCT03529773|594421660|FG008|Overall Study|Lost to Follow-up|0|||
164560318|NCT03529773|594421661|FG009|Overall Study|Lost to Follow-up|0|||
164560319|NCT03529773|594421662|FG010|Overall Study|Lost to Follow-up|0|||
164560320|NCT03529773|594421663|FG011|Overall Study|Lost to Follow-up|0|||
164560321|NCT03529773|594421664|FG012|Overall Study|Lost to Follow-up|0|||
164560322|NCT03529773|594421665|FG013|Overall Study|Lost to Follow-up|1|||
164560323|NCT03529773|594421666|FG014|Overall Study|Lost to Follow-up|4|||
164560324|NCT03529773|594421667|FG015|Overall Study|Lost to Follow-up|1|||
164560325|NCT03529773|594421668|FG016|Overall Study|Lost to Follow-up|1|||
164560326|NCT03529773|594421669|FG017|Overall Study|Lost to Follow-up|0|||
164560327|NCT03529773|594421670|FG018|Overall Study|Lost to Follow-up|1|||
164560328|NCT03529773|594421671|FG019|Overall Study|Lost to Follow-up|1|||
164560329|NCT03529773|594421672|FG020|Overall Study|Lost to Follow-up|2|||
164560330|NCT03529773|594421673|FG021|Overall Study|Lost to Follow-up|4|||
164560331|NCT03529773|594421674|FG022|Overall Study|Lost to Follow-up|3|||
164560332|NCT03529773|594421675|FG023|Overall Study|Lost to Follow-up|4|||
164560333|NCT03529773|594421676|FG024|Overall Study|Lost to Follow-up|3|||
164560334|NCT03529773|594421677|FG025|Overall Study|Lost to Follow-up|5|||
164560335|NCT03529773|594421678|FG026|Overall Study|Lost to Follow-up|5|||
164560336|NCT03529773|594421679|FG027|Overall Study|Lost to Follow-up|0|||
164560337|NCT03529773|594421680|FG028|Overall Study|Lost to Follow-up|0|||
164560338|NCT03529773|594421681|FG029|Overall Study|Lost to Follow-up|0|||
164560339|NCT03529773|594421682|FG030|Overall Study|Lost to Follow-up|1|||
164560340|NCT03529773|594421683|FG031|Overall Study|Lost to Follow-up|0|||
164560341|NCT03529773|594421684|FG032|Overall Study|Lost to Follow-up|0|||
164560342|NCT03529773|594421685|FG033|Overall Study|Lost to Follow-up|1|||
164560343|NCT03529773|594421686|FG034|Overall Study|Lost to Follow-up|1|||
164664572|NCT04947579|594796215|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
164664573|NCT04947579|594796216|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
164560344|NCT03529773|594421687|FG035|Overall Study|Lost to Follow-up|0|||
164560345|NCT03529773|594421688|FG036|Overall Study|Lost to Follow-up|0|||
164664574|NCT00767325|594796217|FG000|Overall Study|Lack of Efficacy|2|||
164664575|NCT00767325|594796217|FG000|Overall Study|Adverse Event|7|||
164664576|NCT00767325|594796217|FG000|Overall Study|Lost to Follow-up|3|||
164664577|NCT00767325|594796217|FG000|Overall Study|No longer met study criteria|2|||
164664578|NCT00767325|594796217|FG000|Overall Study|Missed visit due to family reasons|1|||
164664579|NCT03538756|594796218|FG000|Long-Term Follow-up|Adverse Event|0|||
164664580|NCT03538756|594796219|FG001|Long-Term Follow-up|Adverse Event|0|||
164664581|NCT03538756|594796220|FG002|Long-Term Follow-up|Adverse Event|6|||
164664582|NCT03538756|594796218|FG000|Long-Term Follow-up|Death|0|||
164664583|NCT03538756|594796219|FG001|Long-Term Follow-up|Death|0|||
164664584|NCT03538756|594796220|FG002|Long-Term Follow-up|Death|1|||
164664585|NCT03538756|594796218|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
164664586|NCT03538756|594796219|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
164314866|NCT04237116|593529796|FG000|Overall Study|Adverse Event|0|||
164314867|NCT04237116|593529797|FG001|Overall Study|Adverse Event|1|||
164314868|NCT04237116|593529796|FG000|Overall Study|Study terminated by Sponsor|4|||
164314869|NCT04237116|593529797|FG001|Overall Study|Study terminated by Sponsor|1|||
164314870|NCT03212144|593529798|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
164314871|NCT03212144|593529799|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
164664587|NCT03538756|594796220|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
164664588|NCT03538756|594796218|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
164664589|NCT03538756|594796219|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
164664590|NCT03538756|594796220|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
164664591|NCT03538756|594796218|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
164664592|NCT03538756|594796219|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
164664593|NCT03538756|594796220|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
164664594|NCT00996736|594796221|FG000|Overall Study|Death|1|||
164664595|NCT00996736|594796222|FG001|Overall Study|Death|1|||
164664596|NCT00996736|594796221|FG000|Overall Study|Lost to Follow-up|15|||
164664597|NCT00996736|594796222|FG001|Overall Study|Lost to Follow-up|14|||
164664598|NCT00996736|594796221|FG000|Overall Study|Visit not within 3-month window|5|||
164664599|NCT00996736|594796222|FG001|Overall Study|Visit not within 3-month window|3|||
164664600|NCT02346201|594796223|FG000|Overall Study|Adverse Event|3|||
164664601|NCT02346201|594796224|FG001|Overall Study|Adverse Event|2|||
164664602|NCT02346201|594796223|FG000|Overall Study|Lost to Follow-up|1|||
164664603|NCT02346201|594796224|FG001|Overall Study|Lost to Follow-up|0|||
164664604|NCT02346201|594796223|FG000|Overall Study|Withdrawal by Subject|6|||
164664605|NCT02346201|594796224|FG001|Overall Study|Withdrawal by Subject|3|||
164664606|NCT02346201|594796223|FG000|Overall Study|Unavailable for future follow-up|0|||
164664607|NCT02346201|594796224|FG001|Overall Study|Unavailable for future follow-up|1|||
164664608|NCT02346201|594796223|FG000|Overall Study|Physician Decision|0|||
164664609|NCT02346201|594796224|FG001|Overall Study|Physician Decision|1|||
164664610|NCT02346201|594796223|FG000|Overall Study|Missed final visit|0|||
164664611|NCT02346201|594796224|FG001|Overall Study|Missed final visit|2|||
164664612|NCT00409578|594796225|FG000|Overall Study|Adverse Event|27|||
164664613|NCT00409578|594796226|FG001|Overall Study|Adverse Event|37|||
164664614|NCT00409578|594796227|FG002|Overall Study|Adverse Event|25|||
164664615|NCT00409578|594796228|FG003|Overall Study|Adverse Event|33|||
164664616|NCT00409578|594796225|FG000|Overall Study|Abnormal laboratory value(s)|2|||
164664617|NCT00409578|594796226|FG001|Overall Study|Abnormal laboratory value(s)|2|||
164664618|NCT00409578|594796227|FG002|Overall Study|Abnormal laboratory value(s)|2|||
164664619|NCT00409578|594796228|FG003|Overall Study|Abnormal laboratory value(s)|4|||
164664620|NCT00409578|594796225|FG000|Overall Study|Lack of Efficacy|0|||
164664621|NCT00409578|594796226|FG001|Overall Study|Lack of Efficacy|0|||
164664622|NCT00409578|594796227|FG002|Overall Study|Lack of Efficacy|0|||
164664623|NCT00409578|594796228|FG003|Overall Study|Lack of Efficacy|2|||
164664624|NCT00409578|594796225|FG000|Overall Study|Subject no longer requires study drug|0|||
164664625|NCT00409578|594796226|FG001|Overall Study|Subject no longer requires study drug|0|||
164664626|NCT00409578|594796227|FG002|Overall Study|Subject no longer requires study drug|0|||
164664627|NCT00409578|594796228|FG003|Overall Study|Subject no longer requires study drug|1|||
164664628|NCT00409578|594796225|FG000|Overall Study|Withdrawal by Subject|8|||
164664629|NCT00409578|594796226|FG001|Overall Study|Withdrawal by Subject|15|||
164664630|NCT00409578|594796227|FG002|Overall Study|Withdrawal by Subject|16|||
164664631|NCT00409578|594796228|FG003|Overall Study|Withdrawal by Subject|17|||
164664632|NCT00409578|594796225|FG000|Overall Study|Lost to Follow-up|2|||
164664633|NCT00409578|594796226|FG001|Overall Study|Lost to Follow-up|0|||
164664634|NCT00409578|594796227|FG002|Overall Study|Lost to Follow-up|2|||
164664635|NCT00409578|594796228|FG003|Overall Study|Lost to Follow-up|2|||
164664636|NCT00409578|594796225|FG000|Overall Study|Administrative problems|8|||
164664637|NCT00409578|594796226|FG001|Overall Study|Administrative problems|9|||
164664638|NCT00409578|594796227|FG002|Overall Study|Administrative problems|2|||
164664639|NCT00409578|594796228|FG003|Overall Study|Administrative problems|4|||
164664640|NCT00409578|594796225|FG000|Overall Study|Death|2|||
164664641|NCT00409578|594796226|FG001|Overall Study|Death|4|||
164314872|NCT03212144|593529798|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
164420619|NCT02892409|593910952|FG000|Overall Study|Adverse Event|1|||
164664642|NCT00409578|594796227|FG002|Overall Study|Death|4|||
164664643|NCT00409578|594796228|FG003|Overall Study|Death|2|||
164664644|NCT00409578|594796225|FG000|Overall Study|Protocol Violation|3|||
164664645|NCT00409578|594796226|FG001|Overall Study|Protocol Violation|2|||
164560346|NCT03529773|594421689|FG037|Overall Study|Lost to Follow-up|3|||
164560347|NCT03529773|594421690|FG038|Overall Study|Lost to Follow-up|1|||
164314873|NCT03212144|593529799|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
164314874|NCT00899431|593529800|FG000|Overall Study|Physician Decision|1|||
164314875|NCT00899431|593529801|FG001|Overall Study|Physician Decision|0|||
164314876|NCT00899431|593529802|FG002|Overall Study|Physician Decision|0|||
164314877|NCT00661427|593529806|FG000|Overall Study|Adverse Event|5|||
164314878|NCT00661427|593529807|FG001|Overall Study|Adverse Event|5|||
164560348|NCT03529773|594421691|FG039|Overall Study|Lost to Follow-up|1|||
164560349|NCT03529773|594421652|FG000|Overall Study|No longer meets eligibility criteria|0|||
164560350|NCT03529773|594421653|FG001|Overall Study|No longer meets eligibility criteria|0|||
164560351|NCT03529773|594421654|FG002|Overall Study|No longer meets eligibility criteria|0|||
164560352|NCT03529773|594421655|FG003|Overall Study|No longer meets eligibility criteria|0|||
164560353|NCT03529773|594421656|FG004|Overall Study|No longer meets eligibility criteria|0|||
164560354|NCT03529773|594421657|FG005|Overall Study|No longer meets eligibility criteria|0|||
164560355|NCT03529773|594421658|FG006|Overall Study|No longer meets eligibility criteria|0|||
164560356|NCT03529773|594421659|FG007|Overall Study|No longer meets eligibility criteria|0|||
164560357|NCT03529773|594421660|FG008|Overall Study|No longer meets eligibility criteria|0|||
164560358|NCT03529773|594421661|FG009|Overall Study|No longer meets eligibility criteria|0|||
164560359|NCT03529773|594421662|FG010|Overall Study|No longer meets eligibility criteria|0|||
164560360|NCT03529773|594421663|FG011|Overall Study|No longer meets eligibility criteria|0|||
164560361|NCT03529773|594421664|FG012|Overall Study|No longer meets eligibility criteria|0|||
164560362|NCT03529773|594421665|FG013|Overall Study|No longer meets eligibility criteria|0|||
164560363|NCT03529773|594421666|FG014|Overall Study|No longer meets eligibility criteria|0|||
164560364|NCT03529773|594421667|FG015|Overall Study|No longer meets eligibility criteria|0|||
164560365|NCT03529773|594421668|FG016|Overall Study|No longer meets eligibility criteria|0|||
164560366|NCT03529773|594421669|FG017|Overall Study|No longer meets eligibility criteria|0|||
164560367|NCT03529773|594421670|FG018|Overall Study|No longer meets eligibility criteria|0|||
164560368|NCT03529773|594421671|FG019|Overall Study|No longer meets eligibility criteria|0|||
164560369|NCT03529773|594421672|FG020|Overall Study|No longer meets eligibility criteria|0|||
164560370|NCT03529773|594421673|FG021|Overall Study|No longer meets eligibility criteria|0|||
164560371|NCT03529773|594421674|FG022|Overall Study|No longer meets eligibility criteria|1|||
164560372|NCT03529773|594421675|FG023|Overall Study|No longer meets eligibility criteria|0|||
164560373|NCT03529773|594421676|FG024|Overall Study|No longer meets eligibility criteria|0|||
164560374|NCT03529773|594421677|FG025|Overall Study|No longer meets eligibility criteria|0|||
164560375|NCT03529773|594421678|FG026|Overall Study|No longer meets eligibility criteria|0|||
164560376|NCT03529773|594421679|FG027|Overall Study|No longer meets eligibility criteria|0|||
164560377|NCT03529773|594421680|FG028|Overall Study|No longer meets eligibility criteria|0|||
164560378|NCT03529773|594421681|FG029|Overall Study|No longer meets eligibility criteria|0|||
164560379|NCT03529773|594421682|FG030|Overall Study|No longer meets eligibility criteria|0|||
164560380|NCT03529773|594421683|FG031|Overall Study|No longer meets eligibility criteria|0|||
164560381|NCT03529773|594421684|FG032|Overall Study|No longer meets eligibility criteria|0|||
164560382|NCT03529773|594421685|FG033|Overall Study|No longer meets eligibility criteria|0|||
164560383|NCT03529773|594421686|FG034|Overall Study|No longer meets eligibility criteria|0|||
164560384|NCT03529773|594421687|FG035|Overall Study|No longer meets eligibility criteria|0|||
164560385|NCT03529773|594421688|FG036|Overall Study|No longer meets eligibility criteria|0|||
164560386|NCT03529773|594421689|FG037|Overall Study|No longer meets eligibility criteria|0|||
164560387|NCT03529773|594421690|FG038|Overall Study|No longer meets eligibility criteria|1|||
164560388|NCT03529773|594421691|FG039|Overall Study|No longer meets eligibility criteria|0|||
164560389|NCT03529773|594421652|FG000|Overall Study|Other|0|||
164560390|NCT03529773|594421653|FG001|Overall Study|Other|0|||
164560391|NCT03529773|594421654|FG002|Overall Study|Other|0|||
164560392|NCT03529773|594421655|FG003|Overall Study|Other|0|||
164560393|NCT03529773|594421656|FG004|Overall Study|Other|0|||
164560394|NCT03529773|594421657|FG005|Overall Study|Other|0|||
164560395|NCT03529773|594421658|FG006|Overall Study|Other|0|||
164560396|NCT03529773|594421659|FG007|Overall Study|Other|0|||
164560397|NCT03529773|594421660|FG008|Overall Study|Other|0|||
164560398|NCT03529773|594421661|FG009|Overall Study|Other|0|||
164560399|NCT03529773|594421662|FG010|Overall Study|Other|0|||
164560400|NCT03529773|594421663|FG011|Overall Study|Other|0|||
164560401|NCT03529773|594421664|FG012|Overall Study|Other|1|||
164560402|NCT03529773|594421665|FG013|Overall Study|Other|0|||
164560403|NCT03529773|594421666|FG014|Overall Study|Other|2|||
164664646|NCT00409578|594796227|FG002|Overall Study|Protocol Violation|3|||
164664647|NCT00409578|594796228|FG003|Overall Study|Protocol Violation|1|||
164664648|NCT00409578|594796225|FG000|Overall Study|Missing|0|||
164314879|NCT00661427|593529806|FG000|Overall Study|Patient not treated|0|||
164314880|NCT00661427|593529807|FG001|Overall Study|Patient not treated|2|||
164664649|NCT00409578|594796226|FG001|Overall Study|Missing|1|||
164664650|NCT00409578|594796227|FG002|Overall Study|Missing|0|||
164664651|NCT00409578|594796228|FG003|Overall Study|Missing|1|||
164664652|NCT05200858|594796229|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
164664653|NCT05200858|594796230|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
164664654|NCT05200858|594796231|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
164664655|NCT05200858|594796232|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
164664656|NCT02109133|594796233|FG000|Overall Study|Lost to Follow-up|1|||
164664657|NCT02109133|594796234|FG001|Overall Study|Lost to Follow-up|0|||
164664658|NCT02448771|594796237|FG000|Overall Study|Disease Progression|30|||
164664659|NCT02448771|594796237|FG000|Overall Study|Unacceptable Toxicity|1|||
164664660|NCT02448771|594796237|FG000|Overall Study|Physician Decision|3|||
164664661|NCT02448771|594796237|FG000|Overall Study|Started new therapy|2|||
164664662|NCT00770315|594796239|FG000|Overall Study|Adverse Event|11|||
164664663|NCT00770315|594796240|FG001|Overall Study|Adverse Event|17|||
164664664|NCT00770315|594796241|FG002|Overall Study|Adverse Event|16|||
164664665|NCT00770315|594796242|FG003|Overall Study|Adverse Event|6|||
164664666|NCT00770315|594796239|FG000|Overall Study|Lost to Follow-up|9|||
164664667|NCT00770315|594796240|FG001|Overall Study|Lost to Follow-up|5|||
164664668|NCT00770315|594796241|FG002|Overall Study|Lost to Follow-up|10|||
164664669|NCT00770315|594796242|FG003|Overall Study|Lost to Follow-up|3|||
164664670|NCT00770315|594796239|FG000|Overall Study|Withdrawal by Subject|13|||
164664671|NCT00770315|594796240|FG001|Overall Study|Withdrawal by Subject|17|||
164664672|NCT00770315|594796241|FG002|Overall Study|Withdrawal by Subject|24|||
164664673|NCT00770315|594796242|FG003|Overall Study|Withdrawal by Subject|20|||
164664674|NCT00770315|594796239|FG000|Overall Study|Noncompliance with Protocol|7|||
164664675|NCT00770315|594796240|FG001|Overall Study|Noncompliance with Protocol|4|||
164664676|NCT00770315|594796241|FG002|Overall Study|Noncompliance with Protocol|7|||
164664677|NCT00770315|594796242|FG003|Overall Study|Noncompliance with Protocol|9|||
164664678|NCT05771428|594797985|FG000|Overall Study|Adverse Event|0|||
164664679|NCT05771428|594797986|FG001|Overall Study|Adverse Event|1|||
164664680|NCT05771428|594797987|FG002|Overall Study|Adverse Event|1|||
164664681|NCT05771428|594797988|FG003|Overall Study|Adverse Event|1|||
164664682|NCT05771428|594797985|FG000|Overall Study|Withdrawal by Subject|3|||
164664683|NCT05771428|594797986|FG001|Overall Study|Withdrawal by Subject|2|||
164664684|NCT05771428|594797987|FG002|Overall Study|Withdrawal by Subject|1|||
164664685|NCT05771428|594797988|FG003|Overall Study|Withdrawal by Subject|4|||
164664686|NCT05771428|594797985|FG000|Overall Study|Other|0|||
164664687|NCT05771428|594797986|FG001|Overall Study|Other|1|||
164664688|NCT05771428|594797987|FG002|Overall Study|Other|2|||
164664689|NCT05771428|594797988|FG003|Overall Study|Other|1|||
164664690|NCT05771428|594797985|FG000|Overall Study|Randomized but Not Treated|0|||
164664691|NCT05771428|594797986|FG001|Overall Study|Randomized but Not Treated|0|||
164664692|NCT05771428|594797987|FG002|Overall Study|Randomized but Not Treated|1|||
164664693|NCT05771428|594797988|FG003|Overall Study|Randomized but Not Treated|0|||
164664694|NCT04025229|594797989|FG000|Overall Study|Adverse Event|1|||
164664695|NCT04025229|594797990|FG001|Overall Study|Adverse Event|0|||
164664696|NCT04025229|594797989|FG000|Overall Study|Withdrawal by Subject|0|||
164664697|NCT04025229|594797990|FG001|Overall Study|Withdrawal by Subject|2|||
164664698|NCT04025229|594797989|FG000|Overall Study|Death|0|||
164664699|NCT04025229|594797990|FG001|Overall Study|Death|1|||
164664700|NCT04025229|594797989|FG000|Overall Study|Physician Decision|0|||
164664701|NCT04025229|594797990|FG001|Overall Study|Physician Decision|1|||
164664702|NCT03815942|594797991|FG000|Overall Study|Withdrawal by Subject|0|||
164664703|NCT03815942|594797992|FG001|Overall Study|Withdrawal by Subject|17|||
164664704|NCT02841709|594797993|FG000|5th Intervention|Adverse Event|2|||
164664705|NCT02841709|594797994|FG001|5th Intervention|Adverse Event|0|||
164664706|NCT02841709|594797995|FG002|5th Intervention|Adverse Event|0|||
164664707|NCT02841709|594797996|FG003|5th Intervention|Adverse Event|0|||
164664708|NCT02841709|594797997|FG004|5th Intervention|Adverse Event|2|||
164664709|NCT01374919|594798001|FG000|Overall Study|Withdrawal by Subject|2|||
164664710|NCT00366899|594798002|FG000|Infant Series|Withdrawal by Subject|4|||
164664711|NCT00366899|594798003|FG001|Infant Series|Withdrawal by Subject|7|||
164664712|NCT00366899|594798002|FG000|Infant Series|Protocol Violation|2|||
164664713|NCT00366899|594798003|FG001|Infant Series|Protocol Violation|1|||
164302994|NCT04323124|593484688|FG002|Overall Study|Adverse Event|0|||
164664714|NCT00366899|594798002|FG000|Infant Series|Failed to return|1|||
164664715|NCT00366899|594798003|FG001|Infant Series|Failed to return|1|||
164664716|NCT00366899|594798002|FG000|Infant Series|Lost to Follow-up|0|||
164664717|NCT00366899|594798003|FG001|Infant Series|Lost to Follow-up|2|||
164664718|NCT00366899|594798002|FG000|Infant Series|Adverse Event|0|||
164664719|NCT00366899|594798003|FG001|Infant Series|Adverse Event|1|||
164664720|NCT00366899|594798002|FG000|Infant Series|Physician Decision|1|||
164664721|NCT00366899|594798003|FG001|Infant Series|Physician Decision|0|||
164664722|NCT00366899|594798002|FG000|Infant Series|Randomized but not consented|1|||
164664723|NCT00366899|594798003|FG001|Infant Series|Randomized but not consented|0|||
164664724|NCT00366899|594798002|FG000|After Infant Series|Lost to Follow-up|4|||
164664725|NCT00366899|594798003|FG001|After Infant Series|Lost to Follow-up|3|||
164664726|NCT00366899|594798002|FG000|After Infant Series|Withdrawal by Subject|1|||
164664727|NCT00366899|594798003|FG001|After Infant Series|Withdrawal by Subject|4|||
164664728|NCT00366899|594798002|FG000|After Infant Series|Adverse Event|1|||
164664729|NCT00366899|594798003|FG001|After Infant Series|Adverse Event|2|||
164664730|NCT00366899|594798002|FG000|After Infant Series|Protocol Violation|1|||
164664731|NCT00366899|594798003|FG001|After Infant Series|Protocol Violation|0|||
164664732|NCT00366899|594798002|FG000|Toddler Dose|Withdrawal by Subject|1|||
164664733|NCT00366899|594798003|FG001|Toddler Dose|Withdrawal by Subject|1|||
164664734|NCT00366899|594798002|FG000|Toddler Dose|Protocol Violation|1|||
164664735|NCT00366899|594798003|FG001|Toddler Dose|Protocol Violation|0|||
164664736|NCT04526210|594798004|FG000|Overall Study|Sponsor decision|7|||
164664737|NCT04526210|594798005|FG001|Overall Study|Sponsor decision|5|||
164664738|NCT04526210|594798004|FG000|Overall Study|Withdrawal by Subject|3|||
164664739|NCT04526210|594798005|FG001|Overall Study|Withdrawal by Subject|2|||
164664740|NCT02999178|594798006|FG000|Overall Study|Adverse Event|85|||
164664741|NCT02999178|594798007|FG001|Overall Study|Adverse Event|62|||
164664742|NCT02999178|594798006|FG000|Overall Study|Protocol Violation|1|||
164664743|NCT02999178|594798007|FG001|Overall Study|Protocol Violation|2|||
164664744|NCT02999178|594798006|FG000|Overall Study|Lost to Follow-up|0|||
164664745|NCT02999178|594798007|FG001|Overall Study|Lost to Follow-up|2|||
164664746|NCT02999178|594798006|FG000|Overall Study|Withdrawal by Subject|21|||
164664747|NCT02999178|594798007|FG001|Overall Study|Withdrawal by Subject|21|||
164664748|NCT02999178|594798006|FG000|Overall Study|Other reason not defined above|7|||
164664749|NCT02999178|594798007|FG001|Overall Study|Other reason not defined above|13|||
164664750|NCT05097326|594798009|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
164664751|NCT05097326|594798010|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
164664752|NCT01244126|594798011|FG000|Overall Study|Protocol Violation|3|||
164664753|NCT01244126|594798012|FG001|Overall Study|Protocol Violation|3|||
164664754|NCT01244126|594798013|FG002|Overall Study|Protocol Violation|9|||
164664755|NCT03311646|594798020|FG000|Overall Study|Physician Decision|1|||
164664756|NCT03311646|594798020|FG000|Overall Study|Withdrawal by Subject|5|||
164204117|NCT04006457|593119161|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
164299681|NCT00551642|593472891|FG000|Treatment Period|Withdrawal by Subject|2|||
164560404|NCT03529773|594421667|FG015|Overall Study|Other|0|||
164560405|NCT03529773|594421668|FG016|Overall Study|Other|0|||
164560406|NCT03529773|594421669|FG017|Overall Study|Other|3|||
164560407|NCT03529773|594421670|FG018|Overall Study|Other|0|||
164560408|NCT03529773|594421671|FG019|Overall Study|Other|0|||
164560409|NCT03529773|594421672|FG020|Overall Study|Other|1|||
164560410|NCT03529773|594421673|FG021|Overall Study|Other|0|||
164560411|NCT03529773|594421674|FG022|Overall Study|Other|1|||
164560412|NCT03529773|594421675|FG023|Overall Study|Other|0|||
164560413|NCT03529773|594421676|FG024|Overall Study|Other|3|||
164560414|NCT03529773|594421677|FG025|Overall Study|Other|2|||
164560415|NCT03529773|594421678|FG026|Overall Study|Other|2|||
164560416|NCT03529773|594421679|FG027|Overall Study|Other|0|||
164560417|NCT03529773|594421680|FG028|Overall Study|Other|0|||
164560418|NCT03529773|594421681|FG029|Overall Study|Other|0|||
164560419|NCT03529773|594421682|FG030|Overall Study|Other|0|||
164560420|NCT03529773|594421683|FG031|Overall Study|Other|0|||
164560421|NCT03529773|594421684|FG032|Overall Study|Other|0|||
164560422|NCT03529773|594421685|FG033|Overall Study|Other|0|||
164560423|NCT03529773|594421686|FG034|Overall Study|Other|1|||
164560424|NCT03529773|594421687|FG035|Overall Study|Other|1|||
164560425|NCT03529773|594421688|FG036|Overall Study|Other|0|||
164560426|NCT03529773|594421689|FG037|Overall Study|Other|0|||
164560427|NCT03529773|594421690|FG038|Overall Study|Other|0|||
164560428|NCT03529773|594421691|FG039|Overall Study|Other|0|||
164560429|NCT03529773|594421652|FG000|Overall Study|Physician Decision|0|||
164560430|NCT03529773|594421653|FG001|Overall Study|Physician Decision|0|||
164560431|NCT03529773|594421654|FG002|Overall Study|Physician Decision|0|||
164560432|NCT03529773|594421655|FG003|Overall Study|Physician Decision|0|||
164560433|NCT03529773|594421656|FG004|Overall Study|Physician Decision|0|||
164560434|NCT03529773|594421657|FG005|Overall Study|Physician Decision|0|||
164560435|NCT03529773|594421658|FG006|Overall Study|Physician Decision|0|||
164560436|NCT03529773|594421659|FG007|Overall Study|Physician Decision|0|||
164560437|NCT03529773|594421660|FG008|Overall Study|Physician Decision|0|||
164560438|NCT03529773|594421661|FG009|Overall Study|Physician Decision|0|||
164560439|NCT03529773|594421662|FG010|Overall Study|Physician Decision|0|||
164560440|NCT03529773|594421663|FG011|Overall Study|Physician Decision|0|||
164560441|NCT03529773|594421664|FG012|Overall Study|Physician Decision|0|||
164664757|NCT03311646|594798020|FG000|Overall Study|Lost to Follow-up|5|||
164664758|NCT03311646|594798020|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
164664759|NCT00531206|594798023|FG000|Overall Study|Adverse Event related|5|||
164664760|NCT00531206|594798023|FG000|Overall Study|Lack of Efficacy|2|||
164664761|NCT00531206|594798023|FG000|Overall Study|Lost to Follow-up|5|||
164664762|NCT00531206|594798023|FG000|Overall Study|including non-related adverse events|8|||
164664763|NCT01439165|594798034|FG000|Overall Study|Protocol Violation|3|||
164560442|NCT03529773|594421665|FG013|Overall Study|Physician Decision|0|||
164560443|NCT03529773|594421666|FG014|Overall Study|Physician Decision|0|||
164560444|NCT03529773|594421667|FG015|Overall Study|Physician Decision|0|||
164560445|NCT03529773|594421668|FG016|Overall Study|Physician Decision|0|||
164560446|NCT03529773|594421669|FG017|Overall Study|Physician Decision|0|||
164560447|NCT03529773|594421670|FG018|Overall Study|Physician Decision|0|||
164560448|NCT03529773|594421671|FG019|Overall Study|Physician Decision|1|||
164560449|NCT03529773|594421672|FG020|Overall Study|Physician Decision|1|||
164560450|NCT03529773|594421673|FG021|Overall Study|Physician Decision|0|||
164560451|NCT03529773|594421674|FG022|Overall Study|Physician Decision|0|||
164560452|NCT03529773|594421675|FG023|Overall Study|Physician Decision|0|||
164560453|NCT03529773|594421676|FG024|Overall Study|Physician Decision|0|||
164560454|NCT03529773|594421677|FG025|Overall Study|Physician Decision|0|||
164560455|NCT03529773|594421678|FG026|Overall Study|Physician Decision|0|||
164560456|NCT03529773|594421679|FG027|Overall Study|Physician Decision|0|||
164560457|NCT03529773|594421680|FG028|Overall Study|Physician Decision|0|||
164560458|NCT03529773|594421681|FG029|Overall Study|Physician Decision|0|||
164560459|NCT03529773|594421682|FG030|Overall Study|Physician Decision|0|||
164560460|NCT03529773|594421683|FG031|Overall Study|Physician Decision|0|||
164560461|NCT03529773|594421684|FG032|Overall Study|Physician Decision|0|||
164560462|NCT03529773|594421685|FG033|Overall Study|Physician Decision|0|||
164560463|NCT03529773|594421686|FG034|Overall Study|Physician Decision|0|||
164560464|NCT03529773|594421687|FG035|Overall Study|Physician Decision|0|||
164560465|NCT03529773|594421688|FG036|Overall Study|Physician Decision|0|||
164560466|NCT03529773|594421689|FG037|Overall Study|Physician Decision|0|||
164560467|NCT03529773|594421690|FG038|Overall Study|Physician Decision|0|||
164560468|NCT03529773|594421691|FG039|Overall Study|Physician Decision|0|||
164560469|NCT03529773|594421652|FG000|Overall Study|Protocol Violation|0|||
164560470|NCT03529773|594421653|FG001|Overall Study|Protocol Violation|0|||
164560471|NCT03529773|594421654|FG002|Overall Study|Protocol Violation|0|||
164560472|NCT03529773|594421655|FG003|Overall Study|Protocol Violation|0|||
164560473|NCT03529773|594421656|FG004|Overall Study|Protocol Violation|0|||
164560474|NCT03529773|594421657|FG005|Overall Study|Protocol Violation|0|||
164560475|NCT03529773|594421658|FG006|Overall Study|Protocol Violation|0|||
164560476|NCT03529773|594421659|FG007|Overall Study|Protocol Violation|0|||
164560477|NCT03529773|594421660|FG008|Overall Study|Protocol Violation|0|||
164560478|NCT03529773|594421661|FG009|Overall Study|Protocol Violation|0|||
164560479|NCT03529773|594421662|FG010|Overall Study|Protocol Violation|0|||
164560480|NCT03529773|594421663|FG011|Overall Study|Protocol Violation|0|||
164560481|NCT03529773|594421664|FG012|Overall Study|Protocol Violation|0|||
164560482|NCT03529773|594421665|FG013|Overall Study|Protocol Violation|0|||
164560483|NCT03529773|594421666|FG014|Overall Study|Protocol Violation|0|||
164560484|NCT03529773|594421667|FG015|Overall Study|Protocol Violation|0|||
164560485|NCT03529773|594421668|FG016|Overall Study|Protocol Violation|0|||
164560486|NCT03529773|594421669|FG017|Overall Study|Protocol Violation|0|||
164560487|NCT03529773|594421670|FG018|Overall Study|Protocol Violation|0|||
164560488|NCT03529773|594421671|FG019|Overall Study|Protocol Violation|0|||
164560489|NCT03529773|594421672|FG020|Overall Study|Protocol Violation|0|||
164560490|NCT03529773|594421673|FG021|Overall Study|Protocol Violation|0|||
164560491|NCT03529773|594421674|FG022|Overall Study|Protocol Violation|0|||
164560492|NCT03529773|594421675|FG023|Overall Study|Protocol Violation|0|||
164560493|NCT03529773|594421676|FG024|Overall Study|Protocol Violation|0|||
164560494|NCT03529773|594421677|FG025|Overall Study|Protocol Violation|0|||
164560495|NCT03529773|594421678|FG026|Overall Study|Protocol Violation|0|||
164560496|NCT03529773|594421679|FG027|Overall Study|Protocol Violation|0|||
164560497|NCT03529773|594421680|FG028|Overall Study|Protocol Violation|0|||
164560498|NCT03529773|594421681|FG029|Overall Study|Protocol Violation|0|||
164560499|NCT03529773|594421682|FG030|Overall Study|Protocol Violation|1|||
164560500|NCT03529773|594421683|FG031|Overall Study|Protocol Violation|0|||
164560501|NCT03529773|594421684|FG032|Overall Study|Protocol Violation|0|||
164560502|NCT03529773|594421685|FG033|Overall Study|Protocol Violation|0|||
164560503|NCT03529773|594421686|FG034|Overall Study|Protocol Violation|0|||
164560504|NCT03529773|594421687|FG035|Overall Study|Protocol Violation|0|||
164560505|NCT03529773|594421688|FG036|Overall Study|Protocol Violation|0|||
164560506|NCT03529773|594421689|FG037|Overall Study|Protocol Violation|0|||
164560507|NCT03529773|594421690|FG038|Overall Study|Protocol Violation|0|||
164560508|NCT03529773|594421691|FG039|Overall Study|Protocol Violation|0|||
164560509|NCT03529773|594421652|FG000|Overall Study|Withdrawal by Subject|0|||
164560510|NCT03529773|594421653|FG001|Overall Study|Withdrawal by Subject|0|||
164560511|NCT03529773|594421654|FG002|Overall Study|Withdrawal by Subject|0|||
164560512|NCT03529773|594421655|FG003|Overall Study|Withdrawal by Subject|0|||
164560513|NCT03529773|594421656|FG004|Overall Study|Withdrawal by Subject|0|||
164560514|NCT03529773|594421657|FG005|Overall Study|Withdrawal by Subject|0|||
164560515|NCT03529773|594421658|FG006|Overall Study|Withdrawal by Subject|0|||
164560516|NCT03529773|594421659|FG007|Overall Study|Withdrawal by Subject|1|||
164560517|NCT03529773|594421660|FG008|Overall Study|Withdrawal by Subject|0|||
164664764|NCT01439165|594798035|FG001|Overall Study|Protocol Violation|0|||
164560518|NCT03529773|594421661|FG009|Overall Study|Withdrawal by Subject|1|||
164560519|NCT03529773|594421662|FG010|Overall Study|Withdrawal by Subject|1|||
164560520|NCT03529773|594421663|FG011|Overall Study|Withdrawal by Subject|0|||
164560521|NCT03529773|594421664|FG012|Overall Study|Withdrawal by Subject|0|||
164560522|NCT03529773|594421665|FG013|Overall Study|Withdrawal by Subject|0|||
164560523|NCT03529773|594421666|FG014|Overall Study|Withdrawal by Subject|0|||
164664765|NCT01439165|594798034|FG000|Overall Study|Lost to Follow-up|11|||
164314881|NCT01821560|593529808|FG000|Overall Study|Lost to Follow-up|5|||
164314882|NCT01821560|593529809|FG001|Overall Study|Lost to Follow-up|5|||
164314883|NCT01821560|593529808|FG000|Overall Study|Withdrawal by Subject|1|||
164314884|NCT01821560|593529809|FG001|Overall Study|Withdrawal by Subject|1|||
164560524|NCT03529773|594421667|FG015|Overall Study|Withdrawal by Subject|3|||
164560525|NCT03529773|594421668|FG016|Overall Study|Withdrawal by Subject|0|||
164560526|NCT03529773|594421669|FG017|Overall Study|Withdrawal by Subject|2|||
164560527|NCT03529773|594421670|FG018|Overall Study|Withdrawal by Subject|3|||
164560528|NCT03529773|594421671|FG019|Overall Study|Withdrawal by Subject|1|||
164560529|NCT03529773|594421672|FG020|Overall Study|Withdrawal by Subject|3|||
164560530|NCT03529773|594421673|FG021|Overall Study|Withdrawal by Subject|1|||
164560531|NCT03529773|594421674|FG022|Overall Study|Withdrawal by Subject|1|||
164560532|NCT03529773|594421675|FG023|Overall Study|Withdrawal by Subject|2|||
164560533|NCT03529773|594421676|FG024|Overall Study|Withdrawal by Subject|2|||
164560534|NCT03529773|594421677|FG025|Overall Study|Withdrawal by Subject|4|||
164560535|NCT03529773|594421678|FG026|Overall Study|Withdrawal by Subject|2|||
164560536|NCT03529773|594421679|FG027|Overall Study|Withdrawal by Subject|1|||
164560537|NCT03529773|594421680|FG028|Overall Study|Withdrawal by Subject|1|||
164560538|NCT03529773|594421681|FG029|Overall Study|Withdrawal by Subject|0|||
164560539|NCT03529773|594421682|FG030|Overall Study|Withdrawal by Subject|0|||
164560540|NCT03529773|594421683|FG031|Overall Study|Withdrawal by Subject|0|||
164560541|NCT03529773|594421684|FG032|Overall Study|Withdrawal by Subject|0|||
164560542|NCT03529773|594421685|FG033|Overall Study|Withdrawal by Subject|0|||
164560543|NCT03529773|594421686|FG034|Overall Study|Withdrawal by Subject|1|||
164560544|NCT03529773|594421687|FG035|Overall Study|Withdrawal by Subject|2|||
164560545|NCT03529773|594421688|FG036|Overall Study|Withdrawal by Subject|0|||
164560546|NCT03529773|594421689|FG037|Overall Study|Withdrawal by Subject|2|||
164560547|NCT03529773|594421690|FG038|Overall Study|Withdrawal by Subject|1|||
164560548|NCT03529773|594421691|FG039|Overall Study|Withdrawal by Subject|1|||
164560549|NCT03529773|594421652|FG000|Overall Study|Screen Failure|0|||
164560550|NCT03529773|594421653|FG001|Overall Study|Screen Failure|0|||
164560551|NCT03529773|594421654|FG002|Overall Study|Screen Failure|0|||
164560552|NCT03529773|594421655|FG003|Overall Study|Screen Failure|0|||
164560553|NCT03529773|594421656|FG004|Overall Study|Screen Failure|0|||
164560554|NCT03529773|594421657|FG005|Overall Study|Screen Failure|0|||
164560555|NCT03529773|594421658|FG006|Overall Study|Screen Failure|0|||
164560556|NCT03529773|594421659|FG007|Overall Study|Screen Failure|0|||
164560557|NCT03529773|594421660|FG008|Overall Study|Screen Failure|0|||
164560558|NCT03529773|594421661|FG009|Overall Study|Screen Failure|0|||
164560559|NCT03529773|594421662|FG010|Overall Study|Screen Failure|0|||
164560560|NCT03529773|594421663|FG011|Overall Study|Screen Failure|0|||
164560561|NCT03529773|594421664|FG012|Overall Study|Screen Failure|0|||
164560562|NCT03529773|594421665|FG013|Overall Study|Screen Failure|0|||
164560563|NCT03529773|594421666|FG014|Overall Study|Screen Failure|0|||
164560564|NCT03529773|594421667|FG015|Overall Study|Screen Failure|0|||
164560565|NCT03529773|594421668|FG016|Overall Study|Screen Failure|0|||
164560566|NCT03529773|594421669|FG017|Overall Study|Screen Failure|0|||
164560567|NCT03529773|594421670|FG018|Overall Study|Screen Failure|0|||
164560568|NCT03529773|594421671|FG019|Overall Study|Screen Failure|0|||
164560569|NCT03529773|594421672|FG020|Overall Study|Screen Failure|0|||
164560570|NCT03529773|594421673|FG021|Overall Study|Screen Failure|0|||
164560571|NCT03529773|594421674|FG022|Overall Study|Screen Failure|0|||
164560572|NCT03529773|594421675|FG023|Overall Study|Screen Failure|0|||
164560573|NCT03529773|594421676|FG024|Overall Study|Screen Failure|0|||
164560574|NCT03529773|594421677|FG025|Overall Study|Screen Failure|0|||
164560575|NCT03529773|594421678|FG026|Overall Study|Screen Failure|0|||
164560576|NCT03529773|594421679|FG027|Overall Study|Screen Failure|0|||
164560577|NCT03529773|594421680|FG028|Overall Study|Screen Failure|0|||
164560578|NCT03529773|594421681|FG029|Overall Study|Screen Failure|0|||
164560579|NCT03529773|594421682|FG030|Overall Study|Screen Failure|0|||
164560580|NCT03529773|594421683|FG031|Overall Study|Screen Failure|0|||
164560581|NCT03529773|594421684|FG032|Overall Study|Screen Failure|0|||
164560582|NCT03529773|594421685|FG033|Overall Study|Screen Failure|0|||
164560583|NCT03529773|594421686|FG034|Overall Study|Screen Failure|0|||
164560584|NCT03529773|594421687|FG035|Overall Study|Screen Failure|0|||
164560585|NCT03529773|594421688|FG036|Overall Study|Screen Failure|1|||
164664766|NCT01439165|594798035|FG001|Overall Study|Lost to Follow-up|1|||
164664767|NCT01439165|594798034|FG000|Overall Study|Withdrawal by Subject|7|||
164314885|NCT01821560|593529808|FG000|Overall Study|Protocol Violation|0|||
164560586|NCT03529773|594421689|FG037|Overall Study|Screen Failure|1|||
164560587|NCT03529773|594421690|FG038|Overall Study|Screen Failure|0|||
164560588|NCT03529773|594421691|FG039|Overall Study|Screen Failure|1|||
164560589|NCT03529773|594421652|FG000|Overall Study|Randomized but not vaccinated|0|||
164560590|NCT03529773|594421653|FG001|Overall Study|Randomized but not vaccinated|0|||
164560591|NCT03529773|594421654|FG002|Overall Study|Randomized but not vaccinated|0|||
164314886|NCT01821560|593529809|FG001|Overall Study|Protocol Violation|1|||
164560592|NCT03529773|594421655|FG003|Overall Study|Randomized but not vaccinated|0|||
164314887|NCT01338298|593529810|FG000|Overall Study|Withdrawal by Subject|1|||
164314888|NCT01338298|593529811|FG001|Overall Study|Withdrawal by Subject|1|||
164314889|NCT01338298|593529810|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
164314890|NCT01338298|593529811|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
164314891|NCT01338298|593529810|FG000|Overall Study|Administrative error|0|||
164314892|NCT01338298|593529811|FG001|Overall Study|Administrative error|1|||
164560593|NCT03529773|594421656|FG004|Overall Study|Randomized but not vaccinated|0|||
164560594|NCT03529773|594421657|FG005|Overall Study|Randomized but not vaccinated|0|||
164560595|NCT03529773|594421658|FG006|Overall Study|Randomized but not vaccinated|0|||
164560596|NCT03529773|594421659|FG007|Overall Study|Randomized but not vaccinated|0|||
164560597|NCT03529773|594421660|FG008|Overall Study|Randomized but not vaccinated|0|||
164560598|NCT03529773|594421661|FG009|Overall Study|Randomized but not vaccinated|0|||
164560599|NCT03529773|594421662|FG010|Overall Study|Randomized but not vaccinated|0|||
164560600|NCT03529773|594421663|FG011|Overall Study|Randomized but not vaccinated|0|||
164560601|NCT03529773|594421664|FG012|Overall Study|Randomized but not vaccinated|0|||
164560602|NCT03529773|594421665|FG013|Overall Study|Randomized but not vaccinated|0|||
164560603|NCT03529773|594421666|FG014|Overall Study|Randomized but not vaccinated|0|||
164560604|NCT03529773|594421667|FG015|Overall Study|Randomized but not vaccinated|0|||
164560605|NCT03529773|594421668|FG016|Overall Study|Randomized but not vaccinated|0|||
164560606|NCT03529773|594421669|FG017|Overall Study|Randomized but not vaccinated|1|||
164560607|NCT03529773|594421670|FG018|Overall Study|Randomized but not vaccinated|0|||
164560608|NCT03529773|594421671|FG019|Overall Study|Randomized but not vaccinated|0|||
164560609|NCT03529773|594421672|FG020|Overall Study|Randomized but not vaccinated|0|||
164560610|NCT03529773|594421673|FG021|Overall Study|Randomized but not vaccinated|0|||
164560611|NCT03529773|594421674|FG022|Overall Study|Randomized but not vaccinated|0|||
164560612|NCT03529773|594421675|FG023|Overall Study|Randomized but not vaccinated|0|||
164560613|NCT03529773|594421676|FG024|Overall Study|Randomized but not vaccinated|0|||
164560614|NCT03529773|594421677|FG025|Overall Study|Randomized but not vaccinated|0|||
164560615|NCT03529773|594421678|FG026|Overall Study|Randomized but not vaccinated|0|||
164560616|NCT03529773|594421679|FG027|Overall Study|Randomized but not vaccinated|1|||
164560617|NCT03529773|594421680|FG028|Overall Study|Randomized but not vaccinated|0|||
164560618|NCT03529773|594421681|FG029|Overall Study|Randomized but not vaccinated|0|||
164560619|NCT03529773|594421682|FG030|Overall Study|Randomized but not vaccinated|0|||
164560620|NCT03529773|594421683|FG031|Overall Study|Randomized but not vaccinated|0|||
164560621|NCT03529773|594421684|FG032|Overall Study|Randomized but not vaccinated|0|||
164560622|NCT03529773|594421685|FG033|Overall Study|Randomized but not vaccinated|0|||
164560623|NCT03529773|594421686|FG034|Overall Study|Randomized but not vaccinated|0|||
164560624|NCT03529773|594421687|FG035|Overall Study|Randomized but not vaccinated|0|||
164560625|NCT03529773|594421688|FG036|Overall Study|Randomized but not vaccinated|0|||
164560626|NCT03529773|594421689|FG037|Overall Study|Randomized but not vaccinated|0|||
164560627|NCT03529773|594421690|FG038|Overall Study|Randomized but not vaccinated|0|||
164560628|NCT03529773|594421691|FG039|Overall Study|Randomized but not vaccinated|0|||
164560629|NCT01496066|594421693|FG000|Overall Study|Lost to Follow-up|8|||
164560630|NCT01496066|594421694|FG001|Overall Study|Lost to Follow-up|5|||
164560631|NCT01496066|594421693|FG000|Overall Study|Explant|3|||
164560632|NCT01496066|594421694|FG001|Overall Study|Explant|0|||
164560633|NCT01496066|594421693|FG000|Overall Study|Death|1|||
164560634|NCT01496066|594421694|FG001|Overall Study|Death|4|||
164560635|NCT00253630|594421695|FG000|Overall Study|ineligible|2|||
164560636|NCT03237065|594421696|FG000|Overall Study|Adverse Event|0|||
164560637|NCT03237065|594421697|FG001|Overall Study|Adverse Event|2|||
164560638|NCT03237065|594421696|FG000|Overall Study|Protocol Violation|0|||
164560639|NCT03237065|594421697|FG001|Overall Study|Protocol Violation|1|||
164560640|NCT03237065|594421696|FG000|Overall Study|Withdrawal by Subject|3|||
164560641|NCT03237065|594421697|FG001|Overall Study|Withdrawal by Subject|0|||
164560642|NCT03237065|594421696|FG000|Overall Study|Lost to Follow-up|1|||
164560643|NCT03237065|594421697|FG001|Overall Study|Lost to Follow-up|0|||
164560644|NCT03237065|594421696|FG000|Overall Study|Unable to obtain venous access|0|||
164664768|NCT01439165|594798035|FG001|Overall Study|Withdrawal by Subject|1|||
164314893|NCT01338298|593529810|FG000|Overall Study|Positive symptom worsening|1|||
164314894|NCT01338298|593529811|FG001|Overall Study|Positive symptom worsening|0|||
164314895|NCT01338298|593529810|FG000|Overall Study|Depressive symptoms and nausea|1|||
164314896|NCT01338298|593529811|FG001|Overall Study|Depressive symptoms and nausea|0|||
164560645|NCT03237065|594421697|FG001|Overall Study|Unable to obtain venous access|1|||
164560646|NCT00209339|594421698|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
164560647|NCT00209339|594421698|FG000|At 12 Months Follow-up|Death|1|||
164560648|NCT00209339|594421698|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
164560649|NCT00209339|594421698|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
164560650|NCT00209339|594421698|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
164560651|NCT00209339|594421698|FG000|At 24 Months Follow-up|Death|1|||
164560652|NCT00209339|594421698|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
164560653|NCT00209339|594421698|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
164560654|NCT00209339|594421698|FG000|At 4 Years Follow-up|Death|1|||
164314897|NCT01338298|593529810|FG000|Overall Study|Non-adherence|1|||
164314898|NCT01338298|593529811|FG001|Overall Study|Non-adherence|0|||
164314899|NCT02872285|593529812|FG000|Overall Study|Withdrawal by Subject|2|||
164314900|NCT02872285|593529813|FG001|Overall Study|Withdrawal by Subject|0|||
164314901|NCT02872285|593529812|FG000|Overall Study|Lost to Follow-up|2|||
164560655|NCT00209339|594421698|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
164560656|NCT00209339|594421698|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
164560657|NCT00209339|594421698|FG000|At 5 Years Follow-up|Death|1|||
164560658|NCT01239160|594421699|FG000|Overall Study|Lost to Follow-up|3|||
164560659|NCT01239160|594421700|FG001|Overall Study|Lost to Follow-up|5|||
164560660|NCT01239160|594421701|FG002|Overall Study|Lost to Follow-up|0|||
164560661|NCT01239160|594421699|FG000|Overall Study|Withdrawal by Subject|17|||
164560662|NCT01239160|594421700|FG001|Overall Study|Withdrawal by Subject|6|||
164560663|NCT01239160|594421701|FG002|Overall Study|Withdrawal by Subject|2|||
164560664|NCT01239160|594421699|FG000|Overall Study|Physician Decision|5|||
164560665|NCT01239160|594421700|FG001|Overall Study|Physician Decision|7|||
164560666|NCT01239160|594421701|FG002|Overall Study|Physician Decision|2|||
164560667|NCT01239160|594421699|FG000|Overall Study|Early Termination Due to Study Closure|0|||
164560668|NCT01239160|594421700|FG001|Overall Study|Early Termination Due to Study Closure|1|||
164560669|NCT01239160|594421701|FG002|Overall Study|Early Termination Due to Study Closure|6|||
164560670|NCT02062658|594421703|FG000|Overall Study|Withdrawal by Subject|1|||
164560671|NCT02062658|594421703|FG000|Overall Study|Lack of Efficacy|1|||
164560672|NCT01789970|594421704|FG000|Open-label Titration Period|Adverse Event|68|||
164560673|NCT01789970|594421705|FG001|Open-label Titration Period|Adverse Event|0|||
164560674|NCT01789970|594421706|FG002|Open-label Titration Period|Adverse Event|0|||
164560675|NCT01789970|594421704|FG000|Open-label Titration Period|Lack of Efficacy|31|||
164560676|NCT01789970|594421705|FG001|Open-label Titration Period|Lack of Efficacy|0|||
164560677|NCT01789970|594421706|FG002|Open-label Titration Period|Lack of Efficacy|0|||
164560678|NCT01789970|594421704|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
164560679|NCT01789970|594421705|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
164560680|NCT01789970|594421706|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
164560681|NCT01789970|594421704|FG000|Open-label Titration Period|Protocol Violation|18|||
164560682|NCT01789970|594421705|FG001|Open-label Titration Period|Protocol Violation|0|||
164560683|NCT01789970|594421706|FG002|Open-label Titration Period|Protocol Violation|0|||
164560684|NCT01789970|594421704|FG000|Open-label Titration Period|Lost to Follow-up|5|||
164560685|NCT01789970|594421705|FG001|Open-label Titration Period|Lost to Follow-up|0|||
164560686|NCT01789970|594421706|FG002|Open-label Titration Period|Lost to Follow-up|0|||
164560687|NCT01789970|594421704|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
164560688|NCT01789970|594421705|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
164560689|NCT01789970|594421706|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
164560690|NCT01789970|594421704|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
164560691|NCT01789970|594421705|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
164560692|NCT01789970|594421706|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
164560693|NCT01789970|594421704|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
164560694|NCT01789970|594421705|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
164560695|NCT01789970|594421706|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
164560696|NCT01789970|594421704|FG000|Open-label Titration Period|Pregnancy|2|||
164560697|NCT01789970|594421705|FG001|Open-label Titration Period|Pregnancy|0|||
164560698|NCT01789970|594421706|FG002|Open-label Titration Period|Pregnancy|0|||
164560699|NCT01789970|594421704|FG000|Open-label Titration Period|Other|76|||
164560700|NCT01789970|594421705|FG001|Open-label Titration Period|Other|0|||
164560701|NCT01789970|594421706|FG002|Open-label Titration Period|Other|0|||
164560702|NCT01789970|594421704|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
164560703|NCT01789970|594421705|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
164560704|NCT01789970|594421706|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
164560705|NCT01789970|594421704|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
164560706|NCT01789970|594421705|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
164560707|NCT01789970|594421706|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
164560708|NCT01789970|594421704|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
164560709|NCT01789970|594421705|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
164560710|NCT01789970|594421706|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
164560711|NCT01789970|594421704|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164560712|NCT01789970|594421705|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
164560713|NCT01789970|594421706|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
164560714|NCT01789970|594421704|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
164560715|NCT01789970|594421705|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
164560716|NCT01789970|594421706|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
164560717|NCT01789970|594421704|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
164664769|NCT03331042|594798036|FG000|Overall Study|Protocol Violation|1|||
164664770|NCT03331042|594798037|FG001|Overall Study|Protocol Violation|0|||
164664771|NCT03331042|594798038|FG002|Overall Study|Protocol Violation|0|||
164664772|NCT03331042|594798039|FG003|Overall Study|Protocol Violation|0|||
164664773|NCT03331042|594798036|FG000|Overall Study|Physician Decision|0|||
164664774|NCT03331042|594798037|FG001|Overall Study|Physician Decision|0|||
164664775|NCT03331042|594798038|FG002|Overall Study|Physician Decision|1|||
164664776|NCT03331042|594798039|FG003|Overall Study|Physician Decision|0|||
164664777|NCT03331042|594798036|FG000|Overall Study|Lost to Follow-up|0|||
164664778|NCT03331042|594798037|FG001|Overall Study|Lost to Follow-up|0|||
164664779|NCT03331042|594798038|FG002|Overall Study|Lost to Follow-up|0|||
164664780|NCT03331042|594798039|FG003|Overall Study|Lost to Follow-up|1|||
164664781|NCT00755196|594798041|FG000|Overall Study|Lost to Follow-up|1|||
164664782|NCT00755196|594798041|FG000|Overall Study|Lack of Efficiency|1|||
164664783|NCT02388763|594798042|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
164664784|NCT02388763|594798043|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
164664785|NCT02388763|594798042|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
164664786|NCT02388763|594798043|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
164664787|NCT01604850|594798044|FG000|Overall Study|Enrolled but never treated|0|||
164664788|NCT01604850|594798045|FG001|Overall Study|Enrolled but never treated|1|||
164664789|NCT01604850|594798044|FG000|Overall Study|Efficacy Failure|50|||
164664790|NCT01604850|594798045|FG001|Overall Study|Efficacy Failure|29|||
164664791|NCT01604850|594798044|FG000|Overall Study|Lost to Follow-up|1|||
164664792|NCT01604850|594798045|FG001|Overall Study|Lost to Follow-up|0|||
164664793|NCT01604850|594798044|FG000|Overall Study|Subject withdrew consent|1|||
164314902|NCT02872285|593529813|FG001|Overall Study|Lost to Follow-up|2|||
164314903|NCT02872285|593529812|FG000|Overall Study|Discontinued due to back surgery|1|||
164314904|NCT02872285|593529813|FG001|Overall Study|Discontinued due to back surgery|0|||
164314905|NCT05477108|593529814|FG000|Overall Study|Participants randomized, not treated|1|||
164314906|NCT05477108|593529815|FG001|Overall Study|Participants randomized, not treated|1|||
164314907|NCT05477108|593529816|FG002|Overall Study|Participants randomized, not treated|1|||
164314908|NCT05477108|593529814|FG000|Overall Study|Physician Decision|0|||
164314909|NCT05477108|593529815|FG001|Overall Study|Physician Decision|0|||
164664794|NCT01604850|594798045|FG001|Overall Study|Subject withdrew consent|0|||
164664795|NCT01703832|594798046|FG000|Overall Study|Withdrawal by Subject|1|||
164664796|NCT01703832|594798047|FG001|Overall Study|Withdrawal by Subject|0|||
164664797|NCT00243932|594798048|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
164664798|NCT00243932|594798049|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
164664799|NCT00243932|594798050|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
164664800|NCT01458405|594798054|FG000|Phase 1 (up to 12 Months)|Other|0|||
164664801|NCT01458405|594798055|FG001|Phase 1 (up to 12 Months)|Other|1|||
164664802|NCT01458405|594798056|FG002|Phase 1 (up to 12 Months)|Other|0|||
164664803|NCT01458405|594798057|FG003|Phase 1 (up to 12 Months)|Other|0|||
164314910|NCT05477108|593529816|FG002|Overall Study|Physician Decision|1|||
164314911|NCT05477108|593529814|FG000|Overall Study|withdrawn from study|0|||
164314912|NCT05477108|593529815|FG001|Overall Study|withdrawn from study|0|||
164314913|NCT05477108|593529816|FG002|Overall Study|withdrawn from study|1|||
164314914|NCT01253577|593529817|FG000|Overall Study|Lost to Follow-up|3|||
164314915|NCT02970942|593529818|FG000|Overall Study|Death|0|||
164314916|NCT02970942|593529819|FG001|Overall Study|Death|1|||
164664804|NCT01458405|594798054|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
164664805|NCT01458405|594798055|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
164664806|NCT01458405|594798056|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
164664807|NCT01458405|594798057|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
164664808|NCT01458405|594798054|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
164664809|NCT01458405|594798055|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
164664810|NCT01458405|594798056|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
164664811|NCT01458405|594798057|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
164664812|NCT01458405|594798054|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
164664813|NCT01458405|594798055|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
164664814|NCT01458405|594798056|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
164664815|NCT01458405|594798057|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
164664816|NCT03499964|594798058|FG000|Overall Study|Lack of Efficacy|6|||
164314917|NCT02970942|593529820|FG002|Overall Study|Death|0|||
164314918|NCT02970942|593529821|FG003|Overall Study|Death|0|||
164664817|NCT03499964|594798059|FG001|Overall Study|Lack of Efficacy|26|||
164664818|NCT03499964|594798058|FG000|Overall Study|Adverse Event|1|||
164664819|NCT03499964|594798059|FG001|Overall Study|Adverse Event|0|||
164664820|NCT03499964|594798058|FG000|Overall Study|Death|1|||
164664821|NCT03499964|594798059|FG001|Overall Study|Death|0|||
164664822|NCT03499964|594798058|FG000|Overall Study|Withdrawal by Subject|2|||
164664823|NCT03499964|594798059|FG001|Overall Study|Withdrawal by Subject|1|||
164664824|NCT03499964|594798058|FG000|Overall Study|Lost to Follow-up|1|||
164664825|NCT03499964|594798059|FG001|Overall Study|Lost to Follow-up|0|||
164664826|NCT02497781|594798060|FG000|Overall Study|Withdrawal by Subject|2|||
164314919|NCT02970942|593529818|FG000|Overall Study|Lost to Follow-up|1|||
164664827|NCT02497781|594798061|FG001|Overall Study|Withdrawal by Subject|0|||
164664828|NCT02497781|594798060|FG000|Overall Study|Lack of Efficacy|0|||
164664829|NCT02497781|594798061|FG001|Overall Study|Lack of Efficacy|1|||
164664830|NCT02497781|594798060|FG000|Overall Study|Randomised but not treated|1|||
164664831|NCT02497781|594798061|FG001|Overall Study|Randomised but not treated|1|||
164664832|NCT02497781|594798060|FG000|Overall Study|Lost to Follow-up|1|||
164664833|NCT02497781|594798061|FG001|Overall Study|Lost to Follow-up|1|||
164664834|NCT01193608|594798062|FG000|Overall Study|Other|0|||
164664835|NCT01193608|594798063|FG001|Overall Study|Other|1|||
164664836|NCT01193608|594798064|FG002|Overall Study|Other|0|||
164664837|NCT01193608|594798065|FG003|Overall Study|Other|0|||
164560718|NCT01789970|594421705|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
164664838|NCT01193608|594798066|FG004|Overall Study|Other|0|||
164664839|NCT01193608|594798067|FG005|Overall Study|Other|0|||
164664840|NCT01193608|594798062|FG000|Overall Study|Withdrawal by Subject|0|||
164664841|NCT01193608|594798063|FG001|Overall Study|Withdrawal by Subject|1|||
164664842|NCT01193608|594798064|FG002|Overall Study|Withdrawal by Subject|2|||
164664843|NCT01193608|594798065|FG003|Overall Study|Withdrawal by Subject|3|||
164664844|NCT01193608|594798066|FG004|Overall Study|Withdrawal by Subject|3|||
164664845|NCT01193608|594798067|FG005|Overall Study|Withdrawal by Subject|0|||
164664846|NCT01193608|594798062|FG000|Overall Study|Lost to Follow-up|0|||
164664847|NCT01193608|594798063|FG001|Overall Study|Lost to Follow-up|0|||
164664848|NCT01193608|594798064|FG002|Overall Study|Lost to Follow-up|0|||
164664849|NCT01193608|594798065|FG003|Overall Study|Lost to Follow-up|0|||
164664850|NCT01193608|594798066|FG004|Overall Study|Lost to Follow-up|1|||
164664851|NCT01193608|594798067|FG005|Overall Study|Lost to Follow-up|2|||
164664852|NCT01193608|594798062|FG000|Overall Study|Adverse Event|0|||
164664853|NCT01193608|594798063|FG001|Overall Study|Adverse Event|0|||
164664854|NCT01193608|594798064|FG002|Overall Study|Adverse Event|0|||
164664855|NCT01193608|594798065|FG003|Overall Study|Adverse Event|0|||
164560719|NCT01789970|594421706|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
164560720|NCT01789970|594421704|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
164560721|NCT01789970|594421705|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
164560722|NCT01789970|594421706|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
164560723|NCT01789970|594421704|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164560724|NCT01789970|594421705|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
164560725|NCT01789970|594421706|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
164560726|NCT01789970|594421704|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
164560727|NCT01789970|594421705|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
164560728|NCT01789970|594421706|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
164560729|NCT01789970|594421704|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
164560730|NCT01789970|594421705|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
164560731|NCT01789970|594421706|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
164560732|NCT01789970|594421704|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
164560733|NCT01789970|594421705|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
164560734|NCT01789970|594421706|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
164560735|NCT02475655|594421707|FG000|Overall Study|Lost to Follow-up|0|||
164560736|NCT02475655|594421708|FG001|Overall Study|Lost to Follow-up|1|||
164560737|NCT04016311|594421712|FG000|Overall Study|Withdrawal by Subject|1|||
164560738|NCT04016311|594421713|FG001|Overall Study|Withdrawal by Subject|0|||
164560739|NCT02706730|594421714|FG000|Overall Study|Adverse Event|3|||
164560740|NCT02706730|594421714|FG000|Overall Study|Lack of Efficacy|5|||
164560741|NCT02706730|594421714|FG000|Overall Study|Withdrawal by Subject|11|||
164560742|NCT02706730|594421714|FG000|Overall Study|Study Terminated by Sponsor|11|||
164560743|NCT02706730|594421714|FG000|Overall Study|Subject chose not to receive injection|3|||
164560744|NCT04823949|594421719|FG000|Overall Study|Withdrawal by Subject|0|||
164560745|NCT04823949|594421720|FG001|Overall Study|Withdrawal by Subject|4|||
164560746|NCT04823949|594421719|FG000|Overall Study|Physician Decision|0|||
164560747|NCT04823949|594421720|FG001|Overall Study|Physician Decision|1|||
164560748|NCT00756938|594421721|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
164560749|NCT00756938|594421722|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
164560750|NCT00756938|594421723|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
164560751|NCT00756938|594421724|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
164560752|NCT00756938|594421721|FG000|12-week Base Study|Protocol Violation|0|||
164560753|NCT00756938|594421722|FG001|12-week Base Study|Protocol Violation|0|||
164664856|NCT01193608|594798066|FG004|Overall Study|Adverse Event|1|||
164664857|NCT01193608|594798067|FG005|Overall Study|Adverse Event|0|||
164664858|NCT01047345|594798068|FG000|Base Study|Adverse Event|3|||
164664859|NCT01047345|594798069|FG001|Base Study|Adverse Event|0|||
164664860|NCT01047345|594798070|FG002|Base Study|Adverse Event|0|||
164664861|NCT01047345|594798068|FG000|Base Study|Lost to Follow-up|4|||
164664862|NCT01047345|594798069|FG001|Base Study|Lost to Follow-up|1|||
164664863|NCT01047345|594798070|FG002|Base Study|Lost to Follow-up|0|||
164664864|NCT01047345|594798068|FG000|Base Study|Protocol Violation|3|||
164664865|NCT01047345|594798069|FG001|Base Study|Protocol Violation|1|||
164664866|NCT01047345|594798070|FG002|Base Study|Protocol Violation|0|||
164314920|NCT02970942|593529819|FG001|Overall Study|Lost to Follow-up|0|||
164314921|NCT02970942|593529820|FG002|Overall Study|Lost to Follow-up|2|||
164314922|NCT02970942|593529821|FG003|Overall Study|Lost to Follow-up|1|||
164314923|NCT02970942|593529818|FG000|Overall Study|Withdrawal by Subject|3|||
164314924|NCT02970942|593529819|FG001|Overall Study|Withdrawal by Subject|5|||
164314925|NCT02970942|593529820|FG002|Overall Study|Withdrawal by Subject|3|||
164314926|NCT02970942|593529821|FG003|Overall Study|Withdrawal by Subject|2|||
164560754|NCT00756938|594421723|FG002|12-week Base Study|Protocol Violation|1|||
164560755|NCT00756938|594421724|FG003|12-week Base Study|Protocol Violation|0|||
164560756|NCT00756938|594421721|FG000|12-week Base Study|Lost to Follow-up|1|||
164560757|NCT00756938|594421722|FG001|12-week Base Study|Lost to Follow-up|0|||
164560758|NCT00756938|594421723|FG002|12-week Base Study|Lost to Follow-up|0|||
164560759|NCT00756938|594421724|FG003|12-week Base Study|Lost to Follow-up|0|||
164560760|NCT00756938|594421721|FG000|Optional Extension|Lack of Efficacy|0|||
164560761|NCT00756938|594421722|FG001|Optional Extension|Lack of Efficacy|0|||
164560762|NCT00756938|594421723|FG002|Optional Extension|Lack of Efficacy|0|||
164560763|NCT00756938|594421724|FG003|Optional Extension|Lack of Efficacy|1|||
164560764|NCT00756938|594421721|FG000|Optional Extension|End of Study|0|||
164560765|NCT00756938|594421722|FG001|Optional Extension|End of Study|0|||
164560766|NCT00756938|594421723|FG002|Optional Extension|End of Study|0|||
164560767|NCT00756938|594421724|FG003|Optional Extension|End of Study|11|||
164560768|NCT00756938|594421721|FG000|Optional Extension|Protocol-specific criteria met|0|||
164560769|NCT00756938|594421722|FG001|Optional Extension|Protocol-specific criteria met|0|||
164560770|NCT00756938|594421723|FG002|Optional Extension|Protocol-specific criteria met|0|||
164560771|NCT00756938|594421724|FG003|Optional Extension|Protocol-specific criteria met|9|||
164560772|NCT00756938|594421721|FG000|Optional Extension|Physician Decision|0|||
164560773|NCT00756938|594421722|FG001|Optional Extension|Physician Decision|0|||
164560774|NCT00756938|594421723|FG002|Optional Extension|Physician Decision|0|||
164560775|NCT00756938|594421724|FG003|Optional Extension|Physician Decision|3|||
164560776|NCT00756938|594421721|FG000|Optional Extension|Lost to Follow-up|0|||
164560777|NCT00756938|594421722|FG001|Optional Extension|Lost to Follow-up|0|||
164560778|NCT00756938|594421723|FG002|Optional Extension|Lost to Follow-up|0|||
164560779|NCT00756938|594421724|FG003|Optional Extension|Lost to Follow-up|1|||
164560780|NCT00756938|594421721|FG000|Optional Extension|Protocol Violation|0|||
164560781|NCT00756938|594421722|FG001|Optional Extension|Protocol Violation|0|||
164560782|NCT00756938|594421723|FG002|Optional Extension|Protocol Violation|0|||
164560783|NCT00756938|594421724|FG003|Optional Extension|Protocol Violation|1|||
164560784|NCT00756938|594421721|FG000|Optional Extension|Withdrawal by Subject|0|||
164560785|NCT00756938|594421722|FG001|Optional Extension|Withdrawal by Subject|0|||
164560786|NCT00756938|594421723|FG002|Optional Extension|Withdrawal by Subject|0|||
164560787|NCT00756938|594421724|FG003|Optional Extension|Withdrawal by Subject|10|||
164560788|NCT00756938|594421721|FG000|Optional Extension|Adverse Event|0|||
164560789|NCT00756938|594421722|FG001|Optional Extension|Adverse Event|0|||
164560790|NCT00756938|594421723|FG002|Optional Extension|Adverse Event|0|||
164560791|NCT00756938|594421724|FG003|Optional Extension|Adverse Event|1|||
164560792|NCT00094055|594421725|FG000|Overall Study|Adverse Event|11|||
164560793|NCT00094055|594421725|FG000|Overall Study|Death|4|||
164560794|NCT00094055|594421725|FG000|Overall Study|Lack of Efficacy|17|||
164560795|NCT00094055|594421725|FG000|Overall Study|Lost to Follow-up|2|||
164560796|NCT00094055|594421725|FG000|Overall Study|progressive disease|2|||
164560797|NCT00094055|594421725|FG000|Overall Study|clinical progression|1|||
164560798|NCT00094055|594421725|FG000|Overall Study|roll-over to another study|14|||
164560799|NCT00094055|594421725|FG000|Overall Study|Withdrawal by Subject|9|||
164560800|NCT00441545|594421726|FG000|First Intervention|Adverse Event|6|||
164560801|NCT00441545|594421727|FG001|First Intervention|Adverse Event|5|||
164560802|NCT00441545|594421726|FG000|First Intervention|Protocol Violation|2|||
164560803|NCT00441545|594421727|FG001|First Intervention|Protocol Violation|2|||
164560804|NCT00441545|594421726|FG000|First Intervention|Withdrawal by Subject|3|||
164560805|NCT00441545|594421727|FG001|First Intervention|Withdrawal by Subject|3|||
164560806|NCT00441545|594421726|FG000|First Intervention|Kidney transplant|1|||
164560807|NCT00441545|594421727|FG001|First Intervention|Kidney transplant|1|||
164560808|NCT00441545|594421726|FG000|First Intervention|Lack of Efficacy|2|||
164560809|NCT00441545|594421727|FG001|First Intervention|Lack of Efficacy|0|||
164560810|NCT00441545|594421726|FG000|First Intervention|Subject exceeded safety criteria|0|||
164560811|NCT00441545|594421727|FG001|First Intervention|Subject exceeded safety criteria|1|||
164560812|NCT00441545|594421726|FG000|First Intervention|Subject met an exclusionary criteria|1|||
164560813|NCT00441545|594421727|FG001|First Intervention|Subject met an exclusionary criteria|0|||
164560814|NCT00441545|594421726|FG000|First Intervention|Extended hospitalization|1|||
164560815|NCT00441545|594421727|FG001|First Intervention|Extended hospitalization|0|||
164560816|NCT00441545|594421726|FG000|First Intervention|Site error|1|||
164560817|NCT00441545|594421727|FG001|First Intervention|Site error|0|||
164314927|NCT01065454|593529824|FG000|Treatment|Adverse Event|7|||
164560818|NCT00441545|594421726|FG000|First Intervention|Sponsor's request|1|||
164560819|NCT00441545|594421727|FG001|First Intervention|Sponsor's request|0|||
164560820|NCT00441545|594421726|FG000|Second Intervention|Adverse Event|5|||
164314928|NCT01065454|593529825|FG001|Treatment|Adverse Event|4|||
164314929|NCT01065454|593529826|FG002|Treatment|Adverse Event|3|||
164560821|NCT00441545|594421727|FG001|Second Intervention|Adverse Event|2|||
164560822|NCT00441545|594421726|FG000|Second Intervention|Protocol Violation|4|||
164560823|NCT00441545|594421727|FG001|Second Intervention|Protocol Violation|1|||
164560824|NCT00441545|594421726|FG000|Second Intervention|Withdrawal by Subject|1|||
164560825|NCT00441545|594421727|FG001|Second Intervention|Withdrawal by Subject|1|||
164560826|NCT00441545|594421726|FG000|Second Intervention|Kidney Transplant|1|||
164560827|NCT00441545|594421727|FG001|Second Intervention|Kidney Transplant|1|||
164560828|NCT00441545|594421726|FG000|Second Intervention|Lack of Efficacy|0|||
164560829|NCT00441545|594421727|FG001|Second Intervention|Lack of Efficacy|1|||
164560830|NCT00441545|594421726|FG000|Second Intervention|Subject exceeded safety criteria|1|||
164560831|NCT00441545|594421727|FG001|Second Intervention|Subject exceeded safety criteria|0|||
164560832|NCT00441545|594421726|FG000|Second Intervention|Subject moved|0|||
164560833|NCT00441545|594421727|FG001|Second Intervention|Subject moved|1|||
164560834|NCT00939692|594421732|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
164560835|NCT00939692|594421733|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
164560836|NCT00939692|594421732|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
164560837|NCT00939692|594421733|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
164560838|NCT00699907|594421738|FG000|Overall Study|Withdrawal by Subject|2|||
164560839|NCT00699907|594421739|FG001|Overall Study|Withdrawal by Subject|1|||
164560840|NCT00699907|594421740|FG002|Overall Study|Withdrawal by Subject|0|||
164560841|NCT00699907|594421738|FG000|Overall Study|No usable sample|0|||
164560842|NCT00699907|594421739|FG001|Overall Study|No usable sample|9|||
164560843|NCT00699907|594421740|FG002|Overall Study|No usable sample|8|||
164560844|NCT01081795|594421741|FG000|Overall Study|Adverse Event|18|||
164560845|NCT01081795|594421742|FG001|Overall Study|Adverse Event|23|||
164560846|NCT01081795|594421743|FG002|Overall Study|Adverse Event|6|||
164560847|NCT01081795|594421741|FG000|Overall Study|Lack of Efficacy|7|||
164560848|NCT01081795|594421742|FG001|Overall Study|Lack of Efficacy|5|||
164560849|NCT01081795|594421743|FG002|Overall Study|Lack of Efficacy|19|||
164560850|NCT01081795|594421741|FG000|Overall Study|Subject's schedule|1|||
164560851|NCT01081795|594421742|FG001|Overall Study|Subject's schedule|1|||
164560852|NCT01081795|594421743|FG002|Overall Study|Subject's schedule|2|||
164560853|NCT01081795|594421741|FG000|Overall Study|Revocation of informed consent|2|||
164560854|NCT01081795|594421742|FG001|Overall Study|Revocation of informed consent|0|||
164560855|NCT01081795|594421743|FG002|Overall Study|Revocation of informed consent|0|||
164560856|NCT01081795|594421741|FG000|Overall Study|Ineligible for participation|1|||
164560857|NCT01081795|594421742|FG001|Overall Study|Ineligible for participation|0|||
164560858|NCT01081795|594421743|FG002|Overall Study|Ineligible for participation|0|||
164560859|NCT01081795|594421741|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
164560860|NCT01081795|594421742|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
164560861|NCT01081795|594421743|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
164560862|NCT01081795|594421741|FG000|Overall Study|Using drug with restricted days of use|2|||
164560863|NCT01081795|594421742|FG001|Overall Study|Using drug with restricted days of use|3|||
164560864|NCT01081795|594421743|FG002|Overall Study|Using drug with restricted days of use|2|||
164560865|NCT01081795|594421741|FG000|Overall Study|Other|1|||
164560866|NCT01081795|594421742|FG001|Overall Study|Other|2|||
164560867|NCT01081795|594421743|FG002|Overall Study|Other|0|||
164560868|NCT03115151|594421744|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
164560869|NCT03115151|594421745|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
164560870|NCT03115151|594421744|FG000|Overall Study|Epidural catheter removal|1|||
164560871|NCT03115151|594421745|FG001|Overall Study|Epidural catheter removal|0|||
164560872|NCT03115151|594421744|FG000|Overall Study|Withdrawal by Subject|0|||
164560873|NCT03115151|594421745|FG001|Overall Study|Withdrawal by Subject|1|||
164560874|NCT03115151|594421744|FG000|Overall Study|Intervention not received according to the protocol.|1|||
164560875|NCT03115151|594421745|FG001|Overall Study|Intervention not received according to the protocol.|1|||
164560876|NCT03115151|594421744|FG000|Overall Study|Physician Decision|1|||
164560877|NCT03115151|594421745|FG001|Overall Study|Physician Decision|0|||
164560878|NCT03115151|594421744|FG000|Overall Study|Randomization not applied|1|||
164560879|NCT03115151|594421745|FG001|Overall Study|Randomization not applied|1|||
164560880|NCT00143455|594421748|FG000|Cohort 1|Adverse Event|8|||
164560881|NCT00143455|594421749|FG001|Cohort 1|Adverse Event|4|||
164560882|NCT00143455|594421750|FG002|Cohort 1|Adverse Event|0|||
164560883|NCT00143455|594421751|FG003|Cohort 1|Adverse Event|0|||
164560884|NCT00143455|594421748|FG000|Cohort 1|Death|5|||
164560885|NCT00143455|594421749|FG001|Cohort 1|Death|2|||
164560886|NCT00143455|594421750|FG002|Cohort 1|Death|0|||
164560887|NCT00143455|594421751|FG003|Cohort 1|Death|0|||
164560888|NCT00143455|594421748|FG000|Cohort 1|Progressive Disease|0|||
164560889|NCT00143455|594421749|FG001|Cohort 1|Progressive Disease|6|||
164560890|NCT00143455|594421750|FG002|Cohort 1|Progressive Disease|0|||
164560891|NCT00143455|594421751|FG003|Cohort 1|Progressive Disease|0|||
164560892|NCT00143455|594421748|FG000|Cohort 1|Withdrawal by Subject|1|||
164560893|NCT00143455|594421749|FG001|Cohort 1|Withdrawal by Subject|4|||
164560894|NCT00143455|594421750|FG002|Cohort 1|Withdrawal by Subject|0|||
164664867|NCT01047345|594798068|FG000|Base Study|Withdrawal by Subject|12|||
164664868|NCT01047345|594798069|FG001|Base Study|Withdrawal by Subject|4|||
164664869|NCT01047345|594798070|FG002|Base Study|Withdrawal by Subject|0|||
164664870|NCT01047345|594798068|FG000|Extension|Withdrawal by Subject|0|||
164664871|NCT01047345|594798069|FG001|Extension|Withdrawal by Subject|0|||
164664872|NCT01047345|594798070|FG002|Extension|Withdrawal by Subject|1|||
164664873|NCT01047345|594798068|FG000|Extension|Lost to Follow-up|0|||
164664874|NCT01047345|594798069|FG001|Extension|Lost to Follow-up|0|||
164664875|NCT01047345|594798070|FG002|Extension|Lost to Follow-up|5|||
164664876|NCT00712010|594798071|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
164664877|NCT00995553|594798072|FG000|Overall Study|Withdrawal by Subject|2|||
164664878|NCT00995553|594798073|FG001|Overall Study|Withdrawal by Subject|6|||
164560895|NCT00143455|594421751|FG003|Cohort 1|Withdrawal by Subject|0|||
164560896|NCT00143455|594421748|FG000|Cohort 1|Randomized But Not Treated|0|||
164560897|NCT00143455|594421749|FG001|Cohort 1|Randomized But Not Treated|1|||
164560898|NCT00143455|594421750|FG002|Cohort 1|Randomized But Not Treated|0|||
164560899|NCT00143455|594421751|FG003|Cohort 1|Randomized But Not Treated|0|||
164560900|NCT00143455|594421748|FG000|Cohort 2|Adverse Event|0|||
164560901|NCT00143455|594421749|FG001|Cohort 2|Adverse Event|0|||
164560902|NCT00143455|594421750|FG002|Cohort 2|Adverse Event|42|||
164560903|NCT00143455|594421751|FG003|Cohort 2|Adverse Event|30|||
164560904|NCT00143455|594421748|FG000|Cohort 2|No Longer Required Study Treatment|0|||
164560905|NCT00143455|594421749|FG001|Cohort 2|No Longer Required Study Treatment|0|||
164560906|NCT00143455|594421750|FG002|Cohort 2|No Longer Required Study Treatment|1|||
164560907|NCT00143455|594421751|FG003|Cohort 2|No Longer Required Study Treatment|0|||
164560908|NCT00143455|594421748|FG000|Cohort 2|Protocol Violation|0|||
164560909|NCT00143455|594421749|FG001|Cohort 2|Protocol Violation|0|||
164560910|NCT00143455|594421750|FG002|Cohort 2|Protocol Violation|1|||
164560911|NCT00143455|594421751|FG003|Cohort 2|Protocol Violation|1|||
164560912|NCT00143455|594421748|FG000|Cohort 2|Lost to Follow-up|0|||
164560913|NCT00143455|594421749|FG001|Cohort 2|Lost to Follow-up|0|||
164560914|NCT00143455|594421750|FG002|Cohort 2|Lost to Follow-up|1|||
164560915|NCT00143455|594421751|FG003|Cohort 2|Lost to Follow-up|4|||
164560916|NCT00143455|594421748|FG000|Cohort 2|Death|0|||
164560917|NCT00143455|594421749|FG001|Cohort 2|Death|0|||
164560918|NCT00143455|594421750|FG002|Cohort 2|Death|20|||
164560919|NCT00143455|594421751|FG003|Cohort 2|Death|12|||
164560920|NCT00143455|594421748|FG000|Cohort 2|Progressive Disease|0|||
164560921|NCT00143455|594421749|FG001|Cohort 2|Progressive Disease|0|||
164560922|NCT00143455|594421750|FG002|Cohort 2|Progressive Disease|20|||
164560923|NCT00143455|594421751|FG003|Cohort 2|Progressive Disease|27|||
164560924|NCT00143455|594421748|FG000|Cohort 2|Withdrawal by Subject|0|||
164560925|NCT00143455|594421749|FG001|Cohort 2|Withdrawal by Subject|0|||
164560926|NCT00143455|594421750|FG002|Cohort 2|Withdrawal by Subject|13|||
164560927|NCT00143455|594421751|FG003|Cohort 2|Withdrawal by Subject|12|||
164560928|NCT00143455|594421748|FG000|Cohort 2|Other|0|||
164560929|NCT00143455|594421749|FG001|Cohort 2|Other|0|||
164560930|NCT00143455|594421750|FG002|Cohort 2|Other|7|||
164560931|NCT00143455|594421751|FG003|Cohort 2|Other|6|||
164560932|NCT00143455|594421748|FG000|Cohort 2|Randomized But Not Treated|0|||
164560933|NCT00143455|594421749|FG001|Cohort 2|Randomized But Not Treated|0|||
164560934|NCT00143455|594421750|FG002|Cohort 2|Randomized But Not Treated|1|||
164560935|NCT00143455|594421751|FG003|Cohort 2|Randomized But Not Treated|1|||
164560936|NCT02682901|594421752|FG000|Overall Study|Adverse Event|10|||
164560937|NCT02682901|594421753|FG001|Overall Study|Adverse Event|3|||
164560938|NCT02682901|594421752|FG000|Overall Study|Lack of Efficacy|0|||
164560939|NCT02682901|594421753|FG001|Overall Study|Lack of Efficacy|1|||
164560940|NCT03713944|594421754|FG000|Study Treatment|Patient non-compliance|1|||
164560941|NCT03713944|594421754|FG000|Study Treatment|Alternative Cancer Therapy|3|||
164560942|NCT03713944|594421754|FG000|Study Treatment|Disease Progression|18|||
164560943|NCT03713944|594421754|FG000|Study Treatment|AE/Side Effects/Complications|2|||
164560944|NCT03713944|594421754|FG000|Study Treatment|Death|2|||
164560945|NCT03713944|594421754|FG000|Study Treatment|Withdrawal by Subject|1|||
164560946|NCT03713944|594421754|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
164560947|NCT03713944|594421754|FG000|Study Treatment|Symptomatic Deterioration|2|||
164560948|NCT03713944|594421754|FG000|Follow up|Withdrawal by Subject|2|||
164560949|NCT03713944|594421754|FG000|Follow up|Death|11|||
164560950|NCT03713944|594421754|FG000|Follow up|Study Terminated|3|||
164664879|NCT00950807|594798074|FG000|Treatment Period 1|Lack of Efficacy|1|||
164664880|NCT00950807|594798075|FG001|Treatment Period 1|Lack of Efficacy|0|||
164560951|NCT02902120|594421755|FG000|Overall Study|Lack of Efficacy|1|||
164560952|NCT01353703|594421757|FG000|Overall Study|Migrated/moved from study area|1|||
164560953|NCT01353703|594421758|FG001|Overall Study|Migrated/moved from study area|0|||
164560954|NCT03298022|594421759|FG000|Overall Study|Lack of Efficacy|4|||
164560955|NCT03298022|594421759|FG000|Overall Study|Withdrawal by Subject|7|||
164560956|NCT03298022|594421759|FG000|Overall Study|Adverse Event|1|||
164560957|NCT03298022|594421759|FG000|Overall Study|disease relapse|1|||
164560958|NCT00730639|594421762|FG000|Overall Study|Adverse Event|3|||
164664881|NCT00950807|594798076|FG002|Treatment Period 1|Lack of Efficacy|0|||
164664882|NCT00950807|594798077|FG003|Treatment Period 1|Lack of Efficacy|0|||
164560959|NCT00730639|594421763|FG001|Overall Study|Adverse Event|0|||
164560960|NCT00730639|594421764|FG002|Overall Study|Adverse Event|9|||
164560961|NCT00730639|594421765|FG003|Overall Study|Adverse Event|8|||
164560962|NCT00730639|594421766|FG004|Overall Study|Adverse Event|23|||
164560963|NCT00730639|594421762|FG000|Overall Study|Complete Response|0|||
164560964|NCT00730639|594421763|FG001|Overall Study|Complete Response|0|||
164560965|NCT00730639|594421764|FG002|Overall Study|Complete Response|2|||
164560966|NCT00730639|594421765|FG003|Overall Study|Complete Response|2|||
164560967|NCT00730639|594421766|FG004|Overall Study|Complete Response|1|||
164560968|NCT00730639|594421762|FG000|Overall Study|Completed Maximum Cycles|0|||
164560969|NCT00730639|594421763|FG001|Overall Study|Completed Maximum Cycles|0|||
164560970|NCT00730639|594421764|FG002|Overall Study|Completed Maximum Cycles|11|||
164560971|NCT00730639|594421765|FG003|Overall Study|Completed Maximum Cycles|3|||
164560972|NCT00730639|594421766|FG004|Overall Study|Completed Maximum Cycles|6|||
164560973|NCT00730639|594421762|FG000|Overall Study|Death|0|||
164560974|NCT00730639|594421763|FG001|Overall Study|Death|0|||
164560975|NCT00730639|594421764|FG002|Overall Study|Death|0|||
164560976|NCT00730639|594421765|FG003|Overall Study|Death|0|||
164560977|NCT00730639|594421766|FG004|Overall Study|Death|2|||
164560978|NCT00730639|594421762|FG000|Overall Study|Disease Progression|12|||
164560979|NCT00730639|594421763|FG001|Overall Study|Disease Progression|13|||
164560980|NCT00730639|594421764|FG002|Overall Study|Disease Progression|48|||
164560981|NCT00730639|594421765|FG003|Overall Study|Disease Progression|32|||
164560982|NCT00730639|594421766|FG004|Overall Study|Disease Progression|88|||
164560983|NCT00730639|594421762|FG000|Overall Study|non-specified|0|||
164560984|NCT00730639|594421763|FG001|Overall Study|non-specified|0|||
164560985|NCT00730639|594421764|FG002|Overall Study|non-specified|4|||
164560986|NCT00730639|594421765|FG003|Overall Study|non-specified|2|||
164560987|NCT00730639|594421766|FG004|Overall Study|non-specified|3|||
164560988|NCT00730639|594421762|FG000|Overall Study|Protocol Violation|0|||
164560989|NCT00730639|594421763|FG001|Overall Study|Protocol Violation|0|||
164560990|NCT00730639|594421764|FG002|Overall Study|Protocol Violation|1|||
164560991|NCT00730639|594421765|FG003|Overall Study|Protocol Violation|0|||
164560992|NCT00730639|594421766|FG004|Overall Study|Protocol Violation|0|||
164560993|NCT00730639|594421762|FG000|Overall Study|Withdrawal by Subject|0|||
164560994|NCT00730639|594421763|FG001|Overall Study|Withdrawal by Subject|0|||
164560995|NCT00730639|594421764|FG002|Overall Study|Withdrawal by Subject|6|||
164560996|NCT00730639|594421765|FG003|Overall Study|Withdrawal by Subject|3|||
164560997|NCT00730639|594421766|FG004|Overall Study|Withdrawal by Subject|4|||
164560998|NCT00730639|594421762|FG000|Overall Study|Treatment on-going|2|||
164560999|NCT00730639|594421763|FG001|Overall Study|Treatment on-going|5|||
164561000|NCT00730639|594421764|FG002|Overall Study|Treatment on-going|5|||
164561001|NCT00730639|594421765|FG003|Overall Study|Treatment on-going|4|||
164561002|NCT00730639|594421766|FG004|Overall Study|Treatment on-going|4|||
164561003|NCT00848354|594421770|FG000|Phase 1|Adverse Event|5|||
164561004|NCT00848354|594421771|FG001|Phase 1|Adverse Event|4|||
164561005|NCT00848354|594421770|FG000|Phase 1|Discontinuation of study by sponsor|2|||
164561006|NCT00848354|594421771|FG001|Phase 1|Discontinuation of study by sponsor|1|||
164561007|NCT00848354|594421770|FG000|Phase 1|Failed to return|0|||
164561008|NCT00848354|594421771|FG001|Phase 1|Failed to return|1|||
164561009|NCT00848354|594421770|FG000|Phase 1|Lost to Follow-up|1|||
164561010|NCT00848354|594421771|FG001|Phase 1|Lost to Follow-up|1|||
164561011|NCT00848354|594421770|FG000|Phase 1|Unspecified Reason|1|||
164561012|NCT00848354|594421771|FG001|Phase 1|Unspecified Reason|1|||
164561013|NCT00848354|594421770|FG000|Phase 1|Protocol Violation|1|||
164561014|NCT00848354|594421771|FG001|Phase 1|Protocol Violation|1|||
164561015|NCT00848354|594421770|FG000|Phase 1|Withdrawal by Subject|2|||
164561016|NCT00848354|594421771|FG001|Phase 1|Withdrawal by Subject|4|||
164561017|NCT00848354|594421770|FG000|Phase 1|Lack of Efficacy|0|||
164561018|NCT00848354|594421771|FG001|Phase 1|Lack of Efficacy|1|||
164561019|NCT00848354|594421770|FG000|Phase 2 Year 1|Adverse Event|7|||
164561020|NCT00848354|594421771|FG001|Phase 2 Year 1|Adverse Event|2|||
164561021|NCT00848354|594421770|FG000|Phase 2 Year 1|Death|1|||
164561022|NCT00848354|594421771|FG001|Phase 2 Year 1|Death|0|||
164561023|NCT00848354|594421770|FG000|Phase 2 Year 1|Failed to Return|1|||
164561024|NCT00848354|594421771|FG001|Phase 2 Year 1|Failed to Return|1|||
164561025|NCT00848354|594421770|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
164561026|NCT00848354|594421771|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
164561027|NCT00848354|594421770|FG000|Phase 2 Year 1|Unspecified Reason|3|||
164561028|NCT00848354|594421771|FG001|Phase 2 Year 1|Unspecified Reason|0|||
164561029|NCT00848354|594421770|FG000|Phase 2 Year 1|Protocol Violation|4|||
164561030|NCT00848354|594421771|FG001|Phase 2 Year 1|Protocol Violation|1|||
164561031|NCT00848354|594421770|FG000|Phase 2 Year 1|Subject Request|1|||
164561032|NCT00848354|594421771|FG001|Phase 2 Year 1|Subject Request|2|||
164561033|NCT00848354|594421770|FG000|Phase 2 Year 2|Adverse Event|12|||
164561034|NCT00848354|594421771|FG001|Phase 2 Year 2|Adverse Event|2|||
164561035|NCT00848354|594421770|FG000|Phase 2 Year 2|Death|2|||
164561036|NCT00848354|594421771|FG001|Phase 2 Year 2|Death|0|||
164561037|NCT00848354|594421770|FG000|Phase 2 Year 2|Failed to return|3|||
164561038|NCT00848354|594421771|FG001|Phase 2 Year 2|Failed to return|0|||
164561039|NCT00848354|594421770|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
164664883|NCT00950807|594798078|FG004|Treatment Period 1|Lack of Efficacy|0|||
164664884|NCT00950807|594798079|FG005|Treatment Period 1|Lack of Efficacy|1|||
164664885|NCT00950807|594798080|FG006|Treatment Period 1|Lack of Efficacy|0|||
164664886|NCT00950807|594798081|FG007|Treatment Period 1|Lack of Efficacy|0|||
164664887|NCT00950807|594798082|FG008|Treatment Period 1|Lack of Efficacy|0|||
164664888|NCT00950807|594798083|FG009|Treatment Period 1|Lack of Efficacy|0|||
164664889|NCT00950807|594798074|FG000|Treatment Period 1|Protocol Violation|1|||
164664890|NCT00950807|594798075|FG001|Treatment Period 1|Protocol Violation|0|||
164664891|NCT00950807|594798076|FG002|Treatment Period 1|Protocol Violation|0|||
164664892|NCT00950807|594798077|FG003|Treatment Period 1|Protocol Violation|0|||
164664893|NCT00950807|594798078|FG004|Treatment Period 1|Protocol Violation|0|||
164664894|NCT00950807|594798079|FG005|Treatment Period 1|Protocol Violation|0|||
164664895|NCT00950807|594798080|FG006|Treatment Period 1|Protocol Violation|0|||
164664896|NCT00950807|594798081|FG007|Treatment Period 1|Protocol Violation|0|||
164664897|NCT00950807|594798082|FG008|Treatment Period 1|Protocol Violation|0|||
164664898|NCT00950807|594798083|FG009|Treatment Period 1|Protocol Violation|0|||
164664899|NCT00950807|594798074|FG000|Treatment Period 1|Lost to Follow-up|0|||
164664900|NCT00950807|594798075|FG001|Treatment Period 1|Lost to Follow-up|0|||
164664901|NCT00950807|594798076|FG002|Treatment Period 1|Lost to Follow-up|1|||
164664902|NCT00950807|594798077|FG003|Treatment Period 1|Lost to Follow-up|0|||
164664903|NCT00950807|594798078|FG004|Treatment Period 1|Lost to Follow-up|0|||
164664904|NCT00950807|594798079|FG005|Treatment Period 1|Lost to Follow-up|0|||
164664905|NCT00950807|594798080|FG006|Treatment Period 1|Lost to Follow-up|0|||
164664906|NCT00950807|594798081|FG007|Treatment Period 1|Lost to Follow-up|0|||
164664907|NCT00950807|594798082|FG008|Treatment Period 1|Lost to Follow-up|0|||
164664908|NCT00950807|594798083|FG009|Treatment Period 1|Lost to Follow-up|0|||
164664909|NCT00950807|594798074|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164664910|NCT00950807|594798075|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164664911|NCT00950807|594798076|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164664912|NCT00950807|594798077|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164664913|NCT00950807|594798078|FG004|Treatment Period 1|Withdrawal by Subject|1|||
164664914|NCT00950807|594798079|FG005|Treatment Period 1|Withdrawal by Subject|0|||
164664915|NCT00950807|594798080|FG006|Treatment Period 1|Withdrawal by Subject|0|||
164664916|NCT00950807|594798081|FG007|Treatment Period 1|Withdrawal by Subject|0|||
164664917|NCT00950807|594798082|FG008|Treatment Period 1|Withdrawal by Subject|1|||
164664918|NCT00950807|594798083|FG009|Treatment Period 1|Withdrawal by Subject|0|||
164664919|NCT00950807|594798074|FG000|Treatment Period 1|Adverse Event|0|||
164664920|NCT00950807|594798075|FG001|Treatment Period 1|Adverse Event|0|||
164664921|NCT00950807|594798076|FG002|Treatment Period 1|Adverse Event|0|||
164664922|NCT00950807|594798077|FG003|Treatment Period 1|Adverse Event|0|||
164664923|NCT00950807|594798078|FG004|Treatment Period 1|Adverse Event|0|||
164664924|NCT00950807|594798079|FG005|Treatment Period 1|Adverse Event|1|||
164664925|NCT00950807|594798080|FG006|Treatment Period 1|Adverse Event|0|||
164664926|NCT00950807|594798081|FG007|Treatment Period 1|Adverse Event|0|||
164664927|NCT00950807|594798082|FG008|Treatment Period 1|Adverse Event|0|||
164664928|NCT00950807|594798083|FG009|Treatment Period 1|Adverse Event|0|||
164664929|NCT00950807|594798074|FG000|Washout Period 1|Lack of Efficacy|0|||
164664930|NCT00950807|594798075|FG001|Washout Period 1|Lack of Efficacy|0|||
164664931|NCT00950807|594798076|FG002|Washout Period 1|Lack of Efficacy|0|||
164664932|NCT00950807|594798077|FG003|Washout Period 1|Lack of Efficacy|0|||
164664933|NCT00950807|594798078|FG004|Washout Period 1|Lack of Efficacy|0|||
164664934|NCT00950807|594798079|FG005|Washout Period 1|Lack of Efficacy|0|||
164664935|NCT00950807|594798080|FG006|Washout Period 1|Lack of Efficacy|1|||
164664936|NCT00950807|594798081|FG007|Washout Period 1|Lack of Efficacy|0|||
164664937|NCT00950807|594798082|FG008|Washout Period 1|Lack of Efficacy|0|||
164664938|NCT00950807|594798083|FG009|Washout Period 1|Lack of Efficacy|0|||
164664939|NCT00950807|594798074|FG000|Washout Period 1|Withdrawal by Subject|0|||
164664940|NCT00950807|594798075|FG001|Washout Period 1|Withdrawal by Subject|0|||
164664941|NCT00950807|594798076|FG002|Washout Period 1|Withdrawal by Subject|0|||
164664942|NCT00950807|594798077|FG003|Washout Period 1|Withdrawal by Subject|0|||
164664943|NCT00950807|594798078|FG004|Washout Period 1|Withdrawal by Subject|0|||
164664944|NCT00950807|594798079|FG005|Washout Period 1|Withdrawal by Subject|0|||
164664945|NCT00950807|594798080|FG006|Washout Period 1|Withdrawal by Subject|0|||
164664946|NCT00950807|594798081|FG007|Washout Period 1|Withdrawal by Subject|0|||
164664947|NCT00950807|594798082|FG008|Washout Period 1|Withdrawal by Subject|1|||
164664948|NCT00950807|594798083|FG009|Washout Period 1|Withdrawal by Subject|0|||
164664949|NCT00950807|594798074|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
164664950|NCT00950807|594798075|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
164664951|NCT00950807|594798076|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
164664952|NCT00950807|594798077|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
164664953|NCT00950807|594798078|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
164664954|NCT00950807|594798079|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
164664955|NCT00950807|594798080|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
164664956|NCT00950807|594798081|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
164664957|NCT00950807|594798082|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
164664958|NCT00950807|594798083|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
164664959|NCT00950807|594798074|FG000|Washout Period 1|Adverse Event|2|||
164664960|NCT00950807|594798075|FG001|Washout Period 1|Adverse Event|0|||
164664961|NCT00950807|594798076|FG002|Washout Period 1|Adverse Event|0|||
164664962|NCT00950807|594798077|FG003|Washout Period 1|Adverse Event|1|||
164664963|NCT00950807|594798078|FG004|Washout Period 1|Adverse Event|1|||
164664964|NCT00950807|594798079|FG005|Washout Period 1|Adverse Event|0|||
164664965|NCT00950807|594798080|FG006|Washout Period 1|Adverse Event|0|||
164664966|NCT00950807|594798081|FG007|Washout Period 1|Adverse Event|0|||
164664967|NCT00950807|594798082|FG008|Washout Period 1|Adverse Event|0|||
164664968|NCT00950807|594798083|FG009|Washout Period 1|Adverse Event|0|||
164664969|NCT00950807|594798074|FG000|Treatment Period 2|Lack of Efficacy|1|||
164664970|NCT00950807|594798075|FG001|Treatment Period 2|Lack of Efficacy|0|||
164664971|NCT00950807|594798076|FG002|Treatment Period 2|Lack of Efficacy|0|||
164664972|NCT00950807|594798077|FG003|Treatment Period 2|Lack of Efficacy|0|||
164664973|NCT00950807|594798078|FG004|Treatment Period 2|Lack of Efficacy|0|||
164664974|NCT00950807|594798079|FG005|Treatment Period 2|Lack of Efficacy|0|||
164664975|NCT00950807|594798080|FG006|Treatment Period 2|Lack of Efficacy|0|||
164664976|NCT00950807|594798081|FG007|Treatment Period 2|Lack of Efficacy|0|||
164664977|NCT00950807|594798082|FG008|Treatment Period 2|Lack of Efficacy|0|||
164664978|NCT00950807|594798083|FG009|Treatment Period 2|Lack of Efficacy|0|||
164664979|NCT00950807|594798074|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164664980|NCT00950807|594798075|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164664981|NCT00950807|594798076|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164664982|NCT00950807|594798077|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164664983|NCT00950807|594798078|FG004|Treatment Period 2|Withdrawal by Subject|0|||
164664984|NCT00950807|594798079|FG005|Treatment Period 2|Withdrawal by Subject|0|||
164664985|NCT00950807|594798080|FG006|Treatment Period 2|Withdrawal by Subject|1|||
164664986|NCT00950807|594798081|FG007|Treatment Period 2|Withdrawal by Subject|2|||
164664987|NCT00950807|594798082|FG008|Treatment Period 2|Withdrawal by Subject|0|||
164664988|NCT00950807|594798083|FG009|Treatment Period 2|Withdrawal by Subject|0|||
164664989|NCT00950807|594798074|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
164664990|NCT00950807|594798075|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164664991|NCT00950807|594798076|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164664992|NCT00950807|594798077|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164664993|NCT00950807|594798078|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164664994|NCT00950807|594798079|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164664995|NCT00950807|594798080|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164664996|NCT00950807|594798081|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164664997|NCT00950807|594798082|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164664998|NCT00950807|594798083|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164664999|NCT00950807|594798074|FG000|Treatment Period 2|Adverse Event|0|||
164665000|NCT00950807|594798075|FG001|Treatment Period 2|Adverse Event|1|||
164665001|NCT00950807|594798076|FG002|Treatment Period 2|Adverse Event|0|||
164665002|NCT00950807|594798077|FG003|Treatment Period 2|Adverse Event|1|||
164665003|NCT00950807|594798078|FG004|Treatment Period 2|Adverse Event|0|||
164665004|NCT00950807|594798079|FG005|Treatment Period 2|Adverse Event|1|||
164665005|NCT00950807|594798080|FG006|Treatment Period 2|Adverse Event|0|||
164665006|NCT00950807|594798081|FG007|Treatment Period 2|Adverse Event|1|||
164665007|NCT00950807|594798082|FG008|Treatment Period 2|Adverse Event|0|||
164665008|NCT00950807|594798083|FG009|Treatment Period 2|Adverse Event|0|||
164665009|NCT00950807|594798074|FG000|Washout Period 2|Lack of Efficacy|1|||
164665010|NCT00950807|594798075|FG001|Washout Period 2|Lack of Efficacy|0|||
164665011|NCT00950807|594798076|FG002|Washout Period 2|Lack of Efficacy|0|||
164665012|NCT00950807|594798077|FG003|Washout Period 2|Lack of Efficacy|0|||
164665013|NCT00950807|594798078|FG004|Washout Period 2|Lack of Efficacy|0|||
164665014|NCT00950807|594798079|FG005|Washout Period 2|Lack of Efficacy|0|||
164665015|NCT00950807|594798080|FG006|Washout Period 2|Lack of Efficacy|0|||
164665016|NCT00950807|594798081|FG007|Washout Period 2|Lack of Efficacy|0|||
164665017|NCT00950807|594798082|FG008|Washout Period 2|Lack of Efficacy|0|||
164665018|NCT00950807|594798083|FG009|Washout Period 2|Lack of Efficacy|0|||
164665019|NCT00950807|594798074|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
164665020|NCT00950807|594798075|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
164665021|NCT00950807|594798076|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
164665022|NCT00950807|594798077|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
164665023|NCT00950807|594798078|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
164665024|NCT00950807|594798079|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
164665025|NCT00950807|594798080|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
164665026|NCT00950807|594798081|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
164665027|NCT00950807|594798082|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
164665028|NCT00950807|594798083|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
164665029|NCT00950807|594798074|FG000|Washout Period 2|Adverse Event|3|||
164665030|NCT00950807|594798075|FG001|Washout Period 2|Adverse Event|0|||
164665031|NCT00950807|594798076|FG002|Washout Period 2|Adverse Event|0|||
164665032|NCT00950807|594798077|FG003|Washout Period 2|Adverse Event|1|||
164665033|NCT00950807|594798078|FG004|Washout Period 2|Adverse Event|0|||
164665034|NCT00950807|594798079|FG005|Washout Period 2|Adverse Event|0|||
164665035|NCT00950807|594798080|FG006|Washout Period 2|Adverse Event|0|||
164665036|NCT00950807|594798081|FG007|Washout Period 2|Adverse Event|0|||
164665037|NCT00950807|594798082|FG008|Washout Period 2|Adverse Event|0|||
164665038|NCT00950807|594798083|FG009|Washout Period 2|Adverse Event|0|||
164665039|NCT00950807|594798074|FG000|Treatment Period 3|Withdrawal by Subject|0|||
164665040|NCT00950807|594798075|FG001|Treatment Period 3|Withdrawal by Subject|0|||
164665041|NCT00950807|594798076|FG002|Treatment Period 3|Withdrawal by Subject|0|||
164665042|NCT00950807|594798077|FG003|Treatment Period 3|Withdrawal by Subject|0|||
164665043|NCT00950807|594798078|FG004|Treatment Period 3|Withdrawal by Subject|0|||
164665044|NCT00950807|594798079|FG005|Treatment Period 3|Withdrawal by Subject|0|||
164665045|NCT00950807|594798080|FG006|Treatment Period 3|Withdrawal by Subject|0|||
164665046|NCT00950807|594798081|FG007|Treatment Period 3|Withdrawal by Subject|0|||
164665047|NCT00950807|594798082|FG008|Treatment Period 3|Withdrawal by Subject|0|||
164665048|NCT00950807|594798083|FG009|Treatment Period 3|Withdrawal by Subject|1|||
164665049|NCT00950807|594798074|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
164665050|NCT00950807|594798075|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164665051|NCT00950807|594798076|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164665052|NCT00950807|594798077|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164665053|NCT00950807|594798078|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164665054|NCT00950807|594798079|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164665055|NCT00950807|594798080|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164665056|NCT00950807|594798081|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
164665057|NCT00950807|594798082|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164665058|NCT00950807|594798083|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164665059|NCT00950807|594798074|FG000|Treatment Period 3|Adverse Event|0|||
164665060|NCT00950807|594798075|FG001|Treatment Period 3|Adverse Event|0|||
164665061|NCT00950807|594798076|FG002|Treatment Period 3|Adverse Event|0|||
164665062|NCT00950807|594798077|FG003|Treatment Period 3|Adverse Event|0|||
164665063|NCT00950807|594798078|FG004|Treatment Period 3|Adverse Event|0|||
164665064|NCT00950807|594798079|FG005|Treatment Period 3|Adverse Event|0|||
164665065|NCT00950807|594798080|FG006|Treatment Period 3|Adverse Event|1|||
164665066|NCT00950807|594798081|FG007|Treatment Period 3|Adverse Event|0|||
164665067|NCT00950807|594798082|FG008|Treatment Period 3|Adverse Event|0|||
164665068|NCT00950807|594798083|FG009|Treatment Period 3|Adverse Event|0|||
164665069|NCT01492400|594798087|FG000|Overall Study|Miscellaneous Reasons|2|||
164665070|NCT01492400|594798088|FG001|Overall Study|Miscellaneous Reasons|3|||
164665071|NCT01492400|594798087|FG000|Overall Study|Personal Reasons|0|||
164665072|NCT01492400|594798088|FG001|Overall Study|Personal Reasons|5|||
164665073|NCT01492400|594798087|FG000|Overall Study|Lost to Follow-up|3|||
164665074|NCT01492400|594798088|FG001|Overall Study|Lost to Follow-up|1|||
164665075|NCT01492400|594798087|FG000|Overall Study|Pregnancy|0|||
164665076|NCT01492400|594798088|FG001|Overall Study|Pregnancy|1|||
164665077|NCT01492400|594798087|FG000|Overall Study|Lack of Efficacy|1|||
164665078|NCT01492400|594798088|FG001|Overall Study|Lack of Efficacy|1|||
164665079|NCT01492400|594798087|FG000|Overall Study|Adverse Event|10|||
164665080|NCT01492400|594798088|FG001|Overall Study|Adverse Event|5|||
164665081|NCT00659607|594798089|FG000|Overall Study|No blood pressure recorded|147|||
164665082|NCT00659607|594798089|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
164665083|NCT00659607|594798089|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
164665084|NCT00659607|594798089|FG000|Overall Study|No recorded efficacy data|15|||
164665085|NCT00659607|594798089|FG000|Overall Study|Inconsistent BP measuring date|2|||
164665086|NCT02153736|594798093|FG000|Overall Study|Lost to Follow-up|1|||
164665087|NCT02153736|594798094|FG001|Overall Study|Lost to Follow-up|0|||
164665088|NCT02153736|594798093|FG000|Overall Study|Medical status change made ineligible|1|||
164665089|NCT02153736|594798094|FG001|Overall Study|Medical status change made ineligible|0|||
164665090|NCT02153736|594798093|FG000|Overall Study|Death|0|||
164665091|NCT02153736|594798094|FG001|Overall Study|Death|1|||
164665092|NCT02153736|594798093|FG000|Overall Study|Withdrawal by Subject|0|||
164665093|NCT02153736|594798094|FG001|Overall Study|Withdrawal by Subject|1|||
164665094|NCT02568384|594798095|FG000|Overall Study|Mobile devices incompatible with App|2|||
164665095|NCT01734772|594798096|FG000|Overall Study|Adverse Event|1|||
164665096|NCT01734772|594798097|FG001|Overall Study|Adverse Event|2|||
164665097|NCT01734772|594798096|FG000|Overall Study|Withdrawal by Subject|0|||
164665098|NCT01734772|594798097|FG001|Overall Study|Withdrawal by Subject|1|||
164665099|NCT00720122|594798100|FG000|Overall Study|Lost to Follow-up|1|||
164665100|NCT00720122|594798100|FG000|Overall Study|Physician Decision|1|||
164665101|NCT00720122|594798100|FG000|Overall Study|Withdrawal by Subject|7|||
164665102|NCT03066999|594798101|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
164665103|NCT03066999|594798102|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
164665104|NCT01361126|594798103|FG000|Overall Study|Sponsor decision|0|||
164665105|NCT01361126|594798104|FG001|Overall Study|Sponsor decision|2|||
164665106|NCT02994056|594798105|FG000|Overall Study|Death|8|||
164665107|NCT02994056|594798105|FG000|Overall Study|Withdrew Consent|1|||
164665108|NCT01835145|594798109|FG000|Overall Study|Ineligible prior to treatment|1|||
164665109|NCT01835145|594798110|FG001|Overall Study|Ineligible prior to treatment|0|||
164665110|NCT01658943|594798114|FG000|Overall Study|Adverse Event|6|||
164665111|NCT01658943|594798115|FG001|Overall Study|Adverse Event|13|||
164665112|NCT01658943|594798114|FG000|Overall Study|Withdrawal by Subject|9|||
164665113|NCT01658943|594798115|FG001|Overall Study|Withdrawal by Subject|2|||
164665114|NCT01658943|594798114|FG000|Overall Study|Progression/Relapse|39|||
164665115|NCT01658943|594798115|FG001|Overall Study|Progression/Relapse|40|||
164665116|NCT01658943|594798114|FG000|Overall Study|Death|4|||
164665117|NCT01658943|594798115|FG001|Overall Study|Death|2|||
164665118|NCT01658943|594798114|FG000|Overall Study|not protocol specified|4|||
164665119|NCT01658943|594798115|FG001|Overall Study|not protocol specified|1|||
164665120|NCT01658943|594798114|FG000|Overall Study|Not eligible|7|||
164665121|NCT01658943|594798115|FG001|Overall Study|Not eligible|9|||
164665122|NCT01658943|594798114|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
164665123|NCT01658943|594798115|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
164665124|NCT01592370|594798116|FG000|Overall Study|Disease Progression|62|||
164665125|NCT01592370|594798117|FG001|Overall Study|Disease Progression|16|||
164665126|NCT01592370|594798118|FG002|Overall Study|Disease Progression|52|||
164665127|NCT01592370|594798119|FG003|Overall Study|Disease Progression|3|||
164665128|NCT01592370|594798120|FG004|Overall Study|Disease Progression|3|||
164665129|NCT01592370|594798121|FG005|Overall Study|Disease Progression|31|||
164665130|NCT01592370|594798122|FG006|Overall Study|Disease Progression|14|||
164665131|NCT01592370|594798116|FG000|Overall Study|Study Drug Toxicity|14|||
164665132|NCT01592370|594798117|FG001|Overall Study|Study Drug Toxicity|3|||
164665133|NCT01592370|594798118|FG002|Overall Study|Study Drug Toxicity|0|||
164665134|NCT01592370|594798119|FG003|Overall Study|Study Drug Toxicity|0|||
164665135|NCT01592370|594798120|FG004|Overall Study|Study Drug Toxicity|0|||
164665136|NCT01592370|594798121|FG005|Overall Study|Study Drug Toxicity|0|||
164665137|NCT01592370|594798122|FG006|Overall Study|Study Drug Toxicity|1|||
164665138|NCT01592370|594798116|FG000|Overall Study|AE unrelated to study drug|4|||
164665139|NCT01592370|594798117|FG001|Overall Study|AE unrelated to study drug|3|||
164665140|NCT01592370|594798118|FG002|Overall Study|AE unrelated to study drug|0|||
164665141|NCT01592370|594798119|FG003|Overall Study|AE unrelated to study drug|0|||
164665142|NCT01592370|594798120|FG004|Overall Study|AE unrelated to study drug|0|||
164665143|NCT01592370|594798121|FG005|Overall Study|AE unrelated to study drug|0|||
164665144|NCT01592370|594798122|FG006|Overall Study|AE unrelated to study drug|1|||
164665145|NCT01592370|594798116|FG000|Overall Study|Request to discontinue study treatment|5|||
164665146|NCT01592370|594798117|FG001|Overall Study|Request to discontinue study treatment|0|||
164665147|NCT01592370|594798118|FG002|Overall Study|Request to discontinue study treatment|2|||
164665148|NCT01592370|594798119|FG003|Overall Study|Request to discontinue study treatment|0|||
164665149|NCT01592370|594798120|FG004|Overall Study|Request to discontinue study treatment|1|||
164665150|NCT01592370|594798121|FG005|Overall Study|Request to discontinue study treatment|2|||
164665151|NCT01592370|594798122|FG006|Overall Study|Request to discontinue study treatment|0|||
164665152|NCT01592370|594798116|FG000|Overall Study|Withdrew consent|1|||
164665153|NCT01592370|594798117|FG001|Overall Study|Withdrew consent|2|||
164665154|NCT01592370|594798118|FG002|Overall Study|Withdrew consent|1|||
164665155|NCT01592370|594798119|FG003|Overall Study|Withdrew consent|1|||
164665156|NCT01592370|594798120|FG004|Overall Study|Withdrew consent|0|||
164665157|NCT01592370|594798121|FG005|Overall Study|Withdrew consent|0|||
164665158|NCT01592370|594798122|FG006|Overall Study|Withdrew consent|0|||
164665159|NCT01592370|594798116|FG000|Overall Study|Maximum clinical benefit|11|||
164665160|NCT01592370|594798117|FG001|Overall Study|Maximum clinical benefit|1|||
164665161|NCT01592370|594798118|FG002|Overall Study|Maximum clinical benefit|7|||
164665162|NCT01592370|594798119|FG003|Overall Study|Maximum clinical benefit|1|||
164665163|NCT01592370|594798120|FG004|Overall Study|Maximum clinical benefit|0|||
164665164|NCT01592370|594798121|FG005|Overall Study|Maximum clinical benefit|0|||
164665165|NCT01592370|594798122|FG006|Overall Study|Maximum clinical benefit|0|||
164665166|NCT01592370|594798116|FG000|Overall Study|No longer meets study criteria|1|||
164665167|NCT01592370|594798117|FG001|Overall Study|No longer meets study criteria|0|||
164665168|NCT01592370|594798118|FG002|Overall Study|No longer meets study criteria|0|||
164665169|NCT01592370|594798119|FG003|Overall Study|No longer meets study criteria|0|||
164665170|NCT01592370|594798120|FG004|Overall Study|No longer meets study criteria|0|||
164665171|NCT01592370|594798121|FG005|Overall Study|No longer meets study criteria|0|||
164665172|NCT01592370|594798122|FG006|Overall Study|No longer meets study criteria|0|||
164665173|NCT01592370|594798116|FG000|Overall Study|Other Reasons|6|||
164665174|NCT01592370|594798117|FG001|Overall Study|Other Reasons|0|||
164665175|NCT01592370|594798118|FG002|Overall Study|Other Reasons|10|||
164665176|NCT01592370|594798119|FG003|Overall Study|Other Reasons|0|||
164665177|NCT01592370|594798120|FG004|Overall Study|Other Reasons|0|||
164665178|NCT01592370|594798121|FG005|Overall Study|Other Reasons|1|||
164665179|NCT01592370|594798122|FG006|Overall Study|Other Reasons|0|||
164665180|NCT01592370|594798116|FG000|Overall Study|Not Treated|0|||
164665181|NCT01592370|594798117|FG001|Overall Study|Not Treated|0|||
164665182|NCT01592370|594798118|FG002|Overall Study|Not Treated|0|||
164665183|NCT01592370|594798119|FG003|Overall Study|Not Treated|0|||
164665184|NCT01592370|594798120|FG004|Overall Study|Not Treated|2|||
164665185|NCT01592370|594798121|FG005|Overall Study|Not Treated|2|||
164665186|NCT01592370|594798122|FG006|Overall Study|Not Treated|0|||
164665187|NCT01346410|594798124|FG000|Overall Study|Death|1|||
164665188|NCT00979628|594798125|FG000|Overall Study|received regimen < 24 hours|7|||
164665189|NCT00979628|594798126|FG001|Overall Study|received regimen < 24 hours|6|||
164665190|NCT00979628|594798127|FG002|Overall Study|received regimen < 24 hours|5|||
164314930|NCT01065454|593529827|FG003|Treatment|Adverse Event|6|||
164665191|NCT00979628|594798125|FG000|Overall Study|received steroids|1|||
164665192|NCT00979628|594798126|FG001|Overall Study|received steroids|1|||
164665193|NCT00979628|594798127|FG002|Overall Study|received steroids|0|||
164665194|NCT00979628|594798125|FG000|Overall Study|transferred to ICU|1|||
164665195|NCT00979628|594798126|FG001|Overall Study|transferred to ICU|2|||
164665196|NCT00979628|594798127|FG002|Overall Study|transferred to ICU|1|||
164665197|NCT05905783|594798128|FG000|Overall Study|Lost to Follow-up|12|||
164665198|NCT05905783|594798129|FG001|Overall Study|Lost to Follow-up|18|||
164665199|NCT05905783|594798128|FG000|Overall Study|Withdrawal by Subject|29|||
164665200|NCT05905783|594798129|FG001|Overall Study|Withdrawal by Subject|37|||
164665201|NCT05905783|594798128|FG000|Overall Study|Decision by sponsor|69|||
164665202|NCT05905783|594798129|FG001|Overall Study|Decision by sponsor|65|||
164665203|NCT00911859|594798130|FG000|Treatment Period|Adverse Event|3|||
164665204|NCT00911859|594798131|FG001|Treatment Period|Adverse Event|3|||
164665205|NCT00911859|594798132|FG002|Treatment Period|Adverse Event|7|||
164665206|NCT00911859|594798130|FG000|Treatment Period|Death|1|||
164665207|NCT00911859|594798131|FG001|Treatment Period|Death|3|||
164665208|NCT00911859|594798132|FG002|Treatment Period|Death|5|||
164665209|NCT00911859|594798130|FG000|Treatment Period|Lack of Efficacy|1|||
164665210|NCT00911859|594798131|FG001|Treatment Period|Lack of Efficacy|7|||
164665211|NCT00911859|594798132|FG002|Treatment Period|Lack of Efficacy|5|||
164665212|NCT00911859|594798130|FG000|Treatment Period|Physician Decision|3|||
164665213|NCT00911859|594798131|FG001|Treatment Period|Physician Decision|3|||
164665214|NCT00911859|594798132|FG002|Treatment Period|Physician Decision|3|||
164665215|NCT00911859|594798130|FG000|Treatment Period|Withdrawal by Subject|0|||
164665216|NCT00911859|594798131|FG001|Treatment Period|Withdrawal by Subject|4|||
164665217|NCT00911859|594798132|FG002|Treatment Period|Withdrawal by Subject|5|||
164665218|NCT00911859|594798130|FG000|Treatment Period|Did not receive study treatment|0|||
164665219|NCT00911859|594798131|FG001|Treatment Period|Did not receive study treatment|1|||
164665220|NCT00911859|594798132|FG002|Treatment Period|Did not receive study treatment|0|||
164665221|NCT00911859|594798130|FG000|Maintainance Period|Lack of Efficacy|0|||
164665222|NCT00911859|594798131|FG001|Maintainance Period|Lack of Efficacy|0|||
164665223|NCT00911859|594798132|FG002|Maintainance Period|Lack of Efficacy|9|||
164665224|NCT00911859|594798130|FG000|Maintainance Period|Physician Decision|0|||
164665225|NCT00911859|594798131|FG001|Maintainance Period|Physician Decision|0|||
164665226|NCT00911859|594798132|FG002|Maintainance Period|Physician Decision|9|||
164665227|NCT00911859|594798130|FG000|Maintainance Period|Withdrawal by Subject|0|||
164665228|NCT00911859|594798131|FG001|Maintainance Period|Withdrawal by Subject|0|||
164665229|NCT00911859|594798132|FG002|Maintainance Period|Withdrawal by Subject|3|||
164665230|NCT00911859|594798130|FG000|Follow-up Period|Death|5|||
164665231|NCT00911859|594798131|FG001|Follow-up Period|Death|8|||
164665232|NCT00911859|594798132|FG002|Follow-up Period|Death|10|||
164665233|NCT00911859|594798130|FG000|Follow-up Period|Lost to Follow-up|1|||
164665234|NCT00911859|594798131|FG001|Follow-up Period|Lost to Follow-up|1|||
164665235|NCT00911859|594798132|FG002|Follow-up Period|Lost to Follow-up|0|||
164665236|NCT00911859|594798130|FG000|Follow-up Period|Withdrawal by Subject|0|||
164665237|NCT00911859|594798131|FG001|Follow-up Period|Withdrawal by Subject|4|||
164204118|NCT04006457|593119159|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
164204119|NCT04006457|593119160|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
164204120|NCT04006457|593119161|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
164204121|NCT04006457|593119159|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
164204122|NCT04006457|593119160|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
164204123|NCT04006457|593119161|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
164204124|NCT04006457|593119159|FG000|Main Study: Treatment Period 1|Other|10|||
164204125|NCT04006457|593119160|FG001|Main Study: Treatment Period 1|Other|4|||
164204126|NCT04006457|593119161|FG002|Main Study: Treatment Period 1|Other|0|||
164665238|NCT00911859|594798132|FG002|Follow-up Period|Withdrawal by Subject|4|||
164665239|NCT00911859|594798130|FG000|Follow-up Period|Study terminated by sponsor|5|||
164665240|NCT00911859|594798131|FG001|Follow-up Period|Study terminated by sponsor|33|||
164665241|NCT00911859|594798132|FG002|Follow-up Period|Study terminated by sponsor|27|||
164665242|NCT04272801|594798142|FG000|Overall Study|Withdrawal by Subject|4|||
164665243|NCT04272801|594798142|FG000|Overall Study|Lost to Follow-up|4|||
164665244|NCT04272801|594798142|FG000|Overall Study|Ineligible|1|||
164665245|NCT00752856|594798143|FG000|Overall Study|randomized but did not do viral kinetics|0|||
164665246|NCT00752856|594798144|FG001|Overall Study|randomized but did not do viral kinetics|1|||
164665247|NCT02456909|594798145|FG000|Overall Study|Did not receive allocated intervention|24|||
164665248|NCT02456909|594798146|FG001|Overall Study|Did not receive allocated intervention|26|||
164665249|NCT02456909|594798145|FG000|Overall Study|Did not complete the primary outcome|0|||
164665250|NCT02456909|594798146|FG001|Overall Study|Did not complete the primary outcome|1|||
164665251|NCT01508936|594798149|FG000|Overall Study|Adverse Event|11|||
164665252|NCT01508936|594798150|FG001|Overall Study|Adverse Event|32|||
164665253|NCT01508936|594798149|FG000|Overall Study|Lack of Efficacy|0|||
164665254|NCT01508936|594798150|FG001|Overall Study|Lack of Efficacy|1|||
164665255|NCT01508936|594798149|FG000|Overall Study|Withdrawal by Subject|4|||
164665256|NCT01508936|594798150|FG001|Overall Study|Withdrawal by Subject|18|||
164665257|NCT01508936|594798149|FG000|Overall Study|Protocol Violation|2|||
164665258|NCT01508936|594798150|FG001|Overall Study|Protocol Violation|3|||
164665259|NCT01508936|594798149|FG000|Overall Study|Lost to Follow-up|2|||
164665260|NCT01508936|594798150|FG001|Overall Study|Lost to Follow-up|9|||
164665261|NCT01508936|594798149|FG000|Overall Study|Other|0|||
164665262|NCT01508936|594798150|FG001|Overall Study|Other|5|||
164665263|NCT01508936|594798149|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
164665264|NCT01508936|594798150|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
164665265|NCT00679367|594798151|FG000|Overall Study|Adverse Event|7|||
164665266|NCT00679367|594798151|FG000|Overall Study|inability to swallow oral drugs|1|||
164665267|NCT00679367|594798151|FG000|Overall Study|Lack of Efficacy|3|||
164665268|NCT00679367|594798151|FG000|Overall Study|Withdrawal by Subject|1|||
164665269|NCT01611090|594798152|FG000|Randomized Period|Lost to Follow-up|8|||
164665270|NCT01611090|594798153|FG001|Randomized Period|Lost to Follow-up|3|||
164665271|NCT01611090|594798154|FG002|Randomized Period|Lost to Follow-up|0|||
164665272|NCT01611090|594798152|FG000|Randomized Period|Withdrawal by Subject|22|||
164665273|NCT01611090|594798153|FG001|Randomized Period|Withdrawal by Subject|26|||
164665274|NCT01611090|594798154|FG002|Randomized Period|Withdrawal by Subject|0|||
164665275|NCT01611090|594798152|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
164665276|NCT01611090|594798153|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
164665277|NCT01611090|594798154|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
164665278|NCT01611090|594798152|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
164665279|NCT01611090|594798153|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
164665280|NCT01611090|594798154|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
164665281|NCT00922779|594798155|FG000|Overall Study|Adverse Event|67|||
164665282|NCT00922779|594798155|FG000|Overall Study|Pregnancy|7|||
164665283|NCT00922779|594798155|FG000|Overall Study|Withdrawal by Subject|308|||
164665284|NCT00922779|594798155|FG000|Overall Study|Lost to Follow-up|44|||
164665285|NCT00922779|594798155|FG000|Overall Study|Other|27|||
164665286|NCT00922779|594798155|FG000|Overall Study|Missing|1874|||
164665287|NCT03968224|594798156|FG000|Overall Study|Lost to Follow-up|11|||
164665288|NCT03968224|594798157|FG001|Overall Study|Lost to Follow-up|18|||
164665289|NCT03601637|594799551|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
164665290|NCT03601637|594799552|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
164665291|NCT03601637|594799551|FG000|Overall Study|Adverse Event|1|||
164665292|NCT03601637|594799552|FG001|Overall Study|Adverse Event|1|||
164665293|NCT03601637|594799551|FG000|Overall Study|Other|0|||
164665294|NCT03601637|594799552|FG001|Overall Study|Other|1|||
164665295|NCT02322047|594799554|FG000|Overall Study|Physician Decision|1|||
164665296|NCT02322047|594799555|FG001|Overall Study|Physician Decision|0|||
164665297|NCT02322047|594799556|FG002|Overall Study|Physician Decision|0|||
164665298|NCT02322047|594799557|FG003|Overall Study|Physician Decision|0|||
164665299|NCT02322047|594799554|FG000|Overall Study|Withdrawal by Subject|1|||
164665300|NCT02322047|594799555|FG001|Overall Study|Withdrawal by Subject|0|||
164665301|NCT02322047|594799556|FG002|Overall Study|Withdrawal by Subject|0|||
164665302|NCT02322047|594799557|FG003|Overall Study|Withdrawal by Subject|1|||
164665303|NCT02322047|594799554|FG000|Overall Study|Adverse Event|0|||
164665304|NCT02322047|594799555|FG001|Overall Study|Adverse Event|1|||
164665305|NCT02322047|594799556|FG002|Overall Study|Adverse Event|0|||
164665306|NCT02322047|594799557|FG003|Overall Study|Adverse Event|0|||
164665307|NCT02322047|594799554|FG000|Overall Study|Lost to Follow-up|0|||
164665308|NCT02322047|594799555|FG001|Overall Study|Lost to Follow-up|0|||
164665309|NCT02322047|594799556|FG002|Overall Study|Lost to Follow-up|1|||
164665310|NCT02322047|594799557|FG003|Overall Study|Lost to Follow-up|1|||
164665311|NCT00920140|594799560|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
164204127|NCT04006457|593119159|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
164204128|NCT04006457|593119160|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
164665312|NCT00920140|594799561|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
164665313|NCT00920140|594799562|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
164665314|NCT00920140|594799563|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
164665315|NCT00920140|594799564|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
164665316|NCT00920140|594799560|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
164665317|NCT00920140|594799561|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
164665318|NCT00920140|594799562|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
164665319|NCT00920140|594799563|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
164665320|NCT00920140|594799564|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
164665321|NCT00920140|594799560|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
164665322|NCT00920140|594799561|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
164314931|NCT01065454|593529824|FG000|Treatment|Death|1|||
164314932|NCT01065454|593529825|FG001|Treatment|Death|0|||
164314933|NCT01065454|593529826|FG002|Treatment|Death|0|||
164314934|NCT01065454|593529827|FG003|Treatment|Death|0|||
164314935|NCT01065454|593529824|FG000|Treatment|Non-compliance|1|||
164314936|NCT01065454|593529825|FG001|Treatment|Non-compliance|0|||
164314937|NCT01065454|593529826|FG002|Treatment|Non-compliance|0|||
164314938|NCT01065454|593529827|FG003|Treatment|Non-compliance|1|||
164314939|NCT01065454|593529824|FG000|Treatment|Protocol Decision|0|||
164314940|NCT01065454|593529825|FG001|Treatment|Protocol Decision|0|||
164314941|NCT01065454|593529826|FG002|Treatment|Protocol Decision|3|||
164314942|NCT01065454|593529827|FG003|Treatment|Protocol Decision|2|||
164314943|NCT01065454|593529824|FG000|Treatment|Protocol Violation|1|||
164314944|NCT01065454|593529825|FG001|Treatment|Protocol Violation|0|||
164314945|NCT01065454|593529826|FG002|Treatment|Protocol Violation|1|||
164314946|NCT01065454|593529827|FG003|Treatment|Protocol Violation|0|||
164314947|NCT01065454|593529824|FG000|Treatment|Withdrawal by Subject|3|||
164314948|NCT01065454|593529825|FG001|Treatment|Withdrawal by Subject|1|||
164314949|NCT01065454|593529826|FG002|Treatment|Withdrawal by Subject|2|||
164314950|NCT01065454|593529827|FG003|Treatment|Withdrawal by Subject|3|||
164314951|NCT01065454|593529824|FG000|Follow up|Adverse Event|1|||
164314952|NCT01065454|593529825|FG001|Follow up|Adverse Event|0|||
164314953|NCT01065454|593529826|FG002|Follow up|Adverse Event|0|||
164314954|NCT01065454|593529827|FG003|Follow up|Adverse Event|1|||
164314955|NCT01065454|593529824|FG000|Follow up|Death|0|||
164314956|NCT01065454|593529825|FG001|Follow up|Death|1|||
164314957|NCT01065454|593529826|FG002|Follow up|Death|1|||
164314958|NCT01065454|593529827|FG003|Follow up|Death|0|||
164314959|NCT01065454|593529824|FG000|Follow up|Lost to Follow-up|0|||
164314960|NCT01065454|593529825|FG001|Follow up|Lost to Follow-up|0|||
164314961|NCT01065454|593529826|FG002|Follow up|Lost to Follow-up|0|||
164314962|NCT01065454|593529827|FG003|Follow up|Lost to Follow-up|1|||
164314963|NCT01065454|593529824|FG000|Follow up|Progressive disease|0|||
164314964|NCT01065454|593529825|FG001|Follow up|Progressive disease|0|||
164314965|NCT01065454|593529826|FG002|Follow up|Progressive disease|0|||
164314966|NCT01065454|593529827|FG003|Follow up|Progressive disease|1|||
164314967|NCT01065454|593529824|FG000|Follow up|Withdrawal by Subject|1|||
164314968|NCT01065454|593529825|FG001|Follow up|Withdrawal by Subject|1|||
164314969|NCT01065454|593529826|FG002|Follow up|Withdrawal by Subject|1|||
164314970|NCT01065454|593529827|FG003|Follow up|Withdrawal by Subject|0|||
164314971|NCT01065454|593529824|FG000|Follow up|study ongoing|37|||
164314972|NCT01065454|593529825|FG001|Follow up|study ongoing|22|||
164314973|NCT01065454|593529826|FG002|Follow up|study ongoing|15|||
164314974|NCT01065454|593529827|FG003|Follow up|study ongoing|41|||
164314975|NCT03374202|593529828|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
164314976|NCT03374202|593529829|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
164314977|NCT03374202|593529830|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
164314978|NCT03374202|593529828|FG000|Five Year Long Term Follow Up|Death|0|||
164314979|NCT03374202|593529829|FG001|Five Year Long Term Follow Up|Death|1|||
164314980|NCT03374202|593529830|FG002|Five Year Long Term Follow Up|Death|0|||
164314981|NCT01604278|593531421|FG000|Overall Study|Lack of Efficacy|0|||
164314982|NCT01604278|593531422|FG001|Overall Study|Lack of Efficacy|1|||
164314983|NCT01604278|593531421|FG000|Overall Study|Lost to Follow-up|1|||
164314984|NCT01604278|593531422|FG001|Overall Study|Lost to Follow-up|0|||
164314985|NCT01604278|593531421|FG000|Overall Study|Administrative problems|2|||
164314986|NCT01604278|593531422|FG001|Overall Study|Administrative problems|1|||
164314987|NCT01604278|593531421|FG000|Overall Study|Withdrawal by Subject|3|||
164561040|NCT00848354|594421771|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
164561041|NCT00848354|594421770|FG000|Phase 2 Year 2|Unspecified Reason|1|||
164561042|NCT00848354|594421771|FG001|Phase 2 Year 2|Unspecified Reason|0|||
164561043|NCT00848354|594421770|FG000|Phase 2 Year 2|Protocol Violation|1|||
164561044|NCT00848354|594421771|FG001|Phase 2 Year 2|Protocol Violation|1|||
164561045|NCT00848354|594421770|FG000|Phase 2 Year 2|Subject Request|1|||
164561046|NCT00848354|594421771|FG001|Phase 2 Year 2|Subject Request|1|||
164561047|NCT00848354|594421770|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
164561048|NCT00848354|594421771|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
164561049|NCT04153188|594421774|FG000|Overall Study|Lost to Follow-up|1|||
164561050|NCT04153188|594421775|FG001|Overall Study|Lost to Follow-up|1|||
164314988|NCT01604278|593531422|FG001|Overall Study|Withdrawal by Subject|3|||
164314989|NCT01604278|593531421|FG000|Overall Study|Adverse Event|3|||
164314990|NCT01604278|593531422|FG001|Overall Study|Adverse Event|5|||
164314991|NCT01604278|593531421|FG000|Overall Study|Protocol Deviation|5|||
164314992|NCT01604278|593531422|FG001|Overall Study|Protocol Deviation|3|||
164314993|NCT00361634|593531436|FG000|Overall Study|Lost to Follow-up|1|||
164561051|NCT04153188|594421774|FG000|Overall Study|Withdrawal by Subject|2|||
164314994|NCT00361634|593531436|FG000|Overall Study|Withdrawal by Subject|1|||
164314995|NCT00505076|593531437|FG000|Overall Study|Adverse Event|1|||
164314996|NCT00505076|593531438|FG001|Overall Study|Adverse Event|0|||
164561052|NCT04153188|594421775|FG001|Overall Study|Withdrawal by Subject|0|||
164561053|NCT04153188|594421774|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
164314997|NCT00505076|593531439|FG002|Overall Study|Adverse Event|1|||
164314998|NCT00505076|593531437|FG000|Overall Study|Protocol Violation|2|||
164314999|NCT00505076|593531438|FG001|Overall Study|Protocol Violation|1|||
164315000|NCT00505076|593531439|FG002|Overall Study|Protocol Violation|2|||
164315001|NCT00505076|593531437|FG000|Overall Study|Withdrawal by Subject|0|||
164315002|NCT00505076|593531438|FG001|Overall Study|Withdrawal by Subject|1|||
164315003|NCT00505076|593531439|FG002|Overall Study|Withdrawal by Subject|2|||
164315004|NCT02500056|593531440|FG000|Overall Study|Lost to Follow-up|3|||
164315005|NCT02500056|593531441|FG001|Overall Study|Lost to Follow-up|7|||
164315006|NCT02500056|593531440|FG000|Overall Study|Recurrence|1|||
164315007|NCT02500056|593531441|FG001|Overall Study|Recurrence|0|||
164315008|NCT02500056|593531440|FG000|Overall Study|Death|3|||
164315009|NCT02500056|593531441|FG001|Overall Study|Death|1|||
164315010|NCT03232333|593531446|FG000|Overall Study|Infection or Osteomyelitis|9|||
164315011|NCT03232333|593531446|FG000|Overall Study|Lost to Follow-up|4|||
164315012|NCT03232333|593531446|FG000|Overall Study|Withdrawal by Subject|2|||
164315013|NCT01155011|593531449|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
164315014|NCT01155011|593531450|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
164315015|NCT01155011|593531449|FG000|Baseline to 6 Months|investigator decision, moved|4|||
164315016|NCT01155011|593531450|FG001|Baseline to 6 Months|investigator decision, moved|5|||
164315017|NCT01155011|593531449|FG000|Baseline to 6 Months|Death|0|||
164315018|NCT01155011|593531450|FG001|Baseline to 6 Months|Death|1|||
164315019|NCT01155011|593531449|FG000|6 to 12 Months|Withdrawal by Subject|8|||
164315020|NCT01155011|593531450|FG001|6 to 12 Months|Withdrawal by Subject|5|||
164315021|NCT01155011|593531449|FG000|6 to 12 Months|Death|1|||
164315022|NCT01155011|593531450|FG001|6 to 12 Months|Death|5|||
164315023|NCT01087736|593531451|FG000|Overall Study|Lost to Follow-up|1|||
164315024|NCT01087736|593531452|FG001|Overall Study|Lost to Follow-up|0|||
164315025|NCT01087736|593531451|FG000|Overall Study|Death|0|||
164315026|NCT01087736|593531452|FG001|Overall Study|Death|1|||
164315027|NCT01087736|593531451|FG000|Overall Study|Withdrawal by Subject|0|||
164315028|NCT01087736|593531452|FG001|Overall Study|Withdrawal by Subject|1|||
164315029|NCT01253811|593531453|FG000|Overall Study|Withdrawal criteria|1|||
164561054|NCT04153188|594421775|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
164561055|NCT01489527|594421776|FG000|Overall Study|Pregnancy|9|||
164561056|NCT01489527|594421777|FG001|Overall Study|Pregnancy|14|||
164561057|NCT01489527|594421776|FG000|Overall Study|Participant moved|6|||
164561058|NCT01489527|594421777|FG001|Overall Study|Participant moved|7|||
164561059|NCT01489527|594421776|FG000|Overall Study|Withdrawal by Subject|0|||
164561060|NCT01489527|594421777|FG001|Overall Study|Withdrawal by Subject|4|||
164561061|NCT01489527|594421776|FG000|Overall Study|Lost to Follow-up|5|||
164561062|NCT01489527|594421777|FG001|Overall Study|Lost to Follow-up|1|||
164561063|NCT01489527|594421776|FG000|Overall Study|Procedures|1|||
164561064|NCT01489527|594421777|FG001|Overall Study|Procedures|0|||
164561065|NCT01489527|594421776|FG000|Overall Study|Not compliant|1|||
164561066|NCT01489527|594421777|FG001|Overall Study|Not compliant|0|||
164561067|NCT04899232|594421778|FG000|Screening Period|Physician Decision|1|||
164561068|NCT04899232|594421779|FG001|Screening Period|Physician Decision|0|||
164561069|NCT04899232|594421780|FG002|Screening Period|Physician Decision|0|||
164561070|NCT04899232|594421778|FG000|Screening Period|Withdrawal by Subject|1|||
164561071|NCT04899232|594421779|FG001|Screening Period|Withdrawal by Subject|0|||
164561072|NCT04899232|594421780|FG002|Screening Period|Withdrawal by Subject|0|||
164561073|NCT04899232|594421778|FG000|Screening Period|Participant discharged before receiving intervention|3|||
164561074|NCT04899232|594421779|FG001|Screening Period|Participant discharged before receiving intervention|0|||
164561075|NCT04899232|594421780|FG002|Screening Period|Participant discharged before receiving intervention|0|||
164561076|NCT00700271|594421781|FG000|Overall Study|Adverse Event|4|||
164561077|NCT00700271|594421782|FG001|Overall Study|Adverse Event|6|||
164561078|NCT00700271|594421781|FG000|Overall Study|Protocol Violation|1|||
164561079|NCT00700271|594421782|FG001|Overall Study|Protocol Violation|0|||
164561080|NCT00700271|594421781|FG000|Overall Study|Administrative Reasons|1|||
164561081|NCT00700271|594421782|FG001|Overall Study|Administrative Reasons|0|||
164561082|NCT00700271|594421781|FG000|Overall Study|Withdrawal by Subject|6|||
164561083|NCT00700271|594421782|FG001|Overall Study|Withdrawal by Subject|4|||
164561084|NCT00700271|594421781|FG000|Overall Study|Lost to Follow-up|2|||
164561085|NCT00700271|594421782|FG001|Overall Study|Lost to Follow-up|2|||
164561086|NCT02406781|594421783|FG000|Overall Study|Protocol Violation|2|||
164561087|NCT02406781|594421784|FG001|Overall Study|Protocol Violation|2|||
164561088|NCT02406781|594421785|FG002|Overall Study|Protocol Violation|2|||
164561089|NCT02406781|594421786|FG003|Overall Study|Protocol Violation|2|||
164561090|NCT02406781|594421787|FG004|Overall Study|Protocol Violation|1|||
164561091|NCT02406781|594421788|FG005|Overall Study|Protocol Violation|5|||
164561092|NCT02406781|594421789|FG006|Overall Study|Protocol Violation|3|||
164561093|NCT03505021|594421790|FG000|Overall Study|Protocol Violation|1|||
164561094|NCT03505021|594421791|FG001|Overall Study|Protocol Violation|0|||
164561095|NCT03505021|594421790|FG000|Overall Study|Death|9|||
164561096|NCT03505021|594421791|FG001|Overall Study|Death|8|||
164561097|NCT03505021|594421790|FG000|Overall Study|Consent withdrawn by subject|6|||
164665323|NCT00920140|594799562|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
164665324|NCT00920140|594799563|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
164665325|NCT00920140|594799564|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
164665326|NCT00920140|594799560|FG000|Phase 2|Adverse Event|0|||
164665327|NCT00920140|594799561|FG001|Phase 2|Adverse Event|0|||
164665328|NCT00920140|594799562|FG002|Phase 2|Adverse Event|14|||
164665329|NCT00920140|594799563|FG003|Phase 2|Adverse Event|2|||
164665330|NCT00920140|594799564|FG004|Phase 2|Adverse Event|3|||
164665331|NCT00920140|594799560|FG000|Phase 2|Lack of Efficacy|0|||
164665332|NCT00920140|594799561|FG001|Phase 2|Lack of Efficacy|0|||
164665333|NCT00920140|594799562|FG002|Phase 2|Lack of Efficacy|29|||
164665334|NCT00920140|594799563|FG003|Phase 2|Lack of Efficacy|14|||
164665335|NCT00920140|594799564|FG004|Phase 2|Lack of Efficacy|5|||
164665336|NCT00920140|594799560|FG000|Phase 2|Lost to Follow-up|0|||
164665337|NCT00920140|594799561|FG001|Phase 2|Lost to Follow-up|0|||
164665338|NCT00920140|594799562|FG002|Phase 2|Lost to Follow-up|0|||
164665339|NCT00920140|594799563|FG003|Phase 2|Lost to Follow-up|1|||
164665340|NCT00920140|594799564|FG004|Phase 2|Lost to Follow-up|0|||
164665341|NCT00920140|594799560|FG000|Phase 2|Physician Decision|0|||
164665342|NCT00920140|594799561|FG001|Phase 2|Physician Decision|0|||
164665343|NCT00920140|594799562|FG002|Phase 2|Physician Decision|3|||
164665344|NCT00920140|594799563|FG003|Phase 2|Physician Decision|3|||
164665345|NCT00920140|594799564|FG004|Phase 2|Physician Decision|2|||
164665346|NCT00920140|594799560|FG000|Phase 2|Withdrawal by Subject|0|||
164665347|NCT00920140|594799561|FG001|Phase 2|Withdrawal by Subject|0|||
164665348|NCT00920140|594799562|FG002|Phase 2|Withdrawal by Subject|4|||
164665349|NCT00920140|594799563|FG003|Phase 2|Withdrawal by Subject|2|||
164315030|NCT00759564|593531454|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
164665350|NCT00920140|594799564|FG004|Phase 2|Withdrawal by Subject|1|||
164665351|NCT01400425|594799565|FG000|Overall Study|Withdrawal by Subject|10|||
164665352|NCT00720096|594799567|FG000|Overall Study|Withdrawal by Subject|0|||
164665353|NCT00720096|594799568|FG001|Overall Study|Withdrawal by Subject|2|||
164665354|NCT04557124|594799569|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
164665355|NCT04557124|594799570|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
164665356|NCT04557124|594799569|FG000|Mid-point (1 Month)|Missed testing|5|||
164665357|NCT04557124|594799570|FG001|Mid-point (1 Month)|Missed testing|4|||
164665358|NCT04557124|594799569|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
164665359|NCT04557124|594799570|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
164665360|NCT04557124|594799569|FG000|Post-testing (2 Months)|Missed testing|1|||
164665361|NCT04557124|594799570|FG001|Post-testing (2 Months)|Missed testing|5|||
164665362|NCT04557124|594799569|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
164315031|NCT00759564|593531455|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
164315032|NCT00759564|593531456|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
164315033|NCT00759564|593531457|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
164315034|NCT00759564|593531458|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
164315035|NCT01565343|593531461|FG000|Overall Study|Administrative decision/technical issues|1|||
164315036|NCT01565343|593531462|FG001|Overall Study|Administrative decision/technical issues|0|||
164315037|NCT01565343|593531463|FG002|Overall Study|Administrative decision/technical issues|0|||
164315038|NCT02059291|593531468|FG000|Epoch 2|Lack of Efficacy|0|||
164315039|NCT02059291|593531469|FG001|Epoch 2|Lack of Efficacy|0|||
164315040|NCT02059291|593531470|FG002|Epoch 2|Lack of Efficacy|0|||
164315041|NCT02059291|593531471|FG003|Epoch 2|Lack of Efficacy|1|||
164315042|NCT02059291|593531472|FG004|Epoch 2|Lack of Efficacy|0|||
164315043|NCT02059291|593531473|FG005|Epoch 2|Lack of Efficacy|1|||
164315044|NCT02059291|593531474|FG006|Epoch 2|Lack of Efficacy|0|||
164315045|NCT02059291|593531475|FG007|Epoch 2|Lack of Efficacy|0|||
164315046|NCT02059291|593531476|FG008|Epoch 2|Lack of Efficacy|0|||
164315047|NCT02059291|593531477|FG009|Epoch 2|Lack of Efficacy|0|||
164315048|NCT02059291|593531478|FG010|Epoch 2|Lack of Efficacy|0|||
164315049|NCT02059291|593531479|FG011|Epoch 2|Lack of Efficacy|0|||
164315050|NCT02059291|593531480|FG012|Epoch 2|Lack of Efficacy|0|||
164315051|NCT02059291|593531481|FG013|Epoch 2|Lack of Efficacy|0|||
164315052|NCT02059291|593531482|FG014|Epoch 2|Lack of Efficacy|0|||
164315053|NCT02059291|593531483|FG015|Epoch 2|Lack of Efficacy|0|||
164315054|NCT02059291|593531484|FG016|Epoch 2|Lack of Efficacy|0|||
164665363|NCT04557124|594799570|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
164665364|NCT04557124|594799569|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
164665365|NCT04557124|594799570|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
164665366|NCT00442936|594799571|FG000|Overall Study|Protocol Violation|1|||
164665367|NCT00442936|594799572|FG001|Overall Study|Protocol Violation|0|||
164665368|NCT00442936|594799573|FG002|Overall Study|Protocol Violation|1|||
164665369|NCT00442936|594799574|FG003|Overall Study|Protocol Violation|1|||
164665370|NCT02428699|594799575|FG000|Washout Period 1|Screen Failure|1|||
164665371|NCT02428699|594799576|FG001|Washout Period 1|Screen Failure|2|||
164315055|NCT02059291|593531485|FG017|Epoch 2|Lack of Efficacy|0|||
164315056|NCT02059291|593531486|FG018|Epoch 2|Lack of Efficacy|0|||
164315057|NCT02059291|593531487|FG019|Epoch 2|Lack of Efficacy|0|||
164665372|NCT03127137|594799577|FG000|Overall Study|Requested sedation after consent|1|||
164665373|NCT03127137|594799578|FG001|Overall Study|Requested sedation after consent|0|||
164665374|NCT03127137|594799577|FG000|Overall Study|Malfunction in electronic data collection|1|||
164204129|NCT04006457|593119161|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
164204130|NCT04006457|593119159|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
164204131|NCT04006457|593119160|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
164204132|NCT04006457|593119161|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
164204133|NCT04006457|593119159|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
164204134|NCT04006457|593119160|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
164204135|NCT04006457|593119161|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
164204136|NCT04006457|593119159|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
164204137|NCT04006457|593119160|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
164204138|NCT04006457|593119161|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
164204139|NCT04006457|593119159|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
164204140|NCT04006457|593119160|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
164204141|NCT04006457|593119161|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
164204142|NCT04006457|593119159|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
164204143|NCT04006457|593119160|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
164204144|NCT04006457|593119161|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
164204145|NCT04006457|593119159|FG000|Main Study: Treatment Period 2|Other|2|||
164204146|NCT04006457|593119160|FG001|Main Study: Treatment Period 2|Other|3|||
164204147|NCT04006457|593119161|FG002|Main Study: Treatment Period 2|Other|0|||
164204148|NCT04006457|593119159|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
164204149|NCT04006457|593119160|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
164204150|NCT04006457|593119161|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
164204151|NCT04006457|593119159|FG000|Main Study: Treatment Period 2|Ongoing|86|||
164204152|NCT04006457|593119160|FG001|Main Study: Treatment Period 2|Ongoing|96|||
164204153|NCT04006457|593119161|FG002|Main Study: Treatment Period 2|Ongoing|0|||
164204154|NCT04006457|593119159|FG000|Main Study Observation Period|Adverse Event|1|||
164204155|NCT04006457|593119160|FG001|Main Study Observation Period|Adverse Event|1|||
164204156|NCT04006457|593119161|FG002|Main Study Observation Period|Adverse Event|0|||
164204157|NCT04006457|593119159|FG000|Main Study Observation Period|Lost to Follow-up|0|||
164204158|NCT04006457|593119160|FG001|Main Study Observation Period|Lost to Follow-up|1|||
164204159|NCT04006457|593119161|FG002|Main Study Observation Period|Lost to Follow-up|0|||
164204160|NCT04006457|593119159|FG000|Main Study Observation Period|Pregnancy|1|||
164204161|NCT04006457|593119160|FG001|Main Study Observation Period|Pregnancy|0|||
164204162|NCT04006457|593119161|FG002|Main Study Observation Period|Pregnancy|0|||
164204163|NCT04006457|593119159|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
164204164|NCT04006457|593119160|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
164204165|NCT04006457|593119161|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
164204166|NCT04006457|593119159|FG000|Main Study Observation Period|Other|8|||
164204167|NCT04006457|593119160|FG001|Main Study Observation Period|Other|16|||
164204168|NCT04006457|593119161|FG002|Main Study Observation Period|Other|0|||
164204169|NCT04006457|593119159|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
164204170|NCT04006457|593119160|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
164204171|NCT04006457|593119161|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
164204172|NCT04006457|593119159|FG000|Main Study Observation Period|Ongoing|2|||
164204173|NCT04006457|593119160|FG001|Main Study Observation Period|Ongoing|1|||
164204174|NCT04006457|593119161|FG002|Main Study Observation Period|Ongoing|0|||
164204175|NCT04006457|593119159|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
164204176|NCT04006457|593119160|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
164204177|NCT04006457|593119161|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
164204178|NCT05918055|593119162|FG000|Phase I - Dose Level 1|Ineligible|0|||
164204179|NCT05918055|593119163|FG001|Phase I - Dose Level 1|Ineligible|0|||
164204180|NCT05918055|593119164|FG002|Phase I - Dose Level 1|Ineligible|1|||
164204181|NCT05918055|593119162|FG000|Phase I - Dose Level -1|Physician Decision|1|||
164204182|NCT05918055|593119163|FG001|Phase I - Dose Level -1|Physician Decision|0|||
164204183|NCT05918055|593119164|FG002|Phase I - Dose Level -1|Physician Decision|0|||
164204184|NCT00109343|593119167|FG000|Overall Study|Adverse Event|1|||
164204185|NCT00109343|593119168|FG001|Overall Study|Adverse Event|0|||
164204186|NCT00109343|593119169|FG002|Overall Study|Adverse Event|2|||
164204187|NCT00109343|593119167|FG000|Overall Study|Lack of Efficacy|1|||
164204188|NCT00109343|593119168|FG001|Overall Study|Lack of Efficacy|0|||
164204189|NCT00109343|593119169|FG002|Overall Study|Lack of Efficacy|0|||
164204190|NCT00109343|593119167|FG000|Overall Study|Lost to Follow-up|35|||
164204191|NCT00109343|593119168|FG001|Overall Study|Lost to Follow-up|20|||
164204192|NCT00109343|593119169|FG002|Overall Study|Lost to Follow-up|14|||
164204193|NCT00109343|593119167|FG000|Overall Study|Protocol Violation|1|||
164204194|NCT00109343|593119168|FG001|Overall Study|Protocol Violation|2|||
164204195|NCT00109343|593119169|FG002|Overall Study|Protocol Violation|2|||
164204196|NCT00109343|593119167|FG000|Overall Study|Withdrawal by Subject|15|||
164204197|NCT00109343|593119168|FG001|Overall Study|Withdrawal by Subject|11|||
164204198|NCT00109343|593119169|FG002|Overall Study|Withdrawal by Subject|10|||
164204199|NCT00109343|593119167|FG000|Overall Study|Subject Moved|6|||
164204200|NCT00109343|593119168|FG001|Overall Study|Subject Moved|2|||
164204201|NCT00109343|593119169|FG002|Overall Study|Subject Moved|1|||
164204202|NCT00109343|593119167|FG000|Overall Study|Other|5|||
164204203|NCT00109343|593119168|FG001|Overall Study|Other|2|||
164204204|NCT00109343|593119169|FG002|Overall Study|Other|1|||
164204205|NCT04460885|593119170|FG000|Overall Study|Withdrawal by Subject|6|||
164204206|NCT04460885|593119171|FG001|Overall Study|Withdrawal by Subject|8|||
164204207|NCT04460885|593119170|FG000|Overall Study|Site closure|1|||
164204208|NCT04460885|593119171|FG001|Overall Study|Site closure|0|||
164204209|NCT04460885|593119170|FG000|Overall Study|Death|5|||
164204210|NCT04460885|593119171|FG001|Overall Study|Death|4|||
164204211|NCT04460885|593119170|FG000|Overall Study|Physician Decision|2|||
164204212|NCT04460885|593119171|FG001|Overall Study|Physician Decision|1|||
164204213|NCT04460885|593119170|FG000|Overall Study|Lost to Follow-up|4|||
164204214|NCT04460885|593119171|FG001|Overall Study|Lost to Follow-up|4|||
164204215|NCT01721798|593119174|FG000|Overall Study|Death|0|||
164204216|NCT01721798|593119175|FG001|Overall Study|Death|0|||
164204217|NCT01721798|593119176|FG002|Overall Study|Death|1|||
164204218|NCT01721798|593119177|FG003|Overall Study|Death|1|||
164204219|NCT01721798|593119174|FG000|Overall Study|Lost to Follow-up|2|||
164204220|NCT01721798|593119175|FG001|Overall Study|Lost to Follow-up|2|||
164204221|NCT01721798|593119176|FG002|Overall Study|Lost to Follow-up|9|||
164204222|NCT01721798|593119177|FG003|Overall Study|Lost to Follow-up|9|||
164204223|NCT01721798|593119174|FG000|Overall Study|Pregnancy|0|||
164204224|NCT01721798|593119175|FG001|Overall Study|Pregnancy|0|||
164204225|NCT01721798|593119176|FG002|Overall Study|Pregnancy|1|||
164204226|NCT01721798|593119177|FG003|Overall Study|Pregnancy|1|||
164204227|NCT01721798|593119174|FG000|Overall Study|Withdrawal by Subject|1|||
164204228|NCT01721798|593119175|FG001|Overall Study|Withdrawal by Subject|0|||
164204229|NCT01721798|593119176|FG002|Overall Study|Withdrawal by Subject|2|||
164204230|NCT01721798|593119177|FG003|Overall Study|Withdrawal by Subject|1|||
164204231|NCT01721798|593119174|FG000|Overall Study|Not eligible for 24 month visit|1|||
164204232|NCT01721798|593119175|FG001|Overall Study|Not eligible for 24 month visit|0|||
164204233|NCT01721798|593119176|FG002|Overall Study|Not eligible for 24 month visit|8|||
164204234|NCT01721798|593119177|FG003|Overall Study|Not eligible for 24 month visit|7|||
164204235|NCT00961064|593119178|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
164204236|NCT00961064|593119178|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
164204237|NCT00961064|593119178|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
164204238|NCT00961064|593119178|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
164204239|NCT00961064|593119178|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
164204240|NCT00961064|593119178|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
164204241|NCT00961064|593119178|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
164204242|NCT00961064|593119178|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
164204243|NCT01408641|593119179|FG000|Overall Study|Physician Decision|1|||
164204244|NCT01408641|593119180|FG001|Overall Study|Physician Decision|0|||
164204245|NCT02842866|593119181|FG000|Overall Study|Serious Adverse Event|0|||
164204246|NCT02842866|593119182|FG001|Overall Study|Serious Adverse Event|1|||
164204247|NCT02842866|593119181|FG000|Overall Study|Protocol Violation|4|||
164204248|NCT02842866|593119182|FG001|Overall Study|Protocol Violation|2|||
164204249|NCT02842866|593119181|FG000|Overall Study|Lost to Follow-up|2|||
164204250|NCT02842866|593119182|FG001|Overall Study|Lost to Follow-up|0|||
164204251|NCT02842866|593119181|FG000|Overall Study|Withdrawal by Subject|1|||
164204252|NCT02842866|593119182|FG001|Overall Study|Withdrawal by Subject|0|||
164204253|NCT01432327|593119183|FG000|Posttest 3 Months|depression|3|||
164204254|NCT01432327|593119184|FG001|Posttest 3 Months|depression|0|||
164204255|NCT01432327|593119185|FG002|Posttest 3 Months|depression|0|||
164204256|NCT01432327|593119186|FG003|Posttest 3 Months|depression|0|||
164204257|NCT01432327|593119183|FG000|Posttest 3 Months|Lost to Follow-up|1|||
164204258|NCT01432327|593119184|FG001|Posttest 3 Months|Lost to Follow-up|0|||
164204259|NCT01432327|593119185|FG002|Posttest 3 Months|Lost to Follow-up|2|||
164204260|NCT01432327|593119186|FG003|Posttest 3 Months|Lost to Follow-up|1|||
164204261|NCT01432327|593119183|FG000|Posttest 3 Months|Allergic reaction|0|||
164204262|NCT01432327|593119184|FG001|Posttest 3 Months|Allergic reaction|2|||
164204263|NCT01432327|593119185|FG002|Posttest 3 Months|Allergic reaction|0|||
164204264|NCT01432327|593119186|FG003|Posttest 3 Months|Allergic reaction|0|||
164204265|NCT01432327|593119183|FG000|Posttest 6 Months|Lost to Follow-up|0|||
164204266|NCT01432327|593119184|FG001|Posttest 6 Months|Lost to Follow-up|0|||
164204267|NCT01432327|593119185|FG002|Posttest 6 Months|Lost to Follow-up|3|||
164204268|NCT01432327|593119186|FG003|Posttest 6 Months|Lost to Follow-up|2|||
164204269|NCT01432327|593119183|FG000|Posttest 6 Months|Allergic reaction|0|||
164204270|NCT01432327|593119184|FG001|Posttest 6 Months|Allergic reaction|0|||
164204271|NCT01432327|593119185|FG002|Posttest 6 Months|Allergic reaction|1|||
164204272|NCT01432327|593119186|FG003|Posttest 6 Months|Allergic reaction|0|||
164204273|NCT01432327|593119183|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
164204274|NCT01432327|593119184|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
164204275|NCT01432327|593119185|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
164204276|NCT01432327|593119186|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
164204277|NCT01432327|593119183|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
164204278|NCT01432327|593119184|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
164204279|NCT01432327|593119185|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
164204280|NCT01432327|593119186|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
164204281|NCT01432327|593119183|FG000|Posttest 1 Year|Lost to Follow-up|0|||
164204282|NCT01432327|593119184|FG001|Posttest 1 Year|Lost to Follow-up|0|||
164204283|NCT01432327|593119185|FG002|Posttest 1 Year|Lost to Follow-up|4|||
164204284|NCT01432327|593119186|FG003|Posttest 1 Year|Lost to Follow-up|2|||
164204285|NCT01432327|593119183|FG000|Posttest 1 Year|Allergic reaction|0|||
164204286|NCT01432327|593119184|FG001|Posttest 1 Year|Allergic reaction|0|||
164204287|NCT01432327|593119185|FG002|Posttest 1 Year|Allergic reaction|1|||
164204288|NCT01432327|593119186|FG003|Posttest 1 Year|Allergic reaction|1|||
164204289|NCT05001620|593119189|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
164204290|NCT05001620|593119190|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
164204291|NCT00819039|593119191|FG000|Overall Study|Physician Decision|1|||
164204292|NCT00819039|593119192|FG001|Overall Study|Physician Decision|0|||
164204293|NCT00819039|593119193|FG002|Overall Study|Physician Decision|1|||
164204294|NCT00819039|593119191|FG000|Overall Study|Protocol Violation|1|||
164204295|NCT00819039|593119192|FG001|Overall Study|Protocol Violation|0|||
164204296|NCT00819039|593119193|FG002|Overall Study|Protocol Violation|0|||
164204297|NCT04796415|593119194|FG000|Overall Study|not interested|12|||
164204298|NCT04796415|593119194|FG000|Overall Study|health issue|8|||
164204299|NCT04796415|593119194|FG000|Overall Study|Other|4|||
164204300|NCT04796415|593119194|FG000|Overall Study|discharged from home health service|3|||
164204301|NCT04796415|593119194|FG000|Overall Study|re-hospitalization|2|||
164204302|NCT04796415|593119194|FG000|Overall Study|moving to nursing home|1|||
164204303|NCT04796415|593119194|FG000|Overall Study|lost contact|1|||
164204304|NCT04009837|593119198|FG000|Overall Study|Withdrawal by Subject|5|||
164204305|NCT04009837|593119199|FG001|Overall Study|Withdrawal by Subject|4|||
164204306|NCT04009837|593119198|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
164204307|NCT04009837|593119199|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
164204308|NCT04649359|593119200|FG000|Overall Study|Withdrawal by Subject|7|||
164204309|NCT04649359|593119201|FG001|Overall Study|Withdrawal by Subject|7|||
164204310|NCT04649359|593119200|FG000|Overall Study|Death|41|||
164204311|NCT04649359|593119201|FG001|Overall Study|Death|26|||
164204312|NCT04649359|593119200|FG000|Overall Study|Ongoing in the study|75|||
164204313|NCT04649359|593119201|FG001|Overall Study|Ongoing in the study|31|||
164204314|NCT03307174|593119205|FG000|Overall Study|Unplanned ICU Administrion|5|||
164204315|NCT03307174|593119206|FG001|Overall Study|Unplanned ICU Administrion|3|||
164204316|NCT03307174|593119205|FG000|Overall Study|Aborted Surgery|1|||
164204317|NCT03307174|593119206|FG001|Overall Study|Aborted Surgery|2|||
164204318|NCT03307174|593119205|FG000|Overall Study|Hypotension|6|||
164204319|NCT03307174|593119206|FG001|Overall Study|Hypotension|0|||
164204320|NCT03307174|593119205|FG000|Overall Study|Nonfunctional epidural|1|||
164204321|NCT03307174|593119206|FG001|Overall Study|Nonfunctional epidural|1|||
164204322|NCT03307174|593119205|FG000|Overall Study|Planned epidural removal|1|||
164204323|NCT03307174|593119206|FG001|Overall Study|Planned epidural removal|0|||
164204324|NCT03307174|593119205|FG000|Overall Study|Intrathecal catheter placement|0|||
164204325|NCT03307174|593119206|FG001|Overall Study|Intrathecal catheter placement|1|||
164204326|NCT05911841|593119207|FG000|Induction Period|Study Terminated by Sponsor|2|||
164204327|NCT05911841|593119208|FG001|Induction Period|Study Terminated by Sponsor|0|||
164204328|NCT05911841|593119209|FG002|Induction Period|Study Terminated by Sponsor|14|||
164204329|NCT05911841|593119210|FG003|Induction Period|Study Terminated by Sponsor|6|||
164204330|NCT05911841|593119211|FG004|Induction Period|Study Terminated by Sponsor|0|||
164204331|NCT05911841|593119212|FG005|Induction Period|Study Terminated by Sponsor|0|||
164204332|NCT05911841|593119213|FG006|Induction Period|Study Terminated by Sponsor|0|||
164204333|NCT05911841|593119214|FG007|Induction Period|Study Terminated by Sponsor|0|||
164204334|NCT05911841|593119215|FG008|Induction Period|Study Terminated by Sponsor|0|||
164204335|NCT05911841|593119216|FG009|Induction Period|Study Terminated by Sponsor|0|||
164204336|NCT05911841|593119207|FG000|Induction Period|Withdrawal by Subject|4|||
164204337|NCT05911841|593119208|FG001|Induction Period|Withdrawal by Subject|3|||
164204338|NCT05911841|593119209|FG002|Induction Period|Withdrawal by Subject|4|||
164204339|NCT05911841|593119210|FG003|Induction Period|Withdrawal by Subject|6|||
164204340|NCT05911841|593119211|FG004|Induction Period|Withdrawal by Subject|0|||
164204341|NCT05911841|593119212|FG005|Induction Period|Withdrawal by Subject|0|||
164204342|NCT05911841|593119213|FG006|Induction Period|Withdrawal by Subject|0|||
164204343|NCT05911841|593119214|FG007|Induction Period|Withdrawal by Subject|0|||
164204344|NCT05911841|593119215|FG008|Induction Period|Withdrawal by Subject|0|||
164204345|NCT05911841|593119216|FG009|Induction Period|Withdrawal by Subject|0|||
164204346|NCT05911841|593119207|FG000|Induction Period|Lack of Efficacy|3|||
164204347|NCT05911841|593119208|FG001|Induction Period|Lack of Efficacy|0|||
164204348|NCT05911841|593119209|FG002|Induction Period|Lack of Efficacy|3|||
164204349|NCT05911841|593119210|FG003|Induction Period|Lack of Efficacy|3|||
164204350|NCT05911841|593119211|FG004|Induction Period|Lack of Efficacy|0|||
164204351|NCT05911841|593119212|FG005|Induction Period|Lack of Efficacy|0|||
164204352|NCT05911841|593119213|FG006|Induction Period|Lack of Efficacy|0|||
164204353|NCT05911841|593119214|FG007|Induction Period|Lack of Efficacy|0|||
164665375|NCT03127137|594799578|FG001|Overall Study|Malfunction in electronic data collection|0|||
164665376|NCT03127137|594799577|FG000|Overall Study|Post procedure testing could not be obtained|0|||
164665377|NCT03127137|594799578|FG001|Overall Study|Post procedure testing could not be obtained|1|||
164665378|NCT04424407|594799579|FG000|Overall Study|Withdrawal by Subject|2|||
164665379|NCT04424407|594799579|FG000|Overall Study|Lost to Follow-up|1|||
164665380|NCT00264797|594799580|FG000|Overall Study|Withdrawal by Subject|11|||
164665381|NCT00264797|594799581|FG001|Overall Study|Withdrawal by Subject|11|||
164665382|NCT00264797|594799580|FG000|Overall Study|Lost to Follow-up|9|||
164665383|NCT00264797|594799581|FG001|Overall Study|Lost to Follow-up|17|||
164665384|NCT00264797|594799580|FG000|Overall Study|Moved from area|3|||
164665385|NCT00264797|594799581|FG001|Overall Study|Moved from area|1|||
164665386|NCT00264797|594799580|FG000|Overall Study|Practical Problems|2|||
164665387|NCT00264797|594799581|FG001|Overall Study|Practical Problems|3|||
164665388|NCT00264797|594799580|FG000|Overall Study|Incarceration|4|||
164665389|NCT00264797|594799581|FG001|Overall Study|Incarceration|5|||
164665390|NCT00264797|594799580|FG000|Overall Study|Pressure/advice from Outsiders|1|||
164665391|NCT00264797|594799581|FG001|Overall Study|Pressure/advice from Outsiders|1|||
164665392|NCT00264797|594799580|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
164665393|NCT00264797|594799581|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
164665394|NCT00264797|594799580|FG000|Overall Study|Other|3|||
164665395|NCT00264797|594799581|FG001|Overall Study|Other|4|||
164665396|NCT03992196|594799582|FG000|Enrollment|lost to follow-up prior dosing|1|||
164665397|NCT03992196|594799583|FG001|Enrollment|lost to follow-up prior dosing|0|||
164665398|NCT03992196|594799584|FG002|Enrollment|lost to follow-up prior dosing|0|||
164665399|NCT03992196|594799582|FG000|Treatment|Protocol Violation|0|||
164665400|NCT03992196|594799583|FG001|Treatment|Protocol Violation|0|||
164665401|NCT03992196|594799584|FG002|Treatment|Protocol Violation|1|||
164665402|NCT03992196|594799582|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
164665403|NCT03992196|594799583|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
164665404|NCT03992196|594799584|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
164665405|NCT03992196|594799582|FG000|Treatment|Withdrawal due to non-compliance|0|||
164665406|NCT03992196|594799583|FG001|Treatment|Withdrawal due to non-compliance|0|||
164665407|NCT03992196|594799584|FG002|Treatment|Withdrawal due to non-compliance|1|||
164665408|NCT03992196|594799582|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
164665409|NCT03992196|594799583|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
164665410|NCT03992196|594799584|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
164665411|NCT03992196|594799582|FG000|Treatment|Withdrawal by parent/guardian|0|||
164665412|NCT03992196|594799583|FG001|Treatment|Withdrawal by parent/guardian|0|||
164665413|NCT03992196|594799584|FG002|Treatment|Withdrawal by parent/guardian|2|||
164665414|NCT01249664|594799587|FG000|Overall Study|Withdrawal by Subject|5|||
164665415|NCT01249664|594799588|FG001|Overall Study|Withdrawal by Subject|0|||
164665416|NCT01249664|594799587|FG000|Overall Study|Adverse Event|1|||
164665417|NCT01249664|594799588|FG001|Overall Study|Adverse Event|0|||
164665418|NCT00454636|594799589|FG000|Overall Study|Adverse Event|10|||
164665419|NCT00454636|594799590|FG001|Overall Study|Adverse Event|6|||
164665420|NCT00454636|594799591|FG002|Overall Study|Adverse Event|9|||
164665421|NCT00454636|594799592|FG003|Overall Study|Adverse Event|15|||
164665422|NCT00454636|594799589|FG000|Overall Study|Disease Progression|11|||
164665423|NCT00454636|594799590|FG001|Overall Study|Disease Progression|12|||
164561098|NCT03505021|594421791|FG001|Overall Study|Consent withdrawn by subject|1|||
164561099|NCT03505021|594421790|FG000|Overall Study|Lost to Follow-up|5|||
164561100|NCT03505021|594421791|FG001|Overall Study|Lost to Follow-up|3|||
164561101|NCT03505021|594421790|FG000|Overall Study|Adverse Event|26|||
164561102|NCT03505021|594421791|FG001|Overall Study|Adverse Event|9|||
164561103|NCT03505021|594421790|FG000|Overall Study|Disease progression|33|||
164561104|NCT03505021|594421791|FG001|Overall Study|Disease progression|17|||
164665424|NCT00454636|594799591|FG002|Overall Study|Disease Progression|4|||
164665425|NCT00454636|594799592|FG003|Overall Study|Disease Progression|11|||
164665426|NCT00454636|594799589|FG000|Overall Study|Protocol Violation|3|||
164665427|NCT00454636|594799590|FG001|Overall Study|Protocol Violation|2|||
164665428|NCT00454636|594799591|FG002|Overall Study|Protocol Violation|3|||
164665429|NCT00454636|594799592|FG003|Overall Study|Protocol Violation|3|||
164665430|NCT00454636|594799589|FG000|Overall Study|Death|6|||
164665431|NCT00454636|594799590|FG001|Overall Study|Death|1|||
164665432|NCT00454636|594799591|FG002|Overall Study|Death|1|||
164665433|NCT00454636|594799592|FG003|Overall Study|Death|1|||
164665434|NCT00454636|594799589|FG000|Overall Study|Patient refusal|1|||
164665435|NCT00454636|594799590|FG001|Overall Study|Patient refusal|1|||
164665436|NCT00454636|594799591|FG002|Overall Study|Patient refusal|3|||
164561105|NCT03505021|594421790|FG000|Overall Study|Other|11|||
164561106|NCT03505021|594421791|FG001|Overall Study|Other|5|||
164561107|NCT03505021|594421790|FG000|Overall Study|Personal reason|21|||
164665437|NCT00454636|594799592|FG003|Overall Study|Patient refusal|2|||
164665438|NCT00454636|594799589|FG000|Overall Study|Lost to Follow-up|0|||
164665439|NCT00454636|594799590|FG001|Overall Study|Lost to Follow-up|1|||
164665440|NCT00454636|594799591|FG002|Overall Study|Lost to Follow-up|0|||
164665441|NCT00454636|594799592|FG003|Overall Study|Lost to Follow-up|0|||
164665442|NCT00806156|594799593|FG000|Overall Study|Death|35|||
164665443|NCT00806156|594799594|FG001|Overall Study|Death|95|||
164665444|NCT00806156|594799593|FG000|Overall Study|Did not meet eligibility criteria|1|||
164315058|NCT02059291|593531488|FG020|Epoch 2|Lack of Efficacy|0|||
164315059|NCT02059291|593531489|FG021|Epoch 2|Lack of Efficacy|0|||
164315060|NCT02059291|593531490|FG022|Epoch 2|Lack of Efficacy|0|||
164315061|NCT02059291|593531491|FG023|Epoch 2|Lack of Efficacy|0|||
164315062|NCT02059291|593531492|FG024|Epoch 2|Lack of Efficacy|0|||
164315063|NCT02059291|593531468|FG000|Epoch 2|Adverse Event|0|||
164315064|NCT02059291|593531469|FG001|Epoch 2|Adverse Event|0|||
164315065|NCT02059291|593531470|FG002|Epoch 2|Adverse Event|1|||
164315066|NCT02059291|593531471|FG003|Epoch 2|Adverse Event|1|||
164315067|NCT02059291|593531472|FG004|Epoch 2|Adverse Event|0|||
164665445|NCT00806156|594799594|FG001|Overall Study|Did not meet eligibility criteria|0|||
164665446|NCT00806156|594799593|FG000|Overall Study|Study terminated by Sponsor|2|||
164665447|NCT00806156|594799594|FG001|Overall Study|Study terminated by Sponsor|40|||
164665448|NCT00806156|594799593|FG000|Overall Study|Consent withdrawn by subject|1|||
164665449|NCT00806156|594799594|FG001|Overall Study|Consent withdrawn by subject|3|||
164665450|NCT00806156|594799593|FG000|Overall Study|Lost to Follow-up|0|||
164665451|NCT00806156|594799594|FG001|Overall Study|Lost to Follow-up|1|||
164665452|NCT01025037|594799599|FG000|Overall Study|Adverse Event|3|||
164665453|NCT01025037|594799599|FG000|Overall Study|Lost to Follow-up|7|||
164665454|NCT01025037|594799599|FG000|Overall Study|Withdrawal by Subject|1|||
164665455|NCT02674334|594799600|FG000|Overall Study|Lost to Follow-up|5|||
164665456|NCT02674334|594799601|FG001|Overall Study|Lost to Follow-up|3|||
164665457|NCT02674334|594799600|FG000|Overall Study|participant difficulty breathing|1|||
164665458|NCT02674334|594799601|FG001|Overall Study|participant difficulty breathing|0|||
164665459|NCT02674334|594799600|FG000|Overall Study|NIRS not recording|1|||
164665460|NCT02674334|594799601|FG001|Overall Study|NIRS not recording|0|||
164665461|NCT00860405|594799612|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
164665462|NCT00860405|594799613|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
164665463|NCT00864097|594799614|FG000|Overall Study|Death|0|||
164665464|NCT00864097|594799615|FG001|Overall Study|Death|1|||
164665465|NCT00864097|594799616|FG002|Overall Study|Death|0|||
164665466|NCT00864097|594799617|FG003|Overall Study|Death|0|||
164665467|NCT00864097|594799614|FG000|Overall Study|Adverse Event|6|||
164665468|NCT00864097|594799615|FG001|Overall Study|Adverse Event|8|||
164665469|NCT00864097|594799616|FG002|Overall Study|Adverse Event|11|||
164665470|NCT00864097|594799617|FG003|Overall Study|Adverse Event|9|||
164665471|NCT00864097|594799614|FG000|Overall Study|Lack of Efficacy|9|||
164665472|NCT00864097|594799615|FG001|Overall Study|Lack of Efficacy|3|||
164665473|NCT00864097|594799616|FG002|Overall Study|Lack of Efficacy|7|||
164665474|NCT00864097|594799617|FG003|Overall Study|Lack of Efficacy|2|||
164665475|NCT00864097|594799614|FG000|Overall Study|Lost to Follow-up|0|||
164665476|NCT00864097|594799615|FG001|Overall Study|Lost to Follow-up|1|||
164665477|NCT00864097|594799616|FG002|Overall Study|Lost to Follow-up|0|||
164665478|NCT00864097|594799617|FG003|Overall Study|Lost to Follow-up|1|||
164665479|NCT00864097|594799614|FG000|Overall Study|Withdrawal by Subject|15|||
164665480|NCT00864097|594799615|FG001|Overall Study|Withdrawal by Subject|11|||
164665481|NCT00864097|594799616|FG002|Overall Study|Withdrawal by Subject|11|||
164665482|NCT00864097|594799617|FG003|Overall Study|Withdrawal by Subject|12|||
164665483|NCT00864097|594799614|FG000|Overall Study|Protocol Violation|2|||
164665484|NCT00864097|594799615|FG001|Overall Study|Protocol Violation|1|||
164665485|NCT00864097|594799616|FG002|Overall Study|Protocol Violation|0|||
164665486|NCT00864097|594799617|FG003|Overall Study|Protocol Violation|1|||
164665487|NCT00864097|594799614|FG000|Overall Study|Terminated by sponsor|105|||
164665488|NCT00864097|594799615|FG001|Overall Study|Terminated by sponsor|112|||
164315068|NCT02059291|593531473|FG005|Epoch 2|Adverse Event|0|||
164315069|NCT02059291|593531474|FG006|Epoch 2|Adverse Event|0|||
164315070|NCT02059291|593531475|FG007|Epoch 2|Adverse Event|1|||
164665489|NCT00864097|594799616|FG002|Overall Study|Terminated by sponsor|102|||
164665490|NCT00864097|594799617|FG003|Overall Study|Terminated by sponsor|99|||
164665491|NCT00864097|594799614|FG000|Overall Study|Randomized but not treated|2|||
164665492|NCT00864097|594799615|FG001|Overall Study|Randomized but not treated|0|||
164315071|NCT02059291|593531476|FG008|Epoch 2|Adverse Event|1|||
164315072|NCT02059291|593531477|FG009|Epoch 2|Adverse Event|0|||
164315073|NCT02059291|593531478|FG010|Epoch 2|Adverse Event|0|||
164665493|NCT00864097|594799616|FG002|Overall Study|Randomized but not treated|1|||
164665494|NCT00864097|594799617|FG003|Overall Study|Randomized but not treated|0|||
164665495|NCT00864097|594799614|FG000|Overall Study|Other|0|||
164665496|NCT00864097|594799615|FG001|Overall Study|Other|0|||
164665497|NCT00864097|594799616|FG002|Overall Study|Other|0|||
164665498|NCT00864097|594799617|FG003|Overall Study|Other|1|||
164665499|NCT00927810|594799619|FG000|Overall Study|Withdrawal by Subject|0|||
164665500|NCT00927810|594799620|FG001|Overall Study|Withdrawal by Subject|3|||
164665501|NCT00927810|594799621|FG002|Overall Study|Withdrawal by Subject|0|||
164315074|NCT02059291|593531479|FG011|Epoch 2|Adverse Event|0|||
164665502|NCT00927810|594799622|FG003|Overall Study|Withdrawal by Subject|1|||
164315075|NCT02059291|593531480|FG012|Epoch 2|Adverse Event|0|||
164315076|NCT02059291|593531481|FG013|Epoch 2|Adverse Event|0|||
164315077|NCT02059291|593531482|FG014|Epoch 2|Adverse Event|0|||
164561108|NCT03505021|594421791|FG001|Overall Study|Personal reason|12|||
164561109|NCT03087955|594423620|FG000|Overall Study|Death|4|||
164561110|NCT03087955|594423621|FG001|Overall Study|Death|0|||
164561111|NCT03087955|594423620|FG000|Overall Study|Lack of Efficacy|2|||
164561112|NCT03087955|594423621|FG001|Overall Study|Lack of Efficacy|0|||
164561113|NCT03087955|594423620|FG000|Overall Study|Lost to Follow-up|1|||
164561114|NCT03087955|594423621|FG001|Overall Study|Lost to Follow-up|0|||
164561115|NCT04484285|594423622|FG000|Overall Study|Unable to operate stimulator|3|||
164561116|NCT04484285|594423623|FG001|Overall Study|Unable to operate stimulator|0|||
164561117|NCT06272370|594423624|FG000|Overall Study|Lost to Follow-up|0|||
164561118|NCT06272370|594423625|FG001|Overall Study|Lost to Follow-up|3|||
164561119|NCT06272370|594423626|FG002|Overall Study|Lost to Follow-up|1|||
164561120|NCT06272370|594423627|FG003|Overall Study|Lost to Follow-up|1|||
164561121|NCT01299766|594423629|FG000|Overall Study|Death|5|||
164561122|NCT01299766|594423630|FG001|Overall Study|Death|4|||
164561123|NCT01299766|594423629|FG000|Overall Study|Withdrawal by Subject|29|||
164561124|NCT01299766|594423630|FG001|Overall Study|Withdrawal by Subject|19|||
164561125|NCT04002310|594423631|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
164561126|NCT04002310|594423632|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
164561127|NCT04002310|594423633|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
164561128|NCT04002310|594423634|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
164561129|NCT04002310|594423635|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
164561130|NCT00352534|594423636|FG000|Initial Staging|Ineligible|8|||
164561131|NCT00352534|594423637|FG001|Initial Staging|Ineligible|9|||
164561132|NCT00352534|594423638|FG002|Initial Staging|Ineligible|0|||
164561133|NCT00352534|594423639|FG003|Initial Staging|Ineligible|0|||
164561134|NCT00352534|594423640|FG004|Initial Staging|Ineligible|0|||
164561135|NCT00352534|594423641|FG005|Initial Staging|Ineligible|0|||
164561136|NCT00352534|594423642|FG006|Initial Staging|Ineligible|0|||
164561137|NCT00352534|594423636|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
164561138|NCT00352534|594423637|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
164561139|NCT00352534|594423638|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
164561140|NCT00352534|594423639|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
164561141|NCT00352534|594423640|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
164561142|NCT00352534|594423641|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
164561143|NCT00352534|594423642|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
164561144|NCT00352534|594423636|FG000|Final Risk Group Assignment|Physician Decision|0|||
164561145|NCT00352534|594423637|FG001|Final Risk Group Assignment|Physician Decision|0|||
164561146|NCT00352534|594423638|FG002|Final Risk Group Assignment|Physician Decision|0|||
164561147|NCT00352534|594423639|FG003|Final Risk Group Assignment|Physician Decision|0|||
164561148|NCT00352534|594423640|FG004|Final Risk Group Assignment|Physician Decision|0|||
164561149|NCT00352534|594423641|FG005|Final Risk Group Assignment|Physician Decision|8|||
164561150|NCT00352534|594423642|FG006|Final Risk Group Assignment|Physician Decision|0|||
164561151|NCT00352534|594423636|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
164561152|NCT00352534|594423637|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
164561153|NCT00352534|594423638|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
164561154|NCT00352534|594423639|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
164561155|NCT00352534|594423640|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
164561156|NCT00352534|594423641|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
164561157|NCT00352534|594423642|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
164315078|NCT02059291|593531483|FG015|Epoch 2|Adverse Event|0|||
164315079|NCT02059291|593531484|FG016|Epoch 2|Adverse Event|0|||
164315080|NCT02059291|593531485|FG017|Epoch 2|Adverse Event|0|||
164315081|NCT02059291|593531486|FG018|Epoch 2|Adverse Event|0|||
164315082|NCT02059291|593531487|FG019|Epoch 2|Adverse Event|0|||
164315083|NCT02059291|593531488|FG020|Epoch 2|Adverse Event|0|||
164315084|NCT02059291|593531489|FG021|Epoch 2|Adverse Event|0|||
164315085|NCT02059291|593531490|FG022|Epoch 2|Adverse Event|0|||
164315086|NCT02059291|593531491|FG023|Epoch 2|Adverse Event|0|||
164315087|NCT02059291|593531492|FG024|Epoch 2|Adverse Event|0|||
164315088|NCT02059291|593531468|FG000|Epoch 2|Withdrawal by Subject|0|||
164315089|NCT02059291|593531469|FG001|Epoch 2|Withdrawal by Subject|1|||
164315090|NCT02059291|593531470|FG002|Epoch 2|Withdrawal by Subject|0|||
164315091|NCT02059291|593531471|FG003|Epoch 2|Withdrawal by Subject|0|||
164420620|NCT02892409|593910953|FG001|Overall Study|Adverse Event|0|||
164315092|NCT02059291|593531472|FG004|Epoch 2|Withdrawal by Subject|0|||
164561158|NCT00352534|594423636|FG000|Final Risk Group Assignment|Ineligible|0|||
164561159|NCT00352534|594423637|FG001|Final Risk Group Assignment|Ineligible|0|||
164561160|NCT00352534|594423638|FG002|Final Risk Group Assignment|Ineligible|3|||
164561161|NCT00352534|594423639|FG003|Final Risk Group Assignment|Ineligible|1|||
164561162|NCT00352534|594423640|FG004|Final Risk Group Assignment|Ineligible|0|||
164561163|NCT00352534|594423641|FG005|Final Risk Group Assignment|Ineligible|13|||
164561164|NCT00352534|594423642|FG006|Final Risk Group Assignment|Ineligible|0|||
164561165|NCT00352534|594423636|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
164561166|NCT00352534|594423637|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
164561167|NCT00352534|594423638|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
164561168|NCT00352534|594423639|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
164561169|NCT00352534|594423640|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
164561170|NCT00352534|594423641|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
164561171|NCT00352534|594423642|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
164561172|NCT00352534|594423636|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
164561173|NCT00352534|594423637|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
164561174|NCT00352534|594423638|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
164561175|NCT00352534|594423639|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
164561176|NCT00352534|594423640|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
164561177|NCT00352534|594423641|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
164561178|NCT00352534|594423642|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
164561179|NCT00352534|594423636|FG000|Final Risk Group Assignment|Death|0|||
164561180|NCT00352534|594423637|FG001|Final Risk Group Assignment|Death|0|||
164561181|NCT00352534|594423638|FG002|Final Risk Group Assignment|Death|0|||
164561182|NCT00352534|594423639|FG003|Final Risk Group Assignment|Death|0|||
164561183|NCT00352534|594423640|FG004|Final Risk Group Assignment|Death|0|||
164561184|NCT00352534|594423641|FG005|Final Risk Group Assignment|Death|2|||
164561185|NCT00352534|594423642|FG006|Final Risk Group Assignment|Death|0|||
164561186|NCT00544869|594423643|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
164561187|NCT00544869|594423644|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
164561188|NCT00544869|594423645|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
164561189|NCT00544869|594423643|FG000|Overall Study|Adverse Event|6|||
164561190|NCT00544869|594423644|FG001|Overall Study|Adverse Event|1|||
164561191|NCT00544869|594423645|FG002|Overall Study|Adverse Event|0|||
164561192|NCT00544869|594423643|FG000|Overall Study|Lack of Efficacy|1|||
164561193|NCT00544869|594423644|FG001|Overall Study|Lack of Efficacy|1|||
164561194|NCT00544869|594423645|FG002|Overall Study|Lack of Efficacy|0|||
164561195|NCT00544869|594423643|FG000|Overall Study|Physician Decision|2|||
164561196|NCT00544869|594423644|FG001|Overall Study|Physician Decision|0|||
164561197|NCT00544869|594423645|FG002|Overall Study|Physician Decision|0|||
164561198|NCT01354028|594423656|FG000|Overall Study|Physician Decision|0|||
164561199|NCT01354028|594423657|FG001|Overall Study|Physician Decision|2|||
164561200|NCT01354028|594423656|FG000|Overall Study|Discharged before study start|2|||
164561201|NCT01354028|594423657|FG001|Overall Study|Discharged before study start|2|||
164561202|NCT01354028|594423656|FG000|Overall Study|No quiet alert state|0|||
164561203|NCT01354028|594423657|FG001|Overall Study|No quiet alert state|1|||
164561204|NCT01641939|594423658|FG000|Overall Study|Death|90|||
164561205|NCT01641939|594423659|FG001|Overall Study|Death|187|||
164561206|NCT01641939|594423660|FG002|Overall Study|Death|61|||
164561207|NCT01641939|594423658|FG000|Overall Study|Lost to Follow-up|3|||
164561208|NCT01641939|594423659|FG001|Overall Study|Lost to Follow-up|2|||
164561209|NCT01641939|594423660|FG002|Overall Study|Lost to Follow-up|1|||
164561210|NCT01641939|594423658|FG000|Overall Study|Withdrawal by Subject|14|||
164561211|NCT01641939|594423659|FG001|Overall Study|Withdrawal by Subject|11|||
164561212|NCT01641939|594423660|FG002|Overall Study|Withdrawal by Subject|5|||
164561213|NCT01641939|594423658|FG000|Overall Study|Study Terminated by Sponsor|10|||
164561214|NCT01641939|594423659|FG001|Overall Study|Study Terminated by Sponsor|28|||
164561215|NCT01641939|594423660|FG002|Overall Study|Study Terminated by Sponsor|3|||
164561216|NCT02322710|594423661|FG000|Overall Study|No efficacy assessment post-baseline|0|||
164561217|NCT02322710|594423662|FG001|Overall Study|No efficacy assessment post-baseline|1|||
164561218|NCT02322710|594423661|FG000|Overall Study|Protocol Violation|20|||
164561219|NCT02322710|594423662|FG001|Overall Study|Protocol Violation|25|||
164561220|NCT04161131|594423663|FG000|Overall Study|Ineligible|2|||
164561221|NCT04161131|594423663|FG000|Overall Study|Lost to Follow-up|4|||
164561222|NCT05064059|594423664|FG000|Overall Study|Death|199|||
164561223|NCT05064059|594423665|FG001|Overall Study|Death|196|||
164561224|NCT05064059|594423664|FG000|Overall Study|Physician Decision|4|||
164561225|NCT05064059|594423665|FG001|Overall Study|Physician Decision|2|||
164561226|NCT05064059|594423664|FG000|Overall Study|Sponsor Decision|14|||
164561227|NCT05064059|594423665|FG001|Overall Study|Sponsor Decision|11|||
164561228|NCT05064059|594423664|FG000|Overall Study|Withdrawal by Subject|4|||
164561229|NCT05064059|594423665|FG001|Overall Study|Withdrawal by Subject|11|||
164561230|NCT02894840|594423666|FG000|Overall Study|Lost to Follow-up|1|||
164561231|NCT02894840|594423667|FG001|Overall Study|Lost to Follow-up|0|||
164561232|NCT02894840|594423668|FG002|Overall Study|Lost to Follow-up|3|||
164561233|NCT02894840|594423669|FG003|Overall Study|Lost to Follow-up|0|||
164561234|NCT01072344|594423670|FG000|Overall Study|Relasped-reached end point|7|||
164561235|NCT01072344|594423671|FG001|Overall Study|Relasped-reached end point|12|||
164561236|NCT01072344|594423670|FG000|Overall Study|Protocol Violation|1|||
164561237|NCT01072344|594423671|FG001|Overall Study|Protocol Violation|2|||
164561238|NCT01072344|594423670|FG000|Overall Study|Lost to Follow-up|3|||
164561239|NCT01072344|594423671|FG001|Overall Study|Lost to Follow-up|4|||
164561240|NCT00716976|594423672|FG000|Overall Study|Adverse Event|2|||
164561241|NCT00716976|594423673|FG001|Overall Study|Adverse Event|0|||
164561242|NCT00716976|594423672|FG000|Overall Study|Death|1|||
164665503|NCT00927810|594799619|FG000|Overall Study|Lost to Follow-up|0|||
164665504|NCT00927810|594799620|FG001|Overall Study|Lost to Follow-up|2|||
164665505|NCT00927810|594799621|FG002|Overall Study|Lost to Follow-up|1|||
164665506|NCT00927810|594799622|FG003|Overall Study|Lost to Follow-up|1|||
164665507|NCT00927810|594799619|FG000|Overall Study|Death|0|||
164665508|NCT00927810|594799620|FG001|Overall Study|Death|2|||
164665509|NCT00927810|594799621|FG002|Overall Study|Death|0|||
164665510|NCT00927810|594799622|FG003|Overall Study|Death|0|||
164665511|NCT00927810|594799619|FG000|Overall Study|Abnormal laboratory value(s)|0|||
164665512|NCT00927810|594799620|FG001|Overall Study|Abnormal laboratory value(s)|1|||
164665513|NCT00927810|594799621|FG002|Overall Study|Abnormal laboratory value(s)|0|||
164665514|NCT00927810|594799622|FG003|Overall Study|Abnormal laboratory value(s)|0|||
164665515|NCT00320112|594799624|FG000|Overall Study|Lost to Follow-up|3|||
164665516|NCT00320112|594799625|FG001|Overall Study|Lost to Follow-up|4|||
164665517|NCT00320112|594799624|FG000|Overall Study|Withdrawal by Subject|3|||
164315093|NCT02059291|593531473|FG005|Epoch 2|Withdrawal by Subject|1|||
164315094|NCT02059291|593531474|FG006|Epoch 2|Withdrawal by Subject|0|||
164315095|NCT02059291|593531475|FG007|Epoch 2|Withdrawal by Subject|0|||
164315096|NCT02059291|593531476|FG008|Epoch 2|Withdrawal by Subject|1|||
164315097|NCT02059291|593531477|FG009|Epoch 2|Withdrawal by Subject|0|||
164315098|NCT02059291|593531478|FG010|Epoch 2|Withdrawal by Subject|0|||
164315099|NCT02059291|593531479|FG011|Epoch 2|Withdrawal by Subject|0|||
164315100|NCT02059291|593531480|FG012|Epoch 2|Withdrawal by Subject|0|||
164315101|NCT02059291|593531481|FG013|Epoch 2|Withdrawal by Subject|0|||
164315102|NCT02059291|593531482|FG014|Epoch 2|Withdrawal by Subject|0|||
164315103|NCT02059291|593531483|FG015|Epoch 2|Withdrawal by Subject|0|||
164315104|NCT02059291|593531484|FG016|Epoch 2|Withdrawal by Subject|0|||
164315105|NCT02059291|593531485|FG017|Epoch 2|Withdrawal by Subject|0|||
164315106|NCT02059291|593531486|FG018|Epoch 2|Withdrawal by Subject|0|||
164315107|NCT02059291|593531487|FG019|Epoch 2|Withdrawal by Subject|0|||
164315108|NCT02059291|593531488|FG020|Epoch 2|Withdrawal by Subject|0|||
164315109|NCT02059291|593531489|FG021|Epoch 2|Withdrawal by Subject|0|||
164315110|NCT02059291|593531490|FG022|Epoch 2|Withdrawal by Subject|0|||
164315111|NCT02059291|593531491|FG023|Epoch 2|Withdrawal by Subject|0|||
164315112|NCT02059291|593531492|FG024|Epoch 2|Withdrawal by Subject|0|||
164315113|NCT02059291|593531468|FG000|Epoch 3|Physician Decision|0|||
164315114|NCT02059291|593531469|FG001|Epoch 3|Physician Decision|0|||
164315115|NCT02059291|593531470|FG002|Epoch 3|Physician Decision|0|||
164315116|NCT02059291|593531471|FG003|Epoch 3|Physician Decision|0|||
164315117|NCT02059291|593531472|FG004|Epoch 3|Physician Decision|0|||
164315118|NCT02059291|593531473|FG005|Epoch 3|Physician Decision|0|||
164315119|NCT02059291|593531474|FG006|Epoch 3|Physician Decision|0|||
164315120|NCT02059291|593531475|FG007|Epoch 3|Physician Decision|0|||
164315121|NCT02059291|593531476|FG008|Epoch 3|Physician Decision|0|||
164315122|NCT02059291|593531477|FG009|Epoch 3|Physician Decision|0|||
164315123|NCT02059291|593531478|FG010|Epoch 3|Physician Decision|0|||
164315124|NCT02059291|593531479|FG011|Epoch 3|Physician Decision|0|||
164315125|NCT02059291|593531480|FG012|Epoch 3|Physician Decision|0|||
164315126|NCT02059291|593531481|FG013|Epoch 3|Physician Decision|1|||
164315127|NCT02059291|593531482|FG014|Epoch 3|Physician Decision|0|||
164315128|NCT02059291|593531483|FG015|Epoch 3|Physician Decision|1|||
164315129|NCT02059291|593531484|FG016|Epoch 3|Physician Decision|0|||
164315130|NCT02059291|593531485|FG017|Epoch 3|Physician Decision|0|||
164315131|NCT02059291|593531486|FG018|Epoch 3|Physician Decision|0|||
164315132|NCT02059291|593531487|FG019|Epoch 3|Physician Decision|0|||
164315133|NCT02059291|593531488|FG020|Epoch 3|Physician Decision|0|||
164315134|NCT02059291|593531489|FG021|Epoch 3|Physician Decision|0|||
164315135|NCT02059291|593531490|FG022|Epoch 3|Physician Decision|0|||
164315136|NCT02059291|593531491|FG023|Epoch 3|Physician Decision|0|||
164315137|NCT02059291|593531492|FG024|Epoch 3|Physician Decision|0|||
164665518|NCT00320112|594799625|FG001|Overall Study|Withdrawal by Subject|0|||
164665519|NCT00320112|594799624|FG000|Overall Study|Death|2|||
164665520|NCT00320112|594799625|FG001|Overall Study|Death|1|||
164665521|NCT02899338|594799626|FG000|Overall Study|Adverse Event|1|||
164315138|NCT02059291|593531468|FG000|Epoch 3|Adverse Event|0|||
164315139|NCT02059291|593531469|FG001|Epoch 3|Adverse Event|0|||
164315140|NCT02059291|593531470|FG002|Epoch 3|Adverse Event|0|||
164315141|NCT02059291|593531471|FG003|Epoch 3|Adverse Event|0|||
164315142|NCT02059291|593531472|FG004|Epoch 3|Adverse Event|0|||
164315143|NCT02059291|593531473|FG005|Epoch 3|Adverse Event|0|||
164315144|NCT02059291|593531474|FG006|Epoch 3|Adverse Event|0|||
164315145|NCT02059291|593531475|FG007|Epoch 3|Adverse Event|0|||
164315146|NCT02059291|593531476|FG008|Epoch 3|Adverse Event|0|||
164665522|NCT02899338|594799627|FG001|Overall Study|Adverse Event|2|||
164665523|NCT02899338|594799626|FG000|Overall Study|Withdrawal by Subject|2|||
164315147|NCT02059291|593531477|FG009|Epoch 3|Adverse Event|0|||
164315148|NCT02059291|593531478|FG010|Epoch 3|Adverse Event|0|||
164420621|NCT02892409|593910952|FG000|Overall Study|Withdrawal by Subject|2|||
164315149|NCT02059291|593531479|FG011|Epoch 3|Adverse Event|0|||
164315150|NCT02059291|593531480|FG012|Epoch 3|Adverse Event|0|||
164315151|NCT02059291|593531481|FG013|Epoch 3|Adverse Event|0|||
164315152|NCT02059291|593531482|FG014|Epoch 3|Adverse Event|0|||
164315153|NCT02059291|593531483|FG015|Epoch 3|Adverse Event|1|||
164315154|NCT02059291|593531484|FG016|Epoch 3|Adverse Event|0|||
164315155|NCT02059291|593531485|FG017|Epoch 3|Adverse Event|0|||
164315156|NCT02059291|593531486|FG018|Epoch 3|Adverse Event|0|||
164315157|NCT02059291|593531487|FG019|Epoch 3|Adverse Event|0|||
164315158|NCT02059291|593531488|FG020|Epoch 3|Adverse Event|0|||
164315159|NCT02059291|593531489|FG021|Epoch 3|Adverse Event|0|||
164315160|NCT02059291|593531490|FG022|Epoch 3|Adverse Event|0|||
164315161|NCT02059291|593531491|FG023|Epoch 3|Adverse Event|0|||
164315162|NCT02059291|593531492|FG024|Epoch 3|Adverse Event|0|||
164315163|NCT02059291|593531468|FG000|Epoch 3|Lack of Efficacy|0|||
164315164|NCT02059291|593531469|FG001|Epoch 3|Lack of Efficacy|0|||
164315165|NCT02059291|593531470|FG002|Epoch 3|Lack of Efficacy|0|||
164315166|NCT02059291|593531471|FG003|Epoch 3|Lack of Efficacy|0|||
164315167|NCT02059291|593531472|FG004|Epoch 3|Lack of Efficacy|0|||
164315168|NCT02059291|593531473|FG005|Epoch 3|Lack of Efficacy|0|||
164315169|NCT02059291|593531474|FG006|Epoch 3|Lack of Efficacy|0|||
164665524|NCT02899338|594799627|FG001|Overall Study|Withdrawal by Subject|0|||
164665525|NCT00814463|594799629|FG000|Overall Study|Lost to Follow-up|1|||
164665526|NCT00414765|594799631|FG000|Overall Study|Adverse Event|5|||
164665527|NCT00414765|594799632|FG001|Overall Study|Adverse Event|9|||
164665528|NCT00414765|594799631|FG000|Overall Study|Withdrawal by Subject|1|||
164665529|NCT00414765|594799632|FG001|Overall Study|Withdrawal by Subject|1|||
164665530|NCT00414765|594799631|FG000|Overall Study|Disease Progression|0|||
164665531|NCT00414765|594799632|FG001|Overall Study|Disease Progression|1|||
164665532|NCT05694013|594799635|FG000|Overall Study|Death|6|||
164665533|NCT05694013|594799636|FG001|Overall Study|Death|2|||
164665534|NCT05694013|594799635|FG000|Overall Study|Participant Decision|0|||
164665535|NCT05694013|594799636|FG001|Overall Study|Participant Decision|1|||
164665536|NCT05694013|594799635|FG000|Overall Study|Physician Decision|1|||
164665537|NCT05694013|594799636|FG001|Overall Study|Physician Decision|0|||
164665538|NCT05694013|594799635|FG000|Overall Study|Progressive Disease|0|||
164665539|NCT05694013|594799636|FG001|Overall Study|Progressive Disease|1|||
164665540|NCT05694013|594799635|FG000|Overall Study|Study Terminated by Sponsor|12|||
164665541|NCT05694013|594799636|FG001|Overall Study|Study Terminated by Sponsor|17|||
164315170|NCT02059291|593531475|FG007|Epoch 3|Lack of Efficacy|0|||
164315171|NCT02059291|593531476|FG008|Epoch 3|Lack of Efficacy|0|||
164315172|NCT02059291|593531477|FG009|Epoch 3|Lack of Efficacy|0|||
164315173|NCT02059291|593531478|FG010|Epoch 3|Lack of Efficacy|0|||
164315174|NCT02059291|593531479|FG011|Epoch 3|Lack of Efficacy|0|||
164315175|NCT02059291|593531480|FG012|Epoch 3|Lack of Efficacy|0|||
164315176|NCT02059291|593531481|FG013|Epoch 3|Lack of Efficacy|0|||
164315177|NCT02059291|593531482|FG014|Epoch 3|Lack of Efficacy|0|||
164315178|NCT02059291|593531483|FG015|Epoch 3|Lack of Efficacy|3|||
164315179|NCT02059291|593531484|FG016|Epoch 3|Lack of Efficacy|0|||
164315180|NCT02059291|593531485|FG017|Epoch 3|Lack of Efficacy|0|||
164315181|NCT02059291|593531486|FG018|Epoch 3|Lack of Efficacy|0|||
164315182|NCT02059291|593531487|FG019|Epoch 3|Lack of Efficacy|0|||
164665542|NCT05694013|594799635|FG000|Overall Study|Withdrawal by Subject|3|||
164665543|NCT05694013|594799636|FG001|Overall Study|Withdrawal by Subject|0|||
164665544|NCT04817891|594799637|FG000|Overall Study|Did not pass screening after consenting to participate|1|||
164665545|NCT04817891|594799637|FG000|Overall Study|Adverse Event|1|||
164665546|NCT04817891|594799637|FG000|Overall Study|Withdrawal by Subject|1|||
164665547|NCT03982433|594799638|FG000|Overall Study|Lost to Follow-up|1|||
164315183|NCT02059291|593531488|FG020|Epoch 3|Lack of Efficacy|0|||
164315184|NCT02059291|593531489|FG021|Epoch 3|Lack of Efficacy|0|||
164315185|NCT02059291|593531490|FG022|Epoch 3|Lack of Efficacy|0|||
164315186|NCT02059291|593531491|FG023|Epoch 3|Lack of Efficacy|0|||
164315187|NCT02059291|593531492|FG024|Epoch 3|Lack of Efficacy|0|||
164665548|NCT00368277|594799639|FG000|Overall Study|Adverse Event|33|||
164665549|NCT00368277|594799640|FG001|Overall Study|Adverse Event|49|||
164665550|NCT00368277|594799639|FG000|Overall Study|Death|2|||
164665551|NCT00368277|594799640|FG001|Overall Study|Death|1|||
164665552|NCT00368277|594799639|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
164665553|NCT00368277|594799640|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
164315188|NCT02059291|593531468|FG000|Epoch 3|Withdrawal by Subject|0|||
164315189|NCT02059291|593531469|FG001|Epoch 3|Withdrawal by Subject|0|||
164315190|NCT02059291|593531470|FG002|Epoch 3|Withdrawal by Subject|0|||
164665554|NCT00368277|594799639|FG000|Overall Study|Protocol deviation|7|||
164665555|NCT00368277|594799640|FG001|Overall Study|Protocol deviation|0|||
164665556|NCT00368277|594799639|FG000|Overall Study|Patient withdrew consent|32|||
164665557|NCT00368277|594799640|FG001|Overall Study|Patient withdrew consent|28|||
164665558|NCT00368277|594799639|FG000|Overall Study|Lost to Follow-up|8|||
164315191|NCT02059291|593531471|FG003|Epoch 3|Withdrawal by Subject|0|||
164315192|NCT02059291|593531472|FG004|Epoch 3|Withdrawal by Subject|0|||
164315193|NCT02059291|593531473|FG005|Epoch 3|Withdrawal by Subject|0|||
164315194|NCT02059291|593531474|FG006|Epoch 3|Withdrawal by Subject|0|||
164315195|NCT02059291|593531475|FG007|Epoch 3|Withdrawal by Subject|0|||
164315196|NCT02059291|593531476|FG008|Epoch 3|Withdrawal by Subject|0|||
164315197|NCT02059291|593531477|FG009|Epoch 3|Withdrawal by Subject|0|||
164315198|NCT02059291|593531478|FG010|Epoch 3|Withdrawal by Subject|0|||
164315199|NCT02059291|593531479|FG011|Epoch 3|Withdrawal by Subject|0|||
164315200|NCT02059291|593531480|FG012|Epoch 3|Withdrawal by Subject|0|||
164665559|NCT00368277|594799640|FG001|Overall Study|Lost to Follow-up|6|||
164665560|NCT00661999|594799647|FG000|Overall Study|Adverse Event|11|||
164315201|NCT02059291|593531481|FG013|Epoch 3|Withdrawal by Subject|0|||
164315202|NCT02059291|593531482|FG014|Epoch 3|Withdrawal by Subject|0|||
164315203|NCT02059291|593531483|FG015|Epoch 3|Withdrawal by Subject|1|||
164315204|NCT02059291|593531484|FG016|Epoch 3|Withdrawal by Subject|0|||
164315205|NCT02059291|593531485|FG017|Epoch 3|Withdrawal by Subject|0|||
164315206|NCT02059291|593531486|FG018|Epoch 3|Withdrawal by Subject|0|||
164315207|NCT02059291|593531487|FG019|Epoch 3|Withdrawal by Subject|0|||
164315208|NCT02059291|593531488|FG020|Epoch 3|Withdrawal by Subject|0|||
164315209|NCT02059291|593531489|FG021|Epoch 3|Withdrawal by Subject|0|||
164315210|NCT02059291|593531490|FG022|Epoch 3|Withdrawal by Subject|0|||
164315211|NCT02059291|593531491|FG023|Epoch 3|Withdrawal by Subject|0|||
164315212|NCT02059291|593531492|FG024|Epoch 3|Withdrawal by Subject|0|||
164315213|NCT02059291|593531468|FG000|Epoch 4|Adverse Event|0|||
164315214|NCT02059291|593531469|FG001|Epoch 4|Adverse Event|0|||
164315215|NCT02059291|593531470|FG002|Epoch 4|Adverse Event|0|||
164315216|NCT02059291|593531471|FG003|Epoch 4|Adverse Event|0|||
164315217|NCT02059291|593531472|FG004|Epoch 4|Adverse Event|0|||
164315218|NCT02059291|593531473|FG005|Epoch 4|Adverse Event|0|||
164315219|NCT02059291|593531474|FG006|Epoch 4|Adverse Event|0|||
164315220|NCT02059291|593531475|FG007|Epoch 4|Adverse Event|0|||
164315221|NCT02059291|593531476|FG008|Epoch 4|Adverse Event|0|||
164315222|NCT02059291|593531477|FG009|Epoch 4|Adverse Event|0|||
164315223|NCT02059291|593531478|FG010|Epoch 4|Adverse Event|0|||
164315224|NCT02059291|593531479|FG011|Epoch 4|Adverse Event|0|||
164315225|NCT02059291|593531480|FG012|Epoch 4|Adverse Event|0|||
164315226|NCT02059291|593531481|FG013|Epoch 4|Adverse Event|0|||
164315227|NCT02059291|593531482|FG014|Epoch 4|Adverse Event|0|||
164315228|NCT02059291|593531483|FG015|Epoch 4|Adverse Event|0|||
164315229|NCT02059291|593531484|FG016|Epoch 4|Adverse Event|1|||
164315230|NCT02059291|593531485|FG017|Epoch 4|Adverse Event|0|||
164315231|NCT02059291|593531486|FG018|Epoch 4|Adverse Event|0|||
164315232|NCT02059291|593531487|FG019|Epoch 4|Adverse Event|0|||
164315233|NCT02059291|593531488|FG020|Epoch 4|Adverse Event|0|||
164315234|NCT02059291|593531489|FG021|Epoch 4|Adverse Event|0|||
164315235|NCT02059291|593531490|FG022|Epoch 4|Adverse Event|1|||
164665561|NCT00661999|594799648|FG001|Overall Study|Adverse Event|5|||
164665562|NCT00661999|594799649|FG002|Overall Study|Adverse Event|8|||
164665563|NCT00661999|594799647|FG000|Overall Study|Death|8|||
164665564|NCT00661999|594799648|FG001|Overall Study|Death|6|||
164665565|NCT00661999|594799649|FG002|Overall Study|Death|3|||
164665566|NCT00661999|594799647|FG000|Overall Study|Other Reasons|5|||
164665567|NCT00661999|594799648|FG001|Overall Study|Other Reasons|12|||
164665568|NCT00661999|594799649|FG002|Overall Study|Other Reasons|23|||
164665569|NCT00661999|594799647|FG000|Overall Study|Withdrawal by Subject|30|||
164665570|NCT00661999|594799648|FG001|Overall Study|Withdrawal by Subject|23|||
164665571|NCT00661999|594799649|FG002|Overall Study|Withdrawal by Subject|14|||
164665572|NCT00661999|594799647|FG000|Overall Study|Alternative Treatment|1|||
164665573|NCT00661999|594799648|FG001|Overall Study|Alternative Treatment|0|||
164665574|NCT00661999|594799649|FG002|Overall Study|Alternative Treatment|0|||
164665575|NCT00661999|594799647|FG000|Overall Study|Other Medical Problems|4|||
164665576|NCT00661999|594799648|FG001|Overall Study|Other Medical Problems|4|||
164665577|NCT00661999|594799649|FG002|Overall Study|Other Medical Problems|9|||
164665578|NCT01139164|594799652|FG000|Overall Study|Withdrawn prior to study start|0|||
164665579|NCT01139164|594799653|FG001|Overall Study|Withdrawn prior to study start|2|||
164665580|NCT01139164|594799654|FG002|Overall Study|Withdrawn prior to study start|0|||
164665581|NCT01790568|594799655|FG000|Overall Study|Progression prior to transplant|0|||
164665582|NCT01790568|594799656|FG001|Overall Study|Progression prior to transplant|1|||
164665583|NCT00264810|594799657|FG000|Baseline|Withdrawal by Subject|10|||
164665584|NCT00264810|594799658|FG001|Baseline|Withdrawal by Subject|10|||
164665585|NCT00264810|594799657|FG000|Baseline|Physician Decision|7|||
164665586|NCT00264810|594799658|FG001|Baseline|Physician Decision|8|||
164315236|NCT02059291|593531491|FG023|Epoch 4|Adverse Event|0|||
164315237|NCT02059291|593531492|FG024|Epoch 4|Adverse Event|0|||
164315238|NCT02059291|593531468|FG000|Epoch 4|Pregnancy|0|||
164315239|NCT02059291|593531469|FG001|Epoch 4|Pregnancy|0|||
164315240|NCT02059291|593531470|FG002|Epoch 4|Pregnancy|0|||
164315241|NCT02059291|593531471|FG003|Epoch 4|Pregnancy|0|||
164420622|NCT02892409|593910953|FG001|Overall Study|Withdrawal by Subject|1|||
164665587|NCT00264810|594799657|FG000|Baseline|Subject Compliance Failure|3|||
164665588|NCT00264810|594799658|FG001|Baseline|Subject Compliance Failure|3|||
164665589|NCT00264810|594799657|FG000|Baseline|Insufficient Seizure Frequency|2|||
164665590|NCT00264810|594799658|FG001|Baseline|Insufficient Seizure Frequency|2|||
164315242|NCT02059291|593531472|FG004|Epoch 4|Pregnancy|0|||
164315243|NCT02059291|593531473|FG005|Epoch 4|Pregnancy|0|||
164315244|NCT02059291|593531474|FG006|Epoch 4|Pregnancy|0|||
164315245|NCT02059291|593531475|FG007|Epoch 4|Pregnancy|0|||
164315246|NCT02059291|593531476|FG008|Epoch 4|Pregnancy|0|||
164315247|NCT02059291|593531477|FG009|Epoch 4|Pregnancy|0|||
164315248|NCT02059291|593531478|FG010|Epoch 4|Pregnancy|0|||
164315249|NCT02059291|593531479|FG011|Epoch 4|Pregnancy|0|||
164315250|NCT02059291|593531480|FG012|Epoch 4|Pregnancy|0|||
164315251|NCT02059291|593531481|FG013|Epoch 4|Pregnancy|0|||
164315252|NCT02059291|593531482|FG014|Epoch 4|Pregnancy|0|||
164315253|NCT02059291|593531483|FG015|Epoch 4|Pregnancy|0|||
164315254|NCT02059291|593531484|FG016|Epoch 4|Pregnancy|1|||
164315255|NCT02059291|593531485|FG017|Epoch 4|Pregnancy|0|||
164315256|NCT02059291|593531486|FG018|Epoch 4|Pregnancy|0|||
164315257|NCT02059291|593531487|FG019|Epoch 4|Pregnancy|0|||
164315258|NCT02059291|593531488|FG020|Epoch 4|Pregnancy|0|||
164315259|NCT02059291|593531489|FG021|Epoch 4|Pregnancy|0|||
164420623|NCT01154036|593910962|FG000|Phase I|Physician Decision|0|||
164561243|NCT00716976|594423673|FG001|Overall Study|Death|0|||
164561244|NCT00716976|594423672|FG000|Overall Study|Physician Decision|2|||
164561245|NCT00716976|594423673|FG001|Overall Study|Physician Decision|2|||
164561246|NCT00716976|594423672|FG000|Overall Study|Withdrawal by Subject|5|||
164561247|NCT00716976|594423673|FG001|Overall Study|Withdrawal by Subject|1|||
164561248|NCT00716976|594423672|FG000|Overall Study|Premature discontinuation cisplatin|5|||
164561249|NCT00716976|594423673|FG001|Overall Study|Premature discontinuation cisplatin|4|||
164561250|NCT00716976|594423672|FG000|Overall Study|Radiation during protocol|1|||
164561251|NCT00716976|594423673|FG001|Overall Study|Radiation during protocol|0|||
164561252|NCT00716976|594423672|FG000|Overall Study|Ineligibles|4|||
164561253|NCT00716976|594423673|FG001|Overall Study|Ineligibles|2|||
164561254|NCT00805740|594423674|FG000|Overall Study|Death|7|||
164561255|NCT00805740|594423675|FG001|Overall Study|Death|4|||
164561256|NCT00805740|594423674|FG000|Overall Study|Withdrawal by Subject|1|||
164561257|NCT00805740|594423675|FG001|Overall Study|Withdrawal by Subject|0|||
164561258|NCT00805740|594423674|FG000|Overall Study|Lost to Follow-up|1|||
164561259|NCT00805740|594423675|FG001|Overall Study|Lost to Follow-up|0|||
164561260|NCT00805740|594423674|FG000|Overall Study|Randomized, but not treated|2|||
164561261|NCT00805740|594423675|FG001|Overall Study|Randomized, but not treated|0|||
164561262|NCT05499559|594423676|FG000|Overall Study|Lost to Follow-up|467|||
164561263|NCT03472560|594423683|FG000|Overall Study|Subject transfer to continuation protocol|0|||
164561264|NCT03472560|594423684|FG001|Overall Study|Subject transfer to continuation protocol|1|||
164561265|NCT03472560|594423683|FG000|Overall Study|Withdrawal by Subject|4|||
164561266|NCT03472560|594423684|FG001|Overall Study|Withdrawal by Subject|0|||
164561267|NCT03472560|594423683|FG000|Overall Study|Progressive disease|24|||
164561268|NCT03472560|594423684|FG001|Overall Study|Progressive disease|8|||
164561269|NCT03472560|594423683|FG000|Overall Study|Physician Decision|1|||
164561270|NCT03472560|594423684|FG001|Overall Study|Physician Decision|0|||
164561271|NCT03472560|594423683|FG000|Overall Study|Death|7|||
164561272|NCT03472560|594423684|FG001|Overall Study|Death|4|||
164561273|NCT03472560|594423683|FG000|Overall Study|Adverse Event|5|||
164561274|NCT03472560|594423684|FG001|Overall Study|Adverse Event|3|||
164561275|NCT03472560|594423683|FG000|Overall Study|Global deterioration of health status|0|||
164561276|NCT03472560|594423684|FG001|Overall Study|Global deterioration of health status|4|||
164561277|NCT01946178|594423685|FG000|Overall Study|Pregnancy|1|||
164561278|NCT01946178|594423685|FG000|Overall Study|Lost to Follow-up|1|||
164561279|NCT01534676|594423686|FG000|Overall Study|Study closed due to poor enrollment|2|||
164561280|NCT01534676|594423687|FG001|Overall Study|Study closed due to poor enrollment|1|||
164561281|NCT01790048|594423689|FG000|Overall Study|Incorrect Age|9|||
164561282|NCT01790048|594423690|FG001|Overall Study|Incorrect Age|14|||
164561283|NCT01790048|594423689|FG000|Overall Study|data entry error|0|||
164561284|NCT01790048|594423690|FG001|Overall Study|data entry error|1|||
164561285|NCT01790048|594423689|FG000|Overall Study|Other|0|||
164561286|NCT01790048|594423690|FG001|Overall Study|Other|2|||
164561287|NCT01790048|594423689|FG000|Overall Study|SAM at Enrollment|2|||
164561288|NCT01790048|594423690|FG001|Overall Study|SAM at Enrollment|0|||
164561289|NCT01790048|594423689|FG000|Overall Study|Measurement error|1|||
164561290|NCT01790048|594423690|FG001|Overall Study|Measurement error|0|||
164561291|NCT00584233|594423691|FG000|Overall Study|Withdrawal by Subject|5|||
164561292|NCT00584233|594423691|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
164561293|NCT01491178|594423694|FG000|Overall Study|Adverse Event|1016|||
164561294|NCT01491178|594423694|FG000|Overall Study|Improvement of NVAF|210|||
164561295|NCT01491178|594423694|FG000|Overall Study|To conduct invasive treatment|59|||
164561296|NCT01491178|594423694|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
164561297|NCT01491178|594423694|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
164561298|NCT01491178|594423694|FG000|Overall Study|To take a contraindication|20|||
164561299|NCT01491178|594423694|FG000|Overall Study|Other than specified above|657|||
164561300|NCT03286842|594423697|FG000|Overall Study|Patients rolled over to another study|80|||
164561301|NCT01340209|594423701|FG000|Overall Study|Adverse Event|1|||
164561302|NCT01340209|594423702|FG001|Overall Study|Adverse Event|1|||
164561303|NCT01340209|594423703|FG002|Overall Study|Adverse Event|2|||
164561304|NCT01340209|594423701|FG000|Overall Study|Protocol Violation|1|||
164561305|NCT01340209|594423702|FG001|Overall Study|Protocol Violation|2|||
164561306|NCT01340209|594423703|FG002|Overall Study|Protocol Violation|1|||
164561307|NCT01340209|594423701|FG000|Overall Study|Withdrawal by Subject|0|||
164315260|NCT02059291|593531490|FG022|Epoch 4|Pregnancy|0|||
164315261|NCT02059291|593531491|FG023|Epoch 4|Pregnancy|0|||
164315262|NCT02059291|593531492|FG024|Epoch 4|Pregnancy|0|||
164315263|NCT02059291|593531468|FG000|Epoch 4|Withdrawal by Subject|0|||
164315264|NCT02059291|593531469|FG001|Epoch 4|Withdrawal by Subject|0|||
164315265|NCT02059291|593531470|FG002|Epoch 4|Withdrawal by Subject|0|||
164315266|NCT02059291|593531471|FG003|Epoch 4|Withdrawal by Subject|0|||
164315267|NCT02059291|593531472|FG004|Epoch 4|Withdrawal by Subject|0|||
164315268|NCT02059291|593531473|FG005|Epoch 4|Withdrawal by Subject|0|||
164315269|NCT02059291|593531474|FG006|Epoch 4|Withdrawal by Subject|0|||
164315270|NCT02059291|593531475|FG007|Epoch 4|Withdrawal by Subject|0|||
164315271|NCT02059291|593531476|FG008|Epoch 4|Withdrawal by Subject|0|||
164315272|NCT02059291|593531477|FG009|Epoch 4|Withdrawal by Subject|0|||
164315273|NCT02059291|593531478|FG010|Epoch 4|Withdrawal by Subject|0|||
164315274|NCT02059291|593531479|FG011|Epoch 4|Withdrawal by Subject|0|||
164315275|NCT02059291|593531480|FG012|Epoch 4|Withdrawal by Subject|0|||
164315276|NCT02059291|593531481|FG013|Epoch 4|Withdrawal by Subject|0|||
164315277|NCT02059291|593531482|FG014|Epoch 4|Withdrawal by Subject|0|||
164315278|NCT02059291|593531483|FG015|Epoch 4|Withdrawal by Subject|0|||
164315279|NCT02059291|593531484|FG016|Epoch 4|Withdrawal by Subject|0|||
164315280|NCT02059291|593531485|FG017|Epoch 4|Withdrawal by Subject|0|||
164315281|NCT02059291|593531486|FG018|Epoch 4|Withdrawal by Subject|0|||
164315282|NCT02059291|593531487|FG019|Epoch 4|Withdrawal by Subject|0|||
164315283|NCT02059291|593531488|FG020|Epoch 4|Withdrawal by Subject|1|||
164315284|NCT02059291|593531489|FG021|Epoch 4|Withdrawal by Subject|0|||
164315285|NCT02059291|593531490|FG022|Epoch 4|Withdrawal by Subject|0|||
164665591|NCT00264810|594799657|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
164665592|NCT00264810|594799658|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
164315286|NCT02059291|593531491|FG023|Epoch 4|Withdrawal by Subject|0|||
164315287|NCT02059291|593531492|FG024|Epoch 4|Withdrawal by Subject|0|||
164315288|NCT02059291|593531468|FG000|Epoch 4|Lack of Efficacy|0|||
164315289|NCT02059291|593531469|FG001|Epoch 4|Lack of Efficacy|0|||
164315290|NCT02059291|593531470|FG002|Epoch 4|Lack of Efficacy|0|||
164315291|NCT02059291|593531471|FG003|Epoch 4|Lack of Efficacy|0|||
164315292|NCT02059291|593531472|FG004|Epoch 4|Lack of Efficacy|0|||
164315293|NCT02059291|593531473|FG005|Epoch 4|Lack of Efficacy|0|||
164315294|NCT02059291|593531474|FG006|Epoch 4|Lack of Efficacy|0|||
164315295|NCT02059291|593531475|FG007|Epoch 4|Lack of Efficacy|0|||
164315296|NCT02059291|593531476|FG008|Epoch 4|Lack of Efficacy|0|||
164315297|NCT02059291|593531477|FG009|Epoch 4|Lack of Efficacy|0|||
164315298|NCT02059291|593531478|FG010|Epoch 4|Lack of Efficacy|0|||
164315299|NCT02059291|593531479|FG011|Epoch 4|Lack of Efficacy|0|||
164315300|NCT02059291|593531480|FG012|Epoch 4|Lack of Efficacy|0|||
164315301|NCT02059291|593531481|FG013|Epoch 4|Lack of Efficacy|0|||
164315302|NCT02059291|593531482|FG014|Epoch 4|Lack of Efficacy|0|||
164315303|NCT02059291|593531483|FG015|Epoch 4|Lack of Efficacy|0|||
164315304|NCT02059291|593531484|FG016|Epoch 4|Lack of Efficacy|0|||
164315305|NCT02059291|593531485|FG017|Epoch 4|Lack of Efficacy|0|||
164315306|NCT02059291|593531486|FG018|Epoch 4|Lack of Efficacy|0|||
164315307|NCT02059291|593531487|FG019|Epoch 4|Lack of Efficacy|0|||
164315308|NCT02059291|593531488|FG020|Epoch 4|Lack of Efficacy|0|||
164315309|NCT02059291|593531489|FG021|Epoch 4|Lack of Efficacy|0|||
164315310|NCT02059291|593531490|FG022|Epoch 4|Lack of Efficacy|0|||
164315311|NCT02059291|593531491|FG023|Epoch 4|Lack of Efficacy|1|||
164315312|NCT02059291|593531492|FG024|Epoch 4|Lack of Efficacy|0|||
164315313|NCT04975438|593531498|FG000|Overall Study|Lost to Follow-up|1|||
164315314|NCT04975438|593531499|FG001|Overall Study|Lost to Follow-up|0|||
164315315|NCT04975438|593531500|FG002|Overall Study|Lost to Follow-up|1|||
164315316|NCT04975438|593531501|FG003|Overall Study|Lost to Follow-up|0|||
164665593|NCT00264810|594799657|FG000|Baseline|Other|0|||
164665594|NCT00264810|594799658|FG001|Baseline|Other|1|||
164665595|NCT00264810|594799657|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
164204354|NCT05911841|593119215|FG008|Induction Period|Lack of Efficacy|0|||
164204355|NCT05911841|593119216|FG009|Induction Period|Lack of Efficacy|0|||
164204356|NCT05911841|593119207|FG000|Induction Period|Adverse Event|3|||
164204357|NCT05911841|593119208|FG001|Induction Period|Adverse Event|1|||
164204358|NCT05911841|593119209|FG002|Induction Period|Adverse Event|2|||
164204359|NCT05911841|593119210|FG003|Induction Period|Adverse Event|0|||
164204360|NCT05911841|593119211|FG004|Induction Period|Adverse Event|0|||
164204361|NCT05911841|593119212|FG005|Induction Period|Adverse Event|0|||
164665596|NCT00264810|594799658|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
164204362|NCT05911841|593119213|FG006|Induction Period|Adverse Event|0|||
164315317|NCT04975438|593531498|FG000|Overall Study|Withdrawal by Subject|1|||
164315318|NCT04975438|593531499|FG001|Overall Study|Withdrawal by Subject|0|||
164315319|NCT04975438|593531500|FG002|Overall Study|Withdrawal by Subject|0|||
164315320|NCT04975438|593531501|FG003|Overall Study|Withdrawal by Subject|0|||
164315321|NCT04973436|593531502|FG000|Overall Study|Lost to Follow-up|3|||
164665597|NCT00264810|594799657|FG000|Stimulation Optimization Period|Death|0|||
164665598|NCT00264810|594799658|FG001|Stimulation Optimization Period|Death|1|||
164665599|NCT00264810|594799657|FG000|Blinded Evaluation Period|Explant due to infection|1|||
164665600|NCT00264810|594799658|FG001|Blinded Evaluation Period|Explant due to infection|1|||
164204363|NCT05911841|593119214|FG007|Induction Period|Adverse Event|0|||
164315322|NCT04973436|593531502|FG000|Overall Study|Withdrawal by Subject|1|||
164315323|NCT04973436|593531502|FG000|Overall Study|Death|2|||
164315324|NCT01276054|593531506|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
164315325|NCT01276054|593531507|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
164204364|NCT05911841|593119215|FG008|Induction Period|Adverse Event|0|||
164204365|NCT05911841|593119216|FG009|Induction Period|Adverse Event|0|||
164204366|NCT05911841|593119207|FG000|Induction Period|Assigned Treatment by Mistake|0|||
164204367|NCT05911841|593119208|FG001|Induction Period|Assigned Treatment by Mistake|1|||
164561308|NCT01340209|594423702|FG001|Overall Study|Withdrawal by Subject|0|||
164561309|NCT01340209|594423703|FG002|Overall Study|Withdrawal by Subject|1|||
164204368|NCT05911841|593119209|FG002|Induction Period|Assigned Treatment by Mistake|0|||
164204369|NCT05911841|593119210|FG003|Induction Period|Assigned Treatment by Mistake|1|||
164204370|NCT05911841|593119211|FG004|Induction Period|Assigned Treatment by Mistake|0|||
164204371|NCT05911841|593119212|FG005|Induction Period|Assigned Treatment by Mistake|0|||
164204372|NCT05911841|593119213|FG006|Induction Period|Assigned Treatment by Mistake|0|||
164561310|NCT01340209|594423701|FG000|Overall Study|Other reason not defined above|3|||
164561311|NCT01340209|594423702|FG001|Overall Study|Other reason not defined above|5|||
164561312|NCT01340209|594423703|FG002|Overall Study|Other reason not defined above|4|||
164561313|NCT00257010|594423712|FG000|Overall Study|Lack of Efficacy|11|||
164561314|NCT00257010|594423712|FG000|Overall Study|Lost to Follow-up|53|||
164665601|NCT00264810|594799657|FG000|Open Label Evaluation Period|Explant due to infection|1|||
164204373|NCT05911841|593119214|FG007|Induction Period|Assigned Treatment by Mistake|0|||
164204374|NCT05911841|593119215|FG008|Induction Period|Assigned Treatment by Mistake|0|||
164204375|NCT05911841|593119216|FG009|Induction Period|Assigned Treatment by Mistake|0|||
164204376|NCT05911841|593119207|FG000|Induction Period|Lost to Follow-up|0|||
164204377|NCT05911841|593119208|FG001|Induction Period|Lost to Follow-up|0|||
164204378|NCT05911841|593119209|FG002|Induction Period|Lost to Follow-up|1|||
164204379|NCT05911841|593119210|FG003|Induction Period|Lost to Follow-up|1|||
164204380|NCT05911841|593119211|FG004|Induction Period|Lost to Follow-up|0|||
164204381|NCT05911841|593119212|FG005|Induction Period|Lost to Follow-up|0|||
164204382|NCT05911841|593119213|FG006|Induction Period|Lost to Follow-up|0|||
164204383|NCT05911841|593119214|FG007|Induction Period|Lost to Follow-up|0|||
164204384|NCT05911841|593119215|FG008|Induction Period|Lost to Follow-up|0|||
164204385|NCT05911841|593119216|FG009|Induction Period|Lost to Follow-up|0|||
164204386|NCT05911841|593119207|FG000|Maintenance Period|Enrolled to Escape Arm|0|||
164204387|NCT05911841|593119208|FG001|Maintenance Period|Enrolled to Escape Arm|0|||
164204388|NCT05911841|593119209|FG002|Maintenance Period|Enrolled to Escape Arm|0|||
164204389|NCT05911841|593119210|FG003|Maintenance Period|Enrolled to Escape Arm|0|||
164204390|NCT05911841|593119211|FG004|Maintenance Period|Enrolled to Escape Arm|0|||
164204391|NCT05911841|593119212|FG005|Maintenance Period|Enrolled to Escape Arm|0|||
164204392|NCT05911841|593119213|FG006|Maintenance Period|Enrolled to Escape Arm|3|||
164204393|NCT05911841|593119214|FG007|Maintenance Period|Enrolled to Escape Arm|4|||
164204394|NCT05911841|593119215|FG008|Maintenance Period|Enrolled to Escape Arm|4|||
164204395|NCT05911841|593119216|FG009|Maintenance Period|Enrolled to Escape Arm|0|||
164204396|NCT05911841|593119207|FG000|Maintenance Period|Lack of Efficacy|0|||
164204397|NCT05911841|593119208|FG001|Maintenance Period|Lack of Efficacy|0|||
164204398|NCT05911841|593119209|FG002|Maintenance Period|Lack of Efficacy|0|||
164204399|NCT05911841|593119210|FG003|Maintenance Period|Lack of Efficacy|0|||
164204400|NCT05911841|593119211|FG004|Maintenance Period|Lack of Efficacy|1|||
164204401|NCT05911841|593119212|FG005|Maintenance Period|Lack of Efficacy|0|||
164204402|NCT05911841|593119213|FG006|Maintenance Period|Lack of Efficacy|1|||
164204403|NCT05911841|593119214|FG007|Maintenance Period|Lack of Efficacy|0|||
164204404|NCT05911841|593119215|FG008|Maintenance Period|Lack of Efficacy|0|||
164204405|NCT05911841|593119216|FG009|Maintenance Period|Lack of Efficacy|0|||
164204406|NCT05911841|593119207|FG000|Maintenance Period|Study Terminated by Sponsor|0|||
164204407|NCT05911841|593119208|FG001|Maintenance Period|Study Terminated by Sponsor|0|||
164204408|NCT05911841|593119209|FG002|Maintenance Period|Study Terminated by Sponsor|0|||
164204409|NCT05911841|593119210|FG003|Maintenance Period|Study Terminated by Sponsor|0|||
164204410|NCT05911841|593119211|FG004|Maintenance Period|Study Terminated by Sponsor|11|||
164204411|NCT05911841|593119212|FG005|Maintenance Period|Study Terminated by Sponsor|5|||
164204412|NCT05911841|593119213|FG006|Maintenance Period|Study Terminated by Sponsor|1|||
164204413|NCT05911841|593119214|FG007|Maintenance Period|Study Terminated by Sponsor|7|||
164204414|NCT05911841|593119215|FG008|Maintenance Period|Study Terminated by Sponsor|7|||
164204415|NCT05911841|593119216|FG009|Maintenance Period|Study Terminated by Sponsor|0|||
164204416|NCT05911841|593119207|FG000|Maintenance Period|Withdrawal by Subject|0|||
164204417|NCT05911841|593119208|FG001|Maintenance Period|Withdrawal by Subject|0|||
164204418|NCT05911841|593119209|FG002|Maintenance Period|Withdrawal by Subject|0|||
164204419|NCT05911841|593119210|FG003|Maintenance Period|Withdrawal by Subject|0|||
164204420|NCT05911841|593119211|FG004|Maintenance Period|Withdrawal by Subject|0|||
164204421|NCT05911841|593119212|FG005|Maintenance Period|Withdrawal by Subject|1|||
164204422|NCT05911841|593119213|FG006|Maintenance Period|Withdrawal by Subject|0|||
164204423|NCT05911841|593119214|FG007|Maintenance Period|Withdrawal by Subject|1|||
164204424|NCT05911841|593119215|FG008|Maintenance Period|Withdrawal by Subject|0|||
164204425|NCT05911841|593119216|FG009|Maintenance Period|Withdrawal by Subject|0|||
164204426|NCT05911841|593119207|FG000|Maintenance Period|Adverse Event|0|||
164204427|NCT05911841|593119208|FG001|Maintenance Period|Adverse Event|0|||
164561315|NCT00257010|594423712|FG000|Overall Study|Withdrawal by Subject|34|||
164665602|NCT00264810|594799658|FG001|Open Label Evaluation Period|Explant due to infection|1|||
164315326|NCT05405257|593531511|FG000|Overall Study|Withdrawal by Subject|1|||
164315327|NCT01788215|593531514|FG000|Overall Study|Withdrawal by Subject|0|||
164315328|NCT01788215|593531515|FG001|Overall Study|Withdrawal by Subject|1|||
164315329|NCT01788215|593531514|FG000|Overall Study|Lost to Follow-up|2|||
164315330|NCT01788215|593531515|FG001|Overall Study|Lost to Follow-up|0|||
164315331|NCT03116152|593531516|FG000|Overall Study|Disease Progression|49|||
164315332|NCT03116152|593531517|FG001|Overall Study|Disease Progression|47|||
164315333|NCT03116152|593531516|FG000|Overall Study|Death|5|||
164315334|NCT03116152|593531517|FG001|Overall Study|Death|2|||
164315335|NCT03116152|593531516|FG000|Overall Study|Adverse Event|21|||
164315336|NCT03116152|593531517|FG001|Overall Study|Adverse Event|7|||
164315337|NCT03116152|593531516|FG000|Overall Study|Protocol Violation|2|||
164315338|NCT03116152|593531517|FG001|Overall Study|Protocol Violation|2|||
164665603|NCT00264810|594799657|FG000|Open Label Evaluation Period|Death|3|||
164665604|NCT00264810|594799658|FG001|Open Label Evaluation Period|Death|2|||
164665605|NCT00264810|594799657|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
164665606|NCT00264810|594799658|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
164665607|NCT03008460|594799659|FG000|Overall Study|Protocol deviation|0|||
164665608|NCT03008460|594799660|FG001|Overall Study|Protocol deviation|2|||
164665609|NCT03008460|594799659|FG000|Overall Study|Study drug not dispensed|0|||
164665610|NCT03008460|594799660|FG001|Overall Study|Study drug not dispensed|1|||
164665611|NCT03008460|594799659|FG000|Overall Study|Adverse Event|0|||
164665612|NCT03008460|594799660|FG001|Overall Study|Adverse Event|1|||
164665613|NCT03008460|594799659|FG000|Overall Study|Withdrawal by Subject|5|||
164665614|NCT03008460|594799660|FG001|Overall Study|Withdrawal by Subject|6|||
164665615|NCT03008460|594799659|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
164665616|NCT03008460|594799660|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
164665617|NCT03008460|594799659|FG000|Overall Study|End of study visit outside permitted time window|0|||
164665618|NCT03008460|594799660|FG001|Overall Study|End of study visit outside permitted time window|1|||
164665619|NCT03008460|594799659|FG000|Overall Study|Lost to Follow-up|1|||
164665620|NCT03008460|594799660|FG001|Overall Study|Lost to Follow-up|3|||
164665621|NCT00475020|594799661|FG000|Overall Study|Physician Decision|3|||
164665622|NCT00475020|594799661|FG000|Overall Study|Insurance Denial|1|||
164665623|NCT00475020|594799661|FG000|Overall Study|Donor not able to donate the last minute|1|||
164665624|NCT02688608|594799662|FG000|Overall Study|Lost to Follow-up|1|||
164665625|NCT01575054|594799663|FG000|Overall Study|Other Reasons|5|||
164665626|NCT01575054|594799664|FG001|Overall Study|Other Reasons|3|||
164665627|NCT01575054|594799663|FG000|Overall Study|Protocol Violation|2|||
164665628|NCT01575054|594799664|FG001|Overall Study|Protocol Violation|1|||
164665629|NCT01575054|594799663|FG000|Overall Study|Personal Reasons|10|||
164665630|NCT01575054|594799664|FG001|Overall Study|Personal Reasons|11|||
164665631|NCT01575054|594799663|FG000|Overall Study|Lost to Follow-up|3|||
164665632|NCT01575054|594799664|FG001|Overall Study|Lost to Follow-up|3|||
164665633|NCT01575054|594799663|FG000|Overall Study|Adverse Event|9|||
164665634|NCT01575054|594799664|FG001|Overall Study|Adverse Event|8|||
164665635|NCT03481309|594799665|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
164665636|NCT03481309|594799666|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
164665637|NCT03481309|594799667|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
164665638|NCT03481309|594799668|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
164665639|NCT03481309|594799669|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
164665640|NCT03481309|594799670|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
164665641|NCT03309956|594799671|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
164665642|NCT02768298|594799674|FG000|Overall Study|Adverse Event|1|||
164665643|NCT02768298|594799675|FG001|Overall Study|Adverse Event|4|||
164665644|NCT02768298|594799674|FG000|Overall Study|Death|2|||
164665645|NCT02768298|594799675|FG001|Overall Study|Death|1|||
164665646|NCT02768298|594799674|FG000|Overall Study|Non-compliance with study treatment|0|||
164665647|NCT02768298|594799675|FG001|Overall Study|Non-compliance with study treatment|1|||
164665648|NCT02768298|594799674|FG000|Overall Study|Subject/guardian decision|1|||
164315339|NCT03116152|593531516|FG000|Overall Study|Withdrawal by Subject|0|||
164315340|NCT03116152|593531517|FG001|Overall Study|Withdrawal by Subject|1|||
164315341|NCT03116152|593531516|FG000|Overall Study|Physician Decision|3|||
164665649|NCT02768298|594799675|FG001|Overall Study|Subject/guardian decision|0|||
164665650|NCT02768298|594799674|FG000|Overall Study|Withdrawal of informed consent|0|||
164315342|NCT03116152|593531517|FG001|Overall Study|Physician Decision|2|||
164315343|NCT03116152|593531516|FG000|Overall Study|other|11|||
164315344|NCT03116152|593531517|FG001|Overall Study|other|34|||
164315345|NCT00275340|593531518|FG000|Overall Study|Lost to Follow-up|2|||
164665651|NCT02768298|594799675|FG001|Overall Study|Withdrawal of informed consent|1|||
164665652|NCT02130466|594799676|FG000|Overall Study|Death|4|||
164315346|NCT00275340|593531519|FG001|Overall Study|Lost to Follow-up|4|||
164665653|NCT02130466|594799677|FG001|Overall Study|Death|1|||
164665654|NCT02130466|594799678|FG002|Overall Study|Death|1|||
164315347|NCT00862641|593531522|FG000|Overall Study|Randomized, but drug not received|1|||
164315348|NCT00862641|593531523|FG001|Overall Study|Randomized, but drug not received|4|||
164665655|NCT02130466|594799679|FG003|Overall Study|Death|3|||
164665656|NCT02130466|594799680|FG004|Overall Study|Death|2|||
164665657|NCT02130466|594799681|FG005|Overall Study|Death|30|||
164665658|NCT02130466|594799682|FG006|Overall Study|Death|45|||
164665659|NCT02130466|594799683|FG007|Overall Study|Death|2|||
164665660|NCT02130466|594799684|FG008|Overall Study|Death|3|||
164665661|NCT02130466|594799685|FG009|Overall Study|Death|4|||
164665662|NCT02130466|594799686|FG010|Overall Study|Death|5|||
164665663|NCT02130466|594799687|FG011|Overall Study|Death|3|||
164665664|NCT02130466|594799688|FG012|Overall Study|Death|11|||
164665665|NCT02130466|594799689|FG013|Overall Study|Death|7|||
164665666|NCT02130466|594799676|FG000|Overall Study|Lost to Follow-up|1|||
164665667|NCT02130466|594799677|FG001|Overall Study|Lost to Follow-up|0|||
164665668|NCT02130466|594799678|FG002|Overall Study|Lost to Follow-up|0|||
164665669|NCT02130466|594799679|FG003|Overall Study|Lost to Follow-up|0|||
164665670|NCT02130466|594799680|FG004|Overall Study|Lost to Follow-up|0|||
164665671|NCT02130466|594799681|FG005|Overall Study|Lost to Follow-up|1|||
164665672|NCT02130466|594799682|FG006|Overall Study|Lost to Follow-up|0|||
164665673|NCT02130466|594799683|FG007|Overall Study|Lost to Follow-up|0|||
164665674|NCT02130466|594799684|FG008|Overall Study|Lost to Follow-up|0|||
164665675|NCT02130466|594799685|FG009|Overall Study|Lost to Follow-up|0|||
164665676|NCT02130466|594799686|FG010|Overall Study|Lost to Follow-up|0|||
164665677|NCT02130466|594799687|FG011|Overall Study|Lost to Follow-up|0|||
164665678|NCT02130466|594799688|FG012|Overall Study|Lost to Follow-up|1|||
164665679|NCT02130466|594799689|FG013|Overall Study|Lost to Follow-up|0|||
164665680|NCT02130466|594799676|FG000|Overall Study|Physician Decision|0|||
164665681|NCT02130466|594799677|FG001|Overall Study|Physician Decision|0|||
164665682|NCT02130466|594799678|FG002|Overall Study|Physician Decision|0|||
164665683|NCT02130466|594799679|FG003|Overall Study|Physician Decision|0|||
164665684|NCT02130466|594799680|FG004|Overall Study|Physician Decision|0|||
164561316|NCT00257010|594423712|FG000|Overall Study|Adverse Event|10|||
164561317|NCT00257010|594423712|FG000|Overall Study|various|11|||
164561318|NCT00257010|594423712|FG000|Overall Study|no headache reported|9|||
164561319|NCT00197054|594423718|FG000|Overall Study|Withdrawal by Subject|9|||
164561320|NCT00197054|594423719|FG001|Overall Study|Withdrawal by Subject|3|||
164561321|NCT00197054|594423720|FG002|Overall Study|Withdrawal by Subject|3|||
164561322|NCT00197054|594423718|FG000|Overall Study|Moved from area|7|||
164561323|NCT00197054|594423719|FG001|Overall Study|Moved from area|14|||
164561324|NCT00197054|594423720|FG002|Overall Study|Moved from area|9|||
164561325|NCT00197054|594423718|FG000|Overall Study|Lost to Follow-up|1|||
164561326|NCT00197054|594423719|FG001|Overall Study|Lost to Follow-up|4|||
164561327|NCT00197054|594423720|FG002|Overall Study|Lost to Follow-up|0|||
164561328|NCT02574637|594423721|FG000|Double-blind Period|Adverse Event|1|||
164561329|NCT02574637|594423722|FG001|Double-blind Period|Adverse Event|0|||
164561330|NCT02574637|594423723|FG002|Double-blind Period|Adverse Event|0|||
164561331|NCT02574637|594423724|FG003|Double-blind Period|Adverse Event|0|||
164561332|NCT02574637|594423725|FG004|Double-blind Period|Adverse Event|0|||
164561333|NCT02574637|594423726|FG005|Double-blind Period|Adverse Event|0|||
164561334|NCT02574637|594423727|FG006|Double-blind Period|Adverse Event|0|||
164561335|NCT02574637|594423728|FG007|Double-blind Period|Adverse Event|0|||
164561336|NCT02574637|594423729|FG008|Double-blind Period|Adverse Event|0|||
164561337|NCT02574637|594423730|FG009|Double-blind Period|Adverse Event|0|||
164561338|NCT02574637|594423721|FG000|Double-blind Period|Lack of Efficacy|0|||
164561339|NCT02574637|594423722|FG001|Double-blind Period|Lack of Efficacy|0|||
164561340|NCT02574637|594423723|FG002|Double-blind Period|Lack of Efficacy|2|||
164561341|NCT02574637|594423724|FG003|Double-blind Period|Lack of Efficacy|0|||
164561342|NCT02574637|594423725|FG004|Double-blind Period|Lack of Efficacy|0|||
164561343|NCT02574637|594423726|FG005|Double-blind Period|Lack of Efficacy|0|||
164561344|NCT02574637|594423727|FG006|Double-blind Period|Lack of Efficacy|0|||
164561345|NCT02574637|594423728|FG007|Double-blind Period|Lack of Efficacy|0|||
164561346|NCT02574637|594423729|FG008|Double-blind Period|Lack of Efficacy|0|||
164561347|NCT02574637|594423730|FG009|Double-blind Period|Lack of Efficacy|0|||
164561348|NCT02574637|594423721|FG000|Double-blind Period|Protocol Deviation|1|||
164561349|NCT02574637|594423722|FG001|Double-blind Period|Protocol Deviation|0|||
164561350|NCT02574637|594423723|FG002|Double-blind Period|Protocol Deviation|0|||
164561351|NCT02574637|594423724|FG003|Double-blind Period|Protocol Deviation|0|||
164561352|NCT02574637|594423725|FG004|Double-blind Period|Protocol Deviation|0|||
164665685|NCT02130466|594799681|FG005|Overall Study|Physician Decision|1|||
164665686|NCT02130466|594799682|FG006|Overall Study|Physician Decision|1|||
164665687|NCT02130466|594799683|FG007|Overall Study|Physician Decision|0|||
164665688|NCT02130466|594799684|FG008|Overall Study|Physician Decision|0|||
164665689|NCT02130466|594799685|FG009|Overall Study|Physician Decision|0|||
164665690|NCT02130466|594799686|FG010|Overall Study|Physician Decision|0|||
164561353|NCT02574637|594423726|FG005|Double-blind Period|Protocol Deviation|0|||
164561354|NCT02574637|594423727|FG006|Double-blind Period|Protocol Deviation|0|||
164561355|NCT02574637|594423728|FG007|Double-blind Period|Protocol Deviation|0|||
164561356|NCT02574637|594423729|FG008|Double-blind Period|Protocol Deviation|0|||
164561357|NCT02574637|594423730|FG009|Double-blind Period|Protocol Deviation|0|||
164665691|NCT02130466|594799687|FG011|Overall Study|Physician Decision|0|||
164665692|NCT02130466|594799688|FG012|Overall Study|Physician Decision|0|||
164665693|NCT02130466|594799689|FG013|Overall Study|Physician Decision|0|||
164315349|NCT00862641|593531524|FG002|Overall Study|Randomized, but drug not received|1|||
164315350|NCT00862641|593531525|FG003|Overall Study|Randomized, but drug not received|4|||
164315351|NCT02365480|593531526|FG000|Overall Study|Withdrawal by Subject|2|||
164315352|NCT02365480|593531527|FG001|Overall Study|Withdrawal by Subject|0|||
164315353|NCT01419197|593531531|FG000|Overall Study|Death|247|||
164315354|NCT01419197|593531532|FG001|Overall Study|Death|122|||
164315355|NCT01419197|593531531|FG000|Overall Study|Physician Decision|4|||
164315356|NCT01419197|593531532|FG001|Overall Study|Physician Decision|4|||
164315357|NCT01419197|593531531|FG000|Overall Study|Non-compliance|3|||
164204428|NCT05911841|593119209|FG002|Maintenance Period|Adverse Event|0|||
164315358|NCT01419197|593531532|FG001|Overall Study|Non-compliance|1|||
164315359|NCT01419197|593531531|FG000|Overall Study|Withdrawal by Subject|33|||
164315360|NCT01419197|593531532|FG001|Overall Study|Withdrawal by Subject|32|||
164315361|NCT01419197|593531531|FG000|Overall Study|Study Completed by Sponsor|103|||
164315362|NCT01419197|593531532|FG001|Overall Study|Study Completed by Sponsor|34|||
164315363|NCT01419197|593531531|FG000|Overall Study|Reason Not Specified|0|||
164315364|NCT01419197|593531532|FG001|Overall Study|Reason Not Specified|1|||
164315365|NCT01419197|593531531|FG000|Overall Study|Lost to Follow-up|14|||
164665694|NCT02130466|594799676|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
164665695|NCT02130466|594799677|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
164665696|NCT02130466|594799678|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
164665697|NCT02130466|594799679|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
164665698|NCT02130466|594799680|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
164665699|NCT02130466|594799681|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
164665700|NCT02130466|594799682|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
164665701|NCT02130466|594799683|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
164665702|NCT02130466|594799684|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
164665703|NCT02130466|594799685|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
164665704|NCT02130466|594799686|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
164665705|NCT02130466|594799687|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
164665706|NCT02130466|594799688|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
164665707|NCT02130466|594799689|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
164665708|NCT02130466|594799676|FG000|Overall Study|Withdrawal by Subject|1|||
164665709|NCT02130466|594799677|FG001|Overall Study|Withdrawal by Subject|0|||
164665710|NCT02130466|594799678|FG002|Overall Study|Withdrawal by Subject|0|||
164665711|NCT02130466|594799679|FG003|Overall Study|Withdrawal by Subject|0|||
164665712|NCT02130466|594799680|FG004|Overall Study|Withdrawal by Subject|0|||
164204429|NCT05911841|593119210|FG003|Maintenance Period|Adverse Event|0|||
164204430|NCT05911841|593119211|FG004|Maintenance Period|Adverse Event|0|||
164204431|NCT05911841|593119212|FG005|Maintenance Period|Adverse Event|0|||
164204432|NCT05911841|593119213|FG006|Maintenance Period|Adverse Event|0|||
164204433|NCT05911841|593119214|FG007|Maintenance Period|Adverse Event|1|||
164204434|NCT05911841|593119215|FG008|Maintenance Period|Adverse Event|0|||
164204435|NCT05911841|593119216|FG009|Maintenance Period|Adverse Event|0|||
164204436|NCT05911841|593119207|FG000|Escape Period|Adverse Event|0|||
164204437|NCT05911841|593119208|FG001|Escape Period|Adverse Event|0|||
164204438|NCT05911841|593119209|FG002|Escape Period|Adverse Event|0|||
164204439|NCT05911841|593119210|FG003|Escape Period|Adverse Event|0|||
164204440|NCT05911841|593119211|FG004|Escape Period|Adverse Event|0|||
164204441|NCT05911841|593119212|FG005|Escape Period|Adverse Event|0|||
164204442|NCT05911841|593119213|FG006|Escape Period|Adverse Event|0|||
164204443|NCT05911841|593119214|FG007|Escape Period|Adverse Event|0|||
164204444|NCT05911841|593119215|FG008|Escape Period|Adverse Event|0|||
164204445|NCT05911841|593119216|FG009|Escape Period|Adverse Event|1|||
164204446|NCT05911841|593119207|FG000|Escape Period|Lack of Efficacy|0|||
164204447|NCT05911841|593119208|FG001|Escape Period|Lack of Efficacy|0|||
164204448|NCT05911841|593119209|FG002|Escape Period|Lack of Efficacy|0|||
164204449|NCT05911841|593119210|FG003|Escape Period|Lack of Efficacy|0|||
164204450|NCT05911841|593119211|FG004|Escape Period|Lack of Efficacy|0|||
164204451|NCT05911841|593119212|FG005|Escape Period|Lack of Efficacy|0|||
164204452|NCT05911841|593119213|FG006|Escape Period|Lack of Efficacy|0|||
164204453|NCT05911841|593119214|FG007|Escape Period|Lack of Efficacy|0|||
164204454|NCT05911841|593119215|FG008|Escape Period|Lack of Efficacy|0|||
164204455|NCT05911841|593119216|FG009|Escape Period|Lack of Efficacy|31|||
164204456|NCT05911841|593119207|FG000|Escape Period|Lost to Follow-up|0|||
164204457|NCT05911841|593119208|FG001|Escape Period|Lost to Follow-up|0|||
164204458|NCT05911841|593119209|FG002|Escape Period|Lost to Follow-up|0|||
164204459|NCT05911841|593119210|FG003|Escape Period|Lost to Follow-up|0|||
164204460|NCT05911841|593119211|FG004|Escape Period|Lost to Follow-up|0|||
164315366|NCT01419197|593531532|FG001|Overall Study|Lost to Follow-up|4|||
164315367|NCT00146848|593531536|FG000|Pre-randomization|Death|19|||
164315368|NCT00146848|593531537|FG001|Pre-randomization|Death|0|||
164204461|NCT05911841|593119212|FG005|Escape Period|Lost to Follow-up|0|||
164204462|NCT05911841|593119213|FG006|Escape Period|Lost to Follow-up|0|||
164204463|NCT05911841|593119214|FG007|Escape Period|Lost to Follow-up|0|||
164315369|NCT00146848|593531538|FG002|Pre-randomization|Death|0|||
164665713|NCT02130466|594799681|FG005|Overall Study|Withdrawal by Subject|1|||
164665714|NCT02130466|594799682|FG006|Overall Study|Withdrawal by Subject|0|||
164665715|NCT02130466|594799683|FG007|Overall Study|Withdrawal by Subject|0|||
164665716|NCT02130466|594799684|FG008|Overall Study|Withdrawal by Subject|1|||
164665717|NCT02130466|594799685|FG009|Overall Study|Withdrawal by Subject|0|||
164665718|NCT02130466|594799686|FG010|Overall Study|Withdrawal by Subject|0|||
164665719|NCT02130466|594799687|FG011|Overall Study|Withdrawal by Subject|0|||
164665720|NCT02130466|594799688|FG012|Overall Study|Withdrawal by Subject|0|||
164665721|NCT02130466|594799689|FG013|Overall Study|Withdrawal by Subject|0|||
164665722|NCT04529109|594799690|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
164665723|NCT04529109|594799691|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
164665724|NCT04256421|594799693|FG000|Overall Study|Death|171|||
164665725|NCT04256421|594799694|FG001|Overall Study|Death|180|||
164665726|NCT04256421|594799693|FG000|Overall Study|Lost to Follow-up|1|||
164665727|NCT04256421|594799694|FG001|Overall Study|Lost to Follow-up|1|||
164665728|NCT04256421|594799693|FG000|Overall Study|Withdrawal by Subject|9|||
164665729|NCT04256421|594799694|FG001|Overall Study|Withdrawal by Subject|10|||
164665730|NCT04256421|594799693|FG000|Overall Study|Ongoing in Study|66|||
164665731|NCT04256421|594799694|FG001|Overall Study|Ongoing in Study|52|||
164665732|NCT00419770|594801462|FG000|Overall Study|Withdrawal by Subject|5|||
164665733|NCT00419770|594801463|FG001|Overall Study|Withdrawal by Subject|1|||
164665734|NCT02424188|594801471|FG000|Overall Study|Death|2|||
164665735|NCT02424188|594801472|FG001|Overall Study|Death|2|||
164665736|NCT02424188|594801471|FG000|Overall Study|Lost to Follow-up|1|||
164665737|NCT02424188|594801472|FG001|Overall Study|Lost to Follow-up|3|||
164665738|NCT02424188|594801471|FG000|Overall Study|Incarceration|1|||
164665739|NCT02424188|594801472|FG001|Overall Study|Incarceration|0|||
164665740|NCT00453362|594801477|FG000|Overall Study|Adverse Event|5|||
164204464|NCT05911841|593119215|FG008|Escape Period|Lost to Follow-up|0|||
164204465|NCT05911841|593119216|FG009|Escape Period|Lost to Follow-up|1|||
164204466|NCT05911841|593119207|FG000|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
164204467|NCT05911841|593119208|FG001|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
164204468|NCT05911841|593119209|FG002|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
164204469|NCT05911841|593119210|FG003|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
164204470|NCT05911841|593119211|FG004|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
164204471|NCT05911841|593119212|FG005|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
164204472|NCT05911841|593119213|FG006|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
164204473|NCT05911841|593119214|FG007|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
164204474|NCT05911841|593119215|FG008|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
164204475|NCT05911841|593119216|FG009|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|4|||
164204476|NCT05911841|593119207|FG000|Escape Period|Site Terminated by Sponsor|0|||
164204477|NCT05911841|593119208|FG001|Escape Period|Site Terminated by Sponsor|0|||
164204478|NCT05911841|593119209|FG002|Escape Period|Site Terminated by Sponsor|0|||
164204479|NCT05911841|593119210|FG003|Escape Period|Site Terminated by Sponsor|0|||
164204480|NCT05911841|593119211|FG004|Escape Period|Site Terminated by Sponsor|0|||
164204481|NCT05911841|593119212|FG005|Escape Period|Site Terminated by Sponsor|0|||
164204482|NCT05911841|593119213|FG006|Escape Period|Site Terminated by Sponsor|0|||
164204483|NCT05911841|593119214|FG007|Escape Period|Site Terminated by Sponsor|0|||
164204484|NCT05911841|593119215|FG008|Escape Period|Site Terminated by Sponsor|0|||
164204485|NCT05911841|593119216|FG009|Escape Period|Site Terminated by Sponsor|1|||
164204486|NCT05911841|593119207|FG000|Escape Period|Study Terminated by Sponsor|0|||
164204487|NCT05911841|593119208|FG001|Escape Period|Study Terminated by Sponsor|0|||
164204488|NCT05911841|593119209|FG002|Escape Period|Study Terminated by Sponsor|0|||
164204489|NCT05911841|593119210|FG003|Escape Period|Study Terminated by Sponsor|0|||
164204490|NCT05911841|593119211|FG004|Escape Period|Study Terminated by Sponsor|0|||
164204491|NCT05911841|593119212|FG005|Escape Period|Study Terminated by Sponsor|0|||
164204492|NCT05911841|593119213|FG006|Escape Period|Study Terminated by Sponsor|0|||
164204493|NCT05911841|593119214|FG007|Escape Period|Study Terminated by Sponsor|0|||
164204494|NCT05911841|593119215|FG008|Escape Period|Study Terminated by Sponsor|0|||
164204495|NCT05911841|593119216|FG009|Escape Period|Study Terminated by Sponsor|34|||
164204496|NCT05911841|593119207|FG000|Escape Period|Withdrawal by Subject|0|||
164204497|NCT05911841|593119208|FG001|Escape Period|Withdrawal by Subject|0|||
164204498|NCT05911841|593119209|FG002|Escape Period|Withdrawal by Subject|0|||
164665741|NCT00453362|594801477|FG000|Overall Study|Death|7|||
164665742|NCT00453362|594801477|FG000|Overall Study|Physician Decision|2|||
164204499|NCT05911841|593119210|FG003|Escape Period|Withdrawal by Subject|0|||
164204500|NCT05911841|593119211|FG004|Escape Period|Withdrawal by Subject|0|||
164665743|NCT00453362|594801477|FG000|Overall Study|Withdrawal by Subject|3|||
164204501|NCT05911841|593119212|FG005|Escape Period|Withdrawal by Subject|0|||
164204502|NCT05911841|593119213|FG006|Escape Period|Withdrawal by Subject|0|||
164420624|NCT01154036|593910963|FG001|Phase I|Physician Decision|1|||
164665744|NCT00453362|594801477|FG000|Overall Study|Progression of disease|56|||
164665745|NCT00453362|594801477|FG000|Overall Study|Screening Failure|14|||
164665746|NCT04885296|594801478|FG000|Period 1|Covid-19 Related|1|||
164315370|NCT00146848|593531536|FG000|Pre-randomization|Lost to Follow-up|70|||
164665747|NCT04885296|594801479|FG001|Period 1|Covid-19 Related|0|||
164665748|NCT04885296|594801478|FG000|Period 1|Adverse Event|0|||
164315371|NCT00146848|593531537|FG001|Pre-randomization|Lost to Follow-up|0|||
164665749|NCT04885296|594801479|FG001|Period 1|Adverse Event|1|||
164665750|NCT04885296|594801478|FG000|Period 1|Withdrawal by Subject|1|||
164665751|NCT04885296|594801479|FG001|Period 1|Withdrawal by Subject|1|||
164665752|NCT04885296|594801478|FG000|Period 1|Test Article No Longer Available|1|||
164665753|NCT04885296|594801479|FG001|Period 1|Test Article No Longer Available|0|||
164665754|NCT04885296|594801478|FG000|Period 1|Dispensed Study lens in Error|1|||
164665755|NCT04885296|594801479|FG001|Period 1|Dispensed Study lens in Error|0|||
164665756|NCT04885296|594801478|FG000|Period 1|Lost to Follow-up|1|||
164665757|NCT04885296|594801479|FG001|Period 1|Lost to Follow-up|0|||
164665758|NCT04885296|594801478|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
164665759|NCT04885296|594801479|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
164665760|NCT00433147|594801480|FG000|Overall Study|Adverse Event|0|||
164665761|NCT00433147|594801481|FG001|Overall Study|Adverse Event|1|||
164665762|NCT00433147|594801482|FG002|Overall Study|Adverse Event|0|||
164665763|NCT00433147|594801483|FG003|Overall Study|Adverse Event|0|||
164665764|NCT01124149|594801489|FG000|Acute Phase|Withdrawal by Subject|22|||
164665765|NCT01124149|594801489|FG000|Acute Phase|Adverse Event|21|||
164665766|NCT01124149|594801489|FG000|Acute Phase|Lack of Efficacy|17|||
164665767|NCT01124149|594801489|FG000|Acute Phase|Protocol Violation|14|||
164665768|NCT01124149|594801489|FG000|Acute Phase|Lost to Follow-up|2|||
164665769|NCT01124149|594801489|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
164665770|NCT01124149|594801489|FG000|Acute Phase|Sponsor request|1|||
164665771|NCT01124149|594801489|FG000|Acute Phase|UC symptoms not ameliorated|1|||
164665772|NCT01124149|594801489|FG000|Acute Phase|Non-compliance|1|||
164665773|NCT01124149|594801489|FG000|Acute Phase|Low hemoglobin|1|||
164665774|NCT01124149|594801489|FG000|Acute Phase|Travelling to another country|1|||
164665775|NCT01124149|594801489|FG000|Acute Phase|Sponsor decision|1|||
164315372|NCT00146848|593531538|FG002|Pre-randomization|Lost to Follow-up|0|||
164315373|NCT00146848|593531536|FG000|Pre-randomization|Physician Decision|8|||
164315374|NCT00146848|593531537|FG001|Pre-randomization|Physician Decision|0|||
164315375|NCT00146848|593531538|FG002|Pre-randomization|Physician Decision|0|||
164315376|NCT00146848|593531536|FG000|Pre-randomization|Protocol Violation|172|||
164315377|NCT00146848|593531537|FG001|Pre-randomization|Protocol Violation|0|||
164315378|NCT00146848|593531538|FG002|Pre-randomization|Protocol Violation|0|||
164665776|NCT01124149|594801489|FG000|Maintenance Phase|Lack of Efficacy|40|||
164665777|NCT01124149|594801489|FG000|Maintenance Phase|Adverse Event|24|||
164665778|NCT01124149|594801489|FG000|Maintenance Phase|Lost to Follow-up|15|||
164665779|NCT01124149|594801489|FG000|Maintenance Phase|Withdrawal by Subject|10|||
164665780|NCT01124149|594801489|FG000|Maintenance Phase|Protocol Violation|5|||
164665781|NCT01124149|594801489|FG000|Maintenance Phase|Coordinator error|1|||
164665782|NCT01124149|594801489|FG000|Maintenance Phase|Non-compliance|1|||
164665783|NCT01644500|594801490|FG000|Overall Study|Adverse Event|6|||
164665784|NCT01644500|594801491|FG001|Overall Study|Adverse Event|1|||
164665785|NCT01644500|594801492|FG002|Overall Study|Adverse Event|2|||
164665786|NCT01644500|594801490|FG000|Overall Study|Death|0|||
164665787|NCT01644500|594801491|FG001|Overall Study|Death|1|||
164665788|NCT01644500|594801492|FG002|Overall Study|Death|0|||
164665789|NCT01644500|594801490|FG000|Overall Study|Lost to Follow-up|3|||
164665790|NCT01644500|594801491|FG001|Overall Study|Lost to Follow-up|8|||
164665791|NCT01644500|594801492|FG002|Overall Study|Lost to Follow-up|0|||
164665792|NCT01644500|594801490|FG000|Overall Study|Protocol Violation|1|||
164665793|NCT01644500|594801491|FG001|Overall Study|Protocol Violation|1|||
164665794|NCT01644500|594801492|FG002|Overall Study|Protocol Violation|0|||
164665795|NCT01644500|594801490|FG000|Overall Study|Withdrawal by Subject|11|||
164665796|NCT01644500|594801491|FG001|Overall Study|Withdrawal by Subject|12|||
164665797|NCT01644500|594801492|FG002|Overall Study|Withdrawal by Subject|12|||
164665798|NCT01644500|594801490|FG000|Overall Study|Physician Decision|1|||
164315379|NCT00146848|593531536|FG000|Pre-randomization|Withdrawal by Subject|40|||
164315380|NCT00146848|593531537|FG001|Pre-randomization|Withdrawal by Subject|0|||
164315381|NCT00146848|593531538|FG002|Pre-randomization|Withdrawal by Subject|0|||
164665799|NCT01644500|594801491|FG001|Overall Study|Physician Decision|1|||
164665800|NCT01644500|594801492|FG002|Overall Study|Physician Decision|1|||
164665801|NCT00001849|594801495|FG000|Overall Study|Death|4|||
164665802|NCT00001849|594801495|FG000|Overall Study|Lost to Follow-up|2|||
164665803|NCT00001849|594801495|FG000|Overall Study|Withdrawal by Subject|2|||
164665804|NCT00001849|594801495|FG000|Overall Study|tumor remained occult|6|||
164665805|NCT05518487|594801496|FG000|Overall Study|Withdrawal by Subject|3|||
164665806|NCT00543309|594801497|FG000|Overall Study|Physician Decision|0|||
164665807|NCT00543309|594801498|FG001|Overall Study|Physician Decision|1|||
164665808|NCT00543309|594801499|FG002|Overall Study|Physician Decision|0|||
164665809|NCT02194998|594801504|FG000|On-HCV Treatment|Did not pick up study medication|0|||
164665810|NCT02194998|594801505|FG001|On-HCV Treatment|Did not pick up study medication|1|||
164665811|NCT02194998|594801506|FG002|On-HCV Treatment|Did not pick up study medication|0|||
164665812|NCT02194998|594801507|FG003|On-HCV Treatment|Did not pick up study medication|0|||
164561358|NCT02574637|594423721|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
164561359|NCT02574637|594423722|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
164561360|NCT02574637|594423723|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
164561361|NCT02574637|594423724|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
164561362|NCT02574637|594423725|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
164561363|NCT02574637|594423726|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
164561364|NCT02574637|594423727|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
164561365|NCT02574637|594423728|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
164561366|NCT02574637|594423729|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
164561367|NCT02574637|594423730|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
164561368|NCT02574637|594423721|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
164561369|NCT02574637|594423722|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
164561370|NCT02574637|594423723|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
164561371|NCT02574637|594423724|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
164561372|NCT02574637|594423725|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
164561373|NCT02574637|594423726|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
164561374|NCT02574637|594423727|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
164561375|NCT02574637|594423728|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
164561376|NCT02574637|594423729|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
164561377|NCT02574637|594423730|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
164561378|NCT02574637|594423721|FG000|Double-blind Period|Reason Not Specified|0|||
164561379|NCT02574637|594423722|FG001|Double-blind Period|Reason Not Specified|0|||
164561380|NCT02574637|594423723|FG002|Double-blind Period|Reason Not Specified|0|||
164561381|NCT02574637|594423724|FG003|Double-blind Period|Reason Not Specified|1|||
164561382|NCT02574637|594423725|FG004|Double-blind Period|Reason Not Specified|0|||
164665813|NCT02194998|594801504|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
164204503|NCT05911841|593119214|FG007|Escape Period|Withdrawal by Subject|0|||
164561383|NCT02574637|594423726|FG005|Double-blind Period|Reason Not Specified|0|||
164561384|NCT02574637|594423727|FG006|Double-blind Period|Reason Not Specified|0|||
164561385|NCT02574637|594423728|FG007|Double-blind Period|Reason Not Specified|0|||
164561386|NCT02574637|594423729|FG008|Double-blind Period|Reason Not Specified|0|||
164561387|NCT02574637|594423730|FG009|Double-blind Period|Reason Not Specified|0|||
164561388|NCT02574637|594423721|FG000|Open-label (OL) Period|Adverse Event|0|||
164561389|NCT02574637|594423722|FG001|Open-label (OL) Period|Adverse Event|0|||
164561390|NCT02574637|594423723|FG002|Open-label (OL) Period|Adverse Event|0|||
164561391|NCT02574637|594423724|FG003|Open-label (OL) Period|Adverse Event|0|||
164561392|NCT02574637|594423725|FG004|Open-label (OL) Period|Adverse Event|0|||
164561393|NCT02574637|594423726|FG005|Open-label (OL) Period|Adverse Event|0|||
164561394|NCT02574637|594423727|FG006|Open-label (OL) Period|Adverse Event|0|||
164561395|NCT02574637|594423728|FG007|Open-label (OL) Period|Adverse Event|0|||
164561396|NCT02574637|594423729|FG008|Open-label (OL) Period|Adverse Event|1|||
164561397|NCT02574637|594423730|FG009|Open-label (OL) Period|Adverse Event|0|||
164561398|NCT02574637|594423721|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
164561399|NCT02574637|594423722|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
164561400|NCT02574637|594423723|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
164561401|NCT02574637|594423724|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
164561402|NCT02574637|594423725|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
164665814|NCT02194998|594801505|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
164665815|NCT02194998|594801506|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
164204504|NCT05911841|593119215|FG008|Escape Period|Withdrawal by Subject|0|||
164204505|NCT05911841|593119216|FG009|Escape Period|Withdrawal by Subject|10|||
164204506|NCT05595369|593119217|FG000|Overall Study|Adverse Event|2|||
164204507|NCT05595369|593119218|FG001|Overall Study|Adverse Event|0|||
164204508|NCT05595369|593119219|FG002|Overall Study|Adverse Event|0|||
164204509|NCT05595369|593119217|FG000|Overall Study|Lost to Follow-up|11|||
164204510|NCT05595369|593119218|FG001|Overall Study|Lost to Follow-up|10|||
164204511|NCT05595369|593119219|FG002|Overall Study|Lost to Follow-up|10|||
164204512|NCT05595369|593119217|FG000|Overall Study|Physician Decision|1|||
164204513|NCT05595369|593119218|FG001|Overall Study|Physician Decision|0|||
164204514|NCT05595369|593119219|FG002|Overall Study|Physician Decision|0|||
164204515|NCT05595369|593119217|FG000|Overall Study|Withdrawal by Subject|5|||
164204516|NCT05595369|593119218|FG001|Overall Study|Withdrawal by Subject|7|||
164204517|NCT05595369|593119219|FG002|Overall Study|Withdrawal by Subject|6|||
164204518|NCT05595369|593119217|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
164204519|NCT05595369|593119218|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
164204520|NCT05595369|593119219|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
164204521|NCT05595369|593119217|FG000|Overall Study|Study Drug Non-compliance|0|||
164204522|NCT05595369|593119218|FG001|Overall Study|Study Drug Non-compliance|1|||
164420625|NCT01154036|593910964|FG002|Phase I|Physician Decision|0|||
164204523|NCT05595369|593119219|FG002|Overall Study|Study Drug Non-compliance|0|||
164204524|NCT05595369|593119217|FG000|Overall Study|Moved Out of State Unexpectedly|0|||
164204525|NCT05595369|593119218|FG001|Overall Study|Moved Out of State Unexpectedly|1|||
164665816|NCT02194998|594801507|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
164665817|NCT01400113|594801508|FG000|Overall Study|Withdrawal by Subject|1|||
164665818|NCT01400113|594801509|FG001|Overall Study|Withdrawal by Subject|1|||
164561403|NCT02574637|594423726|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
164561404|NCT02574637|594423727|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
164561405|NCT02574637|594423728|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
164561406|NCT02574637|594423729|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
164561407|NCT02574637|594423730|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
164561408|NCT02574637|594423721|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
164561409|NCT02574637|594423722|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
164561410|NCT02574637|594423723|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
164561411|NCT02574637|594423724|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
164561412|NCT02574637|594423725|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
164561413|NCT02574637|594423726|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
164561414|NCT02574637|594423727|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
164561415|NCT02574637|594423728|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
164561416|NCT02574637|594423729|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
164561417|NCT02574637|594423730|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
164561418|NCT04029519|594423732|FG000|Overall Study|Protocol Violation|1|||
164561419|NCT04029519|594423732|FG000|Overall Study|Withdrawal by Subject|3|||
164561420|NCT04029519|594423732|FG000|Overall Study|Lost to Follow-up|1|||
164561421|NCT03021642|594423737|FG000|Washout Period (21 Days)|Adverse Event|1|||
164561422|NCT03021642|594423738|FG001|Washout Period (21 Days)|Adverse Event|1|||
164561423|NCT01192347|594423739|FG000|Overall Study|Death|3|||
164561424|NCT01192347|594423739|FG000|Overall Study|Lost to Follow-up|3|||
164561425|NCT01192347|594423739|FG000|Overall Study|Withdrawal by Subject|1|||
164561426|NCT01192347|594423739|FG000|Overall Study|Adverse Event|1|||
164561427|NCT01192347|594423739|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
164561428|NCT01192347|594423739|FG000|Overall Study|Patient seen in different hospital|1|||
164665819|NCT00282256|594801510|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
164665820|NCT00282256|594801510|FG000|Extension Treatment Period|Adverse Event|2|||
164665821|NCT02636907|594801515|FG000|Autoinjector Assessment Period|Adverse Event|2|||
164204526|NCT05595369|593119219|FG002|Overall Study|Moved Out of State Unexpectedly|0|||
164204527|NCT02592824|593119225|FG000|Overall Study|Protocol Violation|5|||
164561429|NCT01192347|594423739|FG000|Overall Study|Patient not visiting hospital regularly|1|||
164561430|NCT01192347|594423739|FG000|Overall Study|Patient did not show up for visits|1|||
164561431|NCT00090545|594423740|FG000|Overall Study|Disease progression on study|21|||
164561432|NCT00090545|594423741|FG001|Overall Study|Disease progression on study|17|||
164204528|NCT02592824|593119226|FG001|Overall Study|Protocol Violation|3|||
164204529|NCT02592824|593119225|FG000|Overall Study|Lost to Follow-up|2|||
164204530|NCT02592824|593119226|FG001|Overall Study|Lost to Follow-up|1|||
164204531|NCT02855268|593119227|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
164204532|NCT02855268|593119228|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
164204533|NCT02855268|593119227|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
164204534|NCT02855268|593119228|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
164204535|NCT02855268|593119227|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
164204536|NCT02855268|593119228|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
164204537|NCT02855268|593119227|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
164204538|NCT02855268|593119228|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
164302995|NCT04323124|593484689|FG003|Overall Study|Adverse Event|0|||
164302996|NCT04323124|593484690|FG004|Overall Study|Adverse Event|0|||
164302997|NCT04323124|593484691|FG005|Overall Study|Adverse Event|1|||
164302998|NCT04323124|593484692|FG006|Overall Study|Adverse Event|0|||
164302999|NCT04323124|593484693|FG007|Overall Study|Adverse Event|1|||
164303000|NCT04323124|593484694|FG008|Overall Study|Adverse Event|1|||
164303001|NCT04323124|593484695|FG009|Overall Study|Adverse Event|0|||
164303002|NCT04323124|593484696|FG010|Overall Study|Adverse Event|0|||
164303003|NCT04323124|593484697|FG011|Overall Study|Adverse Event|0|||
164303004|NCT04323124|593484698|FG012|Overall Study|Adverse Event|0|||
164303005|NCT04323124|593484699|FG013|Overall Study|Adverse Event|0|||
164303006|NCT04323124|593484700|FG014|Overall Study|Adverse Event|0|||
164303007|NCT04323124|593484686|FG000|Overall Study|Other|0|||
164303008|NCT04323124|593484687|FG001|Overall Study|Other|0|||
164303009|NCT04323124|593484688|FG002|Overall Study|Other|0|||
164303010|NCT04323124|593484689|FG003|Overall Study|Other|0|||
164303011|NCT04323124|593484690|FG004|Overall Study|Other|1|||
164303012|NCT04323124|593484691|FG005|Overall Study|Other|0|||
164303013|NCT04323124|593484692|FG006|Overall Study|Other|0|||
164303014|NCT04323124|593484693|FG007|Overall Study|Other|0|||
164303015|NCT04323124|593484694|FG008|Overall Study|Other|1|||
164303016|NCT04323124|593484695|FG009|Overall Study|Other|0|||
164303017|NCT04323124|593484696|FG010|Overall Study|Other|0|||
164303018|NCT04323124|593484697|FG011|Overall Study|Other|0|||
164303019|NCT04323124|593484698|FG012|Overall Study|Other|0|||
164303020|NCT04323124|593484699|FG013|Overall Study|Other|0|||
164315382|NCT00146848|593531536|FG000|Post-randomization|Lost to Follow-up|12|||
164315383|NCT00146848|593531537|FG001|Post-randomization|Lost to Follow-up|15|||
164315384|NCT00146848|593531538|FG002|Post-randomization|Lost to Follow-up|12|||
164315385|NCT00146848|593531536|FG000|Post-randomization|Withdrawn|26|||
164315386|NCT00146848|593531537|FG001|Post-randomization|Withdrawn|32|||
164315387|NCT00146848|593531538|FG002|Post-randomization|Withdrawn|27|||
164315388|NCT02395172|593531539|FG000|Overall Study|Participants randomized but not treated|3|||
164315389|NCT02395172|593531540|FG001|Overall Study|Participants randomized but not treated|31|||
164315390|NCT02032238|593531541|FG000|Overall Study|Lost to Follow-up|2|||
164315391|NCT02032238|593531542|FG001|Overall Study|Lost to Follow-up|0|||
164315392|NCT00653939|593531543|FG000|Overall Study|Adverse Event|1|||
164315393|NCT00653939|593531544|FG001|Overall Study|Adverse Event|3|||
164315394|NCT00653939|593531543|FG000|Overall Study|Withdrawal by Subject|3|||
164315395|NCT00653939|593531544|FG001|Overall Study|Withdrawal by Subject|3|||
164315396|NCT00653939|593531543|FG000|Overall Study|Physician Decision|4|||
164315397|NCT00653939|593531544|FG001|Overall Study|Physician Decision|0|||
164315398|NCT00653939|593531543|FG000|Overall Study|Disease Progression|2|||
164315399|NCT00653939|593531544|FG001|Overall Study|Disease Progression|3|||
164315400|NCT00653939|593531543|FG000|Overall Study|Other|2|||
164315401|NCT00653939|593531544|FG001|Overall Study|Other|6|||
164315402|NCT00717236|593531545|FG000|Double-Blind Period|Adverse Event|33|||
164315403|NCT00717236|593531546|FG001|Double-Blind Period|Adverse Event|6|||
164315404|NCT00717236|593531545|FG000|Double-Blind Period|Lack of Efficacy|6|||
164315405|NCT00717236|593531546|FG001|Double-Blind Period|Lack of Efficacy|6|||
164315406|NCT00717236|593531545|FG000|Double-Blind Period|Lost to Follow-up|3|||
164315407|NCT00717236|593531546|FG001|Double-Blind Period|Lost to Follow-up|5|||
164315408|NCT00717236|593531545|FG000|Double-Blind Period|Withdrawal by Subject|10|||
164315409|NCT00717236|593531546|FG001|Double-Blind Period|Withdrawal by Subject|2|||
164315410|NCT00717236|593531545|FG000|Double-Blind Period|Loss of efficacy|3|||
164315411|NCT00717236|593531546|FG001|Double-Blind Period|Loss of efficacy|0|||
164315412|NCT00717236|593531545|FG000|Double-Blind Period|Other: Death|1|||
164315413|NCT00717236|593531546|FG001|Double-Blind Period|Other: Death|0|||
164315414|NCT00717236|593531545|FG000|Double-Blind Period|Other: Pregnancy|1|||
164315415|NCT00717236|593531546|FG001|Double-Blind Period|Other: Pregnancy|0|||
164315416|NCT00717236|593531545|FG000|Double-Blind Period|Other: Protocol Violation|2|||
164315417|NCT00717236|593531546|FG001|Double-Blind Period|Other: Protocol Violation|0|||
164315418|NCT00717236|593531545|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
164315419|NCT00717236|593531546|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
164315420|NCT00717236|593531545|FG000|Double-Blind Period|Other: Site withdrew|2|||
164315421|NCT00717236|593531546|FG001|Double-Blind Period|Other: Site withdrew|0|||
164315422|NCT00717236|593531545|FG000|Double-Blind Period|Other: Screening failure|1|||
164315423|NCT00717236|593531546|FG001|Double-Blind Period|Other: Screening failure|0|||
164315424|NCT00717236|593531545|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
164561433|NCT00090545|594423740|FG000|Overall Study|Refused further treatment|1|||
164204539|NCT02855268|593119227|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
164204540|NCT02855268|593119228|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
164204541|NCT02855268|593119227|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
164204542|NCT02855268|593119228|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
164204543|NCT00465517|593119231|FG000|Overall Study|Adverse Event|7|||
164204544|NCT00465517|593119232|FG001|Overall Study|Adverse Event|3|||
164204545|NCT00465517|593119231|FG000|Overall Study|Lost to Follow-up|1|||
164204546|NCT00465517|593119232|FG001|Overall Study|Lost to Follow-up|0|||
164204547|NCT00465517|593119231|FG000|Overall Study|Withdrawal by Subject|4|||
164204548|NCT00465517|593119232|FG001|Overall Study|Withdrawal by Subject|1|||
164204549|NCT01286129|593119233|FG000|Overall Study|Withdrawal by Subject|4|||
164204550|NCT01286129|593119234|FG001|Overall Study|Withdrawal by Subject|1|||
164204551|NCT01286129|593119233|FG000|Overall Study|Could not comply with study requirements|4|||
164204552|NCT01286129|593119234|FG001|Overall Study|Could not comply with study requirements|4|||
164204553|NCT00111761|593119237|FG000|Part 1|Physician Decision|0|||
164204554|NCT00111761|593119238|FG001|Part 1|Physician Decision|1|||
164204555|NCT00111761|593119237|FG000|Part 1|Death|0|||
164204556|NCT00111761|593119238|FG001|Part 1|Death|2|||
164204557|NCT00111761|593119237|FG000|Part 1|Other|0|||
164204558|NCT00111761|593119238|FG001|Part 1|Other|1|||
164204559|NCT00111761|593119237|FG000|Part 1|Withdrawal by Subject|0|||
164204560|NCT00111761|593119238|FG001|Part 1|Withdrawal by Subject|1|||
164204561|NCT00111761|593119237|FG000|Part 2|Adverse Event|1|||
164204562|NCT00111761|593119238|FG001|Part 2|Adverse Event|0|||
164204563|NCT00111761|593119237|FG000|Part 2|Physician Decision|1|||
164204564|NCT00111761|593119238|FG001|Part 2|Physician Decision|0|||
164204565|NCT00111761|593119237|FG000|Part 2|Death|1|||
164315425|NCT00717236|593531546|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
164315426|NCT00717236|593531545|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
164315427|NCT00717236|593531546|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
164315428|NCT00717236|593531545|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
164204566|NCT00111761|593119238|FG001|Part 2|Death|0|||
164204567|NCT00111761|593119237|FG000|Part 2|Disease progression|3|||
164665822|NCT02636907|594801515|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
164665823|NCT02636907|594801515|FG000|Extension Phase|Adverse Event|2|||
164665824|NCT02636907|594801515|FG000|Extension Phase|Withdrawal by Subject|4|||
164665825|NCT02636907|594801515|FG000|Extension Phase|Physician Decision|1|||
164665826|NCT02636907|594801515|FG000|Extension Phase|Lost to Follow-up|2|||
164665827|NCT02636907|594801515|FG000|Extension Phase|Lack of Efficacy|1|||
164665828|NCT00762086|594801516|FG000|Overall Study|Adverse Event|2|||
164665829|NCT00762086|594801517|FG001|Overall Study|Adverse Event|0|||
164665830|NCT00762086|594801516|FG000|Overall Study|Lost to Follow-up|0|||
164665831|NCT00762086|594801517|FG001|Overall Study|Lost to Follow-up|2|||
164665832|NCT00762086|594801516|FG000|Overall Study|Non compliance|1|||
164665833|NCT00762086|594801517|FG001|Overall Study|Non compliance|0|||
164665834|NCT00762086|594801516|FG000|Overall Study|Withdrawal by Subject|2|||
164665835|NCT00762086|594801517|FG001|Overall Study|Withdrawal by Subject|2|||
164665836|NCT00762086|594801516|FG000|Overall Study|Ineligible to participate in the study|1|||
164665837|NCT00762086|594801517|FG001|Overall Study|Ineligible to participate in the study|0|||
164665838|NCT01074554|594801523|FG000|Overall Study|Adverse Event|3|||
164665839|NCT01074554|594801524|FG001|Overall Study|Adverse Event|3|||
164665840|NCT01074554|594801523|FG000|Overall Study|Lost to Follow-up|0|||
164665841|NCT01074554|594801524|FG001|Overall Study|Lost to Follow-up|1|||
164665842|NCT00497796|594801525|FG000|Overall Study|Adverse event (not related)|9|||
164665843|NCT00497796|594801526|FG001|Overall Study|Adverse event (not related)|9|||
164665844|NCT00497796|594801525|FG000|Overall Study|Adverse event (related)|5|||
164665845|NCT00497796|594801526|FG001|Overall Study|Adverse event (related)|4|||
164665846|NCT00497796|594801525|FG000|Overall Study|CMV infection or disease treatment|30|||
164665847|NCT00497796|594801526|FG001|Overall Study|CMV infection or disease treatment|4|||
164665848|NCT00497796|594801525|FG000|Overall Study|Consent withdrawn|10|||
164665849|NCT00497796|594801526|FG001|Overall Study|Consent withdrawn|3|||
164665850|NCT00497796|594801525|FG000|Overall Study|Investigator/sponsor discretion|31|||
164665851|NCT00497796|594801526|FG001|Overall Study|Investigator/sponsor discretion|34|||
164665852|NCT00497796|594801525|FG000|Overall Study|Lost to Follow-up|0|||
164665853|NCT00497796|594801526|FG001|Overall Study|Lost to Follow-up|1|||
164665854|NCT00497796|594801525|FG000|Overall Study|Not applicable (randomized not treated)|0|||
164665855|NCT00497796|594801526|FG001|Overall Study|Not applicable (randomized not treated)|4|||
164665856|NCT01856309|594801528|FG000|Overall Study|Death|4|||
164665857|NCT01856309|594801529|FG001|Overall Study|Death|6|||
164665858|NCT01856309|594801530|FG002|Overall Study|Death|11|||
164665859|NCT01856309|594801531|FG003|Overall Study|Death|6|||
164665860|NCT01856309|594801528|FG000|Overall Study|Lost to Follow-up|6|||
164665861|NCT01856309|594801529|FG001|Overall Study|Lost to Follow-up|2|||
164665862|NCT01856309|594801530|FG002|Overall Study|Lost to Follow-up|4|||
164665863|NCT01856309|594801531|FG003|Overall Study|Lost to Follow-up|8|||
164665864|NCT01856309|594801528|FG000|Overall Study|Withdrawal by Subject|11|||
164204568|NCT00111761|593119238|FG001|Part 2|Disease progression|0|||
164204569|NCT00111761|593119237|FG000|Part 2|Protocol-specified criteria|1|||
164204570|NCT00111761|593119238|FG001|Part 2|Protocol-specified criteria|0|||
164204571|NCT00111761|593119237|FG000|Part 2|Other|1|||
164204572|NCT00111761|593119238|FG001|Part 2|Other|0|||
164204573|NCT02029417|593119241|FG000|Overall Study|Death|1|||
164204574|NCT02029417|593119241|FG000|Overall Study|Adverse Event|1|||
164204575|NCT00071981|593119242|FG000|Overall Study|Lack of Efficacy|37|||
164204576|NCT00071981|593119243|FG001|Overall Study|Lack of Efficacy|29|||
164204577|NCT00071981|593119244|FG002|Overall Study|Lack of Efficacy|30|||
164204578|NCT00071981|593119245|FG003|Overall Study|Lack of Efficacy|43|||
164204579|NCT00071981|593119242|FG000|Overall Study|Adverse Event|4|||
164204580|NCT00071981|593119243|FG001|Overall Study|Adverse Event|4|||
164204581|NCT00071981|593119244|FG002|Overall Study|Adverse Event|3|||
164204582|NCT00071981|593119245|FG003|Overall Study|Adverse Event|1|||
164204583|NCT00071981|593119242|FG000|Overall Study|Death|0|||
164204584|NCT00071981|593119243|FG001|Overall Study|Death|0|||
164204585|NCT00071981|593119244|FG002|Overall Study|Death|1|||
164204586|NCT00071981|593119245|FG003|Overall Study|Death|1|||
164204587|NCT00071981|593119242|FG000|Overall Study|Withdrawal by Subject|3|||
164665865|NCT01856309|594801529|FG001|Overall Study|Withdrawal by Subject|13|||
164665866|NCT01856309|594801530|FG002|Overall Study|Withdrawal by Subject|28|||
164665867|NCT01856309|594801531|FG003|Overall Study|Withdrawal by Subject|26|||
164665868|NCT01856309|594801528|FG000|Overall Study|Other|227|||
164665869|NCT01856309|594801529|FG001|Overall Study|Other|225|||
164204588|NCT00071981|593119243|FG001|Overall Study|Withdrawal by Subject|1|||
164204589|NCT00071981|593119244|FG002|Overall Study|Withdrawal by Subject|0|||
164204590|NCT00071981|593119245|FG003|Overall Study|Withdrawal by Subject|0|||
164204591|NCT00071981|593119242|FG000|Overall Study|No protocol therapy|2|||
164204592|NCT00071981|593119243|FG001|Overall Study|No protocol therapy|5|||
164204593|NCT00071981|593119244|FG002|Overall Study|No protocol therapy|1|||
164665870|NCT01856309|594801530|FG002|Overall Study|Other|447|||
164665871|NCT01856309|594801531|FG003|Overall Study|Other|469|||
164665872|NCT01856309|594801528|FG000|Overall Study|Lack of Efficacy|14|||
164665873|NCT01856309|594801529|FG001|Overall Study|Lack of Efficacy|9|||
164665874|NCT01856309|594801530|FG002|Overall Study|Lack of Efficacy|40|||
164315429|NCT00717236|593531546|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
164315430|NCT00717236|593531545|FG000|Double-Blind Period|Other: History of cancer|1|||
164315431|NCT00717236|593531546|FG001|Double-Blind Period|Other: History of cancer|0|||
164315432|NCT00717236|593531545|FG000|Double-Blind Period|Other: Sponsor request|1|||
164315433|NCT00717236|593531546|FG001|Double-Blind Period|Other: Sponsor request|0|||
164315434|NCT00717236|593531545|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
164315435|NCT00717236|593531546|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
164315436|NCT00717236|593531545|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
164315437|NCT00717236|593531546|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
164315438|NCT00717236|593531545|FG000|Double-Blind Period|Other: Subject moved|1|||
164315439|NCT00717236|593531546|FG001|Double-Blind Period|Other: Subject moved|1|||
164315440|NCT00717236|593531545|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
164315441|NCT00717236|593531546|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
164315442|NCT00717236|593531545|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
164315443|NCT00717236|593531546|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
164315444|NCT00717236|593531545|FG000|Double-Blind Period|Other: Transportation problems|0|||
164315445|NCT00717236|593531546|FG001|Double-Blind Period|Other: Transportation problems|1|||
164315446|NCT00717236|593531545|FG000|Double-Blind Period|Other: Investigator Decision|0|||
164561434|NCT00090545|594423741|FG001|Overall Study|Refused further treatment|4|||
164561435|NCT00090545|594423740|FG000|Overall Study|Death|0|||
164561436|NCT00090545|594423741|FG001|Overall Study|Death|1|||
164561437|NCT00090545|594423740|FG000|Overall Study|Adverse Event|0|||
164561438|NCT00090545|594423741|FG001|Overall Study|Adverse Event|2|||
164561439|NCT04317274|594423746|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
164561440|NCT04317274|594423747|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
164561441|NCT04317274|594423748|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
164561442|NCT04317274|594423749|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
164561443|NCT02161211|594423750|FG000|Overall Study|Lost to Follow-up|21|||
164561444|NCT02161211|594423751|FG001|Overall Study|Lost to Follow-up|27|||
164561445|NCT02161211|594423752|FG002|Overall Study|Lost to Follow-up|21|||
164561446|NCT02161211|594423750|FG000|Overall Study|Dropped|12|||
164561447|NCT02161211|594423751|FG001|Overall Study|Dropped|5|||
164561448|NCT02161211|594423752|FG002|Overall Study|Dropped|9|||
164561449|NCT01164722|594423754|FG000|Overall Study|Adverse Event|0|||
164561450|NCT01164722|594423755|FG001|Overall Study|Adverse Event|1|||
164561451|NCT01164722|594423754|FG000|Overall Study|Withdrawal by Subject|3|||
164561452|NCT01164722|594423755|FG001|Overall Study|Withdrawal by Subject|4|||
164561453|NCT01164722|594423754|FG000|Overall Study|Lost to Follow-up|3|||
164561454|NCT01164722|594423755|FG001|Overall Study|Lost to Follow-up|6|||
164561455|NCT01164722|594423754|FG000|Overall Study|met protocol criteria for non-treatment|11|||
164561456|NCT01164722|594423755|FG001|Overall Study|met protocol criteria for non-treatment|1|||
164561457|NCT01164722|594423754|FG000|Overall Study|enrolled on other study, concomitant med|1|||
164561458|NCT01164722|594423755|FG001|Overall Study|enrolled on other study, concomitant med|3|||
164561459|NCT01834729|594423762|FG000|Overall Study|Did not return bowel diaries|0|||
164561460|NCT01834729|594423763|FG001|Overall Study|Did not return bowel diaries|0|||
164561461|NCT01834729|594423764|FG002|Overall Study|Did not return bowel diaries|3|||
164561462|NCT01834729|594423765|FG003|Overall Study|Did not return bowel diaries|0|||
164561463|NCT01834729|594423762|FG000|Overall Study|Withdrawal by Subject|1|||
164561464|NCT01834729|594423763|FG001|Overall Study|Withdrawal by Subject|1|||
164561465|NCT01834729|594423764|FG002|Overall Study|Withdrawal by Subject|0|||
164561466|NCT01834729|594423765|FG003|Overall Study|Withdrawal by Subject|0|||
164561467|NCT01834729|594423762|FG000|Overall Study|Adverse Event|0|||
164561468|NCT01834729|594423763|FG001|Overall Study|Adverse Event|0|||
164561469|NCT01834729|594423764|FG002|Overall Study|Adverse Event|0|||
164561470|NCT01834729|594423765|FG003|Overall Study|Adverse Event|2|||
164561471|NCT04673786|594423766|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
164561472|NCT04673786|594423767|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
164561473|NCT04673786|594423768|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
164561474|NCT04673786|594423766|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
164561475|NCT04673786|594423767|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
164561476|NCT04673786|594423768|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
164561477|NCT04673786|594423766|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
164561478|NCT04673786|594423767|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
164561479|NCT04673786|594423768|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
164561480|NCT04673786|594423766|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
164561481|NCT04673786|594423767|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
164561482|NCT04673786|594423768|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
164420626|NCT01154036|593910965|FG003|Phase I|Physician Decision|0|||
164561483|NCT04673786|594423766|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
164665875|NCT01856309|594801531|FG003|Overall Study|Lack of Efficacy|25|||
164315447|NCT00717236|593531546|FG001|Double-Blind Period|Other: Investigator Decision|1|||
164315448|NCT00717236|593531545|FG000|Open-Label Period|Adverse Event|29|||
164315449|NCT00717236|593531546|FG001|Open-Label Period|Adverse Event|4|||
164315450|NCT00717236|593531545|FG000|Open-Label Period|Lack of Efficacy|30|||
164315451|NCT00717236|593531546|FG001|Open-Label Period|Lack of Efficacy|8|||
164315452|NCT00717236|593531545|FG000|Open-Label Period|Lost to Follow-up|28|||
164315453|NCT00717236|593531546|FG001|Open-Label Period|Lost to Follow-up|4|||
164315454|NCT00717236|593531545|FG000|Open-Label Period|Withdrawal by Subject|20|||
164315455|NCT00717236|593531546|FG001|Open-Label Period|Withdrawal by Subject|2|||
164315456|NCT00717236|593531545|FG000|Open-Label Period|Loss of Efficacy|6|||
164315457|NCT00717236|593531546|FG001|Open-Label Period|Loss of Efficacy|1|||
164315458|NCT00717236|593531545|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
164315459|NCT00717236|593531546|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
164315460|NCT00717236|593531545|FG000|Open-Label Period|Other: Lack of Compliance|1|||
164315461|NCT00717236|593531546|FG001|Open-Label Period|Other: Lack of Compliance|1|||
164315462|NCT00717236|593531545|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
164315463|NCT00717236|593531546|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
164315464|NCT00717236|593531545|FG000|Open-Label Period|Other: Moved|1|||
164315465|NCT00717236|593531546|FG001|Open-Label Period|Other: Moved|0|||
164315466|NCT00717236|593531545|FG000|Open-Label Period|Other: Investigator Decision|1|||
164315467|NCT00717236|593531546|FG001|Open-Label Period|Other: Investigator Decision|0|||
164315468|NCT00717236|593531545|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
164315469|NCT00717236|593531546|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
164315470|NCT00717236|593531545|FG000|Open-Label Period|Other: Sponsor Request|3|||
164315471|NCT00717236|593531546|FG001|Open-Label Period|Other: Sponsor Request|0|||
164315472|NCT00717236|593531545|FG000|Open-Label Period|Other: Cataract Surgery|1|||
164315473|NCT00717236|593531546|FG001|Open-Label Period|Other: Cataract Surgery|0|||
164315474|NCT00717236|593531545|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
164315475|NCT00717236|593531546|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
164315476|NCT00717236|593531545|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
164315477|NCT00717236|593531546|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
164315478|NCT00717236|593531545|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
164315479|NCT00717236|593531546|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
164315480|NCT01105767|593531547|FG000|Overall Study|Lost to Follow-up|1160|||
164315481|NCT01105767|593531548|FG001|Overall Study|Lost to Follow-up|1614|||
164315482|NCT01105767|593531549|FG002|Overall Study|Lost to Follow-up|1184|||
164315483|NCT00029146|593531552|FG000|Overall Study|Lost to Follow-up|2|||
164315484|NCT00029146|593531553|FG001|Overall Study|Lost to Follow-up|1|||
164315485|NCT02720042|593531561|FG000|Overall Study|Death|3|||
164315486|NCT02720042|593531561|FG000|Overall Study|Lost to Follow-up|4|||
164315487|NCT02720042|593531561|FG000|Overall Study|Withdrawal by Subject|1|||
164315488|NCT02720042|593531561|FG000|Overall Study|Physician Decision|3|||
164315489|NCT02720042|593531561|FG000|Overall Study|Phasix Mesh explanted|1|||
164315490|NCT02720042|593531561|FG000|Overall Study|unable due to non-study-related illness|3|||
164315491|NCT03704636|593531562|FG000|Overall Study|Inadequate Venous Flow|3|||
164315492|NCT00509145|593531565|FG000|Overall Study|Death|0|||
164315493|NCT00509145|593531566|FG001|Overall Study|Death|2|||
164315494|NCT00509145|593531565|FG000|Overall Study|Adverse Event|42|||
164315495|NCT00509145|593531566|FG001|Overall Study|Adverse Event|28|||
164315496|NCT00509145|593531565|FG000|Overall Study|Withdrawal by Subject|32|||
164315497|NCT00509145|593531566|FG001|Overall Study|Withdrawal by Subject|38|||
164315498|NCT00509145|593531565|FG000|Overall Study|Physician Decision|11|||
164315499|NCT00509145|593531566|FG001|Overall Study|Physician Decision|14|||
164315500|NCT00509145|593531565|FG000|Overall Study|Protocol Violation|1|||
164315501|NCT00509145|593531566|FG001|Overall Study|Protocol Violation|6|||
164315502|NCT00509145|593531565|FG000|Overall Study|Pregnancy|3|||
164315503|NCT00509145|593531566|FG001|Overall Study|Pregnancy|8|||
164315504|NCT00509145|593531565|FG000|Overall Study|Lost to Follow-up|6|||
164315505|NCT00509145|593531566|FG001|Overall Study|Lost to Follow-up|5|||
164315506|NCT00509145|593531565|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
164315507|NCT00509145|593531566|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
164315508|NCT00509145|593531565|FG000|Overall Study|Other|6|||
164315509|NCT00509145|593531566|FG001|Overall Study|Other|6|||
164315510|NCT03500224|593531567|FG000|Overall Study|Withdrawal by Subject|2|||
164315511|NCT01994889|593531570|FG000|Overall Study|Adverse Event|5|||
164315512|NCT01994889|593531571|FG001|Overall Study|Adverse Event|12|||
164315513|NCT01994889|593531572|FG002|Overall Study|Adverse Event|11|||
164315514|NCT01994889|593531570|FG000|Overall Study|Cardiac Device Implantation|0|||
164315515|NCT01994889|593531571|FG001|Overall Study|Cardiac Device Implantation|2|||
164315516|NCT01994889|593531572|FG002|Overall Study|Cardiac Device Implantation|0|||
164315517|NCT01994889|593531570|FG000|Overall Study|Organ Transplantation|1|||
164315518|NCT01994889|593531571|FG001|Overall Study|Organ Transplantation|5|||
164315519|NCT01994889|593531572|FG002|Overall Study|Organ Transplantation|5|||
164315520|NCT01994889|593531570|FG000|Overall Study|No longer willing to participate|8|||
164315521|NCT01994889|593531571|FG001|Overall Study|No longer willing to participate|17|||
164665876|NCT01856309|594801528|FG000|Overall Study|Adverse Event|31|||
164204594|NCT00071981|593119245|FG003|Overall Study|No protocol therapy|0|||
164204595|NCT00071981|593119242|FG000|Overall Study|others (not specified in the study)|0|||
164204596|NCT00071981|593119243|FG001|Overall Study|others (not specified in the study)|2|||
164665877|NCT01856309|594801529|FG001|Overall Study|Adverse Event|31|||
164204597|NCT00071981|593119244|FG002|Overall Study|others (not specified in the study)|2|||
164204598|NCT00071981|593119245|FG003|Overall Study|others (not specified in the study)|0|||
164204599|NCT04458922|593119246|FG000|Overall Study|Withdrawal by Subject|1|||
164204600|NCT04458922|593119247|FG001|Overall Study|Withdrawal by Subject|0|||
164204601|NCT04458922|593119248|FG002|Overall Study|Withdrawal by Subject|2|||
164204602|NCT04458922|593119246|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
164204603|NCT04458922|593119247|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
164204604|NCT04458922|593119248|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
164204605|NCT04458922|593119246|FG000|Overall Study|Adverse Event|1|||
164204606|NCT04458922|593119247|FG001|Overall Study|Adverse Event|0|||
164204607|NCT04458922|593119248|FG002|Overall Study|Adverse Event|0|||
164204608|NCT04458922|593119246|FG000|Overall Study|Started new study|0|||
164204609|NCT04458922|593119247|FG001|Overall Study|Started new study|0|||
164204610|NCT04458922|593119248|FG002|Overall Study|Started new study|1|||
164204611|NCT04458922|593119246|FG000|Overall Study|Progressive disease|6|||
164204612|NCT04458922|593119247|FG001|Overall Study|Progressive disease|8|||
164315522|NCT01994889|593531572|FG002|Overall Study|No longer willing to participate|37|||
164315523|NCT01994889|593531570|FG000|Overall Study|Lost to Follow-up|0|||
164665878|NCT01856309|594801530|FG002|Overall Study|Adverse Event|55|||
164665879|NCT01856309|594801531|FG003|Overall Study|Adverse Event|65|||
164665880|NCT01856309|594801528|FG000|Overall Study|Pregnancy|0|||
164665881|NCT01856309|594801529|FG001|Overall Study|Pregnancy|0|||
164665882|NCT01856309|594801530|FG002|Overall Study|Pregnancy|0|||
164665883|NCT01856309|594801531|FG003|Overall Study|Pregnancy|1|||
164665884|NCT01856309|594801528|FG000|Overall Study|Physician Decision|6|||
164665885|NCT01856309|594801529|FG001|Overall Study|Physician Decision|1|||
164665886|NCT01856309|594801530|FG002|Overall Study|Physician Decision|6|||
164665887|NCT01856309|594801531|FG003|Overall Study|Physician Decision|8|||
164665888|NCT01856309|594801528|FG000|Overall Study|Noncompliance With Study Drug|0|||
164665889|NCT01856309|594801529|FG001|Overall Study|Noncompliance With Study Drug|1|||
164665890|NCT01856309|594801530|FG002|Overall Study|Noncompliance With Study Drug|4|||
164665891|NCT01856309|594801531|FG003|Overall Study|Noncompliance With Study Drug|1|||
164665892|NCT00832377|594801532|FG000|Overall Study|Protocol Violation|1|||
164665893|NCT00220337|594801533|FG000|Overall Study|Adverse Event|70|||
164665894|NCT00220337|594801533|FG000|Overall Study|Lack of Efficacy|17|||
164665895|NCT00220337|594801533|FG000|Overall Study|Withdrawal by Subject|68|||
164665896|NCT00220337|594801533|FG000|Overall Study|Protocol Violation|2|||
164665897|NCT00220337|594801533|FG000|Overall Study|Lost to Follow-up|5|||
164665898|NCT00220337|594801533|FG000|Overall Study|Other|12|||
164665899|NCT00220337|594801533|FG000|Overall Study|Unsatisfactory compliance|5|||
164665900|NCT00944697|594801534|FG000|Overall Study|Withdrawal by Subject|1|||
164665901|NCT00944697|594801535|FG001|Overall Study|Withdrawal by Subject|1|||
164665902|NCT00944697|594801534|FG000|Overall Study|Adverse Event|0|||
164665903|NCT00944697|594801535|FG001|Overall Study|Adverse Event|3|||
164665904|NCT00944697|594801534|FG000|Overall Study|Administrative|1|||
164665905|NCT00944697|594801535|FG001|Overall Study|Administrative|1|||
164665906|NCT03661528|594801536|FG000|Overall Study|Death|1|||
164665907|NCT03661528|594801537|FG001|Overall Study|Death|0|||
164665908|NCT03661528|594801536|FG000|Overall Study|Physician Decision|3|||
164665909|NCT03661528|594801537|FG001|Overall Study|Physician Decision|1|||
164665910|NCT03661528|594801536|FG000|Overall Study|Other than Specified|5|||
164665911|NCT03661528|594801537|FG001|Overall Study|Other than Specified|2|||
164665912|NCT03661528|594801536|FG000|Overall Study|Withdrawal by Subject|5|||
164665913|NCT03661528|594801537|FG001|Overall Study|Withdrawal by Subject|3|||
164665914|NCT03661528|594801536|FG000|Overall Study|Disease Progression|8|||
164665915|NCT03661528|594801537|FG001|Overall Study|Disease Progression|13|||
164665916|NCT03661528|594801536|FG000|Overall Study|Adverse Event|61|||
164665917|NCT03661528|594801537|FG001|Overall Study|Adverse Event|55|||
164665918|NCT06179108|594801538|FG000|Overall Study|Withdrawal by Subject|16|||
164665919|NCT06179108|594801539|FG001|Overall Study|Withdrawal by Subject|19|||
164665920|NCT06179108|594801540|FG002|Overall Study|Withdrawal by Subject|10|||
164665921|NCT06179108|594801541|FG003|Overall Study|Withdrawal by Subject|11|||
164665922|NCT06179108|594801538|FG000|Overall Study|Lost to Follow-up|12|||
164665923|NCT06179108|594801539|FG001|Overall Study|Lost to Follow-up|4|||
164665924|NCT06179108|594801540|FG002|Overall Study|Lost to Follow-up|1|||
164665925|NCT06179108|594801541|FG003|Overall Study|Lost to Follow-up|9|||
164204613|NCT04458922|593119248|FG002|Overall Study|Progressive disease|2|||
164204614|NCT04458922|593119246|FG000|Overall Study|Death|1|||
164204615|NCT04458922|593119247|FG001|Overall Study|Death|0|||
164204616|NCT04458922|593119248|FG002|Overall Study|Death|2|||
164204617|NCT04458922|593119246|FG000|Overall Study|Participant started chemotherapy|0|||
164315524|NCT01994889|593531571|FG001|Overall Study|Lost to Follow-up|1|||
164665926|NCT06179108|594801538|FG000|Overall Study|Adverse Event|2|||
164561484|NCT04673786|594423767|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
164561485|NCT04673786|594423768|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
164561486|NCT04673786|594423766|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
164561487|NCT04673786|594423767|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
164561488|NCT04673786|594423768|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
164561489|NCT01325428|594423769|FG000|Part A|Progressive disease according to RECIST|9|||
164561490|NCT01325428|594423769|FG000|Part A|Clinical signs, symptoms of progression|2|||
164561491|NCT01325428|594423769|FG000|Part A|Other adverse event|1|||
164204618|NCT04458922|593119247|FG001|Overall Study|Participant started chemotherapy|1|||
164204619|NCT04458922|593119248|FG002|Overall Study|Participant started chemotherapy|0|||
164204620|NCT01981616|593119252|FG000|Overall Study|Adverse Event|0|||
164204621|NCT01981616|593119253|FG001|Overall Study|Adverse Event|1|||
164204622|NCT01981616|593119252|FG000|Overall Study|Protocol Violation|1|||
164204623|NCT01981616|593119253|FG001|Overall Study|Protocol Violation|0|||
164204624|NCT05079321|593119255|FG000|Overall Study|Withdrawal by Subject|2|||
164204625|NCT05079321|593119256|FG001|Overall Study|Withdrawal by Subject|2|||
164204626|NCT05079321|593119255|FG000|Overall Study|Lost to Follow-up|0|||
164204627|NCT05079321|593119256|FG001|Overall Study|Lost to Follow-up|1|||
164204628|NCT01081626|593119257|FG000|Overall Study|Dosing error|1|||
164204629|NCT01081626|593119258|FG001|Overall Study|Dosing error|1|||
164204630|NCT01081626|593119257|FG000|Overall Study|Missing Estradiol|25|||
164204631|NCT01081626|593119258|FG001|Overall Study|Missing Estradiol|28|||
164204632|NCT01081626|593119257|FG000|Overall Study|Low antral follicle count|1|||
164204633|NCT01081626|593119258|FG001|Overall Study|Low antral follicle count|0|||
164204634|NCT01081626|593119257|FG000|Overall Study|Overstimulation|0|||
164204635|NCT01081626|593119258|FG001|Overall Study|Overstimulation|1|||
164204636|NCT01081626|593119257|FG000|Overall Study|Lost to Follow-up|0|||
164204637|NCT01081626|593119258|FG001|Overall Study|Lost to Follow-up|1|||
164204638|NCT01081626|593119257|FG000|Overall Study|Other|33|||
164204639|NCT01081626|593119258|FG001|Overall Study|Other|30|||
164204640|NCT02003144|593119259|FG000|Open Label Maintenance Phase|Other than specified|2|||
164204641|NCT02003144|593119260|FG001|Open Label Maintenance Phase|Other than specified|4|||
164204642|NCT02003144|593119259|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
164204643|NCT02003144|593119260|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
164204644|NCT02003144|593119259|FG000|Open Label Maintenance Phase|Pregnancy|0|||
164204645|NCT02003144|593119260|FG001|Open Label Maintenance Phase|Pregnancy|2|||
164204646|NCT02003144|593119259|FG000|Open Label Maintenance Phase|Physician Decision|1|||
164204647|NCT02003144|593119260|FG001|Open Label Maintenance Phase|Physician Decision|1|||
164204648|NCT02003144|593119259|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
164204649|NCT02003144|593119260|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
164204650|NCT02003144|593119259|FG000|Open Label Maintenance Phase|Adverse Event|2|||
164204651|NCT02003144|593119260|FG001|Open Label Maintenance Phase|Adverse Event|1|||
164204652|NCT02074514|593119264|FG000|Overall Study|Lack of Efficacy|3|||
164204653|NCT02074514|593119265|FG001|Overall Study|Lack of Efficacy|2|||
164204654|NCT02074514|593119264|FG000|Overall Study|Lost to Follow-up|0|||
164204655|NCT02074514|593119265|FG001|Overall Study|Lost to Follow-up|1|||
164204656|NCT02074514|593119264|FG000|Overall Study|Withdrew Consent|0|||
164204657|NCT02074514|593119265|FG001|Overall Study|Withdrew Consent|1|||
164204658|NCT00666237|593119268|FG000|Overall Study|Death|5|||
164204659|NCT00666237|593119269|FG001|Overall Study|Death|5|||
164204660|NCT00666237|593119268|FG000|Overall Study|Lost to Follow-up|29|||
164204661|NCT00666237|593119269|FG001|Overall Study|Lost to Follow-up|25|||
164204662|NCT02839707|593119271|FG000|Phase I|Not eligible for analysis|9|||
164204663|NCT02839707|593119272|FG001|Phase I|Not eligible for analysis|0|||
164204664|NCT02839707|593119273|FG002|Phase I|Not eligible for analysis|0|||
164204665|NCT02839707|593119271|FG000|Phase II|Not treated according to protocol|4|||
164204666|NCT02839707|593119272|FG001|Phase II|Not treated according to protocol|0|||
164204667|NCT02839707|593119273|FG002|Phase II|Not treated according to protocol|2|||
164204668|NCT02839707|593119271|FG000|Phase III|Not treated according to protocol|0|||
164204669|NCT02839707|593119272|FG001|Phase III|Not treated according to protocol|0|||
164204670|NCT02839707|593119273|FG002|Phase III|Not treated according to protocol|4|||
164204671|NCT04530630|593121080|FG000|Overall Study|Physician Decision|1|||
164204672|NCT01288430|593121087|FG000|Part 1|Progressive disease|2|||
164204673|NCT01288430|593121088|FG001|Part 1|Progressive disease|1|||
164204674|NCT01288430|593121089|FG002|Part 1|Progressive disease|1|||
164204675|NCT01288430|593121090|FG003|Part 1|Progressive disease|6|||
164204676|NCT01288430|593121091|FG004|Part 1|Progressive disease|2|||
164204677|NCT01288430|593121092|FG005|Part 1|Progressive disease|4|||
164204678|NCT01288430|593121093|FG006|Part 1|Progressive disease|2|||
164204679|NCT01288430|593121094|FG007|Part 1|Progressive disease|0|||
164204680|NCT01288430|593121095|FG008|Part 1|Progressive disease|0|||
164204681|NCT01288430|593121096|FG009|Part 1|Progressive disease|0|||
164204682|NCT01288430|593121087|FG000|Part 1|Clinical disease progression|0|||
164204683|NCT01288430|593121088|FG001|Part 1|Clinical disease progression|0|||
164204684|NCT01288430|593121089|FG002|Part 1|Clinical disease progression|1|||
164204685|NCT01288430|593121090|FG003|Part 1|Clinical disease progression|0|||
164315525|NCT01994889|593531572|FG002|Overall Study|Lost to Follow-up|0|||
164315526|NCT01994889|593531570|FG000|Overall Study|Protocol Violation|0|||
164315527|NCT01994889|593531571|FG001|Overall Study|Protocol Violation|1|||
164315528|NCT01994889|593531572|FG002|Overall Study|Protocol Violation|1|||
164315529|NCT01994889|593531570|FG000|Overall Study|Death|14|||
164315530|NCT01994889|593531571|FG001|Overall Study|Death|25|||
164315531|NCT01994889|593531572|FG002|Overall Study|Death|38|||
164315532|NCT00335764|593531573|FG000|Overall Study|wrong histology|1|||
164315533|NCT00335764|593531574|FG001|Overall Study|wrong histology|0|||
164315534|NCT00335764|593531575|FG002|Overall Study|wrong histology|0|||
164315535|NCT00335764|593531576|FG003|Overall Study|wrong histology|0|||
164315536|NCT00335764|593531577|FG004|Overall Study|wrong histology|1|||
164315537|NCT00929643|593531578|FG000|Overall Study|Protocol Violation|2|||
164315538|NCT00145977|593531582|FG000|Overall Study|Lack of Efficacy|0|||
164315539|NCT00145977|593531583|FG001|Overall Study|Lack of Efficacy|4|||
164315540|NCT00145977|593531582|FG000|Overall Study|Lost to Follow-up|1|||
164315541|NCT00145977|593531583|FG001|Overall Study|Lost to Follow-up|0|||
164315542|NCT00145977|593531582|FG000|Overall Study|Withdrawal by Subject|1|||
164315543|NCT00145977|593531583|FG001|Overall Study|Withdrawal by Subject|0|||
164315544|NCT02717832|593531593|FG000|Overall Study|Inability to place IV|3|||
164315545|NCT01215097|593531594|FG000|Overall Study|Adverse Event|1|||
164315546|NCT01215097|593531595|FG001|Overall Study|Adverse Event|3|||
164315547|NCT01215097|593531594|FG000|Overall Study|Protocol Violation|0|||
164315548|NCT01215097|593531595|FG001|Overall Study|Protocol Violation|2|||
164315549|NCT01215097|593531594|FG000|Overall Study|Lost to Follow-up|2|||
164315550|NCT01215097|593531595|FG001|Overall Study|Lost to Follow-up|0|||
164315551|NCT01215097|593531594|FG000|Overall Study|Withdrawal by Subject|6|||
164315552|NCT01215097|593531595|FG001|Overall Study|Withdrawal by Subject|3|||
164315553|NCT01215097|593531594|FG000|Overall Study|Lack of Efficacy|0|||
164315554|NCT01215097|593531595|FG001|Overall Study|Lack of Efficacy|3|||
164315555|NCT01215097|593531594|FG000|Overall Study|patient's refusal to come|2|||
164315556|NCT01215097|593531595|FG001|Overall Study|patient's refusal to come|2|||
164315557|NCT01215097|593531594|FG000|Overall Study|patient's private reason|1|||
164315558|NCT01215097|593531595|FG001|Overall Study|patient's private reason|1|||
164315559|NCT01325337|593533115|FG000|Overall Study|Adverse Event|0|||
164315560|NCT01325337|593533116|FG001|Overall Study|Adverse Event|2|||
164315561|NCT01325337|593533117|FG002|Overall Study|Adverse Event|2|||
164315562|NCT01325337|593533118|FG003|Overall Study|Adverse Event|1|||
164315563|NCT01325337|593533119|FG004|Overall Study|Adverse Event|2|||
164315564|NCT01325337|593533115|FG000|Overall Study|Lost to Follow-up|2|||
164315565|NCT01325337|593533116|FG001|Overall Study|Lost to Follow-up|2|||
164315566|NCT01325337|593533117|FG002|Overall Study|Lost to Follow-up|2|||
164315567|NCT01325337|593533118|FG003|Overall Study|Lost to Follow-up|1|||
164315568|NCT01325337|593533119|FG004|Overall Study|Lost to Follow-up|2|||
164315569|NCT01325337|593533115|FG000|Overall Study|Personal Reasons|2|||
164315570|NCT01325337|593533116|FG001|Overall Study|Personal Reasons|5|||
164315571|NCT01325337|593533117|FG002|Overall Study|Personal Reasons|4|||
164315572|NCT01325337|593533118|FG003|Overall Study|Personal Reasons|8|||
164315573|NCT01325337|593533119|FG004|Overall Study|Personal Reasons|3|||
164315574|NCT01325337|593533115|FG000|Overall Study|Withdrawal by Subject|1|||
164315575|NCT01325337|593533116|FG001|Overall Study|Withdrawal by Subject|0|||
164315576|NCT01325337|593533117|FG002|Overall Study|Withdrawal by Subject|1|||
164315577|NCT01325337|593533118|FG003|Overall Study|Withdrawal by Subject|0|||
164315578|NCT01325337|593533119|FG004|Overall Study|Withdrawal by Subject|1|||
164315579|NCT02338232|593533140|FG000|Overall Study|Screen Failure|3|||
164315580|NCT02338232|593533140|FG000|Overall Study|Withdrawal by Subject|6|||
164315581|NCT02338232|593533140|FG000|Overall Study|Adverse Event|2|||
164315582|NCT03890666|593533141|FG000|Overall Study|Withdrawal by Subject|0|||
164315583|NCT03890666|593533142|FG001|Overall Study|Withdrawal by Subject|1|||
164315584|NCT03890666|593533141|FG000|Overall Study|Protocol deviation|1|||
164315585|NCT03890666|593533142|FG001|Overall Study|Protocol deviation|4|||
164315586|NCT03890666|593533141|FG000|Overall Study|Lost to Follow-up|2|||
164315587|NCT03890666|593533142|FG001|Overall Study|Lost to Follow-up|5|||
164315588|NCT03890666|593533141|FG000|Overall Study|Other than specified|1|||
164315589|NCT03890666|593533142|FG001|Overall Study|Other than specified|8|||
164315590|NCT01105065|593533143|FG000|Overall Study|Adverse Event|5|||
164315591|NCT01105065|593533143|FG000|Overall Study|Technical Problems|1|||
164315592|NCT02122783|593533147|FG000|Overall Study|Adverse Event|0|||
164315593|NCT02122783|593533148|FG001|Overall Study|Adverse Event|1|||
164315594|NCT00322621|593533149|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
164665927|NCT06179108|594801539|FG001|Overall Study|Adverse Event|3|||
164315595|NCT00322621|593533150|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
164665928|NCT06179108|594801540|FG002|Overall Study|Adverse Event|3|||
164665929|NCT06179108|594801541|FG003|Overall Study|Adverse Event|2|||
164315596|NCT00322621|593533151|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
164315597|NCT00322621|593533149|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
164315598|NCT00322621|593533150|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
164315599|NCT00322621|593533151|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
164315600|NCT00322621|593533149|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
164315601|NCT00322621|593533150|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
164315602|NCT00322621|593533151|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
164315603|NCT00322621|593533149|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
164315604|NCT00322621|593533150|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
164315605|NCT00322621|593533151|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
164315606|NCT00322621|593533149|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
164315607|NCT00322621|593533150|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
164315608|NCT00322621|593533151|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
164315609|NCT00322621|593533149|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
164315610|NCT00322621|593533150|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
164315611|NCT00322621|593533151|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
164315612|NCT00322621|593533149|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
164315613|NCT00322621|593533150|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
164315614|NCT00322621|593533151|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
164315615|NCT00322621|593533149|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
164315616|NCT00322621|593533150|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
164315617|NCT00322621|593533151|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
164315618|NCT00322621|593533149|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
164315619|NCT00322621|593533150|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
164315620|NCT00322621|593533151|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
164315621|NCT00322621|593533149|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
164315622|NCT00322621|593533150|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
164315623|NCT00322621|593533151|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
164315624|NCT00322621|593533149|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
164315625|NCT00322621|593533150|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
164315626|NCT00322621|593533151|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
164315627|NCT01781299|593533157|FG000|Overall Study|Withdrawal by Subject|0|||
164315628|NCT01781299|593533158|FG001|Overall Study|Withdrawal by Subject|1|||
164315629|NCT01798849|593533159|FG000|Overall Study|Physician Decision|0|||
164315630|NCT01798849|593533160|FG001|Overall Study|Physician Decision|0|||
164315631|NCT01798849|593533161|FG002|Overall Study|Physician Decision|1|||
164315632|NCT00612105|593533162|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
164315633|NCT00612105|593533163|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
164315634|NCT00612105|593533162|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
164315635|NCT00612105|593533163|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
164315636|NCT00612105|593533162|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
164315637|NCT00612105|593533163|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
164315638|NCT00612105|593533162|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
164315639|NCT00612105|593533163|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
164315640|NCT00612105|593533162|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
164315641|NCT00612105|593533163|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
164315642|NCT00612105|593533162|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
164315643|NCT00612105|593533163|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
164315644|NCT00612105|593533162|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
164315645|NCT00612105|593533163|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
164315646|NCT00612105|593533162|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
164315647|NCT00612105|593533163|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
164315648|NCT00612105|593533162|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
164315649|NCT00612105|593533163|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
164315650|NCT00612105|593533162|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
164315651|NCT00612105|593533163|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
164315652|NCT00612105|593533162|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
164315653|NCT00612105|593533163|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
164315654|NCT00612105|593533162|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
164315655|NCT00612105|593533163|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
164315656|NCT00475982|593533164|FG000|Overall Study|surgery rescheduled|7|||
164315657|NCT00475982|593533165|FG001|Overall Study|surgery rescheduled|3|||
164315658|NCT00743106|593533166|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
164315659|NCT00743106|593533167|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
164315660|NCT02410343|593533172|FG000|Core Period (24 Weeks)|Adverse Event|1|||
164315661|NCT02410343|593533173|FG001|Core Period (24 Weeks)|Adverse Event|0|||
164315662|NCT02410343|593533172|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
164315663|NCT02410343|593533173|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
164315664|NCT02410343|593533172|FG000|Extension Period (12 Months)|Adverse Event|1|||
164315665|NCT02410343|593533173|FG001|Extension Period (12 Months)|Adverse Event|0|||
164315666|NCT02410343|593533172|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
164315667|NCT02410343|593533173|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
164315668|NCT00946985|593533174|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
164315669|NCT00946985|593533174|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
164315670|NCT00946985|593533174|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
164315671|NCT00946985|593533174|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
164315672|NCT00946985|593533174|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
164315673|NCT00946985|593533174|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
164315674|NCT00946985|593533174|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
164315675|NCT00946985|593533174|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
164315676|NCT00946985|593533174|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
164315677|NCT00271505|593533175|FG000|Overall Study|Screen Failure|3|||
164315678|NCT00271505|593533175|FG000|Overall Study|Adverse Event|1|||
164315679|NCT00271505|593533175|FG000|Overall Study|Death|1|||
164315680|NCT04556383|593533176|FG000|PCP|Lack of Efficacy|28|||
164315681|NCT04556383|593533177|FG001|PCP|Lack of Efficacy|23|||
164315682|NCT04556383|593533178|FG002|PCP|Lack of Efficacy|23|||
164315683|NCT04556383|593533179|FG003|PCP|Lack of Efficacy|0|||
164315684|NCT04556383|593533176|FG000|PCP|Study terminated by sponsor|15|||
164315685|NCT04556383|593533177|FG001|PCP|Study terminated by sponsor|13|||
164315686|NCT04556383|593533178|FG002|PCP|Study terminated by sponsor|16|||
164315687|NCT04556383|593533179|FG003|PCP|Study terminated by sponsor|0|||
164315688|NCT04556383|593533176|FG000|PCP|Withdrawal by Subject|8|||
164315689|NCT04556383|593533177|FG001|PCP|Withdrawal by Subject|6|||
164315690|NCT04556383|593533178|FG002|PCP|Withdrawal by Subject|6|||
164315691|NCT04556383|593533179|FG003|PCP|Withdrawal by Subject|0|||
164315692|NCT04556383|593533176|FG000|PCP|Adverse Event|1|||
164315693|NCT04556383|593533177|FG001|PCP|Adverse Event|7|||
164315694|NCT04556383|593533178|FG002|PCP|Adverse Event|7|||
164315695|NCT04556383|593533179|FG003|PCP|Adverse Event|0|||
164315696|NCT04556383|593533176|FG000|PCP|Other, Not Specified|1|||
164315697|NCT04556383|593533177|FG001|PCP|Other, Not Specified|2|||
164315698|NCT04556383|593533178|FG002|PCP|Other, Not Specified|1|||
164315699|NCT04556383|593533179|FG003|PCP|Other, Not Specified|0|||
164315700|NCT04556383|593533176|FG000|PCP|Protocol Violation|1|||
164315701|NCT04556383|593533177|FG001|PCP|Protocol Violation|0|||
164315702|NCT04556383|593533178|FG002|PCP|Protocol Violation|1|||
164315703|NCT04556383|593533179|FG003|PCP|Protocol Violation|0|||
164315704|NCT04556383|593533176|FG000|PCP|Lost to Follow-up|1|||
164315705|NCT04556383|593533177|FG001|PCP|Lost to Follow-up|0|||
164315706|NCT04556383|593533178|FG002|PCP|Lost to Follow-up|0|||
164315707|NCT04556383|593533179|FG003|PCP|Lost to Follow-up|0|||
164315708|NCT04556383|593533176|FG000|PCP|Physician Decision|0|||
164315709|NCT04556383|593533177|FG001|PCP|Physician Decision|1|||
164315710|NCT04556383|593533178|FG002|PCP|Physician Decision|0|||
164315711|NCT04556383|593533179|FG003|PCP|Physician Decision|0|||
164315712|NCT04556383|593533176|FG000|PCP|Site terminated by sponsor|0|||
164315713|NCT04556383|593533177|FG001|PCP|Site terminated by sponsor|1|||
164315714|NCT04556383|593533178|FG002|PCP|Site terminated by sponsor|0|||
164315715|NCT04556383|593533179|FG003|PCP|Site terminated by sponsor|0|||
164315716|NCT04556383|593533176|FG000|OLE|Study terminated by sponsor|0|||
164315717|NCT04556383|593533177|FG001|OLE|Study terminated by sponsor|0|||
164315718|NCT04556383|593533178|FG002|OLE|Study terminated by sponsor|0|||
164315719|NCT04556383|593533179|FG003|OLE|Study terminated by sponsor|68|||
164315720|NCT04556383|593533176|FG000|OLE|Withdrawal by Subject|0|||
164315721|NCT04556383|593533177|FG001|OLE|Withdrawal by Subject|0|||
164315722|NCT04556383|593533178|FG002|OLE|Withdrawal by Subject|0|||
164315723|NCT04556383|593533179|FG003|OLE|Withdrawal by Subject|10|||
164315724|NCT04556383|593533176|FG000|OLE|Lack of Efficacy|0|||
164315725|NCT04556383|593533177|FG001|OLE|Lack of Efficacy|0|||
164315726|NCT04556383|593533178|FG002|OLE|Lack of Efficacy|0|||
164315727|NCT04556383|593533179|FG003|OLE|Lack of Efficacy|7|||
164315728|NCT04556383|593533176|FG000|OLE|Adverse Event|0|||
164315729|NCT04556383|593533177|FG001|OLE|Adverse Event|0|||
164315730|NCT04556383|593533178|FG002|OLE|Adverse Event|0|||
164315731|NCT04556383|593533179|FG003|OLE|Adverse Event|2|||
164315732|NCT04556383|593533176|FG000|OLE|Other, Not Specified|0|||
164315733|NCT04556383|593533177|FG001|OLE|Other, Not Specified|0|||
164315734|NCT04556383|593533178|FG002|OLE|Other, Not Specified|0|||
164315735|NCT04556383|593533179|FG003|OLE|Other, Not Specified|2|||
164315736|NCT04556383|593533176|FG000|OLE|Death|0|||
164315737|NCT04556383|593533177|FG001|OLE|Death|0|||
164315738|NCT04556383|593533178|FG002|OLE|Death|0|||
164315739|NCT04556383|593533179|FG003|OLE|Death|1|||
164315740|NCT04556383|593533176|FG000|OLE|Lost to Follow-up|0|||
164315741|NCT04556383|593533177|FG001|OLE|Lost to Follow-up|0|||
164315742|NCT04556383|593533178|FG002|OLE|Lost to Follow-up|0|||
164315743|NCT04556383|593533179|FG003|OLE|Lost to Follow-up|1|||
164315744|NCT00539188|593533180|FG000|Overall Study|Withdrawal by Subject|1|||
164315745|NCT00539188|593533181|FG001|Overall Study|Withdrawal by Subject|0|||
164315746|NCT00539188|593533180|FG000|Overall Study|Lost to Follow-up|2|||
164315747|NCT00539188|593533181|FG001|Overall Study|Lost to Follow-up|1|||
164315748|NCT04784442|593533182|FG000|Overall Study|Adverse Event|1|||
164315749|NCT04784442|593533183|FG001|Overall Study|Adverse Event|0|||
164315750|NCT04784442|593533184|FG002|Overall Study|Adverse Event|2|||
164204686|NCT01288430|593121091|FG004|Part 1|Clinical disease progression|0|||
164204687|NCT01288430|593121092|FG005|Part 1|Clinical disease progression|2|||
164204688|NCT01288430|593121093|FG006|Part 1|Clinical disease progression|2|||
164204689|NCT01288430|593121094|FG007|Part 1|Clinical disease progression|0|||
164204690|NCT01288430|593121095|FG008|Part 1|Clinical disease progression|0|||
164204691|NCT01288430|593121096|FG009|Part 1|Clinical disease progression|0|||
164204692|NCT01288430|593121087|FG000|Part 1|Death due to disease progression|0|||
164204693|NCT01288430|593121088|FG001|Part 1|Death due to disease progression|0|||
164204694|NCT01288430|593121089|FG002|Part 1|Death due to disease progression|0|||
164204695|NCT01288430|593121090|FG003|Part 1|Death due to disease progression|0|||
164204696|NCT01288430|593121091|FG004|Part 1|Death due to disease progression|1|||
164204697|NCT01288430|593121092|FG005|Part 1|Death due to disease progression|0|||
164204698|NCT01288430|593121093|FG006|Part 1|Death due to disease progression|0|||
164204699|NCT01288430|593121094|FG007|Part 1|Death due to disease progression|0|||
164204700|NCT01288430|593121095|FG008|Part 1|Death due to disease progression|0|||
164204701|NCT01288430|593121096|FG009|Part 1|Death due to disease progression|0|||
164204702|NCT01288430|593121087|FG000|Part 1|Adverse Event|0|||
164204703|NCT01288430|593121088|FG001|Part 1|Adverse Event|0|||
164204704|NCT01288430|593121089|FG002|Part 1|Adverse Event|3|||
164204705|NCT01288430|593121090|FG003|Part 1|Adverse Event|1|||
164204706|NCT01288430|593121091|FG004|Part 1|Adverse Event|0|||
164204707|NCT01288430|593121092|FG005|Part 1|Adverse Event|0|||
164204708|NCT01288430|593121093|FG006|Part 1|Adverse Event|2|||
164204709|NCT01288430|593121094|FG007|Part 1|Adverse Event|0|||
164204710|NCT01288430|593121095|FG008|Part 1|Adverse Event|0|||
164204711|NCT01288430|593121096|FG009|Part 1|Adverse Event|0|||
164204712|NCT01288430|593121087|FG000|Part 1|Other|0|||
164204713|NCT01288430|593121088|FG001|Part 1|Other|2|||
164204714|NCT01288430|593121089|FG002|Part 1|Other|0|||
164204715|NCT01288430|593121090|FG003|Part 1|Other|0|||
164204716|NCT01288430|593121091|FG004|Part 1|Other|0|||
164204717|NCT01288430|593121092|FG005|Part 1|Other|0|||
164204718|NCT01288430|593121093|FG006|Part 1|Other|1|||
164204719|NCT01288430|593121094|FG007|Part 1|Other|0|||
164204720|NCT01288430|593121095|FG008|Part 1|Other|0|||
164204721|NCT01288430|593121096|FG009|Part 1|Other|0|||
164204722|NCT01288430|593121087|FG000|Part 2|Progressive disease|0|||
164204723|NCT01288430|593121088|FG001|Part 2|Progressive disease|0|||
164204724|NCT01288430|593121089|FG002|Part 2|Progressive disease|0|||
164204725|NCT01288430|593121090|FG003|Part 2|Progressive disease|0|||
164204726|NCT01288430|593121091|FG004|Part 2|Progressive disease|0|||
164204727|NCT01288430|593121092|FG005|Part 2|Progressive disease|0|||
164204728|NCT01288430|593121093|FG006|Part 2|Progressive disease|0|||
164204729|NCT01288430|593121094|FG007|Part 2|Progressive disease|8|||
164204730|NCT01288430|593121095|FG008|Part 2|Progressive disease|7|||
164204731|NCT01288430|593121096|FG009|Part 2|Progressive disease|2|||
164204732|NCT01288430|593121087|FG000|Part 2|Clinical disease progression|0|||
164204733|NCT01288430|593121088|FG001|Part 2|Clinical disease progression|0|||
164204734|NCT01288430|593121089|FG002|Part 2|Clinical disease progression|0|||
164204735|NCT01288430|593121090|FG003|Part 2|Clinical disease progression|0|||
164204736|NCT01288430|593121091|FG004|Part 2|Clinical disease progression|0|||
164204737|NCT01288430|593121092|FG005|Part 2|Clinical disease progression|0|||
164204738|NCT01288430|593121093|FG006|Part 2|Clinical disease progression|0|||
164204739|NCT01288430|593121094|FG007|Part 2|Clinical disease progression|2|||
164204740|NCT01288430|593121095|FG008|Part 2|Clinical disease progression|0|||
164204741|NCT01288430|593121096|FG009|Part 2|Clinical disease progression|0|||
164204742|NCT01288430|593121087|FG000|Part 2|Withdrawal by Subject|0|||
164204743|NCT01288430|593121088|FG001|Part 2|Withdrawal by Subject|0|||
164315751|NCT04784442|593533185|FG003|Overall Study|Adverse Event|1|||
164204744|NCT01288430|593121089|FG002|Part 2|Withdrawal by Subject|0|||
164204745|NCT01288430|593121090|FG003|Part 2|Withdrawal by Subject|0|||
164204746|NCT01288430|593121091|FG004|Part 2|Withdrawal by Subject|0|||
164204747|NCT01288430|593121092|FG005|Part 2|Withdrawal by Subject|0|||
164204748|NCT01288430|593121093|FG006|Part 2|Withdrawal by Subject|0|||
164204749|NCT01288430|593121094|FG007|Part 2|Withdrawal by Subject|1|||
164204750|NCT01288430|593121095|FG008|Part 2|Withdrawal by Subject|4|||
164204751|NCT01288430|593121096|FG009|Part 2|Withdrawal by Subject|0|||
164204752|NCT01288430|593121087|FG000|Part 2|Adverse Event|0|||
164204753|NCT01288430|593121088|FG001|Part 2|Adverse Event|0|||
164204754|NCT01288430|593121089|FG002|Part 2|Adverse Event|0|||
164204755|NCT01288430|593121090|FG003|Part 2|Adverse Event|0|||
164204756|NCT01288430|593121091|FG004|Part 2|Adverse Event|0|||
164204757|NCT01288430|593121092|FG005|Part 2|Adverse Event|0|||
164204758|NCT01288430|593121093|FG006|Part 2|Adverse Event|0|||
164204759|NCT01288430|593121094|FG007|Part 2|Adverse Event|1|||
164204760|NCT01288430|593121095|FG008|Part 2|Adverse Event|1|||
164204761|NCT01288430|593121096|FG009|Part 2|Adverse Event|0|||
164204762|NCT01288430|593121087|FG000|Part 2|Other|0|||
164204763|NCT01288430|593121088|FG001|Part 2|Other|0|||
164204764|NCT01288430|593121089|FG002|Part 2|Other|0|||
164204765|NCT01288430|593121090|FG003|Part 2|Other|0|||
164204766|NCT01288430|593121091|FG004|Part 2|Other|0|||
164204767|NCT01288430|593121092|FG005|Part 2|Other|0|||
164315752|NCT04784442|593533182|FG000|Overall Study|Protocol Violation|1|||
164315753|NCT04784442|593533183|FG001|Overall Study|Protocol Violation|0|||
164315754|NCT04784442|593533184|FG002|Overall Study|Protocol Violation|0|||
164315755|NCT04784442|593533185|FG003|Overall Study|Protocol Violation|0|||
164315756|NCT04784442|593533182|FG000|Overall Study|Non-compliance with study drug|1|||
164315757|NCT04784442|593533183|FG001|Overall Study|Non-compliance with study drug|0|||
164315758|NCT04784442|593533184|FG002|Overall Study|Non-compliance with study drug|0|||
164315759|NCT04784442|593533185|FG003|Overall Study|Non-compliance with study drug|0|||
164315760|NCT02259088|593533187|FG000|Overall Study|Adverse Event|6|||
164315761|NCT02259088|593533188|FG001|Overall Study|Adverse Event|4|||
164315762|NCT02259088|593533187|FG000|Overall Study|Lost to Follow-up|2|||
164315763|NCT02259088|593533188|FG001|Overall Study|Lost to Follow-up|0|||
164315764|NCT02259088|593533187|FG000|Overall Study|Death|2|||
164315765|NCT02259088|593533188|FG001|Overall Study|Death|0|||
164315766|NCT02259088|593533187|FG000|Overall Study|Physician Decision|5|||
164315767|NCT02259088|593533188|FG001|Overall Study|Physician Decision|2|||
164315768|NCT02259088|593533187|FG000|Overall Study|Protocol deviation|5|||
164315769|NCT02259088|593533188|FG001|Overall Study|Protocol deviation|0|||
164315770|NCT02259088|593533187|FG000|Overall Study|Subject/guardian decision|8|||
164315771|NCT02259088|593533188|FG001|Overall Study|Subject/guardian decision|8|||
164315772|NCT03060551|593533189|FG000|Overall Study|Withdrawal by Subject|1|||
164315773|NCT03060551|593533189|FG000|Overall Study|Adverse Event|1|||
164315774|NCT01214395|593533197|FG000|Overall Study|All patients had infection|5|||
164315775|NCT03698591|593533201|FG000|Overall Study|Withdrawal by Subject|2|||
164315776|NCT03698591|593533202|FG001|Overall Study|Withdrawal by Subject|2|||
164315777|NCT03698591|593533201|FG000|Overall Study|Failed drug screen|1|||
164315778|NCT03698591|593533202|FG001|Overall Study|Failed drug screen|1|||
164315779|NCT03698591|593533201|FG000|Overall Study|Failed health screen|0|||
164315780|NCT03698591|593533202|FG001|Overall Study|Failed health screen|1|||
164315781|NCT03698591|593533201|FG000|Overall Study|Ineligible for financial compensation|1|||
164315782|NCT03698591|593533202|FG001|Overall Study|Ineligible for financial compensation|0|||
164315783|NCT03698591|593533201|FG000|Overall Study|Equipment Error|1|||
164315784|NCT03698591|593533202|FG001|Overall Study|Equipment Error|0|||
164315785|NCT03698591|593533201|FG000|Overall Study|Could not establish TMS dosage|0|||
164315786|NCT03698591|593533202|FG001|Overall Study|Could not establish TMS dosage|1|||
164315787|NCT02660983|593533211|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
164315788|NCT02660983|593533212|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
164315789|NCT02660983|593533211|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
164315790|NCT02660983|593533212|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
164315791|NCT02660983|593533211|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
164315792|NCT02660983|593533212|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
164315793|NCT02660983|593533211|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
164315794|NCT02660983|593533212|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
164315795|NCT02660983|593533211|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
164315796|NCT02660983|593533212|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
164315797|NCT02660983|593533211|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
164315798|NCT02660983|593533212|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
164315799|NCT02660983|593533211|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
164315800|NCT02660983|593533212|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
164315801|NCT01165216|593533221|FG000|Overall Study|Adverse Event|6|||
164315802|NCT01165216|593533222|FG001|Overall Study|Adverse Event|3|||
164315803|NCT01165216|593533221|FG000|Overall Study|Withdrawal by Subject|1|||
164315804|NCT01165216|593533222|FG001|Overall Study|Withdrawal by Subject|1|||
164561492|NCT01325428|594423769|FG000|Part A|Refused continue taking trial medication|2|||
164561493|NCT01325428|594423769|FG000|Part A|Other reason not defined above|2|||
164561494|NCT01325428|594423769|FG000|Part B|Refused continue taking trial medication|2|||
164561495|NCT01325428|594423769|FG000|Part B|Other reason not defined above|1|||
164561496|NCT04849780|594423770|FG000|Period 1|Covid-19 Related|1|||
164561497|NCT04849780|594423771|FG001|Period 1|Covid-19 Related|0|||
164561498|NCT04849780|594423770|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
164561499|NCT04849780|594423771|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
164561500|NCT04849780|594423770|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
164561501|NCT04849780|594423771|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
164561502|NCT00725075|594423772|FG000|Overall Study|Use of Excluded Medication|0|||
164561503|NCT00725075|594423773|FG001|Overall Study|Use of Excluded Medication|1|||
164561504|NCT00725075|594423774|FG002|Overall Study|Use of Excluded Medication|0|||
164561505|NCT00725075|594423772|FG000|Overall Study|Protocol Violation|0|||
164561506|NCT00725075|594423773|FG001|Overall Study|Protocol Violation|0|||
164561507|NCT00725075|594423774|FG002|Overall Study|Protocol Violation|1|||
164561508|NCT00725075|594423772|FG000|Overall Study|Lost to Follow-up|1|||
164665930|NCT06179108|594801538|FG000|Overall Study|Protocol Violation|0|||
164561509|NCT00725075|594423773|FG001|Overall Study|Lost to Follow-up|0|||
164561510|NCT00725075|594423774|FG002|Overall Study|Lost to Follow-up|0|||
164561511|NCT00725075|594423772|FG000|Overall Study|Withdrawal by Subject|4|||
164315805|NCT01165216|593533221|FG000|Overall Study|Disease progression|1|||
164315806|NCT01165216|593533222|FG001|Overall Study|Disease progression|3|||
164315807|NCT00243841|593533226|FG000|Overall Study|Physician Decision|0|||
164315808|NCT00243841|593533227|FG001|Overall Study|Physician Decision|0|||
164315809|NCT00243841|593533228|FG002|Overall Study|Physician Decision|1|||
164315810|NCT00243841|593533229|FG003|Overall Study|Physician Decision|0|||
164315811|NCT00243841|593533230|FG004|Overall Study|Physician Decision|0|||
164315812|NCT00243841|593533231|FG005|Overall Study|Physician Decision|2|||
164315813|NCT00363545|593533232|FG000|Overall Study|Serious Adverse Event|0|||
164315814|NCT00363545|593533233|FG001|Overall Study|Serious Adverse Event|1|||
164315815|NCT00363545|593533232|FG000|Overall Study|Withdrawal by Subject|12|||
164315816|NCT00363545|593533233|FG001|Overall Study|Withdrawal by Subject|15|||
164315817|NCT00363545|593533232|FG000|Overall Study|Migrated/moved from study area|3|||
164315818|NCT00363545|593533233|FG001|Overall Study|Migrated/moved from study area|6|||
164315819|NCT00363545|593533232|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
164315820|NCT00363545|593533233|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
164315821|NCT00363545|593533232|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
164315822|NCT00363545|593533233|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
164315823|NCT00363545|593533232|FG000|Overall Study|Others|1|||
164315824|NCT00363545|593533233|FG001|Overall Study|Others|0|||
164315825|NCT00721968|593533234|FG000|Overall Study|Lost to Follow-up|2|||
164315826|NCT00721968|593533235|FG001|Overall Study|Lost to Follow-up|0|||
164315827|NCT01064947|593533236|FG000|Overall Study|negative culture|41|||
164315828|NCT06457204|593533241|FG000|Washout|Adverse Event|0|||
164315829|NCT06457204|593533242|FG001|Washout|Adverse Event|2|||
164315830|NCT01457352|593533243|FG000|Period 1|Adverse Event|2|||
164315831|NCT01457352|593533244|FG001|Period 1|Adverse Event|0|||
164315832|NCT01457352|593533243|FG000|Period 1|Withdrawal by Subject|2|||
164315833|NCT01457352|593533244|FG001|Period 1|Withdrawal by Subject|0|||
164315834|NCT01457352|593533243|FG000|Period 1|Physician Decision|2|||
164315835|NCT01457352|593533244|FG001|Period 1|Physician Decision|0|||
164315836|NCT01457352|593533243|FG000|Period 1|MS related disease progression|1|||
164315837|NCT01457352|593533244|FG001|Period 1|MS related disease progression|0|||
164315838|NCT01457352|593533243|FG000|Period 1|Withdrawn|1|||
164315839|NCT01457352|593533244|FG001|Period 1|Withdrawn|0|||
164315840|NCT01457352|593533243|FG000|Period 1|withdrew per sponsor|1|||
164315841|NCT01457352|593533244|FG001|Period 1|withdrew per sponsor|0|||
164315842|NCT01457352|593533243|FG000|Period 1|Protocol Violation|4|||
164315843|NCT01457352|593533244|FG001|Period 1|Protocol Violation|0|||
164315844|NCT01457352|593533243|FG000|Period 1|Did not meet eligibility criteria|3|||
164315845|NCT01457352|593533244|FG001|Period 1|Did not meet eligibility criteria|0|||
164315846|NCT01457352|593533243|FG000|Period 2|Withdrawal by Subject|23|||
164315847|NCT01457352|593533244|FG001|Period 2|Withdrawal by Subject|0|||
164315848|NCT01457352|593533243|FG000|Period 2|Adverse Event|22|||
164315849|NCT01457352|593533244|FG001|Period 2|Adverse Event|0|||
164315850|NCT01457352|593533243|FG000|Period 2|no analysis|10|||
164315851|NCT01457352|593533244|FG001|Period 2|no analysis|0|||
164315852|NCT01457352|593533243|FG000|Period 2|Lack of Efficacy|8|||
164315853|NCT01457352|593533244|FG001|Period 2|Lack of Efficacy|0|||
164315854|NCT01457352|593533243|FG000|Period 2|Protocol Violation|4|||
164315855|NCT01457352|593533244|FG001|Period 2|Protocol Violation|0|||
164315856|NCT01457352|593533243|FG000|Period 2|Sponsor's withdrawal|7|||
164315857|NCT01457352|593533244|FG001|Period 2|Sponsor's withdrawal|0|||
164315858|NCT01457352|593533243|FG000|Period 2|Lost to Follow-up|1|||
164315859|NCT01457352|593533244|FG001|Period 2|Lost to Follow-up|0|||
164561512|NCT00725075|594423773|FG001|Overall Study|Withdrawal by Subject|5|||
164561513|NCT00725075|594423774|FG002|Overall Study|Withdrawal by Subject|4|||
164561514|NCT00725075|594423772|FG000|Overall Study|Adverse Event|2|||
164561515|NCT00725075|594423773|FG001|Overall Study|Adverse Event|1|||
164561516|NCT00725075|594423774|FG002|Overall Study|Adverse Event|1|||
164561517|NCT00725075|594423772|FG000|Overall Study|Worsening of Disease|2|||
164561518|NCT00725075|594423773|FG001|Overall Study|Worsening of Disease|1|||
164561519|NCT00725075|594423774|FG002|Overall Study|Worsening of Disease|2|||
164561520|NCT00725075|594423772|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
164315860|NCT01457352|593533243|FG000|Period 2|dose change|1|||
164315861|NCT01457352|593533244|FG001|Period 2|dose change|0|||
164315862|NCT01457352|593533243|FG000|Period 2|Physician Decision|1|||
164315863|NCT01457352|593533244|FG001|Period 2|Physician Decision|0|||
164420627|NCT01154036|593910966|FG004|Phase I|Physician Decision|0|||
164420628|NCT01154036|593910967|FG005|Phase I|Physician Decision|0|||
164665931|NCT06179108|594801539|FG001|Overall Study|Protocol Violation|1|||
164665932|NCT06179108|594801540|FG002|Overall Study|Protocol Violation|0|||
164315864|NCT01457352|593533243|FG000|Period 2|Did not meet eligibility criteria|3|||
164315865|NCT01457352|593533244|FG001|Period 2|Did not meet eligibility criteria|0|||
164315866|NCT01457352|593533243|FG000|Period 3|Adverse Event|1|||
164315867|NCT01457352|593533244|FG001|Period 3|Adverse Event|1|||
164315868|NCT01457352|593533243|FG000|Period 3|Withdrawal by Subject|0|||
164315869|NCT01457352|593533244|FG001|Period 3|Withdrawal by Subject|2|||
164561521|NCT00725075|594423773|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
164665933|NCT06179108|594801541|FG003|Overall Study|Protocol Violation|1|||
164665934|NCT06179108|594801538|FG000|Overall Study|Physician Decision|1|||
164665935|NCT06179108|594801539|FG001|Overall Study|Physician Decision|1|||
164665936|NCT06179108|594801540|FG002|Overall Study|Physician Decision|0|||
164665937|NCT06179108|594801541|FG003|Overall Study|Physician Decision|0|||
164665938|NCT06179108|594801538|FG000|Overall Study|Lack of Efficacy|0|||
164665939|NCT06179108|594801539|FG001|Overall Study|Lack of Efficacy|0|||
164665940|NCT06179108|594801540|FG002|Overall Study|Lack of Efficacy|0|||
164665941|NCT06179108|594801541|FG003|Overall Study|Lack of Efficacy|1|||
164665942|NCT06179108|594801538|FG000|Overall Study|Death|0|||
164315870|NCT01457352|593533243|FG000|Period 3|incorrect treatment|0|||
164315871|NCT01457352|593533244|FG001|Period 3|incorrect treatment|1|||
164315872|NCT01457352|593533243|FG000|Period 3|Sponsor's withdrawal|0|||
164315873|NCT01457352|593533244|FG001|Period 3|Sponsor's withdrawal|1|||
164315874|NCT01601652|593533245|FG000|Overall Study|Death|1|||
164315875|NCT04614324|593533256|FG000|Overall Study|Lost to Follow-up|3|||
164315876|NCT04614324|593533256|FG000|Overall Study|Physician Decision|1|||
164315877|NCT04614324|593533256|FG000|Overall Study|Withdrawal by Subject|2|||
164315878|NCT04614324|593533256|FG000|Overall Study|Remaining in Follow up|123|||
164315879|NCT03865316|593535473|FG000|Overall Study|Procedure Cancelled|4|||
164315880|NCT03865316|593535473|FG000|Overall Study|Equipment failure|4|||
164315881|NCT03658876|593535474|FG000|Overall Study|Protocol Violation|3|||
164315882|NCT03658876|593535475|FG001|Overall Study|Protocol Violation|2|||
164315883|NCT03658876|593535474|FG000|Overall Study|Withdrawal by Subject|2|||
164315884|NCT03658876|593535475|FG001|Overall Study|Withdrawal by Subject|0|||
164315885|NCT03658876|593535474|FG000|Overall Study|Death|0|||
164315886|NCT03658876|593535475|FG001|Overall Study|Death|1|||
164315887|NCT03658876|593535474|FG000|Overall Study|Intercurrent illness|6|||
164315888|NCT03658876|593535475|FG001|Overall Study|Intercurrent illness|4|||
164315889|NCT03658876|593535474|FG000|Overall Study|Transplantation/other operation|1|||
164315890|NCT03658876|593535475|FG001|Overall Study|Transplantation/other operation|5|||
164315891|NCT01948193|593535476|FG000|Overall Study|Serious event|2|||
164315892|NCT01948193|593535476|FG000|Overall Study|Lost to Follow-up|7|||
164315893|NCT01330017|593535477|FG000|Overall Study|Adverse Event|0|||
164315894|NCT01330017|593535478|FG001|Overall Study|Adverse Event|1|||
164315895|NCT01330017|593535479|FG002|Overall Study|Adverse Event|1|||
164315896|NCT01330017|593535480|FG003|Overall Study|Adverse Event|4|||
164315897|NCT01330017|593535481|FG004|Overall Study|Adverse Event|0|||
164315898|NCT01330017|593535477|FG000|Overall Study|Withdrawal by Subject|0|||
164315899|NCT01330017|593535478|FG001|Overall Study|Withdrawal by Subject|0|||
164315900|NCT01330017|593535479|FG002|Overall Study|Withdrawal by Subject|1|||
164315901|NCT01330017|593535480|FG003|Overall Study|Withdrawal by Subject|0|||
164315902|NCT01330017|593535481|FG004|Overall Study|Withdrawal by Subject|1|||
164315903|NCT01330017|593535477|FG000|Overall Study|Lost to Follow-up|0|||
164315904|NCT01330017|593535478|FG001|Overall Study|Lost to Follow-up|0|||
164315905|NCT01330017|593535479|FG002|Overall Study|Lost to Follow-up|1|||
164315906|NCT01330017|593535480|FG003|Overall Study|Lost to Follow-up|0|||
164315907|NCT01330017|593535481|FG004|Overall Study|Lost to Follow-up|0|||
164315908|NCT01330017|593535477|FG000|Overall Study|Protocol Violation|0|||
164315909|NCT01330017|593535478|FG001|Overall Study|Protocol Violation|0|||
164315910|NCT01330017|593535479|FG002|Overall Study|Protocol Violation|0|||
164315911|NCT01330017|593535480|FG003|Overall Study|Protocol Violation|1|||
164315912|NCT01330017|593535481|FG004|Overall Study|Protocol Violation|0|||
164315913|NCT01330017|593535477|FG000|Overall Study|Unknown Reason|5|||
164315914|NCT01330017|593535478|FG001|Overall Study|Unknown Reason|3|||
164315915|NCT01330017|593535479|FG002|Overall Study|Unknown Reason|5|||
164315916|NCT01330017|593535480|FG003|Overall Study|Unknown Reason|7|||
164315917|NCT01330017|593535481|FG004|Overall Study|Unknown Reason|2|||
164315918|NCT03137069|593535484|FG000|Overall Study|Withdrawal by Subject|1|||
164315919|NCT03137069|593535485|FG001|Overall Study|Withdrawal by Subject|2|||
164315920|NCT03137069|593535486|FG002|Overall Study|Withdrawal by Subject|2|||
164665943|NCT06179108|594801539|FG001|Overall Study|Death|0|||
164665944|NCT06179108|594801540|FG002|Overall Study|Death|0|||
164665945|NCT06179108|594801541|FG003|Overall Study|Death|1|||
164665946|NCT01370408|594801544|FG000|Overall Study|treatment failure|9|||
164665947|NCT02780687|594801547|FG000|Overall Study|Adverse Event|1|||
164665948|NCT02780687|594801548|FG001|Overall Study|Adverse Event|1|||
164665949|NCT02780687|594801547|FG000|Overall Study|Withdrawal by Subject|2|||
164315921|NCT03137069|593535487|FG003|Overall Study|Withdrawal by Subject|2|||
164315922|NCT03137069|593535488|FG004|Overall Study|Withdrawal by Subject|0|||
164315923|NCT03137069|593535489|FG005|Overall Study|Withdrawal by Subject|0|||
164315924|NCT03137069|593535484|FG000|Overall Study|Adverse Event|0|||
164315925|NCT03137069|593535485|FG001|Overall Study|Adverse Event|3|||
164315926|NCT03137069|593535486|FG002|Overall Study|Adverse Event|1|||
164315927|NCT03137069|593535487|FG003|Overall Study|Adverse Event|1|||
164315928|NCT03137069|593535488|FG004|Overall Study|Adverse Event|0|||
164315929|NCT03137069|593535489|FG005|Overall Study|Adverse Event|1|||
164315930|NCT03137069|593535484|FG000|Overall Study|Protocol Violation|0|||
164315931|NCT03137069|593535485|FG001|Overall Study|Protocol Violation|1|||
164315932|NCT03137069|593535486|FG002|Overall Study|Protocol Violation|0|||
164665950|NCT02780687|594801548|FG001|Overall Study|Withdrawal by Subject|1|||
164315933|NCT03137069|593535487|FG003|Overall Study|Protocol Violation|1|||
164315934|NCT03137069|593535488|FG004|Overall Study|Protocol Violation|1|||
164315935|NCT03137069|593535489|FG005|Overall Study|Protocol Violation|1|||
164315936|NCT03137069|593535484|FG000|Overall Study|Physician Decision|0|||
164315937|NCT03137069|593535485|FG001|Overall Study|Physician Decision|0|||
164315938|NCT03137069|593535486|FG002|Overall Study|Physician Decision|0|||
164315939|NCT03137069|593535487|FG003|Overall Study|Physician Decision|1|||
164315940|NCT03137069|593535488|FG004|Overall Study|Physician Decision|0|||
164315941|NCT03137069|593535489|FG005|Overall Study|Physician Decision|0|||
164315942|NCT03137069|593535484|FG000|Overall Study|Study Terminated by Sponsor|0|||
164315943|NCT03137069|593535485|FG001|Overall Study|Study Terminated by Sponsor|0|||
164315944|NCT03137069|593535486|FG002|Overall Study|Study Terminated by Sponsor|0|||
164315945|NCT03137069|593535487|FG003|Overall Study|Study Terminated by Sponsor|0|||
164315946|NCT03137069|593535488|FG004|Overall Study|Study Terminated by Sponsor|1|||
164315947|NCT03137069|593535489|FG005|Overall Study|Study Terminated by Sponsor|0|||
164315948|NCT03137069|593535484|FG000|Overall Study|Data Entry Error|0|||
164315949|NCT03137069|593535485|FG001|Overall Study|Data Entry Error|0|||
164315950|NCT03137069|593535486|FG002|Overall Study|Data Entry Error|0|||
164315951|NCT03137069|593535487|FG003|Overall Study|Data Entry Error|1|||
164315952|NCT03137069|593535488|FG004|Overall Study|Data Entry Error|0|||
164315953|NCT03137069|593535489|FG005|Overall Study|Data Entry Error|0|||
164315954|NCT01106092|593535491|FG000|Overall Study|Withdrawal by Subject|0|||
164315955|NCT01106092|593535492|FG001|Overall Study|Withdrawal by Subject|0|||
164315956|NCT01106092|593535493|FG002|Overall Study|Withdrawal by Subject|0|||
164315957|NCT01106092|593535494|FG003|Overall Study|Withdrawal by Subject|1|||
164315958|NCT02434471|593535497|FG000|Overall Study|Physician Decision|9|||
164315959|NCT00369629|593535502|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
164315960|NCT00369629|593535503|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
164315961|NCT00369629|593535504|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
164315962|NCT00369629|593535505|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
164315963|NCT00369629|593535502|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
164315964|NCT00369629|593535503|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
164315965|NCT00369629|593535504|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
164315966|NCT00369629|593535505|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
164315967|NCT00369629|593535502|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
164315968|NCT00369629|593535503|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
164315969|NCT00369629|593535504|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
164315970|NCT00369629|593535505|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
164315971|NCT00369629|593535502|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
164315972|NCT00369629|593535503|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
164315973|NCT00369629|593535504|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
164315974|NCT00369629|593535505|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
164315975|NCT00369629|593535502|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
164315976|NCT00369629|593535503|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
164315977|NCT00369629|593535504|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
164315978|NCT00369629|593535505|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
164315979|NCT00369629|593535502|FG000|Completed 4 More Cycles|Progressive disease|2|||
164315980|NCT00369629|593535503|FG001|Completed 4 More Cycles|Progressive disease|1|||
164315981|NCT00369629|593535504|FG002|Completed 4 More Cycles|Progressive disease|2|||
164315982|NCT00369629|593535505|FG003|Completed 4 More Cycles|Progressive disease|0|||
164315983|NCT00369629|593535502|FG000|Follow up for 1 Year|Death|2|||
164315984|NCT00369629|593535503|FG001|Follow up for 1 Year|Death|1|||
164315985|NCT00369629|593535504|FG002|Follow up for 1 Year|Death|1|||
164315986|NCT00369629|593535505|FG003|Follow up for 1 Year|Death|0|||
164315987|NCT00369629|593535502|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
164315988|NCT00369629|593535503|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
164561522|NCT00725075|594423774|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
164561523|NCT00725075|594423772|FG000|Overall Study|Other|1|||
164561524|NCT00725075|594423773|FG001|Overall Study|Other|0|||
164561525|NCT00725075|594423774|FG002|Overall Study|Other|0|||
164561526|NCT01298492|594423775|FG000|Overall Study|Death|2|||
164315989|NCT00369629|593535504|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
164315990|NCT00369629|593535505|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
164315991|NCT00369629|593535502|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
164315992|NCT00369629|593535503|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
164315993|NCT00369629|593535504|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
164315994|NCT00369629|593535505|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
164315995|NCT04839562|593535506|FG000|Overall Study|Withdrawal by Subject|0|||
164315996|NCT04839562|593535507|FG001|Overall Study|Withdrawal by Subject|1|||
164561527|NCT01298492|594423775|FG000|Overall Study|Insufficient Clinical Response|22|||
164561528|NCT01298492|594423775|FG000|Overall Study|Lost to Follow-up|12|||
164561529|NCT01298492|594423775|FG000|Overall Study|Withdrawal by Subject|47|||
164561530|NCT01298492|594423775|FG000|Overall Study|Other (Unspecified)|7|||
164315997|NCT04839562|593535506|FG000|Overall Study|Physician Decision|0|||
164315998|NCT04839562|593535507|FG001|Overall Study|Physician Decision|1|||
164315999|NCT00877773|593535512|FG000|Overall Study|Disease Progression|44|||
164316000|NCT00668733|593535515|FG000|Overall Study|Lost to Follow-up|2|||
164316001|NCT00668733|593535516|FG001|Overall Study|Lost to Follow-up|3|||
164316002|NCT00668733|593535515|FG000|Overall Study|Withdrawal by Subject|0|||
164316003|NCT00668733|593535516|FG001|Overall Study|Withdrawal by Subject|4|||
164316004|NCT01122264|593535519|FG000|Overall Study|Adverse Event|6|||
164316005|NCT01122264|593535520|FG001|Overall Study|Adverse Event|5|||
164316006|NCT01122264|593535521|FG002|Overall Study|Adverse Event|7|||
164316007|NCT01122264|593535519|FG000|Overall Study|Death|1|||
164316008|NCT01122264|593535520|FG001|Overall Study|Death|0|||
164316009|NCT01122264|593535521|FG002|Overall Study|Death|0|||
164316010|NCT01122264|593535519|FG000|Overall Study|Lost to Follow-up|5|||
164316011|NCT01122264|593535520|FG001|Overall Study|Lost to Follow-up|9|||
164316012|NCT01122264|593535521|FG002|Overall Study|Lost to Follow-up|13|||
164316013|NCT01122264|593535519|FG000|Overall Study|Entry Criteria Not Met|1|||
164316014|NCT01122264|593535520|FG001|Overall Study|Entry Criteria Not Met|0|||
164316015|NCT01122264|593535521|FG002|Overall Study|Entry Criteria Not Met|0|||
164316016|NCT01122264|593535519|FG000|Overall Study|Protocol Violation|7|||
164316017|NCT01122264|593535520|FG001|Overall Study|Protocol Violation|7|||
164316018|NCT01122264|593535521|FG002|Overall Study|Protocol Violation|9|||
164316019|NCT01122264|593535519|FG000|Overall Study|Withdrawal by Subject|6|||
164316020|NCT01122264|593535520|FG001|Overall Study|Withdrawal by Subject|6|||
164316021|NCT01122264|593535521|FG002|Overall Study|Withdrawal by Subject|16|||
164316022|NCT01122264|593535519|FG000|Overall Study|Physician Decision|3|||
164316023|NCT01122264|593535520|FG001|Overall Study|Physician Decision|1|||
164316024|NCT01122264|593535521|FG002|Overall Study|Physician Decision|1|||
164316025|NCT01122264|593535519|FG000|Overall Study|Lack of Efficacy|3|||
164316026|NCT01122264|593535520|FG001|Overall Study|Lack of Efficacy|1|||
164316027|NCT01122264|593535521|FG002|Overall Study|Lack of Efficacy|1|||
164316028|NCT00097981|593535522|FG000|Overall Study|Adverse Event|31|||
164316029|NCT00097981|593535523|FG001|Overall Study|Adverse Event|44|||
164316030|NCT00097981|593535522|FG000|Overall Study|Withdrawal by Subject|10|||
164316031|NCT00097981|593535523|FG001|Overall Study|Withdrawal by Subject|8|||
164316032|NCT00097981|593535522|FG000|Overall Study|Protocol Violation|1|||
164316033|NCT00097981|593535523|FG001|Overall Study|Protocol Violation|1|||
164316034|NCT00097981|593535522|FG000|Overall Study|Death|2|||
164316035|NCT00097981|593535523|FG001|Overall Study|Death|4|||
164316036|NCT00097981|593535522|FG000|Overall Study|Physician Decision|7|||
164316037|NCT00097981|593535523|FG001|Overall Study|Physician Decision|1|||
164316038|NCT00097981|593535522|FG000|Overall Study|Disease Progression|8|||
164316039|NCT00097981|593535523|FG001|Overall Study|Disease Progression|2|||
164316040|NCT00097981|593535522|FG000|Overall Study|Transplant planned|28|||
164316041|NCT00097981|593535523|FG001|Overall Study|Transplant planned|27|||
164316042|NCT00097981|593535522|FG000|Overall Study|Other|19|||
164316043|NCT00097981|593535523|FG001|Overall Study|Other|13|||
164316044|NCT03135119|593535524|FG000|Overall Study|Lost to Follow-up|2|||
164316045|NCT03135119|593535525|FG001|Overall Study|Lost to Follow-up|0|||
164316046|NCT03135119|593535524|FG000|Overall Study|Physician Decision|1|||
164316047|NCT03135119|593535525|FG001|Overall Study|Physician Decision|1|||
164316048|NCT03135119|593535524|FG000|Overall Study|COVID-19 Shutdown|2|||
164316049|NCT03135119|593535525|FG001|Overall Study|COVID-19 Shutdown|2|||
164316050|NCT01836276|593535526|FG000|Overall Study|Lost to Follow-up|28|||
164316051|NCT01836276|593535527|FG001|Overall Study|Lost to Follow-up|51|||
164316052|NCT00796445|593535536|FG000|Overall Study|Protocol Violation|5|||
164316053|NCT00796445|593535537|FG001|Overall Study|Protocol Violation|3|||
164665951|NCT02780687|594801547|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
164665952|NCT02780687|594801548|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
164665953|NCT02780687|594801547|FG000|Overall Study|progressive disease|29|||
164316054|NCT00796445|593535536|FG000|Overall Study|Adverse event, serious fatal|10|||
164316055|NCT00796445|593535537|FG001|Overall Study|Adverse event, serious fatal|5|||
164316056|NCT00796445|593535536|FG000|Overall Study|Adverse event, non-fatal|4|||
164316057|NCT00796445|593535537|FG001|Overall Study|Adverse event, non-fatal|0|||
164316058|NCT00796445|593535536|FG000|Overall Study|Disease progression/recurrence|537|||
164316059|NCT00796445|593535537|FG001|Overall Study|Disease progression/recurrence|268|||
164316060|NCT00796445|593535536|FG000|Overall Study|Other|10|||
164316061|NCT00796445|593535537|FG001|Overall Study|Other|7|||
164316062|NCT00796445|593535536|FG000|Overall Study|Withdrawal by Subject|18|||
164316063|NCT00796445|593535537|FG001|Overall Study|Withdrawal by Subject|9|||
164316064|NCT00796445|593535536|FG000|Overall Study|Invalid Informed Consent Form|1|||
164316065|NCT00796445|593535537|FG001|Overall Study|Invalid Informed Consent Form|0|||
164316066|NCT02208063|593535538|FG000|Overall Study|Death|3|||
164316067|NCT02208063|593535539|FG001|Overall Study|Death|5|||
164316068|NCT02208063|593535538|FG000|Overall Study|Not Specified in report|3|||
164665954|NCT02780687|594801548|FG001|Overall Study|progressive disease|6|||
164316069|NCT02208063|593535539|FG001|Overall Study|Not Specified in report|4|||
164316070|NCT02208063|593535538|FG000|Overall Study|Withdrawal by Subject|5|||
164316071|NCT02208063|593535539|FG001|Overall Study|Withdrawal by Subject|2|||
164316072|NCT02208063|593535538|FG000|Overall Study|Lost to Follow-up|1|||
164316073|NCT02208063|593535539|FG001|Overall Study|Lost to Follow-up|0|||
164316074|NCT00388583|593535540|FG000|Overall Study|Protocol Violation|1|||
164316075|NCT00388583|593535541|FG001|Overall Study|Protocol Violation|0|||
164316076|NCT00388583|593535540|FG000|Overall Study|Withdrawal by Subject|3|||
164316077|NCT00388583|593535541|FG001|Overall Study|Withdrawal by Subject|3|||
164316078|NCT00388583|593535540|FG000|Overall Study|Serious Adverse Event|2|||
164316079|NCT00388583|593535541|FG001|Overall Study|Serious Adverse Event|0|||
164316080|NCT00388583|593535540|FG000|Overall Study|Did not receive vaccine|0|||
164316081|NCT00388583|593535541|FG001|Overall Study|Did not receive vaccine|1|||
164316082|NCT00913458|593535542|FG000|Phase 1|Non-Responder|54|||
164316083|NCT00913458|593535543|FG001|Phase 1|Non-Responder|0|||
164316084|NCT00913458|593535544|FG002|Phase 1|Non-Responder|0|||
164316085|NCT00913458|593535545|FG003|Phase 1|Non-Responder|0|||
164316086|NCT00913458|593535546|FG004|Phase 1|Non-Responder|0|||
164316087|NCT00913458|593535547|FG005|Phase 1|Non-Responder|0|||
164316088|NCT00913458|593535548|FG006|Phase 1|Non-Responder|0|||
164316089|NCT00913458|593535542|FG000|Phase 1|Subject Request|17|||
164316090|NCT00913458|593535543|FG001|Phase 1|Subject Request|0|||
164316091|NCT00913458|593535544|FG002|Phase 1|Subject Request|0|||
164316092|NCT00913458|593535545|FG003|Phase 1|Subject Request|0|||
164316093|NCT00913458|593535546|FG004|Phase 1|Subject Request|0|||
164316094|NCT00913458|593535547|FG005|Phase 1|Subject Request|0|||
164316095|NCT00913458|593535548|FG006|Phase 1|Subject Request|0|||
164316096|NCT00913458|593535542|FG000|Phase 1|Adverse Event|20|||
164316097|NCT00913458|593535543|FG001|Phase 1|Adverse Event|0|||
164316098|NCT00913458|593535544|FG002|Phase 1|Adverse Event|0|||
164316099|NCT00913458|593535545|FG003|Phase 1|Adverse Event|0|||
164316100|NCT00913458|593535546|FG004|Phase 1|Adverse Event|0|||
164316101|NCT00913458|593535547|FG005|Phase 1|Adverse Event|0|||
164316102|NCT00913458|593535548|FG006|Phase 1|Adverse Event|0|||
164316103|NCT00913458|593535542|FG000|Phase 1|Lost to Follow-up|2|||
164316104|NCT00913458|593535543|FG001|Phase 1|Lost to Follow-up|0|||
164316105|NCT00913458|593535544|FG002|Phase 1|Lost to Follow-up|0|||
164316106|NCT00913458|593535545|FG003|Phase 1|Lost to Follow-up|0|||
164316107|NCT00913458|593535546|FG004|Phase 1|Lost to Follow-up|0|||
164316108|NCT00913458|593535547|FG005|Phase 1|Lost to Follow-up|0|||
164316109|NCT00913458|593535548|FG006|Phase 1|Lost to Follow-up|0|||
164316110|NCT00913458|593535542|FG000|Phase 1|Protocol Violation|10|||
164316111|NCT00913458|593535543|FG001|Phase 1|Protocol Violation|0|||
164561531|NCT01298492|594423775|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
164561532|NCT01298492|594423775|FG000|Overall Study|Protocol Violation|2|||
164561533|NCT01298492|594423775|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
164204768|NCT01288430|593121093|FG006|Part 2|Other|0|||
164204769|NCT01288430|593121094|FG007|Part 2|Other|0|||
164204770|NCT01288430|593121095|FG008|Part 2|Other|0|||
164204771|NCT01288430|593121096|FG009|Part 2|Other|1|||
164204772|NCT05507437|593121097|FG000|Overall Study|Withdrawal by Subject|1|||
164204773|NCT05507437|593121098|FG001|Overall Study|Withdrawal by Subject|1|||
164204774|NCT05507437|593121097|FG000|Overall Study|Death|3|||
164204775|NCT05507437|593121098|FG001|Overall Study|Death|0|||
164204776|NCT06583096|593121099|FG000|Overall Study|Lost to Follow-up|4|||
164204777|NCT06583096|593121100|FG001|Overall Study|Lost to Follow-up|10|||
164204778|NCT06583096|593121099|FG000|Overall Study|Withdrawal by Subject|0|||
164204779|NCT06583096|593121100|FG001|Overall Study|Withdrawal by Subject|2|||
164204780|NCT05172609|593121101|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
164204781|NCT05172609|593121102|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
164204782|NCT05172609|593121101|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
164204783|NCT05172609|593121102|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
164204784|NCT05172609|593121101|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
164204785|NCT05172609|593121102|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
164204786|NCT05610605|593121105|FG000|6-month Assessment|Death|1|||
164204787|NCT05610605|593121106|FG001|6-month Assessment|Death|1|||
164204788|NCT05610605|593121105|FG000|6-month Assessment|Lost to Follow-up|20|||
164204789|NCT05610605|593121106|FG001|6-month Assessment|Lost to Follow-up|0|||
164204790|NCT05610605|593121105|FG000|6-month Assessment|Institutionalized|1|||
164204791|NCT05610605|593121106|FG001|6-month Assessment|Institutionalized|2|||
164204792|NCT05610605|593121105|FG000|12-month Assessment|Death|2|||
164204793|NCT05610605|593121106|FG001|12-month Assessment|Death|1|||
164204794|NCT05610605|593121105|FG000|12-month Assessment|Lost to Follow-up|1|||
164204795|NCT05610605|593121106|FG001|12-month Assessment|Lost to Follow-up|4|||
164204796|NCT05610605|593121105|FG000|12-month Assessment|Institutionalized|2|||
164204797|NCT05610605|593121106|FG001|12-month Assessment|Institutionalized|1|||
164204798|NCT00753519|593121107|FG000|Overall Study|Withdrawal by Subject|0|||
164204799|NCT00753519|593121108|FG001|Overall Study|Withdrawal by Subject|2|||
164204800|NCT00042289|593121109|FG000|Overall Study|Lost to Follow-up|3|||
164204801|NCT00042289|593121110|FG001|Overall Study|Lost to Follow-up|0|||
164316112|NCT00913458|593535544|FG002|Phase 1|Protocol Violation|0|||
164316113|NCT00913458|593535545|FG003|Phase 1|Protocol Violation|0|||
164316114|NCT00913458|593535546|FG004|Phase 1|Protocol Violation|0|||
164316115|NCT00913458|593535547|FG005|Phase 1|Protocol Violation|0|||
164316116|NCT00913458|593535548|FG006|Phase 1|Protocol Violation|0|||
164316117|NCT00913458|593535542|FG000|Phase 1|Sponsor|2|||
164316118|NCT00913458|593535543|FG001|Phase 1|Sponsor|0|||
164316119|NCT00913458|593535544|FG002|Phase 1|Sponsor|0|||
164316120|NCT00913458|593535545|FG003|Phase 1|Sponsor|0|||
164316121|NCT00913458|593535546|FG004|Phase 1|Sponsor|0|||
164316122|NCT00913458|593535547|FG005|Phase 1|Sponsor|0|||
164316123|NCT00913458|593535548|FG006|Phase 1|Sponsor|0|||
164316124|NCT00913458|593535542|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
164316125|NCT00913458|593535543|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
164316126|NCT00913458|593535544|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
164316127|NCT00913458|593535545|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
164316128|NCT00913458|593535546|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
164316129|NCT00913458|593535547|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
164316130|NCT00913458|593535548|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
164316131|NCT00913458|593535542|FG000|Phase 2|Non-Responder|0|||
164316132|NCT00913458|593535543|FG001|Phase 2|Non-Responder|5|||
164316133|NCT00913458|593535544|FG002|Phase 2|Non-Responder|7|||
164316134|NCT00913458|593535545|FG003|Phase 2|Non-Responder|12|||
164316135|NCT00913458|593535546|FG004|Phase 2|Non-Responder|0|||
164316136|NCT00913458|593535547|FG005|Phase 2|Non-Responder|0|||
164316137|NCT00913458|593535548|FG006|Phase 2|Non-Responder|0|||
164316138|NCT00913458|593535542|FG000|Phase 2|Subject Request|0|||
164316139|NCT00913458|593535543|FG001|Phase 2|Subject Request|0|||
164316140|NCT00913458|593535544|FG002|Phase 2|Subject Request|1|||
164316141|NCT00913458|593535545|FG003|Phase 2|Subject Request|2|||
164316142|NCT00913458|593535546|FG004|Phase 2|Subject Request|0|||
164316143|NCT00913458|593535547|FG005|Phase 2|Subject Request|0|||
164316144|NCT00913458|593535548|FG006|Phase 2|Subject Request|0|||
164316145|NCT00913458|593535542|FG000|Phase 2|Adverse Event|0|||
164316146|NCT00913458|593535543|FG001|Phase 2|Adverse Event|3|||
164316147|NCT00913458|593535544|FG002|Phase 2|Adverse Event|0|||
164316148|NCT00913458|593535545|FG003|Phase 2|Adverse Event|1|||
164316149|NCT00913458|593535546|FG004|Phase 2|Adverse Event|0|||
164316150|NCT00913458|593535547|FG005|Phase 2|Adverse Event|0|||
164316151|NCT00913458|593535548|FG006|Phase 2|Adverse Event|0|||
164316152|NCT00913458|593535542|FG000|Phase 2|Lost to Follow-up|0|||
164316153|NCT00913458|593535543|FG001|Phase 2|Lost to Follow-up|0|||
164316154|NCT00913458|593535544|FG002|Phase 2|Lost to Follow-up|0|||
164316155|NCT00913458|593535545|FG003|Phase 2|Lost to Follow-up|1|||
164316156|NCT00913458|593535546|FG004|Phase 2|Lost to Follow-up|0|||
164316157|NCT00913458|593535547|FG005|Phase 2|Lost to Follow-up|0|||
164316158|NCT00913458|593535548|FG006|Phase 2|Lost to Follow-up|0|||
164316159|NCT00913458|593535542|FG000|Phase 2|Protocol Violation|0|||
164316160|NCT00913458|593535543|FG001|Phase 2|Protocol Violation|2|||
164316161|NCT00913458|593535544|FG002|Phase 2|Protocol Violation|0|||
164316162|NCT00913458|593535545|FG003|Phase 2|Protocol Violation|0|||
164316163|NCT00913458|593535546|FG004|Phase 2|Protocol Violation|0|||
164316164|NCT00913458|593535547|FG005|Phase 2|Protocol Violation|0|||
164316165|NCT00913458|593535548|FG006|Phase 2|Protocol Violation|0|||
164316166|NCT00913458|593535542|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
164316167|NCT00913458|593535543|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
164316168|NCT00913458|593535544|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
164316169|NCT00913458|593535545|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
164316170|NCT00913458|593535546|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
164316171|NCT00913458|593535547|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
164316172|NCT00913458|593535548|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
164316173|NCT00913458|593535542|FG000|Phase 3|Adverse Event|0|||
164316174|NCT00913458|593535543|FG001|Phase 3|Adverse Event|0|||
164316175|NCT00913458|593535544|FG002|Phase 3|Adverse Event|0|||
164316176|NCT00913458|593535545|FG003|Phase 3|Adverse Event|0|||
164316177|NCT00913458|593535546|FG004|Phase 3|Adverse Event|5|||
164316178|NCT00913458|593535547|FG005|Phase 3|Adverse Event|4|||
164316179|NCT00913458|593535548|FG006|Phase 3|Adverse Event|1|||
164316180|NCT00913458|593535542|FG000|Phase 3|Lost to Follow-up|0|||
164316181|NCT00913458|593535543|FG001|Phase 3|Lost to Follow-up|0|||
164316182|NCT00913458|593535544|FG002|Phase 3|Lost to Follow-up|0|||
164316183|NCT00913458|593535545|FG003|Phase 3|Lost to Follow-up|0|||
164316184|NCT00913458|593535546|FG004|Phase 3|Lost to Follow-up|2|||
164316185|NCT00913458|593535547|FG005|Phase 3|Lost to Follow-up|0|||
164316186|NCT00913458|593535548|FG006|Phase 3|Lost to Follow-up|0|||
164316187|NCT00913458|593535542|FG000|Phase 3|Non-Responder|0|||
164316188|NCT00913458|593535543|FG001|Phase 3|Non-Responder|0|||
164316189|NCT00913458|593535544|FG002|Phase 3|Non-Responder|0|||
164316190|NCT00913458|593535545|FG003|Phase 3|Non-Responder|0|||
164316191|NCT00913458|593535546|FG004|Phase 3|Non-Responder|0|||
164316192|NCT00913458|593535547|FG005|Phase 3|Non-Responder|1|||
164316193|NCT00913458|593535548|FG006|Phase 3|Non-Responder|3|||
164316194|NCT00913458|593535542|FG000|Phase 3|Withdrawal by Subject|0|||
164316195|NCT00913458|593535543|FG001|Phase 3|Withdrawal by Subject|0|||
164316196|NCT00913458|593535544|FG002|Phase 3|Withdrawal by Subject|0|||
164316197|NCT00913458|593535545|FG003|Phase 3|Withdrawal by Subject|0|||
164316198|NCT00913458|593535546|FG004|Phase 3|Withdrawal by Subject|1|||
164561534|NCT01298492|594423775|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
164561535|NCT02340663|594423776|FG000|Overall Study|Lost to Follow-up|1|||
164561536|NCT02340663|594423777|FG001|Overall Study|Lost to Follow-up|0|||
164561537|NCT02340663|594423776|FG000|Overall Study|Protocol Violation|1|||
164561538|NCT02340663|594423777|FG001|Overall Study|Protocol Violation|0|||
164561539|NCT02340663|594423776|FG000|Overall Study|Withdrawal by Subject|3|||
164561540|NCT02340663|594423777|FG001|Overall Study|Withdrawal by Subject|1|||
164561541|NCT00087646|594423778|FG000|Overall Study|Adverse Event|37|||
164204802|NCT00042289|593121111|FG002|Overall Study|Lost to Follow-up|0|||
164204803|NCT00042289|593121112|FG003|Overall Study|Lost to Follow-up|1|||
164204804|NCT00042289|593121113|FG004|Overall Study|Lost to Follow-up|3|||
164204805|NCT00042289|593121114|FG005|Overall Study|Lost to Follow-up|3|||
164204806|NCT00042289|593121115|FG006|Overall Study|Lost to Follow-up|6|||
164204807|NCT00042289|593121116|FG007|Overall Study|Lost to Follow-up|1|||
164204808|NCT00042289|593121117|FG008|Overall Study|Lost to Follow-up|1|||
164204809|NCT00042289|593121118|FG009|Overall Study|Lost to Follow-up|0|||
164204810|NCT00042289|593121119|FG010|Overall Study|Lost to Follow-up|0|||
164204811|NCT00042289|593121120|FG011|Overall Study|Lost to Follow-up|0|||
164204812|NCT00042289|593121121|FG012|Overall Study|Lost to Follow-up|0|||
164204813|NCT00042289|593121122|FG013|Overall Study|Lost to Follow-up|0|||
164204814|NCT00042289|593121123|FG014|Overall Study|Lost to Follow-up|0|||
164204815|NCT00042289|593121124|FG015|Overall Study|Lost to Follow-up|1|||
164204816|NCT00042289|593121125|FG016|Overall Study|Lost to Follow-up|1|||
164204817|NCT00042289|593121126|FG017|Overall Study|Lost to Follow-up|0|||
164204818|NCT00042289|593121127|FG018|Overall Study|Lost to Follow-up|3|||
164204819|NCT00042289|593121128|FG019|Overall Study|Lost to Follow-up|2|||
164204820|NCT00042289|593121129|FG020|Overall Study|Lost to Follow-up|0|||
164204821|NCT00042289|593121130|FG021|Overall Study|Lost to Follow-up|0|||
164204822|NCT00042289|593121131|FG022|Overall Study|Lost to Follow-up|0|||
164204823|NCT00042289|593121132|FG023|Overall Study|Lost to Follow-up|0|||
164204824|NCT00042289|593121133|FG024|Overall Study|Lost to Follow-up|0|||
164204825|NCT00042289|593121134|FG025|Overall Study|Lost to Follow-up|0|||
164204826|NCT00042289|593121135|FG026|Overall Study|Lost to Follow-up|2|||
164204827|NCT00042289|593121136|FG027|Overall Study|Lost to Follow-up|2|||
164204828|NCT00042289|593121137|FG028|Overall Study|Lost to Follow-up|2|||
164204829|NCT00042289|593121138|FG029|Overall Study|Lost to Follow-up|0|||
164204830|NCT00042289|593121139|FG030|Overall Study|Lost to Follow-up|0|||
164204831|NCT00042289|593121140|FG031|Overall Study|Lost to Follow-up|2|||
164204832|NCT00042289|593121141|FG032|Overall Study|Lost to Follow-up|1|||
164204833|NCT00042289|593121142|FG033|Overall Study|Lost to Follow-up|1|||
164204834|NCT00042289|593121143|FG034|Overall Study|Lost to Follow-up|1|||
164204835|NCT00042289|593121144|FG035|Overall Study|Lost to Follow-up|2|||
164204836|NCT00042289|593121145|FG036|Overall Study|Lost to Follow-up|1|||
164204837|NCT00042289|593121146|FG037|Overall Study|Lost to Follow-up|1|||
164204838|NCT00042289|593121147|FG038|Overall Study|Lost to Follow-up|0|||
164204839|NCT00042289|593121148|FG039|Overall Study|Lost to Follow-up|5|||
164204840|NCT00042289|593121149|FG040|Overall Study|Lost to Follow-up|0|||
164561542|NCT00087646|594423779|FG001|Overall Study|Adverse Event|6|||
164561543|NCT00087646|594423780|FG002|Overall Study|Adverse Event|18|||
164316199|NCT00913458|593535547|FG005|Phase 3|Withdrawal by Subject|2|||
164316200|NCT00913458|593535548|FG006|Phase 3|Withdrawal by Subject|0|||
164316201|NCT00913458|593535542|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
164316202|NCT00913458|593535543|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
164316203|NCT00913458|593535544|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
164316204|NCT00913458|593535545|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
164316205|NCT00913458|593535546|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
164316206|NCT00913458|593535547|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
164316207|NCT00913458|593535548|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
164316208|NCT02366091|593535549|FG000|Overall Study|Withdrawal by Subject|3|||
164316209|NCT02366091|593535550|FG001|Overall Study|Withdrawal by Subject|7|||
164316210|NCT02366091|593535551|FG002|Overall Study|Withdrawal by Subject|3|||
164316211|NCT02366091|593535552|FG003|Overall Study|Withdrawal by Subject|1|||
164316212|NCT05194579|593535553|FG000|Overall Study|Lost to Follow-up|2|||
164316213|NCT05194579|593535554|FG001|Overall Study|Lost to Follow-up|3|||
164316214|NCT05194579|593535553|FG000|Overall Study|Withdrawal by Subject|3|||
164316215|NCT05194579|593535554|FG001|Overall Study|Withdrawal by Subject|4|||
164316216|NCT05194579|593535553|FG000|Overall Study|Refused further study procedures|0|||
164316217|NCT05194579|593535554|FG001|Overall Study|Refused further study procedures|1|||
164316218|NCT05194579|593535553|FG000|Overall Study|Protocol deviation|1|||
164316219|NCT05194579|593535554|FG001|Overall Study|Protocol deviation|0|||
164316220|NCT00638183|593535556|FG000|Overall Study|Adverse Event|23|||
164316221|NCT00638183|593535556|FG000|Overall Study|Lack of Efficacy|14|||
164316222|NCT00638183|593535556|FG000|Overall Study|Physician Decision|9|||
164316223|NCT00638183|593535556|FG000|Overall Study|Lost to Follow-up|46|||
164316224|NCT00638183|593535556|FG000|Overall Study|Other reason not defined above|27|||
164316225|NCT02350764|593535557|FG000|Overall Study|Adverse Event|4|||
164316226|NCT02350764|593535557|FG000|Overall Study|Death|3|||
164316227|NCT02350764|593535557|FG000|Overall Study|Physician Decision|2|||
164316228|NCT02350764|593535557|FG000|Overall Study|Withdrawal by Subject|2|||
164316229|NCT03180619|593535558|FG000|Overall Study|Withdrew Consent|5|||
164316230|NCT03180619|593535559|FG001|Overall Study|Withdrew Consent|0|||
164316231|NCT03180619|593535560|FG002|Overall Study|Withdrew Consent|2|||
164316232|NCT03180619|593535558|FG000|Overall Study|Death|2|||
164316233|NCT03180619|593535559|FG001|Overall Study|Death|1|||
164316234|NCT03180619|593535560|FG002|Overall Study|Death|2|||
164316235|NCT03180619|593535558|FG000|Overall Study|Adverse Event|2|||
164316236|NCT03180619|593535559|FG001|Overall Study|Adverse Event|0|||
164316237|NCT03180619|593535560|FG002|Overall Study|Adverse Event|1|||
164316238|NCT03180619|593535558|FG000|Overall Study|Investigator's discretion|2|||
164316239|NCT03180619|593535559|FG001|Overall Study|Investigator's discretion|0|||
164316240|NCT03180619|593535560|FG002|Overall Study|Investigator's discretion|1|||
164316241|NCT02743611|593535561|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
164316242|NCT02743611|593535562|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
164316243|NCT02743611|593535563|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
164316244|NCT02743611|593535564|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
164316245|NCT01433289|593535565|FG000|Overall Study|Pregnancy|0|||
164316246|NCT01433289|593535566|FG001|Overall Study|Pregnancy|1|||
164316247|NCT01433289|593535567|FG002|Overall Study|Pregnancy|0|||
164316248|NCT01433289|593535568|FG003|Overall Study|Pregnancy|0|||
164561544|NCT00087646|594423781|FG003|Overall Study|Adverse Event|20|||
164561545|NCT00087646|594423778|FG000|Overall Study|Death|0|||
164561546|NCT00087646|594423779|FG001|Overall Study|Death|1|||
164561547|NCT00087646|594423780|FG002|Overall Study|Death|0|||
164561548|NCT00087646|594423781|FG003|Overall Study|Death|0|||
164561549|NCT00087646|594423778|FG000|Overall Study|Withdrawal by Subject|6|||
164561550|NCT00087646|594423779|FG001|Overall Study|Withdrawal by Subject|1|||
164561551|NCT00087646|594423780|FG002|Overall Study|Withdrawal by Subject|2|||
164561552|NCT00087646|594423781|FG003|Overall Study|Withdrawal by Subject|2|||
164561553|NCT00087646|594423778|FG000|Overall Study|Insufficient therapeutic response|64|||
164561554|NCT00087646|594423779|FG001|Overall Study|Insufficient therapeutic response|24|||
164561555|NCT00087646|594423780|FG002|Overall Study|Insufficient therapeutic response|38|||
164561556|NCT00087646|594423781|FG003|Overall Study|Insufficient therapeutic response|51|||
164561557|NCT00087646|594423778|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
164316249|NCT00729469|593535569|FG000|Overall Study|Adverse Event|14|||
164316250|NCT00729469|593535570|FG001|Overall Study|Adverse Event|25|||
164316251|NCT00729469|593535569|FG000|Overall Study|Lost to Follow-up|9|||
164316252|NCT00729469|593535570|FG001|Overall Study|Lost to Follow-up|9|||
164316253|NCT00729469|593535569|FG000|Overall Study|Protocol Violation|2|||
164316254|NCT00729469|593535570|FG001|Overall Study|Protocol Violation|1|||
164316255|NCT00729469|593535569|FG000|Overall Study|Withdrawal by Subject|19|||
164316256|NCT00729469|593535570|FG001|Overall Study|Withdrawal by Subject|8|||
164316257|NCT00729469|593535569|FG000|Overall Study|Other-Not mentioned|9|||
164316258|NCT00729469|593535570|FG001|Overall Study|Other-Not mentioned|4|||
164561558|NCT00087646|594423779|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
164561559|NCT00087646|594423780|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
164316259|NCT01989208|593535574|FG000|200 mg (7 Days)|Protocol Violation|0|||
164316260|NCT01989208|593535575|FG001|200 mg (7 Days)|Protocol Violation|1|||
164316261|NCT00566696|593535576|FG000|Overall Study|Met Exclusion Criteria|2|||
164316262|NCT00566696|593535576|FG000|Overall Study|Muromonab not available|1|||
164316263|NCT00566696|593535576|FG000|Overall Study|Health Status Change|1|||
164316264|NCT00566696|593535576|FG000|Overall Study|Physician Decision|1|||
164316265|NCT00566696|593535576|FG000|Overall Study|Non-Patient Donors|37|||
164316266|NCT00706342|593535577|FG000|Overall Study|Adverse Event|3|||
164561560|NCT00087646|594423781|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
164561561|NCT00087646|594423778|FG000|Overall Study|Failure to Return|5|||
164561562|NCT00087646|594423779|FG001|Overall Study|Failure to Return|2|||
164561563|NCT00087646|594423780|FG002|Overall Study|Failure to Return|2|||
164561564|NCT00087646|594423781|FG003|Overall Study|Failure to Return|3|||
164561565|NCT00087646|594423778|FG000|Overall Study|Administrative/Other|6|||
164561566|NCT00087646|594423779|FG001|Overall Study|Administrative/Other|1|||
164561567|NCT00087646|594423780|FG002|Overall Study|Administrative/Other|1|||
164561568|NCT00087646|594423781|FG003|Overall Study|Administrative/Other|2|||
164561569|NCT00087646|594423778|FG000|Overall Study|Other Protocol Violation|3|||
164561570|NCT00087646|594423779|FG001|Overall Study|Other Protocol Violation|1|||
164561571|NCT00087646|594423780|FG002|Overall Study|Other Protocol Violation|0|||
164561572|NCT00087646|594423781|FG003|Overall Study|Other Protocol Violation|0|||
164561573|NCT00087646|594423778|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
164561574|NCT00087646|594423779|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
164561575|NCT00087646|594423780|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
164561576|NCT00087646|594423781|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
164561577|NCT03694925|594423784|FG000|Overall Study|Inadequate laboratory testing|0|||
164561578|NCT03694925|594423785|FG001|Overall Study|Inadequate laboratory testing|3|||
164561579|NCT03694925|594423786|FG002|Overall Study|Inadequate laboratory testing|0|||
164561580|NCT01422239|594423787|FG000|Overall Study|Lost to Follow-up|4|||
164561581|NCT01422239|594423788|FG001|Overall Study|Lost to Follow-up|3|||
164561582|NCT03033875|594423793|FG000|Overall Study|Withdrawal by Subject|5|||
164561583|NCT03033875|594423794|FG001|Overall Study|Withdrawal by Subject|9|||
164561584|NCT03033875|594423795|FG002|Overall Study|Withdrawal by Subject|4|||
164561585|NCT03033875|594423793|FG000|Overall Study|Other|14|||
164561586|NCT03033875|594423794|FG001|Overall Study|Other|15|||
164561587|NCT03033875|594423795|FG002|Overall Study|Other|8|||
164561588|NCT00911989|594423799|FG000|Overall Study|Adverse Event|1|||
164561589|NCT03434977|594423800|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
164561590|NCT03434977|594423801|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
164561591|NCT01145066|594423802|FG000|Overall Study|To resume NSAIDs|2|||
164561592|NCT01145066|594423803|FG001|Overall Study|To resume NSAIDs|2|||
164561593|NCT01145066|594423804|FG002|Overall Study|To resume NSAIDs|1|||
164561594|NCT01145066|594423802|FG000|Overall Study|Non-related surgery|0|||
164561595|NCT01145066|594423803|FG001|Overall Study|Non-related surgery|0|||
164561596|NCT01145066|594423804|FG002|Overall Study|Non-related surgery|1|||
164561597|NCT01145066|594423802|FG000|Overall Study|Withdrawal by Subject|0|||
164561598|NCT01145066|594423803|FG001|Overall Study|Withdrawal by Subject|0|||
164561599|NCT01145066|594423804|FG002|Overall Study|Withdrawal by Subject|2|||
164561600|NCT01145066|594423802|FG000|Overall Study|To start new med|1|||
164561601|NCT01145066|594423803|FG001|Overall Study|To start new med|0|||
164561602|NCT01145066|594423804|FG002|Overall Study|To start new med|0|||
164561603|NCT01145066|594423802|FG000|Overall Study|problems swallowing capsule|1|||
164561604|NCT01145066|594423803|FG001|Overall Study|problems swallowing capsule|0|||
164561605|NCT01145066|594423804|FG002|Overall Study|problems swallowing capsule|0|||
164561606|NCT01145066|594423802|FG000|Overall Study|Abdominal discomfort|0|||
164561607|NCT01145066|594423803|FG001|Overall Study|Abdominal discomfort|1|||
164561608|NCT01145066|594423804|FG002|Overall Study|Abdominal discomfort|0|||
164561609|NCT01145066|594423802|FG000|Overall Study|Low platelet count|0|||
164561610|NCT01145066|594423803|FG001|Overall Study|Low platelet count|1|||
164561611|NCT01145066|594423804|FG002|Overall Study|Low platelet count|0|||
164561612|NCT05280756|594425537|FG000|Overall Study|Lost to Follow-up|1|||
164561613|NCT05280756|594425538|FG001|Overall Study|Lost to Follow-up|1|||
164561614|NCT02527707|594425539|FG000|Overall Study|Adverse Event|1|||
164316267|NCT00706342|593535577|FG000|Overall Study|Not responding to treatment|2|||
164316268|NCT00706342|593535577|FG000|Overall Study|Withdrawn due to failure to respond|1|||
164316269|NCT00706342|593535577|FG000|Overall Study|Death|1|||
164561615|NCT02527707|594425539|FG000|Overall Study|Adverse Event|1|||
164561616|NCT01916980|594425540|FG000|Overall Study|Adverse Event|4|||
164561617|NCT01916980|594425541|FG001|Overall Study|Adverse Event|2|||
164561618|NCT01916980|594425540|FG000|Overall Study|Lack of Efficacy|2|||
164561619|NCT01916980|594425541|FG001|Overall Study|Lack of Efficacy|2|||
164561620|NCT01916980|594425540|FG000|Overall Study|Withdrawal by Subject|1|||
164561621|NCT01916980|594425541|FG001|Overall Study|Withdrawal by Subject|0|||
164561622|NCT02090855|594425542|FG000|Overall Study|no evaluable Standard of Truth results|2|||
164561623|NCT00619502|594425544|FG000|Overall Study|Lost to Follow-up|8|||
164561624|NCT00619502|594425545|FG001|Overall Study|Lost to Follow-up|10|||
164561625|NCT03968419|594425546|FG000|Treatment Period|Adverse Event|0|||
164561626|NCT03968419|594425547|FG001|Treatment Period|Adverse Event|0|||
164561627|NCT03968419|594425548|FG002|Treatment Period|Adverse Event|1|||
164561628|NCT03968419|594425546|FG000|Safety Follow-up Period|Death|3|||
164561629|NCT03968419|594425547|FG001|Safety Follow-up Period|Death|2|||
164561630|NCT03968419|594425548|FG002|Safety Follow-up Period|Death|1|||
164561631|NCT03968419|594425546|FG000|Safety Follow-up Period|Subject Decision|2|||
164561632|NCT03968419|594425547|FG001|Safety Follow-up Period|Subject Decision|1|||
164561633|NCT03968419|594425548|FG002|Safety Follow-up Period|Subject Decision|0|||
164561634|NCT02968810|594425551|FG000|Overall Study|Lost to Follow-up|1|||
164561635|NCT02968810|594425552|FG001|Overall Study|Lost to Follow-up|0|||
164561636|NCT02968810|594425551|FG000|Overall Study|Physician Decision|1|||
164561637|NCT02968810|594425552|FG001|Overall Study|Physician Decision|0|||
164561638|NCT02968810|594425551|FG000|Overall Study|Withdrawal by Subject|1|||
164561639|NCT02968810|594425552|FG001|Overall Study|Withdrawal by Subject|3|||
164561640|NCT02968810|594425551|FG000|Overall Study|Disease Progression|0|||
164561641|NCT02968810|594425552|FG001|Overall Study|Disease Progression|1|||
164561642|NCT02971202|594425558|FG000|Overall Study|Pregnancy|1|||
164561643|NCT02971202|594425559|FG001|Overall Study|Pregnancy|0|||
164561644|NCT02971202|594425560|FG002|Overall Study|Pregnancy|0|||
164561645|NCT02971202|594425558|FG000|Overall Study|screen fail after consent|1|||
164561646|NCT02971202|594425559|FG001|Overall Study|screen fail after consent|0|||
164561647|NCT02971202|594425560|FG002|Overall Study|screen fail after consent|1|||
164561648|NCT02908880|594425566|FG000|Overall Study|Lost to Follow-up|4|||
164561649|NCT02908880|594425566|FG000|Overall Study|Explantation of the device|1|||
164561650|NCT02908880|594425566|FG000|Overall Study|Withdrawal by Subject|17|||
164561651|NCT02908880|594425566|FG000|Overall Study|Death|5|||
164561652|NCT05425563|594425571|FG000|Overall Study|Withdrawal by Subject|17|||
164561653|NCT01001702|594425572|FG000|Overall Study|Lost to Follow-up|7|||
164561654|NCT01001702|594425572|FG000|Overall Study|Adverse Event|7|||
164561655|NCT01001702|594425572|FG000|Overall Study|Sponsor Discontinued Study|4|||
164561656|NCT01001702|594425572|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
164561657|NCT01001702|594425572|FG000|Overall Study|Investigator withdrew Subject|10|||
164561658|NCT01001702|594425572|FG000|Overall Study|Withdrawal by Subject|19|||
164561659|NCT01001702|594425572|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
164561660|NCT02494596|594425575|FG000|Overall Study|Insufficient Therapeutic Response|3|||
164561661|NCT02494596|594425576|FG001|Overall Study|Insufficient Therapeutic Response|3|||
164561662|NCT02494596|594425577|FG002|Overall Study|Insufficient Therapeutic Response|1|||
164561663|NCT02494596|594425575|FG000|Overall Study|Adverse Event|0|||
164561664|NCT02494596|594425576|FG001|Overall Study|Adverse Event|1|||
164561665|NCT02494596|594425577|FG002|Overall Study|Adverse Event|0|||
164561666|NCT02494596|594425575|FG000|Overall Study|Refused Treatment|0|||
164561667|NCT02494596|594425576|FG001|Overall Study|Refused Treatment|1|||
164561668|NCT02494596|594425577|FG002|Overall Study|Refused Treatment|0|||
164561669|NCT02222714|594425578|FG000|Overall Study|Death|0|||
164204841|NCT00042289|593121150|FG041|Overall Study|Lost to Follow-up|2|||
164204842|NCT00042289|593121151|FG042|Overall Study|Lost to Follow-up|2|||
164204843|NCT00042289|593121152|FG043|Overall Study|Lost to Follow-up|0|||
164204844|NCT00042289|593121153|FG044|Overall Study|Lost to Follow-up|0|||
164204845|NCT00042289|593121154|FG045|Overall Study|Lost to Follow-up|1|||
164204846|NCT00042289|593121155|FG046|Overall Study|Lost to Follow-up|0|||
164204847|NCT00042289|593121109|FG000|Overall Study|Other reason|0|||
164204848|NCT00042289|593121110|FG001|Overall Study|Other reason|0|||
164204849|NCT00042289|593121111|FG002|Overall Study|Other reason|0|||
164204850|NCT00042289|593121112|FG003|Overall Study|Other reason|2|||
164204851|NCT00042289|593121113|FG004|Overall Study|Other reason|0|||
164204852|NCT00042289|593121114|FG005|Overall Study|Other reason|0|||
164204853|NCT00042289|593121115|FG006|Overall Study|Other reason|0|||
164204854|NCT00042289|593121116|FG007|Overall Study|Other reason|0|||
164204855|NCT00042289|593121117|FG008|Overall Study|Other reason|0|||
164204856|NCT00042289|593121118|FG009|Overall Study|Other reason|0|||
164204857|NCT00042289|593121119|FG010|Overall Study|Other reason|0|||
164204858|NCT00042289|593121120|FG011|Overall Study|Other reason|0|||
164204859|NCT00042289|593121121|FG012|Overall Study|Other reason|0|||
164204860|NCT00042289|593121122|FG013|Overall Study|Other reason|0|||
164204861|NCT00042289|593121123|FG014|Overall Study|Other reason|0|||
164204862|NCT00042289|593121124|FG015|Overall Study|Other reason|0|||
164561670|NCT02222714|594425579|FG001|Overall Study|Death|2|||
164561671|NCT02222714|594425580|FG002|Overall Study|Death|3|||
164561672|NCT02222714|594425581|FG003|Overall Study|Death|4|||
164561673|NCT02222714|594425582|FG004|Overall Study|Death|6|||
164561674|NCT02222714|594425578|FG000|Overall Study|Withdrawal by Subject|0|||
164561675|NCT02222714|594425579|FG001|Overall Study|Withdrawal by Subject|0|||
164204863|NCT00042289|593121125|FG016|Overall Study|Other reason|0|||
164204864|NCT00042289|593121126|FG017|Overall Study|Other reason|0|||
164204865|NCT00042289|593121127|FG018|Overall Study|Other reason|1|||
164204866|NCT00042289|593121128|FG019|Overall Study|Other reason|0|||
164204867|NCT00042289|593121129|FG020|Overall Study|Other reason|0|||
164665955|NCT05014412|594801551|FG000|Overall Study|Death|11|||
164204868|NCT00042289|593121130|FG021|Overall Study|Other reason|0|||
164204869|NCT00042289|593121131|FG022|Overall Study|Other reason|0|||
164316270|NCT00706342|593535577|FG000|Overall Study|Withdrew from the study on his own.|1|||
164316271|NCT00706342|593535577|FG000|Overall Study|Investigator discretion|2|||
164316272|NCT00706342|593535577|FG000|Overall Study|Non-responder Week 12|1|||
164316273|NCT00706342|593535577|FG000|Overall Study|Ongoing|6|||
164316274|NCT00706342|593535577|FG000|Overall Study|WIthdrawal of consent|1|||
164316275|NCT00119678|593535578|FG000|Double-blind Treatment Period|Death|1|||
164316276|NCT00119678|593535579|FG001|Double-blind Treatment Period|Death|0|||
164316277|NCT00119678|593535578|FG000|Double-blind Treatment Period|Adverse Event|7|||
164316278|NCT00119678|593535579|FG001|Double-blind Treatment Period|Adverse Event|1|||
164316279|NCT00119678|593535578|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
164316280|NCT00119678|593535579|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
164316281|NCT00119678|593535578|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
164316282|NCT00119678|593535579|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
164316283|NCT00119678|593535578|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
164316284|NCT00119678|593535579|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
164316285|NCT00119678|593535578|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
164316286|NCT00119678|593535579|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
164316287|NCT00119678|593535578|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
164316288|NCT00119678|593535579|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
164316289|NCT00119678|593535578|FG000|Double-blind Treatment Period|Pregnancy|0|||
164316290|NCT00119678|593535579|FG001|Double-blind Treatment Period|Pregnancy|2|||
164316291|NCT00119678|593535578|FG000|Double-blind Treatment Period|Not treated|1|||
164316292|NCT00119678|593535579|FG001|Double-blind Treatment Period|Not treated|2|||
164316293|NCT00119678|593535578|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
164316294|NCT00119678|593535579|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
164316295|NCT00119678|593535578|FG000|Open-label Treatment Period|Death|1|||
164316296|NCT00119678|593535579|FG001|Open-label Treatment Period|Death|0|||
164316297|NCT00119678|593535578|FG000|Open-label Treatment Period|Adverse Event|3|||
164316298|NCT00119678|593535579|FG001|Open-label Treatment Period|Adverse Event|0|||
164316299|NCT00119678|593535578|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
164316300|NCT00119678|593535579|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
164316301|NCT00119678|593535578|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
164316302|NCT00119678|593535579|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
164316303|NCT00119678|593535578|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
164316304|NCT00119678|593535579|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
164316305|NCT00119678|593535578|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
164316306|NCT00119678|593535579|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
164561676|NCT02222714|594425580|FG002|Overall Study|Withdrawal by Subject|1|||
164561677|NCT02222714|594425581|FG003|Overall Study|Withdrawal by Subject|0|||
164561678|NCT02222714|594425582|FG004|Overall Study|Withdrawal by Subject|1|||
164561679|NCT00159432|594425583|FG000|Overall Study|Adverse Event|1|||
164561680|NCT00159432|594425583|FG000|Overall Study|Death|1|||
164561681|NCT00159432|594425583|FG000|Overall Study|Lack of Efficacy|8|||
164561682|NCT04537208|594425584|FG000|Overall Study|Adverse Event|0|||
164561683|NCT04537208|594425585|FG001|Overall Study|Adverse Event|0|||
164561684|NCT04537208|594425586|FG002|Overall Study|Adverse Event|0|||
164561685|NCT04537208|594425587|FG003|Overall Study|Adverse Event|0|||
164561686|NCT04537208|594425588|FG004|Overall Study|Adverse Event|0|||
164561687|NCT04537208|594425589|FG005|Overall Study|Adverse Event|0|||
164561688|NCT04537208|594425590|FG006|Overall Study|Adverse Event|0|||
164561689|NCT04537208|594425591|FG007|Overall Study|Adverse Event|0|||
164561690|NCT04537208|594425592|FG008|Overall Study|Adverse Event|1|||
164561691|NCT04537208|594425593|FG009|Overall Study|Adverse Event|0|||
164561692|NCT04537208|594425594|FG010|Overall Study|Adverse Event|0|||
164204870|NCT00042289|593121132|FG023|Overall Study|Other reason|1|||
164204871|NCT00042289|593121133|FG024|Overall Study|Other reason|0|||
164204872|NCT00042289|593121134|FG025|Overall Study|Other reason|0|||
164204873|NCT00042289|593121135|FG026|Overall Study|Other reason|1|||
164204874|NCT00042289|593121136|FG027|Overall Study|Other reason|0|||
164204875|NCT00042289|593121137|FG028|Overall Study|Other reason|3|||
164204876|NCT00042289|593121138|FG029|Overall Study|Other reason|0|||
164204877|NCT00042289|593121139|FG030|Overall Study|Other reason|0|||
164204878|NCT00042289|593121140|FG031|Overall Study|Other reason|1|||
164204879|NCT00042289|593121141|FG032|Overall Study|Other reason|0|||
164204880|NCT00042289|593121142|FG033|Overall Study|Other reason|1|||
164204881|NCT00042289|593121143|FG034|Overall Study|Other reason|0|||
164204882|NCT00042289|593121144|FG035|Overall Study|Other reason|2|||
164204883|NCT00042289|593121145|FG036|Overall Study|Other reason|0|||
164204884|NCT00042289|593121146|FG037|Overall Study|Other reason|0|||
164561693|NCT04537208|594425584|FG000|Overall Study|Protocol deviation|0|||
164561694|NCT04537208|594425585|FG001|Overall Study|Protocol deviation|0|||
164561695|NCT04537208|594425586|FG002|Overall Study|Protocol deviation|2|||
164561696|NCT04537208|594425587|FG003|Overall Study|Protocol deviation|0|||
164561697|NCT04537208|594425588|FG004|Overall Study|Protocol deviation|0|||
164204885|NCT00042289|593121147|FG038|Overall Study|Other reason|0|||
164316307|NCT00119678|593535578|FG000|Open-label Treatment Period|Pregnancy|1|||
164316308|NCT00119678|593535579|FG001|Open-label Treatment Period|Pregnancy|0|||
164316309|NCT00119678|593535578|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
164316310|NCT00119678|593535579|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
164316311|NCT03567343|593535580|FG000|Overall Study|Lost to Follow-up|2|||
164316312|NCT03567343|593535581|FG001|Overall Study|Lost to Follow-up|1|||
164316313|NCT03567343|593535580|FG000|Overall Study|No longer eligible|2|||
164204886|NCT00042289|593121148|FG039|Overall Study|Other reason|0|||
164204887|NCT00042289|593121149|FG040|Overall Study|Other reason|0|||
164204888|NCT00042289|593121150|FG041|Overall Study|Other reason|0|||
164204889|NCT00042289|593121151|FG042|Overall Study|Other reason|0|||
164204890|NCT00042289|593121152|FG043|Overall Study|Other reason|1|||
164204891|NCT00042289|593121153|FG044|Overall Study|Other reason|0|||
164204892|NCT00042289|593121154|FG045|Overall Study|Other reason|0|||
164204893|NCT00042289|593121155|FG046|Overall Study|Other reason|0|||
164204894|NCT00042289|593121109|FG000|Overall Study|Severe debilitation, unable to continue|0|||
164316314|NCT03567343|593535581|FG001|Overall Study|No longer eligible|1|||
164316315|NCT03567343|593535580|FG000|Overall Study|Adverse Event|1|||
164316316|NCT03567343|593535581|FG001|Overall Study|Adverse Event|0|||
164316317|NCT03567343|593535580|FG000|Overall Study|Protocol Violation|1|||
164316318|NCT03567343|593535581|FG001|Overall Study|Protocol Violation|1|||
164316319|NCT01134705|593535582|FG000|Overall Study|Adverse Event|1|||
164316320|NCT01134705|593535583|FG001|Overall Study|Adverse Event|7|||
164316321|NCT01134705|593535582|FG000|Overall Study|Withdrawal by Subject|6|||
164316322|NCT01134705|593535583|FG001|Overall Study|Withdrawal by Subject|6|||
164316323|NCT01134705|593535582|FG000|Overall Study|Pregnancy|1|||
164316324|NCT01134705|593535583|FG001|Overall Study|Pregnancy|0|||
164316325|NCT01134705|593535582|FG000|Overall Study|Lost to Follow-up|5|||
164316326|NCT01134705|593535583|FG001|Overall Study|Lost to Follow-up|2|||
164316327|NCT01134705|593535582|FG000|Overall Study|Protocol Violation|1|||
164316328|NCT01134705|593535583|FG001|Overall Study|Protocol Violation|1|||
164316329|NCT01134705|593535582|FG000|Overall Study|Other|1|||
164316330|NCT01134705|593535583|FG001|Overall Study|Other|6|||
164316331|NCT00246740|593535584|FG000|Initial Enrollment|Death|1|||
164316332|NCT00246740|593535585|FG001|Initial Enrollment|Death|0|||
164316333|NCT00246740|593535584|FG000|Initial Enrollment|Additional surgery scheduled|0|||
164316334|NCT00246740|593535585|FG001|Initial Enrollment|Additional surgery scheduled|2|||
164316335|NCT00246740|593535584|FG000|Initial Enrollment|Surgery schedule change|4|||
164316336|NCT00246740|593535585|FG001|Initial Enrollment|Surgery schedule change|4|||
164316337|NCT00246740|593535584|FG000|Initial Enrollment|Other|1|||
164316338|NCT00246740|593535585|FG001|Initial Enrollment|Other|2|||
164316339|NCT00101452|593535586|FG000|Overall Study|Adverse Event|2|||
164316340|NCT00101452|593535587|FG001|Overall Study|Adverse Event|0|||
164316341|NCT00101452|593535588|FG002|Overall Study|Adverse Event|1|||
164316342|NCT00101452|593535586|FG000|Overall Study|Lost to Follow-up|13|||
164316343|NCT00101452|593535587|FG001|Overall Study|Lost to Follow-up|8|||
164316344|NCT00101452|593535588|FG002|Overall Study|Lost to Follow-up|14|||
164316345|NCT00101452|593535586|FG000|Overall Study|Withdrawal by Subject|10|||
164316346|NCT00101452|593535587|FG001|Overall Study|Withdrawal by Subject|14|||
164316347|NCT00101452|593535588|FG002|Overall Study|Withdrawal by Subject|9|||
164316348|NCT00101452|593535586|FG000|Overall Study|Baseline Fail|2|||
164316349|NCT00101452|593535587|FG001|Overall Study|Baseline Fail|1|||
164316350|NCT00101452|593535588|FG002|Overall Study|Baseline Fail|2|||
164316351|NCT00101452|593535586|FG000|Overall Study|Physician Decision|0|||
164316352|NCT00101452|593535587|FG001|Overall Study|Physician Decision|3|||
164316353|NCT00101452|593535588|FG002|Overall Study|Physician Decision|2|||
164316354|NCT00101452|593535586|FG000|Overall Study|Protocol Violation|2|||
164316355|NCT00101452|593535587|FG001|Overall Study|Protocol Violation|1|||
164316356|NCT00101452|593535588|FG002|Overall Study|Protocol Violation|3|||
164316357|NCT00101452|593535586|FG000|Overall Study|Other|15|||
164316358|NCT00101452|593535587|FG001|Overall Study|Other|16|||
164316359|NCT00101452|593535588|FG002|Overall Study|Other|12|||
164316360|NCT01510769|593535589|FG000|Overall Study|Adverse Event|7|||
164316361|NCT01510769|593535590|FG001|Overall Study|Adverse Event|6|||
164316362|NCT01510769|593535591|FG002|Overall Study|Adverse Event|4|||
164316363|NCT01510769|593535589|FG000|Overall Study|Gout Flare|0|||
164316364|NCT01510769|593535590|FG001|Overall Study|Gout Flare|3|||
164316365|NCT01510769|593535591|FG002|Overall Study|Gout Flare|1|||
164316366|NCT01510769|593535589|FG000|Overall Study|Protocol Violation|11|||
164316367|NCT01510769|593535590|FG001|Overall Study|Protocol Violation|10|||
164316368|NCT01510769|593535591|FG002|Overall Study|Protocol Violation|9|||
164316369|NCT01510769|593535589|FG000|Overall Study|Lost to Follow-up|5|||
164316370|NCT01510769|593535590|FG001|Overall Study|Lost to Follow-up|1|||
164204895|NCT00042289|593121110|FG001|Overall Study|Severe debilitation, unable to continue|0|||
164204896|NCT00042289|593121111|FG002|Overall Study|Severe debilitation, unable to continue|0|||
164316371|NCT01510769|593535591|FG002|Overall Study|Lost to Follow-up|5|||
164316372|NCT01510769|593535589|FG000|Overall Study|Withdrawal by Subject|3|||
164316373|NCT01510769|593535590|FG001|Overall Study|Withdrawal by Subject|4|||
164316374|NCT01510769|593535591|FG002|Overall Study|Withdrawal by Subject|3|||
164316375|NCT01510769|593535589|FG000|Overall Study|Death|1|||
164561698|NCT04537208|594425589|FG005|Overall Study|Protocol deviation|2|||
164561699|NCT04537208|594425590|FG006|Overall Study|Protocol deviation|4|||
164561700|NCT04537208|594425591|FG007|Overall Study|Protocol deviation|0|||
164561701|NCT04537208|594425592|FG008|Overall Study|Protocol deviation|1|||
164561702|NCT04537208|594425593|FG009|Overall Study|Protocol deviation|0|||
164561703|NCT04537208|594425594|FG010|Overall Study|Protocol deviation|2|||
164561704|NCT04537208|594425584|FG000|Overall Study|Withdrawal by Subject|4|||
164561705|NCT04537208|594425585|FG001|Overall Study|Withdrawal by Subject|2|||
164561706|NCT04537208|594425586|FG002|Overall Study|Withdrawal by Subject|1|||
164561707|NCT04537208|594425587|FG003|Overall Study|Withdrawal by Subject|3|||
164665956|NCT05014412|594801552|FG001|Overall Study|Death|7|||
164665957|NCT05014412|594801553|FG002|Overall Study|Death|4|||
164665958|NCT05014412|594801554|FG003|Overall Study|Death|7|||
164665959|NCT05014412|594801551|FG000|Overall Study|Withdrawal by Subject|1|||
164204897|NCT00042289|593121112|FG003|Overall Study|Severe debilitation, unable to continue|0|||
164204898|NCT00042289|593121113|FG004|Overall Study|Severe debilitation, unable to continue|0|||
164204899|NCT00042289|593121114|FG005|Overall Study|Severe debilitation, unable to continue|0|||
164561708|NCT04537208|594425588|FG004|Overall Study|Withdrawal by Subject|5|||
164561709|NCT04537208|594425589|FG005|Overall Study|Withdrawal by Subject|1|||
164561710|NCT04537208|594425590|FG006|Overall Study|Withdrawal by Subject|6|||
164561711|NCT04537208|594425591|FG007|Overall Study|Withdrawal by Subject|1|||
164561712|NCT04537208|594425592|FG008|Overall Study|Withdrawal by Subject|7|||
164561713|NCT04537208|594425593|FG009|Overall Study|Withdrawal by Subject|2|||
164561714|NCT04537208|594425594|FG010|Overall Study|Withdrawal by Subject|4|||
164561715|NCT04537208|594425584|FG000|Overall Study|Lost to Follow-up|4|||
164561716|NCT04537208|594425585|FG001|Overall Study|Lost to Follow-up|1|||
164561717|NCT04537208|594425586|FG002|Overall Study|Lost to Follow-up|3|||
164561718|NCT04537208|594425587|FG003|Overall Study|Lost to Follow-up|4|||
164561719|NCT04537208|594425588|FG004|Overall Study|Lost to Follow-up|3|||
164561720|NCT04537208|594425589|FG005|Overall Study|Lost to Follow-up|2|||
164561721|NCT04537208|594425590|FG006|Overall Study|Lost to Follow-up|3|||
164561722|NCT04537208|594425591|FG007|Overall Study|Lost to Follow-up|2|||
164561723|NCT04537208|594425592|FG008|Overall Study|Lost to Follow-up|7|||
164561724|NCT04537208|594425593|FG009|Overall Study|Lost to Follow-up|2|||
164561725|NCT04537208|594425594|FG010|Overall Study|Lost to Follow-up|2|||
164561726|NCT03178487|594425595|FG000|Period 1|Adverse Event|1|||
164561727|NCT03178487|594425596|FG001|Period 1|Adverse Event|2|||
164561728|NCT03178487|594425595|FG000|Period 1|Withdrawal by Subject|2|||
164561729|NCT03178487|594425596|FG001|Period 1|Withdrawal by Subject|1|||
164561730|NCT03178487|594425595|FG000|Period 1|Lost to Follow-up|1|||
164561731|NCT03178487|594425596|FG001|Period 1|Lost to Follow-up|0|||
164561732|NCT03178487|594425595|FG000|Period 1|Other|0|||
164561733|NCT03178487|594425596|FG001|Period 1|Other|1|||
164561734|NCT03178487|594425595|FG000|Period 2|Adverse Event|4|||
164561735|NCT03178487|594425596|FG001|Period 2|Adverse Event|4|||
164204900|NCT00042289|593121115|FG006|Overall Study|Severe debilitation, unable to continue|0|||
164204901|NCT00042289|593121116|FG007|Overall Study|Severe debilitation, unable to continue|0|||
164204902|NCT00042289|593121117|FG008|Overall Study|Severe debilitation, unable to continue|0|||
164204903|NCT00042289|593121118|FG009|Overall Study|Severe debilitation, unable to continue|0|||
164204904|NCT00042289|593121119|FG010|Overall Study|Severe debilitation, unable to continue|0|||
164204905|NCT00042289|593121120|FG011|Overall Study|Severe debilitation, unable to continue|0|||
164204906|NCT00042289|593121121|FG012|Overall Study|Severe debilitation, unable to continue|0|||
164204907|NCT00042289|593121122|FG013|Overall Study|Severe debilitation, unable to continue|0|||
164204908|NCT00042289|593121123|FG014|Overall Study|Severe debilitation, unable to continue|0|||
164204909|NCT00042289|593121124|FG015|Overall Study|Severe debilitation, unable to continue|0|||
164204910|NCT00042289|593121125|FG016|Overall Study|Severe debilitation, unable to continue|0|||
164204911|NCT00042289|593121126|FG017|Overall Study|Severe debilitation, unable to continue|0|||
164204912|NCT00042289|593121127|FG018|Overall Study|Severe debilitation, unable to continue|0|||
164204913|NCT00042289|593121128|FG019|Overall Study|Severe debilitation, unable to continue|0|||
164561736|NCT03178487|594425595|FG000|Period 2|Withdrawal by Subject|6|||
164561737|NCT03178487|594425596|FG001|Period 2|Withdrawal by Subject|6|||
164561738|NCT03178487|594425595|FG000|Period 2|Lost to Follow-up|2|||
164561739|NCT03178487|594425596|FG001|Period 2|Lost to Follow-up|2|||
164561740|NCT03178487|594425595|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
164561741|NCT03178487|594425596|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
164561742|NCT03178487|594425595|FG000|Period 2|Other|8|||
164561743|NCT03178487|594425596|FG001|Period 2|Other|7|||
164561744|NCT01537211|594425601|FG000|Overall Study|Lost to Follow-up|0|||
164665960|NCT05014412|594801552|FG001|Overall Study|Withdrawal by Subject|1|||
164561745|NCT01537211|594425602|FG001|Overall Study|Lost to Follow-up|1|||
164561746|NCT00704964|594425603|FG000|Overall Study|Not completed on time|328|||
164561747|NCT00430508|594425611|FG000|Overall Study|Adverse Event|2|||
164204914|NCT00042289|593121129|FG020|Overall Study|Severe debilitation, unable to continue|0|||
164561748|NCT00430508|594425612|FG001|Overall Study|Adverse Event|3|||
164561749|NCT00430508|594425613|FG002|Overall Study|Adverse Event|5|||
164561750|NCT00430508|594425614|FG003|Overall Study|Adverse Event|3|||
164316376|NCT01510769|593535590|FG001|Overall Study|Death|1|||
164316377|NCT01510769|593535591|FG002|Overall Study|Death|0|||
164316378|NCT02674204|593535592|FG000|Overall Study|Adverse Event|1|||
164316379|NCT02674204|593535593|FG001|Overall Study|Adverse Event|0|||
164316380|NCT02466659|593535596|FG000|Overall Study|Lost to Follow-up|5|||
164316381|NCT02466659|593535597|FG001|Overall Study|Lost to Follow-up|2|||
164316382|NCT01536392|593535598|FG000|Overall Study|Adverse Event|2|||
164316383|NCT01536392|593535599|FG001|Overall Study|Adverse Event|2|||
164316384|NCT01536392|593535598|FG000|Overall Study|Physician Decision|2|||
164316385|NCT01536392|593535599|FG001|Overall Study|Physician Decision|3|||
164316386|NCT01536392|593535598|FG000|Overall Study|Withdrawal by Subject|3|||
164316387|NCT01536392|593535599|FG001|Overall Study|Withdrawal by Subject|6|||
164316388|NCT01536392|593535598|FG000|Overall Study|Non Compliance|3|||
164316389|NCT01536392|593535599|FG001|Overall Study|Non Compliance|4|||
164561751|NCT00430508|594425611|FG000|Overall Study|Withdrawal by Subject|0|||
164561752|NCT00430508|594425612|FG001|Overall Study|Withdrawal by Subject|1|||
164316390|NCT01536392|593535598|FG000|Overall Study|Completed therapy early|3|||
164316391|NCT01536392|593535599|FG001|Overall Study|Completed therapy early|0|||
164316392|NCT02874144|593535600|FG000|Overall Study|Lost to Follow-up|3|||
164316393|NCT02874144|593535601|FG001|Overall Study|Lost to Follow-up|5|||
164316394|NCT00486811|593535603|FG000|Overall Study|Adverse Event|28|||
164316395|NCT00486811|593535604|FG001|Overall Study|Adverse Event|60|||
164316396|NCT00486811|593535605|FG002|Overall Study|Adverse Event|135|||
164316397|NCT00486811|593535603|FG000|Overall Study|Lack of Efficacy|34|||
164316398|NCT00486811|593535604|FG001|Overall Study|Lack of Efficacy|14|||
164316399|NCT00486811|593535605|FG002|Overall Study|Lack of Efficacy|7|||
164316400|NCT00486811|593535603|FG000|Overall Study|Lost to Follow-up|4|||
164316401|NCT00486811|593535604|FG001|Overall Study|Lost to Follow-up|6|||
164316402|NCT00486811|593535605|FG002|Overall Study|Lost to Follow-up|4|||
164316403|NCT00486811|593535603|FG000|Overall Study|Withdrawal by Subject|33|||
164316404|NCT00486811|593535604|FG001|Overall Study|Withdrawal by Subject|44|||
164316405|NCT00486811|593535605|FG002|Overall Study|Withdrawal by Subject|58|||
164316406|NCT00486811|593535603|FG000|Overall Study|Study drug non-compliant|5|||
164316407|NCT00486811|593535604|FG001|Overall Study|Study drug non-compliant|6|||
164316408|NCT00486811|593535605|FG002|Overall Study|Study drug non-compliant|3|||
164316409|NCT00486811|593535603|FG000|Overall Study|All other|18|||
164316410|NCT00486811|593535604|FG001|Overall Study|All other|11|||
164316411|NCT00486811|593535605|FG002|Overall Study|All other|7|||
164316412|NCT00852371|593535611|FG000|Overall Study|Lost to Follow-up|2|||
164316413|NCT00852371|593535612|FG001|Overall Study|Lost to Follow-up|3|||
164316414|NCT00852371|593535613|FG002|Overall Study|Lost to Follow-up|4|||
164316415|NCT00852371|593535614|FG003|Overall Study|Lost to Follow-up|2|||
164316416|NCT01711216|593535615|FG000|Overall Study|Adverse Event|4|||
164316417|NCT01711216|593535615|FG000|Overall Study|Pregnancy|56|||
164316418|NCT01711216|593535615|FG000|Overall Study|Withdrawal by Subject|6|||
164316419|NCT01711216|593535615|FG000|Overall Study|Lost to Follow-up|46|||
164316420|NCT01711216|593535615|FG000|Overall Study|variety of other minor reasons|83|||
164316421|NCT01711216|593535615|FG000|Overall Study|no reason specified|22|||
164316422|NCT02228980|593535616|FG000|Overall Study|Adverse Event|14|||
164316423|NCT02228980|593535617|FG001|Overall Study|Adverse Event|0|||
164316424|NCT02228980|593535618|FG002|Overall Study|Adverse Event|0|||
164561753|NCT00430508|594425613|FG002|Overall Study|Withdrawal by Subject|1|||
164316425|NCT02228980|593535619|FG003|Overall Study|Adverse Event|0|||
164316426|NCT02228980|593535616|FG000|Overall Study|Protocol Violation|7|||
164316427|NCT02228980|593535617|FG001|Overall Study|Protocol Violation|0|||
164316428|NCT02228980|593535618|FG002|Overall Study|Protocol Violation|0|||
164316429|NCT02228980|593535619|FG003|Overall Study|Protocol Violation|0|||
164316430|NCT02228980|593535616|FG000|Overall Study|Withdrawal by Subject|3|||
164316431|NCT02228980|593535617|FG001|Overall Study|Withdrawal by Subject|3|||
164316432|NCT02228980|593535618|FG002|Overall Study|Withdrawal by Subject|2|||
164316433|NCT02228980|593535619|FG003|Overall Study|Withdrawal by Subject|3|||
164316434|NCT02744040|593535620|FG000|Overall Study|Withdrawal by Subject|3|||
164316435|NCT02744040|593535621|FG001|Overall Study|Withdrawal by Subject|2|||
164316436|NCT02744040|593535622|FG002|Overall Study|Withdrawal by Subject|2|||
164316437|NCT02744040|593535620|FG000|Overall Study|Physician Decision|0|||
164316438|NCT02744040|593535621|FG001|Overall Study|Physician Decision|8|||
164316439|NCT02744040|593535622|FG002|Overall Study|Physician Decision|13|||
164316440|NCT02744040|593535620|FG000|Overall Study|Lost to Follow-up|3|||
164316441|NCT02744040|593535621|FG001|Overall Study|Lost to Follow-up|1|||
164561754|NCT00430508|594425614|FG003|Overall Study|Withdrawal by Subject|1|||
164316442|NCT02744040|593535622|FG002|Overall Study|Lost to Follow-up|7|||
164316443|NCT00715910|593535623|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
164316444|NCT00715910|593535624|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
164316445|NCT00715910|593535625|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
164316446|NCT00715910|593535626|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
164316447|NCT00715910|593535627|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
164561755|NCT00430508|594425611|FG000|Overall Study|responder at visit 4|0|||
164316448|NCT00715910|593535628|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
164316449|NCT00715910|593535623|FG000|Booster and ESFU Phase|Other|0|||
164204915|NCT00042289|593121130|FG021|Overall Study|Severe debilitation, unable to continue|1|||
164204916|NCT00042289|593121131|FG022|Overall Study|Severe debilitation, unable to continue|0|||
164204917|NCT00042289|593121132|FG023|Overall Study|Severe debilitation, unable to continue|1|||
164204918|NCT00042289|593121133|FG024|Overall Study|Severe debilitation, unable to continue|0|||
164204919|NCT00042289|593121134|FG025|Overall Study|Severe debilitation, unable to continue|0|||
164204920|NCT00042289|593121135|FG026|Overall Study|Severe debilitation, unable to continue|0|||
164204921|NCT00042289|593121136|FG027|Overall Study|Severe debilitation, unable to continue|1|||
164204922|NCT00042289|593121137|FG028|Overall Study|Severe debilitation, unable to continue|0|||
164204923|NCT00042289|593121138|FG029|Overall Study|Severe debilitation, unable to continue|0|||
164204924|NCT00042289|593121139|FG030|Overall Study|Severe debilitation, unable to continue|0|||
164204925|NCT00042289|593121140|FG031|Overall Study|Severe debilitation, unable to continue|1|||
164204926|NCT00042289|593121141|FG032|Overall Study|Severe debilitation, unable to continue|1|||
164204927|NCT00042289|593121142|FG033|Overall Study|Severe debilitation, unable to continue|0|||
164204928|NCT00042289|593121143|FG034|Overall Study|Severe debilitation, unable to continue|0|||
164204929|NCT00042289|593121144|FG035|Overall Study|Severe debilitation, unable to continue|0|||
164204930|NCT00042289|593121145|FG036|Overall Study|Severe debilitation, unable to continue|0|||
164204931|NCT00042289|593121146|FG037|Overall Study|Severe debilitation, unable to continue|0|||
164204932|NCT00042289|593121147|FG038|Overall Study|Severe debilitation, unable to continue|0|||
164204933|NCT00042289|593121148|FG039|Overall Study|Severe debilitation, unable to continue|0|||
164204934|NCT00042289|593121149|FG040|Overall Study|Severe debilitation, unable to continue|0|||
164204935|NCT00042289|593121150|FG041|Overall Study|Severe debilitation, unable to continue|0|||
164204936|NCT00042289|593121151|FG042|Overall Study|Severe debilitation, unable to continue|0|||
164204937|NCT00042289|593121152|FG043|Overall Study|Severe debilitation, unable to continue|0|||
164204938|NCT00042289|593121153|FG044|Overall Study|Severe debilitation, unable to continue|0|||
164204939|NCT00042289|593121154|FG045|Overall Study|Severe debilitation, unable to continue|0|||
164204940|NCT00042289|593121155|FG046|Overall Study|Severe debilitation, unable to continue|0|||
164204941|NCT00042289|593121109|FG000|Overall Study|Site closed|0|||
164204942|NCT00042289|593121110|FG001|Overall Study|Site closed|0|||
164204943|NCT00042289|593121111|FG002|Overall Study|Site closed|0|||
164204944|NCT00042289|593121112|FG003|Overall Study|Site closed|0|||
164204945|NCT00042289|593121113|FG004|Overall Study|Site closed|0|||
164204946|NCT00042289|593121114|FG005|Overall Study|Site closed|0|||
164204947|NCT00042289|593121115|FG006|Overall Study|Site closed|0|||
164204948|NCT00042289|593121116|FG007|Overall Study|Site closed|0|||
164204949|NCT00042289|593121117|FG008|Overall Study|Site closed|0|||
164204950|NCT00042289|593121118|FG009|Overall Study|Site closed|0|||
164204951|NCT00042289|593121119|FG010|Overall Study|Site closed|0|||
164204952|NCT00042289|593121120|FG011|Overall Study|Site closed|0|||
164204953|NCT00042289|593121121|FG012|Overall Study|Site closed|0|||
164204954|NCT00042289|593121122|FG013|Overall Study|Site closed|0|||
164204955|NCT00042289|593121123|FG014|Overall Study|Site closed|0|||
164204956|NCT00042289|593121124|FG015|Overall Study|Site closed|0|||
164204957|NCT00042289|593121125|FG016|Overall Study|Site closed|0|||
164204958|NCT00042289|593121126|FG017|Overall Study|Site closed|0|||
164204959|NCT00042289|593121127|FG018|Overall Study|Site closed|0|||
164204960|NCT00042289|593121128|FG019|Overall Study|Site closed|0|||
164204961|NCT00042289|593121129|FG020|Overall Study|Site closed|0|||
164204962|NCT00042289|593121130|FG021|Overall Study|Site closed|0|||
164204963|NCT00042289|593121131|FG022|Overall Study|Site closed|0|||
164204964|NCT00042289|593121132|FG023|Overall Study|Site closed|0|||
164204965|NCT00042289|593121133|FG024|Overall Study|Site closed|0|||
164204966|NCT00042289|593121134|FG025|Overall Study|Site closed|0|||
164204967|NCT00042289|593121135|FG026|Overall Study|Site closed|0|||
164204968|NCT00042289|593121136|FG027|Overall Study|Site closed|0|||
164204969|NCT00042289|593121137|FG028|Overall Study|Site closed|0|||
164204970|NCT00042289|593121138|FG029|Overall Study|Site closed|0|||
164204971|NCT00042289|593121139|FG030|Overall Study|Site closed|0|||
164204972|NCT00042289|593121140|FG031|Overall Study|Site closed|3|||
164204973|NCT00042289|593121141|FG032|Overall Study|Site closed|0|||
164204974|NCT00042289|593121142|FG033|Overall Study|Site closed|0|||
164204975|NCT00042289|593121143|FG034|Overall Study|Site closed|0|||
164204976|NCT00042289|593121144|FG035|Overall Study|Site closed|0|||
164204977|NCT00042289|593121145|FG036|Overall Study|Site closed|1|||
164204978|NCT00042289|593121146|FG037|Overall Study|Site closed|0|||
164204979|NCT00042289|593121147|FG038|Overall Study|Site closed|0|||
164204980|NCT00042289|593121148|FG039|Overall Study|Site closed|0|||
164204981|NCT00042289|593121149|FG040|Overall Study|Site closed|0|||
164204982|NCT00042289|593121150|FG041|Overall Study|Site closed|0|||
164204983|NCT00042289|593121151|FG042|Overall Study|Site closed|1|||
164204984|NCT00042289|593121152|FG043|Overall Study|Site closed|0|||
164204985|NCT00042289|593121153|FG044|Overall Study|Site closed|0|||
164204986|NCT00042289|593121154|FG045|Overall Study|Site closed|0|||
164204987|NCT00042289|593121155|FG046|Overall Study|Site closed|0|||
164204988|NCT00042289|593121109|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
164204989|NCT00042289|593121110|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
164204990|NCT00042289|593121111|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
164303021|NCT04323124|593484700|FG014|Overall Study|Other|0|||
164204991|NCT00042289|593121112|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
164204992|NCT00042289|593121113|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
164204993|NCT00042289|593121114|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
164204994|NCT00042289|593121115|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
164204995|NCT00042289|593121116|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
164204996|NCT00042289|593121117|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
164204997|NCT00042289|593121118|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
164204998|NCT00042289|593121119|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
164204999|NCT00042289|593121120|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
164205000|NCT00042289|593121121|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
164205001|NCT00042289|593121122|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
164205002|NCT00042289|593121123|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
164205003|NCT00042289|593121124|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
164205004|NCT00042289|593121125|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
164205005|NCT00042289|593121126|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
164205006|NCT00042289|593121127|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
164205007|NCT00042289|593121128|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
164205008|NCT00042289|593121129|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
164205009|NCT00042289|593121130|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
164205010|NCT00042289|593121131|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
164205011|NCT00042289|593121132|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
164205012|NCT00042289|593121133|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
164205013|NCT00042289|593121134|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
164205014|NCT00042289|593121135|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
164205015|NCT00042289|593121136|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
164205016|NCT00042289|593121137|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
164205017|NCT00042289|593121138|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
164205018|NCT00042289|593121139|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
164205019|NCT00042289|593121140|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
164205020|NCT00042289|593121141|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
164205021|NCT00042289|593121142|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
164205022|NCT00042289|593121143|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
164205023|NCT00042289|593121144|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
164205024|NCT00042289|593121145|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
164205025|NCT00042289|593121146|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
164205026|NCT00042289|593121147|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
164205027|NCT00042289|593121148|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
164205028|NCT00042289|593121149|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
164205029|NCT00042289|593121150|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
164205030|NCT00042289|593121151|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
164205031|NCT00042289|593121152|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
164205032|NCT00042289|593121153|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
164205033|NCT00042289|593121154|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
164205034|NCT00042289|593121155|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
164205035|NCT00042289|593121109|FG000|Overall Study|Protocol Violation|0|||
164205036|NCT00042289|593121110|FG001|Overall Study|Protocol Violation|0|||
164205037|NCT00042289|593121111|FG002|Overall Study|Protocol Violation|0|||
164205038|NCT00042289|593121112|FG003|Overall Study|Protocol Violation|0|||
164205039|NCT00042289|593121113|FG004|Overall Study|Protocol Violation|0|||
164205040|NCT00042289|593121114|FG005|Overall Study|Protocol Violation|1|||
164205041|NCT00042289|593121115|FG006|Overall Study|Protocol Violation|0|||
164205042|NCT00042289|593121116|FG007|Overall Study|Protocol Violation|1|||
164205043|NCT00042289|593121117|FG008|Overall Study|Protocol Violation|0|||
164205044|NCT00042289|593121118|FG009|Overall Study|Protocol Violation|0|||
164205045|NCT00042289|593121119|FG010|Overall Study|Protocol Violation|0|||
164205046|NCT00042289|593121120|FG011|Overall Study|Protocol Violation|0|||
164205047|NCT00042289|593121121|FG012|Overall Study|Protocol Violation|0|||
164205048|NCT00042289|593121122|FG013|Overall Study|Protocol Violation|0|||
164205049|NCT00042289|593121123|FG014|Overall Study|Protocol Violation|0|||
164205050|NCT00042289|593121124|FG015|Overall Study|Protocol Violation|0|||
164205051|NCT00042289|593121125|FG016|Overall Study|Protocol Violation|0|||
164205052|NCT00042289|593121126|FG017|Overall Study|Protocol Violation|0|||
164205053|NCT00042289|593121127|FG018|Overall Study|Protocol Violation|0|||
164205054|NCT00042289|593121128|FG019|Overall Study|Protocol Violation|0|||
164205055|NCT00042289|593121129|FG020|Overall Study|Protocol Violation|0|||
164205056|NCT00042289|593121130|FG021|Overall Study|Protocol Violation|0|||
164561756|NCT00430508|594425612|FG001|Overall Study|responder at visit 4|0|||
164316450|NCT00715910|593535624|FG001|Booster and ESFU Phase|Other|0|||
164316451|NCT00715910|593535625|FG002|Booster and ESFU Phase|Other|0|||
164316452|NCT00715910|593535626|FG003|Booster and ESFU Phase|Other|5|||
164316453|NCT00715910|593535627|FG004|Booster and ESFU Phase|Other|1|||
164316454|NCT00715910|593535628|FG005|Booster and ESFU Phase|Other|0|||
164316455|NCT01185353|593535629|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
164316456|NCT01185353|593535630|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
164316457|NCT01185353|593535631|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
164316458|NCT01185353|593535632|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
164316459|NCT01185353|593535633|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
164316460|NCT01185353|593535634|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
164316461|NCT01185353|593535635|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
164316462|NCT01185353|593535636|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
164316463|NCT01185353|593535637|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
164316464|NCT01185353|593535638|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
164316465|NCT01185353|593535629|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
164316466|NCT01185353|593535630|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
164316467|NCT01185353|593535631|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
164316468|NCT01185353|593535632|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
164316469|NCT01185353|593535633|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
164316470|NCT01185353|593535634|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
164316471|NCT01185353|593535635|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
164316472|NCT01185353|593535636|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
164316473|NCT01185353|593535637|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
164316474|NCT01185353|593535638|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
164316475|NCT01185353|593535629|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
164316476|NCT01185353|593535630|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
164316477|NCT01185353|593535631|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
164316478|NCT01185353|593535632|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
164316479|NCT01185353|593535633|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
164316480|NCT01185353|593535634|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
164316481|NCT01185353|593535635|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
164316482|NCT01185353|593535636|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
164316483|NCT01185353|593535637|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
164316484|NCT01185353|593535638|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
164316485|NCT01185353|593535629|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
164316486|NCT01185353|593535630|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
164316487|NCT01185353|593535631|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
164316488|NCT01185353|593535632|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
164316489|NCT01185353|593535633|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
164316490|NCT01185353|593535634|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
164316491|NCT01185353|593535635|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
164316492|NCT01185353|593535636|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
164316493|NCT01185353|593535637|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
164316494|NCT01185353|593535638|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
164316495|NCT01185353|593535629|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
164316496|NCT01185353|593535630|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
164561757|NCT00430508|594425613|FG002|Overall Study|responder at visit 4|2|||
164561758|NCT00430508|594425614|FG003|Overall Study|responder at visit 4|0|||
164561759|NCT00430508|594425611|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
164561760|NCT00430508|594425612|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
164561761|NCT00430508|594425613|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
164561762|NCT00430508|594425614|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
164561763|NCT00430508|594425611|FG000|Overall Study|Other|1|||
164561764|NCT00430508|594425612|FG001|Overall Study|Other|1|||
164561765|NCT00430508|594425613|FG002|Overall Study|Other|3|||
164561766|NCT00430508|594425614|FG003|Overall Study|Other|0|||
164561767|NCT03889639|594425617|FG000|Overall Study|Withdrawal by Subject|0|||
164561768|NCT03889639|594425618|FG001|Overall Study|Withdrawal by Subject|0|||
164665961|NCT05014412|594801553|FG002|Overall Study|Withdrawal by Subject|1|||
164665962|NCT05014412|594801554|FG003|Overall Study|Withdrawal by Subject|2|||
164316497|NCT01185353|593535631|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
164316498|NCT01185353|593535632|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
164316499|NCT01185353|593535633|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
164316500|NCT01185353|593535634|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
164316501|NCT01185353|593535635|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
164316502|NCT01185353|593535636|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
164316503|NCT01185353|593535637|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
164561769|NCT03889639|594425619|FG002|Overall Study|Withdrawal by Subject|0|||
164561770|NCT03889639|594425620|FG003|Overall Study|Withdrawal by Subject|0|||
164561771|NCT03889639|594425621|FG004|Overall Study|Withdrawal by Subject|0|||
164561772|NCT03889639|594425622|FG005|Overall Study|Withdrawal by Subject|0|||
164205057|NCT00042289|593121131|FG022|Overall Study|Protocol Violation|0|||
164205058|NCT00042289|593121132|FG023|Overall Study|Protocol Violation|1|||
164205059|NCT00042289|593121133|FG024|Overall Study|Protocol Violation|1|||
164205060|NCT00042289|593121134|FG025|Overall Study|Protocol Violation|0|||
164205061|NCT00042289|593121135|FG026|Overall Study|Protocol Violation|2|||
164205062|NCT00042289|593121136|FG027|Overall Study|Protocol Violation|0|||
164205063|NCT00042289|593121137|FG028|Overall Study|Protocol Violation|0|||
164205064|NCT00042289|593121138|FG029|Overall Study|Protocol Violation|0|||
164205065|NCT00042289|593121139|FG030|Overall Study|Protocol Violation|1|||
164205066|NCT00042289|593121140|FG031|Overall Study|Protocol Violation|0|||
164205067|NCT00042289|593121141|FG032|Overall Study|Protocol Violation|0|||
164205068|NCT00042289|593121142|FG033|Overall Study|Protocol Violation|0|||
164205069|NCT00042289|593121143|FG034|Overall Study|Protocol Violation|0|||
164205070|NCT00042289|593121144|FG035|Overall Study|Protocol Violation|0|||
164205071|NCT00042289|593121145|FG036|Overall Study|Protocol Violation|0|||
164205072|NCT00042289|593121146|FG037|Overall Study|Protocol Violation|0|||
164205073|NCT00042289|593121147|FG038|Overall Study|Protocol Violation|0|||
164205074|NCT00042289|593121148|FG039|Overall Study|Protocol Violation|0|||
164205075|NCT00042289|593121149|FG040|Overall Study|Protocol Violation|0|||
164205076|NCT00042289|593121150|FG041|Overall Study|Protocol Violation|1|||
164205077|NCT00042289|593121151|FG042|Overall Study|Protocol Violation|1|||
164205078|NCT00042289|593121152|FG043|Overall Study|Protocol Violation|1|||
164205079|NCT00042289|593121153|FG044|Overall Study|Protocol Violation|0|||
164205080|NCT00042289|593121154|FG045|Overall Study|Protocol Violation|0|||
164205081|NCT00042289|593121155|FG046|Overall Study|Protocol Violation|0|||
164205082|NCT00042289|593121109|FG000|Overall Study|Withdrawal by Subject|4|||
164205083|NCT00042289|593121110|FG001|Overall Study|Withdrawal by Subject|1|||
164205084|NCT00042289|593121111|FG002|Overall Study|Withdrawal by Subject|0|||
164205085|NCT00042289|593121112|FG003|Overall Study|Withdrawal by Subject|2|||
164205086|NCT00042289|593121113|FG004|Overall Study|Withdrawal by Subject|0|||
164205087|NCT00042289|593121114|FG005|Overall Study|Withdrawal by Subject|2|||
164205088|NCT00042289|593121115|FG006|Overall Study|Withdrawal by Subject|0|||
164205089|NCT00042289|593121116|FG007|Overall Study|Withdrawal by Subject|0|||
164205090|NCT00042289|593121117|FG008|Overall Study|Withdrawal by Subject|0|||
164205091|NCT00042289|593121118|FG009|Overall Study|Withdrawal by Subject|1|||
164205092|NCT00042289|593121119|FG010|Overall Study|Withdrawal by Subject|0|||
164205093|NCT00042289|593121120|FG011|Overall Study|Withdrawal by Subject|0|||
164205094|NCT00042289|593121121|FG012|Overall Study|Withdrawal by Subject|2|||
164205095|NCT00042289|593121122|FG013|Overall Study|Withdrawal by Subject|0|||
164205096|NCT00042289|593121123|FG014|Overall Study|Withdrawal by Subject|0|||
164205097|NCT00042289|593121124|FG015|Overall Study|Withdrawal by Subject|0|||
164205098|NCT00042289|593121125|FG016|Overall Study|Withdrawal by Subject|0|||
164205099|NCT00042289|593121126|FG017|Overall Study|Withdrawal by Subject|0|||
164205100|NCT00042289|593121127|FG018|Overall Study|Withdrawal by Subject|0|||
164205101|NCT00042289|593121128|FG019|Overall Study|Withdrawal by Subject|0|||
164205102|NCT00042289|593121129|FG020|Overall Study|Withdrawal by Subject|0|||
164205103|NCT00042289|593121130|FG021|Overall Study|Withdrawal by Subject|1|||
164205104|NCT00042289|593121131|FG022|Overall Study|Withdrawal by Subject|1|||
164205105|NCT00042289|593121132|FG023|Overall Study|Withdrawal by Subject|1|||
164205106|NCT00042289|593121133|FG024|Overall Study|Withdrawal by Subject|0|||
164205107|NCT00042289|593121134|FG025|Overall Study|Withdrawal by Subject|0|||
164205108|NCT00042289|593121135|FG026|Overall Study|Withdrawal by Subject|1|||
164205109|NCT00042289|593121136|FG027|Overall Study|Withdrawal by Subject|0|||
164205110|NCT00042289|593121137|FG028|Overall Study|Withdrawal by Subject|2|||
164205111|NCT00042289|593121138|FG029|Overall Study|Withdrawal by Subject|0|||
164205112|NCT00042289|593121139|FG030|Overall Study|Withdrawal by Subject|0|||
164205113|NCT00042289|593121140|FG031|Overall Study|Withdrawal by Subject|1|||
164205114|NCT00042289|593121141|FG032|Overall Study|Withdrawal by Subject|2|||
164205115|NCT00042289|593121142|FG033|Overall Study|Withdrawal by Subject|1|||
164205116|NCT00042289|593121143|FG034|Overall Study|Withdrawal by Subject|0|||
164205117|NCT00042289|593121144|FG035|Overall Study|Withdrawal by Subject|0|||
164205118|NCT00042289|593121145|FG036|Overall Study|Withdrawal by Subject|0|||
164205119|NCT00042289|593121146|FG037|Overall Study|Withdrawal by Subject|1|||
164205120|NCT00042289|593121147|FG038|Overall Study|Withdrawal by Subject|0|||
164205121|NCT00042289|593121148|FG039|Overall Study|Withdrawal by Subject|0|||
164205122|NCT00042289|593121149|FG040|Overall Study|Withdrawal by Subject|0|||
164205123|NCT00042289|593121150|FG041|Overall Study|Withdrawal by Subject|0|||
164205124|NCT00042289|593121151|FG042|Overall Study|Withdrawal by Subject|1|||
164205125|NCT00042289|593121152|FG043|Overall Study|Withdrawal by Subject|0|||
164205126|NCT00042289|593121153|FG044|Overall Study|Withdrawal by Subject|0|||
164205127|NCT00042289|593121154|FG045|Overall Study|Withdrawal by Subject|0|||
164205128|NCT00042289|593121155|FG046|Overall Study|Withdrawal by Subject|0|||
164205129|NCT00548327|593121160|FG000|Overall Study|Adverse Event|0|||
164205130|NCT00548327|593121161|FG001|Overall Study|Adverse Event|1|||
164205131|NCT01673386|593121162|FG000|Overall Study|Study terminated by sponsor|16|||
164205132|NCT01673386|593121163|FG001|Overall Study|Study terminated by sponsor|22|||
164205133|NCT01673386|593121162|FG000|Overall Study|Adverse Event|5|||
164316504|NCT01185353|593535638|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
164316505|NCT01185353|593535629|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
164316506|NCT01185353|593535630|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
164316507|NCT01185353|593535631|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
164316508|NCT01185353|593535632|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
164316509|NCT01185353|593535633|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
164316510|NCT01185353|593535634|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
164316511|NCT01185353|593535635|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
164316512|NCT01185353|593535636|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
164316513|NCT01185353|593535637|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
164316514|NCT01185353|593535638|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
164316515|NCT01185353|593535629|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
164316516|NCT01185353|593535630|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
164316517|NCT01185353|593535631|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
164316518|NCT01185353|593535632|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
164316519|NCT01185353|593535633|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
164316520|NCT01185353|593535634|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
164316521|NCT01185353|593535635|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
164316522|NCT01185353|593535636|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
164316523|NCT01185353|593535637|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
164316524|NCT01185353|593535638|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
164316525|NCT01185353|593535629|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
164316526|NCT01185353|593535630|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
164316527|NCT01185353|593535631|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
164316528|NCT01185353|593535632|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
164316529|NCT01185353|593535633|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
164316530|NCT01185353|593535634|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
164316531|NCT01185353|593535635|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
164316532|NCT01185353|593535636|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
164316533|NCT01185353|593535637|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
164316534|NCT01185353|593535638|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
164316535|NCT01185353|593535629|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
164316536|NCT01185353|593535630|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
164316537|NCT01185353|593535631|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
164316538|NCT01185353|593535632|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
164316539|NCT01185353|593535633|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
164316540|NCT01185353|593535634|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
164316541|NCT01185353|593535635|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
164316542|NCT01185353|593535636|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
164316543|NCT01185353|593535637|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
164316544|NCT01185353|593535638|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
164316545|NCT01185353|593535629|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
164316546|NCT01185353|593535630|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
164316547|NCT01185353|593535631|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
164316548|NCT01185353|593535632|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
164316549|NCT01185353|593535633|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
164316550|NCT01185353|593535634|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
164316551|NCT01185353|593535635|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
164316552|NCT01185353|593535636|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
164316553|NCT01185353|593535637|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
164316554|NCT01185353|593535638|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
164316555|NCT01185353|593535629|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
164316556|NCT01185353|593535630|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
164316557|NCT01185353|593535631|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
164316558|NCT01185353|593535632|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
164316559|NCT01185353|593535633|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
164316560|NCT01185353|593535634|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
164316561|NCT01185353|593535635|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
164316562|NCT01185353|593535636|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
164316563|NCT01185353|593535637|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
164316564|NCT01185353|593535638|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
164316565|NCT01185353|593535629|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
164316566|NCT01185353|593535630|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
164316567|NCT01185353|593535631|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
164316568|NCT01185353|593535632|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
164316569|NCT01185353|593535633|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
164316570|NCT01185353|593535634|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
164316571|NCT01185353|593535635|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
164316572|NCT01185353|593535636|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
164316573|NCT01185353|593535637|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
164316574|NCT01185353|593535638|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
164316575|NCT01185353|593535629|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
164316576|NCT01185353|593535630|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
164316577|NCT01185353|593535631|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
164316578|NCT01185353|593535632|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
164316579|NCT01185353|593535633|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
164316580|NCT01185353|593535634|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
164316581|NCT01185353|593535635|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
164316582|NCT01185353|593535636|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
164316583|NCT01185353|593535637|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
164316584|NCT01185353|593535638|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
164316585|NCT01185353|593535629|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
164316586|NCT01185353|593535630|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
164316587|NCT01185353|593535631|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
164316588|NCT01185353|593535632|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
164316589|NCT01185353|593535633|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
164316590|NCT01185353|593535634|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
164316591|NCT01185353|593535635|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
164316592|NCT01185353|593535636|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
164316593|NCT01185353|593535637|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
164316594|NCT01185353|593535638|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
164316595|NCT01185353|593535629|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
164316596|NCT01185353|593535630|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
164316597|NCT01185353|593535631|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
164316598|NCT01185353|593535632|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
164316599|NCT01185353|593535633|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
164316600|NCT01185353|593535634|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
164316601|NCT01185353|593535635|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
164316602|NCT01185353|593535636|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
164316603|NCT01185353|593535637|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
164316604|NCT01185353|593535638|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
164316605|NCT01185353|593535629|FG000|Part C (Weeks 24 Through 76)|Death|0|||
164316606|NCT01185353|593535630|FG001|Part C (Weeks 24 Through 76)|Death|0|||
164316607|NCT01185353|593535631|FG002|Part C (Weeks 24 Through 76)|Death|0|||
164316608|NCT01185353|593535632|FG003|Part C (Weeks 24 Through 76)|Death|0|||
164316609|NCT01185353|593535633|FG004|Part C (Weeks 24 Through 76)|Death|0|||
164316610|NCT01185353|593535634|FG005|Part C (Weeks 24 Through 76)|Death|0|||
164316611|NCT01185353|593535635|FG006|Part C (Weeks 24 Through 76)|Death|0|||
164316612|NCT01185353|593535636|FG007|Part C (Weeks 24 Through 76)|Death|0|||
164316613|NCT01185353|593535637|FG008|Part C (Weeks 24 Through 76)|Death|0|||
164316614|NCT01185353|593535638|FG009|Part C (Weeks 24 Through 76)|Death|1|||
164316615|NCT01185353|593535629|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
164316616|NCT01185353|593535630|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
164316617|NCT01185353|593535631|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
164316618|NCT01185353|593535632|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
164561773|NCT03889639|594425623|FG006|Overall Study|Withdrawal by Subject|0|||
164561774|NCT03889639|594425624|FG007|Overall Study|Withdrawal by Subject|1|||
164561775|NCT01703858|594425625|FG000|Overall Study|Withdrawal by Subject|0|||
164561776|NCT01703858|594425626|FG001|Overall Study|Withdrawal by Subject|1|||
164561777|NCT01703858|594425627|FG002|Overall Study|Withdrawal by Subject|0|||
164561778|NCT02556255|594425628|FG000|Overall Study|Lost to Follow-up|4|||
164561779|NCT00993031|594425629|FG000|Overall Study|Death|0|||
164561780|NCT00993031|594425630|FG001|Overall Study|Death|1|||
164561781|NCT00993031|594425629|FG000|Overall Study|Physician Decision|0|||
164561782|NCT00993031|594425630|FG001|Overall Study|Physician Decision|2|||
164561783|NCT00993031|594425629|FG000|Overall Study|Withdrawal by Subject|3|||
164561784|NCT00993031|594425630|FG001|Overall Study|Withdrawal by Subject|3|||
164561785|NCT00993031|594425629|FG000|Overall Study|Lost to Follow-up|19|||
164561786|NCT00993031|594425630|FG001|Overall Study|Lost to Follow-up|13|||
164561787|NCT00288080|594425633|FG000|Overall Study|Withdrawal by Subject|1|||
164665963|NCT05014412|594801551|FG000|Overall Study|Ongoing|21|||
164316619|NCT01185353|593535633|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
164316620|NCT01185353|593535634|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
164316621|NCT01185353|593535635|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
164316622|NCT01185353|593535636|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
164316623|NCT01185353|593535637|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
164561788|NCT00288080|594425634|FG001|Overall Study|Withdrawal by Subject|3|||
164561789|NCT00288080|594425633|FG000|Overall Study|Protocol Violation|25|||
164665964|NCT05014412|594801552|FG001|Overall Study|Ongoing|4|||
164316624|NCT01185353|593535638|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
164561790|NCT00288080|594425634|FG001|Overall Study|Protocol Violation|20|||
164316625|NCT01185353|593535629|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
164316626|NCT01185353|593535630|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
164561791|NCT03403192|594425635|FG000|Overall Study|Lost to Follow-up|1|||
164561792|NCT03403192|594425636|FG001|Overall Study|Lost to Follow-up|2|||
164561793|NCT03403192|594425637|FG002|Overall Study|Lost to Follow-up|0|||
164561794|NCT03403192|594425638|FG003|Overall Study|Lost to Follow-up|0|||
164561795|NCT03403192|594425635|FG000|Overall Study|Unable to respond|0|||
164561796|NCT03403192|594425636|FG001|Overall Study|Unable to respond|1|||
164561797|NCT03403192|594425637|FG002|Overall Study|Unable to respond|0|||
164561798|NCT03403192|594425638|FG003|Overall Study|Unable to respond|0|||
164561799|NCT03403192|594425635|FG000|Overall Study|Incomplete|3|||
164561800|NCT03403192|594425636|FG001|Overall Study|Incomplete|1|||
164561801|NCT03403192|594425637|FG002|Overall Study|Incomplete|3|||
164561802|NCT03403192|594425638|FG003|Overall Study|Incomplete|6|||
164561803|NCT03595553|594425644|FG000|Overall Study|Withdrawal by Subject|20|||
164561804|NCT03595553|594425645|FG001|Overall Study|Withdrawal by Subject|8|||
164561805|NCT03595553|594425644|FG000|Overall Study|Physician Decision|3|||
164561806|NCT03595553|594425645|FG001|Overall Study|Physician Decision|2|||
164561807|NCT03595553|594425644|FG000|Overall Study|Adverse Event|2|||
164561808|NCT03595553|594425645|FG001|Overall Study|Adverse Event|5|||
164561809|NCT03595553|594425644|FG000|Overall Study|Death|24|||
164561810|NCT03595553|594425645|FG001|Overall Study|Death|22|||
164561811|NCT03595553|594425644|FG000|Overall Study|Lost to Follow-up|6|||
164561812|NCT03595553|594425645|FG001|Overall Study|Lost to Follow-up|7|||
164561813|NCT03595553|594425644|FG000|Overall Study|Other as indicated in CSR|3|||
164561814|NCT03595553|594425645|FG001|Overall Study|Other as indicated in CSR|3|||
164561815|NCT03595553|594425644|FG000|Overall Study|Sponsor Decision|0|||
164561816|NCT03595553|594425645|FG001|Overall Study|Sponsor Decision|1|||
164561817|NCT03467958|594425646|FG000|Overall Study|Adverse Event|20|||
164561818|NCT03467958|594425647|FG001|Overall Study|Adverse Event|32|||
164561819|NCT03467958|594425648|FG002|Overall Study|Adverse Event|5|||
164561820|NCT03467958|594425649|FG003|Overall Study|Adverse Event|3|||
164561821|NCT03467958|594425650|FG004|Overall Study|Adverse Event|3|||
164561822|NCT03467958|594425651|FG005|Overall Study|Adverse Event|3|||
164561823|NCT03467958|594425652|FG006|Overall Study|Adverse Event|6|||
164561824|NCT03467958|594425653|FG007|Overall Study|Adverse Event|5|||
164561825|NCT03467958|594425654|FG008|Overall Study|Adverse Event|0|||
164561826|NCT03467958|594425646|FG000|Overall Study|Lack of Efficacy|59|||
164561827|NCT03467958|594425647|FG001|Overall Study|Lack of Efficacy|120|||
164561828|NCT03467958|594425648|FG002|Overall Study|Lack of Efficacy|6|||
164561829|NCT03467958|594425649|FG003|Overall Study|Lack of Efficacy|9|||
164561830|NCT03467958|594425650|FG004|Overall Study|Lack of Efficacy|8|||
164561831|NCT03467958|594425651|FG005|Overall Study|Lack of Efficacy|9|||
164561832|NCT03467958|594425652|FG006|Overall Study|Lack of Efficacy|11|||
164561833|NCT03467958|594425653|FG007|Overall Study|Lack of Efficacy|9|||
164561834|NCT03467958|594425654|FG008|Overall Study|Lack of Efficacy|3|||
164561835|NCT03467958|594425646|FG000|Overall Study|Lost to Follow-up|1|||
164561836|NCT03467958|594425647|FG001|Overall Study|Lost to Follow-up|2|||
164561837|NCT03467958|594425648|FG002|Overall Study|Lost to Follow-up|1|||
164561838|NCT03467958|594425649|FG003|Overall Study|Lost to Follow-up|0|||
164561839|NCT03467958|594425650|FG004|Overall Study|Lost to Follow-up|4|||
164561840|NCT03467958|594425651|FG005|Overall Study|Lost to Follow-up|0|||
164561841|NCT03467958|594425652|FG006|Overall Study|Lost to Follow-up|0|||
164561842|NCT03467958|594425653|FG007|Overall Study|Lost to Follow-up|0|||
164561843|NCT03467958|594425654|FG008|Overall Study|Lost to Follow-up|0|||
164561844|NCT03467958|594425646|FG000|Overall Study|Other reasons|8|||
164665965|NCT05014412|594801553|FG002|Overall Study|Ongoing|6|||
164665966|NCT05014412|594801554|FG003|Overall Study|Ongoing|20|||
164665967|NCT00486837|594801555|FG000|Overall Study|Withdrawal by Subject|1|||
164665968|NCT00486837|594801556|FG001|Overall Study|Withdrawal by Subject|0|||
164561845|NCT03467958|594425647|FG001|Overall Study|Other reasons|14|||
164561846|NCT03467958|594425648|FG002|Overall Study|Other reasons|2|||
164561847|NCT03467958|594425649|FG003|Overall Study|Other reasons|1|||
164561848|NCT03467958|594425650|FG004|Overall Study|Other reasons|4|||
164561849|NCT03467958|594425651|FG005|Overall Study|Other reasons|0|||
164561850|NCT03467958|594425652|FG006|Overall Study|Other reasons|1|||
164561851|NCT03467958|594425653|FG007|Overall Study|Other reasons|0|||
164561852|NCT03467958|594425654|FG008|Overall Study|Other reasons|1|||
164561853|NCT03467958|594425646|FG000|Overall Study|Pregnancy|1|||
164561854|NCT03467958|594425647|FG001|Overall Study|Pregnancy|0|||
164561855|NCT03467958|594425648|FG002|Overall Study|Pregnancy|0|||
164561856|NCT03467958|594425649|FG003|Overall Study|Pregnancy|0|||
164561857|NCT03467958|594425650|FG004|Overall Study|Pregnancy|0|||
164561858|NCT03467958|594425651|FG005|Overall Study|Pregnancy|1|||
164561859|NCT03467958|594425652|FG006|Overall Study|Pregnancy|0|||
164561860|NCT03467958|594425653|FG007|Overall Study|Pregnancy|0|||
164561861|NCT03467958|594425654|FG008|Overall Study|Pregnancy|0|||
164561862|NCT03467958|594425646|FG000|Overall Study|Study terminated by sponsor|65|||
164561863|NCT03467958|594425647|FG001|Overall Study|Study terminated by sponsor|117|||
164561864|NCT03467958|594425648|FG002|Overall Study|Study terminated by sponsor|45|||
164561865|NCT03467958|594425649|FG003|Overall Study|Study terminated by sponsor|64|||
164561866|NCT03467958|594425650|FG004|Overall Study|Study terminated by sponsor|66|||
164561867|NCT03467958|594425651|FG005|Overall Study|Study terminated by sponsor|17|||
164561868|NCT03467958|594425652|FG006|Overall Study|Study terminated by sponsor|11|||
164205134|NCT01673386|593121163|FG001|Overall Study|Adverse Event|2|||
164205135|NCT01673386|593121162|FG000|Overall Study|Progressive disease|4|||
164205136|NCT01673386|593121163|FG001|Overall Study|Progressive disease|1|||
164205137|NCT01673386|593121162|FG000|Overall Study|Withdrawal by Subject|0|||
164205138|NCT01673386|593121163|FG001|Overall Study|Withdrawal by Subject|2|||
164205139|NCT00274456|593121167|FG000|Overall Study|Still on treatment|2|||
164205140|NCT00274456|593121168|FG001|Overall Study|Still on treatment|3|||
164205141|NCT00274456|593121169|FG002|Overall Study|Still on treatment|5|||
164205142|NCT00274456|593121170|FG003|Overall Study|Still on treatment|1|||
164205143|NCT00274456|593121167|FG000|Overall Study|Unacceptable toxicity|10|||
164205144|NCT00274456|593121168|FG001|Overall Study|Unacceptable toxicity|5|||
164205145|NCT00274456|593121169|FG002|Overall Study|Unacceptable toxicity|12|||
164205146|NCT00274456|593121170|FG003|Overall Study|Unacceptable toxicity|16|||
164205147|NCT00274456|593121167|FG000|Overall Study|Adverse Event|0|||
164205148|NCT00274456|593121168|FG001|Overall Study|Adverse Event|1|||
164205149|NCT00274456|593121169|FG002|Overall Study|Adverse Event|2|||
164205150|NCT00274456|593121170|FG003|Overall Study|Adverse Event|2|||
164205151|NCT00274456|593121167|FG000|Overall Study|Physician Decision|7|||
164205152|NCT00274456|593121168|FG001|Overall Study|Physician Decision|5|||
164205153|NCT00274456|593121169|FG002|Overall Study|Physician Decision|6|||
164205154|NCT00274456|593121170|FG003|Overall Study|Physician Decision|13|||
164205155|NCT00274456|593121167|FG000|Overall Study|Lost to Follow-up|0|||
164205156|NCT00274456|593121168|FG001|Overall Study|Lost to Follow-up|0|||
164205157|NCT00274456|593121169|FG002|Overall Study|Lost to Follow-up|1|||
164205158|NCT00274456|593121170|FG003|Overall Study|Lost to Follow-up|0|||
164205159|NCT00274456|593121167|FG000|Overall Study|Withdrawal by Subject|18|||
164205160|NCT00274456|593121168|FG001|Overall Study|Withdrawal by Subject|13|||
164205161|NCT00274456|593121169|FG002|Overall Study|Withdrawal by Subject|9|||
164205162|NCT00274456|593121170|FG003|Overall Study|Withdrawal by Subject|13|||
164205163|NCT00336544|593121175|FG000|Overall Study|Lack of Efficacy|8|||
164205164|NCT00336544|593121176|FG001|Overall Study|Lack of Efficacy|5|||
164205165|NCT00336544|593121175|FG000|Overall Study|Adverse Event|4|||
164205166|NCT00336544|593121176|FG001|Overall Study|Adverse Event|9|||
164205167|NCT00336544|593121175|FG000|Overall Study|Withdrawal by Subject|4|||
164205168|NCT00336544|593121176|FG001|Overall Study|Withdrawal by Subject|3|||
164205169|NCT00336544|593121175|FG000|Overall Study|Other|3|||
164205170|NCT00336544|593121176|FG001|Overall Study|Other|5|||
164205171|NCT00576758|593121177|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
164205172|NCT00576758|593121178|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
164205173|NCT00576758|593121177|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
164205174|NCT00576758|593121178|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
164205175|NCT00576758|593121177|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
164205176|NCT00576758|593121178|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
164205177|NCT00576758|593121177|FG000|Induction Treatment Period|Death|1|||
164205178|NCT00576758|593121178|FG001|Induction Treatment Period|Death|0|||
164205179|NCT00576758|593121177|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
164205180|NCT00576758|593121178|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
164205181|NCT00576758|593121177|FG000|Induction Treatment Period|Withdrew consent|1|||
164205182|NCT00576758|593121178|FG001|Induction Treatment Period|Withdrew consent|0|||
164205183|NCT00576758|593121177|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
164205184|NCT00576758|593121178|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
164205185|NCT00576758|593121177|FG000|Extension Treatment Period|Death|1|||
164205186|NCT00576758|593121178|FG001|Extension Treatment Period|Death|1|||
164205187|NCT00576758|593121177|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
164205188|NCT00576758|593121178|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
164205189|NCT00576758|593121177|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
164205190|NCT00576758|593121178|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
164205191|NCT00576758|593121177|FG000|Extension Treatment Period|Administrative/Other|3|||
164205192|NCT00576758|593121178|FG001|Extension Treatment Period|Administrative/Other|1|||
164205193|NCT00576758|593121177|FG000|Follow-up Period|Administrative/Other|6|||
164205194|NCT00576758|593121178|FG001|Follow-up Period|Administrative/Other|8|||
164205195|NCT00576758|593121177|FG000|Follow-up Period|Death|3|||
164205196|NCT00576758|593121178|FG001|Follow-up Period|Death|3|||
164205197|NCT00576758|593121177|FG000|Follow-up Period|Insufficient therapeutic response|16|||
164205198|NCT00576758|593121178|FG001|Follow-up Period|Insufficient therapeutic response|5|||
164205199|NCT00576758|593121177|FG000|Follow-up Period|Withdrew consent|2|||
164205200|NCT00576758|593121178|FG001|Follow-up Period|Withdrew consent|1|||
164205201|NCT03427411|593121179|FG000|Overall Study|Screen failure - platelets too low|0|||
164205202|NCT03427411|593121180|FG001|Overall Study|Screen failure - platelets too low|1|||
164420629|NCT01154036|593910968|FG006|Phase I|Physician Decision|0|||
164561869|NCT03467958|594425653|FG007|Overall Study|Study terminated by sponsor|5|||
164665969|NCT00486837|594801555|FG000|Overall Study|Adverse Event|1|||
164665970|NCT00486837|594801556|FG001|Overall Study|Adverse Event|1|||
164665971|NCT00486837|594801555|FG000|Overall Study|Protocol Violation|4|||
164665972|NCT00486837|594801556|FG001|Overall Study|Protocol Violation|2|||
164205203|NCT01712178|593121181|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
164205204|NCT01712178|593121182|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
164205205|NCT01712178|593121181|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
164205206|NCT01712178|593121182|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
164205207|NCT01712178|593121181|FG000|Overall Study|Lost to Follow-up|0|||
164205208|NCT01712178|593121182|FG001|Overall Study|Lost to Follow-up|1|||
164205209|NCT00486044|593121183|FG000|Overall Study|Withdrawal by Subject|2|||
164205210|NCT00486044|593121184|FG001|Overall Study|Withdrawal by Subject|1|||
164205211|NCT00486044|593121183|FG000|Overall Study|Adverse Event|0|||
164205212|NCT00486044|593121184|FG001|Overall Study|Adverse Event|1|||
164205213|NCT00486044|593121183|FG000|Overall Study|Lost to Follow-up|0|||
164205214|NCT00486044|593121184|FG001|Overall Study|Lost to Follow-up|1|||
164205215|NCT02701634|593121185|FG000|Overall Study|Adverse Event|2|||
164205216|NCT02701634|593121186|FG001|Overall Study|Adverse Event|3|||
164205217|NCT02701634|593121185|FG000|Overall Study|Death|1|||
164205218|NCT02701634|593121186|FG001|Overall Study|Death|0|||
164205219|NCT02701634|593121185|FG000|Overall Study|Investigator's Discretion|7|||
164205220|NCT02701634|593121186|FG001|Overall Study|Investigator's Discretion|4|||
164205221|NCT02701634|593121185|FG000|Overall Study|Study terminated by Sponsor|15|||
164205222|NCT02701634|593121186|FG001|Overall Study|Study terminated by Sponsor|17|||
164205223|NCT02701634|593121185|FG000|Overall Study|Withdrew Consent|6|||
164205224|NCT02701634|593121186|FG001|Overall Study|Withdrew Consent|7|||
164205225|NCT02701634|593121185|FG000|Overall Study|Randomized but not treated|1|||
164205226|NCT02701634|593121186|FG001|Overall Study|Randomized but not treated|0|||
164205227|NCT01206764|593121187|FG000|Overall Study|Adverse Event|20|||
164205228|NCT01206764|593121187|FG000|Overall Study|Abnormal laboratory value|2|||
164205229|NCT01206764|593121187|FG000|Overall Study|Abnormal test procedure result|1|||
164205230|NCT01206764|593121187|FG000|Overall Study|Patient withdrew consent|5|||
164205231|NCT01206764|593121187|FG000|Overall Study|Lost to Follow-up|6|||
164205232|NCT01206764|593121187|FG000|Overall Study|Death|11|||
164205233|NCT01206764|593121187|FG000|Overall Study|New cancer therapy|2|||
164205234|NCT01206764|593121187|FG000|Overall Study|Disease progression|88|||
164205235|NCT01206764|593121187|FG000|Overall Study|Protocol deviation|3|||
164205236|NCT04494646|593121188|FG000|Overall Study|Adverse Event|0|||
164205237|NCT04494646|593121189|FG001|Overall Study|Adverse Event|1|||
164205238|NCT04494646|593121188|FG000|Overall Study|Withdrawal by Subject|0|||
164205239|NCT04494646|593121189|FG001|Overall Study|Withdrawal by Subject|1|||
164205240|NCT00537277|593121190|FG000|Overall Study|Adverse Event|1|||
164205241|NCT00537277|593121190|FG000|Overall Study|Lack of Efficacy|2|||
164205242|NCT00537277|593121190|FG000|Overall Study|Lost to Follow-up|12|||
164205243|NCT00537277|593121190|FG000|Overall Study|Protocol Violation|11|||
164205244|NCT00537277|593121190|FG000|Overall Study|Unclassified|4|||
164205245|NCT00537277|593121190|FG000|Overall Study|Inability to tolerate trial medication|4|||
164205246|NCT00537277|593121190|FG000|Overall Study|Non-compliance with trial procedures|15|||
164205247|NCT05282823|593121191|FG000|Overall Study|Withdrawal by Subject|9|||
164205248|NCT05282823|593121191|FG000|Overall Study|Adverse Event|1|||
164205249|NCT05282823|593121191|FG000|Overall Study|did not meet protocol criteria|2|||
164205250|NCT05282823|593121191|FG000|Overall Study|Withdrawal by Subject|7|||
164205251|NCT00997893|593121192|FG000|Overall Study|Adverse Event|1|||
164205252|NCT00997893|593121193|FG001|Overall Study|Adverse Event|0|||
164205253|NCT00997893|593121194|FG002|Overall Study|Adverse Event|0|||
164205254|NCT00997893|593121192|FG000|Overall Study|Unable to meet study timelines|1|||
164205255|NCT00997893|593121193|FG001|Overall Study|Unable to meet study timelines|0|||
164205256|NCT00997893|593121194|FG002|Overall Study|Unable to meet study timelines|0|||
164205257|NCT00997893|593121192|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
164205258|NCT00997893|593121193|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
164205259|NCT00997893|593121194|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
164205260|NCT03620162|593121195|FG000|Overall Study|Physician Decision|4|||
164205261|NCT03620162|593121196|FG001|Overall Study|Physician Decision|0|||
164205262|NCT03620162|593121197|FG002|Overall Study|Physician Decision|1|||
164205263|NCT03620162|593121198|FG003|Overall Study|Physician Decision|0|||
164205264|NCT03620162|593121199|FG004|Overall Study|Physician Decision|2|||
164205265|NCT03620162|593121195|FG000|Overall Study|Lost to Follow-up|2|||
164205266|NCT03620162|593121196|FG001|Overall Study|Lost to Follow-up|6|||
164205267|NCT03620162|593121197|FG002|Overall Study|Lost to Follow-up|7|||
164205268|NCT03620162|593121198|FG003|Overall Study|Lost to Follow-up|3|||
164205269|NCT03620162|593121199|FG004|Overall Study|Lost to Follow-up|2|||
164420630|NCT01154036|593910969|FG007|Phase I|Physician Decision|0|||
164205270|NCT03620162|593121195|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
164205271|NCT03620162|593121196|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
164205272|NCT03620162|593121197|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
164205273|NCT03620162|593121198|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
164316627|NCT01185353|593535631|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
164316628|NCT01185353|593535632|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
164316629|NCT01185353|593535633|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
164316630|NCT01185353|593535634|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
164316631|NCT01185353|593535635|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
164316632|NCT01185353|593535636|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
164316633|NCT01185353|593535637|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
164316634|NCT01185353|593535638|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
164316635|NCT01185353|593535629|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
164316636|NCT01185353|593535630|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
164316637|NCT01185353|593535631|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
164316638|NCT01185353|593535632|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
164316639|NCT01185353|593535633|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
164316640|NCT01185353|593535634|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
164316641|NCT01185353|593535635|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
164316642|NCT01185353|593535636|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
164316643|NCT01185353|593535637|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
164316644|NCT01185353|593535638|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
164316645|NCT01185353|593535629|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
164316646|NCT01185353|593535630|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
164316647|NCT01185353|593535631|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
164316648|NCT01185353|593535632|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
164316649|NCT01185353|593535633|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
164316650|NCT01185353|593535634|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
164316651|NCT01185353|593535635|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
164316652|NCT01185353|593535636|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
164316653|NCT01185353|593535637|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
164316654|NCT01185353|593535638|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
164316655|NCT01185353|593535629|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
164316656|NCT01185353|593535630|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
164316657|NCT01185353|593535631|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
164316658|NCT01185353|593535632|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
164316659|NCT01185353|593535633|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
164316660|NCT01185353|593535634|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
164316661|NCT01185353|593535635|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
164316662|NCT01185353|593535636|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
164316663|NCT01185353|593535637|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
164316664|NCT01185353|593535638|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
164316665|NCT01185353|593535629|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
164316666|NCT01185353|593535630|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
164316667|NCT01185353|593535631|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
164316668|NCT01185353|593535632|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
164316669|NCT01185353|593535633|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
164316670|NCT01185353|593535634|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
164316671|NCT01185353|593535635|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
164316672|NCT01185353|593535636|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
164316673|NCT01185353|593535637|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
164316674|NCT01185353|593535638|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
164316675|NCT01030666|593535639|FG000|Overall Study|Lost to Follow-up|3|||
164316676|NCT01030666|593535640|FG001|Overall Study|Lost to Follow-up|2|||
164316677|NCT01144299|593535643|FG000|Overall Study|Lost to Follow-up|1|||
164316678|NCT01144299|593535644|FG001|Overall Study|Lost to Follow-up|0|||
164316679|NCT01144299|593535643|FG000|Overall Study|Withdrawal by Subject|1|||
164316680|NCT01144299|593535644|FG001|Overall Study|Withdrawal by Subject|0|||
164316681|NCT00334113|593535647|FG000|Overall Study|Lost to Follow-up|2|||
164316682|NCT00334113|593535648|FG001|Overall Study|Lost to Follow-up|2|||
164316683|NCT00334113|593535647|FG000|Overall Study|Withdrawal by Subject|0|||
164316684|NCT00334113|593535648|FG001|Overall Study|Withdrawal by Subject|1|||
164316685|NCT02509026|593535651|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
164316686|NCT02509026|593535651|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
164316687|NCT02509026|593535651|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
164316688|NCT02509026|593535651|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
164316689|NCT02509026|593535651|FG000|Induction Period (24 Weeks)|Other|2|||
164316690|NCT02509026|593535651|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
164316691|NCT02509026|593535651|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
164316692|NCT02509026|593535651|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
164316693|NCT02509026|593535651|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
164316694|NCT02509026|593535651|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
164316695|NCT02509026|593535651|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
164316696|NCT02509026|593535651|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
164316697|NCT02509026|593535651|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
164316698|NCT04303195|593535652|FG000|Overall Study|Adverse Event|1|||
164316699|NCT04303195|593535653|FG001|Overall Study|Adverse Event|3|||
164316700|NCT04303195|593535654|FG002|Overall Study|Adverse Event|7|||
164316701|NCT04303195|593535655|FG003|Overall Study|Adverse Event|0|||
164316702|NCT04303195|593535652|FG000|Overall Study|Lost to Follow-up|1|||
164316703|NCT04303195|593535653|FG001|Overall Study|Lost to Follow-up|0|||
164316704|NCT04303195|593535654|FG002|Overall Study|Lost to Follow-up|1|||
164316705|NCT04303195|593535655|FG003|Overall Study|Lost to Follow-up|4|||
164316706|NCT04303195|593535652|FG000|Overall Study|Withdrawal by Subject|3|||
164316707|NCT04303195|593535653|FG001|Overall Study|Withdrawal by Subject|1|||
164316708|NCT04303195|593535654|FG002|Overall Study|Withdrawal by Subject|1|||
164316709|NCT04303195|593535655|FG003|Overall Study|Withdrawal by Subject|1|||
164316710|NCT04303195|593535652|FG000|Overall Study|No study drug administered or protocol deviation|0|||
164316711|NCT04303195|593535653|FG001|Overall Study|No study drug administered or protocol deviation|2|||
164316712|NCT04303195|593535654|FG002|Overall Study|No study drug administered or protocol deviation|0|||
164316713|NCT04303195|593535655|FG003|Overall Study|No study drug administered or protocol deviation|2|||
164316714|NCT01808092|593535657|FG000|Overall Study|Death|39|||
164316715|NCT01808092|593535658|FG001|Overall Study|Death|29|||
164316716|NCT01808092|593535657|FG000|Overall Study|Lost to Follow-up|3|||
164316717|NCT01808092|593535658|FG001|Overall Study|Lost to Follow-up|7|||
164316718|NCT01808092|593535657|FG000|Overall Study|Withdrawal by Subject|9|||
164316719|NCT01808092|593535658|FG001|Overall Study|Withdrawal by Subject|4|||
164316720|NCT01808092|593535657|FG000|Overall Study|Other Eligibility criteria|3|||
164316721|NCT01808092|593535658|FG001|Overall Study|Other Eligibility criteria|5|||
164316722|NCT01097005|593535661|FG000|Overall Study|Case Report Form not collected|18|||
164316723|NCT01097005|593535661|FG000|Overall Study|Subjects cannot visit the hospital|1|||
164316724|NCT01097005|593535661|FG000|Overall Study|Poor medication compliance|1|||
164316725|NCT01097005|593535661|FG000|Overall Study|No examination data available|244|||
164316726|NCT01097005|593535661|FG000|Overall Study|Deviation from exclusion criteria|37|||
164316727|NCT01097005|593535661|FG000|Overall Study|Adverse Event|14|||
164316728|NCT01097005|593535661|FG000|Overall Study|Discontinuance by complication|50|||
164316729|NCT03425253|593535662|FG000|Overall Study|Adverse Event|2|||
164316730|NCT03425253|593535662|FG000|Overall Study|Lost to Follow-up|3|||
164316731|NCT03425253|593535662|FG000|Overall Study|Withdrew Consent|6|||
164316732|NCT03425253|593535662|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
164316733|NCT04174365|593535663|FG000|Overall Study|Lost to Follow-up|1|||
164316734|NCT04174365|593535664|FG001|Overall Study|Lost to Follow-up|2|||
164316735|NCT04174365|593535663|FG000|Overall Study|Adverse Event|2|||
164316736|NCT04174365|593535664|FG001|Overall Study|Adverse Event|1|||
164316737|NCT04174365|593535663|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
164316738|NCT04174365|593535664|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
164316739|NCT04174365|593535663|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
164316740|NCT04174365|593535664|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
164316741|NCT04174365|593535663|FG000|Overall Study|Protocol Deviation|1|||
164316742|NCT04174365|593535664|FG001|Overall Study|Protocol Deviation|0|||
164316743|NCT04174365|593535663|FG000|Overall Study|Lack of Efficacy|0|||
164316744|NCT04174365|593535664|FG001|Overall Study|Lack of Efficacy|2|||
164316745|NCT04174365|593535663|FG000|Overall Study|Disease Relapse|1|||
164316746|NCT04174365|593535664|FG001|Overall Study|Disease Relapse|0|||
164316747|NCT04174365|593535663|FG000|Overall Study|Reason Not Specified|0|||
164316748|NCT04174365|593535664|FG001|Overall Study|Reason Not Specified|1|||
164316749|NCT03472547|593535665|FG000|Overall Study|Withdrawal by Subject|30|||
164316750|NCT05141448|593535666|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
164316751|NCT05141448|593535667|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
164316752|NCT05141448|593535668|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
164316753|NCT05141448|593535669|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
164316754|NCT05141448|593535670|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
164316755|NCT05141448|593535671|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
164316756|NCT05141448|593535666|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
164316757|NCT05141448|593535667|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
164316758|NCT05141448|593535668|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
164316759|NCT05141448|593535669|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
164316760|NCT05141448|593535670|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
164316761|NCT05141448|593535671|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
164316762|NCT05141448|593535666|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
164316763|NCT05141448|593535667|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
164316764|NCT05141448|593535668|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
164316765|NCT05141448|593535669|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
164316766|NCT05141448|593535670|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
164316767|NCT05141448|593535671|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
164561870|NCT03467958|594425654|FG008|Overall Study|Study terminated by sponsor|5|||
164561871|NCT03467958|594425646|FG000|Overall Study|Withdrawal by Subject|25|||
164561872|NCT03467958|594425647|FG001|Overall Study|Withdrawal by Subject|44|||
164561873|NCT03467958|594425648|FG002|Overall Study|Withdrawal by Subject|7|||
164561874|NCT03467958|594425649|FG003|Overall Study|Withdrawal by Subject|8|||
164561875|NCT03467958|594425650|FG004|Overall Study|Withdrawal by Subject|6|||
164561876|NCT03467958|594425651|FG005|Overall Study|Withdrawal by Subject|8|||
164561877|NCT03467958|594425652|FG006|Overall Study|Withdrawal by Subject|4|||
164561878|NCT03467958|594425653|FG007|Overall Study|Withdrawal by Subject|1|||
164561879|NCT03467958|594425654|FG008|Overall Study|Withdrawal by Subject|4|||
164561880|NCT02286947|594425655|FG000|Overall Study|Withdrawal by Subject|2|||
164561881|NCT01687712|594425656|FG000|Cycle 1|Not Biochemically Pregnant|386|||
164665973|NCT00486837|594801555|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
164205274|NCT03620162|593121199|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
164205275|NCT00112957|593121202|FG000|Overall Study|Progressive disease|18|||
164205276|NCT00112957|593121202|FG000|Overall Study|Physician Decision|1|||
164205277|NCT05352815|593121205|FG000|Overall Study|Withdrawal by Subject|28|||
164205278|NCT05352815|593121206|FG001|Overall Study|Withdrawal by Subject|24|||
164205279|NCT05352815|593121205|FG000|Overall Study|Lost to Follow-up|4|||
164205280|NCT05352815|593121206|FG001|Overall Study|Lost to Follow-up|7|||
164205281|NCT05352815|593121205|FG000|Overall Study|Death|2|||
164205282|NCT05352815|593121206|FG001|Overall Study|Death|3|||
164205283|NCT05352815|593121205|FG000|Overall Study|Site closure|1|||
164205284|NCT05352815|593121206|FG001|Overall Study|Site closure|0|||
164205285|NCT00961415|593121209|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
164205286|NCT00961415|593121210|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
164205287|NCT00961415|593121211|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
164205288|NCT00961415|593121209|FG000|Induction Treatment Phase|Death|77|||
164205289|NCT00961415|593121210|FG001|Induction Treatment Phase|Death|0|||
164205290|NCT00961415|593121211|FG002|Induction Treatment Phase|Death|0|||
164205291|NCT00961415|593121209|FG000|Induction Treatment Phase|Protocol Violation|1|||
164205292|NCT00961415|593121210|FG001|Induction Treatment Phase|Protocol Violation|0|||
164205293|NCT00961415|593121211|FG002|Induction Treatment Phase|Protocol Violation|0|||
164205294|NCT00961415|593121209|FG000|Induction Treatment Phase|Physician Decision|2|||
164205295|NCT00961415|593121210|FG001|Induction Treatment Phase|Physician Decision|0|||
164205296|NCT00961415|593121211|FG002|Induction Treatment Phase|Physician Decision|0|||
164205297|NCT00961415|593121209|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
164205298|NCT00961415|593121210|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
164205299|NCT00961415|593121211|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
164205300|NCT00961415|593121209|FG000|Induction Treatment Phase|Other Reason|5|||
164205301|NCT00961415|593121210|FG001|Induction Treatment Phase|Other Reason|0|||
164205302|NCT00961415|593121211|FG002|Induction Treatment Phase|Other Reason|0|||
164205303|NCT00961415|593121209|FG000|Maintenance Treatment Phase|Death|0|||
164205304|NCT00961415|593121210|FG001|Maintenance Treatment Phase|Death|42|||
164205305|NCT00961415|593121211|FG002|Maintenance Treatment Phase|Death|34|||
164205306|NCT00961415|593121209|FG000|Maintenance Treatment Phase|Investigators decision|0|||
164205307|NCT00961415|593121210|FG001|Maintenance Treatment Phase|Investigators decision|2|||
164205308|NCT00961415|593121211|FG002|Maintenance Treatment Phase|Investigators decision|0|||
164205309|NCT00961415|593121209|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
164205310|NCT00961415|593121210|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
164205311|NCT00961415|593121211|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
164205312|NCT00961415|593121209|FG000|Maintenance Treatment Phase|Other reason|0|||
164205313|NCT00961415|593121210|FG001|Maintenance Treatment Phase|Other reason|1|||
164205314|NCT00961415|593121211|FG002|Maintenance Treatment Phase|Other reason|3|||
164205315|NCT00226655|593121212|FG000|Overall Study|Death|13|||
164205316|NCT00226655|593121212|FG000|Overall Study|Withdrawal by Subject|15|||
164205317|NCT00226655|593121212|FG000|Overall Study|Adverse Event|35|||
164205318|NCT00226655|593121212|FG000|Overall Study|Physician Decision|6|||
164205319|NCT00226655|593121212|FG000|Overall Study|Clinical deterioration|10|||
164205320|NCT02309359|593121213|FG000|Overall Study|Adverse Event|4|||
164205321|NCT02309359|593121214|FG001|Overall Study|Adverse Event|5|||
164205322|NCT02309359|593121215|FG002|Overall Study|Adverse Event|5|||
164205323|NCT02309359|593121216|FG003|Overall Study|Adverse Event|4|||
164205324|NCT02309359|593121217|FG004|Overall Study|Adverse Event|4|||
164205325|NCT02309359|593121213|FG000|Overall Study|Death|1|||
164205326|NCT02309359|593121214|FG001|Overall Study|Death|0|||
164205327|NCT02309359|593121215|FG002|Overall Study|Death|0|||
164205328|NCT02309359|593121216|FG003|Overall Study|Death|0|||
164205329|NCT02309359|593121217|FG004|Overall Study|Death|0|||
164205330|NCT02309359|593121213|FG000|Overall Study|Withdrawal by Subject|2|||
164205331|NCT02309359|593121214|FG001|Overall Study|Withdrawal by Subject|2|||
164205332|NCT02309359|593121215|FG002|Overall Study|Withdrawal by Subject|4|||
164205333|NCT02309359|593121216|FG003|Overall Study|Withdrawal by Subject|4|||
164561882|NCT01687712|594425657|FG001|Cycle 1|Not Biochemically Pregnant|348|||
164561883|NCT01687712|594425656|FG000|Cycle 1|Early Pregnancy Loss|43|||
164665974|NCT00486837|594801556|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
164665975|NCT01199861|594801557|FG000|Overall Study|Administrative problems|1|||
164205334|NCT02309359|593121217|FG004|Overall Study|Withdrawal by Subject|0|||
164205335|NCT02309359|593121213|FG000|Overall Study|Lack of Efficacy|3|||
164205336|NCT02309359|593121214|FG001|Overall Study|Lack of Efficacy|1|||
164205337|NCT02309359|593121215|FG002|Overall Study|Lack of Efficacy|0|||
164205338|NCT02309359|593121216|FG003|Overall Study|Lack of Efficacy|0|||
164205339|NCT02309359|593121217|FG004|Overall Study|Lack of Efficacy|3|||
164205340|NCT02309359|593121213|FG000|Overall Study|Lost to Follow-up|0|||
164205341|NCT02309359|593121214|FG001|Overall Study|Lost to Follow-up|0|||
164205342|NCT02309359|593121215|FG002|Overall Study|Lost to Follow-up|0|||
164205343|NCT02309359|593121216|FG003|Overall Study|Lost to Follow-up|1|||
164205344|NCT02309359|593121217|FG004|Overall Study|Lost to Follow-up|0|||
164205345|NCT02309359|593121213|FG000|Overall Study|Other|2|||
164205346|NCT02309359|593121214|FG001|Overall Study|Other|0|||
164205347|NCT02309359|593121215|FG002|Overall Study|Other|2|||
164205348|NCT02309359|593121216|FG003|Overall Study|Other|3|||
164205349|NCT02309359|593121217|FG004|Overall Study|Other|2|||
164205350|NCT05144945|593121219|FG000|Overall Study|Withdrawal by Subject|1|||
164205351|NCT05144945|593121220|FG001|Overall Study|Withdrawal by Subject|0|||
164205352|NCT06129149|593121222|FG000|Overall Study|Death|1|||
164205353|NCT01704261|593121223|FG000|Overall Study|Withdrawal by Subject|12|||
164205354|NCT01704261|593121224|FG001|Overall Study|Withdrawal by Subject|15|||
164205355|NCT01704261|593121223|FG000|Overall Study|Lost to Follow-up|1|||
164205356|NCT01704261|593121224|FG001|Overall Study|Lost to Follow-up|0|||
164205357|NCT02391337|593121225|FG000|6 Months Follow-up|Death|5|||
164205358|NCT02391337|593121226|FG001|6 Months Follow-up|Death|4|||
164205359|NCT02391337|593121225|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
164205360|NCT02391337|593121226|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
164205361|NCT02391337|593121225|FG000|12 Months Follow-up|Death|2|||
164205362|NCT02391337|593121226|FG001|12 Months Follow-up|Death|0|||
164205363|NCT02391337|593121225|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
164205364|NCT02391337|593121226|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
164205365|NCT02391337|593121225|FG000|12 Months Follow-up|Lost to Follow-up|0|||
164205366|NCT02391337|593121226|FG001|12 Months Follow-up|Lost to Follow-up|2|||
164205367|NCT00726609|593121228|FG000|Overall Study|Adverse Event|10|||
164205368|NCT00726609|593121228|FG000|Overall Study|Withdrawal by Subject|2|||
164205369|NCT00726609|593121228|FG000|Overall Study|Lack of Efficacy|25|||
164205370|NCT00726609|593121228|FG000|Overall Study|Other|16|||
164205371|NCT00726609|593121228|FG000|Overall Study|Missing|42|||
164205372|NCT00726609|593121228|FG000|Overall Study|Other|3|||
164205373|NCT00746551|593121232|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
164205374|NCT00746551|593121233|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
164205375|NCT00746551|593121232|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
164205376|NCT00746551|593121233|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
164205377|NCT00746551|593121232|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
164205378|NCT00746551|593121233|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
164205379|NCT00465179|593121237|FG000|Overall Study|Adverse Event|4|||
164205380|NCT00465179|593121237|FG000|Overall Study|Withdrawal by Subject|2|||
164205381|NCT00465179|593121237|FG000|Overall Study|Progression of Disease|47|||
164205382|NCT02867592|593121241|FG000|Overall Study|Adverse Event|3|||
164205383|NCT02867592|593121242|FG001|Overall Study|Adverse Event|0|||
164205384|NCT02867592|593121243|FG002|Overall Study|Adverse Event|2|||
164205385|NCT02867592|593121244|FG003|Overall Study|Adverse Event|1|||
164205386|NCT02867592|593121245|FG004|Overall Study|Adverse Event|1|||
164205387|NCT02867592|593121246|FG005|Overall Study|Adverse Event|5|||
164205388|NCT02867592|593121241|FG000|Overall Study|Death|0|||
164205389|NCT02867592|593121242|FG001|Overall Study|Death|0|||
164205390|NCT02867592|593121243|FG002|Overall Study|Death|0|||
164205391|NCT02867592|593121244|FG003|Overall Study|Death|1|||
164205392|NCT02867592|593121245|FG004|Overall Study|Death|0|||
164205393|NCT02867592|593121246|FG005|Overall Study|Death|1|||
164205394|NCT02867592|593121241|FG000|Overall Study|Lack of Efficacy|8|||
164205395|NCT02867592|593121242|FG001|Overall Study|Lack of Efficacy|10|||
164205396|NCT02867592|593121243|FG002|Overall Study|Lack of Efficacy|8|||
164205397|NCT02867592|593121244|FG003|Overall Study|Lack of Efficacy|8|||
164205398|NCT02867592|593121245|FG004|Overall Study|Lack of Efficacy|12|||
164205399|NCT02867592|593121246|FG005|Overall Study|Lack of Efficacy|17|||
164665976|NCT01199861|594801558|FG001|Overall Study|Administrative problems|0|||
164205400|NCT02867592|593121241|FG000|Overall Study|Physician Decision|1|||
164205401|NCT02867592|593121242|FG001|Overall Study|Physician Decision|2|||
164205402|NCT02867592|593121243|FG002|Overall Study|Physician Decision|2|||
164205403|NCT02867592|593121244|FG003|Overall Study|Physician Decision|0|||
164205404|NCT02867592|593121245|FG004|Overall Study|Physician Decision|5|||
164205405|NCT02867592|593121246|FG005|Overall Study|Physician Decision|1|||
164205406|NCT02867592|593121241|FG000|Overall Study|Protocol Violation|0|||
164205407|NCT02867592|593121242|FG001|Overall Study|Protocol Violation|0|||
164205408|NCT02867592|593121243|FG002|Overall Study|Protocol Violation|0|||
164205409|NCT02867592|593121244|FG003|Overall Study|Protocol Violation|0|||
164205410|NCT02867592|593121245|FG004|Overall Study|Protocol Violation|1|||
164316768|NCT05141448|593535666|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
164316769|NCT05141448|593535667|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
164316770|NCT05141448|593535668|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
164316771|NCT05141448|593535669|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
164316772|NCT05141448|593535670|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
164316773|NCT05141448|593535671|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
164316774|NCT05141448|593535666|FG000|Period 2|COVID-19 Related|0|||
164316775|NCT05141448|593535667|FG001|Period 2|COVID-19 Related|0|||
164316776|NCT05141448|593535668|FG002|Period 2|COVID-19 Related|0|||
164316777|NCT05141448|593535669|FG003|Period 2|COVID-19 Related|1|||
164316778|NCT05141448|593535670|FG004|Period 2|COVID-19 Related|0|||
164316779|NCT05141448|593535671|FG005|Period 2|COVID-19 Related|1|||
164316780|NCT05141448|593535666|FG000|3|Covid-19 related|2|||
164316781|NCT05141448|593535667|FG001|3|Covid-19 related|0|||
164316782|NCT05141448|593535668|FG002|3|Covid-19 related|0|||
164316783|NCT05141448|593535669|FG003|3|Covid-19 related|0|||
164316784|NCT05141448|593535670|FG004|3|Covid-19 related|0|||
164316785|NCT05141448|593535671|FG005|3|Covid-19 related|1|||
164316786|NCT05141448|593535666|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
164316787|NCT05141448|593535667|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
164316788|NCT05141448|593535668|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
164316789|NCT05141448|593535669|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
164316790|NCT05141448|593535670|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
164316791|NCT05141448|593535671|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
164316792|NCT04627285|593535672|FG000|Overall Study|Adverse Event|0|||
164316793|NCT04627285|593535673|FG001|Overall Study|Adverse Event|2|||
164316794|NCT04627285|593535672|FG000|Overall Study|Lost to Follow-up|1|||
164316795|NCT04627285|593535673|FG001|Overall Study|Lost to Follow-up|0|||
164316796|NCT04627285|593535672|FG000|Overall Study|Withdrawal by Subject|1|||
164316797|NCT04627285|593535673|FG001|Overall Study|Withdrawal by Subject|1|||
164316798|NCT04627285|593535672|FG000|Overall Study|Sponsor decision|5|||
164316799|NCT04627285|593535673|FG001|Overall Study|Sponsor decision|0|||
164316800|NCT04627285|593535672|FG000|Overall Study|Participant left country; aunt informed the site|0|||
164316801|NCT04627285|593535673|FG001|Overall Study|Participant left country; aunt informed the site|1|||
164316802|NCT02907892|593537711|FG000|Overall Study|Lost to Follow-up|27|||
164316803|NCT02907892|593537712|FG001|Overall Study|Lost to Follow-up|40|||
164316804|NCT01347580|593537713|FG000|Overall Study|Withdrawal by Subject|13|||
164316805|NCT01347580|593537714|FG001|Overall Study|Withdrawal by Subject|23|||
164316806|NCT01347580|593537713|FG000|Overall Study|Death|30|||
164316807|NCT01347580|593537714|FG001|Overall Study|Death|19|||
164316808|NCT01347580|593537713|FG000|Overall Study|Protocol Violation|10|||
164316809|NCT01347580|593537714|FG001|Overall Study|Protocol Violation|7|||
164316810|NCT01347580|593537713|FG000|Overall Study|Lost to Follow-up|3|||
164316811|NCT01347580|593537714|FG001|Overall Study|Lost to Follow-up|1|||
164316812|NCT01347580|593537713|FG000|Overall Study|Had other reason|9|||
164316813|NCT01347580|593537714|FG001|Overall Study|Had other reason|6|||
164316814|NCT01964755|593537715|FG000|Overall Study|Death|2|||
164316815|NCT00412373|593537718|FG000|Overall Study|Adverse Event|8|||
164316816|NCT00412373|593537719|FG001|Overall Study|Adverse Event|13|||
164316817|NCT00412373|593537718|FG000|Overall Study|Lack of Efficacy|16|||
164316818|NCT00412373|593537719|FG001|Overall Study|Lack of Efficacy|22|||
164316819|NCT00412373|593537718|FG000|Overall Study|Lost to Follow-up|7|||
164316820|NCT00412373|593537719|FG001|Overall Study|Lost to Follow-up|13|||
164316821|NCT00412373|593537718|FG000|Overall Study|Withdrawal by Subject|8|||
164316822|NCT00412373|593537719|FG001|Overall Study|Withdrawal by Subject|27|||
164316823|NCT00412373|593537718|FG000|Overall Study|Other|2|||
164316824|NCT00412373|593537719|FG001|Overall Study|Other|2|||
164316825|NCT00422513|593537720|FG000|Overall Study|Lack of Efficacy|4|||
164316826|NCT00422513|593537721|FG001|Overall Study|Lack of Efficacy|5|||
164316827|NCT00422513|593537720|FG000|Overall Study|Protocol Violation|23|||
164316828|NCT00422513|593537721|FG001|Overall Study|Protocol Violation|7|||
164316829|NCT00422513|593537720|FG000|Overall Study|Refused Treatment|4|||
164316830|NCT00422513|593537721|FG001|Overall Study|Refused Treatment|2|||
164316831|NCT00422513|593537720|FG000|Overall Study|Withdrawal by Subject|2|||
164316832|NCT00422513|593537721|FG001|Overall Study|Withdrawal by Subject|1|||
164316833|NCT00422513|593537720|FG000|Overall Study|early termination of the study|67|||
164316834|NCT00422513|593537721|FG001|Overall Study|early termination of the study|80|||
164316835|NCT00422513|593537720|FG000|Overall Study|Adverse Event|4|||
164316836|NCT00422513|593537721|FG001|Overall Study|Adverse Event|4|||
164316837|NCT00422513|593537720|FG000|Overall Study|Death|3|||
164316838|NCT00422513|593537721|FG001|Overall Study|Death|7|||
164316839|NCT01478048|593537722|FG000|Overall Study|Disease Progression|52|||
164316840|NCT01478048|593537723|FG001|Overall Study|Disease Progression|35|||
164316841|NCT01478048|593537722|FG000|Overall Study|study drug toxicity|11|||
164316842|NCT01478048|593537723|FG001|Overall Study|study drug toxicity|14|||
164316843|NCT01478048|593537722|FG000|Overall Study|Adverse Event|2|||
164316844|NCT01478048|593537723|FG001|Overall Study|Adverse Event|11|||
164561884|NCT01687712|594425657|FG001|Cycle 1|Early Pregnancy Loss|60|||
164561885|NCT01687712|594425656|FG000|Cycle 1|Ectopic Pregnancy|5|||
164561886|NCT01687712|594425657|FG001|Cycle 1|Ectopic Pregnancy|5|||
164205411|NCT02867592|593121246|FG005|Overall Study|Protocol Violation|1|||
164205412|NCT02867592|593121241|FG000|Overall Study|Withdrawal by Subject|0|||
164205413|NCT02867592|593121242|FG001|Overall Study|Withdrawal by Subject|1|||
164205414|NCT02867592|593121243|FG002|Overall Study|Withdrawal by Subject|0|||
164205415|NCT02867592|593121244|FG003|Overall Study|Withdrawal by Subject|1|||
164205416|NCT02867592|593121245|FG004|Overall Study|Withdrawal by Subject|3|||
164205417|NCT02867592|593121246|FG005|Overall Study|Withdrawal by Subject|3|||
164205418|NCT02867592|593121241|FG000|Overall Study|Ineligible|1|||
164205419|NCT02867592|593121242|FG001|Overall Study|Ineligible|1|||
164205420|NCT02867592|593121243|FG002|Overall Study|Ineligible|0|||
164205421|NCT02867592|593121244|FG003|Overall Study|Ineligible|0|||
164205422|NCT02867592|593121245|FG004|Overall Study|Ineligible|2|||
164205423|NCT02867592|593121246|FG005|Overall Study|Ineligible|0|||
164205424|NCT02867592|593121241|FG000|Overall Study|No Treatment|1|||
164205425|NCT02867592|593121242|FG001|Overall Study|No Treatment|0|||
164205426|NCT02867592|593121243|FG002|Overall Study|No Treatment|0|||
164205427|NCT02867592|593121244|FG003|Overall Study|No Treatment|0|||
164205428|NCT02867592|593121245|FG004|Overall Study|No Treatment|0|||
164205429|NCT02867592|593121246|FG005|Overall Study|No Treatment|0|||
164205430|NCT02867592|593121241|FG000|Overall Study|Still on Therapy|0|||
164205431|NCT02867592|593121242|FG001|Overall Study|Still on Therapy|0|||
164205432|NCT02867592|593121243|FG002|Overall Study|Still on Therapy|0|||
164205433|NCT02867592|593121244|FG003|Overall Study|Still on Therapy|0|||
164205434|NCT02867592|593121245|FG004|Overall Study|Still on Therapy|1|||
164205435|NCT02867592|593121246|FG005|Overall Study|Still on Therapy|0|||
164205436|NCT02867592|593121241|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
164205437|NCT02867592|593121242|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
164205438|NCT02867592|593121243|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
164205439|NCT02867592|593121244|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
164205440|NCT02867592|593121245|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
164205441|NCT02867592|593121246|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
164205442|NCT02867592|593121241|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
164205443|NCT02867592|593121242|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
164205444|NCT02867592|593121243|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
164205445|NCT02867592|593121244|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
164205446|NCT02867592|593121245|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
164205447|NCT02867592|593121246|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
164205448|NCT00909870|593121247|FG000|Overall Study|Adverse Event|13|||
164205449|NCT00909870|593121248|FG001|Overall Study|Adverse Event|7|||
164205450|NCT00909870|593121247|FG000|Overall Study|Protocol Violation|1|||
164205451|NCT00909870|593121248|FG001|Overall Study|Protocol Violation|2|||
164205452|NCT00909870|593121247|FG000|Overall Study|Withdrawal by Subject|5|||
164205453|NCT00909870|593121248|FG001|Overall Study|Withdrawal by Subject|8|||
164205454|NCT00909870|593121247|FG000|Overall Study|Lost to Follow-up|3|||
164205455|NCT00909870|593121248|FG001|Overall Study|Lost to Follow-up|3|||
164205456|NCT00909870|593121247|FG000|Overall Study|Physician Decision|0|||
164205457|NCT00909870|593121248|FG001|Overall Study|Physician Decision|2|||
164205458|NCT00909870|593121247|FG000|Overall Study|Other|1|||
164205459|NCT00909870|593121248|FG001|Overall Study|Other|5|||
164205460|NCT01420536|593121257|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
164205461|NCT01420536|593121258|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
164205462|NCT04711005|593121261|FG000|Overall Study|Withdrawal by Subject|0|||
164205463|NCT04711005|593121262|FG001|Overall Study|Withdrawal by Subject|0|||
164205464|NCT04711005|593121263|FG002|Overall Study|Withdrawal by Subject|0|||
164205465|NCT04711005|593121264|FG003|Overall Study|Withdrawal by Subject|0|||
164205466|NCT04711005|593121265|FG004|Overall Study|Withdrawal by Subject|0|||
164205467|NCT04711005|593121266|FG005|Overall Study|Withdrawal by Subject|0|||
164205468|NCT04711005|593121267|FG006|Overall Study|Withdrawal by Subject|0|||
164205469|NCT04711005|593121268|FG007|Overall Study|Withdrawal by Subject|1|||
164205470|NCT04711005|593121269|FG008|Overall Study|Withdrawal by Subject|0|||
164205471|NCT04711005|593121270|FG009|Overall Study|Withdrawal by Subject|0|||
164205472|NCT04711005|593121261|FG000|Overall Study|Physician Decision|0|||
164205473|NCT04711005|593121262|FG001|Overall Study|Physician Decision|0|||
164205474|NCT04711005|593121263|FG002|Overall Study|Physician Decision|0|||
164205475|NCT04711005|593121264|FG003|Overall Study|Physician Decision|0|||
164205476|NCT04711005|593121265|FG004|Overall Study|Physician Decision|0|||
164205477|NCT04711005|593121266|FG005|Overall Study|Physician Decision|0|||
164205478|NCT04711005|593121267|FG006|Overall Study|Physician Decision|0|||
164561887|NCT01687712|594425656|FG000|Cycle 1|Heterotropic Pregnancy|1|||
164561888|NCT01687712|594425657|FG001|Cycle 1|Heterotropic Pregnancy|0|||
164316845|NCT01478048|593537722|FG000|Overall Study|subject request to discontinue treatment|3|||
164316846|NCT01478048|593537723|FG001|Overall Study|subject request to discontinue treatment|5|||
164316847|NCT01478048|593537722|FG000|Overall Study|Withdrawal by Subject|2|||
164316848|NCT01478048|593537723|FG001|Overall Study|Withdrawal by Subject|5|||
164316849|NCT01478048|593537722|FG000|Overall Study|non-specified|6|||
164316850|NCT01478048|593537723|FG001|Overall Study|non-specified|4|||
164316851|NCT01478048|593537722|FG000|Overall Study|poor/non-compliance|0|||
164316852|NCT01478048|593537723|FG001|Overall Study|poor/non-compliance|1|||
164316853|NCT01478048|593537722|FG000|Overall Study|no longer meets study criteria|1|||
164316854|NCT01478048|593537723|FG001|Overall Study|no longer meets study criteria|0|||
164316855|NCT01369329|593537725|FG000|Overall Study|Withdrawal by Subject|8|||
164316856|NCT01369329|593537726|FG001|Overall Study|Withdrawal by Subject|6|||
164316857|NCT01369329|593537727|FG002|Overall Study|Withdrawal by Subject|10|||
164316858|NCT01369329|593537725|FG000|Overall Study|Lost to Follow-up|2|||
164316859|NCT01369329|593537726|FG001|Overall Study|Lost to Follow-up|2|||
164316860|NCT01369329|593537727|FG002|Overall Study|Lost to Follow-up|2|||
164316861|NCT01369329|593537725|FG000|Overall Study|Other|2|||
164316862|NCT01369329|593537726|FG001|Overall Study|Other|3|||
164316863|NCT01369329|593537727|FG002|Overall Study|Other|2|||
164316864|NCT03032380|593537728|FG000|Overall Study|Adverse Event|0|||
164316865|NCT03032380|593537729|FG001|Overall Study|Adverse Event|1|||
164316866|NCT03032380|593537728|FG000|Overall Study|Lack of Efficacy|1|||
164316867|NCT03032380|593537729|FG001|Overall Study|Lack of Efficacy|0|||
164316868|NCT03032380|593537728|FG000|Overall Study|Withdrawal by Subject|2|||
164316869|NCT03032380|593537729|FG001|Overall Study|Withdrawal by Subject|3|||
164316870|NCT03032380|593537728|FG000|Overall Study|Recovery|0|||
164316871|NCT03032380|593537729|FG001|Overall Study|Recovery|1|||
164316872|NCT03032380|593537728|FG000|Overall Study|Death|39|||
164316873|NCT03032380|593537729|FG001|Overall Study|Death|34|||
164316874|NCT03032380|593537728|FG000|Overall Study|Other - Miscellaneous|0|||
164316875|NCT03032380|593537729|FG001|Overall Study|Other - Miscellaneous|1|||
164316876|NCT02937584|593537730|FG000|Period 1|Adverse Event|1|||
164316877|NCT02937584|593537731|FG001|Period 1|Adverse Event|2|||
164316878|NCT02937584|593537730|FG000|Washout|Adverse Event|0|||
164316879|NCT02937584|593537731|FG001|Washout|Adverse Event|1|||
164316880|NCT01883453|593537732|FG000|Overall Study|No episode of common cold|25|||
164316881|NCT01883453|593537733|FG001|Overall Study|No episode of common cold|23|||
164316882|NCT02238080|593537734|FG000|Overall Study|Death|13|||
164316883|NCT02238080|593537734|FG000|Overall Study|Treatment interrupted|6|||
164316884|NCT02238080|593537734|FG000|Overall Study|Withdrawal by Subject|2|||
164316885|NCT02238080|593537734|FG000|Overall Study|Other|4|||
164316886|NCT00701662|593537735|FG000|Overall Study|Lack of Efficacy|1|||
164316887|NCT02267317|593537738|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
164316888|NCT02267317|593537739|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
164316889|NCT02267317|593537740|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
164316890|NCT02267317|593537741|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
164316891|NCT02267317|593537742|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
164316892|NCT02267317|593537743|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
164316893|NCT02267317|593537738|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
164316894|NCT02267317|593537739|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
164316895|NCT02267317|593537740|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
164316896|NCT02267317|593537741|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
164316897|NCT02267317|593537742|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
164316898|NCT02267317|593537743|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
164316899|NCT03595618|593537744|FG000|Overall Study|Adverse Event|16|||
164316900|NCT03595618|593537745|FG001|Overall Study|Adverse Event|17|||
164316901|NCT03595618|593537746|FG002|Overall Study|Adverse Event|20|||
164316902|NCT03595618|593537747|FG003|Overall Study|Adverse Event|8|||
164316903|NCT03595618|593537744|FG000|Overall Study|Withdrawal by Subject|12|||
164316904|NCT03595618|593537745|FG001|Overall Study|Withdrawal by Subject|14|||
164316905|NCT03595618|593537746|FG002|Overall Study|Withdrawal by Subject|14|||
164316906|NCT03595618|593537747|FG003|Overall Study|Withdrawal by Subject|10|||
164316907|NCT03595618|593537744|FG000|Overall Study|Lost to Follow-up|6|||
164316908|NCT03595618|593537745|FG001|Overall Study|Lost to Follow-up|4|||
164316909|NCT03595618|593537746|FG002|Overall Study|Lost to Follow-up|5|||
164316910|NCT03595618|593537747|FG003|Overall Study|Lost to Follow-up|6|||
164316911|NCT03595618|593537744|FG000|Overall Study|Protocol Violation|2|||
164316912|NCT03595618|593537745|FG001|Overall Study|Protocol Violation|0|||
164316913|NCT03595618|593537746|FG002|Overall Study|Protocol Violation|6|||
164316914|NCT03595618|593537747|FG003|Overall Study|Protocol Violation|2|||
164316915|NCT03595618|593537744|FG000|Overall Study|Physician Decision|0|||
164316916|NCT03595618|593537745|FG001|Overall Study|Physician Decision|0|||
164316917|NCT03595618|593537746|FG002|Overall Study|Physician Decision|1|||
164316918|NCT03595618|593537747|FG003|Overall Study|Physician Decision|2|||
164316919|NCT03595618|593537744|FG000|Overall Study|Miscellaneous|7|||
164316920|NCT03595618|593537745|FG001|Overall Study|Miscellaneous|5|||
164316921|NCT03595618|593537746|FG002|Overall Study|Miscellaneous|10|||
164316922|NCT03595618|593537747|FG003|Overall Study|Miscellaneous|6|||
164316923|NCT02279407|593537748|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
164316924|NCT02279407|593537749|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
164316925|NCT02279407|593537750|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
164316926|NCT02279407|593537751|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
164316927|NCT02279407|593537748|FG000|Overall Study|Withdrawal by Subject|1|||
164316928|NCT02279407|593537749|FG001|Overall Study|Withdrawal by Subject|0|||
164316929|NCT02279407|593537750|FG002|Overall Study|Withdrawal by Subject|1|||
164316930|NCT02279407|593537751|FG003|Overall Study|Withdrawal by Subject|1|||
164316931|NCT02279407|593537748|FG000|Overall Study|Adverse Event|1|||
164316932|NCT02279407|593537749|FG001|Overall Study|Adverse Event|1|||
164316933|NCT02279407|593537750|FG002|Overall Study|Adverse Event|2|||
164316934|NCT02279407|593537751|FG003|Overall Study|Adverse Event|0|||
164316935|NCT03996369|593537758|FG000|Overall Study|Protocol deviation|1|||
164316936|NCT03996369|593537759|FG001|Overall Study|Protocol deviation|1|||
164316937|NCT03996369|593537758|FG000|Overall Study|Physician Decision|4|||
164316938|NCT03996369|593537759|FG001|Overall Study|Physician Decision|2|||
164316939|NCT03996369|593537758|FG000|Overall Study|Participant decision|0|||
164316940|NCT03996369|593537759|FG001|Overall Study|Participant decision|1|||
164316941|NCT03996369|593537758|FG000|Overall Study|Lack of Efficacy|4|||
164316942|NCT03996369|593537759|FG001|Overall Study|Lack of Efficacy|0|||
164316943|NCT03996369|593537758|FG000|Overall Study|Adverse Event|9|||
164316944|NCT03996369|593537759|FG001|Overall Study|Adverse Event|0|||
164316945|NCT03996369|593537758|FG000|Overall Study|Withdrawal by Subject|6|||
164316946|NCT03996369|593537759|FG001|Overall Study|Withdrawal by Subject|8|||
164316947|NCT03996369|593537758|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
164316948|NCT03996369|593537759|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
164316949|NCT03996369|593537758|FG000|Overall Study|Lost to Follow-up|0|||
164316950|NCT03996369|593537759|FG001|Overall Study|Lost to Follow-up|1|||
164316951|NCT01782469|593537760|FG000|Overall Study|Lost to Follow-up|1|||
164316952|NCT01038869|593537761|FG000|Overall Study|Withdrawal by Subject|1|||
164316953|NCT01038869|593537761|FG000|Overall Study|Lost to Follow-up|6|||
164316954|NCT04136444|593537762|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
164316955|NCT04136444|593537763|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
164316956|NCT02238067|593537764|FG000|Overall Study|Not completed survey at Month 6|45|||
164316957|NCT02213133|593537765|FG000|Overall Study|Participant discontinued study therapy|2|||
164316958|NCT02213133|593537766|FG001|Overall Study|Participant discontinued study therapy|0|||
164316959|NCT02213133|593537767|FG002|Overall Study|Participant discontinued study therapy|0|||
164316960|NCT02213133|593537765|FG000|Overall Study|Participant withdrew informed consent|2|||
164316961|NCT02213133|593537766|FG001|Overall Study|Participant withdrew informed consent|1|||
164316962|NCT02213133|593537767|FG002|Overall Study|Participant withdrew informed consent|2|||
164316963|NCT02213133|593537765|FG000|Overall Study|Disease progression|11|||
164316964|NCT02213133|593537766|FG001|Overall Study|Disease progression|2|||
164316965|NCT02213133|593537767|FG002|Overall Study|Disease progression|0|||
164316966|NCT02213133|593537765|FG000|Overall Study|Adverse Event (AE)|1|||
164316967|NCT02213133|593537766|FG001|Overall Study|Adverse Event (AE)|0|||
164316968|NCT02213133|593537767|FG002|Overall Study|Adverse Event (AE)|0|||
164316969|NCT02213133|593537765|FG000|Overall Study|Death|16|||
164316970|NCT02213133|593537766|FG001|Overall Study|Death|2|||
164316971|NCT02213133|593537767|FG002|Overall Study|Death|1|||
164316972|NCT02213133|593537765|FG000|Overall Study|Other|5|||
164316973|NCT02213133|593537766|FG001|Overall Study|Other|0|||
164316974|NCT02213133|593537767|FG002|Overall Study|Other|0|||
164316975|NCT01224782|593537768|FG000|Overall Study|Lost to Follow-up|177|||
164316976|NCT01224782|593537768|FG000|Overall Study|Withdrawal by Subject|16|||
164316977|NCT01224782|593537768|FG000|Overall Study|Death|14|||
164316978|NCT01224782|593537768|FG000|Overall Study|Improvement|13|||
164316979|NCT01224782|593537768|FG000|Overall Study|Adverse Event|12|||
164316980|NCT01224782|593537768|FG000|Overall Study|Adverse Reaction|11|||
164316981|NCT01224782|593537768|FG000|Overall Study|Noncompliance|10|||
164561889|NCT01687712|594425656|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
164561890|NCT01687712|594425657|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
164561891|NCT01687712|594425656|FG000|Cycle 1|Abortion|3|||
164561892|NCT01687712|594425657|FG001|Cycle 1|Abortion|0|||
164561893|NCT01687712|594425656|FG000|Cycle 1|Intrauterine Fetal Death|0|||
164316982|NCT01224782|593537768|FG000|Overall Study|Other|4|||
164316983|NCT01224782|593537768|FG000|Overall Study|Start of Dialysis|3|||
164561894|NCT01687712|594425657|FG001|Cycle 1|Intrauterine Fetal Death|1|||
164561895|NCT01687712|594425656|FG000|Cycle 1|Lost to Follow-up|1|||
164316984|NCT01224782|593537768|FG000|Overall Study|Change of Treatment|1|||
164561896|NCT01687712|594425657|FG001|Cycle 1|Lost to Follow-up|1|||
164316985|NCT01224782|593537768|FG000|Overall Study|Financial Reasons|1|||
164316986|NCT01224782|593537768|FG000|Overall Study|Deterioration|1|||
164316987|NCT01224782|593537768|FG000|Overall Study|Transplantation|1|||
164316988|NCT01960907|593537769|FG000|Overall Study|Death|4|||
164316989|NCT01960907|593537770|FG001|Overall Study|Death|3|||
164316990|NCT01960907|593537769|FG000|Overall Study|Withdrawal by Subject|32|||
164561897|NCT01687712|594425656|FG000|Cycle 2|Not Biochemically Pregnant|74|||
164316991|NCT01960907|593537770|FG001|Overall Study|Withdrawal by Subject|42|||
164316992|NCT00783198|593537776|FG000|Overall Study|Adverse Event|15|||
164316993|NCT00783198|593537777|FG001|Overall Study|Adverse Event|19|||
164316994|NCT00783198|593537778|FG002|Overall Study|Adverse Event|3|||
164316995|NCT00783198|593537776|FG000|Overall Study|Lost to Follow-up|11|||
164316996|NCT00783198|593537777|FG001|Overall Study|Lost to Follow-up|1|||
164316997|NCT00783198|593537778|FG002|Overall Study|Lost to Follow-up|7|||
164316998|NCT00783198|593537776|FG000|Overall Study|Withdrawal by Subject|22|||
164316999|NCT00783198|593537777|FG001|Overall Study|Withdrawal by Subject|14|||
164317000|NCT00783198|593537778|FG002|Overall Study|Withdrawal by Subject|20|||
164317001|NCT00783198|593537776|FG000|Overall Study|Noncompliance with protocol|7|||
164317002|NCT00783198|593537777|FG001|Overall Study|Noncompliance with protocol|7|||
164317003|NCT00783198|593537778|FG002|Overall Study|Noncompliance with protocol|10|||
164317004|NCT00783198|593537776|FG000|Overall Study|Did not meet protocol eligibility|0|||
164317005|NCT00783198|593537777|FG001|Overall Study|Did not meet protocol eligibility|1|||
164317006|NCT00783198|593537778|FG002|Overall Study|Did not meet protocol eligibility|0|||
164317007|NCT00783198|593537776|FG000|Overall Study|Administrative|2|||
164317008|NCT00783198|593537777|FG001|Overall Study|Administrative|1|||
164317009|NCT00783198|593537778|FG002|Overall Study|Administrative|2|||
164317010|NCT01546623|593537781|FG000|Overall Study|Adverse Event|2|||
164317011|NCT01546623|593537782|FG001|Overall Study|Adverse Event|3|||
164317012|NCT01546623|593537781|FG000|Overall Study|Major Protocol Deviation|1|||
164317013|NCT01546623|593537782|FG001|Overall Study|Major Protocol Deviation|1|||
164317014|NCT01546623|593537781|FG000|Overall Study|High Prostate specific antigen|2|||
164317015|NCT01546623|593537782|FG001|Overall Study|High Prostate specific antigen|1|||
164317016|NCT01546623|593537781|FG000|Overall Study|Did Not Receive Study Drug|1|||
164317017|NCT01546623|593537782|FG001|Overall Study|Did Not Receive Study Drug|1|||
164317018|NCT04525885|593537783|FG000|Overall Study|Screen Failure|1|||
164317019|NCT04525885|593537784|FG001|Overall Study|Screen Failure|0|||
164317020|NCT04525885|593537785|FG002|Overall Study|Screen Failure|0|||
164317021|NCT04525885|593537783|FG000|Overall Study|Withdrawal by Subject|14|||
164317022|NCT04525885|593537784|FG001|Overall Study|Withdrawal by Subject|6|||
164317023|NCT04525885|593537785|FG002|Overall Study|Withdrawal by Subject|20|||
164317024|NCT04525885|593537783|FG000|Overall Study|Physician Decision|1|||
164317025|NCT04525885|593537784|FG001|Overall Study|Physician Decision|0|||
164317026|NCT04525885|593537785|FG002|Overall Study|Physician Decision|1|||
164317027|NCT02756806|593537786|FG000|Overall Study|Study terminated early|5|||
164317028|NCT03158285|593537787|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
164317029|NCT03158285|593537788|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
164317030|NCT03158285|593537789|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
164317031|NCT03158285|593537787|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
164317032|NCT03158285|593537788|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
164317033|NCT03158285|593537789|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
164317034|NCT03158285|593537787|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
164317035|NCT03158285|593537788|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
164317036|NCT03158285|593537789|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
164317037|NCT03158285|593537787|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
164317038|NCT03158285|593537788|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
164317039|NCT03158285|593537789|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
164317040|NCT03158285|593537787|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
164317041|NCT03158285|593537788|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
164317042|NCT03158285|593537789|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
164317043|NCT03158285|593537787|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
164317044|NCT03158285|593537788|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
164317045|NCT03158285|593537789|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
164317046|NCT03158285|593537787|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
164317047|NCT03158285|593537788|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
164317048|NCT03158285|593537789|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
164317049|NCT03158285|593537787|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
164317050|NCT03158285|593537788|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
164317051|NCT03158285|593537789|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
164317052|NCT03158285|593537787|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
164317053|NCT03158285|593537788|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
164317054|NCT03158285|593537789|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
164317055|NCT03158285|593537787|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
164317056|NCT03158285|593537788|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
164317057|NCT03158285|593537789|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
164317058|NCT03158285|593537787|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
164317059|NCT03158285|593537788|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
164317060|NCT03158285|593537789|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
164317061|NCT03158285|593537787|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
164317062|NCT03158285|593537788|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
164317063|NCT03158285|593537789|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
164317064|NCT03158285|593537787|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
164317065|NCT03158285|593537788|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
164317066|NCT03158285|593537789|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
164317067|NCT03158285|593537787|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
164317068|NCT03158285|593537788|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
164317069|NCT03158285|593537789|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
164317070|NCT03158285|593537787|FG000|Active Treatment Period: Week 52-100|Death|1|||
164317071|NCT03158285|593537788|FG001|Active Treatment Period: Week 52-100|Death|0|||
164317072|NCT03158285|593537789|FG002|Active Treatment Period: Week 52-100|Death|0|||
164317073|NCT03158285|593537787|FG000|Active Treatment Period: Week 52-100|Other|4|||
164317074|NCT03158285|593537788|FG001|Active Treatment Period: Week 52-100|Other|1|||
164317075|NCT03158285|593537789|FG002|Active Treatment Period: Week 52-100|Other|0|||
164317076|NCT01642615|593537792|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
164317077|NCT01642615|593537793|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
164317078|NCT01642615|593537794|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
164317079|NCT01642615|593537792|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
164317080|NCT01642615|593537793|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
164317081|NCT01642615|593537794|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
164317082|NCT01642615|593537792|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
164317083|NCT01642615|593537793|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
164317084|NCT01642615|593537794|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
164317085|NCT01642615|593537792|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
164317086|NCT01642615|593537793|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
164317087|NCT01642615|593537794|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
164317088|NCT01642615|593537792|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
164317089|NCT01642615|593537793|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
164317090|NCT01642615|593537794|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
164317091|NCT01642615|593537792|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
164317092|NCT01642615|593537793|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
164317093|NCT01642615|593537794|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
164317094|NCT01642615|593537792|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
164317095|NCT01642615|593537793|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
164317096|NCT01642615|593537794|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
164317097|NCT01642615|593537792|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
164317098|NCT01642615|593537793|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
164317099|NCT01642615|593537794|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
164317100|NCT01642615|593537792|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
164317101|NCT01642615|593537793|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
164317102|NCT01642615|593537794|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
164317103|NCT00750152|593537795|FG000|Overall Study|Adverse Event|2|||
164317104|NCT00750152|593537796|FG001|Overall Study|Adverse Event|1|||
164317105|NCT00750152|593537795|FG000|Overall Study|Lost to Follow-up|8|||
164317106|NCT00750152|593537796|FG001|Overall Study|Lost to Follow-up|13|||
164317107|NCT00750152|593537795|FG000|Overall Study|Withdrawal by Subject|3|||
164317108|NCT00750152|593537796|FG001|Overall Study|Withdrawal by Subject|3|||
164317109|NCT00750152|593537795|FG000|Overall Study|Physician Decision|1|||
164317110|NCT00750152|593537796|FG001|Overall Study|Physician Decision|1|||
164317111|NCT00750152|593537795|FG000|Overall Study|Non-compliance|0|||
164317112|NCT00750152|593537796|FG001|Overall Study|Non-compliance|1|||
164317113|NCT00750152|593537795|FG000|Overall Study|Termination by sponsor|1|||
164317114|NCT00750152|593537796|FG001|Overall Study|Termination by sponsor|0|||
164317115|NCT00750152|593537795|FG000|Overall Study|Other|7|||
164317116|NCT00750152|593537796|FG001|Overall Study|Other|8|||
164317117|NCT00978757|593537801|FG000|Overall Study|Physician Decision|1|||
164317118|NCT00978757|593537802|FG001|Overall Study|Physician Decision|3|||
164317119|NCT01028300|593537803|FG000|Overall Study|Study Terminated|4|||
164317120|NCT00402740|593537804|FG000|Overall Study|Withdrawal by Subject|18|||
164317121|NCT00402740|593537804|FG000|Overall Study|Death|50|||
164317122|NCT00402740|593537804|FG000|Overall Study|Lost to Follow-up|6|||
164317123|NCT00402740|593537804|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
164317124|NCT00402740|593537804|FG000|Overall Study|Subject disposition unknown.|1|||
164317125|NCT00946153|593537807|FG000|Phase 2|Adverse Event|0|||
164317126|NCT00946153|593537808|FG001|Phase 2|Adverse Event|0|||
164317127|NCT00946153|593537809|FG002|Phase 2|Adverse Event|0|||
164317128|NCT00946153|593537810|FG003|Phase 2|Adverse Event|0|||
164317129|NCT00946153|593537811|FG004|Phase 2|Adverse Event|6|||
164317130|NCT00946153|593537807|FG000|Phase 2|Need more reduction of dose|0|||
164317131|NCT00946153|593537808|FG001|Phase 2|Need more reduction of dose|0|||
164317132|NCT00946153|593537809|FG002|Phase 2|Need more reduction of dose|0|||
164317133|NCT00946153|593537810|FG003|Phase 2|Need more reduction of dose|0|||
164317134|NCT00946153|593537811|FG004|Phase 2|Need more reduction of dose|2|||
164317135|NCT00946153|593537807|FG000|Phase 2|Physician Decision|0|||
164317136|NCT00946153|593537808|FG001|Phase 2|Physician Decision|0|||
164317137|NCT00946153|593537809|FG002|Phase 2|Physician Decision|0|||
164317138|NCT00946153|593537810|FG003|Phase 2|Physician Decision|0|||
164317139|NCT00946153|593537811|FG004|Phase 2|Physician Decision|1|||
164317140|NCT00946153|593537807|FG000|Phase 2|14 days washout for recovery due to AE|0|||
164317141|NCT00946153|593537808|FG001|Phase 2|14 days washout for recovery due to AE|0|||
164317142|NCT00946153|593537809|FG002|Phase 2|14 days washout for recovery due to AE|0|||
164317143|NCT00946153|593537810|FG003|Phase 2|14 days washout for recovery due to AE|0|||
164317144|NCT00946153|593537811|FG004|Phase 2|14 days washout for recovery due to AE|4|||
164317145|NCT04002908|593537822|FG000|Overall Study|Death|41|||
164317146|NCT04002908|593537823|FG001|Overall Study|Death|0|||
164317147|NCT04002908|593537824|FG002|Overall Study|Death|0|||
164317148|NCT04002908|593537825|FG003|Overall Study|Death|0|||
164317149|NCT04002908|593537822|FG000|Overall Study|Withdrawal by Subject|112|||
164317150|NCT04002908|593537823|FG001|Overall Study|Withdrawal by Subject|0|||
164317151|NCT04002908|593537824|FG002|Overall Study|Withdrawal by Subject|0|||
164317152|NCT04002908|593537825|FG003|Overall Study|Withdrawal by Subject|0|||
164317153|NCT04002908|593537822|FG000|Overall Study|Lost to Follow-up|72|||
164317154|NCT04002908|593537823|FG001|Overall Study|Lost to Follow-up|0|||
164317155|NCT04002908|593537824|FG002|Overall Study|Lost to Follow-up|0|||
164317156|NCT04002908|593537825|FG003|Overall Study|Lost to Follow-up|0|||
164317157|NCT04002908|593537822|FG000|Overall Study|Infant died, so mother withdrawn|34|||
164317158|NCT04002908|593537823|FG001|Overall Study|Infant died, so mother withdrawn|0|||
164317159|NCT04002908|593537824|FG002|Overall Study|Infant died, so mother withdrawn|0|||
164317160|NCT04002908|593537825|FG003|Overall Study|Infant died, so mother withdrawn|0|||
164317161|NCT01011309|593537826|FG000|Overall Study|Adverse Event|2|||
164317162|NCT01011309|593537827|FG001|Overall Study|Adverse Event|1|||
164317163|NCT01011309|593537828|FG002|Overall Study|Adverse Event|2|||
164317164|NCT01011309|593537826|FG000|Overall Study|Lack of Efficacy|0|||
164317165|NCT01011309|593537827|FG001|Overall Study|Lack of Efficacy|1|||
164317166|NCT01011309|593537828|FG002|Overall Study|Lack of Efficacy|0|||
164317167|NCT01011309|593537826|FG000|Overall Study|Protocol Violation|0|||
164317168|NCT01011309|593537827|FG001|Overall Study|Protocol Violation|1|||
164317169|NCT01011309|593537828|FG002|Overall Study|Protocol Violation|3|||
164317170|NCT00006289|593537833|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
164317171|NCT00006289|593537834|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
164317172|NCT00006289|593537833|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
164317173|NCT00006289|593537834|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
164317174|NCT04359901|593537842|FG000|Overall Study|Withdrawal by Subject|0|||
164317175|NCT04359901|593537843|FG001|Overall Study|Withdrawal by Subject|1|||
164317176|NCT04359901|593537842|FG000|Overall Study|Death|6|||
164317177|NCT04359901|593537843|FG001|Overall Study|Death|2|||
164317178|NCT00557856|593537844|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
164317179|NCT00557856|593537845|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
164317180|NCT00557856|593537846|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
164317181|NCT00557856|593537847|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
164317182|NCT00557856|593537848|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
164317183|NCT00557856|593537849|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
164317184|NCT00557856|593537850|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
164317185|NCT00557856|593537851|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
164317186|NCT00557856|593537852|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
164317187|NCT00557856|593537844|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
164317188|NCT00557856|593537845|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
164317189|NCT00557856|593537846|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
164317190|NCT00557856|593537847|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
164317191|NCT00557856|593537848|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
164317192|NCT00557856|593537849|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
164317193|NCT00557856|593537850|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
164317194|NCT00557856|593537851|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
164317195|NCT00557856|593537852|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
164317196|NCT00557856|593537844|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
164420631|NCT01154036|593910962|FG000|Phase I|Lost to Follow-up|0|||
164317197|NCT00557856|593537845|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
164317198|NCT00557856|593537846|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
164317199|NCT00557856|593537847|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
164317200|NCT00557856|593537848|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
164317201|NCT00557856|593537849|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
164317202|NCT00557856|593537850|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
164317203|NCT00557856|593537851|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
164420632|NCT01154036|593910963|FG001|Phase I|Lost to Follow-up|3|||
164317204|NCT00557856|593537852|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
164317205|NCT00557856|593537844|FG000|Part 1: Dose Escalation Phase|Other|0|||
164317206|NCT00557856|593537845|FG001|Part 1: Dose Escalation Phase|Other|0|||
164317207|NCT00557856|593537846|FG002|Part 1: Dose Escalation Phase|Other|1|||
164317208|NCT00557856|593537847|FG003|Part 1: Dose Escalation Phase|Other|1|||
164317209|NCT00557856|593537848|FG004|Part 1: Dose Escalation Phase|Other|0|||
164317210|NCT00557856|593537849|FG005|Part 1: Dose Escalation Phase|Other|0|||
164317211|NCT00557856|593537850|FG006|Part 1: Dose Escalation Phase|Other|0|||
164317212|NCT00557856|593537851|FG007|Part 1: Dose Escalation Phase|Other|1|||
164317213|NCT00557856|593537852|FG008|Part 1: Dose Escalation Phase|Other|0|||
164317214|NCT00557856|593537844|FG000|Part 1: Dose Escalation Phase|Death|0|||
164317215|NCT00557856|593537845|FG001|Part 1: Dose Escalation Phase|Death|0|||
164317216|NCT00557856|593537846|FG002|Part 1: Dose Escalation Phase|Death|0|||
164317217|NCT00557856|593537847|FG003|Part 1: Dose Escalation Phase|Death|0|||
164317218|NCT00557856|593537848|FG004|Part 1: Dose Escalation Phase|Death|0|||
164317219|NCT00557856|593537849|FG005|Part 1: Dose Escalation Phase|Death|1|||
164317220|NCT00557856|593537850|FG006|Part 1: Dose Escalation Phase|Death|0|||
164317221|NCT00557856|593537851|FG007|Part 1: Dose Escalation Phase|Death|0|||
164317222|NCT00557856|593537852|FG008|Part 1: Dose Escalation Phase|Death|0|||
164317223|NCT00557856|593537844|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
164317224|NCT00557856|593537845|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
164317225|NCT00557856|593537846|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
164317226|NCT00557856|593537847|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
164317227|NCT00557856|593537848|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
164317228|NCT00557856|593537849|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
164317229|NCT00557856|593537850|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
164317230|NCT00557856|593537851|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
164317231|NCT00557856|593537852|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
164317232|NCT00557856|593537844|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
164317233|NCT00557856|593537845|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
164317234|NCT00557856|593537846|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
164317235|NCT00557856|593537847|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
164317236|NCT00557856|593537848|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
164317237|NCT00557856|593537849|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
164317238|NCT00557856|593537850|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
164317239|NCT00557856|593537851|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
164317240|NCT00557856|593537852|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
164317241|NCT00557856|593537844|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
164317242|NCT00557856|593537845|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
164317243|NCT00557856|593537846|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
164317244|NCT00557856|593537847|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
164317245|NCT00557856|593537848|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
164317246|NCT00557856|593537849|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
164317247|NCT00557856|593537850|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
164317248|NCT00557856|593537851|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
164317249|NCT00557856|593537852|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
164317250|NCT00557856|593537844|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
164317251|NCT00557856|593537845|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
164317252|NCT00557856|593537846|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
164317253|NCT00557856|593537847|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
164317254|NCT00557856|593537848|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
164317255|NCT00557856|593537849|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
164317256|NCT00557856|593537850|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
164561898|NCT01687712|594425657|FG001|Cycle 2|Not Biochemically Pregnant|77|||
164561899|NCT01687712|594425656|FG000|Cycle 2|Early Pregnancy Loss|18|||
164561900|NCT01687712|594425657|FG001|Cycle 2|Early Pregnancy Loss|16|||
164561901|NCT01687712|594425656|FG000|Cycle 2|Ectopic Pregnancy|0|||
164561902|NCT01687712|594425657|FG001|Cycle 2|Ectopic Pregnancy|1|||
164561903|NCT01687712|594425656|FG000|Cycle 2|Still Birth|1|||
164561904|NCT01687712|594425657|FG001|Cycle 2|Still Birth|0|||
164561905|NCT01687712|594425656|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
164561906|NCT01687712|594425657|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
164561907|NCT01687712|594425656|FG000|Cycle 3|Not Biochemically Pregnant|21|||
164561908|NCT01687712|594425657|FG001|Cycle 3|Not Biochemically Pregnant|22|||
164561909|NCT01687712|594425656|FG000|Cycle 3|Early Pregnancy Loss|1|||
164561910|NCT01687712|594425657|FG001|Cycle 3|Early Pregnancy Loss|2|||
164317257|NCT00557856|593537851|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
164317258|NCT00557856|593537852|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
164317259|NCT00557856|593537844|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
164665977|NCT01199861|594801557|FG000|Overall Study|Adverse Event|1|||
164665978|NCT01199861|594801558|FG001|Overall Study|Adverse Event|0|||
164665979|NCT05630547|594801559|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
164317260|NCT00557856|593537845|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
164665980|NCT05630547|594801560|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
164665981|NCT05630547|594801561|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
164665982|NCT05630547|594801562|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
164665983|NCT05630547|594801559|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
164665984|NCT05630547|594801560|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
164665985|NCT05630547|594801561|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
164665986|NCT05630547|594801562|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
164665987|NCT05630547|594801559|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
164665988|NCT05630547|594801560|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
164665989|NCT05630547|594801561|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
164665990|NCT05630547|594801562|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
164665991|NCT05630547|594801559|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
164665992|NCT05630547|594801560|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
164665993|NCT05630547|594801561|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
164665994|NCT05630547|594801562|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
164665995|NCT05630547|594801559|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
164317261|NCT00557856|593537846|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
164317262|NCT00557856|593537847|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
164317263|NCT00557856|593537848|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
164317264|NCT00557856|593537849|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
164317265|NCT00557856|593537850|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
164317266|NCT00557856|593537851|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
164317267|NCT00557856|593537852|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
164317268|NCT00557856|593537844|FG000|Part 2: Exploratory Phase|Other|0|||
164317269|NCT00557856|593537845|FG001|Part 2: Exploratory Phase|Other|0|||
164317270|NCT00557856|593537846|FG002|Part 2: Exploratory Phase|Other|0|||
164317271|NCT00557856|593537847|FG003|Part 2: Exploratory Phase|Other|0|||
164317272|NCT00557856|593537848|FG004|Part 2: Exploratory Phase|Other|0|||
164317273|NCT00557856|593537849|FG005|Part 2: Exploratory Phase|Other|0|||
164317274|NCT00557856|593537850|FG006|Part 2: Exploratory Phase|Other|0|||
164317275|NCT00557856|593537851|FG007|Part 2: Exploratory Phase|Other|0|||
164317276|NCT00557856|593537852|FG008|Part 2: Exploratory Phase|Other|1|||
164317277|NCT00557856|593537844|FG000|Part 2: Exploratory Phase|Death|0|||
164317278|NCT00557856|593537845|FG001|Part 2: Exploratory Phase|Death|0|||
164317279|NCT00557856|593537846|FG002|Part 2: Exploratory Phase|Death|0|||
164317280|NCT00557856|593537847|FG003|Part 2: Exploratory Phase|Death|0|||
164317281|NCT00557856|593537848|FG004|Part 2: Exploratory Phase|Death|0|||
164317282|NCT00557856|593537849|FG005|Part 2: Exploratory Phase|Death|0|||
164317283|NCT00557856|593537850|FG006|Part 2: Exploratory Phase|Death|0|||
164317284|NCT00557856|593537851|FG007|Part 2: Exploratory Phase|Death|0|||
164317285|NCT00557856|593537852|FG008|Part 2: Exploratory Phase|Death|2|||
164317286|NCT00557856|593537844|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
164317287|NCT00557856|593537845|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
164317288|NCT00557856|593537846|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
164317289|NCT00557856|593537847|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
164317290|NCT00557856|593537848|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
164665996|NCT05630547|594801560|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
164665997|NCT05630547|594801561|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
164665998|NCT05630547|594801562|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
164665999|NCT05630547|594801559|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
164666000|NCT05630547|594801560|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
164666001|NCT05630547|594801561|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
164666002|NCT05630547|594801562|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
164666003|NCT05630547|594801559|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
164666004|NCT05630547|594801560|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
164666005|NCT05630547|594801561|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
164317291|NCT00557856|593537849|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
164317292|NCT00557856|593537850|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
164317293|NCT00557856|593537851|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
164317294|NCT00557856|593537852|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
164317295|NCT03255083|593537853|FG000|Overall Study|Clinical progression|1|||
164317296|NCT03255083|593537854|FG001|Overall Study|Clinical progression|0|||
164317297|NCT03255083|593537855|FG002|Overall Study|Clinical progression|0|||
164317298|NCT03255083|593537856|FG003|Overall Study|Clinical progression|0|||
164317299|NCT03255083|593537853|FG000|Overall Study|Adverse Event|0|||
164420633|NCT01154036|593910964|FG002|Phase I|Lost to Follow-up|6|||
164666006|NCT05630547|594801562|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
164666007|NCT05630547|594801559|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
164666008|NCT05630547|594801560|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
164666009|NCT05630547|594801561|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
164666010|NCT05630547|594801562|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
164666011|NCT05630547|594801559|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
164666012|NCT05630547|594801560|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
164666013|NCT05630547|594801561|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
164666014|NCT05630547|594801562|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
164666015|NCT05630547|594801559|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
164666016|NCT05630547|594801560|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
164666017|NCT05630547|594801561|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
164666018|NCT05630547|594801562|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
164666019|NCT05049460|594801563|FG000|Overall Study|Withdrawal by Subject|2|||
164666020|NCT05049460|594801564|FG001|Overall Study|Withdrawal by Subject|2|||
164666021|NCT05049460|594801563|FG000|Overall Study|Lost to Follow-up|2|||
164666022|NCT05049460|594801564|FG001|Overall Study|Lost to Follow-up|2|||
164666023|NCT00117949|594801569|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
164666024|NCT00117949|594801570|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
164666025|NCT00117949|594801571|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
164666026|NCT00117949|594801572|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
164666027|NCT00117949|594801569|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
164666028|NCT00117949|594801570|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
164666029|NCT00117949|594801571|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
164666030|NCT00117949|594801572|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
164666031|NCT00117949|594801569|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
164666032|NCT00117949|594801570|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
164666033|NCT00117949|594801571|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
164666034|NCT00117949|594801572|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
164666035|NCT00117949|594801569|FG000|Overall Study|PSA increase >=10ng/mL|0|||
164666036|NCT00117949|594801570|FG001|Overall Study|PSA increase >=10ng/mL|1|||
164666037|NCT00117949|594801571|FG002|Overall Study|PSA increase >=10ng/mL|1|||
164666038|NCT00117949|594801572|FG003|Overall Study|PSA increase >=10ng/mL|0|||
164666039|NCT00117949|594801569|FG000|Overall Study|PSA reduction <=50%|0|||
164666040|NCT00117949|594801570|FG001|Overall Study|PSA reduction <=50%|2|||
164666041|NCT00117949|594801571|FG002|Overall Study|PSA reduction <=50%|2|||
164666042|NCT00117949|594801572|FG003|Overall Study|PSA reduction <=50%|4|||
164666043|NCT00117949|594801569|FG000|Overall Study|Hepatic abnormalities|0|||
164666044|NCT00117949|594801570|FG001|Overall Study|Hepatic abnormalities|1|||
164666045|NCT00117949|594801571|FG002|Overall Study|Hepatic abnormalities|0|||
164666046|NCT00117949|594801572|FG003|Overall Study|Hepatic abnormalities|1|||
164666047|NCT01974141|594801573|FG000|Overall Study|Other Reasons|28|||
164666048|NCT01974141|594801574|FG001|Overall Study|Other Reasons|18|||
164666049|NCT01974141|594801573|FG000|Overall Study|Protocol Violation|2|||
164666050|NCT01974141|594801574|FG001|Overall Study|Protocol Violation|6|||
164666051|NCT01974141|594801573|FG000|Overall Study|Personal Reasons|21|||
164666052|NCT01974141|594801574|FG001|Overall Study|Personal Reasons|20|||
164666053|NCT01974141|594801573|FG000|Overall Study|Lost to Follow-up|38|||
164666054|NCT01974141|594801574|FG001|Overall Study|Lost to Follow-up|29|||
164666055|NCT01974141|594801573|FG000|Overall Study|Pregnancy|3|||
164666056|NCT01974141|594801574|FG001|Overall Study|Pregnancy|3|||
164561911|NCT01687712|594425656|FG000|Cycle 3|Ectopic Pregnancy|1|||
164561912|NCT01687712|594425657|FG001|Cycle 3|Ectopic Pregnancy|0|||
164561913|NCT01687712|594425656|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
164561914|NCT01687712|594425657|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
164561915|NCT00516737|594425664|FG000|Overall Study|Lost to Follow-up|2|||
164561916|NCT00516737|594425665|FG001|Overall Study|Lost to Follow-up|0|||
164561917|NCT00516737|594425664|FG000|Overall Study|Physician Decision|0|||
164561918|NCT00516737|594425665|FG001|Overall Study|Physician Decision|1|||
164561919|NCT00516737|594425664|FG000|Overall Study|Withdrawal by Subject|0|||
164561920|NCT00516737|594425665|FG001|Overall Study|Withdrawal by Subject|1|||
164561921|NCT00516737|594425664|FG000|Overall Study|Lack of Qualifying Event|9|||
164561922|NCT00516737|594425665|FG001|Overall Study|Lack of Qualifying Event|6|||
164561923|NCT01816243|594425666|FG000|Overall Study|Adverse Event|6|||
164561924|NCT01816243|594425666|FG000|Overall Study|Lost to Follow-up|1|||
164561925|NCT01816243|594425666|FG000|Overall Study|Lack of Efficacy|1|||
164561926|NCT01816243|594425666|FG000|Overall Study|Not eligible for the study|1|||
164666057|NCT01974141|594801573|FG000|Overall Study|Lack of Efficacy|0|||
164666058|NCT01974141|594801574|FG001|Overall Study|Lack of Efficacy|1|||
164666059|NCT01974141|594801573|FG000|Overall Study|Adverse Event|4|||
164666060|NCT01974141|594801574|FG001|Overall Study|Adverse Event|5|||
164666061|NCT01867242|594801579|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
164561927|NCT01816243|594425666|FG000|Overall Study|Amputation|3|||
164561928|NCT00512798|594425667|FG000|Overall Study|Death|0|||
164561929|NCT00512798|594425668|FG001|Overall Study|Death|3|||
164666062|NCT01867242|594801580|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
164666063|NCT01867242|594801581|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
164666064|NCT00406848|594801582|FG000|Overall Study|Withdrawal by Subject|27|||
164666065|NCT00406848|594801583|FG001|Overall Study|Withdrawal by Subject|22|||
164666066|NCT00406848|594801582|FG000|Overall Study|Adverse Event|38|||
164666067|NCT00406848|594801583|FG001|Overall Study|Adverse Event|7|||
164666068|NCT00406848|594801582|FG000|Overall Study|Lack of Efficacy|9|||
164666069|NCT00406848|594801583|FG001|Overall Study|Lack of Efficacy|14|||
164666070|NCT00406848|594801582|FG000|Overall Study|Protocol Violation|10|||
164666071|NCT00406848|594801583|FG001|Overall Study|Protocol Violation|6|||
164666072|NCT00406848|594801582|FG000|Overall Study|Lost to Follow-up|6|||
164666073|NCT00406848|594801583|FG001|Overall Study|Lost to Follow-up|2|||
164205479|NCT04711005|593121268|FG007|Overall Study|Physician Decision|2|||
164205480|NCT04711005|593121269|FG008|Overall Study|Physician Decision|1|||
164205481|NCT04711005|593121270|FG009|Overall Study|Physician Decision|0|||
164205482|NCT00764790|593121271|FG000|Overall Study|Protocol Violation|0|||
164205483|NCT00764790|593121272|FG001|Overall Study|Protocol Violation|0|||
164205484|NCT00764790|593121273|FG002|Overall Study|Protocol Violation|1|||
164205485|NCT00764790|593121271|FG000|Overall Study|Withdrawal by Subject|10|||
164205486|NCT00764790|593121272|FG001|Overall Study|Withdrawal by Subject|12|||
164205487|NCT00764790|593121273|FG002|Overall Study|Withdrawal by Subject|6|||
164205488|NCT00764790|593121271|FG000|Overall Study|Lost to Follow-up|28|||
164205489|NCT00764790|593121272|FG001|Overall Study|Lost to Follow-up|29|||
164205490|NCT00764790|593121273|FG002|Overall Study|Lost to Follow-up|23|||
164205491|NCT03191552|593121274|FG000|Overall Study|Lost to Follow-up|1|||
164205492|NCT03191552|593121275|FG001|Overall Study|Lost to Follow-up|0|||
164205493|NCT03191552|593121276|FG002|Overall Study|Lost to Follow-up|0|||
164205494|NCT03191552|593121274|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
164205495|NCT03191552|593121275|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
164205496|NCT03191552|593121276|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
164205497|NCT00788671|593122615|FG000|Overall Study|Death|2|||
164205498|NCT00788671|593122615|FG000|Overall Study|Unable to biopsy|1|||
164205499|NCT00788671|593122615|FG000|Overall Study|Withdrawal by Subject|4|||
164205500|NCT00788671|593122615|FG000|Overall Study|IUD expulsed|1|||
164205501|NCT00788671|593122615|FG000|Overall Study|Lost to follow up|2|||
164205502|NCT04780659|593122616|FG000|Overall Study|Adverse event, serious fatal|3|||
164205503|NCT04780659|593122617|FG001|Overall Study|Adverse event, serious fatal|0|||
164205504|NCT04780659|593122616|FG000|Overall Study|Withdrawal by Subject|3|||
164205505|NCT04780659|593122617|FG001|Overall Study|Withdrawal by Subject|0|||
164205506|NCT04780659|593122616|FG000|Overall Study|Physician Decision|1|||
164205507|NCT04780659|593122617|FG001|Overall Study|Physician Decision|0|||
164205508|NCT04780659|593122616|FG000|Overall Study|Died in original disease|2|||
164205509|NCT04780659|593122617|FG001|Overall Study|Died in original disease|0|||
164205510|NCT04780659|593122616|FG000|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|1|||
164205511|NCT04780659|593122617|FG001|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|0|||
164205512|NCT03729362|593122618|FG000|Overall Study|Withdrawal by Subject|2|||
164205513|NCT03729362|593122619|FG001|Overall Study|Withdrawal by Subject|0|||
164205514|NCT03729362|593122618|FG000|Overall Study|Physician Decision|1|||
164205515|NCT03729362|593122619|FG001|Overall Study|Physician Decision|0|||
164205516|NCT03729362|593122618|FG000|Overall Study|COVID-19 Pandemic|1|||
164205517|NCT03729362|593122619|FG001|Overall Study|COVID-19 Pandemic|0|||
164205518|NCT03729362|593122618|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
164205519|NCT03729362|593122619|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
164205520|NCT03729362|593122618|FG000|Overall Study|Adverse Event|0|||
164205521|NCT03729362|593122619|FG001|Overall Study|Adverse Event|1|||
164205522|NCT03729362|593122618|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
164205523|NCT03729362|593122619|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
164205524|NCT03405870|593122620|FG000|Overall Study|Withdrawal|1|||
164205525|NCT03405870|593122621|FG001|Overall Study|Withdrawal|0|||
164205526|NCT03405870|593122622|FG002|Overall Study|Withdrawal|1|||
164205527|NCT03405870|593122623|FG003|Overall Study|Withdrawal|0|||
164205528|NCT03405870|593122624|FG004|Overall Study|Withdrawal|0|||
164205529|NCT03405870|593122625|FG005|Overall Study|Withdrawal|0|||
164205530|NCT03405870|593122626|FG006|Overall Study|Withdrawal|1|||
164205531|NCT03405870|593122627|FG007|Overall Study|Withdrawal|0|||
164205532|NCT02807259|593122630|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
164205533|NCT02807259|593122631|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
164205534|NCT02807259|593122630|FG000|Midline (3 Months)|migration, refusal, not available|30|||
164666074|NCT00406848|594801582|FG000|Overall Study|Physician Decision|2|||
164205535|NCT02807259|593122631|FG001|Midline (3 Months)|migration, refusal, not available|34|||
164205536|NCT02807259|593122630|FG000|Endline (3 Months)|migration, refusal, not available|35|||
164205537|NCT02807259|593122631|FG001|Endline (3 Months)|migration, refusal, not available|87|||
164666075|NCT00406848|594801583|FG001|Overall Study|Physician Decision|2|||
164666076|NCT00406848|594801582|FG000|Overall Study|Sponsor Decision|1|||
164317300|NCT03255083|593537854|FG001|Overall Study|Adverse Event|1|||
164666077|NCT00406848|594801583|FG001|Overall Study|Sponsor Decision|1|||
164317301|NCT03255083|593537855|FG002|Overall Study|Adverse Event|0|||
164317302|NCT03255083|593537856|FG003|Overall Study|Adverse Event|0|||
164317303|NCT03255083|593537853|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
164317304|NCT03255083|593537854|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
164317305|NCT03255083|593537855|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
164317306|NCT03255083|593537856|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
164317307|NCT03255083|593537853|FG000|Overall Study|Withdrawal by Subject|1|||
164317308|NCT03255083|593537854|FG001|Overall Study|Withdrawal by Subject|1|||
164317309|NCT03255083|593537855|FG002|Overall Study|Withdrawal by Subject|1|||
164317310|NCT03255083|593537856|FG003|Overall Study|Withdrawal by Subject|0|||
164317311|NCT05601544|593537857|FG000|Phase 2 Period 1|Adverse Event|0|||
164317312|NCT05601544|593537858|FG001|Phase 2 Period 1|Adverse Event|1|||
164317313|NCT05601544|593537859|FG002|Phase 2 Period 1|Adverse Event|0|||
164317314|NCT05601544|593537860|FG003|Phase 2 Period 1|Adverse Event|0|||
164317315|NCT05601544|593537861|FG004|Phase 2 Period 1|Adverse Event|0|||
164317316|NCT05601544|593537862|FG005|Phase 2 Period 1|Adverse Event|0|||
164317317|NCT02537015|593537869|FG000|Overall Study|Adverse Event|3|||
164317318|NCT02537015|593537869|FG000|Overall Study|Withdrawal by Subject|2|||
164317319|NCT02537015|593537869|FG000|Overall Study|Other Miscellaneous Reasons|1|||
164317320|NCT02626624|593537877|FG000|Overall Study|Adverse Event|1|||
164317321|NCT02626624|593537877|FG000|Overall Study|Lost to Follow-up|3|||
164317322|NCT02626624|593537877|FG000|Overall Study|Protocol Violation|4|||
164317323|NCT02626624|593537877|FG000|Overall Study|Death|2|||
164317324|NCT02043899|593539188|FG000|Overall Study|Adverse Event|3|||
164317325|NCT02043899|593539188|FG000|Overall Study|Physician Decision|1|||
164317326|NCT02043899|593539188|FG000|Overall Study|Withdrawal by Subject|2|||
164317327|NCT02043899|593539188|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
164317328|NCT02043899|593539188|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
164317329|NCT02043899|593539188|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
164317330|NCT02043899|593539188|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
164317331|NCT02043899|593539188|FG000|Overall Study|Treatment delayed|1|||
164317332|NCT01771809|593539190|FG000|Overall Study|Adverse Event|4|||
164317333|NCT01771809|593539191|FG001|Overall Study|Adverse Event|12|||
164317334|NCT01771809|593539190|FG000|Overall Study|Protocol Violation|0|||
164317335|NCT01771809|593539191|FG001|Overall Study|Protocol Violation|1|||
164317336|NCT01771809|593539190|FG000|Overall Study|Withdrawal by Subject|34|||
164317337|NCT01771809|593539191|FG001|Overall Study|Withdrawal by Subject|42|||
164317338|NCT01771809|593539190|FG000|Overall Study|Lost to Follow-up|1|||
164317339|NCT01771809|593539191|FG001|Overall Study|Lost to Follow-up|3|||
164317340|NCT01771809|593539190|FG000|Overall Study|Other (Insufficient clinical response)|22|||
164317341|NCT01771809|593539191|FG001|Overall Study|Other (Insufficient clinical response)|20|||
164317342|NCT01771809|593539190|FG000|Overall Study|Death|1|||
164317343|NCT01771809|593539191|FG001|Overall Study|Death|0|||
164317344|NCT01771809|593539190|FG000|Overall Study|Other (other)|9|||
164317345|NCT01771809|593539191|FG001|Overall Study|Other (other)|5|||
164205538|NCT01171534|593122632|FG000|Overall Study|Lost to Follow-up|0|||
164205539|NCT01171534|593122633|FG001|Overall Study|Lost to Follow-up|2|||
164317346|NCT00362180|593539192|FG000|Treated Period|Withdrawal by Subject|1|||
164317347|NCT00362180|593539193|FG001|Treated Period|Withdrawal by Subject|0|||
164317348|NCT00362180|593539194|FG002|Treated Period|Withdrawal by Subject|0|||
164317349|NCT00362180|593539195|FG003|Treated Period|Withdrawal by Subject|0|||
164317350|NCT00362180|593539196|FG004|Treated Period|Withdrawal by Subject|0|||
164317351|NCT00362180|593539197|FG005|Treated Period|Withdrawal by Subject|0|||
164317352|NCT00362180|593539198|FG006|Treated Period|Withdrawal by Subject|0|||
164317353|NCT00362180|593539199|FG007|Treated Period|Withdrawal by Subject|0|||
164317354|NCT00362180|593539200|FG008|Treated Period|Withdrawal by Subject|0|||
164317355|NCT00362180|593539192|FG000|Treated Period|Adverse Event|0|||
164317356|NCT00362180|593539193|FG001|Treated Period|Adverse Event|0|||
164317357|NCT00362180|593539194|FG002|Treated Period|Adverse Event|0|||
164317358|NCT00362180|593539195|FG003|Treated Period|Adverse Event|0|||
164317359|NCT00362180|593539196|FG004|Treated Period|Adverse Event|0|||
164317360|NCT00362180|593539197|FG005|Treated Period|Adverse Event|1|||
164317361|NCT00362180|593539198|FG006|Treated Period|Adverse Event|0|||
164205540|NCT01171534|593122632|FG000|Overall Study|screen failure|0|||
164205541|NCT01171534|593122633|FG001|Overall Study|screen failure|1|||
164205542|NCT00849056|593122634|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
164205543|NCT00849056|593122635|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
164205544|NCT00849056|593122634|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
164205545|NCT00849056|593122635|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
164205546|NCT00849056|593122634|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
164205547|NCT00849056|593122635|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
164205548|NCT00849056|593122634|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
164205549|NCT00849056|593122635|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
164205550|NCT00849056|593122634|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
164317362|NCT00362180|593539199|FG007|Treated Period|Adverse Event|1|||
164317363|NCT00362180|593539200|FG008|Treated Period|Adverse Event|0|||
164317364|NCT02600871|593539203|FG000|Overall Study|Lost to Follow-up|13|||
164317365|NCT02600871|593539204|FG001|Overall Study|Lost to Follow-up|10|||
164317366|NCT00348933|593539211|FG000|Overall Study|Withdrawal by Subject|10|||
164317367|NCT00348933|593539211|FG000|Overall Study|Lost to Follow-up|6|||
164317368|NCT00348933|593539211|FG000|Overall Study|Protocol Violation|2|||
164317369|NCT00348933|593539211|FG000|Overall Study|Adverse Event|7|||
164317370|NCT01489111|593539212|FG000|Overall Study|Withdrawal criterion|1|||
164317371|NCT00003472|593539219|FG000|Overall Study|Not evaluable|3|||
164317372|NCT00874939|593539220|FG000|Overall Study|Study terminated|4|||
164317373|NCT02870933|593539221|FG000|Overall Study|Death|2|||
164317374|NCT02870933|593539222|FG001|Overall Study|Death|1|||
164317375|NCT02870933|593539221|FG000|Overall Study|Withdrawal by Subject|0|||
164317376|NCT02870933|593539222|FG001|Overall Study|Withdrawal by Subject|1|||
164317377|NCT02168387|593539223|FG000|Overall Study|Planned exubation|6|||
164317378|NCT02168387|593539224|FG001|Overall Study|Planned exubation|3|||
164317379|NCT02168387|593539223|FG000|Overall Study|Death|1|||
164317380|NCT02168387|593539224|FG001|Overall Study|Death|0|||
164317381|NCT01659554|593539225|FG000|Overall Study|Study Termination|4|||
164317382|NCT00603590|593539226|FG000|Overall Study|Did not attend study clinic|39|||
164317383|NCT00603590|593539227|FG001|Overall Study|Did not attend study clinic|30|||
164317384|NCT00603590|593539226|FG000|Overall Study|Refused blood test|5|||
164317385|NCT00603590|593539227|FG001|Overall Study|Refused blood test|1|||
164317386|NCT00603590|593539226|FG000|Overall Study|Patient discontinued study drug|22|||
164317387|NCT00603590|593539227|FG001|Overall Study|Patient discontinued study drug|15|||
164317388|NCT00603590|593539226|FG000|Overall Study|Adverse Event|2|||
164317389|NCT00603590|593539227|FG001|Overall Study|Adverse Event|0|||
164317390|NCT00603590|593539226|FG000|Overall Study|Lost to Follow-up|8|||
164317391|NCT00603590|593539227|FG001|Overall Study|Lost to Follow-up|4|||
164317392|NCT00603590|593539226|FG000|Overall Study|Cardiovascular event|0|||
164317393|NCT00603590|593539227|FG001|Overall Study|Cardiovascular event|1|||
164317394|NCT00910624|593539228|FG000|Treatment Phase|Adverse Event|2|||
164317395|NCT00910624|593539229|FG001|Treatment Phase|Adverse Event|6|||
164317396|NCT00910624|593539230|FG002|Treatment Phase|Adverse Event|6|||
164317397|NCT00910624|593539231|FG003|Treatment Phase|Adverse Event|0|||
164317398|NCT00910624|593539228|FG000|Treatment Phase|Treatment Failure|23|||
164317399|NCT00910624|593539229|FG001|Treatment Phase|Treatment Failure|10|||
164317400|NCT00910624|593539230|FG002|Treatment Phase|Treatment Failure|0|||
164317401|NCT00910624|593539231|FG003|Treatment Phase|Treatment Failure|0|||
164317402|NCT00910624|593539228|FG000|Treatment Phase|Lost to Follow-up|0|||
164317403|NCT00910624|593539229|FG001|Treatment Phase|Lost to Follow-up|0|||
164317404|NCT00910624|593539230|FG002|Treatment Phase|Lost to Follow-up|1|||
164317405|NCT00910624|593539231|FG003|Treatment Phase|Lost to Follow-up|0|||
164317406|NCT00910624|593539228|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
164317407|NCT00910624|593539229|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
164317408|NCT00910624|593539230|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
164317409|NCT00910624|593539231|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
164317410|NCT00910624|593539228|FG000|Treatment Phase|Withdrawal by Subject|2|||
164317411|NCT00910624|593539229|FG001|Treatment Phase|Withdrawal by Subject|1|||
164317412|NCT00910624|593539230|FG002|Treatment Phase|Withdrawal by Subject|0|||
164317413|NCT00910624|593539231|FG003|Treatment Phase|Withdrawal by Subject|0|||
164317414|NCT00910624|593539228|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
164317415|NCT00910624|593539229|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
164317416|NCT00910624|593539230|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
164317417|NCT00910624|593539231|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
164317418|NCT00910624|593539228|FG000|Follow-Up Phase|Adverse Event|0|||
164317419|NCT00910624|593539229|FG001|Follow-Up Phase|Adverse Event|0|||
164317420|NCT00910624|593539230|FG002|Follow-Up Phase|Adverse Event|1|||
164317421|NCT00910624|593539231|FG003|Follow-Up Phase|Adverse Event|0|||
164317422|NCT00910624|593539228|FG000|Follow-Up Phase|Lost to Follow-up|3|||
164317423|NCT00910624|593539229|FG001|Follow-Up Phase|Lost to Follow-up|1|||
164317424|NCT00910624|593539230|FG002|Follow-Up Phase|Lost to Follow-up|2|||
164317425|NCT00910624|593539231|FG003|Follow-Up Phase|Lost to Follow-up|0|||
164317426|NCT00910624|593539228|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
164317427|NCT00910624|593539229|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
164317428|NCT00910624|593539230|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
164317429|NCT00910624|593539231|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
164317430|NCT00910624|593539228|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
164317431|NCT00910624|593539229|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
164317432|NCT00910624|593539230|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
164317433|NCT00910624|593539231|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
164317434|NCT00910624|593539228|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
164317435|NCT00910624|593539229|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
164317436|NCT00910624|593539230|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
164317437|NCT00910624|593539231|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
164317438|NCT00910624|593539228|FG000|Follow-Up Phase|Administrative|0|||
164317439|NCT00910624|593539229|FG001|Follow-Up Phase|Administrative|1|||
164317440|NCT00910624|593539230|FG002|Follow-Up Phase|Administrative|1|||
164317441|NCT00910624|593539231|FG003|Follow-Up Phase|Administrative|0|||
164317442|NCT03005873|593539235|FG000|Overall Study|Prohibited medication use post radnomization|1|||
164317443|NCT03005873|593539236|FG001|Overall Study|Prohibited medication use post radnomization|1|||
164317444|NCT03005873|593539237|FG002|Overall Study|Prohibited medication use post radnomization|1|||
164317445|NCT03005873|593539235|FG000|Overall Study|Withdrew consent|0|||
164317446|NCT03005873|593539236|FG001|Overall Study|Withdrew consent|1|||
164317447|NCT03005873|593539237|FG002|Overall Study|Withdrew consent|2|||
164317448|NCT03005873|593539235|FG000|Overall Study|Lost to Follow-up|0|||
164317449|NCT03005873|593539236|FG001|Overall Study|Lost to Follow-up|1|||
164317450|NCT03005873|593539237|FG002|Overall Study|Lost to Follow-up|0|||
164317451|NCT03005873|593539235|FG000|Overall Study|Ineligible post randomization|0|||
164317452|NCT03005873|593539236|FG001|Overall Study|Ineligible post randomization|0|||
164317453|NCT03005873|593539237|FG002|Overall Study|Ineligible post randomization|1|||
164317454|NCT04585009|593539238|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
164317455|NCT04585009|593539239|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
164317456|NCT04585009|593539240|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
164317457|NCT04585009|593539241|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
164317458|NCT04585009|593539242|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
164317459|NCT04585009|593539243|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
164317460|NCT04585009|593539244|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
164317461|NCT04585009|593539245|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
164317462|NCT04585009|593539246|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
164317463|NCT04585009|593539247|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
164317464|NCT04585009|593539248|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
164317465|NCT04585009|593539249|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
164317466|NCT04585009|593539238|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
164317467|NCT04585009|593539239|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
164317468|NCT04585009|593539240|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
164317469|NCT04585009|593539241|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
164317470|NCT04585009|593539242|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
164317471|NCT04585009|593539243|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
164317472|NCT04585009|593539244|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
164317473|NCT04585009|593539245|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
164317474|NCT04585009|593539246|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
164317475|NCT04585009|593539247|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
164317476|NCT04585009|593539248|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
164317477|NCT04585009|593539249|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
164317478|NCT04585009|593539238|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
164317479|NCT04585009|593539239|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
164317480|NCT04585009|593539240|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
164317481|NCT04585009|593539241|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
164317482|NCT04585009|593539242|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
164317483|NCT04585009|593539243|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
164317484|NCT04585009|593539244|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
164317485|NCT04585009|593539245|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
164317486|NCT04585009|593539246|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
164317487|NCT04585009|593539247|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
164317488|NCT04585009|593539248|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
164317489|NCT04585009|593539249|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
164317490|NCT04585009|593539238|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
164317491|NCT04585009|593539239|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
164317492|NCT04585009|593539240|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
164317493|NCT04585009|593539241|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
164317494|NCT04585009|593539242|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
164317495|NCT04585009|593539243|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
164317496|NCT04585009|593539244|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
164317497|NCT04585009|593539245|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
164317498|NCT04585009|593539246|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
164317499|NCT04585009|593539247|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
164317500|NCT04585009|593539248|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
164317501|NCT04585009|593539249|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
164666078|NCT04803357|594801584|FG000|Overall Study|Withdrawal by Subject|31|||
164317502|NCT04585009|593539238|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
164317503|NCT04585009|593539239|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
164317504|NCT04585009|593539240|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
164317505|NCT04585009|593539241|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
164317506|NCT04585009|593539242|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
164317507|NCT04585009|593539243|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
164317508|NCT04585009|593539244|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
164317509|NCT04585009|593539245|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
164317510|NCT04585009|593539246|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
164317511|NCT04585009|593539247|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
164317512|NCT04585009|593539248|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
164317513|NCT04585009|593539249|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
164317514|NCT04585009|593539238|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
164317515|NCT04585009|593539239|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
164317516|NCT04585009|593539240|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
164666079|NCT04803357|594801585|FG001|Overall Study|Withdrawal by Subject|5|||
164666080|NCT02879643|594801587|FG000|Overall Study|Adverse Event|0|||
164666081|NCT02879643|594801588|FG001|Overall Study|Adverse Event|0|||
164666082|NCT02879643|594801589|FG002|Overall Study|Adverse Event|1|||
164666083|NCT02879643|594801590|FG003|Overall Study|Adverse Event|1|||
164666084|NCT02879643|594801591|FG004|Overall Study|Adverse Event|0|||
164666085|NCT00182091|594801592|FG000|Overall Study|Withdrawal by Subject|1|||
164666086|NCT00182091|594801593|FG001|Overall Study|Withdrawal by Subject|0|||
164666087|NCT00182091|594801594|FG002|Overall Study|Withdrawal by Subject|0|||
164666088|NCT00182091|594801595|FG003|Overall Study|Withdrawal by Subject|0|||
164666089|NCT01046253|594801596|FG000|Second Intervention|Adverse Event|0|||
164666090|NCT01046253|594801597|FG001|Second Intervention|Adverse Event|1|||
164666091|NCT01046253|594801596|FG000|Second Intervention|Protocol Violation|0|||
164666092|NCT01046253|594801597|FG001|Second Intervention|Protocol Violation|1|||
164666093|NCT02339909|594801598|FG000|Overall Study|Became ineligible after randomisation|89|||
164666094|NCT02339909|594801599|FG001|Overall Study|Became ineligible after randomisation|63|||
164666095|NCT02339909|594801600|FG002|Overall Study|Became ineligible after randomisation|71|||
164666096|NCT00860028|594801601|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
164666097|NCT00860028|594801602|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
164666098|NCT02576990|594801603|FG000|Overall Study|Death|29|||
164666099|NCT02576990|594801604|FG001|Overall Study|Death|18|||
164666100|NCT02576990|594801603|FG000|Overall Study|Physician Decision|1|||
164666101|NCT02576990|594801604|FG001|Overall Study|Physician Decision|0|||
164666102|NCT02576990|594801603|FG000|Overall Study|Screen failure|2|||
164666103|NCT02576990|594801604|FG001|Overall Study|Screen failure|0|||
164666104|NCT02576990|594801603|FG000|Overall Study|Sponsor's decision|24|||
164666105|NCT02576990|594801604|FG001|Overall Study|Sponsor's decision|4|||
164666106|NCT02576990|594801603|FG000|Overall Study|Withdrawal by Subject|0|||
164666107|NCT02576990|594801604|FG001|Overall Study|Withdrawal by Subject|2|||
164666108|NCT00936390|594801605|FG000|Overall Study|Protocol Violation|21|||
164666109|NCT00936390|594801606|FG001|Overall Study|Protocol Violation|25|||
164666110|NCT02093689|594801607|FG000|Overall Study|Physician Decision|4|||
164666111|NCT02093689|594801608|FG001|Overall Study|Physician Decision|0|||
164666112|NCT02093689|594801609|FG002|Overall Study|Physician Decision|0|||
164666113|NCT03365947|594801610|FG000|Overall Study|Lost to Follow-up|0|||
164666114|NCT03365947|594801611|FG001|Overall Study|Lost to Follow-up|0|||
164666115|NCT03365947|594801612|FG002|Overall Study|Lost to Follow-up|0|||
164666116|NCT03365947|594801613|FG003|Overall Study|Lost to Follow-up|0|||
164666117|NCT03365947|594801614|FG004|Overall Study|Lost to Follow-up|0|||
164666118|NCT03365947|594801615|FG005|Overall Study|Lost to Follow-up|1|||
164666119|NCT03365947|594801616|FG006|Overall Study|Lost to Follow-up|0|||
164666120|NCT03365947|594801617|FG007|Overall Study|Lost to Follow-up|0|||
164666121|NCT03365947|594801618|FG008|Overall Study|Lost to Follow-up|0|||
164666122|NCT03365947|594801619|FG009|Overall Study|Lost to Follow-up|0|||
164666123|NCT03365947|594801620|FG010|Overall Study|Lost to Follow-up|0|||
164666124|NCT03365947|594801621|FG011|Overall Study|Lost to Follow-up|0|||
164666125|NCT03365947|594801622|FG012|Overall Study|Lost to Follow-up|0|||
164666126|NCT03365947|594801623|FG013|Overall Study|Lost to Follow-up|0|||
164666127|NCT03365947|594801624|FG014|Overall Study|Lost to Follow-up|0|||
164666128|NCT03365947|594801625|FG015|Overall Study|Lost to Follow-up|0|||
164666129|NCT03365947|594801626|FG016|Overall Study|Lost to Follow-up|0|||
164666130|NCT03365947|594801627|FG017|Overall Study|Lost to Follow-up|0|||
164666131|NCT03365947|594801628|FG018|Overall Study|Lost to Follow-up|0|||
164666132|NCT02518685|594801629|FG000|Overall Study|Adverse Event|29|||
164666133|NCT02518685|594801630|FG001|Overall Study|Adverse Event|1|||
164666134|NCT02518685|594801629|FG000|Overall Study|Withdrawal by Subject|10|||
164666135|NCT02518685|594801630|FG001|Overall Study|Withdrawal by Subject|3|||
164666136|NCT02518685|594801629|FG000|Overall Study|relocation, study fatigue|7|||
164666137|NCT02518685|594801630|FG001|Overall Study|relocation, study fatigue|2|||
164666138|NCT02518685|594801629|FG000|Overall Study|Pregnancy|1|||
164666139|NCT02518685|594801630|FG001|Overall Study|Pregnancy|0|||
164317517|NCT04585009|593539241|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
164317518|NCT04585009|593539242|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
164317519|NCT04585009|593539243|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
164317520|NCT04585009|593539244|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
164317521|NCT04585009|593539245|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
164317522|NCT04585009|593539246|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
164317523|NCT04585009|593539247|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
164317524|NCT04585009|593539248|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
164317525|NCT04585009|593539249|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
164317526|NCT03699475|593539250|FG000|Overall Study|Death|1|||
164317527|NCT04618770|593539257|FG000|Overall Study|Censored from Analysis|12|||
164317528|NCT04618770|593539257|FG000|Overall Study|Early Termination|25|||
164317529|NCT00422084|593539260|FG000|Overall Study|Adverse Event|21|||
164317530|NCT00422084|593539261|FG001|Overall Study|Adverse Event|7|||
164317531|NCT00422084|593539260|FG000|Overall Study|Withdrawal by Subject|12|||
164317532|NCT00422084|593539261|FG001|Overall Study|Withdrawal by Subject|9|||
164317533|NCT00422084|593539260|FG000|Overall Study|Lost to Follow-up|14|||
164317534|NCT00422084|593539261|FG001|Overall Study|Lost to Follow-up|9|||
164317535|NCT00422084|593539260|FG000|Overall Study|Protocol Violation|4|||
164317536|NCT00422084|593539261|FG001|Overall Study|Protocol Violation|1|||
164317537|NCT00422084|593539260|FG000|Overall Study|Lack of Efficacy|40|||
164317538|NCT00422084|593539261|FG001|Overall Study|Lack of Efficacy|42|||
164317539|NCT00422084|593539260|FG000|Overall Study|P. vivax infection|3|||
164317540|NCT00422084|593539261|FG001|Overall Study|P. vivax infection|6|||
164317541|NCT00422084|593539260|FG000|Overall Study|Cyesis|1|||
164317542|NCT00422084|593539261|FG001|Overall Study|Cyesis|0|||
164317543|NCT00422084|593539260|FG000|Overall Study|Withdrawn from study accidentally|1|||
164317544|NCT00422084|593539261|FG001|Overall Study|Withdrawn from study accidentally|0|||
164317545|NCT00422084|593539260|FG000|Overall Study|Non-compliance|1|||
164317546|NCT00422084|593539261|FG001|Overall Study|Non-compliance|0|||
164317547|NCT00422084|593539260|FG000|Overall Study|Re-location|0|||
164317548|NCT00422084|593539261|FG001|Overall Study|Re-location|1|||
164317549|NCT00422084|593539260|FG000|Overall Study|Not defined|1|||
164317550|NCT00422084|593539261|FG001|Overall Study|Not defined|1|||
164317551|NCT01579812|593539262|FG000|Overall Study|Ineligible after treatment start|40|||
164317552|NCT01579812|593539262|FG000|Overall Study|Patient choice|3|||
164317553|NCT01579812|593539262|FG000|Overall Study|Noncompliance|3|||
164317554|NCT01579812|593539262|FG000|Overall Study|Withdrawal by Subject|6|||
164317555|NCT00653432|593539263|FG000|Overall Study|Adverse Event|4|||
164317556|NCT00653432|593539264|FG001|Overall Study|Adverse Event|1|||
164317557|NCT00653432|593539263|FG000|Overall Study|Withdrawal by Subject|4|||
164317558|NCT00653432|593539264|FG001|Overall Study|Withdrawal by Subject|5|||
164317559|NCT00653432|593539263|FG000|Overall Study|Lost to Follow-up|7|||
164317560|NCT00653432|593539264|FG001|Overall Study|Lost to Follow-up|6|||
164317561|NCT00653432|593539263|FG000|Overall Study|Use/Need of Con Therapy|2|||
164317562|NCT00653432|593539264|FG001|Overall Study|Use/Need of Con Therapy|1|||
164317563|NCT00653432|593539263|FG000|Overall Study|Other - Reason Not Provided|5|||
164317564|NCT00653432|593539264|FG001|Overall Study|Other - Reason Not Provided|3|||
164317565|NCT00357760|593539265|FG000|Overall Study|Disease progression|44|||
164317566|NCT00357760|593539266|FG001|Overall Study|Disease progression|17|||
164317567|NCT00357760|593539265|FG000|Overall Study|Adverse Event|10|||
164317568|NCT00357760|593539266|FG001|Overall Study|Adverse Event|7|||
164317569|NCT00357760|593539265|FG000|Overall Study|Death|0|||
164317570|NCT00357760|593539266|FG001|Overall Study|Death|3|||
164317571|NCT00357760|593539265|FG000|Overall Study|Alternative therapy|1|||
164317572|NCT00357760|593539266|FG001|Overall Study|Alternative therapy|0|||
164317573|NCT00357760|593539265|FG000|Overall Study|Withdrawal by Subject|0|||
164317574|NCT00357760|593539266|FG001|Overall Study|Withdrawal by Subject|2|||
164317575|NCT00357760|593539265|FG000|Overall Study|Never started treatment|2|||
164317576|NCT00357760|593539266|FG001|Overall Study|Never started treatment|1|||
164317577|NCT00357760|593539265|FG000|Overall Study|Ineligible|0|||
164317578|NCT00357760|593539266|FG001|Overall Study|Ineligible|2|||
164317579|NCT00357760|593539265|FG000|Overall Study|Physician Decision|2|||
164561930|NCT00512798|594425667|FG000|Overall Study|Adverse Event|2|||
164561931|NCT00512798|594425668|FG001|Overall Study|Adverse Event|4|||
164561932|NCT00512798|594425667|FG000|Overall Study|Progression of disease|14|||
164561933|NCT00512798|594425668|FG001|Overall Study|Progression of disease|20|||
164561934|NCT00512798|594425667|FG000|Overall Study|Withdrawal by Subject|3|||
164317580|NCT00357760|593539266|FG001|Overall Study|Physician Decision|1|||
164317581|NCT00357760|593539265|FG000|Overall Study|Protocol Violation|0|||
164317582|NCT00357760|593539266|FG001|Overall Study|Protocol Violation|1|||
164317583|NCT00357760|593539265|FG000|Overall Study|To receive hospice care|0|||
164561935|NCT00512798|594425668|FG001|Overall Study|Withdrawal by Subject|0|||
164561936|NCT01920711|594425669|FG000|Overall Study|Death|347|||
164317584|NCT00357760|593539266|FG001|Overall Study|To receive hospice care|1|||
164561937|NCT01920711|594425670|FG001|Overall Study|Death|356|||
164561938|NCT01920711|594425669|FG000|Overall Study|Lost to Follow-up|13|||
164317585|NCT02353143|593539267|FG000|Overall Study|Withdrawal by Subject|1|||
164317586|NCT02353143|593539268|FG001|Overall Study|Withdrawal by Subject|0|||
164317587|NCT02353143|593539269|FG002|Overall Study|Withdrawal by Subject|0|||
164317588|NCT02353143|593539270|FG003|Overall Study|Withdrawal by Subject|0|||
164317589|NCT02353143|593539271|FG004|Overall Study|Withdrawal by Subject|1|||
164317590|NCT02353143|593539272|FG005|Overall Study|Withdrawal by Subject|0|||
164317591|NCT02353143|593539273|FG006|Overall Study|Withdrawal by Subject|0|||
164317592|NCT02353143|593539274|FG007|Overall Study|Withdrawal by Subject|1|||
164317593|NCT02353143|593539275|FG008|Overall Study|Withdrawal by Subject|1|||
164317594|NCT02353143|593539267|FG000|Overall Study|Lack of Efficacy|2|||
164317595|NCT02353143|593539268|FG001|Overall Study|Lack of Efficacy|1|||
164317596|NCT02353143|593539269|FG002|Overall Study|Lack of Efficacy|2|||
164317597|NCT02353143|593539270|FG003|Overall Study|Lack of Efficacy|4|||
164317598|NCT02353143|593539271|FG004|Overall Study|Lack of Efficacy|13|||
164317599|NCT02353143|593539272|FG005|Overall Study|Lack of Efficacy|2|||
164317600|NCT02353143|593539273|FG006|Overall Study|Lack of Efficacy|2|||
164317601|NCT02353143|593539274|FG007|Overall Study|Lack of Efficacy|2|||
164317602|NCT02353143|593539275|FG008|Overall Study|Lack of Efficacy|1|||
164317603|NCT02353143|593539267|FG000|Overall Study|reason not specified|1|||
164317604|NCT02353143|593539268|FG001|Overall Study|reason not specified|2|||
164317605|NCT02353143|593539269|FG002|Overall Study|reason not specified|0|||
164317606|NCT02353143|593539270|FG003|Overall Study|reason not specified|0|||
164317607|NCT02353143|593539271|FG004|Overall Study|reason not specified|6|||
164317608|NCT02353143|593539272|FG005|Overall Study|reason not specified|1|||
164317609|NCT02353143|593539273|FG006|Overall Study|reason not specified|0|||
164317610|NCT02353143|593539274|FG007|Overall Study|reason not specified|3|||
164317611|NCT02353143|593539275|FG008|Overall Study|reason not specified|1|||
164317612|NCT02353143|593539267|FG000|Overall Study|Physician Decision|0|||
164317613|NCT02353143|593539268|FG001|Overall Study|Physician Decision|4|||
164317614|NCT02353143|593539269|FG002|Overall Study|Physician Decision|2|||
164317615|NCT02353143|593539270|FG003|Overall Study|Physician Decision|3|||
164317616|NCT02353143|593539271|FG004|Overall Study|Physician Decision|4|||
164317617|NCT02353143|593539272|FG005|Overall Study|Physician Decision|0|||
164317618|NCT02353143|593539273|FG006|Overall Study|Physician Decision|1|||
164317619|NCT02353143|593539274|FG007|Overall Study|Physician Decision|2|||
164317620|NCT02353143|593539275|FG008|Overall Study|Physician Decision|0|||
164317621|NCT02353143|593539267|FG000|Overall Study|Adverse Event|0|||
164317622|NCT02353143|593539268|FG001|Overall Study|Adverse Event|0|||
164317623|NCT02353143|593539269|FG002|Overall Study|Adverse Event|1|||
164317624|NCT02353143|593539270|FG003|Overall Study|Adverse Event|0|||
164317625|NCT02353143|593539271|FG004|Overall Study|Adverse Event|1|||
164317626|NCT02353143|593539272|FG005|Overall Study|Adverse Event|1|||
164317627|NCT02353143|593539273|FG006|Overall Study|Adverse Event|0|||
164317628|NCT02353143|593539274|FG007|Overall Study|Adverse Event|0|||
164317629|NCT02353143|593539275|FG008|Overall Study|Adverse Event|0|||
164317630|NCT02353143|593539267|FG000|Overall Study|patient receiving other treatment for AML|0|||
164317631|NCT02353143|593539268|FG001|Overall Study|patient receiving other treatment for AML|0|||
164317632|NCT02353143|593539269|FG002|Overall Study|patient receiving other treatment for AML|1|||
164317633|NCT02353143|593539270|FG003|Overall Study|patient receiving other treatment for AML|0|||
164317634|NCT02353143|593539271|FG004|Overall Study|patient receiving other treatment for AML|0|||
164317635|NCT02353143|593539272|FG005|Overall Study|patient receiving other treatment for AML|0|||
164317636|NCT02353143|593539273|FG006|Overall Study|patient receiving other treatment for AML|0|||
164317637|NCT02353143|593539274|FG007|Overall Study|patient receiving other treatment for AML|0|||
164317638|NCT02353143|593539275|FG008|Overall Study|patient receiving other treatment for AML|0|||
164317639|NCT02353143|593539267|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
164317640|NCT02353143|593539268|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
164317641|NCT02353143|593539269|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
164317642|NCT02353143|593539270|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
164317643|NCT02353143|593539271|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
164317644|NCT02353143|593539272|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
164317645|NCT02353143|593539273|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
164317646|NCT02353143|593539274|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
164317647|NCT02353143|593539275|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
164317648|NCT00600119|593539276|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
164317649|NCT00600119|593539277|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
164317650|NCT00600119|593539278|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
164317651|NCT00600119|593539279|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
164317652|NCT00600119|593539280|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
164317653|NCT00600119|593539281|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
164317654|NCT00600119|593539276|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
164317655|NCT00600119|593539277|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
164666140|NCT02518685|594801629|FG000|Overall Study|Physician Decision|1|||
164317656|NCT00600119|593539278|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
164317657|NCT00600119|593539279|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
164317658|NCT00600119|593539280|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
164561939|NCT01920711|594425670|FG001|Overall Study|Lost to Follow-up|14|||
164561940|NCT01920711|594425669|FG000|Overall Study|Withdrawal by Subject|4|||
164561941|NCT01920711|594425670|FG001|Overall Study|Withdrawal by Subject|3|||
164561942|NCT02317562|594425672|FG000|Overall Study|Physician Decision|1|||
164561943|NCT02317562|594425672|FG000|Overall Study|early termination of the study|8|||
164561944|NCT02317562|594425672|FG000|Overall Study|Lack of Efficacy|4|||
164561945|NCT02317562|594425672|FG000|Overall Study|Withdrawal by Subject|1|||
164561946|NCT03551743|594425673|FG000|Overall Study|Adverse Event|1|||
164561947|NCT03551743|594425674|FG001|Overall Study|Adverse Event|0|||
164317659|NCT00600119|593539281|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
164317660|NCT00600119|593539276|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
164317661|NCT00600119|593539277|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
164317662|NCT00600119|593539278|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
164317663|NCT00600119|593539279|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
164317664|NCT00600119|593539280|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
164317665|NCT00600119|593539281|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
164317666|NCT00600119|593539276|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
164317667|NCT00600119|593539277|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
164317668|NCT00600119|593539278|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
164317669|NCT00600119|593539279|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
164317670|NCT00600119|593539280|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
164317671|NCT00600119|593539281|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
164317672|NCT00600119|593539276|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
164317673|NCT00600119|593539277|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
164317674|NCT00600119|593539278|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
164317675|NCT00600119|593539279|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
164561948|NCT03551743|594425675|FG002|Overall Study|Adverse Event|0|||
164561949|NCT03551743|594425676|FG003|Overall Study|Adverse Event|0|||
164561950|NCT03551743|594425673|FG000|Overall Study|Withdrawal by Subject|1|||
164561951|NCT03551743|594425674|FG001|Overall Study|Withdrawal by Subject|0|||
164561952|NCT03551743|594425675|FG002|Overall Study|Withdrawal by Subject|0|||
164561953|NCT03551743|594425676|FG003|Overall Study|Withdrawal by Subject|0|||
164561954|NCT03891901|594425677|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
164561955|NCT03891901|594425678|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
164561956|NCT03891901|594425679|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
164561957|NCT03891901|594425680|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
164561958|NCT03891901|594425681|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
164561959|NCT03891901|594425682|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
164561960|NCT03891901|594425683|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
164561961|NCT03891901|594425684|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
164561962|NCT03891901|594425685|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
164561963|NCT03891901|594425677|FG000|Overall Study|Adverse Event|2|||
164561964|NCT03891901|594425678|FG001|Overall Study|Adverse Event|2|||
164561965|NCT03891901|594425679|FG002|Overall Study|Adverse Event|0|||
164561966|NCT03891901|594425680|FG003|Overall Study|Adverse Event|0|||
164561967|NCT03891901|594425681|FG004|Overall Study|Adverse Event|0|||
164561968|NCT03891901|594425682|FG005|Overall Study|Adverse Event|0|||
164561969|NCT03891901|594425683|FG006|Overall Study|Adverse Event|0|||
164561970|NCT03891901|594425684|FG007|Overall Study|Adverse Event|0|||
164561971|NCT03891901|594425685|FG008|Overall Study|Adverse Event|0|||
164561972|NCT03891901|594425677|FG000|Overall Study|Poor venous access|1|||
164561973|NCT03891901|594425678|FG001|Overall Study|Poor venous access|0|||
164561974|NCT03891901|594425679|FG002|Overall Study|Poor venous access|0|||
164561975|NCT03891901|594425680|FG003|Overall Study|Poor venous access|0|||
164561976|NCT03891901|594425681|FG004|Overall Study|Poor venous access|0|||
164561977|NCT03891901|594425682|FG005|Overall Study|Poor venous access|0|||
164561978|NCT03891901|594425683|FG006|Overall Study|Poor venous access|0|||
164561979|NCT03891901|594425684|FG007|Overall Study|Poor venous access|0|||
164561980|NCT03891901|594425685|FG008|Overall Study|Poor venous access|0|||
164666141|NCT02518685|594801630|FG001|Overall Study|Physician Decision|0|||
164561981|NCT03891901|594425677|FG000|Overall Study|Withdrawal by Subject|0|||
164561982|NCT03891901|594425678|FG001|Overall Study|Withdrawal by Subject|2|||
164561983|NCT03891901|594425679|FG002|Overall Study|Withdrawal by Subject|0|||
164561984|NCT03891901|594425680|FG003|Overall Study|Withdrawal by Subject|0|||
164561985|NCT03891901|594425681|FG004|Overall Study|Withdrawal by Subject|0|||
164561986|NCT03891901|594425682|FG005|Overall Study|Withdrawal by Subject|0|||
164561987|NCT03891901|594425683|FG006|Overall Study|Withdrawal by Subject|0|||
164666142|NCT02518685|594801629|FG000|Overall Study|Lost to Follow-up|1|||
164561988|NCT03891901|594425684|FG007|Overall Study|Withdrawal by Subject|0|||
164561989|NCT03891901|594425685|FG008|Overall Study|Withdrawal by Subject|0|||
164561990|NCT03920670|594425686|FG000|Overall Study|Protocol Violation|2|||
164666143|NCT02518685|594801630|FG001|Overall Study|Lost to Follow-up|4|||
164420634|NCT01154036|593910965|FG003|Phase I|Lost to Follow-up|0|||
164666144|NCT01922349|594801631|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
164666145|NCT01922349|594801632|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
164666146|NCT01922349|594801633|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
164666147|NCT01922349|594801634|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
164666148|NCT05109234|594801635|FG000|Overall Study|Adverse Event|2|||
164666149|NCT05109234|594801636|FG001|Overall Study|Adverse Event|2|||
164666150|NCT05109234|594801635|FG000|Overall Study|Lack of Efficacy|5|||
164666151|NCT05109234|594801636|FG001|Overall Study|Lack of Efficacy|0|||
164666152|NCT05109234|594801635|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
164666153|NCT05109234|594801636|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
164666154|NCT05109234|594801635|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
164666155|NCT05109234|594801636|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
164666156|NCT05109234|594801635|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
164666157|NCT05109234|594801636|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
164666158|NCT05109234|594801635|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
164666159|NCT05109234|594801636|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
164666160|NCT05067504|594801638|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
164666161|NCT05067504|594801639|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
164666162|NCT05067504|594801638|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
164666163|NCT05067504|594801639|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
164666164|NCT05067504|594801638|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
164666165|NCT05067504|594801639|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
164666166|NCT03805438|594803366|FG000|Overall Study|Lack of Efficacy|1|||
164666167|NCT03805438|594803366|FG000|Overall Study|Protocol Violation|1|||
164666168|NCT02684344|594803367|FG000|Overall Study|Withdrawal by Subject|0|||
164666169|NCT02684344|594803368|FG001|Overall Study|Withdrawal by Subject|1|||
164666170|NCT02777528|594803370|FG000|Overall Study|Still in study|24|||
164666171|NCT02777528|594803371|FG001|Overall Study|Still in study|10|||
164666172|NCT02777528|594803372|FG002|Overall Study|Still in study|1|||
164666173|NCT02777528|594803370|FG000|Overall Study|Study Device Explanted|1|||
164666174|NCT02777528|594803371|FG001|Overall Study|Study Device Explanted|0|||
164666175|NCT02777528|594803372|FG002|Overall Study|Study Device Explanted|0|||
164666176|NCT02777528|594803370|FG000|Overall Study|Death|14|||
164666177|NCT02777528|594803371|FG001|Overall Study|Death|7|||
164666178|NCT02777528|594803372|FG002|Overall Study|Death|1|||
164666179|NCT02777528|594803370|FG000|Overall Study|Withdrawal by Subject|2|||
164666180|NCT02777528|594803371|FG001|Overall Study|Withdrawal by Subject|2|||
164666181|NCT02777528|594803372|FG002|Overall Study|Withdrawal by Subject|1|||
164666182|NCT02777528|594803370|FG000|Overall Study|Physician Decision|2|||
164666183|NCT02777528|594803371|FG001|Overall Study|Physician Decision|1|||
164205551|NCT00849056|593122635|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
164205552|NCT00849056|593122634|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
164205553|NCT00849056|593122635|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
164205554|NCT00849056|593122634|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
164205555|NCT00849056|593122635|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
164205556|NCT00849056|593122634|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
164205557|NCT00849056|593122635|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
164205558|NCT00849056|593122634|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
164205559|NCT00849056|593122635|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
164205560|NCT00849056|593122634|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
164205561|NCT00849056|593122635|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
164205562|NCT00849056|593122634|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
164205563|NCT00849056|593122635|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
164205564|NCT00849056|593122634|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
164205565|NCT00849056|593122635|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
164205566|NCT00849056|593122634|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
164205567|NCT00849056|593122635|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
164205568|NCT00849056|593122634|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
164205569|NCT00849056|593122635|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
164205570|NCT00849056|593122634|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
164205571|NCT00849056|593122635|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
164205572|NCT00849056|593122634|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
164205573|NCT00849056|593122635|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
164205574|NCT04588259|593122636|FG000|Run-in period|Run-in failure|0|||
164205575|NCT04588259|593122637|FG001|Run-in period|Run-in failure|23|||
164666184|NCT02777528|594803372|FG002|Overall Study|Physician Decision|0|||
164666185|NCT02777528|594803370|FG000|Overall Study|Lost to Follow-up|2|||
164666186|NCT02777528|594803371|FG001|Overall Study|Lost to Follow-up|0|||
164666187|NCT02777528|594803372|FG002|Overall Study|Lost to Follow-up|0|||
164666188|NCT02777528|594803370|FG000|Overall Study|Discontinued due to Other|1|||
164666189|NCT02777528|594803371|FG001|Overall Study|Discontinued due to Other|0|||
164666190|NCT02777528|594803372|FG002|Overall Study|Discontinued due to Other|0|||
164666191|NCT01882647|594803374|FG000|Overall Study|Lost to Follow-up|2|||
164666192|NCT01882647|594803375|FG001|Overall Study|Lost to Follow-up|2|||
164666193|NCT01882647|594803374|FG000|Overall Study|Withdrawal by Subject|0|||
164666194|NCT01882647|594803375|FG001|Overall Study|Withdrawal by Subject|4|||
164666195|NCT01108094|594803376|FG000|Overall Study|Adverse Event|2|||
164666196|NCT01108094|594803377|FG001|Overall Study|Adverse Event|0|||
164666197|NCT01108094|594803378|FG002|Overall Study|Adverse Event|0|||
164666198|NCT01108094|594803379|FG003|Overall Study|Adverse Event|0|||
164666199|NCT01108094|594803376|FG000|Overall Study|Withdrawal by Subject|1|||
164666200|NCT01108094|594803377|FG001|Overall Study|Withdrawal by Subject|0|||
164666201|NCT01108094|594803378|FG002|Overall Study|Withdrawal by Subject|0|||
164666202|NCT01108094|594803379|FG003|Overall Study|Withdrawal by Subject|0|||
164666203|NCT05037097|594803380|FG000|Overall Study|Withdrawal by Subject|0|||
164666204|NCT05037097|594803381|FG001|Overall Study|Withdrawal by Subject|1|||
164666205|NCT05037097|594803382|FG002|Overall Study|Withdrawal by Subject|0|||
164666206|NCT05037097|594803383|FG003|Overall Study|Withdrawal by Subject|1|||
164317676|NCT00600119|593539280|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
164317677|NCT00600119|593539281|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
164317678|NCT00600119|593539276|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
164317679|NCT00600119|593539277|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
164317680|NCT00600119|593539278|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
164317681|NCT00600119|593539279|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
164317682|NCT00600119|593539280|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
164317683|NCT00600119|593539281|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
164317684|NCT00600119|593539276|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
164317685|NCT00600119|593539277|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
164317686|NCT00600119|593539278|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
164317687|NCT00600119|593539279|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
164317688|NCT00600119|593539280|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
164317689|NCT00600119|593539281|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
164317690|NCT00600119|593539276|FG000|Double-blind Treatment Period|Other|0|||
164317691|NCT00600119|593539277|FG001|Double-blind Treatment Period|Other|0|||
164561991|NCT03920670|594425687|FG001|Overall Study|Protocol Violation|2|||
164561992|NCT03920670|594425686|FG000|Overall Study|Adverse Event|1|||
164561993|NCT03920670|594425687|FG001|Overall Study|Adverse Event|0|||
164561994|NCT04820309|594425701|FG000|Overall Study|Adverse Event|96|||
164561995|NCT04820309|594425701|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
164561996|NCT04820309|594425701|FG000|Overall Study|Consent Withdrawn|93|||
164561997|NCT04820309|594425701|FG000|Overall Study|failure to adhere to protocol|32|||
164561998|NCT04820309|594425701|FG000|Overall Study|alcohol or drug use|6|||
164561999|NCT04820309|594425701|FG000|Overall Study|Lost to Follow-up|46|||
164562000|NCT04820309|594425701|FG000|Overall Study|Death|2|||
164562001|NCT04820309|594425701|FG000|Overall Study|Pregnancy|1|||
164562002|NCT04820309|594425701|FG000|Overall Study|Other reasons|12|||
164562003|NCT04202679|594425704|FG000|Overall Study|Adverse Event|2|||
164562004|NCT04202679|594425705|FG001|Overall Study|Adverse Event|0|||
164562005|NCT04202679|594425704|FG000|Overall Study|Poor compliance to protocol|1|||
164562006|NCT04202679|594425705|FG001|Overall Study|Poor compliance to protocol|0|||
164562007|NCT04202679|594425704|FG000|Overall Study|Withdrawal by Subject|23|||
164562008|NCT04202679|594425705|FG001|Overall Study|Withdrawal by Subject|6|||
164562009|NCT01250379|594425706|FG000|Overall Study|Death|141|||
164562010|NCT01250379|594425707|FG001|Overall Study|Death|148|||
164562011|NCT01250379|594425706|FG000|Overall Study|Withdrawal by Subject|32|||
164562012|NCT01250379|594425707|FG001|Overall Study|Withdrawal by Subject|20|||
164562013|NCT01250379|594425706|FG000|Overall Study|Physician Decision|11|||
164562014|NCT01250379|594425707|FG001|Overall Study|Physician Decision|3|||
164562015|NCT01250379|594425706|FG000|Overall Study|Protocol Violation|2|||
164562016|NCT01250379|594425707|FG001|Overall Study|Protocol Violation|8|||
164562017|NCT01250379|594425706|FG000|Overall Study|Lost to Follow-up|9|||
164562018|NCT01250379|594425707|FG001|Overall Study|Lost to Follow-up|6|||
164562019|NCT01250379|594425706|FG000|Overall Study|Adverse Event|5|||
164562020|NCT01250379|594425707|FG001|Overall Study|Adverse Event|4|||
164562021|NCT01250379|594425706|FG000|Overall Study|Other|0|||
164562022|NCT01250379|594425707|FG001|Overall Study|Other|4|||
164562023|NCT01250379|594425706|FG000|Overall Study|Participant noncompliance|2|||
164562024|NCT01250379|594425707|FG001|Overall Study|Participant noncompliance|0|||
164562025|NCT03864653|594425708|FG000|Overall Study|Withdrawal by Subject|1|||
164562026|NCT02531646|594425709|FG000|Overall Study|equip. image processing issue|5|||
164562027|NCT02531646|594425710|FG001|Overall Study|equip. image processing issue|1|||
164317692|NCT00600119|593539278|FG002|Double-blind Treatment Period|Other|0|||
164562028|NCT02531646|594425711|FG002|Overall Study|equip. image processing issue|0|||
164666207|NCT05037097|594803384|FG004|Overall Study|Withdrawal by Subject|0|||
164666208|NCT05037097|594803385|FG005|Overall Study|Withdrawal by Subject|2|||
164666209|NCT05037097|594803386|FG006|Overall Study|Withdrawal by Subject|0|||
164317693|NCT00600119|593539279|FG003|Double-blind Treatment Period|Other|0|||
164317694|NCT00600119|593539280|FG004|Double-blind Treatment Period|Other|2|||
164317695|NCT00600119|593539281|FG005|Double-blind Treatment Period|Other|1|||
164317696|NCT00600119|593539276|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
164317697|NCT00600119|593539277|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
164317698|NCT00600119|593539278|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
164317699|NCT00600119|593539279|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
164317700|NCT00600119|593539280|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
164317701|NCT00600119|593539281|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
164317702|NCT00600119|593539276|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
164317703|NCT00600119|593539277|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
164666210|NCT05037097|594803387|FG007|Overall Study|Withdrawal by Subject|0|||
164666211|NCT05037097|594803380|FG000|Overall Study|Lost to Follow-up|0|||
164666212|NCT05037097|594803381|FG001|Overall Study|Lost to Follow-up|1|||
164666213|NCT05037097|594803382|FG002|Overall Study|Lost to Follow-up|0|||
164666214|NCT05037097|594803383|FG003|Overall Study|Lost to Follow-up|0|||
164666215|NCT05037097|594803384|FG004|Overall Study|Lost to Follow-up|1|||
164666216|NCT05037097|594803385|FG005|Overall Study|Lost to Follow-up|1|||
164666217|NCT05037097|594803386|FG006|Overall Study|Lost to Follow-up|0|||
164666218|NCT05037097|594803387|FG007|Overall Study|Lost to Follow-up|0|||
164317704|NCT00600119|593539278|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
164666219|NCT02918877|594803388|FG000|Overall Study|Withdrawal by Subject|2|||
164666220|NCT02918877|594803389|FG001|Overall Study|Withdrawal by Subject|2|||
164666221|NCT02918877|594803388|FG000|Overall Study|Surgery cancelled|1|||
164666222|NCT02918877|594803389|FG001|Overall Study|Surgery cancelled|0|||
164666223|NCT02918877|594803388|FG000|Overall Study|Physician Decision|1|||
164666224|NCT02918877|594803389|FG001|Overall Study|Physician Decision|0|||
164666225|NCT02918877|594803388|FG000|Overall Study|Received intraoperative steroids|1|||
164666226|NCT02918877|594803389|FG001|Overall Study|Received intraoperative steroids|0|||
164666227|NCT02918877|594803388|FG000|Overall Study|Unable to obtain lab samples|1|||
164666228|NCT02918877|594803389|FG001|Overall Study|Unable to obtain lab samples|0|||
164666229|NCT02918877|594803388|FG000|Overall Study|Unsafe to perform BAL|0|||
164666230|NCT02918877|594803389|FG001|Overall Study|Unsafe to perform BAL|1|||
164666231|NCT04510857|594803390|FG000|Overall Study|Withdrawal by Subject|1|||
164666232|NCT04510857|594803391|FG001|Overall Study|Withdrawal by Subject|2|||
164666233|NCT05346055|594803392|FG000|Overall Study|Withdrawal by Subject|1|||
164666234|NCT05346055|594803392|FG000|Overall Study|Protocol Violation|1|||
164666235|NCT05346055|594803392|FG000|Overall Study|Therapist decision|1|||
164666236|NCT00376220|594803393|FG000|Overall Study|Lost to Follow-up|7|||
164666237|NCT00376220|594803394|FG001|Overall Study|Lost to Follow-up|10|||
164666238|NCT00376220|594803393|FG000|Overall Study|Withdrawal by Subject|3|||
164666239|NCT00376220|594803394|FG001|Overall Study|Withdrawal by Subject|2|||
164666240|NCT02564263|594803395|FG000|Overall Study|Adverse Event|31|||
164666241|NCT02564263|594803396|FG001|Overall Study|Adverse Event|29|||
164666242|NCT02564263|594803395|FG000|Overall Study|Death|270|||
164666243|NCT02564263|594803396|FG001|Overall Study|Death|262|||
164666244|NCT02564263|594803395|FG000|Overall Study|Withdrawal by Subject|4|||
164666245|NCT02564263|594803396|FG001|Overall Study|Withdrawal by Subject|19|||
164666246|NCT02564263|594803395|FG000|Overall Study|Sponsor's decision|9|||
164666247|NCT02564263|594803396|FG001|Overall Study|Sponsor's decision|4|||
164666248|NCT02906709|594803397|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
164666249|NCT02906709|594803398|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
164666250|NCT02906709|594803397|FG000|Phase A (Week 0 to Week 16)|Death|0|||
164666251|NCT02906709|594803398|FG001|Phase A (Week 0 to Week 16)|Death|1|||
164666252|NCT02906709|594803397|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
164317705|NCT00600119|593539279|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
164317706|NCT00600119|593539280|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
164317707|NCT00600119|593539281|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
164317708|NCT00600119|593539276|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
164317709|NCT00600119|593539277|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
164317710|NCT00600119|593539278|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
164666253|NCT02906709|594803398|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
164317711|NCT00600119|593539279|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
164317712|NCT00600119|593539280|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
164666254|NCT02906709|594803397|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
164666255|NCT02906709|594803398|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
164666256|NCT00977106|594803399|FG000|Overall Study|Adverse Event|5|||
164666257|NCT00977106|594803400|FG001|Overall Study|Adverse Event|6|||
164666258|NCT00977106|594803399|FG000|Overall Study|Withdrawal by Subject|2|||
164666259|NCT00977106|594803400|FG001|Overall Study|Withdrawal by Subject|2|||
164666260|NCT00977106|594803399|FG000|Overall Study|Lack of Efficacy|2|||
164666261|NCT00977106|594803400|FG001|Overall Study|Lack of Efficacy|2|||
164666262|NCT00977106|594803399|FG000|Overall Study|Protocol Violation|0|||
164666263|NCT00977106|594803400|FG001|Overall Study|Protocol Violation|1|||
164666264|NCT00977106|594803399|FG000|Overall Study|Other|1|||
164666265|NCT00977106|594803400|FG001|Overall Study|Other|0|||
164666266|NCT00688064|594803405|FG000|Overall Study|Protocol Violation|0|||
164666267|NCT00688064|594803406|FG001|Overall Study|Protocol Violation|1|||
164666268|NCT00688064|594803405|FG000|Overall Study|Adverse Event|2|||
164666269|NCT00688064|594803406|FG001|Overall Study|Adverse Event|4|||
164205576|NCT04588259|593122636|FG000|Run-in period|Withdrawn before randomisation|0|||
164205577|NCT04588259|593122637|FG001|Run-in period|Withdrawn before randomisation|8|||
164205578|NCT04588259|593122636|FG000|Treatment period|Withdrawal by Subject|6|||
164205579|NCT04588259|593122637|FG001|Treatment period|Withdrawal by Subject|6|||
164205580|NCT02100631|593122641|FG000|Overall Study|Withdrawal by Subject|1|||
164205581|NCT02100631|593122642|FG001|Overall Study|Withdrawal by Subject|0|||
164205582|NCT02100631|593122643|FG002|Overall Study|Withdrawal by Subject|0|||
164205583|NCT02100631|593122641|FG000|Overall Study|Lost to Follow-up|3|||
164205584|NCT02100631|593122642|FG001|Overall Study|Lost to Follow-up|4|||
164205585|NCT02100631|593122643|FG002|Overall Study|Lost to Follow-up|0|||
164205586|NCT02100631|593122641|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
164205587|NCT02100631|593122642|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
164205588|NCT02100631|593122643|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
164205589|NCT04476043|593122644|FG000|Overall Study|Withdrawal by Subject|1|||
164205590|NCT04476043|593122645|FG001|Overall Study|Withdrawal by Subject|3|||
164205591|NCT04476043|593122646|FG002|Overall Study|Withdrawal by Subject|4|||
164205592|NCT04476043|593122647|FG003|Overall Study|Withdrawal by Subject|1|||
164205593|NCT04476043|593122644|FG000|Overall Study|Lost to Follow-up|1|||
164205594|NCT04476043|593122645|FG001|Overall Study|Lost to Follow-up|1|||
164205595|NCT04476043|593122646|FG002|Overall Study|Lost to Follow-up|2|||
164205596|NCT04476043|593122647|FG003|Overall Study|Lost to Follow-up|1|||
164205597|NCT04476043|593122644|FG000|Overall Study|Adverse Event|2|||
164205598|NCT04476043|593122645|FG001|Overall Study|Adverse Event|0|||
164205599|NCT04476043|593122646|FG002|Overall Study|Adverse Event|1|||
164205600|NCT04476043|593122647|FG003|Overall Study|Adverse Event|0|||
164205601|NCT04476043|593122644|FG000|Overall Study|Protocol Violation|0|||
164205602|NCT04476043|593122645|FG001|Overall Study|Protocol Violation|1|||
164205603|NCT04476043|593122646|FG002|Overall Study|Protocol Violation|0|||
164205604|NCT04476043|593122647|FG003|Overall Study|Protocol Violation|0|||
164205605|NCT00715208|593122648|FG000|Overall Study|Withdrawal by Subject|1|||
164205606|NCT00715208|593122649|FG001|Overall Study|Withdrawal by Subject|1|||
164205607|NCT00715208|593122648|FG000|Overall Study|Adverse Event|0|||
164205608|NCT00715208|593122649|FG001|Overall Study|Adverse Event|6|||
164205609|NCT00715208|593122648|FG000|Overall Study|Lack of Efficacy|0|||
164205610|NCT00715208|593122649|FG001|Overall Study|Lack of Efficacy|2|||
164205611|NCT01648764|593122650|FG000|Overall Study|Progressive Disease|0|||
164205612|NCT01648764|593122651|FG001|Overall Study|Progressive Disease|1|||
164205613|NCT01648764|593122652|FG002|Overall Study|Progressive Disease|0|||
164205614|NCT01648764|593122653|FG003|Overall Study|Progressive Disease|0|||
164205615|NCT01648764|593122654|FG004|Overall Study|Progressive Disease|0|||
164205616|NCT01648764|593122655|FG005|Overall Study|Progressive Disease|1|||
164205617|NCT01648764|593122656|FG006|Overall Study|Progressive Disease|1|||
164205618|NCT01648764|593122657|FG007|Overall Study|Progressive Disease|0|||
164205619|NCT01648764|593122658|FG008|Overall Study|Progressive Disease|0|||
164205620|NCT01648764|593122659|FG009|Overall Study|Progressive Disease|2|||
164205621|NCT01648764|593122660|FG010|Overall Study|Progressive Disease|0|||
164205622|NCT01648764|593122661|FG011|Overall Study|Progressive Disease|1|||
164205623|NCT01648764|593122662|FG012|Overall Study|Progressive Disease|2|||
164205624|NCT01648764|593122663|FG013|Overall Study|Progressive Disease|1|||
164205625|NCT01648764|593122650|FG000|Overall Study|Adverse Event|0|||
164205626|NCT01648764|593122651|FG001|Overall Study|Adverse Event|0|||
164205627|NCT01648764|593122652|FG002|Overall Study|Adverse Event|0|||
164205628|NCT01648764|593122653|FG003|Overall Study|Adverse Event|0|||
164205629|NCT01648764|593122654|FG004|Overall Study|Adverse Event|0|||
164205630|NCT01648764|593122655|FG005|Overall Study|Adverse Event|1|||
164205631|NCT01648764|593122656|FG006|Overall Study|Adverse Event|0|||
164205632|NCT01648764|593122657|FG007|Overall Study|Adverse Event|0|||
164205633|NCT01648764|593122658|FG008|Overall Study|Adverse Event|0|||
164205634|NCT01648764|593122659|FG009|Overall Study|Adverse Event|1|||
164205635|NCT01648764|593122660|FG010|Overall Study|Adverse Event|0|||
164205636|NCT01648764|593122661|FG011|Overall Study|Adverse Event|3|||
164205637|NCT01648764|593122662|FG012|Overall Study|Adverse Event|1|||
164205638|NCT01648764|593122663|FG013|Overall Study|Adverse Event|1|||
164205639|NCT01648764|593122650|FG000|Overall Study|Death|0|||
164205640|NCT01648764|593122651|FG001|Overall Study|Death|0|||
164205641|NCT01648764|593122652|FG002|Overall Study|Death|0|||
164205642|NCT01648764|593122653|FG003|Overall Study|Death|0|||
164666270|NCT00688064|594803405|FG000|Overall Study|Withdrawal by Subject|7|||
164666271|NCT00688064|594803406|FG001|Overall Study|Withdrawal by Subject|7|||
164666272|NCT00688064|594803405|FG000|Overall Study|Lost to Follow-up|10|||
164317713|NCT00600119|593539281|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
164317714|NCT00600119|593539276|FG000|Double-blind Treatment Period|Physician Decision|2|||
164317715|NCT00600119|593539277|FG001|Double-blind Treatment Period|Physician Decision|0|||
164317716|NCT00600119|593539278|FG002|Double-blind Treatment Period|Physician Decision|0|||
164317717|NCT00600119|593539279|FG003|Double-blind Treatment Period|Physician Decision|0|||
164317718|NCT00600119|593539280|FG004|Double-blind Treatment Period|Physician Decision|0|||
164317719|NCT00600119|593539281|FG005|Double-blind Treatment Period|Physician Decision|0|||
164317720|NCT00600119|593539276|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
164317721|NCT00600119|593539277|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
164317722|NCT00600119|593539278|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
164317723|NCT00600119|593539279|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
164317724|NCT00600119|593539280|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
164317725|NCT00600119|593539281|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
164317726|NCT00600119|593539276|FG000|Double-blind Treatment Period|Adverse Event|1|||
164317727|NCT00600119|593539277|FG001|Double-blind Treatment Period|Adverse Event|1|||
164317728|NCT00600119|593539278|FG002|Double-blind Treatment Period|Adverse Event|0|||
164317729|NCT00600119|593539279|FG003|Double-blind Treatment Period|Adverse Event|1|||
164317730|NCT00600119|593539280|FG004|Double-blind Treatment Period|Adverse Event|2|||
164317731|NCT00600119|593539281|FG005|Double-blind Treatment Period|Adverse Event|10|||
164317732|NCT00600119|593539276|FG000|Follow-up Period|Adverse Event|0|||
164317733|NCT00600119|593539277|FG001|Follow-up Period|Adverse Event|0|||
164317734|NCT00600119|593539278|FG002|Follow-up Period|Adverse Event|0|||
164317735|NCT00600119|593539279|FG003|Follow-up Period|Adverse Event|0|||
164317736|NCT00600119|593539280|FG004|Follow-up Period|Adverse Event|0|||
164317737|NCT00600119|593539281|FG005|Follow-up Period|Adverse Event|1|||
164317738|NCT00600119|593539276|FG000|Follow-up Period|Other|1|||
164666273|NCT00688064|594803406|FG001|Overall Study|Lost to Follow-up|10|||
164666274|NCT00688064|594803405|FG000|Overall Study|Lack of Efficacy|0|||
164666275|NCT00688064|594803406|FG001|Overall Study|Lack of Efficacy|1|||
164666276|NCT00688064|594803405|FG000|Overall Study|Pregnancy|1|||
164666277|NCT00688064|594803406|FG001|Overall Study|Pregnancy|0|||
164666278|NCT00688064|594803405|FG000|Overall Study|Any other reasons|1|||
164666279|NCT00688064|594803406|FG001|Overall Study|Any other reasons|3|||
164666280|NCT00524459|594803410|FG000|Overall Study|Withdrawal by Subject|1|||
164666281|NCT00524459|594803410|FG000|Overall Study|Other|1|||
164666282|NCT00728949|594803411|FG000|Overall Study|Adverse Event|8|||
164666283|NCT00728949|594803412|FG001|Overall Study|Adverse Event|0|||
164666284|NCT00728949|594803411|FG000|Overall Study|Withdrawal by Subject|2|||
164666285|NCT00728949|594803412|FG001|Overall Study|Withdrawal by Subject|2|||
164666286|NCT00728949|594803411|FG000|Overall Study|Abnormal Lab Results|0|||
164666287|NCT00728949|594803412|FG001|Overall Study|Abnormal Lab Results|2|||
164666288|NCT00728949|594803411|FG000|Overall Study|On treatment at cutoff date|1|||
164666289|NCT00728949|594803412|FG001|Overall Study|On treatment at cutoff date|0|||
164666290|NCT02319148|594803417|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
164666291|NCT02319148|594803418|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
164666292|NCT02319148|594803419|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
164666293|NCT02319148|594803420|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
164666294|NCT02319148|594803417|FG000|Second Intervention Period|No longer willing to participate|0|||
164666295|NCT02319148|594803418|FG001|Second Intervention Period|No longer willing to participate|1|||
164666296|NCT02319148|594803419|FG002|Second Intervention Period|No longer willing to participate|0|||
164666297|NCT02319148|594803420|FG003|Second Intervention Period|No longer willing to participate|0|||
164666298|NCT02319148|594803417|FG000|Second Intervention Period|Other|0|||
164666299|NCT02319148|594803418|FG001|Second Intervention Period|Other|0|||
164666300|NCT02319148|594803419|FG002|Second Intervention Period|Other|0|||
164666301|NCT02319148|594803420|FG003|Second Intervention Period|Other|1|||
164666302|NCT01574248|594803421|FG000|Overall Study|Withdrawal by Subject|2|||
164666303|NCT01574248|594803422|FG001|Overall Study|Withdrawal by Subject|0|||
164666304|NCT01574248|594803421|FG000|Overall Study|Missing primary endpoint data|1|||
164666305|NCT01574248|594803422|FG001|Overall Study|Missing primary endpoint data|0|||
164666306|NCT00048048|594803425|FG000|Core Treatment|Withdrawal by Subject|0|||
164666307|NCT00048048|594803426|FG001|Core Treatment|Withdrawal by Subject|0|||
164666308|NCT00048048|594803427|FG002|Core Treatment|Withdrawal by Subject|1|||
164666309|NCT00048048|594803428|FG003|Core Treatment|Withdrawal by Subject|0|||
164666310|NCT00048048|594803429|FG004|Core Treatment|Withdrawal by Subject|0|||
164666311|NCT00048048|594803430|FG005|Core Treatment|Withdrawal by Subject|0|||
164666312|NCT00048048|594803431|FG006|Core Treatment|Withdrawal by Subject|0|||
164317739|NCT00600119|593539277|FG001|Follow-up Period|Other|0|||
164317740|NCT00600119|593539278|FG002|Follow-up Period|Other|0|||
164317741|NCT00600119|593539279|FG003|Follow-up Period|Other|0|||
164317742|NCT00600119|593539280|FG004|Follow-up Period|Other|0|||
164317743|NCT00600119|593539281|FG005|Follow-up Period|Other|0|||
164666313|NCT00048048|594803432|FG007|Core Treatment|Withdrawal by Subject|0|||
164666314|NCT00048048|594803433|FG008|Core Treatment|Withdrawal by Subject|0|||
164317744|NCT04740905|593539282|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
164317745|NCT04740905|593539283|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
164317746|NCT04740905|593539282|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
164317747|NCT04740905|593539283|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
164317748|NCT04740905|593539282|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
164317749|NCT04740905|593539283|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
164317750|NCT04740905|593539282|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
164317751|NCT04740905|593539283|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
164666315|NCT00048048|594803434|FG009|Core Treatment|Withdrawal by Subject|0|||
164666316|NCT00048048|594803435|FG010|Core Treatment|Withdrawal by Subject|0|||
164666317|NCT00048048|594803436|FG011|Core Treatment|Withdrawal by Subject|0|||
164666318|NCT00048048|594803425|FG000|Core Treatment|Adverse Event|0|||
164666319|NCT00048048|594803426|FG001|Core Treatment|Adverse Event|0|||
164666320|NCT00048048|594803427|FG002|Core Treatment|Adverse Event|0|||
164666321|NCT00048048|594803428|FG003|Core Treatment|Adverse Event|0|||
164666322|NCT00048048|594803429|FG004|Core Treatment|Adverse Event|0|||
164666323|NCT00048048|594803430|FG005|Core Treatment|Adverse Event|0|||
164666324|NCT00048048|594803431|FG006|Core Treatment|Adverse Event|0|||
164666325|NCT00048048|594803432|FG007|Core Treatment|Adverse Event|1|||
164666326|NCT00048048|594803433|FG008|Core Treatment|Adverse Event|0|||
164666327|NCT00048048|594803434|FG009|Core Treatment|Adverse Event|0|||
164666328|NCT00048048|594803435|FG010|Core Treatment|Adverse Event|0|||
164317752|NCT04740905|593539282|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
164317753|NCT04740905|593539283|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
164317754|NCT04740905|593539282|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
164317755|NCT04740905|593539283|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
164317756|NCT04740905|593539282|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
164317757|NCT04740905|593539283|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
164317758|NCT04740905|593539282|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
164317759|NCT04740905|593539283|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
164317760|NCT04740905|593539282|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
164317761|NCT04740905|593539283|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
164317762|NCT04740905|593539282|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
164317763|NCT04740905|593539283|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
164317764|NCT04740905|593539282|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
164317765|NCT04740905|593539283|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
164317766|NCT04740905|593539282|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
164317767|NCT04740905|593539283|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
164317768|NCT04740905|593539282|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
164317769|NCT04740905|593539283|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
164317770|NCT04740905|593539282|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
164317771|NCT04740905|593539283|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
164317772|NCT00561977|593539284|FG000|Overall Study|Withdrawal by Subject|0|||
164317773|NCT00561977|593539285|FG001|Overall Study|Withdrawal by Subject|2|||
164317774|NCT00561977|593539286|FG002|Overall Study|Withdrawal by Subject|1|||
164317775|NCT00561977|593539284|FG000|Overall Study|Pregnancy|0|||
164317776|NCT00561977|593539285|FG001|Overall Study|Pregnancy|1|||
164317777|NCT00561977|593539286|FG002|Overall Study|Pregnancy|1|||
164317778|NCT03077087|593539287|FG000|Overall Study|Physician Decision|2|||
164317779|NCT01989468|593539288|FG000|Overall Study|Adverse Event|10|||
164317780|NCT01989468|593539289|FG001|Overall Study|Adverse Event|15|||
164317781|NCT01989468|593539290|FG002|Overall Study|Adverse Event|4|||
164317782|NCT01989468|593539291|FG003|Overall Study|Adverse Event|5|||
164317783|NCT01989468|593539292|FG004|Overall Study|Adverse Event|4|||
164317784|NCT01989468|593539288|FG000|Overall Study|Lack of Efficacy|11|||
164317785|NCT01989468|593539289|FG001|Overall Study|Lack of Efficacy|11|||
164317786|NCT01989468|593539290|FG002|Overall Study|Lack of Efficacy|7|||
164317787|NCT01989468|593539291|FG003|Overall Study|Lack of Efficacy|4|||
164317788|NCT01989468|593539292|FG004|Overall Study|Lack of Efficacy|2|||
164666329|NCT00048048|594803436|FG011|Core Treatment|Adverse Event|0|||
164666330|NCT00048048|594803425|FG000|Extension Year 1|Early withdrawals|0|||
164666331|NCT00048048|594803426|FG001|Extension Year 1|Early withdrawals|0|||
164666332|NCT00048048|594803427|FG002|Extension Year 1|Early withdrawals|0|||
164666333|NCT00048048|594803428|FG003|Extension Year 1|Early withdrawals|0|||
164666334|NCT00048048|594803429|FG004|Extension Year 1|Early withdrawals|0|||
164317789|NCT01989468|593539288|FG000|Overall Study|Lost to Follow-up|5|||
164317790|NCT01989468|593539289|FG001|Overall Study|Lost to Follow-up|2|||
164317791|NCT01989468|593539290|FG002|Overall Study|Lost to Follow-up|0|||
164317792|NCT01989468|593539291|FG003|Overall Study|Lost to Follow-up|1|||
164317793|NCT01989468|593539292|FG004|Overall Study|Lost to Follow-up|1|||
164317794|NCT01989468|593539288|FG000|Overall Study|Physician Decision|4|||
164317795|NCT01989468|593539289|FG001|Overall Study|Physician Decision|1|||
164317796|NCT01989468|593539290|FG002|Overall Study|Physician Decision|0|||
164666335|NCT00048048|594803430|FG005|Extension Year 1|Early withdrawals|0|||
164317797|NCT01989468|593539291|FG003|Overall Study|Physician Decision|1|||
164317798|NCT01989468|593539292|FG004|Overall Study|Physician Decision|0|||
164317799|NCT01989468|593539288|FG000|Overall Study|Pregnancy|0|||
164317800|NCT01989468|593539289|FG001|Overall Study|Pregnancy|1|||
164317801|NCT01989468|593539290|FG002|Overall Study|Pregnancy|0|||
164317802|NCT01989468|593539291|FG003|Overall Study|Pregnancy|0|||
164317803|NCT01989468|593539292|FG004|Overall Study|Pregnancy|0|||
164317804|NCT01989468|593539288|FG000|Overall Study|Technical Problems|3|||
164317805|NCT01989468|593539289|FG001|Overall Study|Technical Problems|1|||
164317806|NCT01989468|593539290|FG002|Overall Study|Technical Problems|3|||
164317807|NCT01989468|593539291|FG003|Overall Study|Technical Problems|1|||
164317808|NCT01989468|593539292|FG004|Overall Study|Technical Problems|0|||
164317809|NCT01989468|593539288|FG000|Overall Study|Subject Guardian Decision|11|||
164317810|NCT01989468|593539289|FG001|Overall Study|Subject Guardian Decision|6|||
164317811|NCT01989468|593539290|FG002|Overall Study|Subject Guardian Decision|4|||
164562029|NCT00429585|594425712|FG000|Overall Study|Death|1|||
164562030|NCT00429585|594425713|FG001|Overall Study|Death|0|||
164562031|NCT00429585|594425712|FG000|Overall Study|Lost to Follow-up|27|||
164562032|NCT00429585|594425713|FG001|Overall Study|Lost to Follow-up|20|||
164562033|NCT00429585|594425712|FG000|Overall Study|Physician Decision|2|||
164562034|NCT00429585|594425713|FG001|Overall Study|Physician Decision|0|||
164562035|NCT01582308|594425714|FG000|Period 1|Withdrawal by Subject|0|||
164562036|NCT01582308|594425715|FG001|Period 1|Withdrawal by Subject|0|||
164562037|NCT01582308|594425716|FG002|Period 1|Withdrawal by Subject|0|||
164562038|NCT01582308|594425717|FG003|Period 1|Withdrawal by Subject|0|||
164562039|NCT01582308|594425718|FG004|Period 1|Withdrawal by Subject|0|||
164562040|NCT01582308|594425719|FG005|Period 1|Withdrawal by Subject|0|||
164562041|NCT01582308|594425720|FG006|Period 1|Withdrawal by Subject|1|||
164562042|NCT01582308|594425721|FG007|Period 1|Withdrawal by Subject|0|||
164562043|NCT01582308|594425722|FG008|Period 1|Withdrawal by Subject|0|||
164562044|NCT01582308|594425723|FG009|Period 1|Withdrawal by Subject|0|||
164562045|NCT01582308|594425714|FG000|10-day Washout Following Period 1|Physician Decision|0|||
164562046|NCT01582308|594425715|FG001|10-day Washout Following Period 1|Physician Decision|0|||
164562047|NCT01582308|594425716|FG002|10-day Washout Following Period 1|Physician Decision|0|||
164562048|NCT01582308|594425717|FG003|10-day Washout Following Period 1|Physician Decision|0|||
164562049|NCT01582308|594425718|FG004|10-day Washout Following Period 1|Physician Decision|1|||
164562050|NCT01582308|594425719|FG005|10-day Washout Following Period 1|Physician Decision|0|||
164562051|NCT01582308|594425720|FG006|10-day Washout Following Period 1|Physician Decision|0|||
164562052|NCT01582308|594425721|FG007|10-day Washout Following Period 1|Physician Decision|0|||
164562053|NCT01582308|594425722|FG008|10-day Washout Following Period 1|Physician Decision|0|||
164562054|NCT01582308|594425723|FG009|10-day Washout Following Period 1|Physician Decision|0|||
164562055|NCT01582308|594425714|FG000|Period 4|Physician Decision|1|||
164562056|NCT01582308|594425715|FG001|Period 4|Physician Decision|0|||
164562057|NCT01582308|594425716|FG002|Period 4|Physician Decision|0|||
164562058|NCT01582308|594425717|FG003|Period 4|Physician Decision|0|||
164562059|NCT01582308|594425718|FG004|Period 4|Physician Decision|0|||
164562060|NCT01582308|594425719|FG005|Period 4|Physician Decision|1|||
164562061|NCT01582308|594425720|FG006|Period 4|Physician Decision|0|||
164562062|NCT01582308|594425721|FG007|Period 4|Physician Decision|0|||
164562063|NCT01582308|594425722|FG008|Period 4|Physician Decision|0|||
164562064|NCT01582308|594425723|FG009|Period 4|Physician Decision|1|||
164562065|NCT00772668|594425727|FG000|Overall Study|Physician Decision|3|||
164589001|NCT02078713|594521336|FG001|Overall Study|Pregnant at baseline|5|||
164589002|NCT02078713|594521337|FG002|Overall Study|Pregnant at baseline|0|||
164589003|NCT02078713|594521338|FG003|Overall Study|Pregnant at baseline|0|||
164589004|NCT02078713|594521335|FG000|Overall Study|Enrolled twice|0|||
164589005|NCT02078713|594521336|FG001|Overall Study|Enrolled twice|1|||
164589006|NCT02078713|594521337|FG002|Overall Study|Enrolled twice|0|||
164589007|NCT02078713|594521338|FG003|Overall Study|Enrolled twice|0|||
164589008|NCT01703286|594521344|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
164589009|NCT01703286|594521345|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
164589010|NCT01703286|594521346|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
164589011|NCT01703286|594521347|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
164589012|NCT01703286|594521348|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
164589013|NCT01703286|594521349|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
164589014|NCT01703286|594521344|FG000|Period 2 Including Washout|Adverse Event|0|||
164589015|NCT01703286|594521345|FG001|Period 2 Including Washout|Adverse Event|0|||
164589016|NCT01703286|594521346|FG002|Period 2 Including Washout|Adverse Event|0|||
164589017|NCT01703286|594521347|FG003|Period 2 Including Washout|Adverse Event|1|||
164589018|NCT01703286|594521348|FG004|Period 2 Including Washout|Adverse Event|0|||
164589019|NCT01703286|594521349|FG005|Period 2 Including Washout|Adverse Event|0|||
164589020|NCT02421120|594521350|FG000|Overall Study|Adverse Event|1|||
164589021|NCT00931892|594521351|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
164589022|NCT00931892|594521352|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
164589023|NCT00372190|594521353|FG000|Overall Study|Lost to Follow-up|3|||
164589024|NCT00372190|594521354|FG001|Overall Study|Lost to Follow-up|1|||
164562066|NCT01227902|594427411|FG000|Overall Study|Adverse Event|12|||
164562067|NCT01227902|594427412|FG001|Overall Study|Adverse Event|8|||
164562068|NCT01227902|594427413|FG002|Overall Study|Adverse Event|11|||
164562069|NCT01227902|594427414|FG003|Overall Study|Adverse Event|4|||
164562070|NCT01227902|594427411|FG000|Overall Study|Lack of Efficacy|1|||
164562071|NCT01227902|594427412|FG001|Overall Study|Lack of Efficacy|2|||
164562072|NCT01227902|594427413|FG002|Overall Study|Lack of Efficacy|2|||
164562073|NCT01227902|594427414|FG003|Overall Study|Lack of Efficacy|1|||
164562074|NCT01227902|594427411|FG000|Overall Study|Protocol Violation|1|||
164562075|NCT01227902|594427412|FG001|Overall Study|Protocol Violation|0|||
164562076|NCT01227902|594427413|FG002|Overall Study|Protocol Violation|0|||
164562077|NCT01227902|594427414|FG003|Overall Study|Protocol Violation|0|||
164562078|NCT01227902|594427411|FG000|Overall Study|Lost to Follow-up|0|||
164562079|NCT01227902|594427412|FG001|Overall Study|Lost to Follow-up|0|||
164562080|NCT01227902|594427413|FG002|Overall Study|Lost to Follow-up|1|||
164562081|NCT01227902|594427414|FG003|Overall Study|Lost to Follow-up|2|||
164562082|NCT01227902|594427411|FG000|Overall Study|Physician Decision|0|||
164562083|NCT01227902|594427412|FG001|Overall Study|Physician Decision|1|||
164562084|NCT01227902|594427413|FG002|Overall Study|Physician Decision|1|||
164562085|NCT01227902|594427414|FG003|Overall Study|Physician Decision|0|||
164562086|NCT01227902|594427411|FG000|Overall Study|Withdrawal by Subject|4|||
164562087|NCT01227902|594427412|FG001|Overall Study|Withdrawal by Subject|2|||
164562088|NCT01227902|594427413|FG002|Overall Study|Withdrawal by Subject|4|||
164562089|NCT01227902|594427414|FG003|Overall Study|Withdrawal by Subject|3|||
164562090|NCT02363478|594427419|FG000|Overall Study|Lost to Follow-up|4|||
164562091|NCT02363478|594427419|FG000|Overall Study|Adverse Event|4|||
164562092|NCT00930059|594427420|FG000|Overall Study|Death|1|||
164562093|NCT00930059|594427421|FG001|Overall Study|Death|0|||
164562094|NCT00930059|594427420|FG000|Overall Study|Did not meet entrance criteria|1|||
164562095|NCT00930059|594427421|FG001|Overall Study|Did not meet entrance criteria|1|||
164562096|NCT00930059|594427420|FG000|Overall Study|Withdrawal by Subject|3|||
164562097|NCT00930059|594427421|FG001|Overall Study|Withdrawal by Subject|4|||
164562098|NCT00930059|594427420|FG000|Overall Study|Other|1|||
164562099|NCT00930059|594427421|FG001|Overall Study|Other|0|||
164562100|NCT00930059|594427420|FG000|Overall Study|1 site terminated by sponsor|1|||
164562101|NCT00930059|594427421|FG001|Overall Study|1 site terminated by sponsor|1|||
164562102|NCT00930059|594427420|FG000|Overall Study|Adverse Event|1|||
164562103|NCT00930059|594427421|FG001|Overall Study|Adverse Event|6|||
164562104|NCT00546364|594427425|FG000|Overall Study|Disease progression|5|||
164562105|NCT00546364|594427426|FG001|Overall Study|Disease progression|11|||
164562106|NCT00546364|594427427|FG002|Overall Study|Disease progression|8|||
164562107|NCT00546364|594427425|FG000|Overall Study|Completed and off treatment|1|||
164562108|NCT00546364|594427426|FG001|Overall Study|Completed and off treatment|0|||
164562109|NCT00546364|594427427|FG002|Overall Study|Completed and off treatment|2|||
164562110|NCT00546364|594427425|FG000|Overall Study|Administrative reason by sponsor|1|||
164562111|NCT00546364|594427426|FG001|Overall Study|Administrative reason by sponsor|0|||
164562112|NCT00546364|594427427|FG002|Overall Study|Administrative reason by sponsor|0|||
164562113|NCT00546364|594427425|FG000|Overall Study|Poor compliance/noncompliance|0|||
164562114|NCT00546364|594427426|FG001|Overall Study|Poor compliance/noncompliance|0|||
164562115|NCT00546364|594427427|FG002|Overall Study|Poor compliance/noncompliance|1|||
164562116|NCT00546364|594427425|FG000|Overall Study|No longer meets study criteria|1|||
164562117|NCT00546364|594427426|FG001|Overall Study|No longer meets study criteria|1|||
164562118|NCT00546364|594427427|FG002|Overall Study|No longer meets study criteria|0|||
164562119|NCT00546364|594427425|FG000|Overall Study|Withdrawal by Subject|5|||
164562120|NCT00546364|594427426|FG001|Overall Study|Withdrawal by Subject|6|||
164562121|NCT00546364|594427427|FG002|Overall Study|Withdrawal by Subject|3|||
164562122|NCT00546364|594427425|FG000|Overall Study|Prior taxotere|1|||
164562123|NCT00546364|594427426|FG001|Overall Study|Prior taxotere|0|||
164562124|NCT00546364|594427427|FG002|Overall Study|Prior taxotere|0|||
164317812|NCT01989468|593539291|FG003|Overall Study|Subject Guardian Decision|4|||
164317813|NCT01989468|593539292|FG004|Overall Study|Subject Guardian Decision|1|||
164562125|NCT00546364|594427425|FG000|Overall Study|Mixed response|1|||
164562126|NCT00546364|594427426|FG001|Overall Study|Mixed response|0|||
164562127|NCT00546364|594427427|FG002|Overall Study|Mixed response|0|||
164562128|NCT00546364|594427425|FG000|Overall Study|Palliative treatment|1|||
164562129|NCT00546364|594427426|FG001|Overall Study|Palliative treatment|0|||
164562130|NCT00546364|594427427|FG002|Overall Study|Palliative treatment|1|||
164562131|NCT00546364|594427425|FG000|Overall Study|Target lesions resected|1|||
164562132|NCT00546364|594427426|FG001|Overall Study|Target lesions resected|0|||
164562133|NCT00546364|594427427|FG002|Overall Study|Target lesions resected|0|||
164562134|NCT00546364|594427425|FG000|Overall Study|Physician Decision|0|||
164562135|NCT00546364|594427426|FG001|Overall Study|Physician Decision|0|||
164562136|NCT00546364|594427427|FG002|Overall Study|Physician Decision|1|||
164562137|NCT00546364|594427425|FG000|Overall Study|Sponsor decision|0|||
164562138|NCT00546364|594427426|FG001|Overall Study|Sponsor decision|0|||
164562139|NCT00546364|594427427|FG002|Overall Study|Sponsor decision|1|||
164562140|NCT03064763|594427428|FG000|Overall Study|Lost to Follow-up|1|||
164317814|NCT01989468|593539288|FG000|Overall Study|Death|3|||
164317815|NCT01989468|593539289|FG001|Overall Study|Death|0|||
164317816|NCT01989468|593539290|FG002|Overall Study|Death|1|||
164317817|NCT01989468|593539291|FG003|Overall Study|Death|0|||
164317818|NCT01989468|593539292|FG004|Overall Study|Death|0|||
164317819|NCT00065429|593539295|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
164317820|NCT00065429|593539296|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
164317821|NCT00065429|593539297|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
164317822|NCT00065429|593539298|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
164317823|NCT00065429|593539299|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
164317824|NCT00065429|593539300|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
164317825|NCT00065429|593539301|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
164317826|NCT00065429|593539295|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
164317827|NCT00065429|593539296|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
164317828|NCT00065429|593539297|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
164317829|NCT00065429|593539298|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
164317830|NCT00065429|593539299|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
164317831|NCT00065429|593539300|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
164317832|NCT00065429|593539301|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
164317833|NCT00065429|593539295|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
164317834|NCT00065429|593539296|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
164317835|NCT00065429|593539297|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
164317836|NCT00065429|593539298|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
164317837|NCT00065429|593539299|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
164317838|NCT00065429|593539300|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
164317839|NCT00065429|593539301|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
164317840|NCT00065429|593539295|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
164317841|NCT00065429|593539296|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
164317842|NCT00065429|593539297|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
164317843|NCT00065429|593539298|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
164317844|NCT00065429|593539299|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
164317845|NCT00065429|593539300|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
164317846|NCT00065429|593539301|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
164317847|NCT00065429|593539295|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
164317848|NCT00065429|593539296|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
164317849|NCT00065429|593539297|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
164317850|NCT00065429|593539298|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
164317851|NCT00065429|593539299|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
164317852|NCT00065429|593539300|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
164317853|NCT00065429|593539301|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
164317854|NCT00065429|593539295|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
164317855|NCT00065429|593539296|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
164317856|NCT00065429|593539297|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
164317857|NCT00065429|593539298|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
164317858|NCT00065429|593539299|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
164317859|NCT00065429|593539300|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
164317860|NCT00065429|593539301|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
164317861|NCT00065429|593539295|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
164317862|NCT00065429|593539296|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
164317863|NCT00065429|593539297|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
164317864|NCT00065429|593539298|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
164317865|NCT00065429|593539299|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
164317866|NCT00065429|593539300|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
164317867|NCT00065429|593539301|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
164317868|NCT00977080|593539302|FG000|Overall Study|Adverse Event|2|||
164317869|NCT00977080|593539303|FG001|Overall Study|Adverse Event|7|||
164317870|NCT00977080|593539304|FG002|Overall Study|Adverse Event|7|||
164317871|NCT00977080|593539305|FG003|Overall Study|Adverse Event|7|||
164317872|NCT00977080|593539302|FG000|Overall Study|Withdrawal by Subject|1|||
164317873|NCT00977080|593539303|FG001|Overall Study|Withdrawal by Subject|5|||
164317874|NCT00977080|593539304|FG002|Overall Study|Withdrawal by Subject|1|||
164317875|NCT00977080|593539305|FG003|Overall Study|Withdrawal by Subject|5|||
164317876|NCT00977080|593539302|FG000|Overall Study|Protocol Violation|7|||
164317877|NCT00977080|593539303|FG001|Overall Study|Protocol Violation|3|||
164317878|NCT00977080|593539304|FG002|Overall Study|Protocol Violation|4|||
164317879|NCT00977080|593539305|FG003|Overall Study|Protocol Violation|3|||
164317880|NCT00977080|593539302|FG000|Overall Study|Noncompliance|0|||
164317881|NCT00977080|593539303|FG001|Overall Study|Noncompliance|2|||
164317882|NCT00977080|593539304|FG002|Overall Study|Noncompliance|1|||
164317883|NCT00977080|593539305|FG003|Overall Study|Noncompliance|0|||
164317884|NCT00977080|593539302|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
164317885|NCT00977080|593539303|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
164317886|NCT00977080|593539304|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
164317887|NCT00977080|593539305|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
164317888|NCT00977080|593539302|FG000|Overall Study|Required kidney transplantation|1|||
164317889|NCT00977080|593539303|FG001|Overall Study|Required kidney transplantation|3|||
164317890|NCT00977080|593539304|FG002|Overall Study|Required kidney transplantation|3|||
164317891|NCT00977080|593539305|FG003|Overall Study|Required kidney transplantation|1|||
164317892|NCT00977080|593539302|FG000|Overall Study|Travel for family reasons|1|||
164317893|NCT00977080|593539303|FG001|Overall Study|Travel for family reasons|0|||
164317894|NCT00977080|593539304|FG002|Overall Study|Travel for family reasons|0|||
164317895|NCT00977080|593539305|FG003|Overall Study|Travel for family reasons|0|||
164317896|NCT01950013|593539308|FG000|Overall Study|Withdrawal by Subject|0|||
164317897|NCT01950013|593539309|FG001|Overall Study|Withdrawal by Subject|2|||
164317898|NCT01950013|593539310|FG002|Overall Study|Withdrawal by Subject|0|||
164317899|NCT01765218|593539311|FG000|Overall Study|Protocol Violation|1|||
164317900|NCT01765218|593539312|FG001|Overall Study|Protocol Violation|2|||
164317901|NCT00313781|593539313|FG000|Before Crossover|Death|22|||
164317902|NCT00313781|593539314|FG001|Before Crossover|Death|8|||
164317903|NCT00313781|593539315|FG002|Before Crossover|Death|0|||
164317904|NCT00313781|593539313|FG000|Before Crossover|Lost to Follow-up|0|||
164317905|NCT00313781|593539314|FG001|Before Crossover|Lost to Follow-up|3|||
164317906|NCT00313781|593539315|FG002|Before Crossover|Lost to Follow-up|0|||
164317907|NCT00313781|593539313|FG000|Before Crossover|Withdrawal by Subject|3|||
164317908|NCT00313781|593539314|FG001|Before Crossover|Withdrawal by Subject|1|||
164317909|NCT00313781|593539315|FG002|Before Crossover|Withdrawal by Subject|0|||
164317910|NCT00313781|593539313|FG000|Before Crossover|Other|45|||
164317911|NCT00313781|593539314|FG001|Before Crossover|Other|30|||
164317912|NCT00313781|593539315|FG002|Before Crossover|Other|0|||
164317913|NCT00313781|593539313|FG000|Before Crossover|Crossover|0|||
164317914|NCT00313781|593539314|FG001|Before Crossover|Crossover|37|||
164317915|NCT00313781|593539315|FG002|Before Crossover|Crossover|0|||
164317916|NCT00313781|593539313|FG000|Before Crossover|Randomized, not treated|5|||
164317917|NCT00313781|593539314|FG001|Before Crossover|Randomized, not treated|0|||
164317918|NCT00313781|593539315|FG002|Before Crossover|Randomized, not treated|0|||
164317919|NCT00313781|593539313|FG000|After Crossover|Death|0|||
164317920|NCT00313781|593539314|FG001|After Crossover|Death|0|||
164317921|NCT00313781|593539315|FG002|After Crossover|Death|6|||
164317922|NCT00313781|593539313|FG000|After Crossover|Withdrawal by Subject|0|||
164317923|NCT00313781|593539314|FG001|After Crossover|Withdrawal by Subject|0|||
164317924|NCT00313781|593539315|FG002|After Crossover|Withdrawal by Subject|3|||
164317925|NCT00313781|593539313|FG000|After Crossover|Other|0|||
164317926|NCT00313781|593539314|FG001|After Crossover|Other|0|||
164317927|NCT00313781|593539315|FG002|After Crossover|Other|18|||
164317928|NCT03148691|593539316|FG000|Overall Study|Protocol Violation|1|||
164317929|NCT03148691|593539317|FG001|Overall Study|Protocol Violation|2|||
164317930|NCT03148691|593539318|FG002|Overall Study|Protocol Violation|7|||
164317931|NCT03148691|593539316|FG000|Overall Study|Lost to Follow-up|0|||
164317932|NCT03148691|593539317|FG001|Overall Study|Lost to Follow-up|0|||
164317933|NCT03148691|593539318|FG002|Overall Study|Lost to Follow-up|1|||
164317934|NCT03148691|593539316|FG000|Overall Study|Other|1|||
164317935|NCT03148691|593539317|FG001|Overall Study|Other|0|||
164317936|NCT03148691|593539318|FG002|Overall Study|Other|0|||
164317937|NCT03148691|593539316|FG000|Overall Study|Withdrawal by Subject|1|||
164317938|NCT03148691|593539317|FG001|Overall Study|Withdrawal by Subject|0|||
164317939|NCT03148691|593539318|FG002|Overall Study|Withdrawal by Subject|0|||
164317940|NCT01590758|593539319|FG000|Overall Study|Withdrawal by Subject|0|||
164317941|NCT01590758|593539320|FG001|Overall Study|Withdrawal by Subject|3|||
164317942|NCT01590758|593539319|FG000|Overall Study|Physician Decision|1|||
164317943|NCT01590758|593539320|FG001|Overall Study|Physician Decision|2|||
164317944|NCT01590758|593539319|FG000|Overall Study|Lost to Follow-up|4|||
164317945|NCT01590758|593539320|FG001|Overall Study|Lost to Follow-up|2|||
164317946|NCT02929498|593539321|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
164317947|NCT02929498|593539322|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
164317948|NCT02929498|593539323|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
164317949|NCT02929498|593539321|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
164666336|NCT00048048|594803431|FG006|Extension Year 1|Early withdrawals|0|||
164317950|NCT02929498|593539322|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
164317951|NCT02929498|593539323|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
164317952|NCT00096356|593539324|FG000|Overall Study|Adverse Event|11|||
164317953|NCT00096356|593539325|FG001|Overall Study|Adverse Event|9|||
164317954|NCT00096356|593539324|FG000|Overall Study|Physician Decision|5|||
164317955|NCT00096356|593539325|FG001|Overall Study|Physician Decision|3|||
164317956|NCT00096356|593539324|FG000|Overall Study|Withdrawal by Subject|17|||
164317957|NCT00096356|593539325|FG001|Overall Study|Withdrawal by Subject|23|||
164317958|NCT00096356|593539324|FG000|Overall Study|Lack of Efficacy|1|||
164317959|NCT00096356|593539325|FG001|Overall Study|Lack of Efficacy|0|||
164317960|NCT00096356|593539324|FG000|Overall Study|multiple reasons|10|||
164317961|NCT00096356|593539325|FG001|Overall Study|multiple reasons|18|||
164317962|NCT01181986|593539326|FG000|Phase 1|Lost to Follow-up|0|||
164317963|NCT01181986|593539327|FG001|Phase 1|Lost to Follow-up|1|||
164317964|NCT01181986|593539328|FG002|Phase 1|Lost to Follow-up|1|||
164317965|NCT01181986|593539326|FG000|Phase 1|Adverse Event|0|||
164317966|NCT01181986|593539327|FG001|Phase 1|Adverse Event|0|||
164317967|NCT01181986|593539328|FG002|Phase 1|Adverse Event|1|||
164317968|NCT01181986|593539326|FG000|Phase 1|Protocol Violation|1|||
164317969|NCT01181986|593539327|FG001|Phase 1|Protocol Violation|0|||
164317970|NCT01181986|593539328|FG002|Phase 1|Protocol Violation|0|||
164317971|NCT01181986|593539326|FG000|Phase 2|Adverse Event|0|||
164317972|NCT01181986|593539327|FG001|Phase 2|Adverse Event|3|||
164317973|NCT01181986|593539328|FG002|Phase 2|Adverse Event|0|||
164317974|NCT01181986|593539326|FG000|Phase 2|Medical condition|0|||
164317975|NCT01181986|593539327|FG001|Phase 2|Medical condition|1|||
164317976|NCT01181986|593539328|FG002|Phase 2|Medical condition|0|||
164317977|NCT00530504|593539329|FG000|Overall Study|Death|54|||
164317978|NCT00530504|593539329|FG000|Overall Study|Lost to Follow-up|26|||
164317979|NCT00530504|593539329|FG000|Overall Study|Withdrawal by Subject|39|||
164317980|NCT00530504|593539329|FG000|Overall Study|Exited study due to other reasons|33|||
164317981|NCT05009979|593539330|FG000|Overall Study|Withdrawal by Subject|1|||
164317982|NCT00576420|593540808|FG000|Overall Study|Death|0|||
164317983|NCT00576420|593540809|FG001|Overall Study|Death|0|||
164317984|NCT00576420|593540810|FG002|Overall Study|Death|1|||
164317985|NCT02616146|593540811|FG000|Overall Study|Adverse Event|64|||
164317986|NCT02616146|593540812|FG001|Overall Study|Adverse Event|24|||
164317987|NCT02616146|593540811|FG000|Overall Study|Lost to Follow-up|23|||
164317988|NCT02616146|593540812|FG001|Overall Study|Lost to Follow-up|13|||
164317989|NCT02616146|593540811|FG000|Overall Study|Non-compliance with study protocol|2|||
164317990|NCT02616146|593540812|FG001|Overall Study|Non-compliance with study protocol|0|||
164317991|NCT02616146|593540811|FG000|Overall Study|Non-compliance with study drug|4|||
164317992|NCT02616146|593540812|FG001|Overall Study|Non-compliance with study drug|2|||
164317993|NCT02616146|593540811|FG000|Overall Study|Pregnancy|2|||
164317994|NCT02616146|593540812|FG001|Overall Study|Pregnancy|2|||
164317995|NCT02616146|593540811|FG000|Overall Study|Pregnancy wish|3|||
164317996|NCT02616146|593540812|FG001|Overall Study|Pregnancy wish|0|||
164317997|NCT02616146|593540811|FG000|Overall Study|Protocol Violation|6|||
164317998|NCT02616146|593540812|FG001|Overall Study|Protocol Violation|3|||
164317999|NCT02616146|593540811|FG000|Overall Study|Study terminated by sponsor|1372|||
164318000|NCT02616146|593540812|FG001|Overall Study|Study terminated by sponsor|432|||
164318001|NCT02616146|593540811|FG000|Overall Study|Participant moved|4|||
164318002|NCT02616146|593540812|FG001|Overall Study|Participant moved|3|||
164318003|NCT02616146|593540811|FG000|Overall Study|Withdrawal by Subject|30|||
164318004|NCT02616146|593540812|FG001|Overall Study|Withdrawal by Subject|24|||
164318005|NCT02616146|593540811|FG000|Overall Study|Physician Decision|2|||
164318006|NCT02616146|593540812|FG001|Overall Study|Physician Decision|1|||
164318007|NCT01221272|593540813|FG000|Period 1|Adverse Event|2|||
164318008|NCT01221272|593540814|FG001|Period 1|Adverse Event|0|||
164318009|NCT01221272|593540813|FG000|Period 1|Consent Withdrawal|0|||
164318010|NCT01221272|593540814|FG001|Period 1|Consent Withdrawal|1|||
164318011|NCT01221272|593540813|FG000|Period 1|Significant Dosing Noncompliance|0|||
164318012|NCT01221272|593540814|FG001|Period 1|Significant Dosing Noncompliance|1|||
164318013|NCT01221272|593540813|FG000|Period 2|Adverse Event|0|||
164318014|NCT01221272|593540814|FG001|Period 2|Adverse Event|2|||
164318015|NCT01340872|593540815|FG000|Double-blind Phase|Adverse Event|6|||
164318016|NCT01340872|593540816|FG001|Double-blind Phase|Adverse Event|4|||
164318017|NCT01340872|593540817|FG002|Double-blind Phase|Adverse Event|0|||
164318018|NCT01340872|593540818|FG003|Double-blind Phase|Adverse Event|0|||
164318019|NCT01340872|593540815|FG000|Double-blind Phase|Withdrawal by Subject|3|||
164318020|NCT01340872|593540816|FG001|Double-blind Phase|Withdrawal by Subject|5|||
164318021|NCT01340872|593540817|FG002|Double-blind Phase|Withdrawal by Subject|0|||
164318022|NCT01340872|593540818|FG003|Double-blind Phase|Withdrawal by Subject|0|||
164318023|NCT01340872|593540815|FG000|Double-blind Phase|Lost to Follow-up|0|||
164318024|NCT01340872|593540816|FG001|Double-blind Phase|Lost to Follow-up|1|||
164318025|NCT01340872|593540817|FG002|Double-blind Phase|Lost to Follow-up|0|||
164318026|NCT01340872|593540818|FG003|Double-blind Phase|Lost to Follow-up|0|||
164318027|NCT01340872|593540815|FG000|Double-blind Phase|Protocol Violation|0|||
164318028|NCT01340872|593540816|FG001|Double-blind Phase|Protocol Violation|1|||
164318029|NCT01340872|593540817|FG002|Double-blind Phase|Protocol Violation|0|||
164318030|NCT01340872|593540818|FG003|Double-blind Phase|Protocol Violation|0|||
164318031|NCT01340872|593540815|FG000|Open-label Phase|Physician Decision|0|||
164318032|NCT01340872|593540816|FG001|Open-label Phase|Physician Decision|0|||
164318033|NCT01340872|593540817|FG002|Open-label Phase|Physician Decision|2|||
164318034|NCT01340872|593540818|FG003|Open-label Phase|Physician Decision|1|||
164318035|NCT01340872|593540815|FG000|Open-label Phase|Pregnancy|0|||
164318036|NCT01340872|593540816|FG001|Open-label Phase|Pregnancy|0|||
164318037|NCT01340872|593540817|FG002|Open-label Phase|Pregnancy|1|||
164318038|NCT01340872|593540818|FG003|Open-label Phase|Pregnancy|0|||
164318039|NCT01340872|593540815|FG000|Open-label Phase|Adverse Event|0|||
164318040|NCT01340872|593540816|FG001|Open-label Phase|Adverse Event|0|||
164318041|NCT01340872|593540817|FG002|Open-label Phase|Adverse Event|8|||
164318042|NCT01340872|593540818|FG003|Open-label Phase|Adverse Event|4|||
164318043|NCT01340872|593540815|FG000|Open-label Phase|Withdrawal by Subject|0|||
164318044|NCT01340872|593540816|FG001|Open-label Phase|Withdrawal by Subject|0|||
164318045|NCT01340872|593540817|FG002|Open-label Phase|Withdrawal by Subject|1|||
164318046|NCT01340872|593540818|FG003|Open-label Phase|Withdrawal by Subject|6|||
164318047|NCT01340872|593540815|FG000|Open-label Phase|Worsening of IBD|0|||
164318048|NCT01340872|593540816|FG001|Open-label Phase|Worsening of IBD|0|||
164318049|NCT01340872|593540817|FG002|Open-label Phase|Worsening of IBD|1|||
164318050|NCT01340872|593540818|FG003|Open-label Phase|Worsening of IBD|0|||
164318051|NCT03039621|593540823|FG000|Overall Study|Violation of inclusion criteria|3|||
164318052|NCT03039621|593540824|FG001|Overall Study|Violation of inclusion criteria|2|||
164318053|NCT03039621|593540823|FG000|Overall Study|Non-compliance with protocol requirement|4|||
164318054|NCT03039621|593540824|FG001|Overall Study|Non-compliance with protocol requirement|5|||
164318055|NCT03039621|593540823|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
164318056|NCT03039621|593540824|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
164318057|NCT03039621|593540823|FG000|Overall Study|Violation of non-inclusion criteria|1|||
164318058|NCT03039621|593540824|FG001|Overall Study|Violation of non-inclusion criteria|2|||
164318059|NCT02522624|593540825|FG000|Overall Study|Technical failure|1|||
164318060|NCT02522624|593540826|FG001|Overall Study|Technical failure|0|||
164318061|NCT03254108|593540827|FG000|Overall Study|Adverse Event|0|||
164318062|NCT03254108|593540828|FG001|Overall Study|Adverse Event|2|||
164318063|NCT03254108|593540829|FG002|Overall Study|Adverse Event|0|||
164318064|NCT03254108|593540830|FG003|Overall Study|Adverse Event|1|||
164318065|NCT03254108|593540831|FG004|Overall Study|Adverse Event|1|||
164318066|NCT03254108|593540827|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
164318067|NCT03254108|593540828|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
164562141|NCT03064763|594427428|FG000|Overall Study|Death|8|||
164562142|NCT00388947|594427429|FG000|Overall Study|Protocol Violation|47|||
164562143|NCT00935883|594427430|FG000|Treatment Period|Physician Decision|1|||
164562144|NCT00935883|594427431|FG001|Treatment Period|Physician Decision|0|||
164562145|NCT00935883|594427430|FG000|Treatment Period|Withdrawal by Subject|0|||
164562146|NCT00935883|594427431|FG001|Treatment Period|Withdrawal by Subject|2|||
164562147|NCT01220414|594427432|FG000|Overall Study|Withdrawal by Subject|1|||
164562148|NCT01220414|594427433|FG001|Overall Study|Withdrawal by Subject|0|||
164562149|NCT01220414|594427434|FG002|Overall Study|Withdrawal by Subject|0|||
164562150|NCT01220414|594427435|FG003|Overall Study|Withdrawal by Subject|1|||
164562151|NCT00066690|594427436|FG000|Overall Study|Adverse Event|145|||
164562152|NCT00066690|594427437|FG001|Overall Study|Adverse Event|58|||
164562153|NCT00066690|594427438|FG002|Overall Study|Adverse Event|126|||
164562154|NCT00066690|594427436|FG000|Overall Study|Death|3|||
164562155|NCT00066690|594427437|FG001|Overall Study|Death|0|||
164562156|NCT00066690|594427438|FG002|Overall Study|Death|2|||
164562157|NCT00066690|594427436|FG000|Overall Study|Lack of Efficacy|114|||
164562158|NCT00066690|594427437|FG001|Overall Study|Lack of Efficacy|110|||
164562159|NCT00066690|594427438|FG002|Overall Study|Lack of Efficacy|76|||
164562160|NCT00066690|594427436|FG000|Overall Study|Lost to Follow-up|40|||
164562161|NCT00066690|594427437|FG001|Overall Study|Lost to Follow-up|21|||
164562162|NCT00066690|594427438|FG002|Overall Study|Lost to Follow-up|29|||
164562163|NCT00066690|594427436|FG000|Overall Study|Withdrawal by Subject|50|||
164562164|NCT00066690|594427437|FG001|Overall Study|Withdrawal by Subject|55|||
164562165|NCT00066690|594427438|FG002|Overall Study|Withdrawal by Subject|49|||
164562166|NCT00066690|594427436|FG000|Overall Study|Treatment Ongoing|246|||
164562167|NCT00066690|594427437|FG001|Overall Study|Treatment Ongoing|278|||
164562168|NCT00066690|594427438|FG002|Overall Study|Treatment Ongoing|282|||
164562169|NCT00223496|594427439|FG000|Overall Study|screen failure|9|||
164562170|NCT00223496|594427439|FG000|Overall Study|Lost to Follow-up|4|||
164562171|NCT00223496|594427439|FG000|Overall Study|Lack of Efficacy|6|||
164562172|NCT00223496|594427439|FG000|Overall Study|Withdrawal by Subject|1|||
164562173|NCT00223496|594427439|FG000|Overall Study|Physician Decision|2|||
164562174|NCT02161562|594427442|FG000|Overall Study|Withdrawal by Subject|5|||
164562175|NCT02161562|594427443|FG001|Overall Study|Withdrawal by Subject|8|||
164562176|NCT02161562|594427442|FG000|Overall Study|Protocol Violation|9|||
164562177|NCT02161562|594427443|FG001|Overall Study|Protocol Violation|4|||
164562178|NCT02161562|594427442|FG000|Overall Study|Pregnancy|1|||
164562179|NCT02161562|594427443|FG001|Overall Study|Pregnancy|2|||
164562180|NCT02161562|594427442|FG000|Overall Study|Lost to Follow-up|3|||
164562181|NCT02161562|594427443|FG001|Overall Study|Lost to Follow-up|1|||
164562182|NCT02161562|594427442|FG000|Overall Study|Lack of Efficacy|4|||
164562183|NCT02161562|594427443|FG001|Overall Study|Lack of Efficacy|1|||
164562184|NCT02161562|594427442|FG000|Overall Study|Adverse Event|1|||
164562185|NCT02161562|594427443|FG001|Overall Study|Adverse Event|1|||
164562186|NCT02161562|594427442|FG000|Overall Study|Participant moved back to home country|1|||
164562187|NCT02161562|594427443|FG001|Overall Study|Participant moved back to home country|0|||
164562188|NCT02161562|594427442|FG000|Overall Study|Withdrew due to being out of the country|1|||
164562189|NCT02161562|594427443|FG001|Overall Study|Withdrew due to being out of the country|0|||
164562190|NCT02161562|594427442|FG000|Overall Study|Participant moved out of province|1|||
164562191|NCT02161562|594427443|FG001|Overall Study|Participant moved out of province|0|||
164562192|NCT02624492|594427459|FG000|Overall Study|Adverse Event|2|||
164666337|NCT00048048|594803432|FG007|Extension Year 1|Early withdrawals|0|||
164666338|NCT00048048|594803433|FG008|Extension Year 1|Early withdrawals|0|||
164666339|NCT00048048|594803434|FG009|Extension Year 1|Early withdrawals|2|||
164666340|NCT00048048|594803435|FG010|Extension Year 1|Early withdrawals|2|||
164666341|NCT00048048|594803436|FG011|Extension Year 1|Early withdrawals|4|||
164666342|NCT00048048|594803425|FG000|Extension Year 2|Early withdrawals|0|||
164666343|NCT00048048|594803426|FG001|Extension Year 2|Early withdrawals|0|||
164666344|NCT00048048|594803427|FG002|Extension Year 2|Early withdrawals|0|||
164666345|NCT00048048|594803428|FG003|Extension Year 2|Early withdrawals|0|||
164666346|NCT00048048|594803429|FG004|Extension Year 2|Early withdrawals|0|||
164666347|NCT00048048|594803430|FG005|Extension Year 2|Early withdrawals|0|||
164666348|NCT00048048|594803431|FG006|Extension Year 2|Early withdrawals|0|||
164666349|NCT00048048|594803432|FG007|Extension Year 2|Early withdrawals|0|||
164666350|NCT00048048|594803433|FG008|Extension Year 2|Early withdrawals|0|||
164666351|NCT00048048|594803434|FG009|Extension Year 2|Early withdrawals|0|||
164666352|NCT00048048|594803435|FG010|Extension Year 2|Early withdrawals|4|||
164666353|NCT00048048|594803436|FG011|Extension Year 2|Early withdrawals|2|||
164666354|NCT01345019|594803455|FG000|Blinded Treatment Phase|Death|147|||
164666355|NCT01345019|594803456|FG001|Blinded Treatment Phase|Death|137|||
164666356|NCT01345019|594803455|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
164666357|NCT01345019|594803456|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
164666358|NCT01345019|594803455|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
164666359|NCT01345019|594803456|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
164666360|NCT01345019|594803455|FG000|Blinded Treatment Phase|Disease Progression|12|||
164666361|NCT01345019|594803456|FG001|Blinded Treatment Phase|Disease Progression|10|||
164666362|NCT01345019|594803455|FG000|Blinded Treatment Phase|Adverse Event|6|||
164666363|NCT01345019|594803456|FG001|Blinded Treatment Phase|Adverse Event|13|||
164666364|NCT01345019|594803455|FG000|Blinded Treatment Phase|Administrative Decision|10|||
164666365|NCT01345019|594803456|FG001|Blinded Treatment Phase|Administrative Decision|8|||
164666366|NCT01345019|594803455|FG000|Blinded Treatment Phase|Noncompliance|5|||
164666367|NCT01345019|594803456|FG001|Blinded Treatment Phase|Noncompliance|3|||
164666368|NCT01345019|594803455|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
164666369|NCT01345019|594803456|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
164666370|NCT01345019|594803455|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
164666371|NCT01345019|594803456|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
164666372|NCT01345019|594803455|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
164666373|NCT01345019|594803456|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
164666374|NCT01345019|594803455|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
164666375|NCT01345019|594803456|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
164666376|NCT01345019|594803455|FG000|Open Label Treatment Phase|Death|49|||
164666377|NCT01345019|594803456|FG001|Open Label Treatment Phase|Death|48|||
164666378|NCT01345019|594803455|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
164666379|NCT01345019|594803456|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
164666380|NCT01345019|594803455|FG000|Open Label Treatment Phase|Adverse Event|30|||
164666381|NCT01345019|594803456|FG001|Open Label Treatment Phase|Adverse Event|51|||
164205643|NCT01648764|593122654|FG004|Overall Study|Death|0|||
164205644|NCT01648764|593122655|FG005|Overall Study|Death|0|||
164205645|NCT01648764|593122656|FG006|Overall Study|Death|1|||
164205646|NCT01648764|593122657|FG007|Overall Study|Death|0|||
164205647|NCT01648764|593122658|FG008|Overall Study|Death|0|||
164205648|NCT01648764|593122659|FG009|Overall Study|Death|0|||
164205649|NCT01648764|593122660|FG010|Overall Study|Death|0|||
164205650|NCT01648764|593122661|FG011|Overall Study|Death|0|||
164205651|NCT01648764|593122662|FG012|Overall Study|Death|0|||
164205652|NCT01648764|593122663|FG013|Overall Study|Death|1|||
164205653|NCT01648764|593122650|FG000|Overall Study|Withdrawal by Subject|0|||
164205654|NCT01648764|593122651|FG001|Overall Study|Withdrawal by Subject|0|||
164205655|NCT01648764|593122652|FG002|Overall Study|Withdrawal by Subject|0|||
164205656|NCT01648764|593122653|FG003|Overall Study|Withdrawal by Subject|0|||
164205657|NCT01648764|593122654|FG004|Overall Study|Withdrawal by Subject|0|||
164205658|NCT01648764|593122655|FG005|Overall Study|Withdrawal by Subject|0|||
164205659|NCT01648764|593122656|FG006|Overall Study|Withdrawal by Subject|2|||
164205660|NCT01648764|593122657|FG007|Overall Study|Withdrawal by Subject|0|||
164205661|NCT01648764|593122658|FG008|Overall Study|Withdrawal by Subject|0|||
164205662|NCT01648764|593122659|FG009|Overall Study|Withdrawal by Subject|0|||
164205663|NCT01648764|593122660|FG010|Overall Study|Withdrawal by Subject|0|||
164205664|NCT01648764|593122661|FG011|Overall Study|Withdrawal by Subject|0|||
164205665|NCT01648764|593122662|FG012|Overall Study|Withdrawal by Subject|1|||
164205666|NCT01648764|593122663|FG013|Overall Study|Withdrawal by Subject|0|||
164205667|NCT01648764|593122650|FG000|Overall Study|Investigator Decision|0|||
164205668|NCT01648764|593122651|FG001|Overall Study|Investigator Decision|0|||
164205669|NCT01648764|593122652|FG002|Overall Study|Investigator Decision|0|||
164205670|NCT01648764|593122653|FG003|Overall Study|Investigator Decision|0|||
164205671|NCT01648764|593122654|FG004|Overall Study|Investigator Decision|0|||
164420635|NCT01154036|593910966|FG004|Phase I|Lost to Follow-up|0|||
164318068|NCT03254108|593540829|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
164318069|NCT03254108|593540830|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
164318070|NCT03254108|593540831|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
164318071|NCT01142089|593540834|FG000|Overall Study|Physician Decision|1|||
164318072|NCT01142089|593540835|FG001|Overall Study|Physician Decision|0|||
164318073|NCT01142089|593540834|FG000|Overall Study|Withdrawal by Subject|1|||
164318074|NCT01142089|593540835|FG001|Overall Study|Withdrawal by Subject|2|||
164318075|NCT01142089|593540834|FG000|Overall Study|Use of prohibited medications|0|||
164318076|NCT01142089|593540835|FG001|Overall Study|Use of prohibited medications|1|||
164318077|NCT01142089|593540834|FG000|Overall Study|Noncompliance with study procedures|2|||
164318078|NCT01142089|593540835|FG001|Overall Study|Noncompliance with study procedures|1|||
164318079|NCT01142089|593540834|FG000|Overall Study|Patient required rescue medication|8|||
164318080|NCT01142089|593540835|FG001|Overall Study|Patient required rescue medication|17|||
164318081|NCT01974765|593540836|FG000|Overall Study|Withdrawal by Subject|1|||
164318082|NCT01974765|593540836|FG000|Overall Study|Death|1|||
164318083|NCT01974765|593540836|FG000|Overall Study|Adverse Event|2|||
164318084|NCT04531462|593540837|FG000|Overall Study|Withdrawal by Subject|3|||
164318085|NCT04531462|593540838|FG001|Overall Study|Withdrawal by Subject|1|||
164318086|NCT04531462|593540837|FG000|Overall Study|Adverse Event|3|||
164318087|NCT04531462|593540838|FG001|Overall Study|Adverse Event|3|||
164318088|NCT01350544|593540840|FG000|Overall Study|Administrative Withdrawal|0|||
164318089|NCT01350544|593540841|FG001|Overall Study|Administrative Withdrawal|1|||
164318090|NCT01350544|593540840|FG000|Overall Study|Death|1|||
164318091|NCT01350544|593540841|FG001|Overall Study|Death|2|||
164318092|NCT01350544|593540840|FG000|Overall Study|Moved out of LA County|2|||
164318093|NCT01350544|593540841|FG001|Overall Study|Moved out of LA County|2|||
164318094|NCT01350544|593540840|FG000|Overall Study|Medical Issues|1|||
164318095|NCT01350544|593540841|FG001|Overall Study|Medical Issues|1|||
164318096|NCT01350544|593540840|FG000|Overall Study|Withdrawal by Subject|0|||
164318097|NCT01350544|593540841|FG001|Overall Study|Withdrawal by Subject|1|||
164318098|NCT01350544|593540840|FG000|Overall Study|Incarceration|1|||
164205672|NCT01648764|593122655|FG005|Overall Study|Investigator Decision|0|||
164205673|NCT01648764|593122656|FG006|Overall Study|Investigator Decision|1|||
164205674|NCT01648764|593122657|FG007|Overall Study|Investigator Decision|0|||
164205675|NCT01648764|593122658|FG008|Overall Study|Investigator Decision|0|||
164666382|NCT01345019|594803455|FG000|Open Label Treatment Phase|Administrative Decision|30|||
164666383|NCT01345019|594803456|FG001|Open Label Treatment Phase|Administrative Decision|15|||
164666384|NCT01345019|594803455|FG000|Open Label Treatment Phase|Disease Progression|17|||
164666385|NCT01345019|594803456|FG001|Open Label Treatment Phase|Disease Progression|18|||
164666386|NCT01345019|594803455|FG000|Open Label Treatment Phase|Noncompliance|5|||
164666387|NCT01345019|594803456|FG001|Open Label Treatment Phase|Noncompliance|4|||
164205676|NCT01648764|593122659|FG009|Overall Study|Investigator Decision|0|||
164205677|NCT01648764|593122660|FG010|Overall Study|Investigator Decision|0|||
164205678|NCT01648764|593122661|FG011|Overall Study|Investigator Decision|1|||
164205679|NCT01648764|593122662|FG012|Overall Study|Investigator Decision|0|||
164318099|NCT01350544|593540841|FG001|Overall Study|Incarceration|0|||
164318100|NCT01350544|593540840|FG000|Overall Study|Lost to Follow-up|18|||
164205680|NCT01648764|593122663|FG013|Overall Study|Investigator Decision|0|||
164205681|NCT00903968|593122664|FG000|Overall Study|Adverse Event|0|||
164205682|NCT00903968|593122665|FG001|Overall Study|Adverse Event|0|||
164205683|NCT00903968|593122666|FG002|Overall Study|Adverse Event|0|||
164205684|NCT00903968|593122667|FG003|Overall Study|Adverse Event|0|||
164205685|NCT00903968|593122668|FG004|Overall Study|Adverse Event|0|||
164205686|NCT00903968|593122669|FG005|Overall Study|Adverse Event|0|||
164205687|NCT00903968|593122670|FG006|Overall Study|Adverse Event|1|||
164205688|NCT00903968|593122671|FG007|Overall Study|Adverse Event|8|||
164205689|NCT00903968|593122664|FG000|Overall Study|DLT|0|||
164205690|NCT00903968|593122665|FG001|Overall Study|DLT|0|||
164205691|NCT00903968|593122666|FG002|Overall Study|DLT|0|||
164318101|NCT01350544|593540841|FG001|Overall Study|Lost to Follow-up|15|||
164318102|NCT01444092|593540842|FG000|Overall Study|Adverse Event|8|||
164318103|NCT01444092|593540842|FG000|Overall Study|Protocol Violation|1|||
164318104|NCT01444092|593540842|FG000|Overall Study|Withdrawal by Subject|1|||
164318105|NCT01444092|593540842|FG000|Overall Study|Other Eligibility criteria|7|||
164318106|NCT05338671|593540845|FG000|Overall Study|Lost to Follow-up|2|||
164318107|NCT05338671|593540846|FG001|Overall Study|Lost to Follow-up|2|||
164318108|NCT05338671|593540845|FG000|Overall Study|Root canal completed in a single visit|1|||
164318109|NCT05338671|593540846|FG001|Overall Study|Root canal completed in a single visit|0|||
164318110|NCT03859973|593540847|FG000|Overall Study|Other reason than listed|3|||
164318111|NCT03859973|593540848|FG001|Overall Study|Other reason than listed|2|||
164666388|NCT01345019|594803455|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
164666389|NCT01345019|594803456|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
164205692|NCT00903968|593122667|FG003|Overall Study|DLT|0|||
164205693|NCT00903968|593122668|FG004|Overall Study|DLT|0|||
164205694|NCT00903968|593122669|FG005|Overall Study|DLT|0|||
164205695|NCT00903968|593122670|FG006|Overall Study|DLT|2|||
164205696|NCT00903968|593122671|FG007|Overall Study|DLT|0|||
164666390|NCT01345019|594803455|FG000|Open Label Treatment Phase|Pregnancy|1|||
164205697|NCT00903968|593122664|FG000|Overall Study|Withdrawal by Subject|1|||
164205698|NCT00903968|593122665|FG001|Overall Study|Withdrawal by Subject|0|||
164205699|NCT00903968|593122666|FG002|Overall Study|Withdrawal by Subject|1|||
164205700|NCT00903968|593122667|FG003|Overall Study|Withdrawal by Subject|0|||
164205701|NCT00903968|593122668|FG004|Overall Study|Withdrawal by Subject|1|||
164205702|NCT00903968|593122669|FG005|Overall Study|Withdrawal by Subject|1|||
164205703|NCT00903968|593122670|FG006|Overall Study|Withdrawal by Subject|0|||
164205704|NCT00903968|593122671|FG007|Overall Study|Withdrawal by Subject|4|||
164205705|NCT00903968|593122664|FG000|Overall Study|Non-Compliance|0|||
164205706|NCT00903968|593122665|FG001|Overall Study|Non-Compliance|0|||
164205707|NCT00903968|593122666|FG002|Overall Study|Non-Compliance|0|||
164205708|NCT00903968|593122667|FG003|Overall Study|Non-Compliance|0|||
164205709|NCT00903968|593122668|FG004|Overall Study|Non-Compliance|0|||
164205710|NCT00903968|593122669|FG005|Overall Study|Non-Compliance|1|||
164205711|NCT00903968|593122670|FG006|Overall Study|Non-Compliance|0|||
164205712|NCT00903968|593122671|FG007|Overall Study|Non-Compliance|0|||
164205713|NCT00903968|593122664|FG000|Overall Study|Physician Decision|0|||
164205714|NCT00903968|593122665|FG001|Overall Study|Physician Decision|0|||
164205715|NCT00903968|593122666|FG002|Overall Study|Physician Decision|0|||
164205716|NCT00903968|593122667|FG003|Overall Study|Physician Decision|0|||
164205717|NCT00903968|593122668|FG004|Overall Study|Physician Decision|0|||
164205718|NCT00903968|593122669|FG005|Overall Study|Physician Decision|1|||
164205719|NCT00903968|593122670|FG006|Overall Study|Physician Decision|0|||
164205720|NCT00903968|593122671|FG007|Overall Study|Physician Decision|0|||
164205721|NCT00903968|593122664|FG000|Overall Study|Progressive Disease|2|||
164205722|NCT00903968|593122665|FG001|Overall Study|Progressive Disease|3|||
164205723|NCT00903968|593122666|FG002|Overall Study|Progressive Disease|2|||
164205724|NCT00903968|593122667|FG003|Overall Study|Progressive Disease|3|||
164205725|NCT00903968|593122668|FG004|Overall Study|Progressive Disease|3|||
164205726|NCT00903968|593122669|FG005|Overall Study|Progressive Disease|3|||
164205727|NCT00903968|593122670|FG006|Overall Study|Progressive Disease|0|||
164205728|NCT00903968|593122671|FG007|Overall Study|Progressive Disease|18|||
164205729|NCT00903968|593122664|FG000|Overall Study|Lack of Efficacy|0|||
164205730|NCT00903968|593122665|FG001|Overall Study|Lack of Efficacy|0|||
164205731|NCT00903968|593122666|FG002|Overall Study|Lack of Efficacy|0|||
164205732|NCT00903968|593122667|FG003|Overall Study|Lack of Efficacy|0|||
164205733|NCT00903968|593122668|FG004|Overall Study|Lack of Efficacy|0|||
164205734|NCT00903968|593122669|FG005|Overall Study|Lack of Efficacy|0|||
164205735|NCT00903968|593122670|FG006|Overall Study|Lack of Efficacy|0|||
164205736|NCT00903968|593122671|FG007|Overall Study|Lack of Efficacy|3|||
164205737|NCT01294046|593122672|FG000|Overall Study|Infection and surgical explant|1|||
164205738|NCT01294046|593122672|FG000|Overall Study|Eligibility criteria expanded|1|||
164205739|NCT01294046|593122672|FG000|Overall Study|Stimulation response inadqequate|1|||
164205740|NCT03738696|593122678|FG000|Overall Study|Withdrawal by Subject|0|||
164205741|NCT03738696|593122679|FG001|Overall Study|Withdrawal by Subject|1|||
164205742|NCT03738696|593122678|FG000|Overall Study|Lost to Follow-up|8|||
164205743|NCT03738696|593122679|FG001|Overall Study|Lost to Follow-up|14|||
164205744|NCT03801252|593122682|FG000|Overall Study|Protocol Violation|1|||
164205745|NCT03801252|593122683|FG001|Overall Study|Protocol Violation|2|||
164205746|NCT02690727|593122684|FG000|Overall Study|Adverse Event|2|||
164666391|NCT01345019|594803456|FG001|Open Label Treatment Phase|Pregnancy|0|||
164666392|NCT01345019|594803455|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
164666393|NCT01345019|594803456|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
164666394|NCT01345019|594803455|FG000|Open Label Treatment Phase|Protocol Violation|0|||
164666395|NCT01345019|594803456|FG001|Open Label Treatment Phase|Protocol Violation|1|||
164666396|NCT02353169|594803463|FG000|Overall Study|QTc > 450 msec|1|||
164666397|NCT02353169|594803464|FG001|Overall Study|QTc > 450 msec|1|||
164666398|NCT02353169|594803465|FG002|Overall Study|QTc > 450 msec|1|||
164666399|NCT02353169|594803466|FG003|Overall Study|QTc > 450 msec|1|||
164666400|NCT02353169|594803463|FG000|Overall Study|OR team declined|2|||
164666401|NCT02353169|594803464|FG001|Overall Study|OR team declined|0|||
164666402|NCT02353169|594803465|FG002|Overall Study|OR team declined|0|||
164666403|NCT02353169|594803466|FG003|Overall Study|OR team declined|0|||
164666404|NCT02353169|594803463|FG000|Overall Study|Inhalational induction|0|||
164666405|NCT02353169|594803464|FG001|Overall Study|Inhalational induction|2|||
164666406|NCT02353169|594803465|FG002|Overall Study|Inhalational induction|0|||
164666407|NCT02353169|594803466|FG003|Overall Study|Inhalational induction|0|||
164205747|NCT02690727|593122685|FG001|Overall Study|Adverse Event|2|||
164205748|NCT04757636|593122686|FG000|Overall Study|Adverse Event|25|||
164205749|NCT04757636|593122687|FG001|Overall Study|Adverse Event|8|||
164205750|NCT04757636|593122688|FG002|Overall Study|Adverse Event|11|||
164205751|NCT04757636|593122686|FG000|Overall Study|Death|9|||
164205752|NCT04757636|593122687|FG001|Overall Study|Death|12|||
164205753|NCT04757636|593122688|FG002|Overall Study|Death|6|||
164205754|NCT04757636|593122686|FG000|Overall Study|Lack of Efficacy|2|||
164205755|NCT04757636|593122687|FG001|Overall Study|Lack of Efficacy|0|||
164205756|NCT04757636|593122688|FG002|Overall Study|Lack of Efficacy|0|||
164666408|NCT02353169|594803463|FG000|Overall Study|ECG data error|0|||
164318112|NCT03859973|593540847|FG000|Overall Study|COVID-19 related, not due to AE|3|||
164318113|NCT03859973|593540848|FG001|Overall Study|COVID-19 related, not due to AE|4|||
164318114|NCT03859973|593540847|FG000|Overall Study|Withdrawal by Subject|8|||
164318115|NCT03859973|593540848|FG001|Overall Study|Withdrawal by Subject|9|||
164318116|NCT03859973|593540847|FG000|Overall Study|Lost to Follow-up|2|||
164318117|NCT03859973|593540848|FG001|Overall Study|Lost to Follow-up|3|||
164318118|NCT03859973|593540847|FG000|Overall Study|Protocol Violation|1|||
164318119|NCT03859973|593540848|FG001|Overall Study|Protocol Violation|3|||
164318120|NCT03859973|593540847|FG000|Overall Study|Adverse Event|3|||
164318121|NCT03859973|593540848|FG001|Overall Study|Adverse Event|5|||
164318122|NCT00640224|593540849|FG000|Overall Study|Lost to Follow-up|5|||
164318123|NCT00640224|593540850|FG001|Overall Study|Lost to Follow-up|2|||
164318124|NCT00640224|593540851|FG002|Overall Study|Lost to Follow-up|0|||
164318125|NCT00640224|593540852|FG003|Overall Study|Lost to Follow-up|0|||
164318126|NCT00640224|593540849|FG000|Overall Study|Withdrawal by Subject|1|||
164318127|NCT00640224|593540850|FG001|Overall Study|Withdrawal by Subject|0|||
164318128|NCT00640224|593540851|FG002|Overall Study|Withdrawal by Subject|0|||
164318129|NCT00640224|593540852|FG003|Overall Study|Withdrawal by Subject|0|||
164318130|NCT00640224|593540849|FG000|Overall Study|Headaches|0|||
164318131|NCT00640224|593540850|FG001|Overall Study|Headaches|1|||
164318132|NCT00640224|593540851|FG002|Overall Study|Headaches|0|||
164318133|NCT00640224|593540852|FG003|Overall Study|Headaches|0|||
164318134|NCT01252667|593540853|FG000|Overall Study|Transplant aborted post-conditioning|0|||
164318135|NCT01252667|593540854|FG001|Overall Study|Transplant aborted post-conditioning|0|||
164318136|NCT01252667|593540855|FG002|Overall Study|Transplant aborted post-conditioning|0|||
164318137|NCT01252667|593540856|FG003|Overall Study|Transplant aborted post-conditioning|0|||
164318138|NCT01252667|593540857|FG004|Overall Study|Transplant aborted post-conditioning|0|||
164318139|NCT01252667|593540858|FG005|Overall Study|Transplant aborted post-conditioning|1|||
164318140|NCT04644315|593540859|FG000|Overall Study|Subject withdrawal of consent|1|||
164318141|NCT00294762|593540860|FG000|Overall Study|Did not receive study treatment|3|||
164318142|NCT00294762|593540861|FG001|Overall Study|Did not receive study treatment|3|||
164318143|NCT01738646|593540862|FG000|Overall Study|Still Receiving Treatment|2|||
164318144|NCT03642132|593540864|FG000|Chemotherapy Period|Adverse Event|1|||
164318145|NCT03642132|593540865|FG001|Chemotherapy Period|Adverse Event|1|||
164318146|NCT03642132|593540866|FG002|Chemotherapy Period|Adverse Event|0|||
164318147|NCT03642132|593540864|FG000|Chemotherapy Period|Physician's decision|4|||
164318148|NCT03642132|593540865|FG001|Chemotherapy Period|Physician's decision|1|||
164318149|NCT03642132|593540866|FG002|Chemotherapy Period|Physician's decision|0|||
164318150|NCT03642132|593540864|FG000|Chemotherapy Period|Progressive disease|0|||
164318151|NCT03642132|593540865|FG001|Chemotherapy Period|Progressive disease|0|||
164562193|NCT02624492|594427460|FG001|Overall Study|Adverse Event|2|||
164562194|NCT02624492|594427461|FG002|Overall Study|Adverse Event|2|||
164562195|NCT02624492|594427459|FG000|Overall Study|Progressive disease|0|||
164562196|NCT02624492|594427460|FG001|Overall Study|Progressive disease|2|||
164562197|NCT02624492|594427461|FG002|Overall Study|Progressive disease|3|||
164562198|NCT00343512|594427462|FG000|Overall Study|Withdrawal by Subject|2|||
164562199|NCT01163786|594427463|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
164562200|NCT01163786|594427463|FG000|Treatment With Bortezomib|Adverse Event|2|||
164562201|NCT01163786|594427463|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
164562202|NCT02474082|594427464|FG000|Overall Study|Adverse Event|2|||
164562203|NCT02474082|594427465|FG001|Overall Study|Adverse Event|32|||
164562204|NCT02474082|594427464|FG000|Overall Study|Withdrawal of informed consent|1|||
164562205|NCT02474082|594427465|FG001|Overall Study|Withdrawal of informed consent|11|||
164562206|NCT02474082|594427464|FG000|Overall Study|Lost to Follow-up|2|||
164562207|NCT02474082|594427465|FG001|Overall Study|Lost to Follow-up|2|||
164562208|NCT02474082|594427464|FG000|Overall Study|Dose tapering not achieved|0|||
164562209|NCT02474082|594427465|FG001|Overall Study|Dose tapering not achieved|4|||
164562210|NCT02474082|594427464|FG000|Overall Study|Participant/guardian decision|1|||
164562211|NCT02474082|594427465|FG001|Overall Study|Participant/guardian decision|2|||
164562212|NCT02474082|594427464|FG000|Overall Study|Non-compliance with study treatment|0|||
164562213|NCT02474082|594427465|FG001|Overall Study|Non-compliance with study treatment|2|||
164562214|NCT02474082|594427464|FG000|Overall Study|Protocol deviation|0|||
164562215|NCT02474082|594427465|FG001|Overall Study|Protocol deviation|1|||
164562216|NCT01262976|594427466|FG000|Up to Month 2|Serious Adverse Event|0|||
164562217|NCT01262976|594427467|FG001|Up to Month 2|Serious Adverse Event|0|||
164562218|NCT01262976|594427468|FG002|Up to Month 2|Serious Adverse Event|1|||
164562219|NCT01262976|594427469|FG003|Up to Month 2|Serious Adverse Event|0|||
164562220|NCT01262976|594427470|FG004|Up to Month 2|Serious Adverse Event|0|||
164562221|NCT01262976|594427471|FG005|Up to Month 2|Serious Adverse Event|0|||
164562222|NCT01262976|594427466|FG000|Up to Month 2|Withdrawal by Subject|1|||
164562223|NCT01262976|594427467|FG001|Up to Month 2|Withdrawal by Subject|0|||
164562224|NCT01262976|594427468|FG002|Up to Month 2|Withdrawal by Subject|0|||
164562225|NCT01262976|594427469|FG003|Up to Month 2|Withdrawal by Subject|0|||
164318152|NCT03642132|593540866|FG002|Chemotherapy Period|Progressive disease|1|||
164318153|NCT03642132|593540864|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
164562226|NCT01262976|594427470|FG004|Up to Month 2|Withdrawal by Subject|0|||
164318154|NCT03642132|593540865|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
164318155|NCT03642132|593540866|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
164318156|NCT03642132|593540864|FG000|Chemotherapy Period|Other|1|||
164318157|NCT03642132|593540865|FG001|Chemotherapy Period|Other|0|||
164318158|NCT03642132|593540866|FG002|Chemotherapy Period|Other|2|||
164318159|NCT03642132|593540864|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
164666409|NCT02353169|594803464|FG001|Overall Study|ECG data error|3|||
164666410|NCT02353169|594803465|FG002|Overall Study|ECG data error|2|||
164666411|NCT02353169|594803466|FG003|Overall Study|ECG data error|2|||
164666412|NCT02353169|594803463|FG000|Overall Study|Pre-op medication|0|||
164666413|NCT02353169|594803464|FG001|Overall Study|Pre-op medication|0|||
164666414|NCT02353169|594803465|FG002|Overall Study|Pre-op medication|1|||
164666415|NCT02353169|594803466|FG003|Overall Study|Pre-op medication|0|||
164666416|NCT05295953|594803470|FG000|Overall Study|Withdrawal by Subject|0|||
164666417|NCT05295953|594803471|FG001|Overall Study|Withdrawal by Subject|1|||
164666418|NCT03130699|594803472|FG000|Overall Study|Lost to Follow-up|34|||
164666419|NCT03130699|594803473|FG001|Overall Study|Lost to Follow-up|37|||
164666420|NCT03130699|594803474|FG002|Overall Study|Lost to Follow-up|26|||
164666421|NCT03130699|594803472|FG000|Overall Study|Withdrawal by Subject|5|||
164666422|NCT03130699|594803473|FG001|Overall Study|Withdrawal by Subject|1|||
164666423|NCT03130699|594803474|FG002|Overall Study|Withdrawal by Subject|0|||
164666424|NCT03130699|594803472|FG000|Overall Study|Withdrawal by PI|1|||
164666425|NCT03130699|594803473|FG001|Overall Study|Withdrawal by PI|2|||
164666426|NCT03130699|594803474|FG002|Overall Study|Withdrawal by PI|5|||
164666427|NCT03130699|594803472|FG000|Overall Study|Death|0|||
164666428|NCT03130699|594803473|FG001|Overall Study|Death|0|||
164666429|NCT03130699|594803474|FG002|Overall Study|Death|1|||
164666430|NCT04981912|594803475|FG000|Overall Study|Physician Decision|2|||
164666431|NCT04534283|594803478|FG000|Overall Study|Physician Decision|2|||
164666432|NCT04534283|594803478|FG000|Overall Study|Withdrawal by Subject|1|||
164666433|NCT04534283|594803478|FG000|Overall Study|Disease Progression|12|||
164666434|NCT04534283|594803478|FG000|Overall Study|Adverse Event|1|||
164666435|NCT00661505|594803479|FG000|Overall Study|Adverse Event|3|||
164318160|NCT03642132|593540865|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
164318161|NCT03642132|593540866|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
164318162|NCT03642132|593540864|FG000|Maintenance Period|Adverse Event|1|||
164318163|NCT03642132|593540865|FG001|Maintenance Period|Adverse Event|2|||
164318164|NCT03642132|593540866|FG002|Maintenance Period|Adverse Event|0|||
164318165|NCT03642132|593540864|FG000|Maintenance Period|Non-compliance with study drug|0|||
164666436|NCT00661505|594803479|FG000|Overall Study|Protocol Violation|14|||
164666437|NCT00661505|594803479|FG000|Overall Study|Withdrawal by Subject|8|||
164666438|NCT00661505|594803479|FG000|Overall Study|Lost to Follow-up|3|||
164666439|NCT00661505|594803479|FG000|Overall Study|Other|2|||
164666440|NCT05956665|594803480|FG000|Overall Study|Death|1|||
164666441|NCT05956665|594803480|FG000|Overall Study|Withdrawal by Subject|1|||
164666442|NCT00977470|594803481|FG000|Overall Study|Lack of Efficacy|32|||
164666443|NCT00977470|594803482|FG001|Overall Study|Lack of Efficacy|30|||
164666444|NCT00977470|594803481|FG000|Overall Study|Physician Decision|2|||
164666445|NCT00977470|594803482|FG001|Overall Study|Physician Decision|0|||
164666446|NCT00977470|594803481|FG000|Overall Study|Adverse Event|1|||
164666447|NCT00977470|594803482|FG001|Overall Study|Adverse Event|2|||
164666448|NCT00977470|594803481|FG000|Overall Study|Protocol Violation|1|||
164666449|NCT00977470|594803482|FG001|Overall Study|Protocol Violation|0|||
164666450|NCT00977470|594803481|FG000|Overall Study|Withdrawal by Subject|0|||
164666451|NCT00977470|594803482|FG001|Overall Study|Withdrawal by Subject|2|||
164666452|NCT00977470|594803481|FG000|Overall Study|Death|0|||
164666453|NCT00977470|594803482|FG001|Overall Study|Death|2|||
164666454|NCT00977470|594803481|FG000|Overall Study|clinical decline|0|||
164666455|NCT00977470|594803482|FG001|Overall Study|clinical decline|1|||
164666456|NCT00977470|594803481|FG000|Overall Study|prolonged recovery post-surgery|0|||
164318166|NCT03642132|593540865|FG001|Maintenance Period|Non-compliance with study drug|0|||
164318167|NCT03642132|593540866|FG002|Maintenance Period|Non-compliance with study drug|1|||
164318168|NCT03642132|593540864|FG000|Maintenance Period|Physician's decision|2|||
164666457|NCT00977470|594803482|FG001|Overall Study|prolonged recovery post-surgery|1|||
164666458|NCT00977470|594803481|FG000|Overall Study|Still on-study|2|||
164666459|NCT00977470|594803482|FG001|Overall Study|Still on-study|0|||
164666460|NCT03257462|594803485|FG000|Cohort A|Lost to Follow-up|1|||
164666461|NCT03257462|594803486|FG001|Cohort A|Lost to Follow-up|0|||
164666462|NCT03257462|594803487|FG002|Cohort A|Lost to Follow-up|0|||
164666463|NCT03257462|594803488|FG003|Cohort A|Lost to Follow-up|0|||
164666464|NCT03257462|594803485|FG000|Cohort B|Discontinued due to Sponsor decision|0|||
164666465|NCT03257462|594803486|FG001|Cohort B|Discontinued due to Sponsor decision|1|||
164666466|NCT03257462|594803487|FG002|Cohort B|Discontinued due to Sponsor decision|0|||
164666467|NCT03257462|594803488|FG003|Cohort B|Discontinued due to Sponsor decision|0|||
164666468|NCT00796822|594803489|FG000|Overall Study|Lost to Follow-up|2|||
164666469|NCT00796822|594803490|FG001|Overall Study|Lost to Follow-up|0|||
164666470|NCT00796822|594803489|FG000|Overall Study|Adverse Event|1|||
164666471|NCT00796822|594803490|FG001|Overall Study|Adverse Event|0|||
164666472|NCT06354270|594803496|FG000|Overall Study|Withdrawal by Subject|1|||
164318169|NCT03642132|593540865|FG001|Maintenance Period|Physician's decision|2|||
164318170|NCT03642132|593540866|FG002|Maintenance Period|Physician's decision|2|||
164318171|NCT03642132|593540864|FG000|Maintenance Period|Progressive disease|9|||
164318172|NCT03642132|593540865|FG001|Maintenance Period|Progressive disease|3|||
164318173|NCT03642132|593540866|FG002|Maintenance Period|Progressive disease|6|||
164318174|NCT03642132|593540864|FG000|Maintenance Period|Other|0|||
164318175|NCT03642132|593540865|FG001|Maintenance Period|Other|0|||
164318176|NCT03642132|593540866|FG002|Maintenance Period|Other|3|||
164318177|NCT03642132|593540864|FG000|Maintenance Period|Withdrawal by Subject|1|||
164318178|NCT03642132|593540865|FG001|Maintenance Period|Withdrawal by Subject|1|||
164318179|NCT03642132|593540866|FG002|Maintenance Period|Withdrawal by Subject|2|||
164318180|NCT03642132|593540864|FG000|Follow-up Period|Other|0|||
164318181|NCT03642132|593540865|FG001|Follow-up Period|Other|0|||
164318182|NCT03642132|593540866|FG002|Follow-up Period|Other|1|||
164318183|NCT03642132|593540864|FG000|Follow-up Period|Withdrawal by Subject|1|||
164318184|NCT03642132|593540865|FG001|Follow-up Period|Withdrawal by Subject|2|||
164318185|NCT03642132|593540866|FG002|Follow-up Period|Withdrawal by Subject|0|||
164318186|NCT03642132|593540864|FG000|Follow-up Period|Study terminated by sponsor|1|||
164318187|NCT03642132|593540865|FG001|Follow-up Period|Study terminated by sponsor|0|||
164318188|NCT03642132|593540866|FG002|Follow-up Period|Study terminated by sponsor|1|||
164318189|NCT03642132|593540864|FG000|Follow-up Period|Lack of Efficacy|1|||
164318190|NCT03642132|593540865|FG001|Follow-up Period|Lack of Efficacy|0|||
164318191|NCT03642132|593540866|FG002|Follow-up Period|Lack of Efficacy|0|||
164318192|NCT03642132|593540864|FG000|Follow-up Period|Death|1|||
164318193|NCT03642132|593540865|FG001|Follow-up Period|Death|0|||
164318194|NCT03642132|593540866|FG002|Follow-up Period|Death|2|||
164318195|NCT03642132|593540864|FG000|Follow-up Period|Adverse Event|1|||
164318196|NCT03642132|593540865|FG001|Follow-up Period|Adverse Event|0|||
164318197|NCT03642132|593540866|FG002|Follow-up Period|Adverse Event|0|||
164318198|NCT04493892|593540872|FG000|Overall Study|Withdrawal by Subject|15|||
164318199|NCT02577887|593540873|FG000|Overall Study|Death|93|||
164318200|NCT02577887|593540873|FG000|Overall Study|Protocol Violation|125|||
164318201|NCT02577887|593540873|FG000|Overall Study|Withdrawal by Subject|80|||
164318202|NCT00159822|593540874|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
164318203|NCT00159822|593540874|FG000|Voriconazole Treatment Period|Adverse Event|9|||
164318204|NCT00159822|593540874|FG000|Voriconazole Treatment Period|Death|4|||
164318205|NCT00159822|593540874|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
164318206|NCT00159822|593540874|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
164318207|NCT00159822|593540874|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
164318208|NCT00159822|593540874|FG000|Post-treatment Follow-up Period|Death|1|||
164318209|NCT00159822|593540874|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
164318210|NCT00159822|593540874|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
164318211|NCT00864916|593540879|FG000|Overall Study|Lost to Follow-up|4|||
164318212|NCT00864916|593540880|FG001|Overall Study|Lost to Follow-up|4|||
164318213|NCT00864916|593540879|FG000|Overall Study|Protocol Violation|1|||
164318214|NCT00864916|593540880|FG001|Overall Study|Protocol Violation|0|||
164318215|NCT00864916|593540879|FG000|Overall Study|Withdrawal by Subject|1|||
164318216|NCT00864916|593540880|FG001|Overall Study|Withdrawal by Subject|0|||
164318217|NCT03774823|593540882|FG000|Overall Study|Withdrawal by Subject|1|||
164318218|NCT03774823|593540883|FG001|Overall Study|Withdrawal by Subject|1|||
164318219|NCT02946931|593540886|FG000|Overall Study|Did not require collection of CRFs|588|||
164318220|NCT02946931|593540886|FG000|Overall Study|Other than listed|37|||
164318221|NCT02946931|593540886|FG000|Overall Study|Discharge from hospital|118|||
164666473|NCT06354270|594803497|FG001|Overall Study|Withdrawal by Subject|0|||
164318222|NCT02946931|593540886|FG000|Overall Study|Adverse Event|81|||
164318223|NCT02946931|593540886|FG000|Overall Study|CRFs not valid|1|||
164318224|NCT02946931|593540886|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
164318225|NCT00869778|593540890|FG000|Overall Study|Adverse Event|2|||
164318226|NCT00869778|593540891|FG001|Overall Study|Adverse Event|0|||
164318227|NCT00869778|593540892|FG002|Overall Study|Adverse Event|0|||
164318228|NCT00869778|593540890|FG000|Overall Study|Withdrawal by Subject|3|||
164318229|NCT00869778|593540891|FG001|Overall Study|Withdrawal by Subject|4|||
164318230|NCT00869778|593540892|FG002|Overall Study|Withdrawal by Subject|5|||
164318231|NCT00869778|593540890|FG000|Overall Study|Pregnancy|1|||
164318232|NCT00869778|593540891|FG001|Overall Study|Pregnancy|0|||
164318233|NCT00869778|593540892|FG002|Overall Study|Pregnancy|0|||
164318234|NCT00869778|593540890|FG000|Overall Study|Protocol Violation|5|||
164318235|NCT00869778|593540891|FG001|Overall Study|Protocol Violation|3|||
164318236|NCT00869778|593540892|FG002|Overall Study|Protocol Violation|5|||
164318237|NCT00869778|593540890|FG000|Overall Study|Unblinding|1|||
164318238|NCT00869778|593540891|FG001|Overall Study|Unblinding|0|||
164318239|NCT00869778|593540892|FG002|Overall Study|Unblinding|0|||
164318240|NCT00470834|593540893|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
164318241|NCT00470834|593540894|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
164318242|NCT00470834|593540893|FG000|Treatment Period (18 Months)|Adverse Event|7|||
164318243|NCT00470834|593540894|FG001|Treatment Period (18 Months)|Adverse Event|6|||
164318244|NCT00470834|593540893|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
164318245|NCT00470834|593540894|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
164318246|NCT00470834|593540893|FG000|Treatment Period (18 Months)|Physician Decision|4|||
164318247|NCT00470834|593540894|FG001|Treatment Period (18 Months)|Physician Decision|4|||
164318248|NCT00470834|593540893|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
164318249|NCT00470834|593540894|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
164318250|NCT00470834|593540893|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
164318251|NCT00470834|593540894|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
164318252|NCT00470834|593540893|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
164562227|NCT01262976|594427471|FG005|Up to Month 2|Withdrawal by Subject|0|||
164562228|NCT01262976|594427466|FG000|Up to Month 2|Migrated/moved from study area|0|||
164562229|NCT01262976|594427467|FG001|Up to Month 2|Migrated/moved from study area|1|||
164562230|NCT01262976|594427468|FG002|Up to Month 2|Migrated/moved from study area|0|||
164562231|NCT01262976|594427469|FG003|Up to Month 2|Migrated/moved from study area|0|||
164562232|NCT01262976|594427470|FG004|Up to Month 2|Migrated/moved from study area|1|||
164562233|NCT01262976|594427471|FG005|Up to Month 2|Migrated/moved from study area|1|||
164562234|NCT01262976|594427466|FG000|Up to Month 2|Lost to Follow-up|1|||
164562235|NCT01262976|594427467|FG001|Up to Month 2|Lost to Follow-up|0|||
164562236|NCT01262976|594427468|FG002|Up to Month 2|Lost to Follow-up|0|||
164562237|NCT01262976|594427469|FG003|Up to Month 2|Lost to Follow-up|1|||
164562238|NCT01262976|594427470|FG004|Up to Month 2|Lost to Follow-up|1|||
164562239|NCT01262976|594427471|FG005|Up to Month 2|Lost to Follow-up|1|||
164562240|NCT01262976|594427466|FG000|Up to Month 2|Other|1|||
164562241|NCT01262976|594427467|FG001|Up to Month 2|Other|0|||
164562242|NCT01262976|594427468|FG002|Up to Month 2|Other|0|||
164562243|NCT01262976|594427469|FG003|Up to Month 2|Other|1|||
164562244|NCT01262976|594427470|FG004|Up to Month 2|Other|0|||
164562245|NCT01262976|594427471|FG005|Up to Month 2|Other|2|||
164562246|NCT01262976|594427466|FG000|Up to Month 7|Serious Adverse Event|0|||
164562247|NCT01262976|594427467|FG001|Up to Month 7|Serious Adverse Event|0|||
164562248|NCT01262976|594427468|FG002|Up to Month 7|Serious Adverse Event|2|||
164562249|NCT01262976|594427469|FG003|Up to Month 7|Serious Adverse Event|0|||
164562250|NCT01262976|594427470|FG004|Up to Month 7|Serious Adverse Event|0|||
164562251|NCT01262976|594427471|FG005|Up to Month 7|Serious Adverse Event|0|||
164562252|NCT01262976|594427466|FG000|Up to Month 7|Withdrawal by Subject|1|||
164562253|NCT01262976|594427467|FG001|Up to Month 7|Withdrawal by Subject|0|||
164562254|NCT01262976|594427468|FG002|Up to Month 7|Withdrawal by Subject|0|||
164562255|NCT01262976|594427469|FG003|Up to Month 7|Withdrawal by Subject|0|||
164562256|NCT01262976|594427470|FG004|Up to Month 7|Withdrawal by Subject|0|||
164562257|NCT01262976|594427471|FG005|Up to Month 7|Withdrawal by Subject|0|||
164562258|NCT01262976|594427466|FG000|Up to Month 7|Migrated/moved from study area|0|||
164562259|NCT01262976|594427467|FG001|Up to Month 7|Migrated/moved from study area|0|||
164562260|NCT01262976|594427468|FG002|Up to Month 7|Migrated/moved from study area|1|||
164562261|NCT01262976|594427469|FG003|Up to Month 7|Migrated/moved from study area|3|||
164562262|NCT01262976|594427470|FG004|Up to Month 7|Migrated/moved from study area|1|||
164562263|NCT01262976|594427471|FG005|Up to Month 7|Migrated/moved from study area|1|||
164562264|NCT01262976|594427466|FG000|Up to Month 7|Lost to Follow-up|1|||
164562265|NCT01262976|594427467|FG001|Up to Month 7|Lost to Follow-up|0|||
164562266|NCT01262976|594427468|FG002|Up to Month 7|Lost to Follow-up|1|||
164562267|NCT01262976|594427469|FG003|Up to Month 7|Lost to Follow-up|3|||
164562268|NCT01262976|594427470|FG004|Up to Month 7|Lost to Follow-up|1|||
164562269|NCT01262976|594427471|FG005|Up to Month 7|Lost to Follow-up|3|||
164562270|NCT01262976|594427466|FG000|Up to Month 7|Other|3|||
164562271|NCT01262976|594427467|FG001|Up to Month 7|Other|0|||
164562272|NCT01262976|594427468|FG002|Up to Month 7|Other|2|||
164562273|NCT01262976|594427469|FG003|Up to Month 7|Other|0|||
164562274|NCT01262976|594427470|FG004|Up to Month 7|Other|0|||
164562275|NCT01262976|594427471|FG005|Up to Month 7|Other|0|||
164562276|NCT01262976|594427466|FG000|Up to Year 1|Serious Adverse Event|0|||
164562277|NCT01262976|594427467|FG001|Up to Year 1|Serious Adverse Event|0|||
164562278|NCT01262976|594427468|FG002|Up to Year 1|Serious Adverse Event|2|||
164562279|NCT01262976|594427469|FG003|Up to Year 1|Serious Adverse Event|0|||
164562280|NCT01262976|594427470|FG004|Up to Year 1|Serious Adverse Event|0|||
164562281|NCT01262976|594427471|FG005|Up to Year 1|Serious Adverse Event|0|||
164562282|NCT01262976|594427466|FG000|Up to Year 1|Withdrawal by Subject|1|||
164562283|NCT01262976|594427467|FG001|Up to Year 1|Withdrawal by Subject|0|||
164562284|NCT01262976|594427468|FG002|Up to Year 1|Withdrawal by Subject|0|||
164562285|NCT01262976|594427469|FG003|Up to Year 1|Withdrawal by Subject|0|||
164562286|NCT01262976|594427470|FG004|Up to Year 1|Withdrawal by Subject|0|||
164562287|NCT01262976|594427471|FG005|Up to Year 1|Withdrawal by Subject|0|||
164562288|NCT01262976|594427466|FG000|Up to Year 1|Migrated/moved from study area|1|||
164562289|NCT01262976|594427467|FG001|Up to Year 1|Migrated/moved from study area|0|||
164562290|NCT01262976|594427468|FG002|Up to Year 1|Migrated/moved from study area|0|||
164562291|NCT01262976|594427469|FG003|Up to Year 1|Migrated/moved from study area|3|||
164562292|NCT01262976|594427470|FG004|Up to Year 1|Migrated/moved from study area|3|||
164562293|NCT01262976|594427471|FG005|Up to Year 1|Migrated/moved from study area|2|||
164562294|NCT01262976|594427466|FG000|Up to Year 1|Lost to Follow-up|4|||
164318253|NCT00470834|593540894|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
164318254|NCT00470834|593540893|FG000|Treatment Period (18 Months)|Non-compliance|1|||
164318255|NCT00470834|593540894|FG001|Treatment Period (18 Months)|Non-compliance|0|||
164318256|NCT00470834|593540893|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
164318257|NCT00470834|593540894|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
164318258|NCT00470834|593540893|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
164318259|NCT00470834|593540894|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
164318260|NCT00470834|593540893|FG000|Extension Period (24 Months)|Adverse Event|3|||
164318261|NCT00470834|593540894|FG001|Extension Period (24 Months)|Adverse Event|4|||
164318262|NCT00470834|593540893|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
164318263|NCT00470834|593540894|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
164318264|NCT00470834|593540893|FG000|Extension Period (24 Months)|Physician Decision|4|||
164318265|NCT00470834|593540894|FG001|Extension Period (24 Months)|Physician Decision|3|||
164318266|NCT00470834|593540893|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
164318267|NCT00470834|593540894|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
164318268|NCT00470834|593540893|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
164318269|NCT00470834|593540894|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
164318270|NCT00470834|593540893|FG000|Extension Period (24 Months)|Non-compliance|0|||
164318271|NCT00470834|593540894|FG001|Extension Period (24 Months)|Non-compliance|1|||
164318272|NCT00470834|593540893|FG000|Extension Period (24 Months)|Disease Progression|0|||
164318273|NCT00470834|593540894|FG001|Extension Period (24 Months)|Disease Progression|1|||
164318274|NCT03051620|593540895|FG000|Overall Study|Lost to Follow-up|6|||
164318275|NCT03051620|593540895|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
164318276|NCT00393510|593540896|FG000|Overall Study|Physician Decision|3|||
164318277|NCT00393510|593540897|FG001|Overall Study|Physician Decision|9|||
164318278|NCT01534182|593540898|FG000|Overall Study|Administrative problems|1|||
164318279|NCT01534182|593540899|FG001|Overall Study|Administrative problems|0|||
164318280|NCT01534182|593540898|FG000|Overall Study|Withdrawal by Subject|4|||
164318281|NCT01534182|593540899|FG001|Overall Study|Withdrawal by Subject|7|||
164318282|NCT01534182|593540898|FG000|Overall Study|Adverse Event|7|||
164318283|NCT01534182|593540899|FG001|Overall Study|Adverse Event|3|||
164318284|NCT02412488|593540900|FG000|Overall Study|Lost to Follow-up|10|||
164318285|NCT02412488|593540900|FG000|Overall Study|Withdrawal by Subject|5|||
164318286|NCT02412488|593540900|FG000|Overall Study|Physician Decision|1|||
164318287|NCT02412488|593540900|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
164318288|NCT02412488|593540900|FG000|Overall Study|Reveal LINQ explant|1|||
164318289|NCT00674154|593540901|FG000|Overall Study|Withdrawal by Subject|3|||
164318290|NCT00674154|593540902|FG001|Overall Study|Withdrawal by Subject|1|||
164318291|NCT00674154|593540901|FG000|Overall Study|Did not want parathyroidectomy|0|||
164318292|NCT00674154|593540902|FG001|Overall Study|Did not want parathyroidectomy|2|||
164666474|NCT05097989|594803498|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
164205757|NCT04757636|593122686|FG000|Overall Study|Lost to Follow-up|1|||
164205758|NCT04757636|593122687|FG001|Overall Study|Lost to Follow-up|6|||
164205759|NCT04757636|593122688|FG002|Overall Study|Lost to Follow-up|7|||
164205760|NCT04757636|593122686|FG000|Overall Study|Physician Decision|1|||
164205761|NCT04757636|593122687|FG001|Overall Study|Physician Decision|3|||
164205762|NCT04757636|593122688|FG002|Overall Study|Physician Decision|4|||
164205763|NCT04757636|593122686|FG000|Overall Study|Withdrawal by Subject|20|||
164205764|NCT04757636|593122687|FG001|Overall Study|Withdrawal by Subject|23|||
164205765|NCT04757636|593122688|FG002|Overall Study|Withdrawal by Subject|18|||
164205766|NCT04757636|593122686|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
164205767|NCT04757636|593122687|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
164205768|NCT04757636|593122688|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
164205769|NCT04757636|593122686|FG000|Overall Study|Study Terminated by Sponsor|103|||
164205770|NCT04757636|593122687|FG001|Overall Study|Study Terminated by Sponsor|104|||
164205771|NCT04757636|593122688|FG002|Overall Study|Study Terminated by Sponsor|114|||
164205772|NCT04757636|593122686|FG000|Overall Study|Sponsor Decision|0|||
164205773|NCT04757636|593122687|FG001|Overall Study|Sponsor Decision|0|||
164205774|NCT04757636|593122688|FG002|Overall Study|Sponsor Decision|1|||
164205775|NCT04757636|593122686|FG000|Overall Study|Randomized in Error|0|||
164205776|NCT04757636|593122687|FG001|Overall Study|Randomized in Error|0|||
164205777|NCT04757636|593122688|FG002|Overall Study|Randomized in Error|2|||
164205778|NCT01732692|593122692|FG000|Overall Study|Adverse Event|0|||
164205779|NCT01732692|593122693|FG001|Overall Study|Adverse Event|1|||
164666475|NCT05097989|594803499|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
164666476|NCT05097989|594803500|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
164205780|NCT01027949|593122694|FG000|Overall Study|Death|174|||
164205781|NCT01027949|593122694|FG000|Overall Study|Progressive Disease|163|||
164205782|NCT01027949|593122694|FG000|Overall Study|Adverse Event|172|||
164205783|NCT01027949|593122694|FG000|Overall Study|Withdrawal by Subject|113|||
164205784|NCT01027949|593122694|FG000|Overall Study|Lost to Follow-up|17|||
164205785|NCT01027949|593122694|FG000|Overall Study|Protocol Violation|13|||
164318293|NCT00816023|593540903|FG000|Overall Study|Lost to Follow-up|1|||
164318294|NCT00816023|593540904|FG001|Overall Study|Lost to Follow-up|1|||
164318295|NCT00816023|593540905|FG002|Overall Study|Lost to Follow-up|0|||
164318296|NCT00816023|593540906|FG003|Overall Study|Lost to Follow-up|0|||
164318297|NCT00816023|593540903|FG000|Overall Study|Withdrawal by Subject|1|||
164318298|NCT00816023|593540904|FG001|Overall Study|Withdrawal by Subject|0|||
164318299|NCT00816023|593540905|FG002|Overall Study|Withdrawal by Subject|0|||
164318300|NCT00816023|593540906|FG003|Overall Study|Withdrawal by Subject|0|||
164318301|NCT00816023|593540903|FG000|Overall Study|Physician Decision|0|||
164318302|NCT00816023|593540904|FG001|Overall Study|Physician Decision|0|||
164318303|NCT00816023|593540905|FG002|Overall Study|Physician Decision|1|||
164318304|NCT00816023|593540906|FG003|Overall Study|Physician Decision|0|||
164318305|NCT00816023|593540903|FG000|Overall Study|assessments complete prior to window|1|||
164318306|NCT00816023|593540904|FG001|Overall Study|assessments complete prior to window|1|||
164318307|NCT00816023|593540905|FG002|Overall Study|assessments complete prior to window|2|||
164420636|NCT01154036|593910967|FG005|Phase I|Lost to Follow-up|0|||
164562295|NCT01262976|594427467|FG001|Up to Year 1|Lost to Follow-up|0|||
164562296|NCT01262976|594427468|FG002|Up to Year 1|Lost to Follow-up|0|||
164562297|NCT01262976|594427469|FG003|Up to Year 1|Lost to Follow-up|1|||
164562298|NCT01262976|594427470|FG004|Up to Year 1|Lost to Follow-up|6|||
164562299|NCT01262976|594427471|FG005|Up to Year 1|Lost to Follow-up|5|||
164562300|NCT01262976|594427466|FG000|Up to Year 1|Other|3|||
164562301|NCT01262976|594427467|FG001|Up to Year 1|Other|1|||
164562302|NCT01262976|594427468|FG002|Up to Year 1|Other|0|||
164562303|NCT01262976|594427469|FG003|Up to Year 1|Other|0|||
164562304|NCT01262976|594427470|FG004|Up to Year 1|Other|2|||
164562305|NCT01262976|594427471|FG005|Up to Year 1|Other|1|||
164562306|NCT01262976|594427466|FG000|Up to Year 1|Subjects with unknown completion status|0|||
164562307|NCT01262976|594427467|FG001|Up to Year 1|Subjects with unknown completion status|0|||
164562308|NCT01262976|594427468|FG002|Up to Year 1|Subjects with unknown completion status|1|||
164562309|NCT01262976|594427469|FG003|Up to Year 1|Subjects with unknown completion status|0|||
164562310|NCT01262976|594427470|FG004|Up to Year 1|Subjects with unknown completion status|0|||
164562311|NCT01262976|594427471|FG005|Up to Year 1|Subjects with unknown completion status|1|||
164562312|NCT01262976|594427466|FG000|Up to Year 2|Serious Adverse Event|0|||
164562313|NCT01262976|594427467|FG001|Up to Year 2|Serious Adverse Event|0|||
164562314|NCT01262976|594427468|FG002|Up to Year 2|Serious Adverse Event|2|||
164562315|NCT01262976|594427469|FG003|Up to Year 2|Serious Adverse Event|0|||
164562316|NCT01262976|594427470|FG004|Up to Year 2|Serious Adverse Event|0|||
164562317|NCT01262976|594427471|FG005|Up to Year 2|Serious Adverse Event|0|||
164562318|NCT01262976|594427466|FG000|Up to Year 2|Withdrawal by Subject|1|||
164562319|NCT01262976|594427467|FG001|Up to Year 2|Withdrawal by Subject|0|||
164562320|NCT01262976|594427468|FG002|Up to Year 2|Withdrawal by Subject|0|||
164562321|NCT01262976|594427469|FG003|Up to Year 2|Withdrawal by Subject|0|||
164562322|NCT01262976|594427470|FG004|Up to Year 2|Withdrawal by Subject|0|||
164562323|NCT01262976|594427471|FG005|Up to Year 2|Withdrawal by Subject|0|||
164562324|NCT01262976|594427466|FG000|Up to Year 2|Migrated/moved from study area|0|||
164562325|NCT01262976|594427467|FG001|Up to Year 2|Migrated/moved from study area|0|||
164562326|NCT01262976|594427468|FG002|Up to Year 2|Migrated/moved from study area|0|||
164562327|NCT01262976|594427469|FG003|Up to Year 2|Migrated/moved from study area|2|||
164562328|NCT01262976|594427470|FG004|Up to Year 2|Migrated/moved from study area|1|||
164562329|NCT01262976|594427471|FG005|Up to Year 2|Migrated/moved from study area|2|||
164562330|NCT01262976|594427466|FG000|Up to Year 2|Lost to Follow-up|1|||
164562331|NCT01262976|594427467|FG001|Up to Year 2|Lost to Follow-up|1|||
164562332|NCT01262976|594427468|FG002|Up to Year 2|Lost to Follow-up|2|||
164562333|NCT01262976|594427469|FG003|Up to Year 2|Lost to Follow-up|2|||
164562334|NCT01262976|594427470|FG004|Up to Year 2|Lost to Follow-up|3|||
164562335|NCT01262976|594427471|FG005|Up to Year 2|Lost to Follow-up|3|||
164562336|NCT01262976|594427466|FG000|Up to Year 2|Subjects with unknown completion status|0|||
164562337|NCT01262976|594427467|FG001|Up to Year 2|Subjects with unknown completion status|0|||
164562338|NCT01262976|594427468|FG002|Up to Year 2|Subjects with unknown completion status|1|||
164562339|NCT01262976|594427469|FG003|Up to Year 2|Subjects with unknown completion status|0|||
164562340|NCT01262976|594427470|FG004|Up to Year 2|Subjects with unknown completion status|0|||
164562341|NCT01262976|594427471|FG005|Up to Year 2|Subjects with unknown completion status|0|||
164562342|NCT01262976|594427466|FG000|Up to Year 2|Other|3|||
164562343|NCT01262976|594427467|FG001|Up to Year 2|Other|0|||
164562344|NCT01262976|594427468|FG002|Up to Year 2|Other|0|||
164562345|NCT01262976|594427469|FG003|Up to Year 2|Other|0|||
164562346|NCT01262976|594427470|FG004|Up to Year 2|Other|0|||
164562347|NCT01262976|594427471|FG005|Up to Year 2|Other|0|||
164562348|NCT01262976|594427466|FG000|Up to Year 3|Serious Adverse Event|0|||
164562349|NCT01262976|594427467|FG001|Up to Year 3|Serious Adverse Event|0|||
164318308|NCT00816023|593540906|FG003|Overall Study|assessments complete prior to window|1|||
164318309|NCT00816023|593540903|FG000|Overall Study|Randomized Not Treated|6|||
164562350|NCT01262976|594427468|FG002|Up to Year 3|Serious Adverse Event|2|||
164562351|NCT01262976|594427469|FG003|Up to Year 3|Serious Adverse Event|0|||
164562352|NCT01262976|594427470|FG004|Up to Year 3|Serious Adverse Event|0|||
164562353|NCT01262976|594427471|FG005|Up to Year 3|Serious Adverse Event|0|||
164562354|NCT01262976|594427466|FG000|Up to Year 3|Withdrawal by Subject|1|||
164666477|NCT05097989|594803501|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
164666478|NCT05097989|594803502|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
164666479|NCT05097989|594803503|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
164666480|NCT05097989|594803504|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
164666481|NCT05097989|594803505|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
164666482|NCT05097989|594803506|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
164666483|NCT05097989|594803498|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
164666484|NCT05097989|594803499|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
164666485|NCT05097989|594803500|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
164666486|NCT05097989|594803501|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
164666487|NCT05097989|594803502|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
164666488|NCT05097989|594803503|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
164666489|NCT05097989|594803504|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
164666490|NCT05097989|594803505|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
164666491|NCT05097989|594803506|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
164666492|NCT05097989|594803498|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
164666493|NCT05097989|594803499|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
164666494|NCT05097989|594803500|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
164666495|NCT05097989|594803501|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
164666496|NCT05097989|594803502|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
164666497|NCT05097989|594803503|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
164666498|NCT05097989|594803504|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
164666499|NCT05097989|594803505|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
164666500|NCT05097989|594803506|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
164666501|NCT05097989|594803498|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
164666502|NCT05097989|594803499|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
164666503|NCT05097989|594803500|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
164666504|NCT05097989|594803501|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
164666505|NCT05097989|594803502|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
164666506|NCT05097989|594803503|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
164666507|NCT05097989|594803504|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
164666508|NCT05097989|594803505|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
164666509|NCT05097989|594803506|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
164666510|NCT05097989|594803498|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
164666511|NCT05097989|594803499|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
164666512|NCT05097989|594803500|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
164666513|NCT05097989|594803501|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
164666514|NCT05097989|594803502|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
164666515|NCT05097989|594803503|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
164666516|NCT05097989|594803504|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
164666517|NCT05097989|594803505|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
164666518|NCT05097989|594803506|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
164666519|NCT05097989|594803498|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
164666520|NCT05097989|594803499|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
164666521|NCT05097989|594803500|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
164666522|NCT05097989|594803501|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
164666523|NCT05097989|594803502|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
164666524|NCT05097989|594803503|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
164666525|NCT05097989|594803504|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
164666526|NCT05097989|594803505|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
164666527|NCT05097989|594803506|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
164666528|NCT05097989|594803498|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164666529|NCT05097989|594803499|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164562355|NCT01262976|594427467|FG001|Up to Year 3|Withdrawal by Subject|0|||
164562356|NCT01262976|594427468|FG002|Up to Year 3|Withdrawal by Subject|0|||
164562357|NCT01262976|594427469|FG003|Up to Year 3|Withdrawal by Subject|0|||
164562358|NCT01262976|594427470|FG004|Up to Year 3|Withdrawal by Subject|0|||
164562359|NCT01262976|594427471|FG005|Up to Year 3|Withdrawal by Subject|0|||
164562360|NCT01262976|594427466|FG000|Up to Year 3|Migrated/moved from study area|0|||
164562361|NCT01262976|594427467|FG001|Up to Year 3|Migrated/moved from study area|0|||
164562362|NCT01262976|594427468|FG002|Up to Year 3|Migrated/moved from study area|0|||
164666530|NCT05097989|594803500|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164666531|NCT05097989|594803501|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164562363|NCT01262976|594427469|FG003|Up to Year 3|Migrated/moved from study area|2|||
164562364|NCT01262976|594427470|FG004|Up to Year 3|Migrated/moved from study area|1|||
164666532|NCT05097989|594803502|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
164666533|NCT05097989|594803503|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164666534|NCT05097989|594803504|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164666535|NCT05097989|594803505|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164666536|NCT05097989|594803506|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164666537|NCT05097989|594803498|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
164666538|NCT05097989|594803499|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
164666539|NCT05097989|594803500|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
164666540|NCT05097989|594803501|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
164666541|NCT05097989|594803502|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
164666542|NCT05097989|594803503|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
164666543|NCT05097989|594803504|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
164666544|NCT05097989|594803505|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
164666545|NCT05097989|594803506|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
164666546|NCT05097989|594803498|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164666547|NCT05097989|594803499|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
164666548|NCT05097989|594803500|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164666549|NCT05097989|594803501|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
164666550|NCT05097989|594803502|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164666551|NCT05097989|594803503|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164666552|NCT05097989|594803504|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164666553|NCT05097989|594803505|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164666554|NCT05097989|594803506|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164666555|NCT05097989|594803498|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
164666556|NCT05097989|594803499|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
164666557|NCT05097989|594803500|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
164666558|NCT05097989|594803501|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
164666559|NCT05097989|594803502|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
164666560|NCT05097989|594803503|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
164666561|NCT05097989|594803504|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
164666562|NCT05097989|594803505|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
164666563|NCT05097989|594803506|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
164666564|NCT05097989|594803498|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
164666565|NCT05097989|594803499|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
164666566|NCT05097989|594803500|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
164666567|NCT05097989|594803501|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
164666568|NCT05097989|594803502|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
164666569|NCT05097989|594803503|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
164666570|NCT05097989|594803504|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
164666571|NCT05097989|594803505|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
164666572|NCT05097989|594803506|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
164666573|NCT05097989|594803498|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
164666574|NCT05097989|594803499|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
164666575|NCT05097989|594803500|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
164666576|NCT05097989|594803501|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
164666577|NCT05097989|594803502|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
164666578|NCT05097989|594803503|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
164666579|NCT05097989|594803504|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
164666580|NCT05097989|594803505|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
164666581|NCT05097989|594803506|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
164666582|NCT05097989|594803498|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
164666583|NCT05097989|594803499|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
164666584|NCT05097989|594803500|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
164318310|NCT00816023|593540904|FG001|Overall Study|Randomized Not Treated|4|||
164318311|NCT00816023|593540905|FG002|Overall Study|Randomized Not Treated|6|||
164318312|NCT00816023|593540906|FG003|Overall Study|Randomized Not Treated|11|||
164318313|NCT00441116|593540910|FG000|Overall Study|Adverse Event|1|||
164318314|NCT00441116|593540911|FG001|Overall Study|Adverse Event|1|||
164318315|NCT00441116|593540910|FG000|Overall Study|Withdrawal by Subject|1|||
164318316|NCT00441116|593540911|FG001|Overall Study|Withdrawal by Subject|0|||
164318317|NCT00441116|593540910|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
164318318|NCT00441116|593540911|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
164318319|NCT02925338|593540912|FG000|Overall Study|Death|0|||
164318320|NCT02925338|593540913|FG001|Overall Study|Death|2|||
164318321|NCT02925338|593540914|FG002|Overall Study|Death|1|||
164318322|NCT02925338|593540915|FG003|Overall Study|Death|0|||
164318323|NCT02925338|593540916|FG004|Overall Study|Death|0|||
164318324|NCT02925338|593540912|FG000|Overall Study|Lost to Follow-up|30|||
164318325|NCT02925338|593540913|FG001|Overall Study|Lost to Follow-up|10|||
164318326|NCT02925338|593540914|FG002|Overall Study|Lost to Follow-up|1|||
164318327|NCT02925338|593540915|FG003|Overall Study|Lost to Follow-up|16|||
164318328|NCT02925338|593540916|FG004|Overall Study|Lost to Follow-up|3|||
164318329|NCT02925338|593540912|FG000|Overall Study|Withdrawal by Subject|3|||
164318330|NCT02925338|593540913|FG001|Overall Study|Withdrawal by Subject|0|||
164318331|NCT02925338|593540914|FG002|Overall Study|Withdrawal by Subject|3|||
164318332|NCT02925338|593540915|FG003|Overall Study|Withdrawal by Subject|2|||
164318333|NCT02925338|593540916|FG004|Overall Study|Withdrawal by Subject|2|||
164318334|NCT02925338|593540912|FG000|Overall Study|Missing|38|||
164318335|NCT02925338|593540913|FG001|Overall Study|Missing|27|||
164318336|NCT02925338|593540914|FG002|Overall Study|Missing|0|||
164318337|NCT02925338|593540915|FG003|Overall Study|Missing|3|||
164318338|NCT02925338|593540916|FG004|Overall Study|Missing|2|||
164318339|NCT02925338|593540912|FG000|Overall Study|Participant's Decision|11|||
164318340|NCT02925338|593540913|FG001|Overall Study|Participant's Decision|7|||
164318341|NCT02925338|593540914|FG002|Overall Study|Participant's Decision|3|||
164318342|NCT02925338|593540915|FG003|Overall Study|Participant's Decision|8|||
164318343|NCT02925338|593540916|FG004|Overall Study|Participant's Decision|1|||
164318344|NCT02925338|593540912|FG000|Overall Study|Treatment Discontinuation|144|||
164318345|NCT02925338|593540913|FG001|Overall Study|Treatment Discontinuation|65|||
164318346|NCT02925338|593540914|FG002|Overall Study|Treatment Discontinuation|56|||
164318347|NCT02925338|593540915|FG003|Overall Study|Treatment Discontinuation|131|||
164318348|NCT02925338|593540916|FG004|Overall Study|Treatment Discontinuation|22|||
164318349|NCT00636363|593540919|FG000|Overall Study|Conjunctivitis|0|||
164318350|NCT00636363|593540920|FG001|Overall Study|Conjunctivitis|0|||
164318351|NCT00636363|593540921|FG002|Overall Study|Conjunctivitis|1|||
164318352|NCT00636363|593540919|FG000|Overall Study|Adverse Event|0|||
164318353|NCT00636363|593540920|FG001|Overall Study|Adverse Event|0|||
164318354|NCT00636363|593540921|FG002|Overall Study|Adverse Event|1|||
164318355|NCT00636363|593540919|FG000|Overall Study|Positive slit lamp finding|0|||
164318356|NCT00636363|593540920|FG001|Overall Study|Positive slit lamp finding|2|||
164318357|NCT00636363|593540921|FG002|Overall Study|Positive slit lamp finding|1|||
164318358|NCT00636363|593540919|FG000|Overall Study|Study related symptoms/complaints|8|||
164318359|NCT00636363|593540920|FG001|Overall Study|Study related symptoms/complaints|7|||
164318360|NCT00636363|593540921|FG002|Overall Study|Study related symptoms/complaints|4|||
164318361|NCT00636363|593540919|FG000|Overall Study|Met ineligibility criteria|0|||
164318362|NCT00636363|593540920|FG001|Overall Study|Met ineligibility criteria|0|||
164318363|NCT00636363|593540921|FG002|Overall Study|Met ineligibility criteria|3|||
164318364|NCT00636363|593540919|FG000|Overall Study|Missed > 1 visit|0|||
164318365|NCT00636363|593540920|FG001|Overall Study|Missed > 1 visit|1|||
164318366|NCT00636363|593540921|FG002|Overall Study|Missed > 1 visit|3|||
164318367|NCT00636363|593540919|FG000|Overall Study|Lack of motivation|1|||
164318368|NCT00636363|593540920|FG001|Overall Study|Lack of motivation|0|||
164318369|NCT00636363|593540921|FG002|Overall Study|Lack of motivation|1|||
164318370|NCT00636363|593540919|FG000|Overall Study|Protocol Violation|0|||
164318371|NCT00636363|593540920|FG001|Overall Study|Protocol Violation|3|||
164318372|NCT00636363|593540921|FG002|Overall Study|Protocol Violation|0|||
164318373|NCT00636363|593540919|FG000|Overall Study|Lost to Follow-up|3|||
164318374|NCT00636363|593540920|FG001|Overall Study|Lost to Follow-up|4|||
164318375|NCT00636363|593540921|FG002|Overall Study|Lost to Follow-up|2|||
164318376|NCT00636363|593540919|FG000|Overall Study|Withdrawal by Subject|1|||
164318377|NCT00636363|593540920|FG001|Overall Study|Withdrawal by Subject|3|||
164318378|NCT00636363|593540921|FG002|Overall Study|Withdrawal by Subject|2|||
164318379|NCT00835731|593540926|FG000|Overall Study|Withdrawal by Subject|1|||
164318380|NCT00835731|593540927|FG001|Overall Study|Withdrawal by Subject|0|||
164318381|NCT00835731|593540926|FG000|Overall Study|Physician Decision|1|||
164318382|NCT00835731|593540927|FG001|Overall Study|Physician Decision|1|||
164318383|NCT00348881|593540928|FG000|Overall Study|Lost to Follow-up|12|||
164318384|NCT00348881|593540929|FG001|Overall Study|Lost to Follow-up|6|||
164318385|NCT00348881|593540928|FG000|Overall Study|Withdrawal by Subject|3|||
164318386|NCT00348881|593540929|FG001|Overall Study|Withdrawal by Subject|4|||
164318387|NCT00348881|593540928|FG000|Overall Study|Adverse Event|2|||
164318388|NCT00348881|593540929|FG001|Overall Study|Adverse Event|0|||
164318389|NCT00348881|593540928|FG000|Overall Study|Serious Adverse Event|0|||
164666585|NCT05097989|594803501|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
164666586|NCT05097989|594803502|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
164205786|NCT01027949|593122694|FG000|Overall Study|PI Decision|8|||
164205787|NCT01027949|593122694|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
164205788|NCT01027949|593122694|FG000|Overall Study|Non-compliance with Study Procedures|7|||
164205789|NCT01027949|593122694|FG000|Overall Study|Lung Transplant|5|||
164666587|NCT05097989|594803503|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
164666588|NCT05097989|594803504|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
164666589|NCT05097989|594803505|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
164666590|NCT05097989|594803506|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
164666591|NCT05097989|594803498|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
164666592|NCT05097989|594803499|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
164666593|NCT05097989|594803500|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
164666594|NCT05097989|594803501|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
164666595|NCT05097989|594803502|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
164666596|NCT05097989|594803503|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
164666597|NCT05097989|594803504|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
164666598|NCT05097989|594803505|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
164666599|NCT05097989|594803506|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
164666600|NCT00918567|594803515|FG000|Overall Study|Lack of Efficacy|3|||
164666601|NCT00918567|594803516|FG001|Overall Study|Lack of Efficacy|1|||
164666602|NCT00918567|594803515|FG000|Overall Study|Withdrawal by Subject|1|||
164666603|NCT00918567|594803516|FG001|Overall Study|Withdrawal by Subject|1|||
164666604|NCT00918567|594803515|FG000|Overall Study|Adverse Event|1|||
164666605|NCT00918567|594803516|FG001|Overall Study|Adverse Event|0|||
164666606|NCT03283709|594803519|FG000|Overall Study|trial terminated|0|||
164666607|NCT03283709|594803520|FG001|Overall Study|trial terminated|1|||
164666608|NCT05275998|594803521|FG000|Overall Study|Adverse Event|0|||
164666609|NCT05275998|594803522|FG001|Overall Study|Adverse Event|0|||
164666610|NCT05275998|594803523|FG002|Overall Study|Adverse Event|0|||
164666611|NCT05275998|594803524|FG003|Overall Study|Adverse Event|1|||
164666612|NCT05275998|594803521|FG000|Overall Study|Withdrawal by Subject|0|||
164666613|NCT05275998|594803522|FG001|Overall Study|Withdrawal by Subject|0|||
164666614|NCT05275998|594803523|FG002|Overall Study|Withdrawal by Subject|0|||
164666615|NCT05275998|594803524|FG003|Overall Study|Withdrawal by Subject|1|||
164666616|NCT05275998|594803521|FG000|Overall Study|Physician Decision|0|||
164666617|NCT05275998|594803522|FG001|Overall Study|Physician Decision|0|||
164666618|NCT05275998|594803523|FG002|Overall Study|Physician Decision|0|||
164666619|NCT05275998|594803524|FG003|Overall Study|Physician Decision|1|||
164666620|NCT05275998|594803521|FG000|Overall Study|Protocol Violation|0|||
164666621|NCT05275998|594803522|FG001|Overall Study|Protocol Violation|0|||
164666622|NCT05275998|594803523|FG002|Overall Study|Protocol Violation|1|||
164666623|NCT05275998|594803524|FG003|Overall Study|Protocol Violation|0|||
164666624|NCT01936948|594803528|FG000|Overall Study|no 30-day follow-up data|0|||
164666625|NCT01936948|594803529|FG001|Overall Study|no 30-day follow-up data|3|||
164205790|NCT01027949|593122694|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
164205791|NCT01027949|593122694|FG000|Overall Study|Use of Excluded Medication|2|||
164205792|NCT01027949|593122694|FG000|Overall Study|Patient Self-discontinuation|1|||
164205793|NCT01027949|593122694|FG000|Overall Study|Pregnancy|1|||
164205794|NCT01027949|593122694|FG000|Overall Study|Surgery|1|||
164205795|NCT00656617|593122697|FG000|Overall Study|Adverse Event|1|||
164205796|NCT00656617|593122697|FG000|Overall Study|Death|2|||
164205797|NCT00656617|593122697|FG000|Overall Study|Insurance Issues|2|||
164205798|NCT00656617|593122697|FG000|Overall Study|Move to different clinical trial|2|||
164205799|NCT02030600|593122698|FG000|Treatment Period 1|Adverse Event|5|||
164205800|NCT02030600|593122699|FG001|Treatment Period 1|Adverse Event|7|||
164205801|NCT02030600|593122698|FG000|Treatment Period 1|Lack of Efficacy|0|||
164205802|NCT02030600|593122699|FG001|Treatment Period 1|Lack of Efficacy|1|||
164205803|NCT02030600|593122698|FG000|Treatment Period 1|Lost to Follow-up|11|||
164205804|NCT02030600|593122699|FG001|Treatment Period 1|Lost to Follow-up|3|||
164205805|NCT02030600|593122698|FG000|Treatment Period 1|Protocol Violation|22|||
164205806|NCT02030600|593122699|FG001|Treatment Period 1|Protocol Violation|17|||
164205807|NCT02030600|593122698|FG000|Treatment Period 1|Withdrawal by Subject|13|||
164205808|NCT02030600|593122699|FG001|Treatment Period 1|Withdrawal by Subject|17|||
164205809|NCT02030600|593122698|FG000|Treatment Period 1|Casebook Unsigned|1|||
164666626|NCT01936948|594803530|FG002|Overall Study|no 30-day follow-up data|3|||
164666627|NCT01936948|594803531|FG003|Overall Study|no 30-day follow-up data|3|||
164666628|NCT02327130|594803535|FG000|Overall Study|Discharged in less than 5 days|5|||
164205810|NCT02030600|593122699|FG001|Treatment Period 1|Casebook Unsigned|0|||
164205811|NCT02030600|593122698|FG000|Treatment Period 1|Unclassified|1|||
164205812|NCT02030600|593122699|FG001|Treatment Period 1|Unclassified|0|||
164205813|NCT02030600|593122698|FG000|Treatment Period 2|Adverse Event|4|||
164205814|NCT02030600|593122699|FG001|Treatment Period 2|Adverse Event|4|||
164666629|NCT02327130|594803535|FG000|Overall Study|Physician Decision|2|||
164318390|NCT00348881|593540929|FG001|Overall Study|Serious Adverse Event|2|||
164318391|NCT05092360|593540937|FG000|Overall Study|Withdrawal by Subject|21|||
164318392|NCT05092360|593540938|FG001|Overall Study|Withdrawal by Subject|4|||
164318393|NCT05092360|593540939|FG002|Overall Study|Withdrawal by Subject|9|||
164318394|NCT05092360|593540940|FG003|Overall Study|Withdrawal by Subject|26|||
164318395|NCT05092360|593540937|FG000|Overall Study|Death|97|||
164318396|NCT05092360|593540938|FG001|Overall Study|Death|14|||
164318397|NCT05092360|593540939|FG002|Overall Study|Death|31|||
164318398|NCT05092360|593540940|FG003|Overall Study|Death|101|||
164318399|NCT05092360|593540937|FG000|Overall Study|Lost to Follow-up|1|||
164666630|NCT02327130|594803535|FG000|Overall Study|Unable to provide breath sample|1|||
164666631|NCT02327130|594803535|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
164666632|NCT02327130|594803535|FG000|Overall Study|Met exclusion criteria|3|||
164666633|NCT04028843|594803537|FG000|Overall Study|Lost to Follow-up|32|||
164666634|NCT04028843|594803538|FG001|Overall Study|Lost to Follow-up|39|||
164666635|NCT04028843|594803537|FG000|Overall Study|Adverse Event|1|||
164666636|NCT04028843|594803538|FG001|Overall Study|Adverse Event|0|||
164666637|NCT04028843|594803537|FG000|Overall Study|Non-viable Pregnancy|0|||
164666638|NCT04028843|594803538|FG001|Overall Study|Non-viable Pregnancy|1|||
164666639|NCT04028843|594803537|FG000|Overall Study|Withdrawal by Subject|4|||
164666640|NCT04028843|594803538|FG001|Overall Study|Withdrawal by Subject|2|||
164666641|NCT01347710|594803539|FG000|Overall Study|Withdrawal by Subject|2|||
164666642|NCT01347710|594803539|FG000|Overall Study|Adverse Event|4|||
164666643|NCT01347710|594803539|FG000|Overall Study|Angio or SPECT not completed|18|||
164666644|NCT01347710|594803539|FG000|Overall Study|issue with vitals prior to dosing|1|||
164666645|NCT01347710|594803539|FG000|Overall Study|Lost to Follow-up|1|||
164666646|NCT01347710|594803539|FG000|Overall Study|Physician Decision|2|||
164666647|NCT01347710|594803539|FG000|Overall Study|Other|3|||
164666648|NCT02003183|594803547|FG000|Overall Study|Lost to Follow-up|0|||
164666649|NCT02003183|594803548|FG001|Overall Study|Lost to Follow-up|2|||
164666650|NCT00841100|594803549|FG000|Phase 1 (28 Days)|Adverse Event|1|||
164666651|NCT00841100|594803549|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
164666652|NCT03338972|594803550|FG000|Overall Study|Death|1|||
164666653|NCT03338972|594803551|FG001|Overall Study|Death|1|||
164666654|NCT03338972|594803552|FG002|Overall Study|Death|0|||
164666655|NCT03338972|594803553|FG003|Overall Study|Death|0|||
164666656|NCT03338972|594803550|FG000|Overall Study|Withdrawal by Subject|1|||
164666657|NCT03338972|594803551|FG001|Overall Study|Withdrawal by Subject|0|||
164666658|NCT03338972|594803552|FG002|Overall Study|Withdrawal by Subject|0|||
164666659|NCT03338972|594803553|FG003|Overall Study|Withdrawal by Subject|0|||
164666660|NCT01355081|594803554|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
164666661|NCT01355081|594803555|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
164666662|NCT01355081|594803556|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
164666663|NCT01355081|594803554|FG000|Overall Study|Major Protocol Deviation|0|||
164666664|NCT01355081|594803555|FG001|Overall Study|Major Protocol Deviation|1|||
164666665|NCT01355081|594803556|FG002|Overall Study|Major Protocol Deviation|0|||
164666666|NCT01355081|594803554|FG000|Overall Study|Lost to Follow-up|0|||
164666667|NCT01355081|594803555|FG001|Overall Study|Lost to Follow-up|0|||
164666668|NCT01355081|594803556|FG002|Overall Study|Lost to Follow-up|1|||
164666669|NCT01355081|594803554|FG000|Overall Study|Withdrawal of Consent|2|||
164666670|NCT01355081|594803555|FG001|Overall Study|Withdrawal of Consent|3|||
164666671|NCT01355081|594803556|FG002|Overall Study|Withdrawal of Consent|3|||
164666672|NCT01355081|594803554|FG000|Overall Study|Lack of Efficacy|2|||
164205815|NCT02030600|593122698|FG000|Treatment Period 2|Lack of Efficacy|2|||
164205816|NCT02030600|593122699|FG001|Treatment Period 2|Lack of Efficacy|1|||
164205817|NCT02030600|593122698|FG000|Treatment Period 2|Lost to Follow-up|4|||
164205818|NCT02030600|593122699|FG001|Treatment Period 2|Lost to Follow-up|2|||
164205819|NCT02030600|593122698|FG000|Treatment Period 2|Protocol Violation|1|||
164205820|NCT02030600|593122699|FG001|Treatment Period 2|Protocol Violation|2|||
164205821|NCT02030600|593122698|FG000|Treatment Period 2|Withdrawal by Subject|13|||
164205822|NCT02030600|593122699|FG001|Treatment Period 2|Withdrawal by Subject|9|||
164205823|NCT02030600|593122698|FG000|Treatment Period 2|Unclassified|1|||
164205824|NCT02030600|593122699|FG001|Treatment Period 2|Unclassified|0|||
164205825|NCT00091819|593122702|FG000|Overall Study|Adverse Event|1|||
164205826|NCT00091819|593122703|FG001|Overall Study|Adverse Event|1|||
164205827|NCT00091819|593122702|FG000|Overall Study|Death|4|||
164205828|NCT00091819|593122703|FG001|Overall Study|Death|5|||
164205829|NCT00091819|593122702|FG000|Overall Study|Lost to Follow-up|26|||
164666673|NCT01355081|594803555|FG001|Overall Study|Lack of Efficacy|1|||
164666674|NCT01355081|594803556|FG002|Overall Study|Lack of Efficacy|1|||
164666675|NCT01355081|594803554|FG000|Overall Study|Non Compliance with Study Medication|0|||
164205830|NCT00091819|593122703|FG001|Overall Study|Lost to Follow-up|23|||
164318400|NCT05092360|593540938|FG001|Overall Study|Lost to Follow-up|2|||
164318401|NCT05092360|593540939|FG002|Overall Study|Lost to Follow-up|2|||
164318402|NCT05092360|593540940|FG003|Overall Study|Lost to Follow-up|2|||
164666676|NCT01355081|594803555|FG001|Overall Study|Non Compliance with Study Medication|1|||
164666677|NCT01355081|594803556|FG002|Overall Study|Non Compliance with Study Medication|0|||
164666678|NCT02719522|594803559|FG000|Overall Study|Implant Failure|4|||
164666679|NCT02719522|594803559|FG000|Overall Study|Death|2|||
164666680|NCT02719522|594803559|FG000|Overall Study|Lost to Follow-up|5|||
164666681|NCT01868009|594803560|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
164666682|NCT01868009|594803561|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
164666683|NCT01868009|594803560|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
164666684|NCT01868009|594803561|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
164666685|NCT01868009|594803560|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
164666686|NCT01868009|594803561|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
164666687|NCT01451762|594804635|FG000|Overall Study|Lost to Follow-up|3|||
164666688|NCT01451762|594804636|FG001|Overall Study|Lost to Follow-up|6|||
164666689|NCT01451762|594804637|FG002|Overall Study|Lost to Follow-up|6|||
164666690|NCT01494506|594804641|FG000|Overall Study|Lack of Efficacy|77|||
164666691|NCT01494506|594804642|FG001|Overall Study|Lack of Efficacy|83|||
164666692|NCT01494506|594804643|FG002|Overall Study|Lack of Efficacy|57|||
164666693|NCT01494506|594804641|FG000|Overall Study|Adverse Event|17|||
164666694|NCT01494506|594804642|FG001|Overall Study|Adverse Event|10|||
164666695|NCT01494506|594804643|FG002|Overall Study|Adverse Event|11|||
164666696|NCT01494506|594804641|FG000|Overall Study|Death|9|||
164666697|NCT01494506|594804642|FG001|Overall Study|Death|5|||
164205831|NCT00091819|593122702|FG000|Overall Study|Withdrawal by Subject|5|||
164205832|NCT00091819|593122703|FG001|Overall Study|Withdrawal by Subject|8|||
164205833|NCT00091819|593122702|FG000|Overall Study|Protocol Violation|1|||
164205834|NCT00091819|593122703|FG001|Overall Study|Protocol Violation|2|||
164205835|NCT00091819|593122702|FG000|Overall Study|Other|2|||
164205836|NCT00091819|593122703|FG001|Overall Study|Other|3|||
164205837|NCT00091819|593122702|FG000|Overall Study|Never received study treatment|3|||
164205838|NCT00091819|593122703|FG001|Overall Study|Never received study treatment|4|||
164205839|NCT02606253|593122704|FG000|Overall Study|Adverse Event|2|||
164205840|NCT02606253|593122705|FG001|Overall Study|Adverse Event|0|||
164205841|NCT02606253|593122706|FG002|Overall Study|Adverse Event|0|||
164205842|NCT02606253|593122704|FG000|Overall Study|Protocol Violation|2|||
164205843|NCT02606253|593122705|FG001|Overall Study|Protocol Violation|1|||
164205844|NCT02606253|593122706|FG002|Overall Study|Protocol Violation|0|||
164205845|NCT02606253|593122704|FG000|Overall Study|Physician Decision|1|||
164205846|NCT02606253|593122705|FG001|Overall Study|Physician Decision|1|||
164205847|NCT02606253|593122706|FG002|Overall Study|Physician Decision|0|||
164205848|NCT00701363|593122707|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
164205849|NCT00701363|593122708|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
164205850|NCT00701363|593122709|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
164205851|NCT00701363|593122710|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
164205852|NCT00701363|593122707|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
164205853|NCT00701363|593122708|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
164205854|NCT00701363|593122709|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
164205855|NCT00701363|593122710|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
164205856|NCT00701363|593122707|FG000|Treatment Phase 1|Adverse Event|7|||
164205857|NCT00701363|593122708|FG001|Treatment Phase 1|Adverse Event|0|||
164205858|NCT00701363|593122709|FG002|Treatment Phase 1|Adverse Event|0|||
164205859|NCT00701363|593122710|FG003|Treatment Phase 1|Adverse Event|0|||
164205860|NCT00701363|593122707|FG000|Treatment Phase 1|Protocol Violation|1|||
164205861|NCT00701363|593122708|FG001|Treatment Phase 1|Protocol Violation|0|||
164205862|NCT00701363|593122709|FG002|Treatment Phase 1|Protocol Violation|0|||
164205863|NCT00701363|593122710|FG003|Treatment Phase 1|Protocol Violation|0|||
164205864|NCT00701363|593122707|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
164205865|NCT00701363|593122708|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
164205866|NCT00701363|593122709|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
164205867|NCT00701363|593122710|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
164205868|NCT00701363|593122707|FG000|Treatment Phase 1|Lack of Efficacy|1|||
164205869|NCT00701363|593122708|FG001|Treatment Phase 1|Lack of Efficacy|0|||
164205870|NCT00701363|593122709|FG002|Treatment Phase 1|Lack of Efficacy|0|||
164205871|NCT00701363|593122710|FG003|Treatment Phase 1|Lack of Efficacy|0|||
164205872|NCT00701363|593122707|FG000|Treatment Phase 2|Adverse Event|0|||
164205873|NCT00701363|593122708|FG001|Treatment Phase 2|Adverse Event|0|||
164205874|NCT00701363|593122709|FG002|Treatment Phase 2|Adverse Event|1|||
164205875|NCT00701363|593122710|FG003|Treatment Phase 2|Adverse Event|0|||
164205876|NCT00701363|593122707|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
164205877|NCT00701363|593122708|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
164205878|NCT00701363|593122709|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
164205879|NCT00701363|593122710|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
164205880|NCT03426878|593122711|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
164205881|NCT03426878|593122711|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
164205882|NCT03426878|593122711|FG000|Overall Study|Declined to receive results|3|||
164205883|NCT03426878|593122711|FG000|Overall Study|Received negative results by mailed letter|65|||
164666698|NCT01494506|594804643|FG002|Overall Study|Death|2|||
164666699|NCT01494506|594804641|FG000|Overall Study|Physician Decision|7|||
164666700|NCT01494506|594804642|FG001|Overall Study|Physician Decision|5|||
164666701|NCT01494506|594804643|FG002|Overall Study|Physician Decision|4|||
164666702|NCT01494506|594804641|FG000|Overall Study|Withdrawal by Subject|17|||
164318403|NCT05092360|593540937|FG000|Overall Study|Study terminated by sponsor|65|||
164318404|NCT05092360|593540938|FG001|Overall Study|Study terminated by sponsor|7|||
164318405|NCT05092360|593540939|FG002|Overall Study|Study terminated by sponsor|13|||
164318406|NCT05092360|593540940|FG003|Overall Study|Study terminated by sponsor|61|||
164318407|NCT01675167|593540941|FG000|Open-label Titration Phase|Adverse Event|81|||
164318408|NCT01675167|593540942|FG001|Open-label Titration Phase|Adverse Event|0|||
164318409|NCT01675167|593540943|FG002|Open-label Titration Phase|Adverse Event|0|||
164318410|NCT01675167|593540941|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
164318411|NCT01675167|593540942|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
164318412|NCT01675167|593540943|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
164318413|NCT01675167|593540941|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
164318414|NCT01675167|593540942|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
164318415|NCT01675167|593540943|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
164318416|NCT01675167|593540941|FG000|Open-label Titration Phase|Protocol Violation|43|||
164318417|NCT01675167|593540942|FG001|Open-label Titration Phase|Protocol Violation|0|||
164318418|NCT01675167|593540943|FG002|Open-label Titration Phase|Protocol Violation|0|||
164318419|NCT01675167|593540941|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
164318420|NCT01675167|593540942|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
164318421|NCT01675167|593540943|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
164318422|NCT01675167|593540941|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
164318423|NCT01675167|593540942|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
164318424|NCT01675167|593540943|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
164318425|NCT01675167|593540941|FG000|Open-label Titration Phase|Other|55|||
164318426|NCT01675167|593540942|FG001|Open-label Titration Phase|Other|0|||
164318427|NCT01675167|593540943|FG002|Open-label Titration Phase|Other|0|||
164318428|NCT01675167|593540941|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
164318429|NCT01675167|593540942|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
164318430|NCT01675167|593540943|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
164318431|NCT01675167|593540941|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
164318432|NCT01675167|593540942|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
164318433|NCT01675167|593540943|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
164318434|NCT01675167|593540941|FG000|Double-blind Treatment Phase|Adverse Event|0|||
164318435|NCT01675167|593540942|FG001|Double-blind Treatment Phase|Adverse Event|5|||
164318436|NCT01675167|593540943|FG002|Double-blind Treatment Phase|Adverse Event|13|||
164318437|NCT01675167|593540941|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
164318438|NCT01675167|593540942|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
164318439|NCT01675167|593540943|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
164318440|NCT01675167|593540941|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
164318441|NCT01675167|593540942|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
164318442|NCT01675167|593540943|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
164318443|NCT01675167|593540941|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
164318444|NCT01675167|593540942|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
164318445|NCT01675167|593540943|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
164318446|NCT01675167|593540941|FG000|Double-blind Treatment Phase|Other|0|||
164318447|NCT01675167|593540942|FG001|Double-blind Treatment Phase|Other|7|||
164318448|NCT01675167|593540943|FG002|Double-blind Treatment Phase|Other|5|||
164318449|NCT03952039|593540946|FG000|Overall Study|Adverse Event|22|||
164318450|NCT03952039|593540947|FG001|Overall Study|Adverse Event|8|||
164318451|NCT03952039|593540946|FG000|Overall Study|Withdrawal by Participant|17|||
164318452|NCT03952039|593540947|FG001|Overall Study|Withdrawal by Participant|12|||
164318453|NCT03952039|593540946|FG000|Overall Study|Death|13|||
164318454|NCT03952039|593540947|FG001|Overall Study|Death|6|||
164318455|NCT03952039|593540946|FG000|Overall Study|Lack of Efficacy|12|||
164318456|NCT03952039|593540947|FG001|Overall Study|Lack of Efficacy|2|||
164318457|NCT03952039|593540946|FG000|Overall Study|Physician Decision|9|||
164318458|NCT03952039|593540947|FG001|Overall Study|Physician Decision|3|||
164318459|NCT03952039|593540946|FG000|Overall Study|Progressive Disease|6|||
164318460|NCT03952039|593540947|FG001|Overall Study|Progressive Disease|4|||
164318461|NCT03952039|593540946|FG000|Overall Study|Other Reasons|12|||
164318462|NCT03952039|593540947|FG001|Overall Study|Other Reasons|4|||
164562365|NCT01262976|594427471|FG005|Up to Year 3|Migrated/moved from study area|1|||
164562366|NCT01262976|594427466|FG000|Up to Year 3|Lost to Follow-up|2|||
164562367|NCT01262976|594427467|FG001|Up to Year 3|Lost to Follow-up|2|||
164562368|NCT01262976|594427468|FG002|Up to Year 3|Lost to Follow-up|4|||
164562369|NCT01262976|594427469|FG003|Up to Year 3|Lost to Follow-up|3|||
164318463|NCT01246466|593542070|FG000|Overall Study|Death|1|||
164318464|NCT01246466|593542070|FG000|Overall Study|Withdrawal by Subject|1|||
164318465|NCT02855541|593542078|FG000|Overall Study|Change in health status|2|||
164318466|NCT02855541|593542078|FG000|Overall Study|Withdrawal by Subject|2|||
164318467|NCT03085914|593542079|FG000|Overall Study|Death|6|||
164318468|NCT03085914|593542080|FG001|Overall Study|Death|6|||
164318469|NCT03085914|593542081|FG002|Overall Study|Death|4|||
164318470|NCT03085914|593542082|FG003|Overall Study|Death|1|||
164562370|NCT01262976|594427470|FG004|Up to Year 3|Lost to Follow-up|1|||
164318471|NCT03085914|593542083|FG004|Overall Study|Death|5|||
164318472|NCT03085914|593542084|FG005|Overall Study|Death|2|||
164318473|NCT03085914|593542085|FG006|Overall Study|Death|2|||
164318474|NCT03085914|593542079|FG000|Overall Study|Withdrawal by Subject|1|||
164318475|NCT03085914|593542080|FG001|Overall Study|Withdrawal by Subject|1|||
164318476|NCT03085914|593542081|FG002|Overall Study|Withdrawal by Subject|2|||
164318477|NCT03085914|593542082|FG003|Overall Study|Withdrawal by Subject|2|||
164318478|NCT03085914|593542083|FG004|Overall Study|Withdrawal by Subject|2|||
164318479|NCT03085914|593542084|FG005|Overall Study|Withdrawal by Subject|0|||
164318480|NCT03085914|593542085|FG006|Overall Study|Withdrawal by Subject|1|||
164318481|NCT03085914|593542079|FG000|Overall Study|Lost to Follow-up|0|||
164318482|NCT03085914|593542080|FG001|Overall Study|Lost to Follow-up|0|||
164318483|NCT03085914|593542081|FG002|Overall Study|Lost to Follow-up|1|||
164318484|NCT03085914|593542082|FG003|Overall Study|Lost to Follow-up|0|||
164318485|NCT03085914|593542083|FG004|Overall Study|Lost to Follow-up|0|||
164318486|NCT03085914|593542084|FG005|Overall Study|Lost to Follow-up|1|||
164318487|NCT03085914|593542085|FG006|Overall Study|Lost to Follow-up|1|||
164318488|NCT03085914|593542079|FG000|Overall Study|Reason was not specified,|2|||
164318489|NCT03085914|593542080|FG001|Overall Study|Reason was not specified,|2|||
164318490|NCT03085914|593542081|FG002|Overall Study|Reason was not specified,|2|||
164318491|NCT03085914|593542082|FG003|Overall Study|Reason was not specified,|3|||
164318492|NCT03085914|593542083|FG004|Overall Study|Reason was not specified,|3|||
164318493|NCT03085914|593542084|FG005|Overall Study|Reason was not specified,|3|||
164318494|NCT03085914|593542085|FG006|Overall Study|Reason was not specified,|6|||
164318495|NCT03085914|593542079|FG000|Overall Study|Progressive Disease|0|||
164318496|NCT03085914|593542080|FG001|Overall Study|Progressive Disease|0|||
164318497|NCT03085914|593542081|FG002|Overall Study|Progressive Disease|2|||
164318498|NCT03085914|593542082|FG003|Overall Study|Progressive Disease|2|||
164318499|NCT03085914|593542083|FG004|Overall Study|Progressive Disease|1|||
164318500|NCT03085914|593542084|FG005|Overall Study|Progressive Disease|1|||
164318501|NCT03085914|593542085|FG006|Overall Study|Progressive Disease|1|||
164318502|NCT03085914|593542079|FG000|Overall Study|Study Terminated by the Sponsor|0|||
164318503|NCT03085914|593542080|FG001|Overall Study|Study Terminated by the Sponsor|0|||
164318504|NCT03085914|593542081|FG002|Overall Study|Study Terminated by the Sponsor|0|||
164318505|NCT03085914|593542082|FG003|Overall Study|Study Terminated by the Sponsor|1|||
164318506|NCT03085914|593542083|FG004|Overall Study|Study Terminated by the Sponsor|2|||
164318507|NCT03085914|593542084|FG005|Overall Study|Study Terminated by the Sponsor|1|||
164318508|NCT03085914|593542085|FG006|Overall Study|Study Terminated by the Sponsor|0|||
164318509|NCT01561898|593542089|FG000|Overall Study|Withdrawal by Subject|0|||
164318510|NCT01561898|593542090|FG001|Overall Study|Withdrawal by Subject|8|||
164318511|NCT01561898|593542091|FG002|Overall Study|Withdrawal by Subject|12|||
164318512|NCT01561898|593542092|FG003|Overall Study|Withdrawal by Subject|5|||
164318513|NCT01561898|593542089|FG000|Overall Study|Lack of Efficacy|0|||
164318514|NCT01561898|593542090|FG001|Overall Study|Lack of Efficacy|8|||
164318515|NCT01561898|593542091|FG002|Overall Study|Lack of Efficacy|10|||
164318516|NCT01561898|593542092|FG003|Overall Study|Lack of Efficacy|5|||
164318517|NCT01561898|593542089|FG000|Overall Study|Worsening of complications|0|||
164318518|NCT01561898|593542090|FG001|Overall Study|Worsening of complications|1|||
164318519|NCT01561898|593542091|FG002|Overall Study|Worsening of complications|0|||
164318520|NCT01561898|593542092|FG003|Overall Study|Worsening of complications|0|||
164318521|NCT01561898|593542089|FG000|Overall Study|Lost to Follow-up|0|||
164318522|NCT01561898|593542090|FG001|Overall Study|Lost to Follow-up|0|||
164318523|NCT01561898|593542091|FG002|Overall Study|Lost to Follow-up|1|||
164318524|NCT01561898|593542092|FG003|Overall Study|Lost to Follow-up|0|||
164318525|NCT01561898|593542089|FG000|Overall Study|Adverse Event|1|||
164318526|NCT01561898|593542090|FG001|Overall Study|Adverse Event|19|||
164318527|NCT01561898|593542091|FG002|Overall Study|Adverse Event|14|||
164318528|NCT01561898|593542092|FG003|Overall Study|Adverse Event|9|||
164318529|NCT01561898|593542089|FG000|Overall Study|Physician Decision|1|||
164318530|NCT01561898|593542090|FG001|Overall Study|Physician Decision|5|||
164562371|NCT01262976|594427471|FG005|Up to Year 3|Lost to Follow-up|3|||
164318531|NCT01561898|593542091|FG002|Overall Study|Physician Decision|7|||
164318532|NCT01561898|593542092|FG003|Overall Study|Physician Decision|1|||
164318533|NCT03874429|593542093|FG000|Overall Study|Adverse Event|2|||
164318534|NCT03874429|593542094|FG001|Overall Study|Adverse Event|2|||
164318535|NCT03874429|593542093|FG000|Overall Study|Lack of Efficacy|0|||
164318536|NCT03874429|593542094|FG001|Overall Study|Lack of Efficacy|1|||
164318537|NCT03874429|593542093|FG000|Overall Study|Covid-19 pandemic|4|||
164318538|NCT03874429|593542094|FG001|Overall Study|Covid-19 pandemic|2|||
164318539|NCT00331552|593542095|FG000|Period 3: Phase II|Neurological Symptoms|1|||
164318540|NCT00331552|593542096|FG001|Period 3: Phase II|Neurological Symptoms|0|||
164318541|NCT00331552|593542095|FG000|Period 3: Phase II|Severe Nausea|1|||
164318542|NCT00331552|593542096|FG001|Period 3: Phase II|Severe Nausea|0|||
164318543|NCT01445548|593542097|FG000|Overall Study|Adverse Event|1|||
164318544|NCT03560518|593542098|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
164318545|NCT03560518|593542099|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
164318546|NCT03560518|593542100|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
164420637|NCT01154036|593910968|FG006|Phase I|Lost to Follow-up|0|||
164666703|NCT01494506|594804642|FG001|Overall Study|Withdrawal by Subject|20|||
164666704|NCT01494506|594804643|FG002|Overall Study|Withdrawal by Subject|14|||
164666705|NCT01494506|594804641|FG000|Overall Study|Clinical Deterioration|21|||
164205884|NCT03426878|593122711|FG000|Overall Study|Lost to Follow-up|177|||
164205885|NCT03704064|593122712|FG000|Overall Study|Lost to Follow-up|8|||
164205886|NCT03704064|593122713|FG001|Overall Study|Lost to Follow-up|4|||
164205887|NCT03704064|593122712|FG000|Overall Study|Withdrawal by Subject|1|||
164205888|NCT03704064|593122713|FG001|Overall Study|Withdrawal by Subject|1|||
164205889|NCT03704064|593122712|FG000|Overall Study|No longer available for study visits|0|||
164205890|NCT03704064|593122713|FG001|Overall Study|No longer available for study visits|1|||
164205891|NCT03704064|593122712|FG000|Overall Study|Censoring event|1|||
164205892|NCT03704064|593122713|FG001|Overall Study|Censoring event|0|||
164205893|NCT00262925|593122717|FG000|Overall Study|Lack of Efficacy|3|||
164205894|NCT00262925|593122717|FG000|Overall Study|Adverse Event|4|||
164205895|NCT00262925|593122717|FG000|Overall Study|Death|2|||
164205896|NCT00262925|593122717|FG000|Overall Study|alternative therapy|1|||
164205897|NCT00262925|593122717|FG000|Overall Study|Other|1|||
164205898|NCT04682301|593122718|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
164205899|NCT04682301|593122718|FG000|Overall Study|Death|2|||
164205900|NCT04220021|593122719|FG000|Overall Study|Withdrawal by Subject|11|||
164205901|NCT04220021|593122719|FG000|Overall Study|Physician Decision|2|||
164205902|NCT04220021|593122719|FG000|Overall Study|Non-study related illness|5|||
164205903|NCT04935879|593122722|FG000|Overall Study|Adverse Event|2|||
164205904|NCT04935879|593122723|FG001|Overall Study|Adverse Event|1|||
164205905|NCT04935879|593122722|FG000|Overall Study|Lost to Follow-up|1|||
164205906|NCT04935879|593122723|FG001|Overall Study|Lost to Follow-up|1|||
164205907|NCT04935879|593122722|FG000|Overall Study|Pregnancy|2|||
164205908|NCT04935879|593122723|FG001|Overall Study|Pregnancy|3|||
164205909|NCT04935879|593122722|FG000|Overall Study|Withdrawal by Subject|8|||
164205910|NCT04935879|593122723|FG001|Overall Study|Withdrawal by Subject|6|||
164205911|NCT04935879|593122722|FG000|Overall Study|Other|3|||
164205912|NCT04935879|593122723|FG001|Overall Study|Other|3|||
164205913|NCT01652690|593122724|FG000|Overall Study|Withdrawal by Subject|16|||
164205914|NCT01652690|593122725|FG001|Overall Study|Withdrawal by Subject|4|||
164205915|NCT01652690|593122724|FG000|Overall Study|Other|8|||
164205916|NCT01652690|593122725|FG001|Overall Study|Other|9|||
164205917|NCT01652690|593122724|FG000|Overall Study|Lost to Follow-up|6|||
164205918|NCT01652690|593122725|FG001|Overall Study|Lost to Follow-up|6|||
164205919|NCT01652690|593122724|FG000|Overall Study|Death|5|||
164205920|NCT01652690|593122725|FG001|Overall Study|Death|2|||
164205921|NCT03533751|593122726|FG000|Overall Study|Withdrawal by Subject|12|||
164205922|NCT03533751|593122727|FG001|Overall Study|Withdrawal by Subject|6|||
164205923|NCT03533751|593122728|FG002|Overall Study|Withdrawal by Subject|11|||
164205924|NCT03533751|593122729|FG003|Overall Study|Withdrawal by Subject|9|||
164205925|NCT03533751|593122730|FG004|Overall Study|Withdrawal by Subject|10|||
164205926|NCT03533751|593122726|FG000|Overall Study|Adverse Event|4|||
164205927|NCT03533751|593122727|FG001|Overall Study|Adverse Event|7|||
164205928|NCT03533751|593122728|FG002|Overall Study|Adverse Event|2|||
164205929|NCT03533751|593122729|FG003|Overall Study|Adverse Event|4|||
164205930|NCT03533751|593122730|FG004|Overall Study|Adverse Event|5|||
164205931|NCT03533751|593122726|FG000|Overall Study|Physician Decision|0|||
164205932|NCT03533751|593122727|FG001|Overall Study|Physician Decision|2|||
164205933|NCT03533751|593122728|FG002|Overall Study|Physician Decision|1|||
164205934|NCT03533751|593122729|FG003|Overall Study|Physician Decision|2|||
164205935|NCT03533751|593122730|FG004|Overall Study|Physician Decision|1|||
164205936|NCT03533751|593122726|FG000|Overall Study|Sponsor Decision|0|||
164205937|NCT03533751|593122727|FG001|Overall Study|Sponsor Decision|0|||
164205938|NCT03533751|593122728|FG002|Overall Study|Sponsor Decision|1|||
164205939|NCT03533751|593122729|FG003|Overall Study|Sponsor Decision|1|||
164205940|NCT03533751|593122730|FG004|Overall Study|Sponsor Decision|0|||
164205941|NCT03533751|593122726|FG000|Overall Study|Lost to Follow-up|3|||
164205942|NCT03533751|593122727|FG001|Overall Study|Lost to Follow-up|7|||
164205943|NCT03533751|593122728|FG002|Overall Study|Lost to Follow-up|6|||
164205944|NCT03533751|593122729|FG003|Overall Study|Lost to Follow-up|4|||
164205945|NCT03533751|593122730|FG004|Overall Study|Lost to Follow-up|3|||
164205946|NCT03533751|593122726|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
164205947|NCT03533751|593122727|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
164205948|NCT03533751|593122728|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
164205949|NCT03533751|593122729|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
164205950|NCT03533751|593122730|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
164205951|NCT03533751|593122726|FG000|Overall Study|Other|0|||
164205952|NCT03533751|593122727|FG001|Overall Study|Other|2|||
164205953|NCT03533751|593122728|FG002|Overall Study|Other|1|||
164205954|NCT03533751|593122729|FG003|Overall Study|Other|0|||
164205955|NCT03533751|593122730|FG004|Overall Study|Other|3|||
164205956|NCT01884597|593122732|FG000|Overall Study|Adverse Event|0|||
164205957|NCT01884597|593122733|FG001|Overall Study|Adverse Event|0|||
164666706|NCT01494506|594804642|FG001|Overall Study|Clinical Deterioration|17|||
164666707|NCT01494506|594804643|FG002|Overall Study|Clinical Deterioration|13|||
164318547|NCT03560518|593542098|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
164318548|NCT03560518|593542099|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
164318549|NCT03560518|593542100|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
164318550|NCT03560518|593542098|FG000|Double Blind Treatment Period|Protocol Violation|1|||
164318551|NCT03560518|593542099|FG001|Double Blind Treatment Period|Protocol Violation|2|||
164318552|NCT03560518|593542100|FG002|Double Blind Treatment Period|Protocol Violation|0|||
164318553|NCT03560518|593542098|FG000|Double Blind Treatment Period|Pregnancy|0|||
164318554|NCT03560518|593542099|FG001|Double Blind Treatment Period|Pregnancy|2|||
164318555|NCT03560518|593542100|FG002|Double Blind Treatment Period|Pregnancy|0|||
164318556|NCT03560518|593542098|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
164318557|NCT03560518|593542099|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
164318558|NCT03560518|593542100|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
164318559|NCT03560518|593542098|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
164318560|NCT03560518|593542099|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
164318561|NCT03560518|593542100|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
164318562|NCT03560518|593542098|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
164318563|NCT03560518|593542099|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
164318564|NCT03560518|593542100|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
164318565|NCT03560518|593542098|FG000|Double Blind Treatment Period|Adverse Event|0|||
164318566|NCT03560518|593542099|FG001|Double Blind Treatment Period|Adverse Event|3|||
164318567|NCT03560518|593542100|FG002|Double Blind Treatment Period|Adverse Event|1|||
164318568|NCT00958438|593542102|FG000|Overall Study|Protocol Violation|3|||
164318569|NCT00958438|593542103|FG001|Overall Study|Protocol Violation|2|||
164318570|NCT00958438|593542104|FG002|Overall Study|Protocol Violation|2|||
164318571|NCT00958438|593542102|FG000|Overall Study|Withdrawal by Subject|4|||
164318572|NCT00958438|593542103|FG001|Overall Study|Withdrawal by Subject|2|||
164318573|NCT00958438|593542104|FG002|Overall Study|Withdrawal by Subject|1|||
164318574|NCT00958438|593542102|FG000|Overall Study|Adverse Event|0|||
164318575|NCT00958438|593542103|FG001|Overall Study|Adverse Event|3|||
164318576|NCT00958438|593542104|FG002|Overall Study|Adverse Event|0|||
164318577|NCT00958438|593542102|FG000|Overall Study|Physician Decision|1|||
164318578|NCT00958438|593542103|FG001|Overall Study|Physician Decision|0|||
164318579|NCT00958438|593542104|FG002|Overall Study|Physician Decision|1|||
164318580|NCT00958438|593542102|FG000|Overall Study|Other than specified above|2|||
164318581|NCT00958438|593542103|FG001|Overall Study|Other than specified above|3|||
164318582|NCT00958438|593542104|FG002|Overall Study|Other than specified above|2|||
164318583|NCT02788279|593542105|FG000|Overall Study|Death|62|||
164318584|NCT02788279|593542106|FG001|Overall Study|Death|136|||
164318585|NCT02788279|593542107|FG002|Overall Study|Death|72|||
164318586|NCT02788279|593542105|FG000|Overall Study|Withdrawal by Subject|10|||
164318587|NCT02788279|593542106|FG001|Overall Study|Withdrawal by Subject|15|||
164318588|NCT02788279|593542107|FG002|Overall Study|Withdrawal by Subject|5|||
164318589|NCT02788279|593542105|FG000|Overall Study|Lost to Follow-up|0|||
164318590|NCT02788279|593542106|FG001|Overall Study|Lost to Follow-up|3|||
164318591|NCT02788279|593542107|FG002|Overall Study|Lost to Follow-up|2|||
164666708|NCT01494506|594804641|FG000|Overall Study|Sponsor Decision|0|||
164666709|NCT01494506|594804642|FG001|Overall Study|Sponsor Decision|0|||
164666710|NCT01494506|594804643|FG002|Overall Study|Sponsor Decision|1|||
164666711|NCT01494506|594804641|FG000|Overall Study|Other|0|||
164666712|NCT01494506|594804642|FG001|Overall Study|Other|3|||
164666713|NCT01494506|594804643|FG002|Overall Study|Other|1|||
164666714|NCT02127281|594804644|FG000|Overall Study|Lost to Follow-up|1|||
164666715|NCT02127281|594804645|FG001|Overall Study|Lost to Follow-up|0|||
164666716|NCT04349917|594804653|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
164666717|NCT04349917|594804654|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
164666718|NCT04349917|594804653|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
164318592|NCT02788279|593542105|FG000|Overall Study|Sponsor decision|18|||
164318593|NCT02788279|593542106|FG001|Overall Study|Sponsor decision|29|||
164318594|NCT02788279|593542107|FG002|Overall Study|Sponsor decision|11|||
164318595|NCT00329849|593542108|FG000|Overall Study|Withdrawal by Subject|6|||
164318596|NCT00329849|593542109|FG001|Overall Study|Withdrawal by Subject|4|||
164318597|NCT05277337|593542114|FG000|Overall Study|Lost to Follow-up|2|||
164318598|NCT05277337|593542115|FG001|Overall Study|Lost to Follow-up|0|||
164666719|NCT04349917|594804654|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
164666720|NCT00441467|594804660|FG000|Overall Study|Adverse Event|6|||
164666721|NCT00441467|594804660|FG000|Overall Study|Withdrawal by Subject|3|||
164666722|NCT00441467|594804660|FG000|Overall Study|Progressive disease|9|||
164666723|NCT01042522|594804662|FG000|Overall Study|Adverse Event|1|||
164666724|NCT01042522|594804663|FG001|Overall Study|Adverse Event|2|||
164666725|NCT01042522|594804662|FG000|Overall Study|Disease Progression|5|||
164666726|NCT01042522|594804663|FG001|Overall Study|Disease Progression|0|||
164318599|NCT05277337|593542114|FG000|Overall Study|Withdrawal by Subject|1|||
164318600|NCT05277337|593542115|FG001|Overall Study|Withdrawal by Subject|0|||
164318601|NCT01185301|593542116|FG000|Overall Study|Adverse Event|3|||
164318602|NCT01185301|593542117|FG001|Overall Study|Adverse Event|0|||
164666727|NCT01042522|594804662|FG000|Overall Study|Death|1|||
164318603|NCT01185301|593542118|FG002|Overall Study|Adverse Event|2|||
164318604|NCT01185301|593542119|FG003|Overall Study|Adverse Event|3|||
164318605|NCT01185301|593542116|FG000|Overall Study|Withdrawal by Subject|7|||
164318606|NCT01185301|593542117|FG001|Overall Study|Withdrawal by Subject|5|||
164318607|NCT01185301|593542118|FG002|Overall Study|Withdrawal by Subject|2|||
164318608|NCT01185301|593542119|FG003|Overall Study|Withdrawal by Subject|3|||
164318609|NCT01185301|593542116|FG000|Overall Study|Lost to Follow-up|2|||
164318610|NCT01185301|593542117|FG001|Overall Study|Lost to Follow-up|0|||
164318611|NCT01185301|593542118|FG002|Overall Study|Lost to Follow-up|0|||
164318612|NCT01185301|593542119|FG003|Overall Study|Lost to Follow-up|1|||
164318613|NCT01185301|593542116|FG000|Overall Study|Other Reason|3|||
164318614|NCT01185301|593542117|FG001|Overall Study|Other Reason|2|||
164318615|NCT01185301|593542118|FG002|Overall Study|Other Reason|2|||
164318616|NCT01185301|593542119|FG003|Overall Study|Other Reason|2|||
164318617|NCT04987944|593542120|FG000|Overall Study|Adverse Event|0|||
164318618|NCT04987944|593542121|FG001|Overall Study|Adverse Event|1|||
164318619|NCT04987944|593542120|FG000|Overall Study|Withdrawal by Subject|0|||
164318620|NCT04987944|593542121|FG001|Overall Study|Withdrawal by Subject|1|||
164318621|NCT00409175|593542126|FG000|Overall Study|Adverse Event|4|||
164318622|NCT00409175|593542127|FG001|Overall Study|Adverse Event|3|||
164318623|NCT00409175|593542126|FG000|Overall Study|Withdrawal by Subject|1|||
164318624|NCT00409175|593542127|FG001|Overall Study|Withdrawal by Subject|2|||
164318625|NCT00409175|593542126|FG000|Overall Study|Negative genotype|0|||
164318626|NCT00409175|593542127|FG001|Overall Study|Negative genotype|1|||
164318627|NCT00409175|593542126|FG000|Overall Study|Liver transplantation|13|||
164318628|NCT00409175|593542127|FG001|Overall Study|Liver transplantation|13|||
164318629|NCT03339297|593542130|FG000|Overall Study|Relapse of Hematologic Disease|1|||
164318630|NCT03339297|593542131|FG001|Overall Study|Relapse of Hematologic Disease|0|||
164318631|NCT03339297|593542130|FG000|Overall Study|Death|10|||
164318632|NCT03339297|593542131|FG001|Overall Study|Death|7|||
164318633|NCT03339297|593542130|FG000|Overall Study|Hepatic Candidosis|1|||
164318634|NCT03339297|593542131|FG001|Overall Study|Hepatic Candidosis|0|||
164318635|NCT03339297|593542130|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
164318636|NCT03339297|593542131|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
164318637|NCT03339297|593542130|FG000|Overall Study|Consent Withdrawn by Participant|3|||
164318638|NCT03339297|593542131|FG001|Overall Study|Consent Withdrawn by Participant|3|||
164318639|NCT03339297|593542130|FG000|Overall Study|Disease Relapse|2|||
164318640|NCT03339297|593542131|FG001|Overall Study|Disease Relapse|0|||
164318641|NCT03339297|593542130|FG000|Overall Study|Physician Decision|1|||
164318642|NCT03339297|593542131|FG001|Overall Study|Physician Decision|1|||
164318643|NCT03339297|593542130|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
164318644|NCT03339297|593542131|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
164318645|NCT03339297|593542130|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
164318646|NCT03339297|593542131|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
164318647|NCT03339297|593542130|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
164318648|NCT03339297|593542131|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
164318649|NCT03339297|593542130|FG000|Overall Study|Adverse Event, Non-fatal|1|||
164318650|NCT03339297|593542131|FG001|Overall Study|Adverse Event, Non-fatal|0|||
164318651|NCT03339297|593542130|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
164318652|NCT03339297|593542131|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
164318653|NCT03339297|593542130|FG000|Overall Study|Patient Was Not Eligible|1|||
164318654|NCT03339297|593542131|FG001|Overall Study|Patient Was Not Eligible|0|||
164318655|NCT03726996|593542132|FG000|Overall Study|Parent's decision|2|||
164318656|NCT03726996|593542132|FG000|Overall Study|Study early termination|2|||
164318657|NCT03531632|593542137|FG000|Overall Study|Adverse Event|0|||
164318658|NCT03531632|593542138|FG001|Overall Study|Adverse Event|0|||
164318659|NCT03531632|593542139|FG002|Overall Study|Adverse Event|1|||
164318660|NCT03531632|593542137|FG000|Overall Study|Death|4|||
164318661|NCT03531632|593542138|FG001|Overall Study|Death|0|||
164318662|NCT03531632|593542139|FG002|Overall Study|Death|14|||
164318663|NCT03531632|593542137|FG000|Overall Study|Study Terminated|1|||
164318664|NCT03531632|593542138|FG001|Overall Study|Study Terminated|3|||
164318665|NCT03531632|593542139|FG002|Overall Study|Study Terminated|11|||
164318666|NCT03241368|593542144|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
164318667|NCT03241368|593542144|FG000|Overall Study|Lost to Follow-up|1|||
164562372|NCT01262976|594427466|FG000|Up to Year 3|Subjects with unknown completion status|0|||
164318668|NCT03241368|593542144|FG000|Overall Study|Physician Decision|6|||
164318669|NCT03241368|593542144|FG000|Overall Study|Withdrawal by Subject|6|||
164318670|NCT03241368|593542144|FG000|Overall Study|Protocol Violation|1|||
164562373|NCT01262976|594427467|FG001|Up to Year 3|Subjects with unknown completion status|0|||
164318671|NCT01119937|593542145|FG000|Overall Study|Adverse Event|11|||
164318672|NCT01119937|593542146|FG001|Overall Study|Adverse Event|5|||
164318673|NCT01119937|593542145|FG000|Overall Study|Protocol deviation|3|||
164318674|NCT01119937|593542146|FG001|Overall Study|Protocol deviation|1|||
164318675|NCT01119937|593542145|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
164318676|NCT01119937|593542146|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164318677|NCT01119937|593542145|FG000|Overall Study|Withdrawal by Subject|2|||
164318678|NCT01119937|593542146|FG001|Overall Study|Withdrawal by Subject|1|||
164318679|NCT01566214|593542147|FG000|Overall Study|Lost to Follow-up|3|||
164318680|NCT01566214|593542148|FG001|Overall Study|Lost to Follow-up|0|||
164318681|NCT02112045|593542151|FG000|Overall Study|Withdrawal by Subject|1|||
164318682|NCT02112045|593542152|FG001|Overall Study|Withdrawal by Subject|0|||
164318683|NCT00627445|593542153|FG000|Overall Study|Adverse Event|3|||
164318684|NCT00627445|593542154|FG001|Overall Study|Adverse Event|3|||
164318685|NCT00627445|593542153|FG000|Overall Study|Lack of Efficacy|0|||
164318686|NCT00627445|593542154|FG001|Overall Study|Lack of Efficacy|1|||
164318687|NCT00627445|593542153|FG000|Overall Study|Other|6|||
164318688|NCT00627445|593542154|FG001|Overall Study|Other|8|||
164318689|NCT03554486|593542157|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
164318690|NCT03554486|593542158|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
164318691|NCT03554486|593542159|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
164318692|NCT03554486|593542157|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
164318693|NCT03554486|593542158|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
164318694|NCT03554486|593542159|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
164318695|NCT03554486|593542157|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
164318696|NCT03554486|593542158|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
164318697|NCT03554486|593542159|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
164318698|NCT01616693|593542162|FG000|Evaluated for Safety|Physician Decision|1|||
164318699|NCT01616693|593542163|FG001|Evaluated for Safety|Physician Decision|0|||
164318700|NCT01616693|593542164|FG002|Evaluated for Safety|Physician Decision|1|||
164318701|NCT01616693|593542165|FG003|Evaluated for Safety|Physician Decision|0|||
164318702|NCT01616693|593542162|FG000|Received Both Vaccines|Adverse Event|2|||
164318703|NCT01616693|593542163|FG001|Received Both Vaccines|Adverse Event|0|||
164318704|NCT01616693|593542164|FG002|Received Both Vaccines|Adverse Event|0|||
164318705|NCT01616693|593542165|FG003|Received Both Vaccines|Adverse Event|0|||
164318706|NCT01616693|593542162|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
164318707|NCT01616693|593542163|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
164318708|NCT01616693|593542164|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
164318709|NCT01616693|593542165|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
164318710|NCT01616693|593542162|FG000|Received Both Vaccines|Lost to Follow-up|4|||
164318711|NCT01616693|593542163|FG001|Received Both Vaccines|Lost to Follow-up|3|||
164318712|NCT01616693|593542164|FG002|Received Both Vaccines|Lost to Follow-up|4|||
164318713|NCT01616693|593542165|FG003|Received Both Vaccines|Lost to Follow-up|4|||
164318714|NCT01616693|593542162|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
164318715|NCT01616693|593542163|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
164318716|NCT01616693|593542164|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
164318717|NCT01616693|593542165|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
164318718|NCT00321646|593542167|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
164318719|NCT00321646|593542167|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
164318720|NCT00321646|593542167|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
164318721|NCT01008423|593542168|FG000|Overall Study|Adverse Event|13|||
164318722|NCT01008423|593542169|FG001|Overall Study|Adverse Event|6|||
164318723|NCT01008423|593542168|FG000|Overall Study|Withdrawal by Subject|4|||
164318724|NCT01008423|593542169|FG001|Overall Study|Withdrawal by Subject|7|||
164318725|NCT01008423|593542168|FG000|Overall Study|Lost to Follow-up|0|||
164318726|NCT01008423|593542169|FG001|Overall Study|Lost to Follow-up|2|||
164318727|NCT01008423|593542168|FG000|Overall Study|Low Cortisol|0|||
164318728|NCT01008423|593542169|FG001|Overall Study|Low Cortisol|1|||
164318729|NCT01008423|593542168|FG000|Overall Study|Lack of Efficacy|0|||
164318730|NCT01008423|593542169|FG001|Overall Study|Lack of Efficacy|5|||
164318731|NCT01008423|593542168|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
164562374|NCT01262976|594427468|FG002|Up to Year 3|Subjects with unknown completion status|1|||
164562375|NCT01262976|594427469|FG003|Up to Year 3|Subjects with unknown completion status|0|||
164562376|NCT01262976|594427470|FG004|Up to Year 3|Subjects with unknown completion status|0|||
164562377|NCT01262976|594427471|FG005|Up to Year 3|Subjects with unknown completion status|0|||
164562378|NCT01262976|594427466|FG000|Up to Year 3|Other|3|||
164562379|NCT01262976|594427467|FG001|Up to Year 3|Other|0|||
164562380|NCT01262976|594427468|FG002|Up to Year 3|Other|0|||
164562381|NCT01262976|594427469|FG003|Up to Year 3|Other|0|||
164562382|NCT01262976|594427470|FG004|Up to Year 3|Other|0|||
164562383|NCT01262976|594427471|FG005|Up to Year 3|Other|0|||
164562384|NCT03433781|594427472|FG000|Overall Study|Progression of Disease|1|||
164562385|NCT03433781|594427473|FG001|Overall Study|Progression of Disease|0|||
164562386|NCT03433781|594427474|FG002|Overall Study|Progression of Disease|0|||
164318732|NCT01008423|593542169|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
164318733|NCT01008423|593542168|FG000|Overall Study|Personal Conflict|1|||
164318734|NCT01008423|593542169|FG001|Overall Study|Personal Conflict|0|||
164318735|NCT01008423|593542168|FG000|Overall Study|Other|0|||
164318736|NCT01008423|593542169|FG001|Overall Study|Other|1|||
164318737|NCT02034409|593542171|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
164562387|NCT03433781|594427472|FG000|Overall Study|Physician Decision|0|||
164562388|NCT03433781|594427473|FG001|Overall Study|Physician Decision|1|||
164562389|NCT03433781|594427474|FG002|Overall Study|Physician Decision|0|||
164562390|NCT02809833|594427475|FG000|Overall Study|Death|3|||
164562391|NCT02809833|594427475|FG000|Overall Study|Intolerance|54|||
164562392|NCT02809833|594427475|FG000|Overall Study|Lack of Efficacy|89|||
164562393|NCT02809833|594427475|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
164562394|NCT02809833|594427475|FG000|Overall Study|Noncompliance|1|||
164562395|NCT02809833|594427475|FG000|Overall Study|Withdrawal by Subject|34|||
164562396|NCT02809833|594427475|FG000|Overall Study|Lost to Follow-up|35|||
164562397|NCT02809833|594427475|FG000|Overall Study|Adverse Event (AE)|24|||
164666728|NCT01042522|594804663|FG001|Overall Study|Death|0|||
164666729|NCT01042522|594804662|FG000|Overall Study|Patient Refused|0|||
164666730|NCT01042522|594804663|FG001|Overall Study|Patient Refused|3|||
164666731|NCT01042522|594804662|FG000|Overall Study|Withdrawal by Subject|1|||
164666732|NCT01042522|594804663|FG001|Overall Study|Withdrawal by Subject|1|||
164666733|NCT00088829|594804671|FG000|Overall Study|PI left institution and study was close|22|||
164666734|NCT02419313|594804672|FG000|First Intervention|Lost to Follow-up|2|||
164666735|NCT02419313|594804673|FG001|First Intervention|Lost to Follow-up|0|||
164205958|NCT01884597|593122734|FG002|Overall Study|Adverse Event|1|||
164666736|NCT02419313|594804672|FG000|Second Intervention|Lost to Follow-up|1|||
164666737|NCT02419313|594804673|FG001|Second Intervention|Lost to Follow-up|0|||
164666738|NCT00322491|594804676|FG000|Overall Study|Adverse Event|1|||
164666739|NCT00322491|594804677|FG001|Overall Study|Adverse Event|0|||
164666740|NCT00322491|594804676|FG000|Overall Study|Death|1|||
164666741|NCT00322491|594804677|FG001|Overall Study|Death|2|||
164666742|NCT00525590|594804683|FG000|Overall Study|Adverse Event|3|||
164562398|NCT02809833|594427475|FG000|Overall Study|Other|5|||
164562399|NCT02809833|594427475|FG000|Overall Study|Missing Information|52|||
164562400|NCT02971670|594427479|FG000|Overall Study|Withdrawal by Subject|4|||
164562401|NCT02971670|594427480|FG001|Overall Study|Withdrawal by Subject|1|||
164562402|NCT02971670|594427481|FG002|Overall Study|Withdrawal by Subject|1|||
164562403|NCT02971670|594427482|FG003|Overall Study|Withdrawal by Subject|2|||
164562404|NCT00379795|594427483|FG000|Overall Study|Death|31|||
164562405|NCT00379795|594427484|FG001|Overall Study|Death|8|||
164562406|NCT00379795|594427485|FG002|Overall Study|Death|6|||
164562407|NCT00379795|594427486|FG003|Overall Study|Death|4|||
164666743|NCT00525590|594804683|FG000|Overall Study|Physician Decision|3|||
164205959|NCT01884597|593122732|FG000|Overall Study|Lack of Efficacy|1|||
164205960|NCT01884597|593122733|FG001|Overall Study|Lack of Efficacy|0|||
164205961|NCT01884597|593122734|FG002|Overall Study|Lack of Efficacy|0|||
164205962|NCT01884597|593122732|FG000|Overall Study|Death|0|||
164205963|NCT01884597|593122733|FG001|Overall Study|Death|1|||
164205964|NCT01884597|593122734|FG002|Overall Study|Death|0|||
164205965|NCT05965752|593122735|FG000|Overall Study|Adverse Event|0|||
164205966|NCT05965752|593122736|FG001|Overall Study|Adverse Event|1|||
164205967|NCT05965752|593122737|FG002|Overall Study|Adverse Event|0|||
164205968|NCT05965752|593122738|FG003|Overall Study|Adverse Event|1|||
164205969|NCT05965752|593122739|FG004|Overall Study|Adverse Event|3|||
164205970|NCT05965752|593122735|FG000|Overall Study|Lost to Follow-up|2|||
164205971|NCT05965752|593122736|FG001|Overall Study|Lost to Follow-up|0|||
164205972|NCT05965752|593122737|FG002|Overall Study|Lost to Follow-up|1|||
164205973|NCT05965752|593122738|FG003|Overall Study|Lost to Follow-up|1|||
164205974|NCT05965752|593122739|FG004|Overall Study|Lost to Follow-up|1|||
164205975|NCT05965752|593122735|FG000|Overall Study|Withdrawal by Subject|2|||
164205976|NCT05965752|593122736|FG001|Overall Study|Withdrawal by Subject|2|||
164205977|NCT05965752|593122737|FG002|Overall Study|Withdrawal by Subject|1|||
164205978|NCT05965752|593122738|FG003|Overall Study|Withdrawal by Subject|5|||
164205979|NCT05965752|593122739|FG004|Overall Study|Withdrawal by Subject|0|||
164205980|NCT05965752|593122735|FG000|Overall Study|Disease Relapse|1|||
164205981|NCT05965752|593122736|FG001|Overall Study|Disease Relapse|0|||
164205982|NCT05965752|593122737|FG002|Overall Study|Disease Relapse|1|||
164205983|NCT05965752|593122738|FG003|Overall Study|Disease Relapse|0|||
164205984|NCT05965752|593122739|FG004|Overall Study|Disease Relapse|0|||
164205985|NCT05965752|593122735|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
164205986|NCT05965752|593122736|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
164205987|NCT05965752|593122737|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
164205988|NCT05965752|593122738|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
164205989|NCT05965752|593122739|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
164205990|NCT05965752|593122735|FG000|Overall Study|Unable to Return for Study Visits|0|||
164562408|NCT00379795|594427487|FG004|Overall Study|Death|7|||
164562409|NCT00379795|594427483|FG000|Overall Study|Adverse Event|17|||
164562410|NCT00379795|594427484|FG001|Overall Study|Adverse Event|3|||
164205991|NCT05965752|593122736|FG001|Overall Study|Unable to Return for Study Visits|1|||
164666744|NCT00525590|594804683|FG000|Overall Study|Withdrawal by Subject|16|||
164666745|NCT00525590|594804683|FG000|Overall Study|Lost to Follow-up|1|||
164562411|NCT00379795|594427485|FG002|Overall Study|Adverse Event|3|||
164562412|NCT00379795|594427486|FG003|Overall Study|Adverse Event|1|||
164666746|NCT00525590|594804683|FG000|Overall Study|Death|9|||
164666747|NCT00525590|594804683|FG000|Overall Study|Other|13|||
164666748|NCT03830164|594804688|FG000|Overall Study|Adverse Event|0|||
164666749|NCT03830164|594804689|FG001|Overall Study|Adverse Event|2|||
164666750|NCT03830164|594804690|FG002|Overall Study|Adverse Event|0|||
164666751|NCT03830164|594804688|FG000|Overall Study|Lack of Efficacy|1|||
164666752|NCT03830164|594804689|FG001|Overall Study|Lack of Efficacy|5|||
164666753|NCT03830164|594804690|FG002|Overall Study|Lack of Efficacy|0|||
164666754|NCT03830164|594804688|FG000|Overall Study|Lost to Follow-up|0|||
164666755|NCT03830164|594804689|FG001|Overall Study|Lost to Follow-up|1|||
164666756|NCT03830164|594804690|FG002|Overall Study|Lost to Follow-up|0|||
164666757|NCT03830164|594804688|FG000|Overall Study|Withdrawal by Subject|1|||
164666758|NCT03830164|594804689|FG001|Overall Study|Withdrawal by Subject|0|||
164666759|NCT03830164|594804690|FG002|Overall Study|Withdrawal by Subject|0|||
164666760|NCT04099888|594804691|FG000|Overall Study|Study terminated by sponsor|9|||
164666761|NCT04099888|594804692|FG001|Overall Study|Study terminated by sponsor|11|||
164666762|NCT04099888|594804691|FG000|Overall Study|Lost to Follow-up|1|||
164666763|NCT04099888|594804692|FG001|Overall Study|Lost to Follow-up|1|||
164666764|NCT04099888|594804691|FG000|Overall Study|Withdrawal by Subject|5|||
164666765|NCT04099888|594804692|FG001|Overall Study|Withdrawal by Subject|6|||
164666766|NCT04099888|594804691|FG000|Overall Study|Death|5|||
164666767|NCT04099888|594804692|FG001|Overall Study|Death|2|||
164666768|NCT04099888|594804691|FG000|Overall Study|Other|1|||
164666769|NCT04099888|594804692|FG001|Overall Study|Other|0|||
164666770|NCT01273181|594804698|FG000|Phase I, Dose 1|Study termination|1|||
164666771|NCT01273181|594804699|FG001|Phase I, Dose 1|Study termination|0|||
164666772|NCT01273181|594804700|FG002|Phase I, Dose 1|Study termination|0|||
164666773|NCT01273181|594804701|FG003|Phase I, Dose 1|Study termination|0|||
164205992|NCT05965752|593122737|FG002|Overall Study|Unable to Return for Study Visits|0|||
164205993|NCT05965752|593122738|FG003|Overall Study|Unable to Return for Study Visits|3|||
164205994|NCT05965752|593122739|FG004|Overall Study|Unable to Return for Study Visits|1|||
164205995|NCT05965752|593122735|FG000|Overall Study|Early Termination|0|||
164205996|NCT05965752|593122736|FG001|Overall Study|Early Termination|0|||
164205997|NCT05965752|593122737|FG002|Overall Study|Early Termination|1|||
164205998|NCT05965752|593122738|FG003|Overall Study|Early Termination|0|||
164205999|NCT05965752|593122739|FG004|Overall Study|Early Termination|0|||
164206000|NCT05965752|593122735|FG000|Overall Study|Reported Unwanted Symptoms|0|||
164206001|NCT05965752|593122736|FG001|Overall Study|Reported Unwanted Symptoms|0|||
164206002|NCT05965752|593122737|FG002|Overall Study|Reported Unwanted Symptoms|0|||
164206003|NCT05965752|593122738|FG003|Overall Study|Reported Unwanted Symptoms|0|||
164206004|NCT05965752|593122739|FG004|Overall Study|Reported Unwanted Symptoms|1|||
164206005|NCT05965752|593122735|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
164206006|NCT05965752|593122736|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
164206007|NCT05965752|593122737|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
164206008|NCT05965752|593122738|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
164206009|NCT05965752|593122739|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
164206010|NCT00834041|593122741|FG000|Overall Study|Withdrawal by Subject|1|||
164206011|NCT00834041|593122742|FG001|Overall Study|Withdrawal by Subject|0|||
164206012|NCT00834041|593122741|FG000|Overall Study|Lost to Follow-up|0|||
164206013|NCT00834041|593122742|FG001|Overall Study|Lost to Follow-up|1|||
164206014|NCT02634710|593122743|FG000|Overall Study|Death|4|||
164206015|NCT03454555|593124880|FG000|Overall Study|Death|6|||
164206016|NCT03454555|593124881|FG001|Overall Study|Death|6|||
164206017|NCT03454555|593124880|FG000|Overall Study|Lost to Follow-up|31|||
164206018|NCT03454555|593124881|FG001|Overall Study|Lost to Follow-up|12|||
164206019|NCT03454555|593124880|FG000|Overall Study|Physician Decision|2|||
164206020|NCT03454555|593124881|FG001|Overall Study|Physician Decision|6|||
164206021|NCT03454555|593124880|FG000|Overall Study|Withdrawal by Subject|34|||
164206022|NCT03454555|593124881|FG001|Overall Study|Withdrawal by Subject|5|||
164206023|NCT03454555|593124880|FG000|Overall Study|Ineligible|1|||
164206024|NCT03454555|593124881|FG001|Overall Study|Ineligible|5|||
164206025|NCT03834961|593124884|FG000|Overall Study|Lack of Efficacy|1|||
164206026|NCT03834961|593124885|FG001|Overall Study|Lack of Efficacy|1|||
164206027|NCT03834961|593124886|FG002|Overall Study|Lack of Efficacy|0|||
164206028|NCT03834961|593124884|FG000|Overall Study|Physician Decision|0|||
164206029|NCT03834961|593124885|FG001|Overall Study|Physician Decision|1|||
164206030|NCT03834961|593124886|FG002|Overall Study|Physician Decision|0|||
164206031|NCT05493111|593124887|FG000|Overall Study|Adverse Event|3|||
164206032|NCT05493111|593124888|FG001|Overall Study|Adverse Event|4|||
164206033|NCT05493111|593124887|FG000|Overall Study|Withdrawal of Consent|19|||
164206034|NCT05493111|593124888|FG001|Overall Study|Withdrawal of Consent|10|||
164206035|NCT05493111|593124887|FG000|Overall Study|Non-compliance|1|||
164206036|NCT05493111|593124888|FG001|Overall Study|Non-compliance|1|||
164206037|NCT05493111|593124887|FG000|Overall Study|Lost to Follow-up|8|||
164206038|NCT05493111|593124888|FG001|Overall Study|Lost to Follow-up|1|||
164206039|NCT05493111|593124887|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
164206040|NCT05493111|593124888|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
164206041|NCT05493111|593124887|FG000|Overall Study|Withdrawal by Subject|1|||
164206042|NCT05493111|593124888|FG001|Overall Study|Withdrawal by Subject|1|||
164666774|NCT01273181|594804698|FG000|Phase I, Dose 2|Death during treatment|0|||
164666775|NCT01273181|594804699|FG001|Phase I, Dose 2|Death during treatment|1|||
164666776|NCT01273181|594804700|FG002|Phase I, Dose 2|Death during treatment|0|||
164666777|NCT01273181|594804701|FG003|Phase I, Dose 2|Death during treatment|0|||
164666778|NCT01273181|594804698|FG000|Phase 2, Dose 1|Study termination|0|||
164666779|NCT01273181|594804699|FG001|Phase 2, Dose 1|Study termination|0|||
164666780|NCT01273181|594804700|FG002|Phase 2, Dose 1|Study termination|1|||
164666781|NCT01273181|594804701|FG003|Phase 2, Dose 1|Study termination|0|||
164666782|NCT01273181|594804698|FG000|Phase 2, Dose 2|Death during treatment|0|||
164666783|NCT01273181|594804699|FG001|Phase 2, Dose 2|Death during treatment|0|||
164666784|NCT01273181|594804700|FG002|Phase 2, Dose 2|Death during treatment|0|||
164666785|NCT01273181|594804701|FG003|Phase 2, Dose 2|Death during treatment|1|||
164206043|NCT01140906|593124891|FG000|Overall Study|Adverse Event|7|||
164206044|NCT01140906|593124892|FG001|Overall Study|Adverse Event|10|||
164206045|NCT01140906|593124893|FG002|Overall Study|Adverse Event|17|||
164206046|NCT01140906|593124894|FG003|Overall Study|Adverse Event|7|||
164206047|NCT01140906|593124891|FG000|Overall Study|Lack of Efficacy|6|||
164206048|NCT01140906|593124892|FG001|Overall Study|Lack of Efficacy|8|||
164206049|NCT01140906|593124893|FG002|Overall Study|Lack of Efficacy|2|||
164206050|NCT01140906|593124894|FG003|Overall Study|Lack of Efficacy|1|||
164206051|NCT01140906|593124891|FG000|Overall Study|Non-compliance|0|||
164206052|NCT01140906|593124892|FG001|Overall Study|Non-compliance|1|||
164206053|NCT01140906|593124893|FG002|Overall Study|Non-compliance|0|||
164206054|NCT01140906|593124894|FG003|Overall Study|Non-compliance|1|||
164206055|NCT01140906|593124891|FG000|Overall Study|Protocol Violation|5|||
164206056|NCT01140906|593124892|FG001|Overall Study|Protocol Violation|3|||
164206057|NCT01140906|593124893|FG002|Overall Study|Protocol Violation|2|||
164206058|NCT01140906|593124894|FG003|Overall Study|Protocol Violation|1|||
164206059|NCT01140906|593124891|FG000|Overall Study|Withdrawal of consent|6|||
164562413|NCT00379795|594427487|FG004|Overall Study|Adverse Event|4|||
164562414|NCT00379795|594427483|FG000|Overall Study|Lost to Follow-up|8|||
164562415|NCT00379795|594427484|FG001|Overall Study|Lost to Follow-up|1|||
164562416|NCT00379795|594427485|FG002|Overall Study|Lost to Follow-up|2|||
164562417|NCT00379795|594427486|FG003|Overall Study|Lost to Follow-up|1|||
164562418|NCT00379795|594427487|FG004|Overall Study|Lost to Follow-up|4|||
164562419|NCT00379795|594427483|FG000|Overall Study|Physician Decision|25|||
164562420|NCT00379795|594427484|FG001|Overall Study|Physician Decision|0|||
164562421|NCT00379795|594427485|FG002|Overall Study|Physician Decision|2|||
164562422|NCT00379795|594427486|FG003|Overall Study|Physician Decision|2|||
164562423|NCT00379795|594427487|FG004|Overall Study|Physician Decision|2|||
164666786|NCT04276883|594804702|FG000|Overall Study|Withdrawal by Subject|2|||
164206060|NCT01140906|593124892|FG001|Overall Study|Withdrawal of consent|6|||
164666787|NCT04276883|594804703|FG001|Overall Study|Withdrawal by Subject|3|||
164666788|NCT04276883|594804704|FG002|Overall Study|Withdrawal by Subject|6|||
164666789|NCT04276883|594804702|FG000|Overall Study|Lost to Follow-up|1|||
164666790|NCT04276883|594804703|FG001|Overall Study|Lost to Follow-up|3|||
164666791|NCT04276883|594804704|FG002|Overall Study|Lost to Follow-up|0|||
164666792|NCT04276883|594804702|FG000|Overall Study|Adverse Event|0|||
164666793|NCT04276883|594804703|FG001|Overall Study|Adverse Event|1|||
164666794|NCT04276883|594804704|FG002|Overall Study|Adverse Event|0|||
164666795|NCT04276883|594804702|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
164666796|NCT04276883|594804703|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
164666797|NCT04276883|594804704|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
164666798|NCT02458469|594804706|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
164666799|NCT02458469|594804707|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
164666800|NCT02458469|594804708|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
164666801|NCT02458469|594804709|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
164666802|NCT02458469|594804710|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
164666803|NCT02458469|594804711|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
164666804|NCT02458469|594804706|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
164666805|NCT02458469|594804707|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
164666806|NCT02458469|594804708|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
164666807|NCT02458469|594804709|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
164666808|NCT02458469|594804710|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
164666809|NCT02458469|594804711|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
164666810|NCT02458469|594804706|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
164666811|NCT02458469|594804707|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
164666812|NCT02458469|594804708|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
164666813|NCT02458469|594804709|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
164666814|NCT02458469|594804710|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
164666815|NCT02458469|594804711|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
164666816|NCT02603952|594804712|FG000|Overall Study|Withdrawal by Subject|1|||
164666817|NCT02603952|594804713|FG001|Overall Study|Withdrawal by Subject|0|||
164666818|NCT02603952|594804714|FG002|Overall Study|Withdrawal by Subject|0|||
164206061|NCT01140906|593124893|FG002|Overall Study|Withdrawal of consent|2|||
164562424|NCT00379795|594427483|FG000|Overall Study|Withdrawal by Subject|94|||
164666819|NCT02603952|594804715|FG003|Overall Study|Withdrawal by Subject|0|||
164666820|NCT02603952|594804712|FG000|Overall Study|Received oseltamivir by error|0|||
164666821|NCT02603952|594804713|FG001|Overall Study|Received oseltamivir by error|0|||
164666822|NCT02603952|594804714|FG002|Overall Study|Received oseltamivir by error|0|||
164318738|NCT02034409|593542172|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
164318739|NCT02034409|593542171|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
164318740|NCT02034409|593542172|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
164318741|NCT02034409|593542171|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
164318742|NCT02034409|593542172|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
164318743|NCT02034409|593542171|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
164318744|NCT02034409|593542172|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
164318745|NCT02034409|593542171|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
164318746|NCT02034409|593542172|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
164318747|NCT02034409|593542171|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
164318748|NCT02034409|593542172|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
164318749|NCT02342418|593542173|FG000|Overall Study|Adverse Event|0|||
164318750|NCT02342418|593542174|FG001|Overall Study|Adverse Event|1|||
164318751|NCT01699867|593542175|FG000|Overall Study|Screening Failure|3|||
164666823|NCT02603952|594804715|FG003|Overall Study|Received oseltamivir by error|1|||
164318752|NCT04255394|593542176|FG000|Overall Study|Death|35|||
164318753|NCT04255394|593542177|FG001|Overall Study|Death|25|||
164318754|NCT04255394|593542176|FG000|Overall Study|Device removed|2|||
164318755|NCT04255394|593542177|FG001|Overall Study|Device removed|10|||
164318756|NCT04255394|593542176|FG000|Overall Study|Withdrawal by Subject|9|||
164318757|NCT04255394|593542177|FG001|Overall Study|Withdrawal by Subject|8|||
164318758|NCT04255394|593542176|FG000|Overall Study|Screen Failure/Not treated|12|||
164318759|NCT04255394|593542177|FG001|Overall Study|Screen Failure/Not treated|8|||
164318760|NCT04255394|593542176|FG000|Overall Study|Lost to Follow-up|123|||
164318761|NCT04255394|593542177|FG001|Overall Study|Lost to Follow-up|265|||
164318762|NCT04255394|593542176|FG000|Overall Study|Adverse Event|1|||
164318763|NCT04255394|593542177|FG001|Overall Study|Adverse Event|3|||
164318764|NCT01375075|593542184|FG000|Overall Study|Adverse Event|0|||
164318765|NCT01375075|593542185|FG001|Overall Study|Adverse Event|0|||
164318766|NCT01375075|593542186|FG002|Overall Study|Adverse Event|3|||
164318767|NCT01375075|593542187|FG003|Overall Study|Adverse Event|1|||
164318768|NCT01375075|593542188|FG004|Overall Study|Adverse Event|0|||
164318769|NCT01375075|593542189|FG005|Overall Study|Adverse Event|1|||
164318770|NCT01375075|593542184|FG000|Overall Study|Entry Criterion Not Met|1|||
164318771|NCT01375075|593542185|FG001|Overall Study|Entry Criterion Not Met|0|||
164318772|NCT01375075|593542186|FG002|Overall Study|Entry Criterion Not Met|0|||
164318773|NCT01375075|593542187|FG003|Overall Study|Entry Criterion Not Met|0|||
164318774|NCT01375075|593542188|FG004|Overall Study|Entry Criterion Not Met|0|||
164318775|NCT01375075|593542189|FG005|Overall Study|Entry Criterion Not Met|1|||
164318776|NCT01375075|593542184|FG000|Overall Study|Withdrawal by Subject|0|||
164318777|NCT01375075|593542185|FG001|Overall Study|Withdrawal by Subject|1|||
164318778|NCT01375075|593542186|FG002|Overall Study|Withdrawal by Subject|0|||
164318779|NCT01375075|593542187|FG003|Overall Study|Withdrawal by Subject|0|||
164318780|NCT01375075|593542188|FG004|Overall Study|Withdrawal by Subject|0|||
164318781|NCT01375075|593542189|FG005|Overall Study|Withdrawal by Subject|1|||
164318782|NCT00831493|593542190|FG000|Overall Study|Intractable nausea and vomiting|1|||
164318783|NCT00129311|593542197|FG000|Overall Study|Withdrawal by Subject|12|||
164318784|NCT00129311|593542198|FG001|Overall Study|Withdrawal by Subject|19|||
164318785|NCT01525225|593542201|FG000|Enrollment|No longer met study criteria|1|||
164318786|NCT01525225|593542201|FG000|Enrollment|Other|1|||
164318787|NCT01182844|593542202|FG000|Overall Study|Withdrawal by Subject|0|||
164318788|NCT01182844|593542203|FG001|Overall Study|Withdrawal by Subject|2|||
164318789|NCT01379508|593542204|FG000|Treatment to Week 104|Adverse Event|2|||
164318790|NCT01379508|593542205|FG001|Treatment to Week 104|Adverse Event|0|||
164318791|NCT01379508|593542206|FG002|Treatment to Week 104|Adverse Event|5|||
164318792|NCT01379508|593542207|FG003|Treatment to Week 104|Adverse Event|0|||
164666824|NCT00958243|594804719|FG000|Overall Study|Withdrawal by Subject|0|||
164666825|NCT00958243|594804720|FG001|Overall Study|Withdrawal by Subject|1|||
164666826|NCT00958243|594804721|FG002|Overall Study|Withdrawal by Subject|3|||
164318793|NCT01379508|593542204|FG000|Treatment to Week 104|Abnormal lab value|1|||
164318794|NCT01379508|593542205|FG001|Treatment to Week 104|Abnormal lab value|0|||
164318795|NCT01379508|593542206|FG002|Treatment to Week 104|Abnormal lab value|0|||
164318796|NCT01379508|593542207|FG003|Treatment to Week 104|Abnormal lab value|0|||
164318797|NCT01379508|593542204|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
164318798|NCT01379508|593542205|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
164318799|NCT01379508|593542206|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
164318800|NCT01379508|593542207|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
164318801|NCT01379508|593542204|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
164318802|NCT01379508|593542205|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
164318803|NCT01379508|593542206|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
164318804|NCT01379508|593542207|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
164318805|NCT01379508|593542204|FG000|Treatment to Week 104|Lost to Follow-up|5|||
164318806|NCT01379508|593542205|FG001|Treatment to Week 104|Lost to Follow-up|0|||
164318807|NCT01379508|593542206|FG002|Treatment to Week 104|Lost to Follow-up|3|||
164318808|NCT01379508|593542207|FG003|Treatment to Week 104|Lost to Follow-up|0|||
164318809|NCT01379508|593542204|FG000|Treatment to Week 104|Administrative problems|3|||
164318810|NCT01379508|593542205|FG001|Treatment to Week 104|Administrative problems|1|||
164318811|NCT01379508|593542206|FG002|Treatment to Week 104|Administrative problems|0|||
164318812|NCT01379508|593542207|FG003|Treatment to Week 104|Administrative problems|0|||
164318813|NCT01379508|593542204|FG000|Treatment to Week 104|Protocol Violation|1|||
164318814|NCT01379508|593542205|FG001|Treatment to Week 104|Protocol Violation|1|||
164318815|NCT01379508|593542206|FG002|Treatment to Week 104|Protocol Violation|1|||
164318816|NCT01379508|593542207|FG003|Treatment to Week 104|Protocol Violation|0|||
164318817|NCT01379508|593542204|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
164318818|NCT01379508|593542205|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
164318819|NCT01379508|593542206|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
164318820|NCT01379508|593542207|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
164318821|NCT01379508|593542204|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
164318822|NCT01379508|593542205|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
164318823|NCT01379508|593542206|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
164318824|NCT01379508|593542207|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
164318825|NCT01379508|593542204|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
164318826|NCT01379508|593542205|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
164318827|NCT01379508|593542206|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
164318828|NCT01379508|593542207|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
164318829|NCT01379508|593542204|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
164318830|NCT01379508|593542205|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
164318831|NCT01379508|593542206|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
164318832|NCT01379508|593542207|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
164206062|NCT01140906|593124894|FG003|Overall Study|Withdrawal of consent|2|||
164206063|NCT01140906|593124891|FG000|Overall Study|Lost to Follow-up|1|||
164206064|NCT01140906|593124892|FG001|Overall Study|Lost to Follow-up|1|||
164206065|NCT01140906|593124893|FG002|Overall Study|Lost to Follow-up|0|||
164206066|NCT01140906|593124894|FG003|Overall Study|Lost to Follow-up|2|||
164206067|NCT01140906|593124891|FG000|Overall Study|Administrative or other reason|0|||
164206068|NCT01140906|593124892|FG001|Overall Study|Administrative or other reason|5|||
164206069|NCT01140906|593124893|FG002|Overall Study|Administrative or other reason|3|||
164206070|NCT01140906|593124894|FG003|Overall Study|Administrative or other reason|2|||
164206071|NCT04889040|593124895|FG000|Overall Study|Withdrawal by Subject|3|||
164206072|NCT04889040|593124896|FG001|Overall Study|Withdrawal by Subject|3|||
164206073|NCT04889040|593124895|FG000|Overall Study|Lost to Follow-up|0|||
164206074|NCT04889040|593124896|FG001|Overall Study|Lost to Follow-up|1|||
164206075|NCT04889040|593124895|FG000|Overall Study|Adverse Event|2|||
164206076|NCT04889040|593124896|FG001|Overall Study|Adverse Event|1|||
164206077|NCT01155323|593124901|FG000|First Intervention|exclusion criteria|1|||
164206078|NCT01155323|593124902|FG001|First Intervention|exclusion criteria|1|||
164206079|NCT01155323|593124901|FG000|Second Intervention|Lost to Follow-up|1|||
164206080|NCT01155323|593124902|FG001|Second Intervention|Lost to Follow-up|1|||
164206081|NCT01208051|593124905|FG000|Total Enrollment|Withdrawal by Subject|0|||
164206082|NCT01208051|593124906|FG001|Total Enrollment|Withdrawal by Subject|1|||
164318833|NCT02055365|593544499|FG000|Overall Study|Prematurely Withdrawn|1|||
164318834|NCT03603509|593544503|FG000|Overall Study|Lost to Follow-up|3|||
164318835|NCT03603509|593544504|FG001|Overall Study|Lost to Follow-up|4|||
164318836|NCT02656680|593544507|FG000|Overall Study|Lost to Follow-up|0|||
164666827|NCT00958243|594804722|FG003|Overall Study|Withdrawal by Subject|1|||
164666828|NCT00958243|594804723|FG004|Overall Study|Withdrawal by Subject|1|||
164666829|NCT00958243|594804724|FG005|Overall Study|Withdrawal by Subject|5|||
164666830|NCT00958243|594804719|FG000|Overall Study|Lost to Follow-up|2|||
164206083|NCT01208051|593124907|FG002|Total Enrollment|Withdrawal by Subject|0|||
164206084|NCT01208051|593124908|FG003|Total Enrollment|Withdrawal by Subject|0|||
164206085|NCT01208051|593124909|FG004|Total Enrollment|Withdrawal by Subject|2|||
164206086|NCT01208051|593124905|FG000|Total Enrollment|Brain metastases|0|||
164206087|NCT01208051|593124906|FG001|Total Enrollment|Brain metastases|0|||
164206088|NCT01208051|593124907|FG002|Total Enrollment|Brain metastases|1|||
164206089|NCT01208051|593124908|FG003|Total Enrollment|Brain metastases|0|||
164206090|NCT01208051|593124909|FG004|Total Enrollment|Brain metastases|0|||
164206091|NCT02349386|593124910|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
164206092|NCT02349386|593124911|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
164206093|NCT02349386|593124912|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
164206094|NCT02349386|593124913|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
164206095|NCT02349386|593124910|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
164206096|NCT02349386|593124911|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
164206097|NCT02349386|593124912|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
164206098|NCT02349386|593124913|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
164206099|NCT02349386|593124910|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
164206100|NCT02349386|593124911|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
164206101|NCT02349386|593124912|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
164206102|NCT02349386|593124913|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
164206103|NCT02349386|593124910|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
164206104|NCT02349386|593124911|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
164206105|NCT02349386|593124912|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
164206106|NCT02349386|593124913|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
164206107|NCT02349386|593124910|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
164206108|NCT02349386|593124911|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
164206109|NCT02349386|593124912|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
164206110|NCT02349386|593124913|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
164206111|NCT02349386|593124910|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
164206112|NCT02349386|593124911|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
164206113|NCT02349386|593124912|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
164206114|NCT02349386|593124913|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
164206115|NCT00973973|593124914|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
164206116|NCT00973973|593124915|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
164206117|NCT00973973|593124914|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
164206118|NCT00973973|593124915|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
164206119|NCT00973973|593124914|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
164206120|NCT00973973|593124915|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
164206121|NCT00973973|593124914|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
164206122|NCT00973973|593124915|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
164206123|NCT00973973|593124914|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
164318837|NCT02656680|593544508|FG001|Overall Study|Lost to Follow-up|1|||
164562425|NCT00379795|594427484|FG001|Overall Study|Withdrawal by Subject|11|||
164562426|NCT00379795|594427485|FG002|Overall Study|Withdrawal by Subject|19|||
164562427|NCT00379795|594427486|FG003|Overall Study|Withdrawal by Subject|7|||
164562428|NCT00379795|594427487|FG004|Overall Study|Withdrawal by Subject|14|||
164562429|NCT00379795|594427483|FG000|Overall Study|Subject non-compliance|7|||
164562430|NCT00379795|594427484|FG001|Overall Study|Subject non-compliance|2|||
164562431|NCT00379795|594427485|FG002|Overall Study|Subject non-compliance|0|||
164562432|NCT00379795|594427486|FG003|Overall Study|Subject non-compliance|0|||
164562433|NCT00379795|594427487|FG004|Overall Study|Subject non-compliance|1|||
164562434|NCT00379795|594427483|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
164562435|NCT00379795|594427484|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
164562436|NCT00379795|594427485|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
164562437|NCT00379795|594427486|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
164562438|NCT00379795|594427487|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
164562439|NCT00379795|594427483|FG000|Overall Study|Subjects condition mandated intervention|34|||
164562440|NCT00379795|594427484|FG001|Overall Study|Subjects condition mandated intervention|9|||
164562441|NCT00379795|594427485|FG002|Overall Study|Subjects condition mandated intervention|7|||
164562442|NCT00379795|594427486|FG003|Overall Study|Subjects condition mandated intervention|5|||
164562443|NCT00379795|594427487|FG004|Overall Study|Subjects condition mandated intervention|7|||
164562444|NCT00379795|594427483|FG000|Overall Study|Sponsor's decision|257|||
164562445|NCT00379795|594427484|FG001|Overall Study|Sponsor's decision|17|||
164206124|NCT00973973|593124915|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
164206125|NCT00973973|593124914|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
164206126|NCT00973973|593124915|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
164206127|NCT00973973|593124914|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
164206128|NCT00973973|593124915|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
164206129|NCT00973973|593124914|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
164206130|NCT00973973|593124915|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
164206131|NCT00973973|593124914|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
164206132|NCT00973973|593124915|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
164206133|NCT00973973|593124914|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
164206134|NCT00973973|593124915|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
164206135|NCT00973973|593124914|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
164206136|NCT00973973|593124915|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
164206137|NCT00973973|593124914|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
164206138|NCT00973973|593124915|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
164206139|NCT02471339|593124916|FG000|Overall Study|Did not provide follow-up data|2|||
164206140|NCT02471339|593124917|FG001|Overall Study|Did not provide follow-up data|0|||
164206141|NCT06057064|593124918|FG000|Overall Study|Death|2|||
164206142|NCT06057064|593124919|FG001|Overall Study|Death|0|||
164206143|NCT06057064|593124918|FG000|Overall Study|Physician Decision|1|||
164206144|NCT06057064|593124919|FG001|Overall Study|Physician Decision|0|||
164206145|NCT06057064|593124918|FG000|Overall Study|Withdrawal by Subject|1|||
164206146|NCT06057064|593124919|FG001|Overall Study|Withdrawal by Subject|1|||
164206147|NCT00851591|593124921|FG000|Overall Study|Withdrawal by Subject|2|||
164206148|NCT00851591|593124922|FG001|Overall Study|Withdrawal by Subject|0|||
164206149|NCT02736617|593124925|FG000|Treatment|Adverse Event|1|||
164206150|NCT02736617|593124925|FG000|Treatment|Lack of Efficacy|1|||
164206151|NCT02736617|593124925|FG000|Treatment|Withdrawal by Subject|1|||
164206152|NCT02736617|593124925|FG000|Maintenance|Lack of Efficacy|4|||
164206153|NCT02736617|593124925|FG000|Maintenance|Physician Decision|1|||
164206154|NCT00481676|593124932|FG000|Overall Study|Adverse Event|0|||
164206155|NCT00481676|593124933|FG001|Overall Study|Adverse Event|1|||
164206156|NCT00481676|593124932|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164206157|NCT00481676|593124933|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
164206158|NCT00481676|593124932|FG000|Overall Study|Administrative problem|1|||
164206159|NCT00481676|593124933|FG001|Overall Study|Administrative problem|0|||
164206160|NCT02911116|593124934|FG000|Overall Study|Insufficient Therapeutic Response|1|||
164206161|NCT02911116|593124935|FG001|Overall Study|Insufficient Therapeutic Response|0|||
164206162|NCT02911116|593124934|FG000|Overall Study|Lost to Follow-up|0|||
164206163|NCT02911116|593124935|FG001|Overall Study|Lost to Follow-up|1|||
164206164|NCT01240694|593124936|FG000|Overall Study|Adverse Event|9|||
164206165|NCT01240694|593124936|FG000|Overall Study|Lack of Efficacy|6|||
164206166|NCT01240694|593124936|FG000|Overall Study|Withdrawal by Subject|6|||
164206167|NCT01240694|593124936|FG000|Overall Study|Protocol Violation|2|||
164206168|NCT01240694|593124936|FG000|Overall Study|Lost to Follow-up|2|||
164206169|NCT01240694|593124936|FG000|Overall Study|Other than specified|3|||
164206170|NCT01240694|593124936|FG000|Overall Study|Withdrawn due to early study termination|107|||
164206171|NCT01513590|593124937|FG000|Overall Study|Adverse Event|2|||
164206172|NCT01513590|593124938|FG001|Overall Study|Adverse Event|3|||
164206173|NCT01513590|593124937|FG000|Overall Study|Withdrawal Criteria|3|||
164206174|NCT01513590|593124938|FG001|Overall Study|Withdrawal Criteria|0|||
164206175|NCT01513590|593124937|FG000|Overall Study|Unclassified|5|||
164206176|NCT01513590|593124938|FG001|Overall Study|Unclassified|10|||
164206177|NCT02110693|593124939|FG000|Overall Study|Withdrawal by Subject|6|||
164206178|NCT02110693|593124940|FG001|Overall Study|Withdrawal by Subject|7|||
164206179|NCT02110693|593124939|FG000|Overall Study|skipped assessment|15|||
164206180|NCT02110693|593124940|FG001|Overall Study|skipped assessment|18|||
164206181|NCT02110693|593124939|FG000|Overall Study|technical difficulties|6|||
164206182|NCT02110693|593124940|FG001|Overall Study|technical difficulties|4|||
164206183|NCT02110693|593124939|FG000|Overall Study|Other|1|||
164206184|NCT02110693|593124940|FG001|Overall Study|Other|0|||
164318838|NCT02656680|593544509|FG002|Overall Study|Lost to Follow-up|7|||
164318839|NCT01258998|593544510|FG000|Overall Study|Ineligible|1|||
164666831|NCT00958243|594804720|FG001|Overall Study|Lost to Follow-up|5|||
164206185|NCT01056276|593124941|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
164206186|NCT01056276|593124942|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
164206187|NCT01056276|593124941|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
164206188|NCT01056276|593124942|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
164206189|NCT01056276|593124941|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
164206190|NCT01056276|593124942|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
164206191|NCT01056276|593124941|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
164206192|NCT01056276|593124942|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
164206193|NCT01056276|593124941|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
164318840|NCT01143389|593544511|FG000|Overall Study|Lost to Follow-up|26|||
164666832|NCT00958243|594804721|FG002|Overall Study|Lost to Follow-up|11|||
164666833|NCT00958243|594804722|FG003|Overall Study|Lost to Follow-up|2|||
164666834|NCT00958243|594804723|FG004|Overall Study|Lost to Follow-up|8|||
164666835|NCT00958243|594804724|FG005|Overall Study|Lost to Follow-up|5|||
164666836|NCT01004172|594804732|FG000|Overall Study|Progressive Disease in CNS Only|16|||
164666837|NCT01004172|594804732|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
164666838|NCT01004172|594804732|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
164666839|NCT01004172|594804732|FG000|Overall Study|Adverse Event|1|||
164206194|NCT01056276|593124942|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
164206195|NCT01056276|593124941|FG000|Treatment Period-Cycles 1-8|Death|3|||
164206196|NCT01056276|593124942|FG001|Treatment Period-Cycles 1-8|Death|1|||
164206197|NCT01056276|593124941|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
164206198|NCT01056276|593124942|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
164206199|NCT01056276|593124941|FG000|Maintenance Therapy|Toxicity|0|||
164206200|NCT01056276|593124942|FG001|Maintenance Therapy|Toxicity|2|||
164206201|NCT01056276|593124941|FG000|Maintenance Therapy|Progressive Disease|0|||
164206202|NCT01056276|593124942|FG001|Maintenance Therapy|Progressive Disease|9|||
164206203|NCT01056276|593124941|FG000|Maintenance Therapy|Physician Decision|0|||
164206204|NCT01056276|593124942|FG001|Maintenance Therapy|Physician Decision|1|||
164206205|NCT01056276|593124941|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
164206206|NCT01056276|593124942|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
164206207|NCT01056276|593124941|FG000|Maintenance Therapy|Intercurrent Illness|0|||
164206208|NCT01056276|593124942|FG001|Maintenance Therapy|Intercurrent Illness|1|||
164206209|NCT01056276|593124941|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
164206210|NCT01056276|593124942|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
164206211|NCT01881425|593124943|FG000|Overall Study|Death|5|||
164206212|NCT01881425|593124944|FG001|Overall Study|Death|1|||
164206213|NCT01881425|593124943|FG000|Overall Study|Withdrawal by Subject|8|||
164206214|NCT01881425|593124944|FG001|Overall Study|Withdrawal by Subject|3|||
164206215|NCT01881425|593124943|FG000|Overall Study|Physician Decision|2|||
164206216|NCT01881425|593124944|FG001|Overall Study|Physician Decision|1|||
164206217|NCT01881425|593124943|FG000|Overall Study|Adverse Event|3|||
164206218|NCT01881425|593124944|FG001|Overall Study|Adverse Event|0|||
164206219|NCT01881425|593124943|FG000|Overall Study|General Anesthesia panic attack|0|||
164206220|NCT01881425|593124944|FG001|Overall Study|General Anesthesia panic attack|1|||
164206221|NCT01881425|593124943|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
164206222|NCT01881425|593124944|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
164206223|NCT01881425|593124943|FG000|Overall Study|Lost to Follow-up|7|||
164206224|NCT01881425|593124944|FG001|Overall Study|Lost to Follow-up|2|||
164206225|NCT04154956|593124949|FG000|Overall Study|Death|109|||
164206226|NCT04154956|593124950|FG001|Overall Study|Death|110|||
164206227|NCT04154956|593124949|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
164206228|NCT04154956|593124950|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
164206229|NCT04154956|593124949|FG000|Overall Study|Withdrawal by Subject|1|||
164206230|NCT04154956|593124950|FG001|Overall Study|Withdrawal by Subject|7|||
164206231|NCT04154956|593124949|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
164206232|NCT04154956|593124950|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
164206233|NCT04424901|593124951|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
164206234|NCT04424901|593124952|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
164206235|NCT00147238|593124953|FG000|Overall Study|Inevaluable|8|||
164206236|NCT04810962|593124954|FG000|Overall Study|Adverse Event|0|||
164206237|NCT04810962|593124955|FG001|Overall Study|Adverse Event|1|||
164206238|NCT04810962|593124954|FG000|Overall Study|Lost to Follow-up|2|||
164206239|NCT04810962|593124955|FG001|Overall Study|Lost to Follow-up|1|||
164206240|NCT04810962|593124954|FG000|Overall Study|Physician Decision|1|||
164206241|NCT04810962|593124955|FG001|Overall Study|Physician Decision|0|||
164206242|NCT04810962|593124954|FG000|Overall Study|Withdrawal by Subject|1|||
164206243|NCT04810962|593124955|FG001|Overall Study|Withdrawal by Subject|3|||
164206244|NCT04810962|593124954|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
164206245|NCT04810962|593124955|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
164206246|NCT01348269|593124956|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
164206247|NCT01348269|593124957|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
164666840|NCT01004172|594804732|FG000|Overall Study|Physician Decision|1|||
164666841|NCT01004172|594804732|FG000|Overall Study|Symptomatic Deterioration|2|||
164206248|NCT01348269|593124956|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
164206249|NCT01348269|593124957|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
164206250|NCT01348269|593124956|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
164206251|NCT01348269|593124957|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
164206252|NCT00805532|593124958|FG000|Overall Study|invalid data|0|||
164206253|NCT00805532|593124959|FG001|Overall Study|invalid data|1|||
164206254|NCT00920816|593124960|FG000|Overall Study|Death|116|||
164206255|NCT00920816|593124961|FG001|Overall Study|Death|63|||
164206256|NCT00920816|593124962|FG002|Overall Study|Death|8|||
164206257|NCT00920816|593124963|FG003|Overall Study|Death|3|||
164206258|NCT00920816|593124960|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
164206259|NCT00920816|593124961|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
164206260|NCT00920816|593124962|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
164206261|NCT00920816|593124963|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
164318841|NCT01143389|593544512|FG001|Overall Study|Lost to Follow-up|25|||
164318842|NCT04966910|593544513|FG000|Baseline|Participant did not complete measure|0|||
164318843|NCT04966910|593544514|FG001|Baseline|Participant did not complete measure|0|||
164318844|NCT04966910|593544515|FG002|Baseline|Participant did not complete measure|1|||
164318845|NCT04966910|593544516|FG003|Baseline|Participant did not complete measure|0|||
164318846|NCT04966910|593544513|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
164318847|NCT04966910|593544514|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
164318848|NCT04966910|593544515|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
164318849|NCT04966910|593544516|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
164318850|NCT04966910|593544513|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
164318851|NCT04966910|593544514|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
164318852|NCT04966910|593544515|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
164318853|NCT04966910|593544516|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
164318854|NCT04966910|593544513|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
164318855|NCT04966910|593544514|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
164318856|NCT04966910|593544515|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
164318857|NCT04966910|593544516|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
164318858|NCT00002931|593544517|FG000|Overall Study|rapidly progressing disease during|2|||
164318859|NCT00504582|593544524|FG000|Overall Study|Lost to Follow-up|1|||
164318860|NCT00504582|593544525|FG001|Overall Study|Lost to Follow-up|0|||
164318861|NCT00504582|593544526|FG002|Overall Study|Lost to Follow-up|0|||
164318862|NCT02716896|593544527|FG000|Overall Study|Physician Decision|0|||
164318863|NCT02716896|593544528|FG001|Overall Study|Physician Decision|1|||
164666842|NCT00950872|594804733|FG000|Overall Study|Withdrawal by Subject|1|||
164206262|NCT00920816|593124960|FG000|Overall Study|Global deterioration of health status|2|||
164206263|NCT00920816|593124961|FG001|Overall Study|Global deterioration of health status|0|||
164206264|NCT00920816|593124962|FG002|Overall Study|Global deterioration of health status|0|||
164206265|NCT00920816|593124963|FG003|Overall Study|Global deterioration of health status|0|||
164206266|NCT00920816|593124960|FG000|Overall Study|Objective progression or relapse|6|||
164206267|NCT00920816|593124961|FG001|Overall Study|Objective progression or relapse|2|||
164206268|NCT00920816|593124962|FG002|Overall Study|Objective progression or relapse|0|||
164206269|NCT00920816|593124963|FG003|Overall Study|Objective progression or relapse|0|||
164206270|NCT00920816|593124960|FG000|Overall Study|Other|26|||
164206271|NCT00920816|593124961|FG001|Overall Study|Other|15|||
164206272|NCT00920816|593124962|FG002|Overall Study|Other|1|||
164206273|NCT00920816|593124963|FG003|Overall Study|Other|2|||
164206274|NCT00920816|593124960|FG000|Overall Study|Lost to Follow-up|11|||
164206275|NCT00920816|593124961|FG001|Overall Study|Lost to Follow-up|2|||
164206276|NCT00920816|593124962|FG002|Overall Study|Lost to Follow-up|0|||
164206277|NCT00920816|593124963|FG003|Overall Study|Lost to Follow-up|0|||
164206278|NCT00920816|593124960|FG000|Overall Study|Adverse Event|1|||
164206279|NCT00920816|593124961|FG001|Overall Study|Adverse Event|1|||
164206280|NCT00920816|593124962|FG002|Overall Study|Adverse Event|1|||
164206281|NCT00920816|593124963|FG003|Overall Study|Adverse Event|0|||
164206282|NCT00920816|593124960|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
164206283|NCT00920816|593124961|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
164206284|NCT00920816|593124962|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
164206285|NCT00920816|593124963|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
164206286|NCT00920816|593124960|FG000|Overall Study|Randomized but not treated|3|||
164206287|NCT00920816|593124961|FG001|Overall Study|Randomized but not treated|0|||
164206288|NCT00920816|593124962|FG002|Overall Study|Randomized but not treated|0|||
164206289|NCT00920816|593124963|FG003|Overall Study|Randomized but not treated|0|||
164206290|NCT01180777|593124964|FG000|Overall Study|Protocol Violation|6|||
164206291|NCT01180777|593124964|FG000|Overall Study|Poor lens fit|4|||
164206292|NCT01180777|593124964|FG000|Overall Study|Lost to Follow-up|1|||
164206293|NCT01180777|593124964|FG000|Overall Study|Adverse Event|1|||
164318864|NCT01757691|593544530|FG000|Overall Study|Administrative problems|2|||
164206294|NCT03185208|593124965|FG000|Overall Study|Did not start study medication|0|||
164206295|NCT03185208|593124966|FG001|Overall Study|Did not start study medication|3|||
164206296|NCT03834350|593124967|FG000|Overall Study|Withdrawal by Subject|1|||
164318865|NCT01757691|593544531|FG001|Overall Study|Administrative problems|0|||
164318866|NCT02054481|593544534|FG000|Overall Study|Adverse Event|1|||
164206297|NCT02765165|593124968|FG000|Treatment Period|Progressive disease|3|||
164206298|NCT02765165|593124969|FG001|Treatment Period|Progressive disease|2|||
164206299|NCT02765165|593124970|FG002|Treatment Period|Progressive disease|3|||
164206300|NCT02765165|593124971|FG003|Treatment Period|Progressive disease|3|||
164318867|NCT02054481|593544535|FG001|Overall Study|Adverse Event|1|||
164318868|NCT02054481|593544536|FG002|Overall Study|Adverse Event|0|||
164318869|NCT02054481|593544537|FG003|Overall Study|Adverse Event|1|||
164318870|NCT02054481|593544534|FG000|Overall Study|Lost to Follow-up|1|||
164318871|NCT02054481|593544535|FG001|Overall Study|Lost to Follow-up|0|||
164318872|NCT02054481|593544536|FG002|Overall Study|Lost to Follow-up|0|||
164318873|NCT02054481|593544537|FG003|Overall Study|Lost to Follow-up|0|||
164318874|NCT02054481|593544534|FG000|Overall Study|Other reason|2|||
164318875|NCT02054481|593544535|FG001|Overall Study|Other reason|1|||
164318876|NCT02054481|593544536|FG002|Overall Study|Other reason|2|||
164318877|NCT02054481|593544537|FG003|Overall Study|Other reason|0|||
164318878|NCT01713933|593544552|FG000|Overall Study|Lost to Follow-up|2|||
164318879|NCT01713933|593544552|FG000|Overall Study|Withdrawal by Subject|3|||
164318880|NCT01713933|593544552|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
164318881|NCT00528970|593544553|FG000|Overall Study|Adverse Event|6|||
164318882|NCT00528970|593544554|FG001|Overall Study|Adverse Event|8|||
164318883|NCT00528970|593544555|FG002|Overall Study|Adverse Event|5|||
164318884|NCT00528970|593544553|FG000|Overall Study|Lost to Follow-up|0|||
164318885|NCT00528970|593544554|FG001|Overall Study|Lost to Follow-up|0|||
164318886|NCT00528970|593544555|FG002|Overall Study|Lost to Follow-up|1|||
164318887|NCT00528970|593544553|FG000|Overall Study|Other than specified|2|||
164318888|NCT00528970|593544554|FG001|Overall Study|Other than specified|3|||
164318889|NCT00528970|593544555|FG002|Overall Study|Other than specified|3|||
164318890|NCT00528970|593544553|FG000|Overall Study|Protocol Violation|2|||
164318891|NCT00528970|593544554|FG001|Overall Study|Protocol Violation|1|||
164318892|NCT00528970|593544555|FG002|Overall Study|Protocol Violation|4|||
164318893|NCT00528970|593544553|FG000|Overall Study|Lack of Efficacy|0|||
164318894|NCT00528970|593544554|FG001|Overall Study|Lack of Efficacy|0|||
164318895|NCT00528970|593544555|FG002|Overall Study|Lack of Efficacy|1|||
164318896|NCT00528970|593544553|FG000|Overall Study|Withdrawal by Subject|4|||
164318897|NCT00528970|593544554|FG001|Overall Study|Withdrawal by Subject|3|||
164318898|NCT00528970|593544555|FG002|Overall Study|Withdrawal by Subject|5|||
164318899|NCT00528970|593544553|FG000|Overall Study|Randomized but not treated|0|||
164318900|NCT00528970|593544554|FG001|Overall Study|Randomized but not treated|0|||
164318901|NCT00528970|593544555|FG002|Overall Study|Randomized but not treated|1|||
164318902|NCT02882152|593544556|FG000|Overall Study|Lost to Follow-up|1|||
164318903|NCT02882152|593544557|FG001|Overall Study|Lost to Follow-up|0|||
164318904|NCT01104376|593544560|FG000|Overall Study|Withdrawal by Subject|15|||
164318905|NCT01104376|593544560|FG000|Overall Study|Consented but excluded after labs|13|||
164318906|NCT00797966|593544561|FG000|Phase A|Lost to Follow-up|0|||
164318907|NCT00797966|593544562|FG001|Phase A|Lost to Follow-up|0|||
164318908|NCT00797966|593544563|FG002|Phase A|Lost to Follow-up|0|||
164318909|NCT00797966|593544564|FG003|Phase A|Lost to Follow-up|0|||
164562446|NCT00379795|594427485|FG002|Overall Study|Sponsor's decision|54|||
164562447|NCT00379795|594427486|FG003|Overall Study|Sponsor's decision|47|||
164562448|NCT00379795|594427487|FG004|Overall Study|Sponsor's decision|10|||
164562449|NCT01127165|594427488|FG000|Overall Study|Adverse Event|2|||
164562450|NCT01127165|594427489|FG001|Overall Study|Adverse Event|2|||
164562451|NCT01127165|594427488|FG000|Overall Study|Lack of Efficacy|10|||
164562452|NCT01127165|594427489|FG001|Overall Study|Lack of Efficacy|8|||
164562453|NCT01127165|594427488|FG000|Overall Study|Lost to Follow-up|3|||
164562454|NCT01127165|594427489|FG001|Overall Study|Lost to Follow-up|5|||
164562455|NCT01127165|594427488|FG000|Overall Study|Withdrawal by Subject|1|||
164562456|NCT01127165|594427489|FG001|Overall Study|Withdrawal by Subject|3|||
164562457|NCT01127165|594427488|FG000|Overall Study|Protocol Violation|0|||
164562458|NCT01127165|594427489|FG001|Overall Study|Protocol Violation|1|||
164562459|NCT00763321|594427490|FG000|Open-label Period|Adverse Event|24|||
164562460|NCT00763321|594427491|FG001|Open-label Period|Adverse Event|0|||
164562461|NCT00763321|594427492|FG002|Open-label Period|Adverse Event|0|||
164562462|NCT00763321|594427490|FG000|Open-label Period|Lost to Follow-up|14|||
164666843|NCT00950872|594804733|FG000|Overall Study|Did not have surgery|2|||
164666844|NCT00970281|594804734|FG000|Overall Study|Lack of Efficacy|1|||
164666845|NCT00970281|594804735|FG001|Overall Study|Lack of Efficacy|14|||
164318910|NCT00797966|593544565|FG004|Phase A|Lost to Follow-up|33|||
164318911|NCT00797966|593544566|FG005|Phase A|Lost to Follow-up|0|||
164318912|NCT00797966|593544561|FG000|Phase A|Adverse Event|0|||
164318913|NCT00797966|593544562|FG001|Phase A|Adverse Event|0|||
164318914|NCT00797966|593544563|FG002|Phase A|Adverse Event|0|||
164318915|NCT00797966|593544564|FG003|Phase A|Adverse Event|0|||
164318916|NCT00797966|593544565|FG004|Phase A|Adverse Event|46|||
164318917|NCT00797966|593544566|FG005|Phase A|Adverse Event|0|||
164318918|NCT00797966|593544561|FG000|Phase A|Met withdrawal criteria|0|||
164318919|NCT00797966|593544562|FG001|Phase A|Met withdrawal criteria|0|||
164318920|NCT00797966|593544563|FG002|Phase A|Met withdrawal criteria|0|||
164318921|NCT00797966|593544564|FG003|Phase A|Met withdrawal criteria|0|||
164318922|NCT00797966|593544565|FG004|Phase A|Met withdrawal criteria|4|||
164318923|NCT00797966|593544566|FG005|Phase A|Met withdrawal criteria|0|||
164562463|NCT00763321|594427491|FG001|Open-label Period|Lost to Follow-up|0|||
164562464|NCT00763321|594427492|FG002|Open-label Period|Lost to Follow-up|0|||
164562465|NCT00763321|594427490|FG000|Open-label Period|Withdrawal by Subject|7|||
164562466|NCT00763321|594427491|FG001|Open-label Period|Withdrawal by Subject|0|||
164562467|NCT00763321|594427492|FG002|Open-label Period|Withdrawal by Subject|0|||
164562468|NCT00763321|594427490|FG000|Open-label Period|Subject noncompliant|7|||
164562469|NCT00763321|594427491|FG001|Open-label Period|Subject noncompliant|0|||
164562470|NCT00763321|594427492|FG002|Open-label Period|Subject noncompliant|0|||
164562471|NCT00763321|594427490|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
164562472|NCT00763321|594427491|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
164562473|NCT00763321|594427492|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
164562474|NCT00763321|594427490|FG000|Open-label Period|Lack of Efficacy|2|||
164562475|NCT00763321|594427491|FG001|Open-label Period|Lack of Efficacy|0|||
164562476|NCT00763321|594427492|FG002|Open-label Period|Lack of Efficacy|0|||
164562477|NCT00763321|594427490|FG000|Open-label Period|Other|4|||
164562478|NCT00763321|594427491|FG001|Open-label Period|Other|0|||
164562479|NCT00763321|594427492|FG002|Open-label Period|Other|0|||
164562480|NCT00763321|594427490|FG000|Double-blind Period|Lack of Efficacy|0|||
164562481|NCT00763321|594427491|FG001|Double-blind Period|Lack of Efficacy|9|||
164562482|NCT00763321|594427492|FG002|Double-blind Period|Lack of Efficacy|17|||
164562483|NCT00763321|594427490|FG000|Double-blind Period|Adverse Event|0|||
164562484|NCT00763321|594427491|FG001|Double-blind Period|Adverse Event|4|||
164562485|NCT00763321|594427492|FG002|Double-blind Period|Adverse Event|4|||
164562486|NCT00763321|594427490|FG000|Double-blind Period|Lost to Follow-up|0|||
164562487|NCT00763321|594427491|FG001|Double-blind Period|Lost to Follow-up|4|||
164562488|NCT00763321|594427492|FG002|Double-blind Period|Lost to Follow-up|2|||
164562489|NCT00763321|594427490|FG000|Double-blind Period|Withdrawal by Subject|0|||
164562490|NCT00763321|594427491|FG001|Double-blind Period|Withdrawal by Subject|2|||
164562491|NCT00763321|594427492|FG002|Double-blind Period|Withdrawal by Subject|3|||
164562492|NCT00763321|594427490|FG000|Double-blind Period|Other|0|||
164562493|NCT00763321|594427491|FG001|Double-blind Period|Other|2|||
164562494|NCT00763321|594427492|FG002|Double-blind Period|Other|3|||
164562495|NCT02486757|594427493|FG000|Overall Study|Lost to Follow-up|1|||
164562496|NCT02793232|594427494|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
164562497|NCT02793232|594427495|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
164562498|NCT02793232|594427496|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
164562499|NCT02793232|594427497|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
164562500|NCT02793232|594427498|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
164562501|NCT02793232|594427499|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
164562502|NCT02793232|594427500|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
164562503|NCT02793232|594427501|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
164562504|NCT02793232|594427502|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
164562505|NCT02387580|594427505|FG000|Overall Study|Withdrawal by Subject|0|||
164562506|NCT02387580|594427506|FG001|Overall Study|Withdrawal by Subject|0|||
164562507|NCT02387580|594427507|FG002|Overall Study|Withdrawal by Subject|0|||
164562508|NCT02387580|594427508|FG003|Overall Study|Withdrawal by Subject|1|||
164562509|NCT02387580|594427509|FG004|Overall Study|Withdrawal by Subject|0|||
164562510|NCT02387580|594427510|FG005|Overall Study|Withdrawal by Subject|0|||
164562511|NCT01064167|594427511|FG000|Overall Study|Protocol Violation|14|||
164562512|NCT01064167|594427512|FG001|Overall Study|Protocol Violation|15|||
164562513|NCT03984305|594427514|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
164562514|NCT03984305|594427515|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
164562515|NCT03984305|594427514|FG000|Overall Study|Withdrawal by Subject|3|||
164562516|NCT03984305|594427515|FG001|Overall Study|Withdrawal by Subject|3|||
164562517|NCT03984305|594427514|FG000|Overall Study|Lost to Follow-up|1|||
164562518|NCT03984305|594427515|FG001|Overall Study|Lost to Follow-up|0|||
164562519|NCT02883244|594427516|FG000|Overall Study|Lost to Follow-up|0|||
164562520|NCT02883244|594427517|FG001|Overall Study|Lost to Follow-up|1|||
164562521|NCT03979274|594427532|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164562522|NCT03979274|594427533|FG001|Treatment Period 2|Withdrawal by Subject|1|||
164562523|NCT02301403|594427534|FG000|Overall Study|Withdrawal by Subject|28|||
164562524|NCT02301403|594427535|FG001|Overall Study|Withdrawal by Subject|41|||
164562525|NCT01060059|594427536|FG000|Overall Study|Adverse Event|1|||
164562526|NCT01060059|594427537|FG001|Overall Study|Adverse Event|1|||
164666846|NCT00970281|594804734|FG000|Overall Study|Withdrawal by Subject|0|||
164666847|NCT00970281|594804735|FG001|Overall Study|Withdrawal by Subject|1|||
164318924|NCT00797966|593544561|FG000|Phase A|Physician Decision|0|||
164318925|NCT00797966|593544562|FG001|Phase A|Physician Decision|0|||
164318926|NCT00797966|593544563|FG002|Phase A|Physician Decision|0|||
164562527|NCT01060059|594427536|FG000|Overall Study|Death|2|||
164562528|NCT01060059|594427537|FG001|Overall Study|Death|3|||
164562529|NCT01060059|594427536|FG000|Overall Study|Lost to Follow-up|18|||
164562530|NCT01060059|594427537|FG001|Overall Study|Lost to Follow-up|34|||
164562531|NCT01060059|594427536|FG000|Overall Study|entry criteria not met|4|||
164562532|NCT01060059|594427537|FG001|Overall Study|entry criteria not met|3|||
164562533|NCT01060059|594427536|FG000|Overall Study|Withdrawal by Subject|35|||
164562534|NCT01060059|594427537|FG001|Overall Study|Withdrawal by Subject|23|||
164562535|NCT01060059|594427536|FG000|Overall Study|lack of glycemic control|2|||
164206301|NCT02765165|593124972|FG004|Treatment Period|Progressive disease|4|||
164206302|NCT02765165|593124973|FG005|Treatment Period|Progressive disease|2|||
164206303|NCT02765165|593124974|FG006|Treatment Period|Progressive disease|2|||
164206304|NCT02765165|593124968|FG000|Treatment Period|Physician Decision|0|||
164206305|NCT02765165|593124969|FG001|Treatment Period|Physician Decision|1|||
164206306|NCT02765165|593124970|FG002|Treatment Period|Physician Decision|0|||
164206307|NCT02765165|593124971|FG003|Treatment Period|Physician Decision|0|||
164206308|NCT02765165|593124972|FG004|Treatment Period|Physician Decision|0|||
164206309|NCT02765165|593124973|FG005|Treatment Period|Physician Decision|0|||
164206310|NCT02765165|593124974|FG006|Treatment Period|Physician Decision|0|||
164206311|NCT02765165|593124968|FG000|Treatment Period|Adverse Event|0|||
164206312|NCT02765165|593124969|FG001|Treatment Period|Adverse Event|1|||
164206313|NCT02765165|593124970|FG002|Treatment Period|Adverse Event|0|||
164562536|NCT01060059|594427537|FG001|Overall Study|lack of glycemic control|1|||
164562537|NCT01060059|594427536|FG000|Overall Study|lack of compliance|5|||
164562538|NCT01060059|594427537|FG001|Overall Study|lack of compliance|2|||
164562539|NCT02302963|594427538|FG000|Overall Study|Withdrawal by Subject|2|||
164562540|NCT02302963|594427539|FG001|Overall Study|Withdrawal by Subject|1|||
164562541|NCT02302963|594427538|FG000|Overall Study|Steroid injection|0|||
164562542|NCT02302963|594427539|FG001|Overall Study|Steroid injection|1|||
164562543|NCT02302963|594427538|FG000|Overall Study|Physician Decision|1|||
164562544|NCT02302963|594427539|FG001|Overall Study|Physician Decision|0|||
164562545|NCT01614093|594427542|FG000|Overall Study|Withdrawal by Subject|1|||
164589025|NCT01675531|594521355|FG000|Overall Study|Adverse Event|9|||
164666848|NCT00970281|594804734|FG000|Overall Study|Physician Decision|1|||
164666849|NCT00970281|594804735|FG001|Overall Study|Physician Decision|1|||
164318927|NCT00797966|593544564|FG003|Phase A|Physician Decision|0|||
164318928|NCT00797966|593544565|FG004|Phase A|Physician Decision|13|||
164318929|NCT00797966|593544566|FG005|Phase A|Physician Decision|0|||
164318930|NCT00797966|593544561|FG000|Phase A|Withdrawal by Subject|0|||
164318931|NCT00797966|593544562|FG001|Phase A|Withdrawal by Subject|0|||
164318932|NCT00797966|593544563|FG002|Phase A|Withdrawal by Subject|0|||
164318933|NCT00797966|593544564|FG003|Phase A|Withdrawal by Subject|0|||
164318934|NCT00797966|593544565|FG004|Phase A|Withdrawal by Subject|33|||
164318935|NCT00797966|593544566|FG005|Phase A|Withdrawal by Subject|0|||
164318936|NCT00797966|593544561|FG000|Phase A|Protocol deviation|0|||
164318937|NCT00797966|593544562|FG001|Phase A|Protocol deviation|0|||
164318938|NCT00797966|593544563|FG002|Phase A|Protocol deviation|0|||
164318939|NCT00797966|593544564|FG003|Phase A|Protocol deviation|0|||
164318940|NCT00797966|593544565|FG004|Phase A|Protocol deviation|56|||
164318941|NCT00797966|593544566|FG005|Phase A|Protocol deviation|0|||
164318942|NCT00797966|593544561|FG000|Phase B|Lost to Follow-up|0|||
164318943|NCT00797966|593544562|FG001|Phase B|Lost to Follow-up|1|||
164318944|NCT00797966|593544563|FG002|Phase B|Lost to Follow-up|3|||
164318945|NCT00797966|593544564|FG003|Phase B|Lost to Follow-up|0|||
164318946|NCT00797966|593544565|FG004|Phase B|Lost to Follow-up|0|||
164318947|NCT00797966|593544566|FG005|Phase B|Lost to Follow-up|0|||
164318948|NCT00797966|593544561|FG000|Phase B|Adverse Event|2|||
164318949|NCT00797966|593544562|FG001|Phase B|Adverse Event|1|||
164318950|NCT00797966|593544563|FG002|Phase B|Adverse Event|3|||
164318951|NCT00797966|593544564|FG003|Phase B|Adverse Event|1|||
164318952|NCT00797966|593544565|FG004|Phase B|Adverse Event|0|||
164318953|NCT00797966|593544566|FG005|Phase B|Adverse Event|0|||
164318954|NCT00797966|593544561|FG000|Phase B|Met Withdrawal Criteria|3|||
164318955|NCT00797966|593544562|FG001|Phase B|Met Withdrawal Criteria|3|||
164318956|NCT00797966|593544563|FG002|Phase B|Met Withdrawal Criteria|6|||
164318957|NCT00797966|593544564|FG003|Phase B|Met Withdrawal Criteria|1|||
164318958|NCT00797966|593544565|FG004|Phase B|Met Withdrawal Criteria|0|||
164318959|NCT00797966|593544566|FG005|Phase B|Met Withdrawal Criteria|0|||
164318960|NCT00797966|593544561|FG000|Phase B|Physician Decision|1|||
164318961|NCT00797966|593544562|FG001|Phase B|Physician Decision|0|||
164318962|NCT00797966|593544563|FG002|Phase B|Physician Decision|3|||
164318963|NCT00797966|593544564|FG003|Phase B|Physician Decision|1|||
164318964|NCT00797966|593544565|FG004|Phase B|Physician Decision|0|||
164318965|NCT00797966|593544566|FG005|Phase B|Physician Decision|0|||
164318966|NCT00797966|593544561|FG000|Phase B|Withdrawal by Subject|1|||
164318967|NCT00797966|593544562|FG001|Phase B|Withdrawal by Subject|4|||
164318968|NCT00797966|593544563|FG002|Phase B|Withdrawal by Subject|3|||
164318969|NCT00797966|593544564|FG003|Phase B|Withdrawal by Subject|3|||
164318970|NCT00797966|593544565|FG004|Phase B|Withdrawal by Subject|0|||
164318971|NCT00797966|593544566|FG005|Phase B|Withdrawal by Subject|0|||
164318972|NCT00797966|593544561|FG000|Phase B|Protocol Deviation|4|||
164318973|NCT00797966|593544562|FG001|Phase B|Protocol Deviation|8|||
164318974|NCT00797966|593544563|FG002|Phase B|Protocol Deviation|2|||
164318975|NCT00797966|593544564|FG003|Phase B|Protocol Deviation|6|||
164318976|NCT00797966|593544565|FG004|Phase B|Protocol Deviation|0|||
164318977|NCT00797966|593544566|FG005|Phase B|Protocol Deviation|0|||
164666850|NCT06096168|594804740|FG000|Overall Study|Death|30|||
164666851|NCT06096168|594804740|FG000|Overall Study|Revision|2|||
164666852|NCT04603937|594804745|FG000|Overall Study|Adverse Event|9|||
164666853|NCT04603937|594804746|FG001|Overall Study|Adverse Event|10|||
164666854|NCT04603937|594804745|FG000|Overall Study|Withdrawal by Subject|7|||
164666855|NCT04603937|594804746|FG001|Overall Study|Withdrawal by Subject|6|||
164666856|NCT04603937|594804745|FG000|Overall Study|Lost to Follow-up|5|||
164666857|NCT04603937|594804746|FG001|Overall Study|Lost to Follow-up|6|||
164666858|NCT04603937|594804745|FG000|Overall Study|Physician Decision|0|||
164666859|NCT04603937|594804746|FG001|Overall Study|Physician Decision|1|||
164318978|NCT00797966|593544561|FG000|Phase B|Lack of Efficacy|0|||
164318979|NCT00797966|593544562|FG001|Phase B|Lack of Efficacy|1|||
164318980|NCT00797966|593544563|FG002|Phase B|Lack of Efficacy|1|||
164318981|NCT00797966|593544564|FG003|Phase B|Lack of Efficacy|4|||
164318982|NCT00797966|593544565|FG004|Phase B|Lack of Efficacy|0|||
164318983|NCT00797966|593544566|FG005|Phase B|Lack of Efficacy|0|||
164318984|NCT00797966|593544561|FG000|Phase A+|Lost to Follow-up|0|||
164318985|NCT00797966|593544562|FG001|Phase A+|Lost to Follow-up|0|||
164318986|NCT00797966|593544563|FG002|Phase A+|Lost to Follow-up|0|||
164318987|NCT00797966|593544564|FG003|Phase A+|Lost to Follow-up|0|||
164318988|NCT00797966|593544565|FG004|Phase A+|Lost to Follow-up|0|||
164318989|NCT00797966|593544566|FG005|Phase A+|Lost to Follow-up|9|||
164666860|NCT04603937|594804745|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
164318990|NCT00797966|593544561|FG000|Phase A+|Met withdrawal criteria|0|||
164318991|NCT00797966|593544562|FG001|Phase A+|Met withdrawal criteria|0|||
164318992|NCT00797966|593544563|FG002|Phase A+|Met withdrawal criteria|0|||
164318993|NCT00797966|593544564|FG003|Phase A+|Met withdrawal criteria|0|||
164318994|NCT00797966|593544565|FG004|Phase A+|Met withdrawal criteria|0|||
164318995|NCT00797966|593544566|FG005|Phase A+|Met withdrawal criteria|5|||
164318996|NCT00797966|593544561|FG000|Phase A+|Withdrawal by Subject|0|||
164318997|NCT00797966|593544562|FG001|Phase A+|Withdrawal by Subject|0|||
164318998|NCT00797966|593544563|FG002|Phase A+|Withdrawal by Subject|0|||
164318999|NCT00797966|593544564|FG003|Phase A+|Withdrawal by Subject|0|||
164319000|NCT00797966|593544565|FG004|Phase A+|Withdrawal by Subject|0|||
164319001|NCT00797966|593544566|FG005|Phase A+|Withdrawal by Subject|6|||
164319002|NCT00797966|593544561|FG000|Phase A+|Adverse Event|0|||
164319003|NCT00797966|593544562|FG001|Phase A+|Adverse Event|0|||
164319004|NCT00797966|593544563|FG002|Phase A+|Adverse Event|0|||
164319005|NCT00797966|593544564|FG003|Phase A+|Adverse Event|0|||
164319006|NCT00797966|593544565|FG004|Phase A+|Adverse Event|0|||
164319007|NCT00797966|593544566|FG005|Phase A+|Adverse Event|4|||
164319008|NCT00797966|593544561|FG000|Phase A+|Protocol deviation|0|||
164319009|NCT00797966|593544562|FG001|Phase A+|Protocol deviation|0|||
164319010|NCT00797966|593544563|FG002|Phase A+|Protocol deviation|0|||
164319011|NCT00797966|593544564|FG003|Phase A+|Protocol deviation|0|||
164319012|NCT00797966|593544565|FG004|Phase A+|Protocol deviation|0|||
164319013|NCT00797966|593544566|FG005|Phase A+|Protocol deviation|4|||
164319014|NCT01002820|593544570|FG000|Overall Study|Adverse Event|1|||
164319015|NCT01002820|593544570|FG000|Overall Study|Withdrawal by Subject|2|||
164319016|NCT01002820|593544570|FG000|Overall Study|Lack of Efficacy|1|||
164319017|NCT01673347|593544571|FG000|Overall Study|failure of allograft|7|||
164319018|NCT01430754|593544574|FG000|Run-In Phase|Circadian Period Ineligible|24|||
164319019|NCT01430754|593544575|FG001|Run-In Phase|Circadian Period Ineligible|0|||
164319020|NCT01430754|593544574|FG000|Run-In Phase|Protocol Violation|6|||
164319021|NCT01430754|593544575|FG001|Run-In Phase|Protocol Violation|0|||
164319022|NCT01430754|593544574|FG000|Run-In Phase|Adverse Event|2|||
164319023|NCT01430754|593544575|FG001|Run-In Phase|Adverse Event|0|||
164319024|NCT01430754|593544574|FG000|Run-In Phase|Other|2|||
164319025|NCT01430754|593544575|FG001|Run-In Phase|Other|0|||
164319026|NCT01430754|593544574|FG000|Run-In Phase|Withdrawal by Subject|2|||
164319027|NCT01430754|593544575|FG001|Run-In Phase|Withdrawal by Subject|0|||
164319028|NCT01430754|593544574|FG000|Run-In Phase|Lost to Follow-up|1|||
164206314|NCT02765165|593124971|FG003|Treatment Period|Adverse Event|0|||
164206315|NCT02765165|593124972|FG004|Treatment Period|Adverse Event|0|||
164206316|NCT02765165|593124973|FG005|Treatment Period|Adverse Event|0|||
164319029|NCT01430754|593544575|FG001|Run-In Phase|Lost to Follow-up|0|||
164319030|NCT00895011|593544576|FG000|Overall Study|Withdrawal by Subject|14|||
164319031|NCT00895011|593544577|FG001|Overall Study|Withdrawal by Subject|7|||
164319032|NCT00895011|593544578|FG002|Overall Study|Withdrawal by Subject|2|||
164319033|NCT00895011|593544576|FG000|Overall Study|Lost to Follow-up|5|||
164206317|NCT02765165|593124974|FG006|Treatment Period|Adverse Event|0|||
164206318|NCT02765165|593124968|FG000|Treatment Period|Withdrawal by Subject|0|||
164206319|NCT02765165|593124969|FG001|Treatment Period|Withdrawal by Subject|0|||
164206320|NCT02765165|593124970|FG002|Treatment Period|Withdrawal by Subject|0|||
164206321|NCT02765165|593124971|FG003|Treatment Period|Withdrawal by Subject|0|||
164206322|NCT02765165|593124972|FG004|Treatment Period|Withdrawal by Subject|2|||
164206323|NCT02765165|593124973|FG005|Treatment Period|Withdrawal by Subject|0|||
164206324|NCT02765165|593124974|FG006|Treatment Period|Withdrawal by Subject|0|||
164206325|NCT02765165|593124968|FG000|Treatment Period|Study terminated|0|||
164206326|NCT02765165|593124969|FG001|Treatment Period|Study terminated|0|||
164206327|NCT02765165|593124970|FG002|Treatment Period|Study terminated|0|||
164206328|NCT02765165|593124971|FG003|Treatment Period|Study terminated|0|||
164206329|NCT02765165|593124972|FG004|Treatment Period|Study terminated|0|||
164206330|NCT02765165|593124973|FG005|Treatment Period|Study terminated|1|||
164206331|NCT02765165|593124974|FG006|Treatment Period|Study terminated|2|||
164206332|NCT02765165|593124968|FG000|Post-treatment Follow-up|Death|1|||
164206333|NCT02765165|593124969|FG001|Post-treatment Follow-up|Death|2|||
164206334|NCT02765165|593124970|FG002|Post-treatment Follow-up|Death|1|||
164206335|NCT02765165|593124971|FG003|Post-treatment Follow-up|Death|1|||
164206336|NCT02765165|593124972|FG004|Post-treatment Follow-up|Death|1|||
164206337|NCT02765165|593124973|FG005|Post-treatment Follow-up|Death|1|||
164206338|NCT02765165|593124974|FG006|Post-treatment Follow-up|Death|0|||
164206339|NCT02765165|593124968|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
164206340|NCT02765165|593124969|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
164206341|NCT02765165|593124970|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
164319034|NCT00895011|593544577|FG001|Overall Study|Lost to Follow-up|4|||
164319035|NCT00895011|593544578|FG002|Overall Study|Lost to Follow-up|1|||
164319036|NCT00895011|593544576|FG000|Overall Study|Protocol Violation|3|||
164319037|NCT00895011|593544577|FG001|Overall Study|Protocol Violation|1|||
164319038|NCT00895011|593544578|FG002|Overall Study|Protocol Violation|3|||
164206342|NCT02765165|593124971|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
164206343|NCT02765165|593124972|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
164206344|NCT02765165|593124973|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
164206345|NCT02765165|593124974|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
164319039|NCT00895011|593544576|FG000|Overall Study|Adverse Event|1|||
164319040|NCT00895011|593544577|FG001|Overall Study|Adverse Event|2|||
164319041|NCT00895011|593544578|FG002|Overall Study|Adverse Event|2|||
164319042|NCT00895011|593544576|FG000|Overall Study|schedule conflict|1|||
164206346|NCT02765165|593124968|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
164206347|NCT02765165|593124969|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
164206348|NCT02765165|593124970|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
164206349|NCT02765165|593124971|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
164206350|NCT02765165|593124972|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
164206351|NCT02765165|593124973|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
164206352|NCT02765165|593124974|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
164206353|NCT02765165|593124968|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
164206354|NCT02765165|593124969|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
164206355|NCT02765165|593124970|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
164206356|NCT02765165|593124971|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
164206357|NCT02765165|593124972|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
164206358|NCT02765165|593124973|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
164206359|NCT02765165|593124974|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
164206360|NCT02765165|593124968|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
164206361|NCT02765165|593124969|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
164206362|NCT02765165|593124970|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
164206363|NCT02765165|593124971|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
164206364|NCT02765165|593124972|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
164319043|NCT00895011|593544577|FG001|Overall Study|schedule conflict|0|||
164319044|NCT00895011|593544578|FG002|Overall Study|schedule conflict|0|||
164319045|NCT02661178|593544586|FG000|Part 1|Protocol Violation|1|||
164319046|NCT02661178|593544587|FG001|Part 1|Protocol Violation|0|||
164319047|NCT02661178|593544588|FG002|Part 1|Protocol Violation|0|||
164319048|NCT02661178|593544589|FG003|Part 1|Protocol Violation|0|||
164319049|NCT02661178|593544590|FG004|Part 1|Protocol Violation|0|||
164319050|NCT02661178|593544591|FG005|Part 1|Protocol Violation|0|||
164319051|NCT02661178|593544592|FG006|Part 1|Protocol Violation|0|||
164319052|NCT02661178|593544593|FG007|Part 1|Protocol Violation|0|||
164319053|NCT02661178|593544594|FG008|Part 1|Protocol Violation|0|||
164319054|NCT02661178|593544595|FG009|Part 1|Protocol Violation|0|||
164319055|NCT02661178|593544596|FG010|Part 1|Protocol Violation|0|||
164319056|NCT02661178|593544597|FG011|Part 1|Protocol Violation|0|||
164319057|NCT02661178|593544598|FG012|Part 1|Protocol Violation|0|||
164319058|NCT02661178|593544599|FG013|Part 1|Protocol Violation|0|||
164319059|NCT02661178|593544600|FG014|Part 1|Protocol Violation|0|||
164319060|NCT02278471|593544601|FG000|Overall Study|Lost to Follow-up|6|||
164319061|NCT02278471|593544602|FG001|Overall Study|Lost to Follow-up|15|||
164319062|NCT02278471|593544601|FG000|Overall Study|Death|2|||
164319063|NCT02278471|593544602|FG001|Overall Study|Death|2|||
164319064|NCT02278471|593544601|FG000|Overall Study|Withdrawal by Subject|0|||
164319065|NCT02278471|593544602|FG001|Overall Study|Withdrawal by Subject|3|||
164319066|NCT04391049|593544603|FG000|Overall Study|Protocol Violation|1|||
164319067|NCT01242813|593544604|FG000|Overall Study|Lost to Follow-up|2|||
164319068|NCT00275821|593544606|FG000|Overall Study|Adverse Event|4|||
164319069|NCT00275821|593544607|FG001|Overall Study|Adverse Event|12|||
164319070|NCT00275821|593544608|FG002|Overall Study|Adverse Event|5|||
164319071|NCT00275821|593544606|FG000|Overall Study|Administrative problems|3|||
164319072|NCT00275821|593544607|FG001|Overall Study|Administrative problems|4|||
164319073|NCT00275821|593544608|FG002|Overall Study|Administrative problems|4|||
164319074|NCT00275821|593544606|FG000|Overall Study|Withdrawal by Subject|0|||
164319075|NCT00275821|593544607|FG001|Overall Study|Withdrawal by Subject|2|||
164319076|NCT00275821|593544608|FG002|Overall Study|Withdrawal by Subject|1|||
164319077|NCT00275821|593544606|FG000|Overall Study|Lost to Follow-up|0|||
164319078|NCT00275821|593544607|FG001|Overall Study|Lost to Follow-up|1|||
164319079|NCT00275821|593544608|FG002|Overall Study|Lost to Follow-up|1|||
164319080|NCT00275821|593544606|FG000|Overall Study|Death|0|||
164319081|NCT00275821|593544607|FG001|Overall Study|Death|2|||
164319082|NCT00275821|593544608|FG002|Overall Study|Death|1|||
164319083|NCT00275821|593544606|FG000|Overall Study|Lack of Efficacy|2|||
164206365|NCT02765165|593124973|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
164206366|NCT02765165|593124974|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
164319084|NCT00275821|593544607|FG001|Overall Study|Lack of Efficacy|1|||
164319085|NCT00275821|593544608|FG002|Overall Study|Lack of Efficacy|0|||
164319086|NCT00275821|593544606|FG000|Overall Study|Protocol Violation|5|||
164319087|NCT00275821|593544607|FG001|Overall Study|Protocol Violation|1|||
164319088|NCT00275821|593544608|FG002|Overall Study|Protocol Violation|0|||
164319089|NCT01215916|593544609|FG000|Overall Study|Progressive Disease|0|||
164319090|NCT01215916|593544610|FG001|Overall Study|Progressive Disease|2|||
164319091|NCT01215916|593544611|FG002|Overall Study|Progressive Disease|1|||
164562546|NCT03064841|594427543|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
164562547|NCT03064841|594427543|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
164562548|NCT03064841|594427543|FG000|Overall Study|Screen failure|2|||
164562549|NCT00573794|594427544|FG000|Overall Study|Adverse Event|81|||
164319092|NCT01215916|593544612|FG003|Overall Study|Progressive Disease|2|||
164319093|NCT01215916|593544613|FG004|Overall Study|Progressive Disease|5|||
164319094|NCT01215916|593544614|FG005|Overall Study|Progressive Disease|4|||
164206367|NCT02765165|593124968|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
164206368|NCT02765165|593124969|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
164206369|NCT02765165|593124970|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
164206370|NCT02765165|593124971|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
164206371|NCT02765165|593124972|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
164206372|NCT02765165|593124973|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
164206373|NCT02765165|593124974|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
164206374|NCT01189266|593124975|FG000|Overall Study|Adverse Event|1|||
164206375|NCT01189266|593124976|FG001|Overall Study|Adverse Event|0|||
164206376|NCT01189266|593124977|FG002|Overall Study|Adverse Event|5|||
164206377|NCT01189266|593124975|FG000|Overall Study|Death|0|||
164206378|NCT01189266|593124976|FG001|Overall Study|Death|0|||
164206379|NCT01189266|593124977|FG002|Overall Study|Death|5|||
164206380|NCT01189266|593124975|FG000|Overall Study|Lack of Efficacy|4|||
164206381|NCT01189266|593124976|FG001|Overall Study|Lack of Efficacy|5|||
164206382|NCT01189266|593124977|FG002|Overall Study|Lack of Efficacy|44|||
164206383|NCT01189266|593124975|FG000|Overall Study|Physician Decision|0|||
164206384|NCT01189266|593124976|FG001|Overall Study|Physician Decision|0|||
164206385|NCT01189266|593124977|FG002|Overall Study|Physician Decision|1|||
164206386|NCT01189266|593124975|FG000|Overall Study|Protocol Violation|0|||
164206387|NCT01189266|593124976|FG001|Overall Study|Protocol Violation|1|||
164206388|NCT01189266|593124977|FG002|Overall Study|Protocol Violation|1|||
164206389|NCT01189266|593124975|FG000|Overall Study|Withdrawal by Subject|0|||
164206390|NCT01189266|593124976|FG001|Overall Study|Withdrawal by Subject|0|||
164206391|NCT01189266|593124977|FG002|Overall Study|Withdrawal by Subject|1|||
164206392|NCT01189266|593124975|FG000|Overall Study|Patient refuses further therapy|1|||
164206393|NCT01189266|593124976|FG001|Overall Study|Patient refuses further therapy|0|||
164206394|NCT01189266|593124977|FG002|Overall Study|Patient refuses further therapy|7|||
164206395|NCT01189266|593124975|FG000|Overall Study|No treatment|0|||
164206396|NCT01189266|593124976|FG001|Overall Study|No treatment|0|||
164206397|NCT01189266|593124977|FG002|Overall Study|No treatment|1|||
164206398|NCT00321763|593124978|FG000|Overall Study|Adverse Event|1|||
164206399|NCT00321763|593124979|FG001|Overall Study|Adverse Event|1|||
164206400|NCT00321763|593124980|FG002|Overall Study|Adverse Event|0|||
164206401|NCT00321763|593124981|FG003|Overall Study|Adverse Event|1|||
164206402|NCT00321763|593124978|FG000|Overall Study|Withdrawal by Subject|2|||
164206403|NCT00321763|593124979|FG001|Overall Study|Withdrawal by Subject|0|||
164206404|NCT00321763|593124980|FG002|Overall Study|Withdrawal by Subject|1|||
164206405|NCT00321763|593124981|FG003|Overall Study|Withdrawal by Subject|0|||
164206406|NCT00321763|593124978|FG000|Overall Study|Lost to Follow-up|3|||
164206407|NCT00321763|593124979|FG001|Overall Study|Lost to Follow-up|1|||
164206408|NCT00321763|593124980|FG002|Overall Study|Lost to Follow-up|5|||
164206409|NCT00321763|593124981|FG003|Overall Study|Lost to Follow-up|4|||
164206410|NCT00410163|593124982|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
164206411|NCT00410163|593124983|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
164206412|NCT00410163|593124982|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
164206413|NCT00410163|593124983|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
164206414|NCT00410163|593124982|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
164206415|NCT00410163|593124983|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
164206416|NCT00410163|593124982|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
164206417|NCT00410163|593124983|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
164206418|NCT00410163|593124982|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
164206419|NCT00410163|593124983|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
164206420|NCT00410163|593124982|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
164206421|NCT00410163|593124983|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
164206422|NCT00410163|593124982|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
164206423|NCT00410163|593124983|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
164206424|NCT00410163|593124982|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
164206425|NCT00410163|593124983|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
164206426|NCT00410163|593124982|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
164206427|NCT00410163|593124983|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
164206428|NCT00410163|593124982|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
164206429|NCT00410163|593124983|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
164206430|NCT00410163|593124982|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
164206431|NCT00410163|593124983|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
164206432|NCT00410163|593124982|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
164206433|NCT00410163|593124983|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
164206434|NCT00410163|593124982|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
164206435|NCT00410163|593124983|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
164206436|NCT00410163|593124982|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
164206437|NCT00410163|593124983|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
164206438|NCT01572792|593124989|FG000|Lead-in Study|Lost to Follow-up|5|||
164206439|NCT01572792|593124990|FG001|Lead-in Study|Lost to Follow-up|9|||
164206440|NCT01572792|593124991|FG002|Lead-in Study|Lost to Follow-up|4|||
164206441|NCT01572792|593124992|FG003|Lead-in Study|Lost to Follow-up|2|||
164206442|NCT01572792|593124993|FG004|Lead-in Study|Lost to Follow-up|4|||
164206443|NCT01572792|593124989|FG000|Lead-in Study|Withdrawal by Subject|22|||
164206444|NCT01572792|593124990|FG001|Lead-in Study|Withdrawal by Subject|11|||
164206445|NCT01572792|593124991|FG002|Lead-in Study|Withdrawal by Subject|12|||
164206446|NCT01572792|593124992|FG003|Lead-in Study|Withdrawal by Subject|24|||
164206447|NCT01572792|593124993|FG004|Lead-in Study|Withdrawal by Subject|11|||
164206448|NCT01572792|593124989|FG000|Lead-in Study|Protocol Violation|19|||
164206449|NCT01572792|593124990|FG001|Lead-in Study|Protocol Violation|10|||
164206450|NCT01572792|593124991|FG002|Lead-in Study|Protocol Violation|12|||
164206451|NCT01572792|593124992|FG003|Lead-in Study|Protocol Violation|13|||
164206452|NCT01572792|593124993|FG004|Lead-in Study|Protocol Violation|21|||
164206453|NCT01572792|593124989|FG000|Lead-in Study|Lack of Efficacy|20|||
164206454|NCT01572792|593124990|FG001|Lead-in Study|Lack of Efficacy|5|||
164206455|NCT01572792|593124991|FG002|Lead-in Study|Lack of Efficacy|4|||
164206456|NCT01572792|593124992|FG003|Lead-in Study|Lack of Efficacy|8|||
164206457|NCT01572792|593124993|FG004|Lead-in Study|Lack of Efficacy|10|||
164206458|NCT01572792|593124989|FG000|Lead-in Study|Adverse Event|21|||
164206459|NCT01572792|593124990|FG001|Lead-in Study|Adverse Event|21|||
164206460|NCT01572792|593124991|FG002|Lead-in Study|Adverse Event|22|||
164206461|NCT01572792|593124992|FG003|Lead-in Study|Adverse Event|16|||
164206462|NCT01572792|593124993|FG004|Lead-in Study|Adverse Event|14|||
164319095|NCT01215916|593544615|FG006|Overall Study|Progressive Disease|5|||
164319096|NCT01215916|593544616|FG007|Overall Study|Progressive Disease|3|||
164319097|NCT01215916|593544617|FG008|Overall Study|Progressive Disease|1|||
164319098|NCT01215916|593544609|FG000|Overall Study|Adverse Event|1|||
164319099|NCT01215916|593544610|FG001|Overall Study|Adverse Event|1|||
164319100|NCT01215916|593544611|FG002|Overall Study|Adverse Event|0|||
164319101|NCT01215916|593544612|FG003|Overall Study|Adverse Event|1|||
164319102|NCT01215916|593544613|FG004|Overall Study|Adverse Event|0|||
164319103|NCT01215916|593544614|FG005|Overall Study|Adverse Event|0|||
164319104|NCT01215916|593544615|FG006|Overall Study|Adverse Event|3|||
164319105|NCT01215916|593544616|FG007|Overall Study|Adverse Event|0|||
164319106|NCT01215916|593544617|FG008|Overall Study|Adverse Event|0|||
164319107|NCT01215916|593544609|FG000|Overall Study|Withdrawal by Subject|0|||
164319108|NCT01215916|593544610|FG001|Overall Study|Withdrawal by Subject|1|||
164319109|NCT01215916|593544611|FG002|Overall Study|Withdrawal by Subject|1|||
164319110|NCT01215916|593544612|FG003|Overall Study|Withdrawal by Subject|2|||
164319111|NCT01215916|593544613|FG004|Overall Study|Withdrawal by Subject|0|||
164319112|NCT01215916|593544614|FG005|Overall Study|Withdrawal by Subject|0|||
164319113|NCT01215916|593544615|FG006|Overall Study|Withdrawal by Subject|1|||
164319114|NCT01215916|593544616|FG007|Overall Study|Withdrawal by Subject|0|||
164319115|NCT01215916|593544617|FG008|Overall Study|Withdrawal by Subject|0|||
164319116|NCT01215916|593544609|FG000|Overall Study|Death|0|||
164319117|NCT01215916|593544610|FG001|Overall Study|Death|1|||
164319118|NCT01215916|593544611|FG002|Overall Study|Death|0|||
164319119|NCT01215916|593544612|FG003|Overall Study|Death|0|||
164319120|NCT01215916|593544613|FG004|Overall Study|Death|1|||
164319121|NCT01215916|593544614|FG005|Overall Study|Death|0|||
164319122|NCT01215916|593544615|FG006|Overall Study|Death|0|||
164319123|NCT01215916|593544616|FG007|Overall Study|Death|0|||
164319124|NCT01215916|593544617|FG008|Overall Study|Death|1|||
164319125|NCT01215916|593544609|FG000|Overall Study|Physician Decision|0|||
164319126|NCT01215916|593544610|FG001|Overall Study|Physician Decision|0|||
164319127|NCT01215916|593544611|FG002|Overall Study|Physician Decision|1|||
164319128|NCT01215916|593544612|FG003|Overall Study|Physician Decision|1|||
164319129|NCT01215916|593544613|FG004|Overall Study|Physician Decision|0|||
164319130|NCT01215916|593544614|FG005|Overall Study|Physician Decision|0|||
164319131|NCT01215916|593544615|FG006|Overall Study|Physician Decision|0|||
164319132|NCT01215916|593544616|FG007|Overall Study|Physician Decision|0|||
164319133|NCT01215916|593544617|FG008|Overall Study|Physician Decision|0|||
164319134|NCT01133990|593544619|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
164319135|NCT01133990|593544620|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
164206463|NCT01572792|593124989|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
164206464|NCT01572792|593124990|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
164206465|NCT01572792|593124991|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
164206466|NCT01572792|593124992|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
164319136|NCT01133990|593544621|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
164319137|NCT01133990|593544622|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
164319138|NCT01133990|593544623|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
164319139|NCT01133990|593544624|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
164319140|NCT01133990|593544619|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
164319141|NCT01133990|593544620|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
164319142|NCT01133990|593544621|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
164319143|NCT01133990|593544622|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
164319144|NCT01133990|593544623|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
164319145|NCT01133990|593544624|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
164319146|NCT01133990|593544619|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
164319147|NCT01133990|593544620|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
164319148|NCT01133990|593544621|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
164319149|NCT01133990|593544622|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
164319150|NCT01133990|593544623|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
164319151|NCT01133990|593544624|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
164319152|NCT01133990|593544619|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
164319153|NCT01133990|593544620|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
164319154|NCT01133990|593544621|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
164319155|NCT01133990|593544622|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
164319156|NCT01133990|593544623|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
164319157|NCT01133990|593544624|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
164319158|NCT02683746|593544625|FG000|Overall Study|Adverse Event|3|||
164319159|NCT02683746|593544626|FG001|Overall Study|Adverse Event|2|||
164319160|NCT02683746|593544625|FG000|Overall Study|Lost to Follow-up|5|||
164319161|NCT02683746|593544626|FG001|Overall Study|Lost to Follow-up|6|||
164319162|NCT02683746|593544625|FG000|Overall Study|Withdrawal by Subject|6|||
164319163|NCT02683746|593544626|FG001|Overall Study|Withdrawal by Subject|5|||
164319164|NCT02683746|593544625|FG000|Overall Study|Physician Decision|2|||
164319165|NCT02683746|593544626|FG001|Overall Study|Physician Decision|1|||
164319166|NCT01328444|593544641|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
164319167|NCT01328444|593544642|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
164319168|NCT01328444|593544643|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
164319169|NCT01328444|593544644|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
164319170|NCT01328444|593544645|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
164319171|NCT01328444|593544646|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
164319172|NCT01328444|593544641|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
164319173|NCT01328444|593544642|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
164319174|NCT01328444|593544643|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
164319175|NCT01328444|593544644|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
164319176|NCT01328444|593544645|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
164319177|NCT01328444|593544646|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
164319178|NCT01328444|593544641|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
164319179|NCT01328444|593544642|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
164319180|NCT01328444|593544643|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
164319181|NCT01328444|593544644|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
164319182|NCT01328444|593544645|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
164319183|NCT01328444|593544646|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
164319184|NCT01328444|593544641|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
164319185|NCT01328444|593544642|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
164319186|NCT01328444|593544643|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
164319187|NCT01328444|593544644|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
164319188|NCT01328444|593544645|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
164319189|NCT01328444|593544646|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
164319190|NCT01328444|593544641|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
164319191|NCT01328444|593544642|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164319192|NCT01328444|593544643|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164319193|NCT01328444|593544644|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
164319194|NCT01328444|593544645|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164319195|NCT01328444|593544646|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
164319196|NCT01328444|593544641|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
164319197|NCT01328444|593544642|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
164319198|NCT01328444|593544643|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
164319199|NCT01328444|593544644|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
164319200|NCT01328444|593544645|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
164319201|NCT01328444|593544646|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
164319202|NCT01328444|593544641|FG000|Washout Period (14 Days)|Adverse Event|1|||
164319203|NCT01328444|593544642|FG001|Washout Period (14 Days)|Adverse Event|1|||
164319204|NCT01328444|593544643|FG002|Washout Period (14 Days)|Adverse Event|0|||
164319205|NCT01328444|593544644|FG003|Washout Period (14 Days)|Adverse Event|1|||
164319206|NCT01328444|593544645|FG004|Washout Period (14 Days)|Adverse Event|1|||
164562550|NCT00573794|594427544|FG000|Overall Study|Withdrew Consent|90|||
164562551|NCT00573794|594427544|FG000|Overall Study|Lost to Follow-up|13|||
164562552|NCT00573794|594427544|FG000|Overall Study|Protocol Violation|6|||
164319207|NCT01328444|593544646|FG005|Washout Period (14 Days)|Adverse Event|2|||
164319208|NCT01328444|593544641|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
164206467|NCT01572792|593124993|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
164206468|NCT01572792|593124989|FG000|Extension Study|Lost to Follow-up|6|||
164206469|NCT01572792|593124990|FG001|Extension Study|Lost to Follow-up|2|||
164206470|NCT01572792|593124991|FG002|Extension Study|Lost to Follow-up|0|||
164206471|NCT01572792|593124992|FG003|Extension Study|Lost to Follow-up|3|||
164206472|NCT01572792|593124993|FG004|Extension Study|Lost to Follow-up|3|||
164206473|NCT01572792|593124989|FG000|Extension Study|Withdrawal by Subject|7|||
164206474|NCT01572792|593124990|FG001|Extension Study|Withdrawal by Subject|6|||
164206475|NCT01572792|593124991|FG002|Extension Study|Withdrawal by Subject|11|||
164206476|NCT01572792|593124992|FG003|Extension Study|Withdrawal by Subject|8|||
164206477|NCT01572792|593124993|FG004|Extension Study|Withdrawal by Subject|14|||
164206478|NCT01572792|593124989|FG000|Extension Study|Protocol Violation|0|||
164206479|NCT01572792|593124990|FG001|Extension Study|Protocol Violation|4|||
164206480|NCT01572792|593124991|FG002|Extension Study|Protocol Violation|3|||
164206481|NCT01572792|593124992|FG003|Extension Study|Protocol Violation|4|||
164206482|NCT01572792|593124993|FG004|Extension Study|Protocol Violation|3|||
164206483|NCT01572792|593124989|FG000|Extension Study|Lack of Efficacy|2|||
164206484|NCT01572792|593124990|FG001|Extension Study|Lack of Efficacy|3|||
164206485|NCT01572792|593124991|FG002|Extension Study|Lack of Efficacy|3|||
164206486|NCT01572792|593124992|FG003|Extension Study|Lack of Efficacy|2|||
164206487|NCT01572792|593124993|FG004|Extension Study|Lack of Efficacy|2|||
164206488|NCT01572792|593124989|FG000|Extension Study|Adverse Event|7|||
164319209|NCT01328444|593544642|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
164319210|NCT01328444|593544643|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
164319211|NCT01328444|593544644|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
164319212|NCT01328444|593544645|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
164562553|NCT00573794|594427544|FG000|Overall Study|Lack of Efficacy|94|||
164562554|NCT00573794|594427544|FG000|Overall Study|Other|46|||
164562555|NCT02183519|594427551|FG000|Overall Study|computer error|3|||
164562556|NCT02183519|594427552|FG001|Overall Study|computer error|0|||
164562557|NCT02183519|594427551|FG000|Overall Study|Did not respond to cough inducter|0|||
164562558|NCT02183519|594427552|FG001|Overall Study|Did not respond to cough inducter|3|||
164562559|NCT04949841|594427553|FG000|Overall Study|Adverse Event|7|||
164562560|NCT04949841|594427553|FG000|Overall Study|Death|1|||
164562561|NCT04949841|594427553|FG000|Overall Study|Withdrawal by Subject|52|||
164562562|NCT04949841|594427553|FG000|Overall Study|Pregnancy|4|||
164562563|NCT04949841|594427553|FG000|Overall Study|Lost to Follow-up|9|||
164562564|NCT04949841|594427553|FG000|Overall Study|Lack of Efficacy|55|||
164562565|NCT04949841|594427553|FG000|Overall Study|Various reasons|9|||
164562566|NCT01984268|594427554|FG000|Overall Study|Study Terminated|15|||
164562567|NCT01314716|594427555|FG000|Double-Blind Phase|Randomized but not treated|1|||
164562568|NCT01314716|594427556|FG001|Double-Blind Phase|Randomized but not treated|1|||
164562569|NCT01314716|594427555|FG000|Double-Blind Phase|Adverse Event|10|||
164562570|NCT01314716|594427556|FG001|Double-Blind Phase|Adverse Event|4|||
164562571|NCT01314716|594427555|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
164562572|NCT01314716|594427556|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
164562573|NCT01314716|594427555|FG000|Double-Blind Phase|Lost to Follow-up|0|||
164562574|NCT01314716|594427556|FG001|Double-Blind Phase|Lost to Follow-up|1|||
164562575|NCT01314716|594427555|FG000|Double-Blind Phase|Sponsor request|1|||
164562576|NCT01314716|594427556|FG001|Double-Blind Phase|Sponsor request|2|||
164562577|NCT01314716|594427555|FG000|Double-Blind Phase|Physician Decision|0|||
164562578|NCT01314716|594427556|FG001|Double-Blind Phase|Physician Decision|1|||
164562579|NCT01314716|594427555|FG000|Open-Label Phase|Adverse Event|4|||
164562580|NCT01314716|594427556|FG001|Open-Label Phase|Adverse Event|6|||
164562581|NCT01314716|594427555|FG000|Open-Label Phase|Withdrawal by Subject|1|||
164562582|NCT01314716|594427556|FG001|Open-Label Phase|Withdrawal by Subject|2|||
164562583|NCT01314716|594427555|FG000|Open-Label Phase|Physician Decision|5|||
164562584|NCT01314716|594427556|FG001|Open-Label Phase|Physician Decision|4|||
164562585|NCT01928381|594427560|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
164562586|NCT01928381|594427561|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
164562587|NCT01928381|594427562|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
164562588|NCT01928381|594427563|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
164562589|NCT01928381|594427564|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
164562590|NCT01928381|594427565|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
164562591|NCT01928381|594427566|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
164206489|NCT01572792|593124990|FG001|Extension Study|Adverse Event|6|||
164206490|NCT01572792|593124991|FG002|Extension Study|Adverse Event|5|||
164206491|NCT01572792|593124992|FG003|Extension Study|Adverse Event|6|||
164206492|NCT01572792|593124993|FG004|Extension Study|Adverse Event|4|||
164319213|NCT01328444|593544646|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
164666861|NCT04603937|594804746|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
164666862|NCT00993616|594804747|FG000|Overall Study|No tumor at entry|1|||
164206493|NCT01572792|593124989|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
164562592|NCT01928381|594427560|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
164562593|NCT01928381|594427561|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
164206494|NCT01572792|593124990|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
164206495|NCT01572792|593124991|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
164206496|NCT01572792|593124992|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
164206497|NCT01572792|593124993|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
164206498|NCT03530696|593124994|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
164206499|NCT03530696|593124995|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
164206500|NCT04759131|593124996|FG000|Overall Study|Investigator's discretion|1|||
164206501|NCT04759131|593124997|FG001|Overall Study|Investigator's discretion|0|||
164206502|NCT04759131|593124996|FG000|Overall Study|Subject withdrawal|1|||
164206503|NCT04759131|593124997|FG001|Overall Study|Subject withdrawal|0|||
164206504|NCT03692949|593124998|FG000|Overall Study|Lost to Follow-up|0|||
164206505|NCT03692949|593124999|FG001|Overall Study|Lost to Follow-up|0|||
164206506|NCT03692949|593125000|FG002|Overall Study|Lost to Follow-up|0|||
164206507|NCT03692949|593125001|FG003|Overall Study|Lost to Follow-up|0|||
164206508|NCT03692949|593125002|FG004|Overall Study|Lost to Follow-up|0|||
164206509|NCT03692949|593125003|FG005|Overall Study|Lost to Follow-up|0|||
164206510|NCT03692949|593125004|FG006|Overall Study|Lost to Follow-up|0|||
164206511|NCT03692949|593125005|FG007|Overall Study|Lost to Follow-up|1|||
164206512|NCT00833755|593125009|FG000|Overall Study|Physician Decision|4|||
164206513|NCT00833755|593125010|FG001|Overall Study|Physician Decision|4|||
164206514|NCT00833755|593125011|FG002|Overall Study|Physician Decision|2|||
164206515|NCT00833755|593125012|FG003|Overall Study|Physician Decision|6|||
164206516|NCT00833755|593125009|FG000|Overall Study|Subject had scheduling issues|0|||
164206517|NCT00833755|593125010|FG001|Overall Study|Subject had scheduling issues|1|||
164206518|NCT00833755|593125011|FG002|Overall Study|Subject had scheduling issues|0|||
164206519|NCT00833755|593125012|FG003|Overall Study|Subject had scheduling issues|0|||
164206520|NCT00560404|593125014|FG000|Overall Study|Adverse Event|2|||
164206521|NCT00560404|593125015|FG001|Overall Study|Adverse Event|3|||
164206522|NCT00560404|593125014|FG000|Overall Study|Death|3|||
164206523|NCT00560404|593125015|FG001|Overall Study|Death|3|||
164206524|NCT00560404|593125014|FG000|Overall Study|Protocol Violation|12|||
164206525|NCT00560404|593125015|FG001|Overall Study|Protocol Violation|7|||
164206526|NCT00560404|593125014|FG000|Overall Study|Administrative Reasons|1|||
164206527|NCT00560404|593125015|FG001|Overall Study|Administrative Reasons|1|||
164206528|NCT00560404|593125014|FG000|Overall Study|Withdrew Consent|4|||
164206529|NCT00560404|593125015|FG001|Overall Study|Withdrew Consent|0|||
164206530|NCT00560404|593125014|FG000|Overall Study|Failure to return|1|||
164206531|NCT00560404|593125015|FG001|Overall Study|Failure to return|2|||
164206532|NCT00560404|593125014|FG000|Overall Study|Other withdrawal reason|13|||
164206533|NCT00560404|593125015|FG001|Overall Study|Other withdrawal reason|5|||
164206534|NCT02642042|593125022|FG000|Overall Study|Adverse Event|22|||
164206535|NCT02642042|593125022|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
164206536|NCT02642042|593125022|FG000|Overall Study|Progression/Relapse|28|||
164206537|NCT02642042|593125022|FG000|Overall Study|Death|1|||
164206538|NCT02642042|593125022|FG000|Overall Study|Not Protocol Specified|2|||
164206539|NCT04108468|593125023|FG000|Overall Study|Physician Decision|0|||
164206540|NCT04108468|593125024|FG001|Overall Study|Physician Decision|1|||
164206541|NCT04108468|593125023|FG000|Overall Study|Lost to Follow-up|0|||
164206542|NCT04108468|593125024|FG001|Overall Study|Lost to Follow-up|1|||
164206543|NCT04108468|593125023|FG000|Overall Study|Non-compliance|1|||
164206544|NCT04108468|593125024|FG001|Overall Study|Non-compliance|1|||
164206545|NCT04108468|593125023|FG000|Overall Study|Unable to attend final visit|2|||
164206546|NCT04108468|593125024|FG001|Overall Study|Unable to attend final visit|0|||
164206547|NCT04108468|593125023|FG000|Overall Study|Missed study medication|0|||
164206548|NCT04108468|593125024|FG001|Overall Study|Missed study medication|1|||
164562594|NCT01928381|594427562|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
164562595|NCT01928381|594427563|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
164562596|NCT01928381|594427564|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
164562597|NCT01928381|594427565|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
164562598|NCT01928381|594427566|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
164562599|NCT01928381|594427560|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
164562600|NCT01928381|594427561|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
164562601|NCT01928381|594427562|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
164562602|NCT01928381|594427563|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
164206549|NCT03260023|593125025|FG000|Overall Study|Adverse Event|0|||
164206550|NCT03260023|593125026|FG001|Overall Study|Adverse Event|0|||
164206551|NCT03260023|593125027|FG002|Overall Study|Adverse Event|4|||
164206552|NCT03260023|593125028|FG003|Overall Study|Adverse Event|4|||
164206553|NCT03260023|593125029|FG004|Overall Study|Adverse Event|4|||
164206554|NCT03260023|593125030|FG005|Overall Study|Adverse Event|1|||
164206555|NCT03260023|593125031|FG006|Overall Study|Adverse Event|2|||
164206556|NCT03260023|593125025|FG000|Overall Study|Clinical Progression|0|||
164206557|NCT03260023|593125026|FG001|Overall Study|Clinical Progression|1|||
164206558|NCT03260023|593125027|FG002|Overall Study|Clinical Progression|3|||
164206559|NCT03260023|593125028|FG003|Overall Study|Clinical Progression|1|||
164666863|NCT00993616|594804747|FG000|Overall Study|Never treated|1|||
164206560|NCT03260023|593125029|FG004|Overall Study|Clinical Progression|0|||
164206561|NCT03260023|593125030|FG005|Overall Study|Clinical Progression|0|||
164206562|NCT03260023|593125031|FG006|Overall Study|Clinical Progression|0|||
164206563|NCT03260023|593125025|FG000|Overall Study|Physician Decision|0|||
164206564|NCT03260023|593125026|FG001|Overall Study|Physician Decision|0|||
164206565|NCT03260023|593125027|FG002|Overall Study|Physician Decision|0|||
164206566|NCT03260023|593125028|FG003|Overall Study|Physician Decision|1|||
164206567|NCT03260023|593125029|FG004|Overall Study|Physician Decision|1|||
164666864|NCT02585258|594804748|FG000|Overall Study|Adverse Event|28|||
164666865|NCT02585258|594804749|FG001|Overall Study|Adverse Event|29|||
164666866|NCT02585258|594804748|FG000|Overall Study|Death|3|||
164666867|NCT02585258|594804749|FG001|Overall Study|Death|2|||
164666868|NCT02585258|594804748|FG000|Overall Study|Lack of Efficacy|7|||
164206568|NCT03260023|593125030|FG005|Overall Study|Physician Decision|0|||
164206569|NCT03260023|593125031|FG006|Overall Study|Physician Decision|0|||
164206570|NCT03260023|593125025|FG000|Overall Study|Withdrawal by Subject|0|||
164206571|NCT03260023|593125026|FG001|Overall Study|Withdrawal by Subject|0|||
164206572|NCT03260023|593125027|FG002|Overall Study|Withdrawal by Subject|0|||
164206573|NCT03260023|593125028|FG003|Overall Study|Withdrawal by Subject|0|||
164206574|NCT03260023|593125029|FG004|Overall Study|Withdrawal by Subject|3|||
164206575|NCT03260023|593125030|FG005|Overall Study|Withdrawal by Subject|0|||
164206576|NCT03260023|593125031|FG006|Overall Study|Withdrawal by Subject|0|||
164206577|NCT03260023|593125025|FG000|Overall Study|Under trial intervention|0|||
164206578|NCT03260023|593125026|FG001|Overall Study|Under trial intervention|0|||
164206579|NCT03260023|593125027|FG002|Overall Study|Under trial intervention|2|||
164206580|NCT03260023|593125028|FG003|Overall Study|Under trial intervention|5|||
164206581|NCT03260023|593125029|FG004|Overall Study|Under trial intervention|3|||
164206582|NCT03260023|593125030|FG005|Overall Study|Under trial intervention|0|||
164206583|NCT03260023|593125031|FG006|Overall Study|Under trial intervention|0|||
164206584|NCT05035407|593125034|FG000|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|36|||
164206585|NCT05035407|593125035|FG001|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
164206586|NCT05035407|593125036|FG002|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
164206587|NCT05035407|593125037|FG003|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
164206588|NCT05035407|593125038|FG004|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
164206589|NCT05035407|593125039|FG005|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
164206590|NCT04513366|593125040|FG000|Treatment Phase|Withdrawal by Subject|6|||
164206591|NCT04513366|593125041|FG001|Treatment Phase|Withdrawal by Subject|8|||
164206592|NCT04513366|593125042|FG002|Treatment Phase|Withdrawal by Subject|3|||
164206593|NCT04513366|593125040|FG000|Treatment Phase|Lost to Follow-up|1|||
164206594|NCT04513366|593125041|FG001|Treatment Phase|Lost to Follow-up|2|||
164206595|NCT04513366|593125042|FG002|Treatment Phase|Lost to Follow-up|5|||
164206596|NCT04513366|593125040|FG000|Treatment Phase|Other than Specified|1|||
164206597|NCT04513366|593125041|FG001|Treatment Phase|Other than Specified|0|||
164206598|NCT04513366|593125042|FG002|Treatment Phase|Other than Specified|2|||
164206599|NCT04513366|593125040|FG000|Treatment Phase|Physician Decision|2|||
164206600|NCT04513366|593125041|FG001|Treatment Phase|Physician Decision|0|||
164206601|NCT04513366|593125042|FG002|Treatment Phase|Physician Decision|0|||
164206602|NCT04513366|593125040|FG000|Treatment Phase|Adverse Event|0|||
164206603|NCT04513366|593125041|FG001|Treatment Phase|Adverse Event|1|||
164206604|NCT04513366|593125042|FG002|Treatment Phase|Adverse Event|1|||
164206605|NCT04513366|593125040|FG000|Extension Phase|Withdrawal by Subject|3|||
164206606|NCT04513366|593125041|FG001|Extension Phase|Withdrawal by Subject|1|||
164206607|NCT04513366|593125042|FG002|Extension Phase|Withdrawal by Subject|1|||
164206608|NCT04513366|593125040|FG000|Extension Phase|Other than Specified|4|||
164206609|NCT04513366|593125041|FG001|Extension Phase|Other than Specified|0|||
164206610|NCT04513366|593125042|FG002|Extension Phase|Other than Specified|1|||
164206611|NCT04513366|593125040|FG000|Extension Phase|Lost to Follow-up|1|||
164206612|NCT04513366|593125041|FG001|Extension Phase|Lost to Follow-up|1|||
164206613|NCT04513366|593125042|FG002|Extension Phase|Lost to Follow-up|1|||
164206614|NCT04513366|593125040|FG000|Extension Phase|Sponsor Decision|0|||
164206615|NCT04513366|593125041|FG001|Extension Phase|Sponsor Decision|1|||
164206616|NCT04513366|593125042|FG002|Extension Phase|Sponsor Decision|0|||
164206617|NCT04513366|593125040|FG000|Extension Phase|Death|0|||
164206618|NCT04513366|593125041|FG001|Extension Phase|Death|1|||
164206619|NCT04513366|593125042|FG002|Extension Phase|Death|0|||
164206620|NCT04513366|593125040|FG000|Extension Phase|Adverse Event|0|||
164206621|NCT04513366|593125041|FG001|Extension Phase|Adverse Event|0|||
164206622|NCT04513366|593125042|FG002|Extension Phase|Adverse Event|1|||
164206623|NCT06121609|593125044|FG000|Overall Study|Lack of Efficacy|0|||
164666869|NCT02585258|594804749|FG001|Overall Study|Lack of Efficacy|9|||
164206624|NCT06121609|593125045|FG001|Overall Study|Lack of Efficacy|0|||
164206625|NCT06121609|593125046|FG002|Overall Study|Lack of Efficacy|45|||
164206626|NCT03344757|593125047|FG000|Overall Study|Withdrawal by Subject|18|||
164666870|NCT02585258|594804748|FG000|Overall Study|includes covid-related access problems|42|||
164319214|NCT01328444|593544641|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
164562603|NCT01928381|594427564|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
164562604|NCT01928381|594427565|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
164562605|NCT01928381|594427566|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
164562606|NCT01928381|594427560|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
164562607|NCT01928381|594427561|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
164562608|NCT01928381|594427562|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
164562609|NCT01928381|594427563|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
164562610|NCT01928381|594427564|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
164562611|NCT01928381|594427565|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
164562612|NCT01928381|594427566|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
164562613|NCT01928381|594427560|FG000|Part 1 - Pain Training|Protocol Violation|1|||
164562614|NCT01928381|594427561|FG001|Part 1 - Pain Training|Protocol Violation|0|||
164562615|NCT01928381|594427562|FG002|Part 1 - Pain Training|Protocol Violation|0|||
164562616|NCT01928381|594427563|FG003|Part 1 - Pain Training|Protocol Violation|0|||
164562617|NCT01928381|594427564|FG004|Part 1 - Pain Training|Protocol Violation|0|||
164562618|NCT01928381|594427565|FG005|Part 1 - Pain Training|Protocol Violation|0|||
164562619|NCT01928381|594427566|FG006|Part 1 - Pain Training|Protocol Violation|0|||
164562620|NCT01928381|594427560|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
164562621|NCT01928381|594427561|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
164562622|NCT01928381|594427562|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
164562623|NCT01928381|594427563|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
164562624|NCT01928381|594427564|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
164562625|NCT01928381|594427565|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
164562626|NCT01928381|594427566|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
164562627|NCT01928381|594427560|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
164562628|NCT01928381|594427561|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
164562629|NCT01928381|594427562|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
164562630|NCT01928381|594427563|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
164562631|NCT01928381|594427564|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
164562632|NCT01928381|594427565|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
164562633|NCT01928381|594427566|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
164562634|NCT01928381|594427560|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
164562635|NCT01928381|594427561|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
164562636|NCT01928381|594427562|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
164562637|NCT01928381|594427563|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
164562638|NCT01928381|594427564|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
164562639|NCT01928381|594427565|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
164562640|NCT01928381|594427566|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
164562641|NCT01928381|594427560|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
164562642|NCT01928381|594427561|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
164562643|NCT01928381|594427562|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
164562644|NCT01928381|594427563|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
164562645|NCT01928381|594427564|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
164562646|NCT01928381|594427565|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
164562647|NCT01928381|594427566|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
164562648|NCT01928381|594427560|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
164562649|NCT01928381|594427561|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
164562650|NCT01928381|594427562|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
164562651|NCT01928381|594427563|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
164562652|NCT01928381|594427564|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
164319215|NCT01328444|593544642|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
164319216|NCT01328444|593544643|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
164319217|NCT01328444|593544644|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
164319218|NCT01328444|593544645|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
164319219|NCT01328444|593544646|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
164319220|NCT01328444|593544641|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
164319221|NCT01328444|593544642|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
164319222|NCT01328444|593544643|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
164319223|NCT01328444|593544644|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
164319224|NCT01328444|593544645|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
164319225|NCT01328444|593544646|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
164319226|NCT01328444|593544641|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
164319227|NCT01328444|593544642|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
164319228|NCT01328444|593544643|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
164319229|NCT01328444|593544644|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
164319230|NCT01328444|593544645|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
164562653|NCT01928381|594427565|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
164206627|NCT03344757|593125048|FG001|Overall Study|Withdrawal by Subject|16|||
164206628|NCT03344757|593125047|FG000|Overall Study|Lost to Follow-up|0|||
164206629|NCT03344757|593125048|FG001|Overall Study|Lost to Follow-up|2|||
164206630|NCT00269152|593125049|FG000|Overall Study|Adverse Event|9|||
164206631|NCT00269152|593125050|FG001|Overall Study|Adverse Event|3|||
164206632|NCT00269152|593125049|FG000|Overall Study|Withdrawal by Subject|7|||
164206633|NCT00269152|593125050|FG001|Overall Study|Withdrawal by Subject|3|||
164319231|NCT01328444|593544646|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
164319232|NCT01328444|593544641|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
164319233|NCT01328444|593544642|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
164319234|NCT01328444|593544643|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
164319235|NCT01328444|593544644|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
164319236|NCT01328444|593544645|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
164319237|NCT01328444|593544646|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
164319238|NCT01328444|593544641|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
164319239|NCT01328444|593544642|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
164319240|NCT01328444|593544643|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
164319241|NCT01328444|593544644|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
164319242|NCT01328444|593544645|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
164319243|NCT01328444|593544646|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
164206634|NCT00269152|593125049|FG000|Overall Study|Physician Decision|2|||
164206635|NCT00269152|593125050|FG001|Overall Study|Physician Decision|3|||
164206636|NCT00269152|593125049|FG000|Overall Study|Protocol Violation|0|||
164206637|NCT00269152|593125050|FG001|Overall Study|Protocol Violation|1|||
164206638|NCT00848497|593125051|FG000|Overall Study|Screen failure|2|||
164206639|NCT00848497|593125052|FG001|Overall Study|Screen failure|0|||
164206640|NCT00848497|593125051|FG000|Overall Study|Withdrawal by Subject|0|||
164206641|NCT00848497|593125052|FG001|Overall Study|Withdrawal by Subject|1|||
164206642|NCT01832766|593125053|FG000|Washout|Lost to Follow-up|0|||
164206643|NCT01832766|593125054|FG001|Washout|Lost to Follow-up|1|||
164206644|NCT03054428|593125057|FG000|Overall Study|Physician Decision|0|||
164206645|NCT03054428|593125058|FG001|Overall Study|Physician Decision|1|||
164206646|NCT03054428|593125059|FG002|Overall Study|Physician Decision|1|||
164206647|NCT03054428|593125057|FG000|Overall Study|Lack of Efficacy|3|||
164206648|NCT03054428|593125058|FG001|Overall Study|Lack of Efficacy|1|||
164206649|NCT03054428|593125059|FG002|Overall Study|Lack of Efficacy|0|||
164206650|NCT03054428|593125057|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
164206651|NCT03054428|593125058|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
164206652|NCT03054428|593125059|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
164206653|NCT03054428|593125057|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
164206654|NCT03054428|593125058|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
164319244|NCT01328444|593544641|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
164319245|NCT01328444|593544642|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
164562654|NCT01928381|594427566|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
164562655|NCT01928381|594427560|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
164562656|NCT01928381|594427561|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
164562657|NCT01928381|594427562|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
164562658|NCT01928381|594427563|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
164562659|NCT01928381|594427564|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
164562660|NCT01928381|594427565|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
164562661|NCT01928381|594427566|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
164562662|NCT01928381|594427560|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
164562663|NCT01928381|594427561|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
164562664|NCT01928381|594427562|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
164562665|NCT01928381|594427563|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
164562666|NCT01928381|594427564|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
164562667|NCT01928381|594427565|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
164562668|NCT01928381|594427566|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
164562669|NCT01928381|594427560|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
164562670|NCT01928381|594427561|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
164562671|NCT01928381|594427562|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
164206655|NCT03054428|593125059|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
164206656|NCT03054428|593125057|FG000|Overall Study|Transitioned to OLE study|76|||
164206657|NCT03054428|593125058|FG001|Overall Study|Transitioned to OLE study|76|||
164206658|NCT03054428|593125059|FG002|Overall Study|Transitioned to OLE study|73|||
164206659|NCT03054428|593125057|FG000|Overall Study|Withdrawal by Subject|3|||
164562672|NCT01928381|594427563|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
164562673|NCT01928381|594427564|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
164562674|NCT01928381|594427565|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
164206660|NCT03054428|593125058|FG001|Overall Study|Withdrawal by Subject|2|||
164562675|NCT01928381|594427566|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
164562676|NCT01928381|594427560|FG000|Washout First Intervention|Protocol Violation|0|||
164562677|NCT01928381|594427561|FG001|Washout First Intervention|Protocol Violation|0|||
164562678|NCT01928381|594427562|FG002|Washout First Intervention|Protocol Violation|0|||
164562679|NCT01928381|594427563|FG003|Washout First Intervention|Protocol Violation|0|||
164562680|NCT01928381|594427564|FG004|Washout First Intervention|Protocol Violation|1|||
164562681|NCT01928381|594427565|FG005|Washout First Intervention|Protocol Violation|0|||
164562682|NCT01928381|594427566|FG006|Washout First Intervention|Protocol Violation|0|||
164562683|NCT01928381|594427560|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
164666871|NCT02585258|594804749|FG001|Overall Study|includes covid-related access problems|46|||
164666872|NCT02585258|594804748|FG000|Overall Study|Lost to Follow-up|5|||
164666873|NCT02585258|594804749|FG001|Overall Study|Lost to Follow-up|2|||
164666874|NCT05125952|594804750|FG000|Overall Study|Physician Decision|1|||
164666875|NCT03946449|594804751|FG000|Treatment Extension II|Rolled over to another study|0|||
164666876|NCT03946449|594804752|FG001|Treatment Extension II|Rolled over to another study|0|||
164666877|NCT03946449|594804753|FG002|Treatment Extension II|Rolled over to another study|2|||
164666878|NCT03946449|594804751|FG000|Treatment Extension II|Withdrawal by Subject|0|||
164666879|NCT03946449|594804752|FG001|Treatment Extension II|Withdrawal by Subject|0|||
164666880|NCT03946449|594804753|FG002|Treatment Extension II|Withdrawal by Subject|1|||
164666881|NCT02848326|594806387|FG000|Treatment Period|Adverse Event|5|||
164666882|NCT02848326|594806388|FG001|Treatment Period|Adverse Event|4|||
164666883|NCT02848326|594806389|FG002|Treatment Period|Adverse Event|11|||
164666884|NCT02848326|594806390|FG003|Treatment Period|Adverse Event|6|||
164206661|NCT03054428|593125059|FG002|Overall Study|Withdrawal by Subject|3|||
164206662|NCT03054428|593125057|FG000|Overall Study|Lost to Follow-up|0|||
164206663|NCT03054428|593125058|FG001|Overall Study|Lost to Follow-up|0|||
164206664|NCT03054428|593125059|FG002|Overall Study|Lost to Follow-up|1|||
164206665|NCT03225287|593125062|FG000|Overall Study|Adverse Event|0|||
164206666|NCT03225287|593125063|FG001|Overall Study|Adverse Event|0|||
164206667|NCT03225287|593125064|FG002|Overall Study|Adverse Event|1|||
164206668|NCT03225287|593125062|FG000|Overall Study|Protocol non-compliance|0|||
164206669|NCT03225287|593125063|FG001|Overall Study|Protocol non-compliance|0|||
164206670|NCT03225287|593125064|FG002|Overall Study|Protocol non-compliance|1|||
164206671|NCT03225287|593125062|FG000|Overall Study|Subject withdraws consent|3|||
164206672|NCT03225287|593125063|FG001|Overall Study|Subject withdraws consent|0|||
164206673|NCT03225287|593125064|FG002|Overall Study|Subject withdraws consent|0|||
164206674|NCT03225287|593125062|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
164206675|NCT03225287|593125063|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
164206676|NCT03225287|593125064|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
164206677|NCT03225287|593125062|FG000|Overall Study|Trial drug not effective|0|||
164206678|NCT03225287|593125063|FG001|Overall Study|Trial drug not effective|1|||
164206679|NCT03225287|593125064|FG002|Overall Study|Trial drug not effective|0|||
164206680|NCT03225287|593125062|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
164206681|NCT03225287|593125063|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
164206682|NCT03225287|593125064|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
164206683|NCT03225287|593125062|FG000|Overall Study|Stem cell transplantation|0|||
164206684|NCT03225287|593125063|FG001|Overall Study|Stem cell transplantation|1|||
164206685|NCT03225287|593125064|FG002|Overall Study|Stem cell transplantation|0|||
164206686|NCT06070610|593125066|FG000|Washout period|Adverse Event|1|||
164206687|NCT06070610|593125066|FG000|Period 2 (Test treatment period)|Adverse Event|1|||
164206688|NCT01499810|593125067|FG000|Overall Study|Lost to Follow-up|10|||
164206689|NCT01499810|593125067|FG000|Overall Study|Protocol Violation|1|||
164206690|NCT01499810|593125067|FG000|Overall Study|Withdrawal by Subject|1|||
164206691|NCT03836053|593126506|FG000|Overall Study|Protocol-specified criteria|0|||
164206692|NCT03836053|593126507|FG001|Overall Study|Protocol-specified criteria|2|||
164206693|NCT03836053|593126508|FG002|Overall Study|Protocol-specified criteria|1|||
164206694|NCT03836053|593126506|FG000|Overall Study|Death|1|||
164206695|NCT03836053|593126507|FG001|Overall Study|Death|6|||
164206696|NCT03836053|593126508|FG002|Overall Study|Death|4|||
164206697|NCT03836053|593126506|FG000|Overall Study|Withdrawal of consent from study|0|||
164206698|NCT03836053|593126507|FG001|Overall Study|Withdrawal of consent from study|0|||
164206699|NCT03836053|593126508|FG002|Overall Study|Withdrawal of consent from study|1|||
164206700|NCT03836053|593126506|FG000|Overall Study|Decision by sponsor|0|||
164206701|NCT03836053|593126507|FG001|Overall Study|Decision by sponsor|2|||
164206702|NCT03836053|593126508|FG002|Overall Study|Decision by sponsor|4|||
164206703|NCT03846479|593126509|FG000|Overall Study|Death|8|||
164206704|NCT03846479|593126509|FG000|Overall Study|Lost to Follow-up|1|||
164206705|NCT02332707|593126510|FG000|Overall Study|Adverse Event|0|||
164206706|NCT02332707|593126511|FG001|Overall Study|Adverse Event|0|||
164666885|NCT02848326|594806391|FG004|Treatment Period|Adverse Event|5|||
164666886|NCT02848326|594806392|FG005|Treatment Period|Adverse Event|7|||
164666887|NCT02848326|594806387|FG000|Treatment Period|Withdrawal of Consent|20|||
164206707|NCT02332707|593126512|FG002|Overall Study|Adverse Event|0|||
164206708|NCT02332707|593126513|FG003|Overall Study|Adverse Event|0|||
164562684|NCT01928381|594427561|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
164206709|NCT02332707|593126514|FG004|Overall Study|Adverse Event|0|||
164206710|NCT02332707|593126515|FG005|Overall Study|Adverse Event|0|||
164206711|NCT02332707|593126516|FG006|Overall Study|Adverse Event|0|||
164206712|NCT02332707|593126517|FG007|Overall Study|Adverse Event|0|||
164206713|NCT02332707|593126518|FG008|Overall Study|Adverse Event|0|||
164206714|NCT02332707|593126519|FG009|Overall Study|Adverse Event|0|||
164206715|NCT02332707|593126520|FG010|Overall Study|Adverse Event|0|||
164206716|NCT02332707|593126521|FG011|Overall Study|Adverse Event|0|||
164206717|NCT02332707|593126522|FG012|Overall Study|Adverse Event|1|||
164206718|NCT02332707|593126523|FG013|Overall Study|Adverse Event|0|||
164206719|NCT02332707|593126524|FG014|Overall Study|Adverse Event|0|||
164206720|NCT02332707|593126525|FG015|Overall Study|Adverse Event|0|||
164206721|NCT02332707|593126526|FG016|Overall Study|Adverse Event|0|||
164206722|NCT02332707|593126527|FG017|Overall Study|Adverse Event|0|||
164206723|NCT02332707|593126510|FG000|Overall Study|Lost to Follow-up|0|||
164206724|NCT02332707|593126511|FG001|Overall Study|Lost to Follow-up|0|||
164206725|NCT02332707|593126512|FG002|Overall Study|Lost to Follow-up|0|||
164206726|NCT02332707|593126513|FG003|Overall Study|Lost to Follow-up|0|||
164206727|NCT02332707|593126514|FG004|Overall Study|Lost to Follow-up|0|||
164206728|NCT02332707|593126515|FG005|Overall Study|Lost to Follow-up|1|||
164206729|NCT02332707|593126516|FG006|Overall Study|Lost to Follow-up|0|||
164206730|NCT02332707|593126517|FG007|Overall Study|Lost to Follow-up|0|||
164319246|NCT01328444|593544643|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
164319247|NCT01328444|593544644|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
164319248|NCT01328444|593544645|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
164319249|NCT01328444|593544646|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
164319250|NCT01328444|593544641|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
164319251|NCT01328444|593544642|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
164319252|NCT01328444|593544643|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
164319253|NCT01328444|593544644|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
164319254|NCT01328444|593544645|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
164319255|NCT01328444|593544646|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
164319256|NCT03316911|593544647|FG000|Overall Study|Lost to Follow-up|33|||
164319257|NCT03316911|593544648|FG001|Overall Study|Lost to Follow-up|29|||
164319258|NCT01270802|593544649|FG000|Overall Study|Withdrawal by Subject|1|||
164319259|NCT01270802|593544650|FG001|Overall Study|Withdrawal by Subject|0|||
164206731|NCT02332707|593126518|FG008|Overall Study|Lost to Follow-up|0|||
164206732|NCT02332707|593126519|FG009|Overall Study|Lost to Follow-up|0|||
164206733|NCT02332707|593126520|FG010|Overall Study|Lost to Follow-up|2|||
164206734|NCT02332707|593126521|FG011|Overall Study|Lost to Follow-up|0|||
164206735|NCT02332707|593126522|FG012|Overall Study|Lost to Follow-up|3|||
164206736|NCT02332707|593126523|FG013|Overall Study|Lost to Follow-up|0|||
164206737|NCT02332707|593126524|FG014|Overall Study|Lost to Follow-up|0|||
164206738|NCT02332707|593126525|FG015|Overall Study|Lost to Follow-up|0|||
164206739|NCT02332707|593126526|FG016|Overall Study|Lost to Follow-up|0|||
164206740|NCT02332707|593126527|FG017|Overall Study|Lost to Follow-up|0|||
164206741|NCT02332707|593126510|FG000|Overall Study|Physician Decision|0|||
164206742|NCT02332707|593126511|FG001|Overall Study|Physician Decision|0|||
164206743|NCT02332707|593126512|FG002|Overall Study|Physician Decision|0|||
164206744|NCT02332707|593126513|FG003|Overall Study|Physician Decision|1|||
164206745|NCT02332707|593126514|FG004|Overall Study|Physician Decision|0|||
164206746|NCT02332707|593126515|FG005|Overall Study|Physician Decision|0|||
164206747|NCT02332707|593126516|FG006|Overall Study|Physician Decision|0|||
164206748|NCT02332707|593126517|FG007|Overall Study|Physician Decision|0|||
164206749|NCT02332707|593126518|FG008|Overall Study|Physician Decision|0|||
164319260|NCT01270802|593544649|FG000|Overall Study|Adverse Event|1|||
164319261|NCT01270802|593544650|FG001|Overall Study|Adverse Event|0|||
164319262|NCT01270802|593544649|FG000|Overall Study|Lost to Follow-up|0|||
164206750|NCT02332707|593126519|FG009|Overall Study|Physician Decision|0|||
164206751|NCT02332707|593126520|FG010|Overall Study|Physician Decision|0|||
164206752|NCT02332707|593126521|FG011|Overall Study|Physician Decision|0|||
164206753|NCT02332707|593126522|FG012|Overall Study|Physician Decision|1|||
164206754|NCT02332707|593126523|FG013|Overall Study|Physician Decision|0|||
164206755|NCT02332707|593126524|FG014|Overall Study|Physician Decision|0|||
164319263|NCT01270802|593544650|FG001|Overall Study|Lost to Follow-up|1|||
164319264|NCT04620798|593544653|FG000|Overall Study|Lost to Follow-up|126|||
164319265|NCT04620798|593544654|FG001|Overall Study|Lost to Follow-up|138|||
164319266|NCT03222492|593544660|FG000|Overall Study|Withdrawal by Subject|0|||
164319267|NCT03222492|593544661|FG001|Overall Study|Withdrawal by Subject|0|||
164319268|NCT03222492|593544662|FG002|Overall Study|Withdrawal by Subject|1|||
164206756|NCT02332707|593126525|FG015|Overall Study|Physician Decision|0|||
164206757|NCT02332707|593126526|FG016|Overall Study|Physician Decision|0|||
164206758|NCT02332707|593126527|FG017|Overall Study|Physician Decision|0|||
164206759|NCT02332707|593126510|FG000|Overall Study|Withdrawal by Subject|0|||
164206760|NCT02332707|593126511|FG001|Overall Study|Withdrawal by Subject|0|||
164206761|NCT02332707|593126512|FG002|Overall Study|Withdrawal by Subject|1|||
164206762|NCT02332707|593126513|FG003|Overall Study|Withdrawal by Subject|0|||
164206763|NCT02332707|593126514|FG004|Overall Study|Withdrawal by Subject|0|||
164666888|NCT02848326|594806388|FG001|Treatment Period|Withdrawal of Consent|6|||
164666889|NCT02848326|594806389|FG002|Treatment Period|Withdrawal of Consent|9|||
164666890|NCT02848326|594806390|FG003|Treatment Period|Withdrawal of Consent|6|||
164562685|NCT01928381|594427562|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
164666891|NCT02848326|594806391|FG004|Treatment Period|Withdrawal of Consent|9|||
164666892|NCT02848326|594806392|FG005|Treatment Period|Withdrawal of Consent|6|||
164666893|NCT02848326|594806387|FG000|Treatment Period|Lost to Follow-up|5|||
164666894|NCT02848326|594806388|FG001|Treatment Period|Lost to Follow-up|1|||
164666895|NCT02848326|594806389|FG002|Treatment Period|Lost to Follow-up|11|||
164666896|NCT02848326|594806390|FG003|Treatment Period|Lost to Follow-up|7|||
164562686|NCT01928381|594427563|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
164562687|NCT01928381|594427564|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
164562688|NCT01928381|594427565|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
164562689|NCT01928381|594427566|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
164562690|NCT01928381|594427560|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
164562691|NCT01928381|594427561|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
164562692|NCT01928381|594427562|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
164666897|NCT02848326|594806391|FG004|Treatment Period|Lost to Follow-up|2|||
164666898|NCT02848326|594806392|FG005|Treatment Period|Lost to Follow-up|3|||
164666899|NCT02848326|594806387|FG000|Treatment Period|Pregnancy|0|||
164206764|NCT02332707|593126515|FG005|Overall Study|Withdrawal by Subject|0|||
164562693|NCT01928381|594427563|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
164562694|NCT01928381|594427564|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
164562695|NCT01928381|594427565|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
164562696|NCT01928381|594427566|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
164562697|NCT01182428|594427569|FG000|Overall Study|Physician Decision|1|||
164562698|NCT01182428|594427570|FG001|Overall Study|Physician Decision|0|||
164562699|NCT01182428|594427569|FG000|Overall Study|Lost to Follow-up|9|||
164562700|NCT01182428|594427570|FG001|Overall Study|Lost to Follow-up|1|||
164562701|NCT01182428|594427569|FG000|Overall Study|Withdrawal by Subject|1|||
164562702|NCT01182428|594427570|FG001|Overall Study|Withdrawal by Subject|0|||
164562703|NCT03631706|594427572|FG000|Overall Study|Randomized, not treated|1|||
164562704|NCT03631706|594427573|FG001|Overall Study|Randomized, not treated|0|||
164562705|NCT02554929|594429269|FG000|Overall Study|Lost to Follow-up|4|||
164562706|NCT02554929|594429270|FG001|Overall Study|Lost to Follow-up|4|||
164562707|NCT02554929|594429269|FG000|Overall Study|Withdrawal by Subject|2|||
164562708|NCT02554929|594429270|FG001|Overall Study|Withdrawal by Subject|8|||
164562709|NCT04187092|594429273|FG000|Overall Study|Lost to Follow-up|1|||
164562710|NCT04187092|594429274|FG001|Overall Study|Lost to Follow-up|1|||
164562711|NCT04187092|594429273|FG000|Overall Study|Withdrawal by Subject|1|||
164562712|NCT04187092|594429274|FG001|Overall Study|Withdrawal by Subject|1|||
164562713|NCT04187092|594429273|FG000|Overall Study|Adverse Event|0|||
164562714|NCT04187092|594429274|FG001|Overall Study|Adverse Event|1|||
164562715|NCT04660643|594429275|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
164562716|NCT04660643|594429276|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
164562717|NCT04660643|594429277|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
164562718|NCT04660643|594429275|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
164562719|NCT04660643|594429276|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
164562720|NCT04660643|594429277|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
164562721|NCT04660643|594429275|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
164562722|NCT04660643|594429276|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
164562723|NCT04660643|594429277|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
164562724|NCT04660643|594429275|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
164562725|NCT04660643|594429276|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
164666900|NCT02848326|594806388|FG001|Treatment Period|Pregnancy|0|||
164666901|NCT02848326|594806389|FG002|Treatment Period|Pregnancy|1|||
164206765|NCT02332707|593126516|FG006|Overall Study|Withdrawal by Subject|0|||
164206766|NCT02332707|593126517|FG007|Overall Study|Withdrawal by Subject|0|||
164206767|NCT02332707|593126518|FG008|Overall Study|Withdrawal by Subject|0|||
164206768|NCT02332707|593126519|FG009|Overall Study|Withdrawal by Subject|3|||
164206769|NCT02332707|593126520|FG010|Overall Study|Withdrawal by Subject|0|||
164206770|NCT02332707|593126521|FG011|Overall Study|Withdrawal by Subject|0|||
164206771|NCT02332707|593126522|FG012|Overall Study|Withdrawal by Subject|0|||
164319269|NCT03222492|593544663|FG003|Overall Study|Withdrawal by Subject|0|||
164319270|NCT03222492|593544660|FG000|Overall Study|COVID-19 related|0|||
164562726|NCT04660643|594429277|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
164562727|NCT04660643|594429275|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
164562728|NCT04660643|594429276|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
164562729|NCT04660643|594429277|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
164562730|NCT04660643|594429275|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
164562731|NCT04660643|594429276|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
164562732|NCT04660643|594429277|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
164319271|NCT03222492|593544661|FG001|Overall Study|COVID-19 related|0|||
164319272|NCT03222492|593544662|FG002|Overall Study|COVID-19 related|1|||
164319273|NCT03222492|593544663|FG003|Overall Study|COVID-19 related|0|||
164319274|NCT02486627|593544667|FG000|Overall Study|Death|1|||
164319275|NCT02486627|593544668|FG001|Overall Study|Death|0|||
164319276|NCT02486627|593544667|FG000|Overall Study|Other Unspecified|0|||
164319277|NCT02486627|593544668|FG001|Overall Study|Other Unspecified|2|||
164319278|NCT02486627|593544667|FG000|Overall Study|Consent Withdrawn by Participant|4|||
164319279|NCT02486627|593544668|FG001|Overall Study|Consent Withdrawn by Participant|3|||
164319280|NCT02486627|593544667|FG000|Overall Study|Significant Participant Noncompliance|1|||
164319281|NCT02486627|593544668|FG001|Overall Study|Significant Participant Noncompliance|1|||
164319282|NCT02486627|593544667|FG000|Overall Study|Lost to Follow-up|1|||
164319283|NCT02486627|593544668|FG001|Overall Study|Lost to Follow-up|3|||
164319284|NCT05395091|593544670|FG000|Baseline to Month 12|Adverse Event|7|||
164319285|NCT05395091|593544671|FG001|Baseline to Month 12|Adverse Event|2|||
164319286|NCT05395091|593544672|FG002|Baseline to Month 12|Adverse Event|0|||
164319287|NCT05395091|593544670|FG000|Baseline to Month 12|Death|3|||
164319288|NCT05395091|593544671|FG001|Baseline to Month 12|Death|1|||
164319289|NCT05395091|593544672|FG002|Baseline to Month 12|Death|0|||
164319290|NCT05395091|593544670|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
164319291|NCT05395091|593544671|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
164319292|NCT05395091|593544672|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
164319293|NCT05395091|593544670|FG000|Baseline to Month 12|Protocol Violation|2|||
164319294|NCT05395091|593544671|FG001|Baseline to Month 12|Protocol Violation|3|||
164319295|NCT05395091|593544672|FG002|Baseline to Month 12|Protocol Violation|0|||
164319296|NCT05395091|593544670|FG000|Baseline to Month 12|Physician Decision|1|||
164319297|NCT05395091|593544671|FG001|Baseline to Month 12|Physician Decision|0|||
164319298|NCT05395091|593544672|FG002|Baseline to Month 12|Physician Decision|0|||
164319299|NCT05395091|593544670|FG000|Month 12 to Month 18|Death|1|||
164319300|NCT05395091|593544671|FG001|Month 12 to Month 18|Death|0|||
164319301|NCT05395091|593544672|FG002|Month 12 to Month 18|Death|0|||
164319302|NCT05395091|593544670|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
164319303|NCT05395091|593544671|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
164319304|NCT05395091|593544672|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
164319305|NCT05395091|593544670|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
164319306|NCT05395091|593544671|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
164319307|NCT05395091|593544672|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
164319308|NCT05395091|593544670|FG000|Month 12 to Month 18|Other reasons|0|||
164319309|NCT05395091|593544671|FG001|Month 12 to Month 18|Other reasons|0|||
164319310|NCT05395091|593544672|FG002|Month 12 to Month 18|Other reasons|1|||
164319311|NCT00832624|593544677|FG000|Overall Study|Study Terminated|10|||
164319312|NCT00548184|593544678|FG000|Overall Study|Adverse Event|3|||
164319313|NCT00548184|593544678|FG000|Overall Study|took other drug|1|||
164319314|NCT00548184|593544678|FG000|Overall Study|Found Her2 negative|1|||
164319315|NCT00796523|593544681|FG000|Overall Study|Lost to Follow-up|9|||
164319316|NCT00796523|593544682|FG001|Overall Study|Lost to Follow-up|7|||
164319317|NCT02431260|593544686|FG000|Overall Study|Subject Decision|0|||
164319318|NCT02431260|593544687|FG001|Overall Study|Subject Decision|1|||
164319319|NCT02431260|593544688|FG002|Overall Study|Subject Decision|1|||
164319320|NCT02431260|593544689|FG003|Overall Study|Subject Decision|0|||
164319321|NCT02431260|593544690|FG004|Overall Study|Subject Decision|0|||
164319322|NCT02431260|593544691|FG005|Overall Study|Subject Decision|0|||
164319323|NCT02431260|593544692|FG006|Overall Study|Subject Decision|0|||
164319324|NCT02431260|593544693|FG007|Overall Study|Subject Decision|0|||
164319325|NCT02431260|593544694|FG008|Overall Study|Subject Decision|1|||
164319326|NCT02431260|593544695|FG009|Overall Study|Subject Decision|1|||
164319327|NCT02431260|593544696|FG010|Overall Study|Subject Decision|0|||
164319328|NCT02431260|593544697|FG011|Overall Study|Subject Decision|1|||
164319329|NCT02431260|593544698|FG012|Overall Study|Subject Decision|0|||
164319330|NCT02431260|593544699|FG013|Overall Study|Subject Decision|0|||
164319331|NCT02431260|593544686|FG000|Overall Study|Death|4|||
164319332|NCT02431260|593544687|FG001|Overall Study|Death|4|||
164319333|NCT02431260|593544688|FG002|Overall Study|Death|3|||
164319334|NCT02431260|593544689|FG003|Overall Study|Death|4|||
164319335|NCT02431260|593544690|FG004|Overall Study|Death|2|||
164319336|NCT02431260|593544691|FG005|Overall Study|Death|2|||
164319337|NCT02431260|593544692|FG006|Overall Study|Death|3|||
164319338|NCT02431260|593544693|FG007|Overall Study|Death|1|||
164319339|NCT02431260|593544694|FG008|Overall Study|Death|6|||
164319340|NCT02431260|593544695|FG009|Overall Study|Death|6|||
164319341|NCT02431260|593544696|FG010|Overall Study|Death|3|||
164319342|NCT02431260|593544697|FG011|Overall Study|Death|2|||
164319343|NCT02431260|593544698|FG012|Overall Study|Death|5|||
164319344|NCT02431260|593544699|FG013|Overall Study|Death|1|||
164319345|NCT02431260|593544686|FG000|Overall Study|Lost to Follow-up|0|||
164319346|NCT02431260|593544687|FG001|Overall Study|Lost to Follow-up|0|||
164319347|NCT02431260|593544688|FG002|Overall Study|Lost to Follow-up|0|||
164319348|NCT02431260|593544689|FG003|Overall Study|Lost to Follow-up|0|||
164319349|NCT02431260|593544690|FG004|Overall Study|Lost to Follow-up|0|||
164206772|NCT02332707|593126523|FG013|Overall Study|Withdrawal by Subject|0|||
164206773|NCT02332707|593126524|FG014|Overall Study|Withdrawal by Subject|0|||
164206774|NCT02332707|593126525|FG015|Overall Study|Withdrawal by Subject|0|||
164206775|NCT02332707|593126526|FG016|Overall Study|Withdrawal by Subject|0|||
164206776|NCT02332707|593126527|FG017|Overall Study|Withdrawal by Subject|0|||
164206777|NCT01473134|593126528|FG000|Overall Study|Lost to Follow-up|21|||
164206778|NCT01473134|593126529|FG001|Overall Study|Lost to Follow-up|13|||
164206779|NCT01473134|593126528|FG000|Overall Study|Protocol Violation|32|||
164206780|NCT01473134|593126529|FG001|Overall Study|Protocol Violation|19|||
164206781|NCT01473134|593126528|FG000|Overall Study|Withdrawal by Subject|1|||
164206782|NCT01473134|593126529|FG001|Overall Study|Withdrawal by Subject|2|||
164206783|NCT01473134|593126528|FG000|Overall Study|Death|0|||
164206784|NCT01473134|593126529|FG001|Overall Study|Death|1|||
164206785|NCT01473134|593126528|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
164206786|NCT01473134|593126529|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
164206787|NCT00375752|593126532|FG000|Overall Study|Lack of Efficacy|4|||
164206788|NCT00375752|593126533|FG001|Overall Study|Lack of Efficacy|4|||
164319350|NCT02431260|593544691|FG005|Overall Study|Lost to Follow-up|1|||
164666902|NCT02848326|594806390|FG003|Treatment Period|Pregnancy|1|||
164666903|NCT02848326|594806391|FG004|Treatment Period|Pregnancy|0|||
164666904|NCT02848326|594806392|FG005|Treatment Period|Pregnancy|1|||
164666905|NCT02848326|594806387|FG000|Treatment Period|Protocol Violation|4|||
164666906|NCT02848326|594806388|FG001|Treatment Period|Protocol Violation|3|||
164666907|NCT02848326|594806389|FG002|Treatment Period|Protocol Violation|4|||
164666908|NCT02848326|594806390|FG003|Treatment Period|Protocol Violation|2|||
164666909|NCT02848326|594806391|FG004|Treatment Period|Protocol Violation|3|||
164666910|NCT02848326|594806392|FG005|Treatment Period|Protocol Violation|3|||
164666911|NCT02848326|594806387|FG000|Treatment Period|Non-compliance with Study Drug|4|||
164666912|NCT02848326|594806388|FG001|Treatment Period|Non-compliance with Study Drug|0|||
164666913|NCT02848326|594806389|FG002|Treatment Period|Non-compliance with Study Drug|0|||
164666914|NCT02848326|594806390|FG003|Treatment Period|Non-compliance with Study Drug|1|||
164666915|NCT02848326|594806391|FG004|Treatment Period|Non-compliance with Study Drug|0|||
164666916|NCT02848326|594806392|FG005|Treatment Period|Non-compliance with Study Drug|0|||
164562733|NCT04660643|594429275|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
164562734|NCT04660643|594429276|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
164562735|NCT04660643|594429277|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
164562736|NCT04660643|594429275|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
164562737|NCT04660643|594429276|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
164562738|NCT04660643|594429277|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
164562739|NCT04660643|594429275|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
164562740|NCT04660643|594429276|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
164562741|NCT04660643|594429277|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
164562742|NCT04660643|594429275|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
164562743|NCT04660643|594429276|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
164319351|NCT02431260|593544692|FG006|Overall Study|Lost to Follow-up|0|||
164319352|NCT02431260|593544693|FG007|Overall Study|Lost to Follow-up|0|||
164319353|NCT02431260|593544694|FG008|Overall Study|Lost to Follow-up|0|||
164319354|NCT02431260|593544695|FG009|Overall Study|Lost to Follow-up|0|||
164319355|NCT02431260|593544696|FG010|Overall Study|Lost to Follow-up|0|||
164319356|NCT02431260|593544697|FG011|Overall Study|Lost to Follow-up|0|||
164319357|NCT02431260|593544698|FG012|Overall Study|Lost to Follow-up|0|||
164319358|NCT02431260|593544699|FG013|Overall Study|Lost to Follow-up|0|||
164319359|NCT02431260|593544686|FG000|Overall Study|Study Terminated by the Sponsor|0|||
164319360|NCT02431260|593544687|FG001|Overall Study|Study Terminated by the Sponsor|0|||
164319361|NCT02431260|593544688|FG002|Overall Study|Study Terminated by the Sponsor|2|||
164319362|NCT02431260|593544689|FG003|Overall Study|Study Terminated by the Sponsor|1|||
164319363|NCT02431260|593544690|FG004|Overall Study|Study Terminated by the Sponsor|1|||
164319364|NCT02431260|593544691|FG005|Overall Study|Study Terminated by the Sponsor|0|||
164319365|NCT02431260|593544692|FG006|Overall Study|Study Terminated by the Sponsor|1|||
164319366|NCT02431260|593544693|FG007|Overall Study|Study Terminated by the Sponsor|2|||
164319367|NCT02431260|593544694|FG008|Overall Study|Study Terminated by the Sponsor|1|||
164319368|NCT02431260|593544695|FG009|Overall Study|Study Terminated by the Sponsor|1|||
164319369|NCT02431260|593544696|FG010|Overall Study|Study Terminated by the Sponsor|1|||
164319370|NCT02431260|593544697|FG011|Overall Study|Study Terminated by the Sponsor|0|||
164319371|NCT02431260|593544698|FG012|Overall Study|Study Terminated by the Sponsor|4|||
164666917|NCT02848326|594806387|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
164666918|NCT02848326|594806388|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
164666919|NCT02848326|594806389|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
164206789|NCT00375752|593126532|FG000|Overall Study|Adverse Event|1|||
164206790|NCT00375752|593126533|FG001|Overall Study|Adverse Event|6|||
164319372|NCT02431260|593544699|FG013|Overall Study|Study Terminated by the Sponsor|0|||
164319373|NCT02431260|593544686|FG000|Overall Study|Physician Decision|0|||
164666920|NCT02848326|594806390|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
164206791|NCT00375752|593126532|FG000|Overall Study|Withdrawal by Subject|6|||
164206792|NCT00375752|593126533|FG001|Overall Study|Withdrawal by Subject|1|||
164206793|NCT00375752|593126532|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
164206794|NCT00375752|593126533|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
164206795|NCT00375752|593126532|FG000|Overall Study|Protocol Violation|0|||
164206796|NCT00375752|593126533|FG001|Overall Study|Protocol Violation|2|||
164206797|NCT00375752|593126532|FG000|Overall Study|Administrative Problems|0|||
164206798|NCT00375752|593126533|FG001|Overall Study|Administrative Problems|1|||
164206799|NCT01649765|593126538|FG000|Overall Study|Adverse Event|5|||
164206800|NCT01649765|593126539|FG001|Overall Study|Adverse Event|3|||
164206801|NCT01649765|593126538|FG000|Overall Study|Lack of Efficacy|1|||
164206802|NCT01649765|593126539|FG001|Overall Study|Lack of Efficacy|1|||
164206803|NCT01649765|593126538|FG000|Overall Study|Physician Decision|0|||
164206804|NCT01649765|593126539|FG001|Overall Study|Physician Decision|3|||
164206805|NCT01649765|593126538|FG000|Overall Study|Protocol Violation|1|||
164206806|NCT01649765|593126539|FG001|Overall Study|Protocol Violation|0|||
164206807|NCT01649765|593126538|FG000|Overall Study|Withdrawal by Subject|2|||
164206808|NCT01649765|593126539|FG001|Overall Study|Withdrawal by Subject|1|||
164206809|NCT02469233|593126540|FG000|Overall Study|Death|1|||
164206810|NCT02469233|593126541|FG001|Overall Study|Death|1|||
164206811|NCT02469233|593126540|FG000|Overall Study|Lost to post or 6 month follow up|7|||
164206812|NCT02469233|593126541|FG001|Overall Study|Lost to post or 6 month follow up|2|||
164206813|NCT00855582|593126546|FG000|Overall Study|Adverse Event|2|||
164206814|NCT00855582|593126547|FG001|Overall Study|Adverse Event|6|||
164206815|NCT00855582|593126548|FG002|Overall Study|Adverse Event|3|||
164206816|NCT00855582|593126546|FG000|Overall Study|Death|1|||
164206817|NCT00855582|593126547|FG001|Overall Study|Death|0|||
164206818|NCT00855582|593126548|FG002|Overall Study|Death|0|||
164206819|NCT00855582|593126546|FG000|Overall Study|Lack of Efficacy|1|||
164206820|NCT00855582|593126547|FG001|Overall Study|Lack of Efficacy|3|||
164206821|NCT00855582|593126548|FG002|Overall Study|Lack of Efficacy|8|||
164206822|NCT00855582|593126546|FG000|Overall Study|Lost to Follow-up|1|||
164206823|NCT00855582|593126547|FG001|Overall Study|Lost to Follow-up|3|||
164206824|NCT00855582|593126548|FG002|Overall Study|Lost to Follow-up|1|||
164206825|NCT00855582|593126546|FG000|Overall Study|Physician Decision|0|||
164206826|NCT00855582|593126547|FG001|Overall Study|Physician Decision|0|||
164206827|NCT00855582|593126548|FG002|Overall Study|Physician Decision|1|||
164206828|NCT00855582|593126546|FG000|Overall Study|Protocol Violation|6|||
164206829|NCT00855582|593126547|FG001|Overall Study|Protocol Violation|2|||
164206830|NCT00855582|593126548|FG002|Overall Study|Protocol Violation|6|||
164206831|NCT00855582|593126546|FG000|Overall Study|Entry Criteria Not Met|8|||
164206832|NCT00855582|593126547|FG001|Overall Study|Entry Criteria Not Met|6|||
164206833|NCT00855582|593126548|FG002|Overall Study|Entry Criteria Not Met|3|||
164206834|NCT00855582|593126546|FG000|Overall Study|Withdrawal by Subject|7|||
164206835|NCT00855582|593126547|FG001|Overall Study|Withdrawal by Subject|4|||
164206836|NCT00855582|593126548|FG002|Overall Study|Withdrawal by Subject|8|||
164206837|NCT03813654|593126549|FG000|Overall Study|Protocol Violation|0|||
164206838|NCT03813654|593126550|FG001|Overall Study|Protocol Violation|1|||
164206839|NCT03813654|593126551|FG002|Overall Study|Protocol Violation|2|||
164206840|NCT03813654|593126549|FG000|Overall Study|Withdrawal by Subject|1|||
164206841|NCT03813654|593126550|FG001|Overall Study|Withdrawal by Subject|0|||
164206842|NCT03813654|593126551|FG002|Overall Study|Withdrawal by Subject|0|||
164206843|NCT02832037|593126552|FG000|Overall Study|Administrative reasons|0|||
164206844|NCT02832037|593126553|FG001|Overall Study|Administrative reasons|0|||
164206845|NCT02832037|593126554|FG002|Overall Study|Administrative reasons|1|||
164206846|NCT02832037|593126555|FG003|Overall Study|Administrative reasons|0|||
164206847|NCT02832037|593126556|FG004|Overall Study|Administrative reasons|0|||
164206848|NCT02832037|593126552|FG000|Overall Study|Protocol Violation|3|||
164206849|NCT02832037|593126553|FG001|Overall Study|Protocol Violation|0|||
164206850|NCT02832037|593126554|FG002|Overall Study|Protocol Violation|4|||
164206851|NCT02832037|593126555|FG003|Overall Study|Protocol Violation|1|||
164206852|NCT02832037|593126556|FG004|Overall Study|Protocol Violation|2|||
164206853|NCT02832037|593126552|FG000|Overall Study|Lost to Follow-up|2|||
164206854|NCT02832037|593126553|FG001|Overall Study|Lost to Follow-up|0|||
164206855|NCT02832037|593126554|FG002|Overall Study|Lost to Follow-up|3|||
164206856|NCT02832037|593126555|FG003|Overall Study|Lost to Follow-up|0|||
164206857|NCT02832037|593126556|FG004|Overall Study|Lost to Follow-up|5|||
164206858|NCT02832037|593126552|FG000|Overall Study|Withdrawal by Subject|9|||
164206859|NCT02832037|593126553|FG001|Overall Study|Withdrawal by Subject|8|||
164206860|NCT02832037|593126554|FG002|Overall Study|Withdrawal by Subject|0|||
164206861|NCT02832037|593126555|FG003|Overall Study|Withdrawal by Subject|4|||
164206862|NCT02832037|593126556|FG004|Overall Study|Withdrawal by Subject|8|||
164206863|NCT02832037|593126552|FG000|Overall Study|Adverse Event|5|||
164206864|NCT02832037|593126553|FG001|Overall Study|Adverse Event|4|||
164206865|NCT02832037|593126554|FG002|Overall Study|Adverse Event|0|||
164206866|NCT02832037|593126555|FG003|Overall Study|Adverse Event|2|||
164206867|NCT02832037|593126556|FG004|Overall Study|Adverse Event|4|||
164206868|NCT04727749|593126561|FG000|Overall Study|Lost to Follow-up|10|||
164206869|NCT04727749|593126562|FG001|Overall Study|Lost to Follow-up|3|||
164206870|NCT02378181|593126563|FG000|Overall Study|Lost to Follow-up|2|||
164206871|NCT02378181|593126564|FG001|Overall Study|Lost to Follow-up|5|||
164206872|NCT02378181|593126563|FG000|Overall Study|Withdrawal by Subject|1|||
164206873|NCT02378181|593126564|FG001|Overall Study|Withdrawal by Subject|1|||
164206874|NCT02378181|593126563|FG000|Overall Study|Incarcerated|0|||
164206875|NCT02378181|593126564|FG001|Overall Study|Incarcerated|1|||
164206876|NCT01859741|593126565|FG000|Overall Study|Death|3|||
164206877|NCT01859741|593126566|FG001|Overall Study|Death|2|||
164206878|NCT01859741|593126567|FG002|Overall Study|Death|4|||
164206879|NCT01859741|593126568|FG003|Overall Study|Death|3|||
164206880|NCT01859741|593126569|FG004|Overall Study|Death|5|||
164206881|NCT01859741|593126570|FG005|Overall Study|Death|4|||
164206882|NCT01859741|593126571|FG006|Overall Study|Death|51|||
164206883|NCT01859741|593126572|FG007|Overall Study|Death|51|||
164206884|NCT01859741|593126565|FG000|Overall Study|Lost to Follow-up|0|||
164206885|NCT01859741|593126566|FG001|Overall Study|Lost to Follow-up|0|||
164206886|NCT01859741|593126567|FG002|Overall Study|Lost to Follow-up|0|||
164206887|NCT01859741|593126568|FG003|Overall Study|Lost to Follow-up|0|||
164206888|NCT01859741|593126569|FG004|Overall Study|Lost to Follow-up|0|||
164206889|NCT01859741|593126570|FG005|Overall Study|Lost to Follow-up|1|||
164206890|NCT01859741|593126571|FG006|Overall Study|Lost to Follow-up|0|||
164206891|NCT01859741|593126572|FG007|Overall Study|Lost to Follow-up|4|||
164206892|NCT01859741|593126565|FG000|Overall Study|Withdrawal by Subject|0|||
164206893|NCT01859741|593126566|FG001|Overall Study|Withdrawal by Subject|1|||
164206894|NCT01859741|593126567|FG002|Overall Study|Withdrawal by Subject|2|||
164206895|NCT01859741|593126568|FG003|Overall Study|Withdrawal by Subject|0|||
164206896|NCT01859741|593126569|FG004|Overall Study|Withdrawal by Subject|0|||
164206897|NCT01859741|593126570|FG005|Overall Study|Withdrawal by Subject|1|||
164206898|NCT01859741|593126571|FG006|Overall Study|Withdrawal by Subject|1|||
164562744|NCT04660643|594429277|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
164562745|NCT04660643|594429275|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
164562746|NCT04660643|594429276|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
164562747|NCT04660643|594429277|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
164206899|NCT01859741|593126572|FG007|Overall Study|Withdrawal by Subject|1|||
164206900|NCT01859741|593126565|FG000|Overall Study|Study Terminated by Sponsor|0|||
164206901|NCT01859741|593126566|FG001|Overall Study|Study Terminated by Sponsor|0|||
164206902|NCT01859741|593126567|FG002|Overall Study|Study Terminated by Sponsor|0|||
164206903|NCT01859741|593126568|FG003|Overall Study|Study Terminated by Sponsor|0|||
164206904|NCT01859741|593126569|FG004|Overall Study|Study Terminated by Sponsor|1|||
164206905|NCT01859741|593126570|FG005|Overall Study|Study Terminated by Sponsor|0|||
164562748|NCT04660643|594429275|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
164562749|NCT04660643|594429276|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
164562750|NCT04660643|594429277|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
164562751|NCT04660643|594429275|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
164562752|NCT04660643|594429276|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
164562753|NCT04660643|594429277|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
164562754|NCT04660643|594429275|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
164562755|NCT04660643|594429276|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
164562756|NCT04660643|594429277|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
164562757|NCT04660643|594429275|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
164206906|NCT01859741|593126571|FG006|Overall Study|Study Terminated by Sponsor|16|||
164206907|NCT01859741|593126572|FG007|Overall Study|Study Terminated by Sponsor|14|||
164206908|NCT01859741|593126565|FG000|Overall Study|Other|0|||
164206909|NCT01859741|593126566|FG001|Overall Study|Other|0|||
164206910|NCT01859741|593126567|FG002|Overall Study|Other|0|||
164206911|NCT01859741|593126568|FG003|Overall Study|Other|0|||
164206912|NCT01859741|593126569|FG004|Overall Study|Other|0|||
164206913|NCT01859741|593126570|FG005|Overall Study|Other|0|||
164206914|NCT01859741|593126571|FG006|Overall Study|Other|2|||
164206915|NCT01859741|593126572|FG007|Overall Study|Other|0|||
164206916|NCT02412657|593126574|FG000|Overall Study|Lost to Follow-up|1|||
164206917|NCT02412657|593126575|FG001|Overall Study|Lost to Follow-up|0|||
164206918|NCT02412657|593126576|FG002|Overall Study|Lost to Follow-up|0|||
164206919|NCT02412657|593126574|FG000|Overall Study|Protocol Violation|0|||
164206920|NCT02412657|593126575|FG001|Overall Study|Protocol Violation|2|||
164206921|NCT02412657|593126576|FG002|Overall Study|Protocol Violation|3|||
164206922|NCT04167462|593126580|FG000|Overall Study|Other reasons|3|||
164206923|NCT04167462|593126581|FG001|Overall Study|Other reasons|2|||
164206924|NCT04167462|593126580|FG000|Overall Study|Withdrawal by Subject|6|||
164319374|NCT02431260|593544687|FG001|Overall Study|Physician Decision|0|||
164206925|NCT04167462|593126581|FG001|Overall Study|Withdrawal by Subject|7|||
164206926|NCT04167462|593126580|FG000|Overall Study|Adverse Event|4|||
164206927|NCT04167462|593126581|FG001|Overall Study|Adverse Event|0|||
164206928|NCT04167462|593126580|FG000|Overall Study|Pregnancy|1|||
164206929|NCT04167462|593126581|FG001|Overall Study|Pregnancy|0|||
164319375|NCT02431260|593544688|FG002|Overall Study|Physician Decision|0|||
164206930|NCT04167462|593126580|FG000|Overall Study|Lack of Efficacy|0|||
164206931|NCT04167462|593126581|FG001|Overall Study|Lack of Efficacy|1|||
164206932|NCT02320396|593126582|FG000|Overall Study|Adverse Event|2|||
164206933|NCT02320396|593126583|FG001|Overall Study|Adverse Event|2|||
164206934|NCT02320396|593126582|FG000|Overall Study|Pregnancy|0|||
164206935|NCT02320396|593126583|FG001|Overall Study|Pregnancy|1|||
164206936|NCT02320396|593126582|FG000|Overall Study|Protocol Violation|0|||
164206937|NCT02320396|593126583|FG001|Overall Study|Protocol Violation|1|||
164206938|NCT02320396|593126582|FG000|Overall Study|Withdrawal by Subject|2|||
164206939|NCT02320396|593126583|FG001|Overall Study|Withdrawal by Subject|0|||
164206940|NCT02382939|593126590|FG000|Overall Study|Adverse Event|1|||
164206941|NCT02382939|593126591|FG001|Overall Study|Adverse Event|1|||
164206942|NCT02382939|593126590|FG000|Overall Study|Withdrawal by Subject|2|||
164206943|NCT02382939|593126591|FG001|Overall Study|Withdrawal by Subject|2|||
164206944|NCT00142415|593126592|FG000|Overall Study|Physician Decision|0|||
164206945|NCT00142415|593126593|FG001|Overall Study|Physician Decision|0|||
164206946|NCT00142415|593126594|FG002|Overall Study|Physician Decision|0|||
164206947|NCT00142415|593126595|FG003|Overall Study|Physician Decision|0|||
164206948|NCT00142415|593126596|FG004|Overall Study|Physician Decision|1|||
164206949|NCT00142415|593126597|FG005|Overall Study|Physician Decision|2|||
164206950|NCT01129128|593126602|FG000|Overall Study|Lost to Follow-up|2|||
164206951|NCT01129128|593126603|FG001|Overall Study|Lost to Follow-up|2|||
164206952|NCT01129128|593126604|FG002|Overall Study|Lost to Follow-up|1|||
164206953|NCT01129128|593126602|FG000|Overall Study|Protocol Violation|0|||
164206954|NCT01129128|593126603|FG001|Overall Study|Protocol Violation|1|||
164206955|NCT01129128|593126604|FG002|Overall Study|Protocol Violation|0|||
164206956|NCT01129128|593126602|FG000|Overall Study|Withdrawal by Subject|0|||
164206957|NCT01129128|593126603|FG001|Overall Study|Withdrawal by Subject|1|||
164206958|NCT01129128|593126604|FG002|Overall Study|Withdrawal by Subject|3|||
164206959|NCT01129128|593126602|FG000|Overall Study|Physician Decision|1|||
164206960|NCT01129128|593126603|FG001|Overall Study|Physician Decision|0|||
164206961|NCT01129128|593126604|FG002|Overall Study|Physician Decision|0|||
164206962|NCT01311661|593126607|FG000|Overall Study|Adverse Event|2|||
164206963|NCT01311661|593126607|FG000|Overall Study|Protocol Violation|3|||
164206964|NCT01311661|593126607|FG000|Overall Study|Withdrawal by Subject|2|||
164206965|NCT01900314|593126608|FG000|Overall Study|Lost to Follow-up|1|||
164206966|NCT01900314|593126609|FG001|Overall Study|Lost to Follow-up|0|||
164206967|NCT01900314|593126608|FG000|Overall Study|Protocol Violation|0|||
164206968|NCT01900314|593126609|FG001|Overall Study|Protocol Violation|1|||
164206969|NCT01900314|593126608|FG000|Overall Study|Withdrawal by Subject|3|||
164206970|NCT01900314|593126609|FG001|Overall Study|Withdrawal by Subject|3|||
164206971|NCT03197129|593126620|FG000|Overall Study|did not answer the VPT: shyness|4|||
164206972|NCT03197129|593126621|FG001|Overall Study|did not answer the VPT: shyness|5|||
164206973|NCT00289276|593126622|FG000|Second Part of FAST Study (Expansion)|Death|0|||
164206974|NCT00289276|593126623|FG001|Second Part of FAST Study (Expansion)|Death|2|||
164206975|NCT00289276|593126622|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
164206976|NCT00289276|593126623|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
164206977|NCT00869960|593126624|FG000|Overall Study|Lost to Follow-up|2|||
164206978|NCT04848480|593126625|FG000|Main Phase (26 Weeks)|Death|1|||
164206979|NCT04848480|593126626|FG001|Main Phase (26 Weeks)|Death|0|||
164206980|NCT04848480|593126625|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
164206981|NCT04848480|593126626|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
164206982|NCT04848480|593126625|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
164206983|NCT04848480|593126626|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
164206984|NCT04848480|593126625|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
164206985|NCT04848480|593126626|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
164206986|NCT04848480|593126625|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
164206987|NCT04848480|593126626|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
164206988|NCT04848480|593126625|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
164206989|NCT04848480|593126626|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
164206990|NCT05219162|593126627|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
164206991|NCT05219162|593126627|FG000|Overall Study|Withdrawal by Subject|23|||
164206992|NCT02908347|593126630|FG000|Overall Study|Adverse Event|0|||
164206993|NCT02908347|593126631|FG001|Overall Study|Adverse Event|1|||
164206994|NCT02908347|593126630|FG000|Overall Study|Lost to Follow-up|1|||
164206995|NCT02908347|593126631|FG001|Overall Study|Lost to Follow-up|0|||
164206996|NCT02783690|593126632|FG000|Overall Study|Withdrawal by Subject|3|||
164206997|NCT02783690|593126633|FG001|Overall Study|Withdrawal by Subject|3|||
164206998|NCT05516758|593126634|FG000|Overall Study|Adverse Event|5|||
164206999|NCT05516758|593126635|FG001|Overall Study|Adverse Event|1|||
164207000|NCT05516758|593126636|FG002|Overall Study|Adverse Event|3|||
164207001|NCT05516758|593126637|FG003|Overall Study|Adverse Event|0|||
164207002|NCT05516758|593126638|FG004|Overall Study|Adverse Event|1|||
164207003|NCT05516758|593126639|FG005|Overall Study|Adverse Event|3|||
164207004|NCT05516758|593126640|FG006|Overall Study|Adverse Event|5|||
164207005|NCT05516758|593126634|FG000|Overall Study|Assigned treatment by mistake|1|||
164207006|NCT05516758|593126635|FG001|Overall Study|Assigned treatment by mistake|0|||
164207007|NCT05516758|593126636|FG002|Overall Study|Assigned treatment by mistake|0|||
164207008|NCT05516758|593126637|FG003|Overall Study|Assigned treatment by mistake|0|||
164207009|NCT05516758|593126638|FG004|Overall Study|Assigned treatment by mistake|1|||
164207010|NCT05516758|593126639|FG005|Overall Study|Assigned treatment by mistake|0|||
164207011|NCT05516758|593126640|FG006|Overall Study|Assigned treatment by mistake|0|||
164207012|NCT05516758|593126634|FG000|Overall Study|Lack of Efficacy|6|||
164207013|NCT05516758|593126635|FG001|Overall Study|Lack of Efficacy|0|||
164207014|NCT05516758|593126636|FG002|Overall Study|Lack of Efficacy|2|||
164207015|NCT05516758|593126637|FG003|Overall Study|Lack of Efficacy|0|||
164562758|NCT04660643|594429276|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
164562759|NCT04660643|594429277|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
164562760|NCT04660643|594429275|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
164562761|NCT04660643|594429276|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
164562762|NCT04660643|594429277|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
164562763|NCT05162066|594429285|FG000|Overall Study|Adverse Event|1|||
164562764|NCT05162066|594429286|FG001|Overall Study|Adverse Event|0|||
164562765|NCT05162066|594429287|FG002|Overall Study|Adverse Event|0|||
164207016|NCT05516758|593126638|FG004|Overall Study|Lack of Efficacy|3|||
164207017|NCT05516758|593126639|FG005|Overall Study|Lack of Efficacy|6|||
164207018|NCT05516758|593126640|FG006|Overall Study|Lack of Efficacy|3|||
164207019|NCT05516758|593126634|FG000|Overall Study|Lost to Follow-up|2|||
164562766|NCT05162066|594429285|FG000|Overall Study|Perceived lack of efficacy|1|||
164562767|NCT05162066|594429286|FG001|Overall Study|Perceived lack of efficacy|0|||
164562768|NCT05162066|594429287|FG002|Overall Study|Perceived lack of efficacy|0|||
164562769|NCT00669617|594429290|FG000|Period 1|Withdrawal by Subject|0|||
164207020|NCT05516758|593126635|FG001|Overall Study|Lost to Follow-up|0|||
164207021|NCT05516758|593126636|FG002|Overall Study|Lost to Follow-up|2|||
164207022|NCT05516758|593126637|FG003|Overall Study|Lost to Follow-up|0|||
164207023|NCT05516758|593126638|FG004|Overall Study|Lost to Follow-up|3|||
164207024|NCT05516758|593126639|FG005|Overall Study|Lost to Follow-up|2|||
164207025|NCT05516758|593126640|FG006|Overall Study|Lost to Follow-up|1|||
164207026|NCT05516758|593126634|FG000|Overall Study|Other- As reported by the site|2|||
164207027|NCT05516758|593126635|FG001|Overall Study|Other- As reported by the site|1|||
164207028|NCT05516758|593126636|FG002|Overall Study|Other- As reported by the site|8|||
164207029|NCT05516758|593126637|FG003|Overall Study|Other- As reported by the site|1|||
164207030|NCT05516758|593126638|FG004|Overall Study|Other- As reported by the site|2|||
164207031|NCT05516758|593126639|FG005|Overall Study|Other- As reported by the site|3|||
164207032|NCT05516758|593126640|FG006|Overall Study|Other- As reported by the site|8|||
164207033|NCT05516758|593126634|FG000|Overall Study|Physician Decision|1|||
164207034|NCT05516758|593126635|FG001|Overall Study|Physician Decision|0|||
164207035|NCT05516758|593126636|FG002|Overall Study|Physician Decision|7|||
164207036|NCT05516758|593126637|FG003|Overall Study|Physician Decision|0|||
164207037|NCT05516758|593126638|FG004|Overall Study|Physician Decision|1|||
164207038|NCT05516758|593126639|FG005|Overall Study|Physician Decision|1|||
164207039|NCT05516758|593126640|FG006|Overall Study|Physician Decision|2|||
164207040|NCT05516758|593126634|FG000|Overall Study|Protocol Deviation|1|||
164207041|NCT05516758|593126635|FG001|Overall Study|Protocol Deviation|0|||
164207042|NCT05516758|593126636|FG002|Overall Study|Protocol Deviation|0|||
164207043|NCT05516758|593126637|FG003|Overall Study|Protocol Deviation|0|||
164207044|NCT05516758|593126638|FG004|Overall Study|Protocol Deviation|0|||
164207045|NCT05516758|593126639|FG005|Overall Study|Protocol Deviation|1|||
164207046|NCT05516758|593126640|FG006|Overall Study|Protocol Deviation|5|||
164207047|NCT05516758|593126634|FG000|Overall Study|Withdrawal by Subject|11|||
164207048|NCT05516758|593126635|FG001|Overall Study|Withdrawal by Subject|1|||
164207049|NCT05516758|593126636|FG002|Overall Study|Withdrawal by Subject|15|||
164207050|NCT05516758|593126637|FG003|Overall Study|Withdrawal by Subject|2|||
164207051|NCT05516758|593126638|FG004|Overall Study|Withdrawal by Subject|7|||
164207052|NCT05516758|593126639|FG005|Overall Study|Withdrawal by Subject|7|||
164207053|NCT05516758|593126640|FG006|Overall Study|Withdrawal by Subject|6|||
164207054|NCT05516758|593126634|FG000|Overall Study|Death|1|||
164207055|NCT05516758|593126635|FG001|Overall Study|Death|0|||
164207056|NCT05516758|593126636|FG002|Overall Study|Death|0|||
164207057|NCT05516758|593126637|FG003|Overall Study|Death|0|||
164207058|NCT05516758|593126638|FG004|Overall Study|Death|0|||
164207059|NCT05516758|593126639|FG005|Overall Study|Death|0|||
164207060|NCT05516758|593126640|FG006|Overall Study|Death|0|||
164207061|NCT05516758|593126634|FG000|Overall Study|Non-compliance With Study Drug|0|||
164207062|NCT05516758|593126635|FG001|Overall Study|Non-compliance With Study Drug|0|||
164207063|NCT05516758|593126636|FG002|Overall Study|Non-compliance With Study Drug|1|||
164562770|NCT00669617|594429291|FG001|Period 1|Withdrawal by Subject|0|||
164562771|NCT00669617|594429292|FG002|Period 1|Withdrawal by Subject|1|||
164207064|NCT05516758|593126637|FG003|Overall Study|Non-compliance With Study Drug|0|||
164207065|NCT05516758|593126638|FG004|Overall Study|Non-compliance With Study Drug|0|||
164207066|NCT05516758|593126639|FG005|Overall Study|Non-compliance With Study Drug|0|||
164207067|NCT05516758|593126640|FG006|Overall Study|Non-compliance With Study Drug|0|||
164207068|NCT05516758|593126634|FG000|Overall Study|Site Terminated by Sponsor|2|||
164319376|NCT02431260|593544689|FG003|Overall Study|Physician Decision|0|||
164319377|NCT02431260|593544690|FG004|Overall Study|Physician Decision|0|||
164319378|NCT02431260|593544691|FG005|Overall Study|Physician Decision|1|||
164319379|NCT02431260|593544692|FG006|Overall Study|Physician Decision|0|||
164319380|NCT02431260|593544693|FG007|Overall Study|Physician Decision|0|||
164319381|NCT02431260|593544694|FG008|Overall Study|Physician Decision|0|||
164319382|NCT02431260|593544695|FG009|Overall Study|Physician Decision|0|||
164319383|NCT02431260|593544696|FG010|Overall Study|Physician Decision|0|||
164319384|NCT02431260|593544697|FG011|Overall Study|Physician Decision|0|||
164319385|NCT02431260|593544698|FG012|Overall Study|Physician Decision|0|||
164319386|NCT02431260|593544699|FG013|Overall Study|Physician Decision|0|||
164319387|NCT02431260|593544686|FG000|Overall Study|Other Unspecified|0|||
164319388|NCT02431260|593544687|FG001|Overall Study|Other Unspecified|0|||
164319389|NCT02431260|593544688|FG002|Overall Study|Other Unspecified|0|||
164319390|NCT02431260|593544689|FG003|Overall Study|Other Unspecified|0|||
164562772|NCT00669617|594429293|FG003|Period 1|Withdrawal by Subject|0|||
164562773|NCT00669617|594429294|FG004|Period 1|Withdrawal by Subject|0|||
164562774|NCT00669617|594429290|FG000|Period 1|Protocol Deviation|0|||
164562775|NCT00669617|594429291|FG001|Period 1|Protocol Deviation|0|||
164562776|NCT00669617|594429292|FG002|Period 1|Protocol Deviation|0|||
164562777|NCT00669617|594429293|FG003|Period 1|Protocol Deviation|0|||
164562778|NCT00669617|594429294|FG004|Period 1|Protocol Deviation|1|||
164562779|NCT00669617|594429290|FG000|Period 3|Lost to Follow-up|1|||
164562780|NCT00669617|594429291|FG001|Period 3|Lost to Follow-up|0|||
164562781|NCT00669617|594429292|FG002|Period 3|Lost to Follow-up|0|||
164562782|NCT00669617|594429293|FG003|Period 3|Lost to Follow-up|0|||
164562783|NCT00669617|594429294|FG004|Period 3|Lost to Follow-up|0|||
164562784|NCT00623831|594429295|FG000|Overall Study|Withdrawal by Subject|1|||
164562785|NCT00623831|594429296|FG001|Overall Study|Withdrawal by Subject|0|||
164562786|NCT00623831|594429295|FG000|Overall Study|Progressive Disease|0|||
164562787|NCT00623831|594429296|FG001|Overall Study|Progressive Disease|1|||
164562788|NCT01276821|594429297|FG000|Overall Study|Protocol Violation|0|||
164562789|NCT01276821|594429298|FG001|Overall Study|Protocol Violation|1|||
164562790|NCT02939131|594429301|FG000|Overall Study|Unable to get to clinic|6|||
164562791|NCT02939131|594429302|FG001|Overall Study|Unable to get to clinic|4|||
164562792|NCT02939131|594429301|FG000|Overall Study|Lost to Follow-up|2|||
164562793|NCT02939131|594429302|FG001|Overall Study|Lost to Follow-up|4|||
164562794|NCT02939131|594429301|FG000|Overall Study|severe debilitation|1|||
164562795|NCT02939131|594429302|FG001|Overall Study|severe debilitation|0|||
164562796|NCT02939131|594429301|FG000|Overall Study|Other|0|||
164562797|NCT02939131|594429302|FG001|Overall Study|Other|1|||
164562798|NCT02939131|594429301|FG000|Overall Study|not willing to adhere to protocol|2|||
164562799|NCT02939131|594429302|FG001|Overall Study|not willing to adhere to protocol|0|||
164562800|NCT04033367|594429303|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
164562801|NCT04033367|594429304|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
164562802|NCT04033367|594429303|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
164562803|NCT04033367|594429304|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
164562804|NCT04033367|594429303|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
164562805|NCT04033367|594429304|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
164562806|NCT04033367|594429303|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
164562807|NCT04033367|594429304|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
164562808|NCT02723201|594429305|FG000|Second Intervention Period|Protocol Violation|1|||
164562809|NCT02723201|594429306|FG001|Second Intervention Period|Protocol Violation|0|||
164562810|NCT02723201|594429307|FG002|Second Intervention Period|Protocol Violation|0|||
164562811|NCT02723201|594429305|FG000|Second Intervention Period|Adverse Event|1|||
164562812|NCT02723201|594429306|FG001|Second Intervention Period|Adverse Event|0|||
164562813|NCT02723201|594429307|FG002|Second Intervention Period|Adverse Event|0|||
164562814|NCT03569202|594429310|FG000|Part 3|Physician Decision|1|||
164562815|NCT03569202|594429311|FG001|Part 3|Physician Decision|0|||
164562816|NCT03569202|594429310|FG000|Part 3|Other|1|||
164562817|NCT03569202|594429311|FG001|Part 3|Other|1|||
164562818|NCT02415712|594429312|FG000|Overall Study|Protocol Violation|16|||
164562819|NCT00454779|594429313|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
164562820|NCT00454779|594429314|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
164319391|NCT02431260|593544690|FG004|Overall Study|Other Unspecified|0|||
164420638|NCT01154036|593910969|FG007|Phase I|Lost to Follow-up|0|||
164562821|NCT00454779|594429313|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
164562822|NCT00454779|594429314|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
164562823|NCT00454779|594429313|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
164562824|NCT00454779|594429314|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
164562825|NCT00454779|594429313|FG000|First-line Treatment Phase|Protocol Violation|0|||
164562826|NCT00454779|594429314|FG001|First-line Treatment Phase|Protocol Violation|1|||
164562827|NCT00454779|594429313|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
164319392|NCT02431260|593544691|FG005|Overall Study|Other Unspecified|0|||
164319393|NCT02431260|593544692|FG006|Overall Study|Other Unspecified|0|||
164319394|NCT02431260|593544693|FG007|Overall Study|Other Unspecified|0|||
164319395|NCT02431260|593544694|FG008|Overall Study|Other Unspecified|0|||
164319396|NCT02431260|593544695|FG009|Overall Study|Other Unspecified|0|||
164319397|NCT02431260|593544696|FG010|Overall Study|Other Unspecified|0|||
164319398|NCT02431260|593544697|FG011|Overall Study|Other Unspecified|1|||
164319399|NCT02431260|593544698|FG012|Overall Study|Other Unspecified|1|||
164319400|NCT02431260|593544699|FG013|Overall Study|Other Unspecified|0|||
164319401|NCT03288142|593544702|FG000|Overall Study|Lost to Follow-up|22|||
164319402|NCT03288142|593544703|FG001|Overall Study|Lost to Follow-up|15|||
164319403|NCT02270944|593544704|FG000|Overall Study|Lost to Follow-up|9|||
164319404|NCT02270944|593544705|FG001|Overall Study|Lost to Follow-up|4|||
164319405|NCT02270944|593544704|FG000|Overall Study|Withdrawal by Subject|2|||
164319406|NCT02270944|593544705|FG001|Overall Study|Withdrawal by Subject|1|||
164319407|NCT00384111|593544708|FG000|Overall Study|Disease Progression|3|||
164319408|NCT00384111|593544708|FG000|Overall Study|Adverse Event|1|||
164319409|NCT00384111|593544708|FG000|Overall Study|Investigator Decision|3|||
164319410|NCT00384111|593544708|FG000|Overall Study|Study Terminated by the Sponsor|19|||
164319411|NCT01551420|593544709|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
164319412|NCT01551420|593544710|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
164319413|NCT01551420|593544709|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
164319414|NCT01551420|593544710|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
164319415|NCT01551420|593544709|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
164319416|NCT01551420|593544710|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
164319417|NCT01551420|593544709|FG000|Screened for Part B Eligibility|Declined participation|8|||
164319418|NCT01551420|593544710|FG001|Screened for Part B Eligibility|Declined participation|1|||
164319419|NCT01551420|593544709|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
164319420|NCT01551420|593544710|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
164319421|NCT01551420|593544709|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
164319422|NCT01551420|593544710|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
164562828|NCT00454779|594429314|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
164562829|NCT00454779|594429313|FG000|First-line Treatment Phase|Ongoing|1|||
164562830|NCT00454779|594429314|FG001|First-line Treatment Phase|Ongoing|0|||
164562831|NCT00454779|594429313|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
164319423|NCT01551420|593544709|FG000|Home Use (Part B)|Withdrawal by staff|0|||
164319424|NCT01551420|593544710|FG001|Home Use (Part B)|Withdrawal by staff|1|||
164319425|NCT04463069|593544711|FG000|Overall Study|Withdrawal by Subject|2|||
164319426|NCT04463069|593544712|FG001|Overall Study|Withdrawal by Subject|10|||
164319427|NCT04463069|593544711|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
164319428|NCT04463069|593544712|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
164319429|NCT00311584|593544713|FG000|Overall Study|Death|1|||
164319430|NCT00311584|593544714|FG001|Overall Study|Death|0|||
164319431|NCT00311584|593544713|FG000|Overall Study|Lack of Efficacy|12|||
164319432|NCT00311584|593544714|FG001|Overall Study|Lack of Efficacy|15|||
164319433|NCT00311584|593544713|FG000|Overall Study|Physician Decision|4|||
164319434|NCT00311584|593544714|FG001|Overall Study|Physician Decision|5|||
164319435|NCT00311584|593544713|FG000|Overall Study|Withdrawal by Subject|1|||
164319436|NCT00311584|593544714|FG001|Overall Study|Withdrawal by Subject|1|||
164319437|NCT00311584|593544713|FG000|Overall Study|ineligible|2|||
164319438|NCT00311584|593544714|FG001|Overall Study|ineligible|2|||
164319439|NCT03073733|593544715|FG000|Overall Study|Lost to Follow-up|1|||
164319440|NCT03073733|593544716|FG001|Overall Study|Lost to Follow-up|0|||
164319441|NCT03073733|593544717|FG002|Overall Study|Lost to Follow-up|0|||
164319442|NCT03073733|593544715|FG000|Overall Study|Physician Decision|0|||
164319443|NCT03073733|593544716|FG001|Overall Study|Physician Decision|1|||
164319444|NCT03073733|593544717|FG002|Overall Study|Physician Decision|0|||
164319445|NCT03073733|593544715|FG000|Overall Study|Withdrawal by Subject|0|||
164319446|NCT03073733|593544716|FG001|Overall Study|Withdrawal by Subject|0|||
164319447|NCT03073733|593544717|FG002|Overall Study|Withdrawal by Subject|1|||
164319448|NCT02276027|593546868|FG000|Overall Study|Death|1|||
164319449|NCT02276027|593546869|FG001|Overall Study|Death|0|||
164319450|NCT02276027|593546870|FG002|Overall Study|Death|0|||
164319451|NCT02276027|593546871|FG003|Overall Study|Death|2|||
164319452|NCT02276027|593546868|FG000|Overall Study|Physician Decision|0|||
164319453|NCT02276027|593546869|FG001|Overall Study|Physician Decision|0|||
164319454|NCT02276027|593546870|FG002|Overall Study|Physician Decision|0|||
164319455|NCT02276027|593546871|FG003|Overall Study|Physician Decision|1|||
164319456|NCT02276027|593546868|FG000|Overall Study|Progressive disease|1|||
164319457|NCT02276027|593546869|FG001|Overall Study|Progressive disease|13|||
164319458|NCT02276027|593546870|FG002|Overall Study|Progressive disease|12|||
164319459|NCT02276027|593546871|FG003|Overall Study|Progressive disease|14|||
164319460|NCT02276027|593546868|FG000|Overall Study|Subject/guardian decision|0|||
164319461|NCT02276027|593546869|FG001|Overall Study|Subject/guardian decision|1|||
164319462|NCT02276027|593546870|FG002|Overall Study|Subject/guardian decision|0|||
164319463|NCT02276027|593546871|FG003|Overall Study|Subject/guardian decision|3|||
164319464|NCT02276027|593546868|FG000|Overall Study|Adverse Event|0|||
164319465|NCT02276027|593546869|FG001|Overall Study|Adverse Event|2|||
164319466|NCT02276027|593546870|FG002|Overall Study|Adverse Event|8|||
164319467|NCT02276027|593546871|FG003|Overall Study|Adverse Event|2|||
164319468|NCT02446171|593546872|FG000|Overall Study|Withdrawal by Subject|0|||
164319469|NCT02446171|593546873|FG001|Overall Study|Withdrawal by Subject|0|||
164319470|NCT02446171|593546874|FG002|Overall Study|Withdrawal by Subject|2|||
164319471|NCT02446171|593546875|FG003|Overall Study|Withdrawal by Subject|0|||
164319472|NCT01264081|593546876|FG000|Participants Screened|Screening failures|30|||
164319473|NCT01264081|593546876|FG000|Started Treatment|Withdrawal by Subject|1|||
164319474|NCT01264081|593546876|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
164319475|NCT01727700|593546877|FG000|Overall Study|Adverse Event|0|||
164319476|NCT01727700|593546878|FG001|Overall Study|Adverse Event|7|||
164319477|NCT01727700|593546879|FG002|Overall Study|Adverse Event|1|||
164319478|NCT01727700|593546877|FG000|Overall Study|Particpant withdrew consent|0|||
164319479|NCT01727700|593546878|FG001|Overall Study|Particpant withdrew consent|3|||
164319480|NCT01727700|593546879|FG002|Overall Study|Particpant withdrew consent|1|||
164319481|NCT01727700|593546877|FG000|Overall Study|Protocol Violation|2|||
164319482|NCT01727700|593546878|FG001|Overall Study|Protocol Violation|0|||
164319483|NCT01727700|593546879|FG002|Overall Study|Protocol Violation|0|||
164319484|NCT01909791|593546882|FG000|Overall Study|Death|9|||
164319485|NCT01909791|593546883|FG001|Overall Study|Death|8|||
164319486|NCT01909791|593546884|FG002|Overall Study|Death|4|||
164319487|NCT01909791|593546882|FG000|Overall Study|Withdrawal by Subject|5|||
164319488|NCT01909791|593546883|FG001|Overall Study|Withdrawal by Subject|9|||
164319489|NCT01909791|593546884|FG002|Overall Study|Withdrawal by Subject|13|||
164319490|NCT01909791|593546882|FG000|Overall Study|Lost to Follow-up|5|||
164319491|NCT01909791|593546883|FG001|Overall Study|Lost to Follow-up|11|||
164319492|NCT01909791|593546884|FG002|Overall Study|Lost to Follow-up|10|||
164319493|NCT01909791|593546882|FG000|Overall Study|Missed Visit|2|||
164319494|NCT01909791|593546883|FG001|Overall Study|Missed Visit|0|||
164319495|NCT01909791|593546884|FG002|Overall Study|Missed Visit|1|||
164319496|NCT01009840|593546885|FG000|Overall Study|Lost to Follow-up|1|||
164319497|NCT01009840|593546885|FG000|Overall Study|Adverse Event|4|||
164319498|NCT01009840|593546885|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
164319499|NCT01009840|593546885|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
164319500|NCT01009840|593546885|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
164319501|NCT01122394|593546892|FG000|Overall Study|Withdrawal by Subject|1|||
164319502|NCT01122394|593546893|FG001|Overall Study|Withdrawal by Subject|1|||
164319503|NCT01122394|593546892|FG000|Overall Study|Lost to Follow-up|2|||
164319504|NCT01122394|593546893|FG001|Overall Study|Lost to Follow-up|2|||
164319505|NCT01122394|593546892|FG000|Overall Study|Adverse Event|0|||
164319506|NCT01122394|593546893|FG001|Overall Study|Adverse Event|1|||
164319507|NCT03739242|593546894|FG000|Overall Study|Withdrawal by Subject|1|||
164319508|NCT03739242|593546895|FG001|Overall Study|Withdrawal by Subject|1|||
164319509|NCT03739242|593546894|FG000|Overall Study|Protocol Violation|0|||
164319510|NCT03739242|593546895|FG001|Overall Study|Protocol Violation|1|||
164319511|NCT00039871|593546896|FG000|Overall Study|Adverse Event|165|||
164319512|NCT00039871|593546896|FG000|Overall Study|Lost to Follow-up|18|||
164562832|NCT00454779|594429314|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
164562833|NCT00454779|594429313|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
164562834|NCT00454779|594429314|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
164562835|NCT00454779|594429313|FG000|Second-line Treatment Phase|Ongoing|0|||
164562836|NCT00454779|594429314|FG001|Second-line Treatment Phase|Ongoing|1|||
164562837|NCT02450578|594429316|FG000|Overall Study|ECG abnormality so not treated|1|||
164562838|NCT02450578|594429317|FG001|Overall Study|ECG abnormality so not treated|0|||
164562839|NCT02450578|594429318|FG002|Overall Study|ECG abnormality so not treated|0|||
164562840|NCT02450578|594429319|FG003|Overall Study|ECG abnormality so not treated|0|||
164562841|NCT00132730|594429321|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
164562842|NCT00132730|594429322|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
164562843|NCT00132730|594429323|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
164562844|NCT00132730|594429324|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
164562845|NCT00132730|594429325|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
164562846|NCT00132730|594429326|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
164562847|NCT00132730|594429321|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
164562848|NCT00132730|594429322|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
164562849|NCT00132730|594429323|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
164562850|NCT00132730|594429324|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
164562851|NCT00132730|594429325|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
164562852|NCT00132730|594429326|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
164562853|NCT00132730|594429321|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
164562854|NCT00132730|594429322|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
164562855|NCT00132730|594429323|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
164562856|NCT00132730|594429324|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
164562857|NCT00132730|594429325|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
164562858|NCT00132730|594429326|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
164562859|NCT00132730|594429321|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
164562860|NCT00132730|594429322|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
164562861|NCT00132730|594429323|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
164562862|NCT00132730|594429324|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
164562863|NCT00132730|594429325|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
164562864|NCT00132730|594429326|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
164562865|NCT00132730|594429321|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
164562866|NCT00132730|594429322|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
164562867|NCT00132730|594429323|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
164562868|NCT00132730|594429324|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
164562869|NCT00132730|594429325|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
164562870|NCT00132730|594429326|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
164562871|NCT00132730|594429321|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
164562872|NCT00132730|594429322|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
164562873|NCT00132730|594429323|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
164562874|NCT00132730|594429324|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
164562875|NCT00132730|594429325|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
164562876|NCT00132730|594429326|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
164562877|NCT00132730|594429321|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
164562878|NCT00132730|594429322|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
164562879|NCT00132730|594429323|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
164562880|NCT00132730|594429324|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
164562881|NCT00132730|594429325|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
164562882|NCT00132730|594429326|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
164319513|NCT00039871|593546896|FG000|Overall Study|Protocol Violation|24|||
164319514|NCT00039871|593546896|FG000|Overall Study|Withdrawal by Subject|97|||
164319515|NCT00039871|593546896|FG000|Overall Study|Did not meet eligibility criteria|11|||
164319516|NCT00039871|593546896|FG000|Overall Study|Administrative|1|||
164319517|NCT00039871|593546896|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
164319518|NCT00039871|593546896|FG000|Overall Study|Never entered follow-up|7|||
164319519|NCT02446743|593546897|FG000|Overall Study|Withdrawal by Subject|1|||
164319520|NCT02446743|593546898|FG001|Overall Study|Withdrawal by Subject|1|||
164319521|NCT02446743|593546897|FG000|Overall Study|Lost to Follow-up|1|||
164319522|NCT02446743|593546898|FG001|Overall Study|Lost to Follow-up|0|||
164319523|NCT02446743|593546897|FG000|Overall Study|Adverse Event|1|||
164319524|NCT02446743|593546898|FG001|Overall Study|Adverse Event|1|||
164319525|NCT02446743|593546897|FG000|Overall Study|Other|2|||
164319526|NCT02446743|593546898|FG001|Overall Study|Other|3|||
164319527|NCT03086967|593546899|FG000|Overall Study|Screen Failure|2|||
164319528|NCT03086967|593546900|FG001|Overall Study|Screen Failure|2|||
164319529|NCT02478398|593546901|FG000|Overall Study|Adverse Event|20|||
164319530|NCT02478398|593546902|FG001|Overall Study|Adverse Event|5|||
164319531|NCT02478398|593546901|FG000|Overall Study|Lost to Follow-up|5|||
164319532|NCT02478398|593546902|FG001|Overall Study|Lost to Follow-up|4|||
164319533|NCT02478398|593546901|FG000|Overall Study|Non-Compliance With Study Drug|5|||
164319534|NCT02478398|593546902|FG001|Overall Study|Non-Compliance With Study Drug|1|||
164319535|NCT02478398|593546901|FG000|Overall Study|Protocol Violation|3|||
164319536|NCT02478398|593546902|FG001|Overall Study|Protocol Violation|1|||
164319537|NCT02478398|593546901|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
164319538|NCT02478398|593546902|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
164319539|NCT02478398|593546901|FG000|Overall Study|Withdrawal By Participant|10|||
164319540|NCT02478398|593546902|FG001|Overall Study|Withdrawal By Participant|4|||
164319541|NCT01475071|593546910|FG000|Overall Study|Physician Decision|1|||
164319542|NCT01475071|593546910|FG000|Overall Study|Withdrawal by Subject|6|||
164319543|NCT01475071|593546910|FG000|Overall Study|Lost to Follow-up|1|||
164319544|NCT02230527|593546911|FG000|Overall Study|Withdrawal by Subject|1|||
164319545|NCT02230527|593546912|FG001|Overall Study|Withdrawal by Subject|1|||
164319546|NCT02230527|593546911|FG000|Overall Study|Death|1|||
164319547|NCT02230527|593546912|FG001|Overall Study|Death|0|||
164319548|NCT02230527|593546911|FG000|Overall Study|Lost to Follow-up|2|||
164319549|NCT02230527|593546912|FG001|Overall Study|Lost to Follow-up|1|||
164319550|NCT02230527|593546911|FG000|Overall Study|Other|1|||
164319551|NCT02230527|593546912|FG001|Overall Study|Other|0|||
164319552|NCT01752036|593546913|FG000|Overall Study|Death|2|||
164319553|NCT01011478|593546914|FG000|Overall Study|No follow up data|12|||
164319554|NCT01011478|593546915|FG001|Overall Study|No follow up data|7|||
164319555|NCT01205581|593546919|FG000|Overall Study|Withdrawal by Subject|1|||
164319556|NCT01205581|593546920|FG001|Overall Study|Withdrawal by Subject|0|||
164319557|NCT01205581|593546921|FG002|Overall Study|Withdrawal by Subject|0|||
164319558|NCT01205581|593546922|FG003|Overall Study|Withdrawal by Subject|0|||
164319559|NCT01205581|593546923|FG004|Overall Study|Withdrawal by Subject|0|||
164319560|NCT01205581|593546924|FG005|Overall Study|Withdrawal by Subject|0|||
164319561|NCT03337490|593546925|FG000|Overall Study|Withdrawal by Subject|1|||
164319562|NCT03337490|593546926|FG001|Overall Study|Withdrawal by Subject|0|||
164319563|NCT03337490|593546927|FG002|Overall Study|Withdrawal by Subject|0|||
164319564|NCT03337490|593546925|FG000|Overall Study|Lack of Efficacy|10|||
164319565|NCT03337490|593546926|FG001|Overall Study|Lack of Efficacy|12|||
164319566|NCT03337490|593546927|FG002|Overall Study|Lack of Efficacy|35|||
164319567|NCT03337490|593546925|FG000|Overall Study|Physician Decision|0|||
164319568|NCT03337490|593546926|FG001|Overall Study|Physician Decision|1|||
164319569|NCT03337490|593546927|FG002|Overall Study|Physician Decision|0|||
164319570|NCT03337490|593546925|FG000|Overall Study|Lost to Follow-up|0|||
164319571|NCT03337490|593546926|FG001|Overall Study|Lost to Follow-up|1|||
164319572|NCT03337490|593546927|FG002|Overall Study|Lost to Follow-up|0|||
164319573|NCT00917644|593546928|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
164319574|NCT00917644|593546929|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
164666921|NCT02848326|594806391|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
164666922|NCT02848326|594806392|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
164319575|NCT00917644|593546928|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
164666923|NCT02848326|594806387|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
164666924|NCT02848326|594806388|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
164319576|NCT00917644|593546929|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
164319577|NCT00917644|593546928|FG000|Period 2: Second Intervention|family emergency|1|||
164319578|NCT00917644|593546929|FG001|Period 2: Second Intervention|family emergency|0|||
164319579|NCT02108262|593546936|FG000|Overall Study|Non-compliance|0|||
164319580|NCT02108262|593546937|FG001|Overall Study|Non-compliance|2|||
164319581|NCT02108262|593546938|FG002|Overall Study|Non-compliance|1|||
164319582|NCT02108262|593546939|FG003|Overall Study|Non-compliance|1|||
164319583|NCT02108262|593546936|FG000|Overall Study|Randomized by error/screen failure|0|||
164319584|NCT02108262|593546937|FG001|Overall Study|Randomized by error/screen failure|0|||
164319585|NCT02108262|593546938|FG002|Overall Study|Randomized by error/screen failure|1|||
164319586|NCT02108262|593546939|FG003|Overall Study|Randomized by error/screen failure|0|||
164319587|NCT02108262|593546936|FG000|Overall Study|Distance to center|0|||
164319588|NCT02108262|593546937|FG001|Overall Study|Distance to center|1|||
164207069|NCT05516758|593126635|FG001|Overall Study|Site Terminated by Sponsor|0|||
164207070|NCT05516758|593126636|FG002|Overall Study|Site Terminated by Sponsor|0|||
164207071|NCT05516758|593126637|FG003|Overall Study|Site Terminated by Sponsor|0|||
164207072|NCT05516758|593126638|FG004|Overall Study|Site Terminated by Sponsor|0|||
164207073|NCT05516758|593126639|FG005|Overall Study|Site Terminated by Sponsor|0|||
164207074|NCT05516758|593126640|FG006|Overall Study|Site Terminated by Sponsor|0|||
164207075|NCT05516758|593126634|FG000|Overall Study|Study Terminated by Sponsor|4|||
164207076|NCT05516758|593126635|FG001|Overall Study|Study Terminated by Sponsor|0|||
164207077|NCT05516758|593126636|FG002|Overall Study|Study Terminated by Sponsor|3|||
164207078|NCT05516758|593126637|FG003|Overall Study|Study Terminated by Sponsor|0|||
164207079|NCT05516758|593126638|FG004|Overall Study|Study Terminated by Sponsor|2|||
164207080|NCT05516758|593126639|FG005|Overall Study|Study Terminated by Sponsor|3|||
164207081|NCT05516758|593126640|FG006|Overall Study|Study Terminated by Sponsor|0|||
164207082|NCT05516758|593126634|FG000|Overall Study|Participants not proceeding to Follow-up phase|1|||
164207083|NCT05516758|593126635|FG001|Overall Study|Participants not proceeding to Follow-up phase|0|||
164207084|NCT05516758|593126636|FG002|Overall Study|Participants not proceeding to Follow-up phase|2|||
164207085|NCT05516758|593126637|FG003|Overall Study|Participants not proceeding to Follow-up phase|0|||
164207086|NCT05516758|593126638|FG004|Overall Study|Participants not proceeding to Follow-up phase|1|||
164207087|NCT05516758|593126639|FG005|Overall Study|Participants not proceeding to Follow-up phase|0|||
164207088|NCT05516758|593126640|FG006|Overall Study|Participants not proceeding to Follow-up phase|0|||
164207089|NCT05516758|593126634|FG000|Overall Study|Other|0|||
164207090|NCT05516758|593126635|FG001|Overall Study|Other|0|||
164562883|NCT00132730|594429321|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
164562884|NCT00132730|594429322|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
164562885|NCT00132730|594429323|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
164562886|NCT00132730|594429324|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
164562887|NCT00132730|594429325|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
164562888|NCT00132730|594429326|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
164562889|NCT00132730|594429321|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
164562890|NCT00132730|594429322|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
164562891|NCT00132730|594429323|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
164562892|NCT00132730|594429324|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
164562893|NCT00132730|594429325|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
164562894|NCT00132730|594429326|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
164562895|NCT00132730|594429321|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
164562896|NCT00132730|594429322|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
164562897|NCT00132730|594429323|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
164562898|NCT00132730|594429324|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
164562899|NCT00132730|594429325|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
164562900|NCT00132730|594429326|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
164562901|NCT00132730|594429321|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
164562902|NCT00132730|594429322|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
164562903|NCT00132730|594429323|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
164562904|NCT00132730|594429324|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
164562905|NCT00132730|594429325|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
164562906|NCT00132730|594429326|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
164562907|NCT00132730|594429321|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
164562908|NCT00132730|594429322|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
164562909|NCT00132730|594429323|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
164562910|NCT00132730|594429324|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
164562911|NCT00132730|594429325|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
164562912|NCT00132730|594429326|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
164562913|NCT02623335|594429327|FG000|Overall Study|Death|8|||
164562914|NCT02623335|594429328|FG001|Overall Study|Death|7|||
164562915|NCT02623335|594429327|FG000|Overall Study|Lost to Follow-up|15|||
164562916|NCT02623335|594429328|FG001|Overall Study|Lost to Follow-up|23|||
164562917|NCT02623335|594429327|FG000|Overall Study|Withdrawal by Subject|2|||
164562918|NCT02623335|594429328|FG001|Overall Study|Withdrawal by Subject|5|||
164562919|NCT02623335|594429327|FG000|Overall Study|Protocol Violation|2|||
164562920|NCT02623335|594429328|FG001|Overall Study|Protocol Violation|1|||
164562921|NCT00395967|594429329|FG000|Treatment Period|Failed Mobilization|1|||
164562922|NCT00395967|594429329|FG000|Follow-up Period|Death|1|||
164562923|NCT00395967|594429329|FG000|Follow-up Period|Lost to Follow-up|1|||
164562924|NCT02400255|594429335|FG000|Overall Study|Relapse|4|||
164207091|NCT05516758|593126636|FG002|Overall Study|Other|0|||
164207092|NCT05516758|593126637|FG003|Overall Study|Other|0|||
164207093|NCT05516758|593126638|FG004|Overall Study|Other|0|||
164207094|NCT05516758|593126639|FG005|Overall Study|Other|0|||
164207095|NCT05516758|593126640|FG006|Overall Study|Other|1|||
164207096|NCT01316575|593126641|FG000|Overall Study|Withdrawal by Subject|2|||
164207097|NCT01316575|593126642|FG001|Overall Study|Withdrawal by Subject|0|||
164207098|NCT01316575|593126641|FG000|Overall Study|Required alternate treatment|0|||
164207099|NCT01316575|593126642|FG001|Overall Study|Required alternate treatment|1|||
164207100|NCT00402831|593126643|FG000|Overall Study|Lost to Follow-up|1|||
164207101|NCT00402831|593126644|FG001|Overall Study|Lost to Follow-up|2|||
164207102|NCT00402831|593126643|FG000|Overall Study|Non-compliance with protocol|0|||
164207103|NCT00402831|593126644|FG001|Overall Study|Non-compliance with protocol|1|||
164207104|NCT04585893|593126645|FG000|Overall Study|Death|1|||
164562925|NCT02400255|594429336|FG001|Overall Study|Relapse|1|||
164562926|NCT02400255|594429337|FG002|Overall Study|Relapse|1|||
164562927|NCT02400255|594429338|FG003|Overall Study|Relapse|2|||
164562928|NCT02400255|594429335|FG000|Overall Study|Adverse Event|6|||
164562929|NCT02400255|594429336|FG001|Overall Study|Adverse Event|3|||
164562930|NCT02400255|594429337|FG002|Overall Study|Adverse Event|0|||
164562931|NCT02400255|594429338|FG003|Overall Study|Adverse Event|0|||
164562932|NCT02400255|594429335|FG000|Overall Study|Physician Decision|6|||
164562933|NCT02400255|594429336|FG001|Overall Study|Physician Decision|0|||
164562934|NCT02400255|594429337|FG002|Overall Study|Physician Decision|0|||
164562935|NCT02400255|594429338|FG003|Overall Study|Physician Decision|0|||
164562936|NCT02400255|594429335|FG000|Overall Study|Loss of insurance|1|||
164562937|NCT02400255|594429336|FG001|Overall Study|Loss of insurance|0|||
164562938|NCT02400255|594429337|FG002|Overall Study|Loss of insurance|0|||
164562939|NCT02400255|594429338|FG003|Overall Study|Loss of insurance|0|||
164562940|NCT02568046|594429339|FG000|Overall Study|Adverse Event|0|||
164562941|NCT02568046|594429340|FG001|Overall Study|Adverse Event|1|||
164562942|NCT02568046|594429339|FG000|Overall Study|Death|2|||
164562943|NCT02568046|594429340|FG001|Overall Study|Death|0|||
164562944|NCT02568046|594429339|FG000|Overall Study|Progressive Disease|1|||
164562945|NCT02568046|594429340|FG001|Overall Study|Progressive Disease|0|||
164562946|NCT02568046|594429339|FG000|Overall Study|Withdrawal by Subject|2|||
164562947|NCT02568046|594429340|FG001|Overall Study|Withdrawal by Subject|1|||
164562948|NCT02568046|594429339|FG000|Overall Study|Other Events|0|||
164562949|NCT02568046|594429340|FG001|Overall Study|Other Events|1|||
164562950|NCT00408694|594429341|FG000|Overall Study|Ineligible|1|||
164562951|NCT00408694|594429341|FG000|Overall Study|No protocol treatment|1|||
164562952|NCT00523991|594429342|FG000|Overall Study|Adverse Event|6|||
164562953|NCT00523991|594429343|FG001|Overall Study|Adverse Event|5|||
164562954|NCT00523991|594429342|FG000|Overall Study|Protocol Violation|1|||
164562955|NCT00523991|594429343|FG001|Overall Study|Protocol Violation|4|||
164562956|NCT00523991|594429342|FG000|Overall Study|Lost to Follow-up|4|||
164562957|NCT00523991|594429343|FG001|Overall Study|Lost to Follow-up|1|||
164562958|NCT00523991|594429342|FG000|Overall Study|Withdrawal by Subject|7|||
164562959|NCT00523991|594429343|FG001|Overall Study|Withdrawal by Subject|17|||
164562960|NCT00523991|594429342|FG000|Overall Study|Other reason (not specified)|3|||
164562961|NCT00523991|594429343|FG001|Overall Study|Other reason (not specified)|0|||
164562962|NCT00193063|594429344|FG000|Overall Study|Lack of Efficacy|3|||
164562963|NCT00193063|594429344|FG000|Overall Study|Adverse Event|1|||
164562964|NCT03261531|594429345|FG000|Overall Study|Withdrawal by Subject|4|||
164562965|NCT01700192|594429346|FG000|Overall Study|Adverse Event|73|||
164562966|NCT01700192|594429347|FG001|Overall Study|Adverse Event|18|||
164666925|NCT02848326|594806389|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
164666926|NCT02848326|594806390|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
164666927|NCT02848326|594806391|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
164666928|NCT02848326|594806392|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
164666929|NCT00745420|594806407|FG000|Overall Study|Ineligible|1|||
164666930|NCT01367275|594806412|FG000|Overall Study|Ineligible|1|||
164666931|NCT01367275|594806412|FG000|Overall Study|Disease Progression|2|||
164666932|NCT02532764|594806413|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
164666933|NCT02532764|594806414|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
164666934|NCT02532764|594806415|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
164666935|NCT02532764|594806416|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
164666936|NCT02532764|594806417|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
164207105|NCT04585893|593126646|FG001|Overall Study|Death|0|||
164207106|NCT01366092|593126647|FG000|Overall Study|Progressive cGVHD|2|||
164207107|NCT01366092|593126647|FG000|Overall Study|Physician Decision|1|||
164207108|NCT01366092|593126647|FG000|Overall Study|Withdrawal by Subject|1|||
164207109|NCT04761822|593127751|FG000|Overall Study|Adverse Event|3|||
164207110|NCT04761822|593127752|FG001|Overall Study|Adverse Event|1|||
164207111|NCT04761822|593127753|FG002|Overall Study|Adverse Event|1|||
164207112|NCT04761822|593127754|FG003|Overall Study|Adverse Event|3|||
164207113|NCT04761822|593127751|FG000|Overall Study|Lost to Follow-up|1|||
164207114|NCT04761822|593127752|FG001|Overall Study|Lost to Follow-up|0|||
164207115|NCT04761822|593127753|FG002|Overall Study|Lost to Follow-up|2|||
164207116|NCT04761822|593127754|FG003|Overall Study|Lost to Follow-up|3|||
164207117|NCT04761822|593127751|FG000|Overall Study|Physician Decision|0|||
164207118|NCT04761822|593127752|FG001|Overall Study|Physician Decision|1|||
164207119|NCT04761822|593127753|FG002|Overall Study|Physician Decision|0|||
164319589|NCT02108262|593546938|FG002|Overall Study|Distance to center|1|||
164319590|NCT02108262|593546939|FG003|Overall Study|Distance to center|0|||
164319591|NCT02108262|593546936|FG000|Overall Study|Adverse Event|0|||
164319592|NCT02108262|593546937|FG001|Overall Study|Adverse Event|11|||
164319593|NCT02108262|593546938|FG002|Overall Study|Adverse Event|6|||
164319594|NCT02108262|593546939|FG003|Overall Study|Adverse Event|12|||
164319595|NCT02108262|593546936|FG000|Overall Study|Death|0|||
164319596|NCT02108262|593546937|FG001|Overall Study|Death|2|||
164319597|NCT02108262|593546938|FG002|Overall Study|Death|2|||
164319598|NCT02108262|593546939|FG003|Overall Study|Death|1|||
164319599|NCT02108262|593546936|FG000|Overall Study|Lost to Follow-up|0|||
164319600|NCT02108262|593546937|FG001|Overall Study|Lost to Follow-up|0|||
164319601|NCT02108262|593546938|FG002|Overall Study|Lost to Follow-up|1|||
164319602|NCT02108262|593546939|FG003|Overall Study|Lost to Follow-up|0|||
164319603|NCT02108262|593546936|FG000|Overall Study|Physician Decision|0|||
164319604|NCT02108262|593546937|FG001|Overall Study|Physician Decision|0|||
164319605|NCT02108262|593546938|FG002|Overall Study|Physician Decision|2|||
164319606|NCT02108262|593546939|FG003|Overall Study|Physician Decision|0|||
164319607|NCT02108262|593546936|FG000|Overall Study|Withdrawal by Subject|0|||
164319608|NCT02108262|593546937|FG001|Overall Study|Withdrawal by Subject|7|||
164319609|NCT02108262|593546938|FG002|Overall Study|Withdrawal by Subject|3|||
164319610|NCT02108262|593546939|FG003|Overall Study|Withdrawal by Subject|4|||
164319611|NCT02108262|593546936|FG000|Overall Study|Due to key hepatic values|0|||
164319612|NCT02108262|593546937|FG001|Overall Study|Due to key hepatic values|1|||
164319613|NCT02108262|593546938|FG002|Overall Study|Due to key hepatic values|0|||
164319614|NCT02108262|593546939|FG003|Overall Study|Due to key hepatic values|0|||
164319615|NCT02108262|593546936|FG000|Overall Study|Unable to contact patient|0|||
164319616|NCT02108262|593546937|FG001|Overall Study|Unable to contact patient|3|||
164319617|NCT02108262|593546938|FG002|Overall Study|Unable to contact patient|1|||
164319618|NCT02108262|593546939|FG003|Overall Study|Unable to contact patient|2|||
164319619|NCT02108262|593546936|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
164319620|NCT02108262|593546937|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
164319621|NCT02108262|593546938|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
164319622|NCT02108262|593546939|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
164319623|NCT02108262|593546936|FG000|Overall Study|Patient did not want another infusion|0|||
164319624|NCT02108262|593546937|FG001|Overall Study|Patient did not want another infusion|3|||
164319625|NCT02108262|593546938|FG002|Overall Study|Patient did not want another infusion|3|||
164319626|NCT02108262|593546939|FG003|Overall Study|Patient did not want another infusion|2|||
164319627|NCT02108262|593546936|FG000|Overall Study|Vacation|0|||
164319628|NCT02108262|593546937|FG001|Overall Study|Vacation|1|||
164319629|NCT02108262|593546938|FG002|Overall Study|Vacation|0|||
164319630|NCT02108262|593546939|FG003|Overall Study|Vacation|0|||
164319631|NCT02108262|593546936|FG000|Overall Study|Patient decision|0|||
164562967|NCT01700192|594429346|FG000|Overall Study|Lack of Efficacy|1|||
164562968|NCT01700192|594429347|FG001|Overall Study|Lack of Efficacy|0|||
164562969|NCT01700192|594429346|FG000|Overall Study|Lost to Follow-up|42|||
164562970|NCT01700192|594429347|FG001|Overall Study|Lost to Follow-up|29|||
164562971|NCT01700192|594429346|FG000|Overall Study|Noncompliance with study drug|0|||
164562972|NCT01700192|594429347|FG001|Overall Study|Noncompliance with study drug|5|||
164562973|NCT01700192|594429346|FG000|Overall Study|Physician Decision|2|||
164562974|NCT01700192|594429347|FG001|Overall Study|Physician Decision|3|||
164562975|NCT01700192|594429346|FG000|Overall Study|Pregnancy|1|||
164562976|NCT01700192|594429347|FG001|Overall Study|Pregnancy|4|||
164562977|NCT01700192|594429346|FG000|Overall Study|Progressive disease|1|||
164562978|NCT01700192|594429347|FG001|Overall Study|Progressive disease|0|||
164562979|NCT01700192|594429346|FG000|Overall Study|Protocol Violation|3|||
164562980|NCT01700192|594429347|FG001|Overall Study|Protocol Violation|4|||
164666937|NCT02532764|594806418|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
164319632|NCT02108262|593546937|FG001|Overall Study|Patient decision|7|||
164319633|NCT02108262|593546938|FG002|Overall Study|Patient decision|9|||
164319634|NCT02108262|593546939|FG003|Overall Study|Patient decision|14|||
164319635|NCT02108262|593546936|FG000|Overall Study|Missed IV due to pharmacy error|0|||
164319636|NCT02108262|593546937|FG001|Overall Study|Missed IV due to pharmacy error|0|||
164420639|NCT01154036|593910962|FG000|Phase I|Protocol Violation|0|||
164562981|NCT01700192|594429346|FG000|Overall Study|Technical problems|0|||
164666938|NCT02532764|594806419|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
164666939|NCT02532764|594806420|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
164319637|NCT02108262|593546938|FG002|Overall Study|Missed IV due to pharmacy error|1|||
164319638|NCT02108262|593546939|FG003|Overall Study|Missed IV due to pharmacy error|0|||
164319639|NCT01238588|593546945|FG000|Overall Study|Withdrawal by Subject|1|||
164319640|NCT01238588|593546945|FG000|Overall Study|Physician Decision|2|||
164319641|NCT01915303|593546950|FG000|Core Phase|Adverse Event|7|||
164319642|NCT01915303|593546950|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
164319643|NCT01915303|593546950|FG000|Core Phase|Death|2|||
164319644|NCT01915303|593546950|FG000|Core Phase|Protocol Violation|2|||
164319645|NCT01915303|593546950|FG000|Core Phase|Abnormal lab value|1|||
164562982|NCT01700192|594429347|FG001|Overall Study|Technical problems|1|||
164319646|NCT01915303|593546950|FG000|Core Phase|Withdrawal by Subject|1|||
164319647|NCT01915303|593546950|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
164319648|NCT01915303|593546950|FG000|Extension Phase|Withdrawal by Subject|4|||
164319649|NCT01915303|593546950|FG000|Extension Phase|Adverse Event|3|||
164319650|NCT01915303|593546950|FG000|Extension Phase|Death|1|||
164319651|NCT01915303|593546950|FG000|Extension Phase|Protocol Violation|1|||
164319652|NCT02509117|593546952|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
164319653|NCT02509117|593546953|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
164319654|NCT02509117|593546954|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
164319655|NCT02509117|593546955|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
164319656|NCT02509117|593546956|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
164319657|NCT02509117|593546957|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
164319658|NCT02509117|593546958|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
164319659|NCT02509117|593546959|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
164319660|NCT02509117|593546960|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
164319661|NCT02509117|593546961|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
164319662|NCT02509117|593546952|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
164319663|NCT02509117|593546953|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
164319664|NCT02509117|593546954|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
164319665|NCT02509117|593546955|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
164319666|NCT02509117|593546956|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
164319667|NCT02509117|593546957|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
164319668|NCT02509117|593546958|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
164319669|NCT02509117|593546959|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
164319670|NCT02509117|593546960|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
164319671|NCT02509117|593546961|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
164319672|NCT02509117|593546952|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
164319673|NCT02509117|593546953|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
164319674|NCT02509117|593546954|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
164319675|NCT02509117|593546955|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
164319676|NCT02509117|593546956|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
164319677|NCT02509117|593546957|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
164319678|NCT02509117|593546958|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
164319679|NCT02509117|593546959|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
164319680|NCT02509117|593546960|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
164319681|NCT02509117|593546961|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
164319682|NCT00280748|593546970|FG000|Overall Study|Decline in performance|3|||
164666940|NCT02532764|594806421|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
164319683|NCT00280748|593546970|FG000|Overall Study|Extra-cranial disease progression|1|||
164319684|NCT01433250|593546971|FG000|Overall Study|Protocol Violation|0|||
164319685|NCT01433250|593546972|FG001|Overall Study|Protocol Violation|1|||
164319686|NCT01433250|593546971|FG000|Overall Study|Withdrawal by Subject|3|||
164319687|NCT01433250|593546972|FG001|Overall Study|Withdrawal by Subject|2|||
164319688|NCT02576145|593546973|FG000|Overall Study|Adverse Event|1|||
164319689|NCT02576145|593546974|FG001|Overall Study|Adverse Event|0|||
164319690|NCT02576145|593546973|FG000|Overall Study|Withdrawal by Subject|1|||
164319691|NCT02576145|593546974|FG001|Overall Study|Withdrawal by Subject|0|||
164319692|NCT02576145|593546973|FG000|Overall Study|Acute rejection|1|||
164319693|NCT02576145|593546974|FG001|Overall Study|Acute rejection|0|||
164319694|NCT02576145|593546973|FG000|Overall Study|Tetanus Titers Decreased|0|||
164319695|NCT02576145|593546974|FG001|Overall Study|Tetanus Titers Decreased|1|||
164319696|NCT01227824|593546975|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
164319697|NCT01227824|593546976|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
164420640|NCT01154036|593910963|FG001|Phase I|Protocol Violation|3|||
164666941|NCT02532764|594806422|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
164666942|NCT00048568|594806432|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
164666943|NCT00048568|594806433|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
164319698|NCT01227824|593546977|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
164319699|NCT01227824|593546975|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
164319700|NCT01227824|593546976|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
164319701|NCT01227824|593546977|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
164319702|NCT01227824|593546975|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
164319703|NCT01227824|593546976|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
164319704|NCT01227824|593546977|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
164319705|NCT01227824|593546975|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
164319706|NCT01227824|593546976|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
164319707|NCT01227824|593546977|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
164319708|NCT01227824|593546975|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
164319709|NCT01227824|593546976|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
164319710|NCT01227824|593546977|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
164319711|NCT01227824|593546975|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
164319712|NCT01227824|593546976|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
164319713|NCT01227824|593546977|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
164319714|NCT01227824|593546975|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
164319715|NCT01227824|593546976|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
164319716|NCT01227824|593546977|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
164319717|NCT01227824|593546975|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
164319718|NCT01227824|593546976|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
164319719|NCT01227824|593546977|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
164319720|NCT01227824|593546975|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
164319721|NCT01227824|593546976|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
164319722|NCT01227824|593546977|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
164319723|NCT01227824|593546975|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
164319724|NCT01227824|593546976|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
164319725|NCT01227824|593546977|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
164319726|NCT01227824|593546975|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
164319727|NCT01227824|593546976|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
164319728|NCT01227824|593546977|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
164319729|NCT01227824|593546975|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
164319730|NCT01227824|593546976|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
164319731|NCT01227824|593546977|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
164319732|NCT01227824|593546975|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
164319733|NCT01227824|593546976|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
164319734|NCT01227824|593546977|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
164319735|NCT01227824|593546975|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
164319736|NCT01227824|593546976|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
164319737|NCT01227824|593546977|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
164319738|NCT01227824|593546975|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
164319739|NCT01227824|593546976|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
164319740|NCT01227824|593546977|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
164319741|NCT00995566|593546982|FG000|Overall Study|Adverse Event|2|||
164319742|NCT00995566|593546982|FG000|Overall Study|Early study termination|52|||
164319743|NCT00821509|593546985|FG000|Overall Study|Withdrawal by Subject|12|||
164319744|NCT00821509|593546986|FG001|Overall Study|Withdrawal by Subject|11|||
164319745|NCT00821509|593546987|FG002|Overall Study|Withdrawal by Subject|34|||
164319746|NCT03612856|593546988|FG000|Pre-dose Period|Physician Decision|0|||
164319747|NCT03612856|593546989|FG001|Pre-dose Period|Physician Decision|1|||
164319748|NCT03612856|593546990|FG002|Pre-dose Period|Physician Decision|1|||
164319749|NCT03612856|593546988|FG000|Pre-dose Period|Withdrawal by Subject|0|||
164319750|NCT03612856|593546989|FG001|Pre-dose Period|Withdrawal by Subject|1|||
164319751|NCT03612856|593546990|FG002|Pre-dose Period|Withdrawal by Subject|0|||
164319752|NCT01576159|593546991|FG000|Overall Study|Withdrawal by Subject|0|||
164319753|NCT01576159|593546992|FG001|Overall Study|Withdrawal by Subject|1|||
164319754|NCT01576159|593546993|FG002|Overall Study|Withdrawal by Subject|0|||
164319755|NCT01576159|593546994|FG003|Overall Study|Withdrawal by Subject|0|||
164319756|NCT01576159|593546991|FG000|Overall Study|Physician Decision|0|||
164319757|NCT01576159|593546992|FG001|Overall Study|Physician Decision|0|||
164319758|NCT01576159|593546993|FG002|Overall Study|Physician Decision|1|||
164319759|NCT01576159|593546994|FG003|Overall Study|Physician Decision|0|||
164319760|NCT01576159|593546991|FG000|Overall Study|Lost to Follow-up|0|||
164319761|NCT01576159|593546992|FG001|Overall Study|Lost to Follow-up|0|||
164319762|NCT01576159|593546993|FG002|Overall Study|Lost to Follow-up|0|||
164420641|NCT01154036|593910964|FG002|Phase I|Protocol Violation|9|||
164666944|NCT00048568|594806434|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
164319763|NCT01576159|593546994|FG003|Overall Study|Lost to Follow-up|1|||
164319764|NCT01576159|593546991|FG000|Overall Study|Protocol Violation|1|||
164319765|NCT01576159|593546992|FG001|Overall Study|Protocol Violation|0|||
164319766|NCT01576159|593546993|FG002|Overall Study|Protocol Violation|0|||
164319767|NCT01576159|593546994|FG003|Overall Study|Protocol Violation|0|||
164319768|NCT01454778|593546996|FG000|Overall Study|Lost to Follow-up|2|||
164319769|NCT01454778|593546996|FG000|Overall Study|Death|1|||
164319770|NCT01227629|593546998|FG000|Overall Study|Adverse Event|2|||
164319771|NCT01227629|593546999|FG001|Overall Study|Adverse Event|2|||
164319772|NCT01227629|593547000|FG002|Overall Study|Adverse Event|1|||
164562983|NCT01700192|594429346|FG000|Overall Study|Withdrawal by Subject|56|||
164562984|NCT01700192|594429347|FG001|Overall Study|Withdrawal by Subject|64|||
164562985|NCT01700192|594429346|FG000|Overall Study|Never received study drug|1|||
164562986|NCT01700192|594429347|FG001|Overall Study|Never received study drug|0|||
164562987|NCT00744874|594429350|FG000|Overall Study|Lost to Follow-up|1|||
164562988|NCT00744874|594429350|FG000|Overall Study|Withdrawal by Subject|1|||
164562989|NCT00744874|594429350|FG000|Overall Study|Study Device not available at procedure|1|||
164562990|NCT00744874|594429350|FG000|Overall Study|Unable to accomodate schedule|1|||
164562991|NCT02435849|594429356|FG000|Overall Study|Death|23|||
164562992|NCT02435849|594429357|FG001|Overall Study|Death|0|||
164562993|NCT02435849|594429356|FG000|Overall Study|Lack of Efficacy|10|||
164562994|NCT02435849|594429357|FG001|Overall Study|Lack of Efficacy|0|||
164562995|NCT02435849|594429356|FG000|Overall Study|New therapy for study indication|8|||
164562996|NCT02435849|594429357|FG001|Overall Study|New therapy for study indication|0|||
164562997|NCT02435849|594429356|FG000|Overall Study|Subject/guardian decision|5|||
164562998|NCT02435849|594429357|FG001|Overall Study|Subject/guardian decision|1|||
164562999|NCT02435849|594429356|FG000|Overall Study|Lost to Follow-up|1|||
164563000|NCT02435849|594429357|FG001|Overall Study|Lost to Follow-up|0|||
164563001|NCT02435849|594429356|FG000|Overall Study|Physician Decision|1|||
164563002|NCT02435849|594429357|FG001|Overall Study|Physician Decision|0|||
164563003|NCT03175549|594429358|FG000|Overall Study|Lost to Follow-up|2|||
164563004|NCT03175549|594429359|FG001|Overall Study|Lost to Follow-up|2|||
164563005|NCT03175549|594429358|FG000|Overall Study|Medication non-compliance|2|||
164563006|NCT03175549|594429359|FG001|Overall Study|Medication non-compliance|2|||
164563007|NCT01017952|594429360|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
164563008|NCT01017952|594429361|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
164563009|NCT01017952|594429362|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
164563010|NCT01017952|594429363|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
164563011|NCT01017952|594429364|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
164563012|NCT01017952|594429360|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
164563013|NCT01017952|594429361|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
164563014|NCT01017952|594429362|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
164563015|NCT01017952|594429363|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
164563016|NCT01017952|594429364|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
164563017|NCT01017952|594429360|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
164563018|NCT01017952|594429361|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
164563019|NCT01017952|594429362|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
164563020|NCT01017952|594429363|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
164563021|NCT01017952|594429364|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
164563022|NCT01017952|594429360|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
164563023|NCT01017952|594429361|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
164563024|NCT01017952|594429362|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
164563025|NCT01017952|594429363|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
164563026|NCT01017952|594429364|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
164563027|NCT01017952|594429360|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
164563028|NCT01017952|594429361|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
164563029|NCT01017952|594429362|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
164563030|NCT01017952|594429363|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
164563031|NCT01017952|594429364|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
164563032|NCT01017952|594429360|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
164563033|NCT01017952|594429361|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
164563034|NCT01017952|594429362|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
164563035|NCT01017952|594429363|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
164563036|NCT01017952|594429364|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
164563037|NCT01017952|594429360|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
164319773|NCT01227629|593547001|FG003|Overall Study|Adverse Event|6|||
164319774|NCT01227629|593547002|FG004|Overall Study|Adverse Event|1|||
164319775|NCT01227629|593547003|FG005|Overall Study|Adverse Event|1|||
164319776|NCT01227629|593547004|FG006|Overall Study|Adverse Event|6|||
164563038|NCT01017952|594429361|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
164563039|NCT01017952|594429362|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
164563040|NCT01017952|594429363|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
164563041|NCT01017952|594429364|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
164563042|NCT01017952|594429360|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
164563043|NCT01017952|594429361|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
164563044|NCT01017952|594429362|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
164563045|NCT01017952|594429363|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
164563046|NCT01017952|594429364|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
164563047|NCT01017952|594429360|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
164563048|NCT01017952|594429361|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
164563049|NCT01017952|594429362|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
164563050|NCT01017952|594429363|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
164563051|NCT01017952|594429364|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
164563052|NCT01017952|594429360|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
164563053|NCT01017952|594429361|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
164563054|NCT01017952|594429362|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
164563055|NCT01017952|594429363|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
164563056|NCT01017952|594429364|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
164563057|NCT01017952|594429360|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
164563058|NCT01017952|594429361|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
164563059|NCT01017952|594429362|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
164563060|NCT01017952|594429363|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
164563061|NCT01017952|594429364|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
164563062|NCT01017952|594429360|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
164563063|NCT01017952|594429361|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
164563064|NCT01017952|594429362|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
164563065|NCT01017952|594429363|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
164563066|NCT01017952|594429364|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
164563067|NCT01017952|594429360|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164563068|NCT01017952|594429361|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
164563069|NCT01017952|594429362|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
164563070|NCT01017952|594429363|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
164563071|NCT01017952|594429364|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
164563072|NCT01017952|594429360|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
164563073|NCT01017952|594429361|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
164563074|NCT01017952|594429362|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
164563075|NCT01017952|594429363|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
164563076|NCT01017952|594429364|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
164563077|NCT00352105|594429366|FG000|Overall Study|Death|5|||
164563078|NCT00352105|594429366|FG000|Overall Study|Withdrawal by Subject|5|||
164563079|NCT00352105|594429366|FG000|Overall Study|Lack of Efficacy|9|||
164563080|NCT00352105|594429366|FG000|Overall Study|Adverse Event|19|||
164563081|NCT00352105|594429366|FG000|Overall Study|Protocol Violation|2|||
164563082|NCT02979431|594429369|FG000|Overall Study|Parent/guardian withdrew consent|2|||
164563083|NCT02979431|594429370|FG001|Overall Study|Parent/guardian withdrew consent|1|||
164563084|NCT02979431|594429371|FG002|Overall Study|Parent/guardian withdrew consent|1|||
164563085|NCT02979431|594429372|FG003|Overall Study|Parent/guardian withdrew consent|1|||
164563086|NCT02979431|594429369|FG000|Overall Study|Randomized but received no study drug|1|||
164563087|NCT02979431|594429370|FG001|Overall Study|Randomized but received no study drug|1|||
164563088|NCT02979431|594429371|FG002|Overall Study|Randomized but received no study drug|0|||
164563089|NCT02979431|594429372|FG003|Overall Study|Randomized but received no study drug|0|||
164563090|NCT02979431|594429369|FG000|Overall Study|Adverse Event|0|||
164563091|NCT02979431|594429370|FG001|Overall Study|Adverse Event|0|||
164563092|NCT02979431|594429371|FG002|Overall Study|Adverse Event|1|||
164563093|NCT02979431|594429372|FG003|Overall Study|Adverse Event|0|||
164563094|NCT02979431|594429369|FG000|Overall Study|Subject left country after Day14|1|||
164563095|NCT02979431|594429370|FG001|Overall Study|Subject left country after Day14|0|||
164563096|NCT02979431|594429371|FG002|Overall Study|Subject left country after Day14|0|||
164563097|NCT02979431|594429372|FG003|Overall Study|Subject left country after Day14|0|||
164563098|NCT01656434|594429373|FG000|Overall Study|Adverse Event|199|||
164563099|NCT01656434|594429374|FG001|Overall Study|Adverse Event|63|||
164563100|NCT01656434|594429373|FG000|Overall Study|Enrollment terminated at trial site|2|||
164563101|NCT01656434|594429374|FG001|Overall Study|Enrollment terminated at trial site|0|||
164563102|NCT01656434|594429373|FG000|Overall Study|Lost to Follow-up|309|||
164563103|NCT01656434|594429374|FG001|Overall Study|Lost to Follow-up|76|||
164420642|NCT01154036|593910965|FG003|Phase I|Protocol Violation|0|||
164563104|NCT01656434|594429373|FG000|Overall Study|Site discontinued study participation|24|||
164563105|NCT01656434|594429374|FG001|Overall Study|Site discontinued study participation|9|||
164319777|NCT01227629|593547005|FG007|Overall Study|Adverse Event|6|||
164319778|NCT01227629|593547006|FG008|Overall Study|Adverse Event|4|||
164319779|NCT01227629|593547007|FG009|Overall Study|Adverse Event|0|||
164319780|NCT01227629|593546998|FG000|Overall Study|Protocol Violation|0|||
164319781|NCT01227629|593546999|FG001|Overall Study|Protocol Violation|0|||
164319782|NCT01227629|593547000|FG002|Overall Study|Protocol Violation|0|||
164319783|NCT01227629|593547001|FG003|Overall Study|Protocol Violation|1|||
164319784|NCT01227629|593547002|FG004|Overall Study|Protocol Violation|0|||
164319785|NCT01227629|593547003|FG005|Overall Study|Protocol Violation|0|||
164319786|NCT01227629|593547004|FG006|Overall Study|Protocol Violation|0|||
164319787|NCT01227629|593547005|FG007|Overall Study|Protocol Violation|0|||
164319788|NCT01227629|593547006|FG008|Overall Study|Protocol Violation|0|||
164319789|NCT01227629|593547007|FG009|Overall Study|Protocol Violation|0|||
164319790|NCT01227629|593546998|FG000|Overall Study|Lost to Follow-up|0|||
164319791|NCT01227629|593546999|FG001|Overall Study|Lost to Follow-up|0|||
164319792|NCT01227629|593547000|FG002|Overall Study|Lost to Follow-up|0|||
164319793|NCT01227629|593547001|FG003|Overall Study|Lost to Follow-up|0|||
164319794|NCT01227629|593547002|FG004|Overall Study|Lost to Follow-up|1|||
164319795|NCT01227629|593547003|FG005|Overall Study|Lost to Follow-up|0|||
164319796|NCT01227629|593547004|FG006|Overall Study|Lost to Follow-up|0|||
164319797|NCT01227629|593547005|FG007|Overall Study|Lost to Follow-up|0|||
164319798|NCT01227629|593547006|FG008|Overall Study|Lost to Follow-up|0|||
164319799|NCT01227629|593547007|FG009|Overall Study|Lost to Follow-up|0|||
164319800|NCT01227629|593546998|FG000|Overall Study|Withdrawal by Subject|0|||
164319801|NCT01227629|593546999|FG001|Overall Study|Withdrawal by Subject|0|||
164319802|NCT01227629|593547000|FG002|Overall Study|Withdrawal by Subject|0|||
164319803|NCT01227629|593547001|FG003|Overall Study|Withdrawal by Subject|0|||
164319804|NCT01227629|593547002|FG004|Overall Study|Withdrawal by Subject|0|||
164319805|NCT01227629|593547003|FG005|Overall Study|Withdrawal by Subject|0|||
164319806|NCT01227629|593547004|FG006|Overall Study|Withdrawal by Subject|2|||
164319807|NCT01227629|593547005|FG007|Overall Study|Withdrawal by Subject|0|||
164319808|NCT01227629|593547006|FG008|Overall Study|Withdrawal by Subject|0|||
164319809|NCT01227629|593547007|FG009|Overall Study|Withdrawal by Subject|1|||
164319810|NCT01227629|593546998|FG000|Overall Study|Other|0|||
164319811|NCT01227629|593546999|FG001|Overall Study|Other|0|||
164319812|NCT01227629|593547000|FG002|Overall Study|Other|0|||
164319813|NCT01227629|593547001|FG003|Overall Study|Other|1|||
164319814|NCT01227629|593547002|FG004|Overall Study|Other|0|||
164319815|NCT01227629|593547003|FG005|Overall Study|Other|0|||
164319816|NCT01227629|593547004|FG006|Overall Study|Other|0|||
164319817|NCT01227629|593547005|FG007|Overall Study|Other|0|||
164319818|NCT01227629|593547006|FG008|Overall Study|Other|2|||
164319819|NCT01227629|593547007|FG009|Overall Study|Other|1|||
164319820|NCT03224598|593548273|FG000|Overall Study|Lost to Follow-up|0|||
164319821|NCT03224598|593548274|FG001|Overall Study|Lost to Follow-up|2|||
164319822|NCT03224598|593548275|FG002|Overall Study|Lost to Follow-up|0|||
164319823|NCT03224598|593548273|FG000|Overall Study|Other|0|||
164319824|NCT03224598|593548274|FG001|Overall Study|Other|1|||
164319825|NCT03224598|593548275|FG002|Overall Study|Other|0|||
164319826|NCT03328182|593548278|FG000|Overall Study|Withdrawal by Subject|1|||
164319827|NCT03328182|593548278|FG000|Overall Study|Protocol Violation|2|||
164563106|NCT01656434|594429373|FG000|Overall Study|Screen failure|2|||
164563107|NCT01656434|594429374|FG001|Overall Study|Screen failure|0|||
164563108|NCT01656434|594429373|FG000|Overall Study|Protocol Violation|7|||
164563109|NCT01656434|594429374|FG001|Overall Study|Protocol Violation|0|||
164563110|NCT01656434|594429373|FG000|Overall Study|Pregnancy wish|18|||
164563111|NCT01656434|594429374|FG001|Overall Study|Pregnancy wish|6|||
164563112|NCT01656434|594429373|FG000|Overall Study|Pregnancy|45|||
164666945|NCT00048568|594806432|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
164319828|NCT03328182|593548278|FG000|Overall Study|No Product Evaluated|1|||
164319829|NCT02320903|593548279|FG000|Overall Study|Withdrawal by Subject|0|||
164319830|NCT02320903|593548280|FG001|Overall Study|Withdrawal by Subject|9|||
164319831|NCT02320903|593548281|FG002|Overall Study|Withdrawal by Subject|9|||
164319832|NCT02320903|593548279|FG000|Overall Study|Exited therapy; no longer eligible|8|||
164319833|NCT02320903|593548280|FG001|Overall Study|Exited therapy; no longer eligible|2|||
164319834|NCT02320903|593548281|FG002|Overall Study|Exited therapy; no longer eligible|2|||
164319835|NCT02320903|593548279|FG000|Overall Study|Lost to Follow-up|0|||
164319836|NCT02320903|593548280|FG001|Overall Study|Lost to Follow-up|5|||
164319837|NCT02320903|593548281|FG002|Overall Study|Lost to Follow-up|5|||
164319838|NCT00773383|593548282|FG000|Overall Study|Adverse Event|4|||
164319839|NCT00773383|593548282|FG000|Overall Study|Death|1|||
164319840|NCT00773383|593548282|FG000|Overall Study|Progression of Disease|23|||
164319841|NCT00773383|593548282|FG000|Overall Study|Other|2|||
164319842|NCT00773383|593548282|FG000|Overall Study|No study dose received|1|||
164420643|NCT01154036|593910966|FG004|Phase I|Protocol Violation|0|||
164563113|NCT01656434|594429374|FG001|Overall Study|Pregnancy|10|||
164563114|NCT01656434|594429373|FG000|Overall Study|Physician Decision|7|||
164319843|NCT01012219|593548285|FG000|Period 1|Withdrawal by Subject|1|||
164319844|NCT01012219|593548285|FG000|Period 2|Withdrawal by Subject|1|||
164319845|NCT03811093|593548288|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
164319846|NCT03811093|593548289|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
164319847|NCT03811093|593548288|FG000|Overall Study|Unable to measure body fat percentage|2|||
164319848|NCT03811093|593548289|FG001|Overall Study|Unable to measure body fat percentage|0|||
164319849|NCT01095094|593548291|FG000|Overall Study|Withdrawal by Subject|1|||
164319850|NCT01095094|593548291|FG000|Overall Study|Death|1|||
164319851|NCT01095094|593548291|FG000|Overall Study|Physician Decision|1|||
164319852|NCT00464490|593548294|FG000|Overall Study|Physician Decision|11|||
164319853|NCT00464490|593548295|FG001|Overall Study|Physician Decision|11|||
164319854|NCT03188042|593548298|FG000|Overall Study|Withdrawal by Subject|1|||
164319855|NCT03188042|593548299|FG001|Overall Study|Withdrawal by Subject|1|||
164319856|NCT01328366|593548303|FG000|Overall Study|Death|1|||
164319857|NCT01328366|593548303|FG000|Overall Study|Withdrawal by Subject|2|||
164319858|NCT01328366|593548303|FG000|Overall Study|Lost to Follow-up|7|||
164319859|NCT00137839|593548307|FG000|Overall Study|Adverse Event|7|||
164319860|NCT00137839|593548307|FG000|Overall Study|Physician Decision|7|||
164319861|NCT00137839|593548307|FG000|Overall Study|Death|8|||
164319862|NCT00137839|593548307|FG000|Overall Study|Disease Progression|60|||
164319863|NCT00137839|593548307|FG000|Overall Study|Not Start Treatment|1|||
164319864|NCT00137839|593548307|FG000|Overall Study|Prolonged Treatment Delay|1|||
164319865|NCT03860935|593548312|FG000|Overall Study|Withdrawal of Consent|15|||
164319866|NCT03860935|593548313|FG001|Overall Study|Withdrawal of Consent|6|||
164319867|NCT03860935|593548312|FG000|Overall Study|Death|75|||
164319868|NCT03860935|593548313|FG001|Overall Study|Death|51|||
164319869|NCT03361176|593548317|FG000|Overall Study|Lost to Follow-up|1|||
164319870|NCT03361176|593548318|FG001|Overall Study|Lost to Follow-up|2|||
164319871|NCT03361176|593548317|FG000|Overall Study|Adverse Event|0|||
164319872|NCT03361176|593548318|FG001|Overall Study|Adverse Event|2|||
164319873|NCT03361176|593548317|FG000|Overall Study|Withdrawal by Subject|0|||
164319874|NCT03361176|593548318|FG001|Overall Study|Withdrawal by Subject|1|||
164319875|NCT01437995|593548321|FG000|Overall Study|Lost to Follow-up|11|||
164319876|NCT01437995|593548322|FG001|Overall Study|Lost to Follow-up|18|||
164319877|NCT01437995|593548323|FG002|Overall Study|Lost to Follow-up|20|||
164319878|NCT04456673|593548324|FG000|Overall Study|Adverse Event|7|||
164319879|NCT04456673|593548325|FG001|Overall Study|Adverse Event|14|||
164319880|NCT04456673|593548324|FG000|Overall Study|Poor compliance to protocol|1|||
164319881|NCT04456673|593548325|FG001|Overall Study|Poor compliance to protocol|0|||
164319882|NCT04456673|593548324|FG000|Overall Study|Withdrawal by Subject|31|||
164319883|NCT04456673|593548325|FG001|Overall Study|Withdrawal by Subject|23|||
164319884|NCT04456673|593548324|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
164319885|NCT04456673|593548325|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
164319886|NCT02160002|593548326|FG000|Overall Study|Withdrawal by Subject|2|||
164319887|NCT02160002|593548327|FG001|Overall Study|Withdrawal by Subject|1|||
164319888|NCT04418661|593548328|FG000|Overall Study|Adverse Event|0|||
164319889|NCT04418661|593548329|FG001|Overall Study|Adverse Event|1|||
164319890|NCT04418661|593548330|FG002|Overall Study|Adverse Event|5|||
164319891|NCT04418661|593548331|FG003|Overall Study|Adverse Event|3|||
164319892|NCT04418661|593548332|FG004|Overall Study|Adverse Event|0|||
164319893|NCT04418661|593548333|FG005|Overall Study|Adverse Event|2|||
164319894|NCT04418661|593548328|FG000|Overall Study|Progressive disease|4|||
164319895|NCT04418661|593548329|FG001|Overall Study|Progressive disease|11|||
164319896|NCT04418661|593548330|FG002|Overall Study|Progressive disease|6|||
164319897|NCT04418661|593548331|FG003|Overall Study|Progressive disease|11|||
164319898|NCT04418661|593548332|FG004|Overall Study|Progressive disease|1|||
164319899|NCT04418661|593548333|FG005|Overall Study|Progressive disease|12|||
164319900|NCT04418661|593548328|FG000|Overall Study|Withdrawal by Subject|0|||
164319901|NCT04418661|593548329|FG001|Overall Study|Withdrawal by Subject|1|||
164319902|NCT04418661|593548330|FG002|Overall Study|Withdrawal by Subject|0|||
164319903|NCT04418661|593548331|FG003|Overall Study|Withdrawal by Subject|1|||
164319904|NCT04418661|593548332|FG004|Overall Study|Withdrawal by Subject|0|||
164319905|NCT04418661|593548333|FG005|Overall Study|Withdrawal by Subject|0|||
164319906|NCT04418661|593548328|FG000|Overall Study|Other|0|||
164319907|NCT04418661|593548329|FG001|Overall Study|Other|0|||
164319908|NCT04418661|593548330|FG002|Overall Study|Other|1|||
164319909|NCT04418661|593548331|FG003|Overall Study|Other|3|||
164319910|NCT04418661|593548332|FG004|Overall Study|Other|0|||
164319911|NCT04418661|593548333|FG005|Overall Study|Other|1|||
164319912|NCT01689532|593548334|FG000|Overall Study|Adverse Event|9|||
164319913|NCT01689532|593548335|FG001|Overall Study|Adverse Event|5|||
164319914|NCT01689532|593548334|FG000|Overall Study|Lack of Efficacy|2|||
164319915|NCT01689532|593548335|FG001|Overall Study|Lack of Efficacy|2|||
164319916|NCT01689532|593548334|FG000|Overall Study|Withdrawal by Subject|1|||
164319917|NCT01689532|593548335|FG001|Overall Study|Withdrawal by Subject|2|||
164319918|NCT01689532|593548334|FG000|Overall Study|Physician Decision|2|||
164319919|NCT01689532|593548335|FG001|Overall Study|Physician Decision|0|||
164319920|NCT01363349|593548336|FG000|Overall Study|Adverse Event|6|||
164319921|NCT01363349|593548337|FG001|Overall Study|Adverse Event|7|||
164319922|NCT01363349|593548336|FG000|Overall Study|Lack of Efficacy|3|||
164319923|NCT01363349|593548337|FG001|Overall Study|Lack of Efficacy|10|||
164319924|NCT01363349|593548336|FG000|Overall Study|Non compliance/Protocol deviations|2|||
164319925|NCT01363349|593548337|FG001|Overall Study|Non compliance/Protocol deviations|2|||
164319926|NCT01363349|593548336|FG000|Overall Study|Withdrawal by Subject|14|||
164319927|NCT01363349|593548337|FG001|Overall Study|Withdrawal by Subject|6|||
164319928|NCT01363349|593548336|FG000|Overall Study|Lost to Follow-up|5|||
164319929|NCT01363349|593548337|FG001|Overall Study|Lost to Follow-up|6|||
164319930|NCT01363349|593548336|FG000|Overall Study|Not reported|36|||
164319931|NCT01363349|593548337|FG001|Overall Study|Not reported|37|||
164319932|NCT01363349|593548336|FG000|Overall Study|missing|1|||
164319933|NCT01363349|593548337|FG001|Overall Study|missing|2|||
164319934|NCT04449029|593548349|FG000|Overall Study|Adverse Event|0|||
164319935|NCT04449029|593548350|FG001|Overall Study|Adverse Event|1|||
164319936|NCT04449029|593548351|FG002|Overall Study|Adverse Event|1|||
164319937|NCT04449029|593548352|FG003|Overall Study|Adverse Event|0|||
164319938|NCT04449029|593548353|FG004|Overall Study|Adverse Event|1|||
164319939|NCT04449029|593548354|FG005|Overall Study|Adverse Event|0|||
164319940|NCT04449029|593548355|FG006|Overall Study|Adverse Event|1|||
164319941|NCT04449029|593548356|FG007|Overall Study|Adverse Event|0|||
164319942|NCT04449029|593548349|FG000|Overall Study|Lost to Follow-up|0|||
164319943|NCT04449029|593548350|FG001|Overall Study|Lost to Follow-up|1|||
164319944|NCT04449029|593548351|FG002|Overall Study|Lost to Follow-up|0|||
164319945|NCT04449029|593548352|FG003|Overall Study|Lost to Follow-up|0|||
164319946|NCT04449029|593548353|FG004|Overall Study|Lost to Follow-up|0|||
164319947|NCT04449029|593548354|FG005|Overall Study|Lost to Follow-up|0|||
164319948|NCT04449029|593548355|FG006|Overall Study|Lost to Follow-up|0|||
164319949|NCT04449029|593548356|FG007|Overall Study|Lost to Follow-up|0|||
164319950|NCT04449029|593548349|FG000|Overall Study|Protocol Violation|0|||
164319951|NCT04449029|593548350|FG001|Overall Study|Protocol Violation|1|||
164319952|NCT04449029|593548351|FG002|Overall Study|Protocol Violation|0|||
164319953|NCT04449029|593548352|FG003|Overall Study|Protocol Violation|0|||
164319954|NCT04449029|593548353|FG004|Overall Study|Protocol Violation|0|||
164319955|NCT04449029|593548354|FG005|Overall Study|Protocol Violation|0|||
164319956|NCT04449029|593548355|FG006|Overall Study|Protocol Violation|0|||
164319957|NCT04449029|593548356|FG007|Overall Study|Protocol Violation|0|||
164319958|NCT04449029|593548349|FG000|Overall Study|Physician Decision|0|||
164319959|NCT04449029|593548350|FG001|Overall Study|Physician Decision|0|||
164319960|NCT04449029|593548351|FG002|Overall Study|Physician Decision|0|||
164319961|NCT04449029|593548352|FG003|Overall Study|Physician Decision|0|||
164319962|NCT04449029|593548353|FG004|Overall Study|Physician Decision|0|||
164319963|NCT04449029|593548354|FG005|Overall Study|Physician Decision|1|||
164319964|NCT04449029|593548355|FG006|Overall Study|Physician Decision|0|||
164319965|NCT04449029|593548356|FG007|Overall Study|Physician Decision|0|||
164319966|NCT04449029|593548349|FG000|Overall Study|Withdrawal by Subject|3|||
164319967|NCT04449029|593548350|FG001|Overall Study|Withdrawal by Subject|0|||
164319968|NCT04449029|593548351|FG002|Overall Study|Withdrawal by Subject|1|||
164319969|NCT04449029|593548352|FG003|Overall Study|Withdrawal by Subject|1|||
164319970|NCT04449029|593548353|FG004|Overall Study|Withdrawal by Subject|5|||
164319971|NCT04449029|593548354|FG005|Overall Study|Withdrawal by Subject|1|||
164319972|NCT04449029|593548355|FG006|Overall Study|Withdrawal by Subject|4|||
164319973|NCT04449029|593548356|FG007|Overall Study|Withdrawal by Subject|0|||
164319974|NCT01073462|593548358|FG000|Overall Study|Death|14|||
164319975|NCT01073462|593548358|FG000|Overall Study|Kidney transplant|10|||
164563115|NCT01656434|594429374|FG001|Overall Study|Physician Decision|2|||
164563116|NCT01656434|594429373|FG000|Overall Study|Non-compliance with study drug|48|||
164563117|NCT01656434|594429374|FG001|Overall Study|Non-compliance with study drug|9|||
164563118|NCT01656434|594429373|FG000|Overall Study|Study terminated by sponsor|1501|||
164563119|NCT01656434|594429374|FG001|Overall Study|Study terminated by sponsor|348|||
164563120|NCT01656434|594429373|FG000|Overall Study|Participant discontinued; drug related|13|||
164563121|NCT01656434|594429374|FG001|Overall Study|Participant discontinued; drug related|4|||
164563122|NCT01656434|594429373|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
164563123|NCT01656434|594429374|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
164563124|NCT01656434|594429373|FG000|Overall Study|Non-compliance with protocol|39|||
164563125|NCT01656434|594429374|FG001|Overall Study|Non-compliance with protocol|15|||
164563126|NCT01656434|594429373|FG000|Overall Study|Participant moved|40|||
164563127|NCT01656434|594429374|FG001|Overall Study|Participant moved|12|||
164563128|NCT01656434|594429373|FG000|Overall Study|Participant withdrew consent|28|||
164563129|NCT01656434|594429374|FG001|Overall Study|Participant withdrew consent|9|||
164563130|NCT01656434|594429373|FG000|Overall Study|Withdrawal by Subject|64|||
164563131|NCT01656434|594429374|FG001|Overall Study|Withdrawal by Subject|7|||
164563132|NCT02435914|594429375|FG000|Overall Study|Ocular Adverse Event|1|||
164563133|NCT02435914|594429376|FG001|Overall Study|Ocular Adverse Event|0|||
164319976|NCT01073462|593548358|FG000|Overall Study|Low parathyroid hormone levels|8|||
164319977|NCT01073462|593548358|FG000|Overall Study|Serious adverse event|2|||
164319978|NCT01073462|593548358|FG000|Overall Study|Lost to Follow-up|7|||
164420644|NCT01154036|593910967|FG005|Phase I|Protocol Violation|0|||
164319979|NCT00247611|593548361|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
164319980|NCT00247611|593548362|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
164319981|NCT00247611|593548361|FG000|Baselined|Completed baseline only|9|||
164319982|NCT00247611|593548362|FG001|Baselined|Completed baseline only|8|||
164319983|NCT00834080|593548363|FG000|Overall Study|Adverse Event|7|||
164319984|NCT00834080|593548363|FG000|Overall Study|Lost to Follow-up|7|||
164319985|NCT00834080|593548363|FG000|Overall Study|Withdrawal by Subject|5|||
164319986|NCT00834080|593548363|FG000|Overall Study|Other - Pregnancy|1|||
164319987|NCT00834080|593548363|FG000|Overall Study|Other - False positive tests of the UDS|1|||
164319988|NCT00834080|593548363|FG000|Overall Study|Physician Decision|1|||
164319989|NCT00834080|593548363|FG000|Overall Study|Subject Relocated|1|||
164319990|NCT04345367|593548365|FG000|Overall Study|Other|3|||
164319991|NCT04345367|593548366|FG001|Overall Study|Other|4|||
164319992|NCT04345367|593548365|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
164319993|NCT04345367|593548366|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
164319994|NCT04345367|593548365|FG000|Overall Study|Withdrawal by Subject|11|||
164319995|NCT04345367|593548366|FG001|Overall Study|Withdrawal by Subject|11|||
164319996|NCT04345367|593548365|FG000|Overall Study|Protocol Violation|4|||
164319997|NCT04345367|593548366|FG001|Overall Study|Protocol Violation|3|||
164319998|NCT04345367|593548365|FG000|Overall Study|Lost to Follow-up|2|||
164319999|NCT04345367|593548366|FG001|Overall Study|Lost to Follow-up|4|||
164320000|NCT04345367|593548365|FG000|Overall Study|Lack of Efficacy|2|||
164320001|NCT04345367|593548366|FG001|Overall Study|Lack of Efficacy|0|||
164320002|NCT04345367|593548365|FG000|Overall Study|Death|2|||
164320003|NCT04345367|593548366|FG001|Overall Study|Death|0|||
164320004|NCT04345367|593548365|FG000|Overall Study|Adverse Event|10|||
164320005|NCT04345367|593548366|FG001|Overall Study|Adverse Event|9|||
164320006|NCT00439738|593548370|FG000|Overall Study|Withdrawal by Subject|16|||
164320007|NCT00439738|593548371|FG001|Overall Study|Withdrawal by Subject|13|||
164320008|NCT00439738|593548370|FG000|Overall Study|Adverse Event|6|||
164320009|NCT00439738|593548371|FG001|Overall Study|Adverse Event|4|||
164320010|NCT00439738|593548370|FG000|Overall Study|Lost to Follow-up|5|||
164320011|NCT00439738|593548371|FG001|Overall Study|Lost to Follow-up|6|||
164320012|NCT00439738|593548370|FG000|Overall Study|Protocol Violation|6|||
164320013|NCT00439738|593548371|FG001|Overall Study|Protocol Violation|3|||
164320014|NCT00439738|593548370|FG000|Overall Study|Lack of Efficacy|2|||
164320015|NCT00439738|593548371|FG001|Overall Study|Lack of Efficacy|2|||
164320016|NCT00439738|593548370|FG000|Overall Study|Abnormal Lab Values|1|||
164320017|NCT00439738|593548371|FG001|Overall Study|Abnormal Lab Values|0|||
164320018|NCT00781885|593548374|FG000|Overall Study|Physician Decision|1|||
164320019|NCT01755026|593548375|FG000|Overall Study|Adverse Event|1|||
164320020|NCT01755026|593548376|FG001|Overall Study|Adverse Event|0|||
164320021|NCT01755026|593548375|FG000|Overall Study|Withdrawal by Subject|1|||
164320022|NCT01755026|593548376|FG001|Overall Study|Withdrawal by Subject|1|||
164320023|NCT03836001|593548377|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
164320024|NCT03836001|593548378|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
164320025|NCT03836001|593548379|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
164320026|NCT03836001|593548377|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
164320027|NCT03836001|593548378|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
164320028|NCT03836001|593548379|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
164320029|NCT03836001|593548377|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
164320030|NCT03836001|593548378|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
164320031|NCT03836001|593548379|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
164320032|NCT03836001|593548377|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
164320033|NCT03836001|593548378|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
164320034|NCT03836001|593548379|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
164320035|NCT00392379|593548382|FG000|Overall Study|Withdrawal by Subject|17|||
164320036|NCT00392379|593548383|FG001|Overall Study|Withdrawal by Subject|28|||
164320037|NCT00392379|593548382|FG000|Overall Study|Lost to Follow-up|4|||
164320038|NCT00392379|593548383|FG001|Overall Study|Lost to Follow-up|9|||
164320039|NCT00392379|593548382|FG000|Overall Study|Adverse Event|1|||
164320040|NCT00392379|593548383|FG001|Overall Study|Adverse Event|1|||
164320041|NCT01700387|593548389|FG000|Overall Study|Withdrawal by Subject|1|||
164320042|NCT01700387|593548390|FG001|Overall Study|Withdrawal by Subject|2|||
164320043|NCT01700387|593548389|FG000|Overall Study|Adverse Event|1|||
164320044|NCT01700387|593548390|FG001|Overall Study|Adverse Event|1|||
164320045|NCT01700387|593548389|FG000|Overall Study|Lost to Follow-up|2|||
164320046|NCT01700387|593548390|FG001|Overall Study|Lost to Follow-up|1|||
164320047|NCT02730793|593548393|FG000|Overall Study|Physician Decision|0|||
164320048|NCT02730793|593548394|FG001|Overall Study|Physician Decision|1|||
164320049|NCT02730793|593548393|FG000|Overall Study|Withdrawal by Subject|0|||
164320050|NCT02730793|593548394|FG001|Overall Study|Withdrawal by Subject|1|||
164320051|NCT02365233|593548395|FG000|Overall Study|IRB withheld the data|1|||
164320052|NCT02365233|593548396|FG001|Overall Study|IRB withheld the data|2|||
164320053|NCT02365233|593548397|FG002|Overall Study|IRB withheld the data|2|||
164320054|NCT00934843|593548398|FG000|Overall Study|Protocol Violation|0|||
164320055|NCT00934843|593548399|FG001|Overall Study|Protocol Violation|1|||
164320056|NCT00160667|593548400|FG000|Overall Study|Adverse Event|3|||
164320057|NCT00160667|593548401|FG001|Overall Study|Adverse Event|1|||
164320058|NCT00160667|593548402|FG002|Overall Study|Adverse Event|4|||
164320059|NCT00160667|593548400|FG000|Overall Study|Withdrawal by Subject|2|||
164320060|NCT00160667|593548401|FG001|Overall Study|Withdrawal by Subject|0|||
164320061|NCT00160667|593548402|FG002|Overall Study|Withdrawal by Subject|1|||
164320062|NCT00160667|593548400|FG000|Overall Study|Lack of Efficacy|0|||
164320063|NCT00160667|593548401|FG001|Overall Study|Lack of Efficacy|1|||
164320064|NCT00160667|593548402|FG002|Overall Study|Lack of Efficacy|0|||
164320065|NCT00160667|593548400|FG000|Overall Study|Protocol Violation|0|||
164320066|NCT00160667|593548401|FG001|Overall Study|Protocol Violation|1|||
164320067|NCT00160667|593548402|FG002|Overall Study|Protocol Violation|0|||
164320068|NCT00160667|593548400|FG000|Overall Study|Patient decision|0|||
164320069|NCT00160667|593548401|FG001|Overall Study|Patient decision|0|||
164320070|NCT00160667|593548402|FG002|Overall Study|Patient decision|1|||
164320071|NCT00336583|593550100|FG000|Overall Study|Lost to Follow-up|1|||
164320072|NCT00336583|593550100|FG000|Overall Study|Death|1|||
164320073|NCT00003830|593550101|FG000|Overall Study|No follow up data|3|||
164320074|NCT00003830|593550102|FG001|Overall Study|No follow up data|0|||
164320075|NCT00003830|593550101|FG000|Overall Study|Sentinel node positive patients|829|||
164320076|NCT00003830|593550102|FG001|Overall Study|Sentinel node positive patients|793|||
164320077|NCT00883688|593550103|FG000|Overall Study|Ineligible|2|||
164320078|NCT04461600|593550104|FG000|Overall Study|Death|6|||
164320079|NCT04461600|593550105|FG001|Overall Study|Death|5|||
164320080|NCT04461600|593550104|FG000|Overall Study|Withdrawal by Subject|0|||
164320081|NCT04461600|593550105|FG001|Overall Study|Withdrawal by Subject|1|||
164666946|NCT00048568|594806433|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
164666947|NCT00048568|594806434|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
164666948|NCT00048568|594806432|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
164666949|NCT00048568|594806433|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
164666950|NCT00048568|594806434|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
164666951|NCT00048568|594806432|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
164666952|NCT00048568|594806433|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
164666953|NCT00048568|594806434|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
164320082|NCT00704522|593550107|FG000|Overall Study|Lack of Efficacy|65|||
164320083|NCT00704522|593550108|FG001|Overall Study|Lack of Efficacy|17|||
164320084|NCT00704522|593550107|FG000|Overall Study|Failure to appear again at hospital|56|||
164320085|NCT00704522|593550108|FG001|Overall Study|Failure to appear again at hospital|10|||
164320086|NCT00704522|593550107|FG000|Overall Study|Withdrawal by Subject|17|||
164320087|NCT00704522|593550108|FG001|Overall Study|Withdrawal by Subject|8|||
164320088|NCT00704522|593550107|FG000|Overall Study|Adverse Event|9|||
164320089|NCT00704522|593550108|FG001|Overall Study|Adverse Event|1|||
164320090|NCT00704522|593550107|FG000|Overall Study|Undefined causes|9|||
164320091|NCT00704522|593550108|FG001|Overall Study|Undefined causes|7|||
164320092|NCT00704522|593550107|FG000|Overall Study|No information on therapy end|27|||
164320093|NCT00704522|593550108|FG001|Overall Study|No information on therapy end|2|||
164320094|NCT04896229|593550110|FG000|Overall Study|Lost to Follow-up|113|||
164320095|NCT04896229|593550111|FG001|Overall Study|Lost to Follow-up|113|||
164320096|NCT04395001|593550112|FG000|Overall Study|Lost to Follow-up|8|||
164320097|NCT04395001|593550113|FG001|Overall Study|Lost to Follow-up|9|||
164320098|NCT04395001|593550114|FG002|Overall Study|Lost to Follow-up|5|||
164320099|NCT04395001|593550112|FG000|Overall Study|Withdrawal by Subject|3|||
164320100|NCT04395001|593550113|FG001|Overall Study|Withdrawal by Subject|1|||
164666954|NCT00048568|594806432|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
164666955|NCT00048568|594806433|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
164666956|NCT00048568|594806434|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
164666957|NCT00048568|594806432|FG000|Double-Blind Period Days 170 to 365|Death|1|||
164666958|NCT00048568|594806433|FG001|Double-Blind Period Days 170 to 365|Death|1|||
164666959|NCT00048568|594806434|FG002|Double-Blind Period Days 170 to 365|Death|0|||
164666960|NCT00048568|594806432|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
164666961|NCT00048568|594806433|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
164320101|NCT04395001|593550114|FG002|Overall Study|Withdrawal by Subject|3|||
164320102|NCT04395001|593550112|FG000|Overall Study|missed appointment|7|||
164320103|NCT04395001|593550113|FG001|Overall Study|missed appointment|4|||
164320104|NCT04395001|593550114|FG002|Overall Study|missed appointment|1|||
164320105|NCT00635024|593550115|FG000|Overall Study|Adverse Event|1|||
164320106|NCT01958489|593550116|FG000|Period 2|Adverse Event|0|||
164320107|NCT01958489|593550117|FG001|Period 2|Adverse Event|1|||
164320108|NCT00992589|593550118|FG000|Open-Label Phase|Adverse Event|4|||
164320109|NCT00992589|593550119|FG001|Open-Label Phase|Adverse Event|0|||
164320110|NCT00992589|593550120|FG002|Open-Label Phase|Adverse Event|0|||
164320111|NCT00992589|593550121|FG003|Open-Label Phase|Adverse Event|0|||
164320112|NCT00992589|593550118|FG000|Open-Label Phase|Withdrawal by Subject|20|||
164320113|NCT00992589|593550119|FG001|Open-Label Phase|Withdrawal by Subject|0|||
164320114|NCT00992589|593550120|FG002|Open-Label Phase|Withdrawal by Subject|0|||
164666962|NCT00048568|594806434|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
164666963|NCT00048568|594806432|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
164666964|NCT00048568|594806433|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
164666965|NCT00048568|594806434|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
164666966|NCT00048568|594806432|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
164666967|NCT00048568|594806433|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
164666968|NCT00048568|594806434|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
164666969|NCT00048568|594806432|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
164666970|NCT00048568|594806433|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
164666971|NCT00048568|594806434|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
164666972|NCT00048568|594806432|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
164666973|NCT00048568|594806433|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
164666974|NCT00048568|594806434|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
164666975|NCT00048568|594806432|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
164666976|NCT00048568|594806433|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
164666977|NCT00048568|594806434|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
164666978|NCT00048568|594806432|FG000|Open-Label Period|Death|0|||
164666979|NCT00048568|594806433|FG001|Open-Label Period|Death|0|||
164666980|NCT00048568|594806434|FG002|Open-Label Period|Death|13|||
164666981|NCT00048568|594806432|FG000|Open-Label Period|Adverse Event|0|||
164666982|NCT00048568|594806433|FG001|Open-Label Period|Adverse Event|0|||
164666983|NCT00048568|594806434|FG002|Open-Label Period|Adverse Event|49|||
164666984|NCT00048568|594806432|FG000|Open-Label Period|Lack of Efficacy|0|||
164666985|NCT00048568|594806433|FG001|Open-Label Period|Lack of Efficacy|0|||
164666986|NCT00048568|594806434|FG002|Open-Label Period|Lack of Efficacy|32|||
164666987|NCT00048568|594806432|FG000|Open-Label Period|Withdrawal by Subject|0|||
164666988|NCT00048568|594806433|FG001|Open-Label Period|Withdrawal by Subject|0|||
164666989|NCT00048568|594806434|FG002|Open-Label Period|Withdrawal by Subject|26|||
164666990|NCT00048568|594806432|FG000|Open-Label Period|Pregnancy|0|||
164666991|NCT00048568|594806433|FG001|Open-Label Period|Pregnancy|0|||
164666992|NCT00048568|594806434|FG002|Open-Label Period|Pregnancy|5|||
164666993|NCT00048568|594806432|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
164666994|NCT00048568|594806433|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
164666995|NCT00048568|594806434|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
164666996|NCT00048568|594806432|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
164666997|NCT00048568|594806433|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
164666998|NCT00048568|594806434|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
164666999|NCT00048568|594806432|FG000|Open-Label Period|Unknown Reasons|0|||
164667000|NCT00048568|594806433|FG001|Open-Label Period|Unknown Reasons|0|||
164667001|NCT00048568|594806434|FG002|Open-Label Period|Unknown Reasons|25|||
164667002|NCT00048568|594806432|FG000|Open-Label Period|Lost to Follow-up|0|||
164667003|NCT00048568|594806433|FG001|Open-Label Period|Lost to Follow-up|0|||
164667004|NCT00048568|594806434|FG002|Open-Label Period|Lost to Follow-up|7|||
164667005|NCT01717976|594806435|FG000|Overall Study|Protocol Violation|0|||
164667006|NCT01717976|594806436|FG001|Overall Study|Protocol Violation|1|||
164667007|NCT03831048|594806437|FG000|Overall Study|Protocol Violation|9|||
164667008|NCT03831048|594806438|FG001|Overall Study|Protocol Violation|3|||
164667009|NCT03831048|594806437|FG000|Overall Study|Death|4|||
164667010|NCT03831048|594806438|FG001|Overall Study|Death|9|||
164667011|NCT03831048|594806437|FG000|Overall Study|Re-transplant|0|||
164667012|NCT03831048|594806438|FG001|Overall Study|Re-transplant|2|||
164667013|NCT03831048|594806437|FG000|Overall Study|Protocol violation and death|1|||
164667014|NCT03831048|594806438|FG001|Overall Study|Protocol violation and death|1|||
164667015|NCT01996033|594806441|FG000|Overall Study|Death|1|||
164667016|NCT01996033|594806441|FG000|Overall Study|Physician Decision|1|||
164667017|NCT01996033|594806441|FG000|Overall Study|Withdrawal by Subject|4|||
164667018|NCT01996033|594806441|FG000|Overall Study|Lost to Follow-up|3|||
164667019|NCT02896361|594806444|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
164667020|NCT02896361|594806445|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
164667021|NCT02896361|594806446|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
164667022|NCT02896361|594806444|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
164667023|NCT02896361|594806445|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
164667024|NCT02896361|594806446|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
164667025|NCT02143102|594806451|FG000|Overall Study|Lost to Follow-up|11|||
164420645|NCT01154036|593910968|FG006|Phase I|Protocol Violation|0|||
164667026|NCT02143102|594806452|FG001|Overall Study|Lost to Follow-up|0|||
164667027|NCT03164772|594806455|FG000|Overall Study|Death|4|||
164667028|NCT03164772|594806456|FG001|Overall Study|Death|2|||
164667029|NCT03164772|594806455|FG000|Overall Study|Adverse Event|1|||
164667030|NCT03164772|594806456|FG001|Overall Study|Adverse Event|4|||
164667031|NCT03164772|594806455|FG000|Overall Study|Progressive Disease|11|||
164667032|NCT03164772|594806456|FG001|Overall Study|Progressive Disease|21|||
164667033|NCT03164772|594806455|FG000|Overall Study|Physician Decision|2|||
164667034|NCT03164772|594806456|FG001|Overall Study|Physician Decision|0|||
164320115|NCT00992589|593550121|FG003|Open-Label Phase|Withdrawal by Subject|0|||
164320116|NCT00992589|593550118|FG000|Open-Label Phase|Lost to Follow-up|1|||
164320117|NCT00992589|593550119|FG001|Open-Label Phase|Lost to Follow-up|0|||
164320118|NCT00992589|593550120|FG002|Open-Label Phase|Lost to Follow-up|0|||
164320119|NCT00992589|593550121|FG003|Open-Label Phase|Lost to Follow-up|0|||
164320120|NCT00992589|593550118|FG000|Open-Label Phase|Protocol Violation|3|||
164320121|NCT00992589|593550119|FG001|Open-Label Phase|Protocol Violation|0|||
164320122|NCT00992589|593550120|FG002|Open-Label Phase|Protocol Violation|0|||
164320123|NCT00992589|593550121|FG003|Open-Label Phase|Protocol Violation|0|||
164320124|NCT00992589|593550118|FG000|Open-Label Phase|Physician Decision|4|||
164320125|NCT00992589|593550119|FG001|Open-Label Phase|Physician Decision|0|||
164320126|NCT00992589|593550120|FG002|Open-Label Phase|Physician Decision|0|||
164320127|NCT00992589|593550121|FG003|Open-Label Phase|Physician Decision|0|||
164320128|NCT00992589|593550118|FG000|Open-Label Phase|Other|45|||
164320129|NCT00992589|593550119|FG001|Open-Label Phase|Other|0|||
164320130|NCT00992589|593550120|FG002|Open-Label Phase|Other|0|||
164320131|NCT00992589|593550121|FG003|Open-Label Phase|Other|0|||
164320132|NCT00992589|593550118|FG000|Double-Blind Phase|Adverse Event|0|||
164320133|NCT00992589|593550119|FG001|Double-Blind Phase|Adverse Event|6|||
164320134|NCT00992589|593550120|FG002|Double-Blind Phase|Adverse Event|2|||
164320135|NCT00992589|593550121|FG003|Double-Blind Phase|Adverse Event|3|||
164320136|NCT00992589|593550118|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
164320137|NCT00992589|593550119|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
164320138|NCT00992589|593550120|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
164320139|NCT00992589|593550121|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
164320140|NCT00992589|593550118|FG000|Double-Blind Phase|Lost to Follow-up|0|||
164320141|NCT00992589|593550119|FG001|Double-Blind Phase|Lost to Follow-up|0|||
164320142|NCT00992589|593550120|FG002|Double-Blind Phase|Lost to Follow-up|0|||
164320143|NCT00992589|593550121|FG003|Double-Blind Phase|Lost to Follow-up|2|||
164320144|NCT00992589|593550118|FG000|Double-Blind Phase|Other|0|||
164320145|NCT00992589|593550119|FG001|Double-Blind Phase|Other|1|||
164320146|NCT00992589|593550120|FG002|Double-Blind Phase|Other|6|||
164320147|NCT00992589|593550121|FG003|Double-Blind Phase|Other|3|||
164320148|NCT00045942|593550122|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
164320149|NCT00045942|593550123|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
164320150|NCT00045942|593550124|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
164320151|NCT00045942|593550125|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
164320152|NCT00045942|593550126|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
164320153|NCT00045942|593550127|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
164320154|NCT00045942|593550128|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
164320155|NCT00045942|593550129|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
164320156|NCT00045942|593550130|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
164320157|NCT00045942|593550122|FG000|PKC412A2104 (Core)|Adverse Event|5|||
164320158|NCT00045942|593550123|FG001|PKC412A2104 (Core)|Adverse Event|0|||
164320159|NCT00045942|593550124|FG002|PKC412A2104 (Core)|Adverse Event|0|||
164320160|NCT00045942|593550125|FG003|PKC412A2104 (Core)|Adverse Event|0|||
164320161|NCT00045942|593550126|FG004|PKC412A2104 (Core)|Adverse Event|0|||
164320162|NCT00045942|593550127|FG005|PKC412A2104 (Core)|Adverse Event|0|||
164320163|NCT00045942|593550128|FG006|PKC412A2104 (Core)|Adverse Event|0|||
164320164|NCT00045942|593550129|FG007|PKC412A2104 (Core)|Adverse Event|0|||
164320165|NCT00045942|593550130|FG008|PKC412A2104 (Core)|Adverse Event|0|||
164320166|NCT00045942|593550122|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
164563134|NCT02435914|594429377|FG002|Overall Study|Ocular Adverse Event|0|||
164563135|NCT02435914|594429378|FG003|Overall Study|Ocular Adverse Event|0|||
164563136|NCT02435914|594429375|FG000|Overall Study|Withdrawal by Subject|0|||
164563137|NCT02435914|594429376|FG001|Overall Study|Withdrawal by Subject|1|||
164563138|NCT02435914|594429377|FG002|Overall Study|Withdrawal by Subject|0|||
164563139|NCT02435914|594429378|FG003|Overall Study|Withdrawal by Subject|0|||
164563140|NCT02435914|594429375|FG000|Overall Study|Other Miscellaneous Reason|0|||
164667035|NCT03164772|594806455|FG000|Overall Study|Withdrawal by Subject|0|||
164563141|NCT02435914|594429376|FG001|Overall Study|Other Miscellaneous Reason|0|||
164563142|NCT02435914|594429377|FG002|Overall Study|Other Miscellaneous Reason|1|||
164667036|NCT03164772|594806456|FG001|Overall Study|Withdrawal by Subject|4|||
164667037|NCT00324168|594806459|FG000|Overall Study|Lost to Follow-up|19|||
164667038|NCT00324168|594806460|FG001|Overall Study|Lost to Follow-up|18|||
164667039|NCT00324168|594806459|FG000|Overall Study|Death|3|||
164320167|NCT00045942|593550123|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
164320168|NCT00045942|593550124|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
164320169|NCT00045942|593550125|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
164320170|NCT00045942|593550126|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
164320171|NCT00045942|593550127|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
164320172|NCT00045942|593550128|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
164667040|NCT00324168|594806460|FG001|Overall Study|Death|3|||
164320173|NCT00045942|593550129|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
164320174|NCT00045942|593550130|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
164320175|NCT00045942|593550122|FG000|PKC412A2104 (Core)|Death|1|||
164320176|NCT00045942|593550123|FG001|PKC412A2104 (Core)|Death|0|||
164320177|NCT00045942|593550124|FG002|PKC412A2104 (Core)|Death|0|||
164667041|NCT00324168|594806459|FG000|Overall Study|Patient did not visit in f/u window|6|||
164667042|NCT00324168|594806460|FG001|Overall Study|Patient did not visit in f/u window|9|||
164667043|NCT01203878|594806461|FG000|Overall Study|Withdrawal by Subject|0|||
164667044|NCT01203878|594806462|FG001|Overall Study|Withdrawal by Subject|0|||
164667045|NCT01203878|594806463|FG002|Overall Study|Withdrawal by Subject|1|||
164667046|NCT01203878|594806461|FG000|Overall Study|Adverse Event|0|||
164667047|NCT01203878|594806462|FG001|Overall Study|Adverse Event|0|||
164667048|NCT01203878|594806463|FG002|Overall Study|Adverse Event|2|||
164667049|NCT01682083|594806464|FG000|Overall Study|Lost to Follow-up|11|||
164667050|NCT01682083|594806465|FG001|Overall Study|Lost to Follow-up|18|||
164667051|NCT01682083|594806464|FG000|Overall Study|Withdrawal by Subject|31|||
164667052|NCT01682083|594806465|FG001|Overall Study|Withdrawal by Subject|40|||
164667053|NCT01682083|594806464|FG000|Overall Study|Death|60|||
164667054|NCT01682083|594806465|FG001|Overall Study|Death|93|||
164667055|NCT01682083|594806464|FG000|Overall Study|Physician Decision|5|||
164667056|NCT01682083|594806465|FG001|Overall Study|Physician Decision|4|||
164667057|NCT02731157|594806466|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
164667058|NCT03657160|594806469|FG000|Overall Study|Adverse Event|5|||
164667059|NCT03657160|594806470|FG001|Overall Study|Adverse Event|6|||
164667060|NCT03657160|594806469|FG000|Overall Study|Protocol Deviation|3|||
164667061|NCT03657160|594806470|FG001|Overall Study|Protocol Deviation|0|||
164667062|NCT03657160|594806469|FG000|Overall Study|Withdrawal by Subject|18|||
164667063|NCT03657160|594806470|FG001|Overall Study|Withdrawal by Subject|16|||
164667064|NCT03657160|594806469|FG000|Overall Study|Site Termination|1|||
164667065|NCT03657160|594806470|FG001|Overall Study|Site Termination|0|||
164667066|NCT03657160|594806469|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
164667067|NCT03657160|594806470|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
164667068|NCT03657160|594806469|FG000|Overall Study|Death|33|||
164667069|NCT03657160|594806470|FG001|Overall Study|Death|26|||
164667070|NCT03657160|594806469|FG000|Overall Study|Death (COVID-19-Related)|1|||
164667071|NCT03657160|594806470|FG001|Overall Study|Death (COVID-19-Related)|0|||
164667072|NCT03657160|594806469|FG000|Overall Study|Reason Not Specified|5|||
164667073|NCT03657160|594806470|FG001|Overall Study|Reason Not Specified|5|||
164667074|NCT03657160|594806469|FG000|Overall Study|Other (COVID-19-Related)|0|||
164667075|NCT03657160|594806470|FG001|Overall Study|Other (COVID-19-Related)|1|||
164667076|NCT02732210|594806472|FG000|Overall Study|Site Closed|0|||
164667077|NCT02732210|594806473|FG001|Overall Study|Site Closed|11|||
164320178|NCT00045942|593550125|FG003|PKC412A2104 (Core)|Death|0|||
164320179|NCT00045942|593550126|FG004|PKC412A2104 (Core)|Death|0|||
164320180|NCT00045942|593550127|FG005|PKC412A2104 (Core)|Death|0|||
164667078|NCT02732210|594806472|FG000|Overall Study|Study Ended|13|||
164667079|NCT02732210|594806473|FG001|Overall Study|Study Ended|13|||
164667080|NCT02732210|594806472|FG000|Overall Study|Withdrawal by Subject|28|||
164667081|NCT02732210|594806473|FG001|Overall Study|Withdrawal by Subject|87|||
164667082|NCT02732210|594806472|FG000|Overall Study|Lost to Follow-up|5|||
164667083|NCT02732210|594806473|FG001|Overall Study|Lost to Follow-up|57|||
164667084|NCT02732210|594806472|FG000|Overall Study|Death|4|||
164667085|NCT02732210|594806473|FG001|Overall Study|Death|15|||
164667086|NCT02732210|594806472|FG000|Overall Study|Other|35|||
164667087|NCT02732210|594806473|FG001|Overall Study|Other|103|||
164667088|NCT02732210|594806472|FG000|Overall Study|Missing|0|||
164667089|NCT02732210|594806473|FG001|Overall Study|Missing|8|||
164667090|NCT00686959|594806474|FG000|Overall Study|Participants censored (no death events)|124|||
164667091|NCT00686959|594806475|FG001|Overall Study|Participants censored (no death events)|117|||
164667092|NCT01876706|594806476|FG000|Overall Study|BPH Intervention|9|||
164667093|NCT01876706|594806476|FG000|Overall Study|Lost to Follow-up|7|||
164667094|NCT01876706|594806476|FG000|Overall Study|Withdrawals|6|||
164667095|NCT01876706|594806476|FG000|Overall Study|Death|3|||
164667096|NCT00604500|594806477|FG000|Overall Study|Adverse Event|2|||
164667097|NCT00604500|594806477|FG000|Overall Study|Protocol Violation|2|||
164667098|NCT00604500|594806477|FG000|Overall Study|Treatment Failure|1|||
164667099|NCT00604500|594806477|FG000|Overall Study|Withdrawal by Subject|4|||
164667100|NCT00604500|594806477|FG000|Overall Study|Administrative|1|||
164667101|NCT00604500|594806477|FG000|Overall Study|Did not meet protocol eligibility|1|||
164320181|NCT00045942|593550128|FG006|PKC412A2104 (Core)|Death|0|||
164320182|NCT00045942|593550129|FG007|PKC412A2104 (Core)|Death|0|||
164667102|NCT02191891|594806478|FG000|Overall Study|Withdrawal by Subject|0|||
164667103|NCT02191891|594806479|FG001|Overall Study|Withdrawal by Subject|1|||
164320183|NCT00045942|593550130|FG008|PKC412A2104 (Core)|Death|0|||
164667104|NCT02191891|594806480|FG002|Overall Study|Withdrawal by Subject|0|||
164667105|NCT02191891|594806481|FG003|Overall Study|Withdrawal by Subject|0|||
164667106|NCT02191891|594806482|FG004|Overall Study|Withdrawal by Subject|1|||
164667107|NCT02191891|594806478|FG000|Overall Study|Adverse Event|0|||
164667108|NCT02191891|594806479|FG001|Overall Study|Adverse Event|1|||
164667109|NCT02191891|594806480|FG002|Overall Study|Adverse Event|0|||
164667110|NCT02191891|594806481|FG003|Overall Study|Adverse Event|0|||
164667111|NCT02191891|594806482|FG004|Overall Study|Adverse Event|2|||
164667112|NCT02191891|594806478|FG000|Overall Study|Disease Progression|4|||
164320184|NCT00045942|593550122|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
164320185|NCT00045942|593550123|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
164320186|NCT00045942|593550124|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
164320187|NCT00045942|593550125|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
164320188|NCT00045942|593550126|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
164320189|NCT00045942|593550127|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
164320190|NCT00045942|593550128|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
164320191|NCT00045942|593550129|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
164320192|NCT00045942|593550130|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
164320193|NCT00045942|593550122|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
164320194|NCT00045942|593550123|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
164320195|NCT00045942|593550124|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
164320196|NCT00045942|593550125|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
164320197|NCT00045942|593550126|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
164320198|NCT00045942|593550127|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
164320199|NCT00045942|593550128|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
164320200|NCT00045942|593550129|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
164320201|NCT00045942|593550130|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
164320202|NCT00045942|593550122|FG000|PKC412A2104E1|Lack of Efficacy|0|||
164320203|NCT00045942|593550123|FG001|PKC412A2104E1|Lack of Efficacy|11|||
164320204|NCT00045942|593550124|FG002|PKC412A2104E1|Lack of Efficacy|11|||
164320205|NCT00045942|593550125|FG003|PKC412A2104E1|Lack of Efficacy|23|||
164320206|NCT00045942|593550126|FG004|PKC412A2104E1|Lack of Efficacy|17|||
164320207|NCT00045942|593550127|FG005|PKC412A2104E1|Lack of Efficacy|0|||
164320208|NCT00045942|593550128|FG006|PKC412A2104E1|Lack of Efficacy|0|||
164320209|NCT00045942|593550129|FG007|PKC412A2104E1|Lack of Efficacy|0|||
164320210|NCT00045942|593550130|FG008|PKC412A2104E1|Lack of Efficacy|0|||
164320211|NCT00045942|593550122|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
164320212|NCT00045942|593550123|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
164563143|NCT02435914|594429378|FG003|Overall Study|Other Miscellaneous Reason|0|||
164563144|NCT00130286|594429386|FG000|Overall Study|Withdrawal by Subject|0|||
164563145|NCT00130286|594429387|FG001|Overall Study|Withdrawal by Subject|1|||
164563146|NCT00130286|594429388|FG002|Overall Study|Withdrawal by Subject|2|||
164563147|NCT00130286|594429389|FG003|Overall Study|Withdrawal by Subject|2|||
164563148|NCT00130286|594429386|FG000|Overall Study|Adverse Event|0|||
164563149|NCT00130286|594429387|FG001|Overall Study|Adverse Event|0|||
164563150|NCT00130286|594429388|FG002|Overall Study|Adverse Event|2|||
164563151|NCT00130286|594429389|FG003|Overall Study|Adverse Event|0|||
164563152|NCT00130286|594429386|FG000|Overall Study|Missing lab specimens|0|||
164563153|NCT00130286|594429387|FG001|Overall Study|Missing lab specimens|2|||
164563154|NCT00130286|594429388|FG002|Overall Study|Missing lab specimens|0|||
164563155|NCT00130286|594429389|FG003|Overall Study|Missing lab specimens|0|||
164563156|NCT01818726|594429395|FG000|Overall Study|Administrative reasons|5|||
164563157|NCT01818726|594429396|FG001|Overall Study|Administrative reasons|1|||
164563158|NCT01818726|594429395|FG000|Overall Study|Withdrawal by Subject|0|||
164563159|NCT01818726|594429396|FG001|Overall Study|Withdrawal by Subject|1|||
164563160|NCT01818726|594429395|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
164563161|NCT01818726|594429396|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
164563162|NCT00357500|594429397|FG000|Overall Study|Adverse Event|3|||
164563163|NCT00357500|594429397|FG000|Overall Study|Withdrawal by Subject|5|||
164563164|NCT00357500|594429397|FG000|Overall Study|Progressive Disease|65|||
164563165|NCT00357500|594429397|FG000|Overall Study|Not Started Protocol Therapy|4|||
164563166|NCT00993928|594429398|FG000|Overall Study|Withdrawal by Subject|4|||
164563167|NCT00993928|594429399|FG001|Overall Study|Withdrawal by Subject|7|||
164563168|NCT00993928|594429398|FG000|Overall Study|ineligible|1|||
164563169|NCT00993928|594429399|FG001|Overall Study|ineligible|0|||
164563170|NCT00603915|594429400|FG000|Overall Study|Physician Decision|1|||
164563171|NCT02154087|594429404|FG000|Overall Study|Study Termination|1|||
164563172|NCT01724528|594429411|FG000|Overall Study|Death|3|||
164563173|NCT01724528|594429412|FG001|Overall Study|Death|0|||
164563174|NCT01724528|594429411|FG000|Overall Study|Withdrawal by Subject|0|||
164563175|NCT01724528|594429412|FG001|Overall Study|Withdrawal by Subject|2|||
164563176|NCT01724528|594429411|FG000|Overall Study|Protocol Violation|0|||
164563177|NCT01724528|594429412|FG001|Overall Study|Protocol Violation|1|||
164563178|NCT01724528|594429411|FG000|Overall Study|Patient refused to attend last visit|1|||
164563179|NCT01724528|594429412|FG001|Overall Study|Patient refused to attend last visit|0|||
164320213|NCT00045942|593550124|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
164320214|NCT00045942|593550125|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
164563180|NCT04556617|594429417|FG000|Overall Study|progressive disease|0|||
164563181|NCT04556617|594429418|FG001|Overall Study|progressive disease|2|||
164563182|NCT04556617|594429419|FG002|Overall Study|progressive disease|2|||
164320215|NCT00045942|593550126|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
164563183|NCT04556617|594429420|FG003|Overall Study|progressive disease|1|||
164563184|NCT04556617|594429421|FG004|Overall Study|progressive disease|1|||
164563185|NCT04556617|594429417|FG000|Overall Study|Physician Decision|0|||
164563186|NCT04556617|594429418|FG001|Overall Study|Physician Decision|0|||
164320216|NCT00045942|593550127|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
164320217|NCT00045942|593550128|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
164667113|NCT02191891|594806479|FG001|Overall Study|Disease Progression|10|||
164667114|NCT02191891|594806480|FG002|Overall Study|Disease Progression|4|||
164667115|NCT02191891|594806481|FG003|Overall Study|Disease Progression|2|||
164667116|NCT02191891|594806482|FG004|Overall Study|Disease Progression|7|||
164667117|NCT03099538|594806484|FG000|Overall Study|Lack of Efficacy|3|||
164667118|NCT03912337|594806496|FG000|Overall Study|Withdrawal of Consent From Study|1|||
164667119|NCT03912337|594806497|FG001|Overall Study|Withdrawal of Consent From Study|0|||
164667120|NCT03912337|594806496|FG000|Overall Study|Lost to Follow-up|1|||
164667121|NCT03912337|594806497|FG001|Overall Study|Lost to Follow-up|1|||
164667122|NCT03561883|594806500|FG000|Overall Study|Adverse Event|10|||
164667123|NCT03561883|594806501|FG001|Overall Study|Adverse Event|13|||
164667124|NCT03561883|594806500|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164667125|NCT03561883|594806501|FG001|Overall Study|Non-Compliance With Study Drug|2|||
164667126|NCT03561883|594806500|FG000|Overall Study|Protocol Violation|2|||
164667127|NCT03561883|594806501|FG001|Overall Study|Protocol Violation|3|||
164667128|NCT03561883|594806500|FG000|Overall Study|Withdrawal by Subject|14|||
164667129|NCT03561883|594806501|FG001|Overall Study|Withdrawal by Subject|6|||
164667130|NCT03561883|594806500|FG000|Overall Study|Lost to Follow-up|2|||
164667131|NCT03561883|594806501|FG001|Overall Study|Lost to Follow-up|6|||
164667132|NCT03561883|594806500|FG000|Overall Study|Study Terminated by Sponsor|12|||
164667133|NCT03561883|594806501|FG001|Overall Study|Study Terminated by Sponsor|11|||
164667134|NCT03561883|594806500|FG000|Overall Study|Physician Decision|1|||
164667135|NCT03561883|594806501|FG001|Overall Study|Physician Decision|0|||
164667136|NCT03561883|594806500|FG000|Overall Study|Randomized by Mistake|1|||
164667137|NCT03561883|594806501|FG001|Overall Study|Randomized by Mistake|0|||
164667138|NCT03561883|594806500|FG000|Overall Study|Other, Not Specified|3|||
164667139|NCT03561883|594806501|FG001|Overall Study|Other, Not Specified|2|||
164667140|NCT03978624|594806502|FG000|Overall Study|Protocol Violation|1|||
164667141|NCT03978624|594806503|FG001|Overall Study|Protocol Violation|0|||
164667142|NCT04646109|594806515|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
164667143|NCT04646109|594806516|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
164667144|NCT06176768|594806517|FG000|Overall Study|Adverse Event|1|||
164667145|NCT06176768|594806518|FG001|Overall Study|Adverse Event|0|||
164667146|NCT06176768|594806517|FG000|Overall Study|Assigned treatment by mistake|1|||
164667147|NCT06176768|594806518|FG001|Overall Study|Assigned treatment by mistake|0|||
164667148|NCT06176768|594806517|FG000|Overall Study|Lost to Follow-up|0|||
164667149|NCT06176768|594806518|FG001|Overall Study|Lost to Follow-up|3|||
164667150|NCT06176768|594806517|FG000|Overall Study|Physician Decision|1|||
164667151|NCT06176768|594806518|FG001|Overall Study|Physician Decision|0|||
164667152|NCT06176768|594806517|FG000|Overall Study|Protocol deviation|3|||
164667153|NCT06176768|594806518|FG001|Overall Study|Protocol deviation|1|||
164667154|NCT06176768|594806517|FG000|Overall Study|Other|1|||
164667155|NCT06176768|594806518|FG001|Overall Study|Other|0|||
164667156|NCT06176768|594806517|FG000|Overall Study|Withdrawal by Subject|6|||
164667157|NCT06176768|594806518|FG001|Overall Study|Withdrawal by Subject|9|||
164667158|NCT04591626|594806523|FG000|Overall Study|Adverse Event|4|||
164667159|NCT04591626|594806524|FG001|Overall Study|Adverse Event|0|||
164667160|NCT04591626|594806523|FG000|Overall Study|Withdrawal by Subject|5|||
164667161|NCT04591626|594806524|FG001|Overall Study|Withdrawal by Subject|3|||
164667162|NCT04591626|594806523|FG000|Overall Study|Physician Decision|0|||
164667163|NCT04591626|594806524|FG001|Overall Study|Physician Decision|1|||
164667164|NCT04591626|594806523|FG000|Overall Study|Death|0|||
164667165|NCT04591626|594806524|FG001|Overall Study|Death|1|||
164667166|NCT04591626|594806523|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164667167|NCT04591626|594806524|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164667168|NCT02672553|594806525|FG000|Overall Study|Death|3|||
164320218|NCT00045942|593550129|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
164320219|NCT00045942|593550130|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
164320220|NCT00045942|593550122|FG000|PKC412A2104E1|Adverse Event|0|||
164667169|NCT02672553|594806526|FG001|Overall Study|Death|5|||
164667170|NCT02672553|594806525|FG000|Overall Study|Valve Explant|1|||
164667171|NCT02672553|594806526|FG001|Overall Study|Valve Explant|0|||
164667172|NCT02672553|594806525|FG000|Overall Study|Conversion to Commercial Valve|3|||
164667173|NCT02672553|594806526|FG001|Overall Study|Conversion to Commercial Valve|0|||
164320221|NCT00045942|593550123|FG001|PKC412A2104E1|Adverse Event|1|||
164667174|NCT02672553|594806525|FG000|Overall Study|Withdrawal by Subject|3|||
164667175|NCT02672553|594806526|FG001|Overall Study|Withdrawal by Subject|3|||
164667176|NCT02672553|594806525|FG000|Overall Study|Intraoperative screen failure|2|||
164667177|NCT02672553|594806526|FG001|Overall Study|Intraoperative screen failure|0|||
164667178|NCT01606306|594806527|FG000|Overall Study|Lack of Efficacy|2|||
164667179|NCT01606306|594806528|FG001|Overall Study|Lack of Efficacy|1|||
164667180|NCT01606306|594806529|FG002|Overall Study|Lack of Efficacy|4|||
164667181|NCT01606306|594806530|FG003|Overall Study|Lack of Efficacy|4|||
164667182|NCT01606306|594806531|FG004|Overall Study|Lack of Efficacy|1|||
164667183|NCT01606306|594806532|FG005|Overall Study|Lack of Efficacy|2|||
164667184|NCT01606306|594806527|FG000|Overall Study|Adverse Event|1|||
164667185|NCT01606306|594806528|FG001|Overall Study|Adverse Event|0|||
164667186|NCT01606306|594806529|FG002|Overall Study|Adverse Event|1|||
164563187|NCT04556617|594429419|FG002|Overall Study|Physician Decision|2|||
164563188|NCT04556617|594429420|FG003|Overall Study|Physician Decision|0|||
164563189|NCT04556617|594429421|FG004|Overall Study|Physician Decision|0|||
164563190|NCT04556617|594429417|FG000|Overall Study|Adverse Event|0|||
164563191|NCT04556617|594429418|FG001|Overall Study|Adverse Event|0|||
164563192|NCT04556617|594429419|FG002|Overall Study|Adverse Event|2|||
164563193|NCT04556617|594429420|FG003|Overall Study|Adverse Event|3|||
164563194|NCT04556617|594429421|FG004|Overall Study|Adverse Event|0|||
164563195|NCT04556617|594429417|FG000|Overall Study|Withdrawal by Subject|0|||
164563196|NCT04556617|594429418|FG001|Overall Study|Withdrawal by Subject|2|||
164563197|NCT04556617|594429419|FG002|Overall Study|Withdrawal by Subject|1|||
164563198|NCT04556617|594429420|FG003|Overall Study|Withdrawal by Subject|1|||
164563199|NCT04556617|594429421|FG004|Overall Study|Withdrawal by Subject|0|||
164563200|NCT04556617|594429417|FG000|Overall Study|PSA increase|0|||
164563201|NCT04556617|594429418|FG001|Overall Study|PSA increase|1|||
164563202|NCT04556617|594429419|FG002|Overall Study|PSA increase|0|||
164563203|NCT04556617|594429420|FG003|Overall Study|PSA increase|0|||
164563204|NCT04556617|594429421|FG004|Overall Study|PSA increase|0|||
164563205|NCT04556617|594429417|FG000|Overall Study|Sponsor study termination|1|||
164563206|NCT04556617|594429418|FG001|Overall Study|Sponsor study termination|0|||
164563207|NCT04556617|594429419|FG002|Overall Study|Sponsor study termination|0|||
164563208|NCT04556617|594429420|FG003|Overall Study|Sponsor study termination|0|||
164667187|NCT01606306|594806530|FG003|Overall Study|Adverse Event|1|||
164667188|NCT01606306|594806531|FG004|Overall Study|Adverse Event|2|||
164207120|NCT04761822|593127754|FG003|Overall Study|Physician Decision|0|||
164207121|NCT04761822|593127751|FG000|Overall Study|Withdrawal by Subject|3|||
164207122|NCT04761822|593127752|FG001|Overall Study|Withdrawal by Subject|8|||
164207123|NCT04761822|593127753|FG002|Overall Study|Withdrawal by Subject|1|||
164207124|NCT04761822|593127754|FG003|Overall Study|Withdrawal by Subject|11|||
164207125|NCT04761822|593127751|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
164207126|NCT04761822|593127752|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
164207127|NCT04761822|593127753|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
164207128|NCT04761822|593127754|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
164207129|NCT04761822|593127751|FG000|Overall Study|Participant requested unblinding|0|||
164207130|NCT04761822|593127752|FG001|Overall Study|Participant requested unblinding|0|||
164207131|NCT04761822|593127753|FG002|Overall Study|Participant requested unblinding|0|||
164207132|NCT04761822|593127754|FG003|Overall Study|Participant requested unblinding|1|||
164207133|NCT06217380|593127755|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
164207134|NCT06217380|593127755|FG000|Overall Study|Physician Decision|1|||
164207135|NCT06217380|593127755|FG000|Overall Study|Withdrawal by Subject|2|||
164207136|NCT02394275|593127757|FG000|Overall Study|Adverse Event|22|||
164207137|NCT02394275|593127757|FG000|Overall Study|Lost to Follow-up|7|||
164207138|NCT02471183|593127759|FG000|Main Treatment Period|Adverse Event|1|||
164207139|NCT02471183|593127759|FG000|Main Treatment Period|Withdrawal by Subject|1|||
164207140|NCT02471183|593127759|FG000|Extended Treatment Period|Lack of Efficacy|1|||
164207141|NCT00614393|593127761|FG000|Overall Study|Adverse Event|20|||
164207142|NCT00614393|593127762|FG001|Overall Study|Adverse Event|2|||
164207143|NCT00614393|593127763|FG002|Overall Study|Adverse Event|3|||
164207144|NCT00614393|593127764|FG003|Overall Study|Adverse Event|13|||
164207145|NCT00614393|593127765|FG004|Overall Study|Adverse Event|21|||
164207146|NCT00614393|593127761|FG000|Overall Study|Lost to Follow-up|0|||
164207147|NCT00614393|593127762|FG001|Overall Study|Lost to Follow-up|0|||
164207148|NCT00614393|593127763|FG002|Overall Study|Lost to Follow-up|0|||
164207149|NCT00614393|593127764|FG003|Overall Study|Lost to Follow-up|1|||
164207150|NCT00614393|593127765|FG004|Overall Study|Lost to Follow-up|2|||
164207151|NCT00614393|593127761|FG000|Overall Study|Physician Decision|17|||
164207152|NCT00614393|593127762|FG001|Overall Study|Physician Decision|0|||
164207153|NCT00614393|593127763|FG002|Overall Study|Physician Decision|1|||
164207154|NCT00614393|593127764|FG003|Overall Study|Physician Decision|8|||
164207155|NCT00614393|593127765|FG004|Overall Study|Physician Decision|9|||
164207156|NCT00614393|593127761|FG000|Overall Study|Progressive Disease|118|||
164207157|NCT00614393|593127762|FG001|Overall Study|Progressive Disease|5|||
164207158|NCT00614393|593127763|FG002|Overall Study|Progressive Disease|5|||
164207159|NCT00614393|593127764|FG003|Overall Study|Progressive Disease|138|||
164207160|NCT00614393|593127765|FG004|Overall Study|Progressive Disease|130|||
164207161|NCT00614393|593127761|FG000|Overall Study|Protocol Violation|1|||
164207162|NCT00614393|593127762|FG001|Overall Study|Protocol Violation|0|||
164207163|NCT00614393|593127763|FG002|Overall Study|Protocol Violation|0|||
164207164|NCT00614393|593127764|FG003|Overall Study|Protocol Violation|0|||
164563209|NCT04556617|594429421|FG004|Overall Study|Sponsor study termination|0|||
164563210|NCT05902364|594429429|FG000|Overall Study|Adverse Event|1|||
164563211|NCT05902364|594429430|FG001|Overall Study|Adverse Event|0|||
164563212|NCT02270242|594429431|FG000|Overall Study|Withdrawal by Subject|18|||
164667189|NCT01606306|594806532|FG005|Overall Study|Adverse Event|0|||
164207165|NCT00614393|593127765|FG004|Overall Study|Protocol Violation|0|||
164207166|NCT00614393|593127761|FG000|Overall Study|Terminated by Sponsor|0|||
164207167|NCT00614393|593127762|FG001|Overall Study|Terminated by Sponsor|0|||
164207168|NCT00614393|593127763|FG002|Overall Study|Terminated by Sponsor|0|||
164563213|NCT02270242|594429432|FG001|Overall Study|Withdrawal by Subject|25|||
164563214|NCT02270242|594429431|FG000|Overall Study|Lost to Follow-up|41|||
164563215|NCT02270242|594429432|FG001|Overall Study|Lost to Follow-up|27|||
164563216|NCT02270242|594429431|FG000|Overall Study|Physician Decision|0|||
164563217|NCT02270242|594429432|FG001|Overall Study|Physician Decision|1|||
164563218|NCT02321436|594429433|FG000|Overall Study|Withdrawal by Subject|1|||
164563219|NCT02321436|594429434|FG001|Overall Study|Withdrawal by Subject|0|||
164563220|NCT02321436|594429433|FG000|Overall Study|Lost to Follow-up|0|||
164563221|NCT02321436|594429434|FG001|Overall Study|Lost to Follow-up|1|||
164563222|NCT02324270|594431026|FG000|Overall Study|Withdrawal by Subject|0|||
164563223|NCT02324270|594431027|FG001|Overall Study|Withdrawal by Subject|1|||
164563224|NCT02324270|594431028|FG002|Overall Study|Withdrawal by Subject|0|||
164563225|NCT02324270|594431026|FG000|Overall Study|Lost to Follow-up|4|||
164563226|NCT02324270|594431027|FG001|Overall Study|Lost to Follow-up|3|||
164563227|NCT02324270|594431028|FG002|Overall Study|Lost to Follow-up|4|||
164563228|NCT02324270|594431026|FG000|Overall Study|Protocol Violation|0|||
164563229|NCT02324270|594431027|FG001|Overall Study|Protocol Violation|1|||
164563230|NCT02324270|594431028|FG002|Overall Study|Protocol Violation|1|||
164563231|NCT02324270|594431026|FG000|Overall Study|Non Compliance with Study Drug|1|||
164563232|NCT02324270|594431027|FG001|Overall Study|Non Compliance with Study Drug|2|||
164563233|NCT02324270|594431028|FG002|Overall Study|Non Compliance with Study Drug|0|||
164563234|NCT03521791|594431029|FG000|Overall Study|Protocol Violation|7|||
164563235|NCT03521791|594431030|FG001|Overall Study|Protocol Violation|17|||
164563236|NCT03038308|594431032|FG000|Overall Study|Surgical resection|1|||
164563237|NCT03038308|594431032|FG000|Overall Study|Withdrawal by Subject|2|||
164563238|NCT03038308|594431032|FG000|Overall Study|Lost to Follow-up|1|||
164563239|NCT01231555|594431034|FG000|Overall Study|Study terminated|8|||
164563240|NCT01231555|594431035|FG001|Overall Study|Study terminated|5|||
164563241|NCT01231555|594431036|FG002|Overall Study|Study terminated|8|||
164563242|NCT01231555|594431034|FG000|Overall Study|Withdrawal by Subject|0|||
164563243|NCT01231555|594431035|FG001|Overall Study|Withdrawal by Subject|2|||
164563244|NCT01231555|594431036|FG002|Overall Study|Withdrawal by Subject|0|||
164563245|NCT01748071|594431039|FG000|Overall Study|Adverse Event|2|||
164563246|NCT01748071|594431040|FG001|Overall Study|Adverse Event|2|||
164563247|NCT01748071|594431041|FG002|Overall Study|Adverse Event|0|||
164563248|NCT00420511|594431047|FG000|Overall Study|Adverse Event|1|||
164563249|NCT00420511|594431048|FG001|Overall Study|Adverse Event|1|||
164563250|NCT00420511|594431047|FG000|Overall Study|Lost to Follow-up|1|||
164563251|NCT00420511|594431048|FG001|Overall Study|Lost to Follow-up|0|||
164563252|NCT01668654|594431049|FG000|Overall Study|Study Closed/Terminated|3|||
164563253|NCT01668654|594431049|FG000|Overall Study|Withdrawal by Subject|1|||
164563254|NCT01337973|594431050|FG000|Overall Study|Lost to Follow-up|2|||
164563255|NCT01337973|594431051|FG001|Overall Study|Lost to Follow-up|4|||
164563256|NCT01337973|594431052|FG002|Overall Study|Lost to Follow-up|3|||
164563257|NCT01337973|594431050|FG000|Overall Study|Death|1|||
164563258|NCT01337973|594431051|FG001|Overall Study|Death|2|||
164207169|NCT00614393|593127764|FG003|Overall Study|Terminated by Sponsor|0|||
164207170|NCT00614393|593127765|FG004|Overall Study|Terminated by Sponsor|1|||
164207171|NCT00614393|593127761|FG000|Overall Study|Withdrawal by Subject|20|||
164207172|NCT00614393|593127762|FG001|Overall Study|Withdrawal by Subject|1|||
164207173|NCT00614393|593127763|FG002|Overall Study|Withdrawal by Subject|1|||
164207174|NCT00614393|593127764|FG003|Overall Study|Withdrawal by Subject|16|||
164207175|NCT00614393|593127765|FG004|Overall Study|Withdrawal by Subject|13|||
164207176|NCT00614393|593127761|FG000|Overall Study|Other|4|||
164207177|NCT00614393|593127762|FG001|Overall Study|Other|0|||
164207178|NCT00614393|593127763|FG002|Overall Study|Other|0|||
164207179|NCT00614393|593127764|FG003|Overall Study|Other|4|||
164207180|NCT00614393|593127765|FG004|Overall Study|Other|2|||
164207181|NCT00614393|593127761|FG000|Overall Study|Not Treated|0|||
164207182|NCT00614393|593127762|FG001|Overall Study|Not Treated|0|||
164207183|NCT00614393|593127763|FG002|Overall Study|Not Treated|0|||
164420646|NCT01154036|593910969|FG007|Phase I|Protocol Violation|0|||
164563259|NCT01337973|594431052|FG002|Overall Study|Death|1|||
164563260|NCT01337973|594431050|FG000|Overall Study|Withdrawal by Subject|10|||
164563261|NCT01337973|594431051|FG001|Overall Study|Withdrawal by Subject|8|||
164563262|NCT01337973|594431052|FG002|Overall Study|Withdrawal by Subject|4|||
164563263|NCT01337973|594431050|FG000|Overall Study|missing data on primary outcome|3|||
164563264|NCT01337973|594431051|FG001|Overall Study|missing data on primary outcome|1|||
164207184|NCT00614393|593127764|FG003|Overall Study|Not Treated|0|||
164207185|NCT00614393|593127765|FG004|Overall Study|Not Treated|2|||
164207186|NCT03286504|593127773|FG000|Overall Study|Lost to Follow-up|19|||
164207187|NCT03286504|593127774|FG001|Overall Study|Lost to Follow-up|16|||
164207188|NCT00141921|593127776|FG000|Overall Study|Remain on Study|28|||
164420647|NCT01154036|593910962|FG000|Phase I|Withdrawal by Subject|2|||
164207189|NCT00141921|593127776|FG000|Overall Study|Withdrawal by Subject|42|||
164207190|NCT00141921|593127776|FG000|Overall Study|Lost to Follow-up|19|||
164563265|NCT01337973|594431052|FG002|Overall Study|missing data on primary outcome|3|||
164563266|NCT03634800|594431053|FG000|Overall Study|Adverse Event|1|||
164320222|NCT00045942|593550124|FG002|PKC412A2104E1|Adverse Event|1|||
164320223|NCT00045942|593550125|FG003|PKC412A2104E1|Adverse Event|3|||
164320224|NCT00045942|593550126|FG004|PKC412A2104E1|Adverse Event|6|||
164320225|NCT00045942|593550127|FG005|PKC412A2104E1|Adverse Event|0|||
164320226|NCT00045942|593550128|FG006|PKC412A2104E1|Adverse Event|0|||
164320227|NCT00045942|593550129|FG007|PKC412A2104E1|Adverse Event|0|||
164320228|NCT00045942|593550130|FG008|PKC412A2104E1|Adverse Event|0|||
164320229|NCT00045942|593550122|FG000|PKC412A2104E1|Death|0|||
164320230|NCT00045942|593550123|FG001|PKC412A2104E1|Death|4|||
164320231|NCT00045942|593550124|FG002|PKC412A2104E1|Death|1|||
164320232|NCT00045942|593550125|FG003|PKC412A2104E1|Death|1|||
164320233|NCT00045942|593550126|FG004|PKC412A2104E1|Death|1|||
164320234|NCT00045942|593550127|FG005|PKC412A2104E1|Death|0|||
164320235|NCT00045942|593550128|FG006|PKC412A2104E1|Death|0|||
164320236|NCT00045942|593550129|FG007|PKC412A2104E1|Death|0|||
164320237|NCT00045942|593550130|FG008|PKC412A2104E1|Death|0|||
164320238|NCT00045942|593550122|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
164320239|NCT00045942|593550123|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
164320240|NCT00045942|593550124|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
164320241|NCT00045942|593550125|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
164320242|NCT00045942|593550126|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
164320243|NCT00045942|593550127|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
164320244|NCT00045942|593550128|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
164320245|NCT00045942|593550129|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
164320246|NCT00045942|593550130|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
164320247|NCT00045942|593550122|FG000|PKC412A2104E2|Lost to Follow-up|0|||
164320248|NCT00045942|593550123|FG001|PKC412A2104E2|Lost to Follow-up|0|||
164320249|NCT00045942|593550124|FG002|PKC412A2104E2|Lost to Follow-up|0|||
164320250|NCT00045942|593550125|FG003|PKC412A2104E2|Lost to Follow-up|0|||
164320251|NCT00045942|593550126|FG004|PKC412A2104E2|Lost to Follow-up|0|||
164320252|NCT00045942|593550127|FG005|PKC412A2104E2|Lost to Follow-up|0|||
164320253|NCT00045942|593550128|FG006|PKC412A2104E2|Lost to Follow-up|0|||
164320254|NCT00045942|593550129|FG007|PKC412A2104E2|Lost to Follow-up|3|||
164320255|NCT00045942|593550130|FG008|PKC412A2104E2|Lost to Follow-up|0|||
164563267|NCT03634800|594431053|FG000|Overall Study|Disease Progression|4|||
164563268|NCT03634800|594431053|FG000|Overall Study|Withdrawal by Subject|1|||
164563269|NCT00323557|594431054|FG000|Overall Study|Physician Decision|1|||
164563270|NCT00323557|594431055|FG001|Overall Study|Physician Decision|0|||
164563271|NCT00684515|594431056|FG000|Overall Study|Adverse Event|3|||
164563272|NCT00684515|594431057|FG001|Overall Study|Adverse Event|3|||
164563273|NCT00684515|594431058|FG002|Overall Study|Adverse Event|1|||
164563274|NCT00684515|594431056|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
164563275|NCT00684515|594431057|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
164563276|NCT00684515|594431058|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
164563277|NCT01114529|594431059|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
164563278|NCT01114529|594431060|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
164563279|NCT01114529|594431061|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
164563280|NCT01114529|594431059|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
164563281|NCT01114529|594431060|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
164563282|NCT01114529|594431061|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
164563283|NCT01114529|594431059|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
164563284|NCT01114529|594431060|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
164563285|NCT01114529|594431061|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
164563286|NCT01114529|594431059|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
164563287|NCT01114529|594431060|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
164563288|NCT01114529|594431061|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
164563289|NCT01114529|594431059|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
164563290|NCT01114529|594431060|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
164563291|NCT01114529|594431061|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
164563292|NCT01114529|594431059|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
164563293|NCT01114529|594431060|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
164563294|NCT01114529|594431061|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
164563295|NCT01114529|594431059|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
164563296|NCT01114529|594431060|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
164563297|NCT01114529|594431061|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
164563298|NCT01114529|594431059|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
164563299|NCT01114529|594431060|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
164563300|NCT01114529|594431061|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
164563301|NCT01114529|594431059|FG000|Completed Study Medication at Month 24|Death|2|||
164563302|NCT01114529|594431060|FG001|Completed Study Medication at Month 24|Death|1|||
164563303|NCT01114529|594431061|FG002|Completed Study Medication at Month 24|Death|2|||
164667190|NCT01606306|594806527|FG000|Overall Study|Lost to Follow-up|7|||
164667191|NCT01606306|594806528|FG001|Overall Study|Lost to Follow-up|4|||
164667192|NCT01606306|594806529|FG002|Overall Study|Lost to Follow-up|5|||
164667193|NCT01606306|594806530|FG003|Overall Study|Lost to Follow-up|4|||
164667194|NCT01606306|594806531|FG004|Overall Study|Lost to Follow-up|3|||
164667195|NCT01606306|594806532|FG005|Overall Study|Lost to Follow-up|5|||
164667196|NCT01606306|594806527|FG000|Overall Study|Withdrawal by Subject|4|||
164667197|NCT01606306|594806528|FG001|Overall Study|Withdrawal by Subject|3|||
164667198|NCT01606306|594806529|FG002|Overall Study|Withdrawal by Subject|4|||
164667199|NCT01606306|594806530|FG003|Overall Study|Withdrawal by Subject|4|||
164667200|NCT01606306|594806531|FG004|Overall Study|Withdrawal by Subject|5|||
164667201|NCT01606306|594806532|FG005|Overall Study|Withdrawal by Subject|4|||
164667202|NCT01606306|594806527|FG000|Overall Study|Physician Decision|1|||
164667203|NCT01606306|594806528|FG001|Overall Study|Physician Decision|2|||
164667204|NCT01606306|594806529|FG002|Overall Study|Physician Decision|0|||
164667205|NCT01606306|594806530|FG003|Overall Study|Physician Decision|0|||
164667206|NCT01606306|594806531|FG004|Overall Study|Physician Decision|0|||
164667207|NCT01606306|594806532|FG005|Overall Study|Physician Decision|0|||
164320256|NCT00045942|593550122|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
164320257|NCT00045942|593550123|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
164320258|NCT00045942|593550124|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
164320259|NCT00045942|593550125|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
164320260|NCT00045942|593550126|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
164320261|NCT00045942|593550127|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
164320262|NCT00045942|593550128|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
164320263|NCT00045942|593550129|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
164320264|NCT00045942|593550130|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
164320265|NCT00045942|593550122|FG000|PKC412A2104E2|Lack of Efficacy|0|||
164320266|NCT00045942|593550123|FG001|PKC412A2104E2|Lack of Efficacy|0|||
164320267|NCT00045942|593550124|FG002|PKC412A2104E2|Lack of Efficacy|0|||
164320268|NCT00045942|593550125|FG003|PKC412A2104E2|Lack of Efficacy|0|||
164667208|NCT01759290|594806535|FG000|Overall Study|Subjects withdrawn consent|5|||
164667209|NCT01759290|594806535|FG000|Overall Study|Physician Decision|2|||
164667210|NCT01759290|594806535|FG000|Overall Study|Death|17|||
164667211|NCT01759290|594806535|FG000|Overall Study|Lost to Follow-up|53|||
164667212|NCT01759290|594806535|FG000|Overall Study|Unknown reason|4|||
164667213|NCT01766778|594806543|FG000|Overall Study|Adverse Event|4|||
164667214|NCT01766778|594806544|FG001|Overall Study|Adverse Event|4|||
164667215|NCT01766778|594806543|FG000|Overall Study|Withdrawal by Subject|1|||
164667216|NCT01766778|594806544|FG001|Overall Study|Withdrawal by Subject|0|||
164667217|NCT02888171|594806550|FG000|Overall Study|Lost to Follow-up|2|||
164667218|NCT02888171|594806551|FG001|Overall Study|Lost to Follow-up|1|||
164667219|NCT02888171|594806550|FG000|Overall Study|Withdrawal by Subject|3|||
164667220|NCT02888171|594806551|FG001|Overall Study|Withdrawal by Subject|2|||
164667221|NCT02888171|594806550|FG000|Overall Study|Adverse Event|0|||
164667222|NCT02888171|594806551|FG001|Overall Study|Adverse Event|1|||
164667223|NCT02937701|594808324|FG000|Day 1 to Week 22|Adverse Event|11|||
164667224|NCT02937701|594808325|FG001|Day 1 to Week 22|Adverse Event|14|||
164667225|NCT02937701|594808326|FG002|Day 1 to Week 22|Adverse Event|0|||
164667226|NCT02937701|594808327|FG003|Day 1 to Week 22|Adverse Event|0|||
164667227|NCT02937701|594808328|FG004|Day 1 to Week 22|Adverse Event|0|||
164667228|NCT02937701|594808324|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
164667229|NCT02937701|594808325|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
164667230|NCT02937701|594808326|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
164667231|NCT02937701|594808327|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
164667232|NCT02937701|594808328|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
164667233|NCT02937701|594808324|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
164667234|NCT02937701|594808325|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
164667235|NCT02937701|594808326|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
164667236|NCT02937701|594808327|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
164667237|NCT02937701|594808328|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
164667238|NCT02937701|594808324|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
164667239|NCT02937701|594808325|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
164320269|NCT00045942|593550126|FG004|PKC412A2104E2|Lack of Efficacy|0|||
164320270|NCT00045942|593550127|FG005|PKC412A2104E2|Lack of Efficacy|3|||
164320271|NCT00045942|593550128|FG006|PKC412A2104E2|Lack of Efficacy|2|||
164320272|NCT00045942|593550129|FG007|PKC412A2104E2|Lack of Efficacy|2|||
164320273|NCT00045942|593550130|FG008|PKC412A2104E2|Lack of Efficacy|6|||
164320274|NCT00045942|593550122|FG000|PKC412A2104E2|Adverse Event|0|||
164667240|NCT02937701|594808326|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
164320275|NCT00045942|593550123|FG001|PKC412A2104E2|Adverse Event|0|||
164320276|NCT00045942|593550124|FG002|PKC412A2104E2|Adverse Event|0|||
164320277|NCT00045942|593550125|FG003|PKC412A2104E2|Adverse Event|0|||
164667241|NCT02937701|594808327|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
164667242|NCT02937701|594808328|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
164667243|NCT02937701|594808324|FG000|Day 1 to Week 22|Death|1|||
164667244|NCT02937701|594808325|FG001|Day 1 to Week 22|Death|1|||
164667245|NCT02937701|594808326|FG002|Day 1 to Week 22|Death|0|||
164667246|NCT02937701|594808327|FG003|Day 1 to Week 22|Death|0|||
164320278|NCT00045942|593550126|FG004|PKC412A2104E2|Adverse Event|0|||
164320279|NCT00045942|593550127|FG005|PKC412A2104E2|Adverse Event|4|||
164320280|NCT00045942|593550128|FG006|PKC412A2104E2|Adverse Event|3|||
164320281|NCT00045942|593550129|FG007|PKC412A2104E2|Adverse Event|1|||
164320282|NCT00045942|593550130|FG008|PKC412A2104E2|Adverse Event|0|||
164320283|NCT00045942|593550122|FG000|PKC412A2104E2|Death|0|||
164320284|NCT00045942|593550123|FG001|PKC412A2104E2|Death|0|||
164320285|NCT00045942|593550124|FG002|PKC412A2104E2|Death|0|||
164320286|NCT00045942|593550125|FG003|PKC412A2104E2|Death|0|||
164320287|NCT00045942|593550126|FG004|PKC412A2104E2|Death|0|||
164320288|NCT00045942|593550127|FG005|PKC412A2104E2|Death|1|||
164320289|NCT00045942|593550128|FG006|PKC412A2104E2|Death|2|||
164320290|NCT00045942|593550129|FG007|PKC412A2104E2|Death|0|||
164320291|NCT00045942|593550130|FG008|PKC412A2104E2|Death|0|||
164320292|NCT05508074|593550131|FG000|Overall Study|Death|2|||
164320293|NCT05508074|593550132|FG001|Overall Study|Death|5|||
164320294|NCT05508074|593550131|FG000|Overall Study|Withdrawal by Subject|1|||
164320295|NCT05508074|593550132|FG001|Overall Study|Withdrawal by Subject|2|||
164320296|NCT05508074|593550131|FG000|Overall Study|Adverse Event|0|||
164320297|NCT05508074|593550132|FG001|Overall Study|Adverse Event|1|||
164320298|NCT05508074|593550131|FG000|Overall Study|Physician Decision|0|||
164320299|NCT05508074|593550132|FG001|Overall Study|Physician Decision|1|||
164320300|NCT05508074|593550131|FG000|Overall Study|wrongly randomized|0|||
164320301|NCT05508074|593550132|FG001|Overall Study|wrongly randomized|1|||
164320302|NCT05508074|593550131|FG000|Overall Study|non-compliance|0|||
164320303|NCT05508074|593550132|FG001|Overall Study|non-compliance|1|||
164320304|NCT02142387|593550133|FG000|Overall Study|<19 years old|49|||
164320305|NCT02142387|593550134|FG001|Overall Study|<19 years old|326|||
164320306|NCT02142387|593550133|FG000|Overall Study|non-cardiac etiology|504|||
164320307|NCT02142387|593550134|FG001|Overall Study|non-cardiac etiology|3431|||
164320308|NCT02142387|593550133|FG000|Overall Study|CPR not performed|74|||
164320309|NCT02142387|593550134|FG001|Overall Study|CPR not performed|473|||
164320310|NCT02142387|593550133|FG000|Overall Study|witnessed by paramedic|139|||
164320311|NCT02142387|593550134|FG001|Overall Study|witnessed by paramedic|917|||
164320312|NCT02142387|593550133|FG000|Overall Study|incomplete data|1|||
164320313|NCT02142387|593550134|FG001|Overall Study|incomplete data|9|||
164320314|NCT02142387|593550133|FG000|Overall Study|occurred not at home|298|||
164320315|NCT02142387|593550134|FG001|Overall Study|occurred not at home|2474|||
164320316|NCT01101308|593550135|FG000|Period 1|Adverse Event|2|||
164320317|NCT01101308|593550136|FG001|Period 1|Adverse Event|1|||
164320318|NCT01101308|593550135|FG000|Period 1|Positive for cotinine|1|||
164320319|NCT01101308|593550136|FG001|Period 1|Positive for cotinine|0|||
164320320|NCT02984943|593550137|FG000|Overall Study|Withdrawal by Subject|3|||
164320321|NCT02984943|593550137|FG000|Overall Study|Physician Decision|1|||
164320322|NCT02282345|593550140|FG000|Overall Study|Progression|0|||
164320323|NCT02282345|593550141|FG001|Overall Study|Progression|1|||
164320324|NCT02296138|593550142|FG000|Overall Study|Adverse Event|348|||
164320325|NCT02296138|593550143|FG001|Overall Study|Adverse Event|259|||
164320326|NCT02296138|593550142|FG000|Overall Study|Lack of Efficacy|59|||
164320327|NCT02296138|593550143|FG001|Overall Study|Lack of Efficacy|37|||
164320328|NCT02296138|593550142|FG000|Overall Study|Protocol Violation|35|||
164320329|NCT02296138|593550143|FG001|Overall Study|Protocol Violation|36|||
164563304|NCT01114529|594431059|FG000|Completed Study Medication at Month 24|Graft loss|0|||
164563305|NCT01114529|594431060|FG001|Completed Study Medication at Month 24|Graft loss|2|||
164563306|NCT01114529|594431061|FG002|Completed Study Medication at Month 24|Graft loss|0|||
164563307|NCT01114529|594431059|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
164563308|NCT01114529|594431060|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
164563309|NCT01114529|594431061|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
164563310|NCT01114529|594431059|FG000|Completed Study Medication at Month 24|Missing|2|||
164563311|NCT01114529|594431060|FG001|Completed Study Medication at Month 24|Missing|0|||
164563312|NCT01114529|594431061|FG002|Completed Study Medication at Month 24|Missing|0|||
164563313|NCT01114529|594431059|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
164563314|NCT01114529|594431060|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
164320330|NCT02296138|593550142|FG000|Overall Study|Lost to Follow-up|9|||
164320331|NCT02296138|593550143|FG001|Overall Study|Lost to Follow-up|12|||
164320332|NCT02296138|593550142|FG000|Overall Study|Withdrawal by Subject|184|||
164320333|NCT02296138|593550143|FG001|Overall Study|Withdrawal by Subject|131|||
164320334|NCT02296138|593550142|FG000|Overall Study|Not Treated|1|||
164320335|NCT02296138|593550143|FG001|Overall Study|Not Treated|1|||
164320336|NCT02296138|593550142|FG000|Overall Study|Patients with data irregularities|10|||
164320337|NCT02296138|593550143|FG001|Overall Study|Patients with data irregularities|11|||
164320338|NCT02296138|593550142|FG000|Overall Study|Other than specified|15|||
164320339|NCT02296138|593550143|FG001|Overall Study|Other than specified|13|||
164320340|NCT00711516|593550144|FG000|Overall Study|Adverse Event|1|||
164320341|NCT00711516|593550145|FG001|Overall Study|Adverse Event|1|||
164320342|NCT00711516|593550144|FG000|Overall Study|Withdrawal by Subject|0|||
164320343|NCT00711516|593550145|FG001|Overall Study|Withdrawal by Subject|1|||
164320344|NCT00711516|593550144|FG000|Overall Study|Protocol Violation|0|||
164320345|NCT00711516|593550145|FG001|Overall Study|Protocol Violation|1|||
164320346|NCT04575597|593550146|FG000|Overall Study|Death|0|||
164320347|NCT04575597|593550147|FG001|Overall Study|Death|0|||
164320348|NCT04575597|593550148|FG002|Overall Study|Death|0|||
164320349|NCT04575597|593550149|FG003|Overall Study|Death|1|||
164320350|NCT04575597|593550150|FG004|Overall Study|Death|3|||
164320351|NCT04575597|593550151|FG005|Overall Study|Death|14|||
164320352|NCT04575597|593550146|FG000|Overall Study|Lost to Follow-up|2|||
164320353|NCT04575597|593550147|FG001|Overall Study|Lost to Follow-up|1|||
164320354|NCT04575597|593550148|FG002|Overall Study|Lost to Follow-up|1|||
164320355|NCT04575597|593550149|FG003|Overall Study|Lost to Follow-up|2|||
164320356|NCT04575597|593550150|FG004|Overall Study|Lost to Follow-up|10|||
164320357|NCT04575597|593550151|FG005|Overall Study|Lost to Follow-up|8|||
164320358|NCT04575597|593550146|FG000|Overall Study|Withdrawal by Subject|2|||
164320359|NCT04575597|593550147|FG001|Overall Study|Withdrawal by Subject|2|||
164320360|NCT04575597|593550148|FG002|Overall Study|Withdrawal by Subject|4|||
164563315|NCT01114529|594431061|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
164563316|NCT01114529|594431059|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
164563317|NCT01114529|594431060|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
164563318|NCT01114529|594431061|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
164563319|NCT01114529|594431059|FG000|Completed Study Phase at Month 24|Death|8|||
164563320|NCT01114529|594431060|FG001|Completed Study Phase at Month 24|Death|5|||
164563321|NCT01114529|594431061|FG002|Completed Study Phase at Month 24|Death|4|||
164563322|NCT01114529|594431059|FG000|Completed Study Phase at Month 24|Other|2|||
164563323|NCT01114529|594431060|FG001|Completed Study Phase at Month 24|Other|0|||
164563324|NCT01114529|594431061|FG002|Completed Study Phase at Month 24|Other|0|||
164563325|NCT01114529|594431059|FG000|Completed Study Phase at Month 24|Missing|2|||
164563326|NCT01114529|594431060|FG001|Completed Study Phase at Month 24|Missing|0|||
164563327|NCT01114529|594431061|FG002|Completed Study Phase at Month 24|Missing|0|||
164563328|NCT04428411|594431064|FG000|Overall Study|Lost to Follow-up|114|||
164563329|NCT00634569|594431065|FG000|Overall Study|Withdrawal by Subject|0|||
164563330|NCT00634569|594431066|FG001|Overall Study|Withdrawal by Subject|4|||
164563331|NCT00634569|594431065|FG000|Overall Study|Physician Decision|0|||
164563332|NCT00634569|594431066|FG001|Overall Study|Physician Decision|1|||
164563333|NCT02918019|594431067|FG000|Overall Study|Death|0|||
164563334|NCT02918019|594431068|FG001|Overall Study|Death|0|||
164563335|NCT02918019|594431069|FG002|Overall Study|Death|1|||
164563336|NCT02918019|594431070|FG003|Overall Study|Death|0|||
164563337|NCT02918019|594431067|FG000|Overall Study|Lost to Follow-up|1|||
164563338|NCT02918019|594431068|FG001|Overall Study|Lost to Follow-up|1|||
164563339|NCT02918019|594431069|FG002|Overall Study|Lost to Follow-up|0|||
164563340|NCT02918019|594431070|FG003|Overall Study|Lost to Follow-up|1|||
164563341|NCT02918019|594431067|FG000|Overall Study|Principal investigator request|0|||
164563342|NCT02918019|594431068|FG001|Overall Study|Principal investigator request|0|||
164563343|NCT02918019|594431069|FG002|Overall Study|Principal investigator request|0|||
164563344|NCT02918019|594431070|FG003|Overall Study|Principal investigator request|1|||
164563345|NCT02918019|594431067|FG000|Overall Study|Physician Decision|1|||
164563346|NCT02918019|594431068|FG001|Overall Study|Physician Decision|3|||
164563347|NCT02918019|594431069|FG002|Overall Study|Physician Decision|2|||
164563348|NCT02918019|594431070|FG003|Overall Study|Physician Decision|0|||
164563349|NCT02918019|594431067|FG000|Overall Study|Protocol deviation|1|||
164563350|NCT02918019|594431068|FG001|Overall Study|Protocol deviation|1|||
164563351|NCT02918019|594431069|FG002|Overall Study|Protocol deviation|0|||
164563352|NCT02918019|594431070|FG003|Overall Study|Protocol deviation|2|||
164563353|NCT02918019|594431067|FG000|Overall Study|Withdrawal by Subject|3|||
164563354|NCT02918019|594431068|FG001|Overall Study|Withdrawal by Subject|4|||
164563355|NCT02918019|594431069|FG002|Overall Study|Withdrawal by Subject|6|||
164563356|NCT02918019|594431070|FG003|Overall Study|Withdrawal by Subject|4|||
164563357|NCT02918019|594431067|FG000|Overall Study|Adverse Event|0|||
164563358|NCT02918019|594431068|FG001|Overall Study|Adverse Event|1|||
164563359|NCT02918019|594431069|FG002|Overall Study|Adverse Event|0|||
164563360|NCT02918019|594431070|FG003|Overall Study|Adverse Event|1|||
164563361|NCT01212185|594431071|FG000|Overall Study|Protocol Violation|2|||
164563362|NCT01212185|594431072|FG001|Overall Study|Protocol Violation|1|||
164563363|NCT03555266|594431073|FG000|Overall Study|Protocol Violation|6|||
164563364|NCT03555266|594431074|FG001|Overall Study|Protocol Violation|4|||
164563365|NCT03370770|594431075|FG000|Overall Study|Patient was followed in another hospital center|1|||
164563366|NCT03370770|594431075|FG000|Overall Study|Progressive Disease|98|||
164563367|NCT03370770|594431075|FG000|Overall Study|Adverse Event|2|||
164563368|NCT03370770|594431075|FG000|Overall Study|Death|5|||
164563369|NCT01699087|594431076|FG000|Overall Study|Lost to Follow-up|7|||
164320361|NCT04575597|593550149|FG003|Overall Study|Withdrawal by Subject|2|||
164320362|NCT04575597|593550150|FG004|Overall Study|Withdrawal by Subject|25|||
164320363|NCT04575597|593550151|FG005|Overall Study|Withdrawal by Subject|28|||
164320364|NCT04575597|593550146|FG000|Overall Study|Not Recorded|0|||
164320365|NCT04575597|593550147|FG001|Overall Study|Not Recorded|0|||
164320366|NCT04575597|593550148|FG002|Overall Study|Not Recorded|0|||
164320367|NCT04575597|593550149|FG003|Overall Study|Not Recorded|0|||
164320368|NCT04575597|593550150|FG004|Overall Study|Not Recorded|0|||
164320369|NCT04575597|593550151|FG005|Overall Study|Not Recorded|2|||
164320370|NCT04575597|593550146|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164320371|NCT04575597|593550147|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164320372|NCT04575597|593550148|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164320373|NCT04575597|593550149|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164320374|NCT04575597|593550150|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
164320375|NCT04575597|593550151|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
164320376|NCT02095132|593550153|FG000|Overall Study|Adverse Event|0|||
164320377|NCT02095132|593550154|FG001|Overall Study|Adverse Event|0|||
164320378|NCT02095132|593550155|FG002|Overall Study|Adverse Event|0|||
164320379|NCT02095132|593550156|FG003|Overall Study|Adverse Event|0|||
164320380|NCT02095132|593550157|FG004|Overall Study|Adverse Event|1|||
164320381|NCT02095132|593550158|FG005|Overall Study|Adverse Event|0|||
164320382|NCT02095132|593550159|FG006|Overall Study|Adverse Event|1|||
164320383|NCT02095132|593550160|FG007|Overall Study|Adverse Event|0|||
164320384|NCT02095132|593550161|FG008|Overall Study|Adverse Event|0|||
164320385|NCT02095132|593550153|FG000|Overall Study|Death|0|||
164320386|NCT02095132|593550154|FG001|Overall Study|Death|0|||
164320387|NCT02095132|593550155|FG002|Overall Study|Death|0|||
164320388|NCT02095132|593550156|FG003|Overall Study|Death|0|||
164320389|NCT02095132|593550157|FG004|Overall Study|Death|0|||
164320390|NCT02095132|593550158|FG005|Overall Study|Death|0|||
164320391|NCT02095132|593550159|FG006|Overall Study|Death|1|||
164320392|NCT02095132|593550160|FG007|Overall Study|Death|0|||
164320393|NCT02095132|593550161|FG008|Overall Study|Death|0|||
164320394|NCT02095132|593550153|FG000|Overall Study|Lack of Efficacy|3|||
164320395|NCT02095132|593550154|FG001|Overall Study|Lack of Efficacy|5|||
164320396|NCT02095132|593550155|FG002|Overall Study|Lack of Efficacy|2|||
164320397|NCT02095132|593550156|FG003|Overall Study|Lack of Efficacy|8|||
164320398|NCT02095132|593550157|FG004|Overall Study|Lack of Efficacy|3|||
164320399|NCT02095132|593550158|FG005|Overall Study|Lack of Efficacy|6|||
164320400|NCT02095132|593550159|FG006|Overall Study|Lack of Efficacy|10|||
164320401|NCT02095132|593550160|FG007|Overall Study|Lack of Efficacy|9|||
164320402|NCT02095132|593550161|FG008|Overall Study|Lack of Efficacy|8|||
164320403|NCT02095132|593550153|FG000|Overall Study|Physician Decision|1|||
164320404|NCT02095132|593550154|FG001|Overall Study|Physician Decision|0|||
164320405|NCT02095132|593550155|FG002|Overall Study|Physician Decision|0|||
164320406|NCT02095132|593550156|FG003|Overall Study|Physician Decision|0|||
164320407|NCT02095132|593550157|FG004|Overall Study|Physician Decision|0|||
164320408|NCT02095132|593550158|FG005|Overall Study|Physician Decision|0|||
164320409|NCT02095132|593550159|FG006|Overall Study|Physician Decision|1|||
164320410|NCT02095132|593550160|FG007|Overall Study|Physician Decision|0|||
164320411|NCT02095132|593550161|FG008|Overall Study|Physician Decision|2|||
164320412|NCT02095132|593550153|FG000|Overall Study|Withdrawal by Subject|0|||
164320413|NCT02095132|593550154|FG001|Overall Study|Withdrawal by Subject|0|||
164320414|NCT02095132|593550155|FG002|Overall Study|Withdrawal by Subject|2|||
164320415|NCT02095132|593550156|FG003|Overall Study|Withdrawal by Subject|2|||
164320416|NCT02095132|593550157|FG004|Overall Study|Withdrawal by Subject|3|||
164320417|NCT02095132|593550158|FG005|Overall Study|Withdrawal by Subject|0|||
164320418|NCT02095132|593550159|FG006|Overall Study|Withdrawal by Subject|5|||
164320419|NCT02095132|593550160|FG007|Overall Study|Withdrawal by Subject|0|||
164563370|NCT01699087|594431076|FG000|Overall Study|Screen failure (prior to treatment)|15|||
164563371|NCT01699087|594431076|FG000|Overall Study|Unable to make future visits|2|||
164563372|NCT02167945|594431077|FG000|Overall Study|Adverse Event|16|||
164563373|NCT02167945|594431077|FG000|Overall Study|Withdrew Consent|42|||
164563374|NCT02167945|594431077|FG000|Overall Study|Lost to Follow-up|122|||
164563375|NCT02167945|594431077|FG000|Overall Study|COVID-19 logistical restrictions|6|||
164563376|NCT02167945|594431077|FG000|Overall Study|Other, not specified|63|||
164320420|NCT02095132|593550161|FG008|Overall Study|Withdrawal by Subject|0|||
164320421|NCT04905498|593550164|FG000|Overall Study|Lost to Follow-up|0|||
164320422|NCT04905498|593550165|FG001|Overall Study|Lost to Follow-up|2|||
164320423|NCT04905498|593550164|FG000|Overall Study|COVID lockdown|1|||
164320424|NCT04905498|593550165|FG001|Overall Study|COVID lockdown|0|||
164320425|NCT01029405|593550166|FG000|Overall Study|Withdrawal by Subject|0|||
164320426|NCT01029405|593550167|FG001|Overall Study|Withdrawal by Subject|1|||
164320427|NCT01029405|593550168|FG002|Overall Study|Withdrawal by Subject|2|||
164320428|NCT01029405|593550169|FG003|Overall Study|Withdrawal by Subject|0|||
164320429|NCT01029405|593550166|FG000|Overall Study|Protocol Violation|0|||
164320430|NCT01029405|593550167|FG001|Overall Study|Protocol Violation|0|||
164320431|NCT01029405|593550168|FG002|Overall Study|Protocol Violation|0|||
164320432|NCT01029405|593550169|FG003|Overall Study|Protocol Violation|1|||
164320433|NCT01029405|593550166|FG000|Overall Study|Adverse Event|0|||
164320434|NCT01029405|593550167|FG001|Overall Study|Adverse Event|0|||
164320435|NCT01029405|593550168|FG002|Overall Study|Adverse Event|1|||
164320436|NCT01029405|593550169|FG003|Overall Study|Adverse Event|1|||
164320437|NCT01029405|593550166|FG000|Overall Study|Lost to Follow-up|2|||
164320438|NCT01029405|593550167|FG001|Overall Study|Lost to Follow-up|1|||
164320439|NCT01029405|593550168|FG002|Overall Study|Lost to Follow-up|1|||
164320440|NCT01029405|593550169|FG003|Overall Study|Lost to Follow-up|2|||
164320441|NCT01029405|593550166|FG000|Overall Study|Other|0|||
164320442|NCT01029405|593550167|FG001|Overall Study|Other|1|||
164320443|NCT01029405|593550168|FG002|Overall Study|Other|0|||
164320444|NCT01029405|593550169|FG003|Overall Study|Other|1|||
164320445|NCT01268579|593550170|FG000|Overall Study|Adverse Event|1|||
164320446|NCT01268579|593550170|FG000|Overall Study|Withdrawal by Subject|2|||
164320447|NCT03312751|593550171|FG000|Overall Study|Death|7|||
164320448|NCT03312751|593550172|FG001|Overall Study|Death|9|||
164320449|NCT03312751|593550171|FG000|Overall Study|Study discontinuation due to other reason|0|||
164320450|NCT03312751|593550172|FG001|Overall Study|Study discontinuation due to other reason|1|||
164320451|NCT02692651|593550173|FG000|Study Treatment|Death|7|||
164320452|NCT02692651|593550174|FG001|Study Treatment|Death|3|||
164320453|NCT02692651|593550173|FG000|Study Treatment|comfort care|1|||
164320454|NCT02692651|593550174|FG001|Study Treatment|comfort care|1|||
164320455|NCT02692651|593550173|FG000|Study Treatment|Protocol violation per treating team preference|8|||
164320456|NCT02692651|593550174|FG001|Study Treatment|Protocol violation per treating team preference|6|||
164320457|NCT02692651|593550173|FG000|Post Study Treatment Follow-up|Death|4|||
164320458|NCT02692651|593550174|FG001|Post Study Treatment Follow-up|Death|4|||
164320459|NCT03490981|593550175|FG000|Overall Study|Lost to Follow-up|1|||
164320460|NCT03490981|593550176|FG001|Overall Study|Lost to Follow-up|2|||
164320461|NCT02480712|593550183|FG000|Overall Study|Enrolled but Never Treated|1|||
164320462|NCT02480712|593550183|FG000|Overall Study|Lost to Follow-up|5|||
164320463|NCT02480712|593550183|FG000|Overall Study|Withdrew Consent|3|||
164320464|NCT02480712|593550183|FG000|Overall Study|Death|1|||
164320465|NCT02480712|593550183|FG000|Overall Study|Lack of Efficacy|1|||
164320466|NCT01860846|593550184|FG000|Overall Study|Lost to Follow-up|33|||
164320467|NCT00466687|593550185|FG000|Overall Study|Adverse Event|1|||
164320468|NCT00466687|593550185|FG000|Overall Study|Other complicating illness|3|||
164320469|NCT00466687|593550185|FG000|Overall Study|Withdrawal by Subject|1|||
164320470|NCT00466687|593550185|FG000|Overall Study|Disease progression|29|||
164320471|NCT02586506|593550186|FG000|Overall Study|Protocol Violation|6|||
164320472|NCT02586506|593550186|FG000|Overall Study|Lost to Follow-up|1|||
164320473|NCT02586506|593550186|FG000|Overall Study|Other Reason|2|||
164320474|NCT00770146|593550187|FG000|Treatment Period|Withdrawal by Subject|6|||
164320475|NCT00770146|593550188|FG001|Treatment Period|Withdrawal by Subject|13|||
164320476|NCT00770146|593550187|FG000|Treatment Period|Adverse Event|2|||
164320477|NCT00770146|593550188|FG001|Treatment Period|Adverse Event|26|||
164320478|NCT00770146|593550187|FG000|Treatment Period|Other|1|||
164320479|NCT00770146|593550188|FG001|Treatment Period|Other|5|||
164320480|NCT00770146|593550187|FG000|Treatment Period|Protocol non-compliance|0|||
164320481|NCT00770146|593550188|FG001|Treatment Period|Protocol non-compliance|1|||
164320482|NCT00770146|593550187|FG000|Follow-up Period|Withdrawal by Subject|7|||
164320483|NCT00770146|593550188|FG001|Follow-up Period|Withdrawal by Subject|13|||
164320484|NCT00770146|593550187|FG000|Follow-up Period|Adverse Event|0|||
164320485|NCT00770146|593550188|FG001|Follow-up Period|Adverse Event|2|||
164320486|NCT00770146|593550187|FG000|Follow-up Period|Other|4|||
164320487|NCT00770146|593550188|FG001|Follow-up Period|Other|5|||
164320488|NCT01525901|593550189|FG000|Period 2: 12 Weeks|Adverse Event|0|||
164320489|NCT01525901|593550190|FG001|Period 2: 12 Weeks|Adverse Event|1|||
164320490|NCT01525901|593550191|FG002|Period 2: 12 Weeks|Adverse Event|0|||
164320491|NCT01525901|593550192|FG003|Period 2: 12 Weeks|Adverse Event|0|||
164320492|NCT01509053|593550193|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
164320493|NCT01509053|593550193|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
164320494|NCT01509053|593550193|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
164563377|NCT00094757|594431078|FG000|Overall Study|Adverse Event|11|||
164563378|NCT00094757|594431079|FG001|Overall Study|Adverse Event|9|||
164563379|NCT00094757|594431080|FG002|Overall Study|Adverse Event|6|||
164563380|NCT00094757|594431078|FG000|Overall Study|Lack of Efficacy|11|||
164563381|NCT00094757|594431079|FG001|Overall Study|Lack of Efficacy|15|||
164563382|NCT00094757|594431080|FG002|Overall Study|Lack of Efficacy|8|||
164563383|NCT00094757|594431078|FG000|Overall Study|Lost to Follow-up|3|||
164320495|NCT01509053|593550193|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
164320496|NCT01509053|593550193|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
164320497|NCT01509053|593550193|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
164320498|NCT01284491|593550195|FG000|Overall Study|Study termination|13|||
164320499|NCT01978938|593550196|FG000|Overall Study|Lost to Follow-up|12|||
164320500|NCT01978938|593550197|FG001|Overall Study|Lost to Follow-up|6|||
164320501|NCT01978938|593550196|FG000|Overall Study|Withdrawal by Subject|8|||
164320502|NCT01978938|593550197|FG001|Overall Study|Withdrawal by Subject|4|||
164320503|NCT01978938|593550196|FG000|Overall Study|Adverse Event, non-fatal|2|||
164320504|NCT01978938|593550197|FG001|Overall Study|Adverse Event, non-fatal|1|||
164320505|NCT01978938|593550196|FG000|Overall Study|Participant noncompliance|1|||
164563384|NCT00094757|594431079|FG001|Overall Study|Lost to Follow-up|5|||
164563385|NCT00094757|594431080|FG002|Overall Study|Lost to Follow-up|6|||
164320506|NCT01978938|593550197|FG001|Overall Study|Participant noncompliance|1|||
164320507|NCT01978938|593550196|FG000|Overall Study|Did not meet inclusion criteria|0|||
164667247|NCT02937701|594808328|FG004|Day 1 to Week 22|Death|0|||
164320508|NCT01978938|593550197|FG001|Overall Study|Did not meet inclusion criteria|1|||
164320509|NCT01978938|593550196|FG000|Overall Study|Previously scheduled procedure|0|||
164563386|NCT00094757|594431078|FG000|Overall Study|Patient Moved|2|||
164563387|NCT00094757|594431079|FG001|Overall Study|Patient Moved|1|||
164563388|NCT00094757|594431080|FG002|Overall Study|Patient Moved|1|||
164563389|NCT00094757|594431078|FG000|Overall Study|Protocol Violation|8|||
164563390|NCT00094757|594431079|FG001|Overall Study|Protocol Violation|5|||
164563391|NCT00094757|594431080|FG002|Overall Study|Protocol Violation|3|||
164563392|NCT00094757|594431078|FG000|Overall Study|Withdrawal by Subject|14|||
164563393|NCT00094757|594431079|FG001|Overall Study|Withdrawal by Subject|21|||
164563394|NCT00094757|594431080|FG002|Overall Study|Withdrawal by Subject|5|||
164563395|NCT00094757|594431078|FG000|Overall Study|Other|3|||
164563396|NCT00094757|594431079|FG001|Overall Study|Other|3|||
164563397|NCT00094757|594431080|FG002|Overall Study|Other|1|||
164563398|NCT00094757|594431078|FG000|Overall Study|Protocol specified discontinuation|1|||
164563399|NCT00094757|594431079|FG001|Overall Study|Protocol specified discontinuation|3|||
164563400|NCT00094757|594431080|FG002|Overall Study|Protocol specified discontinuation|0|||
164563401|NCT01463098|594431085|FG000|Part A (11 Days)|Participant Choice|2|||
164563402|NCT01463098|594431086|FG001|Part A (11 Days)|Participant Choice|0|||
164563403|NCT01463098|594431087|FG002|Part A (11 Days)|Participant Choice|0|||
164563404|NCT01463098|594431088|FG003|Part A (11 Days)|Participant Choice|0|||
164563405|NCT01463098|594431089|FG004|Part A (11 Days)|Participant Choice|0|||
164563406|NCT01463098|594431090|FG005|Part A (11 Days)|Participant Choice|0|||
164563407|NCT01463098|594431091|FG006|Part A (11 Days)|Participant Choice|0|||
164563408|NCT01463098|594431092|FG007|Part A (11 Days)|Participant Choice|0|||
164563409|NCT01463098|594431093|FG008|Part A (11 Days)|Participant Choice|1|||
164563410|NCT01463098|594431094|FG009|Part A (11 Days)|Participant Choice|0|||
164563411|NCT01463098|594431095|FG010|Part A (11 Days)|Participant Choice|0|||
164563412|NCT01463098|594431096|FG011|Part A (11 Days)|Participant Choice|0|||
164563413|NCT01463098|594431097|FG012|Part A (11 Days)|Participant Choice|0|||
164563414|NCT01463098|594431098|FG013|Part A (11 Days)|Participant Choice|0|||
164563415|NCT01463098|594431085|FG000|Part A (11 Days)|Lost to Follow-up|0|||
164563416|NCT01463098|594431086|FG001|Part A (11 Days)|Lost to Follow-up|0|||
164563417|NCT01463098|594431087|FG002|Part A (11 Days)|Lost to Follow-up|0|||
164563418|NCT01463098|594431088|FG003|Part A (11 Days)|Lost to Follow-up|0|||
164563419|NCT01463098|594431089|FG004|Part A (11 Days)|Lost to Follow-up|1|||
164563420|NCT01463098|594431090|FG005|Part A (11 Days)|Lost to Follow-up|0|||
164563421|NCT01463098|594431091|FG006|Part A (11 Days)|Lost to Follow-up|0|||
164563422|NCT01463098|594431092|FG007|Part A (11 Days)|Lost to Follow-up|0|||
164563423|NCT01463098|594431093|FG008|Part A (11 Days)|Lost to Follow-up|0|||
164563424|NCT01463098|594431094|FG009|Part A (11 Days)|Lost to Follow-up|0|||
164563425|NCT01463098|594431095|FG010|Part A (11 Days)|Lost to Follow-up|0|||
164563426|NCT01463098|594431096|FG011|Part A (11 Days)|Lost to Follow-up|0|||
164563427|NCT01463098|594431097|FG012|Part A (11 Days)|Lost to Follow-up|0|||
164563428|NCT01463098|594431098|FG013|Part A (11 Days)|Lost to Follow-up|0|||
164563429|NCT01463098|594431085|FG000|Part B (11 Days)|Participant Choice|0|||
164563430|NCT01463098|594431086|FG001|Part B (11 Days)|Participant Choice|0|||
164563431|NCT01463098|594431087|FG002|Part B (11 Days)|Participant Choice|0|||
164563432|NCT01463098|594431088|FG003|Part B (11 Days)|Participant Choice|0|||
164563433|NCT01463098|594431089|FG004|Part B (11 Days)|Participant Choice|0|||
164563434|NCT01463098|594431090|FG005|Part B (11 Days)|Participant Choice|0|||
164563435|NCT01463098|594431091|FG006|Part B (11 Days)|Participant Choice|0|||
164563436|NCT01463098|594431092|FG007|Part B (11 Days)|Participant Choice|0|||
164563437|NCT01463098|594431093|FG008|Part B (11 Days)|Participant Choice|0|||
164563438|NCT01463098|594431094|FG009|Part B (11 Days)|Participant Choice|0|||
164563439|NCT01463098|594431095|FG010|Part B (11 Days)|Participant Choice|0|||
164563440|NCT01463098|594431096|FG011|Part B (11 Days)|Participant Choice|1|||
164563441|NCT01463098|594431097|FG012|Part B (11 Days)|Participant Choice|0|||
164563442|NCT01463098|594431098|FG013|Part B (11 Days)|Participant Choice|0|||
164667248|NCT02937701|594808324|FG000|Day 1 to Week 22|Protocol Violation|1|||
164667249|NCT02937701|594808325|FG001|Day 1 to Week 22|Protocol Violation|1|||
164667250|NCT02937701|594808326|FG002|Day 1 to Week 22|Protocol Violation|0|||
164667251|NCT02937701|594808327|FG003|Day 1 to Week 22|Protocol Violation|0|||
164667252|NCT02937701|594808328|FG004|Day 1 to Week 22|Protocol Violation|0|||
164563443|NCT01528787|594431099|FG000|Overall Study|Withdrawal by Subject|0|||
164563444|NCT01528787|594431100|FG001|Overall Study|Withdrawal by Subject|0|||
164563445|NCT01528787|594431101|FG002|Overall Study|Withdrawal by Subject|0|||
164563446|NCT01528787|594431102|FG003|Overall Study|Withdrawal by Subject|1|||
164667253|NCT02937701|594808324|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
164563447|NCT01528787|594431099|FG000|Overall Study|Family Emergency|0|||
164563448|NCT01528787|594431100|FG001|Overall Study|Family Emergency|0|||
164563449|NCT01528787|594431101|FG002|Overall Study|Family Emergency|1|||
164563450|NCT01528787|594431102|FG003|Overall Study|Family Emergency|0|||
164563451|NCT00797823|594431105|FG000|First Period (Initial Randomization)|Physician Decision|1|||
164563452|NCT00797823|594431106|FG001|First Period (Initial Randomization)|Physician Decision|0|||
164320510|NCT01978938|593550197|FG001|Overall Study|Previously scheduled procedure|1|||
164320511|NCT02694757|593550198|FG000|Overall Study|Lack of Efficacy|3|||
164320512|NCT02650921|593550199|FG000|Overall Study|Withdrawal by Subject|4|||
164320513|NCT02650921|593550199|FG000|Overall Study|Lost to Follow-up|2|||
164320514|NCT02650921|593550199|FG000|Overall Study|Adverse Event|1|||
164320515|NCT02650921|593550199|FG000|Overall Study|Due to Medical Condition|1|||
164320516|NCT00783302|593550200|FG000|Overall Study|Lost to Follow-up|17|||
164320517|NCT00783302|593550200|FG000|Overall Study|Technical Problems|11|||
164320518|NCT00783302|593550200|FG000|Overall Study|Protocol Violation|3|||
164320519|NCT00783302|593550200|FG000|Overall Study|Physician Decision|1|||
164320520|NCT00783302|593550200|FG000|Overall Study|Withdrawal by Subject|3|||
164320521|NCT01087788|593550201|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
164320522|NCT01087788|593550202|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
164320523|NCT01087788|593550203|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
164320524|NCT01087788|593550201|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
164320525|NCT01087788|593550202|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
164320526|NCT01087788|593550203|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
164320527|NCT01087788|593550201|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
164320528|NCT01087788|593550202|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
164320529|NCT01087788|593550203|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
164320530|NCT01087788|593550201|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
164320531|NCT01087788|593550202|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
164320532|NCT01087788|593550203|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
164320533|NCT01087788|593550201|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
164320534|NCT01087788|593550202|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
164320535|NCT01087788|593550203|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
164320536|NCT01087788|593550201|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
164320537|NCT01087788|593550202|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
164320538|NCT01087788|593550203|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
164320539|NCT01087788|593550201|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
164320540|NCT01087788|593550202|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
164320541|NCT01087788|593550203|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
164320542|NCT01087788|593550201|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
164320543|NCT01087788|593550202|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
164320544|NCT01087788|593550203|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
164320545|NCT01087788|593550201|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
164320546|NCT01087788|593550202|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
164320547|NCT01087788|593550203|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
164320548|NCT01087788|593550201|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
164320549|NCT01087788|593550202|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
164320550|NCT01087788|593550203|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
164320551|NCT01087788|593550201|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
164320552|NCT01087788|593550202|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
164320553|NCT01087788|593550203|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
164320554|NCT01087788|593550201|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
164320555|NCT01087788|593550202|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
164320556|NCT01087788|593550203|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
164320557|NCT01087788|593550201|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
164320558|NCT01087788|593550202|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
164320559|NCT01087788|593550203|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
164320560|NCT01087788|593550201|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
164320561|NCT01087788|593550202|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
164320562|NCT01087788|593550203|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
164320563|NCT01087788|593550201|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
164320564|NCT01087788|593550202|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
164320565|NCT01087788|593550203|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
164320566|NCT01087788|593550201|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
164320567|NCT01087788|593550202|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
164320568|NCT01087788|593550203|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
164320569|NCT01087788|593550201|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
164320570|NCT01087788|593550202|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
164320571|NCT01087788|593550203|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
164320572|NCT01087788|593550201|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
164320573|NCT01087788|593550202|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
164320574|NCT01087788|593550203|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
164320575|NCT01087788|593550201|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
164320576|NCT01087788|593550202|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
164320577|NCT01087788|593550203|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
164320578|NCT01087788|593550201|FG000|24-weeks Dose-blind Period|Patient moved|0|||
164320579|NCT01087788|593550202|FG001|24-weeks Dose-blind Period|Patient moved|0|||
164320580|NCT01087788|593550203|FG002|24-weeks Dose-blind Period|Patient moved|1|||
164320581|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
164667254|NCT02937701|594808325|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
164667255|NCT02937701|594808326|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
164667256|NCT02937701|594808327|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
164667257|NCT02937701|594808328|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
164667258|NCT02937701|594808324|FG000|Day 1 to Week 22|Physician Decision|2|||
164667259|NCT02937701|594808325|FG001|Day 1 to Week 22|Physician Decision|0|||
164667260|NCT02937701|594808326|FG002|Day 1 to Week 22|Physician Decision|0|||
164667261|NCT02937701|594808327|FG003|Day 1 to Week 22|Physician Decision|0|||
164667262|NCT02937701|594808328|FG004|Day 1 to Week 22|Physician Decision|0|||
164667263|NCT02937701|594808324|FG000|Day 1 to Week 22|Other|1|||
164667264|NCT02937701|594808325|FG001|Day 1 to Week 22|Other|0|||
164667265|NCT02937701|594808326|FG002|Day 1 to Week 22|Other|0|||
164667266|NCT02937701|594808327|FG003|Day 1 to Week 22|Other|0|||
164667267|NCT02937701|594808328|FG004|Day 1 to Week 22|Other|0|||
164667268|NCT02937701|594808324|FG000|Week 22 to Week 50|Adverse Event|0|||
164667269|NCT02937701|594808325|FG001|Week 22 to Week 50|Adverse Event|0|||
164667270|NCT02937701|594808326|FG002|Week 22 to Week 50|Adverse Event|10|||
164667271|NCT02937701|594808327|FG003|Week 22 to Week 50|Adverse Event|3|||
164667272|NCT02937701|594808328|FG004|Week 22 to Week 50|Adverse Event|3|||
164667273|NCT02937701|594808324|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
164667274|NCT02937701|594808325|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
164667275|NCT02937701|594808326|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
164667276|NCT02937701|594808327|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
164667277|NCT02937701|594808328|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
164667278|NCT02937701|594808324|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
164667279|NCT02937701|594808325|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
164667280|NCT02937701|594808326|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
164667281|NCT02937701|594808327|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
164667282|NCT02937701|594808328|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
164667283|NCT02937701|594808324|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
164667284|NCT02937701|594808325|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
164667285|NCT02937701|594808326|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
164667286|NCT02937701|594808327|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
164667287|NCT02937701|594808328|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
164667288|NCT02937701|594808324|FG000|Week 22 to Week 50|Physician Decision|0|||
164667289|NCT02937701|594808325|FG001|Week 22 to Week 50|Physician Decision|0|||
164667290|NCT02937701|594808326|FG002|Week 22 to Week 50|Physician Decision|2|||
164667291|NCT02937701|594808327|FG003|Week 22 to Week 50|Physician Decision|0|||
164667292|NCT02937701|594808328|FG004|Week 22 to Week 50|Physician Decision|1|||
164667293|NCT02937701|594808324|FG000|Week 22 to Week 50|Other|0|||
164667294|NCT02937701|594808325|FG001|Week 22 to Week 50|Other|0|||
164667295|NCT02937701|594808326|FG002|Week 22 to Week 50|Other|0|||
164667296|NCT02937701|594808327|FG003|Week 22 to Week 50|Other|0|||
164667297|NCT02937701|594808328|FG004|Week 22 to Week 50|Other|1|||
164667298|NCT01507051|594808329|FG000|Overall Study|Withdrawal by Subject|1|||
164667299|NCT01507051|594808330|FG001|Overall Study|Withdrawal by Subject|3|||
164667300|NCT01507051|594808331|FG002|Overall Study|Withdrawal by Subject|1|||
164667301|NCT01507051|594808332|FG003|Overall Study|Withdrawal by Subject|6|||
164667302|NCT01507051|594808329|FG000|Overall Study|Physician Decision|0|||
164667303|NCT01507051|594808330|FG001|Overall Study|Physician Decision|0|||
164667304|NCT01507051|594808331|FG002|Overall Study|Physician Decision|0|||
164667305|NCT01507051|594808332|FG003|Overall Study|Physician Decision|1|||
164667306|NCT01507051|594808329|FG000|Overall Study|Adverse Event|1|||
164667307|NCT01507051|594808330|FG001|Overall Study|Adverse Event|0|||
164667308|NCT01507051|594808331|FG002|Overall Study|Adverse Event|0|||
164667309|NCT01507051|594808332|FG003|Overall Study|Adverse Event|0|||
164667310|NCT01101022|594808333|FG000|Overall Study|Adverse Event|6|||
164667311|NCT01101022|594808334|FG001|Overall Study|Adverse Event|2|||
164667312|NCT01101022|594808333|FG000|Overall Study|Protocol Violation|4|||
164667313|NCT01101022|594808334|FG001|Overall Study|Protocol Violation|3|||
164667314|NCT01101022|594808333|FG000|Overall Study|Withdrawal by Subject|3|||
164667315|NCT01101022|594808334|FG001|Overall Study|Withdrawal by Subject|8|||
164667316|NCT01101022|594808333|FG000|Overall Study|Lost to Follow-up|1|||
164667317|NCT01101022|594808334|FG001|Overall Study|Lost to Follow-up|4|||
164667318|NCT01101022|594808333|FG000|Overall Study|Lack of Efficacy|0|||
164667319|NCT01101022|594808334|FG001|Overall Study|Lack of Efficacy|7|||
164667320|NCT01101022|594808333|FG000|Overall Study|Sponsor decision|1|||
164667321|NCT01101022|594808334|FG001|Overall Study|Sponsor decision|1|||
164667322|NCT01101022|594808333|FG000|Overall Study|Non-compliance|1|||
164667323|NCT01101022|594808334|FG001|Overall Study|Non-compliance|0|||
164667324|NCT01101022|594808333|FG000|Overall Study|Work schedule|1|||
164667325|NCT01101022|594808334|FG001|Overall Study|Work schedule|1|||
164320582|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
164667326|NCT01101022|594808333|FG000|Overall Study|Vacation|0|||
164667327|NCT01101022|594808334|FG001|Overall Study|Vacation|1|||
164667328|NCT01139047|594808335|FG000|Overall Study|Withdrawal by Subject|1|||
164320583|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
164320584|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
164320585|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
164320586|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
164320587|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
164320588|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
164320589|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
164320590|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
164320591|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
164320592|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
164320593|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
164320594|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
164320595|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
164320596|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
164320597|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
164320598|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
164320599|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
164320600|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
164320601|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
164320602|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
164320603|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
164320604|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
164320605|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
164320606|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
164320607|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
164320608|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
164320609|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
164320610|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
164320611|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
164320612|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
164320613|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
164320614|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
164320615|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
164320616|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
164320617|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
164320618|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
164320619|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
164320620|NCT01806662|593550204|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
164320621|NCT01806662|593550205|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
164320622|NCT01806662|593550204|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
164320623|NCT01806662|593550205|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
164320624|NCT01806662|593550204|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
164320625|NCT01806662|593550205|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
164320626|NCT01806662|593550204|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
164320627|NCT01806662|593550205|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
164320628|NCT00043550|593550206|FG000|Overall Study|Withdrawal by Subject|22|||
164320629|NCT00043550|593550207|FG001|Overall Study|Withdrawal by Subject|12|||
164667329|NCT01941095|594808340|FG000|Overall Study|Insufficient therapeutic response|13|||
164667330|NCT01941095|594808340|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
164667331|NCT01941095|594808340|FG000|Overall Study|Adverse Event|11|||
164667332|NCT01941095|594808340|FG000|Overall Study|Physician Decision|3|||
164667333|NCT01941095|594808340|FG000|Overall Study|Withdrawal by Subject|17|||
164667334|NCT01941095|594808340|FG000|Overall Study|Lost to Follow-up|10|||
164667335|NCT04455633|594808341|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
164320630|NCT00043550|593550208|FG002|Overall Study|Withdrawal by Subject|20|||
164667336|NCT04455633|594808342|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
164320631|NCT01917656|593550209|FG000|Overall Study|Adverse Event|11|||
164320632|NCT01917656|593550210|FG001|Overall Study|Adverse Event|0|||
164320633|NCT01917656|593550209|FG000|Overall Study|Withdrawal criteria|8|||
164667337|NCT04455633|594808343|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
164320634|NCT01917656|593550210|FG001|Overall Study|Withdrawal criteria|14|||
164320635|NCT01917656|593550209|FG000|Overall Study|Unclassified|0|||
164667338|NCT04455633|594808341|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
164320636|NCT01917656|593550210|FG001|Overall Study|Unclassified|3|||
164320637|NCT01917656|593550209|FG000|Overall Study|Withdrawal by Subject|4|||
164667339|NCT04455633|594808342|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
164667340|NCT04455633|594808343|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
164667341|NCT04455633|594808341|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
164667342|NCT04455633|594808342|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
164667343|NCT04455633|594808343|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
164667344|NCT04455633|594808341|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
164667345|NCT04455633|594808342|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
164667346|NCT04455633|594808343|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
164667347|NCT03527745|594808344|FG000|Overall Study|Lost to Follow-up|3|||
164667348|NCT03527745|594808345|FG001|Overall Study|Lost to Follow-up|6|||
164667349|NCT03527745|594808346|FG002|Overall Study|Lost to Follow-up|7|||
164667350|NCT03527745|594808347|FG003|Overall Study|Lost to Follow-up|9|||
164667351|NCT03527745|594808348|FG004|Overall Study|Lost to Follow-up|0|||
164667352|NCT03527745|594808349|FG005|Overall Study|Lost to Follow-up|2|||
164667353|NCT03527745|594808350|FG006|Overall Study|Lost to Follow-up|3|||
164667354|NCT03527745|594808351|FG007|Overall Study|Lost to Follow-up|2|||
164667355|NCT03527745|594808352|FG008|Overall Study|Lost to Follow-up|3|||
164667356|NCT03527745|594808353|FG009|Overall Study|Lost to Follow-up|2|||
164667357|NCT03527745|594808354|FG010|Overall Study|Lost to Follow-up|1|||
164667358|NCT03527745|594808355|FG011|Overall Study|Lost to Follow-up|1|||
164667359|NCT03527745|594808356|FG012|Overall Study|Lost to Follow-up|0|||
164667360|NCT03527745|594808357|FG013|Overall Study|Lost to Follow-up|0|||
164667361|NCT03527745|594808358|FG014|Overall Study|Lost to Follow-up|0|||
164667362|NCT03527745|594808359|FG015|Overall Study|Lost to Follow-up|0|||
164667363|NCT03527745|594808360|FG016|Overall Study|Lost to Follow-up|1|||
164667364|NCT03527745|594808361|FG017|Overall Study|Lost to Follow-up|0|||
164667365|NCT03527745|594808362|FG018|Overall Study|Lost to Follow-up|0|||
164667366|NCT03527745|594808363|FG019|Overall Study|Lost to Follow-up|1|||
164667367|NCT03527745|594808364|FG020|Overall Study|Lost to Follow-up|1|||
164667368|NCT03527745|594808365|FG021|Overall Study|Lost to Follow-up|5|||
164667369|NCT03527745|594808366|FG022|Overall Study|Lost to Follow-up|6|||
164667370|NCT03527745|594808367|FG023|Overall Study|Lost to Follow-up|8|||
164667371|NCT03527745|594808368|FG024|Overall Study|Lost to Follow-up|1|||
164667372|NCT03527745|594808369|FG025|Overall Study|Lost to Follow-up|3|||
164667373|NCT04015232|594808370|FG000|Overall Study|Withdrawal by Subject|7|||
164667374|NCT04015232|594808371|FG001|Overall Study|Withdrawal by Subject|4|||
164667375|NCT04015232|594808370|FG000|Overall Study|Protocol Violation|1|||
164667376|NCT04015232|594808371|FG001|Overall Study|Protocol Violation|0|||
164667377|NCT04015232|594808370|FG000|Overall Study|Medical Grounds|3|||
164667378|NCT04015232|594808371|FG001|Overall Study|Medical Grounds|3|||
164667379|NCT01087970|594808374|FG000|Overall Study|Protocol Violation|2|||
164667380|NCT03655106|594808375|FG000|Overall Study|Withdrawal by Subject|3|||
164667381|NCT03655106|594808376|FG001|Overall Study|Withdrawal by Subject|2|||
164667382|NCT03655106|594808375|FG000|Overall Study|Lost to Follow-up|2|||
164667383|NCT03655106|594808376|FG001|Overall Study|Lost to Follow-up|1|||
164667384|NCT03655106|594808375|FG000|Overall Study|Duplicate Enrollment|1|||
164667385|NCT03655106|594808376|FG001|Overall Study|Duplicate Enrollment|1|||
164667386|NCT03655106|594808375|FG000|Overall Study|Protocol Violation|3|||
164667387|NCT03655106|594808376|FG001|Overall Study|Protocol Violation|0|||
164667388|NCT00365300|594808377|FG000|Open-label Phase|Adverse Event|4|||
164667389|NCT00365300|594808378|FG001|Open-label Phase|Adverse Event|0|||
164207191|NCT00141921|593127776|FG000|Overall Study|Noncompliance|17|||
164207192|NCT00141921|593127776|FG000|Overall Study|Disease Progression|7|||
164207193|NCT00141921|593127776|FG000|Overall Study|Protocol Deviation|7|||
164207194|NCT00141921|593127776|FG000|Overall Study|Adverse Event|5|||
164207195|NCT00141921|593127776|FG000|Overall Study|Administrative Decision|2|||
164207196|NCT00141921|593127776|FG000|Overall Study|Pregnancy|4|||
164207197|NCT00141921|593127776|FG000|Overall Study|Ineligibility Determined|2|||
164207198|NCT00141921|593127776|FG000|Overall Study|Other|8|||
164207199|NCT03320369|593127777|FG000|Overall Study|Adverse Event|1|||
164207200|NCT03320369|593127777|FG000|Overall Study|Withdrawal by Subject|2|||
164207201|NCT01461551|593127779|FG000|Overall Study|Physician Decision|2|||
164207202|NCT01461551|593127780|FG001|Overall Study|Physician Decision|1|||
164207203|NCT01461551|593127781|FG002|Overall Study|Physician Decision|2|||
164667390|NCT00365300|594808377|FG000|Open-label Phase|Failed to Return|1|||
164667391|NCT00365300|594808378|FG001|Open-label Phase|Failed to Return|0|||
164207204|NCT02326883|593127782|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
164207205|NCT02326883|593127783|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
164667392|NCT00365300|594808377|FG000|Open-label Phase|Physician Decision|1|||
164667393|NCT00365300|594808378|FG001|Open-label Phase|Physician Decision|0|||
164667394|NCT00365300|594808377|FG000|Open-label Phase|Noncompliance|9|||
164667395|NCT00365300|594808378|FG001|Open-label Phase|Noncompliance|0|||
164667396|NCT00365300|594808377|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
164667397|NCT00365300|594808378|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
164667398|NCT00365300|594808377|FG000|Open-label Phase|Protocol Violation|1|||
164667399|NCT00365300|594808378|FG001|Open-label Phase|Protocol Violation|0|||
164667400|NCT00365300|594808377|FG000|Open-label Phase|Lack of Efficacy|1|||
164667401|NCT00365300|594808378|FG001|Open-label Phase|Lack of Efficacy|0|||
164667402|NCT00365300|594808377|FG000|Open-label Phase|Patient skipped open label phase|1|||
164667403|NCT00365300|594808378|FG001|Open-label Phase|Patient skipped open label phase|0|||
164667404|NCT00365300|594808377|FG000|Double-blind Phase|Failed to return|1|||
164667405|NCT00365300|594808378|FG001|Double-blind Phase|Failed to return|0|||
164667406|NCT00365300|594808377|FG000|Double-blind Phase|Noncompliance|1|||
164667407|NCT00365300|594808378|FG001|Double-blind Phase|Noncompliance|1|||
164667408|NCT00365300|594808377|FG000|Double-blind Phase|Withdrawal by Subject|0|||
164667409|NCT00365300|594808378|FG001|Double-blind Phase|Withdrawal by Subject|1|||
164667410|NCT00365300|594808377|FG000|Double-blind Phase|Protocol Violation|3|||
164667411|NCT00365300|594808378|FG001|Double-blind Phase|Protocol Violation|1|||
164667412|NCT00365300|594808377|FG000|Double-blind Phase|Lack of Efficacy|6|||
164667413|NCT00365300|594808378|FG001|Double-blind Phase|Lack of Efficacy|6|||
164667414|NCT01029353|594808379|FG000|Overall Study|Lost to Follow-up|4|||
164667415|NCT01029353|594808380|FG001|Overall Study|Lost to Follow-up|5|||
164667416|NCT01029353|594808381|FG002|Overall Study|Lost to Follow-up|5|||
164667417|NCT01029353|594808382|FG003|Overall Study|Lost to Follow-up|4|||
164667418|NCT01029353|594808379|FG000|Overall Study|Consent Withdrawn|2|||
164667419|NCT01029353|594808380|FG001|Overall Study|Consent Withdrawn|0|||
164667420|NCT01029353|594808381|FG002|Overall Study|Consent Withdrawn|0|||
164667421|NCT01029353|594808382|FG003|Overall Study|Consent Withdrawn|0|||
164667422|NCT01029353|594808379|FG000|Overall Study|Primary Outcome Indeterminate|1|||
164667423|NCT01029353|594808380|FG001|Overall Study|Primary Outcome Indeterminate|3|||
164667424|NCT01029353|594808381|FG002|Overall Study|Primary Outcome Indeterminate|2|||
164667425|NCT01029353|594808382|FG003|Overall Study|Primary Outcome Indeterminate|0|||
164667426|NCT04538170|594808385|FG000|Overall Study|Withdrawal by Subject|104|||
164667427|NCT04538170|594808386|FG001|Overall Study|Withdrawal by Subject|210|||
164667428|NCT00274937|594808389|FG000|Overall Study|Physician Decision|10|||
164667429|NCT00274937|594808389|FG000|Overall Study|Withdrawal by Subject|6|||
164667430|NCT00274937|594808389|FG000|Overall Study|Progressive Disease|4|||
164667431|NCT02932878|594808391|FG000|Overall Study|Due to Lab Results|2|||
164667432|NCT02932878|594808392|FG001|Overall Study|Due to Lab Results|1|||
164667433|NCT01918397|594808394|FG000|Overall Study|Never started treatment|2|||
164667434|NCT01918397|594808395|FG001|Overall Study|Never started treatment|1|||
164667435|NCT01918397|594808396|FG002|Overall Study|Never started treatment|0|||
164667436|NCT01918397|594808397|FG003|Overall Study|Never started treatment|0|||
164667437|NCT01918397|594808394|FG000|Overall Study|Adverse Event|1|||
164667438|NCT01918397|594808395|FG001|Overall Study|Adverse Event|1|||
164667439|NCT01918397|594808396|FG002|Overall Study|Adverse Event|1|||
164667440|NCT01918397|594808397|FG003|Overall Study|Adverse Event|0|||
164667441|NCT01918397|594808394|FG000|Overall Study|Lack of compliance|2|||
164667442|NCT01918397|594808395|FG001|Overall Study|Lack of compliance|2|||
164667443|NCT01918397|594808396|FG002|Overall Study|Lack of compliance|3|||
164667444|NCT01918397|594808397|FG003|Overall Study|Lack of compliance|0|||
164667445|NCT01918397|594808394|FG000|Overall Study|Pregnancy|0|||
164667446|NCT01918397|594808395|FG001|Overall Study|Pregnancy|1|||
164667447|NCT01918397|594808396|FG002|Overall Study|Pregnancy|0|||
164667448|NCT01918397|594808397|FG003|Overall Study|Pregnancy|0|||
164667449|NCT01918397|594808394|FG000|Overall Study|Rifampin susceptible|0|||
164667450|NCT01918397|594808395|FG001|Overall Study|Rifampin susceptible|0|||
164667451|NCT01918397|594808396|FG002|Overall Study|Rifampin susceptible|0|||
164667452|NCT01918397|594808397|FG003|Overall Study|Rifampin susceptible|2|||
164667453|NCT01918397|594808394|FG000|Overall Study|Treatment failure|0|||
164667454|NCT01918397|594808395|FG001|Overall Study|Treatment failure|0|||
164667455|NCT01918397|594808396|FG002|Overall Study|Treatment failure|0|||
164667456|NCT01918397|594808397|FG003|Overall Study|Treatment failure|1|||
164667457|NCT01918397|594808394|FG000|Overall Study|Withdrawal by Subject|3|||
164667458|NCT01918397|594808395|FG001|Overall Study|Withdrawal by Subject|2|||
164667459|NCT01918397|594808396|FG002|Overall Study|Withdrawal by Subject|1|||
164667460|NCT01918397|594808397|FG003|Overall Study|Withdrawal by Subject|1|||
164667461|NCT01918397|594808394|FG000|Overall Study|XDR at baseline|0|||
164667462|NCT01918397|594808395|FG001|Overall Study|XDR at baseline|0|||
164667463|NCT01918397|594808396|FG002|Overall Study|XDR at baseline|1|||
164667464|NCT01918397|594808397|FG003|Overall Study|XDR at baseline|0|||
164667465|NCT01918397|594808394|FG000|Overall Study|Lost to Follow-up|2|||
164667466|NCT01918397|594808395|FG001|Overall Study|Lost to Follow-up|1|||
164667467|NCT01918397|594808396|FG002|Overall Study|Lost to Follow-up|1|||
164667468|NCT01918397|594808397|FG003|Overall Study|Lost to Follow-up|1|||
164207206|NCT02326883|593127784|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
164207207|NCT05853120|593127785|FG000|Overall Study|Lost to Follow-up|4|||
164667469|NCT01918397|594808394|FG000|Overall Study|Increased QTc|1|||
164667470|NCT01918397|594808395|FG001|Overall Study|Increased QTc|0|||
164667471|NCT01918397|594808396|FG002|Overall Study|Increased QTc|0|||
164667472|NCT01918397|594808397|FG003|Overall Study|Increased QTc|1|||
164667473|NCT01918397|594808394|FG000|Overall Study|Death|0|||
164667474|NCT01918397|594808395|FG001|Overall Study|Death|0|||
164667475|NCT01918397|594808396|FG002|Overall Study|Death|1|||
164207208|NCT05853120|593127786|FG001|Overall Study|Lost to Follow-up|4|||
164563453|NCT00797823|594431107|FG002|First Period (Initial Randomization)|Physician Decision|0|||
164563454|NCT01405053|594431108|FG000|Overall Study|Adverse Event|3|||
164563455|NCT01405053|594431109|FG001|Overall Study|Adverse Event|0|||
164563456|NCT01405053|594431108|FG000|Overall Study|Lost to Follow-up|0|||
164563457|NCT01405053|594431109|FG001|Overall Study|Lost to Follow-up|1|||
164563458|NCT01405053|594431108|FG000|Overall Study|Participant choice|2|||
164563459|NCT01405053|594431109|FG001|Overall Study|Participant choice|1|||
164563460|NCT01405053|594431108|FG000|Overall Study|Inadequate therapeutic effect|2|||
164563461|NCT01405053|594431109|FG001|Overall Study|Inadequate therapeutic effect|1|||
164563462|NCT01405053|594431108|FG000|Overall Study|Withdrawal by Subject|3|||
164563463|NCT01405053|594431109|FG001|Overall Study|Withdrawal by Subject|4|||
164563464|NCT01405053|594431108|FG000|Overall Study|Other|0|||
164563465|NCT01405053|594431109|FG001|Overall Study|Other|1|||
164563466|NCT02817087|594431110|FG000|Overall Study|Withdrawal by Subject|2|||
164563467|NCT02817087|594431111|FG001|Overall Study|Withdrawal by Subject|0|||
164563468|NCT04871711|594431112|FG000|Overall Study|Withdrawal by Subject|11|||
164563469|NCT04871711|594431113|FG001|Overall Study|Withdrawal by Subject|5|||
164563470|NCT04871711|594431112|FG000|Overall Study|Lack of Efficacy|5|||
164563471|NCT04871711|594431113|FG001|Overall Study|Lack of Efficacy|7|||
164563472|NCT04871711|594431112|FG000|Overall Study|Adverse Event|2|||
164563473|NCT04871711|594431113|FG001|Overall Study|Adverse Event|6|||
164207209|NCT05853120|593127785|FG000|Overall Study|Physician Decision|3|||
164207210|NCT05853120|593127786|FG001|Overall Study|Physician Decision|0|||
164207211|NCT05853120|593127785|FG000|Overall Study|Withdrawal by Subject|5|||
164207212|NCT05853120|593127786|FG001|Overall Study|Withdrawal by Subject|2|||
164207213|NCT00790036|593127787|FG000|Overall Study|Abnormal lab values|3|||
164207214|NCT00790036|593127788|FG001|Overall Study|Abnormal lab values|2|||
164207215|NCT00790036|593127787|FG000|Overall Study|Administrative problems|5|||
164207216|NCT00790036|593127788|FG001|Overall Study|Administrative problems|9|||
164207217|NCT00790036|593127787|FG000|Overall Study|Adverse Event|113|||
164207218|NCT00790036|593127788|FG001|Overall Study|Adverse Event|44|||
164207219|NCT00790036|593127787|FG000|Overall Study|Death|1|||
164207220|NCT00790036|593127788|FG001|Overall Study|Death|0|||
164207221|NCT00790036|593127787|FG000|Overall Study|Disease progression|24|||
164207222|NCT00790036|593127788|FG001|Overall Study|Disease progression|48|||
164207223|NCT00790036|593127787|FG000|Overall Study|Lost to Follow-up|1|||
164207224|NCT00790036|593127788|FG001|Overall Study|Lost to Follow-up|2|||
164207225|NCT00790036|593127787|FG000|Overall Study|Protocol Violation|10|||
164207226|NCT00790036|593127788|FG001|Overall Study|Protocol Violation|2|||
164207227|NCT00790036|593127787|FG000|Overall Study|Withdrawal by Subject|18|||
164207228|NCT00790036|593127788|FG001|Overall Study|Withdrawal by Subject|7|||
164207229|NCT00790036|593127787|FG000|Overall Study|Subject/guardian decision|20|||
164207230|NCT00790036|593127788|FG001|Overall Study|Subject/guardian decision|7|||
164207231|NCT04428151|593127791|FG000|Overall Study|Death|100|||
164207232|NCT04428151|593127792|FG001|Overall Study|Death|86|||
164207233|NCT04428151|593127793|FG002|Overall Study|Death|57|||
164207234|NCT04428151|593127791|FG000|Overall Study|Lost to Follow-up|1|||
164207235|NCT04428151|593127792|FG001|Overall Study|Lost to Follow-up|1|||
164207236|NCT04428151|593127793|FG002|Overall Study|Lost to Follow-up|0|||
164207237|NCT04428151|593127791|FG000|Overall Study|Withdrawal by Subject|2|||
164207238|NCT04428151|593127792|FG001|Overall Study|Withdrawal by Subject|2|||
164207239|NCT04428151|593127793|FG002|Overall Study|Withdrawal by Subject|3|||
164207240|NCT04428151|593127791|FG000|Overall Study|Participant Ongoing in Study|41|||
164207241|NCT04428151|593127792|FG001|Overall Study|Participant Ongoing in Study|53|||
164207242|NCT04428151|593127793|FG002|Overall Study|Participant Ongoing in Study|28|||
164207243|NCT02187783|593127794|FG000|Overall Study|Adverse Event|8|||
164207244|NCT02187783|593127794|FG000|Overall Study|Death|3|||
164207245|NCT02187783|593127794|FG000|Overall Study|Progressive disease|80|||
164207246|NCT02187783|593127794|FG000|Overall Study|Protocol Violation|3|||
164207247|NCT02187783|593127794|FG000|Overall Study|Physician Decision|2|||
164207248|NCT02187783|593127794|FG000|Overall Study|Withdrawal by Subject|9|||
164207249|NCT02187783|593127794|FG000|Overall Study|Study terminated by sponsor|1|||
164207250|NCT00171249|593127795|FG000|Overall Study|Withdrawal by Subject|2|||
164420648|NCT01154036|593910963|FG001|Phase I|Withdrawal by Subject|10|||
164207251|NCT00171249|593127796|FG001|Overall Study|Withdrawal by Subject|0|||
164207252|NCT00171249|593127797|FG002|Overall Study|Withdrawal by Subject|0|||
164207253|NCT00171249|593127798|FG003|Overall Study|Withdrawal by Subject|6|||
164207254|NCT00171249|593127799|FG004|Overall Study|Withdrawal by Subject|0|||
164207255|NCT00171249|593127800|FG005|Overall Study|Withdrawal by Subject|0|||
164207256|NCT00171249|593127801|FG006|Overall Study|Withdrawal by Subject|0|||
164207257|NCT00171249|593127795|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
164207258|NCT00171249|593127796|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
164563474|NCT04871711|594431112|FG000|Overall Study|Various reasons|2|||
164563475|NCT04871711|594431113|FG001|Overall Study|Various reasons|1|||
164563476|NCT04871711|594431112|FG000|Overall Study|Lost to Follow-up|0|||
164563477|NCT04871711|594431113|FG001|Overall Study|Lost to Follow-up|2|||
164667476|NCT01918397|594808397|FG003|Overall Study|Death|0|||
164667477|NCT01918397|594808394|FG000|Overall Study|Involved in another investigative trial|0|||
164207259|NCT00171249|593127797|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
164207260|NCT00171249|593127798|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
164207261|NCT00171249|593127799|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
164207262|NCT00171249|593127800|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
164207263|NCT00171249|593127801|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
164207264|NCT00171249|593127795|FG000|Overall Study|Death|7|||
164207265|NCT00171249|593127796|FG001|Overall Study|Death|1|||
164207266|NCT00171249|593127797|FG002|Overall Study|Death|0|||
164207267|NCT00171249|593127798|FG003|Overall Study|Death|4|||
164207268|NCT00171249|593127799|FG004|Overall Study|Death|0|||
164207269|NCT00171249|593127800|FG005|Overall Study|Death|3|||
164207270|NCT00171249|593127801|FG006|Overall Study|Death|1|||
164207271|NCT00171249|593127795|FG000|Overall Study|Other|10|||
164207272|NCT00171249|593127796|FG001|Overall Study|Other|0|||
164207273|NCT00171249|593127797|FG002|Overall Study|Other|0|||
164207274|NCT00171249|593127798|FG003|Overall Study|Other|43|||
164207275|NCT00171249|593127799|FG004|Overall Study|Other|0|||
164207276|NCT00171249|593127800|FG005|Overall Study|Other|2|||
164207277|NCT00171249|593127801|FG006|Overall Study|Other|0|||
164207278|NCT00171249|593127795|FG000|Overall Study|No Longer Requires Study Drug|4|||
164207279|NCT00171249|593127796|FG001|Overall Study|No Longer Requires Study Drug|0|||
164207280|NCT00171249|593127797|FG002|Overall Study|No Longer Requires Study Drug|0|||
164207281|NCT00171249|593127798|FG003|Overall Study|No Longer Requires Study Drug|3|||
164207282|NCT00171249|593127799|FG004|Overall Study|No Longer Requires Study Drug|0|||
164207283|NCT00171249|593127800|FG005|Overall Study|No Longer Requires Study Drug|5|||
164207284|NCT00171249|593127801|FG006|Overall Study|No Longer Requires Study Drug|0|||
164207285|NCT00171249|593127795|FG000|Overall Study|Administrative Problems|1|||
164207286|NCT00171249|593127796|FG001|Overall Study|Administrative Problems|0|||
164207287|NCT00171249|593127797|FG002|Overall Study|Administrative Problems|0|||
164207288|NCT00171249|593127798|FG003|Overall Study|Administrative Problems|2|||
164207289|NCT00171249|593127799|FG004|Overall Study|Administrative Problems|0|||
164207290|NCT00171249|593127800|FG005|Overall Study|Administrative Problems|0|||
164207291|NCT00171249|593127801|FG006|Overall Study|Administrative Problems|0|||
164207292|NCT00171249|593127795|FG000|Overall Study|Adverse Event|3|||
164207293|NCT00171249|593127796|FG001|Overall Study|Adverse Event|1|||
164207294|NCT00171249|593127797|FG002|Overall Study|Adverse Event|0|||
164207295|NCT00171249|593127798|FG003|Overall Study|Adverse Event|15|||
164207296|NCT00171249|593127799|FG004|Overall Study|Adverse Event|0|||
164207297|NCT00171249|593127800|FG005|Overall Study|Adverse Event|2|||
164207298|NCT00171249|593127801|FG006|Overall Study|Adverse Event|0|||
164207299|NCT00171249|593127795|FG000|Overall Study|Lost to Follow-up|5|||
164207300|NCT00171249|593127796|FG001|Overall Study|Lost to Follow-up|0|||
164207301|NCT00171249|593127797|FG002|Overall Study|Lost to Follow-up|0|||
164207302|NCT00171249|593127798|FG003|Overall Study|Lost to Follow-up|9|||
164207303|NCT00171249|593127799|FG004|Overall Study|Lost to Follow-up|0|||
164207304|NCT00171249|593127800|FG005|Overall Study|Lost to Follow-up|0|||
164207305|NCT00171249|593127801|FG006|Overall Study|Lost to Follow-up|0|||
164207306|NCT00392223|593127802|FG000|Overall Study|Adverse Event|5|||
164207307|NCT00392223|593127803|FG001|Overall Study|Adverse Event|4|||
164207308|NCT00392223|593127802|FG000|Overall Study|Lost to Follow-up|1|||
164207309|NCT00392223|593127803|FG001|Overall Study|Lost to Follow-up|4|||
164207310|NCT00392223|593127802|FG000|Overall Study|Protocol Violation|0|||
164207311|NCT00392223|593127803|FG001|Overall Study|Protocol Violation|3|||
164207312|NCT00392223|593127802|FG000|Overall Study|Withdrawal by Subject|3|||
164207313|NCT00392223|593127803|FG001|Overall Study|Withdrawal by Subject|2|||
164207314|NCT02792504|593127809|FG000|Overall Study|Lost to Follow-up|24|||
164207315|NCT02792504|593127809|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
164207316|NCT01114724|593127816|FG000|Overall Study|Death|8|||
164207317|NCT01114724|593127816|FG000|Overall Study|Lost to Follow-up|1|||
164207318|NCT01114724|593127816|FG000|Overall Study|Withdrawal by Subject|1|||
164207319|NCT02814526|593127817|FG000|Overall Study|Adverse Event|4|||
164207320|NCT02814526|593127818|FG001|Overall Study|Adverse Event|3|||
164207321|NCT02814526|593127817|FG000|Overall Study|Death|1|||
164207322|NCT02814526|593127818|FG001|Overall Study|Death|1|||
164207323|NCT02814526|593127817|FG000|Overall Study|Lost to Follow-up|3|||
164207324|NCT02814526|593127818|FG001|Overall Study|Lost to Follow-up|4|||
164207325|NCT02814526|593127817|FG000|Overall Study|non site physician decision|1|||
164207326|NCT02814526|593127818|FG001|Overall Study|non site physician decision|0|||
164207327|NCT02814526|593127817|FG000|Overall Study|participant noncompliance|1|||
164207328|NCT02814526|593127818|FG001|Overall Study|participant noncompliance|1|||
164667478|NCT01918397|594808395|FG001|Overall Study|Involved in another investigative trial|0|||
164207329|NCT02814526|593127817|FG000|Overall Study|Withdrawal by Subject|20|||
164207330|NCT02814526|593127818|FG001|Overall Study|Withdrawal by Subject|14|||
164207331|NCT02814526|593127817|FG000|Overall Study|safety risk|2|||
164207332|NCT02814526|593127818|FG001|Overall Study|safety risk|1|||
164207333|NCT02814526|593127817|FG000|Overall Study|early termination-study terminated|1|||
164320638|NCT01917656|593550210|FG001|Overall Study|Withdrawal by Subject|3|||
164320639|NCT01917656|593550209|FG000|Overall Study|Lost to Follow-up|3|||
164320640|NCT01917656|593550210|FG001|Overall Study|Lost to Follow-up|4|||
164320641|NCT02285062|593550211|FG000|Pre-Treatment Period|Protocol Violation|0|||
164320642|NCT02285062|593550212|FG001|Pre-Treatment Period|Protocol Violation|2|||
164320643|NCT02285062|593550211|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
164320644|NCT02285062|593550212|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
164320645|NCT00436501|593550213|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
164320646|NCT00436501|593550214|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
164320647|NCT00436501|593550213|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
164320648|NCT00436501|593550214|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
164320649|NCT03011892|593550227|FG000|Double Blind (DB) Period|Adverse Event|0|||
164320650|NCT03011892|593550228|FG001|Double Blind (DB) Period|Adverse Event|1|||
164320651|NCT03011892|593550229|FG002|Double Blind (DB) Period|Adverse Event|1|||
164320652|NCT03011892|593550230|FG003|Double Blind (DB) Period|Adverse Event|0|||
164320653|NCT03011892|593550231|FG004|Double Blind (DB) Period|Adverse Event|0|||
164320654|NCT03011892|593550232|FG005|Double Blind (DB) Period|Adverse Event|0|||
164320655|NCT03011892|593550233|FG006|Double Blind (DB) Period|Adverse Event|0|||
164320656|NCT03011892|593550234|FG007|Double Blind (DB) Period|Adverse Event|0|||
164320657|NCT03011892|593550235|FG008|Double Blind (DB) Period|Adverse Event|0|||
164320658|NCT03011892|593550236|FG009|Double Blind (DB) Period|Adverse Event|0|||
164320659|NCT03011892|593550237|FG010|Double Blind (DB) Period|Adverse Event|0|||
164320660|NCT03011892|593550238|FG011|Double Blind (DB) Period|Adverse Event|0|||
164320661|NCT03011892|593550227|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
164320662|NCT03011892|593550228|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
164320663|NCT03011892|593550229|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
164320664|NCT03011892|593550230|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
164320665|NCT03011892|593550231|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
164320666|NCT03011892|593550232|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
164320667|NCT03011892|593550233|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
164320668|NCT03011892|593550234|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
164320669|NCT03011892|593550235|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
164320670|NCT03011892|593550236|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
164320671|NCT03011892|593550237|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
164320672|NCT03011892|593550238|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
164320673|NCT03011892|593550227|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
164320674|NCT03011892|593550228|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
164320675|NCT03011892|593550229|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
164320676|NCT03011892|593550230|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
164320677|NCT03011892|593550231|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
164320678|NCT03011892|593550232|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
164320679|NCT03011892|593550233|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
164320680|NCT03011892|593550234|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
164320681|NCT03011892|593550235|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
164320682|NCT03011892|593550236|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
164320683|NCT03011892|593550237|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
164320684|NCT03011892|593550238|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
164320685|NCT03011892|593550227|FG000|Double Blind (DB) Period|Other|1|||
164320686|NCT03011892|593550228|FG001|Double Blind (DB) Period|Other|1|||
164320687|NCT03011892|593550229|FG002|Double Blind (DB) Period|Other|1|||
164320688|NCT03011892|593550230|FG003|Double Blind (DB) Period|Other|0|||
164320689|NCT03011892|593550231|FG004|Double Blind (DB) Period|Other|1|||
164320690|NCT03011892|593550232|FG005|Double Blind (DB) Period|Other|0|||
164320691|NCT03011892|593550233|FG006|Double Blind (DB) Period|Other|0|||
164320692|NCT03011892|593550234|FG007|Double Blind (DB) Period|Other|0|||
164320693|NCT03011892|593550235|FG008|Double Blind (DB) Period|Other|0|||
164320694|NCT03011892|593550236|FG009|Double Blind (DB) Period|Other|0|||
164320695|NCT03011892|593550237|FG010|Double Blind (DB) Period|Other|0|||
164320696|NCT03011892|593550238|FG011|Double Blind (DB) Period|Other|0|||
164320697|NCT03011892|593550227|FG000|Double Blind (DB) Period|Physician Decision|1|||
164320698|NCT03011892|593550228|FG001|Double Blind (DB) Period|Physician Decision|0|||
164320699|NCT03011892|593550229|FG002|Double Blind (DB) Period|Physician Decision|1|||
164420649|NCT01154036|593910964|FG002|Phase I|Withdrawal by Subject|29|||
164667479|NCT01918397|594808396|FG002|Overall Study|Involved in another investigative trial|0|||
164667480|NCT01918397|594808397|FG003|Overall Study|Involved in another investigative trial|1|||
164667481|NCT00849901|594808404|FG000|Acute Treatment Phase|Adverse Event|9|||
164320700|NCT03011892|593550230|FG003|Double Blind (DB) Period|Physician Decision|0|||
164320701|NCT03011892|593550231|FG004|Double Blind (DB) Period|Physician Decision|0|||
164320702|NCT03011892|593550232|FG005|Double Blind (DB) Period|Physician Decision|0|||
164320703|NCT03011892|593550233|FG006|Double Blind (DB) Period|Physician Decision|0|||
164320704|NCT03011892|593550234|FG007|Double Blind (DB) Period|Physician Decision|0|||
164320705|NCT03011892|593550235|FG008|Double Blind (DB) Period|Physician Decision|0|||
164320706|NCT03011892|593550236|FG009|Double Blind (DB) Period|Physician Decision|0|||
164420650|NCT01154036|593910965|FG003|Phase I|Withdrawal by Subject|0|||
164207334|NCT02814526|593127818|FG001|Overall Study|early termination-study terminated|2|||
164207335|NCT02814526|593127817|FG000|Overall Study|Other|0|||
164207336|NCT02814526|593127818|FG001|Overall Study|Other|4|||
164207337|NCT06178991|593127821|FG000|Overall Study|Withdrawal by Subject|2|||
164207338|NCT06178991|593127822|FG001|Overall Study|Withdrawal by Subject|6|||
164207339|NCT06178991|593127823|FG002|Overall Study|Withdrawal by Subject|44|||
164207340|NCT06178991|593127824|FG003|Overall Study|Withdrawal by Subject|23|||
164207341|NCT06178991|593127825|FG004|Overall Study|Withdrawal by Subject|7|||
164207342|NCT06178991|593127826|FG005|Overall Study|Withdrawal by Subject|7|||
164207343|NCT06178991|593127827|FG006|Overall Study|Withdrawal by Subject|7|||
164207344|NCT06178991|593127828|FG007|Overall Study|Withdrawal by Subject|5|||
164207345|NCT06178991|593127821|FG000|Overall Study|Lost to Follow-up|2|||
164207346|NCT06178991|593127822|FG001|Overall Study|Lost to Follow-up|4|||
164207347|NCT06178991|593127823|FG002|Overall Study|Lost to Follow-up|133|||
164207348|NCT06178991|593127824|FG003|Overall Study|Lost to Follow-up|65|||
164207349|NCT06178991|593127825|FG004|Overall Study|Lost to Follow-up|68|||
164207350|NCT06178991|593127826|FG005|Overall Study|Lost to Follow-up|57|||
164207351|NCT06178991|593127827|FG006|Overall Study|Lost to Follow-up|25|||
164207352|NCT06178991|593127828|FG007|Overall Study|Lost to Follow-up|18|||
164207353|NCT06178991|593127821|FG000|Overall Study|Death|1|||
164207354|NCT06178991|593127822|FG001|Overall Study|Death|0|||
164207355|NCT06178991|593127823|FG002|Overall Study|Death|2|||
164207356|NCT06178991|593127824|FG003|Overall Study|Death|1|||
164207357|NCT06178991|593127825|FG004|Overall Study|Death|1|||
164207358|NCT06178991|593127826|FG005|Overall Study|Death|0|||
164207359|NCT06178991|593127827|FG006|Overall Study|Death|1|||
164207360|NCT06178991|593127828|FG007|Overall Study|Death|1|||
164207361|NCT06178991|593127821|FG000|Overall Study|Randomized but not Vaccinated|4|||
164207362|NCT06178991|593127822|FG001|Overall Study|Randomized but not Vaccinated|1|||
164207363|NCT06178991|593127823|FG002|Overall Study|Randomized but not Vaccinated|15|||
164207364|NCT06178991|593127824|FG003|Overall Study|Randomized but not Vaccinated|9|||
164207365|NCT06178991|593127825|FG004|Overall Study|Randomized but not Vaccinated|8|||
164207366|NCT06178991|593127826|FG005|Overall Study|Randomized but not Vaccinated|4|||
164207367|NCT06178991|593127827|FG006|Overall Study|Randomized but not Vaccinated|2|||
164207368|NCT06178991|593127828|FG007|Overall Study|Randomized but not Vaccinated|2|||
164207369|NCT06178991|593127821|FG000|Overall Study|Other: Unspecified|0|||
164207370|NCT06178991|593127822|FG001|Overall Study|Other: Unspecified|1|||
164207371|NCT06178991|593127823|FG002|Overall Study|Other: Unspecified|7|||
164207372|NCT06178991|593127824|FG003|Overall Study|Other: Unspecified|6|||
164207373|NCT06178991|593127825|FG004|Overall Study|Other: Unspecified|1|||
164207374|NCT06178991|593127826|FG005|Overall Study|Other: Unspecified|1|||
164207375|NCT06178991|593127827|FG006|Overall Study|Other: Unspecified|1|||
164207376|NCT06178991|593127828|FG007|Overall Study|Other: Unspecified|0|||
164207377|NCT06178991|593127821|FG000|Overall Study|Physician Decision|0|||
164207378|NCT06178991|593127822|FG001|Overall Study|Physician Decision|0|||
164207379|NCT06178991|593127823|FG002|Overall Study|Physician Decision|2|||
164207380|NCT06178991|593127824|FG003|Overall Study|Physician Decision|0|||
164207381|NCT06178991|593127825|FG004|Overall Study|Physician Decision|2|||
164207382|NCT06178991|593127826|FG005|Overall Study|Physician Decision|1|||
164207383|NCT06178991|593127827|FG006|Overall Study|Physician Decision|0|||
164207384|NCT06178991|593127828|FG007|Overall Study|Physician Decision|0|||
164207385|NCT06178991|593127821|FG000|Overall Study|Protocol Violation|0|||
164207386|NCT06178991|593127822|FG001|Overall Study|Protocol Violation|0|||
164207387|NCT06178991|593127823|FG002|Overall Study|Protocol Violation|1|||
164207388|NCT06178991|593127824|FG003|Overall Study|Protocol Violation|0|||
164207389|NCT06178991|593127825|FG004|Overall Study|Protocol Violation|0|||
164207390|NCT06178991|593127826|FG005|Overall Study|Protocol Violation|0|||
164207391|NCT06178991|593127827|FG006|Overall Study|Protocol Violation|0|||
164207392|NCT06178991|593127828|FG007|Overall Study|Protocol Violation|0|||
164207393|NCT03415178|593127831|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
164207394|NCT03415178|593127832|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
164207395|NCT03415178|593127831|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
164207396|NCT03415178|593127832|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
164207397|NCT02485860|593127834|FG000|Overall Study|Lost to Follow-up|4|||
164207398|NCT02485860|593127835|FG001|Overall Study|Lost to Follow-up|1|||
164207399|NCT02485860|593127834|FG000|Overall Study|Physician Decision|1|||
164207400|NCT02485860|593127835|FG001|Overall Study|Physician Decision|2|||
164207401|NCT02485860|593127834|FG000|Overall Study|Health context (COVID-19)|1|||
164207402|NCT02485860|593127835|FG001|Overall Study|Health context (COVID-19)|0|||
164207403|NCT02273167|593127838|FG000|Overall Study|Adverse Event|1|||
164207404|NCT02273167|593127839|FG001|Overall Study|Adverse Event|0|||
164207405|NCT02273167|593127840|FG002|Overall Study|Adverse Event|0|||
164207406|NCT02273167|593127838|FG000|Overall Study|Protocol Violation|3|||
164207407|NCT02273167|593127839|FG001|Overall Study|Protocol Violation|1|||
164207408|NCT02273167|593127840|FG002|Overall Study|Protocol Violation|1|||
164207409|NCT02273167|593127838|FG000|Overall Study|Lost to Follow-up|0|||
164207410|NCT02273167|593127839|FG001|Overall Study|Lost to Follow-up|1|||
164207411|NCT02273167|593127840|FG002|Overall Study|Lost to Follow-up|1|||
164207412|NCT02273167|593127838|FG000|Overall Study|Withdrawal by Subject|10|||
164320707|NCT03011892|593550237|FG010|Double Blind (DB) Period|Physician Decision|0|||
164320708|NCT03011892|593550238|FG011|Double Blind (DB) Period|Physician Decision|0|||
164320709|NCT03011892|593550227|FG000|Double Blind (DB) Period|Pregnancy|0|||
164320710|NCT03011892|593550228|FG001|Double Blind (DB) Period|Pregnancy|0|||
164320711|NCT03011892|593550229|FG002|Double Blind (DB) Period|Pregnancy|0|||
164320712|NCT03011892|593550230|FG003|Double Blind (DB) Period|Pregnancy|0|||
164320713|NCT03011892|593550231|FG004|Double Blind (DB) Period|Pregnancy|1|||
164320714|NCT03011892|593550232|FG005|Double Blind (DB) Period|Pregnancy|0|||
164320715|NCT03011892|593550233|FG006|Double Blind (DB) Period|Pregnancy|0|||
164320716|NCT03011892|593550234|FG007|Double Blind (DB) Period|Pregnancy|0|||
164320717|NCT03011892|593550235|FG008|Double Blind (DB) Period|Pregnancy|0|||
164320718|NCT03011892|593550236|FG009|Double Blind (DB) Period|Pregnancy|0|||
164320719|NCT03011892|593550237|FG010|Double Blind (DB) Period|Pregnancy|0|||
164320720|NCT03011892|593550238|FG011|Double Blind (DB) Period|Pregnancy|0|||
164320721|NCT03011892|593550227|FG000|Double Blind (DB) Period|Protocol Violation|1|||
164320722|NCT03011892|593550228|FG001|Double Blind (DB) Period|Protocol Violation|0|||
164320723|NCT03011892|593550229|FG002|Double Blind (DB) Period|Protocol Violation|0|||
164320724|NCT03011892|593550230|FG003|Double Blind (DB) Period|Protocol Violation|0|||
164320725|NCT03011892|593550231|FG004|Double Blind (DB) Period|Protocol Violation|0|||
164320726|NCT03011892|593550232|FG005|Double Blind (DB) Period|Protocol Violation|0|||
164320727|NCT03011892|593550233|FG006|Double Blind (DB) Period|Protocol Violation|0|||
164320728|NCT03011892|593550234|FG007|Double Blind (DB) Period|Protocol Violation|0|||
164320729|NCT03011892|593550235|FG008|Double Blind (DB) Period|Protocol Violation|0|||
164320730|NCT03011892|593550236|FG009|Double Blind (DB) Period|Protocol Violation|0|||
164320731|NCT03011892|593550237|FG010|Double Blind (DB) Period|Protocol Violation|0|||
164320732|NCT03011892|593550238|FG011|Double Blind (DB) Period|Protocol Violation|0|||
164320733|NCT03011892|593550227|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
164320734|NCT03011892|593550228|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
164320735|NCT03011892|593550229|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
164320736|NCT03011892|593550230|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
164320737|NCT03011892|593550231|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
164320738|NCT03011892|593550232|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
164320739|NCT03011892|593550233|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
164320740|NCT03011892|593550234|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
164320741|NCT03011892|593550235|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
164320742|NCT03011892|593550236|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
164320743|NCT03011892|593550237|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
164320744|NCT03011892|593550238|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
164320745|NCT03011892|593550227|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
164320746|NCT03011892|593550228|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
164320747|NCT03011892|593550229|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
164320748|NCT03011892|593550230|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
164320749|NCT03011892|593550231|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
164320750|NCT03011892|593550232|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
164320751|NCT03011892|593550233|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
164320752|NCT03011892|593550234|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
164320753|NCT03011892|593550235|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
164320754|NCT03011892|593550236|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
164320755|NCT03011892|593550237|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
164320756|NCT03011892|593550238|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
164320757|NCT03011892|593550227|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
164320758|NCT03011892|593550228|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
164320759|NCT03011892|593550229|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
164563478|NCT01665144|594431114|FG000|Core Part|Withdrawal by Subject|96|||
164563479|NCT01665144|594431115|FG001|Core Part|Withdrawal by Subject|77|||
164563480|NCT01665144|594431116|FG002|Core Part|Withdrawal by Subject|0|||
164563481|NCT01665144|594431114|FG000|Core Part|Adverse Event|45|||
164563482|NCT01665144|594431115|FG001|Core Part|Adverse Event|18|||
164563483|NCT01665144|594431116|FG002|Core Part|Adverse Event|0|||
164563484|NCT01665144|594431114|FG000|Core Part|Lack of Efficacy|16|||
164563485|NCT01665144|594431115|FG001|Core Part|Lack of Efficacy|11|||
164320760|NCT03011892|593550230|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
164320761|NCT03011892|593550231|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
164563486|NCT01665144|594431116|FG002|Core Part|Lack of Efficacy|0|||
164563487|NCT01665144|594431114|FG000|Core Part|Lost to Follow-up|9|||
164563488|NCT01665144|594431115|FG001|Core Part|Lost to Follow-up|8|||
164563489|NCT01665144|594431116|FG002|Core Part|Lost to Follow-up|0|||
164563490|NCT01665144|594431114|FG000|Core Part|Physician Decision|13|||
164563491|NCT01665144|594431115|FG001|Core Part|Physician Decision|1|||
164563492|NCT01665144|594431116|FG002|Core Part|Physician Decision|0|||
164563493|NCT01665144|594431114|FG000|Core Part|Progressive disease|8|||
164563494|NCT01665144|594431115|FG001|Core Part|Progressive disease|4|||
164563495|NCT01665144|594431116|FG002|Core Part|Progressive disease|0|||
164320762|NCT03011892|593550232|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
164320763|NCT03011892|593550233|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
164320764|NCT03011892|593550234|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
164320765|NCT03011892|593550235|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
164320766|NCT03011892|593550236|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
164320767|NCT03011892|593550237|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
164320768|NCT03011892|593550238|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
164320769|NCT03011892|593550227|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
164320770|NCT03011892|593550228|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
164320771|NCT03011892|593550229|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
164320772|NCT03011892|593550230|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
164320773|NCT03011892|593550231|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
164320774|NCT03011892|593550232|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
164320775|NCT03011892|593550233|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
164320776|NCT03011892|593550234|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
164320777|NCT03011892|593550235|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
164320778|NCT03011892|593550236|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
164320779|NCT03011892|593550237|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
164320780|NCT03011892|593550238|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
164320781|NCT03011892|593550227|FG000|Open Label (OL) Period|Reason not specified|0|||
164320782|NCT03011892|593550228|FG001|Open Label (OL) Period|Reason not specified|0|||
164320783|NCT03011892|593550229|FG002|Open Label (OL) Period|Reason not specified|0|||
164320784|NCT03011892|593550230|FG003|Open Label (OL) Period|Reason not specified|0|||
164320785|NCT03011892|593550231|FG004|Open Label (OL) Period|Reason not specified|0|||
164320786|NCT03011892|593550232|FG005|Open Label (OL) Period|Reason not specified|0|||
164320787|NCT03011892|593550233|FG006|Open Label (OL) Period|Reason not specified|0|||
164320788|NCT03011892|593550234|FG007|Open Label (OL) Period|Reason not specified|1|||
164320789|NCT03011892|593550235|FG008|Open Label (OL) Period|Reason not specified|0|||
164320790|NCT03011892|593550236|FG009|Open Label (OL) Period|Reason not specified|0|||
164320791|NCT03011892|593550237|FG010|Open Label (OL) Period|Reason not specified|0|||
164320792|NCT03011892|593550238|FG011|Open Label (OL) Period|Reason not specified|0|||
164320793|NCT00608569|593550239|FG000|Overall Study|Death|4|||
164320794|NCT00608569|593550240|FG001|Overall Study|Death|3|||
164320795|NCT00608569|593550239|FG000|Overall Study|Lost to Follow-up|4|||
164320796|NCT00608569|593550240|FG001|Overall Study|Lost to Follow-up|5|||
164320797|NCT00608569|593550239|FG000|Overall Study|Withdrawal by Subject|1|||
164320798|NCT00608569|593550240|FG001|Overall Study|Withdrawal by Subject|0|||
164320799|NCT00608569|593550239|FG000|Overall Study|Adverse Event|1|||
164563496|NCT01665144|594431114|FG000|Core Part|Non-compliance with study treatment|5|||
164563497|NCT01665144|594431115|FG001|Core Part|Non-compliance with study treatment|0|||
164563498|NCT01665144|594431116|FG002|Core Part|Non-compliance with study treatment|0|||
164563499|NCT01665144|594431114|FG000|Core Part|Death|3|||
164563500|NCT01665144|594431115|FG001|Core Part|Death|1|||
164563501|NCT01665144|594431116|FG002|Core Part|Death|0|||
164563502|NCT01665144|594431114|FG000|Core Part|Protocol deviation|3|||
164563503|NCT01665144|594431115|FG001|Core Part|Protocol deviation|1|||
164563504|NCT01665144|594431116|FG002|Core Part|Protocol deviation|0|||
164563505|NCT01665144|594431114|FG000|Core Part|New therapy for study indication|2|||
164563506|NCT01665144|594431115|FG001|Core Part|New therapy for study indication|1|||
164563507|NCT01665144|594431116|FG002|Core Part|New therapy for study indication|0|||
164563508|NCT01665144|594431114|FG000|Core Part|Technical problems|2|||
164207413|NCT02273167|593127839|FG001|Overall Study|Withdrawal by Subject|12|||
164207414|NCT02273167|593127840|FG002|Overall Study|Withdrawal by Subject|11|||
164207415|NCT02273167|593127838|FG000|Overall Study|Various|10|||
164207416|NCT02273167|593127839|FG001|Overall Study|Various|9|||
164207417|NCT02273167|593127840|FG002|Overall Study|Various|8|||
164207418|NCT03082729|593127841|FG000|Overall Study|Lost to Follow-up|7|||
164207419|NCT03082729|593127841|FG000|Overall Study|Physician Decision|2|||
164207420|NCT03082729|593127841|FG000|Overall Study|Withdrawal by Subject|1|||
164207421|NCT03082729|593127841|FG000|Overall Study|Lack of Efficacy|9|||
164207422|NCT03082729|593127841|FG000|Overall Study|Adverse Event|4|||
164207423|NCT03082729|593127841|FG000|Overall Study|Protocol Violation|6|||
164207424|NCT03082729|593127841|FG000|Overall Study|Fear of study procedure|1|||
164207425|NCT03082729|593127841|FG000|Overall Study|Scheduling conflict|1|||
164207426|NCT01416571|593127845|FG000|Overall Study|Lost to Follow-up|2|||
164207427|NCT03608163|593127846|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
164207428|NCT03608163|593127847|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
164207429|NCT03353220|593127853|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
164207430|NCT03353220|593127854|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
164207431|NCT03586479|593127855|FG000|Overall Study|Treatment schedule disrupted during pandemic|4|||
164563509|NCT01665144|594431115|FG001|Core Part|Technical problems|0|||
164207432|NCT03586479|593127856|FG001|Overall Study|Treatment schedule disrupted during pandemic|2|||
164320800|NCT00608569|593550240|FG001|Overall Study|Adverse Event|0|||
164563510|NCT01665144|594431116|FG002|Core Part|Technical problems|0|||
164207433|NCT03586479|593127857|FG002|Overall Study|Treatment schedule disrupted during pandemic|2|||
164207434|NCT03586479|593127855|FG000|Overall Study|Protocol Violation|2|||
164207435|NCT03586479|593127856|FG001|Overall Study|Protocol Violation|0|||
164207436|NCT03586479|593127857|FG002|Overall Study|Protocol Violation|0|||
164207437|NCT03586479|593127855|FG000|Overall Study|Lost to Follow-up|1|||
164207438|NCT03586479|593127856|FG001|Overall Study|Lost to Follow-up|1|||
164207439|NCT03586479|593127857|FG002|Overall Study|Lost to Follow-up|2|||
164207440|NCT03586479|593127855|FG000|Overall Study|Behavioral Issues|1|||
164563511|NCT01665144|594431114|FG000|Extension Part|Patient/guardian decision|180|||
164563512|NCT01665144|594431115|FG001|Extension Part|Patient/guardian decision|0|||
164563513|NCT01665144|594431116|FG002|Extension Part|Patient/guardian decision|98|||
164563514|NCT01665144|594431114|FG000|Extension Part|Adverse Event|104|||
164563515|NCT01665144|594431115|FG001|Extension Part|Adverse Event|0|||
164207441|NCT03586479|593127856|FG001|Overall Study|Behavioral Issues|0|||
164207442|NCT03586479|593127857|FG002|Overall Study|Behavioral Issues|0|||
164207443|NCT01799889|593129805|FG000|Overall Study|Adverse Event|4|||
164207444|NCT01799889|593129806|FG001|Overall Study|Adverse Event|4|||
164207445|NCT01799889|593129807|FG002|Overall Study|Adverse Event|5|||
164207446|NCT01799889|593129808|FG003|Overall Study|Adverse Event|1|||
164207447|NCT01799889|593129809|FG004|Overall Study|Adverse Event|11|||
164207448|NCT01799889|593129810|FG005|Overall Study|Adverse Event|1|||
164207449|NCT01799889|593129811|FG006|Overall Study|Adverse Event|5|||
164207450|NCT01799889|593129812|FG007|Overall Study|Adverse Event|2|||
164207451|NCT01799889|593129813|FG008|Overall Study|Adverse Event|3|||
164207452|NCT01799889|593129814|FG009|Overall Study|Adverse Event|1|||
164207453|NCT01799889|593129815|FG010|Overall Study|Adverse Event|1|||
164207454|NCT01799889|593129816|FG011|Overall Study|Adverse Event|0|||
164207455|NCT01799889|593129805|FG000|Overall Study|Death|1|||
164207456|NCT01799889|593129806|FG001|Overall Study|Death|0|||
164207457|NCT01799889|593129807|FG002|Overall Study|Death|5|||
164207458|NCT01799889|593129808|FG003|Overall Study|Death|3|||
164207459|NCT01799889|593129809|FG004|Overall Study|Death|1|||
164207460|NCT01799889|593129810|FG005|Overall Study|Death|0|||
164207461|NCT01799889|593129811|FG006|Overall Study|Death|0|||
164207462|NCT01799889|593129812|FG007|Overall Study|Death|0|||
164207463|NCT01799889|593129813|FG008|Overall Study|Death|1|||
164207464|NCT01799889|593129814|FG009|Overall Study|Death|0|||
164207465|NCT01799889|593129815|FG010|Overall Study|Death|1|||
164207466|NCT01799889|593129816|FG011|Overall Study|Death|0|||
164207467|NCT01799889|593129805|FG000|Overall Study|Lack of Efficacy|1|||
164207468|NCT01799889|593129806|FG001|Overall Study|Lack of Efficacy|1|||
164207469|NCT01799889|593129807|FG002|Overall Study|Lack of Efficacy|0|||
164207470|NCT01799889|593129808|FG003|Overall Study|Lack of Efficacy|1|||
164207471|NCT01799889|593129809|FG004|Overall Study|Lack of Efficacy|2|||
164207472|NCT01799889|593129810|FG005|Overall Study|Lack of Efficacy|2|||
164207473|NCT01799889|593129811|FG006|Overall Study|Lack of Efficacy|0|||
164207474|NCT01799889|593129812|FG007|Overall Study|Lack of Efficacy|0|||
164207475|NCT01799889|593129813|FG008|Overall Study|Lack of Efficacy|2|||
164207476|NCT01799889|593129814|FG009|Overall Study|Lack of Efficacy|0|||
164207477|NCT01799889|593129815|FG010|Overall Study|Lack of Efficacy|1|||
164207478|NCT01799889|593129816|FG011|Overall Study|Lack of Efficacy|0|||
164207479|NCT01799889|593129805|FG000|Overall Study|Lost to Follow-up|0|||
164207480|NCT01799889|593129806|FG001|Overall Study|Lost to Follow-up|1|||
164207481|NCT01799889|593129807|FG002|Overall Study|Lost to Follow-up|0|||
164207482|NCT01799889|593129808|FG003|Overall Study|Lost to Follow-up|0|||
164207483|NCT01799889|593129809|FG004|Overall Study|Lost to Follow-up|0|||
164207484|NCT01799889|593129810|FG005|Overall Study|Lost to Follow-up|0|||
164207485|NCT01799889|593129811|FG006|Overall Study|Lost to Follow-up|0|||
164207486|NCT01799889|593129812|FG007|Overall Study|Lost to Follow-up|0|||
164207487|NCT01799889|593129813|FG008|Overall Study|Lost to Follow-up|0|||
164207488|NCT01799889|593129814|FG009|Overall Study|Lost to Follow-up|0|||
164207489|NCT01799889|593129815|FG010|Overall Study|Lost to Follow-up|0|||
164207490|NCT01799889|593129816|FG011|Overall Study|Lost to Follow-up|0|||
164207491|NCT01799889|593129805|FG000|Overall Study|Physician Decision|3|||
164207492|NCT01799889|593129806|FG001|Overall Study|Physician Decision|2|||
164207493|NCT01799889|593129807|FG002|Overall Study|Physician Decision|4|||
164207494|NCT01799889|593129808|FG003|Overall Study|Physician Decision|4|||
164207495|NCT01799889|593129809|FG004|Overall Study|Physician Decision|5|||
164207496|NCT01799889|593129810|FG005|Overall Study|Physician Decision|5|||
164207497|NCT01799889|593129811|FG006|Overall Study|Physician Decision|5|||
164207498|NCT01799889|593129812|FG007|Overall Study|Physician Decision|2|||
164207499|NCT01799889|593129813|FG008|Overall Study|Physician Decision|6|||
164207500|NCT01799889|593129814|FG009|Overall Study|Physician Decision|0|||
164207501|NCT01799889|593129815|FG010|Overall Study|Physician Decision|0|||
164207502|NCT01799889|593129816|FG011|Overall Study|Physician Decision|1|||
164207503|NCT01799889|593129805|FG000|Overall Study|Progressive Disease|30|||
164207504|NCT01799889|593129806|FG001|Overall Study|Progressive Disease|26|||
164207505|NCT01799889|593129807|FG002|Overall Study|Progressive Disease|25|||
164207506|NCT01799889|593129808|FG003|Overall Study|Progressive Disease|30|||
164207507|NCT01799889|593129809|FG004|Overall Study|Progressive Disease|23|||
164563516|NCT01665144|594431116|FG002|Extension Part|Adverse Event|59|||
164320801|NCT00608569|593550239|FG000|Overall Study|Unable to adhere with study requirements|0|||
164320802|NCT00608569|593550240|FG001|Overall Study|Unable to adhere with study requirements|1|||
164320803|NCT02312687|593550254|FG000|Overall Study|Other, Not Specified|1|||
164320804|NCT00906971|593550257|FG000|Overall Study|Withdrawal by Subject|8|||
164320805|NCT00906971|593550258|FG001|Overall Study|Withdrawal by Subject|2|||
164320806|NCT00906971|593550257|FG000|Overall Study|Lost to Follow-up|0|||
164320807|NCT00906971|593550258|FG001|Overall Study|Lost to Follow-up|1|||
164563517|NCT01665144|594431114|FG000|Extension Part|Study closed early|42|||
164563518|NCT01665144|594431115|FG001|Extension Part|Study closed early|0|||
164563519|NCT01665144|594431116|FG002|Extension Part|Study closed early|19|||
164563520|NCT01665144|594431114|FG000|Extension Part|Progressive disease|36|||
164563521|NCT01665144|594431115|FG001|Extension Part|Progressive disease|0|||
164563522|NCT01665144|594431116|FG002|Extension Part|Progressive disease|14|||
164563523|NCT01665144|594431114|FG000|Extension Part|Lack of Efficacy|37|||
164563524|NCT01665144|594431115|FG001|Extension Part|Lack of Efficacy|0|||
164563525|NCT01665144|594431116|FG002|Extension Part|Lack of Efficacy|12|||
164563526|NCT01665144|594431114|FG000|Extension Part|Physician Decision|29|||
164563527|NCT01665144|594431115|FG001|Extension Part|Physician Decision|0|||
164563528|NCT01665144|594431116|FG002|Extension Part|Physician Decision|13|||
164563529|NCT01665144|594431114|FG000|Extension Part|Technical problems|20|||
164563530|NCT01665144|594431115|FG001|Extension Part|Technical problems|0|||
164563531|NCT01665144|594431116|FG002|Extension Part|Technical problems|8|||
164563532|NCT01665144|594431114|FG000|Extension Part|Death|20|||
164563533|NCT01665144|594431115|FG001|Extension Part|Death|0|||
164563534|NCT01665144|594431116|FG002|Extension Part|Death|4|||
164563535|NCT01665144|594431114|FG000|Extension Part|Missing|12|||
164563536|NCT01665144|594431115|FG001|Extension Part|Missing|0|||
164563537|NCT01665144|594431116|FG002|Extension Part|Missing|6|||
164563538|NCT01665144|594431114|FG000|Extension Part|Lost to Follow-up|9|||
164563539|NCT01665144|594431115|FG001|Extension Part|Lost to Follow-up|0|||
164563540|NCT01665144|594431116|FG002|Extension Part|Lost to Follow-up|5|||
164563541|NCT01665144|594431114|FG000|Extension Part|New therapy for study indication|3|||
164563542|NCT01665144|594431115|FG001|Extension Part|New therapy for study indication|0|||
164563543|NCT01665144|594431116|FG002|Extension Part|New therapy for study indication|2|||
164563544|NCT01665144|594431114|FG000|Extension Part|Protocol deviation|3|||
164563545|NCT01665144|594431115|FG001|Extension Part|Protocol deviation|0|||
164563546|NCT01665144|594431116|FG002|Extension Part|Protocol deviation|0|||
164563547|NCT05574062|594431120|FG000|Pre Run-In|Screening failure|3|||
164563548|NCT05574062|594431121|FG001|Pre Run-In|Screening failure|0|||
164563549|NCT05574062|594431122|FG002|Pre Run-In|Screening failure|0|||
164563550|NCT05574062|594431123|FG003|Pre Run-In|Screening failure|0|||
164563551|NCT05574062|594431124|FG004|Pre Run-In|Screening failure|0|||
164563552|NCT05574062|594431120|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
164563553|NCT05574062|594431121|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
164563554|NCT05574062|594431122|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
164563555|NCT05574062|594431123|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
164563556|NCT05574062|594431124|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
164563557|NCT05574062|594431120|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
164563558|NCT05574062|594431121|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
164563559|NCT05574062|594431122|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
164563560|NCT05574062|594431123|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
164563561|NCT05574062|594431124|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
164563562|NCT05574062|594431120|FG000|Continuation Phase Period 1|Physician Decision|1|||
164563563|NCT05574062|594431121|FG001|Continuation Phase Period 1|Physician Decision|0|||
164563564|NCT05574062|594431122|FG002|Continuation Phase Period 1|Physician Decision|0|||
164563565|NCT05574062|594431123|FG003|Continuation Phase Period 1|Physician Decision|0|||
164563566|NCT05574062|594431124|FG004|Continuation Phase Period 1|Physician Decision|0|||
164563567|NCT05574062|594431120|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
164563568|NCT05574062|594431121|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
164563569|NCT05574062|594431122|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
164563570|NCT05574062|594431123|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
164563571|NCT05574062|594431124|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
164563572|NCT05574062|594431120|FG000|Continuation Phase Period 1|Adverse Event|1|||
164563573|NCT05574062|594431121|FG001|Continuation Phase Period 1|Adverse Event|0|||
164563574|NCT05574062|594431122|FG002|Continuation Phase Period 1|Adverse Event|0|||
164563575|NCT05574062|594431123|FG003|Continuation Phase Period 1|Adverse Event|0|||
164563576|NCT05574062|594431124|FG004|Continuation Phase Period 1|Adverse Event|0|||
164563577|NCT05574062|594431120|FG000|Continuation Phase Period 1|Death|1|||
164563578|NCT05574062|594431121|FG001|Continuation Phase Period 1|Death|0|||
164563579|NCT05574062|594431122|FG002|Continuation Phase Period 1|Death|0|||
164563580|NCT05574062|594431123|FG003|Continuation Phase Period 1|Death|0|||
164563581|NCT05574062|594431124|FG004|Continuation Phase Period 1|Death|0|||
164563582|NCT05574062|594431120|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
164320808|NCT00545129|593550259|FG000|Overall Study|Lack of Efficacy|2|||
164320809|NCT00545129|593550260|FG001|Overall Study|Lack of Efficacy|5|||
164667482|NCT00849901|594808405|FG001|Acute Treatment Phase|Adverse Event|1|||
164667483|NCT00849901|594808406|FG002|Acute Treatment Phase|Adverse Event|3|||
164667484|NCT00849901|594808404|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
164667485|NCT00849901|594808405|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
164320810|NCT00545129|593550259|FG000|Overall Study|Death|2|||
164320811|NCT00545129|593550260|FG001|Overall Study|Death|1|||
164320812|NCT00545129|593550259|FG000|Overall Study|Adverse Event|1|||
164320813|NCT00545129|593550260|FG001|Overall Study|Adverse Event|1|||
164320814|NCT00545129|593550259|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
164320815|NCT00545129|593550260|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
164320816|NCT00545129|593550259|FG000|Overall Study|Other|3|||
164320817|NCT00545129|593550260|FG001|Overall Study|Other|3|||
164320818|NCT03678870|593550261|FG000|Overall Study|prescribed non- protocol medications|10|||
164320819|NCT03678870|593550262|FG001|Overall Study|prescribed non- protocol medications|6|||
164320820|NCT03678870|593550261|FG000|Overall Study|Lost to Follow-up|3|||
164320821|NCT03678870|593550262|FG001|Overall Study|Lost to Follow-up|2|||
164320822|NCT03104816|593550264|FG000|Overall Study|Lack of Efficacy|0|||
164320823|NCT03104816|593550265|FG001|Overall Study|Lack of Efficacy|2|||
164320824|NCT03104816|593550266|FG002|Overall Study|Lack of Efficacy|0|||
164320825|NCT03104816|593550264|FG000|Overall Study|Protocol Violation|2|||
164320826|NCT03104816|593550265|FG001|Overall Study|Protocol Violation|0|||
164320827|NCT03104816|593550266|FG002|Overall Study|Protocol Violation|2|||
164320828|NCT01426789|593550267|FG000|Part 1|Protocol deviation|0|||
164320829|NCT01426789|593550268|FG001|Part 1|Protocol deviation|1|||
164320830|NCT01426789|593550269|FG002|Part 1|Protocol deviation|0|||
164320831|NCT01426789|593550270|FG003|Part 1|Protocol deviation|0|||
164320832|NCT01426789|593550271|FG004|Part 1|Protocol deviation|0|||
164320833|NCT01426789|593550272|FG005|Part 1|Protocol deviation|0|||
164320834|NCT01426789|593550267|FG000|Part 1|Lost to Follow-up|1|||
164320835|NCT01426789|593550268|FG001|Part 1|Lost to Follow-up|2|||
164320836|NCT01426789|593550269|FG002|Part 1|Lost to Follow-up|0|||
164320837|NCT01426789|593550270|FG003|Part 1|Lost to Follow-up|0|||
164320838|NCT01426789|593550271|FG004|Part 1|Lost to Follow-up|0|||
164320839|NCT01426789|593550272|FG005|Part 1|Lost to Follow-up|0|||
164320840|NCT01426789|593550267|FG000|Part 1|Lack of Efficacy|2|||
164320841|NCT01426789|593550268|FG001|Part 1|Lack of Efficacy|1|||
164320842|NCT01426789|593550269|FG002|Part 1|Lack of Efficacy|0|||
164320843|NCT01426789|593550270|FG003|Part 1|Lack of Efficacy|0|||
164320844|NCT01426789|593550271|FG004|Part 1|Lack of Efficacy|0|||
164320845|NCT01426789|593550272|FG005|Part 1|Lack of Efficacy|0|||
164320846|NCT01426789|593550267|FG000|Part 1|Adverse Event|3|||
164320847|NCT01426789|593550268|FG001|Part 1|Adverse Event|0|||
164320848|NCT01426789|593550269|FG002|Part 1|Adverse Event|0|||
164320849|NCT01426789|593550270|FG003|Part 1|Adverse Event|0|||
164320850|NCT01426789|593550271|FG004|Part 1|Adverse Event|0|||
164320851|NCT01426789|593550272|FG005|Part 1|Adverse Event|0|||
164320852|NCT01426789|593550267|FG000|Part 2|Protocol deviation|0|||
164320853|NCT01426789|593550268|FG001|Part 2|Protocol deviation|0|||
164320854|NCT01426789|593550269|FG002|Part 2|Protocol deviation|1|||
164320855|NCT01426789|593550270|FG003|Part 2|Protocol deviation|0|||
164320856|NCT01426789|593550271|FG004|Part 2|Protocol deviation|0|||
164320857|NCT01426789|593550272|FG005|Part 2|Protocol deviation|0|||
164320858|NCT01426789|593550267|FG000|Part 2|Death|0|||
164320859|NCT01426789|593550268|FG001|Part 2|Death|0|||
164320860|NCT01426789|593550269|FG002|Part 2|Death|1|||
164320861|NCT01426789|593550270|FG003|Part 2|Death|0|||
164320862|NCT01426789|593550271|FG004|Part 2|Death|1|||
164320863|NCT01426789|593550272|FG005|Part 2|Death|0|||
164320864|NCT01426789|593550267|FG000|Part 2|Administrative problems|0|||
164320865|NCT01426789|593550268|FG001|Part 2|Administrative problems|0|||
164320866|NCT01426789|593550269|FG002|Part 2|Administrative problems|2|||
164320867|NCT01426789|593550270|FG003|Part 2|Administrative problems|0|||
164320868|NCT01426789|593550271|FG004|Part 2|Administrative problems|1|||
164320869|NCT01426789|593550272|FG005|Part 2|Administrative problems|0|||
164320870|NCT01426789|593550267|FG000|Part 2|Lost to Follow-up|0|||
164320871|NCT01426789|593550268|FG001|Part 2|Lost to Follow-up|0|||
164320872|NCT01426789|593550269|FG002|Part 2|Lost to Follow-up|4|||
164320873|NCT01426789|593550270|FG003|Part 2|Lost to Follow-up|0|||
164320874|NCT01426789|593550271|FG004|Part 2|Lost to Follow-up|1|||
164667486|NCT00849901|594808406|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
164667487|NCT00849901|594808404|FG000|Acute Treatment Phase|Protocol Violation|0|||
164320875|NCT01426789|593550272|FG005|Part 2|Lost to Follow-up|0|||
164320876|NCT01426789|593550267|FG000|Part 2|Withdrawal by Subject|0|||
164320877|NCT01426789|593550268|FG001|Part 2|Withdrawal by Subject|0|||
164320878|NCT01426789|593550269|FG002|Part 2|Withdrawal by Subject|0|||
164320879|NCT01426789|593550270|FG003|Part 2|Withdrawal by Subject|1|||
164320880|NCT01426789|593550271|FG004|Part 2|Withdrawal by Subject|2|||
164320881|NCT01426789|593550272|FG005|Part 2|Withdrawal by Subject|0|||
164320882|NCT01426789|593550267|FG000|Part 2|Lack of Efficacy|0|||
164320883|NCT01426789|593550268|FG001|Part 2|Lack of Efficacy|0|||
164320884|NCT01426789|593550269|FG002|Part 2|Lack of Efficacy|5|||
164320885|NCT01426789|593550270|FG003|Part 2|Lack of Efficacy|0|||
164320886|NCT01426789|593550271|FG004|Part 2|Lack of Efficacy|2|||
164320887|NCT01426789|593550272|FG005|Part 2|Lack of Efficacy|0|||
164320888|NCT01426789|593550267|FG000|Part 2|Adverse Event|0|||
164320889|NCT01426789|593550268|FG001|Part 2|Adverse Event|0|||
164320890|NCT01426789|593550269|FG002|Part 2|Adverse Event|2|||
164320891|NCT01426789|593550270|FG003|Part 2|Adverse Event|0|||
164320892|NCT01426789|593550271|FG004|Part 2|Adverse Event|1|||
164320893|NCT01426789|593550272|FG005|Part 2|Adverse Event|0|||
164320894|NCT01895361|593552089|FG000|Overall Study|Adverse Event|1|||
164320895|NCT01895361|593552090|FG001|Overall Study|Adverse Event|1|||
164320896|NCT01895361|593552091|FG002|Overall Study|Adverse Event|3|||
164320897|NCT01895361|593552089|FG000|Overall Study|Death|2|||
164320898|NCT01895361|593552090|FG001|Overall Study|Death|1|||
164667488|NCT00849901|594808405|FG001|Acute Treatment Phase|Protocol Violation|2|||
164667489|NCT00849901|594808406|FG002|Acute Treatment Phase|Protocol Violation|1|||
164667490|NCT00849901|594808404|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
164667491|NCT00849901|594808405|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
164320899|NCT01895361|593552091|FG002|Overall Study|Death|2|||
164320900|NCT01895361|593552089|FG000|Overall Study|Lost to Follow-up|4|||
164320901|NCT01895361|593552090|FG001|Overall Study|Lost to Follow-up|4|||
164320902|NCT01895361|593552091|FG002|Overall Study|Lost to Follow-up|6|||
164320903|NCT01895361|593552089|FG000|Overall Study|Non-compliance with study|1|||
164320904|NCT01895361|593552090|FG001|Overall Study|Non-compliance with study|3|||
164320905|NCT01895361|593552091|FG002|Overall Study|Non-compliance with study|1|||
164320906|NCT01895361|593552089|FG000|Overall Study|Physician Decision|2|||
164320907|NCT01895361|593552090|FG001|Overall Study|Physician Decision|2|||
164320908|NCT01895361|593552091|FG002|Overall Study|Physician Decision|2|||
164320909|NCT01895361|593552089|FG000|Overall Study|Withdrawal by Subject|7|||
164320910|NCT01895361|593552090|FG001|Overall Study|Withdrawal by Subject|6|||
164320911|NCT01895361|593552091|FG002|Overall Study|Withdrawal by Subject|6|||
164320912|NCT01895361|593552089|FG000|Overall Study|Lack of Efficacy|0|||
164320913|NCT01895361|593552090|FG001|Overall Study|Lack of Efficacy|1|||
164320914|NCT01895361|593552091|FG002|Overall Study|Lack of Efficacy|0|||
164320915|NCT01895361|593552089|FG000|Overall Study|Reasons different from categories above|7|||
164320916|NCT01895361|593552090|FG001|Overall Study|Reasons different from categories above|3|||
164320917|NCT01895361|593552091|FG002|Overall Study|Reasons different from categories above|4|||
164320918|NCT02677324|593552092|FG000|Overall Study|Disease Progression|6|||
164320919|NCT02677324|593552092|FG000|Overall Study|Inability to Swallow pills|1|||
164320920|NCT02677324|593552092|FG000|Overall Study|Non-compliance|1|||
164320921|NCT02677324|593552092|FG000|Overall Study|Lack of Efficacy|1|||
164320922|NCT02677324|593552092|FG000|Overall Study|Medical insurance coverage|1|||
164320923|NCT02677324|593552092|FG000|Overall Study|Adverse Event|1|||
164320924|NCT02677324|593552092|FG000|Overall Study|IgM Myeloma diagnosis|1|||
164320925|NCT00282464|593552093|FG000|Overall Study|Adverse Event|26|||
164320926|NCT00282464|593552094|FG001|Overall Study|Adverse Event|20|||
164320927|NCT00282464|593552093|FG000|Overall Study|Lack of Efficacy|8|||
164320928|NCT00282464|593552094|FG001|Overall Study|Lack of Efficacy|8|||
164320929|NCT00282464|593552093|FG000|Overall Study|Lost to Follow-up|10|||
164320930|NCT00282464|593552094|FG001|Overall Study|Lost to Follow-up|10|||
164320931|NCT00282464|593552093|FG000|Overall Study|Withdrawal by Subject|24|||
164320932|NCT00282464|593552094|FG001|Overall Study|Withdrawal by Subject|10|||
164320933|NCT00282464|593552093|FG000|Overall Study|laboratory abnormality|1|||
164320934|NCT00282464|593552094|FG001|Overall Study|laboratory abnormality|2|||
164320935|NCT00282464|593552093|FG000|Overall Study|Protocol Violation|0|||
164320936|NCT00282464|593552094|FG001|Overall Study|Protocol Violation|7|||
164320937|NCT00282464|593552093|FG000|Overall Study|Patient moved|1|||
164320938|NCT00282464|593552094|FG001|Overall Study|Patient moved|0|||
164320939|NCT00282464|593552093|FG000|Overall Study|patient non-compliant|3|||
164320940|NCT00282464|593552094|FG001|Overall Study|patient non-compliant|0|||
164320941|NCT00282464|593552093|FG000|Overall Study|patient no show|0|||
164320942|NCT00282464|593552094|FG001|Overall Study|patient no show|1|||
164320943|NCT00282464|593552093|FG000|Overall Study|patient incarcerated|0|||
164320944|NCT00282464|593552094|FG001|Overall Study|patient incarcerated|1|||
164667492|NCT00849901|594808406|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
164320945|NCT00282464|593552093|FG000|Overall Study|family crisis|0|||
164320946|NCT00282464|593552094|FG001|Overall Study|family crisis|1|||
164320947|NCT00282464|593552093|FG000|Overall Study|dispensed wrong kit|0|||
164320948|NCT00282464|593552094|FG001|Overall Study|dispensed wrong kit|1|||
164320949|NCT00282464|593552093|FG000|Overall Study|dropped due to missed visits|0|||
164320950|NCT00282464|593552094|FG001|Overall Study|dropped due to missed visits|1|||
164320951|NCT00475423|593552095|FG000|Overall Study|Protocol Violation|5|||
164320952|NCT00475423|593552095|FG000|Overall Study|Adverse Event|4|||
164667493|NCT00849901|594808404|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
164667494|NCT00849901|594808405|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
164320953|NCT00475423|593552095|FG000|Overall Study|Withdrawal by Subject|6|||
164320954|NCT00475423|593552095|FG000|Overall Study|Lack of Efficacy|8|||
164320955|NCT00475423|593552095|FG000|Overall Study|Death|1|||
164320956|NCT00475423|593552095|FG000|Overall Study|Reason not specified|1|||
164320957|NCT00475423|593552095|FG000|Overall Study|Lost to Follow-up|7|||
164320958|NCT05463198|593552096|FG000|Overall Study|Withdrawal by Subject|19|||
164667495|NCT00849901|594808406|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
164667496|NCT00849901|594808404|FG000|Acute Treatment Phase|Physician Decision|1|||
164667497|NCT00849901|594808405|FG001|Acute Treatment Phase|Physician Decision|1|||
164667498|NCT00849901|594808406|FG002|Acute Treatment Phase|Physician Decision|1|||
164667499|NCT00849901|594808404|FG000|Acute Treatment Phase|Sponsor Decision|1|||
164667500|NCT00849901|594808405|FG001|Acute Treatment Phase|Sponsor Decision|0|||
164667501|NCT00849901|594808406|FG002|Acute Treatment Phase|Sponsor Decision|0|||
164667502|NCT00849901|594808404|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
164667503|NCT00849901|594808405|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
164667504|NCT00849901|594808406|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
164667505|NCT00849901|594808404|FG000|Extension Phase|Adverse Event|2|||
164667506|NCT00849901|594808405|FG001|Extension Phase|Adverse Event|8|||
164667507|NCT00849901|594808406|FG002|Extension Phase|Adverse Event|4|||
164667508|NCT00849901|594808404|FG000|Extension Phase|Lost to Follow-up|3|||
164667509|NCT00849901|594808405|FG001|Extension Phase|Lost to Follow-up|0|||
164667510|NCT00849901|594808406|FG002|Extension Phase|Lost to Follow-up|1|||
164667511|NCT00849901|594808404|FG000|Extension Phase|Protocol Violation|2|||
164667512|NCT00849901|594808405|FG001|Extension Phase|Protocol Violation|2|||
164667513|NCT00849901|594808406|FG002|Extension Phase|Protocol Violation|4|||
164667514|NCT00849901|594808404|FG000|Extension Phase|Withdrawal by Subject|7|||
164667515|NCT00849901|594808405|FG001|Extension Phase|Withdrawal by Subject|6|||
164667516|NCT00849901|594808406|FG002|Extension Phase|Withdrawal by Subject|3|||
164667517|NCT00849901|594808404|FG000|Extension Phase|Parent or Caregiver Decision|10|||
164667518|NCT00849901|594808405|FG001|Extension Phase|Parent or Caregiver Decision|4|||
164667519|NCT00849901|594808406|FG002|Extension Phase|Parent or Caregiver Decision|4|||
164667520|NCT00849901|594808404|FG000|Extension Phase|Physician Decision|1|||
164667521|NCT00849901|594808405|FG001|Extension Phase|Physician Decision|2|||
164667522|NCT00849901|594808406|FG002|Extension Phase|Physician Decision|0|||
164667523|NCT00849901|594808404|FG000|Extension Phase|Lack of Efficacy|2|||
164667524|NCT00849901|594808405|FG001|Extension Phase|Lack of Efficacy|4|||
164667525|NCT00849901|594808406|FG002|Extension Phase|Lack of Efficacy|1|||
164667526|NCT00262223|594808409|FG000|Treatment Phase|Withdrawal by Subject|3|||
164667527|NCT00262223|594808410|FG001|Treatment Phase|Withdrawal by Subject|6|||
164667528|NCT00262223|594808409|FG000|Treatment Phase|Adverse Event|1|||
164667529|NCT00262223|594808410|FG001|Treatment Phase|Adverse Event|2|||
164667530|NCT00262223|594808409|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
164320959|NCT05463198|593552096|FG000|Overall Study|Procedure Notes Missing|18|||
164320960|NCT01214174|593552097|FG000|Overall Study|Withdrawal by Subject|0|||
164320961|NCT01214174|593552098|FG001|Overall Study|Withdrawal by Subject|0|||
164320962|NCT01214174|593552099|FG002|Overall Study|Withdrawal by Subject|1|||
164320963|NCT02239120|593552102|FG000|Overall Study|Death|56|||
164320964|NCT02239120|593552103|FG001|Overall Study|Death|58|||
164320965|NCT02239120|593552102|FG000|Overall Study|Lost to Follow-up|19|||
164320966|NCT02239120|593552103|FG001|Overall Study|Lost to Follow-up|14|||
164320967|NCT00420641|593552107|FG000|Overall Study|Adverse Event|3|||
164320968|NCT00420641|593552108|FG001|Overall Study|Adverse Event|25|||
164320969|NCT00420641|593552109|FG002|Overall Study|Adverse Event|10|||
164320970|NCT00420641|593552107|FG000|Overall Study|Lost to Follow-up|2|||
164320971|NCT00420641|593552108|FG001|Overall Study|Lost to Follow-up|4|||
164320972|NCT00420641|593552109|FG002|Overall Study|Lost to Follow-up|2|||
164320973|NCT00420641|593552107|FG000|Overall Study|Protocol Violation|8|||
164320974|NCT00420641|593552108|FG001|Overall Study|Protocol Violation|8|||
164320975|NCT00420641|593552109|FG002|Overall Study|Protocol Violation|7|||
164320976|NCT00420641|593552107|FG000|Overall Study|Withdrawal by Subject|15|||
164320977|NCT00420641|593552108|FG001|Overall Study|Withdrawal by Subject|21|||
164320978|NCT00420641|593552109|FG002|Overall Study|Withdrawal by Subject|14|||
164320979|NCT00420641|593552107|FG000|Overall Study|Lack of Efficacy|6|||
164320980|NCT00420641|593552108|FG001|Overall Study|Lack of Efficacy|5|||
164320981|NCT00420641|593552109|FG002|Overall Study|Lack of Efficacy|4|||
164667531|NCT00262223|594808410|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
164667532|NCT00262223|594808409|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
164667533|NCT00262223|594808410|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
164667534|NCT00262223|594808409|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
164667535|NCT00262223|594808410|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
164667536|NCT00437658|594808411|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
164320982|NCT00420641|593552107|FG000|Overall Study|Non-compliance|7|||
164320983|NCT00420641|593552108|FG001|Overall Study|Non-compliance|5|||
164667537|NCT00437658|594808412|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
164320984|NCT00420641|593552109|FG002|Overall Study|Non-compliance|4|||
164320985|NCT00420641|593552107|FG000|Overall Study|Other|4|||
164320986|NCT00420641|593552108|FG001|Overall Study|Other|4|||
164320987|NCT00420641|593552109|FG002|Overall Study|Other|3|||
164320988|NCT02815280|593552121|FG000|Double-Blind Phase|Adverse Event|1|||
164667538|NCT00437658|594808413|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
164667539|NCT00437658|594808411|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
164667540|NCT00437658|594808412|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
164320989|NCT02815280|593552122|FG001|Double-Blind Phase|Adverse Event|1|||
164207508|NCT01799889|593129810|FG005|Overall Study|Progressive Disease|9|||
164207509|NCT01799889|593129811|FG006|Overall Study|Progressive Disease|8|||
164207510|NCT01799889|593129812|FG007|Overall Study|Progressive Disease|13|||
164207511|NCT01799889|593129813|FG008|Overall Study|Progressive Disease|18|||
164207512|NCT01799889|593129814|FG009|Overall Study|Progressive Disease|5|||
164207513|NCT01799889|593129815|FG010|Overall Study|Progressive Disease|3|||
164207514|NCT01799889|593129816|FG011|Overall Study|Progressive Disease|1|||
164207515|NCT01799889|593129805|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
164207516|NCT01799889|593129806|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
164207517|NCT01799889|593129807|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
164207518|NCT01799889|593129808|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
164207519|NCT01799889|593129809|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
164207520|NCT01799889|593129810|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
164207521|NCT01799889|593129811|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
164207522|NCT01799889|593129812|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
164207523|NCT01799889|593129813|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
164207524|NCT01799889|593129814|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
164207525|NCT01799889|593129815|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
164207526|NCT01799889|593129816|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
164207527|NCT01799889|593129805|FG000|Overall Study|Study Terminated By Sponsor|1|||
164207528|NCT01799889|593129806|FG001|Overall Study|Study Terminated By Sponsor|0|||
164207529|NCT01799889|593129807|FG002|Overall Study|Study Terminated By Sponsor|0|||
164207530|NCT01799889|593129808|FG003|Overall Study|Study Terminated By Sponsor|0|||
164207531|NCT01799889|593129809|FG004|Overall Study|Study Terminated By Sponsor|2|||
164207532|NCT01799889|593129810|FG005|Overall Study|Study Terminated By Sponsor|1|||
164207533|NCT01799889|593129811|FG006|Overall Study|Study Terminated By Sponsor|0|||
164207534|NCT01799889|593129812|FG007|Overall Study|Study Terminated By Sponsor|2|||
164207535|NCT01799889|593129813|FG008|Overall Study|Study Terminated By Sponsor|1|||
164207536|NCT01799889|593129814|FG009|Overall Study|Study Terminated By Sponsor|1|||
164207537|NCT01799889|593129815|FG010|Overall Study|Study Terminated By Sponsor|0|||
164207538|NCT01799889|593129816|FG011|Overall Study|Study Terminated By Sponsor|0|||
164207539|NCT01799889|593129805|FG000|Overall Study|Withdrawal by Subject|1|||
164207540|NCT01799889|593129806|FG001|Overall Study|Withdrawal by Subject|6|||
164207541|NCT01799889|593129807|FG002|Overall Study|Withdrawal by Subject|4|||
164207542|NCT01799889|593129808|FG003|Overall Study|Withdrawal by Subject|0|||
164207543|NCT01799889|593129809|FG004|Overall Study|Withdrawal by Subject|5|||
164207544|NCT01799889|593129810|FG005|Overall Study|Withdrawal by Subject|1|||
164207545|NCT01799889|593129811|FG006|Overall Study|Withdrawal by Subject|3|||
164207546|NCT01799889|593129812|FG007|Overall Study|Withdrawal by Subject|1|||
164207547|NCT01799889|593129813|FG008|Overall Study|Withdrawal by Subject|2|||
164207548|NCT01799889|593129814|FG009|Overall Study|Withdrawal by Subject|1|||
164207549|NCT01799889|593129815|FG010|Overall Study|Withdrawal by Subject|1|||
164207550|NCT01799889|593129816|FG011|Overall Study|Withdrawal by Subject|1|||
164207551|NCT01799889|593129805|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164207552|NCT01799889|593129806|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164207553|NCT01799889|593129807|FG002|Overall Study|Non-Compliance With Study Drug|0|||
164207554|NCT01799889|593129808|FG003|Overall Study|Non-Compliance With Study Drug|0|||
164207555|NCT01799889|593129809|FG004|Overall Study|Non-Compliance With Study Drug|0|||
164207556|NCT01799889|593129810|FG005|Overall Study|Non-Compliance With Study Drug|1|||
164207557|NCT01799889|593129811|FG006|Overall Study|Non-Compliance With Study Drug|0|||
164207558|NCT01799889|593129812|FG007|Overall Study|Non-Compliance With Study Drug|0|||
164207559|NCT01799889|593129813|FG008|Overall Study|Non-Compliance With Study Drug|0|||
164207560|NCT01799889|593129814|FG009|Overall Study|Non-Compliance With Study Drug|0|||
164207561|NCT01799889|593129815|FG010|Overall Study|Non-Compliance With Study Drug|0|||
164207562|NCT01799889|593129816|FG011|Overall Study|Non-Compliance With Study Drug|0|||
164207563|NCT01431976|593129817|FG000|Overall Study|Adverse Event|6|||
164207564|NCT01431976|593129817|FG000|Overall Study|Lack of Efficacy|2|||
164207565|NCT01431976|593129817|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
164207566|NCT01431976|593129817|FG000|Overall Study|Physician Decision|1|||
164207567|NCT01431976|593129817|FG000|Overall Study|Withdrawal by Subject|1|||
164207568|NCT01294514|593129820|FG000|Overall Study|Excluded due to Arrhythmia|1|||
164207569|NCT01963611|593129821|FG000|Overall Study|Adverse Event|1|||
164207570|NCT01963611|593129822|FG001|Overall Study|Adverse Event|1|||
164207571|NCT01963611|593129823|FG002|Overall Study|Adverse Event|3|||
164207572|NCT01963611|593129824|FG003|Overall Study|Adverse Event|4|||
164207573|NCT01963611|593129825|FG004|Overall Study|Adverse Event|3|||
164207574|NCT01963611|593129821|FG000|Overall Study|Protocol Violation|0|||
164207575|NCT01963611|593129822|FG001|Overall Study|Protocol Violation|0|||
164207576|NCT01963611|593129823|FG002|Overall Study|Protocol Violation|0|||
164207577|NCT01963611|593129824|FG003|Overall Study|Protocol Violation|1|||
164207578|NCT01963611|593129825|FG004|Overall Study|Protocol Violation|0|||
164207579|NCT01963611|593129821|FG000|Overall Study|Lack of Efficacy|0|||
164207580|NCT01963611|593129822|FG001|Overall Study|Lack of Efficacy|0|||
164207581|NCT01963611|593129823|FG002|Overall Study|Lack of Efficacy|0|||
164207582|NCT01963611|593129824|FG003|Overall Study|Lack of Efficacy|1|||
164320990|NCT02815280|593552121|FG000|Double-Blind Phase|Lost to Follow-up|10|||
164320991|NCT02815280|593552122|FG001|Double-Blind Phase|Lost to Follow-up|9|||
164320992|NCT02815280|593552121|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
164320993|NCT02815280|593552122|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
164320994|NCT02815280|593552121|FG000|Double-Blind Phase|Protocol Violation|2|||
164320995|NCT02815280|593552122|FG001|Double-Blind Phase|Protocol Violation|2|||
164320996|NCT02815280|593552121|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
164320997|NCT02815280|593552122|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
164320998|NCT02815280|593552121|FG000|Open-Label Phase|Adverse Event|2|||
164320999|NCT02815280|593552122|FG001|Open-Label Phase|Adverse Event|3|||
164321000|NCT02815280|593552121|FG000|Open-Label Phase|Lost to Follow-up|18|||
164321001|NCT02815280|593552122|FG001|Open-Label Phase|Lost to Follow-up|9|||
164321002|NCT02815280|593552121|FG000|Open-Label Phase|Withdrawal by Subject|33|||
164321003|NCT02815280|593552122|FG001|Open-Label Phase|Withdrawal by Subject|18|||
164321004|NCT02815280|593552121|FG000|Open-Label Phase|Protocol Violation|3|||
164321005|NCT02815280|593552122|FG001|Open-Label Phase|Protocol Violation|0|||
164321006|NCT02815280|593552121|FG000|Open-Label Phase|Administrative|26|||
164321007|NCT02815280|593552122|FG001|Open-Label Phase|Administrative|12|||
164321008|NCT02815280|593552121|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
164321009|NCT02815280|593552122|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
164321010|NCT01944839|593552138|FG000|Overall Study|Physician Decision|2|||
164321011|NCT01944839|593552139|FG001|Overall Study|Physician Decision|2|||
164321012|NCT01944839|593552138|FG000|Overall Study|Protocol Violation|0|||
164321013|NCT01944839|593552139|FG001|Overall Study|Protocol Violation|1|||
164321014|NCT01944839|593552138|FG000|Overall Study|Adverse Event|10|||
164321015|NCT01944839|593552139|FG001|Overall Study|Adverse Event|5|||
164321016|NCT01944839|593552138|FG000|Overall Study|Withdrawal by Subject|9|||
164321017|NCT01944839|593552139|FG001|Overall Study|Withdrawal by Subject|17|||
164321018|NCT01944839|593552138|FG000|Overall Study|Lost to Follow-up|1|||
164321019|NCT01944839|593552139|FG001|Overall Study|Lost to Follow-up|0|||
164321020|NCT01944839|593552138|FG000|Overall Study|Subject non-compliance|0|||
164321021|NCT01944839|593552139|FG001|Overall Study|Subject non-compliance|3|||
164321022|NCT00609362|593552140|FG000|Overall Study|Withdrawal by Subject|2|||
164321023|NCT00609362|593552141|FG001|Overall Study|Withdrawal by Subject|1|||
164321024|NCT00609362|593552140|FG000|Overall Study|Adverse Event|1|||
164321025|NCT00609362|593552141|FG001|Overall Study|Adverse Event|0|||
164321026|NCT05093790|593552142|FG000|Overall Study|Failure to meet continuation criteria|0|||
164321027|NCT05093790|593552143|FG001|Overall Study|Failure to meet continuation criteria|0|||
164321028|NCT05093790|593552144|FG002|Overall Study|Failure to meet continuation criteria|1|||
164321029|NCT05093790|593552145|FG003|Overall Study|Failure to meet continuation criteria|0|||
164321030|NCT05093790|593552142|FG000|Overall Study|Adverse Event|1|||
164321031|NCT05093790|593552143|FG001|Overall Study|Adverse Event|0|||
164321032|NCT05093790|593552144|FG002|Overall Study|Adverse Event|0|||
164321033|NCT05093790|593552145|FG003|Overall Study|Adverse Event|0|||
164321034|NCT00548405|593552146|FG000|Overall Study|Adverse Event|6|||
164321035|NCT00548405|593552147|FG001|Overall Study|Adverse Event|2|||
164321036|NCT00548405|593552148|FG002|Overall Study|Adverse Event|0|||
164321037|NCT00548405|593552146|FG000|Overall Study|Lack of Efficacy|6|||
164321038|NCT00548405|593552147|FG001|Overall Study|Lack of Efficacy|0|||
164321039|NCT00548405|593552148|FG002|Overall Study|Lack of Efficacy|0|||
164321040|NCT00548405|593552146|FG000|Overall Study|Physician Decision|3|||
164321041|NCT00548405|593552147|FG001|Overall Study|Physician Decision|4|||
164321042|NCT00548405|593552148|FG002|Overall Study|Physician Decision|1|||
164321043|NCT00548405|593552146|FG000|Overall Study|Pregnancy|1|||
164321044|NCT00548405|593552147|FG001|Overall Study|Pregnancy|0|||
164321045|NCT00548405|593552148|FG002|Overall Study|Pregnancy|0|||
164321046|NCT00548405|593552146|FG000|Overall Study|Protocol Violation|1|||
164321047|NCT00548405|593552147|FG001|Overall Study|Protocol Violation|0|||
164321048|NCT00548405|593552148|FG002|Overall Study|Protocol Violation|0|||
164321049|NCT00548405|593552146|FG000|Overall Study|Withdrawal by Subject|36|||
164321050|NCT00548405|593552147|FG001|Overall Study|Withdrawal by Subject|12|||
164321051|NCT00548405|593552148|FG002|Overall Study|Withdrawal by Subject|5|||
164321052|NCT00548405|593552146|FG000|Overall Study|Lost to Follow-up|1|||
164321053|NCT00548405|593552147|FG001|Overall Study|Lost to Follow-up|1|||
164321054|NCT00548405|593552148|FG002|Overall Study|Lost to Follow-up|2|||
164321055|NCT00548405|593552146|FG000|Overall Study|Death|0|||
164321056|NCT00548405|593552147|FG001|Overall Study|Death|1|||
164321057|NCT00548405|593552148|FG002|Overall Study|Death|1|||
164321058|NCT00548405|593552146|FG000|Overall Study|Sponsor decision|1|||
164321059|NCT00548405|593552147|FG001|Overall Study|Sponsor decision|0|||
164321060|NCT00548405|593552148|FG002|Overall Study|Sponsor decision|0|||
164321061|NCT00548405|593552146|FG000|Overall Study|Randomized but not treated|1|||
164321062|NCT00548405|593552147|FG001|Overall Study|Randomized but not treated|0|||
164321063|NCT00548405|593552148|FG002|Overall Study|Randomized but not treated|0|||
164321064|NCT01624870|593552154|FG000|Overall Study|Death|19|||
164321065|NCT01624870|593552154|FG000|Overall Study|Withdrawal by Subject|1|||
164207583|NCT01963611|593129825|FG004|Overall Study|Lack of Efficacy|0|||
164207584|NCT01963611|593129821|FG000|Overall Study|Withdrawal by Subject|3|||
164207585|NCT01963611|593129822|FG001|Overall Study|Withdrawal by Subject|2|||
164207586|NCT01963611|593129823|FG002|Overall Study|Withdrawal by Subject|1|||
164207587|NCT01963611|593129824|FG003|Overall Study|Withdrawal by Subject|1|||
164207588|NCT01963611|593129825|FG004|Overall Study|Withdrawal by Subject|3|||
164207589|NCT01963611|593129821|FG000|Overall Study|Other|47|||
164207590|NCT01963611|593129822|FG001|Overall Study|Other|46|||
164207591|NCT01963611|593129823|FG002|Overall Study|Other|48|||
164207592|NCT01963611|593129824|FG003|Overall Study|Other|45|||
164207593|NCT01963611|593129825|FG004|Overall Study|Other|45|||
164207594|NCT01126424|593129830|FG000|Overall Study|Adverse Event|0|||
164207595|NCT01126424|593129831|FG001|Overall Study|Adverse Event|0|||
164207596|NCT01126424|593129832|FG002|Overall Study|Adverse Event|0|||
164207597|NCT01126424|593129833|FG003|Overall Study|Adverse Event|0|||
164207598|NCT01126424|593129834|FG004|Overall Study|Adverse Event|1|||
164207599|NCT01126424|593129835|FG005|Overall Study|Adverse Event|0|||
164207600|NCT01126424|593129830|FG000|Overall Study|Withdrawal by Subject|0|||
164207601|NCT01126424|593129831|FG001|Overall Study|Withdrawal by Subject|0|||
164207602|NCT01126424|593129832|FG002|Overall Study|Withdrawal by Subject|1|||
164207603|NCT01126424|593129833|FG003|Overall Study|Withdrawal by Subject|3|||
164207604|NCT01126424|593129834|FG004|Overall Study|Withdrawal by Subject|1|||
164207605|NCT01126424|593129835|FG005|Overall Study|Withdrawal by Subject|0|||
164207606|NCT02127671|593129836|FG000|Overall Study|Death|2|||
164207607|NCT02127671|593129837|FG001|Overall Study|Death|2|||
164207608|NCT02127671|593129836|FG000|Overall Study|Lost to Follow-up|4|||
164207609|NCT02127671|593129837|FG001|Overall Study|Lost to Follow-up|2|||
164207610|NCT02127671|593129836|FG000|Overall Study|Physician Decision|1|||
164207611|NCT02127671|593129837|FG001|Overall Study|Physician Decision|0|||
164207612|NCT02127671|593129836|FG000|Overall Study|incarceration|0|||
164207613|NCT02127671|593129837|FG001|Overall Study|incarceration|1|||
164207614|NCT02127671|593129836|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
164207615|NCT02127671|593129837|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
164207616|NCT00782067|593129838|FG000|Overall Study|Adverse Event|35|||
164207617|NCT00782067|593129838|FG000|Overall Study|Subject withdrew consent|11|||
164207618|NCT00782067|593129838|FG000|Overall Study|Lost to Follow-up|2|||
164207619|NCT00782067|593129838|FG000|Overall Study|Administrative problems|14|||
164207620|NCT00782067|593129838|FG000|Overall Study|Death|9|||
164207621|NCT00782067|593129838|FG000|Overall Study|Disease progression|43|||
164207622|NCT00782067|593129838|FG000|Overall Study|Protocol deviation|2|||
164207623|NCT02328105|593129839|FG000|Overall Study|Death|6|||
164207624|NCT02328105|593129839|FG000|Overall Study|Withdrawal by Subject|1|||
164207625|NCT02328105|593129839|FG000|Overall Study|Still On Study in Follow-Up|4|||
164207626|NCT01013753|593129844|FG000|Overall Study|Adverse Event|8|||
164207627|NCT01013753|593129844|FG000|Overall Study|Protocol Violation|3|||
164207628|NCT01013753|593129844|FG000|Overall Study|Lost to Follow-up|1|||
164207629|NCT01013753|593129844|FG000|Overall Study|Withdrawal by Subject|2|||
164207630|NCT01013753|593129844|FG000|Overall Study|Other|2|||
164207631|NCT00303186|593129855|FG000|Overall Study|Other|52|||
164207632|NCT01283386|593129856|FG000|Overall Study|Death|2|||
164207633|NCT01283386|593129857|FG001|Overall Study|Death|0|||
164207634|NCT01283386|593129856|FG000|Overall Study|Withdrawal by Subject|2|||
164207635|NCT01283386|593129857|FG001|Overall Study|Withdrawal by Subject|1|||
164207636|NCT01283386|593129856|FG000|Overall Study|Relapse of underlying disease|1|||
164207637|NCT01283386|593129857|FG001|Overall Study|Relapse of underlying disease|3|||
164207638|NCT01283386|593129856|FG000|Overall Study|Progression of underlying disease|2|||
164207639|NCT01283386|593129857|FG001|Overall Study|Progression of underlying disease|7|||
164207640|NCT01283386|593129856|FG000|Overall Study|Reason not specified|1|||
164207641|NCT01283386|593129857|FG001|Overall Study|Reason not specified|0|||
164207642|NCT01283386|593129856|FG000|Overall Study|Protocol Violation|0|||
164207643|NCT01283386|593129857|FG001|Overall Study|Protocol Violation|1|||
164207644|NCT02469857|593129858|FG000|Overall Study|Death|24|||
164207645|NCT02469857|593129859|FG001|Overall Study|Death|29|||
164207646|NCT02469857|593129858|FG000|Overall Study|Discontinuation|1|||
164207647|NCT02469857|593129859|FG001|Overall Study|Discontinuation|3|||
164207648|NCT01137786|593129860|FG000|Overall Study|Lost to Follow-up|0|||
164207649|NCT01137786|593129861|FG001|Overall Study|Lost to Follow-up|2|||
164207650|NCT01137786|593129860|FG000|Overall Study|Withdrawal by Subject|1|||
164207651|NCT01137786|593129861|FG001|Overall Study|Withdrawal by Subject|1|||
164207652|NCT01531153|593129862|FG000|Overall Study|Withdrawal by Subject|10|||
164207653|NCT01531153|593129863|FG001|Overall Study|Withdrawal by Subject|9|||
164207654|NCT01531153|593129864|FG002|Overall Study|Withdrawal by Subject|15|||
164207655|NCT00297167|593129865|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
164207656|NCT00297167|593129866|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
164207657|NCT00297167|593129867|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
164207658|NCT00297167|593129865|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
164207659|NCT00297167|593129866|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
164420651|NCT01154036|593910966|FG004|Phase I|Withdrawal by Subject|0|||
164207660|NCT00297167|593129867|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
164321066|NCT01624870|593552154|FG000|Overall Study|CoreValve not implanted|6|||
164321067|NCT01624870|593552154|FG000|Overall Study|Lost to follow up|1|||
164321068|NCT05027971|593552159|FG000|Overall Study|Physician Decision|7|||
164321069|NCT05027971|593552160|FG001|Overall Study|Physician Decision|3|||
164321070|NCT05027971|593552159|FG000|Overall Study|Lost to Follow-up|1|||
164321071|NCT05027971|593552160|FG001|Overall Study|Lost to Follow-up|1|||
164321072|NCT05027971|593552159|FG000|Overall Study|Withdrawal by Subject|0|||
164321073|NCT05027971|593552160|FG001|Overall Study|Withdrawal by Subject|2|||
164321074|NCT05027971|593552159|FG000|Overall Study|Non-study fiber used.|0|||
164321075|NCT05027971|593552160|FG001|Overall Study|Non-study fiber used.|1|||
164321076|NCT05027971|593552159|FG000|Overall Study|Protocol Violation|0|||
164321077|NCT05027971|593552160|FG001|Overall Study|Protocol Violation|2|||
164321078|NCT02025556|593552161|FG000|Overall Study|Adverse Event|0|||
164321079|NCT02025556|593552162|FG001|Overall Study|Adverse Event|4|||
164321080|NCT02025556|593552163|FG002|Overall Study|Adverse Event|2|||
164321081|NCT02025556|593552161|FG000|Overall Study|Lack of Efficacy|2|||
164321082|NCT02025556|593552162|FG001|Overall Study|Lack of Efficacy|1|||
164321083|NCT02025556|593552163|FG002|Overall Study|Lack of Efficacy|0|||
164321084|NCT02025556|593552161|FG000|Overall Study|Protocol Violation|2|||
164321085|NCT02025556|593552162|FG001|Overall Study|Protocol Violation|1|||
164321086|NCT02025556|593552163|FG002|Overall Study|Protocol Violation|0|||
164321087|NCT02025556|593552161|FG000|Overall Study|Withdrawal by Subject|0|||
164321088|NCT02025556|593552162|FG001|Overall Study|Withdrawal by Subject|3|||
164321089|NCT02025556|593552163|FG002|Overall Study|Withdrawal by Subject|6|||
164321090|NCT02025556|593552161|FG000|Overall Study|Lost to Follow-up|2|||
164321091|NCT02025556|593552162|FG001|Overall Study|Lost to Follow-up|4|||
164207661|NCT03416179|593129868|FG000|Overall Study|Death|90|||
164207662|NCT03416179|593129869|FG001|Overall Study|Death|87|||
164207663|NCT03416179|593129870|FG002|Overall Study|Death|117|||
164207664|NCT03416179|593129871|FG003|Overall Study|Death|113|||
164207665|NCT03416179|593129868|FG000|Overall Study|Withdrawal by Subject|15|||
164207666|NCT03416179|593129869|FG001|Overall Study|Withdrawal by Subject|20|||
164207667|NCT03416179|593129870|FG002|Overall Study|Withdrawal by Subject|6|||
164207668|NCT03416179|593129871|FG003|Overall Study|Withdrawal by Subject|9|||
164207669|NCT03416179|593129868|FG000|Overall Study|Lost to Follow-up|1|||
164207670|NCT03416179|593129869|FG001|Overall Study|Lost to Follow-up|1|||
164207671|NCT03416179|593129870|FG002|Overall Study|Lost to Follow-up|0|||
164207672|NCT03416179|593129871|FG003|Overall Study|Lost to Follow-up|3|||
164207673|NCT03416179|593129868|FG000|Overall Study|Study participation terminated by Sponsor|93|||
164207674|NCT03416179|593129869|FG001|Overall Study|Study participation terminated by Sponsor|91|||
164207675|NCT03416179|593129870|FG002|Overall Study|Study participation terminated by Sponsor|26|||
164207676|NCT03416179|593129871|FG003|Overall Study|Study participation terminated by Sponsor|31|||
164207677|NCT03416179|593129868|FG000|Overall Study|Other|2|||
164207678|NCT03416179|593129869|FG001|Overall Study|Other|3|||
164207679|NCT03416179|593129870|FG002|Overall Study|Other|1|||
164207680|NCT03416179|593129871|FG003|Overall Study|Other|0|||
164207681|NCT01385176|593129872|FG000|Randomization Phase|Death|1|||
164207682|NCT01385176|593129873|FG001|Randomization Phase|Death|2|||
164207683|NCT01385176|593129872|FG000|6-18 Month All VNS Active|Death|1|||
164207684|NCT01385176|593129873|FG001|6-18 Month All VNS Active|Death|2|||
164207685|NCT01385176|593129872|FG000|6-18 Month All VNS Active|Physician Decision|0|||
164207686|NCT01385176|593129873|FG001|6-18 Month All VNS Active|Physician Decision|1|||
164207687|NCT01385176|593129872|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
164207688|NCT01385176|593129873|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
164207689|NCT01385176|593129872|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
164207690|NCT01385176|593129873|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
164207691|NCT00284856|593129874|FG000|Overall Study|Adverse Event|3|||
164207692|NCT00284856|593129875|FG001|Overall Study|Adverse Event|3|||
164207693|NCT00284856|593129876|FG002|Overall Study|Adverse Event|3|||
164207694|NCT00284856|593129874|FG000|Overall Study|Lack of Efficacy|2|||
164207695|NCT00284856|593129875|FG001|Overall Study|Lack of Efficacy|1|||
164207696|NCT00284856|593129876|FG002|Overall Study|Lack of Efficacy|8|||
164207697|NCT00284856|593129874|FG000|Overall Study|Lost to Follow-up|25|||
164321092|NCT02025556|593552163|FG002|Overall Study|Lost to Follow-up|0|||
164207698|NCT00284856|593129875|FG001|Overall Study|Lost to Follow-up|21|||
164207699|NCT00284856|593129876|FG002|Overall Study|Lost to Follow-up|22|||
164207700|NCT00284856|593129874|FG000|Overall Study|Protocol Violation|5|||
164207701|NCT00284856|593129875|FG001|Overall Study|Protocol Violation|4|||
164207702|NCT00284856|593129876|FG002|Overall Study|Protocol Violation|5|||
164207703|NCT00284856|593129874|FG000|Overall Study|Withdrawal by Subject|12|||
164207704|NCT00284856|593129875|FG001|Overall Study|Withdrawal by Subject|16|||
164321093|NCT02025556|593552161|FG000|Overall Study|Reason not reported|0|||
164321094|NCT02025556|593552162|FG001|Overall Study|Reason not reported|0|||
164321095|NCT02025556|593552163|FG002|Overall Study|Reason not reported|1|||
164321096|NCT02582684|593552165|FG000|Overall Study|Unable to contact subject/parent|4|||
164207705|NCT00284856|593129876|FG002|Overall Study|Withdrawal by Subject|18|||
164207706|NCT00284856|593129874|FG000|Overall Study|Other|4|||
164207707|NCT00284856|593129875|FG001|Overall Study|Other|5|||
164321097|NCT02582684|593552165|FG000|Overall Study|Subject not able to get to clinic|10|||
164321098|NCT02582684|593552165|FG000|Overall Study|Subject withdrew consent|1|||
164321099|NCT02582684|593552165|FG000|Overall Study|Found to be ineligible after enrollment|2|||
164321100|NCT01878149|593552166|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
164321101|NCT01878149|593552167|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
164321102|NCT04672252|593552170|FG000|Overall Study|Protocol Violation|1|||
164321103|NCT04672252|593552171|FG001|Overall Study|Protocol Violation|0|||
164321104|NCT01587898|593552172|FG000|Overall Study|Adverse Event|1|||
164321105|NCT01587898|593552173|FG001|Overall Study|Adverse Event|1|||
164321106|NCT01587898|593552174|FG002|Overall Study|Adverse Event|0|||
164321107|NCT01587898|593552175|FG003|Overall Study|Adverse Event|0|||
164321108|NCT01587898|593552172|FG000|Overall Study|Protocol Violation|0|||
164321109|NCT01587898|593552173|FG001|Overall Study|Protocol Violation|2|||
164321110|NCT01587898|593552174|FG002|Overall Study|Protocol Violation|1|||
164321111|NCT01587898|593552175|FG003|Overall Study|Protocol Violation|1|||
164321112|NCT01587898|593552172|FG000|Overall Study|Lost to Follow-up|0|||
164321113|NCT01587898|593552173|FG001|Overall Study|Lost to Follow-up|0|||
164321114|NCT01587898|593552174|FG002|Overall Study|Lost to Follow-up|0|||
164321115|NCT01587898|593552175|FG003|Overall Study|Lost to Follow-up|1|||
164321116|NCT01587898|593552172|FG000|Overall Study|Withdrawal by Subject|2|||
164321117|NCT01587898|593552173|FG001|Overall Study|Withdrawal by Subject|1|||
164321118|NCT01587898|593552174|FG002|Overall Study|Withdrawal by Subject|0|||
164321119|NCT01587898|593552175|FG003|Overall Study|Withdrawal by Subject|0|||
164321120|NCT01587898|593552172|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
164321121|NCT01587898|593552173|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
164321122|NCT01587898|593552174|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
164321123|NCT01587898|593552175|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
164321124|NCT00796991|593552176|FG000|Overall Study|Adverse Event|0|||
164321125|NCT00796991|593552177|FG001|Overall Study|Adverse Event|0|||
164321126|NCT00796991|593552178|FG002|Overall Study|Adverse Event|1|||
164321127|NCT00796991|593552176|FG000|Overall Study|Death|2|||
164321128|NCT00796991|593552177|FG001|Overall Study|Death|0|||
164321129|NCT00796991|593552178|FG002|Overall Study|Death|0|||
164321130|NCT00796991|593552176|FG000|Overall Study|Disease Progression|10|||
164321131|NCT00796991|593552177|FG001|Overall Study|Disease Progression|9|||
164321132|NCT00796991|593552178|FG002|Overall Study|Disease Progression|7|||
164321133|NCT00796991|593552176|FG000|Overall Study|Study Drug Toxicity|3|||
164321134|NCT00796991|593552177|FG001|Overall Study|Study Drug Toxicity|3|||
164321135|NCT00796991|593552178|FG002|Overall Study|Study Drug Toxicity|5|||
164321136|NCT00796991|593552176|FG000|Overall Study|Withdrawal by Subject|0|||
164321137|NCT00796991|593552177|FG001|Overall Study|Withdrawal by Subject|0|||
164321138|NCT00796991|593552178|FG002|Overall Study|Withdrawal by Subject|1|||
164321139|NCT02437110|593552181|FG000|Screening|Lost to Follow-up|3|||
164321140|NCT02437110|593552181|FG000|Screening|Physician Decision|1|||
164321141|NCT02437110|593552181|FG000|ART|Adverse Event|3|||
164321142|NCT02437110|593552181|FG000|ART|Protocol Violation|3|||
164321143|NCT02437110|593552181|FG000|ART|Withdrawal by Subject|4|||
164321144|NCT02437110|593552181|FG000|ART|Lost to follow-up prior to start of intervention|1|||
164321145|NCT02437110|593552181|FG000|ART|Physician decision prior to start of intervention|2|||
164321146|NCT02437110|593552181|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
164321147|NCT02437110|593552181|FG000|Post-ART|Lost to Follow-up|3|||
164321148|NCT02437110|593552181|FG000|Post-ART|Protocol Violation|4|||
164321149|NCT02437110|593552181|FG000|Post-ART|Withdrawal by Subject|3|||
164321150|NCT00171834|593552182|FG000|Overall Study|Adverse Event|2|||
164321151|NCT00171834|593552183|FG001|Overall Study|Adverse Event|1|||
164321152|NCT00171834|593552184|FG002|Overall Study|Adverse Event|3|||
164321153|NCT00171834|593552185|FG003|Overall Study|Adverse Event|2|||
164321154|NCT00171834|593552186|FG004|Overall Study|Adverse Event|2|||
164321155|NCT00171834|593552187|FG005|Overall Study|Adverse Event|15|||
164321156|NCT00171834|593552188|FG006|Overall Study|Adverse Event|1|||
164321157|NCT00171834|593552182|FG000|Overall Study|Withdrawal by Subject|0|||
164321158|NCT00171834|593552183|FG001|Overall Study|Withdrawal by Subject|2|||
164321159|NCT00171834|593552184|FG002|Overall Study|Withdrawal by Subject|0|||
164321160|NCT00171834|593552185|FG003|Overall Study|Withdrawal by Subject|1|||
164321161|NCT00171834|593552186|FG004|Overall Study|Withdrawal by Subject|1|||
164321162|NCT00171834|593552187|FG005|Overall Study|Withdrawal by Subject|1|||
164321163|NCT00171834|593552188|FG006|Overall Study|Withdrawal by Subject|0|||
164321164|NCT00171834|593552182|FG000|Overall Study|Death from study indication|0|||
164321165|NCT00171834|593552183|FG001|Overall Study|Death from study indication|1|||
164321166|NCT00171834|593552184|FG002|Overall Study|Death from study indication|0|||
164321167|NCT00171834|593552185|FG003|Overall Study|Death from study indication|0|||
164321168|NCT00171834|593552186|FG004|Overall Study|Death from study indication|1|||
164321169|NCT00171834|593552187|FG005|Overall Study|Death from study indication|0|||
164321170|NCT00171834|593552188|FG006|Overall Study|Death from study indication|0|||
164321171|NCT00171834|593552182|FG000|Overall Study|Disease Progression|4|||
164321172|NCT00171834|593552183|FG001|Overall Study|Disease Progression|8|||
164321173|NCT00171834|593552184|FG002|Overall Study|Disease Progression|8|||
164321174|NCT00171834|593552185|FG003|Overall Study|Disease Progression|9|||
164321175|NCT00171834|593552186|FG004|Overall Study|Disease Progression|2|||
164321176|NCT00171834|593552187|FG005|Overall Study|Disease Progression|18|||
164321177|NCT00171834|593552188|FG006|Overall Study|Disease Progression|3|||
164321178|NCT00171834|593552182|FG000|Overall Study|Treatment Duration Completed|0|||
164321179|NCT00171834|593552183|FG001|Overall Study|Treatment Duration Completed|0|||
164321180|NCT00171834|593552184|FG002|Overall Study|Treatment Duration Completed|1|||
164321181|NCT00171834|593552185|FG003|Overall Study|Treatment Duration Completed|0|||
164321182|NCT00171834|593552186|FG004|Overall Study|Treatment Duration Completed|2|||
164321183|NCT00171834|593552187|FG005|Overall Study|Treatment Duration Completed|1|||
164321184|NCT00171834|593552188|FG006|Overall Study|Treatment Duration Completed|0|||
164321185|NCT01261780|593552189|FG000|Overall Study|Withdrawal by Subject|1|||
164321186|NCT01261780|593552190|FG001|Overall Study|Withdrawal by Subject|0|||
164321187|NCT01261780|593552189|FG000|Overall Study|Event not related to subject|1|||
164321188|NCT01261780|593552190|FG001|Overall Study|Event not related to subject|2|||
164321189|NCT01239732|593552191|FG000|Overall Study|Termination of study per protocol|667|||
164321190|NCT01239732|593552191|FG000|Overall Study|Death|226|||
164321191|NCT01239732|593552191|FG000|Overall Study|Withdrawal by Subject|87|||
164321192|NCT01239732|593552191|FG000|Overall Study|Adverse Event|6|||
164321193|NCT01239732|593552191|FG000|Overall Study|Protocol Violation|3|||
164321194|NCT01239732|593552191|FG000|Overall Study|Participant non compliance|5|||
164321195|NCT01239732|593552191|FG000|Overall Study|Study termination by sponsor|2|||
164321196|NCT01239732|593552191|FG000|Overall Study|Investigator's decision|4|||
164321197|NCT01239732|593552191|FG000|Overall Study|Treatment failure|2|||
164321198|NCT01239732|593552191|FG000|Overall Study|Other|19|||
164321199|NCT00927940|593552192|FG000|Overall Study|Death|1|||
164321200|NCT03007888|593552193|FG000|First Intervention (14 Days)|Adverse Event|1|||
164321201|NCT03007888|593552194|FG001|First Intervention (14 Days)|Adverse Event|0|||
164321202|NCT04658940|593552196|FG000|Overall Study|Withdrawal by Subject|1|||
164321203|NCT00827931|593552200|FG000|Overall Study|Death|3|||
164321204|NCT00827931|593552201|FG001|Overall Study|Death|5|||
164321205|NCT00827931|593552200|FG000|Overall Study|Adverse Event|1|||
164321206|NCT00827931|593552201|FG001|Overall Study|Adverse Event|0|||
164321207|NCT00827931|593552200|FG000|Overall Study|Lost to Follow-up|1|||
164321208|NCT00827931|593552201|FG001|Overall Study|Lost to Follow-up|0|||
164321209|NCT00827931|593552200|FG000|Overall Study|Withdrawal by Subject|0|||
164321210|NCT00827931|593552201|FG001|Overall Study|Withdrawal by Subject|1|||
164321211|NCT00827931|593552200|FG000|Overall Study|Other|1|||
164321212|NCT00827931|593552201|FG001|Overall Study|Other|0|||
164321213|NCT02015221|593552202|FG000|Overall Study|Withdrawal by Subject|8|||
164321214|NCT02015221|593552203|FG001|Overall Study|Withdrawal by Subject|6|||
164321215|NCT02015221|593552202|FG000|Overall Study|Lost to Follow-up|1|||
164321216|NCT02015221|593552203|FG001|Overall Study|Lost to Follow-up|0|||
164321217|NCT03579602|593552204|FG000|Overall Study|Subject unable to receive study drug|0|||
164321218|NCT03579602|593552205|FG001|Overall Study|Subject unable to receive study drug|2|||
164321219|NCT03579602|593552204|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
164321220|NCT03579602|593552205|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
164321221|NCT01306929|593552206|FG000|Overall Study|Withdrawal by Subject|23|||
164321222|NCT01306929|593552206|FG000|Overall Study|Adverse Event|21|||
164321223|NCT01306929|593552206|FG000|Overall Study|Physician Decision|13|||
164321224|NCT01306929|593552206|FG000|Overall Study|Death|8|||
164321225|NCT01306929|593552206|FG000|Overall Study|Withdrawal by parent/guardian|5|||
164321226|NCT01306929|593552206|FG000|Overall Study|Protocol Violation|3|||
164321227|NCT01306929|593552206|FG000|Overall Study|Non-compliance with study drug|2|||
164321228|NCT01306929|593552206|FG000|Overall Study|Lost to Follow-up|2|||
164321229|NCT01306929|593552206|FG000|Overall Study|Various|17|||
164321230|NCT01870076|593552207|FG000|Overall Study|Withdrawal by Subject|1|||
164321231|NCT01870076|593552208|FG001|Overall Study|Withdrawal by Subject|0|||
164321232|NCT01870076|593552209|FG002|Overall Study|Withdrawal by Subject|1|||
164321233|NCT01870076|593552210|FG003|Overall Study|Withdrawal by Subject|0|||
164321234|NCT03041129|593552211|FG000|Overall Study|Withdrawal by Subject|2|||
164321235|NCT03041129|593552212|FG001|Overall Study|Withdrawal by Subject|0|||
164321236|NCT03041129|593552213|FG002|Overall Study|Withdrawal by Subject|0|||
164563583|NCT05574062|594431121|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
164563584|NCT05574062|594431122|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
164563585|NCT05574062|594431123|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
164321237|NCT03041129|593552214|FG003|Overall Study|Withdrawal by Subject|0|||
164321238|NCT00483756|593552219|FG000|Overall Study|Death|2|||
164321239|NCT00483756|593552220|FG001|Overall Study|Death|0|||
164563586|NCT05574062|594431124|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
164321240|NCT00483756|593552221|FG002|Overall Study|Death|1|||
164321241|NCT00483756|593552219|FG000|Overall Study|Adverse Event|19|||
164321242|NCT00483756|593552220|FG001|Overall Study|Adverse Event|38|||
164321243|NCT00483756|593552221|FG002|Overall Study|Adverse Event|40|||
164321244|NCT00483756|593552219|FG000|Overall Study|Lack of Efficacy|1|||
164321245|NCT00483756|593552220|FG001|Overall Study|Lack of Efficacy|0|||
164321246|NCT00483756|593552221|FG002|Overall Study|Lack of Efficacy|0|||
164321247|NCT00483756|593552219|FG000|Overall Study|Lost to Follow-up|3|||
164321248|NCT00483756|593552220|FG001|Overall Study|Lost to Follow-up|1|||
164321249|NCT00483756|593552221|FG002|Overall Study|Lost to Follow-up|0|||
164321250|NCT00483756|593552219|FG000|Overall Study|Withdrawal by Subject|5|||
164321251|NCT00483756|593552220|FG001|Overall Study|Withdrawal by Subject|3|||
164321252|NCT00483756|593552221|FG002|Overall Study|Withdrawal by Subject|4|||
164321253|NCT00483756|593552219|FG000|Overall Study|Other|2|||
164321254|NCT00483756|593552220|FG001|Overall Study|Other|4|||
164321255|NCT00483756|593552221|FG002|Overall Study|Other|3|||
164321256|NCT00483756|593552219|FG000|Overall Study|Randomized, Not Treated|1|||
164321257|NCT00483756|593552220|FG001|Overall Study|Randomized, Not Treated|4|||
164321258|NCT00483756|593552221|FG002|Overall Study|Randomized, Not Treated|4|||
164321259|NCT00807573|593552226|FG000|Overall Study|Withdrawal by Subject|1|||
164321260|NCT00807573|593552226|FG000|Overall Study|Adverse Event|1|||
164321261|NCT01007253|593552230|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
164321262|NCT01007253|593552231|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
164321263|NCT01007253|593552232|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
164563587|NCT05702736|594431126|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
164563588|NCT05702736|594431127|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
164563589|NCT05702736|594431126|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
164321264|NCT01007253|593552233|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
164321265|NCT01159431|593552236|FG000|Overall Study|Adverse Event|1|||
164321266|NCT01159431|593552237|FG001|Overall Study|Adverse Event|2|||
164207708|NCT00284856|593129876|FG002|Overall Study|Other|4|||
164207709|NCT01056536|593129877|FG000|Overall Study|Lost to Follow-up|202|||
164207710|NCT01056536|593129878|FG001|Overall Study|Lost to Follow-up|116|||
164207711|NCT01056536|593129879|FG002|Overall Study|Lost to Follow-up|248|||
164207712|NCT01285518|593129880|FG000|Overall Study|Lost to Follow-up|0|||
164207713|NCT01285518|593129881|FG001|Overall Study|Lost to Follow-up|0|||
164207714|NCT01285518|593129882|FG002|Overall Study|Lost to Follow-up|0|||
164207715|NCT01285518|593129883|FG003|Overall Study|Lost to Follow-up|0|||
164207716|NCT01285518|593129884|FG004|Overall Study|Lost to Follow-up|0|||
164207717|NCT01285518|593129885|FG005|Overall Study|Lost to Follow-up|1|||
164207718|NCT01285518|593129886|FG006|Overall Study|Lost to Follow-up|0|||
164207719|NCT01285518|593129887|FG007|Overall Study|Lost to Follow-up|0|||
164207720|NCT00639509|593129894|FG000|Overall Study|Death|1|||
164207721|NCT02921256|593129895|FG000|Arm 1a v. Arm II|Adverse Event|6|||
164207722|NCT02921256|593129896|FG001|Arm 1a v. Arm II|Adverse Event|15|||
164207723|NCT02921256|593129897|FG002|Arm 1a v. Arm II|Adverse Event|0|||
164207724|NCT02921256|593129895|FG000|Arm 1a v. Arm II|Death|0|||
164207725|NCT02921256|593129896|FG001|Arm 1a v. Arm II|Death|2|||
164207726|NCT02921256|593129897|FG002|Arm 1a v. Arm II|Death|0|||
164207727|NCT02921256|593129895|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
164207728|NCT02921256|593129896|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
164207729|NCT02921256|593129897|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
164207730|NCT02921256|593129895|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
164207731|NCT02921256|593129896|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
164207732|NCT02921256|593129897|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
164207733|NCT02921256|593129895|FG000|Arm 1a v. Arm II|Physician Decision|1|||
164207734|NCT02921256|593129896|FG001|Arm 1a v. Arm II|Physician Decision|1|||
164207735|NCT02921256|593129897|FG002|Arm 1a v. Arm II|Physician Decision|0|||
164207736|NCT02921256|593129895|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
164207737|NCT02921256|593129896|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
164207738|NCT02921256|593129897|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
164207739|NCT02921256|593129895|FG000|Arm Ib v Arm III|Adverse Event|9|||
164207740|NCT02921256|593129896|FG001|Arm Ib v Arm III|Adverse Event|0|||
164207741|NCT02921256|593129897|FG002|Arm Ib v Arm III|Adverse Event|4|||
164207742|NCT02921256|593129895|FG000|Arm Ib v Arm III|Death|1|||
164207743|NCT02921256|593129896|FG001|Arm Ib v Arm III|Death|0|||
164207744|NCT02921256|593129897|FG002|Arm Ib v Arm III|Death|1|||
164207745|NCT02921256|593129895|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
164207746|NCT02921256|593129896|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
164207747|NCT02921256|593129897|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
164207748|NCT02921256|593129895|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
164207749|NCT02921256|593129896|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
164207750|NCT02921256|593129897|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
164207751|NCT02921256|593129895|FG000|Arm Ib v Arm III|Physician Decision|4|||
164207752|NCT02921256|593129896|FG001|Arm Ib v Arm III|Physician Decision|0|||
164207753|NCT02921256|593129897|FG002|Arm Ib v Arm III|Physician Decision|1|||
164207754|NCT02921256|593129895|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
164207755|NCT02921256|593129896|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
164207756|NCT02921256|593129897|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
164207757|NCT03507790|593129898|FG000|Overall Study|Adverse Event|0|||
164207758|NCT03507790|593129899|FG001|Overall Study|Adverse Event|11|||
164207759|NCT03507790|593129900|FG002|Overall Study|Adverse Event|3|||
164207760|NCT03507790|593129898|FG000|Overall Study|Withdrawal by Subject|2|||
164207761|NCT03507790|593129899|FG001|Overall Study|Withdrawal by Subject|0|||
164207762|NCT03507790|593129900|FG002|Overall Study|Withdrawal by Subject|0|||
164207763|NCT03507790|593129898|FG000|Overall Study|Subject moved to another location|1|||
164207764|NCT03507790|593129899|FG001|Overall Study|Subject moved to another location|2|||
164207765|NCT03507790|593129900|FG002|Overall Study|Subject moved to another location|0|||
164207766|NCT03507790|593129898|FG000|Overall Study|Non-compliance with study drug|0|||
164207767|NCT03507790|593129899|FG001|Overall Study|Non-compliance with study drug|0|||
164207768|NCT03507790|593129900|FG002|Overall Study|Non-compliance with study drug|1|||
164207769|NCT03507790|593129898|FG000|Overall Study|COVID 19 Pandemic|0|||
164207770|NCT03507790|593129899|FG001|Overall Study|COVID 19 Pandemic|1|||
164207771|NCT03507790|593129900|FG002|Overall Study|COVID 19 Pandemic|0|||
164207772|NCT03507790|593129898|FG000|Overall Study|Lost to Follow-up|0|||
164207773|NCT03507790|593129899|FG001|Overall Study|Lost to Follow-up|1|||
164207774|NCT03507790|593129900|FG002|Overall Study|Lost to Follow-up|0|||
164207775|NCT03507790|593129898|FG000|Overall Study|Discontinuation of the trial at the site|1|||
164207776|NCT03507790|593129899|FG001|Overall Study|Discontinuation of the trial at the site|1|||
164207777|NCT03507790|593129900|FG002|Overall Study|Discontinuation of the trial at the site|0|||
164207778|NCT03507790|593129898|FG000|Overall Study|Randomized in error|0|||
164207779|NCT03507790|593129899|FG001|Overall Study|Randomized in error|0|||
164207780|NCT03507790|593129900|FG002|Overall Study|Randomized in error|1|||
164207781|NCT00157755|593129901|FG000|Overall Study|Death|2|||
164207782|NCT00157755|593129902|FG001|Overall Study|Death|3|||
164207783|NCT00157755|593129903|FG002|Overall Study|Death|3|||
164321267|NCT01159431|593552236|FG000|Overall Study|non-compliance|1|||
164207784|NCT00157755|593129904|FG003|Overall Study|Death|2|||
164207785|NCT00157755|593129905|FG004|Overall Study|Death|0|||
164321268|NCT01159431|593552237|FG001|Overall Study|non-compliance|1|||
164321269|NCT01159431|593552236|FG000|Overall Study|Lack of Efficacy|0|||
164321270|NCT01159431|593552237|FG001|Overall Study|Lack of Efficacy|3|||
164321271|NCT03976648|593552238|FG000|Overall Study|Adverse Event|0|||
164321272|NCT03976648|593552239|FG001|Overall Study|Adverse Event|2|||
164321273|NCT03976648|593552238|FG000|Overall Study|Study terminated by sponsor|21|||
164321274|NCT03976648|593552239|FG001|Overall Study|Study terminated by sponsor|8|||
164321275|NCT03645434|593552240|FG000|Period 1|Adverse Event|0|||
164321276|NCT03645434|593552241|FG001|Period 1|Adverse Event|0|||
164321277|NCT03645434|593552242|FG002|Period 1|Adverse Event|0|||
164321278|NCT03645434|593552243|FG003|Period 1|Adverse Event|1|||
164321279|NCT03645434|593552244|FG004|Period 1|Adverse Event|0|||
164321280|NCT03645434|593552245|FG005|Period 1|Adverse Event|0|||
164321281|NCT03645434|593552240|FG000|Period 1|COPD exacerbation|0|||
164321282|NCT03645434|593552241|FG001|Period 1|COPD exacerbation|0|||
164321283|NCT03645434|593552242|FG002|Period 1|COPD exacerbation|0|||
164321284|NCT03645434|593552243|FG003|Period 1|COPD exacerbation|0|||
164321285|NCT03645434|593552244|FG004|Period 1|COPD exacerbation|1|||
164321286|NCT03645434|593552245|FG005|Period 1|COPD exacerbation|0|||
164321287|NCT00881868|593552246|FG000|Overall Study|Adverse Event|0|||
164321288|NCT00881868|593552247|FG001|Overall Study|Adverse Event|1|||
164321289|NCT00881868|593552246|FG000|Overall Study|Lost to Follow-up|2|||
164321290|NCT00881868|593552247|FG001|Overall Study|Lost to Follow-up|1|||
164321291|NCT00881868|593552246|FG000|Overall Study|Physician Decision|4|||
164321292|NCT00881868|593552247|FG001|Overall Study|Physician Decision|0|||
164321293|NCT00881868|593552246|FG000|Overall Study|Protocol Violation|2|||
164321294|NCT00881868|593552247|FG001|Overall Study|Protocol Violation|0|||
164321295|NCT02880956|593552250|FG000|Overall Study|Adverse Event|3|||
164321296|NCT02880956|593552251|FG001|Overall Study|Adverse Event|6|||
164321297|NCT02880956|593552252|FG002|Overall Study|Adverse Event|5|||
164321298|NCT02880956|593552253|FG003|Overall Study|Adverse Event|4|||
164321299|NCT02880956|593552250|FG000|Overall Study|Withdrawal by Subject|9|||
164321300|NCT02880956|593552251|FG001|Overall Study|Withdrawal by Subject|4|||
164321301|NCT02880956|593552252|FG002|Overall Study|Withdrawal by Subject|6|||
164321302|NCT02880956|593552253|FG003|Overall Study|Withdrawal by Subject|11|||
164321303|NCT02880956|593552250|FG000|Overall Study|Lost to Follow-up|0|||
164321304|NCT02880956|593552251|FG001|Overall Study|Lost to Follow-up|1|||
164321305|NCT02880956|593552252|FG002|Overall Study|Lost to Follow-up|0|||
164321306|NCT02880956|593552253|FG003|Overall Study|Lost to Follow-up|0|||
164321307|NCT02880956|593552250|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
164321308|NCT02880956|593552251|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
164321309|NCT02880956|593552252|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
164321310|NCT02880956|593552253|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
164321311|NCT02880956|593552250|FG000|Overall Study|Other, Not Specified|4|||
164321312|NCT02880956|593552251|FG001|Overall Study|Other, Not Specified|2|||
164321313|NCT02880956|593552252|FG002|Overall Study|Other, Not Specified|0|||
164321314|NCT02880956|593552253|FG003|Overall Study|Other, Not Specified|3|||
164321315|NCT02081859|593552254|FG000|Overall Study|No fertilization|2|||
164321316|NCT02081859|593552255|FG001|Overall Study|No fertilization|2|||
164321317|NCT02081859|593552254|FG000|Overall Study|No sperm|1|||
164321318|NCT02081859|593552255|FG001|Overall Study|No sperm|0|||
164321319|NCT02081859|593552254|FG000|Overall Study|Unanticipated freeze all cycle|2|||
164321320|NCT02081859|593552255|FG001|Overall Study|Unanticipated freeze all cycle|6|||
164321321|NCT02081859|593552254|FG000|Overall Study|< 4 embryos|27|||
164321322|NCT02081859|593552255|FG001|Overall Study|< 4 embryos|23|||
164321323|NCT02081859|593552254|FG000|Overall Study|Other reasons|2|||
164321324|NCT02081859|593552255|FG001|Overall Study|Other reasons|0|||
164321325|NCT00884377|593554097|FG000|Overall Study|Withdrawal by Subject|1|||
164321326|NCT00884377|593554098|FG001|Overall Study|Withdrawal by Subject|0|||
164321327|NCT00884377|593554097|FG000|Overall Study|Could not confirm diagnosis|1|||
164321328|NCT00884377|593554098|FG001|Overall Study|Could not confirm diagnosis|0|||
164321329|NCT00884377|593554097|FG000|Overall Study|Physician Decision|0|||
164321330|NCT00884377|593554098|FG001|Overall Study|Physician Decision|1|||
164321331|NCT05347147|593554099|FG000|Overall Study|Lost to Follow-up|0|||
164321332|NCT05347147|593554100|FG001|Overall Study|Lost to Follow-up|1|||
164321333|NCT05347147|593554099|FG000|Overall Study|Sponsor request|3|||
164321334|NCT05347147|593554100|FG001|Overall Study|Sponsor request|3|||
164321335|NCT05347147|593554099|FG000|Overall Study|Study termination|2|||
164321336|NCT05347147|593554100|FG001|Overall Study|Study termination|1|||
164321337|NCT03718299|593554105|FG000|Overall Study|Adverse Event|1|||
164321338|NCT03718299|593554105|FG000|Overall Study|Withdrawal by Subject|6|||
164321339|NCT03718299|593554105|FG000|Overall Study|Physician Decision|2|||
164321340|NCT03718299|593554105|FG000|Overall Study|Lost to Follow-up|1|||
164321341|NCT04389970|593554107|FG000|Overall Study|Lost to Follow-up|1|||
164321342|NCT03123185|593554108|FG000|Overall Study|Withdrawal by Subject|0|||
164321343|NCT03123185|593554109|FG001|Overall Study|Withdrawal by Subject|0|||
164321344|NCT03123185|593554110|FG002|Overall Study|Withdrawal by Subject|0|||
164321345|NCT03123185|593554111|FG003|Overall Study|Withdrawal by Subject|0|||
164321346|NCT03123185|593554112|FG004|Overall Study|Withdrawal by Subject|0|||
164321347|NCT03123185|593554113|FG005|Overall Study|Withdrawal by Subject|0|||
164321348|NCT03123185|593554114|FG006|Overall Study|Withdrawal by Subject|0|||
164321349|NCT03123185|593554115|FG007|Overall Study|Withdrawal by Subject|0|||
164321350|NCT03123185|593554116|FG008|Overall Study|Withdrawal by Subject|0|||
164321351|NCT03123185|593554117|FG009|Overall Study|Withdrawal by Subject|0|||
164321352|NCT03123185|593554118|FG010|Overall Study|Withdrawal by Subject|0|||
164321353|NCT03123185|593554119|FG011|Overall Study|Withdrawal by Subject|0|||
164321354|NCT03123185|593554120|FG012|Overall Study|Withdrawal by Subject|1|||
164321355|NCT03123185|593554121|FG013|Overall Study|Withdrawal by Subject|0|||
164321356|NCT06400251|593554130|FG000|Overall Study|Never Start Protocol Therapy|1|||
164321357|NCT06400251|593554130|FG000|Overall Study|Ineligible|2|||
164321358|NCT06400251|593554130|FG000|Overall Study|Mutation Status Not Confirmed|3|||
164321359|NCT06400251|593554130|FG000|Overall Study|Disease Progression|25|||
164321360|NCT06400251|593554130|FG000|Overall Study|Adverse Event|1|||
164321361|NCT06400251|593554130|FG000|Overall Study|Complicating Disease|1|||
164321362|NCT06400251|593554130|FG000|Overall Study|Physician Decision|2|||
164321363|NCT02217527|593554131|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
164321364|NCT02217527|593554132|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
164321365|NCT02217527|593554131|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
164321366|NCT02217527|593554132|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
164321367|NCT06390839|593554139|FG000|Overall Study|Ineligible|2|||
164321368|NCT06390839|593554139|FG000|Overall Study|Never start protocol therapy|3|||
164321369|NCT06390839|593554139|FG000|Overall Study|Adverse Event|1|||
164321370|NCT06390839|593554139|FG000|Overall Study|Alternative therapy|2|||
164321371|NCT06390839|593554139|FG000|Overall Study|Death|3|||
164321372|NCT06390839|593554139|FG000|Overall Study|Disease progression|28|||
164321373|NCT06390839|593554139|FG000|Overall Study|Withdrawal by Subject|2|||
164321374|NCT06390839|593554139|FG000|Overall Study|Complicating disease|1|||
164321375|NCT06390839|593554139|FG000|Overall Study|Noncompliance|1|||
164321376|NCT01738477|593554144|FG000|Overall Study|Lost to Follow-up|1|||
164321377|NCT01738477|593554145|FG001|Overall Study|Lost to Follow-up|4|||
164321378|NCT00502203|593554146|FG000|Overall Study|Inevaluable|1|||
164321379|NCT02720094|593554147|FG000|Overall Study|Ongoing|2210|||
164321380|NCT02720094|593554148|FG001|Overall Study|Ongoing|2203|||
164321381|NCT02720094|593554147|FG000|Overall Study|Scheduled exit visit/end of study|2|||
164321382|NCT02720094|593554148|FG001|Overall Study|Scheduled exit visit/end of study|1|||
164321383|NCT02720094|593554147|FG000|Overall Study|Death|4|||
164321384|NCT02720094|593554148|FG001|Overall Study|Death|7|||
164321385|NCT02720094|593554147|FG000|Overall Study|Withdrawal by Subject|55|||
164321386|NCT02720094|593554148|FG001|Overall Study|Withdrawal by Subject|56|||
164321387|NCT02720094|593554147|FG000|Overall Study|Lost to Follow-up|2|||
164321388|NCT02720094|593554148|FG001|Overall Study|Lost to Follow-up|7|||
164321389|NCT02720094|593554147|FG000|Overall Study|Physician Decision|1|||
164321390|NCT02720094|593554148|FG001|Overall Study|Physician Decision|3|||
164321391|NCT02720094|593554147|FG000|Overall Study|Inappropriate enrollment|1|||
164321392|NCT02720094|593554148|FG001|Overall Study|Inappropriate enrollment|3|||
164321393|NCT02720094|593554147|FG000|Overall Study|Relocation|1|||
164321394|NCT02720094|593554148|FG001|Overall Study|Relocation|1|||
164321395|NCT03735238|593554153|FG000|Overall Study|Did not want to participate in research|3|||
164321396|NCT03735238|593554153|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
164321397|NCT02660138|593554154|FG000|Overall Study|Adverse Event|0|||
164321398|NCT02660138|593554155|FG001|Overall Study|Adverse Event|3|||
164321399|NCT02660138|593554156|FG002|Overall Study|Adverse Event|2|||
164321400|NCT02660138|593554154|FG000|Overall Study|Lack of Efficacy|1|||
164321401|NCT02660138|593554155|FG001|Overall Study|Lack of Efficacy|2|||
164321402|NCT02660138|593554156|FG002|Overall Study|Lack of Efficacy|1|||
164321403|NCT02660138|593554154|FG000|Overall Study|Withdrawal by Subject|7|||
164321404|NCT02660138|593554155|FG001|Overall Study|Withdrawal by Subject|6|||
164321405|NCT02660138|593554156|FG002|Overall Study|Withdrawal by Subject|6|||
164321406|NCT02660138|593554154|FG000|Overall Study|Lost to Follow-up|4|||
164321407|NCT02660138|593554155|FG001|Overall Study|Lost to Follow-up|4|||
164321408|NCT02660138|593554156|FG002|Overall Study|Lost to Follow-up|1|||
164321409|NCT02660138|593554154|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
164321410|NCT02660138|593554155|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
164321411|NCT02660138|593554156|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
164321412|NCT02660138|593554154|FG000|Overall Study|Other|1|||
164321413|NCT02660138|593554155|FG001|Overall Study|Other|1|||
164321414|NCT02660138|593554156|FG002|Overall Study|Other|0|||
164321415|NCT02660138|593554154|FG000|Overall Study|Not treated|0|||
164321416|NCT02660138|593554155|FG001|Overall Study|Not treated|1|||
164321417|NCT02660138|593554156|FG002|Overall Study|Not treated|0|||
164321418|NCT00308581|593554160|FG000|Induction Phase|Adverse Event|0|||
164321419|NCT00308581|593554161|FG001|Induction Phase|Adverse Event|0|||
164321420|NCT00308581|593554162|FG002|Induction Phase|Adverse Event|37|||
164420652|NCT01154036|593910967|FG005|Phase I|Withdrawal by Subject|0|||
164321421|NCT00308581|593554160|FG000|Induction Phase|Lack of Efficacy|0|||
164321422|NCT00308581|593554161|FG001|Induction Phase|Lack of Efficacy|0|||
164321423|NCT00308581|593554162|FG002|Induction Phase|Lack of Efficacy|121|||
164207786|NCT00157755|593129906|FG005|Overall Study|Death|0|||
164207787|NCT00157755|593129901|FG000|Overall Study|Lost to Follow-up|0|||
164207788|NCT00157755|593129902|FG001|Overall Study|Lost to Follow-up|0|||
164207789|NCT00157755|593129903|FG002|Overall Study|Lost to Follow-up|1|||
164207790|NCT00157755|593129904|FG003|Overall Study|Lost to Follow-up|0|||
164207791|NCT00157755|593129905|FG004|Overall Study|Lost to Follow-up|0|||
164207792|NCT00157755|593129906|FG005|Overall Study|Lost to Follow-up|0|||
164207793|NCT00157755|593129901|FG000|Overall Study|Withdrawal by Subject|0|||
164207794|NCT00157755|593129902|FG001|Overall Study|Withdrawal by Subject|0|||
164207795|NCT00157755|593129903|FG002|Overall Study|Withdrawal by Subject|1|||
164207796|NCT00157755|593129904|FG003|Overall Study|Withdrawal by Subject|1|||
164207797|NCT00157755|593129905|FG004|Overall Study|Withdrawal by Subject|1|||
164207798|NCT00157755|593129906|FG005|Overall Study|Withdrawal by Subject|2|||
164207799|NCT00157755|593129901|FG000|Overall Study|Explant due to infection|0|||
164207800|NCT00157755|593129902|FG001|Overall Study|Explant due to infection|0|||
164207801|NCT00157755|593129903|FG002|Overall Study|Explant due to infection|1|||
164207802|NCT00157755|593129904|FG003|Overall Study|Explant due to infection|0|||
164207803|NCT00157755|593129905|FG004|Overall Study|Explant due to infection|0|||
164207804|NCT00157755|593129906|FG005|Overall Study|Explant due to infection|0|||
164207805|NCT00157755|593129901|FG000|Overall Study|Medical reason|0|||
164207806|NCT00157755|593129902|FG001|Overall Study|Medical reason|0|||
164207807|NCT00157755|593129903|FG002|Overall Study|Medical reason|1|||
164207808|NCT00157755|593129904|FG003|Overall Study|Medical reason|1|||
164207809|NCT00157755|593129905|FG004|Overall Study|Medical reason|0|||
164207810|NCT00157755|593129906|FG005|Overall Study|Medical reason|0|||
164207811|NCT00157755|593129901|FG000|Overall Study|Study site closure|0|||
164207812|NCT00157755|593129902|FG001|Overall Study|Study site closure|1|||
164207813|NCT00157755|593129903|FG002|Overall Study|Study site closure|0|||
164207814|NCT00157755|593129904|FG003|Overall Study|Study site closure|0|||
164207815|NCT00157755|593129905|FG004|Overall Study|Study site closure|0|||
164207816|NCT00157755|593129906|FG005|Overall Study|Study site closure|0|||
164207817|NCT00157755|593129901|FG000|Overall Study|Subject non-compliance|0|||
164207818|NCT00157755|593129902|FG001|Overall Study|Subject non-compliance|0|||
164207819|NCT00157755|593129903|FG002|Overall Study|Subject non-compliance|0|||
164207820|NCT00157755|593129904|FG003|Overall Study|Subject non-compliance|0|||
164207821|NCT00157755|593129905|FG004|Overall Study|Subject non-compliance|0|||
164207822|NCT00157755|593129906|FG005|Overall Study|Subject non-compliance|1|||
164207823|NCT00157755|593129901|FG000|Overall Study|Study completion|0|||
164207824|NCT00157755|593129902|FG001|Overall Study|Study completion|0|||
164207825|NCT00157755|593129903|FG002|Overall Study|Study completion|0|||
164207826|NCT00157755|593129904|FG003|Overall Study|Study completion|0|||
164207827|NCT00157755|593129905|FG004|Overall Study|Study completion|1|||
164207828|NCT00157755|593129906|FG005|Overall Study|Study completion|2|||
164207829|NCT02421939|593129907|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
164207830|NCT02421939|593129908|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
164207831|NCT02421939|593129907|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
164321424|NCT00308581|593554160|FG000|Induction Phase|Withdrawal by Subject|0|||
164207832|NCT02421939|593129908|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
164207833|NCT02421939|593129907|FG000|Randomization Period: Up to 3 Years|Death|38|||
164207834|NCT02421939|593129908|FG001|Randomization Period: Up to 3 Years|Death|10|||
164207835|NCT02421939|593129907|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
164321425|NCT00308581|593554161|FG001|Induction Phase|Withdrawal by Subject|0|||
164321426|NCT00308581|593554162|FG002|Induction Phase|Withdrawal by Subject|5|||
164321427|NCT00308581|593554160|FG000|Induction Phase|Unknown reason|0|||
164321428|NCT00308581|593554161|FG001|Induction Phase|Unknown reason|0|||
164321429|NCT00308581|593554162|FG002|Induction Phase|Unknown reason|3|||
164321430|NCT00308581|593554160|FG000|Randomized Maintenance Phase|Adverse Event|10|||
164321431|NCT00308581|593554161|FG001|Randomized Maintenance Phase|Adverse Event|17|||
164321432|NCT00308581|593554162|FG002|Randomized Maintenance Phase|Adverse Event|0|||
164321433|NCT00308581|593554160|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
164321434|NCT00308581|593554161|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
164321435|NCT00308581|593554162|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
164321436|NCT00308581|593554160|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
164321437|NCT00308581|593554161|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
164321438|NCT00308581|593554162|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
164321439|NCT00308581|593554160|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
164321440|NCT00308581|593554161|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
164321441|NCT00308581|593554162|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
164321442|NCT00308581|593554160|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
164321443|NCT00308581|593554161|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
164321444|NCT00308581|593554162|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
164321445|NCT00308581|593554160|FG000|Randomized Maintenance Phase|Unknown reason|3|||
164321446|NCT00308581|593554161|FG001|Randomized Maintenance Phase|Unknown reason|0|||
164321447|NCT00308581|593554162|FG002|Randomized Maintenance Phase|Unknown reason|0|||
164321448|NCT00899353|593554165|FG000|Overall Study|Adverse Event|2|||
164321449|NCT00899353|593554165|FG000|Overall Study|Lost to Follow-up|1|||
164321450|NCT00899353|593554165|FG000|Overall Study|Withdrawal by Subject|2|||
164321451|NCT00095147|593554174|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
164321452|NCT00095147|593554175|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
164321453|NCT00095147|593554176|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
164321454|NCT00095147|593554177|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
164321455|NCT00095147|593554178|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
164321456|NCT00095147|593554174|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
164321457|NCT00095147|593554175|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
164321458|NCT00095147|593554176|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
164321459|NCT00095147|593554177|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
164321460|NCT00095147|593554178|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
164321461|NCT00095147|593554174|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
164321462|NCT00095147|593554175|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
164321463|NCT00095147|593554176|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
164321464|NCT00095147|593554177|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
164321465|NCT00095147|593554178|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
164321466|NCT00095147|593554174|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
164321467|NCT00095147|593554175|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
164321468|NCT00095147|593554176|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
164667541|NCT00437658|594808413|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
164321469|NCT00095147|593554177|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
164321470|NCT00095147|593554178|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
164321471|NCT00095147|593554174|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
164321472|NCT00095147|593554175|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
164321473|NCT00095147|593554176|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
164321474|NCT00095147|593554177|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
164321475|NCT00095147|593554178|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
164321476|NCT00095147|593554174|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
164321477|NCT00095147|593554175|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
164321478|NCT00095147|593554176|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
164321479|NCT00095147|593554177|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
164321480|NCT00095147|593554178|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
164321481|NCT00095147|593554174|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
164321482|NCT00095147|593554175|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
164321483|NCT00095147|593554176|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
164667542|NCT00437658|594808411|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
164667543|NCT00437658|594808412|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
164667544|NCT00437658|594808413|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
164667545|NCT00437658|594808411|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
164667546|NCT00437658|594808412|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
164321484|NCT00095147|593554177|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
164321485|NCT00095147|593554178|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
164321486|NCT00095147|593554174|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
164321487|NCT00095147|593554175|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
164321488|NCT00095147|593554176|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
164321489|NCT00095147|593554177|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
164321490|NCT00095147|593554178|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
164321491|NCT00095147|593554174|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
164321492|NCT00095147|593554175|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
164321493|NCT00095147|593554176|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
164207836|NCT02421939|593129908|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
164207837|NCT02421939|593129907|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
164207838|NCT02421939|593129908|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
164207839|NCT02421939|593129907|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
164207840|NCT02421939|593129908|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
164321494|NCT00095147|593554177|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
164321495|NCT00095147|593554178|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
164321496|NCT00095147|593554174|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
164321497|NCT00095147|593554175|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
164321498|NCT00095147|593554176|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
164321499|NCT00095147|593554177|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
164321500|NCT00095147|593554178|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
164321501|NCT00095147|593554174|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
164321502|NCT00095147|593554175|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
164321503|NCT00095147|593554176|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
164321504|NCT00095147|593554177|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
164321505|NCT00095147|593554178|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
164321506|NCT00095147|593554174|FG000|Long-term Extension Period|Death|0|||
164321507|NCT00095147|593554175|FG001|Long-term Extension Period|Death|0|||
164321508|NCT00095147|593554176|FG002|Long-term Extension Period|Death|0|||
164321509|NCT00095147|593554177|FG003|Long-term Extension Period|Death|0|||
164321510|NCT00095147|593554178|FG004|Long-term Extension Period|Death|3|||
164321511|NCT00095147|593554174|FG000|Long-term Extension Period|Adverse Event|0|||
164321512|NCT00095147|593554175|FG001|Long-term Extension Period|Adverse Event|0|||
164321513|NCT00095147|593554176|FG002|Long-term Extension Period|Adverse Event|0|||
164321514|NCT00095147|593554177|FG003|Long-term Extension Period|Adverse Event|0|||
164321515|NCT00095147|593554178|FG004|Long-term Extension Period|Adverse Event|11|||
164321516|NCT00095147|593554174|FG000|Long-term Extension Period|Lack of Efficacy|0|||
164321517|NCT00095147|593554175|FG001|Long-term Extension Period|Lack of Efficacy|0|||
164563590|NCT05702736|594431127|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
164563591|NCT04811716|594431141|FG000|Overall Study|Withdrawal by Subject|2|||
164563592|NCT04811716|594431142|FG001|Overall Study|Withdrawal by Subject|0|||
164563593|NCT03355300|594431143|FG000|Overall Study|Physician Decision|0|||
164563594|NCT03355300|594431144|FG001|Overall Study|Physician Decision|1|||
164563595|NCT03355300|594431143|FG000|Overall Study|Lack of Efficacy|2|||
164563596|NCT03355300|594431144|FG001|Overall Study|Lack of Efficacy|1|||
164563597|NCT03355300|594431143|FG000|Overall Study|Other reason|1|||
164207841|NCT02421939|593129907|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
164207842|NCT02421939|593129908|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
164207843|NCT02421939|593129907|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
164207844|NCT02421939|593129908|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
164207845|NCT02421939|593129907|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
164207846|NCT02421939|593129908|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
164207847|NCT02421939|593129907|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
164207848|NCT02421939|593129908|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
164207849|NCT02421939|593129907|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
164207850|NCT02421939|593129908|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
164207851|NCT02421939|593129907|FG000|Long Term Follow up: up to 3 Years|Death|118|||
164207852|NCT02421939|593129908|FG001|Long Term Follow up: up to 3 Years|Death|65|||
164207853|NCT02421939|593129907|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
164207854|NCT02421939|593129908|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
164563598|NCT03355300|594431144|FG001|Overall Study|Other reason|0|||
164563599|NCT00546052|594431145|FG000|Overall Study|Adverse Event|47|||
164563600|NCT00546052|594431145|FG000|Overall Study|Lost to Follow-up|144|||
164563601|NCT00546052|594431145|FG000|Overall Study|Protocol Violation|9|||
164563602|NCT00546052|594431145|FG000|Overall Study|Withdrawal by Subject|20|||
164563603|NCT00546052|594431145|FG000|Overall Study|Non Compliance|7|||
164563604|NCT01031446|594431148|FG000|Overall Study|Disease Progression|38|||
164563605|NCT01031446|594431148|FG000|Overall Study|Adverse Event|9|||
164563606|NCT01031446|594431148|FG000|Overall Study|Physician Decision|4|||
164563607|NCT01031446|594431148|FG000|Overall Study|Withdrawal by Subject|3|||
164563608|NCT01031446|594431148|FG000|Overall Study|Still on treatment|1|||
164207855|NCT00671788|593129909|FG000|Overall Study|Adverse Event|8|||
164321518|NCT00095147|593554176|FG002|Long-term Extension Period|Lack of Efficacy|0|||
164420653|NCT01154036|593910968|FG006|Phase I|Withdrawal by Subject|0|||
164667547|NCT00437658|594808413|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
164667548|NCT00437658|594808411|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
164667549|NCT00437658|594808412|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
164667550|NCT00437658|594808413|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
164667551|NCT00437658|594808411|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
164667552|NCT00437658|594808412|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
164667553|NCT00437658|594808413|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
164667554|NCT00437658|594808411|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
164667555|NCT00437658|594808412|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
164667556|NCT00437658|594808413|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
164667557|NCT00437658|594808411|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
164667558|NCT00437658|594808412|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
164667559|NCT00437658|594808413|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
164667560|NCT00437658|594808411|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
164667561|NCT00437658|594808412|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
164667562|NCT00437658|594808413|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
164667563|NCT00437658|594808411|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
164667564|NCT00437658|594808412|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
164667565|NCT00437658|594808413|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
164667566|NCT00437658|594808411|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
164667567|NCT00437658|594808412|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
164667568|NCT00437658|594808413|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
164667569|NCT00437658|594808411|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
164667570|NCT00437658|594808412|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
164667571|NCT00437658|594808413|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
164667572|NCT03952143|594808414|FG000|Lead-In Period|Adverse Event|2|||
164667573|NCT03952143|594808415|FG001|Lead-In Period|Adverse Event|0|||
164667574|NCT03952143|594808416|FG002|Lead-In Period|Adverse Event|0|||
164667575|NCT03952143|594808414|FG000|Lead-In Period|Lack of Efficacy|2|||
164667576|NCT03952143|594808415|FG001|Lead-In Period|Lack of Efficacy|0|||
164667577|NCT03952143|594808416|FG002|Lead-In Period|Lack of Efficacy|0|||
164667578|NCT03952143|594808414|FG000|Lead-In Period|Physician Decision|5|||
164667579|NCT03952143|594808415|FG001|Lead-In Period|Physician Decision|0|||
164667580|NCT03952143|594808416|FG002|Lead-In Period|Physician Decision|0|||
164667581|NCT03952143|594808414|FG000|Lead-In Period|Protocol Violation|5|||
164667582|NCT03952143|594808415|FG001|Lead-In Period|Protocol Violation|0|||
164667583|NCT03952143|594808416|FG002|Lead-In Period|Protocol Violation|0|||
164667584|NCT03952143|594808414|FG000|Lead-In Period|Withdrawal by Subject|19|||
164667585|NCT03952143|594808415|FG001|Lead-In Period|Withdrawal by Subject|0|||
164667586|NCT03952143|594808416|FG002|Lead-In Period|Withdrawal by Subject|0|||
164667587|NCT03952143|594808414|FG000|Treatment Period|Adverse Event|0|||
164667588|NCT03952143|594808415|FG001|Treatment Period|Adverse Event|0|||
164667589|NCT03952143|594808416|FG002|Treatment Period|Adverse Event|1|||
164667590|NCT03952143|594808414|FG000|Treatment Period|Lost to Follow-up|0|||
164667591|NCT03952143|594808415|FG001|Treatment Period|Lost to Follow-up|2|||
164667592|NCT03952143|594808416|FG002|Treatment Period|Lost to Follow-up|0|||
164667593|NCT03952143|594808414|FG000|Treatment Period|Physician Decision|0|||
164667594|NCT03952143|594808415|FG001|Treatment Period|Physician Decision|0|||
164667595|NCT03952143|594808416|FG002|Treatment Period|Physician Decision|2|||
164667596|NCT03952143|594808414|FG000|Treatment Period|Protocol Violation|0|||
164667597|NCT03952143|594808415|FG001|Treatment Period|Protocol Violation|0|||
164667598|NCT03952143|594808416|FG002|Treatment Period|Protocol Violation|1|||
164667599|NCT03952143|594808414|FG000|Treatment Period|Withdrawal by Subject|0|||
164667600|NCT03952143|594808415|FG001|Treatment Period|Withdrawal by Subject|5|||
164667601|NCT03952143|594808416|FG002|Treatment Period|Withdrawal by Subject|26|||
164667602|NCT03952143|594808414|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
164563609|NCT01877083|594431149|FG000|Treatment Phase|Disease Progression|10|||
164563610|NCT01877083|594431149|FG000|Treatment Phase|Clinical Progression|1|||
164563611|NCT01877083|594431149|FG000|Treatment Phase|Adverse Event|6|||
164563612|NCT01877083|594431149|FG000|Treatment Phase|Withdrawal by Subject|2|||
164563613|NCT01877083|594431149|FG000|Treatment Phase|Lost to Follow-up|1|||
164563614|NCT01877083|594431149|FG000|Extension Phase|Disease Progression|3|||
164563615|NCT01877083|594431149|FG000|Extension Phase|Adverse Event|2|||
164563616|NCT02320487|594431150|FG000|Overall Study|Reason not Specified|1|||
164563617|NCT02320487|594431150|FG000|Overall Study|Physician Decision|5|||
164563618|NCT02320487|594431150|FG000|Overall Study|Withdrawal by Subject|1|||
164563619|NCT02320487|594431150|FG000|Overall Study|Death|3|||
164667603|NCT03952143|594808415|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
164667604|NCT03952143|594808416|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
164667605|NCT03952143|594808414|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
164563620|NCT02320487|594431150|FG000|Overall Study|Adverse Event|11|||
164667606|NCT03952143|594808415|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
164667607|NCT03952143|594808416|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
164667608|NCT02152566|594808417|FG000|Overall Study|Lost to Follow-up|1|||
164667609|NCT02152566|594808417|FG000|Overall Study|Withdrawal by Subject|2|||
164667610|NCT01866319|594808418|FG000|Overall Study|Adverse Event|12|||
164667611|NCT01866319|594808419|FG001|Overall Study|Adverse Event|5|||
164667612|NCT01866319|594808420|FG002|Overall Study|Adverse Event|9|||
164667613|NCT01866319|594808418|FG000|Overall Study|Clinical progression|3|||
164667614|NCT01866319|594808419|FG001|Overall Study|Clinical progression|2|||
164667615|NCT01866319|594808420|FG002|Overall Study|Clinical progression|2|||
164667616|NCT01866319|594808418|FG000|Overall Study|Death|153|||
164667617|NCT01866319|594808419|FG001|Overall Study|Death|154|||
164667618|NCT01866319|594808420|FG002|Overall Study|Death|147|||
164667619|NCT01866319|594808418|FG000|Overall Study|Lost to Follow-up|6|||
164667620|NCT01866319|594808419|FG001|Overall Study|Lost to Follow-up|3|||
164667621|NCT01866319|594808420|FG002|Overall Study|Lost to Follow-up|8|||
164667622|NCT01866319|594808418|FG000|Overall Study|Physician Decision|1|||
164667623|NCT01866319|594808419|FG001|Overall Study|Physician Decision|0|||
164667624|NCT01866319|594808420|FG002|Overall Study|Physician Decision|1|||
164667625|NCT01866319|594808418|FG000|Overall Study|Protocol Violation|0|||
164667626|NCT01866319|594808419|FG001|Overall Study|Protocol Violation|0|||
164667627|NCT01866319|594808420|FG002|Overall Study|Protocol Violation|1|||
164667628|NCT01866319|594808418|FG000|Overall Study|Withdrawal by Subject|32|||
164667629|NCT01866319|594808419|FG001|Overall Study|Withdrawal by Subject|14|||
164667630|NCT01866319|594808420|FG002|Overall Study|Withdrawal by Subject|12|||
164667631|NCT00496964|594808421|FG000|Overall Study|Withdrawal by Subject|0|||
164667632|NCT00496964|594808422|FG001|Overall Study|Withdrawal by Subject|1|||
164667633|NCT02942264|594808423|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
164667634|NCT02942264|594808424|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
164667635|NCT02942264|594808425|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
164667636|NCT02942264|594808426|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
164667637|NCT02942264|594808427|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
164667638|NCT02942264|594808428|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
164667639|NCT02942264|594808429|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
164667640|NCT02942264|594808430|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
164667641|NCT02942264|594808431|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
164667642|NCT02942264|594808423|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
164667643|NCT02942264|594808424|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
164667644|NCT02942264|594808425|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
164667645|NCT02942264|594808426|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
164667646|NCT02942264|594808427|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
164667647|NCT02942264|594808428|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
164667648|NCT02942264|594808429|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
164667649|NCT02942264|594808430|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
164667650|NCT02942264|594808431|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
164667651|NCT01328093|594808432|FG000|Double-Blind Phase|Adverse Event|78|||
164667652|NCT01328093|594808433|FG001|Double-Blind Phase|Adverse Event|15|||
164667653|NCT01328093|594808432|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
164667654|NCT01328093|594808433|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
164667655|NCT01328093|594808432|FG000|Double-Blind Phase|Lost to Follow-up|39|||
164667656|NCT01328093|594808433|FG001|Double-Blind Phase|Lost to Follow-up|14|||
164667657|NCT01328093|594808432|FG000|Double-Blind Phase|Protocol Violation|30|||
164667658|NCT01328093|594808433|FG001|Double-Blind Phase|Protocol Violation|10|||
164667659|NCT01328093|594808432|FG000|Double-Blind Phase|Lack of Efficacy|55|||
164667660|NCT01328093|594808433|FG001|Double-Blind Phase|Lack of Efficacy|13|||
164667661|NCT01328093|594808432|FG000|Double-Blind Phase|Sponsor Decision|17|||
164667662|NCT01328093|594808433|FG001|Double-Blind Phase|Sponsor Decision|3|||
164667663|NCT01328093|594808432|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
164667664|NCT01328093|594808433|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
164667665|NCT01328093|594808432|FG000|Double-Blind Phase|Scheduling conflict|8|||
164667666|NCT01328093|594808433|FG001|Double-Blind Phase|Scheduling conflict|3|||
164667667|NCT01328093|594808432|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
164667668|NCT01328093|594808433|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
164667669|NCT01328093|594808432|FG000|Double-Blind Phase|Death|1|||
164667670|NCT01328093|594808433|FG001|Double-Blind Phase|Death|0|||
164667671|NCT01328093|594808432|FG000|Open-Label Phase|Sponsor Decision|98|||
164667672|NCT01328093|594808433|FG001|Open-Label Phase|Sponsor Decision|34|||
164667673|NCT01328093|594808432|FG000|Open-Label Phase|Protocol Violation|8|||
164667674|NCT01328093|594808433|FG001|Open-Label Phase|Protocol Violation|3|||
164667675|NCT01328093|594808432|FG000|Open-Label Phase|Lost to Follow-up|10|||
164667676|NCT01328093|594808433|FG001|Open-Label Phase|Lost to Follow-up|1|||
164667677|NCT01328093|594808432|FG000|Open-Label Phase|Adverse Event|10|||
164667678|NCT01328093|594808433|FG001|Open-Label Phase|Adverse Event|4|||
164667679|NCT01328093|594808432|FG000|Open-Label Phase|Lack of Efficacy|5|||
164667680|NCT01328093|594808433|FG001|Open-Label Phase|Lack of Efficacy|6|||
164667681|NCT01328093|594808432|FG000|Open-Label Phase|Withdrawal by Subject|4|||
164207856|NCT00671788|593129909|FG000|Overall Study|Refused further treatment|3|||
164667682|NCT01328093|594808433|FG001|Open-Label Phase|Withdrawal by Subject|1|||
164667683|NCT01328093|594808432|FG000|Open-Label Phase|Scheduling conflict|2|||
164667684|NCT01328093|594808433|FG001|Open-Label Phase|Scheduling conflict|1|||
164667685|NCT01328093|594808432|FG000|Open-Label Phase|Subject is moving or has moved|2|||
164667686|NCT01328093|594808433|FG001|Open-Label Phase|Subject is moving or has moved|0|||
164667687|NCT01328093|594808432|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
164667688|NCT01328093|594808433|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
164667689|NCT03980483|594808436|FG000|Overall Study|Adverse Event|13|||
164667690|NCT03980483|594808437|FG001|Overall Study|Adverse Event|29|||
164667691|NCT03980483|594808438|FG002|Overall Study|Adverse Event|11|||
164667692|NCT03980483|594808439|FG003|Overall Study|Adverse Event|2|||
164667693|NCT03980483|594808440|FG004|Overall Study|Adverse Event|2|||
164667694|NCT03980483|594808441|FG005|Overall Study|Adverse Event|2|||
164667695|NCT03980483|594808436|FG000|Overall Study|Lack of Efficacy|7|||
164667696|NCT03980483|594808437|FG001|Overall Study|Lack of Efficacy|6|||
164667697|NCT03980483|594808438|FG002|Overall Study|Lack of Efficacy|0|||
164667698|NCT03980483|594808439|FG003|Overall Study|Lack of Efficacy|3|||
164667699|NCT03980483|594808440|FG004|Overall Study|Lack of Efficacy|1|||
164667700|NCT03980483|594808441|FG005|Overall Study|Lack of Efficacy|1|||
164667701|NCT03980483|594808436|FG000|Overall Study|Lost to Follow-up|2|||
164667702|NCT03980483|594808437|FG001|Overall Study|Lost to Follow-up|4|||
164667703|NCT03980483|594808438|FG002|Overall Study|Lost to Follow-up|2|||
164667704|NCT03980483|594808439|FG003|Overall Study|Lost to Follow-up|1|||
164667705|NCT03980483|594808440|FG004|Overall Study|Lost to Follow-up|2|||
164667706|NCT03980483|594808441|FG005|Overall Study|Lost to Follow-up|0|||
164667707|NCT03980483|594808436|FG000|Overall Study|Protocol Violation|4|||
164667708|NCT03980483|594808437|FG001|Overall Study|Protocol Violation|2|||
164667709|NCT03980483|594808438|FG002|Overall Study|Protocol Violation|1|||
164667710|NCT03980483|594808439|FG003|Overall Study|Protocol Violation|1|||
164667711|NCT03980483|594808440|FG004|Overall Study|Protocol Violation|0|||
164667712|NCT03980483|594808441|FG005|Overall Study|Protocol Violation|0|||
164667713|NCT03980483|594808436|FG000|Overall Study|Physician Decision|14|||
164667714|NCT03980483|594808437|FG001|Overall Study|Physician Decision|10|||
164667715|NCT03980483|594808438|FG002|Overall Study|Physician Decision|7|||
164667716|NCT03980483|594808439|FG003|Overall Study|Physician Decision|4|||
164667717|NCT03980483|594808440|FG004|Overall Study|Physician Decision|4|||
164667718|NCT03980483|594808441|FG005|Overall Study|Physician Decision|2|||
164667719|NCT03980483|594808436|FG000|Overall Study|Withdrawal by Subject|38|||
164667720|NCT03980483|594808437|FG001|Overall Study|Withdrawal by Subject|21|||
164667721|NCT03980483|594808438|FG002|Overall Study|Withdrawal by Subject|15|||
164667722|NCT03980483|594808439|FG003|Overall Study|Withdrawal by Subject|5|||
164667723|NCT03980483|594808440|FG004|Overall Study|Withdrawal by Subject|3|||
164667724|NCT03980483|594808441|FG005|Overall Study|Withdrawal by Subject|4|||
164667725|NCT03980483|594808436|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
164667726|NCT03980483|594808437|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
164667727|NCT03980483|594808438|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
164667728|NCT03980483|594808439|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
164667729|NCT03980483|594808440|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
164667730|NCT03980483|594808441|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
164667731|NCT03980483|594808436|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
164667732|NCT03980483|594808437|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
164667733|NCT03980483|594808438|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
164667734|NCT03980483|594808439|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
164667735|NCT03980483|594808440|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
164667736|NCT03980483|594808441|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
164667737|NCT03980483|594808436|FG000|Overall Study|Other|0|||
164667738|NCT03980483|594808437|FG001|Overall Study|Other|1|||
164667739|NCT03980483|594808438|FG002|Overall Study|Other|0|||
164667740|NCT03980483|594808439|FG003|Overall Study|Other|0|||
164667741|NCT03980483|594808440|FG004|Overall Study|Other|0|||
164667742|NCT03980483|594808441|FG005|Overall Study|Other|0|||
164667743|NCT05150964|594808442|FG000|Overall Study|Lost to Follow-up|2|||
164667744|NCT01062256|594808447|FG000|Overall Study|Adverse Event|1|||
164667745|NCT01062256|594808448|FG001|Overall Study|Adverse Event|0|||
164667746|NCT01062256|594808449|FG002|Overall Study|Adverse Event|0|||
164667747|NCT01062256|594808447|FG000|Overall Study|Withdrawal by Subject|1|||
164667748|NCT01062256|594808448|FG001|Overall Study|Withdrawal by Subject|1|||
164667749|NCT01062256|594808449|FG002|Overall Study|Withdrawal by Subject|1|||
164667750|NCT01062256|594808447|FG000|Overall Study|Ineligible|1|||
164667751|NCT01062256|594808448|FG001|Overall Study|Ineligible|4|||
164667752|NCT01062256|594808449|FG002|Overall Study|Ineligible|3|||
164667753|NCT01062256|594808447|FG000|Overall Study|Administrative|0|||
164420654|NCT01154036|593910969|FG007|Phase I|Withdrawal by Subject|0|||
164667754|NCT01062256|594808448|FG001|Overall Study|Administrative|2|||
164667755|NCT01062256|594808449|FG002|Overall Study|Administrative|0|||
164667756|NCT01448057|594808451|FG000|Overall Study|Protocol Violation|3|||
164667757|NCT01448057|594808452|FG001|Overall Study|Protocol Violation|2|||
164667758|NCT01448057|594808451|FG000|Overall Study|Lost to Follow-up|3|||
164667759|NCT01448057|594808452|FG001|Overall Study|Lost to Follow-up|0|||
164667760|NCT01448057|594808451|FG000|Overall Study|Adverse Event|0|||
164667761|NCT01448057|594808452|FG001|Overall Study|Adverse Event|2|||
164667762|NCT01448057|594808451|FG000|Overall Study|Withdrawal by Subject|2|||
164667763|NCT01448057|594808452|FG001|Overall Study|Withdrawal by Subject|0|||
164667764|NCT03883906|594808455|FG000|Overall Study|Withdrawal by Subject|2|||
164667765|NCT03883906|594808455|FG000|Overall Study|Physician Decision|5|||
164667766|NCT02468778|594808457|FG000|Overall Study|Death|2|||
164667767|NCT02468778|594808458|FG001|Overall Study|Death|1|||
164667768|NCT02468778|594808459|FG002|Overall Study|Death|0|||
164667769|NCT02468778|594808457|FG000|Overall Study|Lost to Follow-up|1|||
164667770|NCT02468778|594808458|FG001|Overall Study|Lost to Follow-up|2|||
164667771|NCT02468778|594808459|FG002|Overall Study|Lost to Follow-up|2|||
164667772|NCT02468778|594808457|FG000|Overall Study|Withdrawal by Subject|0|||
164667773|NCT02468778|594808458|FG001|Overall Study|Withdrawal by Subject|1|||
164667774|NCT02468778|594808459|FG002|Overall Study|Withdrawal by Subject|1|||
164667775|NCT01629381|594808465|FG000|Overall Study|Withdrawal by Subject|2|||
164667776|NCT01629381|594808466|FG001|Overall Study|Withdrawal by Subject|5|||
164667777|NCT00745095|594808470|FG000|Overall Study|Declined to participate|1|||
164667778|NCT00745095|594808471|FG001|Overall Study|Declined to participate|0|||
164667779|NCT00745095|594808472|FG002|Overall Study|Declined to participate|0|||
164667780|NCT00745095|594808473|FG003|Overall Study|Declined to participate|0|||
164667781|NCT00745095|594808474|FG004|Overall Study|Declined to participate|92|||
164667782|NCT00745095|594808475|FG005|Overall Study|Declined to participate|95|||
164667783|NCT00745095|594808470|FG000|Overall Study|Ineligible due to GFR criteria|0|||
164667784|NCT00745095|594808471|FG001|Overall Study|Ineligible due to GFR criteria|2|||
164667785|NCT00745095|594808472|FG002|Overall Study|Ineligible due to GFR criteria|3|||
164321519|NCT00095147|593554177|FG003|Long-term Extension Period|Lack of Efficacy|0|||
164321520|NCT00095147|593554178|FG004|Long-term Extension Period|Lack of Efficacy|9|||
164321521|NCT00095147|593554174|FG000|Long-term Extension Period|Lost to Follow-up|0|||
164667786|NCT00745095|594808473|FG003|Overall Study|Ineligible due to GFR criteria|3|||
164667787|NCT00745095|594808474|FG004|Overall Study|Ineligible due to GFR criteria|30|||
164667788|NCT00745095|594808475|FG005|Overall Study|Ineligible due to GFR criteria|28|||
164667789|NCT00162123|594808476|FG000|Overall Study|Disease progression|27|||
164667790|NCT00162123|594808477|FG001|Overall Study|Disease progression|19|||
164667791|NCT00162123|594808478|FG002|Overall Study|Disease progression|10|||
164667792|NCT00162123|594808479|FG003|Overall Study|Disease progression|4|||
164667793|NCT00162123|594808480|FG004|Overall Study|Disease progression|8|||
164667794|NCT00162123|594808481|FG005|Overall Study|Disease progression|3|||
164667795|NCT00162123|594808482|FG006|Overall Study|Disease progression|1|||
164667796|NCT00162123|594808483|FG007|Overall Study|Disease progression|0|||
164667797|NCT00162123|594808476|FG000|Overall Study|Study drug toxicity|6|||
164667798|NCT00162123|594808477|FG001|Overall Study|Study drug toxicity|1|||
164667799|NCT00162123|594808478|FG002|Overall Study|Study drug toxicity|5|||
164667800|NCT00162123|594808479|FG003|Overall Study|Study drug toxicity|0|||
164667801|NCT00162123|594808480|FG004|Overall Study|Study drug toxicity|4|||
164667802|NCT00162123|594808481|FG005|Overall Study|Study drug toxicity|1|||
164667803|NCT00162123|594808482|FG006|Overall Study|Study drug toxicity|1|||
164667804|NCT00162123|594808483|FG007|Overall Study|Study drug toxicity|0|||
164667805|NCT00162123|594808476|FG000|Overall Study|Death|3|||
164667806|NCT00162123|594808477|FG001|Overall Study|Death|3|||
164667807|NCT00162123|594808478|FG002|Overall Study|Death|1|||
164667808|NCT00162123|594808479|FG003|Overall Study|Death|1|||
164667809|NCT00162123|594808480|FG004|Overall Study|Death|1|||
164667810|NCT00162123|594808481|FG005|Overall Study|Death|1|||
164667811|NCT00162123|594808482|FG006|Overall Study|Death|0|||
164667812|NCT00162123|594808483|FG007|Overall Study|Death|0|||
164667813|NCT00162123|594808476|FG000|Overall Study|Withdrawal by Subject|2|||
164667814|NCT00162123|594808477|FG001|Overall Study|Withdrawal by Subject|0|||
164321522|NCT00095147|593554175|FG001|Long-term Extension Period|Lost to Follow-up|0|||
164321523|NCT00095147|593554176|FG002|Long-term Extension Period|Lost to Follow-up|0|||
164321524|NCT00095147|593554177|FG003|Long-term Extension Period|Lost to Follow-up|0|||
164321525|NCT00095147|593554178|FG004|Long-term Extension Period|Lost to Follow-up|6|||
164667815|NCT00162123|594808478|FG002|Overall Study|Withdrawal by Subject|2|||
164667816|NCT00162123|594808479|FG003|Overall Study|Withdrawal by Subject|1|||
164667817|NCT00162123|594808480|FG004|Overall Study|Withdrawal by Subject|1|||
164667818|NCT00162123|594808481|FG005|Overall Study|Withdrawal by Subject|2|||
164667819|NCT00162123|594808482|FG006|Overall Study|Withdrawal by Subject|1|||
164667820|NCT00162123|594808483|FG007|Overall Study|Withdrawal by Subject|0|||
164667821|NCT00162123|594808476|FG000|Overall Study|Deterioration without progression|2|||
164667822|NCT00162123|594808477|FG001|Overall Study|Deterioration without progression|2|||
164667823|NCT00162123|594808478|FG002|Overall Study|Deterioration without progression|3|||
164667824|NCT00162123|594808479|FG003|Overall Study|Deterioration without progression|0|||
164667825|NCT00162123|594808480|FG004|Overall Study|Deterioration without progression|1|||
164667826|NCT00162123|594808481|FG005|Overall Study|Deterioration without progression|0|||
164667827|NCT00162123|594808482|FG006|Overall Study|Deterioration without progression|0|||
164667828|NCT00162123|594808483|FG007|Overall Study|Deterioration without progression|0|||
164667829|NCT00162123|594808476|FG000|Overall Study|Adverse Event|1|||
164667830|NCT00162123|594808477|FG001|Overall Study|Adverse Event|2|||
164667831|NCT00162123|594808478|FG002|Overall Study|Adverse Event|0|||
164667832|NCT00162123|594808479|FG003|Overall Study|Adverse Event|2|||
164667833|NCT00162123|594808480|FG004|Overall Study|Adverse Event|1|||
164667834|NCT00162123|594808481|FG005|Overall Study|Adverse Event|0|||
164667835|NCT00162123|594808482|FG006|Overall Study|Adverse Event|0|||
164667836|NCT00162123|594808483|FG007|Overall Study|Adverse Event|0|||
164667837|NCT00162123|594808476|FG000|Overall Study|Not specified (before treatment)|2|||
164667838|NCT00162123|594808477|FG001|Overall Study|Not specified (before treatment)|0|||
164667839|NCT00162123|594808478|FG002|Overall Study|Not specified (before treatment)|0|||
164667840|NCT00162123|594808479|FG003|Overall Study|Not specified (before treatment)|0|||
164667841|NCT00162123|594808480|FG004|Overall Study|Not specified (before treatment)|12|||
164667842|NCT00162123|594808481|FG005|Overall Study|Not specified (before treatment)|1|||
164667843|NCT00162123|594808482|FG006|Overall Study|Not specified (before treatment)|0|||
164667844|NCT00162123|594808483|FG007|Overall Study|Not specified (before treatment)|0|||
164667845|NCT00162123|594808476|FG000|Overall Study|Not specified (after start of treatment)|0|||
164667846|NCT00162123|594808477|FG001|Overall Study|Not specified (after start of treatment)|0|||
164667847|NCT00162123|594808478|FG002|Overall Study|Not specified (after start of treatment)|0|||
164667848|NCT00162123|594808479|FG003|Overall Study|Not specified (after start of treatment)|0|||
164667849|NCT00162123|594808480|FG004|Overall Study|Not specified (after start of treatment)|3|||
164667850|NCT00162123|594808481|FG005|Overall Study|Not specified (after start of treatment)|0|||
164667851|NCT00162123|594808482|FG006|Overall Study|Not specified (after start of treatment)|0|||
164667852|NCT00162123|594808483|FG007|Overall Study|Not specified (after start of treatment)|0|||
164667853|NCT00162123|594808476|FG000|Overall Study|Physician Decision|1|||
164667854|NCT00162123|594808477|FG001|Overall Study|Physician Decision|2|||
164667855|NCT00162123|594808478|FG002|Overall Study|Physician Decision|0|||
164667856|NCT00162123|594808479|FG003|Overall Study|Physician Decision|0|||
164667857|NCT00162123|594808480|FG004|Overall Study|Physician Decision|0|||
164667858|NCT00162123|594808481|FG005|Overall Study|Physician Decision|1|||
164667859|NCT00162123|594808482|FG006|Overall Study|Physician Decision|1|||
164667860|NCT00162123|594808483|FG007|Overall Study|Physician Decision|0|||
164667861|NCT00162123|594808476|FG000|Overall Study|Tumor assessment only (not treated)|0|||
164667862|NCT00162123|594808477|FG001|Overall Study|Tumor assessment only (not treated)|0|||
164667863|NCT00162123|594808478|FG002|Overall Study|Tumor assessment only (not treated)|0|||
164667864|NCT00162123|594808479|FG003|Overall Study|Tumor assessment only (not treated)|0|||
164667865|NCT00162123|594808480|FG004|Overall Study|Tumor assessment only (not treated)|0|||
164667866|NCT00162123|594808481|FG005|Overall Study|Tumor assessment only (not treated)|0|||
164667867|NCT00162123|594808482|FG006|Overall Study|Tumor assessment only (not treated)|0|||
164667868|NCT00162123|594808483|FG007|Overall Study|Tumor assessment only (not treated)|1|||
164667869|NCT00162123|594808476|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
164667870|NCT00162123|594808477|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
164667871|NCT00162123|594808478|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
164667872|NCT00162123|594808479|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
164667873|NCT00162123|594808480|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
164667874|NCT00162123|594808481|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
164667875|NCT00162123|594808482|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
164667876|NCT00162123|594808483|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
164667877|NCT01318499|594808484|FG000|Overall Study|Adverse Event|16|||
164667878|NCT01318499|594808485|FG001|Overall Study|Adverse Event|11|||
164667879|NCT01318499|594808486|FG002|Overall Study|Adverse Event|6|||
164667880|NCT01318499|594808484|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
164667881|NCT01318499|594808485|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
164667882|NCT01318499|594808486|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
164667883|NCT01318499|594808484|FG000|Overall Study|Noncompliance|2|||
164667884|NCT01318499|594808485|FG001|Overall Study|Noncompliance|3|||
164667885|NCT01318499|594808486|FG002|Overall Study|Noncompliance|0|||
164667886|NCT01318499|594808484|FG000|Overall Study|Treatment Failure|19|||
164667887|NCT01318499|594808485|FG001|Overall Study|Treatment Failure|19|||
164667888|NCT01318499|594808486|FG002|Overall Study|Treatment Failure|101|||
164667889|NCT01318499|594808484|FG000|Overall Study|Protocol Violation|2|||
164667890|NCT01318499|594808485|FG001|Overall Study|Protocol Violation|4|||
164667891|NCT01318499|594808486|FG002|Overall Study|Protocol Violation|2|||
164667892|NCT01318499|594808484|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
164667893|NCT01318499|594808485|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
164667894|NCT01318499|594808486|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
164667895|NCT01318499|594808484|FG000|Overall Study|Other|7|||
164667896|NCT01318499|594808485|FG001|Overall Study|Other|10|||
164667897|NCT01318499|594808486|FG002|Overall Study|Other|22|||
164667898|NCT01395030|594808487|FG000|Overall Study|Did not complete FCH PET/CT|7|||
164667899|NCT03629249|594808488|FG000|Overall Study|Study terminated by sponsor|197|||
164667900|NCT03629249|594808489|FG001|Overall Study|Study terminated by sponsor|197|||
164667901|NCT03629249|594808490|FG002|Overall Study|Study terminated by sponsor|194|||
164667902|NCT03629249|594808488|FG000|Overall Study|Protocol deviation|0|||
164667903|NCT03629249|594808489|FG001|Overall Study|Protocol deviation|2|||
164667904|NCT03629249|594808490|FG002|Overall Study|Protocol deviation|5|||
164667905|NCT03629249|594808488|FG000|Overall Study|Subject decision|1|||
164667906|NCT03629249|594808489|FG001|Overall Study|Subject decision|1|||
164667907|NCT03629249|594808490|FG002|Overall Study|Subject decision|3|||
164667908|NCT03629249|594808488|FG000|Overall Study|Adverse Event|1|||
164667909|NCT03629249|594808489|FG001|Overall Study|Adverse Event|1|||
164667910|NCT03629249|594808490|FG002|Overall Study|Adverse Event|0|||
164667911|NCT03629249|594808488|FG000|Overall Study|Death|1|||
164667912|NCT03629249|594808489|FG001|Overall Study|Death|0|||
164667913|NCT03629249|594808490|FG002|Overall Study|Death|0|||
164667914|NCT03629249|594808488|FG000|Overall Study|Physician Decision|1|||
164667915|NCT03629249|594808489|FG001|Overall Study|Physician Decision|0|||
164667916|NCT03629249|594808490|FG002|Overall Study|Physician Decision|0|||
164667917|NCT02534493|594808492|FG000|Overall Study|Lost to Follow-up|1|||
164667918|NCT02534493|594808492|FG000|Overall Study|Withdrawal by Subject|1|||
164667919|NCT02817841|594810030|FG000|Overall Study|Lost to Follow-up|287|||
164667920|NCT02817841|594810030|FG000|Overall Study|Withdrawal by Subject|183|||
164667921|NCT02817841|594810030|FG000|Overall Study|Adverse event not related to bleeding|131|||
164667922|NCT02817841|594810030|FG000|Overall Study|Adverse event related to bleeding|51|||
164667923|NCT02817841|594810030|FG000|Overall Study|Pregnancy|32|||
164667924|NCT02817841|594810030|FG000|Overall Study|Pregnancy wish|17|||
164667925|NCT02817841|594810030|FG000|Overall Study|Other reasons|53|||
164667926|NCT02817841|594810030|FG000|Overall Study|Protocol Violation|94|||
164667927|NCT04188106|594810031|FG000|Overall Study|Lost to Follow-up|5|||
164667928|NCT04188106|594810031|FG000|Overall Study|Non-Compliance|1|||
164667929|NCT00705536|594810032|FG000|Start Period 1|Withdrawal by Subject|0|||
164667930|NCT00705536|594810033|FG001|Start Period 1|Withdrawal by Subject|0|||
164667931|NCT00705536|594810034|FG002|Start Period 1|Withdrawal by Subject|0|||
164667932|NCT00705536|594810035|FG003|Start Period 1|Withdrawal by Subject|1|||
164667933|NCT02289963|594810036|FG000|Overall Study|Adverse Event|1|||
164667934|NCT02289963|594810037|FG001|Overall Study|Adverse Event|2|||
164667935|NCT02289963|594810036|FG000|Overall Study|Poor compliance to protocol|1|||
164667936|NCT02289963|594810037|FG001|Overall Study|Poor compliance to protocol|0|||
164667937|NCT02289963|594810036|FG000|Overall Study|Withdrawal by Subject|1|||
164667938|NCT02289963|594810037|FG001|Overall Study|Withdrawal by Subject|0|||
164667939|NCT02289963|594810036|FG000|Overall Study|Last injection missed|2|||
164667940|NCT02289963|594810037|FG001|Overall Study|Last injection missed|2|||
164667941|NCT02289963|594810036|FG000|Overall Study|End treatment visit outside visit window|0|||
164667942|NCT02289963|594810037|FG001|Overall Study|End treatment visit outside visit window|4|||
164667943|NCT02289963|594810036|FG000|Overall Study|Other than specified above|0|||
164667944|NCT02289963|594810037|FG001|Overall Study|Other than specified above|2|||
164667945|NCT01746017|594810039|FG000|Period 1|Withdrawal by Subject|0|||
164667946|NCT01746017|594810040|FG001|Period 1|Withdrawal by Subject|0|||
164667947|NCT01746017|594810041|FG002|Period 1|Withdrawal by Subject|0|||
164667948|NCT01746017|594810042|FG003|Period 1|Withdrawal by Subject|0|||
164667949|NCT01746017|594810043|FG004|Period 1|Withdrawal by Subject|0|||
164667950|NCT01746017|594810044|FG005|Period 1|Withdrawal by Subject|0|||
164667951|NCT01746017|594810045|FG006|Period 1|Withdrawal by Subject|1|||
164667952|NCT01746017|594810046|FG007|Period 1|Withdrawal by Subject|0|||
164667953|NCT01746017|594810047|FG008|Period 1|Withdrawal by Subject|0|||
164667954|NCT01746017|594810048|FG009|Period 1|Withdrawal by Subject|0|||
164667955|NCT01746017|594810049|FG010|Period 1|Withdrawal by Subject|0|||
164667956|NCT01746017|594810039|FG000|Period 3|Withdrawal by Subject|0|||
164667957|NCT01746017|594810040|FG001|Period 3|Withdrawal by Subject|0|||
164667958|NCT01746017|594810041|FG002|Period 3|Withdrawal by Subject|0|||
164667959|NCT01746017|594810042|FG003|Period 3|Withdrawal by Subject|0|||
164667960|NCT01746017|594810043|FG004|Period 3|Withdrawal by Subject|0|||
164667961|NCT01746017|594810044|FG005|Period 3|Withdrawal by Subject|1|||
164667962|NCT01746017|594810045|FG006|Period 3|Withdrawal by Subject|0|||
164667963|NCT01746017|594810046|FG007|Period 3|Withdrawal by Subject|0|||
164667964|NCT01746017|594810047|FG008|Period 3|Withdrawal by Subject|0|||
164667965|NCT01746017|594810048|FG009|Period 3|Withdrawal by Subject|0|||
164667966|NCT01746017|594810049|FG010|Period 3|Withdrawal by Subject|0|||
164667967|NCT00397488|594810050|FG000|Overall Study|Withdrawal by Subject|3|||
164667968|NCT00397488|594810050|FG000|Overall Study|Adverse Event|3|||
164667969|NCT00397488|594810050|FG000|Overall Study|Death|1|||
164321526|NCT00095147|593554174|FG000|Long-term Extension Period|Withdrawal of consent|0|||
164667970|NCT02424097|594810053|FG000|Overall Study|Lost to Follow-up|1|||
164667971|NCT02424097|594810054|FG001|Overall Study|Lost to Follow-up|2|||
164667972|NCT01675622|594810055|FG000|Overall Study|Withdrawal by Subject|2|||
164667973|NCT01675622|594810056|FG001|Overall Study|Withdrawal by Subject|2|||
164667974|NCT01675622|594810055|FG000|Overall Study|Adverse Event|12|||
164667975|NCT01675622|594810056|FG001|Overall Study|Adverse Event|10|||
164667976|NCT01675622|594810055|FG000|Overall Study|Protocol Violation|4|||
164667977|NCT01675622|594810056|FG001|Overall Study|Protocol Violation|1|||
164667978|NCT01675622|594810055|FG000|Overall Study|Lack of Efficacy|2|||
164667979|NCT01675622|594810056|FG001|Overall Study|Lack of Efficacy|4|||
164667980|NCT01675622|594810055|FG000|Overall Study|Lost to Follow-up|1|||
164667981|NCT01675622|594810056|FG001|Overall Study|Lost to Follow-up|3|||
164667982|NCT01675622|594810055|FG000|Overall Study|Other|5|||
164667983|NCT01675622|594810056|FG001|Overall Study|Other|4|||
164667984|NCT04032977|594810057|FG000|Overall Study|Withdrawal by Subject|6|||
164667985|NCT04032977|594810058|FG001|Overall Study|Withdrawal by Subject|1|||
164667986|NCT04032977|594810057|FG000|Overall Study|Lost to Follow-up|2|||
164667987|NCT04032977|594810058|FG001|Overall Study|Lost to Follow-up|7|||
164667988|NCT04032977|594810057|FG000|Overall Study|Pregnancy|1|||
164667989|NCT04032977|594810058|FG001|Overall Study|Pregnancy|0|||
164667990|NCT02880761|594810060|FG000|Overall Study|Death|6|||
164667991|NCT02880761|594810061|FG001|Overall Study|Death|8|||
164667992|NCT02880761|594810060|FG000|Overall Study|Withdrawal by Subject|3|||
164667993|NCT02880761|594810061|FG001|Overall Study|Withdrawal by Subject|6|||
164667994|NCT02880761|594810060|FG000|Overall Study|Protocol Violation|4|||
164667995|NCT02880761|594810061|FG001|Overall Study|Protocol Violation|3|||
164667996|NCT02880761|594810060|FG000|Overall Study|Lost to Follow-up|3|||
164667997|NCT02880761|594810061|FG001|Overall Study|Lost to Follow-up|4|||
164667998|NCT01519661|594810062|FG000|Overall Study|Protocol deviation|6|||
164667999|NCT01519661|594810062|FG000|Overall Study|Lost to Follow-up|3|||
164668000|NCT01519661|594810062|FG000|Overall Study|Withdrawal by Subject|17|||
164668001|NCT01519661|594810062|FG000|Overall Study|Lack of Efficacy|6|||
164668002|NCT01519661|594810062|FG000|Overall Study|Adverse Event|29|||
164668003|NCT03075761|594810063|FG000|Overall Study|Lost to Follow-up|1|||
164668004|NCT03075761|594810064|FG001|Overall Study|Lost to Follow-up|6|||
164668005|NCT02106156|594810065|FG000|Overall Study|Patient Died|19|||
164668006|NCT02106156|594810066|FG001|Overall Study|Patient Died|0|||
164668007|NCT02106156|594810067|FG002|Overall Study|Patient Died|0|||
164668008|NCT02106156|594810065|FG000|Overall Study|Lack of Tolerability|305|||
164668009|NCT02106156|594810066|FG001|Overall Study|Lack of Tolerability|3|||
164668010|NCT02106156|594810067|FG002|Overall Study|Lack of Tolerability|0|||
164668011|NCT02106156|594810065|FG000|Overall Study|Lack of Virological Response|1044|||
164668012|NCT02106156|594810066|FG001|Overall Study|Lack of Virological Response|8|||
164668013|NCT02106156|594810067|FG002|Overall Study|Lack of Virological Response|0|||
164668014|NCT02106156|594810065|FG000|Overall Study|Concomitant Disease|74|||
164668015|NCT02106156|594810066|FG001|Overall Study|Concomitant Disease|2|||
164668016|NCT02106156|594810067|FG002|Overall Study|Concomitant Disease|0|||
164668017|NCT02106156|594810065|FG000|Overall Study|Lack of Compliance|211|||
164668018|NCT02106156|594810066|FG001|Overall Study|Lack of Compliance|7|||
164668019|NCT02106156|594810067|FG002|Overall Study|Lack of Compliance|0|||
164668020|NCT02106156|594810065|FG000|Overall Study|Patients Request|307|||
164668021|NCT02106156|594810066|FG001|Overall Study|Patients Request|9|||
164668022|NCT02106156|594810067|FG002|Overall Study|Patients Request|0|||
164668023|NCT02106156|594810065|FG000|Overall Study|Lost to Follow-up|451|||
164668024|NCT02106156|594810066|FG001|Overall Study|Lost to Follow-up|8|||
164668025|NCT02106156|594810067|FG002|Overall Study|Lost to Follow-up|0|||
164668026|NCT02106156|594810065|FG000|Overall Study|Unplanned Event|82|||
164668027|NCT02106156|594810066|FG001|Overall Study|Unplanned Event|2|||
164668028|NCT02106156|594810067|FG002|Overall Study|Unplanned Event|0|||
164668029|NCT02106156|594810065|FG000|Overall Study|Change of Laboratory Parameter|10|||
164668030|NCT02106156|594810066|FG001|Overall Study|Change of Laboratory Parameter|0|||
164668031|NCT02106156|594810067|FG002|Overall Study|Change of Laboratory Parameter|0|||
164668032|NCT02106156|594810065|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
164668033|NCT02106156|594810066|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
164668034|NCT02106156|594810067|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
164668035|NCT02106156|594810065|FG000|Overall Study|Relocation/Change of Physician|40|||
164668036|NCT02106156|594810066|FG001|Overall Study|Relocation/Change of Physician|1|||
164668037|NCT02106156|594810067|FG002|Overall Study|Relocation/Change of Physician|0|||
164668038|NCT00420303|594810069|FG000|Overall Study|Serious Adverse Event|1|||
164668039|NCT00420303|594810070|FG001|Overall Study|Serious Adverse Event|0|||
164668040|NCT00420303|594810069|FG000|Overall Study|Lack of Efficacy|0|||
164668041|NCT00420303|594810070|FG001|Overall Study|Lack of Efficacy|3|||
164668042|NCT00420303|594810069|FG000|Overall Study|Physician Decision|0|||
164668043|NCT00420303|594810070|FG001|Overall Study|Physician Decision|1|||
164668044|NCT00840632|594810071|FG000|First Intervention|Withdrawal by Subject|0|||
164668045|NCT00840632|594810072|FG001|First Intervention|Withdrawal by Subject|1|||
164668046|NCT00840632|594810071|FG000|Washout|Withdrawal by Subject|1|||
164668047|NCT00840632|594810072|FG001|Washout|Withdrawal by Subject|1|||
164668048|NCT05017480|594810073|FG000|Stage 1 Study|Withdrawal by Subject|8|||
164668049|NCT05017480|594810074|FG001|Stage 1 Study|Withdrawal by Subject|6|||
164668050|NCT05017480|594810075|FG002|Stage 1 Study|Withdrawal by Subject|0|||
164668051|NCT05017480|594810076|FG003|Stage 1 Study|Withdrawal by Subject|0|||
164668052|NCT05017480|594810077|FG004|Stage 1 Study|Withdrawal by Subject|0|||
164668053|NCT05017480|594810073|FG000|Stage 1 Study|Adverse Event|1|||
164668054|NCT05017480|594810074|FG001|Stage 1 Study|Adverse Event|1|||
164668055|NCT05017480|594810075|FG002|Stage 1 Study|Adverse Event|0|||
164207857|NCT00671788|593129909|FG000|Overall Study|Ineligible|1|||
164207858|NCT00671788|593129909|FG000|Overall Study|MD Decision|1|||
164207859|NCT00671788|593129909|FG000|Overall Study|Other|1|||
164207860|NCT02966834|593129910|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
164207861|NCT02966834|593129911|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
164207862|NCT02966834|593129912|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
164207863|NCT02966834|593129913|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
164207864|NCT02966834|593129914|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
164207865|NCT02966834|593129915|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
164207866|NCT02966834|593129910|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
164207867|NCT02966834|593129911|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
164207868|NCT02966834|593129912|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
164207869|NCT02966834|593129913|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
164207870|NCT02966834|593129914|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
164207871|NCT02966834|593129915|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
164207872|NCT02966834|593129910|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
164207873|NCT02966834|593129911|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
164207874|NCT02966834|593129912|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
164207875|NCT02966834|593129913|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
164207876|NCT02966834|593129914|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
164668056|NCT05017480|594810076|FG003|Stage 1 Study|Adverse Event|0|||
164668057|NCT05017480|594810077|FG004|Stage 1 Study|Adverse Event|0|||
164668058|NCT05017480|594810073|FG000|Stage 1 Study|Poor Compliance|1|||
164668059|NCT05017480|594810074|FG001|Stage 1 Study|Poor Compliance|1|||
164668060|NCT05017480|594810075|FG002|Stage 1 Study|Poor Compliance|0|||
164668061|NCT05017480|594810076|FG003|Stage 1 Study|Poor Compliance|0|||
164668062|NCT05017480|594810077|FG004|Stage 1 Study|Poor Compliance|0|||
164668063|NCT05017480|594810073|FG000|Stage 1 Study|Physician Decision|0|||
164668064|NCT05017480|594810074|FG001|Stage 1 Study|Physician Decision|1|||
164668065|NCT05017480|594810075|FG002|Stage 1 Study|Physician Decision|0|||
164668066|NCT05017480|594810076|FG003|Stage 1 Study|Physician Decision|0|||
164668067|NCT05017480|594810077|FG004|Stage 1 Study|Physician Decision|0|||
164668068|NCT05017480|594810073|FG000|Stage 2 Study|Withdrawal by Subject|0|||
164668069|NCT05017480|594810074|FG001|Stage 2 Study|Withdrawal by Subject|0|||
164668070|NCT05017480|594810075|FG002|Stage 2 Study|Withdrawal by Subject|6|||
164668071|NCT05017480|594810076|FG003|Stage 2 Study|Withdrawal by Subject|9|||
164668072|NCT05017480|594810077|FG004|Stage 2 Study|Withdrawal by Subject|11|||
164668073|NCT05017480|594810073|FG000|Stage 2 Study|Lost to Follow-up|0|||
164668074|NCT05017480|594810074|FG001|Stage 2 Study|Lost to Follow-up|0|||
164668075|NCT05017480|594810075|FG002|Stage 2 Study|Lost to Follow-up|0|||
164668076|NCT05017480|594810076|FG003|Stage 2 Study|Lost to Follow-up|2|||
164668077|NCT05017480|594810077|FG004|Stage 2 Study|Lost to Follow-up|1|||
164668078|NCT05017480|594810073|FG000|Stage 2 Study|Adverse Event|0|||
164668079|NCT05017480|594810074|FG001|Stage 2 Study|Adverse Event|0|||
164668080|NCT05017480|594810075|FG002|Stage 2 Study|Adverse Event|0|||
164668081|NCT05017480|594810076|FG003|Stage 2 Study|Adverse Event|1|||
164668082|NCT05017480|594810077|FG004|Stage 2 Study|Adverse Event|0|||
164668083|NCT05017480|594810073|FG000|Stage 2 Study|COVID-19|0|||
164668084|NCT05017480|594810074|FG001|Stage 2 Study|COVID-19|0|||
164668085|NCT05017480|594810075|FG002|Stage 2 Study|COVID-19|0|||
164668086|NCT05017480|594810076|FG003|Stage 2 Study|COVID-19|1|||
164668087|NCT05017480|594810077|FG004|Stage 2 Study|COVID-19|0|||
164668088|NCT05017480|594810073|FG000|Stage 2 Study|Pregnancy|0|||
164668089|NCT05017480|594810074|FG001|Stage 2 Study|Pregnancy|0|||
164668090|NCT05017480|594810075|FG002|Stage 2 Study|Pregnancy|0|||
164668091|NCT05017480|594810076|FG003|Stage 2 Study|Pregnancy|0|||
164668092|NCT05017480|594810077|FG004|Stage 2 Study|Pregnancy|1|||
164668093|NCT01136382|594810078|FG000|Overall Study|Other|8|||
164668094|NCT01136382|594810079|FG001|Overall Study|Other|3|||
164668095|NCT01136382|594810078|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
164207877|NCT02966834|593129915|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
164420655|NCT01154036|593910962|FG000|Phase I|Adverse Event|1|||
164668096|NCT01136382|594810079|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
164668097|NCT01136382|594810078|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
164668098|NCT01136382|594810079|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
164668099|NCT01136382|594810078|FG000|Overall Study|Withdrawal by Subject|4|||
164668100|NCT01136382|594810079|FG001|Overall Study|Withdrawal by Subject|1|||
164668101|NCT02311361|594810080|FG000|Overall Study|Did not receive treatment|0|||
164668102|NCT02311361|594810081|FG001|Overall Study|Did not receive treatment|1|||
164668103|NCT02311361|594810082|FG002|Overall Study|Did not receive treatment|0|||
164668104|NCT02311361|594810083|FG003|Overall Study|Did not receive treatment|1|||
164668105|NCT05628675|594810088|FG000|Overall Study|Lost to Follow-up|2|||
164668106|NCT05628675|594810088|FG000|Overall Study|Withdrawal by Subject|1|||
164668107|NCT00633594|594810091|FG000|Overall Study|Adverse Event|0|||
164668108|NCT00633594|594810092|FG001|Overall Study|Adverse Event|4|||
164668109|NCT00633594|594810093|FG002|Overall Study|Adverse Event|7|||
164668110|NCT00633594|594810091|FG000|Overall Study|Death|0|||
164668111|NCT00633594|594810092|FG001|Overall Study|Death|1|||
164668112|NCT00633594|594810093|FG002|Overall Study|Death|2|||
164668113|NCT00633594|594810091|FG000|Overall Study|Disease Progression|0|||
164668114|NCT00633594|594810092|FG001|Overall Study|Disease Progression|0|||
164668115|NCT00633594|594810093|FG002|Overall Study|Disease Progression|1|||
164668116|NCT02028715|594810095|FG000|Overall Study|Adverse Event|2|||
164668117|NCT02028715|594810096|FG001|Overall Study|Adverse Event|2|||
164668118|NCT02028715|594810095|FG000|Overall Study|Physician Decision|1|||
164668119|NCT02028715|594810096|FG001|Overall Study|Physician Decision|0|||
164668120|NCT02028715|594810095|FG000|Overall Study|Did not complete satisfaction surveys|2|||
164668121|NCT02028715|594810096|FG001|Overall Study|Did not complete satisfaction surveys|2|||
164668122|NCT01648166|594810097|FG000|Overall Study|inadequate toenail samples|53|||
164668123|NCT01648166|594810098|FG001|Overall Study|inadequate toenail samples|100|||
164668124|NCT00883090|594810099|FG000|Overall Study|Sponsor's decision|1|||
164668125|NCT00883090|594810099|FG000|Overall Study|Withdrawal by Subject|1|||
164668126|NCT01492361|594810100|FG000|Overall Study|Withdrawal by Subject|281|||
164668127|NCT01492361|594810101|FG001|Overall Study|Withdrawal by Subject|297|||
164668128|NCT01492361|594810100|FG000|Overall Study|Physician Decision|12|||
164668129|NCT01492361|594810101|FG001|Overall Study|Physician Decision|12|||
164668130|NCT01492361|594810100|FG000|Overall Study|Lost to Follow-up|6|||
164668131|NCT01492361|594810101|FG001|Overall Study|Lost to Follow-up|13|||
164668132|NCT01492361|594810100|FG000|Overall Study|Other than specified above|106|||
164668133|NCT01492361|594810101|FG001|Overall Study|Other than specified above|138|||
164668134|NCT01475838|594810104|FG000|Randomized Phase|Randomized but Not Treated|0|||
164668135|NCT01475838|594810105|FG001|Randomized Phase|Randomized but Not Treated|5|||
164668136|NCT01475838|594810104|FG000|Randomized Phase|Adverse Event|6|||
164668137|NCT01475838|594810105|FG001|Randomized Phase|Adverse Event|1|||
164668138|NCT01475838|594810104|FG000|Randomized Phase|Pregnancy|0|||
164668139|NCT01475838|594810105|FG001|Randomized Phase|Pregnancy|1|||
164668140|NCT01475838|594810104|FG000|Randomized Phase|Investigators Discretion|1|||
164668141|NCT01475838|594810105|FG001|Randomized Phase|Investigators Discretion|2|||
164668142|NCT01475838|594810104|FG000|Randomized Phase|Withdrew Consent|10|||
164668143|NCT01475838|594810105|FG001|Randomized Phase|Withdrew Consent|14|||
164668144|NCT01475838|594810104|FG000|Randomized Phase|Lost to Follow-up|3|||
164668145|NCT01475838|594810105|FG001|Randomized Phase|Lost to Follow-up|4|||
164668146|NCT01475838|594810104|FG000|Randomized Phase|Participant Noncompliance|1|||
164668147|NCT01475838|594810105|FG001|Randomized Phase|Participant Noncompliance|5|||
164668148|NCT01475838|594810104|FG000|Randomized Phase|Protocol Violation|9|||
164668149|NCT01475838|594810105|FG001|Randomized Phase|Protocol Violation|4|||
164668150|NCT01475838|594810104|FG000|Extension Phase|Participant Noncompliance|1|||
164668151|NCT01475838|594810105|FG001|Extension Phase|Participant Noncompliance|0|||
164668152|NCT00560235|594810109|FG000|Phase 1|Discontinued|8|||
164668153|NCT00560235|594810110|FG001|Phase 1|Discontinued|0|||
164668154|NCT00560235|594810111|FG002|Phase 1|Discontinued|0|||
164668155|NCT00560235|594810109|FG000|Phase 1B|Discontinued|0|||
164668156|NCT00560235|594810110|FG001|Phase 1B|Discontinued|19|||
164668157|NCT00560235|594810111|FG002|Phase 1B|Discontinued|0|||
164668158|NCT00560235|594810109|FG000|Phase 2|Discontinued|0|||
164668159|NCT00560235|594810110|FG001|Phase 2|Discontinued|0|||
164668160|NCT00560235|594810111|FG002|Phase 2|Discontinued|96|||
164668161|NCT00560235|594810109|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
164668162|NCT00560235|594810110|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
164668163|NCT00560235|594810111|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
164668164|NCT03227445|594810113|FG000|Period 1 (28 Days)|Adverse Event|1|||
164668165|NCT03227445|594810114|FG001|Period 1 (28 Days)|Adverse Event|2|||
164668166|NCT03227445|594810115|FG002|Period 1 (28 Days)|Adverse Event|0|||
164668167|NCT03227445|594810116|FG003|Period 1 (28 Days)|Adverse Event|1|||
164668168|NCT03227445|594810113|FG000|Period 1 (28 Days)|Protocol Violation|1|||
164668169|NCT03227445|594810114|FG001|Period 1 (28 Days)|Protocol Violation|0|||
164321527|NCT00095147|593554175|FG001|Long-term Extension Period|Withdrawal of consent|0|||
164321528|NCT00095147|593554176|FG002|Long-term Extension Period|Withdrawal of consent|0|||
164668170|NCT03227445|594810115|FG002|Period 1 (28 Days)|Protocol Violation|0|||
164668171|NCT03227445|594810116|FG003|Period 1 (28 Days)|Protocol Violation|0|||
164668172|NCT03227445|594810113|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
164668173|NCT03227445|594810114|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
164668174|NCT03227445|594810115|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
164668175|NCT03227445|594810116|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
164668176|NCT03227445|594810113|FG000|Period 2 (28 Days)|Adverse Event|1|||
164668177|NCT03227445|594810114|FG001|Period 2 (28 Days)|Adverse Event|0|||
164668178|NCT03227445|594810115|FG002|Period 2 (28 Days)|Adverse Event|2|||
164668179|NCT03227445|594810116|FG003|Period 2 (28 Days)|Adverse Event|1|||
164668180|NCT03227445|594810113|FG000|Period 2 (28 Days)|Protocol Violation|0|||
164668181|NCT03227445|594810114|FG001|Period 2 (28 Days)|Protocol Violation|0|||
164668182|NCT03227445|594810115|FG002|Period 2 (28 Days)|Protocol Violation|0|||
164668183|NCT03227445|594810116|FG003|Period 2 (28 Days)|Protocol Violation|1|||
164668184|NCT03227445|594810113|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
164668185|NCT03227445|594810114|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
164668186|NCT03227445|594810115|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
164668187|NCT03227445|594810116|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
164668188|NCT01991470|594810119|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
164207878|NCT02966834|593129910|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
164207879|NCT02966834|593129911|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
164207880|NCT02966834|593129912|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
164207881|NCT02966834|593129913|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
164207882|NCT02966834|593129914|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
164207883|NCT02966834|593129915|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
164207884|NCT02966834|593129910|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
164207885|NCT02966834|593129911|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
164207886|NCT02966834|593129912|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
164207887|NCT02966834|593129913|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
164668189|NCT01991470|594810119|FG000|Enlite 1 Period|Adverse Event|1|||
164668190|NCT01991470|594810119|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
164668191|NCT01991470|594810119|FG000|Enlite 3 Period|Lost to Follow-up|1|||
164668192|NCT01991470|594810119|FG000|Enlite 3 Period|Physician Decision|2|||
164668193|NCT01991470|594810119|FG000|Enlite 3 Period|Physician Decision|8|||
164668194|NCT01991470|594810119|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
164668195|NCT00760266|594810122|FG000|Overall Study|Adverse Event|13|||
164668196|NCT00760266|594810123|FG001|Overall Study|Adverse Event|7|||
164668197|NCT00760266|594810122|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164668198|NCT00760266|594810123|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164668199|NCT00760266|594810122|FG000|Overall Study|Abnormal test procedure result(s)|1|||
164668200|NCT00760266|594810123|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164668201|NCT00760266|594810122|FG000|Overall Study|Lack of Efficacy|2|||
164668202|NCT00760266|594810123|FG001|Overall Study|Lack of Efficacy|2|||
164668203|NCT00760266|594810122|FG000|Overall Study|Protocol deviation|2|||
164668204|NCT00760266|594810123|FG001|Overall Study|Protocol deviation|4|||
164668205|NCT00760266|594810122|FG000|Overall Study|Patient withdrew consent|3|||
164668206|NCT00760266|594810123|FG001|Overall Study|Patient withdrew consent|3|||
164668207|NCT00760266|594810122|FG000|Overall Study|Lost to Follow-up|2|||
164668208|NCT00760266|594810123|FG001|Overall Study|Lost to Follow-up|1|||
164668209|NCT00760266|594810122|FG000|Overall Study|Administrative Problems|0|||
164668210|NCT00760266|594810123|FG001|Overall Study|Administrative Problems|1|||
164668211|NCT01225146|594810124|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
164668212|NCT01225146|594810125|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
164668213|NCT01239121|594810126|FG000|Overall Study|Withdrawal by Subject|2|||
164668214|NCT01239121|594810127|FG001|Overall Study|Withdrawal by Subject|4|||
164668215|NCT01239121|594810128|FG002|Overall Study|Withdrawal by Subject|0|||
164668216|NCT00623779|594810129|FG000|Overall Study|Adverse Event|1|||
164668217|NCT00623779|594810130|FG001|Overall Study|Adverse Event|3|||
164668218|NCT00623779|594810131|FG002|Overall Study|Adverse Event|0|||
164668219|NCT00623779|594810129|FG000|Overall Study|Criteria from CSR|2|||
164668220|NCT00623779|594810130|FG001|Overall Study|Criteria from CSR|0|||
164668221|NCT00623779|594810131|FG002|Overall Study|Criteria from CSR|1|||
164668222|NCT00906347|594810137|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
164668223|NCT00906347|594810138|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
164668224|NCT00906347|594810137|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
164668225|NCT00906347|594810138|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
164668226|NCT00906347|594810137|FG000|Received Study Drug|Refused study drug|1|||
164668227|NCT00906347|594810138|FG001|Received Study Drug|Refused study drug|0|||
164668228|NCT00906347|594810137|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
164668229|NCT00906347|594810138|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
164668230|NCT00472290|594810141|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
164668231|NCT00472290|594810141|FG000|Overall Study|Protocol Specified Criteria|7|||
164668232|NCT00472290|594810141|FG000|Overall Study|Administrative Decision|37|||
164668233|NCT00472290|594810141|FG000|Overall Study|Death|3|||
164668234|NCT00472290|594810141|FG000|Overall Study|Lost to Follow-up|1|||
164668235|NCT00472290|594810141|FG000|Overall Study|Lack of Efficacy|1|||
164668236|NCT00472290|594810141|FG000|Overall Study|Disease Progression|4|||
164668237|NCT00472290|594810141|FG000|Overall Study|Withdrawal by Subject|5|||
164668238|NCT00472290|594810141|FG000|Overall Study|Adverse Event|6|||
164668239|NCT00472290|594810141|FG000|Overall Study|Requirement for alternative therapy|7|||
164668240|NCT00777829|594810142|FG000|Overall Study|Withdrawal by Subject|0|||
164668241|NCT00777829|594810143|FG001|Overall Study|Withdrawal by Subject|2|||
164668242|NCT02016170|594810149|FG000|Overall Study|Adverse Event|1|||
164668243|NCT02016170|594810150|FG001|Overall Study|Adverse Event|1|||
164668244|NCT02016170|594810151|FG002|Overall Study|Adverse Event|0|||
164207888|NCT02966834|593129914|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
164668245|NCT02016170|594810149|FG000|Overall Study|Protocol Violation|1|||
164668246|NCT02016170|594810150|FG001|Overall Study|Protocol Violation|0|||
164668247|NCT02016170|594810151|FG002|Overall Study|Protocol Violation|0|||
164668248|NCT05214560|594810154|FG000|Overall Study|Screening Failure|1|||
164207889|NCT02966834|593129915|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
164563621|NCT03344003|594431151|FG000|Overall Study|Switched to alternative treatment|1|||
164563622|NCT03344003|594431152|FG001|Overall Study|Switched to alternative treatment|0|||
164563623|NCT03344003|594431151|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
164563624|NCT03344003|594431152|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
164563625|NCT00684957|594431156|FG000|Overall Study|Withdrawal by Subject|1|||
164563626|NCT00684957|594431157|FG001|Overall Study|Withdrawal by Subject|1|||
164563627|NCT00684957|594431156|FG000|Overall Study|Lost to Follow-up|1|||
164563628|NCT00684957|594431157|FG001|Overall Study|Lost to Follow-up|0|||
164563629|NCT04341948|594431158|FG000|Overall Study|Adverse Event|0|||
164563630|NCT04341948|594431159|FG001|Overall Study|Adverse Event|1|||
164563631|NCT04341948|594431158|FG000|Overall Study|Lost to Follow-up|6|||
164563632|NCT04341948|594431159|FG001|Overall Study|Lost to Follow-up|1|||
164668249|NCT05214560|594810154|FG000|Overall Study|Physician Decision|4|||
164668250|NCT05214560|594810154|FG000|Overall Study|Withdrawal by Subject|1|||
164668251|NCT05214560|594810154|FG000|Overall Study|Lost to Follow-up|2|||
164668252|NCT05214560|594810154|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
164668253|NCT05214560|594810154|FG000|Overall Study|Study physician not available for the anesthesia|3|||
164668254|NCT05214560|594810154|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
164668255|NCT05214560|594810154|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
164668256|NCT05214560|594810154|FG000|Overall Study|Surgery not performed|3|||
164668257|NCT04977336|594810155|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
164668258|NCT04977336|594810156|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
164668259|NCT04977336|594810157|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
164668260|NCT04977336|594810158|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
164668261|NCT04977336|594810159|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
164668262|NCT04977336|594810155|FG000|Overall Study|Lost to Follow-up|0|||
164668263|NCT04977336|594810156|FG001|Overall Study|Lost to Follow-up|0|||
164668264|NCT04977336|594810157|FG002|Overall Study|Lost to Follow-up|1|||
164668265|NCT04977336|594810158|FG003|Overall Study|Lost to Follow-up|0|||
164668266|NCT04977336|594810159|FG004|Overall Study|Lost to Follow-up|0|||
164668267|NCT00878995|594810163|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
164668268|NCT00878995|594810164|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
164668269|NCT00352690|594810167|FG000|Overall Study|Determined to be ineligible|2|||
164668270|NCT00352690|594810168|FG001|Overall Study|Determined to be ineligible|0|||
164668271|NCT03633721|594810171|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
164668272|NCT03633721|594810172|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
164668273|NCT03633721|594810173|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
164668274|NCT03633721|594810174|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
164420656|NCT01154036|593910963|FG001|Phase I|Adverse Event|11|||
164207890|NCT02966834|593129910|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
164207891|NCT02966834|593129911|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
164207892|NCT02966834|593129912|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
164207893|NCT02966834|593129913|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
164207894|NCT02966834|593129914|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
164207895|NCT02966834|593129915|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
164207896|NCT01925417|593129925|FG000|Overall Study|Withdrawal by Subject|2|||
164207897|NCT01925417|593129925|FG000|Overall Study|Death|1|||
164207898|NCT00655889|593129926|FG000|Overall Study|Inadequate cell growth|1|||
164207899|NCT00655889|593129926|FG000|Overall Study|Protocol Violation|1|||
164207900|NCT01093846|593129927|FG000|Overall Study|Adverse Event|0|||
164207901|NCT01093846|593129928|FG001|Overall Study|Adverse Event|0|||
164207902|NCT01093846|593129929|FG002|Overall Study|Adverse Event|1|||
164207903|NCT01093846|593129927|FG000|Overall Study|Lack of Efficacy|0|||
164207904|NCT01093846|593129928|FG001|Overall Study|Lack of Efficacy|0|||
164207905|NCT01093846|593129929|FG002|Overall Study|Lack of Efficacy|4|||
164207906|NCT01093846|593129927|FG000|Overall Study|Condition no longer required study drug|1|||
164207907|NCT01093846|593129928|FG001|Overall Study|Condition no longer required study drug|1|||
164207908|NCT01093846|593129929|FG002|Overall Study|Condition no longer required study drug|1|||
164207909|NCT01093846|593129927|FG000|Overall Study|Administrative Problems|18|||
164207910|NCT01093846|593129928|FG001|Overall Study|Administrative Problems|17|||
164207911|NCT01093846|593129929|FG002|Overall Study|Administrative Problems|15|||
164207912|NCT02781324|593129931|FG000|Overall Study|Withdrawal by Subject|1|||
164207913|NCT02781324|593129932|FG001|Overall Study|Withdrawal by Subject|0|||
164207914|NCT02781324|593129931|FG000|Overall Study|Physician Decision|1|||
164207915|NCT02781324|593129932|FG001|Overall Study|Physician Decision|2|||
164207916|NCT00661388|593129933|FG000|Overall Study|Adverse Event|14|||
164207917|NCT00661388|593129933|FG000|Overall Study|Protocol Violation|7|||
164207918|NCT00661388|593129933|FG000|Overall Study|Renal transplantation|1|||
164207919|NCT00661388|593129933|FG000|Overall Study|Dialysis initiation|1|||
164207920|NCT00661388|593129933|FG000|Overall Study|Administrative reasons|1|||
164207921|NCT00362232|593131557|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
164207922|NCT00362232|593131558|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
164207923|NCT00362232|593131557|FG000|Treatment (12 +/- 2 Days)|Death|1|||
164207924|NCT00362232|593131558|FG001|Treatment (12 +/- 2 Days)|Death|3|||
164207925|NCT00362232|593131557|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
164207926|NCT00362232|593131558|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
164207927|NCT00362232|593131557|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
164207928|NCT00362232|593131558|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
164207929|NCT00362232|593131557|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
164207930|NCT00362232|593131558|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
164207931|NCT00362232|593131557|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
164668275|NCT01475474|594810178|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
164668276|NCT01475474|594810178|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
164668277|NCT02343120|594810179|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
164668278|NCT02343120|594810180|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
164668279|NCT02343120|594810181|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
164668280|NCT02343120|594810182|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
164668281|NCT02343120|594810183|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
164668282|NCT02343120|594810179|FG000|Part 1: Dose Escalation|Death|1|||
164668283|NCT02343120|594810180|FG001|Part 1: Dose Escalation|Death|2|||
164668284|NCT02343120|594810181|FG002|Part 1: Dose Escalation|Death|2|||
164668285|NCT02343120|594810182|FG003|Part 1: Dose Escalation|Death|2|||
164668286|NCT02343120|594810183|FG004|Part 1: Dose Escalation|Death|1|||
164668287|NCT02343120|594810179|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
164668288|NCT02343120|594810180|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
164668289|NCT02343120|594810181|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
164668290|NCT02343120|594810182|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
164668291|NCT02343120|594810183|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
164668292|NCT02343120|594810179|FG000|Part 2: Expansion|Sponsor decision|0|||
164668293|NCT02343120|594810180|FG001|Part 2: Expansion|Sponsor decision|0|||
164668294|NCT02343120|594810181|FG002|Part 2: Expansion|Sponsor decision|0|||
164668295|NCT02343120|594810182|FG003|Part 2: Expansion|Sponsor decision|165|||
164668296|NCT02343120|594810183|FG004|Part 2: Expansion|Sponsor decision|67|||
164668297|NCT02343120|594810179|FG000|Part 2: Expansion|Death|0|||
164668298|NCT02343120|594810180|FG001|Part 2: Expansion|Death|0|||
164207932|NCT00362232|593131558|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
164668299|NCT02343120|594810181|FG002|Part 2: Expansion|Death|0|||
164668300|NCT02343120|594810182|FG003|Part 2: Expansion|Death|74|||
164668301|NCT02343120|594810183|FG004|Part 2: Expansion|Death|17|||
164668302|NCT02343120|594810179|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
164668303|NCT02343120|594810180|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
164668304|NCT02343120|594810181|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
164207933|NCT00362232|593131557|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
164321529|NCT00095147|593554177|FG003|Long-term Extension Period|Withdrawal of consent|0|||
164321530|NCT00095147|593554178|FG004|Long-term Extension Period|Withdrawal of consent|12|||
164321531|NCT00095147|593554174|FG000|Long-term Extension Period|Pregnancy|0|||
164321532|NCT00095147|593554175|FG001|Long-term Extension Period|Pregnancy|0|||
164321533|NCT00095147|593554176|FG002|Long-term Extension Period|Pregnancy|0|||
164321534|NCT00095147|593554177|FG003|Long-term Extension Period|Pregnancy|0|||
164321535|NCT00095147|593554178|FG004|Long-term Extension Period|Pregnancy|1|||
164321536|NCT00095147|593554174|FG000|Long-term Extension Period|No longer meets study criteria|0|||
164321537|NCT00095147|593554175|FG001|Long-term Extension Period|No longer meets study criteria|0|||
164321538|NCT00095147|593554176|FG002|Long-term Extension Period|No longer meets study criteria|0|||
164321539|NCT00095147|593554177|FG003|Long-term Extension Period|No longer meets study criteria|0|||
164321540|NCT00095147|593554178|FG004|Long-term Extension Period|No longer meets study criteria|1|||
164321541|NCT00095147|593554174|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
164321542|NCT00095147|593554175|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
164321543|NCT00095147|593554176|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
164321544|NCT00095147|593554177|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
164321545|NCT00095147|593554178|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
164321546|NCT00095147|593554174|FG000|Long-term Extension Period|Leaving country|0|||
164321547|NCT00095147|593554175|FG001|Long-term Extension Period|Leaving country|0|||
164321548|NCT00095147|593554176|FG002|Long-term Extension Period|Leaving country|0|||
164321549|NCT00095147|593554177|FG003|Long-term Extension Period|Leaving country|0|||
164321550|NCT00095147|593554178|FG004|Long-term Extension Period|Leaving country|1|||
164321551|NCT02395302|593554179|FG000|Overall Study|Screen Failure|3|||
164321552|NCT02395302|593554179|FG000|Overall Study|Run In Failure|7|||
164321553|NCT02395302|593554179|FG000|Overall Study|Withdrawal by Subject|2|||
164321554|NCT02395302|593554179|FG000|Overall Study|Physician Decision|2|||
164321555|NCT04604132|593554180|FG000|Overall Study|Adverse Event|2|||
164321556|NCT04604132|593554181|FG001|Overall Study|Adverse Event|0|||
164321557|NCT04604132|593554182|FG002|Overall Study|Adverse Event|0|||
164563633|NCT04341948|594431158|FG000|Overall Study|Physician Decision|1|||
164563634|NCT04341948|594431159|FG001|Overall Study|Physician Decision|2|||
164563635|NCT04341948|594431158|FG000|Overall Study|Withdrawal by Participant|6|||
164563636|NCT04341948|594431159|FG001|Overall Study|Withdrawal by Participant|3|||
164563637|NCT04341948|594431158|FG000|Overall Study|Lack of compliance by Participant|1|||
164563638|NCT04341948|594431159|FG001|Overall Study|Lack of compliance by Participant|0|||
164563639|NCT03406897|594431160|FG000|Overall Study|Lost to Follow-up|1|||
164563640|NCT03406897|594431161|FG001|Overall Study|Lost to Follow-up|2|||
164563641|NCT03406897|594431160|FG000|Overall Study|Withdrawal by Subject|4|||
164563642|NCT03406897|594431161|FG001|Overall Study|Withdrawal by Subject|4|||
164563643|NCT03406897|594431160|FG000|Overall Study|Physician Decision|0|||
164563644|NCT03406897|594431161|FG001|Overall Study|Physician Decision|1|||
164563645|NCT05900115|594432308|FG000|Overall Study|Lost to Follow-up|129|||
164563646|NCT05900115|594432309|FG001|Overall Study|Lost to Follow-up|98|||
164563647|NCT02949128|594432310|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
164563648|NCT02949128|594432310|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
164563649|NCT02949128|594432310|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
164563650|NCT02949128|594432310|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
164563651|NCT02949128|594432310|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
164563652|NCT02949128|594432310|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
164563653|NCT02949128|594432310|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
164563654|NCT02949128|594432310|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
164563655|NCT02949128|594432310|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
164563656|NCT02949128|594432310|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
164563657|NCT01602341|594432311|FG000|Overall Study|Adverse Event|0|||
164563658|NCT01602341|594432312|FG001|Overall Study|Adverse Event|1|||
164563659|NCT02152345|594432313|FG000|Overall Study|Case Cancellations|2|||
164563660|NCT02152345|594432314|FG001|Overall Study|Case Cancellations|4|||
164563661|NCT02152345|594432313|FG000|Overall Study|Withdrawal by Subject|2|||
164563662|NCT02152345|594432314|FG001|Overall Study|Withdrawal by Subject|1|||
164563663|NCT00680836|594432315|FG000|Overall Study|Withdrawal by Subject|3|||
164563664|NCT00680836|594432316|FG001|Overall Study|Withdrawal by Subject|0|||
164563665|NCT00680836|594432315|FG000|Overall Study|Lost to Follow-up|3|||
164563666|NCT00680836|594432316|FG001|Overall Study|Lost to Follow-up|1|||
164563667|NCT00680836|594432315|FG000|Overall Study|Physician Decision|2|||
164563668|NCT00680836|594432316|FG001|Overall Study|Physician Decision|1|||
164668305|NCT02343120|594810182|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
164563669|NCT03786432|594432317|FG000|Overall Study|Screen Failure after consent|1|||
164668306|NCT02343120|594810183|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
164563670|NCT03786432|594432317|FG000|Overall Study|Lost to Follow-up|4|||
164563671|NCT03786432|594432317|FG000|Overall Study|did not complete 12 month CT scan|1|||
164563672|NCT01475734|594432321|FG000|Overall Study|Withdrawal by Subject|1|||
164668307|NCT02343120|594810179|FG000|Part 2: Expansion|Lost to Follow-up|0|||
164668308|NCT02343120|594810180|FG001|Part 2: Expansion|Lost to Follow-up|0|||
164563673|NCT01475734|594432322|FG001|Overall Study|Withdrawal by Subject|0|||
164563674|NCT01475734|594432321|FG000|Overall Study|Protocol Violation|1|||
164207934|NCT00362232|593131558|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
164207935|NCT00362232|593131557|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
164321558|NCT04604132|593554183|FG003|Overall Study|Adverse Event|1|||
164321559|NCT04604132|593554184|FG004|Overall Study|Adverse Event|2|||
164321560|NCT04604132|593554180|FG000|Overall Study|Study terminated by sponsor|0|||
164321561|NCT04604132|593554181|FG001|Overall Study|Study terminated by sponsor|0|||
164321562|NCT04604132|593554182|FG002|Overall Study|Study terminated by sponsor|0|||
164321563|NCT04604132|593554183|FG003|Overall Study|Study terminated by sponsor|0|||
164321564|NCT04604132|593554184|FG004|Overall Study|Study terminated by sponsor|1|||
164321565|NCT04604132|593554180|FG000|Overall Study|Progressive disease: Clinical progression|0|||
164321566|NCT04604132|593554181|FG001|Overall Study|Progressive disease: Clinical progression|0|||
164321567|NCT04604132|593554182|FG002|Overall Study|Progressive disease: Clinical progression|1|||
164321568|NCT04604132|593554183|FG003|Overall Study|Progressive disease: Clinical progression|0|||
164321569|NCT04604132|593554184|FG004|Overall Study|Progressive disease: Clinical progression|0|||
164321570|NCT04604132|593554180|FG000|Overall Study|Progressive disease: Radiological progression|8|||
164321571|NCT04604132|593554181|FG001|Overall Study|Progressive disease: Radiological progression|7|||
164321572|NCT04604132|593554182|FG002|Overall Study|Progressive disease: Radiological progression|10|||
164321573|NCT04604132|593554183|FG003|Overall Study|Progressive disease: Radiological progression|4|||
164321574|NCT04604132|593554184|FG004|Overall Study|Progressive disease: Radiological progression|3|||
164321575|NCT04604132|593554180|FG000|Overall Study|Death|3|||
164321576|NCT04604132|593554181|FG001|Overall Study|Death|1|||
164321577|NCT04604132|593554182|FG002|Overall Study|Death|2|||
164321578|NCT04604132|593554183|FG003|Overall Study|Death|1|||
164321579|NCT04604132|593554184|FG004|Overall Study|Death|0|||
164321580|NCT00952380|593554185|FG000|Overall Study|Other|0|||
164321581|NCT00952380|593554186|FG001|Overall Study|Other|0|||
164321582|NCT00952380|593554187|FG002|Overall Study|Other|0|||
164321583|NCT00952380|593554188|FG003|Overall Study|Other|0|||
164321584|NCT00952380|593554189|FG004|Overall Study|Other|1|||
164321585|NCT00952380|593554185|FG000|Overall Study|Withdrawal by Subject|0|||
164321586|NCT00952380|593554186|FG001|Overall Study|Withdrawal by Subject|0|||
164321587|NCT00952380|593554187|FG002|Overall Study|Withdrawal by Subject|1|||
164321588|NCT00952380|593554188|FG003|Overall Study|Withdrawal by Subject|0|||
164321589|NCT00952380|593554189|FG004|Overall Study|Withdrawal by Subject|2|||
164321590|NCT00952380|593554185|FG000|Overall Study|Adverse Event|0|||
164321591|NCT00952380|593554186|FG001|Overall Study|Adverse Event|1|||
164321592|NCT00952380|593554187|FG002|Overall Study|Adverse Event|0|||
164321593|NCT00952380|593554188|FG003|Overall Study|Adverse Event|0|||
164321594|NCT00952380|593554189|FG004|Overall Study|Adverse Event|3|||
164321595|NCT00952380|593554185|FG000|Overall Study|Physician Decision|0|||
164321596|NCT00952380|593554186|FG001|Overall Study|Physician Decision|0|||
164321597|NCT00952380|593554187|FG002|Overall Study|Physician Decision|1|||
164321598|NCT00952380|593554188|FG003|Overall Study|Physician Decision|2|||
164321599|NCT00952380|593554189|FG004|Overall Study|Physician Decision|0|||
164321600|NCT00952380|593554185|FG000|Overall Study|Non-compliant to protocol|0|||
164321601|NCT00952380|593554186|FG001|Overall Study|Non-compliant to protocol|0|||
164321602|NCT00952380|593554187|FG002|Overall Study|Non-compliant to protocol|0|||
164321603|NCT00952380|593554188|FG003|Overall Study|Non-compliant to protocol|1|||
164321604|NCT00952380|593554189|FG004|Overall Study|Non-compliant to protocol|0|||
164321605|NCT03400956|593554190|FG000|Treatment Period 1|Adverse Event|0|||
164321606|NCT03400956|593554191|FG001|Treatment Period 1|Adverse Event|1|||
164321607|NCT03400956|593554192|FG002|Treatment Period 1|Adverse Event|0|||
164321608|NCT03400956|593554190|FG000|Treatment Period 1|Lost to Follow-up|0|||
164321609|NCT03400956|593554191|FG001|Treatment Period 1|Lost to Follow-up|0|||
164321610|NCT03400956|593554192|FG002|Treatment Period 1|Lost to Follow-up|1|||
164321611|NCT03400956|593554190|FG000|Treatment Period 1|Protocol Violation|0|||
164321612|NCT03400956|593554191|FG001|Treatment Period 1|Protocol Violation|2|||
164321613|NCT03400956|593554192|FG002|Treatment Period 1|Protocol Violation|0|||
164321614|NCT03400956|593554190|FG000|Treatment Period 1|Study terminated by sponsor|3|||
164321615|NCT03400956|593554191|FG001|Treatment Period 1|Study terminated by sponsor|1|||
164321616|NCT03400956|593554192|FG002|Treatment Period 1|Study terminated by sponsor|1|||
164321617|NCT03400956|593554190|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164321618|NCT03400956|593554191|FG001|Treatment Period 1|Withdrawal by Subject|2|||
164321619|NCT03400956|593554192|FG002|Treatment Period 1|Withdrawal by Subject|4|||
164321620|NCT03400956|593554190|FG000|Treatment Period 1|Other|1|||
164321621|NCT03400956|593554191|FG001|Treatment Period 1|Other|2|||
164321622|NCT03400956|593554192|FG002|Treatment Period 1|Other|3|||
164321623|NCT03400956|593554190|FG000|Post-treatment Period 1|Adverse Event|0|||
164321624|NCT03400956|593554191|FG001|Post-treatment Period 1|Adverse Event|0|||
164321625|NCT03400956|593554192|FG002|Post-treatment Period 1|Adverse Event|1|||
164321626|NCT03400956|593554190|FG000|Post-treatment Period 1|Physician Decision|2|||
164321627|NCT03400956|593554191|FG001|Post-treatment Period 1|Physician Decision|3|||
164321628|NCT03400956|593554192|FG002|Post-treatment Period 1|Physician Decision|0|||
164321629|NCT03400956|593554190|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
164321630|NCT03400956|593554191|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
164321631|NCT03400956|593554192|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
164321632|NCT03400956|593554190|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
164321633|NCT03400956|593554191|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
164321634|NCT03400956|593554192|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
164321635|NCT03400956|593554190|FG000|Post-treatment Period 1|Other|4|||
164321636|NCT03400956|593554191|FG001|Post-treatment Period 1|Other|3|||
164321637|NCT03400956|593554192|FG002|Post-treatment Period 1|Other|4|||
164321638|NCT03400956|593554190|FG000|Treatment Period 2|Adverse Event|2|||
164321639|NCT03400956|593554191|FG001|Treatment Period 2|Adverse Event|1|||
164321640|NCT03400956|593554192|FG002|Treatment Period 2|Adverse Event|1|||
164321641|NCT03400956|593554190|FG000|Treatment Period 2|Lost to Follow-up|1|||
164321642|NCT03400956|593554191|FG001|Treatment Period 2|Lost to Follow-up|1|||
164321643|NCT03400956|593554192|FG002|Treatment Period 2|Lost to Follow-up|0|||
164321644|NCT03400956|593554190|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164321645|NCT03400956|593554191|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164321646|NCT03400956|593554192|FG002|Treatment Period 2|Withdrawal by Subject|3|||
164321647|NCT03400956|593554190|FG000|Treatment Period 2|Other|1|||
164321648|NCT03400956|593554191|FG001|Treatment Period 2|Other|1|||
164321649|NCT03400956|593554192|FG002|Treatment Period 2|Other|0|||
164321650|NCT03400956|593554190|FG000|Follow-up Period|Withdrawal by Subject|0|||
164321651|NCT03400956|593554191|FG001|Follow-up Period|Withdrawal by Subject|0|||
164321652|NCT03400956|593554192|FG002|Follow-up Period|Withdrawal by Subject|1|||
164321653|NCT03400956|593554190|FG000|Follow-up Period|Other|0|||
164321654|NCT03400956|593554191|FG001|Follow-up Period|Other|0|||
164321655|NCT03400956|593554192|FG002|Follow-up Period|Other|1|||
164321656|NCT02048241|593554194|FG000|Overall Study|Withdrawal by Subject|0|||
164321657|NCT02048241|593554195|FG001|Overall Study|Withdrawal by Subject|1|||
164321658|NCT00534313|593554196|FG000|Short-term Period|Adverse Event|1|||
164321659|NCT00534313|593554197|FG001|Short-term Period|Adverse Event|2|||
164321660|NCT00534313|593554198|FG002|Short-term Period|Adverse Event|1|||
164321661|NCT00534313|593554199|FG003|Short-term Period|Adverse Event|3|||
164321662|NCT00534313|593554196|FG000|Short-term Period|Lack of Efficacy|3|||
164321663|NCT00534313|593554197|FG001|Short-term Period|Lack of Efficacy|4|||
164321664|NCT00534313|593554198|FG002|Short-term Period|Lack of Efficacy|0|||
164321665|NCT00534313|593554199|FG003|Short-term Period|Lack of Efficacy|3|||
164321666|NCT00534313|593554196|FG000|Short-term Period|Participant not meeting study criteria|0|||
164321667|NCT00534313|593554197|FG001|Short-term Period|Participant not meeting study criteria|0|||
164321668|NCT00534313|593554198|FG002|Short-term Period|Participant not meeting study criteria|0|||
164321669|NCT00534313|593554199|FG003|Short-term Period|Participant not meeting study criteria|1|||
164207936|NCT00362232|593131558|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
164207937|NCT00362232|593131557|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
164207938|NCT00362232|593131558|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
164207939|NCT00362232|593131557|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
164207940|NCT00362232|593131558|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
164207941|NCT00362232|593131557|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
164207942|NCT00362232|593131558|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
164207943|NCT00362232|593131557|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
164207944|NCT00362232|593131558|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
164207945|NCT00362232|593131557|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
164207946|NCT00362232|593131558|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
164207947|NCT05020015|593131561|FG000|Overall Study|Ongoing on study|1|||
164207948|NCT05020015|593131562|FG001|Overall Study|Ongoing on study|3|||
164207949|NCT05020015|593131563|FG002|Overall Study|Ongoing on study|4|||
164207950|NCT05020015|593131564|FG003|Overall Study|Ongoing on study|7|||
164207951|NCT05020015|593131561|FG000|Overall Study|Death|2|||
164207952|NCT05020015|593131562|FG001|Overall Study|Death|3|||
164207953|NCT05020015|593131563|FG002|Overall Study|Death|4|||
164207954|NCT05020015|593131564|FG003|Overall Study|Death|0|||
164207955|NCT05020015|593131561|FG000|Overall Study|Withdrawal by Subject|0|||
164207956|NCT05020015|593131562|FG001|Overall Study|Withdrawal by Subject|0|||
164207957|NCT05020015|593131563|FG002|Overall Study|Withdrawal by Subject|1|||
164207958|NCT05020015|593131564|FG003|Overall Study|Withdrawal by Subject|0|||
164207959|NCT05020015|593131561|FG000|Overall Study|Reason Not Specified|0|||
164207960|NCT05020015|593131562|FG001|Overall Study|Reason Not Specified|0|||
164207961|NCT05020015|593131563|FG002|Overall Study|Reason Not Specified|2|||
164321670|NCT00534313|593554196|FG000|Short-term Period|Participant withdrew consent|2|||
164321671|NCT00534313|593554197|FG001|Short-term Period|Participant withdrew consent|0|||
164321672|NCT00534313|593554198|FG002|Short-term Period|Participant withdrew consent|0|||
164321673|NCT00534313|593554199|FG003|Short-term Period|Participant withdrew consent|2|||
164321674|NCT00534313|593554196|FG000|Short-term Period|Pregnancy|0|||
164321675|NCT00534313|593554197|FG001|Short-term Period|Pregnancy|0|||
164321676|NCT00534313|593554198|FG002|Short-term Period|Pregnancy|1|||
164321677|NCT00534313|593554199|FG003|Short-term Period|Pregnancy|0|||
164207962|NCT05020015|593131564|FG003|Overall Study|Reason Not Specified|0|||
164321678|NCT00534313|593554196|FG000|Long-term Period|Adverse Event|2|||
164321679|NCT00534313|593554197|FG001|Long-term Period|Adverse Event|1|||
164321680|NCT00534313|593554198|FG002|Long-term Period|Adverse Event|0|||
164321681|NCT00534313|593554199|FG003|Long-term Period|Adverse Event|1|||
164321682|NCT00534313|593554196|FG000|Long-term Period|Lack of Efficacy|14|||
164321683|NCT00534313|593554197|FG001|Long-term Period|Lack of Efficacy|10|||
164321684|NCT00534313|593554198|FG002|Long-term Period|Lack of Efficacy|14|||
164321685|NCT00534313|593554199|FG003|Long-term Period|Lack of Efficacy|12|||
164321686|NCT00534313|593554196|FG000|Long-term Period|Lost to Follow-up|1|||
164321687|NCT00534313|593554197|FG001|Long-term Period|Lost to Follow-up|2|||
164321688|NCT00534313|593554198|FG002|Long-term Period|Lost to Follow-up|0|||
164321689|NCT00534313|593554199|FG003|Long-term Period|Lost to Follow-up|0|||
164321690|NCT00534313|593554196|FG000|Long-term Period|Withdrawal by Subject|2|||
164321691|NCT00534313|593554197|FG001|Long-term Period|Withdrawal by Subject|2|||
164321692|NCT00534313|593554198|FG002|Long-term Period|Withdrawal by Subject|0|||
164321693|NCT00534313|593554199|FG003|Long-term Period|Withdrawal by Subject|0|||
164321694|NCT00534313|593554196|FG000|Long-term Period|No longer meets study criteria|0|||
164321695|NCT00534313|593554197|FG001|Long-term Period|No longer meets study criteria|1|||
164321696|NCT00534313|593554198|FG002|Long-term Period|No longer meets study criteria|0|||
164563675|NCT01475734|594432322|FG001|Overall Study|Protocol Violation|0|||
164563676|NCT01475734|594432321|FG000|Overall Study|Physician Decision|0|||
164207963|NCT02233413|593131565|FG000|Overall Study|Lost to Follow-up|7|||
164207964|NCT02233413|593131566|FG001|Overall Study|Lost to Follow-up|9|||
164207965|NCT02233413|593131565|FG000|Overall Study|Withdrawal by Subject|4|||
164207966|NCT02233413|593131566|FG001|Overall Study|Withdrawal by Subject|5|||
164207967|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
164207968|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
164207969|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
164207970|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
164207971|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
164207972|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
164207973|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
164207974|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
164207975|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
164207976|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
164207977|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
164207978|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
164207979|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
164207980|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
164207981|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
164207982|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
164207983|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
164207984|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
164207985|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
164207986|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
164207987|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
164207988|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
164207989|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
164207990|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
164207991|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
164207992|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
164207993|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
164420657|NCT01154036|593910964|FG002|Phase I|Adverse Event|12|||
164563677|NCT01475734|594432322|FG001|Overall Study|Physician Decision|1|||
164321697|NCT00534313|593554199|FG003|Long-term Period|No longer meets study criteria|0|||
164321698|NCT00534313|593554196|FG000|Long-term Period|Poor compliance/noncompliance|0|||
164321699|NCT00534313|593554197|FG001|Long-term Period|Poor compliance/noncompliance|1|||
164321700|NCT00534313|593554198|FG002|Long-term Period|Poor compliance/noncompliance|1|||
164321701|NCT00534313|593554199|FG003|Long-term Period|Poor compliance/noncompliance|0|||
164321702|NCT00534313|593554196|FG000|Long-term Period|Administrative reason by sponsor|17|||
164321703|NCT00534313|593554197|FG001|Long-term Period|Administrative reason by sponsor|15|||
164321704|NCT00534313|593554198|FG002|Long-term Period|Administrative reason by sponsor|26|||
164321705|NCT00534313|593554199|FG003|Long-term Period|Administrative reason by sponsor|18|||
164321706|NCT00534313|593554196|FG000|Long-term Period|Other|1|||
164321707|NCT00534313|593554197|FG001|Long-term Period|Other|2|||
164321708|NCT00534313|593554198|FG002|Long-term Period|Other|2|||
164321709|NCT00534313|593554199|FG003|Long-term Period|Other|2|||
164321710|NCT00402233|593554200|FG000|Overall Study|Adverse Event|1|||
164321711|NCT00402233|593554201|FG001|Overall Study|Adverse Event|7|||
164321712|NCT00402233|593554202|FG002|Overall Study|Adverse Event|9|||
164321713|NCT00402233|593554203|FG003|Overall Study|Adverse Event|9|||
164321714|NCT00402233|593554200|FG000|Overall Study|Protocol Violation|0|||
164321715|NCT00402233|593554201|FG001|Overall Study|Protocol Violation|1|||
164321716|NCT00402233|593554202|FG002|Overall Study|Protocol Violation|0|||
164321717|NCT00402233|593554203|FG003|Overall Study|Protocol Violation|0|||
164321718|NCT00402233|593554200|FG000|Overall Study|Withdrawal by Subject|2|||
164321719|NCT00402233|593554201|FG001|Overall Study|Withdrawal by Subject|1|||
164321720|NCT00402233|593554202|FG002|Overall Study|Withdrawal by Subject|2|||
164321721|NCT00402233|593554203|FG003|Overall Study|Withdrawal by Subject|2|||
164321722|NCT00402233|593554200|FG000|Overall Study|Worsening of disease under study|2|||
164321723|NCT00402233|593554201|FG001|Overall Study|Worsening of disease under study|0|||
164321724|NCT00402233|593554202|FG002|Overall Study|Worsening of disease under study|0|||
164321725|NCT00402233|593554203|FG003|Overall Study|Worsening of disease under study|0|||
164321726|NCT00402233|593554200|FG000|Overall Study|Worsening of other pre-existing disease|0|||
164321727|NCT00402233|593554201|FG001|Overall Study|Worsening of other pre-existing disease|1|||
164321728|NCT00402233|593554202|FG002|Overall Study|Worsening of other pre-existing disease|0|||
164321729|NCT00402233|593554203|FG003|Overall Study|Worsening of other pre-existing disease|0|||
164321730|NCT00492063|593554207|FG000|Overall Study|Death|0|||
164321731|NCT00492063|593554208|FG001|Overall Study|Death|0|||
164321732|NCT00492063|593554209|FG002|Overall Study|Death|1|||
164321733|NCT00492063|593554210|FG003|Overall Study|Death|2|||
164321734|NCT00492063|593554207|FG000|Overall Study|Withdrawal by Subject|4|||
164321735|NCT00492063|593554208|FG001|Overall Study|Withdrawal by Subject|3|||
164321736|NCT00492063|593554209|FG002|Overall Study|Withdrawal by Subject|5|||
164321737|NCT00492063|593554210|FG003|Overall Study|Withdrawal by Subject|4|||
164321738|NCT00492063|593554207|FG000|Overall Study|Lost to Follow-up|6|||
164321739|NCT00492063|593554208|FG001|Overall Study|Lost to Follow-up|11|||
164321740|NCT00492063|593554209|FG002|Overall Study|Lost to Follow-up|5|||
164321741|NCT00492063|593554210|FG003|Overall Study|Lost to Follow-up|3|||
164321742|NCT00492063|593554207|FG000|Overall Study|Protocol Violation|0|||
164321743|NCT00492063|593554208|FG001|Overall Study|Protocol Violation|0|||
164321744|NCT00492063|593554209|FG002|Overall Study|Protocol Violation|0|||
164321745|NCT00492063|593554210|FG003|Overall Study|Protocol Violation|1|||
164321746|NCT00495040|593554211|FG000|Overall Study|Withdrawal by Subject|3|||
164321747|NCT01829243|593554215|FG000|First Intervention|Screen Failure|4|||
164563678|NCT00771472|594432323|FG000|Overall Study|Physician Decision|2|||
164207994|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
164207995|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
164207996|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
164207997|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
164207998|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
164207999|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
164208000|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
164208001|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
164208002|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
164208003|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
164208004|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
164208005|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
164208006|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
164208007|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
164208008|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
164208009|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
164208010|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
164208011|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
164208012|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
164208013|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
164208014|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
164208015|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
164208016|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
164208017|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
164208018|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
164208019|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
164208020|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
164208021|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
164208022|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
164208023|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
164208024|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
164208025|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
164208026|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
164208027|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
164208028|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
164208029|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
164208030|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
164208031|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
164208032|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
164208033|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
164208034|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
164208035|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
164208036|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
164208037|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
164208038|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
164208039|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
164208040|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
164208041|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
164208042|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
164208043|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
164208044|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
164208045|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
164208046|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
164208047|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
164208048|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
164208049|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
164208050|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
164208051|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
164208052|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
164208053|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
164208054|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
164563679|NCT00771472|594432324|FG001|Overall Study|Physician Decision|3|||
164208055|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
164208056|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
164208057|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
164208058|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
164208059|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
164208060|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
164208061|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
164208062|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
164208063|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
164208064|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
164208065|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
164208066|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
164208067|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
164208068|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
164208069|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
164208070|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
164208071|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
164208072|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
164208073|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
164208074|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
164208075|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
164208076|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
164208077|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
164208078|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
164208079|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
164208080|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
164208081|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
164208082|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
164208083|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
164208084|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
164208085|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
164208086|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
164208087|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
164208088|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
164208089|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
164208090|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
164208091|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
164208092|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
164208093|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
164208094|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
164208095|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
164208096|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
164208097|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
164208098|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
164208099|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
164208100|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
164208101|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
164208102|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
164208103|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
164208104|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
164208105|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
164208106|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
164208107|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
164208108|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Death|1|||
164208109|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Death|0|||
164208110|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Death|1|||
164208111|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
164208112|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
164208113|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
164208114|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
164208115|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
164208116|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
164208117|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
164563680|NCT00771472|594432323|FG000|Overall Study|Progressive Disease|3|||
164321748|NCT01829243|593554216|FG001|First Intervention|Screen Failure|2|||
164321749|NCT02282293|593554219|FG000|Overall Study|Lost to Follow-up|2|||
164321750|NCT02282293|593554220|FG001|Overall Study|Lost to Follow-up|2|||
164321751|NCT02282293|593554219|FG000|Overall Study|Unable to comply with study procedures|1|||
164321752|NCT02282293|593554220|FG001|Overall Study|Unable to comply with study procedures|0|||
164321753|NCT02282293|593554219|FG000|Overall Study|Moved out of study area|0|||
164321754|NCT02282293|593554220|FG001|Overall Study|Moved out of study area|1|||
164321755|NCT00053898|593554221|FG000|Overall Study|No follow-up data from any source|9|||
164321756|NCT00053898|593554222|FG001|Overall Study|No follow-up data from any source|12|||
164321757|NCT00053898|593554221|FG000|Overall Study|Follow-up from telephone contact only|5|||
164321758|NCT00053898|593554222|FG001|Overall Study|Follow-up from telephone contact only|1|||
164321759|NCT03985878|593554226|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
164321760|NCT03985878|593554226|FG000|Overall Study|Study Terminated by Sponsor|12|||
164321761|NCT03985878|593554226|FG000|Overall Study|Withdrawal by Subject|1|||
164321762|NCT01894568|593554227|FG000|Overall Study|Adverse Event|2|||
164321763|NCT01894568|593554228|FG001|Overall Study|Adverse Event|3|||
164321764|NCT01894568|593554227|FG000|Overall Study|Protocol required discontinuation|2|||
164321765|NCT01894568|593554228|FG001|Overall Study|Protocol required discontinuation|1|||
164321766|NCT01894568|593554227|FG000|Overall Study|Withdrawal by Subject|5|||
164321767|NCT01894568|593554228|FG001|Overall Study|Withdrawal by Subject|5|||
164321768|NCT01894568|593554227|FG000|Overall Study|Physician Decision|1|||
164321769|NCT01894568|593554228|FG001|Overall Study|Physician Decision|0|||
164321770|NCT01894568|593554227|FG000|Overall Study|Lost to Follow-up|0|||
164321771|NCT01894568|593554228|FG001|Overall Study|Lost to Follow-up|1|||
164321772|NCT01089361|593554230|FG000|Overall Study|Death|1|||
164321773|NCT01089361|593554231|FG001|Overall Study|Death|0|||
164321774|NCT01514370|593554232|FG000|Overall Study|Protocol Violation|2|||
164563681|NCT00771472|594432324|FG001|Overall Study|Progressive Disease|1|||
164563682|NCT00771472|594432323|FG000|Overall Study|Protocol Violation|1|||
164563683|NCT00771472|594432324|FG001|Overall Study|Protocol Violation|0|||
164563684|NCT00880750|594432334|FG000|First Intervention|Adverse Event|1|||
164563685|NCT00880750|594432335|FG001|First Intervention|Adverse Event|0|||
164563686|NCT00880750|594432334|FG000|First Intervention|Unable to collect urine|4|||
164563687|NCT00880750|594432335|FG001|First Intervention|Unable to collect urine|0|||
164563688|NCT00880750|594432334|FG000|First Intervention|Non-compliance with meals|0|||
164563689|NCT00880750|594432335|FG001|First Intervention|Non-compliance with meals|1|||
164563690|NCT00880750|594432334|FG000|First Intervention|Withdrawal by Subject|2|||
164563691|NCT00880750|594432335|FG001|First Intervention|Withdrawal by Subject|0|||
164563692|NCT00880750|594432334|FG000|First Intervention|Lost to Follow-up|2|||
164563693|NCT00880750|594432335|FG001|First Intervention|Lost to Follow-up|0|||
164563694|NCT00880750|594432334|FG000|Second Intervention|Withdrawal by Subject|2|||
164563695|NCT00880750|594432335|FG001|Second Intervention|Withdrawal by Subject|2|||
164563696|NCT00880750|594432334|FG000|Second Intervention|Protocol Violation|1|||
164563697|NCT00880750|594432335|FG001|Second Intervention|Protocol Violation|0|||
164563698|NCT00880750|594432334|FG000|Second Intervention|Unable to collect urine|1|||
164563699|NCT00880750|594432335|FG001|Second Intervention|Unable to collect urine|0|||
164563700|NCT00667576|594432338|FG000|Overall Study|Withdrawal by Subject|1|||
164563701|NCT00667576|594432339|FG001|Overall Study|Withdrawal by Subject|0|||
164563702|NCT00667576|594432340|FG002|Overall Study|Withdrawal by Subject|1|||
164563703|NCT00667576|594432341|FG003|Overall Study|Withdrawal by Subject|1|||
164563704|NCT00667576|594432342|FG004|Overall Study|Withdrawal by Subject|1|||
164563705|NCT00667576|594432338|FG000|Overall Study|Adverse Event|1|||
164563706|NCT00667576|594432339|FG001|Overall Study|Adverse Event|1|||
164563707|NCT00667576|594432340|FG002|Overall Study|Adverse Event|0|||
164563708|NCT00667576|594432341|FG003|Overall Study|Adverse Event|0|||
164563709|NCT00667576|594432342|FG004|Overall Study|Adverse Event|0|||
164563710|NCT00667576|594432338|FG000|Overall Study|Lost to Follow-up|0|||
164563711|NCT00667576|594432339|FG001|Overall Study|Lost to Follow-up|0|||
164563712|NCT00667576|594432340|FG002|Overall Study|Lost to Follow-up|1|||
164563713|NCT00667576|594432341|FG003|Overall Study|Lost to Follow-up|0|||
164668309|NCT02343120|594810181|FG002|Part 2: Expansion|Lost to Follow-up|0|||
164321775|NCT01514370|593554233|FG001|Overall Study|Protocol Violation|3|||
164321776|NCT01514370|593554232|FG000|Overall Study|Lost to Follow-up|0|||
164321777|NCT01514370|593554233|FG001|Overall Study|Lost to Follow-up|2|||
164321778|NCT01514370|593554232|FG000|Overall Study|Withdrawal by Subject|2|||
164321779|NCT01514370|593554233|FG001|Overall Study|Withdrawal by Subject|1|||
164321780|NCT01514370|593554232|FG000|Overall Study|Adverse Event|1|||
164321781|NCT01514370|593554233|FG001|Overall Study|Adverse Event|3|||
164321782|NCT01514370|593554232|FG000|Overall Study|Other|6|||
164321783|NCT01514370|593554233|FG001|Overall Study|Other|7|||
164563714|NCT00667576|594432342|FG004|Overall Study|Lost to Follow-up|0|||
164563715|NCT00667576|594432338|FG000|Overall Study|Protocol Violation|0|||
164563716|NCT00667576|594432339|FG001|Overall Study|Protocol Violation|0|||
164563717|NCT00667576|594432340|FG002|Overall Study|Protocol Violation|0|||
164563718|NCT00667576|594432341|FG003|Overall Study|Protocol Violation|1|||
164563719|NCT00667576|594432342|FG004|Overall Study|Protocol Violation|0|||
164563720|NCT00667576|594432338|FG000|Overall Study|Physician Decision|0|||
164321784|NCT00169442|593554234|FG000|Overall Study|Withdrawal by Subject|0|||
164321785|NCT00169442|593554235|FG001|Overall Study|Withdrawal by Subject|0|||
164321786|NCT00169442|593554236|FG002|Overall Study|Withdrawal by Subject|1|||
164321787|NCT00169442|593554237|FG003|Overall Study|Withdrawal by Subject|0|||
164321788|NCT00169442|593554238|FG004|Overall Study|Withdrawal by Subject|0|||
164321789|NCT00169442|593554239|FG005|Overall Study|Withdrawal by Subject|0|||
164321790|NCT00169442|593554234|FG000|Overall Study|Migrated/moved from study area|0|||
164321791|NCT00169442|593554235|FG001|Overall Study|Migrated/moved from study area|0|||
164321792|NCT00169442|593554236|FG002|Overall Study|Migrated/moved from study area|0|||
164321793|NCT00169442|593554237|FG003|Overall Study|Migrated/moved from study area|0|||
164321794|NCT00169442|593554238|FG004|Overall Study|Migrated/moved from study area|0|||
164321795|NCT00169442|593554239|FG005|Overall Study|Migrated/moved from study area|2|||
164321796|NCT00169442|593554234|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
164321797|NCT00169442|593554235|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
164321798|NCT00169442|593554236|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
164321799|NCT00169442|593554237|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
164321800|NCT00169442|593554238|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
164321801|NCT00169442|593554239|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
164321802|NCT00169442|593554234|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
164563721|NCT00667576|594432339|FG001|Overall Study|Physician Decision|0|||
164321803|NCT00169442|593554235|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
164321804|NCT00169442|593554236|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
164321805|NCT00169442|593554237|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
164321806|NCT00169442|593554238|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
164321807|NCT00169442|593554239|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
164321808|NCT03353740|593554242|FG000|Overall Study|Images for these participants not viable|52|||
164321809|NCT02232880|593554244|FG000|Overall Study|study stopped prior to randomization|1|||
164321810|NCT02519855|593555433|FG000|Overall Study|Adverse Event|0|||
164321811|NCT02519855|593555434|FG001|Overall Study|Adverse Event|1|||
164321812|NCT02519855|593555433|FG000|Overall Study|Lost to Follow-up|3|||
164321813|NCT02519855|593555434|FG001|Overall Study|Lost to Follow-up|3|||
164321814|NCT00640835|593555438|FG000|Overall Study|Adverse Event|5|||
164321815|NCT00640835|593555439|FG001|Overall Study|Adverse Event|3|||
164321816|NCT00640835|593555438|FG000|Overall Study|Withdrawal by Subject|12|||
164321817|NCT00640835|593555439|FG001|Overall Study|Withdrawal by Subject|14|||
164321818|NCT00640835|593555438|FG000|Overall Study|Physician Decision|10|||
164321819|NCT00640835|593555439|FG001|Overall Study|Physician Decision|14|||
164321820|NCT00640835|593555438|FG000|Overall Study|Sponsor's Decision|11|||
164321821|NCT00640835|593555439|FG001|Overall Study|Sponsor's Decision|7|||
164321822|NCT00640835|593555438|FG000|Overall Study|Protocol Violation|2|||
164321823|NCT00640835|593555439|FG001|Overall Study|Protocol Violation|2|||
164321824|NCT00640835|593555438|FG000|Overall Study|Lost to Follow-up|17|||
164321825|NCT00640835|593555439|FG001|Overall Study|Lost to Follow-up|13|||
164321826|NCT00640835|593555438|FG000|Overall Study|Other Reason|19|||
164321827|NCT00640835|593555439|FG001|Overall Study|Other Reason|4|||
164321828|NCT05954143|593555444|FG000|Overall Study|Progressive Disease|1|||
164321829|NCT05954143|593555445|FG001|Overall Study|Progressive Disease|0|||
164321830|NCT05954143|593555444|FG000|Overall Study|Physician Decision|1|||
164321831|NCT05954143|593555445|FG001|Overall Study|Physician Decision|0|||
164321832|NCT05954143|593555444|FG000|Overall Study|Study Terminated by Sponsor|2|||
164321833|NCT05954143|593555445|FG001|Overall Study|Study Terminated by Sponsor|4|||
164321834|NCT05954143|593555444|FG000|Overall Study|Death|1|||
164321835|NCT05954143|593555445|FG001|Overall Study|Death|0|||
164321836|NCT05954143|593555444|FG000|Overall Study|Withdrawal by Subject|0|||
164321837|NCT05954143|593555445|FG001|Overall Study|Withdrawal by Subject|1|||
164321838|NCT05954143|593555444|FG000|Overall Study|Other|1|||
164321839|NCT05954143|593555445|FG001|Overall Study|Other|0|||
164321840|NCT00713310|593555446|FG000|Overall Study|Adverse Event|5|||
164321841|NCT00713310|593555447|FG001|Overall Study|Adverse Event|2|||
164321842|NCT00713310|593555446|FG000|Overall Study|Lack of Efficacy|0|||
164321843|NCT00713310|593555447|FG001|Overall Study|Lack of Efficacy|2|||
164321844|NCT00713310|593555446|FG000|Overall Study|Withdrawal by Subject|0|||
164321845|NCT00713310|593555447|FG001|Overall Study|Withdrawal by Subject|2|||
164321846|NCT00686634|593555448|FG000|Overall Study|Protocol Violation|6|||
164321847|NCT04369924|593555450|FG000|Overall Study|Lost to Follow-up|302|||
164321848|NCT04369924|593555451|FG001|Overall Study|Lost to Follow-up|339|||
164563722|NCT00667576|594432340|FG002|Overall Study|Physician Decision|0|||
164563723|NCT00667576|594432341|FG003|Overall Study|Physician Decision|1|||
164563724|NCT00667576|594432342|FG004|Overall Study|Physician Decision|0|||
164321849|NCT01653132|593555454|FG000|First Intervention|Protocol Violation|1|||
164321850|NCT01653132|593555455|FG001|First Intervention|Protocol Violation|0|||
164321851|NCT03828370|593555456|FG000|3 Month Follow-up|Lost to Follow-up|4|||
164321852|NCT03828370|593555457|FG001|3 Month Follow-up|Lost to Follow-up|12|||
164563725|NCT00667576|594432338|FG000|Overall Study|Missed Visit|0|||
164563726|NCT00667576|594432339|FG001|Overall Study|Missed Visit|0|||
164208118|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
164208119|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
164208120|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
164208121|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
164208122|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
164208123|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
164208124|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
164208125|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
164208126|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
164208127|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
164208128|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
164208129|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
164208130|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
164208131|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
164208132|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Depression|0|||
164208133|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Depression|1|||
164208134|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Depression|0|||
164208135|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
164208136|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
164208137|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
164208138|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Jailed|0|||
164208139|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Jailed|1|||
164208140|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Jailed|0|||
164208141|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Other|0|||
164208142|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Other|1|||
164208143|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Other|0|||
164208144|NCT06633965|593131572|FG000|Overall Study|Withdrawal by Subject|0|||
164208145|NCT06633965|593131573|FG001|Overall Study|Withdrawal by Subject|1|||
164208146|NCT00947544|593131578|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
164208147|NCT00947544|593131579|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
164208148|NCT00300053|593131584|FG000|Overall Study|Patient/Caregiver Preference|2|||
164208149|NCT00300053|593131585|FG001|Overall Study|Patient/Caregiver Preference|2|||
164208150|NCT00300053|593131586|FG002|Overall Study|Patient/Caregiver Preference|3|||
164208151|NCT00300053|593131584|FG000|Overall Study|Death|0|||
164208152|NCT00300053|593131585|FG001|Overall Study|Death|0|||
164208153|NCT00300053|593131586|FG002|Overall Study|Death|3|||
164208154|NCT00300053|593131584|FG000|Overall Study|Lost to Follow-up|0|||
164208155|NCT00300053|593131585|FG001|Overall Study|Lost to Follow-up|1|||
164208156|NCT00300053|593131586|FG002|Overall Study|Lost to Follow-up|0|||
164208157|NCT02566005|593131587|FG000|Overall Study|vaginal bleeding|0|||
164208158|NCT02566005|593131588|FG001|Overall Study|vaginal bleeding|1|||
164208159|NCT02566005|593131587|FG000|Overall Study|received foley|8|||
164208160|NCT02566005|593131588|FG001|Overall Study|received foley|0|||
164208161|NCT02566005|593131587|FG000|Overall Study|did not receive foley|0|||
164208162|NCT02566005|593131588|FG001|Overall Study|did not receive foley|1|||
164208163|NCT02566005|593131587|FG000|Overall Study|labor after randomization|0|||
164208164|NCT02566005|593131588|FG001|Overall Study|labor after randomization|4|||
164208165|NCT02472405|593131589|FG000|Overall Study|Lost to Follow-up|9|||
164208166|NCT02472405|593131589|FG000|Overall Study|Adverse Event|1|||
164208167|NCT03095287|593131590|FG000|Overall Study|Treatment Failure|1|||
164208168|NCT03095287|593131590|FG000|Overall Study|Adverse Event|1|||
164208169|NCT01134042|593131593|FG000|Overall Study|Adverse Event|3|||
164208170|NCT01134042|593131594|FG001|Overall Study|Adverse Event|7|||
164208171|NCT01134042|593131595|FG002|Overall Study|Adverse Event|2|||
164208172|NCT01134042|593131593|FG000|Overall Study|Lack of Efficacy|21|||
164208173|NCT01134042|593131594|FG001|Overall Study|Lack of Efficacy|6|||
164208174|NCT01134042|593131595|FG002|Overall Study|Lack of Efficacy|18|||
164208175|NCT01134042|593131593|FG000|Overall Study|Protocol Violation|5|||
164208176|NCT01134042|593131594|FG001|Overall Study|Protocol Violation|3|||
164208177|NCT01134042|593131595|FG002|Overall Study|Protocol Violation|5|||
164208178|NCT01134042|593131593|FG000|Overall Study|Lost to Follow-up|2|||
164208179|NCT01134042|593131594|FG001|Overall Study|Lost to Follow-up|0|||
164208180|NCT01134042|593131595|FG002|Overall Study|Lost to Follow-up|1|||
164208181|NCT01134042|593131593|FG000|Overall Study|Physician Decision|4|||
164208182|NCT01134042|593131594|FG001|Overall Study|Physician Decision|8|||
164208183|NCT01134042|593131595|FG002|Overall Study|Physician Decision|1|||
164208184|NCT01134042|593131593|FG000|Overall Study|Withdrawal by Subject|13|||
164208185|NCT01134042|593131594|FG001|Overall Study|Withdrawal by Subject|4|||
164208186|NCT01134042|593131595|FG002|Overall Study|Withdrawal by Subject|7|||
164208187|NCT03345004|593131596|FG000|Overall Study|Physician Decision|1|||
164208188|NCT03345004|593131597|FG001|Overall Study|Physician Decision|0|||
164208189|NCT03345004|593131596|FG000|Overall Study|Withdrawal by Subject|0|||
164208190|NCT03345004|593131597|FG001|Overall Study|Withdrawal by Subject|1|||
164208191|NCT05350423|593131598|FG000|Overall Study|Lost to Follow-up|3|||
164208192|NCT05350423|593131599|FG001|Overall Study|Lost to Follow-up|3|||
164563727|NCT00667576|594432340|FG002|Overall Study|Missed Visit|0|||
164563728|NCT00667576|594432341|FG003|Overall Study|Missed Visit|1|||
164563729|NCT00667576|594432342|FG004|Overall Study|Missed Visit|0|||
164208193|NCT05350423|593131598|FG000|Overall Study|screen failure|5|||
164563730|NCT00483327|594432346|FG000|Overall Study|Adverse Event|1|||
164563731|NCT00483327|594432346|FG000|Overall Study|Withdrawal by Subject|3|||
164563732|NCT00483327|594432346|FG000|Overall Study|Lost to Follow-up|4|||
164563733|NCT00483327|594432346|FG000|Overall Study|Patient Non Compliance|2|||
164563734|NCT00568555|594432352|FG000|Overall Study|Withdrawal by Subject|1|||
164563735|NCT00568555|594432353|FG001|Overall Study|Withdrawal by Subject|1|||
164563736|NCT03068325|594432355|FG000|Overall Study|Lost to Follow-up|5|||
164563737|NCT00700180|594432356|FG000|Overall Study|Death|99|||
164563738|NCT00700180|594432357|FG001|Overall Study|Death|114|||
164563739|NCT00700180|594432356|FG000|Overall Study|Alive on treatment|5|||
164563740|NCT00700180|594432357|FG001|Overall Study|Alive on treatment|3|||
164563741|NCT00700180|594432356|FG000|Overall Study|Alive in follow-up|46|||
164563742|NCT00700180|594432357|FG001|Overall Study|Alive in follow-up|27|||
164563743|NCT00700180|594432356|FG000|Overall Study|Lost to Follow-up|4|||
164563744|NCT00700180|594432357|FG001|Overall Study|Lost to Follow-up|5|||
164563745|NCT03588741|594432358|FG000|Overall Study|Withdrawal by Subject|1|||
164563746|NCT01445535|594432359|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
164563747|NCT01445535|594432360|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
164563748|NCT01445535|594432361|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
164563749|NCT01445535|594432362|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
164563750|NCT01445535|594432359|FG000|Overall Study|Disease progression|1|||
164563751|NCT01445535|594432360|FG001|Overall Study|Disease progression|0|||
164563752|NCT01445535|594432361|FG002|Overall Study|Disease progression|1|||
164563753|NCT01445535|594432362|FG003|Overall Study|Disease progression|0|||
164563754|NCT01445535|594432359|FG000|Overall Study|PI discretion|0|||
164563755|NCT01445535|594432360|FG001|Overall Study|PI discretion|0|||
164563756|NCT01445535|594432361|FG002|Overall Study|PI discretion|0|||
164563757|NCT01445535|594432362|FG003|Overall Study|PI discretion|1|||
164563758|NCT01705691|594432363|FG000|Overall Study|Death|1|||
164563759|NCT01705691|594432364|FG001|Overall Study|Death|2|||
164563760|NCT01705691|594432363|FG000|Overall Study|Withdrawal by Subject|1|||
164563761|NCT01705691|594432364|FG001|Overall Study|Withdrawal by Subject|2|||
164563762|NCT01705691|594432363|FG000|Overall Study|Lost to Follow-up|1|||
164563763|NCT01705691|594432364|FG001|Overall Study|Lost to Follow-up|1|||
164563764|NCT01705691|594432363|FG000|Overall Study|Other|0|||
164563765|NCT01705691|594432364|FG001|Overall Study|Other|1|||
164208194|NCT05350423|593131599|FG001|Overall Study|screen failure|6|||
164208195|NCT02097277|593131600|FG000|Overall Study|Subject no longer meets study criteria|0|||
164208196|NCT02097277|593131601|FG001|Overall Study|Subject no longer meets study criteria|1|||
164208197|NCT02097277|593131602|FG002|Overall Study|Subject no longer meets study criteria|0|||
164208198|NCT02097277|593131603|FG003|Overall Study|Subject no longer meets study criteria|1|||
164208199|NCT02097277|593131604|FG004|Overall Study|Subject no longer meets study criteria|0|||
164208200|NCT02097277|593131600|FG000|Overall Study|Subject request to discontinue treatment|0|||
164208201|NCT02097277|593131601|FG001|Overall Study|Subject request to discontinue treatment|0|||
164208202|NCT02097277|593131602|FG002|Overall Study|Subject request to discontinue treatment|0|||
164208203|NCT02097277|593131603|FG003|Overall Study|Subject request to discontinue treatment|0|||
164208204|NCT02097277|593131604|FG004|Overall Study|Subject request to discontinue treatment|1|||
164208205|NCT02097277|593131600|FG000|Overall Study|Lost to Follow-up|0|||
164208206|NCT02097277|593131601|FG001|Overall Study|Lost to Follow-up|1|||
164208207|NCT02097277|593131602|FG002|Overall Study|Lost to Follow-up|1|||
164208208|NCT02097277|593131603|FG003|Overall Study|Lost to Follow-up|0|||
164208209|NCT02097277|593131604|FG004|Overall Study|Lost to Follow-up|0|||
164208210|NCT02097277|593131600|FG000|Overall Study|Withdrawal by Subject|2|||
164208211|NCT02097277|593131601|FG001|Overall Study|Withdrawal by Subject|1|||
164208212|NCT02097277|593131602|FG002|Overall Study|Withdrawal by Subject|0|||
164208213|NCT02097277|593131603|FG003|Overall Study|Withdrawal by Subject|1|||
164208214|NCT02097277|593131604|FG004|Overall Study|Withdrawal by Subject|0|||
164208215|NCT02097277|593131600|FG000|Overall Study|Adverse Event|0|||
164563766|NCT03106779|594432365|FG000|Overall Study|Lack of Efficacy|33|||
164563767|NCT03106779|594432366|FG001|Overall Study|Lack of Efficacy|24|||
164563768|NCT03106779|594432365|FG000|Overall Study|Adverse Event|8|||
164563769|NCT03106779|594432366|FG001|Overall Study|Adverse Event|16|||
164563770|NCT03106779|594432365|FG000|Overall Study|Physician Decision|10|||
164563771|NCT03106779|594432366|FG001|Overall Study|Physician Decision|6|||
164563772|NCT03106779|594432365|FG000|Overall Study|Patient/guardian decision|4|||
164563773|NCT03106779|594432366|FG001|Overall Study|Patient/guardian decision|3|||
164563774|NCT03106779|594432365|FG000|Overall Study|Progressive disease|1|||
164563775|NCT03106779|594432366|FG001|Overall Study|Progressive disease|3|||
164208216|NCT02097277|593131601|FG001|Overall Study|Adverse Event|0|||
164208217|NCT02097277|593131602|FG002|Overall Study|Adverse Event|1|||
164208218|NCT02097277|593131603|FG003|Overall Study|Adverse Event|2|||
164208219|NCT02097277|593131604|FG004|Overall Study|Adverse Event|0|||
164208220|NCT01091259|593131609|FG000|Overall Study|Adverse Event|3|||
164208221|NCT01091259|593131609|FG000|Overall Study|Lack of Efficacy|2|||
164208222|NCT00984867|593131619|FG000|Overall Study|Adverse Event|3|||
164208223|NCT00984867|593131620|FG001|Overall Study|Adverse Event|7|||
164208224|NCT00984867|593131619|FG000|Overall Study|Death|1|||
164208225|NCT00984867|593131620|FG001|Overall Study|Death|0|||
164208226|NCT00984867|593131619|FG000|Overall Study|Withdrawal by Subject|13|||
164208227|NCT00984867|593131620|FG001|Overall Study|Withdrawal by Subject|4|||
164208228|NCT00984867|593131619|FG000|Overall Study|Lost to Follow-up|3|||
164208229|NCT00984867|593131620|FG001|Overall Study|Lost to Follow-up|4|||
164208230|NCT00984867|593131619|FG000|Overall Study|Poor/non-compliance|0|||
164208231|NCT00984867|593131620|FG001|Overall Study|Poor/non-compliance|1|||
164208232|NCT00984867|593131619|FG000|Overall Study|Subject no longer meets study criteria|1|||
164208233|NCT00984867|593131620|FG001|Overall Study|Subject no longer meets study criteria|1|||
164208234|NCT00984867|593131619|FG000|Overall Study|site closing|1|||
164208235|NCT00984867|593131620|FG001|Overall Study|site closing|0|||
164208236|NCT00984867|593131619|FG000|Overall Study|lack of efficacy and subject compliance|1|||
164208237|NCT00984867|593131620|FG001|Overall Study|lack of efficacy and subject compliance|0|||
164208238|NCT00671060|593131621|FG000|Overall Study|Protocol Violation|1|||
164208239|NCT00671060|593131622|FG001|Overall Study|Protocol Violation|0|||
164208240|NCT00671060|593131621|FG000|Overall Study|Physician Decision|0|||
164208241|NCT00671060|593131622|FG001|Overall Study|Physician Decision|1|||
164208242|NCT01541748|593131623|FG000|Overall Study|Lost to Follow-up|17|||
164208243|NCT01541748|593131623|FG000|Overall Study|Moved out of state|1|||
164208244|NCT01541748|593131623|FG000|Overall Study|Withdrawal by Subject|7|||
164208245|NCT01541748|593131623|FG000|Overall Study|Screen failure|5|||
164208246|NCT01541748|593131623|FG000|Overall Study|Did not receive study device|1|||
164208247|NCT00626639|593131631|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
164208248|NCT00626639|593131632|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
164208249|NCT01155141|593131633|FG000|Overall Study|Withdrawal by Subject|1|||
164208250|NCT01155141|593131633|FG000|Overall Study|Screen Failure|1|||
164208251|NCT03473197|593131634|FG000|Overall Study|Adverse Event|4|||
164208252|NCT03473197|593131634|FG000|Overall Study|Lost to Follow-up|1|||
164208253|NCT03473197|593131634|FG000|Overall Study|Withdrawal by Subject|5|||
164208254|NCT00785629|593131635|FG000|Overall Study|Adverse Event|2|||
164208255|NCT00785629|593131636|FG001|Overall Study|Adverse Event|1|||
164208256|NCT00785629|593131637|FG002|Overall Study|Adverse Event|1|||
164208257|NCT00785629|593131638|FG003|Overall Study|Adverse Event|5|||
164208258|NCT00785629|593131635|FG000|Overall Study|Protocol Violation|1|||
164208259|NCT00785629|593131636|FG001|Overall Study|Protocol Violation|2|||
164208260|NCT00785629|593131637|FG002|Overall Study|Protocol Violation|4|||
164208261|NCT00785629|593131638|FG003|Overall Study|Protocol Violation|5|||
164208262|NCT00785629|593131635|FG000|Overall Study|administrative decision|5|||
164208263|NCT00785629|593131636|FG001|Overall Study|administrative decision|1|||
164208264|NCT00785629|593131637|FG002|Overall Study|administrative decision|3|||
164208265|NCT00785629|593131638|FG003|Overall Study|administrative decision|4|||
164208266|NCT00785629|593131635|FG000|Overall Study|Withdrawal by Subject|0|||
164208267|NCT00785629|593131636|FG001|Overall Study|Withdrawal by Subject|1|||
164208268|NCT00785629|593131637|FG002|Overall Study|Withdrawal by Subject|2|||
164208269|NCT00785629|593131638|FG003|Overall Study|Withdrawal by Subject|2|||
164208270|NCT02020941|593131641|FG000|Overall Study|Adverse Event|1|||
164208271|NCT02020941|593131641|FG000|Overall Study|Physician Decision|2|||
164208272|NCT02020941|593131641|FG000|Overall Study|Withdrawal by Subject|1|||
164208273|NCT02020941|593131641|FG000|Overall Study|Disease Progression|4|||
164208274|NCT02107898|593131644|FG000|Overall Study|Adverse Event|4|||
164208275|NCT02107898|593131645|FG001|Overall Study|Adverse Event|7|||
164208276|NCT02107898|593131644|FG000|Overall Study|Poor compliance to protocol|0|||
164208277|NCT02107898|593131645|FG001|Overall Study|Poor compliance to protocol|1|||
164208278|NCT02107898|593131644|FG000|Overall Study|Participant moved|0|||
164208279|NCT02107898|593131645|FG001|Overall Study|Participant moved|2|||
164208280|NCT02107898|593131644|FG000|Overall Study|Consent withdrawn by participant|2|||
164208281|NCT02107898|593131645|FG001|Overall Study|Consent withdrawn by participant|1|||
164208282|NCT02107898|593131644|FG000|Overall Study|Randomized but not treated|0|||
164208283|NCT02107898|593131645|FG001|Overall Study|Randomized but not treated|1|||
164208284|NCT03329989|593131646|FG000|Overall Study|Withdrawal by Subject|9|||
164208285|NCT03329989|593131646|FG000|Overall Study|Lost to Follow-up|8|||
164208286|NCT03329989|593131646|FG000|Overall Study|Adverse Event|5|||
164208287|NCT03329989|593131646|FG000|Overall Study|Protocol Violation|1|||
164208288|NCT00879658|593131648|FG000|Overall Study|Abnormal laboratory value(s)|3|||
164208289|NCT00879658|593131649|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164208290|NCT00879658|593131650|FG002|Overall Study|Abnormal laboratory value(s)|0|||
164208291|NCT00879658|593131651|FG003|Overall Study|Abnormal laboratory value(s)|1|||
164208292|NCT00879658|593131652|FG004|Overall Study|Abnormal laboratory value(s)|0|||
164321853|NCT03828370|593555456|FG000|9 Month Follow up|Lost to Follow-up|12|||
164321854|NCT03828370|593555457|FG001|9 Month Follow up|Lost to Follow-up|20|||
164321855|NCT01209832|593555458|FG000|Period 1|Sponsor Decision and was not dosed|1|||
164321856|NCT01209832|593555458|FG000|Period 2|Sponsor Decision|1|||
164321857|NCT00761150|593555459|FG000|Open-label Period|Adverse Event|36|||
164321858|NCT00761150|593555460|FG001|Open-label Period|Adverse Event|0|||
164321859|NCT00761150|593555461|FG002|Open-label Period|Adverse Event|0|||
164321860|NCT00761150|593555459|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
164321861|NCT00761150|593555460|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
164321862|NCT00761150|593555461|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
164321863|NCT00761150|593555459|FG000|Open-label Period|Lost to Follow-up|7|||
164321864|NCT00761150|593555460|FG001|Open-label Period|Lost to Follow-up|0|||
164321865|NCT00761150|593555461|FG002|Open-label Period|Lost to Follow-up|0|||
164321866|NCT00761150|593555459|FG000|Open-label Period|Lack of Efficacy|4|||
164321867|NCT00761150|593555460|FG001|Open-label Period|Lack of Efficacy|0|||
164321868|NCT00761150|593555461|FG002|Open-label Period|Lack of Efficacy|0|||
164321869|NCT00761150|593555459|FG000|Open-label Period|Withdrawal by Subject|5|||
164321870|NCT00761150|593555460|FG001|Open-label Period|Withdrawal by Subject|0|||
164321871|NCT00761150|593555461|FG002|Open-label Period|Withdrawal by Subject|0|||
164321872|NCT00761150|593555459|FG000|Open-label Period|Noncompliance|2|||
164321873|NCT00761150|593555460|FG001|Open-label Period|Noncompliance|0|||
164321874|NCT00761150|593555461|FG002|Open-label Period|Noncompliance|0|||
164321875|NCT00761150|593555459|FG000|Open-label Period|Other|5|||
164321876|NCT00761150|593555460|FG001|Open-label Period|Other|0|||
164321877|NCT00761150|593555461|FG002|Open-label Period|Other|0|||
164321878|NCT00761150|593555459|FG000|Double-blind Period|Lack of Efficacy|0|||
164321879|NCT00761150|593555460|FG001|Double-blind Period|Lack of Efficacy|2|||
164321880|NCT00761150|593555461|FG002|Double-blind Period|Lack of Efficacy|19|||
164321881|NCT00761150|593555459|FG000|Double-blind Period|Adverse Event|0|||
164321882|NCT00761150|593555460|FG001|Double-blind Period|Adverse Event|3|||
164321883|NCT00761150|593555461|FG002|Double-blind Period|Adverse Event|3|||
164321884|NCT00761150|593555459|FG000|Double-blind Period|Withdrawal by Subject|0|||
164321885|NCT00761150|593555460|FG001|Double-blind Period|Withdrawal by Subject|3|||
164321886|NCT00761150|593555461|FG002|Double-blind Period|Withdrawal by Subject|2|||
164321887|NCT00761150|593555459|FG000|Double-blind Period|Lost to Follow-up|0|||
164321888|NCT00761150|593555460|FG001|Double-blind Period|Lost to Follow-up|2|||
164321889|NCT00761150|593555461|FG002|Double-blind Period|Lost to Follow-up|1|||
164420658|NCT01154036|593910965|FG003|Phase I|Adverse Event|0|||
164208293|NCT00879658|593131653|FG005|Overall Study|Abnormal laboratory value(s)|0|||
164208294|NCT00879658|593131654|FG006|Overall Study|Abnormal laboratory value(s)|0|||
164208295|NCT00879658|593131648|FG000|Overall Study|Administrative problems|2|||
164208296|NCT00879658|593131649|FG001|Overall Study|Administrative problems|1|||
164208297|NCT00879658|593131650|FG002|Overall Study|Administrative problems|0|||
164208298|NCT00879658|593131651|FG003|Overall Study|Administrative problems|1|||
164208299|NCT00879658|593131652|FG004|Overall Study|Administrative problems|0|||
164208300|NCT00879658|593131653|FG005|Overall Study|Administrative problems|0|||
164208301|NCT00879658|593131654|FG006|Overall Study|Administrative problems|0|||
164208302|NCT00879658|593131648|FG000|Overall Study|Adverse Event|6|||
164208303|NCT00879658|593131649|FG001|Overall Study|Adverse Event|4|||
164208304|NCT00879658|593131650|FG002|Overall Study|Adverse Event|3|||
164208305|NCT00879658|593131651|FG003|Overall Study|Adverse Event|1|||
164208306|NCT00879658|593131652|FG004|Overall Study|Adverse Event|2|||
164668310|NCT02343120|594810182|FG003|Part 2: Expansion|Lost to Follow-up|5|||
164668311|NCT02343120|594810183|FG004|Part 2: Expansion|Lost to Follow-up|2|||
164668312|NCT02343120|594810179|FG000|Part 2: Expansion|Other|0|||
164668313|NCT02343120|594810180|FG001|Part 2: Expansion|Other|0|||
164668314|NCT02343120|594810181|FG002|Part 2: Expansion|Other|0|||
164668315|NCT02343120|594810182|FG003|Part 2: Expansion|Other|1|||
164668316|NCT02343120|594810183|FG004|Part 2: Expansion|Other|5|||
164668317|NCT02343120|594810179|FG000|Part 2: Expansion|Adverse Event|0|||
164668318|NCT02343120|594810180|FG001|Part 2: Expansion|Adverse Event|0|||
164668319|NCT02343120|594810181|FG002|Part 2: Expansion|Adverse Event|0|||
164668320|NCT02343120|594810182|FG003|Part 2: Expansion|Adverse Event|1|||
164668321|NCT02343120|594810183|FG004|Part 2: Expansion|Adverse Event|1|||
164668322|NCT01054599|594810191|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
164668323|NCT01054599|594810192|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
164668324|NCT01054599|594810191|FG000|Overall Study|Protocol Violation|1|||
164668325|NCT01054599|594810192|FG001|Overall Study|Protocol Violation|0|||
164668326|NCT01054599|594810191|FG000|Overall Study|Spells/seizure-like episodes|1|||
164668327|NCT01054599|594810192|FG001|Overall Study|Spells/seizure-like episodes|1|||
164668328|NCT01054599|594810191|FG000|Overall Study|Timing/scheduling difficulties|1|||
164668329|NCT01054599|594810192|FG001|Overall Study|Timing/scheduling difficulties|1|||
164668330|NCT01054599|594810191|FG000|Overall Study|Visual impairment, WTAR <80|0|||
164668331|NCT01054599|594810192|FG001|Overall Study|Visual impairment, WTAR <80|1|||
164668332|NCT01054599|594810191|FG000|Overall Study|Lost to Follow-up|0|||
164668333|NCT01054599|594810192|FG001|Overall Study|Lost to Follow-up|2|||
164668334|NCT01054599|594810191|FG000|Overall Study|Adverse Event|0|||
164668335|NCT01054599|594810192|FG001|Overall Study|Adverse Event|1|||
164668336|NCT01054599|594810191|FG000|Overall Study|Withdrawal by Subject|0|||
164668337|NCT01054599|594810192|FG001|Overall Study|Withdrawal by Subject|1|||
164668338|NCT01104662|594810193|FG000|Overall Study|Adverse Event|2|||
164668339|NCT01104662|594810194|FG001|Overall Study|Adverse Event|2|||
164668340|NCT01104662|594810195|FG002|Overall Study|Adverse Event|0|||
164668341|NCT01104662|594810196|FG003|Overall Study|Adverse Event|1|||
164668342|NCT01104662|594810197|FG004|Overall Study|Adverse Event|1|||
164668343|NCT01104662|594810198|FG005|Overall Study|Adverse Event|1|||
164668344|NCT01104662|594810199|FG006|Overall Study|Adverse Event|0|||
164668345|NCT01104662|594810200|FG007|Overall Study|Adverse Event|0|||
164668346|NCT01104662|594810193|FG000|Overall Study|Clinical Failure|1|||
164668347|NCT01104662|594810194|FG001|Overall Study|Clinical Failure|0|||
164668348|NCT01104662|594810195|FG002|Overall Study|Clinical Failure|0|||
164668349|NCT01104662|594810196|FG003|Overall Study|Clinical Failure|0|||
164668350|NCT01104662|594810197|FG004|Overall Study|Clinical Failure|0|||
164668351|NCT01104662|594810198|FG005|Overall Study|Clinical Failure|1|||
164668352|NCT01104662|594810199|FG006|Overall Study|Clinical Failure|0|||
164668353|NCT01104662|594810200|FG007|Overall Study|Clinical Failure|0|||
164208307|NCT00879658|593131653|FG005|Overall Study|Adverse Event|0|||
164208308|NCT00879658|593131654|FG006|Overall Study|Adverse Event|0|||
164208309|NCT00879658|593131648|FG000|Overall Study|Protocol Violation|1|||
164208310|NCT00879658|593131649|FG001|Overall Study|Protocol Violation|0|||
164208311|NCT00879658|593131650|FG002|Overall Study|Protocol Violation|0|||
164208312|NCT00879658|593131651|FG003|Overall Study|Protocol Violation|0|||
164208313|NCT00879658|593131652|FG004|Overall Study|Protocol Violation|0|||
164208314|NCT00879658|593131653|FG005|Overall Study|Protocol Violation|0|||
164208315|NCT00879658|593131654|FG006|Overall Study|Protocol Violation|0|||
164208316|NCT00879658|593131648|FG000|Overall Study|Withdrawal by Subject|3|||
164668354|NCT01104662|594810193|FG000|Overall Study|Participant left investigator's care|1|||
164208317|NCT00879658|593131649|FG001|Overall Study|Withdrawal by Subject|0|||
164208318|NCT00879658|593131650|FG002|Overall Study|Withdrawal by Subject|2|||
164208319|NCT00879658|593131651|FG003|Overall Study|Withdrawal by Subject|0|||
164208320|NCT00879658|593131652|FG004|Overall Study|Withdrawal by Subject|0|||
164208321|NCT00879658|593131653|FG005|Overall Study|Withdrawal by Subject|1|||
164208322|NCT00879658|593131654|FG006|Overall Study|Withdrawal by Subject|0|||
164668355|NCT01104662|594810194|FG001|Overall Study|Participant left investigator's care|1|||
164668356|NCT01104662|594810195|FG002|Overall Study|Participant left investigator's care|0|||
164668357|NCT01104662|594810196|FG003|Overall Study|Participant left investigator's care|0|||
164321890|NCT00761150|593555459|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
164321891|NCT00761150|593555460|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
164321892|NCT00761150|593555461|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
164321893|NCT00761150|593555459|FG000|Double-blind Period|Noncompliance|0|||
164321894|NCT00761150|593555460|FG001|Double-blind Period|Noncompliance|1|||
164321895|NCT00761150|593555461|FG002|Double-blind Period|Noncompliance|0|||
164321896|NCT00761150|593555459|FG000|Double-blind Period|Other|0|||
164321897|NCT00761150|593555460|FG001|Double-blind Period|Other|3|||
164321898|NCT00761150|593555461|FG002|Double-blind Period|Other|3|||
164321899|NCT01925989|593555462|FG000|Period 1|Sponsor Decision|1|||
164321900|NCT01925989|593555463|FG001|Period 1|Sponsor Decision|1|||
164321901|NCT01925989|593555464|FG002|Period 1|Sponsor Decision|0|||
164321902|NCT01925989|593555462|FG000|Period 1|Withdrawal by Subject|0|||
164321903|NCT01925989|593555463|FG001|Period 1|Withdrawal by Subject|1|||
164321904|NCT01925989|593555464|FG002|Period 1|Withdrawal by Subject|0|||
164321905|NCT00046891|593555467|FG000|Overall Study|Cancels|5|||
164321906|NCT00046891|593555468|FG001|Overall Study|Cancels|9|||
164321907|NCT00046891|593555467|FG000|Overall Study|Ineligible|1|||
164321908|NCT00046891|593555468|FG001|Overall Study|Ineligible|1|||
164321909|NCT00046891|593555467|FG000|Overall Study|Withdrawal by Subject|18|||
164321910|NCT00046891|593555468|FG001|Overall Study|Withdrawal by Subject|15|||
164321911|NCT00046891|593555467|FG000|Overall Study|Adverse Event|5|||
164321912|NCT00046891|593555468|FG001|Overall Study|Adverse Event|5|||
164321913|NCT02496676|593555472|FG000|Phase 1 - Period 1|Adverse Event|0|||
164321914|NCT02496676|593555473|FG001|Phase 1 - Period 1|Adverse Event|1|||
164321915|NCT02496676|593555472|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
164321916|NCT02496676|593555473|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
164321917|NCT01009281|593555474|FG000|Overall Study|Administrative problems|7|||
164321918|NCT00924170|593555475|FG000|Overall Study|Refused further treatment|0|||
164321919|NCT00924170|593555476|FG001|Overall Study|Refused further treatment|1|||
164321920|NCT00924170|593555475|FG000|Overall Study|Physician Decision|0|||
164321921|NCT00924170|593555476|FG001|Overall Study|Physician Decision|1|||
164321922|NCT00924170|593555475|FG000|Overall Study|Progressive disease|3|||
164321923|NCT00924170|593555476|FG001|Overall Study|Progressive disease|6|||
164321924|NCT00924170|593555475|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
164321925|NCT00924170|593555476|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
164321926|NCT00924170|593555475|FG000|Overall Study|Death|1|||
164321927|NCT00924170|593555476|FG001|Overall Study|Death|0|||
164321928|NCT03901456|593555479|FG000|Overall Study|Withdrawal by Subject|0|||
164321929|NCT03901456|593555480|FG001|Overall Study|Withdrawal by Subject|0|||
164321930|NCT03901456|593555481|FG002|Overall Study|Withdrawal by Subject|1|||
164321931|NCT03901456|593555479|FG000|Overall Study|Lost to Follow-up|0|||
164321932|NCT03901456|593555480|FG001|Overall Study|Lost to Follow-up|1|||
164321933|NCT03901456|593555481|FG002|Overall Study|Lost to Follow-up|0|||
164321934|NCT05318183|593555482|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
164321935|NCT05318183|593555483|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
164321936|NCT05318183|593555482|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
164321937|NCT05318183|593555483|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
164321938|NCT05318183|593555482|FG000|Second Intervention (2 Weeks)|Protocol Violation|0|||
164321939|NCT05318183|593555483|FG001|Second Intervention (2 Weeks)|Protocol Violation|2|||
164321940|NCT05318183|593555482|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
164321941|NCT05318183|593555483|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
164208323|NCT00879658|593131648|FG000|Overall Study|Lack of Efficacy|0|||
164208324|NCT00879658|593131649|FG001|Overall Study|Lack of Efficacy|0|||
164208325|NCT00879658|593131650|FG002|Overall Study|Lack of Efficacy|2|||
164208326|NCT00879658|593131651|FG003|Overall Study|Lack of Efficacy|0|||
164208327|NCT00879658|593131652|FG004|Overall Study|Lack of Efficacy|0|||
164208328|NCT00879658|593131653|FG005|Overall Study|Lack of Efficacy|0|||
164208329|NCT00879658|593131654|FG006|Overall Study|Lack of Efficacy|0|||
164208330|NCT00879658|593131648|FG000|Overall Study|misrandomized (never received study med)|0|||
164208331|NCT00879658|593131649|FG001|Overall Study|misrandomized (never received study med)|0|||
164563776|NCT03106779|594432365|FG000|Overall Study|Lost to Follow-up|1|||
164563777|NCT03106779|594432366|FG001|Overall Study|Lost to Follow-up|2|||
164563778|NCT03106779|594432365|FG000|Overall Study|Death|1|||
164563779|NCT03106779|594432366|FG001|Overall Study|Death|0|||
164563780|NCT03106779|594432365|FG000|Overall Study|Protocol Violation|1|||
164563781|NCT03106779|594432366|FG001|Overall Study|Protocol Violation|0|||
164563782|NCT03106779|594432365|FG000|Overall Study|Not treated|1|||
164563783|NCT03106779|594432366|FG001|Overall Study|Not treated|0|||
164563784|NCT04233229|594432367|FG000|Overall Study|Withdrawal by Subject|0|||
164563785|NCT04233229|594432368|FG001|Overall Study|Withdrawal by Subject|1|||
164563786|NCT04233229|594432367|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
164563787|NCT04233229|594432368|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
164563788|NCT04233229|594432367|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
164563789|NCT04233229|594432368|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
164563790|NCT02288247|594432369|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
164563791|NCT02288247|594432370|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
164563792|NCT02288247|594432369|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
164563793|NCT02288247|594432370|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
164563794|NCT02288247|594432369|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
164563795|NCT02288247|594432370|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
164563796|NCT02288247|594432369|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
164563797|NCT02288247|594432370|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
164563798|NCT02288247|594432369|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
164563799|NCT02288247|594432370|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
164563800|NCT02288247|594432369|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
164563801|NCT02288247|594432370|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
164563802|NCT02288247|594432369|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
164563803|NCT02288247|594432370|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
164563804|NCT02288247|594432369|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
164563805|NCT02288247|594432370|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
164563806|NCT02288247|594432369|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
164563807|NCT02288247|594432370|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
164563808|NCT02288247|594432369|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
164563809|NCT02288247|594432370|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
164563810|NCT02288247|594432369|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
164563811|NCT02288247|594432370|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
164563812|NCT02288247|594432369|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
164563813|NCT02288247|594432370|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
164563814|NCT02288247|594432369|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
164563815|NCT02288247|594432370|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
164563816|NCT02288247|594432369|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
164563817|NCT02288247|594432370|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
164563818|NCT02288247|594432369|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
164563819|NCT02288247|594432370|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
164563820|NCT02288247|594432369|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
164563821|NCT02288247|594432370|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
164563822|NCT04652804|594432371|FG000|Overall Study|Ineligible post randomization|1|||
164563823|NCT04652804|594432372|FG001|Overall Study|Ineligible post randomization|0|||
164563824|NCT04652804|594432373|FG002|Overall Study|Ineligible post randomization|1|||
164563825|NCT04652804|594432374|FG003|Overall Study|Ineligible post randomization|0|||
164563826|NCT04652804|594432375|FG004|Overall Study|Ineligible post randomization|1|||
164563827|NCT04652804|594432376|FG005|Overall Study|Ineligible post randomization|1|||
164563828|NCT04652804|594432371|FG000|Overall Study|Missing SVR lab results|2|||
164563829|NCT04652804|594432372|FG001|Overall Study|Missing SVR lab results|0|||
164563830|NCT04652804|594432373|FG002|Overall Study|Missing SVR lab results|0|||
164563831|NCT04652804|594432374|FG003|Overall Study|Missing SVR lab results|0|||
164563832|NCT04652804|594432375|FG004|Overall Study|Missing SVR lab results|0|||
164563833|NCT04652804|594432376|FG005|Overall Study|Missing SVR lab results|0|||
164208332|NCT00879658|593131650|FG002|Overall Study|misrandomized (never received study med)|0|||
164321942|NCT04098224|593555484|FG000|Overall Study|Adverse Event|1|||
164321943|NCT04098224|593555485|FG001|Overall Study|Adverse Event|0|||
164321944|NCT04098224|593555484|FG000|Overall Study|Physician Decision|1|||
164321945|NCT04098224|593555485|FG001|Overall Study|Physician Decision|0|||
164321946|NCT04098224|593555484|FG000|Overall Study|Patient not required enteral feeding|1|||
164321947|NCT04098224|593555485|FG001|Overall Study|Patient not required enteral feeding|0|||
164321948|NCT04098224|593555484|FG000|Overall Study|Patient failure nasogastric tube|1|||
164321949|NCT04098224|593555485|FG001|Overall Study|Patient failure nasogastric tube|0|||
164321950|NCT04098224|593555484|FG000|Overall Study|Patient early extubation|1|||
164321951|NCT04098224|593555485|FG001|Overall Study|Patient early extubation|3|||
164321952|NCT01203852|593555489|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
164321953|NCT01203852|593555489|FG000|Washout 2 Weeks|Physician Decision|46|||
164321954|NCT00899392|593555490|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
164321955|NCT00899392|593555491|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
164321956|NCT01431638|593555492|FG000|Overall Study|Adverse Event|1|||
164321957|NCT01431638|593555493|FG001|Overall Study|Adverse Event|3|||
164321958|NCT01431638|593555494|FG002|Overall Study|Adverse Event|1|||
164321959|NCT01431638|593555492|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164321960|NCT01431638|593555493|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164321961|NCT01431638|593555494|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
164321962|NCT01431638|593555492|FG000|Overall Study|Participants condition no longer requires study drug|0|||
164321963|NCT01431638|593555493|FG001|Overall Study|Participants condition no longer requires study drug|1|||
164321964|NCT01431638|593555494|FG002|Overall Study|Participants condition no longer requires study drug|0|||
164321965|NCT01431638|593555492|FG000|Overall Study|Participant withdrew consent|14|||
164321966|NCT01431638|593555493|FG001|Overall Study|Participant withdrew consent|5|||
164321967|NCT01431638|593555494|FG002|Overall Study|Participant withdrew consent|8|||
164321968|NCT01431638|593555492|FG000|Overall Study|Lost to Follow-up|7|||
164321969|NCT01431638|593555493|FG001|Overall Study|Lost to Follow-up|9|||
164321970|NCT01431638|593555494|FG002|Overall Study|Lost to Follow-up|7|||
164321971|NCT01431638|593555492|FG000|Overall Study|Administrative problems|1|||
164321972|NCT01431638|593555493|FG001|Overall Study|Administrative problems|4|||
164321973|NCT01431638|593555494|FG002|Overall Study|Administrative problems|6|||
164321974|NCT01431638|593555492|FG000|Overall Study|Death|1|||
164321975|NCT01431638|593555493|FG001|Overall Study|Death|0|||
164321976|NCT01431638|593555494|FG002|Overall Study|Death|0|||
164321977|NCT01431638|593555492|FG000|Overall Study|Protocol deviation|1|||
164321978|NCT01431638|593555493|FG001|Overall Study|Protocol deviation|1|||
164321979|NCT01431638|593555494|FG002|Overall Study|Protocol deviation|4|||
164321980|NCT01431638|593555492|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
164321981|NCT01431638|593555493|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
164321982|NCT01431638|593555494|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
164321983|NCT01381562|593555495|FG000|Overall Study|Adverse Event|0|||
164321984|NCT01381562|593555496|FG001|Overall Study|Adverse Event|1|||
164321985|NCT01381562|593555497|FG002|Overall Study|Adverse Event|0|||
164321986|NCT03709576|593555506|FG000|Overall Study|progression prior to enrollment|1|||
164321987|NCT01947855|593555507|FG000|Overall Study|Withdrawal by Subject|1|||
164321988|NCT01947855|593555508|FG001|Overall Study|Withdrawal by Subject|0|||
164321989|NCT01947855|593555509|FG002|Overall Study|Withdrawal by Subject|0|||
164321990|NCT00710762|593555510|FG000|Overall Study|Progressive disease|27|||
164321991|NCT00710762|593555511|FG001|Overall Study|Progressive disease|30|||
164321992|NCT00710762|593555510|FG000|Overall Study|Adverse Event other disease worsening|2|||
164321993|NCT00710762|593555511|FG001|Overall Study|Adverse Event other disease worsening|1|||
164321994|NCT00710762|593555510|FG000|Overall Study|Other Adverse Event|7|||
164321995|NCT00710762|593555511|FG001|Overall Study|Other Adverse Event|7|||
164321996|NCT00710762|593555510|FG000|Overall Study|Lost to Follow-up|1|||
164321997|NCT00710762|593555511|FG001|Overall Study|Lost to Follow-up|0|||
164321998|NCT00710762|593555510|FG000|Overall Study|Reason other than listed above|2|||
164321999|NCT00710762|593555511|FG001|Overall Study|Reason other than listed above|2|||
164322000|NCT00592774|593555512|FG000|Overall Study|Adverse Event|5|||
164322001|NCT00592774|593555513|FG001|Overall Study|Adverse Event|19|||
164322002|NCT00592774|593555514|FG002|Overall Study|Adverse Event|2|||
164322003|NCT00592774|593555515|FG003|Overall Study|Adverse Event|14|||
164322004|NCT00592774|593555516|FG004|Overall Study|Adverse Event|8|||
164322005|NCT00592774|593555512|FG000|Overall Study|Protocol Violation|0|||
164322006|NCT00592774|593555513|FG001|Overall Study|Protocol Violation|1|||
164322007|NCT00592774|593555514|FG002|Overall Study|Protocol Violation|0|||
164322008|NCT00592774|593555515|FG003|Overall Study|Protocol Violation|0|||
164322009|NCT00592774|593555516|FG004|Overall Study|Protocol Violation|1|||
164322010|NCT00592774|593555512|FG000|Overall Study|Withdrawal by Subject|3|||
164322011|NCT00592774|593555513|FG001|Overall Study|Withdrawal by Subject|7|||
164322012|NCT00592774|593555514|FG002|Overall Study|Withdrawal by Subject|0|||
164322013|NCT00592774|593555515|FG003|Overall Study|Withdrawal by Subject|0|||
164322014|NCT00592774|593555516|FG004|Overall Study|Withdrawal by Subject|0|||
164322015|NCT00592774|593555512|FG000|Overall Study|Lack of Efficacy|3|||
164322016|NCT00592774|593555513|FG001|Overall Study|Lack of Efficacy|3|||
164322017|NCT00592774|593555514|FG002|Overall Study|Lack of Efficacy|0|||
164322018|NCT00592774|593555515|FG003|Overall Study|Lack of Efficacy|0|||
164322019|NCT00592774|593555516|FG004|Overall Study|Lack of Efficacy|2|||
164322020|NCT00592774|593555512|FG000|Overall Study|Physician Decision|0|||
164322021|NCT00592774|593555513|FG001|Overall Study|Physician Decision|1|||
164322022|NCT00592774|593555514|FG002|Overall Study|Physician Decision|1|||
164322023|NCT00592774|593555515|FG003|Overall Study|Physician Decision|0|||
164322024|NCT00592774|593555516|FG004|Overall Study|Physician Decision|1|||
164322025|NCT00592774|593555512|FG000|Overall Study|Other|0|||
164322026|NCT00592774|593555513|FG001|Overall Study|Other|1|||
164322027|NCT00592774|593555514|FG002|Overall Study|Other|1|||
164322028|NCT00592774|593555515|FG003|Overall Study|Other|0|||
164322029|NCT00592774|593555516|FG004|Overall Study|Other|2|||
164322030|NCT01892384|593555517|FG000|Overall Study|Withdrawal by Subject|1|||
164322031|NCT01892384|593555518|FG001|Overall Study|Withdrawal by Subject|1|||
164322032|NCT01892384|593555519|FG002|Overall Study|Withdrawal by Subject|0|||
164322033|NCT01892384|593555520|FG003|Overall Study|Withdrawal by Subject|0|||
164322034|NCT01700439|593555521|FG000|Overall Study|Lost to Follow-up|47|||
164322035|NCT01700439|593555521|FG000|Overall Study|Withdrawal by Subject|183|||
164322036|NCT01700439|593555521|FG000|Overall Study|Death|186|||
164322037|NCT00621621|593555522|FG000|Overall Study|Subjects were exited at EP study|30|||
164322038|NCT00621621|593555523|FG001|Overall Study|Subjects were exited at EP study|0|||
164322039|NCT02889562|593555527|FG000|Overall Study|Physician Decision|0|||
164322040|NCT02889562|593555528|FG001|Overall Study|Physician Decision|1|||
164322041|NCT02889562|593555527|FG000|Overall Study|Withdrawal by Subject|0|||
164322042|NCT02889562|593555528|FG001|Overall Study|Withdrawal by Subject|1|||
164322043|NCT04054947|593555532|FG000|Overall Study|Withdrawal by Subject|1|||
164322044|NCT04054947|593555533|FG001|Overall Study|Withdrawal by Subject|0|||
164322045|NCT04054947|593555532|FG000|Overall Study|Lost to Follow-up|2|||
164322046|NCT04054947|593555533|FG001|Overall Study|Lost to Follow-up|5|||
164322047|NCT01606878|593555534|FG000|Overall Study|Adverse Event|1|||
164322048|NCT01606878|593555535|FG001|Overall Study|Adverse Event|1|||
164322049|NCT01606878|593555536|FG002|Overall Study|Adverse Event|0|||
164322050|NCT01606878|593555537|FG003|Overall Study|Adverse Event|0|||
164322051|NCT01606878|593555538|FG004|Overall Study|Adverse Event|0|||
164322052|NCT01606878|593555539|FG005|Overall Study|Adverse Event|0|||
164322053|NCT01606878|593555540|FG006|Overall Study|Adverse Event|1|||
164322054|NCT01606878|593555541|FG007|Overall Study|Adverse Event|0|||
164322055|NCT01606878|593555542|FG008|Overall Study|Adverse Event|1|||
164322056|NCT01606878|593555543|FG009|Overall Study|Adverse Event|3|||
164563834|NCT04093531|594432377|FG000|Overall Study|failed screening|4|||
164563835|NCT03604445|594432381|FG000|Overall Study|Death|0|||
164322057|NCT01606878|593555544|FG010|Overall Study|Adverse Event|0|||
164322058|NCT01606878|593555534|FG000|Overall Study|Lack of Efficacy|1|||
164322059|NCT01606878|593555535|FG001|Overall Study|Lack of Efficacy|1|||
164322060|NCT01606878|593555536|FG002|Overall Study|Lack of Efficacy|1|||
164322061|NCT01606878|593555537|FG003|Overall Study|Lack of Efficacy|2|||
164322062|NCT01606878|593555538|FG004|Overall Study|Lack of Efficacy|1|||
164322063|NCT01606878|593555539|FG005|Overall Study|Lack of Efficacy|2|||
164322064|NCT01606878|593555540|FG006|Overall Study|Lack of Efficacy|1|||
164322065|NCT01606878|593555541|FG007|Overall Study|Lack of Efficacy|2|||
164563836|NCT03604445|594432382|FG001|Overall Study|Death|0|||
164322066|NCT01606878|593555542|FG008|Overall Study|Lack of Efficacy|2|||
164322067|NCT01606878|593555543|FG009|Overall Study|Lack of Efficacy|0|||
164563837|NCT03604445|594432383|FG002|Overall Study|Death|0|||
164322068|NCT01606878|593555544|FG010|Overall Study|Lack of Efficacy|1|||
164322069|NCT01606878|593555534|FG000|Overall Study|Physician Decision|1|||
164322070|NCT01606878|593555535|FG001|Overall Study|Physician Decision|0|||
164322071|NCT01606878|593555536|FG002|Overall Study|Physician Decision|2|||
164322072|NCT01606878|593555537|FG003|Overall Study|Physician Decision|1|||
164322073|NCT01606878|593555538|FG004|Overall Study|Physician Decision|1|||
164420659|NCT01154036|593910966|FG004|Phase I|Adverse Event|0|||
164420660|NCT01154036|593910967|FG005|Phase I|Adverse Event|0|||
164420661|NCT01154036|593910968|FG006|Phase I|Adverse Event|0|||
164420662|NCT01154036|593910969|FG007|Phase I|Adverse Event|0|||
164420663|NCT01154036|593910962|FG000|Phase II|Adverse Event|0|||
164420664|NCT01154036|593910963|FG001|Phase II|Adverse Event|0|||
164322074|NCT01606878|593555539|FG005|Overall Study|Physician Decision|1|||
164322075|NCT01606878|593555540|FG006|Overall Study|Physician Decision|2|||
164322076|NCT01606878|593555541|FG007|Overall Study|Physician Decision|0|||
164322077|NCT01606878|593555542|FG008|Overall Study|Physician Decision|1|||
164322078|NCT01606878|593555543|FG009|Overall Study|Physician Decision|0|||
164322079|NCT01606878|593555544|FG010|Overall Study|Physician Decision|0|||
164322080|NCT01606878|593555534|FG000|Overall Study|Withdrawal by Subject|3|||
164322081|NCT01606878|593555535|FG001|Overall Study|Withdrawal by Subject|2|||
164322082|NCT01606878|593555536|FG002|Overall Study|Withdrawal by Subject|2|||
164322083|NCT01606878|593555537|FG003|Overall Study|Withdrawal by Subject|0|||
164322084|NCT01606878|593555538|FG004|Overall Study|Withdrawal by Subject|1|||
164322085|NCT01606878|593555539|FG005|Overall Study|Withdrawal by Subject|1|||
164322086|NCT01606878|593555540|FG006|Overall Study|Withdrawal by Subject|2|||
164322087|NCT01606878|593555541|FG007|Overall Study|Withdrawal by Subject|1|||
164322088|NCT01606878|593555542|FG008|Overall Study|Withdrawal by Subject|2|||
164322089|NCT01606878|593555543|FG009|Overall Study|Withdrawal by Subject|0|||
164322090|NCT01606878|593555544|FG010|Overall Study|Withdrawal by Subject|2|||
164322091|NCT03720652|593555545|FG000|Overall Study|Withdrawal by Subject|2|||
164322092|NCT03720652|593555546|FG001|Overall Study|Withdrawal by Subject|7|||
164322093|NCT03720652|593555545|FG000|Overall Study|Lost to Follow-up|0|||
164322094|NCT03720652|593555546|FG001|Overall Study|Lost to Follow-up|4|||
164322095|NCT01155167|593555550|FG000|Overall Study|Insufficient ultrasound data|2|||
164322096|NCT01155167|593555551|FG001|Overall Study|Insufficient ultrasound data|0|||
164322097|NCT01155167|593555550|FG000|Overall Study|Access site changed to femoral artery|1|||
164322098|NCT01155167|593555551|FG001|Overall Study|Access site changed to femoral artery|0|||
164322099|NCT00167778|593555552|FG000|Overall Study|Withdrawal by Subject|1|||
164322100|NCT02654717|593555553|FG000|Overall Study|Adverse Event|2|||
164322101|NCT02654717|593555554|FG001|Overall Study|Adverse Event|2|||
164322102|NCT02654717|593555553|FG000|Overall Study|Protocol Violation|1|||
164322103|NCT02654717|593555554|FG001|Overall Study|Protocol Violation|2|||
164322104|NCT02654717|593555553|FG000|Overall Study|Withdrawal by Subject|0|||
164322105|NCT02654717|593555554|FG001|Overall Study|Withdrawal by Subject|1|||
164322106|NCT02654717|593555553|FG000|Overall Study|Non-permitted medication|3|||
164322107|NCT02654717|593555554|FG001|Overall Study|Non-permitted medication|0|||
164322108|NCT00960570|593555555|FG000|21 Day Washout Period|Adverse Event|1|||
164322109|NCT00960570|593555555|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
164322110|NCT00960570|593555555|FG000|1 Day Period Between Dosing|Adverse Event|2|||
164322111|NCT00960570|593555555|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
164322112|NCT00853970|593555556|FG000|Overall Study|Withdrawal by Subject|2|||
164322113|NCT00853970|593555557|FG001|Overall Study|Withdrawal by Subject|1|||
164322114|NCT00853970|593555556|FG000|Overall Study|Cancelled surgery|4|||
164322115|NCT00853970|593555557|FG001|Overall Study|Cancelled surgery|2|||
164322116|NCT04085367|593557149|FG000|Overall Study|Adverse Event|1|||
164322117|NCT04085367|593557150|FG001|Overall Study|Adverse Event|1|||
164322118|NCT04085367|593557149|FG000|Overall Study|Withdrawal by Subject|13|||
164322119|NCT04085367|593557150|FG001|Overall Study|Withdrawal by Subject|4|||
164322120|NCT04085367|593557149|FG000|Overall Study|Lost to Follow-up|3|||
164322121|NCT04085367|593557150|FG001|Overall Study|Lost to Follow-up|1|||
164322122|NCT04085367|593557149|FG000|Overall Study|Other unspecified|2|||
164322123|NCT04085367|593557150|FG001|Overall Study|Other unspecified|1|||
164322124|NCT04085367|593557149|FG000|Overall Study|Status Unknown|1|||
164322125|NCT04085367|593557150|FG001|Overall Study|Status Unknown|1|||
164322126|NCT00910247|593557152|FG000|Overall Study|Adverse Event|15|||
164322127|NCT00910247|593557152|FG000|Overall Study|Death|2|||
164322128|NCT00910247|593557152|FG000|Overall Study|Lost to Follow-up|10|||
164322129|NCT00910247|593557152|FG000|Overall Study|Physician Decision|3|||
164322130|NCT00910247|593557152|FG000|Overall Study|Protocol Violation|10|||
164322131|NCT00910247|593557152|FG000|Overall Study|Withdrawal by Subject|25|||
164322132|NCT00910247|593557152|FG000|Overall Study|Not collected|4|||
164322133|NCT00625742|593557153|FG000|Overall Study|Disease Progression|2|||
164322134|NCT00625742|593557153|FG000|Overall Study|Withdrawal by Subject|1|||
164322135|NCT00625742|593557153|FG000|Overall Study|Adverse Event|4|||
164322136|NCT00625742|593557153|FG000|Overall Study|Lost to Follow-up|4|||
164322137|NCT00625742|593557153|FG000|Overall Study|Ineligible|1|||
164322138|NCT03387150|593557154|FG000|Overall Study|Withdrawal by Subject|3|||
164420665|NCT01154036|593910964|FG002|Phase II|Adverse Event|0|||
164322139|NCT03387150|593557155|FG001|Overall Study|Withdrawal by Subject|0|||
164322140|NCT03387150|593557156|FG002|Overall Study|Withdrawal by Subject|3|||
164322141|NCT03387150|593557157|FG003|Overall Study|Withdrawal by Subject|4|||
164322142|NCT03387150|593557158|FG004|Overall Study|Withdrawal by Subject|1|||
164322143|NCT03387150|593557159|FG005|Overall Study|Withdrawal by Subject|2|||
164322144|NCT03387150|593557160|FG006|Overall Study|Withdrawal by Subject|0|||
164322145|NCT03387150|593557154|FG000|Overall Study|Lost to Follow-up|3|||
164322146|NCT03387150|593557155|FG001|Overall Study|Lost to Follow-up|2|||
164322147|NCT03387150|593557156|FG002|Overall Study|Lost to Follow-up|2|||
164322148|NCT03387150|593557157|FG003|Overall Study|Lost to Follow-up|3|||
164322149|NCT03387150|593557158|FG004|Overall Study|Lost to Follow-up|3|||
164322150|NCT03387150|593557159|FG005|Overall Study|Lost to Follow-up|3|||
164322151|NCT03387150|593557160|FG006|Overall Study|Lost to Follow-up|0|||
164322152|NCT03387150|593557154|FG000|Overall Study|Participant unable to adhere to visit|0|||
164322153|NCT03387150|593557155|FG001|Overall Study|Participant unable to adhere to visit|1|||
164322154|NCT03387150|593557156|FG002|Overall Study|Participant unable to adhere to visit|0|||
164322155|NCT03387150|593557157|FG003|Overall Study|Participant unable to adhere to visit|0|||
164322156|NCT03387150|593557158|FG004|Overall Study|Participant unable to adhere to visit|2|||
164322157|NCT03387150|593557159|FG005|Overall Study|Participant unable to adhere to visit|2|||
164322158|NCT03387150|593557160|FG006|Overall Study|Participant unable to adhere to visit|0|||
164322159|NCT04006119|593557161|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
164322160|NCT04006119|593557161|FG000|End of Treatment Veledimex|Adverse Event|2|||
164322161|NCT04006119|593557161|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
164322162|NCT04006119|593557161|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
164322163|NCT04006119|593557161|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
164322164|NCT04006119|593557161|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
164322165|NCT02919969|593557162|FG000|Overall Study|Lack of Efficacy|22|||
164322166|NCT02919969|593557162|FG000|Overall Study|Death|4|||
164322167|NCT02919969|593557162|FG000|Overall Study|Physician Decision|3|||
164322168|NCT02919969|593557162|FG000|Overall Study|Withdrawal by Subject|2|||
164322169|NCT01842633|593557163|FG000|Overall Study|Screen Failure|1|||
164322170|NCT01842633|593557164|FG001|Overall Study|Screen Failure|0|||
164322171|NCT01842633|593557165|FG002|Overall Study|Screen Failure|0|||
164322172|NCT01842633|593557163|FG000|Overall Study|Adverse Event|1|||
164322173|NCT01842633|593557164|FG001|Overall Study|Adverse Event|1|||
164322174|NCT01842633|593557165|FG002|Overall Study|Adverse Event|0|||
164322175|NCT01842633|593557163|FG000|Overall Study|Withdrawal by Subject|0|||
164322176|NCT01842633|593557164|FG001|Overall Study|Withdrawal by Subject|1|||
164322177|NCT01842633|593557165|FG002|Overall Study|Withdrawal by Subject|0|||
164322178|NCT01842633|593557163|FG000|Overall Study|Technical issues|1|||
164322179|NCT01842633|593557164|FG001|Overall Study|Technical issues|0|||
164322180|NCT01842633|593557165|FG002|Overall Study|Technical issues|0|||
164322181|NCT02093351|593557169|FG000|Part A|Adverse Event|0|||
164322182|NCT02093351|593557170|FG001|Part A|Adverse Event|1|||
164322183|NCT02093351|593557171|FG002|Part A|Adverse Event|1|||
164322184|NCT02093351|593557172|FG003|Part A|Adverse Event|0|||
164322185|NCT02093351|593557169|FG000|Part A|Condition under investigation worsened|2|||
164322186|NCT02093351|593557170|FG001|Part A|Condition under investigation worsened|0|||
164322187|NCT02093351|593557171|FG002|Part A|Condition under investigation worsened|2|||
164322188|NCT02093351|593557172|FG003|Part A|Condition under investigation worsened|0|||
164322189|NCT02093351|593557169|FG000|Part A|Death|0|||
164322190|NCT02093351|593557170|FG001|Part A|Death|1|||
164322191|NCT02093351|593557171|FG002|Part A|Death|0|||
164322192|NCT02093351|593557172|FG003|Part A|Death|0|||
164322193|NCT02093351|593557169|FG000|Part B|Patient decision|0|||
164322194|NCT02093351|593557170|FG001|Part B|Patient decision|0|||
164322195|NCT02093351|593557171|FG002|Part B|Patient decision|0|||
164322196|NCT02093351|593557172|FG003|Part B|Patient decision|3|||
164322197|NCT02093351|593557169|FG000|Part B|Disease progression|0|||
164322198|NCT02093351|593557170|FG001|Part B|Disease progression|0|||
164322199|NCT02093351|593557171|FG002|Part B|Disease progression|0|||
164322200|NCT02093351|593557172|FG003|Part B|Disease progression|4|||
164322201|NCT02093351|593557169|FG000|Part B|Complete response|0|||
164322202|NCT02093351|593557170|FG001|Part B|Complete response|0|||
164322203|NCT02093351|593557171|FG002|Part B|Complete response|0|||
164322204|NCT02093351|593557172|FG003|Part B|Complete response|1|||
164322205|NCT02093351|593557169|FG000|Part B|Adverse event + disease progression|0|||
164322206|NCT02093351|593557170|FG001|Part B|Adverse event + disease progression|0|||
164322207|NCT02093351|593557171|FG002|Part B|Adverse event + disease progression|0|||
164322208|NCT02093351|593557172|FG003|Part B|Adverse event + disease progression|1|||
164322209|NCT02093351|593557169|FG000|Part B|Lack of therapeutic response|0|||
164322210|NCT02093351|593557170|FG001|Part B|Lack of therapeutic response|0|||
164322211|NCT02093351|593557171|FG002|Part B|Lack of therapeutic response|0|||
164322212|NCT02093351|593557172|FG003|Part B|Lack of therapeutic response|12|||
164322213|NCT02093351|593557169|FG000|Part B|Condition under investigation worsened|0|||
164322214|NCT02093351|593557170|FG001|Part B|Condition under investigation worsened|0|||
164322215|NCT02093351|593557171|FG002|Part B|Condition under investigation worsened|0|||
164322216|NCT02093351|593557172|FG003|Part B|Condition under investigation worsened|39|||
164322217|NCT02093351|593557169|FG000|Part B|Adverse Event|0|||
164322218|NCT02093351|593557170|FG001|Part B|Adverse Event|0|||
164322219|NCT02093351|593557171|FG002|Part B|Adverse Event|0|||
164322220|NCT02093351|593557172|FG003|Part B|Adverse Event|2|||
164322221|NCT02093351|593557169|FG000|Part B|Death|0|||
164322222|NCT02093351|593557170|FG001|Part B|Death|0|||
164322223|NCT02093351|593557171|FG002|Part B|Death|0|||
164322224|NCT02093351|593557172|FG003|Part B|Death|1|||
164322225|NCT03565367|593557173|FG000|Overall Study|No scan due to technical issues|4|||
164322226|NCT03565367|593557174|FG001|Overall Study|No scan due to technical issues|0|||
164322227|NCT01099709|593557177|FG000|Period 1|Withdrawal by Subject|0|||
164322228|NCT01099709|593557178|FG001|Period 1|Withdrawal by Subject|1|||
164322229|NCT01099709|593557177|FG000|Period 1|Positive cotinine test|0|||
164322230|NCT01099709|593557178|FG001|Period 1|Positive cotinine test|1|||
164322231|NCT01099709|593557177|FG000|Period 1|Adverse Event|1|||
164322232|NCT01099709|593557178|FG001|Period 1|Adverse Event|0|||
164322233|NCT00706849|593557179|FG000|Treatment Period|Adverse Event|0|||
164322234|NCT00706849|593557180|FG001|Treatment Period|Adverse Event|9|||
164322235|NCT00706849|593557179|FG000|Treatment Period|Other|0|||
164322236|NCT00706849|593557180|FG001|Treatment Period|Other|1|||
164322237|NCT00706849|593557179|FG000|Follow-up Period|Withdrawal by Subject|0|||
164322238|NCT00706849|593557180|FG001|Follow-up Period|Withdrawal by Subject|2|||
164322239|NCT00706849|593557179|FG000|Follow-up Period|Protocol non-compliance|0|||
164322240|NCT00706849|593557180|FG001|Follow-up Period|Protocol non-compliance|1|||
164322241|NCT01611454|593557182|FG000|Overall Study|Lack of Efficacy|18|||
164322242|NCT01611454|593557183|FG001|Overall Study|Lack of Efficacy|10|||
164322243|NCT00920907|593557184|FG000|Induction Period|Adverse Event|0|||
164322244|NCT00920907|593557185|FG001|Induction Period|Adverse Event|2|||
164322245|NCT00920907|593557184|FG000|Induction Period|Death|1|||
164322246|NCT00920907|593557185|FG001|Induction Period|Death|1|||
164322247|NCT00920907|593557184|FG000|Induction Period|Disease Progression|12|||
164322248|NCT00920907|593557185|FG001|Induction Period|Disease Progression|11|||
164322249|NCT00920907|593557184|FG000|Induction Period|Study Drug Toxicity|8|||
164322250|NCT00920907|593557185|FG001|Induction Period|Study Drug Toxicity|6|||
164322251|NCT00920907|593557184|FG000|Induction Period|No longer meets study criteria|0|||
164322252|NCT00920907|593557185|FG001|Induction Period|No longer meets study criteria|1|||
164322253|NCT00920907|593557184|FG000|Induction Period|Withdrawal by Subject|1|||
164322254|NCT00920907|593557185|FG001|Induction Period|Withdrawal by Subject|1|||
164322255|NCT00920907|593557184|FG000|Maintenance Period|Disease Progression|3|||
164322256|NCT00920907|593557185|FG001|Maintenance Period|Disease Progression|7|||
164322257|NCT00920907|593557184|FG000|Maintenance Period|Administrative (study closure)|7|||
164322258|NCT00920907|593557185|FG001|Maintenance Period|Administrative (study closure)|2|||
164322259|NCT00920907|593557184|FG000|Maintenance Period|Study Drug Toxicity|0|||
164322260|NCT00920907|593557185|FG001|Maintenance Period|Study Drug Toxicity|2|||
164322261|NCT00920907|593557184|FG000|Maintenance Period|Death|1|||
164322262|NCT00920907|593557185|FG001|Maintenance Period|Death|1|||
164322263|NCT00920907|593557184|FG000|Maintenance Period|Withdrawal by Subject|1|||
164322264|NCT00920907|593557185|FG001|Maintenance Period|Withdrawal by Subject|0|||
164322265|NCT00920907|593557184|FG000|Maintenance Period|Adverse Event|0|||
164322266|NCT00920907|593557185|FG001|Maintenance Period|Adverse Event|1|||
164322267|NCT02616601|593557186|FG000|Overall Study|Withdrawal by Subject|4|||
164322268|NCT02616601|593557187|FG001|Overall Study|Withdrawal by Subject|4|||
164322269|NCT02616601|593557188|FG002|Overall Study|Withdrawal by Subject|3|||
164322270|NCT02616601|593557186|FG000|Overall Study|Adverse Event|2|||
164322271|NCT02616601|593557187|FG001|Overall Study|Adverse Event|0|||
164322272|NCT02616601|593557188|FG002|Overall Study|Adverse Event|2|||
164322273|NCT02616601|593557186|FG000|Overall Study|Death|1|||
164322274|NCT02616601|593557187|FG001|Overall Study|Death|0|||
164322275|NCT02616601|593557188|FG002|Overall Study|Death|0|||
164322276|NCT02616601|593557186|FG000|Overall Study|Lost to Follow-up|1|||
164322277|NCT02616601|593557187|FG001|Overall Study|Lost to Follow-up|0|||
164322278|NCT02616601|593557188|FG002|Overall Study|Lost to Follow-up|1|||
164322279|NCT02616601|593557186|FG000|Overall Study|Non-Compliance with Test Article|1|||
164322280|NCT02616601|593557187|FG001|Overall Study|Non-Compliance with Test Article|0|||
164322281|NCT02616601|593557188|FG002|Overall Study|Non-Compliance with Test Article|1|||
164322282|NCT01275339|593557189|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
164322283|NCT01275339|593557190|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
164322284|NCT01275339|593557191|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
164322285|NCT01275339|593557192|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
164322286|NCT01275339|593557189|FG000|Overall Study|Withdrawal by Subject|0|||
164322287|NCT01275339|593557190|FG001|Overall Study|Withdrawal by Subject|0|||
164322288|NCT01275339|593557191|FG002|Overall Study|Withdrawal by Subject|1|||
164322289|NCT01275339|593557192|FG003|Overall Study|Withdrawal by Subject|0|||
164322290|NCT00923364|593557195|FG000|Overall Study|Death|3|||
164322291|NCT00923364|593557196|FG001|Overall Study|Death|0|||
164322292|NCT00923364|593557195|FG000|Overall Study|Did not go to transplant|1|||
164322293|NCT00923364|593557196|FG001|Overall Study|Did not go to transplant|0|||
164322294|NCT04352127|593557197|FG000|Overall Study|Unable to obtain readings|4|||
164322295|NCT04352127|593557198|FG001|Overall Study|Unable to obtain readings|1|||
164322296|NCT03023046|593557201|FG000|Overall Study|Withdrawal by Subject|1|||
164322297|NCT01249118|593557204|FG000|First Washout Period|Physician Decision|0|||
164322298|NCT01249118|593557205|FG001|First Washout Period|Physician Decision|1|||
164322299|NCT01249118|593557206|FG002|First Washout Period|Physician Decision|0|||
164322300|NCT00880685|593557207|FG000|Memantine 10mg|Lost to Follow-up|2|||
164322301|NCT00880685|593557207|FG000|Memantine 20mg|Withdrawal by Subject|1|||
164322302|NCT04179890|593557208|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
164322303|NCT04179890|593557209|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
164322304|NCT04179890|593557208|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
164322305|NCT04179890|593557209|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
164322306|NCT04179890|593557208|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
164322307|NCT04179890|593557209|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
164322308|NCT04179890|593557208|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
164322309|NCT04179890|593557209|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
164322310|NCT04179890|593557208|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
164322311|NCT04179890|593557209|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
164322312|NCT04179890|593557208|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
164322313|NCT04179890|593557209|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
164322314|NCT04179890|593557208|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
164322315|NCT04179890|593557209|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
164322316|NCT04179890|593557208|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
164322317|NCT04179890|593557209|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
164322318|NCT04179890|593557208|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
164322319|NCT04179890|593557209|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
164322320|NCT04535167|593557211|FG000|Treatment|Adverse Event|0|||
164322321|NCT04535167|593557212|FG001|Treatment|Adverse Event|0|||
164322322|NCT04535167|593557213|FG002|Treatment|Adverse Event|0|||
164322323|NCT04535167|593557214|FG003|Treatment|Adverse Event|0|||
164322324|NCT04535167|593557215|FG004|Treatment|Adverse Event|0|||
164322325|NCT04535167|593557216|FG005|Treatment|Adverse Event|0|||
164322326|NCT04535167|593557217|FG006|Treatment|Adverse Event|1|||
164322327|NCT04535167|593557211|FG000|Follow-Up|Death|0|||
164322328|NCT04535167|593557212|FG001|Follow-Up|Death|0|||
164322329|NCT04535167|593557213|FG002|Follow-Up|Death|0|||
164322330|NCT04535167|593557214|FG003|Follow-Up|Death|0|||
164322331|NCT04535167|593557215|FG004|Follow-Up|Death|0|||
164322332|NCT04535167|593557216|FG005|Follow-Up|Death|0|||
164322333|NCT04535167|593557217|FG006|Follow-Up|Death|1|||
164322334|NCT04535167|593557211|FG000|Follow-Up|Lost to Follow-up|0|||
164322335|NCT04535167|593557212|FG001|Follow-Up|Lost to Follow-up|0|||
164322336|NCT04535167|593557213|FG002|Follow-Up|Lost to Follow-up|0|||
164322337|NCT04535167|593557214|FG003|Follow-Up|Lost to Follow-up|1|||
164322338|NCT04535167|593557215|FG004|Follow-Up|Lost to Follow-up|0|||
164322339|NCT04535167|593557216|FG005|Follow-Up|Lost to Follow-up|0|||
164322340|NCT04535167|593557217|FG006|Follow-Up|Lost to Follow-up|0|||
164322341|NCT00978432|593557218|FG000|Overall Study|Withdrawal by Subject|0|||
164322342|NCT00978432|593557219|FG001|Overall Study|Withdrawal by Subject|0|||
164322343|NCT00978432|593557220|FG002|Overall Study|Withdrawal by Subject|1|||
164322344|NCT00978432|593557218|FG000|Overall Study|Lack of Efficacy|1|||
164322345|NCT00978432|593557219|FG001|Overall Study|Lack of Efficacy|1|||
164322346|NCT00978432|593557220|FG002|Overall Study|Lack of Efficacy|3|||
164322347|NCT00978432|593557218|FG000|Overall Study|Adverse Event|2|||
164322348|NCT00978432|593557219|FG001|Overall Study|Adverse Event|0|||
164322349|NCT00978432|593557220|FG002|Overall Study|Adverse Event|1|||
164322350|NCT04656275|593557223|FG000|Overall Study|Study terminated by sponsor|2|||
164322351|NCT04656275|593557224|FG001|Overall Study|Study terminated by sponsor|4|||
164322352|NCT00329901|593557225|FG000|Overall Study|Withdrawal by Subject|4|||
164322353|NCT00329901|593557226|FG001|Overall Study|Withdrawal by Subject|3|||
164322354|NCT00329901|593557227|FG002|Overall Study|Withdrawal by Subject|2|||
164322355|NCT00329901|593557225|FG000|Overall Study|Lost to Follow-up|2|||
164322356|NCT00329901|593557226|FG001|Overall Study|Lost to Follow-up|0|||
164322357|NCT00329901|593557227|FG002|Overall Study|Lost to Follow-up|1|||
164322358|NCT00329901|593557225|FG000|Overall Study|Protocol Violation|1|||
164322359|NCT00329901|593557226|FG001|Overall Study|Protocol Violation|0|||
164322360|NCT00329901|593557227|FG002|Overall Study|Protocol Violation|1|||
164322361|NCT00329901|593557225|FG000|Overall Study|Unable to classify|2|||
164322362|NCT00329901|593557226|FG001|Overall Study|Unable to classify|2|||
164322363|NCT00329901|593557227|FG002|Overall Study|Unable to classify|0|||
164322364|NCT05028361|593557228|FG000|Overall Study|Withdrawal by Subject|1|||
164322365|NCT05028361|593557229|FG001|Overall Study|Withdrawal by Subject|0|||
164322366|NCT01993836|593557230|FG000|Overall Study|Surgery Cancelled|3|||
164322367|NCT01993836|593557231|FG001|Overall Study|Surgery Cancelled|0|||
164322368|NCT01993836|593557232|FG002|Overall Study|Surgery Cancelled|0|||
164322369|NCT01993836|593557230|FG000|Overall Study|Physician Decision|2|||
164322370|NCT01993836|593557231|FG001|Overall Study|Physician Decision|1|||
164322371|NCT01993836|593557232|FG002|Overall Study|Physician Decision|0|||
164322372|NCT01993836|593557230|FG000|Overall Study|Death|0|||
164322373|NCT01993836|593557231|FG001|Overall Study|Death|2|||
164322374|NCT01993836|593557232|FG002|Overall Study|Death|0|||
164322375|NCT01993836|593557230|FG000|Overall Study|Withdrawal by Subject|12|||
164322376|NCT01993836|593557231|FG001|Overall Study|Withdrawal by Subject|10|||
164322377|NCT01993836|593557232|FG002|Overall Study|Withdrawal by Subject|5|||
164322378|NCT02195687|593557233|FG000|Overall Study|Personal Reasons|1|||
164322379|NCT02195687|593557234|FG001|Overall Study|Personal Reasons|1|||
164322380|NCT02195687|593557233|FG000|Overall Study|Lost to Follow-up|4|||
164322381|NCT02195687|593557234|FG001|Overall Study|Lost to Follow-up|1|||
164322382|NCT00779259|593557235|FG000|Quinine Alone|Adverse Event|2|||
164322383|NCT00924781|593557238|FG000|Overall Study|Study terminated by sponsor|12|||
164322384|NCT00924781|593557239|FG001|Overall Study|Study terminated by sponsor|10|||
164322385|NCT03459690|593557245|FG000|Overall Study|Lost to Follow-up|0|||
164322386|NCT03459690|593557246|FG001|Overall Study|Lost to Follow-up|1|||
164322387|NCT03459690|593557245|FG000|Overall Study|Withdrawal by Subject|1|||
164322388|NCT03459690|593557246|FG001|Overall Study|Withdrawal by Subject|1|||
164322389|NCT02963831|593557247|FG000|Overall Study|Progressive Disease|3|||
164322390|NCT02963831|593557248|FG001|Overall Study|Progressive Disease|3|||
164322391|NCT02963831|593557249|FG002|Overall Study|Progressive Disease|16|||
164322392|NCT02963831|593557250|FG003|Overall Study|Progressive Disease|27|||
164322393|NCT02963831|593557247|FG000|Overall Study|Withdrawal by Subject|1|||
164322394|NCT02963831|593557248|FG001|Overall Study|Withdrawal by Subject|0|||
164322395|NCT02963831|593557249|FG002|Overall Study|Withdrawal by Subject|2|||
164322396|NCT02963831|593557250|FG003|Overall Study|Withdrawal by Subject|4|||
164322397|NCT02963831|593557247|FG000|Overall Study|Adverse Event|0|||
164322398|NCT02963831|593557248|FG001|Overall Study|Adverse Event|1|||
164322399|NCT02963831|593557249|FG002|Overall Study|Adverse Event|1|||
164322400|NCT02963831|593557250|FG003|Overall Study|Adverse Event|2|||
164322401|NCT02963831|593557247|FG000|Overall Study|Death|0|||
164322402|NCT02963831|593557248|FG001|Overall Study|Death|0|||
164322403|NCT02963831|593557249|FG002|Overall Study|Death|0|||
164322404|NCT02963831|593557250|FG003|Overall Study|Death|2|||
164322405|NCT02536404|593557255|FG000|Overall Study|Adverse Event|5|||
164322406|NCT02536404|593557256|FG001|Overall Study|Adverse Event|0|||
164322407|NCT02536404|593557255|FG000|Overall Study|Withdrawal by Subject|4|||
164322408|NCT02536404|593557256|FG001|Overall Study|Withdrawal by Subject|1|||
164322409|NCT02536404|593557255|FG000|Overall Study|Physician Decision|10|||
164322410|NCT02536404|593557256|FG001|Overall Study|Physician Decision|0|||
164322411|NCT02536404|593557255|FG000|Overall Study|Sponsor decision|1|||
164322412|NCT02536404|593557256|FG001|Overall Study|Sponsor decision|0|||
164322413|NCT02514473|593557257|FG000|Overall Study|Adverse Event|0|||
164322414|NCT02514473|593557258|FG001|Overall Study|Adverse Event|2|||
164322415|NCT02514473|593557257|FG000|Overall Study|Withdrawal by Subject|2|||
164322416|NCT02514473|593557258|FG001|Overall Study|Withdrawal by Subject|1|||
164322417|NCT02514473|593557257|FG000|Overall Study|Lost to Follow-up|0|||
164322418|NCT02514473|593557258|FG001|Overall Study|Lost to Follow-up|1|||
164322419|NCT02514473|593557257|FG000|Overall Study|Other|1|||
164322420|NCT02514473|593557258|FG001|Overall Study|Other|1|||
164322421|NCT02158364|593557259|FG000|Overall Study|Case report forms uncollected|10|||
164322422|NCT02158364|593557259|FG000|Overall Study|Protocol Deviation|50|||
164322423|NCT04381988|593557260|FG000|Overall Study|The study was terminated|4|||
164322424|NCT04381988|593557261|FG001|Overall Study|The study was terminated|0|||
164322425|NCT02106923|593557262|FG000|Overall Study|Protocol Violation|0|||
164322426|NCT02106923|593557263|FG001|Overall Study|Protocol Violation|0|||
164322427|NCT02106923|593557264|FG002|Overall Study|Protocol Violation|0|||
164322428|NCT02106923|593557265|FG003|Overall Study|Protocol Violation|0|||
164322429|NCT02106923|593557266|FG004|Overall Study|Protocol Violation|0|||
164322430|NCT02106923|593557267|FG005|Overall Study|Protocol Violation|1|||
164322431|NCT03485495|593557268|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
164322432|NCT03485495|593557269|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
164322433|NCT03915860|593557270|FG000|Overall Study|Adverse Event|3|||
164322434|NCT03915860|593557270|FG000|Overall Study|Withdrawal by Subject|6|||
164322435|NCT03915860|593557270|FG000|Overall Study|Lost to Follow-up|2|||
164322436|NCT03915860|593557270|FG000|Overall Study|Other than specified|3|||
164322437|NCT01107379|593557274|FG000|Overall Study|Withdrawal by Subject|18|||
164322438|NCT01107379|593557274|FG000|Overall Study|Lost to Follow-up|3|||
164322439|NCT04559529|593557275|FG000|First Intervention (1 Day)|Adverse Event|0|||
164322440|NCT04559529|593557276|FG001|First Intervention (1 Day)|Adverse Event|0|||
164322441|NCT04559529|593557277|FG002|First Intervention (1 Day)|Adverse Event|0|||
164322442|NCT04559529|593557278|FG003|First Intervention (1 Day)|Adverse Event|1|||
164322443|NCT04559529|593557275|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
164322444|NCT04559529|593557276|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
164322445|NCT04559529|593557277|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
164322446|NCT04559529|593557278|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
164322447|NCT04559529|593557275|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
164322448|NCT04559529|593557276|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
164322449|NCT04559529|593557277|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
164322450|NCT04559529|593557278|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
164322451|NCT00732940|593557282|FG000|Overall Study|Withdrawal by Subject|1|||
164322452|NCT00732940|593557283|FG001|Overall Study|Withdrawal by Subject|2|||
164322453|NCT00732940|593557282|FG000|Overall Study|Adverse Event|0|||
164322454|NCT00732940|593557283|FG001|Overall Study|Adverse Event|1|||
164322455|NCT00732940|593557282|FG000|Overall Study|Lost to Follow-up|1|||
164322456|NCT00732940|593557283|FG001|Overall Study|Lost to Follow-up|0|||
164322457|NCT01642732|593557284|FG000|Overall Study|Withdrawal by Subject|1|||
164322458|NCT01589770|593557289|FG000|Overall Study|EGFR <60ml/min|6|||
164322459|NCT01589770|593557290|FG001|Overall Study|EGFR <60ml/min|4|||
164322460|NCT01589770|593557289|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
164322461|NCT01589770|593557290|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
164322462|NCT00890045|593557300|FG000|Overall Study|Death|0|||
164322463|NCT00890045|593557301|FG001|Overall Study|Death|1|||
164322464|NCT00890045|593557300|FG000|Overall Study|Did not receive HeRO Graft|0|||
164322465|NCT00890045|593557301|FG001|Overall Study|Did not receive HeRO Graft|2|||
164322466|NCT00890045|593557300|FG000|Overall Study|Lost to Follow-up|5|||
164322467|NCT00890045|593557301|FG001|Overall Study|Lost to Follow-up|7|||
164322468|NCT00510653|593557302|FG000|Overall Study|Withdrawal by Subject|8|||
164322469|NCT00510653|593557302|FG000|Overall Study|Monetary|3|||
164322470|NCT01077375|593557306|FG000|Overall Study|Adverse Event|2|||
164322471|NCT01077375|593557307|FG001|Overall Study|Adverse Event|15|||
164322472|NCT01077375|593557306|FG000|Overall Study|Lack of Efficacy|6|||
164322473|NCT01077375|593557307|FG001|Overall Study|Lack of Efficacy|8|||
164322474|NCT01077375|593557306|FG000|Overall Study|Withdrawal by Subject|0|||
164322475|NCT01077375|593557307|FG001|Overall Study|Withdrawal by Subject|6|||
164322476|NCT01077375|593557306|FG000|Overall Study|Lost to Follow-up|2|||
164322477|NCT01077375|593557307|FG001|Overall Study|Lost to Follow-up|5|||
164322478|NCT01077375|593557306|FG000|Overall Study|Other Reason|0|||
164322479|NCT01077375|593557307|FG001|Overall Study|Other Reason|1|||
164322480|NCT03021564|593557311|FG000|Overall Study|Death|84|||
164322481|NCT03021564|593557312|FG001|Overall Study|Death|466|||
164322482|NCT03021564|593557311|FG000|Overall Study|Lost to Follow-up|0|||
164322483|NCT03021564|593557312|FG001|Overall Study|Lost to Follow-up|2|||
164322484|NCT02520089|593557315|FG000|Overall Study|Lost to Follow-up|3|||
164322485|NCT02520089|593557316|FG001|Overall Study|Lost to Follow-up|4|||
164322486|NCT01981551|593557319|FG000|Overall Study|Refused further treatment|8|||
164322487|NCT01981551|593557319|FG000|Overall Study|Adverse Event|1|||
164322488|NCT01451437|593557322|FG000|Overall Study|Adverse Event|0|||
164322489|NCT01451437|593557323|FG001|Overall Study|Adverse Event|0|||
164322490|NCT01451437|593557324|FG002|Overall Study|Adverse Event|0|||
164322491|NCT01451437|593557325|FG003|Overall Study|Adverse Event|0|||
164322492|NCT01451437|593557326|FG004|Overall Study|Adverse Event|0|||
164322493|NCT01451437|593557327|FG005|Overall Study|Adverse Event|1|||
164322494|NCT01451437|593557328|FG006|Overall Study|Adverse Event|1|||
164322495|NCT01451437|593557329|FG007|Overall Study|Adverse Event|2|||
164322496|NCT01451437|593557330|FG008|Overall Study|Adverse Event|1|||
164322497|NCT01451437|593557322|FG000|Overall Study|Physician Decision|1|||
164322498|NCT01451437|593557323|FG001|Overall Study|Physician Decision|1|||
164322499|NCT01451437|593557324|FG002|Overall Study|Physician Decision|2|||
164322500|NCT01451437|593557325|FG003|Overall Study|Physician Decision|0|||
164322501|NCT01451437|593557326|FG004|Overall Study|Physician Decision|0|||
164322502|NCT01451437|593557327|FG005|Overall Study|Physician Decision|0|||
164322503|NCT01451437|593557328|FG006|Overall Study|Physician Decision|0|||
164322504|NCT01451437|593557329|FG007|Overall Study|Physician Decision|0|||
164322505|NCT01451437|593557330|FG008|Overall Study|Physician Decision|0|||
164322506|NCT01451437|593557322|FG000|Overall Study|Disease Progression|0|||
164322507|NCT01451437|593557323|FG001|Overall Study|Disease Progression|0|||
164322508|NCT01451437|593557324|FG002|Overall Study|Disease Progression|1|||
164322509|NCT01451437|593557325|FG003|Overall Study|Disease Progression|1|||
164322510|NCT01451437|593557326|FG004|Overall Study|Disease Progression|3|||
164322511|NCT01451437|593557327|FG005|Overall Study|Disease Progression|2|||
164322512|NCT01451437|593557328|FG006|Overall Study|Disease Progression|3|||
164322513|NCT01451437|593557329|FG007|Overall Study|Disease Progression|1|||
164322514|NCT01451437|593557330|FG008|Overall Study|Disease Progression|3|||
164322515|NCT01451437|593557322|FG000|Overall Study|Protocol Violation|0|||
164322516|NCT01451437|593557323|FG001|Overall Study|Protocol Violation|0|||
164322517|NCT01451437|593557324|FG002|Overall Study|Protocol Violation|0|||
164322518|NCT01451437|593557325|FG003|Overall Study|Protocol Violation|0|||
164322519|NCT01451437|593557326|FG004|Overall Study|Protocol Violation|0|||
164322520|NCT01451437|593557327|FG005|Overall Study|Protocol Violation|0|||
164322521|NCT01451437|593557328|FG006|Overall Study|Protocol Violation|1|||
164322522|NCT01451437|593557329|FG007|Overall Study|Protocol Violation|0|||
164322523|NCT01451437|593557330|FG008|Overall Study|Protocol Violation|0|||
164322524|NCT01451437|593557322|FG000|Overall Study|Withdrawal by Subject|0|||
164322525|NCT01451437|593557323|FG001|Overall Study|Withdrawal by Subject|0|||
164322526|NCT01451437|593557324|FG002|Overall Study|Withdrawal by Subject|0|||
164322527|NCT01451437|593557325|FG003|Overall Study|Withdrawal by Subject|0|||
164322528|NCT01451437|593557326|FG004|Overall Study|Withdrawal by Subject|1|||
164322529|NCT01451437|593557327|FG005|Overall Study|Withdrawal by Subject|0|||
164322530|NCT01451437|593557328|FG006|Overall Study|Withdrawal by Subject|1|||
164322531|NCT01451437|593557329|FG007|Overall Study|Withdrawal by Subject|0|||
164322532|NCT01451437|593557330|FG008|Overall Study|Withdrawal by Subject|0|||
164322533|NCT00130442|593558935|FG000|Overall Study|Withdrawal by Subject|0|||
164322534|NCT00130442|593558936|FG001|Overall Study|Withdrawal by Subject|1|||
164322535|NCT00130442|593558935|FG000|Overall Study|did not meet criteria|1|||
164322536|NCT00130442|593558936|FG001|Overall Study|did not meet criteria|1|||
164322537|NCT00814333|593558937|FG000|Enrollment|Lost to Follow-up|1|||
164322538|NCT00814333|593558938|FG001|Enrollment|Lost to Follow-up|0|||
164322539|NCT02233946|593558939|FG000|Baseline|Withdrawal by Subject|2|||
164322540|NCT02233946|593558940|FG001|Baseline|Withdrawal by Subject|0|||
164322541|NCT02233946|593558939|FG000|3-months Follow-up|Lost to Follow-up|53|||
164322542|NCT02233946|593558940|FG001|3-months Follow-up|Lost to Follow-up|29|||
164322543|NCT02233946|593558939|FG000|6-months Follow-up|Lost to Follow-up|21|||
164322544|NCT02233946|593558940|FG001|6-months Follow-up|Lost to Follow-up|2|||
164322545|NCT02233946|593558939|FG000|9-month Follow-up|Lost to Follow-up|20|||
164322546|NCT02233946|593558940|FG001|9-month Follow-up|Lost to Follow-up|11|||
164322547|NCT02233946|593558939|FG000|12-month Follow-up|Lost to Follow-up|28|||
164322548|NCT02233946|593558940|FG001|12-month Follow-up|Lost to Follow-up|11|||
164322549|NCT01527357|593558941|FG000|Overall Study|Death|8|||
164322550|NCT01527357|593558942|FG001|Overall Study|Death|2|||
164322551|NCT01527357|593558941|FG000|Overall Study|Lost to Follow-up|6|||
164322552|NCT01527357|593558942|FG001|Overall Study|Lost to Follow-up|4|||
164322553|NCT01527357|593558941|FG000|Overall Study|Withdrew Consent|1|||
164322554|NCT01527357|593558942|FG001|Overall Study|Withdrew Consent|1|||
164322555|NCT01527357|593558941|FG000|Overall Study|Non-compliance|0|||
164322556|NCT01527357|593558942|FG001|Overall Study|Non-compliance|1|||
164322557|NCT01527357|593558941|FG000|Overall Study|No Day 29 Visit|0|||
164322558|NCT01527357|593558942|FG001|Overall Study|No Day 29 Visit|1|||
164322559|NCT01527357|593558941|FG000|Overall Study|Did Not Receive Treatment|2|||
164322560|NCT01527357|593558942|FG001|Overall Study|Did Not Receive Treatment|0|||
164322561|NCT02927067|593558943|FG000|Overall Study|Withdrawn Consent|20|||
164322562|NCT02927067|593558944|FG001|Overall Study|Withdrawn Consent|12|||
164322563|NCT02927067|593558943|FG000|Overall Study|Death|18|||
164322564|NCT02927067|593558944|FG001|Overall Study|Death|31|||
164322565|NCT02927067|593558943|FG000|Overall Study|Adverse Event|13|||
164322566|NCT02927067|593558944|FG001|Overall Study|Adverse Event|10|||
164322567|NCT02927067|593558943|FG000|Overall Study|Noncompliance|5|||
164322568|NCT02927067|593558944|FG001|Overall Study|Noncompliance|2|||
164322569|NCT02927067|593558943|FG000|Overall Study|Reason not Specified|4|||
164322570|NCT02927067|593558944|FG001|Overall Study|Reason not Specified|6|||
164322571|NCT02292784|593558945|FG000|Overall Study|Lost to Follow-up|1|||
164322572|NCT02292784|593558946|FG001|Overall Study|Lost to Follow-up|17|||
164322573|NCT02292784|593558947|FG002|Overall Study|Lost to Follow-up|18|||
164322574|NCT02292784|593558945|FG000|Overall Study|Withdrawal by Subject|0|||
164322575|NCT02292784|593558946|FG001|Overall Study|Withdrawal by Subject|3|||
164322576|NCT02292784|593558947|FG002|Overall Study|Withdrawal by Subject|3|||
164322577|NCT00622739|593558948|FG000|Overall Study|Physician Decision|1|||
164322578|NCT00622739|593558949|FG001|Overall Study|Physician Decision|0|||
164322579|NCT00622739|593558948|FG000|Overall Study|Adverse Event|1|||
164322580|NCT00622739|593558949|FG001|Overall Study|Adverse Event|2|||
164322581|NCT00622739|593558948|FG000|Overall Study|Lack of Efficacy|0|||
164322582|NCT00622739|593558949|FG001|Overall Study|Lack of Efficacy|2|||
164322583|NCT00622739|593558948|FG000|Overall Study|Withdrawal by Subject|0|||
164322584|NCT00622739|593558949|FG001|Overall Study|Withdrawal by Subject|1|||
164322585|NCT00622739|593558948|FG000|Overall Study|Lost to Follow-up|0|||
164322586|NCT00622739|593558949|FG001|Overall Study|Lost to Follow-up|1|||
164322587|NCT00134784|593558950|FG000|Overall Study|Withdrawal by Subject|2|||
164322588|NCT00134784|593558951|FG001|Overall Study|Withdrawal by Subject|2|||
164322589|NCT00134784|593558952|FG002|Overall Study|Withdrawal by Subject|2|||
164322590|NCT00134784|593558953|FG003|Overall Study|Withdrawal by Subject|1|||
164322591|NCT03384693|593558954|FG000|Overall Study|Adverse Event|3|||
164420666|NCT01154036|593910965|FG003|Phase II|Adverse Event|0|||
164322592|NCT03621475|593558955|FG000|Overall Study|No longer required restraints at initiation|0|||
164322593|NCT03621475|593558956|FG001|Overall Study|No longer required restraints at initiation|1|||
164322594|NCT00371761|593558957|FG000|Overall Study|Adverse Event|1|||
164322595|NCT00371761|593558958|FG001|Overall Study|Adverse Event|1|||
164322596|NCT00371761|593558957|FG000|Overall Study|Withdrawal by Subject|1|||
164322597|NCT00371761|593558958|FG001|Overall Study|Withdrawal by Subject|3|||
164322598|NCT00371761|593558957|FG000|Overall Study|Investigator Judgment|2|||
164322599|NCT00371761|593558958|FG001|Overall Study|Investigator Judgment|3|||
164322600|NCT00371761|593558957|FG000|Overall Study|Study termination|4|||
164322601|NCT00371761|593558958|FG001|Overall Study|Study termination|3|||
164322602|NCT00718081|593558960|FG000|Overall Study|Adverse Event|0|||
164322603|NCT00718081|593558961|FG001|Overall Study|Adverse Event|1|||
164322604|NCT00718081|593558962|FG002|Overall Study|Adverse Event|0|||
164322605|NCT00718081|593558960|FG000|Overall Study|Lack of Efficacy|7|||
164322606|NCT00718081|593558961|FG001|Overall Study|Lack of Efficacy|3|||
164322607|NCT00718081|593558962|FG002|Overall Study|Lack of Efficacy|21|||
164322608|NCT01397825|593558963|FG000|Overall Study|Progressive Disease|10|||
164322609|NCT01397825|593558964|FG001|Overall Study|Progressive Disease|3|||
164322610|NCT01397825|593558965|FG002|Overall Study|Progressive Disease|11|||
164322611|NCT01397825|593558966|FG003|Overall Study|Progressive Disease|1|||
164322612|NCT01397825|593558967|FG004|Overall Study|Progressive Disease|0|||
164322613|NCT01397825|593558963|FG000|Overall Study|Symptomatic Deterioration|2|||
164322614|NCT01397825|593558964|FG001|Overall Study|Symptomatic Deterioration|0|||
164322615|NCT01397825|593558965|FG002|Overall Study|Symptomatic Deterioration|4|||
164322616|NCT01397825|593558966|FG003|Overall Study|Symptomatic Deterioration|0|||
164322617|NCT01397825|593558967|FG004|Overall Study|Symptomatic Deterioration|0|||
164322618|NCT01397825|593558963|FG000|Overall Study|Adverse Event|0|||
164322619|NCT01397825|593558964|FG001|Overall Study|Adverse Event|1|||
164322620|NCT01397825|593558965|FG002|Overall Study|Adverse Event|5|||
164322621|NCT01397825|593558966|FG003|Overall Study|Adverse Event|1|||
164322622|NCT01397825|593558967|FG004|Overall Study|Adverse Event|0|||
164322623|NCT01397825|593558963|FG000|Overall Study|Withdrawal by Subject|1|||
164322624|NCT01397825|593558964|FG001|Overall Study|Withdrawal by Subject|0|||
164322625|NCT01397825|593558965|FG002|Overall Study|Withdrawal by Subject|5|||
164322626|NCT01397825|593558966|FG003|Overall Study|Withdrawal by Subject|1|||
164322627|NCT01397825|593558967|FG004|Overall Study|Withdrawal by Subject|0|||
164322628|NCT01931670|593558969|FG000|Treatment Period|Exclusionary Medication Received|1|||
164322629|NCT01931670|593558970|FG001|Treatment Period|Exclusionary Medication Received|1|||
164322630|NCT01931670|593558971|FG002|Treatment Period|Exclusionary Medication Received|1|||
164322631|NCT01931670|593558969|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
164322632|NCT01931670|593558970|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
164322633|NCT01931670|593558971|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
164322634|NCT01931670|593558969|FG000|Treatment Period|Subject Noncompliant|4|||
164322635|NCT01931670|593558970|FG001|Treatment Period|Subject Noncompliant|9|||
164420667|NCT01154036|593910966|FG004|Phase II|Adverse Event|1|||
164668358|NCT01104662|594810197|FG004|Overall Study|Participant left investigator's care|0|||
164668359|NCT01104662|594810198|FG005|Overall Study|Participant left investigator's care|0|||
164668360|NCT01104662|594810199|FG006|Overall Study|Participant left investigator's care|0|||
164668361|NCT01104662|594810200|FG007|Overall Study|Participant left investigator's care|0|||
164668362|NCT01104662|594810193|FG000|Overall Study|Reason not specified|3|||
164668363|NCT01104662|594810194|FG001|Overall Study|Reason not specified|3|||
164668364|NCT01104662|594810195|FG002|Overall Study|Reason not specified|0|||
164668365|NCT01104662|594810196|FG003|Overall Study|Reason not specified|0|||
164668366|NCT01104662|594810197|FG004|Overall Study|Reason not specified|0|||
164668367|NCT01104662|594810198|FG005|Overall Study|Reason not specified|1|||
164668368|NCT01104662|594810199|FG006|Overall Study|Reason not specified|0|||
164668369|NCT01104662|594810200|FG007|Overall Study|Reason not specified|0|||
164668370|NCT01104662|594810193|FG000|Overall Study|Randomized but not treated|3|||
164668371|NCT01104662|594810194|FG001|Overall Study|Randomized but not treated|4|||
164668372|NCT01104662|594810195|FG002|Overall Study|Randomized but not treated|1|||
164668373|NCT01104662|594810196|FG003|Overall Study|Randomized but not treated|0|||
164668374|NCT01104662|594810197|FG004|Overall Study|Randomized but not treated|0|||
164668375|NCT01104662|594810198|FG005|Overall Study|Randomized but not treated|1|||
164668376|NCT01104662|594810199|FG006|Overall Study|Randomized but not treated|0|||
164668377|NCT01104662|594810200|FG007|Overall Study|Randomized but not treated|0|||
164668378|NCT01478620|594810201|FG000|Overall Study|Lost to Follow-up|6|||
164668379|NCT01691248|594810202|FG000|Overall Study|Protocol Violation|43|||
164668380|NCT01691248|594810203|FG001|Overall Study|Protocol Violation|27|||
164668381|NCT01691248|594810202|FG000|Overall Study|Adverse Event|24|||
164668382|NCT01691248|594810203|FG001|Overall Study|Adverse Event|22|||
164322636|NCT01931670|593558971|FG002|Treatment Period|Subject Noncompliant|5|||
164322637|NCT01931670|593558969|FG000|Treatment Period|Adverse Event|19|||
164322638|NCT01931670|593558970|FG001|Treatment Period|Adverse Event|8|||
164322639|NCT01931670|593558971|FG002|Treatment Period|Adverse Event|21|||
164322640|NCT01931670|593558969|FG000|Treatment Period|Lack of Efficacy|11|||
164668383|NCT01691248|594810202|FG000|Overall Study|Withdrawal by Subject|20|||
164322641|NCT01931670|593558970|FG001|Treatment Period|Lack of Efficacy|2|||
164322642|NCT01931670|593558971|FG002|Treatment Period|Lack of Efficacy|2|||
164322643|NCT01931670|593558969|FG000|Treatment Period|Pregnancy|7|||
164322644|NCT01931670|593558970|FG001|Treatment Period|Pregnancy|2|||
164322645|NCT01931670|593558971|FG002|Treatment Period|Pregnancy|0|||
164322646|NCT01931670|593558969|FG000|Treatment Period|Other|8|||
164322647|NCT01931670|593558970|FG001|Treatment Period|Other|7|||
164563838|NCT03604445|594432384|FG003|Overall Study|Death|0|||
164563839|NCT03604445|594432385|FG004|Overall Study|Death|0|||
164563840|NCT03604445|594432386|FG005|Overall Study|Death|0|||
164563841|NCT03604445|594432387|FG006|Overall Study|Death|0|||
164563842|NCT03604445|594432388|FG007|Overall Study|Death|0|||
164563843|NCT03604445|594432389|FG008|Overall Study|Death|1|||
164563844|NCT03604445|594432381|FG000|Overall Study|Withdrawal by Subject|0|||
164563845|NCT03604445|594432382|FG001|Overall Study|Withdrawal by Subject|0|||
164563846|NCT03604445|594432383|FG002|Overall Study|Withdrawal by Subject|0|||
164563847|NCT03604445|594432384|FG003|Overall Study|Withdrawal by Subject|0|||
164563848|NCT03604445|594432385|FG004|Overall Study|Withdrawal by Subject|0|||
164563849|NCT03604445|594432386|FG005|Overall Study|Withdrawal by Subject|0|||
164563850|NCT03604445|594432387|FG006|Overall Study|Withdrawal by Subject|1|||
164563851|NCT03604445|594432388|FG007|Overall Study|Withdrawal by Subject|0|||
164563852|NCT03604445|594432389|FG008|Overall Study|Withdrawal by Subject|0|||
164563853|NCT03604445|594432381|FG000|Overall Study|Missing visit|0|||
164563854|NCT03604445|594432382|FG001|Overall Study|Missing visit|0|||
164563855|NCT03604445|594432383|FG002|Overall Study|Missing visit|0|||
164563856|NCT03604445|594432384|FG003|Overall Study|Missing visit|0|||
164563857|NCT03604445|594432385|FG004|Overall Study|Missing visit|0|||
164563858|NCT03604445|594432386|FG005|Overall Study|Missing visit|1|||
164322648|NCT01931670|593558971|FG002|Treatment Period|Other|2|||
164420668|NCT01154036|593910967|FG005|Phase II|Adverse Event|1|||
164322649|NCT01931670|593558969|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
164322650|NCT01931670|593558970|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
164322651|NCT01931670|593558971|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
164322652|NCT01931670|593558969|FG000|Treatment Period|Lost to Follow-up|19|||
164322653|NCT01931670|593558970|FG001|Treatment Period|Lost to Follow-up|5|||
164322654|NCT01931670|593558971|FG002|Treatment Period|Lost to Follow-up|7|||
164322655|NCT01931670|593558969|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
164322656|NCT01931670|593558970|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
164322657|NCT01931670|593558971|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
164322658|NCT01931670|593558969|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
164322659|NCT01931670|593558970|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
164322660|NCT01931670|593558971|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
164322661|NCT01931670|593558969|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
164322662|NCT01931670|593558970|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
164322663|NCT01931670|593558971|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
164322664|NCT01931670|593558969|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
164322665|NCT01931670|593558970|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
164322666|NCT01931670|593558971|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
164322667|NCT01931670|593558969|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
164322668|NCT01931670|593558970|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
164322669|NCT01931670|593558971|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
164322670|NCT01931670|593558969|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
164322671|NCT01931670|593558970|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
164322672|NCT01931670|593558971|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
164322673|NCT00976508|593558975|FG000|Overall Study|Death|7|||
164322674|NCT00976508|593558976|FG001|Overall Study|Death|1|||
164322675|NCT00976508|593558975|FG000|Overall Study|Lost to Follow-up|1|||
164322676|NCT00976508|593558976|FG001|Overall Study|Lost to Follow-up|0|||
164322677|NCT00976508|593558975|FG000|Overall Study|Withdrawal by Subject|1|||
164322678|NCT00976508|593558976|FG001|Overall Study|Withdrawal by Subject|0|||
164322679|NCT00976508|593558975|FG000|Overall Study|Disease Progression|4|||
164322680|NCT00976508|593558976|FG001|Overall Study|Disease Progression|4|||
164322681|NCT00976508|593558975|FG000|Overall Study|Subject Enrolled in Hospice|1|||
164322682|NCT00976508|593558976|FG001|Overall Study|Subject Enrolled in Hospice|0|||
164322683|NCT00976508|593558975|FG000|Overall Study|Terminated by the Sponsor|0|||
164322684|NCT00976508|593558976|FG001|Overall Study|Terminated by the Sponsor|1|||
164322685|NCT01992159|593558977|FG000|Overall Study|Withdrawal by Subject|4|||
164322686|NCT01992159|593558978|FG001|Overall Study|Withdrawal by Subject|7|||
164322687|NCT01992159|593558979|FG002|Overall Study|Withdrawal by Subject|0|||
164322688|NCT01992159|593558980|FG003|Overall Study|Withdrawal by Subject|3|||
164322689|NCT01992159|593558977|FG000|Overall Study|Adverse Event|0|||
164563859|NCT03604445|594432387|FG006|Overall Study|Missing visit|0|||
164563860|NCT03604445|594432388|FG007|Overall Study|Missing visit|1|||
164563861|NCT03604445|594432389|FG008|Overall Study|Missing visit|0|||
164563862|NCT03604445|594432381|FG000|Overall Study|Adverse Event|0|||
164563863|NCT03604445|594432382|FG001|Overall Study|Adverse Event|0|||
164563864|NCT03604445|594432383|FG002|Overall Study|Adverse Event|0|||
164563865|NCT03604445|594432384|FG003|Overall Study|Adverse Event|1|||
164563866|NCT03604445|594432385|FG004|Overall Study|Adverse Event|0|||
164563867|NCT03604445|594432386|FG005|Overall Study|Adverse Event|0|||
164563868|NCT03604445|594432387|FG006|Overall Study|Adverse Event|0|||
164563869|NCT03604445|594432388|FG007|Overall Study|Adverse Event|0|||
164563870|NCT03604445|594432389|FG008|Overall Study|Adverse Event|1|||
164563871|NCT02154425|594432390|FG000|Screening Period|Adverse Event|1|||
164563872|NCT00480857|594432395|FG000|Overall Study|Lack of Efficacy|2|||
164563873|NCT00611247|594432396|FG000|Overall Study|Death|1|||
164563874|NCT00611247|594432397|FG001|Overall Study|Death|5|||
164563875|NCT00611247|594432396|FG000|Overall Study|Lack of Efficacy|1|||
164563876|NCT00611247|594432397|FG001|Overall Study|Lack of Efficacy|16|||
164563877|NCT02551159|594432400|FG000|Overall Study|Death|352|||
164563878|NCT02551159|594432401|FG001|Overall Study|Death|174|||
164322690|NCT01992159|593558978|FG001|Overall Study|Adverse Event|1|||
164322691|NCT01992159|593558979|FG002|Overall Study|Adverse Event|0|||
164322692|NCT01992159|593558980|FG003|Overall Study|Adverse Event|1|||
164322693|NCT01992159|593558977|FG000|Overall Study|Death|0|||
164322694|NCT01992159|593558978|FG001|Overall Study|Death|0|||
164322695|NCT01992159|593558979|FG002|Overall Study|Death|1|||
164322696|NCT01992159|593558980|FG003|Overall Study|Death|0|||
164322697|NCT00470158|593558981|FG000|Overall Study|Death|0|||
164563879|NCT02551159|594432402|FG002|Overall Study|Death|161|||
164563880|NCT02551159|594432400|FG000|Overall Study|Withdrawal by Subject|8|||
164563881|NCT02551159|594432401|FG001|Overall Study|Withdrawal by Subject|5|||
164563882|NCT02551159|594432402|FG002|Overall Study|Withdrawal by Subject|16|||
164563883|NCT02551159|594432400|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
164208333|NCT00879658|593131651|FG003|Overall Study|misrandomized (never received study med)|1|||
164208334|NCT00879658|593131652|FG004|Overall Study|misrandomized (never received study med)|0|||
164208335|NCT00879658|593131653|FG005|Overall Study|misrandomized (never received study med)|0|||
164208336|NCT00879658|593131654|FG006|Overall Study|misrandomized (never received study med)|0|||
164208337|NCT01035138|593131664|FG000|Overall Study|Adverse Event|4|||
164208338|NCT01035138|593131665|FG001|Overall Study|Adverse Event|0|||
164208339|NCT01035138|593131666|FG002|Overall Study|Adverse Event|2|||
164208340|NCT01035138|593131664|FG000|Overall Study|Caregiver Decision|2|||
164208341|NCT01035138|593131665|FG001|Overall Study|Caregiver Decision|0|||
164208342|NCT01035138|593131666|FG002|Overall Study|Caregiver Decision|1|||
164208343|NCT01035138|593131664|FG000|Overall Study|Withdrawal by Subject|1|||
164208344|NCT01035138|593131665|FG001|Overall Study|Withdrawal by Subject|0|||
164208345|NCT01035138|593131666|FG002|Overall Study|Withdrawal by Subject|0|||
164208346|NCT01035138|593131664|FG000|Overall Study|Physician Decision|0|||
164208347|NCT01035138|593131665|FG001|Overall Study|Physician Decision|0|||
164208348|NCT01035138|593131666|FG002|Overall Study|Physician Decision|1|||
164208349|NCT01035138|593131664|FG000|Overall Study|Sponsor Decision|66|||
164208350|NCT01035138|593131665|FG001|Overall Study|Sponsor Decision|60|||
164208351|NCT01035138|593131666|FG002|Overall Study|Sponsor Decision|42|||
164208352|NCT01035138|593131664|FG000|Overall Study|Lost to Follow-up|0|||
164208353|NCT01035138|593131665|FG001|Overall Study|Lost to Follow-up|0|||
164208354|NCT01035138|593131666|FG002|Overall Study|Lost to Follow-up|1|||
164208355|NCT01101178|593131670|FG000|Period 1|Withdrawal by Subject|1|||
164208356|NCT01101178|593131671|FG001|Period 1|Withdrawal by Subject|2|||
164208357|NCT01101178|593131670|FG000|Period 1|Positive drug screen|1|||
164208358|NCT01101178|593131671|FG001|Period 1|Positive drug screen|1|||
164208359|NCT01101178|593131670|FG000|Period 1|Adverse Event|2|||
164208360|NCT01101178|593131671|FG001|Period 1|Adverse Event|1|||
164208361|NCT01101178|593131670|FG000|Period 2|Withdrawal by Subject|0|||
164208362|NCT01101178|593131671|FG001|Period 2|Withdrawal by Subject|1|||
164208363|NCT01850641|593131672|FG000|Overall Study|Physician Decision|1|||
164208364|NCT01850641|593131672|FG000|Overall Study|Decrease in serum phosphorus|1|||
164208365|NCT01850641|593131672|FG000|Overall Study|Decrease in serum calcium|2|||
164208366|NCT01850641|593131672|FG000|Overall Study|Increase in serum ferritin|1|||
164208367|NCT00141817|593131673|FG000|Overall Study|Protocol Violation|0|||
164208368|NCT00141817|593131674|FG001|Overall Study|Protocol Violation|0|||
164208369|NCT00141817|593131675|FG002|Overall Study|Protocol Violation|1|||
164208370|NCT00141817|593131676|FG003|Overall Study|Protocol Violation|0|||
164208371|NCT00141817|593131673|FG000|Overall Study|Parent request|1|||
164208372|NCT00141817|593131674|FG001|Overall Study|Parent request|0|||
164208373|NCT00141817|593131675|FG002|Overall Study|Parent request|0|||
164208374|NCT00141817|593131676|FG003|Overall Study|Parent request|0|||
164208375|NCT00127803|593131677|FG000|Overall Study|Adverse Event|2|||
164208376|NCT00127803|593131678|FG001|Overall Study|Adverse Event|0|||
164208377|NCT00127803|593131679|FG002|Overall Study|Adverse Event|0|||
164208378|NCT00127803|593131680|FG003|Overall Study|Adverse Event|0|||
164208379|NCT00127803|593131677|FG000|Overall Study|Withdrawal by Subject|1|||
164208380|NCT00127803|593131678|FG001|Overall Study|Withdrawal by Subject|0|||
164208381|NCT00127803|593131679|FG002|Overall Study|Withdrawal by Subject|0|||
164208382|NCT00127803|593131680|FG003|Overall Study|Withdrawal by Subject|0|||
164208383|NCT00127803|593131677|FG000|Overall Study|Lost to Follow-up|0|||
164208384|NCT00127803|593131678|FG001|Overall Study|Lost to Follow-up|0|||
164208385|NCT00127803|593131679|FG002|Overall Study|Lost to Follow-up|0|||
164208386|NCT00127803|593131680|FG003|Overall Study|Lost to Follow-up|1|||
164208387|NCT04739800|593131684|FG000|Overall Study|Adverse Event|2|||
164208388|NCT04739800|593131685|FG001|Overall Study|Adverse Event|1|||
164208389|NCT04739800|593131686|FG002|Overall Study|Adverse Event|4|||
164208390|NCT04739800|593131687|FG003|Overall Study|Adverse Event|5|||
164208391|NCT04739800|593131684|FG000|Overall Study|Never Treated|2|||
164208392|NCT04739800|593131685|FG001|Overall Study|Never Treated|0|||
164208393|NCT04739800|593131686|FG002|Overall Study|Never Treated|1|||
164208394|NCT04739800|593131687|FG003|Overall Study|Never Treated|1|||
164208395|NCT04739800|593131684|FG000|Overall Study|On Treatment|5|||
164208396|NCT04739800|593131685|FG001|Overall Study|On Treatment|9|||
164208397|NCT04739800|593131686|FG002|Overall Study|On Treatment|9|||
164208398|NCT04739800|593131687|FG003|Overall Study|On Treatment|9|||
164208399|NCT04739800|593131684|FG000|Overall Study|Symptomatic Deterioration|1|||
164208400|NCT04739800|593131685|FG001|Overall Study|Symptomatic Deterioration|1|||
164208401|NCT04739800|593131686|FG002|Overall Study|Symptomatic Deterioration|3|||
164208402|NCT04739800|593131687|FG003|Overall Study|Symptomatic Deterioration|0|||
164208403|NCT04739800|593131684|FG000|Overall Study|Withdrawal by Subject|1|||
164208404|NCT04739800|593131685|FG001|Overall Study|Withdrawal by Subject|2|||
164208405|NCT04739800|593131686|FG002|Overall Study|Withdrawal by Subject|1|||
164208406|NCT04739800|593131687|FG003|Overall Study|Withdrawal by Subject|3|||
164208407|NCT04739800|593131684|FG000|Overall Study|Other Reason|1|||
164208408|NCT04739800|593131685|FG001|Overall Study|Other Reason|3|||
164208409|NCT04739800|593131686|FG002|Overall Study|Other Reason|5|||
164208410|NCT04739800|593131687|FG003|Overall Study|Other Reason|4|||
164322698|NCT00470158|593558982|FG001|Overall Study|Death|0|||
164322699|NCT00470158|593558983|FG002|Overall Study|Death|0|||
164322700|NCT00470158|593558984|FG003|Overall Study|Death|0|||
164322701|NCT00470158|593558985|FG004|Overall Study|Death|2|||
164322702|NCT00470158|593558981|FG000|Overall Study|Lost to Follow-up|7|||
164322703|NCT00470158|593558982|FG001|Overall Study|Lost to Follow-up|8|||
164322704|NCT00470158|593558983|FG002|Overall Study|Lost to Follow-up|8|||
164322705|NCT00470158|593558984|FG003|Overall Study|Lost to Follow-up|5|||
164322706|NCT00470158|593558985|FG004|Overall Study|Lost to Follow-up|4|||
164322707|NCT00470158|593558981|FG000|Overall Study|Protocol Violation|1|||
164322708|NCT00470158|593558982|FG001|Overall Study|Protocol Violation|0|||
164322709|NCT00470158|593558983|FG002|Overall Study|Protocol Violation|0|||
164322710|NCT00470158|593558984|FG003|Overall Study|Protocol Violation|0|||
164322711|NCT00470158|593558985|FG004|Overall Study|Protocol Violation|0|||
164322712|NCT00997438|593558986|FG000|Overall Study|Blood draw difficulty|2|||
164322713|NCT00997438|593558987|FG001|Overall Study|Blood draw difficulty|0|||
164322714|NCT00997438|593558988|FG002|Overall Study|Blood draw difficulty|1|||
164322715|NCT00997438|593558986|FG000|Overall Study|Withdrawal by Subject|1|||
164322716|NCT00997438|593558987|FG001|Overall Study|Withdrawal by Subject|1|||
164322717|NCT00997438|593558988|FG002|Overall Study|Withdrawal by Subject|0|||
164322718|NCT00997438|593558986|FG000|Overall Study|Exclusion criteria at visit 1|2|||
164322719|NCT00997438|593558987|FG001|Overall Study|Exclusion criteria at visit 1|2|||
164322720|NCT00997438|593558988|FG002|Overall Study|Exclusion criteria at visit 1|3|||
164322721|NCT01236118|593558989|FG000|Overall Study|Adverse Event|2|||
164322722|NCT01236118|593558990|FG001|Overall Study|Adverse Event|0|||
164322723|NCT01236118|593558991|FG002|Overall Study|Adverse Event|2|||
164322724|NCT01236118|593558989|FG000|Overall Study|Physician Decision|0|||
164322725|NCT01236118|593558990|FG001|Overall Study|Physician Decision|1|||
164322726|NCT01236118|593558991|FG002|Overall Study|Physician Decision|0|||
164322727|NCT01236118|593558989|FG000|Overall Study|Withdrawal by Subject|0|||
164322728|NCT01236118|593558990|FG001|Overall Study|Withdrawal by Subject|0|||
164322729|NCT01236118|593558991|FG002|Overall Study|Withdrawal by Subject|1|||
164322730|NCT00095238|593558992|FG000|Overall Study|Lack of Efficacy|9|||
164322731|NCT00095238|593558993|FG001|Overall Study|Lack of Efficacy|9|||
164322732|NCT00095238|593558992|FG000|Overall Study|Adverse Event|331|||
164322733|NCT00095238|593558993|FG001|Overall Study|Adverse Event|287|||
164322734|NCT00095238|593558992|FG000|Overall Study|Subject Withdrew Consent|208|||
164322735|NCT00095238|593558993|FG001|Overall Study|Subject Withdrew Consent|223|||
164322736|NCT00095238|593558992|FG000|Overall Study|Death|154|||
164322737|NCT00095238|593558993|FG001|Overall Study|Death|170|||
164322738|NCT00095238|593558992|FG000|Overall Study|Lost to Follow-up|19|||
164322739|NCT00095238|593558993|FG001|Overall Study|Lost to Follow-up|24|||
164322740|NCT00095238|593558992|FG000|Overall Study|Noncompliance|44|||
164322741|NCT00095238|593558993|FG001|Overall Study|Noncompliance|45|||
164322742|NCT00095238|593558992|FG000|Overall Study|No longer met study criteria|4|||
164322743|NCT00095238|593558993|FG001|Overall Study|No longer met study criteria|5|||
164322744|NCT00095238|593558992|FG000|Overall Study|Study terminated by sponsor|0|||
164322745|NCT00095238|593558993|FG001|Overall Study|Study terminated by sponsor|1|||
164322746|NCT00095238|593558992|FG000|Overall Study|Missing|1|||
164322747|NCT00095238|593558993|FG001|Overall Study|Missing|0|||
164322748|NCT00095238|593558992|FG000|Overall Study|Other Reasons|87|||
164322749|NCT00095238|593558993|FG001|Overall Study|Other Reasons|88|||
164322750|NCT02579928|593558994|FG000|Overall Study|Withdrawal by Subject|1|||
164322751|NCT02579928|593558995|FG001|Overall Study|Withdrawal by Subject|0|||
164322752|NCT04300751|593558996|FG000|Overall Study|Withdrawal by Subject|1|||
164322753|NCT03754972|593558999|FG000|Overall Study|Protocol Violation|25|||
164322754|NCT02311582|593559000|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
164322755|NCT02311582|593559001|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
164322756|NCT02311582|593559002|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
164322757|NCT02311582|593559003|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
164322758|NCT02311582|593559004|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
164322759|NCT03404960|593559006|FG000|Overall Study|Adverse Event|0|||
164322760|NCT03404960|593559007|FG001|Overall Study|Adverse Event|2|||
164322761|NCT03404960|593559006|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
164322762|NCT03404960|593559007|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
164322763|NCT03404960|593559006|FG000|Overall Study|Bowel obstruction|0|||
164322764|NCT03404960|593559007|FG001|Overall Study|Bowel obstruction|1|||
164322765|NCT03404960|593559006|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
164668384|NCT01691248|594810203|FG001|Overall Study|Withdrawal by Subject|18|||
164668385|NCT01691248|594810202|FG000|Overall Study|Confirmed CDAD|14|||
164322766|NCT03404960|593559007|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
164322767|NCT05171816|593559015|FG000|Overall Study|Death|18|||
164322768|NCT05171816|593559016|FG001|Overall Study|Death|16|||
164322769|NCT04902326|593559018|FG000|Overall Study|Withdrawal by Subject|1|||
164322770|NCT04902326|593559019|FG001|Overall Study|Withdrawal by Subject|3|||
164322771|NCT04902326|593559020|FG002|Overall Study|Withdrawal by Subject|0|||
164322772|NCT04902326|593559021|FG003|Overall Study|Withdrawal by Subject|1|||
164322773|NCT04902326|593559018|FG000|Overall Study|Lost to Follow-up|14|||
164322774|NCT04902326|593559019|FG001|Overall Study|Lost to Follow-up|14|||
164322775|NCT04902326|593559020|FG002|Overall Study|Lost to Follow-up|14|||
164322776|NCT04902326|593559021|FG003|Overall Study|Lost to Follow-up|6|||
164322777|NCT01857310|593559024|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
164322778|NCT01857310|593559025|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
164322779|NCT02360605|593559026|FG000|Overall Study|Withdrawal by Subject|4|||
164322780|NCT02360605|593559027|FG001|Overall Study|Withdrawal by Subject|9|||
164322781|NCT02360605|593559026|FG000|Overall Study|Lost to Follow-up|7|||
164322782|NCT02360605|593559027|FG001|Overall Study|Lost to Follow-up|8|||
164322783|NCT02360605|593559026|FG000|Overall Study|Death|0|||
164322784|NCT02360605|593559027|FG001|Overall Study|Death|1|||
164322785|NCT00290407|593559028|FG000|Overall Study|Physician Decision|2|||
164322786|NCT00868517|593559039|FG000|Overall Study|Withdrawal by Subject|3|||
164322787|NCT00868517|593559040|FG001|Overall Study|Withdrawal by Subject|3|||
164322788|NCT00868517|593559041|FG002|Overall Study|Withdrawal by Subject|2|||
164322789|NCT00868517|593559039|FG000|Overall Study|Protocol Violation|1|||
164322790|NCT00868517|593559040|FG001|Overall Study|Protocol Violation|1|||
164322791|NCT00868517|593559041|FG002|Overall Study|Protocol Violation|0|||
164322792|NCT01721577|593559042|FG000|Overall Study|Lack of Efficacy|1|||
164322793|NCT01721577|593559043|FG001|Overall Study|Lack of Efficacy|0|||
164322794|NCT01721577|593559042|FG000|Overall Study|Death|1|||
164322795|NCT01721577|593559043|FG001|Overall Study|Death|0|||
164322796|NCT01721577|593559042|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
164322797|NCT01721577|593559043|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
164322798|NCT01721577|593559042|FG000|Overall Study|Adverse Event|0|||
164322799|NCT01721577|593559043|FG001|Overall Study|Adverse Event|2|||
164322800|NCT05442775|593559044|FG000|Overall Study|Trial terminated|61|||
164322801|NCT05442775|593559044|FG000|Overall Study|Lack of Efficacy|4|||
164322802|NCT05442775|593559044|FG000|Overall Study|Withdrawal by Subject|4|||
164322803|NCT05442775|593559044|FG000|Overall Study|Death|1|||
164322804|NCT05442775|593559044|FG000|Overall Study|Participant removed at Sponsor request|1|||
164322805|NCT01055496|593559046|FG000|Overall Study|Withdrawal by Subject|2|||
164322806|NCT01055496|593559047|FG001|Overall Study|Withdrawal by Subject|4|||
164322807|NCT01055496|593559046|FG000|Overall Study|Death|13|||
164322808|NCT01055496|593559047|FG001|Overall Study|Death|23|||
164322809|NCT01055496|593559046|FG000|Overall Study|Lost to Follow-up|0|||
164322810|NCT01055496|593559047|FG001|Overall Study|Lost to Follow-up|2|||
164322811|NCT01055496|593559046|FG000|Overall Study|Other - Unspecified|0|||
164322812|NCT01055496|593559047|FG001|Overall Study|Other - Unspecified|1|||
164322813|NCT00584740|593559048|FG000|Overall Study|Adverse Event|1|||
164322814|NCT00584740|593559049|FG001|Overall Study|Adverse Event|1|||
164322815|NCT00584740|593559048|FG000|Overall Study|Lack of Efficacy|8|||
164322816|NCT00584740|593559049|FG001|Overall Study|Lack of Efficacy|2|||
164322817|NCT00584740|593559048|FG000|Overall Study|Withdrawal by Subject|3|||
164322818|NCT00584740|593559049|FG001|Overall Study|Withdrawal by Subject|2|||
164322819|NCT00584740|593559048|FG000|Overall Study|Lost to Follow-up|0|||
164322820|NCT00584740|593559049|FG001|Overall Study|Lost to Follow-up|1|||
164322821|NCT00969280|593559051|FG000|Overall Study|Protocol Violation|2|||
164322822|NCT00969280|593559052|FG001|Overall Study|Protocol Violation|1|||
164322823|NCT00969280|593559051|FG000|Overall Study|Withdrawal by Subject|0|||
164322824|NCT00969280|593559052|FG001|Overall Study|Withdrawal by Subject|1|||
164322825|NCT00969280|593559051|FG000|Overall Study|infection of influenza A(H1N1)|0|||
164322826|NCT00969280|593559052|FG001|Overall Study|infection of influenza A(H1N1)|1|||
164322827|NCT00821327|593559053|FG000|Overall Study|Adverse Event|13|||
164322828|NCT00821327|593559053|FG000|Overall Study|Patient Request|1|||
164322829|NCT00821327|593559053|FG000|Overall Study|Investigator Request|2|||
164322830|NCT00821327|593559053|FG000|Overall Study|Sponsor Request|1|||
164322831|NCT00821327|593559053|FG000|Overall Study|Disease Progression|13|||
164322832|NCT00821327|593559053|FG000|Overall Study|Other/Unknown|5|||
164322833|NCT00217464|593559054|FG000|Overall Study|Progression|15|||
164322834|NCT00217464|593559054|FG000|Overall Study|Other|2|||
164563884|NCT02551159|594432401|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
164563885|NCT02551159|594432402|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
164322835|NCT00459979|593559055|FG000|Overall Study|Withdrawal by Subject|1|||
164322836|NCT00459979|593559055|FG000|Overall Study|Protocol Violation|1|||
164563886|NCT01890421|594432403|FG000|Overall Study|Adverse Event|1|||
164563887|NCT01890421|594432403|FG000|Overall Study|Other reason|10|||
164563888|NCT02319044|594432405|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
164322837|NCT00278915|593559056|FG000|Overall Study|Disease progression|1|||
164322838|NCT05214573|593559057|FG000|Overall Study|Physician Decision|5924|||
164322839|NCT05214573|593559058|FG001|Overall Study|Physician Decision|0|||
164322840|NCT00814801|593559059|FG000|Overall Study|Adverse Event|15|||
164322841|NCT00814801|593559060|FG001|Overall Study|Adverse Event|16|||
164322842|NCT00814801|593559061|FG002|Overall Study|Adverse Event|19|||
164322843|NCT00814801|593559059|FG000|Overall Study|Withdrawal by Subject|9|||
164322844|NCT00814801|593559060|FG001|Overall Study|Withdrawal by Subject|11|||
164322845|NCT00814801|593559061|FG002|Overall Study|Withdrawal by Subject|14|||
164322846|NCT00814801|593559059|FG000|Overall Study|Inappropriate as a subject|1|||
164322847|NCT00814801|593559060|FG001|Overall Study|Inappropriate as a subject|1|||
164322848|NCT00814801|593559061|FG002|Overall Study|Inappropriate as a subject|1|||
164322849|NCT00814801|593559059|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
164322850|NCT00814801|593559060|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
164322851|NCT00814801|593559061|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
164322852|NCT00814801|593559059|FG000|Overall Study|Missing or change of caregiver|6|||
164322853|NCT00814801|593559060|FG001|Overall Study|Missing or change of caregiver|2|||
164322854|NCT00814801|593559061|FG002|Overall Study|Missing or change of caregiver|4|||
164322855|NCT00814801|593559059|FG000|Overall Study|Non-compliance|0|||
164322856|NCT00814801|593559060|FG001|Overall Study|Non-compliance|1|||
164322857|NCT00814801|593559061|FG002|Overall Study|Non-compliance|1|||
164322858|NCT00814801|593559059|FG000|Overall Study|Other|2|||
164322859|NCT00814801|593559060|FG001|Overall Study|Other|6|||
164322860|NCT00814801|593559061|FG002|Overall Study|Other|4|||
164322861|NCT01037088|593559067|FG000|Overall Study|Withdrawal by Subject|3|||
164322862|NCT02216812|593559068|FG000|Overall Study|Lost to Follow-up|10|||
164322863|NCT02216812|593559069|FG001|Overall Study|Lost to Follow-up|5|||
164322864|NCT01986933|593559070|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
164322865|NCT01986933|593559071|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
164322866|NCT01986933|593559072|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
164322867|NCT01986933|593559073|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
164322868|NCT01986933|593559074|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
164322869|NCT01986933|593559070|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
164322870|NCT01986933|593559071|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
164322871|NCT01986933|593559072|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
164322872|NCT01986933|593559073|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
164322873|NCT01986933|593559074|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
164322874|NCT01986933|593559070|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
164322875|NCT01986933|593559071|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
164322876|NCT01986933|593559072|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
164322877|NCT01986933|593559073|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
164322878|NCT01986933|593559074|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
164322879|NCT01986933|593559070|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
164322880|NCT01986933|593559071|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
164322881|NCT01986933|593559072|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
164322882|NCT01986933|593559073|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
164322883|NCT01986933|593559074|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
164322884|NCT01986933|593559070|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
164322885|NCT01986933|593559071|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
164322886|NCT01986933|593559072|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
164322887|NCT01986933|593559073|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
164322888|NCT01986933|593559074|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
164322889|NCT01986933|593559070|FG000|Active-to-active (Part B)|Adverse Event|0|||
164322890|NCT01986933|593559071|FG001|Active-to-active (Part B)|Adverse Event|2|||
164322891|NCT01986933|593559072|FG002|Active-to-active (Part B)|Adverse Event|0|||
164322892|NCT01986933|593559073|FG003|Active-to-active (Part B)|Adverse Event|1|||
164322893|NCT01986933|593559074|FG004|Active-to-active (Part B)|Adverse Event|3|||
164322894|NCT01986933|593559070|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
164322895|NCT01986933|593559071|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
164322896|NCT01986933|593559072|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
164322897|NCT01986933|593559073|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
164322898|NCT01986933|593559074|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
164322899|NCT01986933|593559070|FG000|Active-to-active (Part B)|Pregnancy|0|||
164322900|NCT01986933|593559071|FG001|Active-to-active (Part B)|Pregnancy|0|||
164322901|NCT01986933|593559072|FG002|Active-to-active (Part B)|Pregnancy|0|||
164322902|NCT01986933|593559073|FG003|Active-to-active (Part B)|Pregnancy|0|||
164322903|NCT01986933|593559074|FG004|Active-to-active (Part B)|Pregnancy|1|||
164322904|NCT01986933|593559070|FG000|Active-to-active (Part B)|Physician Decision|0|||
164322905|NCT01986933|593559071|FG001|Active-to-active (Part B)|Physician Decision|0|||
164322906|NCT01986933|593559072|FG002|Active-to-active (Part B)|Physician Decision|1|||
164322907|NCT01986933|593559073|FG003|Active-to-active (Part B)|Physician Decision|1|||
164322908|NCT01986933|593559074|FG004|Active-to-active (Part B)|Physician Decision|0|||
164322909|NCT01986933|593559070|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
164668386|NCT01691248|594810203|FG001|Overall Study|Confirmed CDAD|31|||
164668387|NCT01691248|594810202|FG000|Overall Study|Lost to Follow-up|2|||
164668388|NCT01691248|594810203|FG001|Overall Study|Lost to Follow-up|5|||
164668389|NCT01691248|594810202|FG000|Overall Study|Reason not provided|4|||
164322910|NCT01986933|593559071|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
164322911|NCT01986933|593559072|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
164668390|NCT01691248|594810203|FG001|Overall Study|Reason not provided|4|||
164668391|NCT01691248|594810202|FG000|Overall Study|Not Treated|4|||
164322912|NCT01986933|593559073|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
164322913|NCT01986933|593559074|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
164322914|NCT01986933|593559070|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
164322915|NCT01986933|593559071|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
164322916|NCT01986933|593559072|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
164322917|NCT01986933|593559073|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
164322918|NCT01986933|593559074|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
164322919|NCT01986933|593559070|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
164322920|NCT01986933|593559071|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
164322921|NCT01986933|593559072|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
164322922|NCT01986933|593559073|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
164322923|NCT01986933|593559074|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
164322924|NCT01986933|593559070|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
164322925|NCT01986933|593559071|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
164322926|NCT01986933|593559072|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
164322927|NCT01986933|593559073|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
164322928|NCT01986933|593559074|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
164322929|NCT01986933|593559070|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
164322930|NCT01986933|593559071|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
164322931|NCT01986933|593559072|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
164322932|NCT01986933|593559073|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
164322933|NCT01986933|593559074|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
164322934|NCT01986933|593559070|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
164322935|NCT01986933|593559071|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
164322936|NCT01986933|593559072|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
164322937|NCT01986933|593559073|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
164322938|NCT01986933|593559074|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
164322939|NCT01986933|593559070|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
164322940|NCT01986933|593559071|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
164322941|NCT01986933|593559072|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
164322942|NCT01986933|593559073|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
164322943|NCT01986933|593559074|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
164322944|NCT01986933|593559070|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
164322945|NCT01986933|593559071|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
164322946|NCT01986933|593559072|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
164322947|NCT01986933|593559073|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
164322948|NCT01986933|593559074|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
164322949|NCT01077154|593559075|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
164322950|NCT01077154|593559076|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
164322951|NCT01077154|593559075|FG000|Overall Study|Withdrawal by Subject|369|||
164322952|NCT01077154|593559076|FG001|Overall Study|Withdrawal by Subject|385|||
164322953|NCT01077154|593559075|FG000|Overall Study|Death|215|||
164322954|NCT01077154|593559076|FG001|Overall Study|Death|214|||
164322955|NCT01077154|593559075|FG000|Overall Study|Lost to Follow-up|43|||
164322956|NCT01077154|593559076|FG001|Overall Study|Lost to Follow-up|35|||
164322957|NCT01077154|593559075|FG000|Overall Study|Noncompliance|22|||
164322958|NCT01077154|593559076|FG001|Overall Study|Noncompliance|20|||
164322959|NCT01077154|593559075|FG000|Overall Study|Disease Progression|18|||
164322960|NCT01077154|593559076|FG001|Overall Study|Disease Progression|20|||
164322961|NCT01077154|593559075|FG000|Overall Study|Ineligibility Determined|10|||
164322962|NCT01077154|593559076|FG001|Overall Study|Ineligibility Determined|14|||
164322963|NCT01077154|593559075|FG000|Overall Study|Other|14|||
164322964|NCT01077154|593559076|FG001|Overall Study|Other|11|||
164322965|NCT01077154|593559075|FG000|Overall Study|Adverse Event|9|||
164322966|NCT01077154|593559076|FG001|Overall Study|Adverse Event|9|||
164322967|NCT01077154|593559075|FG000|Overall Study|Administrative Decision|1|||
164322968|NCT01077154|593559076|FG001|Overall Study|Administrative Decision|6|||
164322969|NCT01077154|593559075|FG000|Overall Study|Protocol Deviation|1|||
164322970|NCT01077154|593559076|FG001|Overall Study|Protocol Deviation|0|||
164322971|NCT00604214|593559077|FG000|Baseline to Day 28|Death|223|||
164322972|NCT00604214|593559078|FG001|Baseline to Day 28|Death|202|||
164322973|NCT00604214|593559077|FG000|Baseline to Day 28|Lost to Follow-up|2|||
164322974|NCT00604214|593559078|FG001|Baseline to Day 28|Lost to Follow-up|4|||
164322975|NCT00604214|593559077|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
164322976|NCT00604214|593559078|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
164322977|NCT00604214|593559077|FG000|Day 29 to Day 90|Death|64|||
164322978|NCT00604214|593559078|FG001|Day 29 to Day 90|Death|67|||
164322979|NCT00604214|593559077|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
164322980|NCT00604214|593559078|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
164322981|NCT00604214|593559077|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
164322982|NCT00604214|593559078|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
164322983|NCT00604214|593559077|FG000|Day 91 to Day 180|Death|19|||
164322984|NCT00604214|593559078|FG001|Day 91 to Day 180|Death|23|||
164322985|NCT00604214|593559077|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
164322986|NCT00604214|593559078|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
164322987|NCT00604214|593559077|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
164322988|NCT00604214|593559078|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
164322989|NCT00534599|593559079|FG000|Overall Study|Adverse Event|25|||
164322990|NCT00534599|593559080|FG001|Overall Study|Adverse Event|4|||
164322991|NCT00534599|593559079|FG000|Overall Study|Incorrect enrollment|2|||
164322992|NCT00534599|593559080|FG001|Overall Study|Incorrect enrollment|1|||
164322993|NCT00534599|593559079|FG000|Overall Study|Mis-randomization|2|||
164322994|NCT00534599|593559080|FG001|Overall Study|Mis-randomization|2|||
164322995|NCT00534599|593559079|FG000|Overall Study|Developed study-specific d/c criteria|5|||
164322996|NCT00534599|593559080|FG001|Overall Study|Developed study-specific d/c criteria|0|||
164322997|NCT00534599|593559079|FG000|Overall Study|Lack of Efficacy|0|||
164322998|NCT00534599|593559080|FG001|Overall Study|Lack of Efficacy|1|||
164322999|NCT00534599|593559079|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
164323000|NCT00534599|593559080|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
164323001|NCT00534599|593559079|FG000|Overall Study|Protocol Violation|1|||
164323002|NCT00534599|593559080|FG001|Overall Study|Protocol Violation|3|||
164323003|NCT00534599|593559079|FG000|Overall Study|Lost to Follow-up|11|||
164323004|NCT00534599|593559080|FG001|Overall Study|Lost to Follow-up|14|||
164323005|NCT00534599|593559079|FG000|Overall Study|Withdrawal by Subject|4|||
164323006|NCT00534599|593559080|FG001|Overall Study|Withdrawal by Subject|6|||
164323007|NCT00534599|593559079|FG000|Overall Study|Other|7|||
164323008|NCT00534599|593559080|FG001|Overall Study|Other|0|||
164323009|NCT04285580|593560675|FG000|Overall Study|Protocol Violation|0|||
164323010|NCT04285580|593560676|FG001|Overall Study|Protocol Violation|1|||
164323011|NCT01879579|593560677|FG000|Overall Study|Phone incompatible with texting platform|3|||
164323012|NCT01879579|593560678|FG001|Overall Study|Phone incompatible with texting platform|0|||
164323013|NCT01879579|593560677|FG000|Overall Study|Did not enroll in texting platform|1|||
164323014|NCT01879579|593560678|FG001|Overall Study|Did not enroll in texting platform|0|||
164323015|NCT01879579|593560677|FG000|Overall Study|Did not initiate insulin treatment|1|||
164323016|NCT01879579|593560678|FG001|Overall Study|Did not initiate insulin treatment|0|||
164323017|NCT01879579|593560677|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
164323018|NCT01879579|593560678|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
164323019|NCT01879579|593560677|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
164323020|NCT01879579|593560678|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
164323021|NCT00815516|593560688|FG000|Overall Study|Death|3|||
164323022|NCT00815516|593560689|FG001|Overall Study|Death|1|||
164323023|NCT00815516|593560688|FG000|Overall Study|Physician Decision|1|||
164323024|NCT00815516|593560689|FG001|Overall Study|Physician Decision|0|||
164323025|NCT06460493|593560694|FG000|Overall Study|Withdrawal by Subject|2|||
164323026|NCT00075270|593560699|FG000|Overall Study|Withdrawal by Subject|28|||
164323027|NCT00075270|593560700|FG001|Overall Study|Withdrawal by Subject|21|||
164323028|NCT00075270|593560699|FG000|Overall Study|Lost to Follow-up|25|||
164323029|NCT00075270|593560700|FG001|Overall Study|Lost to Follow-up|28|||
164563889|NCT02319044|594432406|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
164563890|NCT02319044|594432407|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
164563891|NCT02319044|594432405|FG000|Overall Study|Withdrawal by Subject|3|||
164563892|NCT02319044|594432406|FG001|Overall Study|Withdrawal by Subject|3|||
164563893|NCT02319044|594432407|FG002|Overall Study|Withdrawal by Subject|6|||
164563894|NCT02319044|594432405|FG000|Overall Study|Condition under investigation worsened|100|||
164563895|NCT02319044|594432406|FG001|Overall Study|Condition under investigation worsened|50|||
164563896|NCT02319044|594432407|FG002|Overall Study|Condition under investigation worsened|46|||
164563897|NCT02319044|594432405|FG000|Overall Study|Adverse Event|17|||
164563898|NCT02319044|594432406|FG001|Overall Study|Adverse Event|2|||
164563899|NCT02319044|594432407|FG002|Overall Study|Adverse Event|8|||
164563900|NCT02319044|594432405|FG000|Overall Study|Study specific discontinuation criteria|2|||
164563901|NCT02319044|594432406|FG001|Overall Study|Study specific discontinuation criteria|2|||
164563902|NCT02319044|594432407|FG002|Overall Study|Study specific discontinuation criteria|1|||
164563903|NCT02319044|594432405|FG000|Overall Study|Not treated|0|||
164563904|NCT02319044|594432406|FG001|Overall Study|Not treated|2|||
164563905|NCT02319044|594432407|FG002|Overall Study|Not treated|2|||
164563906|NCT02026063|594432412|FG000|Overall Study|Physician Decision|0|||
164563907|NCT02026063|594432413|FG001|Overall Study|Physician Decision|10|||
164563908|NCT02026063|594432412|FG000|Overall Study|Noncompliance with Study Drug|1|||
164563909|NCT02026063|594432413|FG001|Overall Study|Noncompliance with Study Drug|1|||
164563910|NCT02026063|594432412|FG000|Overall Study|Withdrawal of Consent|1|||
164563911|NCT02026063|594432413|FG001|Overall Study|Withdrawal of Consent|6|||
164563912|NCT02026063|594432412|FG000|Overall Study|Adverse Event|5|||
164563913|NCT02026063|594432413|FG001|Overall Study|Adverse Event|20|||
164323030|NCT00075270|593560699|FG000|Overall Study|Protocol Violation|0|||
164323031|NCT00075270|593560700|FG001|Overall Study|Protocol Violation|2|||
164323032|NCT00075270|593560699|FG000|Overall Study|Death|198|||
164323033|NCT00075270|593560700|FG001|Overall Study|Death|215|||
164323034|NCT00075270|593560699|FG000|Overall Study|Other/Unknown|9|||
164323035|NCT00075270|593560700|FG001|Overall Study|Other/Unknown|5|||
164323036|NCT00075270|593560699|FG000|Overall Study|Missing|26|||
164323037|NCT00075270|593560700|FG001|Overall Study|Missing|13|||
164323038|NCT00246571|593560701|FG000|Overall Study|Adverse Event|7|||
164323039|NCT00246571|593560702|FG001|Overall Study|Adverse Event|0|||
164323040|NCT00246571|593560701|FG000|Overall Study|Protocol Violation|0|||
164323041|NCT00246571|593560702|FG001|Overall Study|Protocol Violation|1|||
164323042|NCT00246571|593560701|FG000|Overall Study|Withdrawal by Subject|2|||
164323043|NCT00246571|593560702|FG001|Overall Study|Withdrawal by Subject|3|||
164323044|NCT00246571|593560701|FG000|Overall Study|Lack of Efficacy|84|||
164323045|NCT00246571|593560702|FG001|Overall Study|Lack of Efficacy|21|||
164323046|NCT00246571|593560701|FG000|Overall Study|Death|17|||
164323047|NCT00246571|593560702|FG001|Overall Study|Death|3|||
164323048|NCT00246571|593560701|FG000|Overall Study|Sponsor|0|||
164323049|NCT00246571|593560702|FG001|Overall Study|Sponsor|1|||
164323050|NCT00246571|593560701|FG000|Overall Study|Did not meet entrance criteria|2|||
164323051|NCT00246571|593560702|FG001|Overall Study|Did not meet entrance criteria|1|||
164323052|NCT00246571|593560701|FG000|Overall Study|Laboratory abnormalities|1|||
164323053|NCT00246571|593560702|FG001|Overall Study|Laboratory abnormalities|0|||
164323054|NCT00246571|593560701|FG000|Overall Study|Crossover participants|0|||
164323055|NCT00246571|593560702|FG001|Overall Study|Crossover participants|74|||
164323056|NCT00775203|593560703|FG000|Overall Study|Adverse Event|25|||
164323057|NCT00775203|593560704|FG001|Overall Study|Adverse Event|6|||
164323058|NCT00775203|593560703|FG000|Overall Study|Lack of Efficacy|8|||
164323059|NCT00775203|593560704|FG001|Overall Study|Lack of Efficacy|9|||
164323060|NCT00775203|593560703|FG000|Overall Study|Withdrawal by Subject|11|||
164323061|NCT00775203|593560704|FG001|Overall Study|Withdrawal by Subject|9|||
164323062|NCT00775203|593560703|FG000|Overall Study|Lost to Follow-up|11|||
164323063|NCT00775203|593560704|FG001|Overall Study|Lost to Follow-up|15|||
164323064|NCT00775203|593560703|FG000|Overall Study|Administrative reason|2|||
164323065|NCT00775203|593560704|FG001|Overall Study|Administrative reason|0|||
164323066|NCT00775203|593560703|FG000|Overall Study|Noncompliance|4|||
164323067|NCT00775203|593560704|FG001|Overall Study|Noncompliance|2|||
164323068|NCT00775203|593560703|FG000|Overall Study|Protocol Violation|0|||
164323069|NCT00775203|593560704|FG001|Overall Study|Protocol Violation|1|||
164323070|NCT00775203|593560703|FG000|Overall Study|Entered other study|1|||
164323071|NCT00775203|593560704|FG001|Overall Study|Entered other study|0|||
164323072|NCT00775203|593560703|FG000|Overall Study|Physician Decision|0|||
164323073|NCT00775203|593560704|FG001|Overall Study|Physician Decision|1|||
164323074|NCT02987660|593560705|FG000|Overall Study|Study terminated by sponsor|10|||
164323075|NCT02987660|593560706|FG001|Overall Study|Study terminated by sponsor|10|||
164323076|NCT03422627|593560707|FG000|Overall Study|Protocol-specified Criteria|1|||
164323077|NCT03422627|593560708|FG001|Overall Study|Protocol-specified Criteria|1|||
164323078|NCT03422627|593560709|FG002|Overall Study|Protocol-specified Criteria|0|||
164323079|NCT03422627|593560710|FG003|Overall Study|Protocol-specified Criteria|0|||
164323080|NCT03422627|593560711|FG004|Overall Study|Protocol-specified Criteria|2|||
164323081|NCT03422627|593560707|FG000|Overall Study|Requirement for Alternative Therapy|1|||
164323082|NCT03422627|593560708|FG001|Overall Study|Requirement for Alternative Therapy|1|||
164323083|NCT03422627|593560709|FG002|Overall Study|Requirement for Alternative Therapy|2|||
164323084|NCT03422627|593560710|FG003|Overall Study|Requirement for Alternative Therapy|0|||
164323085|NCT03422627|593560711|FG004|Overall Study|Requirement for Alternative Therapy|0|||
164323086|NCT03422627|593560707|FG000|Overall Study|Disease Progression|1|||
164323087|NCT03422627|593560708|FG001|Overall Study|Disease Progression|0|||
164323088|NCT03422627|593560709|FG002|Overall Study|Disease Progression|1|||
164323089|NCT03422627|593560710|FG003|Overall Study|Disease Progression|2|||
164323090|NCT03422627|593560711|FG004|Overall Study|Disease Progression|0|||
164323091|NCT03422627|593560707|FG000|Overall Study|Adverse Event|2|||
164323092|NCT03422627|593560708|FG001|Overall Study|Adverse Event|1|||
164323093|NCT03422627|593560709|FG002|Overall Study|Adverse Event|0|||
164563914|NCT02026063|594432412|FG000|Overall Study|Lack of Efficacy|0|||
164563915|NCT02026063|594432413|FG001|Overall Study|Lack of Efficacy|4|||
164563916|NCT02026063|594432412|FG000|Overall Study|Lost to Follow-up|0|||
164563917|NCT02026063|594432413|FG001|Overall Study|Lost to Follow-up|1|||
164208411|NCT03573297|593131690|FG000|Open Label Treatment Period|Adverse Event|67|||
164208412|NCT03573297|593131691|FG001|Open Label Treatment Period|Adverse Event|0|||
164208413|NCT03573297|593131692|FG002|Open Label Treatment Period|Adverse Event|0|||
164208414|NCT03573297|593131693|FG003|Open Label Treatment Period|Adverse Event|0|||
164208415|NCT03573297|593131690|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
164208416|NCT03573297|593131691|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
164208417|NCT03573297|593131692|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
164208418|NCT03573297|593131693|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
164208419|NCT03573297|593131690|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
164208420|NCT03573297|593131691|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
164208421|NCT03573297|593131692|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
164208422|NCT03573297|593131693|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
164323094|NCT03422627|593560710|FG003|Overall Study|Adverse Event|0|||
164323095|NCT03422627|593560711|FG004|Overall Study|Adverse Event|2|||
164563918|NCT02026063|594432412|FG000|Overall Study|Reason not Specified|2|||
164668392|NCT01691248|594810203|FG001|Overall Study|Not Treated|7|||
164323096|NCT03422627|593560707|FG000|Overall Study|Ineligibility Determined|0|||
164323097|NCT03422627|593560708|FG001|Overall Study|Ineligibility Determined|1|||
164323098|NCT03422627|593560709|FG002|Overall Study|Ineligibility Determined|0|||
164323099|NCT03422627|593560710|FG003|Overall Study|Ineligibility Determined|0|||
164323100|NCT03422627|593560711|FG004|Overall Study|Ineligibility Determined|0|||
164323101|NCT03422627|593560707|FG000|Overall Study|Death|0|||
164323102|NCT03422627|593560708|FG001|Overall Study|Death|1|||
164323103|NCT03422627|593560709|FG002|Overall Study|Death|1|||
164323104|NCT03422627|593560710|FG003|Overall Study|Death|0|||
164323105|NCT03422627|593560711|FG004|Overall Study|Death|0|||
164323106|NCT03422627|593560707|FG000|Overall Study|Withdrawal by Subject|0|||
164323107|NCT03422627|593560708|FG001|Overall Study|Withdrawal by Subject|0|||
164323108|NCT03422627|593560709|FG002|Overall Study|Withdrawal by Subject|0|||
164323109|NCT03422627|593560710|FG003|Overall Study|Withdrawal by Subject|1|||
164323110|NCT03422627|593560711|FG004|Overall Study|Withdrawal by Subject|0|||
164323111|NCT05247398|593560712|FG000|Overall Study|Withdrawal by Subject|1|||
164323112|NCT04251156|593560713|FG000|Overall Study|Lost to Follow-up|1|||
164323113|NCT04251156|593560714|FG001|Overall Study|Lost to Follow-up|1|||
164323114|NCT04251156|593560713|FG000|Overall Study|Withdrawal by Subject|4|||
164323115|NCT04251156|593560714|FG001|Overall Study|Withdrawal by Subject|4|||
164323116|NCT02937571|593560715|FG000|Overall Study|Adverse Event|0|||
164323117|NCT02937571|593560716|FG001|Overall Study|Adverse Event|0|||
164323118|NCT02937571|593560717|FG002|Overall Study|Adverse Event|4|||
164323119|NCT02937571|593560715|FG000|Overall Study|Withdrawal by Subject|0|||
164323120|NCT02937571|593560716|FG001|Overall Study|Withdrawal by Subject|0|||
164323121|NCT02937571|593560717|FG002|Overall Study|Withdrawal by Subject|3|||
164323122|NCT03675321|593560718|FG000|Overall Study|Lack of Efficacy|2|||
164323123|NCT03675321|593560719|FG001|Overall Study|Lack of Efficacy|2|||
164323124|NCT03675321|593560718|FG000|Overall Study|Withdrawal by Subject|1|||
164323125|NCT03675321|593560719|FG001|Overall Study|Withdrawal by Subject|3|||
164323126|NCT00934648|593560725|FG000|Overall Study|Failure to return|8|||
164323127|NCT00934648|593560725|FG000|Overall Study|Withdrawal by Subject|1|||
164323128|NCT01155479|593560730|FG000|Part I|Adverse Event|13|||
164323129|NCT01155479|593560731|FG001|Part I|Adverse Event|8|||
164323130|NCT01155479|593560732|FG002|Part I|Adverse Event|18|||
164323131|NCT01155479|593560733|FG003|Part I|Adverse Event|7|||
164323132|NCT01155479|593560734|FG004|Part I|Adverse Event|6|||
164323133|NCT01155479|593560730|FG000|Part I|Administrative|2|||
164323134|NCT01155479|593560731|FG001|Part I|Administrative|2|||
164323135|NCT01155479|593560732|FG002|Part I|Administrative|2|||
164323136|NCT01155479|593560733|FG003|Part I|Administrative|0|||
164323137|NCT01155479|593560734|FG004|Part I|Administrative|0|||
164323138|NCT01155479|593560730|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
164323139|NCT01155479|593560731|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
164323140|NCT01155479|593560732|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
164323141|NCT01155479|593560733|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
164323142|NCT01155479|593560734|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
164323143|NCT01155479|593560730|FG000|Part I|Withdrawal by Subject|11|||
164323144|NCT01155479|593560731|FG001|Part I|Withdrawal by Subject|13|||
164323145|NCT01155479|593560732|FG002|Part I|Withdrawal by Subject|8|||
164323146|NCT01155479|593560733|FG003|Part I|Withdrawal by Subject|8|||
164323147|NCT01155479|593560734|FG004|Part I|Withdrawal by Subject|9|||
164323148|NCT01155479|593560730|FG000|Part I|Lost to Follow-up|0|||
164323149|NCT01155479|593560731|FG001|Part I|Lost to Follow-up|0|||
164323150|NCT01155479|593560732|FG002|Part I|Lost to Follow-up|1|||
164323151|NCT01155479|593560733|FG003|Part I|Lost to Follow-up|1|||
164323152|NCT01155479|593560734|FG004|Part I|Lost to Follow-up|0|||
164323153|NCT01155479|593560730|FG000|Part I|Treatment Failure|3|||
164323154|NCT01155479|593560731|FG001|Part I|Treatment Failure|0|||
164323155|NCT01155479|593560732|FG002|Part I|Treatment Failure|3|||
164323156|NCT01155479|593560733|FG003|Part I|Treatment Failure|1|||
164323157|NCT01155479|593560734|FG004|Part I|Treatment Failure|2|||
164323158|NCT01155479|593560730|FG000|Part I|Did Not Receive Treatment|4|||
164323159|NCT01155479|593560731|FG001|Part I|Did Not Receive Treatment|2|||
164323160|NCT01155479|593560732|FG002|Part I|Did Not Receive Treatment|2|||
164323161|NCT01155479|593560733|FG003|Part I|Did Not Receive Treatment|6|||
164323162|NCT01155479|593560734|FG004|Part I|Did Not Receive Treatment|1|||
164323163|NCT01155479|593560730|FG000|Part I|Non-Compliance with Protocol|2|||
164323164|NCT01155479|593560731|FG001|Part I|Non-Compliance with Protocol|1|||
164323165|NCT01155479|593560732|FG002|Part I|Non-Compliance with Protocol|3|||
164323166|NCT01155479|593560733|FG003|Part I|Non-Compliance with Protocol|3|||
164323167|NCT01155479|593560734|FG004|Part I|Non-Compliance with Protocol|2|||
164323168|NCT01155479|593560730|FG000|Part II|Adverse Event|7|||
164323169|NCT01155479|593560731|FG001|Part II|Adverse Event|6|||
164323170|NCT01155479|593560732|FG002|Part II|Adverse Event|8|||
164323171|NCT01155479|593560733|FG003|Part II|Adverse Event|3|||
164323172|NCT01155479|593560734|FG004|Part II|Adverse Event|4|||
164323173|NCT01155479|593560730|FG000|Part II|Administrative|43|||
164323174|NCT01155479|593560731|FG001|Part II|Administrative|49|||
164323175|NCT01155479|593560732|FG002|Part II|Administrative|36|||
164323176|NCT01155479|593560733|FG003|Part II|Administrative|38|||
164323177|NCT01155479|593560734|FG004|Part II|Administrative|46|||
164323178|NCT01155479|593560730|FG000|Part II|Withdrawal by Subject|8|||
164323179|NCT01155479|593560731|FG001|Part II|Withdrawal by Subject|4|||
164323180|NCT01155479|593560732|FG002|Part II|Withdrawal by Subject|12|||
164323181|NCT01155479|593560733|FG003|Part II|Withdrawal by Subject|7|||
164323182|NCT01155479|593560734|FG004|Part II|Withdrawal by Subject|3|||
164323183|NCT01155479|593560730|FG000|Part II|Lost to Follow-up|1|||
164323184|NCT01155479|593560731|FG001|Part II|Lost to Follow-up|0|||
164323185|NCT01155479|593560732|FG002|Part II|Lost to Follow-up|0|||
164323186|NCT01155479|593560733|FG003|Part II|Lost to Follow-up|0|||
164323187|NCT01155479|593560734|FG004|Part II|Lost to Follow-up|1|||
164323188|NCT01155479|593560730|FG000|Part II|Treatment Failure|0|||
164323189|NCT01155479|593560731|FG001|Part II|Treatment Failure|1|||
164323190|NCT01155479|593560732|FG002|Part II|Treatment Failure|2|||
164323191|NCT01155479|593560733|FG003|Part II|Treatment Failure|0|||
164323192|NCT01155479|593560734|FG004|Part II|Treatment Failure|1|||
164323193|NCT01155479|593560730|FG000|Part II|Non-Compliance with Protocol|0|||
164323194|NCT01155479|593560731|FG001|Part II|Non-Compliance with Protocol|1|||
164323195|NCT01155479|593560732|FG002|Part II|Non-Compliance with Protocol|0|||
164323196|NCT01155479|593560733|FG003|Part II|Non-Compliance with Protocol|2|||
164323197|NCT01155479|593560734|FG004|Part II|Non-Compliance with Protocol|0|||
164323198|NCT01933789|593560737|FG000|Overall Study|Death|0|||
164323199|NCT01933789|593560738|FG001|Overall Study|Death|0|||
164323200|NCT01933789|593560739|FG002|Overall Study|Death|0|||
164323201|NCT01933789|593560740|FG003|Overall Study|Death|0|||
164323202|NCT01933789|593560741|FG004|Overall Study|Death|21|||
164323203|NCT01933789|593560742|FG005|Overall Study|Death|32|||
164323204|NCT01933789|593560743|FG006|Overall Study|Death|0|||
164323205|NCT01933789|593560744|FG007|Overall Study|Death|0|||
164323206|NCT01933789|593560745|FG008|Overall Study|Death|0|||
164323207|NCT01933789|593560737|FG000|Overall Study|Lost to Follow-up|0|||
164323208|NCT01933789|593560738|FG001|Overall Study|Lost to Follow-up|0|||
164323209|NCT01933789|593560739|FG002|Overall Study|Lost to Follow-up|0|||
164323210|NCT01933789|593560740|FG003|Overall Study|Lost to Follow-up|1|||
164323211|NCT01933789|593560741|FG004|Overall Study|Lost to Follow-up|8|||
164323212|NCT01933789|593560742|FG005|Overall Study|Lost to Follow-up|9|||
164323213|NCT01933789|593560743|FG006|Overall Study|Lost to Follow-up|1|||
164323214|NCT01933789|593560744|FG007|Overall Study|Lost to Follow-up|4|||
164323215|NCT01933789|593560745|FG008|Overall Study|Lost to Follow-up|0|||
164323216|NCT01933789|593560737|FG000|Overall Study|Withdrawal by Subject|2|||
164323217|NCT01933789|593560738|FG001|Overall Study|Withdrawal by Subject|1|||
164323218|NCT01933789|593560739|FG002|Overall Study|Withdrawal by Subject|0|||
164323219|NCT01933789|593560740|FG003|Overall Study|Withdrawal by Subject|0|||
164323220|NCT01933789|593560741|FG004|Overall Study|Withdrawal by Subject|17|||
164323221|NCT01933789|593560742|FG005|Overall Study|Withdrawal by Subject|16|||
164323222|NCT01933789|593560743|FG006|Overall Study|Withdrawal by Subject|1|||
164323223|NCT01933789|593560744|FG007|Overall Study|Withdrawal by Subject|4|||
164323224|NCT01933789|593560745|FG008|Overall Study|Withdrawal by Subject|0|||
164323225|NCT01933789|593560737|FG000|Overall Study|Became Ineligible|4|||
164323226|NCT01933789|593560738|FG001|Overall Study|Became Ineligible|0|||
164563919|NCT02026063|594432413|FG001|Overall Study|Reason not Specified|7|||
164563920|NCT03687502|594432414|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
164563921|NCT03687502|594432414|FG000|Overall Study|Lumason not available|1|||
164323227|NCT01933789|593560739|FG002|Overall Study|Became Ineligible|0|||
164323228|NCT01933789|593560740|FG003|Overall Study|Became Ineligible|0|||
164323229|NCT01933789|593560741|FG004|Overall Study|Became Ineligible|13|||
164323230|NCT01933789|593560742|FG005|Overall Study|Became Ineligible|10|||
164323231|NCT01933789|593560743|FG006|Overall Study|Became Ineligible|13|||
164323232|NCT01933789|593560744|FG007|Overall Study|Became Ineligible|6|||
164323233|NCT01933789|593560745|FG008|Overall Study|Became Ineligible|0|||
164323234|NCT01966432|593560749|FG000|Overall Study|Lost to Follow-up|3|||
164323235|NCT01966432|593560750|FG001|Overall Study|Lost to Follow-up|2|||
164323236|NCT01966432|593560751|FG002|Overall Study|Lost to Follow-up|5|||
164323237|NCT01966432|593560749|FG000|Overall Study|Withdrawal by Subject|1|||
164323238|NCT01966432|593560750|FG001|Overall Study|Withdrawal by Subject|3|||
164323239|NCT01966432|593560751|FG002|Overall Study|Withdrawal by Subject|0|||
164323240|NCT01966432|593560749|FG000|Overall Study|Subject Incarcerated|0|||
164323241|NCT01966432|593560750|FG001|Overall Study|Subject Incarcerated|0|||
164323242|NCT01966432|593560751|FG002|Overall Study|Subject Incarcerated|1|||
164323243|NCT01966432|593560749|FG000|Overall Study|SBIRT program ended|1|||
164323244|NCT01966432|593560750|FG001|Overall Study|SBIRT program ended|8|||
164323245|NCT01966432|593560751|FG002|Overall Study|SBIRT program ended|20|||
164323246|NCT03562767|593560754|FG000|Overall Study|Physician Decision|2|||
164323247|NCT03562767|593560755|FG001|Overall Study|Physician Decision|0|||
164323248|NCT03562767|593560756|FG002|Overall Study|Physician Decision|0|||
164323249|NCT03562767|593560754|FG000|Overall Study|Logistic Reason|1|||
164323250|NCT03562767|593560755|FG001|Overall Study|Logistic Reason|3|||
164323251|NCT03562767|593560756|FG002|Overall Study|Logistic Reason|0|||
164323252|NCT02518464|593560759|FG000|Overall Study|Adverse Event|2|||
164323253|NCT01120067|593560760|FG000|Overall Study|Lost to Follow-up|3|||
164323254|NCT01120067|593560761|FG001|Overall Study|Lost to Follow-up|1|||
164323255|NCT01120067|593560760|FG000|Overall Study|fail to engage >3 sessions|2|||
164323256|NCT01120067|593560761|FG001|Overall Study|fail to engage >3 sessions|0|||
164323257|NCT03761797|593560762|FG000|Overall Study|Changing hospital|11|||
164323258|NCT03761797|593560762|FG000|Overall Study|Improvement/remission|6|||
164323259|NCT03761797|593560762|FG000|Overall Study|Withdrawal by Subject|19|||
164323260|NCT03761797|593560762|FG000|Overall Study|Lost to Follow-up|33|||
164323261|NCT03761797|593560762|FG000|Overall Study|Adverse Event|37|||
164323262|NCT03761797|593560762|FG000|Overall Study|Case report form (CRF) not collected|5|||
164323263|NCT03761797|593560762|FG000|Overall Study|No patient visit after entry|13|||
164323264|NCT03761797|593560762|FG000|Overall Study|Switch to other diabetes medication|10|||
164323265|NCT03761797|593560762|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
164323266|NCT03761797|593560762|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
164323267|NCT03761797|593560762|FG000|Overall Study|Insufficient effectives|2|||
164323268|NCT03761797|593560762|FG000|Overall Study|Excessive alcohol intake|1|||
164323269|NCT00266877|593560763|FG000|Overall Study|Death|1|||
164323270|NCT00266877|593560764|FG001|Overall Study|Death|1|||
164323271|NCT00266877|593560765|FG002|Overall Study|Death|1|||
164323272|NCT00266877|593560763|FG000|Overall Study|Adverse Event|6|||
164323273|NCT00266877|593560764|FG001|Overall Study|Adverse Event|4|||
164323274|NCT00266877|593560765|FG002|Overall Study|Adverse Event|1|||
164323275|NCT00266877|593560763|FG000|Overall Study|Physician Decision|2|||
164323276|NCT00266877|593560764|FG001|Overall Study|Physician Decision|1|||
164323277|NCT00266877|593560765|FG002|Overall Study|Physician Decision|1|||
164323278|NCT00266877|593560763|FG000|Overall Study|Withdrawal by Subject|3|||
164323279|NCT00266877|593560764|FG001|Overall Study|Withdrawal by Subject|1|||
164323280|NCT00266877|593560765|FG002|Overall Study|Withdrawal by Subject|1|||
164323281|NCT00266877|593560763|FG000|Overall Study|Disease Progression|72|||
164323282|NCT00266877|593560764|FG001|Overall Study|Disease Progression|37|||
164323283|NCT00266877|593560765|FG002|Overall Study|Disease Progression|23|||
164323284|NCT00266877|593560763|FG000|Overall Study|Symptomatic Deterioration|6|||
164323285|NCT00266877|593560764|FG001|Overall Study|Symptomatic Deterioration|3|||
164323286|NCT00266877|593560765|FG002|Overall Study|Symptomatic Deterioration|1|||
164323287|NCT00266877|593560763|FG000|Overall Study|Hospitalization|1|||
164323288|NCT00266877|593560764|FG001|Overall Study|Hospitalization|0|||
164323289|NCT00266877|593560765|FG002|Overall Study|Hospitalization|0|||
164323290|NCT00266877|593560763|FG000|Overall Study|Concomitant Radiotherapy|0|||
164323291|NCT00266877|593560764|FG001|Overall Study|Concomitant Radiotherapy|1|||
164323292|NCT00266877|593560765|FG002|Overall Study|Concomitant Radiotherapy|0|||
164323293|NCT00527488|593560769|FG000|Overall Study|Withdrawn prior to dosing|0|||
164323294|NCT00527488|593560770|FG001|Overall Study|Withdrawn prior to dosing|1|||
164323295|NCT00527488|593560771|FG002|Overall Study|Withdrawn prior to dosing|1|||
164323296|NCT00527488|593560772|FG003|Overall Study|Withdrawn prior to dosing|0|||
164323297|NCT03036800|593560773|FG000|Overall Study|Protocol Violation|1|||
164323298|NCT03036800|593560774|FG001|Overall Study|Protocol Violation|0|||
164323299|NCT03036800|593560773|FG000|Overall Study|Non-compliance|1|||
164323300|NCT03036800|593560774|FG001|Overall Study|Non-compliance|0|||
164323301|NCT03036800|593560773|FG000|Overall Study|Lost to Follow-up|1|||
164323302|NCT03036800|593560774|FG001|Overall Study|Lost to Follow-up|0|||
164323303|NCT03036800|593560773|FG000|Overall Study|Death|1|||
164323304|NCT03036800|593560774|FG001|Overall Study|Death|0|||
164323305|NCT03036800|593560773|FG000|Overall Study|Tolerance|5|||
164323306|NCT03036800|593560774|FG001|Overall Study|Tolerance|0|||
164323307|NCT03036800|593560773|FG000|Overall Study|Unknown/no reason given|50|||
164323308|NCT03036800|593560774|FG001|Overall Study|Unknown/no reason given|39|||
164323309|NCT04030026|593560775|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
164323310|NCT04030026|593560776|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
164323311|NCT04030026|593560775|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
164323312|NCT04030026|593560776|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
164323313|NCT04030026|593560775|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
164323314|NCT04030026|593560776|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
164323315|NCT04030026|593560775|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
164323316|NCT04030026|593560776|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
164323317|NCT04030026|593560775|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
164323318|NCT04030026|593560776|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
164323319|NCT04030026|593560775|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
164323320|NCT04030026|593560776|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
164323321|NCT04030026|593560775|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
164323322|NCT04030026|593560776|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
164323323|NCT02545543|593560777|FG000|Overall Study|Lost to Follow-up|67|||
164323324|NCT02545543|593560778|FG001|Overall Study|Lost to Follow-up|25|||
164323325|NCT02545543|593560777|FG000|Overall Study|Physician Decision|3|||
164323326|NCT02545543|593560778|FG001|Overall Study|Physician Decision|0|||
164323327|NCT02545543|593560777|FG000|Overall Study|Withdrawal by Subject|9|||
164323328|NCT02545543|593560778|FG001|Overall Study|Withdrawal by Subject|8|||
164323329|NCT02545543|593560777|FG000|Overall Study|Noncomplaince|1|||
164323330|NCT02545543|593560778|FG001|Overall Study|Noncomplaince|0|||
164323331|NCT02545543|593560777|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
164323332|NCT02545543|593560778|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
164323333|NCT00811642|593560783|FG000|Overall Study|Adverse Event|3|||
164323334|NCT00811642|593560783|FG000|Overall Study|Protocol Violation|1|||
164323335|NCT00811642|593560783|FG000|Overall Study|Death|2|||
164323336|NCT00811642|593560783|FG000|Overall Study|Withdrawal by Subject|7|||
164323337|NCT00811642|593560783|FG000|Overall Study|Cumulative use of antifungal agent|2|||
164323338|NCT01395784|593560792|FG000|Overall Study|Lost to Follow-up|7|||
164323339|NCT01395784|593560792|FG000|Overall Study|Withdrawal by Subject|3|||
164323340|NCT01395784|593560792|FG000|Overall Study|Physician Decision|5|||
164323341|NCT05772702|593560793|FG000|Overall Study|Adverse Event|1|||
164323342|NCT04268823|593560794|FG000|Overall Study|Adverse Event|1|||
164323343|NCT04268823|593560795|FG001|Overall Study|Adverse Event|0|||
164323344|NCT04268823|593560794|FG000|Overall Study|Participant Decision|1|||
164323345|NCT04268823|593560795|FG001|Overall Study|Participant Decision|0|||
164323346|NCT00562627|593562012|FG000|Overall Study|Protocol Violation|1|||
164323347|NCT00562627|593562013|FG001|Overall Study|Protocol Violation|1|||
164323348|NCT00562627|593562014|FG002|Overall Study|Protocol Violation|1|||
164323349|NCT01107418|593562015|FG000|Overall Study|Disease Progression|45|||
164323350|NCT01107418|593562015|FG000|Overall Study|Adverse Event|3|||
164323351|NCT01107418|593562015|FG000|Overall Study|Withdrawal by Subject|1|||
164323352|NCT01107418|593562015|FG000|Overall Study|Study Closing|1|||
164323353|NCT01107418|593562015|FG000|Overall Study|Started Other Therapy|1|||
164323354|NCT01107418|593562015|FG000|Overall Study|Entered Extension Study|1|||
164323355|NCT05710185|593562016|FG000|Overall Study|Adverse Event|1|||
164323356|NCT05710185|593562016|FG000|Overall Study|Lack of Efficacy|1|||
164323357|NCT02316548|593562017|FG000|Overall Study|Protocol Violation|0|||
164323358|NCT02316548|593562018|FG001|Overall Study|Protocol Violation|1|||
164323359|NCT03269552|593562019|FG000|Overall Study|Adverse Event|2|||
164323360|NCT01343823|593562020|FG000|Overall Study|Study Terminated|1|||
164323361|NCT01343823|593562021|FG001|Overall Study|Study Terminated|0|||
164323362|NCT01343823|593562022|FG002|Overall Study|Study Terminated|0|||
164323363|NCT01343823|593562023|FG003|Overall Study|Study Terminated|1|||
164323364|NCT01343823|593562020|FG000|Overall Study|Withdrawal by Subject|1|||
164323365|NCT01343823|593562021|FG001|Overall Study|Withdrawal by Subject|0|||
164323366|NCT01343823|593562022|FG002|Overall Study|Withdrawal by Subject|0|||
164323367|NCT01343823|593562023|FG003|Overall Study|Withdrawal by Subject|0|||
164323368|NCT03468543|593562028|FG000|Overall Study|Protocol stopping rules met|3|||
164323369|NCT04972630|593562029|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
164323370|NCT04972630|593562030|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
164323371|NCT04972630|593562031|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
164323372|NCT04214288|593562034|FG000|Overall Study|Ongoing in the study|41|||
164323373|NCT04214288|593562035|FG001|Overall Study|Ongoing in the study|51|||
164323374|NCT04214288|593562036|FG002|Overall Study|Ongoing in the study|12|||
164323375|NCT04214288|593562037|FG003|Overall Study|Ongoing in the study|39|||
164323376|NCT04214288|593562034|FG000|Overall Study|Adverse Event|1|||
164323377|NCT04214288|593562035|FG001|Overall Study|Adverse Event|0|||
164323378|NCT04214288|593562036|FG002|Overall Study|Adverse Event|0|||
164323379|NCT04214288|593562037|FG003|Overall Study|Adverse Event|0|||
164323380|NCT04214288|593562034|FG000|Overall Study|Death|22|||
164323381|NCT04214288|593562035|FG001|Overall Study|Death|13|||
164323382|NCT04214288|593562036|FG002|Overall Study|Death|7|||
164323383|NCT04214288|593562037|FG003|Overall Study|Death|19|||
164323384|NCT04214288|593562034|FG000|Overall Study|Lost to Follow-up|1|||
164323385|NCT04214288|593562035|FG001|Overall Study|Lost to Follow-up|2|||
164323386|NCT04214288|593562036|FG002|Overall Study|Lost to Follow-up|1|||
164323387|NCT04214288|593562037|FG003|Overall Study|Lost to Follow-up|0|||
164323388|NCT04214288|593562034|FG000|Overall Study|Other|1|||
164323389|NCT04214288|593562035|FG001|Overall Study|Other|2|||
164323390|NCT04214288|593562036|FG002|Overall Study|Other|0|||
164323391|NCT04214288|593562037|FG003|Overall Study|Other|6|||
164323392|NCT04214288|593562034|FG000|Overall Study|Protocol Violation|0|||
164323393|NCT04214288|593562035|FG001|Overall Study|Protocol Violation|1|||
164323394|NCT04214288|593562036|FG002|Overall Study|Protocol Violation|0|||
164323395|NCT04214288|593562037|FG003|Overall Study|Protocol Violation|0|||
164323396|NCT04214288|593562034|FG000|Overall Study|Withdrawal by Subject|8|||
164323397|NCT04214288|593562035|FG001|Overall Study|Withdrawal by Subject|4|||
164323398|NCT04214288|593562036|FG002|Overall Study|Withdrawal by Subject|0|||
164323399|NCT04214288|593562037|FG003|Overall Study|Withdrawal by Subject|9|||
164323400|NCT02455557|593562039|FG000|Overall Study|Withdrawal by Subject|2|||
164323401|NCT02278341|593562040|FG000|Overall Study|Randomized but never received study drug|1|||
164323402|NCT02278341|593562041|FG001|Overall Study|Randomized but never received study drug|1|||
164323403|NCT02278341|593562040|FG000|Overall Study|Adverse Event|3|||
164323404|NCT02278341|593562041|FG001|Overall Study|Adverse Event|0|||
164323405|NCT02278341|593562040|FG000|Overall Study|Death|68|||
164323406|NCT02278341|593562041|FG001|Overall Study|Death|56|||
164323407|NCT02278341|593562040|FG000|Overall Study|Withdrawal by Subject|30|||
164208423|NCT03573297|593131690|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
164208424|NCT03573297|593131691|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
164208425|NCT03573297|593131692|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
164208426|NCT03573297|593131693|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
164208427|NCT03573297|593131690|FG000|Open Label Treatment Period|Pregnancy|1|||
164563922|NCT01777581|594432420|FG000|Overall Study|Lost to Follow-up|1|||
164208428|NCT03573297|593131691|FG001|Open Label Treatment Period|Pregnancy|0|||
164208429|NCT03573297|593131692|FG002|Open Label Treatment Period|Pregnancy|0|||
164208430|NCT03573297|593131693|FG003|Open Label Treatment Period|Pregnancy|0|||
164208431|NCT03573297|593131690|FG000|Open Label Treatment Period|Protocol Violation|17|||
164208432|NCT03573297|593131691|FG001|Open Label Treatment Period|Protocol Violation|0|||
164208433|NCT03573297|593131692|FG002|Open Label Treatment Period|Protocol Violation|0|||
164208434|NCT03573297|593131693|FG003|Open Label Treatment Period|Protocol Violation|0|||
164208435|NCT03573297|593131690|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
164208436|NCT03573297|593131691|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
164208437|NCT03573297|593131692|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
164208438|NCT03573297|593131693|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
164208439|NCT03573297|593131690|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
164208440|NCT03573297|593131691|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
164208441|NCT03573297|593131692|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
164208442|NCT03573297|593131693|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
164208443|NCT03573297|593131690|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
164208444|NCT03573297|593131691|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
164208445|NCT03573297|593131692|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
164208446|NCT03573297|593131693|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
164208447|NCT03573297|593131690|FG000|Open Label Treatment Period|Other, Not Specified|7|||
164208448|NCT03573297|593131691|FG001|Open Label Treatment Period|Other, Not Specified|0|||
164208449|NCT03573297|593131692|FG002|Open Label Treatment Period|Other, Not Specified|0|||
164208450|NCT03573297|593131693|FG003|Open Label Treatment Period|Other, Not Specified|0|||
164208451|NCT03573297|593131690|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
164208452|NCT03573297|593131691|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
164208453|NCT03573297|593131692|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
164208454|NCT03573297|593131693|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
164208455|NCT03573297|593131690|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164208456|NCT03573297|593131691|FG001|Double-Blind Treatment Period|Adverse Event|1|||
164208457|NCT03573297|593131692|FG002|Double-Blind Treatment Period|Adverse Event|5|||
164208458|NCT03573297|593131693|FG003|Double-Blind Treatment Period|Adverse Event|1|||
164208459|NCT03573297|593131690|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
164208460|NCT03573297|593131691|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
164208461|NCT03573297|593131692|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
164208462|NCT03573297|593131693|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
164208463|NCT03573297|593131690|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164208464|NCT03573297|593131691|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
164208465|NCT03573297|593131692|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
164208466|NCT03573297|593131693|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
164208467|NCT03573297|593131690|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
164208468|NCT03573297|593131691|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
164208469|NCT03573297|593131692|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
164208470|NCT03573297|593131693|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
164208471|NCT03573297|593131690|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
164208472|NCT03573297|593131691|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
164208473|NCT03573297|593131692|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
164208474|NCT03573297|593131693|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
164208475|NCT03573297|593131690|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
164208476|NCT03573297|593131691|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
164208477|NCT03573297|593131692|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
164208478|NCT03573297|593131693|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
164208479|NCT03573297|593131690|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
164208480|NCT03573297|593131691|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
164208481|NCT03573297|593131692|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
164208482|NCT03573297|593131693|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
164208483|NCT02696798|593131696|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
164208484|NCT02696798|593131697|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
164208485|NCT02696798|593131698|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
164208486|NCT02696798|593131696|FG000|Blinded Treatment Dosing Period|Death|0|||
164563923|NCT01777581|594432421|FG001|Overall Study|Lost to Follow-up|1|||
164563924|NCT01777581|594432420|FG000|Overall Study|Adverse Event|2|||
164323408|NCT02278341|593562041|FG001|Overall Study|Withdrawal by Subject|19|||
164323409|NCT02278341|593562040|FG000|Overall Study|Lost to Follow-up|0|||
164323410|NCT02278341|593562041|FG001|Overall Study|Lost to Follow-up|1|||
164323411|NCT02278341|593562040|FG000|Overall Study|Physician Decision|1|||
164323412|NCT02278341|593562041|FG001|Overall Study|Physician Decision|1|||
164323413|NCT02278341|593562040|FG000|Overall Study|Miscellaneous|15|||
164323414|NCT02278341|593562041|FG001|Overall Study|Miscellaneous|14|||
164323415|NCT01129024|593562042|FG000|Overall Study|Physician Decision|5|||
164323416|NCT01129024|593562042|FG000|Overall Study|Study Terminated by Sponsor|8|||
164323417|NCT01129024|593562042|FG000|Overall Study|Withdrawal by Subject|2|||
164323418|NCT01129024|593562042|FG000|Overall Study|Lack of Efficacy|3|||
164323419|NCT01129024|593562042|FG000|Overall Study|Needed a Platelet Transfusion|1|||
164323420|NCT02361580|593562044|FG000|Overall Study|Lost to Follow-up|6|||
164323421|NCT02361580|593562045|FG001|Overall Study|Lost to Follow-up|3|||
164323422|NCT02047318|593562046|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
164323423|NCT02047318|593562046|FG000|Core Study Period|Adverse Event|1|||
164323424|NCT02047318|593562046|FG000|Core Study Period|Withdrawal by caregiver|3|||
164323425|NCT02047318|593562046|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
164323426|NCT01487577|593562047|FG000|Overall Study|Became ineligible after signing consent|1|||
164323427|NCT01479985|593562048|FG000|Overall Study|Tablet malfunction, no data saved|1|||
164323428|NCT01479985|593562049|FG001|Overall Study|Tablet malfunction, no data saved|1|||
164323429|NCT01479985|593562048|FG000|Overall Study|No decisional conflict scale responses|0|||
164323430|NCT01479985|593562049|FG001|Overall Study|No decisional conflict scale responses|2|||
164323431|NCT01479985|593562048|FG000|Overall Study|No post-visit survey|5|||
164323432|NCT01479985|593562049|FG001|Overall Study|No post-visit survey|3|||
164323433|NCT00708201|593562050|FG000|Overall Study|Adverse Event|4|||
164323434|NCT00708201|593562051|FG001|Overall Study|Adverse Event|4|||
164323435|NCT00708201|593562050|FG000|Overall Study|Withdrawal by Subject|1|||
164323436|NCT00708201|593562051|FG001|Overall Study|Withdrawal by Subject|1|||
164323437|NCT00708201|593562050|FG000|Overall Study|Lost to Follow-up|2|||
164323438|NCT00708201|593562051|FG001|Overall Study|Lost to Follow-up|0|||
164323439|NCT00708201|593562050|FG000|Overall Study|Protocol Violation|0|||
164323440|NCT00708201|593562051|FG001|Overall Study|Protocol Violation|1|||
164323441|NCT00761748|593562052|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
164323442|NCT00761748|593562053|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
164323443|NCT00761748|593562052|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
164323444|NCT00761748|593562053|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
164323445|NCT02554279|593562054|FG000|Overall Study|Adverse Event|2|||
164323446|NCT02554279|593562055|FG001|Overall Study|Adverse Event|5|||
164323447|NCT02554279|593562054|FG000|Overall Study|Lost to Follow-up|3|||
164323448|NCT02554279|593562055|FG001|Overall Study|Lost to Follow-up|2|||
164323449|NCT02554279|593562054|FG000|Overall Study|Withdrawal by Subject|6|||
164323450|NCT02554279|593562055|FG001|Overall Study|Withdrawal by Subject|4|||
164323451|NCT02554279|593562054|FG000|Overall Study|Protocol Violation|2|||
164323452|NCT02554279|593562055|FG001|Overall Study|Protocol Violation|1|||
164323453|NCT02554279|593562054|FG000|Overall Study|Other reason|19|||
164323454|NCT02554279|593562055|FG001|Overall Study|Other reason|6|||
164323455|NCT00812487|593562056|FG000|Overall Study|Lost to Follow-up|2|||
164323456|NCT00812487|593562057|FG001|Overall Study|Lost to Follow-up|0|||
164323457|NCT00812487|593562056|FG000|Overall Study|Withdrawal by Subject|3|||
164323458|NCT00812487|593562057|FG001|Overall Study|Withdrawal by Subject|2|||
164323459|NCT00812487|593562056|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
164323460|NCT00812487|593562057|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
164323461|NCT00812487|593562056|FG000|Overall Study|Protocol Violation|0|||
164323462|NCT00812487|593562057|FG001|Overall Study|Protocol Violation|1|||
164323463|NCT00998764|593562058|FG000|Overall Study|Lack of Efficacy|3|||
164323464|NCT00998764|593562059|FG001|Overall Study|Lack of Efficacy|6|||
164323465|NCT00998764|593562058|FG000|Overall Study|Adverse Event|17|||
164323466|NCT00998764|593562059|FG001|Overall Study|Adverse Event|12|||
164323467|NCT00998764|593562058|FG000|Overall Study|Withdrawal by Subject|19|||
164323468|NCT00998764|593562059|FG001|Overall Study|Withdrawal by Subject|25|||
164323469|NCT00998764|593562058|FG000|Overall Study|Physician Decision|3|||
164323470|NCT00998764|593562059|FG001|Overall Study|Physician Decision|3|||
164323471|NCT00998764|593562058|FG000|Overall Study|Death|3|||
164323472|NCT00998764|593562059|FG001|Overall Study|Death|1|||
164323473|NCT00998764|593562058|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
164323474|NCT00998764|593562059|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
164323475|NCT00998764|593562058|FG000|Overall Study|Protocol Violation|0|||
164323476|NCT00998764|593562059|FG001|Overall Study|Protocol Violation|1|||
164323477|NCT00998764|593562058|FG000|Overall Study|Failed to Return|1|||
164323478|NCT00998764|593562059|FG001|Overall Study|Failed to Return|1|||
164323479|NCT00998764|593562058|FG000|Overall Study|Lost to Follow-up|1|||
164323480|NCT00998764|593562059|FG001|Overall Study|Lost to Follow-up|1|||
164323481|NCT00998764|593562058|FG000|Overall Study|Loss of Caregiver|0|||
164323482|NCT00998764|593562059|FG001|Overall Study|Loss of Caregiver|3|||
164323483|NCT00998764|593562058|FG000|Overall Study|Other|4|||
164323484|NCT00998764|593562059|FG001|Overall Study|Other|4|||
164323485|NCT00998764|593562058|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
164323486|NCT00998764|593562059|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
164323487|NCT04761627|593562062|FG000|Run-in Period|Death|1|||
164323488|NCT04761627|593562063|FG001|Run-in Period|Death|0|||
164323489|NCT04761627|593562064|FG002|Run-in Period|Death|0|||
164323490|NCT04761627|593562062|FG000|Run-in Period|Required alternative therapy|2|||
164323491|NCT04761627|593562063|FG001|Run-in Period|Required alternative therapy|0|||
164323492|NCT04761627|593562064|FG002|Run-in Period|Required alternative therapy|0|||
164323493|NCT04761627|593562062|FG000|Run-in Period|Lost to Follow-up|2|||
164323494|NCT04761627|593562063|FG001|Run-in Period|Lost to Follow-up|0|||
164323495|NCT04761627|593562064|FG002|Run-in Period|Lost to Follow-up|0|||
164323496|NCT04761627|593562062|FG000|Run-in Period|Protocol Violation|3|||
164323497|NCT04761627|593562063|FG001|Run-in Period|Protocol Violation|0|||
164323498|NCT04761627|593562064|FG002|Run-in Period|Protocol Violation|0|||
164323499|NCT04761627|593562062|FG000|Run-in Period|Abnormal liver function|1|||
164323500|NCT04761627|593562063|FG001|Run-in Period|Abnormal liver function|0|||
164323501|NCT04761627|593562064|FG002|Run-in Period|Abnormal liver function|0|||
164323502|NCT04761627|593562062|FG000|Run-in Period|Adverse Event|6|||
164323503|NCT04761627|593562063|FG001|Run-in Period|Adverse Event|0|||
164323504|NCT04761627|593562064|FG002|Run-in Period|Adverse Event|0|||
164323505|NCT04761627|593562062|FG000|Run-in Period|Withdrawal by Subject|7|||
164323506|NCT04761627|593562063|FG001|Run-in Period|Withdrawal by Subject|0|||
164323507|NCT04761627|593562064|FG002|Run-in Period|Withdrawal by Subject|0|||
164323508|NCT04761627|593562062|FG000|Run-in Period|Did not meet PASI 50|15|||
164323509|NCT04761627|593562063|FG001|Run-in Period|Did not meet PASI 50|0|||
164323510|NCT04761627|593562064|FG002|Run-in Period|Did not meet PASI 50|0|||
164323511|NCT04761627|593562062|FG000|Run-in Period|Study site closure|2|||
164323512|NCT04761627|593562063|FG001|Run-in Period|Study site closure|0|||
164323513|NCT04761627|593562064|FG002|Run-in Period|Study site closure|0|||
164323514|NCT04761627|593562062|FG000|Run-in Period|Pregnancy|2|||
164323515|NCT04761627|593562063|FG001|Run-in Period|Pregnancy|0|||
164323516|NCT04761627|593562064|FG002|Run-in Period|Pregnancy|0|||
164323517|NCT04761627|593562062|FG000|Post-randomization Period|Military service|0|||
164323518|NCT04761627|593562063|FG001|Post-randomization Period|Military service|1|||
164323519|NCT04761627|593562064|FG002|Post-randomization Period|Military service|0|||
164323520|NCT04761627|593562062|FG000|Post-randomization Period|Adverse Event|0|||
164323521|NCT04761627|593562063|FG001|Post-randomization Period|Adverse Event|4|||
164323522|NCT04761627|593562064|FG002|Post-randomization Period|Adverse Event|2|||
164323523|NCT04761627|593562062|FG000|Post-randomization Period|Lost to Follow-up|0|||
164323524|NCT04761627|593562063|FG001|Post-randomization Period|Lost to Follow-up|6|||
164323525|NCT04761627|593562064|FG002|Post-randomization Period|Lost to Follow-up|6|||
164323526|NCT04761627|593562062|FG000|Post-randomization Period|Withdrawal by Subject|0|||
164323527|NCT04761627|593562063|FG001|Post-randomization Period|Withdrawal by Subject|7|||
164323528|NCT04761627|593562064|FG002|Post-randomization Period|Withdrawal by Subject|6|||
164323529|NCT04761627|593562062|FG000|Post-randomization Period|Pregnancy|0|||
164323530|NCT04761627|593562063|FG001|Post-randomization Period|Pregnancy|0|||
164323531|NCT04761627|593562064|FG002|Post-randomization Period|Pregnancy|1|||
164323532|NCT04761627|593562062|FG000|Post-randomization Period|Study site closure|0|||
164323533|NCT04761627|593562063|FG001|Post-randomization Period|Study site closure|0|||
164323534|NCT04761627|593562064|FG002|Post-randomization Period|Study site closure|1|||
164323535|NCT04761627|593562062|FG000|Post-randomization Period|Family planning|0|||
164323536|NCT04761627|593562063|FG001|Post-randomization Period|Family planning|1|||
164323537|NCT04761627|593562064|FG002|Post-randomization Period|Family planning|0|||
164323538|NCT01634178|593562065|FG000|Treatment Period 1|Adverse Event|0|||
164323539|NCT01634178|593562066|FG001|Treatment Period 1|Adverse Event|1|||
164323540|NCT01634178|593562065|FG000|Treatment Period 2|Adverse Event|1|||
164323541|NCT01634178|593562066|FG001|Treatment Period 2|Adverse Event|0|||
164323542|NCT01117792|593562067|FG000|Overall Study|Death|1|||
164668393|NCT00549718|594811894|FG000|Overall Study|Insufficient clinical response|20|||
164323543|NCT01117792|593562067|FG000|Overall Study|Adverse Event|3|||
164323544|NCT05867342|593562068|FG000|Overall Study|Investigator Decision|3|||
164323545|NCT05867342|593562069|FG001|Overall Study|Investigator Decision|3|||
164323546|NCT00723203|593562070|FG000|Overall Study|Withdrawal by Subject|3|||
164323547|NCT01150474|593562075|FG000|Overall Study|Withdrawal by Subject|5|||
164323548|NCT01150474|593562076|FG001|Overall Study|Withdrawal by Subject|2|||
164323549|NCT01150474|593562075|FG000|Overall Study|Cancer found|1|||
164323550|NCT01150474|593562076|FG001|Overall Study|Cancer found|0|||
164668394|NCT00549718|594811895|FG001|Overall Study|Insufficient clinical response|7|||
164668395|NCT00549718|594811896|FG002|Overall Study|Insufficient clinical response|18|||
164323551|NCT01150474|593562075|FG000|Overall Study|Multiple Studies|0|||
164323552|NCT01150474|593562076|FG001|Overall Study|Multiple Studies|1|||
164323553|NCT01150474|593562075|FG000|Overall Study|Rectotomy|1|||
164668396|NCT00549718|594811897|FG003|Overall Study|Insufficient clinical response|32|||
164323554|NCT01150474|593562076|FG001|Overall Study|Rectotomy|0|||
164668397|NCT00549718|594811894|FG000|Overall Study|Adverse Event|6|||
164323555|NCT01150474|593562075|FG000|Overall Study|Drug did not arrive in time|1|||
164323556|NCT01150474|593562076|FG001|Overall Study|Drug did not arrive in time|0|||
164323557|NCT01150474|593562075|FG000|Overall Study|Drug not administered|1|||
164323558|NCT01150474|593562076|FG001|Overall Study|Drug not administered|0|||
164323559|NCT01150474|593562075|FG000|Overall Study|Surgery Changed|1|||
164323560|NCT01150474|593562076|FG001|Overall Study|Surgery Changed|0|||
164323561|NCT04231981|593562077|FG000|Overall Study|Adverse Event|1|||
164323562|NCT04231981|593562077|FG000|Overall Study|Death|16|||
164323563|NCT04231981|593562077|FG000|Overall Study|Lost to Follow-up|1|||
164323564|NCT02581943|593562078|FG000|Overall Study|Death|5|||
164323565|NCT02581943|593562079|FG001|Overall Study|Death|2|||
164323566|NCT02581943|593562078|FG000|Overall Study|Disease Progression|12|||
164323567|NCT02581943|593562079|FG001|Overall Study|Disease Progression|15|||
164323568|NCT02581943|593562078|FG000|Overall Study|Withdrawal by Subject|1|||
164323569|NCT02581943|593562079|FG001|Overall Study|Withdrawal by Subject|2|||
164323570|NCT01470989|593562080|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
164563925|NCT01777581|594432421|FG001|Overall Study|Adverse Event|0|||
164323571|NCT01470989|593562081|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
164323572|NCT01470989|593562080|FG000|Overall Study|Adverse Event|2|||
164323573|NCT01470989|593562081|FG001|Overall Study|Adverse Event|5|||
164323574|NCT01470989|593562080|FG000|Overall Study|Abnormal laboratory value|1|||
164323575|NCT01470989|593562081|FG001|Overall Study|Abnormal laboratory value|1|||
164323576|NCT01470989|593562080|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164323577|NCT01470989|593562081|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
164323578|NCT01470989|593562080|FG000|Overall Study|Withdrawal by Subject|19|||
164323579|NCT01470989|593562081|FG001|Overall Study|Withdrawal by Subject|17|||
164323580|NCT01470989|593562080|FG000|Overall Study|Lost to Follow-up|18|||
164323581|NCT01470989|593562081|FG001|Overall Study|Lost to Follow-up|13|||
164323582|NCT01470989|593562080|FG000|Overall Study|Administrative problems|2|||
164323583|NCT01470989|593562081|FG001|Overall Study|Administrative problems|4|||
164323584|NCT01470989|593562080|FG000|Overall Study|Death|2|||
164323585|NCT01470989|593562081|FG001|Overall Study|Death|2|||
164323586|NCT01470989|593562080|FG000|Overall Study|Protocol deviation|1|||
164323587|NCT01470989|593562081|FG001|Overall Study|Protocol deviation|2|||
164323588|NCT01233687|593562082|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
164323589|NCT01233687|593562082|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
164323590|NCT01233687|593562082|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
164323591|NCT02197234|593562085|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
164323592|NCT02197234|593562085|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
164323593|NCT02197234|593562085|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
164323594|NCT02197234|593562085|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
164323595|NCT02197234|593562085|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
164323596|NCT02197234|593562085|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
164323597|NCT03783702|593562086|FG000|Overall Study|Lost to Follow-up|6|||
164323598|NCT03783702|593562087|FG001|Overall Study|Lost to Follow-up|8|||
164323599|NCT03783702|593562086|FG000|Overall Study|Protocol Violation|1|||
164323600|NCT03783702|593562087|FG001|Overall Study|Protocol Violation|3|||
164323601|NCT02119676|593562088|FG000|Overall Study|Adverse Event|9|||
164323602|NCT02119676|593562089|FG001|Overall Study|Adverse Event|17|||
164323603|NCT02119676|593562090|FG002|Overall Study|Adverse Event|10|||
164323604|NCT02119676|593562091|FG003|Overall Study|Adverse Event|10|||
164323605|NCT02119676|593562088|FG000|Overall Study|Disease progression|53|||
164323606|NCT02119676|593562089|FG001|Overall Study|Disease progression|55|||
164323607|NCT02119676|593562090|FG002|Overall Study|Disease progression|68|||
164323608|NCT02119676|593562091|FG003|Overall Study|Disease progression|73|||
164323609|NCT02119676|593562088|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
164323610|NCT02119676|593562089|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
164323611|NCT02119676|593562090|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
164323612|NCT02119676|593562091|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
164323613|NCT02119676|593562088|FG000|Overall Study|Physician Decision|4|||
164323614|NCT02119676|593562089|FG001|Overall Study|Physician Decision|2|||
164323615|NCT02119676|593562090|FG002|Overall Study|Physician Decision|3|||
164323616|NCT02119676|593562091|FG003|Overall Study|Physician Decision|2|||
164323617|NCT02119676|593562088|FG000|Overall Study|Death|9|||
164323618|NCT02119676|593562089|FG001|Overall Study|Death|3|||
164323619|NCT02119676|593562090|FG002|Overall Study|Death|2|||
164323620|NCT02119676|593562091|FG003|Overall Study|Death|1|||
164563926|NCT01777581|594432420|FG000|Overall Study|Lack of Efficacy|0|||
164323621|NCT02119676|593562088|FG000|Overall Study|Noncompliance|0|||
164323622|NCT02119676|593562089|FG001|Overall Study|Noncompliance|1|||
164323623|NCT02119676|593562090|FG002|Overall Study|Noncompliance|0|||
164323624|NCT02119676|593562091|FG003|Overall Study|Noncompliance|0|||
164323625|NCT02119676|593562088|FG000|Overall Study|Lost to Follow-up|0|||
164563927|NCT01777581|594432421|FG001|Overall Study|Lack of Efficacy|1|||
164563928|NCT00695565|594432422|FG000|Overall Study|Lost to Follow-up|4|||
164323626|NCT02119676|593562089|FG001|Overall Study|Lost to Follow-up|0|||
164323627|NCT02119676|593562090|FG002|Overall Study|Lost to Follow-up|1|||
164563929|NCT00695565|594432423|FG001|Overall Study|Lost to Follow-up|4|||
164323628|NCT02119676|593562091|FG003|Overall Study|Lost to Follow-up|0|||
164323629|NCT02119676|593562088|FG000|Overall Study|Protocol deviation|0|||
164323630|NCT02119676|593562089|FG001|Overall Study|Protocol deviation|0|||
164323631|NCT02119676|593562090|FG002|Overall Study|Protocol deviation|1|||
164323632|NCT02119676|593562091|FG003|Overall Study|Protocol deviation|0|||
164323633|NCT02119676|593562088|FG000|Overall Study|Other, unspecified|2|||
164323634|NCT02119676|593562089|FG001|Overall Study|Other, unspecified|1|||
164323635|NCT02119676|593562090|FG002|Overall Study|Other, unspecified|3|||
164323636|NCT02119676|593562091|FG003|Overall Study|Other, unspecified|4|||
164323637|NCT02119676|593562088|FG000|Overall Study|Did not receive study med|2|||
164323638|NCT02119676|593562089|FG001|Overall Study|Did not receive study med|2|||
164323639|NCT02119676|593562090|FG002|Overall Study|Did not receive study med|4|||
164323640|NCT02119676|593562091|FG003|Overall Study|Did not receive study med|5|||
164323641|NCT00219544|593562092|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
164323642|NCT00219544|593562093|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
164323643|NCT00219544|593562092|FG000|Single Blind Treatment Period|Adverse Event|9|||
164323644|NCT00219544|593562093|FG001|Single Blind Treatment Period|Adverse Event|0|||
164323645|NCT00219544|593562092|FG000|Single Blind Treatment Period|Protocol Violation|4|||
164323646|NCT00219544|593562093|FG001|Single Blind Treatment Period|Protocol Violation|0|||
164323647|NCT00219544|593562092|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
164323648|NCT00219544|593562093|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
164323649|NCT00219544|593562092|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
164323650|NCT00219544|593562093|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
164323651|NCT00219544|593562092|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
164323652|NCT00219544|593562093|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
164323653|NCT00989573|593562094|FG000|Overall Study|Adverse Event|8|||
164323654|NCT00989573|593562095|FG001|Overall Study|Adverse Event|12|||
164323655|NCT00989573|593562096|FG002|Overall Study|Adverse Event|4|||
164323656|NCT00989573|593562094|FG000|Overall Study|Physician Decision|0|||
164323657|NCT00989573|593562095|FG001|Overall Study|Physician Decision|2|||
164323658|NCT00989573|593562096|FG002|Overall Study|Physician Decision|0|||
164323659|NCT00989573|593562094|FG000|Overall Study|Protocol Violation|1|||
164323660|NCT00989573|593562095|FG001|Overall Study|Protocol Violation|1|||
164323661|NCT00989573|593562096|FG002|Overall Study|Protocol Violation|1|||
164323662|NCT00989573|593562094|FG000|Overall Study|Withdrawal by Subject|4|||
164323663|NCT00989573|593562095|FG001|Overall Study|Withdrawal by Subject|7|||
164323664|NCT00989573|593562096|FG002|Overall Study|Withdrawal by Subject|3|||
164323665|NCT03473548|593562098|FG000|Overall Study|Did not attempt HST testing|3|||
164323666|NCT03473548|593562099|FG001|Overall Study|Did not attempt HST testing|0|||
164323667|NCT02207946|593562106|FG000|Overall Study|Lost to Follow-up|1|||
164323668|NCT02207946|593562107|FG001|Overall Study|Lost to Follow-up|0|||
164323669|NCT02207946|593562106|FG000|Overall Study|Adverse Event|0|||
164323670|NCT02207946|593562107|FG001|Overall Study|Adverse Event|1|||
164323671|NCT02829944|593562108|FG000|Overall Study|Physician Decision|0|||
164323672|NCT02829944|593562109|FG001|Overall Study|Physician Decision|1|||
164323673|NCT02829944|593562108|FG000|Overall Study|Screen Failure|2|||
164323674|NCT02829944|593562109|FG001|Overall Study|Screen Failure|2|||
164323675|NCT02829944|593562108|FG000|Overall Study|Inadequate Neuraxial Block|1|||
164323676|NCT02829944|593562109|FG001|Overall Study|Inadequate Neuraxial Block|1|||
164323677|NCT02829944|593562108|FG000|Overall Study|Withdrawal by Subject|2|||
164323678|NCT02829944|593562109|FG001|Overall Study|Withdrawal by Subject|1|||
164323679|NCT02829944|593562108|FG000|Overall Study|Catheter Displacement|1|||
164323680|NCT02829944|593562109|FG001|Overall Study|Catheter Displacement|0|||
164323681|NCT02829944|593562108|FG000|Overall Study|Catheter broke|0|||
164323682|NCT02829944|593562109|FG001|Overall Study|Catheter broke|1|||
164323683|NCT02829944|593562108|FG000|Overall Study|Staff unavailable|0|||
164323684|NCT02829944|593562109|FG001|Overall Study|Staff unavailable|1|||
164323685|NCT05856760|593562110|FG000|Overall Study|Adverse Event|2|||
164323686|NCT05856760|593562110|FG000|Overall Study|Physician Decision|1|||
164323687|NCT05856760|593562110|FG000|Overall Study|Protocol Violation|1|||
164323688|NCT05856760|593562110|FG000|Overall Study|Withdrawal by Subject|3|||
164323689|NCT04675151|593562111|FG000|Overall Study|Protocol Violation|1|||
164323690|NCT04675151|593562112|FG001|Overall Study|Protocol Violation|0|||
164323691|NCT04675151|593562113|FG002|Overall Study|Protocol Violation|0|||
164323692|NCT04675151|593562114|FG003|Overall Study|Protocol Violation|1|||
164323693|NCT04035486|593562115|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
164323694|NCT04035486|593562116|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
164323695|NCT04035486|593562117|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
164323696|NCT04035486|593562118|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
164323697|NCT04035486|593562115|FG000|Overall Study|Death|6|||
164323698|NCT04035486|593562116|FG001|Overall Study|Death|3|||
164323699|NCT04035486|593562117|FG002|Overall Study|Death|70|||
164323700|NCT04035486|593562118|FG003|Overall Study|Death|77|||
164323701|NCT04035486|593562115|FG000|Overall Study|Screen Failure|0|||
164323702|NCT04035486|593562116|FG001|Overall Study|Screen Failure|0|||
164323703|NCT04035486|593562117|FG002|Overall Study|Screen Failure|1|||
164563930|NCT00695565|594432422|FG000|Overall Study|Adverse Event|3|||
164208487|NCT02696798|593131697|FG001|Blinded Treatment Dosing Period|Death|0|||
164208488|NCT02696798|593131698|FG002|Blinded Treatment Dosing Period|Death|1|||
164208489|NCT02696798|593131696|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
164208490|NCT02696798|593131697|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
164208491|NCT02696798|593131698|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
164208492|NCT02696798|593131696|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
164208493|NCT02696798|593131697|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
164208494|NCT02696798|593131698|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
164208495|NCT02696798|593131696|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
164208496|NCT02696798|593131697|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
164208497|NCT02696798|593131698|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
164208498|NCT02696798|593131696|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
164208499|NCT02696798|593131697|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
164208500|NCT02696798|593131698|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
164208501|NCT02696798|593131696|FG000|Extended Treatment Period|Adverse Event|1|||
164208502|NCT02696798|593131697|FG001|Extended Treatment Period|Adverse Event|4|||
164208503|NCT02696798|593131698|FG002|Extended Treatment Period|Adverse Event|5|||
164208504|NCT02696798|593131696|FG000|Extended Treatment Period|Lack of Efficacy|7|||
164208505|NCT02696798|593131697|FG001|Extended Treatment Period|Lack of Efficacy|2|||
164208506|NCT02696798|593131698|FG002|Extended Treatment Period|Lack of Efficacy|2|||
164208507|NCT02696798|593131696|FG000|Extended Treatment Period|Lost to Follow-up|1|||
164208508|NCT02696798|593131697|FG001|Extended Treatment Period|Lost to Follow-up|0|||
164208509|NCT02696798|593131698|FG002|Extended Treatment Period|Lost to Follow-up|0|||
164208510|NCT02696798|593131696|FG000|Extended Treatment Period|Physician Decision|0|||
164208511|NCT02696798|593131697|FG001|Extended Treatment Period|Physician Decision|1|||
164208512|NCT02696798|593131698|FG002|Extended Treatment Period|Physician Decision|0|||
164208513|NCT02696798|593131696|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
164208514|NCT02696798|593131697|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
164208515|NCT02696798|593131698|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
164208516|NCT02696798|593131696|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
164208517|NCT02696798|593131697|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
164208518|NCT02696798|593131698|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
164208519|NCT02696798|593131696|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
164208520|NCT02696798|593131697|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
164208521|NCT02696798|593131698|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
164208522|NCT02696798|593131696|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
164208523|NCT02696798|593131697|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
164208524|NCT02696798|593131698|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
164208525|NCT02696798|593131696|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
164208526|NCT02696798|593131697|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
164208527|NCT02696798|593131698|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
164208528|NCT02696798|593131696|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
164208529|NCT02696798|593131697|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
164208530|NCT02696798|593131698|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
164208531|NCT02696798|593131696|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
164208532|NCT02696798|593131697|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
164208533|NCT02696798|593131698|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
164208534|NCT04880850|593131699|FG000|Overall Study|Death|2|||
164208535|NCT04880850|593131700|FG001|Overall Study|Death|1|||
164208536|NCT04880850|593131699|FG000|Overall Study|Lost to Follow-up|3|||
164208537|NCT04880850|593131700|FG001|Overall Study|Lost to Follow-up|6|||
164208538|NCT04880850|593131699|FG000|Overall Study|Physician Decision|2|||
164208539|NCT04880850|593131700|FG001|Overall Study|Physician Decision|1|||
164208540|NCT04880850|593131699|FG000|Overall Study|Withdrawal by Subject|9|||
164208541|NCT04880850|593131700|FG001|Overall Study|Withdrawal by Subject|10|||
164208542|NCT04091451|593131701|FG000|Overall Study|Adverse Event|15|||
164208543|NCT04091451|593131702|FG001|Overall Study|Adverse Event|10|||
164208544|NCT04091451|593131701|FG000|Overall Study|Lost to Follow-up|8|||
164208545|NCT04091451|593131702|FG001|Overall Study|Lost to Follow-up|8|||
164208546|NCT04091451|593131701|FG000|Overall Study|Protocol Violation|5|||
164208547|NCT04091451|593131702|FG001|Overall Study|Protocol Violation|4|||
164208548|NCT04091451|593131701|FG000|Overall Study|Withdrawal by Subject|21|||
164208549|NCT04091451|593131702|FG001|Overall Study|Withdrawal by Subject|27|||
164208550|NCT04091451|593131701|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
164208551|NCT04091451|593131702|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
164208552|NCT04091451|593131701|FG000|Overall Study|Migrated/moved from the study area|3|||
164208553|NCT04091451|593131702|FG001|Overall Study|Migrated/moved from the study area|5|||
164208554|NCT04091451|593131701|FG000|Overall Study|Suspected HZ episode|1|||
164208555|NCT04091451|593131702|FG001|Overall Study|Suspected HZ episode|0|||
164208556|NCT03907488|593131703|FG000|Overall Study|Adverse Event|20|||
164208557|NCT03907488|593131704|FG001|Overall Study|Adverse Event|20|||
164323704|NCT04035486|593562118|FG003|Overall Study|Screen Failure|1|||
164208558|NCT03907488|593131703|FG000|Overall Study|Withdrawal by Subject|9|||
164208559|NCT03907488|593131704|FG001|Overall Study|Withdrawal by Subject|13|||
164208560|NCT03907488|593131703|FG000|Overall Study|Lack of Efficacy|0|||
164208561|NCT03907488|593131704|FG001|Overall Study|Lack of Efficacy|9|||
164208562|NCT03907488|593131703|FG000|Overall Study|Death|3|||
164208563|NCT03907488|593131704|FG001|Overall Study|Death|8|||
164208564|NCT03907488|593131703|FG000|Overall Study|not protocol specified|5|||
164208565|NCT03907488|593131704|FG001|Overall Study|not protocol specified|8|||
164208566|NCT03907488|593131703|FG000|Overall Study|Ineligible|9|||
164208567|NCT03907488|593131704|FG001|Overall Study|Ineligible|15|||
164208568|NCT03074500|593131706|FG000|Overall Study|Lost to Follow-up|1|||
164208569|NCT03074500|593131707|FG001|Overall Study|Lost to Follow-up|0|||
164208570|NCT03074500|593131708|FG002|Overall Study|Lost to Follow-up|0|||
164208571|NCT03074500|593131706|FG000|Overall Study|Lack of Efficacy|0|||
164208572|NCT03074500|593131707|FG001|Overall Study|Lack of Efficacy|1|||
164208573|NCT03074500|593131708|FG002|Overall Study|Lack of Efficacy|0|||
164208574|NCT03074500|593131706|FG000|Overall Study|Adverse Event|0|||
164208575|NCT03074500|593131707|FG001|Overall Study|Adverse Event|0|||
164208576|NCT03074500|593131708|FG002|Overall Study|Adverse Event|1|||
164208577|NCT03321721|593131709|FG000|Overall Study|Lost to Follow-up|4|||
164208578|NCT03321721|593131710|FG001|Overall Study|Lost to Follow-up|8|||
164208579|NCT03321721|593131711|FG002|Overall Study|Lost to Follow-up|11|||
164208580|NCT00634504|593133402|FG000|Overall Study|Protocol Violation|1|||
164208581|NCT00634504|593133403|FG001|Overall Study|Protocol Violation|0|||
164208582|NCT00937950|593133404|FG000|Overall Study|Withdrawal by Subject|23|||
164208583|NCT00937950|593133404|FG000|Overall Study|Migrated/moved from study area|27|||
164208584|NCT00937950|593133404|FG000|Overall Study|Lost to Follow-up|144|||
164208585|NCT00937950|593133404|FG000|Overall Study|Missing confirmed|4|||
164208586|NCT00937950|593133404|FG000|Overall Study|Other|18|||
164208587|NCT03483103|593133409|FG000|Pre-Treatment Phase|Other reasons|1|||
164208588|NCT03483103|593133409|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
164208589|NCT03483103|593133409|FG000|Pre-Treatment Phase|Disease-related complications|1|||
164208590|NCT03483103|593133409|FG000|Pre-Treatment Phase|Death|5|||
164208591|NCT03483103|593133409|FG000|Treatment Phase|Withdrawal by Subject|7|||
164208592|NCT03483103|593133409|FG000|Treatment Phase|Other reasons|1|||
164208593|NCT03483103|593133409|FG000|Treatment Phase|Death|23|||
164208594|NCT03483103|593133409|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
164208595|NCT03483103|593133409|FG000|Treatment Phase|Received nonconforming product|1|||
164208596|NCT02475213|593133410|FG000|Overall Study|Adverse Event|2|||
164208597|NCT02475213|593133411|FG001|Overall Study|Adverse Event|0|||
164208598|NCT02475213|593133412|FG002|Overall Study|Adverse Event|0|||
164208599|NCT02475213|593133413|FG003|Overall Study|Adverse Event|1|||
164208600|NCT02475213|593133414|FG004|Overall Study|Adverse Event|1|||
164208601|NCT02475213|593133415|FG005|Overall Study|Adverse Event|4|||
164208602|NCT02475213|593133416|FG006|Overall Study|Adverse Event|6|||
164208603|NCT02475213|593133417|FG007|Overall Study|Adverse Event|2|||
164208604|NCT02475213|593133410|FG000|Overall Study|Physician Decision|1|||
164208605|NCT02475213|593133411|FG001|Overall Study|Physician Decision|1|||
164208606|NCT02475213|593133412|FG002|Overall Study|Physician Decision|1|||
164208607|NCT02475213|593133413|FG003|Overall Study|Physician Decision|0|||
164208608|NCT02475213|593133414|FG004|Overall Study|Physician Decision|0|||
164208609|NCT02475213|593133415|FG005|Overall Study|Physician Decision|1|||
164208610|NCT02475213|593133416|FG006|Overall Study|Physician Decision|4|||
164208611|NCT02475213|593133417|FG007|Overall Study|Physician Decision|0|||
164208612|NCT02475213|593133410|FG000|Overall Study|Progressive Disease|3|||
164208613|NCT02475213|593133411|FG001|Overall Study|Progressive Disease|2|||
164208614|NCT02475213|593133412|FG002|Overall Study|Progressive Disease|2|||
164208615|NCT02475213|593133413|FG003|Overall Study|Progressive Disease|13|||
164208616|NCT02475213|593133414|FG004|Overall Study|Progressive Disease|15|||
164208617|NCT02475213|593133415|FG005|Overall Study|Progressive Disease|25|||
164208618|NCT02475213|593133416|FG006|Overall Study|Progressive Disease|30|||
164208619|NCT02475213|593133417|FG007|Overall Study|Progressive Disease|10|||
164208620|NCT02475213|593133410|FG000|Overall Study|Death|0|||
164208621|NCT02475213|593133411|FG001|Overall Study|Death|0|||
164208622|NCT02475213|593133412|FG002|Overall Study|Death|0|||
164208623|NCT02475213|593133413|FG003|Overall Study|Death|0|||
164208624|NCT02475213|593133414|FG004|Overall Study|Death|0|||
164208625|NCT02475213|593133415|FG005|Overall Study|Death|4|||
164208626|NCT02475213|593133416|FG006|Overall Study|Death|1|||
164208627|NCT02475213|593133417|FG007|Overall Study|Death|0|||
164208628|NCT02475213|593133410|FG000|Overall Study|Protocol Violation|0|||
164208629|NCT02475213|593133411|FG001|Overall Study|Protocol Violation|0|||
164208630|NCT02475213|593133412|FG002|Overall Study|Protocol Violation|0|||
164208631|NCT02475213|593133413|FG003|Overall Study|Protocol Violation|0|||
164208632|NCT02475213|593133414|FG004|Overall Study|Protocol Violation|1|||
164208633|NCT02475213|593133415|FG005|Overall Study|Protocol Violation|0|||
164208634|NCT02475213|593133416|FG006|Overall Study|Protocol Violation|0|||
164208635|NCT02475213|593133417|FG007|Overall Study|Protocol Violation|0|||
164208636|NCT02475213|593133410|FG000|Overall Study|Withdrawal by Subject|0|||
164208637|NCT02475213|593133411|FG001|Overall Study|Withdrawal by Subject|0|||
164208638|NCT02475213|593133412|FG002|Overall Study|Withdrawal by Subject|0|||
164323705|NCT04035486|593562115|FG000|Overall Study|Withdrawal by Subject|1|||
164323706|NCT04035486|593562116|FG001|Overall Study|Withdrawal by Subject|1|||
164323707|NCT04035486|593562117|FG002|Overall Study|Withdrawal by Subject|11|||
164323708|NCT04035486|593562118|FG003|Overall Study|Withdrawal by Subject|9|||
164323709|NCT01730937|593562119|FG000|Overall Study|Protocol Violation|5|||
164323710|NCT01730937|593562120|FG001|Overall Study|Protocol Violation|11|||
164323711|NCT03947684|593562121|FG000|Overall Study|Lost to Follow-up|13|||
164323712|NCT03947684|593562122|FG001|Overall Study|Lost to Follow-up|5|||
164323713|NCT03947684|593562123|FG002|Overall Study|Lost to Follow-up|1|||
164323714|NCT03947684|593562121|FG000|Overall Study|Withdrawal by Subject|11|||
164323715|NCT03947684|593562122|FG001|Overall Study|Withdrawal by Subject|4|||
164323716|NCT03947684|593562123|FG002|Overall Study|Withdrawal by Subject|0|||
164323717|NCT03947684|593562121|FG000|Overall Study|Physician Decision|1|||
164323718|NCT03947684|593562122|FG001|Overall Study|Physician Decision|0|||
164323719|NCT03947684|593562123|FG002|Overall Study|Physician Decision|0|||
164323720|NCT03947684|593562121|FG000|Overall Study|Lack of adherence to study protocol|2|||
164323721|NCT03947684|593562122|FG001|Overall Study|Lack of adherence to study protocol|0|||
164323722|NCT03947684|593562123|FG002|Overall Study|Lack of adherence to study protocol|0|||
164323723|NCT05313009|593563187|FG000|Overall Study|Death|1|||
164323724|NCT05313009|593563188|FG001|Overall Study|Death|0|||
164323725|NCT02186301|593563189|FG000|Overall Study|Progressive Disease|7|||
164323726|NCT02186301|593563190|FG001|Overall Study|Progressive Disease|22|||
164323727|NCT02186301|593563191|FG002|Overall Study|Progressive Disease|27|||
164323728|NCT02186301|593563189|FG000|Overall Study|Adverse Event|5|||
164323729|NCT02186301|593563190|FG001|Overall Study|Adverse Event|5|||
164323730|NCT02186301|593563191|FG002|Overall Study|Adverse Event|5|||
164323731|NCT02186301|593563189|FG000|Overall Study|Death|1|||
164323732|NCT02186301|593563190|FG001|Overall Study|Death|0|||
164323733|NCT02186301|593563191|FG002|Overall Study|Death|0|||
164323734|NCT02186301|593563189|FG000|Overall Study|Withdrawal by Subject|5|||
164323735|NCT02186301|593563190|FG001|Overall Study|Withdrawal by Subject|1|||
164323736|NCT02186301|593563191|FG002|Overall Study|Withdrawal by Subject|3|||
164323737|NCT02186301|593563189|FG000|Overall Study|Physician Decision|1|||
164323738|NCT02186301|593563190|FG001|Overall Study|Physician Decision|0|||
164323739|NCT02186301|593563191|FG002|Overall Study|Physician Decision|1|||
164323740|NCT02186301|593563189|FG000|Overall Study|Study Terminated by Sponsor|1|||
164323741|NCT02186301|593563190|FG001|Overall Study|Study Terminated by Sponsor|0|||
164323742|NCT02186301|593563191|FG002|Overall Study|Study Terminated by Sponsor|11|||
164323743|NCT02186301|593563189|FG000|Overall Study|Protocol Deviation|0|||
164323744|NCT02186301|593563190|FG001|Overall Study|Protocol Deviation|2|||
164323745|NCT02186301|593563191|FG002|Overall Study|Protocol Deviation|0|||
164323746|NCT02186301|593563189|FG000|Overall Study|Missing|0|||
164323747|NCT02186301|593563190|FG001|Overall Study|Missing|0|||
164323748|NCT02186301|593563191|FG002|Overall Study|Missing|2|||
164323749|NCT02186301|593563189|FG000|Overall Study|Other|0|||
164323750|NCT02186301|593563190|FG001|Overall Study|Other|0|||
164323751|NCT02186301|593563191|FG002|Overall Study|Other|1|||
164323752|NCT00749580|593563192|FG000|Overall Study|Lost to Follow-up|4|||
164323753|NCT00749580|593563193|FG001|Overall Study|Lost to Follow-up|8|||
164323754|NCT00749580|593563192|FG000|Overall Study|Adverse Event|0|||
164323755|NCT00749580|593563193|FG001|Overall Study|Adverse Event|1|||
164323756|NCT05128929|593563194|FG000|Overall Study|Adverse Event|0|||
164323757|NCT05128929|593563195|FG001|Overall Study|Adverse Event|1|||
164323758|NCT03553836|593563196|FG000|Overall Study|Ongoing in Study|460|||
164323759|NCT03553836|593563197|FG001|Overall Study|Ongoing in Study|459|||
164323760|NCT03553836|593563196|FG000|Overall Study|Withdrawal by Subject|9|||
164323761|NCT03553836|593563197|FG001|Overall Study|Withdrawal by Subject|10|||
164323762|NCT03553836|593563196|FG000|Overall Study|Lost to Follow-up|1|||
164323763|NCT03553836|593563197|FG001|Overall Study|Lost to Follow-up|3|||
164323764|NCT03553836|593563196|FG000|Overall Study|Death|17|||
164323765|NCT03553836|593563197|FG001|Overall Study|Death|17|||
164323766|NCT00274924|593563198|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
164323767|NCT00274924|593563199|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
164323768|NCT00274924|593563200|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
164323769|NCT00274924|593563198|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
164323770|NCT00274924|593563199|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
164323771|NCT00274924|593563200|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
164323772|NCT00274924|593563198|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
164323773|NCT00274924|593563199|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
164323774|NCT00274924|593563200|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
164323775|NCT00274924|593563198|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
164323776|NCT00274924|593563199|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
164323777|NCT00274924|593563200|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
164323778|NCT00274924|593563198|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
164323779|NCT00274924|593563199|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
164323780|NCT00274924|593563200|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
164323781|NCT00274924|593563198|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
164323782|NCT00274924|593563199|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
164323783|NCT00274924|593563200|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
164323784|NCT00274924|593563198|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
164323785|NCT00274924|593563199|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
164323786|NCT00274924|593563200|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
164323787|NCT00274924|593563198|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
164323788|NCT00274924|593563199|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
164323789|NCT00274924|593563200|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
164323790|NCT00274924|593563198|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
164323791|NCT00274924|593563199|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
164323792|NCT00274924|593563200|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
164323793|NCT00274924|593563198|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
164323794|NCT00274924|593563199|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
164323795|NCT00274924|593563200|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
164323796|NCT00274924|593563198|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
164323797|NCT00274924|593563199|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
164323798|NCT00274924|593563200|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
164323799|NCT00274924|593563198|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
164323800|NCT00274924|593563199|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
164323801|NCT00274924|593563200|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
164323802|NCT00274924|593563198|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
164323803|NCT00274924|593563199|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
164323804|NCT00274924|593563200|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
164323805|NCT01903525|593563203|FG000|Overall Study|Lost to Follow-up|5|||
164323806|NCT01903525|593563204|FG001|Overall Study|Lost to Follow-up|9|||
164323807|NCT01903525|593563203|FG000|Overall Study|Adverse Event|0|||
164323808|NCT01903525|593563204|FG001|Overall Study|Adverse Event|1|||
164323809|NCT04365257|593563205|FG000|Overall Study|Physician Decision|1|||
164323810|NCT04365257|593563206|FG001|Overall Study|Physician Decision|0|||
164323811|NCT04365257|593563205|FG000|Overall Study|Patient Noncompliance|1|||
164323812|NCT04365257|593563206|FG001|Overall Study|Patient Noncompliance|0|||
164323813|NCT04365257|593563205|FG000|Overall Study|Withdrawal by Subject|0|||
164323814|NCT04365257|593563206|FG001|Overall Study|Withdrawal by Subject|1|||
164323815|NCT02129777|593563211|FG000|Double-Blind Period|Adverse Event|0|||
164323816|NCT02129777|593563212|FG001|Double-Blind Period|Adverse Event|0|||
164323817|NCT02129777|593563213|FG002|Double-Blind Period|Adverse Event|0|||
164323818|NCT02129777|593563214|FG003|Double-Blind Period|Adverse Event|0|||
164323819|NCT02129777|593563215|FG004|Double-Blind Period|Adverse Event|1|||
164323820|NCT02129777|593563216|FG005|Double-Blind Period|Adverse Event|0|||
164323821|NCT02129777|593563217|FG006|Double-Blind Period|Adverse Event|0|||
164323822|NCT02129777|593563211|FG000|Double-Blind Period|Lost to Follow-up|1|||
164323823|NCT02129777|593563212|FG001|Double-Blind Period|Lost to Follow-up|1|||
164323824|NCT02129777|593563213|FG002|Double-Blind Period|Lost to Follow-up|1|||
164323825|NCT02129777|593563214|FG003|Double-Blind Period|Lost to Follow-up|2|||
164323826|NCT02129777|593563215|FG004|Double-Blind Period|Lost to Follow-up|0|||
164323827|NCT02129777|593563216|FG005|Double-Blind Period|Lost to Follow-up|0|||
164323828|NCT02129777|593563217|FG006|Double-Blind Period|Lost to Follow-up|0|||
164323829|NCT02129777|593563211|FG000|Double-Blind Period|Withdrawal by Subject|2|||
164323830|NCT02129777|593563212|FG001|Double-Blind Period|Withdrawal by Subject|4|||
164323831|NCT02129777|593563213|FG002|Double-Blind Period|Withdrawal by Subject|3|||
164323832|NCT02129777|593563214|FG003|Double-Blind Period|Withdrawal by Subject|2|||
164323833|NCT02129777|593563215|FG004|Double-Blind Period|Withdrawal by Subject|3|||
164323834|NCT02129777|593563216|FG005|Double-Blind Period|Withdrawal by Subject|0|||
164323835|NCT02129777|593563217|FG006|Double-Blind Period|Withdrawal by Subject|0|||
164323836|NCT02129777|593563211|FG000|Double-Blind Period|Pregnancy|0|||
164323837|NCT02129777|593563212|FG001|Double-Blind Period|Pregnancy|0|||
164323838|NCT02129777|593563213|FG002|Double-Blind Period|Pregnancy|0|||
164323839|NCT02129777|593563214|FG003|Double-Blind Period|Pregnancy|0|||
164323840|NCT02129777|593563215|FG004|Double-Blind Period|Pregnancy|1|||
164323841|NCT02129777|593563216|FG005|Double-Blind Period|Pregnancy|0|||
164323842|NCT02129777|593563217|FG006|Double-Blind Period|Pregnancy|0|||
164323843|NCT02129777|593563211|FG000|Double-Blind Period|Lack of Efficacy|3|||
164323844|NCT02129777|593563212|FG001|Double-Blind Period|Lack of Efficacy|1|||
164323845|NCT02129777|593563213|FG002|Double-Blind Period|Lack of Efficacy|0|||
164323846|NCT02129777|593563214|FG003|Double-Blind Period|Lack of Efficacy|3|||
164323847|NCT02129777|593563215|FG004|Double-Blind Period|Lack of Efficacy|2|||
164323848|NCT02129777|593563216|FG005|Double-Blind Period|Lack of Efficacy|0|||
164563931|NCT00695565|594432423|FG001|Overall Study|Adverse Event|1|||
164323849|NCT02129777|593563217|FG006|Double-Blind Period|Lack of Efficacy|0|||
164323850|NCT02129777|593563211|FG000|Double-Blind Period|Other|1|||
164323851|NCT02129777|593563212|FG001|Double-Blind Period|Other|2|||
164323852|NCT02129777|593563213|FG002|Double-Blind Period|Other|0|||
164323853|NCT02129777|593563214|FG003|Double-Blind Period|Other|0|||
164323854|NCT02129777|593563215|FG004|Double-Blind Period|Other|0|||
164323855|NCT02129777|593563216|FG005|Double-Blind Period|Other|0|||
164208639|NCT02475213|593133413|FG003|Overall Study|Withdrawal by Subject|1|||
164208640|NCT02475213|593133414|FG004|Overall Study|Withdrawal by Subject|0|||
164208641|NCT02475213|593133415|FG005|Overall Study|Withdrawal by Subject|2|||
164208642|NCT02475213|593133416|FG006|Overall Study|Withdrawal by Subject|2|||
164208643|NCT02475213|593133417|FG007|Overall Study|Withdrawal by Subject|0|||
164208644|NCT02475213|593133410|FG000|Overall Study|Other|0|||
164208645|NCT02475213|593133411|FG001|Overall Study|Other|0|||
164208646|NCT02475213|593133412|FG002|Overall Study|Other|0|||
164208647|NCT02475213|593133413|FG003|Overall Study|Other|1|||
164208648|NCT02475213|593133414|FG004|Overall Study|Other|3|||
164208649|NCT02475213|593133415|FG005|Overall Study|Other|1|||
164208650|NCT02475213|593133416|FG006|Overall Study|Other|0|||
164208651|NCT02475213|593133417|FG007|Overall Study|Other|0|||
164208652|NCT00505921|593133418|FG000|Overall Study|Ineligible|1|||
164208653|NCT00505921|593133418|FG000|Overall Study|Failed to Mobilize|8|||
164208654|NCT00630292|593133419|FG000|Overall Study|Withdrawal by Subject|1|||
164208655|NCT00717886|593133421|FG000|Overall Study|Withdrawal by Subject|3|||
164208656|NCT00717886|593133421|FG000|Overall Study|Treatment Failure|1|||
164208657|NCT01369433|593133422|FG000|Overall Study|Adverse Event|31|||
164208658|NCT01369433|593133423|FG001|Overall Study|Adverse Event|1|||
164208659|NCT01369433|593133422|FG000|Overall Study|Required significant surgical procedure|1|||
164208660|NCT01369433|593133423|FG001|Overall Study|Required significant surgical procedure|0|||
164208661|NCT01369433|593133422|FG000|Overall Study|Non-compliance|1|||
164208662|NCT01369433|593133423|FG001|Overall Study|Non-compliance|0|||
164208663|NCT01369433|593133422|FG000|Overall Study|Withdrawal by Subject|5|||
164208664|NCT01369433|593133423|FG001|Overall Study|Withdrawal by Subject|2|||
164208665|NCT01369433|593133422|FG000|Overall Study|Study terminated by Sponsor|67|||
164208666|NCT01369433|593133423|FG001|Overall Study|Study terminated by Sponsor|0|||
164208667|NCT01369433|593133422|FG000|Overall Study|Lost to Follow-up|1|||
164208668|NCT01369433|593133423|FG001|Overall Study|Lost to Follow-up|0|||
164208669|NCT01369433|593133422|FG000|Overall Study|Death|5|||
164208670|NCT01369433|593133423|FG001|Overall Study|Death|0|||
164208671|NCT01369433|593133422|FG000|Overall Study|Investigator discretion|6|||
164208672|NCT01369433|593133423|FG001|Overall Study|Investigator discretion|1|||
164208673|NCT01369433|593133422|FG000|Overall Study|Progressive Disease|92|||
164208674|NCT01369433|593133423|FG001|Overall Study|Progressive Disease|12|||
164208675|NCT01553851|593133424|FG000|Overall Study|Adverse Event|2|||
164208676|NCT01553851|593133424|FG000|Overall Study|constipation|1|||
164208677|NCT00797563|593133425|FG000|Overall Study|Adverse Event|1|||
164208678|NCT02313155|593133432|FG000|Overall Study|Lost to Follow-up|0|||
164208679|NCT02313155|593133433|FG001|Overall Study|Lost to Follow-up|1|||
164208680|NCT03822416|593133437|FG000|Overall Study|Lost to Follow-up|1|||
164208681|NCT03822416|593133438|FG001|Overall Study|Lost to Follow-up|0|||
164208682|NCT03822416|593133437|FG000|Overall Study|Withdrawal by Subject|0|||
164208683|NCT03822416|593133438|FG001|Overall Study|Withdrawal by Subject|1|||
164208684|NCT04666298|593133439|FG000|Overall Study|Subject decision|1|||
164208685|NCT04666298|593133440|FG001|Overall Study|Subject decision|0|||
164208686|NCT04666298|593133441|FG002|Overall Study|Subject decision|0|||
164208687|NCT04666298|593133442|FG003|Overall Study|Subject decision|2|||
164208688|NCT04666298|593133439|FG000|Overall Study|Death|1|||
164208689|NCT04666298|593133440|FG001|Overall Study|Death|0|||
164208690|NCT04666298|593133441|FG002|Overall Study|Death|0|||
164208691|NCT04666298|593133442|FG003|Overall Study|Death|0|||
164208692|NCT04666298|593133439|FG000|Overall Study|Lost to Follow-up|0|||
164208693|NCT04666298|593133440|FG001|Overall Study|Lost to Follow-up|0|||
164208694|NCT04666298|593133441|FG002|Overall Study|Lost to Follow-up|0|||
164208695|NCT04666298|593133442|FG003|Overall Study|Lost to Follow-up|1|||
164208696|NCT04666298|593133439|FG000|Overall Study|Physician Decision|0|||
164208697|NCT04666298|593133440|FG001|Overall Study|Physician Decision|0|||
164208698|NCT04666298|593133441|FG002|Overall Study|Physician Decision|0|||
164208699|NCT04666298|593133442|FG003|Overall Study|Physician Decision|1|||
164208700|NCT04666298|593133439|FG000|Overall Study|Protocol deviation|0|||
164208701|NCT04666298|593133440|FG001|Overall Study|Protocol deviation|0|||
164208702|NCT04666298|593133441|FG002|Overall Study|Protocol deviation|1|||
164208703|NCT04666298|593133442|FG003|Overall Study|Protocol deviation|0|||
164208704|NCT00844519|593133443|FG000|Overall Study|Withdrawal by Subject|1|||
164208705|NCT00844519|593133444|FG001|Overall Study|Withdrawal by Subject|1|||
164208706|NCT00844519|593133443|FG000|Overall Study|Adverse Event|1|||
164208707|NCT00844519|593133444|FG001|Overall Study|Adverse Event|0|||
164208708|NCT01303419|593133445|FG000|Overall Study|Discontinuation of study|60|||
164208709|NCT01303419|593133445|FG000|Overall Study|Did not complete both imaging methods|5|||
164208710|NCT01303419|593133445|FG000|Overall Study|Did not meet all I/E after screening|31|||
164208711|NCT06438601|593133446|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
164208712|NCT06438601|593133447|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
164208713|NCT06438601|593133446|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
164208714|NCT06438601|593133447|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
164208715|NCT03329001|593133448|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
164208716|NCT03329001|593133449|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
164323856|NCT02129777|593563217|FG006|Double-Blind Period|Other|0|||
164323857|NCT02129777|593563211|FG000|Open-Label Period|Lack of Efficacy|0|||
164323858|NCT02129777|593563212|FG001|Open-Label Period|Lack of Efficacy|0|||
164323859|NCT02129777|593563213|FG002|Open-Label Period|Lack of Efficacy|0|||
164323860|NCT02129777|593563214|FG003|Open-Label Period|Lack of Efficacy|0|||
164323861|NCT02129777|593563215|FG004|Open-Label Period|Lack of Efficacy|0|||
164323862|NCT02129777|593563216|FG005|Open-Label Period|Lack of Efficacy|0|||
164323863|NCT02129777|593563217|FG006|Open-Label Period|Lack of Efficacy|5|||
164323864|NCT02129777|593563211|FG000|Open-Label Period|Lost to Follow-up|0|||
164323865|NCT02129777|593563212|FG001|Open-Label Period|Lost to Follow-up|0|||
164323866|NCT02129777|593563213|FG002|Open-Label Period|Lost to Follow-up|0|||
164323867|NCT02129777|593563214|FG003|Open-Label Period|Lost to Follow-up|0|||
164323868|NCT02129777|593563215|FG004|Open-Label Period|Lost to Follow-up|0|||
164323869|NCT02129777|593563216|FG005|Open-Label Period|Lost to Follow-up|1|||
164323870|NCT02129777|593563217|FG006|Open-Label Period|Lost to Follow-up|1|||
164323871|NCT02129777|593563211|FG000|Open-Label Period|Withdrawal by Subject|0|||
164323872|NCT02129777|593563212|FG001|Open-Label Period|Withdrawal by Subject|0|||
164323873|NCT02129777|593563213|FG002|Open-Label Period|Withdrawal by Subject|0|||
164323874|NCT02129777|593563214|FG003|Open-Label Period|Withdrawal by Subject|0|||
164323875|NCT02129777|593563215|FG004|Open-Label Period|Withdrawal by Subject|0|||
164323876|NCT02129777|593563216|FG005|Open-Label Period|Withdrawal by Subject|1|||
164323877|NCT02129777|593563217|FG006|Open-Label Period|Withdrawal by Subject|3|||
164323878|NCT02129777|593563211|FG000|Open-Label Period|Study Termination|0|||
164323879|NCT02129777|593563212|FG001|Open-Label Period|Study Termination|0|||
164323880|NCT02129777|593563213|FG002|Open-Label Period|Study Termination|0|||
164323881|NCT02129777|593563214|FG003|Open-Label Period|Study Termination|0|||
164323882|NCT02129777|593563215|FG004|Open-Label Period|Study Termination|0|||
164323883|NCT02129777|593563216|FG005|Open-Label Period|Study Termination|10|||
164323884|NCT02129777|593563217|FG006|Open-Label Period|Study Termination|39|||
164323885|NCT02915874|593563219|FG000|Overall Study|Lost to Follow-up|5|||
164323886|NCT02915874|593563220|FG001|Overall Study|Lost to Follow-up|4|||
164323887|NCT02915874|593563219|FG000|Overall Study|Withdrawal by Subject|1|||
164323888|NCT02915874|593563220|FG001|Overall Study|Withdrawal by Subject|1|||
164323889|NCT02915874|593563219|FG000|Overall Study|Started New Anxiety Medication|0|||
164323890|NCT02915874|593563220|FG001|Overall Study|Started New Anxiety Medication|1|||
164323891|NCT01609478|593563227|FG000|Overall Study|Adverse Event|3|||
164323892|NCT01609478|593563228|FG001|Overall Study|Adverse Event|1|||
164323893|NCT01609478|593563229|FG002|Overall Study|Adverse Event|5|||
164323894|NCT01609478|593563227|FG000|Overall Study|Protocol Deviation|0|||
164323895|NCT01609478|593563228|FG001|Overall Study|Protocol Deviation|1|||
164323896|NCT01609478|593563229|FG002|Overall Study|Protocol Deviation|1|||
164323897|NCT01609478|593563227|FG000|Overall Study|Non-Compliance with study treatment|1|||
164323898|NCT01609478|593563228|FG001|Overall Study|Non-Compliance with study treatment|0|||
164323899|NCT01609478|593563229|FG002|Overall Study|Non-Compliance with study treatment|0|||
164323900|NCT01609478|593563227|FG000|Overall Study|Physician Decision|1|||
164323901|NCT01609478|593563228|FG001|Overall Study|Physician Decision|0|||
164323902|NCT01609478|593563229|FG002|Overall Study|Physician Decision|1|||
164323903|NCT01609478|593563227|FG000|Overall Study|Withdrawal by Subject|2|||
164323904|NCT01609478|593563228|FG001|Overall Study|Withdrawal by Subject|0|||
164323905|NCT01609478|593563229|FG002|Overall Study|Withdrawal by Subject|2|||
164323906|NCT04973137|593563230|FG000|Double Blind Phase|Adverse Event|4|||
164323907|NCT04973137|593563231|FG001|Double Blind Phase|Adverse Event|0|||
164323908|NCT04973137|593563230|FG000|Double Blind Phase|Death|25|||
164323909|NCT04973137|593563231|FG001|Double Blind Phase|Death|15|||
164323910|NCT04973137|593563230|FG000|Double Blind Phase|Physician Decision|5|||
164323911|NCT04973137|593563231|FG001|Double Blind Phase|Physician Decision|1|||
164323912|NCT04973137|593563230|FG000|Double Blind Phase|Withdrawal by Subject|6|||
164323913|NCT04973137|593563231|FG001|Double Blind Phase|Withdrawal by Subject|1|||
164323914|NCT04973137|593563230|FG000|Double Blind Phase|Other|2|||
164323915|NCT04973137|593563231|FG001|Double Blind Phase|Other|2|||
164323916|NCT04973137|593563230|FG000|Open Label Extension Phase|Death|3|||
164323917|NCT04973137|593563231|FG001|Open Label Extension Phase|Death|0|||
164323918|NCT04973137|593563230|FG000|Open Label Extension Phase|Physician Decision|0|||
164323919|NCT04973137|593563231|FG001|Open Label Extension Phase|Physician Decision|1|||
164323920|NCT04973137|593563230|FG000|Open Label Extension Phase|Withdrawal by Subject|1|||
164323921|NCT04973137|593563231|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
164323922|NCT04973137|593563230|FG000|Open Label Extension Phase|Study Terminated by Sponsor|83|||
164323923|NCT04973137|593563231|FG001|Open Label Extension Phase|Study Terminated by Sponsor|43|||
164323924|NCT04973137|593563230|FG000|Open Label Extension Phase|Site Terminated by Sponsor|5|||
164323925|NCT04973137|593563231|FG001|Open Label Extension Phase|Site Terminated by Sponsor|0|||
164323926|NCT04391569|593563234|FG000|Overall Study|Death|15|||
164323927|NCT04391569|593563235|FG001|Overall Study|Death|10|||
164323928|NCT04391569|593563234|FG000|Overall Study|Withdrawal by Subject|1|||
164323929|NCT04391569|593563235|FG001|Overall Study|Withdrawal by Subject|0|||
164323930|NCT04391569|593563234|FG000|Overall Study|Lost to Follow-up|3|||
164323931|NCT04391569|593563235|FG001|Overall Study|Lost to Follow-up|2|||
164323932|NCT04391569|593563234|FG000|Overall Study|Lack of Efficacy|0|||
164323933|NCT04391569|593563235|FG001|Overall Study|Lack of Efficacy|1|||
164323934|NCT04391569|593563234|FG000|Overall Study|Participant discharged to hospice facility|0|||
164323935|NCT04391569|593563235|FG001|Overall Study|Participant discharged to hospice facility|1|||
164323936|NCT04391569|593563234|FG000|Overall Study|Participant family decision|1|||
164323937|NCT04391569|593563235|FG001|Overall Study|Participant family decision|0|||
164323938|NCT04391569|593563234|FG000|Overall Study|Participant discharged prematurely|1|||
164323939|NCT04391569|593563235|FG001|Overall Study|Participant discharged prematurely|0|||
164323940|NCT01903252|593563252|FG000|Double-Blind Induction|Adverse Event|20|||
164323941|NCT01903252|593563253|FG001|Double-Blind Induction|Adverse Event|18|||
164323942|NCT01903252|593563254|FG002|Double-Blind Induction|Adverse Event|0|||
164323943|NCT01903252|593563255|FG003|Double-Blind Induction|Adverse Event|0|||
164323944|NCT01903252|593563256|FG004|Double-Blind Induction|Adverse Event|0|||
164323945|NCT01903252|593563257|FG005|Double-Blind Induction|Adverse Event|0|||
164323946|NCT01903252|593563252|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
164323947|NCT01903252|593563253|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
164323948|NCT01903252|593563254|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
164323949|NCT01903252|593563255|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
164323950|NCT01903252|593563256|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
164323951|NCT01903252|593563257|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
164323952|NCT01903252|593563252|FG000|Double-Blind Induction|Physician Decision|2|||
164323953|NCT01903252|593563253|FG001|Double-Blind Induction|Physician Decision|3|||
164323954|NCT01903252|593563254|FG002|Double-Blind Induction|Physician Decision|0|||
164323955|NCT01903252|593563255|FG003|Double-Blind Induction|Physician Decision|0|||
164323956|NCT01903252|593563256|FG004|Double-Blind Induction|Physician Decision|0|||
164323957|NCT01903252|593563257|FG005|Double-Blind Induction|Physician Decision|0|||
164323958|NCT01903252|593563252|FG000|Double-Blind Induction|non-compliance,|7|||
164323959|NCT01903252|593563253|FG001|Double-Blind Induction|non-compliance,|7|||
164323960|NCT01903252|593563254|FG002|Double-Blind Induction|non-compliance,|0|||
164323961|NCT01903252|593563255|FG003|Double-Blind Induction|non-compliance,|0|||
164323962|NCT01903252|593563256|FG004|Double-Blind Induction|non-compliance,|0|||
164323963|NCT01903252|593563257|FG005|Double-Blind Induction|non-compliance,|0|||
164323964|NCT01903252|593563252|FG000|Extended Induction, Open-Label|Adverse Event|0|||
164323965|NCT01903252|593563253|FG001|Extended Induction, Open-Label|Adverse Event|0|||
164323966|NCT01903252|593563254|FG002|Extended Induction, Open-Label|Adverse Event|17|||
164323967|NCT01903252|593563255|FG003|Extended Induction, Open-Label|Adverse Event|0|||
164323968|NCT01903252|593563256|FG004|Extended Induction, Open-Label|Adverse Event|0|||
164323969|NCT01903252|593563257|FG005|Extended Induction, Open-Label|Adverse Event|0|||
164323970|NCT01903252|593563252|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
164323971|NCT01903252|593563253|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
164323972|NCT01903252|593563254|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
164323973|NCT01903252|593563255|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
164323974|NCT01903252|593563256|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
164323975|NCT01903252|593563257|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
164323976|NCT01903252|593563252|FG000|Extended Induction, Open-Label|Physician Decision|0|||
164323977|NCT01903252|593563253|FG001|Extended Induction, Open-Label|Physician Decision|0|||
164323978|NCT01903252|593563254|FG002|Extended Induction, Open-Label|Physician Decision|1|||
164323979|NCT01903252|593563255|FG003|Extended Induction, Open-Label|Physician Decision|0|||
164323980|NCT01903252|593563256|FG004|Extended Induction, Open-Label|Physician Decision|0|||
164323981|NCT01903252|593563257|FG005|Extended Induction, Open-Label|Physician Decision|0|||
164323982|NCT01903252|593563252|FG000|Maintenance, Open-Label|Adverse Event|0|||
164323983|NCT01903252|593563253|FG001|Maintenance, Open-Label|Adverse Event|0|||
164323984|NCT01903252|593563254|FG002|Maintenance, Open-Label|Adverse Event|0|||
164323985|NCT01903252|593563255|FG003|Maintenance, Open-Label|Adverse Event|3|||
164323986|NCT01903252|593563256|FG004|Maintenance, Open-Label|Adverse Event|9|||
164323987|NCT01903252|593563257|FG005|Maintenance, Open-Label|Adverse Event|14|||
164323988|NCT01903252|593563252|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
164323989|NCT01903252|593563253|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
164323990|NCT01903252|593563254|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
164323991|NCT01903252|593563255|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
164323992|NCT01903252|593563256|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
164323993|NCT01903252|593563257|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
164323994|NCT01903252|593563252|FG000|Maintenance, Open-Label|Other|0|||
164323995|NCT01903252|593563253|FG001|Maintenance, Open-Label|Other|0|||
164323996|NCT01903252|593563254|FG002|Maintenance, Open-Label|Other|0|||
164323997|NCT01903252|593563255|FG003|Maintenance, Open-Label|Other|2|||
164323998|NCT01903252|593563256|FG004|Maintenance, Open-Label|Other|6|||
164563932|NCT00695565|594432422|FG000|Overall Study|Protocol Violation|3|||
164563933|NCT00695565|594432423|FG001|Overall Study|Protocol Violation|1|||
164563934|NCT00695565|594432422|FG000|Overall Study|Withdrawal by Subject|1|||
164563935|NCT00695565|594432423|FG001|Overall Study|Withdrawal by Subject|1|||
164563936|NCT00695565|594432422|FG000|Overall Study|Lack of Efficacy|1|||
164563937|NCT00695565|594432423|FG001|Overall Study|Lack of Efficacy|1|||
164208717|NCT03329001|593133450|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
164208718|NCT03329001|593133451|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
164208719|NCT03329001|593133452|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
164208720|NCT03329001|593133453|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
164208721|NCT03329001|593133454|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
164208722|NCT03329001|593133455|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
164208723|NCT03329001|593133448|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
164208724|NCT03329001|593133449|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
164208725|NCT03329001|593133450|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
164208726|NCT03329001|593133451|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
164208727|NCT03329001|593133452|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
164208728|NCT03329001|593133453|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
164208729|NCT03329001|593133454|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
164208730|NCT03329001|593133455|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
164208731|NCT03329001|593133448|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
164208732|NCT03329001|593133449|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
164208733|NCT03329001|593133450|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
164208734|NCT03329001|593133451|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
164208735|NCT03329001|593133452|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
164208736|NCT03329001|593133453|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
164208737|NCT03329001|593133454|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
164208738|NCT03329001|593133455|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
164208739|NCT03329001|593133448|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
164208740|NCT03329001|593133449|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
164208741|NCT03329001|593133450|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
164208742|NCT03329001|593133451|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
164208743|NCT03329001|593133452|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
164208744|NCT03329001|593133453|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
164208745|NCT03329001|593133454|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
164208746|NCT03329001|593133455|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
164208747|NCT03329001|593133448|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
164208748|NCT03329001|593133449|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
164208749|NCT03329001|593133450|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
164208750|NCT03329001|593133451|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
164208751|NCT03329001|593133452|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
164208752|NCT03329001|593133453|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
164208753|NCT03329001|593133454|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
164208754|NCT03329001|593133455|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
164208755|NCT03329001|593133448|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
164208756|NCT03329001|593133449|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
164208757|NCT03329001|593133450|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
164208758|NCT03329001|593133451|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
164208759|NCT03329001|593133452|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
164208760|NCT03329001|593133453|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
164208761|NCT03329001|593133454|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
164208762|NCT03329001|593133455|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
164208763|NCT03329001|593133448|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
164208764|NCT03329001|593133449|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
164208765|NCT03329001|593133450|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
164208766|NCT03329001|593133451|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
164208767|NCT03329001|593133452|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
164208768|NCT03329001|593133453|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
164208769|NCT03329001|593133454|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
164299682|NCT00551642|593472892|FG001|Treatment Period|Withdrawal by Subject|1|||
164323999|NCT01903252|593563257|FG005|Maintenance, Open-Label|Other|2|||
164324000|NCT00645788|593563267|FG000|Overall Study|Did not receive study drug|1|||
164324001|NCT00645788|593563268|FG001|Overall Study|Did not receive study drug|1|||
164324002|NCT00645788|593563269|FG002|Overall Study|Did not receive study drug|0|||
164324003|NCT00645788|593563270|FG003|Overall Study|Did not receive study drug|0|||
164324004|NCT00645788|593563267|FG000|Overall Study|Adverse Event|4|||
164324005|NCT00645788|593563268|FG001|Overall Study|Adverse Event|9|||
164324006|NCT00645788|593563269|FG002|Overall Study|Adverse Event|5|||
164324007|NCT00645788|593563270|FG003|Overall Study|Adverse Event|3|||
164324008|NCT00645788|593563267|FG000|Overall Study|Lost to Follow-up|1|||
164324009|NCT00645788|593563268|FG001|Overall Study|Lost to Follow-up|0|||
164324010|NCT00645788|593563269|FG002|Overall Study|Lost to Follow-up|0|||
164324011|NCT00645788|593563270|FG003|Overall Study|Lost to Follow-up|0|||
164324012|NCT00645788|593563267|FG000|Overall Study|Protocol Violation|1|||
164324013|NCT00645788|593563268|FG001|Overall Study|Protocol Violation|0|||
164324014|NCT00645788|593563269|FG002|Overall Study|Protocol Violation|2|||
164324015|NCT00645788|593563270|FG003|Overall Study|Protocol Violation|0|||
164324016|NCT00645788|593563267|FG000|Overall Study|Withdrawal by Subject|0|||
164324017|NCT00645788|593563268|FG001|Overall Study|Withdrawal by Subject|1|||
164324018|NCT00645788|593563269|FG002|Overall Study|Withdrawal by Subject|0|||
164324019|NCT00645788|593563270|FG003|Overall Study|Withdrawal by Subject|2|||
164324020|NCT00645788|593563267|FG000|Overall Study|Pulmonary exacerbation|13|||
164324021|NCT00645788|593563268|FG001|Overall Study|Pulmonary exacerbation|16|||
164324022|NCT00645788|593563269|FG002|Overall Study|Pulmonary exacerbation|11|||
164324023|NCT00645788|593563270|FG003|Overall Study|Pulmonary exacerbation|9|||
164324024|NCT01924429|593563271|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
164324025|NCT01924429|593563272|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
164324026|NCT00327470|593563275|FG000|Overall Study|Randomized, but not treated|0|||
164324027|NCT00327470|593563276|FG001|Overall Study|Randomized, but not treated|2|||
164324028|NCT00327470|593563275|FG000|Overall Study|Adverse Event|9|||
164324029|NCT00327470|593563276|FG001|Overall Study|Adverse Event|14|||
164324030|NCT00327470|593563275|FG000|Overall Study|Lack of Efficacy|7|||
164324031|NCT00327470|593563276|FG001|Overall Study|Lack of Efficacy|19|||
164324032|NCT00327470|593563275|FG000|Overall Study|Other|5|||
164324033|NCT00327470|593563276|FG001|Overall Study|Other|9|||
164324034|NCT00327470|593563275|FG000|Overall Study|Lost to Follow-up|1|||
164324035|NCT00327470|593563276|FG001|Overall Study|Lost to Follow-up|3|||
164324036|NCT00327470|593563275|FG000|Overall Study|Withdrawal by Subject|6|||
164324037|NCT00327470|593563276|FG001|Overall Study|Withdrawal by Subject|12|||
164324038|NCT00327470|593563275|FG000|Overall Study|Death|1|||
164324039|NCT00327470|593563276|FG001|Overall Study|Death|4|||
164324040|NCT01445886|593563286|FG000|Overall Study|Lost to Follow-up|2|||
164324041|NCT01445886|593563286|FG000|Overall Study|Protocol Violation|3|||
164324042|NCT01163032|593563287|FG000|Randomization Phase|Withdrawal by Subject|2|||
164324043|NCT01163032|593563288|FG001|Randomization Phase|Withdrawal by Subject|3|||
164324044|NCT01163032|593563289|FG002|Randomization Phase|Withdrawal by Subject|0|||
164324045|NCT01163032|593563287|FG000|Randomization Phase|Adverse Event|3|||
164324046|NCT01163032|593563288|FG001|Randomization Phase|Adverse Event|3|||
164324047|NCT01163032|593563289|FG002|Randomization Phase|Adverse Event|0|||
164324048|NCT01163032|593563287|FG000|Randomization Phase|Protocol Violation|0|||
164324049|NCT01163032|593563288|FG001|Randomization Phase|Protocol Violation|1|||
164324050|NCT01163032|593563289|FG002|Randomization Phase|Protocol Violation|0|||
164324051|NCT01163032|593563287|FG000|Randomization Phase|Various*|5|||
164324052|NCT01163032|593563288|FG001|Randomization Phase|Various*|4|||
164324053|NCT01163032|593563289|FG002|Randomization Phase|Various*|0|||
164324054|NCT01163032|593563287|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
164324055|NCT01163032|593563288|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
164324056|NCT01163032|593563289|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
164324057|NCT01163032|593563287|FG000|Open Label Extension Phase|Adverse Event|0|||
164324058|NCT01163032|593563288|FG001|Open Label Extension Phase|Adverse Event|0|||
164324059|NCT01163032|593563289|FG002|Open Label Extension Phase|Adverse Event|3|||
164324060|NCT01163032|593563287|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
164324061|NCT01163032|593563288|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
164324062|NCT01163032|593563289|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
164324063|NCT01163032|593563287|FG000|Open Label Extension Phase|Protocol Violation|0|||
164324064|NCT01163032|593563288|FG001|Open Label Extension Phase|Protocol Violation|0|||
164324065|NCT01163032|593563289|FG002|Open Label Extension Phase|Protocol Violation|1|||
164324066|NCT01163032|593563287|FG000|Open Label Extension Phase|Study Termination|0|||
164324067|NCT01163032|593563288|FG001|Open Label Extension Phase|Study Termination|0|||
164324068|NCT01163032|593563289|FG002|Open Label Extension Phase|Study Termination|7|||
164324069|NCT01163032|593563287|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
164324070|NCT01163032|593563288|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
164324071|NCT01163032|593563289|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
164324072|NCT03764033|593563299|FG000|Treatment Phase|Withdrawal by Subject|8|||
164324073|NCT03764033|593563300|FG001|Treatment Phase|Withdrawal by Subject|3|||
164355614|NCT01962207|593676479|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
164324074|NCT03764033|593563299|FG000|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|0|||
164324075|NCT03764033|593563300|FG001|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|1|||
164324076|NCT03764033|593563299|FG000|Six Month Follow-Up|Lost to Follow-up|0|||
164324077|NCT03764033|593563300|FG001|Six Month Follow-Up|Lost to Follow-up|5|||
164324078|NCT04594369|593563301|FG000|Overall Study|Adverse Event|10|||
164324079|NCT04594369|593563302|FG001|Overall Study|Adverse Event|10|||
164563938|NCT00695565|594432422|FG000|Overall Study|Subject did not follow instructions|1|||
164563939|NCT00695565|594432423|FG001|Overall Study|Subject did not follow instructions|1|||
164563940|NCT01462266|594432424|FG000|Overall Study|Adverse Event|7|||
164563941|NCT01462266|594432425|FG001|Overall Study|Adverse Event|6|||
164563942|NCT01462266|594432424|FG000|Overall Study|Death|2|||
164563943|NCT01462266|594432425|FG001|Overall Study|Death|1|||
164563944|NCT01462266|594432424|FG000|Overall Study|Lack of Efficacy|0|||
164563945|NCT01462266|594432425|FG001|Overall Study|Lack of Efficacy|2|||
164563946|NCT01462266|594432424|FG000|Overall Study|Lost to Follow-up|4|||
164563947|NCT01462266|594432425|FG001|Overall Study|Lost to Follow-up|3|||
164563948|NCT01462266|594432424|FG000|Overall Study|Non-compliance with study drug|3|||
164563949|NCT01462266|594432425|FG001|Overall Study|Non-compliance with study drug|0|||
164563950|NCT01462266|594432424|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
164563951|NCT01462266|594432425|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
164563952|NCT01462266|594432424|FG000|Overall Study|Physician Decision|2|||
164563953|NCT01462266|594432425|FG001|Overall Study|Physician Decision|5|||
164563954|NCT01462266|594432424|FG000|Overall Study|Protocol Violation|1|||
164563955|NCT01462266|594432425|FG001|Overall Study|Protocol Violation|3|||
164563956|NCT01462266|594432424|FG000|Overall Study|Withdrawal by Subject|7|||
164563957|NCT01462266|594432425|FG001|Overall Study|Withdrawal by Subject|2|||
164563958|NCT01462266|594432424|FG000|Overall Study|Screen failure|1|||
164563959|NCT01462266|594432425|FG001|Overall Study|Screen failure|1|||
164563960|NCT01106846|594432426|FG000|Overall Study|Change in surgical procedure|0|||
164563961|NCT01106846|594432427|FG001|Overall Study|Change in surgical procedure|1|||
164563962|NCT03110900|594432428|FG000|Overall Study|Sponsor withdrew|1|||
164563963|NCT03110900|594432429|FG001|Overall Study|Sponsor withdrew|1|||
164563964|NCT03048422|594432430|FG000|Overall Study|Death|1|||
164563965|NCT03048422|594432431|FG001|Overall Study|Death|0|||
164563966|NCT03048422|594432432|FG002|Overall Study|Death|0|||
164563967|NCT03048422|594432430|FG000|Overall Study|Lost to Follow-up|5|||
164563968|NCT03048422|594432431|FG001|Overall Study|Lost to Follow-up|0|||
164563969|NCT03048422|594432432|FG002|Overall Study|Lost to Follow-up|1|||
164563970|NCT03048422|594432430|FG000|Overall Study|Withdrawal by Subject|5|||
164563971|NCT03048422|594432431|FG001|Overall Study|Withdrawal by Subject|7|||
164563972|NCT03048422|594432432|FG002|Overall Study|Withdrawal by Subject|4|||
164563973|NCT03048422|594432430|FG000|Overall Study|Moved|3|||
164563974|NCT03048422|594432431|FG001|Overall Study|Moved|2|||
164563975|NCT03048422|594432432|FG002|Overall Study|Moved|2|||
164563976|NCT03048422|594432430|FG000|Overall Study|Noncompliant with Study Requirements|2|||
164563977|NCT03048422|594432431|FG001|Overall Study|Noncompliant with Study Requirements|1|||
164563978|NCT03048422|594432432|FG002|Overall Study|Noncompliant with Study Requirements|2|||
164563979|NCT03048422|594432430|FG000|Overall Study|Not Able to Get to Clinic|1|||
164563980|NCT03048422|594432431|FG001|Overall Study|Not Able to Get to Clinic|0|||
164563981|NCT03048422|594432432|FG002|Overall Study|Not Able to Get to Clinic|0|||
164563982|NCT02482129|594432434|FG000|Overall Study|Adverse Event-prior to treatment|0|||
164563983|NCT02482129|594432435|FG001|Overall Study|Adverse Event-prior to treatment|1|||
164563984|NCT02482129|594432434|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
164563985|NCT02482129|594432435|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
164563986|NCT02482129|594432434|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
164563987|NCT02482129|594432435|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
164563988|NCT02482129|594432434|FG000|Overall Study|Criteria not met-prior to treatment|1|||
164563989|NCT02482129|594432435|FG001|Overall Study|Criteria not met-prior to treatment|0|||
164563990|NCT02482129|594432434|FG000|Overall Study|Adverse Event|1|||
164563991|NCT02482129|594432435|FG001|Overall Study|Adverse Event|0|||
164563992|NCT02482129|594432434|FG000|Overall Study|Withdrawal by Subject|2|||
164563993|NCT02482129|594432435|FG001|Overall Study|Withdrawal by Subject|0|||
164563994|NCT02482129|594432434|FG000|Overall Study|Criteria not met|1|||
164563995|NCT02482129|594432435|FG001|Overall Study|Criteria not met|0|||
164563996|NCT00670007|594434182|FG000|Overall Study|Drug abuse|1|||
164563997|NCT00670007|594434182|FG000|Overall Study|Lung transplant|1|||
164563998|NCT00670007|594434182|FG000|Overall Study|Travel/Vacation|1|||
164563999|NCT00670007|594434182|FG000|Overall Study|Adverse event, serious fatal|1|||
164564000|NCT00670007|594434182|FG000|Overall Study|Adverse Event|1|||
164564001|NCT00670007|594434182|FG000|Overall Study|Withdrawal by Subject|4|||
164564002|NCT00200057|594434183|FG000|Overall Study|Lack of Efficacy|3|||
164564003|NCT00200057|594434183|FG000|Overall Study|Exited due to terminal illness of PI|2|||
164564004|NCT00200057|594434183|FG000|Overall Study|Withdrawal by Subject|1|||
164564005|NCT00200057|594434183|FG000|Overall Study|Change in medical condition|1|||
164564006|NCT00200057|594434183|FG000|Overall Study|Infection|1|||
164668398|NCT00549718|594811895|FG001|Overall Study|Adverse Event|8|||
164668399|NCT00549718|594811896|FG002|Overall Study|Adverse Event|7|||
164668400|NCT00549718|594811897|FG003|Overall Study|Adverse Event|3|||
164668401|NCT00549718|594811894|FG000|Overall Study|Lost to Follow-up|4|||
164668402|NCT00549718|594811895|FG001|Overall Study|Lost to Follow-up|2|||
164668403|NCT00549718|594811896|FG002|Overall Study|Lost to Follow-up|0|||
164668404|NCT00549718|594811897|FG003|Overall Study|Lost to Follow-up|6|||
164668405|NCT00549718|594811894|FG000|Overall Study|Withdrawal by Subject|9|||
164668406|NCT00549718|594811895|FG001|Overall Study|Withdrawal by Subject|18|||
164324080|NCT04594369|593563303|FG002|Overall Study|Adverse Event|9|||
164324081|NCT04594369|593563301|FG000|Overall Study|Death|2|||
164668407|NCT00549718|594811896|FG002|Overall Study|Withdrawal by Subject|12|||
164668408|NCT00549718|594811897|FG003|Overall Study|Withdrawal by Subject|13|||
164668409|NCT00549718|594811894|FG000|Overall Study|Administrative|2|||
164668410|NCT00549718|594811895|FG001|Overall Study|Administrative|2|||
164668411|NCT00549718|594811896|FG002|Overall Study|Administrative|2|||
164668412|NCT00549718|594811897|FG003|Overall Study|Administrative|1|||
164668413|NCT01725529|594811903|FG000|Overall Study|Adverse Event|1|||
164668414|NCT01725529|594811904|FG001|Overall Study|Adverse Event|0|||
164668415|NCT01725529|594811905|FG002|Overall Study|Adverse Event|0|||
164668416|NCT01725529|594811903|FG000|Overall Study|Lost to Follow-up|2|||
164668417|NCT01725529|594811904|FG001|Overall Study|Lost to Follow-up|1|||
164668418|NCT01725529|594811905|FG002|Overall Study|Lost to Follow-up|1|||
164668419|NCT01725529|594811903|FG000|Overall Study|Protocol Violation|0|||
164668420|NCT01725529|594811904|FG001|Overall Study|Protocol Violation|1|||
164668421|NCT01725529|594811905|FG002|Overall Study|Protocol Violation|1|||
164668422|NCT01725529|594811903|FG000|Overall Study|Withdrawal by Subject|12|||
164324082|NCT04594369|593563302|FG001|Overall Study|Death|4|||
164324083|NCT04594369|593563303|FG002|Overall Study|Death|8|||
164324084|NCT04594369|593563301|FG000|Overall Study|Lost to Follow-up|10|||
164324085|NCT04594369|593563302|FG001|Overall Study|Lost to Follow-up|2|||
164324086|NCT04594369|593563303|FG002|Overall Study|Lost to Follow-up|4|||
164324087|NCT04594369|593563301|FG000|Overall Study|Physician Decision|2|||
164324088|NCT04594369|593563302|FG001|Overall Study|Physician Decision|2|||
164324089|NCT04594369|593563303|FG002|Overall Study|Physician Decision|3|||
164324090|NCT04594369|593563301|FG000|Overall Study|Protocol deviation|1|||
164564007|NCT00200057|594434183|FG000|Overall Study|Death|1|||
164668423|NCT01725529|594811904|FG001|Overall Study|Withdrawal by Subject|14|||
164324091|NCT04594369|593563302|FG001|Overall Study|Protocol deviation|3|||
164324092|NCT04594369|593563303|FG002|Overall Study|Protocol deviation|2|||
164564008|NCT00778830|594434185|FG000|Overall Study|Ongoing at data cut-off|0|||
164564009|NCT00778830|594434186|FG001|Overall Study|Ongoing at data cut-off|1|||
164564010|NCT03593915|594434187|FG000|Overall Study|Adverse Event|0|||
164564011|NCT03593915|594434188|FG001|Overall Study|Adverse Event|0|||
164564012|NCT03593915|594434189|FG002|Overall Study|Adverse Event|0|||
164564013|NCT03593915|594434190|FG003|Overall Study|Adverse Event|1|||
164564014|NCT03593915|594434191|FG004|Overall Study|Adverse Event|0|||
164564015|NCT03593915|594434192|FG005|Overall Study|Adverse Event|0|||
164564016|NCT03593915|594434187|FG000|Overall Study|Physician Decision|0|||
164564017|NCT03593915|594434188|FG001|Overall Study|Physician Decision|0|||
164564018|NCT03593915|594434189|FG002|Overall Study|Physician Decision|0|||
164564019|NCT03593915|594434190|FG003|Overall Study|Physician Decision|0|||
164564020|NCT03593915|594434191|FG004|Overall Study|Physician Decision|0|||
164564021|NCT03593915|594434192|FG005|Overall Study|Physician Decision|1|||
164564022|NCT05512949|594434193|FG000|Overall Study|Lost to Follow-up|4|||
164564023|NCT05512949|594434194|FG001|Overall Study|Lost to Follow-up|6|||
164564024|NCT05512949|594434195|FG002|Overall Study|Lost to Follow-up|2|||
164564025|NCT05512949|594434193|FG000|Overall Study|Protocol Violation|0|||
164564026|NCT05512949|594434194|FG001|Overall Study|Protocol Violation|0|||
164564027|NCT05512949|594434195|FG002|Overall Study|Protocol Violation|1|||
164564028|NCT05512949|594434193|FG000|Overall Study|Withdrawal by Subject|1|||
164564029|NCT05512949|594434194|FG001|Overall Study|Withdrawal by Subject|1|||
164564030|NCT05512949|594434195|FG002|Overall Study|Withdrawal by Subject|2|||
164324093|NCT04594369|593563301|FG000|Overall Study|Withdrawal by Subject|40|||
164324094|NCT04594369|593563302|FG001|Overall Study|Withdrawal by Subject|32|||
164324095|NCT04594369|593563303|FG002|Overall Study|Withdrawal by Subject|37|||
164668424|NCT01725529|594811905|FG002|Overall Study|Withdrawal by Subject|8|||
164668425|NCT01315249|594811907|FG000|Overall Study|Adverse Event|22|||
164668426|NCT01315249|594811908|FG001|Overall Study|Adverse Event|26|||
164324096|NCT04594369|593563301|FG000|Overall Study|Reason not specified|60|||
164324097|NCT04594369|593563302|FG001|Overall Study|Reason not specified|56|||
164564031|NCT05512949|594434193|FG000|Overall Study|Completion status unknown|1|||
164564032|NCT05512949|594434194|FG001|Overall Study|Completion status unknown|3|||
164564033|NCT05512949|594434195|FG002|Overall Study|Completion status unknown|0|||
164564034|NCT01246206|594434196|FG000|Overall Study|Patient did not receive study regiments.|1|||
164564035|NCT02002975|594434197|FG000|Overall Study|Case Report Forms Uncollected|135|||
164564036|NCT02002975|594434197|FG000|Overall Study|Protocol Deviation|437|||
164564037|NCT03523351|594434198|FG000|Overall Study|Death|13|||
164668427|NCT01315249|594811907|FG000|Overall Study|Withdrawal by Subject|11|||
164564038|NCT03523351|594434199|FG001|Overall Study|Death|11|||
164564039|NCT03523351|594434198|FG000|Overall Study|Lost to Follow-up|2|||
164564040|NCT03523351|594434199|FG001|Overall Study|Lost to Follow-up|3|||
164564041|NCT03523351|594434198|FG000|Overall Study|Withdrawal by Subject|4|||
164564042|NCT03523351|594434199|FG001|Overall Study|Withdrawal by Subject|0|||
164564043|NCT03523351|594434198|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
164564044|NCT03523351|594434199|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
164564045|NCT03609619|594434200|FG000|Overall Study|Adverse Event|1|||
164564046|NCT03609619|594434201|FG001|Overall Study|Adverse Event|0|||
164564047|NCT03609619|594434200|FG000|Overall Study|Lack of Efficacy|1|||
164564048|NCT03609619|594434201|FG001|Overall Study|Lack of Efficacy|2|||
164564049|NCT03609619|594434200|FG000|Overall Study|Protocol Violation|5|||
164564050|NCT03609619|594434201|FG001|Overall Study|Protocol Violation|0|||
164564051|NCT03609619|594434200|FG000|Overall Study|Withdrawal by Subject|2|||
164564052|NCT03609619|594434201|FG001|Overall Study|Withdrawal by Subject|3|||
164564053|NCT03609619|594434200|FG000|Overall Study|Lost to Follow-up|1|||
164564054|NCT03609619|594434201|FG001|Overall Study|Lost to Follow-up|1|||
164564055|NCT00688909|594434202|FG000|Overall Study|Adverse Event|28|||
164564056|NCT00688909|594434202|FG000|Overall Study|Patient withdrew consent|2|||
164564057|NCT00688909|594434202|FG000|Overall Study|Administrative problems|1|||
164564058|NCT00688909|594434202|FG000|Overall Study|Protocol Violation|2|||
164564059|NCT02472847|594434204|FG000|Overall Study|Withdrawal by Subject|1|||
164564060|NCT02472847|594434205|FG001|Overall Study|Withdrawal by Subject|5|||
164564061|NCT05499520|594434209|FG000|Overall Study|Lost to Follow-up|0|||
164564062|NCT05499520|594434210|FG001|Overall Study|Lost to Follow-up|0|||
164564063|NCT05499520|594434211|FG002|Overall Study|Lost to Follow-up|38|||
164564064|NCT05499520|594434212|FG003|Overall Study|Lost to Follow-up|41|||
164564065|NCT05499520|594434213|FG004|Overall Study|Lost to Follow-up|46|||
164564066|NCT05499520|594434214|FG005|Overall Study|Lost to Follow-up|0|||
164564067|NCT05499520|594434215|FG006|Overall Study|Lost to Follow-up|31|||
164564068|NCT05499520|594434216|FG007|Overall Study|Lost to Follow-up|45|||
164564069|NCT05499520|594434217|FG008|Overall Study|Lost to Follow-up|42|||
164564070|NCT05499520|594434218|FG009|Overall Study|Lost to Follow-up|0|||
164564071|NCT05499520|594434219|FG010|Overall Study|Lost to Follow-up|0|||
164564072|NCT05499520|594434220|FG011|Overall Study|Lost to Follow-up|37|||
164564073|NCT05499520|594434221|FG012|Overall Study|Lost to Follow-up|53|||
164564074|NCT05499520|594434222|FG013|Overall Study|Lost to Follow-up|49|||
164564075|NCT05499520|594434223|FG014|Overall Study|Lost to Follow-up|0|||
164564076|NCT05499520|594434224|FG015|Overall Study|Lost to Follow-up|36|||
164564077|NCT05499520|594434225|FG016|Overall Study|Lost to Follow-up|58|||
164564078|NCT05499520|594434226|FG017|Overall Study|Lost to Follow-up|53|||
164564079|NCT01613326|594434227|FG000|Overall Study|Adverse Event|7|||
164564080|NCT01613326|594434228|FG001|Overall Study|Adverse Event|5|||
164564081|NCT01613326|594434227|FG000|Overall Study|Withdrawal by Subject|3|||
164564082|NCT01613326|594434228|FG001|Overall Study|Withdrawal by Subject|4|||
164564083|NCT01613326|594434227|FG000|Overall Study|Abnormal test procedure result(s)|2|||
164564084|NCT01613326|594434228|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164564085|NCT01613326|594434227|FG000|Overall Study|inability to use device|1|||
164564086|NCT01613326|594434228|FG001|Overall Study|inability to use device|0|||
164564087|NCT01613326|594434227|FG000|Overall Study|Lack of Efficacy|0|||
164564088|NCT01613326|594434228|FG001|Overall Study|Lack of Efficacy|1|||
164564089|NCT01613326|594434227|FG000|Overall Study|Lost to Follow-up|0|||
164564090|NCT01613326|594434228|FG001|Overall Study|Lost to Follow-up|1|||
164564091|NCT01613326|594434227|FG000|Overall Study|Administrative|0|||
164564092|NCT01613326|594434228|FG001|Overall Study|Administrative|2|||
164564093|NCT01613326|594434227|FG000|Overall Study|Protocol Violation|0|||
164564094|NCT01613326|594434228|FG001|Overall Study|Protocol Violation|1|||
164564095|NCT00793793|594434229|FG000|Overall Study|Adverse Event|0|||
164564096|NCT00793793|594434230|FG001|Overall Study|Adverse Event|0|||
164564097|NCT00793793|594434231|FG002|Overall Study|Adverse Event|1|||
164564098|NCT00793793|594434232|FG003|Overall Study|Adverse Event|1|||
164564099|NCT00793793|594434233|FG004|Overall Study|Adverse Event|0|||
164564100|NCT00793793|594434234|FG005|Overall Study|Adverse Event|1|||
164668428|NCT01315249|594811908|FG001|Overall Study|Withdrawal by Subject|10|||
164668429|NCT01315249|594811907|FG000|Overall Study|Protocol Violation|8|||
164564101|NCT00793793|594434235|FG006|Overall Study|Adverse Event|2|||
164564102|NCT00793793|594434236|FG007|Overall Study|Adverse Event|0|||
164564103|NCT00793793|594434237|FG008|Overall Study|Adverse Event|0|||
164564104|NCT00793793|594434238|FG009|Overall Study|Adverse Event|0|||
164564105|NCT00793793|594434239|FG010|Overall Study|Adverse Event|0|||
164564106|NCT00793793|594434240|FG011|Overall Study|Adverse Event|2|||
164564107|NCT00793793|594434229|FG000|Overall Study|Protocol Violation|0|||
164564108|NCT00793793|594434230|FG001|Overall Study|Protocol Violation|0|||
164564109|NCT00793793|594434231|FG002|Overall Study|Protocol Violation|0|||
164564110|NCT00793793|594434232|FG003|Overall Study|Protocol Violation|1|||
164668430|NCT01315249|594811908|FG001|Overall Study|Protocol Violation|5|||
164564111|NCT00793793|594434233|FG004|Overall Study|Protocol Violation|0|||
164564112|NCT00793793|594434234|FG005|Overall Study|Protocol Violation|0|||
164208770|NCT03329001|593133455|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
164208771|NCT03329001|593133448|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
164208772|NCT03329001|593133449|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
164208773|NCT03329001|593133450|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
164208774|NCT03329001|593133451|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
164208775|NCT03329001|593133452|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
164208776|NCT03329001|593133453|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
164208777|NCT03329001|593133454|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
164208778|NCT03329001|593133455|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
164208779|NCT03329001|593133448|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
164208780|NCT03329001|593133449|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
164208781|NCT03329001|593133450|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
164208782|NCT03329001|593133451|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
164299683|NCT03337308|593472893|FG000|Overall Study|Adverse Event|2|||
164299684|NCT03337308|593472894|FG001|Overall Study|Adverse Event|3|||
164324098|NCT04594369|593563303|FG002|Overall Study|Reason not specified|43|||
164324099|NCT01006603|593563304|FG000|Overall Study|Withdrawal by Subject|17|||
164324100|NCT01006603|593563305|FG001|Overall Study|Withdrawal by Subject|19|||
164324101|NCT01006603|593563304|FG000|Overall Study|Lost to Follow-up|0|||
164324102|NCT01006603|593563305|FG001|Overall Study|Lost to Follow-up|1|||
164324103|NCT01006603|593563304|FG000|Overall Study|Safety reason|1|||
164324104|NCT01006603|593563305|FG001|Overall Study|Safety reason|1|||
164324105|NCT01006603|593563304|FG000|Overall Study|Protocol Violation|1|||
164324106|NCT01006603|593563305|FG001|Overall Study|Protocol Violation|3|||
164324107|NCT01006603|593563304|FG000|Overall Study|Incorrect enrolment|0|||
164324108|NCT01006603|593563305|FG001|Overall Study|Incorrect enrolment|2|||
164324109|NCT01006603|593563304|FG000|Overall Study|Adverse Event|15|||
164324110|NCT01006603|593563305|FG001|Overall Study|Adverse Event|7|||
164324111|NCT01006603|593563304|FG000|Overall Study|Death|1|||
164324112|NCT01006603|593563305|FG001|Overall Study|Death|1|||
164324113|NCT01006603|593563304|FG000|Overall Study|Study specific discontinuation criteria|33|||
164324114|NCT01006603|593563305|FG001|Overall Study|Study specific discontinuation criteria|34|||
164324115|NCT01006603|593563304|FG000|Overall Study|Other|3|||
164324116|NCT01006603|593563305|FG001|Overall Study|Other|7|||
164324117|NCT03875235|593563307|FG000|Overall Study|Ongoing study treatment|63|||
164324118|NCT03875235|593563308|FG001|Overall Study|Ongoing study treatment|20|||
164324119|NCT03875235|593563307|FG000|Overall Study|Off treatment|77|||
164324120|NCT03875235|593563308|FG001|Overall Study|Off treatment|91|||
164324121|NCT03875235|593563307|FG000|Overall Study|Withdrawal by Subject|3|||
164324122|NCT03875235|593563308|FG001|Overall Study|Withdrawal by Subject|10|||
164324123|NCT03875235|593563307|FG000|Overall Study|Death|198|||
164324124|NCT03875235|593563308|FG001|Overall Study|Death|223|||
164324125|NCT02003365|593565115|FG000|Overall Study|Lost to Follow-up|0|||
164324126|NCT02003365|593565116|FG001|Overall Study|Lost to Follow-up|0|||
164324127|NCT02003365|593565117|FG002|Overall Study|Lost to Follow-up|1|||
164324128|NCT02582255|593565122|FG000|Overall Study|Protocol Violation|0|||
164324129|NCT02582255|593565123|FG001|Overall Study|Protocol Violation|3|||
164324130|NCT01709578|593565124|FG000|Overall Study|Rescued and entered in long term safety|63|||
164324131|NCT01709578|593565125|FG001|Overall Study|Rescued and entered in long term safety|25|||
164324132|NCT01709578|593565126|FG002|Overall Study|Rescued and entered in long term safety|26|||
164324133|NCT01709578|593565124|FG000|Overall Study|Adverse Event|9|||
164324134|NCT01709578|593565125|FG001|Overall Study|Adverse Event|18|||
164324135|NCT01709578|593565126|FG002|Overall Study|Adverse Event|17|||
164324136|NCT01709578|593565124|FG000|Overall Study|Lack of Efficacy|5|||
164564113|NCT00793793|594434235|FG006|Overall Study|Protocol Violation|0|||
164564114|NCT00793793|594434236|FG007|Overall Study|Protocol Violation|0|||
164564115|NCT00793793|594434237|FG008|Overall Study|Protocol Violation|0|||
164564116|NCT00793793|594434238|FG009|Overall Study|Protocol Violation|0|||
164564117|NCT00793793|594434239|FG010|Overall Study|Protocol Violation|0|||
164564118|NCT00793793|594434240|FG011|Overall Study|Protocol Violation|0|||
164299685|NCT03337308|593472895|FG002|Overall Study|Adverse Event|3|||
164299686|NCT03337308|593472896|FG003|Overall Study|Adverse Event|1|||
164299687|NCT03337308|593472893|FG000|Overall Study|Lost to Follow-up|1|||
164299688|NCT03337308|593472894|FG001|Overall Study|Lost to Follow-up|2|||
164299689|NCT03337308|593472895|FG002|Overall Study|Lost to Follow-up|0|||
164299690|NCT03337308|593472896|FG003|Overall Study|Lost to Follow-up|0|||
164299691|NCT03337308|593472893|FG000|Overall Study|Withdrawal by Subject|2|||
164299692|NCT03337308|593472894|FG001|Overall Study|Withdrawal by Subject|1|||
164299693|NCT03337308|593472895|FG002|Overall Study|Withdrawal by Subject|2|||
164299694|NCT03337308|593472896|FG003|Overall Study|Withdrawal by Subject|1|||
164299695|NCT03337308|593472893|FG000|Overall Study|Protocol Violation|0|||
164299696|NCT03337308|593472894|FG001|Overall Study|Protocol Violation|1|||
164208783|NCT03329001|593133452|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
164208784|NCT03329001|593133453|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
164208785|NCT03329001|593133454|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
164668431|NCT01315249|594811907|FG000|Overall Study|Abnormal test results|1|||
164208786|NCT03329001|593133455|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
164208787|NCT03329001|593133448|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
164208788|NCT03329001|593133449|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
164208789|NCT03329001|593133450|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
164208790|NCT03329001|593133451|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
164208791|NCT03329001|593133452|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
164208792|NCT03329001|593133453|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
164208793|NCT03329001|593133454|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
164208794|NCT03329001|593133455|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
164208795|NCT03329001|593133448|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
164208796|NCT03329001|593133449|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
164208797|NCT03329001|593133450|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
164208798|NCT03329001|593133451|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
164208799|NCT03329001|593133452|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
164208800|NCT03329001|593133453|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
164208801|NCT03329001|593133454|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
164208802|NCT03329001|593133455|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
164208803|NCT03329001|593133448|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
164208804|NCT03329001|593133449|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
164208805|NCT03329001|593133450|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
164208806|NCT03329001|593133451|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
164208807|NCT03329001|593133452|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
164208808|NCT03329001|593133453|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
164208809|NCT03329001|593133454|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
164208810|NCT03329001|593133455|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
164208811|NCT03329001|593133448|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
164208812|NCT03329001|593133449|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
164208813|NCT03329001|593133450|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
164208814|NCT03329001|593133451|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
164208815|NCT03329001|593133452|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
164208816|NCT03329001|593133453|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
164208817|NCT03329001|593133454|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
164208818|NCT03329001|593133455|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
164208819|NCT03329001|593133448|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
164208820|NCT03329001|593133449|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
164208821|NCT03329001|593133450|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
164208822|NCT03329001|593133451|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
164208823|NCT03329001|593133452|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
164208824|NCT03329001|593133453|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
164208825|NCT03329001|593133454|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
164208826|NCT03329001|593133455|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
164208827|NCT03329001|593133448|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
164208828|NCT03329001|593133449|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
164208829|NCT03329001|593133450|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
164208830|NCT03329001|593133451|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
164208831|NCT03329001|593133452|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
164208832|NCT03329001|593133453|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
164208833|NCT03329001|593133454|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
164208834|NCT03329001|593133455|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
164208835|NCT03329001|593133448|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
164208836|NCT03329001|593133449|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
164208837|NCT03329001|593133450|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
164299697|NCT03337308|593472895|FG002|Overall Study|Protocol Violation|0|||
164668432|NCT01315249|594811908|FG001|Overall Study|Abnormal test results|2|||
164668433|NCT01315249|594811907|FG000|Overall Study|Administrative problems|1|||
164668434|NCT01315249|594811908|FG001|Overall Study|Administrative problems|0|||
164668435|NCT01315249|594811907|FG000|Overall Study|inability to use device|1|||
164668436|NCT01315249|594811908|FG001|Overall Study|inability to use device|0|||
164668437|NCT01315249|594811907|FG000|Overall Study|Lack of Efficacy|0|||
164668438|NCT01315249|594811908|FG001|Overall Study|Lack of Efficacy|1|||
164324137|NCT01709578|593565125|FG001|Overall Study|Lack of Efficacy|4|||
164324138|NCT01709578|593565126|FG002|Overall Study|Lack of Efficacy|2|||
164324139|NCT01709578|593565124|FG000|Overall Study|Poor compliance to protocol|1|||
164324140|NCT01709578|593565125|FG001|Overall Study|Poor compliance to protocol|2|||
164324141|NCT01709578|593565126|FG002|Overall Study|Poor compliance to protocol|1|||
164324142|NCT01709578|593565124|FG000|Overall Study|Other, not related to safety or efficacy|2|||
164324143|NCT01709578|593565125|FG001|Overall Study|Other, not related to safety or efficacy|7|||
164324144|NCT01709578|593565126|FG002|Overall Study|Other, not related to safety or efficacy|5|||
164324145|NCT04050371|593565127|FG000|Overall Study|Withdrawal by Subject|1|||
164324146|NCT04050371|593565128|FG001|Overall Study|Withdrawal by Subject|0|||
164564119|NCT00793793|594434229|FG000|Overall Study|Lost to Follow-up|0|||
164564120|NCT00793793|594434230|FG001|Overall Study|Lost to Follow-up|0|||
164564121|NCT00793793|594434231|FG002|Overall Study|Lost to Follow-up|1|||
164564122|NCT00793793|594434232|FG003|Overall Study|Lost to Follow-up|0|||
164564123|NCT00793793|594434233|FG004|Overall Study|Lost to Follow-up|0|||
164564124|NCT00793793|594434234|FG005|Overall Study|Lost to Follow-up|0|||
164564125|NCT00793793|594434235|FG006|Overall Study|Lost to Follow-up|0|||
164564126|NCT00793793|594434236|FG007|Overall Study|Lost to Follow-up|0|||
164564127|NCT00793793|594434237|FG008|Overall Study|Lost to Follow-up|1|||
164564128|NCT00793793|594434238|FG009|Overall Study|Lost to Follow-up|3|||
164564129|NCT00793793|594434239|FG010|Overall Study|Lost to Follow-up|1|||
164564130|NCT00793793|594434240|FG011|Overall Study|Lost to Follow-up|0|||
164564131|NCT00793793|594434229|FG000|Overall Study|Withdrawal by Subject|0|||
164564132|NCT00793793|594434230|FG001|Overall Study|Withdrawal by Subject|0|||
164564133|NCT00793793|594434231|FG002|Overall Study|Withdrawal by Subject|0|||
164564134|NCT00793793|594434232|FG003|Overall Study|Withdrawal by Subject|0|||
164564135|NCT00793793|594434233|FG004|Overall Study|Withdrawal by Subject|1|||
164564136|NCT00793793|594434234|FG005|Overall Study|Withdrawal by Subject|0|||
164564137|NCT00793793|594434235|FG006|Overall Study|Withdrawal by Subject|0|||
164564138|NCT00793793|594434236|FG007|Overall Study|Withdrawal by Subject|0|||
164564139|NCT00793793|594434237|FG008|Overall Study|Withdrawal by Subject|1|||
164564140|NCT00793793|594434238|FG009|Overall Study|Withdrawal by Subject|0|||
164564141|NCT00793793|594434239|FG010|Overall Study|Withdrawal by Subject|0|||
164564142|NCT00793793|594434240|FG011|Overall Study|Withdrawal by Subject|0|||
164564143|NCT00793793|594434229|FG000|Overall Study|reason not specified|0|||
164564144|NCT00793793|594434230|FG001|Overall Study|reason not specified|1|||
164564145|NCT00793793|594434231|FG002|Overall Study|reason not specified|0|||
164564146|NCT00793793|594434232|FG003|Overall Study|reason not specified|1|||
164564147|NCT00793793|594434233|FG004|Overall Study|reason not specified|1|||
164564148|NCT00793793|594434234|FG005|Overall Study|reason not specified|1|||
164564149|NCT00793793|594434235|FG006|Overall Study|reason not specified|2|||
164564150|NCT00793793|594434236|FG007|Overall Study|reason not specified|0|||
164564151|NCT00793793|594434237|FG008|Overall Study|reason not specified|7|||
164564152|NCT00793793|594434238|FG009|Overall Study|reason not specified|6|||
164564153|NCT00793793|594434239|FG010|Overall Study|reason not specified|2|||
164564154|NCT00793793|594434240|FG011|Overall Study|reason not specified|4|||
164564155|NCT00840827|594434241|FG000|Overall Study|Adverse Event|1|||
164564156|NCT00840827|594434241|FG000|Overall Study|Lack of Efficacy|4|||
164564157|NCT00840827|594434241|FG000|Overall Study|Physician Decision|1|||
164564158|NCT01940484|594434242|FG000|Overall Study|Withdrawal by Subject|3|||
164564159|NCT01940484|594434242|FG000|Overall Study|Underwent transplantation|4|||
164564160|NCT01940484|594434242|FG000|Overall Study|Death|2|||
164564161|NCT01940484|594434242|FG000|Overall Study|Adverse Event|1|||
164564162|NCT02658448|594434245|FG000|Overall Study|Lost to Follow-up|1|||
164564163|NCT00584194|594434246|FG000|Overall Study|Other|135|||
164564164|NCT00331409|594434247|FG000|Overall Study|Lack of Efficacy|4|||
164564165|NCT01482910|594434248|FG000|Overall Study|Adverse Event|6|||
164564166|NCT01482910|594434249|FG001|Overall Study|Adverse Event|5|||
164564167|NCT01482910|594434248|FG000|Overall Study|Lost to Follow-up|0|||
164564168|NCT01482910|594434249|FG001|Overall Study|Lost to Follow-up|1|||
164564169|NCT01482910|594434248|FG000|Overall Study|Protocol Violation|1|||
164564170|NCT01482910|594434249|FG001|Overall Study|Protocol Violation|1|||
164564171|NCT01482910|594434248|FG000|Overall Study|Withdrawal by Subject|7|||
164564172|NCT01482910|594434249|FG001|Overall Study|Withdrawal by Subject|2|||
164564173|NCT01482910|594434248|FG000|Overall Study|Death|1|||
164564174|NCT01482910|594434249|FG001|Overall Study|Death|0|||
164564175|NCT02614079|594434250|FG000|Overall Study|Withdrawal by Subject|1|||
164564176|NCT01961544|594434251|FG000|Overall Study|Protocol Violation|1|||
164324147|NCT00597701|593565129|FG000|Overall Study|Withdrawal by Subject|5|||
164564177|NCT01961544|594434251|FG000|Overall Study|Withdrawal by Subject|7|||
164564178|NCT01961544|594434251|FG000|Overall Study|Adverse Event|1|||
164564179|NCT01961544|594434251|FG000|Overall Study|Physician Decision|2|||
164564180|NCT01961544|594434251|FG000|Overall Study|Poor Tolerance|1|||
164564181|NCT01961544|594434251|FG000|Overall Study|Aggravation of Steral Pain|1|||
164564182|NCT03665285|594434254|FG000|Overall Study|Started New Anticancer Treatment|1|||
164668439|NCT01315249|594811907|FG000|Overall Study|Lost to Follow-up|0|||
164668440|NCT01315249|594811908|FG001|Overall Study|Lost to Follow-up|2|||
164668441|NCT01315249|594811907|FG000|Overall Study|Death|0|||
164324148|NCT00597701|593565130|FG001|Overall Study|Withdrawal by Subject|5|||
164324149|NCT00597701|593565129|FG000|Overall Study|Death|0|||
164324150|NCT00597701|593565130|FG001|Overall Study|Death|1|||
164324151|NCT00597701|593565129|FG000|Overall Study|Physician Decision|2|||
164324152|NCT00597701|593565130|FG001|Overall Study|Physician Decision|0|||
164324153|NCT00597701|593565129|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
164324154|NCT00597701|593565130|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
164324155|NCT04078178|593565135|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
164324156|NCT04078178|593565136|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
164324157|NCT04078178|593565135|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
164324158|NCT04078178|593565136|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
164324159|NCT04078178|593565135|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
164324160|NCT04078178|593565136|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
164324161|NCT04078178|593565135|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
164324162|NCT04078178|593565136|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
164324163|NCT04078178|593565135|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
164324164|NCT04078178|593565136|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
164324165|NCT04617795|593565137|FG000|Main Study|Lost to Follow-up|1|||
164324166|NCT04617795|593565138|FG001|Main Study|Lost to Follow-up|0|||
164324167|NCT04850313|593565139|FG000|Overall Study|Withdrawal by Subject|0|||
164324168|NCT04850313|593565140|FG001|Overall Study|Withdrawal by Subject|1|||
164324169|NCT03505671|593565145|FG000|Overall Study|Withdrawal by Subject|2|||
164324170|NCT03505671|593565146|FG001|Overall Study|Withdrawal by Subject|1|||
164324171|NCT03505671|593565145|FG000|Overall Study|Lost to Follow-up|1|||
164324172|NCT03505671|593565146|FG001|Overall Study|Lost to Follow-up|0|||
164324173|NCT02038829|593565147|FG000|Washout Period 1|Death|0|||
164324174|NCT02038829|593565148|FG001|Washout Period 1|Death|0|||
164324175|NCT02038829|593565149|FG002|Washout Period 1|Death|0|||
164324176|NCT02038829|593565150|FG003|Washout Period 1|Death|0|||
164324177|NCT02038829|593565151|FG004|Washout Period 1|Death|1|||
164324178|NCT02038829|593565152|FG005|Washout Period 1|Death|0|||
164324179|NCT02038829|593565153|FG006|Washout Period 1|Death|0|||
164324180|NCT02038829|593565154|FG007|Washout Period 1|Death|0|||
164324181|NCT02038829|593565155|FG008|Washout Period 1|Death|0|||
164324182|NCT02038829|593565156|FG009|Washout Period 1|Death|0|||
164324183|NCT02038829|593565157|FG010|Washout Period 1|Death|0|||
164324184|NCT02038829|593565158|FG011|Washout Period 1|Death|0|||
164324185|NCT02038829|593565147|FG000|Treatment Period 2|Adverse Event|0|||
164324186|NCT02038829|593565148|FG001|Treatment Period 2|Adverse Event|0|||
164324187|NCT02038829|593565149|FG002|Treatment Period 2|Adverse Event|0|||
164324188|NCT02038829|593565150|FG003|Treatment Period 2|Adverse Event|0|||
164324189|NCT02038829|593565151|FG004|Treatment Period 2|Adverse Event|0|||
164324190|NCT02038829|593565152|FG005|Treatment Period 2|Adverse Event|0|||
164324191|NCT02038829|593565153|FG006|Treatment Period 2|Adverse Event|0|||
164564183|NCT03665285|594434255|FG001|Overall Study|Started New Anticancer Treatment|1|||
164564184|NCT03665285|594434256|FG002|Overall Study|Started New Anticancer Treatment|2|||
164564185|NCT03665285|594434257|FG003|Overall Study|Started New Anticancer Treatment|4|||
164564186|NCT03665285|594434258|FG004|Overall Study|Started New Anticancer Treatment|1|||
164564187|NCT03665285|594434259|FG005|Overall Study|Started New Anticancer Treatment|1|||
164564188|NCT03665285|594434260|FG006|Overall Study|Started New Anticancer Treatment|2|||
164564189|NCT03665285|594434261|FG007|Overall Study|Started New Anticancer Treatment|15|||
164564190|NCT03665285|594434262|FG008|Overall Study|Started New Anticancer Treatment|1|||
164564191|NCT03665285|594434254|FG000|Overall Study|Disease Progression|0|||
164564192|NCT03665285|594434255|FG001|Overall Study|Disease Progression|0|||
164564193|NCT03665285|594434256|FG002|Overall Study|Disease Progression|3|||
164564194|NCT03665285|594434257|FG003|Overall Study|Disease Progression|1|||
164564195|NCT03665285|594434258|FG004|Overall Study|Disease Progression|0|||
164564196|NCT03665285|594434259|FG005|Overall Study|Disease Progression|0|||
164564197|NCT03665285|594434260|FG006|Overall Study|Disease Progression|0|||
164564198|NCT03665285|594434261|FG007|Overall Study|Disease Progression|7|||
164564199|NCT03665285|594434262|FG008|Overall Study|Disease Progression|1|||
164564200|NCT03665285|594434254|FG000|Overall Study|Hospice|0|||
164564201|NCT03665285|594434255|FG001|Overall Study|Hospice|0|||
164564202|NCT03665285|594434256|FG002|Overall Study|Hospice|0|||
164324192|NCT02038829|593565154|FG007|Treatment Period 2|Adverse Event|0|||
164324193|NCT02038829|593565155|FG008|Treatment Period 2|Adverse Event|0|||
164324194|NCT02038829|593565156|FG009|Treatment Period 2|Adverse Event|0|||
164564203|NCT03665285|594434257|FG003|Overall Study|Hospice|0|||
164564204|NCT03665285|594434258|FG004|Overall Study|Hospice|0|||
164564205|NCT03665285|594434259|FG005|Overall Study|Hospice|0|||
164564206|NCT03665285|594434260|FG006|Overall Study|Hospice|0|||
164564207|NCT03665285|594434261|FG007|Overall Study|Hospice|2|||
164564208|NCT03665285|594434262|FG008|Overall Study|Hospice|0|||
164324195|NCT02038829|593565157|FG010|Treatment Period 2|Adverse Event|1|||
164324196|NCT02038829|593565158|FG011|Treatment Period 2|Adverse Event|0|||
164324197|NCT02038829|593565147|FG000|Treatment Period 2|Withdrawal by Subject|1|||
164324198|NCT02038829|593565148|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164324199|NCT02038829|593565149|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164324200|NCT02038829|593565150|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164208838|NCT03329001|593133451|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
164208839|NCT03329001|593133452|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
164208840|NCT03329001|593133453|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
164208841|NCT03329001|593133454|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
164208842|NCT03329001|593133455|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
164208843|NCT03329001|593133448|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
164208844|NCT03329001|593133449|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
164208845|NCT03329001|593133450|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
164208846|NCT03329001|593133451|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
164208847|NCT03329001|593133452|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
164208848|NCT03329001|593133453|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
164208849|NCT03329001|593133454|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
164208850|NCT03329001|593133455|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
164208851|NCT03329001|593133448|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
164208852|NCT03329001|593133449|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
164208853|NCT03329001|593133450|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
164208854|NCT03329001|593133451|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
164208855|NCT03329001|593133452|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
164208856|NCT03329001|593133453|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
164208857|NCT03329001|593133454|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
164208858|NCT03329001|593133455|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
164208859|NCT03329001|593133448|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
164208860|NCT03329001|593133449|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
164208861|NCT03329001|593133450|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
164208862|NCT03329001|593133451|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
164208863|NCT03329001|593133452|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
164208864|NCT03329001|593133453|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
164208865|NCT03329001|593133454|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
164208866|NCT03329001|593133455|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
164208867|NCT03329001|593133448|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
164208868|NCT03329001|593133449|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
164208869|NCT03329001|593133450|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
164208870|NCT03329001|593133451|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
164208871|NCT03329001|593133452|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
164208872|NCT03329001|593133453|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
164324201|NCT02038829|593565151|FG004|Treatment Period 2|Withdrawal by Subject|0|||
164324202|NCT02038829|593565152|FG005|Treatment Period 2|Withdrawal by Subject|0|||
164324203|NCT02038829|593565153|FG006|Treatment Period 2|Withdrawal by Subject|0|||
164324204|NCT02038829|593565154|FG007|Treatment Period 2|Withdrawal by Subject|0|||
164324205|NCT02038829|593565155|FG008|Treatment Period 2|Withdrawal by Subject|0|||
164668442|NCT01315249|594811908|FG001|Overall Study|Death|1|||
164668443|NCT01287013|594811914|FG000|Overall Study|Non-evaluable|3|||
164668444|NCT01287013|594811915|FG001|Overall Study|Non-evaluable|5|||
164668445|NCT01287013|594811916|FG002|Overall Study|Non-evaluable|21|||
164668446|NCT00051025|594811917|FG000|Overall Study|Progressive Disease|1|||
164668447|NCT00051025|594811918|FG001|Overall Study|Progressive Disease|1|||
164668448|NCT00051025|594811917|FG000|Overall Study|Adverse Event|1|||
164668449|NCT00051025|594811918|FG001|Overall Study|Adverse Event|1|||
164668450|NCT00051025|594811917|FG000|Overall Study|Withdrawal by Subject|0|||
164668451|NCT00051025|594811918|FG001|Overall Study|Withdrawal by Subject|1|||
164668452|NCT00051025|594811917|FG000|Overall Study|Death|0|||
164668453|NCT00051025|594811918|FG001|Overall Study|Death|1|||
164668454|NCT01900730|594811919|FG000|Overall Study|Withdrawal by Subject|1|||
164668455|NCT01900730|594811920|FG001|Overall Study|Withdrawal by Subject|0|||
164668456|NCT01900730|594811919|FG000|Overall Study|Screen Failure|1|||
164668457|NCT01900730|594811920|FG001|Overall Study|Screen Failure|0|||
164668458|NCT01179048|594811921|FG000|Overall Study|Withdrawn - does not allow contact|4|||
164668459|NCT01179048|594811922|FG001|Overall Study|Withdrawn - does not allow contact|8|||
164668460|NCT01179048|594811921|FG000|Overall Study|Lost to Follow-up|8|||
164668461|NCT01179048|594811922|FG001|Overall Study|Lost to Follow-up|9|||
164668462|NCT01179048|594811921|FG000|Overall Study|Alive|127|||
164668463|NCT01179048|594811922|FG001|Overall Study|Alive|142|||
164668464|NCT02109042|594811923|FG000|Overall Study|Sponsor Decision|15|||
164668465|NCT03203447|594811928|FG000|Overall Study|Withdrawal by Subject|2|||
164208873|NCT03329001|593133454|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
164208874|NCT03329001|593133455|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
164208875|NCT03329001|593133448|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
164208876|NCT03329001|593133449|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
164208877|NCT03329001|593133450|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
164208878|NCT03329001|593133451|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
164208879|NCT03329001|593133452|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
164208880|NCT03329001|593133453|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
164208881|NCT03329001|593133454|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
164208882|NCT03329001|593133455|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
164208883|NCT03329001|593133448|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
164208884|NCT03329001|593133449|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
164208885|NCT03329001|593133450|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
164208886|NCT03329001|593133451|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
164208887|NCT03329001|593133452|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
164208888|NCT03329001|593133453|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
164208889|NCT03329001|593133454|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
164208890|NCT03329001|593133455|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
164208891|NCT03329001|593133448|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
164208892|NCT03329001|593133449|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
164208893|NCT03329001|593133450|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
164208894|NCT03329001|593133451|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
164208895|NCT03329001|593133452|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
164208896|NCT03329001|593133453|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
164208897|NCT03329001|593133454|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
164208898|NCT03329001|593133455|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
164208899|NCT03329001|593133448|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
164208900|NCT03329001|593133449|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
164208901|NCT03329001|593133450|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
164208902|NCT03329001|593133451|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
164208903|NCT03329001|593133452|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
164208904|NCT03329001|593133453|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
164208905|NCT03329001|593133454|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
164208906|NCT03329001|593133455|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
164208907|NCT03329001|593133448|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
164208908|NCT03329001|593133449|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
164564209|NCT03665285|594434254|FG000|Overall Study|Withdrawal by Subject|0|||
164564210|NCT03665285|594434255|FG001|Overall Study|Withdrawal by Subject|0|||
164564211|NCT03665285|594434256|FG002|Overall Study|Withdrawal by Subject|0|||
164564212|NCT03665285|594434257|FG003|Overall Study|Withdrawal by Subject|0|||
164564213|NCT03665285|594434258|FG004|Overall Study|Withdrawal by Subject|1|||
164564214|NCT03665285|594434259|FG005|Overall Study|Withdrawal by Subject|0|||
164564215|NCT03665285|594434260|FG006|Overall Study|Withdrawal by Subject|0|||
164564216|NCT03665285|594434261|FG007|Overall Study|Withdrawal by Subject|2|||
164564217|NCT03665285|594434262|FG008|Overall Study|Withdrawal by Subject|0|||
164564218|NCT03665285|594434254|FG000|Overall Study|Physician Decision|0|||
164564219|NCT03665285|594434255|FG001|Overall Study|Physician Decision|0|||
164564220|NCT03665285|594434256|FG002|Overall Study|Physician Decision|0|||
164564221|NCT03665285|594434257|FG003|Overall Study|Physician Decision|0|||
164564222|NCT03665285|594434258|FG004|Overall Study|Physician Decision|0|||
164564223|NCT03665285|594434259|FG005|Overall Study|Physician Decision|0|||
164564224|NCT03665285|594434260|FG006|Overall Study|Physician Decision|0|||
164564225|NCT03665285|594434261|FG007|Overall Study|Physician Decision|2|||
164564226|NCT03665285|594434262|FG008|Overall Study|Physician Decision|0|||
164564227|NCT03157531|594434263|FG000|Overall Study|Death|2|||
164564228|NCT03157531|594434263|FG000|Overall Study|Lost to Follow-up|4|||
164564229|NCT01580397|594434264|FG000|Overall Study|Lack of Efficacy|14|||
164564230|NCT01727258|594434265|FG000|Overall Study|Adverse Event|0|||
164564231|NCT01727258|594434266|FG001|Overall Study|Adverse Event|2|||
164564232|NCT01727258|594434267|FG002|Overall Study|Adverse Event|0|||
164564233|NCT01727258|594434265|FG000|Overall Study|Noncompliance with Study Drug|0|||
164564234|NCT01727258|594434266|FG001|Overall Study|Noncompliance with Study Drug|0|||
164564235|NCT01727258|594434267|FG002|Overall Study|Noncompliance with Study Drug|1|||
164668466|NCT03203447|594811929|FG001|Overall Study|Withdrawal by Subject|1|||
164668467|NCT03203447|594811928|FG000|Overall Study|Lost to Follow-up|1|||
164668468|NCT03203447|594811929|FG001|Overall Study|Lost to Follow-up|10|||
164564236|NCT01727258|594434265|FG000|Overall Study|Withdrawal by Subject|1|||
164564237|NCT01727258|594434266|FG001|Overall Study|Withdrawal by Subject|1|||
164564238|NCT01727258|594434267|FG002|Overall Study|Withdrawal by Subject|0|||
164564239|NCT01727258|594434265|FG000|Overall Study|Lost to Follow-up|1|||
164564240|NCT01727258|594434266|FG001|Overall Study|Lost to Follow-up|0|||
164668469|NCT03203447|594811928|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
164668470|NCT03203447|594811929|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
164668471|NCT02189941|594811930|FG000|Overall Study|Non-compliance|0|||
164668472|NCT02189941|594811931|FG001|Overall Study|Non-compliance|0|||
164668473|NCT02189941|594811932|FG002|Overall Study|Non-compliance|1|||
164668474|NCT00445003|594811933|FG000|Overall Study|Death|1|||
164668475|NCT00445003|594811934|FG001|Overall Study|Death|2|||
164668476|NCT00445003|594811935|FG002|Overall Study|Death|1|||
164668477|NCT00445003|594811933|FG000|Overall Study|Missed Visit|3|||
164668478|NCT00445003|594811934|FG001|Overall Study|Missed Visit|5|||
164668479|NCT00445003|594811935|FG002|Overall Study|Missed Visit|1|||
164668480|NCT00445003|594811933|FG000|Overall Study|Dropped|1|||
164668481|NCT00445003|594811934|FG001|Overall Study|Dropped|3|||
164668482|NCT00445003|594811935|FG002|Overall Study|Dropped|2|||
164668483|NCT00528606|594811938|FG000|Overall Study|Withdrew consent|4|||
164668484|NCT00528606|594811939|FG001|Overall Study|Withdrew consent|3|||
164668485|NCT00528606|594811938|FG000|Overall Study|Lost to Follow-up|4|||
164668486|NCT00528606|594811939|FG001|Overall Study|Lost to Follow-up|1|||
164668487|NCT00528606|594811938|FG000|Overall Study|Adverse Event|3|||
164668488|NCT00528606|594811939|FG001|Overall Study|Adverse Event|0|||
164668489|NCT00528606|594811938|FG000|Overall Study|Other|2|||
164668490|NCT00528606|594811939|FG001|Overall Study|Other|0|||
164668491|NCT01471093|594811940|FG000|Overall Study|Adverse Event|1|||
164668492|NCT01471093|594811941|FG001|Overall Study|Adverse Event|0|||
164668493|NCT01471093|594811942|FG002|Overall Study|Adverse Event|0|||
164668494|NCT01471093|594811943|FG003|Overall Study|Adverse Event|0|||
164668495|NCT02475954|594811944|FG000|Overall Study|Withdrawal by Subject|2|||
164668496|NCT02475954|594811945|FG001|Overall Study|Withdrawal by Subject|2|||
164668497|NCT02475954|594811944|FG000|Overall Study|Lost to Follow-up|11|||
164668498|NCT02475954|594811945|FG001|Overall Study|Lost to Follow-up|9|||
164668499|NCT02475954|594811944|FG000|Overall Study|Death|1|||
164668500|NCT02475954|594811945|FG001|Overall Study|Death|1|||
164668501|NCT00880568|594811947|FG000|Overall Study|Disease progression|3|||
164668502|NCT00880568|594811948|FG001|Overall Study|Disease progression|3|||
164668503|NCT00880568|594811949|FG002|Overall Study|Disease progression|3|||
164668504|NCT00880568|594811950|FG003|Overall Study|Disease progression|1|||
164668505|NCT00880568|594811951|FG004|Overall Study|Disease progression|3|||
164668506|NCT00880568|594811952|FG005|Overall Study|Disease progression|3|||
164668507|NCT00880568|594811953|FG006|Overall Study|Disease progression|5|||
164668508|NCT00880568|594811954|FG007|Overall Study|Disease progression|0|||
164668509|NCT00880568|594811955|FG008|Overall Study|Disease progression|3|||
164668510|NCT00880568|594811947|FG000|Overall Study|Adverse Event|0|||
164668511|NCT00880568|594811948|FG001|Overall Study|Adverse Event|0|||
164668512|NCT00880568|594811949|FG002|Overall Study|Adverse Event|0|||
164668513|NCT00880568|594811950|FG003|Overall Study|Adverse Event|0|||
164668514|NCT00880568|594811951|FG004|Overall Study|Adverse Event|0|||
164668515|NCT00880568|594811952|FG005|Overall Study|Adverse Event|0|||
164668516|NCT00880568|594811953|FG006|Overall Study|Adverse Event|1|||
164668517|NCT00880568|594811954|FG007|Overall Study|Adverse Event|1|||
164668518|NCT00880568|594811955|FG008|Overall Study|Adverse Event|0|||
164668519|NCT00880568|594811947|FG000|Overall Study|Withdrawal by Subject|0|||
164668520|NCT00880568|594811948|FG001|Overall Study|Withdrawal by Subject|0|||
164668521|NCT00880568|594811949|FG002|Overall Study|Withdrawal by Subject|0|||
164668522|NCT00880568|594811950|FG003|Overall Study|Withdrawal by Subject|0|||
164668523|NCT00880568|594811951|FG004|Overall Study|Withdrawal by Subject|0|||
164668524|NCT00880568|594811952|FG005|Overall Study|Withdrawal by Subject|0|||
164668525|NCT00880568|594811953|FG006|Overall Study|Withdrawal by Subject|0|||
164668526|NCT00880568|594811954|FG007|Overall Study|Withdrawal by Subject|1|||
164668527|NCT00880568|594811955|FG008|Overall Study|Withdrawal by Subject|0|||
164668528|NCT00620022|594811956|FG000|Treatment Period 1|Adverse Event|4|||
164668529|NCT00620022|594811957|FG001|Treatment Period 1|Adverse Event|6|||
164668530|NCT00620022|594811956|FG000|Treatment Period 1|Subject withdrew consent|1|||
164668531|NCT00620022|594811957|FG001|Treatment Period 1|Subject withdrew consent|0|||
164208909|NCT03329001|593133450|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
164208910|NCT03329001|593133451|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
164208911|NCT03329001|593133452|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
164668532|NCT00620022|594811956|FG000|Treatment Period 2|Adverse Event|2|||
164668533|NCT00620022|594811957|FG001|Treatment Period 2|Adverse Event|2|||
164668534|NCT00925769|594811961|FG000|Overall Study|Major toxicity|1|||
164668535|NCT00925769|594811962|FG001|Overall Study|Major toxicity|0|||
164668536|NCT00925769|594811963|FG002|Overall Study|Major toxicity|1|||
164668537|NCT00925769|594811964|FG003|Overall Study|Major toxicity|1|||
164668538|NCT00925769|594811965|FG004|Overall Study|Major toxicity|0|||
164668539|NCT00925769|594811966|FG005|Overall Study|Major toxicity|0|||
164668540|NCT00925769|594811961|FG000|Overall Study|Disease progression|4|||
164668541|NCT00925769|594811962|FG001|Overall Study|Disease progression|5|||
164668542|NCT00925769|594811963|FG002|Overall Study|Disease progression|3|||
164668543|NCT00925769|594811964|FG003|Overall Study|Disease progression|4|||
164668544|NCT00925769|594811965|FG004|Overall Study|Disease progression|2|||
164668545|NCT00925769|594811966|FG005|Overall Study|Disease progression|3|||
164668546|NCT00925769|594811961|FG000|Overall Study|Death|0|||
164668547|NCT00925769|594811962|FG001|Overall Study|Death|0|||
164208912|NCT03329001|593133453|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
164208913|NCT03329001|593133454|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
164208914|NCT03329001|593133455|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
164208915|NCT03329001|593133448|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
164208916|NCT03329001|593133449|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
164208917|NCT03329001|593133450|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
164208918|NCT03329001|593133451|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
164208919|NCT03329001|593133452|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
164208920|NCT03329001|593133453|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
164208921|NCT03329001|593133454|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
164208922|NCT03329001|593133455|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
164208923|NCT03329001|593133448|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
164208924|NCT03329001|593133449|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
164208925|NCT03329001|593133450|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
164208926|NCT03329001|593133451|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
164208927|NCT03329001|593133452|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
164208928|NCT03329001|593133453|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
164208929|NCT03329001|593133454|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
164208930|NCT03329001|593133455|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
164208931|NCT03329001|593133448|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
164208932|NCT03329001|593133449|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
164208933|NCT03329001|593133450|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
164208934|NCT03329001|593133451|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
164208935|NCT03329001|593133452|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
164208936|NCT03329001|593133453|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
164208937|NCT03329001|593133454|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
164208938|NCT03329001|593133455|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
164208939|NCT03329001|593133448|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
164208940|NCT03329001|593133449|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
164208941|NCT03329001|593133450|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
164208942|NCT03329001|593133451|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
164208943|NCT03329001|593133452|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
164208944|NCT03329001|593133453|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
164208945|NCT03329001|593133454|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
164208946|NCT03329001|593133455|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
164208947|NCT02178956|593133456|FG000|Overall Study|Lost to Follow-up|4|||
164208948|NCT02178956|593133457|FG001|Overall Study|Lost to Follow-up|4|||
164208949|NCT02178956|593133456|FG000|Overall Study|Sponsor terminated study|49|||
164208950|NCT02178956|593133457|FG001|Overall Study|Sponsor terminated study|58|||
164208951|NCT02178956|593133456|FG000|Overall Study|Withdrawal by Subject|15|||
164208952|NCT02178956|593133457|FG001|Overall Study|Withdrawal by Subject|11|||
164208953|NCT02178956|593133456|FG000|Overall Study|Various Reasons|3|||
164208954|NCT02178956|593133457|FG001|Overall Study|Various Reasons|5|||
164208955|NCT02709369|593133461|FG000|Overall Study|Lost to Follow-up|15|||
164208956|NCT02709369|593133461|FG000|Overall Study|Withdrawal by Subject|10|||
164208957|NCT02709369|593133461|FG000|Overall Study|Did not received intervention|2|||
164208958|NCT01341470|593133462|FG000|Overall Study|Sponsor decision|0|||
164208959|NCT01341470|593133463|FG001|Overall Study|Sponsor decision|0|||
164208960|NCT01341470|593133464|FG002|Overall Study|Sponsor decision|1|||
164208961|NCT01341470|593133465|FG003|Overall Study|Sponsor decision|1|||
164208962|NCT01341470|593133466|FG004|Overall Study|Sponsor decision|0|||
164208963|NCT01341470|593133467|FG005|Overall Study|Sponsor decision|1|||
164208964|NCT01136915|593133469|FG000|Overall Study|Lost to Follow-up|2|||
164208965|NCT01136915|593133470|FG001|Overall Study|Lost to Follow-up|0|||
164208966|NCT01136915|593133469|FG000|Overall Study|Exclusion criterion met|0|||
164208967|NCT01136915|593133470|FG001|Overall Study|Exclusion criterion met|1|||
164208968|NCT03282097|593133471|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
164208969|NCT03282097|593133472|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
164208970|NCT03282097|593133471|FG000|Intervention Visit Complete|Patient Death|13|||
164208971|NCT03282097|593133472|FG001|Intervention Visit Complete|Patient Death|15|||
164668548|NCT00925769|594811963|FG002|Overall Study|Death|1|||
164668549|NCT00925769|594811964|FG003|Overall Study|Death|0|||
164668550|NCT00925769|594811965|FG004|Overall Study|Death|0|||
164208972|NCT03282097|593133471|FG000|Intervention Visit Complete|Caregiver Death|0|||
164208973|NCT03282097|593133472|FG001|Intervention Visit Complete|Caregiver Death|3|||
164208974|NCT03282097|593133471|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
164564241|NCT01727258|594434267|FG002|Overall Study|Lost to Follow-up|0|||
164564242|NCT00820755|594434268|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
164564243|NCT00820755|594434269|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
164564244|NCT00820755|594434270|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
164564245|NCT00820755|594434268|FG000|Period 1: Combination Therapy Phase|Death|28|||
164564246|NCT00820755|594434269|FG001|Period 1: Combination Therapy Phase|Death|0|||
164564247|NCT00820755|594434270|FG002|Period 1: Combination Therapy Phase|Death|0|||
164564248|NCT00820755|594434268|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
164564249|NCT00820755|594434269|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
164564250|NCT00820755|594434270|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
164564251|NCT00820755|594434268|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
164564252|NCT00820755|594434269|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
164564253|NCT00820755|594434270|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
164564254|NCT00820755|594434268|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
164564255|NCT00820755|594434269|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
164564256|NCT00820755|594434270|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
164564257|NCT00820755|594434268|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
164564258|NCT00820755|594434269|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
164564259|NCT00820755|594434270|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
164564260|NCT00820755|594434268|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
164564261|NCT00820755|594434269|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
164564262|NCT00820755|594434270|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
164564263|NCT00820755|594434268|FG000|Period 1: Combination Therapy Phase|Other|11|||
164564264|NCT00820755|594434269|FG001|Period 1: Combination Therapy Phase|Other|0|||
164564265|NCT00820755|594434270|FG002|Period 1: Combination Therapy Phase|Other|0|||
164564266|NCT00820755|594434268|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
164564267|NCT00820755|594434269|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
164564268|NCT00820755|594434270|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
164564269|NCT01486199|594434271|FG000|Two Year Period Between Study Days|Physician Decision|1|||
164564270|NCT01486199|594434272|FG001|Two Year Period Between Study Days|Physician Decision|0|||
164564271|NCT00243659|594434273|FG000|Overall Study|Withdrawal by Subject|1|||
164564272|NCT00243659|594434274|FG001|Overall Study|Withdrawal by Subject|1|||
164564273|NCT00243659|594434273|FG000|Overall Study|Protocol Violation|1|||
164564274|NCT00243659|594434274|FG001|Overall Study|Protocol Violation|2|||
164564275|NCT06098729|594434275|FG000|Overall Study|Withdrawal by Subject|1|||
164564276|NCT01972074|594434286|FG000|Overall Study|Adverse Event|4|||
164564277|NCT01972074|594434287|FG001|Overall Study|Adverse Event|1|||
164564278|NCT01972074|594434288|FG002|Overall Study|Adverse Event|0|||
164564279|NCT01972074|594434286|FG000|Overall Study|Lack of Efficacy|1|||
164564280|NCT01972074|594434287|FG001|Overall Study|Lack of Efficacy|1|||
164564281|NCT01972074|594434288|FG002|Overall Study|Lack of Efficacy|0|||
164564282|NCT01972074|594434286|FG000|Overall Study|Lost to Follow-up|0|||
164564283|NCT01972074|594434287|FG001|Overall Study|Lost to Follow-up|1|||
164564284|NCT01972074|594434288|FG002|Overall Study|Lost to Follow-up|1|||
164564285|NCT01972074|594434286|FG000|Overall Study|Withdrawal by Subject|1|||
164564286|NCT01972074|594434287|FG001|Overall Study|Withdrawal by Subject|1|||
164564287|NCT01972074|594434288|FG002|Overall Study|Withdrawal by Subject|1|||
164564288|NCT01972074|594434286|FG000|Overall Study|Scanner Unavailable|0|||
164564289|NCT01972074|594434287|FG001|Overall Study|Scanner Unavailable|0|||
164564290|NCT01972074|594434288|FG002|Overall Study|Scanner Unavailable|1|||
164564291|NCT00486278|594434291|FG000|Overall Study|Adverse Event|5|||
164564292|NCT00486278|594434291|FG000|Overall Study|Withdrawal by Subject|2|||
164564293|NCT00486278|594434291|FG000|Overall Study|Physician Decision|2|||
164564294|NCT02887521|594434294|FG000|Overall Study|Withdrawal by Subject|0|||
164208975|NCT03282097|593133472|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
164208976|NCT03282097|593133471|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
164208977|NCT03282097|593133472|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
164208978|NCT03282097|593133471|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
164208979|NCT03282097|593133472|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
164208980|NCT03282097|593133471|FG000|Primary Outcome Data Collection Complete|Missing|2|||
164355615|NCT01535053|593676480|FG000|Overall Study|Ineligible|1|||
164564295|NCT02887521|594434295|FG001|Overall Study|Withdrawal by Subject|3|||
164564296|NCT00644787|594434296|FG000|Period 1: Titration Phase|Adverse Event|11|||
164564297|NCT00644787|594434297|FG001|Period 1: Titration Phase|Adverse Event|0|||
164564298|NCT00644787|594434298|FG002|Period 1: Titration Phase|Adverse Event|0|||
164564299|NCT00644787|594434296|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
164564300|NCT00644787|594434297|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
164564301|NCT00644787|594434298|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
164208981|NCT03282097|593133472|FG001|Primary Outcome Data Collection Complete|Missing|3|||
164208982|NCT03282097|593133471|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
164564302|NCT00644787|594434296|FG000|Period 1: Titration Phase|Physician Decision|1|||
164668551|NCT00925769|594811966|FG005|Overall Study|Death|0|||
164668552|NCT00925769|594811961|FG000|Overall Study|Physician Decision|1|||
164668553|NCT00925769|594811962|FG001|Overall Study|Physician Decision|0|||
164668554|NCT00925769|594811963|FG002|Overall Study|Physician Decision|0|||
164668555|NCT00925769|594811964|FG003|Overall Study|Physician Decision|0|||
164668556|NCT00925769|594811965|FG004|Overall Study|Physician Decision|0|||
164668557|NCT00925769|594811966|FG005|Overall Study|Physician Decision|0|||
164668558|NCT00925769|594811961|FG000|Overall Study|Missing documentation|0|||
164668559|NCT00925769|594811962|FG001|Overall Study|Missing documentation|1|||
164668560|NCT00925769|594811963|FG002|Overall Study|Missing documentation|0|||
164668561|NCT00925769|594811964|FG003|Overall Study|Missing documentation|0|||
164668562|NCT00925769|594811965|FG004|Overall Study|Missing documentation|0|||
164668563|NCT00925769|594811966|FG005|Overall Study|Missing documentation|0|||
164668564|NCT00925769|594811961|FG000|Overall Study|End of study visit not done|0|||
164668565|NCT00925769|594811962|FG001|Overall Study|End of study visit not done|0|||
164668566|NCT00925769|594811963|FG002|Overall Study|End of study visit not done|1|||
164668567|NCT00925769|594811964|FG003|Overall Study|End of study visit not done|0|||
164668568|NCT00925769|594811965|FG004|Overall Study|End of study visit not done|0|||
164668569|NCT00925769|594811966|FG005|Overall Study|End of study visit not done|0|||
164668570|NCT00925769|594811961|FG000|Overall Study|Participant is unable to swallow drug|0|||
164668571|NCT00925769|594811962|FG001|Overall Study|Participant is unable to swallow drug|0|||
164668572|NCT00925769|594811963|FG002|Overall Study|Participant is unable to swallow drug|0|||
164668573|NCT00925769|594811964|FG003|Overall Study|Participant is unable to swallow drug|1|||
164668574|NCT00925769|594811965|FG004|Overall Study|Participant is unable to swallow drug|0|||
164668575|NCT00925769|594811966|FG005|Overall Study|Participant is unable to swallow drug|0|||
164668576|NCT00925769|594811961|FG000|Overall Study|Adverse Event|0|||
164668577|NCT00925769|594811962|FG001|Overall Study|Adverse Event|0|||
164668578|NCT00925769|594811963|FG002|Overall Study|Adverse Event|0|||
164668579|NCT00925769|594811964|FG003|Overall Study|Adverse Event|0|||
164668580|NCT00925769|594811965|FG004|Overall Study|Adverse Event|1|||
164668581|NCT00925769|594811966|FG005|Overall Study|Adverse Event|0|||
164668582|NCT04006171|594811967|FG000|Overall Study|Withdrawal by Subject|8|||
164668583|NCT04006171|594811968|FG001|Overall Study|Withdrawal by Subject|7|||
164564303|NCT00644787|594434297|FG001|Period 1: Titration Phase|Physician Decision|0|||
164564304|NCT00644787|594434298|FG002|Period 1: Titration Phase|Physician Decision|0|||
164564305|NCT00644787|594434296|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
164564306|NCT00644787|594434297|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
164564307|NCT00644787|594434298|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
164564308|NCT00644787|594434296|FG000|Period 1: Titration Phase|Worsening of complications|1|||
164564309|NCT00644787|594434297|FG001|Period 1: Titration Phase|Worsening of complications|0|||
164564310|NCT00644787|594434298|FG002|Period 1: Titration Phase|Worsening of complications|0|||
164564311|NCT00644787|594434296|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
164564312|NCT00644787|594434297|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
164564313|NCT00644787|594434298|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
164564314|NCT00644787|594434296|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
164564315|NCT00644787|594434297|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
164564316|NCT00644787|594434298|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
164564317|NCT00644787|594434296|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
164564318|NCT00644787|594434297|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
164564319|NCT00644787|594434298|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
164564320|NCT00644787|594434296|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
164564321|NCT00644787|594434297|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
164564322|NCT00644787|594434298|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
164564323|NCT00644787|594434296|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
164564324|NCT00644787|594434297|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
164564325|NCT00644787|594434298|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
164668584|NCT04006171|594811967|FG000|Overall Study|missing serum samples|2|||
164668585|NCT04006171|594811968|FG001|Overall Study|missing serum samples|2|||
164668586|NCT04006171|594811967|FG000|Overall Study|insufficient sample volume|2|||
164324206|NCT02038829|593565156|FG009|Treatment Period 2|Withdrawal by Subject|0|||
164324207|NCT02038829|593565157|FG010|Treatment Period 2|Withdrawal by Subject|0|||
164564326|NCT00644787|594434296|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
164564327|NCT00644787|594434297|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
164564328|NCT00644787|594434298|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
164564329|NCT00644787|594434296|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
164564330|NCT00644787|594434297|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
164564331|NCT00644787|594434298|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
164564332|NCT01738971|594434303|FG000|Overall Study|Lost to Follow-up|19|||
164564333|NCT01738971|594434304|FG001|Overall Study|Lost to Follow-up|30|||
164564334|NCT01738971|594434305|FG002|Overall Study|Lost to Follow-up|17|||
164564335|NCT04698629|594434314|FG000|Overall Study|Adverse Event|1|||
164564336|NCT06228586|594434319|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
164564337|NCT06228586|594434320|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
164564338|NCT00865020|594434331|FG000|Overall Study|Withdrawal by Subject|22|||
164564339|NCT00865020|594434332|FG001|Overall Study|Withdrawal by Subject|16|||
164564340|NCT00865020|594434331|FG000|Overall Study|Adverse Event|9|||
164564341|NCT00865020|594434332|FG001|Overall Study|Adverse Event|14|||
164564342|NCT00865020|594434331|FG000|Overall Study|Abnormal test procedure result(s)|6|||
164564343|NCT00865020|594434332|FG001|Overall Study|Abnormal test procedure result(s)|8|||
164564344|NCT00865020|594434331|FG000|Overall Study|Lost to Follow-up|6|||
164564345|NCT00865020|594434332|FG001|Overall Study|Lost to Follow-up|4|||
164564346|NCT00865020|594434331|FG000|Overall Study|Protocol deviation|4|||
164564347|NCT00865020|594434332|FG001|Overall Study|Protocol deviation|1|||
164564348|NCT00865020|594434331|FG000|Overall Study|Administrative problems|0|||
164564349|NCT00865020|594434332|FG001|Overall Study|Administrative problems|2|||
164564350|NCT00865020|594434331|FG000|Overall Study|Abnormal laboratory value(s)|0|||
164564351|NCT00865020|594434332|FG001|Overall Study|Abnormal laboratory value(s)|1|||
164564352|NCT00865020|594434331|FG000|Overall Study|Death|0|||
164564353|NCT00865020|594434332|FG001|Overall Study|Death|1|||
164564354|NCT00865020|594434331|FG000|Overall Study|Randomized but discontinued|2|||
164564355|NCT00865020|594434332|FG001|Overall Study|Randomized but discontinued|4|||
164564356|NCT00618722|594436225|FG000|Overall Study|Refusal of Treatment|0|||
164564357|NCT00618722|594436226|FG001|Overall Study|Refusal of Treatment|0|||
164564358|NCT00618722|594436227|FG002|Overall Study|Refusal of Treatment|1|||
164564359|NCT00618722|594436228|FG003|Overall Study|Refusal of Treatment|0|||
164564360|NCT00618722|594436225|FG000|Overall Study|Patient Request|1|||
164564361|NCT00618722|594436226|FG001|Overall Study|Patient Request|1|||
164564362|NCT00618722|594436227|FG002|Overall Study|Patient Request|1|||
164564363|NCT00618722|594436228|FG003|Overall Study|Patient Request|1|||
164564364|NCT00618722|594436225|FG000|Overall Study|Inability to Complete Study Procedure|0|||
164564365|NCT00618722|594436226|FG001|Overall Study|Inability to Complete Study Procedure|1|||
164564366|NCT00618722|594436227|FG002|Overall Study|Inability to Complete Study Procedure|0|||
164564367|NCT00618722|594436228|FG003|Overall Study|Inability to Complete Study Procedure|0|||
164564368|NCT00618722|594436225|FG000|Overall Study|Lost to Follow-up|2|||
164564369|NCT00618722|594436226|FG001|Overall Study|Lost to Follow-up|0|||
164564370|NCT00618722|594436227|FG002|Overall Study|Lost to Follow-up|0|||
164564371|NCT00618722|594436228|FG003|Overall Study|Lost to Follow-up|2|||
164564372|NCT00618722|594436225|FG000|Overall Study|Miscellaneous Reasons|0|||
164564373|NCT00618722|594436226|FG001|Overall Study|Miscellaneous Reasons|0|||
164564374|NCT00618722|594436227|FG002|Overall Study|Miscellaneous Reasons|1|||
164564375|NCT00618722|594436228|FG003|Overall Study|Miscellaneous Reasons|1|||
164564376|NCT00925600|594436229|FG000|Overall Study|Withdrawal by Subject|16|||
164564377|NCT00925600|594436230|FG001|Overall Study|Withdrawal by Subject|14|||
164564378|NCT00925600|594436229|FG000|Overall Study|Death|4|||
164564379|NCT00925600|594436230|FG001|Overall Study|Death|3|||
164564380|NCT00925600|594436229|FG000|Overall Study|Lost to Follow-up|2|||
164564381|NCT00925600|594436230|FG001|Overall Study|Lost to Follow-up|2|||
164564382|NCT00925600|594436229|FG000|Overall Study|Disease Progression|1|||
164564383|NCT00925600|594436230|FG001|Overall Study|Disease Progression|3|||
164564384|NCT00925600|594436229|FG000|Overall Study|Administrative Decision|1|||
164564385|NCT00925600|594436230|FG001|Overall Study|Administrative Decision|1|||
164564386|NCT00925600|594436229|FG000|Overall Study|Noncompliance|2|||
164564387|NCT00925600|594436230|FG001|Overall Study|Noncompliance|0|||
164564388|NCT00925600|594436229|FG000|Overall Study|Ineligibility Determined|2|||
164564389|NCT00925600|594436230|FG001|Overall Study|Ineligibility Determined|0|||
164564390|NCT00925600|594436229|FG000|Overall Study|Protocol Deviation|0|||
164564391|NCT00925600|594436230|FG001|Overall Study|Protocol Deviation|1|||
164564392|NCT00925600|594436229|FG000|Overall Study|Requirement for Alternative Therapy|0|||
164564393|NCT00925600|594436230|FG001|Overall Study|Requirement for Alternative Therapy|1|||
164564394|NCT00925600|594436229|FG000|Overall Study|Other|3|||
164564395|NCT00925600|594436230|FG001|Overall Study|Other|1|||
164668587|NCT04006171|594811968|FG001|Overall Study|insufficient sample volume|3|||
164668588|NCT03049488|594811970|FG000|Overall Study|Lost to Follow-up|1|||
164564396|NCT00925600|594436229|FG000|Overall Study|Adverse Event|1|||
164668589|NCT03049488|594811971|FG001|Overall Study|Lost to Follow-up|1|||
164324208|NCT02038829|593565158|FG011|Treatment Period 2|Withdrawal by Subject|0|||
164324209|NCT02038829|593565147|FG000|Washout Period 2|Adverse Event|0|||
164324210|NCT02038829|593565148|FG001|Washout Period 2|Adverse Event|0|||
164324211|NCT02038829|593565149|FG002|Washout Period 2|Adverse Event|0|||
164324212|NCT02038829|593565150|FG003|Washout Period 2|Adverse Event|0|||
164324213|NCT02038829|593565151|FG004|Washout Period 2|Adverse Event|0|||
164324214|NCT02038829|593565152|FG005|Washout Period 2|Adverse Event|0|||
164324215|NCT02038829|593565153|FG006|Washout Period 2|Adverse Event|0|||
164324216|NCT02038829|593565154|FG007|Washout Period 2|Adverse Event|0|||
164324217|NCT02038829|593565155|FG008|Washout Period 2|Adverse Event|1|||
164324218|NCT02038829|593565156|FG009|Washout Period 2|Adverse Event|0|||
164324219|NCT02038829|593565157|FG010|Washout Period 2|Adverse Event|0|||
164324220|NCT02038829|593565158|FG011|Washout Period 2|Adverse Event|0|||
164324221|NCT02038829|593565147|FG000|Washout Period 2|Withdrawal by Subject|0|||
164324222|NCT02038829|593565148|FG001|Washout Period 2|Withdrawal by Subject|0|||
164324223|NCT02038829|593565149|FG002|Washout Period 2|Withdrawal by Subject|0|||
164564397|NCT00925600|594436230|FG001|Overall Study|Adverse Event|2|||
164324224|NCT02038829|593565150|FG003|Washout Period 2|Withdrawal by Subject|0|||
164324225|NCT02038829|593565151|FG004|Washout Period 2|Withdrawal by Subject|0|||
164564398|NCT00127127|594436235|FG000|Overall Study|Adverse Event|0|||
164564399|NCT00127127|594436236|FG001|Overall Study|Adverse Event|2|||
164564400|NCT00127127|594436237|FG002|Overall Study|Adverse Event|0|||
164564401|NCT00127127|594436238|FG003|Overall Study|Adverse Event|1|||
164564402|NCT00127127|594436235|FG000|Overall Study|Lack of Efficacy|1|||
164564403|NCT00127127|594436236|FG001|Overall Study|Lack of Efficacy|3|||
164564404|NCT00127127|594436237|FG002|Overall Study|Lack of Efficacy|0|||
164564405|NCT00127127|594436238|FG003|Overall Study|Lack of Efficacy|2|||
164564406|NCT01059448|594436239|FG000|Overall Study|Adverse Event|1|||
164564407|NCT01059448|594436240|FG001|Overall Study|Adverse Event|3|||
164564408|NCT01059448|594436241|FG002|Overall Study|Adverse Event|0|||
164564409|NCT01059448|594436242|FG003|Overall Study|Adverse Event|1|||
164564410|NCT01059448|594436239|FG000|Overall Study|Withdrawal by Subject|2|||
164564411|NCT01059448|594436240|FG001|Overall Study|Withdrawal by Subject|0|||
164564412|NCT01059448|594436241|FG002|Overall Study|Withdrawal by Subject|2|||
164564413|NCT01059448|594436242|FG003|Overall Study|Withdrawal by Subject|4|||
164564414|NCT01059448|594436239|FG000|Overall Study|Disease Progression|2|||
164564415|NCT01059448|594436240|FG001|Overall Study|Disease Progression|1|||
164564416|NCT01059448|594436241|FG002|Overall Study|Disease Progression|4|||
164564417|NCT01059448|594436242|FG003|Overall Study|Disease Progression|2|||
164564418|NCT01059448|594436239|FG000|Overall Study|Administrative Decision|43|||
164564419|NCT01059448|594436240|FG001|Overall Study|Administrative Decision|49|||
164564420|NCT01059448|594436241|FG002|Overall Study|Administrative Decision|45|||
164564421|NCT01059448|594436242|FG003|Overall Study|Administrative Decision|46|||
164564422|NCT01059448|594436239|FG000|Overall Study|Lost to Follow-up|0|||
164564423|NCT01059448|594436240|FG001|Overall Study|Lost to Follow-up|0|||
164564424|NCT01059448|594436241|FG002|Overall Study|Lost to Follow-up|2|||
164564425|NCT01059448|594436242|FG003|Overall Study|Lost to Follow-up|0|||
164564426|NCT01059448|594436239|FG000|Overall Study|Death|0|||
164564427|NCT01059448|594436240|FG001|Overall Study|Death|1|||
164564428|NCT01059448|594436241|FG002|Overall Study|Death|0|||
164564429|NCT01059448|594436242|FG003|Overall Study|Death|0|||
164564430|NCT01059448|594436239|FG000|Overall Study|Other|1|||
164564431|NCT01059448|594436240|FG001|Overall Study|Other|1|||
164564432|NCT01059448|594436241|FG002|Overall Study|Other|0|||
164564433|NCT01059448|594436242|FG003|Overall Study|Other|1|||
164564434|NCT01390389|594436243|FG000|Overall Study|Withdrawal by Subject|2|||
164564435|NCT01390389|594436244|FG001|Overall Study|Withdrawal by Subject|0|||
164564436|NCT01390389|594436243|FG000|Overall Study|Screen Fail|2|||
164564437|NCT01390389|594436244|FG001|Overall Study|Screen Fail|1|||
164564438|NCT01583179|594436245|FG000|Overall Study|Screen failure|1|||
164564439|NCT01583179|594436246|FG001|Overall Study|Screen failure|2|||
164564440|NCT03988907|594436247|FG000|Overall Study|Unable to complete visit|0|||
164564441|NCT03988907|594436248|FG001|Overall Study|Unable to complete visit|1|||
164324226|NCT02038829|593565152|FG005|Washout Period 2|Withdrawal by Subject|1|||
164564442|NCT02810964|594436249|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
164564443|NCT02810964|594436250|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
164668590|NCT03049488|594811972|FG002|Overall Study|Lost to Follow-up|0|||
164668591|NCT03049488|594811973|FG003|Overall Study|Lost to Follow-up|0|||
164668592|NCT03049488|594811974|FG004|Overall Study|Lost to Follow-up|0|||
164324227|NCT02038829|593565153|FG006|Washout Period 2|Withdrawal by Subject|0|||
164564444|NCT02810964|594436249|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
164564445|NCT02810964|594436250|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
164564446|NCT02810964|594436249|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
164564447|NCT02810964|594436250|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
164324228|NCT02038829|593565154|FG007|Washout Period 2|Withdrawal by Subject|0|||
164324229|NCT02038829|593565155|FG008|Washout Period 2|Withdrawal by Subject|0|||
164324230|NCT02038829|593565156|FG009|Washout Period 2|Withdrawal by Subject|0|||
164564448|NCT02810964|594436249|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
164208983|NCT03282097|593133472|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
164208984|NCT03282097|593133471|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
164208985|NCT03282097|593133472|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
164208986|NCT03282097|593133471|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
164208987|NCT03282097|593133472|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
164208988|NCT03916926|593133474|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
164208989|NCT03916926|593133475|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
164208990|NCT03916926|593133474|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
164208991|NCT03916926|593133475|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
164208992|NCT03916926|593133474|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
164208993|NCT03916926|593133475|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
164208994|NCT03916926|593133474|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
164208995|NCT03916926|593133475|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
164208996|NCT03034967|593133481|FG000|Overall Study|Withdrawal by Subject|9|||
164208997|NCT03034967|593133482|FG001|Overall Study|Withdrawal by Subject|2|||
164208998|NCT03034967|593133483|FG002|Overall Study|Withdrawal by Subject|6|||
164208999|NCT03034967|593133484|FG003|Overall Study|Withdrawal by Subject|6|||
164209000|NCT03034967|593133485|FG004|Overall Study|Withdrawal by Subject|9|||
164209001|NCT03034967|593133486|FG005|Overall Study|Withdrawal by Subject|2|||
164209002|NCT03034967|593133481|FG000|Overall Study|Physician Decision|1|||
164209003|NCT03034967|593133482|FG001|Overall Study|Physician Decision|0|||
164209004|NCT03034967|593133483|FG002|Overall Study|Physician Decision|1|||
164209005|NCT03034967|593133484|FG003|Overall Study|Physician Decision|1|||
164209006|NCT03034967|593133485|FG004|Overall Study|Physician Decision|1|||
164209007|NCT03034967|593133486|FG005|Overall Study|Physician Decision|0|||
164209008|NCT03034967|593133481|FG000|Overall Study|Lost to Follow-up|0|||
164209009|NCT03034967|593133482|FG001|Overall Study|Lost to Follow-up|0|||
164209010|NCT03034967|593133483|FG002|Overall Study|Lost to Follow-up|0|||
164209011|NCT03034967|593133484|FG003|Overall Study|Lost to Follow-up|1|||
164209012|NCT03034967|593133485|FG004|Overall Study|Lost to Follow-up|0|||
164209013|NCT03034967|593133486|FG005|Overall Study|Lost to Follow-up|2|||
164209014|NCT03034967|593133481|FG000|Overall Study|Liver function test abnormality|0|||
164209015|NCT03034967|593133482|FG001|Overall Study|Liver function test abnormality|0|||
164209016|NCT03034967|593133483|FG002|Overall Study|Liver function test abnormality|1|||
164209017|NCT03034967|593133484|FG003|Overall Study|Liver function test abnormality|0|||
164209018|NCT03034967|593133485|FG004|Overall Study|Liver function test abnormality|0|||
164209019|NCT03034967|593133486|FG005|Overall Study|Liver function test abnormality|0|||
164209020|NCT03034967|593133481|FG000|Overall Study|Protocol Violation|1|||
164209021|NCT03034967|593133482|FG001|Overall Study|Protocol Violation|0|||
164209022|NCT03034967|593133483|FG002|Overall Study|Protocol Violation|0|||
164209023|NCT03034967|593133484|FG003|Overall Study|Protocol Violation|0|||
164209024|NCT03034967|593133485|FG004|Overall Study|Protocol Violation|0|||
164209025|NCT03034967|593133486|FG005|Overall Study|Protocol Violation|2|||
164209026|NCT03034967|593133481|FG000|Overall Study|Lack of Efficacy|0|||
164209027|NCT03034967|593133482|FG001|Overall Study|Lack of Efficacy|1|||
164209028|NCT03034967|593133483|FG002|Overall Study|Lack of Efficacy|2|||
164209029|NCT03034967|593133484|FG003|Overall Study|Lack of Efficacy|1|||
164209030|NCT03034967|593133485|FG004|Overall Study|Lack of Efficacy|1|||
164209031|NCT03034967|593133486|FG005|Overall Study|Lack of Efficacy|0|||
164209032|NCT03034967|593133481|FG000|Overall Study|Adverse Event, non-fatal|3|||
164209033|NCT03034967|593133482|FG001|Overall Study|Adverse Event, non-fatal|1|||
164324231|NCT02038829|593565157|FG010|Washout Period 2|Withdrawal by Subject|0|||
164324232|NCT02038829|593565158|FG011|Washout Period 2|Withdrawal by Subject|0|||
164564449|NCT02810964|594436250|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
164564450|NCT00947531|594436251|FG000|Overall Study|Withdrawal by Subject|10|||
164564451|NCT00947531|594436252|FG001|Overall Study|Withdrawal by Subject|7|||
164564452|NCT00947531|594436251|FG000|Overall Study|Administrative Reason|0|||
164564453|NCT00947531|594436252|FG001|Overall Study|Administrative Reason|1|||
164564454|NCT00947531|594436251|FG000|Overall Study|Adverse Event|2|||
164209034|NCT03034967|593133483|FG002|Overall Study|Adverse Event, non-fatal|2|||
164209035|NCT03034967|593133484|FG003|Overall Study|Adverse Event, non-fatal|0|||
164209036|NCT03034967|593133485|FG004|Overall Study|Adverse Event, non-fatal|2|||
164209037|NCT03034967|593133486|FG005|Overall Study|Adverse Event, non-fatal|8|||
164209038|NCT03034967|593133481|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
164209039|NCT03034967|593133482|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
164209040|NCT03034967|593133483|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
164209041|NCT03034967|593133484|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
164209042|NCT03034967|593133485|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
164209043|NCT03034967|593133486|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
164209044|NCT03806296|593133487|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
164209045|NCT03806296|593133488|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
164324233|NCT02038829|593565147|FG000|Treatment Period 4|Adverse Event|0|||
164564455|NCT00947531|594436252|FG001|Overall Study|Adverse Event|2|||
164209046|NCT03806296|593133489|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
164209047|NCT03806296|593133487|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
164209048|NCT03806296|593133488|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
164209049|NCT03806296|593133489|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
164209050|NCT03806296|593133487|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
164209051|NCT03806296|593133488|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
164209052|NCT03806296|593133489|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
164209053|NCT02763566|593133501|FG000|Overall Study|Lost to Follow-up|1|||
164209054|NCT02763566|593133502|FG001|Overall Study|Lost to Follow-up|4|||
164209055|NCT02763566|593133503|FG002|Overall Study|Lost to Follow-up|0|||
164209056|NCT02763566|593133504|FG003|Overall Study|Lost to Follow-up|1|||
164209057|NCT02763566|593133501|FG000|Overall Study|On study treatment at study conclusion|114|||
164209058|NCT02763566|593133502|FG001|Overall Study|On study treatment at study conclusion|34|||
164209059|NCT02763566|593133503|FG002|Overall Study|On study treatment at study conclusion|54|||
164209060|NCT02763566|593133504|FG003|Overall Study|On study treatment at study conclusion|13|||
164209061|NCT02763566|593133501|FG000|Overall Study|Withdrawal by Subject|3|||
164209062|NCT02763566|593133502|FG001|Overall Study|Withdrawal by Subject|1|||
164209063|NCT02763566|593133503|FG002|Overall Study|Withdrawal by Subject|0|||
164209064|NCT02763566|593133504|FG003|Overall Study|Withdrawal by Subject|0|||
164209065|NCT04896385|593133505|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
164209066|NCT04896385|593133506|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
164209067|NCT04896385|593133507|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
164209068|NCT04896385|593133508|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
164209069|NCT04896385|593133505|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
164209070|NCT04896385|593133506|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
164209071|NCT04896385|593133507|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
164209072|NCT04896385|593133508|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
164209073|NCT04896385|593133505|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
164209074|NCT04896385|593133506|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
164209075|NCT04896385|593133507|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
164209076|NCT04896385|593133508|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
164209077|NCT04896385|593133505|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
164209078|NCT04896385|593133506|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
164209079|NCT04896385|593133507|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
164209080|NCT04896385|593133508|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
164209081|NCT04896385|593133505|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
164209082|NCT04896385|593133506|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
164209083|NCT04896385|593133507|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
164209084|NCT04896385|593133508|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
164209085|NCT04896385|593133505|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
164209086|NCT04896385|593133506|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
164209087|NCT04896385|593133507|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
164209088|NCT04896385|593133508|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
164209089|NCT05291689|593133511|FG000|Overall Study|Adverse Event|3|||
164209090|NCT05291689|593133511|FG000|Overall Study|Lack of Efficacy|10|||
164209091|NCT05291689|593133511|FG000|Overall Study|Withdrawal by Subject|4|||
164209092|NCT01931098|593133512|FG000|Overall Study|Withdrawal by Subject|0|||
164209093|NCT01931098|593133513|FG001|Overall Study|Withdrawal by Subject|1|||
164209094|NCT01931098|593133512|FG000|Overall Study|Enrolled in different protocol|0|||
164209095|NCT01931098|593133513|FG001|Overall Study|Enrolled in different protocol|1|||
164209096|NCT01931098|593133512|FG000|Overall Study|Unable to begin trmt:active infection|0|||
164209097|NCT01931098|593133513|FG001|Overall Study|Unable to begin trmt:active infection|1|||
164209098|NCT01931098|593133512|FG000|Overall Study|Refused further treatment|0|||
164209099|NCT01931098|593133513|FG001|Overall Study|Refused further treatment|1|||
164209100|NCT02612155|593133514|FG000|Overall Study|Death|1|||
164209101|NCT02612155|593133515|FG001|Overall Study|Death|1|||
164209102|NCT02612155|593133514|FG000|Overall Study|Lost to Follow-up|2|||
164209103|NCT02612155|593133515|FG001|Overall Study|Lost to Follow-up|2|||
164324234|NCT02038829|593565148|FG001|Treatment Period 4|Adverse Event|1|||
164324235|NCT02038829|593565149|FG002|Treatment Period 4|Adverse Event|0|||
164324236|NCT02038829|593565150|FG003|Treatment Period 4|Adverse Event|0|||
164324237|NCT02038829|593565151|FG004|Treatment Period 4|Adverse Event|0|||
164324238|NCT02038829|593565152|FG005|Treatment Period 4|Adverse Event|0|||
164324239|NCT02038829|593565153|FG006|Treatment Period 4|Adverse Event|0|||
164324240|NCT02038829|593565154|FG007|Treatment Period 4|Adverse Event|0|||
164324241|NCT02038829|593565155|FG008|Treatment Period 4|Adverse Event|0|||
164324242|NCT02038829|593565156|FG009|Treatment Period 4|Adverse Event|0|||
164324243|NCT02038829|593565157|FG010|Treatment Period 4|Adverse Event|0|||
164324244|NCT02038829|593565158|FG011|Treatment Period 4|Adverse Event|0|||
164564456|NCT00947531|594436251|FG000|Overall Study|Lack of Efficacy|1|||
164209104|NCT05233761|593133516|FG000|Treatment Period A|Withdrawal by Subject|12|||
164564457|NCT00947531|594436252|FG001|Overall Study|Lack of Efficacy|0|||
164209105|NCT05233761|593133517|FG001|Treatment Period A|Withdrawal by Subject|10|||
164209106|NCT05233761|593133516|FG000|Treatment Period A|Lost to Follow-up|6|||
164209107|NCT05233761|593133517|FG001|Treatment Period A|Lost to Follow-up|12|||
164209108|NCT05233761|593133516|FG000|Treatment Period A|Protocol Violation|8|||
164209109|NCT05233761|593133517|FG001|Treatment Period A|Protocol Violation|15|||
164209110|NCT04235374|593133518|FG000|Overall Study|Death|91|||
164209111|NCT04235374|593133519|FG001|Overall Study|Death|91|||
164209112|NCT04235374|593133518|FG000|Overall Study|Refused|2|||
164209113|NCT04235374|593133519|FG001|Overall Study|Refused|2|||
164209114|NCT04235374|593133518|FG000|Overall Study|Unavailable|12|||
164209115|NCT04235374|593133519|FG001|Overall Study|Unavailable|3|||
164209116|NCT04235374|593133518|FG000|Overall Study|Withdrawal by Subject|0|||
164209117|NCT04235374|593133519|FG001|Overall Study|Withdrawal by Subject|1|||
164209118|NCT04235374|593133518|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
164209119|NCT04235374|593133519|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
164209120|NCT01551173|593133520|FG000|Overall Study|Withdrawal by Subject|11|||
164209121|NCT01551173|593133521|FG001|Overall Study|Withdrawal by Subject|16|||
164209122|NCT01551173|593133520|FG000|Overall Study|Adverse Event|7|||
164209123|NCT01551173|593133521|FG001|Overall Study|Adverse Event|6|||
164209124|NCT01551173|593133520|FG000|Overall Study|Lost to Follow-up|5|||
164209125|NCT01551173|593133521|FG001|Overall Study|Lost to Follow-up|7|||
164209126|NCT01551173|593133520|FG000|Overall Study|Other|5|||
164209127|NCT01551173|593133521|FG001|Overall Study|Other|3|||
164209128|NCT01394276|593133524|FG000|Overall Study|Related Adverse event (AEs)|15|||
164209129|NCT01394276|593133524|FG000|Overall Study|Not related AEs|9|||
164209130|NCT01394276|593133524|FG000|Overall Study|Remission of disease|2|||
164209131|NCT01394276|593133524|FG000|Overall Study|Insufficient therapeutic effect|17|||
164209132|NCT01394276|593133524|FG000|Overall Study|Insufficient compliance|9|||
164209133|NCT01394276|593133524|FG000|Overall Study|Lost to Follow-up|5|||
164209134|NCT01394276|593133524|FG000|Overall Study|Participant moved to another site|1|||
164209135|NCT01394276|593133524|FG000|Overall Study|Pregnancy|1|||
164209136|NCT01394276|593133524|FG000|Overall Study|unavailability of drug at the Hospital|2|||
164209137|NCT01394276|593133524|FG000|Overall Study|Symptoms of concurrent diseases|1|||
164209138|NCT04530344|593133525|FG000|Overall Study|Lost to Follow-up|3|||
164209139|NCT04530344|593133526|FG001|Overall Study|Lost to Follow-up|3|||
164209140|NCT04530344|593133527|FG002|Overall Study|Lost to Follow-up|3|||
164209141|NCT04530344|593133528|FG003|Overall Study|Lost to Follow-up|10|||
164209142|NCT04530344|593133525|FG000|Overall Study|Withdrawal by Subject|14|||
164209143|NCT04530344|593133526|FG001|Overall Study|Withdrawal by Subject|5|||
164209144|NCT04530344|593133527|FG002|Overall Study|Withdrawal by Subject|18|||
164209145|NCT04530344|593133528|FG003|Overall Study|Withdrawal by Subject|33|||
164209146|NCT04530344|593133525|FG000|Overall Study|Adverse Event|0|||
164209147|NCT04530344|593133526|FG001|Overall Study|Adverse Event|0|||
164209148|NCT04530344|593133527|FG002|Overall Study|Adverse Event|0|||
164209149|NCT04530344|593133528|FG003|Overall Study|Adverse Event|1|||
164209150|NCT04530344|593133525|FG000|Overall Study|Lack of Efficacy|0|||
164209151|NCT04530344|593133526|FG001|Overall Study|Lack of Efficacy|0|||
164209152|NCT04530344|593133527|FG002|Overall Study|Lack of Efficacy|0|||
164209153|NCT04530344|593133528|FG003|Overall Study|Lack of Efficacy|1|||
164209154|NCT04530344|593133525|FG000|Overall Study|Physician Decision|0|||
164209155|NCT04530344|593133526|FG001|Overall Study|Physician Decision|0|||
164209156|NCT04530344|593133527|FG002|Overall Study|Physician Decision|1|||
164209157|NCT04530344|593133528|FG003|Overall Study|Physician Decision|1|||
164209158|NCT04530344|593133525|FG000|Overall Study|Pregnancy|0|||
164209159|NCT04530344|593133526|FG001|Overall Study|Pregnancy|0|||
164209160|NCT04530344|593133527|FG002|Overall Study|Pregnancy|2|||
164668593|NCT03049488|594811975|FG005|Overall Study|Lost to Follow-up|0|||
164668594|NCT03049488|594811970|FG000|Overall Study|Moved from Area|1|||
164668595|NCT03049488|594811971|FG001|Overall Study|Moved from Area|0|||
164668596|NCT03049488|594811972|FG002|Overall Study|Moved from Area|0|||
164668597|NCT03049488|594811973|FG003|Overall Study|Moved from Area|1|||
164668598|NCT03049488|594811974|FG004|Overall Study|Moved from Area|1|||
164668599|NCT03049488|594811975|FG005|Overall Study|Moved from Area|0|||
164668600|NCT03049488|594811970|FG000|Overall Study|Physician Decision|0|||
164668601|NCT03049488|594811971|FG001|Overall Study|Physician Decision|1|||
164668602|NCT03049488|594811972|FG002|Overall Study|Physician Decision|0|||
164668603|NCT03049488|594811973|FG003|Overall Study|Physician Decision|0|||
164209161|NCT04530344|593133528|FG003|Overall Study|Pregnancy|1|||
164209162|NCT04530344|593133525|FG000|Overall Study|Protocol Violation|0|||
164209163|NCT04530344|593133526|FG001|Overall Study|Protocol Violation|0|||
164209164|NCT04530344|593133527|FG002|Overall Study|Protocol Violation|0|||
164209165|NCT04530344|593133528|FG003|Overall Study|Protocol Violation|1|||
164209166|NCT04530344|593133525|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
164209167|NCT04530344|593133526|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
164668604|NCT03049488|594811974|FG004|Overall Study|Physician Decision|0|||
164209168|NCT04530344|593133527|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
164299698|NCT03337308|593472896|FG003|Overall Study|Protocol Violation|0|||
164668605|NCT03049488|594811975|FG005|Overall Study|Physician Decision|0|||
164668606|NCT03049488|594811970|FG000|Overall Study|Withdrawal by Subject|0|||
164209169|NCT04530344|593133528|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
164209170|NCT04530344|593133525|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
164209171|NCT04530344|593133526|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
164209172|NCT04530344|593133527|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
164209173|NCT04530344|593133528|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
164209174|NCT04530344|593133525|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
164209175|NCT04530344|593133526|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
164209176|NCT04530344|593133527|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
164209177|NCT04530344|593133528|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
164209178|NCT04530344|593133525|FG000|Overall Study|Personal Reasons|0|||
164209179|NCT04530344|593133526|FG001|Overall Study|Personal Reasons|0|||
164209180|NCT04530344|593133527|FG002|Overall Study|Personal Reasons|0|||
164209181|NCT04530344|593133528|FG003|Overall Study|Personal Reasons|1|||
164209182|NCT04530344|593133525|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
164209183|NCT04530344|593133526|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
164209184|NCT04530344|593133527|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
164209185|NCT04530344|593133528|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
164209186|NCT04478266|593133530|FG000|Overall Study|Adverse Event|20|||
164209187|NCT04478266|593133531|FG001|Overall Study|Adverse Event|21|||
164209188|NCT04478266|593133530|FG000|Overall Study|Progressive disease|146|||
164209189|NCT04478266|593133531|FG001|Overall Study|Progressive disease|168|||
164209190|NCT04478266|593133530|FG000|Overall Study|Poor compliance to protocol|1|||
164209191|NCT04478266|593133531|FG001|Overall Study|Poor compliance to protocol|0|||
164209192|NCT04478266|593133530|FG000|Overall Study|Withdrawal by Subject|19|||
164209193|NCT04478266|593133531|FG001|Overall Study|Withdrawal by Subject|16|||
164209194|NCT04478266|593133530|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
164209195|NCT04478266|593133531|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
164209196|NCT04478266|593133530|FG000|Overall Study|Study terminated by sponsor|33|||
164209197|NCT04478266|593133531|FG001|Overall Study|Study terminated by sponsor|35|||
164209198|NCT04478266|593133530|FG000|Overall Study|Other: unspecified|5|||
164209199|NCT04478266|593133531|FG001|Overall Study|Other: unspecified|7|||
164209200|NCT04478266|593133530|FG000|Overall Study|Randomized but not treated|1|||
164209201|NCT04478266|593133531|FG001|Overall Study|Randomized but not treated|1|||
164209202|NCT04058717|593133532|FG000|Randomization Period|Lost to Follow-up|2|||
164209203|NCT04058717|593133533|FG001|Randomization Period|Lost to Follow-up|3|||
164209204|NCT04058717|593133534|FG002|Randomization Period|Lost to Follow-up|4|||
164209205|NCT04058717|593133535|FG003|Randomization Period|Lost to Follow-up|4|||
164209206|NCT04058717|593133532|FG000|Randomization Period|Withdrawal by Subject|1|||
164209207|NCT04058717|593133533|FG001|Randomization Period|Withdrawal by Subject|3|||
164209208|NCT04058717|593133534|FG002|Randomization Period|Withdrawal by Subject|3|||
164209209|NCT04058717|593133535|FG003|Randomization Period|Withdrawal by Subject|3|||
164209210|NCT04058717|593133532|FG000|Randomization Period|PI decision|0|||
164209211|NCT04058717|593133533|FG001|Randomization Period|PI decision|1|||
164209212|NCT04058717|593133534|FG002|Randomization Period|PI decision|0|||
164209213|NCT04058717|593133535|FG003|Randomization Period|PI decision|0|||
164209214|NCT02799602|593133536|FG000|Overall Study|Protocol Violation|1|||
164209215|NCT02799602|593133537|FG001|Overall Study|Protocol Violation|0|||
164209216|NCT02799602|593133536|FG000|Overall Study|Physician Decision|5|||
164209217|NCT02799602|593133537|FG001|Overall Study|Physician Decision|6|||
164564458|NCT00947531|594436251|FG000|Overall Study|Other|1|||
164564459|NCT00947531|594436252|FG001|Overall Study|Other|1|||
164564460|NCT03502330|594436254|FG000|Overall Study|Adverse Event|2|||
164564461|NCT03502330|594436255|FG001|Overall Study|Adverse Event|1|||
164564462|NCT03502330|594436256|FG002|Overall Study|Adverse Event|0|||
164564463|NCT03502330|594436257|FG003|Overall Study|Adverse Event|0|||
164564464|NCT03502330|594436258|FG004|Overall Study|Adverse Event|1|||
164564465|NCT03502330|594436259|FG005|Overall Study|Adverse Event|0|||
164564466|NCT03502330|594436260|FG006|Overall Study|Adverse Event|1|||
164564467|NCT03502330|594436261|FG007|Overall Study|Adverse Event|1|||
164564468|NCT03502330|594436262|FG008|Overall Study|Adverse Event|0|||
164564469|NCT03502330|594436254|FG000|Overall Study|Lack of Efficacy|1|||
164564470|NCT03502330|594436255|FG001|Overall Study|Lack of Efficacy|5|||
164209218|NCT02799602|593133536|FG000|Overall Study|Lost to Follow-up|4|||
164209219|NCT02799602|593133537|FG001|Overall Study|Lost to Follow-up|2|||
164209220|NCT02799602|593133536|FG000|Overall Study|Additional primary malignancy|11|||
164209221|NCT02799602|593133537|FG001|Overall Study|Additional primary malignancy|6|||
164209222|NCT02799602|593133536|FG000|Overall Study|Non-compliance with study drug|14|||
164209223|NCT02799602|593133537|FG001|Overall Study|Non-compliance with study drug|12|||
164324245|NCT02038829|593565147|FG000|Washout Period 4|Adverse Event|0|||
164564471|NCT03502330|594436256|FG002|Overall Study|Lack of Efficacy|3|||
164564472|NCT03502330|594436257|FG003|Overall Study|Lack of Efficacy|5|||
164564473|NCT03502330|594436258|FG004|Overall Study|Lack of Efficacy|1|||
164564474|NCT03502330|594436259|FG005|Overall Study|Lack of Efficacy|5|||
164209224|NCT02799602|593133536|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
164209225|NCT02799602|593133537|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
164209226|NCT02799602|593133536|FG000|Overall Study|Withdrawal by Subject|26|||
164209227|NCT02799602|593133537|FG001|Overall Study|Withdrawal by Subject|40|||
164209228|NCT02799602|593133536|FG000|Overall Study|Progressive disease - clinical progression|131|||
164209229|NCT02799602|593133537|FG001|Overall Study|Progressive disease - clinical progression|276|||
164209230|NCT02799602|593133536|FG000|Overall Study|Progressive disease - radiological progression|90|||
164209231|NCT02799602|593133537|FG001|Overall Study|Progressive disease - radiological progression|133|||
164209232|NCT02799602|593133536|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
164209233|NCT02799602|593133537|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
164209234|NCT02799602|593133536|FG000|Overall Study|Death|9|||
164209235|NCT02799602|593133537|FG001|Overall Study|Death|5|||
164209236|NCT02799602|593133536|FG000|Overall Study|Other|287|||
164209237|NCT02799602|593133537|FG001|Overall Study|Other|118|||
164209238|NCT02799602|593133536|FG000|Overall Study|Study drug never administered|0|||
164209239|NCT02799602|593133537|FG001|Overall Study|Study drug never administered|3|||
164209240|NCT04809974|593135177|FG000|Lead-in Phase|Withdrawal by Subject|3|||
164209241|NCT04809974|593135178|FG001|Lead-in Phase|Withdrawal by Subject|0|||
164209242|NCT04809974|593135179|FG002|Lead-in Phase|Withdrawal by Subject|0|||
164209243|NCT04809974|593135177|FG000|Lead-in Phase|No longer eligible|11|||
164209244|NCT04809974|593135178|FG001|Lead-in Phase|No longer eligible|0|||
164209245|NCT04809974|593135179|FG002|Lead-in Phase|No longer eligible|0|||
164209246|NCT04809974|593135177|FG000|Randomized Phase|Lost to Follow-up|0|||
164209247|NCT04809974|593135178|FG001|Randomized Phase|Lost to Follow-up|1|||
164209248|NCT04809974|593135179|FG002|Randomized Phase|Lost to Follow-up|5|||
164209249|NCT04809974|593135177|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
164209250|NCT04809974|593135178|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
164209251|NCT04809974|593135179|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
164209252|NCT04809974|593135177|FG000|Randomized Phase|Adverse Event|0|||
164209253|NCT04809974|593135178|FG001|Randomized Phase|Adverse Event|1|||
164209254|NCT04809974|593135179|FG002|Randomized Phase|Adverse Event|4|||
164209255|NCT04809974|593135177|FG000|Randomized Phase|Withdrawal by Subject|0|||
164209256|NCT04809974|593135178|FG001|Randomized Phase|Withdrawal by Subject|0|||
164209257|NCT04809974|593135179|FG002|Randomized Phase|Withdrawal by Subject|5|||
164209258|NCT04338581|593135180|FG000|Overall Study|Lack of Efficacy|1|||
164209259|NCT04338581|593135181|FG001|Overall Study|Lack of Efficacy|0|||
164209260|NCT04338581|593135180|FG000|Overall Study|Withdrawal by Subject|4|||
164209261|NCT04338581|593135181|FG001|Overall Study|Withdrawal by Subject|4|||
164209262|NCT04338581|593135180|FG000|Overall Study|Prohibited Medication|1|||
164209263|NCT04338581|593135181|FG001|Overall Study|Prohibited Medication|0|||
164209264|NCT00549055|593135182|FG000|Overall Study|Adverse Event|4|||
164209265|NCT00549055|593135182|FG000|Overall Study|Lack of Efficacy|18|||
164209266|NCT00549055|593135182|FG000|Overall Study|Stabilization|5|||
164209267|NCT00549055|593135182|FG000|Overall Study|Progression to fibrosis|2|||
164209268|NCT00549055|593135182|FG000|Overall Study|Decrease of size|1|||
164209269|NCT00549055|593135182|FG000|Overall Study|Active choroidal neovascula increased|1|||
164209270|NCT00549055|593135182|FG000|Overall Study|Vitreous hemorrhage|1|||
164209271|NCT00549055|593135182|FG000|Overall Study|Growth choroidal neovascularisation|1|||
164209272|NCT00549055|593135182|FG000|Overall Study|Choroidal neovascularization|1|||
164209273|NCT00549055|593135182|FG000|Overall Study|Very low visual acuity (VA)|1|||
164209274|NCT00770809|593135183|FG000|Overall Study|Adverse Event|9|||
164209275|NCT00770809|593135184|FG001|Overall Study|Adverse Event|1|||
164209276|NCT00770809|593135185|FG002|Overall Study|Adverse Event|12|||
164209277|NCT00770809|593135183|FG000|Overall Study|Death|1|||
164209278|NCT00770809|593135184|FG001|Overall Study|Death|0|||
164209279|NCT00770809|593135185|FG002|Overall Study|Death|0|||
164209280|NCT00770809|593135183|FG000|Overall Study|Withdrawal by Subject|3|||
164209281|NCT00770809|593135184|FG001|Overall Study|Withdrawal by Subject|3|||
164209282|NCT00770809|593135185|FG002|Overall Study|Withdrawal by Subject|7|||
164209283|NCT00770809|593135183|FG000|Overall Study|Progression|2|||
164209284|NCT00770809|593135184|FG001|Overall Study|Progression|2|||
164209285|NCT00770809|593135185|FG002|Overall Study|Progression|0|||
164209286|NCT00770809|593135183|FG000|Overall Study|Complicating illness|0|||
164209287|NCT00770809|593135184|FG001|Overall Study|Complicating illness|0|||
164209288|NCT00770809|593135185|FG002|Overall Study|Complicating illness|1|||
164209289|NCT00770809|593135183|FG000|Overall Study|Other Medical Reasons|2|||
164668607|NCT03049488|594811971|FG001|Overall Study|Withdrawal by Subject|0|||
164209290|NCT00770809|593135184|FG001|Overall Study|Other Medical Reasons|4|||
164209291|NCT00770809|593135185|FG002|Overall Study|Other Medical Reasons|3|||
164209292|NCT00770367|593135188|FG000|First Intervention|Withdrawal by Subject|0|||
164209293|NCT00770367|593135189|FG001|First Intervention|Withdrawal by Subject|2|||
164209294|NCT00770367|593135188|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
164668608|NCT03049488|594811972|FG002|Overall Study|Withdrawal by Subject|0|||
164209295|NCT00770367|593135189|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
164209296|NCT00770367|593135188|FG000|Second Intervention|Lost to Follow-up|2|||
164209297|NCT00770367|593135189|FG001|Second Intervention|Lost to Follow-up|0|||
164209298|NCT00435942|593135190|FG000|Overall Study|Death|17|||
164209299|NCT00435942|593135191|FG001|Overall Study|Death|10|||
164209300|NCT00435942|593135190|FG000|Overall Study|Withdrawal by Subject|2|||
164209301|NCT00435942|593135191|FG001|Overall Study|Withdrawal by Subject|0|||
164209302|NCT00435942|593135190|FG000|Overall Study|Lost to Follow-up|0|||
164209303|NCT00435942|593135191|FG001|Overall Study|Lost to Follow-up|16|||
164209304|NCT00435942|593135190|FG000|Overall Study|Conversion to Open Repair|1|||
164209305|NCT00435942|593135191|FG001|Overall Study|Conversion to Open Repair|0|||
164209306|NCT00435942|593135190|FG000|Overall Study|Technical Failure|3|||
164209307|NCT00435942|593135191|FG001|Overall Study|Technical Failure|0|||
164209308|NCT00435942|593135190|FG000|Overall Study|Other|0|||
164209309|NCT00435942|593135191|FG001|Overall Study|Other|1|||
164209310|NCT01898130|593135192|FG000|Treatment|Withdrawal by Subject|2|||
164209311|NCT01898130|593135192|FG000|Treatment|Progressive Disease|4|||
164209312|NCT01898130|593135192|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
164209313|NCT04115059|593135193|FG000|Overall Study|Withdrawal by Subject|1|||
164209314|NCT04115059|593135193|FG000|Overall Study|Lack of Efficacy|2|||
164209315|NCT04491994|593135194|FG000|Overall Study|Withdrawal by Subject|10|||
164209316|NCT04491994|593135195|FG001|Overall Study|Withdrawal by Subject|5|||
164209317|NCT04491994|593135194|FG000|Overall Study|developed fever > 3 days|4|||
164209318|NCT04491994|593135195|FG001|Overall Study|developed fever > 3 days|1|||
164209319|NCT04491994|593135194|FG000|Overall Study|Protocol Violation|11|||
164209320|NCT04491994|593135195|FG001|Overall Study|Protocol Violation|2|||
164209321|NCT04491994|593135194|FG000|Overall Study|Lost to Follow-up|4|||
164209322|NCT04491994|593135195|FG001|Overall Study|Lost to Follow-up|3|||
164209323|NCT03575364|593135201|FG000|Overall Study|Death|45|||
164209324|NCT03575364|593135201|FG000|Overall Study|Lost to Follow-up|114|||
164209325|NCT03575364|593135201|FG000|Overall Study|Withdrawal by Subject|21|||
164209326|NCT03575364|593135201|FG000|Overall Study|Physician Decision|11|||
164209327|NCT03575364|593135201|FG000|Overall Study|Subject Refused Follow-up|13|||
164209328|NCT03575364|593135201|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
164209329|NCT03575364|593135201|FG000|Overall Study|Patient moved out of the state|1|||
164209330|NCT03575364|593135201|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
164209331|NCT03575364|593135201|FG000|Overall Study|Patient is lost to follow up|1|||
164209332|NCT03575364|593135201|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
164209333|NCT02567188|593135202|FG000|Overall Study|Death|10|||
164209334|NCT02567188|593135202|FG000|Overall Study|Terminated Mircera Treatment|9|||
164209335|NCT02567188|593135202|FG000|Overall Study|Lost to Follow-up|5|||
164209336|NCT02567188|593135202|FG000|Overall Study|Adverse Event|1|||
164209337|NCT02567188|593135202|FG000|Overall Study|Withdrawal by Subject|1|||
164209338|NCT02567188|593135202|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
164209339|NCT02567188|593135202|FG000|Overall Study|Moved and Changed Clinic|1|||
164209340|NCT02567188|593135202|FG000|Overall Study|Started Hemodialysis|2|||
164209341|NCT02567188|593135202|FG000|Overall Study|Protocol Violation|5|||
164209342|NCT01033136|593135203|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
164209343|NCT01033136|593135204|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
164209344|NCT05383209|593135205|FG000|Overall Study|Adverse Event: Non-ocular|0|||
164209345|NCT05383209|593135206|FG001|Overall Study|Adverse Event: Non-ocular|1|||
164209346|NCT05383209|593135207|FG002|Overall Study|Adverse Event: Non-ocular|0|||
164209347|NCT05383209|593135205|FG000|Overall Study|Lost to Follow-up|2|||
164209348|NCT05383209|593135206|FG001|Overall Study|Lost to Follow-up|1|||
164209349|NCT05383209|593135207|FG002|Overall Study|Lost to Follow-up|4|||
164209350|NCT05383209|593135205|FG000|Overall Study|Withdrawal by Subject|2|||
164209351|NCT05383209|593135206|FG001|Overall Study|Withdrawal by Subject|0|||
164209352|NCT05383209|593135207|FG002|Overall Study|Withdrawal by Subject|1|||
164564475|NCT03502330|594436260|FG006|Overall Study|Lack of Efficacy|5|||
164564476|NCT03502330|594436261|FG007|Overall Study|Lack of Efficacy|6|||
164564477|NCT03502330|594436262|FG008|Overall Study|Lack of Efficacy|0|||
164564478|NCT03502330|594436254|FG000|Overall Study|Physician Decision|0|||
164564479|NCT03502330|594436255|FG001|Overall Study|Physician Decision|0|||
164564480|NCT03502330|594436256|FG002|Overall Study|Physician Decision|0|||
164564481|NCT03502330|594436257|FG003|Overall Study|Physician Decision|0|||
164564482|NCT03502330|594436258|FG004|Overall Study|Physician Decision|1|||
164564483|NCT03502330|594436259|FG005|Overall Study|Physician Decision|0|||
164564484|NCT03502330|594436260|FG006|Overall Study|Physician Decision|0|||
164564485|NCT03502330|594436261|FG007|Overall Study|Physician Decision|0|||
164564486|NCT03502330|594436262|FG008|Overall Study|Physician Decision|0|||
164564487|NCT03502330|594436254|FG000|Overall Study|Withdrawal by Subject|0|||
164564488|NCT03502330|594436255|FG001|Overall Study|Withdrawal by Subject|0|||
164209353|NCT05383209|593135205|FG000|Overall Study|Death|1|||
164209354|NCT05383209|593135206|FG001|Overall Study|Death|0|||
164209355|NCT05383209|593135207|FG002|Overall Study|Death|0|||
164209356|NCT05383209|593135205|FG000|Overall Study|Other|0|||
164209357|NCT05383209|593135206|FG001|Overall Study|Other|1|||
164209358|NCT05383209|593135207|FG002|Overall Study|Other|0|||
164209359|NCT00933933|593135209|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
164564489|NCT03502330|594436256|FG002|Overall Study|Withdrawal by Subject|0|||
164209360|NCT00933933|593135210|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
164209361|NCT00933933|593135211|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
164209362|NCT00933933|593135209|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
164209363|NCT00933933|593135210|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
164209364|NCT00933933|593135211|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
164209365|NCT01138046|593135214|FG000|Overall Study|Withdrawal due to death|6|||
164209366|NCT01104766|593135218|FG000|Overall Study|Did not meet inc/exc criteria|1|||
164209367|NCT01104766|593135219|FG001|Overall Study|Did not meet inc/exc criteria|0|||
164209368|NCT01104766|593135220|FG002|Overall Study|Did not meet inc/exc criteria|0|||
164209369|NCT01104766|593135221|FG003|Overall Study|Did not meet inc/exc criteria|0|||
164209370|NCT01104766|593135218|FG000|Overall Study|Adverse Event|17|||
164209371|NCT01104766|593135219|FG001|Overall Study|Adverse Event|15|||
164209372|NCT01104766|593135220|FG002|Overall Study|Adverse Event|20|||
164209373|NCT01104766|593135221|FG003|Overall Study|Adverse Event|14|||
164209374|NCT01104766|593135218|FG000|Overall Study|Lack of Efficacy|20|||
164209375|NCT01104766|593135219|FG001|Overall Study|Lack of Efficacy|15|||
164209376|NCT01104766|593135220|FG002|Overall Study|Lack of Efficacy|14|||
164209377|NCT01104766|593135221|FG003|Overall Study|Lack of Efficacy|8|||
164209378|NCT01104766|593135218|FG000|Overall Study|Protocol Violation|2|||
164209379|NCT01104766|593135219|FG001|Overall Study|Protocol Violation|0|||
164209380|NCT01104766|593135220|FG002|Overall Study|Protocol Violation|0|||
164209381|NCT01104766|593135221|FG003|Overall Study|Protocol Violation|0|||
164209382|NCT01104766|593135218|FG000|Overall Study|Withdrawal by Subject|17|||
164209383|NCT01104766|593135219|FG001|Overall Study|Withdrawal by Subject|19|||
164209384|NCT01104766|593135220|FG002|Overall Study|Withdrawal by Subject|25|||
164209385|NCT01104766|593135221|FG003|Overall Study|Withdrawal by Subject|15|||
164209386|NCT01104766|593135218|FG000|Overall Study|Lost to Follow-up|1|||
164209387|NCT01104766|593135219|FG001|Overall Study|Lost to Follow-up|2|||
164209388|NCT01104766|593135220|FG002|Overall Study|Lost to Follow-up|1|||
164209389|NCT01104766|593135221|FG003|Overall Study|Lost to Follow-up|1|||
164209390|NCT05452239|593135224|FG000|Placebo-controlled Period|Withdrawal by Subject|0|||
164209391|NCT05452239|593135225|FG001|Placebo-controlled Period|Withdrawal by Subject|4|||
164209392|NCT05452239|593135224|FG000|Placebo-controlled Period|Lost to Follow-up|1|||
164209393|NCT05452239|593135225|FG001|Placebo-controlled Period|Lost to Follow-up|0|||
164209394|NCT05452239|593135224|FG000|Placebo-controlled Period|Failure to comply with trial procedures|0|||
164209395|NCT05452239|593135225|FG001|Placebo-controlled Period|Failure to comply with trial procedures|1|||
164209396|NCT05452239|593135224|FG000|Placebo-controlled Period|Randomized but not treated|2|||
164209397|NCT05452239|593135225|FG001|Placebo-controlled Period|Randomized but not treated|2|||
164209398|NCT05452239|593135224|FG000|Placebo-controlled Period|Other than specified|1|||
164209399|NCT05452239|593135225|FG001|Placebo-controlled Period|Other than specified|1|||
164209400|NCT05452239|593135224|FG000|Open-label Period|Withdrawal by Subject|2|||
164209401|NCT05452239|593135225|FG001|Open-label Period|Withdrawal by Subject|1|||
164209402|NCT05452239|593135224|FG000|Open-label Period|Lost to Follow-up|3|||
164209403|NCT05452239|593135225|FG001|Open-label Period|Lost to Follow-up|0|||
164209404|NCT05452239|593135224|FG000|Open-label Period|Other than specified|1|||
164209405|NCT05452239|593135225|FG001|Open-label Period|Other than specified|2|||
164209406|NCT03965923|593135226|FG000|Overall Study|Withdrawal by Subject|1|||
164209407|NCT03965923|593135227|FG001|Overall Study|Withdrawal by Subject|2|||
164209408|NCT03965923|593135228|FG002|Overall Study|Withdrawal by Subject|3|||
164209409|NCT03965923|593135229|FG003|Overall Study|Withdrawal by Subject|1|||
164209410|NCT03965923|593135230|FG004|Overall Study|Withdrawal by Subject|2|||
164209411|NCT03965923|593135231|FG005|Overall Study|Withdrawal by Subject|0|||
164209412|NCT03965923|593135232|FG006|Overall Study|Withdrawal by Subject|4|||
164209413|NCT03965923|593135233|FG007|Overall Study|Withdrawal by Subject|3|||
164209414|NCT03965923|593135234|FG008|Overall Study|Withdrawal by Subject|4|||
164209415|NCT03965923|593135235|FG009|Overall Study|Withdrawal by Subject|0|||
164209416|NCT03965923|593135236|FG010|Overall Study|Withdrawal by Subject|2|||
164209417|NCT03965923|593135237|FG011|Overall Study|Withdrawal by Subject|0|||
164209418|NCT03965923|593135226|FG000|Overall Study|Lost to Follow-up|2|||
164209419|NCT03965923|593135227|FG001|Overall Study|Lost to Follow-up|1|||
164209420|NCT03965923|593135228|FG002|Overall Study|Lost to Follow-up|1|||
164209421|NCT03965923|593135229|FG003|Overall Study|Lost to Follow-up|0|||
164209422|NCT03965923|593135230|FG004|Overall Study|Lost to Follow-up|2|||
164209423|NCT03965923|593135231|FG005|Overall Study|Lost to Follow-up|1|||
164209424|NCT03965923|593135232|FG006|Overall Study|Lost to Follow-up|2|||
164209425|NCT03965923|593135233|FG007|Overall Study|Lost to Follow-up|1|||
164209426|NCT03965923|593135234|FG008|Overall Study|Lost to Follow-up|0|||
164564490|NCT03502330|594436257|FG003|Overall Study|Withdrawal by Subject|0|||
164564491|NCT03502330|594436258|FG004|Overall Study|Withdrawal by Subject|0|||
164564492|NCT03502330|594436259|FG005|Overall Study|Withdrawal by Subject|1|||
164564493|NCT03502330|594436260|FG006|Overall Study|Withdrawal by Subject|0|||
164564494|NCT03502330|594436261|FG007|Overall Study|Withdrawal by Subject|1|||
164564495|NCT03502330|594436262|FG008|Overall Study|Withdrawal by Subject|0|||
164564496|NCT03502330|594436254|FG000|Overall Study|Death|0|||
164209427|NCT03965923|593135235|FG009|Overall Study|Lost to Follow-up|2|||
164209428|NCT03965923|593135236|FG010|Overall Study|Lost to Follow-up|0|||
164209429|NCT03965923|593135237|FG011|Overall Study|Lost to Follow-up|0|||
164209430|NCT03965923|593135226|FG000|Overall Study|Death|0|||
164209431|NCT03965923|593135227|FG001|Overall Study|Death|0|||
164209432|NCT03965923|593135228|FG002|Overall Study|Death|0|||
164209433|NCT03965923|593135229|FG003|Overall Study|Death|0|||
164209434|NCT03965923|593135230|FG004|Overall Study|Death|0|||
164324246|NCT02038829|593565148|FG001|Washout Period 4|Adverse Event|0|||
164324247|NCT02038829|593565149|FG002|Washout Period 4|Adverse Event|0|||
164324248|NCT02038829|593565150|FG003|Washout Period 4|Adverse Event|0|||
164564497|NCT03502330|594436255|FG001|Overall Study|Death|0|||
164564498|NCT03502330|594436256|FG002|Overall Study|Death|0|||
164209435|NCT03965923|593135231|FG005|Overall Study|Death|0|||
164209436|NCT03965923|593135232|FG006|Overall Study|Death|0|||
164209437|NCT03965923|593135233|FG007|Overall Study|Death|1|||
164209438|NCT03965923|593135234|FG008|Overall Study|Death|4|||
164209439|NCT03965923|593135235|FG009|Overall Study|Death|0|||
164324249|NCT02038829|593565151|FG004|Washout Period 4|Adverse Event|0|||
164324250|NCT02038829|593565152|FG005|Washout Period 4|Adverse Event|0|||
164324251|NCT02038829|593565153|FG006|Washout Period 4|Adverse Event|1|||
164324252|NCT02038829|593565154|FG007|Washout Period 4|Adverse Event|0|||
164324253|NCT02038829|593565155|FG008|Washout Period 4|Adverse Event|0|||
164324254|NCT02038829|593565156|FG009|Washout Period 4|Adverse Event|0|||
164324255|NCT02038829|593565157|FG010|Washout Period 4|Adverse Event|0|||
164324256|NCT02038829|593565158|FG011|Washout Period 4|Adverse Event|0|||
164324257|NCT02038829|593565147|FG000|Treatment Period 6|Adverse Event|0|||
164324258|NCT02038829|593565148|FG001|Treatment Period 6|Adverse Event|0|||
164324259|NCT02038829|593565149|FG002|Treatment Period 6|Adverse Event|1|||
164324260|NCT02038829|593565150|FG003|Treatment Period 6|Adverse Event|0|||
164324261|NCT02038829|593565151|FG004|Treatment Period 6|Adverse Event|0|||
164324262|NCT02038829|593565152|FG005|Treatment Period 6|Adverse Event|0|||
164324263|NCT02038829|593565153|FG006|Treatment Period 6|Adverse Event|0|||
164324264|NCT02038829|593565154|FG007|Treatment Period 6|Adverse Event|0|||
164324265|NCT02038829|593565155|FG008|Treatment Period 6|Adverse Event|0|||
164324266|NCT02038829|593565156|FG009|Treatment Period 6|Adverse Event|0|||
164324267|NCT02038829|593565157|FG010|Treatment Period 6|Adverse Event|0|||
164324268|NCT02038829|593565158|FG011|Treatment Period 6|Adverse Event|0|||
164324269|NCT04393298|593565159|FG000|Overall Study|Adverse Event|0|||
164324270|NCT04393298|593565160|FG001|Overall Study|Adverse Event|0|||
164324271|NCT04393298|593565161|FG002|Overall Study|Adverse Event|0|||
164324272|NCT04393298|593565162|FG003|Overall Study|Adverse Event|0|||
164324273|NCT04393298|593565163|FG004|Overall Study|Adverse Event|1|||
164324274|NCT04393298|593565164|FG005|Overall Study|Adverse Event|0|||
164324275|NCT04393298|593565165|FG006|Overall Study|Adverse Event|0|||
164324276|NCT04393298|593565166|FG007|Overall Study|Adverse Event|0|||
164324277|NCT04393298|593565167|FG008|Overall Study|Adverse Event|2|||
164324278|NCT04393298|593565168|FG009|Overall Study|Adverse Event|0|||
164324279|NCT04393298|593565169|FG010|Overall Study|Adverse Event|0|||
164324280|NCT04393298|593565170|FG011|Overall Study|Adverse Event|0|||
164324281|NCT04393298|593565171|FG012|Overall Study|Adverse Event|1|||
164324282|NCT04393298|593565172|FG013|Overall Study|Adverse Event|1|||
164324283|NCT04393298|593565173|FG014|Overall Study|Adverse Event|0|||
164324284|NCT04393298|593565159|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324285|NCT04393298|593565160|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324286|NCT04393298|593565161|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
164324287|NCT04393298|593565162|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324288|NCT04393298|593565163|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324289|NCT04393298|593565164|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324290|NCT04393298|593565165|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324291|NCT04393298|593565166|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324292|NCT04393298|593565167|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324293|NCT04393298|593565168|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324294|NCT04393298|593565169|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324295|NCT04393298|593565170|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324296|NCT04393298|593565171|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324297|NCT04393298|593565172|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324298|NCT04393298|593565173|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
164324299|NCT04393298|593565159|FG000|Overall Study|Lack of Efficacy|0|||
164324300|NCT04393298|593565160|FG001|Overall Study|Lack of Efficacy|0|||
164324301|NCT04393298|593565161|FG002|Overall Study|Lack of Efficacy|0|||
164324302|NCT04393298|593565162|FG003|Overall Study|Lack of Efficacy|0|||
164324303|NCT04393298|593565163|FG004|Overall Study|Lack of Efficacy|0|||
164564499|NCT03502330|594436257|FG003|Overall Study|Death|0|||
164564500|NCT03502330|594436258|FG004|Overall Study|Death|0|||
164564501|NCT03502330|594436259|FG005|Overall Study|Death|0|||
164564502|NCT03502330|594436260|FG006|Overall Study|Death|2|||
164564503|NCT03502330|594436261|FG007|Overall Study|Death|0|||
164564504|NCT03502330|594436262|FG008|Overall Study|Death|0|||
164564505|NCT04656990|594436266|FG000|Baseline|pandemic|20|||
164564506|NCT04656990|594436267|FG001|Baseline|pandemic|24|||
164324304|NCT04393298|593565164|FG005|Overall Study|Lack of Efficacy|0|||
164324305|NCT04393298|593565165|FG006|Overall Study|Lack of Efficacy|0|||
164324306|NCT04393298|593565166|FG007|Overall Study|Lack of Efficacy|0|||
164324307|NCT04393298|593565167|FG008|Overall Study|Lack of Efficacy|0|||
164324308|NCT04393298|593565168|FG009|Overall Study|Lack of Efficacy|0|||
164324309|NCT04393298|593565169|FG010|Overall Study|Lack of Efficacy|0|||
164324310|NCT04393298|593565170|FG011|Overall Study|Lack of Efficacy|0|||
164324311|NCT04393298|593565171|FG012|Overall Study|Lack of Efficacy|0|||
164324312|NCT04393298|593565172|FG013|Overall Study|Lack of Efficacy|0|||
164324313|NCT04393298|593565173|FG014|Overall Study|Lack of Efficacy|1|||
164324314|NCT04393298|593565159|FG000|Overall Study|Progression|1|||
164564507|NCT04656990|594436266|FG000|Follow Up Period|Lost to Follow-up|61|||
164564508|NCT04656990|594436267|FG001|Follow Up Period|Lost to Follow-up|73|||
164564509|NCT03244059|594436268|FG000|Specific Aim 1|Physician Decision|1|||
164564510|NCT03244059|594436269|FG001|Specific Aim 1|Physician Decision|0|||
164324315|NCT04393298|593565160|FG001|Overall Study|Progression|0|||
164324316|NCT04393298|593565161|FG002|Overall Study|Progression|0|||
164324317|NCT04393298|593565162|FG003|Overall Study|Progression|0|||
164324318|NCT04393298|593565163|FG004|Overall Study|Progression|0|||
164668609|NCT03049488|594811973|FG003|Overall Study|Withdrawal by Subject|1|||
164668610|NCT03049488|594811974|FG004|Overall Study|Withdrawal by Subject|1|||
164668611|NCT03049488|594811975|FG005|Overall Study|Withdrawal by Subject|0|||
164668612|NCT01735630|594811976|FG000|Overall Study|Adverse Event|8|||
164668613|NCT01735630|594811977|FG001|Overall Study|Adverse Event|7|||
164668614|NCT01735630|594811976|FG000|Overall Study|Lost to Follow-up|1|||
164668615|NCT01735630|594811977|FG001|Overall Study|Lost to Follow-up|0|||
164668616|NCT01735630|594811976|FG000|Overall Study|Physician Decision|0|||
164668617|NCT01735630|594811977|FG001|Overall Study|Physician Decision|1|||
164668618|NCT01735630|594811976|FG000|Overall Study|Sponsor Decision|2|||
164668619|NCT01735630|594811977|FG001|Overall Study|Sponsor Decision|1|||
164668620|NCT01735630|594811976|FG000|Overall Study|Withdrawal by Subject|7|||
164668621|NCT01735630|594811977|FG001|Overall Study|Withdrawal by Subject|9|||
164668622|NCT00891293|594811979|FG000|Overall Study|Adverse Event|2|||
164668623|NCT00891293|594811979|FG000|Overall Study|Protocol Violation|2|||
164668624|NCT00891293|594811979|FG000|Overall Study|Laboratory abnormality|4|||
164668625|NCT00891293|594811979|FG000|Overall Study|Lost to Follow-up|7|||
164668626|NCT00891293|594811979|FG000|Overall Study|Subject withdrew consent|7|||
164668627|NCT00891293|594811979|FG000|Overall Study|Sponsor termination|62|||
164668628|NCT02178722|594811980|FG000|Overall Study|Withdrawal by Subject|0|||
164668629|NCT02178722|594811981|FG001|Overall Study|Withdrawal by Subject|0|||
164668630|NCT02178722|594811982|FG002|Overall Study|Withdrawal by Subject|0|||
164668631|NCT02178722|594811983|FG003|Overall Study|Withdrawal by Subject|2|||
164668632|NCT02178722|594811984|FG004|Overall Study|Withdrawal by Subject|33|||
164668633|NCT02178722|594811980|FG000|Overall Study|Death|2|||
164668634|NCT02178722|594811981|FG001|Overall Study|Death|13|||
164668635|NCT02178722|594811982|FG002|Overall Study|Death|12|||
164668636|NCT02178722|594811983|FG003|Overall Study|Death|12|||
164668637|NCT02178722|594811984|FG004|Overall Study|Death|205|||
164668638|NCT02178722|594811980|FG000|Overall Study|Lost to Follow-up|0|||
164668639|NCT02178722|594811981|FG001|Overall Study|Lost to Follow-up|0|||
164668640|NCT02178722|594811982|FG002|Overall Study|Lost to Follow-up|0|||
164668641|NCT02178722|594811983|FG003|Overall Study|Lost to Follow-up|2|||
164668642|NCT02178722|594811984|FG004|Overall Study|Lost to Follow-up|11|||
164668643|NCT02178722|594811980|FG000|Overall Study|Study terminated by Sponsor|2|||
164668644|NCT02178722|594811981|FG001|Overall Study|Study terminated by Sponsor|7|||
164668645|NCT02178722|594811982|FG002|Overall Study|Study terminated by Sponsor|6|||
164668646|NCT02178722|594811983|FG003|Overall Study|Study terminated by Sponsor|4|||
164668647|NCT02178722|594811984|FG004|Overall Study|Study terminated by Sponsor|128|||
164668648|NCT02178722|594811980|FG000|Overall Study|Physician Decision|0|||
164209440|NCT03965923|593135236|FG010|Overall Study|Death|4|||
164209441|NCT03965923|593135237|FG011|Overall Study|Death|0|||
164209442|NCT03965923|593135226|FG000|Overall Study|Other reason|0|||
164209443|NCT03965923|593135227|FG001|Overall Study|Other reason|0|||
164209444|NCT03965923|593135228|FG002|Overall Study|Other reason|0|||
164209445|NCT03965923|593135229|FG003|Overall Study|Other reason|1|||
164209446|NCT03965923|593135230|FG004|Overall Study|Other reason|0|||
164209447|NCT03965923|593135231|FG005|Overall Study|Other reason|0|||
164209448|NCT03965923|593135232|FG006|Overall Study|Other reason|0|||
164209449|NCT03965923|593135233|FG007|Overall Study|Other reason|0|||
164209450|NCT03965923|593135234|FG008|Overall Study|Other reason|0|||
164209451|NCT03965923|593135235|FG009|Overall Study|Other reason|0|||
164209452|NCT03965923|593135236|FG010|Overall Study|Other reason|2|||
164209453|NCT03965923|593135237|FG011|Overall Study|Other reason|0|||
164209454|NCT02755090|593135238|FG000|Overall Study|equipment malfunction|1|||
164209455|NCT02755090|593135239|FG001|Overall Study|equipment malfunction|0|||
164209456|NCT00207740|593135240|FG000|Overall Study|Adverse Event|4|||
164209457|NCT00207740|593135241|FG001|Overall Study|Adverse Event|14|||
164209458|NCT00207740|593135242|FG002|Overall Study|Adverse Event|14|||
164209459|NCT00207740|593135243|FG003|Overall Study|Adverse Event|11|||
164668649|NCT02178722|594811981|FG001|Overall Study|Physician Decision|0|||
164668650|NCT02178722|594811982|FG002|Overall Study|Physician Decision|0|||
164668651|NCT02178722|594811983|FG003|Overall Study|Physician Decision|0|||
164668652|NCT02178722|594811984|FG004|Overall Study|Physician Decision|3|||
164209460|NCT00207740|593135240|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164209461|NCT00207740|593135241|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164209462|NCT00207740|593135242|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
164209463|NCT00207740|593135243|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
164209464|NCT00207740|593135240|FG000|Overall Study|Lost to Follow-up|0|||
164324319|NCT04393298|593565164|FG005|Overall Study|Progression|0|||
164324320|NCT04393298|593565165|FG006|Overall Study|Progression|0|||
164668653|NCT02178722|594811980|FG000|Overall Study|Other|0|||
164668654|NCT02178722|594811981|FG001|Overall Study|Other|0|||
164668655|NCT02178722|594811982|FG002|Overall Study|Other|0|||
164668656|NCT02178722|594811983|FG003|Overall Study|Other|0|||
164668657|NCT02178722|594811984|FG004|Overall Study|Other|2|||
164209465|NCT00207740|593135241|FG001|Overall Study|Lost to Follow-up|2|||
164209466|NCT00207740|593135242|FG002|Overall Study|Lost to Follow-up|1|||
164209467|NCT00207740|593135243|FG003|Overall Study|Lost to Follow-up|1|||
164209468|NCT00207740|593135240|FG000|Overall Study|Death|0|||
164209469|NCT00207740|593135241|FG001|Overall Study|Death|0|||
164209470|NCT00207740|593135242|FG002|Overall Study|Death|0|||
164209471|NCT00207740|593135243|FG003|Overall Study|Death|1|||
164209472|NCT00207740|593135240|FG000|Overall Study|Sponsor Directive|22|||
164209473|NCT00207740|593135241|FG001|Overall Study|Sponsor Directive|15|||
164209474|NCT00207740|593135242|FG002|Overall Study|Sponsor Directive|16|||
164209475|NCT00207740|593135243|FG003|Overall Study|Sponsor Directive|21|||
164324321|NCT04393298|593565166|FG007|Overall Study|Progression|0|||
164209476|NCT00207740|593135240|FG000|Overall Study|Other|2|||
164209477|NCT00207740|593135241|FG001|Overall Study|Other|10|||
164209478|NCT00207740|593135242|FG002|Overall Study|Other|7|||
164209479|NCT00207740|593135243|FG003|Overall Study|Other|5|||
164209480|NCT01402700|593135247|FG000|Overall Study|Death|3|||
164209481|NCT01402700|593135247|FG000|Overall Study|Withdrawal by Subject|3|||
164209482|NCT01402700|593135247|FG000|Overall Study|Missed Visit|1|||
164209483|NCT01933594|593135248|FG000|Overall Study|Lost to Follow-up|1|||
164209484|NCT01933594|593135249|FG001|Overall Study|Lost to Follow-up|0|||
164209485|NCT01933594|593135250|FG002|Overall Study|Lost to Follow-up|0|||
164209486|NCT01933594|593135251|FG003|Overall Study|Lost to Follow-up|0|||
164209487|NCT01933594|593135252|FG004|Overall Study|Lost to Follow-up|1|||
164209488|NCT01933594|593135253|FG005|Overall Study|Lost to Follow-up|0|||
164209489|NCT01933594|593135248|FG000|Overall Study|Ineligible for subsequent study step|0|||
164209490|NCT01933594|593135249|FG001|Overall Study|Ineligible for subsequent study step|0|||
164209491|NCT01933594|593135250|FG002|Overall Study|Ineligible for subsequent study step|0|||
164209492|NCT01933594|593135251|FG003|Overall Study|Ineligible for subsequent study step|0|||
164209493|NCT01933594|593135252|FG004|Overall Study|Ineligible for subsequent study step|1|||
164209494|NCT01933594|593135253|FG005|Overall Study|Ineligible for subsequent study step|0|||
164209495|NCT03314935|593135254|FG000|Phase 1|Death|4|||
164209496|NCT03314935|593135255|FG001|Phase 1|Death|2|||
164209497|NCT03314935|593135256|FG002|Phase 1|Death|5|||
164209498|NCT03314935|593135257|FG003|Phase 1|Death|4|||
164209499|NCT03314935|593135258|FG004|Phase 1|Death|3|||
164209500|NCT03314935|593135259|FG005|Phase 1|Death|4|||
164209501|NCT03314935|593135260|FG006|Phase 1|Death|5|||
164209502|NCT03314935|593135261|FG007|Phase 1|Death|4|||
164209503|NCT03314935|593135262|FG008|Phase 1|Death|3|||
164209504|NCT03314935|593135263|FG009|Phase 1|Death|0|||
164209505|NCT03314935|593135264|FG010|Phase 1|Death|0|||
164209506|NCT03314935|593135265|FG011|Phase 1|Death|0|||
164209507|NCT03314935|593135266|FG012|Phase 1|Death|0|||
164209508|NCT03314935|593135267|FG013|Phase 1|Death|0|||
164209509|NCT03314935|593135268|FG014|Phase 1|Death|0|||
164209510|NCT03314935|593135254|FG000|Phase 1|Withdrawal by Subject|2|||
164209511|NCT03314935|593135255|FG001|Phase 1|Withdrawal by Subject|1|||
164209512|NCT03314935|593135256|FG002|Phase 1|Withdrawal by Subject|1|||
164209513|NCT03314935|593135257|FG003|Phase 1|Withdrawal by Subject|2|||
164209514|NCT03314935|593135258|FG004|Phase 1|Withdrawal by Subject|1|||
164209515|NCT03314935|593135259|FG005|Phase 1|Withdrawal by Subject|0|||
164209516|NCT03314935|593135260|FG006|Phase 1|Withdrawal by Subject|1|||
164324322|NCT04393298|593565167|FG008|Overall Study|Progression|0|||
164324323|NCT04393298|593565168|FG009|Overall Study|Progression|0|||
164324324|NCT04393298|593565169|FG010|Overall Study|Progression|1|||
164209517|NCT03314935|593135261|FG007|Phase 1|Withdrawal by Subject|0|||
164209518|NCT03314935|593135262|FG008|Phase 1|Withdrawal by Subject|1|||
164209519|NCT03314935|593135263|FG009|Phase 1|Withdrawal by Subject|0|||
164209520|NCT03314935|593135264|FG010|Phase 1|Withdrawal by Subject|0|||
164209521|NCT03314935|593135265|FG011|Phase 1|Withdrawal by Subject|0|||
164209522|NCT03314935|593135266|FG012|Phase 1|Withdrawal by Subject|0|||
164209523|NCT03314935|593135267|FG013|Phase 1|Withdrawal by Subject|0|||
164209524|NCT03314935|593135268|FG014|Phase 1|Withdrawal by Subject|0|||
164209525|NCT03314935|593135254|FG000|Phase 1|Progressive Disease|2|||
164209526|NCT03314935|593135255|FG001|Phase 1|Progressive Disease|0|||
164209527|NCT03314935|593135256|FG002|Phase 1|Progressive Disease|0|||
164209528|NCT03314935|593135257|FG003|Phase 1|Progressive Disease|1|||
164209529|NCT03314935|593135258|FG004|Phase 1|Progressive Disease|0|||
164209530|NCT03314935|593135259|FG005|Phase 1|Progressive Disease|0|||
164209531|NCT03314935|593135260|FG006|Phase 1|Progressive Disease|0|||
164209532|NCT03314935|593135261|FG007|Phase 1|Progressive Disease|0|||
164209533|NCT03314935|593135262|FG008|Phase 1|Progressive Disease|0|||
164209534|NCT03314935|593135263|FG009|Phase 1|Progressive Disease|0|||
164209535|NCT03314935|593135264|FG010|Phase 1|Progressive Disease|0|||
164209536|NCT03314935|593135265|FG011|Phase 1|Progressive Disease|0|||
164209537|NCT03314935|593135266|FG012|Phase 1|Progressive Disease|0|||
164209538|NCT03314935|593135267|FG013|Phase 1|Progressive Disease|0|||
164209539|NCT03314935|593135268|FG014|Phase 1|Progressive Disease|0|||
164209540|NCT03314935|593135254|FG000|Phase 1|Study Terminated by Sponsor|0|||
164209541|NCT03314935|593135255|FG001|Phase 1|Study Terminated by Sponsor|1|||
164209542|NCT03314935|593135256|FG002|Phase 1|Study Terminated by Sponsor|0|||
164324325|NCT04393298|593565170|FG011|Overall Study|Progression|1|||
164209543|NCT03314935|593135257|FG003|Phase 1|Study Terminated by Sponsor|0|||
164209544|NCT03314935|593135258|FG004|Phase 1|Study Terminated by Sponsor|0|||
164209545|NCT03314935|593135259|FG005|Phase 1|Study Terminated by Sponsor|0|||
164209546|NCT03314935|593135260|FG006|Phase 1|Study Terminated by Sponsor|0|||
164209547|NCT03314935|593135261|FG007|Phase 1|Study Terminated by Sponsor|0|||
164209548|NCT03314935|593135262|FG008|Phase 1|Study Terminated by Sponsor|1|||
164209549|NCT03314935|593135263|FG009|Phase 1|Study Terminated by Sponsor|0|||
164209550|NCT03314935|593135264|FG010|Phase 1|Study Terminated by Sponsor|0|||
164209551|NCT03314935|593135265|FG011|Phase 1|Study Terminated by Sponsor|0|||
164209552|NCT03314935|593135266|FG012|Phase 1|Study Terminated by Sponsor|0|||
164209553|NCT03314935|593135267|FG013|Phase 1|Study Terminated by Sponsor|0|||
164209554|NCT03314935|593135268|FG014|Phase 1|Study Terminated by Sponsor|0|||
164209555|NCT03314935|593135254|FG000|Phase 1|"Captured as Other in Database"|0|||
164209556|NCT03314935|593135255|FG001|Phase 1|"Captured as Other in Database"|2|||
164209557|NCT03314935|593135256|FG002|Phase 1|"Captured as Other in Database"|0|||
164209558|NCT03314935|593135257|FG003|Phase 1|"Captured as Other in Database"|0|||
164209559|NCT03314935|593135258|FG004|Phase 1|"Captured as Other in Database"|0|||
164209560|NCT03314935|593135259|FG005|Phase 1|"Captured as Other in Database"|0|||
164209561|NCT03314935|593135260|FG006|Phase 1|"Captured as Other in Database"|1|||
164209562|NCT03314935|593135261|FG007|Phase 1|"Captured as Other in Database"|1|||
164209563|NCT03314935|593135262|FG008|Phase 1|"Captured as Other in Database"|1|||
164209564|NCT03314935|593135263|FG009|Phase 1|"Captured as Other in Database"|0|||
164209565|NCT03314935|593135264|FG010|Phase 1|"Captured as Other in Database"|0|||
164209566|NCT03314935|593135265|FG011|Phase 1|"Captured as Other in Database"|0|||
164209567|NCT03314935|593135266|FG012|Phase 1|"Captured as Other in Database"|0|||
164209568|NCT03314935|593135267|FG013|Phase 1|"Captured as Other in Database"|0|||
164209569|NCT03314935|593135268|FG014|Phase 1|"Captured as Other in Database"|0|||
164209570|NCT03314935|593135254|FG000|Phase 1|Lost to Follow-up|0|||
164209571|NCT03314935|593135255|FG001|Phase 1|Lost to Follow-up|0|||
164209572|NCT03314935|593135256|FG002|Phase 1|Lost to Follow-up|0|||
164324326|NCT04393298|593565171|FG012|Overall Study|Progression|0|||
164324327|NCT04393298|593565172|FG013|Overall Study|Progression|0|||
164324328|NCT04393298|593565173|FG014|Overall Study|Progression|0|||
164209573|NCT03314935|593135257|FG003|Phase 1|Lost to Follow-up|0|||
164209574|NCT03314935|593135258|FG004|Phase 1|Lost to Follow-up|0|||
164209575|NCT03314935|593135259|FG005|Phase 1|Lost to Follow-up|0|||
164209576|NCT03314935|593135260|FG006|Phase 1|Lost to Follow-up|0|||
164209577|NCT03314935|593135261|FG007|Phase 1|Lost to Follow-up|0|||
164209578|NCT03314935|593135262|FG008|Phase 1|Lost to Follow-up|1|||
164209579|NCT03314935|593135263|FG009|Phase 1|Lost to Follow-up|0|||
164209580|NCT03314935|593135264|FG010|Phase 1|Lost to Follow-up|0|||
164209581|NCT03314935|593135265|FG011|Phase 1|Lost to Follow-up|0|||
164209582|NCT03314935|593135266|FG012|Phase 1|Lost to Follow-up|0|||
164209583|NCT03314935|593135267|FG013|Phase 1|Lost to Follow-up|0|||
164209584|NCT03314935|593135268|FG014|Phase 1|Lost to Follow-up|0|||
164209585|NCT03314935|593135254|FG000|Phase 2|Death|0|||
164209586|NCT03314935|593135255|FG001|Phase 2|Death|0|||
164209587|NCT03314935|593135256|FG002|Phase 2|Death|0|||
164209588|NCT03314935|593135257|FG003|Phase 2|Death|0|||
164209589|NCT03314935|593135258|FG004|Phase 2|Death|0|||
164209590|NCT03314935|593135259|FG005|Phase 2|Death|0|||
164209591|NCT03314935|593135260|FG006|Phase 2|Death|0|||
164209592|NCT03314935|593135261|FG007|Phase 2|Death|0|||
164324329|NCT04393298|593565159|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
164324330|NCT04393298|593565160|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
164209593|NCT03314935|593135262|FG008|Phase 2|Death|0|||
164209594|NCT03314935|593135263|FG009|Phase 2|Death|5|||
164209595|NCT03314935|593135264|FG010|Phase 2|Death|20|||
164209596|NCT03314935|593135265|FG011|Phase 2|Death|6|||
164209597|NCT03314935|593135266|FG012|Phase 2|Death|7|||
164209598|NCT03314935|593135267|FG013|Phase 2|Death|6|||
164209599|NCT03314935|593135268|FG014|Phase 2|Death|17|||
164209600|NCT03314935|593135254|FG000|Phase 2|Withdrawal by Subject|0|||
164209601|NCT03314935|593135255|FG001|Phase 2|Withdrawal by Subject|0|||
164209602|NCT03314935|593135256|FG002|Phase 2|Withdrawal by Subject|0|||
164209603|NCT03314935|593135257|FG003|Phase 2|Withdrawal by Subject|0|||
164209604|NCT03314935|593135258|FG004|Phase 2|Withdrawal by Subject|0|||
164209605|NCT03314935|593135259|FG005|Phase 2|Withdrawal by Subject|0|||
164209606|NCT03314935|593135260|FG006|Phase 2|Withdrawal by Subject|0|||
164209607|NCT03314935|593135261|FG007|Phase 2|Withdrawal by Subject|0|||
164209608|NCT03314935|593135262|FG008|Phase 2|Withdrawal by Subject|0|||
164209609|NCT03314935|593135263|FG009|Phase 2|Withdrawal by Subject|1|||
164209610|NCT03314935|593135264|FG010|Phase 2|Withdrawal by Subject|4|||
164209611|NCT03314935|593135265|FG011|Phase 2|Withdrawal by Subject|0|||
164209612|NCT03314935|593135266|FG012|Phase 2|Withdrawal by Subject|1|||
164209613|NCT03314935|593135267|FG013|Phase 2|Withdrawal by Subject|0|||
164209614|NCT03314935|593135268|FG014|Phase 2|Withdrawal by Subject|1|||
164209615|NCT03314935|593135254|FG000|Phase 2|Progressive Disease|0|||
164209616|NCT03314935|593135255|FG001|Phase 2|Progressive Disease|0|||
164209617|NCT03314935|593135256|FG002|Phase 2|Progressive Disease|0|||
164209618|NCT03314935|593135257|FG003|Phase 2|Progressive Disease|0|||
164209619|NCT03314935|593135258|FG004|Phase 2|Progressive Disease|0|||
164355616|NCT01535053|593676481|FG001|Overall Study|Ineligible|2|||
164209620|NCT03314935|593135259|FG005|Phase 2|Progressive Disease|0|||
164209621|NCT03314935|593135260|FG006|Phase 2|Progressive Disease|0|||
164209622|NCT03314935|593135261|FG007|Phase 2|Progressive Disease|0|||
164209623|NCT03314935|593135262|FG008|Phase 2|Progressive Disease|0|||
164209624|NCT03314935|593135263|FG009|Phase 2|Progressive Disease|1|||
164209625|NCT03314935|593135264|FG010|Phase 2|Progressive Disease|1|||
164209626|NCT03314935|593135265|FG011|Phase 2|Progressive Disease|1|||
164209627|NCT03314935|593135266|FG012|Phase 2|Progressive Disease|2|||
164209628|NCT03314935|593135267|FG013|Phase 2|Progressive Disease|0|||
164209629|NCT03314935|593135268|FG014|Phase 2|Progressive Disease|1|||
164209630|NCT03314935|593135254|FG000|Phase 2|Study Terminated by Sponsor|0|||
164209631|NCT03314935|593135255|FG001|Phase 2|Study Terminated by Sponsor|0|||
164209632|NCT03314935|593135256|FG002|Phase 2|Study Terminated by Sponsor|0|||
164209633|NCT03314935|593135257|FG003|Phase 2|Study Terminated by Sponsor|0|||
164209634|NCT03314935|593135258|FG004|Phase 2|Study Terminated by Sponsor|0|||
164209635|NCT03314935|593135259|FG005|Phase 2|Study Terminated by Sponsor|0|||
164209636|NCT03314935|593135260|FG006|Phase 2|Study Terminated by Sponsor|0|||
164209637|NCT03314935|593135261|FG007|Phase 2|Study Terminated by Sponsor|0|||
164209638|NCT03314935|593135262|FG008|Phase 2|Study Terminated by Sponsor|0|||
164209639|NCT03314935|593135263|FG009|Phase 2|Study Terminated by Sponsor|0|||
164209640|NCT03314935|593135264|FG010|Phase 2|Study Terminated by Sponsor|7|||
164209641|NCT03314935|593135265|FG011|Phase 2|Study Terminated by Sponsor|2|||
164209642|NCT03314935|593135266|FG012|Phase 2|Study Terminated by Sponsor|1|||
164209643|NCT03314935|593135267|FG013|Phase 2|Study Terminated by Sponsor|4|||
164209644|NCT03314935|593135268|FG014|Phase 2|Study Terminated by Sponsor|4|||
164209645|NCT03314935|593135254|FG000|Phase 2|Lost to Follow-up|0|||
164209646|NCT03314935|593135255|FG001|Phase 2|Lost to Follow-up|0|||
164209647|NCT03314935|593135256|FG002|Phase 2|Lost to Follow-up|0|||
164209648|NCT03314935|593135257|FG003|Phase 2|Lost to Follow-up|0|||
164209649|NCT03314935|593135258|FG004|Phase 2|Lost to Follow-up|0|||
164209650|NCT03314935|593135259|FG005|Phase 2|Lost to Follow-up|0|||
164209651|NCT03314935|593135260|FG006|Phase 2|Lost to Follow-up|0|||
164209652|NCT03314935|593135261|FG007|Phase 2|Lost to Follow-up|0|||
164209653|NCT03314935|593135262|FG008|Phase 2|Lost to Follow-up|0|||
164209654|NCT03314935|593135263|FG009|Phase 2|Lost to Follow-up|1|||
164209655|NCT03314935|593135264|FG010|Phase 2|Lost to Follow-up|0|||
164209656|NCT03314935|593135265|FG011|Phase 2|Lost to Follow-up|0|||
164209657|NCT03314935|593135266|FG012|Phase 2|Lost to Follow-up|0|||
164209658|NCT03314935|593135267|FG013|Phase 2|Lost to Follow-up|0|||
164209659|NCT03314935|593135268|FG014|Phase 2|Lost to Follow-up|1|||
164209660|NCT03314935|593135254|FG000|Phase 2|Physician Decision|0|||
164209661|NCT03314935|593135255|FG001|Phase 2|Physician Decision|0|||
164209662|NCT03314935|593135256|FG002|Phase 2|Physician Decision|0|||
164209663|NCT03314935|593135257|FG003|Phase 2|Physician Decision|0|||
164209664|NCT03314935|593135258|FG004|Phase 2|Physician Decision|0|||
164209665|NCT03314935|593135259|FG005|Phase 2|Physician Decision|0|||
164564511|NCT03244059|594436268|FG000|Specific Aim 2|Physician Decision|1|||
164564512|NCT03244059|594436269|FG001|Specific Aim 2|Physician Decision|0|||
164564513|NCT03706365|594436272|FG000|Overall Study|Lost to Follow-up|7|||
164564514|NCT03706365|594436273|FG001|Overall Study|Lost to Follow-up|0|||
164564515|NCT03706365|594436272|FG000|Overall Study|Withdrawal by Subject|17|||
164564516|NCT03706365|594436273|FG001|Overall Study|Withdrawal by Subject|15|||
164564517|NCT03706365|594436272|FG000|Overall Study|On Study Treatment|51|||
164564518|NCT03706365|594436273|FG001|Overall Study|On Study Treatment|51|||
164564519|NCT00605267|594436274|FG000|Overall Study|Adverse Event|0|||
164564520|NCT00605267|594436275|FG001|Overall Study|Adverse Event|1|||
164564521|NCT00605267|594436274|FG000|Overall Study|Lack of Efficacy|1|||
164564522|NCT00605267|594436275|FG001|Overall Study|Lack of Efficacy|5|||
164564523|NCT00605267|594436274|FG000|Overall Study|Withdrawal by Subject|2|||
164564524|NCT00605267|594436275|FG001|Overall Study|Withdrawal by Subject|3|||
164564525|NCT04557384|594436277|FG000|Overall Study|Study Terminated by Sponsor|1|||
164564526|NCT04557384|594436277|FG000|Overall Study|Death|1|||
164564527|NCT01505894|594436280|FG000|Overall Study|Adverse Event|1|||
164564528|NCT01505894|594436281|FG001|Overall Study|Adverse Event|0|||
164564529|NCT01505894|594436282|FG002|Overall Study|Adverse Event|0|||
164668658|NCT01572948|594811985|FG000|Overall Study|Lost to Follow-up|1|||
164564530|NCT01505894|594436283|FG003|Overall Study|Adverse Event|0|||
164564531|NCT01505894|594436284|FG004|Overall Study|Adverse Event|0|||
164564532|NCT01505894|594436285|FG005|Overall Study|Adverse Event|0|||
164209666|NCT03314935|593135260|FG006|Phase 2|Physician Decision|0|||
164564533|NCT01505894|594436286|FG006|Overall Study|Adverse Event|0|||
164209667|NCT03314935|593135261|FG007|Phase 2|Physician Decision|0|||
164209668|NCT03314935|593135262|FG008|Phase 2|Physician Decision|0|||
164209669|NCT03314935|593135263|FG009|Phase 2|Physician Decision|0|||
164209670|NCT03314935|593135264|FG010|Phase 2|Physician Decision|1|||
164209671|NCT03314935|593135265|FG011|Phase 2|Physician Decision|0|||
164209672|NCT03314935|593135266|FG012|Phase 2|Physician Decision|0|||
164209673|NCT03314935|593135267|FG013|Phase 2|Physician Decision|0|||
164209674|NCT03314935|593135268|FG014|Phase 2|Physician Decision|0|||
164564534|NCT01505894|594436287|FG007|Overall Study|Adverse Event|0|||
164564535|NCT01505894|594436288|FG008|Overall Study|Adverse Event|0|||
164209675|NCT05252702|593135272|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
164209676|NCT05252702|593135272|FG000|Overall Study|Death|16|||
164209677|NCT05252702|593135272|FG000|Overall Study|System explant|5|||
164209678|NCT05252702|593135272|FG000|Overall Study|Lost to Follow-up|1|||
164209679|NCT05252702|593135272|FG000|Overall Study|Withdrawn by investigator|1|||
164209680|NCT05252702|593135272|FG000|Overall Study|Visit not due|306|||
164209681|NCT05252702|593135272|FG000|Overall Study|Visit within window but not completed|92|||
164209682|NCT05252702|593135272|FG000|Overall Study|Unsuccessful implant|1|||
164209683|NCT04153864|593135273|FG000|Overall Study|Withdrawal by Subject|21|||
164209684|NCT04153864|593135274|FG001|Overall Study|Withdrawal by Subject|7|||
164209685|NCT04153864|593135275|FG002|Overall Study|Withdrawal by Subject|23|||
164209686|NCT04153864|593135276|FG003|Overall Study|Withdrawal by Subject|2|||
164209687|NCT04153864|593135273|FG000|Overall Study|Lost to Follow-up|4|||
164209688|NCT04153864|593135274|FG001|Overall Study|Lost to Follow-up|0|||
164209689|NCT04153864|593135275|FG002|Overall Study|Lost to Follow-up|3|||
164209690|NCT04153864|593135276|FG003|Overall Study|Lost to Follow-up|0|||
164209691|NCT04153864|593135273|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
164209692|NCT04153864|593135274|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
164209693|NCT04153864|593135275|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
164209694|NCT04153864|593135276|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
164209695|NCT05352399|593135289|FG000|Overall Study|Discontinued intervention|6|||
164209696|NCT06354257|593135290|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164209697|NCT06354257|593135290|FG000|Treatment Period 2|Adverse Event|1|||
164209698|NCT02401230|593135291|FG000|Overall Study|Adverse Event|3|||
164209699|NCT02401230|593135292|FG001|Overall Study|Adverse Event|2|||
164209700|NCT02401230|593135293|FG002|Overall Study|Adverse Event|0|||
164209701|NCT02401230|593135291|FG000|Overall Study|Withdrawal by Subject|2|||
164209702|NCT02401230|593135292|FG001|Overall Study|Withdrawal by Subject|1|||
164209703|NCT02401230|593135293|FG002|Overall Study|Withdrawal by Subject|1|||
164209704|NCT02401230|593135291|FG000|Overall Study|Lost to Follow-up|1|||
164209705|NCT02401230|593135292|FG001|Overall Study|Lost to Follow-up|3|||
164209706|NCT02401230|593135293|FG002|Overall Study|Lost to Follow-up|3|||
164209707|NCT02657551|593135294|FG000|Overall Study|Adverse Event|2|||
164209708|NCT02657551|593135294|FG000|Overall Study|Withdrawal by Subject|1|||
164209709|NCT02657551|593135294|FG000|Overall Study|Non-Compliance|1|||
164209710|NCT02657551|593135294|FG000|Overall Study|Progression / Relapse|4|||
164209711|NCT02164916|593135298|FG000|Overall Study|Adverse Event|3|||
164209712|NCT02164916|593135299|FG001|Overall Study|Adverse Event|8|||
164209713|NCT02164916|593135298|FG000|Overall Study|Death|1|||
164209714|NCT02164916|593135299|FG001|Overall Study|Death|1|||
164209715|NCT02164916|593135298|FG000|Overall Study|Refusal unrelated to adverse event|3|||
164209716|NCT02164916|593135299|FG001|Overall Study|Refusal unrelated to adverse event|7|||
164209717|NCT02164916|593135298|FG000|Overall Study|Progression|37|||
164209718|NCT02164916|593135299|FG001|Overall Study|Progression|26|||
164209719|NCT02164916|593135298|FG000|Overall Study|Not protocol specified|5|||
164209720|NCT02164916|593135299|FG001|Overall Study|Not protocol specified|1|||
164209721|NCT02164916|593135298|FG000|Overall Study|Reason under review|1|||
164209722|NCT02164916|593135299|FG001|Overall Study|Reason under review|6|||
164209723|NCT02164916|593135298|FG000|Overall Study|Not eligible|2|||
164209724|NCT02164916|593135299|FG001|Overall Study|Not eligible|5|||
164209725|NCT00296517|593135300|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
164209726|NCT00296517|593135301|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
164209727|NCT00296517|593135300|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
164209728|NCT00296517|593135301|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
164209729|NCT00296517|593135300|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
164209730|NCT00296517|593135301|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
164209731|NCT00296517|593135300|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
164209732|NCT00296517|593135301|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
164209733|NCT00296517|593135300|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
164209734|NCT00296517|593135301|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
164209735|NCT00296517|593135300|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
164209736|NCT00296517|593135301|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
164209737|NCT00296517|593135300|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
164209738|NCT00296517|593135301|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
164209739|NCT00296517|593135300|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
164209740|NCT00296517|593135301|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
164209741|NCT00296517|593135300|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
164209742|NCT00296517|593135301|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
164209743|NCT00964782|593135304|FG000|Overall Study|Lost to Follow-up|1|||
164209744|NCT00964782|593135305|FG001|Overall Study|Lost to Follow-up|0|||
164209745|NCT00596635|593135307|FG000|Overall Study|Lost to Follow-up|0|||
164209746|NCT00596635|593135308|FG001|Overall Study|Lost to Follow-up|2|||
164209747|NCT00596635|593135309|FG002|Overall Study|Lost to Follow-up|0|||
164209748|NCT00596635|593135307|FG000|Overall Study|Treatment for symptomatic UTI|4|||
164209749|NCT00596635|593135308|FG001|Overall Study|Treatment for symptomatic UTI|6|||
164209750|NCT00596635|593135309|FG002|Overall Study|Treatment for symptomatic UTI|3|||
164209751|NCT00596635|593135307|FG000|Overall Study|Hip fracture|2|||
164209752|NCT00596635|593135308|FG001|Overall Study|Hip fracture|3|||
164209753|NCT00596635|593135309|FG002|Overall Study|Hip fracture|3|||
164209754|NCT00596635|593135307|FG000|Overall Study|Could not provide urine specimen|1|||
164209755|NCT00596635|593135308|FG001|Overall Study|Could not provide urine specimen|2|||
164209756|NCT00596635|593135309|FG002|Overall Study|Could not provide urine specimen|2|||
164209757|NCT00846365|593135314|FG000|Overall Study|Adverse Event|20|||
164209758|NCT00846365|593135315|FG001|Overall Study|Adverse Event|30|||
164209759|NCT00846365|593135316|FG002|Overall Study|Adverse Event|11|||
164209760|NCT00846365|593135314|FG000|Overall Study|Protocol Violation|5|||
164209761|NCT00846365|593135315|FG001|Overall Study|Protocol Violation|4|||
164209762|NCT00846365|593135316|FG002|Overall Study|Protocol Violation|0|||
164209763|NCT00846365|593135314|FG000|Overall Study|Lost to Follow-up|8|||
164209764|NCT00846365|593135315|FG001|Overall Study|Lost to Follow-up|2|||
164209765|NCT00846365|593135316|FG002|Overall Study|Lost to Follow-up|5|||
164209766|NCT00846365|593135314|FG000|Overall Study|Withdrawal by Subject|11|||
164209767|NCT00846365|593135315|FG001|Overall Study|Withdrawal by Subject|11|||
164209768|NCT00846365|593135316|FG002|Overall Study|Withdrawal by Subject|9|||
164209769|NCT00846365|593135314|FG000|Overall Study|Pregnancy|1|||
164209770|NCT00846365|593135315|FG001|Overall Study|Pregnancy|0|||
164209771|NCT00846365|593135316|FG002|Overall Study|Pregnancy|0|||
164209772|NCT00846365|593135314|FG000|Overall Study|Lack of Efficacy|1|||
164209773|NCT00846365|593135315|FG001|Overall Study|Lack of Efficacy|1|||
164209774|NCT00846365|593135316|FG002|Overall Study|Lack of Efficacy|2|||
164209775|NCT00846365|593135314|FG000|Overall Study|Other|9|||
164209776|NCT00846365|593135315|FG001|Overall Study|Other|1|||
164209777|NCT00846365|593135316|FG002|Overall Study|Other|6|||
164209778|NCT00720759|593135317|FG000|Overall Study|Lost to Follow-up|0|||
164209779|NCT00720759|593135318|FG001|Overall Study|Lost to Follow-up|1|||
164209780|NCT00720759|593135319|FG002|Overall Study|Lost to Follow-up|1|||
164209781|NCT00720759|593135320|FG003|Overall Study|Lost to Follow-up|0|||
164209782|NCT02318940|593135321|FG000|Overall Study|lost the record|1|||
164209783|NCT02318940|593135322|FG001|Overall Study|lost the record|0|||
164324331|NCT04393298|593565161|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
164209784|NCT01047319|593135323|FG000|Overall Study|Teva requested participant withdrawal|3|||
164209785|NCT01047319|593135324|FG001|Overall Study|Teva requested participant withdrawal|0|||
164209786|NCT01047319|593135325|FG002|Overall Study|Teva requested participant withdrawal|1|||
164209787|NCT01047319|593135323|FG000|Overall Study|Protocol Violation|3|||
164209788|NCT01047319|593135324|FG001|Overall Study|Protocol Violation|2|||
164209789|NCT01047319|593135325|FG002|Overall Study|Protocol Violation|4|||
164209790|NCT01047319|593135323|FG000|Overall Study|Lack of Efficacy|4|||
164209791|NCT01047319|593135324|FG001|Overall Study|Lack of Efficacy|3|||
164209792|NCT01047319|593135325|FG002|Overall Study|Lack of Efficacy|3|||
164209793|NCT01047319|593135323|FG000|Overall Study|Death|5|||
164209794|NCT01047319|593135324|FG001|Overall Study|Death|1|||
164209795|NCT01047319|593135325|FG002|Overall Study|Death|5|||
164209796|NCT01047319|593135323|FG000|Overall Study|Pregnancy|13|||
164209797|NCT01047319|593135324|FG001|Overall Study|Pregnancy|8|||
164209798|NCT01047319|593135325|FG002|Overall Study|Pregnancy|8|||
164209799|NCT01047319|593135323|FG000|Overall Study|Physician Decision|12|||
164209800|NCT01047319|593135324|FG001|Overall Study|Physician Decision|9|||
164209801|NCT01047319|593135325|FG002|Overall Study|Physician Decision|10|||
164209802|NCT01047319|593135323|FG000|Overall Study|Lost to Follow-up|14|||
164209803|NCT01047319|593135324|FG001|Overall Study|Lost to Follow-up|10|||
164209804|NCT01047319|593135325|FG002|Overall Study|Lost to Follow-up|10|||
164209805|NCT01047319|593135323|FG000|Overall Study|Adverse Event|16|||
164209806|NCT01047319|593135324|FG001|Overall Study|Adverse Event|27|||
164209807|NCT01047319|593135325|FG002|Overall Study|Adverse Event|21|||
164209808|NCT01047319|593135323|FG000|Overall Study|Withdrawal by Subject|77|||
164209809|NCT01047319|593135324|FG001|Overall Study|Withdrawal by Subject|75|||
164209810|NCT01047319|593135325|FG002|Overall Study|Withdrawal by Subject|87|||
164209811|NCT01047319|593135323|FG000|Overall Study|Study terminated by Sponsor|198|||
164209812|NCT01047319|593135324|FG001|Overall Study|Study terminated by Sponsor|215|||
164209813|NCT01047319|593135325|FG002|Overall Study|Study terminated by Sponsor|203|||
164209814|NCT01277861|593135338|FG000|Overall Study|Physician Decision|2|||
164209815|NCT01277861|593135339|FG001|Overall Study|Physician Decision|2|||
164209816|NCT05032196|593135340|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
164209817|NCT05032196|593135341|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
164209818|NCT05032196|593135342|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
164209819|NCT05032196|593135343|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
164209820|NCT05032196|593135344|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
164209821|NCT05032196|593135345|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
164209822|NCT05032196|593135340|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
164209823|NCT05032196|593135341|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
164209824|NCT05032196|593135342|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
164209825|NCT05032196|593135343|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
164209826|NCT05032196|593135344|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
164209827|NCT05032196|593135345|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
164209828|NCT05032196|593135340|FG000|Period 2 (Multidose)|Physician Decision|0|||
164209829|NCT05032196|593135341|FG001|Period 2 (Multidose)|Physician Decision|0|||
164209830|NCT05032196|593135342|FG002|Period 2 (Multidose)|Physician Decision|0|||
164209831|NCT05032196|593135343|FG003|Period 2 (Multidose)|Physician Decision|0|||
164209832|NCT05032196|593135344|FG004|Period 2 (Multidose)|Physician Decision|1|||
164209833|NCT05032196|593135345|FG005|Period 2 (Multidose)|Physician Decision|0|||
164209834|NCT00857389|593135346|FG000|Overall Study|Did not proceed to transplant|2|||
164209835|NCT04817410|593136991|FG000|Overall Study|Withdrawal by Subject|5|||
164209836|NCT04817410|593136991|FG000|Overall Study|Physician Decision|3|||
164209837|NCT03595748|593136992|FG000|Overall Study|Death|11|||
164209838|NCT03595748|593136993|FG001|Overall Study|Death|12|||
164209839|NCT03595748|593136992|FG000|Overall Study|Withdrawal by Subject|28|||
164209840|NCT03595748|593136993|FG001|Overall Study|Withdrawal by Subject|29|||
164564536|NCT01505894|594436280|FG000|Overall Study|Other than specified|0|||
164564537|NCT01505894|594436281|FG001|Overall Study|Other than specified|0|||
164564538|NCT01505894|594436282|FG002|Overall Study|Other than specified|0|||
164564539|NCT01505894|594436283|FG003|Overall Study|Other than specified|0|||
164564540|NCT01505894|594436284|FG004|Overall Study|Other than specified|1|||
164564541|NCT01505894|594436285|FG005|Overall Study|Other than specified|0|||
164564542|NCT01505894|594436286|FG006|Overall Study|Other than specified|0|||
164564543|NCT01505894|594436287|FG007|Overall Study|Other than specified|0|||
164564544|NCT01505894|594436288|FG008|Overall Study|Other than specified|0|||
164564545|NCT00254566|594436289|FG000|Overall Study|Death|1|||
164564546|NCT00254566|594436290|FG001|Overall Study|Death|0|||
164564547|NCT00254566|594436289|FG000|Overall Study|Adverse Event|5|||
164564548|NCT00254566|594436290|FG001|Overall Study|Adverse Event|4|||
164564549|NCT00254566|594436289|FG000|Overall Study|Lack of Efficacy|12|||
164564550|NCT00254566|594436290|FG001|Overall Study|Lack of Efficacy|9|||
164209841|NCT03595748|593136992|FG000|Overall Study|Protocol Violation|0|||
164209842|NCT03595748|593136993|FG001|Overall Study|Protocol Violation|1|||
164209843|NCT02328014|593136994|FG000|Overall Study|Adverse Event|1|||
164209844|NCT02328014|593136995|FG001|Overall Study|Adverse Event|0|||
164209845|NCT02328014|593136996|FG002|Overall Study|Adverse Event|0|||
164209846|NCT02328014|593136997|FG003|Overall Study|Adverse Event|1|||
164209847|NCT02328014|593136994|FG000|Overall Study|Death|0|||
164209848|NCT02328014|593136995|FG001|Overall Study|Death|0|||
164564551|NCT00254566|594436289|FG000|Overall Study|Other|1|||
164564552|NCT00254566|594436290|FG001|Overall Study|Other|5|||
164209849|NCT02328014|593136996|FG002|Overall Study|Death|0|||
164209850|NCT02328014|593136997|FG003|Overall Study|Death|4|||
164564553|NCT00254566|594436289|FG000|Overall Study|Withdrawal by Subject|5|||
164564554|NCT00254566|594436290|FG001|Overall Study|Withdrawal by Subject|6|||
164209851|NCT02328014|593136994|FG000|Overall Study|Physician Decision|0|||
164209852|NCT02328014|593136995|FG001|Overall Study|Physician Decision|0|||
164209853|NCT02328014|593136996|FG002|Overall Study|Physician Decision|0|||
164564555|NCT00254566|594436289|FG000|Overall Study|Lost to Follow-up|7|||
164564556|NCT00254566|594436290|FG001|Overall Study|Lost to Follow-up|2|||
164564557|NCT00059202|594436293|FG000|Overall Study|Withdrawal by Subject|5|||
164564558|NCT00059202|594436294|FG001|Overall Study|Withdrawal by Subject|9|||
164564559|NCT00059202|594436293|FG000|Overall Study|Protocol Violation|1|||
164564560|NCT00059202|594436294|FG001|Overall Study|Protocol Violation|3|||
164564561|NCT00059202|594436293|FG000|Overall Study|drug toxicity|0|||
164564562|NCT00059202|594436294|FG001|Overall Study|drug toxicity|3|||
164564563|NCT04088409|594436297|FG000|Part A|Withdrawal by Subject|2|||
164564564|NCT04088409|594436298|FG001|Part A|Withdrawal by Subject|1|||
164564565|NCT04088409|594436297|FG000|Part A|Did Not Meet Randomization Criteria|2|||
164564566|NCT04088409|594436298|FG001|Part A|Did Not Meet Randomization Criteria|0|||
164564567|NCT04088409|594436297|FG000|Part A|Lack of Efficacy|9|||
164564568|NCT04088409|594436298|FG001|Part A|Lack of Efficacy|0|||
164564569|NCT04088409|594436297|FG000|Part A|Lost to Follow-up|1|||
164564570|NCT04088409|594436298|FG001|Part A|Lost to Follow-up|0|||
164564571|NCT04088409|594436297|FG000|Part A|Adverse Event|1|||
164564572|NCT04088409|594436298|FG001|Part A|Adverse Event|0|||
164564573|NCT04088409|594436297|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
164564574|NCT04088409|594436298|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
164564575|NCT04088409|594436297|FG000|Part B|Ongoing Treatment|10|||
164564576|NCT04088409|594436298|FG001|Part B|Ongoing Treatment|0|||
164564577|NCT00841763|594436299|FG000|Overall Study|Withdrawal by Subject|60|||
164564578|NCT00841763|594436300|FG001|Overall Study|Withdrawal by Subject|17|||
164564579|NCT00841763|594436301|FG002|Overall Study|Withdrawal by Subject|4|||
164209854|NCT02328014|593136997|FG003|Overall Study|Physician Decision|1|||
164209855|NCT02328014|593136994|FG000|Overall Study|Disease Progression|1|||
164209856|NCT02328014|593136995|FG001|Overall Study|Disease Progression|0|||
164209857|NCT02328014|593136996|FG002|Overall Study|Disease Progression|1|||
164324332|NCT04393298|593565162|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
164324333|NCT04393298|593565163|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
164324334|NCT04393298|593565164|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
164324335|NCT04393298|593565165|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
164209858|NCT02328014|593136997|FG003|Overall Study|Disease Progression|3|||
164209859|NCT02328014|593136994|FG000|Overall Study|Study Terminated by Sponsor|4|||
164209860|NCT02328014|593136995|FG001|Overall Study|Study Terminated by Sponsor|1|||
164209861|NCT02328014|593136996|FG002|Overall Study|Study Terminated by Sponsor|1|||
164209862|NCT02328014|593136997|FG003|Overall Study|Study Terminated by Sponsor|0|||
164209863|NCT02328014|593136994|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
164209864|NCT02328014|593136995|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
164209865|NCT02328014|593136996|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
164209866|NCT02328014|593136997|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
164209867|NCT02328014|593136994|FG000|Overall Study|Withdrawal by Subject|0|||
164209868|NCT02328014|593136995|FG001|Overall Study|Withdrawal by Subject|0|||
164209869|NCT02328014|593136996|FG002|Overall Study|Withdrawal by Subject|0|||
164209870|NCT02328014|593136997|FG003|Overall Study|Withdrawal by Subject|1|||
164209871|NCT05028569|593137014|FG000|Double-Blind Phase|Death|0|||
164209872|NCT05028569|593137015|FG001|Double-Blind Phase|Death|0|||
164209873|NCT05028569|593137016|FG002|Double-Blind Phase|Death|0|||
164209874|NCT05028569|593137017|FG003|Double-Blind Phase|Death|1|||
164209875|NCT05028569|593137018|FG004|Double-Blind Phase|Death|0|||
164209876|NCT05028569|593137019|FG005|Double-Blind Phase|Death|0|||
164209877|NCT05028569|593137020|FG006|Double-Blind Phase|Death|0|||
164209878|NCT05028569|593137014|FG000|Double-Blind Phase|Lost to Follow-up|0|||
164209879|NCT05028569|593137015|FG001|Double-Blind Phase|Lost to Follow-up|6|||
164209880|NCT05028569|593137016|FG002|Double-Blind Phase|Lost to Follow-up|3|||
164209881|NCT05028569|593137017|FG003|Double-Blind Phase|Lost to Follow-up|9|||
164209882|NCT05028569|593137018|FG004|Double-Blind Phase|Lost to Follow-up|0|||
164209883|NCT05028569|593137019|FG005|Double-Blind Phase|Lost to Follow-up|0|||
164209884|NCT05028569|593137020|FG006|Double-Blind Phase|Lost to Follow-up|0|||
164209885|NCT05028569|593137014|FG000|Double-Blind Phase|Protocol Deviation|0|||
164209886|NCT05028569|593137015|FG001|Double-Blind Phase|Protocol Deviation|2|||
164209887|NCT05028569|593137016|FG002|Double-Blind Phase|Protocol Deviation|0|||
164209888|NCT05028569|593137017|FG003|Double-Blind Phase|Protocol Deviation|0|||
164209889|NCT05028569|593137018|FG004|Double-Blind Phase|Protocol Deviation|0|||
164209890|NCT05028569|593137019|FG005|Double-Blind Phase|Protocol Deviation|0|||
164209891|NCT05028569|593137020|FG006|Double-Blind Phase|Protocol Deviation|0|||
164209892|NCT05028569|593137014|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
164209893|NCT05028569|593137015|FG001|Double-Blind Phase|Withdrawal by Subject|27|||
164209894|NCT05028569|593137016|FG002|Double-Blind Phase|Withdrawal by Subject|20|||
164209895|NCT05028569|593137017|FG003|Double-Blind Phase|Withdrawal by Subject|22|||
164209896|NCT05028569|593137018|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
164209897|NCT05028569|593137019|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
164209898|NCT05028569|593137020|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
164209899|NCT05028569|593137014|FG000|Double-Blind Phase|Other, not specified|0|||
164209900|NCT05028569|593137015|FG001|Double-Blind Phase|Other, not specified|5|||
164209901|NCT05028569|593137016|FG002|Double-Blind Phase|Other, not specified|4|||
164209902|NCT05028569|593137017|FG003|Double-Blind Phase|Other, not specified|6|||
164209903|NCT05028569|593137018|FG004|Double-Blind Phase|Other, not specified|0|||
164209904|NCT05028569|593137019|FG005|Double-Blind Phase|Other, not specified|0|||
164209905|NCT05028569|593137020|FG006|Double-Blind Phase|Other, not specified|0|||
164564580|NCT00841763|594436302|FG003|Overall Study|Withdrawal by Subject|1|||
164564581|NCT00841763|594436299|FG000|Overall Study|Adverse Event|9|||
164564582|NCT00841763|594436300|FG001|Overall Study|Adverse Event|10|||
164564583|NCT00841763|594436301|FG002|Overall Study|Adverse Event|3|||
164564584|NCT00841763|594436302|FG003|Overall Study|Adverse Event|2|||
164564585|NCT00841763|594436299|FG000|Overall Study|Lost to Follow-up|63|||
164564586|NCT00841763|594436300|FG001|Overall Study|Lost to Follow-up|25|||
164564587|NCT00841763|594436301|FG002|Overall Study|Lost to Follow-up|0|||
164209906|NCT05028569|593137014|FG000|Open-Label Phase|Death|0|||
164209907|NCT05028569|593137015|FG001|Open-Label Phase|Death|0|||
164209908|NCT05028569|593137016|FG002|Open-Label Phase|Death|0|||
164209909|NCT05028569|593137017|FG003|Open-Label Phase|Death|0|||
164209910|NCT05028569|593137018|FG004|Open-Label Phase|Death|0|||
164209911|NCT05028569|593137019|FG005|Open-Label Phase|Death|0|||
164209912|NCT05028569|593137020|FG006|Open-Label Phase|Death|1|||
164324336|NCT04393298|593565166|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
164324337|NCT04393298|593565167|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
164209913|NCT05028569|593137014|FG000|Open-Label Phase|Lost to Follow-up|0|||
164324338|NCT04393298|593565168|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
164564588|NCT00841763|594436302|FG003|Overall Study|Lost to Follow-up|0|||
164564589|NCT00841763|594436299|FG000|Overall Study|Protocol Violation|20|||
164209914|NCT05028569|593137015|FG001|Open-Label Phase|Lost to Follow-up|0|||
164209915|NCT05028569|593137016|FG002|Open-Label Phase|Lost to Follow-up|0|||
164209916|NCT05028569|593137017|FG003|Open-Label Phase|Lost to Follow-up|0|||
164209917|NCT05028569|593137018|FG004|Open-Label Phase|Lost to Follow-up|5|||
164209918|NCT05028569|593137019|FG005|Open-Label Phase|Lost to Follow-up|5|||
164209919|NCT05028569|593137020|FG006|Open-Label Phase|Lost to Follow-up|4|||
164209920|NCT05028569|593137014|FG000|Open-Label Phase|Protocol Deviation|0|||
164209921|NCT05028569|593137015|FG001|Open-Label Phase|Protocol Deviation|0|||
164209922|NCT05028569|593137016|FG002|Open-Label Phase|Protocol Deviation|0|||
164209923|NCT05028569|593137017|FG003|Open-Label Phase|Protocol Deviation|0|||
164209924|NCT05028569|593137018|FG004|Open-Label Phase|Protocol Deviation|1|||
164209925|NCT05028569|593137019|FG005|Open-Label Phase|Protocol Deviation|0|||
164209926|NCT05028569|593137020|FG006|Open-Label Phase|Protocol Deviation|0|||
164209927|NCT05028569|593137014|FG000|Open-Label Phase|Pregnancy|0|||
164209928|NCT05028569|593137015|FG001|Open-Label Phase|Pregnancy|0|||
164209929|NCT05028569|593137016|FG002|Open-Label Phase|Pregnancy|0|||
164209930|NCT05028569|593137017|FG003|Open-Label Phase|Pregnancy|0|||
164209931|NCT05028569|593137018|FG004|Open-Label Phase|Pregnancy|0|||
164209932|NCT05028569|593137019|FG005|Open-Label Phase|Pregnancy|1|||
164209933|NCT05028569|593137020|FG006|Open-Label Phase|Pregnancy|0|||
164209934|NCT05028569|593137014|FG000|Open-Label Phase|Withdrawal by Subject|0|||
164209935|NCT05028569|593137015|FG001|Open-Label Phase|Withdrawal by Subject|0|||
164209936|NCT05028569|593137016|FG002|Open-Label Phase|Withdrawal by Subject|0|||
164209937|NCT05028569|593137017|FG003|Open-Label Phase|Withdrawal by Subject|0|||
164209938|NCT05028569|593137018|FG004|Open-Label Phase|Withdrawal by Subject|15|||
164209939|NCT05028569|593137019|FG005|Open-Label Phase|Withdrawal by Subject|8|||
164209940|NCT05028569|593137020|FG006|Open-Label Phase|Withdrawal by Subject|13|||
164209941|NCT05028569|593137014|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
164209942|NCT05028569|593137015|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
164209943|NCT05028569|593137016|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
164209944|NCT05028569|593137017|FG003|Open-Label Phase|Study Terminated by Sponsor|0|||
164209945|NCT05028569|593137018|FG004|Open-Label Phase|Study Terminated by Sponsor|4|||
164209946|NCT05028569|593137019|FG005|Open-Label Phase|Study Terminated by Sponsor|10|||
164209947|NCT05028569|593137020|FG006|Open-Label Phase|Study Terminated by Sponsor|5|||
164209948|NCT05028569|593137014|FG000|Open-Label Phase|Other, not specified|0|||
164209949|NCT05028569|593137015|FG001|Open-Label Phase|Other, not specified|0|||
164209950|NCT05028569|593137016|FG002|Open-Label Phase|Other, not specified|0|||
164209951|NCT05028569|593137017|FG003|Open-Label Phase|Other, not specified|0|||
164209952|NCT05028569|593137018|FG004|Open-Label Phase|Other, not specified|6|||
164209953|NCT05028569|593137019|FG005|Open-Label Phase|Other, not specified|5|||
164209954|NCT05028569|593137020|FG006|Open-Label Phase|Other, not specified|7|||
164209955|NCT05028569|593137014|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
164209956|NCT05028569|593137015|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
164209957|NCT05028569|593137016|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
164209958|NCT05028569|593137017|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
164209959|NCT05028569|593137018|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
164209960|NCT05028569|593137019|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|2|||
164209961|NCT05028569|593137020|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
164209962|NCT05028569|593137014|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
164209963|NCT05028569|593137015|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
164209964|NCT05028569|593137016|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
164209965|NCT05028569|593137017|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
164209966|NCT05028569|593137018|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
164209967|NCT05028569|593137019|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
164209968|NCT05028569|593137020|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|1|||
164209969|NCT04609553|593137021|FG000|Overall Study|Lost to Follow-up|27|||
164209970|NCT04609553|593137022|FG001|Overall Study|Lost to Follow-up|31|||
164209971|NCT04609553|593137023|FG002|Overall Study|Lost to Follow-up|24|||
164209972|NCT04609553|593137021|FG000|Overall Study|Discontinued|12|||
164209973|NCT04609553|593137022|FG001|Overall Study|Discontinued|10|||
164209974|NCT04609553|593137023|FG002|Overall Study|Discontinued|9|||
164209975|NCT00764517|593137034|FG000|Overall Study|Adverse Event|9|||
164209976|NCT00764517|593137035|FG001|Overall Study|Adverse Event|3|||
164209977|NCT00764517|593137034|FG000|Overall Study|Death|3|||
164209978|NCT00764517|593137035|FG001|Overall Study|Death|11|||
164209979|NCT00764517|593137034|FG000|Overall Study|Physician Decision|3|||
164209980|NCT00764517|593137035|FG001|Overall Study|Physician Decision|0|||
164209981|NCT02362451|593137038|FG000|Overall Study|Withdrawal by Subject|0|||
164209982|NCT02362451|593137039|FG001|Overall Study|Withdrawal by Subject|1|||
164209983|NCT02362451|593137038|FG000|Overall Study|Lack of Efficacy|2|||
164209984|NCT02362451|593137039|FG001|Overall Study|Lack of Efficacy|0|||
164209985|NCT02362451|593137038|FG000|Overall Study|Progression|1|||
164209986|NCT02362451|593137039|FG001|Overall Study|Progression|0|||
164209987|NCT02362451|593137038|FG000|Overall Study|Participant chose other therapy.|1|||
164209988|NCT02362451|593137039|FG001|Overall Study|Participant chose other therapy.|0|||
164209989|NCT00460798|593137040|FG000|Overall Study|Death|59|||
164209990|NCT00460798|593137040|FG000|Overall Study|Adverse Event|27|||
164209991|NCT00460798|593137040|FG000|Overall Study|Lost to Follow-up|19|||
164209992|NCT00460798|593137040|FG000|Overall Study|Progressive Disease|99|||
164209993|NCT00460798|593137040|FG000|Overall Study|Other|27|||
164209994|NCT00460798|593137040|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
164209995|NCT00460798|593137040|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
164209996|NCT03517137|593137046|FG000|Overall Study|Lack of Efficacy|1|||
164209997|NCT03517137|593137046|FG000|Overall Study|Adverse Event|2|||
164209998|NCT03517137|593137046|FG000|Overall Study|Withdrawal by Subject|2|||
164209999|NCT03517137|593137046|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
164210000|NCT01186770|593137047|FG000|Overall Study|Ineligibility|0|||
164564590|NCT00841763|594436300|FG001|Overall Study|Protocol Violation|3|||
164564591|NCT00841763|594436301|FG002|Overall Study|Protocol Violation|1|||
164564592|NCT00841763|594436302|FG003|Overall Study|Protocol Violation|0|||
164564593|NCT00841763|594436299|FG000|Overall Study|Administrative Reasons|3|||
164564594|NCT00841763|594436300|FG001|Overall Study|Administrative Reasons|1|||
164564595|NCT00841763|594436301|FG002|Overall Study|Administrative Reasons|0|||
164564596|NCT00841763|594436302|FG003|Overall Study|Administrative Reasons|0|||
164564597|NCT00841763|594436299|FG000|Overall Study|Unable to Classify|7|||
164564598|NCT00841763|594436300|FG001|Overall Study|Unable to Classify|1|||
164564599|NCT00841763|594436301|FG002|Overall Study|Unable to Classify|0|||
164564600|NCT00841763|594436302|FG003|Overall Study|Unable to Classify|0|||
164564601|NCT00400400|594436303|FG000|Overall Study|Adverse Event|9|||
164564602|NCT00400400|594436304|FG001|Overall Study|Adverse Event|8|||
164564603|NCT00400400|594436303|FG000|Overall Study|Protocol Violation|2|||
164564604|NCT00400400|594436304|FG001|Overall Study|Protocol Violation|0|||
164564605|NCT00400400|594436303|FG000|Overall Study|Withdrawal by Subject|1|||
164564606|NCT00400400|594436304|FG001|Overall Study|Withdrawal by Subject|3|||
164564607|NCT00400400|594436303|FG000|Overall Study|Administrative Problem|1|||
164564608|NCT00400400|594436304|FG001|Overall Study|Administrative Problem|0|||
164564609|NCT00400400|594436303|FG000|Overall Study|Lost to Follow-up|0|||
164564610|NCT00400400|594436304|FG001|Overall Study|Lost to Follow-up|1|||
164564611|NCT00400400|594436303|FG000|Overall Study|Did not receive study drug|1|||
164564612|NCT00400400|594436304|FG001|Overall Study|Did not receive study drug|3|||
164564613|NCT00648167|594436305|FG000|Overall Study|Adverse Event|6|||
164564614|NCT00648167|594436305|FG000|Overall Study|unable to swallow tablets|1|||
164564615|NCT01688050|594436306|FG000|Overall Study|Death|7|||
164210001|NCT01186770|593137048|FG001|Overall Study|Ineligibility|0|||
164210002|NCT01186770|593137049|FG002|Overall Study|Ineligibility|2|||
164210003|NCT01186770|593137050|FG003|Overall Study|Ineligibility|0|||
164210004|NCT01186770|593137047|FG000|Overall Study|Protocol Violation|7|||
164210005|NCT01186770|593137048|FG001|Overall Study|Protocol Violation|9|||
164210006|NCT01186770|593137049|FG002|Overall Study|Protocol Violation|12|||
164210007|NCT01186770|593137050|FG003|Overall Study|Protocol Violation|14|||
164210008|NCT01186770|593137047|FG000|Overall Study|Adverse Event|2|||
164210009|NCT01186770|593137048|FG001|Overall Study|Adverse Event|9|||
164210010|NCT01186770|593137049|FG002|Overall Study|Adverse Event|7|||
164210011|NCT01186770|593137050|FG003|Overall Study|Adverse Event|9|||
164210012|NCT01186770|593137047|FG000|Overall Study|Withdrawal by Subject|15|||
164210013|NCT01186770|593137048|FG001|Overall Study|Withdrawal by Subject|13|||
164210014|NCT01186770|593137049|FG002|Overall Study|Withdrawal by Subject|11|||
164210015|NCT01186770|593137050|FG003|Overall Study|Withdrawal by Subject|17|||
164210016|NCT01186770|593137047|FG000|Overall Study|Lost to Follow-up|10|||
164210017|NCT01186770|593137048|FG001|Overall Study|Lost to Follow-up|6|||
164210018|NCT01186770|593137049|FG002|Overall Study|Lost to Follow-up|14|||
164210019|NCT01186770|593137050|FG003|Overall Study|Lost to Follow-up|9|||
164210020|NCT01186770|593137047|FG000|Overall Study|Insufficient response to treatment|7|||
164210021|NCT01186770|593137048|FG001|Overall Study|Insufficient response to treatment|8|||
164210022|NCT01186770|593137049|FG002|Overall Study|Insufficient response to treatment|5|||
164210023|NCT01186770|593137050|FG003|Overall Study|Insufficient response to treatment|7|||
164210024|NCT01186770|593137047|FG000|Overall Study|Other than specified|0|||
164210025|NCT01186770|593137048|FG001|Overall Study|Other than specified|1|||
164210026|NCT01186770|593137049|FG002|Overall Study|Other than specified|1|||
164668659|NCT01572948|594811986|FG001|Overall Study|Lost to Follow-up|0|||
164668660|NCT01572948|594811985|FG000|Overall Study|unable to contact|0|||
164668661|NCT01572948|594811986|FG001|Overall Study|unable to contact|1|||
164668662|NCT00440557|594811987|FG000|Overall Study|Withdrawal by Subject|10|||
164668663|NCT00440557|594811988|FG001|Overall Study|Withdrawal by Subject|5|||
164668664|NCT00440557|594811989|FG002|Overall Study|Withdrawal by Subject|11|||
164668665|NCT00440557|594811987|FG000|Overall Study|Lost to Follow-up|1|||
164668666|NCT00440557|594811988|FG001|Overall Study|Lost to Follow-up|2|||
164668667|NCT00440557|594811989|FG002|Overall Study|Lost to Follow-up|6|||
164668668|NCT00440557|594811987|FG000|Overall Study|Adverse Event|3|||
164668669|NCT00440557|594811988|FG001|Overall Study|Adverse Event|3|||
164668670|NCT00440557|594811989|FG002|Overall Study|Adverse Event|5|||
164668671|NCT00440557|594811987|FG000|Overall Study|Death|2|||
164668672|NCT00440557|594811988|FG001|Overall Study|Death|6|||
164668673|NCT00440557|594811989|FG002|Overall Study|Death|3|||
164668674|NCT00440557|594811987|FG000|Overall Study|Began Dialysis|4|||
164668675|NCT00440557|594811988|FG001|Overall Study|Began Dialysis|1|||
164668676|NCT00440557|594811989|FG002|Overall Study|Began Dialysis|4|||
164668677|NCT00440557|594811987|FG000|Overall Study|Principal Investigator decision|0|||
164668678|NCT00440557|594811988|FG001|Overall Study|Principal Investigator decision|3|||
164668679|NCT00440557|594811989|FG002|Overall Study|Principal Investigator decision|1|||
164668680|NCT00440557|594811987|FG000|Overall Study|Patient moved|1|||
164668681|NCT00440557|594811988|FG001|Overall Study|Patient moved|2|||
164668682|NCT00440557|594811989|FG002|Overall Study|Patient moved|1|||
164668683|NCT00440557|594811987|FG000|Overall Study|Principal Investigator's office closed|3|||
164668684|NCT00440557|594811988|FG001|Overall Study|Principal Investigator's office closed|6|||
164668685|NCT00440557|594811989|FG002|Overall Study|Principal Investigator's office closed|4|||
164668686|NCT00440557|594811987|FG000|Overall Study|Patient transferred to nursing home|0|||
164668687|NCT00440557|594811988|FG001|Overall Study|Patient transferred to nursing home|1|||
164668688|NCT00440557|594811989|FG002|Overall Study|Patient transferred to nursing home|0|||
164668689|NCT00440557|594811987|FG000|Overall Study|Patient had surgery|1|||
164668690|NCT00440557|594811988|FG001|Overall Study|Patient had surgery|0|||
164668691|NCT00440557|594811989|FG002|Overall Study|Patient had surgery|0|||
164668692|NCT00680121|594811993|FG000|Overall Study|Lost to Follow-up|27|||
164668693|NCT00680121|594811994|FG001|Overall Study|Lost to Follow-up|23|||
164668694|NCT01939197|594811995|FG000|Overall Study|Withdrawal by Subject|1|||
164668695|NCT01939197|594811996|FG001|Overall Study|Withdrawal by Subject|0|||
164668696|NCT01939197|594811997|FG002|Overall Study|Withdrawal by Subject|0|||
164668697|NCT01939197|594811998|FG003|Overall Study|Withdrawal by Subject|0|||
164668698|NCT01939197|594811999|FG004|Overall Study|Withdrawal by Subject|1|||
164668699|NCT01939197|594812000|FG005|Overall Study|Withdrawal by Subject|0|||
164668700|NCT01939197|594812001|FG006|Overall Study|Withdrawal by Subject|0|||
164668701|NCT01939197|594811995|FG000|Overall Study|Lost to Follow-up|0|||
164210027|NCT01186770|593137050|FG003|Overall Study|Other than specified|2|||
164210028|NCT02441283|593137051|FG000|Overall Study|Withdrew consent|15|||
164668702|NCT01939197|594811996|FG001|Overall Study|Lost to Follow-up|1|||
164668703|NCT01939197|594811997|FG002|Overall Study|Lost to Follow-up|0|||
164668704|NCT01939197|594811998|FG003|Overall Study|Lost to Follow-up|1|||
164668705|NCT01939197|594811999|FG004|Overall Study|Lost to Follow-up|3|||
164668706|NCT01939197|594812000|FG005|Overall Study|Lost to Follow-up|1|||
164668707|NCT01939197|594812001|FG006|Overall Study|Lost to Follow-up|2|||
164210029|NCT02441283|593137051|FG000|Overall Study|Lost to Follow-up|42|||
164210030|NCT02441283|593137051|FG000|Overall Study|Death|1|||
164355617|NCT00512707|593676482|FG000|Overall Study|Lost to Follow-up|5|||
164668708|NCT02849652|594812002|FG000|Overall Study|Lost to Follow-up|104|||
164668709|NCT02849652|594812003|FG001|Overall Study|Lost to Follow-up|35|||
164668710|NCT02849652|594812004|FG002|Overall Study|Lost to Follow-up|116|||
164210031|NCT02441283|593137051|FG000|Overall Study|Other, not specified|32|||
164210032|NCT02472353|593137054|FG000|Overall Study|Lost to Follow-up|1|||
164210033|NCT02472353|593137055|FG001|Overall Study|Lost to Follow-up|1|||
164210034|NCT02472353|593137054|FG000|Overall Study|Withdrawal by Subject|2|||
164210035|NCT02472353|593137055|FG001|Overall Study|Withdrawal by Subject|1|||
164210036|NCT02472353|593137054|FG000|Overall Study|Study Termination|1|||
164210037|NCT02472353|593137055|FG001|Overall Study|Study Termination|4|||
164210038|NCT02101294|593137056|FG000|Overall Study|Withdrawal by Subject|5|||
164210039|NCT02101294|593137056|FG000|Overall Study|Lost to Follow-up|6|||
164210040|NCT00688597|593137057|FG000|Overall Study|Adverse Event|2|||
164210041|NCT00688597|593137058|FG001|Overall Study|Adverse Event|0|||
164210042|NCT00688597|593137059|FG002|Overall Study|Adverse Event|0|||
164210043|NCT00688597|593137057|FG000|Overall Study|Physician Decision|1|||
164210044|NCT00688597|593137058|FG001|Overall Study|Physician Decision|0|||
164210045|NCT00688597|593137059|FG002|Overall Study|Physician Decision|0|||
164210046|NCT00689936|593137060|FG000|Active Treatment Phase|Adverse Event|68|||
164210047|NCT00689936|593137061|FG001|Active Treatment Phase|Adverse Event|71|||
164210048|NCT00689936|593137062|FG002|Active Treatment Phase|Adverse Event|76|||
164210049|NCT00689936|593137060|FG000|Active Treatment Phase|Disease Progression|273|||
164210050|NCT00689936|593137061|FG001|Active Treatment Phase|Disease Progression|362|||
164210051|NCT00689936|593137062|FG002|Active Treatment Phase|Disease Progression|339|||
164210052|NCT00689936|593137060|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
164210053|NCT00689936|593137061|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
164210054|NCT00689936|593137062|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
164210055|NCT00689936|593137060|FG000|Active Treatment Phase|Death|60|||
164210056|NCT00689936|593137061|FG001|Active Treatment Phase|Death|28|||
164210057|NCT00689936|593137062|FG002|Active Treatment Phase|Death|37|||
164210058|NCT00689936|593137060|FG000|Active Treatment Phase|Lost to Follow-up|0|||
164210059|NCT00689936|593137061|FG001|Active Treatment Phase|Lost to Follow-up|2|||
164210060|NCT00689936|593137062|FG002|Active Treatment Phase|Lost to Follow-up|2|||
164210061|NCT00689936|593137060|FG000|Active Treatment Phase|Protocol Violation|2|||
164210062|NCT00689936|593137061|FG001|Active Treatment Phase|Protocol Violation|2|||
164210063|NCT00689936|593137062|FG002|Active Treatment Phase|Protocol Violation|4|||
164210064|NCT00689936|593137060|FG000|Active Treatment Phase|Study Close Out|64|||
164210065|NCT00689936|593137061|FG001|Active Treatment Phase|Study Close Out|26|||
164210066|NCT00689936|593137062|FG002|Active Treatment Phase|Study Close Out|21|||
164210067|NCT00689936|593137060|FG000|Active Treatment Phase|Miscellaneous|52|||
164210068|NCT00689936|593137061|FG001|Active Treatment Phase|Miscellaneous|34|||
164210069|NCT00689936|593137062|FG002|Active Treatment Phase|Miscellaneous|47|||
164210070|NCT00689936|593137060|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
164210071|NCT00689936|593137061|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
164210072|NCT00689936|593137062|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
164210073|NCT01995201|593137063|FG000|From Baseline Until Week 24|Adverse Event|4|||
164210074|NCT01995201|593137064|FG001|From Baseline Until Week 24|Adverse Event|15|||
164210075|NCT01995201|593137065|FG002|From Baseline Until Week 24|Adverse Event|0|||
164210076|NCT01995201|593137066|FG003|From Baseline Until Week 24|Adverse Event|0|||
164210077|NCT01995201|593137067|FG004|From Baseline Until Week 24|Adverse Event|0|||
164210078|NCT01995201|593137068|FG005|From Baseline Until Week 24|Adverse Event|0|||
164210079|NCT01995201|593137069|FG006|From Baseline Until Week 24|Adverse Event|0|||
164210080|NCT01995201|593137063|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
164210081|NCT01995201|593137064|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
164210082|NCT01995201|593137065|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
164210083|NCT01995201|593137066|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
164210084|NCT01995201|593137067|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
164210085|NCT01995201|593137068|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
164210086|NCT01995201|593137069|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
164210087|NCT01995201|593137063|FG000|From Baseline Until Week 24|Death|0|||
164210088|NCT01995201|593137064|FG001|From Baseline Until Week 24|Death|1|||
164564616|NCT01688050|594436306|FG000|Overall Study|Conversion to open repair|1|||
164210089|NCT01995201|593137065|FG002|From Baseline Until Week 24|Death|0|||
164564617|NCT01688050|594436306|FG000|Overall Study|Lost to Follow-up|13|||
164564618|NCT01688050|594436306|FG000|Overall Study|Withdrawal by Subject|10|||
164564619|NCT00927368|594436307|FG000|Overall Study|enrollment in another study|1|||
164210090|NCT01995201|593137066|FG003|From Baseline Until Week 24|Death|0|||
164210091|NCT01995201|593137067|FG004|From Baseline Until Week 24|Death|0|||
164210092|NCT01995201|593137068|FG005|From Baseline Until Week 24|Death|0|||
164210093|NCT01995201|593137069|FG006|From Baseline Until Week 24|Death|0|||
164210094|NCT01995201|593137063|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
164564620|NCT00927368|594436308|FG001|Overall Study|enrollment in another study|1|||
164210095|NCT01995201|593137064|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
164210096|NCT01995201|593137065|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
164210097|NCT01995201|593137066|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
164564621|NCT00927368|594436309|FG002|Overall Study|enrollment in another study|2|||
164564622|NCT00927368|594436307|FG000|Overall Study|Lost to Follow-up|4|||
164210098|NCT01995201|593137067|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
164210099|NCT01995201|593137068|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
164210100|NCT01995201|593137069|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
164210101|NCT01995201|593137063|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
164210102|NCT01995201|593137064|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
164210103|NCT01995201|593137065|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
164210104|NCT01995201|593137066|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
164210105|NCT01995201|593137067|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
164210106|NCT01995201|593137068|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
164210107|NCT01995201|593137069|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
164210108|NCT01995201|593137063|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
164210109|NCT01995201|593137064|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
164210110|NCT01995201|593137065|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
164210111|NCT01995201|593137066|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
164210112|NCT01995201|593137067|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
164210113|NCT01995201|593137068|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
164210114|NCT01995201|593137069|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
164210115|NCT01995201|593137063|FG000|From Baseline Until Week 24|Physician Decision|0|||
164210116|NCT01995201|593137064|FG001|From Baseline Until Week 24|Physician Decision|2|||
164210117|NCT01995201|593137065|FG002|From Baseline Until Week 24|Physician Decision|0|||
164210118|NCT01995201|593137066|FG003|From Baseline Until Week 24|Physician Decision|0|||
164210119|NCT01995201|593137067|FG004|From Baseline Until Week 24|Physician Decision|0|||
164210120|NCT01995201|593137068|FG005|From Baseline Until Week 24|Physician Decision|0|||
164210121|NCT01995201|593137069|FG006|From Baseline Until Week 24|Physician Decision|0|||
164210122|NCT01995201|593137063|FG000|From Baseline Until Week 24|Protocol Violation|0|||
164210123|NCT01995201|593137064|FG001|From Baseline Until Week 24|Protocol Violation|9|||
164210124|NCT01995201|593137065|FG002|From Baseline Until Week 24|Protocol Violation|0|||
164668711|NCT02849652|594812005|FG003|Overall Study|Lost to Follow-up|22|||
164668712|NCT02849652|594812002|FG000|Overall Study|Withdrawal by Subject|10|||
164668713|NCT02849652|594812003|FG001|Overall Study|Withdrawal by Subject|2|||
164668714|NCT02849652|594812004|FG002|Overall Study|Withdrawal by Subject|8|||
164668715|NCT02849652|594812005|FG003|Overall Study|Withdrawal by Subject|4|||
164668716|NCT02545998|594812006|FG000|Overall Study|Lost to Follow-up|12|||
164668717|NCT02545998|594812007|FG001|Overall Study|Lost to Follow-up|3|||
164668718|NCT02545998|594812006|FG000|Overall Study|Withdrawal by Subject|3|||
164668719|NCT02545998|594812007|FG001|Overall Study|Withdrawal by Subject|2|||
164668720|NCT01226797|594812008|FG000|Overall Study|Adverse Event|1|||
164668721|NCT01226797|594812009|FG001|Overall Study|Adverse Event|0|||
164668722|NCT01226797|594812008|FG000|Overall Study|No longer willing to participate|1|||
164668723|NCT01226797|594812009|FG001|Overall Study|No longer willing to participate|0|||
164668724|NCT01226797|594812008|FG000|Overall Study|Protocol Violation|0|||
164668725|NCT01226797|594812009|FG001|Overall Study|Protocol Violation|1|||
164668726|NCT00577460|594812010|FG000|Overall Study|Adverse Event|11|||
164668727|NCT00577460|594812011|FG001|Overall Study|Adverse Event|7|||
164668728|NCT00577460|594812012|FG002|Overall Study|Adverse Event|14|||
164668729|NCT00577460|594812010|FG000|Overall Study|Protocol Violation|0|||
164668730|NCT00577460|594812011|FG001|Overall Study|Protocol Violation|1|||
164668731|NCT00577460|594812012|FG002|Overall Study|Protocol Violation|1|||
164668732|NCT00577460|594812010|FG000|Overall Study|Lost to Follow-up|0|||
164324339|NCT04393298|593565169|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
164564623|NCT00927368|594436308|FG001|Overall Study|Lost to Follow-up|0|||
164210125|NCT01995201|593137066|FG003|From Baseline Until Week 24|Protocol Violation|0|||
164564624|NCT00927368|594436309|FG002|Overall Study|Lost to Follow-up|0|||
164564625|NCT00927368|594436307|FG000|Overall Study|equipment failure|1|||
164564626|NCT00927368|594436308|FG001|Overall Study|equipment failure|0|||
164564627|NCT00927368|594436309|FG002|Overall Study|equipment failure|0|||
164564628|NCT00927368|594436307|FG000|Overall Study|ineligible post randomization|0|||
164564629|NCT00927368|594436308|FG001|Overall Study|ineligible post randomization|3|||
164564630|NCT00927368|594436309|FG002|Overall Study|ineligible post randomization|1|||
164668733|NCT00577460|594812011|FG001|Overall Study|Lost to Follow-up|3|||
164668734|NCT00577460|594812012|FG002|Overall Study|Lost to Follow-up|4|||
164668735|NCT00577460|594812010|FG000|Overall Study|Withdrawal by Subject|5|||
164210126|NCT01995201|593137067|FG004|From Baseline Until Week 24|Protocol Violation|0|||
164210127|NCT01995201|593137068|FG005|From Baseline Until Week 24|Protocol Violation|0|||
164210128|NCT01995201|593137069|FG006|From Baseline Until Week 24|Protocol Violation|0|||
164210129|NCT01995201|593137063|FG000|From Week 24 Until Week 48|Adverse Event|0|||
164210130|NCT01995201|593137064|FG001|From Week 24 Until Week 48|Adverse Event|0|||
164210131|NCT01995201|593137065|FG002|From Week 24 Until Week 48|Adverse Event|2|||
164210132|NCT01995201|593137066|FG003|From Week 24 Until Week 48|Adverse Event|1|||
164210133|NCT01995201|593137067|FG004|From Week 24 Until Week 48|Adverse Event|1|||
164210134|NCT01995201|593137068|FG005|From Week 24 Until Week 48|Adverse Event|3|||
164210135|NCT01995201|593137069|FG006|From Week 24 Until Week 48|Adverse Event|1|||
164210136|NCT01995201|593137063|FG000|From Week 24 Until Week 48|Death|0|||
164210137|NCT01995201|593137064|FG001|From Week 24 Until Week 48|Death|0|||
164210138|NCT01995201|593137065|FG002|From Week 24 Until Week 48|Death|0|||
164210139|NCT01995201|593137066|FG003|From Week 24 Until Week 48|Death|0|||
164210140|NCT01995201|593137067|FG004|From Week 24 Until Week 48|Death|0|||
164210141|NCT01995201|593137068|FG005|From Week 24 Until Week 48|Death|2|||
164210142|NCT01995201|593137069|FG006|From Week 24 Until Week 48|Death|0|||
164210143|NCT01995201|593137063|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
164210144|NCT01995201|593137064|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
164210145|NCT01995201|593137065|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
164210146|NCT01995201|593137066|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
164210147|NCT01995201|593137067|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
164210148|NCT01995201|593137068|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
164210149|NCT01995201|593137069|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
164210150|NCT01995201|593137063|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
164210151|NCT01995201|593137064|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
164210152|NCT01995201|593137065|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
164210153|NCT01995201|593137066|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
164210154|NCT01995201|593137067|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
164210155|NCT01995201|593137068|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
164210156|NCT01995201|593137069|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
164210157|NCT01995201|593137063|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
164210158|NCT01995201|593137064|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
164210159|NCT01995201|593137065|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
164210160|NCT01995201|593137066|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
164210161|NCT01995201|593137067|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
164210162|NCT01995201|593137068|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
164210163|NCT01995201|593137069|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
164210164|NCT01995201|593137063|FG000|From Week 24 Until Week 48|Physician Decision|0|||
164210165|NCT01995201|593137064|FG001|From Week 24 Until Week 48|Physician Decision|0|||
164210166|NCT01995201|593137065|FG002|From Week 24 Until Week 48|Physician Decision|0|||
164210167|NCT01995201|593137066|FG003|From Week 24 Until Week 48|Physician Decision|0|||
164210168|NCT01995201|593137067|FG004|From Week 24 Until Week 48|Physician Decision|1|||
164210169|NCT01995201|593137068|FG005|From Week 24 Until Week 48|Physician Decision|0|||
164210170|NCT01995201|593137069|FG006|From Week 24 Until Week 48|Physician Decision|0|||
164210171|NCT01995201|593137063|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
164210172|NCT01995201|593137064|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
164210173|NCT01995201|593137065|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
164210174|NCT01995201|593137066|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
164210175|NCT01995201|593137067|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
164210176|NCT01995201|593137068|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
164210177|NCT01995201|593137069|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
164210178|NCT06001866|593137076|FG000|Overall Study|Withdrawal by Subject|0|||
164210179|NCT06001866|593137077|FG001|Overall Study|Withdrawal by Subject|2|||
164210180|NCT06001866|593137076|FG000|Overall Study|Protocol Violation|0|||
164210181|NCT06001866|593137077|FG001|Overall Study|Protocol Violation|2|||
164210182|NCT04703192|593137078|FG000|Overall Study|Withdrawal by Subject|2|||
164210183|NCT04703192|593137079|FG001|Overall Study|Withdrawal by Subject|0|||
164210184|NCT04703192|593137078|FG000|Overall Study|Death|3|||
164564631|NCT00927368|594436307|FG000|Overall Study|cancellation of surgery|0|||
164210185|NCT04703192|593137079|FG001|Overall Study|Death|1|||
164210186|NCT04703192|593137078|FG000|Overall Study|Adverse Event|13|||
164210187|NCT04703192|593137079|FG001|Overall Study|Adverse Event|2|||
164210188|NCT04703192|593137078|FG000|Overall Study|Progressive or Relapsed Disease|46|||
164210189|NCT04703192|593137079|FG001|Overall Study|Progressive or Relapsed Disease|7|||
164210190|NCT04703192|593137078|FG000|Overall Study|Clinical Progression|19|||
164210191|NCT04703192|593137079|FG001|Overall Study|Clinical Progression|8|||
164210192|NCT04703192|593137078|FG000|Overall Study|Lost to Follow-up|1|||
164210193|NCT04703192|593137079|FG001|Overall Study|Lost to Follow-up|0|||
164210194|NCT04703192|593137078|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
164210195|NCT04703192|593137079|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
164210196|NCT04703192|593137078|FG000|Overall Study|Other|5|||
164210197|NCT04703192|593137079|FG001|Overall Study|Other|1|||
164210198|NCT04797169|593137080|FG000|Overall Study|Lost to Follow-up|84|||
164210199|NCT04797169|593137081|FG001|Overall Study|Lost to Follow-up|67|||
164210200|NCT04797169|593137080|FG000|Overall Study|Pregnancy|1|||
164210201|NCT04797169|593137081|FG001|Overall Study|Pregnancy|3|||
164210202|NCT04797169|593137080|FG000|Overall Study|Withdrawal by Subject|27|||
164210203|NCT04797169|593137081|FG001|Overall Study|Withdrawal by Subject|35|||
164210204|NCT04725188|593137082|FG000|Overall Study|Death|72|||
164210205|NCT04725188|593137083|FG001|Overall Study|Death|69|||
164210206|NCT04725188|593137084|FG002|Overall Study|Death|76|||
164210207|NCT04725188|593137082|FG000|Overall Study|Lost to Follow-up|1|||
164210208|NCT04725188|593137083|FG001|Overall Study|Lost to Follow-up|0|||
164210209|NCT04725188|593137084|FG002|Overall Study|Lost to Follow-up|1|||
164210210|NCT04725188|593137082|FG000|Overall Study|Withdrawal by Subject|2|||
164210211|NCT04725188|593137083|FG001|Overall Study|Withdrawal by Subject|2|||
164210212|NCT04725188|593137084|FG002|Overall Study|Withdrawal by Subject|1|||
164668736|NCT00577460|594812011|FG001|Overall Study|Withdrawal by Subject|5|||
164668737|NCT00577460|594812012|FG002|Overall Study|Withdrawal by Subject|6|||
164210213|NCT04725188|593137082|FG000|Overall Study|Sponsor Decision|12|||
164210214|NCT04725188|593137083|FG001|Overall Study|Sponsor Decision|12|||
164210215|NCT04725188|593137084|FG002|Overall Study|Sponsor Decision|7|||
164210216|NCT00390013|593137086|FG000|Phase 1|tired|0|||
164210217|NCT00390013|593137087|FG001|Phase 1|tired|0|||
164210218|NCT00390013|593137088|FG002|Phase 1|tired|0|||
164210219|NCT00390013|593137089|FG003|Phase 1|tired|1|||
164210220|NCT00390013|593137086|FG000|Phase 2 First Treatment|tired|1|||
164210221|NCT00390013|593137087|FG001|Phase 2 First Treatment|tired|0|||
164210222|NCT00390013|593137088|FG002|Phase 2 First Treatment|tired|0|||
164210223|NCT00390013|593137089|FG003|Phase 2 First Treatment|tired|0|||
164210224|NCT00390013|593137086|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
164210225|NCT00390013|593137087|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
164210226|NCT00390013|593137088|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
164210227|NCT00390013|593137089|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
164210228|NCT03839641|593137090|FG000|Overall Study|Withdrawal by Subject|1|||
164210229|NCT03839641|593137091|FG001|Overall Study|Withdrawal by Subject|1|||
164210230|NCT03188822|593137099|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
164210231|NCT03188822|593137099|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
164210232|NCT04537299|593137100|FG000|Overall Study|Withdrawal by Subject|2|||
164324340|NCT04393298|593565170|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
164668738|NCT00577460|594812010|FG000|Overall Study|Other|0|||
164668739|NCT00577460|594812011|FG001|Overall Study|Other|3|||
164668740|NCT00577460|594812012|FG002|Overall Study|Other|2|||
164210233|NCT04537299|593137101|FG001|Overall Study|Withdrawal by Subject|0|||
164210234|NCT04537299|593137100|FG000|Overall Study|Protocol Violation|1|||
164210235|NCT04537299|593137101|FG001|Overall Study|Protocol Violation|1|||
164210236|NCT00876343|593137114|FG000|Overall Study|Adverse Event|7|||
164210237|NCT00876343|593137115|FG001|Overall Study|Adverse Event|8|||
164210238|NCT00876343|593137116|FG002|Overall Study|Adverse Event|2|||
164210239|NCT00876343|593137114|FG000|Overall Study|Withdrawal by Subject|4|||
164210240|NCT00876343|593137115|FG001|Overall Study|Withdrawal by Subject|4|||
164210241|NCT00876343|593137116|FG002|Overall Study|Withdrawal by Subject|3|||
164210242|NCT00876343|593137114|FG000|Overall Study|Lack of Efficacy|0|||
164210243|NCT00876343|593137115|FG001|Overall Study|Lack of Efficacy|0|||
164355618|NCT00512707|593676483|FG001|Overall Study|Lost to Follow-up|11|||
164668741|NCT02365207|594812013|FG000|Overall Study|Withdrawal by Subject|1|||
164210244|NCT00876343|593137116|FG002|Overall Study|Lack of Efficacy|1|||
164210245|NCT00876343|593137114|FG000|Overall Study|Protocol Violation|4|||
164210246|NCT00876343|593137115|FG001|Overall Study|Protocol Violation|1|||
164210247|NCT00876343|593137116|FG002|Overall Study|Protocol Violation|1|||
164210248|NCT00876343|593137114|FG000|Overall Study|Physician Decision|0|||
164210249|NCT00876343|593137115|FG001|Overall Study|Physician Decision|1|||
164210250|NCT00876343|593137116|FG002|Overall Study|Physician Decision|1|||
164210251|NCT00876343|593137114|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
164210252|NCT00876343|593137115|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
164210253|NCT00876343|593137116|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
164210254|NCT00876343|593137114|FG000|Overall Study|Change of residence or other commitments|2|||
164210255|NCT00876343|593137115|FG001|Overall Study|Change of residence or other commitments|2|||
164210256|NCT00876343|593137116|FG002|Overall Study|Change of residence or other commitments|3|||
164210257|NCT00924898|593137119|FG000|Overall Study|Withdrawal by Subject|2|||
164210258|NCT01901562|593137123|FG000|Overall Study|Protocol Violation|5|||
164210259|NCT01901562|593137123|FG000|Overall Study|Excluded intraoperatively|4|||
164210260|NCT00294658|593137124|FG000|Overall Study|Death|0|||
164210261|NCT00294658|593137125|FG001|Overall Study|Death|1|||
164210262|NCT00294658|593137124|FG000|Overall Study|Lost to Follow-up|4|||
164210263|NCT00294658|593137125|FG001|Overall Study|Lost to Follow-up|0|||
164210264|NCT00294658|593137124|FG000|Overall Study|Physician Decision|1|||
164210265|NCT00294658|593137125|FG001|Overall Study|Physician Decision|2|||
164210266|NCT00294658|593137124|FG000|Overall Study|Pregnancy|0|||
164210267|NCT00294658|593137125|FG001|Overall Study|Pregnancy|1|||
164210268|NCT00294658|593137124|FG000|Overall Study|Withdrawal by Subject|0|||
164210269|NCT00294658|593137125|FG001|Overall Study|Withdrawal by Subject|4|||
164210270|NCT00294658|593137124|FG000|Overall Study|Found to have invasive thymoma|1|||
164210271|NCT00294658|593137125|FG001|Overall Study|Found to have invasive thymoma|0|||
164210272|NCT00294658|593137124|FG000|Overall Study|Patient and family were not satisfied|0|||
164210273|NCT00294658|593137125|FG001|Overall Study|Patient and family were not satisfied|1|||
164210274|NCT01771107|593137132|FG000|Overall Study|Adverse Event|1|||
164210275|NCT01771107|593137133|FG001|Overall Study|Adverse Event|3|||
164210276|NCT01771107|593137132|FG000|Overall Study|Withdrawal by Subject|0|||
164210277|NCT01771107|593137133|FG001|Overall Study|Withdrawal by Subject|2|||
164210278|NCT01771107|593137132|FG000|Overall Study|Lost to Follow-up|0|||
164210279|NCT01771107|593137133|FG001|Overall Study|Lost to Follow-up|1|||
164210280|NCT01771107|593137132|FG000|Overall Study|participant moved|0|||
164210281|NCT01771107|593137133|FG001|Overall Study|participant moved|1|||
164210282|NCT01771107|593137132|FG000|Overall Study|Other|0|||
164210283|NCT01771107|593137133|FG001|Overall Study|Other|1|||
164210284|NCT04717557|593137137|FG000|Overall Study|Withdrawal by Subject|2|||
164210285|NCT04717557|593137138|FG001|Overall Study|Withdrawal by Subject|0|||
164210286|NCT04717557|593137137|FG000|Overall Study|Death|1|||
164210287|NCT04717557|593137138|FG001|Overall Study|Death|0|||
164210288|NCT01654276|593137139|FG000|Overall Study|Lack of Efficacy|1|||
164210289|NCT01654276|593137139|FG000|Overall Study|Lost to Follow-up|4|||
164210290|NCT01654276|593137139|FG000|Overall Study|Withdrawal by Subject|1|||
164210291|NCT00831844|593137145|FG000|Overall Study|Adverse Event|2|||
164210292|NCT00831844|593137146|FG001|Overall Study|Adverse Event|0|||
164210293|NCT00831844|593137147|FG002|Overall Study|Adverse Event|0|||
164210294|NCT00831844|593137148|FG003|Overall Study|Adverse Event|0|||
164210295|NCT00831844|593137149|FG004|Overall Study|Adverse Event|1|||
164210296|NCT00831844|593137150|FG005|Overall Study|Adverse Event|1|||
164210297|NCT00831844|593137151|FG006|Overall Study|Adverse Event|2|||
164210298|NCT00831844|593137152|FG007|Overall Study|Adverse Event|0|||
164210299|NCT00831844|593137153|FG008|Overall Study|Adverse Event|0|||
164210300|NCT00831844|593137154|FG009|Overall Study|Adverse Event|0|||
164210301|NCT00831844|593137145|FG000|Overall Study|Death|0|||
164210302|NCT00831844|593137146|FG001|Overall Study|Death|0|||
164210303|NCT00831844|593137147|FG002|Overall Study|Death|0|||
164210304|NCT00831844|593137148|FG003|Overall Study|Death|1|||
164210305|NCT00831844|593137149|FG004|Overall Study|Death|0|||
164210306|NCT00831844|593137150|FG005|Overall Study|Death|0|||
164210307|NCT00831844|593137151|FG006|Overall Study|Death|0|||
164210308|NCT00831844|593137152|FG007|Overall Study|Death|0|||
164210309|NCT00831844|593137153|FG008|Overall Study|Death|0|||
164564632|NCT00927368|594436308|FG001|Overall Study|cancellation of surgery|1|||
164564633|NCT00927368|594436309|FG002|Overall Study|cancellation of surgery|2|||
164564634|NCT00191451|594436311|FG000|Overall Study|Withdrawal by Subject|2|||
164564635|NCT00191451|594436312|FG001|Overall Study|Withdrawal by Subject|3|||
164564636|NCT00191451|594436313|FG002|Overall Study|Withdrawal by Subject|5|||
164564637|NCT00191451|594436311|FG000|Overall Study|Physician Decision|2|||
164564638|NCT00191451|594436312|FG001|Overall Study|Physician Decision|9|||
164210310|NCT00831844|593137154|FG009|Overall Study|Death|0|||
164668742|NCT02365207|594812013|FG000|Overall Study|Physician Decision|1|||
164210311|NCT00831844|593137145|FG000|Overall Study|Lack of Efficacy|8|||
164210312|NCT00831844|593137146|FG001|Overall Study|Lack of Efficacy|10|||
164210313|NCT00831844|593137147|FG002|Overall Study|Lack of Efficacy|15|||
164210314|NCT00831844|593137148|FG003|Overall Study|Lack of Efficacy|8|||
164210315|NCT00831844|593137149|FG004|Overall Study|Lack of Efficacy|11|||
164210316|NCT00831844|593137150|FG005|Overall Study|Lack of Efficacy|17|||
164210317|NCT00831844|593137151|FG006|Overall Study|Lack of Efficacy|8|||
164210318|NCT00831844|593137152|FG007|Overall Study|Lack of Efficacy|9|||
164210319|NCT00831844|593137153|FG008|Overall Study|Lack of Efficacy|7|||
164210320|NCT00831844|593137154|FG009|Overall Study|Lack of Efficacy|0|||
164210321|NCT00831844|593137145|FG000|Overall Study|Physician Decision|0|||
164210322|NCT00831844|593137146|FG001|Overall Study|Physician Decision|1|||
164210323|NCT00831844|593137147|FG002|Overall Study|Physician Decision|3|||
164210324|NCT00831844|593137148|FG003|Overall Study|Physician Decision|1|||
164210325|NCT00831844|593137149|FG004|Overall Study|Physician Decision|1|||
164564639|NCT00191451|594436313|FG002|Overall Study|Physician Decision|6|||
164324341|NCT04393298|593565171|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
164324342|NCT04393298|593565172|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
164324343|NCT04393298|593565173|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
164564640|NCT00191451|594436311|FG000|Overall Study|Sponsor Decision|1|||
164564641|NCT00191451|594436312|FG001|Overall Study|Sponsor Decision|0|||
164564642|NCT00191451|594436313|FG002|Overall Study|Sponsor Decision|0|||
164564643|NCT00191451|594436311|FG000|Overall Study|Ineligible|0|||
164564644|NCT00191451|594436312|FG001|Overall Study|Ineligible|1|||
164564645|NCT00191451|594436313|FG002|Overall Study|Ineligible|0|||
164564646|NCT00191451|594436311|FG000|Overall Study|Reason Not Specified|2|||
164564647|NCT00191451|594436312|FG001|Overall Study|Reason Not Specified|1|||
164668743|NCT00408902|594812017|FG000|Overall Study|Lack of Efficacy|7|||
164668744|NCT00408902|594812017|FG000|Overall Study|Adverse Event|3|||
164324344|NCT04393298|593565159|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164668745|NCT02480764|594812019|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
164668746|NCT02480764|594812020|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
164668747|NCT02480764|594812021|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
164668748|NCT02480764|594812019|FG000|Overall Study|Major Protocol Deviation|1|||
164668749|NCT02480764|594812020|FG001|Overall Study|Major Protocol Deviation|4|||
164668750|NCT02480764|594812021|FG002|Overall Study|Major Protocol Deviation|3|||
164668751|NCT02480764|594812019|FG000|Overall Study|Lost to Follow-up|0|||
164668752|NCT02480764|594812020|FG001|Overall Study|Lost to Follow-up|1|||
164668753|NCT02480764|594812021|FG002|Overall Study|Lost to Follow-up|2|||
164668754|NCT02480764|594812019|FG000|Overall Study|Voluntary Withdrawal|6|||
164668755|NCT02480764|594812020|FG001|Overall Study|Voluntary Withdrawal|5|||
164668756|NCT02480764|594812021|FG002|Overall Study|Voluntary Withdrawal|10|||
164668757|NCT02480764|594812019|FG000|Overall Study|Lack of Efficacy|0|||
164668758|NCT02480764|594812020|FG001|Overall Study|Lack of Efficacy|3|||
164668759|NCT02480764|594812021|FG002|Overall Study|Lack of Efficacy|3|||
164668760|NCT02480764|594812019|FG000|Overall Study|Reason not Specified|0|||
164668761|NCT02480764|594812020|FG001|Overall Study|Reason not Specified|1|||
164668762|NCT02480764|594812021|FG002|Overall Study|Reason not Specified|0|||
164668763|NCT02457832|594812024|FG000|Training|Lost to Follow-up|10|||
164668764|NCT02457832|594812025|FG001|Training|Lost to Follow-up|6|||
164668765|NCT02457832|594812026|FG002|Training|Lost to Follow-up|3|||
164668766|NCT02457832|594812024|FG000|One Month Washout|Lost to Follow-up|0|||
164668767|NCT02457832|594812025|FG001|One Month Washout|Lost to Follow-up|1|||
164668768|NCT02457832|594812026|FG002|One Month Washout|Lost to Follow-up|1|||
164668769|NCT01044732|594812027|FG000|Overall Study|Lost to Follow-up|2|||
164668770|NCT01044732|594812028|FG001|Overall Study|Lost to Follow-up|1|||
164668771|NCT01044732|594812027|FG000|Overall Study|Physician Decision|5|||
164668772|NCT01044732|594812028|FG001|Overall Study|Physician Decision|3|||
164668773|NCT01044732|594812027|FG000|Overall Study|Protocol Violation|11|||
164668774|NCT01044732|594812028|FG001|Overall Study|Protocol Violation|12|||
164668775|NCT01044732|594812027|FG000|Overall Study|Withdrawal by Subject|0|||
164668776|NCT01044732|594812028|FG001|Overall Study|Withdrawal by Subject|1|||
164668777|NCT01044732|594812027|FG000|Overall Study|Inadequate bowel preparation|11|||
164668778|NCT01044732|594812028|FG001|Overall Study|Inadequate bowel preparation|17|||
164668779|NCT01044732|594812027|FG000|Overall Study|Inability to reach cecum|5|||
164668780|NCT01044732|594812028|FG001|Overall Study|Inability to reach cecum|2|||
164668781|NCT01044732|594812027|FG000|Overall Study|Technical error or malfunction|15|||
164668782|NCT01044732|594812028|FG001|Overall Study|Technical error or malfunction|14|||
164668783|NCT01030965|594812029|FG000|Overall Study|Lack of Efficacy|3|||
164668784|NCT01030965|594812030|FG001|Overall Study|Lack of Efficacy|2|||
164668785|NCT01030965|594812031|FG002|Overall Study|Lack of Efficacy|0|||
164668786|NCT01030965|594812032|FG003|Overall Study|Lack of Efficacy|3|||
164668787|NCT01030965|594812029|FG000|Overall Study|Protocol Violation|1|||
164668788|NCT01030965|594812030|FG001|Overall Study|Protocol Violation|1|||
164668789|NCT01030965|594812031|FG002|Overall Study|Protocol Violation|1|||
164668790|NCT01030965|594812032|FG003|Overall Study|Protocol Violation|1|||
164668791|NCT01030965|594812029|FG000|Overall Study|Adverse Event|0|||
164668792|NCT01030965|594812030|FG001|Overall Study|Adverse Event|1|||
164668793|NCT01030965|594812031|FG002|Overall Study|Adverse Event|2|||
164668794|NCT01030965|594812032|FG003|Overall Study|Adverse Event|1|||
164668795|NCT01030965|594812029|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
164668796|NCT01030965|594812030|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
164668797|NCT01030965|594812031|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
164668798|NCT01030965|594812032|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
164668799|NCT01030965|594812029|FG000|Overall Study|Withdrawal by Subject|0|||
164564648|NCT00191451|594436313|FG002|Overall Study|Reason Not Specified|3|||
164564649|NCT00272987|594436321|FG000|Overall Study|Adverse Event|1|||
164668800|NCT01030965|594812030|FG001|Overall Study|Withdrawal by Subject|1|||
164668801|NCT01030965|594812031|FG002|Overall Study|Withdrawal by Subject|0|||
164668802|NCT01030965|594812032|FG003|Overall Study|Withdrawal by Subject|2|||
164668803|NCT02097290|594812033|FG000|Overall Study|Death|6|||
164668804|NCT02097290|594812033|FG000|Overall Study|Total Withdrawals|3|||
164564650|NCT00272987|594436322|FG001|Overall Study|Adverse Event|0|||
164210326|NCT00831844|593137150|FG005|Overall Study|Physician Decision|1|||
164210327|NCT00831844|593137151|FG006|Overall Study|Physician Decision|0|||
164210328|NCT00831844|593137152|FG007|Overall Study|Physician Decision|0|||
164210329|NCT00831844|593137153|FG008|Overall Study|Physician Decision|1|||
164210330|NCT00831844|593137154|FG009|Overall Study|Physician Decision|0|||
164210331|NCT00831844|593137145|FG000|Overall Study|Withdrawal by Subject|0|||
164210332|NCT00831844|593137146|FG001|Overall Study|Withdrawal by Subject|0|||
164210333|NCT00831844|593137147|FG002|Overall Study|Withdrawal by Subject|1|||
164210334|NCT00831844|593137148|FG003|Overall Study|Withdrawal by Subject|0|||
164210335|NCT00831844|593137149|FG004|Overall Study|Withdrawal by Subject|0|||
164210336|NCT00831844|593137150|FG005|Overall Study|Withdrawal by Subject|0|||
164210337|NCT00831844|593137151|FG006|Overall Study|Withdrawal by Subject|0|||
164210338|NCT00831844|593137152|FG007|Overall Study|Withdrawal by Subject|1|||
164210339|NCT00831844|593137153|FG008|Overall Study|Withdrawal by Subject|1|||
164210340|NCT00831844|593137154|FG009|Overall Study|Withdrawal by Subject|0|||
164210341|NCT00831844|593137145|FG000|Overall Study|Ineligible|0|||
164210342|NCT00831844|593137146|FG001|Overall Study|Ineligible|1|||
164210343|NCT00831844|593137147|FG002|Overall Study|Ineligible|1|||
164210344|NCT00831844|593137148|FG003|Overall Study|Ineligible|0|||
164210345|NCT00831844|593137149|FG004|Overall Study|Ineligible|1|||
164210346|NCT00831844|593137150|FG005|Overall Study|Ineligible|0|||
164210347|NCT00831844|593137151|FG006|Overall Study|Ineligible|0|||
164210348|NCT00831844|593137152|FG007|Overall Study|Ineligible|0|||
164210349|NCT00831844|593137153|FG008|Overall Study|Ineligible|0|||
164210350|NCT00831844|593137154|FG009|Overall Study|Ineligible|0|||
164210351|NCT01192178|593137155|FG000|Overall Study|Withdrawal by Subject|6|||
164210352|NCT01192178|593137156|FG001|Overall Study|Withdrawal by Subject|10|||
164210353|NCT01192178|593137155|FG000|Overall Study|Protocol Violation|10|||
164210354|NCT01192178|593137156|FG001|Overall Study|Protocol Violation|3|||
164210355|NCT01192178|593137155|FG000|Overall Study|Physician Decision|2|||
164210356|NCT01192178|593137156|FG001|Overall Study|Physician Decision|4|||
164210357|NCT01192178|593137155|FG000|Overall Study|Lost to Follow-up|3|||
164210358|NCT01192178|593137156|FG001|Overall Study|Lost to Follow-up|3|||
164210359|NCT01192178|593137155|FG000|Overall Study|Adverse Event|2|||
164210360|NCT01192178|593137156|FG001|Overall Study|Adverse Event|1|||
164210361|NCT01192178|593137155|FG000|Overall Study|Lack of Efficacy|1|||
164210362|NCT01192178|593137156|FG001|Overall Study|Lack of Efficacy|2|||
164210363|NCT01143324|593137159|FG000|Overall Study|Lost to Follow-up|11|||
164210364|NCT01143324|593137159|FG000|Overall Study|Withdrawal by Subject|4|||
164210365|NCT01143324|593137159|FG000|Overall Study|Explant of the device|4|||
164210366|NCT00858988|593137160|FG000|Analysis|Lactulose unable to be detected in urine|2|||
164210367|NCT00858988|593137161|FG001|Analysis|Lactulose unable to be detected in urine|1|||
164210368|NCT00976027|593138187|FG000|Overall Study|Serious Adverse Event|36|||
164210369|NCT00976027|593138188|FG001|Overall Study|Serious Adverse Event|17|||
164210370|NCT00976027|593138187|FG000|Overall Study|Adverse Event|0|||
164210371|NCT00976027|593138188|FG001|Overall Study|Adverse Event|2|||
164210372|NCT00976027|593138187|FG000|Overall Study|Protocol Violation|60|||
164210373|NCT00976027|593138188|FG001|Overall Study|Protocol Violation|27|||
164210374|NCT00976027|593138187|FG000|Overall Study|Lost to Follow-up|208|||
164210375|NCT00976027|593138188|FG001|Overall Study|Lost to Follow-up|103|||
164210376|NCT00976027|593138187|FG000|Overall Study|Withdrawal by Subject|107|||
164210377|NCT00976027|593138188|FG001|Overall Study|Withdrawal by Subject|66|||
164210378|NCT03805841|593138189|FG000|Overall Study|Clinical Progression|2|||
164210379|NCT03805841|593138190|FG001|Overall Study|Clinical Progression|0|||
164210380|NCT03805841|593138191|FG002|Overall Study|Clinical Progression|0|||
164210381|NCT03805841|593138189|FG000|Overall Study|Death|0|||
164210382|NCT03805841|593138190|FG001|Overall Study|Death|3|||
164210383|NCT03805841|593138191|FG002|Overall Study|Death|1|||
164210384|NCT03805841|593138189|FG000|Overall Study|Lost to Follow-up|0|||
164210385|NCT03805841|593138190|FG001|Overall Study|Lost to Follow-up|0|||
164210386|NCT03805841|593138191|FG002|Overall Study|Lost to Follow-up|1|||
164210387|NCT03805841|593138189|FG000|Overall Study|Withdrawal by Subject|2|||
164210388|NCT03805841|593138190|FG001|Overall Study|Withdrawal by Subject|3|||
164210389|NCT03805841|593138191|FG002|Overall Study|Withdrawal by Subject|0|||
164210390|NCT03805841|593138189|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
164210391|NCT03805841|593138190|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
164210392|NCT03805841|593138191|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
164210393|NCT03621592|593138192|FG000|Overall Study|Lost to Follow-up|1|||
164210394|NCT03621592|593138193|FG001|Overall Study|Lost to Follow-up|0|||
164210395|NCT03621592|593138192|FG000|Overall Study|Lack of Improvement|1|||
164210396|NCT03621592|593138193|FG001|Overall Study|Lack of Improvement|0|||
164668805|NCT02097290|594812033|FG000|Overall Study|Attempt|8|||
164210397|NCT03621592|593138192|FG000|Overall Study|Preference to receive wound care closer to home|1|||
164210398|NCT03621592|593138193|FG001|Overall Study|Preference to receive wound care closer to home|0|||
164210399|NCT03621592|593138192|FG000|Overall Study|Lack of healing|0|||
164210400|NCT03621592|593138193|FG001|Overall Study|Lack of healing|2|||
164210401|NCT02629159|593138194|FG000|Overall Study|Adverse Event|17|||
164210402|NCT02629159|593138195|FG001|Overall Study|Adverse Event|20|||
164668806|NCT03991494|594812038|FG000|Overall Study|Progressive Disease|4|||
164324345|NCT04393298|593565160|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
164324346|NCT04393298|593565161|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164668807|NCT05277389|594812039|FG000|Overall Study|Lost to Follow-up|1|||
164668808|NCT05277389|594812040|FG001|Overall Study|Lost to Follow-up|4|||
164668809|NCT03144687|594812041|FG000|Overall Study|Death|0|||
164668810|NCT03144687|594812042|FG001|Overall Study|Death|2|||
164668811|NCT03144687|594812041|FG000|Overall Study|Lost to Follow-up|0|||
164668812|NCT03144687|594812042|FG001|Overall Study|Lost to Follow-up|1|||
164668813|NCT03144687|594812041|FG000|Overall Study|Physician Decision|0|||
164668814|NCT03144687|594812042|FG001|Overall Study|Physician Decision|1|||
164668815|NCT03144687|594812041|FG000|Overall Study|Withdrawal by Subject|1|||
164324347|NCT04393298|593565162|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164324348|NCT04393298|593565163|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164324349|NCT04393298|593565164|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164324350|NCT04393298|593565165|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164324351|NCT04393298|593565166|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164324352|NCT04393298|593565167|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164324353|NCT04393298|593565168|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164324354|NCT04393298|593565169|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164324355|NCT04393298|593565170|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164324356|NCT04393298|593565171|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164324357|NCT04393298|593565172|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164324358|NCT04393298|593565173|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164324359|NCT04393298|593565159|FG000|Overall Study|Clinical Progression|0|||
164324360|NCT04393298|593565160|FG001|Overall Study|Clinical Progression|2|||
164324361|NCT04393298|593565161|FG002|Overall Study|Clinical Progression|0|||
164324362|NCT04393298|593565162|FG003|Overall Study|Clinical Progression|0|||
164324363|NCT04393298|593565163|FG004|Overall Study|Clinical Progression|0|||
164324364|NCT04393298|593565164|FG005|Overall Study|Clinical Progression|0|||
164324365|NCT04393298|593565165|FG006|Overall Study|Clinical Progression|0|||
164324366|NCT04393298|593565166|FG007|Overall Study|Clinical Progression|0|||
164324367|NCT04393298|593565167|FG008|Overall Study|Clinical Progression|0|||
164324368|NCT04393298|593565168|FG009|Overall Study|Clinical Progression|0|||
164324369|NCT04393298|593565169|FG010|Overall Study|Clinical Progression|0|||
164324370|NCT04393298|593565170|FG011|Overall Study|Clinical Progression|0|||
164324371|NCT04393298|593565171|FG012|Overall Study|Clinical Progression|0|||
164324372|NCT04393298|593565172|FG013|Overall Study|Clinical Progression|0|||
164324373|NCT04393298|593565173|FG014|Overall Study|Clinical Progression|0|||
164324374|NCT04393298|593565159|FG000|Overall Study|Disease Progression|0|||
164324375|NCT04393298|593565160|FG001|Overall Study|Disease Progression|1|||
164324376|NCT04393298|593565161|FG002|Overall Study|Disease Progression|0|||
164324377|NCT04393298|593565162|FG003|Overall Study|Disease Progression|0|||
164324378|NCT04393298|593565163|FG004|Overall Study|Disease Progression|0|||
164324379|NCT04393298|593565164|FG005|Overall Study|Disease Progression|3|||
164324380|NCT04393298|593565165|FG006|Overall Study|Disease Progression|2|||
164324381|NCT04393298|593565166|FG007|Overall Study|Disease Progression|1|||
164324382|NCT04393298|593565167|FG008|Overall Study|Disease Progression|2|||
164324383|NCT04393298|593565168|FG009|Overall Study|Disease Progression|1|||
164324384|NCT04393298|593565169|FG010|Overall Study|Disease Progression|0|||
164324385|NCT04393298|593565170|FG011|Overall Study|Disease Progression|3|||
164324386|NCT04393298|593565171|FG012|Overall Study|Disease Progression|0|||
164324387|NCT04393298|593565172|FG013|Overall Study|Disease Progression|0|||
164324388|NCT04393298|593565173|FG014|Overall Study|Disease Progression|1|||
164324389|NCT04393298|593565159|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164324390|NCT04393298|593565160|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164668816|NCT03144687|594812042|FG001|Overall Study|Withdrawal by Subject|3|||
164668817|NCT03144687|594812041|FG000|Overall Study|Not Reported|2|||
164324391|NCT04393298|593565161|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
164324392|NCT04393298|593565162|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164324393|NCT04393298|593565163|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164324394|NCT04393298|593565164|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164668818|NCT03144687|594812042|FG001|Overall Study|Not Reported|0|||
164668819|NCT02514174|594812043|FG000|Overall Study|Patient refused to continue medication|1|||
164668820|NCT02514174|594812043|FG000|Overall Study|Adverse Event|2|||
164668821|NCT02514174|594812043|FG000|Overall Study|Study closed by sponsor|9|||
164668822|NCT02514174|594812043|FG000|Overall Study|Progressive disease|11|||
164668823|NCT02514174|594812043|FG000|Overall Study|Treatment change|1|||
164668824|NCT02514174|594812043|FG000|Overall Study|Treated off study with Afatinib.|1|||
164668825|NCT00824265|594812044|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
164668826|NCT00824265|594812045|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
164668827|NCT00824265|594812044|FG000|Treatment Phase|Protocol Violation|1|||
164668828|NCT00824265|594812045|FG001|Treatment Phase|Protocol Violation|0|||
164668829|NCT00824265|594812044|FG000|Treatment Phase|Lost to Follow-up|1|||
164668830|NCT00824265|594812045|FG001|Treatment Phase|Lost to Follow-up|1|||
164668831|NCT00824265|594812044|FG000|Treatment Phase|Physician Decision|6|||
164668832|NCT00824265|594812045|FG001|Treatment Phase|Physician Decision|12|||
164668833|NCT00824265|594812044|FG000|Treatment Phase|Withdrawal by Subject|6|||
164668834|NCT00824265|594812045|FG001|Treatment Phase|Withdrawal by Subject|15|||
164668835|NCT00824265|594812044|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
164668836|NCT00824265|594812045|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
164668837|NCT00824265|594812044|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
164668838|NCT00824265|594812045|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
164668839|NCT02170688|594812046|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
164668840|NCT02170688|594812047|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
164668841|NCT02170688|594812048|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
164668842|NCT02170688|594812049|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
164668843|NCT02170688|594812050|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
164564651|NCT00272987|594436323|FG002|Overall Study|Adverse Event|0|||
164564652|NCT00272987|594436321|FG000|Overall Study|Lost to Follow-up|3|||
164564653|NCT00272987|594436322|FG001|Overall Study|Lost to Follow-up|1|||
164564654|NCT00272987|594436323|FG002|Overall Study|Lost to Follow-up|1|||
164564655|NCT00272987|594436321|FG000|Overall Study|Withdrawal by Subject|1|||
164564656|NCT00272987|594436322|FG001|Overall Study|Withdrawal by Subject|0|||
164564657|NCT00272987|594436323|FG002|Overall Study|Withdrawal by Subject|3|||
164564658|NCT00272987|594436321|FG000|Overall Study|Sponsor Terminated study|0|||
164564659|NCT00272987|594436322|FG001|Overall Study|Sponsor Terminated study|1|||
164564660|NCT00272987|594436323|FG002|Overall Study|Sponsor Terminated study|1|||
164564661|NCT00272987|594436321|FG000|Overall Study|Disease progression|1|||
164564662|NCT00272987|594436322|FG001|Overall Study|Disease progression|1|||
164564663|NCT00272987|594436323|FG002|Overall Study|Disease progression|2|||
164564664|NCT00272987|594436321|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
164564665|NCT00272987|594436322|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
164564666|NCT00272987|594436323|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
164564667|NCT00272987|594436321|FG000|Overall Study|Death|1|||
164564668|NCT00272987|594436322|FG001|Overall Study|Death|0|||
164564669|NCT00272987|594436323|FG002|Overall Study|Death|0|||
164564670|NCT03222349|594436327|FG000|Overall Study|Treatment B not done|5|||
164564671|NCT03222349|594436328|FG001|Overall Study|Treatment B not done|0|||
164564672|NCT03222349|594436327|FG000|Overall Study|Lost to Follow-up|1|||
164564673|NCT03222349|594436328|FG001|Overall Study|Lost to Follow-up|2|||
164564674|NCT03222349|594436327|FG000|Overall Study|Withdrawal by Subject|1|||
164564675|NCT03222349|594436328|FG001|Overall Study|Withdrawal by Subject|0|||
164564676|NCT03222349|594436327|FG000|Overall Study|Treatment A not done|0|||
164564677|NCT03222349|594436328|FG001|Overall Study|Treatment A not done|5|||
164564678|NCT03222349|594436327|FG000|Overall Study|Study terminated by sponsor|1|||
164564679|NCT03222349|594436328|FG001|Overall Study|Study terminated by sponsor|0|||
164564680|NCT01058096|594436329|FG000|Double-blind Treatment Phase|Adverse Event|11|||
164564681|NCT01058096|594436330|FG001|Double-blind Treatment Phase|Adverse Event|15|||
164564682|NCT01058096|594436329|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
164564683|NCT01058096|594436330|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
164564684|NCT01058096|594436329|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
164564685|NCT01058096|594436330|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
164668844|NCT02170688|594812046|FG000|Overall Study|Full dose not received|0|||
164668845|NCT02170688|594812047|FG001|Overall Study|Full dose not received|1|||
164324395|NCT04393298|593565165|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164668846|NCT02170688|594812048|FG002|Overall Study|Full dose not received|0|||
164324396|NCT04393298|593565166|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164564686|NCT01058096|594436329|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
164564687|NCT01058096|594436330|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
164210403|NCT02629159|593138196|FG002|Overall Study|Adverse Event|22|||
164210404|NCT02629159|593138194|FG000|Overall Study|Withdrawal by Subject|22|||
164210405|NCT02629159|593138195|FG001|Overall Study|Withdrawal by Subject|11|||
164210406|NCT02629159|593138196|FG002|Overall Study|Withdrawal by Subject|15|||
164210407|NCT02629159|593138194|FG000|Overall Study|Lost to Follow-up|7|||
164210408|NCT02629159|593138195|FG001|Overall Study|Lost to Follow-up|4|||
164210409|NCT02629159|593138196|FG002|Overall Study|Lost to Follow-up|5|||
164210410|NCT02629159|593138194|FG000|Overall Study|Lack of Efficacy|4|||
164210411|NCT02629159|593138195|FG001|Overall Study|Lack of Efficacy|0|||
164210412|NCT02629159|593138196|FG002|Overall Study|Lack of Efficacy|1|||
164210413|NCT02629159|593138194|FG000|Overall Study|Other|6|||
164210414|NCT02629159|593138195|FG001|Overall Study|Other|4|||
164210415|NCT02629159|593138196|FG002|Overall Study|Other|8|||
164210416|NCT05722015|593138197|FG000|Overall Study|Death|57|||
164210417|NCT05722015|593138198|FG001|Overall Study|Death|37|||
164210418|NCT05722015|593138197|FG000|Overall Study|Lost to Follow-up|1|||
164210419|NCT05722015|593138198|FG001|Overall Study|Lost to Follow-up|0|||
164210420|NCT05722015|593138197|FG000|Overall Study|Withdrawal by Subject|5|||
164210421|NCT05722015|593138198|FG001|Overall Study|Withdrawal by Subject|1|||
164210422|NCT05722015|593138197|FG000|Overall Study|Participants Ongoing|188|||
164210423|NCT05722015|593138198|FG001|Overall Study|Participants Ongoing|88|||
164210424|NCT02685735|593138199|FG000|Overall Study|Surgery Cancelled|4|||
164210425|NCT02685735|593138200|FG001|Overall Study|Surgery Cancelled|9|||
164210426|NCT02685735|593138199|FG000|Overall Study|Adverse Event|10|||
164210427|NCT02685735|593138200|FG001|Overall Study|Adverse Event|3|||
164210428|NCT02685735|593138199|FG000|Overall Study|Preop testing found to be incomplete|2|||
164210429|NCT02685735|593138200|FG001|Overall Study|Preop testing found to be incomplete|2|||
164210430|NCT02685735|593138199|FG000|Overall Study|Withdrawal by Subject|1|||
164210431|NCT02685735|593138200|FG001|Overall Study|Withdrawal by Subject|2|||
164210432|NCT02685735|593138199|FG000|Overall Study|Death|1|||
164210433|NCT02685735|593138200|FG001|Overall Study|Death|0|||
164210434|NCT04133909|593138203|FG000|Overall Study|Death|11|||
164210435|NCT04133909|593138204|FG001|Overall Study|Death|11|||
164210436|NCT04133909|593138203|FG000|Overall Study|Adverse Event|4|||
164210437|NCT04133909|593138204|FG001|Overall Study|Adverse Event|5|||
164210438|NCT04133909|593138203|FG000|Overall Study|Lost to Follow-up|3|||
164210439|NCT04133909|593138204|FG001|Overall Study|Lost to Follow-up|5|||
164210440|NCT04133909|593138203|FG000|Overall Study|Physician Decision|4|||
164210441|NCT04133909|593138204|FG001|Overall Study|Physician Decision|7|||
164210442|NCT04133909|593138203|FG000|Overall Study|Withdrawal by Subject|40|||
164210443|NCT04133909|593138204|FG001|Overall Study|Withdrawal by Subject|35|||
164210444|NCT04133909|593138203|FG000|Overall Study|Lack of Efficacy|2|||
164210445|NCT04133909|593138204|FG001|Overall Study|Lack of Efficacy|7|||
164210446|NCT04133909|593138203|FG000|Overall Study|Randomized in error|1|||
164210447|NCT04133909|593138204|FG001|Overall Study|Randomized in error|1|||
164210448|NCT05020743|593138205|FG000|Overall Study|Enrollment in Interventional Study|2|||
164210449|NCT05020743|593138206|FG001|Overall Study|Enrollment in Interventional Study|9|||
164210450|NCT05020743|593138207|FG002|Overall Study|Enrollment in Interventional Study|0|||
164210451|NCT05020743|593138205|FG000|Overall Study|Withdrawal by Subject|0|||
164210452|NCT05020743|593138206|FG001|Overall Study|Withdrawal by Subject|3|||
164210453|NCT05020743|593138207|FG002|Overall Study|Withdrawal by Subject|1|||
164210454|NCT05020743|593138205|FG000|Overall Study|Lost to Follow-up|1|||
164210455|NCT05020743|593138206|FG001|Overall Study|Lost to Follow-up|0|||
164210456|NCT05020743|593138207|FG002|Overall Study|Lost to Follow-up|0|||
164210457|NCT05020743|593138205|FG000|Overall Study|Study Termination by Sponsor|10|||
164210458|NCT05020743|593138206|FG001|Overall Study|Study Termination by Sponsor|11|||
164210459|NCT05020743|593138207|FG002|Overall Study|Study Termination by Sponsor|10|||
164210460|NCT02003924|593138208|FG000|Double-blind Phase|Lost to Follow-up|2|||
164210461|NCT02003924|593138209|FG001|Double-blind Phase|Lost to Follow-up|1|||
164210462|NCT02003924|593138210|FG002|Double-blind Phase|Lost to Follow-up|0|||
164564688|NCT01058096|594436329|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
164564689|NCT01058096|594436330|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
164564690|NCT01058096|594436329|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
164564691|NCT01058096|594436330|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
164564692|NCT04451330|594436331|FG000|Overall Study|Adverse Event|1|||
164564693|NCT04451330|594436332|FG001|Overall Study|Adverse Event|2|||
164564694|NCT04451330|594436331|FG000|Overall Study|Lost to Follow-up|5|||
164564695|NCT04451330|594436332|FG001|Overall Study|Lost to Follow-up|0|||
164210463|NCT02003924|593138208|FG000|Double-blind Phase|Protocol Violation|1|||
164210464|NCT02003924|593138209|FG001|Double-blind Phase|Protocol Violation|2|||
164210465|NCT02003924|593138210|FG002|Double-blind Phase|Protocol Violation|0|||
164210466|NCT02003924|593138208|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
164210467|NCT02003924|593138209|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
164210468|NCT02003924|593138210|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
164210469|NCT02003924|593138208|FG000|Double-blind Phase|Disease Progression|229|||
164564696|NCT04451330|594436331|FG000|Overall Study|Withdrawal by Subject|3|||
164210470|NCT02003924|593138209|FG001|Double-blind Phase|Disease Progression|247|||
164210471|NCT02003924|593138210|FG002|Double-blind Phase|Disease Progression|0|||
164210472|NCT02003924|593138208|FG000|Double-blind Phase|Adverse Event|120|||
164210473|NCT02003924|593138209|FG001|Double-blind Phase|Adverse Event|31|||
164210474|NCT02003924|593138210|FG002|Double-blind Phase|Adverse Event|0|||
164210475|NCT02003924|593138208|FG000|Double-blind Phase|Randomized But not Treated|3|||
164210476|NCT02003924|593138209|FG001|Double-blind Phase|Randomized But not Treated|3|||
164210477|NCT02003924|593138210|FG002|Double-blind Phase|Randomized But not Treated|0|||
164210478|NCT02003924|593138208|FG000|Double-blind Phase|Other|29|||
164210479|NCT02003924|593138209|FG001|Double-blind Phase|Other|50|||
164210480|NCT02003924|593138210|FG002|Double-blind Phase|Other|0|||
164210481|NCT02003924|593138208|FG000|Open-label Phase|Lost to Follow-up|0|||
164210482|NCT02003924|593138209|FG001|Open-label Phase|Lost to Follow-up|0|||
164210483|NCT02003924|593138210|FG002|Open-label Phase|Lost to Follow-up|1|||
164210484|NCT02003924|593138208|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
164210485|NCT02003924|593138209|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
164210486|NCT02003924|593138210|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
164210487|NCT02003924|593138208|FG000|Open-label Phase|Disease Progression|59|||
164210488|NCT02003924|593138209|FG001|Open-label Phase|Disease Progression|0|||
164210489|NCT02003924|593138210|FG002|Open-label Phase|Disease Progression|5|||
164210490|NCT02003924|593138208|FG000|Open-label Phase|Adverse Event|25|||
164210491|NCT02003924|593138209|FG001|Open-label Phase|Adverse Event|0|||
164210492|NCT02003924|593138210|FG002|Open-label Phase|Adverse Event|10|||
164210493|NCT02003924|593138208|FG000|Open-label Phase|Other|7|||
164210494|NCT02003924|593138209|FG001|Open-label Phase|Other|0|||
164210495|NCT02003924|593138210|FG002|Open-label Phase|Other|0|||
164210496|NCT02003924|593138208|FG000|Long-term Follow-up Phase|Death|288|||
164210497|NCT02003924|593138209|FG001|Long-term Follow-up Phase|Death|174|||
164210498|NCT02003924|593138210|FG002|Long-term Follow-up Phase|Death|4|||
164210499|NCT02003924|593138208|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
164210500|NCT02003924|593138209|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
164210501|NCT02003924|593138210|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
164210502|NCT02003924|593138208|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
164210503|NCT02003924|593138209|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
164210504|NCT02003924|593138210|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
164210505|NCT02003924|593138208|FG000|Long-term Follow-up Phase|Other|5|||
164210506|NCT02003924|593138209|FG001|Long-term Follow-up Phase|Other|2|||
164210507|NCT02003924|593138210|FG002|Long-term Follow-up Phase|Other|1|||
164210508|NCT02340949|593138211|FG000|Overall Study|Adverse Event|4|||
164210509|NCT02340949|593138212|FG001|Overall Study|Adverse Event|2|||
164210510|NCT02340949|593138211|FG000|Overall Study|Withdrawal by Subject|2|||
164210511|NCT02340949|593138212|FG001|Overall Study|Withdrawal by Subject|0|||
164210512|NCT02340949|593138211|FG000|Overall Study|Progression disease|6|||
164210513|NCT02340949|593138212|FG001|Overall Study|Progression disease|2|||
164210514|NCT02340949|593138211|FG000|Overall Study|Death|3|||
164210515|NCT02340949|593138212|FG001|Overall Study|Death|0|||
164210516|NCT02340949|593138211|FG000|Overall Study|Physician Decision|1|||
164210517|NCT02340949|593138212|FG001|Overall Study|Physician Decision|0|||
164210518|NCT03980223|593138213|FG000|Overall Study|Lost to Follow-up|3|||
164210519|NCT03980223|593138214|FG001|Overall Study|Lost to Follow-up|7|||
164210520|NCT03980223|593138215|FG002|Overall Study|Lost to Follow-up|10|||
164210521|NCT03980223|593138216|FG003|Overall Study|Lost to Follow-up|8|||
164210522|NCT03980223|593138213|FG000|Overall Study|Withdrawal by Subject|0|||
164210523|NCT03980223|593138214|FG001|Overall Study|Withdrawal by Subject|0|||
164210524|NCT03980223|593138215|FG002|Overall Study|Withdrawal by Subject|1|||
164210525|NCT03980223|593138216|FG003|Overall Study|Withdrawal by Subject|2|||
164210526|NCT03980223|593138213|FG000|Overall Study|Physician Decision|0|||
164210527|NCT03980223|593138214|FG001|Overall Study|Physician Decision|0|||
164210528|NCT03980223|593138215|FG002|Overall Study|Physician Decision|1|||
164210529|NCT03980223|593138216|FG003|Overall Study|Physician Decision|0|||
164210530|NCT03980223|593138213|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
164210531|NCT03980223|593138214|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
164564697|NCT04451330|594436332|FG001|Overall Study|Withdrawal by Subject|1|||
164564698|NCT04451330|594436331|FG000|Overall Study|Withdrawal by parent/guardian|1|||
164210532|NCT03980223|593138215|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
164210533|NCT03980223|593138216|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
164210534|NCT02460289|593138220|FG000|Overall Study|Adverse Event|1|||
164210535|NCT02460289|593138220|FG000|Overall Study|Withdrawal by Subject|8|||
164210536|NCT02460289|593138220|FG000|Overall Study|Lost to Follow-up|1|||
164210537|NCT01155570|593138221|FG000|Overall Study|Adverse Event|39|||
164210538|NCT01155570|593138221|FG000|Overall Study|Lack of Efficacy|46|||
164210539|NCT01155570|593138221|FG000|Overall Study|Participant's Economic Reasons|17|||
164564699|NCT04451330|594436332|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164210540|NCT01155570|593138221|FG000|Overall Study|No Hospital Visits|7|||
164564700|NCT04451330|594436331|FG000|Overall Study|Other than specified|0|||
164564701|NCT04451330|594436332|FG001|Overall Study|Other than specified|1|||
164210541|NCT01155570|593138221|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
164210542|NCT01155570|593138221|FG000|Overall Study|Adverse Event + Other Reasons|7|||
164210543|NCT01155570|593138221|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
164210544|NCT01155570|593138221|FG000|Overall Study|Other Reasons|23|||
164210545|NCT01922934|593138222|FG000|Eligible Patients|Death|0|||
164210546|NCT01922934|593138223|FG001|Eligible Patients|Death|7|||
164210547|NCT01922934|593138222|FG000|Eligible Patients|Physician Decision|17|||
164210548|NCT01922934|593138223|FG001|Eligible Patients|Physician Decision|0|||
164210549|NCT01922934|593138222|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
164210550|NCT01922934|593138223|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
164210551|NCT01922934|593138222|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
164210552|NCT01922934|593138223|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
164210553|NCT01922934|593138222|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
164210554|NCT01922934|593138223|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
164210555|NCT01922934|593138222|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
164210556|NCT01922934|593138223|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
164210557|NCT02916927|593138224|FG000|Overall Study|Discharged prior to study drug receipt|0|||
164210558|NCT02916927|593138225|FG001|Overall Study|Discharged prior to study drug receipt|2|||
164210559|NCT02916927|593138224|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
164210560|NCT02916927|593138225|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
164210561|NCT02916927|593138224|FG000|Overall Study|Withdrawal before first time point|1|||
164210562|NCT02916927|593138225|FG001|Overall Study|Withdrawal before first time point|0|||
164210563|NCT02774889|593138228|FG000|Overall Study|Lost to Follow-up|2|||
164210564|NCT02774889|593138229|FG001|Overall Study|Lost to Follow-up|1|||
164210565|NCT01020123|593138230|FG000|Main Period|Withdrawal by Subject|6|||
164210566|NCT01020123|593138231|FG001|Main Period|Withdrawal by Subject|5|||
164210567|NCT01020123|593138232|FG002|Main Period|Withdrawal by Subject|3|||
164210568|NCT01020123|593138233|FG003|Main Period|Withdrawal by Subject|1|||
164210569|NCT01020123|593138234|FG004|Main Period|Withdrawal by Subject|6|||
164210570|NCT01020123|593138235|FG005|Main Period|Withdrawal by Subject|3|||
164210571|NCT01020123|593138236|FG006|Main Period|Withdrawal by Subject|2|||
164210572|NCT01020123|593138230|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
164210573|NCT01020123|593138231|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
164210574|NCT01020123|593138232|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
164210575|NCT01020123|593138233|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
164210576|NCT01020123|593138234|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
164210577|NCT01020123|593138235|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
164210578|NCT01020123|593138236|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
164210579|NCT01020123|593138230|FG000|Main Period|Adverse Event|5|||
164210580|NCT01020123|593138231|FG001|Main Period|Adverse Event|2|||
164210581|NCT01020123|593138232|FG002|Main Period|Adverse Event|2|||
164210582|NCT01020123|593138233|FG003|Main Period|Adverse Event|1|||
164210583|NCT01020123|593138234|FG004|Main Period|Adverse Event|1|||
164210584|NCT01020123|593138235|FG005|Main Period|Adverse Event|2|||
164210585|NCT01020123|593138236|FG006|Main Period|Adverse Event|1|||
164210586|NCT01020123|593138230|FG000|Main Period|Protocol Violation|4|||
164210587|NCT01020123|593138231|FG001|Main Period|Protocol Violation|4|||
164210588|NCT01020123|593138232|FG002|Main Period|Protocol Violation|2|||
164210589|NCT01020123|593138233|FG003|Main Period|Protocol Violation|5|||
164210590|NCT01020123|593138234|FG004|Main Period|Protocol Violation|2|||
164210591|NCT01020123|593138235|FG005|Main Period|Protocol Violation|3|||
164210592|NCT01020123|593138236|FG006|Main Period|Protocol Violation|2|||
164210593|NCT01020123|593138230|FG000|Main Period|Lost to Follow-up|0|||
164210594|NCT01020123|593138231|FG001|Main Period|Lost to Follow-up|2|||
164210595|NCT01020123|593138232|FG002|Main Period|Lost to Follow-up|0|||
164324397|NCT04393298|593565167|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164324398|NCT04393298|593565168|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164324399|NCT04393298|593565169|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164210596|NCT01020123|593138233|FG003|Main Period|Lost to Follow-up|0|||
164210597|NCT01020123|593138234|FG004|Main Period|Lost to Follow-up|0|||
164210598|NCT01020123|593138235|FG005|Main Period|Lost to Follow-up|0|||
164210599|NCT01020123|593138236|FG006|Main Period|Lost to Follow-up|0|||
164210600|NCT01020123|593138230|FG000|Main Period|Unclasified|2|||
164564702|NCT05099640|594436333|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
164210601|NCT01020123|593138231|FG001|Main Period|Unclasified|0|||
164210602|NCT01020123|593138232|FG002|Main Period|Unclasified|1|||
164210603|NCT01020123|593138233|FG003|Main Period|Unclasified|0|||
164210604|NCT01020123|593138234|FG004|Main Period|Unclasified|1|||
164210605|NCT01020123|593138235|FG005|Main Period|Unclasified|3|||
164210606|NCT01020123|593138236|FG006|Main Period|Unclasified|6|||
164210607|NCT01020123|593138230|FG000|Extention Period|Withdrawal by Subject|2|||
164324400|NCT04393298|593565170|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164324401|NCT04393298|593565171|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164210608|NCT01020123|593138231|FG001|Extention Period|Withdrawal by Subject|1|||
164210609|NCT01020123|593138232|FG002|Extention Period|Withdrawal by Subject|1|||
164210610|NCT01020123|593138233|FG003|Extention Period|Withdrawal by Subject|0|||
164210611|NCT01020123|593138234|FG004|Extention Period|Withdrawal by Subject|0|||
164210612|NCT01020123|593138235|FG005|Extention Period|Withdrawal by Subject|0|||
164210613|NCT01020123|593138236|FG006|Extention Period|Withdrawal by Subject|0|||
164210614|NCT01020123|593138230|FG000|Extention Period|Adverse Event|0|||
164210615|NCT01020123|593138231|FG001|Extention Period|Adverse Event|0|||
164210616|NCT01020123|593138232|FG002|Extention Period|Adverse Event|0|||
164210617|NCT01020123|593138233|FG003|Extention Period|Adverse Event|1|||
164210618|NCT01020123|593138234|FG004|Extention Period|Adverse Event|0|||
164210619|NCT01020123|593138235|FG005|Extention Period|Adverse Event|0|||
164210620|NCT01020123|593138236|FG006|Extention Period|Adverse Event|0|||
164210621|NCT01020123|593138230|FG000|Extention Period|Protocol Violation|1|||
164210622|NCT01020123|593138231|FG001|Extention Period|Protocol Violation|1|||
164210623|NCT01020123|593138232|FG002|Extention Period|Protocol Violation|1|||
164210624|NCT01020123|593138233|FG003|Extention Period|Protocol Violation|0|||
164210625|NCT01020123|593138234|FG004|Extention Period|Protocol Violation|0|||
164210626|NCT01020123|593138235|FG005|Extention Period|Protocol Violation|0|||
164210627|NCT01020123|593138236|FG006|Extention Period|Protocol Violation|1|||
164210628|NCT01020123|593138230|FG000|Extention Period|Lost to Follow-up|0|||
164210629|NCT01020123|593138231|FG001|Extention Period|Lost to Follow-up|0|||
164210630|NCT01020123|593138232|FG002|Extention Period|Lost to Follow-up|0|||
164210631|NCT01020123|593138233|FG003|Extention Period|Lost to Follow-up|0|||
164210632|NCT01020123|593138234|FG004|Extention Period|Lost to Follow-up|0|||
164210633|NCT01020123|593138235|FG005|Extention Period|Lost to Follow-up|2|||
164210634|NCT01020123|593138236|FG006|Extention Period|Lost to Follow-up|0|||
164210635|NCT01349595|593138237|FG000|Overall Study|Lack of funding|2|||
164210636|NCT01349595|593138238|FG001|Overall Study|Lack of funding|2|||
164210637|NCT01069939|593138239|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
164210638|NCT01069939|593138240|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
164210639|NCT01069939|593138239|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
164210640|NCT01069939|593138240|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
164210641|NCT01069939|593138239|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
164210642|NCT01069939|593138240|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
164210643|NCT01069939|593138239|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
164210644|NCT01069939|593138240|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
164210645|NCT01069939|593138239|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
164210646|NCT01069939|593138240|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
164210647|NCT01069939|593138239|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
164210648|NCT01069939|593138240|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
164210649|NCT01069939|593138239|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
164210650|NCT01069939|593138240|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
164210651|NCT01069939|593138239|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
164210652|NCT01069939|593138240|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
164210653|NCT01069939|593138239|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
164210654|NCT01069939|593138240|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
164210655|NCT01069939|593138239|FG000|Randomised and Included in the Analyses|Removal|1|||
164210656|NCT01069939|593138240|FG001|Randomised and Included in the Analyses|Removal|0|||
164210657|NCT00658528|593138241|FG000|Overall Study|Adverse Event|5|||
164210658|NCT00658528|593138242|FG001|Overall Study|Adverse Event|7|||
164210659|NCT00658528|593138241|FG000|Overall Study|Lost to Follow-up|14|||
164210660|NCT00658528|593138242|FG001|Overall Study|Lost to Follow-up|22|||
164210661|NCT00658528|593138241|FG000|Overall Study|Withdrawal by Subject|8|||
164210662|NCT00658528|593138242|FG001|Overall Study|Withdrawal by Subject|6|||
164324402|NCT04393298|593565172|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164210663|NCT00658528|593138241|FG000|Overall Study|Withdrawal of consent|5|||
164210664|NCT00658528|593138242|FG001|Overall Study|Withdrawal of consent|6|||
164210665|NCT00658528|593138241|FG000|Overall Study|Other|8|||
164210666|NCT00658528|593138242|FG001|Overall Study|Other|4|||
164210667|NCT01706328|593138251|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
164210668|NCT01706328|593138252|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
164210669|NCT01706328|593138253|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
164324403|NCT04393298|593565173|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164324404|NCT04393298|593565159|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324405|NCT04393298|593565160|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324406|NCT04393298|593565161|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
164210670|NCT01706328|593138251|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
164210671|NCT01706328|593138252|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
164210672|NCT01706328|593138253|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
164210673|NCT01706328|593138251|FG000|2-week Run-in Period|Physician Decision|4|||
164210674|NCT01706328|593138252|FG001|2-week Run-in Period|Physician Decision|0|||
164210675|NCT01706328|593138253|FG002|2-week Run-in Period|Physician Decision|0|||
164210676|NCT01706328|593138251|FG000|2-week Run-in Period|Adverse Event|4|||
164210677|NCT01706328|593138252|FG001|2-week Run-in Period|Adverse Event|0|||
164210678|NCT01706328|593138253|FG002|2-week Run-in Period|Adverse Event|0|||
164210679|NCT01706328|593138251|FG000|2-week Run-in Period|Lost to Follow-up|2|||
164210680|NCT01706328|593138252|FG001|2-week Run-in Period|Lost to Follow-up|0|||
164210681|NCT01706328|593138253|FG002|2-week Run-in Period|Lost to Follow-up|0|||
164210682|NCT01706328|593138251|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
164210683|NCT01706328|593138252|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
164210684|NCT01706328|593138253|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
164210685|NCT01706328|593138251|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
164210686|NCT01706328|593138252|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
164210687|NCT01706328|593138253|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
164210688|NCT01706328|593138251|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
164210689|NCT01706328|593138252|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
164210690|NCT01706328|593138253|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
164210691|NCT01706328|593138251|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
164210692|NCT01706328|593138252|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
164210693|NCT01706328|593138253|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
164210694|NCT01706328|593138251|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
164210695|NCT01706328|593138252|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
164210696|NCT01706328|593138253|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
164210697|NCT01706328|593138251|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
164210698|NCT01706328|593138252|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
164210699|NCT01706328|593138253|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
164210700|NCT01706328|593138251|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
164210701|NCT01706328|593138252|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
164210702|NCT01706328|593138253|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
164210703|NCT04603066|593138255|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
164210704|NCT04603066|593138256|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
164210705|NCT05759338|593138257|FG000|Overall Study|Withdrawal by Subject|3|||
164210706|NCT04409002|593138258|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
164210707|NCT06481579|593138259|FG000|Overall Study|Death|1|||
164210708|NCT06481579|593138260|FG001|Overall Study|Death|0|||
164210709|NCT06481579|593138259|FG000|Overall Study|Withdrawal by Subject|3|||
164210710|NCT06481579|593138260|FG001|Overall Study|Withdrawal by Subject|0|||
164210711|NCT06481579|593138259|FG000|Overall Study|Other|1|||
164210712|NCT06481579|593138260|FG001|Overall Study|Other|1|||
164210713|NCT04611126|593138261|FG000|Overall Study|TIL expansion unsuccessful|1|||
164210714|NCT04611126|593138262|FG001|Overall Study|TIL expansion unsuccessful|0|||
164324407|NCT04393298|593565162|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324408|NCT04393298|593565163|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324409|NCT04393298|593565164|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324410|NCT04393298|593565165|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324411|NCT04393298|593565166|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324412|NCT04393298|593565167|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324413|NCT04393298|593565168|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324414|NCT04393298|593565169|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324415|NCT04393298|593565170|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324416|NCT04393298|593565171|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324417|NCT04393298|593565172|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
164420669|NCT01154036|593910968|FG006|Phase II|Adverse Event|1|||
164210715|NCT05260008|593138263|FG000|Overall Study|Physician Decision|0|||
164210716|NCT05260008|593138264|FG001|Overall Study|Physician Decision|1|||
164210717|NCT05260008|593138265|FG002|Overall Study|Physician Decision|0|||
164210718|NCT05260008|593138266|FG003|Overall Study|Physician Decision|0|||
164210719|NCT01157845|593138269|FG000|Overall Study|Lost to Follow-up|5|||
164210720|NCT01157845|593138269|FG000|Overall Study|Withdrawal by Subject|12|||
164210721|NCT01157845|593138269|FG000|Overall Study|Physician Decision|3|||
164210722|NCT01157845|593138269|FG000|Overall Study|Protocol Violation|13|||
164210723|NCT01157845|593138269|FG000|Overall Study|Study was ended|1|||
164210724|NCT01157845|593138269|FG000|Overall Study|Device malfunction|1|||
164210725|NCT04584788|593138270|FG000|Overall Study|Physician Decision|8|||
164210726|NCT04584788|593138270|FG000|Overall Study|Withdrawal by Subject|1|||
164210727|NCT04584788|593138270|FG000|Overall Study|Adverse Event|3|||
164210728|NCT03311555|593138271|FG000|Overall Study|Adverse Event|1|||
164210729|NCT04284774|593138277|FG000|Overall Study|Progressive disease|5|||
164210730|NCT01240746|593140211|FG000|Overall Study|Adverse Event|2|||
164210731|NCT01240746|593140212|FG001|Overall Study|Adverse Event|0|||
164210732|NCT01240746|593140213|FG002|Overall Study|Adverse Event|10|||
164210733|NCT01240746|593140211|FG000|Overall Study|Lost to Follow-up|23|||
164210734|NCT01240746|593140212|FG001|Overall Study|Lost to Follow-up|20|||
164210735|NCT01240746|593140213|FG002|Overall Study|Lost to Follow-up|102|||
164210736|NCT01240746|593140211|FG000|Overall Study|Protocol Violation|24|||
164210737|NCT01240746|593140212|FG001|Overall Study|Protocol Violation|15|||
164210738|NCT01240746|593140213|FG002|Overall Study|Protocol Violation|72|||
164210739|NCT01240746|593140211|FG000|Overall Study|Withdrawal by Subject|10|||
164210740|NCT01240746|593140212|FG001|Overall Study|Withdrawal by Subject|13|||
164210741|NCT01240746|593140213|FG002|Overall Study|Withdrawal by Subject|59|||
164210742|NCT01136954|593140214|FG000|Overall Study|Adverse Event|3|||
164210743|NCT01136954|593140215|FG001|Overall Study|Adverse Event|2|||
164210744|NCT01136954|593140214|FG000|Overall Study|Withdrawal by Subject|6|||
164210745|NCT01136954|593140215|FG001|Overall Study|Withdrawal by Subject|2|||
164210746|NCT01136954|593140214|FG000|Overall Study|Lack of Efficacy|14|||
164210747|NCT01136954|593140215|FG001|Overall Study|Lack of Efficacy|13|||
164210748|NCT01136954|593140214|FG000|Overall Study|Physician Decision|0|||
164210749|NCT01136954|593140215|FG001|Overall Study|Physician Decision|1|||
164210750|NCT01136954|593140214|FG000|Overall Study|Other|1|||
164210751|NCT01136954|593140215|FG001|Overall Study|Other|3|||
164210752|NCT04190225|593140232|FG000|Overall Study|Lost to Follow-up|2|||
164210753|NCT04190225|593140233|FG001|Overall Study|Lost to Follow-up|3|||
164210754|NCT04190225|593140232|FG000|Overall Study|Withdrawal by Subject|3|||
164210755|NCT04190225|593140233|FG001|Overall Study|Withdrawal by Subject|2|||
164210756|NCT04190225|593140232|FG000|Overall Study|Unrelated health condition|2|||
164210757|NCT04190225|593140233|FG001|Overall Study|Unrelated health condition|0|||
164210758|NCT01732783|593140236|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
164210759|NCT01732783|593140237|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
164210760|NCT01732783|593140238|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
164210761|NCT01732783|593140236|FG000|Overall Study|Death|13|||
164210762|NCT01732783|593140237|FG001|Overall Study|Death|4|||
164210763|NCT01732783|593140238|FG002|Overall Study|Death|1|||
164210764|NCT01732783|593140236|FG000|Overall Study|Lost to Follow-up|7|||
164210765|NCT01732783|593140237|FG001|Overall Study|Lost to Follow-up|1|||
164210766|NCT01732783|593140238|FG002|Overall Study|Lost to Follow-up|1|||
164210767|NCT01732783|593140236|FG000|Overall Study|Administrative Decision|8|||
164210768|NCT01732783|593140237|FG001|Overall Study|Administrative Decision|2|||
164210769|NCT01732783|593140238|FG002|Overall Study|Administrative Decision|1|||
164210770|NCT01732783|593140236|FG000|Overall Study|Withdrawal by Subject|1|||
164210771|NCT01732783|593140237|FG001|Overall Study|Withdrawal by Subject|0|||
164210772|NCT01732783|593140238|FG002|Overall Study|Withdrawal by Subject|0|||
164210773|NCT04429971|593140239|FG000|Overall Study|Lost to Follow-up|7|||
164210774|NCT04429971|593140240|FG001|Overall Study|Lost to Follow-up|8|||
164210775|NCT03331562|593140241|FG000|Overall Study|Adverse Event|2|||
164210776|NCT03331562|593140242|FG001|Overall Study|Adverse Event|0|||
164210777|NCT03331562|593140241|FG000|Overall Study|Death|1|||
164210778|NCT03331562|593140242|FG001|Overall Study|Death|0|||
164210779|NCT03718000|593140250|FG000|Overall Study|Relocation|2|||
164210780|NCT03718000|593140251|FG001|Overall Study|Relocation|4|||
164210781|NCT03718000|593140250|FG000|Overall Study|Pregnancy|0|||
164324418|NCT04393298|593565173|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324419|NCT04393298|593565159|FG000|Overall Study|Progressive Disease (PD)|0|||
164668847|NCT02170688|594812049|FG003|Overall Study|Full dose not received|0|||
164210782|NCT03718000|593140251|FG001|Overall Study|Pregnancy|1|||
164210783|NCT05522751|593140257|FG000|Overall Study|Adverse Event|1|||
164210784|NCT04044690|593140259|FG000|Period 1|Lack of Efficacy|1|||
164210785|NCT04044690|593140260|FG001|Period 1|Lack of Efficacy|1|||
164210786|NCT04044690|593140259|FG000|Period 1|Adverse Event|4|||
164210787|NCT04044690|593140260|FG001|Period 1|Adverse Event|2|||
164324420|NCT04393298|593565160|FG001|Overall Study|Progressive Disease (PD)|0|||
164324421|NCT04393298|593565161|FG002|Overall Study|Progressive Disease (PD)|0|||
164324422|NCT04393298|593565162|FG003|Overall Study|Progressive Disease (PD)|3|||
164668848|NCT02170688|594812050|FG004|Overall Study|Full dose not received|0|||
164668849|NCT02170688|594812046|FG000|Overall Study|Physician Decision|0|||
164668850|NCT02170688|594812047|FG001|Overall Study|Physician Decision|0|||
164210788|NCT04044690|593140259|FG000|Period 1|Physician Decision|0|||
164210789|NCT04044690|593140260|FG001|Period 1|Physician Decision|1|||
164210790|NCT04044690|593140259|FG000|Period 1|Withdrawal by Subject|2|||
164210791|NCT04044690|593140260|FG001|Period 1|Withdrawal by Subject|5|||
164210792|NCT04044690|593140259|FG000|Period 1|Protocol Deviation|2|||
164324423|NCT04393298|593565163|FG004|Overall Study|Progressive Disease (PD)|0|||
164210793|NCT04044690|593140260|FG001|Period 1|Protocol Deviation|0|||
164210794|NCT04044690|593140259|FG000|Period 1|Site Terminated by Sponsor|0|||
164210795|NCT04044690|593140260|FG001|Period 1|Site Terminated by Sponsor|1|||
164210796|NCT04044690|593140259|FG000|Period 1|Study Terminated by Sponsor|0|||
164210797|NCT04044690|593140260|FG001|Period 1|Study Terminated by Sponsor|1|||
164210798|NCT04044690|593140259|FG000|Period 1|Death|1|||
164210799|NCT04044690|593140260|FG001|Period 1|Death|1|||
164210800|NCT04044690|593140259|FG000|Period 1|Other: Unspecified|1|||
164210801|NCT04044690|593140260|FG001|Period 1|Other: Unspecified|0|||
164210802|NCT04044690|593140259|FG000|Period 2|Lack of Efficacy|0|||
164210803|NCT04044690|593140260|FG001|Period 2|Lack of Efficacy|1|||
164210804|NCT04044690|593140259|FG000|Period 2|Adverse Event|0|||
164210805|NCT04044690|593140260|FG001|Period 2|Adverse Event|1|||
164210806|NCT04044690|593140259|FG000|Period 2|Physician Decision|0|||
164210807|NCT04044690|593140260|FG001|Period 2|Physician Decision|2|||
164210808|NCT04044690|593140259|FG000|Period 2|Withdrawal by Subject|5|||
164210809|NCT04044690|593140260|FG001|Period 2|Withdrawal by Subject|5|||
164210810|NCT04044690|593140259|FG000|Period 2|Lost to Follow-up|0|||
164210811|NCT04044690|593140260|FG001|Period 2|Lost to Follow-up|1|||
164210812|NCT04044690|593140259|FG000|Period 2|Site Terminated by Sponsor|1|||
164210813|NCT04044690|593140260|FG001|Period 2|Site Terminated by Sponsor|3|||
164210814|NCT04044690|593140259|FG000|Period 2|Study Terminated by Sponsor|8|||
164210815|NCT04044690|593140260|FG001|Period 2|Study Terminated by Sponsor|3|||
164210816|NCT04044690|593140259|FG000|Period 2|Death|1|||
164210817|NCT04044690|593140260|FG001|Period 2|Death|0|||
164210818|NCT04044690|593140259|FG000|Period 2|Other: Unspecified|1|||
164210819|NCT04044690|593140260|FG001|Period 2|Other: Unspecified|1|||
164210820|NCT04044690|593140259|FG000|Period 3|Site Terminated by Sponsor|1|||
164210821|NCT04044690|593140260|FG001|Period 3|Site Terminated by Sponsor|2|||
164210822|NCT04044690|593140259|FG000|Period 3|Study Terminated by Sponsor|24|||
164210823|NCT04044690|593140260|FG001|Period 3|Study Terminated by Sponsor|18|||
164210824|NCT04044690|593140259|FG000|Period 3|Missing|0|||
164210825|NCT04044690|593140260|FG001|Period 3|Missing|2|||
164210826|NCT01582451|593140266|FG000|Overall Study|Adverse Event|1|||
164210827|NCT01582451|593140267|FG001|Overall Study|Adverse Event|3|||
164210828|NCT01582451|593140266|FG000|Overall Study|Death|3|||
164210829|NCT01582451|593140267|FG001|Overall Study|Death|3|||
164210830|NCT01582451|593140266|FG000|Overall Study|Lost to Follow-up|0|||
164324424|NCT04393298|593565164|FG005|Overall Study|Progressive Disease (PD)|0|||
164324425|NCT04393298|593565165|FG006|Overall Study|Progressive Disease (PD)|0|||
164324426|NCT04393298|593565166|FG007|Overall Study|Progressive Disease (PD)|0|||
164324427|NCT04393298|593565167|FG008|Overall Study|Progressive Disease (PD)|0|||
164324428|NCT04393298|593565168|FG009|Overall Study|Progressive Disease (PD)|0|||
164324429|NCT04393298|593565169|FG010|Overall Study|Progressive Disease (PD)|0|||
164324430|NCT04393298|593565170|FG011|Overall Study|Progressive Disease (PD)|0|||
164324431|NCT04393298|593565171|FG012|Overall Study|Progressive Disease (PD)|0|||
164324432|NCT04393298|593565172|FG013|Overall Study|Progressive Disease (PD)|0|||
164324433|NCT04393298|593565173|FG014|Overall Study|Progressive Disease (PD)|0|||
164324434|NCT04393298|593565159|FG000|Overall Study|Started a New Cancer Treatment|0|||
164324435|NCT04393298|593565160|FG001|Overall Study|Started a New Cancer Treatment|0|||
164324436|NCT04393298|593565161|FG002|Overall Study|Started a New Cancer Treatment|0|||
164324437|NCT04393298|593565162|FG003|Overall Study|Started a New Cancer Treatment|0|||
164324438|NCT04393298|593565163|FG004|Overall Study|Started a New Cancer Treatment|1|||
164324439|NCT04393298|593565164|FG005|Overall Study|Started a New Cancer Treatment|0|||
164324440|NCT04393298|593565165|FG006|Overall Study|Started a New Cancer Treatment|0|||
164324441|NCT04393298|593565166|FG007|Overall Study|Started a New Cancer Treatment|0|||
164324442|NCT04393298|593565167|FG008|Overall Study|Started a New Cancer Treatment|0|||
164324443|NCT04393298|593565168|FG009|Overall Study|Started a New Cancer Treatment|0|||
164324444|NCT04393298|593565169|FG010|Overall Study|Started a New Cancer Treatment|0|||
164564703|NCT05099640|594436334|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
164564704|NCT05099640|594436335|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
164564705|NCT05099640|594436333|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
164564706|NCT05099640|594436334|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
164564707|NCT05099640|594436335|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
164564708|NCT05099640|594436333|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
164210831|NCT01582451|593140267|FG001|Overall Study|Lost to Follow-up|2|||
164210832|NCT01582451|593140266|FG000|Overall Study|Protocol Violation|11|||
164210833|NCT01582451|593140267|FG001|Overall Study|Protocol Violation|3|||
164324445|NCT04393298|593565170|FG011|Overall Study|Started a New Cancer Treatment|0|||
164210834|NCT01582451|593140266|FG000|Overall Study|Withdrawal by Subject|13|||
164210835|NCT01582451|593140267|FG001|Overall Study|Withdrawal by Subject|9|||
164210836|NCT01582451|593140266|FG000|Overall Study|Physician Decision|3|||
164210837|NCT01582451|593140267|FG001|Overall Study|Physician Decision|0|||
164324446|NCT04393298|593565171|FG012|Overall Study|Started a New Cancer Treatment|0|||
164324447|NCT04393298|593565172|FG013|Overall Study|Started a New Cancer Treatment|0|||
164420670|NCT01154036|593910969|FG007|Phase II|Adverse Event|1|||
164210838|NCT01582451|593140266|FG000|Overall Study|Sponsor Decision|1|||
164210839|NCT01582451|593140267|FG001|Overall Study|Sponsor Decision|0|||
164210840|NCT00716417|593140270|FG000|Overall Study|Adverse Event|0|||
164210841|NCT00716417|593140271|FG001|Overall Study|Adverse Event|0|||
164210842|NCT00716417|593140272|FG002|Overall Study|Adverse Event|2|||
164210843|NCT00716417|593140273|FG003|Overall Study|Adverse Event|1|||
164210844|NCT00716417|593140274|FG004|Overall Study|Adverse Event|0|||
164210845|NCT00716417|593140275|FG005|Overall Study|Adverse Event|0|||
164210846|NCT00716417|593140276|FG006|Overall Study|Adverse Event|3|||
164210847|NCT00716417|593140277|FG007|Overall Study|Adverse Event|1|||
164210848|NCT00716417|593140278|FG008|Overall Study|Adverse Event|0|||
164210849|NCT00716417|593140279|FG009|Overall Study|Adverse Event|3|||
164210850|NCT00716417|593140270|FG000|Overall Study|Withdrawal by Subject|0|||
164210851|NCT00716417|593140271|FG001|Overall Study|Withdrawal by Subject|1|||
164210852|NCT00716417|593140272|FG002|Overall Study|Withdrawal by Subject|0|||
164210853|NCT00716417|593140273|FG003|Overall Study|Withdrawal by Subject|2|||
164210854|NCT00716417|593140274|FG004|Overall Study|Withdrawal by Subject|0|||
164210855|NCT00716417|593140275|FG005|Overall Study|Withdrawal by Subject|0|||
164210856|NCT00716417|593140276|FG006|Overall Study|Withdrawal by Subject|1|||
164210857|NCT00716417|593140277|FG007|Overall Study|Withdrawal by Subject|0|||
164210858|NCT00716417|593140278|FG008|Overall Study|Withdrawal by Subject|0|||
164210859|NCT00716417|593140279|FG009|Overall Study|Withdrawal by Subject|0|||
164210860|NCT00716417|593140270|FG000|Overall Study|Progressive disease|3|||
164210861|NCT00716417|593140271|FG001|Overall Study|Progressive disease|5|||
164210862|NCT00716417|593140272|FG002|Overall Study|Progressive disease|3|||
164210863|NCT00716417|593140273|FG003|Overall Study|Progressive disease|8|||
164210864|NCT00716417|593140274|FG004|Overall Study|Progressive disease|0|||
164210865|NCT00716417|593140275|FG005|Overall Study|Progressive disease|3|||
164210866|NCT00716417|593140276|FG006|Overall Study|Progressive disease|3|||
164210867|NCT00716417|593140277|FG007|Overall Study|Progressive disease|1|||
164210868|NCT00716417|593140278|FG008|Overall Study|Progressive disease|5|||
164210869|NCT00716417|593140279|FG009|Overall Study|Progressive disease|0|||
164210870|NCT00716417|593140270|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
164210871|NCT00716417|593140271|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
164210872|NCT00716417|593140272|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
164210873|NCT00716417|593140273|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
164210874|NCT00716417|593140274|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
164210875|NCT00716417|593140275|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
164210876|NCT00716417|593140276|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
164210877|NCT00716417|593140277|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
164210878|NCT00716417|593140278|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
164210879|NCT00716417|593140279|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
164210880|NCT00716417|593140270|FG000|Overall Study|On patient request due to toxicities|0|||
164210881|NCT00716417|593140271|FG001|Overall Study|On patient request due to toxicities|0|||
164210882|NCT00716417|593140272|FG002|Overall Study|On patient request due to toxicities|0|||
164210883|NCT00716417|593140273|FG003|Overall Study|On patient request due to toxicities|0|||
164210884|NCT00716417|593140274|FG004|Overall Study|On patient request due to toxicities|0|||
164210885|NCT00716417|593140275|FG005|Overall Study|On patient request due to toxicities|0|||
164210886|NCT00716417|593140276|FG006|Overall Study|On patient request due to toxicities|0|||
164210887|NCT00716417|593140277|FG007|Overall Study|On patient request due to toxicities|1|||
164210888|NCT00716417|593140278|FG008|Overall Study|On patient request due to toxicities|0|||
164210889|NCT00716417|593140279|FG009|Overall Study|On patient request due to toxicities|0|||
164210890|NCT00487188|593140280|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
164210891|NCT00487188|593140281|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
164210892|NCT00487188|593140282|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
164210893|NCT00487188|593140280|FG000|Induction Phase|Adverse Event|5|||
164210894|NCT00487188|593140281|FG001|Induction Phase|Adverse Event|0|||
164210895|NCT00487188|593140282|FG002|Induction Phase|Adverse Event|0|||
164210896|NCT00487188|593140280|FG000|Induction Phase|Lack of Efficacy|0|||
164210897|NCT00487188|593140281|FG001|Induction Phase|Lack of Efficacy|1|||
164210898|NCT00487188|593140282|FG002|Induction Phase|Lack of Efficacy|0|||
164210899|NCT00487188|593140280|FG000|Induction Phase|Protocol Violation|1|||
164210900|NCT00487188|593140281|FG001|Induction Phase|Protocol Violation|0|||
164210901|NCT00487188|593140282|FG002|Induction Phase|Protocol Violation|0|||
164324448|NCT04393298|593565173|FG014|Overall Study|Started a New Cancer Treatment|0|||
164564709|NCT05099640|594436334|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
164564710|NCT05099640|594436335|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
164210902|NCT00487188|593140280|FG000|Induction Phase|Refused Treatment|1|||
164210903|NCT00487188|593140281|FG001|Induction Phase|Refused Treatment|2|||
164210904|NCT00487188|593140282|FG002|Induction Phase|Refused Treatment|0|||
164210905|NCT00487188|593140280|FG000|Induction Phase|Lost to Follow-up|2|||
164210906|NCT00487188|593140281|FG001|Induction Phase|Lost to Follow-up|2|||
164210907|NCT00487188|593140282|FG002|Induction Phase|Lost to Follow-up|0|||
164210908|NCT00487188|593140280|FG000|Induction Phase|Administrative|0|||
164210909|NCT00487188|593140281|FG001|Induction Phase|Administrative|1|||
164210910|NCT00487188|593140282|FG002|Induction Phase|Administrative|0|||
164210911|NCT00487188|593140280|FG000|Maintenance Phase|Adverse Event|1|||
164210912|NCT00487188|593140281|FG001|Maintenance Phase|Adverse Event|0|||
164210913|NCT00487188|593140282|FG002|Maintenance Phase|Adverse Event|0|||
164210914|NCT00487188|593140280|FG000|Maintenance Phase|Death|1|||
164210915|NCT00487188|593140281|FG001|Maintenance Phase|Death|0|||
164210916|NCT00487188|593140282|FG002|Maintenance Phase|Death|0|||
164210917|NCT00487188|593140280|FG000|Maintenance Phase|Lost to Follow-up|1|||
164210918|NCT00487188|593140281|FG001|Maintenance Phase|Lost to Follow-up|0|||
164210919|NCT00487188|593140282|FG002|Maintenance Phase|Lost to Follow-up|0|||
164210920|NCT00487188|593140280|FG000|Maintenance Phase|Administrative|0|||
164210921|NCT00487188|593140281|FG001|Maintenance Phase|Administrative|0|||
164210922|NCT00487188|593140282|FG002|Maintenance Phase|Administrative|1|||
164210923|NCT03881371|593140283|FG000|Overall Study|Adverse Event|8|||
164210924|NCT03881371|593140284|FG001|Overall Study|Adverse Event|9|||
164210925|NCT03881371|593140283|FG000|Overall Study|Death|1|||
164210926|NCT03881371|593140284|FG001|Overall Study|Death|0|||
164210927|NCT03881371|593140283|FG000|Overall Study|Lost to Follow-up|1|||
164210928|NCT03881371|593140284|FG001|Overall Study|Lost to Follow-up|0|||
164210929|NCT03881371|593140283|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164210930|NCT03881371|593140284|FG001|Overall Study|Non-Compliance with Study Drug|2|||
164324449|NCT04393298|593565159|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324450|NCT04393298|593565160|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324451|NCT04393298|593565161|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324452|NCT04393298|593565162|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324453|NCT04393298|593565163|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
164324454|NCT04393298|593565164|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324455|NCT04393298|593565165|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324456|NCT04393298|593565166|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324457|NCT04393298|593565167|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324458|NCT04393298|593565168|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324459|NCT04393298|593565169|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324460|NCT04393298|593565170|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324461|NCT04393298|593565171|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324462|NCT04393298|593565172|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324463|NCT04393298|593565173|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324464|NCT04393298|593565159|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324465|NCT04393298|593565160|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324466|NCT04393298|593565161|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324467|NCT04393298|593565162|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324468|NCT04393298|593565163|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324469|NCT04393298|593565164|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
164324470|NCT04393298|593565165|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324471|NCT04393298|593565166|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324472|NCT04393298|593565167|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324473|NCT04393298|593565168|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324474|NCT04393298|593565169|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324475|NCT04393298|593565170|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324476|NCT04393298|593565171|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324477|NCT04393298|593565172|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324478|NCT04393298|593565173|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324479|NCT04393298|593565159|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
164324480|NCT04393298|593565160|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
164324481|NCT04393298|593565161|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
164324482|NCT04393298|593565162|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
164324483|NCT04393298|593565163|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
164564711|NCT05099640|594436333|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
164210931|NCT03881371|593140283|FG000|Overall Study|Physician Decision|3|||
164210932|NCT03881371|593140284|FG001|Overall Study|Physician Decision|3|||
164324484|NCT04393298|593565164|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
164324485|NCT04393298|593565165|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
164564712|NCT05099640|594436334|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
164564713|NCT05099640|594436335|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
164564714|NCT05099640|594436333|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
164564715|NCT05099640|594436334|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
164564716|NCT05099640|594436335|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
164210933|NCT03881371|593140283|FG000|Overall Study|Withdrawal by Subject|2|||
164210934|NCT03881371|593140284|FG001|Overall Study|Withdrawal by Subject|10|||
164210935|NCT03881371|593140283|FG000|Overall Study|Discontinuation from Study|1|||
164210936|NCT03881371|593140284|FG001|Overall Study|Discontinuation from Study|0|||
164210937|NCT05376358|593140290|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
164324486|NCT04393298|593565166|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
164668851|NCT02170688|594812048|FG002|Overall Study|Physician Decision|1|||
164210938|NCT05376358|593140291|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
164210939|NCT05376358|593140290|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
164210940|NCT05376358|593140291|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
164210941|NCT05376358|593140290|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
164210942|NCT05376358|593140291|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
164210943|NCT05376358|593140290|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
164210944|NCT05376358|593140291|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
164210945|NCT05376358|593140290|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
164210946|NCT05376358|593140291|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
164210947|NCT05376358|593140290|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
164210948|NCT05376358|593140291|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
164210949|NCT04225832|593140292|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
164210950|NCT04225832|593140293|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
164210951|NCT04225832|593140292|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
164210952|NCT04225832|593140293|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
164210953|NCT00311168|593140294|FG000|First Intervention|Withdrawal by Subject|2|||
164210954|NCT00311168|593140295|FG001|First Intervention|Withdrawal by Subject|2|||
164210955|NCT00311168|593140294|FG000|First Intervention|Lost to Follow-up|1|||
164210956|NCT00311168|593140295|FG001|First Intervention|Lost to Follow-up|1|||
164210957|NCT00311168|593140294|FG000|First Intervention|Protocol Violation|1|||
164210958|NCT00311168|593140295|FG001|First Intervention|Protocol Violation|1|||
164210959|NCT00311168|593140294|FG000|First Intervention|Adverse Event|1|||
164210960|NCT00311168|593140295|FG001|First Intervention|Adverse Event|0|||
164210961|NCT00311168|593140294|FG000|First Intervention|Other|2|||
164210962|NCT00311168|593140295|FG001|First Intervention|Other|2|||
164210963|NCT00311168|593140294|FG000|Second Intervention|Lost to Follow-up|9|||
164210964|NCT00311168|593140295|FG001|Second Intervention|Lost to Follow-up|2|||
164210965|NCT00311168|593140294|FG000|Second Intervention|Withdrawal by Subject|0|||
164210966|NCT00311168|593140295|FG001|Second Intervention|Withdrawal by Subject|1|||
164210967|NCT00311168|593140294|FG000|Second Intervention|Other|1|||
164210968|NCT00311168|593140295|FG001|Second Intervention|Other|1|||
164210969|NCT05472142|593140296|FG000|Total Participants|Lost to Follow-up|312|||
164210970|NCT05472142|593140297|FG001|Total Participants|Lost to Follow-up|0|||
164210971|NCT05472142|593140296|FG000|Clinic Patients|Lost to Follow-up|312|||
164210972|NCT05472142|593140297|FG001|Clinic Patients|Lost to Follow-up|0|||
164210973|NCT02452190|593140298|FG000|Overall Study|Withdrawal by Sponsor|1|||
164324487|NCT04393298|593565167|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
164324488|NCT04393298|593565168|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
164324489|NCT04393298|593565169|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
164324490|NCT04393298|593565170|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
164324491|NCT04393298|593565171|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
164324492|NCT04393298|593565172|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
164324493|NCT04393298|593565173|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
164324494|NCT04393298|593565159|FG000|Overall Study|Death|0|||
164324495|NCT04393298|593565160|FG001|Overall Study|Death|0|||
164324496|NCT04393298|593565161|FG002|Overall Study|Death|0|||
164324497|NCT04393298|593565162|FG003|Overall Study|Death|0|||
164324498|NCT04393298|593565163|FG004|Overall Study|Death|0|||
164324499|NCT04393298|593565164|FG005|Overall Study|Death|1|||
164324500|NCT04393298|593565165|FG006|Overall Study|Death|1|||
164324501|NCT04393298|593565166|FG007|Overall Study|Death|0|||
164324502|NCT04393298|593565167|FG008|Overall Study|Death|1|||
164324503|NCT04393298|593565168|FG009|Overall Study|Death|1|||
164324504|NCT04393298|593565169|FG010|Overall Study|Death|0|||
164324505|NCT04393298|593565170|FG011|Overall Study|Death|1|||
164324506|NCT04393298|593565171|FG012|Overall Study|Death|1|||
164324507|NCT04393298|593565172|FG013|Overall Study|Death|0|||
164324508|NCT04393298|593565173|FG014|Overall Study|Death|1|||
164324509|NCT04393298|593565159|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324510|NCT04393298|593565160|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324511|NCT04393298|593565161|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164564717|NCT05099640|594436333|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
164564718|NCT05099640|594436334|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
164668852|NCT02170688|594812049|FG003|Overall Study|Physician Decision|0|||
164324512|NCT04393298|593565162|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324513|NCT04393298|593565163|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324514|NCT04393298|593565164|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
164420671|NCT01154036|593910962|FG000|Phase II|Physician Decision|0|||
164210974|NCT02452190|593140299|FG001|Overall Study|Withdrawal by Sponsor|3|||
164210975|NCT02452190|593140298|FG000|Overall Study|Pregnancy|1|||
164210976|NCT02452190|593140299|FG001|Overall Study|Pregnancy|0|||
164210977|NCT02452190|593140298|FG000|Overall Study|Investigator's Decision|2|||
164210978|NCT02452190|593140299|FG001|Overall Study|Investigator's Decision|0|||
164210979|NCT02452190|593140298|FG000|Overall Study|Lack of Efficacy|3|||
164210980|NCT02452190|593140299|FG001|Overall Study|Lack of Efficacy|1|||
164210981|NCT02452190|593140298|FG000|Overall Study|Lost to Follow-up|4|||
164210982|NCT02452190|593140299|FG001|Overall Study|Lost to Follow-up|3|||
164210983|NCT02452190|593140298|FG000|Overall Study|Adverse Event|2|||
164210984|NCT02452190|593140299|FG001|Overall Study|Adverse Event|5|||
164210985|NCT02452190|593140298|FG000|Overall Study|Withdrawal by Subject|20|||
164210986|NCT02452190|593140299|FG001|Overall Study|Withdrawal by Subject|11|||
164210987|NCT02452190|593140298|FG000|Overall Study|Noncompliance with study drug|1|||
164210988|NCT02452190|593140299|FG001|Overall Study|Noncompliance with study drug|0|||
164210989|NCT02452190|593140298|FG000|Overall Study|Participant traveled abroad|1|||
164210990|NCT02452190|593140299|FG001|Overall Study|Participant traveled abroad|0|||
164210991|NCT02452190|593140298|FG000|Overall Study|Death|0|||
164210992|NCT02452190|593140299|FG001|Overall Study|Death|1|||
164210993|NCT06001021|593140302|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
164210994|NCT06001021|593140303|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
164210995|NCT06001021|593140304|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
164210996|NCT06001021|593140305|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
164210997|NCT06001021|593140306|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
164210998|NCT06001021|593140307|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
164210999|NCT06001021|593140308|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
164211000|NCT06001021|593140302|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
164211001|NCT06001021|593140303|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
164211002|NCT06001021|593140304|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
164211003|NCT06001021|593140305|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
164211004|NCT06001021|593140306|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
164211005|NCT06001021|593140307|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
164211006|NCT06001021|593140308|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
164211007|NCT03112603|593140311|FG000|End of Randomization Period|Lost to Follow-up|3|||
164211008|NCT03112603|593140312|FG001|End of Randomization Period|Lost to Follow-up|0|||
164211009|NCT03112603|593140313|FG002|End of Randomization Period|Lost to Follow-up|0|||
164211010|NCT03112603|593140311|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
164211011|NCT03112603|593140312|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
164211012|NCT03112603|593140313|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
164211013|NCT03112603|593140311|FG000|End of Randomization Period|Physician Decision|43|||
164211014|NCT03112603|593140312|FG001|End of Randomization Period|Physician Decision|18|||
164564719|NCT05099640|594436335|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
164564720|NCT00179959|594436336|FG000|Overall Study|Lost to Follow-up|3|||
164211015|NCT03112603|593140313|FG002|End of Randomization Period|Physician Decision|0|||
164211016|NCT03112603|593140311|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
164211017|NCT03112603|593140312|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
164211018|NCT03112603|593140313|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
164211019|NCT03112603|593140311|FG000|End of Randomization Period|Death|10|||
164564721|NCT00179959|594436337|FG001|Overall Study|Lost to Follow-up|1|||
164564722|NCT00179959|594436336|FG000|Overall Study|Withdrawal by Subject|3|||
164564723|NCT00179959|594436337|FG001|Overall Study|Withdrawal by Subject|2|||
164564724|NCT01552681|594436342|FG000|Overall Study|Withdrawal by Subject|4|||
164564725|NCT01552681|594436343|FG001|Overall Study|Withdrawal by Subject|0|||
164564726|NCT01552681|594436342|FG000|Overall Study|Physician Decision|1|||
164564727|NCT01552681|594436343|FG001|Overall Study|Physician Decision|0|||
164564728|NCT01552681|594436342|FG000|Overall Study|Subject moved away|0|||
164564729|NCT01552681|594436343|FG001|Overall Study|Subject moved away|1|||
164564730|NCT03075163|594436344|FG000|Overall Study|not eligible for treatment limb|138|||
164564731|NCT03075163|594436345|FG001|Overall Study|not eligible for treatment limb|138|||
164564732|NCT01299727|594436346|FG000|Overall Study|Withdrawal by Subject|1|||
164564733|NCT01299727|594436347|FG001|Overall Study|Withdrawal by Subject|0|||
164564734|NCT01299727|594436348|FG002|Overall Study|Withdrawal by Subject|0|||
164564735|NCT01299727|594436346|FG000|Overall Study|Adverse Event|0|||
164564736|NCT01299727|594436347|FG001|Overall Study|Adverse Event|0|||
164564737|NCT01299727|594436348|FG002|Overall Study|Adverse Event|1|||
164211020|NCT03112603|593140312|FG001|End of Randomization Period|Death|7|||
164211021|NCT03112603|593140313|FG002|End of Randomization Period|Death|0|||
164211022|NCT03112603|593140311|FG000|End of Randomization Period|Disease Relapse|12|||
164211023|NCT03112603|593140312|FG001|End of Randomization Period|Disease Relapse|7|||
164211024|NCT03112603|593140313|FG002|End of Randomization Period|Disease Relapse|0|||
164564738|NCT01299727|594436346|FG000|Overall Study|Completed the Treatment Period|3|||
164564739|NCT01299727|594436347|FG001|Overall Study|Completed the Treatment Period|4|||
164324515|NCT04393298|593565165|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324516|NCT04393298|593565166|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324517|NCT04393298|593565167|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324518|NCT04393298|593565168|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324519|NCT04393298|593565169|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324520|NCT04393298|593565170|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324521|NCT04393298|593565171|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324522|NCT04393298|593565172|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324523|NCT04393298|593565173|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324524|NCT04393298|593565159|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
164324525|NCT04393298|593565160|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
164324526|NCT04393298|593565161|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
164324527|NCT04393298|593565162|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
164324528|NCT04393298|593565163|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
164324529|NCT04393298|593565164|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
164324530|NCT04393298|593565165|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
164324531|NCT04393298|593565166|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
164324532|NCT04393298|593565167|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
164324533|NCT04393298|593565168|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
164324534|NCT04393298|593565169|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
164324535|NCT04393298|593565170|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
164324536|NCT04393298|593565171|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
164324537|NCT04393298|593565172|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
164324538|NCT04393298|593565173|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
164324539|NCT04393298|593565159|FG000|Overall Study|Patient Passed Away|0|||
164324540|NCT04393298|593565160|FG001|Overall Study|Patient Passed Away|0|||
164324541|NCT04393298|593565161|FG002|Overall Study|Patient Passed Away|0|||
164324542|NCT04393298|593565162|FG003|Overall Study|Patient Passed Away|0|||
164324543|NCT04393298|593565163|FG004|Overall Study|Patient Passed Away|0|||
164324544|NCT04393298|593565164|FG005|Overall Study|Patient Passed Away|0|||
164324545|NCT04393298|593565165|FG006|Overall Study|Patient Passed Away|0|||
164324546|NCT04393298|593565166|FG007|Overall Study|Patient Passed Away|1|||
164324547|NCT04393298|593565167|FG008|Overall Study|Patient Passed Away|0|||
164324548|NCT04393298|593565168|FG009|Overall Study|Patient Passed Away|0|||
164324549|NCT04393298|593565169|FG010|Overall Study|Patient Passed Away|0|||
164324550|NCT04393298|593565170|FG011|Overall Study|Patient Passed Away|0|||
164324551|NCT04393298|593565171|FG012|Overall Study|Patient Passed Away|0|||
164324552|NCT04393298|593565172|FG013|Overall Study|Patient Passed Away|0|||
164324553|NCT04393298|593565173|FG014|Overall Study|Patient Passed Away|0|||
164324554|NCT04393298|593565159|FG000|Overall Study|Patient Deceased|0|||
164324555|NCT04393298|593565160|FG001|Overall Study|Patient Deceased|0|||
164324556|NCT04393298|593565161|FG002|Overall Study|Patient Deceased|0|||
164324557|NCT04393298|593565162|FG003|Overall Study|Patient Deceased|0|||
164324558|NCT04393298|593565163|FG004|Overall Study|Patient Deceased|0|||
164324559|NCT04393298|593565164|FG005|Overall Study|Patient Deceased|0|||
164324560|NCT04393298|593565165|FG006|Overall Study|Patient Deceased|0|||
164324561|NCT04393298|593565166|FG007|Overall Study|Patient Deceased|1|||
164324562|NCT04393298|593565167|FG008|Overall Study|Patient Deceased|0|||
164324563|NCT04393298|593565168|FG009|Overall Study|Patient Deceased|0|||
164324564|NCT04393298|593565169|FG010|Overall Study|Patient Deceased|0|||
164324565|NCT04393298|593565170|FG011|Overall Study|Patient Deceased|0|||
164324566|NCT04393298|593565171|FG012|Overall Study|Patient Deceased|0|||
164324567|NCT04393298|593565172|FG013|Overall Study|Patient Deceased|0|||
164324568|NCT04393298|593565173|FG014|Overall Study|Patient Deceased|0|||
164324569|NCT04393298|593565159|FG000|Overall Study|Patient Discharged to Hospice|0|||
164324570|NCT04393298|593565160|FG001|Overall Study|Patient Discharged to Hospice|0|||
164324571|NCT04393298|593565161|FG002|Overall Study|Patient Discharged to Hospice|0|||
164324572|NCT04393298|593565162|FG003|Overall Study|Patient Discharged to Hospice|0|||
164668853|NCT02170688|594812050|FG004|Overall Study|Physician Decision|0|||
164668854|NCT02079532|594812053|FG000|Overall Study|Adverse Event|7|||
164668855|NCT02079532|594812053|FG000|Overall Study|Additional or changed therapy|2|||
164668856|NCT02079532|594812053|FG000|Overall Study|Lack of Efficacy|9|||
164324573|NCT04393298|593565163|FG004|Overall Study|Patient Discharged to Hospice|0|||
164324574|NCT04393298|593565164|FG005|Overall Study|Patient Discharged to Hospice|0|||
164668857|NCT02079532|594812053|FG000|Overall Study|Protocol Violation|3|||
164668858|NCT02079532|594812053|FG000|Overall Study|Withdrawal by Subject|1|||
164324575|NCT04393298|593565165|FG006|Overall Study|Patient Discharged to Hospice|0|||
164324576|NCT04393298|593565166|FG007|Overall Study|Patient Discharged to Hospice|0|||
164324577|NCT04393298|593565167|FG008|Overall Study|Patient Discharged to Hospice|1|||
164324578|NCT04393298|593565168|FG009|Overall Study|Patient Discharged to Hospice|0|||
164324579|NCT04393298|593565169|FG010|Overall Study|Patient Discharged to Hospice|0|||
164324580|NCT04393298|593565170|FG011|Overall Study|Patient Discharged to Hospice|0|||
164324581|NCT04393298|593565171|FG012|Overall Study|Patient Discharged to Hospice|0|||
164324582|NCT04393298|593565172|FG013|Overall Study|Patient Discharged to Hospice|0|||
164324583|NCT04393298|593565173|FG014|Overall Study|Patient Discharged to Hospice|0|||
164324584|NCT04393298|593565159|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324585|NCT04393298|593565160|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324586|NCT04393298|593565161|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324587|NCT04393298|593565162|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324588|NCT04393298|593565163|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324589|NCT04393298|593565164|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324590|NCT04393298|593565165|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324591|NCT04393298|593565166|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324592|NCT04393298|593565167|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324593|NCT04393298|593565168|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
164324594|NCT04393298|593565169|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324595|NCT04393298|593565170|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324596|NCT04393298|593565171|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324597|NCT04393298|593565172|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324598|NCT04393298|593565173|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324599|NCT04393298|593565159|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
164324600|NCT04393298|593565160|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
164324601|NCT04393298|593565161|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
164324602|NCT04393298|593565162|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
164324603|NCT04393298|593565163|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
164324604|NCT04393298|593565164|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
164324605|NCT04393298|593565165|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
164324606|NCT04393298|593565166|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
164324607|NCT04393298|593565167|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
164324608|NCT04393298|593565168|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
164324609|NCT04393298|593565169|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
164324610|NCT04393298|593565170|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
164324611|NCT04393298|593565171|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
164324612|NCT04393298|593565172|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
164324613|NCT04393298|593565173|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
164324614|NCT00807027|593565181|FG000|Overall Study|Withdrawal by Subject|13|||
164324615|NCT00807027|593565182|FG001|Overall Study|Withdrawal by Subject|14|||
164324616|NCT00807027|593565181|FG000|Overall Study|Protocol Violation|1|||
164324617|NCT00807027|593565182|FG001|Overall Study|Protocol Violation|1|||
164324618|NCT00807027|593565181|FG000|Overall Study|Adverse Event|2|||
164324619|NCT00807027|593565182|FG001|Overall Study|Adverse Event|2|||
164324620|NCT05660850|593565186|FG000|Treatment Period 2|Study Terminated by Sponsor|1|||
164324621|NCT05660850|593565187|FG001|Treatment Period 2|Study Terminated by Sponsor|0|||
164324622|NCT05660850|593565188|FG002|Treatment Period 2|Study Terminated by Sponsor|0|||
164324623|NCT05660850|593565189|FG003|Treatment Period 2|Study Terminated by Sponsor|0|||
164324624|NCT02604017|593565190|FG000|Overall Study|Withdrew Consent|0|||
164324625|NCT02604017|593565191|FG001|Overall Study|Withdrew Consent|2|||
164324626|NCT02604017|593565190|FG000|Overall Study|Lost to Follow-up|5|||
164324627|NCT02604017|593565191|FG001|Overall Study|Lost to Follow-up|6|||
164324628|NCT02604017|593565190|FG000|Overall Study|Other|1|||
164324629|NCT02604017|593565191|FG001|Overall Study|Other|0|||
164324630|NCT01653782|593565197|FG000|Overall Study|Withdrawal by Subject|9|||
164324631|NCT01653782|593565198|FG001|Overall Study|Withdrawal by Subject|15|||
164324632|NCT01653782|593565199|FG002|Overall Study|Withdrawal by Subject|4|||
164324633|NCT01653782|593565197|FG000|Overall Study|Lost to Follow-up|7|||
164324634|NCT01653782|593565198|FG001|Overall Study|Lost to Follow-up|3|||
164324635|NCT01653782|593565199|FG002|Overall Study|Lost to Follow-up|2|||
164324636|NCT01315236|593565203|FG000|Double-blind Phase|Death|1|||
164324637|NCT01315236|593565204|FG001|Double-blind Phase|Death|0|||
164324638|NCT01315236|593565203|FG000|Double-blind Phase|Adverse Event|1|||
164324639|NCT01315236|593565204|FG001|Double-blind Phase|Adverse Event|0|||
164324640|NCT01315236|593565203|FG000|Double-blind Phase|Withdrawal of Consent|1|||
164324641|NCT01315236|593565204|FG001|Double-blind Phase|Withdrawal of Consent|0|||
164324642|NCT01315236|593565203|FG000|Double-blind Phase|Lost to Follow-up|1|||
164324643|NCT01315236|593565204|FG001|Double-blind Phase|Lost to Follow-up|0|||
164324644|NCT01315236|593565203|FG000|Open-label Phase|Death|1|||
164324645|NCT01315236|593565204|FG001|Open-label Phase|Death|0|||
164324646|NCT01315236|593565203|FG000|Open-label Phase|Adverse Event|0|||
164324647|NCT01315236|593565204|FG001|Open-label Phase|Adverse Event|1|||
164324648|NCT01315236|593565203|FG000|Open-label Phase|Other|0|||
164324649|NCT01315236|593565204|FG001|Open-label Phase|Other|1|||
164324650|NCT01315236|593565203|FG000|12-Month Follow-up Period|Death|0|||
164324651|NCT01315236|593565204|FG001|12-Month Follow-up Period|Death|1|||
164324652|NCT01315236|593565203|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
164324653|NCT01315236|593565204|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
164324654|NCT02497976|593565207|FG000|Overall Study|Withdrawal by Subject|2|||
164324655|NCT02497976|593565208|FG001|Overall Study|Withdrawal by Subject|0|||
164324656|NCT02497976|593565207|FG000|Overall Study|Moved out of area|0|||
164324657|NCT02497976|593565208|FG001|Overall Study|Moved out of area|1|||
164324658|NCT00058539|593565212|FG000|Overall Study|Disease progression|24|||
164324659|NCT00058539|593565212|FG000|Overall Study|Adverse Event|3|||
164324660|NCT00058539|593565212|FG000|Overall Study|Withdrawal by Subject|5|||
164324661|NCT00058539|593565212|FG000|Overall Study|Physician Decision|9|||
164324662|NCT00058539|593565212|FG000|Overall Study|Death|1|||
164324663|NCT01673282|593565216|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
164324664|NCT01673282|593565217|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
164324665|NCT01673282|593565216|FG000|Overall Study|Lack of Efficacy|9|||
164324666|NCT01673282|593565217|FG001|Overall Study|Lack of Efficacy|2|||
164324667|NCT01673282|593565216|FG000|Overall Study|Lost to Follow-up|11|||
164324668|NCT01673282|593565217|FG001|Overall Study|Lost to Follow-up|10|||
164324669|NCT01673282|593565216|FG000|Overall Study|Withdrawal by Subject|3|||
164324670|NCT01673282|593565217|FG001|Overall Study|Withdrawal by Subject|3|||
164324671|NCT01673282|593565216|FG000|Overall Study|Other|1|||
164324672|NCT01673282|593565217|FG001|Overall Study|Other|6|||
164324673|NCT02483533|593565218|FG000|Overall Study|Lack of Efficacy|50|||
164324674|NCT02483533|593565219|FG001|Overall Study|Lack of Efficacy|50|||
164324675|NCT01323920|593565220|FG000|Overall Study|Death|5|||
164324676|NCT01323920|593565220|FG000|Overall Study|Withdrawal by Subject|1|||
164324677|NCT00768469|593565221|FG000|Overall Study|Adverse Event|0|||
164324678|NCT00768469|593565222|FG001|Overall Study|Adverse Event|2|||
164324679|NCT00768469|593565221|FG000|Overall Study|Disease Progression|3|||
164324680|NCT00768469|593565222|FG001|Overall Study|Disease Progression|4|||
164324681|NCT00768469|593565221|FG000|Overall Study|Withdrawal by Subject|0|||
164324682|NCT00768469|593565222|FG001|Overall Study|Withdrawal by Subject|1|||
164324683|NCT05040971|593565223|FG000|Overall Study|Withdrawal by Subject|0|||
164324684|NCT05040971|593565224|FG001|Overall Study|Withdrawal by Subject|2|||
164324685|NCT05040971|593565223|FG000|Overall Study|Lost to Follow-up|8|||
164324686|NCT05040971|593565224|FG001|Overall Study|Lost to Follow-up|3|||
164324687|NCT05040971|593565223|FG000|Overall Study|Death|2|||
164324688|NCT05040971|593565224|FG001|Overall Study|Death|0|||
164324689|NCT01293799|593565228|FG000|Overall Study|Kidney transplantation|109|||
164324690|NCT01293799|593565229|FG001|Overall Study|Kidney transplantation|96|||
164324691|NCT01293799|593565228|FG000|Overall Study|Transfer to hemodialysis|70|||
164324692|NCT01293799|593565229|FG001|Overall Study|Transfer to hemodialysis|90|||
164324693|NCT01293799|593565228|FG000|Overall Study|Death|27|||
164324694|NCT01293799|593565229|FG001|Overall Study|Death|29|||
164668859|NCT02079532|594812053|FG000|Overall Study|Administrative problems|1|||
164668860|NCT02079532|594812053|FG000|Overall Study|Inclusion into ReFIRST|3|||
164668861|NCT02079532|594812053|FG000|Overall Study|Other|3|||
164668862|NCT02920996|594812054|FG000|Overall Study|Adverse Event|8|||
164668863|NCT02920996|594812055|FG001|Overall Study|Adverse Event|0|||
164668864|NCT02920996|594812054|FG000|Overall Study|Physician Decision|1|||
164668865|NCT02920996|594812055|FG001|Overall Study|Physician Decision|0|||
164668866|NCT02920996|594812054|FG000|Overall Study|Death|1|||
164668867|NCT02920996|594812055|FG001|Overall Study|Death|0|||
164668868|NCT02920996|594812054|FG000|Overall Study|Missing|1|||
164668869|NCT02920996|594812055|FG001|Overall Study|Missing|0|||
164668870|NCT02920996|594812054|FG000|Overall Study|Subject Non-Compliance|1|||
164668871|NCT02920996|594812055|FG001|Overall Study|Subject Non-Compliance|0|||
164668872|NCT01402947|594812056|FG000|First Intervention|Adverse Event|0|||
164668873|NCT01402947|594812057|FG001|First Intervention|Adverse Event|1|||
164668874|NCT00591630|594812058|FG000|Overall Study|Death|0|||
164668875|NCT00591630|594812059|FG001|Overall Study|Death|0|||
164668876|NCT00591630|594812060|FG002|Overall Study|Death|1|||
164668877|NCT00591630|594812061|FG003|Overall Study|Death|0|||
164668878|NCT01471522|594812065|FG000|Overall Study|Withdrawal by Subject|28|||
164668879|NCT01471522|594812066|FG001|Overall Study|Withdrawal by Subject|22|||
164668880|NCT01471522|594812065|FG000|Overall Study|Lost to Follow-up|36|||
164668881|NCT01471522|594812066|FG001|Overall Study|Lost to Follow-up|26|||
164324695|NCT01293799|593565228|FG000|Overall Study|Transfer to assisted PD|24|||
164324696|NCT01293799|593565229|FG001|Overall Study|Transfer to assisted PD|18|||
164324697|NCT01293799|593565228|FG000|Overall Study|Withdrawal by Subject|26|||
164324698|NCT01293799|593565229|FG001|Overall Study|Withdrawal by Subject|0|||
164668882|NCT01248247|594813492|FG000|Overall Study|Adverse Event|2|||
164668883|NCT01248247|594813493|FG001|Overall Study|Adverse Event|4|||
164668884|NCT01248247|594813494|FG002|Overall Study|Adverse Event|4|||
164668885|NCT01248247|594813495|FG003|Overall Study|Adverse Event|2|||
164668886|NCT01248247|594813492|FG000|Overall Study|Death|0|||
164668887|NCT01248247|594813493|FG001|Overall Study|Death|1|||
164324699|NCT01293799|593565228|FG000|Overall Study|Investigator decision|5|||
164324700|NCT01293799|593565229|FG001|Overall Study|Investigator decision|2|||
164324701|NCT01293799|593565228|FG000|Overall Study|Kidney function improved|6|||
164324702|NCT01293799|593565229|FG001|Overall Study|Kidney function improved|7|||
164668888|NCT01248247|594813494|FG002|Overall Study|Death|4|||
164324703|NCT01293799|593565228|FG000|Overall Study|Other causes|6|||
164324704|NCT01293799|593565229|FG001|Overall Study|Other causes|3|||
164324705|NCT06066697|593565239|FG000|Overall Study|Lost to Follow-up|5|||
164324706|NCT06066697|593565240|FG001|Overall Study|Lost to Follow-up|0|||
164324707|NCT00938886|593565241|FG000|Overall Study|Death|0|||
164324708|NCT00938886|593565242|FG001|Overall Study|Death|1|||
164324709|NCT00938886|593565241|FG000|Overall Study|Withdrawal by Subject|4|||
164324710|NCT00938886|593565242|FG001|Overall Study|Withdrawal by Subject|7|||
164324711|NCT00938886|593565241|FG000|Overall Study|Lost to Follow-up|3|||
164324712|NCT00938886|593565242|FG001|Overall Study|Lost to Follow-up|2|||
164324713|NCT02283177|593565243|FG000|Overall Study|Withdrawal by Subject|1|||
164324714|NCT02283177|593565244|FG001|Overall Study|Withdrawal by Subject|1|||
164324715|NCT01101191|593565245|FG000|Period 1|Withdrawal by Subject|1|||
164324716|NCT01101191|593565246|FG001|Period 1|Withdrawal by Subject|0|||
164324717|NCT01101191|593565245|FG000|Period 1|Adverse Event|1|||
164324718|NCT01101191|593565246|FG001|Period 1|Adverse Event|2|||
164324719|NCT03044574|593565247|FG000|Overall Study|Lost to Follow-up|37|||
164324720|NCT03044574|593565248|FG001|Overall Study|Lost to Follow-up|45|||
164324721|NCT01146860|593565249|FG000|Overall Study|Withdrawal by Subject|0|||
164324722|NCT01146860|593565250|FG001|Overall Study|Withdrawal by Subject|1|||
164324723|NCT04779216|593565251|FG000|Overall Study|Lost to Follow-up|1|||
164324724|NCT04779216|593565252|FG001|Overall Study|Lost to Follow-up|0|||
164324725|NCT04779216|593565251|FG000|Overall Study|Withdrawal by Subject|1|||
164324726|NCT04779216|593565252|FG001|Overall Study|Withdrawal by Subject|0|||
164324727|NCT02674854|593565258|FG000|Overall Study|Adverse Event|17|||
164324728|NCT02674854|593565259|FG001|Overall Study|Adverse Event|15|||
164324729|NCT02674854|593565260|FG002|Overall Study|Adverse Event|5|||
164324730|NCT02674854|593565258|FG000|Overall Study|Withdrawal by Subject|1|||
164324731|NCT02674854|593565259|FG001|Overall Study|Withdrawal by Subject|5|||
164324732|NCT02674854|593565260|FG002|Overall Study|Withdrawal by Subject|4|||
164324733|NCT02674854|593565258|FG000|Overall Study|No-compliant subject|1|||
164324734|NCT02674854|593565259|FG001|Overall Study|No-compliant subject|0|||
164324735|NCT02674854|593565260|FG002|Overall Study|No-compliant subject|1|||
164324736|NCT02674854|593565258|FG000|Overall Study|Lost to Follow-up|1|||
164324737|NCT02674854|593565259|FG001|Overall Study|Lost to Follow-up|0|||
164324738|NCT02674854|593565260|FG002|Overall Study|Lost to Follow-up|2|||
164324739|NCT02674854|593565258|FG000|Overall Study|Lack of Efficacy|0|||
164324740|NCT02674854|593565259|FG001|Overall Study|Lack of Efficacy|3|||
164324741|NCT02674854|593565260|FG002|Overall Study|Lack of Efficacy|0|||
164324742|NCT02674854|593565258|FG000|Overall Study|Disallowed Concurrent Medication|2|||
164324743|NCT02674854|593565259|FG001|Overall Study|Disallowed Concurrent Medication|2|||
164324744|NCT02674854|593565260|FG002|Overall Study|Disallowed Concurrent Medication|0|||
164324745|NCT02674854|593565258|FG000|Overall Study|Protocol Violation|1|||
164324746|NCT02674854|593565259|FG001|Overall Study|Protocol Violation|1|||
164324747|NCT02674854|593565260|FG002|Overall Study|Protocol Violation|2|||
164324748|NCT02674854|593565258|FG000|Overall Study|Death|0|||
164324749|NCT02674854|593565259|FG001|Overall Study|Death|1|||
164324750|NCT02674854|593565260|FG002|Overall Study|Death|0|||
164324751|NCT02674854|593565258|FG000|Overall Study|Subject missed V6.2|1|||
164324752|NCT02674854|593565259|FG001|Overall Study|Subject missed V6.2|0|||
164324753|NCT02674854|593565260|FG002|Overall Study|Subject missed V6.2|0|||
164324754|NCT02635646|593565261|FG000|Overall Study|Lost to Follow-up|24|||
164324755|NCT02635646|593565262|FG001|Overall Study|Lost to Follow-up|25|||
164324756|NCT02635646|593565261|FG000|Overall Study|Pregnancy|1|||
164324757|NCT02635646|593565262|FG001|Overall Study|Pregnancy|1|||
164324758|NCT00879879|593565269|FG000|Overall Study|Death|1|||
164324759|NCT00879879|593565269|FG000|Overall Study|Withdrawal by Subject|1|||
164324760|NCT00879879|593565269|FG000|Overall Study|Physician Decision|1|||
164324761|NCT00745615|593565272|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
164324762|NCT00745615|593565273|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
164324763|NCT00745615|593565274|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
164324764|NCT00745615|593565275|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
164324765|NCT00745615|593565276|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
164324766|NCT00745615|593565277|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
164324767|NCT00745615|593565272|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
164324768|NCT00745615|593565273|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
164324769|NCT00745615|593565274|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
164324770|NCT00745615|593565275|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
164324771|NCT00745615|593565276|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
164324772|NCT00745615|593565277|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
164324773|NCT00745615|593565272|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
164324774|NCT00745615|593565273|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
164324775|NCT00745615|593565274|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
164324776|NCT00745615|593565275|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
164324777|NCT00745615|593565276|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
164324778|NCT00745615|593565277|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
164324779|NCT00745615|593565272|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
164324780|NCT00745615|593565273|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
164324781|NCT00745615|593565274|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
164324782|NCT00745615|593565275|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
164324783|NCT00745615|593565276|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
164324784|NCT00745615|593565277|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
164324785|NCT00745615|593565272|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
164324786|NCT00745615|593565273|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
164324787|NCT00745615|593565274|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
164324788|NCT00745615|593565275|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
164324789|NCT00745615|593565276|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
164324790|NCT00745615|593565277|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
164324791|NCT00745615|593565272|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
164324792|NCT00745615|593565273|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
164324793|NCT00745615|593565274|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
164324794|NCT00745615|593565275|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
164324795|NCT00745615|593565276|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
164324796|NCT00745615|593565277|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
164324797|NCT00745615|593565272|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
164324798|NCT00745615|593565273|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
164324799|NCT00745615|593565274|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
164324800|NCT00745615|593565275|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
164324801|NCT00745615|593565276|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
164324802|NCT00745615|593565277|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
164324803|NCT00745615|593565272|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
164324804|NCT00745615|593565273|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
164324805|NCT00745615|593565274|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
164324806|NCT00745615|593565275|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
164324807|NCT00745615|593565276|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
164324808|NCT00745615|593565277|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
164324809|NCT00745615|593565272|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
164324810|NCT00745615|593565273|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
164324811|NCT00745615|593565274|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
164324812|NCT00745615|593565275|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
164324813|NCT00745615|593565276|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
164211025|NCT03112603|593140311|FG000|End of Randomization Period|Lack of Efficacy|25|||
164211026|NCT03112603|593140312|FG001|End of Randomization Period|Lack of Efficacy|77|||
164211027|NCT03112603|593140313|FG002|End of Randomization Period|Lack of Efficacy|0|||
164211028|NCT03112603|593140311|FG000|End of Randomization Period|Adverse Event|32|||
164211029|NCT03112603|593140312|FG001|End of Randomization Period|Adverse Event|12|||
164211030|NCT03112603|593140313|FG002|End of Randomization Period|Adverse Event|0|||
164211031|NCT03112603|593140311|FG000|End of Cross Over Period|Death|0|||
164211032|NCT03112603|593140312|FG001|End of Cross Over Period|Death|0|||
164211033|NCT03112603|593140313|FG002|End of Cross Over Period|Death|2|||
164211034|NCT03112603|593140311|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
164211035|NCT03112603|593140312|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
164211036|NCT03112603|593140313|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
164211037|NCT03112603|593140311|FG000|End of Cross Over Period|Physician Decision|0|||
164211038|NCT03112603|593140312|FG001|End of Cross Over Period|Physician Decision|0|||
164211039|NCT03112603|593140313|FG002|End of Cross Over Period|Physician Decision|29|||
164211040|NCT03112603|593140311|FG000|End of Cross Over Period|Lack of Efficacy|0|||
164211041|NCT03112603|593140312|FG001|End of Cross Over Period|Lack of Efficacy|0|||
164211042|NCT03112603|593140313|FG002|End of Cross Over Period|Lack of Efficacy|8|||
164211043|NCT03112603|593140311|FG000|End of Cross Over Period|Adverse Event|0|||
164211044|NCT03112603|593140312|FG001|End of Cross Over Period|Adverse Event|0|||
164211045|NCT03112603|593140313|FG002|End of Cross Over Period|Adverse Event|6|||
164211046|NCT03112603|593140311|FG000|End of Cross Over Period|Disease Relapse|0|||
164211047|NCT03112603|593140312|FG001|End of Cross Over Period|Disease Relapse|0|||
164211048|NCT03112603|593140313|FG002|End of Cross Over Period|Disease Relapse|2|||
164211049|NCT04092777|593140314|FG000|Overall Study|Lost to Follow-up|28|||
164211050|NCT04092777|593140315|FG001|Overall Study|Lost to Follow-up|46|||
164211051|NCT04092777|593140314|FG000|Overall Study|Withdrawal by Subject|8|||
164211052|NCT04092777|593140315|FG001|Overall Study|Withdrawal by Subject|5|||
164211053|NCT02278354|593140316|FG000|Overall Study|Lost to Follow-up|2|||
164211054|NCT02278354|593140317|FG001|Overall Study|Lost to Follow-up|2|||
164211055|NCT02278354|593140316|FG000|Overall Study|Withdrawal by Subject|0|||
164211056|NCT02278354|593140317|FG001|Overall Study|Withdrawal by Subject|1|||
164211057|NCT02278354|593140316|FG000|Overall Study|<10 professional fights|2|||
164211058|NCT02278354|593140317|FG001|Overall Study|<10 professional fights|0|||
164211059|NCT01925794|593140321|FG000|180 Days|Death|2|||
164211060|NCT01925794|593140321|FG000|180 Days|Withdrawal by Subject|2|||
164211061|NCT01925794|593140321|FG000|270 Days|Death|2|||
164211062|NCT01925794|593140321|FG000|270 Days|Protocol Violation|3|||
164211063|NCT03126110|593140322|FG000|Phase 1|Death|2|||
164211064|NCT03126110|593140323|FG001|Phase 1|Death|2|||
164211065|NCT03126110|593140324|FG002|Phase 1|Death|4|||
164211066|NCT03126110|593140325|FG003|Phase 1|Death|3|||
164211067|NCT03126110|593140326|FG004|Phase 1|Death|4|||
164211068|NCT03126110|593140327|FG005|Phase 1|Death|4|||
164324814|NCT00745615|593565277|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
164211069|NCT03126110|593140328|FG006|Phase 1|Death|3|||
164211070|NCT03126110|593140329|FG007|Phase 1|Death|4|||
164211071|NCT03126110|593140330|FG008|Phase 1|Death|5|||
164324815|NCT00745615|593565272|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
164324816|NCT00745615|593565273|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
164324817|NCT00745615|593565274|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
164668889|NCT01248247|594813495|FG003|Overall Study|Death|7|||
164668890|NCT01248247|594813492|FG000|Overall Study|Lost to Follow-up|0|||
164668891|NCT01248247|594813493|FG001|Overall Study|Lost to Follow-up|1|||
164668892|NCT01248247|594813494|FG002|Overall Study|Lost to Follow-up|1|||
164668893|NCT01248247|594813495|FG003|Overall Study|Lost to Follow-up|0|||
164668894|NCT01248247|594813492|FG000|Overall Study|Alternative treatment|0|||
164668895|NCT01248247|594813493|FG001|Overall Study|Alternative treatment|1|||
164668896|NCT01248247|594813494|FG002|Overall Study|Alternative treatment|0|||
164668897|NCT01248247|594813495|FG003|Overall Study|Alternative treatment|0|||
164668898|NCT01248247|594813492|FG000|Overall Study|Other|2|||
164668899|NCT01248247|594813493|FG001|Overall Study|Other|8|||
164668900|NCT01248247|594813494|FG002|Overall Study|Other|8|||
164668901|NCT01248247|594813495|FG003|Overall Study|Other|5|||
164668902|NCT01248247|594813492|FG000|Overall Study|Progression|18|||
164668903|NCT01248247|594813493|FG001|Overall Study|Progression|27|||
164668904|NCT01248247|594813494|FG002|Overall Study|Progression|56|||
164668905|NCT01248247|594813495|FG003|Overall Study|Progression|44|||
164668906|NCT01248247|594813492|FG000|Overall Study|Refuse further treatment|0|||
164668907|NCT01248247|594813493|FG001|Overall Study|Refuse further treatment|0|||
164668908|NCT01248247|594813494|FG002|Overall Study|Refuse further treatment|1|||
164668909|NCT01248247|594813495|FG003|Overall Study|Refuse further treatment|2|||
164668910|NCT01248247|594813492|FG000|Overall Study|Complicating disease|0|||
164668911|NCT01248247|594813493|FG001|Overall Study|Complicating disease|0|||
164668912|NCT01248247|594813494|FG002|Overall Study|Complicating disease|1|||
164668913|NCT01248247|594813495|FG003|Overall Study|Complicating disease|1|||
164668914|NCT01215981|594813496|FG000|Overall Study|Physician Decision|0|||
164668915|NCT01215981|594813497|FG001|Overall Study|Physician Decision|1|||
164668916|NCT01215981|594813496|FG000|Overall Study|Protocol Violation|1|||
164668917|NCT01215981|594813497|FG001|Overall Study|Protocol Violation|0|||
164668918|NCT01215981|594813496|FG000|Overall Study|Withdrawal by Subject|1|||
164668919|NCT01215981|594813497|FG001|Overall Study|Withdrawal by Subject|0|||
164668920|NCT03597256|594813498|FG000|Overall Study|Lost to Follow-up|3|||
164668921|NCT03597256|594813499|FG001|Overall Study|Lost to Follow-up|1|||
164668922|NCT03597256|594813498|FG000|Overall Study|Withdrawal by Subject|0|||
164668923|NCT03597256|594813499|FG001|Overall Study|Withdrawal by Subject|1|||
164668924|NCT03597256|594813498|FG000|Overall Study|Could not return for treatment|0|||
164668925|NCT03597256|594813499|FG001|Overall Study|Could not return for treatment|1|||
164668926|NCT03597256|594813498|FG000|Overall Study|Moved from location|0|||
164668927|NCT03597256|594813499|FG001|Overall Study|Moved from location|1|||
164668928|NCT03597256|594813498|FG000|Overall Study|Not accepted the treatment|0|||
164668929|NCT03597256|594813499|FG001|Overall Study|Not accepted the treatment|1|||
164668930|NCT02943447|594813500|FG000|Blinded Study Phase|Withdrew Consent|1|||
164668931|NCT02943447|594813501|FG001|Blinded Study Phase|Withdrew Consent|2|||
164668932|NCT02943447|594813502|FG002|Blinded Study Phase|Withdrew Consent|1|||
164668933|NCT02943447|594813500|FG000|Blinded Study Phase|Adverse Event|3|||
164668934|NCT02943447|594813501|FG001|Blinded Study Phase|Adverse Event|0|||
164668935|NCT02943447|594813502|FG002|Blinded Study Phase|Adverse Event|0|||
164668936|NCT02943447|594813500|FG000|Blinded Study Phase|Investigator's discretion|1|||
164668937|NCT02943447|594813501|FG001|Blinded Study Phase|Investigator's discretion|0|||
164668938|NCT02943447|594813502|FG002|Blinded Study Phase|Investigator's discretion|0|||
164668939|NCT02943447|594813500|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
164668940|NCT02943447|594813501|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
164668941|NCT02943447|594813502|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
164668942|NCT02943447|594813500|FG000|Open-Label Extension Phase|Adverse Event|4|||
164668943|NCT02943447|594813501|FG001|Open-Label Extension Phase|Adverse Event|7|||
164668944|NCT02943447|594813502|FG002|Open-Label Extension Phase|Adverse Event|3|||
164668945|NCT02943447|594813500|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
164668946|NCT02943447|594813501|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
164668947|NCT02943447|594813502|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
164668948|NCT02943447|594813500|FG000|Open-Label Extension Phase|Withdrew consent|1|||
164668949|NCT02943447|594813501|FG001|Open-Label Extension Phase|Withdrew consent|1|||
164668950|NCT02943447|594813502|FG002|Open-Label Extension Phase|Withdrew consent|1|||
164668951|NCT02943447|594813500|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
164668952|NCT02943447|594813501|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
164668953|NCT02943447|594813502|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
164668954|NCT02653664|594813516|FG000|Post-Treatment|Withdrawal by Subject|6|||
164668955|NCT02653664|594813517|FG001|Post-Treatment|Withdrawal by Subject|5|||
164668956|NCT02653664|594813518|FG002|Post-Treatment|Withdrawal by Subject|7|||
164668957|NCT02653664|594813516|FG000|Post-Treatment|Lost to Follow-up|8|||
164668958|NCT02653664|594813517|FG001|Post-Treatment|Lost to Follow-up|1|||
164668959|NCT02653664|594813518|FG002|Post-Treatment|Lost to Follow-up|7|||
164668960|NCT02653664|594813516|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
164668961|NCT02653664|594813517|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
164668962|NCT02653664|594813518|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
164668963|NCT02653664|594813516|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
164668964|NCT02653664|594813517|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
164668965|NCT02653664|594813518|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
164668966|NCT02653664|594813516|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
164668967|NCT02653664|594813517|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
164668968|NCT02653664|594813518|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
164668969|NCT02653664|594813516|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
164668970|NCT02653664|594813517|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
164668971|NCT02653664|594813518|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
164668972|NCT02653664|594813516|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
164668973|NCT02653664|594813517|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
164668974|NCT02653664|594813518|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
164668975|NCT02653664|594813516|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
164668976|NCT02653664|594813517|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
164668977|NCT02653664|594813518|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
164668978|NCT02653664|594813516|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
164668979|NCT02653664|594813517|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
164668980|NCT02653664|594813518|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
164668981|NCT02653664|594813516|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
164668982|NCT02653664|594813517|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
164324818|NCT00745615|593565275|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
164324819|NCT00745615|593565276|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
164324820|NCT00745615|593565277|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
164324821|NCT00745615|593565272|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
164324822|NCT00745615|593565273|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
164324823|NCT00745615|593565274|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
164324824|NCT00745615|593565275|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
164324825|NCT00745615|593565276|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
164324826|NCT00745615|593565277|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
164324827|NCT00745615|593565272|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
164324828|NCT00745615|593565273|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
164324829|NCT00745615|593565274|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
164324830|NCT00745615|593565275|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
164324831|NCT00745615|593565276|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
164324832|NCT00745615|593565277|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
164324833|NCT00745615|593565272|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
164324834|NCT00745615|593565273|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
164324835|NCT00745615|593565274|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
164324836|NCT00745615|593565275|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
164324837|NCT00745615|593565276|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
164324838|NCT00745615|593565277|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
164324839|NCT00745615|593565272|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
164324840|NCT00745615|593565273|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
164324841|NCT00745615|593565274|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
164324842|NCT00745615|593565275|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
164324843|NCT00745615|593565276|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
164324844|NCT00745615|593565277|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
164324845|NCT00570232|593565278|FG000|Overall Study|Adverse Event|10|||
164324846|NCT00570232|593565278|FG000|Overall Study|discontinued due to medical condition|3|||
164324847|NCT00570232|593565278|FG000|Overall Study|discontinued due to recurrence|8|||
164324848|NCT00570232|593565278|FG000|Overall Study|discontinued due to noncompliance|2|||
164324849|NCT01076075|593565279|FG000|Overall Study|Adverse Event|3|||
164324850|NCT01076075|593565280|FG001|Overall Study|Adverse Event|9|||
164324851|NCT01076075|593565279|FG000|Overall Study|Lack of Efficacy|5|||
164324852|NCT01076075|593565280|FG001|Overall Study|Lack of Efficacy|4|||
164324853|NCT01076075|593565279|FG000|Overall Study|Lost to Follow-up|6|||
164324854|NCT01076075|593565280|FG001|Overall Study|Lost to Follow-up|5|||
164324855|NCT01076075|593565279|FG000|Overall Study|other|19|||
164324856|NCT01076075|593565280|FG001|Overall Study|other|9|||
164324857|NCT01076075|593565279|FG000|Overall Study|Protocol Violation|0|||
164324858|NCT01076075|593565280|FG001|Overall Study|Protocol Violation|1|||
164324859|NCT01076075|593565279|FG000|Overall Study|Withdrawal by Subject|8|||
164324860|NCT01076075|593565280|FG001|Overall Study|Withdrawal by Subject|19|||
164324861|NCT02751931|593565281|FG000|Overall Study|Adverse Event|3|||
164324862|NCT02751931|593565282|FG001|Overall Study|Adverse Event|0|||
164324863|NCT02751931|593565281|FG000|Overall Study|Other: Miscelleneous|10|||
164324864|NCT02751931|593565282|FG001|Overall Study|Other: Miscelleneous|8|||
164324865|NCT04090411|593565283|FG000|Induction Period|Adverse Event|3|||
164324866|NCT04090411|593565284|FG001|Induction Period|Adverse Event|1|||
164324867|NCT04090411|593565285|FG002|Induction Period|Adverse Event|1|||
164324868|NCT04090411|593565286|FG003|Induction Period|Adverse Event|1|||
164324869|NCT04090411|593565287|FG004|Induction Period|Adverse Event|0|||
164324870|NCT04090411|593565288|FG005|Induction Period|Adverse Event|0|||
164324871|NCT04090411|593565289|FG006|Induction Period|Adverse Event|0|||
164324872|NCT04090411|593565290|FG007|Induction Period|Adverse Event|0|||
164324873|NCT04090411|593565291|FG008|Induction Period|Adverse Event|0|||
164324874|NCT04090411|593565292|FG009|Induction Period|Adverse Event|0|||
164324875|NCT04090411|593565293|FG010|Induction Period|Adverse Event|0|||
164324876|NCT04090411|593565294|FG011|Induction Period|Adverse Event|0|||
164324877|NCT04090411|593565295|FG012|Induction Period|Adverse Event|0|||
164564740|NCT01299727|594436348|FG002|Overall Study|Completed the Treatment Period|3|||
164564741|NCT02772757|594436349|FG000|Overall Study|Withdrawal by Subject|1|||
164564742|NCT02772757|594436350|FG001|Overall Study|Withdrawal by Subject|0|||
164564743|NCT02772757|594436351|FG002|Overall Study|Withdrawal by Subject|1|||
164324878|NCT04090411|593565283|FG000|Induction Period|Lack of Efficacy|0|||
164324879|NCT04090411|593565284|FG001|Induction Period|Lack of Efficacy|0|||
164324880|NCT04090411|593565285|FG002|Induction Period|Lack of Efficacy|1|||
164324881|NCT04090411|593565286|FG003|Induction Period|Lack of Efficacy|1|||
164324882|NCT04090411|593565287|FG004|Induction Period|Lack of Efficacy|0|||
164324883|NCT04090411|593565288|FG005|Induction Period|Lack of Efficacy|0|||
164324884|NCT04090411|593565289|FG006|Induction Period|Lack of Efficacy|0|||
164324885|NCT04090411|593565290|FG007|Induction Period|Lack of Efficacy|0|||
164324886|NCT04090411|593565291|FG008|Induction Period|Lack of Efficacy|0|||
164324887|NCT04090411|593565292|FG009|Induction Period|Lack of Efficacy|0|||
164668983|NCT02653664|594813518|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
164668984|NCT04657770|594813519|FG000|Overall Study|Withdrawal by Subject|3|||
164668985|NCT04657770|594813519|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
164668986|NCT00485472|594813520|FG000|Overall Study|Adverse Event|8|||
164668987|NCT00485472|594813521|FG001|Overall Study|Adverse Event|5|||
164668988|NCT00485472|594813520|FG000|Overall Study|Lack of Efficacy|5|||
164668989|NCT00485472|594813521|FG001|Overall Study|Lack of Efficacy|4|||
164668990|NCT00485472|594813520|FG000|Overall Study|Withdrawal by Subject|1|||
164668991|NCT00485472|594813521|FG001|Overall Study|Withdrawal by Subject|0|||
164668992|NCT00485472|594813520|FG000|Overall Study|Protocol Violation|0|||
164668993|NCT00485472|594813521|FG001|Overall Study|Protocol Violation|1|||
164668994|NCT00485472|594813520|FG000|Overall Study|Other|2|||
164668995|NCT00485472|594813521|FG001|Overall Study|Other|1|||
164668996|NCT00485472|594813520|FG000|Overall Study|Lost to Follow-up|0|||
164668997|NCT00485472|594813521|FG001|Overall Study|Lost to Follow-up|1|||
164668998|NCT00746798|594813522|FG000|Overall Study|Protocol Violation|0|||
164668999|NCT00746798|594813523|FG001|Overall Study|Protocol Violation|1|||
164669000|NCT00746798|594813524|FG002|Overall Study|Protocol Violation|0|||
164669001|NCT00746798|594813525|FG003|Overall Study|Protocol Violation|0|||
164669002|NCT00746798|594813522|FG000|Overall Study|Withdrawal by Subject|0|||
164669003|NCT00746798|594813523|FG001|Overall Study|Withdrawal by Subject|1|||
164669004|NCT00746798|594813524|FG002|Overall Study|Withdrawal by Subject|1|||
164669005|NCT00746798|594813525|FG003|Overall Study|Withdrawal by Subject|0|||
164669006|NCT00746798|594813522|FG000|Overall Study|Death|0|||
164669007|NCT00746798|594813523|FG001|Overall Study|Death|0|||
164669008|NCT00746798|594813524|FG002|Overall Study|Death|2|||
164669009|NCT00746798|594813525|FG003|Overall Study|Death|0|||
164669010|NCT00746798|594813522|FG000|Overall Study|Participant unable to return for visit|1|||
164669011|NCT00746798|594813523|FG001|Overall Study|Participant unable to return for visit|0|||
164669012|NCT00746798|594813524|FG002|Overall Study|Participant unable to return for visit|0|||
164669013|NCT00746798|594813525|FG003|Overall Study|Participant unable to return for visit|0|||
164669014|NCT04915755|594813528|FG000|Overall Study|Physician Decision|3|||
164669015|NCT04915755|594813529|FG001|Overall Study|Physician Decision|2|||
164669016|NCT04915755|594813528|FG000|Overall Study|Withdrawal by Subject|1|||
164669017|NCT04915755|594813529|FG001|Overall Study|Withdrawal by Subject|1|||
164669018|NCT04915755|594813528|FG000|Overall Study|Ongoing for PACT|3|||
164669019|NCT04915755|594813529|FG001|Overall Study|Ongoing for PACT|2|||
164669020|NCT04915755|594813528|FG000|Overall Study|Other|7|||
164669021|NCT04915755|594813529|FG001|Overall Study|Other|11|||
164669022|NCT00727571|594813531|FG000|Overall Study|Ineligibility determined|1|||
164669023|NCT00727571|594813532|FG001|Overall Study|Ineligibility determined|1|||
164669024|NCT00727571|594813533|FG002|Overall Study|Ineligibility determined|1|||
164669025|NCT00727571|594813534|FG003|Overall Study|Ineligibility determined|0|||
164669026|NCT00727571|594813531|FG000|Overall Study|Death|0|||
164669027|NCT00727571|594813532|FG001|Overall Study|Death|19|||
164669028|NCT00727571|594813533|FG002|Overall Study|Death|5|||
164669029|NCT00727571|594813534|FG003|Overall Study|Death|1|||
164669030|NCT00727571|594813531|FG000|Overall Study|Physician Decision|0|||
164669031|NCT00727571|594813532|FG001|Overall Study|Physician Decision|5|||
164669032|NCT00727571|594813533|FG002|Overall Study|Physician Decision|0|||
164669033|NCT00727571|594813534|FG003|Overall Study|Physician Decision|0|||
164669034|NCT00727571|594813531|FG000|Overall Study|Withdrawal by Subject|0|||
164669035|NCT00727571|594813532|FG001|Overall Study|Withdrawal by Subject|10|||
164669036|NCT00727571|594813533|FG002|Overall Study|Withdrawal by Subject|11|||
164669037|NCT00727571|594813534|FG003|Overall Study|Withdrawal by Subject|0|||
164669038|NCT00727571|594813531|FG000|Overall Study|Subject Non Compliance|0|||
164669039|NCT00727571|594813532|FG001|Overall Study|Subject Non Compliance|6|||
164669040|NCT00727571|594813533|FG002|Overall Study|Subject Non Compliance|0|||
164669041|NCT00727571|594813534|FG003|Overall Study|Subject Non Compliance|4|||
164669042|NCT00727571|594813531|FG000|Overall Study|Dismissed from nursing home|0|||
164211072|NCT03126110|593140331|FG009|Phase 1|Death|2|||
164669043|NCT00727571|594813532|FG001|Overall Study|Dismissed from nursing home|9|||
164669044|NCT00727571|594813533|FG002|Overall Study|Dismissed from nursing home|5|||
164669045|NCT00727571|594813534|FG003|Overall Study|Dismissed from nursing home|0|||
164669046|NCT00727571|594813531|FG000|Overall Study|Hospitalization|0|||
164669047|NCT00727571|594813532|FG001|Overall Study|Hospitalization|1|||
164669048|NCT00727571|594813533|FG002|Overall Study|Hospitalization|0|||
164669049|NCT00727571|594813534|FG003|Overall Study|Hospitalization|1|||
164669050|NCT00727571|594813531|FG000|Overall Study|AE not leading to hospitalization|0|||
164669051|NCT00727571|594813532|FG001|Overall Study|AE not leading to hospitalization|0|||
164211073|NCT03126110|593140332|FG010|Phase 1|Death|6|||
164669052|NCT00727571|594813533|FG002|Overall Study|AE not leading to hospitalization|2|||
164669053|NCT00727571|594813534|FG003|Overall Study|AE not leading to hospitalization|0|||
164669054|NCT00727571|594813531|FG000|Overall Study|Other|0|||
164669055|NCT00727571|594813532|FG001|Overall Study|Other|4|||
164669056|NCT00727571|594813533|FG002|Overall Study|Other|6|||
164669057|NCT00727571|594813534|FG003|Overall Study|Other|0|||
164669058|NCT03247556|594813535|FG000|Overall Study|Adverse Event|1|||
164669059|NCT03247556|594813536|FG001|Overall Study|Adverse Event|4|||
164669060|NCT03247556|594813537|FG002|Overall Study|Adverse Event|5|||
164669061|NCT03247556|594813535|FG000|Overall Study|Lost to Follow-up|5|||
164669062|NCT03247556|594813536|FG001|Overall Study|Lost to Follow-up|5|||
164669063|NCT03247556|594813537|FG002|Overall Study|Lost to Follow-up|4|||
164669064|NCT03247556|594813535|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
164669065|NCT03247556|594813536|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
164669066|NCT03247556|594813537|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
164211074|NCT03126110|593140333|FG011|Phase 1|Death|0|||
164211075|NCT03126110|593140334|FG012|Phase 1|Death|0|||
164211076|NCT03126110|593140335|FG013|Phase 1|Death|0|||
164211077|NCT03126110|593140336|FG014|Phase 1|Death|0|||
164211078|NCT03126110|593140337|FG015|Phase 1|Death|0|||
164211079|NCT03126110|593140338|FG016|Phase 1|Death|0|||
164211080|NCT03126110|593140322|FG000|Phase 1|Lost to Follow-up|0|||
164211081|NCT03126110|593140323|FG001|Phase 1|Lost to Follow-up|1|||
164211082|NCT03126110|593140324|FG002|Phase 1|Lost to Follow-up|0|||
164211083|NCT03126110|593140325|FG003|Phase 1|Lost to Follow-up|0|||
164211084|NCT03126110|593140326|FG004|Phase 1|Lost to Follow-up|0|||
164211085|NCT03126110|593140327|FG005|Phase 1|Lost to Follow-up|0|||
164211086|NCT03126110|593140328|FG006|Phase 1|Lost to Follow-up|0|||
164211087|NCT03126110|593140329|FG007|Phase 1|Lost to Follow-up|0|||
164211088|NCT03126110|593140330|FG008|Phase 1|Lost to Follow-up|1|||
164211089|NCT03126110|593140331|FG009|Phase 1|Lost to Follow-up|0|||
164211090|NCT03126110|593140332|FG010|Phase 1|Lost to Follow-up|0|||
164211091|NCT03126110|593140333|FG011|Phase 1|Lost to Follow-up|0|||
164211092|NCT03126110|593140334|FG012|Phase 1|Lost to Follow-up|0|||
164211093|NCT03126110|593140335|FG013|Phase 1|Lost to Follow-up|0|||
164211094|NCT03126110|593140336|FG014|Phase 1|Lost to Follow-up|0|||
164211095|NCT03126110|593140337|FG015|Phase 1|Lost to Follow-up|0|||
164211096|NCT03126110|593140338|FG016|Phase 1|Lost to Follow-up|0|||
164211097|NCT03126110|593140322|FG000|Phase 1|Withdrawal by Subject|1|||
164211098|NCT03126110|593140323|FG001|Phase 1|Withdrawal by Subject|0|||
164211099|NCT03126110|593140324|FG002|Phase 1|Withdrawal by Subject|0|||
164211100|NCT03126110|593140325|FG003|Phase 1|Withdrawal by Subject|1|||
164211101|NCT03126110|593140326|FG004|Phase 1|Withdrawal by Subject|1|||
164211102|NCT03126110|593140327|FG005|Phase 1|Withdrawal by Subject|0|||
164211103|NCT03126110|593140328|FG006|Phase 1|Withdrawal by Subject|0|||
164211104|NCT03126110|593140329|FG007|Phase 1|Withdrawal by Subject|0|||
164211105|NCT03126110|593140330|FG008|Phase 1|Withdrawal by Subject|2|||
164211106|NCT03126110|593140331|FG009|Phase 1|Withdrawal by Subject|1|||
164211107|NCT03126110|593140332|FG010|Phase 1|Withdrawal by Subject|0|||
164211108|NCT03126110|593140333|FG011|Phase 1|Withdrawal by Subject|0|||
164211109|NCT03126110|593140334|FG012|Phase 1|Withdrawal by Subject|0|||
164211110|NCT03126110|593140335|FG013|Phase 1|Withdrawal by Subject|0|||
164211111|NCT03126110|593140336|FG014|Phase 1|Withdrawal by Subject|0|||
164211112|NCT03126110|593140337|FG015|Phase 1|Withdrawal by Subject|0|||
164211113|NCT03126110|593140338|FG016|Phase 1|Withdrawal by Subject|0|||
164211114|NCT03126110|593140322|FG000|Phase 1|Safety follow-up no longer necessary|1|||
164211115|NCT03126110|593140323|FG001|Phase 1|Safety follow-up no longer necessary|0|||
164211116|NCT03126110|593140324|FG002|Phase 1|Safety follow-up no longer necessary|0|||
164211117|NCT03126110|593140325|FG003|Phase 1|Safety follow-up no longer necessary|0|||
164211118|NCT03126110|593140326|FG004|Phase 1|Safety follow-up no longer necessary|0|||
164211119|NCT03126110|593140327|FG005|Phase 1|Safety follow-up no longer necessary|0|||
164211120|NCT03126110|593140328|FG006|Phase 1|Safety follow-up no longer necessary|0|||
164211121|NCT03126110|593140329|FG007|Phase 1|Safety follow-up no longer necessary|0|||
164211122|NCT03126110|593140330|FG008|Phase 1|Safety follow-up no longer necessary|0|||
164211123|NCT03126110|593140331|FG009|Phase 1|Safety follow-up no longer necessary|0|||
164211124|NCT03126110|593140332|FG010|Phase 1|Safety follow-up no longer necessary|0|||
164211125|NCT03126110|593140333|FG011|Phase 1|Safety follow-up no longer necessary|0|||
164211126|NCT03126110|593140334|FG012|Phase 1|Safety follow-up no longer necessary|0|||
164211127|NCT03126110|593140335|FG013|Phase 1|Safety follow-up no longer necessary|0|||
164211128|NCT03126110|593140336|FG014|Phase 1|Safety follow-up no longer necessary|0|||
164211129|NCT03126110|593140337|FG015|Phase 1|Safety follow-up no longer necessary|0|||
164211130|NCT03126110|593140338|FG016|Phase 1|Safety follow-up no longer necessary|0|||
164211131|NCT03126110|593140322|FG000|Phase 1|Survival follow-up no longer necessary|0|||
164211132|NCT03126110|593140323|FG001|Phase 1|Survival follow-up no longer necessary|0|||
164211133|NCT03126110|593140324|FG002|Phase 1|Survival follow-up no longer necessary|1|||
164211134|NCT03126110|593140325|FG003|Phase 1|Survival follow-up no longer necessary|0|||
164211135|NCT03126110|593140326|FG004|Phase 1|Survival follow-up no longer necessary|0|||
164211136|NCT03126110|593140327|FG005|Phase 1|Survival follow-up no longer necessary|0|||
164211137|NCT03126110|593140328|FG006|Phase 1|Survival follow-up no longer necessary|0|||
164669067|NCT03247556|594813535|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
164669068|NCT03247556|594813536|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
164669069|NCT03247556|594813537|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
164324888|NCT04090411|593565293|FG010|Induction Period|Lack of Efficacy|0|||
164324889|NCT04090411|593565294|FG011|Induction Period|Lack of Efficacy|0|||
164324890|NCT04090411|593565295|FG012|Induction Period|Lack of Efficacy|0|||
164324891|NCT04090411|593565283|FG000|Induction Period|Physician Decision|0|||
164324892|NCT04090411|593565284|FG001|Induction Period|Physician Decision|0|||
164324893|NCT04090411|593565285|FG002|Induction Period|Physician Decision|1|||
164324894|NCT04090411|593565286|FG003|Induction Period|Physician Decision|0|||
164324895|NCT04090411|593565287|FG004|Induction Period|Physician Decision|0|||
164324896|NCT04090411|593565288|FG005|Induction Period|Physician Decision|0|||
164324897|NCT04090411|593565289|FG006|Induction Period|Physician Decision|0|||
164324898|NCT04090411|593565290|FG007|Induction Period|Physician Decision|0|||
164324899|NCT04090411|593565291|FG008|Induction Period|Physician Decision|0|||
164324900|NCT04090411|593565292|FG009|Induction Period|Physician Decision|0|||
164324901|NCT04090411|593565293|FG010|Induction Period|Physician Decision|0|||
164324902|NCT04090411|593565294|FG011|Induction Period|Physician Decision|0|||
164324903|NCT04090411|593565295|FG012|Induction Period|Physician Decision|0|||
164324904|NCT04090411|593565283|FG000|Induction Period|Protocol Violation|0|||
164324905|NCT04090411|593565284|FG001|Induction Period|Protocol Violation|0|||
164324906|NCT04090411|593565285|FG002|Induction Period|Protocol Violation|0|||
164324907|NCT04090411|593565286|FG003|Induction Period|Protocol Violation|1|||
164324908|NCT04090411|593565287|FG004|Induction Period|Protocol Violation|0|||
164324909|NCT04090411|593565288|FG005|Induction Period|Protocol Violation|0|||
164324910|NCT04090411|593565289|FG006|Induction Period|Protocol Violation|0|||
164324911|NCT04090411|593565290|FG007|Induction Period|Protocol Violation|0|||
164324912|NCT04090411|593565291|FG008|Induction Period|Protocol Violation|0|||
164324913|NCT04090411|593565292|FG009|Induction Period|Protocol Violation|0|||
164324914|NCT04090411|593565293|FG010|Induction Period|Protocol Violation|0|||
164324915|NCT04090411|593565294|FG011|Induction Period|Protocol Violation|0|||
164324916|NCT04090411|593565295|FG012|Induction Period|Protocol Violation|0|||
164324917|NCT04090411|593565283|FG000|Induction Period|Withdrawal by Subject|2|||
164324918|NCT04090411|593565284|FG001|Induction Period|Withdrawal by Subject|0|||
164324919|NCT04090411|593565285|FG002|Induction Period|Withdrawal by Subject|1|||
164324920|NCT04090411|593565286|FG003|Induction Period|Withdrawal by Subject|5|||
164324921|NCT04090411|593565287|FG004|Induction Period|Withdrawal by Subject|0|||
164324922|NCT04090411|593565288|FG005|Induction Period|Withdrawal by Subject|0|||
164324923|NCT04090411|593565289|FG006|Induction Period|Withdrawal by Subject|0|||
164324924|NCT04090411|593565290|FG007|Induction Period|Withdrawal by Subject|0|||
164324925|NCT04090411|593565291|FG008|Induction Period|Withdrawal by Subject|0|||
164324926|NCT04090411|593565292|FG009|Induction Period|Withdrawal by Subject|0|||
164324927|NCT04090411|593565293|FG010|Induction Period|Withdrawal by Subject|0|||
164324928|NCT04090411|593565294|FG011|Induction Period|Withdrawal by Subject|0|||
164324929|NCT04090411|593565295|FG012|Induction Period|Withdrawal by Subject|0|||
164324930|NCT04090411|593565283|FG000|Chronic Period|Adverse Event|0|||
164324931|NCT04090411|593565284|FG001|Chronic Period|Adverse Event|0|||
164324932|NCT04090411|593565285|FG002|Chronic Period|Adverse Event|0|||
164324933|NCT04090411|593565286|FG003|Chronic Period|Adverse Event|0|||
164324934|NCT04090411|593565287|FG004|Chronic Period|Adverse Event|0|||
164324935|NCT04090411|593565288|FG005|Chronic Period|Adverse Event|1|||
164324936|NCT04090411|593565289|FG006|Chronic Period|Adverse Event|0|||
164324937|NCT04090411|593565290|FG007|Chronic Period|Adverse Event|3|||
164324938|NCT04090411|593565291|FG008|Chronic Period|Adverse Event|0|||
164324939|NCT04090411|593565292|FG009|Chronic Period|Adverse Event|0|||
164324940|NCT04090411|593565293|FG010|Chronic Period|Adverse Event|5|||
164324941|NCT04090411|593565294|FG011|Chronic Period|Adverse Event|1|||
164324942|NCT04090411|593565295|FG012|Chronic Period|Adverse Event|1|||
164324943|NCT04090411|593565283|FG000|Chronic Period|Lack of Efficacy|0|||
164324944|NCT04090411|593565284|FG001|Chronic Period|Lack of Efficacy|0|||
164564744|NCT02772757|594436349|FG000|Overall Study|Protocol Violation|0|||
164564745|NCT02772757|594436350|FG001|Overall Study|Protocol Violation|0|||
164564746|NCT02772757|594436351|FG002|Overall Study|Protocol Violation|1|||
164564747|NCT02772757|594436349|FG000|Overall Study|Physician Decision|0|||
164564748|NCT02772757|594436350|FG001|Overall Study|Physician Decision|3|||
164324945|NCT04090411|593565285|FG002|Chronic Period|Lack of Efficacy|0|||
164324946|NCT04090411|593565286|FG003|Chronic Period|Lack of Efficacy|0|||
164564749|NCT02772757|594436351|FG002|Overall Study|Physician Decision|3|||
164564750|NCT00441792|594436352|FG000|Overall Study|Lost to Follow-up|0|||
164324947|NCT04090411|593565287|FG004|Chronic Period|Lack of Efficacy|0|||
164324948|NCT04090411|593565288|FG005|Chronic Period|Lack of Efficacy|0|||
164324949|NCT04090411|593565289|FG006|Chronic Period|Lack of Efficacy|1|||
164324950|NCT04090411|593565290|FG007|Chronic Period|Lack of Efficacy|4|||
164324951|NCT04090411|593565291|FG008|Chronic Period|Lack of Efficacy|2|||
164324952|NCT04090411|593565292|FG009|Chronic Period|Lack of Efficacy|2|||
164324953|NCT04090411|593565293|FG010|Chronic Period|Lack of Efficacy|2|||
164564751|NCT00441792|594436353|FG001|Overall Study|Lost to Follow-up|2|||
164324954|NCT04090411|593565294|FG011|Chronic Period|Lack of Efficacy|1|||
164324955|NCT04090411|593565295|FG012|Chronic Period|Lack of Efficacy|2|||
164564752|NCT01731678|594436354|FG000|Overall Study|Withdrawal by Subject|3|||
164324956|NCT04090411|593565283|FG000|Chronic Period|Relocation|0|||
164211138|NCT03126110|593140329|FG007|Phase 1|Survival follow-up no longer necessary|0|||
164211139|NCT03126110|593140330|FG008|Phase 1|Survival follow-up no longer necessary|0|||
164211140|NCT03126110|593140331|FG009|Phase 1|Survival follow-up no longer necessary|0|||
164211141|NCT03126110|593140332|FG010|Phase 1|Survival follow-up no longer necessary|0|||
164211142|NCT03126110|593140333|FG011|Phase 1|Survival follow-up no longer necessary|0|||
164211143|NCT03126110|593140334|FG012|Phase 1|Survival follow-up no longer necessary|0|||
164211144|NCT03126110|593140335|FG013|Phase 1|Survival follow-up no longer necessary|0|||
164211145|NCT03126110|593140336|FG014|Phase 1|Survival follow-up no longer necessary|0|||
164211146|NCT03126110|593140337|FG015|Phase 1|Survival follow-up no longer necessary|0|||
164211147|NCT03126110|593140338|FG016|Phase 1|Survival follow-up no longer necessary|0|||
164211148|NCT03126110|593140322|FG000|Phase 2|Study terminated by the sponsor|0|||
164211149|NCT03126110|593140323|FG001|Phase 2|Study terminated by the sponsor|0|||
164211150|NCT03126110|593140324|FG002|Phase 2|Study terminated by the sponsor|0|||
164211151|NCT03126110|593140325|FG003|Phase 2|Study terminated by the sponsor|0|||
164211152|NCT03126110|593140326|FG004|Phase 2|Study terminated by the sponsor|0|||
164211153|NCT03126110|593140327|FG005|Phase 2|Study terminated by the sponsor|0|||
164211154|NCT03126110|593140328|FG006|Phase 2|Study terminated by the sponsor|0|||
164211155|NCT03126110|593140329|FG007|Phase 2|Study terminated by the sponsor|0|||
164211156|NCT03126110|593140330|FG008|Phase 2|Study terminated by the sponsor|0|||
164211157|NCT03126110|593140331|FG009|Phase 2|Study terminated by the sponsor|0|||
164211158|NCT03126110|593140332|FG010|Phase 2|Study terminated by the sponsor|0|||
164211159|NCT03126110|593140333|FG011|Phase 2|Study terminated by the sponsor|0|||
164211160|NCT03126110|593140334|FG012|Phase 2|Study terminated by the sponsor|0|||
164211161|NCT03126110|593140335|FG013|Phase 2|Study terminated by the sponsor|4|||
164211162|NCT03126110|593140336|FG014|Phase 2|Study terminated by the sponsor|0|||
164211163|NCT03126110|593140337|FG015|Phase 2|Study terminated by the sponsor|0|||
164211164|NCT03126110|593140338|FG016|Phase 2|Study terminated by the sponsor|0|||
164211165|NCT03126110|593140322|FG000|Phase 2|Withdrawal by Subject|0|||
164211166|NCT03126110|593140323|FG001|Phase 2|Withdrawal by Subject|0|||
164211167|NCT03126110|593140324|FG002|Phase 2|Withdrawal by Subject|0|||
164211168|NCT03126110|593140325|FG003|Phase 2|Withdrawal by Subject|0|||
164211169|NCT03126110|593140326|FG004|Phase 2|Withdrawal by Subject|0|||
164211170|NCT03126110|593140327|FG005|Phase 2|Withdrawal by Subject|0|||
164211171|NCT03126110|593140328|FG006|Phase 2|Withdrawal by Subject|0|||
164211172|NCT03126110|593140329|FG007|Phase 2|Withdrawal by Subject|0|||
164211173|NCT03126110|593140330|FG008|Phase 2|Withdrawal by Subject|0|||
164211174|NCT03126110|593140331|FG009|Phase 2|Withdrawal by Subject|0|||
164211175|NCT03126110|593140332|FG010|Phase 2|Withdrawal by Subject|0|||
164211176|NCT03126110|593140333|FG011|Phase 2|Withdrawal by Subject|1|||
164211177|NCT03126110|593140334|FG012|Phase 2|Withdrawal by Subject|3|||
164211178|NCT03126110|593140335|FG013|Phase 2|Withdrawal by Subject|3|||
164211179|NCT03126110|593140336|FG014|Phase 2|Withdrawal by Subject|2|||
164211180|NCT03126110|593140337|FG015|Phase 2|Withdrawal by Subject|1|||
164211181|NCT03126110|593140338|FG016|Phase 2|Withdrawal by Subject|0|||
164211182|NCT03126110|593140322|FG000|Phase 2|Lost to Follow-up|0|||
164211183|NCT03126110|593140323|FG001|Phase 2|Lost to Follow-up|0|||
164211184|NCT03126110|593140324|FG002|Phase 2|Lost to Follow-up|0|||
164211185|NCT03126110|593140325|FG003|Phase 2|Lost to Follow-up|0|||
164211186|NCT03126110|593140326|FG004|Phase 2|Lost to Follow-up|0|||
164211187|NCT03126110|593140327|FG005|Phase 2|Lost to Follow-up|0|||
164211188|NCT03126110|593140328|FG006|Phase 2|Lost to Follow-up|0|||
164211189|NCT03126110|593140329|FG007|Phase 2|Lost to Follow-up|0|||
164211190|NCT03126110|593140330|FG008|Phase 2|Lost to Follow-up|0|||
164564753|NCT01731678|594436354|FG000|Overall Study|Did not meet inclusion criteria|1|||
164564754|NCT01731678|594436354|FG000|Overall Study|RMT too high, making TMS difficult|3|||
164564755|NCT00888355|594436357|FG000|Overall Study|Adverse Event|10|||
164564756|NCT00888355|594436358|FG001|Overall Study|Adverse Event|0|||
164564757|NCT00888355|594436359|FG002|Overall Study|Adverse Event|3|||
164564758|NCT00888355|594436360|FG003|Overall Study|Adverse Event|3|||
164564759|NCT00888355|594436357|FG000|Overall Study|Lack of Efficacy|9|||
164564760|NCT00888355|594436358|FG001|Overall Study|Lack of Efficacy|2|||
164564761|NCT00888355|594436359|FG002|Overall Study|Lack of Efficacy|5|||
164564762|NCT00888355|594436360|FG003|Overall Study|Lack of Efficacy|2|||
164564763|NCT00888355|594436357|FG000|Overall Study|Lost to Follow-up|0|||
164564764|NCT00888355|594436358|FG001|Overall Study|Lost to Follow-up|2|||
164564765|NCT00888355|594436359|FG002|Overall Study|Lost to Follow-up|2|||
164564766|NCT00888355|594436360|FG003|Overall Study|Lost to Follow-up|0|||
164564767|NCT00888355|594436357|FG000|Overall Study|Protocol Violation|3|||
164564768|NCT00888355|594436358|FG001|Overall Study|Protocol Violation|2|||
164564769|NCT00888355|594436359|FG002|Overall Study|Protocol Violation|1|||
164564770|NCT00888355|594436360|FG003|Overall Study|Protocol Violation|2|||
164564771|NCT00888355|594436357|FG000|Overall Study|Withdrawal by Subject|0|||
164564772|NCT00888355|594436358|FG001|Overall Study|Withdrawal by Subject|3|||
164564773|NCT00888355|594436359|FG002|Overall Study|Withdrawal by Subject|1|||
164564774|NCT00888355|594436360|FG003|Overall Study|Withdrawal by Subject|3|||
164564775|NCT01235962|594436363|FG000|Overall Study|Withdrawal by Subject|20|||
164211191|NCT03126110|593140331|FG009|Phase 2|Lost to Follow-up|0|||
164211192|NCT03126110|593140332|FG010|Phase 2|Lost to Follow-up|0|||
164211193|NCT03126110|593140333|FG011|Phase 2|Lost to Follow-up|1|||
164211194|NCT03126110|593140334|FG012|Phase 2|Lost to Follow-up|1|||
164211195|NCT03126110|593140335|FG013|Phase 2|Lost to Follow-up|1|||
164564776|NCT01235962|594436364|FG001|Overall Study|Withdrawal by Subject|19|||
164564777|NCT01235962|594436365|FG002|Overall Study|Withdrawal by Subject|62|||
164564778|NCT01235962|594436366|FG003|Overall Study|Withdrawal by Subject|49|||
164564779|NCT01235962|594436363|FG000|Overall Study|Lost to Follow-up|21|||
164564780|NCT01235962|594436364|FG001|Overall Study|Lost to Follow-up|16|||
164564781|NCT01235962|594436365|FG002|Overall Study|Lost to Follow-up|47|||
164211196|NCT03126110|593140336|FG014|Phase 2|Lost to Follow-up|2|||
164211197|NCT03126110|593140337|FG015|Phase 2|Lost to Follow-up|0|||
164211198|NCT03126110|593140338|FG016|Phase 2|Lost to Follow-up|0|||
164211199|NCT03126110|593140322|FG000|Phase 2|Death|0|||
164211200|NCT03126110|593140323|FG001|Phase 2|Death|0|||
164211201|NCT03126110|593140324|FG002|Phase 2|Death|0|||
164564782|NCT01235962|594436366|FG003|Overall Study|Lost to Follow-up|32|||
164564783|NCT01235962|594436363|FG000|Overall Study|Physician Decision|5|||
164564784|NCT01235962|594436364|FG001|Overall Study|Physician Decision|0|||
164564785|NCT01235962|594436365|FG002|Overall Study|Physician Decision|9|||
164564786|NCT01235962|594436366|FG003|Overall Study|Physician Decision|5|||
164564787|NCT03543410|594436367|FG000|Overall Study|Adverse Event|10|||
164564788|NCT03543410|594436368|FG001|Overall Study|Adverse Event|8|||
164564789|NCT03543410|594436369|FG002|Overall Study|Adverse Event|2|||
164564790|NCT03543410|594436367|FG000|Overall Study|Lack of Efficacy|0|||
164564791|NCT03543410|594436368|FG001|Overall Study|Lack of Efficacy|1|||
164564792|NCT03543410|594436369|FG002|Overall Study|Lack of Efficacy|0|||
164564793|NCT03543410|594436367|FG000|Overall Study|Lost to Follow-up|0|||
164564794|NCT03543410|594436368|FG001|Overall Study|Lost to Follow-up|1|||
164564795|NCT03543410|594436369|FG002|Overall Study|Lost to Follow-up|0|||
164564796|NCT03543410|594436367|FG000|Overall Study|Withdrawal by Subject|5|||
164564797|NCT03543410|594436368|FG001|Overall Study|Withdrawal by Subject|2|||
164564798|NCT03543410|594436369|FG002|Overall Study|Withdrawal by Subject|8|||
164564799|NCT03543410|594436367|FG000|Overall Study|Protocol Violation|0|||
164564800|NCT03543410|594436368|FG001|Overall Study|Protocol Violation|1|||
164564801|NCT03543410|594436369|FG002|Overall Study|Protocol Violation|0|||
164564802|NCT03543410|594436367|FG000|Overall Study|Due to COVID-19|4|||
164564803|NCT03543410|594436368|FG001|Overall Study|Due to COVID-19|0|||
164564804|NCT03543410|594436369|FG002|Overall Study|Due to COVID-19|2|||
164564805|NCT03543410|594436367|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
164564806|NCT03543410|594436368|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
164564807|NCT03543410|594436369|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
164564808|NCT03543410|594436367|FG000|Overall Study|Not Due to COVID-19|2|||
164564809|NCT03543410|594436368|FG001|Overall Study|Not Due to COVID-19|0|||
164564810|NCT03543410|594436369|FG002|Overall Study|Not Due to COVID-19|1|||
164564811|NCT01318122|594436372|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
164564812|NCT01318122|594436373|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
164564813|NCT01318122|594436374|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
164564814|NCT01318122|594436375|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
164564815|NCT01318122|594436372|FG000|Enrolled - Long-Term Extension Study|Other|1|||
164564816|NCT01318122|594436373|FG001|Enrolled - Long-Term Extension Study|Other|0|||
164564817|NCT01318122|594436374|FG002|Enrolled - Long-Term Extension Study|Other|0|||
164564818|NCT01318122|594436375|FG003|Enrolled - Long-Term Extension Study|Other|0|||
164564819|NCT01318122|594436372|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
164564820|NCT01318122|594436373|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
164564821|NCT01318122|594436374|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
164564822|NCT01318122|594436375|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
164564823|NCT01318122|594436372|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
164564824|NCT01318122|594436373|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
164564825|NCT01318122|594436374|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
164564826|NCT01318122|594436375|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
164564827|NCT01318122|594436372|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
164564828|NCT01318122|594436373|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
164564829|NCT01318122|594436374|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
164564830|NCT01318122|594436375|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
164211202|NCT03126110|593140325|FG003|Phase 2|Death|0|||
164211203|NCT03126110|593140326|FG004|Phase 2|Death|0|||
164211204|NCT03126110|593140327|FG005|Phase 2|Death|0|||
164211205|NCT03126110|593140328|FG006|Phase 2|Death|0|||
164211206|NCT03126110|593140329|FG007|Phase 2|Death|0|||
164211207|NCT03126110|593140330|FG008|Phase 2|Death|0|||
164211208|NCT03126110|593140331|FG009|Phase 2|Death|0|||
164211209|NCT03126110|593140332|FG010|Phase 2|Death|0|||
164211210|NCT03126110|593140333|FG011|Phase 2|Death|6|||
164211211|NCT03126110|593140334|FG012|Phase 2|Death|12|||
164211212|NCT03126110|593140335|FG013|Phase 2|Death|25|||
164211213|NCT03126110|593140336|FG014|Phase 2|Death|11|||
164211214|NCT03126110|593140337|FG015|Phase 2|Death|3|||
164211215|NCT03126110|593140338|FG016|Phase 2|Death|2|||
164211216|NCT03126110|593140322|FG000|Phase 2|Progressive Disease|0|||
164211217|NCT03126110|593140323|FG001|Phase 2|Progressive Disease|0|||
164211218|NCT03126110|593140324|FG002|Phase 2|Progressive Disease|0|||
164211219|NCT03126110|593140325|FG003|Phase 2|Progressive Disease|0|||
164564831|NCT01318122|594436372|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
164564832|NCT01318122|594436373|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
164211220|NCT03126110|593140326|FG004|Phase 2|Progressive Disease|0|||
164211221|NCT03126110|593140327|FG005|Phase 2|Progressive Disease|0|||
164211222|NCT03126110|593140328|FG006|Phase 2|Progressive Disease|0|||
164211223|NCT03126110|593140329|FG007|Phase 2|Progressive Disease|0|||
164324957|NCT04090411|593565284|FG001|Chronic Period|Relocation|0|||
164324958|NCT04090411|593565285|FG002|Chronic Period|Relocation|0|||
164324959|NCT04090411|593565286|FG003|Chronic Period|Relocation|0|||
164324960|NCT04090411|593565287|FG004|Chronic Period|Relocation|0|||
164324961|NCT04090411|593565288|FG005|Chronic Period|Relocation|0|||
164324962|NCT04090411|593565289|FG006|Chronic Period|Relocation|0|||
164324963|NCT04090411|593565290|FG007|Chronic Period|Relocation|1|||
164324964|NCT04090411|593565291|FG008|Chronic Period|Relocation|0|||
164324965|NCT04090411|593565292|FG009|Chronic Period|Relocation|0|||
164324966|NCT04090411|593565293|FG010|Chronic Period|Relocation|0|||
164324967|NCT04090411|593565294|FG011|Chronic Period|Relocation|0|||
164324968|NCT04090411|593565295|FG012|Chronic Period|Relocation|0|||
164324969|NCT04090411|593565283|FG000|Chronic Period|Physician Decision|0|||
164324970|NCT04090411|593565284|FG001|Chronic Period|Physician Decision|0|||
164324971|NCT04090411|593565285|FG002|Chronic Period|Physician Decision|0|||
164324972|NCT04090411|593565286|FG003|Chronic Period|Physician Decision|0|||
164324973|NCT04090411|593565287|FG004|Chronic Period|Physician Decision|1|||
164324974|NCT04090411|593565288|FG005|Chronic Period|Physician Decision|0|||
164324975|NCT04090411|593565289|FG006|Chronic Period|Physician Decision|0|||
164324976|NCT04090411|593565290|FG007|Chronic Period|Physician Decision|1|||
164324977|NCT04090411|593565291|FG008|Chronic Period|Physician Decision|0|||
164324978|NCT04090411|593565292|FG009|Chronic Period|Physician Decision|0|||
164324979|NCT04090411|593565293|FG010|Chronic Period|Physician Decision|0|||
164324980|NCT04090411|593565294|FG011|Chronic Period|Physician Decision|1|||
164324981|NCT04090411|593565295|FG012|Chronic Period|Physician Decision|1|||
164324982|NCT04090411|593565283|FG000|Chronic Period|Protocol Violation|0|||
164324983|NCT04090411|593565284|FG001|Chronic Period|Protocol Violation|0|||
164324984|NCT04090411|593565285|FG002|Chronic Period|Protocol Violation|0|||
164324985|NCT04090411|593565286|FG003|Chronic Period|Protocol Violation|0|||
164324986|NCT04090411|593565287|FG004|Chronic Period|Protocol Violation|0|||
164324987|NCT04090411|593565288|FG005|Chronic Period|Protocol Violation|0|||
164324988|NCT04090411|593565289|FG006|Chronic Period|Protocol Violation|0|||
164324989|NCT04090411|593565290|FG007|Chronic Period|Protocol Violation|0|||
164324990|NCT04090411|593565291|FG008|Chronic Period|Protocol Violation|0|||
164324991|NCT04090411|593565292|FG009|Chronic Period|Protocol Violation|0|||
164324992|NCT04090411|593565293|FG010|Chronic Period|Protocol Violation|0|||
164324993|NCT04090411|593565294|FG011|Chronic Period|Protocol Violation|0|||
164324994|NCT04090411|593565295|FG012|Chronic Period|Protocol Violation|1|||
164324995|NCT04090411|593565283|FG000|Chronic Period|Withdrawal by Subject|0|||
164324996|NCT04090411|593565284|FG001|Chronic Period|Withdrawal by Subject|0|||
164324997|NCT04090411|593565285|FG002|Chronic Period|Withdrawal by Subject|0|||
164324998|NCT04090411|593565286|FG003|Chronic Period|Withdrawal by Subject|0|||
164324999|NCT04090411|593565287|FG004|Chronic Period|Withdrawal by Subject|0|||
164325000|NCT04090411|593565288|FG005|Chronic Period|Withdrawal by Subject|1|||
164325001|NCT04090411|593565289|FG006|Chronic Period|Withdrawal by Subject|1|||
164325002|NCT04090411|593565290|FG007|Chronic Period|Withdrawal by Subject|3|||
164325003|NCT04090411|593565291|FG008|Chronic Period|Withdrawal by Subject|3|||
164325004|NCT04090411|593565292|FG009|Chronic Period|Withdrawal by Subject|3|||
164325005|NCT04090411|593565293|FG010|Chronic Period|Withdrawal by Subject|1|||
164325006|NCT04090411|593565294|FG011|Chronic Period|Withdrawal by Subject|3|||
164325007|NCT04090411|593565295|FG012|Chronic Period|Withdrawal by Subject|0|||
164669070|NCT03247556|594813535|FG000|Overall Study|Protocol Violation|2|||
164669071|NCT03247556|594813536|FG001|Overall Study|Protocol Violation|0|||
164669072|NCT03247556|594813537|FG002|Overall Study|Protocol Violation|1|||
164669073|NCT03247556|594813535|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
164669074|NCT03247556|594813536|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
164669075|NCT03247556|594813537|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
164669076|NCT00358449|594813539|FG000|Overall Study|Adverse Event|1|||
164669077|NCT00358449|594813540|FG001|Overall Study|Adverse Event|0|||
164669078|NCT00358449|594813541|FG002|Overall Study|Adverse Event|1|||
164669079|NCT00358449|594813539|FG000|Overall Study|Lost to Follow-up|1|||
164669080|NCT00358449|594813540|FG001|Overall Study|Lost to Follow-up|0|||
164669081|NCT00358449|594813541|FG002|Overall Study|Lost to Follow-up|0|||
164325008|NCT02477696|593565302|FG000|Overall Study|Death|89|||
164325009|NCT02477696|593565303|FG001|Overall Study|Death|106|||
164325010|NCT02477696|593565302|FG000|Overall Study|Lost to Follow-up|7|||
164325011|NCT02477696|593565303|FG001|Overall Study|Lost to Follow-up|5|||
164669082|NCT00358449|594813539|FG000|Overall Study|Withdrawal by Subject|2|||
164669083|NCT00358449|594813540|FG001|Overall Study|Withdrawal by Subject|0|||
164325012|NCT02477696|593565302|FG000|Overall Study|Withdrawal by Subject|37|||
164325013|NCT02477696|593565303|FG001|Overall Study|Withdrawal by Subject|34|||
164325014|NCT02477696|593565302|FG000|Overall Study|Physician Decision|7|||
164325015|NCT02477696|593565303|FG001|Overall Study|Physician Decision|9|||
164325016|NCT02477696|593565302|FG000|Overall Study|Study terminated by sponsor|103|||
164325017|NCT02477696|593565303|FG001|Overall Study|Study terminated by sponsor|99|||
164325018|NCT02477696|593565302|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
164325019|NCT02477696|593565303|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
164669084|NCT00358449|594813541|FG002|Overall Study|Withdrawal by Subject|0|||
164669085|NCT00358449|594813539|FG000|Overall Study|Lack of Efficacy|0|||
164669086|NCT00358449|594813540|FG001|Overall Study|Lack of Efficacy|1|||
164211224|NCT03126110|593140330|FG008|Phase 2|Progressive Disease|0|||
164669087|NCT00358449|594813541|FG002|Overall Study|Lack of Efficacy|0|||
164669088|NCT00358449|594813539|FG000|Overall Study|Steriod Inhaler was Increased|0|||
164669089|NCT00358449|594813540|FG001|Overall Study|Steriod Inhaler was Increased|0|||
164669090|NCT00358449|594813541|FG002|Overall Study|Steriod Inhaler was Increased|1|||
164669091|NCT01804270|594813542|FG000|Overall Study|Withdrawal by Subject|1|||
164669092|NCT01804270|594813543|FG001|Overall Study|Withdrawal by Subject|1|||
164669093|NCT02334722|594813545|FG000|Overall Study|Lost to Follow-up|4|||
164669094|NCT02334722|594813546|FG001|Overall Study|Lost to Follow-up|0|||
164669095|NCT02334722|594813545|FG000|Overall Study|6 week questionnaire not completed|2|||
164669096|NCT02334722|594813546|FG001|Overall Study|6 week questionnaire not completed|0|||
164669097|NCT02334722|594813545|FG000|Overall Study|Unable to obtain medication|1|||
164669098|NCT02334722|594813546|FG001|Overall Study|Unable to obtain medication|1|||
164669099|NCT02334722|594813545|FG000|Overall Study|Withdrawal by Subject|0|||
164669100|NCT02334722|594813546|FG001|Overall Study|Withdrawal by Subject|3|||
164669101|NCT02334722|594813545|FG000|Overall Study|Adverse Event|0|||
164669102|NCT02334722|594813546|FG001|Overall Study|Adverse Event|2|||
164669103|NCT02334722|594813545|FG000|Overall Study|Physician Decision|0|||
164669104|NCT02334722|594813546|FG001|Overall Study|Physician Decision|1|||
164669105|NCT01434693|594813549|FG000|Overall Study|Adverse Event|1|||
164669106|NCT01434693|594813550|FG001|Overall Study|Adverse Event|0|||
164669107|NCT01434693|594813551|FG002|Overall Study|Adverse Event|0|||
164669108|NCT01434693|594813552|FG003|Overall Study|Adverse Event|0|||
164669109|NCT01434693|594813549|FG000|Overall Study|Withdrawal by Subject|1|||
164669110|NCT01434693|594813550|FG001|Overall Study|Withdrawal by Subject|0|||
164669111|NCT01434693|594813551|FG002|Overall Study|Withdrawal by Subject|1|||
164669112|NCT01434693|594813552|FG003|Overall Study|Withdrawal by Subject|1|||
164669113|NCT01434693|594813549|FG000|Overall Study|Lost to Follow-up|1|||
164669114|NCT01434693|594813550|FG001|Overall Study|Lost to Follow-up|0|||
164669115|NCT01434693|594813551|FG002|Overall Study|Lost to Follow-up|0|||
164669116|NCT01434693|594813552|FG003|Overall Study|Lost to Follow-up|0|||
164669117|NCT02087904|594813553|FG000|Overall Study|Did Not Receive Study Drug|0|||
164669118|NCT02087904|594813554|FG001|Overall Study|Did Not Receive Study Drug|0|||
164669119|NCT02087904|594813555|FG002|Overall Study|Did Not Receive Study Drug|2|||
164669120|NCT02087904|594813556|FG003|Overall Study|Did Not Receive Study Drug|1|||
164669121|NCT02087904|594813553|FG000|Overall Study|Adverse Event|8|||
164669122|NCT02087904|594813554|FG001|Overall Study|Adverse Event|4|||
164669123|NCT02087904|594813555|FG002|Overall Study|Adverse Event|4|||
164669124|NCT02087904|594813556|FG003|Overall Study|Adverse Event|12|||
164669125|NCT02087904|594813553|FG000|Overall Study|Lack of Efficacy|3|||
164669126|NCT02087904|594813554|FG001|Overall Study|Lack of Efficacy|6|||
164669127|NCT02087904|594813555|FG002|Overall Study|Lack of Efficacy|3|||
164669128|NCT02087904|594813556|FG003|Overall Study|Lack of Efficacy|2|||
164669129|NCT02087904|594813553|FG000|Overall Study|Other|6|||
164669130|NCT02087904|594813554|FG001|Overall Study|Other|2|||
164669131|NCT02087904|594813555|FG002|Overall Study|Other|4|||
164669132|NCT02087904|594813556|FG003|Overall Study|Other|4|||
164669133|NCT02087904|594813553|FG000|Overall Study|Withdrawal by Subject|8|||
164211225|NCT03126110|593140331|FG009|Phase 2|Progressive Disease|0|||
164211226|NCT03126110|593140332|FG010|Phase 2|Progressive Disease|0|||
164211227|NCT03126110|593140333|FG011|Phase 2|Progressive Disease|0|||
164211228|NCT03126110|593140334|FG012|Phase 2|Progressive Disease|0|||
164211229|NCT03126110|593140335|FG013|Phase 2|Progressive Disease|1|||
164211230|NCT03126110|593140336|FG014|Phase 2|Progressive Disease|0|||
164211231|NCT03126110|593140337|FG015|Phase 2|Progressive Disease|0|||
164211232|NCT03126110|593140338|FG016|Phase 2|Progressive Disease|0|||
164211233|NCT03126110|593140322|FG000|Phase 2|Started new treatment|0|||
164211234|NCT03126110|593140323|FG001|Phase 2|Started new treatment|0|||
164211235|NCT03126110|593140324|FG002|Phase 2|Started new treatment|0|||
164211236|NCT03126110|593140325|FG003|Phase 2|Started new treatment|0|||
164211237|NCT03126110|593140326|FG004|Phase 2|Started new treatment|0|||
164211238|NCT03126110|593140327|FG005|Phase 2|Started new treatment|0|||
164211239|NCT03126110|593140328|FG006|Phase 2|Started new treatment|0|||
164211240|NCT03126110|593140329|FG007|Phase 2|Started new treatment|0|||
164211241|NCT03126110|593140330|FG008|Phase 2|Started new treatment|0|||
164211242|NCT03126110|593140331|FG009|Phase 2|Started new treatment|0|||
164211243|NCT03126110|593140332|FG010|Phase 2|Started new treatment|0|||
164211244|NCT03126110|593140333|FG011|Phase 2|Started new treatment|0|||
164211245|NCT03126110|593140334|FG012|Phase 2|Started new treatment|0|||
164211246|NCT03126110|593140335|FG013|Phase 2|Started new treatment|0|||
164211247|NCT03126110|593140336|FG014|Phase 2|Started new treatment|1|||
164211248|NCT03126110|593140337|FG015|Phase 2|Started new treatment|0|||
164211249|NCT03126110|593140338|FG016|Phase 2|Started new treatment|0|||
164669134|NCT02087904|594813554|FG001|Overall Study|Withdrawal by Subject|3|||
164211250|NCT00314145|593140339|FG000|Overall Study|Withdrawal by Subject|8|||
164211251|NCT00314145|593140340|FG001|Overall Study|Withdrawal by Subject|10|||
164325020|NCT02477696|593565302|FG000|Overall Study|Missing/Unknown|2|||
164325021|NCT02477696|593565303|FG001|Overall Study|Missing/Unknown|0|||
164325022|NCT04770753|593566011|FG000|Overall Study|Randomized, never treated|1|||
164325023|NCT04770753|593566012|FG001|Overall Study|Randomized, never treated|1|||
164325024|NCT04770753|593566011|FG000|Overall Study|Withdrawal by Subject|3|||
164325025|NCT04770753|593566012|FG001|Overall Study|Withdrawal by Subject|1|||
164325026|NCT04770753|593566011|FG000|Overall Study|Adverse Event|2|||
164325027|NCT04770753|593566012|FG001|Overall Study|Adverse Event|0|||
164325028|NCT04770753|593566011|FG000|Overall Study|Pregnancy|1|||
164325029|NCT04770753|593566012|FG001|Overall Study|Pregnancy|0|||
164564833|NCT01318122|594436374|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
164564834|NCT01318122|594436375|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
164564835|NCT01573910|594436379|FG000|Overall Study|Adverse Event|4|||
164564836|NCT01573910|594436380|FG001|Overall Study|Adverse Event|4|||
164564837|NCT01573910|594436379|FG000|Overall Study|Lost to Follow-up|2|||
164564838|NCT01573910|594436380|FG001|Overall Study|Lost to Follow-up|1|||
164564839|NCT01573910|594436379|FG000|Overall Study|Withdrawal by Subject|0|||
164564840|NCT01573910|594436380|FG001|Overall Study|Withdrawal by Subject|1|||
164564841|NCT01573910|594436379|FG000|Overall Study|Protocol Violation|3|||
164564842|NCT01573910|594436380|FG001|Overall Study|Protocol Violation|0|||
164564843|NCT01573910|594436379|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
164564844|NCT01573910|594436380|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
164564845|NCT02251912|594436381|FG000|Overall Study|Withdrawal by Subject|2|||
164564846|NCT02251912|594436382|FG001|Overall Study|Withdrawal by Subject|3|||
164564847|NCT02251912|594436381|FG000|Overall Study|Adverse Event|0|||
164564848|NCT02251912|594436382|FG001|Overall Study|Adverse Event|2|||
164564849|NCT00268242|594436384|FG000|Overall Study|Death|1|||
164564850|NCT02175680|594436385|FG000|Overall Study|non-compliance|1|||
164564851|NCT02175680|594436385|FG000|Overall Study|other non-medical reason|1|||
164564852|NCT01913483|594436386|FG000|Overall Study|Withdrawal by Subject|1|||
164564853|NCT01913483|594436387|FG001|Overall Study|Withdrawal by Subject|2|||
164564854|NCT01913483|594436386|FG000|Overall Study|Lost to Follow-up|6|||
164564855|NCT01913483|594436387|FG001|Overall Study|Lost to Follow-up|3|||
164564856|NCT01913483|594436386|FG000|Overall Study|Death|14|||
164564857|NCT01913483|594436387|FG001|Overall Study|Death|17|||
164211252|NCT00314145|593140339|FG000|Overall Study|Lost to Follow-up|5|||
164564858|NCT03969888|594436388|FG000|Overall Study|Never Received Study Drug|0|||
164564859|NCT03969888|594436389|FG001|Overall Study|Never Received Study Drug|0|||
164564860|NCT03969888|594436390|FG002|Overall Study|Never Received Study Drug|1|||
164564861|NCT03969888|594436391|FG003|Overall Study|Never Received Study Drug|0|||
164564862|NCT03969888|594436392|FG004|Overall Study|Never Received Study Drug|0|||
164564863|NCT03969888|594436393|FG005|Overall Study|Never Received Study Drug|0|||
164211253|NCT00314145|593140340|FG001|Overall Study|Lost to Follow-up|12|||
164211254|NCT00314145|593140339|FG000|Overall Study|Physician Decision|3|||
164211255|NCT00314145|593140340|FG001|Overall Study|Physician Decision|4|||
164211256|NCT00314145|593140339|FG000|Overall Study|Adverse Event|0|||
164211257|NCT00314145|593140340|FG001|Overall Study|Adverse Event|3|||
164211258|NCT00314145|593140339|FG000|Overall Study|Protocol Violation|3|||
164211259|NCT00314145|593140340|FG001|Overall Study|Protocol Violation|0|||
164211260|NCT00314145|593140339|FG000|Overall Study|Sponsor Decision|2|||
164211261|NCT00314145|593140340|FG001|Overall Study|Sponsor Decision|0|||
164211262|NCT02382380|593140342|FG000|Overall Study|Withdrawal by Subject|2|||
164211263|NCT02382380|593140343|FG001|Overall Study|Withdrawal by Subject|2|||
164211264|NCT02382380|593140342|FG000|Overall Study|Lost to Follow-up|0|||
164211265|NCT02382380|593140343|FG001|Overall Study|Lost to Follow-up|1|||
164211266|NCT01295944|593140344|FG000|Overall Study|Switched to alternative treatment|1|||
164211267|NCT01295944|593140344|FG000|Overall Study|Ineligible|9|||
164211268|NCT01295944|593140344|FG000|Overall Study|Withdrawal by Subject|1|||
164211269|NCT01295944|593140344|FG000|Overall Study|Participant chose to be treated in Peru|1|||
164211270|NCT01295944|593140344|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
164211271|NCT01295944|593140344|FG000|Overall Study|Physician Decision|1|||
164211272|NCT01295944|593140344|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
164211273|NCT01295944|593140344|FG000|Overall Study|Disease progression|4|||
164211274|NCT01295944|593140344|FG000|Overall Study|Transferred care before starting new treatment|1|||
164211275|NCT03785366|593140345|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
164211276|NCT03785366|593140346|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
164325030|NCT04770753|593566011|FG000|Overall Study|Other un-specified|1|||
164564864|NCT03969888|594436394|FG006|Overall Study|Never Received Study Drug|1|||
164564865|NCT03969888|594436395|FG007|Overall Study|Never Received Study Drug|0|||
164564866|NCT03969888|594436388|FG000|Overall Study|Reason Not Specified|0|||
164564867|NCT03969888|594436389|FG001|Overall Study|Reason Not Specified|0|||
164211277|NCT03785366|593140345|FG000|Overall Study|Lost to Follow-up|1|||
164211278|NCT03785366|593140346|FG001|Overall Study|Lost to Follow-up|0|||
164325031|NCT04770753|593566012|FG001|Overall Study|Other un-specified|0|||
164564868|NCT03969888|594436390|FG002|Overall Study|Reason Not Specified|0|||
164325032|NCT05859698|593566014|FG000|Overall Study|Adverse Event|1|||
164325033|NCT05859698|593566014|FG000|Overall Study|Death|1|||
164325034|NCT05859698|593566014|FG000|Overall Study|Physician Decision|1|||
164325035|NCT05859698|593566014|FG000|Overall Study|Lost to Follow-up|2|||
164325036|NCT05859698|593566014|FG000|Overall Study|Other Than Specified|2|||
164325037|NCT05859698|593566014|FG000|Overall Study|Withdrawal by Subject|1|||
164325038|NCT05900999|593566015|FG000|Overall Study|Withdrawal by Subject|9|||
164325039|NCT05900999|593566015|FG000|Overall Study|transfer to another facility; too complex of a therapy schedule; physician withdrawal|3|||
164325040|NCT04527549|593566017|FG000|Overall Study|Withdrawal by Subject|1|||
164325041|NCT04527549|593566018|FG001|Overall Study|Withdrawal by Subject|1|||
164325042|NCT05411367|593566023|FG000|Overall Study|Adverse Event|9|||
164325043|NCT05411367|593566024|FG001|Overall Study|Adverse Event|3|||
164325044|NCT05411367|593566023|FG000|Overall Study|Protocol Violation|0|||
164325045|NCT05411367|593566024|FG001|Overall Study|Protocol Violation|2|||
164325046|NCT05411367|593566023|FG000|Overall Study|Administrative Reasons|2|||
164325047|NCT05411367|593566024|FG001|Overall Study|Administrative Reasons|1|||
164325048|NCT05411367|593566023|FG000|Overall Study|Withdrawal by Subject|3|||
164325049|NCT05411367|593566024|FG001|Overall Study|Withdrawal by Subject|4|||
164325050|NCT05411367|593566023|FG000|Overall Study|Inclusion Criteria Not Met|0|||
164325051|NCT05411367|593566024|FG001|Overall Study|Inclusion Criteria Not Met|1|||
164325052|NCT02032823|593566025|FG000|Overall Study|Death|75|||
164325053|NCT02032823|593566026|FG001|Overall Study|Death|109|||
164325054|NCT02032823|593566025|FG000|Overall Study|Lost to Follow-up|18|||
164325055|NCT02032823|593566026|FG001|Overall Study|Lost to Follow-up|17|||
164325056|NCT02032823|593566025|FG000|Overall Study|Withdrawal by Subject|70|||
164325057|NCT02032823|593566026|FG001|Overall Study|Withdrawal by Subject|53|||
164325058|NCT02032823|593566025|FG000|Overall Study|Ongoing study at data cut-off|755|||
164325059|NCT02032823|593566026|FG001|Overall Study|Ongoing study at data cut-off|731|||
164325060|NCT02032823|593566025|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
164325061|NCT02032823|593566026|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
164325062|NCT02411448|593566027|FG000|Overall Study|Withdrawal by Subject|1|||
164325063|NCT02411448|593566028|FG001|Overall Study|Withdrawal by Subject|14|||
164325064|NCT02411448|593566029|FG002|Overall Study|Withdrawal by Subject|9|||
164325065|NCT02411448|593566027|FG000|Overall Study|Other|0|||
164325066|NCT02411448|593566028|FG001|Overall Study|Other|2|||
164325067|NCT02411448|593566029|FG002|Overall Study|Other|0|||
164325068|NCT02411448|593566027|FG000|Overall Study|Did not receive study treatment|0|||
164325069|NCT02411448|593566028|FG001|Overall Study|Did not receive study treatment|3|||
164325070|NCT02411448|593566029|FG002|Overall Study|Did not receive study treatment|0|||
164325071|NCT02411448|593566027|FG000|Overall Study|Alive on study treatment|3|||
164325072|NCT02411448|593566028|FG001|Overall Study|Alive on study treatment|64|||
164325073|NCT02411448|593566029|FG002|Overall Study|Alive on study treatment|43|||
164325074|NCT02616562|593566031|FG000|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325075|NCT02616562|593566032|FG001|Main Period (26 Weeks)|Withdrawal by parent/guardian|1|||
164325076|NCT02616562|593566033|FG002|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325077|NCT02616562|593566034|FG003|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325078|NCT02616562|593566035|FG004|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325079|NCT02616562|593566036|FG005|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325080|NCT02616562|593566037|FG006|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325081|NCT02616562|593566038|FG007|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325082|NCT02616562|593566039|FG008|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325083|NCT02616562|593566040|FG009|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325084|NCT02616562|593566041|FG010|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325085|NCT02616562|593566042|FG011|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325086|NCT02616562|593566043|FG012|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325087|NCT02616562|593566044|FG013|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325088|NCT02616562|593566045|FG014|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325089|NCT02616562|593566046|FG015|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325090|NCT02616562|593566047|FG016|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325091|NCT02616562|593566031|FG000|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325092|NCT02616562|593566032|FG001|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325093|NCT02616562|593566033|FG002|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325094|NCT02616562|593566034|FG003|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325095|NCT02616562|593566035|FG004|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325096|NCT02616562|593566036|FG005|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325097|NCT02616562|593566037|FG006|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325098|NCT02616562|593566038|FG007|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325099|NCT02616562|593566039|FG008|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325100|NCT02616562|593566040|FG009|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|1|||
164325101|NCT02616562|593566041|FG010|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164211279|NCT03785366|593140345|FG000|Overall Study|Partial IUD Expulsion|0|||
164211280|NCT03785366|593140346|FG001|Overall Study|Partial IUD Expulsion|2|||
164211281|NCT03785366|593140345|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
164211282|NCT03785366|593140346|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
164211283|NCT03240874|593140347|FG000|Overall Study|Lost to Follow-up|0|||
164211284|NCT03240874|593140348|FG001|Overall Study|Lost to Follow-up|2|||
164211285|NCT03240874|593140349|FG002|Overall Study|Lost to Follow-up|4|||
164211286|NCT03240874|593140350|FG003|Overall Study|Lost to Follow-up|1|||
164211287|NCT04958707|593140351|FG000|Post Intervention|Withdrawal by Subject|1|||
164211288|NCT04958707|593140352|FG001|Post Intervention|Withdrawal by Subject|0|||
164211289|NCT04958707|593140353|FG002|Post Intervention|Withdrawal by Subject|0|||
164211290|NCT04958707|593140351|FG000|3 Months Follow- up|Lost to Follow-up|0|||
164211291|NCT04958707|593140352|FG001|3 Months Follow- up|Lost to Follow-up|3|||
164211292|NCT04958707|593140353|FG002|3 Months Follow- up|Lost to Follow-up|0|||
164211293|NCT04958707|593140351|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
164211294|NCT04958707|593140352|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
164211295|NCT04958707|593140353|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
164211296|NCT02783274|593140357|FG000|Overall Study|Withdrawal by Subject|16|||
164211297|NCT02783274|593140357|FG000|Overall Study|Physician Decision|6|||
164211298|NCT02783274|593140357|FG000|Overall Study|Death|9|||
164211299|NCT02783274|593140357|FG000|Overall Study|Lost to Follow-up|22|||
164211300|NCT02783274|593140357|FG000|Overall Study|Other|22|||
164211301|NCT05567172|593140358|FG000|Overall Study|Death|3|||
164211302|NCT02246777|593140361|FG000|Overall Study|Adverse Event|2|||
164211303|NCT02246777|593140361|FG000|Overall Study|Change of residence|1|||
164211304|NCT00927472|593140362|FG000|Overall Study|Withdrawal by Subject|10|||
164211305|NCT00927472|593140363|FG001|Overall Study|Withdrawal by Subject|11|||
164211306|NCT00927472|593140362|FG000|Overall Study|Lost to Follow-up|1|||
164211307|NCT00927472|593140363|FG001|Overall Study|Lost to Follow-up|6|||
164211308|NCT00927472|593140362|FG000|Overall Study|Protocol Violation|0|||
164211309|NCT00927472|593140363|FG001|Overall Study|Protocol Violation|1|||
164211310|NCT00927472|593140362|FG000|Overall Study|Post treatment Assessment out of window|0|||
164211311|NCT00927472|593140363|FG001|Overall Study|Post treatment Assessment out of window|4|||
164211312|NCT04707469|593140364|FG000|Overall Study|Site closure|0|||
164211313|NCT04707469|593140365|FG001|Overall Study|Site closure|2|||
164211314|NCT04707469|593140366|FG002|Overall Study|Site closure|0|||
164211315|NCT04707469|593140364|FG000|Overall Study|Physician Decision|2|||
164211316|NCT04707469|593140365|FG001|Overall Study|Physician Decision|2|||
164211317|NCT04707469|593140366|FG002|Overall Study|Physician Decision|2|||
164211318|NCT04707469|593140364|FG000|Overall Study|Death|1|||
164211319|NCT04707469|593140365|FG001|Overall Study|Death|6|||
164211320|NCT04707469|593140366|FG002|Overall Study|Death|2|||
164211321|NCT04707469|593140364|FG000|Overall Study|Lost to Follow-up|9|||
164211322|NCT04707469|593140365|FG001|Overall Study|Lost to Follow-up|19|||
164211323|NCT04707469|593140366|FG002|Overall Study|Lost to Follow-up|14|||
164211324|NCT04707469|593140364|FG000|Overall Study|Withdrawal by Subject|17|||
164211325|NCT04707469|593140365|FG001|Overall Study|Withdrawal by Subject|16|||
164211326|NCT04707469|593140366|FG002|Overall Study|Withdrawal by Subject|12|||
164211327|NCT04635423|593140379|FG000|Overall Study|Ongoing|493|||
164211328|NCT04635423|593140380|FG001|Overall Study|Ongoing|501|||
164211329|NCT04635423|593140379|FG000|Overall Study|Withdrawal by Subject|36|||
164211330|NCT04635423|593140380|FG001|Overall Study|Withdrawal by Subject|29|||
164211331|NCT00830765|593140384|FG000|Overall Study|Protocol Violation|3|||
164211332|NCT00830765|593140385|FG001|Overall Study|Protocol Violation|2|||
164211333|NCT01811238|593140386|FG000|Overall Study|Withdrawal by Subject|42|||
164211334|NCT01811238|593140386|FG000|Overall Study|Adverse Event|25|||
164211335|NCT01811238|593140386|FG000|Overall Study|Protocol Violation|4|||
164211336|NCT01811238|593140386|FG000|Overall Study|Lack of Efficacy|4|||
164211337|NCT01811238|593140386|FG000|Overall Study|subject refused study medication|6|||
164325102|NCT02616562|593566042|FG011|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325103|NCT02616562|593566043|FG012|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325104|NCT02616562|593566044|FG013|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325105|NCT02616562|593566045|FG014|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164211338|NCT01977846|593140387|FG000|Total Study - Prospective|Death|0|||
164211339|NCT01977846|593140388|FG001|Total Study - Prospective|Death|1|||
164211340|NCT01977846|593140387|FG000|Total Study - Prospective|Lost to Follow-up|0|||
164211341|NCT01977846|593140388|FG001|Total Study - Prospective|Lost to Follow-up|8|||
164211342|NCT01977846|593140387|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
164211343|NCT01977846|593140388|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
164211344|NCT01977846|593140387|FG000|Total Study - Prospective|Not available at time of visit|0|||
164211345|NCT01977846|593140388|FG001|Total Study - Prospective|Not available at time of visit|5|||
164211346|NCT01977846|593140387|FG000|Total Study - Prospective|No show|0|||
164211347|NCT01977846|593140388|FG001|Total Study - Prospective|No show|1|||
164211348|NCT01977846|593140387|FG000|Total Study - Prospective|Protocol Violation|0|||
164211349|NCT01977846|593140388|FG001|Total Study - Prospective|Protocol Violation|1|||
164564869|NCT03969888|594436391|FG003|Overall Study|Reason Not Specified|0|||
164564870|NCT03969888|594436392|FG004|Overall Study|Reason Not Specified|0|||
164211350|NCT00724945|593140389|FG000|Period 1|non-compliance|1|||
164211351|NCT00724945|593140390|FG001|Period 1|non-compliance|0|||
164211352|NCT00724945|593140389|FG000|Period 1|Adverse Event|1|||
164211353|NCT00724945|593140390|FG001|Period 1|Adverse Event|1|||
164211354|NCT00724945|593140389|FG000|Period 1|Lost to Follow-up|1|||
164211355|NCT00724945|593140390|FG001|Period 1|Lost to Follow-up|0|||
164211356|NCT00724945|593140389|FG000|Period 2|lens comfort issue|3|||
164211357|NCT00724945|593140390|FG001|Period 2|lens comfort issue|0|||
164211358|NCT00724945|593140389|FG000|Period 2|lens physiology issue|1|||
164211359|NCT00724945|593140390|FG001|Period 2|lens physiology issue|0|||
164211360|NCT05166876|593140391|FG000|Overall Study|Withdrawal by Subject|1|||
164211361|NCT05166876|593140392|FG001|Overall Study|Withdrawal by Subject|0|||
164211362|NCT05166876|593140393|FG002|Overall Study|Withdrawal by Subject|0|||
164211363|NCT03479905|593140398|FG000|Overall Study|Other airway method used|4|||
164211364|NCT03479905|593140399|FG001|Overall Study|Other airway method used|5|||
164211365|NCT03479905|593140400|FG002|Overall Study|Other airway method used|5|||
164211366|NCT01147458|593140401|FG000|First Intervention|Study terminated by sponsor|8|||
164211367|NCT01147458|593140402|FG001|First Intervention|Study terminated by sponsor|8|||
164211368|NCT01147458|593140403|FG002|First Intervention|Study terminated by sponsor|7|||
164211369|NCT01147458|593140404|FG003|First Intervention|Study terminated by sponsor|8|||
164211370|NCT01147458|593140401|FG000|First Intervention|Protocol Violation|2|||
164211371|NCT01147458|593140402|FG001|First Intervention|Protocol Violation|3|||
164211372|NCT01147458|593140403|FG002|First Intervention|Protocol Violation|2|||
164211373|NCT01147458|593140404|FG003|First Intervention|Protocol Violation|3|||
164211374|NCT01147458|593140401|FG000|First Intervention|Withdrawal by Subject|3|||
164211375|NCT01147458|593140402|FG001|First Intervention|Withdrawal by Subject|0|||
164211376|NCT01147458|593140403|FG002|First Intervention|Withdrawal by Subject|1|||
164211377|NCT01147458|593140404|FG003|First Intervention|Withdrawal by Subject|0|||
164211378|NCT01147458|593140401|FG000|First Intervention|Adverse Event|0|||
164211379|NCT01147458|593140402|FG001|First Intervention|Adverse Event|3|||
164211380|NCT01147458|593140403|FG002|First Intervention|Adverse Event|2|||
164211381|NCT01147458|593140404|FG003|First Intervention|Adverse Event|3|||
164211382|NCT01147458|593140401|FG000|First Intervention|Other|1|||
164211383|NCT01147458|593140402|FG001|First Intervention|Other|2|||
164211384|NCT01147458|593140403|FG002|First Intervention|Other|0|||
164211385|NCT01147458|593140404|FG003|First Intervention|Other|0|||
164211386|NCT01147458|593140401|FG000|Second Intervention|Study terminated by sponsor|7|||
164211387|NCT01147458|593140402|FG001|Second Intervention|Study terminated by sponsor|5|||
164211388|NCT01147458|593140403|FG002|Second Intervention|Study terminated by sponsor|5|||
164211389|NCT01147458|593140404|FG003|Second Intervention|Study terminated by sponsor|3|||
164211390|NCT01147458|593140401|FG000|Second Intervention|Protocol Violation|0|||
164211391|NCT01147458|593140402|FG001|Second Intervention|Protocol Violation|1|||
164211392|NCT01147458|593140403|FG002|Second Intervention|Protocol Violation|1|||
164211393|NCT01147458|593140404|FG003|Second Intervention|Protocol Violation|0|||
164211394|NCT01147458|593140401|FG000|Second Intervention|Withdrawal by Subject|0|||
164211395|NCT01147458|593140402|FG001|Second Intervention|Withdrawal by Subject|1|||
164211396|NCT01147458|593140403|FG002|Second Intervention|Withdrawal by Subject|0|||
164211397|NCT01147458|593140404|FG003|Second Intervention|Withdrawal by Subject|0|||
164211398|NCT01147458|593140401|FG000|Second Intervention|Adverse Event|2|||
164211399|NCT01147458|593140402|FG001|Second Intervention|Adverse Event|0|||
164211400|NCT01147458|593140403|FG002|Second Intervention|Adverse Event|1|||
164211401|NCT01147458|593140404|FG003|Second Intervention|Adverse Event|1|||
164211402|NCT01147458|593140401|FG000|Second Intervention|Other|0|||
164211403|NCT01147458|593140402|FG001|Second Intervention|Other|0|||
164211404|NCT01147458|593140403|FG002|Second Intervention|Other|1|||
164211405|NCT01147458|593140404|FG003|Second Intervention|Other|0|||
164211406|NCT02811159|593140416|FG000|Treatment Course 1|Lost to Follow-up|1|||
164211407|NCT00143507|593142472|FG000|Overall Study|Death|572|||
164211408|NCT00143507|593142473|FG001|Overall Study|Death|547|||
164211409|NCT00143507|593142472|FG000|Overall Study|Withdrawal by Subject|114|||
164211410|NCT00143507|593142473|FG001|Overall Study|Withdrawal by Subject|102|||
164211411|NCT00143507|593142472|FG000|Overall Study|Lost to Follow-up|1|||
164211412|NCT00143507|593142473|FG001|Overall Study|Lost to Follow-up|0|||
164211413|NCT00143507|593142472|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
164325106|NCT02616562|593566046|FG015|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325107|NCT02616562|593566047|FG016|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164211414|NCT00143507|593142473|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
164211415|NCT00177671|593142474|FG000|Overall Study|Withdrawal by Subject|5|||
164211416|NCT00177671|593142475|FG001|Overall Study|Withdrawal by Subject|6|||
164211417|NCT00177671|593142474|FG000|Overall Study|medical complications|2|||
164211418|NCT00177671|593142475|FG001|Overall Study|medical complications|0|||
164211419|NCT00177671|593142474|FG000|Overall Study|Adverse Event|6|||
164211420|NCT00177671|593142475|FG001|Overall Study|Adverse Event|0|||
164211421|NCT00177671|593142474|FG000|Overall Study|Physician Decision|12|||
164211422|NCT00177671|593142475|FG001|Overall Study|Physician Decision|8|||
164355619|NCT00512707|593676482|FG000|Overall Study|Developed skin irritation|2|||
164211423|NCT00690898|593142476|FG000|SCREENING|Screen failure|18|||
164211424|NCT00690898|593142476|FG000|TREATMENT|Adverse Event|3|||
164325108|NCT02616562|593566031|FG000|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325109|NCT02616562|593566032|FG001|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325110|NCT02616562|593566033|FG002|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325111|NCT02616562|593566034|FG003|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325112|NCT02616562|593566035|FG004|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325113|NCT02616562|593566036|FG005|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325114|NCT02616562|593566037|FG006|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325115|NCT02616562|593566038|FG007|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325116|NCT02616562|593566039|FG008|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|1|||
164325117|NCT02616562|593566040|FG009|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|1|||
164325118|NCT02616562|593566041|FG010|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325119|NCT02616562|593566042|FG011|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325120|NCT02616562|593566043|FG012|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325121|NCT02616562|593566044|FG013|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325122|NCT02616562|593566045|FG014|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325123|NCT02616562|593566046|FG015|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325124|NCT02616562|593566047|FG016|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325125|NCT02616562|593566031|FG000|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325126|NCT02616562|593566032|FG001|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325127|NCT02616562|593566033|FG002|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325128|NCT02616562|593566034|FG003|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325129|NCT02616562|593566035|FG004|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325130|NCT02616562|593566036|FG005|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325131|NCT02616562|593566037|FG006|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325132|NCT02616562|593566038|FG007|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325133|NCT02616562|593566039|FG008|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325134|NCT02616562|593566040|FG009|Safety Extension Period (104 Weeks)|Lost to Follow-up|1|||
164669135|NCT02087904|594813555|FG002|Overall Study|Withdrawal by Subject|7|||
164669136|NCT02087904|594813556|FG003|Overall Study|Withdrawal by Subject|4|||
164669137|NCT02087904|594813553|FG000|Overall Study|Lost to Follow-up|0|||
164669138|NCT02087904|594813554|FG001|Overall Study|Lost to Follow-up|4|||
164669139|NCT02087904|594813555|FG002|Overall Study|Lost to Follow-up|2|||
164669140|NCT02087904|594813556|FG003|Overall Study|Lost to Follow-up|2|||
164211425|NCT00690898|593142476|FG000|TREATMENT|Lack of Efficacy|18|||
164211426|NCT00690898|593142476|FG000|TREATMENT|Withdrawal by Subject|4|||
164211427|NCT00690898|593142476|FG000|TREATMENT|Other (not otherwise specified)|1|||
164211428|NCT00356590|593142478|FG000|Overall Study|Adverse Event|54|||
164211429|NCT00356590|593142478|FG000|Overall Study|Death|10|||
164211430|NCT00356590|593142478|FG000|Overall Study|Lost to Follow-up|35|||
164211431|NCT00356590|593142478|FG000|Overall Study|Physician Decision|46|||
164211432|NCT00356590|593142478|FG000|Overall Study|Withdrawal by Subject|41|||
164211433|NCT00356590|593142478|FG000|Overall Study|Completed month 12 only|2|||
164211434|NCT00356590|593142478|FG000|Overall Study|Protocol issues|6|||
164211435|NCT00356590|593142478|FG000|Overall Study|Response status|28|||
164211436|NCT00356590|593142478|FG000|Overall Study|Other|52|||
164211437|NCT01496456|593142479|FG000|Overall Study|Protocol Violation|1|||
164211438|NCT01496456|593142479|FG000|Overall Study|Lost to Follow-up|7|||
164211439|NCT04919161|593142480|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
164211440|NCT04919161|593142481|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
164211441|NCT04919161|593142480|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
164211442|NCT04919161|593142481|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
164211443|NCT04919161|593142480|FG000|Overall Study|Acute ankle sprain after session 1|0|||
164211444|NCT04919161|593142481|FG001|Overall Study|Acute ankle sprain after session 1|1|||
164211445|NCT02239328|593142482|FG000|Overall Study|Benign disease noted at time of surgery|6|||
164211446|NCT02239328|593142482|FG000|Overall Study|Equipment or website malfunction|2|||
164211447|NCT01838876|593142484|FG000|Overall Study|Adverse Event|49|||
164211448|NCT01838876|593142484|FG000|Overall Study|Insufficient Therapeutic Response|10|||
164211449|NCT01838876|593142484|FG000|Overall Study|Protocol Violation|34|||
164211450|NCT01838876|593142484|FG000|Overall Study|Withdrawal of Consent|33|||
164211451|NCT01838876|593142484|FG000|Overall Study|Lost to Follow-up|21|||
164211452|NCT01838876|593142484|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
164211453|NCT01838876|593142484|FG000|Overall Study|Reason not Specified|7|||
164211454|NCT01838876|593142484|FG000|Overall Study|Did not meet eligibility criteria|78|||
164211455|NCT01682031|593142485|FG000|Overall Study|Withdrawal by Subject|0|||
164211456|NCT01682031|593142486|FG001|Overall Study|Withdrawal by Subject|1|||
164211457|NCT01682031|593142485|FG000|Overall Study|Adverse Event|0|||
164211458|NCT01682031|593142486|FG001|Overall Study|Adverse Event|2|||
164211459|NCT01682031|593142485|FG000|Overall Study|MRI results indicate increased nodul|0|||
164211460|NCT01682031|593142486|FG001|Overall Study|MRI results indicate increased nodul|1|||
164211461|NCT01682031|593142485|FG000|Overall Study|Patient could not swallow tablets|1|||
164211462|NCT01682031|593142486|FG001|Overall Study|Patient could not swallow tablets|0|||
164211463|NCT01682031|593142485|FG000|Overall Study|Patient stopped selenium on his own|0|||
164211464|NCT01682031|593142486|FG001|Overall Study|Patient stopped selenium on his own|1|||
164211465|NCT00963235|593142489|FG000|Overall Study|Withdrawal by Subject|22|||
164211466|NCT00963235|593142489|FG000|Overall Study|Lost to Follow-up|14|||
164211467|NCT00963235|593142489|FG000|Overall Study|Failed to return|9|||
164211468|NCT00963235|593142489|FG000|Overall Study|Protocol Violation|7|||
164211469|NCT00963235|593142489|FG000|Overall Study|Adverse Event|5|||
164211470|NCT00963235|593142489|FG000|Overall Study|Physician Decision|2|||
164211471|NCT00963235|593142489|FG000|Overall Study|Other|1|||
164211472|NCT01756235|593142490|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
164211473|NCT02327078|593142495|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
164211474|NCT02327078|593142496|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
164211475|NCT02327078|593142497|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
164211476|NCT02327078|593142498|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
164211477|NCT02327078|593142499|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
164211478|NCT02327078|593142500|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
164211479|NCT02327078|593142501|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
164211480|NCT02327078|593142502|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
164211481|NCT02327078|593142503|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
164211482|NCT02327078|593142495|FG000|Overall Study|Death|2|||
164211483|NCT02327078|593142496|FG001|Overall Study|Death|4|||
164211484|NCT02327078|593142497|FG002|Overall Study|Death|10|||
164211485|NCT02327078|593142498|FG003|Overall Study|Death|6|||
164211486|NCT02327078|593142499|FG004|Overall Study|Death|4|||
164211487|NCT02327078|593142500|FG005|Overall Study|Death|3|||
164211488|NCT02327078|593142501|FG006|Overall Study|Death|2|||
164211489|NCT02327078|593142502|FG007|Overall Study|Death|51|||
164211490|NCT02327078|593142503|FG008|Overall Study|Death|97|||
164211491|NCT02327078|593142495|FG000|Overall Study|Lost to Follow-up|0|||
164211492|NCT02327078|593142496|FG001|Overall Study|Lost to Follow-up|1|||
164211493|NCT02327078|593142497|FG002|Overall Study|Lost to Follow-up|1|||
164211494|NCT02327078|593142498|FG003|Overall Study|Lost to Follow-up|0|||
164211495|NCT02327078|593142499|FG004|Overall Study|Lost to Follow-up|0|||
164211496|NCT02327078|593142500|FG005|Overall Study|Lost to Follow-up|0|||
164211497|NCT02327078|593142501|FG006|Overall Study|Lost to Follow-up|0|||
164211498|NCT02327078|593142502|FG007|Overall Study|Lost to Follow-up|2|||
164211499|NCT02327078|593142503|FG008|Overall Study|Lost to Follow-up|5|||
164211500|NCT02327078|593142495|FG000|Overall Study|Site Terminated by Sponsor|1|||
164211501|NCT02327078|593142496|FG001|Overall Study|Site Terminated by Sponsor|0|||
164211502|NCT02327078|593142497|FG002|Overall Study|Site Terminated by Sponsor|1|||
164211503|NCT02327078|593142498|FG003|Overall Study|Site Terminated by Sponsor|4|||
164211504|NCT02327078|593142499|FG004|Overall Study|Site Terminated by Sponsor|0|||
164211505|NCT02327078|593142500|FG005|Overall Study|Site Terminated by Sponsor|0|||
164211506|NCT02327078|593142501|FG006|Overall Study|Site Terminated by Sponsor|0|||
164211507|NCT02327078|593142502|FG007|Overall Study|Site Terminated by Sponsor|11|||
164211508|NCT02327078|593142503|FG008|Overall Study|Site Terminated by Sponsor|25|||
164211509|NCT02327078|593142495|FG000|Overall Study|Physician Decision|0|||
164211510|NCT02327078|593142496|FG001|Overall Study|Physician Decision|0|||
164211511|NCT02327078|593142497|FG002|Overall Study|Physician Decision|0|||
164211512|NCT02327078|593142498|FG003|Overall Study|Physician Decision|1|||
164211513|NCT02327078|593142499|FG004|Overall Study|Physician Decision|0|||
164211514|NCT02327078|593142500|FG005|Overall Study|Physician Decision|0|||
164211515|NCT02327078|593142501|FG006|Overall Study|Physician Decision|0|||
164211516|NCT02327078|593142502|FG007|Overall Study|Physician Decision|0|||
164211517|NCT02327078|593142503|FG008|Overall Study|Physician Decision|1|||
164211518|NCT02327078|593142495|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
164211519|NCT02327078|593142496|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
164211520|NCT02327078|593142497|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
164211521|NCT02327078|593142498|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
164211522|NCT02327078|593142499|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
164211523|NCT02327078|593142500|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
164211524|NCT02327078|593142501|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
164211525|NCT02327078|593142502|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
164211526|NCT02327078|593142503|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
164211527|NCT02327078|593142495|FG000|Overall Study|Reason not Specified|0|||
164211528|NCT02327078|593142496|FG001|Overall Study|Reason not Specified|0|||
164211529|NCT02327078|593142497|FG002|Overall Study|Reason not Specified|0|||
164211530|NCT02327078|593142498|FG003|Overall Study|Reason not Specified|0|||
164211531|NCT02327078|593142499|FG004|Overall Study|Reason not Specified|0|||
164211532|NCT02327078|593142500|FG005|Overall Study|Reason not Specified|0|||
164211533|NCT02327078|593142501|FG006|Overall Study|Reason not Specified|0|||
164211534|NCT02327078|593142502|FG007|Overall Study|Reason not Specified|5|||
164211535|NCT02327078|593142503|FG008|Overall Study|Reason not Specified|12|||
164211536|NCT03330197|593142507|FG000|Overall Study|Adverse Event|0|||
164211537|NCT03330197|593142508|FG001|Overall Study|Adverse Event|1|||
164211538|NCT03330197|593142507|FG000|Overall Study|Withdrawal by Subject|0|||
164211539|NCT03330197|593142508|FG001|Overall Study|Withdrawal by Subject|1|||
164211540|NCT03765073|593142509|FG000|Stage 1|Lost to Follow-up|1|||
164211541|NCT03765073|593142510|FG001|Stage 1|Lost to Follow-up|0|||
164211542|NCT03765073|593142511|FG002|Stage 1|Lost to Follow-up|0|||
164211543|NCT03765073|593142512|FG003|Stage 1|Lost to Follow-up|0|||
164211544|NCT03765073|593142513|FG004|Stage 1|Lost to Follow-up|0|||
164211545|NCT03765073|593142514|FG005|Stage 1|Lost to Follow-up|0|||
164211546|NCT03765073|593142515|FG006|Stage 1|Lost to Follow-up|0|||
164211547|NCT03765073|593142516|FG007|Stage 1|Lost to Follow-up|0|||
164211548|NCT03765073|593142517|FG008|Stage 1|Lost to Follow-up|0|||
164211549|NCT03765073|593142518|FG009|Stage 1|Lost to Follow-up|0|||
164211550|NCT03765073|593142519|FG010|Stage 1|Lost to Follow-up|0|||
164211551|NCT03765073|593142520|FG011|Stage 1|Lost to Follow-up|0|||
164211552|NCT03765073|593142521|FG012|Stage 1|Lost to Follow-up|0|||
164211553|NCT03765073|593142522|FG013|Stage 1|Lost to Follow-up|0|||
164211554|NCT03765073|593142523|FG014|Stage 1|Lost to Follow-up|0|||
164211555|NCT03765073|593142524|FG015|Stage 1|Lost to Follow-up|0|||
164211556|NCT03765073|593142525|FG016|Stage 1|Lost to Follow-up|0|||
164211557|NCT03765073|593142526|FG017|Stage 1|Lost to Follow-up|0|||
164211558|NCT03765073|593142527|FG018|Stage 1|Lost to Follow-up|0|||
164211559|NCT03765073|593142528|FG019|Stage 1|Lost to Follow-up|0|||
164211560|NCT03765073|593142529|FG020|Stage 1|Lost to Follow-up|0|||
164211561|NCT03765073|593142509|FG000|Stage 1|Withdrawal by participant|0|||
164211562|NCT03765073|593142510|FG001|Stage 1|Withdrawal by participant|1|||
164211563|NCT03765073|593142511|FG002|Stage 1|Withdrawal by participant|0|||
164211564|NCT03765073|593142512|FG003|Stage 1|Withdrawal by participant|0|||
164211565|NCT03765073|593142513|FG004|Stage 1|Withdrawal by participant|0|||
164211566|NCT03765073|593142514|FG005|Stage 1|Withdrawal by participant|0|||
164211567|NCT03765073|593142515|FG006|Stage 1|Withdrawal by participant|0|||
164211568|NCT03765073|593142516|FG007|Stage 1|Withdrawal by participant|0|||
164211569|NCT03765073|593142517|FG008|Stage 1|Withdrawal by participant|0|||
164211570|NCT03765073|593142518|FG009|Stage 1|Withdrawal by participant|0|||
164211571|NCT03765073|593142519|FG010|Stage 1|Withdrawal by participant|0|||
164211572|NCT03765073|593142520|FG011|Stage 1|Withdrawal by participant|0|||
164211573|NCT03765073|593142521|FG012|Stage 1|Withdrawal by participant|0|||
164211574|NCT03765073|593142522|FG013|Stage 1|Withdrawal by participant|0|||
164211575|NCT03765073|593142523|FG014|Stage 1|Withdrawal by participant|0|||
164211576|NCT03765073|593142524|FG015|Stage 1|Withdrawal by participant|0|||
164211577|NCT03765073|593142525|FG016|Stage 1|Withdrawal by participant|0|||
164211578|NCT03765073|593142526|FG017|Stage 1|Withdrawal by participant|0|||
164211579|NCT03765073|593142527|FG018|Stage 1|Withdrawal by participant|0|||
164211580|NCT03765073|593142528|FG019|Stage 1|Withdrawal by participant|0|||
164211581|NCT03765073|593142529|FG020|Stage 1|Withdrawal by participant|0|||
164211582|NCT03765073|593142509|FG000|Stage 2|Death|0|||
164211583|NCT03765073|593142510|FG001|Stage 2|Death|0|||
164211584|NCT03765073|593142511|FG002|Stage 2|Death|0|||
164211585|NCT03765073|593142512|FG003|Stage 2|Death|0|||
164211586|NCT03765073|593142513|FG004|Stage 2|Death|0|||
164211587|NCT03765073|593142514|FG005|Stage 2|Death|0|||
164211588|NCT03765073|593142515|FG006|Stage 2|Death|0|||
164211589|NCT03765073|593142516|FG007|Stage 2|Death|0|||
164211590|NCT03765073|593142517|FG008|Stage 2|Death|0|||
164211591|NCT03765073|593142518|FG009|Stage 2|Death|1|||
164211592|NCT03765073|593142519|FG010|Stage 2|Death|0|||
164211593|NCT03765073|593142520|FG011|Stage 2|Death|1|||
164211594|NCT03765073|593142521|FG012|Stage 2|Death|0|||
164211595|NCT03765073|593142522|FG013|Stage 2|Death|0|||
164211596|NCT03765073|593142523|FG014|Stage 2|Death|0|||
164211597|NCT03765073|593142524|FG015|Stage 2|Death|0|||
164211598|NCT03765073|593142525|FG016|Stage 2|Death|2|||
164211599|NCT03765073|593142526|FG017|Stage 2|Death|0|||
164211600|NCT03765073|593142527|FG018|Stage 2|Death|0|||
164211601|NCT03765073|593142528|FG019|Stage 2|Death|0|||
164211602|NCT03765073|593142529|FG020|Stage 2|Death|0|||
164211603|NCT03765073|593142509|FG000|Stage 2|Lost to Follow-up|0|||
164211604|NCT03765073|593142510|FG001|Stage 2|Lost to Follow-up|0|||
164211605|NCT03765073|593142511|FG002|Stage 2|Lost to Follow-up|0|||
164211606|NCT03765073|593142512|FG003|Stage 2|Lost to Follow-up|5|||
164211607|NCT03765073|593142513|FG004|Stage 2|Lost to Follow-up|1|||
164211608|NCT03765073|593142514|FG005|Stage 2|Lost to Follow-up|0|||
164211609|NCT03765073|593142515|FG006|Stage 2|Lost to Follow-up|3|||
164211610|NCT03765073|593142516|FG007|Stage 2|Lost to Follow-up|3|||
164211611|NCT03765073|593142517|FG008|Stage 2|Lost to Follow-up|1|||
164211612|NCT03765073|593142518|FG009|Stage 2|Lost to Follow-up|6|||
164211613|NCT03765073|593142519|FG010|Stage 2|Lost to Follow-up|5|||
164211614|NCT03765073|593142520|FG011|Stage 2|Lost to Follow-up|1|||
164211615|NCT03765073|593142521|FG012|Stage 2|Lost to Follow-up|1|||
164211616|NCT03765073|593142522|FG013|Stage 2|Lost to Follow-up|3|||
164211617|NCT03765073|593142523|FG014|Stage 2|Lost to Follow-up|3|||
164211618|NCT03765073|593142524|FG015|Stage 2|Lost to Follow-up|1|||
164211619|NCT03765073|593142525|FG016|Stage 2|Lost to Follow-up|6|||
164211620|NCT03765073|593142526|FG017|Stage 2|Lost to Follow-up|0|||
164211621|NCT03765073|593142527|FG018|Stage 2|Lost to Follow-up|0|||
164211622|NCT03765073|593142528|FG019|Stage 2|Lost to Follow-up|0|||
164211623|NCT03765073|593142529|FG020|Stage 2|Lost to Follow-up|0|||
164211624|NCT03765073|593142509|FG000|Stage 2|Other|0|||
164211625|NCT03765073|593142510|FG001|Stage 2|Other|0|||
164211626|NCT03765073|593142511|FG002|Stage 2|Other|0|||
164211627|NCT03765073|593142512|FG003|Stage 2|Other|0|||
164211628|NCT03765073|593142513|FG004|Stage 2|Other|0|||
164211629|NCT03765073|593142514|FG005|Stage 2|Other|0|||
164211630|NCT03765073|593142515|FG006|Stage 2|Other|0|||
164211631|NCT03765073|593142516|FG007|Stage 2|Other|1|||
164211632|NCT03765073|593142517|FG008|Stage 2|Other|1|||
164211633|NCT03765073|593142518|FG009|Stage 2|Other|3|||
164211634|NCT03765073|593142519|FG010|Stage 2|Other|0|||
164211635|NCT03765073|593142520|FG011|Stage 2|Other|0|||
164211636|NCT03765073|593142521|FG012|Stage 2|Other|0|||
164211637|NCT03765073|593142522|FG013|Stage 2|Other|0|||
164211638|NCT03765073|593142523|FG014|Stage 2|Other|0|||
164211639|NCT03765073|593142524|FG015|Stage 2|Other|1|||
164211640|NCT03765073|593142525|FG016|Stage 2|Other|2|||
164564871|NCT03969888|594436393|FG005|Overall Study|Reason Not Specified|0|||
164211641|NCT03765073|593142526|FG017|Stage 2|Other|0|||
164211642|NCT03765073|593142527|FG018|Stage 2|Other|0|||
164211643|NCT03765073|593142528|FG019|Stage 2|Other|0|||
164211644|NCT03765073|593142529|FG020|Stage 2|Other|0|||
164211645|NCT03765073|593142509|FG000|Stage 2|Withdrawal by parent/guardian|0|||
164211646|NCT03765073|593142510|FG001|Stage 2|Withdrawal by parent/guardian|0|||
164211647|NCT03765073|593142511|FG002|Stage 2|Withdrawal by parent/guardian|0|||
164564872|NCT03969888|594436394|FG006|Overall Study|Reason Not Specified|0|||
164211648|NCT03765073|593142512|FG003|Stage 2|Withdrawal by parent/guardian|0|||
164211649|NCT03765073|593142513|FG004|Stage 2|Withdrawal by parent/guardian|0|||
164211650|NCT03765073|593142514|FG005|Stage 2|Withdrawal by parent/guardian|0|||
164211651|NCT03765073|593142515|FG006|Stage 2|Withdrawal by parent/guardian|0|||
164211652|NCT03765073|593142516|FG007|Stage 2|Withdrawal by parent/guardian|0|||
164211653|NCT03765073|593142517|FG008|Stage 2|Withdrawal by parent/guardian|0|||
164211654|NCT03765073|593142518|FG009|Stage 2|Withdrawal by parent/guardian|0|||
164211655|NCT03765073|593142519|FG010|Stage 2|Withdrawal by parent/guardian|3|||
164211656|NCT03765073|593142520|FG011|Stage 2|Withdrawal by parent/guardian|3|||
164211657|NCT03765073|593142521|FG012|Stage 2|Withdrawal by parent/guardian|3|||
164211658|NCT03765073|593142522|FG013|Stage 2|Withdrawal by parent/guardian|1|||
164211659|NCT03765073|593142523|FG014|Stage 2|Withdrawal by parent/guardian|1|||
164211660|NCT03765073|593142524|FG015|Stage 2|Withdrawal by parent/guardian|0|||
164211661|NCT03765073|593142525|FG016|Stage 2|Withdrawal by parent/guardian|3|||
164211662|NCT03765073|593142526|FG017|Stage 2|Withdrawal by parent/guardian|0|||
164211663|NCT03765073|593142527|FG018|Stage 2|Withdrawal by parent/guardian|0|||
164211664|NCT03765073|593142528|FG019|Stage 2|Withdrawal by parent/guardian|0|||
164211665|NCT03765073|593142529|FG020|Stage 2|Withdrawal by parent/guardian|0|||
164211666|NCT03765073|593142509|FG000|Stage 2|Withdrawal by Subject|0|||
164211667|NCT03765073|593142510|FG001|Stage 2|Withdrawal by Subject|0|||
164211668|NCT03765073|593142511|FG002|Stage 2|Withdrawal by Subject|0|||
164211669|NCT03765073|593142512|FG003|Stage 2|Withdrawal by Subject|3|||
164211670|NCT03765073|593142513|FG004|Stage 2|Withdrawal by Subject|3|||
164211671|NCT03765073|593142514|FG005|Stage 2|Withdrawal by Subject|3|||
164211672|NCT03765073|593142515|FG006|Stage 2|Withdrawal by Subject|0|||
164211673|NCT03765073|593142516|FG007|Stage 2|Withdrawal by Subject|1|||
164211674|NCT03765073|593142517|FG008|Stage 2|Withdrawal by Subject|0|||
164211675|NCT03765073|593142518|FG009|Stage 2|Withdrawal by Subject|5|||
164211676|NCT03765073|593142519|FG010|Stage 2|Withdrawal by Subject|0|||
164211677|NCT03765073|593142520|FG011|Stage 2|Withdrawal by Subject|0|||
164211678|NCT03765073|593142521|FG012|Stage 2|Withdrawal by Subject|0|||
164211679|NCT03765073|593142522|FG013|Stage 2|Withdrawal by Subject|0|||
164211680|NCT03765073|593142523|FG014|Stage 2|Withdrawal by Subject|0|||
164211681|NCT03765073|593142524|FG015|Stage 2|Withdrawal by Subject|0|||
164211682|NCT03765073|593142525|FG016|Stage 2|Withdrawal by Subject|0|||
164211683|NCT03765073|593142526|FG017|Stage 2|Withdrawal by Subject|0|||
164211684|NCT03765073|593142527|FG018|Stage 2|Withdrawal by Subject|0|||
164211685|NCT03765073|593142528|FG019|Stage 2|Withdrawal by Subject|0|||
164211686|NCT03765073|593142529|FG020|Stage 2|Withdrawal by Subject|0|||
164211687|NCT03765073|593142509|FG000|Stage 3|Adverse Event|0|||
164211688|NCT03765073|593142510|FG001|Stage 3|Adverse Event|0|||
164211689|NCT03765073|593142511|FG002|Stage 3|Adverse Event|0|||
164211690|NCT03765073|593142512|FG003|Stage 3|Adverse Event|0|||
164211691|NCT03765073|593142513|FG004|Stage 3|Adverse Event|0|||
164211692|NCT03765073|593142514|FG005|Stage 3|Adverse Event|0|||
164211693|NCT03765073|593142515|FG006|Stage 3|Adverse Event|0|||
164211694|NCT03765073|593142516|FG007|Stage 3|Adverse Event|0|||
164211695|NCT03765073|593142517|FG008|Stage 3|Adverse Event|0|||
164211696|NCT03765073|593142518|FG009|Stage 3|Adverse Event|0|||
164211697|NCT03765073|593142519|FG010|Stage 3|Adverse Event|0|||
164211698|NCT03765073|593142520|FG011|Stage 3|Adverse Event|0|||
164211699|NCT03765073|593142521|FG012|Stage 3|Adverse Event|0|||
164211700|NCT03765073|593142522|FG013|Stage 3|Adverse Event|0|||
164211701|NCT03765073|593142523|FG014|Stage 3|Adverse Event|0|||
164211702|NCT03765073|593142524|FG015|Stage 3|Adverse Event|0|||
164211703|NCT03765073|593142525|FG016|Stage 3|Adverse Event|0|||
164211704|NCT03765073|593142526|FG017|Stage 3|Adverse Event|0|||
164211705|NCT03765073|593142527|FG018|Stage 3|Adverse Event|1|||
164211706|NCT03765073|593142528|FG019|Stage 3|Adverse Event|0|||
164211707|NCT03765073|593142529|FG020|Stage 3|Adverse Event|0|||
164211708|NCT03765073|593142509|FG000|Stage 3|Death|0|||
164211709|NCT03765073|593142510|FG001|Stage 3|Death|0|||
164211710|NCT03765073|593142511|FG002|Stage 3|Death|0|||
164211711|NCT03765073|593142512|FG003|Stage 3|Death|0|||
164211712|NCT03765073|593142513|FG004|Stage 3|Death|0|||
164211713|NCT03765073|593142514|FG005|Stage 3|Death|0|||
164211714|NCT03765073|593142515|FG006|Stage 3|Death|0|||
164211715|NCT03765073|593142516|FG007|Stage 3|Death|0|||
164211716|NCT03765073|593142517|FG008|Stage 3|Death|0|||
164211717|NCT03765073|593142518|FG009|Stage 3|Death|0|||
164211718|NCT03765073|593142519|FG010|Stage 3|Death|0|||
164211719|NCT03765073|593142520|FG011|Stage 3|Death|0|||
164211720|NCT03765073|593142521|FG012|Stage 3|Death|0|||
164211721|NCT03765073|593142522|FG013|Stage 3|Death|0|||
164211722|NCT03765073|593142523|FG014|Stage 3|Death|0|||
164211723|NCT03765073|593142524|FG015|Stage 3|Death|0|||
164211724|NCT03765073|593142525|FG016|Stage 3|Death|0|||
164211725|NCT03765073|593142526|FG017|Stage 3|Death|0|||
164211726|NCT03765073|593142527|FG018|Stage 3|Death|0|||
164211727|NCT03765073|593142528|FG019|Stage 3|Death|3|||
164211728|NCT03765073|593142529|FG020|Stage 3|Death|2|||
164211729|NCT03765073|593142509|FG000|Stage 3|Lost to Follow-up|0|||
164211730|NCT03765073|593142510|FG001|Stage 3|Lost to Follow-up|0|||
164211731|NCT03765073|593142511|FG002|Stage 3|Lost to Follow-up|0|||
164211732|NCT03765073|593142512|FG003|Stage 3|Lost to Follow-up|0|||
164211733|NCT03765073|593142513|FG004|Stage 3|Lost to Follow-up|0|||
164211734|NCT03765073|593142514|FG005|Stage 3|Lost to Follow-up|0|||
164211735|NCT03765073|593142515|FG006|Stage 3|Lost to Follow-up|0|||
164211736|NCT03765073|593142516|FG007|Stage 3|Lost to Follow-up|0|||
164211737|NCT03765073|593142517|FG008|Stage 3|Lost to Follow-up|0|||
164211738|NCT03765073|593142518|FG009|Stage 3|Lost to Follow-up|0|||
164211739|NCT03765073|593142519|FG010|Stage 3|Lost to Follow-up|0|||
164211740|NCT03765073|593142520|FG011|Stage 3|Lost to Follow-up|0|||
164211741|NCT03765073|593142521|FG012|Stage 3|Lost to Follow-up|0|||
164211742|NCT03765073|593142522|FG013|Stage 3|Lost to Follow-up|0|||
164211743|NCT03765073|593142523|FG014|Stage 3|Lost to Follow-up|0|||
164211744|NCT03765073|593142524|FG015|Stage 3|Lost to Follow-up|0|||
164211745|NCT03765073|593142525|FG016|Stage 3|Lost to Follow-up|0|||
164211746|NCT03765073|593142526|FG017|Stage 3|Lost to Follow-up|8|||
164211747|NCT03765073|593142527|FG018|Stage 3|Lost to Follow-up|5|||
164211748|NCT03765073|593142528|FG019|Stage 3|Lost to Follow-up|7|||
164211749|NCT03765073|593142529|FG020|Stage 3|Lost to Follow-up|4|||
164211750|NCT03765073|593142509|FG000|Stage 3|No longer meets eligibility criteria|0|||
164211751|NCT03765073|593142510|FG001|Stage 3|No longer meets eligibility criteria|0|||
164211752|NCT03765073|593142511|FG002|Stage 3|No longer meets eligibility criteria|0|||
164211753|NCT03765073|593142512|FG003|Stage 3|No longer meets eligibility criteria|0|||
164211754|NCT03765073|593142513|FG004|Stage 3|No longer meets eligibility criteria|0|||
164211755|NCT03765073|593142514|FG005|Stage 3|No longer meets eligibility criteria|0|||
164211756|NCT03765073|593142515|FG006|Stage 3|No longer meets eligibility criteria|0|||
164211757|NCT03765073|593142516|FG007|Stage 3|No longer meets eligibility criteria|0|||
164211758|NCT03765073|593142517|FG008|Stage 3|No longer meets eligibility criteria|0|||
164211759|NCT03765073|593142518|FG009|Stage 3|No longer meets eligibility criteria|0|||
164211760|NCT03765073|593142519|FG010|Stage 3|No longer meets eligibility criteria|0|||
164211761|NCT03765073|593142520|FG011|Stage 3|No longer meets eligibility criteria|0|||
164211762|NCT03765073|593142521|FG012|Stage 3|No longer meets eligibility criteria|0|||
164211763|NCT03765073|593142522|FG013|Stage 3|No longer meets eligibility criteria|0|||
164211764|NCT03765073|593142523|FG014|Stage 3|No longer meets eligibility criteria|0|||
164211765|NCT03765073|593142524|FG015|Stage 3|No longer meets eligibility criteria|0|||
164211766|NCT03765073|593142525|FG016|Stage 3|No longer meets eligibility criteria|0|||
164211767|NCT03765073|593142526|FG017|Stage 3|No longer meets eligibility criteria|0|||
164211768|NCT03765073|593142527|FG018|Stage 3|No longer meets eligibility criteria|1|||
164211769|NCT03765073|593142528|FG019|Stage 3|No longer meets eligibility criteria|0|||
164211770|NCT03765073|593142529|FG020|Stage 3|No longer meets eligibility criteria|1|||
164211771|NCT03765073|593142509|FG000|Stage 3|Other|0|||
164211772|NCT03765073|593142510|FG001|Stage 3|Other|0|||
164211773|NCT03765073|593142511|FG002|Stage 3|Other|0|||
164211774|NCT03765073|593142512|FG003|Stage 3|Other|0|||
164211775|NCT03765073|593142513|FG004|Stage 3|Other|0|||
164211776|NCT03765073|593142514|FG005|Stage 3|Other|0|||
164211777|NCT03765073|593142515|FG006|Stage 3|Other|0|||
164211778|NCT03765073|593142516|FG007|Stage 3|Other|0|||
164211779|NCT03765073|593142517|FG008|Stage 3|Other|0|||
164211780|NCT03765073|593142518|FG009|Stage 3|Other|0|||
164211781|NCT03765073|593142519|FG010|Stage 3|Other|0|||
164211782|NCT03765073|593142520|FG011|Stage 3|Other|0|||
164211783|NCT03765073|593142521|FG012|Stage 3|Other|0|||
164211784|NCT03765073|593142522|FG013|Stage 3|Other|0|||
164211785|NCT03765073|593142523|FG014|Stage 3|Other|0|||
164211786|NCT03765073|593142524|FG015|Stage 3|Other|0|||
164211787|NCT03765073|593142525|FG016|Stage 3|Other|0|||
164211788|NCT03765073|593142526|FG017|Stage 3|Other|1|||
164211789|NCT03765073|593142527|FG018|Stage 3|Other|2|||
164211790|NCT03765073|593142528|FG019|Stage 3|Other|2|||
164211791|NCT03765073|593142529|FG020|Stage 3|Other|2|||
164211792|NCT03765073|593142509|FG000|Stage 3|Withdrawal by parent/guardian|0|||
164211793|NCT03765073|593142510|FG001|Stage 3|Withdrawal by parent/guardian|0|||
164211794|NCT03765073|593142511|FG002|Stage 3|Withdrawal by parent/guardian|0|||
164211795|NCT03765073|593142512|FG003|Stage 3|Withdrawal by parent/guardian|0|||
164211796|NCT03765073|593142513|FG004|Stage 3|Withdrawal by parent/guardian|0|||
164211797|NCT03765073|593142514|FG005|Stage 3|Withdrawal by parent/guardian|0|||
164211798|NCT03765073|593142515|FG006|Stage 3|Withdrawal by parent/guardian|0|||
164211799|NCT03765073|593142516|FG007|Stage 3|Withdrawal by parent/guardian|0|||
164211800|NCT03765073|593142517|FG008|Stage 3|Withdrawal by parent/guardian|0|||
164211801|NCT03765073|593142518|FG009|Stage 3|Withdrawal by parent/guardian|0|||
164211802|NCT03765073|593142519|FG010|Stage 3|Withdrawal by parent/guardian|0|||
164211803|NCT03765073|593142520|FG011|Stage 3|Withdrawal by parent/guardian|0|||
164211804|NCT03765073|593142521|FG012|Stage 3|Withdrawal by parent/guardian|0|||
164211805|NCT03765073|593142522|FG013|Stage 3|Withdrawal by parent/guardian|0|||
164211806|NCT03765073|593142523|FG014|Stage 3|Withdrawal by parent/guardian|0|||
164211807|NCT03765073|593142524|FG015|Stage 3|Withdrawal by parent/guardian|0|||
164211808|NCT03765073|593142525|FG016|Stage 3|Withdrawal by parent/guardian|0|||
164211809|NCT03765073|593142526|FG017|Stage 3|Withdrawal by parent/guardian|0|||
164211810|NCT03765073|593142527|FG018|Stage 3|Withdrawal by parent/guardian|0|||
164211811|NCT03765073|593142528|FG019|Stage 3|Withdrawal by parent/guardian|6|||
164211812|NCT03765073|593142529|FG020|Stage 3|Withdrawal by parent/guardian|9|||
164325135|NCT02616562|593566041|FG010|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164211813|NCT03765073|593142509|FG000|Stage 3|Withdrawal by Subject|0|||
164420672|NCT01154036|593910963|FG001|Phase II|Physician Decision|0|||
164211814|NCT03765073|593142510|FG001|Stage 3|Withdrawal by Subject|0|||
164211815|NCT03765073|593142511|FG002|Stage 3|Withdrawal by Subject|0|||
164211816|NCT03765073|593142512|FG003|Stage 3|Withdrawal by Subject|0|||
164211817|NCT03765073|593142513|FG004|Stage 3|Withdrawal by Subject|0|||
164211818|NCT03765073|593142514|FG005|Stage 3|Withdrawal by Subject|0|||
164211819|NCT03765073|593142515|FG006|Stage 3|Withdrawal by Subject|0|||
164211820|NCT03765073|593142516|FG007|Stage 3|Withdrawal by Subject|0|||
164211821|NCT03765073|593142517|FG008|Stage 3|Withdrawal by Subject|0|||
164211822|NCT03765073|593142518|FG009|Stage 3|Withdrawal by Subject|0|||
164211823|NCT03765073|593142519|FG010|Stage 3|Withdrawal by Subject|0|||
164420673|NCT01154036|593910964|FG002|Phase II|Physician Decision|0|||
164211824|NCT03765073|593142520|FG011|Stage 3|Withdrawal by Subject|0|||
164211825|NCT03765073|593142521|FG012|Stage 3|Withdrawal by Subject|0|||
164211826|NCT03765073|593142522|FG013|Stage 3|Withdrawal by Subject|0|||
164211827|NCT03765073|593142523|FG014|Stage 3|Withdrawal by Subject|0|||
164211828|NCT03765073|593142524|FG015|Stage 3|Withdrawal by Subject|0|||
164211829|NCT03765073|593142525|FG016|Stage 3|Withdrawal by Subject|0|||
164211830|NCT03765073|593142526|FG017|Stage 3|Withdrawal by Subject|8|||
164211831|NCT03765073|593142527|FG018|Stage 3|Withdrawal by Subject|11|||
164211832|NCT03765073|593142528|FG019|Stage 3|Withdrawal by Subject|0|||
164211833|NCT03765073|593142529|FG020|Stage 3|Withdrawal by Subject|0|||
164211834|NCT02550795|593142537|FG000|Overall Study|Physician Decision|0|||
164211835|NCT02550795|593142538|FG001|Overall Study|Physician Decision|1|||
164211836|NCT02550795|593142539|FG002|Overall Study|Physician Decision|0|||
164211837|NCT02802228|593142540|FG000|Overall Study|Withdrawal by Subject|2|||
164211838|NCT02802228|593142541|FG001|Overall Study|Withdrawal by Subject|0|||
164211839|NCT02802228|593142540|FG000|Overall Study|Lost to Follow-up|1|||
164211840|NCT02802228|593142541|FG001|Overall Study|Lost to Follow-up|0|||
164211841|NCT02802228|593142540|FG000|Overall Study|Adverse Event|1|||
164211842|NCT02802228|593142541|FG001|Overall Study|Adverse Event|0|||
164211843|NCT02802228|593142540|FG000|Overall Study|Physician Decision|1|||
164211844|NCT02802228|593142541|FG001|Overall Study|Physician Decision|0|||
164211845|NCT00695019|593142544|FG000|Overall Study|Withdrawal by Subject|8|||
164211846|NCT00695019|593142545|FG001|Overall Study|Withdrawal by Subject|6|||
164211847|NCT00695019|593142546|FG002|Overall Study|Withdrawal by Subject|4|||
164211848|NCT00695019|593142544|FG000|Overall Study|Protocol Violation|1|||
164211849|NCT00695019|593142545|FG001|Overall Study|Protocol Violation|3|||
164211850|NCT00695019|593142546|FG002|Overall Study|Protocol Violation|1|||
164211851|NCT00695019|593142544|FG000|Overall Study|Lack of Efficacy|0|||
164211852|NCT00695019|593142545|FG001|Overall Study|Lack of Efficacy|0|||
164211853|NCT00695019|593142546|FG002|Overall Study|Lack of Efficacy|1|||
164211854|NCT00695019|593142544|FG000|Overall Study|Various|4|||
164211855|NCT00695019|593142545|FG001|Overall Study|Various|5|||
164211856|NCT00695019|593142546|FG002|Overall Study|Various|4|||
164211857|NCT01564407|593142556|FG000|Overall Study|Lost to Follow-up|0|||
164211858|NCT01564407|593142557|FG001|Overall Study|Lost to Follow-up|1|||
164211859|NCT01564407|593142558|FG002|Overall Study|Lost to Follow-up|0|||
164211860|NCT01564407|593142559|FG003|Overall Study|Lost to Follow-up|0|||
164211861|NCT01564407|593142560|FG004|Overall Study|Lost to Follow-up|0|||
164211862|NCT01564407|593142556|FG000|Overall Study|Withdrawal by Subject|0|||
164211863|NCT01564407|593142557|FG001|Overall Study|Withdrawal by Subject|1|||
164211864|NCT01564407|593142558|FG002|Overall Study|Withdrawal by Subject|0|||
164211865|NCT01564407|593142559|FG003|Overall Study|Withdrawal by Subject|0|||
164211866|NCT01564407|593142560|FG004|Overall Study|Withdrawal by Subject|0|||
164211867|NCT01564407|593142556|FG000|Overall Study|funding lost, study ended|0|||
164211868|NCT01564407|593142557|FG001|Overall Study|funding lost, study ended|0|||
164211869|NCT01564407|593142558|FG002|Overall Study|funding lost, study ended|0|||
164211870|NCT01564407|593142559|FG003|Overall Study|funding lost, study ended|1|||
164211871|NCT01564407|593142560|FG004|Overall Study|funding lost, study ended|0|||
164211872|NCT04063163|593142563|FG000|Overall Study|Death|281|||
164211873|NCT04063163|593142564|FG001|Overall Study|Death|166|||
164211874|NCT04063163|593142563|FG000|Overall Study|Lost to Follow-up|12|||
164211875|NCT04063163|593142564|FG001|Overall Study|Lost to Follow-up|8|||
164211876|NCT04063163|593142563|FG000|Overall Study|Withdrawal by Subject|19|||
164211877|NCT04063163|593142564|FG001|Overall Study|Withdrawal by Subject|10|||
164211878|NCT00580840|593142567|FG000|Run-in|Adverse Event|17|||
164211879|NCT00580840|593142568|FG001|Run-in|Adverse Event|0|||
164211880|NCT00580840|593142569|FG002|Run-in|Adverse Event|0|||
164211881|NCT00580840|593142570|FG003|Run-in|Adverse Event|0|||
164211882|NCT00580840|593142567|FG000|Run-in|Lack of Efficacy|93|||
164211883|NCT00580840|593142568|FG001|Run-in|Lack of Efficacy|0|||
164211884|NCT00580840|593142569|FG002|Run-in|Lack of Efficacy|0|||
164211885|NCT00580840|593142570|FG003|Run-in|Lack of Efficacy|0|||
164211886|NCT00580840|593142567|FG000|Run-in|Loss of Efficacy|1|||
164211887|NCT00580840|593142568|FG001|Run-in|Loss of Efficacy|0|||
164211888|NCT00580840|593142569|FG002|Run-in|Loss of Efficacy|0|||
164211889|NCT00580840|593142570|FG003|Run-in|Loss of Efficacy|0|||
164211890|NCT00580840|593142567|FG000|Run-in|Lost to Follow-up|4|||
164325136|NCT02616562|593566042|FG011|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164211891|NCT00580840|593142568|FG001|Run-in|Lost to Follow-up|0|||
164211892|NCT00580840|593142569|FG002|Run-in|Lost to Follow-up|0|||
164564873|NCT03969888|594436395|FG007|Overall Study|Reason Not Specified|1|||
164211893|NCT00580840|593142570|FG003|Run-in|Lost to Follow-up|0|||
164564874|NCT00464178|594436396|FG000|Overall Study|Protocol Violation|1|||
164211894|NCT00580840|593142567|FG000|Run-in|Withdrawal by Subject|5|||
164211895|NCT00580840|593142568|FG001|Run-in|Withdrawal by Subject|0|||
164211896|NCT00580840|593142569|FG002|Run-in|Withdrawal by Subject|0|||
164211897|NCT00580840|593142570|FG003|Run-in|Withdrawal by Subject|0|||
164211898|NCT00580840|593142567|FG000|Run-in|Other: Per Sponsor Request|2|||
164211899|NCT00580840|593142568|FG001|Run-in|Other: Per Sponsor Request|0|||
164211900|NCT00580840|593142569|FG002|Run-in|Other: Per Sponsor Request|0|||
164211901|NCT00580840|593142570|FG003|Run-in|Other: Per Sponsor Request|0|||
164211902|NCT00580840|593142567|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
164211903|NCT00580840|593142568|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
164211904|NCT00580840|593142569|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
164211905|NCT00580840|593142570|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
164211906|NCT00580840|593142567|FG000|Run-in|Other: Exclusionary Lab Value|1|||
164211907|NCT00580840|593142568|FG001|Run-in|Other: Exclusionary Lab Value|0|||
164211908|NCT00580840|593142569|FG002|Run-in|Other: Exclusionary Lab Value|0|||
164211909|NCT00580840|593142570|FG003|Run-in|Other: Exclusionary Lab Value|0|||
164211910|NCT00580840|593142567|FG000|Double-Blind|Adverse Event|0|||
164211911|NCT00580840|593142568|FG001|Double-Blind|Adverse Event|3|||
164211912|NCT00580840|593142569|FG002|Double-Blind|Adverse Event|4|||
164211913|NCT00580840|593142570|FG003|Double-Blind|Adverse Event|1|||
164211914|NCT00580840|593142567|FG000|Double-Blind|Loss of Efficacy|0|||
164211915|NCT00580840|593142568|FG001|Double-Blind|Loss of Efficacy|1|||
164211916|NCT00580840|593142569|FG002|Double-Blind|Loss of Efficacy|2|||
164211917|NCT00580840|593142570|FG003|Double-Blind|Loss of Efficacy|10|||
164211918|NCT00580840|593142567|FG000|Double-Blind|Lost to Follow-up|0|||
164211919|NCT00580840|593142568|FG001|Double-Blind|Lost to Follow-up|1|||
164211920|NCT00580840|593142569|FG002|Double-Blind|Lost to Follow-up|0|||
164211921|NCT00580840|593142570|FG003|Double-Blind|Lost to Follow-up|2|||
164211922|NCT00580840|593142567|FG000|Double-Blind|Withdrawal by Subject|0|||
164211923|NCT00580840|593142568|FG001|Double-Blind|Withdrawal by Subject|1|||
164211924|NCT00580840|593142569|FG002|Double-Blind|Withdrawal by Subject|2|||
164211925|NCT00580840|593142570|FG003|Double-Blind|Withdrawal by Subject|2|||
164211926|NCT00580840|593142567|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
164211927|NCT00580840|593142568|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
164211928|NCT00580840|593142569|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
164211929|NCT00580840|593142570|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
164211930|NCT00580840|593142567|FG000|Double-Blind|Other: Forbidden Medication|0|||
164211931|NCT00580840|593142568|FG001|Double-Blind|Other: Forbidden Medication|0|||
164211932|NCT00580840|593142569|FG002|Double-Blind|Other: Forbidden Medication|1|||
164211933|NCT00580840|593142570|FG003|Double-Blind|Other: Forbidden Medication|0|||
164211934|NCT04435626|593142573|FG000|Overall Study|Lost to Follow-up|1|||
164211935|NCT04435626|593142574|FG001|Overall Study|Lost to Follow-up|5|||
164211936|NCT04435626|593142573|FG000|Overall Study|Withdrawal by Subject|6|||
164211937|NCT04435626|593142574|FG001|Overall Study|Withdrawal by Subject|7|||
164211938|NCT04435626|593142573|FG000|Overall Study|major GCP violations|8|||
164211939|NCT04435626|593142574|FG001|Overall Study|major GCP violations|7|||
164211940|NCT01160614|593142580|FG000|Overall Study|Withdrawal by Subject|0|||
164211941|NCT01160614|593142581|FG001|Overall Study|Withdrawal by Subject|2|||
164211942|NCT00984399|593142582|FG000|Overall Study|Adverse Event|0|||
164211943|NCT00984399|593142583|FG001|Overall Study|Adverse Event|1|||
164211944|NCT00984399|593142582|FG000|Overall Study|Physician Decision|1|||
164211945|NCT00984399|593142583|FG001|Overall Study|Physician Decision|0|||
164211946|NCT00984399|593142582|FG000|Overall Study|Withdrawal by Subject|1|||
164211947|NCT00984399|593142583|FG001|Overall Study|Withdrawal by Subject|1|||
164211948|NCT00984399|593142582|FG000|Overall Study|Protocol Violation|0|||
164211949|NCT00984399|593142583|FG001|Overall Study|Protocol Violation|1|||
164211950|NCT00984399|593142582|FG000|Overall Study|Pts did not start treatment|2|||
164211951|NCT00984399|593142583|FG001|Overall Study|Pts did not start treatment|2|||
164211952|NCT05049122|593142584|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
164211953|NCT05049122|593142584|FG000|Overall Study|Participant moved|1|||
164211954|NCT05049122|593142584|FG000|Overall Study|At the direction of the doctor|1|||
164211955|NCT05248386|593142586|FG000|Overall Study|Technical problems|0|||
164211956|NCT05248386|593142587|FG001|Overall Study|Technical problems|1|||
164211957|NCT05248386|593142586|FG000|Overall Study|Withdrawal by Subject|15|||
164211958|NCT05248386|593142587|FG001|Overall Study|Withdrawal by Subject|10|||
164211959|NCT05248386|593142586|FG000|Overall Study|Physician Decision|0|||
164211960|NCT05248386|593142587|FG001|Overall Study|Physician Decision|1|||
164211961|NCT05248386|593142586|FG000|Overall Study|Adverse Event|2|||
164211962|NCT05248386|593142587|FG001|Overall Study|Adverse Event|4|||
164211963|NCT05248386|593142586|FG000|Overall Study|Other|1|||
164211964|NCT05248386|593142587|FG001|Overall Study|Other|0|||
164211965|NCT05248386|593142586|FG000|Overall Study|Lack of Efficacy|14|||
164211966|NCT05248386|593142587|FG001|Overall Study|Lack of Efficacy|12|||
164211967|NCT01723774|593142588|FG000|Neoadjuvant|Ki67 > 10%|4|||
164211968|NCT01723774|593142589|FG001|Neoadjuvant|Ki67 > 10%|0|||
164211969|NCT01723774|593142590|FG002|Neoadjuvant|Ki67 > 10%|10|||
164211970|NCT01723774|593142591|FG003|Neoadjuvant|Ki67 > 10%|0|||
164211971|NCT01723774|593142588|FG000|Neoadjuvant|Withdrawal by Subject|3|||
164211972|NCT01723774|593142589|FG001|Neoadjuvant|Withdrawal by Subject|1|||
164211973|NCT01723774|593142590|FG002|Neoadjuvant|Withdrawal by Subject|0|||
164211974|NCT01723774|593142591|FG003|Neoadjuvant|Withdrawal by Subject|0|||
164211975|NCT01723774|593142588|FG000|Neoadjuvant|Disease progression|0|||
164211976|NCT01723774|593142589|FG001|Neoadjuvant|Disease progression|1|||
164211977|NCT01723774|593142590|FG002|Neoadjuvant|Disease progression|1|||
164211978|NCT01723774|593142591|FG003|Neoadjuvant|Disease progression|0|||
164211979|NCT01723774|593142588|FG000|Neoadjuvant|Adverse Event|0|||
164325137|NCT02616562|593566043|FG012|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325138|NCT02616562|593566044|FG013|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325139|NCT02616562|593566045|FG014|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325140|NCT02616562|593566046|FG015|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325141|NCT02616562|593566047|FG016|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325142|NCT02616562|593566031|FG000|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325143|NCT02616562|593566032|FG001|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325144|NCT02616562|593566033|FG002|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325145|NCT02616562|593566034|FG003|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325146|NCT02616562|593566035|FG004|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325147|NCT02616562|593566036|FG005|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325148|NCT02616562|593566037|FG006|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325149|NCT02616562|593566038|FG007|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325150|NCT02616562|593566039|FG008|Safety Extension Period (104 Weeks)|Protocol Violation|1|||
164325151|NCT02616562|593566040|FG009|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325152|NCT02616562|593566041|FG010|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325153|NCT02616562|593566042|FG011|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325154|NCT02616562|593566043|FG012|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325155|NCT02616562|593566044|FG013|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325156|NCT02616562|593566045|FG014|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325157|NCT02616562|593566046|FG015|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325158|NCT02616562|593566047|FG016|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325159|NCT02616562|593566031|FG000|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325160|NCT02616562|593566032|FG001|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325161|NCT02616562|593566033|FG002|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325162|NCT02616562|593566034|FG003|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325163|NCT02616562|593566035|FG004|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325164|NCT02616562|593566036|FG005|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325165|NCT02616562|593566037|FG006|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325166|NCT02616562|593566038|FG007|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325167|NCT02616562|593566039|FG008|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325168|NCT02616562|593566040|FG009|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325169|NCT02616562|593566041|FG010|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325170|NCT02616562|593566042|FG011|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|4|||
164325171|NCT02616562|593566043|FG012|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325172|NCT02616562|593566044|FG013|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325173|NCT02616562|593566045|FG014|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|1|||
164325174|NCT02616562|593566046|FG015|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325175|NCT02616562|593566047|FG016|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325176|NCT02616562|593566031|FG000|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325177|NCT02616562|593566032|FG001|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325178|NCT02616562|593566033|FG002|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325179|NCT02616562|593566034|FG003|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325180|NCT02616562|593566035|FG004|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325181|NCT02616562|593566036|FG005|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325182|NCT02616562|593566037|FG006|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325183|NCT02616562|593566038|FG007|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325184|NCT02616562|593566039|FG008|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325185|NCT02616562|593566040|FG009|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325186|NCT02616562|593566041|FG010|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325187|NCT02616562|593566042|FG011|Long Term Safety Extension (208 Weeks)|Protocol Violation|1|||
164325188|NCT02616562|593566043|FG012|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325189|NCT02616562|593566044|FG013|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325190|NCT02616562|593566045|FG014|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325191|NCT02616562|593566046|FG015|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325192|NCT02616562|593566047|FG016|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325193|NCT02616562|593566031|FG000|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164325194|NCT02616562|593566032|FG001|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164325195|NCT02616562|593566033|FG002|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164325196|NCT02616562|593566034|FG003|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164325197|NCT02616562|593566035|FG004|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164325198|NCT02616562|593566036|FG005|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164211980|NCT01723774|593142589|FG001|Neoadjuvant|Adverse Event|1|||
164211981|NCT01723774|593142590|FG002|Neoadjuvant|Adverse Event|2|||
164211982|NCT01723774|593142591|FG003|Neoadjuvant|Adverse Event|0|||
164211983|NCT01723774|593142588|FG000|Neoadjuvant|High estradiol|0|||
164211984|NCT01723774|593142589|FG001|Neoadjuvant|High estradiol|1|||
164211985|NCT01723774|593142590|FG002|Neoadjuvant|High estradiol|0|||
164211986|NCT01723774|593142591|FG003|Neoadjuvant|High estradiol|0|||
164211987|NCT01910441|593142592|FG000|Overall Study|Sponsor decision|0|||
164211988|NCT01910441|593142593|FG001|Overall Study|Sponsor decision|2|||
164211989|NCT01910441|593142592|FG000|Overall Study|Lost to Follow-up|6|||
164211990|NCT01910441|593142593|FG001|Overall Study|Lost to Follow-up|5|||
164211991|NCT01910441|593142592|FG000|Overall Study|Withdrawal by Subject|0|||
164211992|NCT01910441|593142593|FG001|Overall Study|Withdrawal by Subject|1|||
164211993|NCT01910441|593142592|FG000|Overall Study|Non-compliance|0|||
164211994|NCT01910441|593142593|FG001|Overall Study|Non-compliance|1|||
164211995|NCT01910441|593142592|FG000|Overall Study|Adverse Event|1|||
164211996|NCT01910441|593142593|FG001|Overall Study|Adverse Event|0|||
164211997|NCT01910441|593142592|FG000|Overall Study|Physician Decision|0|||
164211998|NCT01910441|593142593|FG001|Overall Study|Physician Decision|1|||
164211999|NCT02964182|593142594|FG000|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
164212000|NCT02964182|593142595|FG001|Phase 2 (Weeks 2-4)|Lost to Follow-up|7|||
164212001|NCT02964182|593142596|FG002|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
164212002|NCT02964182|593142597|FG003|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
164212003|NCT02964182|593142598|FG004|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
164212004|NCT02964182|593142599|FG005|Phase 2 (Weeks 2-4)|Lost to Follow-up|2|||
164212005|NCT02964182|593142600|FG006|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
164212006|NCT02964182|593142601|FG007|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
164212007|NCT02964182|593142594|FG000|Phase 2 (Weeks 2-4)|Physician Decision|0|||
164212008|NCT02964182|593142595|FG001|Phase 2 (Weeks 2-4)|Physician Decision|0|||
164212009|NCT02964182|593142596|FG002|Phase 2 (Weeks 2-4)|Physician Decision|0|||
164212010|NCT02964182|593142597|FG003|Phase 2 (Weeks 2-4)|Physician Decision|0|||
164212011|NCT02964182|593142598|FG004|Phase 2 (Weeks 2-4)|Physician Decision|0|||
164212012|NCT02964182|593142599|FG005|Phase 2 (Weeks 2-4)|Physician Decision|12|||
164212013|NCT02964182|593142600|FG006|Phase 2 (Weeks 2-4)|Physician Decision|0|||
164212014|NCT02964182|593142601|FG007|Phase 2 (Weeks 2-4)|Physician Decision|0|||
164212015|NCT02964182|593142594|FG000|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
164212016|NCT02964182|593142595|FG001|Phase 2 (Weeks 2-4)|Withdrawal by Subject|11|||
164212017|NCT02964182|593142596|FG002|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
164212018|NCT02964182|593142597|FG003|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
164212019|NCT02964182|593142598|FG004|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
164212020|NCT02964182|593142599|FG005|Phase 2 (Weeks 2-4)|Withdrawal by Subject|1|||
164212021|NCT02964182|593142600|FG006|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
164212022|NCT02964182|593142601|FG007|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
164212023|NCT02964182|593142594|FG000|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
164212024|NCT02964182|593142595|FG001|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
164212025|NCT02964182|593142596|FG002|Phase 3 (Weeks 5-7)|Lost to Follow-up|3|||
164212026|NCT02964182|593142597|FG003|Phase 3 (Weeks 5-7)|Lost to Follow-up|2|||
164212027|NCT02964182|593142598|FG004|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
164212028|NCT02964182|593142599|FG005|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
164212029|NCT02964182|593142600|FG006|Phase 3 (Weeks 5-7)|Lost to Follow-up|1|||
164212030|NCT02964182|593142601|FG007|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
164212031|NCT02964182|593142594|FG000|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
164212032|NCT02964182|593142595|FG001|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
164212033|NCT02964182|593142596|FG002|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
164212034|NCT02964182|593142597|FG003|Phase 3 (Weeks 5-7)|Withdrawal by Subject|5|||
164212035|NCT02964182|593142598|FG004|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
164212036|NCT02964182|593142599|FG005|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
164212037|NCT02964182|593142600|FG006|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
164212038|NCT02964182|593142601|FG007|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
164212039|NCT02964182|593142594|FG000|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
164212040|NCT02964182|593142595|FG001|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
164212041|NCT02964182|593142596|FG002|Phase 4 (Weeks 8-10)|Lost to Follow-up|1|||
164212042|NCT02964182|593142597|FG003|Phase 4 (Weeks 8-10)|Lost to Follow-up|2|||
164212043|NCT02964182|593142598|FG004|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
164212044|NCT02964182|593142599|FG005|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
164212045|NCT02964182|593142600|FG006|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
164325199|NCT02616562|593566037|FG006|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164325200|NCT02616562|593566038|FG007|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164325201|NCT02616562|593566039|FG008|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164212046|NCT02964182|593142601|FG007|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
164212047|NCT02964182|593142594|FG000|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
164325202|NCT02616562|593566040|FG009|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164212048|NCT02964182|593142595|FG001|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
164325203|NCT02616562|593566041|FG010|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164212049|NCT02964182|593142596|FG002|Phase 4 (Weeks 8-10)|Withdrawal by Subject|3|||
164212050|NCT02964182|593142597|FG003|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
164564875|NCT00464178|594436396|FG000|Overall Study|Withdrawal by Subject|1|||
164564876|NCT01469000|594436398|FG000|Overall Study|Withdrawal by Subject|16|||
164564877|NCT01469000|594436399|FG001|Overall Study|Withdrawal by Subject|3|||
164564878|NCT01469000|594436398|FG000|Overall Study|Sponsor Decision|4|||
164564879|NCT01469000|594436399|FG001|Overall Study|Sponsor Decision|1|||
164212051|NCT02964182|593142598|FG004|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
164212052|NCT02964182|593142599|FG005|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
164212053|NCT02964182|593142600|FG006|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
164212054|NCT02964182|593142601|FG007|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
164212055|NCT05845619|593142602|FG000|Overall Study|duplicate enrollment|2|||
164212056|NCT05845619|593142603|FG001|Overall Study|duplicate enrollment|2|||
164212057|NCT05845619|593142604|FG002|Overall Study|duplicate enrollment|1|||
164212058|NCT03636477|593142608|FG000|Overall Study|Adverse Event|0|||
164212059|NCT03636477|593142609|FG001|Overall Study|Adverse Event|0|||
164325204|NCT02616562|593566042|FG011|Long Term Safety Extension (208 Weeks)|Adverse Event|1|||
164325205|NCT02616562|593566043|FG012|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164325206|NCT02616562|593566044|FG013|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164325207|NCT02616562|593566045|FG014|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164325208|NCT02616562|593566046|FG015|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164325209|NCT02616562|593566047|FG016|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164325210|NCT02616562|593566031|FG000|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325211|NCT02616562|593566032|FG001|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325212|NCT02616562|593566033|FG002|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325213|NCT02616562|593566034|FG003|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325214|NCT02616562|593566035|FG004|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325215|NCT02616562|593566036|FG005|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325216|NCT02616562|593566037|FG006|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325217|NCT02616562|593566038|FG007|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325218|NCT02616562|593566039|FG008|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325219|NCT02616562|593566040|FG009|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325220|NCT02616562|593566041|FG010|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|1|||
164325221|NCT02616562|593566042|FG011|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325222|NCT02616562|593566043|FG012|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325223|NCT02616562|593566044|FG013|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|1|||
164325224|NCT02616562|593566045|FG014|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|1|||
164325225|NCT02616562|593566046|FG015|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325226|NCT02616562|593566047|FG016|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325227|NCT02616562|593566031|FG000|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325228|NCT02616562|593566032|FG001|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325229|NCT02616562|593566033|FG002|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325230|NCT02616562|593566034|FG003|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325231|NCT02616562|593566035|FG004|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325232|NCT02616562|593566036|FG005|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325233|NCT02616562|593566037|FG006|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325234|NCT02616562|593566038|FG007|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325235|NCT02616562|593566039|FG008|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325236|NCT02616562|593566040|FG009|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325237|NCT02616562|593566041|FG010|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|1|||
164325238|NCT02616562|593566042|FG011|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325239|NCT02616562|593566043|FG012|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325240|NCT02616562|593566044|FG013|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325241|NCT02616562|593566045|FG014|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325242|NCT02616562|593566046|FG015|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325243|NCT02616562|593566047|FG016|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325244|NCT02616562|593566031|FG000|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325245|NCT02616562|593566032|FG001|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325246|NCT02616562|593566033|FG002|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325247|NCT02616562|593566034|FG003|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325248|NCT02616562|593566035|FG004|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325249|NCT02616562|593566036|FG005|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325250|NCT02616562|593566037|FG006|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164669141|NCT00874237|594813562|FG000|Overall Study|Physician Decision|0|||
164212060|NCT03636477|593142610|FG002|Overall Study|Adverse Event|1|||
164212061|NCT04967222|593142611|FG000|Randomized|Lost to Follow-up|0|||
164212062|NCT04967222|593142612|FG001|Randomized|Lost to Follow-up|1|||
164212063|NCT04967222|593142613|FG002|Randomized|Lost to Follow-up|1|||
164212064|NCT04967222|593142611|FG000|Randomized|Physician Decision|0|||
164212065|NCT04967222|593142612|FG001|Randomized|Physician Decision|0|||
164212066|NCT04967222|593142613|FG002|Randomized|Physician Decision|1|||
164212067|NCT04967222|593142611|FG000|Randomized|Withdrawal by Subject|0|||
164212068|NCT04967222|593142612|FG001|Randomized|Withdrawal by Subject|0|||
164212069|NCT04967222|593142613|FG002|Randomized|Withdrawal by Subject|2|||
164212070|NCT04967222|593142611|FG000|Randomized|abnormal finding in MRI|0|||
164212071|NCT04967222|593142612|FG001|Randomized|abnormal finding in MRI|2|||
164212072|NCT04967222|593142613|FG002|Randomized|abnormal finding in MRI|0|||
164212073|NCT05168800|593142621|FG000|Time 1 Survey|Did not start T1 survey|182|||
164212074|NCT05168800|593142622|FG001|Time 1 Survey|Did not start T1 survey|150|||
164212075|NCT05168800|593142623|FG002|Time 1 Survey|Did not start T1 survey|140|||
164212076|NCT05168800|593142621|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
164212077|NCT05168800|593142622|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
164212078|NCT05168800|593142623|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
164212079|NCT05168800|593142621|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
164212080|NCT05168800|593142622|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
164212081|NCT05168800|593142623|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
164212082|NCT05168800|593142621|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
164212083|NCT05168800|593142622|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
164212084|NCT05168800|593142623|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
164212085|NCT05168800|593142621|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
164212086|NCT05168800|593142622|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
164212087|NCT05168800|593142623|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
164212088|NCT05168800|593142621|FG000|Time 1 Survey|Withdrawal by Subject|6|||
164212089|NCT05168800|593142622|FG001|Time 1 Survey|Withdrawal by Subject|3|||
164212090|NCT05168800|593142623|FG002|Time 1 Survey|Withdrawal by Subject|2|||
164212091|NCT05168800|593142621|FG000|Time 2 Survey|Already excluded at Time 1|228|||
164212092|NCT05168800|593142622|FG001|Time 2 Survey|Already excluded at Time 1|202|||
164212093|NCT05168800|593142623|FG002|Time 2 Survey|Already excluded at Time 1|173|||
164212094|NCT05168800|593142621|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
164212095|NCT05168800|593142622|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
164212096|NCT05168800|593142623|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
164212097|NCT05168800|593142621|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
164212098|NCT05168800|593142622|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
164212099|NCT05168800|593142623|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
164212100|NCT05168800|593142621|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
164212101|NCT05168800|593142622|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
164212102|NCT05168800|593142623|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
164212103|NCT05168800|593142621|FG000|Time 2 Survey|Withdrawal by Subject|1|||
164212104|NCT05168800|593142622|FG001|Time 2 Survey|Withdrawal by Subject|0|||
164212105|NCT05168800|593142623|FG002|Time 2 Survey|Withdrawal by Subject|1|||
164212106|NCT05168800|593142621|FG000|Time 3 Survey|Already excluded at Time 1|228|||
164212107|NCT05168800|593142622|FG001|Time 3 Survey|Already excluded at Time 1|200|||
164212108|NCT05168800|593142623|FG002|Time 3 Survey|Already excluded at Time 1|173|||
164212109|NCT05168800|593142621|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
164212110|NCT05168800|593142622|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
164212111|NCT05168800|593142623|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
164212112|NCT05168800|593142621|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
164212113|NCT05168800|593142622|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
164212114|NCT05168800|593142623|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
164212115|NCT05168800|593142621|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
164212116|NCT05168800|593142622|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
164212117|NCT05168800|593142623|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
164212118|NCT04279522|593142624|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
164212119|NCT04279522|593142625|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
164212120|NCT04279522|593142624|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
164212121|NCT04279522|593142625|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
164212122|NCT04279522|593142624|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
164212123|NCT04279522|593142625|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
164212124|NCT04279522|593142624|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
164212125|NCT04279522|593142625|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
164212126|NCT04279522|593142624|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
164212127|NCT04279522|593142625|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
164212128|NCT04279522|593142624|FG000|Period 2: Open Label Phase|Physician Decision|0|||
164212129|NCT04279522|593142625|FG001|Period 2: Open Label Phase|Physician Decision|3|||
164212130|NCT04279522|593142624|FG000|Period 2: Open Label Phase|Adverse Event|0|||
164212131|NCT04279522|593142625|FG001|Period 2: Open Label Phase|Adverse Event|1|||
164212132|NCT04279522|593142624|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
164420674|NCT01154036|593910965|FG003|Phase II|Physician Decision|0|||
164325251|NCT02616562|593566038|FG007|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325252|NCT02616562|593566039|FG008|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325253|NCT02616562|593566040|FG009|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325254|NCT02616562|593566041|FG010|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325255|NCT02616562|593566042|FG011|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|1|||
164325256|NCT02616562|593566043|FG012|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164420675|NCT01154036|593910966|FG004|Phase II|Physician Decision|0|||
164564880|NCT00769119|594436402|FG000|Overall Study|Voluntary discontinuation|0|||
164564881|NCT00769119|594436403|FG001|Overall Study|Voluntary discontinuation|2|||
164564882|NCT00769119|594436402|FG000|Overall Study|Adverse Event|1|||
164212133|NCT04279522|593142625|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
164212134|NCT03036254|593142632|FG000|Overall Study|Adverse Event|6|||
164212135|NCT03036254|593142633|FG001|Overall Study|Adverse Event|4|||
164212136|NCT03036254|593142632|FG000|Overall Study|Death|3|||
164212137|NCT03036254|593142633|FG001|Overall Study|Death|1|||
164212138|NCT03036254|593142632|FG000|Overall Study|Lack of Efficacy|5|||
164212139|NCT03036254|593142633|FG001|Overall Study|Lack of Efficacy|1|||
164212140|NCT03036254|593142632|FG000|Overall Study|Withdrawal by Subject|3|||
164212141|NCT03036254|593142633|FG001|Overall Study|Withdrawal by Subject|5|||
164212142|NCT01802281|593142642|FG000|Overall Study|Death|1|||
164212143|NCT01802281|593142643|FG001|Overall Study|Death|2|||
164212144|NCT01802281|593142642|FG000|Overall Study|Withdrawal by Subject|2|||
164212145|NCT01802281|593142643|FG001|Overall Study|Withdrawal by Subject|1|||
164212146|NCT01802281|593142642|FG000|Overall Study|Ineligible|5|||
164212147|NCT01802281|593142643|FG001|Overall Study|Ineligible|3|||
164212148|NCT05556057|593142644|FG000|Overall Study|Lost to Follow-up|5|||
164212149|NCT05556057|593142645|FG001|Overall Study|Lost to Follow-up|4|||
164212150|NCT05556057|593142644|FG000|Overall Study|Withdrawal by Subject|0|||
164212151|NCT05556057|593142645|FG001|Overall Study|Withdrawal by Subject|2|||
164212152|NCT03488524|593142646|FG000|Overall Study|Withdrawal by Subject|51|||
164212153|NCT03488524|593142646|FG000|Overall Study|Death|19|||
164212154|NCT03488524|593142646|FG000|Overall Study|Study Sponsor|11|||
164212155|NCT03488524|593142646|FG000|Overall Study|Physician Decision|4|||
164212156|NCT03488524|593142646|FG000|Overall Study|Lost to Follow-up|3|||
164212157|NCT00315445|593142647|FG000|Overall Study|Adverse Event|7|||
164212158|NCT00315445|593142648|FG001|Overall Study|Adverse Event|12|||
164212159|NCT00315445|593142649|FG002|Overall Study|Adverse Event|15|||
164212160|NCT00315445|593142647|FG000|Overall Study|Lack of Efficacy|16|||
164212161|NCT00315445|593142648|FG001|Overall Study|Lack of Efficacy|1|||
164212162|NCT00315445|593142649|FG002|Overall Study|Lack of Efficacy|7|||
164212163|NCT00315445|593142647|FG000|Overall Study|Lost to Follow-up|1|||
164212164|NCT00315445|593142648|FG001|Overall Study|Lost to Follow-up|0|||
164212165|NCT00315445|593142649|FG002|Overall Study|Lost to Follow-up|1|||
164212166|NCT00315445|593142647|FG000|Overall Study|Protocol Violation|2|||
164212167|NCT00315445|593142648|FG001|Overall Study|Protocol Violation|0|||
164212168|NCT00315445|593142649|FG002|Overall Study|Protocol Violation|1|||
164212169|NCT00315445|593142647|FG000|Overall Study|Other|1|||
164564883|NCT00769119|594436403|FG001|Overall Study|Adverse Event|1|||
164564884|NCT00769119|594436402|FG000|Overall Study|Disallowed medication|1|||
164564885|NCT00769119|594436403|FG001|Overall Study|Disallowed medication|0|||
164564886|NCT01116544|594436406|FG000|Overall Study|Protocol Violation|1|||
164212170|NCT00315445|593142648|FG001|Overall Study|Other|3|||
164212171|NCT00315445|593142649|FG002|Overall Study|Other|0|||
164212172|NCT02390284|593142650|FG000|Overall Study|Physician Decision|0|||
164212173|NCT02390284|593142651|FG001|Overall Study|Physician Decision|0|||
164212174|NCT02390284|593142652|FG002|Overall Study|Physician Decision|9|||
164564887|NCT01116544|594436407|FG001|Overall Study|Protocol Violation|0|||
164564888|NCT01116544|594436406|FG000|Overall Study|Withdrawal by Subject|1|||
164325257|NCT02616562|593566044|FG013|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325258|NCT02616562|593566045|FG014|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325259|NCT02616562|593566046|FG015|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325260|NCT02616562|593566047|FG016|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325261|NCT02616562|593566031|FG000|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325262|NCT02616562|593566032|FG001|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325263|NCT02616562|593566033|FG002|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325264|NCT02616562|593566034|FG003|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325265|NCT02616562|593566035|FG004|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325266|NCT02616562|593566036|FG005|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325267|NCT02616562|593566037|FG006|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325268|NCT02616562|593566038|FG007|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325269|NCT02616562|593566039|FG008|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325270|NCT02616562|593566040|FG009|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325271|NCT02616562|593566041|FG010|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325272|NCT02616562|593566042|FG011|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|1|||
164325273|NCT02616562|593566043|FG012|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325274|NCT02616562|593566044|FG013|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325275|NCT02616562|593566045|FG014|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325276|NCT02616562|593566046|FG015|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325277|NCT02616562|593566047|FG016|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325278|NCT02616562|593566031|FG000|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325279|NCT02616562|593566032|FG001|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325280|NCT02616562|593566033|FG002|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325281|NCT02616562|593566034|FG003|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325282|NCT02616562|593566035|FG004|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325283|NCT02616562|593566036|FG005|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325284|NCT02616562|593566037|FG006|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325285|NCT02616562|593566038|FG007|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325286|NCT02616562|593566039|FG008|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325287|NCT02616562|593566040|FG009|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325288|NCT02616562|593566041|FG010|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325289|NCT02616562|593566042|FG011|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325290|NCT02616562|593566043|FG012|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325291|NCT02616562|593566044|FG013|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|1|||
164325292|NCT02616562|593566045|FG014|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325293|NCT02616562|593566046|FG015|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325294|NCT02616562|593566047|FG016|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325295|NCT02616562|593566031|FG000|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325296|NCT02616562|593566032|FG001|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325297|NCT02616562|593566033|FG002|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325298|NCT02616562|593566034|FG003|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325299|NCT02616562|593566035|FG004|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325300|NCT02616562|593566036|FG005|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325301|NCT02616562|593566037|FG006|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325302|NCT02616562|593566038|FG007|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164564889|NCT01116544|594436407|FG001|Overall Study|Withdrawal by Subject|1|||
164564890|NCT05168267|594436408|FG000|Overall Study|Withdrawal by Subject|2|||
164564891|NCT05168267|594436409|FG001|Overall Study|Withdrawal by Subject|1|||
164564892|NCT05168267|594436408|FG000|Overall Study|Withdrawn by Therapist|1|||
164564893|NCT05168267|594436409|FG001|Overall Study|Withdrawn by Therapist|1|||
164564894|NCT05168267|594436408|FG000|Overall Study|Left Facility|1|||
164564895|NCT05168267|594436409|FG001|Overall Study|Left Facility|0|||
164564896|NCT02937350|594436410|FG000|Overall Study|Withdrawal by Subject|0|||
164669142|NCT00874237|594813563|FG001|Overall Study|Physician Decision|1|||
164212175|NCT01299909|593142653|FG000|Overall Study|Lost to Follow-up|22|||
164212176|NCT01299909|593142654|FG001|Overall Study|Lost to Follow-up|18|||
164212177|NCT01299909|593142655|FG002|Overall Study|Lost to Follow-up|17|||
164212178|NCT02293499|593144081|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
164212179|NCT02293499|593144082|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
164212180|NCT02293499|593144083|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
164212181|NCT02293499|593144081|FG000|Intervention - Camp|Withdrawal by Subject|3|||
164212182|NCT02293499|593144082|FG001|Intervention - Camp|Withdrawal by Subject|6|||
164212183|NCT02293499|593144083|FG002|Intervention - Camp|Withdrawal by Subject|2|||
164212184|NCT02293499|593144081|FG000|Intervention - Camp|these are those not showing up at camp|24|||
164212185|NCT02293499|593144082|FG001|Intervention - Camp|these are those not showing up at camp|28|||
164212186|NCT02293499|593144083|FG002|Intervention - Camp|these are those not showing up at camp|4|||
164212187|NCT02293499|593144081|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
164212188|NCT02293499|593144082|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
164212189|NCT02293499|593144083|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
164212190|NCT02293499|593144081|FG000|3 Month Follow Up|Lost to Follow-up|14|||
164212191|NCT02293499|593144082|FG001|3 Month Follow Up|Lost to Follow-up|15|||
164212192|NCT02293499|593144083|FG002|3 Month Follow Up|Lost to Follow-up|6|||
164212193|NCT02293499|593144081|FG000|6 Month Follow Up|Lost to Follow-up|17|||
164212194|NCT02293499|593144082|FG001|6 Month Follow Up|Lost to Follow-up|27|||
164212195|NCT02293499|593144083|FG002|6 Month Follow Up|Lost to Follow-up|6|||
164212196|NCT02293499|593144081|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
164212197|NCT02293499|593144082|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
164212198|NCT02293499|593144083|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
164212199|NCT02293499|593144081|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
164212200|NCT02293499|593144082|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
164212201|NCT02293499|593144083|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
164212202|NCT02293499|593144081|FG000|9 Month Follow Up|Lost to Follow-up|24|||
164212203|NCT02293499|593144082|FG001|9 Month Follow Up|Lost to Follow-up|28|||
164212204|NCT02293499|593144083|FG002|9 Month Follow Up|Lost to Follow-up|4|||
164212205|NCT02293499|593144081|FG000|12 Month Follow Up|Lost to Follow-up|26|||
164212206|NCT02293499|593144082|FG001|12 Month Follow Up|Lost to Follow-up|25|||
164212207|NCT02293499|593144083|FG002|12 Month Follow Up|Lost to Follow-up|6|||
164212208|NCT02293499|593144081|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
164212209|NCT02293499|593144082|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
164212210|NCT02293499|593144083|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
164212211|NCT02293499|593144081|FG000|15 Month Follow Up|Lost to Follow-up|22|||
164212212|NCT02293499|593144082|FG001|15 Month Follow Up|Lost to Follow-up|22|||
164212213|NCT02293499|593144083|FG002|15 Month Follow Up|Lost to Follow-up|7|||
164212214|NCT03915067|593144084|FG000|Overall Study|Adverse Event|0|||
164212215|NCT03915067|593144085|FG001|Overall Study|Adverse Event|0|||
164212216|NCT03915067|593144086|FG002|Overall Study|Adverse Event|1|||
164212217|NCT03915067|593144084|FG000|Overall Study|Withdrawal by Subject|4|||
164212218|NCT03915067|593144085|FG001|Overall Study|Withdrawal by Subject|3|||
164212219|NCT03915067|593144086|FG002|Overall Study|Withdrawal by Subject|0|||
164212220|NCT03915067|593144084|FG000|Overall Study|Lost to Follow-up|3|||
164212221|NCT03915067|593144085|FG001|Overall Study|Lost to Follow-up|2|||
164212222|NCT03915067|593144086|FG002|Overall Study|Lost to Follow-up|0|||
164212223|NCT03915067|593144084|FG000|Overall Study|Protocol Deviation|0|||
164212224|NCT03915067|593144085|FG001|Overall Study|Protocol Deviation|0|||
164212225|NCT03915067|593144086|FG002|Overall Study|Protocol Deviation|1|||
164212226|NCT03915067|593144084|FG000|Overall Study|Covid-19 Related Issues|2|||
164212227|NCT03915067|593144085|FG001|Overall Study|Covid-19 Related Issues|4|||
164212228|NCT03915067|593144086|FG002|Overall Study|Covid-19 Related Issues|4|||
164212229|NCT03915067|593144084|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
164212230|NCT03915067|593144085|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
164212231|NCT03915067|593144086|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
164669143|NCT00874237|594813564|FG002|Overall Study|Physician Decision|0|||
164212232|NCT03317496|593144087|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
164212233|NCT03317496|593144088|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
164564897|NCT02937350|594436411|FG001|Overall Study|Withdrawal by Subject|1|||
164212234|NCT03317496|593144089|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
164212235|NCT03317496|593144090|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
164212236|NCT03317496|593144091|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
164212237|NCT03317496|593144087|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
164212238|NCT03317496|593144088|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
164212239|NCT03317496|593144089|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
164212240|NCT03317496|593144090|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
164212241|NCT03317496|593144091|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
164212242|NCT03317496|593144087|FG000|Phase 1b Lead-in: Treatment|Death|0|||
164212243|NCT03317496|593144088|FG001|Phase 1b Lead-in: Treatment|Death|0|||
164212244|NCT03317496|593144089|FG002|Phase 1b Lead-in: Treatment|Death|1|||
164212245|NCT03317496|593144090|FG003|Phase 1b Lead-in: Treatment|Death|0|||
164212246|NCT03317496|593144091|FG004|Phase 1b Lead-in: Treatment|Death|0|||
164212247|NCT03317496|593144087|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
164212248|NCT03317496|593144088|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
164212249|NCT03317496|593144089|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
164212250|NCT03317496|593144090|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
164212251|NCT03317496|593144091|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
164212252|NCT03317496|593144087|FG000|Phase 1b Lead-in: Treatment|Other|2|||
164212253|NCT03317496|593144088|FG001|Phase 1b Lead-in: Treatment|Other|1|||
164212254|NCT03317496|593144089|FG002|Phase 1b Lead-in: Treatment|Other|0|||
164212255|NCT03317496|593144090|FG003|Phase 1b Lead-in: Treatment|Other|0|||
164212256|NCT03317496|593144091|FG004|Phase 1b Lead-in: Treatment|Other|0|||
164212257|NCT03317496|593144087|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
164212258|NCT03317496|593144088|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
164212259|NCT03317496|593144089|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
164212260|NCT03317496|593144090|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
164212261|NCT03317496|593144091|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
164212262|NCT03317496|593144087|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
164212263|NCT03317496|593144088|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
164212264|NCT03317496|593144089|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
164212265|NCT03317496|593144090|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
164212266|NCT03317496|593144091|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
164325303|NCT02616562|593566039|FG008|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325304|NCT02616562|593566040|FG009|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325305|NCT02616562|593566041|FG010|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325306|NCT02616562|593566042|FG011|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325307|NCT02616562|593566043|FG012|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325308|NCT02616562|593566044|FG013|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325309|NCT02616562|593566045|FG014|Long Term Safety Extension (208 Weeks)|Adult height reached|1|||
164325310|NCT02616562|593566046|FG015|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325311|NCT02616562|593566047|FG016|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325312|NCT02616562|593566031|FG000|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325313|NCT02616562|593566032|FG001|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325314|NCT02616562|593566033|FG002|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325315|NCT02616562|593566034|FG003|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325316|NCT02616562|593566035|FG004|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325317|NCT02616562|593566036|FG005|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325318|NCT02616562|593566037|FG006|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325319|NCT02616562|593566038|FG007|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325320|NCT02616562|593566039|FG008|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325321|NCT02616562|593566040|FG009|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325322|NCT02616562|593566041|FG010|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325323|NCT02616562|593566042|FG011|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325324|NCT02616562|593566043|FG012|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325325|NCT02616562|593566044|FG013|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325326|NCT02616562|593566045|FG014|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325327|NCT02616562|593566046|FG015|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|5|||
164325328|NCT02616562|593566047|FG016|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|16|||
164420676|NCT01154036|593910967|FG005|Phase II|Physician Decision|0|||
164564898|NCT02937350|594436412|FG002|Overall Study|Withdrawal by Subject|0|||
164564899|NCT02419508|594436413|FG000|Overall Study|Adverse Event|9|||
164564900|NCT02419508|594436414|FG001|Overall Study|Adverse Event|3|||
164212267|NCT03317496|593144087|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
164212268|NCT03317496|593144088|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
164212269|NCT03317496|593144089|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
164212270|NCT03317496|593144090|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
164212271|NCT03317496|593144091|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
164212272|NCT03317496|593144087|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
164212273|NCT03317496|593144088|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
164212274|NCT03317496|593144089|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
164212275|NCT03317496|593144090|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
164212276|NCT03317496|593144091|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
164212277|NCT03317496|593144087|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
164212278|NCT03317496|593144088|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
164212279|NCT03317496|593144089|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
164212280|NCT03317496|593144090|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
164212281|NCT03317496|593144091|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
164212282|NCT03317496|593144087|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
164212283|NCT03317496|593144088|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
164212284|NCT03317496|593144089|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
164212285|NCT03317496|593144090|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
164212286|NCT03317496|593144091|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
164212287|NCT03317496|593144087|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
164212288|NCT03317496|593144088|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
164212289|NCT03317496|593144089|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
164212290|NCT03317496|593144090|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
164212291|NCT03317496|593144091|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
164212292|NCT03317496|593144087|FG000|Phase 2: Treatment|Adverse Event|0|||
164212293|NCT03317496|593144088|FG001|Phase 2: Treatment|Adverse Event|0|||
164212294|NCT03317496|593144089|FG002|Phase 2: Treatment|Adverse Event|0|||
164212295|NCT03317496|593144090|FG003|Phase 2: Treatment|Adverse Event|0|||
164212296|NCT03317496|593144091|FG004|Phase 2: Treatment|Adverse Event|6|||
164212297|NCT03317496|593144087|FG000|Phase 2: Treatment|Progressive disease|0|||
164212298|NCT03317496|593144088|FG001|Phase 2: Treatment|Progressive disease|0|||
164325329|NCT03326206|593566055|FG000|Overall Study - 24 months|Unable to match cases with controls|17|||
164325330|NCT03326206|593566056|FG001|Overall Study - 24 months|Unable to match cases with controls|22721|||
164325331|NCT03326206|593566055|FG000|Overall Study - 24 months|Death|8|||
164325332|NCT03326206|593566056|FG001|Overall Study - 24 months|Death|92|||
164325333|NCT03326206|593566055|FG000|Overall Study - 24 months|Observational data not available|43|||
164325334|NCT03326206|593566056|FG001|Overall Study - 24 months|Observational data not available|2879|||
164325335|NCT03326206|593566055|FG000|12 months|Unable to match cases with controls|17|||
164325336|NCT03326206|593566056|FG001|12 months|Unable to match cases with controls|22721|||
164325337|NCT03326206|593566055|FG000|12 months|Death|2|||
164325338|NCT03326206|593566056|FG001|12 months|Death|50|||
164325339|NCT03326206|593566055|FG000|12 months|Observational data not available|49|||
164325340|NCT03326206|593566056|FG001|12 months|Observational data not available|2921|||
164325341|NCT01958827|593566057|FG000|Overall Study|Adverse Event|3|||
164325342|NCT01958827|593566057|FG000|Overall Study|Lack of Efficacy|6|||
164325343|NCT01958827|593566057|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
164325344|NCT04770779|593566058|FG000|Overall Study|Randomized, never treated|0|||
164325345|NCT04770779|593566059|FG001|Overall Study|Randomized, never treated|1|||
164325346|NCT04770779|593566058|FG000|Overall Study|Adverse Event|9|||
164325347|NCT04770779|593566059|FG001|Overall Study|Adverse Event|1|||
164564901|NCT02419508|594436413|FG000|Overall Study|Withdrawal by Subject|1|||
164669144|NCT00874237|594813565|FG003|Overall Study|Physician Decision|0|||
164669145|NCT00874237|594813566|FG004|Overall Study|Physician Decision|0|||
164669146|NCT00874237|594813567|FG005|Overall Study|Physician Decision|0|||
164669147|NCT00874237|594813562|FG000|Overall Study|Withdrawal by Subject|0|||
164669148|NCT00874237|594813563|FG001|Overall Study|Withdrawal by Subject|0|||
164669149|NCT00874237|594813564|FG002|Overall Study|Withdrawal by Subject|1|||
164669150|NCT00874237|594813565|FG003|Overall Study|Withdrawal by Subject|0|||
164669151|NCT00874237|594813566|FG004|Overall Study|Withdrawal by Subject|0|||
164669152|NCT00874237|594813567|FG005|Overall Study|Withdrawal by Subject|0|||
164669153|NCT00877032|594813570|FG000|Overall Study|Did not meet entrance criteria|0|||
164669154|NCT00877032|594813571|FG001|Overall Study|Did not meet entrance criteria|0|||
164669155|NCT00877032|594813572|FG002|Overall Study|Did not meet entrance criteria|0|||
164669156|NCT00877032|594813573|FG003|Overall Study|Did not meet entrance criteria|1|||
164669157|NCT00877032|594813574|FG004|Overall Study|Did not meet entrance criteria|0|||
164669158|NCT00877032|594813575|FG005|Overall Study|Did not meet entrance criteria|0|||
164669159|NCT00877032|594813576|FG006|Overall Study|Did not meet entrance criteria|2|||
164669160|NCT02107092|594813578|FG000|Overall Study|Miscellaneous|3|||
164669161|NCT02107092|594813578|FG000|Overall Study|Subject compliance|3|||
164669162|NCT02107092|594813578|FG000|Overall Study|Hypo-or hyperkalemia|2|||
164669163|NCT02107092|594813578|FG000|Overall Study|Met ECG withdrawal criteria|3|||
164669164|NCT02107092|594813578|FG000|Overall Study|Physician Decision|3|||
164669165|NCT02107092|594813578|FG000|Overall Study|Lost to Follow-up|2|||
164669166|NCT02107092|594813578|FG000|Overall Study|Withdrawal by Subject|9|||
164669167|NCT02107092|594813578|FG000|Overall Study|Adverse Event|7|||
164669168|NCT02107092|594813578|FG000|Overall Study|Expected progression of CKD|12|||
164669169|NCT00537030|594813579|FG000|Overall Study|Physician Decision|2|||
164669170|NCT00537030|594813579|FG000|Overall Study|Withdrawal by Subject|2|||
164669171|NCT00537030|594813579|FG000|Overall Study|≥ Grade 2 allergy|7|||
164669172|NCT00537030|594813579|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
164669173|NCT00537030|594813579|FG000|Overall Study|Ineligible|2|||
164669174|NCT00537030|594813579|FG000|Overall Study|Inevaluable|2|||
164669175|NCT04213326|594813581|FG000|Overall Study|Consent withdrawn|51|||
164669176|NCT04213326|594813582|FG001|Overall Study|Consent withdrawn|241|||
164669177|NCT04213326|594813581|FG000|Overall Study|Lost to Follow-up|50|||
164669178|NCT04213326|594813582|FG001|Overall Study|Lost to Follow-up|902|||
164669179|NCT04213326|594813581|FG000|Overall Study|Protocol Violation|3|||
164669180|NCT04213326|594813582|FG001|Overall Study|Protocol Violation|25|||
164669181|NCT04213326|594813581|FG000|Overall Study|Participant eligibility changed|106|||
164669182|NCT04213326|594813582|FG001|Overall Study|Participant eligibility changed|19|||
164669183|NCT04213326|594813581|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
164669184|NCT04213326|594813582|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
164669185|NCT04213326|594813581|FG000|Overall Study|Incomplete study visit|0|||
164669186|NCT04213326|594813582|FG001|Overall Study|Incomplete study visit|367|||
164669187|NCT01496183|594813584|FG000|Overall Study|Physician Decision|3|||
164669188|NCT01496183|594813585|FG001|Overall Study|Physician Decision|1|||
164669189|NCT01496183|594813584|FG000|Overall Study|Withdrawal by Subject|0|||
164669190|NCT01496183|594813585|FG001|Overall Study|Withdrawal by Subject|1|||
164669191|NCT01173692|594813588|FG000|Overall Study|Adverse Event|1|||
164669192|NCT01173692|594813589|FG001|Overall Study|Adverse Event|2|||
164669193|NCT01173692|594813588|FG000|Overall Study|Withdrawal by Subject|1|||
164669194|NCT01173692|594813589|FG001|Overall Study|Withdrawal by Subject|3|||
164669195|NCT00669864|594813592|FG000|Overall Study|Lost to Follow-up|2|||
164669196|NCT00669864|594813592|FG000|Overall Study|Protocol Violation|2|||
164669197|NCT00669864|594813592|FG000|Overall Study|Withdrawal by Subject|3|||
164212299|NCT03317496|593144089|FG002|Phase 2: Treatment|Progressive disease|0|||
164212300|NCT03317496|593144090|FG003|Phase 2: Treatment|Progressive disease|0|||
164212301|NCT03317496|593144091|FG004|Phase 2: Treatment|Progressive disease|22|||
164212302|NCT03317496|593144087|FG000|Phase 2: Treatment|Other|0|||
164212303|NCT03317496|593144088|FG001|Phase 2: Treatment|Other|0|||
164212304|NCT03317496|593144089|FG002|Phase 2: Treatment|Other|0|||
164212305|NCT03317496|593144090|FG003|Phase 2: Treatment|Other|0|||
164212306|NCT03317496|593144091|FG004|Phase 2: Treatment|Other|4|||
164212307|NCT03317496|593144087|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
164212308|NCT03317496|593144088|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
164212309|NCT03317496|593144089|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
164212310|NCT03317496|593144090|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
164212311|NCT03317496|593144091|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
164212312|NCT03317496|593144087|FG000|Phase 2: Treatment|Physician Decision|0|||
164212313|NCT03317496|593144088|FG001|Phase 2: Treatment|Physician Decision|0|||
164212314|NCT03317496|593144089|FG002|Phase 2: Treatment|Physician Decision|0|||
164212315|NCT03317496|593144090|FG003|Phase 2: Treatment|Physician Decision|0|||
164212316|NCT03317496|593144091|FG004|Phase 2: Treatment|Physician Decision|1|||
164212317|NCT03317496|593144087|FG000|Phase 2: Treatment|Death|0|||
164212318|NCT03317496|593144088|FG001|Phase 2: Treatment|Death|0|||
164212319|NCT03317496|593144089|FG002|Phase 2: Treatment|Death|0|||
164212320|NCT03317496|593144090|FG003|Phase 2: Treatment|Death|0|||
164212321|NCT03317496|593144091|FG004|Phase 2: Treatment|Death|1|||
164212322|NCT03317496|593144087|FG000|Phase 2: Follow-up|Death|0|||
164212323|NCT03317496|593144088|FG001|Phase 2: Follow-up|Death|0|||
164212324|NCT03317496|593144089|FG002|Phase 2: Follow-up|Death|0|||
164212325|NCT03317496|593144090|FG003|Phase 2: Follow-up|Death|0|||
164212326|NCT03317496|593144091|FG004|Phase 2: Follow-up|Death|24|||
164212327|NCT03317496|593144087|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
164212328|NCT03317496|593144088|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
164212329|NCT03317496|593144089|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
164212330|NCT03317496|593144090|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
164212331|NCT03317496|593144091|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
164212332|NCT03317496|593144087|FG000|Phase 2: Follow-up|Other|0|||
164212333|NCT03317496|593144088|FG001|Phase 2: Follow-up|Other|0|||
164212334|NCT03317496|593144089|FG002|Phase 2: Follow-up|Other|0|||
164212335|NCT03317496|593144090|FG003|Phase 2: Follow-up|Other|0|||
164212336|NCT03317496|593144091|FG004|Phase 2: Follow-up|Other|1|||
164212337|NCT03317496|593144087|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
164212338|NCT03317496|593144088|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
164212339|NCT03317496|593144089|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
164212340|NCT03317496|593144090|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
164212341|NCT03317496|593144091|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
164212342|NCT02693418|593144092|FG000|Overall Study|Lost to Follow-up|1|||
164212343|NCT02693418|593144093|FG001|Overall Study|Lost to Follow-up|2|||
164212344|NCT02693418|593144094|FG002|Overall Study|Lost to Follow-up|0|||
164212345|NCT02693418|593144095|FG003|Overall Study|Lost to Follow-up|0|||
164212346|NCT02693418|593144096|FG004|Overall Study|Lost to Follow-up|0|||
164212347|NCT02693418|593144092|FG000|Overall Study|Menses during study period|0|||
164212348|NCT02693418|593144093|FG001|Overall Study|Menses during study period|0|||
164212349|NCT02693418|593144094|FG002|Overall Study|Menses during study period|2|||
164212350|NCT02693418|593144095|FG003|Overall Study|Menses during study period|0|||
164212351|NCT02693418|593144096|FG004|Overall Study|Menses during study period|0|||
164212352|NCT01750346|593144097|FG000|Overall Study|Adverse Event|1|||
164212353|NCT01750346|593144098|FG001|Overall Study|Adverse Event|0|||
164212354|NCT01750346|593144099|FG002|Overall Study|Adverse Event|0|||
164212355|NCT02034591|593144102|FG000|Overall Study|Withdrawal by Subject|0|||
164212356|NCT02034591|593144103|FG001|Overall Study|Withdrawal by Subject|0|||
164212357|NCT02034591|593144104|FG002|Overall Study|Withdrawal by Subject|0|||
164212358|NCT02034591|593144105|FG003|Overall Study|Withdrawal by Subject|0|||
164212359|NCT02034591|593144106|FG004|Overall Study|Withdrawal by Subject|1|||
164212360|NCT02034591|593144107|FG005|Overall Study|Withdrawal by Subject|0|||
164212361|NCT00599313|593144108|FG000|Overall Study|Adverse Event|19|||
164212362|NCT00599313|593144108|FG000|Overall Study|Disease Progression|12|||
164212363|NCT00599313|593144108|FG000|Overall Study|Patient Request|4|||
164212364|NCT00599313|593144108|FG000|Overall Study|Ineligible|1|||
164212365|NCT02782468|593144109|FG000|Overall Study|Progressive Disease|2|||
164212366|NCT02782468|593144110|FG001|Overall Study|Progressive Disease|5|||
164212367|NCT02782468|593144111|FG002|Overall Study|Progressive Disease|0|||
164212368|NCT02782468|593144112|FG003|Overall Study|Progressive Disease|4|||
164212369|NCT02782468|593144109|FG000|Overall Study|Adverse Event|0|||
164212370|NCT02782468|593144110|FG001|Overall Study|Adverse Event|2|||
164212371|NCT02782468|593144111|FG002|Overall Study|Adverse Event|2|||
164212372|NCT02782468|593144112|FG003|Overall Study|Adverse Event|3|||
164212373|NCT02782468|593144109|FG000|Overall Study|Other|0|||
164212374|NCT02782468|593144110|FG001|Overall Study|Other|0|||
164212375|NCT02782468|593144111|FG002|Overall Study|Other|1|||
164212376|NCT02782468|593144112|FG003|Overall Study|Other|1|||
164212377|NCT02782468|593144109|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
164420677|NCT01154036|593910968|FG006|Phase II|Physician Decision|1|||
164212378|NCT02782468|593144110|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
164212379|NCT02782468|593144111|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
164212380|NCT02782468|593144112|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
164212381|NCT02782468|593144109|FG000|Overall Study|Symptomatic Deterioration|0|||
164212382|NCT02782468|593144110|FG001|Overall Study|Symptomatic Deterioration|0|||
164212383|NCT02782468|593144111|FG002|Overall Study|Symptomatic Deterioration|0|||
164212384|NCT02782468|593144112|FG003|Overall Study|Symptomatic Deterioration|1|||
164212385|NCT02782468|593144109|FG000|Overall Study|Withdrawal by Subject|1|||
164212386|NCT02782468|593144110|FG001|Overall Study|Withdrawal by Subject|0|||
164212387|NCT02782468|593144111|FG002|Overall Study|Withdrawal by Subject|0|||
164212388|NCT02782468|593144112|FG003|Overall Study|Withdrawal by Subject|0|||
164212389|NCT00712920|593144114|FG000|Overall Study|Adverse Event|3|||
164212390|NCT00712920|593144115|FG001|Overall Study|Adverse Event|4|||
164212391|NCT00712920|593144116|FG002|Overall Study|Adverse Event|7|||
164212392|NCT00712920|593144114|FG000|Overall Study|Withdrawal by Subject|4|||
164212393|NCT00712920|593144115|FG001|Overall Study|Withdrawal by Subject|2|||
164212394|NCT00712920|593144116|FG002|Overall Study|Withdrawal by Subject|1|||
164212395|NCT00712920|593144114|FG000|Overall Study|Lost to Follow-up|1|||
164212396|NCT00712920|593144115|FG001|Overall Study|Lost to Follow-up|4|||
164212397|NCT00712920|593144116|FG002|Overall Study|Lost to Follow-up|0|||
164212398|NCT00712920|593144114|FG000|Overall Study|Lack of Efficacy|1|||
164212399|NCT00712920|593144115|FG001|Overall Study|Lack of Efficacy|0|||
164212400|NCT00712920|593144116|FG002|Overall Study|Lack of Efficacy|1|||
164212401|NCT00712920|593144114|FG000|Overall Study|Other|5|||
164212402|NCT00712920|593144115|FG001|Overall Study|Other|7|||
164212403|NCT00712920|593144116|FG002|Overall Study|Other|3|||
164212404|NCT00712920|593144114|FG000|Overall Study|Non-compliance|3|||
164212405|NCT00712920|593144115|FG001|Overall Study|Non-compliance|0|||
164212406|NCT00712920|593144116|FG002|Overall Study|Non-compliance|0|||
164212407|NCT02489773|593144117|FG000|Overall Study|Lost to Follow-up|4|||
164212408|NCT02489773|593144118|FG001|Overall Study|Lost to Follow-up|1|||
164212409|NCT02489773|593144117|FG000|Overall Study|Physician Decision|1|||
164212410|NCT02489773|593144118|FG001|Overall Study|Physician Decision|0|||
164212411|NCT02489773|593144117|FG000|Overall Study|Withdrawal by Subject|1|||
164212412|NCT02489773|593144118|FG001|Overall Study|Withdrawal by Subject|0|||
164212413|NCT02489773|593144117|FG000|Overall Study|Leave the country or the state|1|||
164212414|NCT02489773|593144118|FG001|Overall Study|Leave the country or the state|1|||
164212415|NCT00620542|593144120|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
164212416|NCT00620542|593144121|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
164212417|NCT00620542|593144122|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
164212418|NCT00620542|593144123|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
164212419|NCT00620542|593144120|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
164212420|NCT00620542|593144121|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
164212421|NCT00620542|593144122|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
164212422|NCT00620542|593144123|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
164212423|NCT00620542|593144120|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
164212424|NCT00620542|593144121|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
164212425|NCT00620542|593144122|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
164212426|NCT00620542|593144123|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
164212427|NCT00620542|593144120|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
164212428|NCT00620542|593144121|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
164212429|NCT00620542|593144122|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
164212430|NCT00620542|593144123|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
164212431|NCT00620542|593144120|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
164212432|NCT00620542|593144121|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
164212433|NCT00620542|593144122|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
164212434|NCT00620542|593144123|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
164212435|NCT00620542|593144120|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
164564902|NCT02419508|594436414|FG001|Overall Study|Withdrawal by Subject|0|||
164564903|NCT02419508|594436413|FG000|Overall Study|Other - Reason not specified|0|||
164564904|NCT02419508|594436414|FG001|Overall Study|Other - Reason not specified|1|||
164564905|NCT01891643|594438337|FG000|Overall Study|Adverse event unrelated to study drug|2|||
164212436|NCT00620542|593144121|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
164212437|NCT00620542|593144122|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
164212438|NCT00620542|593144123|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
164212439|NCT00620542|593144120|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
164212440|NCT00620542|593144121|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
164212441|NCT00620542|593144122|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
164212442|NCT00620542|593144123|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
164212443|NCT00620542|593144120|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
164212444|NCT00620542|593144121|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
164212445|NCT00620542|593144122|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
164212446|NCT00620542|593144123|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
164564906|NCT01891643|594438338|FG001|Overall Study|Adverse event unrelated to study drug|5|||
164325348|NCT04770779|593566058|FG000|Overall Study|Withdrawal by Subject|7|||
164325349|NCT04770779|593566059|FG001|Overall Study|Withdrawal by Subject|1|||
164325350|NCT04770779|593566058|FG000|Overall Study|Pregnancy|0|||
164325351|NCT04770779|593566059|FG001|Overall Study|Pregnancy|1|||
164325352|NCT03692052|593566060|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
164325353|NCT03692052|593566060|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
164325354|NCT03692052|593566060|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
164325355|NCT03692052|593566060|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
164325356|NCT01163318|593566061|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
164325357|NCT01163318|593566061|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
164325358|NCT01163318|593566061|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
164325359|NCT01163318|593566061|FG000|Overall Study|Participants Without Case Report Form|7|||
164325360|NCT01163318|593566061|FG000|Overall Study|Multiple Reasons Per Participant|224|||
164325361|NCT03587727|593566062|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
164325362|NCT03587727|593566062|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
164325363|NCT04562480|593566493|FG000|Overall Study|Withdrawal by Subject|1|||
164325364|NCT04001829|593566496|FG000|Overall Study|Never start protocol therapy|5|||
164325365|NCT04001829|593566497|FG001|Overall Study|Never start protocol therapy|5|||
164325366|NCT04001829|593566496|FG000|Overall Study|Adverse Event|11|||
164325367|NCT04001829|593566497|FG001|Overall Study|Adverse Event|7|||
164325368|NCT04001829|593566496|FG000|Overall Study|Alternative therapy|1|||
164325369|NCT04001829|593566497|FG001|Overall Study|Alternative therapy|2|||
164325370|NCT04001829|593566496|FG000|Overall Study|Disease progression/relapse|2|||
164325371|NCT04001829|593566497|FG001|Overall Study|Disease progression/relapse|1|||
164325372|NCT04001829|593566496|FG000|Overall Study|Other complicating disease|1|||
164325373|NCT04001829|593566497|FG001|Overall Study|Other complicating disease|0|||
164325374|NCT04001829|593566496|FG000|Overall Study|Withdrawal by Subject|1|||
164325375|NCT04001829|593566497|FG001|Overall Study|Withdrawal by Subject|4|||
164325376|NCT04001829|593566496|FG000|Overall Study|Ineligible|2|||
164325377|NCT04001829|593566497|FG001|Overall Study|Ineligible|2|||
164325378|NCT04001829|593566496|FG000|Overall Study|Reason missing due to delinquent data|1|||
164325379|NCT04001829|593566497|FG001|Overall Study|Reason missing due to delinquent data|0|||
164325380|NCT05388058|593566498|FG000|Initial Treatment|Withdrawal by Subject|0|||
164325381|NCT05388058|593566499|FG001|Initial Treatment|Withdrawal by Subject|1|||
164325382|NCT05388058|593566498|FG000|Initial Treatment|Ineligible|0|||
164325383|NCT05388058|593566499|FG001|Initial Treatment|Ineligible|1|||
164325384|NCT04831216|593566503|FG000|Overall Study|Lost to Follow-up|32|||
164325385|NCT03470441|593566505|FG000|Overall Study|Death|0|||
164325386|NCT03470441|593566506|FG001|Overall Study|Death|1|||
164325387|NCT03470441|593566507|FG002|Overall Study|Death|1|||
164325388|NCT03470441|593566508|FG003|Overall Study|Death|0|||
164325389|NCT03470441|593566505|FG000|Overall Study|Adverse Event|0|||
164325390|NCT03470441|593566506|FG001|Overall Study|Adverse Event|0|||
164325391|NCT03470441|593566507|FG002|Overall Study|Adverse Event|0|||
164325392|NCT03470441|593566508|FG003|Overall Study|Adverse Event|1|||
164325393|NCT03470441|593566505|FG000|Overall Study|Withdrawal by Subject|1|||
164325394|NCT03470441|593566506|FG001|Overall Study|Withdrawal by Subject|4|||
164325395|NCT03470441|593566507|FG002|Overall Study|Withdrawal by Subject|1|||
164325396|NCT03470441|593566508|FG003|Overall Study|Withdrawal by Subject|3|||
164325397|NCT02656706|593566509|FG000|Overall Study|Insurance Denial|1|||
164325398|NCT05076266|593566510|FG000|Overall Study|Survey not complete - Participant refusal|2|||
164325399|NCT05076266|593566511|FG001|Overall Study|Survey not complete - Participant refusal|0|||
164325400|NCT05169567|593566512|FG000|Overall Study|On study treatment|116|||
164325401|NCT05169567|593566513|FG001|Overall Study|On study treatment|128|||
164325402|NCT05169567|593566512|FG000|Overall Study|Lost to Follow-up|1|||
164325403|NCT05169567|593566513|FG001|Overall Study|Lost to Follow-up|0|||
164325404|NCT05169567|593566512|FG000|Overall Study|Withdrawal by Subject|25|||
164325405|NCT05169567|593566513|FG001|Overall Study|Withdrawal by Subject|21|||
164325406|NCT04576455|593566516|FG000|Overall Study|Ongoing in the Study|48|||
164325407|NCT04576455|593566517|FG001|Overall Study|Ongoing in the Study|58|||
164325408|NCT04576455|593566516|FG000|Overall Study|Death|83|||
164325409|NCT04576455|593566517|FG001|Overall Study|Death|77|||
164325410|NCT04576455|593566516|FG000|Overall Study|Lost to Follow-up|4|||
164325411|NCT04576455|593566517|FG001|Overall Study|Lost to Follow-up|5|||
164325412|NCT04576455|593566516|FG000|Overall Study|Withdrawal by Subject|16|||
164325413|NCT04576455|593566517|FG001|Overall Study|Withdrawal by Subject|12|||
164325414|NCT04449055|593566518|FG000|Overall Study|Lost to Follow-up|2|||
164325415|NCT04449055|593566519|FG001|Overall Study|Lost to Follow-up|1|||
164325416|NCT04449055|593566518|FG000|Overall Study|Missed 4 treatments--removed by PI|1|||
164325417|NCT04449055|593566519|FG001|Overall Study|Missed 4 treatments--removed by PI|1|||
164325418|NCT04449055|593566518|FG000|Overall Study|Could not refrain from methamphetamine for 24 hours before treatment--removed by PI|1|||
164325419|NCT04449055|593566519|FG001|Overall Study|Could not refrain from methamphetamine for 24 hours before treatment--removed by PI|0|||
164325420|NCT04449055|593566518|FG000|Overall Study|Incarcerated|1|||
164325421|NCT04449055|593566519|FG001|Overall Study|Incarcerated|0|||
164325422|NCT06596005|593566520|FG000|Overall Study|Withdrawal by Subject|2|||
164212447|NCT00620542|593144120|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
164212448|NCT00620542|593144121|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
164212449|NCT00620542|593144122|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
164212450|NCT00620542|593144123|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
164212451|NCT00620542|593144120|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
164212452|NCT00620542|593144121|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
164212453|NCT00620542|593144122|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
164212454|NCT00620542|593144123|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
164212455|NCT00620542|593144120|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
164212456|NCT00620542|593144121|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
164212457|NCT00620542|593144122|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
164212458|NCT00620542|593144123|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
164212459|NCT00620542|593144120|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
164212460|NCT00620542|593144121|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
164212461|NCT00620542|593144122|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
164212462|NCT00620542|593144123|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
164212463|NCT00620542|593144120|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
164212464|NCT00620542|593144121|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
164212465|NCT00620542|593144122|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
164212466|NCT00620542|593144123|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
164212467|NCT00620542|593144120|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
164212468|NCT00620542|593144121|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
164212469|NCT00620542|593144122|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
164212470|NCT00620542|593144123|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
164212471|NCT00620542|593144120|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
164212472|NCT00620542|593144121|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
164212473|NCT00620542|593144122|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
164212474|NCT00620542|593144123|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
164212475|NCT02879695|593144126|FG000|Overall Study|Did not start study treatment|2|||
164212476|NCT02879695|593144127|FG001|Overall Study|Did not start study treatment|0|||
164212477|NCT02879695|593144128|FG002|Overall Study|Did not start study treatment|3|||
164212478|NCT02879695|593144129|FG003|Overall Study|Did not start study treatment|0|||
164212479|NCT02572167|593144130|FG000|Overall Study|Withdrawal by Subject|0|||
164212480|NCT02572167|593144131|FG001|Overall Study|Withdrawal by Subject|3|||
164212481|NCT02572167|593144132|FG002|Overall Study|Withdrawal by Subject|0|||
164212482|NCT02572167|593144130|FG000|Overall Study|Lost to Follow-up|2|||
164212483|NCT02572167|593144131|FG001|Overall Study|Lost to Follow-up|5|||
164212484|NCT02572167|593144132|FG002|Overall Study|Lost to Follow-up|3|||
164212485|NCT02572167|593144130|FG000|Overall Study|Death|0|||
164212486|NCT02572167|593144131|FG001|Overall Study|Death|8|||
164212487|NCT02572167|593144132|FG002|Overall Study|Death|3|||
164212488|NCT02572167|593144130|FG000|Overall Study|Did not meet inclusion criteria|0|||
164212489|NCT02572167|593144131|FG001|Overall Study|Did not meet inclusion criteria|0|||
164212490|NCT02572167|593144132|FG002|Overall Study|Did not meet inclusion criteria|1|||
164212491|NCT02572167|593144130|FG000|Overall Study|Study closure by Sponsor|4|||
164212492|NCT02572167|593144131|FG001|Overall Study|Study closure by Sponsor|40|||
164212493|NCT02572167|593144132|FG002|Overall Study|Study closure by Sponsor|24|||
164212494|NCT00005047|593144133|FG000|Overall Study|Withdrawal by Subject|12|||
164212495|NCT00005047|593144134|FG001|Overall Study|Withdrawal by Subject|0|||
164212496|NCT00005047|593144135|FG002|Overall Study|Withdrawal by Subject|0|||
164212497|NCT00005047|593144136|FG003|Overall Study|Withdrawal by Subject|0|||
164325423|NCT06596005|593566521|FG001|Overall Study|Withdrawal by Subject|2|||
164325424|NCT06596005|593566522|FG002|Overall Study|Withdrawal by Subject|1|||
164564907|NCT01891643|594438337|FG000|Overall Study|Disease Progression|4|||
164564908|NCT01891643|594438338|FG001|Overall Study|Disease Progression|3|||
164212498|NCT00005047|593144133|FG000|Overall Study|Adverse Event|5|||
164564909|NCT01891643|594438337|FG000|Overall Study|Study Drug Toxicity|3|||
164564910|NCT01891643|594438338|FG001|Overall Study|Study Drug Toxicity|0|||
164564911|NCT01891643|594438337|FG000|Overall Study|Maximum Clinical Benefit|0|||
164564912|NCT01891643|594438338|FG001|Overall Study|Maximum Clinical Benefit|1|||
164564913|NCT01891643|594438337|FG000|Overall Study|Poor/Non-compliance|0|||
164564914|NCT01891643|594438338|FG001|Overall Study|Poor/Non-compliance|1|||
164564915|NCT01891643|594438337|FG000|Overall Study|Participant request to discontinue|1|||
164564916|NCT01891643|594438338|FG001|Overall Study|Participant request to discontinue|0|||
164564917|NCT01171820|594438346|FG000|Overall Study|Death|3|||
164564918|NCT01171820|594438347|FG001|Overall Study|Death|3|||
164564919|NCT01171820|594438346|FG000|Overall Study|Lost to Follow-up|0|||
164564920|NCT01171820|594438347|FG001|Overall Study|Lost to Follow-up|1|||
164564921|NCT01171820|594438346|FG000|Overall Study|Withdrawal by Subject|2|||
164564922|NCT01171820|594438347|FG001|Overall Study|Withdrawal by Subject|0|||
164564923|NCT01171820|594438346|FG000|Overall Study|Physician Decision|0|||
164564924|NCT01171820|594438347|FG001|Overall Study|Physician Decision|1|||
164564925|NCT01171820|594438346|FG000|Overall Study|1-Year Missed Visit|1|||
164564926|NCT01171820|594438347|FG001|Overall Study|1-Year Missed Visit|1|||
164212499|NCT00005047|593144134|FG001|Overall Study|Adverse Event|0|||
164212500|NCT00005047|593144135|FG002|Overall Study|Adverse Event|0|||
164212501|NCT00005047|593144136|FG003|Overall Study|Adverse Event|0|||
164212502|NCT00005047|593144133|FG000|Overall Study|Lost to Follow-up|1|||
164212503|NCT00005047|593144134|FG001|Overall Study|Lost to Follow-up|0|||
164212504|NCT00005047|593144135|FG002|Overall Study|Lost to Follow-up|0|||
164212505|NCT00005047|593144136|FG003|Overall Study|Lost to Follow-up|0|||
164212506|NCT00005047|593144133|FG000|Overall Study|Lack of Efficacy|1|||
164212507|NCT00005047|593144134|FG001|Overall Study|Lack of Efficacy|0|||
164212508|NCT00005047|593144135|FG002|Overall Study|Lack of Efficacy|0|||
164212509|NCT00005047|593144136|FG003|Overall Study|Lack of Efficacy|0|||
164212510|NCT05523297|593144138|FG000|Overall Study|Death|7|||
164212511|NCT05523297|593144139|FG001|Overall Study|Death|8|||
164212512|NCT05523297|593144138|FG000|Overall Study|Lost to Follow-up|2|||
164212513|NCT05523297|593144139|FG001|Overall Study|Lost to Follow-up|1|||
164212514|NCT03168672|593144142|FG000|Overall Study|Withdrawal by Subject|13|||
164212515|NCT03168672|593144142|FG000|Overall Study|Death|3|||
164212516|NCT03168672|593144142|FG000|Overall Study|Investigator's Decision|137|||
164212517|NCT03168672|593144142|FG000|Overall Study|Adverse Event|1|||
164212518|NCT03168672|593144142|FG000|Overall Study|Other|2|||
164212519|NCT03168672|593144142|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
164212520|NCT00433537|593144143|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
164212521|NCT00433537|593144144|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
164212522|NCT00433537|593144145|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
164212523|NCT00433537|593144143|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
164212524|NCT00433537|593144144|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
164212525|NCT00433537|593144145|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
164212526|NCT00433537|593144143|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
164212527|NCT00433537|593144144|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
164212528|NCT00433537|593144145|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
164212529|NCT00433537|593144143|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
164212530|NCT00433537|593144144|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
164212531|NCT00433537|593144145|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
164212532|NCT00433537|593144143|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
164212533|NCT00433537|593144144|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
164212534|NCT00433537|593144145|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
164212535|NCT00433537|593144143|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
164212536|NCT00433537|593144144|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
164212537|NCT00433537|593144145|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
164212538|NCT00433537|593144143|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
164212539|NCT00433537|593144144|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
164212540|NCT00433537|593144145|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
164212541|NCT00433537|593144143|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
164212542|NCT00433537|593144144|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
164212543|NCT00433537|593144145|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
164212544|NCT00433537|593144143|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
164212545|NCT00433537|593144144|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
164212546|NCT00433537|593144145|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
164212547|NCT04556097|593144146|FG000|Overall Study|Death|0|||
164212548|NCT04556097|593144147|FG001|Overall Study|Death|5|||
164212549|NCT04556097|593144148|FG002|Overall Study|Death|0|||
164212550|NCT04556097|593144149|FG003|Overall Study|Death|0|||
164212551|NCT04556097|593144146|FG000|Overall Study|No caregiver|43|||
164212552|NCT04556097|593144147|FG001|Overall Study|No caregiver|53|||
164212553|NCT04556097|593144148|FG002|Overall Study|No caregiver|0|||
164212554|NCT04556097|593144149|FG003|Overall Study|No caregiver|0|||
164212555|NCT04556097|593144146|FG000|Overall Study|Ineligible, SNF|2|||
164212556|NCT04556097|593144147|FG001|Overall Study|Ineligible, SNF|2|||
164212557|NCT04556097|593144148|FG002|Overall Study|Ineligible, SNF|0|||
164212558|NCT04556097|593144149|FG003|Overall Study|Ineligible, SNF|0|||
164212559|NCT04556097|593144146|FG000|Overall Study|Ineligible, health|3|||
164212560|NCT04556097|593144147|FG001|Overall Study|Ineligible, health|4|||
164212561|NCT04556097|593144148|FG002|Overall Study|Ineligible, health|0|||
164212562|NCT04556097|593144149|FG003|Overall Study|Ineligible, health|0|||
164212563|NCT04556097|593144146|FG000|Overall Study|Ineligible, language|0|||
164212564|NCT04556097|593144147|FG001|Overall Study|Ineligible, language|1|||
164212565|NCT04556097|593144148|FG002|Overall Study|Ineligible, language|0|||
164212566|NCT04556097|593144149|FG003|Overall Study|Ineligible, language|0|||
164212567|NCT04556097|593144146|FG000|Overall Study|Ineligible, no longer in care management|0|||
164212568|NCT04556097|593144147|FG001|Overall Study|Ineligible, no longer in care management|2|||
164212569|NCT04556097|593144148|FG002|Overall Study|Ineligible, no longer in care management|1|||
164212570|NCT04556097|593144149|FG003|Overall Study|Ineligible, no longer in care management|0|||
164212571|NCT04556097|593144146|FG000|Overall Study|No dementia|13|||
164212572|NCT04556097|593144147|FG001|Overall Study|No dementia|3|||
164669198|NCT00669864|594813592|FG000|Overall Study|Other|2|||
164669199|NCT01941030|594813596|FG000|Overall Study|Death|3|||
164669200|NCT01941030|594813597|FG001|Overall Study|Death|2|||
164669201|NCT01941030|594813596|FG000|Overall Study|Lost to Follow-up|6|||
164669202|NCT01941030|594813597|FG001|Overall Study|Lost to Follow-up|5|||
164669203|NCT01941030|594813596|FG000|Overall Study|Withdrawal by Subject|4|||
164669204|NCT01941030|594813597|FG001|Overall Study|Withdrawal by Subject|6|||
164669205|NCT05067647|594813600|FG000|Overall Study|Lost to Follow-up|1|||
164669206|NCT02781727|594813602|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
164669207|NCT02781727|594813603|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
164669208|NCT02781727|594813602|FG000|Treatment Period|Withdrawal by Subject|1|||
164669209|NCT02781727|594813603|FG001|Treatment Period|Withdrawal by Subject|0|||
164669210|NCT02781727|594813602|FG000|Treatment Period|Lost to Follow-up|0|||
164669211|NCT02781727|594813603|FG001|Treatment Period|Lost to Follow-up|1|||
164669212|NCT03069937|594813605|FG000|Overall Study|Second primary malignancy noted|1|||
164669213|NCT01569152|594813609|FG000|Phase IIa, Period 1|Early Escape|5|||
164669214|NCT01569152|594813610|FG001|Phase IIa, Period 1|Early Escape|22|||
164669215|NCT01569152|594813611|FG002|Phase IIa, Period 1|Early Escape|0|||
164669216|NCT01569152|594813609|FG000|Phase IIa, Period 1|Adverse Event|4|||
164669217|NCT01569152|594813610|FG001|Phase IIa, Period 1|Adverse Event|0|||
164669218|NCT01569152|594813611|FG002|Phase IIa, Period 1|Adverse Event|0|||
164669219|NCT01569152|594813609|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
164669220|NCT01569152|594813610|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
164669221|NCT01569152|594813611|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
164669222|NCT01569152|594813609|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
164669223|NCT01569152|594813610|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
164669224|NCT01569152|594813611|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
164669225|NCT01569152|594813609|FG000|Phase IIa, Period 1|Protocol Violation|0|||
164669226|NCT01569152|594813610|FG001|Phase IIa, Period 1|Protocol Violation|1|||
164669227|NCT01569152|594813611|FG002|Phase IIa, Period 1|Protocol Violation|0|||
164669228|NCT01569152|594813609|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
164669229|NCT01569152|594813610|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
164669230|NCT01569152|594813611|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
164669231|NCT01569152|594813609|FG000|Safety Extension, Period 3|Adverse Event|0|||
164669232|NCT01569152|594813610|FG001|Safety Extension, Period 3|Adverse Event|0|||
164669233|NCT01569152|594813611|FG002|Safety Extension, Period 3|Adverse Event|4|||
164669234|NCT01569152|594813609|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
164669235|NCT01569152|594813610|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
164669236|NCT01569152|594813611|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
164669237|NCT01569152|594813609|FG000|Safety Extension, Period 3|Physician Decision|0|||
164669238|NCT01569152|594813610|FG001|Safety Extension, Period 3|Physician Decision|0|||
164669239|NCT01569152|594813611|FG002|Safety Extension, Period 3|Physician Decision|2|||
164669240|NCT01569152|594813609|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
164669241|NCT01569152|594813610|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
164669242|NCT01569152|594813611|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
164669243|NCT00683293|594813612|FG000|Overall Study|Withdrawal by Subject|2|||
164669244|NCT00683293|594813613|FG001|Overall Study|Withdrawal by Subject|3|||
164669245|NCT00743197|594813616|FG000|Overall Study|Study terminated due to departure of PI.|1|||
164669246|NCT00743197|594813617|FG001|Overall Study|Study terminated due to departure of PI.|2|||
164669247|NCT01411332|594813622|FG000|Enrollment|Protocol Violation|0|||
164669248|NCT01411332|594813623|FG001|Enrollment|Protocol Violation|1|||
164669249|NCT01411332|594813622|FG000|Enrollment|Withdrawal by Subject|0|||
164669250|NCT01411332|594813623|FG001|Enrollment|Withdrawal by Subject|1|||
164669251|NCT01411332|594813622|FG000|Treatment|Lost to Follow-up|1|||
164669252|NCT01411332|594813623|FG001|Treatment|Lost to Follow-up|0|||
164669253|NCT01432171|594813624|FG000|Overall Study|Death|1|||
164669254|NCT01432171|594813625|FG001|Overall Study|Death|2|||
164669255|NCT01432171|594813624|FG000|Overall Study|Lost to Follow-up|6|||
164669256|NCT01432171|594813625|FG001|Overall Study|Lost to Follow-up|5|||
164669257|NCT01432171|594813624|FG000|Overall Study|Withdrawal by Subject|3|||
164669258|NCT01432171|594813625|FG001|Overall Study|Withdrawal by Subject|1|||
164669259|NCT01432171|594813624|FG000|Overall Study|Noncompliance|2|||
164669260|NCT01432171|594813625|FG001|Overall Study|Noncompliance|3|||
164669261|NCT01432171|594813624|FG000|Overall Study|Insurance denial trial coverage|1|||
164669262|NCT01432171|594813625|FG001|Overall Study|Insurance denial trial coverage|0|||
164669263|NCT01432171|594813624|FG000|Overall Study|Patient moved to palliative care|1|||
164669264|NCT01432171|594813625|FG001|Overall Study|Patient moved to palliative care|0|||
164669265|NCT02863575|594813626|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
164669266|NCT02863575|594813627|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
164669267|NCT02863575|594813628|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
164212573|NCT04556097|593144148|FG002|Overall Study|No dementia|0|||
164669268|NCT02863575|594813626|FG000|Overall Study|Withdrawal by Subject|0|||
164669269|NCT02863575|594813627|FG001|Overall Study|Withdrawal by Subject|1|||
164669270|NCT02863575|594813628|FG002|Overall Study|Withdrawal by Subject|1|||
164669271|NCT02863575|594813626|FG000|Overall Study|Adverse Event|0|||
164212574|NCT04556097|593144149|FG003|Overall Study|No dementia|0|||
164212575|NCT04556097|593144146|FG000|Overall Study|Missing identifier|2|||
164212576|NCT04556097|593144147|FG001|Overall Study|Missing identifier|4|||
164212577|NCT04556097|593144148|FG002|Overall Study|Missing identifier|0|||
164212578|NCT04556097|593144149|FG003|Overall Study|Missing identifier|0|||
164212579|NCT04556097|593144146|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
164212580|NCT04556097|593144147|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
164212581|NCT04556097|593144148|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
164212582|NCT04556097|593144149|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
164212583|NCT05436613|593144150|FG000|Overall Study|Lost to Follow-up|9|||
164212584|NCT05436613|593144150|FG000|Overall Study|Withdrawal by Subject|3|||
164212585|NCT05317546|593144153|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
164212586|NCT05317546|593144154|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
164212587|NCT05350202|593144155|FG000|Visit 1 - Baseline|Not-treated|18|||
164212588|NCT05350202|593144156|FG001|Visit 1 - Baseline|Not-treated|0|||
164212589|NCT05350202|593144155|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
164212590|NCT05350202|593144156|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
164212591|NCT05350202|593144155|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
164212592|NCT05350202|593144156|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
164212593|NCT05350202|593144155|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
164212594|NCT05350202|593144156|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
164212595|NCT05350202|593144155|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
164212596|NCT05350202|593144156|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
164212597|NCT05350202|593144155|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
164212598|NCT05350202|593144156|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
164212599|NCT05350202|593144155|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
164212600|NCT05350202|593144156|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
164212601|NCT04364646|593144163|FG000|Overall Study|Lost to Follow-up|1|||
164212602|NCT04364646|593144164|FG001|Overall Study|Lost to Follow-up|0|||
164212603|NCT04364646|593144163|FG000|Overall Study|Withdrawal by Subject|7|||
164212604|NCT04364646|593144164|FG001|Overall Study|Withdrawal by Subject|14|||
164212605|NCT04364646|593144163|FG000|Overall Study|Protocol Violation|4|||
164212606|NCT04364646|593144164|FG001|Overall Study|Protocol Violation|5|||
164212607|NCT02555878|593144181|FG000|Overall Study|Lost to Follow-up|2|||
164212608|NCT02555878|593144182|FG001|Overall Study|Lost to Follow-up|3|||
164212609|NCT02555878|593144181|FG000|Overall Study|Withdrawal by Subject|48|||
164212610|NCT02555878|593144182|FG001|Overall Study|Withdrawal by Subject|48|||
164212611|NCT02555878|593144181|FG000|Overall Study|Adverse Event|12|||
164212612|NCT02555878|593144182|FG001|Overall Study|Adverse Event|8|||
164212613|NCT02555878|593144181|FG000|Overall Study|Death|74|||
164212614|NCT02555878|593144182|FG001|Overall Study|Death|59|||
164212615|NCT02555878|593144181|FG000|Overall Study|Protocol Violation|1|||
164212616|NCT02555878|593144182|FG001|Overall Study|Protocol Violation|2|||
164212617|NCT02555878|593144181|FG000|Overall Study|Physician Decision|12|||
164212618|NCT02555878|593144182|FG001|Overall Study|Physician Decision|13|||
164212619|NCT02555878|593144181|FG000|Overall Study|Other|17|||
164212620|NCT02555878|593144182|FG001|Overall Study|Other|17|||
164212621|NCT00765076|593144183|FG000|Overall Study|Adverse Event|1|||
164212622|NCT00765076|593144184|FG001|Overall Study|Adverse Event|0|||
164212623|NCT00765076|593144185|FG002|Overall Study|Adverse Event|0|||
164212624|NCT00765076|593144183|FG000|Overall Study|Withdrawal by Subject|0|||
164212625|NCT00765076|593144184|FG001|Overall Study|Withdrawal by Subject|0|||
164212626|NCT00765076|593144185|FG002|Overall Study|Withdrawal by Subject|1|||
164325425|NCT06596005|593566520|FG000|Overall Study|Other|0|||
164325426|NCT06596005|593566521|FG001|Overall Study|Other|2|||
164325427|NCT06596005|593566522|FG002|Overall Study|Other|0|||
164325428|NCT02445391|593566523|FG000|Overall Study|No active protocol treatment|3|||
164325429|NCT02445391|593566524|FG001|Overall Study|No active protocol treatment|0|||
164325430|NCT02445391|593566525|FG002|Overall Study|No active protocol treatment|0|||
164212627|NCT01164475|593144186|FG000|Overall Study|Lack of Efficacy|1|||
164212628|NCT01164475|593144187|FG001|Overall Study|Lack of Efficacy|0|||
164212629|NCT01164475|593144186|FG000|Overall Study|Other|0|||
164212630|NCT01164475|593144187|FG001|Overall Study|Other|1|||
164212631|NCT01164475|593144186|FG000|Overall Study|Progressive disease|0|||
164325431|NCT02445391|593566523|FG000|Overall Study|Adverse Event|0|||
164325432|NCT02445391|593566524|FG001|Overall Study|Adverse Event|21|||
164212632|NCT01164475|593144187|FG001|Overall Study|Progressive disease|1|||
164212633|NCT01164475|593144186|FG000|Overall Study|Protocol Violation|1|||
164212634|NCT01164475|593144187|FG001|Overall Study|Protocol Violation|0|||
164212635|NCT02335944|593144188|FG000|Treatment Phase|Progressive Disease|2|||
164212636|NCT02335944|593144189|FG001|Treatment Phase|Progressive Disease|5|||
164212637|NCT02335944|593144190|FG002|Treatment Phase|Progressive Disease|2|||
164212638|NCT02335944|593144191|FG003|Treatment Phase|Progressive Disease|11|||
164212639|NCT02335944|593144192|FG004|Treatment Phase|Progressive Disease|4|||
164325433|NCT02445391|593566525|FG002|Overall Study|Adverse Event|12|||
164325434|NCT02445391|593566523|FG000|Overall Study|Alternative therapy|0|||
164325435|NCT02445391|593566524|FG001|Overall Study|Alternative therapy|0|||
164325436|NCT02445391|593566525|FG002|Overall Study|Alternative therapy|1|||
164325437|NCT02445391|593566523|FG000|Overall Study|Disease progression|0|||
164325438|NCT02445391|593566524|FG001|Overall Study|Disease progression|7|||
164325439|NCT02445391|593566525|FG002|Overall Study|Disease progression|22|||
164325440|NCT02445391|593566523|FG000|Overall Study|Complicating disease|0|||
164325441|NCT02445391|593566524|FG001|Overall Study|Complicating disease|2|||
164325442|NCT02445391|593566525|FG002|Overall Study|Complicating disease|1|||
164325443|NCT02445391|593566523|FG000|Overall Study|Withdrawal by Subject|0|||
164325444|NCT02445391|593566524|FG001|Overall Study|Withdrawal by Subject|4|||
164325445|NCT02445391|593566525|FG002|Overall Study|Withdrawal by Subject|9|||
164325446|NCT02445391|593566523|FG000|Overall Study|Financial issue|0|||
164325447|NCT02445391|593566524|FG001|Overall Study|Financial issue|0|||
164325448|NCT02445391|593566525|FG002|Overall Study|Financial issue|2|||
164325449|NCT02445391|593566523|FG000|Overall Study|Still on treatment|0|||
164325450|NCT02445391|593566524|FG001|Overall Study|Still on treatment|7|||
164325451|NCT02445391|593566525|FG002|Overall Study|Still on treatment|16|||
164325452|NCT02445391|593566523|FG000|Overall Study|Not start protocol therapy|0|||
164325453|NCT02445391|593566524|FG001|Overall Study|Not start protocol therapy|12|||
164325454|NCT02445391|593566525|FG002|Overall Study|Not start protocol therapy|9|||
164325455|NCT03516942|593566526|FG000|Registration through baseline survey com|Withdrawal by Subject|36|||
164325456|NCT03516942|593566526|FG000|Registration through baseline survey com|Death|8|||
164325457|NCT03516942|593566526|FG000|Registration through baseline survey com|Could not contact patient after enrollment|58|||
164325458|NCT03516942|593566526|FG000|T0: Baseline|LOST|13|||
164325459|NCT03516942|593566526|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
164325460|NCT03516942|593566526|FG000|T1: 3 Months Survey|Death|10|||
164325461|NCT03516942|593566526|FG000|T1: 3 Months Survey|Lost|163|||
164325462|NCT03516942|593566526|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
164325463|NCT03516942|593566526|FG000|T2: 6 Month Survey|Death|14|||
164325464|NCT03516942|593566526|FG000|T2: 6 Month Survey|Lost|180|||
164325465|NCT03516942|593566526|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
164325466|NCT03516942|593566526|FG000|T3: 12 Month Survey|Death|19|||
164325467|NCT03516942|593566526|FG000|T3: 12 Month Survey|Lost|209|||
164325468|NCT02275910|593566760|FG000|Overall Study|Subject Choice|0|||
164325469|NCT02275910|593566761|FG001|Overall Study|Subject Choice|0|||
164325470|NCT02275910|593566762|FG002|Overall Study|Subject Choice|0|||
164325471|NCT02275910|593566763|FG003|Overall Study|Subject Choice|0|||
164325472|NCT02275910|593566764|FG004|Overall Study|Subject Choice|0|||
164325473|NCT02275910|593566765|FG005|Overall Study|Subject Choice|0|||
164325474|NCT02275910|593566766|FG006|Overall Study|Subject Choice|0|||
164325475|NCT02275910|593566767|FG007|Overall Study|Subject Choice|0|||
164325476|NCT02275910|593566768|FG008|Overall Study|Subject Choice|1|||
164325477|NCT02275910|593566769|FG009|Overall Study|Subject Choice|0|||
164325478|NCT02275910|593566770|FG010|Overall Study|Subject Choice|0|||
164325479|NCT02275910|593566771|FG011|Overall Study|Subject Choice|0|||
164325480|NCT02275910|593566760|FG000|Overall Study|Radiological Disease Progression|0|||
164325481|NCT02275910|593566761|FG001|Overall Study|Radiological Disease Progression|0|||
164325482|NCT02275910|593566762|FG002|Overall Study|Radiological Disease Progression|0|||
164325483|NCT02275910|593566763|FG003|Overall Study|Radiological Disease Progression|0|||
164325484|NCT02275910|593566764|FG004|Overall Study|Radiological Disease Progression|0|||
164325485|NCT02275910|593566765|FG005|Overall Study|Radiological Disease Progression|0|||
164325486|NCT02275910|593566766|FG006|Overall Study|Radiological Disease Progression|1|||
164325487|NCT02275910|593566767|FG007|Overall Study|Radiological Disease Progression|1|||
164325488|NCT02275910|593566768|FG008|Overall Study|Radiological Disease Progression|0|||
164325489|NCT02275910|593566769|FG009|Overall Study|Radiological Disease Progression|1|||
164325490|NCT02275910|593566770|FG010|Overall Study|Radiological Disease Progression|0|||
164325491|NCT02275910|593566771|FG011|Overall Study|Radiological Disease Progression|0|||
164325492|NCT03961555|593566772|FG000|Overall Study|Lost to Follow-up|0|||
164325493|NCT03961555|593566773|FG001|Overall Study|Lost to Follow-up|0|||
164325494|NCT03961555|593566774|FG002|Overall Study|Lost to Follow-up|1|||
164325495|NCT03961555|593566775|FG003|Overall Study|Lost to Follow-up|0|||
164325496|NCT03961555|593566772|FG000|Overall Study|Withdrawal by Subject|0|||
164325497|NCT03961555|593566773|FG001|Overall Study|Withdrawal by Subject|0|||
164325498|NCT03961555|593566774|FG002|Overall Study|Withdrawal by Subject|2|||
164325499|NCT03961555|593566775|FG003|Overall Study|Withdrawal by Subject|4|||
164325500|NCT03961555|593566772|FG000|Overall Study|Death|0|||
164325501|NCT03961555|593566773|FG001|Overall Study|Death|1|||
164325502|NCT03961555|593566774|FG002|Overall Study|Death|0|||
164325503|NCT03961555|593566775|FG003|Overall Study|Death|0|||
164325504|NCT03961555|593566772|FG000|Overall Study|Other|0|||
164325505|NCT03961555|593566773|FG001|Overall Study|Other|0|||
164325506|NCT03961555|593566774|FG002|Overall Study|Other|2|||
164325507|NCT03961555|593566775|FG003|Overall Study|Other|2|||
164325508|NCT03961555|593566772|FG000|Overall Study|No treatment received|0|||
164325509|NCT03961555|593566773|FG001|Overall Study|No treatment received|0|||
164325510|NCT03961555|593566774|FG002|Overall Study|No treatment received|1|||
164325511|NCT03961555|593566775|FG003|Overall Study|No treatment received|0|||
164325512|NCT05222555|593566778|FG000|Overall Study|Ongoing|2|||
164212640|NCT02335944|593144193|FG005|Treatment Phase|Progressive Disease|25|||
164212641|NCT02335944|593144194|FG006|Treatment Phase|Progressive Disease|2|||
164212642|NCT02335944|593144195|FG007|Treatment Phase|Progressive Disease|30|||
164212643|NCT02335944|593144196|FG008|Treatment Phase|Progressive Disease|27|||
164212644|NCT02335944|593144197|FG009|Treatment Phase|Progressive Disease|0|||
164212645|NCT02335944|593144188|FG000|Treatment Phase|Adverse Event|2|||
164212646|NCT02335944|593144189|FG001|Treatment Phase|Adverse Event|0|||
164212647|NCT02335944|593144190|FG002|Treatment Phase|Adverse Event|0|||
164212648|NCT02335944|593144191|FG003|Treatment Phase|Adverse Event|2|||
164564927|NCT03969875|594438348|FG000|Overall Study|did not receive allocated intervention|3|||
164564928|NCT03969875|594438349|FG001|Overall Study|did not receive allocated intervention|3|||
164564929|NCT03969875|594438350|FG002|Overall Study|did not receive allocated intervention|4|||
164564930|NCT03969875|594438348|FG000|Overall Study|Protocol Violation|4|||
164212649|NCT02335944|593144192|FG004|Treatment Phase|Adverse Event|1|||
164212650|NCT02335944|593144193|FG005|Treatment Phase|Adverse Event|15|||
164212651|NCT02335944|593144194|FG006|Treatment Phase|Adverse Event|0|||
164212652|NCT02335944|593144195|FG007|Treatment Phase|Adverse Event|5|||
164212653|NCT02335944|593144196|FG008|Treatment Phase|Adverse Event|7|||
164212654|NCT02335944|593144197|FG009|Treatment Phase|Adverse Event|0|||
164212655|NCT02335944|593144188|FG000|Treatment Phase|Physician Decision|0|||
164212656|NCT02335944|593144189|FG001|Treatment Phase|Physician Decision|0|||
164212657|NCT02335944|593144190|FG002|Treatment Phase|Physician Decision|0|||
164212658|NCT02335944|593144191|FG003|Treatment Phase|Physician Decision|1|||
164212659|NCT02335944|593144192|FG004|Treatment Phase|Physician Decision|0|||
164212660|NCT02335944|593144193|FG005|Treatment Phase|Physician Decision|6|||
164212661|NCT02335944|593144194|FG006|Treatment Phase|Physician Decision|1|||
164212662|NCT02335944|593144195|FG007|Treatment Phase|Physician Decision|2|||
164212663|NCT02335944|593144196|FG008|Treatment Phase|Physician Decision|1|||
164212664|NCT02335944|593144197|FG009|Treatment Phase|Physician Decision|0|||
164212665|NCT02335944|593144188|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
164212666|NCT02335944|593144189|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
164212667|NCT02335944|593144190|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
164212668|NCT02335944|593144191|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
164212669|NCT02335944|593144192|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
164212670|NCT02335944|593144193|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
164212671|NCT02335944|593144194|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
164212672|NCT02335944|593144195|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
164212673|NCT02335944|593144196|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
164212674|NCT02335944|593144197|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
164212675|NCT02335944|593144188|FG000|Treatment Phase|Subject/Guardian Decision|0|||
164212676|NCT02335944|593144189|FG001|Treatment Phase|Subject/Guardian Decision|0|||
164212677|NCT02335944|593144190|FG002|Treatment Phase|Subject/Guardian Decision|1|||
164212678|NCT02335944|593144191|FG003|Treatment Phase|Subject/Guardian Decision|0|||
164212679|NCT02335944|593144192|FG004|Treatment Phase|Subject/Guardian Decision|0|||
164212680|NCT02335944|593144193|FG005|Treatment Phase|Subject/Guardian Decision|1|||
164212681|NCT02335944|593144194|FG006|Treatment Phase|Subject/Guardian Decision|0|||
164212682|NCT02335944|593144195|FG007|Treatment Phase|Subject/Guardian Decision|4|||
164212683|NCT02335944|593144196|FG008|Treatment Phase|Subject/Guardian Decision|0|||
164212684|NCT02335944|593144197|FG009|Treatment Phase|Subject/Guardian Decision|0|||
164212685|NCT02335944|593144188|FG000|Post-treatment Follow-up|Progressive Disease|0|||
164212686|NCT02335944|593144189|FG001|Post-treatment Follow-up|Progressive Disease|0|||
164212687|NCT02335944|593144190|FG002|Post-treatment Follow-up|Progressive Disease|0|||
164212688|NCT02335944|593144191|FG003|Post-treatment Follow-up|Progressive Disease|1|||
164212689|NCT02335944|593144192|FG004|Post-treatment Follow-up|Progressive Disease|0|||
164212690|NCT02335944|593144193|FG005|Post-treatment Follow-up|Progressive Disease|9|||
164212691|NCT02335944|593144194|FG006|Post-treatment Follow-up|Progressive Disease|0|||
164212692|NCT02335944|593144195|FG007|Post-treatment Follow-up|Progressive Disease|2|||
164212693|NCT02335944|593144196|FG008|Post-treatment Follow-up|Progressive Disease|3|||
164212694|NCT02335944|593144197|FG009|Post-treatment Follow-up|Progressive Disease|0|||
164212695|NCT02335944|593144188|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
164212696|NCT02335944|593144189|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
164212697|NCT02335944|593144190|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
164212698|NCT02335944|593144191|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
164212699|NCT02335944|593144192|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
164212700|NCT02335944|593144193|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
164212701|NCT02335944|593144194|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
164564931|NCT03969875|594438349|FG001|Overall Study|Protocol Violation|2|||
164564932|NCT03969875|594438350|FG002|Overall Study|Protocol Violation|2|||
164212702|NCT02335944|593144195|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
164212703|NCT02335944|593144196|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
164212704|NCT02335944|593144197|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
164212705|NCT02335944|593144188|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
164564933|NCT00167245|594438351|FG000|Overall Study|Lost to Follow-up|20|||
164325513|NCT05222555|593566779|FG001|Overall Study|Ongoing|18|||
164325514|NCT05222555|593566778|FG000|Overall Study|Adverse Event|1|||
164325515|NCT05222555|593566779|FG001|Overall Study|Adverse Event|1|||
164325516|NCT05222555|593566778|FG000|Overall Study|Death|0|||
164325517|NCT05222555|593566779|FG001|Overall Study|Death|6|||
164325518|NCT05222555|593566778|FG000|Overall Study|Withdrawal by Subject|0|||
164325519|NCT05222555|593566779|FG001|Overall Study|Withdrawal by Subject|11|||
164325520|NCT00076024|593567870|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
164325521|NCT00076024|593567871|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
164325522|NCT00076024|593567872|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
164325523|NCT00076024|593567873|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
164325524|NCT00076024|593567870|FG000|Phase 1, Lead-in|Adverse Event|1|||
164325525|NCT00076024|593567871|FG001|Phase 1, Lead-in|Adverse Event|0|||
164325526|NCT00076024|593567872|FG002|Phase 1, Lead-in|Adverse Event|0|||
164325527|NCT00076024|593567873|FG003|Phase 1, Lead-in|Adverse Event|0|||
164325528|NCT00076024|593567870|FG000|Phase 1, Lead-in|Clinical progression|1|||
164325529|NCT00076024|593567871|FG001|Phase 1, Lead-in|Clinical progression|0|||
164325530|NCT00076024|593567872|FG002|Phase 1, Lead-in|Clinical progression|0|||
164325531|NCT00076024|593567873|FG003|Phase 1, Lead-in|Clinical progression|0|||
164325532|NCT00076024|593567870|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
164325533|NCT00076024|593567871|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
164325534|NCT00076024|593567872|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
164325535|NCT00076024|593567873|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
164325536|NCT00076024|593567870|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
164325537|NCT00076024|593567871|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
164325538|NCT00076024|593567872|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
164325539|NCT00076024|593567873|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
164325540|NCT00076024|593567870|FG000|Phase 2, Double-blind|Adverse Event|0|||
164325541|NCT00076024|593567871|FG001|Phase 2, Double-blind|Adverse Event|25|||
164325542|NCT00076024|593567872|FG002|Phase 2, Double-blind|Adverse Event|6|||
164325543|NCT00076024|593567873|FG003|Phase 2, Double-blind|Adverse Event|0|||
164325544|NCT00076024|593567870|FG000|Phase 2, Double-blind|Un-specified|0|||
164325545|NCT00076024|593567871|FG001|Phase 2, Double-blind|Un-specified|14|||
164325546|NCT00076024|593567872|FG002|Phase 2, Double-blind|Un-specified|6|||
164325547|NCT00076024|593567873|FG003|Phase 2, Double-blind|Un-specified|0|||
164325548|NCT00076024|593567870|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
164325549|NCT00076024|593567871|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
164325550|NCT00076024|593567872|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
164325551|NCT00076024|593567873|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
164325552|NCT00076024|593567870|FG000|Phase 2, Open-label|Adverse Event|0|||
164325553|NCT00076024|593567871|FG001|Phase 2, Open-label|Adverse Event|0|||
164325554|NCT00076024|593567872|FG002|Phase 2, Open-label|Adverse Event|0|||
164564934|NCT00167245|594438352|FG001|Overall Study|Lost to Follow-up|31|||
164564935|NCT00167245|594438351|FG000|Overall Study|Withdrawal by Subject|5|||
164564936|NCT00167245|594438352|FG001|Overall Study|Withdrawal by Subject|8|||
164564937|NCT00167245|594438351|FG000|Overall Study|Incarcerated|3|||
164564938|NCT00167245|594438352|FG001|Overall Study|Incarcerated|2|||
164564939|NCT00167245|594438351|FG000|Overall Study|Drowsy|1|||
164564940|NCT00167245|594438352|FG001|Overall Study|Drowsy|0|||
164564941|NCT01871090|594438353|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
164564942|NCT01871090|594438354|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
164564943|NCT01871090|594438353|FG000|Overall Study|Interrogation not completed correctly|1|||
164564944|NCT01871090|594438354|FG001|Overall Study|Interrogation not completed correctly|0|||
164564945|NCT01871090|594438353|FG000|Overall Study|Subject Non-Compliance|0|||
164325555|NCT00076024|593567873|FG003|Phase 2, Open-label|Adverse Event|2|||
164325556|NCT00076024|593567870|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
164325557|NCT00076024|593567871|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
164325558|NCT00076024|593567872|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
164325559|NCT00076024|593567873|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
164325560|NCT00076024|593567870|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
164325561|NCT00076024|593567871|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
164325562|NCT00076024|593567872|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
164325563|NCT00076024|593567873|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
164325564|NCT00076024|593567870|FG000|Phase 2, Open-label|Other|0|||
164325565|NCT00076024|593567871|FG001|Phase 2, Open-label|Other|0|||
164564946|NCT01871090|594438354|FG001|Overall Study|Subject Non-Compliance|1|||
164564947|NCT02911688|594438360|FG000|Washout|Lost to Follow-up|1|||
164564948|NCT02911688|594438361|FG001|Washout|Lost to Follow-up|1|||
164564949|NCT02911688|594438360|FG000|Washout|Withdrawal by Subject|0|||
164325566|NCT00076024|593567872|FG002|Phase 2, Open-label|Other|0|||
164325567|NCT00076024|593567873|FG003|Phase 2, Open-label|Other|2|||
164325568|NCT01155219|593567880|FG000|Overall Study|Adverse Event|3|||
164325569|NCT01155219|593567881|FG001|Overall Study|Adverse Event|1|||
164325570|NCT01155219|593567880|FG000|Overall Study|non-medical reason|1|||
164325571|NCT01155219|593567881|FG001|Overall Study|non-medical reason|2|||
164564950|NCT02911688|594438361|FG001|Washout|Withdrawal by Subject|1|||
164325572|NCT03052764|593567882|FG000|Double-Blind Treatment Period|Adverse Event|2|||
164212706|NCT02335944|593144189|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
164212707|NCT02335944|593144190|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
164212708|NCT02335944|593144191|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
164212709|NCT02335944|593144192|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
164212710|NCT02335944|593144193|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
164212711|NCT02335944|593144194|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
164212712|NCT02335944|593144195|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
164212713|NCT02335944|593144196|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
164212714|NCT02335944|593144197|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
164212715|NCT02335944|593144188|FG000|Post-treatment Follow-up|Adverse Event|0|||
164212716|NCT02335944|593144189|FG001|Post-treatment Follow-up|Adverse Event|0|||
164212717|NCT02335944|593144190|FG002|Post-treatment Follow-up|Adverse Event|0|||
164212718|NCT02335944|593144191|FG003|Post-treatment Follow-up|Adverse Event|0|||
164212719|NCT02335944|593144192|FG004|Post-treatment Follow-up|Adverse Event|0|||
164212720|NCT02335944|593144193|FG005|Post-treatment Follow-up|Adverse Event|1|||
164212721|NCT02335944|593144194|FG006|Post-treatment Follow-up|Adverse Event|0|||
164212722|NCT02335944|593144195|FG007|Post-treatment Follow-up|Adverse Event|0|||
164212723|NCT02335944|593144196|FG008|Post-treatment Follow-up|Adverse Event|0|||
164212724|NCT02335944|593144197|FG009|Post-treatment Follow-up|Adverse Event|0|||
164212725|NCT02335944|593144188|FG000|Post-treatment Follow-up|Death|0|||
164212726|NCT02335944|593144189|FG001|Post-treatment Follow-up|Death|0|||
164212727|NCT02335944|593144190|FG002|Post-treatment Follow-up|Death|0|||
164212728|NCT02335944|593144191|FG003|Post-treatment Follow-up|Death|1|||
164212729|NCT02335944|593144192|FG004|Post-treatment Follow-up|Death|0|||
164212730|NCT02335944|593144193|FG005|Post-treatment Follow-up|Death|1|||
164212731|NCT02335944|593144194|FG006|Post-treatment Follow-up|Death|0|||
164212732|NCT02335944|593144195|FG007|Post-treatment Follow-up|Death|0|||
164212733|NCT02335944|593144196|FG008|Post-treatment Follow-up|Death|0|||
164212734|NCT02335944|593144197|FG009|Post-treatment Follow-up|Death|0|||
164212735|NCT02335944|593144188|FG000|Post-treatment Follow-up|Physician Decision|1|||
164212736|NCT02335944|593144189|FG001|Post-treatment Follow-up|Physician Decision|0|||
164212737|NCT02335944|593144190|FG002|Post-treatment Follow-up|Physician Decision|0|||
164212738|NCT02335944|593144191|FG003|Post-treatment Follow-up|Physician Decision|0|||
164212739|NCT02335944|593144192|FG004|Post-treatment Follow-up|Physician Decision|0|||
164212740|NCT02335944|593144193|FG005|Post-treatment Follow-up|Physician Decision|0|||
164212741|NCT02335944|593144194|FG006|Post-treatment Follow-up|Physician Decision|0|||
164212742|NCT02335944|593144195|FG007|Post-treatment Follow-up|Physician Decision|1|||
164212743|NCT02335944|593144196|FG008|Post-treatment Follow-up|Physician Decision|0|||
164212744|NCT02335944|593144197|FG009|Post-treatment Follow-up|Physician Decision|0|||
164212745|NCT00832975|593144198|FG000|Overall Study|Lost to Follow-up|7|||
164212746|NCT00832975|593144198|FG000|Overall Study|Protocol Violation|6|||
164212747|NCT00832975|593144198|FG000|Overall Study|Death|5|||
164212748|NCT00832975|593144198|FG000|Overall Study|Physician Decision|4|||
164212749|NCT00832975|593144198|FG000|Overall Study|Withdrawal by Subject|3|||
164212750|NCT00832975|593144198|FG000|Overall Study|Other reasons|14|||
164212751|NCT06081829|593144205|FG000|Overall Study|Participants still on-study|8|||
164212752|NCT06081829|593144205|FG000|Overall Study|Death|4|||
164212753|NCT04835441|593144206|FG000|Overall Study|Physician Decision|4|||
164212754|NCT04835441|593144207|FG001|Overall Study|Physician Decision|4|||
164212755|NCT04835441|593144206|FG000|Overall Study|Other|1|||
164212756|NCT04835441|593144207|FG001|Overall Study|Other|1|||
164212757|NCT04835441|593144206|FG000|Overall Study|Lost to Follow-up|0|||
164212758|NCT04835441|593144207|FG001|Overall Study|Lost to Follow-up|1|||
164212759|NCT01991314|593145535|FG000|Overall Study|Adverse Event|5|||
164212760|NCT01991314|593145536|FG001|Overall Study|Adverse Event|1|||
164212761|NCT01991314|593145535|FG000|Overall Study|Lost to Follow-up|6|||
164212762|NCT01991314|593145536|FG001|Overall Study|Lost to Follow-up|10|||
164212763|NCT00970944|593145538|FG000|Overall Study|Death|1|||
164212764|NCT00970944|593145539|FG001|Overall Study|Death|0|||
164212765|NCT00970944|593145538|FG000|Overall Study|Physician Decision|0|||
164212766|NCT00970944|593145539|FG001|Overall Study|Physician Decision|2|||
164212767|NCT02008370|593145540|FG000|Overall Study|Lost to Follow-up|7|||
164212768|NCT00662259|593145541|FG000|Overall Study|Adverse Event|2|||
164212769|NCT00662259|593145542|FG001|Overall Study|Adverse Event|0|||
164212770|NCT00972738|593145543|FG000|Overall Study|Adverse Event|7|||
164212771|NCT00972738|593145544|FG001|Overall Study|Adverse Event|1|||
164212772|NCT00972738|593145545|FG002|Overall Study|Adverse Event|8|||
164212773|NCT00972738|593145543|FG000|Overall Study|Protocol Violation|2|||
164212774|NCT00972738|593145544|FG001|Overall Study|Protocol Violation|1|||
164212775|NCT00972738|593145545|FG002|Overall Study|Protocol Violation|3|||
164212776|NCT00972738|593145543|FG000|Overall Study|Lost to Follow-up|1|||
164212777|NCT00972738|593145544|FG001|Overall Study|Lost to Follow-up|0|||
164212778|NCT00972738|593145545|FG002|Overall Study|Lost to Follow-up|1|||
164212779|NCT00972738|593145543|FG000|Overall Study|Lack of Efficacy|5|||
164212780|NCT00972738|593145544|FG001|Overall Study|Lack of Efficacy|1|||
164212781|NCT00972738|593145545|FG002|Overall Study|Lack of Efficacy|11|||
164212782|NCT00972738|593145543|FG000|Overall Study|Withdrawal by Subject|5|||
164212783|NCT00972738|593145544|FG001|Overall Study|Withdrawal by Subject|1|||
164669272|NCT02863575|594813627|FG001|Overall Study|Adverse Event|1|||
164669273|NCT02863575|594813628|FG002|Overall Study|Adverse Event|0|||
164212784|NCT00972738|593145545|FG002|Overall Study|Withdrawal by Subject|4|||
164212785|NCT00972738|593145543|FG000|Overall Study|Moved|0|||
164212786|NCT00972738|593145544|FG001|Overall Study|Moved|0|||
164212787|NCT00972738|593145545|FG002|Overall Study|Moved|1|||
164212788|NCT00972738|593145543|FG000|Overall Study|Other|1|||
164212789|NCT00972738|593145544|FG001|Overall Study|Other|2|||
164212790|NCT00972738|593145545|FG002|Overall Study|Other|1|||
164212791|NCT01001104|593145548|FG000|Overall Study|Adverse Event|2|||
164669274|NCT01706926|594813629|FG000|Overall Study|Lost to Follow-up|0|||
164669275|NCT01706926|594813630|FG001|Overall Study|Lost to Follow-up|0|||
164669276|NCT01706926|594813631|FG002|Overall Study|Lost to Follow-up|1|||
164669277|NCT01706926|594813632|FG003|Overall Study|Lost to Follow-up|0|||
164669278|NCT01706926|594813629|FG000|Overall Study|Withdrawal by Subject|2|||
164212792|NCT01001104|593145549|FG001|Overall Study|Adverse Event|1|||
164212793|NCT01001104|593145550|FG002|Overall Study|Adverse Event|0|||
164212794|NCT01001104|593145551|FG003|Overall Study|Adverse Event|0|||
164212795|NCT01001104|593145548|FG000|Overall Study|Lost to Follow-up|0|||
164212796|NCT01001104|593145549|FG001|Overall Study|Lost to Follow-up|0|||
164212797|NCT01001104|593145550|FG002|Overall Study|Lost to Follow-up|1|||
164212798|NCT01001104|593145551|FG003|Overall Study|Lost to Follow-up|0|||
164212799|NCT01001104|593145548|FG000|Overall Study|Entry Criteria Not Met|0|||
164212800|NCT01001104|593145549|FG001|Overall Study|Entry Criteria Not Met|0|||
164212801|NCT01001104|593145550|FG002|Overall Study|Entry Criteria Not Met|0|||
164212802|NCT01001104|593145551|FG003|Overall Study|Entry Criteria Not Met|1|||
164212803|NCT01001104|593145548|FG000|Overall Study|Withdrawal by Subject|0|||
164212804|NCT01001104|593145549|FG001|Overall Study|Withdrawal by Subject|0|||
164325573|NCT03052764|593567883|FG001|Double-Blind Treatment Period|Adverse Event|0|||
164325574|NCT03052764|593567882|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
164325575|NCT03052764|593567883|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
164325576|NCT03052764|593567882|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
164325577|NCT03052764|593567883|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
164325578|NCT03052764|593567882|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
164325579|NCT03052764|593567883|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
164325580|NCT03052764|593567882|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
164325581|NCT03052764|593567883|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
164325582|NCT01314911|593567884|FG000|Overall Study|Lost to Follow-up|3|||
164325583|NCT01314911|593567885|FG001|Overall Study|Lost to Follow-up|2|||
164325584|NCT01314911|593567884|FG000|Overall Study|Withdrawal by Subject|1|||
164325585|NCT01314911|593567885|FG001|Overall Study|Withdrawal by Subject|3|||
164325586|NCT01314911|593567884|FG000|Overall Study|Received Non-randomized Study Drug|0|||
164325587|NCT01314911|593567885|FG001|Overall Study|Received Non-randomized Study Drug|1|||
164325588|NCT01314911|593567884|FG000|Overall Study|Never Started Treatment|1|||
164325589|NCT01314911|593567885|FG001|Overall Study|Never Started Treatment|0|||
164325590|NCT03150485|593567889|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
164325591|NCT03150485|593567890|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
164325592|NCT03150485|593567891|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
164325593|NCT03150485|593567892|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
164325594|NCT03150485|593567893|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
164325595|NCT03150485|593567894|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
164325596|NCT01695005|593567896|FG000|Overall Study|Lost to Follow-up|0|||
164325597|NCT01695005|593567897|FG001|Overall Study|Lost to Follow-up|1|||
164325598|NCT01695005|593567898|FG002|Overall Study|Lost to Follow-up|1|||
164325599|NCT01695005|593567899|FG003|Overall Study|Lost to Follow-up|0|||
164325600|NCT01695005|593567900|FG004|Overall Study|Lost to Follow-up|0|||
164325601|NCT01695005|593567901|FG005|Overall Study|Lost to Follow-up|1|||
164325602|NCT01695005|593567902|FG006|Overall Study|Lost to Follow-up|1|||
164325603|NCT01695005|593567903|FG007|Overall Study|Lost to Follow-up|1|||
164325604|NCT01695005|593567904|FG008|Overall Study|Lost to Follow-up|3|||
164212805|NCT01001104|593145550|FG002|Overall Study|Withdrawal by Subject|0|||
164212806|NCT01001104|593145551|FG003|Overall Study|Withdrawal by Subject|2|||
164212807|NCT01121926|593145556|FG000|First Intervention Period|Adverse Event|1|||
164212808|NCT01121926|593145557|FG001|First Intervention Period|Adverse Event|0|||
164212809|NCT01121926|593145556|FG000|Washout Period|Adverse Event|0|||
164212810|NCT01121926|593145557|FG001|Washout Period|Adverse Event|1|||
164325605|NCT01695005|593567905|FG009|Overall Study|Lost to Follow-up|3|||
164669279|NCT01706926|594813630|FG001|Overall Study|Withdrawal by Subject|0|||
164669280|NCT01706926|594813631|FG002|Overall Study|Withdrawal by Subject|1|||
164669281|NCT01706926|594813632|FG003|Overall Study|Withdrawal by Subject|2|||
164212811|NCT01121926|593145556|FG000|Washout Period|Positive pregnancy test|0|||
164325606|NCT01695005|593567906|FG010|Overall Study|Lost to Follow-up|8|||
164325607|NCT01695005|593567907|FG011|Overall Study|Lost to Follow-up|5|||
164325608|NCT01695005|593567908|FG012|Overall Study|Lost to Follow-up|2|||
164325609|NCT01695005|593567909|FG013|Overall Study|Lost to Follow-up|5|||
164325610|NCT01695005|593567910|FG014|Overall Study|Lost to Follow-up|0|||
164325611|NCT01695005|593567911|FG015|Overall Study|Lost to Follow-up|4|||
164669282|NCT01706926|594813629|FG000|Overall Study|Other|4|||
164325612|NCT01695005|593567912|FG016|Overall Study|Lost to Follow-up|0|||
164325613|NCT01695005|593567913|FG017|Overall Study|Lost to Follow-up|0|||
164325614|NCT01695005|593567914|FG018|Overall Study|Lost to Follow-up|0|||
164325615|NCT01695005|593567915|FG019|Overall Study|Lost to Follow-up|1|||
164325616|NCT01695005|593567916|FG020|Overall Study|Lost to Follow-up|1|||
164325617|NCT01695005|593567917|FG021|Overall Study|Lost to Follow-up|0|||
164325618|NCT01695005|593567918|FG022|Overall Study|Lost to Follow-up|2|||
164325619|NCT01695005|593567919|FG023|Overall Study|Lost to Follow-up|4|||
164325620|NCT01695005|593567920|FG024|Overall Study|Lost to Follow-up|2|||
164325621|NCT01695005|593567921|FG025|Overall Study|Lost to Follow-up|0|||
164325622|NCT01695005|593567922|FG026|Overall Study|Lost to Follow-up|0|||
164325623|NCT01695005|593567923|FG027|Overall Study|Lost to Follow-up|0|||
164325624|NCT01695005|593567924|FG028|Overall Study|Lost to Follow-up|1|||
164325625|NCT01695005|593567896|FG000|Overall Study|Withdrawal by Subject|0|||
164325626|NCT01695005|593567897|FG001|Overall Study|Withdrawal by Subject|0|||
164325627|NCT01695005|593567898|FG002|Overall Study|Withdrawal by Subject|0|||
164325628|NCT01695005|593567899|FG003|Overall Study|Withdrawal by Subject|2|||
164212812|NCT01121926|593145557|FG001|Washout Period|Positive pregnancy test|1|||
164212813|NCT02175758|593145558|FG000|Treatment Phase|Lost to Follow-up|0|||
164212814|NCT02175758|593145559|FG001|Treatment Phase|Lost to Follow-up|1|||
164212815|NCT02175758|593145560|FG002|Treatment Phase|Lost to Follow-up|0|||
164212816|NCT02175758|593145561|FG003|Treatment Phase|Lost to Follow-up|0|||
164212817|NCT02175758|593145562|FG004|Treatment Phase|Lost to Follow-up|0|||
164212818|NCT02175758|593145563|FG005|Treatment Phase|Lost to Follow-up|0|||
164212819|NCT02175758|593145558|FG000|Treatment Phase|Adverse Event|0|||
164212820|NCT02175758|593145559|FG001|Treatment Phase|Adverse Event|0|||
164212821|NCT02175758|593145560|FG002|Treatment Phase|Adverse Event|0|||
164212822|NCT02175758|593145561|FG003|Treatment Phase|Adverse Event|0|||
164212823|NCT02175758|593145562|FG004|Treatment Phase|Adverse Event|1|||
164212824|NCT02175758|593145563|FG005|Treatment Phase|Adverse Event|0|||
164212825|NCT02636283|593145564|FG000|Overall Study|Adverse Event|2|||
164212826|NCT02636283|593145565|FG001|Overall Study|Adverse Event|0|||
164212827|NCT02636283|593145564|FG000|Overall Study|Trial Terminated Prematurely|0|||
164212828|NCT02636283|593145565|FG001|Overall Study|Trial Terminated Prematurely|3|||
164212829|NCT01879852|593145568|FG000|Overall Study|Withdrawal by Subject|2|||
164212830|NCT01879852|593145569|FG001|Overall Study|Withdrawal by Subject|0|||
164212831|NCT02696616|593145571|FG000|Overall Study|Adverse Event|0|||
164212832|NCT02696616|593145572|FG001|Overall Study|Adverse Event|1|||
164212833|NCT02696616|593145573|FG002|Overall Study|Adverse Event|0|||
164212834|NCT02696616|593145574|FG003|Overall Study|Adverse Event|0|||
164212835|NCT02696616|593145575|FG004|Overall Study|Adverse Event|0|||
164212836|NCT02696616|593145576|FG005|Overall Study|Adverse Event|0|||
164212837|NCT02696616|593145577|FG006|Overall Study|Adverse Event|0|||
164212838|NCT01625182|593145579|FG000|Overall Study|Administrative problems|1|||
164212839|NCT01625182|593145580|FG001|Overall Study|Administrative problems|0|||
164212840|NCT01625182|593145579|FG000|Overall Study|Protocol deviation|0|||
164212841|NCT01625182|593145580|FG001|Overall Study|Protocol deviation|2|||
164212842|NCT01625182|593145579|FG000|Overall Study|Adverse Event|2|||
164212843|NCT01625182|593145580|FG001|Overall Study|Adverse Event|0|||
164212844|NCT01625182|593145579|FG000|Overall Study|Withdrawal by Subject|5|||
164212845|NCT01625182|593145580|FG001|Overall Study|Withdrawal by Subject|1|||
164212846|NCT01625182|593145579|FG000|Overall Study|Lack of Efficacy|12|||
164212847|NCT01625182|593145580|FG001|Overall Study|Lack of Efficacy|8|||
164212848|NCT01500083|593145581|FG000|Overall Study|Adverse Event|4|||
164212849|NCT01500083|593145582|FG001|Overall Study|Adverse Event|17|||
164212850|NCT01500083|593145581|FG000|Overall Study|Death|0|||
164212851|NCT01500083|593145582|FG001|Overall Study|Death|2|||
164212852|NCT01500083|593145581|FG000|Overall Study|Lost to Follow-up|1|||
164212853|NCT01500083|593145582|FG001|Overall Study|Lost to Follow-up|0|||
164212854|NCT01500083|593145581|FG000|Overall Study|Withdrawal of Consent|0|||
164212855|NCT01500083|593145582|FG001|Overall Study|Withdrawal of Consent|1|||
164212856|NCT01500083|593145581|FG000|Overall Study|Disease Progression|2|||
164212857|NCT01500083|593145582|FG001|Overall Study|Disease Progression|10|||
164212858|NCT01500083|593145581|FG000|Overall Study|Investigator Discretion|3|||
164212859|NCT01500083|593145582|FG001|Overall Study|Investigator Discretion|8|||
164212860|NCT01500083|593145581|FG000|Overall Study|Other Reasons|2|||
164212861|NCT01500083|593145582|FG001|Overall Study|Other Reasons|5|||
164212862|NCT00741611|593145583|FG000|Overall Study|Death|0|||
164212863|NCT00741611|593145584|FG001|Overall Study|Death|0|||
164212864|NCT00741611|593145585|FG002|Overall Study|Death|1|||
164212865|NCT00741611|593145583|FG000|Overall Study|Withdrawal by Subject|0|||
164212866|NCT00741611|593145584|FG001|Overall Study|Withdrawal by Subject|2|||
164212867|NCT00741611|593145585|FG002|Overall Study|Withdrawal by Subject|2|||
164212868|NCT01970371|593145586|FG000|Overall Study|Death|8|||
164325629|NCT01695005|593567900|FG004|Overall Study|Withdrawal by Subject|0|||
164212869|NCT01970371|593145587|FG001|Overall Study|Death|13|||
164212870|NCT01970371|593145588|FG002|Overall Study|Death|12|||
164325630|NCT01695005|593567901|FG005|Overall Study|Withdrawal by Subject|1|||
164212871|NCT01970371|593145586|FG000|Overall Study|Lost to Follow-up|0|||
164212872|NCT01970371|593145587|FG001|Overall Study|Lost to Follow-up|0|||
164212873|NCT01970371|593145588|FG002|Overall Study|Lost to Follow-up|1|||
164212874|NCT01555931|593145589|FG000|Overall Study|Lost to Follow-up|2|||
164212875|NCT01555931|593145590|FG001|Overall Study|Lost to Follow-up|5|||
164212876|NCT01922011|593145591|FG000|Overall Study|Protocol Violation|0|||
164212877|NCT01922011|593145592|FG001|Overall Study|Protocol Violation|1|||
164212878|NCT01922011|593145591|FG000|Overall Study|Physician Decision|0|||
164212879|NCT01922011|593145592|FG001|Overall Study|Physician Decision|1|||
164212880|NCT01922011|593145591|FG000|Overall Study|Parent/Guardian Decision|3|||
164212881|NCT01922011|593145592|FG001|Overall Study|Parent/Guardian Decision|0|||
164212882|NCT01922011|593145591|FG000|Overall Study|Lost to Follow-up|0|||
164212883|NCT01922011|593145592|FG001|Overall Study|Lost to Follow-up|1|||
164212884|NCT01922011|593145591|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
164212885|NCT01922011|593145592|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
164212886|NCT01922011|593145591|FG000|Overall Study|Not Treated|1|||
164212887|NCT01922011|593145592|FG001|Overall Study|Not Treated|0|||
164212888|NCT01922011|593145591|FG000|Overall Study|Lack of willing home health agency|1|||
164212889|NCT01922011|593145592|FG001|Overall Study|Lack of willing home health agency|0|||
164212890|NCT01922011|593145591|FG000|Overall Study|Randomized in error|1|||
164212891|NCT01922011|593145592|FG001|Overall Study|Randomized in error|0|||
164212892|NCT01510756|593145593|FG000|Overall Study|Death|1|||
164212893|NCT01510756|593145593|FG000|Overall Study|Lack of Efficacy|2|||
164212894|NCT01510756|593145593|FG000|Overall Study|Physician Decision|1|||
164212895|NCT04398134|593145600|FG000|Overall Study|Adverse Event|0|||
164212896|NCT04398134|593145601|FG001|Overall Study|Adverse Event|0|||
164212897|NCT04398134|593145602|FG002|Overall Study|Adverse Event|1|||
164212898|NCT04398134|593145603|FG003|Overall Study|Adverse Event|0|||
164212899|NCT04398134|593145600|FG000|Overall Study|Withdrawal by Subject|2|||
164212900|NCT04398134|593145601|FG001|Overall Study|Withdrawal by Subject|0|||
164212901|NCT04398134|593145602|FG002|Overall Study|Withdrawal by Subject|0|||
164212902|NCT04398134|593145603|FG003|Overall Study|Withdrawal by Subject|1|||
164212903|NCT04398134|593145600|FG000|Overall Study|Study Terminated by Sponsor|30|||
164212904|NCT04398134|593145601|FG001|Overall Study|Study Terminated by Sponsor|11|||
164212905|NCT04398134|593145602|FG002|Overall Study|Study Terminated by Sponsor|32|||
164212906|NCT04398134|593145603|FG003|Overall Study|Study Terminated by Sponsor|11|||
164212907|NCT02225587|593145606|FG000|Overall Study|Adverse Event|5|||
164212908|NCT02225587|593145607|FG001|Overall Study|Adverse Event|5|||
164212909|NCT02225587|593145606|FG000|Overall Study|Lost to Follow-up|5|||
164212910|NCT02225587|593145607|FG001|Overall Study|Lost to Follow-up|5|||
164212911|NCT02225587|593145606|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164212912|NCT02225587|593145607|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164212913|NCT02225587|593145606|FG000|Overall Study|Physician Decision|2|||
164212914|NCT02225587|593145607|FG001|Overall Study|Physician Decision|0|||
164212915|NCT02225587|593145606|FG000|Overall Study|Protocol Violation|1|||
164212916|NCT02225587|593145607|FG001|Overall Study|Protocol Violation|0|||
164212917|NCT02225587|593145606|FG000|Overall Study|Participant Moved|1|||
164212918|NCT02225587|593145607|FG001|Overall Study|Participant Moved|0|||
164212919|NCT02225587|593145606|FG000|Overall Study|Withdrawal by Subject|13|||
164212920|NCT02225587|593145607|FG001|Overall Study|Withdrawal by Subject|28|||
164212921|NCT03483584|593145610|FG000|Overall Study|Lost to Follow-up|40|||
164212922|NCT03483584|593145611|FG001|Overall Study|Lost to Follow-up|7|||
164212923|NCT03483584|593145610|FG000|Overall Study|Withdrawal by Subject|4|||
164212924|NCT03483584|593145611|FG001|Overall Study|Withdrawal by Subject|1|||
164212925|NCT01525589|593145618|FG000|Overall Study|Non-treatment-related AE|1|||
164212926|NCT01525589|593145619|FG001|Overall Study|Non-treatment-related AE|0|||
164212927|NCT01525589|593145620|FG002|Overall Study|Non-treatment-related AE|0|||
164212928|NCT01525589|593145618|FG000|Overall Study|Progressive disease|48|||
164212929|NCT01525589|593145619|FG001|Overall Study|Progressive disease|15|||
164212930|NCT01525589|593145620|FG002|Overall Study|Progressive disease|29|||
164212931|NCT01525589|593145618|FG000|Overall Study|Never treated|2|||
164212932|NCT01525589|593145619|FG001|Overall Study|Never treated|0|||
164212933|NCT01525589|593145620|FG002|Overall Study|Never treated|0|||
164212934|NCT01525589|593145618|FG000|Overall Study|Physician Decision|4|||
164212935|NCT01525589|593145619|FG001|Overall Study|Physician Decision|2|||
164212936|NCT01525589|593145620|FG002|Overall Study|Physician Decision|2|||
164212937|NCT01525589|593145618|FG000|Overall Study|Death|0|||
164212938|NCT01525589|593145619|FG001|Overall Study|Death|0|||
164212939|NCT01525589|593145620|FG002|Overall Study|Death|2|||
164212940|NCT01525589|593145618|FG000|Overall Study|Treatment-related AE|1|||
164212941|NCT01525589|593145619|FG001|Overall Study|Treatment-related AE|1|||
164212942|NCT01525589|593145620|FG002|Overall Study|Treatment-related AE|2|||
164212943|NCT01525589|593145618|FG000|Overall Study|Other reasons|0|||
164564951|NCT01307033|594438362|FG000|8-week Double-blind Period|Adverse Event|2|||
164212944|NCT01525589|593145619|FG001|Overall Study|Other reasons|1|||
164212945|NCT01525589|593145620|FG002|Overall Study|Other reasons|0|||
164212946|NCT01525589|593145618|FG000|Overall Study|Withdrawal by Subject|0|||
164212947|NCT01525589|593145619|FG001|Overall Study|Withdrawal by Subject|1|||
164212948|NCT01525589|593145620|FG002|Overall Study|Withdrawal by Subject|0|||
164212949|NCT02924376|593145621|FG000|Overall Study|Progressive Disease|4|||
164212950|NCT02924376|593145622|FG001|Overall Study|Progressive Disease|0|||
164325631|NCT01695005|593567902|FG006|Overall Study|Withdrawal by Subject|0|||
164325632|NCT01695005|593567903|FG007|Overall Study|Withdrawal by Subject|1|||
164325633|NCT01695005|593567904|FG008|Overall Study|Withdrawal by Subject|0|||
164325634|NCT01695005|593567905|FG009|Overall Study|Withdrawal by Subject|1|||
164325635|NCT01695005|593567906|FG010|Overall Study|Withdrawal by Subject|2|||
164325636|NCT01695005|593567907|FG011|Overall Study|Withdrawal by Subject|1|||
164325637|NCT01695005|593567908|FG012|Overall Study|Withdrawal by Subject|1|||
164325638|NCT01695005|593567909|FG013|Overall Study|Withdrawal by Subject|0|||
164325639|NCT01695005|593567910|FG014|Overall Study|Withdrawal by Subject|0|||
164325640|NCT01695005|593567911|FG015|Overall Study|Withdrawal by Subject|0|||
164325641|NCT01695005|593567912|FG016|Overall Study|Withdrawal by Subject|0|||
164325642|NCT01695005|593567913|FG017|Overall Study|Withdrawal by Subject|0|||
164325643|NCT01695005|593567914|FG018|Overall Study|Withdrawal by Subject|2|||
164325644|NCT01695005|593567915|FG019|Overall Study|Withdrawal by Subject|0|||
164325645|NCT01695005|593567916|FG020|Overall Study|Withdrawal by Subject|1|||
164325646|NCT01695005|593567917|FG021|Overall Study|Withdrawal by Subject|0|||
164325647|NCT01695005|593567918|FG022|Overall Study|Withdrawal by Subject|0|||
164325648|NCT01695005|593567919|FG023|Overall Study|Withdrawal by Subject|0|||
164325649|NCT01695005|593567920|FG024|Overall Study|Withdrawal by Subject|1|||
164325650|NCT01695005|593567921|FG025|Overall Study|Withdrawal by Subject|0|||
164325651|NCT01695005|593567922|FG026|Overall Study|Withdrawal by Subject|0|||
164325652|NCT01695005|593567923|FG027|Overall Study|Withdrawal by Subject|1|||
164325653|NCT01695005|593567924|FG028|Overall Study|Withdrawal by Subject|0|||
164325654|NCT04478123|593567925|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
164325655|NCT04478123|593567925|FG000|Overall Study|NE|1|||
164325656|NCT00478881|593567926|FG000|Overall Study|Adverse Event|31|||
164325657|NCT00478881|593567927|FG001|Overall Study|Adverse Event|12|||
164325658|NCT00478881|593567926|FG000|Overall Study|Lack of Efficacy|0|||
164325659|NCT00478881|593567927|FG001|Overall Study|Lack of Efficacy|3|||
164325660|NCT00478881|593567926|FG000|Overall Study|Lost to Follow-up|0|||
164325661|NCT00478881|593567927|FG001|Overall Study|Lost to Follow-up|1|||
164325662|NCT00478881|593567926|FG000|Overall Study|Protocol Violation|2|||
164325663|NCT00478881|593567927|FG001|Overall Study|Protocol Violation|2|||
164325664|NCT00478881|593567926|FG000|Overall Study|Withdrawal by Subject|6|||
164325665|NCT00478881|593567927|FG001|Overall Study|Withdrawal by Subject|2|||
164325666|NCT00478881|593567926|FG000|Overall Study|Non-Compliance with Study Medication|0|||
164325667|NCT00478881|593567927|FG001|Overall Study|Non-Compliance with Study Medication|2|||
164325668|NCT04950608|593567931|FG000|Overall Study|Withdrawal by Subject|2|||
164325669|NCT04950608|593567931|FG000|Overall Study|Physician Decision|3|||
164325670|NCT04104438|593567932|FG000|Overall Study|Death|2|||
164325671|NCT04104438|593567933|FG001|Overall Study|Death|1|||
164325672|NCT04104438|593567934|FG002|Overall Study|Death|2|||
164325673|NCT04104438|593567932|FG000|Overall Study|Adverse Event|0|||
164325674|NCT04104438|593567933|FG001|Overall Study|Adverse Event|3|||
164325675|NCT04104438|593567934|FG002|Overall Study|Adverse Event|0|||
164325676|NCT04104438|593567932|FG000|Overall Study|Withdrawal by Subject|0|||
164325677|NCT04104438|593567933|FG001|Overall Study|Withdrawal by Subject|1|||
164325678|NCT04104438|593567934|FG002|Overall Study|Withdrawal by Subject|0|||
164325679|NCT04104438|593567932|FG000|Overall Study|Disenrolled due to noncompliance|0|||
164325680|NCT04104438|593567933|FG001|Overall Study|Disenrolled due to noncompliance|1|||
164325681|NCT04104438|593567934|FG002|Overall Study|Disenrolled due to noncompliance|0|||
164325682|NCT04104438|593567932|FG000|Overall Study|stopped due to possible operation|0|||
164325683|NCT04104438|593567933|FG001|Overall Study|stopped due to possible operation|1|||
164325684|NCT04104438|593567934|FG002|Overall Study|stopped due to possible operation|0|||
164325685|NCT04104438|593567932|FG000|Overall Study|everolimus not started due to bile duct injury|0|||
164325686|NCT04104438|593567933|FG001|Overall Study|everolimus not started due to bile duct injury|1|||
164325687|NCT04104438|593567934|FG002|Overall Study|everolimus not started due to bile duct injury|0|||
164325688|NCT01282203|593567937|FG000|Overall Study|Adverse Event|1|||
164325689|NCT03977454|593567938|FG000|Overall Study|immediate postoperative revision|2|||
164325690|NCT03977454|593567939|FG001|Overall Study|immediate postoperative revision|2|||
164325691|NCT00930982|593567940|FG000|Overall Study|Adverse Event|19|||
164669283|NCT01706926|594813630|FG001|Overall Study|Other|4|||
164325692|NCT00930982|593567941|FG001|Overall Study|Adverse Event|23|||
164325693|NCT00930982|593567940|FG000|Overall Study|Protocol Violation|1|||
164325694|NCT00930982|593567941|FG001|Overall Study|Protocol Violation|5|||
164325695|NCT00930982|593567940|FG000|Overall Study|Withdrawal by Subject|1|||
164325696|NCT00930982|593567941|FG001|Overall Study|Withdrawal by Subject|1|||
164325697|NCT00518973|593567942|FG000|Overall Study|Withdrawal by Subject|3|||
164325698|NCT00518973|593567943|FG001|Overall Study|Withdrawal by Subject|2|||
164325699|NCT00582816|593567944|FG000|Overall Study|Engraftment Failure|3|||
164325700|NCT01923168|593567945|FG000|Overall Study|Protocol Violation|1|||
164325701|NCT01923168|593567946|FG001|Overall Study|Protocol Violation|1|||
164325702|NCT01923168|593567947|FG002|Overall Study|Protocol Violation|0|||
164325703|NCT01923168|593567945|FG000|Overall Study|Subject/guardian decision|14|||
164325704|NCT01923168|593567946|FG001|Overall Study|Subject/guardian decision|14|||
164325705|NCT01923168|593567947|FG002|Overall Study|Subject/guardian decision|4|||
164212951|NCT02924376|593145623|FG002|Overall Study|Progressive Disease|1|||
164212952|NCT02924376|593145624|FG003|Overall Study|Progressive Disease|0|||
164212953|NCT02924376|593145621|FG000|Overall Study|Death|73|||
164212954|NCT02924376|593145622|FG001|Overall Study|Death|18|||
164212955|NCT02924376|593145623|FG002|Overall Study|Death|15|||
164212956|NCT02924376|593145624|FG003|Overall Study|Death|2|||
164212957|NCT02924376|593145621|FG000|Overall Study|Lost to Follow-up|3|||
164212958|NCT02924376|593145622|FG001|Overall Study|Lost to Follow-up|0|||
164212959|NCT02924376|593145623|FG002|Overall Study|Lost to Follow-up|0|||
164212960|NCT02924376|593145624|FG003|Overall Study|Lost to Follow-up|0|||
164212961|NCT02924376|593145621|FG000|Overall Study|Study Terminated by Sponsor|19|||
164212962|NCT02924376|593145622|FG001|Overall Study|Study Terminated by Sponsor|0|||
164212963|NCT02924376|593145623|FG002|Overall Study|Study Terminated by Sponsor|0|||
164212964|NCT02924376|593145624|FG003|Overall Study|Study Terminated by Sponsor|0|||
164212965|NCT02924376|593145621|FG000|Overall Study|Physician Decision|1|||
164212966|NCT02924376|593145622|FG001|Overall Study|Physician Decision|0|||
164212967|NCT02924376|593145623|FG002|Overall Study|Physician Decision|0|||
164212968|NCT02924376|593145624|FG003|Overall Study|Physician Decision|0|||
164212969|NCT02924376|593145621|FG000|Overall Study|Withdrawal by Subject|7|||
164212970|NCT02924376|593145622|FG001|Overall Study|Withdrawal by Subject|2|||
164212971|NCT02924376|593145623|FG002|Overall Study|Withdrawal by Subject|1|||
164212972|NCT02924376|593145624|FG003|Overall Study|Withdrawal by Subject|0|||
164212973|NCT02924376|593145621|FG000|Overall Study|Rolled Over to Another Study|1|||
164212974|NCT02924376|593145622|FG001|Overall Study|Rolled Over to Another Study|0|||
164212975|NCT02924376|593145623|FG002|Overall Study|Rolled Over to Another Study|0|||
164212976|NCT02924376|593145624|FG003|Overall Study|Rolled Over to Another Study|0|||
164212977|NCT03608033|593145625|FG000|Treatment Period|Death|0|||
164212978|NCT03608033|593145626|FG001|Treatment Period|Death|1|||
164212979|NCT03608033|593145625|FG000|Treatment Period|Adverse Event|1|||
164212980|NCT03608033|593145626|FG001|Treatment Period|Adverse Event|5|||
164212981|NCT03608033|593145625|FG000|Treatment Period|Lack of Efficacy|4|||
164212982|NCT03608033|593145626|FG001|Treatment Period|Lack of Efficacy|3|||
164212983|NCT03608033|593145625|FG000|Treatment Period|Lost to Follow-up|2|||
164212984|NCT03608033|593145626|FG001|Treatment Period|Lost to Follow-up|6|||
164212985|NCT03608033|593145625|FG000|Treatment Period|Physician Decision|6|||
164212986|NCT03608033|593145626|FG001|Treatment Period|Physician Decision|10|||
164212987|NCT03608033|593145625|FG000|Treatment Period|Pregnancy|1|||
164212988|NCT03608033|593145626|FG001|Treatment Period|Pregnancy|0|||
164212989|NCT03608033|593145625|FG000|Treatment Period|Protocol Violation|1|||
164212990|NCT03608033|593145626|FG001|Treatment Period|Protocol Violation|2|||
164212991|NCT03608033|593145625|FG000|Treatment Period|Withdrawal by Subject|46|||
164212992|NCT03608033|593145626|FG001|Treatment Period|Withdrawal by Subject|45|||
164212993|NCT03608033|593145625|FG000|Treatment Period|Study terminated by sponsor|82|||
164212994|NCT03608033|593145626|FG001|Treatment Period|Study terminated by sponsor|68|||
164212995|NCT03608033|593145625|FG000|Treatment Period|Site Terminated by Sponsor|1|||
164212996|NCT03608033|593145626|FG001|Treatment Period|Site Terminated by Sponsor|0|||
164212997|NCT03608033|593145625|FG000|Open-Label Period: OMS721|Adverse Event|1|||
164212998|NCT03608033|593145626|FG001|Open-Label Period: OMS721|Adverse Event|0|||
164212999|NCT03608033|593145625|FG000|Open-Label Period: OMS721|Lack of Efficacy|1|||
164213000|NCT03608033|593145626|FG001|Open-Label Period: OMS721|Lack of Efficacy|0|||
164213001|NCT03608033|593145625|FG000|Open-Label Period: OMS721|Lost to Follow-up|1|||
164213002|NCT03608033|593145626|FG001|Open-Label Period: OMS721|Lost to Follow-up|0|||
164213003|NCT03608033|593145625|FG000|Open-Label Period: OMS721|Study Terminated By Sponsor|11|||
164213004|NCT03608033|593145626|FG001|Open-Label Period: OMS721|Study Terminated By Sponsor|0|||
164213005|NCT03608033|593145625|FG000|Open-Label Period: OMS721|Withdrawal by Subject|5|||
164213006|NCT03608033|593145626|FG001|Open-Label Period: OMS721|Withdrawal by Subject|0|||
164213007|NCT05253807|593145628|FG000|Overall Study|Death|1|||
164213008|NCT05253807|593145629|FG001|Overall Study|Death|4|||
164213009|NCT05253807|593145628|FG000|Overall Study|Withdrawal by Subject|1|||
164213010|NCT05253807|593145629|FG001|Overall Study|Withdrawal by Subject|0|||
164213011|NCT05253807|593145628|FG000|Overall Study|Study Terminated by Sponsor|1|||
164213012|NCT05253807|593145629|FG001|Overall Study|Study Terminated by Sponsor|1|||
164213013|NCT02360579|593145631|FG000|Initial|Death|16|||
164213014|NCT02360579|593145632|FG001|Initial|Death|49|||
164213015|NCT02360579|593145633|FG002|Initial|Death|0|||
164213016|NCT02360579|593145634|FG003|Initial|Death|71|||
164669284|NCT01706926|594813631|FG002|Overall Study|Other|4|||
164669285|NCT01706926|594813632|FG003|Overall Study|Other|3|||
164669286|NCT01710657|594814957|FG000|Overall Study|Lost to Follow-up|2|||
164669287|NCT01710657|594814958|FG001|Overall Study|Lost to Follow-up|0|||
164669288|NCT01710657|594814959|FG002|Overall Study|Lost to Follow-up|1|||
164213017|NCT02360579|593145631|FG000|Initial|Lost to Follow-up|0|||
164213018|NCT02360579|593145632|FG001|Initial|Lost to Follow-up|4|||
164213019|NCT02360579|593145633|FG002|Initial|Lost to Follow-up|0|||
164213020|NCT02360579|593145634|FG003|Initial|Lost to Follow-up|1|||
164213021|NCT02360579|593145631|FG000|Initial|Withdrawal by Subject|0|||
164669289|NCT01710657|594814957|FG000|Overall Study|Protocol Violation|2|||
164213022|NCT02360579|593145632|FG001|Initial|Withdrawal by Subject|0|||
164213023|NCT02360579|593145633|FG002|Initial|Withdrawal by Subject|0|||
164213024|NCT02360579|593145634|FG003|Initial|Withdrawal by Subject|3|||
164213025|NCT02360579|593145631|FG000|Initial|Other|7|||
164213026|NCT02360579|593145632|FG001|Initial|Other|0|||
164213027|NCT02360579|593145633|FG002|Initial|Other|0|||
164213028|NCT02360579|593145634|FG003|Initial|Other|0|||
164213029|NCT02360579|593145631|FG000|Initial|Did not receive TIL|8|||
164213030|NCT02360579|593145632|FG001|Initial|Did not receive TIL|11|||
164213031|NCT02360579|593145633|FG002|Initial|Did not receive TIL|0|||
164213032|NCT02360579|593145634|FG003|Initial|Did not receive TIL|22|||
164213033|NCT02360579|593145631|FG000|Retreatment|Death|0|||
164213034|NCT02360579|593145632|FG001|Retreatment|Death|0|||
164213035|NCT02360579|593145633|FG002|Retreatment|Death|11|||
164213036|NCT02360579|593145634|FG003|Retreatment|Death|0|||
164213037|NCT06455111|593145637|FG000|Overall Study|Withdrawal by Subject|11|||
164213038|NCT06455111|593145638|FG001|Overall Study|Withdrawal by Subject|4|||
164213039|NCT01793935|593146313|FG000|Overall Study|Pregnancy|1|||
164213040|NCT01793935|593146314|FG001|Overall Study|Pregnancy|0|||
164213041|NCT01793935|593146313|FG000|Overall Study|Protocol Violation|2|||
164213042|NCT01793935|593146314|FG001|Overall Study|Protocol Violation|1|||
164213043|NCT01793935|593146313|FG000|Overall Study|Adverse Event|2|||
164213044|NCT01793935|593146314|FG001|Overall Study|Adverse Event|0|||
164213045|NCT01793935|593146313|FG000|Overall Study|Patient did not take study medication|1|||
164213046|NCT01793935|593146314|FG001|Overall Study|Patient did not take study medication|1|||
164213047|NCT01793935|593146313|FG000|Overall Study|Lost to Follow-up|0|||
164213048|NCT01793935|593146314|FG001|Overall Study|Lost to Follow-up|1|||
164213049|NCT03439514|593146320|FG000|Double-Blind Treatment Period|Other|4|||
164213050|NCT03439514|593146321|FG001|Double-Blind Treatment Period|Other|1|||
164213051|NCT03439514|593146320|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
164213052|NCT03439514|593146321|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
164213053|NCT03439514|593146320|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
164213054|NCT03439514|593146321|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
164213055|NCT03439514|593146320|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
164213056|NCT03439514|593146321|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
164213057|NCT03439514|593146320|FG000|Double-Blind Treatment Period|Death|1|||
164213058|NCT03439514|593146321|FG001|Double-Blind Treatment Period|Death|2|||
164213059|NCT01481779|593146325|FG000|Overall Study|Adverse Event|23|||
164213060|NCT01481779|593146326|FG001|Overall Study|Adverse Event|5|||
164213061|NCT01481779|593146325|FG000|Overall Study|Lost to Follow-up|3|||
164213062|NCT01481779|593146326|FG001|Overall Study|Lost to Follow-up|2|||
164213063|NCT01481779|593146325|FG000|Overall Study|Protocol Violation|2|||
164213064|NCT01481779|593146326|FG001|Overall Study|Protocol Violation|3|||
164213065|NCT01481779|593146325|FG000|Overall Study|Withdrawal by Subject|26|||
164213066|NCT01481779|593146326|FG001|Overall Study|Withdrawal by Subject|13|||
164213067|NCT01481779|593146325|FG000|Overall Study|Physician Decision|13|||
164213068|NCT01481779|593146326|FG001|Overall Study|Physician Decision|4|||
164213069|NCT01481779|593146325|FG000|Overall Study|Sponsor Decision|3|||
164213070|NCT01481779|593146326|FG001|Overall Study|Sponsor Decision|1|||
164213071|NCT01697579|593146328|FG000|Base Study-Cycle 1|Adverse Event|1|||
164213072|NCT01697579|593146329|FG001|Base Study-Cycle 1|Adverse Event|0|||
164213073|NCT01697579|593146330|FG002|Base Study-Cycle 1|Adverse Event|0|||
164213074|NCT01697579|593146331|FG003|Base Study-Cycle 1|Adverse Event|0|||
164213075|NCT01697579|593146332|FG004|Base Study-Cycle 1|Adverse Event|0|||
164213076|NCT01697579|593146333|FG005|Base Study-Cycle 1|Adverse Event|0|||
164213077|NCT01697579|593146334|FG006|Base Study-Cycle 1|Adverse Event|0|||
164213078|NCT01697579|593146328|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
164213079|NCT01697579|593146329|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
164213080|NCT01697579|593146330|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
164213081|NCT01697579|593146331|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
164213082|NCT01697579|593146332|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
164213083|NCT01697579|593146333|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
164213084|NCT01697579|593146334|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
164213085|NCT01697579|593146328|FG000|Base Study-Cycle 1|Protocol Violation|0|||
164213086|NCT01697579|593146329|FG001|Base Study-Cycle 1|Protocol Violation|0|||
164213087|NCT01697579|593146330|FG002|Base Study-Cycle 1|Protocol Violation|0|||
164213088|NCT01697579|593146331|FG003|Base Study-Cycle 1|Protocol Violation|0|||
164213089|NCT01697579|593146332|FG004|Base Study-Cycle 1|Protocol Violation|3|||
164213090|NCT01697579|593146333|FG005|Base Study-Cycle 1|Protocol Violation|0|||
164213091|NCT01697579|593146334|FG006|Base Study-Cycle 1|Protocol Violation|0|||
164213092|NCT01697579|593146328|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
164213093|NCT01697579|593146329|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
164213094|NCT01697579|593146330|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
164213095|NCT01697579|593146331|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
164213096|NCT01697579|593146332|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
164213097|NCT01697579|593146333|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
164213098|NCT01697579|593146334|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
164213099|NCT01697579|593146328|FG000|Base Study-Cycle 1|Technical Problems|0|||
164213100|NCT01697579|593146329|FG001|Base Study-Cycle 1|Technical Problems|0|||
164213101|NCT01697579|593146330|FG002|Base Study-Cycle 1|Technical Problems|1|||
164213102|NCT01697579|593146331|FG003|Base Study-Cycle 1|Technical Problems|1|||
164213103|NCT01697579|593146332|FG004|Base Study-Cycle 1|Technical Problems|0|||
164213104|NCT01697579|593146333|FG005|Base Study-Cycle 1|Technical Problems|0|||
164213105|NCT01697579|593146334|FG006|Base Study-Cycle 1|Technical Problems|0|||
164213106|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Death|0|||
164213107|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Death|0|||
164213108|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Death|0|||
164213109|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Death|0|||
164213110|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Death|0|||
164213111|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Death|0|||
164213112|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Death|2|||
164213113|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
164213114|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
164213115|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
164213116|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
164213117|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
164213118|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
164213119|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
164213120|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
164213121|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
164213122|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
164213123|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
164213124|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
164213125|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
164213126|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
164213127|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
164213128|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
164213129|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
164213130|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
164213131|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
164213132|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
164213133|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
164213134|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
164213135|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
164213136|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
164213137|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
164213138|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
164213139|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
164213140|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
164213141|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
164213142|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
164213143|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
164213144|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
164213145|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
164213146|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
164213147|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
164213148|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
164213149|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
164213150|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
164213151|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
164213152|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
164213153|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
164213154|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
164213155|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
164213156|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
164669290|NCT01710657|594814958|FG001|Overall Study|Protocol Violation|2|||
164669291|NCT01710657|594814959|FG002|Overall Study|Protocol Violation|0|||
164669292|NCT01710657|594814957|FG000|Overall Study|Adverse Event|14|||
164213157|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
164213158|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
164213159|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
164213160|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
164213161|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
164669293|NCT01710657|594814958|FG001|Overall Study|Adverse Event|8|||
164669294|NCT01710657|594814959|FG002|Overall Study|Adverse Event|28|||
164213162|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
164213163|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
164213164|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
164213165|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
164213166|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
164213167|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
164213168|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
164213169|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
164213170|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
164213171|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
164213172|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
164213173|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
164213174|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
164213175|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
164213176|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
164213177|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
164213178|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
164213179|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
164213180|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
164213181|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
164213182|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
164213183|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
164213184|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
164213185|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
164213186|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
164213187|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
164213188|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
164213189|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
164213190|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
164213191|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
164213192|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
164213193|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
164213194|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
164213195|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
164213196|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
164213197|NCT04225039|593146336|FG000|Overall Study|Withdrawal by Subject|1|||
164213198|NCT04225039|593146337|FG001|Overall Study|Withdrawal by Subject|0|||
164213199|NCT04225039|593146338|FG002|Overall Study|Withdrawal by Subject|0|||
164213200|NCT04225039|593146339|FG003|Overall Study|Withdrawal by Subject|1|||
164213201|NCT04225039|593146336|FG000|Overall Study|Currently active on study treatment|0|||
164213202|NCT04225039|593146337|FG001|Overall Study|Currently active on study treatment|1|||
164213203|NCT04225039|593146338|FG002|Overall Study|Currently active on study treatment|0|||
164213204|NCT04225039|593146339|FG003|Overall Study|Currently active on study treatment|0|||
164213205|NCT04225039|593146336|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
164213206|NCT04225039|593146337|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
164213207|NCT04225039|593146338|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
164213208|NCT04225039|593146339|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
164213209|NCT04225039|593146336|FG000|Overall Study|Ineligible for treatment|0|||
164213210|NCT04225039|593146337|FG001|Overall Study|Ineligible for treatment|0|||
164213211|NCT04225039|593146338|FG002|Overall Study|Ineligible for treatment|0|||
164213212|NCT04225039|593146339|FG003|Overall Study|Ineligible for treatment|4|||
164213213|NCT00975923|593146340|FG000|Overall Study|Withdrawal by Subject|0|||
164213214|NCT00975923|593146341|FG001|Overall Study|Withdrawal by Subject|1|||
164213215|NCT01964404|593146342|FG000|Pre-Randomization - Scan 1|Screen Fail|49|||
164213216|NCT01964404|593146343|FG001|Pre-Randomization - Scan 1|Screen Fail|36|||
164213217|NCT01964404|593146344|FG002|Pre-Randomization - Scan 1|Screen Fail|12|||
164213218|NCT01964404|593146345|FG003|Pre-Randomization - Scan 1|Screen Fail|9|||
164669295|NCT01710657|594814957|FG000|Overall Study|Withdrawal by Subject|0|||
164213219|NCT01964404|593146346|FG004|Pre-Randomization - Scan 1|Screen Fail|0|||
164213220|NCT01964404|593146347|FG005|Pre-Randomization - Scan 1|Screen Fail|0|||
164213221|NCT01964404|593146348|FG006|Pre-Randomization - Scan 1|Screen Fail|0|||
164213222|NCT01964404|593146349|FG007|Pre-Randomization - Scan 1|Screen Fail|0|||
164213223|NCT01964404|593146350|FG008|Pre-Randomization - Scan 1|Screen Fail|0|||
164213224|NCT01964404|593146351|FG009|Pre-Randomization - Scan 1|Screen Fail|0|||
164213225|NCT01964404|593146342|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
164213226|NCT01964404|593146343|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
164213227|NCT01964404|593146344|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
164213228|NCT01964404|593146345|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
164213229|NCT01964404|593146346|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213230|NCT01964404|593146347|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213231|NCT01964404|593146348|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213232|NCT01964404|593146349|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213233|NCT01964404|593146350|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213234|NCT01964404|593146351|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213235|NCT01964404|593146342|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
164213236|NCT01964404|593146343|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
164213237|NCT01964404|593146344|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213238|NCT01964404|593146345|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
164213239|NCT01964404|593146346|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213240|NCT01964404|593146347|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213241|NCT01964404|593146348|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213242|NCT01964404|593146349|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213243|NCT01964404|593146350|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213244|NCT01964404|593146351|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213245|NCT00325416|593146354|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
164213246|NCT00325416|593146355|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
164213247|NCT00325416|593146354|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
164213248|NCT00325416|593146355|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
164213249|NCT00325416|593146354|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
164213250|NCT00325416|593146355|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
164669296|NCT01710657|594814958|FG001|Overall Study|Withdrawal by Subject|1|||
164669297|NCT01710657|594814959|FG002|Overall Study|Withdrawal by Subject|2|||
164669298|NCT01710657|594814957|FG000|Overall Study|Lack of Efficacy|0|||
164669299|NCT01710657|594814958|FG001|Overall Study|Lack of Efficacy|1|||
164669300|NCT01710657|594814959|FG002|Overall Study|Lack of Efficacy|1|||
164669301|NCT01367457|594814967|FG000|Overall Study|Death|2|||
164669302|NCT01367457|594814968|FG001|Overall Study|Death|0|||
164669303|NCT01367457|594814969|FG002|Overall Study|Death|0|||
164669304|NCT01367457|594814967|FG000|Overall Study|Investigator's decision|2|||
164669305|NCT01367457|594814968|FG001|Overall Study|Investigator's decision|0|||
164669306|NCT01367457|594814969|FG002|Overall Study|Investigator's decision|0|||
164213251|NCT00325416|593146354|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
164213252|NCT00325416|593146355|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
164213253|NCT00325416|593146354|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
164213254|NCT00325416|593146355|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
164213255|NCT00325416|593146354|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
164213256|NCT00325416|593146355|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
164325706|NCT01923168|593567945|FG000|Overall Study|Adverse Event|12|||
164325707|NCT01923168|593567946|FG001|Overall Study|Adverse Event|12|||
164325708|NCT01923168|593567947|FG002|Overall Study|Adverse Event|0|||
164669307|NCT01367457|594814967|FG000|Overall Study|Clinical decline (CD)|2|||
164669308|NCT01367457|594814968|FG001|Overall Study|Clinical decline (CD)|0|||
164669309|NCT01367457|594814969|FG002|Overall Study|Clinical decline (CD)|0|||
164669310|NCT01367457|594814967|FG000|Overall Study|Progression and death|8|||
164669311|NCT01367457|594814968|FG001|Overall Study|Progression and death|0|||
164669312|NCT01367457|594814969|FG002|Overall Study|Progression and death|0|||
164669313|NCT01367457|594814967|FG000|Overall Study|Toxicity|16|||
164669314|NCT01367457|594814968|FG001|Overall Study|Toxicity|0|||
164669315|NCT01367457|594814969|FG002|Overall Study|Toxicity|0|||
164669316|NCT01367457|594814967|FG000|Overall Study|Progression|137|||
164669317|NCT01367457|594814968|FG001|Overall Study|Progression|0|||
164669318|NCT01367457|594814969|FG002|Overall Study|Progression|0|||
164669319|NCT01367457|594814967|FG000|Overall Study|Patient asks for rest + slow progression|1|||
164669320|NCT01367457|594814968|FG001|Overall Study|Patient asks for rest + slow progression|0|||
164669321|NCT01367457|594814969|FG002|Overall Study|Patient asks for rest + slow progression|0|||
164669322|NCT01367457|594814967|FG000|Overall Study|Investigator's opinion, stable disease|1|||
164669323|NCT01367457|594814968|FG001|Overall Study|Investigator's opinion, stable disease|0|||
164669324|NCT01367457|594814969|FG002|Overall Study|Investigator's opinion, stable disease|0|||
164213257|NCT06239610|593146356|FG000|Overall Study|no usable migration data for minimum of one day|11|||
164669325|NCT01367457|594814967|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
164669326|NCT01367457|594814968|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
164669327|NCT01367457|594814969|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
164669328|NCT01367457|594814967|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
164213258|NCT02916771|593146357|FG000|Overall Study|Withdrawal by Subject|9|||
164213259|NCT02916771|593146357|FG000|Overall Study|Physician Decision|1|||
164213260|NCT02916771|593146357|FG000|Overall Study|Began treatment for another active malignancy|1|||
164213261|NCT03682848|593146365|FG000|Overall Study|Withdrawal by Subject|3|||
164213262|NCT03682848|593146365|FG000|Overall Study|Site closed|5|||
164213263|NCT03682848|593146365|FG000|Overall Study|Protocol Deviation|1|||
164213264|NCT03682848|593146365|FG000|Overall Study|Adverse Event|2|||
164213265|NCT03682848|593146365|FG000|Overall Study|Lack of Efficacy|1|||
164325709|NCT01923168|593567945|FG000|Overall Study|Physician Decision|6|||
164213266|NCT02872714|593146366|FG000|Overall Study|Progressive Disease|1|||
164213267|NCT02872714|593146367|FG001|Overall Study|Progressive Disease|2|||
164213268|NCT02872714|593146368|FG002|Overall Study|Progressive Disease|0|||
164213269|NCT02872714|593146369|FG003|Overall Study|Progressive Disease|0|||
164213270|NCT02872714|593146370|FG004|Overall Study|Progressive Disease|0|||
164213271|NCT02872714|593146366|FG000|Overall Study|Death|87|||
164213272|NCT02872714|593146367|FG001|Overall Study|Death|36|||
164213273|NCT02872714|593146368|FG002|Overall Study|Death|8|||
164213274|NCT02872714|593146369|FG003|Overall Study|Death|81|||
164213275|NCT02872714|593146370|FG004|Overall Study|Death|2|||
164213276|NCT02872714|593146366|FG000|Overall Study|Lost to Follow-up|2|||
164213277|NCT02872714|593146367|FG001|Overall Study|Lost to Follow-up|1|||
164213278|NCT02872714|593146368|FG002|Overall Study|Lost to Follow-up|0|||
164213279|NCT02872714|593146369|FG003|Overall Study|Lost to Follow-up|3|||
164213280|NCT02872714|593146370|FG004|Overall Study|Lost to Follow-up|0|||
164213281|NCT02872714|593146366|FG000|Overall Study|Physician Decision|0|||
164213282|NCT02872714|593146367|FG001|Overall Study|Physician Decision|0|||
164213283|NCT02872714|593146368|FG002|Overall Study|Physician Decision|0|||
164213284|NCT02872714|593146369|FG003|Overall Study|Physician Decision|1|||
164213285|NCT02872714|593146370|FG004|Overall Study|Physician Decision|0|||
164213286|NCT02872714|593146366|FG000|Overall Study|Withdrawal by Subject|1|||
164213287|NCT02872714|593146367|FG001|Overall Study|Withdrawal by Subject|3|||
164213288|NCT02872714|593146368|FG002|Overall Study|Withdrawal by Subject|0|||
164213289|NCT02872714|593146369|FG003|Overall Study|Withdrawal by Subject|2|||
164213290|NCT02872714|593146370|FG004|Overall Study|Withdrawal by Subject|0|||
164213291|NCT02872714|593146366|FG000|Overall Study|Captured as Other|2|||
164213292|NCT02872714|593146367|FG001|Overall Study|Captured as Other|0|||
164213293|NCT02872714|593146368|FG002|Overall Study|Captured as Other|0|||
164213294|NCT02872714|593146369|FG003|Overall Study|Captured as Other|1|||
164213295|NCT02872714|593146370|FG004|Overall Study|Captured as Other|0|||
164213296|NCT06717399|593146371|FG000|Overall Study|Death|1|||
164213297|NCT03043573|593146372|FG000|Overall Study|Lost to Follow-up|3|||
164213298|NCT03043573|593146373|FG001|Overall Study|Lost to Follow-up|3|||
164213299|NCT03043573|593146372|FG000|Overall Study|Physician Decision|0|||
164213300|NCT03043573|593146373|FG001|Overall Study|Physician Decision|5|||
164213301|NCT03043573|593146372|FG000|Overall Study|Withdrawal by Subject|0|||
164213302|NCT03043573|593146373|FG001|Overall Study|Withdrawal by Subject|4|||
164213303|NCT02337686|593146374|FG000|Overall Study|Adverse Event|1|||
164213304|NCT02145390|593146375|FG000|Overall Study|Withdrawal by Subject|1|||
164213305|NCT03580928|593146379|FG000|Overall Study|Death|0|||
164213306|NCT03580928|593146380|FG001|Overall Study|Death|3|||
164213307|NCT03580928|593146379|FG000|Overall Study|Withdrawal by Subject|2|||
164213308|NCT03580928|593146380|FG001|Overall Study|Withdrawal by Subject|1|||
164213309|NCT03580928|593146379|FG000|Overall Study|Lost to Follow-up|2|||
164213310|NCT03580928|593146380|FG001|Overall Study|Lost to Follow-up|0|||
164213311|NCT03580928|593146379|FG000|Overall Study|Progressive Disease|0|||
164213312|NCT03580928|593146380|FG001|Overall Study|Progressive Disease|1|||
164213313|NCT00479232|593147728|FG000|Overall Study|Adverse Event|0|||
164213314|NCT00479232|593147729|FG001|Overall Study|Adverse Event|0|||
164213315|NCT00479232|593147730|FG002|Overall Study|Adverse Event|5|||
164213316|NCT00479232|593147731|FG003|Overall Study|Adverse Event|0|||
164213317|NCT00479232|593147732|FG004|Overall Study|Adverse Event|0|||
164213318|NCT00479232|593147733|FG005|Overall Study|Adverse Event|10|||
164213319|NCT00479232|593147728|FG000|Overall Study|Deviation from Protocol|0|||
164213320|NCT00479232|593147729|FG001|Overall Study|Deviation from Protocol|0|||
164213321|NCT00479232|593147730|FG002|Overall Study|Deviation from Protocol|1|||
164213322|NCT00479232|593147731|FG003|Overall Study|Deviation from Protocol|0|||
164213323|NCT00479232|593147732|FG004|Overall Study|Deviation from Protocol|0|||
164213324|NCT00479232|593147733|FG005|Overall Study|Deviation from Protocol|0|||
164213325|NCT00479232|593147728|FG000|Overall Study|Lack of Efficacy|0|||
164213326|NCT00479232|593147729|FG001|Overall Study|Lack of Efficacy|0|||
164213327|NCT00479232|593147730|FG002|Overall Study|Lack of Efficacy|2|||
164213328|NCT00479232|593147731|FG003|Overall Study|Lack of Efficacy|0|||
164213329|NCT00479232|593147732|FG004|Overall Study|Lack of Efficacy|0|||
164213330|NCT00479232|593147733|FG005|Overall Study|Lack of Efficacy|4|||
164213331|NCT00479232|593147728|FG000|Overall Study|Physician Decision|0|||
164213332|NCT00479232|593147729|FG001|Overall Study|Physician Decision|0|||
164213333|NCT00479232|593147730|FG002|Overall Study|Physician Decision|2|||
164213334|NCT00479232|593147731|FG003|Overall Study|Physician Decision|0|||
164213335|NCT00479232|593147732|FG004|Overall Study|Physician Decision|0|||
164213336|NCT00479232|593147733|FG005|Overall Study|Physician Decision|1|||
164213337|NCT00479232|593147728|FG000|Overall Study|Progressive Disease|3|||
164213338|NCT00479232|593147729|FG001|Overall Study|Progressive Disease|1|||
164213339|NCT00479232|593147730|FG002|Overall Study|Progressive Disease|12|||
164213340|NCT00479232|593147731|FG003|Overall Study|Progressive Disease|3|||
164213341|NCT00479232|593147732|FG004|Overall Study|Progressive Disease|3|||
164213342|NCT00479232|593147733|FG005|Overall Study|Progressive Disease|12|||
164213343|NCT00479232|593147728|FG000|Overall Study|Withdrew Consent|0|||
164213344|NCT00479232|593147729|FG001|Overall Study|Withdrew Consent|2|||
164213345|NCT00479232|593147730|FG002|Overall Study|Withdrew Consent|6|||
164213346|NCT00479232|593147731|FG003|Overall Study|Withdrew Consent|0|||
164213347|NCT00479232|593147732|FG004|Overall Study|Withdrew Consent|1|||
164213348|NCT00479232|593147733|FG005|Overall Study|Withdrew Consent|3|||
164213349|NCT00484159|593147736|FG000|Overall Study|Lost to Follow-up|1|||
164213350|NCT00484159|593147737|FG001|Overall Study|Lost to Follow-up|1|||
164213351|NCT00484159|593147738|FG002|Overall Study|Lost to Follow-up|0|||
164213352|NCT05977868|593147739|FG000|Overall Study|Withdrawal by Subject|1|||
164213353|NCT05977868|593147740|FG001|Overall Study|Withdrawal by Subject|2|||
164213354|NCT05977868|593147739|FG000|Overall Study|Transitioned to comfort care|1|||
164213355|NCT05977868|593147740|FG001|Overall Study|Transitioned to comfort care|0|||
164213356|NCT00876395|593147741|FG000|Overall Study|Untreated|8|||
164213357|NCT00876395|593147742|FG001|Overall Study|Untreated|1|||
164213358|NCT00876395|593147741|FG000|Overall Study|Adverse Event|63|||
164213359|NCT00876395|593147742|FG001|Overall Study|Adverse Event|11|||
164213360|NCT00876395|593147741|FG000|Overall Study|Abnormal test procedure result(s)|1|||
164213361|NCT00876395|593147742|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164213362|NCT00876395|593147741|FG000|Overall Study|Disease progression|259|||
164213363|NCT00876395|593147742|FG001|Overall Study|Disease progression|162|||
164213364|NCT00876395|593147741|FG000|Overall Study|New cancer therapy|25|||
164213365|NCT00876395|593147742|FG001|Overall Study|New cancer therapy|7|||
164213366|NCT00876395|593147741|FG000|Overall Study|Protocol Violation|5|||
164213367|NCT00876395|593147742|FG001|Overall Study|Protocol Violation|2|||
164213368|NCT00876395|593147741|FG000|Overall Study|Withdrawal by Subject|66|||
164213369|NCT00876395|593147742|FG001|Overall Study|Withdrawal by Subject|33|||
164213370|NCT00876395|593147741|FG000|Overall Study|Lost to Follow-up|2|||
164213371|NCT00876395|593147742|FG001|Overall Study|Lost to Follow-up|0|||
164213372|NCT00876395|593147741|FG000|Overall Study|Administrative problems|39|||
164213373|NCT00876395|593147742|FG001|Overall Study|Administrative problems|23|||
164213374|NCT00876395|593147741|FG000|Overall Study|Death|12|||
164213375|NCT00876395|593147742|FG001|Overall Study|Death|0|||
164213376|NCT01239680|593147745|FG000|Overall Study|Withdrawal by Subject|2|||
164213377|NCT01239680|593147746|FG001|Overall Study|Withdrawal by Subject|0|||
164213378|NCT00639379|593147747|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
164213379|NCT00639379|593147748|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
164213380|NCT00639379|593147747|FG000|Period 1 - 2 Weeks|lens issue|3|||
164213381|NCT00639379|593147748|FG001|Period 1 - 2 Weeks|lens issue|0|||
164213382|NCT01797185|593147753|FG000|Overall Study|Adverse Event|5|||
164213383|NCT01797185|593147754|FG001|Overall Study|Adverse Event|15|||
164213384|NCT01797185|593147755|FG002|Overall Study|Adverse Event|6|||
164213385|NCT01797185|593147753|FG000|Overall Study|Withdrawal by Subject|6|||
164213386|NCT01797185|593147754|FG001|Overall Study|Withdrawal by Subject|9|||
164213387|NCT01797185|593147755|FG002|Overall Study|Withdrawal by Subject|5|||
164213388|NCT01797185|593147753|FG000|Overall Study|Site terminated|8|||
164213389|NCT01797185|593147754|FG001|Overall Study|Site terminated|4|||
164213390|NCT01797185|593147755|FG002|Overall Study|Site terminated|0|||
164213391|NCT01797185|593147753|FG000|Overall Study|Lost to Follow-up|2|||
164213392|NCT01797185|593147754|FG001|Overall Study|Lost to Follow-up|6|||
164213393|NCT01797185|593147755|FG002|Overall Study|Lost to Follow-up|1|||
164213394|NCT01797185|593147753|FG000|Overall Study|Withdrawn per sponsor|5|||
164213395|NCT01797185|593147754|FG001|Overall Study|Withdrawn per sponsor|0|||
164213396|NCT01797185|593147755|FG002|Overall Study|Withdrawn per sponsor|0|||
164213397|NCT01797185|593147753|FG000|Overall Study|Physician Decision|1|||
164213398|NCT01797185|593147754|FG001|Overall Study|Physician Decision|3|||
164213399|NCT01797185|593147755|FG002|Overall Study|Physician Decision|0|||
164213400|NCT01797185|593147753|FG000|Overall Study|Protocol Violation|1|||
164213401|NCT01797185|593147754|FG001|Overall Study|Protocol Violation|1|||
164213402|NCT01797185|593147755|FG002|Overall Study|Protocol Violation|0|||
164213403|NCT01787838|593147756|FG000|Overall Study|refused|1413|||
164213404|NCT01033942|593147760|FG000|Overall Study|Withdrawal by Subject|1|||
164213405|NCT01033942|593147761|FG001|Overall Study|Withdrawal by Subject|1|||
164213406|NCT01033942|593147762|FG002|Overall Study|Withdrawal by Subject|1|||
164213407|NCT01033942|593147760|FG000|Overall Study|Lost to Follow-up|1|||
164213408|NCT01033942|593147761|FG001|Overall Study|Lost to Follow-up|0|||
164213409|NCT01033942|593147762|FG002|Overall Study|Lost to Follow-up|0|||
164213410|NCT01033942|593147760|FG000|Overall Study|Enrolled in Extension Study|0|||
164213411|NCT01033942|593147761|FG001|Overall Study|Enrolled in Extension Study|3|||
164213412|NCT01033942|593147762|FG002|Overall Study|Enrolled in Extension Study|0|||
164213413|NCT02260986|593147770|FG000|Overall Study|Adverse Event|24|||
164213414|NCT02260986|593147771|FG001|Overall Study|Adverse Event|0|||
164213415|NCT02260986|593147772|FG002|Overall Study|Adverse Event|11|||
164213416|NCT02260986|593147770|FG000|Overall Study|Lack of Efficacy|27|||
164213417|NCT02260986|593147771|FG001|Overall Study|Lack of Efficacy|3|||
164213418|NCT02260986|593147772|FG002|Overall Study|Lack of Efficacy|0|||
164213419|NCT02260986|593147770|FG000|Overall Study|Protocol Violation|14|||
164213420|NCT02260986|593147771|FG001|Overall Study|Protocol Violation|5|||
164213421|NCT02260986|593147772|FG002|Overall Study|Protocol Violation|16|||
164213422|NCT02260986|593147770|FG000|Overall Study|Car accident|0|||
164213423|NCT02260986|593147771|FG001|Overall Study|Car accident|0|||
164213424|NCT02260986|593147772|FG002|Overall Study|Car accident|1|||
164213425|NCT02260986|593147770|FG000|Overall Study|Withdrawal by Subject|17|||
164213426|NCT02260986|593147771|FG001|Overall Study|Withdrawal by Subject|4|||
164213427|NCT02260986|593147772|FG002|Overall Study|Withdrawal by Subject|9|||
164213428|NCT02260986|593147770|FG000|Overall Study|Incorrect randomization|0|||
164213429|NCT02260986|593147771|FG001|Overall Study|Incorrect randomization|1|||
164213430|NCT02260986|593147772|FG002|Overall Study|Incorrect randomization|0|||
164213431|NCT02260986|593147770|FG000|Overall Study|Lack of investigation product supply|2|||
164213432|NCT02260986|593147771|FG001|Overall Study|Lack of investigation product supply|0|||
164213433|NCT02260986|593147772|FG002|Overall Study|Lack of investigation product supply|1|||
164213434|NCT02260986|593147770|FG000|Overall Study|Lost to Follow-up|4|||
164213435|NCT02260986|593147771|FG001|Overall Study|Lost to Follow-up|0|||
164213436|NCT02260986|593147772|FG002|Overall Study|Lost to Follow-up|3|||
164213437|NCT02260986|593147770|FG000|Overall Study|Pregnancy|2|||
164213438|NCT02260986|593147771|FG001|Overall Study|Pregnancy|0|||
164213439|NCT02260986|593147772|FG002|Overall Study|Pregnancy|0|||
164213440|NCT02536794|593147774|FG000|Reached 1st Response Assessment|Adverse Event|2|||
164669329|NCT01367457|594814968|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
164669330|NCT01367457|594814969|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
164669331|NCT01367457|594814967|FG000|Overall Study|low grade toxicities + stable disease|1|||
164669332|NCT01367457|594814968|FG001|Overall Study|low grade toxicities + stable disease|0|||
164669333|NCT01367457|594814969|FG002|Overall Study|low grade toxicities + stable disease|0|||
164669334|NCT01367457|594814967|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
164213441|NCT02536794|593147774|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
164213442|NCT02536794|593147774|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
164213443|NCT02536794|593147774|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
164213444|NCT02536794|593147774|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
164213445|NCT02536794|593147774|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
164213446|NCT00313170|593147775|FG000|Overall Study|Death|2|||
164213447|NCT00313170|593147776|FG001|Overall Study|Death|4|||
164213448|NCT00313170|593147777|FG002|Overall Study|Death|2|||
164213449|NCT00313170|593147775|FG000|Overall Study|Adverse Event|1|||
164213450|NCT00313170|593147776|FG001|Overall Study|Adverse Event|2|||
164213451|NCT00313170|593147777|FG002|Overall Study|Adverse Event|0|||
164213452|NCT00313170|593147775|FG000|Overall Study|Disease progression|31|||
164213453|NCT00313170|593147776|FG001|Overall Study|Disease progression|26|||
164213454|NCT00313170|593147777|FG002|Overall Study|Disease progression|27|||
164213455|NCT00313170|593147775|FG000|Overall Study|Withdrawal by Subject|1|||
164213456|NCT00313170|593147776|FG001|Overall Study|Withdrawal by Subject|0|||
164213457|NCT00313170|593147777|FG002|Overall Study|Withdrawal by Subject|1|||
164213458|NCT00313170|593147775|FG000|Overall Study|Incorrect enrollment|0|||
164213459|NCT00313170|593147776|FG001|Overall Study|Incorrect enrollment|2|||
164213460|NCT00313170|593147777|FG002|Overall Study|Incorrect enrollment|1|||
164213461|NCT00313170|593147775|FG000|Overall Study|Lost to Follow-up|0|||
164213462|NCT00313170|593147776|FG001|Overall Study|Lost to Follow-up|0|||
164213463|NCT00313170|593147777|FG002|Overall Study|Lost to Follow-up|1|||
164213464|NCT00313170|593147775|FG000|Overall Study|Progression (investigators opinion)|1|||
164213465|NCT00313170|593147776|FG001|Overall Study|Progression (investigators opinion)|0|||
164213466|NCT00313170|593147777|FG002|Overall Study|Progression (investigators opinion)|0|||
164213467|NCT00817063|593147778|FG000|Overall Study|Adverse Event|32|||
164213468|NCT00817063|593147779|FG001|Overall Study|Adverse Event|13|||
164213469|NCT00817063|593147778|FG000|Overall Study|Death|1|||
164213470|NCT00817063|593147779|FG001|Overall Study|Death|1|||
164213471|NCT00817063|593147778|FG000|Overall Study|Lack of Efficacy|33|||
164213472|NCT00817063|593147779|FG001|Overall Study|Lack of Efficacy|86|||
164213473|NCT00817063|593147778|FG000|Overall Study|Failure to Return|13|||
164213474|NCT00817063|593147779|FG001|Overall Study|Failure to Return|12|||
164213475|NCT00817063|593147778|FG000|Overall Study|Violation of Selection at Entry|7|||
164213476|NCT00817063|593147779|FG001|Overall Study|Violation of Selection at Entry|4|||
164213477|NCT00817063|593147778|FG000|Overall Study|Protocol Violation|3|||
164213478|NCT00817063|593147779|FG001|Overall Study|Protocol Violation|8|||
164213479|NCT00817063|593147778|FG000|Overall Study|Withdrawal by Subject|17|||
164213480|NCT00817063|593147779|FG001|Overall Study|Withdrawal by Subject|37|||
164213481|NCT00817063|593147778|FG000|Overall Study|Early Improvement|19|||
164213482|NCT00817063|593147779|FG001|Overall Study|Early Improvement|4|||
164213483|NCT00817063|593147778|FG000|Overall Study|Administrative|10|||
164213484|NCT00817063|593147779|FG001|Overall Study|Administrative|4|||
164213485|NCT00817063|593147778|FG000|Overall Study|Abnormality of Laboratory Test|2|||
164213486|NCT00817063|593147779|FG001|Overall Study|Abnormality of Laboratory Test|1|||
164213487|NCT00529035|593147780|FG000|Overall Study|Withdrawal by Subject|1|||
164213488|NCT01521364|593147781|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
164213489|NCT01521364|593147781|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
164213490|NCT03418675|593147782|FG000|Overall Study|Lost to Follow-up|13|||
164213491|NCT03418675|593147783|FG001|Overall Study|Lost to Follow-up|10|||
164213492|NCT03418675|593147782|FG000|Overall Study|Adverse Event|2|||
164213493|NCT03418675|593147783|FG001|Overall Study|Adverse Event|0|||
164669335|NCT01367457|594814968|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
164213494|NCT02115386|593147784|FG000|Overall Study|Protocol Violation|1|||
164213495|NCT02115386|593147784|FG000|Overall Study|Administrative - trial was terminated|6|||
164213496|NCT02493855|593147785|FG000|Overall Study|Non-compliance|1|||
164213497|NCT02493855|593147786|FG001|Overall Study|Non-compliance|0|||
164213498|NCT02493855|593147787|FG002|Overall Study|Non-compliance|0|||
164213499|NCT02493855|593147785|FG000|Overall Study|Adverse Event|0|||
164213500|NCT02493855|593147786|FG001|Overall Study|Adverse Event|1|||
164213501|NCT02493855|593147787|FG002|Overall Study|Adverse Event|0|||
164213502|NCT02493855|593147785|FG000|Overall Study|Withdrawal by Subject|1|||
164213503|NCT02493855|593147786|FG001|Overall Study|Withdrawal by Subject|0|||
164213504|NCT02493855|593147787|FG002|Overall Study|Withdrawal by Subject|0|||
164213505|NCT03086343|593147788|FG000|Period 1|Adverse Event|7|||
164213506|NCT03086343|593147789|FG001|Period 1|Adverse Event|7|||
164213507|NCT03086343|593147790|FG002|Period 1|Adverse Event|0|||
164669336|NCT01367457|594814969|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
164669337|NCT01367457|594814967|FG000|Overall Study|Withdrawal by Subject|1|||
164669338|NCT01367457|594814968|FG001|Overall Study|Withdrawal by Subject|0|||
164669339|NCT01367457|594814969|FG002|Overall Study|Withdrawal by Subject|0|||
164669340|NCT01367457|594814967|FG000|Overall Study|CD, associated leukaemia|1|||
164669341|NCT01367457|594814968|FG001|Overall Study|CD, associated leukaemia|0|||
164669342|NCT01367457|594814969|FG002|Overall Study|CD, associated leukaemia|0|||
164669343|NCT01367457|594814967|FG000|Overall Study|Uncontrolled pain|1|||
164669344|NCT01367457|594814968|FG001|Overall Study|Uncontrolled pain|0|||
164669345|NCT01367457|594814969|FG002|Overall Study|Uncontrolled pain|0|||
164669346|NCT01367457|594814967|FG000|Overall Study|Overall status worsens to grade 4|1|||
164669347|NCT01367457|594814968|FG001|Overall Study|Overall status worsens to grade 4|0|||
164669348|NCT01367457|594814969|FG002|Overall Study|Overall status worsens to grade 4|0|||
164669349|NCT01367457|594814967|FG000|Overall Study|Stabilisation + frequent infections|1|||
164669350|NCT01367457|594814968|FG001|Overall Study|Stabilisation + frequent infections|0|||
164669351|NCT01367457|594814969|FG002|Overall Study|Stabilisation + frequent infections|0|||
164669352|NCT01367457|594814967|FG000|Overall Study|No clinical benefit|1|||
164669353|NCT01367457|594814968|FG001|Overall Study|No clinical benefit|0|||
164669354|NCT01367457|594814969|FG002|Overall Study|No clinical benefit|0|||
164669355|NCT01367457|594814967|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
164669356|NCT01367457|594814968|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
164669357|NCT01367457|594814969|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
164669358|NCT01367457|594814967|FG000|Overall Study|Overall decline|1|||
164669359|NCT01367457|594814968|FG001|Overall Study|Overall decline|0|||
164669360|NCT01367457|594814969|FG002|Overall Study|Overall decline|0|||
164669361|NCT01367457|594814967|FG000|Overall Study|Rejection of treatment|1|||
164669362|NCT01367457|594814968|FG001|Overall Study|Rejection of treatment|0|||
164669363|NCT01367457|594814969|FG002|Overall Study|Rejection of treatment|0|||
164669364|NCT01367457|594814967|FG000|Overall Study|Lost to Follow-up|1|||
164669365|NCT01367457|594814968|FG001|Overall Study|Lost to Follow-up|0|||
164669366|NCT01367457|594814969|FG002|Overall Study|Lost to Follow-up|0|||
164669367|NCT01367457|594814967|FG000|Overall Study|Death from septic shock|1|||
164669368|NCT01367457|594814968|FG001|Overall Study|Death from septic shock|0|||
164669369|NCT01367457|594814969|FG002|Overall Study|Death from septic shock|0|||
164213508|NCT03086343|593147791|FG003|Period 1|Adverse Event|1|||
164213509|NCT03086343|593147788|FG000|Period 1|Withdrawal by Subject|6|||
164213510|NCT03086343|593147789|FG001|Period 1|Withdrawal by Subject|10|||
164213511|NCT03086343|593147790|FG002|Period 1|Withdrawal by Subject|0|||
164213512|NCT03086343|593147791|FG003|Period 1|Withdrawal by Subject|0|||
164213513|NCT03086343|593147788|FG000|Period 1|Lost to Follow-up|1|||
164213514|NCT03086343|593147789|FG001|Period 1|Lost to Follow-up|3|||
164213515|NCT03086343|593147790|FG002|Period 1|Lost to Follow-up|1|||
164213516|NCT03086343|593147791|FG003|Period 1|Lost to Follow-up|0|||
164213517|NCT03086343|593147788|FG000|Period 1|Other, Not Specified|10|||
164213518|NCT03086343|593147789|FG001|Period 1|Other, Not Specified|12|||
164213519|NCT03086343|593147790|FG002|Period 1|Other, Not Specified|2|||
164213520|NCT03086343|593147791|FG003|Period 1|Other, Not Specified|1|||
164213521|NCT03086343|593147788|FG000|Period 1|Missing|1|||
164213522|NCT03086343|593147789|FG001|Period 1|Missing|0|||
164213523|NCT03086343|593147790|FG002|Period 1|Missing|0|||
164213524|NCT03086343|593147791|FG003|Period 1|Missing|0|||
164213525|NCT03086343|593147788|FG000|Period 2|Adverse Event|20|||
164213526|NCT03086343|593147789|FG001|Period 2|Adverse Event|11|||
164213527|NCT03086343|593147790|FG002|Period 2|Adverse Event|1|||
164213528|NCT03086343|593147791|FG003|Period 2|Adverse Event|2|||
164213529|NCT03086343|593147788|FG000|Period 2|Withdrawal by Subject|15|||
164213530|NCT03086343|593147789|FG001|Period 2|Withdrawal by Subject|25|||
164213531|NCT03086343|593147790|FG002|Period 2|Withdrawal by Subject|2|||
164213532|NCT03086343|593147791|FG003|Period 2|Withdrawal by Subject|2|||
164669370|NCT01367457|594814967|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
164669371|NCT01367457|594814968|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
164669372|NCT01367457|594814969|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
164669373|NCT01367457|594814967|FG000|Overall Study|Patient's Wish|1|||
164325710|NCT01923168|593567946|FG001|Overall Study|Physician Decision|9|||
164325711|NCT01923168|593567947|FG002|Overall Study|Physician Decision|5|||
164325712|NCT01923168|593567945|FG000|Overall Study|Progressive disease|4|||
164325713|NCT01923168|593567946|FG001|Overall Study|Progressive disease|3|||
164325714|NCT01923168|593567947|FG002|Overall Study|Progressive disease|7|||
164325715|NCT01923168|593567945|FG000|Overall Study|Death|0|||
164325716|NCT01923168|593567946|FG001|Overall Study|Death|0|||
164325717|NCT01923168|593567947|FG002|Overall Study|Death|1|||
164325718|NCT04193410|593567948|FG000|Overall Study|Lost to Follow-up|7|||
164325719|NCT04193410|593567949|FG001|Overall Study|Lost to Follow-up|6|||
164325720|NCT02241889|593567954|FG000|Overall Study|device issues|0|||
164325721|NCT02241889|593567955|FG001|Overall Study|device issues|0|||
164325722|NCT02241889|593567956|FG002|Overall Study|device issues|1|||
164325723|NCT02241889|593567957|FG003|Overall Study|device issues|0|||
164325724|NCT02241889|593567958|FG004|Overall Study|device issues|0|||
164213533|NCT03086343|593147788|FG000|Period 2|Lost to Follow-up|6|||
164213534|NCT03086343|593147789|FG001|Period 2|Lost to Follow-up|11|||
164213535|NCT03086343|593147790|FG002|Period 2|Lost to Follow-up|1|||
164213536|NCT03086343|593147791|FG003|Period 2|Lost to Follow-up|0|||
164213537|NCT03086343|593147788|FG000|Period 2|COVID-19 Infection|5|||
164213538|NCT03086343|593147789|FG001|Period 2|COVID-19 Infection|0|||
164213539|NCT03086343|593147790|FG002|Period 2|COVID-19 Infection|0|||
164213540|NCT03086343|593147791|FG003|Period 2|COVID-19 Infection|0|||
164213541|NCT03086343|593147788|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
164213542|NCT03086343|593147789|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
164213543|NCT03086343|593147790|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
164213544|NCT03086343|593147791|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
164213545|NCT03086343|593147788|FG000|Period 2|Other, Not Specified|23|||
164213546|NCT03086343|593147789|FG001|Period 2|Other, Not Specified|22|||
164213547|NCT03086343|593147790|FG002|Period 2|Other, Not Specified|2|||
164213548|NCT03086343|593147791|FG003|Period 2|Other, Not Specified|4|||
164213549|NCT04900272|593147792|FG000|Overall Study|Lost to Follow-up|2|||
164213550|NCT04900272|593147792|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
164213551|NCT04900272|593147792|FG000|Overall Study|Withdrawal by Subject|1|||
164213552|NCT02447029|593147795|FG000|Overall Study|Withdrawal by Subject|3|||
164213553|NCT02447029|593147796|FG001|Overall Study|Withdrawal by Subject|2|||
164213554|NCT02299167|593147797|FG000|Overall Study|patients were excluded from the study|11|||
164213555|NCT03600428|593147798|FG000|Overall Study|Not eligible|0|||
164213556|NCT03600428|593147799|FG001|Overall Study|Not eligible|1|||
164213557|NCT03600428|593147798|FG000|Overall Study|Lost to Follow-up|5|||
164213558|NCT03600428|593147799|FG001|Overall Study|Lost to Follow-up|4|||
164213559|NCT00549328|593147801|FG000|Overall Study|Adverse Event|2|||
164213560|NCT00549328|593147801|FG000|Overall Study|Disease Progression|10|||
164213561|NCT00549328|593147801|FG000|Overall Study|Death|1|||
164213562|NCT00549328|593147801|FG000|Overall Study|Use of Prohibited Medication|1|||
164213563|NCT06420232|593147806|FG000|Overall Study|Withdrawal by Subject|3|||
164213564|NCT04868682|593147808|FG000|Post-treatment|Lost to Follow-up|1|||
164213565|NCT04868682|593147809|FG001|Post-treatment|Lost to Follow-up|1|||
164213566|NCT04868682|593147808|FG000|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|1|||
164213567|NCT04868682|593147809|FG001|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|2|||
164213568|NCT04868682|593147808|FG000|Six-month Assessment|Lost to Follow-up|1|||
164213569|NCT04868682|593147809|FG001|Six-month Assessment|Lost to Follow-up|0|||
164213570|NCT04868682|593147808|FG000|Six-month Assessment|Death|1|||
164213571|NCT04868682|593147809|FG001|Six-month Assessment|Death|0|||
164213572|NCT04868682|593147808|FG000|Six-month Assessment|Refused|0|||
164213573|NCT04868682|593147809|FG001|Six-month Assessment|Refused|1|||
164213574|NCT04868682|593147808|FG000|12-month Assessment|Lost to Follow-up|2|||
164564952|NCT01307033|594438363|FG001|8-week Double-blind Period|Adverse Event|0|||
164564953|NCT01307033|594438364|FG002|8-week Double-blind Period|Adverse Event|0|||
164564954|NCT01307033|594438365|FG003|8-week Double-blind Period|Adverse Event|0|||
164564955|NCT01307033|594438362|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
164564956|NCT01307033|594438363|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
164564957|NCT01307033|594438364|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
164564958|NCT01307033|594438365|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
164564959|NCT01307033|594438362|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
164213575|NCT04868682|593147809|FG001|12-month Assessment|Lost to Follow-up|1|||
164213576|NCT04868682|593147808|FG000|12-month Assessment|Death|0|||
164213577|NCT04868682|593147809|FG001|12-month Assessment|Death|1|||
164213578|NCT03880565|593147813|FG000|Overall Study|Withdrawal by Subject|1|||
164213579|NCT03880565|593147814|FG001|Overall Study|Withdrawal by Subject|0|||
164213580|NCT02202616|593147815|FG000|Overall Study|Screen failed|24|||
164213581|NCT02202616|593147815|FG000|Overall Study|Adverse Event|32|||
164213582|NCT02202616|593147815|FG000|Overall Study|Protocol deviation|18|||
164213583|NCT02202616|593147815|FG000|Overall Study|Patient withdrew consent|12|||
164213584|NCT02202616|593147815|FG000|Overall Study|Lost to Follow-up|6|||
164213585|NCT02202616|593147815|FG000|Overall Study|Administrative problems|6|||
164213586|NCT02202616|593147815|FG000|Overall Study|Abnormal test procedure result|1|||
164213587|NCT02202616|593147815|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164213588|NCT04327271|593147819|FG000|Overall Study|Death|1|||
164213589|NCT04327271|593147820|FG001|Overall Study|Death|0|||
164213590|NCT04327271|593147819|FG000|Overall Study|Withdrawal by Subject|1|||
164213591|NCT04327271|593147820|FG001|Overall Study|Withdrawal by Subject|0|||
164213592|NCT04327271|593147819|FG000|Overall Study|randomization error (data capture)|4|||
164213593|NCT04327271|593147820|FG001|Overall Study|randomization error (data capture)|3|||
164213594|NCT01044498|593147821|FG000|Overall Study|Withdrew consent|1|||
164213595|NCT01044498|593147822|FG001|Overall Study|Withdrew consent|1|||
164213596|NCT01044498|593147821|FG000|Overall Study|Adverse Event|1|||
164213597|NCT01044498|593147822|FG001|Overall Study|Adverse Event|1|||
164213598|NCT01044498|593147821|FG000|Overall Study|Other|1|||
164213599|NCT01044498|593147822|FG001|Overall Study|Other|0|||
164213600|NCT02903914|593147825|FG000|Overall Study|Adverse Event|0|||
164213601|NCT02903914|593147826|FG001|Overall Study|Adverse Event|0|||
164213602|NCT02903914|593147827|FG002|Overall Study|Adverse Event|1|||
164213603|NCT02903914|593147828|FG003|Overall Study|Adverse Event|0|||
164213604|NCT02903914|593147829|FG004|Overall Study|Adverse Event|0|||
164213605|NCT02903914|593147830|FG005|Overall Study|Adverse Event|0|||
164213606|NCT02903914|593147831|FG006|Overall Study|Adverse Event|2|||
164213607|NCT02903914|593147832|FG007|Overall Study|Adverse Event|0|||
164213608|NCT02903914|593147825|FG000|Overall Study|Withdrawal by Subject|3|||
164213609|NCT02903914|593147826|FG001|Overall Study|Withdrawal by Subject|1|||
164213610|NCT02903914|593147827|FG002|Overall Study|Withdrawal by Subject|28|||
164213611|NCT02903914|593147828|FG003|Overall Study|Withdrawal by Subject|0|||
164213612|NCT02903914|593147829|FG004|Overall Study|Withdrawal by Subject|1|||
164213613|NCT02903914|593147830|FG005|Overall Study|Withdrawal by Subject|2|||
164213614|NCT02903914|593147831|FG006|Overall Study|Withdrawal by Subject|12|||
164213615|NCT02903914|593147832|FG007|Overall Study|Withdrawal by Subject|0|||
164213616|NCT02903914|593147825|FG000|Overall Study|Progressive Disease|1|||
164213617|NCT02903914|593147826|FG001|Overall Study|Progressive Disease|0|||
164213618|NCT02903914|593147827|FG002|Overall Study|Progressive Disease|4|||
164213619|NCT02903914|593147828|FG003|Overall Study|Progressive Disease|0|||
164213620|NCT02903914|593147829|FG004|Overall Study|Progressive Disease|0|||
164213621|NCT02903914|593147830|FG005|Overall Study|Progressive Disease|0|||
164213622|NCT02903914|593147831|FG006|Overall Study|Progressive Disease|2|||
164213623|NCT02903914|593147832|FG007|Overall Study|Progressive Disease|0|||
164213624|NCT02903914|593147825|FG000|Overall Study|Death|0|||
164213625|NCT02903914|593147826|FG001|Overall Study|Death|0|||
164213626|NCT02903914|593147827|FG002|Overall Study|Death|9|||
164325725|NCT02241889|593567959|FG005|Overall Study|device issues|0|||
164325726|NCT02241889|593567954|FG000|Overall Study|Withdrawal by Subject|0|||
164325727|NCT02241889|593567955|FG001|Overall Study|Withdrawal by Subject|0|||
164325728|NCT02241889|593567956|FG002|Overall Study|Withdrawal by Subject|0|||
164325729|NCT02241889|593567957|FG003|Overall Study|Withdrawal by Subject|0|||
164325730|NCT02241889|593567958|FG004|Overall Study|Withdrawal by Subject|0|||
164325731|NCT02241889|593567959|FG005|Overall Study|Withdrawal by Subject|1|||
164325732|NCT00773838|593567960|FG000|Overall Study|Adverse Event|29|||
164325733|NCT00773838|593567960|FG000|Overall Study|Lost to Follow-up|1|||
164325734|NCT00773838|593567960|FG000|Overall Study|Physician Decision|8|||
164325735|NCT00773838|593567960|FG000|Overall Study|Progressive Disease|82|||
164325736|NCT00773838|593567960|FG000|Overall Study|Protocol Violation|2|||
164325737|NCT00773838|593567960|FG000|Overall Study|Withdrawal by Subject|21|||
164325738|NCT00459056|593567963|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
164325739|NCT00459056|593567964|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
164325740|NCT02522871|593567965|FG000|Overall Study|Protocol Violation|1|||
164325741|NCT02522871|593567966|FG001|Overall Study|Protocol Violation|4|||
164325742|NCT02522871|593567965|FG000|Overall Study|Treated without randomization|1|||
164325743|NCT02522871|593567966|FG001|Overall Study|Treated without randomization|0|||
164325744|NCT02522871|593567965|FG000|Overall Study|Death|9|||
164325745|NCT02522871|593567966|FG001|Overall Study|Death|9|||
164325746|NCT02522871|593567965|FG000|Overall Study|Died in operating room prior to transplant|0|||
164325747|NCT02522871|593567966|FG001|Overall Study|Died in operating room prior to transplant|1|||
164325748|NCT01715129|593567967|FG000|Overall Study|Adverse Event, fatal|1|||
164325749|NCT01715129|593567967|FG000|Overall Study|Lack of Efficacy|3|||
164325750|NCT01715129|593567967|FG000|Overall Study|Protocol Violation|1|||
164325751|NCT01715129|593567967|FG000|Overall Study|Consent Withdrawn|2|||
164325752|NCT01715129|593567967|FG000|Overall Study|Lost to Follow-up|1|||
164325753|NCT01715129|593567967|FG000|Overall Study|Other|1|||
164325754|NCT03149848|593567968|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
164325755|NCT03149848|593567968|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
164325756|NCT00378079|593567971|FG000|Overall Study|Lost to Follow-up|6|||
164325757|NCT00378079|593567972|FG001|Overall Study|Lost to Follow-up|1|||
164325758|NCT00378079|593567973|FG002|Overall Study|Lost to Follow-up|0|||
164325759|NCT02274038|593567974|FG000|Overall Study|Death|1|||
164564960|NCT01307033|594438363|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
164564961|NCT01307033|594438364|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
164564962|NCT01307033|594438365|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
164564963|NCT01307033|594438362|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
164564964|NCT01307033|594438363|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
164325760|NCT05458648|593567978|FG000|Overall Study|Physician Decision|1|||
164325761|NCT05458648|593567978|FG000|Overall Study|Patient presented in atrial flutter|1|||
164325762|NCT03610555|593567982|FG000|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
164325763|NCT03610555|593567983|FG001|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
164213627|NCT02903914|593147828|FG003|Overall Study|Death|0|||
164213628|NCT02903914|593147829|FG004|Overall Study|Death|1|||
164213629|NCT02903914|593147830|FG005|Overall Study|Death|3|||
164213630|NCT02903914|593147831|FG006|Overall Study|Death|24|||
164213631|NCT02903914|593147832|FG007|Overall Study|Death|2|||
164213632|NCT02903914|593147825|FG000|Overall Study|Lost to Follow-up|0|||
164213633|NCT02903914|593147826|FG001|Overall Study|Lost to Follow-up|1|||
164213634|NCT02903914|593147827|FG002|Overall Study|Lost to Follow-up|0|||
164213635|NCT02903914|593147828|FG003|Overall Study|Lost to Follow-up|0|||
164213636|NCT02903914|593147829|FG004|Overall Study|Lost to Follow-up|2|||
164213637|NCT02903914|593147830|FG005|Overall Study|Lost to Follow-up|0|||
164213638|NCT02903914|593147831|FG006|Overall Study|Lost to Follow-up|1|||
164213639|NCT02903914|593147832|FG007|Overall Study|Lost to Follow-up|0|||
164213640|NCT02903914|593147825|FG000|Overall Study|Physician Decision|0|||
164213641|NCT02903914|593147826|FG001|Overall Study|Physician Decision|0|||
164213642|NCT02903914|593147827|FG002|Overall Study|Physician Decision|1|||
164213643|NCT02903914|593147828|FG003|Overall Study|Physician Decision|0|||
164213644|NCT02903914|593147829|FG004|Overall Study|Physician Decision|0|||
164213645|NCT02903914|593147830|FG005|Overall Study|Physician Decision|0|||
164213646|NCT02903914|593147831|FG006|Overall Study|Physician Decision|1|||
164213647|NCT02903914|593147832|FG007|Overall Study|Physician Decision|0|||
164213648|NCT02903914|593147825|FG000|Overall Study|Symptomatic Deterioration|0|||
164213649|NCT02903914|593147826|FG001|Overall Study|Symptomatic Deterioration|0|||
164213650|NCT02903914|593147827|FG002|Overall Study|Symptomatic Deterioration|1|||
164213651|NCT02903914|593147828|FG003|Overall Study|Symptomatic Deterioration|0|||
164213652|NCT02903914|593147829|FG004|Overall Study|Symptomatic Deterioration|0|||
164213653|NCT02903914|593147830|FG005|Overall Study|Symptomatic Deterioration|0|||
164213654|NCT02903914|593147831|FG006|Overall Study|Symptomatic Deterioration|0|||
164213655|NCT02903914|593147832|FG007|Overall Study|Symptomatic Deterioration|0|||
164213656|NCT02903914|593147825|FG000|Overall Study|New Cancer Therapy|2|||
164213657|NCT02903914|593147826|FG001|Overall Study|New Cancer Therapy|2|||
164213658|NCT02903914|593147827|FG002|Overall Study|New Cancer Therapy|21|||
164213659|NCT02903914|593147828|FG003|Overall Study|New Cancer Therapy|4|||
164213660|NCT02903914|593147829|FG004|Overall Study|New Cancer Therapy|3|||
164213661|NCT02903914|593147830|FG005|Overall Study|New Cancer Therapy|6|||
164213662|NCT02903914|593147831|FG006|Overall Study|New Cancer Therapy|56|||
164213663|NCT02903914|593147832|FG007|Overall Study|New Cancer Therapy|3|||
164213664|NCT02903914|593147825|FG000|Overall Study|Didn't Return to Site|1|||
164213665|NCT02903914|593147826|FG001|Overall Study|Didn't Return to Site|0|||
164213666|NCT02903914|593147827|FG002|Overall Study|Didn't Return to Site|1|||
164213667|NCT02903914|593147828|FG003|Overall Study|Didn't Return to Site|1|||
164213668|NCT02903914|593147829|FG004|Overall Study|Didn't Return to Site|0|||
164213669|NCT02903914|593147830|FG005|Overall Study|Didn't Return to Site|0|||
164213670|NCT02903914|593147831|FG006|Overall Study|Didn't Return to Site|2|||
164213671|NCT02903914|593147832|FG007|Overall Study|Didn't Return to Site|0|||
164213672|NCT02903914|593147825|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
164213673|NCT02903914|593147826|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
164213674|NCT02903914|593147827|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
164213675|NCT02903914|593147828|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
164213676|NCT02903914|593147829|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
164213677|NCT02903914|593147830|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
164213678|NCT02903914|593147831|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
164213679|NCT02903914|593147832|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
164213680|NCT02903914|593147825|FG000|Overall Study|Follow-up Did Not Occur|0|||
164213681|NCT02903914|593147826|FG001|Overall Study|Follow-up Did Not Occur|1|||
164213682|NCT02903914|593147827|FG002|Overall Study|Follow-up Did Not Occur|1|||
164213683|NCT02903914|593147828|FG003|Overall Study|Follow-up Did Not Occur|0|||
164213684|NCT02903914|593147829|FG004|Overall Study|Follow-up Did Not Occur|2|||
164213685|NCT02903914|593147830|FG005|Overall Study|Follow-up Did Not Occur|0|||
164213686|NCT02903914|593147831|FG006|Overall Study|Follow-up Did Not Occur|8|||
164213687|NCT02903914|593147832|FG007|Overall Study|Follow-up Did Not Occur|0|||
164213688|NCT02903914|593147825|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
164213689|NCT02903914|593147826|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
164213690|NCT02903914|593147827|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
164213691|NCT02903914|593147828|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
164213692|NCT02903914|593147829|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
164213693|NCT02903914|593147830|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
164213694|NCT02903914|593147831|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
164213695|NCT02903914|593147832|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
164213696|NCT02903914|593147825|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
164213697|NCT02903914|593147826|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
164213698|NCT02903914|593147827|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
164325764|NCT03610555|593567984|FG002|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
164213699|NCT02903914|593147828|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
164213700|NCT02903914|593147829|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
164213701|NCT02903914|593147830|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
164213702|NCT02903914|593147831|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
164213703|NCT02903914|593147832|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
164213704|NCT02903914|593147825|FG000|Overall Study|Clinical Disease Progression|0|||
164213705|NCT02903914|593147826|FG001|Overall Study|Clinical Disease Progression|0|||
164213706|NCT02903914|593147827|FG002|Overall Study|Clinical Disease Progression|2|||
164213707|NCT02903914|593147828|FG003|Overall Study|Clinical Disease Progression|0|||
164213708|NCT02903914|593147829|FG004|Overall Study|Clinical Disease Progression|0|||
164213709|NCT02903914|593147830|FG005|Overall Study|Clinical Disease Progression|0|||
164213710|NCT02903914|593147831|FG006|Overall Study|Clinical Disease Progression|0|||
164213711|NCT02903914|593147832|FG007|Overall Study|Clinical Disease Progression|0|||
164213712|NCT02903914|593147825|FG000|Overall Study|Completed Follow-up Period|0|||
164213713|NCT02903914|593147826|FG001|Overall Study|Completed Follow-up Period|0|||
164213714|NCT02903914|593147827|FG002|Overall Study|Completed Follow-up Period|6|||
164213715|NCT02903914|593147828|FG003|Overall Study|Completed Follow-up Period|2|||
164213716|NCT02903914|593147829|FG004|Overall Study|Completed Follow-up Period|1|||
164213717|NCT02903914|593147830|FG005|Overall Study|Completed Follow-up Period|0|||
164213718|NCT02903914|593147831|FG006|Overall Study|Completed Follow-up Period|9|||
164213719|NCT02903914|593147832|FG007|Overall Study|Completed Follow-up Period|1|||
164213720|NCT02903914|593147825|FG000|Overall Study|Taken off Treatment per Protocol|0|||
164213721|NCT02903914|593147826|FG001|Overall Study|Taken off Treatment per Protocol|0|||
164213722|NCT02903914|593147827|FG002|Overall Study|Taken off Treatment per Protocol|0|||
164213723|NCT02903914|593147828|FG003|Overall Study|Taken off Treatment per Protocol|0|||
164213724|NCT02903914|593147829|FG004|Overall Study|Taken off Treatment per Protocol|0|||
164213725|NCT02903914|593147830|FG005|Overall Study|Taken off Treatment per Protocol|1|||
164213726|NCT02903914|593147831|FG006|Overall Study|Taken off Treatment per Protocol|0|||
164213727|NCT02903914|593147832|FG007|Overall Study|Taken off Treatment per Protocol|0|||
164213728|NCT02903914|593147825|FG000|Overall Study|Refused Further Treatment/Contact|0|||
164213729|NCT02903914|593147826|FG001|Overall Study|Refused Further Treatment/Contact|0|||
164213730|NCT02903914|593147827|FG002|Overall Study|Refused Further Treatment/Contact|0|||
164213731|NCT02903914|593147828|FG003|Overall Study|Refused Further Treatment/Contact|0|||
164213732|NCT02903914|593147829|FG004|Overall Study|Refused Further Treatment/Contact|0|||
164213733|NCT02903914|593147830|FG005|Overall Study|Refused Further Treatment/Contact|0|||
164213734|NCT02903914|593147831|FG006|Overall Study|Refused Further Treatment/Contact|1|||
164325765|NCT03610555|593567985|FG003|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
164325766|NCT01892722|593567986|FG000|Overall Study|Protocol deviation|0|||
164325767|NCT01892722|593567987|FG001|Overall Study|Protocol deviation|1|||
164325768|NCT01892722|593567986|FG000|Overall Study|Administrative problems|0|||
164213735|NCT02903914|593147832|FG007|Overall Study|Refused Further Treatment/Contact|0|||
164325769|NCT01892722|593567987|FG001|Overall Study|Administrative problems|1|||
164325770|NCT01892722|593567986|FG000|Overall Study|Patient/guardian decision|0|||
164325771|NCT01892722|593567987|FG001|Overall Study|Patient/guardian decision|2|||
164325772|NCT01892722|593567986|FG000|Overall Study|Physician Decision|1|||
164325773|NCT01892722|593567987|FG001|Overall Study|Physician Decision|2|||
164325774|NCT01892722|593567986|FG000|Overall Study|Adverse Event|3|||
164325775|NCT01892722|593567987|FG001|Overall Study|Adverse Event|2|||
164325776|NCT01892722|593567986|FG000|Overall Study|Lack of Efficacy|0|||
164325777|NCT01892722|593567987|FG001|Overall Study|Lack of Efficacy|7|||
164325778|NCT01892722|593567986|FG000|Overall Study|Withdrawal by Subject|3|||
164325779|NCT01892722|593567987|FG001|Overall Study|Withdrawal by Subject|5|||
164325780|NCT05217927|593567988|FG000|DBT Phase|Adverse Event|7|||
164325781|NCT05217927|593567989|FG001|DBT Phase|Adverse Event|2|||
164325782|NCT05217927|593567990|FG002|DBT Phase|Adverse Event|5|||
164325783|NCT05217927|593567988|FG000|DBT Phase|Lack of Efficacy|1|||
164325784|NCT05217927|593567989|FG001|DBT Phase|Lack of Efficacy|0|||
164325785|NCT05217927|593567990|FG002|DBT Phase|Lack of Efficacy|0|||
164325786|NCT05217927|593567988|FG000|DBT Phase|Lost to Follow-up|0|||
164325787|NCT05217927|593567989|FG001|DBT Phase|Lost to Follow-up|2|||
164325788|NCT05217927|593567990|FG002|DBT Phase|Lost to Follow-up|0|||
164325789|NCT05217927|593567988|FG000|DBT Phase|Non-compliance|1|||
164325790|NCT05217927|593567989|FG001|DBT Phase|Non-compliance|0|||
164325791|NCT05217927|593567990|FG002|DBT Phase|Non-compliance|0|||
164325792|NCT05217927|593567988|FG000|DBT Phase|Pregnancy|0|||
164325793|NCT05217927|593567989|FG001|DBT Phase|Pregnancy|0|||
164564965|NCT01307033|594438364|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
164564966|NCT01307033|594438365|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
164325794|NCT05217927|593567990|FG002|DBT Phase|Pregnancy|1|||
164564967|NCT01307033|594438362|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
164564968|NCT01307033|594438363|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
164213736|NCT02903914|593147825|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
164325795|NCT05217927|593567988|FG000|DBT Phase|Protocol Violation|0|||
164325796|NCT05217927|593567989|FG001|DBT Phase|Protocol Violation|2|||
164325797|NCT05217927|593567990|FG002|DBT Phase|Protocol Violation|1|||
164325798|NCT05217927|593567988|FG000|DBT Phase|Protocol-specified withdrawal criterion met|4|||
164213737|NCT02903914|593147826|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
164213738|NCT02903914|593147827|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
164213739|NCT02903914|593147828|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
164325799|NCT05217927|593567989|FG001|DBT Phase|Protocol-specified withdrawal criterion met|6|||
164325800|NCT05217927|593567990|FG002|DBT Phase|Protocol-specified withdrawal criterion met|5|||
164325801|NCT05217927|593567988|FG000|DBT Phase|Withdrawal of consent|8|||
164325802|NCT05217927|593567989|FG001|DBT Phase|Withdrawal of consent|5|||
164325803|NCT05217927|593567990|FG002|DBT Phase|Withdrawal of consent|7|||
164325804|NCT05217927|593567988|FG000|DBT Phase|Other|7|||
164325805|NCT05217927|593567989|FG001|DBT Phase|Other|3|||
164325806|NCT05217927|593567990|FG002|DBT Phase|Other|4|||
164325807|NCT05217927|593567988|FG000|DBT Phase|Randomized, not treated|2|||
164325808|NCT05217927|593567989|FG001|DBT Phase|Randomized, not treated|3|||
164325809|NCT05217927|593567990|FG002|DBT Phase|Randomized, not treated|2|||
164325810|NCT05217927|593567988|FG000|OLE Phase|Adverse Event|4|||
164325811|NCT05217927|593567989|FG001|OLE Phase|Adverse Event|1|||
164325812|NCT05217927|593567990|FG002|OLE Phase|Adverse Event|1|||
164325813|NCT05217927|593567988|FG000|OLE Phase|Extension phase eligibility failure|1|||
164325814|NCT05217927|593567989|FG001|OLE Phase|Extension phase eligibility failure|0|||
164325815|NCT05217927|593567990|FG002|OLE Phase|Extension phase eligibility failure|0|||
164325816|NCT05217927|593567988|FG000|OLE Phase|Lost to Follow-up|1|||
164325817|NCT05217927|593567989|FG001|OLE Phase|Lost to Follow-up|2|||
164325818|NCT05217927|593567990|FG002|OLE Phase|Lost to Follow-up|1|||
164325819|NCT05217927|593567988|FG000|OLE Phase|Non-compliance|0|||
164325820|NCT05217927|593567989|FG001|OLE Phase|Non-compliance|0|||
164325821|NCT05217927|593567990|FG002|OLE Phase|Non-compliance|1|||
164325822|NCT05217927|593567988|FG000|OLE Phase|Other|3|||
164325823|NCT05217927|593567989|FG001|OLE Phase|Other|5|||
164325824|NCT05217927|593567990|FG002|OLE Phase|Other|4|||
164325825|NCT05217927|593567988|FG000|OLE Phase|Withdrawal of consent|3|||
164325826|NCT05217927|593567989|FG001|OLE Phase|Withdrawal of consent|1|||
164325827|NCT05217927|593567990|FG002|OLE Phase|Withdrawal of consent|5|||
164325828|NCT00588952|593568957|FG000|Overall Study|Adverse Event|0|||
164325829|NCT00588952|593568958|FG001|Overall Study|Adverse Event|2|||
164325830|NCT00588952|593568957|FG000|Overall Study|Withdrawal by Subject|3|||
164325831|NCT00588952|593568958|FG001|Overall Study|Withdrawal by Subject|5|||
164325832|NCT03560739|593568960|FG000|Overall Study|Adverse Event|0|||
164325833|NCT03560739|593568961|FG001|Overall Study|Adverse Event|1|||
164325834|NCT03560739|593568962|FG002|Overall Study|Adverse Event|0|||
164325835|NCT03560739|593568963|FG003|Overall Study|Adverse Event|0|||
164325836|NCT01362595|593568964|FG000|Overall Study|Screen failure|10|||
164325837|NCT01362595|593568964|FG000|Overall Study|Withdrawal by Subject|2|||
164325838|NCT00959374|593568965|FG000|Overall Study|Withdrawal by Subject|2|||
164325839|NCT00959374|593568965|FG000|Overall Study|Lost to Follow-up|14|||
164325840|NCT00959374|593568965|FG000|Overall Study|Death|1|||
164325841|NCT00959374|593568965|FG000|Overall Study|Protocol Violation|1|||
164325842|NCT00959374|593568965|FG000|Overall Study|Implant Removed/Not Replaced|4|||
164325843|NCT00959374|593568965|FG000|Overall Study|Physician Decision|1|||
164325844|NCT02448680|593568966|FG000|Overall Study|Physician Decision|1|||
164325845|NCT02448680|593568967|FG001|Overall Study|Physician Decision|1|||
164325846|NCT02448680|593568966|FG000|Overall Study|Withdrawal by Subject|0|||
164325847|NCT02448680|593568967|FG001|Overall Study|Withdrawal by Subject|2|||
164325848|NCT01739400|593568968|FG000|Overall Study|Physician Decision|3|||
164325849|NCT01739400|593568969|FG001|Overall Study|Physician Decision|0|||
164325850|NCT01739400|593568968|FG000|Overall Study|Lost to Follow-up|2|||
164325851|NCT01739400|593568969|FG001|Overall Study|Lost to Follow-up|0|||
164325852|NCT01739400|593568968|FG000|Overall Study|Death|5|||
164325853|NCT01739400|593568969|FG001|Overall Study|Death|2|||
164325854|NCT01739400|593568968|FG000|Overall Study|Withdrawal by Subject|7|||
164325855|NCT01739400|593568969|FG001|Overall Study|Withdrawal by Subject|7|||
164325856|NCT01736657|593568970|FG000|Overall Study|insufficient vascular access|1|||
164325857|NCT03350984|593568971|FG000|Overall Study|Death|1|||
164325858|NCT03350984|593568972|FG001|Overall Study|Death|0|||
164325859|NCT03350984|593568971|FG000|Overall Study|Lost to Follow-up|5|||
164325860|NCT03350984|593568972|FG001|Overall Study|Lost to Follow-up|6|||
164325861|NCT03350984|593568971|FG000|Overall Study|Protocol Violation|1|||
164325862|NCT03350984|593568972|FG001|Overall Study|Protocol Violation|2|||
164325863|NCT03350984|593568971|FG000|Overall Study|Physician Decision|1|||
164325864|NCT03350984|593568972|FG001|Overall Study|Physician Decision|0|||
164325865|NCT00642473|593568981|FG000|Overall Study|Withdrawal by Subject|0|||
164325866|NCT00642473|593568982|FG001|Overall Study|Withdrawal by Subject|5|||
164325867|NCT00642473|593568981|FG000|Overall Study|Progression or death|2|||
164325868|NCT00642473|593568982|FG001|Overall Study|Progression or death|4|||
164325869|NCT00642473|593568981|FG000|Overall Study|Other|2|||
164669374|NCT01367457|594814968|FG001|Overall Study|Patient's Wish|0|||
164325870|NCT00642473|593568982|FG001|Overall Study|Other|2|||
164325871|NCT04533880|593568983|FG000|Overall Study|Lost to Follow-up|0|||
164325872|NCT04533880|593568984|FG001|Overall Study|Lost to Follow-up|1|||
164325873|NCT04533880|593568985|FG002|Overall Study|Lost to Follow-up|1|||
164325874|NCT02284178|593568987|FG000|Overall Study|Met exclusion criteria|49|||
164325875|NCT02284178|593568988|FG001|Overall Study|Met exclusion criteria|54|||
164325876|NCT01741012|593568989|FG000|Overall Study|Lost to Follow-up|1|||
164325877|NCT01741012|593568989|FG000|Overall Study|Withdrawal by Subject|2|||
164325878|NCT04123665|593568990|FG000|Overall Study|Withdrawal by Subject|7|||
164325879|NCT04123665|593568991|FG001|Overall Study|Withdrawal by Subject|0|||
164325880|NCT04123665|593568990|FG000|Overall Study|Lost to Follow-up|1|||
164325881|NCT04123665|593568991|FG001|Overall Study|Lost to Follow-up|0|||
164325882|NCT01711879|593568994|FG000|Overall Study|Death|1|||
164325883|NCT01711879|593568995|FG001|Overall Study|Death|0|||
164325884|NCT00958789|593568999|FG000|Overall Study|Death|5|||
164325885|NCT00958789|593568999|FG000|Overall Study|Lost to Follow-up|14|||
164325886|NCT00958789|593568999|FG000|Overall Study|Withdrawal by Subject|17|||
164420678|NCT01154036|593910969|FG007|Phase II|Physician Decision|0|||
164564969|NCT01307033|594438364|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
164564970|NCT01307033|594438365|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
164564971|NCT01307033|594438362|FG000|44-week Open-label Extension|Adverse Event|0|||
164564972|NCT01307033|594438363|FG001|44-week Open-label Extension|Adverse Event|0|||
164564973|NCT01307033|594438364|FG002|44-week Open-label Extension|Adverse Event|2|||
164564974|NCT01307033|594438365|FG003|44-week Open-label Extension|Adverse Event|1|||
164564975|NCT01307033|594438362|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
164564976|NCT01307033|594438363|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
164564977|NCT01307033|594438364|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
164564978|NCT01307033|594438365|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
164564979|NCT01307033|594438362|FG000|44-week Open-label Extension|Physician Decision|0|||
164564980|NCT01307033|594438363|FG001|44-week Open-label Extension|Physician Decision|0|||
164564981|NCT01307033|594438364|FG002|44-week Open-label Extension|Physician Decision|1|||
164564982|NCT01307033|594438365|FG003|44-week Open-label Extension|Physician Decision|0|||
164564983|NCT01307033|594438362|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
164564984|NCT01307033|594438363|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
164564985|NCT01307033|594438364|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
164564986|NCT01307033|594438365|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
164564987|NCT01307033|594438362|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
164564988|NCT01307033|594438363|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
164564989|NCT01307033|594438364|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
164564990|NCT01307033|594438365|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
164564991|NCT01307033|594438362|FG000|44-week Open-label Extension|Death|0|||
164564992|NCT01307033|594438363|FG001|44-week Open-label Extension|Death|0|||
164564993|NCT01307033|594438364|FG002|44-week Open-label Extension|Death|0|||
164564994|NCT01307033|594438365|FG003|44-week Open-label Extension|Death|1|||
164564995|NCT01793792|594438370|FG000|Overall Study|Death|5|||
164564996|NCT01793792|594438370|FG000|Overall Study|Lost to Follow-up|5|||
164669375|NCT01367457|594814969|FG002|Overall Study|Patient's Wish|0|||
164213740|NCT02903914|593147829|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
164213741|NCT02903914|593147830|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
164213742|NCT02903914|593147831|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
164213743|NCT02903914|593147832|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
164213744|NCT02406612|593147844|FG000|Overall Study|Screening Failure|3|||
164213745|NCT02406612|593147845|FG001|Overall Study|Screening Failure|0|||
164213746|NCT02406612|593147844|FG000|Overall Study|Intra-procedural Exclusion|1|||
164213747|NCT02406612|593147845|FG001|Overall Study|Intra-procedural Exclusion|3|||
164213748|NCT02406612|593147844|FG000|Overall Study|Guidewire Failure|0|||
164213749|NCT02406612|593147845|FG001|Overall Study|Guidewire Failure|1|||
164213750|NCT02830087|593147846|FG000|Overall Study|No study staff to follow-up patients|4|||
164213751|NCT02830087|593147847|FG001|Overall Study|No study staff to follow-up patients|4|||
164213752|NCT02830087|593147848|FG002|Overall Study|No study staff to follow-up patients|4|||
164213753|NCT02830087|593147849|FG003|Overall Study|No study staff to follow-up patients|3|||
164213754|NCT02830087|593147850|FG004|Overall Study|No study staff to follow-up patients|3|||
164213755|NCT02830087|593147851|FG005|Overall Study|No study staff to follow-up patients|3|||
164213756|NCT03483012|593147855|FG000|Overall Study|Lack of Efficacy|6|||
164213757|NCT02900976|593147856|FG000|Overall Study|Adverse Event|0|||
164213758|NCT02900976|593147857|FG001|Overall Study|Adverse Event|1|||
164213759|NCT02900976|593147856|FG000|Overall Study|Physician Decision|0|||
164213760|NCT02900976|593147857|FG001|Overall Study|Physician Decision|2|||
164213761|NCT02900976|593147856|FG000|Overall Study|Progressive disease|0|||
164213762|NCT02900976|593147857|FG001|Overall Study|Progressive disease|6|||
164213763|NCT03611946|593147860|FG000|Overall Study|Withdrawal by Subject|0|||
164213764|NCT03611946|593147861|FG001|Overall Study|Withdrawal by Subject|0|||
164213765|NCT03611946|593147862|FG002|Overall Study|Withdrawal by Subject|1|||
164213766|NCT03611946|593147863|FG003|Overall Study|Withdrawal by Subject|0|||
164213767|NCT05177094|593149265|FG000|Overall Study|Adverse Event|5|||
164213768|NCT05177094|593149266|FG001|Overall Study|Adverse Event|5|||
164213769|NCT05177094|593149265|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
164213770|NCT05177094|593149266|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
164213771|NCT05177094|593149265|FG000|Overall Study|Protocol Deviation|3|||
164213772|NCT05177094|593149266|FG001|Overall Study|Protocol Deviation|0|||
164213773|NCT05177094|593149265|FG000|Overall Study|Withdrawal by Subject|6|||
164213774|NCT05177094|593149266|FG001|Overall Study|Withdrawal by Subject|3|||
164213775|NCT05177094|593149265|FG000|Overall Study|Participant could not tolerate long study visits|1|||
164213776|NCT05177094|593149266|FG001|Overall Study|Participant could not tolerate long study visits|0|||
164213777|NCT02737618|593149267|FG000|Overall Study|Withdrawal by Subject|9|||
164213778|NCT03487445|593149273|FG000|Randomization|Not treated for administrative reasons|1|||
164213779|NCT03487445|593149274|FG001|Randomization|Not treated for administrative reasons|0|||
164213780|NCT01695746|593149279|FG000|Overall Study|Adverse Event|1|||
164213781|NCT01695746|593149279|FG000|Overall Study|Non-compliance by the participant|3|||
164213782|NCT01695746|593149279|FG000|Overall Study|Protocol Violation|5|||
164213783|NCT01695746|593149279|FG000|Overall Study|Participant not willing to participate|3|||
164213784|NCT04132050|593149287|FG000|Period I (Double-blind Period)|Adverse Event|3|||
164213785|NCT04132050|593149288|FG001|Period I (Double-blind Period)|Adverse Event|0|||
164213786|NCT04132050|593149287|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
164213787|NCT04132050|593149288|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
164213788|NCT04132050|593149287|FG000|R788 Treatment Period|Adverse Event|5|||
164213789|NCT04132050|593149288|FG001|R788 Treatment Period|Adverse Event|0|||
164213790|NCT04132050|593149287|FG000|R788 Treatment Period|Lack of Efficacy|5|||
164213791|NCT04132050|593149288|FG001|R788 Treatment Period|Lack of Efficacy|0|||
164213792|NCT04132050|593149287|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
164213793|NCT04132050|593149288|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
164213794|NCT03506477|593149289|FG000|Overall Study|Withdrawal by Subject|1|||
164213795|NCT03506477|593149290|FG001|Overall Study|Withdrawal by Subject|0|||
164213796|NCT03462680|593149291|FG000|Overall Study|Withdrawal by Subject|3|||
164213797|NCT03462680|593149292|FG001|Overall Study|Withdrawal by Subject|5|||
164213798|NCT02516241|593149293|FG000|Overall Study|Death|255|||
164213799|NCT02516241|593149294|FG001|Overall Study|Death|262|||
164213800|NCT02516241|593149295|FG002|Overall Study|Death|270|||
164564997|NCT01793792|594438370|FG000|Overall Study|Withdrawal by Subject|1|||
164564998|NCT01793792|594438370|FG000|Overall Study|Device Not Implanted|1|||
164564999|NCT01773421|594438371|FG000|Treatment Phase|Other|0|||
164213801|NCT02516241|593149293|FG000|Overall Study|Lost to Follow-up|1|||
164213802|NCT02516241|593149294|FG001|Overall Study|Lost to Follow-up|1|||
164213803|NCT02516241|593149295|FG002|Overall Study|Lost to Follow-up|3|||
164213804|NCT02516241|593149293|FG000|Overall Study|Withdrawal by Subject|2|||
164213805|NCT02516241|593149294|FG001|Overall Study|Withdrawal by Subject|7|||
164213806|NCT02516241|593149295|FG002|Overall Study|Withdrawal by Subject|12|||
164213807|NCT02516241|593149293|FG000|Overall Study|participants ongoing at data cut-off|84|||
164213808|NCT02516241|593149294|FG001|Overall Study|participants ongoing at data cut-off|76|||
164213809|NCT02516241|593149295|FG002|Overall Study|participants ongoing at data cut-off|59|||
164213810|NCT00462462|593149297|FG000|Overall Study|Physician Decision|0|||
164213811|NCT00462462|593149298|FG001|Overall Study|Physician Decision|1|||
164213812|NCT01163617|593149299|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
164213813|NCT01163617|593149300|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
164213814|NCT01163617|593149301|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
164213815|NCT01163617|593149302|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
164213816|NCT01163617|593149303|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
164213817|NCT01163617|593149304|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
164213818|NCT01163617|593149305|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
164213819|NCT01163617|593149306|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
164213820|NCT01163617|593149299|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
164213821|NCT01163617|593149300|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
164213822|NCT01163617|593149301|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
164213823|NCT01163617|593149302|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
164213824|NCT01163617|593149303|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
164213825|NCT01163617|593149304|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
164213826|NCT01163617|593149305|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
164213827|NCT01163617|593149306|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
164213828|NCT01163617|593149299|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
164213829|NCT01163617|593149300|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
164213830|NCT01163617|593149301|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
164213831|NCT01163617|593149302|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
164213832|NCT01163617|593149303|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
164213833|NCT01163617|593149304|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
164213834|NCT01163617|593149305|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
164213835|NCT01163617|593149306|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
164213836|NCT02394756|593149307|FG000|Period 1|Lens Discomfort|0|||
164213837|NCT02394756|593149308|FG001|Period 1|Lens Discomfort|0|||
164213838|NCT02394756|593149309|FG002|Period 1|Lens Discomfort|0|||
164213839|NCT02394756|593149310|FG003|Period 1|Lens Discomfort|0|||
164213840|NCT02394756|593149311|FG004|Period 1|Lens Discomfort|0|||
164213841|NCT02394756|593149312|FG005|Period 1|Lens Discomfort|1|||
164213842|NCT02394756|593149307|FG000|Period 1|Withdrawal by Subject|0|||
164213843|NCT02394756|593149308|FG001|Period 1|Withdrawal by Subject|1|||
164213844|NCT02394756|593149309|FG002|Period 1|Withdrawal by Subject|1|||
164213845|NCT02394756|593149310|FG003|Period 1|Withdrawal by Subject|1|||
164213846|NCT02394756|593149311|FG004|Period 1|Withdrawal by Subject|0|||
164213847|NCT02394756|593149312|FG005|Period 1|Withdrawal by Subject|0|||
164213848|NCT02394756|593149307|FG000|Period 2|Unsatisfactory Visual Response|0|||
164213849|NCT02394756|593149308|FG001|Period 2|Unsatisfactory Visual Response|0|||
164213850|NCT02394756|593149309|FG002|Period 2|Unsatisfactory Visual Response|0|||
164213851|NCT02394756|593149310|FG003|Period 2|Unsatisfactory Visual Response|0|||
164213852|NCT02394756|593149311|FG004|Period 2|Unsatisfactory Visual Response|1|||
164213853|NCT02394756|593149312|FG005|Period 2|Unsatisfactory Visual Response|0|||
164213854|NCT03018938|593149313|FG000|Overall Study|Death|0|||
164213855|NCT03018938|593149314|FG001|Overall Study|Death|1|||
164213856|NCT03018938|593149313|FG000|Overall Study|Lost to Follow-up|21|||
164213857|NCT03018938|593149314|FG001|Overall Study|Lost to Follow-up|32|||
164213858|NCT03018938|593149313|FG000|Overall Study|Withdrawal by Subject|38|||
164213859|NCT03018938|593149314|FG001|Overall Study|Withdrawal by Subject|45|||
164213860|NCT03018938|593149313|FG000|Overall Study|Physician Decision|3|||
164213861|NCT03018938|593149314|FG001|Overall Study|Physician Decision|2|||
164213862|NCT03018938|593149313|FG000|Overall Study|Sponsor Decision|0|||
164213863|NCT03018938|593149314|FG001|Overall Study|Sponsor Decision|1|||
164213864|NCT03018938|593149313|FG000|Overall Study|Screen failure-After randomization|4|||
164213865|NCT03018938|593149314|FG001|Overall Study|Screen failure-After randomization|2|||
164213866|NCT03018938|593149313|FG000|Overall Study|Not recorded|0|||
164213867|NCT03018938|593149314|FG001|Overall Study|Not recorded|2|||
164213868|NCT00191100|593149315|FG000|Overall Study|Adverse Event|18|||
164213869|NCT00191100|593149316|FG001|Overall Study|Adverse Event|1|||
164213870|NCT00191100|593149315|FG000|Overall Study|Lost to Follow-up|2|||
164325887|NCT00958789|593568999|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
164420679|NCT01154036|593910962|FG000|Phase II|Lost to Follow-up|0|||
164213871|NCT00191100|593149316|FG001|Overall Study|Lost to Follow-up|0|||
164213872|NCT00191100|593149315|FG000|Overall Study|Patient Moved|0|||
164213873|NCT00191100|593149316|FG001|Overall Study|Patient Moved|1|||
164213874|NCT00191100|593149315|FG000|Overall Study|Withdrawal by Subject|9|||
164213875|NCT00191100|593149316|FG001|Overall Study|Withdrawal by Subject|3|||
164213876|NCT00191100|593149315|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
164213877|NCT00191100|593149316|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
164213878|NCT00191100|593149315|FG000|Overall Study|Clinical Relapse|2|||
164213879|NCT00191100|593149316|FG001|Overall Study|Clinical Relapse|1|||
164213880|NCT00191100|593149315|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
164213881|NCT00191100|593149316|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
164213882|NCT00191100|593149315|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
164213883|NCT00191100|593149316|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
164213884|NCT00191100|593149315|FG000|Overall Study|Physician Decision|3|||
164213885|NCT00191100|593149316|FG001|Overall Study|Physician Decision|1|||
164213886|NCT00191100|593149315|FG000|Overall Study|Death from Study Drug Toxicity|2|||
164213887|NCT00191100|593149316|FG001|Overall Study|Death from Study Drug Toxicity|0|||
164213888|NCT00191100|593149315|FG000|Overall Study|Protocol Violation|1|||
164213889|NCT00191100|593149316|FG001|Overall Study|Protocol Violation|1|||
164213890|NCT00191100|593149315|FG000|Overall Study|Death from Other Cause|1|||
164213891|NCT00191100|593149316|FG001|Overall Study|Death from Other Cause|0|||
164213892|NCT00191100|593149315|FG000|Overall Study|Reason Not Specified|0|||
164213893|NCT00191100|593149316|FG001|Overall Study|Reason Not Specified|1|||
164213894|NCT03069989|593149334|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
164213895|NCT03069989|593149335|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
164213896|NCT01127061|593150760|FG000|Overall Study|Lost to Follow-up|7|||
164213897|NCT01127061|593150761|FG001|Overall Study|Lost to Follow-up|10|||
164213898|NCT01127061|593150760|FG000|Overall Study|Physician Decision|3|||
164213899|NCT01127061|593150761|FG001|Overall Study|Physician Decision|3|||
164213900|NCT03921541|593150764|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
164213901|NCT03921541|593150765|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
164213902|NCT00003456|593150766|FG000|Overall Study|Not evaluable|8|||
164213903|NCT00420407|593150768|FG000|Overall Study|Lost to Follow-up|0|||
164213904|NCT00420407|593150769|FG001|Overall Study|Lost to Follow-up|3|||
164213905|NCT00420407|593150768|FG000|Overall Study|Physician Decision|2|||
164213906|NCT00420407|593150769|FG001|Overall Study|Physician Decision|1|||
164213907|NCT00420407|593150768|FG000|Overall Study|subject identified as detainee|1|||
164213908|NCT00420407|593150769|FG001|Overall Study|subject identified as detainee|0|||
164213909|NCT00420407|593150768|FG000|Overall Study|subject identified as Jehovah's witness|1|||
164213910|NCT00420407|593150769|FG001|Overall Study|subject identified as Jehovah's witness|0|||
164213911|NCT00420407|593150768|FG000|Overall Study|Withdrawal by Subject|0|||
164213912|NCT00420407|593150769|FG001|Overall Study|Withdrawal by Subject|2|||
164213913|NCT04633447|593150772|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
164213914|NCT04633447|593150773|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
164213915|NCT04633447|593150772|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
164213916|NCT04633447|593150773|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
164213917|NCT04633447|593150772|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
164213918|NCT04633447|593150773|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
164213919|NCT04633447|593150772|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
164213920|NCT04633447|593150773|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
164213921|NCT04633447|593150772|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
164213922|NCT04633447|593150773|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
164213923|NCT04633447|593150772|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
164213924|NCT04633447|593150773|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
164213925|NCT04333498|593150774|FG000|Overall Study|Lost to Follow-up|1|||
164213926|NCT04333498|593150775|FG001|Overall Study|Lost to Follow-up|0|||
164213927|NCT04333498|593150774|FG000|Overall Study|Lost to Follow-up|0|||
164213928|NCT04333498|593150775|FG001|Overall Study|Lost to Follow-up|1|||
164213929|NCT01565694|593150776|FG000|Dose-Titration Period|Adverse Event|4|||
164213930|NCT01565694|593150776|FG000|Dose-Titration Period|Protocol Violation|10|||
164213931|NCT01565694|593150776|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
164213932|NCT05399771|593150778|FG000|Overall Study|Physician Decision|3|||
164213933|NCT05399771|593150778|FG000|Overall Study|Adverse Event|1|||
164213934|NCT04766333|593150783|FG000|Overall Study|Lost to Follow-up|40|||
164213935|NCT04766333|593150784|FG001|Overall Study|Lost to Follow-up|826|||
164213936|NCT03234881|593150785|FG000|Overall Study|Lost to Follow-up|9|||
164213937|NCT03234881|593150786|FG001|Overall Study|Lost to Follow-up|3|||
164213938|NCT00541229|593150787|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
164213939|NCT00541229|593150788|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
164325888|NCT00958789|593568999|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
164325889|NCT00958789|593568999|FG000|Overall Study|Subject terminated|2|||
164213940|NCT00541229|593150789|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
164325890|NCT00958789|593568999|FG000|Overall Study|Revision|7|||
164325891|NCT03183778|593569004|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
164213941|NCT00541229|593150790|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
164213942|NCT00541229|593150791|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
164213943|NCT00541229|593150792|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
164213944|NCT00541229|593150787|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
164213945|NCT00541229|593150788|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
164213946|NCT00541229|593150789|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
164213947|NCT00541229|593150790|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
164213948|NCT00541229|593150791|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
164213949|NCT00541229|593150792|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
164213950|NCT00541229|593150787|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
164213951|NCT00541229|593150788|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
164213952|NCT00541229|593150789|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
164213953|NCT00541229|593150790|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
164213954|NCT00541229|593150791|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
164213955|NCT00541229|593150792|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
164213956|NCT00541229|593150787|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
164213957|NCT00541229|593150788|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
164213958|NCT00541229|593150789|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
164213959|NCT00541229|593150790|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
164213960|NCT00541229|593150791|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
164213961|NCT00541229|593150792|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
164213962|NCT00541229|593150787|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
164213963|NCT00541229|593150788|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
164213964|NCT00541229|593150789|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
164213965|NCT00541229|593150790|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
164213966|NCT00541229|593150791|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
164213967|NCT00541229|593150792|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
164213968|NCT00541229|593150787|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
164213969|NCT00541229|593150788|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
164213970|NCT00541229|593150789|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
164213971|NCT00541229|593150790|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
164213972|NCT00541229|593150791|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
164213973|NCT00541229|593150792|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
164213974|NCT00541229|593150787|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
164213975|NCT00541229|593150788|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
164213976|NCT00541229|593150789|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
164213977|NCT00541229|593150790|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
164213978|NCT00541229|593150791|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
164213979|NCT00541229|593150792|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
164213980|NCT00541229|593150787|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
164213981|NCT00541229|593150788|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
164213982|NCT00541229|593150789|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
164213983|NCT00541229|593150790|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
164213984|NCT00541229|593150791|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
164213985|NCT00541229|593150792|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
164213986|NCT00541229|593150787|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
164213987|NCT00541229|593150788|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
164213988|NCT00541229|593150789|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
164213989|NCT00541229|593150790|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
164213990|NCT00541229|593150791|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
164213991|NCT00541229|593150792|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
164213992|NCT00541229|593150787|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
164213993|NCT00541229|593150788|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
164213994|NCT00541229|593150789|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
164213995|NCT00541229|593150790|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
164213996|NCT00541229|593150791|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
164213997|NCT00541229|593150792|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
164213998|NCT00541229|593150787|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
164213999|NCT00541229|593150788|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
164214000|NCT00541229|593150789|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
164214001|NCT00541229|593150790|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
164214002|NCT00541229|593150791|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
164214003|NCT00541229|593150792|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
164325892|NCT01466179|593569005|FG000|Overall Study|Ongoing in core study|2|||
164325893|NCT01466179|593569005|FG000|Overall Study|Physician Decision|46|||
164325894|NCT01466179|593569005|FG000|Overall Study|Progressive disease|43|||
164214004|NCT00541229|593150787|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
164214005|NCT00541229|593150788|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
164214006|NCT00541229|593150789|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
164325895|NCT01466179|593569005|FG000|Overall Study|Adverse Event|32|||
164325896|NCT01466179|593569005|FG000|Overall Study|Disease relapse|23|||
164214007|NCT00541229|593150790|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
164214008|NCT00541229|593150791|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
164214009|NCT00541229|593150792|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
164214010|NCT00541229|593150787|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
164214011|NCT00541229|593150788|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
164214012|NCT00541229|593150789|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
164214013|NCT00541229|593150790|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
164214014|NCT00541229|593150791|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
164214015|NCT00541229|593150792|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
164214016|NCT00541229|593150787|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
164214017|NCT00541229|593150788|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
164214018|NCT00541229|593150789|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
164214019|NCT00541229|593150790|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
164214020|NCT00541229|593150791|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
164214021|NCT00541229|593150792|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
164214022|NCT00541229|593150787|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
164214023|NCT00541229|593150788|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
164214024|NCT00541229|593150789|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
164214025|NCT00541229|593150790|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
164214026|NCT00541229|593150791|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
164214027|NCT00541229|593150792|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
164214028|NCT00541229|593150787|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
164214029|NCT00541229|593150788|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
164214030|NCT00541229|593150789|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
164214031|NCT00541229|593150790|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
164214032|NCT00541229|593150791|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
164214033|NCT00541229|593150792|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
164214034|NCT03807843|593150793|FG000|Overall Study|Lost to Follow-up|1|||
164214035|NCT03807843|593150794|FG001|Overall Study|Lost to Follow-up|0|||
164214036|NCT01312129|593150795|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
164214037|NCT01312129|593150796|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
164214038|NCT02397837|593150805|FG000|Overall Study|Withdrawal by Subject|6|||
164214039|NCT02397837|593150806|FG001|Overall Study|Withdrawal by Subject|5|||
164214040|NCT02397837|593150805|FG000|Overall Study|Physician Decision|1|||
164214041|NCT02397837|593150806|FG001|Overall Study|Physician Decision|1|||
164214042|NCT05276804|593150813|FG000|Overall Study|screen failure|23|||
164214043|NCT05276804|593150814|FG001|Overall Study|screen failure|0|||
164214044|NCT02827708|593150815|FG000|Overall Study|Lost to Follow-up|3|||
164214045|NCT02827708|593150816|FG001|Overall Study|Lost to Follow-up|1|||
164214046|NCT02827708|593150815|FG000|Overall Study|Withdrawal by Subject|1|||
164214047|NCT02827708|593150816|FG001|Overall Study|Withdrawal by Subject|2|||
164214048|NCT02827708|593150815|FG000|Overall Study|Death|1|||
164214049|NCT02827708|593150816|FG001|Overall Study|Death|2|||
164214050|NCT00407511|593150818|FG000|Overall Study|Adverse Event|9|||
164214051|NCT00407511|593150818|FG000|Overall Study|Lost to Follow-up|4|||
164214052|NCT00407511|593150818|FG000|Overall Study|Other|5|||
164214053|NCT00407511|593150818|FG000|Overall Study|Withdrawal by Subject|4|||
164214054|NCT05059080|593150821|FG000|Overall Study|Withdrawal by Subject|3|||
164214055|NCT05059080|593150821|FG000|Overall Study|Study Terminated by Sponsor|64|||
164214056|NCT00263562|593150822|FG000|Overall Study|Protocol Violation|3|||
164214057|NCT00263562|593150823|FG001|Overall Study|Protocol Violation|0|||
164214058|NCT01047501|593150824|FG000|Overall Study|Adverse Event|7|||
164214059|NCT01047501|593150825|FG001|Overall Study|Adverse Event|8|||
164214060|NCT01047501|593150826|FG002|Overall Study|Adverse Event|5|||
164214061|NCT01047501|593150824|FG000|Overall Study|Withdrew Consent|6|||
164214062|NCT01047501|593150825|FG001|Overall Study|Withdrew Consent|2|||
164214063|NCT01047501|593150826|FG002|Overall Study|Withdrew Consent|4|||
164214064|NCT01047501|593150824|FG000|Overall Study|Lost to Follow-up|0|||
164214065|NCT01047501|593150825|FG001|Overall Study|Lost to Follow-up|1|||
164214066|NCT01047501|593150826|FG002|Overall Study|Lost to Follow-up|1|||
164214067|NCT01047501|593150824|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
164214068|NCT01047501|593150825|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
164214069|NCT01047501|593150826|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
164214070|NCT01047501|593150824|FG000|Overall Study|Death|1|||
164214071|NCT01047501|593150825|FG001|Overall Study|Death|0|||
164214072|NCT01047501|593150826|FG002|Overall Study|Death|0|||
164214073|NCT01047501|593150824|FG000|Overall Study|Other discontinuation|1|||
164214074|NCT01047501|593150825|FG001|Overall Study|Other discontinuation|0|||
164214075|NCT01047501|593150826|FG002|Overall Study|Other discontinuation|1|||
164214076|NCT01047501|593150824|FG000|Overall Study|Investigator judgement|0|||
164214077|NCT01047501|593150825|FG001|Overall Study|Investigator judgement|0|||
164214078|NCT01047501|593150826|FG002|Overall Study|Investigator judgement|1|||
164214079|NCT04602000|593150827|FG000|Overall Study|Withdrawal by Subject|3|||
164214080|NCT04602000|593150828|FG001|Overall Study|Withdrawal by Subject|6|||
164214081|NCT04602000|593150829|FG002|Overall Study|Withdrawal by Subject|3|||
164214082|NCT04602000|593150830|FG003|Overall Study|Withdrawal by Subject|27|||
164214083|NCT04602000|593150831|FG004|Overall Study|Withdrawal by Subject|39|||
164214084|NCT04602000|593150827|FG000|Overall Study|Physician Decision|1|||
164214085|NCT04602000|593150828|FG001|Overall Study|Physician Decision|0|||
164214086|NCT04602000|593150829|FG002|Overall Study|Physician Decision|0|||
164214087|NCT04602000|593150830|FG003|Overall Study|Physician Decision|2|||
164214088|NCT04602000|593150831|FG004|Overall Study|Physician Decision|2|||
164214089|NCT04602000|593150827|FG000|Overall Study|Death|0|||
164214090|NCT04602000|593150828|FG001|Overall Study|Death|1|||
164214091|NCT04602000|593150829|FG002|Overall Study|Death|0|||
164214092|NCT04602000|593150830|FG003|Overall Study|Death|1|||
164214093|NCT04602000|593150831|FG004|Overall Study|Death|2|||
164214094|NCT04602000|593150827|FG000|Overall Study|Lost to Follow-up|0|||
164214095|NCT04602000|593150828|FG001|Overall Study|Lost to Follow-up|0|||
164214096|NCT04602000|593150829|FG002|Overall Study|Lost to Follow-up|0|||
164214097|NCT04602000|593150830|FG003|Overall Study|Lost to Follow-up|3|||
164214098|NCT04602000|593150831|FG004|Overall Study|Lost to Follow-up|4|||
164214099|NCT04602000|593150827|FG000|Overall Study|Other|4|||
164214100|NCT04602000|593150828|FG001|Overall Study|Other|1|||
164214101|NCT04602000|593150829|FG002|Overall Study|Other|2|||
164214102|NCT04602000|593150830|FG003|Overall Study|Other|5|||
164214103|NCT04602000|593150831|FG004|Overall Study|Other|4|||
164214104|NCT04602000|593150827|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
164214105|NCT04602000|593150828|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
164214106|NCT04602000|593150829|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
164214107|NCT04602000|593150830|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
164214108|NCT04602000|593150831|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
164214109|NCT00770484|593150838|FG000|Overall Study|Withdrawal by Subject|1|||
164214110|NCT00770484|593150839|FG001|Overall Study|Withdrawal by Subject|0|||
164214111|NCT00195429|593150840|FG000|Overall Study|Adverse Event|2|||
164214112|NCT00195429|593150841|FG001|Overall Study|Adverse Event|4|||
164214113|NCT00195429|593150840|FG000|Overall Study|Lack of Efficacy|2|||
164214114|NCT00195429|593150841|FG001|Overall Study|Lack of Efficacy|1|||
164214115|NCT00195429|593150840|FG000|Overall Study|Lost to Follow-up|1|||
164214116|NCT00195429|593150841|FG001|Overall Study|Lost to Follow-up|0|||
164214117|NCT00367458|593150842|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
164214118|NCT00367458|593150843|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
164214119|NCT05696847|593150847|FG000|Overall Study|Withdrawal by Subject|1|||
164214120|NCT05696847|593150848|FG001|Overall Study|Withdrawal by Subject|0|||
164214121|NCT05696847|593150849|FG002|Overall Study|Withdrawal by Subject|0|||
164214122|NCT05696847|593150850|FG003|Overall Study|Withdrawal by Subject|0|||
164214123|NCT05696847|593150851|FG004|Overall Study|Withdrawal by Subject|0|||
164214124|NCT05696847|593150852|FG005|Overall Study|Withdrawal by Subject|0|||
164325897|NCT01466179|593569005|FG000|Overall Study|Lack of Efficacy|14|||
164325898|NCT01466179|593569005|FG000|Overall Study|Death|7|||
164325899|NCT01466179|593569005|FG000|Overall Study|Withdrawal by Subject|7|||
164214125|NCT05696847|593150847|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164214126|NCT05696847|593150848|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
164214127|NCT05696847|593150849|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
164325900|NCT01466179|593569005|FG000|Overall Study|Protocol Violation|2|||
164325901|NCT01466179|593569005|FG000|Overall Study|Other|3|||
164325902|NCT03410823|593569006|FG000|Overall Study|Death|1|||
164325903|NCT03410823|593569006|FG000|Overall Study|Withdrawal by Subject|2|||
164325904|NCT03410823|593569006|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
164325905|NCT03707184|593569009|FG000|Overall Study|Withdrawal by Subject|2|||
164325906|NCT04704154|593569010|FG000|Overall Study|Adverse Event|3|||
164325907|NCT04704154|593569011|FG001|Overall Study|Adverse Event|2|||
164325908|NCT04704154|593569012|FG002|Overall Study|Adverse Event|4|||
164325909|NCT04704154|593569013|FG003|Overall Study|Adverse Event|2|||
164325910|NCT04704154|593569014|FG004|Overall Study|Adverse Event|3|||
164325911|NCT04704154|593569015|FG005|Overall Study|Adverse Event|0|||
164325912|NCT04704154|593569010|FG000|Overall Study|Death|3|||
164325913|NCT04704154|593569011|FG001|Overall Study|Death|0|||
164565000|NCT01773421|594438372|FG001|Treatment Phase|Other|0|||
164214128|NCT05696847|593150850|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
164214129|NCT05696847|593150851|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
164214130|NCT05696847|593150852|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
164565001|NCT01773421|594438373|FG002|Treatment Phase|Other|2|||
164565002|NCT01773421|594438374|FG003|Treatment Phase|Other|0|||
164565003|NCT01773421|594438375|FG004|Treatment Phase|Other|0|||
164214131|NCT05696847|593150847|FG000|Overall Study|Adverse Event|0|||
164214132|NCT05696847|593150848|FG001|Overall Study|Adverse Event|0|||
164214133|NCT05696847|593150849|FG002|Overall Study|Adverse Event|0|||
164214134|NCT05696847|593150850|FG003|Overall Study|Adverse Event|0|||
164214135|NCT05696847|593150851|FG004|Overall Study|Adverse Event|0|||
164214136|NCT05696847|593150852|FG005|Overall Study|Adverse Event|1|||
164325914|NCT04704154|593569012|FG002|Overall Study|Death|0|||
164325915|NCT04704154|593569013|FG003|Overall Study|Death|0|||
164325916|NCT04704154|593569014|FG004|Overall Study|Death|3|||
164325917|NCT04704154|593569015|FG005|Overall Study|Death|0|||
164325918|NCT04704154|593569010|FG000|Overall Study|Physician Decision|1|||
164565004|NCT01773421|594438376|FG005|Treatment Phase|Other|0|||
164565005|NCT01773421|594438377|FG006|Treatment Phase|Other|0|||
164565006|NCT01773421|594438371|FG000|Treatment Phase|Adverse Event|0|||
164565007|NCT01773421|594438372|FG001|Treatment Phase|Adverse Event|0|||
164565008|NCT01773421|594438373|FG002|Treatment Phase|Adverse Event|3|||
164565009|NCT01773421|594438374|FG003|Treatment Phase|Adverse Event|1|||
164565010|NCT01773421|594438375|FG004|Treatment Phase|Adverse Event|0|||
164565011|NCT01773421|594438376|FG005|Treatment Phase|Adverse Event|0|||
164565012|NCT01773421|594438377|FG006|Treatment Phase|Adverse Event|0|||
164565013|NCT01773421|594438371|FG000|Treatment Phase|Withdrawal by Subject|0|||
164565014|NCT01773421|594438372|FG001|Treatment Phase|Withdrawal by Subject|0|||
164565015|NCT01773421|594438373|FG002|Treatment Phase|Withdrawal by Subject|1|||
164565016|NCT01773421|594438374|FG003|Treatment Phase|Withdrawal by Subject|1|||
164565017|NCT01773421|594438375|FG004|Treatment Phase|Withdrawal by Subject|0|||
164565018|NCT01773421|594438376|FG005|Treatment Phase|Withdrawal by Subject|0|||
164565019|NCT01773421|594438377|FG006|Treatment Phase|Withdrawal by Subject|0|||
164565020|NCT01773421|594438371|FG000|Extension Phase|Other|0|||
164669376|NCT01367457|594814967|FG000|Overall Study|Palliative. Overall decline|1|||
164669377|NCT01367457|594814968|FG001|Overall Study|Palliative. Overall decline|0|||
164669378|NCT01367457|594814969|FG002|Overall Study|Palliative. Overall decline|0|||
164669379|NCT01367457|594814967|FG000|Overall Study|Suspected DP/suspected active infection|1|||
164565021|NCT01773421|594438372|FG001|Extension Phase|Other|0|||
164565022|NCT01773421|594438373|FG002|Extension Phase|Other|0|||
164565023|NCT01773421|594438374|FG003|Extension Phase|Other|0|||
164669380|NCT01367457|594814968|FG001|Overall Study|Suspected DP/suspected active infection|0|||
164669381|NCT01367457|594814969|FG002|Overall Study|Suspected DP/suspected active infection|0|||
164669382|NCT02495857|594814970|FG000|Overall Study|Adverse Event|5|||
164669383|NCT02495857|594814971|FG001|Overall Study|Adverse Event|0|||
164669384|NCT02495857|594814972|FG002|Overall Study|Adverse Event|1|||
164669385|NCT02495857|594814970|FG000|Overall Study|Withdrawal by Subject|9|||
164669386|NCT02495857|594814971|FG001|Overall Study|Withdrawal by Subject|6|||
164669387|NCT02495857|594814972|FG002|Overall Study|Withdrawal by Subject|10|||
164669388|NCT02495857|594814970|FG000|Overall Study|Physician Decision|0|||
164669389|NCT02495857|594814971|FG001|Overall Study|Physician Decision|1|||
164669390|NCT02495857|594814972|FG002|Overall Study|Physician Decision|0|||
164669391|NCT02495857|594814970|FG000|Overall Study|Protocol Violation|1|||
164669392|NCT02495857|594814971|FG001|Overall Study|Protocol Violation|1|||
164669393|NCT02495857|594814972|FG002|Overall Study|Protocol Violation|2|||
164669394|NCT02495857|594814970|FG000|Overall Study|Lost to Follow-up|4|||
164669395|NCT02495857|594814971|FG001|Overall Study|Lost to Follow-up|5|||
164669396|NCT02495857|594814972|FG002|Overall Study|Lost to Follow-up|3|||
164669397|NCT02495857|594814970|FG000|Overall Study|Other|3|||
164669398|NCT02495857|594814971|FG001|Overall Study|Other|3|||
164669399|NCT02495857|594814972|FG002|Overall Study|Other|2|||
164669400|NCT04407806|594814977|FG000|Overall Study|Withdrawal by Subject|1|||
164669401|NCT04407806|594814978|FG001|Overall Study|Withdrawal by Subject|2|||
164669402|NCT03447262|594814981|FG000|Overall Study|Adverse Event|7|||
164669403|NCT03447262|594814981|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
164669404|NCT03447262|594814981|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
164669405|NCT03447262|594814981|FG000|Overall Study|Death|2|||
164669406|NCT03447262|594814981|FG000|Overall Study|Study Termination by Sponsor|455|||
164669407|NCT03447262|594814981|FG000|Overall Study|Other|4|||
164669408|NCT02058498|594814985|FG000|Overall Study|Withdrawal by Subject|4|||
164669409|NCT04605094|594814986|FG000|Overall Study|Adverse Event|2|||
164669410|NCT04605094|594814987|FG001|Overall Study|Adverse Event|2|||
164669411|NCT04605094|594814986|FG000|Overall Study|Lost to Follow-up|1|||
164669412|NCT04605094|594814987|FG001|Overall Study|Lost to Follow-up|4|||
164669413|NCT04605094|594814986|FG000|Overall Study|Physician Decision|2|||
164669414|NCT04605094|594814987|FG001|Overall Study|Physician Decision|2|||
164669415|NCT04605094|594814986|FG000|Overall Study|Study terminated by Sponsor|31|||
164669416|NCT04605094|594814987|FG001|Overall Study|Study terminated by Sponsor|33|||
164669417|NCT04605094|594814986|FG000|Overall Study|Withdrawal by Subject|22|||
164565024|NCT01773421|594438375|FG004|Extension Phase|Other|1|||
164565025|NCT01773421|594438376|FG005|Extension Phase|Other|2|||
164565026|NCT01773421|594438377|FG006|Extension Phase|Other|0|||
164565027|NCT01773421|594438371|FG000|Extension Phase|Adverse Event|0|||
164565028|NCT01773421|594438372|FG001|Extension Phase|Adverse Event|0|||
164565029|NCT01773421|594438373|FG002|Extension Phase|Adverse Event|0|||
164565030|NCT01773421|594438374|FG003|Extension Phase|Adverse Event|0|||
164565031|NCT01773421|594438375|FG004|Extension Phase|Adverse Event|2|||
164565032|NCT01773421|594438376|FG005|Extension Phase|Adverse Event|0|||
164565033|NCT01773421|594438377|FG006|Extension Phase|Adverse Event|0|||
164565034|NCT02327260|594438378|FG000|Overall Study|Lost to Follow-up|2|||
164565035|NCT02327260|594438379|FG001|Overall Study|Lost to Follow-up|3|||
164565036|NCT02327260|594438380|FG002|Overall Study|Lost to Follow-up|2|||
164565037|NCT02327260|594438378|FG000|Overall Study|invalid phone number|1|||
164669418|NCT04605094|594814987|FG001|Overall Study|Withdrawal by Subject|19|||
164669419|NCT04605094|594814986|FG000|Overall Study|Other|1|||
164669420|NCT04605094|594814987|FG001|Overall Study|Other|1|||
164214137|NCT05696847|593150847|FG000|Overall Study|Sponsor Decision|0|||
164214138|NCT05696847|593150848|FG001|Overall Study|Sponsor Decision|0|||
164214139|NCT05696847|593150849|FG002|Overall Study|Sponsor Decision|0|||
164214140|NCT05696847|593150850|FG003|Overall Study|Sponsor Decision|1|||
164214141|NCT05696847|593150851|FG004|Overall Study|Sponsor Decision|0|||
164214142|NCT05696847|593150852|FG005|Overall Study|Sponsor Decision|0|||
164214143|NCT01716156|593150853|FG000|Overall Study|Protocol Violation|1|||
164214144|NCT01716156|593150854|FG001|Overall Study|Protocol Violation|0|||
164214145|NCT01716156|593150855|FG002|Overall Study|Protocol Violation|0|||
164214146|NCT01716156|593150853|FG000|Overall Study|Withdrawal by Subject|0|||
164214147|NCT01716156|593150854|FG001|Overall Study|Withdrawal by Subject|1|||
164214148|NCT01716156|593150855|FG002|Overall Study|Withdrawal by Subject|2|||
164214149|NCT01716156|593150853|FG000|Overall Study|Lost to Follow-up|1|||
164214150|NCT01716156|593150854|FG001|Overall Study|Lost to Follow-up|0|||
164214151|NCT01716156|593150855|FG002|Overall Study|Lost to Follow-up|0|||
164214152|NCT05513950|593150858|FG000|Overall Study|Not treated due to technical reasons|0|||
164214153|NCT05513950|593150859|FG001|Overall Study|Not treated due to technical reasons|0|||
164214154|NCT05513950|593150860|FG002|Overall Study|Not treated due to technical reasons|1|||
164214155|NCT05513950|593150861|FG003|Overall Study|Not treated due to technical reasons|0|||
164214156|NCT05221866|593150862|FG000|Overall Study|Withdrawal by Subject|5|||
164669421|NCT02724462|594814988|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
164669422|NCT02724462|594814989|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
164669423|NCT02724462|594814988|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
164669424|NCT02724462|594814989|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
164669425|NCT02724462|594814988|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
164669426|NCT02724462|594814989|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
164669427|NCT02724462|594814988|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
164669428|NCT02724462|594814989|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
164669429|NCT02724462|594814988|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
164669430|NCT02724462|594814989|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
164669431|NCT02724462|594814988|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
164669432|NCT02724462|594814989|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
164669433|NCT00469417|594814992|FG000|Overall Study|Treatment failure all lesions|18|||
164669434|NCT00469417|594814993|FG001|Overall Study|Treatment failure all lesions|11|||
164669435|NCT00469417|594814992|FG000|Overall Study|Consent withdrawn|1|||
164669436|NCT00469417|594814993|FG001|Overall Study|Consent withdrawn|1|||
164669437|NCT00469417|594814992|FG000|Overall Study|Adverse Event|8|||
164669438|NCT00469417|594814993|FG001|Overall Study|Adverse Event|2|||
164669439|NCT00469417|594814992|FG000|Overall Study|Lost to Follow-up|1|||
164669440|NCT00469417|594814993|FG001|Overall Study|Lost to Follow-up|2|||
164669441|NCT00469417|594814992|FG000|Overall Study|Intercurrent disease|0|||
164669442|NCT00469417|594814993|FG001|Overall Study|Intercurrent disease|1|||
164669443|NCT00469417|594814992|FG000|Overall Study|Randomized but not treated|2|||
164669444|NCT00469417|594814993|FG001|Overall Study|Randomized but not treated|0|||
164669445|NCT02188303|594814996|FG000|Overall Study|Adverse Event|0|||
164669446|NCT02188303|594814997|FG001|Overall Study|Adverse Event|0|||
164669447|NCT02188303|594814998|FG002|Overall Study|Adverse Event|0|||
164669448|NCT02188303|594814999|FG003|Overall Study|Adverse Event|0|||
164669449|NCT02188303|594815000|FG004|Overall Study|Adverse Event|0|||
164669450|NCT02188303|594815001|FG005|Overall Study|Adverse Event|2|||
164669451|NCT02188303|594815002|FG006|Overall Study|Adverse Event|0|||
164669452|NCT02188303|594815003|FG007|Overall Study|Adverse Event|2|||
164669453|NCT02188303|594814996|FG000|Overall Study|Dose Termination Criteria Met|0|||
164669454|NCT02188303|594814997|FG001|Overall Study|Dose Termination Criteria Met|0|||
164214157|NCT05221866|593150863|FG001|Overall Study|Withdrawal by Subject|7|||
164325919|NCT04704154|593569011|FG001|Overall Study|Physician Decision|0|||
164669455|NCT02188303|594814998|FG002|Overall Study|Dose Termination Criteria Met|0|||
164669456|NCT02188303|594814999|FG003|Overall Study|Dose Termination Criteria Met|0|||
164669457|NCT02188303|594815000|FG004|Overall Study|Dose Termination Criteria Met|0|||
164669458|NCT02188303|594815001|FG005|Overall Study|Dose Termination Criteria Met|0|||
164669459|NCT02188303|594815002|FG006|Overall Study|Dose Termination Criteria Met|2|||
164669460|NCT02188303|594815003|FG007|Overall Study|Dose Termination Criteria Met|4|||
164669461|NCT05612724|594815004|FG000|Overall Study|Lost to Follow-up|4|||
164669462|NCT04000815|594815007|FG000|Overall Study|Lost to Follow-up|9|||
164669463|NCT04000815|594815008|FG001|Overall Study|Lost to Follow-up|2|||
164669464|NCT04000815|594815009|FG002|Overall Study|Lost to Follow-up|3|||
164669465|NCT04000815|594815007|FG000|Overall Study|Withdrawal by Subject|4|||
164669466|NCT04000815|594815008|FG001|Overall Study|Withdrawal by Subject|3|||
164669467|NCT04000815|594815009|FG002|Overall Study|Withdrawal by Subject|2|||
164214158|NCT05221866|593150864|FG002|Overall Study|Withdrawal by Subject|6|||
164214159|NCT05221866|593150865|FG003|Overall Study|Withdrawal by Subject|4|||
164214160|NCT05221866|593150862|FG000|Overall Study|Physician Decision|3|||
164214161|NCT05221866|593150863|FG001|Overall Study|Physician Decision|2|||
164214162|NCT05221866|593150864|FG002|Overall Study|Physician Decision|1|||
164214163|NCT05221866|593150865|FG003|Overall Study|Physician Decision|4|||
164214164|NCT05221866|593150862|FG000|Overall Study|Lost to Follow-up|12|||
164214165|NCT05221866|593150863|FG001|Overall Study|Lost to Follow-up|17|||
164214166|NCT05221866|593150864|FG002|Overall Study|Lost to Follow-up|14|||
164214167|NCT05221866|593150865|FG003|Overall Study|Lost to Follow-up|14|||
164214168|NCT05221866|593150862|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
164214169|NCT05221866|593150863|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
164214170|NCT05221866|593150864|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
164214171|NCT05221866|593150865|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
164214172|NCT05561140|593150866|FG000|Randomized Treatment Period|Adverse Event|1|||
164214173|NCT05561140|593150867|FG001|Randomized Treatment Period|Adverse Event|0|||
164214174|NCT05561140|593150866|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
164214175|NCT05561140|593150867|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
164214176|NCT05561140|593150866|FG000|Open Label Treatment Period|Adverse Event|6|||
164214177|NCT05561140|593150867|FG001|Open Label Treatment Period|Adverse Event|4|||
164214178|NCT05561140|593150866|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
164214179|NCT05561140|593150867|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
164214180|NCT05561140|593150866|FG000|Open Label Treatment Period|Physician Decision|0|||
164214181|NCT05561140|593150867|FG001|Open Label Treatment Period|Physician Decision|1|||
164565038|NCT02327260|594438379|FG001|Overall Study|invalid phone number|1|||
164214182|NCT05561140|593150866|FG000|Open Label Treatment Period|Pregnancy|1|||
164214183|NCT05561140|593150867|FG001|Open Label Treatment Period|Pregnancy|0|||
164565039|NCT02327260|594438380|FG002|Overall Study|invalid phone number|0|||
164565040|NCT02327260|594438378|FG000|Overall Study|non-adherence to protocol|2|||
164565041|NCT02327260|594438379|FG001|Overall Study|non-adherence to protocol|0|||
164565042|NCT02327260|594438380|FG002|Overall Study|non-adherence to protocol|0|||
164565043|NCT02327260|594438378|FG000|Overall Study|cognitive concerns|1|||
164565044|NCT02327260|594438379|FG001|Overall Study|cognitive concerns|0|||
164565045|NCT02327260|594438380|FG002|Overall Study|cognitive concerns|0|||
164565046|NCT02804763|594438381|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
164565047|NCT02804763|594438382|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
164565048|NCT02804763|594438383|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
164565049|NCT02804763|594438384|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
164565050|NCT02804763|594438381|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
164565051|NCT02804763|594438382|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
164565052|NCT02804763|594438383|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
164565053|NCT02804763|594438384|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
164214184|NCT05561140|593150866|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
164214185|NCT05561140|593150867|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
164214186|NCT05561140|593150866|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
164214187|NCT05561140|593150867|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
164214188|NCT05561140|593150866|FG000|Open Label Treatment Period|Other|1|||
164214189|NCT05561140|593150867|FG001|Open Label Treatment Period|Other|0|||
164214190|NCT00221104|593150871|FG000|Overall Study|Adverse Event|1|||
164214191|NCT00221104|593150872|FG001|Overall Study|Adverse Event|0|||
164214192|NCT00221104|593150871|FG000|Overall Study|Physician Decision|1|||
164214193|NCT00221104|593150872|FG001|Overall Study|Physician Decision|0|||
164214194|NCT00221104|593150871|FG000|Overall Study|Protocol Violation|2|||
164214195|NCT00221104|593150872|FG001|Overall Study|Protocol Violation|0|||
164214196|NCT00221104|593150871|FG000|Overall Study|Withdrawal by Subject|42|||
164214197|NCT00221104|593150872|FG001|Overall Study|Withdrawal by Subject|29|||
164214198|NCT00221104|593150871|FG000|Overall Study|Others|37|||
164214199|NCT00221104|593150872|FG001|Overall Study|Others|47|||
164214200|NCT02989389|593150873|FG000|Period 1|Lost to Follow-up|0|||
164325920|NCT04704154|593569012|FG002|Overall Study|Physician Decision|1|||
164565054|NCT02804763|594438381|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
164565055|NCT02804763|594438382|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
164565056|NCT02804763|594438383|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
164565057|NCT02804763|594438384|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
164565058|NCT02804763|594438381|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
164565059|NCT02804763|594438382|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
164565060|NCT02804763|594438383|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
164565061|NCT02804763|594438384|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
164214201|NCT02989389|593150874|FG001|Period 1|Lost to Follow-up|1|||
164214202|NCT02989389|593150875|FG002|Period 1|Lost to Follow-up|0|||
164214203|NCT02989389|593150876|FG003|Period 1|Lost to Follow-up|0|||
164214204|NCT02989389|593150877|FG004|Period 1|Lost to Follow-up|0|||
164214205|NCT02989389|593150878|FG005|Period 1|Lost to Follow-up|0|||
164214206|NCT02989389|593150879|FG006|Period 1|Lost to Follow-up|0|||
164325921|NCT04704154|593569013|FG003|Overall Study|Physician Decision|0|||
164214207|NCT02989389|593150880|FG007|Period 1|Lost to Follow-up|0|||
164214208|NCT02989389|593150881|FG008|Period 1|Lost to Follow-up|0|||
164214209|NCT02989389|593150882|FG009|Period 1|Lost to Follow-up|0|||
164214210|NCT02989389|593150873|FG000|Period 1|Physician Decision|0|||
164214211|NCT02989389|593150874|FG001|Period 1|Physician Decision|0|||
164214212|NCT02989389|593150875|FG002|Period 1|Physician Decision|0|||
164214213|NCT02989389|593150876|FG003|Period 1|Physician Decision|0|||
164214214|NCT02989389|593150877|FG004|Period 1|Physician Decision|0|||
164214215|NCT02989389|593150878|FG005|Period 1|Physician Decision|0|||
164214216|NCT02989389|593150879|FG006|Period 1|Physician Decision|0|||
164214217|NCT02989389|593150880|FG007|Period 1|Physician Decision|0|||
164214218|NCT02989389|593150881|FG008|Period 1|Physician Decision|1|||
164214219|NCT02989389|593150882|FG009|Period 1|Physician Decision|0|||
164214220|NCT01666652|593150883|FG000|Overall Study|Serious Adverse Event|0|||
164214221|NCT01666652|593150884|FG001|Overall Study|Serious Adverse Event|0|||
164669468|NCT04000815|594815007|FG000|Overall Study|Right ovarian cyst occured|1|||
164669469|NCT04000815|594815008|FG001|Overall Study|Right ovarian cyst occured|0|||
164669470|NCT04000815|594815009|FG002|Overall Study|Right ovarian cyst occured|0|||
164669471|NCT04000815|594815007|FG000|Overall Study|Hypertension occured on follow up|0|||
164669472|NCT04000815|594815008|FG001|Overall Study|Hypertension occured on follow up|0|||
164669473|NCT04000815|594815009|FG002|Overall Study|Hypertension occured on follow up|2|||
164669474|NCT03988803|594815012|FG000|Period 2|Prematurely discontinued from medication|2|||
164669475|NCT03988803|594815012|FG000|Period 2|Adverse Event|1|||
164669476|NCT01034358|594815013|FG000|Overall Study|Withdrawal by Subject|1|||
164669477|NCT01034358|594815013|FG000|Overall Study|Protocol Violation|1|||
164669478|NCT00377260|594815016|FG000|Overall Study|Lost to Follow-up|0|||
164669479|NCT00377260|594815017|FG001|Overall Study|Lost to Follow-up|1|||
164669480|NCT00377260|594815016|FG000|Overall Study|Withdrawal by Subject|2|||
164669481|NCT00377260|594815017|FG001|Overall Study|Withdrawal by Subject|4|||
164669482|NCT01617668|594815018|FG000|Overall Study|Adverse Event|7|||
164669483|NCT01617668|594815019|FG001|Overall Study|Adverse Event|0|||
164669484|NCT01617668|594815020|FG002|Overall Study|Adverse Event|12|||
164669485|NCT01617668|594815021|FG003|Overall Study|Adverse Event|5|||
164669486|NCT01617668|594815018|FG000|Overall Study|Physician Decision|1|||
164669487|NCT01617668|594815019|FG001|Overall Study|Physician Decision|2|||
164669488|NCT01617668|594815020|FG002|Overall Study|Physician Decision|3|||
164669489|NCT01617668|594815021|FG003|Overall Study|Physician Decision|0|||
164669490|NCT01617668|594815018|FG000|Overall Study|Progressive Disease|4|||
164669491|NCT01617668|594815019|FG001|Overall Study|Progressive Disease|4|||
164669492|NCT01617668|594815020|FG002|Overall Study|Progressive Disease|6|||
164669493|NCT01617668|594815021|FG003|Overall Study|Progressive Disease|9|||
164669494|NCT01617668|594815018|FG000|Overall Study|Subject/guardian decision|1|||
164669495|NCT01617668|594815019|FG001|Overall Study|Subject/guardian decision|3|||
164669496|NCT01617668|594815020|FG002|Overall Study|Subject/guardian decision|2|||
164669497|NCT01617668|594815021|FG003|Overall Study|Subject/guardian decision|1|||
164669498|NCT02017964|594815022|FG000|Overall Study|Patient deemed ineligible|1|||
164669499|NCT02300103|594815025|FG000|Overall Study|Lack of Efficacy|3|||
164669500|NCT02300103|594815025|FG000|Overall Study|Protocol Violation|1|||
164669501|NCT02300103|594815025|FG000|Overall Study|Withdrew Consent|2|||
164669502|NCT04091971|594815026|FG000|Overall Study|Withdrawal by Subject|1|||
164669503|NCT04091971|594815026|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
164669504|NCT04091971|594815026|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
164669505|NCT01391793|594815027|FG000|Overall Study|Ineligible|3|||
164669506|NCT01391793|594815028|FG001|Overall Study|Ineligible|0|||
164669507|NCT01391793|594815027|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
164214222|NCT01666652|593150885|FG002|Overall Study|Serious Adverse Event|0|||
164669508|NCT01391793|594815028|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
164669509|NCT01391793|594815027|FG000|Overall Study|No DMSA|73|||
164669510|NCT01391793|594815028|FG001|Overall Study|No DMSA|57|||
164669511|NCT01015625|594815029|FG000|Overall Study|Lost to Follow-up|3|||
164669512|NCT01015625|594815030|FG001|Overall Study|Lost to Follow-up|1|||
164669513|NCT01015625|594815029|FG000|Overall Study|Withdrawal by Subject|2|||
164669514|NCT01015625|594815030|FG001|Overall Study|Withdrawal by Subject|3|||
164669515|NCT01015625|594815029|FG000|Overall Study|Physician Decision|2|||
164669516|NCT01015625|594815030|FG001|Overall Study|Physician Decision|0|||
164669517|NCT01015625|594815029|FG000|Overall Study|Death|30|||
164669518|NCT01015625|594815030|FG001|Overall Study|Death|22|||
164669519|NCT00150462|594815033|FG000|Overall Study|Disease Progression or Relapse|3|||
164669520|NCT00150462|594815034|FG001|Overall Study|Disease Progression or Relapse|1|||
164214223|NCT01666652|593150886|FG003|Overall Study|Serious Adverse Event|1|||
164214224|NCT01666652|593150887|FG004|Overall Study|Serious Adverse Event|0|||
164214225|NCT01666652|593150883|FG000|Overall Study|Withdrawal by Subject|0|||
164214226|NCT01666652|593150884|FG001|Overall Study|Withdrawal by Subject|0|||
164214227|NCT01666652|593150885|FG002|Overall Study|Withdrawal by Subject|0|||
164214228|NCT01666652|593150886|FG003|Overall Study|Withdrawal by Subject|0|||
164214229|NCT01666652|593150887|FG004|Overall Study|Withdrawal by Subject|1|||
164214230|NCT01666652|593150883|FG000|Overall Study|Moved from study area|1|||
164214231|NCT01666652|593150884|FG001|Overall Study|Moved from study area|0|||
164214232|NCT01666652|593150885|FG002|Overall Study|Moved from study area|0|||
164214233|NCT01666652|593150886|FG003|Overall Study|Moved from study area|2|||
164214234|NCT01666652|593150887|FG004|Overall Study|Moved from study area|0|||
164214235|NCT01666652|593150883|FG000|Overall Study|Lost to Follow-up|1|||
164214236|NCT01666652|593150884|FG001|Overall Study|Lost to Follow-up|1|||
164214237|NCT01666652|593150885|FG002|Overall Study|Lost to Follow-up|1|||
164214238|NCT01666652|593150886|FG003|Overall Study|Lost to Follow-up|1|||
164214239|NCT01666652|593150887|FG004|Overall Study|Lost to Follow-up|0|||
164214240|NCT00088153|593150888|FG000|Overall Study|Physician Decision|3|||
164214241|NCT00088153|593150889|FG001|Overall Study|Physician Decision|3|||
164214242|NCT00088153|593150888|FG000|Overall Study|Withdrawal by Subject|10|||
164214243|NCT00088153|593150889|FG001|Overall Study|Withdrawal by Subject|10|||
164214244|NCT00088153|593150888|FG000|Overall Study|Lost to Follow-up|11|||
164214245|NCT00088153|593150889|FG001|Overall Study|Lost to Follow-up|12|||
164214246|NCT01132755|593150890|FG000|Overall Study|Procedure not done due to medical reason|23|||
164214247|NCT01132755|593150890|FG000|Overall Study|Protocol Violation|15|||
164214248|NCT01132755|593150890|FG000|Overall Study|Withdrawal by Subject|4|||
164214249|NCT01757847|593150891|FG000|Overall Study|Withdrawal by Subject|3|||
164214250|NCT01757847|593150892|FG001|Overall Study|Withdrawal by Subject|4|||
164214251|NCT04057365|593150893|FG000|Overall Study|Withdrawal by Subject|2|||
164214252|NCT04057365|593150894|FG001|Overall Study|Withdrawal by Subject|0|||
164214253|NCT01063114|593150895|FG000|Overall Study|Lost to Follow-up|1|||
164214254|NCT04598828|593150898|FG000|Overall Study|Physician Decision|1|||
164214255|NCT04598828|593150899|FG001|Overall Study|Physician Decision|0|||
164214256|NCT04598828|593150898|FG000|Overall Study|Withdrawal by Subject|0|||
164214257|NCT04598828|593150899|FG001|Overall Study|Withdrawal by Subject|1|||
164214258|NCT04598828|593150898|FG000|Overall Study|Withdrawal by Subject|0|||
164214259|NCT04598828|593150899|FG001|Overall Study|Withdrawal by Subject|1|||
164214260|NCT02676973|593150900|FG000|Overall Study|Withdrawal by Subject|9|||
164214261|NCT02676973|593150901|FG001|Overall Study|Withdrawal by Subject|8|||
164214262|NCT02676973|593150902|FG002|Overall Study|Withdrawal by Subject|11|||
164214263|NCT02676973|593150900|FG000|Overall Study|Lost to Follow-up|8|||
164214264|NCT02676973|593150901|FG001|Overall Study|Lost to Follow-up|12|||
164214265|NCT02676973|593150902|FG002|Overall Study|Lost to Follow-up|8|||
164214266|NCT02676973|593150900|FG000|Overall Study|Death|2|||
164214267|NCT02676973|593150901|FG001|Overall Study|Death|1|||
164565062|NCT02804763|594438381|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
164565063|NCT02804763|594438382|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
164565064|NCT02804763|594438383|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
164565065|NCT02804763|594438384|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
164565066|NCT02804763|594438381|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
164565067|NCT02804763|594438382|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
164565068|NCT02804763|594438383|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
164565069|NCT02804763|594438384|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
164565070|NCT01400932|594438389|FG000|Overall Study|Adverse Event|10|||
164565071|NCT01400932|594438390|FG001|Overall Study|Adverse Event|5|||
164565072|NCT01400932|594438389|FG000|Overall Study|Lack of Efficacy|0|||
164565073|NCT01400932|594438390|FG001|Overall Study|Lack of Efficacy|3|||
164565074|NCT01400932|594438389|FG000|Overall Study|Withdrawal by Subject|2|||
164565075|NCT01400932|594438390|FG001|Overall Study|Withdrawal by Subject|6|||
164565076|NCT01400932|594438389|FG000|Overall Study|Lost to Follow-up|1|||
164565077|NCT01400932|594438390|FG001|Overall Study|Lost to Follow-up|0|||
164565078|NCT01400932|594438389|FG000|Overall Study|Protocol Deviation|0|||
164565079|NCT01400932|594438390|FG001|Overall Study|Protocol Deviation|1|||
164565080|NCT01400932|594438389|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
164565081|NCT01400932|594438390|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
164214268|NCT02676973|593150902|FG002|Overall Study|Death|5|||
164214269|NCT01078662|593150904|FG000|Overall Study|Death|41|||
164214270|NCT01078662|593150905|FG001|Overall Study|Death|103|||
164214271|NCT01078662|593150906|FG002|Overall Study|Death|18|||
164214272|NCT01078662|593150907|FG003|Overall Study|Death|5|||
164214273|NCT01078662|593150908|FG004|Overall Study|Death|8|||
164214274|NCT01078662|593150904|FG000|Overall Study|Patients reached data cut-off|12|||
164214275|NCT01078662|593150905|FG001|Overall Study|Patients reached data cut-off|53|||
164565082|NCT00270894|594438393|FG000|Overall Study|Adverse Event|1|||
164214276|NCT01078662|593150906|FG002|Overall Study|Patients reached data cut-off|2|||
164214277|NCT01078662|593150907|FG003|Overall Study|Patients reached data cut-off|2|||
164214278|NCT01078662|593150908|FG004|Overall Study|Patients reached data cut-off|3|||
164214279|NCT01078662|593150904|FG000|Overall Study|Withdrawal by Subject|4|||
164214280|NCT01078662|593150905|FG001|Overall Study|Withdrawal by Subject|11|||
164214281|NCT01078662|593150906|FG002|Overall Study|Withdrawal by Subject|1|||
164565083|NCT00270894|594438393|FG000|Overall Study|Withdrawal by Subject|1|||
164565084|NCT03980938|594438401|FG000|Treatment Period 1|Study Terminated|1|||
164565085|NCT03980938|594438402|FG001|Treatment Period 1|Study Terminated|1|||
164214282|NCT01078662|593150907|FG003|Overall Study|Withdrawal by Subject|0|||
164214283|NCT01078662|593150908|FG004|Overall Study|Withdrawal by Subject|0|||
164214284|NCT01078662|593150904|FG000|Overall Study|Protocol Violation|0|||
164214285|NCT01078662|593150905|FG001|Overall Study|Protocol Violation|1|||
164214286|NCT01078662|593150906|FG002|Overall Study|Protocol Violation|0|||
164214287|NCT01078662|593150907|FG003|Overall Study|Protocol Violation|0|||
164214288|NCT01078662|593150908|FG004|Overall Study|Protocol Violation|0|||
164214289|NCT01078662|593150904|FG000|Overall Study|Lost to Follow-up|1|||
164214290|NCT01078662|593150905|FG001|Overall Study|Lost to Follow-up|0|||
164214291|NCT01078662|593150906|FG002|Overall Study|Lost to Follow-up|0|||
164214292|NCT01078662|593150907|FG003|Overall Study|Lost to Follow-up|0|||
164214293|NCT01078662|593150908|FG004|Overall Study|Lost to Follow-up|0|||
164214294|NCT02875080|593150913|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
164214295|NCT02875080|593150914|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
164214296|NCT02875080|593150915|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
164214297|NCT00182637|593151825|FG000|Overall Study|Adverse Event|2|||
164214298|NCT00182637|593151825|FG000|Overall Study|Disease Progression|1|||
164214299|NCT02068794|593151826|FG000|Overall Study|Withdrawal by Subject|0|||
164214300|NCT02068794|593151827|FG001|Overall Study|Withdrawal by Subject|1|||
164214301|NCT02068794|593151828|FG002|Overall Study|Withdrawal by Subject|2|||
164214302|NCT02068794|593151826|FG000|Overall Study|Early Progression|1|||
164214303|NCT02068794|593151827|FG001|Overall Study|Early Progression|0|||
164214304|NCT02068794|593151828|FG002|Overall Study|Early Progression|1|||
164214305|NCT02068794|593151826|FG000|Overall Study|Ineligible|0|||
164214306|NCT02068794|593151827|FG001|Overall Study|Ineligible|0|||
164214307|NCT02068794|593151828|FG002|Overall Study|Ineligible|1|||
164214308|NCT00898807|593151829|FG000|Overall Study|Withdrawal by Subject|5|||
164214309|NCT00898807|593151830|FG001|Overall Study|Withdrawal by Subject|3|||
164214310|NCT00898807|593151829|FG000|Overall Study|Family pressure to discontinue|2|||
164214311|NCT00898807|593151830|FG001|Overall Study|Family pressure to discontinue|2|||
164214312|NCT00898807|593151829|FG000|Overall Study|Lost to Follow-up|1|||
164214313|NCT00898807|593151830|FG001|Overall Study|Lost to Follow-up|3|||
164214314|NCT00898807|593151829|FG000|Overall Study|Death|0|||
164214315|NCT00898807|593151830|FG001|Overall Study|Death|1|||
164214316|NCT01482221|593151833|FG000|Overall Study|Lack of Efficacy|1|||
164214317|NCT01482221|593151834|FG001|Overall Study|Lack of Efficacy|0|||
164214318|NCT01482221|593151835|FG002|Overall Study|Lack of Efficacy|1|||
164214319|NCT01482221|593151833|FG000|Overall Study|Lost to Follow-up|3|||
164214320|NCT01482221|593151834|FG001|Overall Study|Lost to Follow-up|2|||
164214321|NCT01482221|593151835|FG002|Overall Study|Lost to Follow-up|1|||
164214322|NCT01482221|593151833|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
164214323|NCT01482221|593151834|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
164214324|NCT01482221|593151835|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
164214325|NCT01482221|593151833|FG000|Overall Study|Condition under Investigation Worsened|3|||
164214326|NCT01482221|593151834|FG001|Overall Study|Condition under Investigation Worsened|2|||
164214327|NCT01482221|593151835|FG002|Overall Study|Condition under Investigation Worsened|4|||
164214328|NCT01482221|593151833|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
164214329|NCT01482221|593151834|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
164214330|NCT01482221|593151835|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
164214331|NCT01482221|593151833|FG000|Overall Study|Adverse Event|1|||
164214332|NCT01482221|593151834|FG001|Overall Study|Adverse Event|7|||
164214333|NCT01482221|593151835|FG002|Overall Study|Adverse Event|3|||
164214334|NCT01482221|593151833|FG000|Overall Study|Withdrawal by Subject|10|||
164214335|NCT01482221|593151834|FG001|Overall Study|Withdrawal by Subject|7|||
164214336|NCT01482221|593151835|FG002|Overall Study|Withdrawal by Subject|12|||
164214337|NCT01482221|593151833|FG000|Overall Study|Incorrect randomization|0|||
164214338|NCT01482221|593151834|FG001|Overall Study|Incorrect randomization|1|||
164214339|NCT01482221|593151835|FG002|Overall Study|Incorrect randomization|0|||
164214340|NCT01482221|593151833|FG000|Overall Study|Physician Decision|0|||
164214341|NCT01482221|593151834|FG001|Overall Study|Physician Decision|1|||
164214342|NCT01482221|593151835|FG002|Overall Study|Physician Decision|0|||
164214343|NCT05607043|593151836|FG000|Overall Study|Lost to Follow-up|2|||
164214344|NCT05427916|593151840|FG000|Overall Study|Adverse Event|3|||
164565086|NCT03980938|594438401|FG000|Treatment Period 2|Study Terminated|2|||
164214345|NCT05427916|593151841|FG001|Overall Study|Adverse Event|0|||
164214346|NCT05427916|593151840|FG000|Overall Study|Lack of Efficacy|6|||
164214347|NCT05427916|593151841|FG001|Overall Study|Lack of Efficacy|0|||
164565087|NCT03980938|594438402|FG001|Treatment Period 2|Study Terminated|2|||
164214348|NCT05427916|593151840|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
164214349|NCT05427916|593151841|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
164214350|NCT01257542|593151844|FG000|Overall Study|Protocol Violation|3|||
164214351|NCT01257542|593151845|FG001|Overall Study|Protocol Violation|5|||
164214352|NCT01257542|593151844|FG000|Overall Study|Withdrawal by Subject|0|||
164214353|NCT01257542|593151845|FG001|Overall Study|Withdrawal by Subject|2|||
164214354|NCT00081458|593151846|FG000|Overall Study|Adverse Event|1|||
164214355|NCT00081458|593151847|FG001|Overall Study|Adverse Event|5|||
164214356|NCT00081458|593151848|FG002|Overall Study|Adverse Event|2|||
164214357|NCT00081458|593151846|FG000|Overall Study|Withdrawal by Subject|0|||
164214358|NCT00081458|593151847|FG001|Overall Study|Withdrawal by Subject|3|||
164214359|NCT00081458|593151848|FG002|Overall Study|Withdrawal by Subject|1|||
164214360|NCT00081458|593151846|FG000|Overall Study|Randomized but not dosed|0|||
164214361|NCT00081458|593151847|FG001|Overall Study|Randomized but not dosed|0|||
164214362|NCT00081458|593151848|FG002|Overall Study|Randomized but not dosed|1|||
164214363|NCT03097315|593151852|FG000|Overall Study|Withdrawal by Subject|1|||
164214364|NCT03384966|593151853|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
164214365|NCT03384966|593151854|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
164214366|NCT03384966|593151855|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
164214367|NCT03384966|593151853|FG000|Follow-up Period|Adverse Event|1|||
164214368|NCT03384966|593151854|FG001|Follow-up Period|Adverse Event|0|||
164214369|NCT03384966|593151855|FG002|Follow-up Period|Adverse Event|0|||
164214370|NCT04790201|593151856|FG000|Overall Study|Lost to Follow-up|0|||
164214371|NCT04790201|593151857|FG001|Overall Study|Lost to Follow-up|0|||
164214372|NCT04790201|593151858|FG002|Overall Study|Lost to Follow-up|2|||
164214373|NCT04790201|593151856|FG000|Overall Study|Death|0|||
164214374|NCT04790201|593151857|FG001|Overall Study|Death|1|||
164214375|NCT04790201|593151858|FG002|Overall Study|Death|0|||
164214376|NCT04790201|593151856|FG000|Overall Study|Protocol Violation|1|||
164214377|NCT04790201|593151857|FG001|Overall Study|Protocol Violation|0|||
164214378|NCT04790201|593151858|FG002|Overall Study|Protocol Violation|1|||
164214379|NCT01334515|593151859|FG000|Overall Study|Adverse Event|1|||
164214380|NCT01334515|593151860|FG001|Overall Study|Adverse Event|6|||
164214381|NCT01334515|593151859|FG000|Overall Study|Death|1|||
164214382|NCT01334515|593151860|FG001|Overall Study|Death|0|||
164214383|NCT01334515|593151859|FG000|Overall Study|Lack of Efficacy|8|||
164214384|NCT01334515|593151860|FG001|Overall Study|Lack of Efficacy|21|||
164214385|NCT01334515|593151859|FG000|Overall Study|Physician Decision|1|||
164214386|NCT01334515|593151860|FG001|Overall Study|Physician Decision|1|||
164214387|NCT01334515|593151859|FG000|Overall Study|Withdrawal by Subject|1|||
164214388|NCT01334515|593151860|FG001|Overall Study|Withdrawal by Subject|1|||
164214389|NCT03637374|593151861|FG000|Overall Study|Death|2|||
164214390|NCT03637374|593151862|FG001|Overall Study|Death|0|||
164214391|NCT00776997|593151863|FG000|Overall Study|Adverse Event|2|||
164214392|NCT02948400|593151864|FG000|Overall Study|Withdrawal by Subject|17|||
164214393|NCT02948400|593151865|FG001|Overall Study|Withdrawal by Subject|10|||
164214394|NCT02948400|593151864|FG000|Overall Study|failed to attend appointments|47|||
164214395|NCT02948400|593151865|FG001|Overall Study|failed to attend appointments|34|||
164214396|NCT02948400|593151864|FG000|Overall Study|COVID-related closure|6|||
164214397|NCT02948400|593151865|FG001|Overall Study|COVID-related closure|2|||
164214398|NCT02948400|593151864|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
164214399|NCT02948400|593151865|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
164214400|NCT02948400|593151864|FG000|Overall Study|motion sickness in virtual reality|2|||
164214401|NCT02948400|593151865|FG001|Overall Study|motion sickness in virtual reality|0|||
164214402|NCT03925220|593151866|FG000|Overall Study|Withdrawal by Subject|4|||
164214403|NCT03925220|593151867|FG001|Overall Study|Withdrawal by Subject|4|||
164214404|NCT03925220|593151868|FG002|Overall Study|Withdrawal by Subject|4|||
164214405|NCT03925220|593151869|FG003|Overall Study|Withdrawal by Subject|4|||
164214406|NCT03925220|593151866|FG000|Overall Study|Lost to Follow-up|40|||
164214407|NCT03925220|593151867|FG001|Overall Study|Lost to Follow-up|46|||
164214408|NCT03925220|593151868|FG002|Overall Study|Lost to Follow-up|37|||
164214409|NCT03925220|593151869|FG003|Overall Study|Lost to Follow-up|38|||
164214410|NCT05774977|593151870|FG000|Overall Study|Withdrawal by Subject|2|||
164214411|NCT00374868|593151871|FG000|Overall Study|Adverse Event|12|||
164214412|NCT00374868|593151871|FG000|Overall Study|Progressive Disease|7|||
164214413|NCT00374868|593151871|FG000|Overall Study|Physician Decision|13|||
164214414|NCT00374868|593151871|FG000|Overall Study|Lost to Follow-up|1|||
164214415|NCT00374868|593151871|FG000|Overall Study|Death|2|||
164214416|NCT00374868|593151871|FG000|Overall Study|Other - Not Specified|1|||
164214417|NCT04470427|593151872|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
164214418|NCT04470427|593151873|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
164214419|NCT04470427|593151874|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
164214420|NCT04470427|593151875|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
164214421|NCT04470427|593151876|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
164214422|NCT04470427|593151877|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
164214423|NCT04470427|593151872|FG000|Part B :Open-label|Other than specified|0|||
164214424|NCT04470427|593151873|FG001|Part B :Open-label|Other than specified|0|||
164214425|NCT04470427|593151874|FG002|Part B :Open-label|Other than specified|788|||
164214426|NCT04470427|593151875|FG003|Part B :Open-label|Other than specified|0|||
164214427|NCT04470427|593151876|FG004|Part B :Open-label|Other than specified|523|||
164214428|NCT04470427|593151877|FG005|Part B :Open-label|Other than specified|0|||
164214429|NCT04470427|593151872|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
164214430|NCT04470427|593151873|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
164214431|NCT04470427|593151874|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
164565088|NCT02487108|594438403|FG000|Overall Study|Adverse Event|1|||
164565089|NCT02487108|594438404|FG001|Overall Study|Adverse Event|6|||
164565090|NCT02487108|594438405|FG002|Overall Study|Adverse Event|12|||
164565091|NCT02487108|594438406|FG003|Overall Study|Adverse Event|6|||
164565092|NCT02487108|594438403|FG000|Overall Study|Withdrawal by Subject|8|||
164669521|NCT00150462|594815035|FG002|Overall Study|Disease Progression or Relapse|2|||
164669522|NCT00150462|594815036|FG003|Overall Study|Disease Progression or Relapse|1|||
164669523|NCT00150462|594815037|FG004|Overall Study|Disease Progression or Relapse|2|||
164669524|NCT00150462|594815038|FG005|Overall Study|Disease Progression or Relapse|2|||
164669525|NCT00150462|594815039|FG006|Overall Study|Disease Progression or Relapse|3|||
164669526|NCT00150462|594815040|FG007|Overall Study|Disease Progression or Relapse|5|||
164669527|NCT00150462|594815041|FG008|Overall Study|Disease Progression or Relapse|5|||
164669528|NCT00150462|594815042|FG009|Overall Study|Disease Progression or Relapse|3|||
164669529|NCT00150462|594815043|FG010|Overall Study|Disease Progression or Relapse|2|||
164669530|NCT00150462|594815033|FG000|Overall Study|Withdrawal by Subject|0|||
164669531|NCT00150462|594815034|FG001|Overall Study|Withdrawal by Subject|1|||
164669532|NCT00150462|594815035|FG002|Overall Study|Withdrawal by Subject|1|||
164669533|NCT00150462|594815036|FG003|Overall Study|Withdrawal by Subject|0|||
164669534|NCT00150462|594815037|FG004|Overall Study|Withdrawal by Subject|1|||
164669535|NCT00150462|594815038|FG005|Overall Study|Withdrawal by Subject|2|||
164669536|NCT00150462|594815039|FG006|Overall Study|Withdrawal by Subject|0|||
164669537|NCT00150462|594815040|FG007|Overall Study|Withdrawal by Subject|1|||
164669538|NCT00150462|594815041|FG008|Overall Study|Withdrawal by Subject|0|||
164669539|NCT00150462|594815042|FG009|Overall Study|Withdrawal by Subject|1|||
164669540|NCT00150462|594815043|FG010|Overall Study|Withdrawal by Subject|0|||
164669541|NCT00150462|594815033|FG000|Overall Study|Death|0|||
164669542|NCT00150462|594815034|FG001|Overall Study|Death|1|||
164669543|NCT00150462|594815035|FG002|Overall Study|Death|0|||
164669544|NCT00150462|594815036|FG003|Overall Study|Death|0|||
164669545|NCT00150462|594815037|FG004|Overall Study|Death|0|||
164669546|NCT00150462|594815038|FG005|Overall Study|Death|0|||
164669547|NCT00150462|594815039|FG006|Overall Study|Death|0|||
164669548|NCT00150462|594815040|FG007|Overall Study|Death|0|||
164669549|NCT00150462|594815041|FG008|Overall Study|Death|1|||
164669550|NCT00150462|594815042|FG009|Overall Study|Death|0|||
164669551|NCT00150462|594815043|FG010|Overall Study|Death|0|||
164669552|NCT00150462|594815033|FG000|Overall Study|Adverse Event|0|||
164669553|NCT00150462|594815034|FG001|Overall Study|Adverse Event|0|||
164669554|NCT00150462|594815035|FG002|Overall Study|Adverse Event|0|||
164669555|NCT00150462|594815036|FG003|Overall Study|Adverse Event|1|||
164669556|NCT00150462|594815037|FG004|Overall Study|Adverse Event|0|||
164669557|NCT00150462|594815038|FG005|Overall Study|Adverse Event|0|||
164669558|NCT00150462|594815039|FG006|Overall Study|Adverse Event|0|||
164669559|NCT00150462|594815040|FG007|Overall Study|Adverse Event|2|||
164669560|NCT00150462|594815041|FG008|Overall Study|Adverse Event|0|||
164669561|NCT00150462|594815042|FG009|Overall Study|Adverse Event|1|||
164669562|NCT00150462|594815043|FG010|Overall Study|Adverse Event|0|||
164669563|NCT00150462|594815033|FG000|Overall Study|Physician Decision|0|||
164669564|NCT00150462|594815034|FG001|Overall Study|Physician Decision|0|||
164565093|NCT02487108|594438404|FG001|Overall Study|Withdrawal by Subject|5|||
164565094|NCT02487108|594438405|FG002|Overall Study|Withdrawal by Subject|5|||
164565095|NCT02487108|594438406|FG003|Overall Study|Withdrawal by Subject|0|||
164669565|NCT00150462|594815035|FG002|Overall Study|Physician Decision|1|||
164669566|NCT00150462|594815036|FG003|Overall Study|Physician Decision|1|||
164669567|NCT00150462|594815037|FG004|Overall Study|Physician Decision|0|||
164669568|NCT00150462|594815038|FG005|Overall Study|Physician Decision|0|||
164669569|NCT00150462|594815039|FG006|Overall Study|Physician Decision|0|||
164669570|NCT00150462|594815040|FG007|Overall Study|Physician Decision|0|||
164669571|NCT00150462|594815041|FG008|Overall Study|Physician Decision|0|||
164669572|NCT00150462|594815042|FG009|Overall Study|Physician Decision|0|||
164669573|NCT00150462|594815043|FG010|Overall Study|Physician Decision|0|||
164669574|NCT00150462|594815033|FG000|Overall Study|Other|0|||
164669575|NCT00150462|594815034|FG001|Overall Study|Other|0|||
164669576|NCT00150462|594815035|FG002|Overall Study|Other|0|||
164669577|NCT00150462|594815036|FG003|Overall Study|Other|0|||
164669578|NCT00150462|594815037|FG004|Overall Study|Other|0|||
164669579|NCT00150462|594815038|FG005|Overall Study|Other|0|||
164669580|NCT00150462|594815039|FG006|Overall Study|Other|0|||
164669581|NCT00150462|594815040|FG007|Overall Study|Other|0|||
164669582|NCT00150462|594815041|FG008|Overall Study|Other|0|||
164669583|NCT00150462|594815042|FG009|Overall Study|Other|1|||
164669584|NCT00150462|594815043|FG010|Overall Study|Other|1|||
164565096|NCT02487108|594438403|FG000|Overall Study|Non-compliance to study medication|3|||
164669585|NCT01666730|594815046|FG000|Overall Study|Adverse Event|16|||
164669586|NCT01666730|594815046|FG000|Overall Study|Death|2|||
164669587|NCT01666730|594815046|FG000|Overall Study|Physician Decision|5|||
164669588|NCT01666730|594815046|FG000|Overall Study|Withdrawal by Subject|9|||
164669589|NCT01666730|594815046|FG000|Overall Study|Disease progression/relapse|18|||
164669590|NCT03107091|594815047|FG000|Overall Study|Physician Decision|1|||
164669591|NCT00912288|594815050|FG000|Overall Study|Death|0|||
164669592|NCT00912288|594815051|FG001|Overall Study|Death|1|||
164669593|NCT00912288|594815050|FG000|Overall Study|Adverse Event|1|||
164669594|NCT00912288|594815051|FG001|Overall Study|Adverse Event|1|||
164669595|NCT00912288|594815050|FG000|Overall Study|Lost to Follow-up|1|||
164669596|NCT00912288|594815051|FG001|Overall Study|Lost to Follow-up|0|||
164669597|NCT00912288|594815050|FG000|Overall Study|Protocol Violation|1|||
164669598|NCT00912288|594815051|FG001|Overall Study|Protocol Violation|0|||
164669599|NCT00912288|594815050|FG000|Overall Study|Withdrawal by Subject|3|||
164669600|NCT00912288|594815051|FG001|Overall Study|Withdrawal by Subject|3|||
164669601|NCT00912288|594815050|FG000|Overall Study|Study terminated by sponsor|34|||
164669602|NCT00912288|594815051|FG001|Overall Study|Study terminated by sponsor|35|||
164669603|NCT00912288|594815050|FG000|Overall Study|Other|1|||
164214432|NCT04470427|593151875|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
164214433|NCT04470427|593151876|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
164214434|NCT04470427|593151877|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
164214435|NCT04470427|593151872|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
164214436|NCT04470427|593151873|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
164214437|NCT04470427|593151874|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
164214438|NCT04470427|593151875|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
164214439|NCT04470427|593151876|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
164214440|NCT04470427|593151877|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
164214441|NCT01018979|593151878|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
164214442|NCT01018979|593151879|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
164214443|NCT01018979|593151878|FG000|Overall Study|Not received at least one dose|0|||
164214444|NCT01018979|593151879|FG001|Overall Study|Not received at least one dose|1|||
164214445|NCT02324153|593151882|FG000|Overall Study|Withdrawal by Subject|4|||
164214446|NCT02324153|593151883|FG001|Overall Study|Withdrawal by Subject|1|||
164214447|NCT02324153|593151882|FG000|Overall Study|Surgery postponed after randomization|3|||
164214448|NCT02324153|593151883|FG001|Overall Study|Surgery postponed after randomization|0|||
164214449|NCT02324153|593151882|FG000|Overall Study|Developed delirium preoperatively|1|||
164214450|NCT02324153|593151883|FG001|Overall Study|Developed delirium preoperatively|0|||
164214451|NCT01937299|593151884|FG000|Overall Study|Adverse Event|13|||
164214452|NCT01937299|593151885|FG001|Overall Study|Adverse Event|0|||
164214453|NCT01937299|593151884|FG000|Overall Study|Lack of Efficacy|0|||
164214454|NCT01937299|593151885|FG001|Overall Study|Lack of Efficacy|4|||
164214455|NCT01937299|593151884|FG000|Overall Study|Withdrawal by Subject|1|||
164214456|NCT01937299|593151885|FG001|Overall Study|Withdrawal by Subject|0|||
164214457|NCT01913353|593151886|FG000|Overall Study|Adverse Event|2|||
164214458|NCT01913353|593151887|FG001|Overall Study|Adverse Event|0|||
164214459|NCT01913353|593151886|FG000|Overall Study|Physician Decision|0|||
164214460|NCT01913353|593151887|FG001|Overall Study|Physician Decision|2|||
164214461|NCT01913353|593151886|FG000|Overall Study|Withdrawal by Subject|20|||
164214462|NCT01913353|593151887|FG001|Overall Study|Withdrawal by Subject|6|||
164214463|NCT01913353|593151886|FG000|Overall Study|multiple reasons|10|||
164214464|NCT01913353|593151887|FG001|Overall Study|multiple reasons|7|||
164214465|NCT00385840|593151888|FG000|Overall Study|Adverse Event|1|||
164214466|NCT00385840|593151889|FG001|Overall Study|Adverse Event|1|||
164214467|NCT00385840|593151888|FG000|Overall Study|Lost to Follow-up|3|||
164214468|NCT00385840|593151889|FG001|Overall Study|Lost to Follow-up|13|||
164214469|NCT00700635|593151890|FG000|Overall Study|Adverse Event|1|||
164214470|NCT00700635|593151891|FG001|Overall Study|Adverse Event|0|||
164214471|NCT00700635|593151892|FG002|Overall Study|Adverse Event|0|||
164214472|NCT00700635|593151890|FG000|Overall Study|Lost to Follow-up|1|||
164214473|NCT00700635|593151891|FG001|Overall Study|Lost to Follow-up|3|||
164214474|NCT00700635|593151892|FG002|Overall Study|Lost to Follow-up|0|||
164214475|NCT00700635|593151890|FG000|Overall Study|Protocol Violation|2|||
164669604|NCT00912288|594815051|FG001|Overall Study|Other|0|||
164669605|NCT01449630|594815052|FG000|Period 1|Physician Decision|1|||
164669606|NCT01449630|594815053|FG001|Period 1|Physician Decision|0|||
164669607|NCT01449630|594815054|FG002|Period 1|Physician Decision|0|||
164669608|NCT01449630|594815055|FG003|Period 1|Physician Decision|1|||
164669609|NCT01449630|594815056|FG004|Period 1|Physician Decision|0|||
164669610|NCT01449630|594815057|FG005|Period 1|Physician Decision|0|||
164214476|NCT00700635|593151891|FG001|Overall Study|Protocol Violation|2|||
164214477|NCT00700635|593151892|FG002|Overall Study|Protocol Violation|0|||
164214478|NCT00700635|593151890|FG000|Overall Study|Withdrawal by Subject|7|||
164214479|NCT00700635|593151891|FG001|Overall Study|Withdrawal by Subject|3|||
164214480|NCT00700635|593151892|FG002|Overall Study|Withdrawal by Subject|1|||
164669611|NCT01449630|594815058|FG006|Period 1|Physician Decision|0|||
164669612|NCT01449630|594815059|FG007|Period 1|Physician Decision|0|||
164669613|NCT01449630|594815060|FG008|Period 1|Physician Decision|0|||
164669614|NCT01449630|594815052|FG000|Period 1|Sponsor Decision|0|||
164214481|NCT01260948|593151893|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
164214482|NCT01260948|593151894|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
164214483|NCT01260948|593151893|FG000|Second Intervention|Emesis|0|||
164214484|NCT01260948|593151894|FG001|Second Intervention|Emesis|1|||
164214485|NCT03301714|593152864|FG000|Overall Study|Lost to Follow-up|10|||
164565097|NCT02487108|594438404|FG001|Overall Study|Non-compliance to study medication|2|||
164565098|NCT02487108|594438405|FG002|Overall Study|Non-compliance to study medication|5|||
164565099|NCT02487108|594438406|FG003|Overall Study|Non-compliance to study medication|4|||
164565100|NCT02487108|594438403|FG000|Overall Study|Protocol Violation|1|||
164565101|NCT02487108|594438404|FG001|Overall Study|Protocol Violation|1|||
164565102|NCT02487108|594438405|FG002|Overall Study|Protocol Violation|2|||
164214486|NCT03301714|593152865|FG001|Overall Study|Lost to Follow-up|4|||
164214487|NCT03301714|593152866|FG002|Overall Study|Lost to Follow-up|4|||
164214488|NCT03301714|593152864|FG000|Overall Study|Did not receive allocated intervention|0|||
164214489|NCT03301714|593152865|FG001|Overall Study|Did not receive allocated intervention|2|||
164214490|NCT03301714|593152866|FG002|Overall Study|Did not receive allocated intervention|3|||
164214491|NCT03188185|593152867|FG000|Stage 1|Adverse Event|4|||
164214492|NCT03188185|593152868|FG001|Stage 1|Adverse Event|12|||
164214493|NCT03188185|593152869|FG002|Stage 1|Adverse Event|0|||
164214494|NCT03188185|593152870|FG003|Stage 1|Adverse Event|0|||
164214495|NCT03188185|593152867|FG000|Stage 1|Lack of Efficacy|0|||
164214496|NCT03188185|593152868|FG001|Stage 1|Lack of Efficacy|2|||
164214497|NCT03188185|593152869|FG002|Stage 1|Lack of Efficacy|0|||
164325922|NCT04704154|593569014|FG004|Overall Study|Physician Decision|2|||
164325923|NCT04704154|593569015|FG005|Overall Study|Physician Decision|0|||
164325924|NCT04704154|593569010|FG000|Overall Study|Participant Decision|1|||
164325925|NCT04704154|593569011|FG001|Overall Study|Participant Decision|1|||
164325926|NCT04704154|593569012|FG002|Overall Study|Participant Decision|0|||
164325927|NCT04704154|593569013|FG003|Overall Study|Participant Decision|0|||
164325928|NCT04704154|593569014|FG004|Overall Study|Participant Decision|0|||
164325929|NCT04704154|593569015|FG005|Overall Study|Participant Decision|0|||
164325930|NCT04704154|593569010|FG000|Overall Study|Progressive Disease|19|||
164325931|NCT04704154|593569011|FG001|Overall Study|Progressive Disease|17|||
164325932|NCT04704154|593569012|FG002|Overall Study|Progressive Disease|20|||
164325933|NCT04704154|593569013|FG003|Overall Study|Progressive Disease|18|||
164325934|NCT04704154|593569014|FG004|Overall Study|Progressive Disease|36|||
164325935|NCT04704154|593569015|FG005|Overall Study|Progressive Disease|30|||
164325936|NCT04704154|593569010|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
164325937|NCT04704154|593569011|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
164325938|NCT04704154|593569012|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
164325939|NCT04704154|593569013|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
164325940|NCT04704154|593569014|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
164325941|NCT04704154|593569015|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
164325942|NCT04704154|593569010|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
164565103|NCT02487108|594438406|FG003|Overall Study|Protocol Violation|0|||
164565104|NCT02487108|594438403|FG000|Overall Study|Non-compliance to study procedures|0|||
164565105|NCT02487108|594438404|FG001|Overall Study|Non-compliance to study procedures|0|||
164565106|NCT02487108|594438405|FG002|Overall Study|Non-compliance to study procedures|0|||
164565107|NCT02487108|594438406|FG003|Overall Study|Non-compliance to study procedures|1|||
164565108|NCT02487108|594438403|FG000|Overall Study|Other than specified|3|||
164565109|NCT02487108|594438404|FG001|Overall Study|Other than specified|2|||
164565110|NCT02487108|594438405|FG002|Overall Study|Other than specified|2|||
164565111|NCT02487108|594438406|FG003|Overall Study|Other than specified|0|||
164565112|NCT00469612|594438407|FG000|Overall Study|Study terminated before data collected|2|||
164565113|NCT00469612|594438408|FG001|Overall Study|Study terminated before data collected|0|||
164565114|NCT00883493|594438409|FG000|Overall Study|Adverse Event|11|||
164565115|NCT00883493|594438410|FG001|Overall Study|Adverse Event|12|||
164565116|NCT00883493|594438409|FG000|Overall Study|Lack of Efficacy|4|||
164565117|NCT00883493|594438410|FG001|Overall Study|Lack of Efficacy|3|||
164565118|NCT00883493|594438409|FG000|Overall Study|Lost to Follow-up|7|||
164565119|NCT00883493|594438410|FG001|Overall Study|Lost to Follow-up|6|||
164565120|NCT00883493|594438409|FG000|Overall Study|Withdrawal by Subject|11|||
164565121|NCT00883493|594438410|FG001|Overall Study|Withdrawal by Subject|20|||
164565122|NCT00883493|594438409|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
164565123|NCT00883493|594438410|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
164565124|NCT00883493|594438409|FG000|Overall Study|Study specific disc. criteria|2|||
164565125|NCT00883493|594438410|FG001|Overall Study|Study specific disc. criteria|0|||
164565126|NCT00883493|594438409|FG000|Overall Study|Other|5|||
164565127|NCT00883493|594438410|FG001|Overall Study|Other|3|||
164565128|NCT01622569|594438412|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
164565129|NCT01622569|594438413|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
164565130|NCT01622569|594438414|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
164565131|NCT01622569|594438415|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
164565132|NCT01622569|594438412|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
164669615|NCT01449630|594815053|FG001|Period 1|Sponsor Decision|0|||
164214498|NCT03188185|593152870|FG003|Stage 1|Lack of Efficacy|0|||
164214499|NCT03188185|593152867|FG000|Stage 1|Lost to Follow-up|6|||
164214500|NCT03188185|593152868|FG001|Stage 1|Lost to Follow-up|1|||
164214501|NCT03188185|593152869|FG002|Stage 1|Lost to Follow-up|0|||
164214502|NCT03188185|593152870|FG003|Stage 1|Lost to Follow-up|0|||
164214503|NCT03188185|593152867|FG000|Stage 1|Withdrawal by Subject|9|||
164214504|NCT03188185|593152868|FG001|Stage 1|Withdrawal by Subject|0|||
164214505|NCT03188185|593152869|FG002|Stage 1|Withdrawal by Subject|0|||
164214506|NCT03188185|593152870|FG003|Stage 1|Withdrawal by Subject|0|||
164214507|NCT03188185|593152867|FG000|Stage 1|Identified as a professional patient|0|||
164214508|NCT03188185|593152868|FG001|Stage 1|Identified as a professional patient|1|||
164214509|NCT03188185|593152869|FG002|Stage 1|Identified as a professional patient|0|||
164214510|NCT03188185|593152870|FG003|Stage 1|Identified as a professional patient|0|||
164214511|NCT03188185|593152867|FG000|Stage 2|Adverse Event|0|||
164214512|NCT03188185|593152868|FG001|Stage 2|Adverse Event|0|||
164214513|NCT03188185|593152869|FG002|Stage 2|Adverse Event|2|||
164214514|NCT03188185|593152870|FG003|Stage 2|Adverse Event|4|||
164214515|NCT03188185|593152867|FG000|Stage 2|Lack of Efficacy|0|||
164214516|NCT03188185|593152868|FG001|Stage 2|Lack of Efficacy|0|||
164214517|NCT03188185|593152869|FG002|Stage 2|Lack of Efficacy|3|||
164214518|NCT03188185|593152870|FG003|Stage 2|Lack of Efficacy|0|||
164214519|NCT03188185|593152867|FG000|Stage 2|Lost to Follow-up|0|||
164214520|NCT03188185|593152868|FG001|Stage 2|Lost to Follow-up|0|||
164214521|NCT03188185|593152869|FG002|Stage 2|Lost to Follow-up|1|||
164214522|NCT03188185|593152870|FG003|Stage 2|Lost to Follow-up|0|||
164214523|NCT03188185|593152867|FG000|Stage 2|Physician Decision|0|||
164214524|NCT03188185|593152868|FG001|Stage 2|Physician Decision|0|||
164214525|NCT03188185|593152869|FG002|Stage 2|Physician Decision|0|||
164214526|NCT03188185|593152870|FG003|Stage 2|Physician Decision|1|||
164214527|NCT03188185|593152867|FG000|Stage 2|Withdrawal by Subject|0|||
164214528|NCT03188185|593152868|FG001|Stage 2|Withdrawal by Subject|0|||
164214529|NCT03188185|593152869|FG002|Stage 2|Withdrawal by Subject|3|||
164214530|NCT03188185|593152870|FG003|Stage 2|Withdrawal by Subject|1|||
164214531|NCT02965456|593152871|FG000|Overall Study|Lost to Follow-up|40|||
164214532|NCT02965456|593152872|FG001|Overall Study|Lost to Follow-up|18|||
164214533|NCT02965456|593152871|FG000|Overall Study|Subject Request|22|||
164214534|NCT02965456|593152872|FG001|Overall Study|Subject Request|13|||
164214535|NCT02965456|593152871|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
164214536|NCT02965456|593152872|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
164214537|NCT02965456|593152871|FG000|Overall Study|Adverse Event|3|||
164214538|NCT02965456|593152872|FG001|Overall Study|Adverse Event|0|||
164214539|NCT02965456|593152871|FG000|Overall Study|Noncompliance with Study Drug|1|||
164214540|NCT02965456|593152872|FG001|Overall Study|Noncompliance with Study Drug|1|||
164214541|NCT02965456|593152871|FG000|Overall Study|Worsening Condition|0|||
164214542|NCT02965456|593152872|FG001|Overall Study|Worsening Condition|2|||
164325943|NCT04704154|593569011|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
164325944|NCT04704154|593569012|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
164325945|NCT04704154|593569013|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
164325946|NCT04704154|593569014|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
164325947|NCT04704154|593569015|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
164325948|NCT03220438|593569016|FG000|Overall Study|Lost to Follow-up|0|||
164325949|NCT03220438|593569017|FG001|Overall Study|Lost to Follow-up|0|||
164325950|NCT03220438|593569018|FG002|Overall Study|Lost to Follow-up|1|||
164325951|NCT03220438|593569019|FG003|Overall Study|Lost to Follow-up|0|||
164325952|NCT04062123|593569020|FG000|Overall Study|Withdrawal by Subject|0|||
164325953|NCT04062123|593569021|FG001|Overall Study|Withdrawal by Subject|1|||
164325954|NCT04062123|593569022|FG002|Overall Study|Withdrawal by Subject|0|||
164325955|NCT04190680|593569023|FG000|Overall Study|Not meeting criteria for data analysis|1|||
164325956|NCT04190680|593569024|FG001|Overall Study|Not meeting criteria for data analysis|15|||
164325957|NCT04190680|593569023|FG000|Overall Study|Administrative error|0|||
164325958|NCT04190680|593569024|FG001|Overall Study|Administrative error|18|||
164325959|NCT03780400|593569025|FG000|Overall Study|Lost to Follow-up|5|||
164325960|NCT03780400|593569025|FG000|Overall Study|Withdrawal by Subject|2|||
164669616|NCT01449630|594815054|FG002|Period 1|Sponsor Decision|0|||
164214543|NCT02965456|593152871|FG000|Overall Study|Lack of Efficacy|1|||
164214544|NCT02965456|593152872|FG001|Overall Study|Lack of Efficacy|0|||
164214545|NCT02965456|593152871|FG000|Overall Study|Physician Decision|0|||
164214546|NCT02965456|593152872|FG001|Overall Study|Physician Decision|1|||
164214547|NCT02965456|593152871|FG000|Overall Study|Pregnancy|1|||
164669617|NCT01449630|594815055|FG003|Period 1|Sponsor Decision|0|||
164214548|NCT02965456|593152872|FG001|Overall Study|Pregnancy|0|||
164214549|NCT02965456|593152871|FG000|Overall Study|Protocol Violation|0|||
164214550|NCT02965456|593152872|FG001|Overall Study|Protocol Violation|1|||
164214551|NCT02965456|593152871|FG000|Overall Study|Participant ran out of study drug|0|||
164214552|NCT02965456|593152872|FG001|Overall Study|Participant ran out of study drug|1|||
164214553|NCT05073315|593152873|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
164214554|NCT05073315|593152874|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
164214555|NCT05073315|593152875|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
164214556|NCT05073315|593152873|FG000|Period 1 (Lead-in Period)|Death|1|||
164214557|NCT05073315|593152874|FG001|Period 1 (Lead-in Period)|Death|0|||
164214558|NCT05073315|593152875|FG002|Period 1 (Lead-in Period)|Death|0|||
164214559|NCT05073315|593152873|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
164214560|NCT05073315|593152874|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
164214561|NCT05073315|593152875|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
164214562|NCT05073315|593152873|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
164214563|NCT05073315|593152874|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
164214564|NCT05073315|593152875|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
164214565|NCT05073315|593152873|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
164214566|NCT05073315|593152874|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
164214567|NCT05073315|593152875|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
164214568|NCT05073315|593152873|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
164214569|NCT05073315|593152874|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
164214570|NCT05073315|593152875|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
164214571|NCT05073315|593152873|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
164214572|NCT05073315|593152874|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
164214573|NCT05073315|593152875|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
164214574|NCT05073315|593152873|FG000|Period 2|Adverse Event|0|||
164214575|NCT05073315|593152874|FG001|Period 2|Adverse Event|3|||
164214576|NCT05073315|593152875|FG002|Period 2|Adverse Event|6|||
164214577|NCT05073315|593152873|FG000|Period 2|Lost to Follow-up|0|||
164214578|NCT05073315|593152874|FG001|Period 2|Lost to Follow-up|5|||
164214579|NCT05073315|593152875|FG002|Period 2|Lost to Follow-up|5|||
164214580|NCT05073315|593152873|FG000|Period 2|Withdrawal by Subject|0|||
164214581|NCT05073315|593152874|FG001|Period 2|Withdrawal by Subject|4|||
164214582|NCT05073315|593152875|FG002|Period 2|Withdrawal by Subject|9|||
164214583|NCT05073315|593152873|FG000|Period 2|Protocol Violation|0|||
164214584|NCT05073315|593152874|FG001|Period 2|Protocol Violation|0|||
164214585|NCT05073315|593152875|FG002|Period 2|Protocol Violation|1|||
164214586|NCT01529268|593152876|FG000|Overall Study|Lost to Follow-up|9|||
164214587|NCT01529268|593152877|FG001|Overall Study|Lost to Follow-up|3|||
164214588|NCT01529268|593152876|FG000|Overall Study|Moved|3|||
164214589|NCT01529268|593152877|FG001|Overall Study|Moved|0|||
164214590|NCT00303953|593152878|FG000|Overall Study|Ineligible|1|||
164214591|NCT00303953|593152878|FG000|Overall Study|Death|1|||
164214592|NCT00303953|593152878|FG000|Overall Study|Adverse Event|4|||
164214593|NCT00303953|593152878|FG000|Overall Study|Lack of Efficacy|12|||
164214594|NCT00303953|593152878|FG000|Overall Study|Physician Decision|1|||
164214595|NCT04465955|593152879|FG000|Overall Study|Withdrew consent|6|||
164214596|NCT04465955|593152880|FG001|Overall Study|Withdrew consent|10|||
164214597|NCT04465955|593152881|FG002|Overall Study|Withdrew consent|7|||
164214598|NCT04465955|593152879|FG000|Overall Study|Adverse Event|6|||
164214599|NCT04465955|593152880|FG001|Overall Study|Adverse Event|5|||
164214600|NCT04465955|593152881|FG002|Overall Study|Adverse Event|1|||
164214601|NCT04465955|593152879|FG000|Overall Study|Lost to Follow-up|2|||
164214602|NCT04465955|593152880|FG001|Overall Study|Lost to Follow-up|0|||
164214603|NCT04465955|593152881|FG002|Overall Study|Lost to Follow-up|3|||
164214604|NCT04465955|593152879|FG000|Overall Study|Other|1|||
164214605|NCT04465955|593152880|FG001|Overall Study|Other|1|||
164214606|NCT04465955|593152881|FG002|Overall Study|Other|3|||
164214607|NCT02393755|593152882|FG000|Overall Study|Withdrawal by Subject|0|||
164214608|NCT02393755|593152883|FG001|Overall Study|Withdrawal by Subject|3|||
164214609|NCT02393755|593152882|FG000|Overall Study|Adverse Event|0|||
164325961|NCT01850602|593569026|FG000|Overall Study|Adverse Event|7|||
164214610|NCT02393755|593152883|FG001|Overall Study|Adverse Event|2|||
164214611|NCT02393755|593152882|FG000|Overall Study|Physician Decision|0|||
164214612|NCT02393755|593152883|FG001|Overall Study|Physician Decision|2|||
164214613|NCT05324371|593152884|FG000|Overall Study|Withdrawal by Subject|1|||
164214614|NCT05324371|593152884|FG000|Overall Study|Death|1|||
164214615|NCT04822194|593152885|FG000|Overall Study|Withdrawal by Subject|5|||
164214616|NCT04822194|593152886|FG001|Overall Study|Withdrawal by Subject|4|||
164214617|NCT04822194|593152885|FG000|Overall Study|Technical issues with MR scanner|1|||
164214618|NCT04822194|593152886|FG001|Overall Study|Technical issues with MR scanner|0|||
164214619|NCT04822194|593152885|FG000|Overall Study|Lost to Follow-up|5|||
164214620|NCT04822194|593152886|FG001|Overall Study|Lost to Follow-up|7|||
164214621|NCT05182125|593152887|FG000|Overall Study|Withdrawal by Subject|0|||
164214622|NCT05182125|593152888|FG001|Overall Study|Withdrawal by Subject|0|||
164214623|NCT05182125|593152889|FG002|Overall Study|Withdrawal by Subject|0|||
164214624|NCT05182125|593152890|FG003|Overall Study|Withdrawal by Subject|0|||
164214625|NCT05182125|593152891|FG004|Overall Study|Withdrawal by Subject|2|||
164214626|NCT05182125|593152892|FG005|Overall Study|Withdrawal by Subject|0|||
164214627|NCT05182125|593152887|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
164214628|NCT05182125|593152888|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
164214629|NCT05182125|593152889|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
164214630|NCT05182125|593152890|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
164325962|NCT01850602|593569027|FG001|Overall Study|Adverse Event|10|||
164214631|NCT05182125|593152891|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
164214632|NCT05182125|593152892|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
164214633|NCT05182125|593152887|FG000|Overall Study|Death|0|||
164214634|NCT05182125|593152888|FG001|Overall Study|Death|0|||
164214635|NCT05182125|593152889|FG002|Overall Study|Death|0|||
164214636|NCT05182125|593152890|FG003|Overall Study|Death|0|||
164214637|NCT05182125|593152891|FG004|Overall Study|Death|1|||
164214638|NCT05182125|593152892|FG005|Overall Study|Death|0|||
164214639|NCT02965833|593152896|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
164214640|NCT02965833|593152897|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
164214641|NCT02965833|593152896|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
164214642|NCT02965833|593152897|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
164214643|NCT02965833|593152896|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
164214644|NCT02965833|593152897|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
164214645|NCT02965833|593152896|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
164214646|NCT02965833|593152897|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
164214647|NCT02965833|593152896|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
164214648|NCT02965833|593152897|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
164214649|NCT03370302|593152899|FG000|Dose Escalation Phase|Other|0|||
164214650|NCT03370302|593152900|FG001|Dose Escalation Phase|Other|1|||
164214651|NCT03370302|593152901|FG002|Dose Escalation Phase|Other|1|||
164214652|NCT03370302|593152902|FG003|Dose Escalation Phase|Other|0|||
164214653|NCT03370302|593152903|FG004|Dose Escalation Phase|Other|0|||
164214654|NCT03370302|593152904|FG005|Dose Escalation Phase|Other|0|||
164669618|NCT01449630|594815056|FG004|Period 1|Sponsor Decision|0|||
164669619|NCT01449630|594815057|FG005|Period 1|Sponsor Decision|1|||
164669620|NCT01449630|594815058|FG006|Period 1|Sponsor Decision|0|||
164669621|NCT01449630|594815059|FG007|Period 1|Sponsor Decision|0|||
164669622|NCT01449630|594815060|FG008|Period 1|Sponsor Decision|0|||
164669623|NCT01449630|594815052|FG000|Period 2|Sponsor Decision|0|||
164669624|NCT01449630|594815053|FG001|Period 2|Sponsor Decision|0|||
164669625|NCT01449630|594815054|FG002|Period 2|Sponsor Decision|0|||
164669626|NCT01449630|594815055|FG003|Period 2|Sponsor Decision|0|||
164669627|NCT01449630|594815056|FG004|Period 2|Sponsor Decision|0|||
164669628|NCT01449630|594815057|FG005|Period 2|Sponsor Decision|0|||
164669629|NCT01449630|594815058|FG006|Period 2|Sponsor Decision|1|||
164669630|NCT01449630|594815059|FG007|Period 2|Sponsor Decision|0|||
164669631|NCT01449630|594815060|FG008|Period 2|Sponsor Decision|0|||
164669632|NCT00105196|594815061|FG000|Overall Study|Lack of Efficacy|2|||
164669633|NCT00105196|594815062|FG001|Overall Study|Lack of Efficacy|3|||
164214655|NCT03370302|593152899|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
164214656|NCT03370302|593152900|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
164214657|NCT03370302|593152901|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
164214658|NCT03370302|593152902|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
164214659|NCT03370302|593152903|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
164214660|NCT03370302|593152904|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
164214661|NCT03370302|593152899|FG000|Dose Escalation Phase|Adverse Event|1|||
164214662|NCT03370302|593152900|FG001|Dose Escalation Phase|Adverse Event|0|||
164214663|NCT03370302|593152901|FG002|Dose Escalation Phase|Adverse Event|2|||
164214664|NCT03370302|593152902|FG003|Dose Escalation Phase|Adverse Event|0|||
164214665|NCT03370302|593152903|FG004|Dose Escalation Phase|Adverse Event|0|||
164214666|NCT03370302|593152904|FG005|Dose Escalation Phase|Adverse Event|0|||
164214667|NCT03370302|593152899|FG000|Dose Escalation Phase|Progressive Disease|2|||
164214668|NCT03370302|593152900|FG001|Dose Escalation Phase|Progressive Disease|4|||
164669634|NCT00105196|594815061|FG000|Overall Study|Adverse Event|11|||
164669635|NCT00105196|594815062|FG001|Overall Study|Adverse Event|3|||
164669636|NCT00105196|594815061|FG000|Overall Study|Withdrawal by Subject|6|||
164669637|NCT00105196|594815062|FG001|Overall Study|Withdrawal by Subject|6|||
164214669|NCT03370302|593152901|FG002|Dose Escalation Phase|Progressive Disease|2|||
164214670|NCT03370302|593152902|FG003|Dose Escalation Phase|Progressive Disease|0|||
164214671|NCT03370302|593152903|FG004|Dose Escalation Phase|Progressive Disease|3|||
164669638|NCT00105196|594815061|FG000|Overall Study|Lost to Follow-up|3|||
164669639|NCT00105196|594815062|FG001|Overall Study|Lost to Follow-up|2|||
164669640|NCT00105196|594815061|FG000|Overall Study|Poor/noncompliance|3|||
164669641|NCT00105196|594815062|FG001|Overall Study|Poor/noncompliance|4|||
164214672|NCT03370302|593152904|FG005|Dose Escalation Phase|Progressive Disease|1|||
164214673|NCT03370302|593152899|FG000|Dose Expansion Phase|Progressive Disease|0|||
164214674|NCT03370302|593152900|FG001|Dose Expansion Phase|Progressive Disease|0|||
164214675|NCT03370302|593152901|FG002|Dose Expansion Phase|Progressive Disease|0|||
164214676|NCT03370302|593152902|FG003|Dose Expansion Phase|Progressive Disease|6|||
164214677|NCT03370302|593152903|FG004|Dose Expansion Phase|Progressive Disease|0|||
164214678|NCT03370302|593152904|FG005|Dose Expansion Phase|Progressive Disease|0|||
164214679|NCT00118287|593152905|FG000|Overall Study|Intracranial haemorrhage|1|||
164214680|NCT00118287|593152905|FG000|Overall Study|Muscle pain|1|||
164669642|NCT00105196|594815061|FG000|Overall Study|Protocol Violation|5|||
164669643|NCT00105196|594815062|FG001|Overall Study|Protocol Violation|2|||
164325963|NCT01850602|593569026|FG000|Overall Study|Physician Decision|2|||
164669644|NCT00105196|594815061|FG000|Overall Study|pending surgery|0|||
164669645|NCT00105196|594815062|FG001|Overall Study|pending surgery|1|||
164669646|NCT00105196|594815061|FG000|Overall Study|marijuana use|0|||
164669647|NCT00105196|594815062|FG001|Overall Study|marijuana use|1|||
164214681|NCT04738487|593152906|FG000|Overall Study|Participant Ongoing in Study|298|||
164214682|NCT04738487|593152907|FG001|Overall Study|Participant Ongoing in Study|297|||
164214683|NCT04738487|593152906|FG000|Overall Study|Withdrawal by Subject|7|||
164214684|NCT04738487|593152907|FG001|Overall Study|Withdrawal by Subject|9|||
164214685|NCT04738487|593152906|FG000|Overall Study|Lost to Follow-up|2|||
164214686|NCT04738487|593152907|FG001|Overall Study|Lost to Follow-up|0|||
164214687|NCT04738487|593152906|FG000|Overall Study|Death|287|||
164214688|NCT04738487|593152907|FG001|Overall Study|Death|306|||
164214689|NCT03976375|593152908|FG000|Overall Study|Death|158|||
164214690|NCT03976375|593152909|FG001|Overall Study|Death|160|||
164214691|NCT03976375|593152910|FG002|Overall Study|Death|42|||
164214692|NCT03976375|593152908|FG000|Overall Study|Lost to Follow-up|2|||
164214693|NCT03976375|593152909|FG001|Overall Study|Lost to Follow-up|1|||
164214694|NCT03976375|593152910|FG002|Overall Study|Lost to Follow-up|1|||
164214695|NCT03976375|593152908|FG000|Overall Study|Withdrawal by Subject|5|||
164214696|NCT03976375|593152909|FG001|Overall Study|Withdrawal by Subject|9|||
164669648|NCT00105196|594815061|FG000|Overall Study|Subject became unblinded|0|||
164669649|NCT00105196|594815062|FG001|Overall Study|Subject became unblinded|1|||
164669650|NCT03340727|594815063|FG000|Overall Study|Death|1|||
164214697|NCT03976375|593152910|FG002|Overall Study|Withdrawal by Subject|4|||
164214698|NCT03976375|593152908|FG000|Overall Study|Sponsor decision|20|||
164214699|NCT03976375|593152909|FG001|Overall Study|Sponsor decision|19|||
164214700|NCT03976375|593152910|FG002|Overall Study|Sponsor decision|1|||
164214701|NCT04818112|593152911|FG000|Overall Study|Withdrawal by Subject|54|||
164214702|NCT04818112|593152912|FG001|Overall Study|Withdrawal by Subject|12|||
164214703|NCT04818112|593152911|FG000|Overall Study|Lost to Follow-up|38|||
164214704|NCT04818112|593152912|FG001|Overall Study|Lost to Follow-up|10|||
164214705|NCT03091439|593152913|FG000|Overall Study|Study Terminated by the Sponsor|1|||
164214706|NCT03091439|593152914|FG001|Overall Study|Study Terminated by the Sponsor|0|||
164565133|NCT01622569|594438413|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
164565134|NCT01622569|594438414|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
164565135|NCT01622569|594438415|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
164565136|NCT01622569|594438412|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
164565137|NCT01622569|594438413|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
164565138|NCT01622569|594438414|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
164565139|NCT01622569|594438415|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
164565140|NCT01622569|594438412|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
164565141|NCT01622569|594438413|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
164565142|NCT01622569|594438414|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
164565143|NCT01622569|594438415|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
164565144|NCT01622569|594438412|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
164565145|NCT01622569|594438413|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
164565146|NCT01622569|594438414|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
164565147|NCT01622569|594438415|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
164565148|NCT01622569|594438412|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
164565149|NCT01622569|594438413|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
164565150|NCT01622569|594438414|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
164565151|NCT01622569|594438415|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
164565152|NCT01622569|594438412|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
164565153|NCT01622569|594438413|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
164565154|NCT01622569|594438414|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
164565155|NCT01622569|594438415|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
164565156|NCT01622569|594438412|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
164565157|NCT01622569|594438413|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
164565158|NCT01622569|594438414|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
164565159|NCT01622569|594438415|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
164565160|NCT02522767|594438416|FG000|Double-blind|Withdrawal by Subject|8|||
164565161|NCT02522767|594438417|FG001|Double-blind|Withdrawal by Subject|11|||
164565162|NCT02522767|594438416|FG000|Double-blind|Lost to Follow-up|1|||
164565163|NCT02522767|594438417|FG001|Double-blind|Lost to Follow-up|0|||
164565164|NCT02522767|594438416|FG000|Double-blind|Adverse Event|1|||
164565165|NCT02522767|594438417|FG001|Double-blind|Adverse Event|10|||
164565166|NCT02522767|594438416|FG000|Double-blind|Protocol Violation|0|||
164565167|NCT02522767|594438417|FG001|Double-blind|Protocol Violation|1|||
164565168|NCT02522767|594438416|FG000|Double-blind|Lack of Efficacy|0|||
164565169|NCT02522767|594438417|FG001|Double-blind|Lack of Efficacy|2|||
164565170|NCT02522767|594438416|FG000|Double-blind|Protocol Deviation|1|||
164565171|NCT02522767|594438417|FG001|Double-blind|Protocol Deviation|0|||
164669651|NCT03340727|594815064|FG001|Overall Study|Death|0|||
164669652|NCT03340727|594815063|FG000|Overall Study|Lost to Follow-up|31|||
164669653|NCT03340727|594815064|FG001|Overall Study|Lost to Follow-up|35|||
164669654|NCT03340727|594815063|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
164669655|NCT03340727|594815064|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
164669656|NCT03340727|594815063|FG000|Overall Study|Transferred to another facility|10|||
164669657|NCT03340727|594815064|FG001|Overall Study|Transferred to another facility|7|||
164669658|NCT03340727|594815063|FG000|Overall Study|Withdrawal by Subject|28|||
164325964|NCT01850602|593569027|FG001|Overall Study|Physician Decision|1|||
164325965|NCT01850602|593569026|FG000|Overall Study|Withdrawal by Subject|2|||
164669659|NCT03340727|594815064|FG001|Overall Study|Withdrawal by Subject|17|||
164325966|NCT01850602|593569027|FG001|Overall Study|Withdrawal by Subject|4|||
164325967|NCT01850602|593569026|FG000|Overall Study|Decrease in serum calcium|2|||
164669660|NCT01873586|594815065|FG000|Overall Study|Lost to Follow-up|3|||
164214707|NCT03122106|593152915|FG000|Overall Study|Not enough tissue|1|||
164214708|NCT03122106|593152915|FG000|Overall Study|Disease progression during screening|2|||
164214709|NCT03122106|593152915|FG000|Overall Study|Poor RNA quality for vaccine|1|||
164214710|NCT04017962|593152916|FG000|Overall Study|Death|2|||
164214711|NCT04017962|593152917|FG001|Overall Study|Death|0|||
164214712|NCT04017962|593152916|FG000|Overall Study|Lost to Follow-up|2|||
164214713|NCT04017962|593152917|FG001|Overall Study|Lost to Follow-up|0|||
164214714|NCT04017962|593152916|FG000|Overall Study|Physician Decision|1|||
164214715|NCT04017962|593152917|FG001|Overall Study|Physician Decision|0|||
164214716|NCT04017962|593152916|FG000|Overall Study|Discontinued LTV|5|||
164214717|NCT04017962|593152917|FG001|Overall Study|Discontinued LTV|0|||
164214718|NCT05172570|593152918|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
164214719|NCT05172570|593152919|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
164214720|NCT05172570|593152920|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
164214721|NCT05172570|593152918|FG000|Overall Study|PI Decision due to equipment shortages|0|||
164214722|NCT05172570|593152919|FG001|Overall Study|PI Decision due to equipment shortages|0|||
164214723|NCT05172570|593152920|FG002|Overall Study|PI Decision due to equipment shortages|1|||
164214724|NCT00640289|593152921|FG000|Overall Study|Death|3|||
164325968|NCT01850602|593569027|FG001|Overall Study|Decrease in serum calcium|3|||
164325969|NCT01850602|593569026|FG000|Overall Study|Increase in serum ferritin|1|||
164325970|NCT01850602|593569027|FG001|Overall Study|Increase in serum ferritin|0|||
164325971|NCT00740051|593569030|FG000|Overall Study|Lack of Efficacy|2|||
164325972|NCT00740051|593569031|FG001|Overall Study|Lack of Efficacy|5|||
164325973|NCT00740051|593569030|FG000|Overall Study|Adverse Event|1|||
164325974|NCT00740051|593569031|FG001|Overall Study|Adverse Event|4|||
164325975|NCT00740051|593569030|FG000|Overall Study|Protocol Violation|2|||
164325976|NCT00740051|593569031|FG001|Overall Study|Protocol Violation|6|||
164325977|NCT00740051|593569030|FG000|Overall Study|Lost to Follow-up|3|||
164325978|NCT00740051|593569031|FG001|Overall Study|Lost to Follow-up|8|||
164325979|NCT00740051|593569030|FG000|Overall Study|Withdrawal by Subject|6|||
164325980|NCT00740051|593569031|FG001|Overall Study|Withdrawal by Subject|8|||
164325981|NCT00740051|593569030|FG000|Overall Study|Other reason (not specified)|4|||
164214725|NCT00640289|593152921|FG000|Overall Study|Withdrawal by Subject|1|||
164214726|NCT00640289|593152921|FG000|Overall Study|Lost to Follow-up|1|||
164214727|NCT00640289|593152921|FG000|Overall Study|Data collected under different amendment|2|||
164214728|NCT00640289|593152921|FG000|Overall Study|Transferred to another center|1|||
164214729|NCT00640289|593152921|FG000|Overall Study|Missing status|5|||
164214730|NCT03550209|593152923|FG000|Overall Study|Lost to Follow-up|1|||
164214731|NCT03550209|593152924|FG001|Overall Study|Lost to Follow-up|0|||
164214732|NCT03550209|593152925|FG002|Overall Study|Lost to Follow-up|1|||
164214733|NCT03550209|593152926|FG003|Overall Study|Lost to Follow-up|0|||
164214734|NCT03550209|593152923|FG000|Overall Study|Withdrawal by Subject|0|||
164214735|NCT03550209|593152924|FG001|Overall Study|Withdrawal by Subject|3|||
164214736|NCT03550209|593152925|FG002|Overall Study|Withdrawal by Subject|1|||
164214737|NCT03550209|593152926|FG003|Overall Study|Withdrawal by Subject|2|||
164214738|NCT03550209|593152923|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
164214739|NCT03550209|593152924|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
164214740|NCT03550209|593152925|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
164214741|NCT03550209|593152926|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
164214742|NCT00768053|593152927|FG000|Overall Study|Adverse Event|10|||
164214743|NCT00768053|593152927|FG000|Overall Study|Lost to Follow-up|1|||
164214744|NCT01202591|593152930|FG000|Overall Study|Adverse Event|2|||
164214745|NCT01202591|593152931|FG001|Overall Study|Adverse Event|1|||
164214746|NCT01202591|593152932|FG002|Overall Study|Adverse Event|4|||
164214747|NCT01202591|593152933|FG003|Overall Study|Adverse Event|4|||
164214748|NCT01202591|593152934|FG004|Overall Study|Adverse Event|0|||
164214749|NCT01202591|593152935|FG005|Overall Study|Adverse Event|0|||
164214750|NCT01202591|593152930|FG000|Overall Study|Other reason as per investigator|3|||
164214751|NCT01202591|593152931|FG001|Overall Study|Other reason as per investigator|4|||
164214752|NCT01202591|593152932|FG002|Overall Study|Other reason as per investigator|7|||
164214753|NCT01202591|593152933|FG003|Overall Study|Other reason as per investigator|3|||
164214754|NCT01202591|593152934|FG004|Overall Study|Other reason as per investigator|1|||
164214755|NCT01202591|593152935|FG005|Overall Study|Other reason as per investigator|3|||
164214756|NCT01202591|593152930|FG000|Overall Study|Withdrawal by Subject|0|||
164214757|NCT01202591|593152931|FG001|Overall Study|Withdrawal by Subject|0|||
164214758|NCT01202591|593152932|FG002|Overall Study|Withdrawal by Subject|0|||
164214759|NCT01202591|593152933|FG003|Overall Study|Withdrawal by Subject|0|||
164214760|NCT01202591|593152934|FG004|Overall Study|Withdrawal by Subject|2|||
164214761|NCT01202591|593152935|FG005|Overall Study|Withdrawal by Subject|1|||
164214762|NCT01202591|593152930|FG000|Overall Study|Objective Disease Progression|0|||
164214763|NCT01202591|593152931|FG001|Overall Study|Objective Disease Progression|0|||
164214764|NCT01202591|593152932|FG002|Overall Study|Objective Disease Progression|0|||
164214765|NCT01202591|593152933|FG003|Overall Study|Objective Disease Progression|0|||
164214766|NCT01202591|593152934|FG004|Overall Study|Objective Disease Progression|2|||
164214767|NCT01202591|593152935|FG005|Overall Study|Objective Disease Progression|0|||
164214768|NCT00632359|593152939|FG000|Overall Study|Withdrawal by Subject|2|||
164214769|NCT03599713|593152942|FG000|Overall Study|Death|38|||
164214770|NCT03599713|593152943|FG001|Overall Study|Death|3|||
164214771|NCT03599713|593152942|FG000|Overall Study|Withdrawal by Subject|17|||
164214772|NCT03599713|593152943|FG001|Overall Study|Withdrawal by Subject|0|||
164214773|NCT03599713|593152942|FG000|Overall Study|Lost to Follow-up|4|||
164214774|NCT03599713|593152943|FG001|Overall Study|Lost to Follow-up|0|||
164214775|NCT03599713|593152942|FG000|Overall Study|Discontinued Due to End of Study|42|||
164214776|NCT03599713|593152943|FG001|Overall Study|Discontinued Due to End of Study|3|||
164214777|NCT05578872|593152944|FG000|Overall Study|Withdrawal by Subject|2|||
164214778|NCT05578872|593152945|FG001|Overall Study|Withdrawal by Subject|1|||
164214779|NCT05578872|593152944|FG000|Overall Study|Adverse Event|1|||
164214780|NCT05578872|593152945|FG001|Overall Study|Adverse Event|1|||
164214781|NCT05578872|593152944|FG000|Overall Study|Physician Decision|1|||
164214782|NCT05578872|593152945|FG001|Overall Study|Physician Decision|2|||
164214783|NCT05578872|593152944|FG000|Overall Study|Progressive disease|10|||
164214784|NCT05578872|593152945|FG001|Overall Study|Progressive disease|9|||
164214785|NCT05578872|593152944|FG000|Overall Study|Sponsor decision|0|||
164214786|NCT05578872|593152945|FG001|Overall Study|Sponsor decision|1|||
164325982|NCT00740051|593569031|FG001|Overall Study|Other reason (not specified)|1|||
164325983|NCT03452527|593569032|FG000|Overall Study|Withdrawal by Subject|1|||
164214787|NCT05578872|593152944|FG000|Overall Study|Toxicity and Patient's decision|0|||
164214788|NCT05578872|593152945|FG001|Overall Study|Toxicity and Patient's decision|1|||
164214789|NCT05643794|593154260|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
164214790|NCT05643794|593154261|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
164214791|NCT05643794|593154262|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
164214792|NCT05643794|593154260|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
164214793|NCT05643794|593154261|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164214794|NCT05643794|593154262|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164214795|NCT05643794|593154260|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
164325984|NCT03452527|593569033|FG001|Overall Study|Withdrawal by Subject|1|||
164214796|NCT05643794|593154261|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
164214797|NCT05643794|593154262|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
164214798|NCT05643794|593154260|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
164214799|NCT05643794|593154261|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
164214800|NCT05643794|593154262|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
164214801|NCT05643794|593154260|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
164214802|NCT05643794|593154261|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
164214803|NCT05643794|593154262|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
164214804|NCT05643794|593154260|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
164214805|NCT05643794|593154261|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
164214806|NCT05643794|593154262|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
164214807|NCT04941898|593154263|FG000|Overall Study|Protocol Violation|1|||
164214808|NCT03641924|593154264|FG000|Overall Study|Withdrawal by Subject|26|||
164214809|NCT03641924|593154264|FG000|Overall Study|Lost to Follow-up|16|||
164214810|NCT03641924|593154264|FG000|Overall Study|Protocol Violation|10|||
164214811|NCT00587457|593154265|FG000|Overall Study|Adverse Event|1|||
164214812|NCT00587457|593154266|FG001|Overall Study|Adverse Event|2|||
164214813|NCT00587457|593154267|FG002|Overall Study|Adverse Event|1|||
164214814|NCT00587457|593154265|FG000|Overall Study|Disease progression|2|||
164214815|NCT00587457|593154266|FG001|Overall Study|Disease progression|0|||
164214816|NCT00587457|593154267|FG002|Overall Study|Disease progression|2|||
164214817|NCT00587457|593154265|FG000|Overall Study|Initiation of alternative therapy|0|||
164214818|NCT00587457|593154266|FG001|Overall Study|Initiation of alternative therapy|1|||
164214819|NCT00587457|593154267|FG002|Overall Study|Initiation of alternative therapy|0|||
164214820|NCT00587457|593154265|FG000|Overall Study|Undefined|0|||
164214821|NCT00587457|593154266|FG001|Overall Study|Undefined|0|||
164214822|NCT00587457|593154267|FG002|Overall Study|Undefined|1|||
164214823|NCT00587457|593154265|FG000|Overall Study|Development of neutralizing Abs|0|||
164214824|NCT00587457|593154266|FG001|Overall Study|Development of neutralizing Abs|0|||
164214825|NCT00587457|593154267|FG002|Overall Study|Development of neutralizing Abs|1|||
164214826|NCT01022580|593154268|FG000|Overall Study|Death|18|||
164214827|NCT01022580|593154269|FG001|Overall Study|Death|22|||
164214828|NCT03439839|593154270|FG000|Overall Study|Death|3|||
164214829|NCT03439839|593154271|FG001|Overall Study|Death|0|||
164214830|NCT03720847|593154272|FG000|Washout|Physician Decision|1|||
164214831|NCT03720847|593154273|FG001|Washout|Physician Decision|2|||
164214832|NCT01500096|593154274|FG000|Overall Study|Lost to Follow-up|1|||
164214833|NCT01500096|593154275|FG001|Overall Study|Lost to Follow-up|0|||
164214834|NCT01500096|593154276|FG002|Overall Study|Lost to Follow-up|0|||
164214835|NCT01500096|593154277|FG003|Overall Study|Lost to Follow-up|2|||
164214836|NCT03033901|593154281|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
164214837|NCT03033901|593154281|FG000|Overall Study|Refused PSG|23|||
164214838|NCT03033901|593154281|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
164214839|NCT03033901|593154281|FG000|Overall Study|Missing Oximetry Data|3|||
164214840|NCT00924651|593154284|FG000|Overall Study|Chemo started too soon|2|||
164214841|NCT00924651|593154285|FG001|Overall Study|Chemo started too soon|3|||
164214842|NCT00924651|593154284|FG000|Overall Study|No Reason|3|||
164214843|NCT00924651|593154285|FG001|Overall Study|No Reason|7|||
164214844|NCT00924651|593154284|FG000|Overall Study|Overwhelmed|6|||
164214845|NCT00924651|593154285|FG001|Overall Study|Overwhelmed|6|||
164214846|NCT00924651|593154284|FG000|Overall Study|Noncompliant|1|||
164214847|NCT00924651|593154285|FG001|Overall Study|Noncompliant|4|||
164325985|NCT03452527|593569032|FG000|Overall Study|Study Terminated|2|||
164325986|NCT03452527|593569033|FG001|Overall Study|Study Terminated|3|||
164214848|NCT00924651|593154284|FG000|Overall Study|Medical|1|||
164214849|NCT00924651|593154285|FG001|Overall Study|Medical|3|||
164214850|NCT00924651|593154284|FG000|Overall Study|Changed Mind|10|||
164214851|NCT00924651|593154285|FG001|Overall Study|Changed Mind|1|||
164214852|NCT00924651|593154284|FG000|Overall Study|Incomplete Form|2|||
164325987|NCT01001299|593569034|FG000|Overall Study|Insufficient Therapeutic Response|20|||
164214853|NCT00924651|593154285|FG001|Overall Study|Incomplete Form|1|||
164214854|NCT00723944|593154286|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
164214855|NCT00723944|593154287|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
164214856|NCT00723944|593154286|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
164214857|NCT00723944|593154287|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
164214858|NCT00723944|593154286|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
164214859|NCT00723944|593154287|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
164214860|NCT00835978|593154288|FG000|Overall Study|Death|33|||
164214861|NCT00835978|593154289|FG001|Overall Study|Death|40|||
164214862|NCT00835978|593154290|FG002|Overall Study|Death|49|||
164214863|NCT00835978|593154291|FG003|Overall Study|Death|4|||
164214864|NCT00835978|593154288|FG000|Overall Study|Lost to Follow-up|3|||
164214865|NCT00835978|593154289|FG001|Overall Study|Lost to Follow-up|4|||
164214866|NCT00835978|593154290|FG002|Overall Study|Lost to Follow-up|2|||
164214867|NCT00835978|593154291|FG003|Overall Study|Lost to Follow-up|1|||
164214868|NCT00835978|593154288|FG000|Overall Study|Other|5|||
164214869|NCT00835978|593154289|FG001|Overall Study|Other|1|||
164214870|NCT00835978|593154290|FG002|Overall Study|Other|8|||
164214871|NCT00835978|593154291|FG003|Overall Study|Other|0|||
164214872|NCT00835978|593154288|FG000|Overall Study|Objective progression or relapse|2|||
164214873|NCT00835978|593154289|FG001|Overall Study|Objective progression or relapse|0|||
164214874|NCT00835978|593154290|FG002|Overall Study|Objective progression or relapse|1|||
164214875|NCT00835978|593154291|FG003|Overall Study|Objective progression or relapse|0|||
164214876|NCT00835978|593154288|FG000|Overall Study|Adverse Event|1|||
164214877|NCT00835978|593154289|FG001|Overall Study|Adverse Event|0|||
164214878|NCT00835978|593154290|FG002|Overall Study|Adverse Event|1|||
164214879|NCT00835978|593154291|FG003|Overall Study|Adverse Event|0|||
164214880|NCT00835978|593154288|FG000|Overall Study|Withdrawal by Subject|0|||
164214881|NCT00835978|593154289|FG001|Overall Study|Withdrawal by Subject|3|||
164214882|NCT00835978|593154290|FG002|Overall Study|Withdrawal by Subject|0|||
164214883|NCT00835978|593154291|FG003|Overall Study|Withdrawal by Subject|5|||
164214884|NCT00835978|593154288|FG000|Overall Study|Study terminated by sponsor|12|||
164214885|NCT00835978|593154289|FG001|Overall Study|Study terminated by sponsor|8|||
164214886|NCT00835978|593154290|FG002|Overall Study|Study terminated by sponsor|30|||
164214887|NCT00835978|593154291|FG003|Overall Study|Study terminated by sponsor|0|||
164214888|NCT02927145|593154292|FG000|Initial Recruitment|Withdrawal by Subject|0|||
164214889|NCT02927145|593154293|FG001|Initial Recruitment|Withdrawal by Subject|1|||
164214890|NCT02927145|593154294|FG002|Initial Recruitment|Withdrawal by Subject|1|||
164214891|NCT02927145|593154295|FG003|Initial Recruitment|Withdrawal by Subject|4|||
164214892|NCT02927145|593154296|FG004|Initial Recruitment|Withdrawal by Subject|1|||
164214893|NCT02927145|593154297|FG005|Initial Recruitment|Withdrawal by Subject|1|||
164214894|NCT02927145|593154298|FG006|Initial Recruitment|Withdrawal by Subject|0|||
164214895|NCT02927145|593154299|FG007|Initial Recruitment|Withdrawal by Subject|0|||
164214896|NCT02927145|593154300|FG008|Initial Recruitment|Withdrawal by Subject|2|||
164214897|NCT02927145|593154292|FG000|Initial Recruitment|Adverse Event|0|||
164214898|NCT02927145|593154293|FG001|Initial Recruitment|Adverse Event|0|||
164214899|NCT02927145|593154294|FG002|Initial Recruitment|Adverse Event|0|||
164214900|NCT02927145|593154295|FG003|Initial Recruitment|Adverse Event|0|||
164214901|NCT02927145|593154296|FG004|Initial Recruitment|Adverse Event|2|||
164214902|NCT02927145|593154297|FG005|Initial Recruitment|Adverse Event|0|||
164214903|NCT02927145|593154298|FG006|Initial Recruitment|Adverse Event|0|||
164214904|NCT02927145|593154299|FG007|Initial Recruitment|Adverse Event|0|||
164214905|NCT02927145|593154300|FG008|Initial Recruitment|Adverse Event|0|||
164669661|NCT00615069|594815066|FG000|Overall Study|Death|10|||
164669662|NCT00615069|594815066|FG000|Overall Study|Physician Decision|2|||
164669663|NCT00615069|594815066|FG000|Overall Study|Withdrawal by Subject|4|||
164214906|NCT02927145|593154292|FG000|Invitation for Additional Challenge|Pregnancy|0|||
164214907|NCT02927145|593154293|FG001|Invitation for Additional Challenge|Pregnancy|0|||
164214908|NCT02927145|593154294|FG002|Invitation for Additional Challenge|Pregnancy|0|||
164214909|NCT02927145|593154295|FG003|Invitation for Additional Challenge|Pregnancy|0|||
164214910|NCT02927145|593154296|FG004|Invitation for Additional Challenge|Pregnancy|0|||
164214911|NCT02927145|593154297|FG005|Invitation for Additional Challenge|Pregnancy|0|||
164214912|NCT02927145|593154298|FG006|Invitation for Additional Challenge|Pregnancy|1|||
164214913|NCT02927145|593154299|FG007|Invitation for Additional Challenge|Pregnancy|0|||
164214914|NCT02927145|593154300|FG008|Invitation for Additional Challenge|Pregnancy|0|||
164214915|NCT03298061|593154301|FG000|Overall Study|Adverse Event|3|||
164214916|NCT03298061|593154301|FG000|Overall Study|Lack of Efficacy|6|||
164214917|NCT03298061|593154301|FG000|Overall Study|Protocol Violation|1|||
164214918|NCT03298061|593154301|FG000|Overall Study|Physician Decision|7|||
164325988|NCT01001299|593569034|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
164214919|NCT03298061|593154301|FG000|Overall Study|Withdrawal by Subject|10|||
164325989|NCT01001299|593569034|FG000|Overall Study|Death|1|||
164214920|NCT02506036|593154303|FG000|First Intervention (4-6 Weeks)|Death|1|||
164214921|NCT02506036|593154304|FG001|First Intervention (4-6 Weeks)|Death|0|||
164214922|NCT02506036|593154303|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
164214923|NCT02506036|593154304|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
164669664|NCT00259012|594815068|FG000|Overall Study|Adverse Event|0|||
164325990|NCT01001299|593569034|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
164325991|NCT01001299|593569034|FG000|Overall Study|Withdrew Consent|1|||
164325992|NCT01565499|593569035|FG000|Overall Study|Physician Decision|1|||
164325993|NCT01565499|593569035|FG000|Overall Study|Adverse Event|5|||
164325994|NCT01565499|593569035|FG000|Overall Study|Withdrawal by Subject|2|||
164325995|NCT00476047|593569036|FG000|Overall Study|Lost to Follow-up|1|||
164325996|NCT02398227|593569038|FG000|Overall Study|Lost to Follow-up|21|||
164325997|NCT02398227|593569039|FG001|Overall Study|Lost to Follow-up|12|||
164325998|NCT02398227|593569038|FG000|Overall Study|Withdrawal by Subject|5|||
164325999|NCT02398227|593569039|FG001|Overall Study|Withdrawal by Subject|6|||
164326000|NCT02398227|593569038|FG000|Overall Study|Removed from treatment and dropped out|1|||
164326001|NCT02398227|593569039|FG001|Overall Study|Removed from treatment and dropped out|0|||
164326002|NCT02793622|593569040|FG000|Overall Study|Lost to Follow-up|31|||
164326003|NCT02793622|593569041|FG001|Overall Study|Lost to Follow-up|19|||
164326004|NCT02793622|593569040|FG000|Overall Study|Withdrawal by Subject|21|||
164326005|NCT02793622|593569041|FG001|Overall Study|Withdrawal by Subject|17|||
164326006|NCT02793622|593569040|FG000|Overall Study|Adverse Event|0|||
164326007|NCT02793622|593569041|FG001|Overall Study|Adverse Event|1|||
164326008|NCT02793622|593569040|FG000|Overall Study|Protocol Violation|1|||
164326009|NCT02793622|593569041|FG001|Overall Study|Protocol Violation|5|||
164326010|NCT04738318|593569042|FG000|Overall Study|Protocol Violation|1|||
164326011|NCT04738318|593569043|FG001|Overall Study|Protocol Violation|0|||
164326012|NCT00586664|593569048|FG000|Overall Study|Withdrawal by Subject|3|||
164326013|NCT00586664|593569049|FG001|Overall Study|Withdrawal by Subject|7|||
164326014|NCT00586664|593569050|FG002|Overall Study|Withdrawal by Subject|1|||
164326015|NCT00586664|593569048|FG000|Overall Study|Exclusion criteria met|2|||
164326016|NCT00586664|593569049|FG001|Overall Study|Exclusion criteria met|0|||
164326017|NCT00586664|593569050|FG002|Overall Study|Exclusion criteria met|0|||
164326018|NCT01585584|593569051|FG000|Overall Study|Lack of Efficacy|1|||
164326019|NCT01585584|593569051|FG000|Overall Study|Withdrawal by Subject|1|||
164326020|NCT01585584|593569051|FG000|Overall Study|Physician Decision|2|||
164326021|NCT01602666|593569055|FG000|Induction Chemotherapy|Death|2|||
164326022|NCT01602666|593569056|FG001|Induction Chemotherapy|Death|1|||
164326023|NCT01602666|593569055|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
164326024|NCT01602666|593569056|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
164326025|NCT01602666|593569055|FG000|Induction Chemotherapy|Physician Decision|12|||
164326026|NCT01602666|593569056|FG001|Induction Chemotherapy|Physician Decision|5|||
164326027|NCT01602666|593569055|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
164326028|NCT01602666|593569056|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
164326029|NCT01602666|593569055|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
164326030|NCT01602666|593569056|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
164326031|NCT01602666|593569055|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
164326032|NCT01602666|593569056|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
164326033|NCT01602666|593569055|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
164326034|NCT01602666|593569056|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
164326035|NCT01602666|593569055|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
164326036|NCT01602666|593569056|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
164326037|NCT01602666|593569055|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
164326038|NCT01602666|593569056|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
164326039|NCT01602666|593569055|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
164326040|NCT01602666|593569056|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
164326041|NCT01602666|593569055|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
164326042|NCT01602666|593569056|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
164565172|NCT02522767|594438416|FG000|Open-label|Withdrawal by Subject|2|||
164565173|NCT02522767|594438417|FG001|Open-label|Withdrawal by Subject|3|||
164565174|NCT02522767|594438416|FG000|Open-label|Lost to Follow-up|0|||
164565175|NCT02522767|594438417|FG001|Open-label|Lost to Follow-up|1|||
164565176|NCT02522767|594438416|FG000|Open-label|Adverse Event|2|||
164565177|NCT02522767|594438417|FG001|Open-label|Adverse Event|1|||
164565178|NCT02522767|594438416|FG000|Open-label|Lack of Efficacy|1|||
164565179|NCT02522767|594438417|FG001|Open-label|Lack of Efficacy|1|||
164565180|NCT02522767|594438416|FG000|Open-label|Protocol Violation|0|||
164565181|NCT02522767|594438417|FG001|Open-label|Protocol Violation|1|||
164565182|NCT00548548|594438418|FG000|Overall Study|Death|345|||
164565183|NCT00548548|594438419|FG001|Overall Study|Death|348|||
164565184|NCT00548548|594438418|FG000|Overall Study|Lost to Follow-up|17|||
164565185|NCT00548548|594438419|FG001|Overall Study|Lost to Follow-up|18|||
164326043|NCT04369053|593570102|FG000|Overall Study|Enrolled prior to the Pre-specified Cut-off Date|16264|||
164326044|NCT04369053|593570102|FG000|Overall Study|Withdrawal by Subject|773|||
164326045|NCT04369053|593570102|FG000|Overall Study|Lost to Follow-up|182|||
164565186|NCT01848145|594438420|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
164565187|NCT01848145|594438420|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
164565188|NCT01848145|594438420|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
164669665|NCT00259012|594815069|FG001|Overall Study|Adverse Event|1|||
164214924|NCT02506036|593154303|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
164214925|NCT02506036|593154304|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
164214926|NCT01410604|593154306|FG000|Overall Study|Adverse Event|2|||
164214927|NCT01410604|593154307|FG001|Overall Study|Adverse Event|1|||
164214928|NCT01410604|593154306|FG000|Overall Study|Lost to Follow-up|1|||
164214929|NCT01410604|593154307|FG001|Overall Study|Lost to Follow-up|0|||
164214930|NCT01410604|593154306|FG000|Overall Study|Physician Decision|0|||
164214931|NCT01410604|593154307|FG001|Overall Study|Physician Decision|1|||
164214932|NCT02383173|593154312|FG000|Overall Study|Palliative Care Team withdrew|0|||
164214933|NCT02383173|593154313|FG001|Overall Study|Palliative Care Team withdrew|2|||
164214934|NCT00800540|593154317|FG000|Period One: 6 Weeks|Noncompliance|1|||
164214935|NCT00800540|593154318|FG001|Period One: 6 Weeks|Noncompliance|0|||
164214936|NCT00800540|593154317|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
164214937|NCT00800540|593154318|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
164214938|NCT00800540|593154317|FG000|Period 2: 6 Weeks|Adverse Event|0|||
164214939|NCT00800540|593154318|FG001|Period 2: 6 Weeks|Adverse Event|1|||
164214940|NCT00429299|593154319|FG000|Overall Study|Disease Progression|1|||
164214941|NCT00429299|593154320|FG001|Overall Study|Disease Progression|1|||
164214942|NCT00429299|593154321|FG002|Overall Study|Disease Progression|0|||
164214943|NCT00429299|593154319|FG000|Overall Study|Adverse Event|2|||
164214944|NCT00429299|593154320|FG001|Overall Study|Adverse Event|5|||
164214945|NCT00429299|593154321|FG002|Overall Study|Adverse Event|1|||
164214946|NCT00429299|593154319|FG000|Overall Study|Protocol Violation|1|||
164214947|NCT00429299|593154320|FG001|Overall Study|Protocol Violation|0|||
164214948|NCT00429299|593154321|FG002|Overall Study|Protocol Violation|0|||
164214949|NCT00429299|593154319|FG000|Overall Study|Withdrawal by Subject|0|||
164214950|NCT00429299|593154320|FG001|Overall Study|Withdrawal by Subject|1|||
164214951|NCT00429299|593154321|FG002|Overall Study|Withdrawal by Subject|3|||
164214952|NCT04871113|593154322|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
164214953|NCT04871113|593154323|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
164214954|NCT04871113|593154324|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
164214955|NCT04871113|593154325|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
164214956|NCT04871113|593154326|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
164214957|NCT04871113|593154327|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
164214958|NCT04871113|593154328|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
164214959|NCT04871113|593154329|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
164214960|NCT04871113|593154330|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
164214961|NCT04871113|593154331|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
164214962|NCT04871113|593154322|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
164214963|NCT04871113|593154323|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
164214964|NCT04871113|593154324|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
164214965|NCT04871113|593154325|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
164214966|NCT04871113|593154326|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
164214967|NCT04871113|593154327|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
164214968|NCT04871113|593154328|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
164214969|NCT04871113|593154329|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
164214970|NCT04871113|593154330|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
164214971|NCT04871113|593154331|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
164214972|NCT01239745|593154332|FG000|Overall Study|Study terminated by sponsor|45|||
164214973|NCT01239745|593154332|FG000|Overall Study|Adverse Event|1|||
164214974|NCT02143778|593154337|FG000|Overall Study|Withdrawal by Subject|2|||
164214975|NCT02143778|593154337|FG000|Overall Study|Device malfunction|1|||
164214976|NCT05630755|593154338|FG000|Overall Study|Lost to Follow-up|7|||
164214977|NCT05630755|593154339|FG001|Overall Study|Lost to Follow-up|0|||
164214978|NCT05630755|593154338|FG000|Overall Study|Randomized by Mistake Without Study Treatment|1|||
164214979|NCT05630755|593154339|FG001|Overall Study|Randomized by Mistake Without Study Treatment|0|||
164214980|NCT05630755|593154338|FG000|Overall Study|Withdrawal by Subject|9|||
164214981|NCT05630755|593154339|FG001|Overall Study|Withdrawal by Subject|3|||
164214982|NCT05630755|593154338|FG000|Overall Study|Participant moved away from trial site|0|||
164214983|NCT05630755|593154339|FG001|Overall Study|Participant moved away from trial site|1|||
164214984|NCT05630755|593154338|FG000|Overall Study|Status not Recorded|316|||
164214985|NCT05630755|593154339|FG001|Overall Study|Status not Recorded|161|||
164214986|NCT02969018|593154340|FG000|Overall Study|Adverse Event|2|||
164214987|NCT02969018|593154341|FG001|Overall Study|Adverse Event|4|||
164214988|NCT02969018|593154342|FG002|Overall Study|Adverse Event|1|||
164214989|NCT02969018|593154343|FG003|Overall Study|Adverse Event|2|||
164214990|NCT02969018|593154344|FG004|Overall Study|Adverse Event|0|||
164214991|NCT02969018|593154345|FG005|Overall Study|Adverse Event|1|||
164214992|NCT02969018|593154346|FG006|Overall Study|Adverse Event|2|||
164214993|NCT02969018|593154347|FG007|Overall Study|Adverse Event|0|||
164214994|NCT02969018|593154340|FG000|Overall Study|Lack of Efficacy|0|||
164214995|NCT02969018|593154341|FG001|Overall Study|Lack of Efficacy|1|||
164214996|NCT02969018|593154342|FG002|Overall Study|Lack of Efficacy|0|||
164214997|NCT02969018|593154343|FG003|Overall Study|Lack of Efficacy|0|||
164214998|NCT02969018|593154344|FG004|Overall Study|Lack of Efficacy|1|||
164214999|NCT02969018|593154345|FG005|Overall Study|Lack of Efficacy|1|||
164215000|NCT02969018|593154346|FG006|Overall Study|Lack of Efficacy|1|||
164215001|NCT02969018|593154347|FG007|Overall Study|Lack of Efficacy|1|||
164215002|NCT02969018|593154340|FG000|Overall Study|Lost to Follow-up|1|||
164215003|NCT02969018|593154341|FG001|Overall Study|Lost to Follow-up|2|||
164215004|NCT02969018|593154342|FG002|Overall Study|Lost to Follow-up|2|||
164215005|NCT02969018|593154343|FG003|Overall Study|Lost to Follow-up|0|||
164215006|NCT02969018|593154344|FG004|Overall Study|Lost to Follow-up|1|||
164215007|NCT02969018|593154345|FG005|Overall Study|Lost to Follow-up|1|||
164215008|NCT02969018|593154346|FG006|Overall Study|Lost to Follow-up|0|||
164215009|NCT02969018|593154347|FG007|Overall Study|Lost to Follow-up|1|||
164215010|NCT02969018|593154340|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
164215011|NCT02969018|593154341|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
164215012|NCT02969018|593154342|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
164215013|NCT02969018|593154343|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
164215014|NCT02969018|593154344|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
164215015|NCT02969018|593154345|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
164215016|NCT02969018|593154346|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
164215017|NCT02969018|593154347|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
164215018|NCT02969018|593154340|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164215019|NCT02969018|593154341|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164215020|NCT02969018|593154342|FG002|Overall Study|Non-Compliance With Study Drug|0|||
164215021|NCT02969018|593154343|FG003|Overall Study|Non-Compliance With Study Drug|0|||
164215022|NCT02969018|593154344|FG004|Overall Study|Non-Compliance With Study Drug|0|||
164215023|NCT02969018|593154345|FG005|Overall Study|Non-Compliance With Study Drug|0|||
164215024|NCT02969018|593154346|FG006|Overall Study|Non-Compliance With Study Drug|0|||
164215025|NCT02969018|593154347|FG007|Overall Study|Non-Compliance With Study Drug|0|||
164215026|NCT02969018|593154340|FG000|Overall Study|Other|0|||
164215027|NCT02969018|593154341|FG001|Overall Study|Other|0|||
164215028|NCT02969018|593154342|FG002|Overall Study|Other|0|||
164215029|NCT02969018|593154343|FG003|Overall Study|Other|1|||
164215030|NCT02969018|593154344|FG004|Overall Study|Other|0|||
164215031|NCT02969018|593154345|FG005|Overall Study|Other|0|||
164215032|NCT02969018|593154346|FG006|Overall Study|Other|0|||
164215033|NCT02969018|593154347|FG007|Overall Study|Other|2|||
164215034|NCT02969018|593154340|FG000|Overall Study|Pregnancy|0|||
164215035|NCT02969018|593154341|FG001|Overall Study|Pregnancy|0|||
164215036|NCT02969018|593154342|FG002|Overall Study|Pregnancy|0|||
164215037|NCT02969018|593154343|FG003|Overall Study|Pregnancy|0|||
164215038|NCT02969018|593154344|FG004|Overall Study|Pregnancy|0|||
164215039|NCT02969018|593154345|FG005|Overall Study|Pregnancy|1|||
164215040|NCT02969018|593154346|FG006|Overall Study|Pregnancy|0|||
164215041|NCT02969018|593154347|FG007|Overall Study|Pregnancy|0|||
164215042|NCT02969018|593154340|FG000|Overall Study|Protocol Violation|0|||
164215043|NCT02969018|593154341|FG001|Overall Study|Protocol Violation|0|||
164215044|NCT02969018|593154342|FG002|Overall Study|Protocol Violation|1|||
164215045|NCT02969018|593154343|FG003|Overall Study|Protocol Violation|1|||
164215046|NCT02969018|593154344|FG004|Overall Study|Protocol Violation|0|||
164215047|NCT02969018|593154345|FG005|Overall Study|Protocol Violation|0|||
164215048|NCT02969018|593154346|FG006|Overall Study|Protocol Violation|0|||
164215049|NCT02969018|593154347|FG007|Overall Study|Protocol Violation|0|||
164215050|NCT02969018|593154340|FG000|Overall Study|Withdrawal by Subject|0|||
164215051|NCT02969018|593154341|FG001|Overall Study|Withdrawal by Subject|1|||
164215052|NCT02969018|593154342|FG002|Overall Study|Withdrawal by Subject|2|||
164215053|NCT02969018|593154343|FG003|Overall Study|Withdrawal by Subject|1|||
164326046|NCT04369053|593570102|FG000|Overall Study|Blood Test and/or Colonoscopy Reasons|4766|||
164326047|NCT01394718|593570103|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
164215054|NCT02969018|593154344|FG004|Overall Study|Withdrawal by Subject|0|||
164215055|NCT02969018|593154345|FG005|Overall Study|Withdrawal by Subject|4|||
164215056|NCT02969018|593154346|FG006|Overall Study|Withdrawal by Subject|4|||
164215057|NCT02969018|593154347|FG007|Overall Study|Withdrawal by Subject|3|||
164215058|NCT01479530|593154353|FG000|Overall Study|Adverse Event|5|||
164326048|NCT01394718|593570104|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
164326049|NCT00472459|593570105|FG000|Overall Study|Adverse Event|13|||
164215059|NCT01479530|593154354|FG001|Overall Study|Adverse Event|6|||
164215060|NCT01479530|593154353|FG000|Overall Study|Lack of Efficacy|0|||
164215061|NCT01479530|593154354|FG001|Overall Study|Lack of Efficacy|1|||
164215062|NCT01479530|593154353|FG000|Overall Study|Protocol Violation|2|||
164215063|NCT01479530|593154354|FG001|Overall Study|Protocol Violation|3|||
164215064|NCT01479530|593154353|FG000|Overall Study|Withdrawal of Consent|3|||
164215065|NCT01479530|593154354|FG001|Overall Study|Withdrawal of Consent|2|||
164326050|NCT00472459|593570106|FG001|Overall Study|Adverse Event|13|||
164215066|NCT02836769|593154355|FG000|Overall Study|Lost to Follow-up|10|||
164215067|NCT02836769|593154355|FG000|Overall Study|Medical withdrawal|2|||
164215068|NCT02836769|593154355|FG000|Overall Study|Withdrawal by Subject|3|||
164215069|NCT04339972|593154356|FG000|Overall Study|Scheduling Issues|3|||
164215070|NCT04339972|593154357|FG001|Overall Study|Scheduling Issues|3|||
164215071|NCT04339972|593154356|FG000|Overall Study|dropout|1|||
164215072|NCT04339972|593154357|FG001|Overall Study|dropout|1|||
164215073|NCT04339972|593154356|FG000|Overall Study|Technical issues|1|||
164215074|NCT04339972|593154357|FG001|Overall Study|Technical issues|0|||
164215075|NCT04339972|593154356|FG000|Overall Study|Claustraphobia|0|||
164215076|NCT04339972|593154357|FG001|Overall Study|Claustraphobia|1|||
164215077|NCT00376506|593154359|FG000|Overall Study|Death|0|||
164215078|NCT00376506|593154360|FG001|Overall Study|Death|2|||
164215079|NCT00933166|593154362|FG000|Overall Study|Lost to Follow-up|4|||
164215080|NCT00933166|593154362|FG000|Overall Study|Lack of Efficacy|9|||
164215081|NCT00933166|593154362|FG000|Overall Study|Unavailable|4|||
164215082|NCT00933166|593154362|FG000|Overall Study|Withdrawal by Subject|1|||
164215083|NCT02403271|593154367|FG000|Period 1|Other varied reasons|1|||
164215084|NCT02403271|593154368|FG001|Period 1|Other varied reasons|0|||
164215085|NCT02403271|593154367|FG000|Period 2|Withdrawal by Subject|0|||
164215086|NCT02403271|593154368|FG001|Period 2|Withdrawal by Subject|14|||
164215087|NCT02403271|593154367|FG000|Period 2|Death|0|||
164215088|NCT02403271|593154368|FG001|Period 2|Death|84|||
164215089|NCT02403271|593154367|FG000|Period 2|Lost to Follow-up|0|||
164215090|NCT02403271|593154368|FG001|Period 2|Lost to Follow-up|2|||
164215091|NCT02403271|593154367|FG000|Period 2|Study Terminated by Sponsor|0|||
164215092|NCT02403271|593154368|FG001|Period 2|Study Terminated by Sponsor|14|||
164215093|NCT02403271|593154367|FG000|Period 2|Other varied reasons|0|||
164215094|NCT02403271|593154368|FG001|Period 2|Other varied reasons|10|||
164215095|NCT02112552|593154371|FG000|Overall Study|Withdrawal by Subject|1|||
164215096|NCT02112552|593154371|FG000|Overall Study|Adverse Event|1|||
164215097|NCT00774748|593154372|FG000|Overall Study|Lost to Follow-up|3|||
164215098|NCT03349515|593154376|FG000|Overall Study|Lack of Efficacy|2|||
164215099|NCT03349515|593154377|FG001|Overall Study|Lack of Efficacy|0|||
164215100|NCT03349515|593154376|FG000|Overall Study|Physician Decision|3|||
164215101|NCT03349515|593154377|FG001|Overall Study|Physician Decision|1|||
164215102|NCT02232698|593154382|FG000|Overall Study|Pregnancy|1|||
164215103|NCT02232698|593154383|FG001|Overall Study|Pregnancy|1|||
164215104|NCT02232698|593154382|FG000|Overall Study|Met exclusion criteria|1|||
164215105|NCT02232698|593154383|FG001|Overall Study|Met exclusion criteria|1|||
164215106|NCT02232698|593154382|FG000|Overall Study|Had device-associated symptoms|7|||
164215107|NCT02232698|593154383|FG001|Overall Study|Had device-associated symptoms|0|||
164215108|NCT02232698|593154382|FG000|Overall Study|Non-compliance with study device|1|||
164215109|NCT02232698|593154383|FG001|Overall Study|Non-compliance with study device|4|||
164215110|NCT02232698|593154382|FG000|Overall Study|Allocated to control group|0|||
164215111|NCT02232698|593154383|FG001|Overall Study|Allocated to control group|3|||
164215112|NCT02232698|593154382|FG000|Overall Study|Withdrawal by Subject|0|||
164215113|NCT02232698|593154383|FG001|Overall Study|Withdrawal by Subject|11|||
164215114|NCT00317369|593154385|FG000|Overall Study|Adverse Event|2|||
164215115|NCT00317369|593154386|FG001|Overall Study|Adverse Event|1|||
164215116|NCT00317369|593154387|FG002|Overall Study|Adverse Event|0|||
164215117|NCT00317369|593154385|FG000|Overall Study|Lack of Efficacy|0|||
164215118|NCT00317369|593154386|FG001|Overall Study|Lack of Efficacy|1|||
164215119|NCT00317369|593154387|FG002|Overall Study|Lack of Efficacy|1|||
164215120|NCT00317369|593154385|FG000|Overall Study|Withdrawal by Subject|0|||
164215121|NCT00317369|593154386|FG001|Overall Study|Withdrawal by Subject|0|||
164215122|NCT00317369|593154387|FG002|Overall Study|Withdrawal by Subject|1|||
164215123|NCT04069520|593154392|FG000|Overall Study|Lost to Follow-up|0|||
164215124|NCT04069520|593154393|FG001|Overall Study|Lost to Follow-up|2|||
164215125|NCT04069520|593154392|FG000|Overall Study|Withdrawal by Subject|0|||
164215126|NCT04069520|593154393|FG001|Overall Study|Withdrawal by Subject|1|||
164215127|NCT04069520|593154392|FG000|Overall Study|Prior Injury|1|||
164215128|NCT04069520|593154393|FG001|Overall Study|Prior Injury|0|||
164565189|NCT01848145|594438420|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
164565190|NCT01848145|594438420|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
164565191|NCT01848145|594438420|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
164565192|NCT01848145|594438420|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
164565193|NCT00364689|594438421|FG000|Overall Study|Lost to Follow-up|1|||
164565194|NCT03683394|594438431|FG000|Overall Study|Withdrawal by Subject|4|||
164565195|NCT03683394|594438432|FG001|Overall Study|Withdrawal by Subject|8|||
164215129|NCT04069520|593154392|FG000|Overall Study|Orthodontia|1|||
164565196|NCT03683394|594438431|FG000|Overall Study|Lost to Follow-up|7|||
164565197|NCT03683394|594438432|FG001|Overall Study|Lost to Follow-up|0|||
164215130|NCT04069520|593154393|FG001|Overall Study|Orthodontia|0|||
164215131|NCT04069520|593154392|FG000|Overall Study|Cut from team|0|||
164215132|NCT04069520|593154393|FG001|Overall Study|Cut from team|2|||
164215133|NCT04615507|593154394|FG000|Period 1|Covid-19 exposure|2|||
164215134|NCT04615507|593154395|FG001|Period 1|Covid-19 exposure|1|||
164215135|NCT04615507|593154394|FG000|Period 2|Covid-19 exposure|0|||
164215136|NCT04615507|593154395|FG001|Period 2|Covid-19 exposure|1|||
164215137|NCT04615507|593154394|FG000|Period 2|Protocol Violation|1|||
164326051|NCT00472459|593570105|FG000|Overall Study|Withdrawal by Subject|5|||
164326052|NCT00472459|593570106|FG001|Overall Study|Withdrawal by Subject|5|||
164326053|NCT00472459|593570105|FG000|Overall Study|Protocol Violation|3|||
164326054|NCT00472459|593570106|FG001|Overall Study|Protocol Violation|3|||
164215138|NCT04615507|593154395|FG001|Period 2|Protocol Violation|0|||
164215139|NCT04615507|593154394|FG000|Period 2|Withdrawal by Subject|1|||
164215140|NCT04615507|593154395|FG001|Period 2|Withdrawal by Subject|0|||
164215141|NCT04615507|593154394|FG000|Period 2|Adverse Event|0|||
164215142|NCT04615507|593154395|FG001|Period 2|Adverse Event|1|||
164215143|NCT04615507|593154394|FG000|Period 3|Covid-19 exposure|0|||
164215144|NCT04615507|593154395|FG001|Period 3|Covid-19 exposure|1|||
164215145|NCT03407482|593154396|FG000|Overall Study|Adverse Event|12|||
164215146|NCT03407482|593154396|FG000|Overall Study|Disease Relapse|1|||
164215147|NCT03407482|593154396|FG000|Overall Study|Lost to Follow-up|1|||
164215148|NCT03407482|593154396|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164215149|NCT03407482|593154396|FG000|Overall Study|Pregnancy|2|||
164215150|NCT03407482|593154396|FG000|Overall Study|Protocol Violation|1|||
164215151|NCT03407482|593154396|FG000|Overall Study|Study Terminated By Sponsor|106|||
164215152|NCT03407482|593154396|FG000|Overall Study|Withdrawal by Subject|6|||
164215153|NCT03407482|593154396|FG000|Overall Study|Data Entry Error|1|||
164215154|NCT02207608|593154400|FG000|Overall Study|Adverse Event|1|||
164215155|NCT02207608|593154401|FG001|Overall Study|Adverse Event|0|||
164215156|NCT02850406|593154402|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
164215157|NCT02850406|593154403|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
164215158|NCT02850406|593154404|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
164215159|NCT02850406|593154405|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
164215160|NCT02850406|593154406|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
164215161|NCT02850406|593154407|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
164215162|NCT02850406|593154408|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
164215163|NCT02850406|593154409|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
164215164|NCT02850406|593154402|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
164215165|NCT02850406|593154403|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
164215166|NCT02850406|593154404|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
164215167|NCT02850406|593154405|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
164215168|NCT02850406|593154406|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
164215169|NCT02850406|593154407|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
164215170|NCT02850406|593154408|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
164215171|NCT02850406|593154409|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
164215172|NCT02850406|593154402|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
164215173|NCT02850406|593154403|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
164215174|NCT02850406|593154404|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
164215175|NCT02850406|593154405|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
164215176|NCT02850406|593154406|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
164215177|NCT02850406|593154407|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
164215178|NCT02850406|593154408|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
164215179|NCT02850406|593154409|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
164215180|NCT02850406|593154402|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
164215181|NCT02850406|593154403|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
164215182|NCT02850406|593154404|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
164215183|NCT02850406|593154405|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
164215184|NCT02850406|593154406|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
164215185|NCT02850406|593154407|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
164215186|NCT02850406|593154408|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
164215187|NCT02850406|593154409|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
164215188|NCT02850406|593154402|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
164215189|NCT02850406|593154403|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
164215190|NCT02850406|593154404|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
164215191|NCT02850406|593154405|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
164215192|NCT02850406|593154406|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
164215193|NCT02850406|593154407|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
164215194|NCT02850406|593154408|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
164215195|NCT02850406|593154409|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
164215196|NCT02850406|593154402|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
164215197|NCT02850406|593154403|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
164215198|NCT02850406|593154404|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
164215199|NCT02850406|593154405|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
164215200|NCT02850406|593154406|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
164215201|NCT02850406|593154407|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
164215202|NCT02850406|593154408|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
164420680|NCT01154036|593910963|FG001|Phase II|Lost to Follow-up|0|||
164215203|NCT02850406|593154409|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
164215204|NCT02850406|593154402|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
164215205|NCT02850406|593154403|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
164215206|NCT02850406|593154404|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
164215207|NCT02850406|593154405|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
164215208|NCT02850406|593154406|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
164215209|NCT02850406|593154407|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
164215210|NCT02850406|593154408|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
164215211|NCT02850406|593154409|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
164215212|NCT02850406|593154402|FG000|Part C (Up to 52 Weeks)|Other|0|||
164215213|NCT02850406|593154403|FG001|Part C (Up to 52 Weeks)|Other|0|||
164215214|NCT02850406|593154404|FG002|Part C (Up to 52 Weeks)|Other|0|||
164215215|NCT02850406|593154405|FG003|Part C (Up to 52 Weeks)|Other|0|||
164215216|NCT02850406|593154406|FG004|Part C (Up to 52 Weeks)|Other|1|||
164215217|NCT02850406|593154407|FG005|Part C (Up to 52 Weeks)|Other|3|||
164215218|NCT02850406|593154408|FG006|Part C (Up to 52 Weeks)|Other|0|||
164215219|NCT02850406|593154409|FG007|Part C (Up to 52 Weeks)|Other|0|||
164215220|NCT02850406|593154402|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
164215221|NCT02850406|593154403|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
164215222|NCT02850406|593154404|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
164215223|NCT02850406|593154405|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
164215224|NCT02850406|593154406|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
164215225|NCT02850406|593154407|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
164215226|NCT02850406|593154408|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
164215227|NCT02850406|593154409|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
164215228|NCT02850406|593154402|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
164215229|NCT02850406|593154403|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
164215230|NCT02850406|593154404|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
164215231|NCT02850406|593154405|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
164215232|NCT02850406|593154406|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
164215233|NCT02850406|593154407|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
164215234|NCT02850406|593154408|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
164215235|NCT02850406|593154409|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
164215236|NCT02850406|593154402|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
164215237|NCT02850406|593154403|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
164215238|NCT02850406|593154404|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
164215239|NCT02850406|593154405|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
164215240|NCT02850406|593154406|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
164215241|NCT02850406|593154407|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
164215242|NCT02850406|593154408|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
164215243|NCT02850406|593154409|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
164215244|NCT02850406|593154402|FG000|Part D (Up to 52 Weeks)|Other|0|||
164215245|NCT02850406|593154403|FG001|Part D (Up to 52 Weeks)|Other|0|||
164215246|NCT02850406|593154404|FG002|Part D (Up to 52 Weeks)|Other|0|||
164215247|NCT02850406|593154405|FG003|Part D (Up to 52 Weeks)|Other|0|||
164215248|NCT02850406|593154406|FG004|Part D (Up to 52 Weeks)|Other|0|||
164215249|NCT02850406|593154407|FG005|Part D (Up to 52 Weeks)|Other|0|||
164215250|NCT02850406|593154408|FG006|Part D (Up to 52 Weeks)|Other|0|||
164215251|NCT02850406|593154409|FG007|Part D (Up to 52 Weeks)|Other|1|||
164215252|NCT01653262|593155808|FG000|Overall Study|Lack of Efficacy|1|||
164215253|NCT01653262|593155808|FG000|Overall Study|SAE, non-fatal|1|||
164215254|NCT01653262|593155808|FG000|Overall Study|AE, non-serious non-fatal|1|||
164215255|NCT01112267|593155809|FG000|Overall Study|Adverse Event|24|||
164215256|NCT01112267|593155810|FG001|Overall Study|Adverse Event|6|||
164215257|NCT01112267|593155809|FG000|Overall Study|Withdrawal by Subject|3|||
164215258|NCT01112267|593155810|FG001|Overall Study|Withdrawal by Subject|5|||
164215259|NCT01112267|593155809|FG000|Overall Study|Protocol Violation|5|||
164215260|NCT01112267|593155810|FG001|Overall Study|Protocol Violation|3|||
164215261|NCT01112267|593155809|FG000|Overall Study|Participants not compliant|1|||
164215262|NCT01112267|593155810|FG001|Overall Study|Participants not compliant|2|||
164215263|NCT01112267|593155809|FG000|Overall Study|Participants not receive any study drug|1|||
164215264|NCT01112267|593155810|FG001|Overall Study|Participants not receive any study drug|2|||
164215265|NCT01373229|593155813|FG000|Overall Study|Death|3|||
164215266|NCT01373229|593155813|FG000|Overall Study|Physician Decision|3|||
164565198|NCT03683394|594438431|FG000|Overall Study|Death|3|||
164215267|NCT00726557|593155816|FG000|Overall Study|Screening failure|4|||
164215268|NCT00726557|593155816|FG000|Overall Study|No end of treatment documentation|37|||
164215269|NCT00726557|593155816|FG000|Overall Study|No follow-up documentation available|55|||
164565199|NCT03683394|594438432|FG001|Overall Study|Death|1|||
164215270|NCT00726557|593155816|FG000|Overall Study|Treatment less than 3 months|17|||
164215271|NCT00726557|593155816|FG000|Overall Study|Inclusion criteria not met|15|||
164215272|NCT01946802|593155819|FG000|Overall Study|Death|1|||
164215273|NCT01946802|593155819|FG000|Overall Study|Withdrawal by Subject|2|||
164215274|NCT01946802|593155819|FG000|Overall Study|Combined septic shock|1|||
164215275|NCT01946802|593155819|FG000|Overall Study|Protocol Violation|1|||
164215276|NCT00153920|593155820|FG000|Overall Study|Adverse Event|9|||
164215277|NCT00153920|593155820|FG000|Overall Study|Progressive Disease|9|||
164565200|NCT03739528|594438433|FG000|Overall Study|Not treated|8|||
164215278|NCT00153920|593155820|FG000|Overall Study|Physician Decision|3|||
164215279|NCT00153920|593155820|FG000|Overall Study|Lack of Response|3|||
164215280|NCT00153920|593155820|FG000|Overall Study|Death|2|||
164215281|NCT00153920|593155820|FG000|Overall Study|Withdrawal by Subject|1|||
164215282|NCT00153920|593155820|FG000|Overall Study|Non-Protocol Therapy|1|||
164215283|NCT00153920|593155820|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
164215284|NCT00153920|593155820|FG000|Overall Study|Progressive Disease before Trt|1|||
164215285|NCT02541903|593155821|FG000|Overall Study|Death|1|||
164215286|NCT00827242|593155822|FG000|Overall Study|Withdrawal by Subject|2|||
164215287|NCT00827242|593155823|FG001|Overall Study|Withdrawal by Subject|4|||
164215288|NCT00827242|593155822|FG000|Overall Study|Protocol Violation|1|||
164215289|NCT00827242|593155823|FG001|Overall Study|Protocol Violation|3|||
164215290|NCT00827242|593155822|FG000|Overall Study|Lost to Follow-up|0|||
164215291|NCT00827242|593155823|FG001|Overall Study|Lost to Follow-up|3|||
164215292|NCT00827242|593155822|FG000|Overall Study|Adverse Event Excluding Death|2|||
164215293|NCT00827242|593155823|FG001|Overall Study|Adverse Event Excluding Death|1|||
164215294|NCT00827242|593155822|FG000|Overall Study|Entry Criteria Not Met|4|||
164215295|NCT00827242|593155823|FG001|Overall Study|Entry Criteria Not Met|1|||
164215296|NCT00827242|593155822|FG000|Overall Study|Physician Decision|2|||
164215297|NCT00827242|593155823|FG001|Overall Study|Physician Decision|0|||
164215298|NCT00827242|593155822|FG000|Overall Study|Death|1|||
164215299|NCT00827242|593155823|FG001|Overall Study|Death|0|||
164215300|NCT00827242|593155822|FG000|Overall Study|Lack of Efficacy|1|||
164215301|NCT00827242|593155823|FG001|Overall Study|Lack of Efficacy|0|||
164215302|NCT05762679|593155824|FG000|Overall Study|Withdrawal by Subject|1|||
164215303|NCT05762679|593155824|FG000|Overall Study|No analyzable imaging data|1|||
164215304|NCT04795323|593155825|FG000|Overall Study|Did not interact with TARA|1|||
164215305|NCT04795323|593155826|FG001|Overall Study|Did not interact with TARA|0|||
164215306|NCT01944774|593155827|FG000|Overall Study|Withdrawal by Subject|2|||
164215307|NCT01944774|593155828|FG001|Overall Study|Withdrawal by Subject|3|||
164215308|NCT01944774|593155829|FG002|Overall Study|Withdrawal by Subject|3|||
164215309|NCT01944774|593155827|FG000|Overall Study|Adverse Event|3|||
164420681|NCT01154036|593910964|FG002|Phase II|Lost to Follow-up|0|||
164215310|NCT01944774|593155828|FG001|Overall Study|Adverse Event|2|||
164215311|NCT01944774|593155829|FG002|Overall Study|Adverse Event|3|||
164215312|NCT01944774|593155827|FG000|Overall Study|Lack of Efficacy|1|||
164215313|NCT01944774|593155828|FG001|Overall Study|Lack of Efficacy|2|||
164565201|NCT03739528|594438434|FG001|Overall Study|Not treated|12|||
164565202|NCT03739528|594438433|FG000|Overall Study|Treatment and study discontinued|6|||
164565203|NCT03739528|594438434|FG001|Overall Study|Treatment and study discontinued|2|||
164565204|NCT03739528|594438433|FG000|Overall Study|Treatment discontinued + study completed|1|||
164565205|NCT03739528|594438434|FG001|Overall Study|Treatment discontinued + study completed|3|||
164565206|NCT02239263|594438435|FG000|Overall Study|Protocol Violation|6|||
164565207|NCT04303000|594438436|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
164565208|NCT04303000|594438437|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
164565209|NCT04303000|594438438|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
164565210|NCT05655377|594438439|FG000|Overall Study|Withdrawal by Subject|2|||
164565211|NCT02769624|594438441|FG000|Overall Study|Lost to Follow-up|0|||
164565212|NCT02769624|594438442|FG001|Overall Study|Lost to Follow-up|1|||
164565213|NCT01987908|594438452|FG000|Placebo Lead-in Period|Adverse Event|2|||
164565214|NCT01987908|594438453|FG001|Placebo Lead-in Period|Adverse Event|0|||
164565215|NCT01987908|594438454|FG002|Placebo Lead-in Period|Adverse Event|0|||
164565216|NCT01987908|594438452|FG000|Placebo Lead-in Period|Physician Decision|2|||
164565217|NCT01987908|594438453|FG001|Placebo Lead-in Period|Physician Decision|0|||
164565218|NCT01987908|594438454|FG002|Placebo Lead-in Period|Physician Decision|0|||
164565219|NCT01987908|594438452|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
164565220|NCT01987908|594438453|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
164565221|NCT01987908|594438454|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
164565222|NCT01987908|594438452|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
164565223|NCT01987908|594438453|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
164565224|NCT01987908|594438454|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
164565225|NCT01987908|594438452|FG000|Treatment Period|Adverse Event|0|||
164565226|NCT01987908|594438453|FG001|Treatment Period|Adverse Event|1|||
164565227|NCT01987908|594438454|FG002|Treatment Period|Adverse Event|1|||
164565228|NCT01987908|594438452|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
164565229|NCT01987908|594438453|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
164565230|NCT01987908|594438454|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
164565231|NCT01987908|594438452|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
164565232|NCT01987908|594438453|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
164565233|NCT01987908|594438454|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
164565234|NCT01869348|594438456|FG000|Overall Study|Withdrawal by Subject|1|||
164669666|NCT00259012|594815068|FG000|Overall Study|Withdrawal by Subject|1|||
164669667|NCT00259012|594815069|FG001|Overall Study|Withdrawal by Subject|0|||
164669668|NCT00259012|594815068|FG000|Overall Study|Physician Decision|0|||
164565235|NCT01869348|594438457|FG001|Overall Study|Withdrawal by Subject|1|||
164565236|NCT02789657|594438458|FG000|Overall Study|Withdrawal by Subject|2|||
164565237|NCT02789657|594438459|FG001|Overall Study|Withdrawal by Subject|0|||
164669669|NCT00259012|594815069|FG001|Overall Study|Physician Decision|1|||
164669670|NCT00259012|594815068|FG000|Overall Study|Lost to Follow-up|0|||
164669671|NCT00259012|594815069|FG001|Overall Study|Lost to Follow-up|1|||
164669672|NCT00259012|594815068|FG000|Overall Study|Protocol Violation|1|||
164669673|NCT00259012|594815069|FG001|Overall Study|Protocol Violation|1|||
164669674|NCT02674477|594815070|FG000|Overall Study|Protocol Violation|8|||
164669675|NCT02674477|594815071|FG001|Overall Study|Protocol Violation|2|||
164669676|NCT00834756|594815075|FG000|First Intervention|Adverse Event|1|||
164669677|NCT00834756|594815076|FG001|First Intervention|Adverse Event|0|||
164669678|NCT00834756|594815075|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
164669679|NCT00834756|594815076|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
164565238|NCT02789657|594438460|FG002|Overall Study|Withdrawal by Subject|0|||
164669680|NCT04625114|594815088|FG000|Overall Study|Adverse Event|3|||
164669681|NCT04625114|594815089|FG001|Overall Study|Adverse Event|1|||
164669682|NCT04625114|594815088|FG000|Overall Study|Withdrawal by Subject|2|||
164565239|NCT02789657|594438461|FG003|Overall Study|Withdrawal by Subject|0|||
164215314|NCT01944774|593155829|FG002|Overall Study|Lack of Efficacy|2|||
164215315|NCT01944774|593155827|FG000|Overall Study|Lost to Follow-up|0|||
164215316|NCT01944774|593155828|FG001|Overall Study|Lost to Follow-up|1|||
164215317|NCT01944774|593155829|FG002|Overall Study|Lost to Follow-up|0|||
164215318|NCT02503865|593155830|FG000|Overall Study|Moved out of area|1|||
164215319|NCT02503865|593155831|FG001|Overall Study|Moved out of area|8|||
164215320|NCT02503865|593155832|FG002|Overall Study|Moved out of area|0|||
164215321|NCT02503865|593155830|FG000|Overall Study|Refused treatment|4|||
164215322|NCT02503865|593155831|FG001|Overall Study|Refused treatment|39|||
164215323|NCT02503865|593155832|FG002|Overall Study|Refused treatment|2|||
164215324|NCT00021255|593155833|FG000|Overall Study|Death|1|||
164215325|NCT00021255|593155834|FG001|Overall Study|Death|0|||
164215326|NCT00021255|593155835|FG002|Overall Study|Death|2|||
164215327|NCT00021255|593155833|FG000|Overall Study|Breast cancer relapse|5|||
164215328|NCT00021255|593155834|FG001|Overall Study|Breast cancer relapse|18|||
164215329|NCT00021255|593155835|FG002|Overall Study|Breast cancer relapse|11|||
164215330|NCT00021255|593155833|FG000|Overall Study|Second primary malignancy|0|||
164215331|NCT00021255|593155834|FG001|Overall Study|Second primary malignancy|4|||
164215332|NCT00021255|593155835|FG002|Overall Study|Second primary malignancy|1|||
164215333|NCT00021255|593155833|FG000|Overall Study|Withdrawal by Subject|41|||
164215334|NCT00021255|593155834|FG001|Overall Study|Withdrawal by Subject|64|||
164215335|NCT00021255|593155835|FG002|Overall Study|Withdrawal by Subject|26|||
164215336|NCT00021255|593155833|FG000|Overall Study|Lost to Follow-up|0|||
164215337|NCT00021255|593155834|FG001|Overall Study|Lost to Follow-up|2|||
164215338|NCT00021255|593155835|FG002|Overall Study|Lost to Follow-up|3|||
164215339|NCT00021255|593155833|FG000|Overall Study|Cardiac toxicity|0|||
164215340|NCT00021255|593155834|FG001|Overall Study|Cardiac toxicity|61|||
164215341|NCT00021255|593155835|FG002|Overall Study|Cardiac toxicity|32|||
164215342|NCT00021255|593155833|FG000|Overall Study|Herceptin toxicity|0|||
164215343|NCT00021255|593155834|FG001|Overall Study|Herceptin toxicity|22|||
164215344|NCT00021255|593155835|FG002|Overall Study|Herceptin toxicity|6|||
164215345|NCT00021255|593155833|FG000|Overall Study|Adverse Event|46|||
164215346|NCT00021255|593155834|FG001|Overall Study|Adverse Event|30|||
164565240|NCT01728779|594438462|FG000|Overall Study|Withdrawal by Subject|1|||
164565241|NCT01925209|594438463|FG000|Treatment Epoch|Physician Decision|1|||
164565242|NCT01925209|594438464|FG001|Treatment Epoch|Physician Decision|0|||
164215347|NCT00021255|593155835|FG002|Overall Study|Adverse Event|18|||
164215348|NCT00021255|593155833|FG000|Overall Study|Protocol Violation|0|||
164215349|NCT00021255|593155834|FG001|Overall Study|Protocol Violation|2|||
164215350|NCT00021255|593155835|FG002|Overall Study|Protocol Violation|0|||
164215351|NCT00021255|593155833|FG000|Overall Study|Other than specified above|0|||
164215352|NCT00021255|593155834|FG001|Overall Study|Other than specified above|38|||
164215353|NCT00021255|593155835|FG002|Overall Study|Other than specified above|19|||
164215354|NCT00021255|593155833|FG000|Overall Study|Missing|0|||
164215355|NCT00021255|593155834|FG001|Overall Study|Missing|27|||
164215356|NCT00021255|593155835|FG002|Overall Study|Missing|13|||
164215357|NCT00021255|593155833|FG000|Overall Study|Randomized but not treated|28|||
164215358|NCT00021255|593155834|FG001|Overall Study|Randomized but not treated|2|||
164215359|NCT00021255|593155835|FG002|Overall Study|Randomized but not treated|18|||
164215360|NCT00927082|593155836|FG000|Overall Study|Lost to Follow-up|9|||
164215361|NCT00927082|593155837|FG001|Overall Study|Lost to Follow-up|8|||
164215362|NCT00927082|593155838|FG002|Overall Study|Lost to Follow-up|12|||
164215363|NCT00927082|593155839|FG003|Overall Study|Lost to Follow-up|16|||
164215364|NCT00927082|593155836|FG000|Overall Study|Withdrawal by Subject|3|||
164215365|NCT00927082|593155837|FG001|Overall Study|Withdrawal by Subject|2|||
164215366|NCT00927082|593155838|FG002|Overall Study|Withdrawal by Subject|7|||
164215367|NCT00927082|593155839|FG003|Overall Study|Withdrawal by Subject|2|||
164215368|NCT00927082|593155836|FG000|Overall Study|Death|0|||
164215369|NCT00927082|593155837|FG001|Overall Study|Death|0|||
164215370|NCT00927082|593155838|FG002|Overall Study|Death|1|||
164215371|NCT00927082|593155839|FG003|Overall Study|Death|0|||
164215372|NCT00927082|593155836|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
164215373|NCT00927082|593155837|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
164215374|NCT00927082|593155838|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
164215375|NCT00927082|593155839|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
164215376|NCT02513563|593155842|FG000|Overall Study|Death|4|||
164215377|NCT02513563|593155842|FG000|Overall Study|Withdrawal by Subject|4|||
164215378|NCT02513563|593155842|FG000|Overall Study|Physician Decision|1|||
164215379|NCT01068912|593155843|FG000|Overall Study|Adverse Event|2|||
164215380|NCT01068912|593155844|FG001|Overall Study|Adverse Event|3|||
164215381|NCT01068912|593155845|FG002|Overall Study|Adverse Event|2|||
164215382|NCT01068912|593155843|FG000|Overall Study|Withdrawal by Subject|5|||
164215383|NCT01068912|593155844|FG001|Overall Study|Withdrawal by Subject|6|||
164215384|NCT01068912|593155845|FG002|Overall Study|Withdrawal by Subject|6|||
164215385|NCT01068912|593155843|FG000|Overall Study|Lost to Follow-up|3|||
164215386|NCT01068912|593155844|FG001|Overall Study|Lost to Follow-up|7|||
164215387|NCT01068912|593155845|FG002|Overall Study|Lost to Follow-up|3|||
164215388|NCT01068912|593155843|FG000|Overall Study|Protocol Violation|0|||
164215389|NCT01068912|593155844|FG001|Overall Study|Protocol Violation|2|||
164215390|NCT01068912|593155845|FG002|Overall Study|Protocol Violation|0|||
164215391|NCT01068912|593155843|FG000|Overall Study|aggravation influenza|1|||
164215392|NCT01068912|593155844|FG001|Overall Study|aggravation influenza|1|||
164215393|NCT01068912|593155845|FG002|Overall Study|aggravation influenza|1|||
164215394|NCT01068912|593155843|FG000|Overall Study|other underlying illness|0|||
164215395|NCT01068912|593155844|FG001|Overall Study|other underlying illness|3|||
164215396|NCT01068912|593155845|FG002|Overall Study|other underlying illness|3|||
164215397|NCT00825175|593155846|FG000|Overall Study|Withdrawal by Subject|0|||
164215398|NCT00825175|593155847|FG001|Overall Study|Withdrawal by Subject|5|||
164215399|NCT05128942|593155850|FG000|Overall Study|Withdrawal by Subject|1|||
164215400|NCT05128942|593155851|FG001|Overall Study|Withdrawal by Subject|0|||
164215401|NCT05128942|593155852|FG002|Overall Study|Withdrawal by Subject|1|||
164215402|NCT05128942|593155853|FG003|Overall Study|Withdrawal by Subject|0|||
164215403|NCT05128942|593155854|FG004|Overall Study|Withdrawal by Subject|0|||
164215404|NCT05128942|593155855|FG005|Overall Study|Withdrawal by Subject|0|||
164215405|NCT05128942|593155856|FG006|Overall Study|Withdrawal by Subject|0|||
164215406|NCT05128942|593155857|FG007|Overall Study|Withdrawal by Subject|0|||
164215407|NCT05128942|593155858|FG008|Overall Study|Withdrawal by Subject|0|||
164215408|NCT05128942|593155850|FG000|Overall Study|Other|2|||
164215409|NCT05128942|593155851|FG001|Overall Study|Other|0|||
164215410|NCT05128942|593155852|FG002|Overall Study|Other|2|||
164215411|NCT05128942|593155853|FG003|Overall Study|Other|0|||
164215412|NCT05128942|593155854|FG004|Overall Study|Other|0|||
164215413|NCT05128942|593155855|FG005|Overall Study|Other|0|||
164215414|NCT05128942|593155856|FG006|Overall Study|Other|0|||
164215415|NCT05128942|593155857|FG007|Overall Study|Other|0|||
164215416|NCT05128942|593155858|FG008|Overall Study|Other|0|||
164215417|NCT05128942|593155850|FG000|Overall Study|Termination by Sponsor|2|||
164215418|NCT05128942|593155851|FG001|Overall Study|Termination by Sponsor|6|||
164215419|NCT05128942|593155852|FG002|Overall Study|Termination by Sponsor|14|||
164215420|NCT05128942|593155853|FG003|Overall Study|Termination by Sponsor|2|||
164215421|NCT05128942|593155854|FG004|Overall Study|Termination by Sponsor|4|||
164215422|NCT05128942|593155855|FG005|Overall Study|Termination by Sponsor|8|||
164215423|NCT05128942|593155856|FG006|Overall Study|Termination by Sponsor|11|||
164215424|NCT05128942|593155857|FG007|Overall Study|Termination by Sponsor|6|||
164215425|NCT05128942|593155858|FG008|Overall Study|Termination by Sponsor|0|||
164215426|NCT05128942|593155850|FG000|Overall Study|Adverse Event|0|||
164215427|NCT05128942|593155851|FG001|Overall Study|Adverse Event|0|||
164215428|NCT05128942|593155852|FG002|Overall Study|Adverse Event|0|||
164215429|NCT05128942|593155853|FG003|Overall Study|Adverse Event|0|||
164215430|NCT05128942|593155854|FG004|Overall Study|Adverse Event|0|||
164215431|NCT05128942|593155855|FG005|Overall Study|Adverse Event|0|||
164215432|NCT05128942|593155856|FG006|Overall Study|Adverse Event|1|||
164215433|NCT05128942|593155857|FG007|Overall Study|Adverse Event|1|||
164215434|NCT05128942|593155858|FG008|Overall Study|Adverse Event|0|||
164215435|NCT05128942|593155850|FG000|Overall Study|Lost to Follow-up|0|||
164215436|NCT05128942|593155851|FG001|Overall Study|Lost to Follow-up|0|||
164215437|NCT05128942|593155852|FG002|Overall Study|Lost to Follow-up|0|||
164215438|NCT05128942|593155853|FG003|Overall Study|Lost to Follow-up|0|||
164215439|NCT05128942|593155854|FG004|Overall Study|Lost to Follow-up|1|||
164565243|NCT01925209|594438465|FG002|Treatment Epoch|Physician Decision|0|||
164565244|NCT01925209|594438466|FG003|Treatment Epoch|Physician Decision|0|||
164565245|NCT01925209|594438463|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
164565246|NCT01925209|594438464|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
164565247|NCT01925209|594438465|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
164565248|NCT01925209|594438466|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
164565249|NCT01925209|594438463|FG000|Treatment Epoch|Death|1|||
164565250|NCT01925209|594438464|FG001|Treatment Epoch|Death|0|||
164215440|NCT05128942|593155855|FG005|Overall Study|Lost to Follow-up|0|||
164215441|NCT05128942|593155856|FG006|Overall Study|Lost to Follow-up|0|||
164215442|NCT05128942|593155857|FG007|Overall Study|Lost to Follow-up|0|||
164215443|NCT05128942|593155858|FG008|Overall Study|Lost to Follow-up|0|||
164215444|NCT03998462|593155860|FG000|Overall Study|Withdrawal by Subject|10|||
164215445|NCT03998462|593155861|FG001|Overall Study|Withdrawal by Subject|4|||
164215446|NCT03998462|593155860|FG000|Overall Study|Lost to Follow-up|1|||
164215447|NCT03998462|593155861|FG001|Overall Study|Lost to Follow-up|0|||
164215448|NCT03998462|593155860|FG000|Overall Study|Technical Difficulties|1|||
164215449|NCT03998462|593155861|FG001|Overall Study|Technical Difficulties|2|||
164215450|NCT05710224|593155862|FG000|Overall Study|Death|1|||
164215451|NCT05710224|593155863|FG001|Overall Study|Death|0|||
164215452|NCT05710224|593155862|FG000|Overall Study|Lost to Follow-up|16|||
164215453|NCT05710224|593155863|FG001|Overall Study|Lost to Follow-up|7|||
164215454|NCT05710224|593155862|FG000|Overall Study|Withdrawal by Subject|4|||
164215455|NCT05710224|593155863|FG001|Overall Study|Withdrawal by Subject|6|||
164215456|NCT05710224|593155862|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
164215457|NCT05710224|593155863|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
164215458|NCT05710224|593155862|FG000|Overall Study|Participants Left The City|0|||
164215459|NCT05710224|593155863|FG001|Overall Study|Participants Left The City|2|||
164215460|NCT03369223|593155866|FG000|Overall Study|Lost to Follow-up|0|||
164215461|NCT03369223|593155867|FG001|Overall Study|Lost to Follow-up|0|||
164215462|NCT03369223|593155868|FG002|Overall Study|Lost to Follow-up|0|||
164215463|NCT03369223|593155869|FG003|Overall Study|Lost to Follow-up|0|||
164215464|NCT03369223|593155870|FG004|Overall Study|Lost to Follow-up|0|||
164215465|NCT03369223|593155871|FG005|Overall Study|Lost to Follow-up|0|||
164215466|NCT03369223|593155872|FG006|Overall Study|Lost to Follow-up|0|||
164215467|NCT03369223|593155873|FG007|Overall Study|Lost to Follow-up|0|||
164215468|NCT03369223|593155874|FG008|Overall Study|Lost to Follow-up|0|||
164215469|NCT03369223|593155875|FG009|Overall Study|Lost to Follow-up|0|||
164215470|NCT03369223|593155876|FG010|Overall Study|Lost to Follow-up|0|||
164215471|NCT03369223|593155877|FG011|Overall Study|Lost to Follow-up|0|||
164215472|NCT03369223|593155878|FG012|Overall Study|Lost to Follow-up|0|||
164215473|NCT03369223|593155879|FG013|Overall Study|Lost to Follow-up|0|||
164215474|NCT03369223|593155880|FG014|Overall Study|Lost to Follow-up|0|||
164215475|NCT03369223|593155881|FG015|Overall Study|Lost to Follow-up|0|||
164215476|NCT03369223|593155882|FG016|Overall Study|Lost to Follow-up|0|||
164215477|NCT03369223|593155883|FG017|Overall Study|Lost to Follow-up|0|||
164215478|NCT03369223|593155884|FG018|Overall Study|Lost to Follow-up|2|||
164565251|NCT01925209|594438465|FG002|Treatment Epoch|Death|0|||
164565252|NCT01925209|594438466|FG003|Treatment Epoch|Death|0|||
164565253|NCT01925209|594438463|FG000|Treatment Epoch|Protocol deviation|0|||
164565254|NCT01925209|594438464|FG001|Treatment Epoch|Protocol deviation|0|||
164565255|NCT01925209|594438465|FG002|Treatment Epoch|Protocol deviation|1|||
164565256|NCT01925209|594438466|FG003|Treatment Epoch|Protocol deviation|1|||
164565257|NCT01925209|594438463|FG000|Treatment Epoch|Withdrawal by Subject|4|||
164565258|NCT01925209|594438464|FG001|Treatment Epoch|Withdrawal by Subject|3|||
164565259|NCT01925209|594438465|FG002|Treatment Epoch|Withdrawal by Subject|3|||
164565260|NCT01925209|594438466|FG003|Treatment Epoch|Withdrawal by Subject|2|||
164565261|NCT01925209|594438463|FG000|Treatment Epoch|Adverse Event|3|||
164565262|NCT01925209|594438464|FG001|Treatment Epoch|Adverse Event|5|||
164565263|NCT01925209|594438465|FG002|Treatment Epoch|Adverse Event|3|||
164565264|NCT01925209|594438466|FG003|Treatment Epoch|Adverse Event|1|||
164565265|NCT01925209|594438463|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
164565266|NCT01925209|594438464|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
164565267|NCT01925209|594438465|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
164565268|NCT01925209|594438466|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
164565269|NCT01925209|594438463|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
164565270|NCT01925209|594438464|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
164565271|NCT01925209|594438465|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
164565272|NCT01925209|594438466|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
164565273|NCT01925209|594438463|FG000|Follow-up|Adverse Event|1|||
164565274|NCT01925209|594438464|FG001|Follow-up|Adverse Event|4|||
164565275|NCT01925209|594438465|FG002|Follow-up|Adverse Event|0|||
164565276|NCT01925209|594438466|FG003|Follow-up|Adverse Event|1|||
164565277|NCT01925209|594438463|FG000|Follow-up|Physician Decision|0|||
164565278|NCT01925209|594438464|FG001|Follow-up|Physician Decision|0|||
164565279|NCT01925209|594438465|FG002|Follow-up|Physician Decision|1|||
164565280|NCT01925209|594438466|FG003|Follow-up|Physician Decision|0|||
164215479|NCT03369223|593155885|FG019|Overall Study|Lost to Follow-up|1|||
164215480|NCT03369223|593155866|FG000|Overall Study|Participant no longer meets study criteria|0|||
164565281|NCT01925209|594438463|FG000|Follow-up|Non-compliance with study treatment|0|||
164565282|NCT01925209|594438464|FG001|Follow-up|Non-compliance with study treatment|0|||
164215481|NCT03369223|593155867|FG001|Overall Study|Participant no longer meets study criteria|0|||
164215482|NCT03369223|593155868|FG002|Overall Study|Participant no longer meets study criteria|0|||
164215483|NCT03369223|593155869|FG003|Overall Study|Participant no longer meets study criteria|0|||
164215484|NCT03369223|593155870|FG004|Overall Study|Participant no longer meets study criteria|0|||
164215485|NCT03369223|593155871|FG005|Overall Study|Participant no longer meets study criteria|0|||
164215486|NCT03369223|593155872|FG006|Overall Study|Participant no longer meets study criteria|0|||
164215487|NCT03369223|593155873|FG007|Overall Study|Participant no longer meets study criteria|0|||
164215488|NCT03369223|593155874|FG008|Overall Study|Participant no longer meets study criteria|0|||
164215489|NCT03369223|593155875|FG009|Overall Study|Participant no longer meets study criteria|0|||
164215490|NCT03369223|593155876|FG010|Overall Study|Participant no longer meets study criteria|0|||
164215491|NCT03369223|593155877|FG011|Overall Study|Participant no longer meets study criteria|0|||
164215492|NCT03369223|593155878|FG012|Overall Study|Participant no longer meets study criteria|0|||
164215493|NCT03369223|593155879|FG013|Overall Study|Participant no longer meets study criteria|0|||
164215494|NCT03369223|593155880|FG014|Overall Study|Participant no longer meets study criteria|2|||
164215495|NCT03369223|593155881|FG015|Overall Study|Participant no longer meets study criteria|0|||
164215496|NCT03369223|593155882|FG016|Overall Study|Participant no longer meets study criteria|2|||
164215497|NCT03369223|593155883|FG017|Overall Study|Participant no longer meets study criteria|0|||
164215498|NCT03369223|593155884|FG018|Overall Study|Participant no longer meets study criteria|0|||
164215499|NCT03369223|593155885|FG019|Overall Study|Participant no longer meets study criteria|0|||
164215500|NCT03369223|593155866|FG000|Overall Study|Other reasons|0|||
164215501|NCT03369223|593155867|FG001|Overall Study|Other reasons|0|||
164215502|NCT03369223|593155868|FG002|Overall Study|Other reasons|0|||
164215503|NCT03369223|593155869|FG003|Overall Study|Other reasons|0|||
164215504|NCT03369223|593155870|FG004|Overall Study|Other reasons|0|||
164669683|NCT04625114|594815089|FG001|Overall Study|Withdrawal by Subject|0|||
164669684|NCT02507375|594815096|FG000|Overall Study|Progressive Disease|4|||
164669685|NCT02507375|594815097|FG001|Overall Study|Progressive Disease|5|||
164669686|NCT02507375|594815096|FG000|Overall Study|Death|0|||
164669687|NCT02507375|594815097|FG001|Overall Study|Death|1|||
164669688|NCT02507375|594815096|FG000|Overall Study|Refused treatment|0|||
164669689|NCT02507375|594815097|FG001|Overall Study|Refused treatment|1|||
164669690|NCT02507375|594815096|FG000|Overall Study|Adverse Event|0|||
164669691|NCT02507375|594815097|FG001|Overall Study|Adverse Event|1|||
164669692|NCT03478397|594816718|FG000|Overall Study|Refused to participate|31|||
164669693|NCT03478397|594816719|FG001|Overall Study|Refused to participate|7|||
164669694|NCT05327491|594816720|FG000|Periods 1 & 2|Miscellaneous|0|||
164669695|NCT05327491|594816721|FG001|Periods 1 & 2|Miscellaneous|1|||
164669696|NCT05327491|594816722|FG002|Periods 1 & 2|Miscellaneous|0|||
164669697|NCT05327491|594816723|FG003|Periods 1 & 2|Miscellaneous|0|||
164669698|NCT05327491|594816720|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
164669699|NCT05327491|594816721|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
164669700|NCT05327491|594816722|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
164669701|NCT05327491|594816723|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
164669702|NCT04206332|594816725|FG000|Part A|Lost to Follow-up|0|||
164669703|NCT04206332|594816726|FG001|Part A|Lost to Follow-up|1|||
164669704|NCT04206332|594816727|FG002|Part A|Lost to Follow-up|0|||
164669705|NCT04206332|594816728|FG003|Part A|Lost to Follow-up|0|||
164669706|NCT04206332|594816729|FG004|Part A|Lost to Follow-up|0|||
164669707|NCT04206332|594816730|FG005|Part A|Lost to Follow-up|0|||
164669708|NCT04206332|594816731|FG006|Part A|Lost to Follow-up|0|||
164669709|NCT04206332|594816732|FG007|Part A|Lost to Follow-up|0|||
164669710|NCT04206332|594816733|FG008|Part A|Lost to Follow-up|0|||
164669711|NCT04206332|594816734|FG009|Part A|Lost to Follow-up|0|||
164669712|NCT04206332|594816735|FG010|Part A|Lost to Follow-up|0|||
164669713|NCT04206332|594816736|FG011|Part A|Lost to Follow-up|0|||
164669714|NCT04206332|594816737|FG012|Part A|Lost to Follow-up|0|||
164669715|NCT04206332|594816738|FG013|Part A|Lost to Follow-up|0|||
164669716|NCT04206332|594816739|FG014|Part A|Lost to Follow-up|0|||
164669717|NCT04206332|594816740|FG015|Part A|Lost to Follow-up|0|||
164215505|NCT03369223|593155871|FG005|Overall Study|Other reasons|0|||
164215506|NCT03369223|593155872|FG006|Overall Study|Other reasons|0|||
164215507|NCT03369223|593155873|FG007|Overall Study|Other reasons|0|||
164215508|NCT03369223|593155874|FG008|Overall Study|Other reasons|0|||
164215509|NCT03369223|593155875|FG009|Overall Study|Other reasons|0|||
164215510|NCT03369223|593155876|FG010|Overall Study|Other reasons|0|||
164215511|NCT03369223|593155877|FG011|Overall Study|Other reasons|0|||
164215512|NCT03369223|593155878|FG012|Overall Study|Other reasons|0|||
164215513|NCT03369223|593155879|FG013|Overall Study|Other reasons|1|||
164215514|NCT03369223|593155880|FG014|Overall Study|Other reasons|2|||
164215515|NCT03369223|593155881|FG015|Overall Study|Other reasons|0|||
164215516|NCT03369223|593155882|FG016|Overall Study|Other reasons|1|||
164669718|NCT04206332|594816741|FG016|Part A|Lost to Follow-up|0|||
164669719|NCT04206332|594816725|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164215517|NCT03369223|593155883|FG017|Overall Study|Other reasons|0|||
164669720|NCT04206332|594816726|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164669721|NCT04206332|594816727|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164669722|NCT04206332|594816728|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164215518|NCT03369223|593155884|FG018|Overall Study|Other reasons|0|||
164669723|NCT04206332|594816729|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164669724|NCT04206332|594816730|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
164669725|NCT04206332|594816731|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164669726|NCT04206332|594816732|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164669727|NCT04206332|594816733|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164669728|NCT04206332|594816734|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164669729|NCT04206332|594816735|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164669730|NCT04206332|594816736|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164669731|NCT04206332|594816737|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164669732|NCT04206332|594816738|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164669733|NCT04206332|594816739|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164669734|NCT04206332|594816740|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164669735|NCT04206332|594816741|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164669736|NCT04206332|594816725|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669737|NCT04206332|594816726|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669738|NCT04206332|594816727|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669739|NCT04206332|594816728|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669740|NCT04206332|594816729|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669741|NCT04206332|594816730|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669742|NCT04206332|594816731|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669743|NCT04206332|594816732|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
164669744|NCT04206332|594816733|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669745|NCT04206332|594816734|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669746|NCT04206332|594816735|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
164669747|NCT04206332|594816736|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669748|NCT04206332|594816737|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669749|NCT04206332|594816738|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669750|NCT04206332|594816739|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669751|NCT04206332|594816740|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669752|NCT04206332|594816741|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669753|NCT04206332|594816725|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669754|NCT04206332|594816726|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669755|NCT04206332|594816727|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669756|NCT04206332|594816728|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669757|NCT04206332|594816729|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669758|NCT04206332|594816730|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669759|NCT04206332|594816731|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669760|NCT04206332|594816732|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669761|NCT04206332|594816733|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669762|NCT04206332|594816734|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669763|NCT04206332|594816735|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669764|NCT04206332|594816736|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669765|NCT04206332|594816737|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669766|NCT04206332|594816738|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669767|NCT04206332|594816739|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669768|NCT04206332|594816740|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164669769|NCT04206332|594816741|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
164669770|NCT04206332|594816725|FG000|Part C|Withdrawal by Subject|0|||
164669771|NCT04206332|594816726|FG001|Part C|Withdrawal by Subject|0|||
164215519|NCT03369223|593155885|FG019|Overall Study|Other reasons|2|||
164669772|NCT04206332|594816727|FG002|Part C|Withdrawal by Subject|0|||
164669773|NCT04206332|594816728|FG003|Part C|Withdrawal by Subject|0|||
164669774|NCT04206332|594816729|FG004|Part C|Withdrawal by Subject|0|||
164215520|NCT03369223|593155866|FG000|Overall Study|Death|0|||
164215521|NCT03369223|593155867|FG001|Overall Study|Death|0|||
164215522|NCT03369223|593155868|FG002|Overall Study|Death|0|||
164215523|NCT03369223|593155869|FG003|Overall Study|Death|0|||
164215524|NCT03369223|593155870|FG004|Overall Study|Death|0|||
164215525|NCT03369223|593155871|FG005|Overall Study|Death|0|||
164215526|NCT03369223|593155872|FG006|Overall Study|Death|0|||
164215527|NCT03369223|593155873|FG007|Overall Study|Death|0|||
164215528|NCT03369223|593155874|FG008|Overall Study|Death|0|||
164215529|NCT03369223|593155875|FG009|Overall Study|Death|0|||
164215530|NCT03369223|593155876|FG010|Overall Study|Death|0|||
164215531|NCT03369223|593155877|FG011|Overall Study|Death|0|||
164215532|NCT03369223|593155878|FG012|Overall Study|Death|0|||
164215533|NCT03369223|593155879|FG013|Overall Study|Death|1|||
164215534|NCT03369223|593155880|FG014|Overall Study|Death|0|||
164215535|NCT03369223|593155881|FG015|Overall Study|Death|0|||
164215536|NCT03369223|593155882|FG016|Overall Study|Death|0|||
164215537|NCT03369223|593155883|FG017|Overall Study|Death|0|||
164215538|NCT03369223|593155884|FG018|Overall Study|Death|1|||
164215539|NCT03369223|593155885|FG019|Overall Study|Death|0|||
164215540|NCT03369223|593155866|FG000|Overall Study|Adverse event unrelated to study drug|0|||
164215541|NCT03369223|593155867|FG001|Overall Study|Adverse event unrelated to study drug|0|||
164215542|NCT03369223|593155868|FG002|Overall Study|Adverse event unrelated to study drug|0|||
164215543|NCT03369223|593155869|FG003|Overall Study|Adverse event unrelated to study drug|0|||
164215544|NCT03369223|593155870|FG004|Overall Study|Adverse event unrelated to study drug|0|||
164215545|NCT03369223|593155871|FG005|Overall Study|Adverse event unrelated to study drug|0|||
164215546|NCT03369223|593155872|FG006|Overall Study|Adverse event unrelated to study drug|1|||
164215547|NCT03369223|593155873|FG007|Overall Study|Adverse event unrelated to study drug|0|||
164215548|NCT03369223|593155874|FG008|Overall Study|Adverse event unrelated to study drug|0|||
164215549|NCT03369223|593155875|FG009|Overall Study|Adverse event unrelated to study drug|1|||
164669775|NCT04206332|594816730|FG005|Part C|Withdrawal by Subject|0|||
164215550|NCT03369223|593155876|FG010|Overall Study|Adverse event unrelated to study drug|0|||
164215551|NCT03369223|593155877|FG011|Overall Study|Adverse event unrelated to study drug|0|||
164215552|NCT03369223|593155878|FG012|Overall Study|Adverse event unrelated to study drug|0|||
164326055|NCT00472459|593570105|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
164326056|NCT00472459|593570106|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
164326057|NCT00472459|593570105|FG000|Overall Study|Lost to Follow-up|1|||
164326058|NCT00472459|593570106|FG001|Overall Study|Lost to Follow-up|1|||
164326059|NCT02395016|593570107|FG000|Overall Study|Adverse Event|4|||
164326060|NCT02395016|593570108|FG001|Overall Study|Adverse Event|3|||
164326061|NCT02395016|593570107|FG000|Overall Study|Withdrawal by Subject|9|||
164326062|NCT02395016|593570108|FG001|Overall Study|Withdrawal by Subject|6|||
164326063|NCT02395016|593570107|FG000|Overall Study|Protocol Violation|2|||
164326064|NCT02395016|593570108|FG001|Overall Study|Protocol Violation|3|||
164326065|NCT01547780|593570109|FG000|Baseline PET Scan|Physician Decision|1|||
164326066|NCT01547780|593570110|FG001|Baseline PET Scan|Physician Decision|0|||
164326067|NCT01547780|593570111|FG002|Baseline PET Scan|Physician Decision|1|||
164326068|NCT01547780|593570112|FG003|Baseline PET Scan|Physician Decision|0|||
164326069|NCT01547780|593570109|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
164326070|NCT01547780|593570110|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
164326071|NCT01547780|593570111|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
164326072|NCT01547780|593570112|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
164326073|NCT00814879|593570114|FG000|By Week 24|Cancer Diagnosis|1|||
164326074|NCT00814879|593570115|FG001|By Week 24|Cancer Diagnosis|0|||
164326075|NCT00814879|593570114|FG000|By Week 24|Incarceration|0|||
164326076|NCT00814879|593570115|FG001|By Week 24|Incarceration|1|||
164326077|NCT00814879|593570114|FG000|By Week 48|Lost to Follow-up|2|||
164326078|NCT00814879|593570115|FG001|By Week 48|Lost to Follow-up|2|||
164669776|NCT04206332|594816731|FG006|Part C|Withdrawal by Subject|0|||
164669777|NCT04206332|594816732|FG007|Part C|Withdrawal by Subject|0|||
164326079|NCT00814879|593570114|FG000|By Week 48|Death|0|||
164326080|NCT00814879|593570115|FG001|By Week 48|Death|1|||
164326081|NCT01461057|593570116|FG000|Overall Study|Death|10|||
164669778|NCT04206332|594816733|FG008|Part C|Withdrawal by Subject|0|||
164215553|NCT03369223|593155879|FG013|Overall Study|Adverse event unrelated to study drug|4|||
164215554|NCT03369223|593155880|FG014|Overall Study|Adverse event unrelated to study drug|2|||
164215555|NCT03369223|593155881|FG015|Overall Study|Adverse event unrelated to study drug|0|||
164215556|NCT03369223|593155882|FG016|Overall Study|Adverse event unrelated to study drug|2|||
164215557|NCT03369223|593155883|FG017|Overall Study|Adverse event unrelated to study drug|1|||
164215558|NCT03369223|593155884|FG018|Overall Study|Adverse event unrelated to study drug|3|||
164326082|NCT01461057|593570117|FG001|Overall Study|Death|9|||
164326083|NCT01461057|593570116|FG000|Overall Study|Withdrawal by Subject|2|||
164669779|NCT04206332|594816734|FG009|Part C|Withdrawal by Subject|0|||
164669780|NCT04206332|594816735|FG010|Part C|Withdrawal by Subject|0|||
164326084|NCT01461057|593570117|FG001|Overall Study|Withdrawal by Subject|3|||
164669781|NCT04206332|594816736|FG011|Part C|Withdrawal by Subject|0|||
164669782|NCT04206332|594816737|FG012|Part C|Withdrawal by Subject|0|||
164669783|NCT04206332|594816738|FG013|Part C|Withdrawal by Subject|0|||
164215559|NCT03369223|593155885|FG019|Overall Study|Adverse event unrelated to study drug|2|||
164215560|NCT03369223|593155866|FG000|Overall Study|Disease progression|6|||
164215561|NCT03369223|593155867|FG001|Overall Study|Disease progression|8|||
164215562|NCT03369223|593155868|FG002|Overall Study|Disease progression|5|||
164215563|NCT03369223|593155869|FG003|Overall Study|Disease progression|1|||
164215564|NCT03369223|593155870|FG004|Overall Study|Disease progression|9|||
164215565|NCT03369223|593155871|FG005|Overall Study|Disease progression|9|||
164215566|NCT03369223|593155872|FG006|Overall Study|Disease progression|4|||
164215567|NCT03369223|593155873|FG007|Overall Study|Disease progression|6|||
164215568|NCT03369223|593155874|FG008|Overall Study|Disease progression|10|||
164215569|NCT03369223|593155875|FG009|Overall Study|Disease progression|7|||
164215570|NCT03369223|593155876|FG010|Overall Study|Disease progression|4|||
164215571|NCT03369223|593155877|FG011|Overall Study|Disease progression|1|||
164215572|NCT03369223|593155878|FG012|Overall Study|Disease progression|1|||
164215573|NCT03369223|593155879|FG013|Overall Study|Disease progression|25|||
164215574|NCT03369223|593155880|FG014|Overall Study|Disease progression|22|||
164215575|NCT03369223|593155881|FG015|Overall Study|Disease progression|2|||
164215576|NCT03369223|593155882|FG016|Overall Study|Disease progression|10|||
164215577|NCT03369223|593155883|FG017|Overall Study|Disease progression|1|||
164215578|NCT03369223|593155884|FG018|Overall Study|Disease progression|18|||
164215579|NCT03369223|593155885|FG019|Overall Study|Disease progression|28|||
164215580|NCT03369223|593155866|FG000|Overall Study|Study drug toxicity|0|||
164215581|NCT03369223|593155867|FG001|Overall Study|Study drug toxicity|1|||
164215582|NCT03369223|593155868|FG002|Overall Study|Study drug toxicity|4|||
164215583|NCT03369223|593155869|FG003|Overall Study|Study drug toxicity|0|||
164215584|NCT03369223|593155870|FG004|Overall Study|Study drug toxicity|1|||
164215585|NCT03369223|593155871|FG005|Overall Study|Study drug toxicity|2|||
164215586|NCT03369223|593155872|FG006|Overall Study|Study drug toxicity|4|||
164215587|NCT03369223|593155873|FG007|Overall Study|Study drug toxicity|2|||
164215588|NCT03369223|593155874|FG008|Overall Study|Study drug toxicity|2|||
164215589|NCT03369223|593155875|FG009|Overall Study|Study drug toxicity|0|||
164215590|NCT03369223|593155876|FG010|Overall Study|Study drug toxicity|6|||
164215591|NCT03369223|593155877|FG011|Overall Study|Study drug toxicity|1|||
164215592|NCT03369223|593155878|FG012|Overall Study|Study drug toxicity|2|||
164215593|NCT03369223|593155879|FG013|Overall Study|Study drug toxicity|19|||
164215594|NCT03369223|593155880|FG014|Overall Study|Study drug toxicity|19|||
164215595|NCT03369223|593155881|FG015|Overall Study|Study drug toxicity|0|||
164215596|NCT03369223|593155882|FG016|Overall Study|Study drug toxicity|18|||
164215597|NCT03369223|593155883|FG017|Overall Study|Study drug toxicity|3|||
164215598|NCT03369223|593155884|FG018|Overall Study|Study drug toxicity|11|||
164215599|NCT03369223|593155885|FG019|Overall Study|Study drug toxicity|7|||
164215600|NCT03369223|593155866|FG000|Overall Study|Participant request to discontinue study treatment|0|||
164215601|NCT03369223|593155867|FG001|Overall Study|Participant request to discontinue study treatment|1|||
164215602|NCT03369223|593155868|FG002|Overall Study|Participant request to discontinue study treatment|0|||
164215603|NCT03369223|593155869|FG003|Overall Study|Participant request to discontinue study treatment|0|||
164215604|NCT03369223|593155870|FG004|Overall Study|Participant request to discontinue study treatment|1|||
164215605|NCT03369223|593155871|FG005|Overall Study|Participant request to discontinue study treatment|1|||
164215606|NCT03369223|593155872|FG006|Overall Study|Participant request to discontinue study treatment|1|||
164215607|NCT03369223|593155873|FG007|Overall Study|Participant request to discontinue study treatment|0|||
164215608|NCT03369223|593155874|FG008|Overall Study|Participant request to discontinue study treatment|0|||
164215609|NCT03369223|593155875|FG009|Overall Study|Participant request to discontinue study treatment|0|||
164215610|NCT03369223|593155876|FG010|Overall Study|Participant request to discontinue study treatment|0|||
164215611|NCT03369223|593155877|FG011|Overall Study|Participant request to discontinue study treatment|0|||
164215612|NCT03369223|593155878|FG012|Overall Study|Participant request to discontinue study treatment|0|||
164215613|NCT03369223|593155879|FG013|Overall Study|Participant request to discontinue study treatment|1|||
164215614|NCT03369223|593155880|FG014|Overall Study|Participant request to discontinue study treatment|1|||
164215615|NCT03369223|593155881|FG015|Overall Study|Participant request to discontinue study treatment|0|||
164215616|NCT03369223|593155882|FG016|Overall Study|Participant request to discontinue study treatment|0|||
164215617|NCT03369223|593155883|FG017|Overall Study|Participant request to discontinue study treatment|0|||
164215618|NCT03369223|593155884|FG018|Overall Study|Participant request to discontinue study treatment|1|||
164215619|NCT03369223|593155885|FG019|Overall Study|Participant request to discontinue study treatment|0|||
164326085|NCT01461057|593570116|FG000|Overall Study|Physician Decision|0|||
164326086|NCT01461057|593570117|FG001|Overall Study|Physician Decision|2|||
164669784|NCT04206332|594816739|FG014|Part C|Withdrawal by Subject|2|||
164215620|NCT03369223|593155866|FG000|Overall Study|Participant withdrew consent|0|||
164215621|NCT03369223|593155867|FG001|Overall Study|Participant withdrew consent|1|||
164215622|NCT03369223|593155868|FG002|Overall Study|Participant withdrew consent|1|||
164215623|NCT03369223|593155869|FG003|Overall Study|Participant withdrew consent|0|||
164215624|NCT03369223|593155870|FG004|Overall Study|Participant withdrew consent|0|||
164326087|NCT01461057|593570116|FG000|Overall Study|Adverse Event|0|||
164669785|NCT04206332|594816740|FG015|Part C|Withdrawal by Subject|0|||
164215625|NCT03369223|593155871|FG005|Overall Study|Participant withdrew consent|0|||
164215626|NCT03369223|593155872|FG006|Overall Study|Participant withdrew consent|1|||
164215627|NCT03369223|593155873|FG007|Overall Study|Participant withdrew consent|1|||
164215628|NCT03369223|593155874|FG008|Overall Study|Participant withdrew consent|1|||
164215629|NCT03369223|593155875|FG009|Overall Study|Participant withdrew consent|0|||
164215630|NCT03369223|593155876|FG010|Overall Study|Participant withdrew consent|0|||
164215631|NCT03369223|593155877|FG011|Overall Study|Participant withdrew consent|1|||
164215632|NCT03369223|593155878|FG012|Overall Study|Participant withdrew consent|0|||
164215633|NCT03369223|593155879|FG013|Overall Study|Participant withdrew consent|0|||
164215634|NCT03369223|593155880|FG014|Overall Study|Participant withdrew consent|3|||
164215635|NCT03369223|593155881|FG015|Overall Study|Participant withdrew consent|0|||
164215636|NCT03369223|593155882|FG016|Overall Study|Participant withdrew consent|1|||
164215637|NCT03369223|593155883|FG017|Overall Study|Participant withdrew consent|0|||
164215638|NCT03369223|593155884|FG018|Overall Study|Participant withdrew consent|4|||
164215639|NCT03369223|593155885|FG019|Overall Study|Participant withdrew consent|2|||
164215640|NCT03369223|593155866|FG000|Overall Study|Randomized but not treated|0|||
164215641|NCT03369223|593155867|FG001|Overall Study|Randomized but not treated|0|||
164215642|NCT03369223|593155868|FG002|Overall Study|Randomized but not treated|0|||
164215643|NCT03369223|593155869|FG003|Overall Study|Randomized but not treated|0|||
164215644|NCT03369223|593155870|FG004|Overall Study|Randomized but not treated|0|||
164215645|NCT03369223|593155871|FG005|Overall Study|Randomized but not treated|0|||
164215646|NCT03369223|593155872|FG006|Overall Study|Randomized but not treated|0|||
164215647|NCT03369223|593155873|FG007|Overall Study|Randomized but not treated|0|||
164215648|NCT03369223|593155874|FG008|Overall Study|Randomized but not treated|0|||
164215649|NCT03369223|593155875|FG009|Overall Study|Randomized but not treated|0|||
164215650|NCT03369223|593155876|FG010|Overall Study|Randomized but not treated|0|||
164215651|NCT03369223|593155877|FG011|Overall Study|Randomized but not treated|0|||
164215652|NCT03369223|593155878|FG012|Overall Study|Randomized but not treated|0|||
164215653|NCT03369223|593155879|FG013|Overall Study|Randomized but not treated|1|||
164215654|NCT03369223|593155880|FG014|Overall Study|Randomized but not treated|1|||
164215655|NCT03369223|593155881|FG015|Overall Study|Randomized but not treated|0|||
164215656|NCT03369223|593155882|FG016|Overall Study|Randomized but not treated|0|||
164215657|NCT03369223|593155883|FG017|Overall Study|Randomized but not treated|0|||
164215658|NCT03369223|593155884|FG018|Overall Study|Randomized but not treated|0|||
164215659|NCT03369223|593155885|FG019|Overall Study|Randomized but not treated|0|||
164215660|NCT03010501|593155890|FG000|Study Week 1|Withdrawal by Subject|2|||
164215661|NCT03010501|593155891|FG001|Study Week 1|Withdrawal by Subject|1|||
164215662|NCT03010501|593155892|FG002|Study Week 1|Withdrawal by Subject|0|||
164215663|NCT03010501|593155893|FG003|Study Week 1|Withdrawal by Subject|2|||
164215664|NCT03010501|593155894|FG004|Study Week 1|Withdrawal by Subject|0|||
164215665|NCT03010501|593155895|FG005|Study Week 1|Withdrawal by Subject|0|||
164215666|NCT03010501|593155890|FG000|Study Week 3|Withdrawal by Subject|0|||
164215667|NCT03010501|593155891|FG001|Study Week 3|Withdrawal by Subject|0|||
164326088|NCT01461057|593570117|FG001|Overall Study|Adverse Event|1|||
164326089|NCT01461057|593570116|FG000|Overall Study|Progression of Disease|1|||
164326090|NCT01461057|593570117|FG001|Overall Study|Progression of Disease|0|||
164326091|NCT01461057|593570116|FG000|Overall Study|Study Terminated by Sponsor|2|||
164326092|NCT01461057|593570117|FG001|Overall Study|Study Terminated by Sponsor|0|||
164326093|NCT01288976|593570118|FG000|Overall Study|Withdrawal by Subject|58|||
164326094|NCT01288976|593570119|FG001|Overall Study|Withdrawal by Subject|12|||
164326095|NCT01288976|593570120|FG002|Overall Study|Withdrawal by Subject|9|||
164326096|NCT01288976|593570118|FG000|Overall Study|Death|98|||
164326097|NCT01288976|593570119|FG001|Overall Study|Death|6|||
164326098|NCT01288976|593570120|FG002|Overall Study|Death|4|||
164326099|NCT01288976|593570118|FG000|Overall Study|Data unavailable|22|||
164326100|NCT01288976|593570119|FG001|Overall Study|Data unavailable|9|||
164326101|NCT01288976|593570120|FG002|Overall Study|Data unavailable|7|||
164326102|NCT03228420|593570125|FG000|Overall Study|Lost to Follow-up|5|||
164326103|NCT03228420|593570126|FG001|Overall Study|Lost to Follow-up|3|||
164326104|NCT03228420|593570125|FG000|Overall Study|Withdrawal by Subject|10|||
164326105|NCT03228420|593570126|FG001|Overall Study|Withdrawal by Subject|0|||
164326106|NCT03228420|593570125|FG000|Overall Study|Adverse Event|5|||
164565283|NCT01925209|594438465|FG002|Follow-up|Non-compliance with study treatment|0|||
164565284|NCT01925209|594438466|FG003|Follow-up|Non-compliance with study treatment|1|||
164565285|NCT01925209|594438463|FG000|Follow-up|Withdrawal by Subject|0|||
164565286|NCT01925209|594438464|FG001|Follow-up|Withdrawal by Subject|2|||
164215668|NCT03010501|593155892|FG002|Study Week 3|Withdrawal by Subject|0|||
164215669|NCT03010501|593155893|FG003|Study Week 3|Withdrawal by Subject|1|||
164215670|NCT03010501|593155894|FG004|Study Week 3|Withdrawal by Subject|0|||
164215671|NCT03010501|593155895|FG005|Study Week 3|Withdrawal by Subject|0|||
164215672|NCT02347787|593155898|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
164215673|NCT02347787|593155899|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
164215674|NCT02347787|593155898|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
164215675|NCT02347787|593155899|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
164215676|NCT02347787|593155898|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
164326107|NCT03228420|593570126|FG001|Overall Study|Adverse Event|2|||
164326108|NCT01083173|593570127|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
164326109|NCT01083173|593570128|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
164326110|NCT01083173|593570127|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
164326111|NCT01083173|593570128|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
164669786|NCT04206332|594816741|FG016|Part C|Withdrawal by Subject|0|||
164669787|NCT00239577|594816747|FG000|Primary Phase|Adverse Event|0|||
164669788|NCT00239577|594816748|FG001|Primary Phase|Adverse Event|0|||
164669789|NCT00239577|594816749|FG002|Primary Phase|Adverse Event|1|||
164669790|NCT00239577|594816750|FG003|Primary Phase|Adverse Event|0|||
164669791|NCT00239577|594816747|FG000|Primary Phase|Other|5|||
164669792|NCT00239577|594816748|FG001|Primary Phase|Other|3|||
164669793|NCT00239577|594816749|FG002|Primary Phase|Other|2|||
164669794|NCT00239577|594816750|FG003|Primary Phase|Other|0|||
164669795|NCT00096447|594816751|FG000|Overall Study|Never treated|1|||
164669796|NCT00569374|594816754|FG000|Overall Study|Withdrawal by Subject|4|||
164669797|NCT01126736|594816755|FG000|Overall Study|Death|2|||
164669798|NCT01126736|594816756|FG001|Overall Study|Death|2|||
164669799|NCT01126736|594816757|FG002|Overall Study|Death|1|||
164669800|NCT01126736|594816758|FG003|Overall Study|Death|19|||
164669801|NCT01126736|594816759|FG004|Overall Study|Death|19|||
164669802|NCT01126736|594816755|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
164669803|NCT01126736|594816756|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
164669804|NCT01126736|594816757|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
164669805|NCT01126736|594816758|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
164669806|NCT01126736|594816759|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
164669807|NCT01126736|594816755|FG000|Overall Study|Lost to Follow-up|0|||
164669808|NCT01126736|594816756|FG001|Overall Study|Lost to Follow-up|0|||
164669809|NCT01126736|594816757|FG002|Overall Study|Lost to Follow-up|0|||
164669810|NCT01126736|594816758|FG003|Overall Study|Lost to Follow-up|1|||
164669811|NCT01126736|594816759|FG004|Overall Study|Lost to Follow-up|1|||
164215677|NCT02347787|593155899|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
164215678|NCT02347787|593155898|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
164215679|NCT02347787|593155899|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
164215680|NCT00544882|593155903|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
164215681|NCT00544882|593155904|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
164215682|NCT00544882|593155905|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
164215683|NCT00544882|593155903|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
164215684|NCT00544882|593155904|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
164215685|NCT00544882|593155905|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
164215686|NCT00544882|593155903|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
164215687|NCT00544882|593155904|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
164215688|NCT00544882|593155905|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
164215689|NCT00544882|593155903|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
164215690|NCT00544882|593155904|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
164215691|NCT00544882|593155905|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
164215692|NCT00544882|593155903|FG000|Cycle 3: Follow-up|Noncompliance|0|||
164215693|NCT00544882|593155904|FG001|Cycle 3: Follow-up|Noncompliance|1|||
164215694|NCT00544882|593155905|FG002|Cycle 3: Follow-up|Noncompliance|0|||
164215695|NCT00544882|593155903|FG000|Cycle 3: Follow-up|Pregnancy|0|||
164215696|NCT00544882|593155904|FG001|Cycle 3: Follow-up|Pregnancy|1|||
164215697|NCT00544882|593155905|FG002|Cycle 3: Follow-up|Pregnancy|0|||
164215698|NCT00308685|593155906|FG000|Overall Study|Lost to Follow-up|1|||
164215699|NCT00308685|593155907|FG001|Overall Study|Lost to Follow-up|0|||
164215700|NCT00308685|593155906|FG000|Overall Study|Need to administer prohibited medication|1|||
164215701|NCT00308685|593155907|FG001|Overall Study|Need to administer prohibited medication|2|||
164215702|NCT00308685|593155906|FG000|Overall Study|Other than specified|1|||
164215703|NCT00308685|593155907|FG001|Overall Study|Other than specified|3|||
164215704|NCT01121575|593155908|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
164215705|NCT01121575|593155909|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
164215706|NCT01121575|593155910|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
164215707|NCT01121575|593155911|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
164215708|NCT01121575|593155912|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
164215709|NCT01121575|593155913|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
164215710|NCT01121575|593155908|FG000|Overall Study|Unspecified Reasons|8|||
164215711|NCT01121575|593155909|FG001|Overall Study|Unspecified Reasons|6|||
164215712|NCT01121575|593155910|FG002|Overall Study|Unspecified Reasons|7|||
164215713|NCT01121575|593155911|FG003|Overall Study|Unspecified Reasons|5|||
164215714|NCT01121575|593155912|FG004|Overall Study|Unspecified Reasons|13|||
164215715|NCT01121575|593155913|FG005|Overall Study|Unspecified Reasons|10|||
164215716|NCT01121575|593155908|FG000|Overall Study|Death|6|||
164215717|NCT01121575|593155909|FG001|Overall Study|Death|0|||
164215718|NCT01121575|593155910|FG002|Overall Study|Death|0|||
164215719|NCT01121575|593155911|FG003|Overall Study|Death|1|||
164215720|NCT01121575|593155912|FG004|Overall Study|Death|7|||
164215721|NCT01121575|593155913|FG005|Overall Study|Death|1|||
164215722|NCT02583269|593155914|FG000|Overall Study|Patient hospitalized prior to start|1|||
164215723|NCT02583269|593155915|FG001|Overall Study|Patient hospitalized prior to start|0|||
164215724|NCT02583269|593155916|FG002|Overall Study|Patient hospitalized prior to start|0|||
164215725|NCT02583269|593155917|FG003|Overall Study|Patient hospitalized prior to start|0|||
164215726|NCT02583269|593155918|FG004|Overall Study|Patient hospitalized prior to start|0|||
164215727|NCT03244189|593155920|FG000|Overall Study|Death|0|||
164326112|NCT01083173|593570127|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
164326113|NCT01083173|593570128|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
164326114|NCT01083173|593570127|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
164326115|NCT01083173|593570128|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
164326116|NCT01083173|593570127|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
164326117|NCT01083173|593570128|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
164326118|NCT01083173|593570127|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
164326119|NCT01083173|593570128|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
164326120|NCT01083173|593570127|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
164565287|NCT01925209|594438465|FG002|Follow-up|Withdrawal by Subject|0|||
164565288|NCT01925209|594438466|FG003|Follow-up|Withdrawal by Subject|2|||
164565289|NCT00236080|594438467|FG000|Overall Study|Adverse Event|0|||
164565290|NCT00236080|594438468|FG001|Overall Study|Adverse Event|0|||
164215728|NCT03244189|593155921|FG001|Overall Study|Death|2|||
164215729|NCT03244189|593155920|FG000|Overall Study|Lost to Follow-up|92|||
164215730|NCT03244189|593155921|FG001|Overall Study|Lost to Follow-up|107|||
164215731|NCT03244189|593155920|FG000|Overall Study|Physician Decision|4|||
164215732|NCT03244189|593155921|FG001|Overall Study|Physician Decision|2|||
164215733|NCT03244189|593155920|FG000|Overall Study|Pregnancy|7|||
164215734|NCT03244189|593155921|FG001|Overall Study|Pregnancy|5|||
164215735|NCT03244189|593155920|FG000|Overall Study|Protocol Violation|0|||
164215736|NCT03244189|593155921|FG001|Overall Study|Protocol Violation|2|||
164565291|NCT00236080|594438469|FG002|Overall Study|Adverse Event|3|||
164565292|NCT00236080|594438470|FG003|Overall Study|Adverse Event|1|||
164565293|NCT00236080|594438471|FG004|Overall Study|Adverse Event|0|||
164565294|NCT00236080|594438467|FG000|Overall Study|Lost to Follow-up|0|||
164565295|NCT00236080|594438468|FG001|Overall Study|Lost to Follow-up|1|||
164565296|NCT00236080|594438469|FG002|Overall Study|Lost to Follow-up|0|||
164565297|NCT00236080|594438470|FG003|Overall Study|Lost to Follow-up|0|||
164565298|NCT00236080|594438471|FG004|Overall Study|Lost to Follow-up|0|||
164565299|NCT00236080|594438467|FG000|Overall Study|Physician Decision|1|||
164565300|NCT00236080|594438468|FG001|Overall Study|Physician Decision|0|||
164565301|NCT00236080|594438469|FG002|Overall Study|Physician Decision|1|||
164565302|NCT00236080|594438470|FG003|Overall Study|Physician Decision|1|||
164565303|NCT00236080|594438471|FG004|Overall Study|Physician Decision|1|||
164215737|NCT03244189|593155920|FG000|Overall Study|Withdrawal by Subject|45|||
164215738|NCT03244189|593155921|FG001|Overall Study|Withdrawal by Subject|23|||
164215739|NCT03244189|593155920|FG000|Overall Study|Technical Problems|2|||
164215740|NCT03244189|593155921|FG001|Overall Study|Technical Problems|0|||
164215741|NCT06170827|593155922|FG000|Overall Study|Withdrawal by Subject|1|||
164215742|NCT06170827|593155923|FG001|Overall Study|Withdrawal by Subject|1|||
164215743|NCT03860584|593155931|FG000|First Intervention (2 Weeks)|Lack of Efficacy|1|||
164215744|NCT03860584|593155932|FG001|First Intervention (2 Weeks)|Lack of Efficacy|0|||
164215745|NCT03860584|593155931|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
164215746|NCT03860584|593155932|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
164215747|NCT03860584|593155931|FG000|Second Intervention (2 Weeks)|Lost to Follow-up|3|||
164326121|NCT01083173|593570128|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
164326122|NCT01083173|593570127|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
164565304|NCT00236080|594438467|FG000|Overall Study|Withdrawal by Subject|1|||
164565305|NCT00236080|594438468|FG001|Overall Study|Withdrawal by Subject|0|||
164565306|NCT00236080|594438469|FG002|Overall Study|Withdrawal by Subject|0|||
164565307|NCT00236080|594438470|FG003|Overall Study|Withdrawal by Subject|0|||
164565308|NCT00236080|594438471|FG004|Overall Study|Withdrawal by Subject|0|||
164565309|NCT00236080|594438467|FG000|Overall Study|Miscellaneous|0|||
164565310|NCT00236080|594438468|FG001|Overall Study|Miscellaneous|0|||
164565311|NCT00236080|594438469|FG002|Overall Study|Miscellaneous|1|||
164565312|NCT00236080|594438470|FG003|Overall Study|Miscellaneous|0|||
164565313|NCT00236080|594438471|FG004|Overall Study|Miscellaneous|0|||
164565314|NCT03882424|594438472|FG000|Overall Study|Lost to Follow-up|3|||
164565315|NCT03882424|594438473|FG001|Overall Study|Lost to Follow-up|0|||
164565316|NCT03882424|594438474|FG002|Overall Study|Lost to Follow-up|0|||
164565317|NCT03882424|594438472|FG000|Overall Study|schedule conflict|1|||
164565318|NCT03882424|594438473|FG001|Overall Study|schedule conflict|0|||
164565319|NCT03882424|594438474|FG002|Overall Study|schedule conflict|0|||
164565320|NCT01214044|594438475|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
164565321|NCT01214044|594438475|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
164565322|NCT01214044|594438475|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
164565323|NCT01214044|594438475|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
164565324|NCT01214044|594438475|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
164565325|NCT01214044|594438475|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
164565326|NCT04698525|594438481|FG000|Overall Study|Lost to Follow-up|1|||
164565327|NCT04698525|594438482|FG001|Overall Study|Lost to Follow-up|2|||
164565328|NCT04698525|594438481|FG000|Overall Study|Three suffered of Covid-19|2|||
164565329|NCT04698525|594438482|FG001|Overall Study|Three suffered of Covid-19|1|||
164565330|NCT00510276|594438486|FG000|Acute Double-Blind Phase|Adverse Event|21|||
164565331|NCT00510276|594438487|FG001|Acute Double-Blind Phase|Adverse Event|6|||
164565332|NCT00510276|594438486|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
164565333|NCT00510276|594438487|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
164565334|NCT00510276|594438486|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
164565335|NCT00510276|594438487|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
164565336|NCT00510276|594438486|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
164565337|NCT00510276|594438487|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
164565338|NCT00510276|594438486|FG000|Acute Double-Blind Phase|Physician Decision|0|||
164565339|NCT00510276|594438487|FG001|Acute Double-Blind Phase|Physician Decision|3|||
164565340|NCT00510276|594438486|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
164565341|NCT00510276|594438487|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
164565342|NCT00510276|594438486|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
164565343|NCT00510276|594438487|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
164565344|NCT00510276|594438486|FG000|Acute Double-Blind Phase|Subject Decision|26|||
164565345|NCT00510276|594438487|FG001|Acute Double-Blind Phase|Subject Decision|28|||
164565346|NCT00510276|594438486|FG000|Extension Open-Label Phase|Adverse Event|9|||
164565347|NCT00510276|594438487|FG001|Extension Open-Label Phase|Adverse Event|18|||
164565348|NCT00510276|594438486|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
164565349|NCT00510276|594438487|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
164565350|NCT00510276|594438486|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
164565351|NCT00510276|594438487|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
164565352|NCT00510276|594438486|FG000|Extension Open-Label Phase|Physician Decision|2|||
164565353|NCT00510276|594438487|FG001|Extension Open-Label Phase|Physician Decision|3|||
164565354|NCT00510276|594438486|FG000|Extension Open-Label Phase|Protocol Violation|0|||
164565355|NCT00510276|594438487|FG001|Extension Open-Label Phase|Protocol Violation|1|||
164565356|NCT00510276|594438486|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
164565357|NCT00510276|594438487|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
164215748|NCT03860584|593155932|FG001|Second Intervention (2 Weeks)|Lost to Follow-up|0|||
164215749|NCT03860584|593155931|FG000|Second Intervention (2 Weeks)|Lack of Efficacy|0|||
164215750|NCT03860584|593155932|FG001|Second Intervention (2 Weeks)|Lack of Efficacy|1|||
164215751|NCT02369458|593155934|FG000|Overall Study|Determined to be not eligible|1|||
164565358|NCT00510276|594438486|FG000|Extension Open-Label Phase|Subject Decision|7|||
164215752|NCT02369458|593155935|FG001|Overall Study|Determined to be not eligible|0|||
164215753|NCT03853798|593155936|FG000|Overall Study|Death|0|||
164215754|NCT03853798|593155937|FG001|Overall Study|Death|0|||
164215755|NCT03853798|593155938|FG002|Overall Study|Death|0|||
164215756|NCT03853798|593155939|FG003|Overall Study|Death|0|||
164215757|NCT03853798|593155940|FG004|Overall Study|Death|0|||
164215758|NCT03853798|593155941|FG005|Overall Study|Death|1|||
164215759|NCT03853798|593155942|FG006|Overall Study|Death|0|||
164215760|NCT03853798|593155943|FG007|Overall Study|Death|0|||
164215761|NCT03853798|593155944|FG008|Overall Study|Death|0|||
164215762|NCT03853798|593155936|FG000|Overall Study|Adverse Event|0|||
164215763|NCT03853798|593155937|FG001|Overall Study|Adverse Event|0|||
164215764|NCT03853798|593155938|FG002|Overall Study|Adverse Event|2|||
164215765|NCT03853798|593155939|FG003|Overall Study|Adverse Event|0|||
164215766|NCT03853798|593155940|FG004|Overall Study|Adverse Event|0|||
164215767|NCT03853798|593155941|FG005|Overall Study|Adverse Event|0|||
164215768|NCT03853798|593155942|FG006|Overall Study|Adverse Event|0|||
164215769|NCT03853798|593155943|FG007|Overall Study|Adverse Event|0|||
164215770|NCT03853798|593155944|FG008|Overall Study|Adverse Event|0|||
164215771|NCT03853798|593155936|FG000|Overall Study|Withdrawal by Subject|0|||
164215772|NCT03853798|593155937|FG001|Overall Study|Withdrawal by Subject|1|||
164215773|NCT03853798|593155938|FG002|Overall Study|Withdrawal by Subject|4|||
164215774|NCT03853798|593155939|FG003|Overall Study|Withdrawal by Subject|0|||
164215775|NCT03853798|593155940|FG004|Overall Study|Withdrawal by Subject|0|||
164215776|NCT03853798|593155941|FG005|Overall Study|Withdrawal by Subject|5|||
164215777|NCT03853798|593155942|FG006|Overall Study|Withdrawal by Subject|0|||
164215778|NCT03853798|593155943|FG007|Overall Study|Withdrawal by Subject|0|||
164215779|NCT03853798|593155944|FG008|Overall Study|Withdrawal by Subject|4|||
164215780|NCT03853798|593155936|FG000|Overall Study|Physician Decision|1|||
164215781|NCT03853798|593155937|FG001|Overall Study|Physician Decision|0|||
164215782|NCT03853798|593155938|FG002|Overall Study|Physician Decision|0|||
164215783|NCT03853798|593155939|FG003|Overall Study|Physician Decision|0|||
164215784|NCT03853798|593155940|FG004|Overall Study|Physician Decision|0|||
164215785|NCT03853798|593155941|FG005|Overall Study|Physician Decision|0|||
164215786|NCT03853798|593155942|FG006|Overall Study|Physician Decision|0|||
164215787|NCT03853798|593155943|FG007|Overall Study|Physician Decision|0|||
164215788|NCT03853798|593155944|FG008|Overall Study|Physician Decision|1|||
164215789|NCT03853798|593155936|FG000|Overall Study|Lack of Efficacy|0|||
164215790|NCT03853798|593155937|FG001|Overall Study|Lack of Efficacy|0|||
164215791|NCT03853798|593155938|FG002|Overall Study|Lack of Efficacy|2|||
164215792|NCT03853798|593155939|FG003|Overall Study|Lack of Efficacy|0|||
164215793|NCT03853798|593155940|FG004|Overall Study|Lack of Efficacy|0|||
164215794|NCT03853798|593155941|FG005|Overall Study|Lack of Efficacy|0|||
164215795|NCT03853798|593155942|FG006|Overall Study|Lack of Efficacy|0|||
164215796|NCT03853798|593155943|FG007|Overall Study|Lack of Efficacy|0|||
164215797|NCT03853798|593155944|FG008|Overall Study|Lack of Efficacy|1|||
164215798|NCT03853798|593155936|FG000|Overall Study|Approved Drug Available for Indication|0|||
164215799|NCT03853798|593155937|FG001|Overall Study|Approved Drug Available for Indication|0|||
164326123|NCT01083173|593570128|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
164326124|NCT01083173|593570127|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
164326125|NCT01083173|593570128|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
164326126|NCT01083173|593570127|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
164326127|NCT01083173|593570128|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
164326128|NCT01083173|593570127|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
164326129|NCT01083173|593570128|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
164326130|NCT04626310|593570134|FG000|Overall Study|4-miss from treatment|6|||
164326131|NCT04626310|593570135|FG001|Overall Study|4-miss from treatment|5|||
164326132|NCT04626310|593570136|FG002|Overall Study|4-miss from treatment|5|||
164326133|NCT04626310|593570134|FG000|Overall Study|Withdrawal by Subject|1|||
164326134|NCT04626310|593570135|FG001|Overall Study|Withdrawal by Subject|0|||
164326135|NCT04626310|593570136|FG002|Overall Study|Withdrawal by Subject|3|||
164326136|NCT00740246|593570137|FG000|Overall Study|Received Blood Transfusion|0|||
164326137|NCT00740246|593570138|FG001|Overall Study|Received Blood Transfusion|1|||
164565359|NCT00510276|594438487|FG001|Extension Open-Label Phase|Subject Decision|9|||
164215800|NCT03853798|593155938|FG002|Overall Study|Approved Drug Available for Indication|1|||
164215801|NCT03853798|593155939|FG003|Overall Study|Approved Drug Available for Indication|0|||
164215802|NCT03853798|593155940|FG004|Overall Study|Approved Drug Available for Indication|0|||
164565360|NCT02211261|594438489|FG000|Overall Study|Withdrawal by Subject|0|||
164565361|NCT02211261|594438490|FG001|Overall Study|Withdrawal by Subject|0|||
164565362|NCT02211261|594438491|FG002|Overall Study|Withdrawal by Subject|1|||
164215803|NCT03853798|593155941|FG005|Overall Study|Approved Drug Available for Indication|1|||
164215804|NCT03853798|593155942|FG006|Overall Study|Approved Drug Available for Indication|0|||
164215805|NCT03853798|593155943|FG007|Overall Study|Approved Drug Available for Indication|0|||
164215806|NCT03853798|593155944|FG008|Overall Study|Approved Drug Available for Indication|0|||
164215807|NCT03853798|593155936|FG000|Overall Study|Other un-specified|0|||
164669812|NCT01126736|594816755|FG000|Overall Study|Administrative reasons|0|||
164669813|NCT01126736|594816756|FG001|Overall Study|Administrative reasons|0|||
164669814|NCT01126736|594816757|FG002|Overall Study|Administrative reasons|0|||
164669815|NCT01126736|594816758|FG003|Overall Study|Administrative reasons|0|||
164669816|NCT01126736|594816759|FG004|Overall Study|Administrative reasons|1|||
164669817|NCT01126736|594816755|FG000|Overall Study|Progressive disease|0|||
164669818|NCT01126736|594816756|FG001|Overall Study|Progressive disease|0|||
164669819|NCT01126736|594816757|FG002|Overall Study|Progressive disease|0|||
164669820|NCT01126736|594816758|FG003|Overall Study|Progressive disease|2|||
164669821|NCT01126736|594816759|FG004|Overall Study|Progressive disease|1|||
164669822|NCT01126736|594816755|FG000|Overall Study|Withdrawal by Subject|0|||
164669823|NCT01126736|594816756|FG001|Overall Study|Withdrawal by Subject|0|||
164669824|NCT01126736|594816757|FG002|Overall Study|Withdrawal by Subject|0|||
164669825|NCT01126736|594816758|FG003|Overall Study|Withdrawal by Subject|1|||
164669826|NCT01126736|594816759|FG004|Overall Study|Withdrawal by Subject|1|||
164669827|NCT01126736|594816755|FG000|Overall Study|Other|2|||
164669828|NCT01126736|594816756|FG001|Overall Study|Other|4|||
164669829|NCT01126736|594816757|FG002|Overall Study|Other|4|||
164669830|NCT01126736|594816758|FG003|Overall Study|Other|16|||
164669831|NCT01126736|594816759|FG004|Overall Study|Other|15|||
164669832|NCT02202850|594816761|FG000|Overall Study|Other|2|||
164669833|NCT02202850|594816762|FG001|Overall Study|Other|2|||
164669834|NCT02202850|594816761|FG000|Overall Study|Enbrel treatment discontinued|15|||
164669835|NCT02202850|594816762|FG001|Overall Study|Enbrel treatment discontinued|3|||
164669836|NCT02202850|594816761|FG000|Overall Study|Lost to Follow-up|7|||
164669837|NCT02202850|594816762|FG001|Overall Study|Lost to Follow-up|1|||
164669838|NCT00669942|594816763|FG000|Parts 2 and 3|Adverse Event|0|||
164326138|NCT00740246|593570137|FG000|Overall Study|Adverse Event|1|||
164326139|NCT00740246|593570138|FG001|Overall Study|Adverse Event|2|||
164669839|NCT00669942|594816764|FG001|Parts 2 and 3|Adverse Event|0|||
164669840|NCT00669942|594816765|FG002|Parts 2 and 3|Adverse Event|0|||
164669841|NCT00669942|594816766|FG003|Parts 2 and 3|Adverse Event|0|||
164669842|NCT00669942|594816767|FG004|Parts 2 and 3|Adverse Event|0|||
164669843|NCT00669942|594816768|FG005|Parts 2 and 3|Adverse Event|0|||
164669844|NCT00669942|594816769|FG006|Parts 2 and 3|Adverse Event|0|||
164669845|NCT00669942|594816770|FG007|Parts 2 and 3|Adverse Event|2|||
164669846|NCT00669942|594816771|FG008|Parts 2 and 3|Adverse Event|1|||
164669847|NCT00669942|594816772|FG009|Parts 2 and 3|Adverse Event|0|||
164669848|NCT00669942|594816773|FG010|Parts 2 and 3|Adverse Event|0|||
164669849|NCT00669942|594816774|FG011|Parts 2 and 3|Adverse Event|0|||
164669850|NCT00669942|594816763|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
164669851|NCT00669942|594816764|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
164669852|NCT00669942|594816765|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
164669853|NCT00669942|594816766|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
164669854|NCT00669942|594816767|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
164669855|NCT00669942|594816768|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
164669856|NCT00669942|594816769|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
164669857|NCT00669942|594816770|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
164669858|NCT00669942|594816771|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
164669859|NCT00669942|594816772|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
164669860|NCT00669942|594816773|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
164669861|NCT00669942|594816774|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
164669862|NCT00669942|594816763|FG000|Parts 2 and 3|Protocol Violation|0|||
164669863|NCT00669942|594816764|FG001|Parts 2 and 3|Protocol Violation|0|||
164669864|NCT00669942|594816765|FG002|Parts 2 and 3|Protocol Violation|0|||
164326140|NCT00740246|593570137|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
164326141|NCT00740246|593570138|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
164326142|NCT00740246|593570137|FG000|Overall Study|Lost to Follow-up|2|||
164326143|NCT00740246|593570138|FG001|Overall Study|Lost to Follow-up|2|||
164326144|NCT00740246|593570137|FG000|Overall Study|Withdrawal by Subject|4|||
164326145|NCT00740246|593570138|FG001|Overall Study|Withdrawal by Subject|3|||
164669865|NCT00669942|594816766|FG003|Parts 2 and 3|Protocol Violation|0|||
164669866|NCT00669942|594816767|FG004|Parts 2 and 3|Protocol Violation|0|||
164669867|NCT00669942|594816768|FG005|Parts 2 and 3|Protocol Violation|1|||
164669868|NCT00669942|594816769|FG006|Parts 2 and 3|Protocol Violation|0|||
164669869|NCT00669942|594816770|FG007|Parts 2 and 3|Protocol Violation|0|||
164669870|NCT00669942|594816771|FG008|Parts 2 and 3|Protocol Violation|0|||
164669871|NCT00669942|594816772|FG009|Parts 2 and 3|Protocol Violation|0|||
164669872|NCT00669942|594816773|FG010|Parts 2 and 3|Protocol Violation|0|||
164669873|NCT00669942|594816774|FG011|Parts 2 and 3|Protocol Violation|0|||
164326146|NCT00740246|593570137|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
164326147|NCT00740246|593570138|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
164326148|NCT00740246|593570137|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
164669874|NCT00282048|594816775|FG000|Overall Study|Lack of Efficacy|30|||
164669875|NCT00282048|594816775|FG000|Overall Study|Adverse Event|22|||
164669876|NCT00282048|594816775|FG000|Overall Study|Withdrawal by Subject|1|||
164669877|NCT00282048|594816775|FG000|Overall Study|Other|8|||
164669878|NCT00282048|594816775|FG000|Overall Study|Ongoing|1|||
164669879|NCT03522675|594816776|FG000|Overall Study|Screen fail|1|||
164215808|NCT03853798|593155937|FG001|Overall Study|Other un-specified|0|||
164215809|NCT03853798|593155938|FG002|Overall Study|Other un-specified|2|||
164215810|NCT03853798|593155939|FG003|Overall Study|Other un-specified|0|||
164215811|NCT03853798|593155940|FG004|Overall Study|Other un-specified|0|||
164215812|NCT03853798|593155941|FG005|Overall Study|Other un-specified|1|||
164215813|NCT03853798|593155942|FG006|Overall Study|Other un-specified|0|||
164215814|NCT03853798|593155943|FG007|Overall Study|Other un-specified|0|||
164215815|NCT03853798|593155944|FG008|Overall Study|Other un-specified|0|||
164215816|NCT02743494|593155945|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
164215817|NCT02743494|593155946|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
164215818|NCT02743494|593155945|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
164215819|NCT02743494|593155946|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
164215820|NCT02743494|593155945|FG000|Treatment Period|Disease recurrence|152|||
164215821|NCT02743494|593155946|FG001|Treatment Period|Disease recurrence|115|||
164215822|NCT02743494|593155945|FG000|Treatment Period|Study drug toxicity|56|||
164215823|NCT02743494|593155946|FG001|Treatment Period|Study drug toxicity|8|||
164215824|NCT02743494|593155945|FG000|Treatment Period|Death|1|||
164215825|NCT02743494|593155946|FG001|Treatment Period|Death|1|||
164215826|NCT02743494|593155945|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
164215827|NCT02743494|593155946|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
164215828|NCT02743494|593155945|FG000|Treatment Period|Participant request to discontinue treatment|31|||
164215829|NCT02743494|593155946|FG001|Treatment Period|Participant request to discontinue treatment|5|||
164215830|NCT02743494|593155945|FG000|Treatment Period|Participant withdrew consent|11|||
164215831|NCT02743494|593155946|FG001|Treatment Period|Participant withdrew consent|4|||
164215832|NCT02743494|593155945|FG000|Treatment Period|Lost to Follow-up|0|||
164215833|NCT02743494|593155946|FG001|Treatment Period|Lost to Follow-up|1|||
164215834|NCT02743494|593155945|FG000|Treatment Period|Poor/Non-compliance|2|||
164215835|NCT02743494|593155946|FG001|Treatment Period|Poor/Non-compliance|0|||
164215836|NCT02743494|593155945|FG000|Treatment Period|Other reasons|4|||
164215837|NCT02743494|593155946|FG001|Treatment Period|Other reasons|1|||
164215838|NCT04167670|593157244|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
164215839|NCT04167670|593157245|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
164215840|NCT04167670|593157246|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
164215841|NCT04167670|593157244|FG000|Overall Study|Significant protocol deviation|3|||
164215842|NCT04167670|593157245|FG001|Overall Study|Significant protocol deviation|1|||
164215843|NCT04167670|593157246|FG002|Overall Study|Significant protocol deviation|0|||
164215844|NCT04167670|593157244|FG000|Overall Study|Lost to Follow-up|0|||
164215845|NCT04167670|593157245|FG001|Overall Study|Lost to Follow-up|3|||
164215846|NCT04167670|593157246|FG002|Overall Study|Lost to Follow-up|3|||
164215847|NCT04167670|593157244|FG000|Overall Study|Voluntary Withdrawal|0|||
164215848|NCT04167670|593157245|FG001|Overall Study|Voluntary Withdrawal|1|||
164215849|NCT04167670|593157246|FG002|Overall Study|Voluntary Withdrawal|1|||
164215850|NCT04167670|593157244|FG000|Overall Study|Withdrawal of Consent|4|||
164215851|NCT04167670|593157245|FG001|Overall Study|Withdrawal of Consent|1|||
164215852|NCT04167670|593157246|FG002|Overall Study|Withdrawal of Consent|3|||
164215853|NCT04167670|593157244|FG000|Overall Study|Miscellaneous|7|||
164215854|NCT04167670|593157245|FG001|Overall Study|Miscellaneous|5|||
164215855|NCT04167670|593157246|FG002|Overall Study|Miscellaneous|3|||
164215856|NCT05399485|593157247|FG000|DBT Phase|Other|6|||
164215857|NCT05399485|593157248|FG001|DBT Phase|Other|5|||
164215858|NCT05399485|593157247|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
164215859|NCT05399485|593157248|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
164215860|NCT05399485|593157247|FG000|DBT Phase|Withdrawal by Subject|3|||
164215861|NCT05399485|593157248|FG001|DBT Phase|Withdrawal by Subject|2|||
164215862|NCT05399485|593157247|FG000|DBT Phase|Protocol Violation|2|||
164215863|NCT05399485|593157248|FG001|DBT Phase|Protocol Violation|1|||
164215864|NCT05399485|593157247|FG000|DBT Phase|Physician Decision|0|||
164215865|NCT05399485|593157248|FG001|DBT Phase|Physician Decision|1|||
164215866|NCT05399485|593157247|FG000|DBT Phase|Adverse Event|2|||
164215867|NCT05399485|593157248|FG001|DBT Phase|Adverse Event|1|||
164215868|NCT05399485|593157247|FG000|OLE Phase|Protocol deviation|1|||
164215869|NCT05399485|593157248|FG001|OLE Phase|Protocol deviation|0|||
164215870|NCT05399485|593157247|FG000|OLE Phase|Other|5|||
164215871|NCT05399485|593157248|FG001|OLE Phase|Other|5|||
164215872|NCT05399485|593157247|FG000|OLE Phase|Withdrawal by Subject|12|||
164215873|NCT05399485|593157248|FG001|OLE Phase|Withdrawal by Subject|7|||
164215874|NCT05399485|593157247|FG000|OLE Phase|Pregnancy|0|||
164215875|NCT05399485|593157248|FG001|OLE Phase|Pregnancy|2|||
164215876|NCT05399485|593157247|FG000|OLE Phase|Physician Decision|3|||
164215877|NCT05399485|593157248|FG001|OLE Phase|Physician Decision|0|||
164215878|NCT05399485|593157247|FG000|OLE Phase|Adverse Event|2|||
164215879|NCT05399485|593157248|FG001|OLE Phase|Adverse Event|2|||
164215880|NCT03554473|593157251|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
164215881|NCT03554473|593157252|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
164215882|NCT03554473|593157253|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
164420682|NCT01154036|593910965|FG003|Phase II|Lost to Follow-up|1|||
164215883|NCT03554473|593157251|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
164215884|NCT03554473|593157252|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
164215885|NCT03554473|593157253|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
164215886|NCT03554473|593157251|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
164215887|NCT03554473|593157252|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
164215888|NCT03554473|593157253|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
164215889|NCT01363076|593157254|FG000|Overall Study|Withdrawal by Subject|0|||
164215890|NCT01363076|593157255|FG001|Overall Study|Withdrawal by Subject|1|||
164215891|NCT02014103|593157256|FG000|Overall Study|Protocol Violation|7|||
164215892|NCT02014103|593157257|FG001|Overall Study|Protocol Violation|7|||
164215893|NCT02014103|593157256|FG000|Overall Study|Adverse Event|1|||
164215894|NCT02014103|593157257|FG001|Overall Study|Adverse Event|0|||
164215895|NCT02014103|593157256|FG000|Overall Study|Lost venous access|1|||
164215896|NCT02014103|593157257|FG001|Overall Study|Lost venous access|0|||
164215897|NCT02014103|593157256|FG000|Overall Study|Withdrawal by Subject|0|||
164215898|NCT02014103|593157257|FG001|Overall Study|Withdrawal by Subject|2|||
164215899|NCT04439175|593157258|FG000|Overall Study|Never started treatment|4|||
164215900|NCT04439175|593157258|FG000|Overall Study|Ineligible|5|||
164215901|NCT04439175|593157258|FG000|Overall Study|Adverse Event|6|||
164215902|NCT04439175|593157258|FG000|Overall Study|Death|4|||
164215903|NCT04439175|593157258|FG000|Overall Study|Disease progression|44|||
164215904|NCT04439175|593157258|FG000|Overall Study|Withdrawal by Subject|4|||
164215905|NCT04439175|593157258|FG000|Overall Study|Alternative Therapy|1|||
164215906|NCT04439175|593157258|FG000|Overall Study|Other|2|||
164215907|NCT05417113|593157261|FG000|Overall Study|Lost to Follow-up|2|||
164215908|NCT05417113|593157262|FG001|Overall Study|Lost to Follow-up|2|||
164215909|NCT01847209|593157263|FG000|Overall Study|Withdrawal by Subject|1|||
164215910|NCT01847209|593157263|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
164215911|NCT00729586|593157264|FG000|Overall Study|Ineligible|0|||
164215912|NCT00729586|593157265|FG001|Overall Study|Ineligible|1|||
164215913|NCT00729586|593157264|FG000|Overall Study|never treated|1|||
164215914|NCT00729586|593157265|FG001|Overall Study|never treated|0|||
164215915|NCT01631188|593157266|FG000|Overall Study|Physician Decision|75|||
164215916|NCT02513199|593157272|FG000|Treatment|Death|1|||
164215917|NCT02513199|593157272|FG000|Treatment|Lost to Follow-up|1|||
164215918|NCT02513199|593157272|FG000|Follow-Up|Death|11|||
164215919|NCT02582632|593157276|FG000|Overall Study|Other|1|||
164215920|NCT04307394|593157279|FG000|Overall Study|Lost to Follow-up|3|||
164215921|NCT04307394|593157279|FG000|Overall Study|Withdrawal by Subject|2|||
164215922|NCT02323334|593157280|FG000|Period 3|Lost to Follow-up|0|||
164215923|NCT02323334|593157281|FG001|Period 3|Lost to Follow-up|0|||
164215924|NCT02323334|593157282|FG002|Period 3|Lost to Follow-up|1|||
164215925|NCT02323334|593157283|FG003|Period 3|Lost to Follow-up|0|||
164215926|NCT02323334|593157284|FG004|Period 3|Lost to Follow-up|0|||
164215927|NCT02323334|593157285|FG005|Period 3|Lost to Follow-up|0|||
164215928|NCT02323334|593157286|FG006|Period 3|Lost to Follow-up|0|||
164215929|NCT02323334|593157287|FG007|Period 3|Lost to Follow-up|0|||
164215930|NCT02323334|593157288|FG008|Period 3|Lost to Follow-up|0|||
164215931|NCT02323334|593157289|FG009|Period 3|Lost to Follow-up|0|||
164215932|NCT02323334|593157290|FG010|Period 3|Lost to Follow-up|0|||
164215933|NCT02323334|593157291|FG011|Period 3|Lost to Follow-up|0|||
164215934|NCT02323334|593157292|FG012|Period 3|Lost to Follow-up|0|||
164215935|NCT02323334|593157293|FG013|Period 3|Lost to Follow-up|0|||
164215936|NCT02323334|593157294|FG014|Period 3|Lost to Follow-up|0|||
164215937|NCT02323334|593157295|FG015|Period 3|Lost to Follow-up|0|||
164215938|NCT02323334|593157296|FG016|Period 3|Lost to Follow-up|0|||
164215939|NCT02323334|593157280|FG000|Period 3|Withdrawal by Subject|1|||
164215940|NCT02323334|593157281|FG001|Period 3|Withdrawal by Subject|0|||
164215941|NCT02323334|593157282|FG002|Period 3|Withdrawal by Subject|0|||
164215942|NCT02323334|593157283|FG003|Period 3|Withdrawal by Subject|0|||
164215943|NCT02323334|593157284|FG004|Period 3|Withdrawal by Subject|0|||
164215944|NCT02323334|593157285|FG005|Period 3|Withdrawal by Subject|0|||
164215945|NCT02323334|593157286|FG006|Period 3|Withdrawal by Subject|0|||
164215946|NCT02323334|593157287|FG007|Period 3|Withdrawal by Subject|0|||
164215947|NCT02323334|593157288|FG008|Period 3|Withdrawal by Subject|0|||
164215948|NCT02323334|593157289|FG009|Period 3|Withdrawal by Subject|0|||
164215949|NCT02323334|593157290|FG010|Period 3|Withdrawal by Subject|0|||
164215950|NCT02323334|593157291|FG011|Period 3|Withdrawal by Subject|0|||
164215951|NCT02323334|593157292|FG012|Period 3|Withdrawal by Subject|0|||
164215952|NCT02323334|593157293|FG013|Period 3|Withdrawal by Subject|0|||
164215953|NCT02323334|593157294|FG014|Period 3|Withdrawal by Subject|0|||
164215954|NCT02323334|593157295|FG015|Period 3|Withdrawal by Subject|0|||
164215955|NCT02323334|593157296|FG016|Period 3|Withdrawal by Subject|0|||
164215956|NCT01617967|593157298|FG000|Overall Study|Protocol Violation|0|||
164215957|NCT01617967|593157299|FG001|Overall Study|Protocol Violation|0|||
164215958|NCT01617967|593157300|FG002|Overall Study|Protocol Violation|0|||
164215959|NCT01617967|593157301|FG003|Overall Study|Protocol Violation|1|||
164215960|NCT01617967|593157302|FG004|Overall Study|Protocol Violation|0|||
164215961|NCT01617967|593157303|FG005|Overall Study|Protocol Violation|0|||
164215962|NCT01617967|593157298|FG000|Overall Study|Withdrawal by Subject|0|||
164215963|NCT01617967|593157299|FG001|Overall Study|Withdrawal by Subject|0|||
164215964|NCT01617967|593157300|FG002|Overall Study|Withdrawal by Subject|0|||
164215965|NCT01617967|593157301|FG003|Overall Study|Withdrawal by Subject|0|||
164215966|NCT01617967|593157302|FG004|Overall Study|Withdrawal by Subject|0|||
164215967|NCT01617967|593157303|FG005|Overall Study|Withdrawal by Subject|1|||
164215968|NCT01617967|593157298|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
164215969|NCT01617967|593157299|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
164215970|NCT01617967|593157300|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
164215971|NCT01617967|593157301|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
164215972|NCT01617967|593157302|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
164215973|NCT01617967|593157303|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
164215974|NCT02453048|593157304|FG000|Overall Study|Only part of initial 6 mo. study|0|||
164215975|NCT02453048|593157305|FG001|Overall Study|Only part of initial 6 mo. study|0|||
164215976|NCT02453048|593157306|FG002|Overall Study|Only part of initial 6 mo. study|0|||
164215977|NCT02453048|593157307|FG003|Overall Study|Only part of initial 6 mo. study|0|||
164215978|NCT02453048|593157308|FG004|Overall Study|Only part of initial 6 mo. study|6|||
164215979|NCT02453048|593157304|FG000|Overall Study|Lost to Follow-up|0|||
164215980|NCT02453048|593157305|FG001|Overall Study|Lost to Follow-up|1|||
164215981|NCT02453048|593157306|FG002|Overall Study|Lost to Follow-up|2|||
164215982|NCT02453048|593157307|FG003|Overall Study|Lost to Follow-up|0|||
164215983|NCT02453048|593157308|FG004|Overall Study|Lost to Follow-up|0|||
164215984|NCT00447278|593157310|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
164215985|NCT00447278|593157311|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
164215986|NCT00447278|593157310|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
164215987|NCT00447278|593157311|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
164215988|NCT00447278|593157310|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
164215989|NCT00447278|593157311|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
164215990|NCT00447278|593157310|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
164215991|NCT00447278|593157311|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
164326149|NCT00740246|593570138|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
164326150|NCT00740246|593570137|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
164326151|NCT00740246|593570138|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
164326152|NCT00740246|593570137|FG000|Overall Study|Unable To Comply With Study Visits|2|||
164326153|NCT00740246|593570138|FG001|Overall Study|Unable To Comply With Study Visits|0|||
164326154|NCT00740246|593570137|FG000|Overall Study|Unable to Access Vein|0|||
164326155|NCT00740246|593570138|FG001|Overall Study|Unable to Access Vein|2|||
164326156|NCT00740246|593570137|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
164326157|NCT00740246|593570138|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
164326158|NCT01041495|593570139|FG000|Overall Study|Withdrawal by Subject|2|||
164326159|NCT01041495|593570140|FG001|Overall Study|Withdrawal by Subject|5|||
164326160|NCT01041495|593570139|FG000|Overall Study|Adverse Event|2|||
164326161|NCT01041495|593570140|FG001|Overall Study|Adverse Event|1|||
164326162|NCT01041495|593570139|FG000|Overall Study|Lost to Follow-up|0|||
164326163|NCT01041495|593570140|FG001|Overall Study|Lost to Follow-up|1|||
164326164|NCT03584373|593570141|FG000|Overall Study|Lost to Follow-up|7|||
164326165|NCT03584373|593570142|FG001|Overall Study|Lost to Follow-up|8|||
164326166|NCT00662532|593570144|FG000|Overall Study|Adverse Event|0|||
164326167|NCT00662532|593570145|FG001|Overall Study|Adverse Event|1|||
164326168|NCT00662532|593570144|FG000|Overall Study|Lost to Follow-up|0|||
164669880|NCT03522675|594816776|FG000|Overall Study|Non-reactive to histamine|1|||
164669881|NCT00707161|594816777|FG000|Overall Study|Physician Decision|6|||
164326169|NCT00662532|593570145|FG001|Overall Study|Lost to Follow-up|1|||
164669882|NCT02336165|594816781|FG000|Overall Study|Death|3|||
164215992|NCT00447278|593157310|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
164215993|NCT00447278|593157311|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
164215994|NCT00447278|593157310|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
164215995|NCT00447278|593157311|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
164215996|NCT00447278|593157310|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
164215997|NCT00447278|593157311|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
164215998|NCT00447278|593157310|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
164326170|NCT01853618|593570149|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
164326171|NCT01853618|593570150|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
164669883|NCT02336165|594816782|FG001|Overall Study|Death|0|||
164215999|NCT00447278|593157311|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
164216000|NCT00447278|593157310|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
164669884|NCT02336165|594816783|FG002|Overall Study|Death|0|||
164216001|NCT00447278|593157311|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
164216002|NCT00447278|593157310|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
164216003|NCT00447278|593157311|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
164216004|NCT00447278|593157310|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
164216005|NCT00447278|593157311|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
164216006|NCT00447278|593157310|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
164216007|NCT00447278|593157311|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
164216008|NCT00447278|593157310|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
164216009|NCT00447278|593157311|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
164216010|NCT00447278|593157310|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
164216011|NCT00447278|593157311|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
164216012|NCT03677401|593157312|FG000|Overall Study|Adverse Event|4|||
164216013|NCT03677401|593157313|FG001|Overall Study|Adverse Event|14|||
164216014|NCT03677401|593157312|FG000|Overall Study|Lack of Efficacy|3|||
164216015|NCT03677401|593157313|FG001|Overall Study|Lack of Efficacy|1|||
164216016|NCT03677401|593157312|FG000|Overall Study|Withdrawal by Subject|2|||
164216017|NCT03677401|593157313|FG001|Overall Study|Withdrawal by Subject|2|||
164216018|NCT03677401|593157312|FG000|Overall Study|Sponsor decision|0|||
164216019|NCT03677401|593157313|FG001|Overall Study|Sponsor decision|1|||
164216020|NCT03677401|593157312|FG000|Overall Study|Reason Unspecified|1|||
164216021|NCT03677401|593157313|FG001|Overall Study|Reason Unspecified|0|||
164216022|NCT06262607|593157314|FG000|Overall Study|Physician Decision|0|||
164216023|NCT06262607|593157315|FG001|Overall Study|Physician Decision|1|||
164216024|NCT06262607|593157314|FG000|Overall Study|Withdrawal by Subject|2|||
164216025|NCT06262607|593157315|FG001|Overall Study|Withdrawal by Subject|0|||
164216026|NCT00574951|593157316|FG000|Overall Study|Ineligible - improper prior treatment|1|||
164216027|NCT05161936|593157317|FG000|Overall Study|Study terminated by Sponsor|1|||
164216028|NCT05161936|593157318|FG001|Overall Study|Study terminated by Sponsor|0|||
164216029|NCT05161936|593157319|FG002|Overall Study|Study terminated by Sponsor|0|||
164216030|NCT05161936|593157317|FG000|Overall Study|Withdrawal by Subject|0|||
164216031|NCT05161936|593157318|FG001|Overall Study|Withdrawal by Subject|0|||
164216032|NCT05161936|593157319|FG002|Overall Study|Withdrawal by Subject|1|||
164216033|NCT04925934|593157335|FG000|Overall Study|Adverse Event|1|||
164216034|NCT04925934|593157336|FG001|Overall Study|Adverse Event|0|||
164216035|NCT04925934|593157337|FG002|Overall Study|Adverse Event|0|||
164216036|NCT04925934|593157335|FG000|Overall Study|Lost to Follow-up|2|||
164216037|NCT04925934|593157336|FG001|Overall Study|Lost to Follow-up|0|||
164326172|NCT01853618|593570151|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
164326173|NCT01853618|593570152|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
164326174|NCT01853618|593570153|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
164326175|NCT01853618|593570149|FG000|Overall Study|Progressive disease|1|||
164326176|NCT01853618|593570150|FG001|Overall Study|Progressive disease|1|||
164326177|NCT01853618|593570151|FG002|Overall Study|Progressive disease|1|||
164326178|NCT01853618|593570152|FG003|Overall Study|Progressive disease|1|||
164326179|NCT01853618|593570153|FG004|Overall Study|Progressive disease|2|||
164326180|NCT01853618|593570149|FG000|Overall Study|Physician Decision|0|||
164326181|NCT01853618|593570150|FG001|Overall Study|Physician Decision|1|||
164326182|NCT01853618|593570151|FG002|Overall Study|Physician Decision|1|||
164326183|NCT01853618|593570152|FG003|Overall Study|Physician Decision|0|||
164326184|NCT01853618|593570153|FG004|Overall Study|Physician Decision|0|||
164326185|NCT01853618|593570149|FG000|Overall Study|Refused further treatment|0|||
164326186|NCT01853618|593570150|FG001|Overall Study|Refused further treatment|0|||
164326187|NCT01853618|593570151|FG002|Overall Study|Refused further treatment|0|||
164326188|NCT01853618|593570152|FG003|Overall Study|Refused further treatment|0|||
164326189|NCT01853618|593570153|FG004|Overall Study|Refused further treatment|1|||
164326190|NCT01658813|593570154|FG000|Overall Study|Disease progression|3|||
164326191|NCT01092832|593570159|FG000|Overall Study|Other|1|||
164326192|NCT01092832|593570160|FG001|Overall Study|Other|0|||
164326193|NCT04777331|593570161|FG000|DBT Period|Death|2|||
164326194|NCT04777331|593570162|FG001|DBT Period|Death|1|||
164326195|NCT04777331|593570163|FG002|DBT Period|Death|0|||
164216038|NCT04925934|593157337|FG002|Overall Study|Lost to Follow-up|1|||
164326196|NCT04777331|593570161|FG000|DBT Period|Reason not Specified|1|||
164216039|NCT04925934|593157335|FG000|Overall Study|Death|0|||
164216040|NCT04925934|593157336|FG001|Overall Study|Death|1|||
164216041|NCT04925934|593157337|FG002|Overall Study|Death|0|||
164216042|NCT04925934|593157335|FG000|Overall Study|Withdrawal by Subject|8|||
164216043|NCT04925934|593157336|FG001|Overall Study|Withdrawal by Subject|5|||
164216044|NCT04925934|593157337|FG002|Overall Study|Withdrawal by Subject|9|||
164216045|NCT04925934|593157335|FG000|Overall Study|Other|2|||
164326197|NCT04777331|593570162|FG001|DBT Period|Reason not Specified|1|||
164326198|NCT04777331|593570163|FG002|DBT Period|Reason not Specified|0|||
164326199|NCT04777331|593570161|FG000|DBT Period|Physician Decision|4|||
164326200|NCT04777331|593570162|FG001|DBT Period|Physician Decision|0|||
164216046|NCT04925934|593157336|FG001|Overall Study|Other|2|||
164216047|NCT04925934|593157337|FG002|Overall Study|Other|2|||
164326201|NCT04777331|593570163|FG002|DBT Period|Physician Decision|0|||
164326202|NCT04777331|593570161|FG000|DBT Period|Withdrawal by Subject|12|||
164669885|NCT02336165|594816784|FG003|Overall Study|Death|0|||
164669886|NCT02336165|594816785|FG004|Overall Study|Death|1|||
164669887|NCT02336165|594816781|FG000|Overall Study|Physician Decision|2|||
164669888|NCT02336165|594816782|FG001|Overall Study|Physician Decision|2|||
164669889|NCT02336165|594816783|FG002|Overall Study|Physician Decision|1|||
164669890|NCT02336165|594816784|FG003|Overall Study|Physician Decision|1|||
164669891|NCT02336165|594816785|FG004|Overall Study|Physician Decision|0|||
164669892|NCT02336165|594816781|FG000|Overall Study|Withdrawal by Subject|0|||
164669893|NCT02336165|594816782|FG001|Overall Study|Withdrawal by Subject|0|||
164669894|NCT02336165|594816783|FG002|Overall Study|Withdrawal by Subject|1|||
164669895|NCT02336165|594816784|FG003|Overall Study|Withdrawal by Subject|0|||
164669896|NCT02336165|594816785|FG004|Overall Study|Withdrawal by Subject|1|||
164669897|NCT02336165|594816781|FG000|Overall Study|Adverse Event|4|||
164669898|NCT02336165|594816782|FG001|Overall Study|Adverse Event|1|||
164669899|NCT02336165|594816783|FG002|Overall Study|Adverse Event|2|||
164669900|NCT02336165|594816784|FG003|Overall Study|Adverse Event|4|||
164216048|NCT04925934|593157335|FG000|Overall Study|Eastern European Conflict|7|||
164216049|NCT04925934|593157336|FG001|Overall Study|Eastern European Conflict|3|||
164216050|NCT04925934|593157337|FG002|Overall Study|Eastern European Conflict|2|||
164216051|NCT04425018|593157339|FG000|Overall Study|Withdrawal by Subject|1|||
164216052|NCT04425018|593157340|FG001|Overall Study|Withdrawal by Subject|2|||
164216053|NCT02337946|593157345|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
164326203|NCT04777331|593570162|FG001|DBT Period|Withdrawal by Subject|11|||
164326204|NCT04777331|593570163|FG002|DBT Period|Withdrawal by Subject|0|||
164326205|NCT04777331|593570161|FG000|DBT Period|Randomized but not Treated|1|||
164326206|NCT04777331|593570162|FG001|DBT Period|Randomized but not Treated|3|||
164216054|NCT02337946|593157346|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
164216055|NCT02337946|593157347|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
164216056|NCT02337946|593157345|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
164216057|NCT02337946|593157346|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
164216058|NCT02337946|593157347|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
164216059|NCT02337946|593157345|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
164216060|NCT02337946|593157346|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
164216061|NCT02337946|593157347|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
164216062|NCT02337946|593157345|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
164216063|NCT02337946|593157346|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
164216064|NCT02337946|593157347|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
164216065|NCT02337946|593157345|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
164216066|NCT02337946|593157346|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
164216067|NCT02337946|593157347|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
164216068|NCT02337946|593157345|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
164216069|NCT02337946|593157346|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
164216070|NCT02337946|593157347|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
164216071|NCT02337946|593157345|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
164216072|NCT02337946|593157346|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
164216073|NCT02337946|593157347|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
164216074|NCT02337946|593157345|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
164216075|NCT02337946|593157346|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
164216076|NCT02337946|593157347|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
164216077|NCT02337946|593157345|FG000|In-between Period|Without Informed Consent|1|||
164216078|NCT02337946|593157346|FG001|In-between Period|Without Informed Consent|0|||
164216079|NCT02337946|593157347|FG002|In-between Period|Without Informed Consent|0|||
164216080|NCT02337946|593157345|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
164216081|NCT02337946|593157346|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
164216082|NCT02337946|593157347|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
164216083|NCT02337946|593157345|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
164216084|NCT02337946|593157346|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
164216085|NCT02337946|593157347|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
164216086|NCT02337946|593157345|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
164216087|NCT02337946|593157346|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
164216088|NCT02337946|593157347|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
164326207|NCT04777331|593570163|FG002|DBT Period|Randomized but not Treated|0|||
164326208|NCT04777331|593570161|FG000|OLE Period|Ongoing in OLE|0|||
164669901|NCT02336165|594816785|FG004|Overall Study|Adverse Event|1|||
164216089|NCT02337946|593157345|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
164669902|NCT02336165|594816781|FG000|Overall Study|Progressive disease|23|||
164669903|NCT02336165|594816782|FG001|Overall Study|Progressive disease|22|||
164669904|NCT02336165|594816783|FG002|Overall Study|Progressive disease|27|||
164669905|NCT02336165|594816784|FG003|Overall Study|Progressive disease|24|||
164669906|NCT02336165|594816785|FG004|Overall Study|Progressive disease|19|||
164669907|NCT02336165|594816781|FG000|Overall Study|Non-compliance|1|||
164669908|NCT02336165|594816782|FG001|Overall Study|Non-compliance|0|||
164669909|NCT02336165|594816783|FG002|Overall Study|Non-compliance|0|||
164216090|NCT02337946|593157346|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
164216091|NCT02337946|593157347|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
164216092|NCT02337946|593157345|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
164216093|NCT02337946|593157346|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
164216094|NCT02337946|593157347|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
164216095|NCT02337946|593157345|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
164216096|NCT02337946|593157346|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
164216097|NCT02337946|593157347|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
164216098|NCT01327703|593157348|FG000|Second Treatment Period|Adverse Event|1|||
164216099|NCT01327703|593157349|FG001|Second Treatment Period|Adverse Event|1|||
164326209|NCT04777331|593570162|FG001|OLE Period|Ongoing in OLE|0|||
164669910|NCT02336165|594816784|FG003|Overall Study|Non-compliance|1|||
164669911|NCT02336165|594816785|FG004|Overall Study|Non-compliance|0|||
164669912|NCT02336165|594816781|FG000|Overall Study|Other|1|||
164669913|NCT02336165|594816782|FG001|Overall Study|Other|0|||
164669914|NCT02336165|594816783|FG002|Overall Study|Other|0|||
164669915|NCT02336165|594816784|FG003|Overall Study|Other|1|||
164669916|NCT02336165|594816785|FG004|Overall Study|Other|0|||
164669917|NCT00450190|594816786|FG000|Overall Study|Withdrawal by Subject|2|||
164669918|NCT03002077|594816789|FG000|Overall Study|Non-compliance with Study Drug|4|||
164326210|NCT04777331|593570163|FG002|OLE Period|Ongoing in OLE|534|||
164326211|NCT01401959|593570164|FG000|Enrolled|Withdrawal by Subject|1|||
164326212|NCT01401959|593570165|FG001|Enrolled|Withdrawal by Subject|0|||
164326213|NCT01401959|593570166|FG002|Enrolled|Withdrawal by Subject|0|||
164326214|NCT01401959|593570164|FG000|Treated|Disease Progression|2|||
164326215|NCT01401959|593570165|FG001|Treated|Disease Progression|2|||
164326216|NCT01401959|593570166|FG002|Treated|Disease Progression|1|||
164326217|NCT01401959|593570164|FG000|Treated|Adverse Event|4|||
164326218|NCT01401959|593570165|FG001|Treated|Adverse Event|3|||
164326219|NCT01401959|593570166|FG002|Treated|Adverse Event|2|||
164326220|NCT01401959|593570164|FG000|Treated|Withdrawal by Subject|1|||
164326221|NCT01401959|593570165|FG001|Treated|Withdrawal by Subject|2|||
164326222|NCT01401959|593570166|FG002|Treated|Withdrawal by Subject|2|||
164326223|NCT01401959|593570164|FG000|Treated|Protocol Violation|0|||
164326224|NCT01401959|593570165|FG001|Treated|Protocol Violation|1|||
164326225|NCT01401959|593570166|FG002|Treated|Protocol Violation|0|||
164326226|NCT00400153|593570167|FG000|Overall Study|AE due to study disease worsening|14|||
164326227|NCT00400153|593570168|FG001|Overall Study|AE due to study disease worsening|19|||
164326228|NCT00400153|593570169|FG002|Overall Study|AE due to study disease worsening|20|||
164326229|NCT00400153|593570167|FG000|Overall Study|AE due to other disease worsening|2|||
164326230|NCT00400153|593570168|FG001|Overall Study|AE due to other disease worsening|1|||
164326231|NCT00400153|593570169|FG002|Overall Study|AE due to other disease worsening|0|||
164326232|NCT00400153|593570167|FG000|Overall Study|AE due to other condition|3|||
164326233|NCT00400153|593570168|FG001|Overall Study|AE due to other condition|14|||
164326234|NCT00400153|593570169|FG002|Overall Study|AE due to other condition|15|||
164326235|NCT00400153|593570167|FG000|Overall Study|Protocol Violation|7|||
164326236|NCT00400153|593570168|FG001|Overall Study|Protocol Violation|4|||
164326237|NCT00400153|593570169|FG002|Overall Study|Protocol Violation|9|||
164326238|NCT00400153|593570167|FG000|Overall Study|Lost to Follow-up|2|||
164326239|NCT00400153|593570168|FG001|Overall Study|Lost to Follow-up|1|||
164669919|NCT03002077|594816789|FG000|Overall Study|Non-compliance w/Background ADT|1|||
164669920|NCT03002077|594816789|FG000|Overall Study|Study Terminated by Sponsor|257|||
164669921|NCT03002077|594816789|FG000|Overall Study|Site Terminated by Sponsor|5|||
164669922|NCT03002077|594816789|FG000|Overall Study|Miscellaneous Reasons|10|||
164669923|NCT03002077|594816789|FG000|Overall Study|Adverse Event|23|||
164326240|NCT00400153|593570169|FG002|Overall Study|Lost to Follow-up|4|||
164326241|NCT00400153|593570167|FG000|Overall Study|Withdrawal by Subject|12|||
164326242|NCT00400153|593570168|FG001|Overall Study|Withdrawal by Subject|11|||
164326243|NCT00400153|593570169|FG002|Overall Study|Withdrawal by Subject|10|||
164326244|NCT00400153|593570167|FG000|Overall Study|Other reasons - not mentioned above|8|||
164326245|NCT00400153|593570168|FG001|Overall Study|Other reasons - not mentioned above|5|||
164326246|NCT00400153|593570169|FG002|Overall Study|Other reasons - not mentioned above|3|||
164326247|NCT01423604|593570170|FG000|Safety Run-In|Adverse Event|3|||
164326248|NCT01423604|593570171|FG001|Safety Run-In|Adverse Event|0|||
164326249|NCT01423604|593570170|FG000|Safety Run-In|Death|1|||
164326250|NCT01423604|593570171|FG001|Safety Run-In|Death|0|||
164326251|NCT01423604|593570170|FG000|Safety Run-In|Physician Decision|1|||
164326252|NCT01423604|593570171|FG001|Safety Run-In|Physician Decision|0|||
164326253|NCT01423604|593570170|FG000|Safety Run-In|Disease progression|3|||
164326254|NCT01423604|593570171|FG001|Safety Run-In|Disease progression|0|||
164669924|NCT03002077|594816789|FG000|Overall Study|Lack of Efficacy|20|||
164669925|NCT03002077|594816789|FG000|Overall Study|Withdrawal by Subject|72|||
164669926|NCT03002077|594816789|FG000|Overall Study|Lost to Follow-up|21|||
164326255|NCT01423604|593570170|FG000|Safety Run-In|Patient decision|1|||
164326256|NCT01423604|593570171|FG001|Safety Run-In|Patient decision|0|||
164669927|NCT03002077|594816789|FG000|Overall Study|Pregnancy|4|||
164669928|NCT03002077|594816789|FG000|Overall Study|Protocol Violation|21|||
164216100|NCT01327703|593157348|FG000|Second Treatment Period|Protocol Violation|0|||
164216101|NCT01327703|593157349|FG001|Second Treatment Period|Protocol Violation|1|||
164216102|NCT01131585|593157351|FG000|Overall Study|Adverse Event|0|||
164216103|NCT01131585|593157352|FG001|Overall Study|Adverse Event|2|||
164216104|NCT01131585|593157351|FG000|Overall Study|Abnormal laboratory value|1|||
164216105|NCT01131585|593157352|FG001|Overall Study|Abnormal laboratory value|0|||
164216106|NCT01131585|593157351|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164216107|NCT01131585|593157352|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
164216108|NCT01131585|593157351|FG000|Overall Study|Protocol Violation|2|||
164216109|NCT01131585|593157352|FG001|Overall Study|Protocol Violation|1|||
164216110|NCT01131585|593157351|FG000|Overall Study|Withdrawal by Subject|3|||
164216111|NCT01131585|593157352|FG001|Overall Study|Withdrawal by Subject|3|||
164216112|NCT01131585|593157351|FG000|Overall Study|Lost to Follow-up|0|||
164216113|NCT01131585|593157352|FG001|Overall Study|Lost to Follow-up|1|||
164216114|NCT01131585|593157351|FG000|Overall Study|Administrative problems|1|||
164216115|NCT01131585|593157352|FG001|Overall Study|Administrative problems|1|||
164216116|NCT01131585|593157351|FG000|Overall Study|Study termination|78|||
164216117|NCT01131585|593157352|FG001|Overall Study|Study termination|32|||
164216118|NCT00812097|593157353|FG000|Overall Study|Death|3|||
164216119|NCT00812097|593157354|FG001|Overall Study|Death|10|||
164216120|NCT00812097|593157355|FG002|Overall Study|Death|3|||
164216121|NCT00812097|593157356|FG003|Overall Study|Death|3|||
164216122|NCT00812097|593157353|FG000|Overall Study|Withdrawal by Subject|14|||
164216123|NCT00812097|593157354|FG001|Overall Study|Withdrawal by Subject|12|||
164216124|NCT00812097|593157355|FG002|Overall Study|Withdrawal by Subject|8|||
164216125|NCT00812097|593157356|FG003|Overall Study|Withdrawal by Subject|2|||
164216126|NCT00812097|593157353|FG000|Overall Study|Lost to Follow-up|90|||
164216127|NCT00812097|593157354|FG001|Overall Study|Lost to Follow-up|14|||
164216128|NCT00812097|593157355|FG002|Overall Study|Lost to Follow-up|17|||
164216129|NCT00812097|593157356|FG003|Overall Study|Lost to Follow-up|5|||
164216130|NCT00812097|593157353|FG000|Overall Study|Explantation of study device(s)|27|||
164216131|NCT00812097|593157354|FG001|Overall Study|Explantation of study device(s)|29|||
164216132|NCT00812097|593157355|FG002|Overall Study|Explantation of study device(s)|14|||
164216133|NCT00812097|593157356|FG003|Overall Study|Explantation of study device(s)|20|||
164216134|NCT00812097|593157353|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
164216135|NCT00812097|593157354|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
164216136|NCT00812097|593157355|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
164216137|NCT00812097|593157356|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
164216138|NCT01786109|593157357|FG000|Overall Study|fail manometry barostat tube placement|1|||
164216139|NCT01786109|593157358|FG001|Overall Study|fail manometry barostat tube placement|0|||
164216140|NCT01786109|593157359|FG002|Overall Study|fail manometry barostat tube placement|0|||
164216141|NCT01786109|593157357|FG000|Overall Study|unrelated illness|0|||
164216142|NCT01786109|593157358|FG001|Overall Study|unrelated illness|0|||
164216143|NCT01786109|593157359|FG002|Overall Study|unrelated illness|1|||
164216144|NCT01786109|593157357|FG000|Overall Study|adverse effects colon preparation|0|||
164216145|NCT01786109|593157358|FG001|Overall Study|adverse effects colon preparation|0|||
164216146|NCT01786109|593157359|FG002|Overall Study|adverse effects colon preparation|1|||
164216147|NCT02949934|593157364|FG000|Natural Drinking Period|Adverse Event|1|||
164216148|NCT02949934|593157365|FG001|Natural Drinking Period|Adverse Event|0|||
164216149|NCT02949934|593157366|FG002|Natural Drinking Period|Adverse Event|0|||
164216150|NCT02949934|593157367|FG003|Natural Drinking Period|Adverse Event|1|||
164216151|NCT02949934|593157368|FG004|Natural Drinking Period|Adverse Event|0|||
164216152|NCT02949934|593157369|FG005|Natural Drinking Period|Adverse Event|0|||
164216153|NCT02949934|593157364|FG000|Natural Drinking Period|Lost to Follow-up|0|||
164216154|NCT02949934|593157365|FG001|Natural Drinking Period|Lost to Follow-up|0|||
164216155|NCT02949934|593157366|FG002|Natural Drinking Period|Lost to Follow-up|0|||
164216156|NCT02949934|593157367|FG003|Natural Drinking Period|Lost to Follow-up|0|||
164216157|NCT02949934|593157368|FG004|Natural Drinking Period|Lost to Follow-up|1|||
164216158|NCT02949934|593157369|FG005|Natural Drinking Period|Lost to Follow-up|0|||
164216159|NCT02949934|593157364|FG000|Neuroimaging|Protocol Violation|2|||
164216160|NCT02949934|593157365|FG001|Neuroimaging|Protocol Violation|0|||
164216161|NCT02949934|593157366|FG002|Neuroimaging|Protocol Violation|0|||
164216162|NCT02949934|593157367|FG003|Neuroimaging|Protocol Violation|0|||
164216163|NCT02949934|593157368|FG004|Neuroimaging|Protocol Violation|1|||
164326257|NCT01423604|593570170|FG000|Randomized|Adverse Event|4|||
164326258|NCT01423604|593570171|FG001|Randomized|Adverse Event|10|||
164216164|NCT02949934|593157369|FG005|Neuroimaging|Protocol Violation|0|||
164326259|NCT01423604|593570170|FG000|Randomized|Death|1|||
164326260|NCT01423604|593570171|FG001|Randomized|Death|0|||
164216165|NCT02949934|593157364|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
164216166|NCT02949934|593157365|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
164216167|NCT02949934|593157366|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
164216168|NCT02949934|593157367|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
164216169|NCT02949934|593157368|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
164216170|NCT02949934|593157369|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
164216171|NCT02949934|593157364|FG000|Neuroimaging|Not scanned|0|||
164216172|NCT02949934|593157365|FG001|Neuroimaging|Not scanned|0|||
164216173|NCT02949934|593157366|FG002|Neuroimaging|Not scanned|1|||
164216174|NCT02949934|593157367|FG003|Neuroimaging|Not scanned|0|||
164216175|NCT02949934|593157368|FG004|Neuroimaging|Not scanned|0|||
164216176|NCT02949934|593157369|FG005|Neuroimaging|Not scanned|2|||
164216177|NCT02949934|593157364|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
164216178|NCT02949934|593157365|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
164216179|NCT02949934|593157366|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
164216180|NCT02949934|593157367|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
164216181|NCT02949934|593157368|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
164216182|NCT02949934|593157369|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
164216183|NCT02949934|593157364|FG000|Bar Laboratory|Adverse Event|1|||
164216184|NCT02949934|593157365|FG001|Bar Laboratory|Adverse Event|0|||
164216185|NCT02949934|593157366|FG002|Bar Laboratory|Adverse Event|2|||
164216186|NCT02949934|593157367|FG003|Bar Laboratory|Adverse Event|0|||
164216187|NCT02949934|593157368|FG004|Bar Laboratory|Adverse Event|1|||
164216188|NCT02949934|593157369|FG005|Bar Laboratory|Adverse Event|0|||
164216189|NCT02949934|593157364|FG000|Bar Laboratory|Protocol Violation|0|||
164216190|NCT02949934|593157365|FG001|Bar Laboratory|Protocol Violation|0|||
164216191|NCT02949934|593157366|FG002|Bar Laboratory|Protocol Violation|0|||
164216192|NCT02949934|593157367|FG003|Bar Laboratory|Protocol Violation|1|||
164216193|NCT02949934|593157368|FG004|Bar Laboratory|Protocol Violation|0|||
164216194|NCT02949934|593157369|FG005|Bar Laboratory|Protocol Violation|0|||
164216195|NCT00849472|593157371|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
164216196|NCT00849472|593157371|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
164216197|NCT00849472|593157371|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
164216198|NCT00849472|593157371|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
164216199|NCT00849472|593157371|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
164216200|NCT00849472|593157371|FG000|Weekly Paclitaxel|Disease Progression|1|||
164216201|NCT00849472|593157371|FG000|Weekly Paclitaxel|Adverse Event|11|||
164216202|NCT00849472|593157371|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
164216203|NCT00849472|593157371|FG000|Weekly Paclitaxel|Physician Decision|3|||
164216204|NCT00849472|593157371|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
164216205|NCT00849472|593157371|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
164669929|NCT00986245|594816790|FG000|First Intervention|Poor compliance|8|||
164216206|NCT00849472|593157371|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
164216207|NCT00849472|593157371|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
164216208|NCT00849472|593157371|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
164216209|NCT00849472|593157371|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
164216210|NCT00849472|593157371|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
164216211|NCT00849472|593157371|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
164216212|NCT05887401|593157374|FG000|Overall Study|Withdrawal by Subject|0|||
164216213|NCT05887401|593157375|FG001|Overall Study|Withdrawal by Subject|0|||
164216214|NCT05887401|593157376|FG002|Overall Study|Withdrawal by Subject|0|||
164216215|NCT05887401|593157377|FG003|Overall Study|Withdrawal by Subject|0|||
164216216|NCT05887401|593157378|FG004|Overall Study|Withdrawal by Subject|0|||
164216217|NCT05887401|593157379|FG005|Overall Study|Withdrawal by Subject|0|||
164216218|NCT05887401|593157380|FG006|Overall Study|Withdrawal by Subject|0|||
164216219|NCT05887401|593157381|FG007|Overall Study|Withdrawal by Subject|0|||
164216220|NCT05887401|593157382|FG008|Overall Study|Withdrawal by Subject|0|||
164216221|NCT05887401|593157383|FG009|Overall Study|Withdrawal by Subject|1|||
164216222|NCT05887401|593157384|FG010|Overall Study|Withdrawal by Subject|0|||
164216223|NCT05887401|593157385|FG011|Overall Study|Withdrawal by Subject|0|||
164216224|NCT05887401|593157386|FG012|Overall Study|Withdrawal by Subject|0|||
164216225|NCT05887401|593157387|FG013|Overall Study|Withdrawal by Subject|0|||
164216226|NCT05887401|593157388|FG014|Overall Study|Withdrawal by Subject|0|||
164216227|NCT05887401|593157389|FG015|Overall Study|Withdrawal by Subject|1|||
164216228|NCT05887401|593157374|FG000|Overall Study|Lost to Follow-up|0|||
164216229|NCT05887401|593157375|FG001|Overall Study|Lost to Follow-up|1|||
164216230|NCT05887401|593157376|FG002|Overall Study|Lost to Follow-up|1|||
164216231|NCT05887401|593157377|FG003|Overall Study|Lost to Follow-up|2|||
164216232|NCT05887401|593157378|FG004|Overall Study|Lost to Follow-up|0|||
164216233|NCT05887401|593157379|FG005|Overall Study|Lost to Follow-up|0|||
164216234|NCT05887401|593157380|FG006|Overall Study|Lost to Follow-up|0|||
164669930|NCT00986245|594816791|FG001|First Intervention|Poor compliance|4|||
164216235|NCT05887401|593157381|FG007|Overall Study|Lost to Follow-up|0|||
164216236|NCT05887401|593157382|FG008|Overall Study|Lost to Follow-up|1|||
164216237|NCT05887401|593157383|FG009|Overall Study|Lost to Follow-up|1|||
164216238|NCT05887401|593157384|FG010|Overall Study|Lost to Follow-up|2|||
164216239|NCT05887401|593157385|FG011|Overall Study|Lost to Follow-up|1|||
164216240|NCT05887401|593157386|FG012|Overall Study|Lost to Follow-up|0|||
164216241|NCT05887401|593157387|FG013|Overall Study|Lost to Follow-up|0|||
164216242|NCT05887401|593157388|FG014|Overall Study|Lost to Follow-up|0|||
164216243|NCT05887401|593157389|FG015|Overall Study|Lost to Follow-up|0|||
164326261|NCT01423604|593570170|FG000|Randomized|Physician Decision|16|||
164326262|NCT01423604|593570171|FG001|Randomized|Physician Decision|13|||
164326263|NCT01423604|593570170|FG000|Randomized|Other - unspecified|37|||
164326264|NCT01423604|593570171|FG001|Randomized|Other - unspecified|31|||
164326265|NCT01423604|593570170|FG000|Randomized|Patient decision|5|||
164326266|NCT01423604|593570171|FG001|Randomized|Patient decision|9|||
164326267|NCT06785857|593570186|FG000|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|2|||
164326268|NCT06785857|593570187|FG001|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|3|||
164326269|NCT05952401|593570195|FG000|Overall Study|Lost to Follow-up|4|||
164326270|NCT05952401|593570196|FG001|Overall Study|Lost to Follow-up|1|||
164326271|NCT00543855|593571476|FG000|Overall Study|Adverse Event|3|||
164326272|NCT00543855|593571477|FG001|Overall Study|Adverse Event|1|||
164326273|NCT00543855|593571478|FG002|Overall Study|Adverse Event|3|||
164326274|NCT00543855|593571479|FG003|Overall Study|Adverse Event|4|||
164326275|NCT00543855|593571476|FG000|Overall Study|Lost to Follow-up|0|||
164326276|NCT00543855|593571477|FG001|Overall Study|Lost to Follow-up|0|||
164326277|NCT00543855|593571478|FG002|Overall Study|Lost to Follow-up|1|||
164326278|NCT00543855|593571479|FG003|Overall Study|Lost to Follow-up|0|||
164326279|NCT00543855|593571476|FG000|Overall Study|Withdrawal by Subject|0|||
164326280|NCT00543855|593571477|FG001|Overall Study|Withdrawal by Subject|1|||
164326281|NCT00543855|593571478|FG002|Overall Study|Withdrawal by Subject|2|||
164326282|NCT00543855|593571479|FG003|Overall Study|Withdrawal by Subject|0|||
164326283|NCT00543855|593571476|FG000|Overall Study|Protocol Violation|1|||
164326284|NCT00543855|593571477|FG001|Overall Study|Protocol Violation|0|||
164326285|NCT00543855|593571478|FG002|Overall Study|Protocol Violation|0|||
164326286|NCT00543855|593571479|FG003|Overall Study|Protocol Violation|0|||
164326287|NCT01994590|593571483|FG000|Overall Study|Adverse Event|1|||
164326288|NCT01994590|593571483|FG000|Overall Study|Trial Terminated|1|||
164326289|NCT00096954|593571487|FG000|Overall Study|Adverse Event|3|||
164326290|NCT00096954|593571488|FG001|Overall Study|Adverse Event|1|||
164326291|NCT00096954|593571487|FG000|Overall Study|Withdrawal by Subject|9|||
164326292|NCT00096954|593571488|FG001|Overall Study|Withdrawal by Subject|8|||
164326293|NCT00096954|593571487|FG000|Overall Study|Physician Decision|1|||
164326294|NCT00096954|593571488|FG001|Overall Study|Physician Decision|1|||
164326295|NCT00096954|593571487|FG000|Overall Study|Sponsors Decision|1|||
164326296|NCT00096954|593571488|FG001|Overall Study|Sponsors Decision|1|||
164326297|NCT00096954|593571487|FG000|Overall Study|Pregnancy|1|||
164326298|NCT00096954|593571488|FG001|Overall Study|Pregnancy|1|||
164326299|NCT00096954|593571487|FG000|Overall Study|Initiation of immunotherapy|1|||
164326300|NCT00096954|593571488|FG001|Overall Study|Initiation of immunotherapy|0|||
164326301|NCT00096954|593571487|FG000|Overall Study|Non-compliance|0|||
164326302|NCT00096954|593571488|FG001|Overall Study|Non-compliance|3|||
164216244|NCT04530526|593157390|FG000|Overall Study|Withdrawal by Subject|6|||
164216245|NCT05942040|593157391|FG000|Overall Study|No longer employed at study site.|0|||
164216246|NCT05942040|593157392|FG001|Overall Study|No longer employed at study site.|0|||
164216247|NCT05942040|593157393|FG002|Overall Study|No longer employed at study site.|3|||
164216248|NCT03442569|593157394|FG000|Overall Study|Subject was ineligible after enrollment|1|||
164216249|NCT06461455|593157395|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
164216250|NCT06461455|593157396|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
164216251|NCT06461455|593157395|FG000|First Wear Period (Approx 30 Days)|Screen failure|1|||
164216252|NCT06461455|593157396|FG001|First Wear Period (Approx 30 Days)|Screen failure|0|||
164216253|NCT06461455|593157395|FG000|Washout Period (Approx 2-4 Days)|Adverse Event|0|||
164216254|NCT06461455|593157396|FG001|Washout Period (Approx 2-4 Days)|Adverse Event|1|||
164216255|NCT06142383|593157397|FG000|Overall Study|Mis-randomized|0|||
164216256|NCT06142383|593157398|FG001|Overall Study|Mis-randomized|0|||
164216257|NCT06142383|593157399|FG002|Overall Study|Mis-randomized|1|||
164216258|NCT06142383|593157400|FG003|Overall Study|Mis-randomized|0|||
164216259|NCT06142383|593157401|FG004|Overall Study|Mis-randomized|0|||
164326303|NCT00096954|593571487|FG000|Overall Study|Lost to Follow-up|8|||
164326304|NCT00096954|593571488|FG001|Overall Study|Lost to Follow-up|5|||
164326305|NCT00719264|593571489|FG000|Overall Study|Adverse Event|41|||
164326306|NCT00719264|593571490|FG001|Overall Study|Adverse Event|49|||
164326307|NCT00719264|593571489|FG000|Overall Study|Death|13|||
164326308|NCT00719264|593571490|FG001|Overall Study|Death|10|||
164326309|NCT00719264|593571489|FG000|Overall Study|Administrative Problems|6|||
164326310|NCT00719264|593571490|FG001|Overall Study|Administrative Problems|4|||
164326311|NCT00719264|593571489|FG000|Overall Study|Lost to Follow-up|1|||
164326312|NCT00719264|593571490|FG001|Overall Study|Lost to Follow-up|1|||
164326313|NCT00719264|593571489|FG000|Overall Study|Withdrawal by Subject|12|||
164326314|NCT00719264|593571490|FG001|Overall Study|Withdrawal by Subject|7|||
164326315|NCT00719264|593571489|FG000|Overall Study|Protocol Deviation|1|||
164326316|NCT00719264|593571490|FG001|Overall Study|Protocol Deviation|3|||
164326317|NCT00719264|593571489|FG000|Overall Study|New Cancer Therapy|4|||
164326318|NCT00719264|593571490|FG001|Overall Study|New Cancer Therapy|2|||
164326319|NCT00719264|593571489|FG000|Overall Study|Disease Progression|104|||
164326320|NCT00719264|593571490|FG001|Overall Study|Disease Progression|107|||
164326321|NCT01277042|593571491|FG000|Overall Study|Adverse Event|4|||
164326322|NCT01277042|593571492|FG001|Overall Study|Adverse Event|3|||
164216260|NCT06142383|593157397|FG000|Overall Study|Adverse Event|0|||
164216261|NCT06142383|593157398|FG001|Overall Study|Adverse Event|1|||
164216262|NCT06142383|593157399|FG002|Overall Study|Adverse Event|1|||
164216263|NCT06142383|593157400|FG003|Overall Study|Adverse Event|0|||
164216264|NCT06142383|593157401|FG004|Overall Study|Adverse Event|0|||
164216265|NCT06142383|593157397|FG000|Overall Study|Death|0|||
164216266|NCT06142383|593157398|FG001|Overall Study|Death|1|||
164216267|NCT06142383|593157399|FG002|Overall Study|Death|3|||
164216268|NCT06142383|593157400|FG003|Overall Study|Death|0|||
164216269|NCT06142383|593157401|FG004|Overall Study|Death|1|||
164216270|NCT06142383|593157397|FG000|Overall Study|Study Terminated by Sponsor|20|||
164216271|NCT06142383|593157398|FG001|Overall Study|Study Terminated by Sponsor|17|||
164216272|NCT06142383|593157399|FG002|Overall Study|Study Terminated by Sponsor|33|||
164216273|NCT06142383|593157400|FG003|Overall Study|Study Terminated by Sponsor|0|||
164216274|NCT06142383|593157401|FG004|Overall Study|Study Terminated by Sponsor|21|||
164216275|NCT06142383|593157397|FG000|Overall Study|Subject Decision|0|||
164216276|NCT06142383|593157398|FG001|Overall Study|Subject Decision|1|||
164216277|NCT06142383|593157399|FG002|Overall Study|Subject Decision|2|||
164216278|NCT06142383|593157400|FG003|Overall Study|Subject Decision|0|||
164216279|NCT06142383|593157401|FG004|Overall Study|Subject Decision|0|||
164216280|NCT05800145|593157402|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
164216281|NCT05800145|593157403|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
164216282|NCT05800145|593157404|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
164216283|NCT05800145|593157405|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
164216284|NCT05800145|593157406|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
164216285|NCT05800145|593157407|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
164216286|NCT05800145|593157402|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
164216287|NCT05800145|593157403|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
164216288|NCT05800145|593157404|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
164216289|NCT05800145|593157405|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
164216290|NCT05800145|593157406|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
164216291|NCT05800145|593157407|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
164216292|NCT05800145|593157402|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
164216293|NCT05800145|593157403|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
164216294|NCT05800145|593157404|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
164216295|NCT05800145|593157405|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
164216296|NCT05800145|593157406|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
164216297|NCT05800145|593157407|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
164216298|NCT04827446|593159067|FG000|Overall Study|Lost to Follow-up|1|||
164216299|NCT04827446|593159068|FG001|Overall Study|Lost to Follow-up|1|||
164216300|NCT04827446|593159067|FG000|Overall Study|Death|2|||
164216301|NCT04827446|593159068|FG001|Overall Study|Death|0|||
164216302|NCT04827446|593159067|FG000|Overall Study|Withdrawal by Subject|2|||
164216303|NCT04827446|593159068|FG001|Overall Study|Withdrawal by Subject|2|||
164216304|NCT04706403|593159069|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
164216305|NCT04706403|593159070|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
164216306|NCT04706403|593159071|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
164216307|NCT04706403|593159072|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
164216308|NCT04706403|593159073|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
164216309|NCT02642679|593159074|FG000|Overall Study|Withdrawal by Subject|1|||
164216310|NCT02642679|593159074|FG000|Overall Study|Physician Decision|1|||
164216311|NCT02642679|593159074|FG000|Overall Study|Physician Decision|1|||
164216312|NCT05206604|593159075|FG000|Overall Study|Non-compliance with study drug|0|||
164216313|NCT05206604|593159076|FG001|Overall Study|Non-compliance with study drug|0|||
164216314|NCT05206604|593159077|FG002|Overall Study|Non-compliance with study drug|0|||
164216315|NCT05206604|593159078|FG003|Overall Study|Non-compliance with study drug|0|||
164216316|NCT05206604|593159079|FG004|Overall Study|Non-compliance with study drug|0|||
164216317|NCT05206604|593159080|FG005|Overall Study|Non-compliance with study drug|1|||
164216318|NCT05206604|593159081|FG006|Overall Study|Non-compliance with study drug|0|||
164216319|NCT05206604|593159082|FG007|Overall Study|Non-compliance with study drug|0|||
164216320|NCT03735498|593159083|FG000|Overall Study|Withdrawal by Subject|3|||
164216321|NCT03735498|593159083|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
164216322|NCT00160615|593159085|FG000|Overall Study|Adverse Event|5|||
164216323|NCT00160615|593159086|FG001|Overall Study|Adverse Event|12|||
164216324|NCT00160615|593159085|FG000|Overall Study|Withdrawal by Subject|0|||
164216325|NCT00160615|593159086|FG001|Overall Study|Withdrawal by Subject|2|||
164216326|NCT00160615|593159085|FG000|Overall Study|Lack of Efficacy|11|||
164216327|NCT00160615|593159086|FG001|Overall Study|Lack of Efficacy|23|||
164216328|NCT00160615|593159085|FG000|Overall Study|Patient decision|1|||
164216329|NCT00160615|593159086|FG001|Overall Study|Patient decision|2|||
164216330|NCT00160615|593159085|FG000|Overall Study|Investigator decision|1|||
164216331|NCT00160615|593159086|FG001|Overall Study|Investigator decision|1|||
164216332|NCT00160615|593159085|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
164216333|NCT00160615|593159086|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
164216334|NCT00160615|593159085|FG000|Overall Study|Switch to surgical treatment|0|||
164216335|NCT00160615|593159086|FG001|Overall Study|Switch to surgical treatment|2|||
164216336|NCT00160615|593159085|FG000|Overall Study|Non-compliance was suspected|0|||
164216337|NCT00160615|593159086|FG001|Overall Study|Non-compliance was suspected|1|||
164216338|NCT00160615|593159085|FG000|Overall Study|Poor compliance|0|||
164216339|NCT00160615|593159086|FG001|Overall Study|Poor compliance|1|||
164216340|NCT05638737|593159087|FG000|Overall Study|Withdrawal by Subject|4|||
164216341|NCT05638737|593159088|FG001|Overall Study|Withdrawal by Subject|7|||
164216342|NCT03928704|593159093|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
164216343|NCT03928704|593159094|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
164216344|NCT03928704|593159095|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
164216345|NCT03928704|593159096|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
164216346|NCT03928704|593159097|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
164216347|NCT03928704|593159098|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
164216348|NCT03928704|593159093|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
164216349|NCT03928704|593159094|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
164216350|NCT03928704|593159095|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
164216351|NCT03928704|593159096|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
164216352|NCT03928704|593159097|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
164216353|NCT03928704|593159098|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
164216354|NCT03928704|593159093|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
164216355|NCT03928704|593159094|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
164216356|NCT03928704|593159095|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
164216357|NCT03928704|593159096|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
164216358|NCT03928704|593159097|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
164216359|NCT03928704|593159098|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
164216360|NCT03928704|593159093|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
164216361|NCT03928704|593159094|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
164216362|NCT03928704|593159095|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
164216363|NCT03928704|593159096|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
164216364|NCT03928704|593159097|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
164216365|NCT03928704|593159098|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
164216366|NCT03928704|593159093|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
164216367|NCT03928704|593159094|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
164216368|NCT03928704|593159095|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
164216369|NCT03928704|593159096|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
164216370|NCT03928704|593159097|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
164216371|NCT03928704|593159098|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
164216372|NCT03928704|593159093|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
164216373|NCT03928704|593159094|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
164216374|NCT03928704|593159095|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
164216375|NCT03928704|593159096|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
164216376|NCT03928704|593159097|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
164216377|NCT03928704|593159098|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
164216378|NCT03928704|593159093|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
164216379|NCT03928704|593159094|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
164216380|NCT03928704|593159095|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
164216381|NCT03928704|593159096|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
164216382|NCT03928704|593159097|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
164216383|NCT03928704|593159098|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
164216384|NCT03928704|593159093|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
164216385|NCT03928704|593159094|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
164216386|NCT03928704|593159095|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
164216387|NCT03928704|593159096|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
164216388|NCT03928704|593159097|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
164216389|NCT03928704|593159098|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
164216390|NCT03928704|593159093|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
164216391|NCT03928704|593159094|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
164216392|NCT03928704|593159095|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
164216393|NCT03928704|593159096|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
164216394|NCT03928704|593159097|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
164326323|NCT01277042|593571491|FG000|Overall Study|Lost to Follow-up|2|||
164565363|NCT02211261|594438492|FG003|Overall Study|Withdrawal by Subject|0|||
164565364|NCT02211261|594438493|FG004|Overall Study|Withdrawal by Subject|2|||
164565365|NCT02211261|594438494|FG005|Overall Study|Withdrawal by Subject|0|||
164565366|NCT02211261|594438495|FG006|Overall Study|Withdrawal by Subject|0|||
164565367|NCT02211261|594438496|FG007|Overall Study|Withdrawal by Subject|0|||
164565368|NCT02211261|594438497|FG008|Overall Study|Withdrawal by Subject|0|||
164565369|NCT02211261|594438498|FG009|Overall Study|Withdrawal by Subject|0|||
164565370|NCT02211261|594438499|FG010|Overall Study|Withdrawal by Subject|0|||
164565371|NCT02211261|594438489|FG000|Overall Study|Other|0|||
164565372|NCT02211261|594438490|FG001|Overall Study|Other|0|||
164565373|NCT02211261|594438491|FG002|Overall Study|Other|0|||
164565374|NCT02211261|594438492|FG003|Overall Study|Other|0|||
164216395|NCT03928704|593159098|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
164326324|NCT01277042|593571492|FG001|Overall Study|Lost to Follow-up|2|||
164565375|NCT02211261|594438493|FG004|Overall Study|Other|0|||
164565376|NCT02211261|594438494|FG005|Overall Study|Other|1|||
164565377|NCT02211261|594438495|FG006|Overall Study|Other|0|||
164565378|NCT02211261|594438496|FG007|Overall Study|Other|0|||
164565379|NCT02211261|594438497|FG008|Overall Study|Other|0|||
164565380|NCT02211261|594438498|FG009|Overall Study|Other|2|||
164565381|NCT02211261|594438499|FG010|Overall Study|Other|0|||
164565382|NCT02211261|594438489|FG000|Overall Study|Lost to Follow-up|0|||
164565383|NCT02211261|594438490|FG001|Overall Study|Lost to Follow-up|0|||
164565384|NCT02211261|594438491|FG002|Overall Study|Lost to Follow-up|0|||
164565385|NCT02211261|594438492|FG003|Overall Study|Lost to Follow-up|0|||
164565386|NCT02211261|594438493|FG004|Overall Study|Lost to Follow-up|0|||
164565387|NCT02211261|594438494|FG005|Overall Study|Lost to Follow-up|0|||
164565388|NCT02211261|594438495|FG006|Overall Study|Lost to Follow-up|0|||
164565389|NCT02211261|594438496|FG007|Overall Study|Lost to Follow-up|1|||
164565390|NCT02211261|594438497|FG008|Overall Study|Lost to Follow-up|0|||
164565391|NCT02211261|594438498|FG009|Overall Study|Lost to Follow-up|0|||
164565392|NCT02211261|594438499|FG010|Overall Study|Lost to Follow-up|0|||
164565393|NCT04062214|594438502|FG000|Week 12|Death|1|||
164565394|NCT04062214|594438503|FG001|Week 12|Death|1|||
164565395|NCT04062214|594438502|FG000|Week 12|Withdrawal by Subject|14|||
164565396|NCT04062214|594438503|FG001|Week 12|Withdrawal by Subject|13|||
164565397|NCT04062214|594438502|FG000|Week 12|Lost to Follow-up|55|||
164565398|NCT04062214|594438503|FG001|Week 12|Lost to Follow-up|68|||
164565399|NCT04062214|594438502|FG000|Week 12|Intermittent missing|31|||
164565400|NCT04062214|594438503|FG001|Week 12|Intermittent missing|29|||
164565401|NCT04062214|594438502|FG000|Week 36|Withdrawal by Subject|4|||
164565402|NCT04062214|594438503|FG001|Week 36|Withdrawal by Subject|5|||
164565403|NCT04062214|594438502|FG000|Week 36|Lost to Follow-up|50|||
164565404|NCT04062214|594438503|FG001|Week 36|Lost to Follow-up|46|||
164565405|NCT04062214|594438502|FG000|Week 36|Death|0|||
164565406|NCT04062214|594438503|FG001|Week 36|Death|1|||
164565407|NCT04506294|594438508|FG000|Overall Study|Lost to Follow-up|70|||
164565408|NCT04506294|594438509|FG001|Overall Study|Lost to Follow-up|20|||
164565409|NCT04506294|594438508|FG000|Overall Study|Withdrawal by Subject|16|||
164565410|NCT04506294|594438509|FG001|Overall Study|Withdrawal by Subject|2|||
164565411|NCT04025632|594440356|FG000|Overall Study|Adverse Event|1|||
164565412|NCT04025632|594440357|FG001|Overall Study|Adverse Event|1|||
164565413|NCT04025632|594440356|FG000|Overall Study|Withdrawal by Subject|1|||
164565414|NCT04025632|594440357|FG001|Overall Study|Withdrawal by Subject|1|||
164565415|NCT04025632|594440356|FG000|Overall Study|Study Terminated by Sponsor|10|||
164565416|NCT04025632|594440357|FG001|Overall Study|Study Terminated by Sponsor|9|||
164565417|NCT04025632|594440356|FG000|Overall Study|Physician Decision|3|||
164565418|NCT04025632|594440357|FG001|Overall Study|Physician Decision|1|||
164565419|NCT00376961|594440358|FG000|Initial Registration|Adverse Event|1|||
164565420|NCT00376961|594440359|FG001|Initial Registration|Adverse Event|0|||
164565421|NCT00376961|594440358|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
164565422|NCT00376961|594440359|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
164565423|NCT00376961|594440358|FG000|Initial Registration|Progression/relapse|1|||
164565424|NCT00376961|594440359|FG001|Initial Registration|Progression/relapse|0|||
164565425|NCT00376961|594440358|FG000|Initial Registration|Ineligible|3|||
164565426|NCT00376961|594440359|FG001|Initial Registration|Ineligible|0|||
164565427|NCT00376961|594440358|FG000|Maintenance|Adverse Event|0|||
164565428|NCT00376961|594440359|FG001|Maintenance|Adverse Event|1|||
164565429|NCT00376961|594440358|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
164565430|NCT00376961|594440359|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
164565431|NCT00376961|594440358|FG000|Maintenance|Progression/relapse|0|||
164565432|NCT00376961|594440359|FG001|Maintenance|Progression/relapse|18|||
164565433|NCT00376961|594440358|FG000|Maintenance|Ineligible|0|||
164565434|NCT00376961|594440359|FG001|Maintenance|Ineligible|3|||
164565435|NCT02591615|594440361|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
164565436|NCT02591615|594440362|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
164565437|NCT02591615|594440363|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
164565438|NCT02591615|594440364|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
164565439|NCT02591615|594440361|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
164216396|NCT03928704|593159093|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
164216397|NCT03928704|593159094|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
164216398|NCT03928704|593159095|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
164216399|NCT03928704|593159096|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
164216400|NCT03928704|593159097|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
164216401|NCT03928704|593159098|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
164216402|NCT00327171|593159101|FG000|Overall Study|Did not receive study medication|3|||
164216403|NCT00327171|593159102|FG001|Overall Study|Did not receive study medication|0|||
164216404|NCT00327171|593159101|FG000|Overall Study|Adverse Event|23|||
164216405|NCT00327171|593159102|FG001|Overall Study|Adverse Event|23|||
164216406|NCT00327171|593159101|FG000|Overall Study|Disease progression/lack of efficacy|68|||
164216407|NCT00327171|593159102|FG001|Overall Study|Disease progression/lack of efficacy|69|||
164216408|NCT00327171|593159101|FG000|Overall Study|Investigator/participant request|1|||
164216409|NCT00327171|593159102|FG001|Overall Study|Investigator/participant request|8|||
164216410|NCT00327171|593159101|FG000|Overall Study|Clinical progression|12|||
164216411|NCT00327171|593159102|FG001|Overall Study|Clinical progression|8|||
164216412|NCT00327171|593159101|FG000|Overall Study|Undisclosed history of ischemia|0|||
164216413|NCT00327171|593159102|FG001|Overall Study|Undisclosed history of ischemia|1|||
164216414|NCT00327171|593159101|FG000|Overall Study|Other|1|||
164216415|NCT00327171|593159102|FG001|Overall Study|Other|0|||
164216416|NCT01363440|593159103|FG000|Overall Study|Adverse Event|5|||
164216417|NCT01363440|593159104|FG001|Overall Study|Adverse Event|4|||
164216418|NCT01363440|593159105|FG002|Overall Study|Adverse Event|4|||
164216419|NCT01363440|593159103|FG000|Overall Study|Death|3|||
164216420|NCT01363440|593159104|FG001|Overall Study|Death|7|||
164216421|NCT01363440|593159105|FG002|Overall Study|Death|5|||
164216422|NCT01363440|593159103|FG000|Overall Study|Withdrawal by Subject|9|||
164216423|NCT01363440|593159104|FG001|Overall Study|Withdrawal by Subject|11|||
164216424|NCT01363440|593159105|FG002|Overall Study|Withdrawal by Subject|11|||
164216425|NCT01363440|593159103|FG000|Overall Study|Lost to Follow-up|2|||
164216426|NCT01363440|593159104|FG001|Overall Study|Lost to Follow-up|4|||
164216427|NCT01363440|593159105|FG002|Overall Study|Lost to Follow-up|5|||
164216428|NCT01363440|593159103|FG000|Overall Study|Other|4|||
164216429|NCT01363440|593159104|FG001|Overall Study|Other|5|||
164216430|NCT01363440|593159105|FG002|Overall Study|Other|2|||
164216431|NCT00992836|593159106|FG000|Overall Study|Lost to Follow-up|1|||
164216432|NCT00992836|593159106|FG000|Overall Study|Withdrawal by Subject|2|||
164216433|NCT00992836|593159106|FG000|Overall Study|Protocol Violation|2|||
164216434|NCT00266812|593159107|FG000|Overall Study|Disease Progression|9|||
164216435|NCT00266812|593159108|FG001|Overall Study|Disease Progression|3|||
164216436|NCT00266812|593159107|FG000|Overall Study|Death|5|||
164216437|NCT00266812|593159108|FG001|Overall Study|Death|4|||
164216438|NCT00266812|593159107|FG000|Overall Study|Adverse Event|3|||
164216439|NCT00266812|593159108|FG001|Overall Study|Adverse Event|1|||
164216440|NCT00266812|593159107|FG000|Overall Study|Protocol Violation|0|||
164216441|NCT00266812|593159108|FG001|Overall Study|Protocol Violation|1|||
164216442|NCT00266812|593159107|FG000|Overall Study|Withdrawal by Subject|0|||
164216443|NCT00266812|593159108|FG001|Overall Study|Withdrawal by Subject|2|||
164216444|NCT00266812|593159107|FG000|Overall Study|Discontinued before starting study drug|4|||
164216445|NCT00266812|593159108|FG001|Overall Study|Discontinued before starting study drug|0|||
164216446|NCT03695094|593159109|FG000|Overall Study|Adverse Event|1|||
164216447|NCT03695094|593159110|FG001|Overall Study|Adverse Event|1|||
164216448|NCT03695094|593159109|FG000|Overall Study|Withdrawal by Subject|1|||
164216449|NCT03695094|593159110|FG001|Overall Study|Withdrawal by Subject|0|||
164216450|NCT00530075|593159111|FG000|Overall Study|Adverse Event|1|||
164216451|NCT00530075|593159111|FG000|Overall Study|Death|1|||
164216452|NCT00530075|593159111|FG000|Overall Study|Lack of Efficacy|3|||
164216453|NCT00530075|593159111|FG000|Overall Study|Protocol Violation|1|||
164216454|NCT00530075|593159111|FG000|Overall Study|Withdrawal by Subject|1|||
164216455|NCT00416949|593159114|FG000|Overall Study|Patients refused to participate|5|||
164216456|NCT01166945|593159115|FG000|Randomized|diagnosed with Group A strep|4|||
164216457|NCT01166945|593159116|FG001|Randomized|diagnosed with Group A strep|4|||
164216458|NCT01166945|593159115|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
164216459|NCT01166945|593159116|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
164216460|NCT01166945|593159115|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
164565440|NCT02591615|594440362|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
164216461|NCT01166945|593159116|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
164216462|NCT01166945|593159115|FG000|Day 30|Lost to Follow-up|4|||
164216463|NCT01166945|593159116|FG001|Day 30|Lost to Follow-up|3|||
164216464|NCT03520569|593159121|FG000|Overall Study|Withdrawal by Subject|1|||
164216465|NCT01178411|593159122|FG000|Overall Study|Adverse Event|5|||
164216466|NCT01178411|593159122|FG000|Overall Study|Withdrawal by Subject|4|||
164216467|NCT01178411|593159122|FG000|Overall Study|Protocol Violation|1|||
164216468|NCT01178411|593159122|FG000|Overall Study|Progressive disease per RECIST|32|||
164216469|NCT01178411|593159122|FG000|Overall Study|Progressive disease per clinician|9|||
164216470|NCT01178411|593159122|FG000|Overall Study|Physician Decision|6|||
164216471|NCT01178411|593159122|FG000|Overall Study|Death|1|||
164216472|NCT01178411|593159122|FG000|Overall Study|No reason provided|1|||
164216473|NCT01178411|593159122|FG000|Overall Study|Drug manufacturing ended|1|||
164216474|NCT00784927|593159123|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
164216475|NCT00784927|593159123|FG000|Overall Study|Protocol Violation|1|||
164216476|NCT00784927|593159123|FG000|Overall Study|Ineligible|1|||
164216477|NCT01471574|593159126|FG000|Treatment Period|Lack of Efficacy|12|||
164216478|NCT01471574|593159127|FG001|Treatment Period|Lack of Efficacy|4|||
164326325|NCT01277042|593571491|FG000|Overall Study|Withdrawal by Subject|2|||
164326326|NCT01277042|593571492|FG001|Overall Study|Withdrawal by Subject|0|||
164326327|NCT03581786|593571499|FG000|Overall Study|Death|67|||
164326328|NCT03581786|593571500|FG001|Overall Study|Death|47|||
164326329|NCT03581786|593571499|FG000|Overall Study|Withdrawal by Subject|2|||
164326330|NCT03581786|593571500|FG001|Overall Study|Withdrawal by Subject|5|||
164326331|NCT03581786|593571499|FG000|Overall Study|Lost to Follow-up|7|||
164326332|NCT03581786|593571500|FG001|Overall Study|Lost to Follow-up|4|||
164326333|NCT03581786|593571499|FG000|Overall Study|reason other than specified above|0|||
164326334|NCT03581786|593571500|FG001|Overall Study|reason other than specified above|1|||
164326335|NCT02469038|593571501|FG000|Overall Study|Physician Decision|4|||
164326336|NCT02469038|593571502|FG001|Overall Study|Physician Decision|5|||
164326337|NCT03435640|593571503|FG000|Overall Study|Withdrawal by Subject|0|||
164326338|NCT03435640|593571504|FG001|Overall Study|Withdrawal by Subject|1|||
164326339|NCT03435640|593571505|FG002|Overall Study|Withdrawal by Subject|0|||
164326340|NCT03435640|593571506|FG003|Overall Study|Withdrawal by Subject|2|||
164326341|NCT03435640|593571507|FG004|Overall Study|Withdrawal by Subject|0|||
164326342|NCT03435640|593571508|FG005|Overall Study|Withdrawal by Subject|0|||
164326343|NCT03435640|593571509|FG006|Overall Study|Withdrawal by Subject|3|||
164326344|NCT03435640|593571510|FG007|Overall Study|Withdrawal by Subject|0|||
164326345|NCT03435640|593571511|FG008|Overall Study|Withdrawal by Subject|0|||
164326346|NCT03435640|593571512|FG009|Overall Study|Withdrawal by Subject|2|||
164326347|NCT03435640|593571513|FG010|Overall Study|Withdrawal by Subject|3|||
164326348|NCT03435640|593571503|FG000|Overall Study|Lost to Follow-up|0|||
164326349|NCT03435640|593571504|FG001|Overall Study|Lost to Follow-up|0|||
164326350|NCT03435640|593571505|FG002|Overall Study|Lost to Follow-up|1|||
164326351|NCT03435640|593571506|FG003|Overall Study|Lost to Follow-up|0|||
164326352|NCT03435640|593571507|FG004|Overall Study|Lost to Follow-up|0|||
164326353|NCT03435640|593571508|FG005|Overall Study|Lost to Follow-up|0|||
164326354|NCT03435640|593571509|FG006|Overall Study|Lost to Follow-up|0|||
164326355|NCT03435640|593571510|FG007|Overall Study|Lost to Follow-up|0|||
164326356|NCT03435640|593571511|FG008|Overall Study|Lost to Follow-up|0|||
164326357|NCT03435640|593571512|FG009|Overall Study|Lost to Follow-up|0|||
164326358|NCT03435640|593571513|FG010|Overall Study|Lost to Follow-up|0|||
164326359|NCT01347307|593571514|FG000|Overall Study|Death|0|||
164326360|NCT01347307|593571515|FG001|Overall Study|Death|4|||
164326361|NCT01347307|593571514|FG000|Overall Study|Physician Decision|0|||
164326362|NCT01347307|593571515|FG001|Overall Study|Physician Decision|1|||
164326363|NCT01483690|593571516|FG000|Overall Study|Adverse Event|1|||
164326364|NCT01483690|593571517|FG001|Overall Study|Adverse Event|2|||
164326365|NCT01483690|593571516|FG000|Overall Study|clinical deterioration|1|||
164326366|NCT01483690|593571517|FG001|Overall Study|clinical deterioration|0|||
164326367|NCT01483690|593571516|FG000|Overall Study|Physician Decision|0|||
164326368|NCT01483690|593571517|FG001|Overall Study|Physician Decision|2|||
164326369|NCT01483690|593571516|FG000|Overall Study|exclusionary procedure|0|||
164326370|NCT01483690|593571517|FG001|Overall Study|exclusionary procedure|1|||
164326371|NCT02239224|593571518|FG000|Overall Study|Administrative|0|||
164565441|NCT02591615|594440363|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
164565442|NCT02591615|594440364|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
164565443|NCT02591615|594440361|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
164565444|NCT02591615|594440362|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
164565445|NCT02591615|594440363|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
164565446|NCT02591615|594440364|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
164565447|NCT02591615|594440361|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
164326372|NCT02239224|593571519|FG001|Overall Study|Administrative|0|||
164326373|NCT02239224|593571520|FG002|Overall Study|Administrative|3|||
164326374|NCT02239224|593571521|FG003|Overall Study|Administrative|1|||
164326375|NCT04565236|593571526|FG000|Overall Study|Patient/Guardian Decision|0|||
164326376|NCT04565236|593571527|FG001|Overall Study|Patient/Guardian Decision|0|||
164326377|NCT04565236|593571528|FG002|Overall Study|Patient/Guardian Decision|1|||
164326378|NCT04565236|593571529|FG003|Overall Study|Patient/Guardian Decision|0|||
164326379|NCT00366340|593571530|FG000|Infant Series|Protocol Violation|3|||
164326380|NCT00366340|593571531|FG001|Infant Series|Protocol Violation|4|||
164326381|NCT00366340|593571530|FG000|Infant Series|Withdrawal by Subject|3|||
164326382|NCT00366340|593571531|FG001|Infant Series|Withdrawal by Subject|3|||
164326383|NCT00366340|593571530|FG000|Infant Series|Adverse Event|0|||
164216479|NCT01471574|593159128|FG002|Treatment Period|Lack of Efficacy|14|||
164216480|NCT01471574|593159129|FG003|Treatment Period|Lack of Efficacy|1|||
164216481|NCT01471574|593159126|FG000|Treatment Period|Adverse Event|7|||
164326384|NCT00366340|593571531|FG001|Infant Series|Adverse Event|2|||
164326385|NCT00366340|593571530|FG000|Infant Series|Lost to Follow-up|1|||
164326386|NCT00366340|593571531|FG001|Infant Series|Lost to Follow-up|1|||
164326387|NCT00366340|593571530|FG000|Infant Series|Failure to return|1|||
164326388|NCT00366340|593571531|FG001|Infant Series|Failure to return|0|||
164326389|NCT00366340|593571530|FG000|After the Infant Series|Parent/legal guardian request|1|||
164326390|NCT00366340|593571531|FG001|After the Infant Series|Parent/legal guardian request|1|||
164326391|NCT00366340|593571530|FG000|After the Infant Series|Failed to return|0|||
164326392|NCT00366340|593571531|FG001|After the Infant Series|Failed to return|1|||
164326393|NCT00366340|593571530|FG000|After the Infant Series|Protocol Violation|2|||
164326394|NCT00366340|593571531|FG001|After the Infant Series|Protocol Violation|2|||
164326395|NCT00366340|593571530|FG000|After the Infant Series|Adverse Event|0|||
164326396|NCT00366340|593571531|FG001|After the Infant Series|Adverse Event|1|||
164326397|NCT00366340|593571530|FG000|After the Infant Series|Lost to Follow-up|0|||
164326398|NCT00366340|593571531|FG001|After the Infant Series|Lost to Follow-up|1|||
164326399|NCT00366340|593571530|FG000|Toddler Dose|Failed to return|1|||
164326400|NCT00366340|593571531|FG001|Toddler Dose|Failed to return|0|||
164326401|NCT00366340|593571530|FG000|Toddler Dose|Parent/legal guardian request|0|||
164326402|NCT00366340|593571531|FG001|Toddler Dose|Parent/legal guardian request|1|||
164326403|NCT00367770|593571532|FG000|Overall Study|Adverse Event|1|||
164326404|NCT00367770|593571532|FG000|Overall Study|Withdrawal by Subject|1|||
164326405|NCT03282565|593571537|FG000|Overall Study|COVID-19 Research Shutdown|0|||
164326406|NCT03282565|593571538|FG001|Overall Study|COVID-19 Research Shutdown|2|||
164326407|NCT03282565|593571539|FG002|Overall Study|COVID-19 Research Shutdown|2|||
164326408|NCT02011893|593571541|FG000|Enrollment to Randomization|Adverse Event|2|||
164326409|NCT02011893|593571542|FG001|Enrollment to Randomization|Adverse Event|0|||
164326410|NCT02011893|593571543|FG002|Enrollment to Randomization|Adverse Event|0|||
164326411|NCT02011893|593571541|FG000|Enrollment to Randomization|Physician Decision|10|||
164326412|NCT02011893|593571542|FG001|Enrollment to Randomization|Physician Decision|0|||
164326413|NCT02011893|593571543|FG002|Enrollment to Randomization|Physician Decision|0|||
164326414|NCT02011893|593571541|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
164326415|NCT02011893|593571542|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
164326416|NCT02011893|593571543|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
164326417|NCT02011893|593571541|FG000|Enrollment to Randomization|Screening Failure|29|||
164326418|NCT02011893|593571542|FG001|Enrollment to Randomization|Screening Failure|0|||
164326419|NCT02011893|593571543|FG002|Enrollment to Randomization|Screening Failure|0|||
164326420|NCT02011893|593571541|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
164326421|NCT02011893|593571542|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
164326422|NCT02011893|593571543|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
164326423|NCT02011893|593571541|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
164326424|NCT02011893|593571542|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
164326425|NCT02011893|593571543|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
164326426|NCT02011893|593571541|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
164326427|NCT02011893|593571542|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
164326428|NCT02011893|593571543|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
164326429|NCT02011893|593571541|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
164326430|NCT02011893|593571542|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
164326431|NCT02011893|593571543|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
164326432|NCT02011893|593571541|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
164326433|NCT02011893|593571542|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
164326434|NCT02011893|593571543|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
164326435|NCT00991952|593571544|FG000|Overall Study|Adverse Event|0|||
164326436|NCT00991952|593571545|FG001|Overall Study|Adverse Event|1|||
164326437|NCT03116347|593571546|FG000|Overall Study|Withdrawal by Subject|1|||
164326438|NCT03116347|593571547|FG001|Overall Study|Withdrawal by Subject|2|||
164326439|NCT01255787|593571548|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
164326440|NCT01255787|593571549|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
164326441|NCT01255787|593571550|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
164326442|NCT01255787|593571551|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
164326443|NCT01255787|593571548|FG000|Overall Study|Major Protocol Deviation|1|||
164326444|NCT01255787|593571549|FG001|Overall Study|Major Protocol Deviation|1|||
164326445|NCT01255787|593571550|FG002|Overall Study|Major Protocol Deviation|0|||
164326446|NCT01255787|593571551|FG003|Overall Study|Major Protocol Deviation|4|||
164326447|NCT01255787|593571548|FG000|Overall Study|Lost to Follow-up|1|||
164326448|NCT01255787|593571549|FG001|Overall Study|Lost to Follow-up|2|||
164326449|NCT01255787|593571550|FG002|Overall Study|Lost to Follow-up|4|||
164326450|NCT01255787|593571551|FG003|Overall Study|Lost to Follow-up|2|||
164326451|NCT01255787|593571548|FG000|Overall Study|Withdrawal of Consent|3|||
164326452|NCT01255787|593571549|FG001|Overall Study|Withdrawal of Consent|9|||
164326453|NCT01255787|593571550|FG002|Overall Study|Withdrawal of Consent|3|||
164326454|NCT01255787|593571551|FG003|Overall Study|Withdrawal of Consent|4|||
164326455|NCT01255787|593571548|FG000|Overall Study|Pregnancy|0|||
164669931|NCT00986245|594816790|FG000|First Intervention|Lack of Efficacy|1|||
164326456|NCT01255787|593571549|FG001|Overall Study|Pregnancy|0|||
164326457|NCT01255787|593571550|FG002|Overall Study|Pregnancy|0|||
164326458|NCT01255787|593571551|FG003|Overall Study|Pregnancy|1|||
164669932|NCT00986245|594816791|FG001|First Intervention|Lack of Efficacy|2|||
164669933|NCT00986245|594816790|FG000|First Intervention|Withdrawal by Subject|0|||
164669934|NCT00986245|594816791|FG001|First Intervention|Withdrawal by Subject|1|||
164669935|NCT00986245|594816790|FG000|First Intervention|Protocol Violation|0|||
164669936|NCT00986245|594816791|FG001|First Intervention|Protocol Violation|1|||
164326459|NCT01255787|593571548|FG000|Overall Study|Lack of Efficacy|2|||
164326460|NCT01255787|593571549|FG001|Overall Study|Lack of Efficacy|2|||
164326461|NCT01255787|593571550|FG002|Overall Study|Lack of Efficacy|2|||
164326462|NCT01255787|593571551|FG003|Overall Study|Lack of Efficacy|2|||
164326463|NCT01255787|593571548|FG000|Overall Study|Noncompliance with Study Drug|3|||
164326464|NCT01255787|593571549|FG001|Overall Study|Noncompliance with Study Drug|1|||
164326465|NCT01255787|593571550|FG002|Overall Study|Noncompliance with Study Drug|0|||
164326466|NCT01255787|593571551|FG003|Overall Study|Noncompliance with Study Drug|0|||
164326467|NCT04966741|593571552|FG000|Overall Study|Lost to Follow-up|1|||
164326468|NCT04966741|593571553|FG001|Overall Study|Lost to Follow-up|0|||
164326469|NCT05764265|593571556|FG000|Overall Study|Adverse Event|1|||
164326470|NCT05764265|593571557|FG001|Overall Study|Adverse Event|0|||
164326471|NCT05764265|593571556|FG000|Overall Study|Physician Decision|1|||
164326472|NCT05764265|593571557|FG001|Overall Study|Physician Decision|8|||
164326473|NCT05764265|593571556|FG000|Overall Study|Study Terminated By Sponsor|20|||
164326474|NCT05764265|593571557|FG001|Overall Study|Study Terminated By Sponsor|0|||
164326475|NCT05764265|593571556|FG000|Overall Study|Participant Decision|1|||
164326476|NCT05764265|593571557|FG001|Overall Study|Participant Decision|0|||
164326477|NCT00509262|593571558|FG000|Overall Study|Adverse Event|16|||
164326478|NCT00509262|593571559|FG001|Overall Study|Adverse Event|18|||
164326479|NCT00509262|593571558|FG000|Overall Study|Other|2|||
164326480|NCT00509262|593571559|FG001|Overall Study|Other|2|||
164326481|NCT00509262|593571558|FG000|Overall Study|Lack of Efficacy|1|||
164326482|NCT00509262|593571559|FG001|Overall Study|Lack of Efficacy|0|||
164326483|NCT00509262|593571558|FG000|Overall Study|Lost to Follow-up|1|||
164326484|NCT00509262|593571559|FG001|Overall Study|Lost to Follow-up|6|||
164326485|NCT00509262|593571558|FG000|Overall Study|Physician Decision|1|||
164326486|NCT00509262|593571559|FG001|Overall Study|Physician Decision|3|||
164326487|NCT00509262|593571558|FG000|Overall Study|Protocol Violation|2|||
164326488|NCT00509262|593571559|FG001|Overall Study|Protocol Violation|2|||
164326489|NCT00509262|593571558|FG000|Overall Study|Withdrawal by Subject|24|||
164326490|NCT00509262|593571559|FG001|Overall Study|Withdrawal by Subject|11|||
164326491|NCT00725842|593571560|FG000|Overall Study|Lost to Follow-up|19|||
164326492|NCT00725842|593571560|FG000|Overall Study|Death|1|||
164326493|NCT00725842|593571560|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
164326494|NCT00725842|593571560|FG000|Overall Study|Consent date prior to study start date|5|||
164326495|NCT00725842|593571560|FG000|Overall Study|Inclusion criterion not met|1|||
164326496|NCT00725842|593571560|FG000|Overall Study|No Visit 1 data|1|||
164326497|NCT02009384|593571564|FG000|Overall Study|Death|2|||
164326498|NCT01075191|593571565|FG000|Overall Study|Death|1|||
164326499|NCT01075191|593571565|FG000|Overall Study|Intensification|3|||
164326500|NCT01075191|593571565|FG000|Overall Study|Co-morbidities|1|||
164326501|NCT01075191|593571565|FG000|Overall Study|Adverse Event|4|||
164326502|NCT01075191|593571565|FG000|Overall Study|Noncompliance|3|||
164326503|NCT01075191|593571565|FG000|Overall Study|Therapy Break|3|||
164326504|NCT01075191|593571565|FG000|Overall Study|Patient's Wish|2|||
164326505|NCT01075191|593571565|FG000|Overall Study|Unknown Reasons|1|||
164326506|NCT01244490|593571570|FG000|Overall Study|Lack of Efficacy|14|||
164326507|NCT01244490|593571571|FG001|Overall Study|Lack of Efficacy|5|||
164326508|NCT01244490|593571572|FG002|Overall Study|Lack of Efficacy|5|||
164326509|NCT01244490|593571570|FG000|Overall Study|Withdrawal by Subject|4|||
164326510|NCT01244490|593571571|FG001|Overall Study|Withdrawal by Subject|4|||
164326511|NCT01244490|593571572|FG002|Overall Study|Withdrawal by Subject|9|||
164326512|NCT01244490|593571570|FG000|Overall Study|Adverse Event|1|||
164326513|NCT01244490|593571571|FG001|Overall Study|Adverse Event|9|||
164326514|NCT01244490|593571572|FG002|Overall Study|Adverse Event|5|||
164326515|NCT01244490|593571570|FG000|Overall Study|Lost to Follow-up|0|||
164326516|NCT01244490|593571571|FG001|Overall Study|Lost to Follow-up|6|||
164326517|NCT01244490|593571572|FG002|Overall Study|Lost to Follow-up|3|||
164326518|NCT01244490|593571570|FG000|Overall Study|Other|0|||
164326519|NCT01244490|593571571|FG001|Overall Study|Other|0|||
164326520|NCT01244490|593571572|FG002|Overall Study|Other|1|||
164326521|NCT02414139|593571577|FG000|Treatment Period|Adverse Event|11|||
164326522|NCT02414139|593571578|FG001|Treatment Period|Adverse Event|6|||
164326523|NCT02414139|593571579|FG002|Treatment Period|Adverse Event|8|||
164326524|NCT02414139|593571580|FG003|Treatment Period|Adverse Event|5|||
164326525|NCT02414139|593571581|FG004|Treatment Period|Adverse Event|14|||
164326526|NCT02414139|593571582|FG005|Treatment Period|Adverse Event|3|||
164326527|NCT02414139|593571583|FG006|Treatment Period|Adverse Event|6|||
164326528|NCT02414139|593571584|FG007|Treatment Period|Adverse Event|1|||
164669937|NCT00986245|594816790|FG000|First Intervention|Out of indication|1|||
164326529|NCT02414139|593571585|FG008|Treatment Period|Adverse Event|6|||
164326530|NCT02414139|593571586|FG009|Treatment Period|Adverse Event|8|||
164326531|NCT02414139|593571577|FG000|Treatment Period|Death|0|||
164326532|NCT02414139|593571578|FG001|Treatment Period|Death|0|||
164326533|NCT02414139|593571579|FG002|Treatment Period|Death|1|||
164326534|NCT02414139|593571580|FG003|Treatment Period|Death|1|||
164326535|NCT02414139|593571581|FG004|Treatment Period|Death|0|||
164326536|NCT02414139|593571582|FG005|Treatment Period|Death|0|||
164326537|NCT02414139|593571583|FG006|Treatment Period|Death|0|||
164326538|NCT02414139|593571584|FG007|Treatment Period|Death|0|||
164326539|NCT02414139|593571585|FG008|Treatment Period|Death|0|||
164326540|NCT02414139|593571586|FG009|Treatment Period|Death|1|||
164326541|NCT02414139|593571577|FG000|Treatment Period|Physician Decision|5|||
164326542|NCT02414139|593571578|FG001|Treatment Period|Physician Decision|4|||
164326543|NCT02414139|593571579|FG002|Treatment Period|Physician Decision|6|||
164326544|NCT02414139|593571580|FG003|Treatment Period|Physician Decision|1|||
164326545|NCT02414139|593571581|FG004|Treatment Period|Physician Decision|4|||
164326546|NCT02414139|593571582|FG005|Treatment Period|Physician Decision|0|||
164326547|NCT02414139|593571583|FG006|Treatment Period|Physician Decision|2|||
164326548|NCT02414139|593571584|FG007|Treatment Period|Physician Decision|0|||
164326549|NCT02414139|593571585|FG008|Treatment Period|Physician Decision|1|||
164326550|NCT02414139|593571586|FG009|Treatment Period|Physician Decision|4|||
164326551|NCT02414139|593571577|FG000|Treatment Period|Progressive disease|48|||
164326552|NCT02414139|593571578|FG001|Treatment Period|Progressive disease|31|||
164326553|NCT02414139|593571579|FG002|Treatment Period|Progressive disease|37|||
164326554|NCT02414139|593571580|FG003|Treatment Period|Progressive disease|21|||
164326555|NCT02414139|593571581|FG004|Treatment Period|Progressive disease|43|||
164326556|NCT02414139|593571582|FG005|Treatment Period|Progressive disease|12|||
164326557|NCT02414139|593571583|FG006|Treatment Period|Progressive disease|16|||
164326558|NCT02414139|593571584|FG007|Treatment Period|Progressive disease|2|||
164326559|NCT02414139|593571585|FG008|Treatment Period|Progressive disease|20|||
164326560|NCT02414139|593571586|FG009|Treatment Period|Progressive disease|14|||
164326561|NCT02414139|593571577|FG000|Treatment Period|Protocol deviation|0|||
164326562|NCT02414139|593571578|FG001|Treatment Period|Protocol deviation|0|||
164326563|NCT02414139|593571579|FG002|Treatment Period|Protocol deviation|1|||
164326564|NCT02414139|593571580|FG003|Treatment Period|Protocol deviation|0|||
164326565|NCT02414139|593571581|FG004|Treatment Period|Protocol deviation|0|||
164326566|NCT02414139|593571582|FG005|Treatment Period|Protocol deviation|0|||
164326567|NCT02414139|593571583|FG006|Treatment Period|Protocol deviation|0|||
164326568|NCT02414139|593571584|FG007|Treatment Period|Protocol deviation|0|||
164326569|NCT02414139|593571585|FG008|Treatment Period|Protocol deviation|0|||
164326570|NCT02414139|593571586|FG009|Treatment Period|Protocol deviation|0|||
164326571|NCT02414139|593571577|FG000|Treatment Period|Subject/Guardian decision|5|||
164326572|NCT02414139|593571578|FG001|Treatment Period|Subject/Guardian decision|1|||
164326573|NCT02414139|593571579|FG002|Treatment Period|Subject/Guardian decision|1|||
164326574|NCT02414139|593571580|FG003|Treatment Period|Subject/Guardian decision|2|||
164326575|NCT02414139|593571581|FG004|Treatment Period|Subject/Guardian decision|5|||
164326576|NCT02414139|593571582|FG005|Treatment Period|Subject/Guardian decision|0|||
164326577|NCT02414139|593571583|FG006|Treatment Period|Subject/Guardian decision|2|||
164326578|NCT02414139|593571584|FG007|Treatment Period|Subject/Guardian decision|0|||
164326579|NCT02414139|593571585|FG008|Treatment Period|Subject/Guardian decision|1|||
164326580|NCT02414139|593571586|FG009|Treatment Period|Subject/Guardian decision|1|||
164326581|NCT02414139|593571577|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
164326582|NCT02414139|593571578|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
164326583|NCT02414139|593571579|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
164326584|NCT02414139|593571580|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
164326585|NCT02414139|593571581|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
164326586|NCT02414139|593571582|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
164326587|NCT02414139|593571583|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
164326588|NCT02414139|593571584|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
164326589|NCT02414139|593571585|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
164326590|NCT02414139|593571586|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
164326591|NCT02414139|593571577|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
164326592|NCT02414139|593571578|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
164326593|NCT02414139|593571579|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
164326594|NCT02414139|593571580|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
164326595|NCT02414139|593571581|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
164326596|NCT02414139|593571582|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
164326597|NCT02414139|593571583|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
164326598|NCT02414139|593571584|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
164326599|NCT02414139|593571585|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
164326600|NCT02414139|593571586|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
164216482|NCT01471574|593159127|FG001|Treatment Period|Adverse Event|3|||
164216483|NCT01471574|593159128|FG002|Treatment Period|Adverse Event|6|||
164216484|NCT01471574|593159129|FG003|Treatment Period|Adverse Event|1|||
164216485|NCT01471574|593159126|FG000|Treatment Period|Withdrawal by Subject|5|||
164216486|NCT01471574|593159127|FG001|Treatment Period|Withdrawal by Subject|1|||
164216487|NCT01471574|593159128|FG002|Treatment Period|Withdrawal by Subject|1|||
164216488|NCT01471574|593159129|FG003|Treatment Period|Withdrawal by Subject|0|||
164216489|NCT01471574|593159126|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
164216490|NCT01471574|593159127|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
164216491|NCT01471574|593159128|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
164216492|NCT01471574|593159129|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
164216493|NCT01471574|593159126|FG000|Treatment Period|Lost to Follow-up|1|||
164216494|NCT01471574|593159127|FG001|Treatment Period|Lost to Follow-up|2|||
164216495|NCT01471574|593159128|FG002|Treatment Period|Lost to Follow-up|2|||
164216496|NCT01471574|593159129|FG003|Treatment Period|Lost to Follow-up|0|||
164216497|NCT01471574|593159126|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
164216498|NCT01471574|593159127|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
164216499|NCT01471574|593159128|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
164216500|NCT01471574|593159129|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
164216501|NCT01471574|593159126|FG000|Treatment Period|Other|1|||
164216502|NCT01471574|593159127|FG001|Treatment Period|Other|0|||
164216503|NCT01471574|593159128|FG002|Treatment Period|Other|0|||
164216504|NCT01471574|593159129|FG003|Treatment Period|Other|0|||
164216505|NCT01471574|593159126|FG000|Follow-up Period|Withdrawal by Subject|3|||
164216506|NCT01471574|593159127|FG001|Follow-up Period|Withdrawal by Subject|0|||
164216507|NCT01471574|593159128|FG002|Follow-up Period|Withdrawal by Subject|3|||
164216508|NCT01471574|593159129|FG003|Follow-up Period|Withdrawal by Subject|1|||
164216509|NCT01471574|593159126|FG000|Follow-up Period|Lost to Follow-up|4|||
164216510|NCT01471574|593159127|FG001|Follow-up Period|Lost to Follow-up|1|||
164216511|NCT01471574|593159128|FG002|Follow-up Period|Lost to Follow-up|3|||
164216512|NCT01471574|593159129|FG003|Follow-up Period|Lost to Follow-up|2|||
164216513|NCT01471574|593159126|FG000|Follow-up Period|Death|0|||
164216514|NCT01471574|593159127|FG001|Follow-up Period|Death|0|||
164216515|NCT01471574|593159128|FG002|Follow-up Period|Death|1|||
164216516|NCT01471574|593159129|FG003|Follow-up Period|Death|0|||
164216517|NCT01471574|593159126|FG000|Follow-up Period|Follow-up no longer required|0|||
164216518|NCT01471574|593159127|FG001|Follow-up Period|Follow-up no longer required|1|||
164216519|NCT01471574|593159128|FG002|Follow-up Period|Follow-up no longer required|0|||
164216520|NCT01471574|593159129|FG003|Follow-up Period|Follow-up no longer required|0|||
164216521|NCT01795937|593159130|FG000|Overall Study|Withdrawal by Subject|1|||
164216522|NCT01795937|593159131|FG001|Overall Study|Withdrawal by Subject|0|||
164216523|NCT01795937|593159132|FG002|Overall Study|Withdrawal by Subject|0|||
164216524|NCT01795937|593159130|FG000|Overall Study|Physician Decision|0|||
164216525|NCT01795937|593159131|FG001|Overall Study|Physician Decision|1|||
164216526|NCT01795937|593159132|FG002|Overall Study|Physician Decision|0|||
164216527|NCT01137812|593159133|FG000|Overall Study|Adverse Event|21|||
164216528|NCT01137812|593159134|FG001|Overall Study|Adverse Event|14|||
164216529|NCT01137812|593159133|FG000|Overall Study|Lost to Follow-up|6|||
164216530|NCT01137812|593159134|FG001|Overall Study|Lost to Follow-up|8|||
164216531|NCT01137812|593159133|FG000|Overall Study|Physician Decision|25|||
164216532|NCT01137812|593159134|FG001|Overall Study|Physician Decision|17|||
164216533|NCT01137812|593159133|FG000|Overall Study|Protocol Violation|5|||
164216534|NCT01137812|593159134|FG001|Overall Study|Protocol Violation|4|||
164216535|NCT01137812|593159133|FG000|Overall Study|Withdrawal by Subject|5|||
164216536|NCT01137812|593159134|FG001|Overall Study|Withdrawal by Subject|13|||
164216537|NCT01137812|593159133|FG000|Overall Study|Death|2|||
164216538|NCT01137812|593159134|FG001|Overall Study|Death|0|||
164216539|NCT01137812|593159133|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
164216540|NCT01137812|593159134|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
164216541|NCT01137812|593159133|FG000|Overall Study|Other|19|||
164216542|NCT01137812|593159134|FG001|Overall Study|Other|27|||
164216543|NCT03927157|593159138|FG000|Overall Study|Adverse Event|1|||
164216544|NCT03927157|593159139|FG001|Overall Study|Adverse Event|3|||
164216545|NCT03927157|593159138|FG000|Overall Study|Protocol Violation|1|||
164216546|NCT03927157|593159139|FG001|Overall Study|Protocol Violation|2|||
164216547|NCT03927157|593159138|FG000|Overall Study|Withdrawal by Subject|8|||
164216548|NCT03927157|593159139|FG001|Overall Study|Withdrawal by Subject|21|||
164216549|NCT03927157|593159138|FG000|Overall Study|Due to COVID-19 pandemic|5|||
164216550|NCT03927157|593159139|FG001|Overall Study|Due to COVID-19 pandemic|2|||
164216551|NCT03927157|593159138|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
164216552|NCT03927157|593159139|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
164326601|NCT02414139|593571577|FG000|Post-treatment Efficacy Follow-up|Death|0|||
164326602|NCT02414139|593571578|FG001|Post-treatment Efficacy Follow-up|Death|1|||
164326603|NCT02414139|593571579|FG002|Post-treatment Efficacy Follow-up|Death|0|||
164326604|NCT02414139|593571580|FG003|Post-treatment Efficacy Follow-up|Death|0|||
164326605|NCT02414139|593571581|FG004|Post-treatment Efficacy Follow-up|Death|1|||
164326606|NCT02414139|593571582|FG005|Post-treatment Efficacy Follow-up|Death|0|||
164326607|NCT02414139|593571583|FG006|Post-treatment Efficacy Follow-up|Death|0|||
164326608|NCT02414139|593571584|FG007|Post-treatment Efficacy Follow-up|Death|0|||
164326609|NCT02414139|593571585|FG008|Post-treatment Efficacy Follow-up|Death|0|||
164326610|NCT02414139|593571586|FG009|Post-treatment Efficacy Follow-up|Death|1|||
164326611|NCT02414139|593571577|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
164326612|NCT02414139|593571578|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
164326613|NCT02414139|593571579|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
164326614|NCT02414139|593571580|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
164326615|NCT02414139|593571581|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
164326616|NCT02414139|593571582|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
164326617|NCT02414139|593571583|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
164326618|NCT02414139|593571584|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
164326619|NCT02414139|593571585|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
164326620|NCT02414139|593571586|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
164326621|NCT02414139|593571577|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
164326622|NCT02414139|593571578|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
164326623|NCT02414139|593571579|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
164326624|NCT02414139|593571580|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
164326625|NCT02414139|593571581|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
164326626|NCT02414139|593571582|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
164326627|NCT02414139|593571583|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
164326628|NCT02414139|593571584|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
164326629|NCT02414139|593571585|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
164326630|NCT02414139|593571586|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
164326631|NCT02414139|593571577|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
164326632|NCT02414139|593571578|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
164326633|NCT02414139|593571579|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
164326634|NCT02414139|593571580|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
164326635|NCT02414139|593571581|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
164326636|NCT02414139|593571582|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
164326637|NCT02414139|593571583|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
164326638|NCT02414139|593571584|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
164326639|NCT02414139|593571585|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
164326640|NCT02414139|593571586|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
164326641|NCT02414139|593571577|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
164326642|NCT02414139|593571578|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
164326643|NCT02414139|593571579|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
164326644|NCT02414139|593571580|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
164326645|NCT02414139|593571581|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
164326646|NCT02414139|593571582|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
164326647|NCT02414139|593571583|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
164326648|NCT02414139|593571584|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
164326649|NCT02414139|593571585|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
164565448|NCT02591615|594440362|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
164565449|NCT02591615|594440363|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
164565450|NCT02591615|594440364|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
164565451|NCT02591615|594440361|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
164565452|NCT02591615|594440362|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
164565453|NCT02591615|594440363|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
164565454|NCT02591615|594440364|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
164565455|NCT02591615|594440361|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
164565456|NCT02591615|594440362|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
164565457|NCT02591615|594440363|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
164565458|NCT02591615|594440364|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
164565459|NCT02591615|594440361|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
164565460|NCT02591615|594440362|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
164565461|NCT02591615|594440363|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
164565462|NCT02591615|594440364|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
164669938|NCT00986245|594816791|FG001|First Intervention|Out of indication|0|||
164669939|NCT00986245|594816790|FG000|Second Intervention|Poor compliance|1|||
164669940|NCT00986245|594816791|FG001|Second Intervention|Poor compliance|0|||
164216553|NCT03927157|593159138|FG000|Overall Study|Other than above|0|||
164216554|NCT03927157|593159139|FG001|Overall Study|Other than above|1|||
164216555|NCT02965716|593159140|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
164216556|NCT02965716|593159141|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
164216557|NCT02965716|593159140|FG000|Overall Study|Progression/Relapse|8|||
164216558|NCT02965716|593159141|FG001|Overall Study|Progression/Relapse|16|||
164216559|NCT02965716|593159140|FG000|Overall Study|Death|1|||
164216560|NCT02965716|593159141|FG001|Overall Study|Death|0|||
164216561|NCT02965716|593159140|FG000|Overall Study|Not Protocol Specified|1|||
164216562|NCT02965716|593159141|FG001|Overall Study|Not Protocol Specified|3|||
164216563|NCT02265744|593159144|FG000|Overall Study|Poor/Non-compliance|1|||
164216564|NCT02265744|593159145|FG001|Overall Study|Poor/Non-compliance|1|||
164216565|NCT02265744|593159146|FG002|Overall Study|Poor/Non-compliance|0|||
164216566|NCT02265744|593159147|FG003|Overall Study|Poor/Non-compliance|0|||
164216567|NCT02265744|593159148|FG004|Overall Study|Poor/Non-compliance|2|||
164216568|NCT02265744|593159144|FG000|Overall Study|Lost to Follow-up|0|||
164216569|NCT02265744|593159145|FG001|Overall Study|Lost to Follow-up|0|||
164216570|NCT02265744|593159146|FG002|Overall Study|Lost to Follow-up|0|||
164216571|NCT02265744|593159147|FG003|Overall Study|Lost to Follow-up|1|||
164216572|NCT02265744|593159148|FG004|Overall Study|Lost to Follow-up|0|||
164216573|NCT02265744|593159144|FG000|Overall Study|Death|0|||
164216574|NCT02265744|593159145|FG001|Overall Study|Death|0|||
164216575|NCT02265744|593159146|FG002|Overall Study|Death|0|||
164216576|NCT02265744|593159147|FG003|Overall Study|Death|2|||
164216577|NCT02265744|593159148|FG004|Overall Study|Death|0|||
164216578|NCT02265744|593159144|FG000|Overall Study|Withdrawal by Subject|2|||
164216579|NCT02265744|593159145|FG001|Overall Study|Withdrawal by Subject|0|||
164216580|NCT02265744|593159146|FG002|Overall Study|Withdrawal by Subject|0|||
164216581|NCT02265744|593159147|FG003|Overall Study|Withdrawal by Subject|2|||
164216582|NCT02265744|593159148|FG004|Overall Study|Withdrawal by Subject|0|||
164216583|NCT02265744|593159144|FG000|Overall Study|Participant request to discontinue|2|||
164216584|NCT02265744|593159145|FG001|Overall Study|Participant request to discontinue|2|||
164216585|NCT02265744|593159146|FG002|Overall Study|Participant request to discontinue|2|||
164216586|NCT02265744|593159147|FG003|Overall Study|Participant request to discontinue|0|||
164216587|NCT02265744|593159148|FG004|Overall Study|Participant request to discontinue|0|||
164216588|NCT02265744|593159144|FG000|Overall Study|Adverse Event|8|||
164216589|NCT02265744|593159145|FG001|Overall Study|Adverse Event|4|||
164216590|NCT02265744|593159146|FG002|Overall Study|Adverse Event|9|||
164216591|NCT02265744|593159147|FG003|Overall Study|Adverse Event|8|||
164216592|NCT02265744|593159148|FG004|Overall Study|Adverse Event|2|||
164216593|NCT02265744|593159144|FG000|Overall Study|Lack of Efficacy|2|||
164216594|NCT02265744|593159145|FG001|Overall Study|Lack of Efficacy|4|||
164216595|NCT02265744|593159146|FG002|Overall Study|Lack of Efficacy|3|||
164216596|NCT02265744|593159147|FG003|Overall Study|Lack of Efficacy|4|||
164216597|NCT02265744|593159148|FG004|Overall Study|Lack of Efficacy|5|||
164216598|NCT02265744|593159144|FG000|Overall Study|Reason not provided by Investigator|1|||
164216599|NCT02265744|593159145|FG001|Overall Study|Reason not provided by Investigator|0|||
164216600|NCT02265744|593159146|FG002|Overall Study|Reason not provided by Investigator|0|||
164216601|NCT02265744|593159147|FG003|Overall Study|Reason not provided by Investigator|2|||
164216602|NCT02265744|593159148|FG004|Overall Study|Reason not provided by Investigator|0|||
164216603|NCT02265744|593159144|FG000|Overall Study|Administrative reason by sponsor|3|||
164216604|NCT02265744|593159145|FG001|Overall Study|Administrative reason by sponsor|2|||
164216605|NCT02265744|593159146|FG002|Overall Study|Administrative reason by sponsor|2|||
164216606|NCT02265744|593159147|FG003|Overall Study|Administrative reason by sponsor|3|||
164216607|NCT02265744|593159148|FG004|Overall Study|Administrative reason by sponsor|3|||
164216608|NCT02265744|593159144|FG000|Overall Study|Subject no longer meets study criteria|0|||
164216609|NCT02265744|593159145|FG001|Overall Study|Subject no longer meets study criteria|0|||
164216610|NCT02265744|593159146|FG002|Overall Study|Subject no longer meets study criteria|0|||
164216611|NCT02265744|593159147|FG003|Overall Study|Subject no longer meets study criteria|0|||
164216612|NCT02265744|593159148|FG004|Overall Study|Subject no longer meets study criteria|1|||
164326650|NCT02414139|593571586|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
164326651|NCT02414139|593571577|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
164326652|NCT02414139|593571578|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
164326653|NCT02414139|593571579|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
164326654|NCT02414139|593571580|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
164216613|NCT02265744|593159144|FG000|Overall Study|Pregnancy|1|||
164216614|NCT02265744|593159145|FG001|Overall Study|Pregnancy|2|||
164216615|NCT02265744|593159146|FG002|Overall Study|Pregnancy|1|||
164216616|NCT02265744|593159147|FG003|Overall Study|Pregnancy|1|||
164216617|NCT02265744|593159148|FG004|Overall Study|Pregnancy|0|||
164216618|NCT00923702|593159149|FG000|Overall Study|Ongoing enrollment|0|||
164216619|NCT00923702|593159150|FG001|Overall Study|Ongoing enrollment|0|||
164216620|NCT00923702|593159151|FG002|Overall Study|Ongoing enrollment|0|||
164216621|NCT00923702|593159152|FG003|Overall Study|Ongoing enrollment|0|||
164216622|NCT00923702|593159153|FG004|Overall Study|Ongoing enrollment|354|||
164216623|NCT05950906|593159157|FG000|Overall Study|Adverse Event|0|||
164326655|NCT02414139|593571581|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
164326656|NCT02414139|593571582|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
164326657|NCT02414139|593571583|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
164326658|NCT02414139|593571584|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
164326659|NCT02414139|593571585|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
164326660|NCT02414139|593571586|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
164326661|NCT01226121|593571587|FG000|Overall Study|Lost to Follow-up|2|||
164326662|NCT01226121|593571588|FG001|Overall Study|Lost to Follow-up|0|||
164326663|NCT01226121|593571589|FG002|Overall Study|Lost to Follow-up|1|||
164326664|NCT03324581|593571590|FG000|Overall Study|Adverse Event|18|||
164326665|NCT03324581|593571591|FG001|Overall Study|Adverse Event|11|||
164326666|NCT03324581|593571592|FG002|Overall Study|Adverse Event|7|||
164326667|NCT03324581|593571590|FG000|Overall Study|Lack of Efficacy|0|||
164326668|NCT03324581|593571591|FG001|Overall Study|Lack of Efficacy|1|||
164326669|NCT03324581|593571592|FG002|Overall Study|Lack of Efficacy|0|||
164326670|NCT03324581|593571590|FG000|Overall Study|Lost to Follow-up|5|||
164326671|NCT03324581|593571591|FG001|Overall Study|Lost to Follow-up|3|||
164326672|NCT03324581|593571592|FG002|Overall Study|Lost to Follow-up|6|||
164326673|NCT03324581|593571590|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
164326674|NCT03324581|593571591|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
164326675|NCT03324581|593571592|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
164565463|NCT02591615|594440361|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
164565464|NCT02591615|594440362|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
164565465|NCT02591615|594440363|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
164565466|NCT02591615|594440364|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
164565467|NCT02591615|594440361|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
164565468|NCT02591615|594440362|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
164565469|NCT02591615|594440363|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
164565470|NCT02591615|594440364|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
164565471|NCT02591615|594440361|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
164565472|NCT02591615|594440362|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
164565473|NCT02591615|594440363|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
164565474|NCT02591615|594440364|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
164565475|NCT02591615|594440361|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
164565476|NCT02591615|594440362|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
164565477|NCT02591615|594440363|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
164565478|NCT02591615|594440364|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
164565479|NCT02591615|594440361|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
164565480|NCT02591615|594440362|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
164565481|NCT02591615|594440363|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
164565482|NCT02591615|594440364|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
164565483|NCT02591615|594440361|FG000|Maintenance MK-3475|Adverse Event|0|||
164565484|NCT02591615|594440362|FG001|Maintenance MK-3475|Adverse Event|3|||
164565485|NCT02591615|594440363|FG002|Maintenance MK-3475|Adverse Event|1|||
164565486|NCT02591615|594440364|FG003|Maintenance MK-3475|Adverse Event|2|||
164565487|NCT02591615|594440361|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
164565488|NCT02591615|594440362|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
164565489|NCT02591615|594440363|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
164565490|NCT02591615|594440364|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
164565491|NCT02591615|594440361|FG000|Maintenance MK-3475|Death|0|||
164565492|NCT02591615|594440362|FG001|Maintenance MK-3475|Death|1|||
164565493|NCT02591615|594440363|FG002|Maintenance MK-3475|Death|1|||
164565494|NCT02591615|594440364|FG003|Maintenance MK-3475|Death|0|||
164565495|NCT02591615|594440361|FG000|Maintenance MK-3475|Physician discretion|0|||
164565496|NCT02591615|594440362|FG001|Maintenance MK-3475|Physician discretion|0|||
164565497|NCT02591615|594440363|FG002|Maintenance MK-3475|Physician discretion|1|||
164565498|NCT02591615|594440364|FG003|Maintenance MK-3475|Physician discretion|0|||
164565499|NCT02591615|594440361|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
164565500|NCT02591615|594440362|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
164565501|NCT02591615|594440363|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
164565502|NCT02591615|594440364|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
164565503|NCT02591615|594440361|FG000|Maintenance MK-3475|In active treatment|2|||
164565504|NCT02591615|594440362|FG001|Maintenance MK-3475|In active treatment|0|||
164565505|NCT02591615|594440363|FG002|Maintenance MK-3475|In active treatment|0|||
164326676|NCT03324581|593571590|FG000|Overall Study|Physician Decision|0|||
164565506|NCT02591615|594440364|FG003|Maintenance MK-3475|In active treatment|1|||
164565507|NCT04047797|594440365|FG000|Overall Study|Progressive Disease|1|||
164565508|NCT01430442|594440366|FG000|Overall Study|Subject Withdrew Consent|3|||
164326677|NCT03324581|593571591|FG001|Overall Study|Physician Decision|1|||
164565509|NCT01430442|594440367|FG001|Overall Study|Subject Withdrew Consent|0|||
164565510|NCT01430442|594440368|FG002|Overall Study|Subject Withdrew Consent|1|||
164565511|NCT01430442|594440369|FG003|Overall Study|Subject Withdrew Consent|0|||
164216624|NCT05950906|593159158|FG001|Overall Study|Adverse Event|0|||
164216625|NCT05950906|593159159|FG002|Overall Study|Adverse Event|0|||
164216626|NCT05950906|593159160|FG003|Overall Study|Adverse Event|0|||
164216627|NCT05950906|593159161|FG004|Overall Study|Adverse Event|0|||
164216628|NCT05950906|593159162|FG005|Overall Study|Adverse Event|0|||
164216629|NCT05950906|593159163|FG006|Overall Study|Adverse Event|0|||
164216630|NCT05950906|593159164|FG007|Overall Study|Adverse Event|0|||
164216631|NCT05950906|593159165|FG008|Overall Study|Adverse Event|0|||
164216632|NCT05950906|593159166|FG009|Overall Study|Adverse Event|0|||
164216633|NCT05950906|593159167|FG010|Overall Study|Adverse Event|0|||
164216634|NCT05950906|593159168|FG011|Overall Study|Adverse Event|0|||
164216635|NCT05950906|593159169|FG012|Overall Study|Adverse Event|1|||
164216636|NCT05950906|593159170|FG013|Overall Study|Adverse Event|0|||
164216637|NCT05950906|593159157|FG000|Overall Study|Physician Decision|0|||
164216638|NCT05950906|593159158|FG001|Overall Study|Physician Decision|0|||
164216639|NCT05950906|593159159|FG002|Overall Study|Physician Decision|0|||
164216640|NCT05950906|593159160|FG003|Overall Study|Physician Decision|0|||
164216641|NCT05950906|593159161|FG004|Overall Study|Physician Decision|0|||
164216642|NCT05950906|593159162|FG005|Overall Study|Physician Decision|0|||
164216643|NCT05950906|593159163|FG006|Overall Study|Physician Decision|0|||
164216644|NCT05950906|593159164|FG007|Overall Study|Physician Decision|0|||
164216645|NCT05950906|593159165|FG008|Overall Study|Physician Decision|0|||
164216646|NCT05950906|593159166|FG009|Overall Study|Physician Decision|0|||
164216647|NCT05950906|593159167|FG010|Overall Study|Physician Decision|0|||
164216648|NCT05950906|593159168|FG011|Overall Study|Physician Decision|0|||
164216649|NCT05950906|593159169|FG012|Overall Study|Physician Decision|1|||
164216650|NCT05950906|593159170|FG013|Overall Study|Physician Decision|0|||
164216651|NCT02448043|593159171|FG000|Overall Study|Withdrawal by Subject|2|||
164216652|NCT02448043|593159172|FG001|Overall Study|Withdrawal by Subject|2|||
164216653|NCT02448043|593159171|FG000|Overall Study|Protocol Violation|1|||
164216654|NCT02448043|593159172|FG001|Overall Study|Protocol Violation|2|||
164216655|NCT03325439|593159175|FG000|Overall Study|Ineligibility|3|||
164216656|NCT02315625|593159178|FG000|First Intervention|Disease Progression|1|||
164216657|NCT02315625|593159179|FG001|First Intervention|Disease Progression|0|||
164216658|NCT02315625|593159178|FG000|Second Intervention|Physician Decision|2|||
164216659|NCT02315625|593159179|FG001|Second Intervention|Physician Decision|1|||
164216660|NCT02315625|593159178|FG000|Second Intervention|Study closure|1|||
164216661|NCT02315625|593159179|FG001|Second Intervention|Study closure|0|||
164216662|NCT02315625|593159178|FG000|Second Intervention|Disease Progression|1|||
164216663|NCT02315625|593159179|FG001|Second Intervention|Disease Progression|0|||
164216664|NCT06132386|593159182|FG000|Overall Study|ineligble laboratory|1|||
164216665|NCT06132386|593159183|FG001|Overall Study|ineligble laboratory|0|||
164216666|NCT06132386|593159184|FG002|Overall Study|ineligble laboratory|0|||
164216667|NCT06132386|593159185|FG003|Overall Study|ineligble laboratory|0|||
164216668|NCT06132386|593159186|FG004|Overall Study|ineligble laboratory|1|||
164216669|NCT06132386|593159187|FG005|Overall Study|ineligble laboratory|0|||
164216670|NCT06132386|593159182|FG000|Overall Study|ineligible vital signs|0|||
164216671|NCT06132386|593159183|FG001|Overall Study|ineligible vital signs|1|||
164216672|NCT06132386|593159184|FG002|Overall Study|ineligible vital signs|0|||
164216673|NCT06132386|593159185|FG003|Overall Study|ineligible vital signs|0|||
164326678|NCT03324581|593571592|FG002|Overall Study|Physician Decision|2|||
164216674|NCT06132386|593159186|FG004|Overall Study|ineligible vital signs|0|||
164216675|NCT06132386|593159187|FG005|Overall Study|ineligible vital signs|0|||
164216676|NCT03514017|593159192|FG000|Overall Study|Death|1|||
164216677|NCT03514017|593159192|FG000|Overall Study|Adverse Event|1|||
164216678|NCT03971422|593160422|FG000|Overall Study|Lost to Follow-up|0|||
164216679|NCT03971422|593160423|FG001|Overall Study|Lost to Follow-up|1|||
164216680|NCT03971422|593160424|FG002|Overall Study|Lost to Follow-up|0|||
164216681|NCT03971422|593160422|FG000|Overall Study|Lack of Efficacy|5|||
164216682|NCT03971422|593160423|FG001|Overall Study|Lack of Efficacy|1|||
164216683|NCT03971422|593160424|FG002|Overall Study|Lack of Efficacy|1|||
164216684|NCT03971422|593160422|FG000|Overall Study|Adverse event, not fatal|2|||
164216685|NCT03971422|593160423|FG001|Overall Study|Adverse event, not fatal|2|||
164216686|NCT03971422|593160424|FG002|Overall Study|Adverse event, not fatal|5|||
164216687|NCT03971422|593160422|FG000|Overall Study|Worsening of MG Symptoms|1|||
164216688|NCT03971422|593160423|FG001|Overall Study|Worsening of MG Symptoms|4|||
164216689|NCT03971422|593160424|FG002|Overall Study|Worsening of MG Symptoms|2|||
164216690|NCT03971422|593160422|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
164565512|NCT01430442|594440370|FG004|Overall Study|Subject Withdrew Consent|2|||
164216691|NCT03971422|593160423|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
164216692|NCT03971422|593160424|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
164216693|NCT03971422|593160422|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
164216694|NCT03971422|593160423|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
164216695|NCT03971422|593160424|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
164216696|NCT03971422|593160422|FG000|Overall Study|Due to COVID-19 pandemic|0|||
164216697|NCT03971422|593160423|FG001|Overall Study|Due to COVID-19 pandemic|1|||
164216698|NCT03971422|593160424|FG002|Overall Study|Due to COVID-19 pandemic|1|||
164216699|NCT04575324|593160427|FG000|Overall Study|Lost to Follow-up|29|||
164216700|NCT04575324|593160428|FG001|Overall Study|Lost to Follow-up|25|||
164216701|NCT04575324|593160427|FG000|Overall Study|Death|1|||
164216702|NCT04575324|593160428|FG001|Overall Study|Death|2|||
164216703|NCT04575324|593160427|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
164216704|NCT04575324|593160428|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
164216705|NCT01105130|593160429|FG000|Overall Study|Withdrawal by Subject|4|||
164216706|NCT01105130|593160430|FG001|Overall Study|Withdrawal by Subject|6|||
164216707|NCT01105130|593160431|FG002|Overall Study|Withdrawal by Subject|2|||
164216708|NCT01105130|593160429|FG000|Overall Study|Never Started|2|||
164216709|NCT01105130|593160430|FG001|Overall Study|Never Started|2|||
164216710|NCT01105130|593160431|FG002|Overall Study|Never Started|4|||
164216711|NCT01105130|593160429|FG000|Overall Study|Toxicity|1|||
164216712|NCT01105130|593160430|FG001|Overall Study|Toxicity|3|||
164216713|NCT01105130|593160431|FG002|Overall Study|Toxicity|2|||
164216714|NCT01105130|593160429|FG000|Overall Study|Multiple Reasons|3|||
164216715|NCT01105130|593160430|FG001|Overall Study|Multiple Reasons|0|||
164216716|NCT01105130|593160431|FG002|Overall Study|Multiple Reasons|2|||
164216717|NCT01028053|593160439|FG000|Overall Study|Screen Failure|113|||
164216718|NCT01028053|593160439|FG000|Overall Study|Patient Request|11|||
164216719|NCT01028053|593160439|FG000|Overall Study|Protocol Violation|1|||
164216720|NCT01028053|593160439|FG000|Overall Study|Physician Decision|2|||
164216721|NCT01028053|593160439|FG000|Overall Study|Technical Problem|1|||
164216722|NCT01028053|593160439|FG000|Overall Study|Terminated by Sponsor|1|||
164216723|NCT01028053|593160439|FG000|Overall Study|Various reasons|4|||
164216724|NCT01177410|593160440|FG000|Overall Study|Adverse Event|0|||
164216725|NCT01177410|593160441|FG001|Overall Study|Adverse Event|2|||
164216726|NCT01177410|593160442|FG002|Overall Study|Adverse Event|2|||
164216727|NCT01177410|593160440|FG000|Overall Study|Withdrawal by Subject|1|||
164216728|NCT01177410|593160441|FG001|Overall Study|Withdrawal by Subject|4|||
164216729|NCT01177410|593160442|FG002|Overall Study|Withdrawal by Subject|3|||
164216730|NCT01177410|593160440|FG000|Overall Study|Lost to Follow-up|0|||
164216731|NCT01177410|593160441|FG001|Overall Study|Lost to Follow-up|1|||
164216732|NCT01177410|593160442|FG002|Overall Study|Lost to Follow-up|0|||
164216733|NCT00471354|593160443|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
164216734|NCT00471354|593160443|FG000|Overall Study|Adverse Event|13|||
164216735|NCT00471354|593160443|FG000|Overall Study|Protocol Violation|12|||
164216736|NCT00471354|593160443|FG000|Overall Study|Withdrawal by Subject|1|||
164216737|NCT00471354|593160443|FG000|Overall Study|Physician Decision|4|||
164216738|NCT00471354|593160443|FG000|Overall Study|Sponsor Decision|1|||
164216739|NCT00471354|593160443|FG000|Overall Study|Lost to Follow-up|3|||
164216740|NCT00471354|593160443|FG000|Overall Study|Lack of Efficacy|5|||
164216741|NCT00471354|593160443|FG000|Overall Study|Patient/Caregiver Decision|12|||
164216742|NCT01336972|593160444|FG000|Overall Study|Adverse Event|1|||
164216743|NCT01336972|593160445|FG001|Overall Study|Adverse Event|1|||
164216744|NCT01336972|593160446|FG002|Overall Study|Adverse Event|0|||
164216745|NCT03446573|593160450|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
164216746|NCT03446573|593160451|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
164216747|NCT03446573|593160450|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
164216748|NCT03446573|593160451|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
164216749|NCT03446573|593160450|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
164326679|NCT03324581|593571590|FG000|Overall Study|Protocol Deviation|8|||
164326680|NCT03324581|593571591|FG001|Overall Study|Protocol Deviation|9|||
164326681|NCT03324581|593571592|FG002|Overall Study|Protocol Deviation|4|||
164326682|NCT03324581|593571590|FG000|Overall Study|Withdrawal by Subject|6|||
164326683|NCT03324581|593571591|FG001|Overall Study|Withdrawal by Subject|8|||
164326684|NCT03324581|593571592|FG002|Overall Study|Withdrawal by Subject|6|||
164326685|NCT03324581|593571590|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
164326686|NCT03324581|593571591|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
164326687|NCT03324581|593571592|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
164326688|NCT04473482|593571593|FG000|Overall Study|Death|0|||
164326689|NCT04473482|593571594|FG001|Overall Study|Death|3|||
164326690|NCT04473482|593571593|FG000|Overall Study|Lost to Follow-up|9|||
164326691|NCT04473482|593571594|FG001|Overall Study|Lost to Follow-up|7|||
164326692|NCT04473482|593571593|FG000|Overall Study|Withdrawal by Subject|2|||
164216750|NCT03446573|593160451|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
164326693|NCT04473482|593571594|FG001|Overall Study|Withdrawal by Subject|1|||
164216751|NCT03446573|593160450|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
164326694|NCT00266864|593571596|FG000|Overall Study|Lost to Follow-up|4|||
164326695|NCT00266864|593571597|FG001|Overall Study|Lost to Follow-up|1|||
164326696|NCT00266864|593571596|FG000|Overall Study|Withdrawal by Subject|1|||
164216752|NCT03446573|593160451|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
164216753|NCT03446573|593160450|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
164216754|NCT03446573|593160451|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
164216755|NCT03446573|593160450|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
164216756|NCT03446573|593160451|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
164326697|NCT00266864|593571597|FG001|Overall Study|Withdrawal by Subject|1|||
164326698|NCT00727532|593571598|FG000|Overall Study|Adverse Event|1|||
164216757|NCT03446573|593160450|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
164216758|NCT03446573|593160451|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
164216759|NCT03446573|593160450|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
164216760|NCT03446573|593160451|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
164216761|NCT03446573|593160450|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
164216762|NCT03446573|593160451|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
164216763|NCT03446573|593160450|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
164216764|NCT03446573|593160451|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
164216765|NCT03446573|593160450|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
164216766|NCT03446573|593160451|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
164216767|NCT03446573|593160450|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
164216768|NCT03446573|593160451|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
164216769|NCT03446573|593160450|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
164216770|NCT03446573|593160451|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
164216771|NCT02639559|593160452|FG000|Overall Study|Mobilization failure|0|||
164216772|NCT02639559|593160453|FG001|Overall Study|Mobilization failure|3|||
164216773|NCT02639559|593160452|FG000|Overall Study|Issues with vascular acess|1|||
164216774|NCT02639559|593160453|FG001|Overall Study|Issues with vascular acess|0|||
164216775|NCT02691663|593160460|FG000|Overall Study|Screen failure after baseline|2|||
164216776|NCT02691663|593160461|FG001|Overall Study|Screen failure after baseline|2|||
164216777|NCT02691663|593160460|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
164216778|NCT02691663|593160461|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
164216779|NCT02691663|593160460|FG000|Overall Study|Withdrawn after Follow up 2|1|||
164216780|NCT02691663|593160461|FG001|Overall Study|Withdrawn after Follow up 2|1|||
164216781|NCT02691663|593160460|FG000|Overall Study|Lost to Follow-up|3|||
164216782|NCT02691663|593160461|FG001|Overall Study|Lost to Follow-up|2|||
164216783|NCT03142750|593160462|FG000|Overall Study|Lost to Follow-up|4|||
164216784|NCT03142750|593160463|FG001|Overall Study|Lost to Follow-up|1|||
164216785|NCT00303628|593160468|FG000|Overall Study|Disease progression|0|||
164216786|NCT00303628|593160469|FG001|Overall Study|Disease progression|1|||
164216787|NCT00303628|593160468|FG000|Overall Study|Adverse Event|26|||
164216788|NCT00303628|593160469|FG001|Overall Study|Adverse Event|36|||
164216789|NCT00303628|593160468|FG000|Overall Study|Death|0|||
164216790|NCT00303628|593160469|FG001|Overall Study|Death|1|||
164216791|NCT00303628|593160468|FG000|Overall Study|Withdrawal by Subject|11|||
164216792|NCT00303628|593160469|FG001|Overall Study|Withdrawal by Subject|20|||
164216793|NCT00303628|593160468|FG000|Overall Study|Alternative therapy|2|||
164216794|NCT00303628|593160469|FG001|Overall Study|Alternative therapy|0|||
164216795|NCT00303628|593160468|FG000|Overall Study|Other complicating disease|0|||
164216796|NCT00303628|593160469|FG001|Overall Study|Other complicating disease|1|||
164216797|NCT00303628|593160468|FG000|Overall Study|Not start protocol therapy|3|||
164216798|NCT00303628|593160469|FG001|Overall Study|Not start protocol therapy|5|||
164216799|NCT00303628|593160468|FG000|Overall Study|Other|8|||
164216800|NCT00303628|593160469|FG001|Overall Study|Other|9|||
164326699|NCT00727532|593571598|FG000|Overall Study|Withdrawal by Subject|1|||
164326700|NCT00829933|593571599|FG000|Overall Study|Adverse Event|2|||
164326701|NCT00829933|593571600|FG001|Overall Study|Adverse Event|3|||
164326702|NCT00829933|593571601|FG002|Overall Study|Adverse Event|2|||
164216801|NCT03158688|593160470|FG000|Overall Study|Withdrawal by Subject|14|||
164326703|NCT00829933|593571602|FG003|Overall Study|Adverse Event|1|||
164326704|NCT00829933|593571599|FG000|Overall Study|Death|0|||
164326705|NCT00829933|593571600|FG001|Overall Study|Death|0|||
164326706|NCT00829933|593571601|FG002|Overall Study|Death|1|||
164326707|NCT00829933|593571602|FG003|Overall Study|Death|1|||
164326708|NCT00829933|593571599|FG000|Overall Study|Lack of Efficacy|0|||
164326709|NCT00829933|593571600|FG001|Overall Study|Lack of Efficacy|1|||
164326710|NCT00829933|593571601|FG002|Overall Study|Lack of Efficacy|0|||
164216802|NCT03158688|593160471|FG001|Overall Study|Withdrawal by Subject|28|||
164216803|NCT03158688|593160470|FG000|Overall Study|Decision by sponsor|13|||
164216804|NCT03158688|593160471|FG001|Overall Study|Decision by sponsor|37|||
164326711|NCT00829933|593571602|FG003|Overall Study|Lack of Efficacy|0|||
164326712|NCT00829933|593571599|FG000|Overall Study|Physician Decision|5|||
164326713|NCT00829933|593571600|FG001|Overall Study|Physician Decision|7|||
164326714|NCT00829933|593571601|FG002|Overall Study|Physician Decision|8|||
164216805|NCT03158688|593160470|FG000|Overall Study|Lost to Follow-up|4|||
164216806|NCT03158688|593160471|FG001|Overall Study|Lost to Follow-up|3|||
164216807|NCT03158688|593160470|FG000|Overall Study|Death|74|||
164326715|NCT00829933|593571602|FG003|Overall Study|Physician Decision|1|||
164326716|NCT00829933|593571599|FG000|Overall Study|Pregnancy|0|||
164216808|NCT03158688|593160471|FG001|Overall Study|Death|142|||
164216809|NCT00471107|593160472|FG000|Overall Study|Technical problems/data loss|3|||
164326717|NCT00829933|593571600|FG001|Overall Study|Pregnancy|0|||
164326718|NCT00829933|593571601|FG002|Overall Study|Pregnancy|0|||
164216810|NCT00471107|593160473|FG001|Overall Study|Technical problems/data loss|1|||
164216811|NCT00471107|593160474|FG002|Overall Study|Technical problems/data loss|3|||
164216812|NCT02942407|593160475|FG000|Overall Study|Lost to Follow-up|3|||
164216813|NCT02942407|593160476|FG001|Overall Study|Lost to Follow-up|2|||
164216814|NCT02942407|593160475|FG000|Overall Study|Withdrawal by Subject|7|||
164216815|NCT02942407|593160476|FG001|Overall Study|Withdrawal by Subject|9|||
164216816|NCT02942407|593160475|FG000|Overall Study|Death|16|||
164216817|NCT02942407|593160476|FG001|Overall Study|Death|13|||
164216818|NCT05887908|593160477|FG000|Overall Study|Adverse Event|6|||
164216819|NCT05887908|593160478|FG001|Overall Study|Adverse Event|1|||
164216820|NCT05887908|593160479|FG002|Overall Study|Adverse Event|1|||
164216821|NCT05887908|593160477|FG000|Overall Study|Physician Decision|4|||
164216822|NCT05887908|593160478|FG001|Overall Study|Physician Decision|1|||
164216823|NCT05887908|593160479|FG002|Overall Study|Physician Decision|0|||
164216824|NCT05887908|593160477|FG000|Overall Study|Withdrawal by Subject|3|||
164216825|NCT05887908|593160478|FG001|Overall Study|Withdrawal by Subject|2|||
164216826|NCT05887908|593160479|FG002|Overall Study|Withdrawal by Subject|3|||
164216827|NCT05887908|593160477|FG000|Overall Study|Ineligibility after the start of the study|4|||
164216828|NCT05887908|593160478|FG001|Overall Study|Ineligibility after the start of the study|1|||
164216829|NCT05887908|593160479|FG002|Overall Study|Ineligibility after the start of the study|0|||
164216830|NCT05887908|593160477|FG000|Overall Study|Subject non-compliance|4|||
164216831|NCT05887908|593160478|FG001|Overall Study|Subject non-compliance|0|||
164216832|NCT05887908|593160479|FG002|Overall Study|Subject non-compliance|4|||
164216833|NCT05887908|593160477|FG000|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
164216834|NCT05887908|593160478|FG001|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
164216835|NCT05887908|593160479|FG002|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|1|||
164216836|NCT05887908|593160477|FG000|Overall Study|Pregnancy|0|||
164216837|NCT05887908|593160478|FG001|Overall Study|Pregnancy|1|||
164216838|NCT05887908|593160479|FG002|Overall Study|Pregnancy|0|||
164216839|NCT05887908|593160477|FG000|Overall Study|Required Use of Prohibited Concomitant Medications|1|||
164216840|NCT05887908|593160478|FG001|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
164216841|NCT05887908|593160479|FG002|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
164216842|NCT05887908|593160477|FG000|Overall Study|Significant prolongation of the QT/QTc interval|0|||
164216843|NCT05887908|593160478|FG001|Overall Study|Significant prolongation of the QT/QTc interval|1|||
164216844|NCT05887908|593160479|FG002|Overall Study|Significant prolongation of the QT/QTc interval|0|||
164216845|NCT05887908|593160477|FG000|Overall Study|Other Reason|3|||
164216846|NCT05887908|593160478|FG001|Overall Study|Other Reason|3|||
164216847|NCT05887908|593160479|FG002|Overall Study|Other Reason|3|||
164216848|NCT03928743|593160483|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
164326719|NCT00829933|593571602|FG003|Overall Study|Pregnancy|2|||
164326720|NCT00829933|593571599|FG000|Overall Study|Protocol Violation|2|||
164326721|NCT00829933|593571600|FG001|Overall Study|Protocol Violation|1|||
164326722|NCT00829933|593571601|FG002|Overall Study|Protocol Violation|0|||
164326723|NCT00829933|593571602|FG003|Overall Study|Protocol Violation|0|||
164326724|NCT00829933|593571599|FG000|Overall Study|withdrew before treatment started|5|||
164326725|NCT00829933|593571600|FG001|Overall Study|withdrew before treatment started|1|||
164326726|NCT00829933|593571601|FG002|Overall Study|withdrew before treatment started|2|||
164326727|NCT00829933|593571602|FG003|Overall Study|withdrew before treatment started|9|||
164326728|NCT03687970|593571606|FG000|Overall Study|visit scheduling conflicts|2|||
164326729|NCT03687970|593571607|FG001|Overall Study|visit scheduling conflicts|0|||
164326730|NCT00686998|593571608|FG000|Overall Study|Adverse Event|3|||
164326731|NCT00686998|593571609|FG001|Overall Study|Adverse Event|2|||
164326732|NCT00686998|593571610|FG002|Overall Study|Adverse Event|1|||
164326733|NCT00686998|593571608|FG000|Overall Study|Withdrawal by Subject|2|||
164326734|NCT00686998|593571609|FG001|Overall Study|Withdrawal by Subject|1|||
164326735|NCT00686998|593571610|FG002|Overall Study|Withdrawal by Subject|2|||
164326736|NCT00686998|593571608|FG000|Overall Study|Lack of Efficacy|7|||
164326737|NCT00686998|593571609|FG001|Overall Study|Lack of Efficacy|5|||
164326738|NCT00686998|593571610|FG002|Overall Study|Lack of Efficacy|0|||
164326739|NCT00686998|593571608|FG000|Overall Study|Other|0|||
164326740|NCT00686998|593571609|FG001|Overall Study|Other|0|||
164326741|NCT00686998|593571610|FG002|Overall Study|Other|1|||
164326742|NCT00686998|593571608|FG000|Overall Study|Safety Reasons|1|||
164326743|NCT00686998|593571609|FG001|Overall Study|Safety Reasons|0|||
164326744|NCT00686998|593571610|FG002|Overall Study|Safety Reasons|0|||
164326745|NCT06374394|593571614|FG000|Overall Study|Adverse Event|0|||
164565513|NCT01430442|594440371|FG005|Overall Study|Subject Withdrew Consent|1|||
164216849|NCT03928743|593160484|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
164216850|NCT03928743|593160485|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
164216851|NCT03928743|593160483|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
164216852|NCT03928743|593160484|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
164326746|NCT06374394|593571615|FG001|Overall Study|Adverse Event|2|||
164326747|NCT06374394|593571614|FG000|Overall Study|Lost to Follow-up|6|||
164326748|NCT06374394|593571615|FG001|Overall Study|Lost to Follow-up|9|||
164326749|NCT06374394|593571614|FG000|Overall Study|Withdrawal by Subject|1|||
164216853|NCT03928743|593160485|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
164216854|NCT03928743|593160483|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
164216855|NCT03928743|593160484|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
164216856|NCT03928743|593160485|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
164216857|NCT03928743|593160483|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
164216858|NCT03928743|593160484|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
164216859|NCT03928743|593160485|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
164216860|NCT03928743|593160483|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
164216861|NCT03928743|593160484|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
164216862|NCT03928743|593160485|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
164216863|NCT03928743|593160483|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
164216864|NCT03928743|593160484|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
164216865|NCT03928743|593160485|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
164216866|NCT03928743|593160483|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
164216867|NCT03928743|593160484|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
164216868|NCT03928743|593160485|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
164216869|NCT03928743|593160483|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
164216870|NCT03928743|593160484|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
164216871|NCT03928743|593160485|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
164216872|NCT03928743|593160483|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
164216873|NCT03928743|593160484|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
164216874|NCT03928743|593160485|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
164216875|NCT03928743|593160483|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
164216876|NCT03928743|593160484|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
164216877|NCT03928743|593160485|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
164216878|NCT03928743|593160483|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
164216879|NCT03928743|593160484|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
164216880|NCT03928743|593160485|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
164216881|NCT04828486|593160488|FG000|Overall Study|Adverse Event|2|||
164216882|NCT04828486|593160488|FG000|Overall Study|Death|1|||
164216883|NCT04828486|593160488|FG000|Overall Study|Disease Progression|8|||
164216884|NCT04828486|593160488|FG000|Overall Study|Other Complicating Disease|1|||
164216885|NCT04828486|593160488|FG000|Overall Study|Withdrawal by Subject|1|||
164216886|NCT06204887|593160489|FG000|Overall Study|Lost to Follow-up|3|||
164216887|NCT06204887|593160490|FG001|Overall Study|Lost to Follow-up|4|||
164216888|NCT06204887|593160491|FG002|Overall Study|Lost to Follow-up|1|||
164216889|NCT06204887|593160492|FG003|Overall Study|Lost to Follow-up|6|||
164216890|NCT02762604|593160496|FG000|Overall Study|Lost to Follow-up|2|||
164216891|NCT02762604|593160497|FG001|Overall Study|Lost to Follow-up|7|||
164216892|NCT02762604|593160496|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
164216893|NCT02762604|593160497|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
164216894|NCT03833167|593160498|FG000|Overall Study|Withdrawal by Subject|4|||
164216895|NCT03833167|593160499|FG001|Overall Study|Withdrawal by Subject|6|||
164216896|NCT03833167|593160498|FG000|Overall Study|Ongoing|186|||
164216897|NCT03833167|593160499|FG001|Overall Study|Ongoing|194|||
164216898|NCT03833167|593160498|FG000|Overall Study|Lost to Follow-up|1|||
164216899|NCT03833167|593160499|FG001|Overall Study|Lost to Follow-up|1|||
164326750|NCT06374394|593571615|FG001|Overall Study|Withdrawal by Subject|7|||
164326751|NCT06374394|593571614|FG000|Overall Study|Other|1|||
164326752|NCT06374394|593571615|FG001|Overall Study|Other|0|||
164326753|NCT00356122|593571616|FG000|TREATMENT|Lack of Efficacy|26|||
164326754|NCT00356122|593571616|FG000|TREATMENT|Adverse Event|10|||
164565514|NCT01430442|594440372|FG006|Overall Study|Subject Withdrew Consent|5|||
164565515|NCT01430442|594440373|FG007|Overall Study|Subject Withdrew Consent|2|||
164565516|NCT01430442|594440366|FG000|Overall Study|Lost to Follow-up|2|||
164565517|NCT01430442|594440367|FG001|Overall Study|Lost to Follow-up|0|||
164565518|NCT01430442|594440368|FG002|Overall Study|Lost to Follow-up|1|||
164565519|NCT01430442|594440369|FG003|Overall Study|Lost to Follow-up|2|||
164565520|NCT01430442|594440370|FG004|Overall Study|Lost to Follow-up|2|||
164565521|NCT01430442|594440371|FG005|Overall Study|Lost to Follow-up|1|||
164565522|NCT01430442|594440372|FG006|Overall Study|Lost to Follow-up|5|||
164326755|NCT00356122|593571616|FG000|TREATMENT|Subject's request|4|||
164565523|NCT01430442|594440373|FG007|Overall Study|Lost to Follow-up|1|||
164565524|NCT01430442|594440366|FG000|Overall Study|Pregnancy|1|||
164216900|NCT03833167|593160498|FG000|Overall Study|Physician Decision|0|||
164216901|NCT03833167|593160499|FG001|Overall Study|Physician Decision|2|||
164216902|NCT03833167|593160498|FG000|Overall Study|Death|34|||
164216903|NCT03833167|593160499|FG001|Overall Study|Death|22|||
164326756|NCT00356122|593571616|FG000|TREATMENT|Other|4|||
164565525|NCT01430442|594440367|FG001|Overall Study|Pregnancy|0|||
164565526|NCT01430442|594440368|FG002|Overall Study|Pregnancy|0|||
164565527|NCT01430442|594440369|FG003|Overall Study|Pregnancy|0|||
164216904|NCT02227199|593160502|FG000|Overall Study|Physician Decision|0|||
164216905|NCT02227199|593160503|FG001|Overall Study|Physician Decision|0|||
164216906|NCT02227199|593160504|FG002|Overall Study|Physician Decision|1|||
164216907|NCT02227199|593160502|FG000|Overall Study|Adverse Event|0|||
164216908|NCT02227199|593160503|FG001|Overall Study|Adverse Event|0|||
164216909|NCT02227199|593160504|FG002|Overall Study|Adverse Event|3|||
164216910|NCT03003962|593160505|FG000|Overall Study|Withdrawal by Subject|5|||
164216911|NCT03003962|593160506|FG001|Overall Study|Withdrawal by Subject|17|||
164216912|NCT03003962|593160505|FG000|Overall Study|Death|274|||
164216913|NCT03003962|593160506|FG001|Overall Study|Death|277|||
164216914|NCT03003962|593160505|FG000|Overall Study|Participants ongoing at DCO|55|||
164216915|NCT03003962|593160506|FG001|Overall Study|Participants ongoing at DCO|40|||
164216916|NCT05179603|593160507|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
164216917|NCT05179603|593160507|FG000|Overall Study|Withdrawal by Subject|1|||
164216918|NCT05179603|593160507|FG000|Overall Study|Progressive disease|4|||
164216919|NCT05179603|593160507|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
164216920|NCT05937373|593160508|FG000|Overall Study|Out of Window|2|||
164216921|NCT05937373|593160509|FG001|Overall Study|Out of Window|0|||
164216922|NCT05937373|593160508|FG000|Overall Study|Device fell off prior to date of surgery|0|||
164216923|NCT05937373|593160509|FG001|Overall Study|Device fell off prior to date of surgery|2|||
164216924|NCT06061952|593160510|FG000|Overall Study|Withdrawal by Subject|1|||
164216925|NCT06061952|593160511|FG001|Overall Study|Withdrawal by Subject|2|||
164216926|NCT06061952|593160510|FG000|Overall Study|Lost to Follow-up|2|||
164216927|NCT06061952|593160511|FG001|Overall Study|Lost to Follow-up|2|||
164216928|NCT01405911|593160512|FG000|Overall Study|Pre-treatment lab AE|0|||
164216929|NCT01405911|593160513|FG001|Overall Study|Pre-treatment lab AE|1|||
164216930|NCT01405911|593160514|FG002|Overall Study|Pre-treatment lab AE|0|||
164216931|NCT01405911|593160512|FG000|Overall Study|Lost to Follow-up|0|||
164216932|NCT01405911|593160513|FG001|Overall Study|Lost to Follow-up|1|||
164216933|NCT01405911|593160514|FG002|Overall Study|Lost to Follow-up|0|||
164216934|NCT01405911|593160512|FG000|Overall Study|Protocol Violation|1|||
164216935|NCT01405911|593160513|FG001|Overall Study|Protocol Violation|0|||
164216936|NCT01405911|593160514|FG002|Overall Study|Protocol Violation|0|||
164216937|NCT01405911|593160512|FG000|Overall Study|Withdrawal by Subject|3|||
164216938|NCT01405911|593160513|FG001|Overall Study|Withdrawal by Subject|1|||
164216939|NCT01405911|593160514|FG002|Overall Study|Withdrawal by Subject|1|||
164216940|NCT01685437|593160516|FG000|Overall Study|Withdrawal by Subject|22|||
164216941|NCT01685437|593160516|FG000|Overall Study|Lost to Follow-up|3|||
164216942|NCT01685437|593160516|FG000|Overall Study|Adverse Event|1|||
164216943|NCT01685437|593160516|FG000|Overall Study|Protocol Violation|4|||
164216944|NCT01685437|593160516|FG000|Overall Study|Unable to make visits due to work|1|||
164216945|NCT03770455|593160523|FG000|Overall Study|Screen failures|3|||
164216946|NCT04937387|593160524|FG000|Overall Study|Adverse Event|1|||
164565528|NCT01430442|594440370|FG004|Overall Study|Pregnancy|0|||
164565529|NCT01430442|594440371|FG005|Overall Study|Pregnancy|1|||
164565530|NCT01430442|594440372|FG006|Overall Study|Pregnancy|0|||
164565531|NCT01430442|594440373|FG007|Overall Study|Pregnancy|0|||
164565532|NCT01430442|594440366|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
164565533|NCT01430442|594440367|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
164565534|NCT01430442|594440368|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
164565535|NCT01430442|594440369|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
164565536|NCT01430442|594440370|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
164565537|NCT01430442|594440371|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
164565538|NCT01430442|594440372|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
164565539|NCT01430442|594440373|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
164565540|NCT00772629|594440375|FG000|Overall Study|Subject was not vaccinated|1|||
164565541|NCT00772629|594440376|FG001|Overall Study|Subject was not vaccinated|0|||
164565542|NCT00132041|594440383|FG000|Baseline|Ineligible|6|||
164565543|NCT00132041|594440383|FG000|3 Months Post Ablation|Transplant|1|||
164565544|NCT00132041|594440383|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
164565545|NCT00132041|594440383|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
164565546|NCT00132041|594440383|FG000|6 Months Post Ablation|Death|2|||
164216947|NCT04937387|593160525|FG001|Overall Study|Adverse Event|0|||
164216948|NCT04937387|593160526|FG002|Overall Study|Adverse Event|2|||
164216949|NCT04937387|593160527|FG003|Overall Study|Adverse Event|0|||
164216950|NCT04937387|593160524|FG000|Overall Study|Lack of Efficacy|1|||
164565547|NCT00132041|594440383|FG000|6 Months Post Ablation|Transplant|6|||
164565548|NCT00132041|594440383|FG000|9 Months Post Ablation|Death|1|||
164216951|NCT04937387|593160525|FG001|Overall Study|Lack of Efficacy|0|||
164565549|NCT00132041|594440383|FG000|9 Months Post Ablation|Transplant|1|||
164216952|NCT04937387|593160526|FG002|Overall Study|Lack of Efficacy|0|||
164216953|NCT04937387|593160527|FG003|Overall Study|Lack of Efficacy|1|||
164216954|NCT04937387|593160524|FG000|Overall Study|Withdrawal by Subject|1|||
164216955|NCT04937387|593160525|FG001|Overall Study|Withdrawal by Subject|0|||
164216956|NCT04937387|593160526|FG002|Overall Study|Withdrawal by Subject|1|||
164216957|NCT04937387|593160527|FG003|Overall Study|Withdrawal by Subject|1|||
164216958|NCT04937387|593160524|FG000|Overall Study|Randomized in error|0|||
164216959|NCT04937387|593160525|FG001|Overall Study|Randomized in error|0|||
164565550|NCT00132041|594440383|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
164565551|NCT00132041|594440383|FG000|12 Months Post Ablation|Death|1|||
164565552|NCT00132041|594440383|FG000|12 Months Post Ablation|Transplant|1|||
164565553|NCT00132041|594440383|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
164565554|NCT00132041|594440383|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
164565555|NCT00132041|594440383|FG000|15 Months Post Ablation|Death|1|||
164565556|NCT00132041|594440383|FG000|15 Months Post Ablation|Transplant|5|||
164565557|NCT00132041|594440383|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
164565558|NCT00132041|594440383|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
164565559|NCT00132041|594440383|FG000|18 Months Post Ablation|Transplant|1|||
164565560|NCT00132041|594440383|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
164565561|NCT00132041|594440383|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
164565562|NCT00860158|594440384|FG000|Overall Study|Study Terminated|1|||
164565563|NCT00282243|594440385|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
164565564|NCT00282243|594440385|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
164565565|NCT00282243|594440385|FG000|Extension Treatment Period|Adverse Event|15|||
164565566|NCT00282243|594440385|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
164565567|NCT00282243|594440385|FG000|Extension Treatment Period|Non-compliance|2|||
164565568|NCT00282243|594440385|FG000|Extension Treatment Period|Physician Decision|1|||
164565569|NCT00851903|594440386|FG000|Overall Study|Withdrawal by Subject|2|||
164565570|NCT01070329|594440387|FG000|Overall Study|Adverse Event|13|||
164565571|NCT01070329|594440388|FG001|Overall Study|Adverse Event|10|||
164565572|NCT01070329|594440387|FG000|Overall Study|Lost to Follow-up|22|||
164565573|NCT01070329|594440388|FG001|Overall Study|Lost to Follow-up|12|||
164565574|NCT01070329|594440387|FG000|Overall Study|Withdrawal by Subject|9|||
164669941|NCT00986245|594816790|FG000|Second Intervention|Lost to Follow-up|1|||
164669942|NCT00986245|594816791|FG001|Second Intervention|Lost to Follow-up|0|||
164669943|NCT00986245|594816790|FG000|Second Intervention|Protocol Violation|0|||
164669944|NCT00986245|594816791|FG001|Second Intervention|Protocol Violation|1|||
164669945|NCT00854308|594816797|FG000|Overall Study|Disease progression|42|||
164669946|NCT00854308|594816798|FG001|Overall Study|Disease progression|50|||
164669947|NCT00854308|594816797|FG000|Overall Study|Adverse Event|8|||
164669948|NCT00854308|594816798|FG001|Overall Study|Adverse Event|3|||
164669949|NCT00854308|594816797|FG000|Overall Study|Death|2|||
164669950|NCT00854308|594816798|FG001|Overall Study|Death|5|||
164669951|NCT00854308|594816797|FG000|Overall Study|Physician Decision|6|||
164669952|NCT00854308|594816798|FG001|Overall Study|Physician Decision|6|||
164669953|NCT00854308|594816797|FG000|Overall Study|Withdrawal by Subject|4|||
164669954|NCT00854308|594816798|FG001|Overall Study|Withdrawal by Subject|2|||
164669955|NCT00854308|594816797|FG000|Overall Study|Sponsor's decision to terminate study|0|||
164669956|NCT00854308|594816798|FG001|Overall Study|Sponsor's decision to terminate study|1|||
164669957|NCT01390844|594816799|FG000|Treatment Phase|Adverse Event|12|||
164669958|NCT01390844|594816800|FG001|Treatment Phase|Adverse Event|2|||
164669959|NCT01390844|594816801|FG002|Treatment Phase|Adverse Event|3|||
164669960|NCT01390844|594816802|FG003|Treatment Phase|Adverse Event|2|||
164669961|NCT01390844|594816799|FG000|Treatment Phase|Treatment Failure|23|||
164669962|NCT01390844|594816800|FG001|Treatment Phase|Treatment Failure|25|||
164669963|NCT01390844|594816801|FG002|Treatment Phase|Treatment Failure|10|||
164669964|NCT01390844|594816802|FG003|Treatment Phase|Treatment Failure|13|||
164669965|NCT01390844|594816799|FG000|Treatment Phase|Non-Medical Reasons|5|||
164669966|NCT01390844|594816800|FG001|Treatment Phase|Non-Medical Reasons|1|||
164669967|NCT01390844|594816801|FG002|Treatment Phase|Non-Medical Reasons|8|||
164669968|NCT01390844|594816802|FG003|Treatment Phase|Non-Medical Reasons|1|||
164669969|NCT01390844|594816799|FG000|Treatment Phase|Non-GCP Compliant|0|||
164669970|NCT01390844|594816800|FG001|Treatment Phase|Non-GCP Compliant|0|||
164669971|NCT01390844|594816801|FG002|Treatment Phase|Non-GCP Compliant|10|||
164669972|NCT01390844|594816802|FG003|Treatment Phase|Non-GCP Compliant|3|||
164669973|NCT01390844|594816799|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
164669974|NCT01390844|594816800|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
164669975|NCT01390844|594816801|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
164669976|NCT01390844|594816802|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
164669977|NCT00610363|594816803|FG000|Overall Study|Non-compliance with protocol|0|||
164669978|NCT00610363|594816804|FG001|Overall Study|Non-compliance with protocol|1|||
164669979|NCT00610363|594816803|FG000|Overall Study|Adverse Event|3|||
164669980|NCT00610363|594816804|FG001|Overall Study|Adverse Event|1|||
164216960|NCT04937387|593160526|FG002|Overall Study|Randomized in error|0|||
164565575|NCT01070329|594440388|FG001|Overall Study|Withdrawal by Subject|11|||
164565576|NCT01070329|594440387|FG000|Overall Study|Protocol Violation|3|||
164669981|NCT00610363|594816803|FG000|Overall Study|Lack of Efficacy|2|||
164669982|NCT00610363|594816804|FG001|Overall Study|Lack of Efficacy|0|||
164669983|NCT00610363|594816803|FG000|Overall Study|Lost to Follow-up|4|||
164669984|NCT00610363|594816804|FG001|Overall Study|Lost to Follow-up|0|||
164216961|NCT04937387|593160527|FG003|Overall Study|Randomized in error|1|||
164216962|NCT01039675|593160528|FG000|Overall Study|Adverse Event|0|||
164216963|NCT01039675|593160529|FG001|Overall Study|Adverse Event|2|||
164216964|NCT01039675|593160528|FG000|Overall Study|Lack of Efficacy|0|||
164216965|NCT01039675|593160529|FG001|Overall Study|Lack of Efficacy|2|||
164216966|NCT01039675|593160528|FG000|Overall Study|Withdrawal by Subject|0|||
164216967|NCT01039675|593160529|FG001|Overall Study|Withdrawal by Subject|1|||
164216968|NCT01039675|593160528|FG000|Overall Study|Lost to Follow-up|0|||
164216969|NCT01039675|593160529|FG001|Overall Study|Lost to Follow-up|1|||
164216970|NCT01039675|593160528|FG000|Overall Study|Physician Decision|0|||
164216971|NCT01039675|593160529|FG001|Overall Study|Physician Decision|1|||
164216972|NCT00567580|593162011|FG000|Overall Study|Protocol Violation|28|||
164216973|NCT00567580|593162012|FG001|Overall Study|Protocol Violation|24|||
164216974|NCT00567580|593162013|FG002|Overall Study|Protocol Violation|24|||
164216975|NCT01658878|593162014|FG000|Treatment Period|Disease Progression|1|||
164216976|NCT01658878|593162015|FG001|Treatment Period|Disease Progression|3|||
164216977|NCT01658878|593162016|FG002|Treatment Period|Disease Progression|2|||
164216978|NCT01658878|593162017|FG003|Treatment Period|Disease Progression|1|||
164216979|NCT01658878|593162018|FG004|Treatment Period|Disease Progression|13|||
164216980|NCT01658878|593162019|FG005|Treatment Period|Disease Progression|3|||
164216981|NCT01658878|593162020|FG006|Treatment Period|Disease Progression|4|||
164216982|NCT01658878|593162021|FG007|Treatment Period|Disease Progression|3|||
164216983|NCT01658878|593162022|FG008|Treatment Period|Disease Progression|5|||
164216984|NCT01658878|593162023|FG009|Treatment Period|Disease Progression|3|||
164216985|NCT01658878|593162024|FG010|Treatment Period|Disease Progression|3|||
164216986|NCT01658878|593162025|FG011|Treatment Period|Disease Progression|4|||
164216987|NCT01658878|593162026|FG012|Treatment Period|Disease Progression|43|||
164216988|NCT01658878|593162027|FG013|Treatment Period|Disease Progression|48|||
164216989|NCT01658878|593162028|FG014|Treatment Period|Disease Progression|33|||
164216990|NCT01658878|593162029|FG015|Treatment Period|Disease Progression|46|||
164216991|NCT01658878|593162030|FG016|Treatment Period|Disease Progression|41|||
164216992|NCT01658878|593162031|FG017|Treatment Period|Disease Progression|42|||
164216993|NCT01658878|593162032|FG018|Treatment Period|Disease Progression|28|||
164216994|NCT01658878|593162033|FG019|Treatment Period|Disease Progression|37|||
164216995|NCT01658878|593162034|FG020|Treatment Period|Disease Progression|37|||
164216996|NCT01658878|593162035|FG021|Treatment Period|Disease Progression|39|||
164216997|NCT01658878|593162036|FG022|Treatment Period|Disease Progression|27|||
164216998|NCT01658878|593162037|FG023|Treatment Period|Disease Progression|19|||
164216999|NCT01658878|593162014|FG000|Treatment Period|Study Drug Toxicity|0|||
164217000|NCT01658878|593162015|FG001|Treatment Period|Study Drug Toxicity|0|||
164217001|NCT01658878|593162016|FG002|Treatment Period|Study Drug Toxicity|0|||
164217002|NCT01658878|593162017|FG003|Treatment Period|Study Drug Toxicity|1|||
164217003|NCT01658878|593162018|FG004|Treatment Period|Study Drug Toxicity|0|||
164217004|NCT01658878|593162019|FG005|Treatment Period|Study Drug Toxicity|0|||
164217005|NCT01658878|593162020|FG006|Treatment Period|Study Drug Toxicity|0|||
164217006|NCT01658878|593162021|FG007|Treatment Period|Study Drug Toxicity|0|||
164217007|NCT01658878|593162022|FG008|Treatment Period|Study Drug Toxicity|0|||
164217008|NCT01658878|593162023|FG009|Treatment Period|Study Drug Toxicity|0|||
164217009|NCT01658878|593162024|FG010|Treatment Period|Study Drug Toxicity|0|||
164217010|NCT01658878|593162025|FG011|Treatment Period|Study Drug Toxicity|0|||
164217011|NCT01658878|593162026|FG012|Treatment Period|Study Drug Toxicity|7|||
164217012|NCT01658878|593162027|FG013|Treatment Period|Study Drug Toxicity|1|||
164217013|NCT01658878|593162028|FG014|Treatment Period|Study Drug Toxicity|5|||
164217014|NCT01658878|593162029|FG015|Treatment Period|Study Drug Toxicity|0|||
164217015|NCT01658878|593162030|FG016|Treatment Period|Study Drug Toxicity|5|||
164217016|NCT01658878|593162031|FG017|Treatment Period|Study Drug Toxicity|10|||
164217017|NCT01658878|593162032|FG018|Treatment Period|Study Drug Toxicity|12|||
164217018|NCT01658878|593162033|FG019|Treatment Period|Study Drug Toxicity|4|||
164217019|NCT01658878|593162034|FG020|Treatment Period|Study Drug Toxicity|2|||
164565577|NCT01070329|594440388|FG001|Overall Study|Protocol Violation|8|||
164565578|NCT01070329|594440387|FG000|Overall Study|Lack of Efficacy|2|||
164565579|NCT01070329|594440388|FG001|Overall Study|Lack of Efficacy|6|||
164565580|NCT01070329|594440387|FG000|Overall Study|Physician Decision|2|||
164565581|NCT01070329|594440388|FG001|Overall Study|Physician Decision|1|||
164565582|NCT01070329|594440387|FG000|Overall Study|Entry Criteria Not Met|1|||
164565583|NCT01070329|594440388|FG001|Overall Study|Entry Criteria Not Met|0|||
164217020|NCT01658878|593162035|FG021|Treatment Period|Study Drug Toxicity|3|||
164217021|NCT01658878|593162036|FG022|Treatment Period|Study Drug Toxicity|2|||
164217022|NCT01658878|593162037|FG023|Treatment Period|Study Drug Toxicity|6|||
164217023|NCT01658878|593162014|FG000|Treatment Period|Maximum Clinical Benefit|0|||
164217024|NCT01658878|593162015|FG001|Treatment Period|Maximum Clinical Benefit|0|||
164217025|NCT01658878|593162016|FG002|Treatment Period|Maximum Clinical Benefit|1|||
164217026|NCT01658878|593162017|FG003|Treatment Period|Maximum Clinical Benefit|0|||
164217027|NCT01658878|593162018|FG004|Treatment Period|Maximum Clinical Benefit|0|||
164217028|NCT01658878|593162019|FG005|Treatment Period|Maximum Clinical Benefit|0|||
164217029|NCT01658878|593162020|FG006|Treatment Period|Maximum Clinical Benefit|0|||
164217030|NCT01658878|593162021|FG007|Treatment Period|Maximum Clinical Benefit|0|||
164217031|NCT01658878|593162022|FG008|Treatment Period|Maximum Clinical Benefit|0|||
164217032|NCT01658878|593162023|FG009|Treatment Period|Maximum Clinical Benefit|0|||
164217033|NCT01658878|593162024|FG010|Treatment Period|Maximum Clinical Benefit|0|||
164217034|NCT01658878|593162025|FG011|Treatment Period|Maximum Clinical Benefit|0|||
164217035|NCT01658878|593162026|FG012|Treatment Period|Maximum Clinical Benefit|0|||
164217036|NCT01658878|593162027|FG013|Treatment Period|Maximum Clinical Benefit|0|||
164217037|NCT01658878|593162028|FG014|Treatment Period|Maximum Clinical Benefit|0|||
164217038|NCT01658878|593162029|FG015|Treatment Period|Maximum Clinical Benefit|0|||
164217039|NCT01658878|593162030|FG016|Treatment Period|Maximum Clinical Benefit|0|||
164217040|NCT01658878|593162031|FG017|Treatment Period|Maximum Clinical Benefit|0|||
164217041|NCT01658878|593162032|FG018|Treatment Period|Maximum Clinical Benefit|1|||
164217042|NCT01658878|593162033|FG019|Treatment Period|Maximum Clinical Benefit|1|||
164217043|NCT01658878|593162034|FG020|Treatment Period|Maximum Clinical Benefit|0|||
164217044|NCT01658878|593162035|FG021|Treatment Period|Maximum Clinical Benefit|0|||
164217045|NCT01658878|593162036|FG022|Treatment Period|Maximum Clinical Benefit|0|||
164217046|NCT01658878|593162037|FG023|Treatment Period|Maximum Clinical Benefit|0|||
164217047|NCT01658878|593162014|FG000|Treatment Period|Other Reasons|0|||
164217048|NCT01658878|593162015|FG001|Treatment Period|Other Reasons|0|||
164217049|NCT01658878|593162016|FG002|Treatment Period|Other Reasons|0|||
164217050|NCT01658878|593162017|FG003|Treatment Period|Other Reasons|1|||
164217051|NCT01658878|593162018|FG004|Treatment Period|Other Reasons|0|||
164217052|NCT01658878|593162019|FG005|Treatment Period|Other Reasons|0|||
164217053|NCT01658878|593162020|FG006|Treatment Period|Other Reasons|0|||
164217054|NCT01658878|593162021|FG007|Treatment Period|Other Reasons|0|||
164217055|NCT01658878|593162022|FG008|Treatment Period|Other Reasons|0|||
164217056|NCT01658878|593162023|FG009|Treatment Period|Other Reasons|0|||
164217057|NCT01658878|593162024|FG010|Treatment Period|Other Reasons|0|||
164217058|NCT01658878|593162025|FG011|Treatment Period|Other Reasons|0|||
164217059|NCT01658878|593162026|FG012|Treatment Period|Other Reasons|2|||
164217060|NCT01658878|593162027|FG013|Treatment Period|Other Reasons|0|||
164217061|NCT01658878|593162028|FG014|Treatment Period|Other Reasons|0|||
164217062|NCT01658878|593162029|FG015|Treatment Period|Other Reasons|2|||
164217063|NCT01658878|593162030|FG016|Treatment Period|Other Reasons|1|||
164217064|NCT01658878|593162031|FG017|Treatment Period|Other Reasons|1|||
164217065|NCT01658878|593162032|FG018|Treatment Period|Other Reasons|3|||
164217066|NCT01658878|593162033|FG019|Treatment Period|Other Reasons|1|||
164217067|NCT01658878|593162034|FG020|Treatment Period|Other Reasons|4|||
164217068|NCT01658878|593162035|FG021|Treatment Period|Other Reasons|0|||
164217069|NCT01658878|593162036|FG022|Treatment Period|Other Reasons|0|||
164217070|NCT01658878|593162037|FG023|Treatment Period|Other Reasons|4|||
164217071|NCT01658878|593162014|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217072|NCT01658878|593162015|FG001|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217073|NCT01658878|593162016|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217074|NCT01658878|593162017|FG003|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217075|NCT01658878|593162018|FG004|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217076|NCT01658878|593162019|FG005|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217077|NCT01658878|593162020|FG006|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217078|NCT01658878|593162021|FG007|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217079|NCT01658878|593162022|FG008|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217080|NCT01658878|593162023|FG009|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217081|NCT01658878|593162024|FG010|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217082|NCT01658878|593162025|FG011|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217083|NCT01658878|593162026|FG012|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217084|NCT01658878|593162027|FG013|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217085|NCT01658878|593162028|FG014|Treatment Period|Participant No Longer Meets Study Criteria|1|||
164217086|NCT01658878|593162029|FG015|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217087|NCT01658878|593162030|FG016|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217088|NCT01658878|593162031|FG017|Treatment Period|Participant No Longer Meets Study Criteria|1|||
164217089|NCT01658878|593162032|FG018|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217090|NCT01658878|593162033|FG019|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217091|NCT01658878|593162034|FG020|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217092|NCT01658878|593162035|FG021|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217093|NCT01658878|593162036|FG022|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217094|NCT01658878|593162037|FG023|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217095|NCT01658878|593162014|FG000|Treatment Period|Poor/Non-compliance|0|||
164217096|NCT01658878|593162015|FG001|Treatment Period|Poor/Non-compliance|0|||
164217097|NCT01658878|593162016|FG002|Treatment Period|Poor/Non-compliance|0|||
164217098|NCT01658878|593162017|FG003|Treatment Period|Poor/Non-compliance|0|||
164217099|NCT01658878|593162018|FG004|Treatment Period|Poor/Non-compliance|0|||
164669985|NCT00610363|594816803|FG000|Overall Study|Withdrawal by Subject|1|||
164669986|NCT00610363|594816804|FG001|Overall Study|Withdrawal by Subject|0|||
164217100|NCT01658878|593162019|FG005|Treatment Period|Poor/Non-compliance|0|||
164217101|NCT01658878|593162020|FG006|Treatment Period|Poor/Non-compliance|0|||
164217102|NCT01658878|593162021|FG007|Treatment Period|Poor/Non-compliance|0|||
164217103|NCT01658878|593162022|FG008|Treatment Period|Poor/Non-compliance|0|||
164217104|NCT01658878|593162023|FG009|Treatment Period|Poor/Non-compliance|0|||
164217105|NCT01658878|593162024|FG010|Treatment Period|Poor/Non-compliance|0|||
164217106|NCT01658878|593162025|FG011|Treatment Period|Poor/Non-compliance|0|||
164217107|NCT01658878|593162026|FG012|Treatment Period|Poor/Non-compliance|0|||
164217108|NCT01658878|593162027|FG013|Treatment Period|Poor/Non-compliance|0|||
164217109|NCT01658878|593162028|FG014|Treatment Period|Poor/Non-compliance|0|||
164217110|NCT01658878|593162029|FG015|Treatment Period|Poor/Non-compliance|1|||
164217111|NCT01658878|593162030|FG016|Treatment Period|Poor/Non-compliance|0|||
164217112|NCT01658878|593162031|FG017|Treatment Period|Poor/Non-compliance|0|||
164217113|NCT01658878|593162032|FG018|Treatment Period|Poor/Non-compliance|0|||
164217114|NCT01658878|593162033|FG019|Treatment Period|Poor/Non-compliance|0|||
164217115|NCT01658878|593162034|FG020|Treatment Period|Poor/Non-compliance|0|||
164217116|NCT01658878|593162035|FG021|Treatment Period|Poor/Non-compliance|0|||
164565584|NCT01070329|594440387|FG000|Overall Study|Sponsor Decision|0|||
164565585|NCT01070329|594440388|FG001|Overall Study|Sponsor Decision|1|||
164565586|NCT02863848|594440389|FG000|Overall Study|Lost to Follow-up|1|||
164217117|NCT01658878|593162036|FG022|Treatment Period|Poor/Non-compliance|0|||
164217118|NCT01658878|593162037|FG023|Treatment Period|Poor/Non-compliance|0|||
164217119|NCT01658878|593162014|FG000|Treatment Period|Participant Withdrew Consent|0|||
164217120|NCT01658878|593162015|FG001|Treatment Period|Participant Withdrew Consent|0|||
164217121|NCT01658878|593162016|FG002|Treatment Period|Participant Withdrew Consent|0|||
164217122|NCT01658878|593162017|FG003|Treatment Period|Participant Withdrew Consent|0|||
164217123|NCT01658878|593162018|FG004|Treatment Period|Participant Withdrew Consent|0|||
164217124|NCT01658878|593162019|FG005|Treatment Period|Participant Withdrew Consent|0|||
164217125|NCT01658878|593162020|FG006|Treatment Period|Participant Withdrew Consent|0|||
164217126|NCT01658878|593162021|FG007|Treatment Period|Participant Withdrew Consent|0|||
164217127|NCT01658878|593162022|FG008|Treatment Period|Participant Withdrew Consent|0|||
164217128|NCT01658878|593162023|FG009|Treatment Period|Participant Withdrew Consent|0|||
164217129|NCT01658878|593162024|FG010|Treatment Period|Participant Withdrew Consent|0|||
164217130|NCT01658878|593162025|FG011|Treatment Period|Participant Withdrew Consent|0|||
164217131|NCT01658878|593162026|FG012|Treatment Period|Participant Withdrew Consent|1|||
164217132|NCT01658878|593162027|FG013|Treatment Period|Participant Withdrew Consent|0|||
164217133|NCT01658878|593162028|FG014|Treatment Period|Participant Withdrew Consent|2|||
164217134|NCT01658878|593162029|FG015|Treatment Period|Participant Withdrew Consent|0|||
164217135|NCT01658878|593162030|FG016|Treatment Period|Participant Withdrew Consent|0|||
164217136|NCT01658878|593162031|FG017|Treatment Period|Participant Withdrew Consent|2|||
164217137|NCT01658878|593162032|FG018|Treatment Period|Participant Withdrew Consent|1|||
164217138|NCT01658878|593162033|FG019|Treatment Period|Participant Withdrew Consent|2|||
164217139|NCT01658878|593162034|FG020|Treatment Period|Participant Withdrew Consent|1|||
164217140|NCT01658878|593162035|FG021|Treatment Period|Participant Withdrew Consent|0|||
164217141|NCT01658878|593162036|FG022|Treatment Period|Participant Withdrew Consent|2|||
164217142|NCT01658878|593162037|FG023|Treatment Period|Participant Withdrew Consent|2|||
164217143|NCT01658878|593162014|FG000|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217144|NCT01658878|593162015|FG001|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217145|NCT01658878|593162016|FG002|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217146|NCT01658878|593162017|FG003|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217147|NCT01658878|593162018|FG004|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217148|NCT01658878|593162019|FG005|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217149|NCT01658878|593162020|FG006|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217150|NCT01658878|593162021|FG007|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217151|NCT01658878|593162022|FG008|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217152|NCT01658878|593162023|FG009|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217153|NCT01658878|593162024|FG010|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217154|NCT01658878|593162025|FG011|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217155|NCT01658878|593162026|FG012|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
164217156|NCT01658878|593162027|FG013|Treatment Period|Participant Request to Discontinue Study Treatment|4|||
164217157|NCT01658878|593162028|FG014|Treatment Period|Participant Request to Discontinue Study Treatment|3|||
164217158|NCT01658878|593162029|FG015|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
164217159|NCT01658878|593162030|FG016|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
164217160|NCT01658878|593162031|FG017|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
164565587|NCT02863848|594440390|FG001|Overall Study|Lost to Follow-up|1|||
164565588|NCT02863848|594440389|FG000|Overall Study|Protocol Violation|1|||
164217161|NCT01658878|593162032|FG018|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164299699|NCT00283296|593472900|FG000|Overall Study|in-home trial not completed|5|||
164669987|NCT00610363|594816803|FG000|Overall Study|Other than specified above|1|||
164669988|NCT00610363|594816804|FG001|Overall Study|Other than specified above|1|||
164217162|NCT01658878|593162033|FG019|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
164217163|NCT01658878|593162034|FG020|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
164217164|NCT01658878|593162035|FG021|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
164217165|NCT01658878|593162036|FG022|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217166|NCT01658878|593162037|FG023|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
164217167|NCT01658878|593162014|FG000|Treatment Period|Adverse Event Related to Study Drug|0|||
164217168|NCT01658878|593162015|FG001|Treatment Period|Adverse Event Related to Study Drug|0|||
164217169|NCT01658878|593162016|FG002|Treatment Period|Adverse Event Related to Study Drug|0|||
164217170|NCT01658878|593162017|FG003|Treatment Period|Adverse Event Related to Study Drug|0|||
164217171|NCT01658878|593162018|FG004|Treatment Period|Adverse Event Related to Study Drug|0|||
164217172|NCT01658878|593162019|FG005|Treatment Period|Adverse Event Related to Study Drug|0|||
164217173|NCT01658878|593162020|FG006|Treatment Period|Adverse Event Related to Study Drug|0|||
164217174|NCT01658878|593162021|FG007|Treatment Period|Adverse Event Related to Study Drug|0|||
164217175|NCT01658878|593162022|FG008|Treatment Period|Adverse Event Related to Study Drug|0|||
164217176|NCT01658878|593162023|FG009|Treatment Period|Adverse Event Related to Study Drug|0|||
164217177|NCT01658878|593162024|FG010|Treatment Period|Adverse Event Related to Study Drug|0|||
164217178|NCT01658878|593162025|FG011|Treatment Period|Adverse Event Related to Study Drug|0|||
164217179|NCT01658878|593162026|FG012|Treatment Period|Adverse Event Related to Study Drug|0|||
164217180|NCT01658878|593162027|FG013|Treatment Period|Adverse Event Related to Study Drug|4|||
164217181|NCT01658878|593162028|FG014|Treatment Period|Adverse Event Related to Study Drug|6|||
164217182|NCT01658878|593162029|FG015|Treatment Period|Adverse Event Related to Study Drug|0|||
164217183|NCT01658878|593162030|FG016|Treatment Period|Adverse Event Related to Study Drug|0|||
164217184|NCT01658878|593162031|FG017|Treatment Period|Adverse Event Related to Study Drug|0|||
164217185|NCT01658878|593162032|FG018|Treatment Period|Adverse Event Related to Study Drug|0|||
164217186|NCT01658878|593162033|FG019|Treatment Period|Adverse Event Related to Study Drug|0|||
164217187|NCT01658878|593162034|FG020|Treatment Period|Adverse Event Related to Study Drug|0|||
164217188|NCT01658878|593162035|FG021|Treatment Period|Adverse Event Related to Study Drug|0|||
164217189|NCT01658878|593162036|FG022|Treatment Period|Adverse Event Related to Study Drug|0|||
164217190|NCT01658878|593162037|FG023|Treatment Period|Adverse Event Related to Study Drug|0|||
164217191|NCT01658878|593162014|FG000|Treatment Period|Death|0|||
164217192|NCT01658878|593162015|FG001|Treatment Period|Death|0|||
164217193|NCT01658878|593162016|FG002|Treatment Period|Death|0|||
164217194|NCT01658878|593162017|FG003|Treatment Period|Death|0|||
164217195|NCT01658878|593162018|FG004|Treatment Period|Death|0|||
164217196|NCT01658878|593162019|FG005|Treatment Period|Death|0|||
164217197|NCT01658878|593162020|FG006|Treatment Period|Death|0|||
164217198|NCT01658878|593162021|FG007|Treatment Period|Death|0|||
164217199|NCT01658878|593162022|FG008|Treatment Period|Death|0|||
164217200|NCT01658878|593162023|FG009|Treatment Period|Death|0|||
164217201|NCT01658878|593162024|FG010|Treatment Period|Death|0|||
164217202|NCT01658878|593162025|FG011|Treatment Period|Death|0|||
164217203|NCT01658878|593162026|FG012|Treatment Period|Death|1|||
164217204|NCT01658878|593162027|FG013|Treatment Period|Death|0|||
164217205|NCT01658878|593162028|FG014|Treatment Period|Death|0|||
164217206|NCT01658878|593162029|FG015|Treatment Period|Death|0|||
164217207|NCT01658878|593162030|FG016|Treatment Period|Death|1|||
164217208|NCT01658878|593162031|FG017|Treatment Period|Death|1|||
164217209|NCT01658878|593162032|FG018|Treatment Period|Death|0|||
164217210|NCT01658878|593162033|FG019|Treatment Period|Death|0|||
164217211|NCT01658878|593162034|FG020|Treatment Period|Death|0|||
164217212|NCT01658878|593162035|FG021|Treatment Period|Death|2|||
164217213|NCT01658878|593162036|FG022|Treatment Period|Death|0|||
164217214|NCT01658878|593162037|FG023|Treatment Period|Death|0|||
164217215|NCT01658878|593162014|FG000|Treatment Period|Adverse Event|0|||
164217216|NCT01658878|593162015|FG001|Treatment Period|Adverse Event|0|||
164217217|NCT01658878|593162016|FG002|Treatment Period|Adverse Event|0|||
164217218|NCT01658878|593162017|FG003|Treatment Period|Adverse Event|0|||
164217219|NCT01658878|593162018|FG004|Treatment Period|Adverse Event|0|||
164217220|NCT01658878|593162019|FG005|Treatment Period|Adverse Event|0|||
164217221|NCT01658878|593162020|FG006|Treatment Period|Adverse Event|0|||
164217222|NCT01658878|593162021|FG007|Treatment Period|Adverse Event|0|||
164217223|NCT01658878|593162022|FG008|Treatment Period|Adverse Event|0|||
164217224|NCT01658878|593162023|FG009|Treatment Period|Adverse Event|0|||
164217225|NCT01658878|593162024|FG010|Treatment Period|Adverse Event|0|||
164217226|NCT01658878|593162025|FG011|Treatment Period|Adverse Event|0|||
164217227|NCT01658878|593162026|FG012|Treatment Period|Adverse Event|0|||
164217228|NCT01658878|593162027|FG013|Treatment Period|Adverse Event|0|||
164217229|NCT01658878|593162028|FG014|Treatment Period|Adverse Event|0|||
164217230|NCT01658878|593162029|FG015|Treatment Period|Adverse Event|0|||
164669989|NCT03048500|594816807|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
164669990|NCT03048500|594816807|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
164217231|NCT01658878|593162030|FG016|Treatment Period|Adverse Event|10|||
164217232|NCT01658878|593162031|FG017|Treatment Period|Adverse Event|3|||
164217233|NCT01658878|593162032|FG018|Treatment Period|Adverse Event|3|||
164217234|NCT01658878|593162033|FG019|Treatment Period|Adverse Event|2|||
164217235|NCT01658878|593162034|FG020|Treatment Period|Adverse Event|3|||
164217236|NCT01658878|593162035|FG021|Treatment Period|Adverse Event|3|||
164217237|NCT01658878|593162036|FG022|Treatment Period|Adverse Event|4|||
164217238|NCT01658878|593162037|FG023|Treatment Period|Adverse Event|3|||
164217239|NCT01658878|593162014|FG000|Treatment Period|Lost to Follow-up|0|||
164217240|NCT01658878|593162015|FG001|Treatment Period|Lost to Follow-up|0|||
164217241|NCT01658878|593162016|FG002|Treatment Period|Lost to Follow-up|0|||
164217242|NCT01658878|593162017|FG003|Treatment Period|Lost to Follow-up|0|||
164217243|NCT01658878|593162018|FG004|Treatment Period|Lost to Follow-up|0|||
164217244|NCT01658878|593162019|FG005|Treatment Period|Lost to Follow-up|0|||
164217245|NCT01658878|593162020|FG006|Treatment Period|Lost to Follow-up|0|||
164217246|NCT01658878|593162021|FG007|Treatment Period|Lost to Follow-up|0|||
164217247|NCT01658878|593162022|FG008|Treatment Period|Lost to Follow-up|0|||
164217248|NCT01658878|593162023|FG009|Treatment Period|Lost to Follow-up|0|||
164217249|NCT01658878|593162024|FG010|Treatment Period|Lost to Follow-up|0|||
164217250|NCT01658878|593162025|FG011|Treatment Period|Lost to Follow-up|0|||
164217251|NCT01658878|593162026|FG012|Treatment Period|Lost to Follow-up|0|||
164217252|NCT01658878|593162027|FG013|Treatment Period|Lost to Follow-up|0|||
164217253|NCT01658878|593162028|FG014|Treatment Period|Lost to Follow-up|0|||
164217254|NCT01658878|593162029|FG015|Treatment Period|Lost to Follow-up|0|||
164217255|NCT01658878|593162030|FG016|Treatment Period|Lost to Follow-up|1|||
164217256|NCT01658878|593162031|FG017|Treatment Period|Lost to Follow-up|0|||
164217257|NCT01658878|593162032|FG018|Treatment Period|Lost to Follow-up|1|||
164217258|NCT01658878|593162033|FG019|Treatment Period|Lost to Follow-up|1|||
164217259|NCT01658878|593162034|FG020|Treatment Period|Lost to Follow-up|0|||
164217260|NCT01658878|593162035|FG021|Treatment Period|Lost to Follow-up|0|||
164217261|NCT01658878|593162036|FG022|Treatment Period|Lost to Follow-up|1|||
164217262|NCT01658878|593162037|FG023|Treatment Period|Lost to Follow-up|0|||
164217263|NCT00134719|593162039|FG000|Primary Vaccination Phase|Adverse Event|4|||
164217264|NCT00134719|593162040|FG001|Primary Vaccination Phase|Adverse Event|0|||
164217265|NCT00134719|593162041|FG002|Primary Vaccination Phase|Adverse Event|0|||
164217266|NCT00134719|593162039|FG000|Primary Vaccination Phase|Protocol Violation|1|||
164217267|NCT00134719|593162040|FG001|Primary Vaccination Phase|Protocol Violation|0|||
164217268|NCT00134719|593162041|FG002|Primary Vaccination Phase|Protocol Violation|0|||
164217269|NCT00134719|593162039|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
164217270|NCT00134719|593162040|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
164217271|NCT00134719|593162041|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
164217272|NCT00134719|593162039|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
164217273|NCT00134719|593162040|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
164217274|NCT00134719|593162041|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
164217275|NCT00134719|593162039|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
164217276|NCT00134719|593162040|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
164217277|NCT00134719|593162041|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
164217278|NCT00134719|593162039|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
164217279|NCT00134719|593162040|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
164217280|NCT00134719|593162041|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
164217281|NCT01807520|593162042|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
164217282|NCT01807520|593162043|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
164217283|NCT01807520|593162044|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
164217284|NCT01807520|593162045|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
164217285|NCT01807520|593162046|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
164217286|NCT01807520|593162047|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
164217287|NCT01807520|593162048|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
164217288|NCT01807520|593162042|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
164217289|NCT01807520|593162043|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
164217290|NCT01807520|593162044|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
164217291|NCT01807520|593162045|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
164217292|NCT01807520|593162046|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
164217293|NCT01807520|593162047|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
164217294|NCT01807520|593162048|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
164217295|NCT01807520|593162042|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
164217296|NCT01807520|593162043|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
164217297|NCT01807520|593162044|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
164326757|NCT00356122|593571616|FG000|TREATMENT|Did not receive study medication|1|||
164217298|NCT01807520|593162045|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
164217299|NCT01807520|593162046|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
164217300|NCT01807520|593162047|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
164217301|NCT01807520|593162048|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
164217302|NCT01807520|593162042|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
164217303|NCT01807520|593162043|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
164217304|NCT01807520|593162044|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
164217305|NCT01807520|593162045|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
164217306|NCT01807520|593162046|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
164217307|NCT01807520|593162047|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
164217308|NCT01807520|593162048|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
164217309|NCT01807520|593162042|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
164217310|NCT01807520|593162043|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
164217311|NCT01807520|593162044|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
164217312|NCT01807520|593162045|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
164217313|NCT01807520|593162046|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
164217314|NCT01807520|593162047|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
164217315|NCT01807520|593162048|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
164217316|NCT01807520|593162042|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
164217317|NCT01807520|593162043|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
164217318|NCT01807520|593162044|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
164217319|NCT01807520|593162045|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
164217320|NCT01807520|593162046|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
164217321|NCT01807520|593162047|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
164217322|NCT01807520|593162048|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
164217323|NCT01807520|593162042|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
164217324|NCT01807520|593162043|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
164217325|NCT01807520|593162044|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
164217326|NCT01807520|593162045|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
164217327|NCT01807520|593162046|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
164217328|NCT01807520|593162047|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
164217329|NCT01807520|593162048|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
164217330|NCT01807520|593162042|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
164217331|NCT01807520|593162043|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
164217332|NCT01807520|593162044|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
164217333|NCT01807520|593162045|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
164217334|NCT01807520|593162046|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
164217335|NCT01807520|593162047|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
164217336|NCT01807520|593162048|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
164217337|NCT01807520|593162042|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
164217338|NCT01807520|593162043|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
164217339|NCT01807520|593162044|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
164217340|NCT01807520|593162045|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
164217341|NCT01807520|593162046|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
164217342|NCT01807520|593162047|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
164217343|NCT01807520|593162048|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
164217344|NCT01807520|593162042|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
164217345|NCT01807520|593162043|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
164217346|NCT01807520|593162044|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
164217347|NCT01807520|593162045|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
164217348|NCT01807520|593162046|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
164217349|NCT01807520|593162047|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
164217350|NCT01807520|593162048|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
164217351|NCT01807520|593162042|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
164217352|NCT01807520|593162043|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
164217353|NCT01807520|593162044|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
164217354|NCT01807520|593162045|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
164217355|NCT01807520|593162046|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
164217356|NCT01807520|593162047|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
164217357|NCT01807520|593162048|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
164217358|NCT01807520|593162042|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
164217359|NCT01807520|593162043|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
164217360|NCT01807520|593162044|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
164217361|NCT01807520|593162045|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
164217362|NCT01807520|593162046|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
164217363|NCT01807520|593162047|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
164217364|NCT01807520|593162048|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
164217365|NCT01807520|593162042|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
164217366|NCT01807520|593162043|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
164217367|NCT01807520|593162044|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
164217368|NCT01807520|593162045|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
164217369|NCT01807520|593162046|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
164217370|NCT01807520|593162047|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
164217371|NCT01807520|593162048|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
164217372|NCT01807520|593162042|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
164217373|NCT01807520|593162043|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
164217374|NCT01807520|593162044|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
164217375|NCT01807520|593162045|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
164217376|NCT01807520|593162046|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
164217377|NCT01807520|593162047|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
164217378|NCT01807520|593162048|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
164217379|NCT01807520|593162042|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
164217380|NCT01807520|593162043|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
164217381|NCT01807520|593162044|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
164217382|NCT01807520|593162045|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
164217383|NCT01807520|593162046|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
164217384|NCT01807520|593162047|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
164217385|NCT01807520|593162048|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
164217386|NCT01807520|593162042|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
164217387|NCT01807520|593162043|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
164565589|NCT02863848|594440390|FG001|Overall Study|Protocol Violation|2|||
164565590|NCT00686127|594440393|FG000|Overall Study|Withdrawal by Subject|14|||
164217388|NCT01807520|593162044|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
164217389|NCT01807520|593162045|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
164217390|NCT01807520|593162046|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
164217391|NCT01807520|593162047|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
164217392|NCT01807520|593162048|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
164217393|NCT01807520|593162042|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
164217394|NCT01807520|593162043|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
164217395|NCT01807520|593162044|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
164217396|NCT01807520|593162045|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
164217397|NCT01807520|593162046|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
164217398|NCT01807520|593162047|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
164217399|NCT01807520|593162048|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
164217400|NCT00620035|593162051|FG000|Overall Study|Adverse Event|106|||
164217401|NCT00620035|593162051|FG000|Overall Study|Withdrawal of Informed Consent|1|||
164217402|NCT00620035|593162051|FG000|Overall Study|Other Reason|38|||
164217403|NCT03600350|593162053|FG000|Overall Study|Death|1|||
164217404|NCT03600350|593162053|FG000|Overall Study|On Follow Up|18|||
164217405|NCT02400736|593162054|FG000|Overall Study|Lost to Follow-up|6|||
164217406|NCT02400736|593162055|FG001|Overall Study|Lost to Follow-up|6|||
164217407|NCT02400736|593162054|FG000|Overall Study|Withdrawal by Subject|2|||
164217408|NCT02400736|593162055|FG001|Overall Study|Withdrawal by Subject|1|||
164326758|NCT00356122|593571616|FG000|FOLLOW-UP|Death|37|||
164326759|NCT00356122|593571616|FG000|FOLLOW-UP|Lost to Follow-up|2|||
164326760|NCT00356122|593571616|FG000|FOLLOW-UP|Other|2|||
164326761|NCT00636987|593572546|FG000|Overall Study|Death|44|||
164326762|NCT00636987|593572546|FG000|Overall Study|Explanted|13|||
164326763|NCT00636987|593572546|FG000|Overall Study|Lost to Follow-up|63|||
164326764|NCT00636987|593572546|FG000|Overall Study|5 year visit window not complete|69|||
164326765|NCT03954041|593572552|FG000|Overall Study|Lost to Follow-up|3|||
164326766|NCT03954041|593572553|FG001|Overall Study|Lost to Follow-up|3|||
164326767|NCT03954041|593572554|FG002|Overall Study|Lost to Follow-up|6|||
164326768|NCT03954041|593572552|FG000|Overall Study|Death|4|||
164326769|NCT03954041|593572553|FG001|Overall Study|Death|0|||
164326770|NCT03954041|593572554|FG002|Overall Study|Death|1|||
164326771|NCT03954041|593572552|FG000|Overall Study|Death by neurologic criteria|0|||
164326772|NCT03954041|593572553|FG001|Overall Study|Death by neurologic criteria|0|||
164326773|NCT03954041|593572554|FG002|Overall Study|Death by neurologic criteria|1|||
164326774|NCT03954041|593572552|FG000|Overall Study|Reason not specified|7|||
164565591|NCT00686127|594440394|FG001|Overall Study|Withdrawal by Subject|6|||
164565592|NCT05195528|594440395|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
164565593|NCT05195528|594440396|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
164565594|NCT05195528|594440397|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
164217409|NCT02400736|593162054|FG000|Overall Study|Moved from the area|3|||
164217410|NCT02400736|593162055|FG001|Overall Study|Moved from the area|1|||
164217411|NCT01771913|593162056|FG000|Overall Study|Withdrawal by Subject|1|||
164217412|NCT01771913|593162057|FG001|Overall Study|Withdrawal by Subject|0|||
164326775|NCT03954041|593572553|FG001|Overall Study|Reason not specified|4|||
164217413|NCT04621760|593162058|FG000|Overall Study|Lost to Follow-up|2|||
164217414|NCT04621760|593162059|FG001|Overall Study|Lost to Follow-up|4|||
164217415|NCT04621760|593162058|FG000|Overall Study|Withdrawal by Subject|1|||
164326776|NCT03954041|593572554|FG002|Overall Study|Reason not specified|2|||
164326777|NCT03954041|593572552|FG000|Overall Study|Withdrew prior to dosing|4|||
164326778|NCT03954041|593572553|FG001|Overall Study|Withdrew prior to dosing|2|||
164326779|NCT03954041|593572554|FG002|Overall Study|Withdrew prior to dosing|0|||
164326780|NCT00442468|593572562|FG000|Overall Study|Adverse Event|4|||
164326781|NCT00442468|593572562|FG000|Overall Study|Withdrawal by Subject|91|||
164326782|NCT00442468|593572562|FG000|Overall Study|Did not complete all study procedures|88|||
164326783|NCT00589784|593572563|FG000|Overall Study|Withdrawal by Subject|0|||
164326784|NCT00589784|593572564|FG001|Overall Study|Withdrawal by Subject|6|||
164326785|NCT00589784|593572563|FG000|Overall Study|Patient inevaluable|1|||
164326786|NCT00589784|593572564|FG001|Overall Study|Patient inevaluable|0|||
164326787|NCT00589784|593572563|FG000|Overall Study|Adverse Event|0|||
164326788|NCT00589784|593572564|FG001|Overall Study|Adverse Event|4|||
164326789|NCT00287079|593572566|FG000|Overall Study|Qualifying relapse|12|||
164326790|NCT00287079|593572567|FG001|Overall Study|Qualifying relapse|1|||
164326791|NCT00287079|593572566|FG000|Overall Study|Non-qualifying relapse|1|||
164326792|NCT00287079|593572567|FG001|Overall Study|Non-qualifying relapse|0|||
164326793|NCT00287079|593572566|FG000|Overall Study|Adverse Event|5|||
164326794|NCT00287079|593572567|FG001|Overall Study|Adverse Event|0|||
164326795|NCT00287079|593572566|FG000|Overall Study|Protocol Violation|1|||
164326796|NCT00287079|593572567|FG001|Overall Study|Protocol Violation|0|||
164326797|NCT00287079|593572566|FG000|Overall Study|Other|3|||
164217416|NCT04621760|593162059|FG001|Overall Study|Withdrawal by Subject|0|||
164217417|NCT02029443|593162060|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
164217418|NCT02029443|593162061|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
164217419|NCT02029443|593162062|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
164217420|NCT02029443|593162063|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
164217421|NCT02029443|593162064|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
164217422|NCT02029443|593162060|FG000|Overall Study|Death|13|||
164217423|NCT02029443|593162061|FG001|Overall Study|Death|2|||
164217424|NCT02029443|593162062|FG002|Overall Study|Death|2|||
164326798|NCT00287079|593572567|FG001|Overall Study|Other|0|||
164326799|NCT02953509|593572572|FG000|Overall Study|Death|1|||
164326800|NCT02953509|593572573|FG001|Overall Study|Death|3|||
164326801|NCT02953509|593572574|FG002|Overall Study|Death|3|||
164326802|NCT02953509|593572575|FG003|Overall Study|Death|4|||
164326803|NCT02953509|593572576|FG004|Overall Study|Death|12|||
164326804|NCT02953509|593572577|FG005|Overall Study|Death|3|||
164326805|NCT02953509|593572578|FG006|Overall Study|Death|25|||
164326806|NCT02953509|593572579|FG007|Overall Study|Death|10|||
164326807|NCT02953509|593572580|FG008|Overall Study|Death|21|||
164326808|NCT02953509|593572581|FG009|Overall Study|Death|20|||
164326809|NCT02953509|593572572|FG000|Overall Study|Reason Not Specified|0|||
164326810|NCT02953509|593572573|FG001|Overall Study|Reason Not Specified|2|||
164326811|NCT02953509|593572574|FG002|Overall Study|Reason Not Specified|8|||
164326812|NCT02953509|593572575|FG003|Overall Study|Reason Not Specified|2|||
164326813|NCT02953509|593572576|FG004|Overall Study|Reason Not Specified|11|||
164326814|NCT02953509|593572577|FG005|Overall Study|Reason Not Specified|4|||
164326815|NCT02953509|593572578|FG006|Overall Study|Reason Not Specified|12|||
164326816|NCT02953509|593572579|FG007|Overall Study|Reason Not Specified|2|||
164326817|NCT02953509|593572580|FG008|Overall Study|Reason Not Specified|7|||
164326818|NCT02953509|593572581|FG009|Overall Study|Reason Not Specified|2|||
164326819|NCT02953509|593572572|FG000|Overall Study|Consent Withdrawn|1|||
164326820|NCT02953509|593572573|FG001|Overall Study|Consent Withdrawn|1|||
164326821|NCT02953509|593572574|FG002|Overall Study|Consent Withdrawn|2|||
164326822|NCT02953509|593572575|FG003|Overall Study|Consent Withdrawn|1|||
164326823|NCT02953509|593572576|FG004|Overall Study|Consent Withdrawn|3|||
164326824|NCT02953509|593572577|FG005|Overall Study|Consent Withdrawn|0|||
164326825|NCT02953509|593572578|FG006|Overall Study|Consent Withdrawn|4|||
164326826|NCT02953509|593572579|FG007|Overall Study|Consent Withdrawn|1|||
164326827|NCT02953509|593572580|FG008|Overall Study|Consent Withdrawn|1|||
164326828|NCT02953509|593572581|FG009|Overall Study|Consent Withdrawn|4|||
164326829|NCT02953509|593572572|FG000|Overall Study|Lost to Follow-up|0|||
164326830|NCT02953509|593572573|FG001|Overall Study|Lost to Follow-up|0|||
164326831|NCT02953509|593572574|FG002|Overall Study|Lost to Follow-up|0|||
164326832|NCT02953509|593572575|FG003|Overall Study|Lost to Follow-up|0|||
164326833|NCT02953509|593572576|FG004|Overall Study|Lost to Follow-up|0|||
164326834|NCT02953509|593572577|FG005|Overall Study|Lost to Follow-up|0|||
164326835|NCT02953509|593572578|FG006|Overall Study|Lost to Follow-up|1|||
164326836|NCT02953509|593572579|FG007|Overall Study|Lost to Follow-up|1|||
164326837|NCT02953509|593572580|FG008|Overall Study|Lost to Follow-up|1|||
164326838|NCT02953509|593572581|FG009|Overall Study|Lost to Follow-up|1|||
164217425|NCT02029443|593162063|FG003|Overall Study|Death|11|||
164217426|NCT02029443|593162064|FG004|Overall Study|Death|2|||
164326839|NCT02953509|593572572|FG000|Overall Study|Study terminated by sponsor|1|||
164326840|NCT02953509|593572573|FG001|Overall Study|Study terminated by sponsor|0|||
164326841|NCT02953509|593572574|FG002|Overall Study|Study terminated by sponsor|0|||
164326842|NCT02953509|593572575|FG003|Overall Study|Study terminated by sponsor|0|||
164326843|NCT02953509|593572576|FG004|Overall Study|Study terminated by sponsor|0|||
164326844|NCT02953509|593572577|FG005|Overall Study|Study terminated by sponsor|0|||
164217427|NCT02029443|593162060|FG000|Overall Study|Lost to Follow-up|1|||
164217428|NCT02029443|593162061|FG001|Overall Study|Lost to Follow-up|0|||
164217429|NCT02029443|593162062|FG002|Overall Study|Lost to Follow-up|1|||
164217430|NCT02029443|593162063|FG003|Overall Study|Lost to Follow-up|1|||
164217431|NCT02029443|593162064|FG004|Overall Study|Lost to Follow-up|0|||
164217432|NCT02029443|593162060|FG000|Overall Study|Started other anti-cancer therapy|17|||
164217433|NCT02029443|593162061|FG001|Overall Study|Started other anti-cancer therapy|4|||
164217434|NCT02029443|593162062|FG002|Overall Study|Started other anti-cancer therapy|7|||
164217435|NCT02029443|593162063|FG003|Overall Study|Started other anti-cancer therapy|9|||
164326845|NCT02953509|593572578|FG006|Overall Study|Study terminated by sponsor|1|||
164326846|NCT02953509|593572579|FG007|Overall Study|Study terminated by sponsor|0|||
164326847|NCT02953509|593572580|FG008|Overall Study|Study terminated by sponsor|1|||
164326848|NCT02953509|593572581|FG009|Overall Study|Study terminated by sponsor|1|||
164326849|NCT02325791|593572586|FG000|Overall Study|Adverse Event|0|||
164326850|NCT02325791|593572587|FG001|Overall Study|Adverse Event|1|||
164326851|NCT02325791|593572588|FG002|Overall Study|Adverse Event|1|||
164326852|NCT02325791|593572589|FG003|Overall Study|Adverse Event|0|||
164326853|NCT02325791|593572586|FG000|Overall Study|Death|0|||
164326854|NCT02325791|593572587|FG001|Overall Study|Death|3|||
164326855|NCT02325791|593572588|FG002|Overall Study|Death|0|||
164326856|NCT02325791|593572589|FG003|Overall Study|Death|1|||
164326857|NCT02325791|593572586|FG000|Overall Study|Lost to Follow-up|0|||
164326858|NCT02325791|593572587|FG001|Overall Study|Lost to Follow-up|15|||
164326859|NCT02325791|593572588|FG002|Overall Study|Lost to Follow-up|14|||
164326860|NCT02325791|593572589|FG003|Overall Study|Lost to Follow-up|9|||
164326861|NCT02325791|593572586|FG000|Overall Study|Physician Decision|0|||
164326862|NCT02325791|593572587|FG001|Overall Study|Physician Decision|1|||
164326863|NCT02325791|593572588|FG002|Overall Study|Physician Decision|1|||
164326864|NCT02325791|593572589|FG003|Overall Study|Physician Decision|0|||
164326865|NCT02325791|593572586|FG000|Overall Study|Protocol Violation|0|||
164326866|NCT02325791|593572587|FG001|Overall Study|Protocol Violation|0|||
164326867|NCT02325791|593572588|FG002|Overall Study|Protocol Violation|1|||
164326868|NCT02325791|593572589|FG003|Overall Study|Protocol Violation|0|||
164326869|NCT02325791|593572586|FG000|Overall Study|Withdrawal by Subject|0|||
164326870|NCT02325791|593572587|FG001|Overall Study|Withdrawal by Subject|5|||
164326871|NCT02325791|593572588|FG002|Overall Study|Withdrawal by Subject|8|||
164326872|NCT02325791|593572589|FG003|Overall Study|Withdrawal by Subject|16|||
164326873|NCT00722371|593572590|FG000|Overall Study|Adverse Event|6|||
164326874|NCT00722371|593572591|FG001|Overall Study|Adverse Event|13|||
164326875|NCT00722371|593572592|FG002|Overall Study|Adverse Event|9|||
164326876|NCT00722371|593572593|FG003|Overall Study|Adverse Event|10|||
164326877|NCT00722371|593572594|FG004|Overall Study|Adverse Event|6|||
164326878|NCT00722371|593572595|FG005|Overall Study|Adverse Event|8|||
164326879|NCT00722371|593572596|FG006|Overall Study|Adverse Event|4|||
164326880|NCT00722371|593572590|FG000|Overall Study|Contraindication|0|||
164326881|NCT00722371|593572591|FG001|Overall Study|Contraindication|0|||
164326882|NCT00722371|593572592|FG002|Overall Study|Contraindication|1|||
164326883|NCT00722371|593572593|FG003|Overall Study|Contraindication|0|||
164326884|NCT00722371|593572594|FG004|Overall Study|Contraindication|0|||
164326885|NCT00722371|593572595|FG005|Overall Study|Contraindication|0|||
164326886|NCT00722371|593572596|FG006|Overall Study|Contraindication|0|||
164326887|NCT00722371|593572590|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
164326888|NCT00722371|593572591|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
164326889|NCT00722371|593572592|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
164326890|NCT00722371|593572593|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
164326891|NCT00722371|593572594|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
164669991|NCT03048500|594816807|FG000|Reached 1st Response/Continued Treatment|Death|1|||
164669992|NCT03048500|594816807|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
164669993|NCT03048500|594816807|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
164669994|NCT03048500|594816807|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
164669995|NCT03048500|594816807|FG000|Follow up for 3 Years|Death|12|||
164669996|NCT03361228|594816817|FG000|Overall Study|Other|1|||
164669997|NCT03361228|594816818|FG001|Overall Study|Other|1|||
164669998|NCT03361228|594816817|FG000|Overall Study|Death|3|||
164669999|NCT03361228|594816818|FG001|Overall Study|Death|0|||
164670000|NCT01479439|594816819|FG000|Overall Study|Adverse Event|1|||
164670001|NCT01479439|594816820|FG001|Overall Study|Adverse Event|0|||
164670002|NCT01479439|594816821|FG002|Overall Study|Adverse Event|0|||
164670003|NCT01479439|594816819|FG000|Overall Study|Lost to Follow-up|0|||
164670004|NCT01479439|594816820|FG001|Overall Study|Lost to Follow-up|1|||
164670005|NCT01479439|594816821|FG002|Overall Study|Lost to Follow-up|0|||
164670006|NCT01479439|594816819|FG000|Overall Study|Protocol Violation|0|||
164670007|NCT01479439|594816820|FG001|Overall Study|Protocol Violation|0|||
164670008|NCT01479439|594816821|FG002|Overall Study|Protocol Violation|2|||
164217436|NCT02029443|593162064|FG004|Overall Study|Started other anti-cancer therapy|3|||
164326892|NCT00722371|593572595|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
164326893|NCT00722371|593572596|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
164326894|NCT00722371|593572590|FG000|Overall Study|Excluded medication|0|||
164217437|NCT02029443|593162060|FG000|Overall Study|Withdrawal by Subject|3|||
164217438|NCT02029443|593162061|FG001|Overall Study|Withdrawal by Subject|1|||
164217439|NCT02029443|593162062|FG002|Overall Study|Withdrawal by Subject|1|||
164217440|NCT02029443|593162063|FG003|Overall Study|Withdrawal by Subject|1|||
164217441|NCT02029443|593162064|FG004|Overall Study|Withdrawal by Subject|0|||
164326895|NCT00722371|593572591|FG001|Overall Study|Excluded medication|1|||
164326896|NCT00722371|593572592|FG002|Overall Study|Excluded medication|1|||
164326897|NCT00722371|593572593|FG003|Overall Study|Excluded medication|0|||
164326898|NCT00722371|593572594|FG004|Overall Study|Excluded medication|0|||
164326899|NCT00722371|593572595|FG005|Overall Study|Excluded medication|0|||
164326900|NCT00722371|593572596|FG006|Overall Study|Excluded medication|1|||
164326901|NCT00722371|593572590|FG000|Overall Study|Hyperglycemia|2|||
164326902|NCT00722371|593572591|FG001|Overall Study|Hyperglycemia|6|||
164326903|NCT00722371|593572592|FG002|Overall Study|Hyperglycemia|4|||
164326904|NCT00722371|593572593|FG003|Overall Study|Hyperglycemia|2|||
164326905|NCT00722371|593572594|FG004|Overall Study|Hyperglycemia|5|||
164217442|NCT02029443|593162060|FG000|Overall Study|Other|6|||
164217443|NCT02029443|593162061|FG001|Overall Study|Other|6|||
164217444|NCT02029443|593162062|FG002|Overall Study|Other|4|||
164217445|NCT02029443|593162063|FG003|Overall Study|Other|2|||
164217446|NCT02029443|593162064|FG004|Overall Study|Other|0|||
164217447|NCT00366535|593162065|FG000|First Phase: 12 Weeks|Adverse Event|1|||
164217448|NCT00366535|593162066|FG001|First Phase: 12 Weeks|Adverse Event|3|||
164217449|NCT00366535|593162065|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
164217450|NCT00366535|593162066|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
164217451|NCT00366535|593162065|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
164217452|NCT00366535|593162066|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
164217453|NCT00366535|593162065|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
164217454|NCT00366535|593162066|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
164217455|NCT06042855|593162071|FG000|Overall Study|No Receipt of Study Drug|48|||
164217456|NCT06042855|593162072|FG001|Overall Study|No Receipt of Study Drug|57|||
164217457|NCT06042855|593162071|FG000|Overall Study|Administratively Withdrawn|59|||
164217458|NCT06042855|593162072|FG001|Overall Study|Administratively Withdrawn|59|||
164217459|NCT01428128|593162077|FG000|Overall Study|Withdrawal by Subject|4|||
164217460|NCT01428128|593162077|FG000|Overall Study|Screen failure by p53|10|||
164217461|NCT01428128|593162077|FG000|Overall Study|Received Neulasta in one cycle|2|||
164217462|NCT01428128|593162077|FG000|Overall Study|Adverse Event|1|||
164217463|NCT06100250|593162079|FG000|Overall Study|Lost to Follow-up|5|||
164217464|NCT05259033|593162081|FG000|Overall Study|Withdrawal by Subject|10|||
164217465|NCT05259033|593162082|FG001|Overall Study|Withdrawal by Subject|5|||
164217466|NCT05259033|593162081|FG000|Overall Study|Lost to Follow-up|1|||
164217467|NCT05259033|593162082|FG001|Overall Study|Lost to Follow-up|0|||
164217468|NCT05259033|593162081|FG000|Overall Study|Death|2|||
164217469|NCT05259033|593162082|FG001|Overall Study|Death|0|||
164217470|NCT05537571|593162083|FG000|Overall Study|Withdrawal by Subject|1|||
164217471|NCT05537571|593162084|FG001|Overall Study|Withdrawal by Subject|1|||
164217472|NCT05537571|593162085|FG002|Overall Study|Withdrawal by Subject|0|||
164217473|NCT05537571|593162086|FG003|Overall Study|Withdrawal by Subject|0|||
164217474|NCT05537571|593162087|FG004|Overall Study|Withdrawal by Subject|0|||
164217475|NCT05537571|593162083|FG000|Overall Study|Adverse Event|2|||
164217476|NCT05537571|593162084|FG001|Overall Study|Adverse Event|0|||
164217477|NCT05537571|593162085|FG002|Overall Study|Adverse Event|0|||
164217478|NCT05537571|593162086|FG003|Overall Study|Adverse Event|0|||
164217479|NCT05537571|593162087|FG004|Overall Study|Adverse Event|0|||
164217480|NCT05537571|593162083|FG000|Overall Study|Hepatitis A screening result|2|||
164217481|NCT05537571|593162084|FG001|Overall Study|Hepatitis A screening result|0|||
164217482|NCT05537571|593162085|FG002|Overall Study|Hepatitis A screening result|0|||
164217483|NCT05537571|593162086|FG003|Overall Study|Hepatitis A screening result|0|||
164217484|NCT05537571|593162087|FG004|Overall Study|Hepatitis A screening result|0|||
164217485|NCT05537571|593162083|FG000|Overall Study|Lost to Follow-up|0|||
164217486|NCT05537571|593162084|FG001|Overall Study|Lost to Follow-up|0|||
164217487|NCT05537571|593162085|FG002|Overall Study|Lost to Follow-up|1|||
164217488|NCT05537571|593162086|FG003|Overall Study|Lost to Follow-up|0|||
164217489|NCT05537571|593162087|FG004|Overall Study|Lost to Follow-up|1|||
164217490|NCT06375655|593162088|FG000|Overall Study|premature delivery (prior to 35 weeks GA)|2|||
164217491|NCT06375655|593162089|FG001|Overall Study|premature delivery (prior to 35 weeks GA)|1|||
164217492|NCT00283959|593162091|FG000|Extension Period|Low Compliance|1|||
164217493|NCT05865886|593162092|FG000|Overall Study|Serious adverse event|0|||
164217494|NCT05865886|593162093|FG001|Overall Study|Serious adverse event|1|||
164217495|NCT06394323|593162094|FG000|Overall Study|Death|0|||
164217496|NCT06394323|593162095|FG001|Overall Study|Death|1|||
164217497|NCT06394323|593162096|FG002|Overall Study|Death|0|||
164217498|NCT06394323|593162097|FG003|Overall Study|Death|0|||
164217499|NCT06394323|593162094|FG000|Overall Study|Physician Decision|0|||
164217500|NCT06394323|593162095|FG001|Overall Study|Physician Decision|2|||
164217501|NCT06394323|593162096|FG002|Overall Study|Physician Decision|0|||
164217502|NCT06394323|593162097|FG003|Overall Study|Physician Decision|0|||
164217503|NCT06394323|593162094|FG000|Overall Study|Withdrawal by Subject|4|||
164670009|NCT01722877|594816828|FG000|Overall Study|Death|1|||
164670010|NCT01722877|594816828|FG000|Overall Study|Lost to Follow-up|1|||
164670011|NCT03693430|594816829|FG000|Overall Study|Lost to Follow-up|3|||
164670012|NCT03693430|594816830|FG001|Overall Study|Lost to Follow-up|14|||
164670013|NCT03693430|594816829|FG000|Overall Study|Death|1|||
164670014|NCT03693430|594816830|FG001|Overall Study|Death|0|||
164670015|NCT03693430|594816829|FG000|Overall Study|Withdrawal by Subject|0|||
164670016|NCT03693430|594816830|FG001|Overall Study|Withdrawal by Subject|4|||
164670017|NCT02079766|594816831|FG000|Overall Study|Physician Decision|1|||
164670018|NCT02079766|594816832|FG001|Overall Study|Physician Decision|0|||
164670019|NCT02079766|594816831|FG000|Overall Study|Withdrawal by Subject|1|||
164670020|NCT02079766|594816832|FG001|Overall Study|Withdrawal by Subject|0|||
164670021|NCT02930005|594816834|FG000|Overall Study|Lost to Follow-up|1|||
164670022|NCT02930005|594816835|FG001|Overall Study|Lost to Follow-up|5|||
164670023|NCT00585689|594816836|FG000|Overall Study|Received different ABI-007 schedule|3|||
164670024|NCT00585689|594816836|FG000|Overall Study|Adverse Event|1|||
164670025|NCT00585689|594816836|FG000|Overall Study|Patient Declined Surgery|1|||
164670026|NCT00585689|594816836|FG000|Overall Study|Patient had unresectable disease|1|||
164670027|NCT00585689|594816836|FG000|Overall Study|Death|1|||
164670028|NCT02373098|594816837|FG000|Overall Study|Lost to Follow-up|1|||
164670029|NCT02373098|594816838|FG001|Overall Study|Lost to Follow-up|0|||
164670030|NCT02373098|594816837|FG000|Overall Study|Protocol Violation|3|||
164670031|NCT02373098|594816838|FG001|Overall Study|Protocol Violation|0|||
164670032|NCT02373098|594816837|FG000|Overall Study|Withdrawal by Subject|5|||
164670033|NCT02373098|594816838|FG001|Overall Study|Withdrawal by Subject|0|||
164670034|NCT02373098|594816837|FG000|Overall Study|Adverse Event|3|||
164670035|NCT02373098|594816838|FG001|Overall Study|Adverse Event|0|||
164670036|NCT03018249|594816845|FG000|Overall Study|Withdrawal by Subject|2|||
164670037|NCT03018249|594816846|FG001|Overall Study|Withdrawal by Subject|2|||
164670038|NCT00304083|594816848|FG000|Overall Study|Withdrawal by Subject|4|||
164670039|NCT00304083|594816849|FG001|Overall Study|Withdrawal by Subject|2|||
164670040|NCT00304083|594816848|FG000|Overall Study|Physician Decision|8|||
164670041|NCT00304083|594816849|FG001|Overall Study|Physician Decision|3|||
164326906|NCT00722371|593572595|FG005|Overall Study|Hyperglycemia|1|||
164326907|NCT00722371|593572596|FG006|Overall Study|Hyperglycemia|1|||
164326908|NCT00722371|593572590|FG000|Overall Study|Hypoglycemia|1|||
164326909|NCT00722371|593572591|FG001|Overall Study|Hypoglycemia|0|||
164326910|NCT00722371|593572592|FG002|Overall Study|Hypoglycemia|0|||
164326911|NCT00722371|593572593|FG003|Overall Study|Hypoglycemia|0|||
164326912|NCT00722371|593572594|FG004|Overall Study|Hypoglycemia|0|||
164326913|NCT00722371|593572595|FG005|Overall Study|Hypoglycemia|0|||
164326914|NCT00722371|593572596|FG006|Overall Study|Hypoglycemia|0|||
164326915|NCT00722371|593572590|FG000|Overall Study|Lack of Efficacy|4|||
164326916|NCT00722371|593572591|FG001|Overall Study|Lack of Efficacy|6|||
164326917|NCT00722371|593572592|FG002|Overall Study|Lack of Efficacy|6|||
164326918|NCT00722371|593572593|FG003|Overall Study|Lack of Efficacy|6|||
164326919|NCT00722371|593572594|FG004|Overall Study|Lack of Efficacy|2|||
164326920|NCT00722371|593572595|FG005|Overall Study|Lack of Efficacy|3|||
164326921|NCT00722371|593572596|FG006|Overall Study|Lack of Efficacy|0|||
164326922|NCT00722371|593572590|FG000|Overall Study|Lost to Follow-up|11|||
164326923|NCT00722371|593572591|FG001|Overall Study|Lost to Follow-up|14|||
164326924|NCT00722371|593572592|FG002|Overall Study|Lost to Follow-up|21|||
164326925|NCT00722371|593572593|FG003|Overall Study|Lost to Follow-up|13|||
164326926|NCT00722371|593572594|FG004|Overall Study|Lost to Follow-up|8|||
164326927|NCT00722371|593572595|FG005|Overall Study|Lost to Follow-up|16|||
164670042|NCT00304083|594816848|FG000|Overall Study|Disease Progression|5|||
164670043|NCT00304083|594816849|FG001|Overall Study|Disease Progression|1|||
164670044|NCT00304083|594816848|FG000|Overall Study|Other|5|||
164326928|NCT00722371|593572596|FG006|Overall Study|Lost to Follow-up|13|||
164326929|NCT00722371|593572590|FG000|Overall Study|Physician Decision|5|||
164326930|NCT00722371|593572591|FG001|Overall Study|Physician Decision|2|||
164326931|NCT00722371|593572592|FG002|Overall Study|Physician Decision|2|||
164326932|NCT00722371|593572593|FG003|Overall Study|Physician Decision|5|||
164326933|NCT00722371|593572594|FG004|Overall Study|Physician Decision|2|||
164326934|NCT00722371|593572595|FG005|Overall Study|Physician Decision|3|||
164326935|NCT00722371|593572596|FG006|Overall Study|Physician Decision|4|||
164326936|NCT00722371|593572590|FG000|Overall Study|Pregnancy|1|||
164326937|NCT00722371|593572591|FG001|Overall Study|Pregnancy|1|||
164670045|NCT00304083|594816849|FG001|Overall Study|Other|2|||
164326938|NCT00722371|593572592|FG002|Overall Study|Pregnancy|0|||
164326939|NCT00722371|593572593|FG003|Overall Study|Pregnancy|0|||
164670046|NCT03966365|594816850|FG000|Overall Study|Protocol Violation|1|||
164670047|NCT03966365|594816851|FG001|Overall Study|Protocol Violation|0|||
164670048|NCT01378975|594816852|FG000|Overall Study|Death|77|||
164670049|NCT01378975|594816853|FG001|Overall Study|Death|46|||
164326940|NCT00722371|593572594|FG004|Overall Study|Pregnancy|0|||
164670050|NCT01378975|594816852|FG000|Overall Study|Investigator Request|1|||
164670051|NCT01378975|594816853|FG001|Overall Study|Investigator Request|0|||
164217504|NCT06394323|593162095|FG001|Overall Study|Withdrawal by Subject|4|||
164217505|NCT06394323|593162096|FG002|Overall Study|Withdrawal by Subject|0|||
164217506|NCT06394323|593162097|FG003|Overall Study|Withdrawal by Subject|0|||
164217507|NCT01778985|593162982|FG000|Overall Study|Lost to Follow-up|1|||
164217508|NCT01778985|593162983|FG001|Overall Study|Lost to Follow-up|0|||
164217509|NCT01778985|593162982|FG000|Overall Study|Physician Decision|2|||
164217510|NCT01778985|593162983|FG001|Overall Study|Physician Decision|2|||
164217511|NCT01778985|593162982|FG000|Overall Study|Protocol Violation|4|||
164217512|NCT01778985|593162983|FG001|Overall Study|Protocol Violation|1|||
164217513|NCT01002105|593162984|FG000|Overall Study|Lost to Follow-up|10|||
164217514|NCT01002105|593162985|FG001|Overall Study|Lost to Follow-up|16|||
164217515|NCT01002105|593162984|FG000|Overall Study|non compliance|5|||
164326941|NCT00722371|593572595|FG005|Overall Study|Pregnancy|1|||
164326942|NCT00722371|593572596|FG006|Overall Study|Pregnancy|0|||
164326943|NCT00722371|593572590|FG000|Overall Study|Protocol Violation|6|||
164326944|NCT00722371|593572591|FG001|Overall Study|Protocol Violation|1|||
164326945|NCT00722371|593572592|FG002|Overall Study|Protocol Violation|0|||
164326946|NCT00722371|593572593|FG003|Overall Study|Protocol Violation|1|||
164326947|NCT00722371|593572594|FG004|Overall Study|Protocol Violation|4|||
164326948|NCT00722371|593572595|FG005|Overall Study|Protocol Violation|2|||
164326949|NCT00722371|593572596|FG006|Overall Study|Protocol Violation|1|||
164326950|NCT00722371|593572590|FG000|Overall Study|Withdrawal by Subject|18|||
164326951|NCT00722371|593572591|FG001|Overall Study|Withdrawal by Subject|27|||
164326952|NCT00722371|593572592|FG002|Overall Study|Withdrawal by Subject|19|||
164326953|NCT00722371|593572593|FG003|Overall Study|Withdrawal by Subject|23|||
164326954|NCT00722371|593572594|FG004|Overall Study|Withdrawal by Subject|19|||
164326955|NCT00722371|593572595|FG005|Overall Study|Withdrawal by Subject|18|||
164326956|NCT00722371|593572596|FG006|Overall Study|Withdrawal by Subject|26|||
164326957|NCT00718237|593572597|FG000|Overall Study|Adverse Event|1|||
164326958|NCT00718237|593572598|FG001|Overall Study|Adverse Event|3|||
164326959|NCT00718237|593572597|FG000|Overall Study|Lost to Follow-up|2|||
164326960|NCT00718237|593572598|FG001|Overall Study|Lost to Follow-up|2|||
164326961|NCT00718237|593572597|FG000|Overall Study|Physician Decision|1|||
164326962|NCT00718237|593572598|FG001|Overall Study|Physician Decision|0|||
164326963|NCT00718237|593572597|FG000|Overall Study|Withdrawal by Subject|9|||
164326964|NCT00718237|593572598|FG001|Overall Study|Withdrawal by Subject|10|||
164326965|NCT00555425|593572599|FG000|Overall Study|Missed Medication > 1 wk|34|||
164326966|NCT00555425|593572600|FG001|Overall Study|Missed Medication > 1 wk|15|||
164326967|NCT00555425|593572599|FG000|Overall Study|Missed 3 physician management visits|1|||
164326968|NCT00555425|593572600|FG001|Overall Study|Missed 3 physician management visits|0|||
164326969|NCT00555425|593572599|FG000|Overall Study|Met criteria for protective transfer|16|||
164326970|NCT00555425|593572600|FG001|Overall Study|Met criteria for protective transfer|3|||
164326971|NCT00555425|593572599|FG000|Overall Study|Became pregnant and transferred care|0|||
164326972|NCT00555425|593572600|FG001|Overall Study|Became pregnant and transferred care|1|||
164326973|NCT01185834|593572601|FG000|Overall Study|Lost to Follow-up|2|||
164326974|NCT01185834|593572601|FG000|Overall Study|Discomfort|4|||
164326975|NCT01185834|593572601|FG000|Overall Study|Biomicroscopy|4|||
164326976|NCT01185834|593572601|FG000|Overall Study|Time/Job Conflict|2|||
164326977|NCT01185834|593572601|FG000|Overall Study|Early exit - Site error|2|||
164326978|NCT02694718|593572603|FG000|Overall Study|Death|1|||
164326979|NCT02694718|593572603|FG000|Overall Study|Withdrawal by Subject|1|||
164326980|NCT00322153|593572605|FG000|Overall Study|Adverse Event|21|||
164326981|NCT00322153|593572606|FG001|Overall Study|Adverse Event|34|||
164326982|NCT00322153|593572605|FG000|Overall Study|Protocol Violation|6|||
164326983|NCT00322153|593572606|FG001|Overall Study|Protocol Violation|14|||
164326984|NCT00322153|593572605|FG000|Overall Study|Withdrawal by Subject|18|||
164326985|NCT00322153|593572606|FG001|Overall Study|Withdrawal by Subject|10|||
164326986|NCT00322153|593572605|FG000|Overall Study|Lack of Efficacy|8|||
164326987|NCT00322153|593572606|FG001|Overall Study|Lack of Efficacy|3|||
164565595|NCT05195528|594440398|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
164565596|NCT05195528|594440399|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
164565597|NCT05195528|594440395|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
164326988|NCT00322153|593572605|FG000|Overall Study|Lost to Follow-up|5|||
164326989|NCT00322153|593572606|FG001|Overall Study|Lost to Follow-up|4|||
164326990|NCT00322153|593572605|FG000|Overall Study|Withdrawn for other reasons|5|||
164326991|NCT00322153|593572606|FG001|Overall Study|Withdrawn for other reasons|4|||
164326992|NCT03523000|593572608|FG000|Overall Study|Withdrawal by Subject|3|||
164326993|NCT03523000|593572609|FG001|Overall Study|Withdrawal by Subject|0|||
164326994|NCT03523000|593572608|FG000|Overall Study|Unsuccessful trial|2|||
164217516|NCT01002105|593162985|FG001|Overall Study|non compliance|3|||
164217517|NCT01002105|593162984|FG000|Overall Study|condition worsened|4|||
164217518|NCT01002105|593162985|FG001|Overall Study|condition worsened|2|||
164217519|NCT00552058|593162986|FG000|Overall Study|Adverse Event|8|||
164326995|NCT03523000|593572609|FG001|Overall Study|Unsuccessful trial|0|||
164326996|NCT00772070|593572610|FG000|Overall Study|Lost to Follow-up|0|||
164326997|NCT00772070|593572611|FG001|Overall Study|Lost to Follow-up|8|||
164326998|NCT00772070|593572610|FG000|Overall Study|Withdrawal by Subject|0|||
164670052|NCT01378975|594816852|FG000|Overall Study|Lost to Follow-up|4|||
164670053|NCT01378975|594816853|FG001|Overall Study|Lost to Follow-up|1|||
164670054|NCT01378975|594816852|FG000|Overall Study|Withdrew Consent|4|||
164670055|NCT01378975|594816853|FG001|Overall Study|Withdrew Consent|3|||
164670056|NCT00694551|594816868|FG000|Overall Study|Disease Progression|1|||
164670057|NCT00694551|594816869|FG001|Overall Study|Disease Progression|0|||
164670058|NCT00694551|594816870|FG002|Overall Study|Disease Progression|1|||
164670059|NCT01937390|594816874|FG000|Overall Study|Death|2|||
164670060|NCT01937390|594816874|FG000|Overall Study|Lost to Follow-up|7|||
164670061|NCT01937390|594816874|FG000|Overall Study|Withdrawal by Subject|5|||
164670062|NCT01937390|594816874|FG000|Overall Study|Fail to return|21|||
164670063|NCT02216071|594816877|FG000|Overall Study|Withdrawal by Subject|7|||
164670064|NCT02216071|594816878|FG001|Overall Study|Withdrawal by Subject|2|||
164670065|NCT02216071|594816877|FG000|Overall Study|Lost to Follow-up|3|||
164670066|NCT02216071|594816878|FG001|Overall Study|Lost to Follow-up|3|||
164670067|NCT02216071|594816877|FG000|Overall Study|Protocol Violation|3|||
164670068|NCT02216071|594816878|FG001|Overall Study|Protocol Violation|5|||
164217520|NCT00552058|593162987|FG001|Overall Study|Adverse Event|7|||
164217521|NCT00552058|593162986|FG000|Overall Study|Lack of Efficacy|1|||
164217522|NCT00552058|593162987|FG001|Overall Study|Lack of Efficacy|5|||
164217523|NCT00552058|593162986|FG000|Overall Study|Lost to Follow-up|1|||
164217524|NCT00552058|593162987|FG001|Overall Study|Lost to Follow-up|0|||
164217525|NCT00552058|593162986|FG000|Overall Study|Withdrawal by Subject|4|||
164217526|NCT00552058|593162987|FG001|Overall Study|Withdrawal by Subject|4|||
164217527|NCT00552058|593162986|FG000|Overall Study|Other: Protocol Violation|0|||
164217528|NCT00552058|593162987|FG001|Overall Study|Other: Protocol Violation|1|||
164217529|NCT00552058|593162986|FG000|Overall Study|Other: Non Compliance|1|||
164217530|NCT00552058|593162987|FG001|Overall Study|Other: Non Compliance|2|||
164217531|NCT00552058|593162986|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
164217532|NCT00552058|593162987|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
164217533|NCT00552058|593162986|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
164217534|NCT00552058|593162987|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
164217535|NCT00552058|593162986|FG000|Overall Study|Other: Positive Stool Result|0|||
164217536|NCT00552058|593162987|FG001|Overall Study|Other: Positive Stool Result|1|||
164217537|NCT00552058|593162986|FG000|Overall Study|Other: Randomized in error|0|||
164217538|NCT00552058|593162987|FG001|Overall Study|Other: Randomized in error|1|||
164217539|NCT00552058|593162986|FG000|Overall Study|Other: Sponsors Decision|0|||
164217540|NCT00552058|593162987|FG001|Overall Study|Other: Sponsors Decision|1|||
164217541|NCT00552058|593162986|FG000|Overall Study|Other: Early Roll Over|1|||
164217542|NCT00552058|593162987|FG001|Overall Study|Other: Early Roll Over|0|||
164217543|NCT05788328|593162988|FG000|Treatment Period 4 (5 Days)|Other|1|||
164217544|NCT05788328|593162988|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
164217545|NCT00845182|593162989|FG000|Overall Study|Lost to Follow-up|3|||
164217546|NCT00845182|593162990|FG001|Overall Study|Lost to Follow-up|3|||
164217547|NCT00845182|593162991|FG002|Overall Study|Lost to Follow-up|4|||
164217548|NCT00845182|593162989|FG000|Overall Study|Adverse Event|0|||
164217549|NCT00845182|593162990|FG001|Overall Study|Adverse Event|1|||
164217550|NCT00845182|593162991|FG002|Overall Study|Adverse Event|1|||
164217551|NCT00845182|593162989|FG000|Overall Study|Physician Decision|0|||
164217552|NCT00845182|593162990|FG001|Overall Study|Physician Decision|0|||
164217553|NCT00845182|593162991|FG002|Overall Study|Physician Decision|1|||
164217554|NCT01875237|593162992|FG000|Overall Study|GVDH before DLI|1|||
164217555|NCT01875237|593162993|FG001|Overall Study|GVDH before DLI|0|||
164217556|NCT01875237|593162992|FG000|Overall Study|DLI cells could not be produced|1|||
164217557|NCT01875237|593162993|FG001|Overall Study|DLI cells could not be produced|0|||
164217558|NCT05558410|593162994|FG000|Overall Study|Adverse Event|1|||
164217559|NCT05558410|593162995|FG001|Overall Study|Adverse Event|2|||
164217560|NCT05558410|593162996|FG002|Overall Study|Adverse Event|0|||
164217561|NCT05558410|593162994|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
164217562|NCT05558410|593162995|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
164217563|NCT05558410|593162996|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
164217564|NCT05558410|593162994|FG000|Overall Study|Lost to Follow-up|10|||
164217565|NCT05558410|593162995|FG001|Overall Study|Lost to Follow-up|17|||
164217566|NCT05558410|593162996|FG002|Overall Study|Lost to Follow-up|19|||
164670069|NCT02216071|594816877|FG000|Overall Study|Other|2|||
164670070|NCT02216071|594816878|FG001|Overall Study|Other|2|||
164217567|NCT05558410|593162994|FG000|Overall Study|Death|1|||
164217568|NCT05558410|593162995|FG001|Overall Study|Death|0|||
164217569|NCT05558410|593162996|FG002|Overall Study|Death|0|||
164217570|NCT05558410|593162994|FG000|Overall Study|Other non-compliance|0|||
164217571|NCT05558410|593162995|FG001|Overall Study|Other non-compliance|1|||
164217572|NCT05558410|593162996|FG002|Overall Study|Other non-compliance|2|||
164217573|NCT05558410|593162994|FG000|Overall Study|Sponsor Decision|1|||
164217574|NCT05558410|593162995|FG001|Overall Study|Sponsor Decision|0|||
164217575|NCT05558410|593162996|FG002|Overall Study|Sponsor Decision|0|||
164217576|NCT05558410|593162994|FG000|Overall Study|Other|1|||
164670071|NCT01706536|594816879|FG000|Overall Study|Withdrawal by Subject|1|||
164670072|NCT01706536|594816880|FG001|Overall Study|Withdrawal by Subject|0|||
164217577|NCT05558410|593162995|FG001|Overall Study|Other|0|||
164217578|NCT05558410|593162996|FG002|Overall Study|Other|1|||
164326999|NCT00772070|593572611|FG001|Overall Study|Withdrawal by Subject|2|||
164327000|NCT00772070|593572610|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
164327001|NCT00772070|593572611|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
164327002|NCT03993379|593572616|FG000|Overall Study|The study was terminated early due to business decision.|0|||
164327003|NCT03993379|593572617|FG001|Overall Study|The study was terminated early due to business decision.|2|||
164327004|NCT03993379|593572618|FG002|Overall Study|The study was terminated early due to business decision.|0|||
164327005|NCT03993379|593572619|FG003|Overall Study|The study was terminated early due to business decision.|0|||
164327006|NCT03993379|593572616|FG000|Overall Study|Withdrawal by Subject|0|||
164327007|NCT03993379|593572617|FG001|Overall Study|Withdrawal by Subject|1|||
164327008|NCT03993379|593572618|FG002|Overall Study|Withdrawal by Subject|0|||
164327009|NCT03993379|593572619|FG003|Overall Study|Withdrawal by Subject|0|||
164327010|NCT02380690|593572620|FG000|Overall Study|Lost to Follow-up|14|||
164327011|NCT02380690|593572621|FG001|Overall Study|Lost to Follow-up|4|||
164327012|NCT02380690|593572620|FG000|Overall Study|Withdrawal by Subject|20|||
164327013|NCT02380690|593572621|FG001|Overall Study|Withdrawal by Subject|8|||
164327014|NCT02361346|593572622|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
164327015|NCT02361346|593572623|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
164327016|NCT02361346|593572624|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
164327017|NCT02361346|593572625|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
164327018|NCT02361346|593572626|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
164327019|NCT02361346|593572627|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
164327020|NCT02361346|593572628|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
164327021|NCT02361346|593572629|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
164327022|NCT02361346|593572630|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
164327023|NCT02361346|593572622|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
164327024|NCT02361346|593572623|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
164217579|NCT05141357|593162997|FG000|Overall Study|Adverse Event|3|||
164217580|NCT05141357|593162997|FG000|Overall Study|Lack of Efficacy|2|||
164217581|NCT01028560|593162998|FG000|Overall Study|Lack of Efficacy|3|||
164217582|NCT01028560|593162999|FG001|Overall Study|Lack of Efficacy|6|||
164327025|NCT02361346|593572624|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
164327026|NCT02361346|593572625|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
164327027|NCT02361346|593572626|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
164327028|NCT02361346|593572627|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
164327029|NCT02361346|593572628|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
164327030|NCT02361346|593572629|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
164327031|NCT02361346|593572630|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
164327032|NCT02361346|593572622|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
164327033|NCT02361346|593572623|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
164327034|NCT02361346|593572624|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
164327035|NCT02361346|593572625|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
164327036|NCT02361346|593572626|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
164327037|NCT02361346|593572627|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
164327038|NCT02361346|593572628|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
164327039|NCT02361346|593572629|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
164327040|NCT02361346|593572630|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
164327041|NCT02361346|593572622|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
164327042|NCT02361346|593572623|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
164327043|NCT02361346|593572624|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
164327044|NCT02361346|593572625|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
164327045|NCT02361346|593572626|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
164670073|NCT01706536|594816881|FG002|Overall Study|Withdrawal by Subject|1|||
164670074|NCT01706536|594816882|FG003|Overall Study|Withdrawal by Subject|0|||
164217583|NCT01028560|593162998|FG000|Overall Study|Withdrawal by Subject|7|||
164217584|NCT01028560|593162999|FG001|Overall Study|Withdrawal by Subject|12|||
164217585|NCT01960842|593163002|FG000|Overall Study|Adverse Event|1|||
164217586|NCT01960842|593163002|FG000|Overall Study|Withdrawal by Subject|2|||
164217587|NCT02441114|593163004|FG000|Washout2|Withdrawal by Subject|4|||
164217588|NCT05278065|593163005|FG000|Overall Study|Withdrawal by Subject|1|||
164217589|NCT05278065|593163006|FG001|Overall Study|Withdrawal by Subject|0|||
164217590|NCT02070991|593163011|FG000|Overall Study|Death|2|||
164217591|NCT02070991|593163012|FG001|Overall Study|Death|0|||
164217592|NCT02070991|593163011|FG000|Overall Study|Withdrawal by Subject|1|||
164217593|NCT02070991|593163012|FG001|Overall Study|Withdrawal by Subject|0|||
164217594|NCT04999020|593163013|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
164217595|NCT04999020|593163014|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
164217596|NCT04999020|593163015|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
164420683|NCT01154036|593910966|FG004|Phase II|Lost to Follow-up|2|||
164217597|NCT04999020|593163016|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
164217598|NCT04999020|593163013|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
164217599|NCT04999020|593163014|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
164217600|NCT04999020|593163015|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
164217601|NCT04999020|593163016|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
164217602|NCT04999020|593163013|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
164217603|NCT04999020|593163014|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
164217604|NCT04999020|593163015|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
164217605|NCT04999020|593163016|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
164217606|NCT04999020|593163013|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
164217607|NCT04999020|593163014|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
164217608|NCT04999020|593163015|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
164217609|NCT04999020|593163016|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
164217610|NCT04999020|593163013|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
164217611|NCT04999020|593163014|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
164217612|NCT04999020|593163015|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
164217613|NCT04999020|593163016|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
164217614|NCT04999020|593163013|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
164217615|NCT04999020|593163014|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
164217616|NCT04999020|593163015|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
164217617|NCT04999020|593163016|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
164217618|NCT04999020|593163013|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
164217619|NCT04999020|593163014|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
164217620|NCT04999020|593163015|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
164217621|NCT04999020|593163016|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
164217622|NCT04999020|593163013|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
164217623|NCT04999020|593163014|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
164327046|NCT02361346|593572627|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
164327047|NCT02361346|593572628|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
164327048|NCT02361346|593572629|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
164327049|NCT02361346|593572630|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
164327050|NCT02361346|593572622|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
164327051|NCT02361346|593572623|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
164327052|NCT02361346|593572624|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
164327053|NCT02361346|593572625|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
164327054|NCT02361346|593572626|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
164327055|NCT02361346|593572627|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
164327056|NCT02361346|593572628|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
164327057|NCT02361346|593572629|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
164327058|NCT02361346|593572630|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
164327059|NCT02361346|593572622|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
164327060|NCT02361346|593572623|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
164327061|NCT02361346|593572624|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
164327062|NCT02361346|593572625|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
164327063|NCT02361346|593572626|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
164327064|NCT02361346|593572627|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
164327065|NCT02361346|593572628|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
164327066|NCT02361346|593572629|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
164327067|NCT02361346|593572630|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
164327068|NCT02483429|593572634|FG000|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|8|||
164327069|NCT02483429|593572635|FG001|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|9|||
164327070|NCT03576274|593572636|FG000|Overall Study|Lost to Follow-up|3|||
164327071|NCT03576274|593572637|FG001|Overall Study|Lost to Follow-up|2|||
164327072|NCT03576274|593572638|FG002|Overall Study|Lost to Follow-up|3|||
164327073|NCT03576274|593572639|FG003|Overall Study|Lost to Follow-up|1|||
164327074|NCT03576274|593572640|FG004|Overall Study|Lost to Follow-up|3|||
164327075|NCT03576274|593572636|FG000|Overall Study|Withdrawal by Subject|5|||
164327076|NCT03576274|593572637|FG001|Overall Study|Withdrawal by Subject|3|||
164327077|NCT03576274|593572638|FG002|Overall Study|Withdrawal by Subject|2|||
164327078|NCT03576274|593572639|FG003|Overall Study|Withdrawal by Subject|8|||
164327079|NCT03576274|593572640|FG004|Overall Study|Withdrawal by Subject|6|||
164327080|NCT04854642|593574140|FG000|Overall Study|Adverse Event|1|||
164565598|NCT05195528|594440396|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
164565599|NCT05195528|594440397|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
164565600|NCT05195528|594440398|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
164565601|NCT05195528|594440399|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
164217624|NCT04999020|593163015|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
164670075|NCT01706536|594816883|FG004|Overall Study|Withdrawal by Subject|0|||
164670076|NCT01706536|594816879|FG000|Overall Study|Adverse Event|2|||
164670077|NCT01706536|594816880|FG001|Overall Study|Adverse Event|3|||
164670078|NCT01706536|594816881|FG002|Overall Study|Adverse Event|4|||
164670079|NCT01706536|594816882|FG003|Overall Study|Adverse Event|3|||
164217625|NCT04999020|593163016|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
164217626|NCT03123588|593163017|FG000|Overall Study|Study Terminated by Sponsor|2|||
164217627|NCT03123588|593163018|FG001|Overall Study|Study Terminated by Sponsor|5|||
164217628|NCT03123588|593163017|FG000|Overall Study|Withdrawal by Subject|1|||
164217629|NCT03123588|593163018|FG001|Overall Study|Withdrawal by Subject|0|||
164217630|NCT03123588|593163017|FG000|Overall Study|Adverse Event|1|||
164217631|NCT03123588|593163018|FG001|Overall Study|Adverse Event|0|||
164217632|NCT03123588|593163017|FG000|Overall Study|Physician Decision|2|||
164217633|NCT03123588|593163018|FG001|Overall Study|Physician Decision|1|||
164217634|NCT04740567|593163019|FG000|Overall Study|Death|31|||
164217635|NCT04740567|593163020|FG001|Overall Study|Death|43|||
164217636|NCT04740567|593163019|FG000|Overall Study|Lost to Follow-up|2|||
164217637|NCT04740567|593163020|FG001|Overall Study|Lost to Follow-up|11|||
164217638|NCT04740567|593163019|FG000|Overall Study|Patient declined to participate|13|||
164217639|NCT04740567|593163020|FG001|Overall Study|Patient declined to participate|26|||
164217640|NCT04740567|593163019|FG000|Overall Study|Patient was physically incapable|1|||
164217641|NCT04740567|593163020|FG001|Overall Study|Patient was physically incapable|3|||
164217642|NCT04740567|593163019|FG000|Overall Study|Patient's spouse was had prolongued ICU stay|0|||
164217643|NCT04740567|593163020|FG001|Overall Study|Patient's spouse was had prolongued ICU stay|1|||
164217644|NCT02063724|593163021|FG000|Overall Study|Disease progression|1|||
164217645|NCT02697422|593163022|FG000|Overall Study|Declined exit survey|9|||
164217646|NCT02697422|593163023|FG001|Overall Study|Declined exit survey|2|||
164217647|NCT02697422|593163022|FG000|Overall Study|Lost to Follow-up|13|||
164217648|NCT02697422|593163023|FG001|Overall Study|Lost to Follow-up|8|||
164217649|NCT02697422|593163022|FG000|Overall Study|Death|2|||
164217650|NCT02697422|593163023|FG001|Overall Study|Death|1|||
164217651|NCT02697422|593163022|FG000|Overall Study|Withdrawal by Subject|0|||
164217652|NCT02697422|593163023|FG001|Overall Study|Withdrawal by Subject|1|||
164217653|NCT02697422|593163022|FG000|Overall Study|Physician Decision|1|||
164217654|NCT02697422|593163023|FG001|Overall Study|Physician Decision|1|||
164217655|NCT02697422|593163022|FG000|Overall Study|Exit survey data lost|1|||
164217656|NCT02697422|593163023|FG001|Overall Study|Exit survey data lost|0|||
164217657|NCT02068599|593163025|FG000|Overall Study|Adverse Event|4|||
164217658|NCT02068599|593163026|FG001|Overall Study|Adverse Event|1|||
164217659|NCT02068599|593163027|FG002|Overall Study|Adverse Event|1|||
164217660|NCT02068599|593163025|FG000|Overall Study|Withdrawal by Subject|2|||
164217661|NCT02068599|593163026|FG001|Overall Study|Withdrawal by Subject|7|||
164217662|NCT02068599|593163027|FG002|Overall Study|Withdrawal by Subject|5|||
164217663|NCT02068599|593163025|FG000|Overall Study|Protocol Violation|4|||
164217664|NCT02068599|593163026|FG001|Overall Study|Protocol Violation|2|||
164217665|NCT02068599|593163027|FG002|Overall Study|Protocol Violation|3|||
164217666|NCT02068599|593163025|FG000|Overall Study|Lost to Follow-up|1|||
164217667|NCT02068599|593163026|FG001|Overall Study|Lost to Follow-up|0|||
164217668|NCT02068599|593163027|FG002|Overall Study|Lost to Follow-up|0|||
164217669|NCT02068599|593163025|FG000|Overall Study|Lack of Efficacy|0|||
164217670|NCT02068599|593163026|FG001|Overall Study|Lack of Efficacy|0|||
164217671|NCT02068599|593163027|FG002|Overall Study|Lack of Efficacy|3|||
164217672|NCT02068599|593163025|FG000|Overall Study|Noncompliance|0|||
164217673|NCT02068599|593163026|FG001|Overall Study|Noncompliance|0|||
164217674|NCT02068599|593163027|FG002|Overall Study|Noncompliance|1|||
164217675|NCT03019588|593163028|FG000|Overall Study|Death|44|||
164217676|NCT03019588|593163029|FG001|Overall Study|Death|46|||
164217677|NCT03019588|593163028|FG000|Overall Study|Study terminated by Sponsor|3|||
164217678|NCT03019588|593163029|FG001|Overall Study|Study terminated by Sponsor|1|||
164217679|NCT02958527|593163030|FG000|Overall Study|Not collected CRFs|12|||
164217680|NCT00699751|593163033|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
164217681|NCT00699751|593163034|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
164217682|NCT00699751|593163033|FG000|Period 1: Without/Before Drug Switch|Death|28|||
164217683|NCT00699751|593163034|FG001|Period 1: Without/Before Drug Switch|Death|29|||
164217684|NCT00699751|593163033|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
164670080|NCT01706536|594816883|FG004|Overall Study|Adverse Event|2|||
164670081|NCT01706536|594816879|FG000|Overall Study|Lack of Efficacy|1|||
164217685|NCT00699751|593163034|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
164217686|NCT00699751|593163033|FG000|Period 1: Without/Before Drug Switch|Other|30|||
164217687|NCT00699751|593163034|FG001|Period 1: Without/Before Drug Switch|Other|20|||
164217688|NCT00699751|593163033|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
164217689|NCT00699751|593163034|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
164217690|NCT00699751|593163033|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
164217691|NCT00699751|593163034|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
164217692|NCT00699751|593163033|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
164670082|NCT01706536|594816880|FG001|Overall Study|Lack of Efficacy|0|||
164327081|NCT04854642|593574141|FG001|Overall Study|Adverse Event|2|||
164327082|NCT04854642|593574140|FG000|Overall Study|Withdrawal by Subject|0|||
164327083|NCT04854642|593574141|FG001|Overall Study|Withdrawal by Subject|1|||
164327084|NCT02294773|593574143|FG000|Overall Study|Withdrawal by Subject|0|||
164327085|NCT02294773|593574144|FG001|Overall Study|Withdrawal by Subject|2|||
164327086|NCT01865084|593574145|FG000|Double Blind Period (DB)|Adverse Event|2|||
164327087|NCT01865084|593574146|FG001|Double Blind Period (DB)|Adverse Event|2|||
164327088|NCT01865084|593574147|FG002|Double Blind Period (DB)|Adverse Event|1|||
164327089|NCT01865084|593574145|FG000|Double Blind Period (DB)|Protocol Violation|0|||
164327090|NCT01865084|593574146|FG001|Double Blind Period (DB)|Protocol Violation|0|||
164327091|NCT01865084|593574147|FG002|Double Blind Period (DB)|Protocol Violation|1|||
164327092|NCT01865084|593574145|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
164327093|NCT01865084|593574146|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
164327094|NCT01865084|593574147|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
164327095|NCT01865084|593574145|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
164327096|NCT01865084|593574146|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
164327097|NCT01865084|593574147|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
164327098|NCT01865084|593574145|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
164327099|NCT01865084|593574146|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
164327100|NCT01865084|593574147|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
164327101|NCT01865084|593574145|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
164327102|NCT01865084|593574146|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
164327103|NCT01865084|593574147|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
164327104|NCT01865084|593574145|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
164327105|NCT01865084|593574146|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
164327106|NCT01865084|593574147|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
164327107|NCT01865084|593574145|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
164327108|NCT01865084|593574146|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
164327109|NCT01865084|593574147|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
164327110|NCT01865084|593574145|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
164327111|NCT01865084|593574146|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
164327112|NCT01865084|593574147|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
164327113|NCT03442764|593574148|FG000|Overall Study|Adverse Event|1|||
164327114|NCT03442764|593574149|FG001|Overall Study|Adverse Event|0|||
164327115|NCT03442764|593574150|FG002|Overall Study|Adverse Event|0|||
164327116|NCT01801072|593574151|FG000|Overall Study|Lost to Follow-up|17|||
164327117|NCT01801072|593574152|FG001|Overall Study|Lost to Follow-up|14|||
164327118|NCT01801072|593574151|FG000|Overall Study|Physician Decision|2|||
164327119|NCT01801072|593574152|FG001|Overall Study|Physician Decision|3|||
164327120|NCT01801072|593574151|FG000|Overall Study|Withdrawal by Subject|1|||
164327121|NCT01801072|593574152|FG001|Overall Study|Withdrawal by Subject|0|||
164327122|NCT01801072|593574151|FG000|Overall Study|Protocol Violation|2|||
164327123|NCT01801072|593574152|FG001|Overall Study|Protocol Violation|0|||
164327124|NCT01801072|593574151|FG000|Overall Study|Death|7|||
164327125|NCT01801072|593574152|FG001|Overall Study|Death|8|||
164217693|NCT00699751|593163034|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
164217694|NCT00699751|593163033|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
164217695|NCT00699751|593163034|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
164217696|NCT01947933|593163035|FG000|Overall Study|Withdrawal by Subject|0|||
164217697|NCT01947933|593163036|FG001|Overall Study|Withdrawal by Subject|0|||
164217698|NCT01947933|593163037|FG002|Overall Study|Withdrawal by Subject|1|||
164217699|NCT01947933|593163038|FG003|Overall Study|Withdrawal by Subject|0|||
164327126|NCT03693170|593574153|FG000|Overall Study|Disease Progression|48|||
164327127|NCT03693170|593574153|FG000|Overall Study|Adverse Event|16|||
164327128|NCT03693170|593574153|FG000|Overall Study|Physician Decision|6|||
164327129|NCT03693170|593574153|FG000|Overall Study|Protocol Violation|2|||
164217700|NCT01947933|593163039|FG004|Overall Study|Withdrawal by Subject|0|||
164217701|NCT01947933|593163040|FG005|Overall Study|Withdrawal by Subject|0|||
164217702|NCT01947933|593163041|FG006|Overall Study|Withdrawal by Subject|0|||
164217703|NCT01947933|593163042|FG007|Overall Study|Withdrawal by Subject|0|||
164217704|NCT01947933|593163043|FG008|Overall Study|Withdrawal by Subject|0|||
164327130|NCT03693170|593574153|FG000|Overall Study|Death|1|||
164327131|NCT03693170|593574153|FG000|Overall Study|Non compliance with study drug|1|||
164327132|NCT03693170|593574153|FG000|Overall Study|Withdrawal by Subject|1|||
164327133|NCT04444895|593574154|FG000|Overall Study|Adverse Event|2|||
164327134|NCT04444895|593574154|FG000|Overall Study|Lost to Follow-up|2|||
164327135|NCT04444895|593574154|FG000|Overall Study|Withdrawal by Subject|5|||
164327136|NCT03034200|593574155|FG000|Overall Study|Disease progression|8|||
164327137|NCT03034200|593574156|FG001|Overall Study|Disease progression|10|||
164327138|NCT03034200|593574157|FG002|Overall Study|Disease progression|4|||
164217705|NCT01947933|593163035|FG000|Overall Study|Lost to Follow-up|0|||
164327139|NCT03034200|593574155|FG000|Overall Study|Physician Decision|2|||
164327140|NCT03034200|593574156|FG001|Overall Study|Physician Decision|0|||
164217706|NCT01947933|593163036|FG001|Overall Study|Lost to Follow-up|0|||
164217707|NCT01947933|593163037|FG002|Overall Study|Lost to Follow-up|0|||
164217708|NCT01947933|593163038|FG003|Overall Study|Lost to Follow-up|0|||
164217709|NCT01947933|593163039|FG004|Overall Study|Lost to Follow-up|0|||
164217710|NCT01947933|593163040|FG005|Overall Study|Lost to Follow-up|0|||
164217711|NCT01947933|593163041|FG006|Overall Study|Lost to Follow-up|0|||
164217712|NCT01947933|593163042|FG007|Overall Study|Lost to Follow-up|0|||
164217713|NCT01947933|593163043|FG008|Overall Study|Lost to Follow-up|1|||
164217714|NCT00294398|593163044|FG000|Overall Study|Lost to Follow-up|21|||
164217715|NCT00294398|593163045|FG001|Overall Study|Lost to Follow-up|26|||
164217716|NCT02939781|593163048|FG000|Overall Study|Protocol Violation|8|||
164217717|NCT02939781|593163048|FG000|Overall Study|Withdrawal by Subject|1|||
164217718|NCT04337021|593163053|FG000|Overall Study|Lost to Follow-up|54|||
164217719|NCT04337021|593163054|FG001|Overall Study|Lost to Follow-up|66|||
164217720|NCT02593864|593163056|FG000|Overall Study|Withdrawal by Subject|3|||
164217721|NCT02593864|593163056|FG000|Overall Study|Lost to Follow-up|3|||
164327141|NCT03034200|593574157|FG002|Overall Study|Physician Decision|3|||
164327142|NCT03034200|593574155|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
164327143|NCT03034200|593574156|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
164327144|NCT03034200|593574157|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
164217722|NCT06991803|593163060|FG000|Overall Study|Lost to Follow-up|0|||
164217723|NCT06991803|593163061|FG001|Overall Study|Lost to Follow-up|4|||
164327145|NCT03034200|593574155|FG000|Overall Study|Adjuvant Therapy|0|||
164327146|NCT03034200|593574156|FG001|Overall Study|Adjuvant Therapy|0|||
164327147|NCT03034200|593574157|FG002|Overall Study|Adjuvant Therapy|1|||
164327148|NCT00510874|593574158|FG000|Overall Study|Withdrawal by Subject|1|||
164327149|NCT00510874|593574159|FG001|Overall Study|Withdrawal by Subject|1|||
164327150|NCT00510874|593574160|FG002|Overall Study|Withdrawal by Subject|0|||
164327151|NCT00510874|593574161|FG003|Overall Study|Withdrawal by Subject|0|||
164327152|NCT00510874|593574162|FG004|Overall Study|Withdrawal by Subject|3|||
164327153|NCT00510874|593574163|FG005|Overall Study|Withdrawal by Subject|0|||
164327154|NCT00510874|593574164|FG006|Overall Study|Withdrawal by Subject|0|||
164327155|NCT00510874|593574158|FG000|Overall Study|Lost to Follow-up|2|||
164327156|NCT00510874|593574159|FG001|Overall Study|Lost to Follow-up|3|||
164327157|NCT00510874|593574160|FG002|Overall Study|Lost to Follow-up|1|||
164327158|NCT00510874|593574161|FG003|Overall Study|Lost to Follow-up|3|||
164327159|NCT00510874|593574162|FG004|Overall Study|Lost to Follow-up|4|||
164327160|NCT00510874|593574163|FG005|Overall Study|Lost to Follow-up|0|||
164327161|NCT00510874|593574164|FG006|Overall Study|Lost to Follow-up|1|||
164327162|NCT01251146|593574165|FG000|Overall Study|Lost to Follow-up|3|||
164327163|NCT01251146|593574166|FG001|Overall Study|Lost to Follow-up|10|||
164327164|NCT00053365|593574168|FG000|Overall Study|Incorrect cell type|1|||
164327165|NCT00053365|593574168|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
164327166|NCT00053365|593574168|FG000|Overall Study|Never treated|4|||
164327167|NCT03347188|593574178|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
164327168|NCT03347188|593574179|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
164327169|NCT03347188|593574178|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
164327170|NCT03347188|593574179|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
164327171|NCT03347188|593574178|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
164327172|NCT03347188|593574179|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
164327173|NCT03347188|593574178|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
164327174|NCT03347188|593574179|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
164327175|NCT03347188|593574178|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
164327176|NCT03347188|593574179|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
164327177|NCT03347188|593574178|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
164327178|NCT03347188|593574179|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
164327179|NCT03347188|593574178|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
164327180|NCT03347188|593574179|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
164327181|NCT03347188|593574178|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
164327182|NCT03347188|593574179|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
164327183|NCT03139604|593574180|FG000|Overall Study|Other|7|||
164327184|NCT03139604|593574181|FG001|Overall Study|Other|3|||
164327185|NCT03139604|593574180|FG000|Overall Study|Withdrawal by Subject|16|||
164327186|NCT03139604|593574181|FG001|Overall Study|Withdrawal by Subject|17|||
164327187|NCT03139604|593574180|FG000|Overall Study|Physician Decision|1|||
164327188|NCT03139604|593574181|FG001|Overall Study|Physician Decision|2|||
164327189|NCT03139604|593574180|FG000|Overall Study|Lost to Follow-up|3|||
164327190|NCT03139604|593574181|FG001|Overall Study|Lost to Follow-up|1|||
164217724|NCT06991803|593163062|FG002|Overall Study|Lost to Follow-up|0|||
164217725|NCT06991803|593163063|FG003|Overall Study|Lost to Follow-up|3|||
164217726|NCT06991803|593163064|FG004|Overall Study|Lost to Follow-up|2|||
164217727|NCT06991803|593163065|FG005|Overall Study|Lost to Follow-up|5|||
164217728|NCT02564978|593163071|FG000|Overall Study|Adverse Event|8|||
164217729|NCT02564978|593163071|FG000|Overall Study|Death|1|||
164217730|NCT02564978|593163071|FG000|Overall Study|Lost to Follow-up|1|||
164327191|NCT03139604|593574180|FG000|Overall Study|Death|65|||
164327192|NCT03139604|593574181|FG001|Overall Study|Death|67|||
164327193|NCT03139604|593574180|FG000|Overall Study|Study Terminated by Sponsor|122|||
164327194|NCT03139604|593574181|FG001|Overall Study|Study Terminated by Sponsor|127|||
164327195|NCT03139604|593574180|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
164327196|NCT03139604|593574181|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
164327197|NCT04148911|593574182|FG000|Overall Study|Death|104|||
164327198|NCT04148911|593574182|FG000|Overall Study|Lost to Follow-up|5|||
164327199|NCT04148911|593574182|FG000|Overall Study|Withdrawal by Subject|17|||
164327200|NCT04148911|593574182|FG000|Overall Study|Study Ended by Sponsor|56|||
164327201|NCT00521001|593574185|FG000|Overall Study|Ineligible|1|||
164327202|NCT00470184|593574186|FG000|Overall Study|Not Treated(became ineligible)|4|||
164327203|NCT00470184|593574186|FG000|Overall Study|Not treated (other)|1|||
164327204|NCT00470184|593574186|FG000|Overall Study|disease Progression|4|||
164327205|NCT00470184|593574186|FG000|Overall Study|Adverse Event|3|||
164327206|NCT00470184|593574186|FG000|Overall Study|Withdrawal by Subject|4|||
164327207|NCT00470184|593574186|FG000|Overall Study|other|5|||
164327208|NCT00470184|593574186|FG000|Overall Study|recurrence|1|||
164327209|NCT03190369|593574190|FG000|Overall Study|Poor compliance to protocol|0|||
164327210|NCT03190369|593574191|FG001|Overall Study|Poor compliance to protocol|1|||
164327211|NCT03190369|593574190|FG000|Overall Study|Withdraw before treatment|1|||
164327212|NCT03190369|593574191|FG001|Overall Study|Withdraw before treatment|5|||
164327213|NCT03190369|593574190|FG000|Overall Study|Randomized but not treated|0|||
164327214|NCT03190369|593574191|FG001|Overall Study|Randomized but not treated|2|||
164327215|NCT01606254|593574194|FG000|Overall Study|Withdrawal by Subject|1|||
164327216|NCT01606254|593574195|FG001|Overall Study|Withdrawal by Subject|3|||
164327217|NCT01606254|593574196|FG002|Overall Study|Withdrawal by Subject|0|||
164327218|NCT01606254|593574197|FG003|Overall Study|Withdrawal by Subject|2|||
164327219|NCT01606254|593574194|FG000|Overall Study|Adverse Event|1|||
164327220|NCT01606254|593574195|FG001|Overall Study|Adverse Event|1|||
164327221|NCT01606254|593574196|FG002|Overall Study|Adverse Event|0|||
164327222|NCT01606254|593574197|FG003|Overall Study|Adverse Event|1|||
164327223|NCT04543409|593574198|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
164327224|NCT04543409|593574199|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
164327225|NCT04543409|593574198|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
164327226|NCT04543409|593574199|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
164327227|NCT04543409|593574198|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
164327228|NCT04543409|593574199|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
164327229|NCT04543409|593574198|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
164327230|NCT04543409|593574199|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
164327231|NCT04543409|593574198|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
164327232|NCT04543409|593574199|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
164327233|NCT04543409|593574198|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
164327234|NCT04543409|593574199|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
164327235|NCT04543409|593574198|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
164327236|NCT04543409|593574199|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
164327237|NCT04543409|593574198|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
164327238|NCT04543409|593574199|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
164327239|NCT04543409|593574198|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
164327240|NCT04543409|593574199|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
164327241|NCT04543409|593574198|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
164327242|NCT04543409|593574199|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
164327243|NCT04543409|593574198|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
164327244|NCT04543409|593574199|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
164327245|NCT01052844|593574200|FG000|Overall Study|Adverse Event|0|||
164327246|NCT01052844|593574201|FG001|Overall Study|Adverse Event|1|||
164327247|NCT02093026|593574202|FG000|Overall Study|Adverse Event|26|||
164327248|NCT02093026|593574202|FG000|Overall Study|Death|10|||
164327249|NCT02093026|593574202|FG000|Overall Study|Other|157|||
164327250|NCT02195011|593574211|FG000|Overall Study|Adverse Event|4|||
164327251|NCT02195011|593574212|FG001|Overall Study|Adverse Event|0|||
164327252|NCT02195011|593574211|FG000|Overall Study|Progressive Disease|18|||
164327253|NCT02195011|593574212|FG001|Overall Study|Progressive Disease|1|||
164327254|NCT02195011|593574211|FG000|Overall Study|Withdrawal by Subject|3|||
164327255|NCT02195011|593574212|FG001|Overall Study|Withdrawal by Subject|0|||
164327256|NCT00174291|593574214|FG000|Overall Study|Lost to Follow-up|1|||
164327257|NCT00174291|593574215|FG001|Overall Study|Lost to Follow-up|1|||
164327258|NCT00174291|593574214|FG000|Overall Study|Protocol Violation|0|||
164327259|NCT00174291|593574215|FG001|Overall Study|Protocol Violation|2|||
164327260|NCT00174291|593574214|FG000|Overall Study|Study terminated by sponsor|1|||
164327261|NCT00174291|593574215|FG001|Overall Study|Study terminated by sponsor|0|||
164565602|NCT05195528|594440395|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
164565603|NCT05195528|594440396|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
164565604|NCT05195528|594440397|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
164565605|NCT05195528|594440398|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
164565606|NCT05195528|594440399|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
164565607|NCT05195528|594440395|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
164565608|NCT05195528|594440396|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
164565609|NCT05195528|594440397|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
164565610|NCT05195528|594440398|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
164565611|NCT05195528|594440399|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
164565612|NCT05195528|594440395|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
164565613|NCT05195528|594440396|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
164565614|NCT05195528|594440397|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
164565615|NCT05195528|594440398|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
164565616|NCT05195528|594440399|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
164565617|NCT05195528|594440395|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
164565618|NCT05195528|594440396|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
164565619|NCT05195528|594440397|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
164217731|NCT02564978|593163071|FG000|Overall Study|Withdrawal by Subject|15|||
164217732|NCT02564978|593163071|FG000|Overall Study|Early Study Closure|2|||
164217733|NCT02564978|593163071|FG000|Overall Study|Other Reason|5|||
164299700|NCT03558737|593472901|FG000|Overall Study|Death|1|||
164299701|NCT03558737|593472902|FG001|Overall Study|Death|1|||
164299702|NCT01294553|593472903|FG000|Overall Study|Duplicated Participants|1|||
164299703|NCT01294553|593472903|FG000|Overall Study|Protocol Violation|268|||
164299704|NCT01217229|593472904|FG000|Overall Study|Adverse Event|1|||
164327262|NCT00174291|593574214|FG000|Overall Study|Withdrawal by Subject|3|||
164327263|NCT00174291|593574215|FG001|Overall Study|Withdrawal by Subject|3|||
164327264|NCT01466595|593574216|FG000|Overall Study|Withdrawal by Subject|0|||
164327265|NCT01466595|593574217|FG001|Overall Study|Withdrawal by Subject|1|||
164327266|NCT00450112|593574220|FG000|Overall Study|Other Treatment Required|5|||
164327267|NCT00450112|593574221|FG001|Overall Study|Other Treatment Required|1|||
164327268|NCT00450112|593574220|FG000|Overall Study|Withdrawal by Subject|4|||
164327269|NCT00450112|593574221|FG001|Overall Study|Withdrawal by Subject|1|||
164327270|NCT00450112|593574220|FG000|Overall Study|Lost to Follow-up|2|||
164327271|NCT00450112|593574221|FG001|Overall Study|Lost to Follow-up|1|||
164327272|NCT00450112|593574220|FG000|Overall Study|Others|2|||
164327273|NCT00450112|593574221|FG001|Overall Study|Others|3|||
164327274|NCT03418571|593574222|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
164327275|NCT03418571|593574223|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
164327276|NCT00559754|593574224|FG000|Overall Study|Disease progression|1|||
164327277|NCT00559754|593574224|FG000|Overall Study|Adverse Event|5|||
164327278|NCT00559754|593574224|FG000|Overall Study|Protocol Violation|1|||
164327279|NCT00559754|593574224|FG000|Overall Study|Investigator criteria|2|||
164327280|NCT00559754|593574224|FG000|Overall Study|Withdrawal by Subject|2|||
164327281|NCT00586326|593574225|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
164327282|NCT00586326|593574225|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
164327283|NCT00586326|593574225|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
164327284|NCT00586326|593574225|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
164327285|NCT00586326|593574225|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
164327286|NCT00586326|593574225|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
164327287|NCT00586326|593574225|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
164327288|NCT00586326|593574225|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
164327289|NCT00586326|593574225|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
164327290|NCT00586326|593574225|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
164327291|NCT00586326|593574225|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
164327292|NCT00586326|593574225|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
164327293|NCT00586326|593574225|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
164327294|NCT00586326|593574225|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
164327295|NCT00586326|593574225|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
164327296|NCT00586326|593574225|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
164327297|NCT00586326|593574225|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
164327298|NCT01439347|593574226|FG000|Overall Study|Death|10|||
164327299|NCT01439347|593574227|FG001|Overall Study|Death|9|||
164327300|NCT01439347|593574226|FG000|Overall Study|Withdrawal by Subject|0|||
164327301|NCT01439347|593574227|FG001|Overall Study|Withdrawal by Subject|1|||
164327302|NCT01439347|593574226|FG000|Overall Study|Physician Decision|1|||
164299705|NCT01217229|593472904|FG000|Overall Study|Disease progression, deterioration|2|||
164299706|NCT01217229|593472904|FG000|Overall Study|Disease progression, Cheson criteria|14|||
164299707|NCT01217229|593472904|FG000|Overall Study|Protocol Violation|1|||
164327303|NCT01439347|593574227|FG001|Overall Study|Physician Decision|0|||
164420684|NCT01154036|593910967|FG005|Phase II|Lost to Follow-up|0|||
164327304|NCT01439347|593574226|FG000|Overall Study|Sponsor Terminated Study|2|||
164327305|NCT01439347|593574227|FG001|Overall Study|Sponsor Terminated Study|3|||
164327306|NCT03595774|593574228|FG000|Overall Study|Adverse Event|1|||
164327307|NCT03595774|593574229|FG001|Overall Study|Adverse Event|0|||
164327308|NCT03595774|593574230|FG002|Overall Study|Adverse Event|1|||
164327309|NCT03595774|593574231|FG003|Overall Study|Adverse Event|0|||
164327310|NCT03595774|593574228|FG000|Overall Study|screen failure|0|||
164327311|NCT03595774|593574229|FG001|Overall Study|screen failure|1|||
164327312|NCT03595774|593574230|FG002|Overall Study|screen failure|0|||
164327313|NCT03595774|593574231|FG003|Overall Study|screen failure|1|||
164327314|NCT03882008|593574232|FG000|Overall Study|Withdrawal by Subject|1|||
164327315|NCT03882008|593574232|FG000|Overall Study|Lost to Follow-up|1|||
164327316|NCT03519386|593574237|FG000|Overall Study|Withdrawal by Subject|4|||
164327317|NCT03519386|593574238|FG001|Overall Study|Withdrawal by Subject|1|||
164327318|NCT03519386|593574239|FG002|Overall Study|Withdrawal by Subject|2|||
164327319|NCT03519386|593574237|FG000|Overall Study|Physician Decision|1|||
164327320|NCT03519386|593574238|FG001|Overall Study|Physician Decision|1|||
164327321|NCT03519386|593574239|FG002|Overall Study|Physician Decision|1|||
164327322|NCT03519386|593574237|FG000|Overall Study|Lost to Follow-up|0|||
164327323|NCT03519386|593574238|FG001|Overall Study|Lost to Follow-up|1|||
164327324|NCT03519386|593574239|FG002|Overall Study|Lost to Follow-up|1|||
164327325|NCT03519386|593574237|FG000|Overall Study|Death|1|||
164327326|NCT03519386|593574238|FG001|Overall Study|Death|0|||
164327327|NCT03519386|593574239|FG002|Overall Study|Death|4|||
164327328|NCT03519386|593574237|FG000|Overall Study|Adverse Event|2|||
164327329|NCT03519386|593574238|FG001|Overall Study|Adverse Event|1|||
164327330|NCT03519386|593574239|FG002|Overall Study|Adverse Event|2|||
164327331|NCT03519386|593574237|FG000|Overall Study|Explanted|2|||
164327332|NCT03519386|593574238|FG001|Overall Study|Explanted|1|||
164327333|NCT03519386|593574239|FG002|Overall Study|Explanted|0|||
164327334|NCT03519386|593574237|FG000|Overall Study|Ongoing in study|190|||
164327335|NCT03519386|593574238|FG001|Overall Study|Ongoing in study|192|||
164327336|NCT03519386|593574239|FG002|Overall Study|Ongoing in study|183|||
164327337|NCT01582854|593574241|FG000|Overall Study|Death|8|||
164327338|NCT01582854|593574242|FG001|Overall Study|Death|5|||
164327339|NCT01582854|593574241|FG000|Overall Study|Adverse Event|2|||
164327340|NCT01582854|593574242|FG001|Overall Study|Adverse Event|3|||
164327341|NCT01582854|593574241|FG000|Overall Study|Withdrawal by Participant|8|||
164327342|NCT01582854|593574242|FG001|Overall Study|Withdrawal by Participant|11|||
164327343|NCT01582854|593574241|FG000|Overall Study|Lost to Follow-up|1|||
164327344|NCT01582854|593574242|FG001|Overall Study|Lost to Follow-up|2|||
164327345|NCT01582854|593574241|FG000|Overall Study|Physician Decision|0|||
164327346|NCT01582854|593574242|FG001|Overall Study|Physician Decision|1|||
164327347|NCT01582854|593574241|FG000|Overall Study|Recurrent Stroke|13|||
164327348|NCT01582854|593574242|FG001|Overall Study|Recurrent Stroke|8|||
164327349|NCT01582854|593574241|FG000|Overall Study|Disallowed Concomitant Medication|3|||
164327350|NCT01582854|593574242|FG001|Overall Study|Disallowed Concomitant Medication|2|||
164670083|NCT01706536|594816881|FG002|Overall Study|Lack of Efficacy|0|||
164670084|NCT01706536|594816882|FG003|Overall Study|Lack of Efficacy|1|||
164670085|NCT01706536|594816883|FG004|Overall Study|Lack of Efficacy|0|||
164670086|NCT01706536|594816879|FG000|Overall Study|non compliance|0|||
164670087|NCT01706536|594816880|FG001|Overall Study|non compliance|1|||
164327351|NCT01582854|593574241|FG000|Overall Study|Carotid or Neurosurgery|0|||
164327352|NCT01582854|593574242|FG001|Overall Study|Carotid or Neurosurgery|1|||
164327353|NCT01582854|593574241|FG000|Overall Study|General Anaesthesia|0|||
164327354|NCT01582854|593574242|FG001|Overall Study|General Anaesthesia|1|||
164327355|NCT01582854|593574241|FG000|Overall Study|Other Miscellaneous Reason|1|||
164327356|NCT01582854|593574242|FG001|Overall Study|Other Miscellaneous Reason|0|||
164327357|NCT03101267|593574243|FG000|Primary Study Period|Withdrawal by Subject|1|||
164327358|NCT03101267|593574244|FG001|Primary Study Period|Withdrawal by Subject|2|||
164327359|NCT03101267|593574245|FG002|Primary Study Period|Withdrawal by Subject|3|||
164327360|NCT03101267|593574243|FG000|Primary Study Period|Miscellaneous|2|||
164327361|NCT03101267|593574244|FG001|Primary Study Period|Miscellaneous|0|||
164327362|NCT03101267|593574245|FG002|Primary Study Period|Miscellaneous|0|||
164327363|NCT04068896|593574246|FG000|Overall Study|Adverse Event|2|||
164327364|NCT04068896|593574247|FG001|Overall Study|Adverse Event|0|||
164327365|NCT04068896|593574248|FG002|Overall Study|Adverse Event|1|||
164327366|NCT04068896|593574249|FG003|Overall Study|Adverse Event|0|||
164327367|NCT04068896|593574250|FG004|Overall Study|Adverse Event|0|||
164670088|NCT01706536|594816881|FG002|Overall Study|non compliance|0|||
164670089|NCT01706536|594816882|FG003|Overall Study|non compliance|0|||
164327368|NCT04068896|593574251|FG005|Overall Study|Adverse Event|0|||
164327369|NCT04068896|593574246|FG000|Overall Study|Death|3|||
164327370|NCT04068896|593574247|FG001|Overall Study|Death|1|||
164327371|NCT04068896|593574248|FG002|Overall Study|Death|3|||
164327372|NCT04068896|593574249|FG003|Overall Study|Death|19|||
164327373|NCT04068896|593574250|FG004|Overall Study|Death|17|||
164327374|NCT04068896|593574251|FG005|Overall Study|Death|0|||
164327375|NCT04068896|593574246|FG000|Overall Study|Physician Decision|0|||
164327376|NCT04068896|593574247|FG001|Overall Study|Physician Decision|0|||
164327377|NCT04068896|593574248|FG002|Overall Study|Physician Decision|0|||
164327378|NCT04068896|593574249|FG003|Overall Study|Physician Decision|1|||
164327379|NCT04068896|593574250|FG004|Overall Study|Physician Decision|0|||
164327380|NCT04068896|593574251|FG005|Overall Study|Physician Decision|0|||
164327381|NCT04068896|593574246|FG000|Overall Study|progressive disease|3|||
164327382|NCT04068896|593574247|FG001|Overall Study|progressive disease|5|||
164327383|NCT04068896|593574248|FG002|Overall Study|progressive disease|3|||
164327384|NCT04068896|593574249|FG003|Overall Study|progressive disease|2|||
164327385|NCT04068896|593574250|FG004|Overall Study|progressive disease|1|||
164327386|NCT04068896|593574251|FG005|Overall Study|progressive disease|2|||
164327387|NCT04068896|593574246|FG000|Overall Study|Study terminated by sponsor|0|||
164327388|NCT04068896|593574247|FG001|Overall Study|Study terminated by sponsor|0|||
164327389|NCT04068896|593574248|FG002|Overall Study|Study terminated by sponsor|1|||
164327390|NCT04068896|593574249|FG003|Overall Study|Study terminated by sponsor|2|||
164327391|NCT04068896|593574250|FG004|Overall Study|Study terminated by sponsor|1|||
164327392|NCT04068896|593574251|FG005|Overall Study|Study terminated by sponsor|4|||
164327393|NCT04068896|593574246|FG000|Overall Study|Protocol Violation|0|||
164327394|NCT04068896|593574247|FG001|Overall Study|Protocol Violation|0|||
164327395|NCT04068896|593574248|FG002|Overall Study|Protocol Violation|0|||
164327396|NCT04068896|593574249|FG003|Overall Study|Protocol Violation|1|||
164327397|NCT04068896|593574250|FG004|Overall Study|Protocol Violation|0|||
164327398|NCT04068896|593574251|FG005|Overall Study|Protocol Violation|0|||
164327399|NCT04068896|593574246|FG000|Overall Study|Withdrawal by Subject|0|||
164327400|NCT04068896|593574247|FG001|Overall Study|Withdrawal by Subject|3|||
164327401|NCT04068896|593574248|FG002|Overall Study|Withdrawal by Subject|0|||
164327402|NCT04068896|593574249|FG003|Overall Study|Withdrawal by Subject|2|||
164327403|NCT04068896|593574250|FG004|Overall Study|Withdrawal by Subject|1|||
164327404|NCT04068896|593574251|FG005|Overall Study|Withdrawal by Subject|0|||
164327405|NCT04068896|593574246|FG000|Overall Study|Symptomatic deterioration|2|||
164327406|NCT04068896|593574247|FG001|Overall Study|Symptomatic deterioration|0|||
164327407|NCT04068896|593574248|FG002|Overall Study|Symptomatic deterioration|0|||
164327408|NCT04068896|593574249|FG003|Overall Study|Symptomatic deterioration|0|||
164327409|NCT04068896|593574250|FG004|Overall Study|Symptomatic deterioration|0|||
164327410|NCT04068896|593574251|FG005|Overall Study|Symptomatic deterioration|0|||
164327411|NCT00484185|593574252|FG000|Overall Study|Lost to Follow-up|44|||
164327412|NCT00484185|593574252|FG000|Overall Study|Other|20|||
164327413|NCT00484185|593574252|FG000|Overall Study|Randomized but not treated|5|||
164327414|NCT00484185|593574252|FG000|Overall Study|Death|2|||
164327415|NCT01222403|593574253|FG000|Overall Study|Inappropriate enrollment|0|||
164327416|NCT01222403|593574254|FG001|Overall Study|Inappropriate enrollment|2|||
164327417|NCT02068768|593574256|FG000|Overall Study|Lost to Follow-up|5|||
164327418|NCT02068768|593574256|FG000|Overall Study|Early Termination by Sponsor|2|||
164327419|NCT00913692|593574257|FG000|Screening (4 Months)|Physician Decision|3|||
164327420|NCT00913692|593574257|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
164327421|NCT00913692|593574257|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
164327422|NCT02290431|593574259|FG000|Overall Study|Adverse Event|20|||
164327423|NCT02290431|593574259|FG000|Overall Study|Progressive disease|4|||
164327424|NCT02290431|593574259|FG000|Overall Study|Study terminated by Sponsor|1|||
164327425|NCT02290431|593574259|FG000|Overall Study|Physician Decision|2|||
164327426|NCT00321893|593574260|FG000|Overall Study|Non-Compliance/Refusal|16|||
164327427|NCT00321893|593574261|FG001|Overall Study|Non-Compliance/Refusal|10|||
164327428|NCT00321893|593574260|FG000|Overall Study|Lost to Follow-up|2|||
164327429|NCT00321893|593574261|FG001|Overall Study|Lost to Follow-up|1|||
164327430|NCT00321893|593574260|FG000|Overall Study|Adverse Event|6|||
164327431|NCT00321893|593574261|FG001|Overall Study|Adverse Event|3|||
164327432|NCT03455764|593574262|FG000|Overall Study|Adverse Event|1|||
164327433|NCT03455764|593574263|FG001|Overall Study|Adverse Event|0|||
164327434|NCT03455764|593574264|FG002|Overall Study|Adverse Event|0|||
164327435|NCT03455764|593574265|FG003|Overall Study|Adverse Event|0|||
164327436|NCT03455764|593574266|FG004|Overall Study|Adverse Event|0|||
164327437|NCT03455764|593574262|FG000|Overall Study|Disease Progression|4|||
164327438|NCT03455764|593574263|FG001|Overall Study|Disease Progression|0|||
164565620|NCT05195528|594440398|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
164565621|NCT05195528|594440399|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
164565622|NCT05195528|594440395|FG000|Placebo-controlled Treatment Period|Other|0|||
164565623|NCT05195528|594440396|FG001|Placebo-controlled Treatment Period|Other|0|||
164565624|NCT05195528|594440397|FG002|Placebo-controlled Treatment Period|Other|1|||
164565625|NCT05195528|594440398|FG003|Placebo-controlled Treatment Period|Other|0|||
164565626|NCT05195528|594440399|FG004|Placebo-controlled Treatment Period|Other|0|||
164565627|NCT05195528|594440395|FG000|Extension Period|PTE or AE or SAE|0|||
164565628|NCT05195528|594440396|FG001|Extension Period|PTE or AE or SAE|4|||
164565629|NCT05195528|594440397|FG002|Extension Period|PTE or AE or SAE|5|||
164565630|NCT05195528|594440398|FG003|Extension Period|PTE or AE or SAE|4|||
164327439|NCT03455764|593574264|FG002|Overall Study|Disease Progression|0|||
164327440|NCT03455764|593574265|FG003|Overall Study|Disease Progression|0|||
164327441|NCT03455764|593574266|FG004|Overall Study|Disease Progression|0|||
164565631|NCT05195528|594440399|FG004|Extension Period|PTE or AE or SAE|4|||
164217734|NCT03787212|593165044|FG000|Period 1|Study Termination|2|||
164217735|NCT03787212|593165045|FG001|Period 1|Study Termination|2|||
164217736|NCT02316613|593165048|FG000|Overall Study|Death|63|||
164217737|NCT02316613|593165048|FG000|Overall Study|Lost to Follow-up|9|||
164217738|NCT02316613|593165048|FG000|Overall Study|Lymphoma transformation|2|||
164217739|NCT02316613|593165048|FG000|Overall Study|Participant moved/changed medical team|11|||
164217740|NCT02316613|593165048|FG000|Overall Study|No data and duplicate cases|5|||
164217741|NCT02316613|593165048|FG000|Overall Study|Did not met selection criteria|14|||
164217742|NCT02545127|593165049|FG000|Overall Study|Lost to Follow-up|1|||
164217743|NCT02545127|593165050|FG001|Overall Study|Lost to Follow-up|0|||
164217744|NCT03309605|593165053|FG000|Overall Study|Adverse Event|0|||
164217745|NCT03309605|593165054|FG001|Overall Study|Adverse Event|0|||
164217746|NCT03309605|593165055|FG002|Overall Study|Adverse Event|0|||
164217747|NCT03309605|593165056|FG003|Overall Study|Adverse Event|1|||
164217748|NCT03309605|593165057|FG004|Overall Study|Adverse Event|0|||
164217749|NCT03309605|593165058|FG005|Overall Study|Adverse Event|0|||
164217750|NCT03309605|593165059|FG006|Overall Study|Adverse Event|2|||
164217751|NCT03309605|593165060|FG007|Overall Study|Adverse Event|1|||
164217752|NCT03309605|593165053|FG000|Overall Study|Withdrawal by Subject|0|||
164217753|NCT03309605|593165054|FG001|Overall Study|Withdrawal by Subject|0|||
164217754|NCT03309605|593165055|FG002|Overall Study|Withdrawal by Subject|0|||
164217755|NCT03309605|593165056|FG003|Overall Study|Withdrawal by Subject|0|||
164217756|NCT03309605|593165057|FG004|Overall Study|Withdrawal by Subject|1|||
164327442|NCT03455764|593574262|FG000|Overall Study|On Treatment|1|||
164327443|NCT03455764|593574263|FG001|Overall Study|On Treatment|0|||
164327444|NCT03455764|593574264|FG002|Overall Study|On Treatment|0|||
164327445|NCT03455764|593574265|FG003|Overall Study|On Treatment|0|||
164327446|NCT03455764|593574266|FG004|Overall Study|On Treatment|0|||
164327447|NCT02125604|593574269|FG000|Overall Study|Other|4|||
164327448|NCT02125604|593574269|FG000|Overall Study|Investigator Decision|1|||
164327449|NCT02125604|593574269|FG000|Overall Study|Lost to Follow-up|2|||
164327450|NCT02125604|593574269|FG000|Overall Study|Consent Withdrawn|4|||
164327451|NCT02125604|593574269|FG000|Overall Study|Adverse Event|20|||
164327452|NCT00782795|593574272|FG000|Overall Study|Withdrawal by Subject|1|||
164327453|NCT00782795|593574273|FG001|Overall Study|Withdrawal by Subject|2|||
164327454|NCT01683019|593576008|FG000|Overall Study|Withdrawal by Subject|2|||
164327455|NCT01683019|593576009|FG001|Overall Study|Withdrawal by Subject|1|||
164327456|NCT01683019|593576010|FG002|Overall Study|Withdrawal by Subject|4|||
164327457|NCT03437512|593576011|FG000|Randomized|Withdrawal by Subject|0|||
164327458|NCT03437512|593576012|FG001|Randomized|Withdrawal by Subject|2|||
164327459|NCT03437512|593576011|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
164327460|NCT03437512|593576012|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
164327461|NCT00301821|593576013|FG000|Overall Study|Ineligible|25|||
164327462|NCT00301821|593576013|FG000|Overall Study|Cancel|1|||
164327463|NCT03332771|593576014|FG000|Overall Study|Adverse Event|6|||
164327464|NCT03332771|593576015|FG001|Overall Study|Adverse Event|4|||
164327465|NCT03332771|593576016|FG002|Overall Study|Adverse Event|1|||
164327466|NCT03332771|593576017|FG003|Overall Study|Adverse Event|3|||
164217757|NCT03309605|593165058|FG005|Overall Study|Withdrawal by Subject|0|||
164217758|NCT03309605|593165059|FG006|Overall Study|Withdrawal by Subject|1|||
164217759|NCT03309605|593165060|FG007|Overall Study|Withdrawal by Subject|1|||
164217760|NCT02082483|593165061|FG000|Overall Study|Lost to Follow-up|1|||
164217761|NCT02082483|593165062|FG001|Overall Study|Lost to Follow-up|1|||
164217762|NCT02082483|593165061|FG000|Overall Study|Withdrawal by Subject|2|||
164217763|NCT02082483|593165062|FG001|Overall Study|Withdrawal by Subject|1|||
164327467|NCT03332771|593576014|FG000|Overall Study|Poor Compliance to Protocol|0|||
164327468|NCT03332771|593576015|FG001|Overall Study|Poor Compliance to Protocol|1|||
164327469|NCT03332771|593576016|FG002|Overall Study|Poor Compliance to Protocol|0|||
164327470|NCT03332771|593576017|FG003|Overall Study|Poor Compliance to Protocol|1|||
164327471|NCT03332771|593576014|FG000|Overall Study|Lost to Follow-up|2|||
164327472|NCT03332771|593576015|FG001|Overall Study|Lost to Follow-up|2|||
164327473|NCT03332771|593576016|FG002|Overall Study|Lost to Follow-up|1|||
164217764|NCT02082483|593165061|FG000|Overall Study|Physician Decision|1|||
164217765|NCT02082483|593165062|FG001|Overall Study|Physician Decision|1|||
164217766|NCT02082483|593165061|FG000|Overall Study|Death|2|||
164217767|NCT02082483|593165062|FG001|Overall Study|Death|3|||
164217768|NCT00422461|593165063|FG000|Overall Study|Adverse Event|1|||
164217769|NCT00422461|593165064|FG001|Overall Study|Adverse Event|2|||
164217770|NCT00422461|593165065|FG002|Overall Study|Adverse Event|1|||
164217771|NCT00422461|593165066|FG003|Overall Study|Adverse Event|1|||
164217772|NCT00422461|593165063|FG000|Overall Study|Other|0|||
164217773|NCT00422461|593165064|FG001|Overall Study|Other|0|||
164217774|NCT00422461|593165065|FG002|Overall Study|Other|0|||
164217775|NCT00422461|593165066|FG003|Overall Study|Other|2|||
164217776|NCT00422461|593165063|FG000|Overall Study|Participants no longer willing to participate in study|1|||
164217777|NCT00422461|593165064|FG001|Overall Study|Participants no longer willing to participate in study|0|||
164217778|NCT00422461|593165065|FG002|Overall Study|Participants no longer willing to participate in study|0|||
164217779|NCT00422461|593165066|FG003|Overall Study|Participants no longer willing to participate in study|0|||
164217780|NCT00422461|593165063|FG000|Overall Study|Randomized but not treated|1|||
164217781|NCT00422461|593165064|FG001|Overall Study|Randomized but not treated|1|||
164217782|NCT00422461|593165065|FG002|Overall Study|Randomized but not treated|0|||
164217783|NCT00422461|593165066|FG003|Overall Study|Randomized but not treated|0|||
164217784|NCT02181621|593165067|FG000|Overall Study|Adverse Event|1|||
164327474|NCT03332771|593576017|FG003|Overall Study|Lost to Follow-up|2|||
164327475|NCT03332771|593576014|FG000|Overall Study|At the Participant's own request|20|||
164327476|NCT03332771|593576015|FG001|Overall Study|At the Participant's own request|26|||
164327477|NCT03332771|593576016|FG002|Overall Study|At the Participant's own request|14|||
164327478|NCT03332771|593576017|FG003|Overall Study|At the Participant's own request|23|||
164327479|NCT03332771|593576014|FG000|Overall Study|Reason Not Specified|6|||
164327480|NCT03332771|593576015|FG001|Overall Study|Reason Not Specified|18|||
164327481|NCT03332771|593576016|FG002|Overall Study|Reason Not Specified|16|||
164327482|NCT03332771|593576017|FG003|Overall Study|Reason Not Specified|19|||
164327483|NCT00737464|593576020|FG000|Overall Study|Adverse Event|1|||
164327484|NCT00737464|593576020|FG000|Overall Study|Death|6|||
164327485|NCT00737464|593576020|FG000|Overall Study|Other - Failure to Return|1|||
164217785|NCT02181621|593165068|FG001|Overall Study|Adverse Event|0|||
164217786|NCT02181621|593165067|FG000|Overall Study|Previously Enrolled|0|||
164217787|NCT02181621|593165068|FG001|Overall Study|Previously Enrolled|1|||
164217788|NCT02181621|593165067|FG000|Overall Study|Enrollment Hold|1|||
164217789|NCT02181621|593165068|FG001|Overall Study|Enrollment Hold|1|||
164217790|NCT00145327|593165069|FG000|Overall Study|Withdrawal by Subject|77|||
164217791|NCT00145327|593165070|FG001|Overall Study|Withdrawal by Subject|72|||
164217792|NCT00145327|593165071|FG002|Overall Study|Withdrawal by Subject|164|||
164217793|NCT00145327|593165069|FG000|Overall Study|Death|26|||
164327486|NCT00737464|593576020|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
164327487|NCT00737464|593576020|FG000|Overall Study|Other reasons|4|||
164327488|NCT02423109|593576021|FG000|Lens 1|Adverse Event|1|||
164327489|NCT02423109|593576022|FG001|Lens 1|Adverse Event|0|||
164327490|NCT04177355|593576024|FG000|Overall Study|Lost to Follow-up|0|||
164327491|NCT04177355|593576025|FG001|Overall Study|Lost to Follow-up|2|||
164327492|NCT04177355|593576026|FG002|Overall Study|Lost to Follow-up|0|||
164327493|NCT04177355|593576027|FG003|Overall Study|Lost to Follow-up|1|||
164327494|NCT04177355|593576028|FG004|Overall Study|Lost to Follow-up|2|||
164327495|NCT04177355|593576029|FG005|Overall Study|Lost to Follow-up|0|||
164327496|NCT04177355|593576030|FG006|Overall Study|Lost to Follow-up|1|||
164327497|NCT04177355|593576031|FG007|Overall Study|Lost to Follow-up|0|||
164327498|NCT04177355|593576032|FG008|Overall Study|Lost to Follow-up|0|||
164327499|NCT04177355|593576033|FG009|Overall Study|Lost to Follow-up|0|||
164327500|NCT04177355|593576034|FG010|Overall Study|Lost to Follow-up|0|||
164327501|NCT04177355|593576024|FG000|Overall Study|Withdrawal by Subject|0|||
164327502|NCT04177355|593576025|FG001|Overall Study|Withdrawal by Subject|0|||
164327503|NCT04177355|593576026|FG002|Overall Study|Withdrawal by Subject|0|||
164327504|NCT04177355|593576027|FG003|Overall Study|Withdrawal by Subject|1|||
164327505|NCT04177355|593576028|FG004|Overall Study|Withdrawal by Subject|1|||
164327506|NCT04177355|593576029|FG005|Overall Study|Withdrawal by Subject|0|||
164217794|NCT00145327|593165070|FG001|Overall Study|Death|18|||
164217795|NCT00145327|593165071|FG002|Overall Study|Death|30|||
164217796|NCT00145327|593165069|FG000|Overall Study|Adverse Event|14|||
164327507|NCT04177355|593576030|FG006|Overall Study|Withdrawal by Subject|0|||
164327508|NCT04177355|593576031|FG007|Overall Study|Withdrawal by Subject|0|||
164217797|NCT00145327|593165070|FG001|Overall Study|Adverse Event|11|||
164217798|NCT00145327|593165071|FG002|Overall Study|Adverse Event|22|||
164217799|NCT00145327|593165069|FG000|Overall Study|Lost to Follow-up|9|||
164327509|NCT04177355|593576032|FG008|Overall Study|Withdrawal by Subject|1|||
164327510|NCT04177355|593576033|FG009|Overall Study|Withdrawal by Subject|0|||
164217800|NCT00145327|593165070|FG001|Overall Study|Lost to Follow-up|14|||
164217801|NCT00145327|593165071|FG002|Overall Study|Lost to Follow-up|14|||
164327511|NCT04177355|593576034|FG010|Overall Study|Withdrawal by Subject|0|||
164327512|NCT02742246|593576035|FG000|Overall Study|Never initiated treatment|5|||
164327513|NCT02742246|593576036|FG001|Overall Study|Never initiated treatment|3|||
164327514|NCT02742246|593576037|FG002|Overall Study|Never initiated treatment|1|||
164327515|NCT02742246|593576035|FG000|Overall Study|dropped out during treatment|7|||
164327516|NCT02742246|593576036|FG001|Overall Study|dropped out during treatment|13|||
164327517|NCT02742246|593576037|FG002|Overall Study|dropped out during treatment|10|||
164327518|NCT02742246|593576035|FG000|Overall Study|Death|1|||
164327519|NCT02742246|593576036|FG001|Overall Study|Death|0|||
164327520|NCT02742246|593576037|FG002|Overall Study|Death|0|||
164327521|NCT03489551|593576038|FG000|Overall Study|Withdrawal by Subject|2|||
164327522|NCT00054717|593576039|FG000|Overall Study|Randomized but not treated|2|||
164327523|NCT00054717|593576040|FG001|Overall Study|Randomized but not treated|8|||
164327524|NCT00054717|593576039|FG000|Overall Study|Adverse Event|70|||
164327525|NCT00054717|593576040|FG001|Overall Study|Adverse Event|22|||
164327526|NCT00054717|593576039|FG000|Overall Study|Protocol Violation|18|||
164327527|NCT00054717|593576040|FG001|Overall Study|Protocol Violation|19|||
164327528|NCT00054717|593576039|FG000|Overall Study|Lost to Follow-up|23|||
164327529|NCT00054717|593576040|FG001|Overall Study|Lost to Follow-up|13|||
164327530|NCT00054717|593576039|FG000|Overall Study|Withdrawal by Subject|32|||
164327531|NCT00054717|593576040|FG001|Overall Study|Withdrawal by Subject|20|||
164327532|NCT00054717|593576039|FG000|Overall Study|Other reason not defined above|117|||
164327533|NCT00054717|593576040|FG001|Overall Study|Other reason not defined above|217|||
164327534|NCT01082640|593576049|FG000|Overall Study|Adverse Event|9|||
164327535|NCT01082640|593576050|FG001|Overall Study|Adverse Event|5|||
164327536|NCT01082640|593576051|FG002|Overall Study|Adverse Event|3|||
164327537|NCT01082640|593576049|FG000|Overall Study|Withdrawal by Subject|3|||
164327538|NCT01082640|593576050|FG001|Overall Study|Withdrawal by Subject|3|||
164327539|NCT01082640|593576051|FG002|Overall Study|Withdrawal by Subject|2|||
164327540|NCT01082640|593576049|FG000|Overall Study|Major protocol deviation|3|||
164327541|NCT01082640|593576050|FG001|Overall Study|Major protocol deviation|3|||
164327542|NCT01082640|593576051|FG002|Overall Study|Major protocol deviation|0|||
164327543|NCT01082640|593576049|FG000|Overall Study|Lost to Follow-up|0|||
164327544|NCT01082640|593576050|FG001|Overall Study|Lost to Follow-up|3|||
164327545|NCT01082640|593576051|FG002|Overall Study|Lost to Follow-up|0|||
164327546|NCT01082640|593576049|FG000|Overall Study|Other|2|||
164217802|NCT00145327|593165069|FG000|Overall Study|Administrative problems|12|||
164217803|NCT00145327|593165070|FG001|Overall Study|Administrative problems|9|||
164217804|NCT00145327|593165071|FG002|Overall Study|Administrative problems|13|||
164217805|NCT00145327|593165069|FG000|Overall Study|Protocol Violation|2|||
164217806|NCT00145327|593165070|FG001|Overall Study|Protocol Violation|0|||
164217807|NCT00145327|593165071|FG002|Overall Study|Protocol Violation|2|||
164217808|NCT00145327|593165069|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164217809|NCT00145327|593165070|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164217810|NCT00145327|593165071|FG002|Overall Study|Abnormal laboratory value(s)|2|||
164217811|NCT00145327|593165069|FG000|Overall Study|Missing - not stated|1|||
164217812|NCT00145327|593165070|FG001|Overall Study|Missing - not stated|0|||
164217813|NCT00145327|593165071|FG002|Overall Study|Missing - not stated|1|||
164217814|NCT00960856|593165073|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
164217815|NCT00960856|593165074|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
164217816|NCT00960856|593165075|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
164217817|NCT00960856|593165076|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
164217818|NCT00960856|593165073|FG000|Washout Period of 7 Days|Adverse Event|0|||
164217819|NCT00960856|593165074|FG001|Washout Period of 7 Days|Adverse Event|0|||
164217820|NCT00960856|593165075|FG002|Washout Period of 7 Days|Adverse Event|1|||
164217821|NCT00960856|593165076|FG003|Washout Period of 7 Days|Adverse Event|0|||
164217822|NCT04027946|593165077|FG000|Overall Study|Screen failures|3|||
164217823|NCT05938010|593165079|FG000|Overall Study|Lost to Follow-up|2|||
164217824|NCT00985192|593165080|FG000|Overall Study|Withdrawal by Subject|1|||
164217825|NCT00985192|593165080|FG000|Overall Study|Disease Progression|1|||
164217826|NCT00985192|593165080|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
164217827|NCT01454063|593165081|FG000|Randomized|Adverse Event|1|||
164217828|NCT01454063|593165082|FG001|Randomized|Adverse Event|1|||
164217829|NCT01454063|593165081|FG000|Randomized|Protocol Violation|0|||
164217830|NCT01454063|593165082|FG001|Randomized|Protocol Violation|1|||
164217831|NCT01562444|593165086|FG000|Overall Study|Did not meet entry criteria|2|||
164217832|NCT01562444|593165087|FG001|Overall Study|Did not meet entry criteria|0|||
164217833|NCT01562444|593165088|FG002|Overall Study|Did not meet entry criteria|3|||
164217834|NCT01562444|593165086|FG000|Overall Study|Did not comply with blood draw schedule|1|||
164217835|NCT01562444|593165087|FG001|Overall Study|Did not comply with blood draw schedule|0|||
164217836|NCT01562444|593165088|FG002|Overall Study|Did not comply with blood draw schedule|1|||
164217837|NCT01562444|593165086|FG000|Overall Study|Unavailable serological results|0|||
164217838|NCT01562444|593165087|FG001|Overall Study|Unavailable serological results|2|||
164217839|NCT01562444|593165088|FG002|Overall Study|Unavailable serological results|2|||
164217840|NCT01562444|593165086|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
164217841|NCT01562444|593165087|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
164217842|NCT01562444|593165088|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
164217843|NCT01562444|593165086|FG000|Overall Study|Protocol forbidden medication|1|||
164217844|NCT01562444|593165087|FG001|Overall Study|Protocol forbidden medication|0|||
164217845|NCT01562444|593165088|FG002|Overall Study|Protocol forbidden medication|0|||
164217846|NCT03055195|593165093|FG000|Overall Study|Lack of Efficacy|1|||
164217847|NCT03055195|593165094|FG001|Overall Study|Lack of Efficacy|0|||
164327547|NCT01082640|593576050|FG001|Overall Study|Other|1|||
164217848|NCT03055195|593165093|FG000|Overall Study|Withdrawal by Subject|6|||
164217849|NCT03055195|593165094|FG001|Overall Study|Withdrawal by Subject|7|||
164217850|NCT03055195|593165093|FG000|Overall Study|Study Terminated by Sponsor|2|||
164217851|NCT03055195|593165094|FG001|Overall Study|Study Terminated by Sponsor|6|||
164217852|NCT03055195|593165093|FG000|Overall Study|Protocol Violation|2|||
164217853|NCT03055195|593165094|FG001|Overall Study|Protocol Violation|1|||
164217854|NCT03055195|593165093|FG000|Overall Study|Physician Decision|1|||
164217855|NCT03055195|593165094|FG001|Overall Study|Physician Decision|0|||
164327548|NCT01082640|593576051|FG002|Overall Study|Other|3|||
164217856|NCT00790933|593165098|FG000|Overall Study|Adverse Event|94|||
164217857|NCT00790933|593165099|FG001|Overall Study|Adverse Event|119|||
164217858|NCT00790933|593165100|FG002|Overall Study|Adverse Event|65|||
164217859|NCT00790933|593165101|FG003|Overall Study|Adverse Event|5|||
164217860|NCT00790933|593165102|FG004|Overall Study|Adverse Event|69|||
164217861|NCT00790933|593165098|FG000|Overall Study|Protocol Violation(s)|8|||
164217862|NCT00790933|593165099|FG001|Overall Study|Protocol Violation(s)|18|||
164217863|NCT00790933|593165100|FG002|Overall Study|Protocol Violation(s)|7|||
164217864|NCT00790933|593165101|FG003|Overall Study|Protocol Violation(s)|0|||
164217865|NCT00790933|593165102|FG004|Overall Study|Protocol Violation(s)|12|||
164217866|NCT00790933|593165098|FG000|Overall Study|Lack of Efficacy|192|||
164217867|NCT00790933|593165099|FG001|Overall Study|Lack of Efficacy|176|||
164217868|NCT00790933|593165100|FG002|Overall Study|Lack of Efficacy|130|||
164217869|NCT00790933|593165101|FG003|Overall Study|Lack of Efficacy|1|||
164217870|NCT00790933|593165102|FG004|Overall Study|Lack of Efficacy|121|||
164217871|NCT00790933|593165098|FG000|Overall Study|Study Terminated by Sponsor|0|||
164217872|NCT00790933|593165099|FG001|Overall Study|Study Terminated by Sponsor|0|||
164217873|NCT00790933|593165100|FG002|Overall Study|Study Terminated by Sponsor|1|||
164217874|NCT00790933|593165101|FG003|Overall Study|Study Terminated by Sponsor|0|||
164217875|NCT00790933|593165102|FG004|Overall Study|Study Terminated by Sponsor|0|||
164217876|NCT00790933|593165098|FG000|Overall Study|Withdrawal by Subject|123|||
164217877|NCT00790933|593165099|FG001|Overall Study|Withdrawal by Subject|120|||
164217878|NCT00790933|593165100|FG002|Overall Study|Withdrawal by Subject|52|||
164217879|NCT00790933|593165101|FG003|Overall Study|Withdrawal by Subject|6|||
164217880|NCT00790933|593165102|FG004|Overall Study|Withdrawal by Subject|50|||
164217881|NCT00790933|593165098|FG000|Overall Study|Lost to Follow-up|13|||
164217882|NCT00790933|593165099|FG001|Overall Study|Lost to Follow-up|31|||
164217883|NCT00790933|593165100|FG002|Overall Study|Lost to Follow-up|10|||
164217884|NCT00790933|593165101|FG003|Overall Study|Lost to Follow-up|1|||
164217885|NCT00790933|593165102|FG004|Overall Study|Lost to Follow-up|15|||
164217886|NCT00790933|593165098|FG000|Overall Study|Reason Not Specified|8|||
164217887|NCT00790933|593165099|FG001|Overall Study|Reason Not Specified|16|||
164217888|NCT00790933|593165100|FG002|Overall Study|Reason Not Specified|4|||
164217889|NCT00790933|593165101|FG003|Overall Study|Reason Not Specified|1|||
164217890|NCT00790933|593165102|FG004|Overall Study|Reason Not Specified|9|||
164217891|NCT00245570|593165104|FG000|Washout Between Periods III and IV|Adverse Event|0|||
164217892|NCT00245570|593165105|FG001|Washout Between Periods III and IV|Adverse Event|1|||
164217893|NCT00245570|593165106|FG002|Washout Between Periods III and IV|Adverse Event|0|||
164217894|NCT00245570|593165107|FG003|Washout Between Periods III and IV|Adverse Event|0|||
164217895|NCT00245570|593165108|FG004|Washout Between Periods III and IV|Adverse Event|0|||
164217896|NCT00245570|593165109|FG005|Washout Between Periods III and IV|Adverse Event|0|||
164217897|NCT00866320|593165119|FG000|Overall Study|Withdrawal by Subject|4|||
164217898|NCT00866320|593165119|FG000|Overall Study|Death|2|||
164217899|NCT00896233|593165120|FG000|Overall Study|Claustrophobia during MRI|1|||
164217900|NCT05507450|593165121|FG000|Overall Study|Death|0|||
164217901|NCT05507450|593165122|FG001|Overall Study|Death|0|||
164217902|NCT05507450|593165123|FG002|Overall Study|Death|1|||
164217903|NCT05507450|593165124|FG003|Overall Study|Death|0|||
164217904|NCT05507450|593165121|FG000|Overall Study|Lost to Follow-up|22|||
164217905|NCT05507450|593165122|FG001|Overall Study|Lost to Follow-up|20|||
164217906|NCT05507450|593165123|FG002|Overall Study|Lost to Follow-up|20|||
164217907|NCT05507450|593165124|FG003|Overall Study|Lost to Follow-up|7|||
164217908|NCT05507450|593165121|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164217909|NCT05507450|593165122|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
164217910|NCT05507450|593165123|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
164217911|NCT05507450|593165124|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164217912|NCT05507450|593165121|FG000|Overall Study|Withdrawal by Subject|4|||
164217913|NCT05507450|593165122|FG001|Overall Study|Withdrawal by Subject|11|||
164217914|NCT05507450|593165123|FG002|Overall Study|Withdrawal by Subject|7|||
164217915|NCT05507450|593165124|FG003|Overall Study|Withdrawal by Subject|3|||
164327549|NCT03823378|593576053|FG000|Overall Study|Adverse Event|2|||
164327550|NCT03823378|593576054|FG001|Overall Study|Adverse Event|2|||
164327551|NCT03823378|593576055|FG002|Overall Study|Adverse Event|0|||
164670090|NCT01706536|594816883|FG004|Overall Study|non compliance|0|||
164217916|NCT05507450|593165121|FG000|Overall Study|Participant left the country|0|||
164217917|NCT05507450|593165122|FG001|Overall Study|Participant left the country|0|||
164217918|NCT05507450|593165123|FG002|Overall Study|Participant left the country|1|||
164670091|NCT04753437|594816884|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
164217919|NCT05507450|593165124|FG003|Overall Study|Participant left the country|0|||
164217920|NCT05436288|593165125|FG000|Overall Study|Lost to Follow-up|1|||
164217921|NCT05436288|593165125|FG000|Overall Study|Adverse Event|1|||
164327552|NCT03823378|593576056|FG003|Overall Study|Adverse Event|0|||
164327553|NCT03823378|593576057|FG004|Overall Study|Adverse Event|0|||
164217922|NCT03767894|593165131|FG000|Overall Study|Withdrawal by Subject|1|||
164217923|NCT00387127|593165132|FG000|Overall Study|Lost to Follow-up|0|||
164217924|NCT00387127|593165133|FG001|Overall Study|Lost to Follow-up|4|||
164217925|NCT00387127|593165132|FG000|Overall Study|Death|16|||
164217926|NCT00387127|593165133|FG001|Overall Study|Death|16|||
164217927|NCT00387127|593165132|FG000|Overall Study|Physician Decision|0|||
164217928|NCT00387127|593165133|FG001|Overall Study|Physician Decision|1|||
164217929|NCT00387127|593165132|FG000|Overall Study|Withdrawal by Subject|3|||
164217930|NCT00387127|593165133|FG001|Overall Study|Withdrawal by Subject|2|||
164217931|NCT00387127|593165132|FG000|Overall Study|Required by Protocol Amendment #4|12|||
164217932|NCT00387127|593165133|FG001|Overall Study|Required by Protocol Amendment #4|10|||
164217933|NCT00387127|593165132|FG000|Overall Study|Serious Adverse Event|1|||
164217934|NCT00387127|593165133|FG001|Overall Study|Serious Adverse Event|1|||
164217935|NCT00387127|593165132|FG000|Overall Study|Sponsor Unblinded|1|||
164217936|NCT00387127|593165133|FG001|Overall Study|Sponsor Unblinded|0|||
164217937|NCT04149353|593165137|FG000|Overall Study|Study terminated|1|||
164217938|NCT01871727|593165138|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
164217939|NCT01871727|593165139|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
164217940|NCT01871727|593165140|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
164217941|NCT01871727|593165141|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
164217942|NCT01871727|593165142|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
164217943|NCT01871727|593165138|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
164217944|NCT01871727|593165139|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
164217945|NCT01871727|593165140|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
164217946|NCT01871727|593165141|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
164217947|NCT01871727|593165142|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
164217948|NCT01871727|593165138|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
164217949|NCT01871727|593165139|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
164217950|NCT01871727|593165140|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
164217951|NCT01871727|593165141|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
164217952|NCT01871727|593165142|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
164217953|NCT01871727|593165138|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
164217954|NCT01871727|593165139|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
164217955|NCT01871727|593165140|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
164217956|NCT01871727|593165141|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
164217957|NCT01871727|593165142|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
164217958|NCT01871727|593165138|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
164217959|NCT01871727|593165139|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
164217960|NCT01871727|593165140|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
164217961|NCT01871727|593165141|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
164217962|NCT01871727|593165142|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
164217963|NCT01871727|593165138|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
164217964|NCT01871727|593165139|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
164217965|NCT01871727|593165140|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
164217966|NCT01871727|593165141|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
164217967|NCT01871727|593165142|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
164217968|NCT01871727|593165138|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
164217969|NCT01871727|593165139|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
164217970|NCT01871727|593165140|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
164217971|NCT01871727|593165141|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
164217972|NCT01871727|593165142|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
164217973|NCT01263028|593165143|FG000|Overall Study|Withdrawal by Subject|1|||
164217974|NCT01263028|593165143|FG000|Overall Study|Adverse Event|1|||
164217975|NCT01263028|593165143|FG000|Overall Study|Study terminated due to low enrollment.|4|||
164217976|NCT06038643|593165144|FG000|Overall Study|Withdrawal by Subject|9|||
164217977|NCT06038643|593165145|FG001|Overall Study|Withdrawal by Subject|4|||
164217978|NCT06038643|593165144|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
164217979|NCT06038643|593165145|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
164217980|NCT03573882|593165146|FG000|Overall Study|Study Terminated by Sponsor|22|||
164217981|NCT03573882|593165147|FG001|Overall Study|Study Terminated by Sponsor|17|||
164217982|NCT03573882|593165148|FG002|Overall Study|Study Terminated by Sponsor|18|||
164217983|NCT03573882|593165146|FG000|Overall Study|Withdrawal by Subject|6|||
164217984|NCT03573882|593165147|FG001|Overall Study|Withdrawal by Subject|11|||
164217985|NCT03573882|593165148|FG002|Overall Study|Withdrawal by Subject|7|||
164217986|NCT03573882|593165146|FG000|Overall Study|Adverse Event|7|||
164217987|NCT03573882|593165147|FG001|Overall Study|Adverse Event|5|||
164217988|NCT03573882|593165148|FG002|Overall Study|Adverse Event|6|||
164217989|NCT03573882|593165146|FG000|Overall Study|Lost to Follow-up|2|||
164217990|NCT03573882|593165147|FG001|Overall Study|Lost to Follow-up|5|||
164217991|NCT03573882|593165148|FG002|Overall Study|Lost to Follow-up|3|||
164217992|NCT03573882|593165146|FG000|Overall Study|Physician Decision|4|||
164217993|NCT03573882|593165147|FG001|Overall Study|Physician Decision|3|||
164217994|NCT03573882|593165148|FG002|Overall Study|Physician Decision|2|||
164217995|NCT03573882|593165146|FG000|Overall Study|Participant is Noncompliant with Study Drug|1|||
164217996|NCT03573882|593165147|FG001|Overall Study|Participant is Noncompliant with Study Drug|2|||
164217997|NCT03573882|593165148|FG002|Overall Study|Participant is Noncompliant with Study Drug|1|||
164217998|NCT03573882|593165146|FG000|Overall Study|Pregnancy|1|||
164217999|NCT03573882|593165147|FG001|Overall Study|Pregnancy|2|||
164218000|NCT03573882|593165148|FG002|Overall Study|Pregnancy|0|||
164218001|NCT03573882|593165146|FG000|Overall Study|Other|4|||
164218002|NCT03573882|593165147|FG001|Overall Study|Other|2|||
164218003|NCT03573882|593165148|FG002|Overall Study|Other|2|||
164218004|NCT02691572|593165149|FG000|Overall Study|Withdrawal by Subject|1|||
164218005|NCT02691572|593165150|FG001|Overall Study|Withdrawal by Subject|0|||
164218006|NCT02691572|593165149|FG000|Overall Study|Protocol Violation|0|||
164218007|NCT02691572|593165150|FG001|Overall Study|Protocol Violation|1|||
164218008|NCT00250718|593165151|FG000|Overall Study|Death|1|||
164218009|NCT00250718|593165151|FG000|Overall Study|Adverse Event|1|||
164218010|NCT00250718|593165151|FG000|Overall Study|Withdrawal by Subject|1|||
164218011|NCT04439123|593165152|FG000|Overall Study|Adverse Event|11|||
164218012|NCT04439123|593165152|FG000|Overall Study|Death|1|||
164218013|NCT04439123|593165152|FG000|Overall Study|Disease progression|19|||
164218014|NCT04439123|593165152|FG000|Overall Study|Withdrawal by Subject|2|||
164218015|NCT04439123|593165152|FG000|Overall Study|Still on treatment|2|||
164218016|NCT00424008|593165153|FG000|Overall Study|Adverse Event|8|||
164218017|NCT00424008|593165154|FG001|Overall Study|Adverse Event|6|||
164218018|NCT00424008|593165153|FG000|Overall Study|Lack of Efficacy|40|||
164218019|NCT00424008|593165154|FG001|Overall Study|Lack of Efficacy|34|||
164218020|NCT00424008|593165153|FG000|Overall Study|Lost to Follow-up|1|||
164218021|NCT00424008|593165154|FG001|Overall Study|Lost to Follow-up|2|||
164218022|NCT00424008|593165153|FG000|Overall Study|Withdrawal by Subject|5|||
164218023|NCT00424008|593165154|FG001|Overall Study|Withdrawal by Subject|8|||
164218024|NCT00424008|593165153|FG000|Overall Study|Noncompliance with protocol|13|||
164218025|NCT00424008|593165154|FG001|Overall Study|Noncompliance with protocol|7|||
164218026|NCT00424008|593165153|FG000|Overall Study|Did not meet protocol eligibility|16|||
164218027|NCT00424008|593165154|FG001|Overall Study|Did not meet protocol eligibility|21|||
164218028|NCT00424008|593165153|FG000|Overall Study|Administrative|266|||
164218029|NCT00424008|593165154|FG001|Overall Study|Administrative|257|||
164218030|NCT02530242|593165160|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
164218031|NCT02530242|593165161|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
164218032|NCT02665455|593165164|FG000|Overall Study|Withdrawal by Subject|6|||
164218033|NCT02665455|593165164|FG000|Overall Study|Lost to Follow-up|1|||
164218034|NCT02665455|593165164|FG000|Overall Study|Adverse Event|1|||
164218035|NCT02665455|593165164|FG000|Overall Study|Protocol Violation|1|||
164218036|NCT01671059|593165168|FG000|Overall Study|Adverse Event|4|||
164218037|NCT01671059|593165168|FG000|Overall Study|Lack of Efficacy|1|||
164218038|NCT04971837|593166647|FG000|Overall Study|Long Term Illness|1|||
164218039|NCT04971837|593166647|FG000|Overall Study|BMI too low|9|||
164218040|NCT04971837|593166647|FG000|Overall Study|geographic location|1|||
164218041|NCT04971837|593166647|FG000|Overall Study|Discontinued scheduling conflict|1|||
164218042|NCT03166631|593166648|FG000|Overall Study|Progressive disease|2|||
164218043|NCT03166631|593166649|FG001|Overall Study|Progressive disease|1|||
164218044|NCT03166631|593166650|FG002|Overall Study|Progressive disease|3|||
164218045|NCT03166631|593166651|FG003|Overall Study|Progressive disease|4|||
164218046|NCT03166631|593166652|FG004|Overall Study|Progressive disease|2|||
164218047|NCT03166631|593166653|FG005|Overall Study|Progressive disease|2|||
164218048|NCT03166631|593166654|FG006|Overall Study|Progressive disease|5|||
164218049|NCT03166631|593166655|FG007|Overall Study|Progressive disease|6|||
164218050|NCT03166631|593166656|FG008|Overall Study|Progressive disease|11|||
164218051|NCT03166631|593166657|FG009|Overall Study|Progressive disease|5|||
164218052|NCT03166631|593166658|FG010|Overall Study|Progressive disease|7|||
164218053|NCT03166631|593166648|FG000|Overall Study|Physician Decision|0|||
164218054|NCT03166631|593166649|FG001|Overall Study|Physician Decision|0|||
164218055|NCT03166631|593166650|FG002|Overall Study|Physician Decision|0|||
164218056|NCT03166631|593166651|FG003|Overall Study|Physician Decision|0|||
164218057|NCT03166631|593166652|FG004|Overall Study|Physician Decision|0|||
164218058|NCT03166631|593166653|FG005|Overall Study|Physician Decision|0|||
164218059|NCT03166631|593166654|FG006|Overall Study|Physician Decision|1|||
164218060|NCT03166631|593166655|FG007|Overall Study|Physician Decision|0|||
164218061|NCT03166631|593166656|FG008|Overall Study|Physician Decision|1|||
164218062|NCT03166631|593166657|FG009|Overall Study|Physician Decision|0|||
164218063|NCT03166631|593166658|FG010|Overall Study|Physician Decision|1|||
164218064|NCT03166631|593166648|FG000|Overall Study|Death|0|||
164218065|NCT03166631|593166649|FG001|Overall Study|Death|0|||
164218066|NCT03166631|593166650|FG002|Overall Study|Death|0|||
164218067|NCT03166631|593166651|FG003|Overall Study|Death|0|||
164218068|NCT03166631|593166652|FG004|Overall Study|Death|1|||
164218069|NCT03166631|593166653|FG005|Overall Study|Death|0|||
164218070|NCT03166631|593166654|FG006|Overall Study|Death|1|||
164218071|NCT03166631|593166655|FG007|Overall Study|Death|0|||
164218072|NCT03166631|593166656|FG008|Overall Study|Death|0|||
164218073|NCT03166631|593166657|FG009|Overall Study|Death|0|||
164218074|NCT03166631|593166658|FG010|Overall Study|Death|0|||
164218075|NCT03166631|593166648|FG000|Overall Study|Adverse Event|1|||
164218076|NCT03166631|593166649|FG001|Overall Study|Adverse Event|0|||
164218077|NCT03166631|593166650|FG002|Overall Study|Adverse Event|0|||
164218078|NCT03166631|593166651|FG003|Overall Study|Adverse Event|0|||
164218079|NCT03166631|593166652|FG004|Overall Study|Adverse Event|0|||
164218080|NCT03166631|593166653|FG005|Overall Study|Adverse Event|1|||
164218081|NCT03166631|593166654|FG006|Overall Study|Adverse Event|1|||
164218082|NCT03166631|593166655|FG007|Overall Study|Adverse Event|0|||
164218083|NCT03166631|593166656|FG008|Overall Study|Adverse Event|1|||
164218084|NCT03166631|593166657|FG009|Overall Study|Adverse Event|2|||
164218085|NCT03166631|593166658|FG010|Overall Study|Adverse Event|1|||
164218086|NCT03166631|593166648|FG000|Overall Study|Withdrawal by Subject|0|||
164218087|NCT03166631|593166649|FG001|Overall Study|Withdrawal by Subject|0|||
164218088|NCT03166631|593166650|FG002|Overall Study|Withdrawal by Subject|0|||
164218089|NCT03166631|593166651|FG003|Overall Study|Withdrawal by Subject|0|||
164218090|NCT03166631|593166652|FG004|Overall Study|Withdrawal by Subject|0|||
164218091|NCT03166631|593166653|FG005|Overall Study|Withdrawal by Subject|0|||
164218092|NCT03166631|593166654|FG006|Overall Study|Withdrawal by Subject|0|||
164218093|NCT03166631|593166655|FG007|Overall Study|Withdrawal by Subject|0|||
164218094|NCT03166631|593166656|FG008|Overall Study|Withdrawal by Subject|1|||
164218095|NCT03166631|593166657|FG009|Overall Study|Withdrawal by Subject|1|||
164218096|NCT03166631|593166658|FG010|Overall Study|Withdrawal by Subject|0|||
164218097|NCT03022630|593166659|FG000|Overall Study|Death|9|||
164218098|NCT03022630|593166660|FG001|Overall Study|Death|7|||
164218099|NCT03022630|593166659|FG000|Overall Study|Withdrawal by Subject|0|||
164218100|NCT03022630|593166660|FG001|Overall Study|Withdrawal by Subject|5|||
164218101|NCT00382070|593166661|FG000|Overall Study|No follow up data mapped to Other|17|||
164218102|NCT00382070|593166662|FG001|Overall Study|No follow up data mapped to Other|19|||
164218103|NCT00382070|593166661|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
164218104|NCT00382070|593166662|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
164218105|NCT00382070|593166661|FG000|Overall Study|No clinical assessment|9|||
164218106|NCT00382070|593166662|FG001|Overall Study|No clinical assessment|11|||
164218107|NCT04289298|593166663|FG000|Overall Study|Lost to Follow-up|5|||
164218108|NCT04289298|593166664|FG001|Overall Study|Lost to Follow-up|0|||
164218109|NCT04289298|593166663|FG000|Overall Study|Withdrawal by Subject|2|||
164218110|NCT04289298|593166664|FG001|Overall Study|Withdrawal by Subject|0|||
164218111|NCT01734928|593166665|FG000|Randomization|Physician Decision|0|||
164218112|NCT01734928|593166666|FG001|Randomization|Physician Decision|1|||
164218113|NCT01734928|593166665|FG000|Randomization|clinical progression|0|||
164218114|NCT01734928|593166666|FG001|Randomization|clinical progression|1|||
164218115|NCT01734928|593166665|FG000|Randomization|progressive disease|0|||
164218116|NCT01734928|593166666|FG001|Randomization|progressive disease|2|||
164218117|NCT01734928|593166665|FG000|Randomization|Withdrew informed consent|0|||
164218118|NCT01734928|593166666|FG001|Randomization|Withdrew informed consent|4|||
164218119|NCT01734928|593166665|FG000|Randomization|Death|1|||
164218120|NCT01734928|593166666|FG001|Randomization|Death|0|||
164218121|NCT01734928|593166665|FG000|Randomization|Randomization error|1|||
164218122|NCT01734928|593166666|FG001|Randomization|Randomization error|0|||
164218123|NCT01734928|593166665|FG000|Randomization|Lost to Follow-up|1|||
164218124|NCT01734928|593166666|FG001|Randomization|Lost to Follow-up|0|||
164218125|NCT01734928|593166665|FG000|Treatment Period|Lost to Follow-up|0|||
164218126|NCT01734928|593166666|FG001|Treatment Period|Lost to Follow-up|2|||
164218127|NCT01734928|593166665|FG000|Treatment Period|Progressive Disease|167|||
164218128|NCT01734928|593166666|FG001|Treatment Period|Progressive Disease|165|||
164218129|NCT01734928|593166665|FG000|Treatment Period|Adverse Event|39|||
164218130|NCT01734928|593166666|FG001|Treatment Period|Adverse Event|52|||
164218131|NCT01734928|593166665|FG000|Treatment Period|Withdrawal of Consent|25|||
164218132|NCT01734928|593166666|FG001|Treatment Period|Withdrawal of Consent|22|||
164218133|NCT01734928|593166665|FG000|Treatment Period|Death|20|||
164218134|NCT01734928|593166666|FG001|Treatment Period|Death|9|||
164218135|NCT01734928|593166665|FG000|Treatment Period|Other Reasons|27|||
164218136|NCT01734928|593166666|FG001|Treatment Period|Other Reasons|19|||
164218137|NCT01734928|593166665|FG000|Treatment Period|Pregnancy|0|||
164218138|NCT01734928|593166666|FG001|Treatment Period|Pregnancy|1|||
164218139|NCT00504231|593166667|FG000|Overall Study|Discrepant chart documentation re route|0|||
164218140|NCT00504231|593166668|FG001|Overall Study|Discrepant chart documentation re route|0|||
164218141|NCT00504231|593166669|FG002|Overall Study|Discrepant chart documentation re route|1|||
164218142|NCT00504231|593166670|FG003|Overall Study|Discrepant chart documentation re route|0|||
164218143|NCT01629563|593166671|FG000|Overall Study|Adverse Event|16|||
164218144|NCT01629563|593166672|FG001|Overall Study|Adverse Event|16|||
164218145|NCT01629563|593166671|FG000|Overall Study|Death|2|||
164218146|NCT01629563|593166672|FG001|Overall Study|Death|0|||
164327554|NCT03823378|593576058|FG005|Overall Study|Adverse Event|0|||
164327555|NCT03823378|593576053|FG000|Overall Study|Lost to Follow-up|0|||
164327556|NCT03823378|593576054|FG001|Overall Study|Lost to Follow-up|1|||
164327557|NCT03823378|593576055|FG002|Overall Study|Lost to Follow-up|0|||
164327558|NCT03823378|593576056|FG003|Overall Study|Lost to Follow-up|0|||
164327559|NCT03823378|593576057|FG004|Overall Study|Lost to Follow-up|1|||
164327560|NCT03823378|593576058|FG005|Overall Study|Lost to Follow-up|0|||
164327561|NCT03823378|593576053|FG000|Overall Study|Withdrawal by Subject|0|||
164327562|NCT03823378|593576054|FG001|Overall Study|Withdrawal by Subject|1|||
164327563|NCT03823378|593576055|FG002|Overall Study|Withdrawal by Subject|4|||
164327564|NCT03823378|593576056|FG003|Overall Study|Withdrawal by Subject|2|||
164327565|NCT03823378|593576057|FG004|Overall Study|Withdrawal by Subject|0|||
164327566|NCT03823378|593576058|FG005|Overall Study|Withdrawal by Subject|1|||
164327567|NCT03823378|593576053|FG000|Overall Study|Other, not specified|19|||
164327568|NCT03823378|593576054|FG001|Overall Study|Other, not specified|12|||
164327569|NCT03823378|593576055|FG002|Overall Study|Other, not specified|6|||
164327570|NCT03823378|593576056|FG003|Overall Study|Other, not specified|8|||
164327571|NCT03823378|593576057|FG004|Overall Study|Other, not specified|17|||
164327572|NCT03823378|593576058|FG005|Overall Study|Other, not specified|7|||
164327573|NCT01289782|593576059|FG000|Overall Study|Lost to Follow-up|14|||
164327574|NCT01289782|593576060|FG001|Overall Study|Lost to Follow-up|7|||
164327575|NCT01289782|593576059|FG000|Overall Study|Protocol Violation|1|||
164327576|NCT01289782|593576060|FG001|Overall Study|Protocol Violation|1|||
164327577|NCT01289782|593576059|FG000|Overall Study|Withdrawal by Subject|8|||
164327578|NCT01289782|593576060|FG001|Overall Study|Withdrawal by Subject|2|||
164327579|NCT01289782|593576059|FG000|Overall Study|Sponsor's Decision|1|||
164327580|NCT01289782|593576060|FG001|Overall Study|Sponsor's Decision|0|||
164327581|NCT01289782|593576059|FG000|Overall Study|Reason not specified|1|||
164327582|NCT01289782|593576060|FG001|Overall Study|Reason not specified|2|||
164327583|NCT01264016|593576066|FG000|Overall Study|Withdrawal by Subject|1|||
164327584|NCT01264016|593576066|FG000|Overall Study|Felt faint at sight of blood|1|||
164327585|NCT01056380|593576067|FG000|Overall Study|Lost to Follow-up|2|||
164327586|NCT01056380|593576068|FG001|Overall Study|Lost to Follow-up|3|||
164327587|NCT01629706|593576069|FG000|Phase 1 PureVision|Screen Failure|4|||
164565632|NCT05195528|594440395|FG000|Extension Period|Protocol Violation|0|||
164565633|NCT05195528|594440396|FG001|Extension Period|Protocol Violation|2|||
164565634|NCT05195528|594440397|FG002|Extension Period|Protocol Violation|1|||
164218147|NCT01629563|593166671|FG000|Overall Study|Lack of Efficacy|2|||
164218148|NCT01629563|593166672|FG001|Overall Study|Lack of Efficacy|3|||
164218149|NCT01629563|593166671|FG000|Overall Study|Lost to Follow-up|1|||
164218150|NCT01629563|593166672|FG001|Overall Study|Lost to Follow-up|0|||
164218151|NCT01629563|593166671|FG000|Overall Study|Pregnancy|1|||
164218152|NCT01629563|593166672|FG001|Overall Study|Pregnancy|2|||
164218153|NCT01629563|593166671|FG000|Overall Study|Protocol Violation|0|||
164218154|NCT01629563|593166672|FG001|Overall Study|Protocol Violation|1|||
164218155|NCT01629563|593166671|FG000|Overall Study|Withdrawal by Subject|27|||
164218156|NCT01629563|593166672|FG001|Overall Study|Withdrawal by Subject|20|||
164218157|NCT01629563|593166671|FG000|Overall Study|surgery|0|||
164327588|NCT01629706|593576069|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
164327589|NCT01629706|593576069|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
164327590|NCT01629706|593576069|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
164327591|NCT01629706|593576069|FG000|Phase 2 Habitual|Screen Failure|6|||
164327592|NCT01629706|593576069|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
164327593|NCT01629706|593576069|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
164327594|NCT01629706|593576069|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
164565635|NCT05195528|594440398|FG003|Extension Period|Protocol Violation|0|||
164565636|NCT05195528|594440399|FG004|Extension Period|Protocol Violation|1|||
164565637|NCT05195528|594440395|FG000|Extension Period|Lost to Follow-up|0|||
164565638|NCT05195528|594440396|FG001|Extension Period|Lost to Follow-up|6|||
164565639|NCT05195528|594440397|FG002|Extension Period|Lost to Follow-up|13|||
164565640|NCT05195528|594440398|FG003|Extension Period|Lost to Follow-up|3|||
164565641|NCT05195528|594440399|FG004|Extension Period|Lost to Follow-up|7|||
164565642|NCT05195528|594440395|FG000|Extension Period|Withdrawal by Subject|0|||
164565643|NCT05195528|594440396|FG001|Extension Period|Withdrawal by Subject|12|||
164565644|NCT05195528|594440397|FG002|Extension Period|Withdrawal by Subject|9|||
164565645|NCT05195528|594440398|FG003|Extension Period|Withdrawal by Subject|6|||
164565646|NCT05195528|594440399|FG004|Extension Period|Withdrawal by Subject|5|||
164420685|NCT01154036|593910968|FG006|Phase II|Lost to Follow-up|2|||
164218158|NCT01629563|593166672|FG001|Overall Study|surgery|3|||
164218159|NCT01629563|593166671|FG000|Overall Study|Lack of return of menses|12|||
164218160|NCT01629563|593166672|FG001|Overall Study|Lack of return of menses|7|||
164218161|NCT01629563|593166671|FG000|Overall Study|Protocol Violation|0|||
164218162|NCT01629563|593166672|FG001|Overall Study|Protocol Violation|1|||
164327595|NCT01629706|593576069|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
164327596|NCT00048061|593576070|FG000|Overall Study|Adverse Event|41|||
164327597|NCT00048061|593576071|FG001|Overall Study|Adverse Event|32|||
164327598|NCT00048061|593576072|FG002|Overall Study|Adverse Event|44|||
164327599|NCT00048061|593576073|FG003|Overall Study|Adverse Event|37|||
164327600|NCT00048061|593576070|FG000|Overall Study|Lost to Follow-up|3|||
164327601|NCT00048061|593576071|FG001|Overall Study|Lost to Follow-up|2|||
164327602|NCT00048061|593576072|FG002|Overall Study|Lost to Follow-up|4|||
164327603|NCT00048061|593576073|FG003|Overall Study|Lost to Follow-up|5|||
164327604|NCT00048061|593576070|FG000|Overall Study|Withdrawal by Subject|20|||
164327605|NCT00048061|593576071|FG001|Overall Study|Withdrawal by Subject|29|||
164327606|NCT00048061|593576072|FG002|Overall Study|Withdrawal by Subject|29|||
164327607|NCT00048061|593576073|FG003|Overall Study|Withdrawal by Subject|32|||
164327608|NCT00048061|593576070|FG000|Overall Study|Did not follow-up|5|||
164327609|NCT00048061|593576071|FG001|Overall Study|Did not follow-up|5|||
164327610|NCT00048061|593576072|FG002|Overall Study|Did not follow-up|4|||
164327611|NCT00048061|593576073|FG003|Overall Study|Did not follow-up|5|||
164327612|NCT00048061|593576070|FG000|Overall Study|Early improvement|6|||
164327613|NCT00048061|593576071|FG001|Overall Study|Early improvement|5|||
164327614|NCT00048061|593576072|FG002|Overall Study|Early improvement|3|||
164327615|NCT00048061|593576073|FG003|Overall Study|Early improvement|0|||
164327616|NCT03583073|593576074|FG000|Overall Study|Lost to Follow-up|8|||
164327617|NCT03583073|593576075|FG001|Overall Study|Lost to Follow-up|12|||
164327618|NCT01262352|593576080|FG000|Period 1|Illness after randomization|1|||
164327619|NCT01262352|593576081|FG001|Period 1|Illness after randomization|0|||
164327620|NCT01262352|593576080|FG000|Washout|Adverse Event|1|||
164327621|NCT01262352|593576081|FG001|Washout|Adverse Event|1|||
164327622|NCT01262352|593576080|FG000|Washout|Extended Washout|0|||
164327623|NCT01262352|593576081|FG001|Washout|Extended Washout|1|||
164327624|NCT01298193|593576082|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
164327625|NCT01298193|593576082|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
164327626|NCT01298193|593576082|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
164327627|NCT01298193|593576082|FG000|Efficacy Phase (Second Cycle)|Death|1|||
164327628|NCT01975831|593576083|FG000|Overall Study|Adverse Event|1|||
164327629|NCT01975831|593576084|FG001|Overall Study|Adverse Event|2|||
164327630|NCT01975831|593576085|FG002|Overall Study|Adverse Event|2|||
164327631|NCT01975831|593576086|FG003|Overall Study|Adverse Event|0|||
164327632|NCT01975831|593576087|FG004|Overall Study|Adverse Event|1|||
164327633|NCT01975831|593576088|FG005|Overall Study|Adverse Event|1|||
164327634|NCT01975831|593576089|FG006|Overall Study|Adverse Event|3|||
164327635|NCT01975831|593576090|FG007|Overall Study|Adverse Event|4|||
164327636|NCT01975831|593576091|FG008|Overall Study|Adverse Event|1|||
164327637|NCT01975831|593576083|FG000|Overall Study|Death|1|||
164327638|NCT01975831|593576084|FG001|Overall Study|Death|1|||
164327639|NCT01975831|593576085|FG002|Overall Study|Death|0|||
164327640|NCT01975831|593576086|FG003|Overall Study|Death|0|||
164327641|NCT01975831|593576087|FG004|Overall Study|Death|1|||
164327642|NCT01975831|593576088|FG005|Overall Study|Death|0|||
164327643|NCT01975831|593576089|FG006|Overall Study|Death|1|||
164327644|NCT01975831|593576090|FG007|Overall Study|Death|0|||
164327645|NCT01975831|593576091|FG008|Overall Study|Death|0|||
164327646|NCT01975831|593576083|FG000|Overall Study|Progressive Disease|1|||
164327647|NCT01975831|593576084|FG001|Overall Study|Progressive Disease|3|||
164327648|NCT01975831|593576085|FG002|Overall Study|Progressive Disease|2|||
164327649|NCT01975831|593576086|FG003|Overall Study|Progressive Disease|4|||
164327650|NCT01975831|593576087|FG004|Overall Study|Progressive Disease|13|||
164327651|NCT01975831|593576088|FG005|Overall Study|Progressive Disease|9|||
164327652|NCT01975831|593576089|FG006|Overall Study|Progressive Disease|10|||
164327653|NCT01975831|593576090|FG007|Overall Study|Progressive Disease|8|||
164327654|NCT01975831|593576091|FG008|Overall Study|Progressive Disease|10|||
164327655|NCT01975831|593576083|FG000|Overall Study|Withdrawal by Subject|0|||
164327656|NCT01975831|593576084|FG001|Overall Study|Withdrawal by Subject|3|||
164327657|NCT01975831|593576085|FG002|Overall Study|Withdrawal by Subject|0|||
164327658|NCT01975831|593576086|FG003|Overall Study|Withdrawal by Subject|0|||
164327659|NCT01975831|593576087|FG004|Overall Study|Withdrawal by Subject|3|||
164327660|NCT01975831|593576088|FG005|Overall Study|Withdrawal by Subject|1|||
164218163|NCT00088881|593166674|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
164218164|NCT00088881|593166674|FG000|Step 1 - R-CHOP|Adverse Event|1|||
164218165|NCT00088881|593166674|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
164218166|NCT00088881|593166674|FG000|Step 1 - R-CHOP|Physician Decision|1|||
164218167|NCT00088881|593166674|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
164218168|NCT00088881|593166674|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
164218169|NCT00088881|593166674|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
164218170|NCT02370394|593166682|FG000|Overall Study|Lost to Follow-up|2|||
164218171|NCT02370394|593166683|FG001|Overall Study|Lost to Follow-up|1|||
164218172|NCT02370394|593166682|FG000|Overall Study|Withdrawal by Subject|0|||
164218173|NCT02370394|593166683|FG001|Overall Study|Withdrawal by Subject|1|||
164218174|NCT00456612|593166685|FG000|Overall Study|Withdrawal by Subject|3|||
164218175|NCT00720083|593166689|FG000|Overall Study|Ineligible|1|||
164218176|NCT00720083|593166690|FG001|Overall Study|Ineligible|2|||
164218177|NCT00894647|593166691|FG000|Overall Study|Adverse Event|5|||
164218178|NCT00894647|593166692|FG001|Overall Study|Adverse Event|4|||
164218179|NCT00894647|593166691|FG000|Overall Study|Withdrawal by Subject|4|||
164218180|NCT00894647|593166692|FG001|Overall Study|Withdrawal by Subject|4|||
164218181|NCT00894647|593166691|FG000|Overall Study|Lost to Follow-up|0|||
164218182|NCT00894647|593166692|FG001|Overall Study|Lost to Follow-up|2|||
164218183|NCT00894647|593166691|FG000|Overall Study|Non-compliance with study procedures|0|||
164218184|NCT00894647|593166692|FG001|Overall Study|Non-compliance with study procedures|2|||
164218185|NCT00894647|593166691|FG000|Overall Study|Other, not due to AE|1|||
164218186|NCT00894647|593166692|FG001|Overall Study|Other, not due to AE|2|||
164218187|NCT01913470|593166698|FG000|Overall Study|Lost to Follow-up|0|||
164218188|NCT01913470|593166699|FG001|Overall Study|Lost to Follow-up|1|||
164218189|NCT01913470|593166698|FG000|Overall Study|Physician Decision|0|||
164218190|NCT01913470|593166699|FG001|Overall Study|Physician Decision|1|||
164218191|NCT01913470|593166698|FG000|Overall Study|Withdrawal by Subject|0|||
164218192|NCT01913470|593166699|FG001|Overall Study|Withdrawal by Subject|1|||
164218193|NCT01524705|593166700|FG000|Overall Study|Adverse Event|2|||
164218194|NCT01524705|593166701|FG001|Overall Study|Adverse Event|0|||
164218195|NCT01524705|593166700|FG000|Overall Study|Death|1|||
164218196|NCT01524705|593166701|FG001|Overall Study|Death|0|||
164218197|NCT01524705|593166700|FG000|Overall Study|Lost to Follow-up|0|||
164218198|NCT01524705|593166701|FG001|Overall Study|Lost to Follow-up|1|||
164218199|NCT01524705|593166700|FG000|Overall Study|Withdrawal by Subject|0|||
164218200|NCT01524705|593166701|FG001|Overall Study|Withdrawal by Subject|1|||
164218201|NCT01524705|593166700|FG000|Overall Study|Pancreatic Cancer|0|||
164218202|NCT01524705|593166701|FG001|Overall Study|Pancreatic Cancer|1|||
164218203|NCT02573467|593166710|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
164218204|NCT02573467|593166711|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
164218205|NCT02573467|593166712|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
164218206|NCT02573467|593166713|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
164218207|NCT02573467|593166710|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
164218208|NCT02573467|593166711|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
164218209|NCT02573467|593166712|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
164218210|NCT02573467|593166713|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
164218211|NCT02573467|593166710|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
164218212|NCT02573467|593166711|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
164218213|NCT02573467|593166712|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
164218214|NCT02573467|593166713|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
164218215|NCT02573467|593166710|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
164327661|NCT01975831|593576089|FG006|Overall Study|Withdrawal by Subject|1|||
164218216|NCT02573467|593166711|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
164218217|NCT02573467|593166712|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
164218218|NCT02573467|593166713|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
164218219|NCT02573467|593166710|FG000|Post-treatment Follow up Epoch|Death|1|||
164218220|NCT02573467|593166711|FG001|Post-treatment Follow up Epoch|Death|1|||
164218221|NCT02573467|593166712|FG002|Post-treatment Follow up Epoch|Death|0|||
164218222|NCT02573467|593166713|FG003|Post-treatment Follow up Epoch|Death|1|||
164218223|NCT02573467|593166710|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
164218224|NCT02573467|593166711|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
164565647|NCT05195528|594440395|FG000|Extension Period|Lack of Efficacy|0|||
164565648|NCT05195528|594440396|FG001|Extension Period|Lack of Efficacy|3|||
164565649|NCT05195528|594440397|FG002|Extension Period|Lack of Efficacy|0|||
164565650|NCT05195528|594440398|FG003|Extension Period|Lack of Efficacy|0|||
164565651|NCT05195528|594440399|FG004|Extension Period|Lack of Efficacy|2|||
164565652|NCT05195528|594440395|FG000|Extension Period|Not Treated|0|||
164565653|NCT05195528|594440396|FG001|Extension Period|Not Treated|0|||
164565654|NCT05195528|594440397|FG002|Extension Period|Not Treated|2|||
164565655|NCT05195528|594440398|FG003|Extension Period|Not Treated|3|||
164565656|NCT05195528|594440399|FG004|Extension Period|Not Treated|0|||
164218225|NCT02573467|593166712|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
164218226|NCT02573467|593166713|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
164218227|NCT02573467|593166710|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
164218228|NCT02573467|593166711|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
164218229|NCT02573467|593166712|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
164218230|NCT02573467|593166713|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
164218231|NCT00103506|593166715|FG000|Overall Study|Study closed by sponsor|34|||
164218232|NCT00103506|593166716|FG001|Overall Study|Study closed by sponsor|37|||
164218233|NCT00103506|593166715|FG000|Overall Study|Death|257|||
164218234|NCT00103506|593166716|FG001|Overall Study|Death|253|||
164218235|NCT00103506|593166715|FG000|Overall Study|Lost to Follow-up|13|||
164218236|NCT00103506|593166716|FG001|Overall Study|Lost to Follow-up|13|||
164218237|NCT00103506|593166715|FG000|Overall Study|Withdrawal by Subject|18|||
164218238|NCT00103506|593166716|FG001|Overall Study|Withdrawal by Subject|21|||
164218239|NCT00710970|593166719|FG000|Overall Study|Never took drug|3|||
164218240|NCT02153827|593166720|FG000|Overall Study|Lost to Follow-up|3|||
164218241|NCT02153827|593166721|FG001|Overall Study|Lost to Follow-up|9|||
164218242|NCT04233580|593166726|FG000|Overall Study|Adverse Event|3|||
164218243|NCT04233580|593166727|FG001|Overall Study|Adverse Event|3|||
164218244|NCT04233580|593166726|FG000|Overall Study|Withdrawal by Subject|2|||
164218245|NCT04233580|593166727|FG001|Overall Study|Withdrawal by Subject|1|||
164218246|NCT00625378|593166728|FG000|Overall Study|Adverse Event|22|||
164565657|NCT05195528|594440395|FG000|Extension Period|Other|0|||
164565658|NCT05195528|594440396|FG001|Extension Period|Other|1|||
164565659|NCT05195528|594440397|FG002|Extension Period|Other|1|||
164565660|NCT05195528|594440398|FG003|Extension Period|Other|0|||
164218247|NCT00625378|593166729|FG001|Overall Study|Adverse Event|0|||
164218248|NCT00625378|593166728|FG000|Overall Study|Withdrawal by Subject|16|||
164218249|NCT00625378|593166729|FG001|Overall Study|Withdrawal by Subject|0|||
164218250|NCT00625378|593166728|FG000|Overall Study|Death|38|||
164218251|NCT00625378|593166729|FG001|Overall Study|Death|0|||
164565661|NCT05195528|594440399|FG004|Extension Period|Other|0|||
164565662|NCT01552902|594440400|FG000|Overall Study|Adverse Event|1|||
164218252|NCT00625378|593166728|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
164218253|NCT00625378|593166729|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
164218254|NCT00625378|593166728|FG000|Overall Study|Lost to Follow-up|17|||
164218255|NCT00625378|593166729|FG001|Overall Study|Lost to Follow-up|0|||
164218256|NCT00625378|593166728|FG000|Overall Study|Non-compliant with study medication|3|||
164218257|NCT00625378|593166729|FG001|Overall Study|Non-compliant with study medication|0|||
164218258|NCT00625378|593166728|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
164218259|NCT00625378|593166729|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
164218260|NCT00625378|593166728|FG000|Overall Study|Medical decision|1|||
164218261|NCT00625378|593166729|FG001|Overall Study|Medical decision|0|||
164218262|NCT00625378|593166728|FG000|Overall Study|Multiple toxicities|1|||
164218263|NCT00625378|593166729|FG001|Overall Study|Multiple toxicities|0|||
164218264|NCT00625378|593166728|FG000|Overall Study|New cancer|1|||
164218265|NCT00625378|593166729|FG001|Overall Study|New cancer|0|||
164218266|NCT00625378|593166728|FG000|Overall Study|PTA program|2|||
164218267|NCT00625378|593166729|FG001|Overall Study|PTA program|0|||
164218268|NCT00625378|593166728|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
164218269|NCT00625378|593166729|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
164218270|NCT00625378|593166728|FG000|Overall Study|Sponsor decision|1|||
164218271|NCT00625378|593166729|FG001|Overall Study|Sponsor decision|0|||
164218272|NCT00625378|593166728|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
164218273|NCT00625378|593166729|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
164218274|NCT00625378|593166728|FG000|Overall Study|Switch to commercial drug|6|||
164218275|NCT00625378|593166729|FG001|Overall Study|Switch to commercial drug|1|||
164218276|NCT00625378|593166728|FG000|Overall Study|Missing|2|||
164218277|NCT00625378|593166729|FG001|Overall Study|Missing|0|||
164218278|NCT00625378|593166728|FG000|Overall Study|End of treatment not available|2|||
164218279|NCT00625378|593166729|FG001|Overall Study|End of treatment not available|0|||
164218280|NCT00625378|593166728|FG000|Overall Study|Never treated|2|||
164218281|NCT00625378|593166729|FG001|Overall Study|Never treated|0|||
164218282|NCT01371565|593166730|FG000|Overall Study|Withdrawal by Subject|1|||
164218283|NCT01371565|593166730|FG000|Overall Study|Death|1|||
164218284|NCT01371565|593166730|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
164218285|NCT02565186|593166731|FG000|Overall Study|Adverse Event|113|||
164218286|NCT02565186|593166732|FG001|Overall Study|Adverse Event|148|||
164218287|NCT02565186|593166731|FG000|Overall Study|Lost to Follow-up|102|||
164218288|NCT02565186|593166732|FG001|Overall Study|Lost to Follow-up|93|||
164218289|NCT02565186|593166731|FG000|Overall Study|Non-Compliance|57|||
164218290|NCT02565186|593166732|FG001|Overall Study|Non-Compliance|55|||
164218291|NCT02565186|593166731|FG000|Overall Study|Withdrawal by Subject|229|||
164218292|NCT02565186|593166732|FG001|Overall Study|Withdrawal by Subject|214|||
164218293|NCT02565186|593166731|FG000|Overall Study|Physician Decision|18|||
164218294|NCT02565186|593166732|FG001|Overall Study|Physician Decision|16|||
164218295|NCT02565186|593166731|FG000|Overall Study|Sponsor Request|5|||
164218296|NCT02565186|593166732|FG001|Overall Study|Sponsor Request|9|||
164218297|NCT02565186|593166731|FG000|Overall Study|Missing|1|||
164218298|NCT02565186|593166732|FG001|Overall Study|Missing|0|||
164218299|NCT02565186|593166731|FG000|Overall Study|Did Not Receive Study Drug|55|||
164218300|NCT02565186|593166732|FG001|Overall Study|Did Not Receive Study Drug|86|||
164218301|NCT00617903|593166733|FG000|Overall Study|Withdrawal by Subject|2|||
164218302|NCT00617903|593166734|FG001|Overall Study|Withdrawal by Subject|3|||
164218303|NCT00617903|593166733|FG000|Overall Study|Lost to Follow-up|1|||
164218304|NCT00617903|593166734|FG001|Overall Study|Lost to Follow-up|1|||
164218305|NCT00617903|593166733|FG000|Overall Study|Lack of Efficacy|0|||
164218306|NCT00617903|593166734|FG001|Overall Study|Lack of Efficacy|1|||
164218307|NCT00617903|593166733|FG000|Overall Study|Adverse Event|0|||
164327662|NCT01975831|593576090|FG007|Overall Study|Withdrawal by Subject|0|||
164327663|NCT01975831|593576091|FG008|Overall Study|Withdrawal by Subject|0|||
164218308|NCT00617903|593166734|FG001|Overall Study|Adverse Event|1|||
164218309|NCT00617903|593166733|FG000|Overall Study|noncompliance|0|||
164327664|NCT01975831|593576083|FG000|Overall Study|Physician Decision|0|||
164218310|NCT00617903|593166734|FG001|Overall Study|noncompliance|1|||
164218311|NCT04676646|593166735|FG000|Open-label Run-in Phase|Adverse Event|3|||
164218312|NCT04676646|593166736|FG001|Open-label Run-in Phase|Adverse Event|0|||
164218313|NCT04676646|593166737|FG002|Open-label Run-in Phase|Adverse Event|0|||
164218314|NCT04676646|593166735|FG000|Open-label Run-in Phase|Death|3|||
164327665|NCT01975831|593576084|FG001|Overall Study|Physician Decision|0|||
164218315|NCT04676646|593166736|FG001|Open-label Run-in Phase|Death|0|||
164218316|NCT04676646|593166737|FG002|Open-label Run-in Phase|Death|0|||
164327666|NCT01975831|593576085|FG002|Overall Study|Physician Decision|0|||
164327667|NCT01975831|593576086|FG003|Overall Study|Physician Decision|0|||
164327668|NCT01975831|593576087|FG004|Overall Study|Physician Decision|0|||
164327669|NCT01975831|593576088|FG005|Overall Study|Physician Decision|1|||
164327670|NCT01975831|593576089|FG006|Overall Study|Physician Decision|0|||
164327671|NCT01975831|593576090|FG007|Overall Study|Physician Decision|1|||
164327672|NCT01975831|593576091|FG008|Overall Study|Physician Decision|0|||
164327673|NCT01975831|593576083|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
164327674|NCT01975831|593576084|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
164327675|NCT01975831|593576085|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
164327676|NCT01975831|593576086|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
164327677|NCT01975831|593576087|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
164327678|NCT01975831|593576088|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
164327679|NCT01975831|593576089|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
164327680|NCT01975831|593576090|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
164327681|NCT01975831|593576091|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
164327682|NCT01975831|593576083|FG000|Overall Study|Entered Hospice|0|||
164327683|NCT01975831|593576084|FG001|Overall Study|Entered Hospice|0|||
164327684|NCT01975831|593576085|FG002|Overall Study|Entered Hospice|0|||
164327685|NCT01975831|593576086|FG003|Overall Study|Entered Hospice|0|||
164327686|NCT01975831|593576087|FG004|Overall Study|Entered Hospice|0|||
164327687|NCT01975831|593576088|FG005|Overall Study|Entered Hospice|1|||
164327688|NCT01975831|593576089|FG006|Overall Study|Entered Hospice|0|||
164327689|NCT01975831|593576090|FG007|Overall Study|Entered Hospice|0|||
164327690|NCT01975831|593576091|FG008|Overall Study|Entered Hospice|0|||
164327691|NCT01975831|593576083|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
164327692|NCT01975831|593576084|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
164327693|NCT01975831|593576085|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
164327694|NCT01975831|593576086|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
164327695|NCT01975831|593576087|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
164327696|NCT01975831|593576088|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
164327697|NCT01975831|593576089|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
164327698|NCT01975831|593576090|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
164327699|NCT01975831|593576091|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
164327700|NCT02925793|593576092|FG000|Overall Study|Adverse Event|3|||
164327701|NCT02925793|593576093|FG001|Overall Study|Adverse Event|3|||
164327702|NCT02925793|593576094|FG002|Overall Study|Adverse Event|6|||
164327703|NCT02925793|593576092|FG000|Overall Study|Withdrawal by Subject|16|||
164327704|NCT02925793|593576093|FG001|Overall Study|Withdrawal by Subject|15|||
164327705|NCT02925793|593576094|FG002|Overall Study|Withdrawal by Subject|13|||
164327706|NCT02925793|593576092|FG000|Overall Study|Investigator Discretion|0|||
164327707|NCT02925793|593576093|FG001|Overall Study|Investigator Discretion|1|||
164327708|NCT02925793|593576094|FG002|Overall Study|Investigator Discretion|1|||
164327709|NCT02925793|593576092|FG000|Overall Study|Lost to Follow-up|2|||
164327710|NCT02925793|593576093|FG001|Overall Study|Lost to Follow-up|3|||
164327711|NCT02925793|593576094|FG002|Overall Study|Lost to Follow-up|1|||
164327712|NCT02925793|593576092|FG000|Overall Study|Lack of Efficacy|2|||
164327713|NCT02925793|593576093|FG001|Overall Study|Lack of Efficacy|6|||
164327714|NCT02925793|593576094|FG002|Overall Study|Lack of Efficacy|4|||
164327715|NCT02925793|593576092|FG000|Overall Study|Other:|2|||
164327716|NCT02925793|593576093|FG001|Overall Study|Other:|1|||
164327717|NCT02925793|593576094|FG002|Overall Study|Other:|3|||
164327718|NCT00393042|593576097|FG000|First Intervention|Withdrawal by Subject|1|||
164327719|NCT00393042|593576098|FG001|First Intervention|Withdrawal by Subject|2|||
164327720|NCT00393042|593576097|FG000|First Intervention|Lost to Follow-up|3|||
164327721|NCT00393042|593576098|FG001|First Intervention|Lost to Follow-up|3|||
164327722|NCT00393042|593576097|FG000|First Intervention|Protocol Violation|1|||
164327723|NCT00393042|593576098|FG001|First Intervention|Protocol Violation|0|||
164327724|NCT00393042|593576097|FG000|First Intervention|Adverse Event|0|||
164327725|NCT00393042|593576098|FG001|First Intervention|Adverse Event|1|||
164327726|NCT00393042|593576097|FG000|Second Intervetion|Adverse Event|0|||
164327727|NCT00393042|593576098|FG001|Second Intervetion|Adverse Event|3|||
164327728|NCT00393042|593576097|FG000|Second Intervetion|Withdrawal by Subject|0|||
164327729|NCT00393042|593576098|FG001|Second Intervetion|Withdrawal by Subject|2|||
164327730|NCT00393042|593576097|FG000|Second Intervetion|Lack of Efficacy|1|||
164327731|NCT00393042|593576098|FG001|Second Intervetion|Lack of Efficacy|0|||
164327732|NCT00393042|593576097|FG000|Second Intervetion|Lost to Follow-up|0|||
164327733|NCT00393042|593576098|FG001|Second Intervetion|Lost to Follow-up|2|||
164327734|NCT00393042|593576097|FG000|Second Intervetion|Protocol Violation|1|||
164327735|NCT00393042|593576098|FG001|Second Intervetion|Protocol Violation|1|||
164327736|NCT03475875|593576099|FG000|Period 1|Lost to Follow-up|1|||
164327737|NCT03475875|593576100|FG001|Period 1|Lost to Follow-up|0|||
164327738|NCT03475875|593576099|FG000|Period 1|Adverse Event|2|||
164327739|NCT03475875|593576100|FG001|Period 1|Adverse Event|1|||
164327740|NCT03475875|593576099|FG000|Period 2|Adverse Event|3|||
164327741|NCT03475875|593576100|FG001|Period 2|Adverse Event|0|||
164327742|NCT03475875|593576099|FG000|Period 2|Protocol Violation|0|||
164327743|NCT03475875|593576100|FG001|Period 2|Protocol Violation|1|||
164327744|NCT02045303|593576104|FG000|Overall Study|Protocol Violation|2|||
164327745|NCT02045303|593576105|FG001|Overall Study|Protocol Violation|1|||
164327746|NCT02045303|593576106|FG002|Overall Study|Protocol Violation|0|||
164327747|NCT02045303|593576104|FG000|Overall Study|Withdrawal by Subject|0|||
164327748|NCT02045303|593576105|FG001|Overall Study|Withdrawal by Subject|2|||
164327749|NCT02045303|593576106|FG002|Overall Study|Withdrawal by Subject|0|||
164327750|NCT01642407|593576107|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
164327751|NCT01642407|593576107|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
164327752|NCT01642407|593576107|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
164670092|NCT04753437|594816885|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
164670093|NCT04753437|594816884|FG000|Overall Study|Liver Function Test Abnormalities|2|||
164670094|NCT04753437|594816885|FG001|Overall Study|Liver Function Test Abnormalities|4|||
164670095|NCT00385684|594816888|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
164670096|NCT00385684|594816889|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
164670097|NCT00385684|594816888|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
164670098|NCT00385684|594816889|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
164670099|NCT00385684|594816888|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
164670100|NCT00385684|594816889|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
164670101|NCT00463606|594816890|FG000|Overall Study|Adverse Event|21|||
164670102|NCT00463606|594816891|FG001|Overall Study|Adverse Event|18|||
164670103|NCT00463606|594816892|FG002|Overall Study|Adverse Event|11|||
164670104|NCT00463606|594816890|FG000|Overall Study|Withdrawal by Subject|11|||
164670105|NCT00463606|594816891|FG001|Overall Study|Withdrawal by Subject|11|||
164670106|NCT00463606|594816892|FG002|Overall Study|Withdrawal by Subject|5|||
164670107|NCT00463606|594816890|FG000|Overall Study|Lost to Follow-up|2|||
164670108|NCT00463606|594816891|FG001|Overall Study|Lost to Follow-up|2|||
164670109|NCT00463606|594816892|FG002|Overall Study|Lost to Follow-up|3|||
164670110|NCT00463606|594816890|FG000|Overall Study|Subject noncompliance|1|||
164670111|NCT00463606|594816891|FG001|Overall Study|Subject noncompliance|1|||
164670112|NCT00463606|594816892|FG002|Overall Study|Subject noncompliance|0|||
164327753|NCT00256282|593576108|FG000|Overall Study|Disease progression, relapse during acti|12|||
164327754|NCT00256282|593576108|FG000|Overall Study|Adverse Event|3|||
164327755|NCT00256282|593576108|FG000|Overall Study|Physician Decision|1|||
164327756|NCT02431247|593576109|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
164327757|NCT02431247|593576110|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
164327758|NCT02431247|593576111|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
164327759|NCT02431247|593576109|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
164327760|NCT02431247|593576110|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
164327761|NCT02431247|593576111|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
164327762|NCT02431247|593576109|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
164327763|NCT02431247|593576110|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
164327764|NCT02431247|593576111|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
164327765|NCT02431247|593576109|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
164327766|NCT02431247|593576110|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
164327767|NCT02431247|593576111|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
164327768|NCT02431247|593576109|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
164420686|NCT01154036|593910969|FG007|Phase II|Lost to Follow-up|1|||
164670113|NCT00463606|594816890|FG000|Overall Study|Subject moved out of town|1|||
164670114|NCT00463606|594816891|FG001|Overall Study|Subject moved out of town|0|||
164670115|NCT00463606|594816892|FG002|Overall Study|Subject moved out of town|0|||
164670116|NCT00463606|594816890|FG000|Overall Study|Physician Decision|0|||
164670117|NCT00463606|594816891|FG001|Overall Study|Physician Decision|1|||
164670118|NCT00463606|594816892|FG002|Overall Study|Physician Decision|0|||
164670119|NCT00463606|594816890|FG000|Overall Study|Sponsor request|0|||
164218317|NCT04676646|593166735|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
164218318|NCT04676646|593166736|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
164218319|NCT04676646|593166737|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
164218320|NCT04676646|593166735|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
164218321|NCT04676646|593166736|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
164218322|NCT04676646|593166737|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
164218323|NCT04676646|593166735|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
164218324|NCT04676646|593166736|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
164218325|NCT04676646|593166737|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
164218326|NCT04676646|593166735|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
164218327|NCT04676646|593166736|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
164218328|NCT04676646|593166737|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
164218329|NCT04676646|593166735|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
164218330|NCT04676646|593166736|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
164218331|NCT04676646|593166737|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
164218332|NCT04676646|593166735|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
164218333|NCT04676646|593166736|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
164218334|NCT04676646|593166737|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
164218335|NCT04676646|593166735|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
164565663|NCT01552902|594440401|FG001|Overall Study|Adverse Event|15|||
164565664|NCT01552902|594440402|FG002|Overall Study|Adverse Event|14|||
164565665|NCT01552902|594440400|FG000|Overall Study|Protocol Violation|3|||
164565666|NCT01552902|594440401|FG001|Overall Study|Protocol Violation|3|||
164565667|NCT01552902|594440402|FG002|Overall Study|Protocol Violation|3|||
164565668|NCT01552902|594440400|FG000|Overall Study|Lack of Efficacy|4|||
164565669|NCT01552902|594440401|FG001|Overall Study|Lack of Efficacy|3|||
164565670|NCT01552902|594440402|FG002|Overall Study|Lack of Efficacy|1|||
164565671|NCT01552902|594440400|FG000|Overall Study|Withdrawal by Subject|1|||
164565672|NCT01552902|594440401|FG001|Overall Study|Withdrawal by Subject|9|||
164565673|NCT01552902|594440402|FG002|Overall Study|Withdrawal by Subject|6|||
164565674|NCT01552902|594440400|FG000|Overall Study|Lost to Follow-up|1|||
164565675|NCT01552902|594440401|FG001|Overall Study|Lost to Follow-up|3|||
164565676|NCT01552902|594440402|FG002|Overall Study|Lost to Follow-up|6|||
164565677|NCT01552902|594440400|FG000|Overall Study|Other|3|||
164565678|NCT01552902|594440401|FG001|Overall Study|Other|4|||
164565679|NCT01552902|594440402|FG002|Overall Study|Other|3|||
164565680|NCT02720757|594440403|FG000|Overall Study|Other reason|5|||
164565681|NCT02720757|594440403|FG000|Overall Study|Loss of contact|4|||
164565682|NCT02720757|594440403|FG000|Overall Study|Informed consent withdrawal|1|||
164565683|NCT02720757|594440403|FG000|Overall Study|Patients wish to withdraw|2|||
164565684|NCT02720757|594440403|FG000|Overall Study|Missing|3|||
164565685|NCT02720757|594440403|FG000|Overall Study|General exclusion|3|||
164565686|NCT00168831|594440405|FG000|Overall Study|Adverse Event|36|||
164565687|NCT00168831|594440406|FG001|Overall Study|Adverse Event|47|||
164565688|NCT00168831|594440407|FG002|Overall Study|Adverse Event|74|||
164565689|NCT00168831|594440405|FG000|Overall Study|Lost to Follow-up|5|||
164565690|NCT00168831|594440406|FG001|Overall Study|Lost to Follow-up|6|||
164565691|NCT00168831|594440407|FG002|Overall Study|Lost to Follow-up|4|||
164565692|NCT00168831|594440405|FG000|Overall Study|Withdrawal by Subject|7|||
164565693|NCT00168831|594440406|FG001|Overall Study|Withdrawal by Subject|14|||
164565694|NCT00168831|594440407|FG002|Overall Study|Withdrawal by Subject|19|||
164565695|NCT00168831|594440405|FG000|Overall Study|Protocol Violation|6|||
164565696|NCT00168831|594440406|FG001|Overall Study|Protocol Violation|11|||
164565697|NCT00168831|594440407|FG002|Overall Study|Protocol Violation|11|||
164565698|NCT00168831|594440405|FG000|Overall Study|Other|6|||
164565699|NCT00168831|594440406|FG001|Overall Study|Other|3|||
164565700|NCT00168831|594440407|FG002|Overall Study|Other|6|||
164565701|NCT04173741|594440409|FG000|Overall Study|IVC measurement cannot be done|1|||
164565702|NCT04173741|594440410|FG001|Overall Study|IVC measurement cannot be done|1|||
164565703|NCT02357420|594440411|FG000|Overall Study|Adverse Event|3|||
164565704|NCT02357420|594440412|FG001|Overall Study|Adverse Event|3|||
164565705|NCT02357420|594440413|FG002|Overall Study|Adverse Event|8|||
164565706|NCT02357420|594440414|FG003|Overall Study|Adverse Event|9|||
164565707|NCT02357420|594440411|FG000|Overall Study|Investigator Decision|1|||
164565708|NCT02357420|594440412|FG001|Overall Study|Investigator Decision|0|||
164565709|NCT02357420|594440413|FG002|Overall Study|Investigator Decision|0|||
164565710|NCT02357420|594440414|FG003|Overall Study|Investigator Decision|0|||
164565711|NCT02357420|594440411|FG000|Overall Study|Prohibited Medication|1|||
164565712|NCT02357420|594440412|FG001|Overall Study|Prohibited Medication|1|||
164565713|NCT02357420|594440413|FG002|Overall Study|Prohibited Medication|0|||
164565714|NCT02357420|594440414|FG003|Overall Study|Prohibited Medication|0|||
164565715|NCT02357420|594440411|FG000|Overall Study|Protocol Non-compliance|0|||
164565716|NCT02357420|594440412|FG001|Overall Study|Protocol Non-compliance|0|||
164565717|NCT02357420|594440413|FG002|Overall Study|Protocol Non-compliance|0|||
164565718|NCT02357420|594440414|FG003|Overall Study|Protocol Non-compliance|1|||
164565719|NCT02357420|594440411|FG000|Overall Study|Withdrawn Consent|4|||
164565720|NCT02357420|594440412|FG001|Overall Study|Withdrawn Consent|8|||
164218336|NCT04676646|593166736|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
164565721|NCT02357420|594440413|FG002|Overall Study|Withdrawn Consent|6|||
164565722|NCT02357420|594440414|FG003|Overall Study|Withdrawn Consent|6|||
164565723|NCT02357420|594440411|FG000|Overall Study|Lost to Follow-up|3|||
164565724|NCT02357420|594440412|FG001|Overall Study|Lost to Follow-up|0|||
164565725|NCT02357420|594440413|FG002|Overall Study|Lost to Follow-up|2|||
164565726|NCT02357420|594440414|FG003|Overall Study|Lost to Follow-up|3|||
164565727|NCT01554579|594440415|FG000|Overall Study|Adverse Event|6|||
164218337|NCT04676646|593166737|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
164218338|NCT04676646|593166735|FG000|Randomised-withdrawal Phase|Death|0|||
164565728|NCT01554579|594440416|FG001|Overall Study|Adverse Event|25|||
164565729|NCT01554579|594440415|FG000|Overall Study|Lack of Efficacy|2|||
164565730|NCT01554579|594440416|FG001|Overall Study|Lack of Efficacy|1|||
164565731|NCT01554579|594440415|FG000|Overall Study|Withdrawal by Subject|2|||
164565732|NCT01554579|594440416|FG001|Overall Study|Withdrawal by Subject|1|||
164565733|NCT00234039|594440417|FG000|Overall Study|Adverse Event|2|||
164565734|NCT00234039|594440417|FG000|Overall Study|Progression/relapse|34|||
164565735|NCT00234039|594440417|FG000|Overall Study|Other - Not Protocol Specified|3|||
164565736|NCT00234039|594440417|FG000|Overall Study|Ineligible|9|||
164565737|NCT00234039|594440417|FG000|Overall Study|No Protocol Treatment Received|2|||
164565738|NCT03072160|594440418|FG000|Overall Study|Adverse Event|3|||
164565739|NCT03072160|594440419|FG001|Overall Study|Adverse Event|1|||
164565740|NCT03072160|594440418|FG000|Overall Study|Refused further treatment|6|||
164565741|NCT03072160|594440419|FG001|Overall Study|Refused further treatment|1|||
164565742|NCT03072160|594440418|FG000|Overall Study|Physician Decision|1|||
164565743|NCT03072160|594440419|FG001|Overall Study|Physician Decision|0|||
164565744|NCT03072160|594440418|FG000|Overall Study|Disease progression on study|1|||
164565745|NCT03072160|594440419|FG001|Overall Study|Disease progression on study|1|||
164565746|NCT03072160|594440418|FG000|Overall Study|No contact|0|||
164565747|NCT03072160|594440419|FG001|Overall Study|No contact|1|||
164565748|NCT01046695|594440420|FG000|Overall Study|Subject had a pacemaker|0|||
164565749|NCT01046695|594440421|FG001|Overall Study|Subject had a pacemaker|1|||
164565750|NCT01046695|594440420|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
164565751|NCT01046695|594440421|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
164565752|NCT04426695|594440422|FG000|Overall Study|Death|2|||
164565753|NCT04426695|594440423|FG001|Overall Study|Death|0|||
164565754|NCT04426695|594440424|FG002|Overall Study|Death|1|||
164565755|NCT04426695|594440425|FG003|Overall Study|Death|27|||
164565756|NCT04426695|594440426|FG004|Overall Study|Death|25|||
164565757|NCT04426695|594440427|FG005|Overall Study|Death|21|||
164565758|NCT04426695|594440428|FG006|Overall Study|Death|42|||
164565759|NCT04426695|594440429|FG007|Overall Study|Death|23|||
164565760|NCT04426695|594440430|FG008|Overall Study|Death|37|||
164565761|NCT04426695|594440431|FG009|Overall Study|Death|14|||
164565762|NCT04426695|594440432|FG010|Overall Study|Death|8|||
164565763|NCT04426695|594440433|FG011|Overall Study|Death|7|||
164565764|NCT04426695|594440434|FG012|Overall Study|Death|13|||
164565765|NCT04426695|594440435|FG013|Overall Study|Death|25|||
164565766|NCT04426695|594440436|FG014|Overall Study|Death|19|||
164565767|NCT04426695|594440437|FG015|Overall Study|Death|7|||
164565768|NCT04426695|594440438|FG016|Overall Study|Death|8|||
164565769|NCT04426695|594440439|FG017|Overall Study|Death|4|||
164565770|NCT04426695|594440422|FG000|Overall Study|Lost to Follow-up|2|||
164565771|NCT04426695|594440423|FG001|Overall Study|Lost to Follow-up|4|||
164565772|NCT04426695|594440424|FG002|Overall Study|Lost to Follow-up|1|||
164565773|NCT04426695|594440425|FG003|Overall Study|Lost to Follow-up|19|||
164565774|NCT04426695|594440426|FG004|Overall Study|Lost to Follow-up|10|||
164565775|NCT04426695|594440427|FG005|Overall Study|Lost to Follow-up|14|||
164565776|NCT04426695|594440428|FG006|Overall Study|Lost to Follow-up|5|||
164565777|NCT04426695|594440429|FG007|Overall Study|Lost to Follow-up|14|||
164565778|NCT04426695|594440430|FG008|Overall Study|Lost to Follow-up|10|||
164565779|NCT04426695|594440431|FG009|Overall Study|Lost to Follow-up|11|||
164565780|NCT04426695|594440432|FG010|Overall Study|Lost to Follow-up|12|||
164565781|NCT04426695|594440433|FG011|Overall Study|Lost to Follow-up|6|||
164565782|NCT04426695|594440434|FG012|Overall Study|Lost to Follow-up|2|||
164565783|NCT04426695|594440435|FG013|Overall Study|Lost to Follow-up|2|||
164565784|NCT04426695|594440436|FG014|Overall Study|Lost to Follow-up|2|||
164565785|NCT04426695|594440437|FG015|Overall Study|Lost to Follow-up|0|||
164565786|NCT04426695|594440438|FG016|Overall Study|Lost to Follow-up|0|||
164565787|NCT04426695|594440439|FG017|Overall Study|Lost to Follow-up|0|||
164565788|NCT04426695|594440422|FG000|Overall Study|Participant Decision|1|||
164565789|NCT04426695|594440423|FG001|Overall Study|Participant Decision|2|||
164218339|NCT04676646|593166736|FG001|Randomised-withdrawal Phase|Death|1|||
164218340|NCT04676646|593166737|FG002|Randomised-withdrawal Phase|Death|2|||
164218341|NCT04676646|593166735|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
164218342|NCT04676646|593166736|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
164218343|NCT04676646|593166737|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
164565790|NCT04426695|594440424|FG002|Overall Study|Participant Decision|2|||
164565791|NCT04426695|594440425|FG003|Overall Study|Participant Decision|12|||
164565792|NCT04426695|594440426|FG004|Overall Study|Participant Decision|18|||
164565793|NCT04426695|594440427|FG005|Overall Study|Participant Decision|22|||
164565794|NCT04426695|594440428|FG006|Overall Study|Participant Decision|13|||
164565795|NCT04426695|594440429|FG007|Overall Study|Participant Decision|13|||
164565796|NCT04426695|594440430|FG008|Overall Study|Participant Decision|10|||
164420687|NCT01154036|593910962|FG000|Phase II|Protocol Violation|0|||
164565797|NCT04426695|594440431|FG009|Overall Study|Participant Decision|15|||
164565798|NCT04426695|594440432|FG010|Overall Study|Participant Decision|16|||
164565799|NCT04426695|594440433|FG011|Overall Study|Participant Decision|17|||
164565800|NCT04426695|594440434|FG012|Overall Study|Participant Decision|2|||
164565801|NCT04426695|594440435|FG013|Overall Study|Participant Decision|1|||
164565802|NCT04426695|594440436|FG014|Overall Study|Participant Decision|2|||
164565803|NCT04426695|594440437|FG015|Overall Study|Participant Decision|0|||
164565804|NCT04426695|594440438|FG016|Overall Study|Participant Decision|0|||
164327769|NCT02431247|593576110|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
164327770|NCT02431247|593576111|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
164327771|NCT02431247|593576109|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
164327772|NCT02431247|593576110|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
164327773|NCT02431247|593576111|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
164327774|NCT02431247|593576109|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
164327775|NCT02431247|593576110|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
164327776|NCT02431247|593576111|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
164327777|NCT02431247|593576109|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
164327778|NCT02431247|593576110|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
164327779|NCT02431247|593576111|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
164327780|NCT02431247|593576109|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
164327781|NCT02431247|593576110|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
164327782|NCT02431247|593576111|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
164327783|NCT02431247|593576109|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
164327784|NCT02431247|593576110|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
164327785|NCT02431247|593576111|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
164327786|NCT02431247|593576109|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
164327787|NCT02431247|593576110|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
164327788|NCT02431247|593576111|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
164327789|NCT02431247|593576109|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
164327790|NCT02431247|593576110|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
164327791|NCT02431247|593576111|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
164327792|NCT02431247|593576109|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
164327793|NCT02431247|593576110|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
164327794|NCT02431247|593576111|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
164327795|NCT02431247|593576109|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
164327796|NCT02431247|593576110|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
164327797|NCT02431247|593576111|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
164327798|NCT00667446|593576112|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
164327799|NCT00667446|593576113|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
164327800|NCT00667446|593576112|FG000|Treatment Period (36 Months)|Other|2|||
164327801|NCT00667446|593576113|FG001|Treatment Period (36 Months)|Other|2|||
164327802|NCT00667446|593576112|FG000|Treatment Period (36 Months)|Personal reasons|2|||
164327803|NCT00667446|593576113|FG001|Treatment Period (36 Months)|Personal reasons|2|||
164327804|NCT00667446|593576112|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
164327805|NCT00667446|593576113|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
164327806|NCT00667446|593576112|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
164327807|NCT00667446|593576113|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
164327808|NCT00667446|593576112|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
164327809|NCT00667446|593576113|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
164327810|NCT00667446|593576112|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
164327811|NCT00667446|593576113|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
164327812|NCT00667446|593576112|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
164327813|NCT00667446|593576113|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
164327814|NCT00667446|593576112|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
164327815|NCT00667446|593576113|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
164327816|NCT03631355|593576114|FG000|Overall Study|Lost to Follow-up|1|||
164327817|NCT03631355|593576115|FG001|Overall Study|Lost to Follow-up|2|||
164327818|NCT02810340|593576116|FG000|Overall Study|Withdrawal by Subject|1|||
164327819|NCT02810340|593576117|FG001|Overall Study|Withdrawal by Subject|0|||
164327820|NCT02810340|593576118|FG002|Overall Study|Withdrawal by Subject|0|||
164327821|NCT02810340|593576116|FG000|Overall Study|Incarceration|0|||
164327822|NCT02810340|593576117|FG001|Overall Study|Incarceration|1|||
164327823|NCT02810340|593576118|FG002|Overall Study|Incarceration|0|||
164327824|NCT02810340|593576116|FG000|Overall Study|Lost to Follow-up|0|||
164327825|NCT02810340|593576117|FG001|Overall Study|Lost to Follow-up|0|||
164565805|NCT04426695|594440439|FG017|Overall Study|Participant Decision|0|||
164565806|NCT04426695|594440422|FG000|Overall Study|Adverse Event|0|||
164565807|NCT04426695|594440423|FG001|Overall Study|Adverse Event|0|||
164565808|NCT04426695|594440424|FG002|Overall Study|Adverse Event|0|||
164565809|NCT04426695|594440425|FG003|Overall Study|Adverse Event|0|||
164565810|NCT04426695|594440426|FG004|Overall Study|Adverse Event|0|||
164565811|NCT04426695|594440427|FG005|Overall Study|Adverse Event|0|||
164565812|NCT04426695|594440428|FG006|Overall Study|Adverse Event|0|||
164565813|NCT04426695|594440429|FG007|Overall Study|Adverse Event|1|||
164565814|NCT04426695|594440430|FG008|Overall Study|Adverse Event|0|||
164565815|NCT04426695|594440431|FG009|Overall Study|Adverse Event|0|||
164565816|NCT04426695|594440432|FG010|Overall Study|Adverse Event|1|||
164565817|NCT04426695|594440433|FG011|Overall Study|Adverse Event|1|||
164565818|NCT04426695|594440434|FG012|Overall Study|Adverse Event|0|||
164565819|NCT04426695|594440435|FG013|Overall Study|Adverse Event|0|||
164565820|NCT04426695|594440436|FG014|Overall Study|Adverse Event|0|||
164218344|NCT04676646|593166735|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
164218345|NCT04676646|593166736|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
164218346|NCT04676646|593166737|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
164218347|NCT04676646|593166735|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
164218348|NCT04676646|593166736|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
164218349|NCT04676646|593166737|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
164218350|NCT04676646|593166735|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
164218351|NCT04676646|593166736|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
164327826|NCT02810340|593576118|FG002|Overall Study|Lost to Follow-up|1|||
164327827|NCT03945175|593576119|FG000|Overall Study|Did not meet inclusion criteria|31|||
164327828|NCT03945175|593576119|FG000|Overall Study|Withdrew consent|2|||
164327829|NCT03945175|593576119|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
164327830|NCT03945175|593576119|FG000|Overall Study|Early termination during Mydayis treatment|1|||
164327831|NCT01306877|593576127|FG000|Overall Study|Lost to Follow-up|3|||
164327832|NCT01306877|593576128|FG001|Overall Study|Lost to Follow-up|3|||
164327833|NCT01306877|593576127|FG000|Overall Study|Physician Decision|0|||
164327834|NCT01306877|593576128|FG001|Overall Study|Physician Decision|1|||
164327835|NCT01307020|593576134|FG000|Overall Study|Lost to Follow-up|0|||
164327836|NCT01307020|593576135|FG001|Overall Study|Lost to Follow-up|0|||
164327837|NCT01307020|593576136|FG002|Overall Study|Lost to Follow-up|1|||
164327838|NCT01307020|593576137|FG003|Overall Study|Lost to Follow-up|1|||
164327839|NCT01307020|593576138|FG004|Overall Study|Lost to Follow-up|0|||
164327840|NCT01307020|593576139|FG005|Overall Study|Lost to Follow-up|0|||
164327841|NCT01307020|593576140|FG006|Overall Study|Lost to Follow-up|1|||
164327842|NCT01307020|593576141|FG007|Overall Study|Lost to Follow-up|0|||
164327843|NCT01307020|593576142|FG008|Overall Study|Lost to Follow-up|0|||
164327844|NCT01307020|593576143|FG009|Overall Study|Lost to Follow-up|0|||
164327845|NCT01307020|593576134|FG000|Overall Study|Electronic data capture failure|0|||
164327846|NCT01307020|593576135|FG001|Overall Study|Electronic data capture failure|1|||
164327847|NCT01307020|593576136|FG002|Overall Study|Electronic data capture failure|0|||
164327848|NCT01307020|593576137|FG003|Overall Study|Electronic data capture failure|0|||
164327849|NCT01307020|593576138|FG004|Overall Study|Electronic data capture failure|0|||
164327850|NCT01307020|593576139|FG005|Overall Study|Electronic data capture failure|0|||
164327851|NCT01307020|593576140|FG006|Overall Study|Electronic data capture failure|0|||
164327852|NCT01307020|593576141|FG007|Overall Study|Electronic data capture failure|0|||
164565821|NCT04426695|594440437|FG015|Overall Study|Adverse Event|0|||
164565822|NCT04426695|594440438|FG016|Overall Study|Adverse Event|0|||
164218352|NCT04676646|593166737|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
164218353|NCT04676646|593166735|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
164218354|NCT04676646|593166736|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
164218355|NCT04676646|593166737|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
164218356|NCT04676646|593166735|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
164218357|NCT04676646|593166736|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
164218358|NCT04676646|593166737|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
164218359|NCT04676646|593166735|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
164218360|NCT04676646|593166736|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
164218361|NCT04676646|593166737|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
164327853|NCT01307020|593576142|FG008|Overall Study|Electronic data capture failure|0|||
164565823|NCT04426695|594440439|FG017|Overall Study|Adverse Event|0|||
164565824|NCT04426695|594440422|FG000|Overall Study|Sponsor Request|0|||
164565825|NCT04426695|594440423|FG001|Overall Study|Sponsor Request|0|||
164565826|NCT04426695|594440424|FG002|Overall Study|Sponsor Request|0|||
164565827|NCT04426695|594440425|FG003|Overall Study|Sponsor Request|0|||
164565828|NCT04426695|594440426|FG004|Overall Study|Sponsor Request|0|||
164565829|NCT04426695|594440427|FG005|Overall Study|Sponsor Request|0|||
164565830|NCT04426695|594440428|FG006|Overall Study|Sponsor Request|1|||
164565831|NCT04426695|594440429|FG007|Overall Study|Sponsor Request|0|||
164565832|NCT04426695|594440430|FG008|Overall Study|Sponsor Request|0|||
164565833|NCT04426695|594440431|FG009|Overall Study|Sponsor Request|0|||
164565834|NCT04426695|594440432|FG010|Overall Study|Sponsor Request|0|||
164565835|NCT04426695|594440433|FG011|Overall Study|Sponsor Request|0|||
164565836|NCT04426695|594440434|FG012|Overall Study|Sponsor Request|0|||
164565837|NCT04426695|594440435|FG013|Overall Study|Sponsor Request|0|||
164565838|NCT04426695|594440436|FG014|Overall Study|Sponsor Request|0|||
164670120|NCT00463606|594816891|FG001|Overall Study|Sponsor request|1|||
164670121|NCT00463606|594816892|FG002|Overall Study|Sponsor request|0|||
164218362|NCT05156125|593166738|FG000|Overall Study|Lack of Efficacy|1|||
164218363|NCT05156125|593166739|FG001|Overall Study|Lack of Efficacy|1|||
164218364|NCT05156125|593166740|FG002|Overall Study|Lack of Efficacy|1|||
164218365|NCT05156125|593166738|FG000|Overall Study|Physician Decision|0|||
164218366|NCT05156125|593166739|FG001|Overall Study|Physician Decision|0|||
164218367|NCT05156125|593166740|FG002|Overall Study|Physician Decision|1|||
164218368|NCT05156125|593166738|FG000|Overall Study|Non-compliance|0|||
164218369|NCT05156125|593166739|FG001|Overall Study|Non-compliance|1|||
164218370|NCT05156125|593166740|FG002|Overall Study|Non-compliance|1|||
164218371|NCT05156125|593166738|FG000|Overall Study|Withdrawal by Subject|0|||
164218372|NCT05156125|593166739|FG001|Overall Study|Withdrawal by Subject|0|||
164218373|NCT05156125|593166740|FG002|Overall Study|Withdrawal by Subject|1|||
164218374|NCT05156125|593166738|FG000|Overall Study|Adverse Event|2|||
164218375|NCT05156125|593166739|FG001|Overall Study|Adverse Event|1|||
164218376|NCT05156125|593166740|FG002|Overall Study|Adverse Event|0|||
164218377|NCT02609633|593166743|FG000|Overall Study|Consent Withdrawn|0|||
164218378|NCT02609633|593166744|FG001|Overall Study|Consent Withdrawn|1|||
164218379|NCT02609633|593166743|FG000|Overall Study|Protocol Deviation|1|||
164218380|NCT02609633|593166744|FG001|Overall Study|Protocol Deviation|0|||
164218381|NCT02609633|593166743|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
164218382|NCT02609633|593166744|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
164218383|NCT02609633|593166743|FG000|Overall Study|Reason not Specified|2|||
164218384|NCT02609633|593166744|FG001|Overall Study|Reason not Specified|1|||
164218385|NCT03670628|593166747|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
164218386|NCT03670628|593166748|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
164218387|NCT03670628|593166747|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
164218388|NCT03670628|593166748|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
164218389|NCT00997126|593166752|FG000|Overall Study|Physician Decision|7|||
164218390|NCT00997126|593166753|FG001|Overall Study|Physician Decision|11|||
164218391|NCT02287025|593166754|FG000|Overall Study|Not treated|2|||
164218392|NCT02287025|593166755|FG001|Overall Study|Not treated|0|||
164218393|NCT02287025|593166754|FG000|Overall Study|Progression of disease|3|||
164218394|NCT02287025|593166755|FG001|Overall Study|Progression of disease|2|||
164218395|NCT02287025|593166754|FG000|Overall Study|Adverse Event|2|||
164218396|NCT02287025|593166755|FG001|Overall Study|Adverse Event|4|||
164218397|NCT02287025|593166754|FG000|Overall Study|Withdrawal by Subject|2|||
164218398|NCT02287025|593166755|FG001|Overall Study|Withdrawal by Subject|2|||
164218399|NCT02287025|593166754|FG000|Overall Study|Screening failed|1|||
164218400|NCT02287025|593166755|FG001|Overall Study|Screening failed|1|||
164218401|NCT00899847|593166756|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
164218402|NCT01769443|593166757|FG000|Overall Study|Study closure|1|||
164218403|NCT01769443|593166758|FG001|Overall Study|Study closure|0|||
164218404|NCT04996264|593166759|FG000|Overall Study|Lost to Follow-up|0|||
164218405|NCT04996264|593166760|FG001|Overall Study|Lost to Follow-up|1|||
164218406|NCT04996264|593166759|FG000|Overall Study|Withdrawal by Subject|4|||
164218407|NCT04996264|593166760|FG001|Overall Study|Withdrawal by Subject|3|||
164327854|NCT01307020|593576143|FG009|Overall Study|Electronic data capture failure|0|||
164327855|NCT02359851|593576144|FG000|Overall Study|Death|1|||
164670122|NCT00463606|594816890|FG000|Overall Study|Exclusion criteria violation|2|||
164218408|NCT04996264|593166759|FG000|Overall Study|1 left AMA|0|||
164218409|NCT04996264|593166760|FG001|Overall Study|1 left AMA|1|||
164218410|NCT04996264|593166759|FG000|Overall Study|Subject changed hospitals|0|||
164218411|NCT04996264|593166760|FG001|Overall Study|Subject changed hospitals|1|||
164218412|NCT04996264|593166759|FG000|Overall Study|unable to complete due to work|0|||
164218413|NCT04996264|593166760|FG001|Overall Study|unable to complete due to work|1|||
164218414|NCT00685698|593166761|FG000|Overall Study|Withdrawal by Subject|1|||
164218415|NCT00685698|593166761|FG000|Overall Study|Protocol Violation|6|||
164218416|NCT00685698|593166761|FG000|Overall Study|Adverse Event|3|||
164565839|NCT04426695|594440437|FG015|Overall Study|Sponsor Request|0|||
164565840|NCT04426695|594440438|FG016|Overall Study|Sponsor Request|0|||
164565841|NCT04426695|594440439|FG017|Overall Study|Sponsor Request|0|||
164565842|NCT04426695|594440422|FG000|Overall Study|Physician Decision|0|||
164218417|NCT00685698|593166761|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
164218418|NCT00685698|593166761|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
164218419|NCT00685698|593166761|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
164218420|NCT02583477|593166762|FG000|Overall Study|Adverse Event|0|||
164218421|NCT02583477|593166763|FG001|Overall Study|Adverse Event|2|||
164218422|NCT02583477|593166762|FG000|Overall Study|Death|1|||
164218423|NCT02583477|593166763|FG001|Overall Study|Death|16|||
164565843|NCT04426695|594440423|FG001|Overall Study|Physician Decision|0|||
164565844|NCT04426695|594440424|FG002|Overall Study|Physician Decision|0|||
164565845|NCT04426695|594440425|FG003|Overall Study|Physician Decision|0|||
164565846|NCT04426695|594440426|FG004|Overall Study|Physician Decision|0|||
164565847|NCT04426695|594440427|FG005|Overall Study|Physician Decision|0|||
164565848|NCT04426695|594440428|FG006|Overall Study|Physician Decision|0|||
164565849|NCT04426695|594440429|FG007|Overall Study|Physician Decision|0|||
164565850|NCT04426695|594440430|FG008|Overall Study|Physician Decision|0|||
164565851|NCT04426695|594440431|FG009|Overall Study|Physician Decision|1|||
164565852|NCT04426695|594440432|FG010|Overall Study|Physician Decision|0|||
164565853|NCT04426695|594440433|FG011|Overall Study|Physician Decision|0|||
164565854|NCT04426695|594440434|FG012|Overall Study|Physician Decision|1|||
164565855|NCT04426695|594440435|FG013|Overall Study|Physician Decision|0|||
164565856|NCT04426695|594440436|FG014|Overall Study|Physician Decision|0|||
164565857|NCT04426695|594440437|FG015|Overall Study|Physician Decision|0|||
164565858|NCT04426695|594440438|FG016|Overall Study|Physician Decision|0|||
164565859|NCT04426695|594440439|FG017|Overall Study|Physician Decision|0|||
164565860|NCT04426695|594440422|FG000|Overall Study|Randomized but Never Treated|3|||
164565861|NCT04426695|594440423|FG001|Overall Study|Randomized but Never Treated|1|||
164565862|NCT04426695|594440424|FG002|Overall Study|Randomized but Never Treated|0|||
164565863|NCT04426695|594440425|FG003|Overall Study|Randomized but Never Treated|4|||
164565864|NCT04426695|594440426|FG004|Overall Study|Randomized but Never Treated|5|||
164565865|NCT04426695|594440427|FG005|Overall Study|Randomized but Never Treated|5|||
164565866|NCT04426695|594440428|FG006|Overall Study|Randomized but Never Treated|4|||
164565867|NCT04426695|594440429|FG007|Overall Study|Randomized but Never Treated|6|||
164565868|NCT04426695|594440430|FG008|Overall Study|Randomized but Never Treated|6|||
164565869|NCT04426695|594440431|FG009|Overall Study|Randomized but Never Treated|3|||
164565870|NCT04426695|594440432|FG010|Overall Study|Randomized but Never Treated|3|||
164565871|NCT04426695|594440433|FG011|Overall Study|Randomized but Never Treated|6|||
164565872|NCT04426695|594440434|FG012|Overall Study|Randomized but Never Treated|1|||
164565873|NCT04426695|594440435|FG013|Overall Study|Randomized but Never Treated|2|||
164565874|NCT04426695|594440436|FG014|Overall Study|Randomized but Never Treated|0|||
164565875|NCT04426695|594440437|FG015|Overall Study|Randomized but Never Treated|0|||
164565876|NCT04426695|594440438|FG016|Overall Study|Randomized but Never Treated|0|||
164565877|NCT04426695|594440439|FG017|Overall Study|Randomized but Never Treated|0|||
164565878|NCT03118947|594440441|FG000|Overall Study|Adverse Event|7|||
164565879|NCT03118947|594440441|FG000|Overall Study|Death|3|||
164565880|NCT03118947|594440441|FG000|Overall Study|Lack of Efficacy|4|||
164565881|NCT03118947|594440441|FG000|Overall Study|Non-compliance with study drug|1|||
164565882|NCT03118947|594440441|FG000|Overall Study|Protocol Violation|2|||
164565883|NCT03118947|594440441|FG000|Overall Study|Withdrawal by Subject|3|||
164565884|NCT03118947|594440441|FG000|Overall Study|Withdrawal by caregiver|3|||
164565885|NCT03118947|594440441|FG000|Overall Study|Change in patient's living situation|4|||
164565886|NCT03118947|594440441|FG000|Overall Study|Lost to Follow-up|2|||
164565887|NCT01109940|594440442|FG000|Overall Study|Administrative problems|2|||
164565888|NCT01109940|594440443|FG001|Overall Study|Administrative problems|0|||
164565889|NCT01109940|594440444|FG002|Overall Study|Administrative problems|0|||
164565890|NCT01109940|594440445|FG003|Overall Study|Administrative problems|0|||
164565891|NCT01109940|594440442|FG000|Overall Study|Serious Adverse Event|2|||
164565892|NCT01109940|594440443|FG001|Overall Study|Serious Adverse Event|1|||
164565893|NCT01109940|594440444|FG002|Overall Study|Serious Adverse Event|0|||
164565894|NCT01109940|594440445|FG003|Overall Study|Serious Adverse Event|0|||
164565895|NCT01109940|594440442|FG000|Overall Study|Lost to Follow-up|1|||
164565896|NCT01109940|594440443|FG001|Overall Study|Lost to Follow-up|0|||
164565897|NCT01109940|594440444|FG002|Overall Study|Lost to Follow-up|0|||
164565898|NCT01109940|594440445|FG003|Overall Study|Lost to Follow-up|0|||
164565899|NCT01109940|594440442|FG000|Overall Study|Patient withdrew consent|1|||
164565900|NCT01109940|594440443|FG001|Overall Study|Patient withdrew consent|1|||
164565901|NCT01109940|594440444|FG002|Overall Study|Patient withdrew consent|0|||
164565902|NCT01109940|594440445|FG003|Overall Study|Patient withdrew consent|0|||
164565903|NCT01109940|594440442|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164565904|NCT01109940|594440443|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164218424|NCT02583477|593166762|FG000|Overall Study|Study terminated|2|||
164218425|NCT02583477|593166763|FG001|Overall Study|Study terminated|2|||
164218426|NCT00567112|593166765|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
164565905|NCT01109940|594440444|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
164565906|NCT01109940|594440445|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
164565907|NCT03653390|594440446|FG000|Overall Study|Lost to Follow-up|12|||
164565908|NCT03653390|594440447|FG001|Overall Study|Lost to Follow-up|8|||
164565909|NCT03653390|594440448|FG002|Overall Study|Lost to Follow-up|7|||
164565910|NCT03653390|594440446|FG000|Overall Study|Withdrawal by Subject|6|||
164565911|NCT03653390|594440447|FG001|Overall Study|Withdrawal by Subject|1|||
164565912|NCT03653390|594440448|FG002|Overall Study|Withdrawal by Subject|1|||
164565913|NCT03653390|594440446|FG000|Overall Study|Death|1|||
164565914|NCT03653390|594440447|FG001|Overall Study|Death|0|||
164565915|NCT03653390|594440448|FG002|Overall Study|Death|0|||
164218427|NCT00567112|593166766|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
164218428|NCT00567112|593166767|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
164565916|NCT03653390|594440446|FG000|Overall Study|Paper Survey Lost|1|||
164565917|NCT03653390|594440447|FG001|Overall Study|Paper Survey Lost|0|||
164565918|NCT03653390|594440448|FG002|Overall Study|Paper Survey Lost|0|||
164565919|NCT01262625|594440453|FG000|Overall Study|Administrative Error|1|||
164565920|NCT01262625|594440454|FG001|Overall Study|Administrative Error|1|||
164565921|NCT01262625|594440453|FG000|Overall Study|Site Closed|1|||
164218429|NCT00567112|593166765|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
164218430|NCT00567112|593166766|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
164218431|NCT00567112|593166767|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
164218432|NCT00567112|593166765|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
164218433|NCT00567112|593166766|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
164218434|NCT00567112|593166767|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
164218435|NCT03753542|593166768|FG000|Overall Study|Lost to Follow-up|9|||
164218436|NCT03753542|593166769|FG001|Overall Study|Lost to Follow-up|14|||
164218437|NCT00002874|593166770|FG000|Overall Study|Withdrawal by Subject|1|||
164565922|NCT01262625|594440454|FG001|Overall Study|Site Closed|0|||
164565923|NCT00448708|594440455|FG000|Overall Study|Death|21|||
164565924|NCT00448708|594440456|FG001|Overall Study|Death|17|||
164218438|NCT00002874|593166771|FG001|Overall Study|Withdrawal by Subject|1|||
164218439|NCT00002874|593166770|FG000|Overall Study|Protocol Violation|44|||
164565925|NCT00448708|594440455|FG000|Overall Study|Withdrawal by Subject|8|||
164565926|NCT00448708|594440456|FG001|Overall Study|Withdrawal by Subject|4|||
164565927|NCT00448708|594440455|FG000|Overall Study|Lost to Follow-up|6|||
164565928|NCT00448708|594440456|FG001|Overall Study|Lost to Follow-up|8|||
164565929|NCT00448708|594440455|FG000|Overall Study|not listed|0|||
164565930|NCT00448708|594440456|FG001|Overall Study|not listed|2|||
164565931|NCT00110994|594440457|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
164565932|NCT00110994|594440458|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
164565933|NCT00110994|594440457|FG000|Double-blind (DB) Treatment|Death|1|||
164565934|NCT00110994|594440458|FG001|Double-blind (DB) Treatment|Death|0|||
164565935|NCT00110994|594440457|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
164565936|NCT00110994|594440458|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
164565937|NCT00110994|594440457|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
164565938|NCT00110994|594440458|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
164565939|NCT00110994|594440457|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
164218440|NCT00002874|593166771|FG001|Overall Study|Protocol Violation|34|||
164218441|NCT02114684|593166779|FG000|Overall Study|Death|6|||
164218442|NCT02114684|593166780|FG001|Overall Study|Death|4|||
164218443|NCT02114684|593166779|FG000|Overall Study|Lost to Follow-up|1|||
164218444|NCT02114684|593166780|FG001|Overall Study|Lost to Follow-up|2|||
164218445|NCT02114684|593166779|FG000|Overall Study|Withdrawal by Subject|1|||
164218446|NCT02114684|593166780|FG001|Overall Study|Withdrawal by Subject|2|||
164218447|NCT02114684|593166779|FG000|Overall Study|Relocation|3|||
164218448|NCT02114684|593166780|FG001|Overall Study|Relocation|1|||
164218449|NCT02114684|593166779|FG000|Overall Study|Rifampicin resistant on culture|0|||
164218450|NCT02114684|593166780|FG001|Overall Study|Rifampicin resistant on culture|1|||
164218451|NCT02114684|593166779|FG000|Overall Study|Patient Incarcerated|1|||
164218452|NCT02114684|593166780|FG001|Overall Study|Patient Incarcerated|0|||
164218453|NCT04625972|593166781|FG000|Overall Study|Death|3|||
164218454|NCT04625972|593166782|FG001|Overall Study|Death|2|||
164218455|NCT04625972|593166781|FG000|Overall Study|Lost to Follow-up|82|||
164218456|NCT04625972|593166782|FG001|Overall Study|Lost to Follow-up|38|||
164218457|NCT04625972|593166781|FG000|Overall Study|Physician Decision|2|||
164218458|NCT04625972|593166782|FG001|Overall Study|Physician Decision|0|||
164218459|NCT04625972|593166781|FG000|Overall Study|Protocol Violation|0|||
164218460|NCT04625972|593166782|FG001|Overall Study|Protocol Violation|1|||
164218461|NCT04625972|593166781|FG000|Overall Study|Withdrawal by Subject|37|||
164218462|NCT04625972|593166782|FG001|Overall Study|Withdrawal by Subject|24|||
164218463|NCT04625972|593166781|FG000|Overall Study|Not specified elsewhere|8|||
164218464|NCT04625972|593166782|FG001|Overall Study|Not specified elsewhere|6|||
164218465|NCT05591755|593166783|FG000|Overall Study|Screen Failure|1|||
164218466|NCT05591755|593166784|FG001|Overall Study|Screen Failure|0|||
164218467|NCT05591755|593166785|FG002|Overall Study|Screen Failure|0|||
164218468|NCT05591755|593166786|FG003|Overall Study|Screen Failure|0|||
164218469|NCT05591755|593166783|FG000|Overall Study|Protocol Violation|0|||
164218470|NCT05591755|593166784|FG001|Overall Study|Protocol Violation|0|||
164218471|NCT05591755|593166785|FG002|Overall Study|Protocol Violation|2|||
164218472|NCT05591755|593166786|FG003|Overall Study|Protocol Violation|0|||
164218473|NCT05591755|593166783|FG000|Overall Study|Withdrawal by Subject|0|||
164218474|NCT05591755|593166784|FG001|Overall Study|Withdrawal by Subject|1|||
164218475|NCT05591755|593166785|FG002|Overall Study|Withdrawal by Subject|0|||
164218476|NCT05591755|593166786|FG003|Overall Study|Withdrawal by Subject|0|||
164218477|NCT03828383|593166792|FG000|Overall Study|Lost to Follow-up|3|||
164218478|NCT03828383|593166793|FG001|Overall Study|Lost to Follow-up|2|||
164218479|NCT03828383|593166792|FG000|Overall Study|Withdrawal by Subject|4|||
164218480|NCT03828383|593166793|FG001|Overall Study|Withdrawal by Subject|5|||
164218481|NCT00504309|593166794|FG000|Overall Study|Death|0|||
164218482|NCT00504309|593166795|FG001|Overall Study|Death|0|||
164218483|NCT00504309|593166796|FG002|Overall Study|Death|0|||
164218484|NCT00504309|593166797|FG003|Overall Study|Death|0|||
164565940|NCT00110994|594440458|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
164218485|NCT00504309|593166798|FG004|Overall Study|Death|1|||
164218486|NCT00504309|593166799|FG005|Overall Study|Death|0|||
164218487|NCT00504309|593166794|FG000|Overall Study|Withdrawal by Subject|0|||
164218488|NCT00504309|593166795|FG001|Overall Study|Withdrawal by Subject|0|||
164218489|NCT00504309|593166796|FG002|Overall Study|Withdrawal by Subject|1|||
164218490|NCT00504309|593166797|FG003|Overall Study|Withdrawal by Subject|0|||
164218491|NCT00504309|593166798|FG004|Overall Study|Withdrawal by Subject|0|||
164218492|NCT00504309|593166799|FG005|Overall Study|Withdrawal by Subject|0|||
164218493|NCT03345095|593166801|FG000|Overall Study|Lack of Efficacy|184|||
164218494|NCT03345095|593166802|FG001|Overall Study|Lack of Efficacy|156|||
164218495|NCT03345095|593166801|FG000|Overall Study|Adverse Event|36|||
164565941|NCT00110994|594440457|FG000|Double-blind (DB) Treatment|other reasons|2|||
164565942|NCT00110994|594440458|FG001|Double-blind (DB) Treatment|other reasons|3|||
164565943|NCT00110994|594440457|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
164565944|NCT00110994|594440458|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
164565945|NCT00110994|594440457|FG000|Active Follow-up|Other reasons|0|||
164565946|NCT00110994|594440458|FG001|Active Follow-up|Other reasons|2|||
164565947|NCT00110994|594440457|FG000|Long Term Follow-up|Death|19|||
164565948|NCT00110994|594440458|FG001|Long Term Follow-up|Death|17|||
164218496|NCT03345095|593166802|FG001|Overall Study|Adverse Event|118|||
164218497|NCT03345095|593166801|FG000|Overall Study|Withdrawal by Subject|22|||
164218498|NCT03345095|593166802|FG001|Overall Study|Withdrawal by Subject|59|||
164218499|NCT03345095|593166801|FG000|Overall Study|Physician Decision|3|||
164218500|NCT03345095|593166802|FG001|Overall Study|Physician Decision|18|||
164218501|NCT03345095|593166801|FG000|Overall Study|Death|2|||
164218502|NCT03345095|593166802|FG001|Overall Study|Death|4|||
164218503|NCT03345095|593166801|FG000|Overall Study|Other reasons|2|||
164218504|NCT03345095|593166802|FG001|Overall Study|Other reasons|11|||
164218505|NCT03345095|593166801|FG000|Overall Study|Protocol Violation|0|||
164218506|NCT03345095|593166802|FG001|Overall Study|Protocol Violation|1|||
164218507|NCT00983957|593166806|FG000|Overall Study|Adverse Event|1|||
164218508|NCT00983957|593166806|FG000|Overall Study|Personal Reasons|1|||
164218509|NCT00884949|593168345|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
164327856|NCT02359851|593576144|FG000|Overall Study|Disease progression|1|||
164327857|NCT00491556|593576145|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
164327858|NCT00491556|593576146|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
164218510|NCT00884949|593168345|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
164218511|NCT01108796|593168348|FG000|Overall Study|Adverse Event|0|||
164218512|NCT01108796|593168349|FG001|Overall Study|Adverse Event|1|||
164218513|NCT01108796|593168348|FG000|Overall Study|Lost to Follow-up|7|||
164218514|NCT01108796|593168349|FG001|Overall Study|Lost to Follow-up|6|||
164218515|NCT01129284|593168362|FG000|Overall Study|Adverse Event|2|||
164218516|NCT01129284|593168363|FG001|Overall Study|Adverse Event|0|||
164218517|NCT01129284|593168364|FG002|Overall Study|Adverse Event|1|||
164218518|NCT03197935|593168370|FG000|Overall Study|Death due to any cause|26|||
164218519|NCT03197935|593168371|FG001|Overall Study|Death due to any cause|15|||
164218520|NCT03197935|593168370|FG000|Overall Study|Lost to Follow-up|3|||
164218521|NCT03197935|593168371|FG001|Overall Study|Lost to Follow-up|5|||
164218522|NCT03197935|593168370|FG000|Overall Study|Physician Decision|2|||
164218523|NCT03197935|593168371|FG001|Overall Study|Physician Decision|1|||
164218524|NCT03197935|593168370|FG000|Overall Study|Withdrawal by Subject|16|||
164218525|NCT03197935|593168371|FG001|Overall Study|Withdrawal by Subject|8|||
164327859|NCT00491556|593576145|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
164565949|NCT01500057|594440467|FG000|Overall Study|Lost to Follow-up|6|||
164565950|NCT01500057|594440468|FG001|Overall Study|Lost to Follow-up|4|||
164218526|NCT03315689|593168377|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
164327860|NCT00491556|593576146|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
164327861|NCT00491556|593576145|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
164327862|NCT00491556|593576146|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
164327863|NCT00491556|593576145|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
164327864|NCT00491556|593576146|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
164327865|NCT00491556|593576145|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
164327866|NCT00491556|593576146|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
164327867|NCT00491556|593576145|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
164327868|NCT00491556|593576146|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
164327869|NCT00491556|593576145|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
164327870|NCT00491556|593576146|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
164327871|NCT00491556|593576145|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
164327872|NCT00491556|593576146|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
164327873|NCT00491556|593576145|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
164327874|NCT00491556|593576146|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
164327875|NCT00491556|593576145|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
164327876|NCT00491556|593576146|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
164327877|NCT00491556|593576145|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
164327878|NCT00491556|593576146|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
164327879|NCT00491556|593576145|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
164327880|NCT00491556|593576146|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
164327881|NCT00491556|593576145|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
164327882|NCT00491556|593576146|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
164327883|NCT00491556|593576145|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
164327884|NCT00491556|593576146|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
164327885|NCT00491556|593576145|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
164327886|NCT00491556|593576146|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
164327887|NCT00491556|593576145|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
164327888|NCT00491556|593576146|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
164327889|NCT00491556|593576145|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
164327890|NCT00491556|593576146|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
164327891|NCT00491556|593576145|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
164327892|NCT00491556|593576146|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
164327893|NCT00491556|593576145|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
164327894|NCT00491556|593576146|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
164327895|NCT00491556|593576145|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
164327896|NCT00491556|593576146|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
164327897|NCT04480424|593576147|FG000|Overall Study|Withdrawal by Subject|0|||
164327898|NCT04480424|593576148|FG001|Overall Study|Withdrawal by Subject|2|||
164327899|NCT04480424|593576147|FG000|Overall Study|Lost to Follow-up|3|||
164327900|NCT04480424|593576148|FG001|Overall Study|Lost to Follow-up|3|||
164327901|NCT04480424|593576147|FG000|Overall Study|Death|14|||
164327902|NCT04480424|593576148|FG001|Overall Study|Death|16|||
164327903|NCT04480424|593576147|FG000|Overall Study|Reason not Specified|5|||
164670123|NCT00463606|594816891|FG001|Overall Study|Exclusion criteria violation|0|||
164670124|NCT00463606|594816892|FG002|Overall Study|Exclusion criteria violation|0|||
164670125|NCT00463606|594816890|FG000|Overall Study|Coordinator error|1|||
164670126|NCT00463606|594816891|FG001|Overall Study|Coordinator error|0|||
164670127|NCT00463606|594816892|FG002|Overall Study|Coordinator error|0|||
164670128|NCT00463606|594816890|FG000|Overall Study|Patient randomized in error|1|||
164670129|NCT00463606|594816891|FG001|Overall Study|Patient randomized in error|0|||
164670130|NCT00463606|594816892|FG002|Overall Study|Patient randomized in error|0|||
164670131|NCT00463606|594816890|FG000|Overall Study|Participation in another ABT-335 trial|1|||
164670132|NCT00463606|594816891|FG001|Overall Study|Participation in another ABT-335 trial|0|||
164670133|NCT00463606|594816892|FG002|Overall Study|Participation in another ABT-335 trial|0|||
164670134|NCT00463606|594816890|FG000|Overall Study|Protocol Violation|0|||
164670135|NCT00463606|594816891|FG001|Overall Study|Protocol Violation|0|||
164670136|NCT00463606|594816892|FG002|Overall Study|Protocol Violation|1|||
164670137|NCT02682602|594816894|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
164670138|NCT02682602|594816895|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
164670139|NCT02682602|594816894|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
164670140|NCT02682602|594816895|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
164670141|NCT03567174|594816896|FG000|Overall Study|Death|24|||
164327904|NCT04480424|593576148|FG001|Overall Study|Reason not Specified|5|||
164327905|NCT00993044|593576149|FG000|Irinotecan 50 mg|Physician Decision|1|||
164327906|NCT00734747|593576150|FG000|SRS Procedure|No staples placed|3|||
164670142|NCT03567174|594816897|FG001|Overall Study|Death|31|||
164670143|NCT03567174|594816896|FG000|Overall Study|Lost to Follow-up|165|||
164670144|NCT03567174|594816897|FG001|Overall Study|Lost to Follow-up|174|||
164565951|NCT02318784|594440471|FG000|Overall Study|Adverse Event|13|||
164565952|NCT02318784|594440471|FG000|Overall Study|Death|2|||
164565953|NCT02318784|594440471|FG000|Overall Study|Progressive Disease|37|||
164565954|NCT02318784|594440471|FG000|Overall Study|Withdrawal by Subject|10|||
164565955|NCT00354601|594440474|FG000|Overall Study|Protocol Violation|1|||
164565956|NCT00354601|594440474|FG000|Overall Study|progression|1|||
164565957|NCT02471716|594440475|FG000|Overall Study|Withdrawal by Subject|0|||
164565958|NCT02471716|594440476|FG001|Overall Study|Withdrawal by Subject|1|||
164565959|NCT02471716|594440477|FG002|Overall Study|Withdrawal by Subject|0|||
164565960|NCT02471716|594440478|FG003|Overall Study|Withdrawal by Subject|2|||
164565961|NCT02471716|594440479|FG004|Overall Study|Withdrawal by Subject|5|||
164565962|NCT02471716|594440475|FG000|Overall Study|Study Terminiated by sponsor|0|||
164565963|NCT02471716|594440476|FG001|Overall Study|Study Terminiated by sponsor|0|||
164565964|NCT02471716|594440477|FG002|Overall Study|Study Terminiated by sponsor|0|||
164565965|NCT02471716|594440478|FG003|Overall Study|Study Terminiated by sponsor|1|||
164565966|NCT02471716|594440479|FG004|Overall Study|Study Terminiated by sponsor|0|||
164565967|NCT02471716|594440475|FG000|Overall Study|Lost to Follow-up|0|||
164565968|NCT02471716|594440476|FG001|Overall Study|Lost to Follow-up|0|||
164565969|NCT02471716|594440477|FG002|Overall Study|Lost to Follow-up|0|||
164565970|NCT02471716|594440478|FG003|Overall Study|Lost to Follow-up|3|||
164565971|NCT02471716|594440479|FG004|Overall Study|Lost to Follow-up|2|||
164565972|NCT02471716|594440475|FG000|Overall Study|Death|0|||
164565973|NCT02471716|594440476|FG001|Overall Study|Death|0|||
164565974|NCT02471716|594440477|FG002|Overall Study|Death|0|||
164565975|NCT02471716|594440478|FG003|Overall Study|Death|1|||
164565976|NCT02471716|594440479|FG004|Overall Study|Death|0|||
164565977|NCT02471716|594440475|FG000|Overall Study|Other|0|||
164565978|NCT02471716|594440476|FG001|Overall Study|Other|0|||
164565979|NCT02471716|594440477|FG002|Overall Study|Other|0|||
164565980|NCT02471716|594440478|FG003|Overall Study|Other|8|||
164565981|NCT02471716|594440479|FG004|Overall Study|Other|9|||
164565982|NCT01838044|594440495|FG000|Overall Study|Adverse Event|4|||
164565983|NCT01838044|594440496|FG001|Overall Study|Adverse Event|6|||
164565984|NCT01838044|594440495|FG000|Overall Study|Protocol Violation|3|||
164565985|NCT01838044|594440496|FG001|Overall Study|Protocol Violation|3|||
164565986|NCT01838044|594440495|FG000|Overall Study|Withdrawal by Subject|0|||
164565987|NCT01838044|594440496|FG001|Overall Study|Withdrawal by Subject|2|||
164565988|NCT01838044|594440495|FG000|Overall Study|Insufficient clinical response|1|||
164565989|NCT01838044|594440496|FG001|Overall Study|Insufficient clinical response|2|||
164565990|NCT01838044|594440495|FG000|Overall Study|Medication error without associated AE|0|||
164565991|NCT01838044|594440496|FG001|Overall Study|Medication error without associated AE|1|||
164565992|NCT01838044|594440495|FG000|Overall Study|Lost to Follow-up|0|||
164565993|NCT01838044|594440496|FG001|Overall Study|Lost to Follow-up|2|||
164565994|NCT00330187|594440497|FG000|Overall Study|Lost to Follow-up|12|||
164565995|NCT00330187|594440498|FG001|Overall Study|Lost to Follow-up|13|||
164565996|NCT00330187|594440499|FG002|Overall Study|Lost to Follow-up|14|||
164565997|NCT00330187|594440500|FG003|Overall Study|Lost to Follow-up|10|||
164565998|NCT00330187|594440497|FG000|Overall Study|Withdrawal by Subject|8|||
164565999|NCT00330187|594440498|FG001|Overall Study|Withdrawal by Subject|5|||
164566000|NCT00330187|594440499|FG002|Overall Study|Withdrawal by Subject|4|||
164566001|NCT00330187|594440500|FG003|Overall Study|Withdrawal by Subject|4|||
164566002|NCT01162421|594440506|FG000|Overall Study|Did not receive study drug|2|||
164670145|NCT02140060|594816898|FG000|Overall Study|Adverse Event|0|||
164670146|NCT02140060|594816899|FG001|Overall Study|Adverse Event|0|||
164670147|NCT02140060|594816900|FG002|Overall Study|Adverse Event|0|||
164670148|NCT02140060|594816901|FG003|Overall Study|Adverse Event|1|||
164670149|NCT02140060|594816902|FG004|Overall Study|Adverse Event|1|||
164670150|NCT02140060|594816903|FG005|Overall Study|Adverse Event|1|||
164670151|NCT02140060|594816898|FG000|Overall Study|Lack of Efficacy|0|||
164670152|NCT02140060|594816899|FG001|Overall Study|Lack of Efficacy|0|||
164670153|NCT02140060|594816900|FG002|Overall Study|Lack of Efficacy|0|||
164670154|NCT02140060|594816901|FG003|Overall Study|Lack of Efficacy|1|||
164670155|NCT02140060|594816902|FG004|Overall Study|Lack of Efficacy|0|||
164670156|NCT02140060|594816903|FG005|Overall Study|Lack of Efficacy|0|||
164327907|NCT00734747|593576150|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
164566003|NCT01162421|594440507|FG001|Overall Study|Did not receive study drug|1|||
164566004|NCT01162421|594440506|FG000|Overall Study|Adverse Event|2|||
164566005|NCT01162421|594440507|FG001|Overall Study|Adverse Event|5|||
164566006|NCT01162421|594440506|FG000|Overall Study|Lost to Follow-up|0|||
164566007|NCT01162421|594440507|FG001|Overall Study|Lost to Follow-up|2|||
164566008|NCT01162421|594440506|FG000|Overall Study|Lack of Efficacy|2|||
164566009|NCT01162421|594440507|FG001|Overall Study|Lack of Efficacy|2|||
164566010|NCT01162421|594440506|FG000|Overall Study|Other|2|||
164566011|NCT01162421|594440507|FG001|Overall Study|Other|3|||
164670157|NCT00522457|594816904|FG000|Overall Study|Due to disease progression|16|||
164670158|NCT00522457|594816904|FG000|Overall Study|Adverse Event|2|||
164670159|NCT01066143|594818999|FG000|Overall Study|ineligible for the study|8|||
164670160|NCT05376319|594819000|FG000|Overall Study|Funding termination|2|||
164670161|NCT05376319|594819001|FG001|Overall Study|Funding termination|4|||
164327908|NCT01897714|593577804|FG000|Phase I (Dose Escalation)|Disease progression|3|||
164327909|NCT01897714|593577805|FG001|Phase I (Dose Escalation)|Disease progression|5|||
164327910|NCT01897714|593577806|FG002|Phase I (Dose Escalation)|Disease progression|1|||
164327911|NCT01897714|593577807|FG003|Phase I (Dose Escalation)|Disease progression|3|||
164327912|NCT01897714|593577808|FG004|Phase I (Dose Escalation)|Disease progression|0|||
164327913|NCT01897714|593577809|FG005|Phase I (Dose Escalation)|Disease progression|0|||
164327914|NCT01897714|593577804|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
164327915|NCT01897714|593577805|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
164327916|NCT01897714|593577806|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
164327917|NCT01897714|593577807|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
164327918|NCT01897714|593577808|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
164327919|NCT01897714|593577809|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
164327920|NCT01897714|593577804|FG000|Phase I (Dose Escalation)|Other|0|||
164327921|NCT01897714|593577805|FG001|Phase I (Dose Escalation)|Other|1|||
164327922|NCT01897714|593577806|FG002|Phase I (Dose Escalation)|Other|0|||
164327923|NCT01897714|593577807|FG003|Phase I (Dose Escalation)|Other|0|||
164327924|NCT01897714|593577808|FG004|Phase I (Dose Escalation)|Other|0|||
164327925|NCT01897714|593577809|FG005|Phase I (Dose Escalation)|Other|0|||
164327926|NCT01897714|593577804|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
164327927|NCT01897714|593577805|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
164327928|NCT01897714|593577806|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
164327929|NCT01897714|593577807|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
164327930|NCT01897714|593577808|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
164327931|NCT01897714|593577809|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
164566012|NCT01133171|594440512|FG000|Overall Study|Withdrawal by Subject|1|||
164566013|NCT01133171|594440513|FG001|Overall Study|Withdrawal by Subject|2|||
164566014|NCT01133171|594440514|FG002|Overall Study|Withdrawal by Subject|0|||
164566015|NCT00686647|594440521|FG000|Overall Study|Lost to Follow-up|1|||
164566016|NCT00686647|594440521|FG000|Overall Study|Death|1|||
164566017|NCT00578643|594440522|FG000|Overall Study|Death|1|||
164566018|NCT00578643|594440522|FG000|Overall Study|Lost to Follow-up|1|||
164566019|NCT01725750|594440523|FG000|Overall Study|Adverse Event|1|||
164566020|NCT01725750|594440524|FG001|Overall Study|Adverse Event|0|||
164566021|NCT01725750|594440523|FG000|Overall Study|Lost to Follow-up|1|||
164566022|NCT01725750|594440524|FG001|Overall Study|Lost to Follow-up|1|||
164566023|NCT01725750|594440523|FG000|Overall Study|Withdrawal by Subject|0|||
164566024|NCT01725750|594440524|FG001|Overall Study|Withdrawal by Subject|9|||
164566025|NCT01634555|594440526|FG000|Overall Study|Adverse Event|3|||
164566026|NCT01634555|594440526|FG000|Overall Study|Physician Decision|1|||
164566027|NCT01506882|594440527|FG000|Overall Study|Lack of Efficacy|4|||
164566028|NCT01506882|594440528|FG001|Overall Study|Lack of Efficacy|3|||
164566029|NCT01506882|594440527|FG000|Overall Study|Lost to Follow-up|1|||
164566030|NCT01506882|594440528|FG001|Overall Study|Lost to Follow-up|0|||
164566031|NCT01506882|594440527|FG000|Overall Study|Withdrawal by Subject|9|||
164566032|NCT01506882|594440528|FG001|Overall Study|Withdrawal by Subject|3|||
164566033|NCT01506882|594440527|FG000|Overall Study|SAE, non-fatal|2|||
164566034|NCT01506882|594440528|FG001|Overall Study|SAE, non-fatal|0|||
164566035|NCT01506882|594440527|FG000|Overall Study|AE, non-serious non-fatal|3|||
164566036|NCT01506882|594440528|FG001|Overall Study|AE, non-serious non-fatal|1|||
164566037|NCT01506882|594440527|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
164566038|NCT01506882|594440528|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
164566039|NCT01506882|594440527|FG000|Overall Study|Other Reason|2|||
164566040|NCT01506882|594440528|FG001|Overall Study|Other Reason|0|||
164566041|NCT02663895|594442943|FG000|Overall Study|Adverse Event|3|||
164566042|NCT02663895|594442943|FG000|Overall Study|Physician Decision|2|||
164566043|NCT02663895|594442943|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
164566044|NCT02663895|594442943|FG000|Overall Study|Withdrawal by Subject|1|||
164566045|NCT00809328|594442944|FG000|Overall Study|Lack of Efficacy|18|||
164566046|NCT00809328|594442944|FG000|Overall Study|Adverse Event|6|||
164566047|NCT00809328|594442944|FG000|Overall Study|Protocol Violation|3|||
164566048|NCT00809328|594442944|FG000|Overall Study|Withdrawal by Subject|2|||
164566049|NCT00008385|594442945|FG000|Overall Study|Off treatment reasons not reported|79|||
164566050|NCT00008385|594442946|FG001|Overall Study|Off treatment reasons not reported|70|||
164566051|NCT00008385|594442945|FG000|Overall Study|Progressive disease|52|||
164566052|NCT00008385|594442946|FG001|Overall Study|Progressive disease|117|||
164566053|NCT00008385|594442945|FG000|Overall Study|Adverse Event|8|||
164566054|NCT00008385|594442946|FG001|Overall Study|Adverse Event|20|||
164566055|NCT00008385|594442945|FG000|Overall Study|Death|12|||
164566056|NCT00008385|594442946|FG001|Overall Study|Death|18|||
164566057|NCT00008385|594442945|FG000|Overall Study|Withdrawal by Subject|67|||
164566058|NCT00008385|594442946|FG001|Overall Study|Withdrawal by Subject|157|||
164566059|NCT00008385|594442945|FG000|Overall Study|Start non-protocol therapy|3|||
164566060|NCT00008385|594442946|FG001|Overall Study|Start non-protocol therapy|1|||
164566061|NCT00008385|594442945|FG000|Overall Study|Other complicating disease|17|||
164566062|NCT00008385|594442946|FG001|Overall Study|Other complicating disease|30|||
164566063|NCT00008385|594442945|FG000|Overall Study|Maximum dose reached|0|||
164566064|NCT00008385|594442946|FG001|Overall Study|Maximum dose reached|2|||
164566065|NCT00008385|594442945|FG000|Overall Study|Other|105|||
164566066|NCT00008385|594442946|FG001|Overall Study|Other|212|||
164566067|NCT00008385|594442945|FG000|Overall Study|Not start protocol therapy|44|||
164566068|NCT00008385|594442946|FG001|Overall Study|Not start protocol therapy|175|||
164566069|NCT00365989|594442949|FG000|Overall Study|Withdrawal by Subject|1|||
164566070|NCT00365989|594442949|FG000|Overall Study|Non-compliance|1|||
164566071|NCT00317044|594442950|FG000|Overall Study|Protocol Violation|28|||
164566072|NCT00317044|594442951|FG001|Overall Study|Protocol Violation|22|||
164566073|NCT00317044|594442952|FG002|Overall Study|Protocol Violation|20|||
164566074|NCT00317044|594442950|FG000|Overall Study|Adverse Event|4|||
164566075|NCT00317044|594442951|FG001|Overall Study|Adverse Event|7|||
164566076|NCT00317044|594442952|FG002|Overall Study|Adverse Event|4|||
164566077|NCT00317044|594442950|FG000|Overall Study|Withdrawal by Subject|10|||
164566078|NCT00317044|594442951|FG001|Overall Study|Withdrawal by Subject|7|||
164566079|NCT00317044|594442952|FG002|Overall Study|Withdrawal by Subject|12|||
164566080|NCT00317044|594442950|FG000|Overall Study|Lost to Follow-up|0|||
164566081|NCT00317044|594442951|FG001|Overall Study|Lost to Follow-up|2|||
164566082|NCT00317044|594442952|FG002|Overall Study|Lost to Follow-up|3|||
164566083|NCT00317044|594442950|FG000|Overall Study|Multiple Reasons|6|||
164566084|NCT00317044|594442951|FG001|Overall Study|Multiple Reasons|2|||
164566085|NCT00317044|594442952|FG002|Overall Study|Multiple Reasons|6|||
164566086|NCT04317690|594442953|FG000|Overall Study|did not have complete information for primary outcome|0|||
164566087|NCT04317690|594442954|FG001|Overall Study|did not have complete information for primary outcome|4|||
164327932|NCT01897714|593577804|FG000|Phase II (MTD)|Lost to Follow-up|0|||
164327933|NCT01897714|593577805|FG001|Phase II (MTD)|Lost to Follow-up|0|||
164327934|NCT01897714|593577806|FG002|Phase II (MTD)|Lost to Follow-up|0|||
164327935|NCT01897714|593577807|FG003|Phase II (MTD)|Lost to Follow-up|0|||
164327936|NCT01897714|593577808|FG004|Phase II (MTD)|Lost to Follow-up|1|||
164327937|NCT01897714|593577809|FG005|Phase II (MTD)|Lost to Follow-up|0|||
164327938|NCT01897714|593577804|FG000|Phase II (MTD)|Death|0|||
164327939|NCT01897714|593577805|FG001|Phase II (MTD)|Death|0|||
164327940|NCT01897714|593577806|FG002|Phase II (MTD)|Death|0|||
164327941|NCT01897714|593577807|FG003|Phase II (MTD)|Death|0|||
164327942|NCT01897714|593577808|FG004|Phase II (MTD)|Death|25|||
164327943|NCT01897714|593577809|FG005|Phase II (MTD)|Death|10|||
164327944|NCT01897714|593577804|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
164327945|NCT01897714|593577805|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
164327946|NCT01897714|593577806|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
164327947|NCT01897714|593577807|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
164327948|NCT01897714|593577808|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
164327949|NCT01897714|593577809|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
164327950|NCT01897714|593577804|FG000|Phase II (MTD)|Other|0|||
164327951|NCT01897714|593577805|FG001|Phase II (MTD)|Other|0|||
164327952|NCT01897714|593577806|FG002|Phase II (MTD)|Other|0|||
164327953|NCT01897714|593577807|FG003|Phase II (MTD)|Other|0|||
164327954|NCT01897714|593577808|FG004|Phase II (MTD)|Other|3|||
164327955|NCT01897714|593577809|FG005|Phase II (MTD)|Other|0|||
164327956|NCT05828095|593577818|FG000|Overall Study|Lost to Follow-up|1|||
164327957|NCT05828095|593577819|FG001|Overall Study|Lost to Follow-up|0|||
164327958|NCT05828095|593577818|FG000|Overall Study|Reactogenicity symptom|0|||
164327959|NCT05828095|593577819|FG001|Overall Study|Reactogenicity symptom|1|||
164327960|NCT03206073|593577820|FG000|Overall Study|Participant Noncompliance|0|||
164327961|NCT03206073|593577821|FG001|Overall Study|Participant Noncompliance|1|||
164327962|NCT03206073|593577822|FG002|Overall Study|Participant Noncompliance|0|||
164327963|NCT03206073|593577823|FG003|Overall Study|Participant Noncompliance|0|||
164327964|NCT03206073|593577820|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
164327965|NCT03206073|593577821|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
164327966|NCT03206073|593577822|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
164327967|NCT03206073|593577823|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
164327968|NCT03206073|593577820|FG000|Overall Study|Death|0|||
164327969|NCT03206073|593577821|FG001|Overall Study|Death|0|||
164327970|NCT03206073|593577822|FG002|Overall Study|Death|1|||
164327971|NCT03206073|593577823|FG003|Overall Study|Death|0|||
164327972|NCT03206073|593577820|FG000|Overall Study|Taken off active treatment|0|||
164327973|NCT03206073|593577821|FG001|Overall Study|Taken off active treatment|0|||
164327974|NCT03206073|593577822|FG002|Overall Study|Taken off active treatment|3|||
164327975|NCT03206073|593577823|FG003|Overall Study|Taken off active treatment|0|||
164327976|NCT05523323|593577824|FG000|Overall Study|Death|26|||
164327977|NCT05523323|593577825|FG001|Overall Study|Death|21|||
164327978|NCT05523323|593577824|FG000|Overall Study|Ongoing participants|35|||
164327979|NCT05523323|593577825|FG001|Overall Study|Ongoing participants|30|||
164327980|NCT02428608|593577830|FG000|Overall Study|Pregnancy|2|||
164566088|NCT04317690|594442955|FG002|Overall Study|did not have complete information for primary outcome|0|||
164566089|NCT04317690|594442956|FG003|Overall Study|did not have complete information for primary outcome|2|||
164566090|NCT04317690|594442957|FG004|Overall Study|did not have complete information for primary outcome|0|||
164566091|NCT02318095|594442958|FG000|Overall Study|Adverse Event|1|||
164566092|NCT00600171|594442961|FG000|Overall Study|Adverse Event|0|||
164566093|NCT00600171|594442962|FG001|Overall Study|Adverse Event|1|||
164566094|NCT00600171|594442963|FG002|Overall Study|Adverse Event|0|||
164566095|NCT00600171|594442964|FG003|Overall Study|Adverse Event|0|||
164566096|NCT00600171|594442965|FG004|Overall Study|Adverse Event|1|||
164566097|NCT00600171|594442966|FG005|Overall Study|Adverse Event|0|||
164566098|NCT00600171|594442961|FG000|Overall Study|Lack of Efficacy|9|||
164566099|NCT00600171|594442962|FG001|Overall Study|Lack of Efficacy|12|||
164566100|NCT00600171|594442963|FG002|Overall Study|Lack of Efficacy|3|||
164327981|NCT02428608|593577830|FG000|Overall Study|Lost to Follow-up|37|||
164566101|NCT00600171|594442964|FG003|Overall Study|Lack of Efficacy|5|||
164566102|NCT00600171|594442965|FG004|Overall Study|Lack of Efficacy|4|||
164327982|NCT02428608|593577830|FG000|Overall Study|Withdrawal by Subject|2|||
164327983|NCT02428608|593577830|FG000|Overall Study|scheduling conflicts|15|||
164327984|NCT02428608|593577830|FG000|Overall Study|moved away|10|||
164327985|NCT02428608|593577830|FG000|Overall Study|Death|1|||
164327986|NCT02428608|593577830|FG000|Overall Study|various|16|||
164327987|NCT03868124|593577831|FG000|Overall Study|Withdrawal by Subject|4|||
164566103|NCT00600171|594442966|FG005|Overall Study|Lack of Efficacy|0|||
164566104|NCT00600171|594442961|FG000|Overall Study|Protocol Violation|1|||
164566105|NCT00600171|594442962|FG001|Overall Study|Protocol Violation|2|||
164566106|NCT00600171|594442963|FG002|Overall Study|Protocol Violation|0|||
164566107|NCT00600171|594442964|FG003|Overall Study|Protocol Violation|1|||
164566108|NCT00600171|594442965|FG004|Overall Study|Protocol Violation|0|||
164566109|NCT00600171|594442966|FG005|Overall Study|Protocol Violation|0|||
164566110|NCT00600171|594442961|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
164566111|NCT00600171|594442962|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
164566112|NCT00600171|594442963|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
164566113|NCT00600171|594442964|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
164566114|NCT00600171|594442965|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
164566115|NCT00600171|594442966|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
164566116|NCT00600171|594442961|FG000|Overall Study|Withdrawal by Subject|3|||
164566117|NCT00600171|594442962|FG001|Overall Study|Withdrawal by Subject|0|||
164566118|NCT00600171|594442963|FG002|Overall Study|Withdrawal by Subject|0|||
164566119|NCT00600171|594442964|FG003|Overall Study|Withdrawal by Subject|1|||
164566120|NCT00600171|594442965|FG004|Overall Study|Withdrawal by Subject|1|||
164566121|NCT00600171|594442966|FG005|Overall Study|Withdrawal by Subject|1|||
164566122|NCT00600171|594442961|FG000|Overall Study|Physician Decision|0|||
164566123|NCT00600171|594442962|FG001|Overall Study|Physician Decision|1|||
164566124|NCT00600171|594442963|FG002|Overall Study|Physician Decision|0|||
164566125|NCT00600171|594442964|FG003|Overall Study|Physician Decision|1|||
164566126|NCT00600171|594442965|FG004|Overall Study|Physician Decision|0|||
164566127|NCT00600171|594442966|FG005|Overall Study|Physician Decision|2|||
164566128|NCT00600171|594442961|FG000|Overall Study|Lost to Follow-up|0|||
164566129|NCT00600171|594442962|FG001|Overall Study|Lost to Follow-up|0|||
164566130|NCT00600171|594442963|FG002|Overall Study|Lost to Follow-up|0|||
164566131|NCT00600171|594442964|FG003|Overall Study|Lost to Follow-up|1|||
164566132|NCT00600171|594442965|FG004|Overall Study|Lost to Follow-up|0|||
164566133|NCT00600171|594442966|FG005|Overall Study|Lost to Follow-up|0|||
164566134|NCT02367521|594442967|FG000|Overall Study|severe headache after intervention|2|||
164566135|NCT02367521|594442968|FG001|Overall Study|severe headache after intervention|0|||
164566136|NCT02367521|594442967|FG000|Overall Study|unable to find transportation|2|||
164566137|NCT02367521|594442968|FG001|Overall Study|unable to find transportation|0|||
164566138|NCT03617705|594442972|FG000|Overall Study|Withdrawal by Subject|2|||
164566139|NCT03617705|594442972|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
164566140|NCT03617705|594442972|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
164566141|NCT03502187|594442973|FG000|Overall Study|Withdrawal by Subject|4|||
164566142|NCT03502187|594442974|FG001|Overall Study|Withdrawal by Subject|3|||
164566143|NCT03502187|594442975|FG002|Overall Study|Withdrawal by Subject|3|||
164566144|NCT03502187|594442973|FG000|Overall Study|Lost to Follow-up|5|||
164566145|NCT03502187|594442974|FG001|Overall Study|Lost to Follow-up|4|||
164566146|NCT03502187|594442975|FG002|Overall Study|Lost to Follow-up|5|||
164566147|NCT00214461|594442976|FG000|Overall Study|Adverse Event|0|||
164566148|NCT00214461|594442977|FG001|Overall Study|Adverse Event|0|||
164566149|NCT00214461|594442978|FG002|Overall Study|Adverse Event|1|||
164566150|NCT00214461|594442979|FG003|Overall Study|Adverse Event|1|||
164566151|NCT00214461|594442976|FG000|Overall Study|Withdrawal by Subject|0|||
164566152|NCT00214461|594442977|FG001|Overall Study|Withdrawal by Subject|0|||
164566153|NCT00214461|594442978|FG002|Overall Study|Withdrawal by Subject|1|||
164566154|NCT00214461|594442979|FG003|Overall Study|Withdrawal by Subject|0|||
164566155|NCT06118385|594442980|FG000|Overall Study|Protocol Violation|0|||
164670162|NCT01340495|594819002|FG000|Overall Study|Withdrawal by Subject|1|||
164670163|NCT03497897|594819003|FG000|Overall Study|Adverse Event|1|||
164670164|NCT03497897|594819004|FG001|Overall Study|Adverse Event|1|||
164670165|NCT03497897|594819005|FG002|Overall Study|Adverse Event|1|||
164670166|NCT03497897|594819003|FG000|Overall Study|Lost to Follow-up|2|||
164670167|NCT03497897|594819004|FG001|Overall Study|Lost to Follow-up|0|||
164670168|NCT03497897|594819005|FG002|Overall Study|Lost to Follow-up|2|||
164670169|NCT03497897|594819003|FG000|Overall Study|Physician Decision|1|||
164670170|NCT03497897|594819004|FG001|Overall Study|Physician Decision|0|||
164670171|NCT03497897|594819005|FG002|Overall Study|Physician Decision|0|||
164670172|NCT03497897|594819003|FG000|Overall Study|Subject/Guardian Decision|2|||
164670173|NCT03497897|594819004|FG001|Overall Study|Subject/Guardian Decision|1|||
164670174|NCT03497897|594819005|FG002|Overall Study|Subject/Guardian Decision|3|||
164670175|NCT00723528|594819006|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
164670176|NCT00723528|594819007|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
164670177|NCT00723528|594819008|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
164670178|NCT00723528|594819009|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
164670179|NCT00723528|594819010|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
164670180|NCT00723528|594819011|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
164670181|NCT00723528|594819012|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
164670182|NCT00723528|594819006|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
164670183|NCT00723528|594819007|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
164670184|NCT00723528|594819008|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
164670185|NCT00723528|594819009|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
164670186|NCT00723528|594819010|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
164670187|NCT00723528|594819011|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
164566156|NCT06118385|594442981|FG001|Overall Study|Protocol Violation|0|||
164566157|NCT06118385|594442982|FG002|Overall Study|Protocol Violation|0|||
164566158|NCT06118385|594442983|FG003|Overall Study|Protocol Violation|0|||
164566159|NCT06118385|594442984|FG004|Overall Study|Protocol Violation|0|||
164566160|NCT06118385|594442985|FG005|Overall Study|Protocol Violation|0|||
164566161|NCT06118385|594442986|FG006|Overall Study|Protocol Violation|0|||
164566162|NCT06118385|594442987|FG007|Overall Study|Protocol Violation|0|||
164566163|NCT06118385|594442988|FG008|Overall Study|Protocol Violation|1|||
164566164|NCT06118385|594442989|FG009|Overall Study|Protocol Violation|0|||
164566165|NCT06118385|594442990|FG010|Overall Study|Protocol Violation|0|||
164566166|NCT06118385|594442991|FG011|Overall Study|Protocol Violation|0|||
164566167|NCT06118385|594442980|FG000|Overall Study|Out-of-range blood tests|0|||
164566168|NCT06118385|594442981|FG001|Overall Study|Out-of-range blood tests|0|||
164566169|NCT06118385|594442982|FG002|Overall Study|Out-of-range blood tests|0|||
164566170|NCT06118385|594442983|FG003|Overall Study|Out-of-range blood tests|0|||
164566171|NCT06118385|594442984|FG004|Overall Study|Out-of-range blood tests|0|||
164566172|NCT06118385|594442985|FG005|Overall Study|Out-of-range blood tests|0|||
164670188|NCT00723528|594819012|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
164327988|NCT03868124|593577832|FG001|Overall Study|Withdrawal by Subject|0|||
164327989|NCT03868124|593577833|FG002|Overall Study|Withdrawal by Subject|1|||
164327990|NCT03868124|593577831|FG000|Overall Study|Physician Decision|1|||
164327991|NCT03868124|593577832|FG001|Overall Study|Physician Decision|0|||
164327992|NCT03868124|593577833|FG002|Overall Study|Physician Decision|1|||
164327993|NCT03868124|593577831|FG000|Overall Study|Lost to Follow-up|1|||
164327994|NCT03868124|593577832|FG001|Overall Study|Lost to Follow-up|1|||
164327995|NCT03868124|593577833|FG002|Overall Study|Lost to Follow-up|2|||
164327996|NCT03868124|593577831|FG000|Overall Study|Death|1|||
164327997|NCT03868124|593577832|FG001|Overall Study|Death|1|||
164327998|NCT03868124|593577833|FG002|Overall Study|Death|2|||
164327999|NCT03868124|593577831|FG000|Overall Study|Adverse Event|0|||
164328000|NCT03868124|593577832|FG001|Overall Study|Adverse Event|0|||
164328001|NCT03868124|593577833|FG002|Overall Study|Adverse Event|3|||
164328002|NCT03868124|593577831|FG000|Overall Study|Explanted|2|||
164328003|NCT03868124|593577832|FG001|Overall Study|Explanted|1|||
164328004|NCT03868124|593577833|FG002|Overall Study|Explanted|0|||
164328005|NCT03868124|593577831|FG000|Overall Study|Ongoing in study|176|||
164328006|NCT03868124|593577832|FG001|Overall Study|Ongoing in study|180|||
164328007|NCT03868124|593577833|FG002|Overall Study|Ongoing in study|183|||
164328008|NCT00397943|593577834|FG000|Overall Study|Unspecified reasons|12|||
164328009|NCT00397943|593577835|FG001|Overall Study|Unspecified reasons|9|||
164328010|NCT00397943|593577836|FG002|Overall Study|Unspecified reasons|0|||
164328011|NCT00397943|593577837|FG003|Overall Study|Unspecified reasons|0|||
164328012|NCT00397943|593577838|FG004|Overall Study|Unspecified reasons|0|||
164328013|NCT05007717|593577839|FG000|Overall Study|Death|3|||
164328014|NCT05007717|593577840|FG001|Overall Study|Death|2|||
164328015|NCT01117051|593577841|FG000|Overall Study|Withdrawal by Subject|5|||
164328016|NCT01117051|593577842|FG001|Overall Study|Withdrawal by Subject|3|||
164328017|NCT01117051|593577841|FG000|Overall Study|Adverse Event|4|||
164328018|NCT01117051|593577842|FG001|Overall Study|Adverse Event|3|||
164328019|NCT01117051|593577841|FG000|Overall Study|Lost to Follow-up|0|||
164328020|NCT01117051|593577842|FG001|Overall Study|Lost to Follow-up|1|||
164328021|NCT01117051|593577841|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
164328022|NCT01117051|593577842|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
164328023|NCT01117051|593577841|FG000|Overall Study|Sponsor's decision|3|||
164328024|NCT01117051|593577842|FG001|Overall Study|Sponsor's decision|1|||
164328025|NCT01117051|593577841|FG000|Overall Study|Surgical procedure|0|||
164328026|NCT01117051|593577842|FG001|Overall Study|Surgical procedure|1|||
164328027|NCT01117051|593577841|FG000|Overall Study|Randomized by mistake|0|||
164328028|NCT01117051|593577842|FG001|Overall Study|Randomized by mistake|1|||
164328029|NCT01117051|593577841|FG000|Overall Study|Convenience issue|1|||
164328030|NCT01117051|593577842|FG001|Overall Study|Convenience issue|0|||
164328031|NCT00206076|593577844|FG000|Overall Study|Physician Decision|2|||
164328032|NCT00206076|593577845|FG001|Overall Study|Physician Decision|0|||
164328033|NCT00206076|593577844|FG000|Overall Study|Withdrawal by Subject|1|||
164328034|NCT00206076|593577845|FG001|Overall Study|Withdrawal by Subject|1|||
164328035|NCT00427960|593577846|FG000|Overall Study|Adverse Event|2|||
164328036|NCT00427960|593577847|FG001|Overall Study|Adverse Event|0|||
164328037|NCT00427960|593577846|FG000|Overall Study|Withdrawal by Subject|0|||
164328038|NCT00427960|593577847|FG001|Overall Study|Withdrawal by Subject|3|||
164328039|NCT00427960|593577846|FG000|Overall Study|Other|0|||
164328040|NCT00427960|593577847|FG001|Overall Study|Other|1|||
164328041|NCT01142128|593577848|FG000|Overall Study|Physician Decision|1|||
164328042|NCT01142128|593577848|FG000|Overall Study|Lost to Follow-up|1|||
164328043|NCT01142128|593577848|FG000|Overall Study|Withdrawal by Subject|2|||
164328044|NCT03355664|593577849|FG000|Overall Study|Adverse Event|1|||
164328045|NCT03355664|593577850|FG001|Overall Study|Adverse Event|2|||
164328046|NCT03355664|593577849|FG000|Overall Study|Lost to Follow-up|11|||
164328047|NCT03355664|593577850|FG001|Overall Study|Lost to Follow-up|7|||
164328048|NCT03355664|593577849|FG000|Overall Study|Protocol Violation|1|||
164328049|NCT03355664|593577850|FG001|Overall Study|Protocol Violation|2|||
164328050|NCT03355664|593577849|FG000|Overall Study|Withdrawal by Subject|2|||
164328051|NCT03355664|593577850|FG001|Overall Study|Withdrawal by Subject|1|||
164328052|NCT02821910|593577854|FG000|Overall Study|Withdrawal by Subject|0|||
164328053|NCT02821910|593577855|FG001|Overall Study|Withdrawal by Subject|0|||
164328054|NCT02821910|593577856|FG002|Overall Study|Withdrawal by Subject|1|||
164328055|NCT02821910|593577857|FG003|Overall Study|Withdrawal by Subject|0|||
164328056|NCT02821910|593577858|FG004|Overall Study|Withdrawal by Subject|0|||
164328057|NCT02821910|593577859|FG005|Overall Study|Withdrawal by Subject|1|||
164328058|NCT02821910|593577854|FG000|Overall Study|Other than specified|1|||
164328059|NCT02821910|593577855|FG001|Overall Study|Other than specified|0|||
164328060|NCT02821910|593577856|FG002|Overall Study|Other than specified|1|||
164328061|NCT02821910|593577857|FG003|Overall Study|Other than specified|0|||
164328062|NCT02821910|593577858|FG004|Overall Study|Other than specified|0|||
164328063|NCT02821910|593577859|FG005|Overall Study|Other than specified|0|||
164328064|NCT00423670|593577860|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
164328065|NCT00423670|593577861|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
164328066|NCT00423670|593577862|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
164328067|NCT00423670|593577863|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
164328068|NCT00423670|593577864|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
164328069|NCT00423670|593577865|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
164328070|NCT00423670|593577866|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
164328071|NCT00423670|593577867|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
164328072|NCT00423670|593577860|FG000|Treatment Period|Adverse Event|8|||
164328073|NCT00423670|593577861|FG001|Treatment Period|Adverse Event|12|||
164328074|NCT00423670|593577862|FG002|Treatment Period|Adverse Event|15|||
164328075|NCT00423670|593577863|FG003|Treatment Period|Adverse Event|20|||
164328076|NCT00423670|593577864|FG004|Treatment Period|Adverse Event|9|||
164328077|NCT00423670|593577865|FG005|Treatment Period|Adverse Event|4|||
164328078|NCT00423670|593577866|FG006|Treatment Period|Adverse Event|7|||
164328079|NCT00423670|593577867|FG007|Treatment Period|Adverse Event|2|||
164328080|NCT00423670|593577860|FG000|Treatment Period|Protocol-defined clinical event|0|||
164328081|NCT00423670|593577861|FG001|Treatment Period|Protocol-defined clinical event|7|||
164328082|NCT00423670|593577862|FG002|Treatment Period|Protocol-defined clinical event|4|||
164328083|NCT00423670|593577863|FG003|Treatment Period|Protocol-defined clinical event|12|||
164328084|NCT00423670|593577864|FG004|Treatment Period|Protocol-defined clinical event|5|||
164328085|NCT00423670|593577865|FG005|Treatment Period|Protocol-defined clinical event|4|||
164328086|NCT00423670|593577866|FG006|Treatment Period|Protocol-defined clinical event|16|||
164328087|NCT00423670|593577867|FG007|Treatment Period|Protocol-defined clinical event|15|||
164328088|NCT00423670|593577860|FG000|Treatment Period|Lost to Follow-up|2|||
164328089|NCT00423670|593577861|FG001|Treatment Period|Lost to Follow-up|1|||
164328090|NCT00423670|593577862|FG002|Treatment Period|Lost to Follow-up|3|||
164328091|NCT00423670|593577863|FG003|Treatment Period|Lost to Follow-up|1|||
164328092|NCT00423670|593577864|FG004|Treatment Period|Lost to Follow-up|6|||
164328093|NCT00423670|593577865|FG005|Treatment Period|Lost to Follow-up|0|||
164328094|NCT00423670|593577866|FG006|Treatment Period|Lost to Follow-up|3|||
164328095|NCT00423670|593577867|FG007|Treatment Period|Lost to Follow-up|1|||
164328096|NCT00423670|593577860|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
164328097|NCT00423670|593577861|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
164328098|NCT00423670|593577862|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
164328099|NCT00423670|593577863|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
164328100|NCT00423670|593577864|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
164328101|NCT00423670|593577865|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
164328102|NCT00423670|593577866|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
164328103|NCT00423670|593577867|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
164328104|NCT00423670|593577860|FG000|Treatment Period|Investigator decision|0|||
164328105|NCT00423670|593577861|FG001|Treatment Period|Investigator decision|0|||
164328106|NCT00423670|593577862|FG002|Treatment Period|Investigator decision|0|||
164328107|NCT00423670|593577863|FG003|Treatment Period|Investigator decision|0|||
164328108|NCT00423670|593577864|FG004|Treatment Period|Investigator decision|0|||
164328109|NCT00423670|593577865|FG005|Treatment Period|Investigator decision|0|||
164328110|NCT00423670|593577866|FG006|Treatment Period|Investigator decision|0|||
164328111|NCT00423670|593577867|FG007|Treatment Period|Investigator decision|1|||
164328112|NCT00423670|593577860|FG000|Treatment Period|Non-compliance with protocol|3|||
164328113|NCT00423670|593577861|FG001|Treatment Period|Non-compliance with protocol|1|||
164328114|NCT00423670|593577862|FG002|Treatment Period|Non-compliance with protocol|1|||
164328115|NCT00423670|593577863|FG003|Treatment Period|Non-compliance with protocol|3|||
164328116|NCT00423670|593577864|FG004|Treatment Period|Non-compliance with protocol|2|||
164328117|NCT00423670|593577865|FG005|Treatment Period|Non-compliance with protocol|0|||
164328118|NCT00423670|593577866|FG006|Treatment Period|Non-compliance with protocol|2|||
164328119|NCT00423670|593577867|FG007|Treatment Period|Non-compliance with protocol|2|||
164328120|NCT00423670|593577860|FG000|Follow-up Period|Lost to Follow-up|0|||
164328121|NCT00423670|593577861|FG001|Follow-up Period|Lost to Follow-up|12|||
164328122|NCT00423670|593577862|FG002|Follow-up Period|Lost to Follow-up|8|||
164328123|NCT00423670|593577863|FG003|Follow-up Period|Lost to Follow-up|3|||
164328124|NCT00423670|593577864|FG004|Follow-up Period|Lost to Follow-up|1|||
164328125|NCT00423670|593577865|FG005|Follow-up Period|Lost to Follow-up|0|||
164328126|NCT00423670|593577866|FG006|Follow-up Period|Lost to Follow-up|5|||
164328127|NCT00423670|593577867|FG007|Follow-up Period|Lost to Follow-up|0|||
164328128|NCT00423670|593577860|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
164328129|NCT00423670|593577861|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
164328130|NCT00423670|593577862|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
164328131|NCT00423670|593577863|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
164328132|NCT00423670|593577864|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
164328133|NCT00423670|593577865|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
164328134|NCT00423670|593577866|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
164328135|NCT00423670|593577867|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
164328136|NCT00423670|593577860|FG000|Follow-up Period|Non-compliance with protocol|2|||
164328137|NCT00423670|593577861|FG001|Follow-up Period|Non-compliance with protocol|0|||
164328138|NCT00423670|593577862|FG002|Follow-up Period|Non-compliance with protocol|1|||
164328139|NCT00423670|593577863|FG003|Follow-up Period|Non-compliance with protocol|1|||
164328140|NCT00423670|593577864|FG004|Follow-up Period|Non-compliance with protocol|0|||
164328141|NCT00423670|593577865|FG005|Follow-up Period|Non-compliance with protocol|0|||
164328142|NCT00423670|593577866|FG006|Follow-up Period|Non-compliance with protocol|3|||
164328143|NCT00423670|593577867|FG007|Follow-up Period|Non-compliance with protocol|2|||
164328144|NCT00900601|593577868|FG000|Overall Study|Physician Decision|1|||
164328145|NCT02131532|593577869|FG000|Overall Study|Withdrawal by Subject|1|||
164328146|NCT02131532|593577869|FG000|Overall Study|Physician Decision|1|||
164328147|NCT02131532|593577869|FG000|Overall Study|Other health conditions|2|||
164328148|NCT01856023|593577870|FG000|Overall Study|Death|1|||
164328149|NCT01856023|593577871|FG001|Overall Study|Death|2|||
164328150|NCT01856023|593577870|FG000|Overall Study|Adverse Event|2|||
164328151|NCT01856023|593577871|FG001|Overall Study|Adverse Event|1|||
164328152|NCT01856023|593577870|FG000|Overall Study|Lack of Efficacy|5|||
164328153|NCT01856023|593577871|FG001|Overall Study|Lack of Efficacy|5|||
164328154|NCT01856023|593577870|FG000|Overall Study|non compliance, study closure|1|||
164670189|NCT00723528|594819006|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
164670190|NCT00723528|594819007|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
164670191|NCT00723528|594819008|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
164670192|NCT00723528|594819009|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
164670193|NCT00723528|594819010|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
164670194|NCT00723528|594819011|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
164328155|NCT01856023|593577871|FG001|Overall Study|non compliance, study closure|3|||
164328156|NCT01856023|593577870|FG000|Overall Study|Withdrawal by Subject|1|||
164328157|NCT01856023|593577871|FG001|Overall Study|Withdrawal by Subject|1|||
164328158|NCT00829283|593577872|FG000|Overall Study|Lost to Follow-up|7|||
164328159|NCT00829283|593577873|FG001|Overall Study|Lost to Follow-up|25|||
164328160|NCT00424255|593577874|FG000|Overall Study|Death|115|||
164328161|NCT00424255|593577875|FG001|Overall Study|Death|111|||
164328162|NCT00424255|593577874|FG000|Overall Study|Lost to Follow-up|26|||
164328163|NCT00424255|593577875|FG001|Overall Study|Lost to Follow-up|20|||
164328164|NCT00424255|593577874|FG000|Overall Study|Protocol Violation|0|||
164328165|NCT00424255|593577875|FG001|Overall Study|Protocol Violation|1|||
164328166|NCT00424255|593577874|FG000|Overall Study|Withdrawal by Subject|34|||
164328167|NCT00424255|593577875|FG001|Overall Study|Withdrawal by Subject|38|||
164328168|NCT00424255|593577874|FG000|Overall Study|Physician Decision|3|||
164328169|NCT00424255|593577875|FG001|Overall Study|Physician Decision|7|||
164328170|NCT00424255|593577874|FG000|Overall Study|Cognitive Disturbance|1|||
164328171|NCT00424255|593577875|FG001|Overall Study|Cognitive Disturbance|0|||
164328172|NCT00424255|593577874|FG000|Overall Study|Non-compliance by Participants|1|||
164328173|NCT00424255|593577875|FG001|Overall Study|Non-compliance by Participants|0|||
164328174|NCT00424255|593577874|FG000|Overall Study|Fatigue|1|||
164328175|NCT00424255|593577875|FG001|Overall Study|Fatigue|0|||
164328176|NCT00424255|593577874|FG000|Overall Study|Disease Progression|0|||
164670195|NCT00723528|594819012|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
164670196|NCT00723528|594819006|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
164670197|NCT00723528|594819007|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
164670198|NCT00723528|594819008|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
164670199|NCT00723528|594819009|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
164218527|NCT03315689|593168378|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
164218528|NCT03315689|593168377|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
164218529|NCT03315689|593168378|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
164218530|NCT03315689|593168377|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
164218531|NCT03315689|593168378|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
164218532|NCT00864513|593168379|FG000|Overall Study|Withdrawal by Subject|3|||
164218533|NCT00762788|593168380|FG000|Overall Study|Lost to Follow-up|26|||
164218534|NCT00762788|593168381|FG001|Overall Study|Lost to Follow-up|37|||
164218535|NCT00762788|593168382|FG002|Overall Study|Lost to Follow-up|21|||
164218536|NCT00762788|593168383|FG003|Overall Study|Lost to Follow-up|26|||
164218537|NCT00762788|593168384|FG004|Overall Study|Lost to Follow-up|13|||
164218538|NCT00762788|593168385|FG005|Overall Study|Lost to Follow-up|21|||
164218539|NCT03073109|593168386|FG000|Overall Study|Adverse Event|0|||
164218540|NCT03073109|593168387|FG001|Overall Study|Adverse Event|1|||
164218541|NCT03073109|593168386|FG000|Overall Study|Other|2|||
164328177|NCT00424255|593577875|FG001|Overall Study|Disease Progression|2|||
164328178|NCT00424255|593577874|FG000|Overall Study|Sponsor Terminated Study|161|||
164328179|NCT00424255|593577875|FG001|Overall Study|Sponsor Terminated Study|167|||
164218542|NCT03073109|593168387|FG001|Overall Study|Other|0|||
164218543|NCT03073109|593168386|FG000|Overall Study|Lost to Follow-up|8|||
164328180|NCT00591578|593577877|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
164328181|NCT00591578|593577878|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
164328182|NCT00591578|593577879|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
164328183|NCT00591578|593577877|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
164218544|NCT03073109|593168387|FG001|Overall Study|Lost to Follow-up|1|||
164218545|NCT00421733|593168388|FG000|Overall Study|Adverse Event|4|||
164218546|NCT00421733|593168389|FG001|Overall Study|Adverse Event|9|||
164218547|NCT00421733|593168390|FG002|Overall Study|Adverse Event|2|||
164218548|NCT00421733|593168388|FG000|Overall Study|Lost to Follow-up|1|||
164218549|NCT00421733|593168389|FG001|Overall Study|Lost to Follow-up|2|||
164218550|NCT00421733|593168390|FG002|Overall Study|Lost to Follow-up|4|||
164218551|NCT00421733|593168388|FG000|Overall Study|Withdrawal by Subject|1|||
164218552|NCT00421733|593168389|FG001|Overall Study|Withdrawal by Subject|2|||
164218553|NCT00421733|593168390|FG002|Overall Study|Withdrawal by Subject|7|||
164218554|NCT00421733|593168388|FG000|Overall Study|Death|0|||
164218555|NCT00421733|593168389|FG001|Overall Study|Death|3|||
164218556|NCT00421733|593168390|FG002|Overall Study|Death|0|||
164218557|NCT00421733|593168388|FG000|Overall Study|Required dialysis|1|||
164218558|NCT00421733|593168389|FG001|Overall Study|Required dialysis|0|||
164218559|NCT00421733|593168390|FG002|Overall Study|Required dialysis|0|||
164218560|NCT00421733|593168388|FG000|Overall Study|Administrative|2|||
164218561|NCT00421733|593168389|FG001|Overall Study|Administrative|0|||
164218562|NCT00421733|593168390|FG002|Overall Study|Administrative|0|||
164218563|NCT00421733|593168388|FG000|Overall Study|Did not satisfy entry criteria|1|||
164218564|NCT00421733|593168389|FG001|Overall Study|Did not satisfy entry criteria|3|||
164218565|NCT00421733|593168390|FG002|Overall Study|Did not satisfy entry criteria|2|||
164218566|NCT00421733|593168388|FG000|Overall Study|Sponsor request|1|||
164218567|NCT00421733|593168389|FG001|Overall Study|Sponsor request|0|||
164218568|NCT00421733|593168390|FG002|Overall Study|Sponsor request|3|||
164218569|NCT00421733|593168388|FG000|Overall Study|Protocol deviation|4|||
164218570|NCT00421733|593168389|FG001|Overall Study|Protocol deviation|7|||
164218571|NCT00421733|593168390|FG002|Overall Study|Protocol deviation|2|||
164218572|NCT00120250|593168391|FG000|Overall Study|Lost to Follow-up|1|||
164218573|NCT00120250|593168392|FG001|Overall Study|Lost to Follow-up|1|||
164218574|NCT00120250|593168391|FG000|Overall Study|Protocol Violation|0|||
164218575|NCT00120250|593168392|FG001|Overall Study|Protocol Violation|1|||
164218576|NCT01967277|593168393|FG000|Overall Study|Lost to Follow-up|1|||
164218577|NCT01967277|593168394|FG001|Overall Study|Lost to Follow-up|2|||
164218578|NCT01967277|593168393|FG000|Overall Study|Unrelated illness|0|||
164218579|NCT01967277|593168394|FG001|Overall Study|Unrelated illness|1|||
164218580|NCT01829165|593168395|FG000|Overall Study|Did not complete intervention|2|||
164218581|NCT01829165|593168396|FG001|Overall Study|Did not complete intervention|0|||
164218582|NCT00397930|593168399|FG000|Overall Study|Personal reasons|14|||
164218583|NCT00397930|593168400|FG001|Overall Study|Personal reasons|8|||
164218584|NCT00397930|593168399|FG000|Overall Study|Other medical|9|||
164218585|NCT00397930|593168400|FG001|Overall Study|Other medical|4|||
164218586|NCT00397930|593168399|FG000|Overall Study|Unknown reasons|9|||
164218587|NCT00397930|593168400|FG001|Overall Study|Unknown reasons|14|||
164218588|NCT00397930|593168399|FG000|Overall Study|Noncompliant|3|||
164218589|NCT00397930|593168400|FG001|Overall Study|Noncompliant|2|||
164218590|NCT00397930|593168399|FG000|Overall Study|Too time-consuming|2|||
164218591|NCT00397930|593168400|FG001|Overall Study|Too time-consuming|9|||
164218592|NCT00397930|593168399|FG000|Overall Study|Started own yoga program|1|||
164218593|NCT00397930|593168400|FG001|Overall Study|Started own yoga program|1|||
164218594|NCT00397930|593168399|FG000|Overall Study|Did not want to be in control group|0|||
164218595|NCT00397930|593168400|FG001|Overall Study|Did not want to be in control group|1|||
164670200|NCT00723528|594819010|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
164670201|NCT00723528|594819011|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
164670202|NCT00723528|594819012|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
164670203|NCT00723528|594819006|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
164670204|NCT00723528|594819007|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
164670205|NCT00723528|594819008|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
164670206|NCT00723528|594819009|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
164670207|NCT00723528|594819010|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
164670208|NCT00723528|594819011|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
164670209|NCT00723528|594819012|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
164670210|NCT00723528|594819006|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
164670211|NCT00723528|594819007|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
164670212|NCT00723528|594819008|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
164670213|NCT00723528|594819009|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
164670214|NCT00723528|594819010|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
164670215|NCT00723528|594819011|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
164670216|NCT00723528|594819012|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
164670217|NCT00723528|594819006|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
164670218|NCT00723528|594819007|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
164670219|NCT00723528|594819008|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
164670220|NCT00723528|594819009|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
164670221|NCT00723528|594819010|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
164670222|NCT00723528|594819011|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
164670223|NCT00723528|594819012|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
164670224|NCT00723528|594819006|FG000|Period 2: After Controlled Period|Other|0|||
164670225|NCT00723528|594819007|FG001|Period 2: After Controlled Period|Other|0|||
164670226|NCT00723528|594819008|FG002|Period 2: After Controlled Period|Other|0|||
164670227|NCT00723528|594819009|FG003|Period 2: After Controlled Period|Other|0|||
164670228|NCT00723528|594819010|FG004|Period 2: After Controlled Period|Other|1|||
164670229|NCT00723528|594819011|FG005|Period 2: After Controlled Period|Other|4|||
164670230|NCT00723528|594819012|FG006|Period 2: After Controlled Period|Other|0|||
164670231|NCT00723528|594819006|FG000|Period 2: After Controlled Period|Adverse Event|0|||
164670232|NCT00723528|594819007|FG001|Period 2: After Controlled Period|Adverse Event|0|||
164670233|NCT00723528|594819008|FG002|Period 2: After Controlled Period|Adverse Event|0|||
164670234|NCT00723528|594819009|FG003|Period 2: After Controlled Period|Adverse Event|0|||
164670235|NCT00723528|594819010|FG004|Period 2: After Controlled Period|Adverse Event|1|||
164670236|NCT00723528|594819011|FG005|Period 2: After Controlled Period|Adverse Event|0|||
164670237|NCT00723528|594819012|FG006|Period 2: After Controlled Period|Adverse Event|1|||
164670238|NCT00723528|594819006|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
164670239|NCT00723528|594819007|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
164670240|NCT00723528|594819008|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
164670241|NCT00723528|594819009|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
164670242|NCT00723528|594819010|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
164670243|NCT00723528|594819011|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
164670244|NCT00723528|594819012|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
164670245|NCT00723528|594819006|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
164670246|NCT00723528|594819007|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
164670247|NCT00723528|594819008|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
164670248|NCT00723528|594819009|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
164670249|NCT00723528|594819010|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
164218596|NCT00397930|593168399|FG000|Overall Study|Withdrawal by Subject|0|||
164218597|NCT00397930|593168400|FG001|Overall Study|Withdrawal by Subject|8|||
164328184|NCT00591578|593577878|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
164328185|NCT00591578|593577879|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
164328186|NCT00591578|593577877|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
164328187|NCT00591578|593577878|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
164328188|NCT00591578|593577879|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
164328189|NCT00591578|593577877|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
164328190|NCT00591578|593577878|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
164328191|NCT00591578|593577879|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
164328192|NCT00591578|593577877|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
164328193|NCT00591578|593577878|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
164328194|NCT00591578|593577879|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
164328195|NCT00591578|593577877|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
164328196|NCT00591578|593577878|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
164328197|NCT00591578|593577879|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
164328198|NCT00591578|593577877|FG000|Double-Blind Treatment Phase|Other|4|||
164328199|NCT00591578|593577878|FG001|Double-Blind Treatment Phase|Other|9|||
164328200|NCT00591578|593577879|FG002|Double-Blind Treatment Phase|Other|4|||
164328201|NCT00591578|593577877|FG000|Open-Label Extension Phase|Adverse Event|3|||
164328202|NCT00591578|593577878|FG001|Open-Label Extension Phase|Adverse Event|5|||
164328203|NCT00591578|593577879|FG002|Open-Label Extension Phase|Adverse Event|0|||
164328204|NCT00591578|593577877|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
164328205|NCT00591578|593577878|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
164328206|NCT00591578|593577879|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
164328207|NCT00591578|593577877|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
164328208|NCT00591578|593577878|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
164328209|NCT00591578|593577879|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
164328210|NCT00591578|593577877|FG000|Open-Label Extension Phase|Other|1|||
164328211|NCT00591578|593577878|FG001|Open-Label Extension Phase|Other|0|||
164328212|NCT00591578|593577879|FG002|Open-Label Extension Phase|Other|0|||
164328213|NCT00870233|593577882|FG000|Overall Study|Withdrawal by Subject|18|||
164328214|NCT00870233|593577882|FG000|Overall Study|Did not undergo laparotomy|3|||
164328215|NCT00870233|593577882|FG000|Overall Study|Incompatible internet browser|2|||
164328216|NCT00870233|593577882|FG000|Overall Study|Death|1|||
164328217|NCT01369485|593577883|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
164328218|NCT01369485|593577884|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
164328219|NCT01369485|593577883|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
164328220|NCT01369485|593577884|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
164328221|NCT01369485|593577883|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
164328222|NCT01369485|593577884|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
164328223|NCT01369485|593577883|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
164328224|NCT01369485|593577884|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
164328225|NCT01369485|593577883|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
164328226|NCT01369485|593577884|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
164328227|NCT01369485|593577883|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
164328228|NCT01369485|593577884|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
164328229|NCT01369485|593577883|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
164328230|NCT01369485|593577884|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
164328231|NCT01369485|593577883|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
164328232|NCT01369485|593577884|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
164328233|NCT01369485|593577883|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
164328234|NCT01369485|593577884|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
164328235|NCT01369485|593577883|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
164328236|NCT01369485|593577884|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
164328237|NCT02942576|593577885|FG000|Overall Study|Adverse Event|28|||
164328238|NCT02942576|593577886|FG001|Overall Study|Adverse Event|6|||
164328239|NCT02942576|593577885|FG000|Overall Study|Withdrawal by Subject|7|||
164328240|NCT02942576|593577886|FG001|Overall Study|Withdrawal by Subject|5|||
164328241|NCT02942576|593577885|FG000|Overall Study|Physician Decision|1|||
164328242|NCT02942576|593577886|FG001|Overall Study|Physician Decision|4|||
164328243|NCT02942576|593577885|FG000|Overall Study|Other|10|||
164328244|NCT02942576|593577886|FG001|Overall Study|Other|8|||
164328245|NCT00769483|593577887|FG000|Overall Study|Withdrawal by Subject|0|||
164328246|NCT00769483|593577888|FG001|Overall Study|Withdrawal by Subject|1|||
164328247|NCT00769483|593577889|FG002|Overall Study|Withdrawal by Subject|0|||
164328248|NCT00769483|593577890|FG003|Overall Study|Withdrawal by Subject|0|||
164328249|NCT00769483|593577891|FG004|Overall Study|Withdrawal by Subject|1|||
164328250|NCT00769483|593577892|FG005|Overall Study|Withdrawal by Subject|0|||
164328251|NCT00006389|593577893|FG000|Overall Study|Adverse Event|1|||
164328252|NCT01285960|593577900|FG000|Overall Study|Withdrawal by Subject|2|||
164328253|NCT01285960|593577900|FG000|Overall Study|Lost to Follow-up|2|||
164328254|NCT01285960|593577900|FG000|Overall Study|2 subjects received less 10 sonications|2|||
164328255|NCT01309308|593577901|FG000|Overall Study|Lost to Follow-up|6|||
164328256|NCT01309308|593577902|FG001|Overall Study|Lost to Follow-up|4|||
164328257|NCT00473746|593577903|FG000|Period 1 (Phase 1)|Adverse Event|1|||
164328258|NCT00473746|593577904|FG001|Period 1 (Phase 1)|Adverse Event|0|||
164328259|NCT00473746|593577905|FG002|Period 1 (Phase 1)|Adverse Event|0|||
164328260|NCT00473746|593577906|FG003|Period 1 (Phase 1)|Adverse Event|0|||
164328261|NCT00473746|593577907|FG004|Period 1 (Phase 1)|Adverse Event|0|||
164328262|NCT00473746|593577903|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
164328263|NCT00473746|593577904|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
164328264|NCT00473746|593577905|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
164328265|NCT00473746|593577906|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
164328266|NCT00473746|593577907|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
164328267|NCT00473746|593577903|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
164328268|NCT00473746|593577904|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
164328269|NCT00473746|593577905|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
164328270|NCT00473746|593577906|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
164328271|NCT00473746|593577907|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
164328272|NCT00473746|593577903|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
164328273|NCT00473746|593577904|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
164328274|NCT00473746|593577905|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
164328275|NCT00473746|593577906|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
164328276|NCT00473746|593577907|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
164328277|NCT00473746|593577903|FG000|Period 1 (Phase 1)|Reason not specified|0|||
164328278|NCT00473746|593577904|FG001|Period 1 (Phase 1)|Reason not specified|1|||
164328279|NCT00473746|593577905|FG002|Period 1 (Phase 1)|Reason not specified|0|||
164328280|NCT00473746|593577906|FG003|Period 1 (Phase 1)|Reason not specified|0|||
164328281|NCT00473746|593577907|FG004|Period 1 (Phase 1)|Reason not specified|0|||
164328282|NCT00473746|593577903|FG000|Period 2 (Phase 2)|Adverse Event|0|||
164328283|NCT00473746|593577904|FG001|Period 2 (Phase 2)|Adverse Event|0|||
164328284|NCT00473746|593577905|FG002|Period 2 (Phase 2)|Adverse Event|0|||
164328285|NCT00473746|593577906|FG003|Period 2 (Phase 2)|Adverse Event|0|||
164328286|NCT00473746|593577907|FG004|Period 2 (Phase 2)|Adverse Event|3|||
164328287|NCT00473746|593577903|FG000|Period 2 (Phase 2)|Death|0|||
164328288|NCT00473746|593577904|FG001|Period 2 (Phase 2)|Death|0|||
164328289|NCT00473746|593577905|FG002|Period 2 (Phase 2)|Death|0|||
164328290|NCT00473746|593577906|FG003|Period 2 (Phase 2)|Death|0|||
164328291|NCT00473746|593577907|FG004|Period 2 (Phase 2)|Death|1|||
164328292|NCT00473746|593577903|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
164328293|NCT00473746|593577904|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
164328294|NCT00473746|593577905|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
164328295|NCT00473746|593577906|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
164328296|NCT00473746|593577907|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
164328297|NCT00473746|593577903|FG000|Period 2 (Phase 2)|Reason not specified|0|||
164328298|NCT00473746|593577904|FG001|Period 2 (Phase 2)|Reason not specified|0|||
164328299|NCT00473746|593577905|FG002|Period 2 (Phase 2)|Reason not specified|0|||
164328300|NCT00473746|593577906|FG003|Period 2 (Phase 2)|Reason not specified|0|||
164328301|NCT00473746|593577907|FG004|Period 2 (Phase 2)|Reason not specified|3|||
164328302|NCT01017575|593577910|FG000|Overall Study|Lack of Efficacy|0|||
164328303|NCT01017575|593577911|FG001|Overall Study|Lack of Efficacy|1|||
164328304|NCT01017575|593577912|FG002|Overall Study|Lack of Efficacy|0|||
164328305|NCT01017575|593577913|FG003|Overall Study|Lack of Efficacy|1|||
164328306|NCT01017575|593577914|FG004|Overall Study|Lack of Efficacy|1|||
164328307|NCT01017575|593577910|FG000|Overall Study|Adverse Event|0|||
164328308|NCT01017575|593577911|FG001|Overall Study|Adverse Event|1|||
164328309|NCT01017575|593577912|FG002|Overall Study|Adverse Event|0|||
164328310|NCT01017575|593577913|FG003|Overall Study|Adverse Event|0|||
164328311|NCT01017575|593577914|FG004|Overall Study|Adverse Event|2|||
164328312|NCT01017575|593577910|FG000|Overall Study|Withdrawal by Subject|1|||
164328313|NCT01017575|593577911|FG001|Overall Study|Withdrawal by Subject|0|||
164328314|NCT01017575|593577912|FG002|Overall Study|Withdrawal by Subject|0|||
164328315|NCT01017575|593577913|FG003|Overall Study|Withdrawal by Subject|0|||
164328316|NCT01017575|593577914|FG004|Overall Study|Withdrawal by Subject|0|||
164328317|NCT01962922|593577915|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
164328318|NCT01962922|593577916|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
164328319|NCT01962922|593577915|FG000|PK Portion Day 7|non-compliance|1|||
164566173|NCT06118385|594442986|FG006|Overall Study|Out-of-range blood tests|0|||
164566174|NCT06118385|594442987|FG007|Overall Study|Out-of-range blood tests|0|||
164566175|NCT06118385|594442988|FG008|Overall Study|Out-of-range blood tests|1|||
164566176|NCT06118385|594442989|FG009|Overall Study|Out-of-range blood tests|0|||
164566177|NCT06118385|594442990|FG010|Overall Study|Out-of-range blood tests|0|||
164566178|NCT06118385|594442991|FG011|Overall Study|Out-of-range blood tests|0|||
164566179|NCT01808612|594442993|FG000|Treatment Period|Adverse Event|8|||
164566180|NCT01808612|594442994|FG001|Treatment Period|Adverse Event|4|||
164566181|NCT01808612|594442995|FG002|Treatment Period|Adverse Event|3|||
164566182|NCT01808612|594442993|FG000|Treatment Period|Lost to Follow-up|2|||
164566183|NCT01808612|594442994|FG001|Treatment Period|Lost to Follow-up|2|||
164566184|NCT01808612|594442995|FG002|Treatment Period|Lost to Follow-up|1|||
164566185|NCT01808612|594442993|FG000|Treatment Period|Protocol Violation|1|||
164566186|NCT01808612|594442994|FG001|Treatment Period|Protocol Violation|0|||
164566187|NCT01808612|594442995|FG002|Treatment Period|Protocol Violation|0|||
164566188|NCT01808612|594442993|FG000|Treatment Period|Withdrawal by Subject|1|||
164566189|NCT01808612|594442994|FG001|Treatment Period|Withdrawal by Subject|0|||
164566190|NCT01808612|594442995|FG002|Treatment Period|Withdrawal by Subject|4|||
164566191|NCT01808612|594442993|FG000|Treatment Period|Physician Decision|1|||
164566192|NCT01808612|594442994|FG001|Treatment Period|Physician Decision|0|||
164566193|NCT01808612|594442995|FG002|Treatment Period|Physician Decision|4|||
164566194|NCT01808612|594442993|FG000|Treatment Period|Sponsor Decision|1|||
164566195|NCT01808612|594442994|FG001|Treatment Period|Sponsor Decision|0|||
164566196|NCT01808612|594442995|FG002|Treatment Period|Sponsor Decision|0|||
164566197|NCT01808612|594442993|FG000|Treatment Period|Lack of Efficacy|1|||
164566198|NCT01808612|594442994|FG001|Treatment Period|Lack of Efficacy|1|||
164566199|NCT01808612|594442995|FG002|Treatment Period|Lack of Efficacy|2|||
164566200|NCT01808612|594442993|FG000|Discontinuation Period|Adverse Event|1|||
164566201|NCT01808612|594442994|FG001|Discontinuation Period|Adverse Event|0|||
164566202|NCT01808612|594442995|FG002|Discontinuation Period|Adverse Event|0|||
164566203|NCT01808612|594442993|FG000|Discontinuation Period|Physician Decision|1|||
164566204|NCT01808612|594442994|FG001|Discontinuation Period|Physician Decision|0|||
164566205|NCT01808612|594442995|FG002|Discontinuation Period|Physician Decision|0|||
164566206|NCT01808612|594442993|FG000|Discontinuation Period|Lost to Follow-up|0|||
164566207|NCT01808612|594442994|FG001|Discontinuation Period|Lost to Follow-up|1|||
164566208|NCT01808612|594442995|FG002|Discontinuation Period|Lost to Follow-up|0|||
164670250|NCT00723528|594819011|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
164670251|NCT00723528|594819012|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
164670252|NCT00667862|594819014|FG000|Overall Study|Adverse Event|9|||
164670253|NCT00667862|594819014|FG000|Overall Study|Death|1|||
164670254|NCT00667862|594819014|FG000|Overall Study|Disease Progression|22|||
164670255|NCT00667862|594819014|FG000|Overall Study|Withdrawal by Subject|3|||
164670256|NCT00667095|594819018|FG000|Overall Study|Withdrawal by Subject|0|||
164670257|NCT00667095|594819019|FG001|Overall Study|Withdrawal by Subject|1|||
164670258|NCT01520909|594819020|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
164670259|NCT01520909|594819021|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
164670260|NCT01520909|594819022|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
164670261|NCT01520909|594819020|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
164670262|NCT01520909|594819021|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
164670263|NCT01520909|594819022|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
164670264|NCT01520909|594819020|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
164670265|NCT01520909|594819021|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
164670266|NCT01520909|594819022|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
164670267|NCT01520909|594819020|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
164670268|NCT01520909|594819021|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
164670269|NCT01520909|594819022|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
164670270|NCT01435265|594819024|FG000|Overall Study|Lost to Follow-up|0|||
164670271|NCT01435265|594819025|FG001|Overall Study|Lost to Follow-up|1|||
164670272|NCT02128997|594819026|FG000|Overall Study|Lost to Follow-up|6|||
164670273|NCT02128997|594819027|FG001|Overall Study|Lost to Follow-up|11|||
164670274|NCT00856388|594819037|FG000|Overall Study|Other|1|||
164670275|NCT05038293|594819038|FG000|Overall Study|device was not operating properly for one subject.|1|||
164670276|NCT05038293|594819039|FG001|Overall Study|device was not operating properly for one subject.|0|||
164670277|NCT05038293|594819038|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
164566209|NCT00559273|594442998|FG000|Correction Period (20 Weeks)|Death|3|||
164566210|NCT00559273|594442999|FG001|Correction Period (20 Weeks)|Death|4|||
164566211|NCT00559273|594442998|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
164566212|NCT00559273|594442999|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
164670278|NCT05038293|594819039|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
164670279|NCT01171989|594819041|FG000|Overall Study|Lost to Follow-up|0|||
164670280|NCT01171989|594819042|FG001|Overall Study|Lost to Follow-up|0|||
164670281|NCT01171989|594819043|FG002|Overall Study|Lost to Follow-up|1|||
164670282|NCT00418184|594819044|FG000|Double-blind Phase|Withdrawal by Subject|22|||
164218598|NCT00397930|593168399|FG000|Overall Study|Missing data|0|||
164218599|NCT00397930|593168400|FG001|Overall Study|Missing data|4|||
164328320|NCT01962922|593577916|FG001|PK Portion Day 7|non-compliance|0|||
164328321|NCT01962922|593577915|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
164328322|NCT01962922|593577916|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
164328323|NCT01962922|593577915|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
164328324|NCT01962922|593577916|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
164328325|NCT00976573|593577924|FG000|Overall Study|Ineligible|0|||
164328326|NCT00976573|593577925|FG001|Overall Study|Ineligible|1|||
164328327|NCT00976573|593577924|FG000|Overall Study|Cancel prior to receiving treatment|4|||
164328328|NCT00976573|593577925|FG001|Overall Study|Cancel prior to receiving treatment|2|||
164328329|NCT02730208|593577926|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
164328330|NCT02730208|593577927|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
164328331|NCT00995865|593577932|FG000|Overall Study|Protocol Violation|2|||
164218600|NCT01158404|593168401|FG000|Overall Study|Withdrawal by Subject|0|||
164218601|NCT01158404|593168402|FG001|Overall Study|Withdrawal by Subject|1|||
164218602|NCT01158404|593168403|FG002|Overall Study|Withdrawal by Subject|0|||
164218603|NCT01158404|593168404|FG003|Overall Study|Withdrawal by Subject|0|||
164218604|NCT01158404|593168405|FG004|Overall Study|Withdrawal by Subject|3|||
164218605|NCT01158404|593168406|FG005|Overall Study|Withdrawal by Subject|1|||
164218606|NCT01158404|593168407|FG006|Overall Study|Withdrawal by Subject|0|||
164218607|NCT01158404|593168408|FG007|Overall Study|Withdrawal by Subject|1|||
164218608|NCT01158404|593168401|FG000|Overall Study|Physician Decision|0|||
164218609|NCT01158404|593168402|FG001|Overall Study|Physician Decision|0|||
164218610|NCT01158404|593168403|FG002|Overall Study|Physician Decision|0|||
164218611|NCT01158404|593168404|FG003|Overall Study|Physician Decision|0|||
164218612|NCT01158404|593168405|FG004|Overall Study|Physician Decision|0|||
164218613|NCT01158404|593168406|FG005|Overall Study|Physician Decision|0|||
164218614|NCT01158404|593168407|FG006|Overall Study|Physician Decision|0|||
164218615|NCT01158404|593168408|FG007|Overall Study|Physician Decision|1|||
164218616|NCT01158404|593168401|FG000|Overall Study|Progressive Disease|0|||
164218617|NCT01158404|593168402|FG001|Overall Study|Progressive Disease|0|||
164218618|NCT01158404|593168403|FG002|Overall Study|Progressive Disease|0|||
164218619|NCT01158404|593168404|FG003|Overall Study|Progressive Disease|0|||
164218620|NCT01158404|593168405|FG004|Overall Study|Progressive Disease|0|||
164218621|NCT01158404|593168406|FG005|Overall Study|Progressive Disease|0|||
164218622|NCT01158404|593168407|FG006|Overall Study|Progressive Disease|1|||
164218623|NCT01158404|593168408|FG007|Overall Study|Progressive Disease|0|||
164218624|NCT02056288|593168409|FG000|In-Hospital Data|Surgery cancelled|1|||
164218625|NCT02056288|593168410|FG001|In-Hospital Data|Surgery cancelled|0|||
164218626|NCT02056288|593168409|FG000|In-Hospital Data|Protocol Violation|3|||
164218627|NCT02056288|593168410|FG001|In-Hospital Data|Protocol Violation|0|||
164218628|NCT02056288|593168409|FG000|In-Hospital Data|Physician Decision|1|||
164218629|NCT02056288|593168410|FG001|In-Hospital Data|Physician Decision|0|||
164218630|NCT02056288|593168409|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
164218631|NCT02056288|593168410|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
164218632|NCT02384460|593168413|FG000|Overall Study|Protocol Violation|0|||
164218633|NCT02384460|593168414|FG001|Overall Study|Protocol Violation|1|||
164218634|NCT02384460|593168413|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
164218635|NCT02384460|593168414|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
164218636|NCT02384460|593168413|FG000|Overall Study|Adverse Event|5|||
164218637|NCT02384460|593168414|FG001|Overall Study|Adverse Event|2|||
164218638|NCT02384460|593168413|FG000|Overall Study|Withdrawal by Subject|0|||
164218639|NCT02384460|593168414|FG001|Overall Study|Withdrawal by Subject|3|||
164218640|NCT02384460|593168413|FG000|Overall Study|Elective medical treatment|1|||
164218641|NCT02384460|593168414|FG001|Overall Study|Elective medical treatment|0|||
164218642|NCT02384460|593168413|FG000|Overall Study|Non-compliance|1|||
164218643|NCT02384460|593168414|FG001|Overall Study|Non-compliance|0|||
164218644|NCT02400580|593168415|FG000|Overall Study|Withdrawal by Subject|1|||
164218645|NCT02400580|593168416|FG001|Overall Study|Withdrawal by Subject|1|||
164218646|NCT02400580|593168415|FG000|Overall Study|Adverse Event|1|||
164218647|NCT02400580|593168416|FG001|Overall Study|Adverse Event|0|||
164218648|NCT00965094|593168419|FG000|Overall Study|Adverse Event|5|||
164218649|NCT00965094|593168420|FG001|Overall Study|Adverse Event|0|||
164218650|NCT00965094|593168419|FG000|Overall Study|Lost to Follow-up|0|||
164218651|NCT00965094|593168420|FG001|Overall Study|Lost to Follow-up|1|||
164218652|NCT01060111|593168421|FG000|Overall Study|Adverse Event|9|||
164328332|NCT00995865|593577933|FG001|Overall Study|Protocol Violation|0|||
164328333|NCT00995865|593577934|FG002|Overall Study|Protocol Violation|0|||
164566213|NCT00559273|594442998|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
164566214|NCT00559273|594442999|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
164566215|NCT00559273|594442998|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
164566216|NCT00559273|594442999|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
164566217|NCT00559273|594442998|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
164566218|NCT00559273|594442999|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
164566219|NCT00559273|594442998|FG000|Evaluation Period (8 Weeks)|Death|1|||
164566220|NCT00559273|594442999|FG001|Evaluation Period (8 Weeks)|Death|3|||
164566221|NCT00559273|594442998|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
164566222|NCT00559273|594442999|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
164566223|NCT00559273|594442998|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
164566224|NCT00559273|594442999|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
164566225|NCT00559273|594442998|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
164566226|NCT00559273|594442999|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
164566227|NCT00849667|594443003|FG000|Overall Study|Withdrawal by Subject|16|||
164566228|NCT00849667|594443004|FG001|Overall Study|Withdrawal by Subject|33|||
164566229|NCT00849667|594443005|FG002|Overall Study|Withdrawal by Subject|35|||
164566230|NCT00849667|594443003|FG000|Overall Study|Lost to Follow-up|8|||
164566231|NCT00849667|594443004|FG001|Overall Study|Lost to Follow-up|8|||
164566232|NCT00849667|594443005|FG002|Overall Study|Lost to Follow-up|8|||
164566233|NCT00849667|594443003|FG000|Overall Study|Adverse Event|1|||
164566234|NCT00849667|594443004|FG001|Overall Study|Adverse Event|2|||
164566235|NCT00849667|594443005|FG002|Overall Study|Adverse Event|0|||
164566236|NCT00849667|594443003|FG000|Overall Study|Other|18|||
164566237|NCT00849667|594443004|FG001|Overall Study|Other|19|||
164566238|NCT00849667|594443005|FG002|Overall Study|Other|18|||
164566239|NCT00849667|594443003|FG000|Overall Study|Progressive disease|119|||
164566240|NCT00849667|594443004|FG001|Overall Study|Progressive disease|100|||
164566241|NCT00849667|594443005|FG002|Overall Study|Progressive disease|112|||
164566242|NCT00849667|594443003|FG000|Overall Study|Sponsor decision|208|||
164566243|NCT00849667|594443004|FG001|Overall Study|Sponsor decision|204|||
164566244|NCT00849667|594443005|FG002|Overall Study|Sponsor decision|190|||
164566245|NCT00849667|594443003|FG000|Overall Study|Investigator discretion|0|||
164566246|NCT00849667|594443004|FG001|Overall Study|Investigator discretion|0|||
164218653|NCT01060111|593168422|FG001|Overall Study|Adverse Event|5|||
164566247|NCT00849667|594443005|FG002|Overall Study|Investigator discretion|1|||
164566248|NCT00189462|594443006|FG000|Overall Study|Lack of Efficacy|5|||
164566249|NCT00189462|594443007|FG001|Overall Study|Lack of Efficacy|1|||
164566250|NCT00189462|594443006|FG000|Overall Study|Lost to Follow-up|18|||
164566251|NCT00189462|594443007|FG001|Overall Study|Lost to Follow-up|20|||
164566252|NCT00553462|594443008|FG000|Overall Study|Adverse Event|4|||
164566253|NCT00553462|594443008|FG000|Overall Study|Progression|4|||
164218654|NCT01060111|593168423|FG002|Overall Study|Adverse Event|18|||
164218655|NCT01060111|593168421|FG000|Overall Study|Lack of Efficacy|2|||
164218656|NCT01060111|593168422|FG001|Overall Study|Lack of Efficacy|1|||
164566254|NCT00553462|594443008|FG000|Overall Study|Withdrawal by Subject|5|||
164566255|NCT00553462|594443008|FG000|Overall Study|Physician Decision|1|||
164566256|NCT04398732|594443009|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
164566257|NCT03213366|594443019|FG000|Overall Study|Lost to Follow-up|9|||
164566258|NCT03213366|594443020|FG001|Overall Study|Lost to Follow-up|4|||
164566259|NCT02532855|594443024|FG000|Overall Study|Lost to Follow-up|4|||
164566260|NCT02532855|594443025|FG001|Overall Study|Lost to Follow-up|3|||
164566261|NCT02532855|594443024|FG000|Overall Study|Withdrawal by Subject|4|||
164566262|NCT02532855|594443025|FG001|Overall Study|Withdrawal by Subject|8|||
164566263|NCT00666926|594443026|FG000|Overall Study|Adverse Event|0|||
164566264|NCT00666926|594443027|FG001|Overall Study|Adverse Event|0|||
164566265|NCT00666926|594443028|FG002|Overall Study|Adverse Event|0|||
164566266|NCT00666926|594443029|FG003|Overall Study|Adverse Event|0|||
164566267|NCT00666926|594443030|FG004|Overall Study|Adverse Event|0|||
164566268|NCT00666926|594443031|FG005|Overall Study|Adverse Event|0|||
164566269|NCT00666926|594443032|FG006|Overall Study|Adverse Event|0|||
164566270|NCT00666926|594443033|FG007|Overall Study|Adverse Event|0|||
164566271|NCT00666926|594443034|FG008|Overall Study|Adverse Event|0|||
164566272|NCT00666926|594443035|FG009|Overall Study|Adverse Event|2|||
164566273|NCT00666926|594443036|FG010|Overall Study|Adverse Event|2|||
164566274|NCT00666926|594443037|FG011|Overall Study|Adverse Event|2|||
164566275|NCT00666926|594443038|FG012|Overall Study|Adverse Event|0|||
164566276|NCT00666926|594443039|FG013|Overall Study|Adverse Event|1|||
164566277|NCT00666926|594443040|FG014|Overall Study|Adverse Event|0|||
164566278|NCT00666926|594443041|FG015|Overall Study|Adverse Event|0|||
164566279|NCT00666926|594443026|FG000|Overall Study|Laboratory abnormality|0|||
164566280|NCT00666926|594443027|FG001|Overall Study|Laboratory abnormality|0|||
164566281|NCT00666926|594443028|FG002|Overall Study|Laboratory abnormality|0|||
164566282|NCT00666926|594443029|FG003|Overall Study|Laboratory abnormality|0|||
164566283|NCT00666926|594443030|FG004|Overall Study|Laboratory abnormality|0|||
164566284|NCT00666926|594443031|FG005|Overall Study|Laboratory abnormality|0|||
164566285|NCT00666926|594443032|FG006|Overall Study|Laboratory abnormality|0|||
164566286|NCT00666926|594443033|FG007|Overall Study|Laboratory abnormality|0|||
164566287|NCT00666926|594443034|FG008|Overall Study|Laboratory abnormality|0|||
164566288|NCT00666926|594443035|FG009|Overall Study|Laboratory abnormality|0|||
164566289|NCT00666926|594443036|FG010|Overall Study|Laboratory abnormality|1|||
164566290|NCT00666926|594443037|FG011|Overall Study|Laboratory abnormality|0|||
164566291|NCT00666926|594443038|FG012|Overall Study|Laboratory abnormality|0|||
164566292|NCT00666926|594443039|FG013|Overall Study|Laboratory abnormality|0|||
164566293|NCT00666926|594443040|FG014|Overall Study|Laboratory abnormality|0|||
164566294|NCT00666926|594443041|FG015|Overall Study|Laboratory abnormality|1|||
164566295|NCT00666926|594443026|FG000|Overall Study|Lack of Efficacy|0|||
164566296|NCT00666926|594443027|FG001|Overall Study|Lack of Efficacy|0|||
164566297|NCT00666926|594443028|FG002|Overall Study|Lack of Efficacy|0|||
164566298|NCT00666926|594443029|FG003|Overall Study|Lack of Efficacy|0|||
164566299|NCT00666926|594443030|FG004|Overall Study|Lack of Efficacy|0|||
164566300|NCT00666926|594443031|FG005|Overall Study|Lack of Efficacy|1|||
164566301|NCT00666926|594443032|FG006|Overall Study|Lack of Efficacy|0|||
164566302|NCT00666926|594443033|FG007|Overall Study|Lack of Efficacy|0|||
164566303|NCT00666926|594443034|FG008|Overall Study|Lack of Efficacy|0|||
164566304|NCT00666926|594443035|FG009|Overall Study|Lack of Efficacy|0|||
164566305|NCT00666926|594443036|FG010|Overall Study|Lack of Efficacy|0|||
164566306|NCT00666926|594443037|FG011|Overall Study|Lack of Efficacy|1|||
164218657|NCT01060111|593168423|FG002|Overall Study|Lack of Efficacy|0|||
164566307|NCT00666926|594443038|FG012|Overall Study|Lack of Efficacy|0|||
164566308|NCT00666926|594443039|FG013|Overall Study|Lack of Efficacy|0|||
164566309|NCT00666926|594443040|FG014|Overall Study|Lack of Efficacy|0|||
164566310|NCT00666926|594443041|FG015|Overall Study|Lack of Efficacy|0|||
164566311|NCT00666926|594443026|FG000|Overall Study|Lost to Follow-up|0|||
164328334|NCT00995865|593577932|FG000|Overall Study|Lost to Follow-up|0|||
164328335|NCT00995865|593577933|FG001|Overall Study|Lost to Follow-up|0|||
164328336|NCT00995865|593577934|FG002|Overall Study|Lost to Follow-up|1|||
164328337|NCT02021656|593577940|FG000|Overall Study|Adverse Event|1|||
164328338|NCT02021656|593577940|FG000|Overall Study|Lack of Efficacy|2|||
164328339|NCT02021656|593577940|FG000|Overall Study|Lost to Follow-up|1|||
164328340|NCT02021656|593577940|FG000|Overall Study|Withdrew Consent|2|||
164328341|NCT00596362|593577950|FG000|Overall Study|Progressive Disease|1|||
164328342|NCT00817479|593577951|FG000|Overall Study|Physician Decision|1|||
164218658|NCT01060111|593168421|FG000|Overall Study|Inappropriate participant|5|||
164218659|NCT01060111|593168422|FG001|Overall Study|Inappropriate participant|4|||
164218660|NCT01060111|593168423|FG002|Overall Study|Inappropriate participant|5|||
164218661|NCT01060111|593168421|FG000|Overall Study|Participants' evasion for hospital visit|0|||
164218662|NCT01060111|593168422|FG001|Overall Study|Participants' evasion for hospital visit|3|||
164218663|NCT01060111|593168423|FG002|Overall Study|Participants' evasion for hospital visit|2|||
164218664|NCT01060111|593168421|FG000|Overall Study|Participants' non-cooperation|8|||
164218665|NCT01060111|593168422|FG001|Overall Study|Participants' non-cooperation|6|||
164328343|NCT00817479|593577952|FG001|Overall Study|Physician Decision|1|||
164328344|NCT05985980|593577955|FG000|Overall Study|Withdrawal by Subject|1|||
164328345|NCT05985980|593577955|FG000|Overall Study|Withdrawal by Subject|1|||
164328346|NCT05985980|593577955|FG000|Overall Study|Withdrawal by Subject|1|||
164328347|NCT05985980|593577955|FG000|Overall Study|Withdrawal by Subject|1|||
164328348|NCT00523367|593577956|FG000|Overall Study|19 screen failures|19|||
164328349|NCT00523367|593577956|FG000|Overall Study|4 Withdrawn by PI|4|||
164328350|NCT02793128|593577957|FG000|Overall Study|Death|4|||
164328351|NCT02793128|593577957|FG000|Overall Study|Withdrawal by Subject|2|||
164328352|NCT02793128|593577957|FG000|Overall Study|Physician Decision|1|||
164328353|NCT02793128|593577957|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
164328354|NCT02793128|593577957|FG000|Overall Study|Patient elected nephroureterectomy|1|||
164328355|NCT00055471|593577961|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
164328356|NCT00055471|593577962|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
164328357|NCT00055471|593577963|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
164328358|NCT00055471|593577961|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
164328359|NCT00055471|593577962|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
164328360|NCT00055471|593577963|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
164328361|NCT00055471|593577961|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
164328362|NCT00055471|593577962|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
164328363|NCT00055471|593577963|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
164328364|NCT01854944|593577964|FG000|Overall Study|Withdrawal by Subject|0|||
164328365|NCT01854944|593577965|FG001|Overall Study|Withdrawal by Subject|0|||
164328366|NCT01854944|593577966|FG002|Overall Study|Withdrawal by Subject|1|||
164328367|NCT00282347|593577969|FG000|Treatment Period|Death|2|||
164328368|NCT00282347|593577970|FG001|Treatment Period|Death|0|||
164328369|NCT00282347|593577969|FG000|Treatment Period|Lost to Follow-up|2|||
164328370|NCT00282347|593577970|FG001|Treatment Period|Lost to Follow-up|5|||
164328371|NCT00282347|593577969|FG000|Treatment Period|Withdrawal by Subject|1|||
164328372|NCT00282347|593577970|FG001|Treatment Period|Withdrawal by Subject|3|||
164328373|NCT00282347|593577969|FG000|Treatment Period|Physician Decision|0|||
164328374|NCT00282347|593577970|FG001|Treatment Period|Physician Decision|1|||
164328375|NCT00282347|593577969|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
164328376|NCT00282347|593577970|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
164328377|NCT00282347|593577969|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
164328378|NCT00282347|593577970|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
164328379|NCT00282347|593577969|FG000|Safety Follow-up Period|Physician Decision|1|||
164328380|NCT00282347|593577970|FG001|Safety Follow-up Period|Physician Decision|1|||
164328381|NCT00282347|593577969|FG000|Safety Follow-up Period|Protocol Deviation|0|||
164328382|NCT00282347|593577970|FG001|Safety Follow-up Period|Protocol Deviation|2|||
164218666|NCT01060111|593168423|FG002|Overall Study|Participants' non-cooperation|6|||
164218667|NCT01060111|593168421|FG000|Overall Study|Adverse event and insufficient effect|0|||
164218668|NCT01060111|593168422|FG001|Overall Study|Adverse event and insufficient effect|1|||
164328383|NCT00282347|593577969|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
164328384|NCT00282347|593577970|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
164328385|NCT00282347|593577969|FG000|B Cell Follow-up Period|Physician Decision|1|||
164566312|NCT00666926|594443027|FG001|Overall Study|Lost to Follow-up|0|||
164218669|NCT01060111|593168423|FG002|Overall Study|Adverse event and insufficient effect|0|||
164328386|NCT00282347|593577970|FG001|B Cell Follow-up Period|Physician Decision|0|||
164328387|NCT00282347|593577969|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
164420688|NCT01154036|593910963|FG001|Phase II|Protocol Violation|0|||
164566313|NCT00666926|594443028|FG002|Overall Study|Lost to Follow-up|0|||
164566314|NCT00666926|594443029|FG003|Overall Study|Lost to Follow-up|1|||
164566315|NCT00666926|594443030|FG004|Overall Study|Lost to Follow-up|0|||
164566316|NCT00666926|594443031|FG005|Overall Study|Lost to Follow-up|0|||
164566317|NCT00666926|594443032|FG006|Overall Study|Lost to Follow-up|0|||
164566318|NCT00666926|594443033|FG007|Overall Study|Lost to Follow-up|0|||
164566319|NCT00666926|594443034|FG008|Overall Study|Lost to Follow-up|0|||
164566320|NCT00666926|594443035|FG009|Overall Study|Lost to Follow-up|0|||
164566321|NCT00666926|594443036|FG010|Overall Study|Lost to Follow-up|0|||
164566322|NCT00666926|594443037|FG011|Overall Study|Lost to Follow-up|0|||
164566323|NCT00666926|594443038|FG012|Overall Study|Lost to Follow-up|0|||
164670283|NCT00418184|594819045|FG001|Double-blind Phase|Withdrawal by Subject|9|||
164670284|NCT00418184|594819044|FG000|Double-blind Phase|Adverse Event|2|||
164670285|NCT00418184|594819045|FG001|Double-blind Phase|Adverse Event|1|||
164670286|NCT00418184|594819044|FG000|Double-blind Phase|Poor compliance|3|||
164670287|NCT00418184|594819045|FG001|Double-blind Phase|Poor compliance|1|||
164670288|NCT00620074|594819047|FG000|Overall Study|Adverse Event|1|||
164670289|NCT04466111|594819052|FG000|Prior to Trial Phase|Physician Decision|1|||
164670290|NCT03553823|594819061|FG000|Overall Study|Physician Decision|0|||
164670291|NCT03553823|594819062|FG001|Overall Study|Physician Decision|1|||
164670292|NCT00893464|594819063|FG000|Overall Study|Did not complete therapy/experience PD|0|||
164670293|NCT00893464|594819064|FG001|Overall Study|Did not complete therapy/experience PD|0|||
164670294|NCT00893464|594819065|FG002|Overall Study|Did not complete therapy/experience PD|0|||
164670295|NCT00893464|594819066|FG003|Overall Study|Did not complete therapy/experience PD|0|||
164670296|NCT00893464|594819067|FG004|Overall Study|Did not complete therapy/experience PD|0|||
164670297|NCT00893464|594819068|FG005|Overall Study|Did not complete therapy/experience PD|0|||
164670298|NCT00893464|594819069|FG006|Overall Study|Did not complete therapy/experience PD|2|||
164670299|NCT00893464|594819070|FG007|Overall Study|Did not complete therapy/experience PD|2|||
164670300|NCT03450070|594819071|FG000|Overall Study|Withdrawal by Subject|8|||
164670301|NCT02910037|594819072|FG000|Overall Study|Withdrawal by Subject|4|||
164670302|NCT02910037|594819072|FG000|Overall Study|Lost to Follow-up|6|||
164670303|NCT00813293|594819075|FG000|Overall Study|Intercurrent illness|1|||
164670304|NCT00813293|594819076|FG001|Overall Study|Intercurrent illness|0|||
164670305|NCT00813293|594819075|FG000|Overall Study|Adverse Event|0|||
164670306|NCT00813293|594819076|FG001|Overall Study|Adverse Event|1|||
164670307|NCT02794974|594819077|FG000|Overall Study|Physician Decision|0|||
164670308|NCT02794974|594819078|FG001|Overall Study|Physician Decision|1|||
164670309|NCT00533273|594819081|FG000|Double-blind|Withdrew consent|0|||
164670310|NCT00533273|594819082|FG001|Double-blind|Withdrew consent|2|||
164670311|NCT00533273|594819081|FG000|Open-label|Withdrawal by Subject|6|||
164670312|NCT00533273|594819082|FG001|Open-label|Withdrawal by Subject|0|||
164670313|NCT00454909|594819083|FG000|Overall Study|Withdrawal by Subject|1|||
164670314|NCT00454909|594819084|FG001|Overall Study|Withdrawal by Subject|0|||
164670315|NCT00454909|594819085|FG002|Overall Study|Withdrawal by Subject|0|||
164670316|NCT00454909|594819083|FG000|Overall Study|Migrated/moved from study area|0|||
164670317|NCT00454909|594819084|FG001|Overall Study|Migrated/moved from study area|0|||
164670318|NCT00454909|594819085|FG002|Overall Study|Migrated/moved from study area|1|||
164670319|NCT00454909|594819083|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
164670320|NCT00454909|594819084|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
164670321|NCT00454909|594819085|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
164670322|NCT00454909|594819083|FG000|Overall Study|Others|1|||
164670323|NCT00454909|594819084|FG001|Overall Study|Others|0|||
164670324|NCT00454909|594819085|FG002|Overall Study|Others|0|||
164670325|NCT03752528|594819086|FG000|Part A|Lost to Follow-up|1|||
164670326|NCT03752528|594819086|FG000|Part A|Protocol Violation|1|||
164670327|NCT03752528|594819086|FG000|Part B|Protocol Violation|1|||
164670328|NCT03752528|594819086|FG000|Part B|Study terminated by sponsor|3|||
164670329|NCT01981720|594819087|FG000|Overall Study|Adverse Event|1|||
164670330|NCT01981720|594819087|FG000|Overall Study|Withdrawal by Subject|3|||
164670331|NCT01981720|594819087|FG000|Overall Study|Pregnancy|1|||
164670332|NCT02549092|594819089|FG000|Treatment Period|Adverse Event|2|||
164670333|NCT02549092|594819090|FG001|Treatment Period|Adverse Event|2|||
164670334|NCT02549092|594819089|FG000|Treatment Period|Withdrawal by Subject|1|||
164670335|NCT02549092|594819090|FG001|Treatment Period|Withdrawal by Subject|3|||
164670336|NCT02549092|594819089|FG000|Treatment Period|Lack of Efficacy|0|||
164670337|NCT02549092|594819090|FG001|Treatment Period|Lack of Efficacy|2|||
164670338|NCT02549092|594819089|FG000|Extension/Transition Period|Adverse Event|1|||
164670339|NCT02549092|594819090|FG001|Extension/Transition Period|Adverse Event|1|||
164670340|NCT02549092|594819089|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
164670341|NCT02549092|594819090|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
164670342|NCT02549092|594819089|FG000|Extension/Transition Period|Other, Not Specified|4|||
164670343|NCT02549092|594819090|FG001|Extension/Transition Period|Other, Not Specified|2|||
164670344|NCT00910663|594819091|FG000|Period 1|Withdrawal by Subject|0|||
164670345|NCT00910663|594819092|FG001|Period 1|Withdrawal by Subject|1|||
164670346|NCT01772537|594819096|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
164566324|NCT00666926|594443039|FG013|Overall Study|Lost to Follow-up|0|||
164218670|NCT01060111|593168421|FG000|Overall Study|Participants' non-cooperation|1|||
164218671|NCT01060111|593168422|FG001|Overall Study|Participants' non-cooperation|0|||
164218672|NCT01060111|593168423|FG002|Overall Study|Participants' non-cooperation|0|||
164218673|NCT01060111|593168421|FG000|Overall Study|Other|2|||
164218674|NCT01060111|593168422|FG001|Overall Study|Other|3|||
164218675|NCT01060111|593168423|FG002|Overall Study|Other|4|||
164218676|NCT01433978|593168424|FG000|Core Study|Adverse Event, Non-Fatal|0|||
164218677|NCT01433978|593168425|FG001|Core Study|Adverse Event, Non-Fatal|1|||
164218678|NCT01433978|593168426|FG002|Core Study|Adverse Event, Non-Fatal|0|||
164218679|NCT01433978|593168424|FG000|Core Study|Lack of Efficacy|5|||
164218680|NCT01433978|593168425|FG001|Core Study|Lack of Efficacy|1|||
164218681|NCT01433978|593168426|FG002|Core Study|Lack of Efficacy|0|||
164218682|NCT01433978|593168424|FG000|Core Study|Study Terminated by Sponsor|6|||
164218683|NCT01433978|593168425|FG001|Core Study|Study Terminated by Sponsor|9|||
164218684|NCT01433978|593168426|FG002|Core Study|Study Terminated by Sponsor|0|||
164218685|NCT01433978|593168424|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
164218686|NCT01433978|593168425|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
164218687|NCT01433978|593168426|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
164218688|NCT01433978|593168424|FG000|Extension Phase|Lack of Efficacy|0|||
164218689|NCT01433978|593168425|FG001|Extension Phase|Lack of Efficacy|0|||
164218690|NCT01433978|593168426|FG002|Extension Phase|Lack of Efficacy|1|||
164218691|NCT01433978|593168424|FG000|Extension Phase|Study Terminated by Sponsor|0|||
164218692|NCT01433978|593168425|FG001|Extension Phase|Study Terminated by Sponsor|0|||
164218693|NCT01433978|593168426|FG002|Extension Phase|Study Terminated by Sponsor|4|||
164218694|NCT01773889|593168429|FG000|Overall Study|lack of funding|2|||
164218695|NCT02301429|593168430|FG000|Overall Study|not acceptable vascular anatomy|3|||
164218696|NCT03954938|593168431|FG000|Overall Study|Withdrawal by Subject|2|||
164218697|NCT03954938|593168431|FG000|Overall Study|Adverse Event|1|||
164218698|NCT00976391|593168433|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
164218699|NCT00976391|593168434|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
164218700|NCT00976391|593168433|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
164218701|NCT00976391|593168434|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
164218702|NCT00976391|593168433|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
164218703|NCT00976391|593168434|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
164218704|NCT00976391|593168433|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
164218705|NCT00976391|593168434|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
164218706|NCT00976391|593168433|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
164218707|NCT00976391|593168434|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
164218708|NCT00976391|593168433|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
164218709|NCT00976391|593168434|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
164218710|NCT00976391|593168433|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
164218711|NCT00976391|593168434|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
164218712|NCT00976391|593168433|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
164218713|NCT00976391|593168434|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
164328388|NCT00282347|593577970|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
164328389|NCT02101112|593577971|FG000|Overall Study|Adverse Event|0|||
164328390|NCT02101112|593577972|FG001|Overall Study|Adverse Event|0|||
164328391|NCT02101112|593577973|FG002|Overall Study|Adverse Event|1|||
164328392|NCT02101112|593577974|FG003|Overall Study|Adverse Event|0|||
164328393|NCT02101112|593577975|FG004|Overall Study|Adverse Event|0|||
164328394|NCT02101112|593577976|FG005|Overall Study|Adverse Event|0|||
164328395|NCT02101112|593577971|FG000|Overall Study|Withdrawal by Subject|0|||
164328396|NCT02101112|593577972|FG001|Overall Study|Withdrawal by Subject|0|||
164328397|NCT02101112|593577973|FG002|Overall Study|Withdrawal by Subject|0|||
164328398|NCT02101112|593577974|FG003|Overall Study|Withdrawal by Subject|0|||
164328399|NCT02101112|593577975|FG004|Overall Study|Withdrawal by Subject|1|||
164328400|NCT02101112|593577976|FG005|Overall Study|Withdrawal by Subject|0|||
164328401|NCT04340063|593577977|FG000|Overall Study|Withdrawal by Subject|1|||
164328402|NCT04340063|593577978|FG001|Overall Study|Withdrawal by Subject|2|||
164328403|NCT04340063|593577977|FG000|Overall Study|Lost to Follow-up|3|||
164328404|NCT04340063|593577978|FG001|Overall Study|Lost to Follow-up|1|||
164328405|NCT04340063|593577977|FG000|Overall Study|Protocol Violation|0|||
164328406|NCT04340063|593577978|FG001|Overall Study|Protocol Violation|1|||
164328407|NCT00920829|593579482|FG000|Allocation|No post randomization data|3|||
164328408|NCT00920829|593579483|FG001|Allocation|No post randomization data|1|||
164328409|NCT00920829|593579484|FG002|Allocation|No post randomization data|0|||
164328410|NCT00920829|593579485|FG003|Allocation|No post randomization data|2|||
164328411|NCT00920829|593579482|FG000|Available for Analysis|Withdrawal by Subject|6|||
164328412|NCT00920829|593579483|FG001|Available for Analysis|Withdrawal by Subject|6|||
164328413|NCT00920829|593579484|FG002|Available for Analysis|Withdrawal by Subject|6|||
164328414|NCT00920829|593579485|FG003|Available for Analysis|Withdrawal by Subject|10|||
164328415|NCT00920829|593579482|FG000|Available for Analysis|Required Medical Treatment|0|||
164328416|NCT00920829|593579483|FG001|Available for Analysis|Required Medical Treatment|1|||
164328417|NCT00920829|593579484|FG002|Available for Analysis|Required Medical Treatment|2|||
164328418|NCT00920829|593579485|FG003|Available for Analysis|Required Medical Treatment|0|||
164328419|NCT00920829|593579482|FG000|Available for Analysis|Adverse Event|1|||
164328420|NCT00920829|593579483|FG001|Available for Analysis|Adverse Event|2|||
164328421|NCT00920829|593579484|FG002|Available for Analysis|Adverse Event|1|||
164328422|NCT00920829|593579485|FG003|Available for Analysis|Adverse Event|0|||
164328423|NCT00920829|593579482|FG000|Available for Analysis|Death|1|||
164328424|NCT00920829|593579483|FG001|Available for Analysis|Death|0|||
164328425|NCT00920829|593579484|FG002|Available for Analysis|Death|0|||
164328426|NCT00920829|593579485|FG003|Available for Analysis|Death|0|||
164328427|NCT00920829|593579482|FG000|Available for Analysis|Protocol Violation|0|||
164218714|NCT00976391|593168433|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
164218715|NCT00976391|593168434|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
164218716|NCT00976391|593168433|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
164218717|NCT00976391|593168434|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
164218718|NCT00976391|593168433|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
164218719|NCT00976391|593168434|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
164218720|NCT00976391|593168433|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
164218721|NCT00976391|593168434|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
164218722|NCT00976391|593168433|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
164218723|NCT00976391|593168434|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
164218724|NCT00976391|593168433|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
164218725|NCT00976391|593168434|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
164218726|NCT04270760|593168435|FG000|Overall Study|Withdrawal by Subject|0|||
164218727|NCT04270760|593168436|FG001|Overall Study|Withdrawal by Subject|1|||
164218728|NCT04270760|593168437|FG002|Overall Study|Withdrawal by Subject|3|||
164218729|NCT04270760|593168438|FG003|Overall Study|Withdrawal by Subject|0|||
164218730|NCT04270760|593168439|FG004|Overall Study|Withdrawal by Subject|0|||
164218731|NCT04270760|593168435|FG000|Overall Study|Lost to Follow-up|1|||
164218732|NCT04270760|593168436|FG001|Overall Study|Lost to Follow-up|2|||
164218733|NCT04270760|593168437|FG002|Overall Study|Lost to Follow-up|1|||
164218734|NCT04270760|593168438|FG003|Overall Study|Lost to Follow-up|0|||
164218735|NCT04270760|593168439|FG004|Overall Study|Lost to Follow-up|0|||
164218736|NCT04270760|593168435|FG000|Overall Study|Death|0|||
164218737|NCT04270760|593168436|FG001|Overall Study|Death|0|||
164218738|NCT04270760|593168437|FG002|Overall Study|Death|0|||
164218739|NCT04270760|593168438|FG003|Overall Study|Death|0|||
164218740|NCT04270760|593168439|FG004|Overall Study|Death|1|||
164218741|NCT00887588|593168440|FG000|Core Period|Death|1|||
164218742|NCT00887588|593168441|FG001|Core Period|Death|1|||
164218743|NCT00887588|593168440|FG000|Core Period|Lost to Follow-up|3|||
164218744|NCT00887588|593168441|FG001|Core Period|Lost to Follow-up|1|||
164218745|NCT00887588|593168440|FG000|Core Period|Withdrawal by Subject|6|||
164218746|NCT00887588|593168441|FG001|Core Period|Withdrawal by Subject|8|||
164218747|NCT00887588|593168440|FG000|Core Period|Adverse Event|9|||
164218748|NCT00887588|593168441|FG001|Core Period|Adverse Event|11|||
164218749|NCT00887588|593168440|FG000|Extension Period|Adverse Event|4|||
164218750|NCT00887588|593168441|FG001|Extension Period|Adverse Event|4|||
164218751|NCT00887588|593168440|FG000|Extension Period|Death|0|||
164218752|NCT00887588|593168441|FG001|Extension Period|Death|1|||
164218753|NCT00887588|593168440|FG000|Extension Period|Protocol deviation|1|||
164218754|NCT00887588|593168441|FG001|Extension Period|Protocol deviation|0|||
164218755|NCT00887588|593168440|FG000|Extension Period|Lost to Follow-up|1|||
164218756|NCT00887588|593168441|FG001|Extension Period|Lost to Follow-up|0|||
164218757|NCT04180696|593168450|FG000|Overall Study|Death|5|||
164218758|NCT04180696|593168451|FG001|Overall Study|Death|6|||
164218759|NCT04180696|593168450|FG000|Overall Study|Lost to Follow-up|1|||
164218760|NCT04180696|593168451|FG001|Overall Study|Lost to Follow-up|0|||
164218761|NCT04180696|593168450|FG000|Overall Study|Withdrawal by Subject|0|||
164218762|NCT04180696|593168451|FG001|Overall Study|Withdrawal by Subject|1|||
164218763|NCT04210375|593168455|FG000|Overall Study|Death|0|||
164218764|NCT04210375|593168456|FG001|Overall Study|Death|1|||
164218765|NCT04210375|593168457|FG002|Overall Study|Death|0|||
164218766|NCT04210375|593168458|FG003|Overall Study|Death|0|||
164566325|NCT00666926|594443040|FG014|Overall Study|Lost to Follow-up|0|||
164566326|NCT00666926|594443041|FG015|Overall Study|Lost to Follow-up|0|||
164566327|NCT00666926|594443026|FG000|Overall Study|Other|2|||
164566328|NCT00666926|594443027|FG001|Overall Study|Other|4|||
164566329|NCT00666926|594443028|FG002|Overall Study|Other|3|||
164566330|NCT00666926|594443029|FG003|Overall Study|Other|3|||
164566331|NCT00666926|594443030|FG004|Overall Study|Other|3|||
164566332|NCT00666926|594443031|FG005|Overall Study|Other|3|||
164566333|NCT00666926|594443032|FG006|Overall Study|Other|4|||
164566334|NCT00666926|594443033|FG007|Overall Study|Other|0|||
164218767|NCT05752487|593168461|FG000|Overall Study|Enrolled, not treated|9|||
164218768|NCT05752487|593168461|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
164218769|NCT05752487|593168461|FG000|Overall Study|Withdrawal by Subject|2|||
164218770|NCT04124965|593168463|FG000|Overall Study|Adverse event, non-fatal|3|||
164218771|NCT04124965|593168464|FG001|Overall Study|Adverse event, non-fatal|1|||
164218772|NCT04124965|593168463|FG000|Overall Study|Withdrawal by Subject|1|||
164218773|NCT04124965|593168464|FG001|Overall Study|Withdrawal by Subject|1|||
164218774|NCT04124965|593168463|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
164218775|NCT04124965|593168464|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
164218776|NCT04124965|593168463|FG000|Overall Study|Pregnancy|1|||
164218777|NCT04124965|593168464|FG001|Overall Study|Pregnancy|0|||
164566335|NCT00666926|594443034|FG008|Overall Study|Other|3|||
164566336|NCT00666926|594443035|FG009|Overall Study|Other|5|||
164218778|NCT04124965|593168463|FG000|Overall Study|Sponsor and participant decision|0|||
164566337|NCT00666926|594443036|FG010|Overall Study|Other|3|||
164218779|NCT04124965|593168464|FG001|Overall Study|Sponsor and participant decision|1|||
164218780|NCT04124965|593168463|FG000|Overall Study|Personal surgery|0|||
164218781|NCT04124965|593168464|FG001|Overall Study|Personal surgery|1|||
164218782|NCT04124965|593168463|FG000|Overall Study|Physician Decision|0|||
164218783|NCT04124965|593168464|FG001|Overall Study|Physician Decision|1|||
164218784|NCT02405962|593168465|FG000|Overall Study|Lost to Follow-up|1|||
164218785|NCT02405962|593168466|FG001|Overall Study|Lost to Follow-up|4|||
164218786|NCT02405962|593168465|FG000|Overall Study|A participant has moved to another place|0|||
164218787|NCT02405962|593168466|FG001|Overall Study|A participant has moved to another place|1|||
164218788|NCT01214720|593168469|FG000|Overall Study|Alive and still on treatment|34|||
164218789|NCT01214720|593168470|FG001|Overall Study|Alive and still on treatment|18|||
164218790|NCT01214720|593168469|FG000|Overall Study|Alive and in follow-up|45|||
164218791|NCT01214720|593168470|FG001|Overall Study|Alive and in follow-up|48|||
164218792|NCT01214720|593168469|FG000|Overall Study|Lost to Follow-up|6|||
164218793|NCT01214720|593168470|FG001|Overall Study|Lost to Follow-up|2|||
164218794|NCT01980888|593168471|FG000|Overall Study|Study Terminated by Sponsor|116|||
164218795|NCT01980888|593168472|FG001|Overall Study|Study Terminated by Sponsor|122|||
164218796|NCT01980888|593168471|FG000|Overall Study|Withdrew Consent|17|||
164218797|NCT01980888|593168472|FG001|Overall Study|Withdrew Consent|6|||
164218798|NCT01980888|593168471|FG000|Overall Study|Investigator's Discretion|8|||
164218799|NCT01980888|593168472|FG001|Overall Study|Investigator's Discretion|3|||
164218800|NCT01980888|593168471|FG000|Overall Study|Non-Compliance with Study Drug|3|||
164218801|NCT01980888|593168472|FG001|Overall Study|Non-Compliance with Study Drug|2|||
164218802|NCT00433290|593168473|FG000|Overall Study|Adverse Event|24|||
164218803|NCT00433290|593168474|FG001|Overall Study|Adverse Event|7|||
164218804|NCT00433290|593168473|FG000|Overall Study|Lack of Efficacy|1|||
164218805|NCT00433290|593168474|FG001|Overall Study|Lack of Efficacy|5|||
164218806|NCT00433290|593168473|FG000|Overall Study|Withdrawal by Subject|4|||
164218807|NCT00433290|593168474|FG001|Overall Study|Withdrawal by Subject|2|||
164218808|NCT00433290|593168473|FG000|Overall Study|Protocol Violation|3|||
164218809|NCT00433290|593168474|FG001|Overall Study|Protocol Violation|2|||
164218810|NCT00433290|593168473|FG000|Overall Study|Physician Decision|2|||
164218811|NCT00433290|593168474|FG001|Overall Study|Physician Decision|0|||
164218812|NCT00433290|593168473|FG000|Overall Study|Entry Criteria Not Met|0|||
164218813|NCT00433290|593168474|FG001|Overall Study|Entry Criteria Not Met|1|||
164218814|NCT00433290|593168473|FG000|Overall Study|Lost to Follow-up|1|||
164218815|NCT00433290|593168474|FG001|Overall Study|Lost to Follow-up|0|||
164218816|NCT01397747|593168479|FG000|Overall Study|Multitarget DNA test excluded|689|||
164218817|NCT01397747|593168479|FG000|Overall Study|Colonoscopy excluded|304|||
164218818|NCT01397747|593168479|FG000|Overall Study|FIT excluded|34|||
164218819|NCT00086307|593168480|FG000|Overall Study|Lack of Efficacy|1|||
164328428|NCT00920829|593579483|FG001|Available for Analysis|Protocol Violation|0|||
164566338|NCT00666926|594443037|FG011|Overall Study|Other|26|||
164566339|NCT00666926|594443038|FG012|Overall Study|Other|3|||
164566340|NCT00666926|594443039|FG013|Overall Study|Other|2|||
164566341|NCT00666926|594443040|FG014|Overall Study|Other|4|||
164566342|NCT00666926|594443041|FG015|Overall Study|Other|4|||
164566343|NCT00666926|594443026|FG000|Overall Study|Withdrawal by Subject|0|||
164566344|NCT00666926|594443027|FG001|Overall Study|Withdrawal by Subject|0|||
164566345|NCT00666926|594443028|FG002|Overall Study|Withdrawal by Subject|0|||
164566346|NCT00666926|594443029|FG003|Overall Study|Withdrawal by Subject|0|||
164566347|NCT00666926|594443030|FG004|Overall Study|Withdrawal by Subject|0|||
164566348|NCT00666926|594443031|FG005|Overall Study|Withdrawal by Subject|0|||
164566349|NCT00666926|594443032|FG006|Overall Study|Withdrawal by Subject|0|||
164566350|NCT00666926|594443033|FG007|Overall Study|Withdrawal by Subject|1|||
164566351|NCT00666926|594443034|FG008|Overall Study|Withdrawal by Subject|0|||
164566352|NCT00666926|594443035|FG009|Overall Study|Withdrawal by Subject|3|||
164566353|NCT00666926|594443036|FG010|Overall Study|Withdrawal by Subject|0|||
164566354|NCT00666926|594443037|FG011|Overall Study|Withdrawal by Subject|3|||
164566355|NCT00666926|594443038|FG012|Overall Study|Withdrawal by Subject|0|||
164566356|NCT00666926|594443039|FG013|Overall Study|Withdrawal by Subject|1|||
164566357|NCT00666926|594443040|FG014|Overall Study|Withdrawal by Subject|3|||
164670347|NCT01772537|594819097|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
164670348|NCT01772537|594819098|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
164670349|NCT01376167|594819099|FG000|Overall Study|Lost to Follow-up|2|||
164670350|NCT01376167|594819100|FG001|Overall Study|Lost to Follow-up|4|||
164670351|NCT01376167|594819101|FG002|Overall Study|Lost to Follow-up|2|||
164670352|NCT01376167|594819099|FG000|Overall Study|Physician Decision|1|||
164670353|NCT01376167|594819100|FG001|Overall Study|Physician Decision|1|||
164670354|NCT01376167|594819101|FG002|Overall Study|Physician Decision|0|||
164670355|NCT01376167|594819099|FG000|Overall Study|Withdrawal by Subject|1|||
164670356|NCT01376167|594819100|FG001|Overall Study|Withdrawal by Subject|5|||
164670357|NCT01376167|594819101|FG002|Overall Study|Withdrawal by Subject|4|||
164670358|NCT02193165|594819104|FG000|4 Week Product Use|Lost to Follow-up|1|||
164566358|NCT00666926|594443041|FG015|Overall Study|Withdrawal by Subject|3|||
164566359|NCT00666926|594443026|FG000|Overall Study|Death|0|||
164566360|NCT00666926|594443027|FG001|Overall Study|Death|0|||
164566361|NCT00666926|594443028|FG002|Overall Study|Death|0|||
164566362|NCT00666926|594443029|FG003|Overall Study|Death|0|||
164566363|NCT00666926|594443030|FG004|Overall Study|Death|0|||
164566364|NCT00666926|594443031|FG005|Overall Study|Death|0|||
164566365|NCT00666926|594443032|FG006|Overall Study|Death|0|||
164566366|NCT00666926|594443033|FG007|Overall Study|Death|0|||
164566367|NCT00666926|594443034|FG008|Overall Study|Death|0|||
164566368|NCT00666926|594443035|FG009|Overall Study|Death|0|||
164566369|NCT00666926|594443036|FG010|Overall Study|Death|0|||
164566370|NCT00666926|594443037|FG011|Overall Study|Death|1|||
164566371|NCT00666926|594443038|FG012|Overall Study|Death|0|||
164566372|NCT00666926|594443039|FG013|Overall Study|Death|0|||
164566373|NCT00666926|594443040|FG014|Overall Study|Death|0|||
164566374|NCT00666926|594443041|FG015|Overall Study|Death|0|||
164566375|NCT01960855|594443044|FG000|Overall Study|Subject noncompliant|1|||
164566376|NCT01960855|594443045|FG001|Overall Study|Subject noncompliant|0|||
164566377|NCT01960855|594443046|FG002|Overall Study|Subject noncompliant|0|||
164566378|NCT01960855|594443047|FG003|Overall Study|Subject noncompliant|0|||
164566379|NCT01960855|594443048|FG004|Overall Study|Subject noncompliant|0|||
164566380|NCT01960855|594443044|FG000|Overall Study|Adverse Event|2|||
164566381|NCT01960855|594443045|FG001|Overall Study|Adverse Event|0|||
164566382|NCT01960855|594443046|FG002|Overall Study|Adverse Event|6|||
164566383|NCT01960855|594443047|FG003|Overall Study|Adverse Event|2|||
164566384|NCT01960855|594443048|FG004|Overall Study|Adverse Event|2|||
164566385|NCT01960855|594443044|FG000|Overall Study|Lack of Efficacy|1|||
164566386|NCT01960855|594443045|FG001|Overall Study|Lack of Efficacy|1|||
164566387|NCT01960855|594443046|FG002|Overall Study|Lack of Efficacy|0|||
164566388|NCT01960855|594443047|FG003|Overall Study|Lack of Efficacy|0|||
164566389|NCT01960855|594443048|FG004|Overall Study|Lack of Efficacy|0|||
164566390|NCT01960855|594443044|FG000|Overall Study|Other|2|||
164566391|NCT01960855|594443045|FG001|Overall Study|Other|1|||
164566392|NCT01960855|594443046|FG002|Overall Study|Other|1|||
164566393|NCT01960855|594443047|FG003|Overall Study|Other|1|||
164566394|NCT01960855|594443048|FG004|Overall Study|Other|0|||
164566395|NCT01960855|594443044|FG000|Overall Study|Consent withdrawn by subject|3|||
164566396|NCT01960855|594443045|FG001|Overall Study|Consent withdrawn by subject|1|||
164566397|NCT01960855|594443046|FG002|Overall Study|Consent withdrawn by subject|2|||
164566398|NCT01960855|594443047|FG003|Overall Study|Consent withdrawn by subject|1|||
164566399|NCT01960855|594443048|FG004|Overall Study|Consent withdrawn by subject|1|||
164566400|NCT01960855|594443044|FG000|Overall Study|Lost to Follow-up|2|||
164566401|NCT01960855|594443045|FG001|Overall Study|Lost to Follow-up|1|||
164566402|NCT01960855|594443046|FG002|Overall Study|Lost to Follow-up|0|||
164566403|NCT01960855|594443047|FG003|Overall Study|Lost to Follow-up|0|||
164566404|NCT01960855|594443048|FG004|Overall Study|Lost to Follow-up|2|||
164566405|NCT01879410|594443049|FG000|Overall Study|Adverse Event|9|||
164566406|NCT01879410|594443050|FG001|Overall Study|Adverse Event|14|||
164566407|NCT01879410|594443049|FG000|Overall Study|Lack of Efficacy|4|||
164566408|NCT01879410|594443050|FG001|Overall Study|Lack of Efficacy|6|||
164566409|NCT01879410|594443049|FG000|Overall Study|Protocol Violation|1|||
164566410|NCT01879410|594443050|FG001|Overall Study|Protocol Violation|7|||
164566411|NCT01879410|594443049|FG000|Overall Study|Lost to Follow-up|2|||
164566412|NCT01879410|594443050|FG001|Overall Study|Lost to Follow-up|1|||
164566413|NCT01879410|594443049|FG000|Overall Study|Withdrawal by Subject|7|||
164566414|NCT01879410|594443050|FG001|Overall Study|Withdrawal by Subject|8|||
164566415|NCT01879410|594443049|FG000|Overall Study|Randomised in Error|1|||
164670359|NCT02193165|594819105|FG001|4 Week Product Use|Lost to Follow-up|1|||
164670360|NCT02193165|594819106|FG002|4 Week Product Use|Lost to Follow-up|1|||
164670361|NCT02193165|594819104|FG000|6 Week Product Use|Lost to Follow-up|0|||
164566416|NCT01879410|594443050|FG001|Overall Study|Randomised in Error|2|||
164566417|NCT02058147|594443051|FG000|Overall Study|Randomized but not treated|0|||
164566418|NCT02058147|594443052|FG001|Overall Study|Randomized but not treated|0|||
164670362|NCT02193165|594819105|FG001|6 Week Product Use|Lost to Follow-up|1|||
164670363|NCT02193165|594819106|FG002|6 Week Product Use|Lost to Follow-up|0|||
164670364|NCT00678639|594819109|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
164670365|NCT00678639|594819110|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
164670366|NCT01546545|594819112|FG000|Overall Study|Withdrawal by Subject|1|||
164670367|NCT01214850|594819113|FG000|Overall Study|Withdrawal by Subject|38|||
164670368|NCT01214850|594819114|FG001|Overall Study|Withdrawal by Subject|31|||
164670369|NCT01214850|594819115|FG002|Overall Study|Withdrawal by Subject|28|||
164670370|NCT01214850|594819113|FG000|Overall Study|Lost to Follow-up|124|||
164670371|NCT01214850|594819114|FG001|Overall Study|Lost to Follow-up|98|||
164670372|NCT01214850|594819115|FG002|Overall Study|Lost to Follow-up|123|||
164670373|NCT01214850|594819113|FG000|Overall Study|Protocol Violation|5|||
164670374|NCT01214850|594819114|FG001|Overall Study|Protocol Violation|5|||
164670375|NCT01214850|594819115|FG002|Overall Study|Protocol Violation|6|||
164670376|NCT01214850|594819113|FG000|Overall Study|Adverse event or death|11|||
164670377|NCT01214850|594819114|FG001|Overall Study|Adverse event or death|8|||
164670378|NCT01214850|594819115|FG002|Overall Study|Adverse event or death|3|||
164670379|NCT01214850|594819113|FG000|Overall Study|Inappropriate enrollment|2|||
164670380|NCT01214850|594819114|FG001|Overall Study|Inappropriate enrollment|1|||
164670381|NCT01214850|594819115|FG002|Overall Study|Inappropriate enrollment|0|||
164670382|NCT01214850|594819113|FG000|Overall Study|Administrative reason|1|||
164670383|NCT01214850|594819114|FG001|Overall Study|Administrative reason|0|||
164670384|NCT01214850|594819115|FG002|Overall Study|Administrative reason|0|||
164670385|NCT01214850|594819113|FG000|Overall Study|Unable to classify|2|||
164670386|NCT01214850|594819114|FG001|Overall Study|Unable to classify|1|||
164670387|NCT01214850|594819115|FG002|Overall Study|Unable to classify|1|||
164670388|NCT05615935|594819116|FG000|Overall Study|Lost to Follow-up|1|||
164670389|NCT05615935|594819117|FG001|Overall Study|Lost to Follow-up|1|||
164670390|NCT00735904|594819118|FG000|Overall Study|Adverse Event|3|||
164670391|NCT00735904|594819118|FG000|Overall Study|Death|20|||
164670392|NCT00735904|594819118|FG000|Overall Study|Protocol Violation|1|||
164670393|NCT00735904|594819118|FG000|Overall Study|Withdrawal by Subject|1|||
164670394|NCT00735904|594819118|FG000|Overall Study|Study Terminated by Sponsor|5|||
164670395|NCT00735904|594819118|FG000|Overall Study|Other|8|||
164670396|NCT00048581|594819125|FG000|Double-Blind Period|Adverse Event|9|||
164670397|NCT00048581|594819126|FG001|Double-Blind Period|Adverse Event|5|||
164670398|NCT00048581|594819127|FG002|Double-Blind Period|Adverse Event|0|||
164670399|NCT00048581|594819125|FG000|Double-Blind Period|Lack of Efficacy|14|||
164670400|NCT00048581|594819126|FG001|Double-Blind Period|Lack of Efficacy|27|||
164670401|NCT00048581|594819127|FG002|Double-Blind Period|Lack of Efficacy|0|||
164670402|NCT00048581|594819125|FG000|Double-Blind Period|Lost to Follow-up|5|||
164670403|NCT00048581|594819126|FG001|Double-Blind Period|Lost to Follow-up|0|||
164670404|NCT00048581|594819127|FG002|Double-Blind Period|Lost to Follow-up|0|||
164670405|NCT00048581|594819125|FG000|Double-Blind Period|Withdrawal by Subject|5|||
164670406|NCT00048581|594819126|FG001|Double-Blind Period|Withdrawal by Subject|2|||
164670407|NCT00048581|594819127|FG002|Double-Blind Period|Withdrawal by Subject|0|||
164670408|NCT00048581|594819125|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
164670409|NCT00048581|594819126|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
164670410|NCT00048581|594819127|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
164670411|NCT00048581|594819125|FG000|Double-Blind Period|Investigator Decision|1|||
164670412|NCT00048581|594819126|FG001|Double-Blind Period|Investigator Decision|0|||
164670413|NCT00048581|594819127|FG002|Double-Blind Period|Investigator Decision|0|||
164670414|NCT00048581|594819125|FG000|Open-Label Period|Death|0|||
164670415|NCT00048581|594819126|FG001|Open-Label Period|Death|0|||
164670416|NCT00048581|594819127|FG002|Open-Label Period|Death|4|||
164670417|NCT00048581|594819125|FG000|Open-Label Period|Adverse Event|0|||
164670418|NCT00048581|594819126|FG001|Open-Label Period|Adverse Event|0|||
164670419|NCT00048581|594819127|FG002|Open-Label Period|Adverse Event|37|||
164670420|NCT00048581|594819125|FG000|Open-Label Period|Lack of Efficacy|0|||
164670421|NCT00048581|594819126|FG001|Open-Label Period|Lack of Efficacy|0|||
164670422|NCT00048581|594819127|FG002|Open-Label Period|Lack of Efficacy|69|||
164670423|NCT00048581|594819125|FG000|Open-Label Period|Lost to Follow-up|0|||
164670424|NCT00048581|594819126|FG001|Open-Label Period|Lost to Follow-up|0|||
164670425|NCT00048581|594819127|FG002|Open-Label Period|Lost to Follow-up|14|||
164670426|NCT00048581|594819125|FG000|Open-Label Period|Withdrawal by Subject|0|||
164670427|NCT00048581|594819126|FG001|Open-Label Period|Withdrawal by Subject|0|||
164670428|NCT00048581|594819127|FG002|Open-Label Period|Withdrawal by Subject|20|||
164670429|NCT00048581|594819125|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
164670430|NCT00048581|594819126|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
164670431|NCT00048581|594819127|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
164670432|NCT00048581|594819125|FG000|Open-Label Period|Poor/Non-compliance|0|||
164670433|NCT00048581|594819126|FG001|Open-Label Period|Poor/Non-compliance|0|||
164670434|NCT00048581|594819127|FG002|Open-Label Period|Poor/Non-compliance|5|||
164670435|NCT00048581|594819125|FG000|Open-Label Period|Pregnancy|0|||
164670436|NCT00048581|594819126|FG001|Open-Label Period|Pregnancy|0|||
164670437|NCT00048581|594819127|FG002|Open-Label Period|Pregnancy|7|||
164670438|NCT00048581|594819125|FG000|Open-Label Period|Study Site Closure|0|||
164670439|NCT00048581|594819126|FG001|Open-Label Period|Study Site Closure|0|||
164670440|NCT00048581|594819127|FG002|Open-Label Period|Study Site Closure|2|||
164670441|NCT00048581|594819125|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
164670442|NCT00048581|594819126|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
164670443|NCT00048581|594819127|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
164670444|NCT00048581|594819125|FG000|Open-Label Period|Problem With Transportation To Site|0|||
164670445|NCT00048581|594819126|FG001|Open-Label Period|Problem With Transportation To Site|0|||
164670446|NCT00048581|594819127|FG002|Open-Label Period|Problem With Transportation To Site|1|||
164670447|NCT00048581|594819125|FG000|Open-Label Period|Primary Investigator Retired|0|||
164670448|NCT00048581|594819126|FG001|Open-Label Period|Primary Investigator Retired|0|||
164670449|NCT00048581|594819127|FG002|Open-Label Period|Primary Investigator Retired|2|||
164670450|NCT00048581|594819125|FG000|Open-Label Period|Study Ended By Sponsor|0|||
164670451|NCT00048581|594819126|FG001|Open-Label Period|Study Ended By Sponsor|0|||
164670452|NCT00048581|594819127|FG002|Open-Label Period|Study Ended By Sponsor|1|||
164670453|NCT03639311|594819131|FG000|Maintenance Phase|Lost to Follow-up|1|||
164670454|NCT03639311|594819132|FG001|Maintenance Phase|Lost to Follow-up|0|||
164670455|NCT03639311|594819133|FG002|Maintenance Phase|Lost to Follow-up|0|||
164670456|NCT03639311|594819131|FG000|Maintenance Phase|Adverse Event|1|||
164670457|NCT03639311|594819132|FG001|Maintenance Phase|Adverse Event|0|||
164670458|NCT03639311|594819133|FG002|Maintenance Phase|Adverse Event|0|||
164670459|NCT03639311|594819131|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
164670460|NCT03639311|594819132|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
164670461|NCT03639311|594819133|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
164670462|NCT03639311|594819131|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
164670463|NCT03639311|594819132|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
164670464|NCT03639311|594819133|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
164670465|NCT03639311|594819131|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
164670466|NCT03639311|594819132|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
164670467|NCT03639311|594819133|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
164670468|NCT03639311|594819131|FG000|Maintenance Phase|Lack of Efficacy|1|||
164670469|NCT03639311|594819132|FG001|Maintenance Phase|Lack of Efficacy|0|||
164670470|NCT03639311|594819133|FG002|Maintenance Phase|Lack of Efficacy|0|||
164670471|NCT00855738|594819134|FG000|Overall Study|Lost to Follow-up|2|||
164670472|NCT00855738|594819134|FG000|Overall Study|Adverse Event|1|||
164670473|NCT00855738|594819134|FG000|Overall Study|Subject Defaulted|1|||
164670474|NCT00855738|594819134|FG000|Overall Study|Death|1|||
164670475|NCT00319735|594819139|FG000|Overall Study|Death|2|||
164670476|NCT03929393|594819140|FG000|Overall Study|Death|1|||
164670477|NCT03929393|594819141|FG001|Overall Study|Death|0|||
164670478|NCT03929393|594819140|FG000|Overall Study|Time Commitment|2|||
164670479|NCT03929393|594819141|FG001|Overall Study|Time Commitment|5|||
164670480|NCT03929393|594819140|FG000|Overall Study|Motor Vehicle Accident|0|||
164670481|NCT03929393|594819141|FG001|Overall Study|Motor Vehicle Accident|1|||
164670482|NCT03929393|594819140|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
164670483|NCT03929393|594819141|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
164670484|NCT03929393|594819140|FG000|Overall Study|Other|1|||
164670485|NCT03929393|594819141|FG001|Overall Study|Other|3|||
164670486|NCT03544138|594819151|FG000|Overall Study|Lost to Follow-up|29|||
164670487|NCT00154102|594819154|FG000|Overall Study|investigational study phase ongoing|7|||
164670488|NCT00154102|594819155|FG001|Overall Study|investigational study phase ongoing|2|||
164670489|NCT02158936|594819156|FG000|Overall Study|Study closed/ terminated|57|||
164670490|NCT02158936|594819157|FG001|Overall Study|Study closed/ terminated|77|||
164670491|NCT02158936|594819156|FG000|Overall Study|Azacitidine tx discontinued|53|||
164670492|NCT02158936|594819157|FG001|Overall Study|Azacitidine tx discontinued|46|||
164670493|NCT02158936|594819156|FG000|Overall Study|Adverse Event|39|||
164670494|NCT02158936|594819157|FG001|Overall Study|Adverse Event|24|||
164670495|NCT02158936|594819156|FG000|Overall Study|Withdrawal by Subject|15|||
164670496|NCT02158936|594819157|FG001|Overall Study|Withdrawal by Subject|16|||
164670497|NCT02158936|594819156|FG000|Overall Study|Physician Decision|15|||
164670498|NCT02158936|594819157|FG001|Overall Study|Physician Decision|13|||
164670499|NCT02158936|594819156|FG000|Overall Study|Lost to Follow-up|0|||
164670500|NCT02158936|594819157|FG001|Overall Study|Lost to Follow-up|1|||
164670501|NCT01149473|594821208|FG000|First Intervention|Adverse Event|1|||
164670502|NCT01149473|594821209|FG001|First Intervention|Adverse Event|1|||
164670503|NCT01149473|594821208|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
164670504|NCT01149473|594821209|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
164670505|NCT01247701|594821210|FG000|Overall Study|Death|2|||
164670506|NCT01247701|594821210|FG000|Overall Study|Relapsed|8|||
164670507|NCT04166630|594821211|FG000|Overall Study|Withdrawal by Subject|0|||
164670508|NCT04166630|594821212|FG001|Overall Study|Withdrawal by Subject|1|||
164670509|NCT01838941|594821213|FG000|Overall Study|Adverse Event|1|||
164670510|NCT01838941|594821213|FG000|Overall Study|Withdrawal by Subject|1|||
164670511|NCT02822235|594821214|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
164566419|NCT02058147|594443053|FG002|Overall Study|Randomized but not treated|1|||
164566420|NCT02058147|594443051|FG000|Overall Study|Adverse Event|12|||
164566421|NCT02058147|594443052|FG001|Overall Study|Adverse Event|9|||
164566422|NCT02058147|594443053|FG002|Overall Study|Adverse Event|21|||
164566423|NCT02058147|594443051|FG000|Overall Study|Lack of Efficacy|1|||
164566424|NCT02058147|594443052|FG001|Overall Study|Lack of Efficacy|0|||
164566425|NCT02058147|594443053|FG002|Overall Study|Lack of Efficacy|3|||
164566426|NCT02058147|594443051|FG000|Overall Study|Poor compliance to protocol|8|||
164566427|NCT02058147|594443052|FG001|Overall Study|Poor compliance to protocol|9|||
164566428|NCT02058147|594443053|FG002|Overall Study|Poor compliance to protocol|4|||
164670512|NCT02822235|594821215|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
164670513|NCT02822235|594821214|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
164670514|NCT02822235|594821215|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
164670515|NCT02822235|594821214|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
164670516|NCT02822235|594821215|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
164670517|NCT02822235|594821214|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
164670518|NCT02822235|594821215|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
164670519|NCT02822235|594821214|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
164670520|NCT02822235|594821215|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
164670521|NCT02822235|594821214|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
164670522|NCT02822235|594821215|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
164670523|NCT00829530|594821216|FG000|First Intervention|Adverse Event|0|||
164670524|NCT00829530|594821217|FG001|First Intervention|Adverse Event|1|||
164670525|NCT00829530|594821216|FG000|First Intervention|Intolerance to Venopuncture|0|||
164670526|NCT00829530|594821217|FG001|First Intervention|Intolerance to Venopuncture|1|||
164670527|NCT00829530|594821216|FG000|Second Intervention|Intolerance to Venopuncture|1|||
164670528|NCT00829530|594821217|FG001|Second Intervention|Intolerance to Venopuncture|0|||
164670529|NCT01038856|594821220|FG000|Overall Study|Adverse Event|2|||
164670530|NCT04638153|594821221|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164670531|NCT04638153|594821222|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164670532|NCT04638153|594821223|FG002|Overall Study|Withdrawal by parent/guardian|1|||
164670533|NCT04638153|594821221|FG000|Overall Study|Study terminated by sponsor|4|||
164670534|NCT04638153|594821222|FG001|Overall Study|Study terminated by sponsor|2|||
164670535|NCT04638153|594821223|FG002|Overall Study|Study terminated by sponsor|14|||
164566429|NCT02058147|594443051|FG000|Overall Study|Other than specified|8|||
164566430|NCT02058147|594443052|FG001|Overall Study|Other than specified|9|||
164566431|NCT02058147|594443053|FG002|Overall Study|Other than specified|0|||
164566432|NCT00773279|594443058|FG000|Period 1|Adverse Event|2|||
164566433|NCT00773279|594443059|FG001|Period 1|Adverse Event|1|||
164566434|NCT00773279|594443058|FG000|Period 1|Lack of Efficacy|0|||
164566435|NCT00773279|594443059|FG001|Period 1|Lack of Efficacy|2|||
164566436|NCT00773279|594443058|FG000|Period 1|Unclassified|5|||
164566437|NCT00773279|594443059|FG001|Period 1|Unclassified|1|||
164566438|NCT00773279|594443058|FG000|Period 2|Adverse Event|0|||
164566439|NCT00773279|594443059|FG001|Period 2|Adverse Event|1|||
164566440|NCT00773279|594443058|FG000|Period 2|Lack of Efficacy|1|||
164566441|NCT00773279|594443059|FG001|Period 2|Lack of Efficacy|0|||
164566442|NCT00773279|594443058|FG000|Period 2|Protocol Violation|0|||
164566443|NCT00773279|594443059|FG001|Period 2|Protocol Violation|3|||
164566444|NCT00773279|594443058|FG000|Period 2|Unclassified|2|||
164566445|NCT00773279|594443059|FG001|Period 2|Unclassified|2|||
164566446|NCT04178772|594443060|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
164566447|NCT04178772|594443060|FG000|Overall Study|study terminated early due to COVID-19|7|||
164566448|NCT01737931|594443061|FG000|Overall Study|Withdrawal by Subject|0|||
164566449|NCT01737931|594443062|FG001|Overall Study|Withdrawal by Subject|1|||
164566450|NCT01737931|594443063|FG002|Overall Study|Withdrawal by Subject|1|||
164566451|NCT01737931|594443061|FG000|Overall Study|Physician Decision|0|||
164566452|NCT01737931|594443062|FG001|Overall Study|Physician Decision|1|||
164670536|NCT01389102|594821224|FG000|Overall Study|Adverse Event|1|||
164670537|NCT01389102|594821225|FG001|Overall Study|Adverse Event|3|||
164670538|NCT01389102|594821226|FG002|Overall Study|Adverse Event|2|||
164670539|NCT01389102|594821227|FG003|Overall Study|Adverse Event|2|||
164566453|NCT01737931|594443063|FG002|Overall Study|Physician Decision|0|||
164566454|NCT01686568|594443064|FG000|Main Study|Withdrawal by Subject|1|||
164566455|NCT01686568|594443065|FG001|Main Study|Withdrawal by Subject|3|||
164566456|NCT01686568|594443064|FG000|Main Study|Noncompliance with protocol|0|||
164566457|NCT01686568|594443065|FG001|Main Study|Noncompliance with protocol|1|||
164566458|NCT01686568|594443064|FG000|Main Study|Liver enzymes above range of exclusion|1|||
164566459|NCT01686568|594443065|FG001|Main Study|Liver enzymes above range of exclusion|0|||
164566460|NCT01686568|594443064|FG000|Sub-Study|Not consented for sub-study|2|||
164670540|NCT01389102|594821228|FG004|Overall Study|Adverse Event|2|||
164670541|NCT01389102|594821229|FG005|Overall Study|Adverse Event|2|||
164670542|NCT01389102|594821224|FG000|Overall Study|Hurricane Katrina|4|||
164670543|NCT01389102|594821225|FG001|Overall Study|Hurricane Katrina|2|||
164670544|NCT01389102|594821226|FG002|Overall Study|Hurricane Katrina|3|||
164670545|NCT01389102|594821227|FG003|Overall Study|Hurricane Katrina|0|||
164670546|NCT01389102|594821228|FG004|Overall Study|Hurricane Katrina|3|||
164670547|NCT01389102|594821229|FG005|Overall Study|Hurricane Katrina|1|||
164670548|NCT01389102|594821224|FG000|Overall Study|Lost to Follow-up|4|||
164670549|NCT01389102|594821225|FG001|Overall Study|Lost to Follow-up|1|||
164670550|NCT01389102|594821226|FG002|Overall Study|Lost to Follow-up|1|||
164670551|NCT01389102|594821227|FG003|Overall Study|Lost to Follow-up|2|||
164670552|NCT01389102|594821228|FG004|Overall Study|Lost to Follow-up|4|||
164670553|NCT01389102|594821229|FG005|Overall Study|Lost to Follow-up|1|||
164566461|NCT01686568|594443065|FG001|Sub-Study|Not consented for sub-study|2|||
164566462|NCT02601573|594443068|FG000|Overall Study|Lost to Follow-up|0|||
164566463|NCT02601573|594443069|FG001|Overall Study|Lost to Follow-up|3|||
164566464|NCT02601573|594443070|FG002|Overall Study|Lost to Follow-up|1|||
164566465|NCT02601573|594443071|FG003|Overall Study|Lost to Follow-up|0|||
164566466|NCT02601573|594443072|FG004|Overall Study|Lost to Follow-up|2|||
164566467|NCT02601573|594443068|FG000|Overall Study|Withdrawal by Subject|0|||
164566468|NCT02601573|594443069|FG001|Overall Study|Withdrawal by Subject|1|||
164566469|NCT02601573|594443070|FG002|Overall Study|Withdrawal by Subject|0|||
164566470|NCT02601573|594443071|FG003|Overall Study|Withdrawal by Subject|1|||
164566471|NCT02601573|594443072|FG004|Overall Study|Withdrawal by Subject|0|||
164566472|NCT00974220|594443073|FG000|Treatment Period 1|Adverse Event|2|||
164566473|NCT00974220|594443074|FG001|Treatment Period 1|Adverse Event|1|||
164566474|NCT00974220|594443073|FG000|Treatment Period 1|noncompliant subjects|0|||
164566475|NCT00974220|594443074|FG001|Treatment Period 1|noncompliant subjects|1|||
164566476|NCT01850615|594443075|FG000|Overall Study|Protocol Violation|4|||
164566477|NCT01850615|594443076|FG001|Overall Study|Protocol Violation|1|||
164566478|NCT01850615|594443075|FG000|Overall Study|Adverse Event|2|||
164566479|NCT01850615|594443076|FG001|Overall Study|Adverse Event|1|||
164566480|NCT01850615|594443075|FG000|Overall Study|Withdrawal by Subject|3|||
164566481|NCT01850615|594443076|FG001|Overall Study|Withdrawal by Subject|1|||
164566482|NCT01850615|594443075|FG000|Overall Study|Lost to Follow-up|0|||
164566483|NCT01850615|594443076|FG001|Overall Study|Lost to Follow-up|1|||
164566484|NCT01850615|594443075|FG000|Overall Study|Unclassified|0|||
164566485|NCT01850615|594443076|FG001|Overall Study|Unclassified|1|||
164566486|NCT00706628|594443077|FG000|Overall Study|Other Adverse Event|16|||
164566487|NCT00706628|594443078|FG001|Overall Study|Other Adverse Event|5|||
164566488|NCT00706628|594443079|FG002|Overall Study|Other Adverse Event|5|||
164566489|NCT00706628|594443080|FG003|Overall Study|Other Adverse Event|2|||
164566490|NCT00706628|594443077|FG000|Overall Study|Non compliant with protocol|0|||
164566491|NCT00706628|594443078|FG001|Overall Study|Non compliant with protocol|1|||
164566492|NCT00706628|594443079|FG002|Overall Study|Non compliant with protocol|0|||
164566493|NCT00706628|594443080|FG003|Overall Study|Non compliant with protocol|0|||
164566494|NCT00706628|594443077|FG000|Overall Study|Consent withdrawn|6|||
164566495|NCT00706628|594443078|FG001|Overall Study|Consent withdrawn|1|||
164566496|NCT00706628|594443079|FG002|Overall Study|Consent withdrawn|3|||
164566497|NCT00706628|594443080|FG003|Overall Study|Consent withdrawn|0|||
164566498|NCT00706628|594443077|FG000|Overall Study|Progressive disease|20|||
164566499|NCT00706628|594443078|FG001|Overall Study|Progressive disease|13|||
164566500|NCT00706628|594443079|FG002|Overall Study|Progressive disease|8|||
164566501|NCT00706628|594443080|FG003|Overall Study|Progressive disease|1|||
164566502|NCT00706628|594443077|FG000|Overall Study|Other than those stated above|4|||
164566503|NCT00706628|594443078|FG001|Overall Study|Other than those stated above|0|||
164566504|NCT00706628|594443079|FG002|Overall Study|Other than those stated above|0|||
164566505|NCT00706628|594443080|FG003|Overall Study|Other than those stated above|0|||
164566506|NCT00706628|594443077|FG000|Overall Study|Not treated|1|||
164566507|NCT00706628|594443078|FG001|Overall Study|Not treated|1|||
164566508|NCT00706628|594443079|FG002|Overall Study|Not treated|0|||
164670554|NCT01389102|594821224|FG000|Overall Study|Protocol Violation|0|||
164566509|NCT00706628|594443080|FG003|Overall Study|Not treated|0|||
164566510|NCT02921425|594443082|FG000|Overall Study|Protocol Violation|9|||
164566511|NCT01227967|594443083|FG000|Overall Study|Protocol Violation|3|||
164566512|NCT01227967|594443084|FG001|Overall Study|Protocol Violation|1|||
164566513|NCT01227967|594443083|FG000|Overall Study|Death|0|||
164566514|NCT01227967|594443084|FG001|Overall Study|Death|1|||
164566515|NCT01227967|594443083|FG000|Overall Study|Lost to Follow-up|8|||
164566516|NCT01227967|594443084|FG001|Overall Study|Lost to Follow-up|3|||
164566517|NCT01227967|594443083|FG000|Overall Study|Withdrawal by Subject|4|||
164566518|NCT01227967|594443084|FG001|Overall Study|Withdrawal by Subject|3|||
164566519|NCT01227967|594443083|FG000|Overall Study|Physician Decision|0|||
164566520|NCT01227967|594443084|FG001|Overall Study|Physician Decision|1|||
164566521|NCT01227967|594443083|FG000|Overall Study|Never Started Treatment|0|||
164566522|NCT01227967|594443084|FG001|Overall Study|Never Started Treatment|4|||
164566523|NCT01227967|594443083|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
164670555|NCT01389102|594821225|FG001|Overall Study|Protocol Violation|0|||
164566524|NCT01227967|594443084|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
164566525|NCT03403400|594443085|FG000|Overall Study|Lost to Follow-up|1|||
164566526|NCT03403400|594443086|FG001|Overall Study|Lost to Follow-up|0|||
164566527|NCT03403400|594443087|FG002|Overall Study|Lost to Follow-up|1|||
164566528|NCT03403400|594443085|FG000|Overall Study|Hospitalization|1|||
164566529|NCT03403400|594443086|FG001|Overall Study|Hospitalization|0|||
164566530|NCT03403400|594443087|FG002|Overall Study|Hospitalization|0|||
164566531|NCT03403400|594443085|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
164566532|NCT03403400|594443086|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
164566533|NCT03403400|594443087|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
164566534|NCT01948830|594443091|FG000|Overall Study|Physician Decision|1|||
164566535|NCT01948830|594443092|FG001|Overall Study|Physician Decision|3|||
164566536|NCT01948830|594443091|FG000|Overall Study|Protocol deviation|1|||
164566537|NCT01948830|594443092|FG001|Overall Study|Protocol deviation|2|||
164566538|NCT01948830|594443091|FG000|Overall Study|Lost to Follow-up|5|||
164566539|NCT01948830|594443092|FG001|Overall Study|Lost to Follow-up|4|||
164566540|NCT01948830|594443091|FG000|Overall Study|Withdrawal by Subject|14|||
164566541|NCT01948830|594443092|FG001|Overall Study|Withdrawal by Subject|17|||
164566542|NCT01948830|594443091|FG000|Overall Study|Adverse Event|9|||
164566543|NCT01948830|594443092|FG001|Overall Study|Adverse Event|2|||
164566544|NCT01948830|594443091|FG000|Overall Study|Death|3|||
164566545|NCT01948830|594443092|FG001|Overall Study|Death|4|||
164566546|NCT02526550|594443093|FG000|Overall Study|Lost to Follow-up|1|||
164566547|NCT00091832|594443096|FG000|Overall Study|Physician Decision|1|||
164566548|NCT00091832|594443097|FG001|Overall Study|Physician Decision|0|||
164566549|NCT00091832|594443098|FG002|Overall Study|Physician Decision|0|||
164566550|NCT00091832|594443099|FG003|Overall Study|Physician Decision|0|||
164566551|NCT00091832|594443100|FG004|Overall Study|Physician Decision|0|||
164566552|NCT00091832|594443101|FG005|Overall Study|Physician Decision|0|||
164566553|NCT00091832|594443096|FG000|Overall Study|Adverse Event|0|||
164566554|NCT00091832|594443097|FG001|Overall Study|Adverse Event|0|||
164566555|NCT00091832|594443098|FG002|Overall Study|Adverse Event|0|||
164566556|NCT00091832|594443099|FG003|Overall Study|Adverse Event|1|||
164566557|NCT00091832|594443100|FG004|Overall Study|Adverse Event|3|||
164566558|NCT00091832|594443101|FG005|Overall Study|Adverse Event|0|||
164566559|NCT00091832|594443096|FG000|Overall Study|Withdrawal by Subject|4|||
164566560|NCT00091832|594443097|FG001|Overall Study|Withdrawal by Subject|5|||
164566561|NCT00091832|594443098|FG002|Overall Study|Withdrawal by Subject|0|||
164566562|NCT00091832|594443099|FG003|Overall Study|Withdrawal by Subject|1|||
164566563|NCT00091832|594443100|FG004|Overall Study|Withdrawal by Subject|3|||
164566564|NCT00091832|594443101|FG005|Overall Study|Withdrawal by Subject|1|||
164566565|NCT00091832|594443096|FG000|Overall Study|Death|6|||
164566566|NCT00091832|594443097|FG001|Overall Study|Death|4|||
164566567|NCT00091832|594443098|FG002|Overall Study|Death|5|||
164566568|NCT00091832|594443099|FG003|Overall Study|Death|8|||
164566569|NCT00091832|594443100|FG004|Overall Study|Death|5|||
164566570|NCT00091832|594443101|FG005|Overall Study|Death|6|||
164566571|NCT00091832|594443096|FG000|Overall Study|Disease Progression|2|||
164566572|NCT00091832|594443097|FG001|Overall Study|Disease Progression|0|||
164566573|NCT00091832|594443098|FG002|Overall Study|Disease Progression|0|||
164566574|NCT00091832|594443099|FG003|Overall Study|Disease Progression|1|||
164566575|NCT00091832|594443100|FG004|Overall Study|Disease Progression|1|||
164566576|NCT00091832|594443101|FG005|Overall Study|Disease Progression|2|||
164566577|NCT00091832|594443096|FG000|Overall Study|Ineligibility Determined|0|||
164566578|NCT00091832|594443097|FG001|Overall Study|Ineligibility Determined|0|||
164566579|NCT00091832|594443098|FG002|Overall Study|Ineligibility Determined|1|||
164566580|NCT00091832|594443099|FG003|Overall Study|Ineligibility Determined|0|||
164566581|NCT00091832|594443100|FG004|Overall Study|Ineligibility Determined|1|||
164566582|NCT00091832|594443101|FG005|Overall Study|Ineligibility Determined|0|||
164566583|NCT00091832|594443096|FG000|Overall Study|Lost to Follow-up|1|||
164566584|NCT00091832|594443097|FG001|Overall Study|Lost to Follow-up|0|||
164670556|NCT01389102|594821226|FG002|Overall Study|Protocol Violation|3|||
164670557|NCT01389102|594821227|FG003|Overall Study|Protocol Violation|0|||
164670558|NCT01389102|594821228|FG004|Overall Study|Protocol Violation|1|||
164670559|NCT01389102|594821229|FG005|Overall Study|Protocol Violation|1|||
164566585|NCT00091832|594443098|FG002|Overall Study|Lost to Follow-up|3|||
164566586|NCT00091832|594443099|FG003|Overall Study|Lost to Follow-up|3|||
164566587|NCT00091832|594443100|FG004|Overall Study|Lost to Follow-up|2|||
164566588|NCT00091832|594443101|FG005|Overall Study|Lost to Follow-up|1|||
164566589|NCT00091832|594443096|FG000|Overall Study|Noncompliance|0|||
164566590|NCT00091832|594443097|FG001|Overall Study|Noncompliance|1|||
164566591|NCT00091832|594443098|FG002|Overall Study|Noncompliance|0|||
164566592|NCT00091832|594443099|FG003|Overall Study|Noncompliance|0|||
164566593|NCT00091832|594443100|FG004|Overall Study|Noncompliance|0|||
164566594|NCT00091832|594443101|FG005|Overall Study|Noncompliance|0|||
164566595|NCT00091832|594443096|FG000|Overall Study|Other|0|||
164566596|NCT00091832|594443097|FG001|Overall Study|Other|1|||
164566597|NCT00091832|594443098|FG002|Overall Study|Other|2|||
164566598|NCT00091832|594443099|FG003|Overall Study|Other|0|||
164566599|NCT00091832|594443100|FG004|Overall Study|Other|0|||
164218820|NCT00086307|593168481|FG001|Overall Study|Lack of Efficacy|1|||
164218821|NCT00086307|593168482|FG002|Overall Study|Lack of Efficacy|2|||
164218822|NCT00086307|593168480|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
164566600|NCT00091832|594443101|FG005|Overall Study|Other|0|||
164566601|NCT00091832|594443096|FG000|Overall Study|Protocol Violation|0|||
164566602|NCT00091832|594443097|FG001|Overall Study|Protocol Violation|0|||
164566603|NCT00091832|594443098|FG002|Overall Study|Protocol Violation|1|||
164566604|NCT00091832|594443099|FG003|Overall Study|Protocol Violation|0|||
164566605|NCT00091832|594443100|FG004|Overall Study|Protocol Violation|0|||
164566606|NCT00091832|594443101|FG005|Overall Study|Protocol Violation|1|||
164566607|NCT01446419|594443104|FG000|Overall Study|Death|1|||
164566608|NCT01446419|594443105|FG001|Overall Study|Death|0|||
164566609|NCT01446419|594443104|FG000|Overall Study|Withdrawal by Subject|1|||
164566610|NCT01446419|594443105|FG001|Overall Study|Withdrawal by Subject|1|||
164566611|NCT01446419|594443104|FG000|Overall Study|Terminated per protocol|3|||
164566612|NCT01446419|594443105|FG001|Overall Study|Terminated per protocol|0|||
164566613|NCT01557166|594443106|FG000|Overall Study|Adverse Event|20|||
164566614|NCT01557166|594443107|FG001|Overall Study|Adverse Event|6|||
164566615|NCT01557166|594443106|FG000|Overall Study|Lack of Efficacy|2|||
164566616|NCT01557166|594443107|FG001|Overall Study|Lack of Efficacy|1|||
164566617|NCT01557166|594443106|FG000|Overall Study|Protocol Violation|8|||
164566618|NCT01557166|594443107|FG001|Overall Study|Protocol Violation|5|||
164566619|NCT01557166|594443106|FG000|Overall Study|Withdrawn consent|12|||
164566620|NCT01557166|594443107|FG001|Overall Study|Withdrawn consent|20|||
164566621|NCT01557166|594443106|FG000|Overall Study|Target dose not tolerated|1|||
164566622|NCT01557166|594443107|FG001|Overall Study|Target dose not tolerated|0|||
164566623|NCT01557166|594443106|FG000|Overall Study|Psychiatric disorder|1|||
164566624|NCT01557166|594443107|FG001|Overall Study|Psychiatric disorder|0|||
164566625|NCT01557166|594443106|FG000|Overall Study|Unclassified|2|||
164566626|NCT01557166|594443107|FG001|Overall Study|Unclassified|5|||
164566627|NCT00946309|594443108|FG000|Overall Study|Protocol Violation|1|||
164566628|NCT00946309|594443109|FG001|Overall Study|Protocol Violation|0|||
164566629|NCT00946309|594443108|FG000|Overall Study|Lost to Follow-up|0|||
164566630|NCT00946309|594443109|FG001|Overall Study|Lost to Follow-up|1|||
164566631|NCT00946309|594443108|FG000|Overall Study|Procedure cancelled/discontinued|0|||
164566632|NCT00946309|594443109|FG001|Overall Study|Procedure cancelled/discontinued|3|||
164566633|NCT01465659|594443110|FG000|Completed 1 Cycle of Treatment|Death|0|||
164566634|NCT01465659|594443111|FG001|Completed 1 Cycle of Treatment|Death|1|||
164566635|NCT01465659|594443112|FG002|Completed 1 Cycle of Treatment|Death|0|||
164566636|NCT01465659|594443113|FG003|Completed 1 Cycle of Treatment|Death|0|||
164566637|NCT01465659|594443110|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
164566638|NCT01465659|594443111|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
164566639|NCT01465659|594443112|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
164566640|NCT01465659|594443113|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
164566641|NCT01465659|594443110|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
164566642|NCT01465659|594443111|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
164566643|NCT01465659|594443112|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
164566644|NCT01465659|594443113|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
164566645|NCT01465659|594443110|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
164566646|NCT01465659|594443111|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
164566647|NCT01465659|594443112|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
164566648|NCT01465659|594443113|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
164566649|NCT01465659|594443110|FG000|Completed Follow for 1 Year|Death|6|||
164566650|NCT01465659|594443111|FG001|Completed Follow for 1 Year|Death|3|||
164566651|NCT01465659|594443112|FG002|Completed Follow for 1 Year|Death|2|||
164566652|NCT01465659|594443113|FG003|Completed Follow for 1 Year|Death|4|||
164566653|NCT03434379|594443114|FG000|Global Period|Lost to Follow-up|3|||
164566654|NCT03434379|594443115|FG001|Global Period|Lost to Follow-up|6|||
164566655|NCT03434379|594443116|FG002|Global Period|Lost to Follow-up|0|||
164566656|NCT03434379|594443117|FG003|Global Period|Lost to Follow-up|0|||
164566657|NCT03434379|594443114|FG000|Global Period|Death|115|||
164566658|NCT03434379|594443115|FG001|Global Period|Death|228|||
164566659|NCT03434379|594443116|FG002|Global Period|Death|0|||
164566660|NCT03434379|594443117|FG003|Global Period|Death|0|||
164566661|NCT03434379|594443114|FG000|Global Period|Withdrawal by Subject|20|||
164566662|NCT03434379|594443115|FG001|Global Period|Withdrawal by Subject|21|||
164566663|NCT03434379|594443116|FG002|Global Period|Withdrawal by Subject|0|||
164566664|NCT03434379|594443117|FG003|Global Period|Withdrawal by Subject|0|||
164566665|NCT03434379|594443114|FG000|Global Period|Reason Unspecified|0|||
164566666|NCT03434379|594443115|FG001|Global Period|Reason Unspecified|1|||
164566667|NCT03434379|594443116|FG002|Global Period|Reason Unspecified|0|||
164566668|NCT03434379|594443117|FG003|Global Period|Reason Unspecified|0|||
164566669|NCT03434379|594443114|FG000|Global Period|Study Ended by Sponsor|26|||
164566670|NCT03434379|594443115|FG001|Global Period|Study Ended by Sponsor|80|||
164566671|NCT03434379|594443116|FG002|Global Period|Study Ended by Sponsor|0|||
164566672|NCT03434379|594443117|FG003|Global Period|Study Ended by Sponsor|0|||
164670560|NCT01389102|594821224|FG000|Overall Study|Withdrawal by Subject|7|||
164670561|NCT01389102|594821225|FG001|Overall Study|Withdrawal by Subject|4|||
164670562|NCT01389102|594821226|FG002|Overall Study|Withdrawal by Subject|9|||
164670563|NCT01389102|594821227|FG003|Overall Study|Withdrawal by Subject|2|||
164670564|NCT01389102|594821228|FG004|Overall Study|Withdrawal by Subject|3|||
164670565|NCT01389102|594821229|FG005|Overall Study|Withdrawal by Subject|3|||
164670566|NCT01389102|594821224|FG000|Overall Study|Subject Traveling Out of Country|0|||
164670567|NCT01389102|594821225|FG001|Overall Study|Subject Traveling Out of Country|0|||
164670568|NCT01389102|594821226|FG002|Overall Study|Subject Traveling Out of Country|0|||
164218823|NCT00086307|593168481|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
164218824|NCT00086307|593168482|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
164218825|NCT00086307|593168480|FG000|Overall Study|Nausea and headaches|0|||
164218826|NCT00086307|593168481|FG001|Overall Study|Nausea and headaches|0|||
164218827|NCT00086307|593168482|FG002|Overall Study|Nausea and headaches|1|||
164670569|NCT01389102|594821227|FG003|Overall Study|Subject Traveling Out of Country|1|||
164670570|NCT01389102|594821228|FG004|Overall Study|Subject Traveling Out of Country|0|||
164670571|NCT01389102|594821229|FG005|Overall Study|Subject Traveling Out of Country|0|||
164670572|NCT01389102|594821224|FG000|Overall Study|Subject Moved|2|||
164670573|NCT01389102|594821225|FG001|Overall Study|Subject Moved|0|||
164670574|NCT01389102|594821226|FG002|Overall Study|Subject Moved|1|||
164670575|NCT01389102|594821227|FG003|Overall Study|Subject Moved|0|||
164670576|NCT01389102|594821228|FG004|Overall Study|Subject Moved|0|||
164670577|NCT01389102|594821229|FG005|Overall Study|Subject Moved|0|||
164670578|NCT01389102|594821224|FG000|Overall Study|Unavailable due to husband's illness|0|||
164670579|NCT01389102|594821225|FG001|Overall Study|Unavailable due to husband's illness|1|||
164670580|NCT01389102|594821226|FG002|Overall Study|Unavailable due to husband's illness|0|||
164670581|NCT01389102|594821227|FG003|Overall Study|Unavailable due to husband's illness|0|||
164670582|NCT01389102|594821228|FG004|Overall Study|Unavailable due to husband's illness|0|||
164670583|NCT01389102|594821229|FG005|Overall Study|Unavailable due to husband's illness|0|||
164670584|NCT01389102|594821224|FG000|Overall Study|Investigator Judgement|0|||
164328429|NCT00920829|593579484|FG002|Available for Analysis|Protocol Violation|1|||
164328430|NCT00920829|593579485|FG003|Available for Analysis|Protocol Violation|0|||
164328431|NCT00920829|593579482|FG000|Available for Analysis|Required more treatment|0|||
164328432|NCT00920829|593579483|FG001|Available for Analysis|Required more treatment|2|||
164328433|NCT00920829|593579484|FG002|Available for Analysis|Required more treatment|0|||
164328434|NCT00920829|593579485|FG003|Available for Analysis|Required more treatment|1|||
164328435|NCT03875118|593579486|FG000|Overall Study|Withdrawal by Subject|4|||
164328436|NCT03875118|593579487|FG001|Overall Study|Withdrawal by Subject|4|||
164328437|NCT02237911|593579488|FG000|Overall Study|Withdrawal by Subject|4|||
164670585|NCT01389102|594821225|FG001|Overall Study|Investigator Judgement|1|||
164670586|NCT01389102|594821226|FG002|Overall Study|Investigator Judgement|0|||
164670587|NCT01389102|594821227|FG003|Overall Study|Investigator Judgement|0|||
164670588|NCT01389102|594821228|FG004|Overall Study|Investigator Judgement|0|||
164670589|NCT01389102|594821229|FG005|Overall Study|Investigator Judgement|0|||
164670590|NCT00050778|594821230|FG000|Overall Study|Adverse Event|13|||
164670591|NCT00050778|594821231|FG001|Overall Study|Adverse Event|3|||
164670592|NCT00050778|594821232|FG002|Overall Study|Adverse Event|2|||
164670593|NCT00050778|594821230|FG000|Overall Study|Death|0|||
164670594|NCT00050778|594821231|FG001|Overall Study|Death|1|||
164670595|NCT00050778|594821232|FG002|Overall Study|Death|1|||
164670596|NCT00050778|594821230|FG000|Overall Study|Lack of Efficacy|16|||
164670597|NCT00050778|594821231|FG001|Overall Study|Lack of Efficacy|2|||
164670598|NCT00050778|594821232|FG002|Overall Study|Lack of Efficacy|2|||
164670599|NCT00050778|594821230|FG000|Overall Study|Lost to Follow-up|0|||
164670600|NCT00050778|594821231|FG001|Overall Study|Lost to Follow-up|2|||
164670601|NCT00050778|594821232|FG002|Overall Study|Lost to Follow-up|4|||
164670602|NCT00050778|594821230|FG000|Overall Study|Physician Decision|3|||
164670603|NCT00050778|594821231|FG001|Overall Study|Physician Decision|0|||
164670604|NCT00050778|594821232|FG002|Overall Study|Physician Decision|2|||
164670605|NCT00050778|594821230|FG000|Overall Study|Protocol Violation|2|||
164670606|NCT00050778|594821231|FG001|Overall Study|Protocol Violation|0|||
164670607|NCT00050778|594821232|FG002|Overall Study|Protocol Violation|1|||
164670608|NCT00050778|594821230|FG000|Overall Study|Withdrawal by Subject|6|||
164670609|NCT00050778|594821231|FG001|Overall Study|Withdrawal by Subject|8|||
164670610|NCT00050778|594821232|FG002|Overall Study|Withdrawal by Subject|4|||
164670611|NCT00050778|594821230|FG000|Overall Study|Randomized but not treated|4|||
164670612|NCT00050778|594821231|FG001|Overall Study|Randomized but not treated|5|||
164670613|NCT00050778|594821232|FG002|Overall Study|Randomized but not treated|2|||
164670614|NCT00050778|594821230|FG000|Overall Study|Familial and personal reasons|1|||
164670615|NCT00050778|594821231|FG001|Overall Study|Familial and personal reasons|0|||
164670616|NCT00050778|594821232|FG002|Overall Study|Familial and personal reasons|0|||
164670617|NCT01035060|594821233|FG000|Overall Study|Lost to Follow-up|0|||
164670618|NCT01035060|594821234|FG001|Overall Study|Lost to Follow-up|7|||
164670619|NCT01035060|594821233|FG000|Overall Study|Did not quality after 2nd screening|14|||
164670620|NCT01035060|594821234|FG001|Overall Study|Did not quality after 2nd screening|1|||
164670621|NCT01035060|594821233|FG000|Overall Study|Withdrawal by Subject|8|||
164670622|NCT01035060|594821234|FG001|Overall Study|Withdrawal by Subject|6|||
164670623|NCT01035060|594821233|FG000|Overall Study|Physician Decision|2|||
164670624|NCT01035060|594821234|FG001|Overall Study|Physician Decision|0|||
164328438|NCT02237911|593579489|FG001|Overall Study|Withdrawal by Subject|7|||
164670625|NCT00625443|594821236|FG000|Overall Study|Adverse Event|1|||
164670626|NCT00625443|594821237|FG001|Overall Study|Adverse Event|4|||
164670627|NCT00625443|594821238|FG002|Overall Study|Adverse Event|0|||
164670628|NCT00625443|594821236|FG000|Overall Study|Non-compliance with protocol|0|||
164670629|NCT00625443|594821237|FG001|Overall Study|Non-compliance with protocol|1|||
164670630|NCT00625443|594821238|FG002|Overall Study|Non-compliance with protocol|0|||
164670631|NCT00625443|594821236|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
164566673|NCT03434379|594443114|FG000|Global Period|Physician Decision|1|||
164566674|NCT03434379|594443115|FG001|Global Period|Physician Decision|0|||
164566675|NCT03434379|594443116|FG002|Global Period|Physician Decision|0|||
164566676|NCT03434379|594443117|FG003|Global Period|Physician Decision|0|||
164566677|NCT03434379|594443114|FG000|China Extension Period|Lost to Follow-up|0|||
164566678|NCT03434379|594443115|FG001|China Extension Period|Lost to Follow-up|0|||
164566679|NCT03434379|594443116|FG002|China Extension Period|Lost to Follow-up|2|||
164566680|NCT03434379|594443117|FG003|China Extension Period|Lost to Follow-up|3|||
164566681|NCT03434379|594443114|FG000|China Extension Period|Death|0|||
164566682|NCT03434379|594443115|FG001|China Extension Period|Death|0|||
164566683|NCT03434379|594443116|FG002|China Extension Period|Death|46|||
164566684|NCT03434379|594443117|FG003|China Extension Period|Death|88|||
164566685|NCT03434379|594443114|FG000|China Extension Period|Withdrawal by Subject|0|||
164566686|NCT03434379|594443115|FG001|China Extension Period|Withdrawal by Subject|0|||
164566687|NCT03434379|594443116|FG002|China Extension Period|Withdrawal by Subject|8|||
164566688|NCT03434379|594443117|FG003|China Extension Period|Withdrawal by Subject|6|||
164566689|NCT03434379|594443114|FG000|China Extension Period|Study Ended by Sponsor|0|||
164566690|NCT03434379|594443115|FG001|China Extension Period|Study Ended by Sponsor|0|||
164566691|NCT03434379|594443116|FG002|China Extension Period|Study Ended by Sponsor|5|||
164566692|NCT03434379|594443117|FG003|China Extension Period|Study Ended by Sponsor|36|||
164566693|NCT02411747|594443118|FG000|Overall Study|Withdrawal by Subject|1|||
164566694|NCT02411747|594443119|FG001|Overall Study|Withdrawal by Subject|0|||
164566695|NCT02411747|594443118|FG000|Overall Study|Protocol Violation|2|||
164566696|NCT02411747|594443119|FG001|Overall Study|Protocol Violation|4|||
164566697|NCT02149810|594443120|FG000|Overall Study|Physician Decision|1|||
164566698|NCT02149810|594443121|FG001|Overall Study|Physician Decision|2|||
164566699|NCT02149810|594443120|FG000|Overall Study|Lost to Follow-up|2|||
164566700|NCT02149810|594443121|FG001|Overall Study|Lost to Follow-up|1|||
164566701|NCT02149810|594443120|FG000|Overall Study|Withdrawal by Subject|5|||
164566702|NCT02149810|594443121|FG001|Overall Study|Withdrawal by Subject|1|||
164566703|NCT00428597|594443122|FG000|Overall Study|Randomized but not treated|3|||
164566704|NCT00428597|594443123|FG001|Overall Study|Randomized but not treated|3|||
164566705|NCT00428597|594443122|FG000|Overall Study|Objective Progression or Relapse|19|||
164566706|NCT00428597|594443123|FG001|Overall Study|Objective Progression or Relapse|47|||
164566707|NCT00428597|594443122|FG000|Overall Study|Study Terminated by Sponsor|41|||
164566708|NCT00428597|594443123|FG001|Overall Study|Study Terminated by Sponsor|16|||
164566709|NCT00428597|594443122|FG000|Overall Study|Adverse Event|15|||
164566710|NCT00428597|594443123|FG001|Overall Study|Adverse Event|7|||
164566711|NCT00428597|594443122|FG000|Overall Study|Global Deterioration of Health Status|1|||
164566712|NCT00428597|594443123|FG001|Overall Study|Global Deterioration of Health Status|5|||
164566713|NCT00428597|594443122|FG000|Overall Study|Protocol Violation|2|||
164566714|NCT00428597|594443123|FG001|Overall Study|Protocol Violation|1|||
164566715|NCT00428597|594443122|FG000|Overall Study|Withdrawal by Subject|2|||
164566716|NCT00428597|594443123|FG001|Overall Study|Withdrawal by Subject|1|||
164566717|NCT00428597|594443122|FG000|Overall Study|Other|1|||
164566718|NCT00428597|594443123|FG001|Overall Study|Other|1|||
164566719|NCT00428597|594443122|FG000|Overall Study|Lost to Follow-up|0|||
164566720|NCT00428597|594443123|FG001|Overall Study|Lost to Follow-up|1|||
164566721|NCT00428597|594443122|FG000|Overall Study|Pregnancy|1|||
164566722|NCT00428597|594443123|FG001|Overall Study|Pregnancy|0|||
164566723|NCT00428597|594443122|FG000|Overall Study|Death|1|||
164566724|NCT00428597|594443123|FG001|Overall Study|Death|3|||
164566725|NCT00675597|594443124|FG000|Overall Study|Withdrawal by Subject|3|||
164566726|NCT00560755|594443126|FG000|Overall Study|Protocol Violation|15|||
164566727|NCT00560755|594443126|FG000|Overall Study|Withdrawal by Subject|26|||
164566728|NCT00560755|594443126|FG000|Overall Study|Lost to Follow-up|9|||
164566729|NCT00560755|594443126|FG000|Overall Study|Adverse Event|8|||
164566730|NCT00560755|594443126|FG000|Overall Study|Physician Decision|2|||
164566731|NCT03828487|594443129|FG000|Overall Study|Physician Decision|1|||
164566732|NCT03179436|594443134|FG000|Overall Study|Withdrawal by Subject|1|||
164566733|NCT03179436|594443135|FG001|Overall Study|Withdrawal by Subject|0|||
164566734|NCT03179436|594443136|FG002|Overall Study|Withdrawal by Subject|0|||
164566735|NCT03179436|594443137|FG003|Overall Study|Withdrawal by Subject|4|||
164566736|NCT03179436|594443138|FG004|Overall Study|Withdrawal by Subject|2|||
164566737|NCT03179436|594443139|FG005|Overall Study|Withdrawal by Subject|2|||
164566738|NCT03179436|594443140|FG006|Overall Study|Withdrawal by Subject|5|||
164566739|NCT03179436|594443141|FG007|Overall Study|Withdrawal by Subject|0|||
164566740|NCT03179436|594443142|FG008|Overall Study|Withdrawal by Subject|3|||
164566741|NCT03179436|594443143|FG009|Overall Study|Withdrawal by Subject|0|||
164566742|NCT03179436|594443144|FG010|Overall Study|Withdrawal by Subject|0|||
164566743|NCT03179436|594443145|FG011|Overall Study|Withdrawal by Subject|0|||
164566744|NCT03179436|594443134|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164566745|NCT03179436|594443135|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164566746|NCT03179436|594443136|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
164566747|NCT03179436|594443137|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
164566748|NCT03179436|594443138|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
164670632|NCT00625443|594821237|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
164670633|NCT00625443|594821238|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
164670634|NCT00625443|594821236|FG000|Overall Study|Withdrawal by Subject|0|||
164670635|NCT00625443|594821237|FG001|Overall Study|Withdrawal by Subject|1|||
164670636|NCT00625443|594821238|FG002|Overall Study|Withdrawal by Subject|2|||
164670637|NCT00625443|594821236|FG000|Overall Study|Physician Decision|0|||
164670638|NCT00625443|594821237|FG001|Overall Study|Physician Decision|4|||
164670639|NCT00625443|594821238|FG002|Overall Study|Physician Decision|2|||
164670640|NCT00625443|594821236|FG000|Overall Study|Other|0|||
164670641|NCT00625443|594821237|FG001|Overall Study|Other|1|||
164670642|NCT00625443|594821238|FG002|Overall Study|Other|1|||
164670643|NCT02015390|594821239|FG000|Overall Study|Lost to Follow-up|1|||
164670644|NCT02015390|594821240|FG001|Overall Study|Lost to Follow-up|0|||
164670645|NCT02015390|594821239|FG000|Overall Study|Adverse Event|0|||
164670646|NCT02015390|594821240|FG001|Overall Study|Adverse Event|3|||
164670647|NCT02015390|594821239|FG000|Overall Study|Physician Decision|0|||
164670648|NCT02015390|594821240|FG001|Overall Study|Physician Decision|1|||
164670649|NCT03136380|594821241|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
164670650|NCT03136380|594821242|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
164670651|NCT03136380|594821243|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
164670652|NCT03136380|594821244|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
164670653|NCT03136380|594821245|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
164670654|NCT01661686|594821246|FG000|Overall Study|Lost to Follow-up|2|||
164670655|NCT01661686|594821247|FG001|Overall Study|Lost to Follow-up|1|||
164670656|NCT01661686|594821246|FG000|Overall Study|did not receive allocated intervention|0|||
164670657|NCT01661686|594821247|FG001|Overall Study|did not receive allocated intervention|1|||
164670658|NCT01720264|594821254|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
164670659|NCT01720264|594821254|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
164670660|NCT01720264|594821254|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
164670661|NCT02728102|594821255|FG000|Overall Study|Death|3|||
164670662|NCT02728102|594821256|FG001|Overall Study|Death|0|||
164670663|NCT02728102|594821257|FG002|Overall Study|Death|1|||
164670664|NCT02728102|594821255|FG000|Overall Study|Withdrawal by Subject|0|||
164670665|NCT02728102|594821256|FG001|Overall Study|Withdrawal by Subject|2|||
164670666|NCT02728102|594821257|FG002|Overall Study|Withdrawal by Subject|3|||
164670667|NCT02728102|594821255|FG000|Overall Study|Physician Decision|1|||
164670668|NCT02728102|594821256|FG001|Overall Study|Physician Decision|1|||
164670669|NCT02728102|594821257|FG002|Overall Study|Physician Decision|0|||
164670670|NCT02728102|594821255|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
164670671|NCT02728102|594821256|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
164670672|NCT02728102|594821257|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
164670673|NCT02728102|594821255|FG000|Overall Study|Covid|0|||
164670674|NCT02728102|594821256|FG001|Overall Study|Covid|0|||
164670675|NCT02728102|594821257|FG002|Overall Study|Covid|1|||
164670676|NCT04869787|594821258|FG000|Screening|Physician Decision|1|||
164670677|NCT04869787|594821258|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
164670678|NCT00553280|594821260|FG000|Overall Study|Adverse Event|19|||
164670679|NCT00553280|594821260|FG000|Overall Study|Lack of Efficacy|3|||
164670680|NCT00553280|594821260|FG000|Overall Study|Withdrawal by Subject|3|||
164670681|NCT00553280|594821260|FG000|Overall Study|Physician Decision|1|||
164670682|NCT01544127|594821261|FG000|Overall Study|Lost to Follow-up|4|||
164670683|NCT01544127|594821262|FG001|Overall Study|Lost to Follow-up|2|||
164670684|NCT01544127|594821263|FG002|Overall Study|Lost to Follow-up|9|||
164670685|NCT01544127|594821261|FG000|Overall Study|Withdrawal by Subject|2|||
164670686|NCT01544127|594821262|FG001|Overall Study|Withdrawal by Subject|2|||
164670687|NCT01544127|594821263|FG002|Overall Study|Withdrawal by Subject|1|||
164670688|NCT01544127|594821261|FG000|Overall Study|Discharged out of catchment area|1|||
164670689|NCT01544127|594821262|FG001|Overall Study|Discharged out of catchment area|1|||
164670690|NCT01544127|594821263|FG002|Overall Study|Discharged out of catchment area|1|||
164670691|NCT01544127|594821261|FG000|Overall Study|Death|1|||
164670692|NCT01544127|594821262|FG001|Overall Study|Death|0|||
164670693|NCT01544127|594821263|FG002|Overall Study|Death|0|||
164670694|NCT01544127|594821261|FG000|Overall Study|Jail or Prison|1|||
164670695|NCT01544127|594821262|FG001|Overall Study|Jail or Prison|1|||
164670696|NCT01544127|594821263|FG002|Overall Study|Jail or Prison|2|||
164670697|NCT01544127|594821261|FG000|Overall Study|Became Psychotic|1|||
164670698|NCT01544127|594821262|FG001|Overall Study|Became Psychotic|0|||
164670699|NCT01544127|594821263|FG002|Overall Study|Became Psychotic|0|||
164670700|NCT01544127|594821261|FG000|Overall Study|Researcher withdrew|1|||
164670701|NCT01544127|594821262|FG001|Overall Study|Researcher withdrew|0|||
164670702|NCT01544127|594821263|FG002|Overall Study|Researcher withdrew|0|||
164670703|NCT01544127|594821261|FG000|Overall Study|Went active duty|0|||
164670704|NCT01544127|594821262|FG001|Overall Study|Went active duty|0|||
164670705|NCT01544127|594821263|FG002|Overall Study|Went active duty|1|||
164670706|NCT02996682|594821267|FG000|Overall Study|Death|0|||
164670707|NCT02996682|594821268|FG001|Overall Study|Death|3|||
164670708|NCT00696020|594821273|FG000|Overall Study|Adverse Event|3|||
164328439|NCT02237911|593579490|FG002|Overall Study|Withdrawal by Subject|2|||
164328440|NCT02237911|593579488|FG000|Overall Study|Lost to Follow-up|3|||
164328441|NCT02237911|593579489|FG001|Overall Study|Lost to Follow-up|1|||
164328442|NCT02237911|593579490|FG002|Overall Study|Lost to Follow-up|1|||
164328443|NCT00721123|593579491|FG000|Overall Study|Adverse Event|96|||
164328444|NCT00721123|593579491|FG000|Overall Study|Death|10|||
164328445|NCT00721123|593579491|FG000|Overall Study|Insufficient Therapeutic Response|21|||
164328446|NCT00721123|593579491|FG000|Overall Study|Protocol Violation|1|||
164328447|NCT00721123|593579491|FG000|Overall Study|Refused Treatment|41|||
164328448|NCT00721123|593579491|FG000|Overall Study|Failure to Return|9|||
164328449|NCT00721123|593579491|FG000|Overall Study|Withdrawal by Subject|5|||
164328450|NCT03468985|593579492|FG000|Overall Study|Adverse Event|0|||
164328451|NCT03468985|593579493|FG001|Overall Study|Adverse Event|2|||
164328452|NCT03468985|593579494|FG002|Overall Study|Adverse Event|0|||
164328453|NCT03468985|593579495|FG003|Overall Study|Adverse Event|0|||
164328454|NCT03468985|593579492|FG000|Overall Study|Withdrawal by Subject|0|||
164328455|NCT03468985|593579493|FG001|Overall Study|Withdrawal by Subject|0|||
164328456|NCT03468985|593579494|FG002|Overall Study|Withdrawal by Subject|0|||
164328457|NCT03468985|593579495|FG003|Overall Study|Withdrawal by Subject|1|||
164328458|NCT03981822|593579496|FG000|Overall Study|Lost to Follow-up|0|||
164328459|NCT03981822|593579497|FG001|Overall Study|Lost to Follow-up|1|||
164328460|NCT03981822|593579498|FG002|Overall Study|Lost to Follow-up|1|||
164328461|NCT03981822|593579499|FG003|Overall Study|Lost to Follow-up|0|||
164328462|NCT03981822|593579500|FG004|Overall Study|Lost to Follow-up|6|||
164328463|NCT03981822|593579501|FG005|Overall Study|Lost to Follow-up|4|||
164328464|NCT03981822|593579502|FG006|Overall Study|Lost to Follow-up|4|||
164328465|NCT03981822|593579503|FG007|Overall Study|Lost to Follow-up|2|||
164328466|NCT03981822|593579496|FG000|Overall Study|Withdrawal by Subject|0|||
164328467|NCT03981822|593579497|FG001|Overall Study|Withdrawal by Subject|1|||
164566749|NCT03179436|594443139|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
164566750|NCT03179436|594443140|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
164566751|NCT03179436|594443141|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
164566752|NCT03179436|594443142|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
164566753|NCT03179436|594443143|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
164566754|NCT03179436|594443144|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
164566755|NCT03179436|594443145|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
164566756|NCT03179436|594443134|FG000|Overall Study|Sponsor Decision|0|||
164566757|NCT03179436|594443135|FG001|Overall Study|Sponsor Decision|0|||
164566758|NCT03179436|594443136|FG002|Overall Study|Sponsor Decision|1|||
164566759|NCT03179436|594443137|FG003|Overall Study|Sponsor Decision|3|||
164566760|NCT03179436|594443138|FG004|Overall Study|Sponsor Decision|9|||
164566761|NCT03179436|594443139|FG005|Overall Study|Sponsor Decision|7|||
164566762|NCT03179436|594443140|FG006|Overall Study|Sponsor Decision|2|||
164566763|NCT03179436|594443141|FG007|Overall Study|Sponsor Decision|4|||
164566764|NCT03179436|594443142|FG008|Overall Study|Sponsor Decision|23|||
164566765|NCT03179436|594443143|FG009|Overall Study|Sponsor Decision|6|||
164566766|NCT03179436|594443144|FG010|Overall Study|Sponsor Decision|7|||
164566767|NCT03179436|594443145|FG011|Overall Study|Sponsor Decision|5|||
164566768|NCT03179436|594443134|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
164566769|NCT03179436|594443135|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
164566770|NCT03179436|594443136|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
164566771|NCT03179436|594443137|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
164566772|NCT03179436|594443138|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
164566773|NCT03179436|594443139|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
164566774|NCT03179436|594443140|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
164566775|NCT03179436|594443141|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
164566776|NCT03179436|594443142|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
164566777|NCT03179436|594443143|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
164566778|NCT03179436|594443144|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
164566779|NCT03179436|594443145|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
164566780|NCT03179436|594443134|FG000|Overall Study|Lost to Follow-up|1|||
164566781|NCT03179436|594443135|FG001|Overall Study|Lost to Follow-up|0|||
164566782|NCT03179436|594443136|FG002|Overall Study|Lost to Follow-up|0|||
164566783|NCT03179436|594443137|FG003|Overall Study|Lost to Follow-up|1|||
164566784|NCT03179436|594443138|FG004|Overall Study|Lost to Follow-up|0|||
164566785|NCT03179436|594443139|FG005|Overall Study|Lost to Follow-up|1|||
164566786|NCT03179436|594443140|FG006|Overall Study|Lost to Follow-up|0|||
164566787|NCT03179436|594443141|FG007|Overall Study|Lost to Follow-up|0|||
164328468|NCT03981822|593579498|FG002|Overall Study|Withdrawal by Subject|0|||
164328469|NCT03981822|593579499|FG003|Overall Study|Withdrawal by Subject|0|||
164328470|NCT03981822|593579500|FG004|Overall Study|Withdrawal by Subject|0|||
164328471|NCT03981822|593579501|FG005|Overall Study|Withdrawal by Subject|1|||
164328472|NCT03981822|593579502|FG006|Overall Study|Withdrawal by Subject|0|||
164328473|NCT03981822|593579503|FG007|Overall Study|Withdrawal by Subject|2|||
164328474|NCT03981822|593579496|FG000|Overall Study|COVID-19 Related|0|||
164328475|NCT03981822|593579497|FG001|Overall Study|COVID-19 Related|0|||
164328476|NCT03981822|593579498|FG002|Overall Study|COVID-19 Related|0|||
164328477|NCT03981822|593579499|FG003|Overall Study|COVID-19 Related|0|||
164328478|NCT03981822|593579500|FG004|Overall Study|COVID-19 Related|2|||
164328479|NCT03981822|593579501|FG005|Overall Study|COVID-19 Related|1|||
164328480|NCT03981822|593579502|FG006|Overall Study|COVID-19 Related|2|||
164328481|NCT03981822|593579503|FG007|Overall Study|COVID-19 Related|1|||
164328482|NCT04521777|593579505|FG000|Overall Study|Death|2|||
164328483|NCT04521777|593579505|FG000|Overall Study|Withdrawal by Subject|2|||
164328484|NCT01143207|593579509|FG000|Overall Study|Lost to Follow-up|2|||
164328485|NCT03416374|593579512|FG000|Between Treatment Period I and II|Other|0|||
164328486|NCT03416374|593579513|FG001|Between Treatment Period I and II|Other|9|||
164328487|NCT03416374|593579512|FG000|Treatment Period II|Lack of Efficacy|3|||
164328488|NCT03416374|593579513|FG001|Treatment Period II|Lack of Efficacy|11|||
164328489|NCT03416374|593579512|FG000|Treatment Period II|Adverse Event|1|||
164328490|NCT03416374|593579513|FG001|Treatment Period II|Adverse Event|4|||
164328491|NCT03416374|593579512|FG000|Treatment Period II|Death|0|||
164328492|NCT03416374|593579513|FG001|Treatment Period II|Death|1|||
164328493|NCT03416374|593579512|FG000|Treatment Period II|Other|0|||
164328494|NCT03416374|593579513|FG001|Treatment Period II|Other|2|||
164328495|NCT03463031|593579514|FG000|Overall Study|Withdrawal by Subject|4|||
164328496|NCT03463031|593579515|FG001|Overall Study|Withdrawal by Subject|2|||
164328497|NCT03463031|593579514|FG000|Overall Study|Investigator/Sponsor Decision|0|||
164328498|NCT03463031|593579515|FG001|Overall Study|Investigator/Sponsor Decision|1|||
164328499|NCT03463031|593579514|FG000|Overall Study|Lost to Follow-up|1|||
164328500|NCT03463031|593579515|FG001|Overall Study|Lost to Follow-up|1|||
164328501|NCT03463031|593579514|FG000|Overall Study|Adverse Event|4|||
164328502|NCT03463031|593579515|FG001|Overall Study|Adverse Event|1|||
164328503|NCT03463031|593579514|FG000|Overall Study|Use of prohibited medication by subject|1|||
164328504|NCT03463031|593579515|FG001|Overall Study|Use of prohibited medication by subject|0|||
164328505|NCT01241240|593579516|FG000|Overall Study|Adverse Event|5|||
164328506|NCT01241240|593579517|FG001|Overall Study|Adverse Event|4|||
164328507|NCT01241240|593579516|FG000|Overall Study|Lost to Follow-up|2|||
164328508|NCT01241240|593579517|FG001|Overall Study|Lost to Follow-up|4|||
164328509|NCT01241240|593579516|FG000|Overall Study|Personal Reasons|1|||
164328510|NCT01241240|593579517|FG001|Overall Study|Personal Reasons|1|||
164328511|NCT01025154|593579518|FG000|Overall Study|Lost to Follow-up|1|||
164328512|NCT01025154|593579518|FG000|Overall Study|Withdrawal by Subject|1|||
164328513|NCT02376829|593579525|FG000|Overall Study|Withdrawal by Subject|27|||
164328514|NCT02376829|593579526|FG001|Overall Study|Withdrawal by Subject|44|||
164328515|NCT00057954|593579527|FG000|Overall Study|Death|1|||
164328516|NCT00057954|593579527|FG000|Overall Study|Disease progression|1|||
164328517|NCT01251744|593579528|FG000|Overall Study|Lost to Follow-up|1|||
164328518|NCT01251744|593579529|FG001|Overall Study|Lost to Follow-up|0|||
164328519|NCT02147184|593579530|FG000|Overall Study|Lost to Follow-up|28|||
164328520|NCT02147184|593579531|FG001|Overall Study|Lost to Follow-up|15|||
164328521|NCT02147184|593579530|FG000|Overall Study|Study Burden|11|||
164566788|NCT03179436|594443142|FG008|Overall Study|Lost to Follow-up|1|||
164566789|NCT03179436|594443143|FG009|Overall Study|Lost to Follow-up|1|||
164566790|NCT03179436|594443144|FG010|Overall Study|Lost to Follow-up|0|||
164566791|NCT03179436|594443145|FG011|Overall Study|Lost to Follow-up|0|||
164566792|NCT03179436|594443134|FG000|Overall Study|Death|12|||
164566793|NCT03179436|594443135|FG001|Overall Study|Death|17|||
164566794|NCT03179436|594443136|FG002|Overall Study|Death|7|||
164566795|NCT03179436|594443137|FG003|Overall Study|Death|32|||
164566796|NCT03179436|594443138|FG004|Overall Study|Death|29|||
164566797|NCT03179436|594443139|FG005|Overall Study|Death|30|||
164566798|NCT03179436|594443140|FG006|Overall Study|Death|33|||
164566799|NCT03179436|594443141|FG007|Overall Study|Death|9|||
164566800|NCT03179436|594443142|FG008|Overall Study|Death|84|||
164566801|NCT03179436|594443143|FG009|Overall Study|Death|33|||
164566802|NCT03179436|594443144|FG010|Overall Study|Death|22|||
164566803|NCT03179436|594443145|FG011|Overall Study|Death|15|||
164566804|NCT02474329|594443146|FG000|Overall Study|Withdraw or did not contribute data.|13|||
164566805|NCT01356589|594443147|FG000|Overall Study|Enrolled, but not treated|3|||
164566806|NCT01356589|594443147|FG000|Overall Study|Dose data not recorded|2|||
164566807|NCT02447848|594443148|FG000|Overall Study|Patient discharged|3|||
164328522|NCT02147184|593579531|FG001|Overall Study|Study Burden|7|||
164328523|NCT02147184|593579530|FG000|Overall Study|Pregnancy|6|||
164328524|NCT02147184|593579531|FG001|Overall Study|Pregnancy|0|||
164328525|NCT02147184|593579530|FG000|Overall Study|Moved out of state|3|||
164328526|NCT02147184|593579531|FG001|Overall Study|Moved out of state|3|||
164328527|NCT02147184|593579530|FG000|Overall Study|Physician Decision|0|||
164566808|NCT02447848|594443148|FG000|Overall Study|Lack of Efficacy|4|||
164328528|NCT02147184|593579531|FG001|Overall Study|Physician Decision|2|||
164328529|NCT02147184|593579530|FG000|Overall Study|Other|1|||
164328530|NCT02147184|593579531|FG001|Overall Study|Other|0|||
164566809|NCT02447848|594443148|FG000|Overall Study|Withdrawal by Subject|4|||
164670709|NCT00696020|594821274|FG001|Overall Study|Adverse Event|1|||
164670710|NCT00696020|594821275|FG002|Overall Study|Adverse Event|2|||
164670711|NCT00696020|594821276|FG003|Overall Study|Adverse Event|1|||
164670712|NCT00696020|594821273|FG000|Overall Study|Lack of Efficacy|1|||
164670713|NCT00696020|594821274|FG001|Overall Study|Lack of Efficacy|0|||
164670714|NCT00696020|594821275|FG002|Overall Study|Lack of Efficacy|0|||
164670715|NCT00696020|594821276|FG003|Overall Study|Lack of Efficacy|0|||
164670716|NCT00696020|594821273|FG000|Overall Study|Protocol Violation|0|||
164670717|NCT00696020|594821274|FG001|Overall Study|Protocol Violation|0|||
164670718|NCT00696020|594821275|FG002|Overall Study|Protocol Violation|0|||
164670719|NCT00696020|594821276|FG003|Overall Study|Protocol Violation|1|||
164670720|NCT00696020|594821273|FG000|Overall Study|Withdrawal by Subject|0|||
164670721|NCT00696020|594821274|FG001|Overall Study|Withdrawal by Subject|1|||
164670722|NCT00696020|594821275|FG002|Overall Study|Withdrawal by Subject|0|||
164670723|NCT00696020|594821276|FG003|Overall Study|Withdrawal by Subject|1|||
164670724|NCT00696020|594821273|FG000|Overall Study|Other not stated above|0|||
164670725|NCT00696020|594821274|FG001|Overall Study|Other not stated above|0|||
164670726|NCT00696020|594821275|FG002|Overall Study|Other not stated above|1|||
164670727|NCT00696020|594821276|FG003|Overall Study|Other not stated above|1|||
164670728|NCT03687736|594821279|FG000|Overall Study|Lost to Follow-up|7|||
164670729|NCT03687736|594821279|FG000|Overall Study|Withdrawal by Subject|3|||
164670730|NCT02511782|594821280|FG000|Overall Study|Withdrawal by Subject|1|||
164670731|NCT02511782|594821281|FG001|Overall Study|Withdrawal by Subject|0|||
164670732|NCT02511782|594821282|FG002|Overall Study|Withdrawal by Subject|0|||
164670733|NCT01536574|594821283|FG000|Overall Study|Adverse Event|4|||
164670734|NCT01536574|594821284|FG001|Overall Study|Adverse Event|5|||
164670735|NCT01536574|594821283|FG000|Overall Study|Withdrawal by Subject|1|||
164670736|NCT01536574|594821284|FG001|Overall Study|Withdrawal by Subject|2|||
164670737|NCT01536574|594821283|FG000|Overall Study|Lack of Efficacy|1|||
164670738|NCT01536574|594821284|FG001|Overall Study|Lack of Efficacy|0|||
164670739|NCT02514122|594821285|FG000|Overall Study|Withdrawal by Subject|2|||
164670740|NCT02514122|594821286|FG001|Overall Study|Withdrawal by Subject|0|||
164670741|NCT01472341|594821290|FG000|Overall Study|Started insulin therapy|55|||
164670742|NCT01472341|594821290|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
164218828|NCT00086307|593168480|FG000|Overall Study|Constipation and sleepiness|0|||
164218829|NCT00086307|593168481|FG001|Overall Study|Constipation and sleepiness|0|||
164218830|NCT00086307|593168482|FG002|Overall Study|Constipation and sleepiness|1|||
164218831|NCT00086307|593168480|FG000|Overall Study|Suicidal ideation|0|||
164218832|NCT00086307|593168481|FG001|Overall Study|Suicidal ideation|0|||
164218833|NCT00086307|593168482|FG002|Overall Study|Suicidal ideation|1|||
164218834|NCT00086307|593168480|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
164218835|NCT00086307|593168481|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
164566810|NCT01097629|594445231|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
164566811|NCT01097629|594445232|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
164566812|NCT01097629|594445233|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
164566813|NCT01097629|594445234|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
164566814|NCT01097629|594445235|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
164566815|NCT01097629|594445236|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
164566816|NCT01097629|594445237|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
164566817|NCT01097629|594445238|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
164566818|NCT01097629|594445231|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
164566819|NCT01097629|594445232|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
164566820|NCT01097629|594445233|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
164566821|NCT01097629|594445234|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
164566822|NCT01097629|594445235|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
164566823|NCT01097629|594445236|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
164566824|NCT01097629|594445237|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
164566825|NCT01097629|594445238|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
164566826|NCT01097629|594445231|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
164566827|NCT01097629|594445232|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
164566828|NCT01097629|594445233|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
164566829|NCT01097629|594445234|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
164566830|NCT01097629|594445235|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
164566831|NCT01097629|594445236|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
164566832|NCT01097629|594445237|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
164566833|NCT01097629|594445238|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
164566834|NCT01097629|594445231|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
164566835|NCT01097629|594445232|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
164566836|NCT01097629|594445233|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
164566837|NCT01097629|594445234|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
164566838|NCT01097629|594445235|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
164566839|NCT01097629|594445236|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
164566840|NCT01097629|594445237|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
164566841|NCT01097629|594445238|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
164566842|NCT01097629|594445231|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
164566843|NCT01097629|594445232|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
164566844|NCT01097629|594445233|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
164566845|NCT01097629|594445234|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
164566846|NCT01097629|594445235|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
164566847|NCT01097629|594445236|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
164566848|NCT01097629|594445237|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
164566849|NCT01097629|594445238|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
164566850|NCT01097629|594445231|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
164566851|NCT01097629|594445232|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
164566852|NCT01097629|594445233|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
164566853|NCT01097629|594445234|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
164566854|NCT01097629|594445235|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
164566855|NCT01097629|594445236|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
164566856|NCT01097629|594445237|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
164566857|NCT01097629|594445238|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
164566858|NCT01097629|594445231|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
164566859|NCT01097629|594445232|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
164566860|NCT01097629|594445233|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
164566861|NCT01097629|594445234|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
164566862|NCT01097629|594445235|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
164566863|NCT01097629|594445236|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
164566864|NCT01097629|594445237|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
164566865|NCT01097629|594445238|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
164566866|NCT01097629|594445231|FG000|DB RO Phase|Withdrawal by Subject|0|||
164566867|NCT01097629|594445232|FG001|DB RO Phase|Withdrawal by Subject|0|||
164566868|NCT01097629|594445233|FG002|DB RO Phase|Withdrawal by Subject|0|||
164566869|NCT01097629|594445234|FG003|DB RO Phase|Withdrawal by Subject|0|||
164566870|NCT01097629|594445235|FG004|DB RO Phase|Withdrawal by Subject|0|||
164566871|NCT01097629|594445236|FG005|DB RO Phase|Withdrawal by Subject|0|||
164566872|NCT01097629|594445237|FG006|DB RO Phase|Withdrawal by Subject|0|||
164566873|NCT01097629|594445238|FG007|DB RO Phase|Withdrawal by Subject|1|||
164566874|NCT01097629|594445231|FG000|DB RO Phase|Protocol Violation|0|||
164566875|NCT01097629|594445232|FG001|DB RO Phase|Protocol Violation|0|||
164566876|NCT01097629|594445233|FG002|DB RO Phase|Protocol Violation|0|||
164566877|NCT01097629|594445234|FG003|DB RO Phase|Protocol Violation|1|||
164566878|NCT01097629|594445235|FG004|DB RO Phase|Protocol Violation|0|||
164566879|NCT01097629|594445236|FG005|DB RO Phase|Protocol Violation|1|||
164566880|NCT01097629|594445237|FG006|DB RO Phase|Protocol Violation|1|||
164566881|NCT01097629|594445238|FG007|DB RO Phase|Protocol Violation|0|||
164566882|NCT01097629|594445231|FG000|DB RO Phase|Lost to Follow-up|0|||
164566883|NCT01097629|594445232|FG001|DB RO Phase|Lost to Follow-up|0|||
164566884|NCT01097629|594445233|FG002|DB RO Phase|Lost to Follow-up|0|||
164566885|NCT01097629|594445234|FG003|DB RO Phase|Lost to Follow-up|0|||
164670743|NCT01472341|594821290|FG000|Overall Study|Withdrawal by Subject|39|||
164670744|NCT01472341|594821290|FG000|Overall Study|Lost to Follow-up|52|||
164670745|NCT01472341|594821290|FG000|Overall Study|Laboratory parameters unavailable|25|||
164670746|NCT01472341|594821290|FG000|Overall Study|Death|9|||
164670747|NCT00579670|594821291|FG000|Overall Study|Death|1|||
164670748|NCT00579670|594821292|FG001|Overall Study|Death|0|||
164670749|NCT00579670|594821293|FG002|Overall Study|Death|0|||
164670750|NCT00579670|594821294|FG003|Overall Study|Death|0|||
164670751|NCT00579670|594821295|FG004|Overall Study|Death|0|||
164670752|NCT00579670|594821291|FG000|Overall Study|Adverse Event|1|||
164670753|NCT00579670|594821292|FG001|Overall Study|Adverse Event|0|||
164670754|NCT00579670|594821293|FG002|Overall Study|Adverse Event|1|||
164670755|NCT00579670|594821294|FG003|Overall Study|Adverse Event|2|||
164670756|NCT00579670|594821295|FG004|Overall Study|Adverse Event|0|||
164670757|NCT00579670|594821291|FG000|Overall Study|Lack of Efficacy|0|||
164670758|NCT00579670|594821292|FG001|Overall Study|Lack of Efficacy|0|||
164670759|NCT00579670|594821293|FG002|Overall Study|Lack of Efficacy|1|||
164670760|NCT00579670|594821294|FG003|Overall Study|Lack of Efficacy|14|||
164670761|NCT00579670|594821295|FG004|Overall Study|Lack of Efficacy|0|||
164670762|NCT00579670|594821291|FG000|Overall Study|Lost to Follow-up|0|||
164670763|NCT00579670|594821292|FG001|Overall Study|Lost to Follow-up|1|||
164670764|NCT00579670|594821293|FG002|Overall Study|Lost to Follow-up|0|||
164670765|NCT00579670|594821294|FG003|Overall Study|Lost to Follow-up|4|||
164670766|NCT00579670|594821295|FG004|Overall Study|Lost to Follow-up|0|||
164670767|NCT00579670|594821291|FG000|Overall Study|Other|0|||
164670768|NCT00579670|594821292|FG001|Overall Study|Other|0|||
164670769|NCT00579670|594821293|FG002|Overall Study|Other|1|||
164328531|NCT02117414|593579532|FG000|Overall Study|Death|5|||
164328532|NCT02117414|593579533|FG001|Overall Study|Death|2|||
164328533|NCT02117414|593579532|FG000|Overall Study|Withdrawal by Subject|10|||
164328534|NCT02117414|593579533|FG001|Overall Study|Withdrawal by Subject|4|||
164328535|NCT02663687|593579535|FG000|Overall Study|Adverse Event|1|||
164328536|NCT02663687|593579536|FG001|Overall Study|Adverse Event|0|||
164328537|NCT02663687|593579537|FG002|Overall Study|Adverse Event|0|||
164328538|NCT02663687|593579538|FG003|Overall Study|Adverse Event|0|||
164328539|NCT02663687|593579539|FG004|Overall Study|Adverse Event|0|||
164328540|NCT02663687|593579535|FG000|Overall Study|Other|1|||
164328541|NCT02663687|593579536|FG001|Overall Study|Other|0|||
164328542|NCT02663687|593579537|FG002|Overall Study|Other|1|||
164328543|NCT02663687|593579538|FG003|Overall Study|Other|0|||
164328544|NCT02663687|593579539|FG004|Overall Study|Other|0|||
164328545|NCT00417482|593579540|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
164328546|NCT00417482|593579541|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
164328547|NCT00417482|593579542|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
164328548|NCT00417482|593579540|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
164328549|NCT00417482|593579541|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
164328550|NCT00417482|593579542|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
164328551|NCT00417482|593579540|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
164328552|NCT00417482|593579541|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
164328553|NCT00417482|593579542|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
164328554|NCT00417482|593579540|FG000|Phase B 1st 16 Weeks|Death|1|||
164328555|NCT00417482|593579541|FG001|Phase B 1st 16 Weeks|Death|0|||
164328556|NCT00417482|593579542|FG002|Phase B 1st 16 Weeks|Death|0|||
164328557|NCT00417482|593579540|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
164328558|NCT00417482|593579541|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
164328559|NCT00417482|593579542|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
164328560|NCT00417482|593579540|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
164328561|NCT00417482|593579541|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
164328562|NCT00417482|593579542|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
164328563|NCT00417482|593579540|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
164328564|NCT00417482|593579541|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
164328565|NCT00417482|593579542|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
164328566|NCT00417482|593579540|FG000|Phase B 2nd 16 Weeks|Death|1|||
164670770|NCT00579670|594821294|FG003|Overall Study|Other|2|||
164218836|NCT00086307|593168482|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
164218837|NCT00086307|593168480|FG000|Overall Study|Withdrawal by Subject|0|||
164218838|NCT00086307|593168481|FG001|Overall Study|Withdrawal by Subject|0|||
164218839|NCT00086307|593168482|FG002|Overall Study|Withdrawal by Subject|2|||
164218840|NCT03158311|593168485|FG000|Overall Study|Subject/Guardian Decision|10|||
164218841|NCT03158311|593168486|FG001|Overall Study|Subject/Guardian Decision|6|||
164218842|NCT03158311|593168487|FG002|Overall Study|Subject/Guardian Decision|11|||
164218843|NCT03158311|593168485|FG000|Overall Study|Adverse Event|5|||
164218844|NCT03158311|593168486|FG001|Overall Study|Adverse Event|3|||
164218845|NCT03158311|593168487|FG002|Overall Study|Adverse Event|3|||
164218846|NCT03158311|593168485|FG000|Overall Study|Techinical Problems|3|||
164218847|NCT03158311|593168486|FG001|Overall Study|Techinical Problems|1|||
164218848|NCT03158311|593168487|FG002|Overall Study|Techinical Problems|5|||
164218849|NCT03158311|593168485|FG000|Overall Study|Physician Decision|2|||
164218850|NCT03158311|593168486|FG001|Overall Study|Physician Decision|3|||
164218851|NCT03158311|593168487|FG002|Overall Study|Physician Decision|7|||
164218852|NCT03158311|593168485|FG000|Overall Study|Lost to Follow-up|1|||
164218853|NCT03158311|593168486|FG001|Overall Study|Lost to Follow-up|1|||
164218854|NCT03158311|593168487|FG002|Overall Study|Lost to Follow-up|1|||
164218855|NCT03158311|593168485|FG000|Overall Study|Sponsor decision|1|||
164218856|NCT03158311|593168486|FG001|Overall Study|Sponsor decision|0|||
164218857|NCT03158311|593168487|FG002|Overall Study|Sponsor decision|0|||
164218858|NCT03158311|593168485|FG000|Overall Study|Pregnancy|0|||
164218859|NCT03158311|593168486|FG001|Overall Study|Pregnancy|2|||
164218860|NCT03158311|593168487|FG002|Overall Study|Pregnancy|0|||
164218861|NCT03158311|593168485|FG000|Overall Study|Randomized in error|0|||
164218862|NCT03158311|593168486|FG001|Overall Study|Randomized in error|0|||
164218863|NCT03158311|593168487|FG002|Overall Study|Randomized in error|1|||
164328567|NCT00417482|593579541|FG001|Phase B 2nd 16 Weeks|Death|1|||
164328568|NCT00417482|593579542|FG002|Phase B 2nd 16 Weeks|Death|0|||
164328569|NCT01323946|593579543|FG000|Overall Study|Lost to Follow-up|0|||
164328570|NCT01323946|593579544|FG001|Overall Study|Lost to Follow-up|1|||
164328571|NCT01323946|593579545|FG002|Overall Study|Lost to Follow-up|0|||
164218864|NCT01018953|593168488|FG000|Overall Study|Adverse Event|2|||
164218865|NCT01018953|593168488|FG000|Overall Study|Withdrawal by Subject|1|||
164218866|NCT01018953|593168488|FG000|Overall Study|Study termination by sponsor|5|||
164218867|NCT00724503|593168489|FG000|Overall Study|Lost to Follow-up|4|||
164218868|NCT00724503|593168490|FG001|Overall Study|Lost to Follow-up|8|||
164218869|NCT00724503|593168489|FG000|Overall Study|Withdrawal by Subject|11|||
164328572|NCT01323946|593579543|FG000|Overall Study|Parents refused the last blood draw|1|||
164328573|NCT01323946|593579544|FG001|Overall Study|Parents refused the last blood draw|0|||
164670771|NCT00579670|594821295|FG004|Overall Study|Other|0|||
164328574|NCT01323946|593579545|FG002|Overall Study|Parents refused the last blood draw|0|||
164328575|NCT01323946|593579543|FG000|Overall Study|Withdrawal by Subject|2|||
164670772|NCT00579670|594821291|FG000|Overall Study|Withdrawal by Subject|0|||
164670773|NCT00579670|594821292|FG001|Overall Study|Withdrawal by Subject|0|||
164328576|NCT01323946|593579544|FG001|Overall Study|Withdrawal by Subject|2|||
164328577|NCT01323946|593579545|FG002|Overall Study|Withdrawal by Subject|0|||
164328578|NCT03189381|593579547|FG000|Overall Study|Death|1|||
164328579|NCT03189381|593579548|FG001|Overall Study|Death|0|||
164328580|NCT00251004|593579549|FG000|Overall Study|Withdrawal by Subject|23|||
164670774|NCT00579670|594821293|FG002|Overall Study|Withdrawal by Subject|1|||
164670775|NCT00579670|594821294|FG003|Overall Study|Withdrawal by Subject|0|||
164670776|NCT00579670|594821295|FG004|Overall Study|Withdrawal by Subject|0|||
164670777|NCT00112463|594821296|FG000|Overall Study|Physician Decision|1|||
164670778|NCT00112463|594821296|FG000|Overall Study|Progression|30|||
164670779|NCT00112463|594821296|FG000|Overall Study|Second Primary|1|||
164670780|NCT00112463|594821296|FG000|Overall Study|Toxicity|3|||
164328581|NCT00251004|593579550|FG001|Overall Study|Withdrawal by Subject|16|||
164670781|NCT00112463|594821296|FG000|Overall Study|Withdrawal by Subject|2|||
164328582|NCT00251004|593579551|FG002|Overall Study|Withdrawal by Subject|14|||
164670782|NCT00112463|594821296|FG000|Overall Study|Never started treatment|2|||
164328583|NCT00251004|593579549|FG000|Overall Study|Death|9|||
164328584|NCT00251004|593579550|FG001|Overall Study|Death|10|||
164670783|NCT00296647|594821298|FG000|Overall Study|Death|4|||
164670784|NCT00296647|594821299|FG001|Overall Study|Death|1|||
164670785|NCT00296647|594821300|FG002|Overall Study|Death|2|||
164670786|NCT00296647|594821301|FG003|Overall Study|Death|1|||
164218870|NCT00724503|593168490|FG001|Overall Study|Withdrawal by Subject|23|||
164218871|NCT00724503|593168489|FG000|Overall Study|Death|190|||
164218872|NCT00724503|593168490|FG001|Overall Study|Death|182|||
164218873|NCT00724503|593168489|FG000|Overall Study|Adverse Event|1|||
164218874|NCT00724503|593168490|FG001|Overall Study|Adverse Event|0|||
164218875|NCT00724503|593168489|FG000|Overall Study|Not otherwise specified|4|||
164218876|NCT00724503|593168490|FG001|Overall Study|Not otherwise specified|7|||
164218877|NCT01184118|593168491|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
164218878|NCT01184118|593168491|FG000|Overall Study|No physiologic confirmation of asthma|8|||
164218879|NCT01184118|593168491|FG000|Overall Study|FEV1 <60% predicted|2|||
164218880|NCT01184118|593168491|FG000|Overall Study|Exclusionary medical condition|2|||
164218881|NCT01184118|593168491|FG000|Overall Study|Withdrawal by Subject|5|||
164218882|NCT01186419|593168492|FG000|Overall Study|Withdrawal by Subject|5|||
164218883|NCT01186419|593168493|FG001|Overall Study|Withdrawal by Subject|3|||
164218884|NCT01186419|593168492|FG000|Overall Study|Adverse Event|1|||
164218885|NCT01186419|593168493|FG001|Overall Study|Adverse Event|2|||
164218886|NCT01186419|593168492|FG000|Overall Study|Physician Decision|0|||
164218887|NCT01186419|593168493|FG001|Overall Study|Physician Decision|3|||
164218888|NCT01186419|593168492|FG000|Overall Study|Other|1|||
164218889|NCT01186419|593168493|FG001|Overall Study|Other|1|||
164218890|NCT01560416|593168502|FG000|Randomized Phase|Crossover Participants|7|||
164218891|NCT01560416|593168503|FG001|Randomized Phase|Crossover Participants|0|||
164218892|NCT01033071|593168504|FG000|Overall Study|Adverse Event|28|||
164218893|NCT01033071|593168505|FG001|Overall Study|Adverse Event|51|||
164218894|NCT01033071|593168506|FG002|Overall Study|Adverse Event|26|||
164218895|NCT01033071|593168504|FG000|Overall Study|Protocol Violation|0|||
164218896|NCT01033071|593168505|FG001|Overall Study|Protocol Violation|2|||
164218897|NCT01033071|593168506|FG002|Overall Study|Protocol Violation|1|||
164218898|NCT01033071|593168504|FG000|Overall Study|Lost to Follow-up|4|||
164218899|NCT01033071|593168505|FG001|Overall Study|Lost to Follow-up|5|||
164218900|NCT01033071|593168506|FG002|Overall Study|Lost to Follow-up|5|||
164218901|NCT01033071|593168504|FG000|Overall Study|Withdrawal by Subject|17|||
164218902|NCT01033071|593168505|FG001|Overall Study|Withdrawal by Subject|14|||
164218903|NCT01033071|593168506|FG002|Overall Study|Withdrawal by Subject|11|||
164218904|NCT01033071|593168504|FG000|Overall Study|Lack of Efficacy|0|||
164218905|NCT01033071|593168505|FG001|Overall Study|Lack of Efficacy|1|||
164218906|NCT01033071|593168506|FG002|Overall Study|Lack of Efficacy|1|||
164218907|NCT01033071|593168504|FG000|Overall Study|Other|6|||
164218908|NCT01033071|593168505|FG001|Overall Study|Other|4|||
164218909|NCT01033071|593168506|FG002|Overall Study|Other|3|||
164218910|NCT04073407|593168509|FG000|Part 1|Withdrawal by Subject|1|||
164218911|NCT04073407|593168510|FG001|Part 1|Withdrawal by Subject|0|||
164218912|NCT04073407|593168509|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
164218913|NCT04073407|593168510|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
164218914|NCT04073407|593168509|FG000|Part 2|Withdrawal by Subject|0|||
164218915|NCT04073407|593168510|FG001|Part 2|Withdrawal by Subject|1|||
164218916|NCT03684057|593169905|FG000|Overall Study|Withdrawal by Subject|4|||
164218917|NCT03684057|593169906|FG001|Overall Study|Withdrawal by Subject|5|||
164218918|NCT00758043|593169907|FG000|Overall Study|Adverse Event|1|||
164218919|NCT00758043|593169908|FG001|Overall Study|Adverse Event|20|||
164218920|NCT00758043|593169909|FG002|Overall Study|Adverse Event|12|||
164218921|NCT00758043|593169910|FG003|Overall Study|Adverse Event|62|||
164218922|NCT00758043|593169907|FG000|Overall Study|Lack of Efficacy|0|||
164218923|NCT00758043|593169908|FG001|Overall Study|Lack of Efficacy|6|||
164218924|NCT00758043|593169909|FG002|Overall Study|Lack of Efficacy|18|||
164218925|NCT00758043|593169910|FG003|Overall Study|Lack of Efficacy|12|||
164218926|NCT00758043|593169907|FG000|Overall Study|Refused Further Treatment|0|||
164218927|NCT00758043|593169908|FG001|Overall Study|Refused Further Treatment|11|||
164218928|NCT00758043|593169909|FG002|Overall Study|Refused Further Treatment|5|||
164218929|NCT00758043|593169910|FG003|Overall Study|Refused Further Treatment|8|||
164218930|NCT00758043|593169907|FG000|Overall Study|Lost to Follow-up|0|||
164218931|NCT00758043|593169908|FG001|Overall Study|Lost to Follow-up|2|||
164218932|NCT00758043|593169909|FG002|Overall Study|Lost to Follow-up|2|||
164566886|NCT01097629|594445235|FG004|DB RO Phase|Lost to Follow-up|0|||
164566887|NCT01097629|594445236|FG005|DB RO Phase|Lost to Follow-up|0|||
164218933|NCT00758043|593169910|FG003|Overall Study|Lost to Follow-up|5|||
164218934|NCT00758043|593169907|FG000|Overall Study|Withdrawal by Subject|0|||
164218935|NCT00758043|593169908|FG001|Overall Study|Withdrawal by Subject|1|||
164218936|NCT00758043|593169909|FG002|Overall Study|Withdrawal by Subject|1|||
164218937|NCT00758043|593169910|FG003|Overall Study|Withdrawal by Subject|4|||
164218938|NCT00758043|593169907|FG000|Overall Study|Required Prohibited Medication|0|||
164218939|NCT00758043|593169908|FG001|Overall Study|Required Prohibited Medication|0|||
164218940|NCT00758043|593169909|FG002|Overall Study|Required Prohibited Medication|1|||
164218941|NCT00758043|593169910|FG003|Overall Study|Required Prohibited Medication|3|||
164218942|NCT00758043|593169907|FG000|Overall Study|Non-Compliant With study Drug|0|||
164218943|NCT00758043|593169908|FG001|Overall Study|Non-Compliant With study Drug|0|||
164566888|NCT01097629|594445237|FG006|DB RO Phase|Lost to Follow-up|2|||
164566889|NCT01097629|594445238|FG007|DB RO Phase|Lost to Follow-up|0|||
164566890|NCT02613208|594445239|FG000|Overall Study|Withdrawal by Subject|1|||
164328585|NCT00251004|593579551|FG002|Overall Study|Death|8|||
164328586|NCT00251004|593579549|FG000|Overall Study|Lost to Follow-up|1|||
164328587|NCT00251004|593579550|FG001|Overall Study|Lost to Follow-up|2|||
164328588|NCT00251004|593579551|FG002|Overall Study|Lost to Follow-up|1|||
164328589|NCT00251004|593579549|FG000|Overall Study|Graft Loss|12|||
164328590|NCT00251004|593579550|FG001|Overall Study|Graft Loss|13|||
164328591|NCT00251004|593579551|FG002|Overall Study|Graft Loss|8|||
164328592|NCT00887744|593579552|FG000|Overall Study|Adverse Event|3|||
164328593|NCT00887744|593579552|FG000|Overall Study|Death|1|||
164328594|NCT00887744|593579552|FG000|Overall Study|Lost to Follow-up|3|||
164328595|NCT00887744|593579552|FG000|Overall Study|Withdrawal by Subject|18|||
164328596|NCT00887744|593579552|FG000|Overall Study|Various reasons|9|||
164328597|NCT01569464|593579553|FG000|Overall Study|Adverse Event|4|||
164328598|NCT01569464|593579554|FG001|Overall Study|Adverse Event|0|||
164328599|NCT01569464|593579553|FG000|Overall Study|Lack of Efficacy|1|||
164328600|NCT01569464|593579554|FG001|Overall Study|Lack of Efficacy|0|||
164328601|NCT01569464|593579553|FG000|Overall Study|Protocol Violation|1|||
164328602|NCT01569464|593579554|FG001|Overall Study|Protocol Violation|0|||
164328603|NCT01569464|593579553|FG000|Overall Study|Lost to Follow-up|2|||
164328604|NCT01569464|593579554|FG001|Overall Study|Lost to Follow-up|3|||
164328605|NCT01569464|593579553|FG000|Overall Study|Withdrawal by Subject|1|||
164328606|NCT01569464|593579554|FG001|Overall Study|Withdrawal by Subject|1|||
164328607|NCT01569464|593579553|FG000|Overall Study|Other|1|||
164328608|NCT01569464|593579554|FG001|Overall Study|Other|1|||
164328609|NCT04025710|593579560|FG000|Overall Study|Death|3|||
164328610|NCT04025710|593579560|FG000|Overall Study|Lost to Follow-up|5|||
164328611|NCT04025710|593579560|FG000|Overall Study|Withdrawal by Subject|1|||
164328612|NCT04025710|593579560|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
164328613|NCT04025710|593579560|FG000|Overall Study|Drop-out according to protocol|34|||
164328614|NCT01343901|593579563|FG000|Overall Study|Death|85|||
164328615|NCT01343901|593579563|FG000|Overall Study|Physician Decision|4|||
164566891|NCT02613208|594445239|FG000|Overall Study|Change of address|2|||
164566892|NCT02613208|594445239|FG000|Overall Study|Physician Decision|2|||
164566893|NCT02613208|594445239|FG000|Overall Study|Lost to Follow-up|5|||
164566894|NCT02613208|594445239|FG000|Overall Study|Death|37|||
164670787|NCT00296647|594821302|FG004|Overall Study|Death|1|||
164670788|NCT00296647|594821298|FG000|Overall Study|Withdrawal by Subject|28|||
164670789|NCT00296647|594821299|FG001|Overall Study|Withdrawal by Subject|27|||
164670790|NCT00296647|594821300|FG002|Overall Study|Withdrawal by Subject|32|||
164670791|NCT00296647|594821301|FG003|Overall Study|Withdrawal by Subject|16|||
164670792|NCT00296647|594821302|FG004|Overall Study|Withdrawal by Subject|19|||
164670793|NCT01863745|594821303|FG000|Overall Study|Disease Progression|9|||
164670794|NCT01863745|594821303|FG000|Overall Study|Adverse Event|2|||
164670795|NCT01863745|594821303|FG000|Overall Study|Death|1|||
164670796|NCT01863745|594821303|FG000|Overall Study|Withdrawal by Subject|1|||
164670797|NCT01171963|594821306|FG000|Overall Study|Adverse Event|10|||
164670798|NCT01171963|594821307|FG001|Overall Study|Adverse Event|15|||
164670799|NCT01171963|594821306|FG000|Overall Study|Lost to Follow-up|23|||
164670800|NCT01171963|594821307|FG001|Overall Study|Lost to Follow-up|24|||
164670801|NCT01171963|594821306|FG000|Overall Study|Other - diarrhoea|1|||
164670802|NCT01171963|594821307|FG001|Overall Study|Other - diarrhoea|0|||
164670803|NCT01171963|594821306|FG000|Overall Study|Withdrawal by Subject|114|||
164670804|NCT01171963|594821307|FG001|Overall Study|Withdrawal by Subject|129|||
164670805|NCT05093205|594821308|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
164670806|NCT05093205|594821309|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
164566895|NCT01524991|594445240|FG000|Overall Study|Adverse Event|12|||
164566896|NCT01524991|594445240|FG000|Overall Study|Death|1|||
164566897|NCT01524991|594445240|FG000|Overall Study|Disease ProgressionDu|17|||
164566898|NCT01524991|594445240|FG000|Overall Study|Other complicating disease|1|||
164566899|NCT01524991|594445240|FG000|Overall Study|Withdrawal by Subject|2|||
164566900|NCT01524991|594445240|FG000|Overall Study|Symptomatic Deterioration|1|||
164670807|NCT05093205|594821310|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
164670808|NCT05093205|594821311|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
164670809|NCT05093205|594821312|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
164670810|NCT05093205|594821313|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
164328616|NCT01343901|593579563|FG000|Overall Study|Lost to Follow-up|12|||
164328617|NCT01343901|593579563|FG000|Overall Study|Management by another medical team|11|||
164328618|NCT01343901|593579563|FG000|Overall Study|Participant decision|1|||
164328619|NCT01562873|593579564|FG000|Overall Study|Disease Progression per RECIST|10|||
164328620|NCT01562873|593579565|FG001|Overall Study|Disease Progression per RECIST|0|||
164328621|NCT01562873|593579564|FG000|Overall Study|Adverse Event|1|||
164670811|NCT05093205|594821314|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
164670812|NCT05093205|594821315|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
164670813|NCT05093205|594821316|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
164670814|NCT05093205|594821317|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
164218944|NCT00758043|593169909|FG002|Overall Study|Non-Compliant With study Drug|0|||
164218945|NCT00758043|593169910|FG003|Overall Study|Non-Compliant With study Drug|1|||
164218946|NCT00758043|593169907|FG000|Overall Study|Other Reasons|0|||
164218947|NCT00758043|593169908|FG001|Overall Study|Other Reasons|1|||
164218948|NCT00758043|593169909|FG002|Overall Study|Other Reasons|0|||
164218949|NCT00758043|593169910|FG003|Overall Study|Other Reasons|5|||
164218950|NCT03422718|593169914|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
164218951|NCT03422718|593169915|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
164218952|NCT03422718|593169916|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
164218953|NCT03422718|593169917|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
164218954|NCT03422718|593169918|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
164218955|NCT03422718|593169919|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
164218956|NCT03422718|593169920|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
164218957|NCT03422718|593169921|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
164218958|NCT03422718|593169914|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
164218959|NCT03422718|593169915|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
164218960|NCT03422718|593169916|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
164218961|NCT03422718|593169917|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
164218962|NCT03422718|593169918|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
164218963|NCT03422718|593169919|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
164218964|NCT03422718|593169920|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
164218965|NCT03422718|593169921|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
164218966|NCT03422718|593169914|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
164218967|NCT03422718|593169915|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
164218968|NCT03422718|593169916|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
164218969|NCT03422718|593169917|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
164218970|NCT03422718|593169918|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
164218971|NCT03422718|593169919|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
164218972|NCT03422718|593169920|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
164218973|NCT03422718|593169921|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
164218974|NCT03422718|593169914|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
164218975|NCT03422718|593169915|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
164218976|NCT03422718|593169916|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
164218977|NCT03422718|593169917|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
164218978|NCT03422718|593169918|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
164218979|NCT03422718|593169919|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
164328622|NCT01562873|593579565|FG001|Overall Study|Adverse Event|0|||
164328623|NCT01562873|593579564|FG000|Overall Study|Clinical Disease Progression|9|||
164328624|NCT01562873|593579565|FG001|Overall Study|Clinical Disease Progression|0|||
164328625|NCT01562873|593579564|FG000|Overall Study|Clinical PD and adverse event|1|||
164328626|NCT01562873|593579565|FG001|Overall Study|Clinical PD and adverse event|0|||
164328627|NCT05308290|593579569|FG000|Overall Study|Death|1|||
164566901|NCT04574999|594445243|FG000|Overall Study|Adverse Event|1|||
164566902|NCT04574999|594445244|FG001|Overall Study|Adverse Event|0|||
164566903|NCT04574999|594445243|FG000|Overall Study|Lack of Efficacy|2|||
164566904|NCT04574999|594445244|FG001|Overall Study|Lack of Efficacy|3|||
164566905|NCT04574999|594445243|FG000|Overall Study|Protocol Violation|1|||
164566906|NCT04574999|594445244|FG001|Overall Study|Protocol Violation|0|||
164566907|NCT04574999|594445243|FG000|Overall Study|Withdrawal by Subject|2|||
164566908|NCT04574999|594445244|FG001|Overall Study|Withdrawal by Subject|2|||
164566909|NCT04574999|594445243|FG000|Overall Study|Lost to Follow-up|1|||
164566910|NCT04574999|594445244|FG001|Overall Study|Lost to Follow-up|0|||
164566911|NCT04574999|594445243|FG000|Overall Study|Personal problems|1|||
164566912|NCT04574999|594445244|FG001|Overall Study|Personal problems|0|||
164566913|NCT04574999|594445243|FG000|Overall Study|Previous planned surgery|1|||
164566914|NCT04574999|594445244|FG001|Overall Study|Previous planned surgery|0|||
164566915|NCT00206726|594445246|FG000|Overall Study|Delayed recovery of blood counts|1|||
164566916|NCT00206726|594445246|FG000|Overall Study|Progressive disease or relapsed disease|18|||
164566917|NCT00206726|594445246|FG000|Overall Study|Placed on new protocol|1|||
164566918|NCT00206726|594445246|FG000|Overall Study|Bone marrow transplant|1|||
164566919|NCT00206726|594445246|FG000|Overall Study|Adverse Event|17|||
164566920|NCT00206726|594445246|FG000|Overall Study|Death|4|||
164566921|NCT00206726|594445246|FG000|Overall Study|Protocol Violation|1|||
164566922|NCT00206726|594445246|FG000|Overall Study|Withdrawal by Subject|8|||
164566923|NCT05148884|594445247|FG000|Overall Study|Withdrawal by Subject|3|||
164218980|NCT03422718|593169920|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
164218981|NCT03422718|593169921|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
164566924|NCT05148884|594445248|FG001|Overall Study|Withdrawal by Subject|0|||
164566925|NCT05148884|594445247|FG000|Overall Study|Deep brain stimulation operation|0|||
164328628|NCT05308290|593579570|FG001|Overall Study|Death|0|||
164328629|NCT05308290|593579569|FG000|Overall Study|Lost to Follow-up|2|||
164328630|NCT05308290|593579570|FG001|Overall Study|Lost to Follow-up|1|||
164328631|NCT05308290|593579569|FG000|Overall Study|still in study followup|0|||
164328632|NCT05308290|593579570|FG001|Overall Study|still in study followup|1|||
164328633|NCT02117427|593579571|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
164328634|NCT02117427|593579572|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
164328635|NCT02117427|593579573|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
164328636|NCT02117427|593579571|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
164328637|NCT02117427|593579572|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
164328638|NCT02117427|593579573|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
164328639|NCT02117427|593579571|FG000|Overall Study|Physician Decision|0|||
164328640|NCT02117427|593579572|FG001|Overall Study|Physician Decision|2|||
164328641|NCT02117427|593579573|FG002|Overall Study|Physician Decision|0|||
164328642|NCT02117427|593579571|FG000|Overall Study|No longer meets inclusion criteria|0|||
164328643|NCT02117427|593579572|FG001|Overall Study|No longer meets inclusion criteria|1|||
164328644|NCT02117427|593579573|FG002|Overall Study|No longer meets inclusion criteria|0|||
164328645|NCT02117427|593579571|FG000|Overall Study|Death|0|||
164328646|NCT02117427|593579572|FG001|Overall Study|Death|1|||
164328647|NCT02117427|593579573|FG002|Overall Study|Death|0|||
164328648|NCT00410202|593579574|FG000|On-Treatment|Continuing treatment|69|||
164328649|NCT00410202|593579575|FG001|On-Treatment|Continuing treatment|71|||
164328650|NCT00410202|593579576|FG002|On-Treatment|Continuing treatment|66|||
164328651|NCT00410202|593579574|FG000|On-Treatment|Adverse Event|1|||
164328652|NCT00410202|593579575|FG001|On-Treatment|Adverse Event|3|||
164218982|NCT03422718|593169914|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
164218983|NCT03422718|593169915|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
164218984|NCT03422718|593169916|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
164218985|NCT03422718|593169917|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
164218986|NCT03422718|593169918|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
164218987|NCT03422718|593169919|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
164218988|NCT03422718|593169920|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
164218989|NCT03422718|593169921|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
164218990|NCT03422718|593169914|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
164218991|NCT03422718|593169915|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
164218992|NCT03422718|593169916|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
164218993|NCT03422718|593169917|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
164218994|NCT03422718|593169918|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
164218995|NCT03422718|593169919|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
164218996|NCT03422718|593169920|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
164218997|NCT03422718|593169921|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
164218998|NCT00669331|593169924|FG000|Randomisation to First Dose|Adverse Event|1|||
164218999|NCT00669331|593169925|FG001|Randomisation to First Dose|Adverse Event|0|||
164219000|NCT00669331|593169924|FG000|Randomisation to First Dose|Protocol Violation|1|||
164219001|NCT00669331|593169925|FG001|Randomisation to First Dose|Protocol Violation|0|||
164219002|NCT00669331|593169924|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
164219003|NCT00669331|593169925|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
164219004|NCT00669331|593169924|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
164219005|NCT00669331|593169925|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
164219006|NCT00669331|593169924|FG000|Randomisation to First Dose|Death|1|||
164219007|NCT00669331|593169925|FG001|Randomisation to First Dose|Death|0|||
164219008|NCT00669331|593169924|FG000|Randomisation to First Dose|Sponsor decision|0|||
164219009|NCT00669331|593169925|FG001|Randomisation to First Dose|Sponsor decision|1|||
164219010|NCT00669331|593169924|FG000|Randomisation to First Dose|Randomised in error|3|||
164219011|NCT00669331|593169925|FG001|Randomisation to First Dose|Randomised in error|10|||
164219012|NCT00669331|593169924|FG000|Blinded Treatment Period|Adverse Event|16|||
164219013|NCT00669331|593169925|FG001|Blinded Treatment Period|Adverse Event|10|||
164219014|NCT00669331|593169924|FG000|Blinded Treatment Period|Protocol Violation|1|||
164219015|NCT00669331|593169925|FG001|Blinded Treatment Period|Protocol Violation|1|||
164219016|NCT00669331|593169924|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
164566926|NCT05148884|594445248|FG001|Overall Study|Deep brain stimulation operation|1|||
164566927|NCT01341457|594445249|FG000|Overall Study|Adverse Event|2|||
164566928|NCT01341457|594445250|FG001|Overall Study|Adverse Event|0|||
164566929|NCT00832819|594445253|FG000|Overall Study|Adverse Event|0|||
164219017|NCT00669331|593169925|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
164219018|NCT00669331|593169924|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
164566930|NCT00832819|594445254|FG001|Overall Study|Adverse Event|1|||
164566931|NCT00832819|594445255|FG002|Overall Study|Adverse Event|0|||
164566932|NCT00832819|594445253|FG000|Overall Study|Protocol Violation|0|||
164566933|NCT00832819|594445254|FG001|Overall Study|Protocol Violation|0|||
164566934|NCT00832819|594445255|FG002|Overall Study|Protocol Violation|1|||
164566935|NCT01717638|594445258|FG000|Overall Study|Lost to Follow-up|0|||
164566936|NCT01717638|594445259|FG001|Overall Study|Lost to Follow-up|0|||
164219019|NCT00669331|593169925|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
164219020|NCT00669331|593169924|FG000|Blinded Treatment Period|Death|0|||
164566937|NCT01717638|594445260|FG002|Overall Study|Lost to Follow-up|0|||
164566938|NCT01717638|594445261|FG003|Overall Study|Lost to Follow-up|0|||
164566939|NCT01717638|594445262|FG004|Overall Study|Lost to Follow-up|0|||
164566940|NCT01717638|594445263|FG005|Overall Study|Lost to Follow-up|1|||
164566941|NCT01717638|594445264|FG006|Overall Study|Lost to Follow-up|0|||
164219021|NCT00669331|593169925|FG001|Blinded Treatment Period|Death|2|||
164219022|NCT00669331|593169924|FG000|Blinded Treatment Period|Physician Decision|3|||
164219023|NCT00669331|593169925|FG001|Blinded Treatment Period|Physician Decision|3|||
164219024|NCT00669331|593169924|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
164219025|NCT00669331|593169925|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
164219026|NCT03387046|593169926|FG000|Overall Study|Adverse Event|1|||
164219027|NCT03387046|593169927|FG001|Overall Study|Adverse Event|1|||
164219028|NCT00509600|593169928|FG000|Overall Study|Adverse Event|1|||
164219029|NCT00986232|593169929|FG000|Overall Study|Adverse Event|1|||
164219030|NCT00986232|593169930|FG001|Overall Study|Adverse Event|2|||
164219031|NCT00986232|593169931|FG002|Overall Study|Adverse Event|3|||
164219032|NCT00986232|593169932|FG003|Overall Study|Adverse Event|0|||
164219033|NCT00986232|593169929|FG000|Overall Study|Lost to Follow-up|19|||
164219034|NCT00986232|593169930|FG001|Overall Study|Lost to Follow-up|12|||
164219035|NCT00986232|593169931|FG002|Overall Study|Lost to Follow-up|12|||
164219036|NCT00986232|593169932|FG003|Overall Study|Lost to Follow-up|7|||
164219037|NCT00986232|593169929|FG000|Overall Study|Protocol Violation|2|||
164219038|NCT00986232|593169930|FG001|Overall Study|Protocol Violation|3|||
164219039|NCT00986232|593169931|FG002|Overall Study|Protocol Violation|0|||
164219040|NCT00986232|593169932|FG003|Overall Study|Protocol Violation|1|||
164219041|NCT00986232|593169929|FG000|Overall Study|Withdrawal by Subject|13|||
164219042|NCT00986232|593169930|FG001|Overall Study|Withdrawal by Subject|16|||
164219043|NCT00986232|593169931|FG002|Overall Study|Withdrawal by Subject|12|||
164219044|NCT00986232|593169932|FG003|Overall Study|Withdrawal by Subject|3|||
164219045|NCT00986232|593169929|FG000|Overall Study|Missed one or more bleeds|13|||
164219046|NCT00986232|593169930|FG001|Overall Study|Missed one or more bleeds|10|||
164219047|NCT00986232|593169931|FG002|Overall Study|Missed one or more bleeds|6|||
164219048|NCT00986232|593169932|FG003|Overall Study|Missed one or more bleeds|7|||
164219049|NCT00986232|593169929|FG000|Overall Study|Incomplete safety follow-up|3|||
164219050|NCT00986232|593169930|FG001|Overall Study|Incomplete safety follow-up|7|||
164219051|NCT00986232|593169931|FG002|Overall Study|Incomplete safety follow-up|2|||
164219052|NCT00986232|593169932|FG003|Overall Study|Incomplete safety follow-up|2|||
164219053|NCT02568423|593169933|FG000|Overall Study|Lost to Follow-up|0|||
164219054|NCT02568423|593169934|FG001|Overall Study|Lost to Follow-up|2|||
164219055|NCT02568423|593169935|FG002|Overall Study|Lost to Follow-up|0|||
164219056|NCT02568423|593169936|FG003|Overall Study|Lost to Follow-up|0|||
164328653|NCT00410202|593579576|FG002|On-Treatment|Adverse Event|2|||
164328654|NCT00410202|593579574|FG000|On-Treatment|Death|1|||
164328655|NCT00410202|593579575|FG001|On-Treatment|Death|0|||
164328656|NCT00410202|593579576|FG002|On-Treatment|Death|0|||
164328657|NCT00410202|593579574|FG000|On-Treatment|Lost to Follow-up|1|||
164328658|NCT00410202|593579575|FG001|On-Treatment|Lost to Follow-up|0|||
164328659|NCT00410202|593579576|FG002|On-Treatment|Lost to Follow-up|1|||
164328660|NCT00410202|593579574|FG000|On-Treatment|Lack of Efficacy|1|||
164328661|NCT00410202|593579575|FG001|On-Treatment|Lack of Efficacy|4|||
164328662|NCT00410202|593579576|FG002|On-Treatment|Lack of Efficacy|0|||
164328663|NCT00410202|593579574|FG000|On-Treatment|Withdrawal by Subject|2|||
164328664|NCT00410202|593579575|FG001|On-Treatment|Withdrawal by Subject|1|||
164328665|NCT00410202|593579576|FG002|On-Treatment|Withdrawal by Subject|1|||
164328666|NCT00410202|593579574|FG000|On-Treatment|Other Reason|0|||
164328667|NCT00410202|593579575|FG001|On-Treatment|Other Reason|0|||
164328668|NCT00410202|593579576|FG002|On-Treatment|Other Reason|1|||
164328669|NCT00410202|593579574|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
164328670|NCT00410202|593579575|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
164328671|NCT00410202|593579576|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
164328672|NCT00410202|593579574|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
164328673|NCT00410202|593579575|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
164328674|NCT00410202|593579576|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
164328675|NCT00410202|593579574|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
164328676|NCT00410202|593579575|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
164219057|NCT02568423|593169937|FG004|Overall Study|Lost to Follow-up|0|||
164219058|NCT02568423|593169938|FG005|Overall Study|Lost to Follow-up|0|||
164219059|NCT02568423|593169939|FG006|Overall Study|Lost to Follow-up|0|||
164328677|NCT00410202|593579576|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
164328678|NCT01178073|593579579|FG000|Overall Study|Adverse Event|34|||
164219060|NCT02568423|593169940|FG007|Overall Study|Lost to Follow-up|0|||
164328679|NCT01178073|593579580|FG001|Overall Study|Adverse Event|27|||
164328680|NCT01178073|593579581|FG002|Overall Study|Adverse Event|24|||
164219061|NCT02568423|593169933|FG000|Overall Study|Physician Decision|0|||
164219062|NCT02568423|593169934|FG001|Overall Study|Physician Decision|0|||
164219063|NCT02568423|593169935|FG002|Overall Study|Physician Decision|0|||
164219064|NCT02568423|593169936|FG003|Overall Study|Physician Decision|0|||
164328681|NCT01178073|593579579|FG000|Overall Study|Protocol Violation|1|||
164219065|NCT02568423|593169937|FG004|Overall Study|Physician Decision|0|||
164219066|NCT02568423|593169938|FG005|Overall Study|Physician Decision|1|||
164219067|NCT02568423|593169939|FG006|Overall Study|Physician Decision|0|||
164219068|NCT02568423|593169940|FG007|Overall Study|Physician Decision|0|||
164670815|NCT05093205|594821318|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
164670816|NCT05093205|594821319|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
164670817|NCT05093205|594821320|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
164670818|NCT05093205|594821308|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
164670819|NCT05093205|594821309|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
164670820|NCT05093205|594821310|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
164670821|NCT05093205|594821311|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
164219069|NCT03794544|593169941|FG000|Overall Study|Withdrawal by Subject|1|||
164219070|NCT03794544|593169942|FG001|Overall Study|Withdrawal by Subject|1|||
164219071|NCT03794544|593169943|FG002|Overall Study|Withdrawal by Subject|0|||
164219072|NCT03794544|593169944|FG003|Overall Study|Withdrawal by Subject|0|||
164219073|NCT03794544|593169941|FG000|Overall Study|Death|0|||
164219074|NCT03794544|593169942|FG001|Overall Study|Death|0|||
164219075|NCT03794544|593169943|FG002|Overall Study|Death|0|||
164219076|NCT03794544|593169944|FG003|Overall Study|Death|1|||
164219077|NCT03794544|593169941|FG000|Overall Study|Lost to Follow-up|0|||
164219078|NCT03794544|593169942|FG001|Overall Study|Lost to Follow-up|1|||
164219079|NCT03794544|593169943|FG002|Overall Study|Lost to Follow-up|1|||
164219080|NCT03794544|593169944|FG003|Overall Study|Lost to Follow-up|0|||
164219081|NCT03794544|593169941|FG000|Overall Study|Other|0|||
164219082|NCT03794544|593169942|FG001|Overall Study|Other|1|||
164219083|NCT03794544|593169943|FG002|Overall Study|Other|0|||
164219084|NCT03794544|593169944|FG003|Overall Study|Other|0|||
164219085|NCT00585585|593169952|FG000|Overall Study|Adverse Event|1|||
164219086|NCT01964560|593169955|FG000|Overall Study|Adverse Event|23|||
164219087|NCT01964560|593169955|FG000|Overall Study|Lack of Efficacy|46|||
164219088|NCT01964560|593169955|FG000|Overall Study|Protocol deviation|2|||
164219089|NCT01964560|593169955|FG000|Overall Study|Lost to Follow-up|4|||
164219090|NCT01964560|593169955|FG000|Overall Study|Withdrawal by Subject|64|||
164219091|NCT01964560|593169955|FG000|Overall Study|Surgery-hemispherotomy|1|||
164219092|NCT01964560|593169955|FG000|Overall Study|Surgery|1|||
164219093|NCT01964560|593169955|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
164219094|NCT01964560|593169955|FG000|Overall Study|Patient and Investigator choice|1|||
164219095|NCT01964560|593169955|FG000|Overall Study|Patient was prescribed CBD|1|||
164219096|NCT01964560|593169955|FG000|Overall Study|Participant moved to another country|1|||
164219097|NCT02217982|593169969|FG000|Overall Study|Trial discontinued|1|||
164219098|NCT02217982|593169970|FG001|Overall Study|Trial discontinued|0|||
164219099|NCT02217982|593169969|FG000|Overall Study|Adverse Event|0|||
164219100|NCT02217982|593169970|FG001|Overall Study|Adverse Event|1|||
164219101|NCT01755637|593169971|FG000|Period 1|Adverse Event|0|||
164219102|NCT01755637|593169972|FG001|Period 1|Adverse Event|1|||
164219103|NCT03338023|593169975|FG000|Overall Study|Withdrawal by Subject|3|||
164219104|NCT03338023|593169976|FG001|Overall Study|Withdrawal by Subject|4|||
164219105|NCT03338023|593169975|FG000|Overall Study|Protocol Violation|3|||
164219106|NCT03338023|593169976|FG001|Overall Study|Protocol Violation|3|||
164219107|NCT03338023|593169975|FG000|Overall Study|Lost to Follow-up|2|||
164219108|NCT03338023|593169976|FG001|Overall Study|Lost to Follow-up|1|||
164219109|NCT03338023|593169975|FG000|Overall Study|Physician Decision|1|||
164219110|NCT03338023|593169976|FG001|Overall Study|Physician Decision|2|||
164219111|NCT02030418|593169980|FG000|Overall Study|Death|78|||
164219112|NCT02030418|593169980|FG000|Overall Study|Missed 12-Month Visit|9|||
164219113|NCT02030418|593169980|FG000|Overall Study|Withdrawn|57|||
164219114|NCT00724893|593169981|FG000|Overall Study|Adverse Event|76|||
164219115|NCT00724893|593169982|FG001|Overall Study|Adverse Event|142|||
164219116|NCT00724893|593169981|FG000|Overall Study|Withdrawal by Subject|0|||
164219117|NCT00724893|593169982|FG001|Overall Study|Withdrawal by Subject|1|||
164219118|NCT00724893|593169981|FG000|Overall Study|Lack of virologic response|94|||
164219119|NCT00724893|593169982|FG001|Overall Study|Lack of virologic response|202|||
164219120|NCT00724893|593169981|FG000|Overall Study|Reason not specified|193|||
164219121|NCT00724893|593169982|FG001|Overall Study|Reason not specified|7|||
164219122|NCT00724893|593169981|FG000|Overall Study|Patient choice|0|||
164219123|NCT00724893|593169982|FG001|Overall Study|Patient choice|26|||
164219124|NCT00724893|593169981|FG000|Overall Study|Geographic reasons|0|||
164219125|NCT00724893|593169982|FG001|Overall Study|Geographic reasons|11|||
164219126|NCT00724893|593169981|FG000|Overall Study|Incarceration|0|||
164219127|NCT00724893|593169982|FG001|Overall Study|Incarceration|9|||
164219128|NCT00724893|593169981|FG000|Overall Study|Substance abuse|0|||
164219129|NCT00724893|593169982|FG001|Overall Study|Substance abuse|3|||
164219130|NCT00724893|593169981|FG000|Overall Study|Financial reasons|0|||
164219131|NCT00724893|593169982|FG001|Overall Study|Financial reasons|2|||
164219132|NCT00724893|593169981|FG000|Overall Study|Assigned shorter treatment|0|||
164219133|NCT00724893|593169982|FG001|Overall Study|Assigned shorter treatment|2|||
164219134|NCT00724893|593169981|FG000|Overall Study|Lost to Follow-up|0|||
164219135|NCT00724893|593169982|FG001|Overall Study|Lost to Follow-up|52|||
164219136|NCT00724893|593169981|FG000|Overall Study|Unknown, missing data|1|||
164219137|NCT00724893|593169982|FG001|Overall Study|Unknown, missing data|1|||
164219138|NCT01279200|593169985|FG000|Overall Study|Withdrawal by Subject|1|||
164219139|NCT01279200|593169986|FG001|Overall Study|Withdrawal by Subject|3|||
164219140|NCT01279200|593169985|FG000|Overall Study|Patient withdrawal due to high cost|0|||
164219141|NCT01279200|593169986|FG001|Overall Study|Patient withdrawal due to high cost|1|||
164219142|NCT01279200|593169985|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
164219143|NCT01279200|593169986|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
164219144|NCT01279200|593169985|FG000|Overall Study|ultrasound screening failure|0|||
164219145|NCT01279200|593169986|FG001|Overall Study|ultrasound screening failure|1|||
164219146|NCT01279200|593169985|FG000|Overall Study|Lost to Follow-up|0|||
164219147|NCT01279200|593169986|FG001|Overall Study|Lost to Follow-up|1|||
164219148|NCT01279200|593169985|FG000|Overall Study|Adverse Event|1|||
164219149|NCT01279200|593169986|FG001|Overall Study|Adverse Event|0|||
164219150|NCT01399099|593169987|FG000|Overall Study|Lost to Follow-up|14|||
164219151|NCT01399099|593169987|FG000|Overall Study|Physician Decision|1|||
164219152|NCT01399099|593169987|FG000|Overall Study|Protocol Violation|1|||
164328682|NCT01178073|593579580|FG001|Overall Study|Protocol Violation|1|||
164328683|NCT01178073|593579581|FG002|Overall Study|Protocol Violation|1|||
164328684|NCT01178073|593579579|FG000|Overall Study|Lost to Follow-up|2|||
164328685|NCT01178073|593579580|FG001|Overall Study|Lost to Follow-up|0|||
164328686|NCT01178073|593579581|FG002|Overall Study|Lost to Follow-up|3|||
164328687|NCT01178073|593579579|FG000|Overall Study|Physician Decision|14|||
164328688|NCT01178073|593579580|FG001|Overall Study|Physician Decision|10|||
164328689|NCT01178073|593579581|FG002|Overall Study|Physician Decision|10|||
164328690|NCT01178073|593579579|FG000|Overall Study|Withdrawal by Subject|10|||
164328691|NCT01178073|593579580|FG001|Overall Study|Withdrawal by Subject|6|||
164328692|NCT01178073|593579581|FG002|Overall Study|Withdrawal by Subject|8|||
164328693|NCT01178073|593579579|FG000|Overall Study|Missing Completion Status|1|||
164328694|NCT01178073|593579580|FG001|Overall Study|Missing Completion Status|0|||
164328695|NCT01178073|593579581|FG002|Overall Study|Missing Completion Status|0|||
164328696|NCT01674634|593579582|FG000|Overall Study|Withdrawal by Subject|3|||
164328697|NCT01674634|593579582|FG000|Overall Study|Lost to Follow-up|3|||
164328698|NCT00937391|593579583|FG000|Stage 2|Withdrawal by Subject|1|||
164328699|NCT01226043|593579593|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
164328700|NCT01226043|593579594|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
164328701|NCT01226043|593579595|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
164328702|NCT01226043|593579596|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
164328703|NCT01226043|593579593|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
164328704|NCT01226043|593579594|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
164328705|NCT01226043|593579595|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
164328706|NCT01226043|593579596|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
164328707|NCT01226043|593579593|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
164328708|NCT01226043|593579594|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
164328709|NCT01226043|593579595|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
164328710|NCT01226043|593579596|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
164328711|NCT01226043|593579593|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
164328712|NCT01226043|593579594|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
164328713|NCT01226043|593579595|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
164328714|NCT01226043|593579596|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
164328715|NCT01226043|593579593|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
164328716|NCT01226043|593579594|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
164328717|NCT01226043|593579595|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
164328718|NCT01226043|593579596|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
164328719|NCT01226043|593579593|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
164328720|NCT01226043|593579594|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
164328721|NCT01226043|593579595|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
164328722|NCT01226043|593579596|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
164328723|NCT01226043|593579593|FG000|6-week Re-randomization Phase|Adverse Event|0|||
164328724|NCT01226043|593579594|FG001|6-week Re-randomization Phase|Adverse Event|0|||
164328725|NCT01226043|593579595|FG002|6-week Re-randomization Phase|Adverse Event|1|||
164328726|NCT01226043|593579596|FG003|6-week Re-randomization Phase|Adverse Event|1|||
164328727|NCT01226043|593579593|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
164328728|NCT01226043|593579594|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
164328729|NCT01226043|593579595|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
164328730|NCT01226043|593579596|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
164219153|NCT01399099|593169987|FG000|Overall Study|Skin Irritation|13|||
164219154|NCT01399099|593169987|FG000|Overall Study|Infection|1|||
164328731|NCT01226043|593579593|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
164219155|NCT01399099|593169987|FG000|Overall Study|Miscellaneous|4|||
164219156|NCT01179516|593169988|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
164328732|NCT01226043|593579594|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
164219157|NCT01179516|593169989|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
164328733|NCT01226043|593579595|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
164219158|NCT01179516|593169990|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
164219159|NCT01179516|593169988|FG000|Overall Study|Lack of Efficacy|4|||
164219160|NCT01179516|593169989|FG001|Overall Study|Lack of Efficacy|2|||
164219161|NCT01179516|593169990|FG002|Overall Study|Lack of Efficacy|0|||
164219162|NCT01179516|593169988|FG000|Overall Study|Noncompliance with Study Drug|2|||
164219163|NCT01179516|593169989|FG001|Overall Study|Noncompliance with Study Drug|0|||
164219164|NCT01179516|593169990|FG002|Overall Study|Noncompliance with Study Drug|1|||
164219165|NCT01179516|593169988|FG000|Overall Study|Protocol Deviations|4|||
164219166|NCT01179516|593169989|FG001|Overall Study|Protocol Deviations|3|||
164219167|NCT01179516|593169990|FG002|Overall Study|Protocol Deviations|3|||
164219168|NCT01179516|593169988|FG000|Overall Study|Withdrawal of Consent|2|||
164219169|NCT01179516|593169989|FG001|Overall Study|Withdrawal of Consent|6|||
164219170|NCT01179516|593169990|FG002|Overall Study|Withdrawal of Consent|10|||
164219171|NCT01179516|593169988|FG000|Overall Study|Lost to Follow-up|7|||
164219172|NCT01179516|593169989|FG001|Overall Study|Lost to Follow-up|7|||
164219173|NCT01179516|593169990|FG002|Overall Study|Lost to Follow-up|3|||
164219174|NCT01179516|593169988|FG000|Overall Study|Other|2|||
164219175|NCT01179516|593169989|FG001|Overall Study|Other|0|||
164219176|NCT01179516|593169990|FG002|Overall Study|Other|2|||
164219177|NCT01668537|593169991|FG000|Overall Study|Request to Discontinue Prematurely|1|||
164219178|NCT01668537|593169992|FG001|Overall Study|Request to Discontinue Prematurely|1|||
164219179|NCT01668537|593169991|FG000|Overall Study|Subject unwilling/unable to comply|5|||
164219180|NCT01668537|593169992|FG001|Overall Study|Subject unwilling/unable to comply|0|||
164219181|NCT01668537|593169991|FG000|Overall Study|Reason Precludes Participation|1|||
164219182|NCT01668537|593169992|FG001|Overall Study|Reason Precludes Participation|0|||
164219183|NCT01668537|593169991|FG000|Overall Study|Lost to Follow-up|13|||
164219184|NCT01668537|593169992|FG001|Overall Study|Lost to Follow-up|6|||
164219185|NCT01668537|593169991|FG000|Overall Study|Other|2|||
164219186|NCT01668537|593169992|FG001|Overall Study|Other|3|||
164219187|NCT01149538|593169993|FG000|Overall Study|Lost to Follow-up|0|||
164219188|NCT01149538|593169994|FG001|Overall Study|Lost to Follow-up|1|||
164219189|NCT01149538|593169993|FG000|Overall Study|Withdrawal by Subject|5|||
164219190|NCT01149538|593169994|FG001|Overall Study|Withdrawal by Subject|3|||
164219191|NCT03412890|593169997|FG000|Overall Study|Adverse Event|5|||
164219192|NCT03412890|593169998|FG001|Overall Study|Adverse Event|5|||
164219193|NCT03412890|593169999|FG002|Overall Study|Adverse Event|9|||
164219194|NCT03412890|593169997|FG000|Overall Study|Protocol deviation|2|||
164219195|NCT03412890|593169998|FG001|Overall Study|Protocol deviation|1|||
164219196|NCT03412890|593169999|FG002|Overall Study|Protocol deviation|2|||
164219197|NCT03412890|593169997|FG000|Overall Study|Lost to Follow-up|7|||
164219198|NCT03412890|593169998|FG001|Overall Study|Lost to Follow-up|10|||
164219199|NCT03412890|593169999|FG002|Overall Study|Lost to Follow-up|10|||
164420689|NCT01154036|593910964|FG002|Phase II|Protocol Violation|0|||
164219200|NCT03412890|593169997|FG000|Overall Study|Withdrawal by Subject|9|||
164219201|NCT03412890|593169998|FG001|Overall Study|Withdrawal by Subject|12|||
164219202|NCT03412890|593169999|FG002|Overall Study|Withdrawal by Subject|11|||
164219203|NCT03412890|593169997|FG000|Overall Study|Lack of Efficacy|2|||
164219204|NCT03412890|593169998|FG001|Overall Study|Lack of Efficacy|7|||
164219205|NCT03412890|593169999|FG002|Overall Study|Lack of Efficacy|5|||
164219206|NCT03412890|593169997|FG000|Overall Study|Other|5|||
164219207|NCT03412890|593169998|FG001|Overall Study|Other|6|||
164219208|NCT03412890|593169999|FG002|Overall Study|Other|5|||
164219209|NCT03412890|593169997|FG000|Overall Study|Participants who did not receive any study drug|0|||
164219210|NCT03412890|593169998|FG001|Overall Study|Participants who did not receive any study drug|1|||
164219211|NCT03412890|593169999|FG002|Overall Study|Participants who did not receive any study drug|0|||
164219212|NCT02336503|593170000|FG000|Overall Study|Lost to Follow-up|0|||
164219213|NCT02336503|593170001|FG001|Overall Study|Lost to Follow-up|3|||
164219214|NCT02336503|593170002|FG002|Overall Study|Lost to Follow-up|0|||
164219215|NCT02336503|593170003|FG003|Overall Study|Lost to Follow-up|2|||
164219216|NCT02336503|593170000|FG000|Overall Study|Withdrawal by Subject|2|||
164219217|NCT02336503|593170001|FG001|Overall Study|Withdrawal by Subject|0|||
164219218|NCT02336503|593170002|FG002|Overall Study|Withdrawal by Subject|0|||
164219219|NCT02336503|593170003|FG003|Overall Study|Withdrawal by Subject|4|||
164219220|NCT02336503|593170000|FG000|Overall Study|Adverse Event|0|||
164219221|NCT02336503|593170001|FG001|Overall Study|Adverse Event|0|||
164219222|NCT02336503|593170002|FG002|Overall Study|Adverse Event|1|||
164328734|NCT01226043|593579596|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
164328735|NCT01226043|593579593|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
164328736|NCT01226043|593579594|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
164566942|NCT01717638|594445265|FG007|Overall Study|Lost to Follow-up|0|||
164566943|NCT01717638|594445266|FG008|Overall Study|Lost to Follow-up|0|||
164566944|NCT01717638|594445267|FG009|Overall Study|Lost to Follow-up|0|||
164566945|NCT01717638|594445268|FG010|Overall Study|Lost to Follow-up|0|||
164566946|NCT01717638|594445269|FG011|Overall Study|Lost to Follow-up|0|||
164566947|NCT01717638|594445270|FG012|Overall Study|Lost to Follow-up|0|||
164566948|NCT01717638|594445258|FG000|Overall Study|Father in hospital|0|||
164566949|NCT01717638|594445259|FG001|Overall Study|Father in hospital|0|||
164566950|NCT01717638|594445260|FG002|Overall Study|Father in hospital|0|||
164566951|NCT01717638|594445261|FG003|Overall Study|Father in hospital|0|||
164566952|NCT01717638|594445262|FG004|Overall Study|Father in hospital|0|||
164566953|NCT01717638|594445263|FG005|Overall Study|Father in hospital|0|||
164566954|NCT01717638|594445264|FG006|Overall Study|Father in hospital|0|||
164566955|NCT01717638|594445265|FG007|Overall Study|Father in hospital|0|||
164566956|NCT01717638|594445266|FG008|Overall Study|Father in hospital|0|||
164566957|NCT01717638|594445267|FG009|Overall Study|Father in hospital|0|||
164566958|NCT01717638|594445268|FG010|Overall Study|Father in hospital|0|||
164566959|NCT01717638|594445269|FG011|Overall Study|Father in hospital|0|||
164566960|NCT01717638|594445270|FG012|Overall Study|Father in hospital|1|||
164566961|NCT01717638|594445258|FG000|Overall Study|Withdrawal by Subject|0|||
164566962|NCT01717638|594445259|FG001|Overall Study|Withdrawal by Subject|1|||
164566963|NCT01717638|594445260|FG002|Overall Study|Withdrawal by Subject|1|||
164566964|NCT01717638|594445261|FG003|Overall Study|Withdrawal by Subject|0|||
164566965|NCT01717638|594445262|FG004|Overall Study|Withdrawal by Subject|1|||
164566966|NCT01717638|594445263|FG005|Overall Study|Withdrawal by Subject|0|||
164566967|NCT01717638|594445264|FG006|Overall Study|Withdrawal by Subject|2|||
164566968|NCT01717638|594445265|FG007|Overall Study|Withdrawal by Subject|1|||
164566969|NCT01717638|594445266|FG008|Overall Study|Withdrawal by Subject|2|||
164566970|NCT01717638|594445267|FG009|Overall Study|Withdrawal by Subject|1|||
164566971|NCT01717638|594445268|FG010|Overall Study|Withdrawal by Subject|0|||
164566972|NCT01717638|594445269|FG011|Overall Study|Withdrawal by Subject|0|||
164566973|NCT01717638|594445270|FG012|Overall Study|Withdrawal by Subject|18|||
164566974|NCT01719757|594445271|FG000|Overall Study|Adverse Event|38|||
164566975|NCT01719757|594445271|FG000|Overall Study|Withdrawal by Subject|15|||
164566976|NCT01719757|594445271|FG000|Overall Study|Lost to Follow-up|20|||
164566977|NCT01719757|594445271|FG000|Overall Study|Protocol Violation|1|||
164219223|NCT02336503|593170003|FG003|Overall Study|Adverse Event|0|||
164219224|NCT01436500|593170004|FG000|Overall Study|Death|1|||
164219225|NCT01436500|593170005|FG001|Overall Study|Death|0|||
164219226|NCT01436500|593170006|FG002|Overall Study|Death|0|||
164219227|NCT01436500|593170007|FG003|Overall Study|Death|0|||
164219228|NCT01436500|593170008|FG004|Overall Study|Death|0|||
164219229|NCT01436500|593170004|FG000|Overall Study|Adverse Event|0|||
164566978|NCT01719757|594445271|FG000|Overall Study|well controlled pain|27|||
164566979|NCT02626338|594445272|FG000|Overall Study|Lack of Efficacy|3|||
164219230|NCT01436500|593170005|FG001|Overall Study|Adverse Event|2|||
164219231|NCT01436500|593170006|FG002|Overall Study|Adverse Event|2|||
164219232|NCT01436500|593170007|FG003|Overall Study|Adverse Event|0|||
164219233|NCT01436500|593170008|FG004|Overall Study|Adverse Event|1|||
164566980|NCT02626338|594445273|FG001|Overall Study|Lack of Efficacy|2|||
164566981|NCT02626338|594445274|FG002|Overall Study|Lack of Efficacy|0|||
164566982|NCT03312218|594445280|FG000|Overall Study|Never signed in to access the app|54|||
164566983|NCT03312218|594445281|FG001|Overall Study|Never signed in to access the app|58|||
164566984|NCT05742984|594445282|FG000|Overall Study|Adverse Event|0|||
164566985|NCT05742984|594445283|FG001|Overall Study|Adverse Event|0|||
164566986|NCT05742984|594445284|FG002|Overall Study|Adverse Event|1|||
164566987|NCT05742984|594445285|FG003|Overall Study|Adverse Event|0|||
164566988|NCT05742984|594445286|FG004|Overall Study|Adverse Event|1|||
164566989|NCT05742984|594445287|FG005|Overall Study|Adverse Event|1|||
164566990|NCT05742984|594445282|FG000|Overall Study|Withdrawal by Subject|0|||
164566991|NCT05742984|594445283|FG001|Overall Study|Withdrawal by Subject|1|||
164566992|NCT05742984|594445284|FG002|Overall Study|Withdrawal by Subject|0|||
164566993|NCT05742984|594445285|FG003|Overall Study|Withdrawal by Subject|0|||
164566994|NCT05742984|594445286|FG004|Overall Study|Withdrawal by Subject|0|||
164566995|NCT05742984|594445287|FG005|Overall Study|Withdrawal by Subject|2|||
164566996|NCT02162862|594445288|FG000|Overall Study|Lost to Follow-up|0|||
164566997|NCT02162862|594445289|FG001|Overall Study|Lost to Follow-up|11|||
164566998|NCT02162862|594445290|FG002|Overall Study|Lost to Follow-up|0|||
164566999|NCT02162862|594445288|FG000|Overall Study|Subject did not feel the med was needed|0|||
164567000|NCT02162862|594445289|FG001|Overall Study|Subject did not feel the med was needed|0|||
164567001|NCT02162862|594445290|FG002|Overall Study|Subject did not feel the med was needed|4|||
164567002|NCT03116113|594445291|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
164567003|NCT03116113|594445292|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
164567004|NCT03116113|594445293|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
164567005|NCT03116113|594445294|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
164567006|NCT03116113|594445295|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
164567007|NCT03116113|594445296|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
164219234|NCT01436500|593170004|FG000|Overall Study|Withdrawal by Subject|0|||
164219235|NCT01436500|593170005|FG001|Overall Study|Withdrawal by Subject|0|||
164219236|NCT01436500|593170006|FG002|Overall Study|Withdrawal by Subject|2|||
164219237|NCT01436500|593170007|FG003|Overall Study|Withdrawal by Subject|0|||
164219238|NCT01436500|593170008|FG004|Overall Study|Withdrawal by Subject|2|||
164219239|NCT01436500|593170004|FG000|Overall Study|Physician Decision|0|||
164567008|NCT03116113|594445297|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
164567009|NCT03116113|594445298|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
164567010|NCT03116113|594445299|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
164567011|NCT02159807|594445300|FG000|Overall Study|Adverse Event|0|||
164567012|NCT02159807|594445301|FG001|Overall Study|Adverse Event|0|||
164567013|NCT02159807|594445302|FG002|Overall Study|Adverse Event|1|||
164567014|NCT02159807|594445300|FG000|Overall Study|No CSF|1|||
164567015|NCT02159807|594445301|FG001|Overall Study|No CSF|1|||
164567016|NCT02159807|594445302|FG002|Overall Study|No CSF|1|||
164567017|NCT02159807|594445300|FG000|Overall Study|elevated blood pressure|0|||
164567018|NCT02159807|594445301|FG001|Overall Study|elevated blood pressure|0|||
164567019|NCT02159807|594445302|FG002|Overall Study|elevated blood pressure|1|||
164567020|NCT01254669|594445303|FG000|Overall Study|Withdrawal by Subject|0|||
164567021|NCT01254669|594445304|FG001|Overall Study|Withdrawal by Subject|1|||
164567022|NCT01254669|594445303|FG000|Overall Study|time constraint|2|||
164567023|NCT01254669|594445304|FG001|Overall Study|time constraint|2|||
164219240|NCT01436500|593170005|FG001|Overall Study|Physician Decision|0|||
164219241|NCT01436500|593170006|FG002|Overall Study|Physician Decision|1|||
164219242|NCT01436500|593170007|FG003|Overall Study|Physician Decision|0|||
164219243|NCT01436500|593170008|FG004|Overall Study|Physician Decision|0|||
164219244|NCT01436500|593170004|FG000|Overall Study|liver transplant|1|||
164219245|NCT01436500|593170005|FG001|Overall Study|liver transplant|0|||
164219246|NCT01436500|593170006|FG002|Overall Study|liver transplant|0|||
164219247|NCT01436500|593170007|FG003|Overall Study|liver transplant|0|||
164219248|NCT01436500|593170008|FG004|Overall Study|liver transplant|0|||
164219249|NCT01436500|593170004|FG000|Overall Study|initiation of dialysis|0|||
164219250|NCT01436500|593170005|FG001|Overall Study|initiation of dialysis|0|||
164219251|NCT01436500|593170006|FG002|Overall Study|initiation of dialysis|0|||
164219252|NCT01436500|593170007|FG003|Overall Study|initiation of dialysis|0|||
164219253|NCT01436500|593170008|FG004|Overall Study|initiation of dialysis|1|||
164219254|NCT01436500|593170004|FG000|Overall Study|discontinued study drug|1|||
164219255|NCT01436500|593170005|FG001|Overall Study|discontinued study drug|0|||
164219256|NCT01436500|593170006|FG002|Overall Study|discontinued study drug|0|||
164219257|NCT01436500|593170007|FG003|Overall Study|discontinued study drug|0|||
164219258|NCT01436500|593170008|FG004|Overall Study|discontinued study drug|0|||
164219259|NCT01436500|593170004|FG000|Overall Study|Other|0|||
164219260|NCT01436500|593170005|FG001|Overall Study|Other|1|||
164219261|NCT01436500|593170006|FG002|Overall Study|Other|0|||
164219262|NCT01436500|593170007|FG003|Overall Study|Other|1|||
164219263|NCT01436500|593170008|FG004|Overall Study|Other|0|||
164219264|NCT02021318|593170012|FG000|Overall Study|Adverse Event|2|||
164219265|NCT02021318|593170013|FG001|Overall Study|Adverse Event|1|||
164219266|NCT02021318|593170012|FG000|Overall Study|Death|33|||
164219267|NCT02021318|593170013|FG001|Overall Study|Death|34|||
164219268|NCT02021318|593170012|FG000|Overall Study|Lost to Follow-up|3|||
164219269|NCT02021318|593170013|FG001|Overall Study|Lost to Follow-up|3|||
164219270|NCT02021318|593170012|FG000|Overall Study|Progressive Disease|0|||
164219271|NCT02021318|593170013|FG001|Overall Study|Progressive Disease|1|||
164219272|NCT02021318|593170012|FG000|Overall Study|Withdrawal by Subject|30|||
164219273|NCT02021318|593170013|FG001|Overall Study|Withdrawal by Subject|18|||
164219274|NCT02021318|593170012|FG000|Overall Study|Physician Decision|3|||
164219275|NCT02021318|593170013|FG001|Overall Study|Physician Decision|3|||
164219276|NCT02021318|593170012|FG000|Overall Study|Miscellaneous|2|||
164219277|NCT02021318|593170013|FG001|Overall Study|Miscellaneous|3|||
164219278|NCT01068249|593170014|FG000|Overall Study|Death|1|||
164219279|NCT01068249|593170014|FG000|Overall Study|Withdrawal by Subject|3|||
164219280|NCT01740427|593170015|FG000|Overall Study|Objective Progression or Relapse|286|||
164219281|NCT01740427|593170016|FG001|Overall Study|Objective Progression or Relapse|172|||
164219282|NCT01740427|593170015|FG000|Overall Study|Adverse Event|32|||
164219283|NCT01740427|593170016|FG001|Overall Study|Adverse Event|9|||
164219284|NCT01740427|593170015|FG000|Overall Study|Global Deterioration of Health Status|28|||
164219285|NCT01740427|593170016|FG001|Overall Study|Global Deterioration of Health Status|12|||
164219286|NCT01740427|593170015|FG000|Overall Study|Participant Refused Continued Treatment|27|||
164219287|NCT01740427|593170016|FG001|Overall Study|Participant Refused Continued Treatment|15|||
164219288|NCT01740427|593170015|FG000|Overall Study|Unspecified reasons|52|||
164219289|NCT01740427|593170016|FG001|Overall Study|Unspecified reasons|8|||
164670822|NCT05093205|594821312|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
164670823|NCT05093205|594821313|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
164670824|NCT05093205|594821314|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
164670825|NCT05093205|594821315|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
164670826|NCT05093205|594821316|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
164670827|NCT05093205|594821317|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
164670828|NCT05093205|594821318|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
164670829|NCT05093205|594821319|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
164670830|NCT05093205|594821320|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
164670831|NCT05093205|594821308|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
164670832|NCT05093205|594821309|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
164670833|NCT05093205|594821310|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
164670834|NCT05093205|594821311|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
164670835|NCT05093205|594821312|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
164670836|NCT05093205|594821313|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
164670837|NCT05093205|594821314|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
164670838|NCT05093205|594821315|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
164670839|NCT05093205|594821316|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
164670840|NCT05093205|594821317|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
164219290|NCT01740427|593170015|FG000|Overall Study|Death|10|||
164219291|NCT01740427|593170016|FG001|Overall Study|Death|3|||
164219292|NCT01740427|593170015|FG000|Overall Study|Protocol Violation|5|||
164219293|NCT01740427|593170016|FG001|Overall Study|Protocol Violation|3|||
164219294|NCT01740427|593170015|FG000|Overall Study|Lost to Follow-up|3|||
164219295|NCT01740427|593170016|FG001|Overall Study|Lost to Follow-up|0|||
164219296|NCT01740427|593170015|FG000|Overall Study|Site Terminated by Sponsor|1|||
164219297|NCT01740427|593170016|FG001|Overall Study|Site Terminated by Sponsor|0|||
164219298|NCT02184156|593170019|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
164219299|NCT02184156|593170020|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
164219300|NCT02184156|593170019|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
164219301|NCT02184156|593170020|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
164219302|NCT00165698|593170022|FG000|Overall Study|Adverse Event|2|||
164219303|NCT00165698|593170023|FG001|Overall Study|Adverse Event|10|||
164219304|NCT00165698|593170022|FG000|Overall Study|Lost to Follow-up|2|||
164219305|NCT00165698|593170023|FG001|Overall Study|Lost to Follow-up|2|||
164219306|NCT00165698|593170022|FG000|Overall Study|Withdrawal by Subject|2|||
164219307|NCT00165698|593170023|FG001|Overall Study|Withdrawal by Subject|1|||
164219308|NCT00165698|593170022|FG000|Overall Study|Protocol Violation|1|||
164219309|NCT00165698|593170023|FG001|Overall Study|Protocol Violation|0|||
164219310|NCT00165698|593170022|FG000|Overall Study|Not Taken/Lost the medicine|1|||
164567024|NCT01254669|594445303|FG000|Overall Study|called to clinic during intervention|1|||
164567025|NCT01254669|594445304|FG001|Overall Study|called to clinic during intervention|1|||
164219311|NCT00165698|593170023|FG001|Overall Study|Not Taken/Lost the medicine|2|||
164219312|NCT01483651|593170024|FG000|Overall Study|Withdrawal by Subject|0|||
164219313|NCT01483651|593170025|FG001|Overall Study|Withdrawal by Subject|1|||
164567026|NCT00542191|594445308|FG000|Overall Study|Death|3|||
164567027|NCT00103012|594445309|FG000|Overall Study|Withdrawal by Subject|2|||
164567028|NCT00103012|594445310|FG001|Overall Study|Withdrawal by Subject|1|||
164567029|NCT00103012|594445311|FG002|Overall Study|Withdrawal by Subject|2|||
164567030|NCT00103012|594445309|FG000|Overall Study|Pregnancy|1|||
164567031|NCT00103012|594445310|FG001|Overall Study|Pregnancy|0|||
164567032|NCT00103012|594445311|FG002|Overall Study|Pregnancy|0|||
164567033|NCT00103012|594445309|FG000|Overall Study|Adverse Event|0|||
164567034|NCT00103012|594445310|FG001|Overall Study|Adverse Event|0|||
164567035|NCT00103012|594445311|FG002|Overall Study|Adverse Event|1|||
164219314|NCT01483651|593170026|FG002|Overall Study|Withdrawal by Subject|1|||
164670841|NCT05093205|594821318|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
164670842|NCT05093205|594821319|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
164670843|NCT05093205|594821320|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
164670844|NCT05093205|594821308|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
164670845|NCT05093205|594821309|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
164670846|NCT05093205|594821310|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
164670847|NCT05093205|594821311|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
164670848|NCT05093205|594821312|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
164670849|NCT05093205|594821313|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
164670850|NCT05093205|594821314|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
164670851|NCT05093205|594821315|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
164670852|NCT05093205|594821316|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
164670853|NCT05093205|594821317|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
164670854|NCT05093205|594821318|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
164670855|NCT05093205|594821319|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
164670856|NCT05093205|594821320|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
164670857|NCT05093205|594821308|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
164219315|NCT01483651|593170027|FG003|Overall Study|Withdrawal by Subject|0|||
164219316|NCT01483651|593170028|FG004|Overall Study|Withdrawal by Subject|0|||
164219317|NCT01483651|593170029|FG005|Overall Study|Withdrawal by Subject|1|||
164219318|NCT02547935|593170030|FG000|Overall Study|Other|0|||
164219319|NCT02547935|593170031|FG001|Overall Study|Other|1|||
164219320|NCT02547935|593170032|FG002|Overall Study|Other|0|||
164219321|NCT02547935|593170030|FG000|Overall Study|Withdrawal by Subject|2|||
164219322|NCT02547935|593170031|FG001|Overall Study|Withdrawal by Subject|3|||
164219323|NCT02547935|593170032|FG002|Overall Study|Withdrawal by Subject|4|||
164219324|NCT02547935|593170030|FG000|Overall Study|Screen Failure|2|||
164219325|NCT02547935|593170031|FG001|Overall Study|Screen Failure|0|||
164219326|NCT02547935|593170032|FG002|Overall Study|Screen Failure|0|||
164219327|NCT02547935|593170030|FG000|Overall Study|Physician Decision|0|||
164219328|NCT02547935|593170031|FG001|Overall Study|Physician Decision|1|||
164219329|NCT02547935|593170032|FG002|Overall Study|Physician Decision|0|||
164219330|NCT02547935|593170030|FG000|Overall Study|Lost to Follow-up|0|||
164219331|NCT02547935|593170031|FG001|Overall Study|Lost to Follow-up|2|||
164219332|NCT02547935|593170032|FG002|Overall Study|Lost to Follow-up|1|||
164219333|NCT02547935|593170030|FG000|Overall Study|Death|1|||
164219334|NCT02547935|593170031|FG001|Overall Study|Death|1|||
164219335|NCT02547935|593170032|FG002|Overall Study|Death|0|||
164219336|NCT01937117|593170037|FG000|Overall Study|Disease Progression|7|||
164219337|NCT01937117|593170037|FG000|Overall Study|Physician Decision|4|||
164219338|NCT01937117|593170037|FG000|Overall Study|Adverse Event|2|||
164219339|NCT01695772|593170044|FG000|Overall Study|Withdrawal by Subject|18|||
164219340|NCT01695772|593170044|FG000|Overall Study|Progressive Disease|8|||
164219341|NCT01695772|593170044|FG000|Overall Study|Investigator Decision|5|||
164219342|NCT01695772|593170044|FG000|Overall Study|Lost to Follow-up|4|||
164219343|NCT01695772|593170044|FG000|Overall Study|Protocol Violation|2|||
164219344|NCT01695772|593170044|FG000|Overall Study|Unspecified Reason|1|||
164219345|NCT01567085|593171732|FG000|Overall Study|Death|6|||
164219346|NCT01567085|593171732|FG000|Overall Study|Adverse Event|6|||
164219347|NCT01567085|593171732|FG000|Overall Study|Lost to Follow-up|3|||
164219348|NCT01567085|593171732|FG000|Overall Study|Graft loss|2|||
164219349|NCT01567085|593171732|FG000|Overall Study|Renal transplantectomy|1|||
164219350|NCT01567085|593171732|FG000|Overall Study|Returned to chronic dialysis|1|||
164219351|NCT01567085|593171732|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
164219352|NCT04193176|593171733|FG000|Overall Study|Withdrawal by Subject|6|||
164219353|NCT04193176|593171734|FG001|Overall Study|Withdrawal by Subject|10|||
164219354|NCT00944645|593171739|FG000|Period 2|Adverse Event|1|||
164219355|NCT00944645|593171740|FG001|Period 2|Adverse Event|0|||
164219356|NCT00944645|593171739|FG000|Period 2|Lost to Follow-up|0|||
164219357|NCT00944645|593171740|FG001|Period 2|Lost to Follow-up|3|||
164219358|NCT00944645|593171739|FG000|Period 2|Withdrawal by Subject|7|||
164219359|NCT00944645|593171740|FG001|Period 2|Withdrawal by Subject|6|||
164219360|NCT03537729|593171744|FG000|Overall Study|Death|2|||
164219361|NCT03537729|593171745|FG001|Overall Study|Death|2|||
164219362|NCT03537729|593171746|FG002|Overall Study|Death|7|||
164219363|NCT03537729|593171744|FG000|Overall Study|Withdrawal by Subject|3|||
164219364|NCT03537729|593171745|FG001|Overall Study|Withdrawal by Subject|3|||
164219365|NCT03537729|593171746|FG002|Overall Study|Withdrawal by Subject|0|||
164219366|NCT03537729|593171744|FG000|Overall Study|Subject Moved|8|||
164219367|NCT03537729|593171745|FG001|Overall Study|Subject Moved|5|||
164670858|NCT05093205|594821309|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
164670859|NCT05093205|594821310|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
164670860|NCT05093205|594821311|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
164219368|NCT03537729|593171746|FG002|Overall Study|Subject Moved|4|||
164219369|NCT03537729|593171744|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
164219370|NCT03537729|593171745|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
164219371|NCT03537729|593171746|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
164219372|NCT03537729|593171744|FG000|Overall Study|COVID-19 Site Restrictions|11|||
164219373|NCT03537729|593171745|FG001|Overall Study|COVID-19 Site Restrictions|15|||
164219374|NCT03537729|593171746|FG002|Overall Study|COVID-19 Site Restrictions|18|||
164219375|NCT03537729|593171744|FG000|Overall Study|Decline in Health|5|||
164219376|NCT03537729|593171745|FG001|Overall Study|Decline in Health|9|||
164219377|NCT03537729|593171746|FG002|Overall Study|Decline in Health|4|||
164219378|NCT03537729|593171744|FG000|Overall Study|Determined Ineligible|0|||
164219379|NCT03537729|593171745|FG001|Overall Study|Determined Ineligible|0|||
164219380|NCT03537729|593171746|FG002|Overall Study|Determined Ineligible|1|||
164219381|NCT00284934|593171749|FG000|Overall Study|Adverse Event|1|||
164219382|NCT00284934|593171750|FG001|Overall Study|Adverse Event|2|||
164219383|NCT00284934|593171749|FG000|Overall Study|Other reasons|3|||
164219384|NCT00284934|593171750|FG001|Overall Study|Other reasons|1|||
164219385|NCT01783015|593171756|FG000|Blinded Treatment|Adverse Event|0|||
164219386|NCT01783015|593171757|FG001|Blinded Treatment|Adverse Event|1|||
164219387|NCT01783015|593171758|FG002|Blinded Treatment|Adverse Event|0|||
164219388|NCT01783015|593171756|FG000|Blinded Treatment|Protocol Violation|0|||
164219389|NCT01783015|593171757|FG001|Blinded Treatment|Protocol Violation|1|||
164219390|NCT01783015|593171758|FG002|Blinded Treatment|Protocol Violation|0|||
164219391|NCT01783015|593171756|FG000|Blinded Treatment|Withdrawal by Subject|0|||
164219392|NCT01783015|593171757|FG001|Blinded Treatment|Withdrawal by Subject|1|||
164219393|NCT01783015|593171758|FG002|Blinded Treatment|Withdrawal by Subject|0|||
164219394|NCT01783015|593171756|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
164219395|NCT01783015|593171757|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
164219396|NCT01783015|593171758|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
164219397|NCT01783015|593171756|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
164219398|NCT01783015|593171757|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
164219399|NCT01783015|593171758|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
164219400|NCT01348698|593171759|FG000|Overall Study|Does not meet lesion size criteria|1|||
164219401|NCT01348698|593171759|FG000|Overall Study|Death|3|||
164219402|NCT01348698|593171759|FG000|Overall Study|PI decision to close study|68|||
164219403|NCT02502383|593171762|FG000|Overall Study|Lost to Follow-up|130|||
164219404|NCT02502383|593171763|FG001|Overall Study|Lost to Follow-up|131|||
164219405|NCT02502383|593171762|FG000|Overall Study|Withdrawal by Subject|31|||
164219406|NCT02502383|593171763|FG001|Overall Study|Withdrawal by Subject|24|||
164219407|NCT01428713|593171764|FG000|Overall Study|Non-compliance|2|||
164219408|NCT01428713|593171765|FG001|Overall Study|Non-compliance|2|||
164219409|NCT01428713|593171764|FG000|Overall Study|Withdrawal by Subject|1|||
164219410|NCT01428713|593171765|FG001|Overall Study|Withdrawal by Subject|1|||
164219411|NCT01428713|593171764|FG000|Overall Study|Adverse Event|0|||
164219412|NCT01428713|593171765|FG001|Overall Study|Adverse Event|2|||
164219413|NCT00875667|593171766|FG000|Overall Study|Adverse Event|29|||
164219414|NCT00875667|593171767|FG001|Overall Study|Adverse Event|10|||
164219415|NCT00875667|593171766|FG000|Overall Study|Withdrawal by Subject|17|||
164219416|NCT00875667|593171767|FG001|Overall Study|Withdrawal by Subject|5|||
164219417|NCT00875667|593171766|FG000|Overall Study|Death|7|||
164219418|NCT00875667|593171767|FG001|Overall Study|Death|2|||
164219419|NCT00875667|593171766|FG000|Overall Study|Protocol Violation|2|||
164219420|NCT00875667|593171767|FG001|Overall Study|Protocol Violation|0|||
164219421|NCT00875667|593171766|FG000|Overall Study|Disease Progression|100|||
164219422|NCT00875667|593171767|FG001|Overall Study|Disease Progression|49|||
164219423|NCT00875667|593171766|FG000|Overall Study|Miscellaneous|12|||
164567036|NCT00103012|594445309|FG000|Overall Study|Subject non-compliant with medications|0|||
164567037|NCT00103012|594445310|FG001|Overall Study|Subject non-compliant with medications|0|||
164219424|NCT00875667|593171767|FG001|Overall Study|Miscellaneous|6|||
164219425|NCT00875667|593171766|FG000|Overall Study|Randomized but no Study Drug Given|3|||
164219426|NCT00875667|593171767|FG001|Overall Study|Randomized but no Study Drug Given|1|||
164219427|NCT01441414|593171780|FG000|Overall Study|Participant died|9|||
164219428|NCT01441414|593171780|FG000|Overall Study|Other reasons|3|||
164219429|NCT01441414|593171780|FG000|Overall Study|Study terminated by sponsor|2|||
164219430|NCT01441414|593171780|FG000|Overall Study|Subject refused further follow-up|1|||
164219431|NCT03791060|593171781|FG000|Overall Study|Withdrawal by Subject|1|||
164219432|NCT01011283|593171782|FG000|Overall Study|Adverse Event|4|||
164219433|NCT01011283|593171783|FG001|Overall Study|Adverse Event|2|||
164219434|NCT01011283|593171782|FG000|Overall Study|Progressive Disease|0|||
164219435|NCT01011283|593171783|FG001|Overall Study|Progressive Disease|2|||
164219436|NCT01011283|593171782|FG000|Overall Study|Terminated by Sponsor|5|||
164219437|NCT01011283|593171783|FG001|Overall Study|Terminated by Sponsor|5|||
164219438|NCT01011283|593171782|FG000|Overall Study|Other|2|||
164219439|NCT01011283|593171783|FG001|Overall Study|Other|2|||
164219440|NCT01717859|593171784|FG000|Overall Study|Adverse Event|5|||
164219441|NCT01717859|593171784|FG000|Overall Study|Moved out of state|1|||
164219442|NCT01717859|593171784|FG000|Overall Study|Patient concerned about mental health|1|||
164219443|NCT01717859|593171784|FG000|Overall Study|Lost to Follow-up|1|||
164219444|NCT01717859|593171784|FG000|Overall Study|Withdrawal by Subject|2|||
164219445|NCT01814332|593171785|FG000|Overall Study|Adverse Event|8|||
164219446|NCT01814332|593171786|FG001|Overall Study|Adverse Event|3|||
164567038|NCT00103012|594445311|FG002|Overall Study|Subject non-compliant with medications|1|||
164567039|NCT00393718|594445318|FG000|Overall Study|Adverse Event|20|||
164567040|NCT00393718|594445319|FG001|Overall Study|Adverse Event|8|||
164567041|NCT00393718|594445318|FG000|Overall Study|Protocol Violation|1|||
164567042|NCT00393718|594445319|FG001|Overall Study|Protocol Violation|2|||
164567043|NCT00393718|594445318|FG000|Overall Study|Lack of Efficacy|10|||
164567044|NCT00393718|594445319|FG001|Overall Study|Lack of Efficacy|9|||
164567045|NCT00393718|594445318|FG000|Overall Study|Hypoglycaemia|3|||
164567046|NCT00393718|594445319|FG001|Overall Study|Hypoglycaemia|2|||
164567047|NCT00393718|594445318|FG000|Overall Study|Subject decision|5|||
164567048|NCT00393718|594445319|FG001|Overall Study|Subject decision|0|||
164567049|NCT00393718|594445318|FG000|Overall Study|Withdrawal of consent|2|||
164567050|NCT00393718|594445319|FG001|Overall Study|Withdrawal of consent|1|||
164567051|NCT00393718|594445318|FG000|Overall Study|Missed measurement|1|||
164567052|NCT00393718|594445319|FG001|Overall Study|Missed measurement|0|||
164567053|NCT00393718|594445318|FG000|Overall Study|Move|1|||
164567054|NCT00393718|594445319|FG001|Overall Study|Move|0|||
164567055|NCT01084551|594445324|FG000|Overall Study|Adverse Event|2|||
164567056|NCT01084551|594445325|FG001|Overall Study|Adverse Event|9|||
164567057|NCT01084551|594445326|FG002|Overall Study|Adverse Event|4|||
164567058|NCT01084551|594445324|FG000|Overall Study|Lack of Efficacy|2|||
164567059|NCT01084551|594445325|FG001|Overall Study|Lack of Efficacy|0|||
164567060|NCT01084551|594445326|FG002|Overall Study|Lack of Efficacy|1|||
164567061|NCT01084551|594445324|FG000|Overall Study|Withdrawal by Subject|2|||
164567062|NCT01084551|594445325|FG001|Overall Study|Withdrawal by Subject|1|||
164567063|NCT01084551|594445326|FG002|Overall Study|Withdrawal by Subject|0|||
164567064|NCT01084551|594445324|FG000|Overall Study|Protocol Violation|2|||
164567065|NCT01084551|594445325|FG001|Overall Study|Protocol Violation|4|||
164567066|NCT01084551|594445326|FG002|Overall Study|Protocol Violation|0|||
164567067|NCT01084551|594445324|FG000|Overall Study|Lost to Follow-up|0|||
164567068|NCT01084551|594445325|FG001|Overall Study|Lost to Follow-up|0|||
164567069|NCT01084551|594445326|FG002|Overall Study|Lost to Follow-up|3|||
164567070|NCT01084551|594445324|FG000|Overall Study|Physician Decision|1|||
164567071|NCT01084551|594445325|FG001|Overall Study|Physician Decision|0|||
164567072|NCT01084551|594445326|FG002|Overall Study|Physician Decision|0|||
164567073|NCT00289913|594445327|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
164567074|NCT00289913|594445328|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
164567075|NCT00289913|594445329|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
164567076|NCT00289913|594445330|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
164567077|NCT00289913|594445331|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
164567078|NCT00289913|594445327|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
164567079|NCT00289913|594445328|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
164567080|NCT00289913|594445329|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
164567081|NCT00289913|594445330|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
164567082|NCT00289913|594445331|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
164567083|NCT00289913|594445327|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
164567084|NCT00289913|594445328|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
164567085|NCT00289913|594445329|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
164567086|NCT00289913|594445330|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
164567087|NCT00289913|594445331|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
164567088|NCT00289913|594445327|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
164567089|NCT00289913|594445328|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
164567090|NCT00289913|594445329|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
164567091|NCT00289913|594445330|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
164567092|NCT00289913|594445331|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
164567093|NCT00289913|594445327|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
164567094|NCT00289913|594445328|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
164567095|NCT00289913|594445329|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
164567096|NCT00289913|594445330|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
164567097|NCT00289913|594445331|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
164567098|NCT00289913|594445327|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
164567099|NCT00289913|594445328|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
164567100|NCT00289913|594445329|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
164567101|NCT00289913|594445330|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
164567102|NCT00289913|594445331|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
164567103|NCT00289913|594445327|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
164567104|NCT00289913|594445328|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
164219447|NCT01814332|593171785|FG000|Overall Study|Withdrawal by Subject|3|||
164219448|NCT01814332|593171786|FG001|Overall Study|Withdrawal by Subject|8|||
164219449|NCT01814332|593171785|FG000|Overall Study|Protocol Violation|0|||
164219450|NCT01814332|593171786|FG001|Overall Study|Protocol Violation|4|||
164219451|NCT01814332|593171785|FG000|Overall Study|Lost to Follow-up|5|||
164219452|NCT01814332|593171786|FG001|Overall Study|Lost to Follow-up|1|||
164219453|NCT04389671|593171787|FG000|Overall Study|Death|7|||
164219454|NCT05987540|593171788|FG000|Overall Study|Withdrawal by Subject|2|||
164219455|NCT05987540|593171788|FG000|Overall Study|Death|1|||
164219456|NCT05987540|593171788|FG000|Overall Study|Study Termination|1|||
164219457|NCT05987540|593171788|FG000|Overall Study|Adverse Event|2|||
164219458|NCT00122187|593171789|FG000|Overall Study|Withdrew because of resource limitations|2|||
164219459|NCT00122187|593171790|FG001|Overall Study|Withdrew because of resource limitations|2|||
164219460|NCT01290731|593171794|FG000|Overall Study|Withdrawal by Subject|1|||
164219461|NCT02181738|593171800|FG000|Overall Study|Participant Withdrew Consent|2|||
164219462|NCT02181738|593171801|FG001|Overall Study|Participant Withdrew Consent|1|||
164219463|NCT02181738|593171802|FG002|Overall Study|Participant Withdrew Consent|1|||
164219464|NCT02181738|593171803|FG003|Overall Study|Participant Withdrew Consent|1|||
164219465|NCT02181738|593171800|FG000|Overall Study|Lost to Follow-up|1|||
164219466|NCT02181738|593171801|FG001|Overall Study|Lost to Follow-up|2|||
164219467|NCT02181738|593171802|FG002|Overall Study|Lost to Follow-up|1|||
164219468|NCT02181738|593171803|FG003|Overall Study|Lost to Follow-up|1|||
164219469|NCT02181738|593171800|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
164219470|NCT02181738|593171801|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
164219471|NCT02181738|593171802|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
164219472|NCT02181738|593171803|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
164219473|NCT02181738|593171800|FG000|Overall Study|Poor/Non-Compliance|1|||
164219474|NCT02181738|593171801|FG001|Overall Study|Poor/Non-Compliance|0|||
164219475|NCT02181738|593171802|FG002|Overall Study|Poor/Non-Compliance|2|||
164219476|NCT02181738|593171803|FG003|Overall Study|Poor/Non-Compliance|1|||
164219477|NCT02181738|593171800|FG000|Overall Study|Disease Progression|28|||
164219478|NCT02181738|593171801|FG001|Overall Study|Disease Progression|35|||
164219479|NCT02181738|593171802|FG002|Overall Study|Disease Progression|40|||
164219480|NCT02181738|593171803|FG003|Overall Study|Disease Progression|0|||
164219481|NCT02181738|593171800|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
164219482|NCT02181738|593171801|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
164670861|NCT05093205|594821312|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
164670862|NCT05093205|594821313|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
164670863|NCT05093205|594821314|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
164670864|NCT05093205|594821315|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
164219483|NCT02181738|593171802|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
164219484|NCT02181738|593171803|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
164219485|NCT02181738|593171800|FG000|Overall Study|Study Drug Toxicity|6|||
164219486|NCT02181738|593171801|FG001|Overall Study|Study Drug Toxicity|11|||
164219487|NCT02181738|593171802|FG002|Overall Study|Study Drug Toxicity|8|||
164219488|NCT02181738|593171803|FG003|Overall Study|Study Drug Toxicity|1|||
164219489|NCT02181738|593171800|FG000|Overall Study|Other Reasons|14|||
164219490|NCT02181738|593171801|FG001|Overall Study|Other Reasons|16|||
164219491|NCT02181738|593171802|FG002|Overall Study|Other Reasons|28|||
164219492|NCT02181738|593171803|FG003|Overall Study|Other Reasons|0|||
164219493|NCT02181738|593171800|FG000|Overall Study|Maximum Clinical Benefit|3|||
164219494|NCT02181738|593171801|FG001|Overall Study|Maximum Clinical Benefit|0|||
164219495|NCT02181738|593171802|FG002|Overall Study|Maximum Clinical Benefit|1|||
164219496|NCT02181738|593171803|FG003|Overall Study|Maximum Clinical Benefit|0|||
164219497|NCT02181738|593171800|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
164219498|NCT02181738|593171801|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
164219499|NCT02181738|593171802|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
164219500|NCT02181738|593171803|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
164219501|NCT00888849|593171808|FG000|Overall Study|Death|4|||
164219502|NCT00888849|593171809|FG001|Overall Study|Death|7|||
164219503|NCT00888849|593171808|FG000|Overall Study|Lost to Follow-up|1|||
164219504|NCT00888849|593171809|FG001|Overall Study|Lost to Follow-up|2|||
164219505|NCT05064800|593171810|FG000|Period 3|Withdrawal by Subject|0|||
164219506|NCT05064800|593171811|FG001|Period 3|Withdrawal by Subject|0|||
164219507|NCT05064800|593171812|FG002|Period 3|Withdrawal by Subject|0|||
164219508|NCT05064800|593171813|FG003|Period 3|Withdrawal by Subject|0|||
164219509|NCT05064800|593171814|FG004|Period 3|Withdrawal by Subject|1|||
164219510|NCT05064800|593171815|FG005|Period 3|Withdrawal by Subject|0|||
164219511|NCT00629239|593171816|FG000|Overall Study|Adverse Event|7|||
164219512|NCT00629239|593171817|FG001|Overall Study|Adverse Event|4|||
164219513|NCT00629239|593171816|FG000|Overall Study|Physician Decision|1|||
164219514|NCT00629239|593171817|FG001|Overall Study|Physician Decision|0|||
164219515|NCT01851369|593171820|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
164219516|NCT01851369|593171821|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
164219517|NCT01851369|593171822|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
164219518|NCT01851369|593171823|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
164219519|NCT01851369|593171824|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
164219520|NCT01851369|593171825|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
164219521|NCT01851369|593171826|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
164219522|NCT01851369|593171827|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
164219523|NCT01851369|593171828|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
164219524|NCT01851369|593171829|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
164219525|NCT01851369|593171830|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
164219526|NCT01851369|593171831|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
164219527|NCT01851369|593171832|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
164219528|NCT00183391|593171833|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
164219529|NCT00183391|593171834|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
164219530|NCT00183391|593171833|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
164219531|NCT00183391|593171834|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
164219532|NCT00395512|593171835|FG000|Overall Study|Adverse Event|3|||
164219533|NCT00395512|593171836|FG001|Overall Study|Adverse Event|8|||
164219534|NCT00395512|593171837|FG002|Overall Study|Adverse Event|6|||
164219535|NCT00395512|593171838|FG003|Overall Study|Adverse Event|6|||
164219536|NCT00395512|593171835|FG000|Overall Study|Protocol Violation|2|||
164219537|NCT00395512|593171836|FG001|Overall Study|Protocol Violation|3|||
164219538|NCT00395512|593171837|FG002|Overall Study|Protocol Violation|6|||
164219539|NCT00395512|593171838|FG003|Overall Study|Protocol Violation|7|||
164219540|NCT00395512|593171835|FG000|Overall Study|Lost to Follow-up|2|||
164219541|NCT00395512|593171836|FG001|Overall Study|Lost to Follow-up|6|||
164219542|NCT00395512|593171837|FG002|Overall Study|Lost to Follow-up|5|||
164420690|NCT01154036|593910965|FG003|Phase II|Protocol Violation|0|||
164219543|NCT00395512|593171838|FG003|Overall Study|Lost to Follow-up|5|||
164219544|NCT00395512|593171835|FG000|Overall Study|Withdrawal by Subject|6|||
164219545|NCT00395512|593171836|FG001|Overall Study|Withdrawal by Subject|5|||
164219546|NCT00395512|593171837|FG002|Overall Study|Withdrawal by Subject|5|||
164219547|NCT00395512|593171838|FG003|Overall Study|Withdrawal by Subject|12|||
164219548|NCT00395512|593171835|FG000|Overall Study|Physician Decision|6|||
164219549|NCT00395512|593171836|FG001|Overall Study|Physician Decision|4|||
164219550|NCT00395512|593171837|FG002|Overall Study|Physician Decision|2|||
164219551|NCT00395512|593171838|FG003|Overall Study|Physician Decision|2|||
164219552|NCT00395512|593171835|FG000|Overall Study|Other|1|||
164219553|NCT00395512|593171836|FG001|Overall Study|Other|1|||
164219554|NCT00395512|593171837|FG002|Overall Study|Other|0|||
164219555|NCT00395512|593171838|FG003|Overall Study|Other|0|||
164219556|NCT00395512|593171835|FG000|Overall Study|Hyperglycemic Rescue|18|||
164219557|NCT00395512|593171836|FG001|Overall Study|Hyperglycemic Rescue|10|||
164219558|NCT00395512|593171837|FG002|Overall Study|Hyperglycemic Rescue|4|||
164219559|NCT00395512|593171838|FG003|Overall Study|Hyperglycemic Rescue|6|||
164219560|NCT01936974|593171839|FG000|Overall Study|Physician Decision|2|||
164219561|NCT01936974|593171840|FG001|Overall Study|Physician Decision|5|||
164219562|NCT04584554|593171841|FG000|Overall Study|Withdrawal by Subject|2|||
164219563|NCT04584554|593171842|FG001|Overall Study|Withdrawal by Subject|2|||
164219564|NCT00063999|593171843|FG000|Overall Study|Withdrawal by Subject|1|||
164219565|NCT00063999|593171844|FG001|Overall Study|Withdrawal by Subject|0|||
164219566|NCT00063999|593171843|FG000|Overall Study|Ineligible|44|||
164219567|NCT00063999|593171844|FG001|Overall Study|Ineligible|24|||
164219568|NCT02497755|593171847|FG000|Overall Study|Protocol Violation|1|||
164219569|NCT02497755|593171848|FG001|Overall Study|Protocol Violation|0|||
164219570|NCT03983109|593171859|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
164219571|NCT03983109|593171860|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
164219572|NCT05085405|593171861|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
164219573|NCT05085405|593171862|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
164219574|NCT05085405|593171863|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
164219575|NCT05085405|593171864|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
164219576|NCT05085405|593171865|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
164219577|NCT05085405|593171866|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
164219578|NCT05085405|593171861|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
164219579|NCT05085405|593171862|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
164219580|NCT05085405|593171863|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
164219581|NCT05085405|593171864|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
164219582|NCT05085405|593171865|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
164219583|NCT05085405|593171866|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
164219584|NCT01860404|593171867|FG000|Overall Study|Lost to Follow-up|3|||
164219585|NCT01860404|593171868|FG001|Overall Study|Lost to Follow-up|4|||
164219586|NCT01860404|593171869|FG002|Overall Study|Lost to Follow-up|1|||
164219587|NCT01860404|593171870|FG003|Overall Study|Lost to Follow-up|6|||
164219588|NCT01860404|593171871|FG004|Overall Study|Lost to Follow-up|4|||
164219589|NCT01860404|593171867|FG000|Overall Study|Withdrawal by Subject|0|||
164219590|NCT01860404|593171868|FG001|Overall Study|Withdrawal by Subject|0|||
164219591|NCT01860404|593171869|FG002|Overall Study|Withdrawal by Subject|4|||
164219592|NCT01860404|593171870|FG003|Overall Study|Withdrawal by Subject|0|||
164219593|NCT01860404|593171871|FG004|Overall Study|Withdrawal by Subject|0|||
164219594|NCT01928771|593171881|FG000|Overall Study|Adverse Event|6|||
164219595|NCT01928771|593171882|FG001|Overall Study|Adverse Event|5|||
164219596|NCT01928771|593171883|FG002|Overall Study|Adverse Event|1|||
164219597|NCT01928771|593171881|FG000|Overall Study|Death|2|||
164219598|NCT01928771|593171882|FG001|Overall Study|Death|2|||
164219599|NCT01928771|593171883|FG002|Overall Study|Death|2|||
164328737|NCT01226043|593579595|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
164328738|NCT01226043|593579596|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
164328739|NCT01226043|593579593|FG000|6-week Re-randomization Phase|Physician Decision|0|||
164328740|NCT01226043|593579594|FG001|6-week Re-randomization Phase|Physician Decision|0|||
164328741|NCT01226043|593579595|FG002|6-week Re-randomization Phase|Physician Decision|3|||
164328742|NCT01226043|593579596|FG003|6-week Re-randomization Phase|Physician Decision|2|||
164328743|NCT01226043|593579593|FG000|6-week Re-randomization Phase|completed in error|0|||
164328744|NCT01226043|593579594|FG001|6-week Re-randomization Phase|completed in error|0|||
164328745|NCT01226043|593579595|FG002|6-week Re-randomization Phase|completed in error|0|||
164328746|NCT01226043|593579596|FG003|6-week Re-randomization Phase|completed in error|1|||
164328747|NCT01226043|593579593|FG000|30-week Observational Phase|Adverse Event|0|||
164328748|NCT01226043|593579594|FG001|30-week Observational Phase|Adverse Event|0|||
164328749|NCT01226043|593579595|FG002|30-week Observational Phase|Adverse Event|1|||
164328750|NCT01226043|593579596|FG003|30-week Observational Phase|Adverse Event|1|||
164328751|NCT01226043|593579593|FG000|30-week Observational Phase|Protocol Violation|0|||
164328752|NCT01226043|593579594|FG001|30-week Observational Phase|Protocol Violation|0|||
164328753|NCT01226043|593579595|FG002|30-week Observational Phase|Protocol Violation|0|||
164328754|NCT01226043|593579596|FG003|30-week Observational Phase|Protocol Violation|1|||
164328755|NCT01226043|593579593|FG000|30-week Observational Phase|Lost to Follow-up|0|||
164328756|NCT01226043|593579594|FG001|30-week Observational Phase|Lost to Follow-up|0|||
164328757|NCT01226043|593579595|FG002|30-week Observational Phase|Lost to Follow-up|2|||
164328758|NCT01226043|593579596|FG003|30-week Observational Phase|Lost to Follow-up|2|||
164328759|NCT01226043|593579593|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
164328760|NCT01226043|593579594|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
164328761|NCT01226043|593579595|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
164328762|NCT01226043|593579596|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
164328763|NCT01226043|593579593|FG000|30-week Observational Phase|Physician Decision|0|||
164328764|NCT01226043|593579594|FG001|30-week Observational Phase|Physician Decision|0|||
164328765|NCT01226043|593579595|FG002|30-week Observational Phase|Physician Decision|2|||
164328766|NCT01226043|593579596|FG003|30-week Observational Phase|Physician Decision|2|||
164328767|NCT00510952|593579604|FG000|Overall Study|Adverse Event|1|||
164328768|NCT00510952|593579605|FG001|Overall Study|Adverse Event|0|||
164328769|NCT00510952|593579604|FG000|Overall Study|Entry Criteria Not Met|3|||
164328770|NCT00510952|593579605|FG001|Overall Study|Entry Criteria Not Met|1|||
164328771|NCT00510952|593579604|FG000|Overall Study|Lost to Follow-up|5|||
164328772|NCT00510952|593579605|FG001|Overall Study|Lost to Follow-up|3|||
164328773|NCT00510952|593579604|FG000|Overall Study|Physician Decision|1|||
164328774|NCT00510952|593579605|FG001|Overall Study|Physician Decision|1|||
164328775|NCT00510952|593579604|FG000|Overall Study|Protocol Violation|7|||
164328776|NCT00510952|593579605|FG001|Overall Study|Protocol Violation|4|||
164328777|NCT00510952|593579604|FG000|Overall Study|Sponsor Decision|1|||
164328778|NCT00510952|593579605|FG001|Overall Study|Sponsor Decision|0|||
164328779|NCT00510952|593579604|FG000|Overall Study|Withdrawal by Subject|6|||
164328780|NCT00510952|593579605|FG001|Overall Study|Withdrawal by Subject|7|||
164328781|NCT00510952|593579604|FG000|Overall Study|Did Not Receive Study Drug|2|||
164328782|NCT00510952|593579605|FG001|Overall Study|Did Not Receive Study Drug|0|||
164328783|NCT02782923|593579606|FG000|Overall Study|Lost to Follow-up|15|||
164328784|NCT02418156|593579607|FG000|Overall Study|Lost to Follow-up|12|||
164219600|NCT01928771|593171881|FG000|Overall Study|Lost to Follow-up|5|||
164219601|NCT01928771|593171882|FG001|Overall Study|Lost to Follow-up|6|||
164328785|NCT02418156|593579607|FG000|Overall Study|Death|2|||
164328786|NCT02418156|593579607|FG000|Overall Study|Physician Decision|1|||
164328787|NCT02418156|593579607|FG000|Overall Study|Withdrawal by Subject|1|||
164328788|NCT02418156|593579607|FG000|Overall Study|Subject refused to return|1|||
164219602|NCT01928771|593171883|FG002|Overall Study|Lost to Follow-up|3|||
164328789|NCT05063318|593579615|FG000|Overall Study|Progressive disease|2|||
164328790|NCT05063318|593579616|FG001|Overall Study|Progressive disease|0|||
164328791|NCT05063318|593579617|FG002|Overall Study|Progressive disease|3|||
164328792|NCT05063318|593579615|FG000|Overall Study|Compassionate use|1|||
164219603|NCT01928771|593171881|FG000|Overall Study|Withdrawal by Subject|20|||
164219604|NCT01928771|593171882|FG001|Overall Study|Withdrawal by Subject|15|||
164219605|NCT01928771|593171883|FG002|Overall Study|Withdrawal by Subject|17|||
164219606|NCT01928771|593171881|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
164219607|NCT01928771|593171882|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
164219608|NCT01928771|593171883|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
164219609|NCT01928771|593171881|FG000|Overall Study|Other Reasons|9|||
164219610|NCT01928771|593171882|FG001|Overall Study|Other Reasons|9|||
164219611|NCT01928771|593171883|FG002|Overall Study|Other Reasons|14|||
164219612|NCT01928771|593171881|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
164219613|NCT01928771|593171882|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
164219614|NCT01928771|593171883|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
164219615|NCT01030900|593171884|FG000|Overall Study|Not treated due to congestive heart failure|1|||
164219616|NCT01030900|593171884|FG000|Overall Study|Not treated due to rapid disease|1|||
164219617|NCT00441896|593171885|FG000|Overall Study|Withdrawal by Subject|0|||
164219618|NCT00441896|593171886|FG001|Overall Study|Withdrawal by Subject|0|||
164219619|NCT00441896|593171887|FG002|Overall Study|Withdrawal by Subject|0|||
164219620|NCT00441896|593171888|FG003|Overall Study|Withdrawal by Subject|1|||
164219621|NCT00441896|593171889|FG004|Overall Study|Withdrawal by Subject|0|||
164219622|NCT00441896|593171890|FG005|Overall Study|Withdrawal by Subject|0|||
164219623|NCT00441896|593171891|FG006|Overall Study|Withdrawal by Subject|0|||
164219624|NCT00441896|593171892|FG007|Overall Study|Withdrawal by Subject|0|||
164219625|NCT00441896|593171893|FG008|Overall Study|Withdrawal by Subject|0|||
164219626|NCT00441896|593171894|FG009|Overall Study|Withdrawal by Subject|0|||
164219627|NCT00441896|593171885|FG000|Overall Study|Other|0|||
164219628|NCT00441896|593171886|FG001|Overall Study|Other|0|||
164219629|NCT00441896|593171887|FG002|Overall Study|Other|0|||
164219630|NCT00441896|593171888|FG003|Overall Study|Other|0|||
164219631|NCT00441896|593171889|FG004|Overall Study|Other|1|||
164219632|NCT00441896|593171890|FG005|Overall Study|Other|0|||
164219633|NCT00441896|593171891|FG006|Overall Study|Other|0|||
164219634|NCT00441896|593171892|FG007|Overall Study|Other|0|||
164219635|NCT00441896|593171893|FG008|Overall Study|Other|0|||
164219636|NCT00441896|593171894|FG009|Overall Study|Other|0|||
164219637|NCT01301092|593171895|FG000|Overall Study|Lost to Follow-up|0|||
164219638|NCT01301092|593171896|FG001|Overall Study|Lost to Follow-up|0|||
164219639|NCT01301092|593171897|FG002|Overall Study|Lost to Follow-up|1|||
164219640|NCT03334175|593171898|FG000|Overall Study|Lost to Follow-up|0|||
164219641|NCT03334175|593171899|FG001|Overall Study|Lost to Follow-up|1|||
164219642|NCT00004859|593171904|FG000|Overall Study|Lack of Efficacy|43|||
164219643|NCT00004859|593171905|FG001|Overall Study|Lack of Efficacy|113|||
164328793|NCT05063318|593579616|FG001|Overall Study|Compassionate use|3|||
164328794|NCT05063318|593579617|FG002|Overall Study|Compassionate use|3|||
164328795|NCT05063318|593579615|FG000|Overall Study|Adverse Event|0|||
164328796|NCT05063318|593579616|FG001|Overall Study|Adverse Event|1|||
164219644|NCT00004859|593171904|FG000|Overall Study|Adverse Event|31|||
164219645|NCT00004859|593171905|FG001|Overall Study|Adverse Event|93|||
164219646|NCT00004859|593171904|FG000|Overall Study|Death|5|||
164328797|NCT05063318|593579617|FG002|Overall Study|Adverse Event|0|||
164328798|NCT05063318|593579615|FG000|Overall Study|Withdrawal by Subject|0|||
164219647|NCT00004859|593171905|FG001|Overall Study|Death|5|||
164219648|NCT00004859|593171904|FG000|Overall Study|Withdrawal by Subject|7|||
164219649|NCT00004859|593171905|FG001|Overall Study|Withdrawal by Subject|33|||
164219650|NCT00004859|593171904|FG000|Overall Study|Protocol Violation|2|||
164219651|NCT00004859|593171905|FG001|Overall Study|Protocol Violation|2|||
164328799|NCT05063318|593579616|FG001|Overall Study|Withdrawal by Subject|1|||
164328800|NCT05063318|593579617|FG002|Overall Study|Withdrawal by Subject|0|||
164219652|NCT00004859|593171904|FG000|Overall Study|other disease|0|||
164219653|NCT00004859|593171905|FG001|Overall Study|other disease|3|||
164219654|NCT00004859|593171904|FG000|Overall Study|error|3|||
164219655|NCT00004859|593171905|FG001|Overall Study|error|1|||
164328801|NCT03287635|593579618|FG000|Overall Study|Lost to Follow-up|5|||
164420691|NCT01154036|593910966|FG004|Phase II|Protocol Violation|1|||
164420692|NCT01154036|593910967|FG005|Phase II|Protocol Violation|2|||
164420693|NCT01154036|593910968|FG006|Phase II|Protocol Violation|0|||
164420694|NCT01154036|593910969|FG007|Phase II|Protocol Violation|0|||
164420695|NCT01154036|593910962|FG000|Phase II|Withdrawal by Subject|0|||
164420696|NCT01154036|593910963|FG001|Phase II|Withdrawal by Subject|0|||
164420697|NCT01154036|593910964|FG002|Phase II|Withdrawal by Subject|0|||
164420698|NCT01154036|593910965|FG003|Phase II|Withdrawal by Subject|0|||
164567105|NCT00289913|594445329|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
164567106|NCT00289913|594445330|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
164420699|NCT01154036|593910966|FG004|Phase II|Withdrawal by Subject|4|||
164420700|NCT01154036|593910967|FG005|Phase II|Withdrawal by Subject|2|||
164420701|NCT01154036|593910968|FG006|Phase II|Withdrawal by Subject|5|||
164567107|NCT00289913|594445331|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
164567108|NCT00289913|594445327|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
164567109|NCT00289913|594445328|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
164567110|NCT00289913|594445329|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
164567111|NCT00289913|594445330|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
164567112|NCT00289913|594445331|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
164567113|NCT00289913|594445327|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
164567114|NCT00289913|594445328|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
164567115|NCT00289913|594445329|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
164567116|NCT00289913|594445330|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
164567117|NCT00289913|594445331|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
164567118|NCT00289913|594445327|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
164567119|NCT00289913|594445328|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
164567120|NCT00289913|594445329|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
164567121|NCT00289913|594445330|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
164567122|NCT00289913|594445331|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
164567123|NCT00289913|594445327|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
164567124|NCT00289913|594445328|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
164567125|NCT00289913|594445329|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
164567126|NCT00289913|594445330|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
164567127|NCT00289913|594445331|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
164567128|NCT00289913|594445327|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
164567129|NCT00289913|594445328|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
164567130|NCT00289913|594445329|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
164567131|NCT00289913|594445330|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
164567132|NCT00289913|594445331|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
164567133|NCT00289913|594445327|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
164567134|NCT00289913|594445328|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
164567135|NCT00289913|594445329|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
164567136|NCT00289913|594445330|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
164567137|NCT00289913|594445331|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
164567138|NCT00289913|594445327|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
164567139|NCT00289913|594445328|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
164567140|NCT00289913|594445329|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
164567141|NCT00289913|594445330|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
164567142|NCT00289913|594445331|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
164567143|NCT00289913|594445327|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
164567144|NCT00289913|594445328|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
164567145|NCT00289913|594445329|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
164567146|NCT00289913|594445330|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
164567147|NCT00289913|594445331|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
164567148|NCT00289913|594445327|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
164567149|NCT00289913|594445328|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
164567150|NCT00289913|594445329|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
164567151|NCT00289913|594445330|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
164567152|NCT00289913|594445331|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
164670865|NCT05093205|594821316|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
164670866|NCT05093205|594821317|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
164670867|NCT05093205|594821318|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
164670868|NCT05093205|594821319|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
164670869|NCT05093205|594821320|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
164420702|NCT01154036|593910969|FG007|Phase II|Withdrawal by Subject|4|||
164420703|NCT02264574|593910970|FG000|Overall Study|Death|21|||
164219656|NCT00004859|593171904|FG000|Overall Study|missing data|14|||
164219657|NCT00004859|593171905|FG001|Overall Study|missing data|11|||
164219658|NCT00004859|593171904|FG000|Overall Study|Other|13|||
164219659|NCT00004859|593171905|FG001|Overall Study|Other|21|||
164219660|NCT03882801|593173507|FG000|Period 1|Adverse Event|0|||
164219661|NCT03882801|593173508|FG001|Period 1|Adverse Event|1|||
164219662|NCT03882801|593173507|FG000|Period 1|Non-compliance with study drug|1|||
164219663|NCT03882801|593173508|FG001|Period 1|Non-compliance with study drug|1|||
164219664|NCT03882801|593173507|FG000|Period 1|Never treated with study drug|1|||
164219665|NCT03882801|593173508|FG001|Period 1|Never treated with study drug|0|||
164219666|NCT03882801|593173507|FG000|Washout Period|Physician Decision|0|||
164219667|NCT03882801|593173508|FG001|Washout Period|Physician Decision|1|||
164219668|NCT03882801|593173507|FG000|Period 2|Non-compliance with study drug|0|||
164219669|NCT03882801|593173508|FG001|Period 2|Non-compliance with study drug|1|||
164219670|NCT03548415|593173511|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
164219671|NCT03548415|593173512|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
164219672|NCT03548415|593173513|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
164219673|NCT03548415|593173514|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
164219674|NCT03548415|593173515|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
164219675|NCT04605588|593173516|FG000|Overall Study|Withdrawal by Subject|1|||
164219676|NCT04605588|593173517|FG001|Overall Study|Withdrawal by Subject|0|||
164219677|NCT01230814|593173518|FG000|Overall Study|Lost to Follow-up|11|||
164219678|NCT01230814|593173519|FG001|Overall Study|Lost to Follow-up|3|||
164219679|NCT01230814|593173518|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
164219680|NCT01230814|593173519|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
164219681|NCT01297244|593173520|FG000|Overall Study|Progressive disease|22|||
164219682|NCT01297244|593173521|FG001|Overall Study|Progressive disease|3|||
164219683|NCT01297244|593173520|FG000|Overall Study|Adverse Event|9|||
164219684|NCT01297244|593173521|FG001|Overall Study|Adverse Event|1|||
164219685|NCT01297244|593173520|FG000|Overall Study|Death|1|||
164219686|NCT01297244|593173521|FG001|Overall Study|Death|1|||
164219687|NCT01297244|593173520|FG000|Overall Study|Clinical progression|1|||
164219688|NCT01297244|593173521|FG001|Overall Study|Clinical progression|1|||
164219689|NCT01297244|593173520|FG000|Overall Study|Withdrawal by Subject|2|||
164219690|NCT01297244|593173521|FG001|Overall Study|Withdrawal by Subject|0|||
164219691|NCT02595749|593173522|FG000|Overall Study|Withdrawal by Subject|12|||
164219692|NCT02595749|593173523|FG001|Overall Study|Withdrawal by Subject|7|||
164219693|NCT01803737|593173524|FG000|Overall Study|Lack of Time|1|||
164219694|NCT01803737|593173525|FG001|Overall Study|Lack of Time|0|||
164219695|NCT01803737|593173524|FG000|Overall Study|Medical Reason|0|||
164219696|NCT01803737|593173525|FG001|Overall Study|Medical Reason|1|||
164219697|NCT01803737|593173524|FG000|Overall Study|Lost to Follow-up|0|||
164219698|NCT01803737|593173525|FG001|Overall Study|Lost to Follow-up|2|||
164219699|NCT00504556|593173531|FG000|Overall Study|Adverse Event|11|||
164219700|NCT00504556|593173532|FG001|Overall Study|Adverse Event|11|||
164219701|NCT00504556|593173533|FG002|Overall Study|Adverse Event|14|||
164219702|NCT00504556|593173534|FG003|Overall Study|Adverse Event|13|||
164219703|NCT00504556|593173535|FG004|Overall Study|Adverse Event|5|||
164219704|NCT00504556|593173531|FG000|Overall Study|Death|3|||
164219705|NCT00504556|593173532|FG001|Overall Study|Death|3|||
164219706|NCT00504556|593173533|FG002|Overall Study|Death|1|||
164219707|NCT00504556|593173534|FG003|Overall Study|Death|0|||
164219708|NCT00504556|593173535|FG004|Overall Study|Death|2|||
164219709|NCT00504556|593173531|FG000|Overall Study|Protocol Violation|1|||
164219710|NCT00504556|593173532|FG001|Overall Study|Protocol Violation|3|||
164219711|NCT00504556|593173533|FG002|Overall Study|Protocol Violation|2|||
164219712|NCT00504556|593173534|FG003|Overall Study|Protocol Violation|1|||
164219713|NCT00504556|593173535|FG004|Overall Study|Protocol Violation|2|||
164219714|NCT00504556|593173531|FG000|Overall Study|Lost to Follow-up|0|||
164219715|NCT00504556|593173532|FG001|Overall Study|Lost to Follow-up|0|||
164219716|NCT00504556|593173533|FG002|Overall Study|Lost to Follow-up|1|||
164328802|NCT03287635|593579618|FG000|Overall Study|Withdrawal by Subject|1|||
164328803|NCT03287635|593579618|FG000|Overall Study|Physician Decision|1|||
164328804|NCT02247531|593581180|FG000|Overall Study|Adverse Event|3|||
164328805|NCT02247531|593581181|FG001|Overall Study|Adverse Event|4|||
164328806|NCT02247531|593581182|FG002|Overall Study|Adverse Event|9|||
164328807|NCT02247531|593581180|FG000|Overall Study|Death|8|||
164328808|NCT02247531|593581181|FG001|Overall Study|Death|9|||
164328809|NCT02247531|593581182|FG002|Overall Study|Death|5|||
164328810|NCT02247531|593581180|FG000|Overall Study|Lost to Follow-up|1|||
164328811|NCT02247531|593581181|FG001|Overall Study|Lost to Follow-up|8|||
164420704|NCT02264574|593910971|FG001|Overall Study|Death|21|||
164219717|NCT00504556|593173534|FG003|Overall Study|Lost to Follow-up|1|||
164219718|NCT00504556|593173535|FG004|Overall Study|Lost to Follow-up|1|||
164219719|NCT00504556|593173531|FG000|Overall Study|Withdrawal by Subject|16|||
164219720|NCT00504556|593173532|FG001|Overall Study|Withdrawal by Subject|16|||
164219721|NCT00504556|593173533|FG002|Overall Study|Withdrawal by Subject|7|||
164328812|NCT02247531|593581182|FG002|Overall Study|Lost to Follow-up|3|||
164328813|NCT02247531|593581180|FG000|Overall Study|Non-compliance|2|||
164219722|NCT00504556|593173534|FG003|Overall Study|Withdrawal by Subject|8|||
164219723|NCT00504556|593173535|FG004|Overall Study|Withdrawal by Subject|12|||
164219724|NCT00504556|593173531|FG000|Overall Study|administrative reasons|0|||
164219725|NCT00504556|593173532|FG001|Overall Study|administrative reasons|2|||
164219726|NCT00504556|593173533|FG002|Overall Study|administrative reasons|2|||
164219727|NCT00504556|593173534|FG003|Overall Study|administrative reasons|1|||
164219728|NCT00504556|593173535|FG004|Overall Study|administrative reasons|2|||
164219729|NCT00504556|593173531|FG000|Overall Study|did not meet entry criteria|2|||
164219730|NCT00504556|593173532|FG001|Overall Study|did not meet entry criteria|0|||
164219731|NCT00504556|593173533|FG002|Overall Study|did not meet entry criteria|1|||
164219732|NCT00504556|593173534|FG003|Overall Study|did not meet entry criteria|1|||
164219733|NCT00504556|593173535|FG004|Overall Study|did not meet entry criteria|0|||
164219734|NCT00504556|593173531|FG000|Overall Study|data monitor committee decision|0|||
164219735|NCT00504556|593173532|FG001|Overall Study|data monitor committee decision|0|||
164219736|NCT00504556|593173533|FG002|Overall Study|data monitor committee decision|0|||
164219737|NCT00504556|593173534|FG003|Overall Study|data monitor committee decision|100|||
164219738|NCT00504556|593173535|FG004|Overall Study|data monitor committee decision|0|||
164219739|NCT00504556|593173531|FG000|Overall Study|Other|2|||
164219740|NCT00504556|593173532|FG001|Overall Study|Other|2|||
164219741|NCT00504556|593173533|FG002|Overall Study|Other|2|||
164219742|NCT00504556|593173534|FG003|Overall Study|Other|3|||
164219743|NCT00504556|593173535|FG004|Overall Study|Other|0|||
164219744|NCT00504556|593173531|FG000|Overall Study|not in safety analysis set|0|||
164219745|NCT00504556|593173532|FG001|Overall Study|not in safety analysis set|1|||
164219746|NCT00504556|593173533|FG002|Overall Study|not in safety analysis set|1|||
164219747|NCT00504556|593173534|FG003|Overall Study|not in safety analysis set|0|||
164219748|NCT00504556|593173535|FG004|Overall Study|not in safety analysis set|1|||
164219749|NCT03558672|593173536|FG000|Overall Study|Study Early Termination|10|||
164219750|NCT03607695|593173537|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
164219751|NCT03607695|593173537|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
164219752|NCT01027416|593173538|FG000|Overall Study|Withdrawal by Subject|0|||
164219753|NCT01027416|593173539|FG001|Overall Study|Withdrawal by Subject|1|||
164219754|NCT01027416|593173538|FG000|Overall Study|Physician Decision|1|||
164219755|NCT01027416|593173539|FG001|Overall Study|Physician Decision|4|||
164219756|NCT02741193|593173540|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
164219757|NCT02741193|593173540|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
164219758|NCT00676052|593173544|FG000|Overall Study|Adverse Event|0|||
164219759|NCT00676052|593173545|FG001|Overall Study|Adverse Event|1|||
164219760|NCT00676052|593173546|FG002|Overall Study|Adverse Event|1|||
164219761|NCT00676052|593173547|FG003|Overall Study|Adverse Event|2|||
164219762|NCT00676052|593173548|FG004|Overall Study|Adverse Event|2|||
164219763|NCT00676052|593173549|FG005|Overall Study|Adverse Event|2|||
164219764|NCT00676052|593173544|FG000|Overall Study|Lack of Efficacy|2|||
164219765|NCT00676052|593173545|FG001|Overall Study|Lack of Efficacy|2|||
164219766|NCT00676052|593173546|FG002|Overall Study|Lack of Efficacy|1|||
164219767|NCT00676052|593173547|FG003|Overall Study|Lack of Efficacy|1|||
164219768|NCT00676052|593173548|FG004|Overall Study|Lack of Efficacy|2|||
164219769|NCT00676052|593173549|FG005|Overall Study|Lack of Efficacy|1|||
164219770|NCT00676052|593173544|FG000|Overall Study|Protocol Violation|5|||
164219771|NCT00676052|593173545|FG001|Overall Study|Protocol Violation|3|||
164219772|NCT00676052|593173546|FG002|Overall Study|Protocol Violation|2|||
164219773|NCT00676052|593173547|FG003|Overall Study|Protocol Violation|2|||
164219774|NCT00676052|593173548|FG004|Overall Study|Protocol Violation|1|||
164420705|NCT02264574|593910970|FG000|Overall Study|Withdrawal by Subject|8|||
164420706|NCT02264574|593910971|FG001|Overall Study|Withdrawal by Subject|6|||
164420707|NCT02264574|593910970|FG000|Overall Study|Other, Not Specified|0|||
164420708|NCT02264574|593910971|FG001|Overall Study|Other, Not Specified|3|||
164420709|NCT02080520|593910972|FG000|Overall Study|Self-reported symptoms|5|||
164567153|NCT00289913|594445327|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
164567154|NCT00289913|594445328|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
164219775|NCT00676052|593173549|FG005|Overall Study|Protocol Violation|2|||
164219776|NCT00676052|593173544|FG000|Overall Study|Lost to Follow-up|0|||
164420710|NCT02080520|593910973|FG001|Overall Study|Self-reported symptoms|6|||
164219777|NCT00676052|593173545|FG001|Overall Study|Lost to Follow-up|0|||
164219778|NCT00676052|593173546|FG002|Overall Study|Lost to Follow-up|0|||
164219779|NCT00676052|593173547|FG003|Overall Study|Lost to Follow-up|0|||
164219780|NCT00676052|593173548|FG004|Overall Study|Lost to Follow-up|1|||
164219781|NCT00676052|593173549|FG005|Overall Study|Lost to Follow-up|0|||
164219782|NCT00676052|593173544|FG000|Overall Study|Physician Decision|1|||
164219783|NCT00676052|593173545|FG001|Overall Study|Physician Decision|1|||
164219784|NCT00676052|593173546|FG002|Overall Study|Physician Decision|1|||
164219785|NCT00676052|593173547|FG003|Overall Study|Physician Decision|0|||
164219786|NCT00676052|593173548|FG004|Overall Study|Physician Decision|0|||
164219787|NCT00676052|593173549|FG005|Overall Study|Physician Decision|1|||
164219788|NCT00676052|593173544|FG000|Overall Study|Withdrawal by Subject|1|||
164219789|NCT00676052|593173545|FG001|Overall Study|Withdrawal by Subject|0|||
164219790|NCT00676052|593173546|FG002|Overall Study|Withdrawal by Subject|1|||
164219791|NCT00676052|593173547|FG003|Overall Study|Withdrawal by Subject|0|||
164219792|NCT00676052|593173548|FG004|Overall Study|Withdrawal by Subject|0|||
164219793|NCT00676052|593173549|FG005|Overall Study|Withdrawal by Subject|0|||
164219794|NCT02365064|593173561|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
164219795|NCT02365064|593173562|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
164219796|NCT02365064|593173561|FG000|Overall Study|Withdrawal by Subject|6|||
164219797|NCT02365064|593173562|FG001|Overall Study|Withdrawal by Subject|9|||
164219798|NCT02365064|593173561|FG000|Overall Study|Treatment intolerance|2|||
164219799|NCT02365064|593173562|FG001|Overall Study|Treatment intolerance|4|||
164219800|NCT00500110|593173571|FG000|Overall Study|Withdrawal by Subject|3|||
164219801|NCT00605657|593173572|FG000|Overall Study|Adverse Event|1|||
164219802|NCT00605657|593173572|FG000|Overall Study|Protocol Violation|1|||
164219803|NCT00662038|593173575|FG000|Overall Study|Reason not specified|3|||
164219804|NCT00662038|593173575|FG000|Overall Study|Withdrawn consent|22|||
164219805|NCT00662038|593173575|FG000|Overall Study|Withdrawal by Subject|83|||
164219806|NCT00662038|593173575|FG000|Overall Study|Sponsor decision|1|||
164219807|NCT00662038|593173575|FG000|Overall Study|Physician Decision|19|||
164219808|NCT00662038|593173575|FG000|Overall Study|Lung transplantation|44|||
164219809|NCT00662038|593173575|FG000|Overall Study|Lost to Follow-up|1|||
164219810|NCT00662038|593173575|FG000|Overall Study|Death|95|||
164219811|NCT00662038|593173575|FG000|Overall Study|Adverse Event|358|||
164219812|NCT00662038|593173575|FG000|Overall Study|Continued treatment|5|||
164219813|NCT00397046|593173576|FG000|Overall Study|Disease Progression|3|||
164219814|NCT00397046|593173577|FG001|Overall Study|Disease Progression|3|||
164420711|NCT02080520|593910972|FG000|Overall Study|Unable to contact|2|||
164420712|NCT02080520|593910973|FG001|Overall Study|Unable to contact|1|||
164420713|NCT02080520|593910972|FG000|Overall Study|Initiated aspirin|2|||
164420714|NCT02080520|593910973|FG001|Overall Study|Initiated aspirin|0|||
164420715|NCT02080520|593910972|FG000|Overall Study|Atrial fibrillation|1|||
164420716|NCT02080520|593910973|FG001|Overall Study|Atrial fibrillation|1|||
164420717|NCT02080520|593910972|FG000|Overall Study|Cancer|1|||
164420718|NCT02080520|593910973|FG001|Overall Study|Cancer|2|||
164420719|NCT02080520|593910972|FG000|Overall Study|Not interested in study|1|||
164420720|NCT02080520|593910973|FG001|Overall Study|Not interested in study|3|||
164219815|NCT00397046|593173578|FG002|Overall Study|Disease Progression|10|||
164219816|NCT00397046|593173579|FG003|Overall Study|Disease Progression|5|||
164219817|NCT01975285|593173581|FG000|Overall Study|Failed Block and follow up|2|||
164219818|NCT01975285|593173582|FG001|Overall Study|Failed Block and follow up|2|||
164219819|NCT04535362|593173583|FG000|Overall Study|Lost to Follow-up|3|||
164219820|NCT04535362|593173584|FG001|Overall Study|Lost to Follow-up|1|||
164219821|NCT02018887|593173590|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
164219822|NCT02018887|593173591|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
164219823|NCT02018887|593173592|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
164219824|NCT02018887|593173593|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
164219825|NCT02018887|593173594|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
164328814|NCT02247531|593581181|FG001|Overall Study|Non-compliance|2|||
164328815|NCT02247531|593581182|FG002|Overall Study|Non-compliance|0|||
164328816|NCT02247531|593581180|FG000|Overall Study|Withdrawal by Subject|26|||
164328817|NCT02247531|593581181|FG001|Overall Study|Withdrawal by Subject|31|||
164328818|NCT02247531|593581182|FG002|Overall Study|Withdrawal by Subject|25|||
164328819|NCT02247531|593581180|FG000|Overall Study|Study Terminated by Sponsor|64|||
164328820|NCT02247531|593581181|FG001|Overall Study|Study Terminated by Sponsor|66|||
164328821|NCT02247531|593581182|FG002|Overall Study|Study Terminated by Sponsor|62|||
164328822|NCT02247531|593581180|FG000|Overall Study|Physician Decision|0|||
164328823|NCT02247531|593581181|FG001|Overall Study|Physician Decision|2|||
164328824|NCT02247531|593581182|FG002|Overall Study|Physician Decision|2|||
164328825|NCT02247531|593581180|FG000|Overall Study|Unspecified Reason|2|||
164328826|NCT02247531|593581181|FG001|Overall Study|Unspecified Reason|3|||
164328827|NCT02247531|593581182|FG002|Overall Study|Unspecified Reason|4|||
164328828|NCT04879225|593581185|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
164328829|NCT04879225|593581185|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
164328830|NCT01751802|593581191|FG000|Overall Study|Adverse Event|4|||
164328831|NCT01751802|593581192|FG001|Overall Study|Adverse Event|2|||
164328832|NCT00608543|593581193|FG000|Overall Study|Adverse Event|4|||
164328833|NCT01869725|593581194|FG000|Overall Study|ineligible after registration|1|||
164328834|NCT01869725|593581194|FG000|Overall Study|Death|1|||
164328835|NCT01869725|593581194|FG000|Overall Study|Lost to Follow-up|2|||
164328836|NCT01068652|593581197|FG000|Overall Study|Adverse Event|4|||
164328837|NCT01068652|593581198|FG001|Overall Study|Adverse Event|0|||
164328838|NCT01068652|593581197|FG000|Overall Study|Lack of Efficacy|0|||
164328839|NCT01068652|593581198|FG001|Overall Study|Lack of Efficacy|2|||
164328840|NCT01068652|593581197|FG000|Overall Study|Lost to Follow-up|2|||
164328841|NCT01068652|593581198|FG001|Overall Study|Lost to Follow-up|1|||
164328842|NCT01068652|593581197|FG000|Overall Study|Protocol Violation|3|||
164219826|NCT02018887|593173595|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
164219827|NCT02018887|593173596|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
164219828|NCT02018887|593173597|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
164219829|NCT02018887|593173598|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
164219830|NCT02018887|593173599|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
164219831|NCT02018887|593173600|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
164219832|NCT02018887|593173590|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
164219833|NCT02018887|593173591|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
164219834|NCT02018887|593173592|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
164219835|NCT02018887|593173593|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
164219836|NCT02018887|593173594|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
164219837|NCT02018887|593173595|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
164219838|NCT02018887|593173596|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
164219839|NCT02018887|593173597|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
164219840|NCT02018887|593173598|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
164219841|NCT02018887|593173599|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
164219842|NCT02018887|593173600|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
164219843|NCT02018887|593173590|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
164219844|NCT02018887|593173591|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
164219845|NCT02018887|593173592|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
164219846|NCT02018887|593173593|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
164219847|NCT02018887|593173594|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
164219848|NCT02018887|593173595|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
164219849|NCT02018887|593173596|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
164219850|NCT02018887|593173597|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
164219851|NCT02018887|593173598|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
164219852|NCT02018887|593173599|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
164219853|NCT02018887|593173600|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
164219854|NCT02018887|593173590|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
164219855|NCT02018887|593173591|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
164219856|NCT02018887|593173592|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
164219857|NCT02018887|593173593|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
164219858|NCT02018887|593173594|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
164219859|NCT02018887|593173595|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
164219860|NCT02018887|593173596|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
164219861|NCT02018887|593173597|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
164219862|NCT02018887|593173598|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
164219863|NCT02018887|593173599|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
164219864|NCT02018887|593173600|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
164219865|NCT04053452|593173601|FG000|Overall Study|Withdrawal by Subject|1|||
164219866|NCT04053452|593173602|FG001|Overall Study|Withdrawal by Subject|0|||
164219867|NCT04053452|593173601|FG000|Overall Study|Time restraint due to inpatient needs|1|||
164219868|NCT04053452|593173602|FG001|Overall Study|Time restraint due to inpatient needs|2|||
164219869|NCT01421134|593173603|FG000|Overall Study|Adverse Event|3|||
164219870|NCT01421134|593173604|FG001|Overall Study|Adverse Event|5|||
164219871|NCT01421134|593173603|FG000|Overall Study|Lack of Efficacy|2|||
164219872|NCT01421134|593173604|FG001|Overall Study|Lack of Efficacy|4|||
164219873|NCT01421134|593173603|FG000|Overall Study|Protocol Violation|0|||
164219874|NCT01421134|593173604|FG001|Overall Study|Protocol Violation|3|||
164219875|NCT01421134|593173603|FG000|Overall Study|Withdrawal by Subject|1|||
164219876|NCT01421134|593173604|FG001|Overall Study|Withdrawal by Subject|1|||
164219877|NCT01421134|593173603|FG000|Overall Study|Administrative|0|||
164219878|NCT01421134|593173604|FG001|Overall Study|Administrative|1|||
164219879|NCT01421134|593173603|FG000|Overall Study|Lost to Follow-up|1|||
164219880|NCT01421134|593173604|FG001|Overall Study|Lost to Follow-up|1|||
164219881|NCT02959892|593173605|FG000|Overall Study|PET tracer synthesis failure|1|||
164219882|NCT02959892|593173606|FG001|Overall Study|PET tracer synthesis failure|0|||
164219883|NCT02959892|593173605|FG000|Overall Study|Study termination|0|||
164219884|NCT02959892|593173606|FG001|Overall Study|Study termination|1|||
164219885|NCT02061592|593173610|FG000|Period 1|Withdrawal by Subject|1|||
164219886|NCT02061592|593173611|FG001|Period 1|Withdrawal by Subject|0|||
164219887|NCT02061592|593173610|FG000|Period 1|Protocol Violation|1|||
164219888|NCT02061592|593173611|FG001|Period 1|Protocol Violation|0|||
164219889|NCT02061592|593173610|FG000|Period 2|Lost to Follow-up|0|||
164219890|NCT02061592|593173611|FG001|Period 2|Lost to Follow-up|1|||
164219891|NCT04433975|593173612|FG000|1-month Follow Up|Withdrawal by Subject|1|||
164420721|NCT02080520|593910972|FG000|Overall Study|Too busy|1|||
164420722|NCT02080520|593910973|FG001|Overall Study|Too busy|1|||
164328843|NCT01068652|593581198|FG001|Overall Study|Protocol Violation|6|||
164328844|NCT01068652|593581197|FG000|Overall Study|Withdrawal criteria|1|||
164328845|NCT01068652|593581198|FG001|Overall Study|Withdrawal criteria|2|||
164328846|NCT01068652|593581197|FG000|Overall Study|Patient was not eligible|1|||
164328847|NCT01068652|593581198|FG001|Overall Study|Patient was not eligible|0|||
164328848|NCT01068652|593581197|FG000|Overall Study|Unclassified|7|||
164328849|NCT01068652|593581198|FG001|Overall Study|Unclassified|4|||
164328850|NCT00214500|593581199|FG000|Treatment Period|Adverse Event|1|||
164328851|NCT00214500|593581199|FG000|Extension Period|Withdrawal by Subject|2|||
164328852|NCT03170232|593581200|FG000|Overall Study|Adverse Event|0|||
164328853|NCT03170232|593581201|FG001|Overall Study|Adverse Event|1|||
164328854|NCT03170232|593581200|FG000|Overall Study|Protocol Violation|0|||
164328855|NCT03170232|593581201|FG001|Overall Study|Protocol Violation|1|||
164328856|NCT03170232|593581200|FG000|Overall Study|Lack of Efficacy|0|||
164328857|NCT03170232|593581201|FG001|Overall Study|Lack of Efficacy|1|||
164328858|NCT03170232|593581200|FG000|Overall Study|Study closed/terminated|26|||
164328859|NCT03170232|593581201|FG001|Overall Study|Study closed/terminated|23|||
164328860|NCT03170232|593581200|FG000|Overall Study|Lost to Follow-up|1|||
164328861|NCT03170232|593581201|FG001|Overall Study|Lost to Follow-up|0|||
164328862|NCT03170232|593581200|FG000|Overall Study|Withdrawal by Subject|0|||
164328863|NCT03170232|593581201|FG001|Overall Study|Withdrawal by Subject|1|||
164328864|NCT00147251|593581202|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
164328865|NCT00147251|593581203|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
164328866|NCT02537574|593581204|FG000|Overall Study|Adverse Event|1|||
164328867|NCT02537574|593581205|FG001|Overall Study|Adverse Event|3|||
164328868|NCT02537574|593581206|FG002|Overall Study|Adverse Event|2|||
164328869|NCT02537574|593581204|FG000|Overall Study|Lost to Follow-up|40|||
164328870|NCT02537574|593581205|FG001|Overall Study|Lost to Follow-up|51|||
164328871|NCT02537574|593581206|FG002|Overall Study|Lost to Follow-up|55|||
164328872|NCT02537574|593581204|FG000|Overall Study|Noncompliance with study drug|0|||
164328873|NCT02537574|593581205|FG001|Overall Study|Noncompliance with study drug|1|||
164328874|NCT02537574|593581206|FG002|Overall Study|Noncompliance with study drug|1|||
164328875|NCT02537574|593581204|FG000|Overall Study|Physician Decision|2|||
164328876|NCT02537574|593581205|FG001|Overall Study|Physician Decision|0|||
164328877|NCT02537574|593581206|FG002|Overall Study|Physician Decision|0|||
164328878|NCT02537574|593581204|FG000|Overall Study|Protocol Violation|4|||
164328879|NCT02537574|593581205|FG001|Overall Study|Protocol Violation|2|||
164328880|NCT02537574|593581206|FG002|Overall Study|Protocol Violation|3|||
164328881|NCT02537574|593581204|FG000|Overall Study|Withdrawal by Subject|37|||
164328882|NCT02537574|593581205|FG001|Overall Study|Withdrawal by Subject|27|||
164328883|NCT02537574|593581206|FG002|Overall Study|Withdrawal by Subject|29|||
164328884|NCT02537574|593581204|FG000|Overall Study|Lack of Efficacy|14|||
164328885|NCT02537574|593581205|FG001|Overall Study|Lack of Efficacy|16|||
164328886|NCT02537574|593581206|FG002|Overall Study|Lack of Efficacy|15|||
164328887|NCT02537574|593581204|FG000|Overall Study|Duplicate Patient|1|||
164328888|NCT02537574|593581205|FG001|Overall Study|Duplicate Patient|0|||
164328889|NCT02537574|593581206|FG002|Overall Study|Duplicate Patient|0|||
164328890|NCT02537574|593581204|FG000|Overall Study|Patient not Stable|0|||
164328891|NCT02537574|593581205|FG001|Overall Study|Patient not Stable|1|||
164328892|NCT02537574|593581206|FG002|Overall Study|Patient not Stable|0|||
164328893|NCT02537574|593581204|FG000|Overall Study|Incarceration|0|||
164328894|NCT02537574|593581205|FG001|Overall Study|Incarceration|1|||
164328895|NCT02537574|593581206|FG002|Overall Study|Incarceration|0|||
164328896|NCT02537574|593581204|FG000|Overall Study|Failed Naloxone Challenge|0|||
164328897|NCT02537574|593581205|FG001|Overall Study|Failed Naloxone Challenge|1|||
164328898|NCT02537574|593581206|FG002|Overall Study|Failed Naloxone Challenge|0|||
164328899|NCT02537574|593581204|FG000|Overall Study|Transportation Issues|0|||
164328900|NCT02537574|593581205|FG001|Overall Study|Transportation Issues|0|||
164328901|NCT02537574|593581206|FG002|Overall Study|Transportation Issues|1|||
164328902|NCT02537574|593581204|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
164328903|NCT02537574|593581205|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
164328904|NCT02537574|593581206|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
164328905|NCT02537574|593581204|FG000|Overall Study|Noncompliance with Protocol|0|||
164328906|NCT02537574|593581205|FG001|Overall Study|Noncompliance with Protocol|0|||
164328907|NCT02537574|593581206|FG002|Overall Study|Noncompliance with Protocol|1|||
164328908|NCT01151098|593581207|FG000|Overall Study|Adverse Event|82|||
164328909|NCT01151098|593581207|FG000|Overall Study|Lost to Follow-up|6|||
164328910|NCT01151098|593581207|FG000|Overall Study|Lack of Efficacy|15|||
164328911|NCT01151098|593581207|FG000|Overall Study|Protocol Violation|1|||
164328912|NCT01151098|593581207|FG000|Overall Study|Miscellaneous|13|||
164219892|NCT04433975|593173613|FG001|1-month Follow Up|Withdrawal by Subject|1|||
164219893|NCT04433975|593173612|FG000|1-month Follow Up|Lost to Follow-up|21|||
164219894|NCT04433975|593173613|FG001|1-month Follow Up|Lost to Follow-up|25|||
164219895|NCT04433975|593173612|FG000|3-month Follow Up|Lost to Follow-up|20|||
164219896|NCT04433975|593173613|FG001|3-month Follow Up|Lost to Follow-up|24|||
164219897|NCT04433975|593173612|FG000|3-month Follow Up|Death|1|||
164219898|NCT04433975|593173613|FG001|3-month Follow Up|Death|0|||
164219899|NCT04433975|593173612|FG000|3-month Follow Up|Withdrawal by Subject|2|||
164219900|NCT04433975|593173613|FG001|3-month Follow Up|Withdrawal by Subject|0|||
164219901|NCT04433975|593173612|FG000|6-month Follow Up|Lost to Follow-up|23|||
164219902|NCT04433975|593173613|FG001|6-month Follow Up|Lost to Follow-up|28|||
164219903|NCT04433975|593173612|FG000|6-month Follow Up|Withdrawal by Subject|1|||
164219904|NCT04433975|593173613|FG001|6-month Follow Up|Withdrawal by Subject|1|||
164219905|NCT04433975|593173612|FG000|9-month Follow Up|Lost to Follow-up|27|||
164219906|NCT04433975|593173613|FG001|9-month Follow Up|Lost to Follow-up|36|||
164219907|NCT04433975|593173612|FG000|9-month Follow Up|Death|0|||
164219908|NCT04433975|593173613|FG001|9-month Follow Up|Death|1|||
164219909|NCT04433975|593173612|FG000|12-month Follow Up|Lost to Follow-up|27|||
164219910|NCT04433975|593173613|FG001|12-month Follow Up|Lost to Follow-up|31|||
164219911|NCT04882215|593173614|FG000|Overall Study|Withdrawal by Subject|5|||
164219912|NCT04882215|593173615|FG001|Overall Study|Withdrawal by Subject|0|||
164219913|NCT06083493|593173616|FG000|Overall Study|Technical issues with the interventional device|2|||
164219914|NCT06083493|593173617|FG001|Overall Study|Technical issues with the interventional device|2|||
164219915|NCT06083493|593173616|FG000|Overall Study|Performed incorrect visual task|1|||
164219916|NCT06083493|593173617|FG001|Overall Study|Performed incorrect visual task|0|||
164219917|NCT06083493|593173616|FG000|Overall Study|Insufficient baseline performance|0|||
164219918|NCT06083493|593173617|FG001|Overall Study|Insufficient baseline performance|1|||
164219919|NCT04392635|593173620|FG000|Overall Study|Lost to Follow-up|0|||
164219920|NCT04392635|593173621|FG001|Overall Study|Lost to Follow-up|1|||
164219921|NCT00114777|593173633|FG000|Randomization to Month 36|Death|10|||
164219922|NCT00114777|593173634|FG001|Randomization to Month 36|Death|4|||
164219923|NCT00114777|593173635|FG002|Randomization to Month 36|Death|3|||
164219924|NCT00114777|593173633|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
164219925|NCT00114777|593173634|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
164219926|NCT00114777|593173635|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
164219927|NCT00114777|593173633|FG000|Randomization to Month 36|Lack of Efficacy|19|||
164219928|NCT00114777|593173634|FG001|Randomization to Month 36|Lack of Efficacy|15|||
164219929|NCT00114777|593173635|FG002|Randomization to Month 36|Lack of Efficacy|17|||
164219930|NCT00114777|593173633|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
164219931|NCT00114777|593173634|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
164219932|NCT00114777|593173635|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
164219933|NCT00114777|593173633|FG000|Randomization to Month 36|Adverse Event|34|||
164219934|NCT00114777|593173634|FG001|Randomization to Month 36|Adverse Event|35|||
164219935|NCT00114777|593173635|FG002|Randomization to Month 36|Adverse Event|44|||
164219936|NCT00114777|593173633|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
164219937|NCT00114777|593173634|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
164219938|NCT00114777|593173635|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
164219939|NCT00114777|593173633|FG000|Randomization to Month 36|Other|9|||
164219940|NCT00114777|593173634|FG001|Randomization to Month 36|Other|3|||
164219941|NCT00114777|593173635|FG002|Randomization to Month 36|Other|12|||
164219942|NCT00114777|593173633|FG000|Long-Term Extension to Month 84|Death|8|||
164219943|NCT00114777|593173634|FG001|Long-Term Extension to Month 84|Death|13|||
164219944|NCT00114777|593173635|FG002|Long-Term Extension to Month 84|Death|7|||
164219945|NCT00114777|593173633|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
164567155|NCT00289913|594445329|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
164567156|NCT00289913|594445330|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
164567157|NCT00289913|594445331|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
164567158|NCT00289913|594445327|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
164567159|NCT00289913|594445328|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
164567160|NCT00289913|594445329|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
164567161|NCT00289913|594445330|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
164567162|NCT00289913|594445331|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
164567163|NCT00289913|594445327|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
164567164|NCT00289913|594445328|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
164567165|NCT00289913|594445329|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
164567166|NCT00289913|594445330|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
164567167|NCT00289913|594445331|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
164219946|NCT00114777|593173634|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
164219947|NCT00114777|593173635|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
164420723|NCT02080520|593910972|FG000|Overall Study|Work-related injury|1|||
164420724|NCT02080520|593910973|FG001|Overall Study|Work-related injury|0|||
164219948|NCT00114777|593173633|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
164219949|NCT00114777|593173634|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
164219950|NCT00114777|593173635|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
164219951|NCT00114777|593173633|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
164219952|NCT00114777|593173634|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
164219953|NCT00114777|593173635|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
164219954|NCT00114777|593173633|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
164219955|NCT00114777|593173634|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
164219956|NCT00114777|593173635|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
164219957|NCT00114777|593173633|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
164219958|NCT00114777|593173634|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
164219959|NCT00114777|593173635|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
164219960|NCT00114777|593173633|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
164219961|NCT00114777|593173634|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
164219962|NCT00114777|593173635|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
164219963|NCT00114777|593173633|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
164219964|NCT00114777|593173634|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
164219965|NCT00114777|593173635|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
164219966|NCT00114777|593173633|FG000|Long-Term Extension to Month 84|Other|2|||
164219967|NCT00114777|593173634|FG001|Long-Term Extension to Month 84|Other|0|||
164219968|NCT00114777|593173635|FG002|Long-Term Extension to Month 84|Other|2|||
164219969|NCT01181128|593173636|FG000|Overall Study|Withdrawal by Subject|2|||
164219970|NCT01181128|593173637|FG001|Overall Study|Withdrawal by Subject|2|||
164219971|NCT01181128|593173638|FG002|Overall Study|Withdrawal by Subject|0|||
164219972|NCT01181128|593173636|FG000|Overall Study|Death|1|||
164219973|NCT01181128|593173637|FG001|Overall Study|Death|0|||
164219974|NCT01181128|593173638|FG002|Overall Study|Death|0|||
164219975|NCT01181128|593173636|FG000|Overall Study|Physician Decision|2|||
164219976|NCT01181128|593173637|FG001|Overall Study|Physician Decision|0|||
164219977|NCT01181128|593173638|FG002|Overall Study|Physician Decision|0|||
164219978|NCT01181128|593173636|FG000|Overall Study|Adverse Event|0|||
164219979|NCT01181128|593173637|FG001|Overall Study|Adverse Event|2|||
164219980|NCT01181128|593173638|FG002|Overall Study|Adverse Event|0|||
164219981|NCT01181128|593173636|FG000|Overall Study|Other|1|||
164219982|NCT01181128|593173637|FG001|Overall Study|Other|1|||
164219983|NCT01181128|593173638|FG002|Overall Study|Other|1|||
164219984|NCT04477486|593173641|FG000|Overall Study|Death|2|||
164219985|NCT04477486|593173641|FG000|Overall Study|Ongoing at Time of Analysis|11|||
164219986|NCT02460380|593173644|FG000|Overall Study|Withdrawal by Subject|10|||
164219987|NCT02460380|593173645|FG001|Overall Study|Withdrawal by Subject|5|||
164219988|NCT00514917|593173656|FG000|Overall Study|Death|4|||
164219989|NCT00514917|593173657|FG001|Overall Study|Death|10|||
164219990|NCT00514917|593173656|FG000|Overall Study|Protocol Violation|1|||
164219991|NCT00514917|593173657|FG001|Overall Study|Protocol Violation|0|||
164219992|NCT00514917|593173656|FG000|Overall Study|Lost to Follow-up|4|||
164219993|NCT00514917|593173657|FG001|Overall Study|Lost to Follow-up|3|||
164219994|NCT00514917|593173656|FG000|Overall Study|Withdrawal by Subject|18|||
164219995|NCT00514917|593173657|FG001|Overall Study|Withdrawal by Subject|16|||
164219996|NCT00514917|593173656|FG000|Overall Study|Discontinued due to study closure|88|||
164219997|NCT00514917|593173657|FG001|Overall Study|Discontinued due to study closure|81|||
164219998|NCT00514917|593173656|FG000|Overall Study|Undefined|11|||
164219999|NCT00514917|593173657|FG001|Overall Study|Undefined|5|||
164220000|NCT02280499|593173658|FG000|Overall Study|Death|14|||
164220001|NCT02280499|593173658|FG000|Overall Study|Lost to Follow-up|42|||
164220002|NCT02280499|593173658|FG000|Overall Study|Adverse Event|5|||
164220003|NCT04560309|593173665|FG000|Overall Study|Meet drop out criteria|1|||
164220004|NCT04560309|593173666|FG001|Overall Study|Meet drop out criteria|1|||
164220005|NCT00356421|593173668|FG000|Overall Study|Lack of Efficacy|3|||
164220006|NCT00356421|593173669|FG001|Overall Study|Lack of Efficacy|0|||
164220007|NCT00356421|593173668|FG000|Overall Study|Withdrawal by Subject|9|||
164220008|NCT00356421|593173669|FG001|Overall Study|Withdrawal by Subject|2|||
164220009|NCT00356421|593173668|FG000|Overall Study|Related to study drug|15|||
164670870|NCT05093205|594821308|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
164670871|NCT05093205|594821309|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
164220010|NCT00356421|593173669|FG001|Overall Study|Related to study drug|12|||
164220011|NCT00356421|593173668|FG000|Overall Study|Not related to study drug|5|||
164220012|NCT00356421|593173669|FG001|Overall Study|Not related to study drug|3|||
164220013|NCT04689009|593173670|FG000|Overall Study|Adverse Event|1|||
164220014|NCT04689009|593173671|FG001|Overall Study|Adverse Event|0|||
164220015|NCT04689009|593173670|FG000|Overall Study|Lost to Follow-up|1|||
164220016|NCT04689009|593173671|FG001|Overall Study|Lost to Follow-up|2|||
164220017|NCT04689009|593173670|FG000|Overall Study|Withdrawal by Subject|4|||
164220018|NCT04689009|593173671|FG001|Overall Study|Withdrawal by Subject|3|||
164220019|NCT04689009|593173670|FG000|Overall Study|Protocol Violation|1|||
164220020|NCT04689009|593173671|FG001|Overall Study|Protocol Violation|0|||
164220021|NCT02187055|593173672|FG000|Overall Study|Lack of Efficacy|10|||
164220022|NCT02187055|593173673|FG001|Overall Study|Lack of Efficacy|3|||
164220023|NCT02187055|593173674|FG002|Overall Study|Lack of Efficacy|7|||
164220024|NCT02187055|593173672|FG000|Overall Study|Lost to Follow-up|2|||
164220025|NCT02187055|593173673|FG001|Overall Study|Lost to Follow-up|7|||
164220026|NCT02187055|593173674|FG002|Overall Study|Lost to Follow-up|3|||
164420725|NCT02080520|593910972|FG000|Overall Study|Personal reasons|0|||
164220027|NCT02187055|593173672|FG000|Overall Study|No longer meets eligibility criteria|0|||
164420726|NCT02080520|593910973|FG001|Overall Study|Personal reasons|3|||
164420727|NCT00390455|593910974|FG000|Overall Study|Adverse Event|17|||
164420728|NCT00390455|593910975|FG001|Overall Study|Adverse Event|3|||
164420729|NCT00390455|593910974|FG000|Overall Study|Withdrawal by Subject|8|||
164420730|NCT00390455|593910975|FG001|Overall Study|Withdrawal by Subject|8|||
164420731|NCT00390455|593910974|FG000|Overall Study|Alternate Treatment|0|||
164420732|NCT00390455|593910975|FG001|Overall Study|Alternate Treatment|1|||
164420733|NCT00390455|593910974|FG000|Overall Study|Other Medical Reasons|7|||
164420734|NCT00390455|593910975|FG001|Overall Study|Other Medical Reasons|11|||
164420735|NCT01591460|593910981|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
164567168|NCT00289913|594445327|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
164670872|NCT05093205|594821310|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
164670873|NCT05093205|594821311|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
164670874|NCT05093205|594821312|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
164670875|NCT05093205|594821313|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
164670876|NCT05093205|594821314|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
164670877|NCT05093205|594821315|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
164670878|NCT05093205|594821316|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
164670879|NCT05093205|594821317|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
164670880|NCT05093205|594821318|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
164670881|NCT05093205|594821319|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
164220028|NCT02187055|593173673|FG001|Overall Study|No longer meets eligibility criteria|2|||
164567169|NCT00289913|594445328|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
164567170|NCT00289913|594445329|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
164567171|NCT00289913|594445330|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
164567172|NCT00289913|594445331|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
164567173|NCT00289913|594445327|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
164567174|NCT00289913|594445328|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
164567175|NCT00289913|594445329|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
164567176|NCT00289913|594445330|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
164567177|NCT00289913|594445331|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
164567178|NCT00289913|594445327|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
164567179|NCT00289913|594445328|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
164567180|NCT00289913|594445329|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
164567181|NCT00289913|594445330|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
164567182|NCT00289913|594445331|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
164567183|NCT00289913|594445327|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
164567184|NCT00289913|594445328|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
164567185|NCT00289913|594445329|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
164567186|NCT00289913|594445330|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
164567187|NCT00289913|594445331|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
164567188|NCT00289913|594445327|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
164567189|NCT00289913|594445328|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
164567190|NCT00289913|594445329|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
164567191|NCT00289913|594445330|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
164567192|NCT00289913|594445331|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
164567193|NCT00289913|594445327|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
164567194|NCT00289913|594445328|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
164567195|NCT00289913|594445329|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
164567196|NCT00289913|594445330|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
164567197|NCT00289913|594445331|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
164567198|NCT00289913|594445327|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
164567199|NCT00289913|594445328|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
164567200|NCT00289913|594445329|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
164567201|NCT00289913|594445330|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
164567202|NCT00289913|594445331|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
164567203|NCT00289913|594445327|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
164567204|NCT00289913|594445328|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
164567205|NCT00289913|594445329|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
164567206|NCT00289913|594445330|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
164567207|NCT00289913|594445331|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
164220029|NCT02187055|593173674|FG002|Overall Study|No longer meets eligibility criteria|0|||
164220030|NCT02187055|593173672|FG000|Overall Study|No longer willing to participate|6|||
164220031|NCT02187055|593173673|FG001|Overall Study|No longer willing to participate|8|||
164220032|NCT02187055|593173674|FG002|Overall Study|No longer willing to participate|10|||
164220033|NCT02187055|593173672|FG000|Overall Study|Other|5|||
164220034|NCT02187055|593173673|FG001|Overall Study|Other|6|||
164220035|NCT02187055|593173674|FG002|Overall Study|Other|3|||
164220036|NCT02187055|593173672|FG000|Overall Study|Protocol Violation|9|||
164220037|NCT02187055|593173673|FG001|Overall Study|Protocol Violation|9|||
164220038|NCT02187055|593173674|FG002|Overall Study|Protocol Violation|4|||
164220039|NCT02187055|593173672|FG000|Overall Study|Pregnancy|3|||
164220040|NCT02187055|593173673|FG001|Overall Study|Pregnancy|1|||
164220041|NCT02187055|593173674|FG002|Overall Study|Pregnancy|0|||
164220042|NCT02187055|593173672|FG000|Overall Study|Withdrawal by Subject|11|||
164220043|NCT02187055|593173673|FG001|Overall Study|Withdrawal by Subject|11|||
164220044|NCT02187055|593173674|FG002|Overall Study|Withdrawal by Subject|11|||
164220045|NCT02187055|593173672|FG000|Overall Study|Adverse Event|21|||
164220046|NCT02187055|593173673|FG001|Overall Study|Adverse Event|26|||
164220047|NCT02187055|593173674|FG002|Overall Study|Adverse Event|36|||
164220048|NCT02187055|593173672|FG000|Overall Study|Death|2|||
164220049|NCT02187055|593173673|FG001|Overall Study|Death|0|||
164220050|NCT02187055|593173674|FG002|Overall Study|Death|0|||
164220051|NCT00985790|593173677|FG000|Overall Study|Withdrawal by Subject|1|||
164220052|NCT00985790|593173678|FG001|Overall Study|Withdrawal by Subject|1|||
164220053|NCT00985790|593173677|FG000|Overall Study|Lost to Follow-up|6|||
164220054|NCT00985790|593173678|FG001|Overall Study|Lost to Follow-up|7|||
164220055|NCT03462563|593173682|FG000|Overall Study|Death|1|||
164220056|NCT03462563|593173683|FG001|Overall Study|Death|1|||
164220057|NCT03462563|593173682|FG000|Overall Study|Termination of study|2|||
164220058|NCT03462563|593173683|FG001|Overall Study|Termination of study|1|||
164220059|NCT03462563|593173682|FG000|Overall Study|Adverse Event|1|||
164220060|NCT03462563|593173683|FG001|Overall Study|Adverse Event|3|||
164220061|NCT03462563|593173682|FG000|Overall Study|Unspecified reason|10|||
164220062|NCT03462563|593173683|FG001|Overall Study|Unspecified reason|12|||
164220063|NCT03462563|593173682|FG000|Overall Study|Physician Decision|1|||
164220064|NCT03462563|593173683|FG001|Overall Study|Physician Decision|0|||
164220065|NCT05089357|593173684|FG000|Overall Study|Withdrawal by Subject|23|||
164220066|NCT05089357|593173684|FG000|Overall Study|Lost to Follow-up|6|||
164220067|NCT05089357|593173684|FG000|Overall Study|Medical reason|1|||
164220068|NCT05089357|593173684|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
164220069|NCT05089357|593173684|FG000|Overall Study|Pregnancy|2|||
164220070|NCT00689052|593173685|FG000|Overall Study|Adverse Event|4|||
164220071|NCT00689052|593173686|FG001|Overall Study|Adverse Event|6|||
164220072|NCT00689052|593173685|FG000|Overall Study|Protocol Violation|1|||
164220073|NCT00689052|593173686|FG001|Overall Study|Protocol Violation|0|||
164220074|NCT00689052|593173685|FG000|Overall Study|Lost to Follow-up|2|||
164220075|NCT00689052|593173686|FG001|Overall Study|Lost to Follow-up|0|||
164220076|NCT00689052|593173685|FG000|Overall Study|Withdrawal by Subject|2|||
164220077|NCT00689052|593173686|FG001|Overall Study|Withdrawal by Subject|0|||
164220078|NCT00689052|593173685|FG000|Overall Study|Early termination of the trial|22|||
164420736|NCT01591460|593910981|FG000|Overall Study|Futility Rule (Week 12)|7|||
164420737|NCT01591460|593910981|FG000|Overall Study|Futility Rule (Week 24)|3|||
164420738|NCT01591460|593910981|FG000|Overall Study|Rebound or Breakthrough|3|||
164420739|NCT01591460|593910981|FG000|Overall Study|Treatment Discontinued by Error|1|||
164220079|NCT00689052|593173686|FG001|Overall Study|Early termination of the trial|24|||
164220080|NCT03020888|593173687|FG000|Overall Study|Physician Decision|4|||
164220081|NCT03020888|593173687|FG000|Overall Study|Withdrawal by Subject|6|||
164220082|NCT03020888|593173687|FG000|Overall Study|Insurance coverage|2|||
164220083|NCT03020888|593173687|FG000|Overall Study|Lost to Follow-up|1|||
164220084|NCT01407367|593173688|FG000|Overall Study|Death|24|||
164220085|NCT01407367|593173689|FG001|Overall Study|Death|32|||
164220086|NCT01407367|593173688|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
164420740|NCT01591460|593910981|FG000|Overall Study|Lost to Follow-up|1|||
164420741|NCT01591460|593910981|FG000|Overall Study|Noncompliance|1|||
164220087|NCT01407367|593173689|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
164220088|NCT01407367|593173688|FG000|Overall Study|Withdrawal by Subject|4|||
164220089|NCT01407367|593173689|FG001|Overall Study|Withdrawal by Subject|15|||
164220090|NCT01407367|593173688|FG000|Overall Study|Lost to Follow-up|0|||
164220091|NCT01407367|593173689|FG001|Overall Study|Lost to Follow-up|2|||
164220092|NCT01793129|593175450|FG000|Overall Study|Lost to Follow-up|3|||
164220093|NCT01793129|593175451|FG001|Overall Study|Lost to Follow-up|7|||
164220094|NCT01793129|593175450|FG000|Overall Study|Withdrawal by Subject|0|||
164220095|NCT01793129|593175451|FG001|Overall Study|Withdrawal by Subject|2|||
164220096|NCT02469961|593175460|FG000|Overall Study|Physician Decision|4|||
164220097|NCT02469961|593175461|FG001|Overall Study|Physician Decision|1|||
164220098|NCT00454142|593175462|FG000|Overall Study|Withdrawal by Subject|1|||
164220099|NCT00520572|593175463|FG000|Overall Study|Adverse Event|9|||
164420742|NCT01591460|593910981|FG000|Overall Study|Participant Refusal|3|||
164220100|NCT00520572|593175464|FG001|Overall Study|Adverse Event|3|||
164220101|NCT00520572|593175465|FG002|Overall Study|Adverse Event|6|||
164220102|NCT00520572|593175466|FG003|Overall Study|Adverse Event|9|||
164220103|NCT00520572|593175467|FG004|Overall Study|Adverse Event|7|||
164220104|NCT00520572|593175468|FG005|Overall Study|Adverse Event|2|||
164567208|NCT00289913|594445327|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
164220105|NCT00520572|593175463|FG000|Overall Study|Withdrawal by Subject|0|||
164220106|NCT00520572|593175464|FG001|Overall Study|Withdrawal by Subject|9|||
164220107|NCT00520572|593175465|FG002|Overall Study|Withdrawal by Subject|5|||
164220108|NCT00520572|593175466|FG003|Overall Study|Withdrawal by Subject|2|||
164220109|NCT00520572|593175467|FG004|Overall Study|Withdrawal by Subject|2|||
164220110|NCT00520572|593175468|FG005|Overall Study|Withdrawal by Subject|0|||
164220111|NCT00520572|593175463|FG000|Overall Study|Protocol Violation|0|||
164220112|NCT00520572|593175464|FG001|Overall Study|Protocol Violation|0|||
164220113|NCT00520572|593175465|FG002|Overall Study|Protocol Violation|1|||
164220114|NCT00520572|593175466|FG003|Overall Study|Protocol Violation|0|||
164220115|NCT00520572|593175467|FG004|Overall Study|Protocol Violation|0|||
164220116|NCT00520572|593175468|FG005|Overall Study|Protocol Violation|0|||
164220117|NCT00520572|593175463|FG000|Overall Study|Lack of Efficacy|1|||
164220118|NCT00520572|593175464|FG001|Overall Study|Lack of Efficacy|1|||
164220119|NCT00520572|593175465|FG002|Overall Study|Lack of Efficacy|1|||
164220120|NCT00520572|593175466|FG003|Overall Study|Lack of Efficacy|2|||
164220121|NCT00520572|593175467|FG004|Overall Study|Lack of Efficacy|1|||
164220122|NCT00520572|593175468|FG005|Overall Study|Lack of Efficacy|0|||
164220123|NCT00520572|593175463|FG000|Overall Study|Lost to Follow-up|0|||
164220124|NCT00520572|593175464|FG001|Overall Study|Lost to Follow-up|0|||
164220125|NCT00520572|593175465|FG002|Overall Study|Lost to Follow-up|0|||
164220126|NCT00520572|593175466|FG003|Overall Study|Lost to Follow-up|0|||
164220127|NCT00520572|593175467|FG004|Overall Study|Lost to Follow-up|1|||
164220128|NCT00520572|593175468|FG005|Overall Study|Lost to Follow-up|0|||
164220129|NCT00520572|593175463|FG000|Overall Study|Incorrect enrollment|1|||
164220130|NCT00520572|593175464|FG001|Overall Study|Incorrect enrollment|0|||
164220131|NCT00520572|593175465|FG002|Overall Study|Incorrect enrollment|1|||
164220132|NCT00520572|593175466|FG003|Overall Study|Incorrect enrollment|0|||
164220133|NCT00520572|593175467|FG004|Overall Study|Incorrect enrollment|1|||
164220134|NCT00520572|593175468|FG005|Overall Study|Incorrect enrollment|0|||
164220135|NCT00520572|593175463|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
164220136|NCT00520572|593175464|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
164220137|NCT00520572|593175465|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
164220138|NCT00520572|593175466|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
164220139|NCT00520572|593175467|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
164220140|NCT00520572|593175468|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
164220141|NCT00520572|593175463|FG000|Overall Study|Long break in taking Medication|0|||
164220142|NCT00520572|593175464|FG001|Overall Study|Long break in taking Medication|0|||
164220143|NCT00520572|593175465|FG002|Overall Study|Long break in taking Medication|0|||
164220144|NCT00520572|593175466|FG003|Overall Study|Long break in taking Medication|1|||
164220145|NCT00520572|593175467|FG004|Overall Study|Long break in taking Medication|0|||
164220146|NCT00520572|593175468|FG005|Overall Study|Long break in taking Medication|0|||
164220147|NCT00520572|593175463|FG000|Overall Study|Did not receive Treatment|1|||
164220148|NCT00520572|593175464|FG001|Overall Study|Did not receive Treatment|0|||
164220149|NCT00520572|593175465|FG002|Overall Study|Did not receive Treatment|1|||
164220150|NCT00520572|593175466|FG003|Overall Study|Did not receive Treatment|0|||
164220151|NCT00520572|593175467|FG004|Overall Study|Did not receive Treatment|0|||
164328913|NCT00107952|593581208|FG000|Overall Study|Death|75|||
164328914|NCT00107952|593581209|FG001|Overall Study|Death|61|||
164328915|NCT00107952|593581208|FG000|Overall Study|Lost to Follow-up|0|||
164328916|NCT00107952|593581209|FG001|Overall Study|Lost to Follow-up|3|||
164328917|NCT00107952|593581208|FG000|Overall Study|Withdrawal by Subject|9|||
164328918|NCT00107952|593581209|FG001|Overall Study|Withdrawal by Subject|6|||
164328919|NCT00107952|593581208|FG000|Overall Study|Other|2|||
164328920|NCT00107952|593581209|FG001|Overall Study|Other|5|||
164328921|NCT00107952|593581208|FG000|Overall Study|Never received study treatment|9|||
164328922|NCT00107952|593581209|FG001|Overall Study|Never received study treatment|6|||
164328923|NCT03533686|593581210|FG000|Overall Study|Withdrawal by Subject|1|||
164328924|NCT03533686|593581211|FG001|Overall Study|Withdrawal by Subject|0|||
164328925|NCT03533686|593581212|FG002|Overall Study|Withdrawal by Subject|0|||
164328926|NCT03533686|593581213|FG003|Overall Study|Withdrawal by Subject|3|||
164328927|NCT03533686|593581214|FG004|Overall Study|Withdrawal by Subject|5|||
164328928|NCT03533686|593581215|FG005|Overall Study|Withdrawal by Subject|1|||
164328929|NCT03533686|593581210|FG000|Overall Study|Lost to Follow-up|0|||
164220152|NCT00520572|593175468|FG005|Overall Study|Did not receive Treatment|0|||
164220153|NCT01748552|593175473|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
164220154|NCT01748552|593175474|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
164220155|NCT01748552|593175475|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
164220156|NCT01748552|593175476|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
164220157|NCT01748552|593175477|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
164220158|NCT01748552|593175478|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
164220159|NCT01748552|593175479|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
164220160|NCT01748552|593175480|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
164220161|NCT01748552|593175481|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
164220162|NCT01748552|593175482|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
164220163|NCT01748552|593175483|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
164220164|NCT01748552|593175484|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
164220165|NCT01748552|593175473|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
164220166|NCT01748552|593175474|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
164220167|NCT01748552|593175475|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
164220168|NCT01748552|593175476|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
164220169|NCT01748552|593175477|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
164220170|NCT01748552|593175478|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
164220171|NCT01748552|593175479|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
164220172|NCT01748552|593175480|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
164220173|NCT01748552|593175481|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
164220174|NCT01748552|593175482|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
164220175|NCT01748552|593175483|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
164220176|NCT01748552|593175484|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
164220177|NCT01386645|593175485|FG000|Overall Study|Physician Decision|0|||
164220178|NCT01386645|593175486|FG001|Overall Study|Physician Decision|0|||
164220179|NCT01386645|593175487|FG002|Overall Study|Physician Decision|1|||
164220180|NCT01386645|593175485|FG000|Overall Study|Withdrawal by Subject|0|||
164220181|NCT01386645|593175486|FG001|Overall Study|Withdrawal by Subject|1|||
164220182|NCT01386645|593175487|FG002|Overall Study|Withdrawal by Subject|1|||
164220183|NCT02930941|593175488|FG000|Overall Study|Lost to Follow-up|1|||
164220184|NCT02930941|593175489|FG001|Overall Study|Lost to Follow-up|2|||
164220185|NCT00289978|593175490|FG000|Overall Study|Withdrawal by Subject|31|||
164220186|NCT00289978|593175491|FG001|Overall Study|Withdrawal by Subject|17|||
164220187|NCT00289978|593175492|FG002|Overall Study|Withdrawal by Subject|28|||
164220188|NCT00289978|593175490|FG000|Overall Study|Adverse Event|22|||
164220189|NCT00289978|593175491|FG001|Overall Study|Adverse Event|13|||
164220190|NCT00289978|593175492|FG002|Overall Study|Adverse Event|18|||
164220191|NCT00289978|593175490|FG000|Overall Study|Lack of Efficacy|13|||
164220192|NCT00289978|593175491|FG001|Overall Study|Lack of Efficacy|6|||
164220193|NCT00289978|593175492|FG002|Overall Study|Lack of Efficacy|25|||
164220194|NCT00289978|593175490|FG000|Overall Study|Abnormal laboratory value(s)|20|||
164220195|NCT00289978|593175491|FG001|Overall Study|Abnormal laboratory value(s)|9|||
164220196|NCT00289978|593175492|FG002|Overall Study|Abnormal laboratory value(s)|1|||
164220197|NCT00289978|593175490|FG000|Overall Study|Lost to Follow-up|3|||
164220198|NCT00289978|593175491|FG001|Overall Study|Lost to Follow-up|5|||
164220199|NCT00289978|593175492|FG002|Overall Study|Lost to Follow-up|7|||
164220200|NCT00289978|593175490|FG000|Overall Study|Protocol Violation|5|||
164220201|NCT00289978|593175491|FG001|Overall Study|Protocol Violation|5|||
164220202|NCT00289978|593175492|FG002|Overall Study|Protocol Violation|4|||
164220203|NCT00289978|593175490|FG000|Overall Study|Abnormal test procedure result(s)|2|||
164220204|NCT00289978|593175491|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164220205|NCT00289978|593175492|FG002|Overall Study|Abnormal test procedure result(s)|1|||
164220206|NCT00289978|593175490|FG000|Overall Study|Death|1|||
164220207|NCT00289978|593175491|FG001|Overall Study|Death|0|||
164220208|NCT00289978|593175492|FG002|Overall Study|Death|2|||
164220209|NCT00903344|593175493|FG000|Overall Study|Pregnancy|2|||
164220210|NCT00903344|593175494|FG001|Overall Study|Pregnancy|3|||
164220211|NCT00903344|593175493|FG000|Overall Study|Lost to Follow-up|3|||
164328930|NCT03533686|593581211|FG001|Overall Study|Lost to Follow-up|1|||
164328931|NCT03533686|593581212|FG002|Overall Study|Lost to Follow-up|0|||
164328932|NCT03533686|593581213|FG003|Overall Study|Lost to Follow-up|0|||
164328933|NCT03533686|593581214|FG004|Overall Study|Lost to Follow-up|2|||
164328934|NCT03533686|593581215|FG005|Overall Study|Lost to Follow-up|0|||
164328935|NCT03533686|593581210|FG000|Overall Study|Screen Failure|0|||
164328936|NCT03533686|593581211|FG001|Overall Study|Screen Failure|0|||
164328937|NCT03533686|593581212|FG002|Overall Study|Screen Failure|0|||
164328938|NCT03533686|593581213|FG003|Overall Study|Screen Failure|2|||
164220212|NCT00903344|593175494|FG001|Overall Study|Lost to Follow-up|0|||
164328939|NCT03533686|593581214|FG004|Overall Study|Screen Failure|0|||
164328940|NCT03533686|593581215|FG005|Overall Study|Screen Failure|0|||
164420743|NCT01591460|593910981|FG000|Overall Study|Withdrawal by Subject|1|||
164220213|NCT00585169|593175495|FG000|Overall Study|Withdrawal by Subject|1|||
164220214|NCT00527748|593175508|FG000|Overall Study|Other|3|||
164220215|NCT03055221|593175509|FG000|Overall Study|Adverse Event|2|||
164220216|NCT03055221|593175509|FG000|Overall Study|Withdrawal by Subject|4|||
164220217|NCT03055221|593175509|FG000|Overall Study|Death|6|||
164220218|NCT03055221|593175509|FG000|Overall Study|Physician Decision|1|||
164220219|NCT03055221|593175509|FG000|Overall Study|Study terminated by Sponsor|3|||
164220220|NCT03055221|593175509|FG000|Overall Study|Lost to Follow-up|4|||
164220221|NCT01243424|593175510|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
164220222|NCT01243424|593175511|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
164220223|NCT01243424|593175510|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
164220224|NCT01243424|593175511|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
164220225|NCT01243424|593175510|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
164220226|NCT01243424|593175511|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
164220227|NCT01243424|593175510|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
164220228|NCT01243424|593175511|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
164220229|NCT01243424|593175510|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
164220230|NCT01243424|593175511|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
164220231|NCT01243424|593175510|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
164220232|NCT01243424|593175511|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
164220233|NCT01243424|593175510|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
164220234|NCT01243424|593175511|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
164220235|NCT01243424|593175510|FG000|Discontinuation From Treatment|Not treated|5|||
164220236|NCT01243424|593175511|FG001|Discontinuation From Treatment|Not treated|4|||
164220237|NCT01243424|593175510|FG000|Discontinuation From Treatment|Adverse Event|457|||
164220238|NCT01243424|593175511|FG001|Discontinuation From Treatment|Adverse Event|523|||
164220239|NCT01243424|593175510|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
164220240|NCT01243424|593175511|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
164220241|NCT01243424|593175510|FG000|Discontinuation From Treatment|Protocol Violation|46|||
164220242|NCT01243424|593175511|FG001|Discontinuation From Treatment|Protocol Violation|47|||
164220243|NCT01243424|593175510|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
164220244|NCT01243424|593175511|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
164220245|NCT01243424|593175510|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
164220246|NCT01243424|593175511|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
164220247|NCT01243424|593175510|FG000|Discontinuation From Treatment|Other than listed above|230|||
164220248|NCT01243424|593175511|FG001|Discontinuation From Treatment|Other than listed above|211|||
164220249|NCT01093885|593175512|FG000|Overall Study|Adverse Event|4|||
164220250|NCT01093885|593175512|FG000|Overall Study|Lost to Follow-up|1|||
164220251|NCT00710554|593175513|FG000|Overall Study|Adverse Event|24|||
164220252|NCT00710554|593175514|FG001|Overall Study|Adverse Event|7|||
164220253|NCT00710554|593175513|FG000|Overall Study|Withdrawal by Subject|7|||
164220254|NCT00710554|593175514|FG001|Overall Study|Withdrawal by Subject|3|||
164220255|NCT00710554|593175513|FG000|Overall Study|Lost to Follow-up|7|||
164220256|NCT00710554|593175514|FG001|Overall Study|Lost to Follow-up|1|||
164220257|NCT00710554|593175513|FG000|Overall Study|Lack of Efficacy|11|||
164220258|NCT00710554|593175514|FG001|Overall Study|Lack of Efficacy|12|||
164220259|NCT00710554|593175513|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
164220260|NCT00710554|593175514|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
164220261|NCT04621786|593175515|FG000|Overall Study|Lost to Follow-up|9|||
164220262|NCT04621786|593175515|FG000|Overall Study|Protocol Violation|3|||
164220263|NCT00292370|593175520|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
164220264|NCT00292370|593175521|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
164220265|NCT00292370|593175522|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
164220266|NCT00292370|593175520|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
164220267|NCT00292370|593175521|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
164220268|NCT00292370|593175522|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
164220269|NCT00292370|593175520|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
164220270|NCT00292370|593175521|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
164220271|NCT00292370|593175522|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
164220272|NCT00292370|593175520|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
164220273|NCT00292370|593175521|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
164220274|NCT00292370|593175522|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
164220275|NCT00292370|593175520|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
164420744|NCT01591460|593910981|FG000|Overall Study|Protocol Violation|1|||
164420745|NCT04102540|593910986|FG000|Overall Study|Withdrawn by PI|2|||
164220276|NCT00292370|593175521|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
164220277|NCT00292370|593175522|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
164220278|NCT00292370|593175520|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
164220279|NCT00292370|593175521|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
164220280|NCT00292370|593175522|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
164220281|NCT01301001|593175523|FG000|First Intervention|Lost to Follow-up|4|||
164220282|NCT01301001|593175524|FG001|First Intervention|Lost to Follow-up|4|||
164220283|NCT01301001|593175523|FG000|First Intervention|Withdrawal by Subject|1|||
164220284|NCT01301001|593175524|FG001|First Intervention|Withdrawal by Subject|4|||
164220285|NCT01301001|593175523|FG000|First Intervention|Adverse Event|5|||
164220286|NCT01301001|593175524|FG001|First Intervention|Adverse Event|0|||
164220287|NCT01301001|593175523|FG000|First Intervention|Protocol Violation|0|||
164220288|NCT01301001|593175524|FG001|First Intervention|Protocol Violation|1|||
164220289|NCT01301001|593175523|FG000|Second Intervention|Adverse Event|2|||
164220290|NCT01301001|593175524|FG001|Second Intervention|Adverse Event|0|||
164220291|NCT01301001|593175523|FG000|Second Intervention|Withdrawal by Subject|2|||
164220292|NCT01301001|593175524|FG001|Second Intervention|Withdrawal by Subject|0|||
164220293|NCT01560988|593175525|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
164220294|NCT01560988|593175526|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
164220295|NCT01560988|593175525|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
164220296|NCT01560988|593175526|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
164220297|NCT01560988|593175525|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
164220298|NCT01560988|593175526|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
164220299|NCT01346709|593175527|FG000|Overall Study|Protocol Violation|35|||
164220300|NCT01346709|593175527|FG000|Overall Study|Lost to Follow-up|31|||
164220301|NCT01346709|593175527|FG000|Overall Study|Missing data in candidate risk factor|285|||
164220302|NCT04821245|593175528|FG000|Overall Study|Withdrawal by Subject|3|||
164220303|NCT04821245|593175528|FG000|Overall Study|Physician Decision|1|||
164220304|NCT04821245|593175528|FG000|Overall Study|Protocol Violation|5|||
164220305|NCT01840163|593175529|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
164220306|NCT01840163|593175530|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
164220307|NCT01840163|593175529|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
164220308|NCT01840163|593175530|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
164220309|NCT01840163|593175529|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
164220310|NCT01840163|593175530|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
164220311|NCT02421510|593175534|FG000|Overall Study|Other|4|||
164220312|NCT02421510|593175535|FG001|Overall Study|Other|2|||
164220313|NCT02421510|593175536|FG002|Overall Study|Other|3|||
164220314|NCT02421510|593175534|FG000|Overall Study|Protocol Violation|1|||
164220315|NCT02421510|593175535|FG001|Overall Study|Protocol Violation|2|||
164220316|NCT02421510|593175536|FG002|Overall Study|Protocol Violation|0|||
164220317|NCT02421510|593175534|FG000|Overall Study|Death|1|||
164567209|NCT00289913|594445328|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
164567210|NCT00289913|594445329|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
164567211|NCT00289913|594445330|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
164567212|NCT00289913|594445331|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
164567213|NCT00289913|594445327|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
164567214|NCT00289913|594445328|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
164567215|NCT00289913|594445329|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
164567216|NCT00289913|594445330|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
164567217|NCT00289913|594445331|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
164567218|NCT00289913|594445327|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
164567219|NCT00289913|594445328|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
164567220|NCT00289913|594445329|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
164567221|NCT00289913|594445330|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
164567222|NCT00289913|594445331|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
164567223|NCT00289913|594445327|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
164567224|NCT00289913|594445328|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
164567225|NCT00289913|594445329|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
164567226|NCT00289913|594445330|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
164220318|NCT02421510|593175535|FG001|Overall Study|Death|0|||
164220319|NCT02421510|593175536|FG002|Overall Study|Death|0|||
164220320|NCT02421510|593175534|FG000|Overall Study|Noncompliance with study drug|1|||
164567227|NCT00289913|594445331|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
164220321|NCT02421510|593175535|FG001|Overall Study|Noncompliance with study drug|0|||
164220322|NCT02421510|593175536|FG002|Overall Study|Noncompliance with study drug|0|||
164567228|NCT03822884|594445332|FG000|Overall Study|Withdrawal by Subject|0|||
164220323|NCT02421510|593175534|FG000|Overall Study|Physician Decision|1|||
164220324|NCT02421510|593175535|FG001|Overall Study|Physician Decision|1|||
164220325|NCT02421510|593175536|FG002|Overall Study|Physician Decision|3|||
164220326|NCT02421510|593175534|FG000|Overall Study|Adverse Event|9|||
164220327|NCT02421510|593175535|FG001|Overall Study|Adverse Event|10|||
164220328|NCT02421510|593175536|FG002|Overall Study|Adverse Event|18|||
164220329|NCT02421510|593175534|FG000|Overall Study|Pregnancy|1|||
164220330|NCT02421510|593175535|FG001|Overall Study|Pregnancy|1|||
164220331|NCT02421510|593175536|FG002|Overall Study|Pregnancy|0|||
164220332|NCT02421510|593175534|FG000|Overall Study|Withdrawal by Subject|14|||
164220333|NCT02421510|593175535|FG001|Overall Study|Withdrawal by Subject|18|||
164220334|NCT02421510|593175536|FG002|Overall Study|Withdrawal by Subject|12|||
164220335|NCT02421510|593175534|FG000|Overall Study|Lost to Follow-up|1|||
164220336|NCT02421510|593175535|FG001|Overall Study|Lost to Follow-up|1|||
164220337|NCT02421510|593175536|FG002|Overall Study|Lost to Follow-up|0|||
164220338|NCT01058005|593175539|FG000|Overall Study|Adverse Event|0|||
164220339|NCT01058005|593175540|FG001|Overall Study|Adverse Event|2|||
164220340|NCT01058005|593175541|FG002|Overall Study|Adverse Event|1|||
164220341|NCT01058005|593175539|FG000|Overall Study|Physician Decision|2|||
164220342|NCT01058005|593175540|FG001|Overall Study|Physician Decision|2|||
164220343|NCT01058005|593175541|FG002|Overall Study|Physician Decision|0|||
164220344|NCT01058005|593175539|FG000|Overall Study|Withdrawal by Subject|4|||
164220345|NCT01058005|593175540|FG001|Overall Study|Withdrawal by Subject|5|||
164220346|NCT01058005|593175541|FG002|Overall Study|Withdrawal by Subject|11|||
164220347|NCT01058005|593175539|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
164220348|NCT01058005|593175540|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
164220349|NCT01058005|593175541|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
164220350|NCT01058005|593175539|FG000|Overall Study|Reason Missing|5|||
164220351|NCT01058005|593175540|FG001|Overall Study|Reason Missing|3|||
164670882|NCT05093205|594821320|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
164670883|NCT05093205|594821308|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
164670884|NCT05093205|594821309|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
164670885|NCT05093205|594821310|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
164670886|NCT05093205|594821311|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
164670887|NCT05093205|594821312|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
164670888|NCT05093205|594821313|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
164670889|NCT05093205|594821314|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
164670890|NCT05093205|594821315|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
164220352|NCT01058005|593175541|FG002|Overall Study|Reason Missing|1|||
164220353|NCT01698008|593175542|FG000|Overall Study|Withdrawal by Subject|1|||
164220354|NCT01698008|593175543|FG001|Overall Study|Withdrawal by Subject|2|||
164220355|NCT01623752|593175547|FG000|Phase 1 (78 Weeks)|No Data|249|||
164220356|NCT01623752|593175548|FG001|Phase 1 (78 Weeks)|No Data|66|||
164220357|NCT01623752|593175549|FG002|Phase 1 (78 Weeks)|No Data|2|||
164220358|NCT01623752|593175547|FG000|Phase 1 (78 Weeks)|Other|33|||
164220359|NCT01623752|593175548|FG001|Phase 1 (78 Weeks)|Other|20|||
164220360|NCT01623752|593175549|FG002|Phase 1 (78 Weeks)|Other|0|||
164220361|NCT01623752|593175547|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
164220362|NCT01623752|593175548|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
164220363|NCT01623752|593175549|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
164220364|NCT01623752|593175547|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
164220365|NCT01623752|593175548|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
164220366|NCT01623752|593175549|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
164220367|NCT01623752|593175547|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
164220368|NCT01623752|593175548|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
164220369|NCT01623752|593175549|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
164220370|NCT01623752|593175547|FG000|Phase 2 (78 Weeks)|Other|5|||
164328941|NCT02632838|593581216|FG000|Overall Study|Withdrawal by Subject|3|||
164220371|NCT01623752|593175548|FG001|Phase 2 (78 Weeks)|Other|1|||
164220372|NCT01623752|593175549|FG002|Phase 2 (78 Weeks)|Other|0|||
164220373|NCT01623752|593175547|FG000|Phase 2 (78 Weeks)|No Data|43|||
164220374|NCT01623752|593175548|FG001|Phase 2 (78 Weeks)|No Data|11|||
164220375|NCT01623752|593175549|FG002|Phase 2 (78 Weeks)|No Data|0|||
164220376|NCT01623752|593175547|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
164328942|NCT02632838|593581217|FG001|Overall Study|Withdrawal by Subject|0|||
164220377|NCT01623752|593175548|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
164220378|NCT01623752|593175549|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
164220379|NCT00981175|593175550|FG000|Primary Dose Vaccination|Adverse Event|1|||
164220380|NCT00981175|593175551|FG001|Primary Dose Vaccination|Adverse Event|0|||
164220381|NCT00981175|593175550|FG000|Primary Dose Vaccination|Protocol Violation|0|||
164220382|NCT00981175|593175551|FG001|Primary Dose Vaccination|Protocol Violation|1|||
164220383|NCT00981175|593175550|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
164220384|NCT00981175|593175551|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
164220385|NCT00981175|593175550|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
164220386|NCT00981175|593175551|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
164220387|NCT02619812|593175552|FG000|Overall Study|Withdrawal by Subject|0|||
164220388|NCT02619812|593175553|FG001|Overall Study|Withdrawal by Subject|0|||
164220389|NCT02619812|593175554|FG002|Overall Study|Withdrawal by Subject|1|||
164220390|NCT02619812|593175555|FG003|Overall Study|Withdrawal by Subject|2|||
164220391|NCT04865978|593175569|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
164220392|NCT04865978|593175570|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
164220393|NCT04263532|593175571|FG000|Overall Study|Withdrawal by Subject|2|||
164220394|NCT04263532|593175572|FG001|Overall Study|Withdrawal by Subject|0|||
164220395|NCT04098302|593175573|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
164220396|NCT04098302|593175574|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
164328943|NCT02632838|593581216|FG000|Overall Study|Lost to Follow-up|0|||
164328944|NCT02632838|593581217|FG001|Overall Study|Lost to Follow-up|2|||
164328945|NCT03370289|593581224|FG000|Overall Study|Screen Failure|1|||
164328946|NCT03370289|593581224|FG000|Overall Study|Sample Size Sufficient|4|||
164328947|NCT02140775|593581226|FG000|Overall Study|Withdrawal by Subject|30|||
164328948|NCT02140775|593581227|FG001|Overall Study|Withdrawal by Subject|7|||
164328949|NCT00938964|593581229|FG000|Overall Study|Death|3|||
164328950|NCT00938964|593581230|FG001|Overall Study|Death|3|||
164328951|NCT00938964|593581229|FG000|Overall Study|Lost to Follow-up|2|||
164328952|NCT00938964|593581230|FG001|Overall Study|Lost to Follow-up|3|||
164328953|NCT00938964|593581229|FG000|Overall Study|Withdrawal by Subject|22|||
164328954|NCT00938964|593581230|FG001|Overall Study|Withdrawal by Subject|18|||
164328955|NCT00938964|593581229|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
164328956|NCT00938964|593581230|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
164328957|NCT01858636|593581231|FG000|Overall Study|No Device Deployment Attempted|24|||
164328958|NCT01858636|593581231|FG000|Overall Study|Physician Decision|1|||
164328959|NCT01858636|593581231|FG000|Overall Study|Death|1|||
164328960|NCT01858636|593581231|FG000|Overall Study|Lost to Follow-up|1|||
164328961|NCT01858636|593581231|FG000|Overall Study|Withdrawal by Subject|1|||
164328962|NCT01227564|593581235|FG000|Overall Study|No Longer Willing to Participate|4|||
164328963|NCT01227564|593581236|FG001|Overall Study|No Longer Willing to Participate|2|||
164328964|NCT01227564|593581237|FG002|Overall Study|No Longer Willing to Participate|5|||
164328965|NCT01227564|593581235|FG000|Overall Study|Participant moved to another town|0|||
164328966|NCT01227564|593581236|FG001|Overall Study|Participant moved to another town|0|||
164328967|NCT01227564|593581237|FG002|Overall Study|Participant moved to another town|1|||
164328968|NCT00999921|593581253|FG000|Overall Study|Lost to Follow-up|10|||
164328969|NCT00999921|593581254|FG001|Overall Study|Lost to Follow-up|19|||
164328970|NCT04650854|593581255|FG000|Overall Study|Adverse Event|1|||
164328971|NCT04650854|593581256|FG001|Overall Study|Adverse Event|12|||
164328972|NCT04650854|593581257|FG002|Overall Study|Adverse Event|14|||
164328973|NCT04650854|593581255|FG000|Overall Study|Lack of Efficacy|1|||
164328974|NCT04650854|593581256|FG001|Overall Study|Lack of Efficacy|3|||
164328975|NCT04650854|593581257|FG002|Overall Study|Lack of Efficacy|6|||
164328976|NCT04650854|593581255|FG000|Overall Study|Lost to Follow-up|1|||
164328977|NCT04650854|593581256|FG001|Overall Study|Lost to Follow-up|1|||
164328978|NCT04650854|593581257|FG002|Overall Study|Lost to Follow-up|0|||
164328979|NCT04650854|593581255|FG000|Overall Study|Withdrawal by Subject|2|||
164328980|NCT04650854|593581256|FG001|Overall Study|Withdrawal by Subject|17|||
164328981|NCT04650854|593581257|FG002|Overall Study|Withdrawal by Subject|9|||
164328982|NCT04650854|593581255|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
164328983|NCT04650854|593581256|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
164328984|NCT04650854|593581257|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
164328985|NCT04650854|593581255|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
164328986|NCT04650854|593581256|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
164328987|NCT04650854|593581257|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
164220397|NCT04098302|593175575|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
164220398|NCT04098302|593175576|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
164328988|NCT04650854|593581255|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
164328989|NCT04650854|593581256|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
164328990|NCT04650854|593581257|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
164220399|NCT04098302|593175573|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
164328991|NCT04650854|593581255|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
164420746|NCT04102540|593910986|FG000|Overall Study|Lost to Follow-up|6|||
164420747|NCT01720797|593910987|FG000|Overall Study|Withdrawal by Subject|3|||
164420748|NCT01720797|593910988|FG001|Overall Study|Withdrawal by Subject|0|||
164420749|NCT01686932|593910989|FG000|Period 1|Adverse Event|1|||
164420750|NCT01686932|593910990|FG001|Period 1|Adverse Event|1|||
164420751|NCT00924469|593910992|FG000|Overall Study|Adverse Event|2|||
164420752|NCT00924469|593910993|FG001|Overall Study|Adverse Event|0|||
164420753|NCT00924469|593910992|FG000|Overall Study|Withdrawal by Subject|0|||
164420754|NCT00924469|593910993|FG001|Overall Study|Withdrawal by Subject|1|||
164420755|NCT00924469|593910992|FG000|Overall Study|Lost to Follow-up|0|||
164420756|NCT00924469|593910993|FG001|Overall Study|Lost to Follow-up|1|||
164420757|NCT03044353|593910994|FG000|Overall Study|Adverse Event|0|||
164420758|NCT03044353|593910995|FG001|Overall Study|Adverse Event|1|||
164420759|NCT03044353|593910996|FG002|Overall Study|Adverse Event|0|||
164420760|NCT03358329|593910997|FG000|Overall Study|Lost to Follow-up|2|||
164420761|NCT03358329|593910997|FG000|Overall Study|Withdrawal by Subject|2|||
164420762|NCT03875911|593911000|FG000|Overall Study|Lost to Follow-up|3|||
164420763|NCT03875911|593911001|FG001|Overall Study|Lost to Follow-up|6|||
164420764|NCT03875911|593911002|FG002|Overall Study|Lost to Follow-up|2|||
164420765|NCT03875911|593911000|FG000|Overall Study|Surgery cancelled|1|||
164420766|NCT03875911|593911001|FG001|Overall Study|Surgery cancelled|0|||
164420767|NCT03875911|593911002|FG002|Overall Study|Surgery cancelled|1|||
164420768|NCT03875911|593911000|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
164670891|NCT05093205|594821316|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
164670892|NCT05093205|594821317|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
164670893|NCT05093205|594821318|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
164670894|NCT05093205|594821319|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
164670895|NCT05093205|594821320|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
164670896|NCT05093205|594821308|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
164670897|NCT05093205|594821309|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
164670898|NCT05093205|594821310|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
164420769|NCT03875911|593911001|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
164420770|NCT03875911|593911002|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
164420771|NCT05284019|593911003|FG000|Overall Study|Study terminated|2|||
164420772|NCT05284019|593911004|FG001|Overall Study|Study terminated|2|||
164420773|NCT05284019|593911005|FG002|Overall Study|Study terminated|2|||
164420774|NCT05284019|593911006|FG003|Overall Study|Study terminated|5|||
164420775|NCT05284019|593911007|FG004|Overall Study|Study terminated|15|||
164420776|NCT05284019|593911003|FG000|Overall Study|Withdrawal by Subject|0|||
164420777|NCT05284019|593911004|FG001|Overall Study|Withdrawal by Subject|0|||
164420778|NCT05284019|593911005|FG002|Overall Study|Withdrawal by Subject|0|||
164420779|NCT05284019|593911006|FG003|Overall Study|Withdrawal by Subject|1|||
164420780|NCT05284019|593911007|FG004|Overall Study|Withdrawal by Subject|1|||
164420781|NCT05284019|593911003|FG000|Overall Study|Lost to Follow-up|1|||
164420782|NCT05284019|593911004|FG001|Overall Study|Lost to Follow-up|0|||
164420783|NCT05284019|593911005|FG002|Overall Study|Lost to Follow-up|0|||
164420784|NCT05284019|593911006|FG003|Overall Study|Lost to Follow-up|2|||
164420785|NCT05284019|593911007|FG004|Overall Study|Lost to Follow-up|1|||
164420786|NCT01990300|593911008|FG000|Overall Study|Case Report Forms Uncollected|89|||
164420787|NCT01990300|593911008|FG000|Overall Study|Protocol Deviation|53|||
164420788|NCT01231503|593911009|FG000|Overall Study|Adverse Event|0|||
164420789|NCT01231503|593911010|FG001|Overall Study|Adverse Event|0|||
164420790|NCT01231503|593911011|FG002|Overall Study|Adverse Event|0|||
164420791|NCT01231503|593911012|FG003|Overall Study|Adverse Event|0|||
164420792|NCT01231503|593911013|FG004|Overall Study|Adverse Event|0|||
164420793|NCT01231503|593911014|FG005|Overall Study|Adverse Event|1|||
164420794|NCT01231503|593911015|FG006|Overall Study|Adverse Event|0|||
164420795|NCT01231503|593911016|FG007|Overall Study|Adverse Event|0|||
164420796|NCT01231503|593911009|FG000|Overall Study|Adverse event, serious fatal|0|||
164420797|NCT01231503|593911010|FG001|Overall Study|Adverse event, serious fatal|0|||
164420798|NCT01231503|593911011|FG002|Overall Study|Adverse event, serious fatal|1|||
164420799|NCT01231503|593911012|FG003|Overall Study|Adverse event, serious fatal|1|||
164420800|NCT01231503|593911013|FG004|Overall Study|Adverse event, serious fatal|0|||
164670899|NCT05093205|594821311|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
164670900|NCT05093205|594821312|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
164420801|NCT01231503|593911014|FG005|Overall Study|Adverse event, serious fatal|1|||
164420802|NCT01231503|593911015|FG006|Overall Study|Adverse event, serious fatal|0|||
164420803|NCT01231503|593911016|FG007|Overall Study|Adverse event, serious fatal|0|||
164420804|NCT01231503|593911009|FG000|Overall Study|Withdrawal by Subject|6|||
164420805|NCT01231503|593911010|FG001|Overall Study|Withdrawal by Subject|3|||
164420806|NCT01231503|593911011|FG002|Overall Study|Withdrawal by Subject|3|||
164420807|NCT01231503|593911012|FG003|Overall Study|Withdrawal by Subject|1|||
164670901|NCT05093205|594821313|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
164670902|NCT05093205|594821314|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
164420808|NCT01231503|593911013|FG004|Overall Study|Withdrawal by Subject|3|||
164420809|NCT01231503|593911014|FG005|Overall Study|Withdrawal by Subject|5|||
164567229|NCT03822884|594445333|FG001|Overall Study|Withdrawal by Subject|0|||
164567230|NCT03822884|594445334|FG002|Overall Study|Withdrawal by Subject|0|||
164567231|NCT03822884|594445335|FG003|Overall Study|Withdrawal by Subject|0|||
164567232|NCT03822884|594445336|FG004|Overall Study|Withdrawal by Subject|1|||
164567233|NCT03822884|594445337|FG005|Overall Study|Withdrawal by Subject|0|||
164567234|NCT00434967|594445340|FG000|Overall Study|Adverse Event|2|||
164567235|NCT00434967|594445341|FG001|Overall Study|Adverse Event|4|||
164567236|NCT00434967|594445342|FG002|Overall Study|Adverse Event|3|||
164567237|NCT00434967|594445343|FG003|Overall Study|Adverse Event|3|||
164567238|NCT00434967|594445340|FG000|Overall Study|Lost to Follow-up|0|||
164567239|NCT00434967|594445341|FG001|Overall Study|Lost to Follow-up|0|||
164567240|NCT00434967|594445342|FG002|Overall Study|Lost to Follow-up|1|||
164567241|NCT00434967|594445343|FG003|Overall Study|Lost to Follow-up|0|||
164567242|NCT00434967|594445340|FG000|Overall Study|Withdrawal by Subject|2|||
164567243|NCT00434967|594445341|FG001|Overall Study|Withdrawal by Subject|2|||
164567244|NCT00434967|594445342|FG002|Overall Study|Withdrawal by Subject|4|||
164567245|NCT00434967|594445343|FG003|Overall Study|Withdrawal by Subject|6|||
164567246|NCT00434967|594445340|FG000|Overall Study|Randomized in error|0|||
164567247|NCT00434967|594445341|FG001|Overall Study|Randomized in error|0|||
164567248|NCT00434967|594445342|FG002|Overall Study|Randomized in error|0|||
164567249|NCT00434967|594445343|FG003|Overall Study|Randomized in error|1|||
164567250|NCT00434967|594445340|FG000|Overall Study|Protocol Violation|0|||
164567251|NCT00434967|594445341|FG001|Overall Study|Protocol Violation|1|||
164567252|NCT00434967|594445342|FG002|Overall Study|Protocol Violation|0|||
164567253|NCT00434967|594445343|FG003|Overall Study|Protocol Violation|1|||
164567254|NCT00434967|594445340|FG000|Overall Study|Physician Decision|1|||
164567255|NCT00434967|594445341|FG001|Overall Study|Physician Decision|1|||
164567256|NCT00434967|594445342|FG002|Overall Study|Physician Decision|1|||
164567257|NCT00434967|594445343|FG003|Overall Study|Physician Decision|0|||
164567258|NCT00434967|594445340|FG000|Overall Study|Patient Disposition Challenges|2|||
164567259|NCT00434967|594445341|FG001|Overall Study|Patient Disposition Challenges|0|||
164567260|NCT00434967|594445342|FG002|Overall Study|Patient Disposition Challenges|0|||
164567261|NCT00434967|594445343|FG003|Overall Study|Patient Disposition Challenges|3|||
164567262|NCT03603652|594445344|FG000|Overall Study|Death|2|||
164567263|NCT01014585|594445347|FG000|Overall Study|Adverse Event|0|||
164567264|NCT01014585|594445348|FG001|Overall Study|Adverse Event|2|||
164567265|NCT01014585|594445349|FG002|Overall Study|Adverse Event|0|||
164567266|NCT01014585|594445350|FG003|Overall Study|Adverse Event|3|||
164567267|NCT01014585|594445347|FG000|Overall Study|Withdrawal by Subject|2|||
164567268|NCT01014585|594445348|FG001|Overall Study|Withdrawal by Subject|0|||
164567269|NCT01014585|594445349|FG002|Overall Study|Withdrawal by Subject|1|||
164567270|NCT01014585|594445350|FG003|Overall Study|Withdrawal by Subject|3|||
164567271|NCT01014585|594445347|FG000|Overall Study|Lost to Follow-up|0|||
164567272|NCT01014585|594445348|FG001|Overall Study|Lost to Follow-up|0|||
164567273|NCT01014585|594445349|FG002|Overall Study|Lost to Follow-up|0|||
164567274|NCT01014585|594445350|FG003|Overall Study|Lost to Follow-up|2|||
164567275|NCT01014585|594445347|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
164567276|NCT01014585|594445348|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
164567277|NCT01014585|594445349|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
164567278|NCT01014585|594445350|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
164567279|NCT04897867|594445351|FG000|Overall Study|Withdrawal of Consent|1|||
164567280|NCT04897867|594445351|FG000|Overall Study|Pregnancy|1|||
164567281|NCT04897867|594445351|FG000|Overall Study|Lost to Follow-up|7|||
164567282|NCT04897867|594445351|FG000|Overall Study|Reason not Specified|2|||
164567283|NCT00508391|594445352|FG000|First Treatment|Withdrawal by Subject|6|||
164567284|NCT00508391|594445353|FG001|First Treatment|Withdrawal by Subject|3|||
164567285|NCT00508391|594445352|FG000|Second Treatment|Withdrawal by Subject|2|||
164567286|NCT00508391|594445353|FG001|Second Treatment|Withdrawal by Subject|0|||
164567287|NCT00880256|594445354|FG000|Overall Study|Lost to Follow-up|28|||
164567288|NCT02041962|594445358|FG000|Overall Study|Lost Aetna Coverage|43|||
164567289|NCT02041962|594445359|FG001|Overall Study|Lost Aetna Coverage|40|||
164567290|NCT02041962|594445358|FG000|Overall Study|Death|1|||
164567291|NCT02041962|594445359|FG001|Overall Study|Death|1|||
164567292|NCT02041962|594445358|FG000|Overall Study|Lost to Follow-up|37|||
164567293|NCT02041962|594445359|FG001|Overall Study|Lost to Follow-up|32|||
164420810|NCT01231503|593911015|FG006|Overall Study|Withdrawal by Subject|1|||
164420811|NCT01231503|593911016|FG007|Overall Study|Withdrawal by Subject|2|||
164567294|NCT02041962|594445358|FG000|Overall Study|Withdrawal by Subject|0|||
164567295|NCT02041962|594445359|FG001|Overall Study|Withdrawal by Subject|11|||
164567296|NCT01481896|594445360|FG000|Overall Study|Lost to Follow-up|12|||
164567297|NCT00364182|594445361|FG000|First Intervention|Secondary prophylaxis|1|||
164567298|NCT00364182|594445362|FG001|First Intervention|Secondary prophylaxis|0|||
164567299|NCT00364182|594445363|FG002|First Intervention|Secondary prophylaxis|0|||
164567300|NCT00364182|594445361|FG000|First Intervention|Withdrawal by Subject|2|||
164567301|NCT00364182|594445362|FG001|First Intervention|Withdrawal by Subject|0|||
164567302|NCT00364182|594445363|FG002|First Intervention|Withdrawal by Subject|0|||
164567303|NCT00364182|594445361|FG000|Second Intervention|non-compliance|0|||
164420812|NCT01231503|593911009|FG000|Overall Study|Lost to Follow-up|8|||
164420813|NCT01231503|593911010|FG001|Overall Study|Lost to Follow-up|10|||
164420814|NCT01231503|593911011|FG002|Overall Study|Lost to Follow-up|8|||
164420815|NCT01231503|593911012|FG003|Overall Study|Lost to Follow-up|5|||
164420816|NCT01231503|593911013|FG004|Overall Study|Lost to Follow-up|7|||
164420817|NCT01231503|593911014|FG005|Overall Study|Lost to Follow-up|9|||
164420818|NCT01231503|593911015|FG006|Overall Study|Lost to Follow-up|6|||
164420819|NCT01231503|593911016|FG007|Overall Study|Lost to Follow-up|6|||
164420820|NCT01231503|593911009|FG000|Overall Study|Protocol Violation|0|||
164420821|NCT01231503|593911010|FG001|Overall Study|Protocol Violation|0|||
164420822|NCT01231503|593911011|FG002|Overall Study|Protocol Violation|0|||
164420823|NCT01231503|593911012|FG003|Overall Study|Protocol Violation|1|||
164420824|NCT01231503|593911013|FG004|Overall Study|Protocol Violation|0|||
164420825|NCT01231503|593911014|FG005|Overall Study|Protocol Violation|0|||
164420826|NCT01231503|593911015|FG006|Overall Study|Protocol Violation|0|||
164420827|NCT01231503|593911016|FG007|Overall Study|Protocol Violation|0|||
164420828|NCT02293837|593911017|FG000|Overall Study|Lost to Follow-up|0|||
164420829|NCT02293837|593911018|FG001|Overall Study|Lost to Follow-up|2|||
164420830|NCT02293837|593911019|FG002|Overall Study|Lost to Follow-up|1|||
164220400|NCT04098302|593175574|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
164220401|NCT04098302|593175575|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
164420831|NCT02293837|593911020|FG003|Overall Study|Lost to Follow-up|0|||
164420832|NCT02293837|593911017|FG000|Overall Study|Withdrawal by Subject|2|||
164420833|NCT02293837|593911018|FG001|Overall Study|Withdrawal by Subject|1|||
164420834|NCT02293837|593911019|FG002|Overall Study|Withdrawal by Subject|2|||
164420835|NCT02293837|593911020|FG003|Overall Study|Withdrawal by Subject|1|||
164567304|NCT00364182|594445362|FG001|Second Intervention|non-compliance|1|||
164567305|NCT00364182|594445363|FG002|Second Intervention|non-compliance|1|||
164567306|NCT00364182|594445361|FG000|Second Intervention|Protocol Violation|0|||
164567307|NCT00364182|594445362|FG001|Second Intervention|Protocol Violation|1|||
164567308|NCT00364182|594445363|FG002|Second Intervention|Protocol Violation|0|||
164220402|NCT04098302|593175576|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
164220403|NCT04098302|593175573|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
164220404|NCT04098302|593175574|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
164220405|NCT04098302|593175575|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
164220406|NCT04098302|593175576|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
164220407|NCT04098302|593175573|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
164220408|NCT04098302|593175574|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
164220409|NCT04098302|593175575|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
164220410|NCT04098302|593175576|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
164220411|NCT04098302|593175573|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
164220412|NCT04098302|593175574|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
164220413|NCT04098302|593175575|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
164220414|NCT04098302|593175576|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
164220415|NCT04098302|593175573|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
164220416|NCT04098302|593175574|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
164220417|NCT04098302|593175575|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
164220418|NCT04098302|593175576|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
164220419|NCT04098302|593175573|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
164220420|NCT04098302|593175574|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
164220421|NCT04098302|593175575|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
164220422|NCT04098302|593175576|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
164220423|NCT04098302|593175573|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
164220424|NCT04098302|593175574|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
164220425|NCT04098302|593175575|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
164220426|NCT04098302|593175576|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
164220427|NCT05061706|593175577|FG000|Overall Study|Adverse Event|29|||
164220428|NCT05061706|593175578|FG001|Overall Study|Adverse Event|1|||
164220429|NCT05061706|593175577|FG000|Overall Study|Lack of Efficacy|0|||
164220430|NCT05061706|593175578|FG001|Overall Study|Lack of Efficacy|1|||
164220431|NCT05061706|593175577|FG000|Overall Study|Lost to Follow-up|2|||
164220432|NCT05061706|593175578|FG001|Overall Study|Lost to Follow-up|2|||
164220433|NCT05061706|593175577|FG000|Overall Study|Protocol Violation|3|||
164567309|NCT00364182|594445361|FG000|Second Intervention|Adverse Event|0|||
164567310|NCT00364182|594445362|FG001|Second Intervention|Adverse Event|0|||
164567311|NCT00364182|594445363|FG002|Second Intervention|Adverse Event|1|||
164567312|NCT00364182|594445361|FG000|Third Intervention|non-compliance|0|||
164220434|NCT05061706|593175578|FG001|Overall Study|Protocol Violation|1|||
164420836|NCT02293837|593911017|FG000|Overall Study|COVID-19 Related|1|||
164420837|NCT02293837|593911018|FG001|Overall Study|COVID-19 Related|1|||
164420838|NCT02293837|593911019|FG002|Overall Study|COVID-19 Related|0|||
164420839|NCT02293837|593911020|FG003|Overall Study|COVID-19 Related|0|||
164567313|NCT00364182|594445362|FG001|Third Intervention|non-compliance|1|||
164567314|NCT00364182|594445363|FG002|Third Intervention|non-compliance|0|||
164220435|NCT05061706|593175577|FG000|Overall Study|Withdrawal by Subject|3|||
164220436|NCT05061706|593175578|FG001|Overall Study|Withdrawal by Subject|9|||
164220437|NCT00191152|593175579|FG000|Initial Treatment|Adverse Event|43|||
164220438|NCT00191152|593175580|FG001|Initial Treatment|Adverse Event|67|||
164220439|NCT00191152|593175579|FG000|Initial Treatment|Physician Decision|40|||
164220440|NCT00191152|593175580|FG001|Initial Treatment|Physician Decision|31|||
164220441|NCT00191152|593175579|FG000|Initial Treatment|Withdrawal by Subject|40|||
164220442|NCT00191152|593175580|FG001|Initial Treatment|Withdrawal by Subject|28|||
164220443|NCT00191152|593175579|FG000|Initial Treatment|Lost to Follow-up|0|||
164220444|NCT00191152|593175580|FG001|Initial Treatment|Lost to Follow-up|6|||
164220445|NCT00191152|593175579|FG000|Initial Treatment|Other|18|||
164220446|NCT00191152|593175580|FG001|Initial Treatment|Other|21|||
164220447|NCT00191152|593175579|FG000|Crossover Treatment|Adverse Event|8|||
164220448|NCT00191152|593175580|FG001|Crossover Treatment|Adverse Event|8|||
164220449|NCT00191152|593175579|FG000|Crossover Treatment|Physician Decision|7|||
164220450|NCT00191152|593175580|FG001|Crossover Treatment|Physician Decision|7|||
164220451|NCT00191152|593175579|FG000|Crossover Treatment|Withdrawal by Subject|6|||
164220452|NCT00191152|593175580|FG001|Crossover Treatment|Withdrawal by Subject|9|||
164220453|NCT00191152|593175579|FG000|Crossover Treatment|Lost to Follow-up|2|||
164220454|NCT00191152|593175580|FG001|Crossover Treatment|Lost to Follow-up|1|||
164220455|NCT00191152|593175579|FG000|Crossover Treatment|Other|4|||
164220456|NCT00191152|593175580|FG001|Crossover Treatment|Other|3|||
164220457|NCT01543503|593175581|FG000|Overall Study|Lost to Follow-up|32|||
164220458|NCT01543503|593175582|FG001|Overall Study|Lost to Follow-up|36|||
164220459|NCT01543503|593175581|FG000|Overall Study|Adverse Event|9|||
164220460|NCT01543503|593175582|FG001|Overall Study|Adverse Event|13|||
164220461|NCT01543503|593175581|FG000|Overall Study|Lack of Efficacy|4|||
164220462|NCT01543503|593175582|FG001|Overall Study|Lack of Efficacy|16|||
164220463|NCT01543503|593175581|FG000|Overall Study|Participant withdrew informed consent|8|||
164220464|NCT01543503|593175582|FG001|Overall Study|Participant withdrew informed consent|10|||
164220465|NCT01543503|593175581|FG000|Overall Study|Change of jobs|0|||
164220466|NCT01543503|593175582|FG001|Overall Study|Change of jobs|1|||
164220467|NCT01543503|593175581|FG000|Overall Study|Intolerance to the biologic treatment|0|||
164220468|NCT01543503|593175582|FG001|Overall Study|Intolerance to the biologic treatment|1|||
164220469|NCT01543503|593175581|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
164220470|NCT01543503|593175582|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
164220471|NCT01543503|593175581|FG000|Overall Study|Participant did not complete last visit|0|||
164220472|NCT01543503|593175582|FG001|Overall Study|Participant did not complete last visit|2|||
164220473|NCT01543503|593175581|FG000|Overall Study|Refused to continue treatment|7|||
164220474|NCT01543503|593175582|FG001|Overall Study|Refused to continue treatment|0|||
164220475|NCT01543503|593175581|FG000|Overall Study|Incorrect medication received|1|||
164220476|NCT01543503|593175582|FG001|Overall Study|Incorrect medication received|0|||
164220477|NCT01543503|593175581|FG000|Overall Study|Participant moved to another city|2|||
164220478|NCT01543503|593175582|FG001|Overall Study|Participant moved to another city|0|||
164220479|NCT01543503|593175581|FG000|Overall Study|Participant will not return for visits|0|||
164220480|NCT01543503|593175582|FG001|Overall Study|Participant will not return for visits|2|||
164220481|NCT01543503|593175581|FG000|Overall Study|Participant transferred to another city|1|||
164220482|NCT01543503|593175582|FG001|Overall Study|Participant transferred to another city|0|||
164220483|NCT01543503|593175581|FG000|Overall Study|Participant moved to Scotland|1|||
164220484|NCT01543503|593175582|FG001|Overall Study|Participant moved to Scotland|0|||
164220485|NCT01543503|593175581|FG000|Overall Study|Participant decision to stop treatment|1|||
164220486|NCT01543503|593175582|FG001|Overall Study|Participant decision to stop treatment|0|||
164220487|NCT01543503|593175581|FG000|Overall Study|Investigator did not wish to participate|1|||
164220488|NCT01543503|593175582|FG001|Overall Study|Investigator did not wish to participate|1|||
164220489|NCT01543503|593175581|FG000|Overall Study|Participant recruited after closing date|0|||
164220490|NCT01543503|593175582|FG001|Overall Study|Participant recruited after closing date|1|||
164220491|NCT01543503|593175581|FG000|Overall Study|Site stopped participation|5|||
164220492|NCT01543503|593175582|FG001|Overall Study|Site stopped participation|1|||
164220493|NCT01543503|593175581|FG000|Overall Study|Participant did not attend a visit|1|||
164567315|NCT00364182|594445361|FG000|Third Intervention|Lost to Follow-up|0|||
164567316|NCT00364182|594445362|FG001|Third Intervention|Lost to Follow-up|0|||
164567317|NCT00364182|594445363|FG002|Third Intervention|Lost to Follow-up|1|||
164567318|NCT03336502|594445364|FG000|Overall Study|Physician Decision|0|||
164220494|NCT01543503|593175582|FG001|Overall Study|Participant did not attend a visit|0|||
164220495|NCT01543503|593175581|FG000|Overall Study|Moved to other rheumatologic site|0|||
164220496|NCT01543503|593175582|FG001|Overall Study|Moved to other rheumatologic site|1|||
164220497|NCT01543503|593175581|FG000|Overall Study|Participant consented to another study|0|||
164220498|NCT01543503|593175582|FG001|Overall Study|Participant consented to another study|2|||
164220499|NCT01543503|593175581|FG000|Overall Study|Participant went to United States|1|||
164220500|NCT01543503|593175582|FG001|Overall Study|Participant went to United States|0|||
164220501|NCT01543503|593175581|FG000|Overall Study|Screen failure|1|||
164220502|NCT01543503|593175582|FG001|Overall Study|Screen failure|0|||
164567319|NCT03336502|594445365|FG001|Overall Study|Physician Decision|1|||
164220503|NCT01986751|593175583|FG000|Overall Study|improperly consented|10|||
164220504|NCT01986751|593175584|FG001|Overall Study|improperly consented|2|||
164220505|NCT00052715|593175590|FG000|Overall Study|wrong histology|1|||
164220506|NCT01078545|593175591|FG000|Overall Study|Lost to Follow-up|13|||
164220507|NCT01078545|593175591|FG000|Overall Study|Physician Decision|6|||
164220508|NCT01078545|593175591|FG000|Overall Study|Withdrawal by Subject|3|||
164220509|NCT01078545|593175591|FG000|Overall Study|Death|3|||
164220510|NCT01078545|593175591|FG000|Overall Study|Participant moved to another physician|1|||
164220511|NCT01774370|593175594|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
164220512|NCT01774370|593175594|FG000|Overall Study|Administered prior to the contract date|4|||
164220513|NCT01774370|593175594|FG000|Overall Study|Subjects of contraindications|34|||
164220514|NCT01774370|593175594|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
164220515|NCT01774370|593175594|FG000|Overall Study|Follow-up failure|34|||
164220516|NCT04243837|593175597|FG000|Overall Study|Adverse Event|2|||
164220517|NCT04243837|593175598|FG001|Overall Study|Adverse Event|1|||
164220518|NCT04243837|593175597|FG000|Overall Study|Withdrawal by Subject|4|||
164220519|NCT04243837|593175598|FG001|Overall Study|Withdrawal by Subject|2|||
164220520|NCT04243837|593175597|FG000|Overall Study|Covid-19 lock down|1|||
164220521|NCT04243837|593175598|FG001|Overall Study|Covid-19 lock down|0|||
164220522|NCT04243837|593175597|FG000|Overall Study|Study Terminated by Sponsor|11|||
164220523|NCT04243837|593175598|FG001|Overall Study|Study Terminated by Sponsor|12|||
164220524|NCT03501277|593175602|FG000|Intervention Period 1 (4 Days)|Other|0|||
164220525|NCT03501277|593175603|FG001|Intervention Period 1 (4 Days)|Other|0|||
164220526|NCT03501277|593175604|FG002|Intervention Period 1 (4 Days)|Other|1|||
164220527|NCT03501277|593175605|FG003|Intervention Period 1 (4 Days)|Other|0|||
164220528|NCT03501277|593175602|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
164220529|NCT03501277|593175603|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
164220530|NCT03501277|593175604|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
164220531|NCT03501277|593175605|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
164220532|NCT03501277|593175602|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
164220533|NCT03501277|593175603|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
164220534|NCT03501277|593175604|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
164220535|NCT03501277|593175605|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
164220536|NCT03501277|593175602|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
164220537|NCT03501277|593175603|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
164220538|NCT03501277|593175604|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
164220539|NCT03501277|593175605|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
164220540|NCT01489358|593175607|FG000|Overall Study|Lost to Follow-up|0|||
164220541|NCT01489358|593175608|FG001|Overall Study|Lost to Follow-up|0|||
164220542|NCT01489358|593175609|FG002|Overall Study|Lost to Follow-up|2|||
164220543|NCT01873833|593175610|FG000|Overall Study|Withdrawal by Subject|1|||
164220544|NCT00098293|593175612|FG000|Double-blind (DB) Phase|Adverse Event|14|||
164220545|NCT00098293|593175613|FG001|Double-blind (DB) Phase|Adverse Event|27|||
164220546|NCT00098293|593175614|FG002|Double-blind (DB) Phase|Adverse Event|60|||
164220547|NCT00098293|593175615|FG003|Double-blind (DB) Phase|Adverse Event|0|||
164220548|NCT00098293|593175616|FG004|Double-blind (DB) Phase|Adverse Event|0|||
164220549|NCT00098293|593175612|FG000|Double-blind (DB) Phase|Pregnancy|0|||
164220550|NCT00098293|593175613|FG001|Double-blind (DB) Phase|Pregnancy|7|||
164220551|NCT00098293|593175614|FG002|Double-blind (DB) Phase|Pregnancy|9|||
164220552|NCT00098293|593175615|FG003|Double-blind (DB) Phase|Pregnancy|0|||
164220553|NCT00098293|593175616|FG004|Double-blind (DB) Phase|Pregnancy|0|||
164220554|NCT00098293|593175612|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
164567320|NCT03336502|594445364|FG000|Overall Study|Prohibited Drugs|1|||
164567321|NCT03336502|594445365|FG001|Overall Study|Prohibited Drugs|1|||
164567322|NCT03336502|594445364|FG000|Overall Study|Death|1|||
164567323|NCT03336502|594445365|FG001|Overall Study|Death|2|||
164567324|NCT03336502|594445364|FG000|Overall Study|Adverse Event|2|||
164567325|NCT03336502|594445365|FG001|Overall Study|Adverse Event|5|||
164567326|NCT02928952|594445367|FG000|Overall Study|Lost to Follow-up|5|||
164567327|NCT02928952|594445368|FG001|Overall Study|Lost to Follow-up|5|||
164567328|NCT02928952|594445367|FG000|Overall Study|Withdrawal by Subject|5|||
164670903|NCT05093205|594821315|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
164670904|NCT05093205|594821316|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
164670905|NCT05093205|594821317|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
164670906|NCT05093205|594821318|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
164670907|NCT05093205|594821319|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
164670908|NCT05093205|594821320|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
164670909|NCT05093205|594821308|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
164220555|NCT00098293|593175613|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
164670910|NCT05093205|594821309|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
164220556|NCT00098293|593175614|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
164220557|NCT00098293|593175615|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
164220558|NCT00098293|593175616|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
164220559|NCT00098293|593175612|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
164567329|NCT02928952|594445368|FG001|Overall Study|Withdrawal by Subject|1|||
164567330|NCT02928952|594445367|FG000|Overall Study|Physician Decision|0|||
164567331|NCT02928952|594445368|FG001|Overall Study|Physician Decision|1|||
164567332|NCT01107444|594445369|FG000|Overall Study|Withdrawal by Subject|8|||
164567333|NCT01107444|594445370|FG001|Overall Study|Withdrawal by Subject|12|||
164567334|NCT01107444|594445369|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
164567335|NCT01107444|594445370|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
164567336|NCT02266433|594445374|FG000|Overall Study|Lost to Follow-up|54|||
164567337|NCT02266433|594445375|FG001|Overall Study|Lost to Follow-up|46|||
164567338|NCT02266433|594445374|FG000|Overall Study|Withdrawal by Subject|5|||
164567339|NCT02266433|594445375|FG001|Overall Study|Withdrawal by Subject|7|||
164567340|NCT00737529|594445379|FG000|Overall Study|Disease Progression|95|||
164567341|NCT00737529|594445379|FG000|Overall Study|Adverse Event|24|||
164567342|NCT00737529|594445379|FG000|Overall Study|Withdrawal by Subject|5|||
164567343|NCT00737529|594445379|FG000|Overall Study|Death|4|||
164567344|NCT00737529|594445379|FG000|Overall Study|Protocol Violation|1|||
164567345|NCT00737529|594445379|FG000|Overall Study|Other|4|||
164567346|NCT01145560|594445380|FG000|Overall Study|Withdrawal by Subject|2|||
164567347|NCT01145560|594445381|FG001|Overall Study|Withdrawal by Subject|1|||
164567348|NCT01145560|594445382|FG002|Overall Study|Withdrawal by Subject|0|||
164567349|NCT01145560|594445380|FG000|Overall Study|Lost to Follow-up|1|||
164567350|NCT01145560|594445381|FG001|Overall Study|Lost to Follow-up|1|||
164567351|NCT01145560|594445382|FG002|Overall Study|Lost to Follow-up|1|||
164567352|NCT01145560|594445380|FG000|Overall Study|No study drug by 24h after organ failure|1|||
164567353|NCT01145560|594445381|FG001|Overall Study|No study drug by 24h after organ failure|0|||
164567354|NCT01145560|594445382|FG002|Overall Study|No study drug by 24h after organ failure|0|||
164567355|NCT01145560|594445380|FG000|Overall Study|Accidental unblinding of study treatment|0|||
164567356|NCT01145560|594445381|FG001|Overall Study|Accidental unblinding of study treatment|1|||
164567357|NCT01145560|594445382|FG002|Overall Study|Accidental unblinding of study treatment|0|||
164567358|NCT01145560|594445380|FG000|Overall Study|False insurance information|0|||
164567359|NCT01145560|594445381|FG001|Overall Study|False insurance information|1|||
164567360|NCT01145560|594445382|FG002|Overall Study|False insurance information|0|||
164567361|NCT01145560|594445380|FG000|Overall Study|Withdrawal of therapy|0|||
164567362|NCT01145560|594445381|FG001|Overall Study|Withdrawal of therapy|0|||
164567363|NCT01145560|594445382|FG002|Overall Study|Withdrawal of therapy|1|||
164567364|NCT00712348|594445383|FG000|Overall Study|Withdrawal by Subject|1|||
164567365|NCT03310970|594445385|FG000|Overall Study|Withdrawal by Subject|0|||
164567366|NCT03310970|594445386|FG001|Overall Study|Withdrawal by Subject|1|||
164567367|NCT05032950|594445403|FG000|Overall Study|Adverse Event|0|||
164567368|NCT05032950|594445404|FG001|Overall Study|Adverse Event|0|||
164567369|NCT05032950|594445405|FG002|Overall Study|Adverse Event|1|||
164567370|NCT05032950|594445406|FG003|Overall Study|Adverse Event|1|||
164567371|NCT05032950|594445407|FG004|Overall Study|Adverse Event|0|||
164567372|NCT05032950|594445408|FG005|Overall Study|Adverse Event|0|||
164567373|NCT02959814|594445409|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
164567374|NCT02959814|594445409|FG000|Overall Study|Excluded based on anatomical criteria|2|||
164567375|NCT02959814|594445409|FG000|Overall Study|Protocol Violation|7|||
164567376|NCT02959814|594445409|FG000|Overall Study|FFR not measured|2|||
164567377|NCT02959814|594445409|FG000|Overall Study|In-procedure QFR not computed|6|||
164567378|NCT02959814|594445409|FG000|Overall Study|Excluded by FFR core-lab|24|||
164567379|NCT04343651|594445413|FG000|Overall Study|Physician Decision|2|||
164567380|NCT04343651|594445414|FG001|Overall Study|Physician Decision|1|||
164567381|NCT04343651|594445413|FG000|Overall Study|Lost to Follow-up|2|||
164567382|NCT04343651|594445414|FG001|Overall Study|Lost to Follow-up|1|||
164567383|NCT04343651|594445413|FG000|Overall Study|Protocol Violation|4|||
164567384|NCT04343651|594445414|FG001|Overall Study|Protocol Violation|6|||
164567385|NCT04343651|594445413|FG000|Overall Study|Missing|3|||
164567386|NCT04343651|594445414|FG001|Overall Study|Missing|9|||
164567387|NCT04343651|594445413|FG000|Overall Study|Withdrawal by Subject|0|||
164567388|NCT04343651|594445414|FG001|Overall Study|Withdrawal by Subject|4|||
164567389|NCT04343651|594445413|FG000|Overall Study|Death|0|||
164567390|NCT04343651|594445414|FG001|Overall Study|Death|1|||
164567391|NCT04343651|594445413|FG000|Overall Study|Did not start treatment|1|||
164567392|NCT04343651|594445414|FG001|Overall Study|Did not start treatment|1|||
164670911|NCT05093205|594821310|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
164567393|NCT04343651|594445413|FG000|Overall Study|Patient did not complete visits 3-6|0|||
164567394|NCT04343651|594445414|FG001|Overall Study|Patient did not complete visits 3-6|1|||
164567395|NCT03219164|594447163|FG000|Overall Study|Study Terminated by Sponsor|16|||
164567396|NCT03219164|594447164|FG001|Overall Study|Study Terminated by Sponsor|12|||
164567397|NCT03219164|594447163|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
164567398|NCT03219164|594447164|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
164567399|NCT03219164|594447163|FG000|Overall Study|Lost to Follow-up|1|||
164567400|NCT03219164|594447164|FG001|Overall Study|Lost to Follow-up|1|||
164567401|NCT03219164|594447163|FG000|Overall Study|Adverse Event|1|||
164670912|NCT05093205|594821311|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
164567402|NCT03219164|594447164|FG001|Overall Study|Adverse Event|0|||
164567403|NCT03219164|594447163|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164220560|NCT00098293|593175613|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
164220561|NCT00098293|593175614|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
164220562|NCT00098293|593175615|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
164220563|NCT00098293|593175616|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
164220564|NCT00098293|593175612|FG000|Double-blind (DB) Phase|Death|1|||
164220565|NCT00098293|593175613|FG001|Double-blind (DB) Phase|Death|2|||
164220566|NCT00098293|593175614|FG002|Double-blind (DB) Phase|Death|2|||
164220567|NCT00098293|593175615|FG003|Double-blind (DB) Phase|Death|0|||
164220568|NCT00098293|593175616|FG004|Double-blind (DB) Phase|Death|0|||
164220569|NCT00098293|593175612|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
164220570|NCT00098293|593175613|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
164220571|NCT00098293|593175614|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
164220572|NCT00098293|593175615|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
164220573|NCT00098293|593175616|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
164220574|NCT00098293|593175612|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
164220575|NCT00098293|593175613|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
164220576|NCT00098293|593175614|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
164220577|NCT00098293|593175615|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
164220578|NCT00098293|593175616|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
164220579|NCT00098293|593175612|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
164220580|NCT00098293|593175613|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
164220581|NCT00098293|593175614|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
164220582|NCT00098293|593175615|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
164220583|NCT00098293|593175616|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
164220584|NCT00098293|593175612|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
164220585|NCT00098293|593175613|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
164220586|NCT00098293|593175614|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
164220587|NCT00098293|593175615|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
164220588|NCT00098293|593175616|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
164220589|NCT00098293|593175612|FG000|Open-label (OL) Phase|Adverse Event|0|||
164220590|NCT00098293|593175613|FG001|Open-label (OL) Phase|Adverse Event|3|||
164220591|NCT00098293|593175614|FG002|Open-label (OL) Phase|Adverse Event|7|||
164220592|NCT00098293|593175615|FG003|Open-label (OL) Phase|Adverse Event|6|||
164220593|NCT00098293|593175616|FG004|Open-label (OL) Phase|Adverse Event|0|||
164220594|NCT00098293|593175612|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
164220595|NCT00098293|593175613|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
164220596|NCT00098293|593175614|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
164220597|NCT00098293|593175615|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
164220598|NCT00098293|593175616|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
164220599|NCT00098293|593175612|FG000|Open-label (OL) Phase|Pregnancy|0|||
164220600|NCT00098293|593175613|FG001|Open-label (OL) Phase|Pregnancy|1|||
164220601|NCT00098293|593175614|FG002|Open-label (OL) Phase|Pregnancy|0|||
164220602|NCT00098293|593175615|FG003|Open-label (OL) Phase|Pregnancy|3|||
164220603|NCT00098293|593175616|FG004|Open-label (OL) Phase|Pregnancy|0|||
164220604|NCT00098293|593175612|FG000|Open-label (OL) Phase|Protocol Violation|0|||
164220605|NCT00098293|593175613|FG001|Open-label (OL) Phase|Protocol Violation|6|||
164220606|NCT00098293|593175614|FG002|Open-label (OL) Phase|Protocol Violation|13|||
164220607|NCT00098293|593175615|FG003|Open-label (OL) Phase|Protocol Violation|16|||
164220608|NCT00098293|593175616|FG004|Open-label (OL) Phase|Protocol Violation|0|||
164220609|NCT00098293|593175612|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
164220610|NCT00098293|593175613|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
164220611|NCT00098293|593175614|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
164220612|NCT00098293|593175615|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
164220613|NCT00098293|593175616|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
164220614|NCT00098293|593175612|FG000|Open-label (OL) Phase|Death|0|||
164220615|NCT00098293|593175613|FG001|Open-label (OL) Phase|Death|2|||
164220616|NCT00098293|593175614|FG002|Open-label (OL) Phase|Death|3|||
164220617|NCT00098293|593175615|FG003|Open-label (OL) Phase|Death|0|||
164567404|NCT03219164|594447164|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164220618|NCT00098293|593175616|FG004|Open-label (OL) Phase|Death|0|||
164220619|NCT00098293|593175612|FG000|Supplemental Phase (SP)|Death|0|||
164220620|NCT00098293|593175613|FG001|Supplemental Phase (SP)|Death|0|||
164220621|NCT00098293|593175614|FG002|Supplemental Phase (SP)|Death|0|||
164567405|NCT03219164|594447163|FG000|Overall Study|Protocol Violation|0|||
164220622|NCT00098293|593175615|FG003|Supplemental Phase (SP)|Death|0|||
164220623|NCT00098293|593175616|FG004|Supplemental Phase (SP)|Death|1|||
164567406|NCT03219164|594447164|FG001|Overall Study|Protocol Violation|1|||
164567407|NCT03219164|594447163|FG000|Overall Study|Withdrew Assent|1|||
164567408|NCT03219164|594447164|FG001|Overall Study|Withdrew Assent|0|||
164567409|NCT00956943|594447167|FG000|Overall Study|Lost to Follow-up|9|||
164220624|NCT00098293|593175612|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
164220625|NCT00098293|593175613|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
164220626|NCT00098293|593175614|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
164220627|NCT00098293|593175615|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
164567410|NCT00956943|594447168|FG001|Overall Study|Lost to Follow-up|10|||
164220628|NCT00098293|593175616|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
164220629|NCT00098293|593175612|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
164220630|NCT00098293|593175613|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
164220631|NCT00098293|593175614|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
164220632|NCT00098293|593175615|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
164220633|NCT00098293|593175616|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
164220634|NCT00098293|593175612|FG000|Supplemental Phase (SP)|Other|0|||
164220635|NCT00098293|593175613|FG001|Supplemental Phase (SP)|Other|0|||
164567411|NCT01805180|594447169|FG000|Lead-in Donor Phase|screen failure|1|||
164567412|NCT01805180|594447170|FG001|Lead-in Donor Phase|screen failure|0|||
164220636|NCT00098293|593175614|FG002|Supplemental Phase (SP)|Other|0|||
164328992|NCT04650854|593581256|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
164220637|NCT00098293|593175615|FG003|Supplemental Phase (SP)|Other|0|||
164220638|NCT00098293|593175616|FG004|Supplemental Phase (SP)|Other|22|||
164328993|NCT04650854|593581257|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
164220639|NCT01968785|593175617|FG000|Overall Study|Withdrawal by Subject|1|||
164220640|NCT01968785|593175618|FG001|Overall Study|Withdrawal by Subject|0|||
164220641|NCT01666314|593175626|FG000|Overall Study|Adverse Event|3|||
164220642|NCT01666314|593175627|FG001|Overall Study|Adverse Event|13|||
164220643|NCT01666314|593175628|FG002|Overall Study|Adverse Event|7|||
164220644|NCT01666314|593175629|FG003|Overall Study|Adverse Event|7|||
164220645|NCT01666314|593175626|FG000|Overall Study|Progressive Disease|11|||
164220646|NCT01666314|593175627|FG001|Overall Study|Progressive Disease|9|||
164220647|NCT01666314|593175628|FG002|Overall Study|Progressive Disease|19|||
164220648|NCT01666314|593175629|FG003|Overall Study|Progressive Disease|20|||
164220649|NCT01666314|593175626|FG000|Overall Study|Symptomatic Deterioration|1|||
164220650|NCT01666314|593175627|FG001|Overall Study|Symptomatic Deterioration|0|||
164220651|NCT01666314|593175628|FG002|Overall Study|Symptomatic Deterioration|2|||
164220652|NCT01666314|593175629|FG003|Overall Study|Symptomatic Deterioration|0|||
164220653|NCT01666314|593175626|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
164220654|NCT01666314|593175627|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
164220655|NCT01666314|593175628|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
164220656|NCT01666314|593175629|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
164220657|NCT01666314|593175626|FG000|Overall Study|Withdrawal by Subject|1|||
164220658|NCT01666314|593175627|FG001|Overall Study|Withdrawal by Subject|1|||
164220659|NCT01666314|593175628|FG002|Overall Study|Withdrawal by Subject|2|||
164220660|NCT01666314|593175629|FG003|Overall Study|Withdrawal by Subject|3|||
164220661|NCT01666314|593175626|FG000|Overall Study|Reason not Specified|10|||
164220662|NCT01666314|593175627|FG001|Overall Study|Reason not Specified|7|||
164220663|NCT01666314|593175628|FG002|Overall Study|Reason not Specified|5|||
164220664|NCT01666314|593175629|FG003|Overall Study|Reason not Specified|5|||
164220665|NCT04739709|593175630|FG000|Overall Study|Physician Decision|1|||
164220666|NCT04739709|593175631|FG001|Overall Study|Physician Decision|0|||
164220667|NCT01452347|593175634|FG000|Overall Study|Adverse Event|2|||
164220668|NCT01452347|593175635|FG001|Overall Study|Adverse Event|1|||
164220669|NCT01452347|593175634|FG000|Overall Study|Non compliance protocol|2|||
164220670|NCT01452347|593175635|FG001|Overall Study|Non compliance protocol|0|||
164220671|NCT01452347|593175634|FG000|Overall Study|Lost to Follow-up|2|||
164220672|NCT01452347|593175635|FG001|Overall Study|Lost to Follow-up|0|||
164220673|NCT01452347|593175634|FG000|Overall Study|Withdrawal by Subject|3|||
164220674|NCT01452347|593175635|FG001|Overall Study|Withdrawal by Subject|3|||
164220675|NCT01452347|593175634|FG000|Overall Study|Not treated|6|||
164220676|NCT01452347|593175635|FG001|Overall Study|Not treated|3|||
164220677|NCT01452347|593175634|FG000|Overall Study|Other reason not defined above|2|||
164220678|NCT01452347|593175635|FG001|Overall Study|Other reason not defined above|0|||
164220679|NCT05762744|593175636|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
164220680|NCT05762744|593175637|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
164220681|NCT05762744|593175636|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
164220682|NCT05762744|593175637|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
164220683|NCT02724644|593177687|FG000|Overall Study|Adverse Event|7|||
164220684|NCT02724644|593177688|FG001|Overall Study|Adverse Event|1|||
164220685|NCT02724644|593177687|FG000|Overall Study|Lost to Follow-up|6|||
164220686|NCT02724644|593177688|FG001|Overall Study|Lost to Follow-up|2|||
164220687|NCT02724644|593177687|FG000|Overall Study|Withdrawal by Subject|7|||
164220688|NCT02724644|593177688|FG001|Overall Study|Withdrawal by Subject|1|||
164220689|NCT02724644|593177687|FG000|Overall Study|Administrative|1|||
164220690|NCT02724644|593177688|FG001|Overall Study|Administrative|0|||
164220691|NCT01882829|593177689|FG000|Overall Study|Adverse Event|4|||
164220692|NCT01882829|593177689|FG000|Overall Study|Protocol Violation|1|||
164220693|NCT01882829|593177689|FG000|Overall Study|Withdrawal by Subject|1|||
164220694|NCT03312114|593177690|FG000|Overall Study|All the five enrolled dropped out of the|5|||
164220695|NCT01245751|593177698|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
164220696|NCT01245751|593177699|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
164220697|NCT01245751|593177700|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
164220698|NCT01245751|593177701|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
164220699|NCT01245751|593177698|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
164220700|NCT01245751|593177699|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
164220701|NCT01245751|593177700|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
164220702|NCT01245751|593177701|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
164220703|NCT01245751|593177698|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
164220704|NCT01245751|593177699|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
164220705|NCT01245751|593177700|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
164220706|NCT01245751|593177701|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
164220707|NCT02391584|593177707|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
164220708|NCT02391584|593177708|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
164220709|NCT02391584|593177707|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
164220710|NCT02391584|593177708|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
164220711|NCT02391584|593177707|FG000|3 Month|Lost to Follow-up|1|||
164220712|NCT02391584|593177708|FG001|3 Month|Lost to Follow-up|0|||
164220713|NCT02391584|593177707|FG000|6 Month|Withdrawal by Subject|1|||
164220714|NCT02391584|593177708|FG001|6 Month|Withdrawal by Subject|0|||
164220715|NCT02391584|593177707|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
164220716|NCT02391584|593177708|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
164220717|NCT03636269|593177709|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
164220718|NCT03636269|593177710|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
164220719|NCT03636269|593177711|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
164220720|NCT03636269|593177709|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
164220721|NCT03636269|593177710|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
164220722|NCT03636269|593177711|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
164220723|NCT03636269|593177709|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
164220724|NCT03636269|593177710|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
164220725|NCT03636269|593177711|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
164220726|NCT03636269|593177709|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
164220727|NCT03636269|593177710|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
164220728|NCT03636269|593177711|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
164220729|NCT03636269|593177709|FG000|Period 1: Double-blind Phase|Other|6|||
164220730|NCT03636269|593177710|FG001|Period 1: Double-blind Phase|Other|3|||
164220731|NCT03636269|593177711|FG002|Period 1: Double-blind Phase|Other|0|||
164220732|NCT03636269|593177709|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
164220733|NCT03636269|593177710|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
164220734|NCT03636269|593177711|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
164220735|NCT03636269|593177709|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
164220736|NCT03636269|593177710|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
164220737|NCT03636269|593177711|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
164220738|NCT03636269|593177709|FG000|Period 2: Open-label Phase|Adverse Event|0|||
164220739|NCT03636269|593177710|FG001|Period 2: Open-label Phase|Adverse Event|0|||
164220740|NCT03636269|593177711|FG002|Period 2: Open-label Phase|Adverse Event|21|||
164220741|NCT03636269|593177709|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
164220742|NCT03636269|593177710|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
164220743|NCT03636269|593177711|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
164220744|NCT03636269|593177709|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
164220745|NCT03636269|593177710|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
164220746|NCT03636269|593177711|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
164220747|NCT03636269|593177709|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
164220748|NCT03636269|593177710|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
164220749|NCT03636269|593177711|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
164220750|NCT03636269|593177709|FG000|Period 2: Open-label Phase|Administrative|0|||
164220751|NCT03636269|593177710|FG001|Period 2: Open-label Phase|Administrative|0|||
164220752|NCT03636269|593177711|FG002|Period 2: Open-label Phase|Administrative|36|||
164220753|NCT03636269|593177709|FG000|Period 2: Open-label Phase|Other|0|||
164220754|NCT03636269|593177710|FG001|Period 2: Open-label Phase|Other|0|||
164220755|NCT03636269|593177711|FG002|Period 2: Open-label Phase|Other|9|||
164220756|NCT03636269|593177709|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
164220757|NCT03636269|593177710|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
164220758|NCT03636269|593177711|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
164220759|NCT02852434|593177727|FG000|Overall Study|Withdrawal by Subject|0|||
164220760|NCT02852434|593177728|FG001|Overall Study|Withdrawal by Subject|1|||
164420840|NCT02293837|593911017|FG000|Overall Study|Participant ill and could not be infused|0|||
164420841|NCT02293837|593911018|FG001|Overall Study|Participant ill and could not be infused|0|||
164420842|NCT02293837|593911019|FG002|Overall Study|Participant ill and could not be infused|1|||
164420843|NCT02293837|593911020|FG003|Overall Study|Participant ill and could not be infused|0|||
164420844|NCT03285113|593911021|FG000|Overall Study|Unable to implant leads|2|||
164420845|NCT01076088|593911022|FG000|Overall Study|Adverse Event|1|||
164420846|NCT01076088|593911023|FG001|Overall Study|Adverse Event|6|||
164420847|NCT01076088|593911024|FG002|Overall Study|Adverse Event|3|||
164420848|NCT01076088|593911025|FG003|Overall Study|Adverse Event|2|||
164420849|NCT01076088|593911026|FG004|Overall Study|Adverse Event|3|||
164420850|NCT01076088|593911027|FG005|Overall Study|Adverse Event|3|||
164420851|NCT01076088|593911022|FG000|Overall Study|Lost to Follow-up|1|||
164670913|NCT05093205|594821312|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
164220761|NCT02852434|593177727|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
164220762|NCT02852434|593177728|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
164220763|NCT03188705|593177731|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
164220764|NCT03188705|593177731|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
164220765|NCT03774810|593177732|FG000|Phase 1|Lack of Efficacy|21|||
164220766|NCT03774810|593177733|FG001|Phase 1|Lack of Efficacy|0|||
164220767|NCT03774810|593177734|FG002|Phase 1|Lack of Efficacy|0|||
164420852|NCT01076088|593911023|FG001|Overall Study|Lost to Follow-up|1|||
164420853|NCT01076088|593911024|FG002|Overall Study|Lost to Follow-up|0|||
164420854|NCT01076088|593911025|FG003|Overall Study|Lost to Follow-up|1|||
164670914|NCT05093205|594821313|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
164220768|NCT03774810|593177735|FG003|Phase 1|Lack of Efficacy|0|||
164220769|NCT03774810|593177736|FG004|Phase 1|Lack of Efficacy|0|||
164220770|NCT03774810|593177732|FG000|Phase 1|Withdrawal by Subject|9|||
164220771|NCT03774810|593177733|FG001|Phase 1|Withdrawal by Subject|0|||
164220772|NCT03774810|593177734|FG002|Phase 1|Withdrawal by Subject|0|||
164220773|NCT03774810|593177735|FG003|Phase 1|Withdrawal by Subject|0|||
164220774|NCT03774810|593177736|FG004|Phase 1|Withdrawal by Subject|0|||
164220775|NCT03774810|593177732|FG000|Phase 1|Lost to Follow-up|2|||
164220776|NCT03774810|593177733|FG001|Phase 1|Lost to Follow-up|0|||
164220777|NCT03774810|593177734|FG002|Phase 1|Lost to Follow-up|0|||
164220778|NCT03774810|593177735|FG003|Phase 1|Lost to Follow-up|0|||
164220779|NCT03774810|593177736|FG004|Phase 1|Lost to Follow-up|0|||
164220780|NCT03774810|593177732|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
164220781|NCT03774810|593177733|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
164220782|NCT03774810|593177734|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
164220783|NCT03774810|593177735|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
164220784|NCT03774810|593177736|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
164220785|NCT03774810|593177732|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
164220786|NCT03774810|593177733|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
164220787|NCT03774810|593177734|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
164220788|NCT03774810|593177735|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
164220789|NCT03774810|593177736|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
164220790|NCT03774810|593177732|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
164220791|NCT03774810|593177733|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
164220792|NCT03774810|593177734|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
164220793|NCT03774810|593177735|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
164220794|NCT03774810|593177736|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
164220795|NCT03774810|593177732|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
164220796|NCT03774810|593177733|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
164220797|NCT03774810|593177734|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
164220798|NCT03774810|593177735|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
164220799|NCT03774810|593177736|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
164220800|NCT03774810|593177732|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
164220801|NCT03774810|593177733|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
164567413|NCT01805180|594447171|FG002|Lead-in Donor Phase|screen failure|0|||
164567414|NCT01901224|594447172|FG000|Overall Study|study was not funded and terminated|2|||
164567415|NCT06441877|594447173|FG000|Overall Study|Withdrawal by Subject|0|||
164567416|NCT06441877|594447174|FG001|Overall Study|Withdrawal by Subject|2|||
164567417|NCT06441877|594447175|FG002|Overall Study|Withdrawal by Subject|0|||
164567418|NCT06441877|594447176|FG003|Overall Study|Withdrawal by Subject|0|||
164567419|NCT00950170|594447177|FG000|Overall Study|Parent/Legal Guardian Request|1|||
164567420|NCT00950170|594447177|FG000|Overall Study|Adverse Event|2|||
164567421|NCT00950170|594447177|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
164567422|NCT03902080|594447180|FG000|Overall Study|Adverse Event|17|||
164567423|NCT03902080|594447181|FG001|Overall Study|Adverse Event|15|||
164567424|NCT03902080|594447180|FG000|Overall Study|Withdrawal by Subject|28|||
164567425|NCT03902080|594447181|FG001|Overall Study|Withdrawal by Subject|35|||
164567426|NCT03902080|594447180|FG000|Overall Study|Lost to Follow-up|6|||
164567427|NCT03902080|594447181|FG001|Overall Study|Lost to Follow-up|7|||
164567428|NCT03902080|594447180|FG000|Overall Study|Other|3|||
164567429|NCT03902080|594447181|FG001|Overall Study|Other|5|||
164567430|NCT03902080|594447180|FG000|Overall Study|Non compliance|4|||
164567431|NCT03902080|594447181|FG001|Overall Study|Non compliance|3|||
164567432|NCT03902080|594447180|FG000|Overall Study|Physician Decision|5|||
164567433|NCT03902080|594447181|FG001|Overall Study|Physician Decision|1|||
164567434|NCT03902080|594447180|FG000|Overall Study|Protocol Violation|3|||
164567435|NCT03902080|594447181|FG001|Overall Study|Protocol Violation|3|||
164567436|NCT03902080|594447180|FG000|Overall Study|Lack of Efficacy|1|||
164567437|NCT03902080|594447181|FG001|Overall Study|Lack of Efficacy|3|||
164567438|NCT03902080|594447180|FG000|Overall Study|Withdrawn prior to dosing|0|||
164567439|NCT03902080|594447181|FG001|Overall Study|Withdrawn prior to dosing|1|||
164567440|NCT01703000|594447183|FG000|Overall Study|Death|1|||
164567441|NCT01279057|594447184|FG000|Overall Study|Adverse Event|1|||
164567442|NCT01279057|594447185|FG001|Overall Study|Adverse Event|0|||
164567443|NCT01279057|594447186|FG002|Overall Study|Adverse Event|1|||
164567444|NCT01279057|594447184|FG000|Overall Study|Insufficient therapeutic response|0|||
164567445|NCT01279057|594447185|FG001|Overall Study|Insufficient therapeutic response|0|||
164220802|NCT03774810|593177734|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
164220803|NCT03774810|593177735|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
164567446|NCT01279057|594447186|FG002|Overall Study|Insufficient therapeutic response|1|||
164567447|NCT01279057|594447184|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
164567448|NCT01279057|594447185|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
164567449|NCT01279057|594447186|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
164220804|NCT03774810|593177736|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
164220805|NCT03774810|593177732|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
164220806|NCT03774810|593177733|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
164220807|NCT03774810|593177734|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
164220808|NCT03774810|593177735|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
164220809|NCT03774810|593177736|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
164220810|NCT01145222|593177739|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
164220811|NCT01145222|593177740|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
164220812|NCT01145222|593177741|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
164220813|NCT01145222|593177742|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
164220814|NCT01145222|593177739|FG000|Overall Study|Poor bowel preparation|0|||
164220815|NCT01145222|593177740|FG001|Overall Study|Poor bowel preparation|0|||
164220816|NCT01145222|593177741|FG002|Overall Study|Poor bowel preparation|0|||
164220817|NCT01145222|593177742|FG003|Overall Study|Poor bowel preparation|1|||
164328994|NCT04650854|593581255|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
164328995|NCT04650854|593581256|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
164328996|NCT04650854|593581257|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
164328997|NCT04650854|593581255|FG000|Overall Study|Use of Rescue Medication|0|||
164328998|NCT04650854|593581256|FG001|Overall Study|Use of Rescue Medication|0|||
164328999|NCT04650854|593581257|FG002|Overall Study|Use of Rescue Medication|1|||
164329000|NCT04650854|593581255|FG000|Overall Study|Last Treatment Per Sponsor|0|||
164329001|NCT04650854|593581256|FG001|Overall Study|Last Treatment Per Sponsor|0|||
164329002|NCT04650854|593581257|FG002|Overall Study|Last Treatment Per Sponsor|2|||
164329003|NCT04650854|593581255|FG000|Overall Study|Rescue Medication|0|||
164329004|NCT04650854|593581256|FG001|Overall Study|Rescue Medication|0|||
164329005|NCT04650854|593581257|FG002|Overall Study|Rescue Medication|1|||
164329006|NCT04650854|593581255|FG000|Overall Study|Participant Want to Start a Family|0|||
164329007|NCT04650854|593581256|FG001|Overall Study|Participant Want to Start a Family|0|||
164329008|NCT04650854|593581257|FG002|Overall Study|Participant Want to Start a Family|1|||
164329009|NCT04650854|593581255|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
164329010|NCT04650854|593581256|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
164329011|NCT04650854|593581257|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
164329012|NCT04650854|593581255|FG000|Overall Study|Participant Screened For MG0020|0|||
164329013|NCT04650854|593581256|FG001|Overall Study|Participant Screened For MG0020|2|||
164329014|NCT04650854|593581257|FG002|Overall Study|Participant Screened For MG0020|3|||
164329015|NCT04650854|593581255|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
164329016|NCT04650854|593581256|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
164329017|NCT04650854|593581257|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
164329018|NCT04650854|593581255|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
164329019|NCT04650854|593581256|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
164329020|NCT04650854|593581257|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
164329021|NCT04650854|593581255|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
164329022|NCT04650854|593581256|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
164329023|NCT04650854|593581257|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
164329024|NCT04650854|593581255|FG000|Overall Study|End Of Study|0|||
164329025|NCT04650854|593581256|FG001|Overall Study|End Of Study|2|||
164567450|NCT01279057|594447184|FG000|Overall Study|Withdrew consent|2|||
164567451|NCT01279057|594447185|FG001|Overall Study|Withdrew consent|0|||
164567452|NCT01279057|594447186|FG002|Overall Study|Withdrew consent|1|||
164567453|NCT01279057|594447184|FG000|Overall Study|Pregnancy|0|||
164567454|NCT01279057|594447185|FG001|Overall Study|Pregnancy|1|||
164567455|NCT01279057|594447186|FG002|Overall Study|Pregnancy|0|||
164567456|NCT01279057|594447184|FG000|Overall Study|Other|3|||
164567457|NCT01279057|594447185|FG001|Overall Study|Other|3|||
164567458|NCT01279057|594447186|FG002|Overall Study|Other|0|||
164567459|NCT01427309|594447188|FG000|Overall Study|Lost to Follow-up|130|||
164567460|NCT01427309|594447189|FG001|Overall Study|Lost to Follow-up|145|||
164567461|NCT01427309|594447190|FG002|Overall Study|Lost to Follow-up|122|||
164567462|NCT01427309|594447191|FG003|Overall Study|Lost to Follow-up|135|||
164567463|NCT01427309|594447188|FG000|Overall Study|Protocol Violation|42|||
164567464|NCT01427309|594447189|FG001|Overall Study|Protocol Violation|69|||
164567465|NCT01427309|594447190|FG002|Overall Study|Protocol Violation|125|||
164567466|NCT01427309|594447191|FG003|Overall Study|Protocol Violation|124|||
164567467|NCT01427309|594447188|FG000|Overall Study|Adverse Event|0|||
164670915|NCT05093205|594821314|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
164670916|NCT05093205|594821315|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
164329026|NCT04650854|593581257|FG002|Overall Study|End Of Study|1|||
164567468|NCT01427309|594447189|FG001|Overall Study|Adverse Event|0|||
164567469|NCT01427309|594447190|FG002|Overall Study|Adverse Event|3|||
164567470|NCT01427309|594447191|FG003|Overall Study|Adverse Event|1|||
164567471|NCT01427309|594447188|FG000|Overall Study|Serious adverse event|52|||
164567472|NCT01427309|594447189|FG001|Overall Study|Serious adverse event|45|||
164567473|NCT01427309|594447190|FG002|Overall Study|Serious adverse event|50|||
164670917|NCT05093205|594821316|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
164670918|NCT05093205|594821317|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
164567474|NCT01427309|594447191|FG003|Overall Study|Serious adverse event|61|||
164567475|NCT01427309|594447188|FG000|Overall Study|Withdrawal by Subject|148|||
164567476|NCT01427309|594447189|FG001|Overall Study|Withdrawal by Subject|148|||
164567477|NCT01427309|594447190|FG002|Overall Study|Withdrawal by Subject|61|||
164567478|NCT01427309|594447191|FG003|Overall Study|Withdrawal by Subject|55|||
164567479|NCT00928070|594447194|FG000|Overall Study|Lost to Follow-up|1|||
164567480|NCT00928070|594447195|FG001|Overall Study|Lost to Follow-up|2|||
164567481|NCT00928070|594447194|FG000|Overall Study|Withdrawal by Subject|10|||
164567482|NCT00928070|594447195|FG001|Overall Study|Withdrawal by Subject|3|||
164567483|NCT00928070|594447194|FG000|Overall Study|Adverse Event|14|||
164567484|NCT00928070|594447195|FG001|Overall Study|Adverse Event|26|||
164567485|NCT00928070|594447194|FG000|Overall Study|Lack of Efficacy|9|||
164567486|NCT00928070|594447195|FG001|Overall Study|Lack of Efficacy|5|||
164567487|NCT00928070|594447194|FG000|Overall Study|Did not meet entrance criteria|16|||
164567488|NCT00928070|594447195|FG001|Overall Study|Did not meet entrance criteria|9|||
164567489|NCT00928070|594447194|FG000|Overall Study|Protocol Violation|6|||
164567490|NCT00928070|594447195|FG001|Overall Study|Protocol Violation|5|||
164567491|NCT00928070|594447194|FG000|Overall Study|Randomized but not treated|2|||
164567492|NCT00928070|594447195|FG001|Overall Study|Randomized but not treated|2|||
164567493|NCT00928070|594447194|FG000|Overall Study|Other|5|||
164567494|NCT00928070|594447195|FG001|Overall Study|Other|5|||
164567495|NCT02913313|594447196|FG000|Overall Study|DISEASE PROGRESSION|1|||
164567496|NCT02913313|594447197|FG001|Overall Study|DISEASE PROGRESSION|2|||
164567497|NCT02913313|594447198|FG002|Overall Study|DISEASE PROGRESSION|2|||
164567498|NCT02913313|594447199|FG003|Overall Study|DISEASE PROGRESSION|4|||
164567499|NCT02913313|594447200|FG004|Overall Study|DISEASE PROGRESSION|6|||
164567500|NCT02913313|594447201|FG005|Overall Study|DISEASE PROGRESSION|4|||
164567501|NCT02913313|594447202|FG006|Overall Study|DISEASE PROGRESSION|19|||
164220818|NCT00927186|593177743|FG000|12 Months Primary Study|Adverse Event|5|||
164220819|NCT00927186|593177744|FG001|12 Months Primary Study|Adverse Event|2|||
164220820|NCT00927186|593177743|FG000|12 Months Primary Study|Lost to Follow-up|1|||
164220821|NCT00927186|593177744|FG001|12 Months Primary Study|Lost to Follow-up|0|||
164220822|NCT00927186|593177743|FG000|12 Months Primary Study|Protocol Violation|0|||
164220823|NCT00927186|593177744|FG001|12 Months Primary Study|Protocol Violation|1|||
164220824|NCT00927186|593177743|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
164220825|NCT00927186|593177744|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
164220826|NCT00604383|593177745|FG000|Overall Study|Withdrawal by Subject|33|||
164220827|NCT00604383|593177746|FG001|Overall Study|Withdrawal by Subject|31|||
164220828|NCT00604383|593177745|FG000|Overall Study|Lost to Follow-up|24|||
164220829|NCT00604383|593177746|FG001|Overall Study|Lost to Follow-up|19|||
164220830|NCT00604383|593177745|FG000|Overall Study|Death|14|||
164220831|NCT00604383|593177746|FG001|Overall Study|Death|22|||
164220832|NCT00604383|593177745|FG000|Overall Study|Adverse Event|16|||
164220833|NCT00604383|593177746|FG001|Overall Study|Adverse Event|9|||
164220834|NCT00604383|593177745|FG000|Overall Study|Physician Decision|0|||
164220835|NCT00604383|593177746|FG001|Overall Study|Physician Decision|3|||
164220836|NCT04985682|593177748|FG000|Overall Study|Withdrawal by Subject|1|||
164220837|NCT03016403|593177751|FG000|Baseline|Death|5|||
164220838|NCT03016403|593177752|FG001|Baseline|Death|8|||
164220839|NCT03016403|593177753|FG002|Baseline|Death|1|||
164220840|NCT03016403|593177754|FG003|Baseline|Death|0|||
164220841|NCT03016403|593177751|FG000|Baseline|Withdrawal by Subject|2|||
164220842|NCT03016403|593177752|FG001|Baseline|Withdrawal by Subject|8|||
164220843|NCT03016403|593177753|FG002|Baseline|Withdrawal by Subject|4|||
164220844|NCT03016403|593177754|FG003|Baseline|Withdrawal by Subject|10|||
164220845|NCT03016403|593177751|FG000|Baseline|Lost to Follow-up|9|||
164220846|NCT03016403|593177752|FG001|Baseline|Lost to Follow-up|11|||
164220847|NCT03016403|593177753|FG002|Baseline|Lost to Follow-up|6|||
164220848|NCT03016403|593177754|FG003|Baseline|Lost to Follow-up|24|||
164220849|NCT03016403|593177751|FG000|6-week Follow-up|Death|1|||
164220850|NCT03016403|593177752|FG001|6-week Follow-up|Death|4|||
164220851|NCT03016403|593177753|FG002|6-week Follow-up|Death|0|||
164220852|NCT03016403|593177754|FG003|6-week Follow-up|Death|0|||
164220853|NCT03016403|593177751|FG000|6-week Follow-up|Lost to Follow-up|2|||
164220854|NCT03016403|593177752|FG001|6-week Follow-up|Lost to Follow-up|7|||
164220855|NCT03016403|593177753|FG002|6-week Follow-up|Lost to Follow-up|4|||
164220856|NCT03016403|593177754|FG003|6-week Follow-up|Lost to Follow-up|8|||
164220857|NCT03016403|593177751|FG000|6-week Follow-up|Withdrawal by Subject|0|||
164220858|NCT03016403|593177752|FG001|6-week Follow-up|Withdrawal by Subject|2|||
164220859|NCT03016403|593177753|FG002|6-week Follow-up|Withdrawal by Subject|0|||
164220860|NCT03016403|593177754|FG003|6-week Follow-up|Withdrawal by Subject|1|||
164220861|NCT03016403|593177751|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
164220862|NCT03016403|593177752|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
164220863|NCT03016403|593177753|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
164220864|NCT03016403|593177754|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
164220865|NCT03016403|593177751|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
164220866|NCT03016403|593177752|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
164220867|NCT03016403|593177753|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
164220868|NCT03016403|593177754|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
164220869|NCT03016403|593177751|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
164220870|NCT03016403|593177752|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
164220871|NCT03016403|593177753|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
164220872|NCT03016403|593177754|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
164220873|NCT00799864|593177755|FG000|Overall Study|Participant reached a virologic endpoint|9|||
164220874|NCT00799864|593177756|FG001|Overall Study|Participant reached a virologic endpoint|2|||
164220875|NCT00799864|593177757|FG002|Overall Study|Participant reached a virologic endpoint|2|||
164220876|NCT00799864|593177758|FG003|Overall Study|Participant reached a virologic endpoint|0|||
164567502|NCT02913313|594447203|FG007|Overall Study|DISEASE PROGRESSION|3|||
164567503|NCT02913313|594447204|FG008|Overall Study|DISEASE PROGRESSION|4|||
164567504|NCT02913313|594447205|FG009|Overall Study|DISEASE PROGRESSION|4|||
164567505|NCT02913313|594447206|FG010|Overall Study|DISEASE PROGRESSION|11|||
164567506|NCT02913313|594447207|FG011|Overall Study|DISEASE PROGRESSION|5|||
164567507|NCT02913313|594447208|FG012|Overall Study|DISEASE PROGRESSION|14|||
164567508|NCT02913313|594447209|FG013|Overall Study|DISEASE PROGRESSION|3|||
164220877|NCT00799864|593177759|FG004|Overall Study|Participant reached a virologic endpoint|0|||
164220878|NCT00799864|593177755|FG000|Overall Study|Other|2|||
164220879|NCT00799864|593177756|FG001|Overall Study|Other|1|||
164220880|NCT00799864|593177757|FG002|Overall Study|Other|0|||
164220881|NCT00799864|593177758|FG003|Overall Study|Other|0|||
164220882|NCT00799864|593177759|FG004|Overall Study|Other|0|||
164220883|NCT00576407|593177760|FG000|Overall Study|Death|7|||
164567509|NCT02913313|594447196|FG000|Overall Study|Not Reported|0|||
164567510|NCT02913313|594447197|FG001|Overall Study|Not Reported|0|||
164220884|NCT00576407|593177760|FG000|Overall Study|Physician Decision|1|||
164220885|NCT00621322|593177761|FG000|Overall Study|Lost to Follow-up|0|||
164220886|NCT00621322|593177762|FG001|Overall Study|Lost to Follow-up|0|||
164220887|NCT00621322|593177763|FG002|Overall Study|Lost to Follow-up|0|||
164220888|NCT00621322|593177764|FG003|Overall Study|Lost to Follow-up|0|||
164220889|NCT00621322|593177765|FG004|Overall Study|Lost to Follow-up|1|||
164220890|NCT00621322|593177766|FG005|Overall Study|Lost to Follow-up|0|||
164220891|NCT00621322|593177761|FG000|Overall Study|Physician Decision|0|||
164220892|NCT00621322|593177762|FG001|Overall Study|Physician Decision|0|||
164220893|NCT00621322|593177763|FG002|Overall Study|Physician Decision|1|||
164220894|NCT00621322|593177764|FG003|Overall Study|Physician Decision|1|||
164220895|NCT00621322|593177765|FG004|Overall Study|Physician Decision|0|||
164220896|NCT00621322|593177766|FG005|Overall Study|Physician Decision|0|||
164220897|NCT00621322|593177761|FG000|Overall Study|Withdrawal by Subject|0|||
164220898|NCT00621322|593177762|FG001|Overall Study|Withdrawal by Subject|0|||
164220899|NCT00621322|593177763|FG002|Overall Study|Withdrawal by Subject|0|||
164220900|NCT00621322|593177764|FG003|Overall Study|Withdrawal by Subject|1|||
164220901|NCT00621322|593177765|FG004|Overall Study|Withdrawal by Subject|0|||
164220902|NCT00621322|593177766|FG005|Overall Study|Withdrawal by Subject|2|||
164220903|NCT00621322|593177761|FG000|Overall Study|Migrated/moved from study area|1|||
164220904|NCT00621322|593177762|FG001|Overall Study|Migrated/moved from study area|0|||
164220905|NCT00621322|593177763|FG002|Overall Study|Migrated/moved from study area|1|||
164220906|NCT00621322|593177764|FG003|Overall Study|Migrated/moved from study area|1|||
164220907|NCT00621322|593177765|FG004|Overall Study|Migrated/moved from study area|0|||
164220908|NCT00621322|593177766|FG005|Overall Study|Migrated/moved from study area|2|||
164220909|NCT00225758|593177767|FG000|Overall Study|Adverse Event|4|||
164220910|NCT04641975|593177768|FG000|Overall Study|Protocol Violation|1|||
164220911|NCT04641975|593177769|FG001|Overall Study|Protocol Violation|2|||
164220912|NCT04641975|593177770|FG002|Overall Study|Protocol Violation|0|||
164220913|NCT04641975|593177771|FG003|Overall Study|Protocol Violation|0|||
164220914|NCT04641975|593177768|FG000|Overall Study|Adverse Event|0|||
164220915|NCT04641975|593177769|FG001|Overall Study|Adverse Event|0|||
164220916|NCT04641975|593177770|FG002|Overall Study|Adverse Event|1|||
164220917|NCT04641975|593177771|FG003|Overall Study|Adverse Event|1|||
164220918|NCT04641975|593177768|FG000|Overall Study|Withdrawal by Subject|1|||
164220919|NCT04641975|593177769|FG001|Overall Study|Withdrawal by Subject|0|||
164220920|NCT04641975|593177770|FG002|Overall Study|Withdrawal by Subject|0|||
164220921|NCT04641975|593177771|FG003|Overall Study|Withdrawal by Subject|0|||
164220922|NCT05587998|593177777|FG000|Overall Study|Withdrawal by Subject|1|||
164220923|NCT05587998|593177778|FG001|Overall Study|Withdrawal by Subject|1|||
164220924|NCT05587998|593177777|FG000|Overall Study|Not treated|3|||
164220925|NCT05587998|593177778|FG001|Overall Study|Not treated|1|||
164220926|NCT05587998|593177777|FG000|Overall Study|Non-compliance with study procedures|0|||
164220927|NCT05587998|593177778|FG001|Overall Study|Non-compliance with study procedures|1|||
164220928|NCT03528577|593177781|FG000|Sequence 1|Failed Spirometry|1|||
164220929|NCT03528577|593177781|FG000|Sequence 1|Restricted medication|1|||
164220930|NCT03528577|593177781|FG000|Sequence 2|Adverse Event|1|||
164220931|NCT03528577|593177781|FG000|Sequence 2|Withdrawal by Subject|1|||
164220932|NCT03528577|593177781|FG000|Sequence 2|Failed Spirometry|1|||
164220933|NCT03528577|593177781|FG000|Sequence 3|Failed Spirometry|1|||
164220934|NCT03528577|593177781|FG000|Sequence 4|Failed Spirometry|2|||
164220935|NCT03528577|593177781|FG000|Sequence 4|Adverse Event|1|||
164220936|NCT00601107|593177782|FG000|Overall Study|Adverse Event|0|||
164220937|NCT00601107|593177783|FG001|Overall Study|Adverse Event|1|||
164220938|NCT00601107|593177784|FG002|Overall Study|Adverse Event|3|||
164220939|NCT00601107|593177785|FG003|Overall Study|Adverse Event|0|||
164220940|NCT00601107|593177782|FG000|Overall Study|Withdrawal by Subject|5|||
164220941|NCT00601107|593177783|FG001|Overall Study|Withdrawal by Subject|4|||
164220942|NCT00601107|593177784|FG002|Overall Study|Withdrawal by Subject|7|||
164220943|NCT00601107|593177785|FG003|Overall Study|Withdrawal by Subject|4|||
164220944|NCT00601107|593177782|FG000|Overall Study|Lost to Follow-up|3|||
164329027|NCT04650854|593581255|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
164329028|NCT04650854|593581256|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
164567511|NCT02913313|594447198|FG002|Overall Study|Not Reported|0|||
164220945|NCT00601107|593177783|FG001|Overall Study|Lost to Follow-up|3|||
164220946|NCT00601107|593177784|FG002|Overall Study|Lost to Follow-up|0|||
164220947|NCT00601107|593177785|FG003|Overall Study|Lost to Follow-up|3|||
164220948|NCT00601107|593177782|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
164220949|NCT00601107|593177783|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
164220950|NCT00601107|593177784|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
164220951|NCT00601107|593177785|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
164220952|NCT00601107|593177782|FG000|Overall Study|Worsening of Psoriasis|4|||
164220953|NCT00601107|593177783|FG001|Overall Study|Worsening of Psoriasis|1|||
164220954|NCT00601107|593177784|FG002|Overall Study|Worsening of Psoriasis|1|||
164220955|NCT00601107|593177785|FG003|Overall Study|Worsening of Psoriasis|4|||
164220956|NCT00601107|593177782|FG000|Overall Study|Undefined|1|||
164567512|NCT02913313|594447199|FG003|Overall Study|Not Reported|0|||
164567513|NCT02913313|594447200|FG004|Overall Study|Not Reported|1|||
164567514|NCT02913313|594447201|FG005|Overall Study|Not Reported|0|||
164567515|NCT02913313|594447202|FG006|Overall Study|Not Reported|0|||
164567516|NCT02913313|594447203|FG007|Overall Study|Not Reported|0|||
164567517|NCT02913313|594447204|FG008|Overall Study|Not Reported|0|||
164567518|NCT02913313|594447205|FG009|Overall Study|Not Reported|0|||
164567519|NCT02913313|594447206|FG010|Overall Study|Not Reported|4|||
164567520|NCT02913313|594447207|FG011|Overall Study|Not Reported|0|||
164567521|NCT02913313|594447208|FG012|Overall Study|Not Reported|0|||
164567522|NCT02913313|594447209|FG013|Overall Study|Not Reported|0|||
164567523|NCT02913313|594447196|FG000|Overall Study|Other reasons|0|||
164567524|NCT02913313|594447197|FG001|Overall Study|Other reasons|0|||
164567525|NCT02913313|594447198|FG002|Overall Study|Other reasons|0|||
164567526|NCT02913313|594447199|FG003|Overall Study|Other reasons|0|||
164567527|NCT02913313|594447200|FG004|Overall Study|Other reasons|1|||
164567528|NCT02913313|594447201|FG005|Overall Study|Other reasons|0|||
164567529|NCT02913313|594447202|FG006|Overall Study|Other reasons|0|||
164567530|NCT02913313|594447203|FG007|Overall Study|Other reasons|0|||
164567531|NCT02913313|594447204|FG008|Overall Study|Other reasons|0|||
164567532|NCT02913313|594447205|FG009|Overall Study|Other reasons|0|||
164567533|NCT02913313|594447206|FG010|Overall Study|Other reasons|1|||
164567534|NCT02913313|594447207|FG011|Overall Study|Other reasons|0|||
164567535|NCT02913313|594447208|FG012|Overall Study|Other reasons|0|||
164567536|NCT02913313|594447209|FG013|Overall Study|Other reasons|0|||
164567537|NCT02913313|594447196|FG000|Overall Study|Withdrawal by Subject|0|||
164567538|NCT02913313|594447197|FG001|Overall Study|Withdrawal by Subject|0|||
164567539|NCT02913313|594447198|FG002|Overall Study|Withdrawal by Subject|1|||
164567540|NCT02913313|594447199|FG003|Overall Study|Withdrawal by Subject|0|||
164567541|NCT02913313|594447200|FG004|Overall Study|Withdrawal by Subject|0|||
164567542|NCT02913313|594447201|FG005|Overall Study|Withdrawal by Subject|0|||
164567543|NCT02913313|594447202|FG006|Overall Study|Withdrawal by Subject|1|||
164567544|NCT02913313|594447203|FG007|Overall Study|Withdrawal by Subject|1|||
164567545|NCT02913313|594447204|FG008|Overall Study|Withdrawal by Subject|0|||
164567546|NCT02913313|594447205|FG009|Overall Study|Withdrawal by Subject|0|||
164567547|NCT02913313|594447206|FG010|Overall Study|Withdrawal by Subject|1|||
164567548|NCT02913313|594447207|FG011|Overall Study|Withdrawal by Subject|0|||
164567549|NCT02913313|594447208|FG012|Overall Study|Withdrawal by Subject|0|||
164567550|NCT02913313|594447209|FG013|Overall Study|Withdrawal by Subject|0|||
164567551|NCT02913313|594447196|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
164567552|NCT02913313|594447197|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
164567553|NCT02913313|594447198|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
164567554|NCT02913313|594447199|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
164567555|NCT02913313|594447200|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
164567556|NCT02913313|594447201|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
164567557|NCT02913313|594447202|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
164567558|NCT02913313|594447203|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
164567559|NCT02913313|594447204|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
164567560|NCT02913313|594447205|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
164567561|NCT02913313|594447206|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
164567562|NCT02913313|594447207|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
164567563|NCT02913313|594447208|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
164567564|NCT02913313|594447209|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
164567565|NCT02913313|594447196|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
164567566|NCT02913313|594447197|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
164567567|NCT02913313|594447198|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
164567568|NCT02913313|594447199|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
164567569|NCT02913313|594447200|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
164567570|NCT02913313|594447201|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
164567571|NCT02913313|594447202|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
164567572|NCT02913313|594447203|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
164567573|NCT02913313|594447204|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
164567574|NCT02913313|594447205|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
164567575|NCT02913313|594447206|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
164567576|NCT02913313|594447207|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
164329029|NCT04650854|593581257|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
164329030|NCT04650854|593581255|FG000|Overall Study|Participant Received Rescue Medication|0|||
164329031|NCT04650854|593581256|FG001|Overall Study|Participant Received Rescue Medication|1|||
164329032|NCT04650854|593581257|FG002|Overall Study|Participant Received Rescue Medication|0|||
164329033|NCT04650854|593581255|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
164329034|NCT04650854|593581256|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
164329035|NCT04650854|593581257|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
164420855|NCT01076088|593911026|FG004|Overall Study|Lost to Follow-up|1|||
164567577|NCT02913313|594447208|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
164220957|NCT00601107|593177783|FG001|Overall Study|Undefined|0|||
164220958|NCT00601107|593177784|FG002|Overall Study|Undefined|1|||
164220959|NCT00601107|593177785|FG003|Overall Study|Undefined|0|||
164220960|NCT03892915|593177786|FG000|Overall Study|Lost to Follow-up|6|||
164220961|NCT03892915|593177787|FG001|Overall Study|Lost to Follow-up|12|||
164220962|NCT03892915|593177786|FG000|Overall Study|Death|0|||
164220963|NCT03892915|593177787|FG001|Overall Study|Death|2|||
164220964|NCT03892915|593177786|FG000|Overall Study|Withdrawal by Subject|1|||
164220965|NCT03892915|593177787|FG001|Overall Study|Withdrawal by Subject|1|||
164220966|NCT03892915|593177786|FG000|Overall Study|unsuccessful delivery|13|||
164220967|NCT03892915|593177787|FG001|Overall Study|unsuccessful delivery|18|||
164220968|NCT03364686|593177788|FG000|Overall Study|Physician Decision|2|||
164220969|NCT01520714|593177789|FG000|Overall Study|Protocol Violation|0|||
164220970|NCT01520714|593177790|FG001|Overall Study|Protocol Violation|3|||
164220971|NCT01520714|593177789|FG000|Overall Study|Adverse Event|0|||
164220972|NCT01520714|593177790|FG001|Overall Study|Adverse Event|2|||
164220973|NCT01520714|593177789|FG000|Overall Study|Lack of Efficacy|0|||
164220974|NCT01520714|593177790|FG001|Overall Study|Lack of Efficacy|1|||
164220975|NCT01478087|593177799|FG000|Overall Study|due to sponsor closing study|1|||
164220976|NCT03518203|593177802|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
164220977|NCT03518203|593177802|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
164220978|NCT04146909|593177804|FG000|Overall Study|Withdrawal by Subject|3|||
164220979|NCT04146909|593177804|FG000|Overall Study|Did not qualify after consented|1|||
164220980|NCT00345592|593177805|FG000|Overall Study|Death|14|||
164220981|NCT00345592|593177806|FG001|Overall Study|Death|16|||
164220982|NCT00345592|593177805|FG000|Overall Study|Withdrawal by Subject|11|||
164220983|NCT00345592|593177806|FG001|Overall Study|Withdrawal by Subject|8|||
164220984|NCT03336866|593177821|FG000|Overall Study|Lost to Follow-up|2|||
164220985|NCT03336866|593177822|FG001|Overall Study|Lost to Follow-up|0|||
164220986|NCT03336866|593177823|FG002|Overall Study|Lost to Follow-up|3|||
164220987|NCT03336866|593177821|FG000|Overall Study|Withdrawal by Subject|1|||
164220988|NCT03336866|593177822|FG001|Overall Study|Withdrawal by Subject|1|||
164220989|NCT03336866|593177823|FG002|Overall Study|Withdrawal by Subject|0|||
164220990|NCT03336866|593177821|FG000|Overall Study|Noncompliance with clinic house rules|0|||
164220991|NCT03336866|593177822|FG001|Overall Study|Noncompliance with clinic house rules|0|||
164220992|NCT03336866|593177823|FG002|Overall Study|Noncompliance with clinic house rules|1|||
164220993|NCT00032487|593177824|FG000|Overall Study|Withdrawal by Subject|67|||
164220994|NCT00032487|593177825|FG001|Overall Study|Withdrawal by Subject|43|||
164220995|NCT00032487|593177824|FG000|Overall Study|Adverse Event|3|||
164220996|NCT00032487|593177825|FG001|Overall Study|Adverse Event|7|||
164220997|NCT00032487|593177824|FG000|Overall Study|Lost to Follow-up|57|||
164220998|NCT00032487|593177825|FG001|Overall Study|Lost to Follow-up|58|||
164220999|NCT00032487|593177824|FG000|Overall Study|Had other reason|12|||
164221000|NCT00032487|593177825|FG001|Overall Study|Had other reason|12|||
164221001|NCT04796207|593177826|FG000|Overall Study|Lost to Follow-up|7|||
164221002|NCT04796207|593177827|FG001|Overall Study|Lost to Follow-up|2|||
164221003|NCT01860989|593177828|FG000|Overall Study|Unsatisfactory therapeutic|5|||
164221004|NCT00421993|593177833|FG000|Overall Study|Withdrawal by Subject|22|||
164221005|NCT00421993|593177834|FG001|Overall Study|Withdrawal by Subject|23|||
164221006|NCT00421993|593177835|FG002|Overall Study|Withdrawal by Subject|23|||
164221007|NCT00421993|593177836|FG003|Overall Study|Withdrawal by Subject|24|||
164221008|NCT00421993|593177833|FG000|Overall Study|Lost to Follow-up|18|||
164221009|NCT00421993|593177834|FG001|Overall Study|Lost to Follow-up|19|||
164221010|NCT00421993|593177835|FG002|Overall Study|Lost to Follow-up|22|||
164221011|NCT00421993|593177836|FG003|Overall Study|Lost to Follow-up|20|||
164567578|NCT02913313|594447209|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
164567579|NCT01061008|594447210|FG000|Overall Study|Badiocephalic fistula failed|3|||
164567580|NCT01061008|594447211|FG001|Overall Study|Badiocephalic fistula failed|2|||
164221012|NCT00421993|593177833|FG000|Overall Study|Adverse Event|11|||
164221013|NCT00421993|593177834|FG001|Overall Study|Adverse Event|1|||
164221014|NCT00421993|593177835|FG002|Overall Study|Adverse Event|6|||
164221015|NCT00421993|593177836|FG003|Overall Study|Adverse Event|4|||
164221016|NCT00421993|593177833|FG000|Overall Study|Protocol Violation|2|||
164567581|NCT01061008|594447210|FG000|Overall Study|Death|1|||
164567582|NCT01061008|594447211|FG001|Overall Study|Death|0|||
164221017|NCT00421993|593177834|FG001|Overall Study|Protocol Violation|2|||
164221018|NCT00421993|593177835|FG002|Overall Study|Protocol Violation|0|||
164221019|NCT00421993|593177836|FG003|Overall Study|Protocol Violation|1|||
164221020|NCT00421993|593177833|FG000|Overall Study|Lack of Efficacy|0|||
164221021|NCT00421993|593177834|FG001|Overall Study|Lack of Efficacy|3|||
164221022|NCT00421993|593177835|FG002|Overall Study|Lack of Efficacy|0|||
164221023|NCT00421993|593177836|FG003|Overall Study|Lack of Efficacy|5|||
164221024|NCT00421993|593177833|FG000|Overall Study|Pregnancy|0|||
164221025|NCT00421993|593177834|FG001|Overall Study|Pregnancy|1|||
164221026|NCT00421993|593177835|FG002|Overall Study|Pregnancy|1|||
164221027|NCT00421993|593177836|FG003|Overall Study|Pregnancy|2|||
164221028|NCT00421993|593177833|FG000|Overall Study|Subject transportation issues|0|||
164221029|NCT00421993|593177834|FG001|Overall Study|Subject transportation issues|0|||
164221030|NCT00421993|593177835|FG002|Overall Study|Subject transportation issues|0|||
164221031|NCT00421993|593177836|FG003|Overall Study|Subject transportation issues|1|||
164221032|NCT01751685|593177837|FG000|6-mo Followup|Missed study visit|1|||
164221033|NCT01751685|593177838|FG001|6-mo Followup|Missed study visit|0|||
164221034|NCT01751685|593177837|FG000|6-mo Followup|Withdrawal by Subject|2|||
164221035|NCT01751685|593177838|FG001|6-mo Followup|Withdrawal by Subject|2|||
164221036|NCT01751685|593177837|FG000|6-mo Followup|Lost to Follow-up|0|||
164221037|NCT01751685|593177838|FG001|6-mo Followup|Lost to Follow-up|1|||
164221038|NCT01751685|593177837|FG000|12-mo Followup|Lost to Follow-up|5|||
164221039|NCT01751685|593177838|FG001|12-mo Followup|Lost to Follow-up|0|||
164221040|NCT01107457|593177840|FG000|Part A|Adverse Event|1|||
164221041|NCT01107457|593177841|FG001|Part A|Adverse Event|2|||
164221042|NCT01107457|593177842|FG002|Part A|Adverse Event|1|||
164221043|NCT01107457|593177843|FG003|Part A|Adverse Event|0|||
164221044|NCT01107457|593177844|FG004|Part A|Adverse Event|0|||
164221045|NCT01107457|593177845|FG005|Part A|Adverse Event|0|||
164221046|NCT01107457|593177840|FG000|Part A|Withdrawal by Subject|3|||
164221047|NCT01107457|593177841|FG001|Part A|Withdrawal by Subject|3|||
164221048|NCT01107457|593177842|FG002|Part A|Withdrawal by Subject|0|||
164221049|NCT01107457|593177843|FG003|Part A|Withdrawal by Subject|3|||
164221050|NCT01107457|593177844|FG004|Part A|Withdrawal by Subject|1|||
164221051|NCT01107457|593177845|FG005|Part A|Withdrawal by Subject|0|||
164221052|NCT01107457|593177840|FG000|Part A|Lost to Follow-up|0|||
164221053|NCT01107457|593177841|FG001|Part A|Lost to Follow-up|1|||
164221054|NCT01107457|593177842|FG002|Part A|Lost to Follow-up|0|||
164221055|NCT01107457|593177843|FG003|Part A|Lost to Follow-up|0|||
164221056|NCT01107457|593177844|FG004|Part A|Lost to Follow-up|0|||
164221057|NCT01107457|593177845|FG005|Part A|Lost to Follow-up|0|||
164221058|NCT01107457|593177840|FG000|Part A|Lack of Efficacy|1|||
164221059|NCT01107457|593177841|FG001|Part A|Lack of Efficacy|0|||
164221060|NCT01107457|593177842|FG002|Part A|Lack of Efficacy|0|||
164221061|NCT01107457|593177843|FG003|Part A|Lack of Efficacy|0|||
164221062|NCT01107457|593177844|FG004|Part A|Lack of Efficacy|0|||
164221063|NCT01107457|593177845|FG005|Part A|Lack of Efficacy|0|||
164221064|NCT01107457|593177840|FG000|Part A|Protocol Violation|0|||
164221065|NCT01107457|593177841|FG001|Part A|Protocol Violation|1|||
164221066|NCT01107457|593177842|FG002|Part A|Protocol Violation|0|||
164221067|NCT01107457|593177843|FG003|Part A|Protocol Violation|0|||
164221068|NCT01107457|593177844|FG004|Part A|Protocol Violation|0|||
164221069|NCT01107457|593177845|FG005|Part A|Protocol Violation|0|||
164221070|NCT01107457|593177840|FG000|Part B and C|Adverse Event|0|||
164221071|NCT01107457|593177841|FG001|Part B and C|Adverse Event|0|||
164567583|NCT01061008|594447210|FG000|Overall Study|Withdrawal by Subject|1|||
164567584|NCT01061008|594447211|FG001|Overall Study|Withdrawal by Subject|3|||
164567585|NCT01061008|594447210|FG000|Overall Study|Unable to exercise following surgery|1|||
164567586|NCT01061008|594447211|FG001|Overall Study|Unable to exercise following surgery|0|||
164567587|NCT01061008|594447210|FG000|Overall Study|Adverse Event|0|||
164567588|NCT01061008|594447211|FG001|Overall Study|Adverse Event|1|||
164567589|NCT02908100|594447214|FG000|Overall Study|Adverse Event|7|||
164567590|NCT02908100|594447215|FG001|Overall Study|Adverse Event|6|||
164567591|NCT02908100|594447216|FG002|Overall Study|Adverse Event|9|||
164567592|NCT02908100|594447214|FG000|Overall Study|Death|2|||
164567593|NCT02908100|594447215|FG001|Overall Study|Death|0|||
164221072|NCT01107457|593177842|FG002|Part B and C|Adverse Event|0|||
164221073|NCT01107457|593177843|FG003|Part B and C|Adverse Event|0|||
164221074|NCT01107457|593177844|FG004|Part B and C|Adverse Event|0|||
164567594|NCT02908100|594447216|FG002|Overall Study|Death|0|||
164567595|NCT02908100|594447214|FG000|Overall Study|Lack of Efficacy|2|||
164567596|NCT02908100|594447215|FG001|Overall Study|Lack of Efficacy|3|||
164221075|NCT01107457|593177845|FG005|Part B and C|Adverse Event|12|||
164221076|NCT01107457|593177840|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
164221077|NCT01107457|593177841|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
164221078|NCT01107457|593177842|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
164567597|NCT02908100|594447216|FG002|Overall Study|Lack of Efficacy|3|||
164567598|NCT02908100|594447214|FG000|Overall Study|Lost to Follow-up|0|||
164221079|NCT01107457|593177843|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
164221080|NCT01107457|593177844|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
164221081|NCT01107457|593177845|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
164221082|NCT01107457|593177840|FG000|Part B and C|Physician Decision|0|||
164221083|NCT01107457|593177841|FG001|Part B and C|Physician Decision|0|||
164221084|NCT01107457|593177842|FG002|Part B and C|Physician Decision|0|||
164221085|NCT01107457|593177843|FG003|Part B and C|Physician Decision|0|||
164221086|NCT01107457|593177844|FG004|Part B and C|Physician Decision|0|||
164221087|NCT01107457|593177845|FG005|Part B and C|Physician Decision|3|||
164221088|NCT01107457|593177840|FG000|Part B and C|Lack of Efficacy|0|||
164221089|NCT01107457|593177841|FG001|Part B and C|Lack of Efficacy|0|||
164221090|NCT01107457|593177842|FG002|Part B and C|Lack of Efficacy|0|||
164221091|NCT01107457|593177843|FG003|Part B and C|Lack of Efficacy|0|||
164221092|NCT01107457|593177844|FG004|Part B and C|Lack of Efficacy|0|||
164221093|NCT01107457|593177845|FG005|Part B and C|Lack of Efficacy|7|||
164221094|NCT01107457|593177840|FG000|Part B and C|Lost to Follow-up|0|||
164221095|NCT01107457|593177841|FG001|Part B and C|Lost to Follow-up|0|||
164221096|NCT01107457|593177842|FG002|Part B and C|Lost to Follow-up|0|||
164221097|NCT01107457|593177843|FG003|Part B and C|Lost to Follow-up|0|||
164221098|NCT01107457|593177844|FG004|Part B and C|Lost to Follow-up|0|||
164221099|NCT01107457|593177845|FG005|Part B and C|Lost to Follow-up|10|||
164221100|NCT01107457|593177840|FG000|Part B and C|Protocol Violation|0|||
164221101|NCT01107457|593177841|FG001|Part B and C|Protocol Violation|0|||
164221102|NCT01107457|593177842|FG002|Part B and C|Protocol Violation|0|||
164221103|NCT01107457|593177843|FG003|Part B and C|Protocol Violation|0|||
164221104|NCT01107457|593177844|FG004|Part B and C|Protocol Violation|0|||
164221105|NCT01107457|593177845|FG005|Part B and C|Protocol Violation|1|||
164221106|NCT01107457|593177840|FG000|Part B and C|Sponsor Decision|0|||
164221107|NCT01107457|593177841|FG001|Part B and C|Sponsor Decision|0|||
164221108|NCT01107457|593177842|FG002|Part B and C|Sponsor Decision|0|||
164221109|NCT01107457|593177843|FG003|Part B and C|Sponsor Decision|0|||
164221110|NCT01107457|593177844|FG004|Part B and C|Sponsor Decision|0|||
164221111|NCT01107457|593177845|FG005|Part B and C|Sponsor Decision|66|||
164221112|NCT01107457|593177840|FG000|Part B and C|Withdrawal by Subject|0|||
164221113|NCT01107457|593177841|FG001|Part B and C|Withdrawal by Subject|0|||
164221114|NCT01107457|593177842|FG002|Part B and C|Withdrawal by Subject|0|||
164221115|NCT01107457|593177843|FG003|Part B and C|Withdrawal by Subject|0|||
164221116|NCT01107457|593177844|FG004|Part B and C|Withdrawal by Subject|0|||
164221117|NCT01107457|593177845|FG005|Part B and C|Withdrawal by Subject|16|||
164221118|NCT01107457|593177840|FG000|Part B and C|Clinical Relapse|0|||
164221119|NCT01107457|593177841|FG001|Part B and C|Clinical Relapse|0|||
164221120|NCT01107457|593177842|FG002|Part B and C|Clinical Relapse|0|||
164221121|NCT01107457|593177843|FG003|Part B and C|Clinical Relapse|0|||
164221122|NCT01107457|593177844|FG004|Part B and C|Clinical Relapse|0|||
164221123|NCT01107457|593177845|FG005|Part B and C|Clinical Relapse|4|||
164221124|NCT03601052|593177846|FG000|Overall Study|Lost to Follow-up|2|||
164221125|NCT01727154|593177850|FG000|Overall Study|Death|17|||
164221126|NCT01727154|593177850|FG000|Overall Study|Withdrawal by Subject|14|||
164221127|NCT01727154|593177850|FG000|Overall Study|Subject Withdrew Consent|18|||
164221128|NCT01727154|593177850|FG000|Overall Study|Study Terminated|6|||
164221129|NCT01727154|593177850|FG000|Overall Study|No Discontinuation Documentation|4|||
164221130|NCT00003474|593177851|FG000|Overall Study|Not Evaluable|14|||
164221131|NCT01198548|593177853|FG000|Overall Study|Disease Progression|9|||
164221132|NCT01198548|593177853|FG000|Overall Study|Administrative Decision|1|||
164221133|NCT02186171|593177855|FG000|Overall Study|Withdrawal by Subject|1|||
164221134|NCT02186171|593177856|FG001|Overall Study|Withdrawal by Subject|9|||
164221135|NCT02186171|593177855|FG000|Overall Study|Lost to Follow-up|2|||
164221136|NCT02186171|593177856|FG001|Overall Study|Lost to Follow-up|2|||
164221137|NCT02186171|593177855|FG000|Overall Study|Death|1|||
164221138|NCT02186171|593177856|FG001|Overall Study|Death|2|||
164221139|NCT02186171|593177855|FG000|Overall Study|Protocol-specified Criteria|0|||
164221140|NCT02186171|593177856|FG001|Overall Study|Protocol-specified Criteria|2|||
164221141|NCT01245062|593177857|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
164221142|NCT01245062|593177858|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
164221143|NCT01245062|593177859|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
164221144|NCT01245062|593177857|FG000|Randomization and Crossover Phase|Physician Decision|2|||
164221145|NCT01245062|593177858|FG001|Randomization and Crossover Phase|Physician Decision|4|||
164221146|NCT01245062|593177859|FG002|Randomization and Crossover Phase|Physician Decision|0|||
164221147|NCT01245062|593177857|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
164221148|NCT01245062|593177858|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
164567599|NCT02908100|594447215|FG001|Overall Study|Lost to Follow-up|1|||
164567600|NCT02908100|594447216|FG002|Overall Study|Lost to Follow-up|2|||
164567601|NCT02908100|594447214|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164567602|NCT02908100|594447215|FG001|Overall Study|Non-Compliance With Study Drug|1|||
164567603|NCT02908100|594447216|FG002|Overall Study|Non-Compliance With Study Drug|2|||
164221149|NCT01245062|593177859|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
164221150|NCT01245062|593177857|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
164221151|NCT01245062|593177858|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
164221152|NCT01245062|593177859|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
164221153|NCT01245062|593177857|FG000|Cross-over Phase|Lost to Follow-up|0|||
164329036|NCT04650854|593581255|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
164567604|NCT02908100|594447214|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
164567605|NCT02908100|594447215|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
164567606|NCT02908100|594447216|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
164221154|NCT01245062|593177858|FG001|Cross-over Phase|Lost to Follow-up|0|||
164221155|NCT01245062|593177859|FG002|Cross-over Phase|Lost to Follow-up|1|||
164567607|NCT02908100|594447214|FG000|Overall Study|Physician Decision|0|||
164567608|NCT02908100|594447215|FG001|Overall Study|Physician Decision|1|||
164567609|NCT02908100|594447216|FG002|Overall Study|Physician Decision|0|||
164567610|NCT02908100|594447214|FG000|Overall Study|Pregnancy|1|||
164329037|NCT04650854|593581256|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
164329038|NCT04650854|593581257|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
164329039|NCT04650854|593581255|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
164329040|NCT04650854|593581256|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
164329041|NCT04650854|593581257|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
164329042|NCT04650854|593581255|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
164329043|NCT04650854|593581256|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
164329044|NCT04650854|593581257|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
164329045|NCT04650854|593581255|FG000|Overall Study|Enrollment Cup|0|||
164329046|NCT04650854|593581256|FG001|Overall Study|Enrollment Cup|0|||
164329047|NCT04650854|593581257|FG002|Overall Study|Enrollment Cup|1|||
164329048|NCT00704808|593581272|FG000|Overall Study|Discontinued prior to starting treatment|14|||
164329049|NCT00704808|593581272|FG000|Overall Study|Death|7|||
164329050|NCT00704808|593581272|FG000|Overall Study|Tumor progression|80|||
164329051|NCT00704808|593581272|FG000|Overall Study|Patient's decision|11|||
164329052|NCT00704808|593581272|FG000|Overall Study|Early therapy discontinuation|16|||
164329053|NCT00704808|593581272|FG000|Overall Study|Adverse Event|1|||
164420856|NCT01076088|593911027|FG005|Overall Study|Lost to Follow-up|2|||
164420857|NCT01076088|593911022|FG000|Overall Study|Non-compliance with study drug|0|||
164420858|NCT01076088|593911023|FG001|Overall Study|Non-compliance with study drug|0|||
164420859|NCT01076088|593911024|FG002|Overall Study|Non-compliance with study drug|0|||
164420860|NCT01076088|593911025|FG003|Overall Study|Non-compliance with study drug|1|||
164420861|NCT01076088|593911026|FG004|Overall Study|Non-compliance with study drug|0|||
164420862|NCT01076088|593911027|FG005|Overall Study|Non-compliance with study drug|0|||
164420863|NCT01076088|593911022|FG000|Overall Study|Physician Decision|1|||
164420864|NCT01076088|593911023|FG001|Overall Study|Physician Decision|3|||
164420865|NCT01076088|593911024|FG002|Overall Study|Physician Decision|0|||
164329054|NCT00704808|593581272|FG000|Overall Study|Lost to Follow-up|1|||
164329055|NCT00704808|593581272|FG000|Overall Study|Treatment change|1|||
164329056|NCT01982331|593581281|FG000|Received Vaccination 2|Adverse Event|1|||
164329057|NCT01982331|593581282|FG001|Received Vaccination 2|Adverse Event|2|||
164329058|NCT01982331|593581281|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
164329059|NCT01982331|593581282|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
164329060|NCT01982331|593581281|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
164329061|NCT01982331|593581282|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
164329062|NCT03500679|593581283|FG000|Overall Study|Lost to Follow-up|6|||
164420866|NCT01076088|593911025|FG003|Overall Study|Physician Decision|1|||
164420867|NCT01076088|593911026|FG004|Overall Study|Physician Decision|1|||
164420868|NCT01076088|593911027|FG005|Overall Study|Physician Decision|0|||
164420869|NCT01076088|593911022|FG000|Overall Study|Withdrawal by Subject|8|||
164420870|NCT01076088|593911023|FG001|Overall Study|Withdrawal by Subject|8|||
164420871|NCT01076088|593911024|FG002|Overall Study|Withdrawal by Subject|14|||
164420872|NCT01076088|593911025|FG003|Overall Study|Withdrawal by Subject|10|||
164420873|NCT01076088|593911026|FG004|Overall Study|Withdrawal by Subject|11|||
164420874|NCT01076088|593911027|FG005|Overall Study|Withdrawal by Subject|17|||
164420875|NCT01076088|593911022|FG000|Overall Study|Other protocol specified criteria|0|||
164420876|NCT01076088|593911023|FG001|Overall Study|Other protocol specified criteria|0|||
164420877|NCT01076088|593911024|FG002|Overall Study|Other protocol specified criteria|0|||
164420878|NCT01076088|593911025|FG003|Overall Study|Other protocol specified criteria|0|||
164420879|NCT01076088|593911026|FG004|Overall Study|Other protocol specified criteria|0|||
164420880|NCT01076088|593911027|FG005|Overall Study|Other protocol specified criteria|1|||
164420881|NCT03053492|593911028|FG000|Overall Study|Adverse Event|1|||
164420882|NCT03053492|593911029|FG001|Overall Study|Adverse Event|1|||
164420883|NCT03053492|593911028|FG000|Overall Study|Withdrawal by Subject|7|||
164420884|NCT03053492|593911029|FG001|Overall Study|Withdrawal by Subject|5|||
164420885|NCT01448044|593911034|FG000|Treatment Period|Adverse Event|4|||
164221156|NCT01245062|593177857|FG000|Cross-over Phase|Physician Decision|0|||
164221157|NCT01245062|593177858|FG001|Cross-over Phase|Physician Decision|0|||
164221158|NCT01245062|593177859|FG002|Cross-over Phase|Physician Decision|1|||
164221159|NCT01245062|593177857|FG000|Cross-over Phase|Withdrew Consent|0|||
164221160|NCT01245062|593177858|FG001|Cross-over Phase|Withdrew Consent|0|||
164221161|NCT01245062|593177859|FG002|Cross-over Phase|Withdrew Consent|4|||
164221162|NCT01245062|593177857|FG000|Cross-over Phase|Study closed/ terminated|0|||
164221163|NCT01245062|593177858|FG001|Cross-over Phase|Study closed/ terminated|0|||
164221164|NCT01245062|593177859|FG002|Cross-over Phase|Study closed/ terminated|11|||
164221165|NCT02015104|593177861|FG000|Overall Study|Withdrew consent after first dose drug|1|||
164221166|NCT02015104|593177862|FG001|Overall Study|Withdrew consent after first dose drug|0|||
164221167|NCT02015104|593177861|FG000|Overall Study|Withdrew consent prior to treatment|0|||
164221168|NCT02015104|593177862|FG001|Overall Study|Withdrew consent prior to treatment|1|||
164221169|NCT06025695|593177863|FG000|Overall Study|Adverse Event|5|||
164221170|NCT06025695|593177864|FG001|Overall Study|Adverse Event|6|||
164221171|NCT06025695|593177863|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
164221172|NCT06025695|593177864|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
164221173|NCT06025695|593177863|FG000|Overall Study|Other|23|||
164221174|NCT06025695|593177864|FG001|Overall Study|Other|19|||
164221175|NCT06025695|593177863|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
164221176|NCT06025695|593177864|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
164221177|NCT03011372|593177865|FG000|Overall Study|Death|16|||
164221178|NCT03011372|593177865|FG000|Overall Study|Lost to Follow-up|2|||
164221179|NCT03011372|593177865|FG000|Overall Study|Sponsor Decision|17|||
164221180|NCT03011372|593177865|FG000|Overall Study|Withdrawal by Subject|7|||
164221181|NCT03011372|593177865|FG000|Overall Study|Moved to Commercial Supply of Investigational Drug|2|||
164221182|NCT03011372|593177865|FG000|Overall Study|Received First Dose of Chemotherapy for Stem Cell Transplant|1|||
164221183|NCT03011372|593177865|FG000|Overall Study|Sponsor's Decision|2|||
164221184|NCT03572218|593177866|FG000|Overall Study|Lost to Follow-up|3|||
164221185|NCT03572218|593177867|FG001|Overall Study|Lost to Follow-up|2|||
164221186|NCT03572218|593177866|FG000|Overall Study|No longer available for study visits|2|||
164221187|NCT03572218|593177867|FG001|Overall Study|No longer available for study visits|1|||
164221188|NCT03572218|593177866|FG000|Overall Study|No longer interested|1|||
164221189|NCT03572218|593177867|FG001|Overall Study|No longer interested|2|||
164221190|NCT01350973|593177871|FG000|Overall Study|Adverse Event|4|||
164221191|NCT01350973|593177872|FG001|Overall Study|Adverse Event|7|||
164221192|NCT01350973|593177873|FG002|Overall Study|Adverse Event|7|||
164221193|NCT01350973|593177871|FG000|Overall Study|Voluntary Withdrawal|2|||
164221194|NCT01350973|593177872|FG001|Overall Study|Voluntary Withdrawal|1|||
164221195|NCT01350973|593177873|FG002|Overall Study|Voluntary Withdrawal|1|||
164221196|NCT00853047|593177874|FG000|Core Phase|Participant Request|0|||
164221197|NCT00853047|593177875|FG001|Core Phase|Participant Request|0|||
164221198|NCT00853047|593177876|FG002|Core Phase|Participant Request|0|||
164221199|NCT00853047|593177877|FG003|Core Phase|Participant Request|1|||
164221200|NCT00853047|593177878|FG004|Core Phase|Participant Request|0|||
164221201|NCT00853047|593177879|FG005|Core Phase|Participant Request|0|||
164221202|NCT00853047|593177874|FG000|Open-Label Extension Phase|Participant Request|0|||
164221203|NCT00853047|593177875|FG001|Open-Label Extension Phase|Participant Request|0|||
164221204|NCT00853047|593177876|FG002|Open-Label Extension Phase|Participant Request|0|||
164221205|NCT00853047|593177877|FG003|Open-Label Extension Phase|Participant Request|0|||
164221206|NCT00853047|593177878|FG004|Open-Label Extension Phase|Participant Request|0|||
164221207|NCT00853047|593177879|FG005|Open-Label Extension Phase|Participant Request|7|||
164221208|NCT00853047|593177874|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
164221209|NCT00853047|593177875|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
164221210|NCT00853047|593177876|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
164221211|NCT00853047|593177877|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
164221212|NCT00853047|593177878|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
164221213|NCT00853047|593177879|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
164221214|NCT00853047|593177874|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
164221215|NCT00853047|593177875|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
164221216|NCT00853047|593177876|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
164221217|NCT00853047|593177877|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
164221218|NCT00853047|593177878|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
164221219|NCT00853047|593177879|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
164221220|NCT00853047|593177874|FG000|Open-Label Extension Phase|Investigator Decision|0|||
164221221|NCT00853047|593177875|FG001|Open-Label Extension Phase|Investigator Decision|0|||
164221222|NCT00853047|593177876|FG002|Open-Label Extension Phase|Investigator Decision|0|||
164221223|NCT00853047|593177877|FG003|Open-Label Extension Phase|Investigator Decision|0|||
164221224|NCT00853047|593177878|FG004|Open-Label Extension Phase|Investigator Decision|0|||
164221225|NCT00853047|593177879|FG005|Open-Label Extension Phase|Investigator Decision|1|||
164567611|NCT02908100|594447215|FG001|Overall Study|Pregnancy|2|||
164567612|NCT02908100|594447216|FG002|Overall Study|Pregnancy|0|||
164567613|NCT02908100|594447214|FG000|Overall Study|Withdrawal by Subject|8|||
164567614|NCT02908100|594447215|FG001|Overall Study|Withdrawal by Subject|7|||
164567615|NCT02908100|594447216|FG002|Overall Study|Withdrawal by Subject|5|||
164567616|NCT02908100|594447214|FG000|Overall Study|Randomised in Error|1|||
164567617|NCT02908100|594447215|FG001|Overall Study|Randomised in Error|0|||
164567618|NCT02908100|594447216|FG002|Overall Study|Randomised in Error|0|||
164567619|NCT02024971|594447217|FG000|Overall Study|Data Not Available|30|||
164567620|NCT02024971|594447217|FG000|Overall Study|Lost to Follow-up|6|||
164567621|NCT05254418|594447219|FG000|Overall Study|Adverse Event|2|||
164567622|NCT02631538|594447221|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
164567623|NCT02631538|594447222|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
164567624|NCT02631538|594447223|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
164567625|NCT02631538|594447224|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
164567626|NCT02631538|594447221|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
164567627|NCT02631538|594447222|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
164567628|NCT02631538|594447223|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
164567629|NCT02631538|594447224|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
164567630|NCT02631538|594447221|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
164567631|NCT02631538|594447222|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
164567632|NCT02631538|594447223|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
164567633|NCT02631538|594447224|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
164567634|NCT02631538|594447221|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
164567635|NCT02631538|594447222|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
164567636|NCT02631538|594447223|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
164567637|NCT02631538|594447224|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
164567638|NCT02631538|594447221|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
164567639|NCT02631538|594447222|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
164567640|NCT02631538|594447223|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
164567641|NCT02631538|594447224|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
164567642|NCT02631538|594447221|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
164567643|NCT02631538|594447222|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
164567644|NCT02631538|594447223|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
164567645|NCT02631538|594447224|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
164567646|NCT00440726|594447227|FG000|Phase 1|Dose-Limiting Toxicity|0|||
164567647|NCT00440726|594447228|FG001|Phase 1|Dose-Limiting Toxicity|1|||
164567648|NCT00440726|594447229|FG002|Phase 1|Dose-Limiting Toxicity|0|||
164567649|NCT00440726|594447227|FG000|Phase 1|Physician Decision|1|||
164567650|NCT00440726|594447228|FG001|Phase 1|Physician Decision|0|||
164567651|NCT00440726|594447229|FG002|Phase 1|Physician Decision|0|||
164567652|NCT00440726|594447227|FG000|Phase 2|Death|0|||
164567653|NCT00440726|594447228|FG001|Phase 2|Death|0|||
164567654|NCT00440726|594447229|FG002|Phase 2|Death|1|||
164567655|NCT00440726|594447227|FG000|Phase 2|Adverse Event|0|||
164567656|NCT00440726|594447228|FG001|Phase 2|Adverse Event|0|||
164567657|NCT00440726|594447229|FG002|Phase 2|Adverse Event|1|||
164567658|NCT04276207|594447232|FG000|Period 1|Withdrawal by Subject|0|||
164567659|NCT04276207|594447233|FG001|Period 1|Withdrawal by Subject|1|||
164567660|NCT01256177|594447234|FG000|Overall Study|Withdrawal by Subject|23|||
164567661|NCT01256177|594447235|FG001|Overall Study|Withdrawal by Subject|22|||
164567662|NCT01256177|594447234|FG000|Overall Study|Lost to Follow-up|2|||
164567663|NCT01256177|594447235|FG001|Overall Study|Lost to Follow-up|2|||
164567664|NCT01256177|594447234|FG000|Overall Study|Adverse Event|8|||
164567665|NCT01256177|594447235|FG001|Overall Study|Adverse Event|9|||
164567666|NCT01256177|594447234|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
164567667|NCT01256177|594447235|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
164567668|NCT01256177|594447234|FG000|Overall Study|Condition under Investigation Worsened|1|||
164567669|NCT01256177|594447235|FG001|Overall Study|Condition under Investigation Worsened|0|||
164567670|NCT01256177|594447234|FG000|Overall Study|Lack of Efficacy|11|||
164567671|NCT01256177|594447235|FG001|Overall Study|Lack of Efficacy|2|||
164567672|NCT01256177|594447234|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
164567673|NCT01256177|594447235|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
164567674|NCT02690194|594447236|FG000|Overall Study|Withdrawal by Subject|1|||
164567675|NCT02690194|594447237|FG001|Overall Study|Withdrawal by Subject|4|||
164567676|NCT02690194|594447238|FG002|Overall Study|Withdrawal by Subject|0|||
164567677|NCT03624946|594447239|FG000|Overall Study|Lost to Follow-up|0|||
164567678|NCT03624946|594447240|FG001|Overall Study|Lost to Follow-up|1|||
164567679|NCT00862251|594447244|FG000|Overall Study|Adverse Event|8|||
164221226|NCT00853047|593177874|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
164221227|NCT00853047|593177875|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
164420886|NCT01448044|593911035|FG001|Treatment Period|Adverse Event|3|||
164420887|NCT01448044|593911034|FG000|Treatment Period|Lack of Efficacy|5|||
164420888|NCT01448044|593911035|FG001|Treatment Period|Lack of Efficacy|12|||
164420889|NCT01448044|593911034|FG000|Treatment Period|Subject requested discontinue study drug|1|||
164420890|NCT01448044|593911035|FG001|Treatment Period|Subject requested discontinue study drug|0|||
164420891|NCT01448044|593911034|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
164420892|NCT01448044|593911035|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
164420893|NCT01448044|593911034|FG000|Treatment Period|Participant does not meet study criteria|1|||
164420894|NCT01448044|593911035|FG001|Treatment Period|Participant does not meet study criteria|0|||
164420895|NCT01448044|593911034|FG000|Treatment Period|Lost to Follow-up|2|||
164420896|NCT01448044|593911035|FG001|Treatment Period|Lost to Follow-up|1|||
164420897|NCT01448044|593911034|FG000|Treatment Period|Other reason|2|||
164420898|NCT01448044|593911035|FG001|Treatment Period|Other reason|0|||
164420899|NCT01448044|593911034|FG000|Follow Up Period|Withdrawal by Subject|1|||
164420900|NCT01448044|593911035|FG001|Follow Up Period|Withdrawal by Subject|1|||
164221228|NCT00853047|593177876|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
164221229|NCT00853047|593177877|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
164221230|NCT00853047|593177878|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
164221231|NCT00853047|593177879|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
164221232|NCT02638493|593177880|FG000|Overall Study|Inability to provide semen samples|2|||
164221233|NCT02638493|593177881|FG001|Overall Study|Inability to provide semen samples|0|||
164221234|NCT02638493|593177882|FG002|Overall Study|Inability to provide semen samples|0|||
164221235|NCT01569763|593179929|FG000|Overall Study|Lack of Efficacy|2|||
164221236|NCT01569763|593179930|FG001|Overall Study|Lack of Efficacy|7|||
164221237|NCT01569763|593179929|FG000|Overall Study|Adverse Event|1|||
164221238|NCT01569763|593179930|FG001|Overall Study|Adverse Event|0|||
164221239|NCT01926509|593179931|FG000|Overall Study|vital sign met discontinuation criteria|1|||
164221240|NCT01926509|593179932|FG001|Overall Study|vital sign met discontinuation criteria|0|||
164221241|NCT01926509|593179933|FG002|Overall Study|vital sign met discontinuation criteria|0|||
164221242|NCT01926509|593179934|FG003|Overall Study|vital sign met discontinuation criteria|0|||
164221243|NCT02730169|593179935|FG000|Overall Study|Protocol Violation|1|||
164221244|NCT02730169|593179936|FG001|Overall Study|Protocol Violation|0|||
164221245|NCT02730169|593179937|FG002|Overall Study|Protocol Violation|0|||
164221246|NCT02730169|593179938|FG003|Overall Study|Protocol Violation|1|||
164221247|NCT02730169|593179935|FG000|Overall Study|Adverse Event|2|||
164221248|NCT02730169|593179936|FG001|Overall Study|Adverse Event|3|||
164221249|NCT02730169|593179937|FG002|Overall Study|Adverse Event|3|||
164221250|NCT02730169|593179938|FG003|Overall Study|Adverse Event|0|||
164221251|NCT02730169|593179935|FG000|Overall Study|Adverse Event of Special Interest|0|||
164221252|NCT02730169|593179936|FG001|Overall Study|Adverse Event of Special Interest|1|||
164221253|NCT02730169|593179937|FG002|Overall Study|Adverse Event of Special Interest|2|||
164221254|NCT02730169|593179938|FG003|Overall Study|Adverse Event of Special Interest|0|||
164221255|NCT02730169|593179935|FG000|Overall Study|Withdrawal by Subject|6|||
164221256|NCT02730169|593179936|FG001|Overall Study|Withdrawal by Subject|11|||
164221257|NCT02730169|593179937|FG002|Overall Study|Withdrawal by Subject|6|||
164221258|NCT02730169|593179938|FG003|Overall Study|Withdrawal by Subject|8|||
164221259|NCT02730169|593179935|FG000|Overall Study|Lost to Follow-up|5|||
164221260|NCT02730169|593179936|FG001|Overall Study|Lost to Follow-up|6|||
164221261|NCT02730169|593179937|FG002|Overall Study|Lost to Follow-up|5|||
164221262|NCT02730169|593179938|FG003|Overall Study|Lost to Follow-up|6|||
164221263|NCT02730169|593179935|FG000|Overall Study|Other|0|||
164221264|NCT02730169|593179936|FG001|Overall Study|Other|0|||
164221265|NCT02730169|593179937|FG002|Overall Study|Other|1|||
164221266|NCT02730169|593179938|FG003|Overall Study|Other|1|||
164221267|NCT03004183|593179939|FG000|Overall Study|Adverse Event|7|||
164221268|NCT03004183|593179939|FG000|Overall Study|Lost to Follow-up|1|||
164221269|NCT03004183|593179939|FG000|Overall Study|Physician Decision|40|||
164221270|NCT03004183|593179939|FG000|Overall Study|Withdrawal by Subject|1|||
164221271|NCT03004183|593179939|FG000|Overall Study|COVID-19|1|||
164221272|NCT02698787|593179943|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
164221273|NCT02698787|593179944|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
164221274|NCT02533674|593179950|FG000|Dose Level I|Progressive disease|1|||
164221275|NCT02533674|593179951|FG001|Dose Level I|Progressive disease|0|||
164221276|NCT02533674|593179952|FG002|Dose Level I|Progressive disease|0|||
164221277|NCT02533674|593179953|FG003|Dose Level I|Progressive disease|0|||
164221278|NCT02533674|593179954|FG004|Dose Level I|Progressive disease|0|||
164420901|NCT01448044|593911034|FG000|Follow Up Period|Lost to Follow-up|6|||
164420902|NCT01448044|593911035|FG001|Follow Up Period|Lost to Follow-up|2|||
164420903|NCT01448044|593911034|FG000|Follow Up Period|Other|5|||
164567680|NCT00862251|594447245|FG001|Overall Study|Adverse Event|3|||
164567681|NCT00862251|594447246|FG002|Overall Study|Adverse Event|1|||
164567682|NCT00862251|594447244|FG000|Overall Study|Lost to Follow-up|0|||
164221279|NCT02533674|593179955|FG005|Dose Level I|Progressive disease|0|||
164221280|NCT02533674|593179956|FG006|Dose Level I|Progressive disease|0|||
164567683|NCT00862251|594447245|FG001|Overall Study|Lost to Follow-up|0|||
164221281|NCT02533674|593179957|FG007|Dose Level I|Progressive disease|0|||
164221282|NCT02533674|593179950|FG000|Dose Level I|Withdrawal by Subject|1|||
164221283|NCT02533674|593179951|FG001|Dose Level I|Withdrawal by Subject|0|||
164221284|NCT02533674|593179952|FG002|Dose Level I|Withdrawal by Subject|0|||
164221285|NCT02533674|593179953|FG003|Dose Level I|Withdrawal by Subject|0|||
164221286|NCT02533674|593179954|FG004|Dose Level I|Withdrawal by Subject|0|||
164221287|NCT02533674|593179955|FG005|Dose Level I|Withdrawal by Subject|0|||
164221288|NCT02533674|593179956|FG006|Dose Level I|Withdrawal by Subject|0|||
164221289|NCT02533674|593179957|FG007|Dose Level I|Withdrawal by Subject|0|||
164420904|NCT01448044|593911035|FG001|Follow Up Period|Other|11|||
164567684|NCT00862251|594447246|FG002|Overall Study|Lost to Follow-up|1|||
164221290|NCT02533674|593179950|FG000|Dose Level I|Physician Decision|1|||
164221291|NCT02533674|593179951|FG001|Dose Level I|Physician Decision|0|||
164221292|NCT02533674|593179952|FG002|Dose Level I|Physician Decision|0|||
164221293|NCT02533674|593179953|FG003|Dose Level I|Physician Decision|0|||
164221294|NCT02533674|593179954|FG004|Dose Level I|Physician Decision|0|||
164221295|NCT02533674|593179955|FG005|Dose Level I|Physician Decision|0|||
164221296|NCT02533674|593179956|FG006|Dose Level I|Physician Decision|0|||
164221297|NCT02533674|593179957|FG007|Dose Level I|Physician Decision|0|||
164221298|NCT02533674|593179950|FG000|Dose Level I|Death|1|||
164221299|NCT02533674|593179951|FG001|Dose Level I|Death|0|||
164221300|NCT02533674|593179952|FG002|Dose Level I|Death|0|||
164221301|NCT02533674|593179953|FG003|Dose Level I|Death|0|||
164221302|NCT02533674|593179954|FG004|Dose Level I|Death|0|||
164221303|NCT02533674|593179955|FG005|Dose Level I|Death|0|||
164221304|NCT02533674|593179956|FG006|Dose Level I|Death|0|||
164221305|NCT02533674|593179957|FG007|Dose Level I|Death|0|||
164221306|NCT02533674|593179950|FG000|Dose Level I|Never Treated|1|||
164221307|NCT02533674|593179951|FG001|Dose Level I|Never Treated|0|||
164221308|NCT02533674|593179952|FG002|Dose Level I|Never Treated|0|||
164221309|NCT02533674|593179953|FG003|Dose Level I|Never Treated|0|||
164221310|NCT02533674|593179954|FG004|Dose Level I|Never Treated|0|||
164221311|NCT02533674|593179955|FG005|Dose Level I|Never Treated|0|||
164221312|NCT02533674|593179956|FG006|Dose Level I|Never Treated|0|||
164221313|NCT02533674|593179957|FG007|Dose Level I|Never Treated|0|||
164420905|NCT01951092|593911039|FG000|Overall Study|Lost to Follow-up|10|||
164420906|NCT01951092|593911039|FG000|Overall Study|Incarceration|1|||
164420907|NCT01951092|593911039|FG000|Overall Study|Transfer of Care|1|||
164420908|NCT01712789|593911040|FG000|Overall Study|Lack of Efficacy|2|||
164420909|NCT01712789|593911040|FG000|Overall Study|Lost to Follow-up|1|||
164420910|NCT01712789|593911040|FG000|Overall Study|Progressive Disease|504|||
164221314|NCT02533674|593179950|FG000|Dose Level II|Progressive disease|0|||
164221315|NCT02533674|593179951|FG001|Dose Level II|Progressive disease|3|||
164221316|NCT02533674|593179952|FG002|Dose Level II|Progressive disease|0|||
164221317|NCT02533674|593179953|FG003|Dose Level II|Progressive disease|0|||
164221318|NCT02533674|593179954|FG004|Dose Level II|Progressive disease|0|||
164221319|NCT02533674|593179955|FG005|Dose Level II|Progressive disease|0|||
164221320|NCT02533674|593179956|FG006|Dose Level II|Progressive disease|0|||
164221321|NCT02533674|593179957|FG007|Dose Level II|Progressive disease|0|||
164221322|NCT02533674|593179950|FG000|Dose Level II|Withdrawal by Subject|0|||
164221323|NCT02533674|593179951|FG001|Dose Level II|Withdrawal by Subject|1|||
164221324|NCT02533674|593179952|FG002|Dose Level II|Withdrawal by Subject|0|||
164221325|NCT02533674|593179953|FG003|Dose Level II|Withdrawal by Subject|0|||
164221326|NCT02533674|593179954|FG004|Dose Level II|Withdrawal by Subject|0|||
164221327|NCT02533674|593179955|FG005|Dose Level II|Withdrawal by Subject|0|||
164221328|NCT02533674|593179956|FG006|Dose Level II|Withdrawal by Subject|0|||
164221329|NCT02533674|593179957|FG007|Dose Level II|Withdrawal by Subject|0|||
164221330|NCT02533674|593179950|FG000|Dose Level II|Treatment-related AE|0|||
164221331|NCT02533674|593179951|FG001|Dose Level II|Treatment-related AE|1|||
164221332|NCT02533674|593179952|FG002|Dose Level II|Treatment-related AE|0|||
164221333|NCT02533674|593179953|FG003|Dose Level II|Treatment-related AE|0|||
164221334|NCT02533674|593179954|FG004|Dose Level II|Treatment-related AE|0|||
164221335|NCT02533674|593179955|FG005|Dose Level II|Treatment-related AE|0|||
164221336|NCT02533674|593179956|FG006|Dose Level II|Treatment-related AE|0|||
164221337|NCT02533674|593179957|FG007|Dose Level II|Treatment-related AE|0|||
164420911|NCT01712789|593911040|FG000|Overall Study|Death|57|||
164420912|NCT01712789|593911040|FG000|Overall Study|Adverse Event|52|||
164420913|NCT01712789|593911040|FG000|Overall Study|Miscellaneous|31|||
164221338|NCT02533674|593179950|FG000|Dose Level II|Physician Decision|0|||
164221339|NCT02533674|593179951|FG001|Dose Level II|Physician Decision|1|||
164221340|NCT02533674|593179952|FG002|Dose Level II|Physician Decision|0|||
164420914|NCT01712789|593911040|FG000|Overall Study|Withdrawal by Subject|21|||
164221341|NCT02533674|593179953|FG003|Dose Level II|Physician Decision|0|||
164221342|NCT02533674|593179954|FG004|Dose Level II|Physician Decision|0|||
164221343|NCT02533674|593179955|FG005|Dose Level II|Physician Decision|0|||
164420915|NCT01712789|593911040|FG000|Overall Study|Transition to Commercial Treatment|8|||
164221344|NCT02533674|593179956|FG006|Dose Level II|Physician Decision|0|||
164221345|NCT02533674|593179957|FG007|Dose Level II|Physician Decision|0|||
164221346|NCT02533674|593179950|FG000|Dose Level II|Non-treatment-related AE|0|||
164221347|NCT02533674|593179951|FG001|Dose Level II|Non-treatment-related AE|1|||
164221348|NCT02533674|593179952|FG002|Dose Level II|Non-treatment-related AE|0|||
164221349|NCT02533674|593179953|FG003|Dose Level II|Non-treatment-related AE|0|||
164420916|NCT01712789|593911040|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
164420917|NCT00219141|593911041|FG000|Overall Study|Adverse Event|4|||
164420918|NCT00219141|593911042|FG001|Overall Study|Adverse Event|10|||
164420919|NCT00219141|593911043|FG002|Overall Study|Adverse Event|5|||
164420920|NCT00219141|593911041|FG000|Overall Study|Lack of Efficacy|3|||
164420921|NCT00219141|593911042|FG001|Overall Study|Lack of Efficacy|2|||
164420922|NCT00219141|593911043|FG002|Overall Study|Lack of Efficacy|0|||
164420923|NCT00219141|593911041|FG000|Overall Study|Administrative problems|0|||
164221350|NCT02533674|593179954|FG004|Dose Level II|Non-treatment-related AE|0|||
164567685|NCT00862251|594447244|FG000|Overall Study|Protocol Violation|2|||
164567686|NCT00862251|594447245|FG001|Overall Study|Protocol Violation|0|||
164567687|NCT00862251|594447246|FG002|Overall Study|Protocol Violation|1|||
164567688|NCT00862251|594447244|FG000|Overall Study|Withdrawal by Subject|9|||
164567689|NCT00862251|594447245|FG001|Overall Study|Withdrawal by Subject|2|||
164567690|NCT00862251|594447246|FG002|Overall Study|Withdrawal by Subject|6|||
164567691|NCT00624520|594447247|FG000|Overall Study|Withdrawal by Subject|12|||
164567692|NCT00624520|594447248|FG001|Overall Study|Withdrawal by Subject|7|||
164567693|NCT00624520|594447247|FG000|Overall Study|Death|0|||
164567694|NCT00624520|594447248|FG001|Overall Study|Death|1|||
164567695|NCT02796755|594447249|FG000|Overall Study|Adverse Event|2|||
164567696|NCT02796755|594447250|FG001|Overall Study|Adverse Event|0|||
164567697|NCT00675025|594447251|FG000|Overall Study|Study Terminated by Sponsor|38|||
164567698|NCT00675025|594447252|FG001|Overall Study|Study Terminated by Sponsor|42|||
164567699|NCT00675025|594447251|FG000|Overall Study|Adverse Event|6|||
164567700|NCT00675025|594447252|FG001|Overall Study|Adverse Event|11|||
164567701|NCT00675025|594447251|FG000|Overall Study|Lost to Follow-up|6|||
164567702|NCT00675025|594447252|FG001|Overall Study|Lost to Follow-up|4|||
164567703|NCT00675025|594447251|FG000|Overall Study|Withdrawal by Subject|4|||
164567704|NCT00675025|594447252|FG001|Overall Study|Withdrawal by Subject|6|||
164567705|NCT00556426|594447256|FG000|Overall Study|Withdrawal by Subject|3|||
164567706|NCT00556426|594447256|FG000|Overall Study|Death|6|||
164567707|NCT00531960|594447259|FG000|Overall Study|Adverse Event|5|||
164567708|NCT00531960|594447260|FG001|Overall Study|Adverse Event|4|||
164567709|NCT00531960|594447259|FG000|Overall Study|Death|3|||
164567710|NCT00531960|594447260|FG001|Overall Study|Death|2|||
164567711|NCT00531960|594447259|FG000|Overall Study|Lack of Efficacy|42|||
164567712|NCT00531960|594447260|FG001|Overall Study|Lack of Efficacy|41|||
164567713|NCT00531960|594447259|FG000|Overall Study|Violation of Selection Criteria|2|||
164567714|NCT00531960|594447260|FG001|Overall Study|Violation of Selection Criteria|0|||
164567715|NCT00531960|594447259|FG000|Overall Study|Refused Treatment|5|||
164567716|NCT00531960|594447260|FG001|Overall Study|Refused Treatment|6|||
164567717|NCT00531960|594447259|FG000|Overall Study|Other|4|||
164567718|NCT00531960|594447260|FG001|Overall Study|Other|10|||
164567719|NCT04258579|594447262|FG000|Overall Study|Withdrawal by Subject|7|||
164567720|NCT04258579|594447262|FG000|Overall Study|Lost to Follow-up|3|||
164567721|NCT04258579|594447262|FG000|Overall Study|Protocol Violation|2|||
164567722|NCT04258579|594447262|FG000|Overall Study|Adverse Event|1|||
164567723|NCT04007159|594447263|FG000|Induction Phase|(missed study visits)|16|||
164567724|NCT04007159|594447263|FG000|Induction Phase|Withdrawal by Subject|4|||
164567725|NCT04007159|594447263|FG000|Induction Phase|Adverse Event|2|||
164567726|NCT04007159|594447263|FG000|Challenge Phase|missed study visits|3|||
164567727|NCT00331006|594447265|FG000|Screening Phase|Withdrawal by Subject|1|||
164567728|NCT00331006|594447265|FG000|Screening Phase|enrollment halted|1|||
164567729|NCT00331006|594447265|FG000|Screening Phase|Lost to Follow-up|1|||
164567730|NCT00331006|594447265|FG000|Screening Phase|Ineligible for treatment phase|4|||
164567731|NCT00331006|594447265|FG000|Treatment Phase|Withdrawal by Subject|1|||
164567732|NCT00331006|594447265|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
164567733|NCT00331006|594447265|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
164567734|NCT03804684|594447266|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
164567735|NCT03804684|594447267|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
164567736|NCT00238264|594447268|FG000|Overall Study|Death|7|||
164567737|NCT00238264|594447268|FG000|Overall Study|Lost to Follow-up|18|||
164567738|NCT00238264|594447268|FG000|Overall Study|Withdrawal by Subject|4|||
164567739|NCT00238264|594447268|FG000|Overall Study|Ineligible|7|||
164567740|NCT00713219|594447269|FG000|Overall Study|Death|1|||
164567741|NCT00713219|594447269|FG000|Overall Study|Protocol Violation|1|||
164567742|NCT03183128|594447270|FG000|Overall Study|Adverse Event|1|||
164567743|NCT03183128|594447271|FG001|Overall Study|Adverse Event|2|||
164567744|NCT03183128|594447270|FG000|Overall Study|Withdrawal by Subject|1|||
164567745|NCT03183128|594447271|FG001|Overall Study|Withdrawal by Subject|8|||
164567746|NCT03183128|594447270|FG000|Overall Study|Protocol Violation|2|||
164567747|NCT03183128|594447271|FG001|Overall Study|Protocol Violation|0|||
164567748|NCT03183128|594447270|FG000|Overall Study|Lack of Efficacy|4|||
164567749|NCT03183128|594447271|FG001|Overall Study|Lack of Efficacy|27|||
164567750|NCT03183128|594447270|FG000|Overall Study|Lost to Follow-up|1|||
164567751|NCT03183128|594447271|FG001|Overall Study|Lost to Follow-up|0|||
164567752|NCT03183128|594447270|FG000|Overall Study|Death|2|||
164567753|NCT03183128|594447271|FG001|Overall Study|Death|0|||
164567754|NCT03183128|594447270|FG000|Overall Study|Physician Decision|1|||
164567755|NCT03183128|594447271|FG001|Overall Study|Physician Decision|0|||
164567756|NCT02978222|594447272|FG000|Overall Study|Withdrawal by Subject|2|||
164567757|NCT02978222|594447273|FG001|Overall Study|Withdrawal by Subject|2|||
164567758|NCT02978222|594447272|FG000|Overall Study|Physician Decision|2|||
164567759|NCT02978222|594447273|FG001|Overall Study|Physician Decision|0|||
164567760|NCT02978222|594447272|FG000|Overall Study|Adverse Event|0|||
164567761|NCT02978222|594447273|FG001|Overall Study|Adverse Event|1|||
164567762|NCT02978222|594447272|FG000|Overall Study|Death|1|||
164567763|NCT02978222|594447273|FG001|Overall Study|Death|0|||
164567764|NCT02978222|594447272|FG000|Overall Study|Disease Progression|32|||
164567765|NCT02978222|594447273|FG001|Overall Study|Disease Progression|32|||
164567766|NCT02978222|594447272|FG000|Overall Study|Early Study Termination|24|||
164567767|NCT02978222|594447273|FG001|Overall Study|Early Study Termination|21|||
164567768|NCT03258814|594447274|FG000|Overall Study|Early Termination|4|||
164567769|NCT03258814|594447275|FG001|Overall Study|Early Termination|3|||
164567770|NCT03258814|594447276|FG002|Overall Study|Early Termination|10|||
164567771|NCT01413958|594447277|FG000|Overall Study|Lost to Follow-up|0|||
164567772|NCT01413958|594447278|FG001|Overall Study|Lost to Follow-up|1|||
164567773|NCT02908516|594447279|FG000|Overall Study|Study Terminated|3|||
164567774|NCT02908516|594447280|FG001|Overall Study|Study Terminated|3|||
164567775|NCT01225562|594447283|FG000|Overall Study|Withdrawal by Subject|52|||
164567776|NCT01225562|594447284|FG001|Overall Study|Withdrawal by Subject|50|||
164567777|NCT01225562|594447285|FG002|Overall Study|Withdrawal by Subject|52|||
164670919|NCT05093205|594821318|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
164670920|NCT05093205|594821319|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
164567778|NCT01225562|594447283|FG000|Overall Study|Lost to Follow-up|3|||
164567779|NCT01225562|594447284|FG001|Overall Study|Lost to Follow-up|6|||
164567780|NCT01225562|594447285|FG002|Overall Study|Lost to Follow-up|1|||
164567781|NCT00348140|594447289|FG000|Overall Study|Adverse Event|46|||
164567782|NCT00348140|594447290|FG001|Overall Study|Adverse Event|49|||
164670921|NCT05093205|594821320|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
164670922|NCT05093205|594821308|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
164670923|NCT05093205|594821309|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
164670924|NCT05093205|594821310|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
164670925|NCT05093205|594821311|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
164670926|NCT05093205|594821312|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
164670927|NCT05093205|594821313|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
164670928|NCT05093205|594821314|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
164670929|NCT05093205|594821315|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
164670930|NCT05093205|594821316|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
164670931|NCT05093205|594821317|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
164670932|NCT05093205|594821318|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
164670933|NCT05093205|594821319|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
164670934|NCT05093205|594821320|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
164670935|NCT05093205|594821308|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
164670936|NCT05093205|594821309|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
164670937|NCT05093205|594821310|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
164670938|NCT05093205|594821311|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
164670939|NCT05093205|594821312|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
164670940|NCT05093205|594821313|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
164670941|NCT05093205|594821314|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
164670942|NCT05093205|594821315|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
164670943|NCT05093205|594821316|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
164670944|NCT05093205|594821317|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
164670945|NCT05093205|594821318|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
164670946|NCT05093205|594821319|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
164670947|NCT05093205|594821320|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
164670948|NCT05093205|594821308|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
164670949|NCT05093205|594821309|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
164670950|NCT05093205|594821310|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
164670951|NCT05093205|594821311|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
164670952|NCT05093205|594821312|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
164670953|NCT05093205|594821313|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
164670954|NCT05093205|594821314|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
164670955|NCT05093205|594821315|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
164670956|NCT05093205|594821316|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
164670957|NCT05093205|594821317|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
164670958|NCT05093205|594821318|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
164670959|NCT05093205|594821319|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
164221351|NCT02533674|593179955|FG005|Dose Level II|Non-treatment-related AE|0|||
164221352|NCT02533674|593179956|FG006|Dose Level II|Non-treatment-related AE|0|||
164221353|NCT02533674|593179957|FG007|Dose Level II|Non-treatment-related AE|0|||
164221354|NCT02533674|593179950|FG000|Dose Level III|Progressive disease|0|||
164221355|NCT02533674|593179951|FG001|Dose Level III|Progressive disease|0|||
164221356|NCT02533674|593179952|FG002|Dose Level III|Progressive disease|2|||
164221357|NCT02533674|593179953|FG003|Dose Level III|Progressive disease|0|||
164221358|NCT02533674|593179954|FG004|Dose Level III|Progressive disease|0|||
164221359|NCT02533674|593179955|FG005|Dose Level III|Progressive disease|0|||
164221360|NCT02533674|593179956|FG006|Dose Level III|Progressive disease|0|||
164221361|NCT02533674|593179957|FG007|Dose Level III|Progressive disease|0|||
164221362|NCT02533674|593179950|FG000|Dose Level III|Withdrawal by Subject|0|||
164221363|NCT02533674|593179951|FG001|Dose Level III|Withdrawal by Subject|0|||
164221364|NCT02533674|593179952|FG002|Dose Level III|Withdrawal by Subject|1|||
164221365|NCT02533674|593179953|FG003|Dose Level III|Withdrawal by Subject|0|||
164221366|NCT02533674|593179954|FG004|Dose Level III|Withdrawal by Subject|0|||
164221367|NCT02533674|593179955|FG005|Dose Level III|Withdrawal by Subject|0|||
164221368|NCT02533674|593179956|FG006|Dose Level III|Withdrawal by Subject|0|||
164221369|NCT02533674|593179957|FG007|Dose Level III|Withdrawal by Subject|0|||
164221370|NCT02533674|593179950|FG000|Dose Level III|Treatment-related AE|0|||
164221371|NCT02533674|593179951|FG001|Dose Level III|Treatment-related AE|0|||
164221372|NCT02533674|593179952|FG002|Dose Level III|Treatment-related AE|1|||
164221373|NCT02533674|593179953|FG003|Dose Level III|Treatment-related AE|0|||
164221374|NCT02533674|593179954|FG004|Dose Level III|Treatment-related AE|0|||
164221375|NCT02533674|593179955|FG005|Dose Level III|Treatment-related AE|0|||
164221376|NCT02533674|593179956|FG006|Dose Level III|Treatment-related AE|0|||
164221377|NCT02533674|593179957|FG007|Dose Level III|Treatment-related AE|0|||
164221378|NCT02533674|593179950|FG000|Dose Level IV|Progressive disease|0|||
164221379|NCT02533674|593179951|FG001|Dose Level IV|Progressive disease|0|||
164221380|NCT02533674|593179952|FG002|Dose Level IV|Progressive disease|0|||
164221381|NCT02533674|593179953|FG003|Dose Level IV|Progressive disease|3|||
164221382|NCT02533674|593179954|FG004|Dose Level IV|Progressive disease|0|||
164221383|NCT02533674|593179955|FG005|Dose Level IV|Progressive disease|0|||
164221384|NCT02533674|593179956|FG006|Dose Level IV|Progressive disease|0|||
164221385|NCT02533674|593179957|FG007|Dose Level IV|Progressive disease|0|||
164221386|NCT02533674|593179950|FG000|Dose Level IV|Withdrawal by Subject|0|||
164221387|NCT02533674|593179951|FG001|Dose Level IV|Withdrawal by Subject|0|||
164221388|NCT02533674|593179952|FG002|Dose Level IV|Withdrawal by Subject|0|||
164221389|NCT02533674|593179953|FG003|Dose Level IV|Withdrawal by Subject|1|||
164221390|NCT02533674|593179954|FG004|Dose Level IV|Withdrawal by Subject|0|||
164221391|NCT02533674|593179955|FG005|Dose Level IV|Withdrawal by Subject|0|||
164221392|NCT02533674|593179956|FG006|Dose Level IV|Withdrawal by Subject|0|||
164221393|NCT02533674|593179957|FG007|Dose Level IV|Withdrawal by Subject|0|||
164221394|NCT02533674|593179950|FG000|Dose Level IV|Physician Decision|0|||
164221395|NCT02533674|593179951|FG001|Dose Level IV|Physician Decision|0|||
164221396|NCT02533674|593179952|FG002|Dose Level IV|Physician Decision|0|||
164221397|NCT02533674|593179953|FG003|Dose Level IV|Physician Decision|1|||
164221398|NCT02533674|593179954|FG004|Dose Level IV|Physician Decision|0|||
164221399|NCT02533674|593179955|FG005|Dose Level IV|Physician Decision|0|||
164221400|NCT02533674|593179956|FG006|Dose Level IV|Physician Decision|0|||
164221401|NCT02533674|593179957|FG007|Dose Level IV|Physician Decision|0|||
164221402|NCT02533674|593179950|FG000|Dose Level V|Progressive disease|0|||
164221403|NCT02533674|593179951|FG001|Dose Level V|Progressive disease|0|||
164221404|NCT02533674|593179952|FG002|Dose Level V|Progressive disease|0|||
164221405|NCT02533674|593179953|FG003|Dose Level V|Progressive disease|0|||
164221406|NCT02533674|593179954|FG004|Dose Level V|Progressive disease|3|||
164221407|NCT02533674|593179955|FG005|Dose Level V|Progressive disease|0|||
164221408|NCT02533674|593179956|FG006|Dose Level V|Progressive disease|0|||
164221409|NCT02533674|593179957|FG007|Dose Level V|Progressive disease|0|||
164221410|NCT02533674|593179950|FG000|Dose Level V|Withdrawal by Subject|0|||
164329063|NCT03500679|593581284|FG001|Overall Study|Lost to Follow-up|3|||
164329064|NCT03500679|593581283|FG000|Overall Study|Withdrawal by Subject|3|||
164329065|NCT03500679|593581284|FG001|Overall Study|Withdrawal by Subject|0|||
164329066|NCT00744471|593581286|FG000|Overall Study|Randomized but not treated|1|||
164221411|NCT02533674|593179951|FG001|Dose Level V|Withdrawal by Subject|0|||
164221412|NCT02533674|593179952|FG002|Dose Level V|Withdrawal by Subject|0|||
164221413|NCT02533674|593179953|FG003|Dose Level V|Withdrawal by Subject|0|||
164221414|NCT02533674|593179954|FG004|Dose Level V|Withdrawal by Subject|1|||
164329067|NCT00744471|593581287|FG001|Overall Study|Randomized but not treated|1|||
164221415|NCT02533674|593179955|FG005|Dose Level V|Withdrawal by Subject|0|||
164221416|NCT02533674|593179956|FG006|Dose Level V|Withdrawal by Subject|0|||
164221417|NCT02533674|593179957|FG007|Dose Level V|Withdrawal by Subject|0|||
164221418|NCT02533674|593179950|FG000|Dose Level V|Physician Decision|0|||
164221419|NCT02533674|593179951|FG001|Dose Level V|Physician Decision|0|||
164221420|NCT02533674|593179952|FG002|Dose Level V|Physician Decision|0|||
164221421|NCT02533674|593179953|FG003|Dose Level V|Physician Decision|0|||
164221422|NCT02533674|593179954|FG004|Dose Level V|Physician Decision|1|||
164221423|NCT02533674|593179955|FG005|Dose Level V|Physician Decision|0|||
164221424|NCT02533674|593179956|FG006|Dose Level V|Physician Decision|0|||
164221425|NCT02533674|593179957|FG007|Dose Level V|Physician Decision|0|||
164221426|NCT02533674|593179950|FG000|Dose Level VI|Progressive disease|0|||
164221427|NCT02533674|593179951|FG001|Dose Level VI|Progressive disease|0|||
164221428|NCT02533674|593179952|FG002|Dose Level VI|Progressive disease|0|||
164221429|NCT02533674|593179953|FG003|Dose Level VI|Progressive disease|0|||
164221430|NCT02533674|593179954|FG004|Dose Level VI|Progressive disease|0|||
164221431|NCT02533674|593179955|FG005|Dose Level VI|Progressive disease|7|||
164221432|NCT02533674|593179956|FG006|Dose Level VI|Progressive disease|0|||
164221433|NCT02533674|593179957|FG007|Dose Level VI|Progressive disease|0|||
164221434|NCT02533674|593179950|FG000|Dose Level VI|Withdrawal by Subject|0|||
164221435|NCT02533674|593179951|FG001|Dose Level VI|Withdrawal by Subject|0|||
164221436|NCT02533674|593179952|FG002|Dose Level VI|Withdrawal by Subject|0|||
164221437|NCT02533674|593179953|FG003|Dose Level VI|Withdrawal by Subject|0|||
164221438|NCT02533674|593179954|FG004|Dose Level VI|Withdrawal by Subject|0|||
164221439|NCT02533674|593179955|FG005|Dose Level VI|Withdrawal by Subject|1|||
164221440|NCT02533674|593179956|FG006|Dose Level VI|Withdrawal by Subject|0|||
164221441|NCT02533674|593179957|FG007|Dose Level VI|Withdrawal by Subject|0|||
164221442|NCT02533674|593179950|FG000|Dose Level VI|Treatment-related AE|0|||
164221443|NCT02533674|593179951|FG001|Dose Level VI|Treatment-related AE|0|||
164221444|NCT02533674|593179952|FG002|Dose Level VI|Treatment-related AE|0|||
164221445|NCT02533674|593179953|FG003|Dose Level VI|Treatment-related AE|0|||
164221446|NCT02533674|593179954|FG004|Dose Level VI|Treatment-related AE|0|||
164221447|NCT02533674|593179955|FG005|Dose Level VI|Treatment-related AE|1|||
164221448|NCT02533674|593179956|FG006|Dose Level VI|Treatment-related AE|0|||
164221449|NCT02533674|593179957|FG007|Dose Level VI|Treatment-related AE|0|||
164221450|NCT02533674|593179950|FG000|Dose Level VII|Progressive disease|0|||
164221451|NCT02533674|593179951|FG001|Dose Level VII|Progressive disease|0|||
164221452|NCT02533674|593179952|FG002|Dose Level VII|Progressive disease|0|||
164221453|NCT02533674|593179953|FG003|Dose Level VII|Progressive disease|0|||
164221454|NCT02533674|593179954|FG004|Dose Level VII|Progressive disease|0|||
164221455|NCT02533674|593179955|FG005|Dose Level VII|Progressive disease|0|||
164221456|NCT02533674|593179956|FG006|Dose Level VII|Progressive disease|10|||
164221457|NCT02533674|593179957|FG007|Dose Level VII|Progressive disease|0|||
164221458|NCT02533674|593179950|FG000|Dose Level VII|Withdrawal by Subject|0|||
164221459|NCT02533674|593179951|FG001|Dose Level VII|Withdrawal by Subject|0|||
164221460|NCT02533674|593179952|FG002|Dose Level VII|Withdrawal by Subject|0|||
164221461|NCT02533674|593179953|FG003|Dose Level VII|Withdrawal by Subject|0|||
164221462|NCT02533674|593179954|FG004|Dose Level VII|Withdrawal by Subject|0|||
164221463|NCT02533674|593179955|FG005|Dose Level VII|Withdrawal by Subject|0|||
164221464|NCT02533674|593179956|FG006|Dose Level VII|Withdrawal by Subject|3|||
164221465|NCT02533674|593179957|FG007|Dose Level VII|Withdrawal by Subject|0|||
164221466|NCT02533674|593179950|FG000|Dose Level VII|Treatment-related AE|0|||
164221467|NCT02533674|593179951|FG001|Dose Level VII|Treatment-related AE|0|||
164221468|NCT02533674|593179952|FG002|Dose Level VII|Treatment-related AE|0|||
164221469|NCT02533674|593179953|FG003|Dose Level VII|Treatment-related AE|0|||
164221470|NCT02533674|593179954|FG004|Dose Level VII|Treatment-related AE|0|||
164221471|NCT02533674|593179955|FG005|Dose Level VII|Treatment-related AE|0|||
164221472|NCT02533674|593179956|FG006|Dose Level VII|Treatment-related AE|1|||
164221473|NCT02533674|593179957|FG007|Dose Level VII|Treatment-related AE|0|||
164221474|NCT02533674|593179950|FG000|Dose Level VII|Death|0|||
164221475|NCT02533674|593179951|FG001|Dose Level VII|Death|0|||
164221476|NCT02533674|593179952|FG002|Dose Level VII|Death|0|||
164221477|NCT02533674|593179953|FG003|Dose Level VII|Death|0|||
164221478|NCT02533674|593179954|FG004|Dose Level VII|Death|0|||
164221479|NCT02533674|593179955|FG005|Dose Level VII|Death|0|||
164221480|NCT02533674|593179956|FG006|Dose Level VII|Death|2|||
164221481|NCT02533674|593179957|FG007|Dose Level VII|Death|0|||
164221482|NCT02533674|593179950|FG000|Dose Level VIII|Progressive disease|0|||
164221483|NCT02533674|593179951|FG001|Dose Level VIII|Progressive disease|0|||
164221484|NCT02533674|593179952|FG002|Dose Level VIII|Progressive disease|0|||
164221485|NCT02533674|593179953|FG003|Dose Level VIII|Progressive disease|0|||
164221486|NCT02533674|593179954|FG004|Dose Level VIII|Progressive disease|0|||
164221487|NCT02533674|593179955|FG005|Dose Level VIII|Progressive disease|0|||
164221488|NCT02533674|593179956|FG006|Dose Level VIII|Progressive disease|0|||
164221489|NCT02533674|593179957|FG007|Dose Level VIII|Progressive disease|3|||
164221490|NCT02533674|593179950|FG000|Dose Level VIII|Withdrawal by Subject|0|||
164221491|NCT02533674|593179951|FG001|Dose Level VIII|Withdrawal by Subject|0|||
164221492|NCT02533674|593179952|FG002|Dose Level VIII|Withdrawal by Subject|0|||
164221493|NCT02533674|593179953|FG003|Dose Level VIII|Withdrawal by Subject|0|||
164221494|NCT02533674|593179954|FG004|Dose Level VIII|Withdrawal by Subject|0|||
164221495|NCT02533674|593179955|FG005|Dose Level VIII|Withdrawal by Subject|0|||
164221496|NCT02533674|593179956|FG006|Dose Level VIII|Withdrawal by Subject|0|||
164221497|NCT02533674|593179957|FG007|Dose Level VIII|Withdrawal by Subject|1|||
164221498|NCT02533674|593179950|FG000|Dose Level VIII|Treatment-related AE|0|||
164221499|NCT02533674|593179951|FG001|Dose Level VIII|Treatment-related AE|0|||
164221500|NCT02533674|593179952|FG002|Dose Level VIII|Treatment-related AE|0|||
164221501|NCT02533674|593179953|FG003|Dose Level VIII|Treatment-related AE|0|||
164221502|NCT02533674|593179954|FG004|Dose Level VIII|Treatment-related AE|0|||
164221503|NCT02533674|593179955|FG005|Dose Level VIII|Treatment-related AE|0|||
164221504|NCT02533674|593179956|FG006|Dose Level VIII|Treatment-related AE|0|||
164221505|NCT02533674|593179957|FG007|Dose Level VIII|Treatment-related AE|1|||
164221506|NCT02533674|593179950|FG000|Dose Level VIII|Never treated|0|||
164221507|NCT02533674|593179951|FG001|Dose Level VIII|Never treated|0|||
164221508|NCT02533674|593179952|FG002|Dose Level VIII|Never treated|0|||
164221509|NCT02533674|593179953|FG003|Dose Level VIII|Never treated|0|||
164221510|NCT02533674|593179954|FG004|Dose Level VIII|Never treated|0|||
164221511|NCT02533674|593179955|FG005|Dose Level VIII|Never treated|0|||
164221512|NCT02533674|593179956|FG006|Dose Level VIII|Never treated|0|||
164221513|NCT02533674|593179957|FG007|Dose Level VIII|Never treated|1|||
164221514|NCT01160744|593179961|FG000|Overall Study|Withdrawal by Subject|11|||
164221515|NCT01160744|593179962|FG001|Overall Study|Withdrawal by Subject|5|||
164221516|NCT01160744|593179963|FG002|Overall Study|Withdrawal by Subject|6|||
164221517|NCT01160744|593179964|FG003|Overall Study|Withdrawal by Subject|4|||
164221518|NCT01160744|593179961|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
164221519|NCT01160744|593179962|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
164221520|NCT01160744|593179963|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
164221521|NCT01160744|593179964|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
164221522|NCT01502072|593179966|FG000|Overall Study|Withdrawal by Subject|1|||
164221523|NCT01502072|593179967|FG001|Overall Study|Withdrawal by Subject|0|||
164221524|NCT01502072|593179968|FG002|Overall Study|Withdrawal by Subject|0|||
164567783|NCT00348140|594447291|FG002|Overall Study|Adverse Event|78|||
164567784|NCT00348140|594447289|FG000|Overall Study|Lost to Follow-up|4|||
164221525|NCT01502072|593179966|FG000|Overall Study|Death|0|||
164221526|NCT01502072|593179967|FG001|Overall Study|Death|1|||
164221527|NCT01502072|593179968|FG002|Overall Study|Death|0|||
164221528|NCT02773537|593179976|FG000|Overall Study|Lost to Follow-up|0|||
164221529|NCT02773537|593179977|FG001|Overall Study|Lost to Follow-up|1|||
164221530|NCT02773537|593179978|FG002|Overall Study|Lost to Follow-up|4|||
164567785|NCT00348140|594447290|FG001|Overall Study|Lost to Follow-up|4|||
164567786|NCT00348140|594447291|FG002|Overall Study|Lost to Follow-up|4|||
164567787|NCT00348140|594447289|FG000|Overall Study|Protocol Violation|12|||
164567788|NCT00348140|594447290|FG001|Overall Study|Protocol Violation|13|||
164567789|NCT00348140|594447291|FG002|Overall Study|Protocol Violation|14|||
164567790|NCT00348140|594447289|FG000|Overall Study|Withdrawal by Subject|32|||
164567791|NCT00348140|594447290|FG001|Overall Study|Withdrawal by Subject|40|||
164221531|NCT01908699|593179985|FG000|Overall Study|Adverse Event|8|||
164567792|NCT00348140|594447291|FG002|Overall Study|Withdrawal by Subject|40|||
164567793|NCT00348140|594447289|FG000|Overall Study|Non-compliance|8|||
164221532|NCT01908699|593179986|FG001|Overall Study|Adverse Event|12|||
164221533|NCT01908699|593179985|FG000|Overall Study|Lack of Efficacy|2|||
164221534|NCT01908699|593179986|FG001|Overall Study|Lack of Efficacy|2|||
164221535|NCT01908699|593179985|FG000|Overall Study|Lost to Follow-up|2|||
164221536|NCT01908699|593179986|FG001|Overall Study|Lost to Follow-up|4|||
164221537|NCT01908699|593179985|FG000|Overall Study|Physician Decision|8|||
164221538|NCT01908699|593179986|FG001|Overall Study|Physician Decision|8|||
164221539|NCT01908699|593179985|FG000|Overall Study|Withdrawal by Subject|15|||
164221540|NCT01908699|593179986|FG001|Overall Study|Withdrawal by Subject|10|||
164221541|NCT01908699|593179985|FG000|Overall Study|Pregnancy|0|||
164221542|NCT01908699|593179986|FG001|Overall Study|Pregnancy|1|||
164221543|NCT01908699|593179985|FG000|Overall Study|Randomized in Error|1|||
164221544|NCT01908699|593179986|FG001|Overall Study|Randomized in Error|0|||
164221545|NCT01908699|593179985|FG000|Overall Study|Death|9|||
164221546|NCT01908699|593179986|FG001|Overall Study|Death|12|||
164221547|NCT01908699|593179985|FG000|Overall Study|Progressive Disease|30|||
164221548|NCT01908699|593179986|FG001|Overall Study|Progressive Disease|29|||
164221549|NCT01697501|593179987|FG000|Overall Study|Protocol Violation|2|||
164221550|NCT02242903|593179988|FG000|Overall Study|Withdrawal by Subject|1|||
164221551|NCT02242903|593179989|FG001|Overall Study|Withdrawal by Subject|0|||
164221552|NCT02242903|593179990|FG002|Overall Study|Withdrawal by Subject|0|||
164221553|NCT02242903|593179991|FG003|Overall Study|Withdrawal by Subject|0|||
164221554|NCT02242903|593179992|FG004|Overall Study|Withdrawal by Subject|0|||
164221555|NCT02242903|593179993|FG005|Overall Study|Withdrawal by Subject|0|||
164221556|NCT02242903|593179994|FG006|Overall Study|Withdrawal by Subject|0|||
164221557|NCT02105012|593179995|FG000|Overall Study|Withdrawal by Subject|11|||
164221558|NCT02105012|593179995|FG000|Overall Study|Protocol Specified Criteria|9|||
164221559|NCT02105012|593179995|FG000|Overall Study|Lost to Follow-up|4|||
164221560|NCT02105012|593179995|FG000|Overall Study|Protocol Violation|4|||
164221561|NCT02105012|593179995|FG000|Overall Study|Physician Decision|3|||
164221562|NCT02105012|593179995|FG000|Overall Study|Adverse Event|1|||
164221563|NCT02105012|593179995|FG000|Overall Study|Lack of Efficacy|1|||
164221564|NCT00493285|593179996|FG000|Overall Study|Lost to Follow-up|0|||
164221565|NCT00493285|593179997|FG001|Overall Study|Lost to Follow-up|0|||
164221566|NCT00493285|593179998|FG002|Overall Study|Lost to Follow-up|0|||
164221567|NCT00493285|593179999|FG003|Overall Study|Lost to Follow-up|0|||
164221568|NCT00493285|593180000|FG004|Overall Study|Lost to Follow-up|1|||
164221569|NCT00493285|593180001|FG005|Overall Study|Lost to Follow-up|0|||
164221570|NCT03021005|593180002|FG000|Overall Study|Lost to Follow-up|39|||
164221571|NCT03021005|593180003|FG001|Overall Study|Lost to Follow-up|26|||
164221572|NCT03994120|593180010|FG000|Overall Study|Lost to Follow-up|3|||
164221573|NCT03994120|593180011|FG001|Overall Study|Lost to Follow-up|1|||
164221574|NCT00215553|593180012|FG000|Overall Study|Adverse Event|0|||
164221575|NCT00215553|593180013|FG001|Overall Study|Adverse Event|1|||
164221576|NCT00215553|593180014|FG002|Overall Study|Adverse Event|2|||
164221577|NCT00215553|593180015|FG003|Overall Study|Adverse Event|1|||
164221578|NCT00215553|593180016|FG004|Overall Study|Adverse Event|2|||
164221579|NCT00215553|593180017|FG005|Overall Study|Adverse Event|6|||
164221580|NCT00215553|593180018|FG006|Overall Study|Adverse Event|0|||
164221581|NCT01111292|593180019|FG000|Treatment|Physician Decision|1|||
164221582|NCT01111292|593180020|FG001|Treatment|Physician Decision|1|||
164221583|NCT01429623|593180021|FG000|Overall Study|Death|1|||
164221584|NCT01429623|593180022|FG001|Overall Study|Death|0|||
164221585|NCT01429623|593180021|FG000|Overall Study|Adverse Event|7|||
164221586|NCT01429623|593180022|FG001|Overall Study|Adverse Event|14|||
164221587|NCT01429623|593180021|FG000|Overall Study|Withdrawal by Subject|19|||
164221588|NCT01429623|593180022|FG001|Overall Study|Withdrawal by Subject|13|||
164221589|NCT01429623|593180021|FG000|Overall Study|Physician Decision|2|||
164221590|NCT01429623|593180022|FG001|Overall Study|Physician Decision|3|||
164221591|NCT01429623|593180021|FG000|Overall Study|Protocol Violation|3|||
164221592|NCT01429623|593180022|FG001|Overall Study|Protocol Violation|2|||
164221593|NCT01429623|593180021|FG000|Overall Study|Assorted|1|||
164221594|NCT01429623|593180022|FG001|Overall Study|Assorted|2|||
164221595|NCT01429623|593180021|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
164221596|NCT01429623|593180022|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
164221597|NCT01429623|593180021|FG000|Overall Study|No post baseline data|4|||
164221598|NCT01429623|593180022|FG001|Overall Study|No post baseline data|4|||
164221599|NCT03156621|593180023|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
164221600|NCT03156621|593180024|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
164221601|NCT03156621|593180023|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
164221602|NCT03156621|593180024|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
164221603|NCT01259024|593180026|FG000|Overall Study|Physician Decision|1|||
164221604|NCT01657500|593180027|FG000|Overall Study|set impropperly matched|3|||
164221605|NCT01657500|593180028|FG001|Overall Study|set impropperly matched|3|||
164221606|NCT01657500|593180027|FG000|Overall Study|Lost to Follow-up|2|||
164221607|NCT01657500|593180028|FG001|Overall Study|Lost to Follow-up|2|||
164221608|NCT00756444|593180029|FG000|Overall Study|Adverse Event|1|||
164221609|NCT00756444|593180030|FG001|Overall Study|Adverse Event|1|||
164221610|NCT00756444|593180029|FG000|Overall Study|Withdrawal by Subject|6|||
164329068|NCT00744471|593581288|FG002|Overall Study|Randomized but not treated|4|||
164329069|NCT00744471|593581289|FG003|Overall Study|Randomized but not treated|0|||
164329070|NCT00744471|593581286|FG000|Overall Study|Death|0|||
164329071|NCT00744471|593581287|FG001|Overall Study|Death|0|||
164329072|NCT00744471|593581288|FG002|Overall Study|Death|0|||
164329073|NCT00744471|593581289|FG003|Overall Study|Death|1|||
164329074|NCT00744471|593581286|FG000|Overall Study|Adverse Event|6|||
164329075|NCT00744471|593581287|FG001|Overall Study|Adverse Event|7|||
164329076|NCT00744471|593581288|FG002|Overall Study|Adverse Event|5|||
164329077|NCT00744471|593581289|FG003|Overall Study|Adverse Event|9|||
164329078|NCT00744471|593581286|FG000|Overall Study|Withdrawal by Subject|9|||
164329079|NCT00744471|593581287|FG001|Overall Study|Withdrawal by Subject|9|||
164329080|NCT00744471|593581288|FG002|Overall Study|Withdrawal by Subject|15|||
164329081|NCT00744471|593581289|FG003|Overall Study|Withdrawal by Subject|12|||
164329082|NCT00744471|593581286|FG000|Overall Study|Protocol Violation|1|||
164329083|NCT00744471|593581287|FG001|Overall Study|Protocol Violation|4|||
164329084|NCT00744471|593581288|FG002|Overall Study|Protocol Violation|1|||
164329085|NCT00744471|593581289|FG003|Overall Study|Protocol Violation|2|||
164329086|NCT00744471|593581286|FG000|Overall Study|Entered extension study|41|||
164329087|NCT00744471|593581287|FG001|Overall Study|Entered extension study|84|||
164329088|NCT00744471|593581288|FG002|Overall Study|Entered extension study|100|||
164329089|NCT00744471|593581289|FG003|Overall Study|Entered extension study|91|||
164329090|NCT00744471|593581286|FG000|Overall Study|Other|2|||
164329091|NCT00744471|593581287|FG001|Overall Study|Other|3|||
164329092|NCT00744471|593581288|FG002|Overall Study|Other|6|||
164329093|NCT00744471|593581289|FG003|Overall Study|Other|2|||
164329094|NCT00744471|593581286|FG000|Overall Study|Lack of Efficacy|83|||
164329095|NCT00744471|593581287|FG001|Overall Study|Lack of Efficacy|37|||
164329096|NCT00744471|593581288|FG002|Overall Study|Lack of Efficacy|19|||
164329097|NCT00744471|593581289|FG003|Overall Study|Lack of Efficacy|31|||
164329098|NCT00744471|593581286|FG000|Overall Study|Lost to Follow-up|0|||
164329099|NCT00744471|593581287|FG001|Overall Study|Lost to Follow-up|0|||
164329100|NCT00744471|593581288|FG002|Overall Study|Lost to Follow-up|2|||
164329101|NCT00744471|593581289|FG003|Overall Study|Lost to Follow-up|0|||
164329102|NCT04706416|593581292|FG000|Overall Study|Lost to Follow-up|2|||
164329103|NCT04706416|593581293|FG001|Overall Study|Lost to Follow-up|0|||
164329104|NCT01280955|593581294|FG000|Overall Study|Death|2|||
164329105|NCT01280955|593581294|FG000|Overall Study|Withdrawal by Subject|1|||
164329106|NCT01484054|593581295|FG000|Period 1|Withdrawal by Subject|0|||
164329107|NCT01484054|593581296|FG001|Period 1|Withdrawal by Subject|1|||
164329108|NCT05281601|593581299|FG000|Overall Study|Physician Decision|2|||
164329109|NCT05281601|593581300|FG001|Overall Study|Physician Decision|0|||
164329110|NCT05281601|593581299|FG000|Overall Study|Lost to Follow-up|2|||
164329111|NCT05281601|593581300|FG001|Overall Study|Lost to Follow-up|0|||
164329112|NCT05281601|593581299|FG000|Overall Study|Death|1|||
164329113|NCT05281601|593581300|FG001|Overall Study|Death|0|||
164329114|NCT05281601|593581299|FG000|Overall Study|Withdrawal by parent/guardian|2|||
164329115|NCT05281601|593581300|FG001|Overall Study|Withdrawal by parent/guardian|1|||
164329116|NCT00901927|593581303|FG000|Overall Study|Lack of Efficacy|1|||
164329117|NCT00901927|593581303|FG000|Overall Study|Protocol Violation|3|||
164329118|NCT00901927|593581303|FG000|Overall Study|Withdrawal by Subject|2|||
164329119|NCT03119701|593581316|FG000|6-day Dosing|Death|4|||
164329120|NCT03119701|593581317|FG001|6-day Dosing|Death|1|||
164329121|NCT03119701|593581316|FG000|6-day Dosing|Adverse Event|3|||
164329122|NCT03119701|593581317|FG001|6-day Dosing|Adverse Event|0|||
164329123|NCT03119701|593581316|FG000|6-day Dosing|Physician Decision|0|||
164221611|NCT00756444|593180030|FG001|Overall Study|Withdrawal by Subject|8|||
164221612|NCT00756444|593180029|FG000|Overall Study|Lost to Follow-up|0|||
164221613|NCT00756444|593180030|FG001|Overall Study|Lost to Follow-up|1|||
164221614|NCT00756444|593180029|FG000|Overall Study|Death|5|||
164221615|NCT00756444|593180030|FG001|Overall Study|Death|4|||
164221616|NCT00756444|593180029|FG000|Overall Study|Disease Progression|2|||
164221617|NCT00756444|593180030|FG001|Overall Study|Disease Progression|7|||
164221618|NCT00756444|593180029|FG000|Overall Study|Ineligibility Determined|1|||
164221619|NCT00756444|593180030|FG001|Overall Study|Ineligibility Determined|0|||
164221620|NCT01530997|593180031|FG000|Overall Study|Physician Decision|1|||
164221621|NCT01530997|593180031|FG000|Overall Study|Withdrawal by Subject|1|||
164221622|NCT02318277|593180033|FG000|Overall Study|Physician Decision|0|||
164221623|NCT02318277|593180034|FG001|Overall Study|Physician Decision|0|||
164221624|NCT02318277|593180035|FG002|Overall Study|Physician Decision|0|||
164221625|NCT02318277|593180036|FG003|Overall Study|Physician Decision|0|||
164221626|NCT02318277|593180037|FG004|Overall Study|Physician Decision|0|||
164221627|NCT02318277|593180038|FG005|Overall Study|Physician Decision|0|||
164221628|NCT02318277|593180039|FG006|Overall Study|Physician Decision|0|||
164221629|NCT02318277|593180040|FG007|Overall Study|Physician Decision|1|||
164221630|NCT02318277|593180033|FG000|Overall Study|Other|0|||
164221631|NCT02318277|593180034|FG001|Overall Study|Other|0|||
164221632|NCT02318277|593180035|FG002|Overall Study|Other|0|||
164221633|NCT02318277|593180036|FG003|Overall Study|Other|0|||
164221634|NCT02318277|593180037|FG004|Overall Study|Other|0|||
164221635|NCT02318277|593180038|FG005|Overall Study|Other|0|||
164221636|NCT02318277|593180039|FG006|Overall Study|Other|1|||
164221637|NCT02318277|593180040|FG007|Overall Study|Other|0|||
164221638|NCT02318277|593180033|FG000|Overall Study|Withdrawal by Subject|0|||
164221639|NCT02318277|593180034|FG001|Overall Study|Withdrawal by Subject|0|||
164221640|NCT02318277|593180035|FG002|Overall Study|Withdrawal by Subject|1|||
164221641|NCT02318277|593180036|FG003|Overall Study|Withdrawal by Subject|0|||
164221642|NCT02318277|593180037|FG004|Overall Study|Withdrawal by Subject|1|||
164221643|NCT02318277|593180038|FG005|Overall Study|Withdrawal by Subject|1|||
164221644|NCT02318277|593180039|FG006|Overall Study|Withdrawal by Subject|6|||
164221645|NCT02318277|593180040|FG007|Overall Study|Withdrawal by Subject|14|||
164221646|NCT02318277|593180033|FG000|Overall Study|Participant trial terminated by sponsor|0|||
164221647|NCT02318277|593180034|FG001|Overall Study|Participant trial terminated by sponsor|0|||
164221648|NCT02318277|593180035|FG002|Overall Study|Participant trial terminated by sponsor|1|||
164221649|NCT02318277|593180036|FG003|Overall Study|Participant trial terminated by sponsor|0|||
164221650|NCT02318277|593180037|FG004|Overall Study|Participant trial terminated by sponsor|1|||
164221651|NCT02318277|593180038|FG005|Overall Study|Participant trial terminated by sponsor|2|||
164221652|NCT02318277|593180039|FG006|Overall Study|Participant trial terminated by sponsor|5|||
164221653|NCT02318277|593180040|FG007|Overall Study|Participant trial terminated by sponsor|16|||
164221654|NCT02318277|593180033|FG000|Overall Study|Lost to Follow-up|1|||
164221655|NCT02318277|593180034|FG001|Overall Study|Lost to Follow-up|0|||
164221656|NCT02318277|593180035|FG002|Overall Study|Lost to Follow-up|1|||
164221657|NCT02318277|593180036|FG003|Overall Study|Lost to Follow-up|0|||
164221658|NCT02318277|593180037|FG004|Overall Study|Lost to Follow-up|0|||
164221659|NCT02318277|593180038|FG005|Overall Study|Lost to Follow-up|0|||
164221660|NCT02318277|593180039|FG006|Overall Study|Lost to Follow-up|3|||
164221661|NCT02318277|593180040|FG007|Overall Study|Lost to Follow-up|4|||
164221662|NCT02318277|593180033|FG000|Overall Study|Death|5|||
164221663|NCT02318277|593180034|FG001|Overall Study|Death|3|||
164221664|NCT02318277|593180035|FG002|Overall Study|Death|1|||
164221665|NCT02318277|593180036|FG003|Overall Study|Death|4|||
164221666|NCT02318277|593180037|FG004|Overall Study|Death|6|||
164221667|NCT02318277|593180038|FG005|Overall Study|Death|5|||
164221668|NCT02318277|593180039|FG006|Overall Study|Death|34|||
164221669|NCT02318277|593180040|FG007|Overall Study|Death|58|||
164221670|NCT02318277|593180033|FG000|Overall Study|Transitioned to Hospice|0|||
164221671|NCT02318277|593180034|FG001|Overall Study|Transitioned to Hospice|0|||
164567794|NCT00348140|594447290|FG001|Overall Study|Non-compliance|13|||
164329124|NCT03119701|593581317|FG001|6-day Dosing|Physician Decision|1|||
164567795|NCT00348140|594447291|FG002|Overall Study|Non-compliance|5|||
164221672|NCT02318277|593180035|FG002|Overall Study|Transitioned to Hospice|0|||
164221673|NCT02318277|593180036|FG003|Overall Study|Transitioned to Hospice|0|||
164329125|NCT03119701|593581316|FG000|6-day Dosing|Withdrawal by Subject|0|||
164221674|NCT02318277|593180037|FG004|Overall Study|Transitioned to Hospice|0|||
164221675|NCT02318277|593180038|FG005|Overall Study|Transitioned to Hospice|1|||
164221676|NCT02318277|593180039|FG006|Overall Study|Transitioned to Hospice|0|||
164329126|NCT03119701|593581317|FG001|6-day Dosing|Withdrawal by Subject|1|||
164221677|NCT02318277|593180040|FG007|Overall Study|Transitioned to Hospice|0|||
164221678|NCT03566550|593180042|FG000|Overall Study|Withdrawal by Subject|0|||
164221679|NCT03566550|593180043|FG001|Overall Study|Withdrawal by Subject|1|||
164221680|NCT02829957|593180046|FG000|Overall Study|Lost to Follow-up|2|||
164329127|NCT03119701|593581316|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
164221681|NCT02829957|593180047|FG001|Overall Study|Lost to Follow-up|1|||
164221682|NCT03511066|593180048|FG000|Overall Study|Withdrawal by Subject|1|||
164221683|NCT03511066|593180049|FG001|Overall Study|Withdrawal by Subject|2|||
164221684|NCT03511066|593180050|FG002|Overall Study|Withdrawal by Subject|3|||
164221685|NCT03511066|593180048|FG000|Overall Study|Lost to Follow-up|2|||
164221686|NCT03511066|593180049|FG001|Overall Study|Lost to Follow-up|3|||
164221687|NCT03511066|593180050|FG002|Overall Study|Lost to Follow-up|0|||
164221688|NCT03113136|593180055|FG000|Overall Study|Lost to Follow-up|22|||
164221689|NCT03113136|593180056|FG001|Overall Study|Lost to Follow-up|47|||
164221690|NCT03113136|593180057|FG002|Overall Study|Lost to Follow-up|54|||
164221691|NCT03113136|593180055|FG000|Overall Study|Withdrawal by Subject|4|||
164221692|NCT03113136|593180056|FG001|Overall Study|Withdrawal by Subject|13|||
164221693|NCT03113136|593180057|FG002|Overall Study|Withdrawal by Subject|14|||
164221694|NCT03113136|593180055|FG000|Overall Study|Ineligible|0|||
164221695|NCT03113136|593180056|FG001|Overall Study|Ineligible|2|||
164221696|NCT03113136|593180057|FG002|Overall Study|Ineligible|1|||
164221697|NCT03113136|593180055|FG000|Overall Study|Study Team Decision|1|||
164221698|NCT03113136|593180056|FG001|Overall Study|Study Team Decision|4|||
164221699|NCT03113136|593180057|FG002|Overall Study|Study Team Decision|0|||
164221700|NCT02675452|593180059|FG000|Overall Study|Sponsor decision|0|||
164221701|NCT02675452|593180060|FG001|Overall Study|Sponsor decision|0|||
164221702|NCT02675452|593180061|FG002|Overall Study|Sponsor decision|0|||
164221703|NCT02675452|593180062|FG003|Overall Study|Sponsor decision|0|||
164221704|NCT02675452|593180063|FG004|Overall Study|Sponsor decision|0|||
164221705|NCT02675452|593180064|FG005|Overall Study|Sponsor decision|0|||
164221706|NCT02675452|593180065|FG006|Overall Study|Sponsor decision|0|||
164221707|NCT02675452|593180066|FG007|Overall Study|Sponsor decision|0|||
164420924|NCT00219141|593911042|FG001|Overall Study|Administrative problems|1|||
164420925|NCT00219141|593911043|FG002|Overall Study|Administrative problems|0|||
164221708|NCT02675452|593180067|FG008|Overall Study|Sponsor decision|0|||
164221709|NCT02675452|593180068|FG009|Overall Study|Sponsor decision|1|||
164221710|NCT02675452|593180069|FG010|Overall Study|Sponsor decision|0|||
164221711|NCT02675452|593180070|FG011|Overall Study|Sponsor decision|0|||
164221712|NCT02675452|593180071|FG012|Overall Study|Sponsor decision|0|||
164221713|NCT02675452|593180072|FG013|Overall Study|Sponsor decision|2|||
164221714|NCT02675452|593180073|FG014|Overall Study|Sponsor decision|1|||
164221715|NCT02675452|593180074|FG015|Overall Study|Sponsor decision|0|||
164221716|NCT02675452|593180075|FG016|Overall Study|Sponsor decision|1|||
164221717|NCT02675452|593180076|FG017|Overall Study|Sponsor decision|0|||
164221718|NCT02675452|593180077|FG018|Overall Study|Sponsor decision|0|||
164221719|NCT02675452|593180078|FG019|Overall Study|Sponsor decision|0|||
164221720|NCT02675452|593180079|FG020|Overall Study|Sponsor decision|0|||
164221721|NCT02675452|593180080|FG021|Overall Study|Sponsor decision|0|||
164221722|NCT02675452|593180081|FG022|Overall Study|Sponsor decision|0|||
164221723|NCT02675452|593180082|FG023|Overall Study|Sponsor decision|0|||
164221724|NCT02675452|593180083|FG024|Overall Study|Sponsor decision|0|||
164221725|NCT02675452|593180084|FG025|Overall Study|Sponsor decision|0|||
164221726|NCT02675452|593180085|FG026|Overall Study|Sponsor decision|2|||
164221727|NCT02675452|593180086|FG027|Overall Study|Sponsor decision|0|||
164221728|NCT02675452|593180087|FG028|Overall Study|Sponsor decision|0|||
164221729|NCT02675452|593180059|FG000|Overall Study|Withdrawal by Subject|0|||
164221730|NCT02675452|593180060|FG001|Overall Study|Withdrawal by Subject|0|||
164221731|NCT02675452|593180061|FG002|Overall Study|Withdrawal by Subject|0|||
164420926|NCT00219141|593911041|FG000|Overall Study|Lost to Follow-up|2|||
164420927|NCT00219141|593911042|FG001|Overall Study|Lost to Follow-up|4|||
164420928|NCT00219141|593911043|FG002|Overall Study|Lost to Follow-up|1|||
164420929|NCT00219141|593911041|FG000|Overall Study|Protocol Violation|3|||
164420930|NCT00219141|593911042|FG001|Overall Study|Protocol Violation|1|||
164221732|NCT02675452|593180062|FG003|Overall Study|Withdrawal by Subject|0|||
164221733|NCT02675452|593180063|FG004|Overall Study|Withdrawal by Subject|0|||
164221734|NCT02675452|593180064|FG005|Overall Study|Withdrawal by Subject|0|||
164221735|NCT02675452|593180065|FG006|Overall Study|Withdrawal by Subject|0|||
164221736|NCT02675452|593180066|FG007|Overall Study|Withdrawal by Subject|0|||
164221737|NCT02675452|593180067|FG008|Overall Study|Withdrawal by Subject|0|||
164221738|NCT02675452|593180068|FG009|Overall Study|Withdrawal by Subject|1|||
164221739|NCT02675452|593180069|FG010|Overall Study|Withdrawal by Subject|0|||
164670960|NCT05093205|594821320|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
164420931|NCT00219141|593911043|FG002|Overall Study|Protocol Violation|1|||
164420932|NCT00219141|593911041|FG000|Overall Study|Withdrawal by Subject|1|||
164670961|NCT05093205|594821308|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
164221740|NCT02675452|593180070|FG011|Overall Study|Withdrawal by Subject|1|||
164221741|NCT02675452|593180071|FG012|Overall Study|Withdrawal by Subject|0|||
164221742|NCT02675452|593180072|FG013|Overall Study|Withdrawal by Subject|1|||
164221743|NCT02675452|593180073|FG014|Overall Study|Withdrawal by Subject|1|||
164221744|NCT02675452|593180074|FG015|Overall Study|Withdrawal by Subject|0|||
164221745|NCT02675452|593180075|FG016|Overall Study|Withdrawal by Subject|2|||
164221746|NCT02675452|593180076|FG017|Overall Study|Withdrawal by Subject|0|||
164221747|NCT02675452|593180077|FG018|Overall Study|Withdrawal by Subject|0|||
164221748|NCT02675452|593180078|FG019|Overall Study|Withdrawal by Subject|0|||
164221749|NCT02675452|593180079|FG020|Overall Study|Withdrawal by Subject|0|||
164670962|NCT05093205|594821309|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
164221750|NCT02675452|593180080|FG021|Overall Study|Withdrawal by Subject|0|||
164221751|NCT02675452|593180081|FG022|Overall Study|Withdrawal by Subject|3|||
164221752|NCT02675452|593180082|FG023|Overall Study|Withdrawal by Subject|0|||
164221753|NCT02675452|593180083|FG024|Overall Study|Withdrawal by Subject|1|||
164221754|NCT02675452|593180084|FG025|Overall Study|Withdrawal by Subject|0|||
164221755|NCT02675452|593180085|FG026|Overall Study|Withdrawal by Subject|1|||
164221756|NCT02675452|593180086|FG027|Overall Study|Withdrawal by Subject|3|||
164221757|NCT02675452|593180087|FG028|Overall Study|Withdrawal by Subject|4|||
164221758|NCT02675452|593180059|FG000|Overall Study|Death|0|||
164221759|NCT02675452|593180060|FG001|Overall Study|Death|0|||
164221760|NCT02675452|593180061|FG002|Overall Study|Death|1|||
164221761|NCT02675452|593180062|FG003|Overall Study|Death|0|||
164221762|NCT02675452|593180063|FG004|Overall Study|Death|0|||
164221763|NCT02675452|593180064|FG005|Overall Study|Death|1|||
164221764|NCT02675452|593180065|FG006|Overall Study|Death|0|||
164221765|NCT02675452|593180066|FG007|Overall Study|Death|0|||
164221766|NCT02675452|593180067|FG008|Overall Study|Death|1|||
164221767|NCT02675452|593180068|FG009|Overall Study|Death|0|||
164221768|NCT02675452|593180069|FG010|Overall Study|Death|0|||
164221769|NCT02675452|593180070|FG011|Overall Study|Death|0|||
164221770|NCT02675452|593180071|FG012|Overall Study|Death|1|||
164221771|NCT02675452|593180072|FG013|Overall Study|Death|0|||
164221772|NCT02675452|593180073|FG014|Overall Study|Death|0|||
164221773|NCT02675452|593180074|FG015|Overall Study|Death|2|||
164221774|NCT02675452|593180075|FG016|Overall Study|Death|0|||
164221775|NCT02675452|593180076|FG017|Overall Study|Death|0|||
164221776|NCT02675452|593180077|FG018|Overall Study|Death|4|||
164221777|NCT02675452|593180078|FG019|Overall Study|Death|3|||
164221778|NCT02675452|593180079|FG020|Overall Study|Death|3|||
164221779|NCT02675452|593180080|FG021|Overall Study|Death|3|||
164221780|NCT02675452|593180081|FG022|Overall Study|Death|7|||
164221781|NCT02675452|593180082|FG023|Overall Study|Death|5|||
164221782|NCT02675452|593180083|FG024|Overall Study|Death|3|||
164221783|NCT02675452|593180084|FG025|Overall Study|Death|4|||
164221784|NCT02675452|593180085|FG026|Overall Study|Death|7|||
164221785|NCT02675452|593180086|FG027|Overall Study|Death|6|||
164221786|NCT02675452|593180087|FG028|Overall Study|Death|9|||
164221787|NCT02675452|593180059|FG000|Overall Study|Lost to Follow-up|0|||
164221788|NCT02675452|593180060|FG001|Overall Study|Lost to Follow-up|1|||
164221789|NCT02675452|593180061|FG002|Overall Study|Lost to Follow-up|0|||
164221790|NCT02675452|593180062|FG003|Overall Study|Lost to Follow-up|0|||
164221791|NCT02675452|593180063|FG004|Overall Study|Lost to Follow-up|0|||
164221792|NCT02675452|593180064|FG005|Overall Study|Lost to Follow-up|0|||
164221793|NCT02675452|593180065|FG006|Overall Study|Lost to Follow-up|0|||
164221794|NCT02675452|593180066|FG007|Overall Study|Lost to Follow-up|0|||
164221795|NCT02675452|593180067|FG008|Overall Study|Lost to Follow-up|0|||
164221796|NCT02675452|593180068|FG009|Overall Study|Lost to Follow-up|0|||
164221797|NCT02675452|593180069|FG010|Overall Study|Lost to Follow-up|0|||
164221798|NCT02675452|593180070|FG011|Overall Study|Lost to Follow-up|0|||
164221799|NCT02675452|593180071|FG012|Overall Study|Lost to Follow-up|1|||
164567796|NCT00348140|594447289|FG000|Overall Study|Participant at risk due to study drug|2|||
164567797|NCT00348140|594447290|FG001|Overall Study|Participant at risk due to study drug|0|||
164567798|NCT00348140|594447291|FG002|Overall Study|Participant at risk due to study drug|0|||
164567799|NCT00348140|594447289|FG000|Overall Study|Conditional medication increased dose|1|||
164567800|NCT00348140|594447290|FG001|Overall Study|Conditional medication increased dose|0|||
164567801|NCT00348140|594447291|FG002|Overall Study|Conditional medication increased dose|0|||
164567802|NCT00348140|594447289|FG000|Overall Study|Caregiver related|4|||
164567803|NCT00348140|594447290|FG001|Overall Study|Caregiver related|7|||
164221800|NCT02675452|593180072|FG013|Overall Study|Lost to Follow-up|0|||
164221801|NCT02675452|593180073|FG014|Overall Study|Lost to Follow-up|0|||
164221802|NCT02675452|593180074|FG015|Overall Study|Lost to Follow-up|0|||
164221803|NCT02675452|593180075|FG016|Overall Study|Lost to Follow-up|0|||
164221804|NCT02675452|593180076|FG017|Overall Study|Lost to Follow-up|0|||
164221805|NCT02675452|593180077|FG018|Overall Study|Lost to Follow-up|0|||
164221806|NCT02675452|593180078|FG019|Overall Study|Lost to Follow-up|0|||
164221807|NCT02675452|593180079|FG020|Overall Study|Lost to Follow-up|0|||
164567804|NCT00348140|594447291|FG002|Overall Study|Caregiver related|3|||
164221808|NCT02675452|593180080|FG021|Overall Study|Lost to Follow-up|0|||
164221809|NCT02675452|593180081|FG022|Overall Study|Lost to Follow-up|0|||
164221810|NCT02675452|593180082|FG023|Overall Study|Lost to Follow-up|0|||
164221811|NCT02675452|593180083|FG024|Overall Study|Lost to Follow-up|0|||
164221812|NCT02675452|593180084|FG025|Overall Study|Lost to Follow-up|0|||
164221813|NCT02675452|593180085|FG026|Overall Study|Lost to Follow-up|1|||
164221814|NCT02675452|593180086|FG027|Overall Study|Lost to Follow-up|0|||
164567805|NCT00348140|594447289|FG000|Overall Study|Participant hospitalised|3|||
164221815|NCT02675452|593180087|FG028|Overall Study|Lost to Follow-up|0|||
164221816|NCT02675452|593180059|FG000|Overall Study|Other|0|||
164221817|NCT02675452|593180060|FG001|Overall Study|Other|0|||
164221818|NCT02675452|593180061|FG002|Overall Study|Other|0|||
164221819|NCT02675452|593180062|FG003|Overall Study|Other|0|||
164221820|NCT02675452|593180063|FG004|Overall Study|Other|0|||
164221821|NCT02675452|593180064|FG005|Overall Study|Other|0|||
164221822|NCT02675452|593180065|FG006|Overall Study|Other|0|||
164221823|NCT02675452|593180066|FG007|Overall Study|Other|0|||
164221824|NCT02675452|593180067|FG008|Overall Study|Other|0|||
164221825|NCT02675452|593180068|FG009|Overall Study|Other|0|||
164221826|NCT02675452|593180069|FG010|Overall Study|Other|0|||
164221827|NCT02675452|593180070|FG011|Overall Study|Other|0|||
164221828|NCT02675452|593180071|FG012|Overall Study|Other|0|||
164221829|NCT02675452|593180072|FG013|Overall Study|Other|0|||
164221830|NCT02675452|593180073|FG014|Overall Study|Other|0|||
164221831|NCT02675452|593180074|FG015|Overall Study|Other|0|||
164221832|NCT02675452|593180075|FG016|Overall Study|Other|0|||
164221833|NCT02675452|593180076|FG017|Overall Study|Other|0|||
164221834|NCT02675452|593180077|FG018|Overall Study|Other|0|||
164221835|NCT02675452|593180078|FG019|Overall Study|Other|0|||
164221836|NCT02675452|593180079|FG020|Overall Study|Other|0|||
164221837|NCT02675452|593180080|FG021|Overall Study|Other|0|||
164221838|NCT02675452|593180081|FG022|Overall Study|Other|0|||
164221839|NCT02675452|593180082|FG023|Overall Study|Other|0|||
164221840|NCT02675452|593180083|FG024|Overall Study|Other|0|||
164221841|NCT02675452|593180084|FG025|Overall Study|Other|0|||
164221842|NCT02675452|593180085|FG026|Overall Study|Other|1|||
164221843|NCT02675452|593180086|FG027|Overall Study|Other|0|||
164221844|NCT02675452|593180087|FG028|Overall Study|Other|0|||
164221845|NCT03467945|593180088|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164221846|NCT03467945|593180089|FG001|Treatment Period 2|Withdrawal by Subject|1|||
164221847|NCT03467945|593180090|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164221848|NCT03467945|593180091|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164221849|NCT03467945|593180088|FG000|Treatment Period 3|Withdrawal by Subject|1|||
164221850|NCT03467945|593180089|FG001|Treatment Period 3|Withdrawal by Subject|0|||
164221851|NCT03467945|593180090|FG002|Treatment Period 3|Withdrawal by Subject|2|||
164221852|NCT03467945|593180091|FG003|Treatment Period 3|Withdrawal by Subject|1|||
164221853|NCT00977561|593180092|FG000|Overall Study|Death|3|||
164221854|NCT00977561|593180093|FG001|Overall Study|Death|2|||
164221855|NCT00977561|593180092|FG000|Overall Study|Study terminated|0|||
164221856|NCT00977561|593180093|FG001|Overall Study|Study terminated|2|||
164221857|NCT00977561|593180092|FG000|Overall Study|Other|2|||
164221858|NCT00977561|593180093|FG001|Overall Study|Other|0|||
164221859|NCT02218268|593180094|FG000|24 Hour Washout|Physician Decision|11|||
164221860|NCT02218268|593180095|FG001|24 Hour Washout|Physician Decision|9|||
164221861|NCT03651336|593180096|FG000|Overall Study|Withdrawal by Subject|4|||
164221862|NCT01341990|593180097|FG000|Overall Study|Adverse Event|0|||
164221863|NCT01341990|593180098|FG001|Overall Study|Adverse Event|1|||
164221864|NCT01341990|593180097|FG000|Overall Study|Torn Study Lens|1|||
164221865|NCT01341990|593180098|FG001|Overall Study|Torn Study Lens|0|||
164221866|NCT01341990|593180097|FG000|Overall Study|Withdrawal by Subject|2|||
164221867|NCT01341990|593180098|FG001|Overall Study|Withdrawal by Subject|0|||
164221868|NCT01125748|593180100|FG000|Overall Study|Adverse Event|0|||
164221869|NCT01125748|593180101|FG001|Overall Study|Adverse Event|2|||
164221870|NCT01125748|593180100|FG000|Overall Study|Lost to Follow-up|0|||
164221871|NCT01125748|593180101|FG001|Overall Study|Lost to Follow-up|1|||
164221872|NCT01125748|593180100|FG000|Overall Study|Physician Decision|8|||
164221873|NCT01125748|593180101|FG001|Overall Study|Physician Decision|7|||
164221874|NCT01125748|593180100|FG000|Overall Study|Patient Decision to Withdraw|2|||
164221875|NCT01125748|593180101|FG001|Overall Study|Patient Decision to Withdraw|4|||
164221876|NCT01028391|593180102|FG000|Overall Study|Adverse Event|4|||
164221877|NCT01028391|593180103|FG001|Overall Study|Adverse Event|0|||
164221878|NCT01028391|593180102|FG000|Overall Study|Lack of Efficacy|0|||
164221879|NCT01028391|593180103|FG001|Overall Study|Lack of Efficacy|2|||
164221880|NCT01028391|593180102|FG000|Overall Study|Lost to Follow-up|3|||
164221881|NCT01028391|593180103|FG001|Overall Study|Lost to Follow-up|4|||
164221882|NCT01028391|593180102|FG000|Overall Study|Physician Decision|0|||
164221883|NCT01028391|593180103|FG001|Overall Study|Physician Decision|1|||
164221884|NCT01028391|593180102|FG000|Overall Study|Withdrawal by Subject|6|||
164221885|NCT01028391|593180103|FG001|Overall Study|Withdrawal by Subject|3|||
164221886|NCT01028391|593180102|FG000|Overall Study|Needed excluded medication|1|||
164221887|NCT01028391|593180103|FG001|Overall Study|Needed excluded medication|1|||
164221888|NCT00694161|593180104|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
164221889|NCT00694161|593180104|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
164221890|NCT00694161|593180104|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
164221891|NCT00837330|593180105|FG000|Overall Study|Lost to Follow-up|1|||
164221892|NCT00837330|593180106|FG001|Overall Study|Lost to Follow-up|3|||
164221893|NCT01227395|593180107|FG000|Overall Study|Protocol Violation|0|||
164221894|NCT01227395|593180108|FG001|Overall Study|Protocol Violation|1|||
164221895|NCT02774278|593180109|FG000|Overall Study|Lack of Efficacy|199|||
164221896|NCT02774278|593180109|FG000|Overall Study|Death|29|||
164221897|NCT02774278|593180109|FG000|Overall Study|Adverse event/intercurrent illness|16|||
164221898|NCT02774278|593180109|FG000|Overall Study|Refused treatment/did not cooperate|9|||
164221899|NCT02774278|593180109|FG000|Overall Study|Administrative reasons|6|||
164221900|NCT02774278|593180109|FG000|Overall Study|Withdrawal by Subject|3|||
164221901|NCT02774278|593180109|FG000|Overall Study|Protocol Violation|2|||
164420933|NCT00219141|593911042|FG001|Overall Study|Withdrawal by Subject|3|||
164420934|NCT00219141|593911043|FG002|Overall Study|Withdrawal by Subject|5|||
164420935|NCT00219141|593911041|FG000|Overall Study|Condition no longer requires study drug|1|||
164221902|NCT00694122|593180112|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
164221903|NCT00694122|593180113|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
164221904|NCT00694122|593180112|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
164420936|NCT00219141|593911042|FG001|Overall Study|Condition no longer requires study drug|0|||
164420937|NCT00219141|593911043|FG002|Overall Study|Condition no longer requires study drug|0|||
164420938|NCT03018106|593911044|FG000|Overall Study|Lost to Follow-up|0|||
164420939|NCT03018106|593911045|FG001|Overall Study|Lost to Follow-up|1|||
164420940|NCT00972179|593911046|FG000|Overall Study|Noncompliance|1|||
164420941|NCT00972179|593911047|FG001|Overall Study|Noncompliance|0|||
164420942|NCT00972179|593911048|FG002|Overall Study|Noncompliance|0|||
164420943|NCT00972179|593911049|FG003|Overall Study|Noncompliance|0|||
164420944|NCT00972179|593911050|FG004|Overall Study|Noncompliance|1|||
164420945|NCT00972179|593911051|FG005|Overall Study|Noncompliance|0|||
164420946|NCT00972179|593911052|FG006|Overall Study|Noncompliance|1|||
164420947|NCT00972179|593911046|FG000|Overall Study|Withdrawal by Subject|0|||
164420948|NCT00972179|593911047|FG001|Overall Study|Withdrawal by Subject|3|||
164420949|NCT00972179|593911048|FG002|Overall Study|Withdrawal by Subject|0|||
164420950|NCT00972179|593911049|FG003|Overall Study|Withdrawal by Subject|1|||
164420951|NCT00972179|593911050|FG004|Overall Study|Withdrawal by Subject|0|||
164420952|NCT00972179|593911051|FG005|Overall Study|Withdrawal by Subject|0|||
164420953|NCT00972179|593911052|FG006|Overall Study|Withdrawal by Subject|2|||
164420954|NCT00972179|593911046|FG000|Overall Study|Administrative Decision|0|||
164420955|NCT00972179|593911047|FG001|Overall Study|Administrative Decision|0|||
164420956|NCT00972179|593911048|FG002|Overall Study|Administrative Decision|0|||
164420957|NCT00972179|593911049|FG003|Overall Study|Administrative Decision|0|||
164420958|NCT00972179|593911050|FG004|Overall Study|Administrative Decision|1|||
164420959|NCT00972179|593911051|FG005|Overall Study|Administrative Decision|0|||
164420960|NCT00972179|593911052|FG006|Overall Study|Administrative Decision|0|||
164420961|NCT00972179|593911046|FG000|Overall Study|Lost to Follow-up|0|||
164420962|NCT00972179|593911047|FG001|Overall Study|Lost to Follow-up|0|||
164420963|NCT00972179|593911048|FG002|Overall Study|Lost to Follow-up|1|||
164420964|NCT00972179|593911049|FG003|Overall Study|Lost to Follow-up|0|||
164420965|NCT00972179|593911050|FG004|Overall Study|Lost to Follow-up|0|||
164420966|NCT00972179|593911051|FG005|Overall Study|Lost to Follow-up|3|||
164420967|NCT00972179|593911052|FG006|Overall Study|Lost to Follow-up|1|||
164420968|NCT00136916|593911053|FG000|Overall Study|Never received study treatment|3|||
164420969|NCT00136916|593911054|FG001|Overall Study|Never received study treatment|5|||
164420970|NCT00136916|593911053|FG000|Overall Study|Death|1|||
164420971|NCT00136916|593911054|FG001|Overall Study|Death|3|||
164420972|NCT00136916|593911053|FG000|Overall Study|Adverse Event|27|||
164420973|NCT00136916|593911054|FG001|Overall Study|Adverse Event|8|||
164420974|NCT00136916|593911053|FG000|Overall Study|Laboratory abnormality|0|||
164420975|NCT00136916|593911054|FG001|Overall Study|Laboratory abnormality|1|||
164420976|NCT00136916|593911053|FG000|Overall Study|Lack of Efficacy|13|||
164420977|NCT00136916|593911054|FG001|Overall Study|Lack of Efficacy|3|||
164420978|NCT00136916|593911053|FG000|Overall Study|Lost to Follow-up|12|||
164420979|NCT00136916|593911054|FG001|Overall Study|Lost to Follow-up|14|||
164420980|NCT00136916|593911053|FG000|Overall Study|Withdrawal by Subject|44|||
164420981|NCT00136916|593911054|FG001|Overall Study|Withdrawal by Subject|46|||
164420982|NCT00136916|593911053|FG000|Overall Study|Other|22|||
164420983|NCT00136916|593911054|FG001|Overall Study|Other|24|||
164420984|NCT00136916|593911053|FG000|Overall Study|Discontinued in follow up period|3|||
164420985|NCT00136916|593911054|FG001|Overall Study|Discontinued in follow up period|0|||
164420986|NCT01994720|593911055|FG000|Overall Study|Withdrawal by Subject|46|||
164420987|NCT01994720|593911056|FG001|Overall Study|Withdrawal by Subject|56|||
164420988|NCT01010217|593911058|FG000|Overall Study|Lost to Follow-up|4|||
164420989|NCT01010217|593911059|FG001|Overall Study|Lost to Follow-up|5|||
164420990|NCT01010217|593911060|FG002|Overall Study|Lost to Follow-up|1|||
164420991|NCT01010217|593911061|FG003|Overall Study|Lost to Follow-up|0|||
164420992|NCT01010217|593911062|FG004|Overall Study|Lost to Follow-up|0|||
164420993|NCT01010217|593911058|FG000|Overall Study|Withdrawal by Subject|1|||
164420994|NCT01010217|593911059|FG001|Overall Study|Withdrawal by Subject|0|||
164420995|NCT01010217|593911060|FG002|Overall Study|Withdrawal by Subject|0|||
164420996|NCT01010217|593911061|FG003|Overall Study|Withdrawal by Subject|0|||
164420997|NCT01010217|593911062|FG004|Overall Study|Withdrawal by Subject|0|||
164420998|NCT01010217|593911058|FG000|Overall Study|Physician Decision|0|||
164420999|NCT01010217|593911059|FG001|Overall Study|Physician Decision|0|||
164421000|NCT01010217|593911060|FG002|Overall Study|Physician Decision|0|||
164421001|NCT01010217|593911061|FG003|Overall Study|Physician Decision|6|||
164421002|NCT01010217|593911062|FG004|Overall Study|Physician Decision|3|||
164421003|NCT00577720|593911063|FG000|Overall Study|Adverse Event|2|||
164221905|NCT00694122|593180113|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
164421004|NCT00577720|593911064|FG001|Overall Study|Adverse Event|1|||
164221906|NCT00694122|593180112|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
164221907|NCT00694122|593180113|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
164221908|NCT00105508|593180114|FG000|Overall Study|Prephase Dropout|1|||
164221909|NCT00105508|593180115|FG001|Overall Study|Prephase Dropout|0|||
164221910|NCT00105508|593180114|FG000|Overall Study|Adverse Event|16|||
164221911|NCT00105508|593180115|FG001|Overall Study|Adverse Event|19|||
164221912|NCT00105508|593180114|FG000|Overall Study|Insufficient Efficacy|1|||
164221913|NCT00105508|593180115|FG001|Overall Study|Insufficient Efficacy|0|||
164221914|NCT00105508|593180114|FG000|Overall Study|Withdrawal by Subject|10|||
164221915|NCT00105508|593180115|FG001|Overall Study|Withdrawal by Subject|6|||
164221916|NCT00105508|593180114|FG000|Overall Study|Lost to Follow-up|3|||
164221917|NCT00105508|593180115|FG001|Overall Study|Lost to Follow-up|0|||
164221918|NCT00105508|593180114|FG000|Overall Study|Protocol Violation|1|||
164221919|NCT00105508|593180115|FG001|Overall Study|Protocol Violation|2|||
164221920|NCT00105508|593180114|FG000|Overall Study|Other|8|||
164221921|NCT00105508|593180115|FG001|Overall Study|Other|9|||
164221922|NCT00683384|593180116|FG000|Overall Study|Death|1|||
164221923|NCT00683384|593180116|FG000|Overall Study|Adverse Event|1|||
164221924|NCT03632720|593180120|FG000|Overall Study|Adverse Event|2|||
164221925|NCT03632720|593180121|FG001|Overall Study|Adverse Event|0|||
164221926|NCT03632720|593180122|FG002|Overall Study|Adverse Event|0|||
164221927|NCT03632720|593180120|FG000|Overall Study|Lost to Follow-up|0|||
164221928|NCT03632720|593180121|FG001|Overall Study|Lost to Follow-up|1|||
164221929|NCT03632720|593180122|FG002|Overall Study|Lost to Follow-up|0|||
164221930|NCT03632720|593180120|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
164221931|NCT03632720|593180121|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
164221932|NCT03632720|593180122|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
164221933|NCT03632720|593180120|FG000|Overall Study|Screen failure|0|||
164221934|NCT03632720|593180121|FG001|Overall Study|Screen failure|1|||
164221935|NCT03632720|593180122|FG002|Overall Study|Screen failure|0|||
164221936|NCT01049828|593180125|FG000|Overall Study|Claustrophibia and Frustration|2|||
164221937|NCT00290238|593180126|FG000|Overall Study|Study terminated|27|||
164221938|NCT00290238|593180127|FG001|Overall Study|Study terminated|27|||
164221939|NCT00290238|593180126|FG000|Overall Study|Lost to Follow-up|0|||
164221940|NCT00290238|593180127|FG001|Overall Study|Lost to Follow-up|1|||
164221941|NCT00290238|593180126|FG000|Overall Study|Withdrawal by Subject|15|||
164221942|NCT00290238|593180127|FG001|Overall Study|Withdrawal by Subject|13|||
164221943|NCT01179399|593180128|FG000|Overall Study|Adverse Event|1|||
164221944|NCT01179399|593180128|FG000|Overall Study|Lack of Efficacy|30|||
164221945|NCT01179399|593180128|FG000|Overall Study|Withdrawal by Subject|1|||
164221946|NCT03738215|593180129|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
164221947|NCT03738215|593180130|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
164221948|NCT03738215|593180131|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
164421005|NCT00577720|593911065|FG002|Overall Study|Adverse Event|0|||
164421006|NCT00577720|593911066|FG003|Overall Study|Adverse Event|4|||
164421007|NCT00577720|593911063|FG000|Overall Study|Lost to Follow-up|0|||
164421008|NCT00577720|593911064|FG001|Overall Study|Lost to Follow-up|0|||
164421009|NCT00577720|593911065|FG002|Overall Study|Lost to Follow-up|1|||
164421010|NCT00577720|593911066|FG003|Overall Study|Lost to Follow-up|0|||
164421011|NCT00577720|593911063|FG000|Overall Study|Protocol Violation|0|||
164421012|NCT00577720|593911064|FG001|Overall Study|Protocol Violation|0|||
164421013|NCT00577720|593911065|FG002|Overall Study|Protocol Violation|0|||
164421014|NCT00577720|593911066|FG003|Overall Study|Protocol Violation|1|||
164421015|NCT00577720|593911063|FG000|Overall Study|Withdrawal by Subject|2|||
164421016|NCT00577720|593911064|FG001|Overall Study|Withdrawal by Subject|0|||
164421017|NCT00577720|593911065|FG002|Overall Study|Withdrawal by Subject|0|||
164421018|NCT00577720|593911066|FG003|Overall Study|Withdrawal by Subject|2|||
164421019|NCT05868954|593911072|FG000|Overall Study|Lost to Follow-up|0|||
164421020|NCT05868954|593911073|FG001|Overall Study|Lost to Follow-up|1|||
164421021|NCT05868954|593911072|FG000|Overall Study|Withdrawal by Subject|2|||
164221949|NCT03738215|593180129|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
164421022|NCT05868954|593911073|FG001|Overall Study|Withdrawal by Subject|2|||
164421023|NCT05868954|593911072|FG000|Overall Study|Participant delivered|1|||
164221950|NCT03738215|593180130|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
164221951|NCT03738215|593180131|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
164421024|NCT05868954|593911073|FG001|Overall Study|Participant delivered|1|||
164221952|NCT03738215|593180129|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
164221953|NCT03738215|593180130|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
164221954|NCT03738215|593180131|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
164221955|NCT03738215|593180129|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
164421025|NCT05868954|593911072|FG000|Overall Study|Miscarriage|0|||
164421026|NCT05868954|593911073|FG001|Overall Study|Miscarriage|1|||
164421027|NCT01680458|593911083|FG000|Overall Study|Protocol Violation|3|||
164421028|NCT02138747|593911084|FG000|Treatment Period 1|Adverse Event|10|||
164421029|NCT02138747|593911085|FG001|Treatment Period 1|Adverse Event|14|||
164421030|NCT02138747|593911086|FG002|Treatment Period 1|Adverse Event|2|||
164567806|NCT00348140|594447290|FG001|Overall Study|Participant hospitalised|0|||
164567807|NCT00348140|594447291|FG002|Overall Study|Participant hospitalised|0|||
164567808|NCT00348140|594447289|FG000|Overall Study|Efficacy related|1|||
164567809|NCT00348140|594447290|FG001|Overall Study|Efficacy related|1|||
164567810|NCT00348140|594447291|FG002|Overall Study|Efficacy related|0|||
164567811|NCT00348140|594447289|FG000|Overall Study|Administration related|3|||
164567812|NCT00348140|594447290|FG001|Overall Study|Administration related|1|||
164567813|NCT00348140|594447291|FG002|Overall Study|Administration related|1|||
164567814|NCT00348140|594447289|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
164567815|NCT00348140|594447290|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
164567816|NCT00348140|594447291|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
164567817|NCT00348140|594447289|FG000|Overall Study|Participant unwell|1|||
164567818|NCT00348140|594447290|FG001|Overall Study|Participant unwell|0|||
164670963|NCT05093205|594821310|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
164670964|NCT05093205|594821311|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
164670965|NCT05093205|594821312|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
164670966|NCT05093205|594821313|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
164670967|NCT05093205|594821314|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
164670968|NCT05093205|594821315|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
164670969|NCT05093205|594821316|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
164670970|NCT05093205|594821317|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
164670971|NCT05093205|594821318|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
164670972|NCT05093205|594821319|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
164670973|NCT05093205|594821320|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
164670974|NCT05093205|594821308|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
164670975|NCT05093205|594821309|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
164670976|NCT05093205|594821310|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
164670977|NCT05093205|594821311|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
164670978|NCT05093205|594821312|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
164670979|NCT05093205|594821313|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
164670980|NCT05093205|594821314|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
164670981|NCT05093205|594821315|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
164670982|NCT05093205|594821316|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
164670983|NCT05093205|594821317|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
164670984|NCT05093205|594821318|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
164670985|NCT05093205|594821319|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
164670986|NCT05093205|594821320|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
164670987|NCT00268905|594821328|FG000|Overall Study|Adverse Event|3|||
164670988|NCT00268905|594821329|FG001|Overall Study|Adverse Event|0|||
164670989|NCT00268905|594821330|FG002|Overall Study|Adverse Event|4|||
164670990|NCT00268905|594821328|FG000|Overall Study|Lost to Follow-up|0|||
164670991|NCT00268905|594821329|FG001|Overall Study|Lost to Follow-up|1|||
164670992|NCT00268905|594821330|FG002|Overall Study|Lost to Follow-up|0|||
164670993|NCT00268905|594821328|FG000|Overall Study|Withdrawal by Subject|0|||
164670994|NCT00268905|594821329|FG001|Overall Study|Withdrawal by Subject|0|||
164670995|NCT00268905|594821330|FG002|Overall Study|Withdrawal by Subject|3|||
164670996|NCT00268905|594821328|FG000|Overall Study|Progressive Disease|28|||
164670997|NCT00268905|594821329|FG001|Overall Study|Progressive Disease|4|||
164670998|NCT00268905|594821330|FG002|Overall Study|Progressive Disease|3|||
164670999|NCT00268905|594821328|FG000|Overall Study|Physician Decision|3|||
164671000|NCT00268905|594821329|FG001|Overall Study|Physician Decision|0|||
164671001|NCT00268905|594821330|FG002|Overall Study|Physician Decision|1|||
164671002|NCT00268905|594821328|FG000|Overall Study|Clinical Progression|9|||
164671003|NCT00268905|594821329|FG001|Overall Study|Clinical Progression|4|||
164671004|NCT00268905|594821330|FG002|Overall Study|Clinical Progression|1|||
164671005|NCT04510285|594821331|FG000|Overall Study|Death|1|||
164671006|NCT00870870|594821332|FG000|Overall Study|Withdrawal by Subject|0|||
164567819|NCT00348140|594447291|FG002|Overall Study|Participant unwell|0|||
164567820|NCT00348140|594447289|FG000|Overall Study|Screen failure|1|||
164567821|NCT00348140|594447290|FG001|Overall Study|Screen failure|0|||
164567822|NCT00348140|594447291|FG002|Overall Study|Screen failure|0|||
164567823|NCT00348140|594447289|FG000|Overall Study|Investigator decided to discontinue|4|||
164567824|NCT00348140|594447290|FG001|Overall Study|Investigator decided to discontinue|1|||
164567825|NCT00348140|594447291|FG002|Overall Study|Investigator decided to discontinue|4|||
164567826|NCT00348140|594447289|FG000|Overall Study|Decided to discontinue on their own|1|||
164567827|NCT00348140|594447290|FG001|Overall Study|Decided to discontinue on their own|4|||
164567828|NCT00348140|594447291|FG002|Overall Study|Decided to discontinue on their own|1|||
164567829|NCT00348140|594447289|FG000|Overall Study|Use of prohibited drug|1|||
164567830|NCT00348140|594447290|FG001|Overall Study|Use of prohibited drug|0|||
164567831|NCT00348140|594447291|FG002|Overall Study|Use of prohibited drug|2|||
164567832|NCT00348140|594447289|FG000|Overall Study|Disease progression|1|||
164567833|NCT00348140|594447290|FG001|Overall Study|Disease progression|2|||
164567834|NCT00348140|594447291|FG002|Overall Study|Disease progression|5|||
164567835|NCT00348140|594447289|FG000|Overall Study|Increased risk of cardiac infarction|0|||
164567836|NCT00348140|594447290|FG001|Overall Study|Increased risk of cardiac infarction|1|||
164567837|NCT00348140|594447291|FG002|Overall Study|Increased risk of cardiac infarction|0|||
164567838|NCT00348140|594447289|FG000|Overall Study|Serious adverse event|0|||
164567839|NCT00348140|594447290|FG001|Overall Study|Serious adverse event|1|||
164567840|NCT00348140|594447291|FG002|Overall Study|Serious adverse event|0|||
164567841|NCT00348140|594447289|FG000|Overall Study|Abnormal ECG|0|||
164567842|NCT00348140|594447290|FG001|Overall Study|Abnormal ECG|1|||
164567843|NCT00348140|594447291|FG002|Overall Study|Abnormal ECG|3|||
164567844|NCT00348140|594447289|FG000|Overall Study|Participant died|0|||
164567845|NCT00348140|594447290|FG001|Overall Study|Participant died|1|||
164567846|NCT00348140|594447291|FG002|Overall Study|Participant died|0|||
164567847|NCT00348140|594447289|FG000|Overall Study|Exclusion criteria met|0|||
164671007|NCT00870870|594821333|FG001|Overall Study|Withdrawal by Subject|1|||
164671008|NCT00870870|594821334|FG002|Overall Study|Withdrawal by Subject|1|||
164221956|NCT03738215|593180130|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
164221957|NCT03738215|593180131|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
164221958|NCT03738215|593180129|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
164221959|NCT03738215|593180130|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
164221960|NCT03738215|593180131|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
164221961|NCT03738215|593180129|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
164221962|NCT03738215|593180130|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
164221963|NCT03738215|593180131|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
164221964|NCT03738215|593180129|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
164221965|NCT03738215|593180130|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
164221966|NCT03738215|593180131|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
164221967|NCT03738215|593180129|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
164221968|NCT03738215|593180130|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
164221969|NCT03738215|593180131|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
164221970|NCT03738215|593180129|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
164221971|NCT03738215|593180130|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
164221972|NCT03738215|593180131|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
164221973|NCT03738215|593180129|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
164221974|NCT03738215|593180130|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
164221975|NCT03738215|593180131|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
164221976|NCT00394472|593181716|FG000|Overall Study|Protocol Violation|1|||
164221977|NCT00394472|593181717|FG001|Overall Study|Protocol Violation|3|||
164221978|NCT00394472|593181716|FG000|Overall Study|incorrect enrolment|4|||
164221979|NCT00394472|593181717|FG001|Overall Study|incorrect enrolment|2|||
164221980|NCT00394472|593181716|FG000|Overall Study|Adverse Event|4|||
164221981|NCT00394472|593181717|FG001|Overall Study|Adverse Event|2|||
164671009|NCT00870870|594821335|FG003|Overall Study|Withdrawal by Subject|3|||
164671010|NCT00870870|594821332|FG000|Overall Study|Adverse Event|0|||
164671011|NCT00870870|594821333|FG001|Overall Study|Adverse Event|0|||
164671012|NCT00870870|594821334|FG002|Overall Study|Adverse Event|2|||
164671013|NCT00870870|594821335|FG003|Overall Study|Adverse Event|2|||
164671014|NCT01406795|594821336|FG000|Overall Study|Withdrawal by Subject|1|||
164671015|NCT00822926|594821339|FG000|Second Injection Visit|Lost to Follow-up|1|||
164671016|NCT00822926|594821340|FG001|Second Injection Visit|Lost to Follow-up|0|||
164671017|NCT00822926|594821339|FG000|Second Injection Visit|Withdrawal by Subject|0|||
164671018|NCT00822926|594821340|FG001|Second Injection Visit|Withdrawal by Subject|1|||
164671019|NCT03897088|594821341|FG000|Overall Study|Withdrawal by Subject|12|||
164671020|NCT03897088|594821342|FG001|Overall Study|Withdrawal by Subject|12|||
164671021|NCT03897088|594821341|FG000|Overall Study|Lost to Follow-up|7|||
164671022|NCT03897088|594821342|FG001|Overall Study|Lost to Follow-up|15|||
164671023|NCT03897088|594821341|FG000|Overall Study|Sponsor Decision|1|||
164671024|NCT03897088|594821342|FG001|Overall Study|Sponsor Decision|2|||
164671025|NCT03897088|594821341|FG000|Overall Study|COVID-19|2|||
164671026|NCT03897088|594821342|FG001|Overall Study|COVID-19|0|||
164671027|NCT03897088|594821341|FG000|Overall Study|Other|3|||
164671028|NCT03897088|594821342|FG001|Overall Study|Other|0|||
164671029|NCT03897088|594821341|FG000|Overall Study|Non-compliance with Study Drug|1|||
164221982|NCT00394472|593181716|FG000|Overall Study|Withdrawal by Subject|0|||
164221983|NCT00394472|593181717|FG001|Overall Study|Withdrawal by Subject|2|||
164221984|NCT00394472|593181716|FG000|Overall Study|Physician Decision|0|||
164221985|NCT00394472|593181717|FG001|Overall Study|Physician Decision|1|||
164221986|NCT00394472|593181716|FG000|Overall Study|Lost to Follow-up|0|||
164567848|NCT00348140|594447290|FG001|Overall Study|Exclusion criteria met|0|||
164567849|NCT00348140|594447291|FG002|Overall Study|Exclusion criteria met|1|||
164567850|NCT00348140|594447289|FG000|Overall Study|Memory declined|0|||
164567851|NCT00348140|594447290|FG001|Overall Study|Memory declined|0|||
164567852|NCT00348140|594447291|FG002|Overall Study|Memory declined|1|||
164567853|NCT03887130|594447292|FG000|Overall Study|Progressive disease|23|||
164567854|NCT03887130|594447293|FG001|Overall Study|Progressive disease|14|||
164567855|NCT03887130|594447294|FG002|Overall Study|Progressive disease|7|||
164567856|NCT03887130|594447292|FG000|Overall Study|Protocol Violation|3|||
164567857|NCT03887130|594447293|FG001|Overall Study|Protocol Violation|1|||
164567858|NCT03887130|594447294|FG002|Overall Study|Protocol Violation|2|||
164671030|NCT03897088|594821342|FG001|Overall Study|Non-compliance with Study Drug|1|||
164671031|NCT03897088|594821341|FG000|Overall Study|Pregnancy|0|||
164671032|NCT03897088|594821342|FG001|Overall Study|Pregnancy|1|||
164671033|NCT04320849|594821357|FG000|Overall Study|Withdrawal by Subject|4|||
164671034|NCT04320849|594821357|FG000|Overall Study|Imaging data unavailable|2|||
164671035|NCT04320849|594821357|FG000|Overall Study|Incomplete imaging|2|||
164671036|NCT03135834|594821358|FG000|Stage 1|Adverse Event|1|||
164567859|NCT03887130|594447292|FG000|Overall Study|Drug related toxicity|7|||
164567860|NCT03887130|594447293|FG001|Overall Study|Drug related toxicity|7|||
164567861|NCT03887130|594447294|FG002|Overall Study|Drug related toxicity|13|||
164567862|NCT03887130|594447292|FG000|Overall Study|Non drug related toxicity|3|||
164567863|NCT03887130|594447293|FG001|Overall Study|Non drug related toxicity|0|||
164567864|NCT03887130|594447294|FG002|Overall Study|Non drug related toxicity|0|||
164567865|NCT03887130|594447292|FG000|Overall Study|Death|2|||
164567866|NCT03887130|594447293|FG001|Overall Study|Death|2|||
164567867|NCT03887130|594447294|FG002|Overall Study|Death|1|||
164567868|NCT03887130|594447292|FG000|Overall Study|Withdrawal by Subject|7|||
164567869|NCT03887130|594447293|FG001|Overall Study|Withdrawal by Subject|6|||
164567870|NCT03887130|594447294|FG002|Overall Study|Withdrawal by Subject|11|||
164567871|NCT03887130|594447292|FG000|Overall Study|other reason|6|||
164567872|NCT03887130|594447293|FG001|Overall Study|other reason|20|||
164567873|NCT03887130|594447294|FG002|Overall Study|other reason|17|||
164567874|NCT01990261|594447295|FG000|Overall Study|Death Before Treatment Start|2|||
164567875|NCT01990261|594447295|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
164567876|NCT01990261|594447295|FG000|Overall Study|Death From other Causes|1|||
164567877|NCT01990261|594447295|FG000|Overall Study|Disease Progression (PD)|8|||
164567878|NCT01990261|594447295|FG000|Overall Study|PD Before Treatment Start|1|||
164567879|NCT01990261|594447295|FG000|Overall Study|Dossier not Approved|1|||
164567880|NCT01990261|594447295|FG000|Overall Study|Lost to Follow-up|2|||
164567881|NCT01078805|594447298|FG000|Overall Study|Clinically significant abnormal lab|5|||
164567882|NCT01078805|594447298|FG000|Overall Study|Death|134|||
164567883|NCT01078805|594447298|FG000|Overall Study|Lost to Follow-up|676|||
164567884|NCT01078805|594447298|FG000|Overall Study|Physician Decision|169|||
164567885|NCT01078805|594447298|FG000|Overall Study|Serious adverse event|26|||
164567886|NCT01078805|594447298|FG000|Overall Study|Sponsor decision|46|||
164567887|NCT01078805|594447298|FG000|Overall Study|Withdrawal by Subject|739|||
164567888|NCT01078805|594447298|FG000|Overall Study|Other|173|||
164567889|NCT01078805|594447298|FG000|Overall Study|Didn't take study drug|82|||
164567890|NCT01609842|594447299|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
164567891|NCT01609842|594447300|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
164567892|NCT04722991|594447301|FG000|Overall Study|Adverse Event|12|||
164567893|NCT04722991|594447302|FG001|Overall Study|Adverse Event|4|||
164567894|NCT04722991|594447301|FG000|Overall Study|Death|2|||
164567895|NCT04722991|594447302|FG001|Overall Study|Death|0|||
164567896|NCT04722991|594447301|FG000|Overall Study|Lost to Follow-up|1|||
164567897|NCT04722991|594447302|FG001|Overall Study|Lost to Follow-up|1|||
164567898|NCT04722991|594447301|FG000|Overall Study|Withdrawal cirterion met|2|||
164567899|NCT04722991|594447302|FG001|Overall Study|Withdrawal cirterion met|2|||
164567900|NCT04722991|594447301|FG000|Overall Study|Other|1|||
164567901|NCT04722991|594447302|FG001|Overall Study|Other|0|||
164567902|NCT04722991|594447301|FG000|Overall Study|Non-compliance|0|||
164567903|NCT04722991|594447302|FG001|Overall Study|Non-compliance|1|||
164567904|NCT04722991|594447301|FG000|Overall Study|Withdrawal by Subject|0|||
164567905|NCT04722991|594447302|FG001|Overall Study|Withdrawal by Subject|1|||
164567906|NCT03186989|594447303|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
164567907|NCT03186989|594447304|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
164567908|NCT03186989|594447305|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
164567909|NCT03186989|594447306|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
164567910|NCT03186989|594447307|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
164567911|NCT03186989|594447308|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
164567912|NCT03186989|594447309|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
164567913|NCT03186989|594447310|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
164567914|NCT03186989|594447311|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
164567915|NCT03186989|594447312|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
164567916|NCT03186989|594447313|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
164567917|NCT03186989|594447303|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
164567918|NCT03186989|594447304|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
164567919|NCT03186989|594447305|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
164567920|NCT03186989|594447306|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
164567921|NCT03186989|594447307|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
164567922|NCT03186989|594447308|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
164567923|NCT03186989|594447309|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
164567924|NCT03186989|594447310|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
164567925|NCT03186989|594447311|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
164567926|NCT03186989|594447312|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
164567927|NCT03186989|594447313|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
164567928|NCT03186989|594447303|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
164567929|NCT03186989|594447304|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
164567930|NCT03186989|594447305|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
164567931|NCT03186989|594447306|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
164671037|NCT03135834|594821359|FG001|Stage 1|Adverse Event|2|||
164671038|NCT03135834|594821360|FG002|Stage 1|Adverse Event|2|||
164671039|NCT03135834|594821361|FG003|Stage 1|Adverse Event|1|||
164671040|NCT03135834|594821358|FG000|Stage 1|Death|1|||
164671041|NCT03135834|594821359|FG001|Stage 1|Death|0|||
164671042|NCT03135834|594821360|FG002|Stage 1|Death|0|||
164671043|NCT03135834|594821361|FG003|Stage 1|Death|0|||
164221987|NCT00394472|593181717|FG001|Overall Study|Lost to Follow-up|1|||
164221988|NCT03211858|593181718|FG000|Overall Study|Adverse Event|8|||
164221989|NCT03211858|593181719|FG001|Overall Study|Adverse Event|6|||
164221990|NCT03211858|593181718|FG000|Overall Study|Lack of Efficacy|0|||
164221991|NCT03211858|593181719|FG001|Overall Study|Lack of Efficacy|4|||
164221992|NCT03211858|593181718|FG000|Overall Study|Poor compliance to protocol|6|||
164221993|NCT03211858|593181719|FG001|Overall Study|Poor compliance to protocol|2|||
164221994|NCT03211858|593181718|FG000|Overall Study|Non-serious Hypoglycemia|1|||
164221995|NCT03211858|593181719|FG001|Overall Study|Non-serious Hypoglycemia|0|||
164221996|NCT03211858|593181718|FG000|Overall Study|Other than specified above|22|||
164221997|NCT03211858|593181719|FG001|Overall Study|Other than specified above|21|||
164221998|NCT00004228|593181720|FG000|Overall Study|Adverse Event|0|||
164221999|NCT00004228|593181721|FG001|Overall Study|Adverse Event|1|||
164222000|NCT00004228|593181722|FG002|Overall Study|Adverse Event|0|||
164421031|NCT02138747|593911087|FG003|Treatment Period 1|Adverse Event|1|||
164421032|NCT02138747|593911084|FG000|Treatment Period 1|Lost to Follow-up|0|||
164671044|NCT03135834|594821358|FG000|Stage 1|Lost to Follow-up|17|||
164671045|NCT03135834|594821359|FG001|Stage 1|Lost to Follow-up|24|||
164671046|NCT03135834|594821360|FG002|Stage 1|Lost to Follow-up|21|||
164671047|NCT03135834|594821361|FG003|Stage 1|Lost to Follow-up|38|||
164671048|NCT03135834|594821358|FG000|Stage 1|No longer met eligibility criteria|1|||
164671049|NCT03135834|594821359|FG001|Stage 1|No longer met eligibility criteria|6|||
164671050|NCT03135834|594821360|FG002|Stage 1|No longer met eligibility criteria|2|||
164671051|NCT03135834|594821361|FG003|Stage 1|No longer met eligibility criteria|5|||
164671052|NCT03135834|594821358|FG000|Stage 1|Other|0|||
164671053|NCT03135834|594821359|FG001|Stage 1|Other|2|||
164671054|NCT03135834|594821360|FG002|Stage 1|Other|1|||
164671055|NCT03135834|594821361|FG003|Stage 1|Other|0|||
164671056|NCT03135834|594821358|FG000|Stage 1|Physician Decision|0|||
164671057|NCT03135834|594821359|FG001|Stage 1|Physician Decision|1|||
164671058|NCT03135834|594821360|FG002|Stage 1|Physician Decision|0|||
164671059|NCT03135834|594821361|FG003|Stage 1|Physician Decision|0|||
164671060|NCT03135834|594821358|FG000|Stage 1|Pregnancy|0|||
164671061|NCT03135834|594821359|FG001|Stage 1|Pregnancy|4|||
164671062|NCT03135834|594821360|FG002|Stage 1|Pregnancy|2|||
164671063|NCT03135834|594821361|FG003|Stage 1|Pregnancy|4|||
164671064|NCT03135834|594821358|FG000|Stage 1|Protocol Violation|1|||
164671065|NCT03135834|594821359|FG001|Stage 1|Protocol Violation|1|||
164671066|NCT03135834|594821360|FG002|Stage 1|Protocol Violation|2|||
164671067|NCT03135834|594821361|FG003|Stage 1|Protocol Violation|1|||
164671068|NCT03135834|594821358|FG000|Stage 1|Withdrawal by parent/guardian|2|||
164671069|NCT03135834|594821359|FG001|Stage 1|Withdrawal by parent/guardian|10|||
164671070|NCT03135834|594821360|FG002|Stage 1|Withdrawal by parent/guardian|2|||
164671071|NCT03135834|594821361|FG003|Stage 1|Withdrawal by parent/guardian|1|||
164671072|NCT03135834|594821358|FG000|Stage 1|Withdrawal by Subject|16|||
164671073|NCT03135834|594821359|FG001|Stage 1|Withdrawal by Subject|22|||
164671074|NCT03135834|594821360|FG002|Stage 1|Withdrawal by Subject|7|||
164671075|NCT03135834|594821361|FG003|Stage 1|Withdrawal by Subject|10|||
164671076|NCT03135834|594821358|FG000|Stage 1|Randomized but not Vaccinated|0|||
164671077|NCT03135834|594821359|FG001|Stage 1|Randomized but not Vaccinated|3|||
164671078|NCT03135834|594821360|FG002|Stage 1|Randomized but not Vaccinated|1|||
164671079|NCT03135834|594821361|FG003|Stage 1|Randomized but not Vaccinated|6|||
164671080|NCT03135834|594821358|FG000|Stage 2|Lost to Follow-up|0|||
164671081|NCT03135834|594821359|FG001|Stage 2|Lost to Follow-up|1|||
164671082|NCT03135834|594821360|FG002|Stage 2|Lost to Follow-up|0|||
164671083|NCT03135834|594821361|FG003|Stage 2|Lost to Follow-up|0|||
164671084|NCT03135834|594821358|FG000|Stage 2|Withdrawal by Subject|0|||
164222001|NCT00004228|593181723|FG003|Overall Study|Adverse Event|0|||
164222002|NCT00004228|593181724|FG004|Overall Study|Adverse Event|1|||
164671085|NCT03135834|594821359|FG001|Stage 2|Withdrawal by Subject|1|||
164671086|NCT03135834|594821360|FG002|Stage 2|Withdrawal by Subject|0|||
164671087|NCT03135834|594821361|FG003|Stage 2|Withdrawal by Subject|0|||
164671088|NCT03135834|594821358|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
164671089|NCT03135834|594821359|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
164671090|NCT03135834|594821360|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
164671091|NCT03135834|594821361|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
164671092|NCT03135834|594821358|FG000|Stage 2|Did not receive Booster Vaccination|1|||
164671093|NCT03135834|594821359|FG001|Stage 2|Did not receive Booster Vaccination|1|||
164671094|NCT03135834|594821360|FG002|Stage 2|Did not receive Booster Vaccination|0|||
164671095|NCT03135834|594821361|FG003|Stage 2|Did not receive Booster Vaccination|0|||
164671096|NCT00119379|594821364|FG000|Overall Study|Adverse Event|4|||
164671097|NCT00119379|594821365|FG001|Overall Study|Adverse Event|1|||
164671098|NCT03262012|594821369|FG000|Overall Study|Withdrawal by Subject|15|||
164671099|NCT03262012|594821370|FG001|Overall Study|Withdrawal by Subject|13|||
164671100|NCT03262012|594821371|FG002|Overall Study|Withdrawal by Subject|8|||
164671101|NCT03262012|594821372|FG003|Overall Study|Withdrawal by Subject|7|||
164671102|NCT03262012|594821369|FG000|Overall Study|Adverse Event|10|||
164671103|NCT03262012|594821370|FG001|Overall Study|Adverse Event|12|||
164671104|NCT03262012|594821371|FG002|Overall Study|Adverse Event|4|||
164671105|NCT03262012|594821372|FG003|Overall Study|Adverse Event|6|||
164671106|NCT03262012|594821369|FG000|Overall Study|Physician Decision|2|||
164671107|NCT03262012|594821370|FG001|Overall Study|Physician Decision|5|||
164671108|NCT03262012|594821371|FG002|Overall Study|Physician Decision|1|||
164671109|NCT03262012|594821372|FG003|Overall Study|Physician Decision|0|||
164671110|NCT03262012|594821369|FG000|Overall Study|Lack of Efficacy|0|||
164671111|NCT03262012|594821370|FG001|Overall Study|Lack of Efficacy|5|||
164671112|NCT03262012|594821371|FG002|Overall Study|Lack of Efficacy|1|||
164671113|NCT03262012|594821372|FG003|Overall Study|Lack of Efficacy|2|||
164671114|NCT03262012|594821369|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
164671115|NCT03262012|594821370|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
164671116|NCT03262012|594821371|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
164671117|NCT03262012|594821372|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
164671118|NCT01469546|594821375|FG000|Received 5 mg Dose|Adverse Event|13|||
164671119|NCT01469546|594821375|FG000|Received 5 mg Dose|Death|2|||
164671120|NCT01469546|594821375|FG000|Received 5 mg Dose|Protocol Violation|2|||
164671121|NCT01469546|594821375|FG000|Received 5 mg Dose|Progressive Disease|3|||
164671122|NCT01469546|594821375|FG000|Received 5 mg Dose|Physician Decision|3|||
164671123|NCT02801877|594821376|FG000|Overall Study|Lost to Follow-up|1|||
164671124|NCT02801877|594821377|FG001|Overall Study|Lost to Follow-up|1|||
164671125|NCT02801877|594821378|FG002|Overall Study|Lost to Follow-up|2|||
164671126|NCT02801877|594821379|FG003|Overall Study|Lost to Follow-up|0|||
164671127|NCT02801877|594821376|FG000|Overall Study|Never Started Treatment|2|||
164671128|NCT02801877|594821377|FG001|Overall Study|Never Started Treatment|0|||
164671129|NCT02801877|594821378|FG002|Overall Study|Never Started Treatment|4|||
164671130|NCT02801877|594821379|FG003|Overall Study|Never Started Treatment|0|||
164329128|NCT03119701|593581317|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
164567932|NCT03186989|594447307|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
164567933|NCT03186989|594447308|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
164567934|NCT03186989|594447309|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
164567935|NCT03186989|594447310|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
164567936|NCT03186989|594447311|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
164567937|NCT03186989|594447312|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
164567938|NCT03186989|594447313|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
164567939|NCT03186989|594447303|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
164567940|NCT03186989|594447304|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
164567941|NCT03186989|594447305|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
164567942|NCT03186989|594447306|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
164567943|NCT03186989|594447307|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
164567944|NCT03186989|594447308|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
164567945|NCT03186989|594447309|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
164567946|NCT03186989|594447310|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
164567947|NCT03186989|594447311|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
164567948|NCT03186989|594447312|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
164567949|NCT03186989|594447313|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
164567950|NCT01583374|594447317|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
164567951|NCT01583374|594447318|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
164567952|NCT01583374|594447319|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
164567953|NCT01583374|594447320|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
164567954|NCT01583374|594447321|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
164567955|NCT01583374|594447322|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
164567956|NCT01583374|594447323|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
164567957|NCT01583374|594447324|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
164671131|NCT02865122|594821380|FG000|Overall Study|Adverse Event|1|||
164671132|NCT02865122|594821381|FG001|Overall Study|Adverse Event|0|||
164671133|NCT02865122|594821382|FG002|Overall Study|Adverse Event|0|||
164671134|NCT04934722|594822923|FG000|Overall Study|Death|4|||
164671135|NCT04934722|594822924|FG001|Overall Study|Death|3|||
164671136|NCT04934722|594822923|FG000|Overall Study|Participants Ongoing|88|||
164671137|NCT04934722|594822924|FG001|Overall Study|Participants Ongoing|91|||
164671138|NCT06358820|594822925|FG000|Overall Study|Adverse Event|11|||
164671139|NCT06358820|594822925|FG000|Overall Study|kidney transplantation|3|||
164329129|NCT00406718|593581323|FG000|Overall Study|Withdrawal by Subject|2|||
164671140|NCT06358820|594822925|FG000|Overall Study|patient voluntary withdrawal|6|||
164567958|NCT01583374|594447325|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
164567959|NCT01583374|594447317|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
164567960|NCT01583374|594447318|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
164567961|NCT01583374|594447319|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
164567962|NCT01583374|594447320|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
164567963|NCT01583374|594447321|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
164567964|NCT01583374|594447322|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
164567965|NCT01583374|594447323|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
164567966|NCT01583374|594447324|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
164567967|NCT01583374|594447325|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
164567968|NCT01583374|594447317|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
164567969|NCT01583374|594447318|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
164567970|NCT01583374|594447319|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
164567971|NCT01583374|594447320|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
164567972|NCT01583374|594447321|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
164567973|NCT01583374|594447322|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
164567974|NCT01583374|594447323|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
164567975|NCT01583374|594447324|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
164567976|NCT01583374|594447325|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
164567977|NCT01583374|594447317|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
164567978|NCT01583374|594447318|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
164567979|NCT01583374|594447319|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
164567980|NCT01583374|594447320|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
164567981|NCT01583374|594447321|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
164567982|NCT01583374|594447322|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
164567983|NCT01583374|594447323|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
164567984|NCT01583374|594447324|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
164567985|NCT01583374|594447325|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
164567986|NCT01583374|594447317|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
164567987|NCT01583374|594447318|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
164567988|NCT01583374|594447319|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
164567989|NCT01583374|594447320|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
164567990|NCT01583374|594447321|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
164567991|NCT01583374|594447322|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
164567992|NCT01583374|594447323|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
164567993|NCT01583374|594447324|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
164567994|NCT01583374|594447325|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
164567995|NCT01583374|594447317|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
164567996|NCT01583374|594447318|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
164567997|NCT01583374|594447319|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
164567998|NCT01583374|594447320|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
164567999|NCT01583374|594447321|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
164568000|NCT01583374|594447322|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
164568001|NCT01583374|594447323|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
164671141|NCT06358820|594822925|FG000|Overall Study|Physician Decision|1|||
164671142|NCT01294787|594822926|FG000|Period 1|Adverse Event|0|||
164671143|NCT01294787|594822927|FG001|Period 1|Adverse Event|0|||
164671144|NCT01294787|594822928|FG002|Period 1|Adverse Event|0|||
164671145|NCT01294787|594822929|FG003|Period 1|Adverse Event|0|||
164671146|NCT01294787|594822930|FG004|Period 1|Adverse Event|1|||
164671147|NCT01294787|594822931|FG005|Period 1|Adverse Event|0|||
164222003|NCT00004228|593181725|FG005|Overall Study|Adverse Event|0|||
164222004|NCT00004228|593181726|FG006|Overall Study|Adverse Event|0|||
164222005|NCT00004228|593181720|FG000|Overall Study|Death|0|||
164222006|NCT00004228|593181721|FG001|Overall Study|Death|1|||
164222007|NCT00004228|593181722|FG002|Overall Study|Death|2|||
164222008|NCT00004228|593181723|FG003|Overall Study|Death|0|||
164222009|NCT00004228|593181724|FG004|Overall Study|Death|1|||
164222010|NCT00004228|593181725|FG005|Overall Study|Death|0|||
164222011|NCT00004228|593181726|FG006|Overall Study|Death|0|||
164222012|NCT00004228|593181720|FG000|Overall Study|Lack of Efficacy|1|||
164222013|NCT00004228|593181721|FG001|Overall Study|Lack of Efficacy|6|||
164222014|NCT00004228|593181722|FG002|Overall Study|Lack of Efficacy|5|||
164222015|NCT00004228|593181723|FG003|Overall Study|Lack of Efficacy|3|||
164222016|NCT00004228|593181724|FG004|Overall Study|Lack of Efficacy|9|||
164222017|NCT00004228|593181725|FG005|Overall Study|Lack of Efficacy|8|||
164222018|NCT00004228|593181726|FG006|Overall Study|Lack of Efficacy|4|||
164222019|NCT00004228|593181720|FG000|Overall Study|Lost to Follow-up|0|||
164222020|NCT00004228|593181721|FG001|Overall Study|Lost to Follow-up|0|||
164222021|NCT00004228|593181722|FG002|Overall Study|Lost to Follow-up|1|||
164222022|NCT00004228|593181723|FG003|Overall Study|Lost to Follow-up|0|||
164222023|NCT00004228|593181724|FG004|Overall Study|Lost to Follow-up|0|||
164222024|NCT00004228|593181725|FG005|Overall Study|Lost to Follow-up|0|||
164222025|NCT00004228|593181726|FG006|Overall Study|Lost to Follow-up|0|||
164222026|NCT00004228|593181720|FG000|Overall Study|Physician Decision|1|||
164222027|NCT00004228|593181721|FG001|Overall Study|Physician Decision|0|||
164222028|NCT00004228|593181722|FG002|Overall Study|Physician Decision|3|||
164222029|NCT00004228|593181723|FG003|Overall Study|Physician Decision|2|||
164222030|NCT00004228|593181724|FG004|Overall Study|Physician Decision|1|||
164222031|NCT00004228|593181725|FG005|Overall Study|Physician Decision|1|||
164222032|NCT00004228|593181726|FG006|Overall Study|Physician Decision|1|||
164222033|NCT00004228|593181720|FG000|Overall Study|Protocol Violation|0|||
164222034|NCT00004228|593181721|FG001|Overall Study|Protocol Violation|5|||
164222035|NCT00004228|593181722|FG002|Overall Study|Protocol Violation|2|||
164222036|NCT00004228|593181723|FG003|Overall Study|Protocol Violation|1|||
164222037|NCT00004228|593181724|FG004|Overall Study|Protocol Violation|1|||
164222038|NCT00004228|593181725|FG005|Overall Study|Protocol Violation|2|||
164222039|NCT00004228|593181726|FG006|Overall Study|Protocol Violation|0|||
164222040|NCT00004228|593181720|FG000|Overall Study|Withdrawal by Subject|3|||
164222041|NCT00004228|593181721|FG001|Overall Study|Withdrawal by Subject|0|||
164222042|NCT00004228|593181722|FG002|Overall Study|Withdrawal by Subject|1|||
164222043|NCT00004228|593181723|FG003|Overall Study|Withdrawal by Subject|0|||
164222044|NCT00004228|593181724|FG004|Overall Study|Withdrawal by Subject|2|||
164222045|NCT00004228|593181725|FG005|Overall Study|Withdrawal by Subject|1|||
164222046|NCT00004228|593181726|FG006|Overall Study|Withdrawal by Subject|2|||
164222047|NCT00004228|593181720|FG000|Overall Study|Other|0|||
164222048|NCT00004228|593181721|FG001|Overall Study|Other|0|||
164222049|NCT00004228|593181722|FG002|Overall Study|Other|1|||
164222050|NCT00004228|593181723|FG003|Overall Study|Other|0|||
164222051|NCT00004228|593181724|FG004|Overall Study|Other|0|||
164222052|NCT00004228|593181725|FG005|Overall Study|Other|0|||
164222053|NCT00004228|593181726|FG006|Overall Study|Other|0|||
164222054|NCT00004228|593181720|FG000|Overall Study|ineligible|4|||
164222055|NCT00004228|593181721|FG001|Overall Study|ineligible|2|||
164222056|NCT00004228|593181722|FG002|Overall Study|ineligible|4|||
164222057|NCT00004228|593181723|FG003|Overall Study|ineligible|1|||
164222058|NCT00004228|593181724|FG004|Overall Study|ineligible|1|||
164222059|NCT00004228|593181725|FG005|Overall Study|ineligible|2|||
164222060|NCT00004228|593181726|FG006|Overall Study|ineligible|5|||
164329130|NCT00406718|593581324|FG001|Overall Study|Withdrawal by Subject|9|||
164329131|NCT00406718|593581325|FG002|Overall Study|Withdrawal by Subject|4|||
164329132|NCT00406718|593581323|FG000|Overall Study|Lost to Follow-up|2|||
164222061|NCT01529112|593181727|FG000|Overall Study|Adverse Event|2|||
164222062|NCT01529112|593181728|FG001|Overall Study|Adverse Event|0|||
164222063|NCT01529112|593181727|FG000|Overall Study|Death|59|||
164222064|NCT01529112|593181728|FG001|Overall Study|Death|38|||
164222065|NCT01529112|593181727|FG000|Overall Study|Protocol Violation|1|||
164222066|NCT01529112|593181728|FG001|Overall Study|Protocol Violation|0|||
164222067|NCT01529112|593181727|FG000|Overall Study|Withdrawal by Subject|7|||
164222068|NCT01529112|593181728|FG001|Overall Study|Withdrawal by Subject|3|||
164222069|NCT00107614|593181729|FG000|Overall Study|Physician Decision|10|||
164222070|NCT00107614|593181729|FG000|Overall Study|Death|2|||
164222071|NCT01013870|593181730|FG000|Overall Study|Lost to Follow-up|1|||
164222072|NCT01013870|593181731|FG001|Overall Study|Lost to Follow-up|3|||
164222073|NCT02457546|593181733|FG000|Overall Study|Other reasons|4|||
164222074|NCT02457546|593181734|FG001|Overall Study|Other reasons|1|||
164222075|NCT02457546|593181733|FG000|Overall Study|Refused to complete study/procedures|1|||
164222076|NCT02457546|593181734|FG001|Overall Study|Refused to complete study/procedures|1|||
164222077|NCT02457546|593181733|FG000|Overall Study|Lost to Follow-up|4|||
164222078|NCT02457546|593181734|FG001|Overall Study|Lost to Follow-up|1|||
164222079|NCT02457546|593181733|FG000|Overall Study|Adverse Event|0|||
164222080|NCT02457546|593181734|FG001|Overall Study|Adverse Event|1|||
164222081|NCT00779909|593181738|FG000|Overall Study|Lost to Follow-up|1|||
164222082|NCT00779909|593181739|FG001|Overall Study|Lost to Follow-up|0|||
164222083|NCT00779909|593181740|FG002|Overall Study|Lost to Follow-up|0|||
164222084|NCT00779909|593181741|FG003|Overall Study|Lost to Follow-up|1|||
164222085|NCT00779909|593181738|FG000|Overall Study|Withdrawal by Subject|0|||
164222086|NCT00779909|593181739|FG001|Overall Study|Withdrawal by Subject|1|||
164222087|NCT00779909|593181740|FG002|Overall Study|Withdrawal by Subject|0|||
164222088|NCT00779909|593181741|FG003|Overall Study|Withdrawal by Subject|0|||
164222089|NCT01174459|593181745|FG000|Overall Study|case report form (CRF) not collected|5|||
164222090|NCT00290758|593181746|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
164222091|NCT00290758|593181747|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
164222092|NCT00290758|593181746|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
164222093|NCT00290758|593181747|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
164222094|NCT00290758|593181746|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
164222095|NCT00290758|593181747|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
164222096|NCT00290758|593181746|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
164222097|NCT00290758|593181747|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
164222098|NCT00290758|593181746|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
164222099|NCT00290758|593181747|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
164222100|NCT00290758|593181746|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
164222101|NCT00290758|593181747|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
164222102|NCT00290758|593181746|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
164222103|NCT00290758|593181747|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
164222104|NCT00290758|593181746|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
164222105|NCT00290758|593181747|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
164222106|NCT00474968|593181749|FG000|Overall Study|Withdrawal by Subject|8|||
164222107|NCT00474968|593181750|FG001|Overall Study|Withdrawal by Subject|7|||
164222108|NCT00474968|593181749|FG000|Overall Study|Protocol Violation|9|||
164222109|NCT00474968|593181750|FG001|Overall Study|Protocol Violation|8|||
164222110|NCT00474968|593181749|FG000|Overall Study|Sample not collected|1|||
164222111|NCT00474968|593181750|FG001|Overall Study|Sample not collected|1|||
164222112|NCT04914000|593181751|FG000|Overall Study|Lost to Follow-up|8|||
164222113|NCT04914000|593181751|FG000|Overall Study|Withdrawal by Subject|1|||
164222114|NCT01096186|593181753|FG000|Overall Study|Adverse Event|16|||
164671148|NCT01294787|594822926|FG000|Period 1|Withdrawal by Subject|0|||
164671149|NCT01294787|594822927|FG001|Period 1|Withdrawal by Subject|0|||
164671150|NCT01294787|594822928|FG002|Period 1|Withdrawal by Subject|0|||
164671151|NCT01294787|594822929|FG003|Period 1|Withdrawal by Subject|1|||
164671152|NCT01294787|594822930|FG004|Period 1|Withdrawal by Subject|1|||
164671153|NCT01294787|594822931|FG005|Period 1|Withdrawal by Subject|1|||
164222115|NCT01096186|593181753|FG000|Overall Study|Death|4|||
164222116|NCT01096186|593181753|FG000|Overall Study|Lack of Efficacy|4|||
164222117|NCT01096186|593181753|FG000|Overall Study|Lost to Follow-up|2|||
164671154|NCT01294787|594822926|FG000|Period 1|Administrative problem|0|||
164222118|NCT01096186|593181753|FG000|Overall Study|Withdrawal by Subject|22|||
164671155|NCT01294787|594822927|FG001|Period 1|Administrative problem|0|||
164671156|NCT01294787|594822928|FG002|Period 1|Administrative problem|1|||
164671157|NCT01294787|594822929|FG003|Period 1|Administrative problem|0|||
164222119|NCT01096186|593181753|FG000|Overall Study|Physician Decision|1|||
164222120|NCT01096186|593181753|FG000|Overall Study|Noncompliance with study drug|1|||
164222121|NCT00079781|593181754|FG000|Pre-implant Period|Withdrawal by Subject|2|||
164222122|NCT00079781|593181755|FG001|Pre-implant Period|Withdrawal by Subject|0|||
164222123|NCT00079781|593181756|FG002|Pre-implant Period|Withdrawal by Subject|0|||
164222124|NCT00079781|593181754|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
164222125|NCT00079781|593181755|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
164222126|NCT00079781|593181756|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
164671158|NCT01294787|594822930|FG004|Period 1|Administrative problem|0|||
164671159|NCT01294787|594822931|FG005|Period 1|Administrative problem|1|||
164222127|NCT00079781|593181754|FG000|Follow-up Period|Withdrawal by Subject|3|||
164222128|NCT00079781|593181755|FG001|Follow-up Period|Withdrawal by Subject|0|||
164222129|NCT00079781|593181756|FG002|Follow-up Period|Withdrawal by Subject|1|||
164222130|NCT00079781|593181754|FG000|Follow-up Period|Lost to Follow-up|1|||
164222131|NCT00079781|593181755|FG001|Follow-up Period|Lost to Follow-up|0|||
164222132|NCT00079781|593181756|FG002|Follow-up Period|Lost to Follow-up|0|||
164222133|NCT00079781|593181754|FG000|Follow-up Period|Death|0|||
164222134|NCT00079781|593181755|FG001|Follow-up Period|Death|0|||
164222135|NCT00079781|593181756|FG002|Follow-up Period|Death|1|||
164222136|NCT00564070|593181757|FG000|Overall Study|Lost to Follow-up|9|||
164222137|NCT00564070|593181758|FG001|Overall Study|Lost to Follow-up|7|||
164222138|NCT00564070|593181757|FG000|Overall Study|Worsening depression, referred to care|3|||
164222139|NCT00564070|593181758|FG001|Overall Study|Worsening depression, referred to care|0|||
164222140|NCT03142334|593181759|FG000|Overall Study|Death|18|||
164222141|NCT03142334|593181760|FG001|Overall Study|Death|33|||
164222142|NCT03142334|593181759|FG000|Overall Study|Withdrawal by Subject|15|||
164222143|NCT03142334|593181760|FG001|Overall Study|Withdrawal by Subject|11|||
164222144|NCT03142334|593181759|FG000|Overall Study|Ongoing on trial follow up|463|||
164222145|NCT03142334|593181760|FG001|Overall Study|Ongoing on trial follow up|454|||
164222146|NCT01217047|593181761|FG000|Overall Study|Lost to Follow-up|0|||
164222147|NCT01217047|593181762|FG001|Overall Study|Lost to Follow-up|1|||
164222148|NCT01217047|593181763|FG002|Overall Study|Lost to Follow-up|0|||
164222149|NCT03835117|593181764|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
164222150|NCT03835117|593181765|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
164222151|NCT03225989|593181769|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
164222152|NCT03225989|593181770|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
164222153|NCT03225989|593181771|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
164222154|NCT03225989|593181769|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
164222155|NCT03225989|593181770|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
164222156|NCT03225989|593181771|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
164222157|NCT03225989|593181769|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
164222158|NCT03225989|593181770|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
164222159|NCT03225989|593181771|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
164222160|NCT03225989|593181769|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
164222161|NCT03225989|593181770|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
164222162|NCT03225989|593181771|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
164222163|NCT03225989|593181769|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
164222164|NCT03225989|593181770|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
164222165|NCT03225989|593181771|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
164222166|NCT03225989|593181769|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
164222167|NCT03225989|593181770|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
164222168|NCT03225989|593181771|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
164222169|NCT03225989|593181769|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
164222170|NCT03225989|593181770|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
164222171|NCT03225989|593181771|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
164222172|NCT03225989|593181769|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
164222173|NCT03225989|593181770|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
164222174|NCT03225989|593181771|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
164222175|NCT03225989|593181769|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
164222176|NCT03225989|593181770|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
164222177|NCT03225989|593181771|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
164222178|NCT03225989|593181769|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
164222179|NCT03225989|593181770|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
164222180|NCT03225989|593181771|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
164568002|NCT01583374|594447324|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
164568003|NCT01583374|594447325|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
164568004|NCT01583374|594447317|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
164568005|NCT01583374|594447318|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
164568006|NCT01583374|594447319|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
164568007|NCT01583374|594447320|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
164568008|NCT01583374|594447321|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
164568009|NCT01583374|594447322|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
164568010|NCT01583374|594447323|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
164568011|NCT01583374|594447324|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
164568012|NCT01583374|594447325|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
164671160|NCT01294787|594822926|FG000|Period 2|Adverse Event|0|||
164222181|NCT03225989|593181769|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
164568013|NCT01583374|594447317|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
164568014|NCT01583374|594447318|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
164568015|NCT01583374|594447319|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
164222182|NCT03225989|593181770|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
164222183|NCT03225989|593181771|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
164222184|NCT03225989|593181769|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
164222185|NCT03225989|593181770|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
164222186|NCT03225989|593181771|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
164222187|NCT03093870|593181775|FG000|Overall Study|Withdrawal by Subject|2|||
164222188|NCT03093870|593181776|FG001|Overall Study|Withdrawal by Subject|6|||
164222189|NCT03093870|593181777|FG002|Overall Study|Withdrawal by Subject|5|||
164222190|NCT03093870|593181775|FG000|Overall Study|Death|1|||
164222191|NCT03093870|593181776|FG001|Overall Study|Death|35|||
164222192|NCT03093870|593181777|FG002|Overall Study|Death|35|||
164222193|NCT03093870|593181775|FG000|Overall Study|Radiographic disease progression|10|||
164222194|NCT03093870|593181776|FG001|Overall Study|Radiographic disease progression|0|||
164222195|NCT03093870|593181777|FG002|Overall Study|Radiographic disease progression|0|||
164222196|NCT03093870|593181775|FG000|Overall Study|Clinical disease progression|1|||
164222197|NCT03093870|593181776|FG001|Overall Study|Clinical disease progression|0|||
164222198|NCT03093870|593181777|FG002|Overall Study|Clinical disease progression|0|||
164222199|NCT03093870|593181775|FG000|Overall Study|Physician Decision|2|||
164222200|NCT03093870|593181776|FG001|Overall Study|Physician Decision|0|||
164222201|NCT03093870|593181777|FG002|Overall Study|Physician Decision|0|||
164222202|NCT03093870|593181775|FG000|Overall Study|Adverse Event|7|||
164222203|NCT03093870|593181776|FG001|Overall Study|Adverse Event|0|||
164222204|NCT03093870|593181777|FG002|Overall Study|Adverse Event|0|||
164222205|NCT03093870|593181775|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
164222206|NCT03093870|593181776|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
164222207|NCT03093870|593181777|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
164222208|NCT03093870|593181775|FG000|Overall Study|Lost to Follow-up|0|||
164222209|NCT03093870|593181776|FG001|Overall Study|Lost to Follow-up|0|||
164222210|NCT03093870|593181777|FG002|Overall Study|Lost to Follow-up|1|||
164222211|NCT02006654|593181778|FG000|Overall Study|Withdrawal before treatment|4|||
164222212|NCT02006654|593181779|FG001|Overall Study|Withdrawal before treatment|2|||
164222213|NCT02006654|593181778|FG000|Overall Study|Adverse Event|16|||
164222214|NCT02006654|593181779|FG001|Overall Study|Adverse Event|17|||
164222215|NCT02006654|593181778|FG000|Overall Study|Death|1|||
164222216|NCT02006654|593181779|FG001|Overall Study|Death|0|||
164222217|NCT02006654|593181778|FG000|Overall Study|Withdrawal by Subject|14|||
164222218|NCT02006654|593181779|FG001|Overall Study|Withdrawal by Subject|12|||
164222219|NCT02006654|593181778|FG000|Overall Study|Protocol Violation|5|||
164222220|NCT02006654|593181779|FG001|Overall Study|Protocol Violation|8|||
164222221|NCT02006654|593181778|FG000|Overall Study|Lost to Follow-up|1|||
164222222|NCT02006654|593181779|FG001|Overall Study|Lost to Follow-up|0|||
164222223|NCT02006654|593181778|FG000|Overall Study|patient's will|2|||
164222224|NCT02006654|593181779|FG001|Overall Study|patient's will|1|||
164222225|NCT02006654|593181778|FG000|Overall Study|insufficient compliance|1|||
164222226|NCT02006654|593181779|FG001|Overall Study|insufficient compliance|0|||
164222227|NCT02006654|593181778|FG000|Overall Study|worsening cognitive condition|0|||
164222228|NCT02006654|593181779|FG001|Overall Study|worsening cognitive condition|1|||
164222229|NCT02006654|593181778|FG000|Overall Study|faecal incontinence|0|||
164222230|NCT02006654|593181779|FG001|Overall Study|faecal incontinence|1|||
164222231|NCT02006654|593181778|FG000|Overall Study|mood disorder|0|||
164222232|NCT02006654|593181779|FG001|Overall Study|mood disorder|1|||
164222233|NCT02006654|593181778|FG000|Overall Study|disallowed medication|1|||
164222234|NCT02006654|593181779|FG001|Overall Study|disallowed medication|0|||
164222235|NCT02006654|593181778|FG000|Overall Study|moving out of state|0|||
164222236|NCT02006654|593181779|FG001|Overall Study|moving out of state|1|||
164222237|NCT04193527|593181780|FG000|Overall Study|Other|1|||
164568016|NCT01583374|594447320|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
164568017|NCT01583374|594447321|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
164568018|NCT01583374|594447322|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
164568019|NCT01583374|594447323|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
164568020|NCT01583374|594447324|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
164568021|NCT01583374|594447325|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
164568022|NCT01583374|594447317|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
164568023|NCT01583374|594447318|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
164222238|NCT04193527|593181781|FG001|Overall Study|Other|1|||
164222239|NCT04193527|593181782|FG002|Overall Study|Other|0|||
164222240|NCT03808909|593181783|FG000|Overall Study|Lost to Follow-up|3|||
164222241|NCT03808909|593181784|FG001|Overall Study|Lost to Follow-up|0|||
164222242|NCT01608308|593181785|FG000|Overall Study|pretreatment medical and billing reasons|0|||
164222243|NCT01608308|593181786|FG001|Overall Study|pretreatment medical and billing reasons|2|||
164222244|NCT02362412|593181791|FG000|Treatment Period III|Lost to Follow-up|0|||
164222245|NCT02362412|593181792|FG001|Treatment Period III|Lost to Follow-up|1|||
164222246|NCT00545948|593181794|FG000|Overall Study|Not Treated|1|||
164222247|NCT00545948|593181795|FG001|Overall Study|Not Treated|1|||
164222248|NCT00545948|593181796|FG002|Overall Study|Not Treated|7|||
164222249|NCT04595370|593181797|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
164222250|NCT04595370|593181798|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
164222251|NCT04595370|593181799|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
164222252|NCT04595370|593181800|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
164222253|NCT04595370|593181801|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
164222254|NCT04595370|593181802|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
164222255|NCT04595370|593181797|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
164222256|NCT04595370|593181798|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
164222257|NCT04595370|593181799|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
164222258|NCT04595370|593181800|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
164222259|NCT04595370|593181801|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
164222260|NCT04595370|593181802|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
164222261|NCT04595370|593181797|FG000|Overall Study|Adverse Event|0|||
164222262|NCT04595370|593181798|FG001|Overall Study|Adverse Event|4|||
164222263|NCT04595370|593181799|FG002|Overall Study|Adverse Event|3|||
164222264|NCT04595370|593181800|FG003|Overall Study|Adverse Event|1|||
164222265|NCT04595370|593181801|FG004|Overall Study|Adverse Event|1|||
164222266|NCT04595370|593181802|FG005|Overall Study|Adverse Event|1|||
164222267|NCT04595370|593181797|FG000|Overall Study|Withdrawal of Consent|1|||
164222268|NCT04595370|593181798|FG001|Overall Study|Withdrawal of Consent|1|||
164222269|NCT04595370|593181799|FG002|Overall Study|Withdrawal of Consent|1|||
164222270|NCT04595370|593181800|FG003|Overall Study|Withdrawal of Consent|0|||
164222271|NCT04595370|593181801|FG004|Overall Study|Withdrawal of Consent|0|||
164222272|NCT04595370|593181802|FG005|Overall Study|Withdrawal of Consent|0|||
164222273|NCT04595370|593181797|FG000|Overall Study|Death|0|||
164222274|NCT04595370|593181798|FG001|Overall Study|Death|1|||
164222275|NCT04595370|593181799|FG002|Overall Study|Death|0|||
164222276|NCT04595370|593181800|FG003|Overall Study|Death|0|||
164222277|NCT04595370|593181801|FG004|Overall Study|Death|1|||
164222278|NCT04595370|593181802|FG005|Overall Study|Death|0|||
164222279|NCT04595370|593181797|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164222280|NCT04595370|593181798|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164222281|NCT04595370|593181799|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
164222282|NCT04595370|593181800|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164222283|NCT04595370|593181801|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164222284|NCT04595370|593181802|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164222285|NCT04595370|593181797|FG000|Overall Study|Withdrawal by Subject|0|||
164222286|NCT04595370|593181798|FG001|Overall Study|Withdrawal by Subject|0|||
164222287|NCT04595370|593181799|FG002|Overall Study|Withdrawal by Subject|1|||
164222288|NCT04595370|593181800|FG003|Overall Study|Withdrawal by Subject|0|||
164222289|NCT04595370|593181801|FG004|Overall Study|Withdrawal by Subject|2|||
164222290|NCT04595370|593181802|FG005|Overall Study|Withdrawal by Subject|0|||
164222291|NCT04595370|593181797|FG000|Overall Study|Lost to Follow-up|0|||
164222292|NCT04595370|593181798|FG001|Overall Study|Lost to Follow-up|0|||
164222293|NCT04595370|593181799|FG002|Overall Study|Lost to Follow-up|0|||
164222294|NCT04595370|593181800|FG003|Overall Study|Lost to Follow-up|0|||
164222295|NCT04595370|593181801|FG004|Overall Study|Lost to Follow-up|1|||
164222296|NCT04595370|593181802|FG005|Overall Study|Lost to Follow-up|0|||
164222297|NCT04595370|593181797|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
164222298|NCT04595370|593181798|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
164222299|NCT04595370|593181799|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
164222300|NCT04595370|593181800|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
164222301|NCT04595370|593181801|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
164222302|NCT04595370|593181802|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
164222303|NCT03520387|593181803|FG000|Pre-Randomization|Withdrawal by Subject|1|||
164222304|NCT03520387|593181804|FG001|Pre-Randomization|Withdrawal by Subject|0|||
164222305|NCT03520387|593181805|FG002|Pre-Randomization|Withdrawal by Subject|0|||
164222306|NCT03520387|593181806|FG003|Pre-Randomization|Withdrawal by Subject|0|||
164222307|NCT03520387|593181807|FG004|Pre-Randomization|Withdrawal by Subject|0|||
164222308|NCT03520387|593181803|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
164222309|NCT03520387|593181804|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
164222310|NCT03520387|593181805|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
164222311|NCT03520387|593181806|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
164222312|NCT03520387|593181807|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
164222313|NCT00541775|593181808|FG000|Overall Study|Adverse Event|3|||
164222314|NCT00541775|593181809|FG001|Overall Study|Adverse Event|2|||
164222315|NCT00541775|593181810|FG002|Overall Study|Adverse Event|1|||
164222316|NCT00541775|593181808|FG000|Overall Study|Lack of Efficacy|0|||
164671161|NCT01294787|594822927|FG001|Period 2|Adverse Event|3|||
164671162|NCT01294787|594822928|FG002|Period 2|Adverse Event|0|||
164671163|NCT01294787|594822929|FG003|Period 2|Adverse Event|1|||
164671164|NCT01294787|594822930|FG004|Period 2|Adverse Event|0|||
164671165|NCT01294787|594822931|FG005|Period 2|Adverse Event|0|||
164671166|NCT01294787|594822926|FG000|Period 2|No longer needs study drug|0|||
164671167|NCT01294787|594822927|FG001|Period 2|No longer needs study drug|0|||
164671168|NCT01294787|594822928|FG002|Period 2|No longer needs study drug|0|||
164671169|NCT01294787|594822929|FG003|Period 2|No longer needs study drug|1|||
164671170|NCT01294787|594822930|FG004|Period 2|No longer needs study drug|0|||
164671171|NCT01294787|594822931|FG005|Period 2|No longer needs study drug|0|||
164671172|NCT01294787|594822926|FG000|Period 3|Adverse Event|0|||
164671173|NCT01294787|594822927|FG001|Period 3|Adverse Event|0|||
164222317|NCT00541775|593181809|FG001|Overall Study|Lack of Efficacy|0|||
164671174|NCT01294787|594822928|FG002|Period 3|Adverse Event|0|||
164671175|NCT01294787|594822929|FG003|Period 3|Adverse Event|0|||
164671176|NCT01294787|594822930|FG004|Period 3|Adverse Event|1|||
164671177|NCT01294787|594822931|FG005|Period 3|Adverse Event|0|||
164671178|NCT01124175|594822932|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
164671179|NCT01124175|594822933|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
164671180|NCT00942968|594822934|FG000|Overall Study|Adverse Event|60|||
164671181|NCT00942968|594822934|FG000|Overall Study|Death|76|||
164671182|NCT00942968|594822934|FG000|Overall Study|Protocol Violation|9|||
164671183|NCT00942968|594822934|FG000|Overall Study|Lost to Follow-up|4|||
164671184|NCT00942968|594822934|FG000|Overall Study|Withdrawal by Subject|44|||
164671185|NCT00942968|594822934|FG000|Overall Study|Sponsor request|5|||
164671186|NCT00942968|594822934|FG000|Overall Study|Physician Decision|11|||
164671187|NCT00942968|594822934|FG000|Overall Study|Progression of disease|12|||
164671188|NCT00942968|594822934|FG000|Overall Study|Inferior vena cava filter placement|4|||
164671189|NCT00942968|594822934|FG000|Overall Study|Pulmonary embolism (PE)|1|||
164671190|NCT00942968|594822934|FG000|Overall Study|Participant required pancreatic biopsy|1|||
164671191|NCT00942968|594822934|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
164671192|NCT01948258|594822935|FG000|Overall Study|Pregnancy|41|||
164671193|NCT01948258|594822935|FG000|Overall Study|Did not complete by cut-off date|35|||
164671194|NCT01948258|594822935|FG000|Overall Study|Lost to Follow-up|27|||
164671195|NCT01948258|594822935|FG000|Overall Study|Withdrawal by SPD|8|||
164671196|NCT01948258|594822935|FG000|Overall Study|Withdrawal by Subject|6|||
164222318|NCT00541775|593181810|FG002|Overall Study|Lack of Efficacy|3|||
164222319|NCT00541775|593181808|FG000|Overall Study|Lost to Follow-up|0|||
164222320|NCT00541775|593181809|FG001|Overall Study|Lost to Follow-up|0|||
164222321|NCT00541775|593181810|FG002|Overall Study|Lost to Follow-up|2|||
164222322|NCT00541775|593181808|FG000|Overall Study|Protocol Violation|1|||
164222323|NCT00541775|593181809|FG001|Overall Study|Protocol Violation|0|||
164222324|NCT00541775|593181810|FG002|Overall Study|Protocol Violation|0|||
164222325|NCT00541775|593181808|FG000|Overall Study|Withdrawal by Subject and Other|5|||
164222326|NCT00541775|593181809|FG001|Overall Study|Withdrawal by Subject and Other|0|||
164222327|NCT00541775|593181810|FG002|Overall Study|Withdrawal by Subject and Other|2|||
164222328|NCT01945242|593181811|FG000|Overall Study|Physician Decision|3|||
164222329|NCT01945242|593181812|FG001|Overall Study|Physician Decision|3|||
164222330|NCT04913675|593181814|FG000|Main Study (Up to Week 36)|Death|0|||
164222331|NCT04913675|593181815|FG001|Main Study (Up to Week 36)|Death|2|||
164222332|NCT04913675|593181816|FG002|Main Study (Up to Week 36)|Death|2|||
164222333|NCT04913675|593181817|FG003|Main Study (Up to Week 36)|Death|0|||
164222334|NCT04913675|593181814|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
164671197|NCT01948258|594822935|FG000|Overall Study|Health Care Professional|43|||
164671198|NCT01948258|594822935|FG000|Overall Study|Removed from statistical analysis|2|||
164671199|NCT00909610|594822942|FG000|Period: First Intervention|Adverse Event|0|||
164671200|NCT00909610|594822943|FG001|Period: First Intervention|Adverse Event|1|||
164671201|NCT00909610|594822942|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
164671202|NCT00909610|594822943|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
164671203|NCT00909610|594822942|FG000|Period: Second Intervention|Adverse Event|1|||
164671204|NCT00909610|594822943|FG001|Period: Second Intervention|Adverse Event|0|||
164671205|NCT02422264|594822947|FG000|Overall Study|Serious Adverse Event|1|||
164671206|NCT02422264|594822948|FG001|Overall Study|Serious Adverse Event|0|||
164671207|NCT02422264|594822947|FG000|Overall Study|Withdrawal by Subject|1|||
164671208|NCT02422264|594822948|FG001|Overall Study|Withdrawal by Subject|2|||
164222335|NCT04913675|593181815|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
164222336|NCT04913675|593181816|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
164222337|NCT04913675|593181817|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
164222338|NCT04913675|593181814|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
164222339|NCT04913675|593181815|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
164671209|NCT02422264|594822947|FG000|Overall Study|Migrated/moved from study area|3|||
164671210|NCT02422264|594822948|FG001|Overall Study|Migrated/moved from study area|1|||
164671211|NCT02422264|594822947|FG000|Overall Study|Subject vaccinated outside of the study|0|||
164671212|NCT02422264|594822948|FG001|Overall Study|Subject vaccinated outside of the study|1|||
164671213|NCT03021018|594822949|FG000|Overall Study|Adverse Event|1|||
164671214|NCT03021018|594822950|FG001|Overall Study|Adverse Event|0|||
164222340|NCT04913675|593181816|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
164222341|NCT04913675|593181817|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
164222342|NCT04913675|593181814|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
164222343|NCT04913675|593181815|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
164222344|NCT04913675|593181816|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
164222345|NCT04913675|593181817|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
164222346|NCT04913675|593181814|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
164222347|NCT04913675|593181815|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
164222348|NCT04913675|593181816|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
164222349|NCT04913675|593181817|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
164222350|NCT01541254|593181821|FG000|Overall Study|Withdrawal by Subject|1|||
164222351|NCT01541254|593181821|FG000|Overall Study|excluded - metal allergy|1|||
164222352|NCT01541254|593181821|FG000|Overall Study|enrolled after study closed|1|||
164222353|NCT01541254|593181821|FG000|Overall Study|GI bleed prior to procedure|1|||
164222354|NCT01541254|593181821|FG000|Overall Study|stent not required|1|||
164222355|NCT01541254|593181821|FG000|Overall Study|alternate stent used|1|||
164222356|NCT05660538|593181822|FG000|Overall Study|Adverse Event|0|||
164222357|NCT05660538|593181823|FG001|Overall Study|Adverse Event|0|||
164222358|NCT05660538|593181824|FG002|Overall Study|Adverse Event|1|||
164222359|NCT05660538|593181825|FG003|Overall Study|Adverse Event|0|||
164222360|NCT05660538|593181822|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
164222361|NCT05660538|593181823|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
164222362|NCT05660538|593181824|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
164222363|NCT05660538|593181825|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
164222364|NCT05660538|593181822|FG000|Overall Study|Lost to Follow-up|0|||
164222365|NCT05660538|593181823|FG001|Overall Study|Lost to Follow-up|0|||
164222366|NCT05660538|593181824|FG002|Overall Study|Lost to Follow-up|1|||
164222367|NCT05660538|593181825|FG003|Overall Study|Lost to Follow-up|1|||
164222368|NCT05660538|593181822|FG000|Overall Study|Death|0|||
164222369|NCT05660538|593181823|FG001|Overall Study|Death|0|||
164222370|NCT05660538|593181824|FG002|Overall Study|Death|1|||
164222371|NCT05660538|593181825|FG003|Overall Study|Death|0|||
164222372|NCT05660538|593181822|FG000|Overall Study|Physician Decision|0|||
164222373|NCT05660538|593181823|FG001|Overall Study|Physician Decision|0|||
164222374|NCT05660538|593181824|FG002|Overall Study|Physician Decision|0|||
164222375|NCT05660538|593181825|FG003|Overall Study|Physician Decision|1|||
164222376|NCT05660538|593181822|FG000|Overall Study|Sponsor Decision|1|||
164222377|NCT05660538|593181823|FG001|Overall Study|Sponsor Decision|0|||
164222378|NCT05660538|593181824|FG002|Overall Study|Sponsor Decision|0|||
164222379|NCT05660538|593181825|FG003|Overall Study|Sponsor Decision|0|||
164222380|NCT05660538|593181822|FG000|Overall Study|Other|1|||
164222381|NCT05660538|593181823|FG001|Overall Study|Other|0|||
164222382|NCT05660538|593181824|FG002|Overall Study|Other|0|||
164222383|NCT05660538|593181825|FG003|Overall Study|Other|1|||
164222384|NCT05660538|593181822|FG000|Overall Study|Randomized but did not receive study drug|1|||
164222385|NCT05660538|593181823|FG001|Overall Study|Randomized but did not receive study drug|0|||
164222386|NCT05660538|593181824|FG002|Overall Study|Randomized but did not receive study drug|0|||
164222387|NCT05660538|593181825|FG003|Overall Study|Randomized but did not receive study drug|1|||
164568024|NCT01583374|594447319|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
164568025|NCT01583374|594447320|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
164222388|NCT05660538|593181822|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
164222389|NCT05660538|593181823|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
164222390|NCT05660538|593181824|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
164222391|NCT05660538|593181825|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
164222392|NCT04648241|593181826|FG000|Overall Study|Lost to Follow-up|1|||
164222393|NCT04648241|593181827|FG001|Overall Study|Lost to Follow-up|0|||
164222394|NCT02489045|593181830|FG000|Overall Study|unable to collect usable data|53|||
164222395|NCT02489045|593181830|FG000|Follow-up|Lost to Follow-up|10|||
164222396|NCT00120874|593181835|FG000|Overall Study|Death|0|||
164222397|NCT00120874|593181836|FG001|Overall Study|Death|1|||
164222398|NCT01108055|593181837|FG000|Overall Study|Ineligible|11|||
164222399|NCT01108055|593181837|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
164222400|NCT03339453|593181844|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
164222401|NCT03339453|593181845|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
164222402|NCT01348490|593181847|FG000|Overall Study|Death|1|||
164222403|NCT01348490|593181847|FG000|Overall Study|Adverse Event|3|||
164222404|NCT01348490|593181847|FG000|Overall Study|Consent withdrawn|7|||
164222405|NCT01348490|593181847|FG000|Overall Study|Disease progression|3|||
164222406|NCT01348490|593181847|FG000|Overall Study|Lost to Follow-up|1|||
164222407|NCT01348490|593181847|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
164222408|NCT01348490|593181847|FG000|Overall Study|Other Unspecified|8|||
164222409|NCT00300495|593181848|FG000|Overall Study|Protocol Violation|4|||
164222410|NCT00300495|593181849|FG001|Overall Study|Protocol Violation|1|||
164222411|NCT03834883|593181858|FG000|Second Treatment|Withdrawal by Subject|1|||
164222412|NCT03834883|593181859|FG001|Second Treatment|Withdrawal by Subject|0|||
164222413|NCT03834883|593181860|FG002|Second Treatment|Withdrawal by Subject|0|||
164222414|NCT03834883|593181861|FG003|Second Treatment|Withdrawal by Subject|0|||
164222415|NCT03834883|593181858|FG000|Second Treatment|COVID-19 pandemic|1|||
164222416|NCT03834883|593181859|FG001|Second Treatment|COVID-19 pandemic|0|||
164222417|NCT03834883|593181860|FG002|Second Treatment|COVID-19 pandemic|1|||
164222418|NCT03834883|593181861|FG003|Second Treatment|COVID-19 pandemic|1|||
164222419|NCT02487199|593181863|FG000|Overall Study|Withdrew Consent|0|||
164222420|NCT02487199|593181864|FG001|Overall Study|Withdrew Consent|1|||
164222421|NCT00286455|593181865|FG000|Overall Study|Hyperglycemia rescue|19|||
164222422|NCT00286455|593181866|FG001|Overall Study|Hyperglycemia rescue|13|||
164222423|NCT00286455|593181867|FG002|Overall Study|Hyperglycemia rescue|10|||
164222424|NCT00286455|593181865|FG000|Overall Study|Adverse Event|1|||
164222425|NCT00286455|593181866|FG001|Overall Study|Adverse Event|3|||
164222426|NCT00286455|593181867|FG002|Overall Study|Adverse Event|2|||
164222427|NCT00286455|593181865|FG000|Overall Study|Lost to Follow-up|0|||
164222428|NCT00286455|593181866|FG001|Overall Study|Lost to Follow-up|3|||
164222429|NCT00286455|593181867|FG002|Overall Study|Lost to Follow-up|3|||
164222430|NCT00286455|593181865|FG000|Overall Study|Physician Decision|3|||
164222431|NCT00286455|593181866|FG001|Overall Study|Physician Decision|0|||
164222432|NCT00286455|593181867|FG002|Overall Study|Physician Decision|2|||
164222433|NCT00286455|593181865|FG000|Overall Study|Protocol Violation|1|||
164222434|NCT00286455|593181866|FG001|Overall Study|Protocol Violation|1|||
164222435|NCT00286455|593181867|FG002|Overall Study|Protocol Violation|0|||
164222436|NCT00286455|593181865|FG000|Overall Study|Participant Non-compliance|1|||
164222437|NCT00286455|593181866|FG001|Overall Study|Participant Non-compliance|0|||
164222438|NCT00286455|593181867|FG002|Overall Study|Participant Non-compliance|0|||
164222439|NCT00286455|593181865|FG000|Overall Study|Withdrawal by Subject|0|||
164222440|NCT00286455|593181866|FG001|Overall Study|Withdrawal by Subject|8|||
164222441|NCT00286455|593181867|FG002|Overall Study|Withdrawal by Subject|7|||
164222442|NCT01213251|593184552|FG000|Overall Study|Death|2|||
164222443|NCT01213251|593184553|FG001|Overall Study|Death|1|||
164222444|NCT01213251|593184554|FG002|Overall Study|Death|2|||
164222445|NCT01213251|593184552|FG000|Overall Study|Exit|3|||
164222446|NCT01213251|593184553|FG001|Overall Study|Exit|2|||
164222447|NCT01213251|593184554|FG002|Overall Study|Exit|8|||
164222448|NCT01213251|593184552|FG000|Overall Study|Protocol Violation|1|||
164222449|NCT01213251|593184553|FG001|Overall Study|Protocol Violation|1|||
164222450|NCT01213251|593184554|FG002|Overall Study|Protocol Violation|0|||
164222451|NCT01213251|593184552|FG000|Overall Study|Missed 18-Month Follow-up|0|||
164222452|NCT01213251|593184553|FG001|Overall Study|Missed 18-Month Follow-up|0|||
164222453|NCT01213251|593184554|FG002|Overall Study|Missed 18-Month Follow-up|1|||
164222454|NCT02933151|593184555|FG000|Overall Study|Lost to Follow-up|19|||
164222455|NCT02933151|593184556|FG001|Overall Study|Lost to Follow-up|18|||
164568026|NCT01583374|594447321|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
164222456|NCT02933151|593184555|FG000|Overall Study|Death|1732|||
164222457|NCT02933151|593184556|FG001|Overall Study|Death|1827|||
164222458|NCT02933151|593184555|FG000|Overall Study|Transplant|210|||
164222459|NCT02933151|593184556|FG001|Overall Study|Transplant|278|||
164222460|NCT02933151|593184555|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
164222461|NCT02933151|593184556|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
164222462|NCT02933151|593184555|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
164222463|NCT02933151|593184556|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
164222464|NCT02933151|593184555|FG000|Overall Study|Recovered Kidney Function|47|||
164222465|NCT02933151|593184556|FG001|Overall Study|Recovered Kidney Function|29|||
164222466|NCT00862277|593184559|FG000|Overall Study|Protocol Violation|1|||
164222467|NCT00862277|593184560|FG001|Overall Study|Protocol Violation|2|||
164222468|NCT00862277|593184561|FG002|Overall Study|Protocol Violation|5|||
164568027|NCT01583374|594447322|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
164568028|NCT01583374|594447323|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
164568029|NCT01583374|594447324|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
164222469|NCT02168439|593184562|FG000|Overall Study|Protocol Violation|0|||
164222470|NCT02168439|593184563|FG001|Overall Study|Protocol Violation|2|||
164222471|NCT02004275|593184564|FG000|Phase 1|Ineligible|0|||
164222472|NCT02004275|593184565|FG001|Phase 1|Ineligible|0|||
164222473|NCT02004275|593184566|FG002|Phase 1|Ineligible|0|||
164222474|NCT02004275|593184567|FG003|Phase 1|Ineligible|1|||
164222475|NCT02004275|593184568|FG004|Phase 1|Ineligible|1|||
164222476|NCT02004275|593184569|FG005|Phase 1|Ineligible|0|||
164222477|NCT02004275|593184564|FG000|Phase 1|Protocol Violation|0|||
164222478|NCT02004275|593184565|FG001|Phase 1|Protocol Violation|0|||
164222479|NCT02004275|593184566|FG002|Phase 1|Protocol Violation|0|||
164222480|NCT02004275|593184567|FG003|Phase 1|Protocol Violation|1|||
164222481|NCT02004275|593184568|FG004|Phase 1|Protocol Violation|0|||
164222482|NCT02004275|593184569|FG005|Phase 1|Protocol Violation|5|||
164222483|NCT02004275|593184564|FG000|Phase 2 Part 1|Ineligible|6|||
164222484|NCT02004275|593184565|FG001|Phase 2 Part 1|Ineligible|9|||
164222485|NCT02004275|593184566|FG002|Phase 2 Part 1|Ineligible|0|||
164222486|NCT02004275|593184567|FG003|Phase 2 Part 1|Ineligible|0|||
164222487|NCT02004275|593184568|FG004|Phase 2 Part 1|Ineligible|0|||
164222488|NCT02004275|593184569|FG005|Phase 2 Part 1|Ineligible|0|||
164222489|NCT02004275|593184564|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
164222490|NCT02004275|593184565|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
164222491|NCT02004275|593184566|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
164222492|NCT02004275|593184567|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
164222493|NCT02004275|593184568|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
164222494|NCT02004275|593184569|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
164222495|NCT04432298|593184572|FG000|Overall Study|Other than specified|1|||
164222496|NCT04432298|593184573|FG001|Overall Study|Other than specified|0|||
164222497|NCT04432298|593184572|FG000|Overall Study|Lost to Follow-up|0|||
164222498|NCT04432298|593184573|FG001|Overall Study|Lost to Follow-up|1|||
164222499|NCT04432298|593184572|FG000|Overall Study|Death|3|||
164222500|NCT04432298|593184573|FG001|Overall Study|Death|2|||
164222501|NCT04432298|593184572|FG000|Overall Study|Withdrawal by Subject|2|||
164222502|NCT04432298|593184573|FG001|Overall Study|Withdrawal by Subject|0|||
164222503|NCT01423084|593184576|FG000|Overall Study|Adverse Event|0|||
164222504|NCT01423084|593184577|FG001|Overall Study|Adverse Event|1|||
164222505|NCT01423084|593184576|FG000|Overall Study|Withdrawal by Subject|2|||
164671215|NCT03021018|594822951|FG002|Overall Study|Adverse Event|0|||
164671216|NCT03021018|594822949|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
164671217|NCT03021018|594822950|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
164671218|NCT03021018|594822951|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
164671219|NCT00328926|594822954|FG000|Overall Study|Pregnancy|2|||
164671220|NCT00328926|594822955|FG001|Overall Study|Pregnancy|1|||
164671221|NCT00328926|594822956|FG002|Overall Study|Pregnancy|0|||
164671222|NCT00328926|594822954|FG000|Overall Study|Lost to Follow-up|0|||
164671223|NCT00328926|594822955|FG001|Overall Study|Lost to Follow-up|1|||
164671224|NCT00328926|594822956|FG002|Overall Study|Lost to Follow-up|0|||
164671225|NCT00328926|594822954|FG000|Overall Study|Death|0|||
164671226|NCT00328926|594822955|FG001|Overall Study|Death|0|||
164671227|NCT00328926|594822956|FG002|Overall Study|Death|1|||
164671228|NCT00328926|594822954|FG000|Overall Study|In vitro fertilization treatment|0|||
164671229|NCT00328926|594822955|FG001|Overall Study|In vitro fertilization treatment|0|||
164671230|NCT00328926|594822956|FG002|Overall Study|In vitro fertilization treatment|1|||
164671231|NCT00328926|594822954|FG000|Overall Study|Lack of ovarian response|0|||
164671232|NCT00328926|594822955|FG001|Overall Study|Lack of ovarian response|1|||
164671233|NCT00328926|594822956|FG002|Overall Study|Lack of ovarian response|0|||
164671234|NCT02269657|594822957|FG000|Overall Study|Protocol Violation|3|||
164671235|NCT00834249|594822964|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
164671236|NCT00834249|594822965|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
164671237|NCT00834249|594822964|FG000|Second Intervention|Adverse Event|1|||
164671238|NCT00834249|594822965|FG001|Second Intervention|Adverse Event|0|||
164671239|NCT00834743|594822966|FG000|Second Intervention|Withdrawal by Subject|1|||
164671240|NCT00834743|594822967|FG001|Second Intervention|Withdrawal by Subject|0|||
164671241|NCT01534663|594822968|FG000|Overall Study|Lost to Follow-up|0|||
164222506|NCT01423084|593184577|FG001|Overall Study|Withdrawal by Subject|3|||
164222507|NCT01682603|593184581|FG000|Overall Study|Lost to Follow-up|3|||
164222508|NCT02462057|593184582|FG000|Overall Study|Left Vitality|32|||
164222509|NCT02462057|593184583|FG001|Overall Study|Left Vitality|27|||
164222510|NCT02462057|593184584|FG002|Overall Study|Left Vitality|23|||
164222511|NCT02462057|593184585|FG003|Overall Study|Left Vitality|35|||
164671242|NCT01534663|594822969|FG001|Overall Study|Lost to Follow-up|2|||
164671243|NCT01534663|594822968|FG000|Overall Study|Adverse Event|2|||
164671244|NCT01534663|594822969|FG001|Overall Study|Adverse Event|1|||
164222512|NCT02462057|593184586|FG004|Overall Study|Left Vitality|33|||
164671245|NCT04112823|594822972|FG000|Overall Study|Lost to Follow-up|2|||
164671246|NCT04112823|594822973|FG001|Overall Study|Lost to Follow-up|3|||
164671247|NCT01693523|594822974|FG000|Overall Study|Adverse Event|2|||
164222513|NCT02462057|593184582|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
164222514|NCT02462057|593184583|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
164222515|NCT02462057|593184584|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
164671248|NCT01693523|594822975|FG001|Overall Study|Adverse Event|1|||
164671249|NCT01693523|594822976|FG002|Overall Study|Adverse Event|0|||
164671250|NCT01693523|594822974|FG000|Overall Study|Death|0|||
164222516|NCT02462057|593184585|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
164222517|NCT02462057|593184586|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
164222518|NCT01791205|593184587|FG000|Phase II|Lack of Efficacy|6|||
164222519|NCT01791205|593184588|FG001|Phase II|Lack of Efficacy|0|||
164222520|NCT01791205|593184587|FG000|Phase II|Adverse Event|2|||
164222521|NCT01791205|593184588|FG001|Phase II|Adverse Event|0|||
164222522|NCT01791205|593184587|FG000|Phase II|Safety|1|||
164222523|NCT01791205|593184588|FG001|Phase II|Safety|0|||
164222524|NCT01791205|593184587|FG000|Phase II|Lost to Follow-up|1|||
164222525|NCT01791205|593184588|FG001|Phase II|Lost to Follow-up|0|||
164222526|NCT01791205|593184587|FG000|Phase II|Remission of disease|1|||
164222527|NCT01791205|593184588|FG001|Phase II|Remission of disease|0|||
164222528|NCT01791205|593184587|FG000|Phase II|Physician's decision|1|||
164222529|NCT01791205|593184588|FG001|Phase II|Physician's decision|0|||
164222530|NCT05345405|593184589|FG000|Overall Study|Withdrawal by Subject|2|||
164222531|NCT05345405|593184590|FG001|Overall Study|Withdrawal by Subject|0|||
164222532|NCT05345405|593184591|FG002|Overall Study|Withdrawal by Subject|0|||
164222533|NCT05345405|593184589|FG000|Overall Study|Did not meet eligibility criteria|0|||
164222534|NCT05345405|593184590|FG001|Overall Study|Did not meet eligibility criteria|2|||
164222535|NCT05345405|593184591|FG002|Overall Study|Did not meet eligibility criteria|0|||
164222536|NCT05345405|593184589|FG000|Overall Study|Lost to Follow-up|0|||
164222537|NCT05345405|593184590|FG001|Overall Study|Lost to Follow-up|0|||
164222538|NCT05345405|593184591|FG002|Overall Study|Lost to Follow-up|1|||
164222539|NCT01896986|593184592|FG000|Overall Study|samples lost|14|||
164222540|NCT01896986|593184593|FG001|Overall Study|samples lost|23|||
164222541|NCT01750281|593184594|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
164222542|NCT01750281|593184595|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
164222543|NCT01750281|593184596|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
164222544|NCT01750281|593184594|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
164222545|NCT01750281|593184595|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
164222546|NCT01750281|593184596|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
164222547|NCT01750281|593184594|FG000|Overall Study|Did not receive treatment|0|||
164222548|NCT01750281|593184595|FG001|Overall Study|Did not receive treatment|1|||
164222549|NCT01750281|593184596|FG002|Overall Study|Did not receive treatment|0|||
164222550|NCT04189588|593184597|FG000|Overall Study|Death|0|||
164222551|NCT04189588|593184598|FG001|Overall Study|Death|1|||
164222552|NCT04189588|593184597|FG000|Overall Study|Lost to Follow-up|0|||
164222553|NCT04189588|593184598|FG001|Overall Study|Lost to Follow-up|1|||
164222554|NCT01658735|593184602|FG000|Overall Study|Lack of Efficacy|1|||
164222555|NCT01658735|593184603|FG001|Overall Study|Lack of Efficacy|0|||
164222556|NCT01658735|593184604|FG002|Overall Study|Lack of Efficacy|1|||
164222557|NCT01658735|593184602|FG000|Overall Study|Lost to Follow-up|1|||
164222558|NCT01658735|593184603|FG001|Overall Study|Lost to Follow-up|1|||
164222559|NCT01658735|593184604|FG002|Overall Study|Lost to Follow-up|0|||
164222560|NCT01658735|593184602|FG000|Overall Study|Protocol Violation|0|||
164222561|NCT01658735|593184603|FG001|Overall Study|Protocol Violation|1|||
164222562|NCT01658735|593184604|FG002|Overall Study|Protocol Violation|0|||
164222563|NCT01658735|593184602|FG000|Overall Study|Withdrawal by Subject|3|||
164222564|NCT01658735|593184603|FG001|Overall Study|Withdrawal by Subject|5|||
164222565|NCT01658735|593184604|FG002|Overall Study|Withdrawal by Subject|3|||
164222566|NCT03757715|593184605|FG000|Overall Study|Lost to Follow-up|4|||
164222567|NCT03757715|593184606|FG001|Overall Study|Lost to Follow-up|9|||
164222568|NCT03757715|593184605|FG000|Overall Study|Withdrawal by Subject|1|||
164222569|NCT03757715|593184606|FG001|Overall Study|Withdrawal by Subject|1|||
164222570|NCT00281580|593184607|FG000|Overall Study|Adverse Event|2|||
164222571|NCT00281580|593184608|FG001|Overall Study|Adverse Event|0|||
164222572|NCT00281580|593184609|FG002|Overall Study|Adverse Event|2|||
164222573|NCT00281580|593184610|FG003|Overall Study|Adverse Event|4|||
164222574|NCT00281580|593184611|FG004|Overall Study|Adverse Event|1|||
164222575|NCT00281580|593184612|FG005|Overall Study|Adverse Event|0|||
164222576|NCT00281580|593184613|FG006|Overall Study|Adverse Event|1|||
164222577|NCT00281580|593184614|FG007|Overall Study|Adverse Event|0|||
164568030|NCT01583374|594447325|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
164222578|NCT00281580|593184615|FG008|Overall Study|Adverse Event|1|||
164222579|NCT00281580|593184616|FG009|Overall Study|Adverse Event|6|||
164568031|NCT01583374|594447317|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
164568032|NCT01583374|594447318|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
164568033|NCT01583374|594447319|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
164568034|NCT01583374|594447320|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
164568035|NCT01583374|594447321|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
164568036|NCT01583374|594447322|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
164568037|NCT01583374|594447323|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
164568038|NCT01583374|594447324|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
164222580|NCT00281580|593184617|FG010|Overall Study|Adverse Event|0|||
164222581|NCT00281580|593184618|FG011|Overall Study|Adverse Event|5|||
164222582|NCT00281580|593184619|FG012|Overall Study|Adverse Event|8|||
164222583|NCT00281580|593184620|FG013|Overall Study|Adverse Event|2|||
164222584|NCT00281580|593184621|FG014|Overall Study|Adverse Event|3|||
164222585|NCT00281580|593184622|FG015|Overall Study|Adverse Event|3|||
164222586|NCT00281580|593184607|FG000|Overall Study|Protocol Violation|0|||
164222587|NCT00281580|593184608|FG001|Overall Study|Protocol Violation|0|||
164222588|NCT00281580|593184609|FG002|Overall Study|Protocol Violation|1|||
164222589|NCT00281580|593184610|FG003|Overall Study|Protocol Violation|1|||
164568039|NCT01583374|594447325|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
164568040|NCT01583374|594447317|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
164568041|NCT01583374|594447318|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
164568042|NCT01583374|594447319|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
164568043|NCT01583374|594447320|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
164568044|NCT01583374|594447321|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
164568045|NCT01583374|594447322|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
164568046|NCT01583374|594447323|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
164568047|NCT01583374|594447324|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
164568048|NCT01583374|594447325|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
164568049|NCT01583374|594447317|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
164568050|NCT01583374|594447318|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
164568051|NCT01583374|594447319|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
164568052|NCT01583374|594447320|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
164568053|NCT01583374|594447321|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
164568054|NCT01583374|594447322|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
164568055|NCT01583374|594447323|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
164568056|NCT01583374|594447324|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
164568057|NCT01583374|594447325|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
164568058|NCT01583374|594447317|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
164568059|NCT01583374|594447318|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
164568060|NCT01583374|594447319|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
164568061|NCT01583374|594447320|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
164568062|NCT01583374|594447321|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
164568063|NCT01583374|594447322|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
164568064|NCT01583374|594447323|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
164568065|NCT01583374|594447324|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
164568066|NCT01583374|594447325|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
164568067|NCT01583374|594447317|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
164568068|NCT01583374|594447318|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
164568069|NCT01583374|594447319|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
164568070|NCT01583374|594447320|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
164568071|NCT01583374|594447321|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
164568072|NCT01583374|594447322|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
164568073|NCT01583374|594447323|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
164568074|NCT01583374|594447324|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
164568075|NCT01583374|594447325|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
164568076|NCT01583374|594447317|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
164568077|NCT01583374|594447318|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
164568078|NCT01583374|594447319|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
164568079|NCT01583374|594447320|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
164568080|NCT01583374|594447321|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
164568081|NCT01583374|594447322|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
164568082|NCT01583374|594447323|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
164568083|NCT01583374|594447324|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
164568084|NCT01583374|594447325|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
164568085|NCT01583374|594447317|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
164568086|NCT01583374|594447318|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
164568087|NCT01583374|594447319|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
164568088|NCT01583374|594447320|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
164568089|NCT01583374|594447321|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
164568090|NCT01583374|594447322|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
164568091|NCT01583374|594447323|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
164568092|NCT01583374|594447324|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
164671251|NCT01693523|594822975|FG001|Overall Study|Death|1|||
164222590|NCT00281580|593184611|FG004|Overall Study|Protocol Violation|0|||
164421033|NCT02138747|593911085|FG001|Treatment Period 1|Lost to Follow-up|1|||
164421034|NCT02138747|593911086|FG002|Treatment Period 1|Lost to Follow-up|1|||
164222591|NCT00281580|593184612|FG005|Overall Study|Protocol Violation|0|||
164568093|NCT01583374|594447325|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
164568094|NCT01583374|594447317|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
164568095|NCT01583374|594447318|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
164568096|NCT01583374|594447319|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
164568097|NCT01583374|594447320|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
164568098|NCT01583374|594447321|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
164568099|NCT01583374|594447322|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
164568100|NCT01583374|594447323|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
164568101|NCT01583374|594447324|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
164568102|NCT01583374|594447325|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
164568103|NCT01583374|594447317|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
164568104|NCT01583374|594447318|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
164568105|NCT01583374|594447319|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
164568106|NCT01583374|594447320|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
164568107|NCT01583374|594447321|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
164568108|NCT01583374|594447322|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
164568109|NCT01583374|594447323|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
164568110|NCT01583374|594447324|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
164568111|NCT01583374|594447325|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
164568112|NCT01583374|594447317|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
164568113|NCT01583374|594447318|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
164568114|NCT01583374|594447319|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
164568115|NCT01583374|594447320|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
164568116|NCT01583374|594447321|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
164568117|NCT01583374|594447322|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
164568118|NCT01583374|594447323|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
164568119|NCT01583374|594447324|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
164568120|NCT01583374|594447325|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
164568121|NCT01292057|594447326|FG000|Overall Study|Protocol Violation|1|||
164568122|NCT01292057|594447327|FG001|Overall Study|Protocol Violation|1|||
164568123|NCT01292057|594447326|FG000|Overall Study|Lost to Follow-up|1|||
164568124|NCT01292057|594447327|FG001|Overall Study|Lost to Follow-up|1|||
164568125|NCT02307370|594447328|FG000|Overall Study|Death|5|||
164568126|NCT02307370|594447328|FG000|Overall Study|Lost to Follow-up|1|||
164568127|NCT02307370|594447328|FG000|Overall Study|Withdrawal by Subject|1|||
164568128|NCT02307370|594447328|FG000|Overall Study|Declined Addendum ICF|6|||
164568129|NCT02307370|594447328|FG000|Overall Study|No response during telephone contact|5|||
164568130|NCT02307370|594447328|FG000|Overall Study|Protocol Violation|1|||
164568131|NCT03641560|594447329|FG000|Overall Study|Withdrawal by Subject|6|||
164568132|NCT03641560|594447329|FG000|Overall Study|Progressive disease|40|||
164568133|NCT03641560|594447329|FG000|Overall Study|Death|6|||
164568134|NCT02732951|594449075|FG000|Overall Study|Other than listed|1|||
164568135|NCT02732951|594449076|FG001|Overall Study|Other than listed|0|||
164568136|NCT02732951|594449075|FG000|Overall Study|Lost to Follow-up|0|||
164568137|NCT02732951|594449076|FG001|Overall Study|Lost to Follow-up|1|||
164568138|NCT02732951|594449075|FG000|Overall Study|Adverse Event|4|||
164568139|NCT02732951|594449076|FG001|Overall Study|Adverse Event|4|||
164568140|NCT02732951|594449075|FG000|Overall Study|Protocol Violation|0|||
164568141|NCT02732951|594449076|FG001|Overall Study|Protocol Violation|1|||
164568142|NCT02031679|594449077|FG000|Overall Study|Protocol Violation|0|||
164568143|NCT02031679|594449078|FG001|Overall Study|Protocol Violation|1|||
164568144|NCT02031679|594449077|FG000|Overall Study|Lack of Efficacy|0|||
164568145|NCT02031679|594449078|FG001|Overall Study|Lack of Efficacy|1|||
164568146|NCT01974817|594449079|FG000|Overall Study|Death|4|||
164568147|NCT01974817|594449079|FG000|Overall Study|Lost to Follow-up|2|||
164568148|NCT01974817|594449079|FG000|Overall Study|Protocol Violation|2|||
164568149|NCT00110305|594449084|FG000|Overall Study|Adverse Event|46|||
164568150|NCT00110305|594449085|FG001|Overall Study|Adverse Event|13|||
164568151|NCT00110305|594449084|FG000|Overall Study|Sponsors Decision|1|||
164568152|NCT00110305|594449085|FG001|Overall Study|Sponsors Decision|0|||
164568153|NCT00110305|594449084|FG000|Overall Study|Subject Non-Compliant|9|||
164568154|NCT00110305|594449085|FG001|Overall Study|Subject Non-Compliant|2|||
164568155|NCT00110305|594449084|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
164568156|NCT00110305|594449085|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
164222592|NCT00281580|593184613|FG006|Overall Study|Protocol Violation|1|||
164222593|NCT00281580|593184614|FG007|Overall Study|Protocol Violation|0|||
164222594|NCT00281580|593184615|FG008|Overall Study|Protocol Violation|2|||
164222595|NCT00281580|593184616|FG009|Overall Study|Protocol Violation|0|||
164222596|NCT00281580|593184617|FG010|Overall Study|Protocol Violation|1|||
164222597|NCT00281580|593184618|FG011|Overall Study|Protocol Violation|2|||
164222598|NCT00281580|593184619|FG012|Overall Study|Protocol Violation|0|||
164222599|NCT00281580|593184620|FG013|Overall Study|Protocol Violation|1|||
164222600|NCT00281580|593184621|FG014|Overall Study|Protocol Violation|1|||
164222601|NCT00281580|593184622|FG015|Overall Study|Protocol Violation|3|||
164222602|NCT00281580|593184607|FG000|Overall Study|Withdrawal by Subject|3|||
164568157|NCT00110305|594449084|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
164568158|NCT00110305|594449085|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
164568159|NCT00110305|594449084|FG000|Overall Study|Protocol Violation|0|||
164568160|NCT00110305|594449085|FG001|Overall Study|Protocol Violation|1|||
164568161|NCT00110305|594449084|FG000|Overall Study|Withdrawal by Subject|7|||
164568162|NCT00110305|594449085|FG001|Overall Study|Withdrawal by Subject|7|||
164568163|NCT00110305|594449084|FG000|Overall Study|Lost to Follow-up|20|||
164568164|NCT00110305|594449085|FG001|Overall Study|Lost to Follow-up|3|||
164568165|NCT00110305|594449084|FG000|Overall Study|Other|8|||
164568166|NCT00110305|594449085|FG001|Overall Study|Other|2|||
164568167|NCT03658889|594449086|FG000|Overall Study|Protocol Violation|2|||
164568168|NCT03658889|594449087|FG001|Overall Study|Protocol Violation|0|||
164568169|NCT01609933|594449091|FG000|Overall Study|Adverse Event|1|||
164568170|NCT01609933|594449091|FG000|Overall Study|Withdrawal by Subject|3|||
164568171|NCT04188197|594449093|FG000|Overall Study|Lost to Follow-up|4|||
164568172|NCT04188197|594449094|FG001|Overall Study|Lost to Follow-up|1|||
164568173|NCT04188197|594449093|FG000|Overall Study|Withdrawal by Subject|1|||
164568174|NCT04188197|594449094|FG001|Overall Study|Withdrawal by Subject|1|||
164568175|NCT04188197|594449093|FG000|Overall Study|Pregnancy|0|||
164568176|NCT04188197|594449094|FG001|Overall Study|Pregnancy|1|||
164568177|NCT00463476|594449099|FG000|Overall Study|Withdrawal by Subject|1|||
164568178|NCT00463476|594449100|FG001|Overall Study|Withdrawal by Subject|2|||
164568179|NCT00463476|594449099|FG000|Overall Study|Lost to Follow-up|1|||
164568180|NCT00463476|594449100|FG001|Overall Study|Lost to Follow-up|1|||
164568181|NCT00849017|594449102|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
164568182|NCT00849017|594449103|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
164568183|NCT00849017|594449104|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
164568184|NCT00849017|594449102|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
164568185|NCT00849017|594449103|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
164568186|NCT00849017|594449104|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
164568187|NCT00849017|594449102|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
164568188|NCT00849017|594449103|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
164568189|NCT00849017|594449104|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
164568190|NCT00849017|594449102|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
164568191|NCT00849017|594449103|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
164568192|NCT00849017|594449104|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
164568193|NCT00849017|594449102|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
164568194|NCT00849017|594449103|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
164568195|NCT00849017|594449104|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
164568196|NCT00849017|594449102|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
164568197|NCT00849017|594449103|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
164568198|NCT00849017|594449104|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
164568199|NCT00849017|594449102|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
164568200|NCT00849017|594449103|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
164568201|NCT00849017|594449104|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
164568202|NCT00849017|594449102|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
164568203|NCT00849017|594449103|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
164568204|NCT00849017|594449104|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
164568205|NCT00849017|594449102|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
164568206|NCT00849017|594449103|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
164568207|NCT00849017|594449104|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
164568208|NCT00849017|594449102|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
164568209|NCT00849017|594449103|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
164568210|NCT00849017|594449104|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
164568211|NCT00849017|594449102|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
164568212|NCT00849017|594449103|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
164568213|NCT00849017|594449104|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
164568214|NCT00849017|594449102|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
164568215|NCT00849017|594449103|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
164568216|NCT00849017|594449104|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
164568217|NCT00849017|594449102|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
164568218|NCT00849017|594449103|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
164568219|NCT00849017|594449104|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
164568220|NCT00849017|594449102|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
164568221|NCT00849017|594449103|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
164568222|NCT00849017|594449104|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
164568223|NCT00849017|594449102|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
164568224|NCT00849017|594449103|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
164222603|NCT00281580|593184608|FG001|Overall Study|Withdrawal by Subject|0|||
164222604|NCT00281580|593184609|FG002|Overall Study|Withdrawal by Subject|1|||
164222605|NCT00281580|593184610|FG003|Overall Study|Withdrawal by Subject|1|||
164222606|NCT00281580|593184611|FG004|Overall Study|Withdrawal by Subject|1|||
164222607|NCT00281580|593184612|FG005|Overall Study|Withdrawal by Subject|2|||
164222608|NCT00281580|593184613|FG006|Overall Study|Withdrawal by Subject|2|||
164222609|NCT00281580|593184614|FG007|Overall Study|Withdrawal by Subject|0|||
164222610|NCT00281580|593184615|FG008|Overall Study|Withdrawal by Subject|1|||
164222611|NCT00281580|593184616|FG009|Overall Study|Withdrawal by Subject|4|||
164222612|NCT00281580|593184617|FG010|Overall Study|Withdrawal by Subject|1|||
164222613|NCT00281580|593184618|FG011|Overall Study|Withdrawal by Subject|1|||
164222614|NCT00281580|593184619|FG012|Overall Study|Withdrawal by Subject|2|||
164222615|NCT00281580|593184620|FG013|Overall Study|Withdrawal by Subject|2|||
164222616|NCT00281580|593184621|FG014|Overall Study|Withdrawal by Subject|1|||
164222617|NCT00281580|593184622|FG015|Overall Study|Withdrawal by Subject|5|||
164222618|NCT00281580|593184607|FG000|Overall Study|Lack of Efficacy|2|||
164222619|NCT00281580|593184608|FG001|Overall Study|Lack of Efficacy|1|||
164222620|NCT00281580|593184609|FG002|Overall Study|Lack of Efficacy|1|||
164222621|NCT00281580|593184610|FG003|Overall Study|Lack of Efficacy|6|||
164222622|NCT00281580|593184611|FG004|Overall Study|Lack of Efficacy|2|||
164222623|NCT00281580|593184612|FG005|Overall Study|Lack of Efficacy|0|||
164222624|NCT00281580|593184613|FG006|Overall Study|Lack of Efficacy|0|||
164222625|NCT00281580|593184614|FG007|Overall Study|Lack of Efficacy|0|||
164222626|NCT00281580|593184615|FG008|Overall Study|Lack of Efficacy|0|||
164222627|NCT00281580|593184616|FG009|Overall Study|Lack of Efficacy|0|||
164222628|NCT00281580|593184617|FG010|Overall Study|Lack of Efficacy|0|||
164222629|NCT00281580|593184618|FG011|Overall Study|Lack of Efficacy|1|||
164222630|NCT00281580|593184619|FG012|Overall Study|Lack of Efficacy|0|||
164222631|NCT00281580|593184620|FG013|Overall Study|Lack of Efficacy|2|||
164222632|NCT00281580|593184621|FG014|Overall Study|Lack of Efficacy|1|||
164222633|NCT00281580|593184622|FG015|Overall Study|Lack of Efficacy|0|||
164222634|NCT00281580|593184607|FG000|Overall Study|Lost to Follow-up|0|||
164222635|NCT00281580|593184608|FG001|Overall Study|Lost to Follow-up|0|||
164222636|NCT00281580|593184609|FG002|Overall Study|Lost to Follow-up|0|||
164222637|NCT00281580|593184610|FG003|Overall Study|Lost to Follow-up|3|||
164222638|NCT00281580|593184611|FG004|Overall Study|Lost to Follow-up|0|||
164222639|NCT00281580|593184612|FG005|Overall Study|Lost to Follow-up|1|||
164222640|NCT00281580|593184613|FG006|Overall Study|Lost to Follow-up|0|||
164222641|NCT00281580|593184614|FG007|Overall Study|Lost to Follow-up|1|||
164222642|NCT00281580|593184615|FG008|Overall Study|Lost to Follow-up|2|||
164222643|NCT00281580|593184616|FG009|Overall Study|Lost to Follow-up|1|||
164222644|NCT00281580|593184617|FG010|Overall Study|Lost to Follow-up|1|||
164222645|NCT00281580|593184618|FG011|Overall Study|Lost to Follow-up|0|||
164222646|NCT00281580|593184619|FG012|Overall Study|Lost to Follow-up|1|||
164222647|NCT00281580|593184620|FG013|Overall Study|Lost to Follow-up|0|||
164671252|NCT01693523|594822976|FG002|Overall Study|Death|1|||
164671253|NCT01693523|594822974|FG000|Overall Study|Lost to Follow-up|0|||
164671254|NCT01693523|594822975|FG001|Overall Study|Lost to Follow-up|0|||
164671255|NCT01693523|594822976|FG002|Overall Study|Lost to Follow-up|4|||
164671256|NCT01693523|594822974|FG000|Overall Study|Physician Decision|0|||
164671257|NCT01693523|594822975|FG001|Overall Study|Physician Decision|0|||
164671258|NCT01693523|594822976|FG002|Overall Study|Physician Decision|1|||
164671259|NCT01693523|594822974|FG000|Overall Study|Withdrawal by Subject|1|||
164671260|NCT01693523|594822975|FG001|Overall Study|Withdrawal by Subject|2|||
164671261|NCT01693523|594822976|FG002|Overall Study|Withdrawal by Subject|2|||
164671262|NCT01693523|594822974|FG000|Overall Study|Lack of compliance study medication|1|||
164671263|NCT01693523|594822975|FG001|Overall Study|Lack of compliance study medication|2|||
164671264|NCT01693523|594822976|FG002|Overall Study|Lack of compliance study medication|0|||
164671265|NCT01693523|594822974|FG000|Overall Study|Chemotherapy was held|1|||
164671266|NCT01693523|594822975|FG001|Overall Study|Chemotherapy was held|2|||
164671267|NCT01693523|594822976|FG002|Overall Study|Chemotherapy was held|0|||
164671268|NCT01440283|594822979|FG000|Overall Study|Death|3|||
164671269|NCT01440283|594822979|FG000|Overall Study|Withdrawal by Subject|4|||
164671270|NCT01440283|594822979|FG000|Overall Study|Physician Decision|3|||
164671271|NCT01196052|594822980|FG000|Overall Study|Adverse Event|9|||
164671272|NCT01196052|594822980|FG000|Overall Study|Lost to Follow-up|1|||
164671273|NCT01196052|594822980|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
164671274|NCT01196052|594822980|FG000|Overall Study|Reason not Specified|5|||
164671275|NCT01196052|594822980|FG000|Overall Study|Withdrawal by Subject|6|||
164671276|NCT03603314|594822981|FG000|Overall Study|Lost to Follow-up|0|||
164671277|NCT03603314|594822982|FG001|Overall Study|Lost to Follow-up|3|||
164671278|NCT03603314|594822983|FG002|Overall Study|Lost to Follow-up|0|||
164222648|NCT00281580|593184621|FG014|Overall Study|Lost to Follow-up|0|||
164222649|NCT00281580|593184622|FG015|Overall Study|Lost to Follow-up|0|||
164222650|NCT00281580|593184607|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
164222651|NCT00281580|593184608|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
164222652|NCT00281580|593184609|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
164329133|NCT00406718|593581324|FG001|Overall Study|Lost to Follow-up|5|||
164222653|NCT00281580|593184610|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
164222654|NCT00281580|593184611|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
164222655|NCT00281580|593184612|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
164222656|NCT00281580|593184613|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
164222657|NCT00281580|593184614|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
164222658|NCT00281580|593184615|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
164222659|NCT00281580|593184616|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
164222660|NCT00281580|593184617|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
164222661|NCT00281580|593184618|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
164222662|NCT00281580|593184619|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
164222663|NCT00281580|593184620|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
164222664|NCT00281580|593184621|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
164222665|NCT00281580|593184622|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
164222666|NCT03302936|593184624|FG000|Overall Study|Protocol Violation|3|||
164222667|NCT03302936|593184625|FG001|Overall Study|Protocol Violation|4|||
164222668|NCT01379937|593184626|FG000|Overall Study|Protocol Violation|0|||
164222669|NCT01379937|593184627|FG001|Overall Study|Protocol Violation|0|||
164222670|NCT01379937|593184628|FG002|Overall Study|Protocol Violation|0|||
164222671|NCT01379937|593184629|FG003|Overall Study|Protocol Violation|1|||
164222672|NCT01379937|593184626|FG000|Overall Study|Consent withdrawal|0|||
164222673|NCT01379937|593184627|FG001|Overall Study|Consent withdrawal|1|||
164222674|NCT01379937|593184628|FG002|Overall Study|Consent withdrawal|0|||
164222675|NCT01379937|593184629|FG003|Overall Study|Consent withdrawal|0|||
164222676|NCT01379937|593184626|FG000|Overall Study|Lost to Follow-up|1|||
164222677|NCT01379937|593184627|FG001|Overall Study|Lost to Follow-up|2|||
164568225|NCT00849017|594449104|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
164568226|NCT00849017|594449102|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
164568227|NCT00849017|594449103|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
164222678|NCT01379937|593184628|FG002|Overall Study|Lost to Follow-up|2|||
164222679|NCT01379937|593184629|FG003|Overall Study|Lost to Follow-up|0|||
164222680|NCT01122680|593184630|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
164222681|NCT01122680|593184631|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
164222682|NCT01122680|593184632|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
164222683|NCT01122680|593184633|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
164222684|NCT01122680|593184630|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
164222685|NCT01122680|593184631|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
164222686|NCT01122680|593184632|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
164222687|NCT01122680|593184633|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
164222688|NCT01122680|593184630|FG000|Period 1 (4 Weeks)|Other|1|||
164222689|NCT01122680|593184631|FG001|Period 1 (4 Weeks)|Other|1|||
164222690|NCT01122680|593184632|FG002|Period 1 (4 Weeks)|Other|0|||
164222691|NCT01122680|593184633|FG003|Period 1 (4 Weeks)|Other|0|||
164222692|NCT01122680|593184630|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
164222693|NCT01122680|593184631|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
164222694|NCT01122680|593184632|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
164222695|NCT01122680|593184633|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
164222696|NCT01122680|593184630|FG000|Period 2 (4 Weeks)|Other|1|||
164222697|NCT01122680|593184631|FG001|Period 2 (4 Weeks)|Other|0|||
164222698|NCT01122680|593184632|FG002|Period 2 (4 Weeks)|Other|0|||
164222699|NCT01122680|593184633|FG003|Period 2 (4 Weeks)|Other|0|||
164222700|NCT01122680|593184630|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
164222701|NCT01122680|593184631|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
164222702|NCT01122680|593184632|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
164222703|NCT01122680|593184633|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
164222704|NCT01122680|593184630|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
164222705|NCT01122680|593184631|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
164222706|NCT01122680|593184632|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
164222707|NCT01122680|593184633|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
164222708|NCT02264821|593184636|FG000|Overall Study|Protocol Violation|1|||
164222709|NCT02264821|593184637|FG001|Overall Study|Protocol Violation|3|||
164222710|NCT02264821|593184638|FG002|Overall Study|Protocol Violation|6|||
164222711|NCT02067156|593184641|FG000|Overall Study|Lost to Follow-up|4|||
164222712|NCT01853280|593184642|FG000|Overall Study|Lack of Efficacy|2|||
164222713|NCT01853280|593184643|FG001|Overall Study|Lack of Efficacy|2|||
164222714|NCT01853280|593184642|FG000|Overall Study|Lost to Follow-up|0|||
164222715|NCT01853280|593184643|FG001|Overall Study|Lost to Follow-up|1|||
164222716|NCT01853280|593184642|FG000|Overall Study|Physician Decision|0|||
164222717|NCT01853280|593184643|FG001|Overall Study|Physician Decision|1|||
164222718|NCT01853280|593184642|FG000|Overall Study|Withdrawal by Subject|0|||
164222719|NCT01853280|593184643|FG001|Overall Study|Withdrawal by Subject|1|||
164222720|NCT01853280|593184642|FG000|Overall Study|Ineligible|0|||
164222721|NCT01853280|593184643|FG001|Overall Study|Ineligible|1|||
164222722|NCT01655069|593184644|FG000|Overall Study|Physician Decision|0|||
164222723|NCT01655069|593184645|FG001|Overall Study|Physician Decision|0|||
164222724|NCT01655069|593184646|FG002|Overall Study|Physician Decision|0|||
164222725|NCT01655069|593184647|FG003|Overall Study|Physician Decision|1|||
164222726|NCT01655069|593184644|FG000|Overall Study|Adverse Event|6|||
164222727|NCT01655069|593184645|FG001|Overall Study|Adverse Event|7|||
164222728|NCT01655069|593184646|FG002|Overall Study|Adverse Event|2|||
164222729|NCT01655069|593184647|FG003|Overall Study|Adverse Event|3|||
164222730|NCT01655069|593184644|FG000|Overall Study|Lack of Efficacy|0|||
164222731|NCT01655069|593184645|FG001|Overall Study|Lack of Efficacy|1|||
164222732|NCT01655069|593184646|FG002|Overall Study|Lack of Efficacy|0|||
164222733|NCT01655069|593184647|FG003|Overall Study|Lack of Efficacy|0|||
164222734|NCT01655069|593184644|FG000|Overall Study|No Treatment Needed|0|||
164222735|NCT01655069|593184645|FG001|Overall Study|No Treatment Needed|1|||
164222736|NCT01655069|593184646|FG002|Overall Study|No Treatment Needed|0|||
164222737|NCT01655069|593184647|FG003|Overall Study|No Treatment Needed|0|||
164222738|NCT01655069|593184644|FG000|Overall Study|Withdrawal by Subject|2|||
164222739|NCT01655069|593184645|FG001|Overall Study|Withdrawal by Subject|3|||
164222740|NCT01655069|593184646|FG002|Overall Study|Withdrawal by Subject|0|||
164222741|NCT01655069|593184647|FG003|Overall Study|Withdrawal by Subject|0|||
164222742|NCT00104884|593184648|FG000|Overall Study|Disease progression|4|||
164222743|NCT03473301|593184649|FG000|Overall Study|Protocol Violation|4|||
164222744|NCT03473301|593184650|FG001|Overall Study|Protocol Violation|0|||
164222745|NCT03473301|593184651|FG002|Overall Study|Protocol Violation|0|||
164222746|NCT03473301|593184649|FG000|Overall Study|Withdrawal by Subject|0|||
164222747|NCT03473301|593184650|FG001|Overall Study|Withdrawal by Subject|1|||
164222748|NCT03473301|593184651|FG002|Overall Study|Withdrawal by Subject|0|||
164222749|NCT03473301|593184649|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
164222750|NCT03473301|593184650|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
164222751|NCT03473301|593184651|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
164222752|NCT05529173|593184652|FG000|Overall Study|Physician Decision|3|||
164222753|NCT05529173|593184653|FG001|Overall Study|Physician Decision|6|||
164222754|NCT05529173|593184652|FG000|Overall Study|Sample shipment delay more than one day|4|||
164222755|NCT05529173|593184653|FG001|Overall Study|Sample shipment delay more than one day|0|||
164222756|NCT00835042|593184656|FG000|First Intervention|Withdrawal by Subject|3|||
164222757|NCT00835042|593184657|FG001|First Intervention|Withdrawal by Subject|0|||
164222758|NCT00835042|593184656|FG000|First Intervention|Adverse Event|1|||
164222759|NCT00835042|593184657|FG001|First Intervention|Adverse Event|2|||
164222760|NCT00835042|593184656|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
164222761|NCT00835042|593184657|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
164222762|NCT03760081|593184658|FG000|Overall Study|Miscellaneous|0|||
164222763|NCT03760081|593184659|FG001|Overall Study|Miscellaneous|1|||
164222764|NCT03760081|593184658|FG000|Overall Study|Progressive Disease|5|||
164222765|NCT03760081|593184659|FG001|Overall Study|Progressive Disease|10|||
164222766|NCT03760081|593184658|FG000|Overall Study|Death|1|||
164222767|NCT03760081|593184659|FG001|Overall Study|Death|1|||
164222768|NCT04034056|593184660|FG000|Overall Study|Withdrawal by Subject|2|||
164222769|NCT04034056|593184660|FG000|Overall Study|Reason Not Specified|13|||
164222770|NCT04034056|593184660|FG000|Overall Study|Adverse Event|56|||
164222771|NCT04135352|593184662|FG000|Overall Study|Not treated-randomization error|0|||
164222772|NCT04135352|593184663|FG001|Overall Study|Not treated-randomization error|0|||
164222773|NCT04135352|593184664|FG002|Overall Study|Not treated-randomization error|1|||
164222774|NCT04135352|593184665|FG003|Overall Study|Not treated-randomization error|0|||
164222775|NCT04135352|593184666|FG004|Overall Study|Not treated-randomization error|0|||
164222776|NCT04135352|593184667|FG005|Overall Study|Not treated-randomization error|0|||
164222777|NCT04135352|593184668|FG006|Overall Study|Not treated-randomization error|0|||
164222778|NCT04135352|593184669|FG007|Overall Study|Not treated-randomization error|0|||
164222779|NCT04135352|593184662|FG000|Overall Study|Withdrawal by Subject|0|||
164222780|NCT04135352|593184663|FG001|Overall Study|Withdrawal by Subject|0|||
164222781|NCT04135352|593184664|FG002|Overall Study|Withdrawal by Subject|2|||
164222782|NCT04135352|593184665|FG003|Overall Study|Withdrawal by Subject|0|||
164222783|NCT04135352|593184666|FG004|Overall Study|Withdrawal by Subject|0|||
164222784|NCT04135352|593184667|FG005|Overall Study|Withdrawal by Subject|0|||
164222785|NCT04135352|593184668|FG006|Overall Study|Withdrawal by Subject|0|||
164222786|NCT04135352|593184669|FG007|Overall Study|Withdrawal by Subject|0|||
164222787|NCT04135352|593184662|FG000|Overall Study|Sponsor Decision|0|||
164222788|NCT04135352|593184663|FG001|Overall Study|Sponsor Decision|0|||
164222789|NCT04135352|593184664|FG002|Overall Study|Sponsor Decision|2|||
164222790|NCT04135352|593184665|FG003|Overall Study|Sponsor Decision|5|||
164222791|NCT04135352|593184666|FG004|Overall Study|Sponsor Decision|1|||
164222792|NCT04135352|593184667|FG005|Overall Study|Sponsor Decision|4|||
164222793|NCT04135352|593184668|FG006|Overall Study|Sponsor Decision|0|||
164222794|NCT04135352|593184669|FG007|Overall Study|Sponsor Decision|0|||
164222795|NCT04135352|593184662|FG000|Overall Study|Physician Decision|0|||
164222796|NCT04135352|593184663|FG001|Overall Study|Physician Decision|0|||
164222797|NCT04135352|593184664|FG002|Overall Study|Physician Decision|1|||
164222798|NCT04135352|593184665|FG003|Overall Study|Physician Decision|0|||
164222799|NCT04135352|593184666|FG004|Overall Study|Physician Decision|1|||
164222800|NCT04135352|593184667|FG005|Overall Study|Physician Decision|0|||
164222801|NCT04135352|593184668|FG006|Overall Study|Physician Decision|0|||
164222802|NCT04135352|593184669|FG007|Overall Study|Physician Decision|0|||
164222803|NCT04135352|593184662|FG000|Overall Study|Death|3|||
164222804|NCT04135352|593184663|FG001|Overall Study|Death|4|||
164222805|NCT04135352|593184664|FG002|Overall Study|Death|7|||
164222806|NCT04135352|593184665|FG003|Overall Study|Death|0|||
164222807|NCT04135352|593184666|FG004|Overall Study|Death|3|||
164222808|NCT04135352|593184667|FG005|Overall Study|Death|1|||
164222809|NCT04135352|593184668|FG006|Overall Study|Death|0|||
164222810|NCT04135352|593184669|FG007|Overall Study|Death|0|||
164222811|NCT02453191|593184670|FG000|Overall Study|Withdrawal by Subject|1|||
164222812|NCT02571244|593184671|FG000|Overall Study|Lost to Follow-up|0|||
164222813|NCT02571244|593184672|FG001|Overall Study|Lost to Follow-up|1|||
164222814|NCT02571244|593184671|FG000|Overall Study|Unable to reach out post discharge|3|||
164222815|NCT02571244|593184672|FG001|Overall Study|Unable to reach out post discharge|0|||
164222816|NCT01696214|593184675|FG000|Overall Study|Lost to Follow-up|1|||
164222817|NCT01696214|593184676|FG001|Overall Study|Lost to Follow-up|0|||
164222818|NCT01696214|593184677|FG002|Overall Study|Lost to Follow-up|0|||
164222819|NCT01696214|593184678|FG003|Overall Study|Lost to Follow-up|0|||
164222820|NCT02134028|593184679|FG000|Overall Study|Lack of Efficacy|1|||
164222821|NCT02134028|593184680|FG001|Overall Study|Lack of Efficacy|0|||
164222822|NCT02134028|593184681|FG002|Overall Study|Lack of Efficacy|3|||
164222823|NCT02134028|593184682|FG003|Overall Study|Lack of Efficacy|2|||
164222824|NCT02134028|593184683|FG004|Overall Study|Lack of Efficacy|1|||
164222825|NCT02134028|593184684|FG005|Overall Study|Lack of Efficacy|2|||
164222826|NCT02134028|593184685|FG006|Overall Study|Lack of Efficacy|1|||
164222827|NCT02134028|593184686|FG007|Overall Study|Lack of Efficacy|0|||
164222828|NCT02134028|593184679|FG000|Overall Study|Poor compliance to protocol|1|||
164222829|NCT02134028|593184680|FG001|Overall Study|Poor compliance to protocol|1|||
164222830|NCT02134028|593184681|FG002|Overall Study|Poor compliance to protocol|3|||
164222831|NCT02134028|593184682|FG003|Overall Study|Poor compliance to protocol|7|||
164222832|NCT02134028|593184683|FG004|Overall Study|Poor compliance to protocol|1|||
164222833|NCT02134028|593184684|FG005|Overall Study|Poor compliance to protocol|1|||
164222834|NCT02134028|593184685|FG006|Overall Study|Poor compliance to protocol|0|||
164222835|NCT02134028|593184686|FG007|Overall Study|Poor compliance to protocol|0|||
164222836|NCT02134028|593184679|FG000|Overall Study|Other unspecified|4|||
164222837|NCT02134028|593184680|FG001|Overall Study|Other unspecified|22|||
164222838|NCT02134028|593184681|FG002|Overall Study|Other unspecified|33|||
164222839|NCT02134028|593184682|FG003|Overall Study|Other unspecified|64|||
164222840|NCT02134028|593184683|FG004|Overall Study|Other unspecified|8|||
164222841|NCT02134028|593184684|FG005|Overall Study|Other unspecified|6|||
164222842|NCT02134028|593184685|FG006|Overall Study|Other unspecified|2|||
164222843|NCT02134028|593184686|FG007|Overall Study|Other unspecified|1|||
164222844|NCT02134028|593184679|FG000|Overall Study|Adverse Event|3|||
164222845|NCT02134028|593184680|FG001|Overall Study|Adverse Event|19|||
164222846|NCT02134028|593184681|FG002|Overall Study|Adverse Event|13|||
164222847|NCT02134028|593184682|FG003|Overall Study|Adverse Event|32|||
164222848|NCT02134028|593184683|FG004|Overall Study|Adverse Event|4|||
164222849|NCT02134028|593184684|FG005|Overall Study|Adverse Event|5|||
164222850|NCT02134028|593184685|FG006|Overall Study|Adverse Event|1|||
164222851|NCT02134028|593184686|FG007|Overall Study|Adverse Event|2|||
164222852|NCT01210443|593184687|FG000|Overall Study|Study terminated by sponsor|2|||
164222853|NCT02807181|593184690|FG000|Overall Study|Death|28|||
164222854|NCT02807181|593184691|FG001|Overall Study|Death|24|||
164222855|NCT02807181|593184690|FG000|Overall Study|Withdrawal by Subject|1|||
164222856|NCT02807181|593184691|FG001|Overall Study|Withdrawal by Subject|1|||
164222857|NCT02807181|593184690|FG000|Overall Study|Lost to Follow-up|0|||
164222858|NCT02807181|593184691|FG001|Overall Study|Lost to Follow-up|2|||
164222859|NCT02807181|593184690|FG000|Overall Study|Subject decision|1|||
164222860|NCT02807181|593184691|FG001|Overall Study|Subject decision|0|||
164222861|NCT02807181|593184690|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
164671279|NCT03603314|594822981|FG000|Overall Study|Protocol Violation|0|||
164671280|NCT03603314|594822982|FG001|Overall Study|Protocol Violation|1|||
164671281|NCT03603314|594822983|FG002|Overall Study|Protocol Violation|0|||
164671282|NCT03603314|594822981|FG000|Overall Study|Adverse Event|2|||
164671283|NCT03603314|594822982|FG001|Overall Study|Adverse Event|0|||
164671284|NCT03603314|594822983|FG002|Overall Study|Adverse Event|0|||
164671285|NCT03603314|594822981|FG000|Overall Study|Physician Decision|1|||
164671286|NCT03603314|594822982|FG001|Overall Study|Physician Decision|1|||
164671287|NCT03603314|594822983|FG002|Overall Study|Physician Decision|0|||
164671288|NCT03603314|594822981|FG000|Overall Study|Withdrawal by Subject|4|||
164671289|NCT03603314|594822982|FG001|Overall Study|Withdrawal by Subject|5|||
164222862|NCT02807181|593184691|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
164222863|NCT02807181|593184690|FG000|Overall Study|In Study|3|||
164222864|NCT02807181|593184691|FG001|Overall Study|In Study|3|||
164222865|NCT02807181|593184690|FG000|Overall Study|Post Progression|3|||
164222866|NCT02807181|593184691|FG001|Overall Study|Post Progression|2|||
164222867|NCT01309100|593184694|FG000|Overall Study|Protocol Violation|1|||
164222868|NCT01309100|593184694|FG000|Overall Study|Positive Slit lamp finding|1|||
164222869|NCT03722030|593184695|FG000|Overall Study|Withdrawal by Subject|1|||
164671290|NCT03603314|594822983|FG002|Overall Study|Withdrawal by Subject|3|||
164671291|NCT03603314|594822981|FG000|Overall Study|Other|0|||
164671292|NCT03603314|594822982|FG001|Overall Study|Other|1|||
164222870|NCT03722030|593184696|FG001|Overall Study|Withdrawal by Subject|0|||
164222871|NCT01663987|593184698|FG000|Overall Study|Adverse Event|7|||
164222872|NCT01663987|593184699|FG001|Overall Study|Adverse Event|2|||
164222873|NCT01663987|593184698|FG000|Overall Study|Lost to Follow-up|1|||
164222874|NCT01663987|593184699|FG001|Overall Study|Lost to Follow-up|1|||
164222875|NCT01663987|593184698|FG000|Overall Study|Withdrawal by Subject|2|||
164222876|NCT01663987|593184699|FG001|Overall Study|Withdrawal by Subject|3|||
164222877|NCT01663987|593184698|FG000|Overall Study|Other reason not defined above|3|||
164222878|NCT01663987|593184699|FG001|Overall Study|Other reason not defined above|0|||
164222879|NCT00468546|593184701|FG000|Week 24 Analysis|Lack of Efficacy|83|||
164222880|NCT00468546|593184702|FG001|Week 24 Analysis|Lack of Efficacy|37|||
164222881|NCT00468546|593184701|FG000|Week 24 Analysis|Refused treatment|5|||
164222882|NCT00468546|593184702|FG001|Week 24 Analysis|Refused treatment|5|||
164222883|NCT00468546|593184701|FG000|Week 24 Analysis|Adverse Event|1|||
164222884|NCT00468546|593184702|FG001|Week 24 Analysis|Adverse Event|8|||
164222885|NCT00468546|593184701|FG000|Week 24 Analysis|Failure to return|3|||
164222886|NCT00468546|593184702|FG001|Week 24 Analysis|Failure to return|4|||
164222887|NCT00468546|593184701|FG000|Week 24 Analysis|Rescue therapy|2|||
164222888|NCT00468546|593184702|FG001|Week 24 Analysis|Rescue therapy|0|||
164222889|NCT00468546|593184701|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
164222890|NCT00468546|593184702|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
164222891|NCT00468546|593184701|FG000|Week 24 Analysis|Due to clinical hold|1|||
164222892|NCT00468546|593184702|FG001|Week 24 Analysis|Due to clinical hold|0|||
164222893|NCT00468546|593184701|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
164222894|NCT00468546|593184702|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
164222895|NCT00468546|593184701|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
164222896|NCT00468546|593184702|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
164222897|NCT00468546|593184701|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
164222898|NCT00468546|593184702|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
164222899|NCT00468546|593184701|FG000|Week 24 to Week 104 Analysis|Death|1|||
164222900|NCT00468546|593184702|FG001|Week 24 to Week 104 Analysis|Death|0|||
164222901|NCT00468546|593184701|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
164222902|NCT00468546|593184702|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
164222903|NCT00468546|593184701|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
164222904|NCT00468546|593184702|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
164222905|NCT00468546|593184701|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
164222906|NCT00468546|593184702|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
164222907|NCT00468546|593184701|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
164222908|NCT00468546|593184702|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
164222909|NCT00468546|593184701|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
164222910|NCT00468546|593184702|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
164222911|NCT00468546|593184701|FG000|Week 24 to Week 104 Analysis|Other|17|||
164222912|NCT00468546|593184702|FG001|Week 24 to Week 104 Analysis|Other|14|||
164222913|NCT04000724|593184705|FG000|Overall Study|Withdrawal by Subject|5|||
164222914|NCT04000724|593184706|FG001|Overall Study|Withdrawal by Subject|3|||
164222915|NCT04000724|593184707|FG002|Overall Study|Withdrawal by Subject|4|||
164222916|NCT04000724|593184705|FG000|Overall Study|Lost to Follow-up|11|||
164222917|NCT04000724|593184706|FG001|Overall Study|Lost to Follow-up|7|||
164222918|NCT04000724|593184707|FG002|Overall Study|Lost to Follow-up|13|||
164222919|NCT00455455|593184708|FG000|Washout|Withdrawal by Subject|0|||
164222920|NCT00455455|593184709|FG001|Washout|Withdrawal by Subject|1|||
164222921|NCT00455455|593184708|FG000|Washout|Withdrawal by Subject|1|||
164222922|NCT00455455|593184709|FG001|Washout|Withdrawal by Subject|0|||
164222923|NCT00472641|593184710|FG000|Overall Study|Lack of Efficacy|3|||
164222924|NCT00472641|593184710|FG000|Overall Study|Adverse Event|3|||
164222925|NCT00472641|593184710|FG000|Overall Study|Lost to Follow-up|1|||
164222926|NCT00676689|593184713|FG000|Overall Study|Screen Failure|2|||
164222927|NCT00676689|593184713|FG000|Overall Study|Death|2|||
164222928|NCT00676689|593184713|FG000|Overall Study|Lost to Follow-up|4|||
164222929|NCT00676689|593184713|FG000|Overall Study|Physician Decision|1|||
164222930|NCT00676689|593184713|FG000|Overall Study|Withdrawal by Subject|3|||
164222931|NCT00676689|593184713|FG000|Overall Study|Continuing FU|49|||
164222932|NCT01827943|593184714|FG000|Overall Study|Protocol Violation|8|||
164222933|NCT01827943|593184714|FG000|Overall Study|Never treated because of an rapid progression|1|||
164421035|NCT02138747|593911087|FG003|Treatment Period 1|Lost to Follow-up|0|||
164421036|NCT02138747|593911084|FG000|Treatment Period 1|Protocol Violation|0|||
164222934|NCT00501085|593184715|FG000|Overall Study|Lost to Follow-up|195|||
164222935|NCT00501085|593184715|FG000|Overall Study|Withdrawal by Subject|34|||
164222936|NCT00501085|593184715|FG000|Overall Study|Subject Decision|1|||
164222937|NCT00501085|593184715|FG000|Overall Study|Revision Surgery|7|||
164222938|NCT00501085|593184715|FG000|Overall Study|Explantation Surgery|26|||
164222939|NCT00501085|593184715|FG000|Overall Study|Adverse Event|4|||
164222940|NCT00501085|593184715|FG000|Overall Study|Non-Compliance|24|||
164222941|NCT00501085|593184715|FG000|Overall Study|Study closed by sponsor|109|||
164222942|NCT00501085|593184715|FG000|Overall Study|Other loss to follow-up|32|||
164222943|NCT01487161|593184716|FG000|Overall Study|Adverse Event|1|||
164222944|NCT01487161|593184717|FG001|Overall Study|Adverse Event|0|||
164222945|NCT01487161|593184718|FG002|Overall Study|Adverse Event|0|||
164222946|NCT01487161|593184719|FG003|Overall Study|Adverse Event|0|||
164222947|NCT01487161|593184716|FG000|Overall Study|Withdrawal by Subject|1|||
164222948|NCT01487161|593184717|FG001|Overall Study|Withdrawal by Subject|1|||
164222949|NCT01487161|593184718|FG002|Overall Study|Withdrawal by Subject|1|||
164222950|NCT01487161|593184719|FG003|Overall Study|Withdrawal by Subject|2|||
164222951|NCT01487161|593184716|FG000|Overall Study|missing data|0|||
164222952|NCT01487161|593184717|FG001|Overall Study|missing data|1|||
164222953|NCT01487161|593184718|FG002|Overall Study|missing data|0|||
164222954|NCT01487161|593184719|FG003|Overall Study|missing data|0|||
164222955|NCT01084135|593184720|FG000|20 Week|Physician Decision|0|||
164222956|NCT01084135|593184721|FG001|20 Week|Physician Decision|1|||
164222957|NCT00663351|593184722|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
164222958|NCT00663351|593184723|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
164222959|NCT00663351|593184722|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
164222960|NCT00663351|593184723|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
164222961|NCT00663351|593184722|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
164222962|NCT00663351|593184723|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
164222963|NCT00663351|593184722|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
164222964|NCT00663351|593184723|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
164222965|NCT00663351|593184722|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
164222966|NCT00663351|593184723|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
164222967|NCT00663351|593184722|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
164222968|NCT00663351|593184723|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
164222969|NCT02366130|593184724|FG000|Overall Study|Withdrawal by Subject|3|||
164222970|NCT02366130|593184724|FG000|Overall Study|Ineligible|6|||
164222971|NCT01065766|593184725|FG000|Overall Study|Assessed before the contracted date|1|||
164222972|NCT01065766|593184725|FG000|Overall Study|Contraindication to administration|6|||
164222973|NCT01065766|593184725|FG000|Overall Study|Violated dosage/administration|25|||
164222974|NCT04518410|593184729|FG000|Overall Study|Lost to Follow-up|1|||
164222975|NCT04518410|593184730|FG001|Overall Study|Lost to Follow-up|1|||
164222976|NCT04518410|593184731|FG002|Overall Study|Lost to Follow-up|8|||
164222977|NCT04518410|593184732|FG003|Overall Study|Lost to Follow-up|5|||
164222978|NCT04518410|593184733|FG004|Overall Study|Lost to Follow-up|92|||
164222979|NCT04518410|593184734|FG005|Overall Study|Lost to Follow-up|25|||
164222980|NCT04518410|593184735|FG006|Overall Study|Lost to Follow-up|25|||
164222981|NCT04518410|593184736|FG007|Overall Study|Lost to Follow-up|3|||
164222982|NCT04518410|593184737|FG008|Overall Study|Lost to Follow-up|2|||
164222983|NCT04518410|593184738|FG009|Overall Study|Lost to Follow-up|13|||
164222984|NCT04518410|593184739|FG010|Overall Study|Lost to Follow-up|9|||
164222985|NCT04518410|593184740|FG011|Overall Study|Lost to Follow-up|13|||
164222986|NCT04518410|593184741|FG012|Overall Study|Lost to Follow-up|9|||
164222987|NCT04518410|593184742|FG013|Overall Study|Lost to Follow-up|13|||
164222988|NCT04518410|593184743|FG014|Overall Study|Lost to Follow-up|8|||
164222989|NCT04518410|593184744|FG015|Overall Study|Lost to Follow-up|10|||
164222990|NCT04518410|593184745|FG016|Overall Study|Lost to Follow-up|6|||
164222991|NCT04518410|593184746|FG017|Overall Study|Lost to Follow-up|13|||
164222992|NCT04518410|593184747|FG018|Overall Study|Lost to Follow-up|21|||
164222993|NCT04518410|593184748|FG019|Overall Study|Lost to Follow-up|6|||
164222994|NCT04518410|593184749|FG020|Overall Study|Lost to Follow-up|7|||
164222995|NCT04518410|593184750|FG021|Overall Study|Lost to Follow-up|21|||
164222996|NCT04518410|593184751|FG022|Overall Study|Lost to Follow-up|1|||
164222997|NCT04518410|593184752|FG023|Overall Study|Lost to Follow-up|7|||
164222998|NCT04518410|593184753|FG024|Overall Study|Lost to Follow-up|6|||
164222999|NCT04518410|593184729|FG000|Overall Study|Withdrawal by Subject|1|||
164223000|NCT04518410|593184730|FG001|Overall Study|Withdrawal by Subject|2|||
164223001|NCT04518410|593184731|FG002|Overall Study|Withdrawal by Subject|2|||
164223002|NCT04518410|593184732|FG003|Overall Study|Withdrawal by Subject|3|||
164223003|NCT04518410|593184733|FG004|Overall Study|Withdrawal by Subject|20|||
164223004|NCT04518410|593184734|FG005|Overall Study|Withdrawal by Subject|20|||
164223005|NCT04518410|593184735|FG006|Overall Study|Withdrawal by Subject|25|||
164223006|NCT04518410|593184736|FG007|Overall Study|Withdrawal by Subject|6|||
164223007|NCT04518410|593184737|FG008|Overall Study|Withdrawal by Subject|1|||
164223008|NCT04518410|593184738|FG009|Overall Study|Withdrawal by Subject|12|||
164223009|NCT04518410|593184739|FG010|Overall Study|Withdrawal by Subject|5|||
164223010|NCT04518410|593184740|FG011|Overall Study|Withdrawal by Subject|7|||
164223011|NCT04518410|593184741|FG012|Overall Study|Withdrawal by Subject|2|||
164223012|NCT04518410|593184742|FG013|Overall Study|Withdrawal by Subject|13|||
164223013|NCT04518410|593184743|FG014|Overall Study|Withdrawal by Subject|4|||
164223014|NCT04518410|593184744|FG015|Overall Study|Withdrawal by Subject|9|||
164223015|NCT04518410|593184745|FG016|Overall Study|Withdrawal by Subject|0|||
164223016|NCT04518410|593184746|FG017|Overall Study|Withdrawal by Subject|15|||
164223017|NCT04518410|593184747|FG018|Overall Study|Withdrawal by Subject|12|||
164223018|NCT04518410|593184748|FG019|Overall Study|Withdrawal by Subject|9|||
164223019|NCT04518410|593184749|FG020|Overall Study|Withdrawal by Subject|14|||
164223020|NCT04518410|593184750|FG021|Overall Study|Withdrawal by Subject|3|||
164223021|NCT04518410|593184751|FG022|Overall Study|Withdrawal by Subject|2|||
164223022|NCT04518410|593184752|FG023|Overall Study|Withdrawal by Subject|9|||
164223023|NCT04518410|593184753|FG024|Overall Study|Withdrawal by Subject|8|||
164223024|NCT04518410|593184729|FG000|Overall Study|Other|1|||
164223025|NCT04518410|593184730|FG001|Overall Study|Other|0|||
164223026|NCT04518410|593184731|FG002|Overall Study|Other|0|||
164223027|NCT04518410|593184732|FG003|Overall Study|Other|1|||
164223028|NCT04518410|593184733|FG004|Overall Study|Other|6|||
164223029|NCT04518410|593184734|FG005|Overall Study|Other|6|||
164223030|NCT04518410|593184735|FG006|Overall Study|Other|5|||
164223031|NCT04518410|593184736|FG007|Overall Study|Other|2|||
164223032|NCT04518410|593184737|FG008|Overall Study|Other|0|||
164223033|NCT04518410|593184738|FG009|Overall Study|Other|1|||
164223034|NCT04518410|593184739|FG010|Overall Study|Other|0|||
164223035|NCT04518410|593184740|FG011|Overall Study|Other|2|||
164223036|NCT04518410|593184741|FG012|Overall Study|Other|0|||
164223037|NCT04518410|593184742|FG013|Overall Study|Other|0|||
164223038|NCT04518410|593184743|FG014|Overall Study|Other|0|||
164223039|NCT04518410|593184744|FG015|Overall Study|Other|3|||
164223040|NCT04518410|593184745|FG016|Overall Study|Other|1|||
164223041|NCT04518410|593184746|FG017|Overall Study|Other|1|||
164223042|NCT04518410|593184747|FG018|Overall Study|Other|1|||
164223043|NCT04518410|593184748|FG019|Overall Study|Other|0|||
164223044|NCT04518410|593184749|FG020|Overall Study|Other|1|||
164223045|NCT04518410|593184750|FG021|Overall Study|Other|0|||
164223046|NCT04518410|593184751|FG022|Overall Study|Other|1|||
164223047|NCT04518410|593184752|FG023|Overall Study|Other|2|||
164223048|NCT04518410|593184753|FG024|Overall Study|Other|2|||
164223049|NCT04518410|593184729|FG000|Overall Study|Protocol Violation|0|||
164223050|NCT04518410|593184730|FG001|Overall Study|Protocol Violation|0|||
164223051|NCT04518410|593184731|FG002|Overall Study|Protocol Violation|0|||
164223052|NCT04518410|593184732|FG003|Overall Study|Protocol Violation|2|||
164223053|NCT04518410|593184733|FG004|Overall Study|Protocol Violation|17|||
164223054|NCT04518410|593184734|FG005|Overall Study|Protocol Violation|1|||
164223055|NCT04518410|593184735|FG006|Overall Study|Protocol Violation|2|||
164223056|NCT04518410|593184736|FG007|Overall Study|Protocol Violation|1|||
164223057|NCT04518410|593184737|FG008|Overall Study|Protocol Violation|0|||
164223058|NCT04518410|593184738|FG009|Overall Study|Protocol Violation|0|||
164223059|NCT04518410|593184739|FG010|Overall Study|Protocol Violation|0|||
164223060|NCT04518410|593184740|FG011|Overall Study|Protocol Violation|0|||
164223061|NCT04518410|593184741|FG012|Overall Study|Protocol Violation|0|||
164223062|NCT04518410|593184742|FG013|Overall Study|Protocol Violation|0|||
164223063|NCT04518410|593184743|FG014|Overall Study|Protocol Violation|0|||
164223064|NCT04518410|593184744|FG015|Overall Study|Protocol Violation|0|||
164223065|NCT04518410|593184745|FG016|Overall Study|Protocol Violation|1|||
164223066|NCT04518410|593184746|FG017|Overall Study|Protocol Violation|1|||
164223067|NCT04518410|593184747|FG018|Overall Study|Protocol Violation|0|||
164223068|NCT04518410|593184748|FG019|Overall Study|Protocol Violation|0|||
164223069|NCT04518410|593184749|FG020|Overall Study|Protocol Violation|1|||
164223070|NCT04518410|593184750|FG021|Overall Study|Protocol Violation|2|||
164223071|NCT04518410|593184751|FG022|Overall Study|Protocol Violation|0|||
164223072|NCT04518410|593184752|FG023|Overall Study|Protocol Violation|3|||
164223073|NCT04518410|593184753|FG024|Overall Study|Protocol Violation|0|||
164223074|NCT04518410|593184729|FG000|Overall Study|Death|0|||
164223075|NCT04518410|593184730|FG001|Overall Study|Death|0|||
164568228|NCT00849017|594449104|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
164568229|NCT00849017|594449102|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
164568230|NCT00849017|594449103|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
164568231|NCT00849017|594449104|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
164223076|NCT04518410|593184731|FG002|Overall Study|Death|0|||
164568232|NCT00849017|594449102|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
164568233|NCT00849017|594449103|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
164568234|NCT00849017|594449104|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
164223077|NCT04518410|593184732|FG003|Overall Study|Death|0|||
164568235|NCT00849017|594449102|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
164223078|NCT04518410|593184733|FG004|Overall Study|Death|12|||
164223079|NCT04518410|593184734|FG005|Overall Study|Death|2|||
164223080|NCT04518410|593184735|FG006|Overall Study|Death|11|||
164223081|NCT04518410|593184736|FG007|Overall Study|Death|0|||
164223082|NCT04518410|593184737|FG008|Overall Study|Death|1|||
164223083|NCT04518410|593184738|FG009|Overall Study|Death|0|||
164223084|NCT04518410|593184739|FG010|Overall Study|Death|0|||
164223085|NCT04518410|593184740|FG011|Overall Study|Death|0|||
164223086|NCT04518410|593184741|FG012|Overall Study|Death|0|||
164223087|NCT04518410|593184742|FG013|Overall Study|Death|1|||
164223088|NCT04518410|593184743|FG014|Overall Study|Death|1|||
164223089|NCT04518410|593184744|FG015|Overall Study|Death|0|||
164223090|NCT04518410|593184745|FG016|Overall Study|Death|0|||
164223091|NCT04518410|593184746|FG017|Overall Study|Death|1|||
164223092|NCT04518410|593184747|FG018|Overall Study|Death|4|||
164223093|NCT04518410|593184748|FG019|Overall Study|Death|4|||
164223094|NCT04518410|593184749|FG020|Overall Study|Death|1|||
164223095|NCT04518410|593184750|FG021|Overall Study|Death|0|||
164223096|NCT04518410|593184751|FG022|Overall Study|Death|0|||
164223097|NCT04518410|593184752|FG023|Overall Study|Death|0|||
164223098|NCT04518410|593184753|FG024|Overall Study|Death|0|||
164223099|NCT04518410|593184729|FG000|Overall Study|Requirement to start alternative therapy|0|||
164223100|NCT04518410|593184730|FG001|Overall Study|Requirement to start alternative therapy|0|||
164223101|NCT04518410|593184731|FG002|Overall Study|Requirement to start alternative therapy|1|||
164223102|NCT04518410|593184732|FG003|Overall Study|Requirement to start alternative therapy|0|||
164223103|NCT04518410|593184733|FG004|Overall Study|Requirement to start alternative therapy|0|||
164223104|NCT04518410|593184734|FG005|Overall Study|Requirement to start alternative therapy|0|||
164223105|NCT04518410|593184735|FG006|Overall Study|Requirement to start alternative therapy|0|||
164223106|NCT04518410|593184736|FG007|Overall Study|Requirement to start alternative therapy|0|||
164223107|NCT04518410|593184737|FG008|Overall Study|Requirement to start alternative therapy|0|||
164223108|NCT04518410|593184738|FG009|Overall Study|Requirement to start alternative therapy|0|||
164223109|NCT04518410|593184739|FG010|Overall Study|Requirement to start alternative therapy|0|||
164223110|NCT04518410|593184740|FG011|Overall Study|Requirement to start alternative therapy|0|||
164223111|NCT04518410|593184741|FG012|Overall Study|Requirement to start alternative therapy|0|||
164223112|NCT04518410|593184742|FG013|Overall Study|Requirement to start alternative therapy|0|||
164223113|NCT04518410|593184743|FG014|Overall Study|Requirement to start alternative therapy|0|||
164223114|NCT04518410|593184744|FG015|Overall Study|Requirement to start alternative therapy|0|||
164223115|NCT04518410|593184745|FG016|Overall Study|Requirement to start alternative therapy|0|||
164223116|NCT04518410|593184746|FG017|Overall Study|Requirement to start alternative therapy|0|||
164223117|NCT04518410|593184747|FG018|Overall Study|Requirement to start alternative therapy|0|||
164223118|NCT04518410|593184748|FG019|Overall Study|Requirement to start alternative therapy|0|||
164223119|NCT04518410|593184749|FG020|Overall Study|Requirement to start alternative therapy|0|||
164223120|NCT04518410|593184750|FG021|Overall Study|Requirement to start alternative therapy|0|||
164223121|NCT04518410|593184751|FG022|Overall Study|Requirement to start alternative therapy|0|||
164223122|NCT04518410|593184752|FG023|Overall Study|Requirement to start alternative therapy|0|||
164223123|NCT04518410|593184753|FG024|Overall Study|Requirement to start alternative therapy|0|||
164223124|NCT04518410|593184729|FG000|Overall Study|Randomized but not treated|0|||
164223125|NCT04518410|593184730|FG001|Overall Study|Randomized but not treated|0|||
164223126|NCT04518410|593184731|FG002|Overall Study|Randomized but not treated|0|||
164223127|NCT04518410|593184732|FG003|Overall Study|Randomized but not treated|2|||
164223128|NCT04518410|593184733|FG004|Overall Study|Randomized but not treated|6|||
164223129|NCT04518410|593184734|FG005|Overall Study|Randomized but not treated|4|||
164223130|NCT04518410|593184735|FG006|Overall Study|Randomized but not treated|3|||
164223131|NCT04518410|593184736|FG007|Overall Study|Randomized but not treated|3|||
164223132|NCT04518410|593184737|FG008|Overall Study|Randomized but not treated|0|||
164223133|NCT04518410|593184738|FG009|Overall Study|Randomized but not treated|4|||
164223134|NCT04518410|593184739|FG010|Overall Study|Randomized but not treated|0|||
164223135|NCT04518410|593184740|FG011|Overall Study|Randomized but not treated|0|||
164223136|NCT04518410|593184741|FG012|Overall Study|Randomized but not treated|1|||
164223137|NCT04518410|593184742|FG013|Overall Study|Randomized but not treated|3|||
164223138|NCT04518410|593184743|FG014|Overall Study|Randomized but not treated|3|||
164223139|NCT04518410|593184744|FG015|Overall Study|Randomized but not treated|3|||
164223140|NCT04518410|593184745|FG016|Overall Study|Randomized but not treated|4|||
164223141|NCT04518410|593184746|FG017|Overall Study|Randomized but not treated|5|||
164223142|NCT04518410|593184747|FG018|Overall Study|Randomized but not treated|4|||
164223143|NCT04518410|593184748|FG019|Overall Study|Randomized but not treated|0|||
164223144|NCT04518410|593184749|FG020|Overall Study|Randomized but not treated|0|||
164223145|NCT04518410|593184750|FG021|Overall Study|Randomized but not treated|5|||
164223146|NCT04518410|593184751|FG022|Overall Study|Randomized but not treated|0|||
164223147|NCT04518410|593184752|FG023|Overall Study|Randomized but not treated|3|||
164223148|NCT04518410|593184753|FG024|Overall Study|Randomized but not treated|1|||
164223149|NCT04518410|593184729|FG000|Overall Study|Screen Fail but Randomized|0|||
164223150|NCT04518410|593184730|FG001|Overall Study|Screen Fail but Randomized|0|||
164223151|NCT04518410|593184731|FG002|Overall Study|Screen Fail but Randomized|0|||
164223152|NCT04518410|593184732|FG003|Overall Study|Screen Fail but Randomized|0|||
164223153|NCT04518410|593184733|FG004|Overall Study|Screen Fail but Randomized|2|||
164223154|NCT04518410|593184734|FG005|Overall Study|Screen Fail but Randomized|0|||
164223155|NCT04518410|593184735|FG006|Overall Study|Screen Fail but Randomized|0|||
164223156|NCT04518410|593184736|FG007|Overall Study|Screen Fail but Randomized|0|||
164223157|NCT04518410|593184737|FG008|Overall Study|Screen Fail but Randomized|0|||
164223158|NCT04518410|593184738|FG009|Overall Study|Screen Fail but Randomized|0|||
164223159|NCT04518410|593184739|FG010|Overall Study|Screen Fail but Randomized|0|||
164223160|NCT04518410|593184740|FG011|Overall Study|Screen Fail but Randomized|0|||
164223161|NCT04518410|593184741|FG012|Overall Study|Screen Fail but Randomized|0|||
164223162|NCT04518410|593184742|FG013|Overall Study|Screen Fail but Randomized|0|||
164223163|NCT04518410|593184743|FG014|Overall Study|Screen Fail but Randomized|0|||
164223164|NCT04518410|593184744|FG015|Overall Study|Screen Fail but Randomized|0|||
164223165|NCT04518410|593184745|FG016|Overall Study|Screen Fail but Randomized|0|||
164223166|NCT04518410|593184746|FG017|Overall Study|Screen Fail but Randomized|0|||
164223167|NCT04518410|593184747|FG018|Overall Study|Screen Fail but Randomized|0|||
164223168|NCT04518410|593184748|FG019|Overall Study|Screen Fail but Randomized|0|||
164223169|NCT04518410|593184749|FG020|Overall Study|Screen Fail but Randomized|0|||
164223170|NCT04518410|593184750|FG021|Overall Study|Screen Fail but Randomized|0|||
164223171|NCT04518410|593184751|FG022|Overall Study|Screen Fail but Randomized|0|||
164223172|NCT04518410|593184752|FG023|Overall Study|Screen Fail but Randomized|0|||
164223173|NCT04518410|593184753|FG024|Overall Study|Screen Fail but Randomized|0|||
164223174|NCT04518410|593184729|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
164223175|NCT04518410|593184730|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
164223176|NCT04518410|593184731|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
164223177|NCT04518410|593184732|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
164223178|NCT04518410|593184733|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
164223179|NCT04518410|593184734|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
164671293|NCT03603314|594822983|FG002|Overall Study|Other|0|||
164223180|NCT04518410|593184735|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
164223181|NCT04518410|593184736|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
164329134|NCT00406718|593581325|FG002|Overall Study|Lost to Follow-up|4|||
164223182|NCT04518410|593184737|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
164223183|NCT04518410|593184738|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
164223184|NCT04518410|593184739|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
164223185|NCT04518410|593184740|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
164223186|NCT04518410|593184741|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
164223187|NCT04518410|593184742|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
164223188|NCT04518410|593184743|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
164223189|NCT04518410|593184744|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
164223190|NCT04518410|593184745|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
164223191|NCT04518410|593184746|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
164223192|NCT04518410|593184747|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
164223193|NCT04518410|593184748|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
164223194|NCT04518410|593184749|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
164223195|NCT04518410|593184750|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
164223196|NCT04518410|593184751|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
164223197|NCT04518410|593184752|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
164223198|NCT04518410|593184753|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
164223199|NCT04518410|593184729|FG000|Overall Study|Dual Enrolled Subject|0|||
164223200|NCT04518410|593184730|FG001|Overall Study|Dual Enrolled Subject|0|||
164223201|NCT04518410|593184731|FG002|Overall Study|Dual Enrolled Subject|0|||
164223202|NCT04518410|593184732|FG003|Overall Study|Dual Enrolled Subject|0|||
164223203|NCT04518410|593184733|FG004|Overall Study|Dual Enrolled Subject|0|||
164223204|NCT04518410|593184734|FG005|Overall Study|Dual Enrolled Subject|0|||
164223205|NCT04518410|593184735|FG006|Overall Study|Dual Enrolled Subject|0|||
164223206|NCT04518410|593184736|FG007|Overall Study|Dual Enrolled Subject|0|||
164223207|NCT04518410|593184737|FG008|Overall Study|Dual Enrolled Subject|0|||
164223208|NCT04518410|593184738|FG009|Overall Study|Dual Enrolled Subject|0|||
164223209|NCT04518410|593184739|FG010|Overall Study|Dual Enrolled Subject|0|||
164223210|NCT04518410|593184740|FG011|Overall Study|Dual Enrolled Subject|0|||
164223211|NCT04518410|593184741|FG012|Overall Study|Dual Enrolled Subject|0|||
164223212|NCT04518410|593184742|FG013|Overall Study|Dual Enrolled Subject|0|||
164223213|NCT04518410|593184743|FG014|Overall Study|Dual Enrolled Subject|0|||
164223214|NCT04518410|593184744|FG015|Overall Study|Dual Enrolled Subject|0|||
164223215|NCT04518410|593184745|FG016|Overall Study|Dual Enrolled Subject|0|||
164223216|NCT04518410|593184746|FG017|Overall Study|Dual Enrolled Subject|1|||
164223217|NCT04518410|593184747|FG018|Overall Study|Dual Enrolled Subject|0|||
164223218|NCT04518410|593184748|FG019|Overall Study|Dual Enrolled Subject|0|||
164223219|NCT04518410|593184749|FG020|Overall Study|Dual Enrolled Subject|0|||
164223220|NCT04518410|593184750|FG021|Overall Study|Dual Enrolled Subject|0|||
164223221|NCT04518410|593184751|FG022|Overall Study|Dual Enrolled Subject|0|||
164223222|NCT04518410|593184752|FG023|Overall Study|Dual Enrolled Subject|0|||
164223223|NCT04518410|593184753|FG024|Overall Study|Dual Enrolled Subject|0|||
164223224|NCT05737745|593184754|FG000|Overall Study|Withdrawal by Subject|0|||
164223225|NCT05737745|593184755|FG001|Overall Study|Withdrawal by Subject|6|||
164223226|NCT05737745|593184756|FG002|Overall Study|Withdrawal by Subject|1|||
164223227|NCT02569242|593184757|FG000|Overall Study|Death|1|||
164223228|NCT02569242|593184758|FG001|Overall Study|Death|0|||
164223229|NCT02569242|593184757|FG000|Overall Study|Withdrawal by Subject|0|||
164223230|NCT02569242|593184758|FG001|Overall Study|Withdrawal by Subject|1|||
164223231|NCT02057666|593184759|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
164421037|NCT02138747|593911085|FG001|Treatment Period 1|Protocol Violation|2|||
164223232|NCT02057666|593184760|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
164223233|NCT02057666|593184759|FG000|Double Blind Treatment Period|Poor tolerability|7|||
164223234|NCT02057666|593184760|FG001|Double Blind Treatment Period|Poor tolerability|2|||
164223235|NCT02057666|593184759|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
164223236|NCT02057666|593184760|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
164223237|NCT02057666|593184759|FG000|Double Blind Treatment Period|Physician Decision|1|||
164568236|NCT00849017|594449103|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
164568237|NCT00849017|594449104|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
164568238|NCT04067518|594449106|FG000|Overall Study|Adverse Event|1|||
164568239|NCT04067518|594449107|FG001|Overall Study|Adverse Event|3|||
164568240|NCT04067518|594449106|FG000|Overall Study|Screen failures|0|||
164568241|NCT04067518|594449107|FG001|Overall Study|Screen failures|1|||
164568242|NCT04067518|594449106|FG000|Overall Study|Enrolled but not treated|0|||
164568243|NCT04067518|594449107|FG001|Overall Study|Enrolled but not treated|1|||
164568244|NCT00110019|594449108|FG000|Overall Study|Lack of Efficacy|253|||
164568245|NCT00110019|594449109|FG001|Overall Study|Lack of Efficacy|285|||
164568246|NCT00110019|594449108|FG000|Overall Study|Adverse Event|61|||
164568247|NCT00110019|594449109|FG001|Overall Study|Adverse Event|40|||
164568248|NCT00110019|594449108|FG000|Overall Study|Death|13|||
164568249|NCT00110019|594449109|FG001|Overall Study|Death|15|||
164568250|NCT00110019|594449108|FG000|Overall Study|Withdrawal by Subject|21|||
164568251|NCT00110019|594449109|FG001|Overall Study|Withdrawal by Subject|9|||
164223238|NCT02057666|593184760|FG001|Double Blind Treatment Period|Physician Decision|0|||
164223239|NCT02057666|593184759|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
164568252|NCT00110019|594449108|FG000|Overall Study|alternative therapy|5|||
164568253|NCT00110019|594449109|FG001|Overall Study|alternative therapy|1|||
164568254|NCT00110019|594449108|FG000|Overall Study|complicating disease|1|||
164671294|NCT00436553|594822984|FG000|Overall Study|Adverse Event|4|||
164671295|NCT00436553|594822985|FG001|Overall Study|Adverse Event|3|||
164671296|NCT00436553|594822986|FG002|Overall Study|Adverse Event|4|||
164671297|NCT00436553|594822984|FG000|Overall Study|Death|3|||
164671298|NCT00436553|594822985|FG001|Overall Study|Death|1|||
164671299|NCT00436553|594822986|FG002|Overall Study|Death|3|||
164671300|NCT00436553|594822984|FG000|Overall Study|Lost to Follow-up|0|||
164223240|NCT02057666|593184760|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
164223241|NCT02057666|593184759|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
164223242|NCT02057666|593184760|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
164223243|NCT02057666|593184759|FG000|Double Blind Treatment Period|Sponsor's request|70|||
164223244|NCT02057666|593184760|FG001|Double Blind Treatment Period|Sponsor's request|34|||
164223245|NCT02057666|593184759|FG000|Open-Label Treatment Period|Poor tolerability|0|||
164671301|NCT00436553|594822985|FG001|Overall Study|Lost to Follow-up|2|||
164671302|NCT00436553|594822986|FG002|Overall Study|Lost to Follow-up|0|||
164223246|NCT02057666|593184760|FG001|Open-Label Treatment Period|Poor tolerability|1|||
164223247|NCT02057666|593184759|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
164223248|NCT02057666|593184760|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
164223249|NCT02057666|593184759|FG000|Open-Label Treatment Period|Sponsor's request|0|||
164223250|NCT02057666|593184760|FG001|Open-Label Treatment Period|Sponsor's request|4|||
164223251|NCT05661734|593184761|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
164671303|NCT00436553|594822984|FG000|Overall Study|Protocol Violation|1|||
164223252|NCT05661734|593184761|FG000|Overall Study|Lost to Follow-up|13|||
164223253|NCT05661734|593184761|FG000|Overall Study|Enrolled but not dosed|2|||
164671304|NCT00436553|594822985|FG001|Overall Study|Protocol Violation|0|||
164671305|NCT00436553|594822986|FG002|Overall Study|Protocol Violation|0|||
164671306|NCT00436553|594822984|FG000|Overall Study|Withdrawal by Subject|5|||
164223254|NCT03259308|593184762|FG000|Overall Study|Adverse Event|5|||
164223255|NCT03259308|593184763|FG001|Overall Study|Adverse Event|4|||
164223256|NCT03259308|593184764|FG002|Overall Study|Adverse Event|1|||
164223257|NCT03259308|593184762|FG000|Overall Study|Withdrawal by Subject|2|||
164223258|NCT03259308|593184763|FG001|Overall Study|Withdrawal by Subject|1|||
164223259|NCT03259308|593184764|FG002|Overall Study|Withdrawal by Subject|3|||
164223260|NCT03259308|593184762|FG000|Overall Study|Lost to Follow-up|0|||
164223261|NCT03259308|593184763|FG001|Overall Study|Lost to Follow-up|0|||
164671307|NCT00436553|594822985|FG001|Overall Study|Withdrawal by Subject|6|||
164223262|NCT03259308|593184764|FG002|Overall Study|Lost to Follow-up|1|||
164223263|NCT03259308|593184762|FG000|Overall Study|Pregnancy|0|||
164223264|NCT03259308|593184763|FG001|Overall Study|Pregnancy|0|||
164568255|NCT00110019|594449109|FG001|Overall Study|complicating disease|1|||
164671308|NCT00436553|594822986|FG002|Overall Study|Withdrawal by Subject|3|||
164223265|NCT03259308|593184764|FG002|Overall Study|Pregnancy|1|||
164568256|NCT00110019|594449108|FG000|Overall Study|symptom deterioration|13|||
164568257|NCT00110019|594449109|FG001|Overall Study|symptom deterioration|16|||
164568258|NCT00110019|594449108|FG000|Overall Study|Not start protocol therapy|17|||
164671309|NCT00064753|594822995|FG000|Overall Study|Death|251|||
164671310|NCT00064753|594822996|FG001|Overall Study|Death|242|||
164671311|NCT00064753|594822995|FG000|Overall Study|Withdrawal by Subject|198|||
164223266|NCT03259308|593184762|FG000|Overall Study|Protocol Deviation|0|||
164223267|NCT03259308|593184763|FG001|Overall Study|Protocol Deviation|3|||
164223268|NCT03259308|593184764|FG002|Overall Study|Protocol Deviation|0|||
164223269|NCT03259308|593184762|FG000|Overall Study|Lack of Efficacy|0|||
164223270|NCT03259308|593184763|FG001|Overall Study|Lack of Efficacy|0|||
164223271|NCT03259308|593184764|FG002|Overall Study|Lack of Efficacy|1|||
164223272|NCT01251965|593186483|FG000|Overall Study|Participant/physician decision|1|||
164223273|NCT01251965|593186484|FG001|Overall Study|Participant/physician decision|2|||
164223274|NCT01251965|593186485|FG002|Overall Study|Participant/physician decision|0|||
164223275|NCT01251965|593186483|FG000|Overall Study|Death|0|||
164223276|NCT01251965|593186484|FG001|Overall Study|Death|0|||
164223277|NCT01251965|593186485|FG002|Overall Study|Death|11|||
164223278|NCT01027754|593186486|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
164223279|NCT01027754|593186487|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
164223280|NCT01027754|593186486|FG000|Overall Study|Withdrawal by Subject|0|||
164223281|NCT01027754|593186487|FG001|Overall Study|Withdrawal by Subject|5|||
164223282|NCT02529488|593186488|FG000|Overall Study|Adverse Event|1|||
164223283|NCT02529488|593186488|FG000|Overall Study|Death|3|||
164223284|NCT01557244|593186495|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
164223285|NCT01557244|593186496|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
164223286|NCT01557244|593186497|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
164223287|NCT01557244|593186498|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
164223288|NCT01557244|593186499|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
164223289|NCT01557244|593186500|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
164223290|NCT01557244|593186501|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
164223291|NCT01557244|593186495|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
164223292|NCT01557244|593186496|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
164223293|NCT01557244|593186497|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
164223294|NCT01557244|593186498|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
164223295|NCT01557244|593186499|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
164223296|NCT01557244|593186500|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
164223297|NCT01557244|593186501|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
164223298|NCT01557244|593186495|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
164223299|NCT01557244|593186496|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
164223300|NCT01557244|593186497|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
164223301|NCT01557244|593186498|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
164223302|NCT01557244|593186499|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
164223303|NCT01557244|593186500|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
164223304|NCT01557244|593186501|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
164223305|NCT01557244|593186495|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
164223306|NCT01557244|593186496|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
164223307|NCT01557244|593186497|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
164223308|NCT01557244|593186498|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
164223309|NCT01557244|593186499|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
164223310|NCT01557244|593186500|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
164421038|NCT02138747|593911086|FG002|Treatment Period 1|Protocol Violation|0|||
164568259|NCT00110019|594449109|FG001|Overall Study|Not start protocol therapy|16|||
164568260|NCT00110019|594449108|FG000|Overall Study|other reasons|22|||
164568261|NCT00110019|594449109|FG001|Overall Study|other reasons|30|||
164568262|NCT00944034|594449112|FG000|Overall Study|Inappropriate enrollment|0|||
164568263|NCT00944034|594449113|FG001|Overall Study|Inappropriate enrollment|1|||
164568264|NCT00944034|594449114|FG002|Overall Study|Inappropriate enrollment|0|||
164568265|NCT00944034|594449115|FG003|Overall Study|Inappropriate enrollment|1|||
164568266|NCT00944034|594449116|FG004|Overall Study|Inappropriate enrollment|2|||
164568267|NCT00944034|594449117|FG005|Overall Study|Inappropriate enrollment|1|||
164568268|NCT00944034|594449118|FG006|Overall Study|Inappropriate enrollment|0|||
164568269|NCT00944034|594449119|FG007|Overall Study|Inappropriate enrollment|0|||
164568270|NCT00944034|594449120|FG008|Overall Study|Inappropriate enrollment|1|||
164568271|NCT00944034|594449121|FG009|Overall Study|Inappropriate enrollment|1|||
164568272|NCT00944034|594449122|FG010|Overall Study|Inappropriate enrollment|0|||
164568273|NCT00944034|594449123|FG011|Overall Study|Inappropriate enrollment|0|||
164568274|NCT00944034|594449112|FG000|Overall Study|Withdrawal by Subject|3|||
164568275|NCT00944034|594449113|FG001|Overall Study|Withdrawal by Subject|2|||
164568276|NCT00944034|594449114|FG002|Overall Study|Withdrawal by Subject|6|||
164568277|NCT00944034|594449115|FG003|Overall Study|Withdrawal by Subject|2|||
164223311|NCT01557244|593186501|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
164223312|NCT01557244|593186495|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
164568278|NCT00944034|594449116|FG004|Overall Study|Withdrawal by Subject|5|||
164568279|NCT00944034|594449117|FG005|Overall Study|Withdrawal by Subject|8|||
164568280|NCT00944034|594449118|FG006|Overall Study|Withdrawal by Subject|2|||
164568281|NCT00944034|594449119|FG007|Overall Study|Withdrawal by Subject|2|||
164568282|NCT00944034|594449120|FG008|Overall Study|Withdrawal by Subject|3|||
164568283|NCT00944034|594449121|FG009|Overall Study|Withdrawal by Subject|4|||
164568284|NCT00944034|594449122|FG010|Overall Study|Withdrawal by Subject|0|||
164568285|NCT00944034|594449123|FG011|Overall Study|Withdrawal by Subject|4|||
164568286|NCT00944034|594449112|FG000|Overall Study|Lost to Follow-up|0|||
164568287|NCT00944034|594449113|FG001|Overall Study|Lost to Follow-up|4|||
164568288|NCT00944034|594449114|FG002|Overall Study|Lost to Follow-up|2|||
164568289|NCT00944034|594449115|FG003|Overall Study|Lost to Follow-up|0|||
164568290|NCT00944034|594449116|FG004|Overall Study|Lost to Follow-up|5|||
164568291|NCT00944034|594449117|FG005|Overall Study|Lost to Follow-up|7|||
164568292|NCT00944034|594449118|FG006|Overall Study|Lost to Follow-up|0|||
164568293|NCT00944034|594449119|FG007|Overall Study|Lost to Follow-up|1|||
164223313|NCT01557244|593186496|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
164223314|NCT01557244|593186497|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
164223315|NCT01557244|593186498|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
164223316|NCT01557244|593186499|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
164223317|NCT01557244|593186500|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
164223318|NCT01557244|593186501|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
164223319|NCT01557244|593186495|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
164223320|NCT01557244|593186496|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
164223321|NCT01557244|593186497|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
164223322|NCT01557244|593186498|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
164223323|NCT01557244|593186499|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
164223324|NCT01557244|593186500|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
164223325|NCT01557244|593186501|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
164223326|NCT01557244|593186495|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
164223327|NCT01557244|593186496|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
164223328|NCT01557244|593186497|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
164223329|NCT01557244|593186498|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
164223330|NCT01557244|593186499|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
164223331|NCT01557244|593186500|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
164223332|NCT01557244|593186501|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
164223333|NCT01557244|593186495|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
164223334|NCT01557244|593186496|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
164223335|NCT01557244|593186497|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
164223336|NCT01557244|593186498|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
164223337|NCT01557244|593186499|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
164223338|NCT01557244|593186500|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
164223339|NCT01557244|593186501|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
164223340|NCT01557244|593186495|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
164223341|NCT01557244|593186496|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
164223342|NCT01557244|593186497|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
164223343|NCT01557244|593186498|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
164223344|NCT01557244|593186499|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
164223345|NCT01557244|593186500|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
164223346|NCT01557244|593186501|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
164223347|NCT01557244|593186495|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
164223348|NCT01557244|593186496|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
164223349|NCT01557244|593186497|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
164223350|NCT01557244|593186498|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
164223351|NCT01557244|593186499|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
164421039|NCT02138747|593911087|FG003|Treatment Period 1|Protocol Violation|0|||
164568294|NCT00944034|594449120|FG008|Overall Study|Lost to Follow-up|5|||
164568295|NCT00944034|594449121|FG009|Overall Study|Lost to Follow-up|1|||
164223352|NCT01557244|593186500|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
164223353|NCT01557244|593186501|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
164223354|NCT01557244|593186495|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
164223355|NCT01557244|593186496|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
164223356|NCT01557244|593186497|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
164223357|NCT01557244|593186498|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
164223358|NCT01557244|593186499|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
164223359|NCT01557244|593186500|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
164223360|NCT01557244|593186501|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
164223361|NCT01557244|593186495|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
164223362|NCT01557244|593186496|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
164223363|NCT01557244|593186497|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
164223364|NCT01557244|593186498|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
164223365|NCT01557244|593186499|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
164223366|NCT01557244|593186500|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
164223367|NCT01557244|593186501|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
164223368|NCT01313676|593186502|FG000|Overall Study|Adverse Event|395|||
164223369|NCT01313676|593186503|FG001|Overall Study|Adverse Event|365|||
164223370|NCT01313676|593186504|FG002|Overall Study|Adverse Event|372|||
164223371|NCT01313676|593186505|FG003|Overall Study|Adverse Event|333|||
164223372|NCT01313676|593186502|FG000|Overall Study|Lack of Efficacy|98|||
164223373|NCT01313676|593186503|FG001|Overall Study|Lack of Efficacy|90|||
164223374|NCT01313676|593186504|FG002|Overall Study|Lack of Efficacy|65|||
164223375|NCT01313676|593186505|FG003|Overall Study|Lack of Efficacy|46|||
164223376|NCT01313676|593186502|FG000|Overall Study|Protocol Violation|37|||
164223377|NCT01313676|593186503|FG001|Overall Study|Protocol Violation|44|||
164223378|NCT01313676|593186504|FG002|Overall Study|Protocol Violation|46|||
164223379|NCT01313676|593186505|FG003|Overall Study|Protocol Violation|44|||
164223380|NCT01313676|593186502|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
164223381|NCT01313676|593186503|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
164223382|NCT01313676|593186504|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
164223383|NCT01313676|593186505|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
164223384|NCT01313676|593186502|FG000|Overall Study|Study Closed/terminated|7|||
164223385|NCT01313676|593186503|FG001|Overall Study|Study Closed/terminated|6|||
164223386|NCT01313676|593186504|FG002|Overall Study|Study Closed/terminated|9|||
164223387|NCT01313676|593186505|FG003|Overall Study|Study Closed/terminated|9|||
164223388|NCT01313676|593186502|FG000|Overall Study|Lost to Follow-up|0|||
164223389|NCT01313676|593186503|FG001|Overall Study|Lost to Follow-up|0|||
164223390|NCT01313676|593186504|FG002|Overall Study|Lost to Follow-up|1|||
164223391|NCT01313676|593186505|FG003|Overall Study|Lost to Follow-up|0|||
164223392|NCT01313676|593186502|FG000|Overall Study|Physician Decision|53|||
164223393|NCT01313676|593186503|FG001|Overall Study|Physician Decision|64|||
164223394|NCT01313676|593186504|FG002|Overall Study|Physician Decision|62|||
164223395|NCT01313676|593186505|FG003|Overall Study|Physician Decision|48|||
164223396|NCT01313676|593186502|FG000|Overall Study|Decision by Participant or Proxy|643|||
164223397|NCT01313676|593186503|FG001|Overall Study|Decision by Participant or Proxy|527|||
164223398|NCT01313676|593186504|FG002|Overall Study|Decision by Participant or Proxy|515|||
164223399|NCT01313676|593186505|FG003|Overall Study|Decision by Participant or Proxy|492|||
164223400|NCT01313676|593186502|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
164223401|NCT01313676|593186503|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
164223402|NCT01313676|593186504|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
164223403|NCT01313676|593186505|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
164223404|NCT01313676|593186502|FG000|Overall Study|Investigator Site Closed|12|||
164223405|NCT01313676|593186503|FG001|Overall Study|Investigator Site Closed|11|||
164223406|NCT01313676|593186504|FG002|Overall Study|Investigator Site Closed|15|||
164223407|NCT01313676|593186505|FG003|Overall Study|Investigator Site Closed|10|||
164223408|NCT01313676|593186502|FG000|Overall Study|Missing|1|||
164223409|NCT01313676|593186503|FG001|Overall Study|Missing|1|||
164223410|NCT01313676|593186504|FG002|Overall Study|Missing|1|||
164223411|NCT01313676|593186505|FG003|Overall Study|Missing|0|||
164223412|NCT01654250|593186506|FG000|Overall Study|Lost to Follow-up|1|||
164568296|NCT00944034|594449122|FG010|Overall Study|Lost to Follow-up|1|||
164568297|NCT00944034|594449123|FG011|Overall Study|Lost to Follow-up|0|||
164568298|NCT00944034|594449112|FG000|Overall Study|Death|0|||
164568299|NCT00944034|594449113|FG001|Overall Study|Death|0|||
164223413|NCT01654250|593186507|FG001|Overall Study|Lost to Follow-up|0|||
164223414|NCT02596893|593186508|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
164223415|NCT02596893|593186509|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
164223416|NCT02596893|593186510|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
164223417|NCT02596893|593186511|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
164223418|NCT02596893|593186508|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
164223419|NCT02596893|593186509|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
164223420|NCT02596893|593186510|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
164568300|NCT00944034|594449114|FG002|Overall Study|Death|1|||
164223421|NCT02596893|593186511|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
164223422|NCT02596893|593186508|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
164223423|NCT02596893|593186509|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
164223424|NCT02596893|593186510|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
164223425|NCT02596893|593186511|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
164223426|NCT02596893|593186508|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
164223427|NCT02596893|593186509|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
164223428|NCT02596893|593186510|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
164223429|NCT02596893|593186511|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
164223430|NCT02596893|593186508|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
164223431|NCT02596893|593186509|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
164223432|NCT02596893|593186510|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
164223433|NCT02596893|593186511|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
164223434|NCT02596893|593186508|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
164223435|NCT02596893|593186509|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
164223436|NCT02596893|593186510|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
164223437|NCT02596893|593186511|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
164223438|NCT02596893|593186508|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
164223439|NCT02596893|593186509|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
164223440|NCT02596893|593186510|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
164223441|NCT02596893|593186511|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
164223442|NCT02596893|593186508|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
164223443|NCT02596893|593186509|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
164223444|NCT02596893|593186510|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
164223445|NCT02596893|593186511|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
164223446|NCT02596893|593186508|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
164223447|NCT02596893|593186509|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
164223448|NCT02596893|593186510|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
164223449|NCT02596893|593186511|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
164223450|NCT02596893|593186508|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
164223451|NCT02596893|593186509|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
164223452|NCT02596893|593186510|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
164223453|NCT02596893|593186511|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
164223454|NCT02596893|593186508|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
164223455|NCT02596893|593186509|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
164223456|NCT02596893|593186510|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
164223457|NCT02596893|593186511|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
164223458|NCT03280615|593186512|FG000|Overall Study|Lost to Follow-up|1|||
164223459|NCT03280615|593186513|FG001|Overall Study|Lost to Follow-up|2|||
164223460|NCT03280615|593186512|FG000|Overall Study|Adverse Event|1|||
164223461|NCT03280615|593186513|FG001|Overall Study|Adverse Event|1|||
164223462|NCT03280615|593186512|FG000|Overall Study|Withdrawal by Subject|2|||
164223463|NCT03280615|593186513|FG001|Overall Study|Withdrawal by Subject|2|||
164223464|NCT00090402|593186514|FG000|Overall Study|Death|1|||
164223465|NCT00090402|593186515|FG001|Overall Study|Death|1|||
164223466|NCT00090402|593186516|FG002|Overall Study|Death|0|||
164223467|NCT00090402|593186514|FG000|Overall Study|subject moved|0|||
164223468|NCT00090402|593186515|FG001|Overall Study|subject moved|1|||
164223469|NCT00090402|593186516|FG002|Overall Study|subject moved|0|||
164568301|NCT00944034|594449115|FG003|Overall Study|Death|0|||
164568302|NCT00944034|594449116|FG004|Overall Study|Death|0|||
164568303|NCT00944034|594449117|FG005|Overall Study|Death|0|||
164568304|NCT00944034|594449118|FG006|Overall Study|Death|0|||
164568305|NCT00944034|594449119|FG007|Overall Study|Death|0|||
164568306|NCT00944034|594449120|FG008|Overall Study|Death|0|||
164568307|NCT00944034|594449121|FG009|Overall Study|Death|0|||
164568308|NCT00944034|594449122|FG010|Overall Study|Death|0|||
164568309|NCT00944034|594449123|FG011|Overall Study|Death|0|||
164568310|NCT00944034|594449112|FG000|Overall Study|Protocol Violation|2|||
164568311|NCT00944034|594449113|FG001|Overall Study|Protocol Violation|0|||
164568312|NCT00944034|594449114|FG002|Overall Study|Protocol Violation|0|||
164568313|NCT00944034|594449115|FG003|Overall Study|Protocol Violation|1|||
164568314|NCT00944034|594449116|FG004|Overall Study|Protocol Violation|2|||
164568315|NCT00944034|594449117|FG005|Overall Study|Protocol Violation|3|||
164568316|NCT00944034|594449118|FG006|Overall Study|Protocol Violation|0|||
164568317|NCT00944034|594449119|FG007|Overall Study|Protocol Violation|1|||
164568318|NCT00944034|594449120|FG008|Overall Study|Protocol Violation|1|||
164568319|NCT00944034|594449121|FG009|Overall Study|Protocol Violation|4|||
164568320|NCT00944034|594449122|FG010|Overall Study|Protocol Violation|0|||
164223470|NCT00090402|593186514|FG000|Overall Study|stopped taking study medication|1|||
164223471|NCT00090402|593186515|FG001|Overall Study|stopped taking study medication|0|||
164223472|NCT00090402|593186516|FG002|Overall Study|stopped taking study medication|1|||
164223473|NCT01530256|593186517|FG000|Overall Study|Death|2|||
164223474|NCT02123511|593186522|FG000|Overall Study|Cancelled treatment|1|||
164223475|NCT02123511|593186523|FG001|Overall Study|Cancelled treatment|0|||
164223476|NCT02123511|593186522|FG000|Overall Study|Incomplete data|1|||
164223477|NCT02123511|593186523|FG001|Overall Study|Incomplete data|3|||
164223478|NCT02123511|593186522|FG000|Overall Study|Ineligible|0|||
164223479|NCT02123511|593186523|FG001|Overall Study|Ineligible|1|||
164223480|NCT02180672|593186524|FG000|Overall Study|Lost to Follow-up|5|||
164223481|NCT02180672|593186525|FG001|Overall Study|Lost to Follow-up|7|||
164223482|NCT01133977|593186526|FG000|Overall Study|Adverse Event|0|||
164223483|NCT01133977|593186527|FG001|Overall Study|Adverse Event|0|||
164223484|NCT01133977|593186528|FG002|Overall Study|Adverse Event|1|||
164223485|NCT01133977|593186529|FG003|Overall Study|Adverse Event|0|||
164223486|NCT01133977|593186530|FG004|Overall Study|Adverse Event|0|||
164223487|NCT01133977|593186526|FG000|Overall Study|Death|1|||
164223488|NCT01133977|593186527|FG001|Overall Study|Death|1|||
164223489|NCT01133977|593186528|FG002|Overall Study|Death|1|||
164223490|NCT01133977|593186529|FG003|Overall Study|Death|7|||
164223491|NCT01133977|593186530|FG004|Overall Study|Death|3|||
164223492|NCT01133977|593186526|FG000|Overall Study|Started a New Line of Therapy|2|||
164223493|NCT01133977|593186527|FG001|Overall Study|Started a New Line of Therapy|6|||
164223494|NCT01133977|593186528|FG002|Overall Study|Started a New Line of Therapy|4|||
164223495|NCT01133977|593186529|FG003|Overall Study|Started a New Line of Therapy|25|||
164223496|NCT01133977|593186530|FG004|Overall Study|Started a New Line of Therapy|33|||
164223497|NCT01133977|593186526|FG000|Overall Study|Lost to Follow-up|0|||
164223498|NCT01133977|593186527|FG001|Overall Study|Lost to Follow-up|0|||
164223499|NCT01133977|593186528|FG002|Overall Study|Lost to Follow-up|0|||
164223500|NCT01133977|593186529|FG003|Overall Study|Lost to Follow-up|2|||
164223501|NCT01133977|593186530|FG004|Overall Study|Lost to Follow-up|1|||
164223502|NCT01133977|593186526|FG000|Overall Study|Withdrawal by Subject|0|||
164223503|NCT01133977|593186527|FG001|Overall Study|Withdrawal by Subject|0|||
164223504|NCT01133977|593186528|FG002|Overall Study|Withdrawal by Subject|0|||
164223505|NCT01133977|593186529|FG003|Overall Study|Withdrawal by Subject|5|||
164223506|NCT01133977|593186530|FG004|Overall Study|Withdrawal by Subject|1|||
164223507|NCT02662582|593186546|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
164223508|NCT02662582|593186547|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
164223509|NCT02662582|593186546|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
164223510|NCT02662582|593186547|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
164223511|NCT02662582|593186546|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
164223512|NCT02662582|593186547|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
164223513|NCT02662582|593186546|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
164223514|NCT02662582|593186547|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
164223515|NCT00609973|593186549|FG000|Overall Study|Adverse Event|2|||
164223516|NCT00609973|593186550|FG001|Overall Study|Adverse Event|1|||
164223517|NCT00609973|593186549|FG000|Overall Study|Protocol Violation|4|||
164223518|NCT00609973|593186550|FG001|Overall Study|Protocol Violation|3|||
164223519|NCT00609973|593186549|FG000|Overall Study|Lost to Follow-up|2|||
164223520|NCT00609973|593186550|FG001|Overall Study|Lost to Follow-up|1|||
164223521|NCT00609973|593186549|FG000|Overall Study|Withdrawal by Subject|0|||
164223522|NCT00609973|593186550|FG001|Overall Study|Withdrawal by Subject|1|||
164223523|NCT01392495|593186553|FG000|Overall Study|Death|3|||
164223524|NCT01392495|593186553|FG000|Overall Study|Administrative problems|8|||
164223525|NCT01392495|593186553|FG000|Overall Study|Withdrawal by Subject|2|||
164223526|NCT01392495|593186553|FG000|Overall Study|Adverse Event|3|||
164223527|NCT00806026|593186554|FG000|Overall Study|Death|0|||
164223528|NCT00806026|593186555|FG001|Overall Study|Death|0|||
164223529|NCT00806026|593186556|FG002|Overall Study|Death|0|||
164223530|NCT00806026|593186557|FG003|Overall Study|Death|1|||
164223531|NCT00806026|593186558|FG004|Overall Study|Death|0|||
164223532|NCT00806026|593186559|FG005|Overall Study|Death|0|||
164223533|NCT00806026|593186554|FG000|Overall Study|Did not meet entrance criteria|4|||
164223534|NCT00806026|593186555|FG001|Overall Study|Did not meet entrance criteria|1|||
164223535|NCT00806026|593186556|FG002|Overall Study|Did not meet entrance criteria|2|||
164223536|NCT00806026|593186557|FG003|Overall Study|Did not meet entrance criteria|1|||
164223537|NCT00806026|593186558|FG004|Overall Study|Did not meet entrance criteria|0|||
164223538|NCT00806026|593186559|FG005|Overall Study|Did not meet entrance criteria|0|||
164223539|NCT00806026|593186554|FG000|Overall Study|Lack of Efficacy|5|||
164223540|NCT00806026|593186555|FG001|Overall Study|Lack of Efficacy|18|||
164223541|NCT00806026|593186556|FG002|Overall Study|Lack of Efficacy|13|||
164223542|NCT00806026|593186557|FG003|Overall Study|Lack of Efficacy|4|||
164223543|NCT00806026|593186558|FG004|Overall Study|Lack of Efficacy|8|||
164223544|NCT00806026|593186559|FG005|Overall Study|Lack of Efficacy|7|||
164223545|NCT00806026|593186554|FG000|Overall Study|Lost to Follow-up|8|||
164223546|NCT00806026|593186555|FG001|Overall Study|Lost to Follow-up|15|||
164223547|NCT00806026|593186556|FG002|Overall Study|Lost to Follow-up|8|||
164223548|NCT00806026|593186557|FG003|Overall Study|Lost to Follow-up|2|||
164223549|NCT00806026|593186558|FG004|Overall Study|Lost to Follow-up|6|||
164223550|NCT00806026|593186559|FG005|Overall Study|Lost to Follow-up|6|||
164223551|NCT00806026|593186554|FG000|Overall Study|Withdrawal by Subject|14|||
164223552|NCT00806026|593186555|FG001|Overall Study|Withdrawal by Subject|17|||
164223553|NCT00806026|593186556|FG002|Overall Study|Withdrawal by Subject|9|||
164223554|NCT00806026|593186557|FG003|Overall Study|Withdrawal by Subject|2|||
164223555|NCT00806026|593186558|FG004|Overall Study|Withdrawal by Subject|5|||
164223556|NCT00806026|593186559|FG005|Overall Study|Withdrawal by Subject|3|||
164223557|NCT00806026|593186554|FG000|Overall Study|Other|3|||
164223558|NCT00806026|593186555|FG001|Overall Study|Other|6|||
164223559|NCT00806026|593186556|FG002|Overall Study|Other|8|||
164223560|NCT00806026|593186557|FG003|Overall Study|Other|2|||
164223561|NCT00806026|593186558|FG004|Overall Study|Other|0|||
164223562|NCT00806026|593186559|FG005|Overall Study|Other|4|||
164223563|NCT00806026|593186554|FG000|Overall Study|Protocol Violation|6|||
164223564|NCT00806026|593186555|FG001|Overall Study|Protocol Violation|9|||
164223565|NCT00806026|593186556|FG002|Overall Study|Protocol Violation|9|||
164223566|NCT00806026|593186557|FG003|Overall Study|Protocol Violation|0|||
164223567|NCT00806026|593186558|FG004|Overall Study|Protocol Violation|2|||
164223568|NCT00806026|593186559|FG005|Overall Study|Protocol Violation|3|||
164223569|NCT00806026|593186554|FG000|Overall Study|Adverse Event|52|||
164223570|NCT00806026|593186555|FG001|Overall Study|Adverse Event|35|||
164223571|NCT00806026|593186556|FG002|Overall Study|Adverse Event|44|||
164223572|NCT00806026|593186557|FG003|Overall Study|Adverse Event|17|||
164223573|NCT00806026|593186558|FG004|Overall Study|Adverse Event|9|||
164223574|NCT00806026|593186559|FG005|Overall Study|Adverse Event|9|||
164223575|NCT01452789|593186564|FG000|Overall Study|Withdrawal by Subject|3|||
164223576|NCT01452789|593186565|FG001|Overall Study|Withdrawal by Subject|2|||
164223577|NCT01927861|593186573|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
164223578|NCT01927861|593186574|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
164223579|NCT01927861|593186573|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
164223580|NCT01927861|593186574|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
164223581|NCT00987935|593186575|FG000|Overall Study|Progressive disease|3|||
164223582|NCT00987935|593186576|FG001|Overall Study|Progressive disease|2|||
164223583|NCT00987935|593186577|FG002|Overall Study|Progressive disease|3|||
164223584|NCT00987935|593186578|FG003|Overall Study|Progressive disease|2|||
164223585|NCT00987935|593186579|FG004|Overall Study|Progressive disease|5|||
164223586|NCT00987935|593186580|FG005|Overall Study|Progressive disease|3|||
164223587|NCT00987935|593186581|FG006|Overall Study|Progressive disease|9|||
164223588|NCT00987935|593186582|FG007|Overall Study|Progressive disease|48|||
164223589|NCT00987935|593186583|FG008|Overall Study|Progressive disease|23|||
164223590|NCT00987935|593186575|FG000|Overall Study|Adverse Event|0|||
164223591|NCT00987935|593186576|FG001|Overall Study|Adverse Event|1|||
164223592|NCT00987935|593186577|FG002|Overall Study|Adverse Event|0|||
164223593|NCT00987935|593186578|FG003|Overall Study|Adverse Event|1|||
164223594|NCT00987935|593186579|FG004|Overall Study|Adverse Event|1|||
164223595|NCT00987935|593186580|FG005|Overall Study|Adverse Event|0|||
164223596|NCT00987935|593186581|FG006|Overall Study|Adverse Event|2|||
164223597|NCT00987935|593186582|FG007|Overall Study|Adverse Event|10|||
164223598|NCT00987935|593186583|FG008|Overall Study|Adverse Event|6|||
164223599|NCT00987935|593186575|FG000|Overall Study|Refused to continue taking trial med.|1|||
164223600|NCT00987935|593186576|FG001|Overall Study|Refused to continue taking trial med.|0|||
164223601|NCT00987935|593186577|FG002|Overall Study|Refused to continue taking trial med.|0|||
164223602|NCT00987935|593186578|FG003|Overall Study|Refused to continue taking trial med.|0|||
164223603|NCT00987935|593186579|FG004|Overall Study|Refused to continue taking trial med.|1|||
164223604|NCT00987935|593186580|FG005|Overall Study|Refused to continue taking trial med.|0|||
164223605|NCT00987935|593186581|FG006|Overall Study|Refused to continue taking trial med.|4|||
164223606|NCT00987935|593186582|FG007|Overall Study|Refused to continue taking trial med.|4|||
164223607|NCT00987935|593186583|FG008|Overall Study|Refused to continue taking trial med.|2|||
164223608|NCT00987935|593186575|FG000|Overall Study|Reason other than those specified above|0|||
164223609|NCT00987935|593186576|FG001|Overall Study|Reason other than those specified above|0|||
164223610|NCT00987935|593186577|FG002|Overall Study|Reason other than those specified above|0|||
164223611|NCT00987935|593186578|FG003|Overall Study|Reason other than those specified above|0|||
164223612|NCT00987935|593186579|FG004|Overall Study|Reason other than those specified above|0|||
164223613|NCT00987935|593186580|FG005|Overall Study|Reason other than those specified above|0|||
164223614|NCT00987935|593186581|FG006|Overall Study|Reason other than those specified above|0|||
164223615|NCT00987935|593186582|FG007|Overall Study|Reason other than those specified above|0|||
164223616|NCT00987935|593186583|FG008|Overall Study|Reason other than those specified above|1|||
164223617|NCT01089543|593186584|FG000|Overall Study|Withdrawal by Subject|2|||
164223618|NCT01089543|593186585|FG001|Overall Study|Withdrawal by Subject|3|||
164223619|NCT01089543|593186586|FG002|Overall Study|Withdrawal by Subject|3|||
164223620|NCT01089543|593186587|FG003|Overall Study|Withdrawal by Subject|1|||
164223621|NCT01089543|593186584|FG000|Overall Study|Physician Decision|1|||
164223622|NCT01089543|593186585|FG001|Overall Study|Physician Decision|0|||
164223623|NCT01089543|593186586|FG002|Overall Study|Physician Decision|0|||
164223624|NCT01089543|593186587|FG003|Overall Study|Physician Decision|1|||
164223625|NCT01089543|593186584|FG000|Overall Study|Adverse Event|0|||
164223626|NCT01089543|593186585|FG001|Overall Study|Adverse Event|1|||
164671312|NCT00064753|594822996|FG001|Overall Study|Withdrawal by Subject|171|||
164671313|NCT00064753|594822995|FG000|Overall Study|Lost to Follow-up|225|||
164671314|NCT00064753|594822996|FG001|Overall Study|Lost to Follow-up|235|||
164671315|NCT02193880|594822999|FG000|Overall Study|patients did not collect enough HPC|3|||
164671316|NCT02419937|594823005|FG000|Overall Study|Lost to Follow-up|1|||
164671317|NCT02419937|594823006|FG001|Overall Study|Lost to Follow-up|0|||
164671318|NCT01256684|594823007|FG000|Overall Study|Adverse Event|1|||
164671319|NCT01256684|594823008|FG001|Overall Study|Adverse Event|4|||
164671320|NCT01256684|594823009|FG002|Overall Study|Adverse Event|2|||
164223627|NCT01089543|593186586|FG002|Overall Study|Adverse Event|0|||
164568321|NCT00944034|594449123|FG011|Overall Study|Protocol Violation|0|||
164568322|NCT00944034|594449112|FG000|Overall Study|Unable to classify|0|||
164568323|NCT00944034|594449113|FG001|Overall Study|Unable to classify|0|||
164568324|NCT00944034|594449114|FG002|Overall Study|Unable to classify|0|||
164568325|NCT00944034|594449115|FG003|Overall Study|Unable to classify|0|||
164568326|NCT00944034|594449116|FG004|Overall Study|Unable to classify|0|||
164568327|NCT00944034|594449117|FG005|Overall Study|Unable to classify|1|||
164568328|NCT00944034|594449118|FG006|Overall Study|Unable to classify|1|||
164568329|NCT00944034|594449119|FG007|Overall Study|Unable to classify|1|||
164568330|NCT00944034|594449120|FG008|Overall Study|Unable to classify|0|||
164568331|NCT00944034|594449121|FG009|Overall Study|Unable to classify|0|||
164568332|NCT00944034|594449122|FG010|Overall Study|Unable to classify|0|||
164568333|NCT00944034|594449123|FG011|Overall Study|Unable to classify|0|||
164568334|NCT00944034|594449112|FG000|Overall Study|Administrative reason|0|||
164568335|NCT00944034|594449113|FG001|Overall Study|Administrative reason|0|||
164568336|NCT00944034|594449114|FG002|Overall Study|Administrative reason|0|||
164568337|NCT00944034|594449115|FG003|Overall Study|Administrative reason|0|||
164568338|NCT00944034|594449116|FG004|Overall Study|Administrative reason|0|||
164568339|NCT00944034|594449117|FG005|Overall Study|Administrative reason|0|||
164568340|NCT00944034|594449118|FG006|Overall Study|Administrative reason|1|||
164568341|NCT00944034|594449119|FG007|Overall Study|Administrative reason|0|||
164568342|NCT00944034|594449120|FG008|Overall Study|Administrative reason|0|||
164568343|NCT00944034|594449121|FG009|Overall Study|Administrative reason|0|||
164568344|NCT00944034|594449122|FG010|Overall Study|Administrative reason|0|||
164568345|NCT00944034|594449123|FG011|Overall Study|Administrative reason|0|||
164568346|NCT01596257|594449124|FG000|Overall Study|Inadequate Collection|23|||
164568347|NCT01596257|594449125|FG001|Overall Study|Inadequate Collection|19|||
164568348|NCT01570244|594449129|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
164568349|NCT03371355|594449140|FG000|Overall Study|Investigator judgment|0|||
164568350|NCT03371355|594449141|FG001|Overall Study|Investigator judgment|0|||
164568351|NCT03371355|594449142|FG002|Overall Study|Investigator judgment|1|||
164568352|NCT03371355|594449143|FG003|Overall Study|Investigator judgment|1|||
164568353|NCT03371355|594449140|FG000|Overall Study|Voluntary withdrawal|1|||
164568354|NCT03371355|594449141|FG001|Overall Study|Voluntary withdrawal|0|||
164568355|NCT03371355|594449142|FG002|Overall Study|Voluntary withdrawal|1|||
164568356|NCT03371355|594449143|FG003|Overall Study|Voluntary withdrawal|2|||
164568357|NCT03371355|594449140|FG000|Overall Study|Adverse Event|0|||
164568358|NCT03371355|594449141|FG001|Overall Study|Adverse Event|1|||
164568359|NCT03371355|594449142|FG002|Overall Study|Adverse Event|2|||
164568360|NCT03371355|594449143|FG003|Overall Study|Adverse Event|3|||
164568361|NCT03371355|594449140|FG000|Overall Study|Reason not Specified|0|||
164568362|NCT03371355|594449141|FG001|Overall Study|Reason not Specified|1|||
164568363|NCT03371355|594449142|FG002|Overall Study|Reason not Specified|0|||
164568364|NCT03371355|594449143|FG003|Overall Study|Reason not Specified|1|||
164568365|NCT02909153|594449144|FG000|Overall Study|Withdrawal by Subject|0|||
164568366|NCT02909153|594449145|FG001|Overall Study|Withdrawal by Subject|1|||
164568367|NCT02909153|594449146|FG002|Overall Study|Withdrawal by Subject|0|||
164568368|NCT02909153|594449147|FG003|Overall Study|Withdrawal by Subject|0|||
164568369|NCT02909153|594449148|FG004|Overall Study|Withdrawal by Subject|0|||
164568370|NCT01273064|594449149|FG000|Overall Study|Adverse Event|5|||
164568371|NCT01273064|594449150|FG001|Overall Study|Adverse Event|1|||
164568372|NCT01273064|594449151|FG002|Overall Study|Adverse Event|3|||
164568373|NCT01273064|594449152|FG003|Overall Study|Adverse Event|2|||
164568374|NCT01273064|594449153|FG004|Overall Study|Adverse Event|1|||
164568375|NCT01273064|594449149|FG000|Overall Study|Withdrawal by Subject|4|||
164568376|NCT01273064|594449150|FG001|Overall Study|Withdrawal by Subject|2|||
164568377|NCT01273064|594449151|FG002|Overall Study|Withdrawal by Subject|2|||
164568378|NCT01273064|594449152|FG003|Overall Study|Withdrawal by Subject|2|||
164568379|NCT01273064|594449153|FG004|Overall Study|Withdrawal by Subject|0|||
164568380|NCT01273064|594449149|FG000|Overall Study|Study Termination|13|||
164568381|NCT01273064|594449150|FG001|Overall Study|Study Termination|27|||
164568382|NCT01273064|594449151|FG002|Overall Study|Study Termination|26|||
164568383|NCT01273064|594449152|FG003|Overall Study|Study Termination|16|||
164568384|NCT01273064|594449153|FG004|Overall Study|Study Termination|8|||
164568385|NCT01273064|594449149|FG000|Overall Study|Lost to Follow-up|1|||
164568386|NCT01273064|594449150|FG001|Overall Study|Lost to Follow-up|0|||
164671321|NCT01256684|594823007|FG000|Overall Study|Withdrawal by Subject|4|||
164671322|NCT01256684|594823008|FG001|Overall Study|Withdrawal by Subject|0|||
164223628|NCT01089543|593186587|FG003|Overall Study|Adverse Event|0|||
164223629|NCT00754559|593186589|FG000|Overall Study|Adverse Event|15|||
164223630|NCT00754559|593186589|FG000|Overall Study|Protocol Violation|11|||
164223631|NCT00754559|593186589|FG000|Overall Study|Lack of Efficacy|10|||
164223632|NCT00754559|593186589|FG000|Overall Study|Lost to Follow-up|2|||
164223633|NCT00754559|593186589|FG000|Overall Study|Administrative reason|1|||
164223634|NCT00754559|593186589|FG000|Overall Study|Other|5|||
164223635|NCT00754559|593186589|FG000|Overall Study|Withdrawal by Subject|3|||
164223636|NCT01248468|593186590|FG000|Overall Study|Administrative problem|1|||
164223637|NCT01248468|593186591|FG001|Overall Study|Administrative problem|0|||
164223638|NCT01248468|593186592|FG002|Overall Study|Administrative problem|0|||
164223639|NCT01248468|593186590|FG000|Overall Study|Lost to Follow-up|9|||
164223640|NCT01248468|593186591|FG001|Overall Study|Lost to Follow-up|12|||
164223641|NCT01248468|593186592|FG002|Overall Study|Lost to Follow-up|4|||
164223642|NCT01248468|593186590|FG000|Overall Study|Pregnancy|1|||
164223643|NCT01248468|593186591|FG001|Overall Study|Pregnancy|0|||
164223644|NCT01248468|593186592|FG002|Overall Study|Pregnancy|0|||
164223645|NCT01248468|593186590|FG000|Overall Study|Withdrawal by Subject|4|||
164223646|NCT01248468|593186591|FG001|Overall Study|Withdrawal by Subject|2|||
164223647|NCT01248468|593186592|FG002|Overall Study|Withdrawal by Subject|0|||
164223648|NCT01370538|593186593|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
164223649|NCT01370538|593186594|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
164223650|NCT01370538|593186593|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164223651|NCT01370538|593186594|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
164223652|NCT01370538|593186593|FG000|Overall Study|Adverse Event|1|||
164223653|NCT01370538|593186594|FG001|Overall Study|Adverse Event|0|||
164223654|NCT01370538|593186593|FG000|Overall Study|Protocol Violation|8|||
164223655|NCT01370538|593186594|FG001|Overall Study|Protocol Violation|5|||
164223656|NCT01370538|593186593|FG000|Overall Study|Development of study specific withdrawal|1|||
164223657|NCT01370538|593186594|FG001|Overall Study|Development of study specific withdrawal|1|||
164223658|NCT01370538|593186593|FG000|Overall Study|Lost to follow up|6|||
164223659|NCT01370538|593186594|FG001|Overall Study|Lost to follow up|10|||
164223660|NCT00728182|593186595|FG000|Overall Study|Adverse Event|1|||
164223661|NCT00728182|593186596|FG001|Overall Study|Adverse Event|0|||
164223662|NCT00728182|593186595|FG000|Overall Study|Lost to Follow-up|2|||
164223663|NCT00728182|593186596|FG001|Overall Study|Lost to Follow-up|0|||
164223664|NCT00728182|593186595|FG000|Overall Study|Death|0|||
164223665|NCT00728182|593186596|FG001|Overall Study|Death|2|||
164223666|NCT00728182|593186595|FG000|Overall Study|Protocol Noncompliance|0|||
164223667|NCT00728182|593186596|FG001|Overall Study|Protocol Noncompliance|1|||
164223668|NCT01898091|593186599|FG000|Overall Study|Lost to Follow-up|1|||
164223669|NCT01898091|593186600|FG001|Overall Study|Lost to Follow-up|1|||
164223670|NCT01898091|593186599|FG000|Overall Study|Withdrawal by Subject|1|||
164223671|NCT01898091|593186600|FG001|Overall Study|Withdrawal by Subject|5|||
164223672|NCT00309244|593186601|FG000|Overall Study|Adverse Event|29|||
164223673|NCT00309244|593186602|FG001|Overall Study|Adverse Event|12|||
164223674|NCT00309244|593186601|FG000|Overall Study|Lost to Follow-up|6|||
164223675|NCT00309244|593186602|FG001|Overall Study|Lost to Follow-up|22|||
164223676|NCT00309244|593186601|FG000|Overall Study|Physician Decision|5|||
164223677|NCT00309244|593186602|FG001|Overall Study|Physician Decision|8|||
164223678|NCT00309244|593186601|FG000|Overall Study|Protocol Violation|6|||
164223679|NCT00309244|593186602|FG001|Overall Study|Protocol Violation|3|||
164223680|NCT00309244|593186601|FG000|Overall Study|Withdrawal by Subject|50|||
164223681|NCT00309244|593186602|FG001|Overall Study|Withdrawal by Subject|32|||
164223682|NCT00309244|593186601|FG000|Overall Study|Various|7|||
164223683|NCT00309244|593186602|FG001|Overall Study|Various|7|||
164568387|NCT01273064|594449151|FG002|Overall Study|Lost to Follow-up|0|||
164568388|NCT01273064|594449152|FG003|Overall Study|Lost to Follow-up|0|||
164568389|NCT01273064|594449153|FG004|Overall Study|Lost to Follow-up|0|||
164568390|NCT01273064|594449149|FG000|Overall Study|Physician Decision|0|||
164568391|NCT01273064|594449150|FG001|Overall Study|Physician Decision|0|||
164568392|NCT01273064|594449151|FG002|Overall Study|Physician Decision|0|||
164568393|NCT01273064|594449152|FG003|Overall Study|Physician Decision|0|||
164568394|NCT01273064|594449153|FG004|Overall Study|Physician Decision|1|||
164568395|NCT04666038|594449154|FG000|Overall Study|Progressive Disease|2|||
164568396|NCT04666038|594449155|FG001|Overall Study|Progressive Disease|0|||
164568397|NCT04666038|594449154|FG000|Overall Study|Death|38|||
164568398|NCT04666038|594449155|FG001|Overall Study|Death|32|||
164568399|NCT04666038|594449154|FG000|Overall Study|Withdrawal by Subject|10|||
164568400|NCT04666038|594449155|FG001|Overall Study|Withdrawal by Subject|19|||
164568401|NCT04666038|594449154|FG000|Overall Study|Lost to Follow-up|0|||
164671323|NCT01256684|594823009|FG002|Overall Study|Withdrawal by Subject|2|||
164671324|NCT01256684|594823007|FG000|Overall Study|Physician Decision|0|||
164223684|NCT00309244|593186601|FG000|Overall Study|Randomized but not dosed|11|||
164223685|NCT00309244|593186602|FG001|Overall Study|Randomized but not dosed|12|||
164223686|NCT00309244|593186601|FG000|Overall Study|Death|4|||
164223687|NCT00309244|593186602|FG001|Overall Study|Death|1|||
164223688|NCT01905267|593186603|FG000|Overall Study|Physician Decision|2|||
164568402|NCT04666038|594449155|FG001|Overall Study|Lost to Follow-up|2|||
164223689|NCT01905267|593186604|FG001|Overall Study|Physician Decision|2|||
164223690|NCT03438656|593186605|FG000|Overall Study|Lost to Follow-up|2|||
164223691|NCT03335566|593186606|FG000|Overall Study|Adverse Event|0|||
164223692|NCT03335566|593186607|FG001|Overall Study|Adverse Event|1|||
164223693|NCT03335566|593186606|FG000|Overall Study|Lost to Follow-up|1|||
164223694|NCT03335566|593186607|FG001|Overall Study|Lost to Follow-up|0|||
164223695|NCT03335566|593186606|FG000|Overall Study|Technical Problems|1|||
164223696|NCT03335566|593186607|FG001|Overall Study|Technical Problems|0|||
164223697|NCT03335566|593186606|FG000|Overall Study|Protocol Violation|1|||
164223698|NCT03335566|593186607|FG001|Overall Study|Protocol Violation|0|||
164223699|NCT03335566|593186606|FG000|Overall Study|Other than specified above|1|||
164223700|NCT03335566|593186607|FG001|Overall Study|Other than specified above|2|||
164223701|NCT04223687|593186608|FG000|Overall Study|Missing primary outcome|1|||
164223702|NCT04223687|593186609|FG001|Overall Study|Missing primary outcome|0|||
164223703|NCT02945046|593186611|FG000|Overall Study|Adverse Event|1|||
164223704|NCT02945046|593186612|FG001|Overall Study|Adverse Event|0|||
164223705|NCT02945046|593186613|FG002|Overall Study|Adverse Event|2|||
164223706|NCT02945046|593186611|FG000|Overall Study|Withdrawal by Subject|3|||
164223707|NCT02945046|593186612|FG001|Overall Study|Withdrawal by Subject|3|||
164223708|NCT02945046|593186613|FG002|Overall Study|Withdrawal by Subject|3|||
164223709|NCT02945046|593186611|FG000|Overall Study|Protocol Violation|2|||
164223710|NCT02945046|593186612|FG001|Overall Study|Protocol Violation|3|||
164223711|NCT02945046|593186613|FG002|Overall Study|Protocol Violation|2|||
164223712|NCT02945046|593186611|FG000|Overall Study|Lost to Follow-up|1|||
164223713|NCT02945046|593186612|FG001|Overall Study|Lost to Follow-up|1|||
164223714|NCT02945046|593186613|FG002|Overall Study|Lost to Follow-up|0|||
164223715|NCT02945046|593186611|FG000|Overall Study|Lack of Efficacy|1|||
164223716|NCT02945046|593186612|FG001|Overall Study|Lack of Efficacy|2|||
164223717|NCT02945046|593186613|FG002|Overall Study|Lack of Efficacy|1|||
164223718|NCT02945046|593186611|FG000|Overall Study|Other than specified|5|||
164223719|NCT02945046|593186612|FG001|Overall Study|Other than specified|4|||
164223720|NCT02945046|593186613|FG002|Overall Study|Other than specified|7|||
164223721|NCT00362609|593186621|FG000|Overall Study|Withdrawal by Subject|0|||
164223722|NCT00362609|593186622|FG001|Overall Study|Withdrawal by Subject|1|||
164223723|NCT00362609|593186621|FG000|Overall Study|Protocol Violation|0|||
164223724|NCT00362609|593186622|FG001|Overall Study|Protocol Violation|1|||
164223725|NCT02205359|593186623|FG000|Overall Study|Death|293|||
164223726|NCT02205359|593186624|FG001|Overall Study|Death|327|||
164223727|NCT02205359|593186623|FG000|Overall Study|Lost to Follow-up|182|||
164223728|NCT02205359|593186624|FG001|Overall Study|Lost to Follow-up|162|||
164223729|NCT02205359|593186623|FG000|Overall Study|Physician Decision|51|||
164223730|NCT02205359|593186624|FG001|Overall Study|Physician Decision|53|||
164223731|NCT02205359|593186623|FG000|Overall Study|Withdrawal by Subject|167|||
164223732|NCT02205359|593186624|FG001|Overall Study|Withdrawal by Subject|169|||
164223733|NCT00236197|593186625|FG000|Overall Study|Withdrawal by Subject|3|||
164223734|NCT00236197|593186626|FG001|Overall Study|Withdrawal by Subject|2|||
164223735|NCT00236197|593186625|FG000|Overall Study|Lost to Follow-up|1|||
164223736|NCT00236197|593186626|FG001|Overall Study|Lost to Follow-up|5|||
164223737|NCT00236197|593186625|FG000|Overall Study|Protocol Violation|0|||
164223738|NCT00236197|593186626|FG001|Overall Study|Protocol Violation|3|||
164223739|NCT00236197|593186625|FG000|Overall Study|Medication non-compliance|1|||
164223740|NCT00236197|593186626|FG001|Overall Study|Medication non-compliance|2|||
164223741|NCT00236197|593186625|FG000|Overall Study|Other|0|||
164329135|NCT01888003|593581328|FG000|Overall Study|Study Terminated|5|||
164671325|NCT01256684|594823008|FG001|Overall Study|Physician Decision|1|||
164671326|NCT01256684|594823009|FG002|Overall Study|Physician Decision|0|||
164671327|NCT01256684|594823007|FG000|Overall Study|Lack of Efficacy|0|||
164671328|NCT01256684|594823008|FG001|Overall Study|Lack of Efficacy|1|||
164671329|NCT01256684|594823009|FG002|Overall Study|Lack of Efficacy|1|||
164671330|NCT01256684|594823007|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
164671331|NCT01256684|594823008|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
164671332|NCT01256684|594823009|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
164671333|NCT02914600|594823011|FG000|Overall Study|Adverse Event|298|||
164671334|NCT02914600|594823012|FG001|Overall Study|Adverse Event|35|||
164671335|NCT02914600|594823013|FG002|Overall Study|Adverse Event|25|||
164671336|NCT02914600|594823011|FG000|Overall Study|Sponsors decision|287|||
164671337|NCT02914600|594823012|FG001|Overall Study|Sponsors decision|41|||
164223742|NCT00236197|593186626|FG001|Overall Study|Other|2|||
164223743|NCT00480025|593186627|FG000|Overall Study|Protocol Violation|12|||
164223744|NCT00480025|593186628|FG001|Overall Study|Protocol Violation|7|||
164223745|NCT00480025|593186627|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
164223746|NCT00480025|593186628|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
164223747|NCT00480025|593186627|FG000|Overall Study|Disease Progression / Recurrence|449|||
164223748|NCT00480025|593186628|FG001|Overall Study|Disease Progression / Recurrence|224|||
164223749|NCT00480025|593186627|FG000|Overall Study|Adverse Event|44|||
164223750|NCT00480025|593186628|FG001|Overall Study|Adverse Event|12|||
164223751|NCT00480025|593186627|FG000|Overall Study|Other|70|||
164223752|NCT00480025|593186628|FG001|Overall Study|Other|29|||
164223753|NCT00480025|593186627|FG000|Overall Study|SAE including intercurrent illness|76|||
164568403|NCT04666038|594449154|FG000|Overall Study|On Study Treatment|46|||
164568404|NCT04666038|594449155|FG001|Overall Study|On Study Treatment|5|||
164568405|NCT04666038|594449154|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
164568406|NCT04666038|594449155|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
164568407|NCT01375764|594449159|FG000|Overall Study|Lost to Follow-up|0|||
164568408|NCT01375764|594449160|FG001|Overall Study|Lost to Follow-up|1|||
164568409|NCT01375764|594449161|FG002|Overall Study|Lost to Follow-up|0|||
164568410|NCT01375764|594449162|FG003|Overall Study|Lost to Follow-up|0|||
164568411|NCT01375764|594449163|FG004|Overall Study|Lost to Follow-up|0|||
164568412|NCT01375764|594449159|FG000|Overall Study|Withdrawal by Subject|2|||
164568413|NCT01375764|594449160|FG001|Overall Study|Withdrawal by Subject|0|||
164568414|NCT01375764|594449161|FG002|Overall Study|Withdrawal by Subject|0|||
164568415|NCT01375764|594449162|FG003|Overall Study|Withdrawal by Subject|0|||
164568416|NCT01375764|594449163|FG004|Overall Study|Withdrawal by Subject|1|||
164568417|NCT01375764|594449159|FG000|Overall Study|Other|0|||
164568418|NCT01375764|594449160|FG001|Overall Study|Other|0|||
164568419|NCT01375764|594449161|FG002|Overall Study|Other|0|||
164568420|NCT01375764|594449162|FG003|Overall Study|Other|1|||
164568421|NCT01375764|594449163|FG004|Overall Study|Other|0|||
164568422|NCT03595280|594449167|FG000|Overall Study|Lost to Follow-up|6|||
164568423|NCT03595280|594449168|FG001|Overall Study|Lost to Follow-up|9|||
164568424|NCT03595280|594449169|FG002|Overall Study|Lost to Follow-up|15|||
164568425|NCT02658812|594449172|FG000|Overall Study|Disease Progression|7|||
164568426|NCT02658812|594449172|FG000|Overall Study|Unrelated to study treatment|1|||
164568427|NCT02658812|594449172|FG000|Overall Study|Adverse Event|1|||
164568428|NCT02445586|594449175|FG000|Overall Study|Death|14|||
164568429|NCT02445586|594449175|FG000|Overall Study|Withdrawal by Subject|13|||
164568430|NCT02445586|594449175|FG000|Overall Study|Disease Progression|10|||
164568431|NCT02445586|594449175|FG000|Overall Study|Protocol Violation|1|||
164568432|NCT02445586|594449175|FG000|Overall Study|Medical Condition|1|||
164568433|NCT01194440|594449176|FG000|Baseline (First Dose)|Reason not specified|4|||
164568434|NCT01194440|594449176|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
164568435|NCT01194440|594449176|FG000|Baseline (First Dose)|Change in therapy|1|||
164568436|NCT01194440|594449176|FG000|Baseline (First Dose)|Adverse Event|1|||
164568437|NCT01194440|594449176|FG000|6-months (2nd Dose)|Change in therapy|4|||
164568438|NCT00854828|594449177|FG000|Overall Study|Death|1|||
164568439|NCT00854828|594449178|FG001|Overall Study|Death|0|||
164568440|NCT00854828|594449179|FG002|Overall Study|Death|0|||
164568441|NCT00854828|594449180|FG003|Overall Study|Death|0|||
164568442|NCT00854828|594449177|FG000|Overall Study|Withdrawal by Subject|1|||
164568443|NCT00854828|594449178|FG001|Overall Study|Withdrawal by Subject|1|||
164568444|NCT00854828|594449179|FG002|Overall Study|Withdrawal by Subject|0|||
164568445|NCT00854828|594449180|FG003|Overall Study|Withdrawal by Subject|9|||
164568446|NCT00854828|594449177|FG000|Overall Study|Missed 24mo visit|1|||
164568447|NCT00854828|594449178|FG001|Overall Study|Missed 24mo visit|1|||
164568448|NCT00854828|594449179|FG002|Overall Study|Missed 24mo visit|8|||
164568449|NCT00854828|594449180|FG003|Overall Study|Missed 24mo visit|8|||
164568450|NCT01931059|594449181|FG000|Day 1|Pregnancy|0|||
164568451|NCT01931059|594449182|FG001|Day 1|Pregnancy|1|||
164568452|NCT01931059|594449181|FG000|Day3|Lost to Follow-up|1|||
164568453|NCT01931059|594449182|FG001|Day3|Lost to Follow-up|0|||
164568454|NCT02292212|594449184|FG000|ViE Phase|Withdrawal by Subject|1|||
164568455|NCT02292212|594449184|FG000|ViE Phase|Protocol Violation|2|||
164568456|NCT02675075|594449193|FG000|Overall Study|Lost to Follow-up|3|||
164568457|NCT02675075|594449194|FG001|Overall Study|Lost to Follow-up|0|||
164568458|NCT04957290|594449195|FG000|Overall Study|Progressive disease|3|||
164568459|NCT04957290|594449196|FG001|Overall Study|Progressive disease|3|||
164568460|NCT04957290|594449197|FG002|Overall Study|Progressive disease|2|||
164568461|NCT04957290|594449198|FG003|Overall Study|Progressive disease|0|||
164568462|NCT04957290|594449199|FG004|Overall Study|Progressive disease|0|||
164568463|NCT04957290|594449200|FG005|Overall Study|Progressive disease|0|||
164223754|NCT00480025|593186628|FG001|Overall Study|SAE including intercurrent illness|42|||
164223755|NCT06868667|593186634|FG000|Overall Study|Death|0|||
164223756|NCT06868667|593186635|FG001|Overall Study|Death|4|||
164223757|NCT06868667|593186634|FG000|Overall Study|Lost to Follow-up|0|||
164223758|NCT06868667|593186635|FG001|Overall Study|Lost to Follow-up|1|||
164223759|NCT06868667|593186634|FG000|Overall Study|Withdrawal by Subject|1|||
164223760|NCT06868667|593186635|FG001|Overall Study|Withdrawal by Subject|0|||
164223761|NCT06868667|593186634|FG000|Overall Study|Ongoing|9|||
164223762|NCT06868667|593186635|FG001|Overall Study|Ongoing|9|||
164223763|NCT01699685|593188444|FG000|Period 1|Adverse Event|1|||
164223764|NCT01699685|593188445|FG001|Period 1|Adverse Event|1|||
164223765|NCT01699685|593188444|FG000|Period 1|Medical or ethical, noncompliance|2|||
164223766|NCT01699685|593188445|FG001|Period 1|Medical or ethical, noncompliance|0|||
164223767|NCT01699685|593188444|FG000|Period 1|Other|0|||
164223768|NCT01699685|593188445|FG001|Period 1|Other|1|||
164223769|NCT01699685|593188444|FG000|Period 1|Patient request|0|||
164223770|NCT01699685|593188445|FG001|Period 1|Patient request|1|||
164223771|NCT01699685|593188444|FG000|Period 2|Lost to Follow-up|1|||
164223772|NCT01699685|593188445|FG001|Period 2|Lost to Follow-up|0|||
164223773|NCT02821000|593188446|FG000|Overall Study|Death|89|||
164223774|NCT02821000|593188446|FG000|Overall Study|Sponsor Decision|12|||
164223775|NCT02821000|593188446|FG000|Overall Study|Withdrawal by Subject|2|||
164223776|NCT00326495|593188447|FG000|Overall Study|Switched to alternative treatment|1|||
164223777|NCT00326495|593188447|FG000|Overall Study|Disease progression before treatment|1|||
164223778|NCT00326495|593188447|FG000|Overall Study|Refused further treatment|2|||
164223779|NCT00326495|593188447|FG000|Overall Study|Subject off study before assessment|1|||
164223780|NCT05058456|593188448|FG000|Overall Study|Death|1|||
164223781|NCT05058456|593188448|FG000|Overall Study|End of Study data not yet due for release|34|||
164223782|NCT03931785|593188449|FG000|Overall Study|Lost to Follow-up|4|||
164223783|NCT03931785|593188450|FG001|Overall Study|Lost to Follow-up|1|||
164223784|NCT03931785|593188451|FG002|Overall Study|Lost to Follow-up|4|||
164223785|NCT03931785|593188452|FG003|Overall Study|Lost to Follow-up|3|||
164223786|NCT03931785|593188449|FG000|Overall Study|Adverse Event|1|||
164223787|NCT03931785|593188450|FG001|Overall Study|Adverse Event|0|||
164223788|NCT03931785|593188451|FG002|Overall Study|Adverse Event|3|||
164223789|NCT03931785|593188452|FG003|Overall Study|Adverse Event|4|||
164223790|NCT03931785|593188449|FG000|Overall Study|Protocol Violation|0|||
164223791|NCT03931785|593188450|FG001|Overall Study|Protocol Violation|1|||
164223792|NCT03931785|593188451|FG002|Overall Study|Protocol Violation|0|||
164223793|NCT03931785|593188452|FG003|Overall Study|Protocol Violation|0|||
164223794|NCT03931785|593188449|FG000|Overall Study|Noncompliance With Study drug|0|||
164223795|NCT03931785|593188450|FG001|Overall Study|Noncompliance With Study drug|1|||
164223796|NCT03931785|593188451|FG002|Overall Study|Noncompliance With Study drug|0|||
164223797|NCT03931785|593188452|FG003|Overall Study|Noncompliance With Study drug|0|||
164223798|NCT03931785|593188449|FG000|Overall Study|Other Not specified|0|||
164223799|NCT03931785|593188450|FG001|Overall Study|Other Not specified|2|||
164223800|NCT03931785|593188451|FG002|Overall Study|Other Not specified|2|||
164568464|NCT04957290|594449195|FG000|Overall Study|Withdrawal by Subject|1|||
164223801|NCT03931785|593188452|FG003|Overall Study|Other Not specified|2|||
164223802|NCT03931785|593188449|FG000|Overall Study|Withdrawal by Subject|0|||
164223803|NCT03931785|593188450|FG001|Overall Study|Withdrawal by Subject|2|||
164223804|NCT03931785|593188451|FG002|Overall Study|Withdrawal by Subject|4|||
164223805|NCT03931785|593188452|FG003|Overall Study|Withdrawal by Subject|1|||
164223806|NCT03931785|593188449|FG000|Overall Study|Pregnancy|0|||
164223807|NCT03931785|593188450|FG001|Overall Study|Pregnancy|0|||
164223808|NCT03931785|593188451|FG002|Overall Study|Pregnancy|0|||
164223809|NCT03931785|593188452|FG003|Overall Study|Pregnancy|1|||
164223810|NCT01897896|593188459|FG000|Overall Study|Death|1|||
164223811|NCT01897896|593188460|FG001|Overall Study|Death|0|||
164223812|NCT01897896|593188459|FG000|Overall Study|Adverse Event|11|||
164223813|NCT01897896|593188460|FG001|Overall Study|Adverse Event|1|||
164223814|NCT01897896|593188459|FG000|Overall Study|Lost to Follow-up|1|||
164223815|NCT01897896|593188460|FG001|Overall Study|Lost to Follow-up|0|||
164223816|NCT01897896|593188459|FG000|Overall Study|Non-compliance with study drug dosing|1|||
164223817|NCT01897896|593188460|FG001|Overall Study|Non-compliance with study drug dosing|1|||
164223818|NCT01897896|593188459|FG000|Overall Study|Withdrawal by Subject|7|||
164223819|NCT01897896|593188460|FG001|Overall Study|Withdrawal by Subject|1|||
164223820|NCT01897896|593188459|FG000|Overall Study|Require drug that interfere with study|1|||
164223821|NCT01897896|593188460|FG001|Overall Study|Require drug that interfere with study|4|||
164223822|NCT01897896|593188459|FG000|Overall Study|Protocol Violation|1|||
164223823|NCT01897896|593188460|FG001|Overall Study|Protocol Violation|1|||
164223824|NCT01897896|593188459|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
164223825|NCT01897896|593188460|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
164223826|NCT01897896|593188459|FG000|Overall Study|Caregiver can no longer participate|0|||
164223827|NCT01897896|593188460|FG001|Overall Study|Caregiver can no longer participate|2|||
164223828|NCT01897896|593188459|FG000|Overall Study|Other than specified|2|||
164223829|NCT01897896|593188460|FG001|Overall Study|Other than specified|1|||
164223830|NCT02451007|593188470|FG000|Overall Study|Withdrawal by Subject|4|||
164223831|NCT02451007|593188470|FG000|Overall Study|Adverse Event|1|||
164223832|NCT02451007|593188470|FG000|Overall Study|Disease Progression|2|||
164223833|NCT01716559|593188471|FG000|Overall Study|Adverse Event|11|||
164223834|NCT01716559|593188471|FG000|Overall Study|Death|21|||
164223835|NCT01716559|593188471|FG000|Overall Study|Withdrawal by Subject|4|||
164223836|NCT01716559|593188471|FG000|Overall Study|Other withdrawal reason|75|||
164223837|NCT00348374|593188472|FG000|Overall Study|Adverse Event|1|||
164223838|NCT00348374|593188473|FG001|Overall Study|Adverse Event|4|||
164223839|NCT00348374|593188472|FG000|Overall Study|Lost to Follow-up|1|||
164223840|NCT00348374|593188473|FG001|Overall Study|Lost to Follow-up|3|||
164223841|NCT00348374|593188472|FG000|Overall Study|Withdrawal by Subject|5|||
164223842|NCT00348374|593188473|FG001|Overall Study|Withdrawal by Subject|5|||
164223843|NCT00348374|593188472|FG000|Overall Study|Other|11|||
164223844|NCT00348374|593188473|FG001|Overall Study|Other|12|||
164223845|NCT00348374|593188472|FG000|Overall Study|ongoing at date of cutoff|1|||
164223846|NCT00348374|593188473|FG001|Overall Study|ongoing at date of cutoff|1|||
164223847|NCT00348374|593188472|FG000|Overall Study|randomized but did not receive treatment|0|||
164223848|NCT00348374|593188473|FG001|Overall Study|randomized but did not receive treatment|7|||
164223849|NCT00458705|593188481|FG000|Overall Study|Adverse Event|4|||
164223850|NCT00458705|593188481|FG000|Overall Study|Not Treated|1|||
164223851|NCT03574389|593188485|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
164223852|NCT03574389|593188486|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
164223853|NCT03574389|593188487|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
164223854|NCT03574389|593188488|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
164223855|NCT03574389|593188489|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
164223856|NCT03574389|593188490|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
164223857|NCT03574389|593188491|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
164223858|NCT03574389|593188485|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
164223859|NCT03574389|593188486|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
164421040|NCT02138747|593911084|FG000|Treatment Period 1|Withdrawal by Subject|8|||
164568465|NCT04957290|594449196|FG001|Overall Study|Withdrawal by Subject|0|||
164568466|NCT04957290|594449197|FG002|Overall Study|Withdrawal by Subject|1|||
164568467|NCT04957290|594449198|FG003|Overall Study|Withdrawal by Subject|0|||
164568468|NCT04957290|594449199|FG004|Overall Study|Withdrawal by Subject|0|||
164568469|NCT04957290|594449200|FG005|Overall Study|Withdrawal by Subject|0|||
164568470|NCT04957290|594449195|FG000|Overall Study|Death|0|||
164568471|NCT04957290|594449196|FG001|Overall Study|Death|2|||
164223860|NCT03574389|593188487|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
164223861|NCT03574389|593188488|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
164223862|NCT03574389|593188489|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
164223863|NCT03574389|593188490|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
164223864|NCT03574389|593188491|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
164223865|NCT03574389|593188485|FG000|Vaccination Period|Other|6|||
164223866|NCT03574389|593188486|FG001|Vaccination Period|Other|0|||
164223867|NCT03574389|593188487|FG002|Vaccination Period|Other|0|||
164223868|NCT03574389|593188488|FG003|Vaccination Period|Other|0|||
164568472|NCT04957290|594449197|FG002|Overall Study|Death|1|||
164568473|NCT04957290|594449198|FG003|Overall Study|Death|0|||
164568474|NCT04957290|594449199|FG004|Overall Study|Death|0|||
164568475|NCT04957290|594449200|FG005|Overall Study|Death|0|||
164223869|NCT03574389|593188489|FG004|Vaccination Period|Other|0|||
164223870|NCT03574389|593188490|FG005|Vaccination Period|Other|0|||
164223871|NCT03574389|593188491|FG006|Vaccination Period|Other|0|||
164223872|NCT03574389|593188485|FG000|Vaccination Period|Adverse Event|0|||
164223873|NCT03574389|593188486|FG001|Vaccination Period|Adverse Event|1|||
164223874|NCT03574389|593188487|FG002|Vaccination Period|Adverse Event|0|||
164223875|NCT03574389|593188488|FG003|Vaccination Period|Adverse Event|0|||
164223876|NCT03574389|593188489|FG004|Vaccination Period|Adverse Event|0|||
164223877|NCT03574389|593188490|FG005|Vaccination Period|Adverse Event|0|||
164223878|NCT03574389|593188491|FG006|Vaccination Period|Adverse Event|0|||
164223879|NCT03574389|593188485|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
164223880|NCT03574389|593188486|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
164223881|NCT03574389|593188487|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
164223882|NCT03574389|593188488|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
164223883|NCT03574389|593188489|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
164223884|NCT03574389|593188490|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
164223885|NCT03574389|593188491|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
164223886|NCT00378560|593188492|FG000|Overall Study|Adverse Event|1|||
164223887|NCT00378560|593188493|FG001|Overall Study|Adverse Event|0|||
164223888|NCT00378560|593188492|FG000|Overall Study|Lost to Follow-up|24|||
164223889|NCT00378560|593188493|FG001|Overall Study|Lost to Follow-up|29|||
164223890|NCT00378560|593188492|FG000|Overall Study|Protocol Violation|2|||
164223891|NCT00378560|593188493|FG001|Overall Study|Protocol Violation|0|||
164223892|NCT00378560|593188492|FG000|Overall Study|Withdrawal by Subject|17|||
164223893|NCT00378560|593188493|FG001|Overall Study|Withdrawal by Subject|21|||
164223894|NCT00378560|593188492|FG000|Overall Study|Moved|4|||
164223895|NCT00378560|593188493|FG001|Overall Study|Moved|3|||
164223896|NCT00378560|593188492|FG000|Overall Study|Pregnancy|7|||
164223897|NCT00378560|593188493|FG001|Overall Study|Pregnancy|5|||
164223898|NCT00378560|593188492|FG000|Overall Study|Laboratory test values abnormal|1|||
164223899|NCT00378560|593188493|FG001|Overall Study|Laboratory test values abnormal|0|||
164223900|NCT02070380|593188496|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
164223901|NCT02070380|593188497|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
164223902|NCT02070380|593188498|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
164223903|NCT02070380|593188499|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
164223904|NCT02070380|593188496|FG000|Second Injection|Image sets missing or technically inadeq|0|||
164223905|NCT02070380|593188497|FG001|Second Injection|Image sets missing or technically inadeq|1|||
164223906|NCT02070380|593188498|FG002|Second Injection|Image sets missing or technically inadeq|0|||
164223907|NCT02070380|593188499|FG003|Second Injection|Image sets missing or technically inadeq|0|||
164223908|NCT02070380|593188496|FG000|Second Injection|Protocol Violation|0|||
164223909|NCT02070380|593188497|FG001|Second Injection|Protocol Violation|1|||
164223910|NCT02070380|593188498|FG002|Second Injection|Protocol Violation|1|||
164223911|NCT02070380|593188499|FG003|Second Injection|Protocol Violation|5|||
164223912|NCT00337194|593188510|FG000|Overall Study|Adverse Event|5|||
164223913|NCT00337194|593188511|FG001|Overall Study|Adverse Event|1|||
164223914|NCT00337194|593188510|FG000|Overall Study|Death|2|||
164223915|NCT00337194|593188511|FG001|Overall Study|Death|0|||
164568476|NCT04957290|594449195|FG000|Overall Study|non compliance with study drug|0|||
164568477|NCT04957290|594449196|FG001|Overall Study|non compliance with study drug|1|||
164568478|NCT04957290|594449197|FG002|Overall Study|non compliance with study drug|0|||
164568479|NCT04957290|594449198|FG003|Overall Study|non compliance with study drug|0|||
164568480|NCT04957290|594449199|FG004|Overall Study|non compliance with study drug|0|||
164568481|NCT04957290|594449200|FG005|Overall Study|non compliance with study drug|0|||
164568482|NCT04957290|594449195|FG000|Overall Study|none specified.|0|||
164568483|NCT04957290|594449196|FG001|Overall Study|none specified.|1|||
164568484|NCT04957290|594449197|FG002|Overall Study|none specified.|2|||
164568485|NCT04957290|594449198|FG003|Overall Study|none specified.|0|||
164568486|NCT04957290|594449199|FG004|Overall Study|none specified.|0|||
164223916|NCT00337194|593188510|FG000|Overall Study|Withdrawal by Subject|1|||
164223917|NCT00337194|593188511|FG001|Overall Study|Withdrawal by Subject|0|||
164223918|NCT00337194|593188510|FG000|Overall Study|Disease progression|1|||
164223919|NCT00337194|593188511|FG001|Overall Study|Disease progression|2|||
164223920|NCT00337194|593188510|FG000|Overall Study|Subsequent non-protocol therapy|3|||
164223921|NCT00337194|593188511|FG001|Overall Study|Subsequent non-protocol therapy|1|||
164223922|NCT00159874|593188516|FG000|Overall Study|Adverse Event|2|||
164223923|NCT00159874|593188517|FG001|Overall Study|Adverse Event|2|||
164223924|NCT00159874|593188518|FG002|Overall Study|Adverse Event|5|||
164223925|NCT00159874|593188519|FG003|Overall Study|Adverse Event|1|||
164223926|NCT00159874|593188520|FG004|Overall Study|Adverse Event|1|||
164223927|NCT00159874|593188521|FG005|Overall Study|Adverse Event|2|||
164223928|NCT00159874|593188522|FG006|Overall Study|Adverse Event|0|||
164568487|NCT04957290|594449200|FG005|Overall Study|none specified.|0|||
164568488|NCT04957290|594449195|FG000|Overall Study|unacceptable toxicity|0|||
164568489|NCT04957290|594449196|FG001|Overall Study|unacceptable toxicity|0|||
164223929|NCT00159874|593188516|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
164223930|NCT00159874|593188517|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
164223931|NCT00159874|593188518|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
164223932|NCT00159874|593188519|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
164223933|NCT00159874|593188520|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
164223934|NCT00159874|593188521|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
164223935|NCT00159874|593188522|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
164223936|NCT00159874|593188516|FG000|Overall Study|Lack of Efficacy|2|||
164223937|NCT00159874|593188517|FG001|Overall Study|Lack of Efficacy|0|||
164223938|NCT00159874|593188518|FG002|Overall Study|Lack of Efficacy|1|||
164223939|NCT00159874|593188519|FG003|Overall Study|Lack of Efficacy|1|||
164223940|NCT00159874|593188520|FG004|Overall Study|Lack of Efficacy|0|||
164223941|NCT00159874|593188521|FG005|Overall Study|Lack of Efficacy|3|||
164223942|NCT00159874|593188522|FG006|Overall Study|Lack of Efficacy|0|||
164223943|NCT00159874|593188516|FG000|Overall Study|Lost to Follow-up|1|||
164223944|NCT00159874|593188517|FG001|Overall Study|Lost to Follow-up|0|||
164223945|NCT00159874|593188518|FG002|Overall Study|Lost to Follow-up|3|||
164223946|NCT00159874|593188519|FG003|Overall Study|Lost to Follow-up|0|||
164223947|NCT00159874|593188520|FG004|Overall Study|Lost to Follow-up|1|||
164223948|NCT00159874|593188521|FG005|Overall Study|Lost to Follow-up|2|||
164223949|NCT00159874|593188522|FG006|Overall Study|Lost to Follow-up|1|||
164223950|NCT00159874|593188516|FG000|Overall Study|Other|8|||
164223951|NCT00159874|593188517|FG001|Overall Study|Other|8|||
164223952|NCT00159874|593188518|FG002|Overall Study|Other|8|||
164223953|NCT00159874|593188519|FG003|Overall Study|Other|0|||
164223954|NCT00159874|593188520|FG004|Overall Study|Other|2|||
164223955|NCT00159874|593188521|FG005|Overall Study|Other|1|||
164223956|NCT00159874|593188522|FG006|Overall Study|Other|3|||
164223957|NCT00159874|593188516|FG000|Overall Study|Protocol Violation|0|||
164223958|NCT00159874|593188517|FG001|Overall Study|Protocol Violation|5|||
164223959|NCT00159874|593188518|FG002|Overall Study|Protocol Violation|2|||
164223960|NCT00159874|593188519|FG003|Overall Study|Protocol Violation|0|||
164223961|NCT00159874|593188520|FG004|Overall Study|Protocol Violation|0|||
164223962|NCT00159874|593188521|FG005|Overall Study|Protocol Violation|0|||
164223963|NCT00159874|593188522|FG006|Overall Study|Protocol Violation|0|||
164223964|NCT00159874|593188516|FG000|Overall Study|Death|3|||
164223965|NCT00159874|593188517|FG001|Overall Study|Death|8|||
164223966|NCT00159874|593188518|FG002|Overall Study|Death|15|||
164223967|NCT00159874|593188519|FG003|Overall Study|Death|0|||
164223968|NCT00159874|593188520|FG004|Overall Study|Death|1|||
164223969|NCT00159874|593188521|FG005|Overall Study|Death|2|||
164223970|NCT00159874|593188522|FG006|Overall Study|Death|0|||
164223971|NCT00159874|593188516|FG000|Overall Study|Withdrawal by Subject|2|||
164223972|NCT00159874|593188517|FG001|Overall Study|Withdrawal by Subject|6|||
164223973|NCT00159874|593188518|FG002|Overall Study|Withdrawal by Subject|8|||
164223974|NCT00159874|593188519|FG003|Overall Study|Withdrawal by Subject|4|||
164223975|NCT00159874|593188520|FG004|Overall Study|Withdrawal by Subject|3|||
164223976|NCT00159874|593188521|FG005|Overall Study|Withdrawal by Subject|2|||
164223977|NCT00159874|593188522|FG006|Overall Study|Withdrawal by Subject|1|||
164223978|NCT00159874|593188516|FG000|Overall Study|Pregnancy|1|||
164223979|NCT00159874|593188517|FG001|Overall Study|Pregnancy|1|||
164223980|NCT00159874|593188518|FG002|Overall Study|Pregnancy|0|||
164223981|NCT00159874|593188519|FG003|Overall Study|Pregnancy|0|||
164223982|NCT00159874|593188520|FG004|Overall Study|Pregnancy|0|||
164223983|NCT00159874|593188521|FG005|Overall Study|Pregnancy|0|||
164223984|NCT00159874|593188522|FG006|Overall Study|Pregnancy|0|||
164223985|NCT01104870|593188523|FG000|Overall Study|Adverse Event|1|||
164223986|NCT01104870|593188524|FG001|Overall Study|Adverse Event|1|||
164329136|NCT01888003|593581329|FG001|Overall Study|Study Terminated|6|||
164671338|NCT02914600|594823013|FG002|Overall Study|Sponsors decision|12|||
164671339|NCT02914600|594823011|FG000|Overall Study|Withdrawal by Subject|158|||
164671340|NCT02914600|594823012|FG001|Overall Study|Withdrawal by Subject|20|||
164671341|NCT02914600|594823013|FG002|Overall Study|Withdrawal by Subject|18|||
164671342|NCT02914600|594823011|FG000|Overall Study|Investigators discretion|169|||
164671343|NCT02914600|594823012|FG001|Overall Study|Investigators discretion|14|||
164671344|NCT02914600|594823013|FG002|Overall Study|Investigators discretion|13|||
164671345|NCT02914600|594823011|FG000|Overall Study|Lost to Follow-up|10|||
164671346|NCT02914600|594823012|FG001|Overall Study|Lost to Follow-up|4|||
164671347|NCT02914600|594823013|FG002|Overall Study|Lost to Follow-up|0|||
164671348|NCT02914600|594823011|FG000|Overall Study|Pregnancy|8|||
164223987|NCT01104870|593188525|FG002|Overall Study|Adverse Event|0|||
164223988|NCT01104870|593188523|FG000|Overall Study|Death|0|||
164223989|NCT01104870|593188524|FG001|Overall Study|Death|0|||
164223990|NCT01104870|593188525|FG002|Overall Study|Death|1|||
164223991|NCT01104870|593188523|FG000|Overall Study|Withdrawal by Subject|0|||
164223992|NCT01104870|593188524|FG001|Overall Study|Withdrawal by Subject|0|||
164223993|NCT01104870|593188525|FG002|Overall Study|Withdrawal by Subject|1|||
164223994|NCT05463705|593188528|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
164671349|NCT02914600|594823012|FG001|Overall Study|Pregnancy|0|||
164671350|NCT02914600|594823013|FG002|Overall Study|Pregnancy|0|||
164671351|NCT02914600|594823011|FG000|Overall Study|Protocol Violation|5|||
164223995|NCT05463705|593188529|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
164223996|NCT05463705|593188530|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
164223997|NCT05463705|593188531|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
164223998|NCT05463705|593188532|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
164223999|NCT05463705|593188533|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
164224000|NCT02771145|593188534|FG000|Overall Study|Adverse Event|3|||
164224001|NCT02771145|593188534|FG000|Overall Study|Lost to Follow-up|1|||
164224002|NCT00276380|593188535|FG000|Overall Study|Adverse Event|5|||
164224003|NCT00276380|593188536|FG001|Overall Study|Adverse Event|3|||
164224004|NCT00276380|593188535|FG000|Overall Study|Lost to Follow-up|1|||
164224005|NCT00276380|593188536|FG001|Overall Study|Lost to Follow-up|1|||
164224006|NCT00276380|593188535|FG000|Overall Study|Withdrawal by Subject|3|||
164224007|NCT00276380|593188536|FG001|Overall Study|Withdrawal by Subject|6|||
164224008|NCT00276380|593188535|FG000|Overall Study|Death|5|||
164224009|NCT00276380|593188536|FG001|Overall Study|Death|3|||
164224010|NCT00276380|593188535|FG000|Overall Study|Abnormal aPPT Levels|0|||
164224011|NCT00276380|593188536|FG001|Overall Study|Abnormal aPPT Levels|1|||
164224012|NCT03596983|593188537|FG000|Overall Study|Withdrawal by Subject|3|||
164224013|NCT03071965|593188538|FG000|Overall Study|Adverse Event|0|||
164224014|NCT03071965|593188539|FG001|Overall Study|Adverse Event|0|||
164224015|NCT03071965|593188540|FG002|Overall Study|Adverse Event|1|||
164224016|NCT03071965|593188541|FG003|Overall Study|Adverse Event|0|||
164224017|NCT03071965|593188538|FG000|Overall Study|Death|0|||
164224018|NCT03071965|593188539|FG001|Overall Study|Death|0|||
164224019|NCT03071965|593188540|FG002|Overall Study|Death|1|||
164224020|NCT03071965|593188541|FG003|Overall Study|Death|1|||
164224021|NCT03071965|593188538|FG000|Overall Study|COVID-19|0|||
164224022|NCT03071965|593188539|FG001|Overall Study|COVID-19|1|||
164224023|NCT03071965|593188540|FG002|Overall Study|COVID-19|0|||
164224024|NCT03071965|593188541|FG003|Overall Study|COVID-19|1|||
164224025|NCT03071965|593188538|FG000|Overall Study|Other Health Reason|0|||
164224026|NCT03071965|593188539|FG001|Overall Study|Other Health Reason|0|||
164224027|NCT03071965|593188540|FG002|Overall Study|Other Health Reason|0|||
164224028|NCT03071965|593188541|FG003|Overall Study|Other Health Reason|1|||
164224029|NCT02346370|593188542|FG000|Overall Study|Not treated|1|||
164224030|NCT02346370|593188543|FG001|Overall Study|Not treated|0|||
164224031|NCT02346370|593188544|FG002|Overall Study|Not treated|0|||
164224032|NCT02346370|593188542|FG000|Overall Study|Withdrawal of consent|1|||
164568490|NCT04957290|594449197|FG002|Overall Study|unacceptable toxicity|1|||
164568491|NCT04957290|594449198|FG003|Overall Study|unacceptable toxicity|0|||
164568492|NCT04957290|594449199|FG004|Overall Study|unacceptable toxicity|0|||
164568493|NCT04957290|594449200|FG005|Overall Study|unacceptable toxicity|0|||
164568494|NCT04957290|594449195|FG000|Overall Study|Adverse Event|0|||
164568495|NCT04957290|594449196|FG001|Overall Study|Adverse Event|0|||
164568496|NCT04957290|594449197|FG002|Overall Study|Adverse Event|1|||
164568497|NCT04957290|594449198|FG003|Overall Study|Adverse Event|0|||
164568498|NCT04957290|594449199|FG004|Overall Study|Adverse Event|0|||
164568499|NCT04957290|594449200|FG005|Overall Study|Adverse Event|0|||
164568500|NCT04957290|594449195|FG000|Overall Study|study terminated by sponsor|0|||
164568501|NCT04957290|594449196|FG001|Overall Study|study terminated by sponsor|0|||
164568502|NCT04957290|594449197|FG002|Overall Study|study terminated by sponsor|2|||
164568503|NCT04957290|594449198|FG003|Overall Study|study terminated by sponsor|0|||
164568504|NCT04957290|594449199|FG004|Overall Study|study terminated by sponsor|0|||
164224033|NCT02346370|593188543|FG001|Overall Study|Withdrawal of consent|0|||
164224034|NCT02346370|593188544|FG002|Overall Study|Withdrawal of consent|0|||
164224035|NCT02346370|593188542|FG000|Overall Study|Death|1|||
164224036|NCT02346370|593188543|FG001|Overall Study|Death|3|||
164224037|NCT02346370|593188544|FG002|Overall Study|Death|1|||
164224038|NCT02346370|593188542|FG000|Overall Study|Sponsor discontinued study|5|||
164224039|NCT02346370|593188543|FG001|Overall Study|Sponsor discontinued study|0|||
164224040|NCT02346370|593188544|FG002|Overall Study|Sponsor discontinued study|2|||
164224041|NCT02346370|593188542|FG000|Overall Study|Radiologic progression|0|||
164224042|NCT02346370|593188543|FG001|Overall Study|Radiologic progression|0|||
164224043|NCT02346370|593188544|FG002|Overall Study|Radiologic progression|1|||
164224044|NCT02346370|593188542|FG000|Overall Study|Physician Decision|0|||
164224045|NCT02346370|593188543|FG001|Overall Study|Physician Decision|1|||
164224046|NCT02346370|593188544|FG002|Overall Study|Physician Decision|0|||
164568505|NCT04957290|594449200|FG005|Overall Study|study terminated by sponsor|0|||
164568506|NCT01282229|594449201|FG000|Overall Study|Protocol Violation|2|||
164671352|NCT02914600|594823012|FG001|Overall Study|Protocol Violation|3|||
164671353|NCT02914600|594823013|FG002|Overall Study|Protocol Violation|0|||
164671354|NCT02914600|594823011|FG000|Overall Study|Non-compliance with study drug|6|||
164671355|NCT02914600|594823012|FG001|Overall Study|Non-compliance with study drug|1|||
164671356|NCT02914600|594823013|FG002|Overall Study|Non-compliance with study drug|0|||
164671357|NCT02914600|594823011|FG000|Overall Study|Death|3|||
164671358|NCT02914600|594823012|FG001|Overall Study|Death|1|||
164671359|NCT02914600|594823013|FG002|Overall Study|Death|1|||
164671360|NCT02914600|594823011|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
164671361|NCT02914600|594823012|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
164671362|NCT02914600|594823013|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
164671363|NCT02914600|594823011|FG000|Overall Study|Enrolled but not treated|1|||
164671364|NCT02914600|594823012|FG001|Overall Study|Enrolled but not treated|0|||
164671365|NCT02914600|594823013|FG002|Overall Study|Enrolled but not treated|0|||
164671366|NCT02457520|594823015|FG000|Active Treatment Phase|Adverse Event|10|||
164224047|NCT03654326|593188545|FG000|Overall Study|Withdrawal by Subject|5|||
164224048|NCT03654326|593188546|FG001|Overall Study|Withdrawal by Subject|3|||
164224049|NCT03654326|593188545|FG000|Overall Study|Physician Decision|0|||
164224050|NCT03654326|593188546|FG001|Overall Study|Physician Decision|1|||
164224051|NCT03654326|593188545|FG000|Overall Study|Unable to adhere to study schedule|0|||
164224052|NCT03654326|593188546|FG001|Overall Study|Unable to adhere to study schedule|1|||
164671367|NCT02457520|594823015|FG000|Active Treatment Phase|Lost to Follow-up|8|||
164671368|NCT02457520|594823015|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
164671369|NCT02457520|594823015|FG000|Active Treatment Phase|other|4|||
164671370|NCT02457520|594823015|FG000|Active Treatment Phase|Physician Decision|1|||
164671371|NCT02457520|594823015|FG000|Active Treatment Phase|Protocol Violation|1|||
164671372|NCT02457520|594823015|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
164671373|NCT02457520|594823015|FG000|Post-treatment Period|Other: Retreatment Required|7|||
164671374|NCT02457520|594823015|FG000|Post-treatment Period|Lost to Follow-up|23|||
164671375|NCT02457520|594823015|FG000|Post-treatment Period|Other|3|||
164224053|NCT03654326|593188545|FG000|Overall Study|Lost to Follow-up|1|||
164224054|NCT03654326|593188546|FG001|Overall Study|Lost to Follow-up|1|||
164671376|NCT02457520|594823015|FG000|Post-treatment Period|Physician Decision|1|||
164671377|NCT02457520|594823015|FG000|Post-treatment Period|Withdrawal by Subject|14|||
164671378|NCT02587962|594823016|FG000|Overall Study|Adverse Event|0|||
164671379|NCT02587962|594823017|FG001|Overall Study|Adverse Event|0|||
164671380|NCT02587962|594823018|FG002|Overall Study|Adverse Event|1|||
164671381|NCT02587962|594823019|FG003|Overall Study|Adverse Event|0|||
164671382|NCT02587962|594823020|FG004|Overall Study|Adverse Event|0|||
164671383|NCT02587962|594823016|FG000|Overall Study|Withdrawal by Subject|0|||
164671384|NCT02587962|594823017|FG001|Overall Study|Withdrawal by Subject|0|||
164671385|NCT02587962|594823018|FG002|Overall Study|Withdrawal by Subject|1|||
164671386|NCT02587962|594823019|FG003|Overall Study|Withdrawal by Subject|1|||
164671387|NCT02587962|594823020|FG004|Overall Study|Withdrawal by Subject|4|||
164671388|NCT02587962|594823016|FG000|Overall Study|Radiological progression|2|||
164671389|NCT02587962|594823017|FG001|Overall Study|Radiological progression|2|||
164671390|NCT02587962|594823018|FG002|Overall Study|Radiological progression|2|||
164671391|NCT02587962|594823019|FG003|Overall Study|Radiological progression|5|||
164671392|NCT02587962|594823020|FG004|Overall Study|Radiological progression|10|||
164671393|NCT02587962|594823016|FG000|Overall Study|Clinical progression|0|||
164671394|NCT02587962|594823017|FG001|Overall Study|Clinical progression|1|||
164671395|NCT02587962|594823018|FG002|Overall Study|Clinical progression|2|||
164671396|NCT02587962|594823019|FG003|Overall Study|Clinical progression|0|||
164671397|NCT02587962|594823020|FG004|Overall Study|Clinical progression|1|||
164671398|NCT00624065|594823021|FG000|Overall Study|Adverse Event|5|||
164224055|NCT01362270|593188551|FG000|Overall Study|Withdrawal by Subject|1|||
164224056|NCT01362270|593188552|FG001|Overall Study|Withdrawal by Subject|0|||
164224057|NCT01362270|593188551|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
164224058|NCT01362270|593188552|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
164224059|NCT01362270|593188551|FG000|Overall Study|Met excl. criteria before 1st session|1|||
164224060|NCT01362270|593188552|FG001|Overall Study|Met excl. criteria before 1st session|1|||
164224061|NCT01691482|593188553|FG000|Treatment Period 2|Adverse Event|0|||
164224062|NCT01691482|593188554|FG001|Treatment Period 2|Adverse Event|1|||
164224063|NCT01691482|593188553|FG000|Treatment Period 2|Protocol Violation|1|||
164224064|NCT01691482|593188554|FG001|Treatment Period 2|Protocol Violation|1|||
164224065|NCT01953354|593188555|FG000|Overall Study|Withdrawal by Subject|0|||
164671399|NCT00624065|594823022|FG001|Overall Study|Adverse Event|6|||
164671400|NCT00624065|594823021|FG000|Overall Study|Lost to Follow-up|4|||
164224066|NCT01953354|593188556|FG001|Overall Study|Withdrawal by Subject|1|||
164224067|NCT01953354|593188555|FG000|Overall Study|Decision of Sponsor|0|||
164224068|NCT01953354|593188556|FG001|Overall Study|Decision of Sponsor|1|||
164224069|NCT01953354|593188555|FG000|Overall Study|Disease Exacerbation|1|||
164224070|NCT01953354|593188556|FG001|Overall Study|Disease Exacerbation|0|||
164671401|NCT00624065|594823022|FG001|Overall Study|Lost to Follow-up|1|||
164671402|NCT00624065|594823021|FG000|Overall Study|Consent withdrawn|6|||
164224071|NCT00819832|593188557|FG000|Overall Study|Sponsor Termination of Study|3|||
164224072|NCT00819832|593188558|FG001|Overall Study|Sponsor Termination of Study|0|||
164224073|NCT00819832|593188559|FG002|Overall Study|Sponsor Termination of Study|0|||
164224074|NCT00819832|593188560|FG003|Overall Study|Sponsor Termination of Study|0|||
164224075|NCT00819832|593188561|FG004|Overall Study|Sponsor Termination of Study|0|||
164224076|NCT00819832|593188562|FG005|Overall Study|Sponsor Termination of Study|0|||
164224077|NCT01063881|593188563|FG000|Overall Study|Adverse Event|12|||
164224078|NCT01063881|593188564|FG001|Overall Study|Adverse Event|2|||
164224079|NCT01063881|593188565|FG002|Overall Study|Adverse Event|0|||
164224080|NCT01063881|593188563|FG000|Overall Study|Lost to Follow-up|13|||
164568507|NCT00896532|594449202|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
164568508|NCT00896532|594449203|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
164568509|NCT00896532|594449204|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
164568510|NCT00896532|594449205|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
164568511|NCT00896532|594449206|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
164568512|NCT00896532|594449207|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
164568513|NCT00896532|594449208|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
164568514|NCT00896532|594449209|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
164568515|NCT00896532|594449210|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
164568516|NCT00896532|594449211|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
164568517|NCT00896532|594449212|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
164568518|NCT00896532|594449213|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
164568519|NCT00896532|594449214|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
164568520|NCT00896532|594449215|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
164568521|NCT00896532|594449216|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
164568522|NCT00896532|594449217|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
164568523|NCT00896532|594449218|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
164568524|NCT00896532|594449219|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
164568525|NCT00896532|594449220|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
164568526|NCT00896532|594449221|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
164568527|NCT00896532|594449222|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
164568528|NCT00896532|594449223|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
164568529|NCT00896532|594449224|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
164568530|NCT00896532|594449202|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
164568531|NCT00896532|594449203|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
164568532|NCT00896532|594449204|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
164568533|NCT00896532|594449205|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
164568534|NCT00896532|594449206|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
164568535|NCT00896532|594449207|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
164568536|NCT00896532|594449208|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
164568537|NCT00896532|594449209|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
164568538|NCT00896532|594449210|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
164568539|NCT00896532|594449211|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
164568540|NCT00896532|594449212|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
164568541|NCT00896532|594449213|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
164568542|NCT00896532|594449214|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
164568543|NCT00896532|594449215|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
164568544|NCT00896532|594449216|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
164568545|NCT00896532|594449217|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
164568546|NCT00896532|594449218|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
164568547|NCT00896532|594449219|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
164568548|NCT00896532|594449220|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
164568549|NCT00896532|594449221|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
164568550|NCT00896532|594449222|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
164568551|NCT00896532|594449223|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
164568552|NCT00896532|594449224|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
164568553|NCT00896532|594449202|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
164568554|NCT00896532|594449203|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
164568555|NCT00896532|594449204|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
164568556|NCT00896532|594449205|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
164568557|NCT00896532|594449206|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
164568558|NCT00896532|594449207|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
164568559|NCT00896532|594449208|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
164568560|NCT00896532|594449209|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
164671403|NCT00624065|594823022|FG001|Overall Study|Consent withdrawn|5|||
164224081|NCT01063881|593188564|FG001|Overall Study|Lost to Follow-up|7|||
164224082|NCT01063881|593188565|FG002|Overall Study|Lost to Follow-up|1|||
164224083|NCT01063881|593188563|FG000|Overall Study|Withdrawal by Subject|25|||
164224084|NCT01063881|593188564|FG001|Overall Study|Withdrawal by Subject|1|||
164224085|NCT01063881|593188565|FG002|Overall Study|Withdrawal by Subject|0|||
164224086|NCT01063881|593188563|FG000|Overall Study|Reason for not completed not specified|5|||
164224087|NCT01063881|593188564|FG001|Overall Study|Reason for not completed not specified|1|||
164224088|NCT01063881|593188565|FG002|Overall Study|Reason for not completed not specified|0|||
164224089|NCT00066170|593188566|FG000|Overall Study|Adverse Event|2|||
164224090|NCT00066170|593188567|FG001|Overall Study|Adverse Event|4|||
164224091|NCT00066170|593188568|FG002|Overall Study|Adverse Event|1|||
164224092|NCT00066170|593188569|FG003|Overall Study|Adverse Event|7|||
164224093|NCT00066170|593188566|FG000|Overall Study|Serious Adverse Event|0|||
164224094|NCT00066170|593188567|FG001|Overall Study|Serious Adverse Event|0|||
164224095|NCT00066170|593188568|FG002|Overall Study|Serious Adverse Event|1|||
164224096|NCT00066170|593188569|FG003|Overall Study|Serious Adverse Event|1|||
164224097|NCT00066170|593188566|FG000|Overall Study|Lost to Follow-up|0|||
164224098|NCT00066170|593188567|FG001|Overall Study|Lost to Follow-up|1|||
164224099|NCT00066170|593188568|FG002|Overall Study|Lost to Follow-up|0|||
164224100|NCT00066170|593188569|FG003|Overall Study|Lost to Follow-up|0|||
164224101|NCT00066170|593188566|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
164224102|NCT00066170|593188567|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
164224103|NCT00066170|593188568|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
164224104|NCT00066170|593188569|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
164224105|NCT00066170|593188566|FG000|Overall Study|Protocol Violation|3|||
164224106|NCT00066170|593188567|FG001|Overall Study|Protocol Violation|0|||
164224107|NCT00066170|593188568|FG002|Overall Study|Protocol Violation|0|||
164224108|NCT00066170|593188569|FG003|Overall Study|Protocol Violation|0|||
164224109|NCT00066170|593188566|FG000|Overall Study|Other|1|||
164224110|NCT00066170|593188567|FG001|Overall Study|Other|5|||
164224111|NCT00066170|593188568|FG002|Overall Study|Other|2|||
164224112|NCT00066170|593188569|FG003|Overall Study|Other|0|||
164224113|NCT01370642|593188572|FG000|Overall Study|Adverse Event|2|||
164224114|NCT01370642|593188573|FG001|Overall Study|Adverse Event|1|||
164671404|NCT00624065|594823021|FG000|Overall Study|Lack of Efficacy|0|||
164671405|NCT00624065|594823022|FG001|Overall Study|Lack of Efficacy|3|||
164671406|NCT00624065|594823021|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
164671407|NCT00624065|594823022|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
164671408|NCT01387022|594823023|FG000|Overall Study|Death|1|||
164671409|NCT01387022|594823024|FG001|Overall Study|Death|1|||
164671410|NCT01387022|594823023|FG000|Overall Study|Lost to Follow-up|0|||
164671411|NCT01387022|594823024|FG001|Overall Study|Lost to Follow-up|3|||
164671412|NCT02076022|594823025|FG000|Overall Study|Withdrawal by Subject|2|||
164671413|NCT02076022|594823026|FG001|Overall Study|Withdrawal by Subject|0|||
164671414|NCT01536405|594823029|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
164671415|NCT01536405|594823030|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
164671416|NCT01536405|594823029|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
164671417|NCT01536405|594823030|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
164671418|NCT01536405|594823029|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
164671419|NCT01536405|594823030|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
164671420|NCT01536405|594823029|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
164671421|NCT01536405|594823030|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
164671422|NCT01536405|594823029|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
164671423|NCT01536405|594823030|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
164224115|NCT01370642|593188574|FG002|Overall Study|Adverse Event|1|||
164224116|NCT01370642|593188572|FG000|Overall Study|Detectable HCV RNA|0|||
164224117|NCT01370642|593188573|FG001|Overall Study|Detectable HCV RNA|0|||
164224118|NCT01370642|593188574|FG002|Overall Study|Detectable HCV RNA|22|||
164224119|NCT01370642|593188572|FG000|Overall Study|Lost to Follow-up|0|||
164224120|NCT01370642|593188573|FG001|Overall Study|Lost to Follow-up|0|||
164224121|NCT01370642|593188574|FG002|Overall Study|Lost to Follow-up|1|||
164224122|NCT01370642|593188572|FG000|Overall Study|Physician Decision|4|||
164224123|NCT01370642|593188573|FG001|Overall Study|Physician Decision|1|||
164224124|NCT01370642|593188574|FG002|Overall Study|Physician Decision|2|||
164671424|NCT01536405|594823029|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
164671425|NCT01536405|594823030|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
164671426|NCT01536405|594823029|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
164671427|NCT01536405|594823030|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
164671428|NCT01536405|594823029|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
164671429|NCT01536405|594823030|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
164671430|NCT01536405|594823029|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
164671431|NCT01536405|594823030|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
164671432|NCT01536405|594823029|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
164671433|NCT01536405|594823030|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
164671434|NCT01536405|594823029|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
164671435|NCT01536405|594823030|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
164671436|NCT01536405|594823029|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
164671437|NCT01536405|594823030|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
164671438|NCT01536405|594823029|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
164671439|NCT01536405|594823030|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
164671440|NCT01844375|594823034|FG000|Overall Study|Protocol Violation|1|||
164671441|NCT01844375|594823035|FG001|Overall Study|Protocol Violation|1|||
164671442|NCT03195491|594823036|FG000|Overall Study|Study drug toxicity|25|||
164671443|NCT03195491|594823037|FG001|Overall Study|Study drug toxicity|3|||
164671444|NCT03195491|594823036|FG000|Overall Study|Maximum clinical benefit|5|||
164671445|NCT03195491|594823037|FG001|Overall Study|Maximum clinical benefit|0|||
164671446|NCT03195491|594823036|FG000|Overall Study|Lost to Follow-up|1|||
164671447|NCT03195491|594823037|FG001|Overall Study|Lost to Follow-up|0|||
164671448|NCT03195491|594823036|FG000|Overall Study|Death|3|||
164671449|NCT03195491|594823037|FG001|Overall Study|Death|0|||
164671450|NCT03195491|594823036|FG000|Overall Study|Adverse event unrelated to study drug|19|||
164671451|NCT03195491|594823037|FG001|Overall Study|Adverse event unrelated to study drug|2|||
164671452|NCT03195491|594823036|FG000|Overall Study|Disease progression|266|||
164671453|NCT03195491|594823037|FG001|Overall Study|Disease progression|8|||
164671454|NCT03195491|594823036|FG000|Overall Study|Other reasons|10|||
164671455|NCT03195491|594823037|FG001|Overall Study|Other reasons|0|||
164671456|NCT03195491|594823036|FG000|Overall Study|Participant withdrew consent|8|||
164224125|NCT01370642|593188572|FG000|Overall Study|Withdrawal by Subject|2|||
164671457|NCT03195491|594823037|FG001|Overall Study|Participant withdrew consent|1|||
164671458|NCT03195491|594823036|FG000|Overall Study|Participant no longer meets study criteria|0|||
164671459|NCT03195491|594823037|FG001|Overall Study|Participant no longer meets study criteria|1|||
164224126|NCT01370642|593188573|FG001|Overall Study|Withdrawal by Subject|4|||
164224127|NCT01370642|593188574|FG002|Overall Study|Withdrawal by Subject|3|||
164224128|NCT01796470|593188575|FG000|Overall Study|Adverse Event|4|||
164224129|NCT01796470|593188576|FG001|Overall Study|Adverse Event|2|||
164224130|NCT01796470|593188577|FG002|Overall Study|Adverse Event|2|||
164224131|NCT01796470|593188578|FG003|Overall Study|Adverse Event|1|||
164224132|NCT01796470|593188579|FG004|Overall Study|Adverse Event|3|||
164224133|NCT01796470|593188575|FG000|Overall Study|Death|2|||
164224134|NCT01796470|593188576|FG001|Overall Study|Death|0|||
164224135|NCT01796470|593188577|FG002|Overall Study|Death|0|||
164224136|NCT01796470|593188578|FG003|Overall Study|Death|0|||
164224137|NCT01796470|593188579|FG004|Overall Study|Death|1|||
164224138|NCT01796470|593188575|FG000|Overall Study|Initiated New Therapy|9|||
164224139|NCT01796470|593188576|FG001|Overall Study|Initiated New Therapy|0|||
164224140|NCT01796470|593188577|FG002|Overall Study|Initiated New Therapy|0|||
164224141|NCT01796470|593188578|FG003|Overall Study|Initiated New Therapy|0|||
164224142|NCT01796470|593188579|FG004|Overall Study|Initiated New Therapy|2|||
164224143|NCT01796470|593188575|FG000|Overall Study|Lost to Follow-up|0|||
164224144|NCT01796470|593188576|FG001|Overall Study|Lost to Follow-up|1|||
164224145|NCT01796470|593188577|FG002|Overall Study|Lost to Follow-up|0|||
164224146|NCT01796470|593188578|FG003|Overall Study|Lost to Follow-up|0|||
164224147|NCT01796470|593188579|FG004|Overall Study|Lost to Follow-up|0|||
164224148|NCT01796470|593188575|FG000|Overall Study|Physician Decision|5|||
164224149|NCT01796470|593188576|FG001|Overall Study|Physician Decision|4|||
164224150|NCT01796470|593188577|FG002|Overall Study|Physician Decision|1|||
164224151|NCT01796470|593188578|FG003|Overall Study|Physician Decision|0|||
164568561|NCT00896532|594449210|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
164568562|NCT00896532|594449211|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
164568563|NCT00896532|594449212|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
164568564|NCT00896532|594449213|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
164568565|NCT00896532|594449214|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
164568566|NCT00896532|594449215|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
164568567|NCT00896532|594449216|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
164568568|NCT00896532|594449217|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
164224152|NCT01796470|593188579|FG004|Overall Study|Physician Decision|1|||
164224153|NCT01796470|593188575|FG000|Overall Study|Progressive Disease|7|||
164224154|NCT01796470|593188576|FG001|Overall Study|Progressive Disease|7|||
164224155|NCT01796470|593188577|FG002|Overall Study|Progressive Disease|3|||
164224156|NCT01796470|593188578|FG003|Overall Study|Progressive Disease|2|||
164568569|NCT00896532|594449218|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
164568570|NCT00896532|594449219|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
164568571|NCT00896532|594449220|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
164568572|NCT00896532|594449221|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
164568573|NCT00896532|594449222|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
164568574|NCT00896532|594449223|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
164568575|NCT00896532|594449224|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
164568576|NCT00896532|594449202|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
164568577|NCT00896532|594449203|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
164568578|NCT00896532|594449204|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
164568579|NCT00896532|594449205|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
164568580|NCT00896532|594449206|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
164568581|NCT00896532|594449207|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
164568582|NCT00896532|594449208|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
164568583|NCT00896532|594449209|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
164568584|NCT00896532|594449210|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
164568585|NCT00896532|594449211|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
164568586|NCT00896532|594449212|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
164568587|NCT00896532|594449213|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
164568588|NCT00896532|594449214|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
164568589|NCT00896532|594449215|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
164568590|NCT00896532|594449216|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
164568591|NCT00896532|594449217|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
164568592|NCT00896532|594449218|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
164568593|NCT00896532|594449219|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
164568594|NCT00896532|594449220|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
164568595|NCT00896532|594449221|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
164568596|NCT00896532|594449222|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
164568597|NCT00896532|594449223|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
164568598|NCT00896532|594449224|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
164568599|NCT00896532|594449202|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
164224157|NCT01796470|593188579|FG004|Overall Study|Progressive Disease|0|||
164224158|NCT01796470|593188575|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
164224159|NCT01796470|593188576|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
164224160|NCT01796470|593188577|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
164224161|NCT01796470|593188578|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
164224162|NCT01796470|593188579|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
164224163|NCT01796470|593188575|FG000|Overall Study|Withdrawal by Subject|7|||
164224164|NCT01796470|593188576|FG001|Overall Study|Withdrawal by Subject|0|||
164224165|NCT01796470|593188577|FG002|Overall Study|Withdrawal by Subject|0|||
164568600|NCT00896532|594449203|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
164568601|NCT00896532|594449204|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
164568602|NCT00896532|594449205|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
164568603|NCT00896532|594449206|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
164568604|NCT00896532|594449207|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
164568605|NCT00896532|594449208|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
164568606|NCT00896532|594449209|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
164568607|NCT00896532|594449210|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
164568608|NCT00896532|594449211|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
164568609|NCT00896532|594449212|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
164568610|NCT00896532|594449213|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
164568611|NCT00896532|594449214|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
164568612|NCT00896532|594449215|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
164671460|NCT03195491|594823036|FG000|Overall Study|Participant request to discontinue study treatment|10|||
164671461|NCT03195491|594823037|FG001|Overall Study|Participant request to discontinue study treatment|0|||
164671462|NCT03627091|594823038|FG000|Overall Study|Adverse Event|0|||
164671463|NCT03627091|594823039|FG001|Overall Study|Adverse Event|0|||
164671464|NCT03627091|594823040|FG002|Overall Study|Adverse Event|2|||
164671465|NCT03627091|594823038|FG000|Overall Study|Withdrawal by Subject|2|||
164671466|NCT03627091|594823039|FG001|Overall Study|Withdrawal by Subject|0|||
164671467|NCT03627091|594823040|FG002|Overall Study|Withdrawal by Subject|2|||
164671468|NCT03627091|594823038|FG000|Overall Study|Physician Decision|2|||
164671469|NCT03627091|594823039|FG001|Overall Study|Physician Decision|0|||
164671470|NCT03627091|594823040|FG002|Overall Study|Physician Decision|0|||
164671471|NCT03627091|594823038|FG000|Overall Study|Site terminated by sponsor|0|||
164671472|NCT03627091|594823039|FG001|Overall Study|Site terminated by sponsor|1|||
164671473|NCT03627091|594823040|FG002|Overall Study|Site terminated by sponsor|0|||
164671474|NCT03627091|594823038|FG000|Overall Study|Disease relapse|7|||
164671475|NCT03627091|594823039|FG001|Overall Study|Disease relapse|5|||
164671476|NCT03627091|594823040|FG002|Overall Study|Disease relapse|1|||
164671477|NCT03627091|594823038|FG000|Overall Study|Other|1|||
164671478|NCT03627091|594823039|FG001|Overall Study|Other|0|||
164671479|NCT03627091|594823040|FG002|Overall Study|Other|0|||
164671480|NCT03496623|594823041|FG000|Run-In Period (2 Weeks)|Death|1|||
164671481|NCT03496623|594823042|FG001|Run-In Period (2 Weeks)|Death|0|||
164671482|NCT03496623|594823043|FG002|Run-In Period (2 Weeks)|Death|0|||
164671483|NCT03496623|594823044|FG003|Run-In Period (2 Weeks)|Death|0|||
164671484|NCT03496623|594823045|FG004|Run-In Period (2 Weeks)|Death|0|||
164671485|NCT03496623|594823041|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
164671486|NCT03496623|594823042|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
164671487|NCT03496623|594823043|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
164671488|NCT03496623|594823044|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
164671489|NCT03496623|594823045|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
164671490|NCT03496623|594823041|FG000|Period 1 (12 Weeks)|Death|0|||
164671491|NCT03496623|594823042|FG001|Period 1 (12 Weeks)|Death|3|||
164671492|NCT03496623|594823043|FG002|Period 1 (12 Weeks)|Death|0|||
164671493|NCT03496623|594823044|FG003|Period 1 (12 Weeks)|Death|0|||
164671494|NCT03496623|594823045|FG004|Period 1 (12 Weeks)|Death|0|||
164671495|NCT03496623|594823041|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
164671496|NCT03496623|594823042|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
164671497|NCT03496623|594823043|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
164671498|NCT03496623|594823044|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
164671499|NCT03496623|594823045|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
164671500|NCT03496623|594823041|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
164671501|NCT03496623|594823042|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
164671502|NCT03496623|594823043|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
164671503|NCT03496623|594823044|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
164671504|NCT03496623|594823045|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
164671505|NCT03496623|594823041|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
164671506|NCT03496623|594823042|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
164671507|NCT03496623|594823043|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
164224166|NCT01796470|593188578|FG003|Overall Study|Withdrawal by Subject|0|||
164671508|NCT03496623|594823044|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
164671509|NCT03496623|594823045|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
164671510|NCT03496623|594823041|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
164671511|NCT03496623|594823042|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
164671512|NCT03496623|594823043|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
164671513|NCT03496623|594823044|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
164671514|NCT03496623|594823045|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
164671515|NCT03496623|594823041|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
164671516|NCT03496623|594823042|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
164671517|NCT03496623|594823043|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
164671518|NCT03496623|594823044|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
164671519|NCT03496623|594823045|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
164671520|NCT03496623|594823041|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
164671521|NCT03496623|594823042|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
164671522|NCT03496623|594823043|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
164671523|NCT03496623|594823044|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
164671524|NCT03496623|594823045|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
164671525|NCT02543203|594823046|FG000|Overall Study|Unpalatable Fragrance|2|||
164671526|NCT02543203|594823047|FG001|Overall Study|Unpalatable Fragrance|2|||
164671527|NCT02543203|594823046|FG000|Overall Study|Lost to Follow-up|1|||
164671528|NCT02543203|594823047|FG001|Overall Study|Lost to Follow-up|0|||
164671529|NCT02543203|594823046|FG000|Overall Study|Increased Irritability|1|||
164671530|NCT02543203|594823047|FG001|Overall Study|Increased Irritability|0|||
164671531|NCT02543203|594823046|FG000|Overall Study|Family|1|||
164671532|NCT02543203|594823047|FG001|Overall Study|Family|2|||
164671533|NCT02543203|594823046|FG000|Overall Study|Negative Behavior|1|||
164671534|NCT02543203|594823047|FG001|Overall Study|Negative Behavior|0|||
164671535|NCT02543203|594823046|FG000|Overall Study|Withdrawal by Subject|0|||
164671536|NCT02543203|594823047|FG001|Overall Study|Withdrawal by Subject|1|||
164671537|NCT00626548|594823048|FG000|Overall Study|Adverse Event|164|||
164671538|NCT00626548|594823049|FG001|Overall Study|Adverse Event|44|||
164671539|NCT00626548|594823048|FG000|Overall Study|Withdrawal by Subject|42|||
164671540|NCT00626548|594823049|FG001|Overall Study|Withdrawal by Subject|46|||
164671541|NCT00626548|594823048|FG000|Overall Study|Protocol Violation|4|||
164671542|NCT00626548|594823049|FG001|Overall Study|Protocol Violation|11|||
164671543|NCT00626548|594823048|FG000|Overall Study|Lost to Follow-up|2|||
164671544|NCT00626548|594823049|FG001|Overall Study|Lost to Follow-up|2|||
164671545|NCT00626548|594823048|FG000|Overall Study|Other termination reason|493|||
164671546|NCT00626548|594823049|FG001|Overall Study|Other termination reason|613|||
164671547|NCT00385593|594823050|FG000|Overall Study|Adverse Event|3|||
164671548|NCT00385593|594823051|FG001|Overall Study|Adverse Event|2|||
164671549|NCT00385593|594823050|FG000|Overall Study|Withdrawal by Subject|17|||
164671550|NCT00385593|594823051|FG001|Overall Study|Withdrawal by Subject|7|||
164671551|NCT00385593|594823050|FG000|Overall Study|Lost to Follow-up|12|||
164671552|NCT00385593|594823051|FG001|Overall Study|Lost to Follow-up|8|||
164224167|NCT01796470|593188579|FG004|Overall Study|Withdrawal by Subject|1|||
164224168|NCT00147537|593188580|FG000|Phase 1b|Death|0|||
164224169|NCT00147537|593188581|FG001|Phase 1b|Death|1|||
164224170|NCT00147537|593188582|FG002|Phase 1b|Death|2|||
164224171|NCT00147537|593188583|FG003|Phase 1b|Death|1|||
164224172|NCT00147537|593188584|FG004|Phase 1b|Death|2|||
164224173|NCT00147537|593188585|FG005|Phase 1b|Death|2|||
164224174|NCT00147537|593188586|FG006|Phase 1b|Death|1|||
164224175|NCT00147537|593188587|FG007|Phase 1b|Death|3|||
164224176|NCT00147537|593188588|FG008|Phase 1b|Death|9|||
164224177|NCT00147537|593188589|FG009|Phase 1b|Death|0|||
164224178|NCT00147537|593188590|FG010|Phase 1b|Death|0|||
164224179|NCT00147537|593188580|FG000|Phase 1b|Lost to Follow-up|2|||
164224180|NCT00147537|593188581|FG001|Phase 1b|Lost to Follow-up|1|||
164224181|NCT00147537|593188582|FG002|Phase 1b|Lost to Follow-up|0|||
164224182|NCT00147537|593188583|FG003|Phase 1b|Lost to Follow-up|0|||
164224183|NCT00147537|593188584|FG004|Phase 1b|Lost to Follow-up|0|||
164224184|NCT00147537|593188585|FG005|Phase 1b|Lost to Follow-up|0|||
164224185|NCT00147537|593188586|FG006|Phase 1b|Lost to Follow-up|2|||
164224186|NCT00147537|593188587|FG007|Phase 1b|Lost to Follow-up|0|||
164224187|NCT00147537|593188588|FG008|Phase 1b|Lost to Follow-up|1|||
164224188|NCT00147537|593188589|FG009|Phase 1b|Lost to Follow-up|0|||
164224189|NCT00147537|593188590|FG010|Phase 1b|Lost to Follow-up|0|||
164224190|NCT00147537|593188580|FG000|Phase 1b|Other|0|||
164224191|NCT00147537|593188581|FG001|Phase 1b|Other|0|||
164224192|NCT00147537|593188582|FG002|Phase 1b|Other|2|||
164224193|NCT00147537|593188583|FG003|Phase 1b|Other|1|||
164224194|NCT00147537|593188584|FG004|Phase 1b|Other|1|||
164224195|NCT00147537|593188585|FG005|Phase 1b|Other|1|||
164671553|NCT00385593|594823050|FG000|Overall Study|Protocol Violation|7|||
164671554|NCT00385593|594823051|FG001|Overall Study|Protocol Violation|4|||
164671555|NCT00385593|594823050|FG000|Overall Study|Several reasons|17|||
164671556|NCT00385593|594823051|FG001|Overall Study|Several reasons|15|||
164671557|NCT00385593|594823050|FG000|Overall Study|Incorrect inclusion|2|||
164224196|NCT00147537|593188586|FG006|Phase 1b|Other|14|||
164224197|NCT00147537|593188587|FG007|Phase 1b|Other|4|||
164224198|NCT00147537|593188588|FG008|Phase 1b|Other|4|||
164224199|NCT00147537|593188589|FG009|Phase 1b|Other|0|||
164671558|NCT00385593|594823051|FG001|Overall Study|Incorrect inclusion|0|||
164671559|NCT00385593|594823050|FG000|Overall Study|Incorrect randomization|0|||
164671560|NCT00385593|594823051|FG001|Overall Study|Incorrect randomization|1|||
164671561|NCT03125200|594823054|FG000|Overall Study|Study Termination|0|||
164671562|NCT03125200|594823055|FG001|Overall Study|Study Termination|0|||
164671563|NCT03125200|594823056|FG002|Overall Study|Study Termination|0|||
164671564|NCT03125200|594823057|FG003|Overall Study|Study Termination|1|||
164671565|NCT03125200|594823058|FG004|Overall Study|Study Termination|1|||
164671566|NCT03125200|594823059|FG005|Overall Study|Study Termination|2|||
164671567|NCT03125200|594823060|FG006|Overall Study|Study Termination|1|||
164671568|NCT03125200|594823054|FG000|Overall Study|Clinical Progression|0|||
164671569|NCT03125200|594823055|FG001|Overall Study|Clinical Progression|0|||
164671570|NCT03125200|594823056|FG002|Overall Study|Clinical Progression|0|||
164671571|NCT03125200|594823057|FG003|Overall Study|Clinical Progression|1|||
164671572|NCT03125200|594823058|FG004|Overall Study|Clinical Progression|0|||
164671573|NCT03125200|594823059|FG005|Overall Study|Clinical Progression|1|||
164671574|NCT03125200|594823060|FG006|Overall Study|Clinical Progression|0|||
164671575|NCT03125200|594823054|FG000|Overall Study|Progressive Disease|2|||
164671576|NCT03125200|594823055|FG001|Overall Study|Progressive Disease|1|||
164671577|NCT03125200|594823056|FG002|Overall Study|Progressive Disease|2|||
164671578|NCT03125200|594823057|FG003|Overall Study|Progressive Disease|1|||
164671579|NCT03125200|594823058|FG004|Overall Study|Progressive Disease|2|||
164671580|NCT03125200|594823059|FG005|Overall Study|Progressive Disease|0|||
164671581|NCT03125200|594823060|FG006|Overall Study|Progressive Disease|1|||
164671582|NCT03125200|594823054|FG000|Overall Study|Lack of Efficacy|0|||
164671583|NCT03125200|594823055|FG001|Overall Study|Lack of Efficacy|0|||
164671584|NCT03125200|594823056|FG002|Overall Study|Lack of Efficacy|0|||
164671585|NCT03125200|594823057|FG003|Overall Study|Lack of Efficacy|1|||
164671586|NCT03125200|594823058|FG004|Overall Study|Lack of Efficacy|0|||
164671587|NCT03125200|594823059|FG005|Overall Study|Lack of Efficacy|0|||
164671588|NCT03125200|594823060|FG006|Overall Study|Lack of Efficacy|0|||
164671589|NCT03125200|594823054|FG000|Overall Study|Toxicity|0|||
164671590|NCT03125200|594823055|FG001|Overall Study|Toxicity|0|||
164671591|NCT03125200|594823056|FG002|Overall Study|Toxicity|0|||
164671592|NCT03125200|594823057|FG003|Overall Study|Toxicity|1|||
164671593|NCT03125200|594823058|FG004|Overall Study|Toxicity|0|||
164671594|NCT03125200|594823059|FG005|Overall Study|Toxicity|0|||
164671595|NCT03125200|594823060|FG006|Overall Study|Toxicity|0|||
164671596|NCT03125200|594823054|FG000|Overall Study|Consent Withdrawn by Subject|0|||
164671597|NCT03125200|594823055|FG001|Overall Study|Consent Withdrawn by Subject|1|||
164671598|NCT03125200|594823056|FG002|Overall Study|Consent Withdrawn by Subject|0|||
164671599|NCT03125200|594823057|FG003|Overall Study|Consent Withdrawn by Subject|0|||
164671600|NCT03125200|594823058|FG004|Overall Study|Consent Withdrawn by Subject|1|||
164671601|NCT03125200|594823059|FG005|Overall Study|Consent Withdrawn by Subject|0|||
164671602|NCT03125200|594823060|FG006|Overall Study|Consent Withdrawn by Subject|1|||
164671603|NCT02421952|594823064|FG000|Overall Study|Diary Not Returned|93|||
164671604|NCT02421952|594823064|FG000|Overall Study|Failed seriation task|13|||
164671605|NCT02421952|594823064|FG000|Overall Study|Subject uncooperative for baseline test|2|||
164671606|NCT02421952|594823064|FG000|Overall Study|Surgery cancelled|1|||
164224200|NCT00147537|593188590|FG010|Phase 1b|Other|0|||
164224201|NCT00147537|593188580|FG000|Phase 1b|Withdrawal by Subject|0|||
164568613|NCT00896532|594449216|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
164568614|NCT00896532|594449217|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
164568615|NCT00896532|594449218|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
164568616|NCT00896532|594449219|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
164568617|NCT00896532|594449220|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
164568618|NCT00896532|594449221|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
164568619|NCT00896532|594449222|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
164568620|NCT00896532|594449223|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
164568621|NCT00896532|594449224|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
164568622|NCT00896532|594449202|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
164568623|NCT00896532|594449203|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
164568624|NCT00896532|594449204|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
164568625|NCT00896532|594449205|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
164568626|NCT00896532|594449206|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
164568627|NCT00896532|594449207|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
164568628|NCT00896532|594449208|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
164568629|NCT00896532|594449209|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
164568630|NCT00896532|594449210|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
164568631|NCT00896532|594449211|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
164568632|NCT00896532|594449212|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
164568633|NCT00896532|594449213|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
164568634|NCT00896532|594449214|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
164568635|NCT00896532|594449215|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
164568636|NCT00896532|594449216|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
164568637|NCT00896532|594449217|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
164568638|NCT00896532|594449218|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
164568639|NCT00896532|594449219|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
164568640|NCT00896532|594449220|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
164568641|NCT00896532|594449221|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
164568642|NCT00896532|594449222|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
164568643|NCT00896532|594449223|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
164568644|NCT00896532|594449224|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
164568645|NCT00896532|594449202|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
164568646|NCT00896532|594449203|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
164568647|NCT00896532|594449204|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
164568648|NCT00896532|594449205|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
164568649|NCT00896532|594449206|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
164568650|NCT00896532|594449207|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
164568651|NCT00896532|594449208|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
164568652|NCT00896532|594449209|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
164568653|NCT00896532|594449210|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
164568654|NCT00896532|594449211|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
164568655|NCT00896532|594449212|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
164568656|NCT00896532|594449213|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
164568657|NCT00896532|594449214|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
164568658|NCT00896532|594449215|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
164568659|NCT00896532|594449216|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
164568660|NCT00896532|594449217|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
164568661|NCT00896532|594449218|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
164568662|NCT00896532|594449219|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
164568663|NCT00896532|594449220|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
164568664|NCT00896532|594449221|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
164568665|NCT00896532|594449222|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
164568666|NCT00896532|594449223|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
164568667|NCT00896532|594449224|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
164568668|NCT00896532|594449202|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
164568669|NCT00896532|594449203|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
164568670|NCT00896532|594449204|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
164568671|NCT00896532|594449205|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
164568672|NCT00896532|594449206|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
164568673|NCT00896532|594449207|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
164224202|NCT00147537|593188581|FG001|Phase 1b|Withdrawal by Subject|0|||
164224203|NCT00147537|593188582|FG002|Phase 1b|Withdrawal by Subject|0|||
164568674|NCT00896532|594449208|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
164568675|NCT00896532|594449209|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
164568676|NCT00896532|594449210|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
164568677|NCT00896532|594449211|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
164568678|NCT00896532|594449212|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
164568679|NCT00896532|594449213|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
164568680|NCT00896532|594449214|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
164568681|NCT00896532|594449215|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
164568682|NCT00896532|594449216|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
164568683|NCT00896532|594449217|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
164568684|NCT00896532|594449218|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
164568685|NCT00896532|594449219|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
164568686|NCT00896532|594449220|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
164568687|NCT00896532|594449221|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
164568688|NCT00896532|594449222|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
164568689|NCT00896532|594449223|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
164568690|NCT00896532|594449224|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
164568691|NCT00896532|594449202|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
164568692|NCT00896532|594449203|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
164568693|NCT00896532|594449204|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
164568694|NCT00896532|594449205|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
164568695|NCT00896532|594449206|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
164568696|NCT00896532|594449207|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
164568697|NCT00896532|594449208|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
164568698|NCT00896532|594449209|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
164568699|NCT00896532|594449210|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
164568700|NCT00896532|594449211|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
164568701|NCT00896532|594449212|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
164568702|NCT00896532|594449213|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
164568703|NCT00896532|594449214|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
164568704|NCT00896532|594449215|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
164568705|NCT00896532|594449216|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
164568706|NCT00896532|594449217|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
164568707|NCT00896532|594449218|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
164568708|NCT00896532|594449219|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
164568709|NCT00896532|594449220|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
164568710|NCT00896532|594449221|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
164568711|NCT00896532|594449222|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
164568712|NCT00896532|594449223|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
164568713|NCT00896532|594449224|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
164568714|NCT00896532|594449202|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
164568715|NCT00896532|594449203|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
164568716|NCT00896532|594449204|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
164568717|NCT00896532|594449205|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
164568718|NCT00896532|594449206|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
164568719|NCT00896532|594449207|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
164568720|NCT00896532|594449208|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
164568721|NCT00896532|594449209|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
164568722|NCT00896532|594449210|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
164568723|NCT00896532|594449211|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
164568724|NCT00896532|594449212|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
164568725|NCT00896532|594449213|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
164568726|NCT00896532|594449214|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
164568727|NCT00896532|594449215|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
164568728|NCT00896532|594449216|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
164568729|NCT00896532|594449217|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
164568730|NCT00896532|594449218|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
164671607|NCT03041025|594823066|FG000|Overall Study|Adverse Event|0|||
164224204|NCT00147537|593188583|FG003|Phase 1b|Withdrawal by Subject|0|||
164224205|NCT00147537|593188584|FG004|Phase 1b|Withdrawal by Subject|0|||
164224206|NCT00147537|593188585|FG005|Phase 1b|Withdrawal by Subject|0|||
164224207|NCT00147537|593188586|FG006|Phase 1b|Withdrawal by Subject|0|||
164224208|NCT00147537|593188587|FG007|Phase 1b|Withdrawal by Subject|0|||
164224209|NCT00147537|593188588|FG008|Phase 1b|Withdrawal by Subject|2|||
164224210|NCT00147537|593188589|FG009|Phase 1b|Withdrawal by Subject|0|||
164568731|NCT00896532|594449219|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
164568732|NCT00896532|594449220|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
164568733|NCT00896532|594449221|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
164568734|NCT00896532|594449222|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
164568735|NCT00896532|594449223|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
164568736|NCT00896532|594449224|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
164568737|NCT00896532|594449202|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
164568738|NCT00896532|594449203|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
164568739|NCT00896532|594449204|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
164568740|NCT00896532|594449205|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
164568741|NCT00896532|594449206|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
164568742|NCT00896532|594449207|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
164568743|NCT00896532|594449208|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
164568744|NCT00896532|594449209|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
164568745|NCT00896532|594449210|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
164568746|NCT00896532|594449211|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
164568747|NCT00896532|594449212|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
164568748|NCT00896532|594449213|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
164568749|NCT00896532|594449214|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
164568750|NCT00896532|594449215|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
164568751|NCT00896532|594449216|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
164568752|NCT00896532|594449217|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
164568753|NCT00896532|594449218|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
164568754|NCT00896532|594449219|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
164568755|NCT00896532|594449220|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
164568756|NCT00896532|594449221|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
164568757|NCT00896532|594449222|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
164568758|NCT00896532|594449223|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
164568759|NCT00896532|594449224|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
164568760|NCT00896532|594449202|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
164568761|NCT00896532|594449203|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
164568762|NCT00896532|594449204|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
164568763|NCT00896532|594449205|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
164568764|NCT00896532|594449206|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
164568765|NCT00896532|594449207|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
164568766|NCT00896532|594449208|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
164568767|NCT00896532|594449209|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
164568768|NCT00896532|594449210|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
164568769|NCT00896532|594449211|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
164568770|NCT00896532|594449212|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
164568771|NCT00896532|594449213|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
164568772|NCT00896532|594449214|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
164568773|NCT00896532|594449215|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
164568774|NCT00896532|594449216|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
164568775|NCT00896532|594449217|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
164568776|NCT00896532|594449218|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
164568777|NCT00896532|594449219|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
164568778|NCT00896532|594449220|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
164568779|NCT00896532|594449221|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
164568780|NCT00896532|594449222|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
164568781|NCT00896532|594449223|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
164568782|NCT00896532|594449224|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
164568783|NCT00896532|594449202|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
164568784|NCT00896532|594449203|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
164568785|NCT00896532|594449204|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
164568786|NCT00896532|594449205|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
164568787|NCT00896532|594449206|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
164568788|NCT00896532|594449207|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
164568789|NCT00896532|594449208|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
164568790|NCT00896532|594449209|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
164568791|NCT00896532|594449210|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
164568792|NCT00896532|594449211|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
164671608|NCT03041025|594823067|FG001|Overall Study|Adverse Event|0|||
164224211|NCT00147537|593188590|FG010|Phase 1b|Withdrawal by Subject|0|||
164671609|NCT03041025|594823068|FG002|Overall Study|Adverse Event|1|||
164671610|NCT03041025|594823066|FG000|Overall Study|Lost to Follow-up|1|||
164671611|NCT03041025|594823067|FG001|Overall Study|Lost to Follow-up|0|||
164671612|NCT03041025|594823068|FG002|Overall Study|Lost to Follow-up|0|||
164671613|NCT03041025|594823066|FG000|Overall Study|Withdrawal by Subject|0|||
164671614|NCT03041025|594823067|FG001|Overall Study|Withdrawal by Subject|0|||
164671615|NCT03041025|594823068|FG002|Overall Study|Withdrawal by Subject|1|||
164671616|NCT02963259|594823069|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
164671617|NCT02963259|594823069|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
164671618|NCT02963259|594823069|FG000|Overall Study|Death|1|||
164671619|NCT02963259|594823069|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
164671620|NCT02131129|594823070|FG000|Overall Study|Withdrawal by Subject|1|||
164671621|NCT02131129|594823071|FG001|Overall Study|Withdrawal by Subject|0|||
164671622|NCT01811953|594824975|FG000|Overall Study|Adverse Event|0|||
164671623|NCT01811953|594824976|FG001|Overall Study|Adverse Event|0|||
164671624|NCT01811953|594824977|FG002|Overall Study|Adverse Event|0|||
164671625|NCT01811953|594824978|FG003|Overall Study|Adverse Event|1|||
164671626|NCT01811953|594824979|FG004|Overall Study|Adverse Event|0|||
164671627|NCT01811953|594824980|FG005|Overall Study|Adverse Event|1|||
164671628|NCT01811953|594824975|FG000|Overall Study|Protocol Violation|0|||
164671629|NCT01811953|594824976|FG001|Overall Study|Protocol Violation|0|||
164671630|NCT01811953|594824977|FG002|Overall Study|Protocol Violation|0|||
164671631|NCT01811953|594824978|FG003|Overall Study|Protocol Violation|0|||
164671632|NCT01811953|594824979|FG004|Overall Study|Protocol Violation|1|||
164671633|NCT01811953|594824980|FG005|Overall Study|Protocol Violation|0|||
164671634|NCT00520130|594824984|FG000|Overall Study|Disease progression on study|4|||
164671635|NCT00520130|594824985|FG001|Overall Study|Disease progression on study|0|||
164671636|NCT00520130|594824984|FG000|Overall Study|Physician Decision|1|||
164671637|NCT00520130|594824985|FG001|Overall Study|Physician Decision|1|||
164671638|NCT01045096|594824986|FG000|Overall Study|Withdrawal by Subject|2|||
164671639|NCT01045096|594824987|FG001|Overall Study|Withdrawal by Subject|0|||
164671640|NCT01045096|594824988|FG002|Overall Study|Withdrawal by Subject|0|||
164671641|NCT01045096|594824986|FG000|Overall Study|Other|1|||
164671642|NCT01045096|594824987|FG001|Overall Study|Other|0|||
164671643|NCT01045096|594824988|FG002|Overall Study|Other|0|||
164671644|NCT01900691|594824996|FG000|Overall Study|Death|7|||
164671645|NCT01900691|594824996|FG000|Overall Study|Lost to Follow-up|4|||
164671646|NCT01900691|594824996|FG000|Overall Study|Study Device Not Placed|3|||
164671647|NCT01900691|594824996|FG000|Overall Study|Non study stent placed|2|||
164671648|NCT01900691|594824996|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
164671649|NCT01900691|594824996|FG000|Overall Study|Complete stent migration through digestive tract|1|||
164671650|NCT01954394|594824997|FG000|Overall Study|Enrolled but not treated|1|||
164671651|NCT01954394|594824998|FG001|Overall Study|Enrolled but not treated|0|||
164671652|NCT01954394|594824997|FG000|Overall Study|Adverse Event|10|||
164671653|NCT01954394|594824998|FG001|Overall Study|Adverse Event|23|||
164671654|NCT01954394|594824997|FG000|Overall Study|Poor compliance to protocol|7|||
164671655|NCT01954394|594824998|FG001|Overall Study|Poor compliance to protocol|7|||
164671656|NCT01954394|594824997|FG000|Overall Study|Participant Moved|0|||
164671657|NCT01954394|594824998|FG001|Overall Study|Participant Moved|4|||
164671658|NCT01954394|594824997|FG000|Overall Study|Related to Study Drug administration|2|||
164671659|NCT01954394|594824998|FG001|Overall Study|Related to Study Drug administration|2|||
164671660|NCT01954394|594824997|FG000|Overall Study|Other than specified above|10|||
164671661|NCT01954394|594824998|FG001|Overall Study|Other than specified above|21|||
164671662|NCT04123548|594825005|FG000|Overall Study|Withdrawal by Subject|1|||
164671663|NCT04123548|594825005|FG000|Overall Study|Lost to Follow-up|8|||
164671664|NCT04123548|594825005|FG000|Overall Study|Death|4|||
164671665|NCT04123548|594825005|FG000|Overall Study|Reason Not Specified|1|||
164671666|NCT02956460|594825006|FG000|Lens 1|Lost to Follow-up|1|||
164671667|NCT02956460|594825007|FG001|Lens 1|Lost to Follow-up|0|||
164671668|NCT00851877|594825008|FG000|Phase I-1|Death|1|||
164671669|NCT00851877|594825009|FG001|Phase I-1|Death|0|||
164671670|NCT00851877|594825010|FG002|Phase I-1|Death|0|||
164671671|NCT00851877|594825008|FG000|Phase II|Withdrawal by Subject|0|||
164671672|NCT00851877|594825009|FG001|Phase II|Withdrawal by Subject|0|||
164671673|NCT00851877|594825010|FG002|Phase II|Withdrawal by Subject|3|||
164671674|NCT02440711|594825011|FG000|Second Intervention|Lost to Follow-up|1|||
164671675|NCT02440711|594825012|FG001|Second Intervention|Lost to Follow-up|0|||
164671676|NCT04129346|594825013|FG000|Overall Study|Death|1|||
164671677|NCT04129346|594825014|FG001|Overall Study|Death|0|||
164671678|NCT05755282|594825015|FG000|Overall Study|Protocol Violation|0|||
164671679|NCT05755282|594825016|FG001|Overall Study|Protocol Violation|1|||
164671680|NCT00573066|594825017|FG000|Overall Study|Exclusion criteria|18|||
164671681|NCT00573066|594825017|FG000|Overall Study|IV malfunction|1|||
164671682|NCT00573066|594825017|FG000|Overall Study|Postoperative bleeding|1|||
164671683|NCT04088760|594825020|FG000|Overall Study|Physician Decision|1|||
164671684|NCT03025880|594825021|FG000|Overall Study|Adverse Event|1|||
164671685|NCT03025880|594825022|FG001|Overall Study|Adverse Event|0|||
164671686|NCT03025880|594825021|FG000|Overall Study|Death|1|||
164671687|NCT03025880|594825022|FG001|Overall Study|Death|1|||
164671688|NCT03025880|594825021|FG000|Overall Study|Withdrawal by Subject|0|||
164671689|NCT03025880|594825022|FG001|Overall Study|Withdrawal by Subject|1|||
164671690|NCT03025880|594825021|FG000|Overall Study|Physician Decision|0|||
164671691|NCT03025880|594825022|FG001|Overall Study|Physician Decision|1|||
164671692|NCT03025880|594825021|FG000|Overall Study|Progressive Disease|12|||
164671693|NCT03025880|594825022|FG001|Overall Study|Progressive Disease|19|||
164671694|NCT01182415|594825024|FG000|Overall Study|Lost to Follow-up|1|||
164671695|NCT01185548|594825025|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
164671696|NCT01422538|594825027|FG000|Overall Study|Lost to Follow-up|0|||
164671697|NCT01422538|594825028|FG001|Overall Study|Lost to Follow-up|1|||
164671698|NCT01422538|594825029|FG002|Overall Study|Lost to Follow-up|1|||
164671699|NCT01422538|594825027|FG000|Overall Study|Missed visit|0|||
164671700|NCT01422538|594825028|FG001|Overall Study|Missed visit|1|||
164671701|NCT01422538|594825029|FG002|Overall Study|Missed visit|1|||
164671702|NCT00184600|594825030|FG000|Overall Study|Adverse Event|9|||
164671703|NCT00184600|594825031|FG001|Overall Study|Adverse Event|0|||
164671704|NCT00184600|594825032|FG002|Overall Study|Adverse Event|5|||
164671705|NCT00184600|594825030|FG000|Overall Study|Death|3|||
164671706|NCT00184600|594825031|FG001|Overall Study|Death|9|||
164671707|NCT00184600|594825032|FG002|Overall Study|Death|7|||
164671708|NCT00184600|594825030|FG000|Overall Study|Lack of Efficacy|3|||
164671709|NCT00184600|594825031|FG001|Overall Study|Lack of Efficacy|1|||
164671710|NCT00184600|594825032|FG002|Overall Study|Lack of Efficacy|3|||
164671711|NCT00184600|594825030|FG000|Overall Study|Lost to Follow-up|4|||
164671712|NCT00184600|594825031|FG001|Overall Study|Lost to Follow-up|6|||
164671713|NCT00184600|594825032|FG002|Overall Study|Lost to Follow-up|1|||
164671714|NCT00184600|594825030|FG000|Overall Study|Protocol Violation|2|||
164671715|NCT00184600|594825031|FG001|Overall Study|Protocol Violation|2|||
164671716|NCT00184600|594825032|FG002|Overall Study|Protocol Violation|3|||
164671717|NCT00184600|594825030|FG000|Overall Study|Withdrawal by Subject|20|||
164671718|NCT00184600|594825031|FG001|Overall Study|Withdrawal by Subject|28|||
164671719|NCT00184600|594825032|FG002|Overall Study|Withdrawal by Subject|12|||
164671720|NCT00184600|594825030|FG000|Overall Study|Unclassified|4|||
164671721|NCT00184600|594825031|FG001|Overall Study|Unclassified|5|||
164671722|NCT00184600|594825032|FG002|Overall Study|Unclassified|3|||
164671723|NCT02770820|594825033|FG000|Overall Study|Death|1|||
164671724|NCT02770820|594825033|FG000|Overall Study|Physician Decision|2|||
164671725|NCT00312663|594825034|FG000|Immunization Phase|Adverse Event|0|||
164671726|NCT00312663|594825035|FG001|Immunization Phase|Adverse Event|1|||
164671727|NCT00312663|594825036|FG002|Immunization Phase|Adverse Event|0|||
164671728|NCT00376623|594825037|FG000|Overall Study|Progressive disease|35|||
164671729|NCT00376623|594825038|FG001|Overall Study|Progressive disease|22|||
164671730|NCT00376623|594825039|FG002|Overall Study|Progressive disease|17|||
164671731|NCT00376623|594825037|FG000|Overall Study|Lost to Follow-up|0|||
164671732|NCT00376623|594825038|FG001|Overall Study|Lost to Follow-up|1|||
164671733|NCT00376623|594825039|FG002|Overall Study|Lost to Follow-up|0|||
164671734|NCT00376623|594825037|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
164671735|NCT00376623|594825038|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
164671736|NCT00376623|594825039|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
164671737|NCT00376623|594825037|FG000|Overall Study|Not treated with BI 2536|1|||
164671738|NCT00376623|594825038|FG001|Overall Study|Not treated with BI 2536|0|||
164671739|NCT00376623|594825039|FG002|Overall Study|Not treated with BI 2536|0|||
164671740|NCT00376623|594825037|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
164671741|NCT00376623|594825038|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
164671742|NCT00376623|594825039|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
164671743|NCT00376623|594825037|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
164671744|NCT00376623|594825038|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
164671745|NCT00376623|594825039|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
164671746|NCT00376623|594825037|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
164671747|NCT00376623|594825038|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
164671748|NCT00376623|594825039|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
164671749|NCT00376623|594825037|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
164671750|NCT00376623|594825038|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
164671751|NCT00376623|594825039|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
164671752|NCT00376623|594825037|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
164671753|NCT00376623|594825038|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
164671754|NCT00376623|594825039|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
164671755|NCT00376623|594825037|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
164671756|NCT00376623|594825038|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
164671757|NCT00376623|594825039|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
164671758|NCT00376623|594825037|FG000|Overall Study|Increase of tumour markers|0|||
164671759|NCT00376623|594825038|FG001|Overall Study|Increase of tumour markers|1|||
164671760|NCT00376623|594825039|FG002|Overall Study|Increase of tumour markers|0|||
164671761|NCT00376623|594825037|FG000|Overall Study|Bone metastasis|1|||
164671762|NCT00376623|594825038|FG001|Overall Study|Bone metastasis|0|||
164671763|NCT00376623|594825039|FG002|Overall Study|Bone metastasis|0|||
164671764|NCT00286754|594825042|FG000|Overall Study|Adverse Event|2|||
164671765|NCT00286754|594825043|FG001|Overall Study|Adverse Event|2|||
164671766|NCT00286754|594825044|FG002|Overall Study|Adverse Event|3|||
164671767|NCT00286754|594825042|FG000|Overall Study|Withdrawal by Subject|6|||
164671768|NCT00286754|594825043|FG001|Overall Study|Withdrawal by Subject|2|||
164671769|NCT00286754|594825044|FG002|Overall Study|Withdrawal by Subject|0|||
164671770|NCT00286754|594825042|FG000|Overall Study|Lost to Follow-up|12|||
164671771|NCT00286754|594825043|FG001|Overall Study|Lost to Follow-up|14|||
164671772|NCT00286754|594825044|FG002|Overall Study|Lost to Follow-up|6|||
164671773|NCT00286754|594825042|FG000|Overall Study|Moved out of state|0|||
164671774|NCT00286754|594825043|FG001|Overall Study|Moved out of state|0|||
164671775|NCT00286754|594825044|FG002|Overall Study|Moved out of state|1|||
164671776|NCT02661295|594825045|FG000|Overall Study|Death|1|||
164671777|NCT02661295|594825045|FG000|Overall Study|Transferred Out|1|||
164671778|NCT02661295|594825045|FG000|Overall Study|Kidney Transplant|1|||
164671779|NCT02661295|594825045|FG000|Overall Study|Withdrawn due to side effects|8|||
164671780|NCT02661295|594825045|FG000|Overall Study|Withdrawn due to access type|1|||
164671781|NCT02661295|594825045|FG000|Overall Study|Withdrawn due to allergies|1|||
164671782|NCT02661295|594825045|FG000|Overall Study|Withdrawn due to non-compliance|1|||
164671783|NCT02661295|594825045|FG000|Overall Study|Withdrawal by Subject|3|||
164671784|NCT02661295|594825045|FG000|Overall Study|Failed screening|2|||
164224212|NCT00147537|593188580|FG000|Phase 1b|Randomized but not treated|0|||
164224213|NCT00147537|593188581|FG001|Phase 1b|Randomized but not treated|0|||
164224214|NCT00147537|593188582|FG002|Phase 1b|Randomized but not treated|0|||
164224215|NCT00147537|593188583|FG003|Phase 1b|Randomized but not treated|0|||
164224216|NCT00147537|593188584|FG004|Phase 1b|Randomized but not treated|0|||
164224217|NCT00147537|593188585|FG005|Phase 1b|Randomized but not treated|0|||
164224218|NCT00147537|593188586|FG006|Phase 1b|Randomized but not treated|1|||
164224219|NCT00147537|593188587|FG007|Phase 1b|Randomized but not treated|0|||
164329137|NCT01888003|593581330|FG002|Overall Study|Study Terminated|40|||
164671785|NCT00301366|594825046|FG000|Overall Study|Adverse Event|1|||
164671786|NCT01313273|594825047|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
164671787|NCT01313273|594825048|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
164671788|NCT01313273|594825047|FG000|Overall Study|Withdrawal by Subject|1|||
164671789|NCT01313273|594825048|FG001|Overall Study|Withdrawal by Subject|0|||
164329138|NCT03187756|593581331|FG000|Overall Study|Termination of study|4|||
164224220|NCT00147537|593188588|FG008|Phase 1b|Randomized but not treated|1|||
164224221|NCT00147537|593188589|FG009|Phase 1b|Randomized but not treated|0|||
164224222|NCT00147537|593188590|FG010|Phase 1b|Randomized but not treated|0|||
164224223|NCT00147537|593188580|FG000|Phase 2|Death|0|||
164224224|NCT00147537|593188581|FG001|Phase 2|Death|0|||
164224225|NCT00147537|593188582|FG002|Phase 2|Death|0|||
164224226|NCT00147537|593188583|FG003|Phase 2|Death|0|||
164224227|NCT00147537|593188584|FG004|Phase 2|Death|0|||
164224228|NCT00147537|593188585|FG005|Phase 2|Death|0|||
164224229|NCT00147537|593188586|FG006|Phase 2|Death|0|||
164224230|NCT00147537|593188587|FG007|Phase 2|Death|0|||
164224231|NCT00147537|593188588|FG008|Phase 2|Death|0|||
164224232|NCT00147537|593188589|FG009|Phase 2|Death|85|||
164224233|NCT00147537|593188590|FG010|Phase 2|Death|31|||
164224234|NCT00147537|593188580|FG000|Phase 2|Lost to Follow-up|0|||
164224235|NCT00147537|593188581|FG001|Phase 2|Lost to Follow-up|0|||
164224236|NCT00147537|593188582|FG002|Phase 2|Lost to Follow-up|0|||
164224237|NCT00147537|593188583|FG003|Phase 2|Lost to Follow-up|0|||
164224238|NCT00147537|593188584|FG004|Phase 2|Lost to Follow-up|0|||
164224239|NCT00147537|593188585|FG005|Phase 2|Lost to Follow-up|0|||
164224240|NCT00147537|593188586|FG006|Phase 2|Lost to Follow-up|0|||
164224241|NCT00147537|593188587|FG007|Phase 2|Lost to Follow-up|0|||
164568793|NCT00896532|594449212|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
164568794|NCT00896532|594449213|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
164568795|NCT00896532|594449214|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
164568796|NCT00896532|594449215|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
164568797|NCT00896532|594449216|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
164568798|NCT00896532|594449217|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
164224242|NCT00147537|593188588|FG008|Phase 2|Lost to Follow-up|0|||
164224243|NCT00147537|593188589|FG009|Phase 2|Lost to Follow-up|12|||
164568799|NCT00896532|594449218|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
164568800|NCT00896532|594449219|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
164568801|NCT00896532|594449220|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
164568802|NCT00896532|594449221|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
164568803|NCT00896532|594449222|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
164568804|NCT00896532|594449223|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
164568805|NCT00896532|594449224|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
164568806|NCT00896532|594449202|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
164568807|NCT00896532|594449203|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
164568808|NCT00896532|594449204|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
164568809|NCT00896532|594449205|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
164568810|NCT00896532|594449206|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
164568811|NCT00896532|594449207|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
164568812|NCT00896532|594449208|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
164568813|NCT00896532|594449209|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
164568814|NCT00896532|594449210|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
164568815|NCT00896532|594449211|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
164568816|NCT00896532|594449212|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
164568817|NCT00896532|594449213|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
164568818|NCT00896532|594449214|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
164568819|NCT00896532|594449215|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
164568820|NCT00896532|594449216|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
164568821|NCT00896532|594449217|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
164224244|NCT00147537|593188590|FG010|Phase 2|Lost to Follow-up|4|||
164224245|NCT00147537|593188580|FG000|Phase 2|Other|0|||
164224246|NCT00147537|593188581|FG001|Phase 2|Other|0|||
164224247|NCT00147537|593188582|FG002|Phase 2|Other|0|||
164224248|NCT00147537|593188583|FG003|Phase 2|Other|0|||
164224249|NCT00147537|593188584|FG004|Phase 2|Other|0|||
164224250|NCT00147537|593188585|FG005|Phase 2|Other|0|||
164224251|NCT00147537|593188586|FG006|Phase 2|Other|0|||
164224252|NCT00147537|593188587|FG007|Phase 2|Other|0|||
164224253|NCT00147537|593188588|FG008|Phase 2|Other|0|||
164224254|NCT00147537|593188589|FG009|Phase 2|Other|47|||
164224255|NCT00147537|593188590|FG010|Phase 2|Other|12|||
164224256|NCT00147537|593188580|FG000|Phase 2|Withdrawal by Subject|0|||
164224257|NCT00147537|593188581|FG001|Phase 2|Withdrawal by Subject|0|||
164224258|NCT00147537|593188582|FG002|Phase 2|Withdrawal by Subject|0|||
164568822|NCT00896532|594449218|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
164224259|NCT00147537|593188583|FG003|Phase 2|Withdrawal by Subject|0|||
164224260|NCT00147537|593188584|FG004|Phase 2|Withdrawal by Subject|0|||
164224261|NCT00147537|593188585|FG005|Phase 2|Withdrawal by Subject|0|||
164224262|NCT00147537|593188586|FG006|Phase 2|Withdrawal by Subject|0|||
164224263|NCT00147537|593188587|FG007|Phase 2|Withdrawal by Subject|0|||
164224264|NCT00147537|593188588|FG008|Phase 2|Withdrawal by Subject|0|||
164224265|NCT00147537|593188589|FG009|Phase 2|Withdrawal by Subject|16|||
164224266|NCT00147537|593188590|FG010|Phase 2|Withdrawal by Subject|4|||
164224267|NCT00147537|593188580|FG000|Phase 2|Randomized but not treated|0|||
164224268|NCT00147537|593188581|FG001|Phase 2|Randomized but not treated|0|||
164224269|NCT00147537|593188582|FG002|Phase 2|Randomized but not treated|0|||
164224270|NCT00147537|593188583|FG003|Phase 2|Randomized but not treated|0|||
164224271|NCT00147537|593188584|FG004|Phase 2|Randomized but not treated|0|||
164224272|NCT00147537|593188585|FG005|Phase 2|Randomized but not treated|0|||
164224273|NCT00147537|593188586|FG006|Phase 2|Randomized but not treated|0|||
164224274|NCT00147537|593188587|FG007|Phase 2|Randomized but not treated|0|||
164224275|NCT00147537|593188588|FG008|Phase 2|Randomized but not treated|0|||
164224276|NCT00147537|593188589|FG009|Phase 2|Randomized but not treated|1|||
164224277|NCT00147537|593188590|FG010|Phase 2|Randomized but not treated|1|||
164224278|NCT02191397|593188591|FG000|Overall Study|Adverse Event|28|||
164224279|NCT02191397|593188592|FG001|Overall Study|Adverse Event|17|||
164224280|NCT02191397|593188591|FG000|Overall Study|Lack of Efficacy|10|||
164224281|NCT02191397|593188592|FG001|Overall Study|Lack of Efficacy|5|||
164224282|NCT02191397|593188591|FG000|Overall Study|Protocol Violation|0|||
164568823|NCT00896532|594449219|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
164568824|NCT00896532|594449220|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
164568825|NCT00896532|594449221|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
164568826|NCT00896532|594449222|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
164568827|NCT00896532|594449223|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
164568828|NCT00896532|594449224|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
164568829|NCT00896532|594449202|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
164568830|NCT00896532|594449203|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
164568831|NCT00896532|594449204|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
164568832|NCT00896532|594449205|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
164568833|NCT00896532|594449206|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
164568834|NCT00896532|594449207|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
164568835|NCT00896532|594449208|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
164568836|NCT00896532|594449209|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
164568837|NCT00896532|594449210|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
164568838|NCT00896532|594449211|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
164568839|NCT00896532|594449212|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
164568840|NCT00896532|594449213|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
164568841|NCT00896532|594449214|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
164568842|NCT00896532|594449215|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
164568843|NCT00896532|594449216|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
164568844|NCT00896532|594449217|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
164568845|NCT00896532|594449218|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
164568846|NCT00896532|594449219|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
164568847|NCT00896532|594449220|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
164568848|NCT00896532|594449221|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
164568849|NCT00896532|594449222|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
164568850|NCT00896532|594449223|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
164568851|NCT00896532|594449224|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
164568852|NCT00896532|594449202|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
164568853|NCT00896532|594449203|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
164568854|NCT00896532|594449204|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
164568855|NCT00896532|594449205|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
164568856|NCT00896532|594449206|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
164568857|NCT00896532|594449207|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
164568858|NCT00896532|594449208|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
164568859|NCT00896532|594449209|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
164568860|NCT00896532|594449210|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
164568861|NCT00896532|594449211|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
164568862|NCT00896532|594449212|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
164568863|NCT00896532|594449213|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
164568864|NCT00896532|594449214|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
164568865|NCT00896532|594449215|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
164568866|NCT00896532|594449216|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
164568867|NCT00896532|594449217|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
164568868|NCT00896532|594449218|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
164568869|NCT00896532|594449219|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
164568870|NCT00896532|594449220|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
164568871|NCT00896532|594449221|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
164224283|NCT02191397|593188592|FG001|Overall Study|Protocol Violation|3|||
164224284|NCT02191397|593188591|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
164329139|NCT00323869|593581334|FG000|Overall Study|Death|1|||
164671790|NCT01313273|594825047|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
164671791|NCT01313273|594825048|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
164671792|NCT02726581|594825053|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
164671793|NCT02726581|594825054|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
164671794|NCT02726581|594825055|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
164671795|NCT02726581|594825053|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
164671796|NCT02726581|594825054|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
164671797|NCT02726581|594825055|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
164671798|NCT02726581|594825053|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
164671799|NCT02726581|594825054|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164671800|NCT02726581|594825055|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164671801|NCT02726581|594825053|FG000|Treatment Period|Disease progression|47|||
164671802|NCT02726581|594825054|FG001|Treatment Period|Disease progression|50|||
164671803|NCT02726581|594825055|FG002|Treatment Period|Disease progression|16|||
164671804|NCT02726581|594825053|FG000|Treatment Period|Other reasons|9|||
164671805|NCT02726581|594825054|FG001|Treatment Period|Other reasons|8|||
164671806|NCT02726581|594825055|FG002|Treatment Period|Other reasons|2|||
164671807|NCT02726581|594825053|FG000|Treatment Period|Study drug toxicity|6|||
164671808|NCT02726581|594825054|FG001|Treatment Period|Study drug toxicity|3|||
164671809|NCT02726581|594825055|FG002|Treatment Period|Study drug toxicity|2|||
164671810|NCT02726581|594825053|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
164671811|NCT02726581|594825054|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
164671812|NCT02726581|594825055|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
164671813|NCT02726581|594825053|FG000|Treatment Period|Participant withdrew consent|3|||
164671814|NCT02726581|594825054|FG001|Treatment Period|Participant withdrew consent|1|||
164671815|NCT02726581|594825055|FG002|Treatment Period|Participant withdrew consent|1|||
164671816|NCT02726581|594825053|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
164671817|NCT02726581|594825054|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
164671818|NCT02726581|594825055|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
164671819|NCT02726581|594825053|FG000|Treatment Period|Maximum clinical benefit|0|||
164671820|NCT02726581|594825054|FG001|Treatment Period|Maximum clinical benefit|2|||
164671821|NCT02726581|594825055|FG002|Treatment Period|Maximum clinical benefit|0|||
164671822|NCT02726581|594825053|FG000|Treatment Period|Death|1|||
164671823|NCT02726581|594825054|FG001|Treatment Period|Death|0|||
164671824|NCT02726581|594825055|FG002|Treatment Period|Death|0|||
164671825|NCT02726581|594825053|FG000|Treatment Period|Poor/non-compliance|1|||
164671826|NCT02726581|594825054|FG001|Treatment Period|Poor/non-compliance|0|||
164671827|NCT02726581|594825055|FG002|Treatment Period|Poor/non-compliance|0|||
164671828|NCT02726581|594825053|FG000|Treatment Period|Participant no longer meets study criteria|0|||
164671829|NCT02726581|594825054|FG001|Treatment Period|Participant no longer meets study criteria|1|||
164671830|NCT02726581|594825055|FG002|Treatment Period|Participant no longer meets study criteria|0|||
164671831|NCT01270503|594825057|FG000|Overall Study|Lost to Follow-up|1|||
164671832|NCT02459951|594825058|FG000|Overall Study|Unable to meet holding requirement|1|||
164671833|NCT04786184|594825059|FG000|Overall Study|Adverse Event|4|||
164671834|NCT04786184|594825060|FG001|Overall Study|Adverse Event|0|||
164671835|NCT04786184|594825059|FG000|Overall Study|Withdrawal by Subject|3|||
164671836|NCT04786184|594825060|FG001|Overall Study|Withdrawal by Subject|1|||
164671837|NCT04786184|594825059|FG000|Overall Study|Lost to Follow-up|4|||
164671838|NCT04786184|594825060|FG001|Overall Study|Lost to Follow-up|2|||
164671839|NCT02255097|594825061|FG000|Overall Study|Death|151|||
164671840|NCT02255097|594825061|FG000|Overall Study|Lost to Follow-up|5|||
164671841|NCT02255097|594825061|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
164671842|NCT02255097|594825061|FG000|Overall Study|Withdrawal by Subject|7|||
164671843|NCT02255097|594825061|FG000|Overall Study|Allocated but not treated|1|||
164671844|NCT04239872|594825062|FG000|Overall Study|Lost to Follow-up|0|||
164671845|NCT04239872|594825063|FG001|Overall Study|Lost to Follow-up|1|||
164671846|NCT03956862|594825066|FG000|Overall Study|Lost to Follow-up|1|||
164671847|NCT03956862|594825067|FG001|Overall Study|Lost to Follow-up|1|||
164671848|NCT03956862|594825066|FG000|Overall Study|Withdrawal by Subject|1|||
164671849|NCT03956862|594825067|FG001|Overall Study|Withdrawal by Subject|1|||
164671850|NCT01498120|594825068|FG000|Overall Study|Lost to Follow-up|1|||
164671851|NCT01498120|594825068|FG000|Overall Study|Withdrawal by Subject|5|||
164671852|NCT01498120|594825068|FG000|Overall Study|AE, non-serious non-fatal|3|||
164671853|NCT01498120|594825068|FG000|Overall Study|Other|4|||
164671854|NCT02294604|594825069|FG000|Overall Study|Did not provide samples for culture|0|||
164671855|NCT02294604|594825070|FG001|Overall Study|Did not provide samples for culture|1|||
164671856|NCT02294604|594825071|FG002|Overall Study|Did not provide samples for culture|0|||
164671857|NCT02294604|594825069|FG000|Overall Study|Culture contamination|1|||
164671858|NCT02294604|594825070|FG001|Overall Study|Culture contamination|2|||
164671859|NCT02294604|594825071|FG002|Overall Study|Culture contamination|0|||
164671860|NCT01118312|594825072|FG000|Overall Study|Lost to Follow-up|33|||
164671861|NCT01118312|594825073|FG001|Overall Study|Lost to Follow-up|32|||
164671862|NCT01118312|594825072|FG000|Overall Study|Withdrawal by Subject|1|||
164671863|NCT01118312|594825073|FG001|Overall Study|Withdrawal by Subject|3|||
164671864|NCT01975948|594825074|FG000|Overall Study|Withdrawal by Subject|17|||
164671865|NCT01975948|594825075|FG001|Overall Study|Withdrawal by Subject|21|||
164568872|NCT00896532|594449222|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
164568873|NCT00896532|594449223|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
164568874|NCT00896532|594449224|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
164568875|NCT00896532|594449202|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
164568876|NCT00896532|594449203|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
164568877|NCT00896532|594449204|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
164568878|NCT00896532|594449205|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
164568879|NCT00896532|594449206|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
164568880|NCT00896532|594449207|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
164568881|NCT00896532|594449208|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
164568882|NCT00896532|594449209|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
164568883|NCT00896532|594449210|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
164568884|NCT00896532|594449211|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
164568885|NCT00896532|594449212|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
164568886|NCT00896532|594449213|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
164568887|NCT00896532|594449214|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
164568888|NCT00896532|594449215|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
164568889|NCT00896532|594449216|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
164568890|NCT00896532|594449217|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
164568891|NCT00896532|594449218|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
164568892|NCT00896532|594449219|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
164568893|NCT00896532|594449220|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
164568894|NCT00896532|594449221|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
164568895|NCT00896532|594449222|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
164568896|NCT00896532|594449223|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
164568897|NCT00896532|594449224|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
164568898|NCT00896532|594449202|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
164568899|NCT00896532|594449203|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
164568900|NCT00896532|594449204|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
164568901|NCT00896532|594449205|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
164568902|NCT00896532|594449206|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
164568903|NCT00896532|594449207|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
164568904|NCT00896532|594449208|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
164568905|NCT00896532|594449209|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
164568906|NCT00896532|594449210|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
164671866|NCT01975948|594825076|FG002|Overall Study|Withdrawal by Subject|7|||
164671867|NCT01975948|594825077|FG003|Overall Study|Withdrawal by Subject|6|||
164671868|NCT01675765|594825078|FG000|Overall Study|Progressive disease|4|||
164671869|NCT01675765|594825079|FG001|Overall Study|Progressive disease|4|||
164671870|NCT01675765|594825078|FG000|Overall Study|Adverse Event|1|||
164671871|NCT01675765|594825079|FG001|Overall Study|Adverse Event|2|||
164671872|NCT01675765|594825078|FG000|Overall Study|Withdrawal by Subject|2|||
164671873|NCT01675765|594825079|FG001|Overall Study|Withdrawal by Subject|0|||
164671874|NCT01675765|594825078|FG000|Overall Study|Death|1|||
164671875|NCT01675765|594825079|FG001|Overall Study|Death|0|||
164671876|NCT01675765|594825078|FG000|Overall Study|Clinical progression|3|||
164671877|NCT01675765|594825079|FG001|Overall Study|Clinical progression|2|||
164671878|NCT03965091|594825080|FG000|Overall Study|Adverse Event|0|||
164671879|NCT03965091|594825081|FG001|Overall Study|Adverse Event|2|||
164671880|NCT03965091|594825082|FG002|Overall Study|Adverse Event|3|||
164671881|NCT03965091|594825080|FG000|Overall Study|Withdrawal by Subject|11|||
164671882|NCT03965091|594825081|FG001|Overall Study|Withdrawal by Subject|3|||
164671883|NCT03965091|594825082|FG002|Overall Study|Withdrawal by Subject|5|||
164671884|NCT03965091|594825080|FG000|Overall Study|Non-compliance with study drug|0|||
164671885|NCT03965091|594825081|FG001|Overall Study|Non-compliance with study drug|0|||
164671886|NCT03965091|594825082|FG002|Overall Study|Non-compliance with study drug|1|||
164671887|NCT03965091|594825080|FG000|Overall Study|Lost to Follow-up|1|||
164671888|NCT03965091|594825081|FG001|Overall Study|Lost to Follow-up|1|||
164671889|NCT03965091|594825082|FG002|Overall Study|Lost to Follow-up|1|||
164671890|NCT03965091|594825080|FG000|Overall Study|Lack of Efficacy|2|||
164671891|NCT03965091|594825081|FG001|Overall Study|Lack of Efficacy|0|||
164671892|NCT03965091|594825082|FG002|Overall Study|Lack of Efficacy|0|||
164671893|NCT03965091|594825080|FG000|Overall Study|Other than specified|9|||
164671894|NCT03965091|594825081|FG001|Overall Study|Other than specified|11|||
164671895|NCT03965091|594825082|FG002|Overall Study|Other than specified|8|||
164671896|NCT04060147|594825084|FG000|Overall Study|Withdrew consent|1|||
164671897|NCT01534520|594825085|FG000|Overall Study|Adverse Event|0|||
164671898|NCT01534520|594825086|FG001|Overall Study|Adverse Event|1|||
164671899|NCT00565448|594825089|FG000|Overall Study|Adverse Event|1|||
164671900|NCT00565448|594825090|FG001|Overall Study|Adverse Event|2|||
164671901|NCT00565448|594825089|FG000|Overall Study|Disease progression|1|||
164671902|NCT00565448|594825090|FG001|Overall Study|Disease progression|0|||
164671903|NCT00565448|594825089|FG000|Overall Study|Withdrawal by Subject|1|||
164671904|NCT00565448|594825090|FG001|Overall Study|Withdrawal by Subject|0|||
164671905|NCT00193609|594825091|FG000|Overall Study|Lack of Efficacy|2|||
164671906|NCT00193609|594825091|FG000|Overall Study|Adverse Event|2|||
164671907|NCT00302952|594825092|FG000|Overall Study|Physician Decision|1|||
164671908|NCT00302952|594825093|FG001|Overall Study|Physician Decision|1|||
164671909|NCT00302952|594825092|FG000|Overall Study|Withdrawal by Subject|2|||
164671910|NCT00302952|594825093|FG001|Overall Study|Withdrawal by Subject|3|||
164671911|NCT00302952|594825092|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
164671912|NCT00302952|594825093|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
164671913|NCT02979353|594825094|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
164671914|NCT02979353|594825095|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
164671915|NCT02979353|594825094|FG000|Overall Study|Withdrawal by Subject|16|||
164671916|NCT02979353|594825095|FG001|Overall Study|Withdrawal by Subject|12|||
164671917|NCT02979353|594825094|FG000|Overall Study|Death|10|||
164671918|NCT02979353|594825095|FG001|Overall Study|Death|11|||
164671919|NCT02979353|594825094|FG000|Overall Study|Transfer to Hospice Care|19|||
164671920|NCT02979353|594825095|FG001|Overall Study|Transfer to Hospice Care|14|||
164671921|NCT02979353|594825094|FG000|Overall Study|Lost to Follow-up|1|||
164671922|NCT02979353|594825095|FG001|Overall Study|Lost to Follow-up|5|||
164671923|NCT00857623|594825096|FG000|Overall Study|Adverse Event|5|||
164671924|NCT00857623|594825097|FG001|Overall Study|Adverse Event|2|||
164671925|NCT00857623|594825096|FG000|Overall Study|Study-specific discontinuation criteria|5|||
164671926|NCT00857623|594825097|FG001|Overall Study|Study-specific discontinuation criteria|3|||
164671927|NCT00857623|594825096|FG000|Overall Study|Withdrawal by Subject|2|||
164671928|NCT00857623|594825097|FG001|Overall Study|Withdrawal by Subject|1|||
164671929|NCT00857623|594825096|FG000|Overall Study|Lack of Efficacy|1|||
164671930|NCT00857623|594825097|FG001|Overall Study|Lack of Efficacy|1|||
164671931|NCT00857623|594825096|FG000|Overall Study|Severe non-compliance to protocol|1|||
164671932|NCT00857623|594825097|FG001|Overall Study|Severe non-compliance to protocol|1|||
164671933|NCT00857623|594825096|FG000|Overall Study|Intake of prohibited medication|0|||
164671934|NCT00857623|594825097|FG001|Overall Study|Intake of prohibited medication|1|||
164671935|NCT00857623|594825096|FG000|Overall Study|Positive for HEP C|0|||
164671936|NCT00857623|594825097|FG001|Overall Study|Positive for HEP C|1|||
164671937|NCT04185909|594825098|FG000|Overall Study|Lost to Follow-up|1|||
164671938|NCT03435081|594825099|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
164671939|NCT03435081|594825100|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
164671940|NCT03435081|594825101|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
164671941|NCT03435081|594825099|FG000|Week 0 to Week 16|Adverse Event|2|||
164671942|NCT03435081|594825100|FG001|Week 0 to Week 16|Adverse Event|2|||
164671943|NCT03435081|594825101|FG002|Week 0 to Week 16|Adverse Event|2|||
164671944|NCT03435081|594825099|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
164671945|NCT03435081|594825100|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
164671946|NCT03435081|594825101|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
164671947|NCT03435081|594825099|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
164671948|NCT03435081|594825100|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
164671949|NCT03435081|594825101|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
164671950|NCT03435081|594825099|FG000|Week 0 to Week 16|Pregnancy|1|||
164671951|NCT03435081|594825100|FG001|Week 0 to Week 16|Pregnancy|0|||
164671952|NCT03435081|594825101|FG002|Week 0 to Week 16|Pregnancy|0|||
164671953|NCT03435081|594825099|FG000|Week 0 to Week 16|Non-compliance|1|||
164671954|NCT03435081|594825100|FG001|Week 0 to Week 16|Non-compliance|0|||
164671955|NCT03435081|594825101|FG002|Week 0 to Week 16|Non-compliance|2|||
164671956|NCT03435081|594825099|FG000|Week 0 to Week 16|Inadequate Response|0|||
164671957|NCT03435081|594825100|FG001|Week 0 to Week 16|Inadequate Response|1|||
164671958|NCT03435081|594825101|FG002|Week 0 to Week 16|Inadequate Response|0|||
164671959|NCT03435081|594825099|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
164671960|NCT03435081|594825100|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
164671961|NCT03435081|594825101|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
164671962|NCT03435081|594825099|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
164671963|NCT03435081|594825100|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
164671964|NCT03435081|594825101|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
164671965|NCT03435081|594825099|FG000|Week 16 to Week 104|Adverse Event|1|||
164671966|NCT03435081|594825100|FG001|Week 16 to Week 104|Adverse Event|0|||
164671967|NCT03435081|594825101|FG002|Week 16 to Week 104|Adverse Event|2|||
164671968|NCT03435081|594825099|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
164671969|NCT03435081|594825100|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
164671970|NCT03435081|594825101|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
164671971|NCT03435081|594825099|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
164671972|NCT03435081|594825100|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
164671973|NCT03435081|594825101|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
164671974|NCT03435081|594825099|FG000|Week 16 to Week 104|Non--Compliance|0|||
164224285|NCT02191397|593188592|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
164224286|NCT02191397|593188591|FG000|Overall Study|Lost to Follow-up|10|||
164224287|NCT02191397|593188592|FG001|Overall Study|Lost to Follow-up|11|||
164224288|NCT02191397|593188591|FG000|Overall Study|Physician Decision|8|||
164224289|NCT02191397|593188592|FG001|Overall Study|Physician Decision|3|||
164224290|NCT02191397|593188591|FG000|Overall Study|Withdrawal by Subject|22|||
164224291|NCT02191397|593188592|FG001|Overall Study|Withdrawal by Subject|27|||
164224292|NCT03888482|593188596|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
164224293|NCT03888482|593188597|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
164224294|NCT03888482|593188596|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
164224295|NCT03888482|593188597|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
164224296|NCT02294019|593188598|FG000|Overall Study|Adverse Event|2|||
164224297|NCT02294019|593188598|FG000|Overall Study|Protocol Violation|68|||
164224298|NCT02294019|593188598|FG000|Overall Study|Lost to Follow-up|31|||
164224299|NCT02294019|593188598|FG000|Overall Study|Other|1|||
164224300|NCT02294019|593188598|FG000|Overall Study|Withdrawal by Subject|1|||
164224301|NCT01189227|593188600|FG000|Overall Study|Study terminated due to low accrual|6|||
164224302|NCT01189227|593188601|FG001|Overall Study|Study terminated due to low accrual|3|||
164224303|NCT04818086|593188602|FG000|Overall Study|Physician Decision|1|||
164224304|NCT04818086|593188603|FG001|Overall Study|Physician Decision|0|||
164224305|NCT04818086|593188602|FG000|Overall Study|Withdrawal by Subject|0|||
164224306|NCT04818086|593188603|FG001|Overall Study|Withdrawal by Subject|1|||
164224307|NCT04128228|593188605|FG000|Overall Study|Withdrawal by Subject|3|||
164224308|NCT04128228|593188606|FG001|Overall Study|Withdrawal by Subject|3|||
164568907|NCT00896532|594449211|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
164568908|NCT00896532|594449212|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
164568909|NCT00896532|594449213|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
164568910|NCT00896532|594449214|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
164568911|NCT00896532|594449215|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
164568912|NCT00896532|594449216|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
164568913|NCT00896532|594449217|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
164568914|NCT00896532|594449218|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
164568915|NCT00896532|594449219|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
164568916|NCT00896532|594449220|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
164568917|NCT00896532|594449221|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
164568918|NCT00896532|594449222|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
164568919|NCT00896532|594449223|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
164568920|NCT00896532|594449224|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
164568921|NCT00896532|594449202|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
164568922|NCT00896532|594449203|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
164568923|NCT00896532|594449204|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
164568924|NCT00896532|594449205|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
164568925|NCT00896532|594449206|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
164568926|NCT00896532|594449207|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
164568927|NCT00896532|594449208|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
164568928|NCT00896532|594449209|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
164568929|NCT00896532|594449210|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
164568930|NCT00896532|594449211|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
164568931|NCT00896532|594449212|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
164568932|NCT00896532|594449213|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
164568933|NCT00896532|594449214|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
164568934|NCT00896532|594449215|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
164568935|NCT00896532|594449216|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
164568936|NCT00896532|594449217|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
164568937|NCT00896532|594449218|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
164568938|NCT00896532|594449219|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
164568939|NCT00896532|594449220|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
164568940|NCT00896532|594449221|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
164568941|NCT00896532|594449222|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
164568942|NCT00896532|594449223|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
164568943|NCT00896532|594449224|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
164568944|NCT00896532|594449202|FG000|Months 48-72: Follow-on Phase|Death|0|||
164224309|NCT04128228|593188607|FG002|Overall Study|Withdrawal by Subject|0|||
164224310|NCT04128228|593188608|FG003|Overall Study|Withdrawal by Subject|0|||
164224311|NCT04128228|593188605|FG000|Overall Study|noncompliance|2|||
164224312|NCT04128228|593188606|FG001|Overall Study|noncompliance|2|||
164224313|NCT04128228|593188607|FG002|Overall Study|noncompliance|0|||
164224314|NCT04128228|593188608|FG003|Overall Study|noncompliance|0|||
164224315|NCT01016015|593188609|FG000|Overall Study|Not Treated|3|||
164224316|NCT01016015|593188609|FG000|Overall Study|Withdrawal by Subject|1|||
164224317|NCT01016015|593188609|FG000|Overall Study|Adverse Event|15|||
164224318|NCT01117350|593188613|FG000|Comparative Period|Not Treated|5|||
164224319|NCT01117350|593188614|FG001|Comparative Period|Not Treated|8|||
164224320|NCT01117350|593188613|FG000|Comparative Period|Adverse Event|6|||
164224321|NCT01117350|593188614|FG001|Comparative Period|Adverse Event|33|||
164224322|NCT01117350|593188613|FG000|Comparative Period|Lost to Follow-up|11|||
164224323|NCT01117350|593188614|FG001|Comparative Period|Lost to Follow-up|7|||
164224324|NCT01117350|593188613|FG000|Comparative Period|Withdrawal by Subject|9|||
164224325|NCT01117350|593188614|FG001|Comparative Period|Withdrawal by Subject|13|||
164224326|NCT01117350|593188613|FG000|Comparative Period|Protocol Violation|8|||
164224327|NCT01117350|593188614|FG001|Comparative Period|Protocol Violation|12|||
164224328|NCT01117350|593188613|FG000|Comparative Period|Lack of Efficacy|1|||
164224329|NCT01117350|593188614|FG001|Comparative Period|Lack of Efficacy|0|||
164224330|NCT01117350|593188613|FG000|Comparative Period|Physician Decision|0|||
164568945|NCT00896532|594449203|FG001|Months 48-72: Follow-on Phase|Death|0|||
164568946|NCT00896532|594449204|FG002|Months 48-72: Follow-on Phase|Death|0|||
164568947|NCT00896532|594449205|FG003|Months 48-72: Follow-on Phase|Death|0|||
164568948|NCT00896532|594449206|FG004|Months 48-72: Follow-on Phase|Death|0|||
164568949|NCT00896532|594449207|FG005|Months 48-72: Follow-on Phase|Death|0|||
164568950|NCT00896532|594449208|FG006|Months 48-72: Follow-on Phase|Death|0|||
164568951|NCT00896532|594449209|FG007|Months 48-72: Follow-on Phase|Death|0|||
164568952|NCT00896532|594449210|FG008|Months 48-72: Follow-on Phase|Death|0|||
164568953|NCT00896532|594449211|FG009|Months 48-72: Follow-on Phase|Death|0|||
164568954|NCT00896532|594449212|FG010|Months 48-72: Follow-on Phase|Death|0|||
164568955|NCT00896532|594449213|FG011|Months 48-72: Follow-on Phase|Death|0|||
164568956|NCT00896532|594449214|FG012|Months 48-72: Follow-on Phase|Death|0|||
164568957|NCT00896532|594449215|FG013|Months 48-72: Follow-on Phase|Death|0|||
164568958|NCT00896532|594449216|FG014|Months 48-72: Follow-on Phase|Death|0|||
164568959|NCT00896532|594449217|FG015|Months 48-72: Follow-on Phase|Death|0|||
164568960|NCT00896532|594449218|FG016|Months 48-72: Follow-on Phase|Death|0|||
164568961|NCT00896532|594449219|FG017|Months 48-72: Follow-on Phase|Death|0|||
164568962|NCT00896532|594449220|FG018|Months 48-72: Follow-on Phase|Death|1|||
164568963|NCT00896532|594449221|FG019|Months 48-72: Follow-on Phase|Death|0|||
164568964|NCT00896532|594449222|FG020|Months 48-72: Follow-on Phase|Death|0|||
164568965|NCT00896532|594449223|FG021|Months 48-72: Follow-on Phase|Death|0|||
164568966|NCT00896532|594449224|FG022|Months 48-72: Follow-on Phase|Death|0|||
164568967|NCT00896532|594449202|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164568968|NCT00896532|594449203|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164568969|NCT00896532|594449204|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164568970|NCT00896532|594449205|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164568971|NCT00896532|594449206|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164568972|NCT00896532|594449207|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164568973|NCT00896532|594449208|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164568974|NCT00896532|594449209|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164568975|NCT00896532|594449210|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164568976|NCT00896532|594449211|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164568977|NCT00896532|594449212|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164568978|NCT00896532|594449213|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164568979|NCT00896532|594449214|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164568980|NCT00896532|594449215|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164568981|NCT00896532|594449216|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164568982|NCT00896532|594449217|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164568983|NCT00896532|594449218|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164568984|NCT00896532|594449219|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164568985|NCT00896532|594449220|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164671975|NCT03435081|594825100|FG001|Week 16 to Week 104|Non--Compliance|0|||
164671976|NCT03435081|594825101|FG002|Week 16 to Week 104|Non--Compliance|1|||
164671977|NCT02601560|594825102|FG000|Overall Study|Other|0|||
164224331|NCT01117350|593188614|FG001|Comparative Period|Physician Decision|1|||
164224332|NCT01117350|593188613|FG000|Comparative Period|Move to another city/country|2|||
164224333|NCT01117350|593188614|FG001|Comparative Period|Move to another city/country|1|||
164224334|NCT01117350|593188613|FG000|Extension Period|Not included in extension, not treated|0|||
164224335|NCT01117350|593188614|FG001|Extension Period|Not included in extension, not treated|50|||
164568986|NCT00896532|594449221|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164671978|NCT02601560|594825103|FG001|Overall Study|Other|0|||
164224336|NCT01117350|593188613|FG000|Extension Period|Adverse Event|0|||
164224337|NCT01117350|593188614|FG001|Extension Period|Adverse Event|2|||
164224338|NCT01117350|593188613|FG000|Extension Period|Protocol Violation|0|||
164224339|NCT01117350|593188614|FG001|Extension Period|Protocol Violation|2|||
164224340|NCT01117350|593188613|FG000|Extension Period|Lost to Follow-up|0|||
164224341|NCT01117350|593188614|FG001|Extension Period|Lost to Follow-up|2|||
164224342|NCT01117350|593188613|FG000|Extension Period|Withdrawal by Subject|0|||
164224343|NCT01117350|593188614|FG001|Extension Period|Withdrawal by Subject|3|||
164224344|NCT01117350|593188613|FG000|Extension Period|Lack of Efficacy|0|||
164568987|NCT00896532|594449222|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164224345|NCT01117350|593188614|FG001|Extension Period|Lack of Efficacy|2|||
164568988|NCT00896532|594449223|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
164568989|NCT00896532|594449224|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164568990|NCT00896532|594449202|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
164568991|NCT00896532|594449203|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
164568992|NCT00896532|594449204|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
164568993|NCT00896532|594449205|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
164568994|NCT00896532|594449206|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
164568995|NCT00896532|594449207|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
164568996|NCT00896532|594449208|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
164568997|NCT00896532|594449209|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
164568998|NCT00896532|594449210|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
164568999|NCT00896532|594449211|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
164569000|NCT00896532|594449212|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
164569001|NCT00896532|594449213|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
164569002|NCT00896532|594449214|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
164569003|NCT00896532|594449215|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
164569004|NCT00896532|594449216|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
164569005|NCT00896532|594449217|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
164569006|NCT00896532|594449218|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
164569007|NCT00896532|594449219|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
164569008|NCT00896532|594449220|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
164569009|NCT00896532|594449221|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
164569010|NCT00896532|594449222|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
164569011|NCT00896532|594449223|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
164569012|NCT00896532|594449224|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
164569013|NCT01176916|594449225|FG000|Overall Study|Adverse Event|61|||
164569014|NCT01176916|594449225|FG000|Overall Study|Death|1|||
164569015|NCT01176916|594449225|FG000|Overall Study|Lost to Follow-up|15|||
164569016|NCT01176916|594449225|FG000|Overall Study|Objective progression or relapse|17|||
164569017|NCT01176916|594449225|FG000|Overall Study|Protocol Violation|24|||
164569018|NCT01176916|594449225|FG000|Overall Study|Withdrawal by Subject|37|||
164224346|NCT01117350|593188613|FG000|Extension Period|Inclusion criteria not respected|0|||
164224347|NCT01117350|593188614|FG001|Extension Period|Inclusion criteria not respected|1|||
164224348|NCT01117350|593188613|FG000|Extension Period|Prohibited medication|0|||
164671979|NCT02601560|594825104|FG002|Overall Study|Other|0|||
164671980|NCT02601560|594825105|FG003|Overall Study|Other|0|||
164671981|NCT02601560|594825106|FG004|Overall Study|Other|0|||
164671982|NCT02601560|594825107|FG005|Overall Study|Other|0|||
164671983|NCT02601560|594825108|FG006|Overall Study|Other|1|||
164671984|NCT02601560|594825109|FG007|Overall Study|Other|0|||
164671985|NCT00420238|594825112|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
164671986|NCT00420238|594825113|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
164671987|NCT00420238|594825112|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
164671988|NCT00420238|594825113|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
164671989|NCT00420238|594825112|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
164671990|NCT00420238|594825113|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
164671991|NCT00420238|594825112|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
164671992|NCT00420238|594825113|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
164671993|NCT00420238|594825112|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
164671994|NCT00420238|594825113|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
164671995|NCT00420238|594825112|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
164671996|NCT00420238|594825113|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
164671997|NCT04384978|594825114|FG000|Overall Study|Withdrawal by Subject|4|||
164671998|NCT04384978|594825115|FG001|Overall Study|Withdrawal by Subject|0|||
164671999|NCT00214422|594825116|FG000|Overall Study|Physician Decision|2|||
164672000|NCT00214422|594825117|FG001|Overall Study|Physician Decision|0|||
164672001|NCT00214422|594825118|FG002|Overall Study|Physician Decision|0|||
164672002|NCT00214422|594825116|FG000|Overall Study|Developed esophageal ca|1|||
164672003|NCT00214422|594825117|FG001|Overall Study|Developed esophageal ca|0|||
164672004|NCT00214422|594825118|FG002|Overall Study|Developed esophageal ca|0|||
164672005|NCT00214422|594825116|FG000|Overall Study|Pt taken off study|1|||
164672006|NCT00214422|594825117|FG001|Overall Study|Pt taken off study|1|||
164672007|NCT00214422|594825118|FG002|Overall Study|Pt taken off study|0|||
164672008|NCT00214422|594825116|FG000|Overall Study|Disease progression on study|1|||
164672009|NCT00214422|594825117|FG001|Overall Study|Disease progression on study|0|||
164672010|NCT00214422|594825118|FG002|Overall Study|Disease progression on study|0|||
164672011|NCT00214422|594825116|FG000|Overall Study|Unable to make a radiation treatment|0|||
164672012|NCT00214422|594825117|FG001|Overall Study|Unable to make a radiation treatment|0|||
164672013|NCT00214422|594825118|FG002|Overall Study|Unable to make a radiation treatment|1|||
164672014|NCT01993030|594826647|FG000|Overall Study|Adverse Event|0|||
164672015|NCT01993030|594826648|FG001|Overall Study|Adverse Event|4|||
164672016|NCT03785548|594826649|FG000|Overall Study|age > 80|1|||
164672017|NCT03785548|594826650|FG001|Overall Study|age > 80|0|||
164672018|NCT03785548|594826649|FG000|Overall Study|no Postop queries|1|||
164672019|NCT03785548|594826650|FG001|Overall Study|no Postop queries|0|||
164672020|NCT00396279|594826653|FG000|Overall Study|Ongoing in study|26|||
164672021|NCT00396279|594826653|FG000|Overall Study|Disease progression|2|||
164672022|NCT00396279|594826653|FG000|Overall Study|Withdrawal by Subject|1|||
164672023|NCT00396279|594826653|FG000|Overall Study|Physician Decision|1|||
164672024|NCT01882257|594826655|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
164672025|NCT01882257|594826656|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
164672026|NCT01882257|594826657|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
164672027|NCT01882257|594826655|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
164672028|NCT01882257|594826656|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
164672029|NCT01882257|594826657|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
164672030|NCT00830206|594826658|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
164672031|NCT00830206|594826659|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
164672032|NCT00905346|594826663|FG000|Period 1|Withdrawal by Subject|1|||
164672033|NCT00905346|594826664|FG001|Period 1|Withdrawal by Subject|0|||
164672034|NCT03351335|594826665|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
164672035|NCT03351335|594826666|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
164672036|NCT03351335|594826667|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
164672037|NCT04089735|594826668|FG000|Overall Study|Adverse Event|1|||
164672038|NCT04089735|594826669|FG001|Overall Study|Adverse Event|0|||
164672039|NCT04089735|594826670|FG002|Overall Study|Adverse Event|1|||
164672040|NCT04089735|594826671|FG003|Overall Study|Adverse Event|1|||
164672041|NCT04089735|594826672|FG004|Overall Study|Adverse Event|0|||
164672042|NCT04089735|594826673|FG005|Overall Study|Adverse Event|0|||
164672043|NCT04089735|594826668|FG000|Overall Study|Physician Decision|0|||
164672044|NCT04089735|594826669|FG001|Overall Study|Physician Decision|3|||
164672045|NCT04089735|594826670|FG002|Overall Study|Physician Decision|0|||
164672046|NCT04089735|594826671|FG003|Overall Study|Physician Decision|0|||
164672047|NCT04089735|594826672|FG004|Overall Study|Physician Decision|0|||
164672048|NCT04089735|594826673|FG005|Overall Study|Physician Decision|0|||
164672049|NCT04089735|594826668|FG000|Overall Study|Withdrawal by Subject|0|||
164672050|NCT04089735|594826669|FG001|Overall Study|Withdrawal by Subject|0|||
164672051|NCT04089735|594826670|FG002|Overall Study|Withdrawal by Subject|1|||
164672052|NCT04089735|594826671|FG003|Overall Study|Withdrawal by Subject|0|||
164672053|NCT04089735|594826672|FG004|Overall Study|Withdrawal by Subject|0|||
164672054|NCT04089735|594826673|FG005|Overall Study|Withdrawal by Subject|0|||
164672055|NCT04089735|594826668|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
164672056|NCT04089735|594826669|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
164672057|NCT04089735|594826670|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
164672058|NCT04089735|594826671|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
164672059|NCT04089735|594826672|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
164672060|NCT04089735|594826673|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
164672061|NCT02736721|594826674|FG000|Overall Study|Adverse Event|8|||
164672062|NCT02736721|594826674|FG000|Overall Study|Lost to Follow-up|3|||
164672063|NCT02736721|594826674|FG000|Overall Study|Other|5|||
164672064|NCT01439880|594826678|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
164672065|NCT01439880|594826679|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
164672066|NCT01439880|594826678|FG000|SOC-controlled Period (Year 1)|Death|2|||
164672067|NCT01439880|594826679|FG001|SOC-controlled Period (Year 1)|Death|1|||
164672068|NCT01439880|594826678|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
164672069|NCT01439880|594826679|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
164672070|NCT01439880|594826678|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
164672071|NCT01439880|594826679|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
164672072|NCT01439880|594826678|FG000|SOC-controlled Period (Year 1)|Other|8|||
164672073|NCT01439880|594826679|FG001|SOC-controlled Period (Year 1)|Other|13|||
164672074|NCT01439880|594826678|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
164672075|NCT01439880|594826679|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
164672076|NCT01439880|594826678|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
164672077|NCT01439880|594826679|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
164672078|NCT01439880|594826678|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
164672079|NCT01439880|594826679|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
164672080|NCT01439880|594826678|FG000|All-IP Period (Years 2 to 5)|Death|3|||
164672081|NCT01439880|594826679|FG001|All-IP Period (Years 2 to 5)|Death|13|||
164672082|NCT01439880|594826678|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
164672083|NCT01439880|594826679|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
164672084|NCT01439880|594826678|FG000|All-IP Period (Years 2 to 5)|Other|14|||
164672085|NCT01439880|594826679|FG001|All-IP Period (Years 2 to 5)|Other|31|||
164672086|NCT01439880|594826678|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
164672087|NCT01439880|594826679|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
164672088|NCT00829673|594826682|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
164672089|NCT00829673|594826683|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
164672090|NCT00272779|594826684|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
164672091|NCT00272779|594826685|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
164672092|NCT00272779|594826684|FG000|Baseline Through Week 48|Death before Week 48|4|||
164672093|NCT00272779|594826685|FG001|Baseline Through Week 48|Death before Week 48|4|||
164672094|NCT00272779|594826684|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
164672095|NCT00272779|594826685|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
164672096|NCT00272779|594826684|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
164672097|NCT00272779|594826685|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
164672098|NCT00272779|594826684|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
164672099|NCT00272779|594826685|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
164672100|NCT00272779|594826684|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
164672101|NCT00272779|594826685|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
164672102|NCT00272779|594826684|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
164672103|NCT00272779|594826685|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
164672104|NCT00272779|594826684|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
164672105|NCT00272779|594826685|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
164672106|NCT00272779|594826684|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
164672107|NCT00272779|594826685|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
164672108|NCT00272779|594826684|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
164672109|NCT00272779|594826685|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
164672110|NCT00272779|594826684|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
164672111|NCT00272779|594826685|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
164672112|NCT00272779|594826684|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
164672113|NCT00272779|594826685|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
164672114|NCT00272779|594826684|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
164672115|NCT00272779|594826685|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
164672116|NCT00272779|594826684|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
164672117|NCT00272779|594826685|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
164672118|NCT00272779|594826684|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
164672119|NCT00272779|594826685|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
164672120|NCT00272779|594826684|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
164672121|NCT00272779|594826685|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
164672122|NCT00272779|594826684|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
164672123|NCT00272779|594826685|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
164672124|NCT00272779|594826684|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
164672125|NCT00272779|594826685|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
164672126|NCT00272779|594826684|FG000|Baseline Through Week 48|Continuing treatment|385|||
164672127|NCT00272779|594826685|FG001|Baseline Through Week 48|Continuing treatment|368|||
164672128|NCT00272779|594826684|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
164672129|NCT00272779|594826685|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
164672130|NCT00272779|594826684|FG000|Baseline Through Week 48|Never treated|2|||
164672131|NCT00272779|594826685|FG001|Baseline Through Week 48|Never treated|3|||
164672132|NCT00272779|594826684|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
164672133|NCT00272779|594826685|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
164672134|NCT00272779|594826684|FG000|Baseline Through Week 96|Death before Week 96|6|||
164672135|NCT00272779|594826685|FG001|Baseline Through Week 96|Death before Week 96|5|||
164672136|NCT00272779|594826684|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
164672137|NCT00272779|594826685|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
164672138|NCT00272779|594826684|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
164672139|NCT00272779|594826685|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
164672140|NCT00272779|594826684|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
164672141|NCT00272779|594826685|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
164672142|NCT00272779|594826684|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
164672143|NCT00272779|594826685|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
164224349|NCT01117350|593188614|FG001|Extension Period|Prohibited medication|1|||
164224350|NCT02931539|593188615|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
164224351|NCT02931539|593188616|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
164224352|NCT02931539|593188617|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
164224353|NCT02931539|593188615|FG000|Period 1: Treatment Phase|Adverse Event|5|||
164224354|NCT02931539|593188616|FG001|Period 1: Treatment Phase|Adverse Event|1|||
164569019|NCT01176916|594449225|FG000|Overall Study|Other|6|||
164569020|NCT01176916|594449225|FG000|Overall Study|Withdrawal prior to Treatment|6|||
164569021|NCT03158220|594449228|FG000|Overall Study|Screen Failure|0|||
164569022|NCT03158220|594449229|FG001|Overall Study|Screen Failure|1|||
164569023|NCT03158220|594449228|FG000|Overall Study|Withdrawal by Subject|8|||
164569024|NCT03158220|594449229|FG001|Overall Study|Withdrawal by Subject|9|||
164569025|NCT03158220|594449228|FG000|Overall Study|Status unknown|0|||
164569026|NCT03158220|594449229|FG001|Overall Study|Status unknown|1|||
164569027|NCT03158220|594449228|FG000|Overall Study|Lost to Follow-up|8|||
164569028|NCT03158220|594449229|FG001|Overall Study|Lost to Follow-up|5|||
164569029|NCT03158220|594449228|FG000|Overall Study|Physician Decision|1|||
164569030|NCT03158220|594449229|FG001|Overall Study|Physician Decision|0|||
164569031|NCT01671280|594449230|FG000|Overall Study|Withdrawal by Subject|2|||
164569032|NCT00996203|594449231|FG000|Overall Study|Adverse Event|3|||
164569033|NCT00996203|594449231|FG000|Overall Study|Lost to Follow-up|1|||
164569034|NCT00996203|594449231|FG000|Overall Study|Lack of Efficacy|1|||
164569035|NCT00996203|594449231|FG000|Overall Study|Protocol Violation|2|||
164569036|NCT01959165|594449232|FG000|Overall Study|Adverse Event|0|||
164569037|NCT01959165|594449233|FG001|Overall Study|Adverse Event|0|||
164569038|NCT01959165|594449234|FG002|Overall Study|Adverse Event|0|||
164569039|NCT01959165|594449235|FG003|Overall Study|Adverse Event|1|||
164569040|NCT01959165|594449232|FG000|Overall Study|Lack of Efficacy|1|||
164569041|NCT01959165|594449233|FG001|Overall Study|Lack of Efficacy|0|||
164569042|NCT01959165|594449234|FG002|Overall Study|Lack of Efficacy|0|||
164569043|NCT01959165|594449235|FG003|Overall Study|Lack of Efficacy|0|||
164569044|NCT01959165|594449232|FG000|Overall Study|overdose|0|||
164569045|NCT01959165|594449233|FG001|Overall Study|overdose|0|||
164569046|NCT01959165|594449234|FG002|Overall Study|overdose|0|||
164224355|NCT02931539|593188617|FG002|Period 1: Treatment Phase|Adverse Event|0|||
164569047|NCT01959165|594449235|FG003|Overall Study|overdose|1|||
164569048|NCT01959165|594449232|FG000|Overall Study|Welfare recipient|0|||
164569049|NCT01959165|594449233|FG001|Overall Study|Welfare recipient|1|||
164569050|NCT01959165|594449234|FG002|Overall Study|Welfare recipient|0|||
164569051|NCT01959165|594449235|FG003|Overall Study|Welfare recipient|0|||
164672144|NCT00272779|594826684|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
164672145|NCT00272779|594826685|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
164672146|NCT00272779|594826684|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
164672147|NCT00272779|594826685|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
164672148|NCT00272779|594826684|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
164672149|NCT00272779|594826685|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
164672150|NCT00272779|594826684|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
164672151|NCT00272779|594826685|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
164672152|NCT00272779|594826684|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
164569052|NCT03686969|594449236|FG000|Overall Study|Study terminated|1|||
164672153|NCT00272779|594826685|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
164672154|NCT00272779|594826684|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
164672155|NCT00272779|594826685|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
164672156|NCT00272779|594826684|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
164672157|NCT00272779|594826685|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
164672158|NCT00272779|594826684|FG000|Baseline Through Week 96|Never treated|2|||
164672159|NCT00272779|594826685|FG001|Baseline Through Week 96|Never treated|3|||
164672160|NCT00272779|594826684|FG000|Baseline Through Week 96|Continuing on treatment|61|||
164672161|NCT00272779|594826685|FG001|Baseline Through Week 96|Continuing on treatment|38|||
164672162|NCT00627016|594826687|FG000|Overall Study|Adverse Event|1|||
164672163|NCT00627016|594826688|FG001|Overall Study|Adverse Event|1|||
164672164|NCT00627016|594826687|FG000|Overall Study|Protocol Violation|0|||
164672165|NCT00627016|594826688|FG001|Overall Study|Protocol Violation|2|||
164672166|NCT00627016|594826687|FG000|Overall Study|Lost to Follow-up|0|||
164672167|NCT00627016|594826688|FG001|Overall Study|Lost to Follow-up|1|||
164672168|NCT00627016|594826687|FG000|Overall Study|Withdrawal by Subject|2|||
164672169|NCT00627016|594826688|FG001|Overall Study|Withdrawal by Subject|1|||
164672170|NCT00627016|594826687|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
164672171|NCT00627016|594826688|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
164672172|NCT00627016|594826687|FG000|Overall Study|Lack of Efficacy|1|||
164672173|NCT00627016|594826688|FG001|Overall Study|Lack of Efficacy|0|||
164672174|NCT00627016|594826687|FG000|Overall Study|Placed on Excluded Drugs|1|||
164672175|NCT00627016|594826688|FG001|Overall Study|Placed on Excluded Drugs|0|||
164672176|NCT00627016|594826687|FG000|Overall Study|Pregnancy|1|||
164569053|NCT03686969|594449237|FG001|Overall Study|Study terminated|0|||
164569054|NCT00848120|594449239|FG000|Overall Study|Adverse Event|1|||
164569055|NCT01961115|594449243|FG000|Overall Study|Disease Progression|1|||
164569056|NCT01961115|594449244|FG001|Overall Study|Disease Progression|0|||
164569057|NCT01961115|594449245|FG002|Overall Study|Disease Progression|3|||
164569058|NCT01961115|594449243|FG000|Overall Study|Adverse Event|1|||
164569059|NCT01961115|594449244|FG001|Overall Study|Adverse Event|0|||
164569060|NCT01961115|594449245|FG002|Overall Study|Adverse Event|1|||
164569061|NCT02497001|594449246|FG000|Overall Study|Lost to Follow-up|10|||
164569062|NCT02497001|594449247|FG001|Overall Study|Lost to Follow-up|2|||
164569063|NCT02497001|594449248|FG002|Overall Study|Lost to Follow-up|0|||
164569064|NCT02497001|594449249|FG003|Overall Study|Lost to Follow-up|2|||
164569065|NCT02497001|594449246|FG000|Overall Study|Adverse Event|28|||
164569066|NCT02497001|594449247|FG001|Overall Study|Adverse Event|30|||
164569067|NCT02497001|594449248|FG002|Overall Study|Adverse Event|11|||
164672177|NCT00627016|594826688|FG001|Overall Study|Pregnancy|0|||
164672178|NCT00086996|594826690|FG000|Overall Study|Adverse Event|29|||
164672179|NCT00086996|594826690|FG000|Overall Study|Death|4|||
164569068|NCT02497001|594449249|FG003|Overall Study|Adverse Event|11|||
164569069|NCT02497001|594449246|FG000|Overall Study|Withdrawal by Subject|14|||
164672180|NCT00086996|594826690|FG000|Overall Study|progression/relapse|7|||
164672181|NCT00086996|594826690|FG000|Overall Study|Withdrawal by Subject|13|||
164672182|NCT00086996|594826690|FG000|Overall Study|Other|6|||
164672183|NCT00086996|594826690|FG000|Overall Study|not eligible|5|||
164672184|NCT02331394|594826692|FG000|Overall Study|Disease progression|1|||
164672185|NCT02865850|594826695|FG000|Overall Study|Death|15|||
164672186|NCT02865850|594826696|FG001|Overall Study|Death|19|||
164672187|NCT02865850|594826695|FG000|Overall Study|Withdrawal by Subject|3|||
164672188|NCT02865850|594826696|FG001|Overall Study|Withdrawal by Subject|2|||
164672189|NCT02865850|594826695|FG000|Overall Study|Lost to Follow-up|3|||
164672190|NCT02865850|594826696|FG001|Overall Study|Lost to Follow-up|2|||
164672191|NCT00552669|594826697|FG000|Overall Study|Death|3|||
164672192|NCT00552669|594826698|FG001|Overall Study|Death|7|||
164672193|NCT02098876|594826701|FG000|Overall Study|Withdrawal by Subject|5|||
164672194|NCT02098876|594826702|FG001|Overall Study|Withdrawal by Subject|5|||
164672195|NCT01263704|594826703|FG000|Overall Study|Progressive disease|18|||
164672196|NCT01263704|594826703|FG000|Overall Study|Adverse Event|3|||
164672197|NCT01263704|594826703|FG000|Overall Study|Death|2|||
164672198|NCT01263704|594826703|FG000|Overall Study|Patient withdrew consent|2|||
164672199|NCT01263704|594826703|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
164672200|NCT01263704|594826703|FG000|Overall Study|Lost to Follow-up|1|||
164672201|NCT01263704|594826703|FG000|Overall Study|Colon metastases|1|||
164672202|NCT01263704|594826703|FG000|Overall Study|Principal Investigator (PI) decision|1|||
164672203|NCT01061866|594826706|FG000|Overall Study|Adverse Event|2|||
164672204|NCT00252720|594826707|FG000|Overall Study|Withdrawal by Subject|95|||
164672205|NCT00252720|594826708|FG001|Overall Study|Withdrawal by Subject|97|||
164672206|NCT00252720|594826707|FG000|Overall Study|Death|7|||
164672207|NCT00252720|594826708|FG001|Overall Study|Death|8|||
164672208|NCT00252720|594826707|FG000|Overall Study|Moving|23|||
164672209|NCT00252720|594826708|FG001|Overall Study|Moving|42|||
164672210|NCT00252720|594826707|FG000|Overall Study|Mainly patients lost to follow-up|7|||
164672211|NCT00252720|594826708|FG001|Overall Study|Mainly patients lost to follow-up|18|||
164672212|NCT01010542|594826710|FG000|Overall Study|Adverse Event|0|||
164672213|NCT01010542|594826711|FG001|Overall Study|Adverse Event|1|||
164672214|NCT01010542|594826712|FG002|Overall Study|Adverse Event|0|||
164672215|NCT01010542|594826710|FG000|Overall Study|Lost to Follow-up|0|||
164672216|NCT01010542|594826711|FG001|Overall Study|Lost to Follow-up|1|||
164672217|NCT01010542|594826712|FG002|Overall Study|Lost to Follow-up|0|||
164672218|NCT01010542|594826710|FG000|Overall Study|Withdrawal by Subject|0|||
164672219|NCT01010542|594826711|FG001|Overall Study|Withdrawal by Subject|3|||
164672220|NCT01010542|594826712|FG002|Overall Study|Withdrawal by Subject|2|||
164672221|NCT03204539|594826724|FG000|Overall Study|Loss of funding|0|||
164672222|NCT03204539|594826725|FG001|Overall Study|Loss of funding|1|||
164672223|NCT00550537|594826728|FG000|Overall Study|Death|18|||
164672224|NCT00550537|594826728|FG000|Overall Study|Adverse Event|20|||
164672225|NCT00550537|594826728|FG000|Overall Study|Disease progression before|46|||
164672226|NCT00550537|594826728|FG000|Overall Study|Withdrawal by Subject|7|||
164672227|NCT00550537|594826728|FG000|Overall Study|Change in treatment plan|4|||
164672228|NCT00550537|594826728|FG000|Overall Study|Other complicating ilness|3|||
164672229|NCT00550537|594826728|FG000|Overall Study|Declining performance status|2|||
164672230|NCT00550537|594826728|FG000|Overall Study|Treated closer to home|4|||
164672231|NCT02008565|594826729|FG000|Overall Study|Protocol Violation|1|||
164672232|NCT02008565|594826730|FG001|Overall Study|Protocol Violation|1|||
164672233|NCT02008565|594826731|FG002|Overall Study|Protocol Violation|2|||
164672234|NCT02008565|594826732|FG003|Overall Study|Protocol Violation|0|||
164672235|NCT00617305|594826733|FG000|Overall Study|Adverse Event|4|||
164672236|NCT00617305|594826734|FG001|Overall Study|Adverse Event|0|||
164672237|NCT00617305|594826735|FG002|Overall Study|Adverse Event|0|||
164672238|NCT00617305|594826733|FG000|Overall Study|Death|1|||
164672239|NCT00617305|594826734|FG001|Overall Study|Death|0|||
164672240|NCT00617305|594826735|FG002|Overall Study|Death|0|||
164672241|NCT00617305|594826733|FG000|Overall Study|Physician Decision|1|||
164672242|NCT00617305|594826734|FG001|Overall Study|Physician Decision|0|||
164672243|NCT00617305|594826735|FG002|Overall Study|Physician Decision|0|||
164672244|NCT00617305|594826733|FG000|Overall Study|Protocol Violation|1|||
164672245|NCT00617305|594826734|FG001|Overall Study|Protocol Violation|0|||
164672246|NCT00617305|594826735|FG002|Overall Study|Protocol Violation|1|||
164672247|NCT00617305|594826733|FG000|Overall Study|Withdrawal by Subject|1|||
164672248|NCT00617305|594826734|FG001|Overall Study|Withdrawal by Subject|0|||
164672249|NCT00617305|594826735|FG002|Overall Study|Withdrawal by Subject|0|||
164672250|NCT00537979|594826737|FG000|Overall Study|Adverse Event|2|||
164672251|NCT00537979|594826738|FG001|Overall Study|Adverse Event|2|||
164672252|NCT00537979|594826737|FG000|Overall Study|Withdrawal by Subject|1|||
164672253|NCT00537979|594826738|FG001|Overall Study|Withdrawal by Subject|4|||
164672254|NCT00537979|594826737|FG000|Overall Study|Lost to Follow-up|1|||
164672255|NCT00537979|594826738|FG001|Overall Study|Lost to Follow-up|4|||
164672256|NCT00537979|594826737|FG000|Overall Study|Lack of Efficacy|0|||
164672257|NCT00537979|594826738|FG001|Overall Study|Lack of Efficacy|1|||
164672258|NCT00537979|594826737|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
164672259|NCT00537979|594826738|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
164672260|NCT00537979|594826737|FG000|Overall Study|Death|0|||
164672261|NCT00537979|594826738|FG001|Overall Study|Death|3|||
164672262|NCT00537979|594826737|FG000|Overall Study|Kidney transplant|0|||
164672263|NCT00537979|594826738|FG001|Overall Study|Kidney transplant|3|||
164672264|NCT00537979|594826737|FG000|Overall Study|Heart failure|0|||
164672265|NCT00537979|594826738|FG001|Overall Study|Heart failure|1|||
164672266|NCT02193178|594826739|FG000|Overall Study|Lost to Follow-up|1|||
164672267|NCT02193178|594826739|FG000|Overall Study|Dry eyes|1|||
164672268|NCT01059903|594826741|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
164672269|NCT01059903|594826742|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
164672270|NCT03555305|594826743|FG000|Period 1|Physician Decision|0|||
164672271|NCT03555305|594826744|FG001|Period 1|Physician Decision|1|||
164672272|NCT03555305|594826743|FG000|Period 1|Adverse Event|0|||
164672273|NCT03555305|594826744|FG001|Period 1|Adverse Event|1|||
164672274|NCT00858845|594826758|FG000|Overall Study|Patient underwent heart transplant.|0|||
164672275|NCT00858845|594826759|FG001|Overall Study|Patient underwent heart transplant.|1|||
164672276|NCT03031847|594826760|FG000|Overall Study|Death|1|||
164672277|NCT03031847|594826761|FG001|Overall Study|Death|1|||
164672278|NCT03031847|594826762|FG002|Overall Study|Death|2|||
164672279|NCT03031847|594826763|FG003|Overall Study|Death|3|||
164672280|NCT03031847|594826760|FG000|Overall Study|Lost to Follow-up|1|||
164672281|NCT03031847|594826761|FG001|Overall Study|Lost to Follow-up|1|||
164672282|NCT03031847|594826762|FG002|Overall Study|Lost to Follow-up|2|||
164672283|NCT03031847|594826763|FG003|Overall Study|Lost to Follow-up|3|||
164672284|NCT02100228|594826765|FG000|Overall Study|Other|19|||
164672285|NCT02100228|594826766|FG001|Overall Study|Other|19|||
164672286|NCT02100228|594826765|FG000|Overall Study|Administrative reason|0|||
164672287|NCT02100228|594826766|FG001|Overall Study|Administrative reason|1|||
164672288|NCT02100228|594826765|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
164672289|NCT02100228|594826766|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
164672290|NCT02100228|594826765|FG000|Overall Study|Non-compliance|0|||
164672291|NCT02100228|594826766|FG001|Overall Study|Non-compliance|3|||
164672292|NCT02100228|594826765|FG000|Overall Study|Lost to Follow-up|0|||
164672293|NCT02100228|594826766|FG001|Overall Study|Lost to Follow-up|1|||
164672294|NCT02100228|594826765|FG000|Overall Study|Withdrawal by Subject|27|||
164672295|NCT02100228|594826766|FG001|Overall Study|Withdrawal by Subject|37|||
164672296|NCT02100228|594826765|FG000|Overall Study|Adverse Event|16|||
164672297|NCT02100228|594826766|FG001|Overall Study|Adverse Event|12|||
164672298|NCT02100228|594826765|FG000|Overall Study|Death|1|||
164224356|NCT02931539|593188615|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
164672299|NCT02100228|594826766|FG001|Overall Study|Death|1|||
164672300|NCT00854100|594826777|FG000|Overall Study|Inability to complete the study visits|0|||
164672301|NCT00854100|594826778|FG001|Overall Study|Inability to complete the study visits|0|||
164672302|NCT00854100|594826779|FG002|Overall Study|Inability to complete the study visits|1|||
164672303|NCT00854100|594826777|FG000|Overall Study|Lost to Follow-up|2|||
164672304|NCT00854100|594826778|FG001|Overall Study|Lost to Follow-up|0|||
164672305|NCT00854100|594826779|FG002|Overall Study|Lost to Follow-up|3|||
164672306|NCT00854100|594826777|FG000|Overall Study|Withdrawal by Subject|3|||
164672307|NCT00854100|594826778|FG001|Overall Study|Withdrawal by Subject|1|||
164672308|NCT00854100|594826779|FG002|Overall Study|Withdrawal by Subject|2|||
164672309|NCT00854100|594826777|FG000|Overall Study|Protocol Violation|2|||
164672310|NCT00854100|594826778|FG001|Overall Study|Protocol Violation|4|||
164672311|NCT00854100|594826779|FG002|Overall Study|Protocol Violation|3|||
164224357|NCT02931539|593188616|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
164224358|NCT02931539|593188617|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
164224359|NCT02931539|593188615|FG000|Period 1: Treatment Phase|Death|8|||
164224360|NCT02931539|593188616|FG001|Period 1: Treatment Phase|Death|24|||
164224361|NCT02931539|593188617|FG002|Period 1: Treatment Phase|Death|0|||
164672312|NCT00854100|594826777|FG000|Overall Study|Adverse Event|2|||
164672313|NCT00854100|594826778|FG001|Overall Study|Adverse Event|1|||
164224362|NCT02931539|593188615|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
164224363|NCT02931539|593188616|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
164224364|NCT02931539|593188617|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
164672314|NCT00854100|594826779|FG002|Overall Study|Adverse Event|2|||
164672315|NCT02242201|594826781|FG000|Overall Study|preoperative identified neuropathy|2|||
164672316|NCT02242201|594826782|FG001|Overall Study|preoperative identified neuropathy|0|||
164672317|NCT02242201|594826783|FG002|Overall Study|preoperative identified neuropathy|0|||
164672318|NCT02242201|594826781|FG000|Overall Study|planned post-op anticoagulation|1|||
164672319|NCT02242201|594826782|FG001|Overall Study|planned post-op anticoagulation|0|||
164224365|NCT02931539|593188615|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
164224366|NCT02931539|593188616|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
164672320|NCT02242201|594826783|FG002|Overall Study|planned post-op anticoagulation|0|||
164672321|NCT02242201|594826781|FG000|Overall Study|changed surgical procedure|1|||
164672322|NCT02242201|594826782|FG001|Overall Study|changed surgical procedure|0|||
164672323|NCT02242201|594826783|FG002|Overall Study|changed surgical procedure|0|||
164672324|NCT02242201|594826781|FG000|Overall Study|postponed surgery|0|||
164672325|NCT02242201|594826782|FG001|Overall Study|postponed surgery|0|||
164672326|NCT02242201|594826783|FG002|Overall Study|postponed surgery|1|||
164672327|NCT02242201|594826781|FG000|Overall Study|preoperative opioid consumption|0|||
164672328|NCT02242201|594826782|FG001|Overall Study|preoperative opioid consumption|1|||
164672329|NCT02242201|594826783|FG002|Overall Study|preoperative opioid consumption|0|||
164672330|NCT03880266|594826786|FG000|Overall Study|Withdrawal by Subject|0|||
164672331|NCT03880266|594826787|FG001|Overall Study|Withdrawal by Subject|1|||
164672332|NCT03880266|594826788|FG002|Overall Study|Withdrawal by Subject|1|||
164672333|NCT03880266|594826789|FG003|Overall Study|Withdrawal by Subject|0|||
164672334|NCT03880266|594826790|FG004|Overall Study|Withdrawal by Subject|0|||
164672335|NCT03880266|594826791|FG005|Overall Study|Withdrawal by Subject|0|||
164672336|NCT03880266|594826792|FG006|Overall Study|Withdrawal by Subject|0|||
164672337|NCT03880266|594826793|FG007|Overall Study|Withdrawal by Subject|0|||
164672338|NCT05472038|594828172|FG000|Overall Study|Adverse Event|0|||
164672339|NCT05472038|594828173|FG001|Overall Study|Adverse Event|0|||
164672340|NCT05472038|594828174|FG002|Overall Study|Adverse Event|1|||
164672341|NCT05472038|594828175|FG003|Overall Study|Adverse Event|0|||
164672342|NCT05472038|594828176|FG004|Overall Study|Adverse Event|0|||
164672343|NCT05472038|594828177|FG005|Overall Study|Adverse Event|0|||
164672344|NCT05472038|594828178|FG006|Overall Study|Adverse Event|0|||
164672345|NCT05472038|594828179|FG007|Overall Study|Adverse Event|0|||
164672346|NCT05472038|594828180|FG008|Overall Study|Adverse Event|0|||
164672347|NCT05472038|594828181|FG009|Overall Study|Adverse Event|0|||
164672348|NCT05472038|594828182|FG010|Overall Study|Adverse Event|0|||
164672349|NCT05472038|594828183|FG011|Overall Study|Adverse Event|0|||
164672350|NCT05472038|594828172|FG000|Overall Study|Death|0|||
164672351|NCT05472038|594828173|FG001|Overall Study|Death|0|||
164672352|NCT05472038|594828174|FG002|Overall Study|Death|0|||
164672353|NCT05472038|594828175|FG003|Overall Study|Death|0|||
164672354|NCT05472038|594828176|FG004|Overall Study|Death|0|||
164672355|NCT05472038|594828177|FG005|Overall Study|Death|1|||
164672356|NCT05472038|594828178|FG006|Overall Study|Death|0|||
164672357|NCT05472038|594828179|FG007|Overall Study|Death|0|||
164672358|NCT05472038|594828180|FG008|Overall Study|Death|0|||
164672359|NCT05472038|594828181|FG009|Overall Study|Death|0|||
164672360|NCT05472038|594828182|FG010|Overall Study|Death|0|||
164672361|NCT05472038|594828183|FG011|Overall Study|Death|0|||
164672362|NCT05472038|594828172|FG000|Overall Study|Lost to Follow-up|1|||
164672363|NCT05472038|594828173|FG001|Overall Study|Lost to Follow-up|3|||
164672364|NCT05472038|594828174|FG002|Overall Study|Lost to Follow-up|3|||
164672365|NCT05472038|594828175|FG003|Overall Study|Lost to Follow-up|9|||
164672366|NCT05472038|594828176|FG004|Overall Study|Lost to Follow-up|2|||
164672367|NCT05472038|594828177|FG005|Overall Study|Lost to Follow-up|2|||
164672368|NCT05472038|594828178|FG006|Overall Study|Lost to Follow-up|1|||
164672369|NCT05472038|594828179|FG007|Overall Study|Lost to Follow-up|0|||
164672370|NCT05472038|594828180|FG008|Overall Study|Lost to Follow-up|1|||
164672371|NCT05472038|594828181|FG009|Overall Study|Lost to Follow-up|0|||
164672372|NCT05472038|594828182|FG010|Overall Study|Lost to Follow-up|2|||
164672373|NCT05472038|594828183|FG011|Overall Study|Lost to Follow-up|1|||
164672374|NCT05472038|594828172|FG000|Overall Study|Physician Decision|0|||
164672375|NCT05472038|594828173|FG001|Overall Study|Physician Decision|0|||
164672376|NCT05472038|594828174|FG002|Overall Study|Physician Decision|0|||
164672377|NCT05472038|594828175|FG003|Overall Study|Physician Decision|0|||
164672378|NCT05472038|594828176|FG004|Overall Study|Physician Decision|1|||
164672379|NCT05472038|594828177|FG005|Overall Study|Physician Decision|0|||
164672380|NCT05472038|594828178|FG006|Overall Study|Physician Decision|0|||
164672381|NCT05472038|594828179|FG007|Overall Study|Physician Decision|0|||
164672382|NCT05472038|594828180|FG008|Overall Study|Physician Decision|0|||
164672383|NCT05472038|594828181|FG009|Overall Study|Physician Decision|0|||
164672384|NCT05472038|594828182|FG010|Overall Study|Physician Decision|0|||
164672385|NCT05472038|594828183|FG011|Overall Study|Physician Decision|0|||
164672386|NCT05472038|594828172|FG000|Overall Study|Withdrawal by Subject|1|||
164672387|NCT05472038|594828173|FG001|Overall Study|Withdrawal by Subject|3|||
164672388|NCT05472038|594828174|FG002|Overall Study|Withdrawal by Subject|1|||
164672389|NCT05472038|594828175|FG003|Overall Study|Withdrawal by Subject|6|||
164672390|NCT05472038|594828176|FG004|Overall Study|Withdrawal by Subject|1|||
164672391|NCT05472038|594828177|FG005|Overall Study|Withdrawal by Subject|3|||
164672392|NCT05472038|594828178|FG006|Overall Study|Withdrawal by Subject|0|||
164672393|NCT05472038|594828179|FG007|Overall Study|Withdrawal by Subject|2|||
164672394|NCT05472038|594828180|FG008|Overall Study|Withdrawal by Subject|3|||
164672395|NCT05472038|594828181|FG009|Overall Study|Withdrawal by Subject|1|||
164672396|NCT05472038|594828182|FG010|Overall Study|Withdrawal by Subject|2|||
164672397|NCT05472038|594828183|FG011|Overall Study|Withdrawal by Subject|2|||
164672398|NCT05472038|594828172|FG000|Overall Study|Protocol Violation|0|||
164672399|NCT05472038|594828173|FG001|Overall Study|Protocol Violation|0|||
164672400|NCT05472038|594828174|FG002|Overall Study|Protocol Violation|0|||
164672401|NCT05472038|594828175|FG003|Overall Study|Protocol Violation|0|||
164672402|NCT05472038|594828176|FG004|Overall Study|Protocol Violation|0|||
164672403|NCT05472038|594828177|FG005|Overall Study|Protocol Violation|0|||
164672404|NCT05472038|594828178|FG006|Overall Study|Protocol Violation|0|||
164672405|NCT05472038|594828179|FG007|Overall Study|Protocol Violation|1|||
164672406|NCT05472038|594828180|FG008|Overall Study|Protocol Violation|1|||
164672407|NCT05472038|594828181|FG009|Overall Study|Protocol Violation|1|||
164672408|NCT05472038|594828182|FG010|Overall Study|Protocol Violation|1|||
164672409|NCT05472038|594828183|FG011|Overall Study|Protocol Violation|1|||
164672410|NCT05472038|594828172|FG000|Overall Study|Not vaccinated|0|||
164672411|NCT05472038|594828173|FG001|Overall Study|Not vaccinated|0|||
164672412|NCT05472038|594828174|FG002|Overall Study|Not vaccinated|0|||
164672413|NCT05472038|594828175|FG003|Overall Study|Not vaccinated|1|||
164672414|NCT05472038|594828176|FG004|Overall Study|Not vaccinated|0|||
164224367|NCT02931539|593188617|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
164224368|NCT02931539|593188615|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
164224369|NCT02931539|593188616|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
164224370|NCT02931539|593188617|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
164224371|NCT02931539|593188615|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
164224372|NCT02931539|593188616|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
164224373|NCT02931539|593188617|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
164224374|NCT06097273|593188620|FG000|Overall Study|Death|2|||
164224375|NCT06097273|593188621|FG001|Overall Study|Death|1|||
164224376|NCT06097273|593188622|FG002|Overall Study|Death|2|||
164224377|NCT06097273|593188623|FG003|Overall Study|Death|2|||
164224378|NCT06097273|593188620|FG000|Overall Study|Lost to Follow-up|27|||
164224379|NCT06097273|593188621|FG001|Overall Study|Lost to Follow-up|18|||
164224380|NCT06097273|593188622|FG002|Overall Study|Lost to Follow-up|36|||
164224381|NCT06097273|593188623|FG003|Overall Study|Lost to Follow-up|31|||
164224382|NCT06097273|593188620|FG000|Overall Study|Physician Decision|0|||
164224383|NCT06097273|593188621|FG001|Overall Study|Physician Decision|1|||
164224384|NCT06097273|593188622|FG002|Overall Study|Physician Decision|0|||
164224385|NCT06097273|593188623|FG003|Overall Study|Physician Decision|3|||
164224386|NCT06097273|593188620|FG000|Overall Study|Protocol Violation|1|||
164224387|NCT06097273|593188621|FG001|Overall Study|Protocol Violation|1|||
164224388|NCT06097273|593188622|FG002|Overall Study|Protocol Violation|2|||
164224389|NCT06097273|593188623|FG003|Overall Study|Protocol Violation|1|||
164224390|NCT06097273|593188620|FG000|Overall Study|Withdrawal by Subject|14|||
164672415|NCT05472038|594828177|FG005|Overall Study|Not vaccinated|0|||
164672416|NCT05472038|594828178|FG006|Overall Study|Not vaccinated|0|||
164672417|NCT05472038|594828179|FG007|Overall Study|Not vaccinated|0|||
164672418|NCT05472038|594828180|FG008|Overall Study|Not vaccinated|0|||
164672419|NCT05472038|594828181|FG009|Overall Study|Not vaccinated|0|||
164672420|NCT05472038|594828182|FG010|Overall Study|Not vaccinated|0|||
164672421|NCT05472038|594828183|FG011|Overall Study|Not vaccinated|0|||
164672422|NCT03235739|594828184|FG000|Overall Study|Withdrawal by Subject|2|||
164672423|NCT03235739|594828185|FG001|Overall Study|Withdrawal by Subject|2|||
164672424|NCT03235739|594828184|FG000|Overall Study|Physician Decision|0|||
164672425|NCT03235739|594828185|FG001|Overall Study|Physician Decision|1|||
164672426|NCT00467896|594828186|FG000|Overall Study|Consent Withdrawal|18|||
164672427|NCT00467896|594828186|FG000|Overall Study|Adverse Event|7|||
164672428|NCT00467896|594828186|FG000|Overall Study|Serious Adverse Event|13|||
164672429|NCT00467896|594828186|FG000|Overall Study|Non-compliance|3|||
164672430|NCT00467896|594828186|FG000|Overall Study|Changed therapy|2|||
164672431|NCT00467896|594828186|FG000|Overall Study|Patient received transplant|2|||
164672432|NCT00467896|594828186|FG000|Overall Study|Patient had atrial septostomy|1|||
164672433|NCT00467896|594828186|FG000|Overall Study|Patient weaned off iloprost|1|||
164672434|NCT00467896|594828186|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
164672435|NCT00467896|594828186|FG000|Overall Study|Started intravenous prostacyclin|1|||
164672436|NCT00467896|594828186|FG000|Overall Study|Started inhaled Remodulin|1|||
164672437|NCT00467896|594828186|FG000|Overall Study|Patient had no improvement|1|||
164224391|NCT06097273|593188621|FG001|Overall Study|Withdrawal by Subject|11|||
164224392|NCT06097273|593188622|FG002|Overall Study|Withdrawal by Subject|14|||
164224393|NCT06097273|593188623|FG003|Overall Study|Withdrawal by Subject|15|||
164672438|NCT02847650|594828187|FG000|Overall Study|Adverse Event|2|||
164224394|NCT06097273|593188620|FG000|Overall Study|Other Than Specified|7|||
164672439|NCT02847650|594828188|FG001|Overall Study|Adverse Event|4|||
164672440|NCT02847650|594828187|FG000|Overall Study|Lost to Follow-up|1|||
164672441|NCT02847650|594828188|FG001|Overall Study|Lost to Follow-up|0|||
164672442|NCT02847650|594828187|FG000|Overall Study|Protocol Violation|0|||
164672443|NCT02847650|594828188|FG001|Overall Study|Protocol Violation|1|||
164224395|NCT06097273|593188621|FG001|Overall Study|Other Than Specified|3|||
164224396|NCT06097273|593188622|FG002|Overall Study|Other Than Specified|11|||
164224397|NCT06097273|593188623|FG003|Overall Study|Other Than Specified|6|||
164224398|NCT03681093|593190233|FG000|Overall Study|Subject decision|0|||
164224399|NCT03681093|593190234|FG001|Overall Study|Subject decision|2|||
164672444|NCT02847650|594828187|FG000|Overall Study|Withdrawal by Subject|1|||
164672445|NCT02847650|594828188|FG001|Overall Study|Withdrawal by Subject|1|||
164672446|NCT03818581|594828191|FG000|Overall Study|Adverse Event|1|||
164224400|NCT03681093|593190235|FG002|Overall Study|Subject decision|1|||
164224401|NCT00368849|593190239|FG000|Overall Study|Withdrawal by Subject|0|||
164224402|NCT00368849|593190240|FG001|Overall Study|Withdrawal by Subject|1|||
164224403|NCT00368849|593190239|FG000|Overall Study|Physician Decision|0|||
164224404|NCT00368849|593190240|FG001|Overall Study|Physician Decision|1|||
164224405|NCT01902303|593190241|FG000|Overall Study|Adverse Event|0|||
164224406|NCT01902303|593190242|FG001|Overall Study|Adverse Event|1|||
164224407|NCT01902303|593190241|FG000|Overall Study|Lost to Follow-up|0|||
164224408|NCT01902303|593190242|FG001|Overall Study|Lost to Follow-up|1|||
164224409|NCT01902303|593190241|FG000|Overall Study|Protocol Violation|2|||
164224410|NCT01902303|593190242|FG001|Overall Study|Protocol Violation|2|||
164224411|NCT01902303|593190241|FG000|Overall Study|subject lost investigational product|0|||
164224412|NCT01902303|593190242|FG001|Overall Study|subject lost investigational product|1|||
164224413|NCT01902303|593190241|FG000|Overall Study|Did not develop a cold sore|21|||
164224414|NCT01902303|593190242|FG001|Overall Study|Did not develop a cold sore|19|||
164224415|NCT03635996|593190243|FG000|Overall Study|Study terminated by Sponsor|94|||
164224416|NCT03635996|593190243|FG000|Overall Study|Withdrawal by Subject|20|||
164224417|NCT03635996|593190243|FG000|Overall Study|Ablation|26|||
164224418|NCT03635996|593190243|FG000|Overall Study|Adverse Event|7|||
164224419|NCT03635996|593190243|FG000|Overall Study|Physician Decision|3|||
164224420|NCT03635996|593190243|FG000|Overall Study|Prohibited medication|5|||
164224421|NCT03635996|593190243|FG000|Overall Study|Did not meet eligibility criteria|5|||
164224422|NCT03635996|593190243|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
164224423|NCT03635996|593190243|FG000|Overall Study|Protocol Violation|1|||
164224424|NCT03635996|593190243|FG000|Overall Study|Lost to Follow-up|1|||
164224425|NCT04359680|593190244|FG000|Overall Study|Withdrawal by Subject|29|||
164224426|NCT04359680|593190245|FG001|Overall Study|Withdrawal by Subject|24|||
164224427|NCT04359680|593190244|FG000|Overall Study|Adverse Event|6|||
164224428|NCT04359680|593190245|FG001|Overall Study|Adverse Event|2|||
164224429|NCT04359680|593190244|FG000|Overall Study|Lost to Follow-up|56|||
164224430|NCT04359680|593190245|FG001|Overall Study|Lost to Follow-up|59|||
164224431|NCT04359680|593190244|FG000|Overall Study|Protocol Violation|3|||
164224432|NCT04359680|593190245|FG001|Overall Study|Protocol Violation|5|||
164224433|NCT04359680|593190244|FG000|Overall Study|Physician Decision|1|||
164224434|NCT04359680|593190245|FG001|Overall Study|Physician Decision|1|||
164224435|NCT04359680|593190244|FG000|Overall Study|Sponsor Decision|0|||
164224436|NCT04359680|593190245|FG001|Overall Study|Sponsor Decision|1|||
164224437|NCT02802865|593190246|FG000|Overall Study|Pregnancy|1|||
164224438|NCT02802865|593190247|FG001|Overall Study|Pregnancy|1|||
164224439|NCT02802865|593190246|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
164224440|NCT02802865|593190247|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
164672447|NCT03818581|594828192|FG001|Overall Study|Adverse Event|0|||
164672448|NCT03818581|594828193|FG002|Overall Study|Adverse Event|0|||
164672449|NCT03818581|594828194|FG003|Overall Study|Adverse Event|0|||
164672450|NCT03818581|594828195|FG004|Overall Study|Adverse Event|0|||
164672451|NCT03818581|594828191|FG000|Overall Study|Covid-19|2|||
164672452|NCT03818581|594828192|FG001|Overall Study|Covid-19|0|||
164672453|NCT03818581|594828193|FG002|Overall Study|Covid-19|0|||
164672454|NCT03818581|594828194|FG003|Overall Study|Covid-19|0|||
164672455|NCT03818581|594828195|FG004|Overall Study|Covid-19|1|||
164672456|NCT03818581|594828191|FG000|Overall Study|Withdrawal by Subject|0|||
164672457|NCT03818581|594828192|FG001|Overall Study|Withdrawal by Subject|0|||
164672458|NCT03818581|594828193|FG002|Overall Study|Withdrawal by Subject|0|||
164672459|NCT03818581|594828194|FG003|Overall Study|Withdrawal by Subject|0|||
164672460|NCT03818581|594828195|FG004|Overall Study|Withdrawal by Subject|1|||
164672461|NCT03818581|594828191|FG000|Overall Study|No longer met study criteria|0|||
164224441|NCT01862029|593190248|FG000|Overall Study|Physician Decision|1|||
164224442|NCT01832038|593190249|FG000|Overall Study|Death|5|||
164224443|NCT01832038|593190249|FG000|Overall Study|Adverse Event|50|||
164224444|NCT01832038|593190249|FG000|Overall Study|Lack of Efficacy|81|||
164224445|NCT01832038|593190249|FG000|Overall Study|Protocol Violation|7|||
164224446|NCT01832038|593190249|FG000|Overall Study|Lost to Follow-up|10|||
164224447|NCT01832038|593190249|FG000|Overall Study|Withdrawal by Subject|49|||
164224448|NCT01832038|593190249|FG000|Overall Study|Visit non-compliance|2|||
164224449|NCT01832038|593190249|FG000|Overall Study|Subject refused to return visit|2|||
164224450|NCT01832038|593190249|FG000|Overall Study|Not convenient to come back to site|2|||
164672462|NCT03818581|594828192|FG001|Overall Study|No longer met study criteria|0|||
164672463|NCT03818581|594828193|FG002|Overall Study|No longer met study criteria|0|||
164672464|NCT03818581|594828194|FG003|Overall Study|No longer met study criteria|0|||
164224451|NCT01832038|593190249|FG000|Overall Study|Participant was asked to quit|5|||
164224452|NCT01832038|593190249|FG000|Overall Study|Back home|1|||
164224453|NCT01832038|593190249|FG000|Overall Study|Pregnancy|1|||
164224454|NCT01832038|593190249|FG000|Overall Study|Low compliance|3|||
164224455|NCT01832038|593190249|FG000|Overall Study|Prohibit procedure|2|||
164224456|NCT01832038|593190249|FG000|Overall Study|Not possible to visit the hospital|1|||
164224457|NCT01832038|593190249|FG000|Overall Study|Changes of implementation system|3|||
164224458|NCT01832038|593190249|FG000|Overall Study|Plan to pregnancy|7|||
164224459|NCT01832038|593190249|FG000|Overall Study|Bad mood and has suicidal thought|1|||
164224460|NCT01832038|593190249|FG000|Overall Study|Prohibited concomitant medication|1|||
164224461|NCT01832038|593190249|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
164224462|NCT01832038|593190249|FG000|Overall Study|Subject considered the efficacy was poor|1|||
164224463|NCT03810365|593190250|FG000|Overall Study|Lost to Follow-up|2|||
164224464|NCT03810365|593190251|FG001|Overall Study|Lost to Follow-up|2|||
164224465|NCT03810365|593190250|FG000|Overall Study|Withdrawal by Subject|4|||
164224466|NCT03810365|593190251|FG001|Overall Study|Withdrawal by Subject|5|||
164224467|NCT01755156|593190252|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
164224468|NCT01755156|593190253|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
164224469|NCT01755156|593190252|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
164224470|NCT01755156|593190253|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
164224471|NCT01755156|593190252|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
164224472|NCT01755156|593190253|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
164224473|NCT01755156|593190252|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
164224474|NCT01755156|593190253|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
164224475|NCT01755156|593190252|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
164224476|NCT01755156|593190253|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
164569070|NCT02497001|594449247|FG001|Overall Study|Withdrawal by Subject|37|||
164224477|NCT01755156|593190252|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
164224478|NCT01755156|593190253|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
164569071|NCT02497001|594449248|FG002|Overall Study|Withdrawal by Subject|19|||
164569072|NCT02497001|594449249|FG003|Overall Study|Withdrawal by Subject|15|||
164569073|NCT02497001|594449246|FG000|Overall Study|Physician Decision|5|||
164569074|NCT02497001|594449247|FG001|Overall Study|Physician Decision|11|||
164569075|NCT02497001|594449248|FG002|Overall Study|Physician Decision|5|||
164569076|NCT02497001|594449249|FG003|Overall Study|Physician Decision|1|||
164569077|NCT02497001|594449246|FG000|Overall Study|subjects that were not treated|1|||
164569078|NCT02497001|594449247|FG001|Overall Study|subjects that were not treated|2|||
164569079|NCT02497001|594449248|FG002|Overall Study|subjects that were not treated|2|||
164569080|NCT02497001|594449249|FG003|Overall Study|subjects that were not treated|1|||
164569081|NCT02497001|594449246|FG000|Overall Study|Major Protocol Deviation|3|||
164569082|NCT02497001|594449247|FG001|Overall Study|Major Protocol Deviation|4|||
164569083|NCT02497001|594449248|FG002|Overall Study|Major Protocol Deviation|4|||
164569084|NCT02497001|594449249|FG003|Overall Study|Major Protocol Deviation|4|||
164569085|NCT02497001|594449246|FG000|Overall Study|Lack of Efficacy|10|||
164569086|NCT02497001|594449247|FG001|Overall Study|Lack of Efficacy|16|||
164569087|NCT02497001|594449248|FG002|Overall Study|Lack of Efficacy|6|||
164569088|NCT02497001|594449249|FG003|Overall Study|Lack of Efficacy|6|||
164569089|NCT02497001|594449246|FG000|Overall Study|Protocol Violation|3|||
164569090|NCT02497001|594449247|FG001|Overall Study|Protocol Violation|1|||
164569091|NCT02497001|594449248|FG002|Overall Study|Protocol Violation|3|||
164569092|NCT02497001|594449249|FG003|Overall Study|Protocol Violation|1|||
164569093|NCT00705263|594449250|FG000|Overall Study|Withdrawal by Subject|2|||
164569094|NCT00484315|594449252|FG000|12-Month Clinical Follow-up|Death|6|||
164569095|NCT00484315|594449253|FG001|12-Month Clinical Follow-up|Death|2|||
164569096|NCT00484315|594449252|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
164569097|NCT00484315|594449253|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
164569098|NCT00484315|594449252|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
164569099|NCT00484315|594449253|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
164224479|NCT01755156|593190252|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
164224480|NCT01755156|593190253|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
164224481|NCT01755156|593190252|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
164224482|NCT01755156|593190253|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
164224483|NCT01755156|593190252|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
164224484|NCT01755156|593190253|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
164224485|NCT01755156|593190252|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
164224486|NCT01755156|593190253|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
164224487|NCT01755156|593190252|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
164224488|NCT01755156|593190253|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
164224489|NCT03048019|593190254|FG000|Overall Study|Adverse Event|1|||
164224490|NCT03048019|593190255|FG001|Overall Study|Adverse Event|0|||
164224491|NCT01730729|593190256|FG000|Overall Study|Adverse Event|1|||
164224492|NCT01730729|593190256|FG000|Overall Study|Death|1|||
164224493|NCT01730729|593190256|FG000|Overall Study|Progressive Disease|12|||
164224494|NCT00382863|593190257|FG000|Overall Study|Death|9|||
164224495|NCT00382863|593190258|FG001|Overall Study|Death|9|||
164224496|NCT00382863|593190257|FG000|Overall Study|Lost to Follow-up|1|||
164224497|NCT00382863|593190258|FG001|Overall Study|Lost to Follow-up|2|||
164224498|NCT00382863|593190257|FG000|Overall Study|Withdrawal by Subject|5|||
164224499|NCT00382863|593190258|FG001|Overall Study|Withdrawal by Subject|25|||
164224500|NCT01292473|593190261|FG000|Overall Study|Adverse Event|1|||
164224501|NCT01292473|593190262|FG001|Overall Study|Adverse Event|0|||
164224502|NCT01292473|593190263|FG002|Overall Study|Adverse Event|1|||
164224503|NCT01292473|593190264|FG003|Overall Study|Adverse Event|1|||
164224504|NCT01292473|593190261|FG000|Overall Study|Lost to Follow-up|1|||
164224505|NCT01292473|593190262|FG001|Overall Study|Lost to Follow-up|1|||
164224506|NCT01292473|593190263|FG002|Overall Study|Lost to Follow-up|2|||
164224507|NCT01292473|593190264|FG003|Overall Study|Lost to Follow-up|2|||
164224508|NCT01292473|593190261|FG000|Overall Study|Withdrawal by Subject|3|||
164224509|NCT01292473|593190262|FG001|Overall Study|Withdrawal by Subject|4|||
164224510|NCT01292473|593190263|FG002|Overall Study|Withdrawal by Subject|3|||
164224511|NCT01292473|593190264|FG003|Overall Study|Withdrawal by Subject|3|||
164224512|NCT01292473|593190261|FG000|Overall Study|Physician Decision|0|||
164224513|NCT01292473|593190262|FG001|Overall Study|Physician Decision|1|||
164224514|NCT01292473|593190263|FG002|Overall Study|Physician Decision|0|||
164224515|NCT01292473|593190264|FG003|Overall Study|Physician Decision|0|||
164224516|NCT01292473|593190261|FG000|Overall Study|Disease Progression|0|||
164224517|NCT01292473|593190262|FG001|Overall Study|Disease Progression|1|||
164224518|NCT01292473|593190263|FG002|Overall Study|Disease Progression|3|||
164224519|NCT01292473|593190264|FG003|Overall Study|Disease Progression|6|||
164224520|NCT00203242|593190265|FG000|Overall Study|Lost to Follow-up|1|||
164224521|NCT00449787|593190266|FG000|Overall Study|Lost to Follow-up|10|||
164224522|NCT00449787|593190267|FG001|Overall Study|Lost to Follow-up|8|||
164224523|NCT00449787|593190266|FG000|Overall Study|Did not require medication|95|||
164224524|NCT00449787|593190267|FG001|Overall Study|Did not require medication|92|||
164224525|NCT02094885|593190273|FG000|Overall Study|Death|1|||
164224526|NCT02094885|593190274|FG001|Overall Study|Death|5|||
164224527|NCT02094885|593190273|FG000|Overall Study|Withdrawn due to age|1|||
164224528|NCT02094885|593190274|FG001|Overall Study|Withdrawn due to age|0|||
164224529|NCT01061710|593190275|FG000|Overall Study|Protocol Violation|14|||
164224530|NCT01903720|593190276|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
164224531|NCT01903720|593190276|FG000|Overall Study|Adverse Event|1|||
164224532|NCT01903720|593190276|FG000|Overall Study|Rescinding of informed consent|2|||
164224533|NCT01903720|593190276|FG000|Overall Study|Lost to Follow-up|2|||
164224534|NCT01903720|593190276|FG000|Overall Study|Treatment with alternative drug|1|||
164224535|NCT00552279|593190285|FG000|Overall Study|Adverse Event|0|||
164224536|NCT00552279|593190286|FG001|Overall Study|Adverse Event|1|||
164224537|NCT00552279|593190285|FG000|Overall Study|Withdrawal by Subject|12|||
164224538|NCT00552279|593190286|FG001|Overall Study|Withdrawal by Subject|1|||
164224539|NCT00552279|593190285|FG000|Overall Study|Lost to Follow-up|1|||
164224540|NCT00552279|593190286|FG001|Overall Study|Lost to Follow-up|0|||
164224541|NCT00552279|593190285|FG000|Overall Study|Other|1|||
164224542|NCT00552279|593190286|FG001|Overall Study|Other|1|||
164224543|NCT02150863|593190287|FG000|Overall Study|Lost to Follow-up|0|||
164224544|NCT02150863|593190288|FG001|Overall Study|Lost to Follow-up|1|||
164224545|NCT02150863|593190289|FG002|Overall Study|Lost to Follow-up|0|||
164224546|NCT04829214|593190290|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
164224547|NCT04829214|593190291|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
164224548|NCT04829214|593190290|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
164569100|NCT00484315|594449252|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
164569101|NCT00484315|594449253|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
164224549|NCT04829214|593190291|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
164224550|NCT05287685|593190292|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
164224551|NCT05287685|593190293|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
164224552|NCT05287685|593190292|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
164224553|NCT05287685|593190293|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
164224554|NCT06399471|593190294|FG000|Overall Study|Withdrawal by Subject|1|||
164224555|NCT04008069|593190295|FG000|Open-Label Period|Adverse Event|1|||
164224556|NCT04008069|593190296|FG001|Open-Label Period|Adverse Event|0|||
164224557|NCT04008069|593190297|FG002|Open-Label Period|Adverse Event|0|||
164224558|NCT04008069|593190295|FG000|Open-Label Period|Lack of Efficacy|4|||
164224559|NCT04008069|593190296|FG001|Open-Label Period|Lack of Efficacy|0|||
164224560|NCT04008069|593190297|FG002|Open-Label Period|Lack of Efficacy|0|||
164224561|NCT04008069|593190295|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
164224562|NCT04008069|593190296|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
164224563|NCT04008069|593190297|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
164224564|NCT04008069|593190295|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
164224565|NCT04008069|593190296|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
164224566|NCT04008069|593190297|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
164224567|NCT00511199|593190298|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
164224568|NCT00511199|593190299|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
164224569|NCT00511199|593190298|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
164224570|NCT00511199|593190299|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
164224571|NCT00511199|593190298|FG000|Overall Study|Withdrawal of Informed Consent|19|||
164224572|NCT00511199|593190299|FG001|Overall Study|Withdrawal of Informed Consent|4|||
164224573|NCT00511199|593190298|FG000|Overall Study|Pregnancy|6|||
164224574|NCT00511199|593190299|FG001|Overall Study|Pregnancy|3|||
164224575|NCT00511199|593190298|FG000|Overall Study|Pregnancy Wish|16|||
164224576|NCT00511199|593190299|FG001|Overall Study|Pregnancy Wish|8|||
164224577|NCT00511199|593190298|FG000|Overall Study|Lost to Follow-up|40|||
164224578|NCT00511199|593190299|FG001|Overall Study|Lost to Follow-up|17|||
164224579|NCT00511199|593190298|FG000|Overall Study|Other Reason|78|||
164224580|NCT00511199|593190299|FG001|Overall Study|Other Reason|37|||
164224581|NCT01570192|593190305|FG000|Overall Study|no qualifying organism|6|||
164224582|NCT01570192|593190306|FG001|Overall Study|no qualifying organism|12|||
164224583|NCT01570192|593190305|FG000|Overall Study|changed to palliative care|1|||
164224584|NCT01570192|593190306|FG001|Overall Study|changed to palliative care|0|||
164224585|NCT01570192|593190305|FG000|Overall Study|Physician Decision|0|||
164224586|NCT01570192|593190306|FG001|Overall Study|Physician Decision|1|||
164224587|NCT02965976|593190307|FG000|Overall Study|Withdrawal by Subject|2|||
164224588|NCT02965976|593190308|FG001|Overall Study|Withdrawal by Subject|0|||
164224589|NCT00407030|593190309|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
164224590|NCT00407030|593190310|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
164224591|NCT00407030|593190311|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
164224592|NCT00407030|593190309|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
164224593|NCT00407030|593190310|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
164224594|NCT00407030|593190311|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
164224595|NCT00407030|593190309|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
164224596|NCT00407030|593190310|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
164224597|NCT00407030|593190311|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
164224598|NCT00407030|593190309|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
164224599|NCT00407030|593190310|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
164224600|NCT00407030|593190311|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
164224601|NCT00407030|593190309|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
164224602|NCT00407030|593190310|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
164224603|NCT00407030|593190311|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
164224604|NCT00407030|593190309|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
164224605|NCT00407030|593190310|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
164224606|NCT00407030|593190311|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
164224607|NCT00407030|593190309|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
164672465|NCT03818581|594828195|FG004|Overall Study|No longer met study criteria|1|||
164672466|NCT02378935|594828203|FG000|Overall Study|Lack of Efficacy|10|||
164672467|NCT02378935|594828204|FG001|Overall Study|Lack of Efficacy|0|||
164672468|NCT02378935|594828205|FG002|Overall Study|Lack of Efficacy|2|||
164672469|NCT02378935|594828206|FG003|Overall Study|Lack of Efficacy|6|||
164672470|NCT02378935|594828207|FG004|Overall Study|Lack of Efficacy|0|||
164672471|NCT02378935|594828208|FG005|Overall Study|Lack of Efficacy|0|||
164672472|NCT02378935|594828209|FG006|Overall Study|Lack of Efficacy|0|||
164672473|NCT02378935|594828203|FG000|Overall Study|Death|0|||
164672474|NCT02378935|594828204|FG001|Overall Study|Death|0|||
164672475|NCT02378935|594828205|FG002|Overall Study|Death|1|||
164224608|NCT00407030|593190310|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
164224609|NCT00407030|593190311|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
164224610|NCT00407030|593190309|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
164672476|NCT02378935|594828206|FG003|Overall Study|Death|0|||
164224611|NCT00407030|593190310|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
164569102|NCT00484315|594449252|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
164672477|NCT02378935|594828207|FG004|Overall Study|Death|0|||
164672478|NCT02378935|594828208|FG005|Overall Study|Death|0|||
164672479|NCT02378935|594828209|FG006|Overall Study|Death|0|||
164672480|NCT03450057|594828213|FG000|Overall Study|Death|17|||
164672481|NCT03450057|594828213|FG000|Overall Study|ICF withdrawal|4|||
164672482|NCT03450057|594828213|FG000|Overall Study|Lost to Follow-up|2|||
164672483|NCT00829790|594828216|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
164672484|NCT00829790|594828217|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
164329140|NCT03172910|593583232|FG000|Overall Study|Adverse Event|0|||
164569103|NCT00484315|594449253|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
164569104|NCT00484315|594449252|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
164569105|NCT00484315|594449253|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
164569106|NCT00484315|594449252|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
164569107|NCT00484315|594449253|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
164569108|NCT02246621|594449254|FG000|Overall Study|Withdrawal by Subject|28|||
164569109|NCT02246621|594449255|FG001|Overall Study|Withdrawal by Subject|16|||
164569110|NCT02246621|594449254|FG000|Overall Study|Lost to Follow-up|1|||
164569111|NCT02246621|594449255|FG001|Overall Study|Lost to Follow-up|0|||
164569112|NCT02246621|594449254|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
164569113|NCT02246621|594449255|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
164569114|NCT01445678|594449256|FG000|Overall Study|Adverse Event|12|||
164569115|NCT01445678|594449257|FG001|Overall Study|Adverse Event|8|||
164569116|NCT01445678|594449256|FG000|Overall Study|Lack of Efficacy|0|||
164569117|NCT01445678|594449257|FG001|Overall Study|Lack of Efficacy|2|||
164569118|NCT01445678|594449256|FG000|Overall Study|Lost to Follow-up|8|||
164569119|NCT01445678|594449257|FG001|Overall Study|Lost to Follow-up|5|||
164569120|NCT01445678|594449256|FG000|Overall Study|Protocol Violation|1|||
164569121|NCT01445678|594449257|FG001|Overall Study|Protocol Violation|1|||
164569122|NCT01445678|594449256|FG000|Overall Study|Withdrawal by Subject|9|||
164569123|NCT01445678|594449257|FG001|Overall Study|Withdrawal by Subject|5|||
164569124|NCT01565980|594449258|FG000|Overall Study|Death|1|||
164569125|NCT01565980|594449259|FG001|Overall Study|Death|0|||
164569126|NCT01565980|594449258|FG000|Overall Study|Lost to Follow-up|1|||
164569127|NCT01565980|594449259|FG001|Overall Study|Lost to Follow-up|0|||
164569128|NCT01565980|594449258|FG000|Overall Study|health complications|1|||
164569129|NCT01565980|594449259|FG001|Overall Study|health complications|1|||
164569130|NCT01565980|594449258|FG000|Overall Study|stopped medical treatment|1|||
164569131|NCT01565980|594449259|FG001|Overall Study|stopped medical treatment|0|||
164569132|NCT01565980|594449258|FG000|Overall Study|Withdrawal by Subject|0|||
164569133|NCT01565980|594449259|FG001|Overall Study|Withdrawal by Subject|3|||
164569134|NCT02078219|594449260|FG000|Overall Study|Other|2|||
164569135|NCT02078219|594449261|FG001|Overall Study|Other|2|||
164569136|NCT02078219|594449262|FG002|Overall Study|Other|3|||
164569137|NCT02078219|594449263|FG003|Overall Study|Other|0|||
164569138|NCT02078219|594449264|FG004|Overall Study|Other|1|||
164569139|NCT02078219|594449260|FG000|Overall Study|Withdrawal by Subject|0|||
164569140|NCT02078219|594449261|FG001|Overall Study|Withdrawal by Subject|1|||
164569141|NCT02078219|594449262|FG002|Overall Study|Withdrawal by Subject|0|||
164569142|NCT02078219|594449263|FG003|Overall Study|Withdrawal by Subject|1|||
164569143|NCT02078219|594449264|FG004|Overall Study|Withdrawal by Subject|1|||
164569144|NCT02078219|594449260|FG000|Overall Study|Protocol Violation|0|||
164569145|NCT02078219|594449261|FG001|Overall Study|Protocol Violation|0|||
164569146|NCT02078219|594449262|FG002|Overall Study|Protocol Violation|0|||
164569147|NCT02078219|594449263|FG003|Overall Study|Protocol Violation|1|||
164569148|NCT02078219|594449264|FG004|Overall Study|Protocol Violation|0|||
164569149|NCT02078219|594449260|FG000|Overall Study|Death|0|||
164569150|NCT02078219|594449261|FG001|Overall Study|Death|0|||
164569151|NCT02078219|594449262|FG002|Overall Study|Death|0|||
164672485|NCT03214952|594828218|FG000|Overall Study|Protocol Deviation|45|||
164672486|NCT03214952|594828218|FG000|Overall Study|Case Report Forms Uncollected|13|||
164672487|NCT03935880|594828219|FG000|Overall Study|Lost to Follow-up|0|||
164672488|NCT03935880|594828220|FG001|Overall Study|Lost to Follow-up|1|||
164672489|NCT00365365|594828221|FG000|Overall Study|Randomized but not treated|0|||
164672490|NCT00365365|594828222|FG001|Overall Study|Randomized but not treated|2|||
164672491|NCT00365365|594828223|FG002|Overall Study|Randomized but not treated|0|||
164672492|NCT00365365|594828221|FG000|Overall Study|Poor compliance to protocol|0|||
164672493|NCT00365365|594828222|FG001|Overall Study|Poor compliance to protocol|1|||
164672494|NCT00365365|594828223|FG002|Overall Study|Poor compliance to protocol|0|||
164672495|NCT00365365|594828221|FG000|Overall Study|Lost to Follow-up|3|||
164672496|NCT00365365|594828222|FG001|Overall Study|Lost to Follow-up|3|||
164672497|NCT00365365|594828223|FG002|Overall Study|Lost to Follow-up|3|||
164672498|NCT00365365|594828221|FG000|Overall Study|Death|1|||
164672499|NCT00365365|594828222|FG001|Overall Study|Death|3|||
164672500|NCT00365365|594828223|FG002|Overall Study|Death|0|||
164672501|NCT00365365|594828221|FG000|Overall Study|Subject's request|11|||
164672502|NCT00365365|594828222|FG001|Overall Study|Subject's request|13|||
164672503|NCT00365365|594828223|FG002|Overall Study|Subject's request|1|||
164672504|NCT00365365|594828221|FG000|Overall Study|Disease progression/relapse|9|||
164672505|NCT00365365|594828222|FG001|Overall Study|Disease progression/relapse|6|||
164672506|NCT00365365|594828223|FG002|Overall Study|Disease progression/relapse|7|||
164672507|NCT00365365|594828221|FG000|Overall Study|Adverse Event|6|||
164672508|NCT00365365|594828222|FG001|Overall Study|Adverse Event|6|||
164672509|NCT00365365|594828223|FG002|Overall Study|Adverse Event|3|||
164672510|NCT00365365|594828221|FG000|Overall Study|Moved|2|||
164672511|NCT00365365|594828222|FG001|Overall Study|Moved|0|||
164672512|NCT00365365|594828223|FG002|Overall Study|Moved|0|||
164672513|NCT00365365|594828221|FG000|Overall Study|New cancer|1|||
164672514|NCT00365365|594828222|FG001|Overall Study|New cancer|0|||
164672515|NCT00365365|594828223|FG002|Overall Study|New cancer|0|||
164672516|NCT00365365|594828221|FG000|Overall Study|Withdrew consent|1|||
164672517|NCT00365365|594828222|FG001|Overall Study|Withdrew consent|1|||
164672518|NCT00365365|594828223|FG002|Overall Study|Withdrew consent|0|||
164672519|NCT00365365|594828221|FG000|Overall Study|Second malignancy|0|||
164672520|NCT00365365|594828222|FG001|Overall Study|Second malignancy|1|||
164672521|NCT00365365|594828223|FG002|Overall Study|Second malignancy|0|||
164672522|NCT00365365|594828221|FG000|Overall Study|Patient/physician decision|0|||
164672523|NCT00365365|594828222|FG001|Overall Study|Patient/physician decision|0|||
164672524|NCT00365365|594828223|FG002|Overall Study|Patient/physician decision|1|||
164672525|NCT00984022|594828224|FG000|Overall Study|Lost to Follow-up|10|||
164672526|NCT00984022|594828225|FG001|Overall Study|Lost to Follow-up|14|||
164672527|NCT02924883|594828228|FG000|Overall Study|Death|39|||
164672528|NCT02924883|594828229|FG001|Overall Study|Death|20|||
164672529|NCT02924883|594828228|FG000|Overall Study|Lost to Follow-up|1|||
164672530|NCT02924883|594828229|FG001|Overall Study|Lost to Follow-up|0|||
164672531|NCT02924883|594828228|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
164672532|NCT02924883|594828229|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
164672533|NCT02924883|594828228|FG000|Overall Study|Protocol Violation|1|||
164672534|NCT02924883|594828229|FG001|Overall Study|Protocol Violation|0|||
164672535|NCT02924883|594828228|FG000|Overall Study|Withdrawal by Subject|22|||
164672536|NCT02924883|594828229|FG001|Overall Study|Withdrawal by Subject|16|||
164569152|NCT02078219|594449263|FG003|Overall Study|Death|1|||
164569153|NCT02078219|594449264|FG004|Overall Study|Death|0|||
164569154|NCT02078219|594449260|FG000|Overall Study|Adverse Event|1|||
164569155|NCT02078219|594449261|FG001|Overall Study|Adverse Event|1|||
164569156|NCT02078219|594449262|FG002|Overall Study|Adverse Event|3|||
164569157|NCT02078219|594449263|FG003|Overall Study|Adverse Event|1|||
164569158|NCT02078219|594449264|FG004|Overall Study|Adverse Event|0|||
164569159|NCT00821678|594449265|FG000|Overall Study|Withdrawal by Subject|8|||
164569160|NCT00821678|594449266|FG001|Overall Study|Withdrawal by Subject|0|||
164569161|NCT00821678|594449265|FG000|Overall Study|Lost to Follow-up|13|||
164569162|NCT00821678|594449266|FG001|Overall Study|Lost to Follow-up|12|||
164569163|NCT00821678|594449265|FG000|Overall Study|Death|0|||
164569164|NCT00821678|594449266|FG001|Overall Study|Death|2|||
164672537|NCT02924883|594828228|FG000|Overall Study|Progressive Disease|1|||
164672538|NCT02924883|594828229|FG001|Overall Study|Progressive Disease|0|||
164672539|NCT02924883|594828228|FG000|Overall Study|Study Terminated by Sponsor|69|||
164569165|NCT00891202|594449272|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
164569166|NCT00891202|594449273|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
164569167|NCT00891202|594449274|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
164569168|NCT00891202|594449275|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
164569169|NCT00891202|594449272|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
164569170|NCT00891202|594449273|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
164672540|NCT02924883|594828229|FG001|Overall Study|Study Terminated by Sponsor|32|||
164672541|NCT00004562|594828230|FG000|Overall Study|Lost to Follow-up|102|||
164672542|NCT00004562|594828231|FG001|Overall Study|Lost to Follow-up|91|||
164672543|NCT00102440|594828235|FG000|Overall Study|Lost to Follow-up|25|||
164672544|NCT00102440|594828236|FG001|Overall Study|Lost to Follow-up|18|||
164672545|NCT00102440|594828237|FG002|Overall Study|Lost to Follow-up|21|||
164672546|NCT00102440|594828235|FG000|Overall Study|Adverse Event|16|||
164672547|NCT00102440|594828236|FG001|Overall Study|Adverse Event|23|||
164672548|NCT00102440|594828237|FG002|Overall Study|Adverse Event|8|||
164672549|NCT00102440|594828235|FG000|Overall Study|Gout Flare|10|||
164672550|NCT00102440|594828236|FG001|Overall Study|Gout Flare|28|||
164672551|NCT00102440|594828237|FG002|Overall Study|Gout Flare|9|||
164672552|NCT00102440|594828235|FG000|Overall Study|Personal Reason(s)|19|||
164672553|NCT00102440|594828236|FG001|Overall Study|Personal Reason(s)|13|||
164672554|NCT00102440|594828237|FG002|Overall Study|Personal Reason(s)|13|||
164672555|NCT00102440|594828235|FG000|Overall Study|Other|11|||
164672556|NCT00102440|594828236|FG001|Overall Study|Other|14|||
164672557|NCT00102440|594828237|FG002|Overall Study|Other|14|||
164672558|NCT00102440|594828235|FG000|Overall Study|Protocol Violation|7|||
164672559|NCT00102440|594828236|FG001|Overall Study|Protocol Violation|2|||
164672560|NCT00102440|594828237|FG002|Overall Study|Protocol Violation|1|||
164672561|NCT04627038|594828238|FG000|Overall Study|Adverse Event|36|||
164672562|NCT04627038|594828239|FG001|Overall Study|Adverse Event|8|||
164672563|NCT04627038|594828238|FG000|Overall Study|Lost to Follow-up|1|||
164672564|NCT04627038|594828239|FG001|Overall Study|Lost to Follow-up|0|||
164672565|NCT04627038|594828238|FG000|Overall Study|Physician Decision|0|||
164672566|NCT04627038|594828239|FG001|Overall Study|Physician Decision|1|||
164672567|NCT04627038|594828238|FG000|Overall Study|Protocol Violation|3|||
164672568|NCT04627038|594828239|FG001|Overall Study|Protocol Violation|1|||
164672569|NCT04627038|594828238|FG000|Overall Study|Withdrawal by Subject|13|||
164672570|NCT04627038|594828239|FG001|Overall Study|Withdrawal by Subject|3|||
164672571|NCT04627038|594828238|FG000|Overall Study|Non-compliance with study drug|0|||
164672572|NCT04627038|594828239|FG001|Overall Study|Non-compliance with study drug|1|||
164672573|NCT04627038|594828238|FG000|Overall Study|Prohibited Concomitant Medication|1|||
164672574|NCT04627038|594828239|FG001|Overall Study|Prohibited Concomitant Medication|0|||
164672575|NCT01792635|594828244|FG000|Part B|Adverse Event|0|||
164672576|NCT01792635|594828245|FG001|Part B|Adverse Event|0|||
164672577|NCT01792635|594828246|FG002|Part B|Adverse Event|1|||
164672578|NCT01792635|594828244|FG000|Part B|Study terminated|0|||
164672579|NCT01792635|594828245|FG001|Part B|Study terminated|4|||
164672580|NCT01792635|594828246|FG002|Part B|Study terminated|3|||
164672581|NCT01401647|594828251|FG000|Overall Study|Withdrawal by Subject|1|||
164672582|NCT01401647|594828252|FG001|Overall Study|Withdrawal by Subject|5|||
164672583|NCT01401647|594828253|FG002|Overall Study|Withdrawal by Subject|2|||
164672584|NCT01401647|594828251|FG000|Overall Study|Lost to Follow-up|3|||
164672585|NCT01401647|594828252|FG001|Overall Study|Lost to Follow-up|3|||
164672586|NCT01401647|594828253|FG002|Overall Study|Lost to Follow-up|1|||
164672587|NCT00473330|594828258|FG000|Core Study|Adverse Event|4|||
164672588|NCT00473330|594828259|FG001|Core Study|Adverse Event|4|||
164672589|NCT00473330|594828260|FG002|Core Study|Adverse Event|1|||
164672590|NCT00473330|594828258|FG000|Core Study|Death|6|||
164672591|NCT00473330|594828259|FG001|Core Study|Death|4|||
164672592|NCT00473330|594828260|FG002|Core Study|Death|4|||
164672593|NCT00473330|594828258|FG000|Core Study|Lost to Follow-up|5|||
164672594|NCT00473330|594828259|FG001|Core Study|Lost to Follow-up|5|||
164672595|NCT00473330|594828260|FG002|Core Study|Lost to Follow-up|10|||
164672596|NCT00473330|594828258|FG000|Core Study|Physician Decision|2|||
164672597|NCT00473330|594828259|FG001|Core Study|Physician Decision|1|||
164672598|NCT00473330|594828260|FG002|Core Study|Physician Decision|3|||
164672599|NCT00473330|594828258|FG000|Core Study|Subject Non-compliance|1|||
164672600|NCT00473330|594828259|FG001|Core Study|Subject Non-compliance|2|||
164672601|NCT00473330|594828260|FG002|Core Study|Subject Non-compliance|1|||
164672602|NCT00473330|594828258|FG000|Core Study|Subject Required Other Therapy|0|||
164672603|NCT00473330|594828259|FG001|Core Study|Subject Required Other Therapy|1|||
164672604|NCT00473330|594828260|FG002|Core Study|Subject Required Other Therapy|3|||
164672605|NCT00473330|594828258|FG000|Core Study|Subject's Decision|9|||
164672606|NCT00473330|594828259|FG001|Core Study|Subject's Decision|8|||
164672607|NCT00473330|594828260|FG002|Core Study|Subject's Decision|19|||
164672608|NCT00473330|594828258|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
164672609|NCT00473330|594828259|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
164672610|NCT00473330|594828260|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
164672611|NCT00473330|594828258|FG000|Open-label Extension Through Month 48|Death|2|||
164672612|NCT00473330|594828259|FG001|Open-label Extension Through Month 48|Death|0|||
164672613|NCT00473330|594828260|FG002|Open-label Extension Through Month 48|Death|0|||
164672614|NCT00473330|594828258|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
164672615|NCT00473330|594828259|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
164672616|NCT00473330|594828260|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
164672617|NCT00473330|594828258|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
164672618|NCT00473330|594828259|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
164672619|NCT00473330|594828260|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
164672620|NCT00473330|594828258|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
164672621|NCT00473330|594828259|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
164672622|NCT00473330|594828260|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
164569171|NCT00891202|594449274|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
164569172|NCT00891202|594449275|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
164569173|NCT00891202|594449272|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
164569174|NCT00891202|594449273|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
164569175|NCT00891202|594449274|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
164569176|NCT00891202|594449275|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
164569177|NCT00891202|594449272|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
164569178|NCT00891202|594449273|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
164569179|NCT00891202|594449274|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
164569180|NCT00891202|594449275|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
164569181|NCT04439279|594451217|FG000|Overall Study|Adverse Event|7|||
164569182|NCT04439279|594451217|FG000|Overall Study|Death|4|||
164569183|NCT04439279|594451217|FG000|Overall Study|Disease progression|17|||
164569184|NCT04439279|594451217|FG000|Overall Study|Complicating disease|3|||
164569185|NCT04439279|594451217|FG000|Overall Study|Withdrawal by Subject|2|||
164569186|NCT04439279|594451217|FG000|Overall Study|Ineligible|1|||
164569187|NCT04439279|594451217|FG000|Overall Study|Treatment still ongoing|1|||
164569188|NCT05047523|594451220|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
164569189|NCT05047523|594451221|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
164569190|NCT05047523|594451222|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
164569191|NCT05047523|594451223|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
164569192|NCT05047523|594451224|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
164569193|NCT05047523|594451225|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
164569194|NCT05047523|594451220|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
164569195|NCT05047523|594451221|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
164569196|NCT05047523|594451222|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
164569197|NCT05047523|594451223|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
164569198|NCT05047523|594451224|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
164569199|NCT05047523|594451225|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
164569200|NCT05047523|594451220|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
164569201|NCT05047523|594451221|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
164569202|NCT05047523|594451222|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
164569203|NCT05047523|594451223|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
164569204|NCT05047523|594451224|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
164569205|NCT05047523|594451225|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
164569206|NCT05047523|594451220|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
164569207|NCT05047523|594451221|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
164569208|NCT05047523|594451222|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
164569209|NCT05047523|594451223|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
164569210|NCT05047523|594451224|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
164672623|NCT00473330|594828258|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
164672624|NCT00473330|594828259|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
164672625|NCT00473330|594828260|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
164672626|NCT00473330|594828258|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
164672627|NCT00473330|594828259|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
164672628|NCT00473330|594828260|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
164672629|NCT00473330|594828258|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
164672630|NCT00473330|594828259|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
164672631|NCT00473330|594828260|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
164672632|NCT00473330|594828258|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
164672633|NCT00473330|594828259|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
164672634|NCT00473330|594828260|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
164672635|NCT00473330|594828258|FG000|Open-label Extension Through Month 60|Death|2|||
164672636|NCT00473330|594828259|FG001|Open-label Extension Through Month 60|Death|2|||
164672637|NCT00473330|594828260|FG002|Open-label Extension Through Month 60|Death|1|||
164672638|NCT00473330|594828258|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
164672639|NCT00473330|594828259|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
164672640|NCT00473330|594828260|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
164672641|NCT00473330|594828258|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
164672642|NCT00473330|594828259|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
164672643|NCT00473330|594828260|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
164672644|NCT00473330|594828258|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
164672645|NCT00473330|594828259|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
164672646|NCT00473330|594828260|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
164672647|NCT00473330|594828258|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
164672648|NCT00473330|594828259|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
164672649|NCT00473330|594828260|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
164672650|NCT00473330|594828258|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
164672651|NCT00473330|594828259|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
164672652|NCT00473330|594828260|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
164672653|NCT00473330|594828258|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
164672654|NCT00473330|594828259|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
164672655|NCT00473330|594828260|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
164672656|NCT00846495|594828264|FG000|Overall Study|Lost to Follow-up|1|||
164672657|NCT00846495|594828265|FG001|Overall Study|Lost to Follow-up|0|||
164672658|NCT00846495|594828264|FG000|Overall Study|Adverse Event|5|||
164672659|NCT00846495|594828265|FG001|Overall Study|Adverse Event|1|||
164672660|NCT00846495|594828264|FG000|Overall Study|Lack of Efficacy|1|||
164672661|NCT00846495|594828265|FG001|Overall Study|Lack of Efficacy|2|||
164672662|NCT00846495|594828264|FG000|Overall Study|Physician Decision|1|||
164672663|NCT00846495|594828265|FG001|Overall Study|Physician Decision|0|||
164672664|NCT01079988|594828266|FG000|Overall Study|Lost to Follow-up|0|||
164672665|NCT01079988|594828267|FG001|Overall Study|Lost to Follow-up|0|||
164672666|NCT01079988|594828268|FG002|Overall Study|Lost to Follow-up|0|||
164672667|NCT01079988|594828269|FG003|Overall Study|Lost to Follow-up|1|||
164672668|NCT01079988|594828270|FG004|Overall Study|Lost to Follow-up|0|||
164672669|NCT01079988|594828266|FG000|Overall Study|Lack of Efficacy|1|||
164672670|NCT01079988|594828267|FG001|Overall Study|Lack of Efficacy|0|||
164672671|NCT01079988|594828268|FG002|Overall Study|Lack of Efficacy|0|||
164672672|NCT01079988|594828269|FG003|Overall Study|Lack of Efficacy|0|||
164672673|NCT01079988|594828270|FG004|Overall Study|Lack of Efficacy|0|||
164672674|NCT01079988|594828266|FG000|Overall Study|Other|0|||
164672675|NCT01079988|594828267|FG001|Overall Study|Other|0|||
164672676|NCT01079988|594828268|FG002|Overall Study|Other|0|||
164672677|NCT01079988|594828269|FG003|Overall Study|Other|2|||
164672678|NCT01079988|594828270|FG004|Overall Study|Other|1|||
164672679|NCT01265056|594828272|FG000|Initial Study Period|Withdrawal by Subject|1|||
164672680|NCT01265056|594828273|FG001|Initial Study Period|Withdrawal by Subject|1|||
164672681|NCT01265056|594828272|FG000|Initial Study Period|Withdrawal by Subject|1|||
164672682|NCT01265056|594828273|FG001|Initial Study Period|Withdrawal by Subject|1|||
164672683|NCT01265056|594828272|FG000|Follow up|Lost to Follow-up|7|||
164672684|NCT01265056|594828273|FG001|Follow up|Lost to Follow-up|3|||
164672685|NCT02711852|594828278|FG000|Overall Study|Death|5|||
164672686|NCT02711852|594828278|FG000|Overall Study|Lost to Follow-up|1|||
164672687|NCT02711852|594828278|FG000|Overall Study|Completed follow-up|3|||
164672688|NCT02711852|594828278|FG000|Overall Study|Withdrawal by Subject|1|||
164672689|NCT03459807|594828279|FG000|Overall Study|Withdrawal due to transplant|0|||
164672690|NCT03459807|594828280|FG001|Overall Study|Withdrawal due to transplant|1|||
164672691|NCT01417078|594828284|FG000|Overall Study|Withdrawal by Subject|1|||
164672692|NCT02392000|594828289|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
164672693|NCT02392000|594828289|FG000|Overall Study|Withdrawal by Subject|1|||
164672694|NCT02392000|594828289|FG000|Overall Study|Lost to Follow-up|8|||
164672695|NCT00833937|594828290|FG000|Washout|Withdrawal by Subject|1|||
164672696|NCT00833937|594828291|FG001|Washout|Withdrawal by Subject|0|||
164672697|NCT02612337|594828296|FG000|Overall Study|Lack of Efficacy|1|||
164672698|NCT02612337|594828297|FG001|Overall Study|Lack of Efficacy|0|||
164672699|NCT02612337|594828296|FG000|Overall Study|Withdrawal by Subject|2|||
164672700|NCT02612337|594828297|FG001|Overall Study|Withdrawal by Subject|2|||
164672701|NCT02612337|594828296|FG000|Overall Study|Did not receive study drug|0|||
164672702|NCT02612337|594828297|FG001|Overall Study|Did not receive study drug|1|||
164672703|NCT00389064|594828298|FG000|Overall Study|Adverse Event|11|||
164672704|NCT00389064|594828299|FG001|Overall Study|Adverse Event|3|||
164672705|NCT00389064|594828298|FG000|Overall Study|Lack of Efficacy|3|||
164672706|NCT00389064|594828299|FG001|Overall Study|Lack of Efficacy|14|||
164672707|NCT00389064|594828298|FG000|Overall Study|Withdrawal by Subject|17|||
164672708|NCT00389064|594828299|FG001|Overall Study|Withdrawal by Subject|27|||
164672709|NCT00389064|594828298|FG000|Overall Study|Physician Decision|2|||
164672710|NCT00389064|594828299|FG001|Overall Study|Physician Decision|2|||
164672711|NCT00389064|594828298|FG000|Overall Study|Lost to Follow-up|1|||
164672712|NCT00389064|594828299|FG001|Overall Study|Lost to Follow-up|2|||
164672713|NCT00389064|594828298|FG000|Overall Study|Protocol Violation|2|||
164672714|NCT00389064|594828299|FG001|Overall Study|Protocol Violation|0|||
164672715|NCT00389064|594828298|FG000|Overall Study|Multiple Reasons|9|||
164672716|NCT00389064|594828299|FG001|Overall Study|Multiple Reasons|11|||
164672717|NCT01697696|594828300|FG000|Overall Study|Study terminated by sponsor|0|||
164672718|NCT01697696|594828301|FG001|Overall Study|Study terminated by sponsor|3|||
164672719|NCT01697696|594828300|FG000|Overall Study|Protocol deviation|1|||
164672720|NCT01697696|594828301|FG001|Overall Study|Protocol deviation|0|||
164672721|NCT01697696|594828300|FG000|Overall Study|Physician Decision|1|||
164672722|NCT01697696|594828301|FG001|Overall Study|Physician Decision|0|||
164672723|NCT01697696|594828300|FG000|Overall Study|Death|4|||
164672724|NCT01697696|594828301|FG001|Overall Study|Death|2|||
164672725|NCT01697696|594828300|FG000|Overall Study|Lost to Follow-up|10|||
164672726|NCT01697696|594828301|FG001|Overall Study|Lost to Follow-up|7|||
164672727|NCT01697696|594828300|FG000|Overall Study|Subject/guardian decision|31|||
164672728|NCT01697696|594828301|FG001|Overall Study|Subject/guardian decision|35|||
164672729|NCT03616106|594828302|FG000|Overall Study|Removed by PI|6|||
164672730|NCT03616106|594828303|FG001|Overall Study|Removed by PI|0|||
164672731|NCT03616106|594828302|FG000|Overall Study|Withdrawal by Subject|1|||
164672732|NCT03616106|594828303|FG001|Overall Study|Withdrawal by Subject|1|||
164672733|NCT03616106|594828302|FG000|Overall Study|Lost to Follow-up|7|||
164672734|NCT03616106|594828303|FG001|Overall Study|Lost to Follow-up|0|||
164672735|NCT01880593|594828304|FG000|Overall Study|Adverse Event|1|||
164672736|NCT01880593|594828305|FG001|Overall Study|Adverse Event|0|||
164672737|NCT01880593|594828304|FG000|Overall Study|Lack of Efficacy|1|||
164672738|NCT01880593|594828305|FG001|Overall Study|Lack of Efficacy|5|||
164672739|NCT01880593|594828304|FG000|Overall Study|Withdrawal by Subject|6|||
164672740|NCT01880593|594828305|FG001|Overall Study|Withdrawal by Subject|1|||
164672741|NCT05275205|594828310|FG000|Overall Study|Adverse Event|1|||
164672742|NCT05275205|594828311|FG001|Overall Study|Adverse Event|2|||
164672743|NCT05275205|594828310|FG000|Overall Study|Physician Decision|1|||
164672744|NCT05275205|594828311|FG001|Overall Study|Physician Decision|1|||
164672745|NCT05275205|594828310|FG000|Overall Study|Withdrawal by Subject|2|||
164672746|NCT05275205|594828311|FG001|Overall Study|Withdrawal by Subject|3|||
164672747|NCT05275205|594828310|FG000|Overall Study|Death|1|||
164672748|NCT05275205|594828311|FG001|Overall Study|Death|0|||
164672749|NCT05275205|594828310|FG000|Overall Study|Patient unable to attend visits|1|||
164672750|NCT05275205|594828311|FG001|Overall Study|Patient unable to attend visits|0|||
164672751|NCT01223365|594828313|FG000|Open-label Titration Period|Enrolled but not treated|1|||
164672752|NCT01223365|594828313|FG000|Open-label Titration Period|Adverse Event|23|||
164672753|NCT01223365|594828313|FG000|Open-label Titration Period|Lack of Efficacy|3|||
164672754|NCT01223365|594828313|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
164672755|NCT01223365|594828313|FG000|Open-label Titration Period|Protocol Violation|1|||
164672756|NCT01223365|594828313|FG000|Open-label Titration Period|Lost to Follow-up|2|||
164672757|NCT01223365|594828313|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
164672758|NCT01223365|594828313|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
164672759|NCT01223365|594828313|FG000|Open-label Titration Period|Starting physical therapy|1|||
164672760|NCT01223365|594828313|FG000|Open-label Treatment Period|Adverse Event|39|||
164672761|NCT01223365|594828313|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
164672762|NCT01223365|594828313|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
164672763|NCT01223365|594828313|FG000|Open-label Treatment Period|Protocol Violation|15|||
164672764|NCT01223365|594828313|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
164672765|NCT01223365|594828313|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
164672766|NCT01223365|594828313|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
164672767|NCT01223365|594828313|FG000|Open-label Treatment Period|Moved out of area|2|||
164672768|NCT01223365|594828313|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
164672769|NCT01223365|594828313|FG000|Open-label Treatment Period|"Out of window"|1|||
164672770|NCT01223365|594828313|FG000|Open-label Treatment Period|Starting physical therapy|1|||
164672771|NCT01223365|594828313|FG000|Open-label Treatment Period|Physician Decision|2|||
164672772|NCT03243630|594828315|FG000|Overall Study|Protocol Violation|1|||
164672773|NCT03243630|594828315|FG000|Overall Study|Physician Decision|1|||
164672774|NCT00939003|594828318|FG000|Double-blind Treatment Period|Adverse Event|1|||
164672775|NCT00939003|594828319|FG001|Double-blind Treatment Period|Adverse Event|1|||
164672776|NCT00939003|594828318|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
164672777|NCT00939003|594828319|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
164672778|NCT00939003|594828318|FG000|Double-blind Treatment Period|Pregnancy|0|||
164672779|NCT00939003|594828319|FG001|Double-blind Treatment Period|Pregnancy|1|||
164672780|NCT00939003|594828318|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
164672781|NCT00939003|594828319|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
164672782|NCT00939003|594828318|FG000|Open-label Treatment Period|Adverse Event|4|||
164672783|NCT00939003|594828319|FG001|Open-label Treatment Period|Adverse Event|8|||
164672784|NCT00939003|594828318|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
164672785|NCT00939003|594828319|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
164672786|NCT00939003|594828318|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
164672787|NCT00939003|594828319|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
164672788|NCT00939003|594828318|FG000|Open-label Treatment Period|Pregnancy|1|||
164672789|NCT00939003|594828319|FG001|Open-label Treatment Period|Pregnancy|1|||
164672790|NCT00939003|594828318|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
164672791|NCT00939003|594828319|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
164672792|NCT00939003|594828318|FG000|Open-label Treatment Period|Site Closure|3|||
164672793|NCT00939003|594828319|FG001|Open-label Treatment Period|Site Closure|4|||
164672794|NCT03707912|594828320|FG000|Overall Study|Violation of inclusion criteria|1|||
164672795|NCT03707912|594828321|FG001|Overall Study|Violation of inclusion criteria|0|||
164672796|NCT01313780|594828324|FG000|Overall Study|Lack of Efficacy|4|||
164672797|NCT01313780|594828325|FG001|Overall Study|Lack of Efficacy|2|||
164672798|NCT01313780|594828324|FG000|Overall Study|Adverse Event|6|||
164672799|NCT01313780|594828325|FG001|Overall Study|Adverse Event|11|||
164672800|NCT01313780|594828324|FG000|Overall Study|Withdrawal by Subject|2|||
164672801|NCT01313780|594828325|FG001|Overall Study|Withdrawal by Subject|8|||
164672802|NCT01313780|594828324|FG000|Overall Study|Protocol Violation|10|||
164672803|NCT01313780|594828325|FG001|Overall Study|Protocol Violation|4|||
164672804|NCT01313780|594828324|FG000|Overall Study|missing data|3|||
164672805|NCT01313780|594828325|FG001|Overall Study|missing data|3|||
164672806|NCT01466166|594829404|FG000|Overall Study|Death|1|||
164672807|NCT01466166|594829404|FG000|Overall Study|Lost to Follow-up|7|||
164672808|NCT01466166|594829404|FG000|Overall Study|Infusion Reaction (IR)|27|||
164672809|NCT01466166|594829404|FG000|Overall Study|Adverse Event (Other than IR)|11|||
164672810|NCT01466166|594829404|FG000|Overall Study|Elevated Serum Uric Acid|78|||
164672811|NCT01466166|594829404|FG000|Overall Study|Withdrawal by Subject|13|||
164672812|NCT01466166|594829404|FG000|Overall Study|Sponsor Decision|4|||
164672813|NCT01466166|594829404|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
164672814|NCT01466166|594829404|FG000|Overall Study|Other|20|||
164672815|NCT02262377|594829405|FG000|Overall Study|Lost to Follow-up|5|||
164672816|NCT02262377|594829406|FG001|Overall Study|Lost to Follow-up|6|||
164672817|NCT02262377|594829405|FG000|Overall Study|Found ineligible after enrollment|3|||
164672818|NCT02262377|594829406|FG001|Overall Study|Found ineligible after enrollment|0|||
164672819|NCT02262377|594829405|FG000|Overall Study|Withdrawal by Subject|4|||
164672820|NCT02262377|594829406|FG001|Overall Study|Withdrawal by Subject|0|||
164672821|NCT00371839|594829407|FG000|Overall Study|Death|4|||
164672822|NCT00371839|594829408|FG001|Overall Study|Death|0|||
164672823|NCT00371839|594829409|FG002|Overall Study|Death|0|||
164672824|NCT00371839|594829407|FG000|Overall Study|Withdrawal by Subject|7|||
164672825|NCT00371839|594829408|FG001|Overall Study|Withdrawal by Subject|4|||
164672826|NCT00371839|594829409|FG002|Overall Study|Withdrawal by Subject|0|||
164672827|NCT00371839|594829407|FG000|Overall Study|Lost to Follow-up|6|||
164672828|NCT00371839|594829408|FG001|Overall Study|Lost to Follow-up|3|||
164672829|NCT00371839|594829409|FG002|Overall Study|Lost to Follow-up|2|||
164672830|NCT01511939|594829410|FG000|Overall Study|Withdrawal by Subject|2|||
164672831|NCT01511939|594829411|FG001|Overall Study|Withdrawal by Subject|1|||
164672832|NCT01511939|594829412|FG002|Overall Study|Withdrawal by Subject|0|||
164672833|NCT01049334|594829413|FG000|Overall Study|Withdrawal by Subject|5|||
164672834|NCT01049334|594829414|FG001|Overall Study|Withdrawal by Subject|3|||
164672835|NCT01049334|594829413|FG000|Overall Study|Adverse Event|2|||
164672836|NCT01049334|594829414|FG001|Overall Study|Adverse Event|3|||
164672837|NCT01049334|594829413|FG000|Overall Study|Physician Decision|2|||
164672838|NCT01049334|594829414|FG001|Overall Study|Physician Decision|0|||
164672839|NCT01049334|594829413|FG000|Overall Study|Protocol Violation|0|||
164672840|NCT01049334|594829414|FG001|Overall Study|Protocol Violation|1|||
164672841|NCT03769896|594829416|FG000|Open-label Phase|Lack of Efficacy|5|||
164672842|NCT03769896|594829417|FG001|Open-label Phase|Lack of Efficacy|0|||
164672843|NCT03769896|594829416|FG000|Open-label Phase|Adverse Event|3|||
164672844|NCT03769896|594829417|FG001|Open-label Phase|Adverse Event|0|||
164672845|NCT03769896|594829416|FG000|Open-label Phase|Withdrawal by Subject|1|||
164672846|NCT03769896|594829417|FG001|Open-label Phase|Withdrawal by Subject|0|||
164672847|NCT01015703|594829418|FG000|Overall Study|Withdrawal by Subject|0|||
164672848|NCT01015703|594829419|FG001|Overall Study|Withdrawal by Subject|1|||
164672849|NCT01015703|594829420|FG002|Overall Study|Withdrawal by Subject|0|||
164672850|NCT01015703|594829421|FG003|Overall Study|Withdrawal by Subject|0|||
164672851|NCT01015703|594829422|FG004|Overall Study|Withdrawal by Subject|0|||
164672852|NCT01015703|594829418|FG000|Overall Study|Adverse Event|1|||
164672853|NCT01015703|594829419|FG001|Overall Study|Adverse Event|0|||
164672854|NCT01015703|594829420|FG002|Overall Study|Adverse Event|0|||
164672855|NCT01015703|594829421|FG003|Overall Study|Adverse Event|0|||
164672856|NCT01015703|594829422|FG004|Overall Study|Adverse Event|0|||
164672857|NCT01015703|594829418|FG000|Overall Study|Protocol Violation|1|||
164672858|NCT01015703|594829419|FG001|Overall Study|Protocol Violation|0|||
164672859|NCT01015703|594829420|FG002|Overall Study|Protocol Violation|0|||
164672860|NCT01015703|594829421|FG003|Overall Study|Protocol Violation|0|||
164672861|NCT01015703|594829422|FG004|Overall Study|Protocol Violation|0|||
164672862|NCT03122535|594829423|FG000|Overall Study|Lost to Follow-up|68|||
164672863|NCT03122535|594829424|FG001|Overall Study|Lost to Follow-up|68|||
164672864|NCT03122535|594829423|FG000|Overall Study|Physician Decision|3|||
164672865|NCT03122535|594829424|FG001|Overall Study|Physician Decision|3|||
164672866|NCT03122535|594829423|FG000|Overall Study|Withdrawal by Subject|2|||
164672867|NCT03122535|594829424|FG001|Overall Study|Withdrawal by Subject|2|||
164672868|NCT02646124|594829425|FG000|Overall Study|Lost to Follow-up|0|||
164672869|NCT02646124|594829426|FG001|Overall Study|Lost to Follow-up|2|||
164672870|NCT00857454|594829429|FG000|Overall Study|Withdrawal by Subject|2|||
164672871|NCT00857454|594829429|FG000|Overall Study|Lost to Follow-up|1|||
164672872|NCT00857454|594829429|FG000|Overall Study|Adverse Event|2|||
164672873|NCT00857454|594829429|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
164672874|NCT00857454|594829429|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
164672875|NCT00857454|594829429|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
164672876|NCT03154047|594829430|FG000|Overall Study|Death|1|||
164672877|NCT03154047|594829430|FG000|Overall Study|Study terminated by sponsor|76|||
164672878|NCT03154047|594829430|FG000|Overall Study|Withdrawal by Subject|3|||
164672879|NCT00573443|594829431|FG000|Double-Blind Phase|Lost to Follow-up|1|||
164672880|NCT00573443|594829432|FG001|Double-Blind Phase|Lost to Follow-up|3|||
164672881|NCT00573443|594829433|FG002|Double-Blind Phase|Lost to Follow-up|2|||
164672882|NCT00573443|594829431|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
164672883|NCT00573443|594829432|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
164672884|NCT00573443|594829433|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
164672885|NCT00573443|594829431|FG000|Double-Blind Phase|Adverse Event|1|||
164672886|NCT00573443|594829432|FG001|Double-Blind Phase|Adverse Event|5|||
164672887|NCT00573443|594829433|FG002|Double-Blind Phase|Adverse Event|0|||
164672888|NCT00573443|594829431|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
164672889|NCT00573443|594829432|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
164672890|NCT00573443|594829433|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
164672891|NCT00573443|594829431|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
164672892|NCT00573443|594829432|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
164672893|NCT00573443|594829433|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
164672894|NCT00573443|594829431|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
164672895|NCT00573443|594829432|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
164672896|NCT00573443|594829433|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
164672897|NCT00573443|594829431|FG000|Double-Blind Phase|Protocol Violation|0|||
164672898|NCT00573443|594829432|FG001|Double-Blind Phase|Protocol Violation|2|||
164672899|NCT00573443|594829433|FG002|Double-Blind Phase|Protocol Violation|1|||
164672900|NCT00573443|594829431|FG000|Double-Blind Phase|Other|0|||
164672901|NCT00573443|594829432|FG001|Double-Blind Phase|Other|2|||
164672902|NCT00573443|594829433|FG002|Double-Blind Phase|Other|3|||
164672903|NCT00573443|594829431|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
164672904|NCT00573443|594829432|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
164672905|NCT00573443|594829433|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
164672906|NCT00573443|594829431|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
164672907|NCT00573443|594829432|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
164672908|NCT00573443|594829433|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
164672909|NCT00573443|594829431|FG000|Open-Label Extension Phase|Adverse Event|3|||
164672910|NCT00573443|594829432|FG001|Open-Label Extension Phase|Adverse Event|0|||
164672911|NCT00573443|594829433|FG002|Open-Label Extension Phase|Adverse Event|0|||
164672912|NCT00573443|594829431|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
164672913|NCT00573443|594829432|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
164672914|NCT00573443|594829433|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
164672915|NCT00573443|594829431|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
164672916|NCT00573443|594829432|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
164672917|NCT00573443|594829433|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
164672918|NCT00573443|594829431|FG000|Open-Label Extension Phase|Protocol Violation|2|||
164672919|NCT00573443|594829432|FG001|Open-Label Extension Phase|Protocol Violation|0|||
164672920|NCT00573443|594829433|FG002|Open-Label Extension Phase|Protocol Violation|0|||
164672921|NCT00573443|594829431|FG000|Open-Label Extension Phase|Other|2|||
164672922|NCT00573443|594829432|FG001|Open-Label Extension Phase|Other|0|||
164672923|NCT00573443|594829433|FG002|Open-Label Extension Phase|Other|0|||
164672924|NCT04567186|594829437|FG000|Period 1|COVID-19 related|1|||
164672925|NCT04567186|594829438|FG001|Period 1|COVID-19 related|0|||
164672926|NCT04567186|594829437|FG000|Period 1|Protocol Violation|0|||
164672927|NCT04567186|594829438|FG001|Period 1|Protocol Violation|1|||
164672928|NCT04567186|594829437|FG000|Period 1|Adverse Event|0|||
164672929|NCT04567186|594829438|FG001|Period 1|Adverse Event|2|||
164672930|NCT04567186|594829437|FG000|Period 2|COVID-19 Related|0|||
164672931|NCT04567186|594829438|FG001|Period 2|COVID-19 Related|1|||
164672932|NCT04567186|594829437|FG000|Period 2|Protocol Violation|0|||
164672933|NCT04567186|594829438|FG001|Period 2|Protocol Violation|1|||
164672934|NCT04567186|594829437|FG000|Period 2|Lost to Follow-up|0|||
164672935|NCT04567186|594829438|FG001|Period 2|Lost to Follow-up|1|||
164672936|NCT04567186|594829437|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
164672937|NCT04567186|594829438|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
164672938|NCT04247282|594829439|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
164672939|NCT04247282|594829440|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
164672940|NCT04247282|594829441|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
164672941|NCT04247282|594829442|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
164672942|NCT04247282|594829439|FG000|Overall Study|Refused further treatment|0|||
164672943|NCT04247282|594829440|FG001|Overall Study|Refused further treatment|1|||
164672944|NCT04247282|594829441|FG002|Overall Study|Refused further treatment|0|||
164672945|NCT04247282|594829442|FG003|Overall Study|Refused further treatment|0|||
164672946|NCT02481830|594829444|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
164672947|NCT02481830|594829445|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
164672948|NCT02481830|594829444|FG000|Pre-treatment|Withdrawal by Subject|0|||
164672949|NCT02481830|594829445|FG001|Pre-treatment|Withdrawal by Subject|10|||
164672950|NCT02481830|594829444|FG000|Pre-treatment|Disease Progression|1|||
164672951|NCT02481830|594829445|FG001|Pre-treatment|Disease Progression|1|||
164672952|NCT02481830|594829444|FG000|Pre-treatment|Other reasons|0|||
164672953|NCT02481830|594829445|FG001|Pre-treatment|Other reasons|1|||
164672954|NCT02481830|594829444|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
164672955|NCT02481830|594829445|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
164672956|NCT02481830|594829444|FG000|Treatment|Disease Progression|233|||
164672957|NCT02481830|594829445|FG001|Treatment|Disease Progression|171|||
164672958|NCT02481830|594829444|FG000|Treatment|Study drug toxicity|18|||
164672959|NCT02481830|594829445|FG001|Treatment|Study drug toxicity|38|||
164672960|NCT02481830|594829444|FG000|Treatment|Death|1|||
164672961|NCT02481830|594829445|FG001|Treatment|Death|1|||
164672962|NCT02481830|594829444|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
164672963|NCT02481830|594829445|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
164672964|NCT02481830|594829444|FG000|Treatment|Participants request to discontinue Study treatment|6|||
164672965|NCT02481830|594829445|FG001|Treatment|Participants request to discontinue Study treatment|34|||
164672966|NCT02481830|594829444|FG000|Treatment|Withdrawal by Subject|2|||
164672967|NCT02481830|594829445|FG001|Treatment|Withdrawal by Subject|3|||
164672968|NCT02481830|594829444|FG000|Treatment|Lost to Follow-up|1|||
164672969|NCT02481830|594829445|FG001|Treatment|Lost to Follow-up|0|||
164672970|NCT02481830|594829444|FG000|Treatment|Maximum Clinical Benefit|0|||
164672971|NCT02481830|594829445|FG001|Treatment|Maximum Clinical Benefit|5|||
164672972|NCT02481830|594829444|FG000|Treatment|Administrative reason by sponsor|1|||
164672973|NCT02481830|594829445|FG001|Treatment|Administrative reason by sponsor|1|||
164672974|NCT02481830|594829444|FG000|Treatment|Other reasons|6|||
164672975|NCT02481830|594829445|FG001|Treatment|Other reasons|1|||
164672976|NCT00772941|594829446|FG000|Overall Study|CRFs not available|195|||
164672977|NCT00772941|594829446|FG000|Overall Study|Study not completed|16|||
164672978|NCT00772941|594829446|FG000|Overall Study|Missed Visits|374|||
164672979|NCT00772941|594829446|FG000|Overall Study|Poor Compliance|7|||
164672980|NCT00772941|594829446|FG000|Overall Study|GPSP Violation|90|||
164672981|NCT02714062|594829448|FG000|Overall Study|Adverse Event|0|||
164672982|NCT02714062|594829449|FG001|Overall Study|Adverse Event|0|||
164672983|NCT02714062|594829450|FG002|Overall Study|Adverse Event|2|||
164672984|NCT02714062|594829448|FG000|Overall Study|Withdrawal by Subject|1|||
164672985|NCT02714062|594829449|FG001|Overall Study|Withdrawal by Subject|0|||
164672986|NCT02714062|594829450|FG002|Overall Study|Withdrawal by Subject|1|||
164672987|NCT02714062|594829448|FG000|Overall Study|Protocol Violation|0|||
164672988|NCT02714062|594829449|FG001|Overall Study|Protocol Violation|1|||
164672989|NCT02714062|594829450|FG002|Overall Study|Protocol Violation|0|||
164672990|NCT02682784|594829451|FG000|Overall Study|Withdrawal by Subject|0|||
164672991|NCT02682784|594829452|FG001|Overall Study|Withdrawal by Subject|2|||
164672992|NCT02682784|594829453|FG002|Overall Study|Withdrawal by Subject|1|||
164672993|NCT02682784|594829454|FG003|Overall Study|Withdrawal by Subject|2|||
164672994|NCT02682784|594829451|FG000|Overall Study|Physician Decision|1|||
164672995|NCT02682784|594829452|FG001|Overall Study|Physician Decision|0|||
164672996|NCT02682784|594829453|FG002|Overall Study|Physician Decision|1|||
164672997|NCT02682784|594829454|FG003|Overall Study|Physician Decision|1|||
164672998|NCT01702987|594829455|FG000|Overall Study|Withdrawal by Subject|1|||
164672999|NCT01702987|594829456|FG001|Overall Study|Withdrawal by Subject|0|||
164673000|NCT00467363|594829457|FG000|Overall Study|Lost to Follow-up|80|||
164673001|NCT00467363|594829458|FG001|Overall Study|Lost to Follow-up|70|||
164673002|NCT03181594|594829459|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
164673003|NCT03181594|594829459|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
164673004|NCT03181594|594829459|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
164673005|NCT03181594|594829459|FG000|Initial Study Protocol (12-month FU)|Death|1|||
164673006|NCT03181594|594829459|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
164673007|NCT03181594|594829459|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
164673008|NCT02017223|594829460|FG000|Overall Study|Algorithm problems|2|||
164673009|NCT00365846|594829462|FG000|Overall Study|Lost to Follow-up|1|||
164673010|NCT00904215|594829463|FG000|Overall Study|Adverse Event|25|||
164673011|NCT00904215|594829463|FG000|Overall Study|Protocol Violation|10|||
164673012|NCT00904215|594829463|FG000|Overall Study|Lost to Follow-up|63|||
164673013|NCT00904215|594829463|FG000|Overall Study|Withdrawal by Subject|9|||
164673014|NCT00904215|594829463|FG000|Overall Study|Other|28|||
164673015|NCT00838630|594829467|FG000|First Intervention|Adverse Event|1|||
164673016|NCT00838630|594829468|FG001|First Intervention|Adverse Event|0|||
164673017|NCT00838630|594829467|FG000|Washout: 7 Days|Protocol Violation|1|||
164673018|NCT00838630|594829468|FG001|Washout: 7 Days|Protocol Violation|0|||
164673019|NCT02057458|594829473|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
164673020|NCT02057458|594829474|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
164673021|NCT02057458|594829475|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
164673022|NCT02057458|594829473|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
164673023|NCT02057458|594829474|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
164673024|NCT02057458|594829475|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
164673025|NCT02057458|594829473|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
164673026|NCT02057458|594829474|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
164673027|NCT02057458|594829475|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
164673028|NCT00723710|594829480|FG000|Overall Study|Disease progression|48|||
164673029|NCT00723710|594829480|FG000|Overall Study|Adverse Event|88|||
164673030|NCT00723710|594829480|FG000|Overall Study|Withdrawal by Subject|36|||
164673031|NCT00723710|594829480|FG000|Overall Study|Physician Decision|2|||
164673032|NCT00336479|594829481|FG000|Overall Study|Adverse Event|8|||
164673033|NCT00336479|594829482|FG001|Overall Study|Adverse Event|11|||
164673034|NCT00336479|594829483|FG002|Overall Study|Adverse Event|18|||
164673035|NCT00336479|594829484|FG003|Overall Study|Adverse Event|4|||
164673036|NCT00336479|594829481|FG000|Overall Study|Noncompliant|1|||
164673037|NCT00336479|594829482|FG001|Overall Study|Noncompliant|7|||
164673038|NCT00336479|594829483|FG002|Overall Study|Noncompliant|3|||
164673039|NCT00336479|594829484|FG003|Overall Study|Noncompliant|0|||
164673040|NCT00336479|594829481|FG000|Overall Study|Physician Decision|2|||
164673041|NCT00336479|594829482|FG001|Overall Study|Physician Decision|3|||
164673042|NCT00336479|594829483|FG002|Overall Study|Physician Decision|1|||
164673043|NCT00336479|594829484|FG003|Overall Study|Physician Decision|0|||
164673044|NCT00336479|594829481|FG000|Overall Study|Lost to Follow-up|3|||
164673045|NCT00336479|594829482|FG001|Overall Study|Lost to Follow-up|2|||
164673046|NCT00336479|594829483|FG002|Overall Study|Lost to Follow-up|0|||
164673047|NCT00336479|594829484|FG003|Overall Study|Lost to Follow-up|0|||
164673048|NCT00336479|594829481|FG000|Overall Study|Withdrawal by Subject|3|||
164673049|NCT00336479|594829482|FG001|Overall Study|Withdrawal by Subject|2|||
164673050|NCT00336479|594829483|FG002|Overall Study|Withdrawal by Subject|3|||
164673051|NCT00336479|594829484|FG003|Overall Study|Withdrawal by Subject|0|||
164673052|NCT00336479|594829481|FG000|Overall Study|Other|0|||
164673053|NCT00336479|594829482|FG001|Overall Study|Other|0|||
164673054|NCT00336479|594829483|FG002|Overall Study|Other|1|||
164673055|NCT00336479|594829484|FG003|Overall Study|Other|0|||
164673056|NCT00336479|594829481|FG000|Overall Study|Virologic Stopping Rule|20|||
164673057|NCT00336479|594829482|FG001|Overall Study|Virologic Stopping Rule|0|||
164673058|NCT00336479|594829483|FG002|Overall Study|Virologic Stopping Rule|0|||
164673059|NCT00336479|594829484|FG003|Overall Study|Virologic Stopping Rule|0|||
164673060|NCT01864174|594829485|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
164673061|NCT01864174|594829486|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
164673062|NCT01864174|594829485|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
164673063|NCT01864174|594829486|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
164673064|NCT01864174|594829485|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
164673065|NCT01864174|594829486|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
164673066|NCT01864174|594829485|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
164673067|NCT01864174|594829486|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
164673068|NCT01864174|594829485|FG000|Double Blind - Compliant Randomized|Death|1|||
164673069|NCT01864174|594829486|FG001|Double Blind - Compliant Randomized|Death|0|||
164673070|NCT01864174|594829485|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
164673071|NCT01864174|594829486|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
164673072|NCT01864174|594829485|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
164673073|NCT01864174|594829486|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
164673074|NCT01864174|594829485|FG000|Double Blind - Compliant Randomized|Other|6|||
164673075|NCT01864174|594829486|FG001|Double Blind - Compliant Randomized|Other|10|||
164673076|NCT01864174|594829485|FG000|Off Treatment Follow-Up|Other|2|||
164673077|NCT01864174|594829486|FG001|Off Treatment Follow-Up|Other|0|||
164673078|NCT01864174|594829485|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
164673079|NCT01864174|594829486|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
164673080|NCT00468286|594829489|FG000|Overall Study|Adverse Event|1|||
164673081|NCT00468286|594829490|FG001|Overall Study|Adverse Event|6|||
164673082|NCT00468286|594829489|FG000|Overall Study|Protocol Violation|2|||
164673083|NCT00468286|594829490|FG001|Overall Study|Protocol Violation|2|||
164673084|NCT00468286|594829489|FG000|Overall Study|Withdrawal by Subject|4|||
164673085|NCT00468286|594829490|FG001|Overall Study|Withdrawal by Subject|3|||
164673086|NCT00468286|594829489|FG000|Overall Study|Physician Decision|0|||
164673087|NCT00468286|594829490|FG001|Overall Study|Physician Decision|1|||
164673088|NCT02196675|594829491|FG000|Overall Study|Withdrawal by Subject|1|||
164673089|NCT02196675|594829492|FG001|Overall Study|Withdrawal by Subject|0|||
164673090|NCT02196675|594829493|FG002|Overall Study|Withdrawal by Subject|0|||
164673091|NCT02196675|594829491|FG000|Overall Study|Intra-operative surgical exclusion|1|||
164673092|NCT02196675|594829492|FG001|Overall Study|Intra-operative surgical exclusion|1|||
164673093|NCT02196675|594829493|FG002|Overall Study|Intra-operative surgical exclusion|0|||
164673094|NCT02196675|594829491|FG000|Overall Study|Protocol Violation|0|||
164673095|NCT02196675|594829492|FG001|Overall Study|Protocol Violation|1|||
164673096|NCT02196675|594829493|FG002|Overall Study|Protocol Violation|0|||
164673097|NCT02196675|594829491|FG000|Overall Study|Death|0|||
164673098|NCT02196675|594829492|FG001|Overall Study|Death|0|||
164673099|NCT02196675|594829493|FG002|Overall Study|Death|1|||
164673100|NCT02158663|594829494|FG000|Overall Study|Withdrawal by Subject|5|||
164673101|NCT02158663|594829495|FG001|Overall Study|Withdrawal by Subject|4|||
164673102|NCT00576056|594829496|FG000|Overall Study|Adverse Event|1|||
164673103|NCT00576056|594829496|FG000|Overall Study|Death|1|||
164569211|NCT05047523|594451225|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
164569212|NCT05047523|594451220|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
164569213|NCT05047523|594451221|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
164569214|NCT05047523|594451222|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
164569215|NCT05047523|594451223|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
164569216|NCT05047523|594451224|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
164569217|NCT05047523|594451225|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
164569218|NCT05047523|594451220|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
164569219|NCT05047523|594451221|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
164569220|NCT05047523|594451222|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
164569221|NCT05047523|594451223|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
164673104|NCT00576056|594829496|FG000|Overall Study|Lack of Efficacy|1|||
164673105|NCT00576056|594829496|FG000|Overall Study|Withdrawal by Subject|2|||
164673106|NCT00576056|594829496|FG000|Overall Study|did not meet eligibility criteria|8|||
164673107|NCT00576056|594829496|FG000|Overall Study|Physician Decision|1|||
164673108|NCT03273153|594829497|FG000|Overall Study|Adverse Event|1|||
164569222|NCT05047523|594451224|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
164569223|NCT05047523|594451225|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
164569224|NCT00224016|594451226|FG000|Titration Period|Withdrawal by Subject|0|||
164569225|NCT00224016|594451227|FG001|Titration Period|Withdrawal by Subject|1|||
164569226|NCT00224016|594451226|FG000|Titration Period|Lost to Follow-up|1|||
164569227|NCT00224016|594451227|FG001|Titration Period|Lost to Follow-up|0|||
164673109|NCT03273153|594829498|FG001|Overall Study|Adverse Event|2|||
164673110|NCT03273153|594829497|FG000|Overall Study|Missing|0|||
164673111|NCT03273153|594829498|FG001|Overall Study|Missing|2|||
164673112|NCT03273153|594829497|FG000|Overall Study|Other|3|||
164673113|NCT03273153|594829498|FG001|Overall Study|Other|2|||
164673114|NCT03273153|594829497|FG000|Overall Study|Symptomatic Deterioration|0|||
164673115|NCT03273153|594829498|FG001|Overall Study|Symptomatic Deterioration|1|||
164673116|NCT03273153|594829497|FG000|Overall Study|Progressive Disease|6|||
164673117|NCT03273153|594829498|FG001|Overall Study|Progressive Disease|5|||
164673118|NCT03273153|594829497|FG000|Overall Study|Physician Decision|1|||
164673119|NCT03273153|594829498|FG001|Overall Study|Physician Decision|3|||
164673120|NCT03273153|594829497|FG000|Overall Study|Study Terminated by Sponsor|112|||
164673121|NCT03273153|594829498|FG001|Overall Study|Study Terminated by Sponsor|102|||
164673122|NCT03273153|594829497|FG000|Overall Study|Withdrawal by Subject|26|||
164673123|NCT03273153|594829498|FG001|Overall Study|Withdrawal by Subject|25|||
164673124|NCT03273153|594829497|FG000|Overall Study|Protocol Deviation|3|||
164673125|NCT03273153|594829498|FG001|Overall Study|Protocol Deviation|0|||
164673126|NCT03273153|594829497|FG000|Overall Study|Lost to Follow-up|6|||
164673127|NCT03273153|594829498|FG001|Overall Study|Lost to Follow-up|11|||
164673128|NCT03273153|594829497|FG000|Overall Study|Death|66|||
164673129|NCT03273153|594829498|FG001|Overall Study|Death|69|||
164673130|NCT02409355|594829499|FG000|Overall Study|Withdrawal by Subject|1|||
164673131|NCT02409355|594829500|FG001|Overall Study|Withdrawal by Subject|0|||
164673132|NCT02409355|594829499|FG000|Overall Study|Death|1|||
164673133|NCT02409355|594829500|FG001|Overall Study|Death|1|||
164673134|NCT02409355|594829499|FG000|Overall Study|Study terminated by Sponsor|2|||
164673135|NCT02409355|594829500|FG001|Overall Study|Study terminated by Sponsor|3|||
164673136|NCT01237054|594829501|FG000|Overall Study|imaging 10C0096|1|||
164673137|NCT00838539|594829502|FG000|Overall Study|Disease Progression|2|||
164673138|NCT00838539|594829503|FG001|Overall Study|Disease Progression|4|||
164673139|NCT00838539|594829504|FG002|Overall Study|Disease Progression|3|||
164673140|NCT00838539|594829505|FG003|Overall Study|Disease Progression|2|||
164673141|NCT00838539|594829506|FG004|Overall Study|Disease Progression|4|||
164673142|NCT00838539|594829507|FG005|Overall Study|Disease Progression|2|||
164673143|NCT00838539|594829508|FG006|Overall Study|Disease Progression|3|||
164673144|NCT00838539|594829509|FG007|Overall Study|Disease Progression|4|||
164673145|NCT00838539|594829510|FG008|Overall Study|Disease Progression|4|||
164673146|NCT00838539|594829511|FG009|Overall Study|Disease Progression|5|||
164673147|NCT00838539|594829512|FG010|Overall Study|Disease Progression|1|||
164673148|NCT00838539|594829513|FG011|Overall Study|Disease Progression|4|||
164673149|NCT00838539|594829502|FG000|Overall Study|Adverse Event|1|||
164673150|NCT00838539|594829503|FG001|Overall Study|Adverse Event|1|||
164673151|NCT00838539|594829504|FG002|Overall Study|Adverse Event|1|||
164673152|NCT00838539|594829505|FG003|Overall Study|Adverse Event|1|||
164673153|NCT00838539|594829506|FG004|Overall Study|Adverse Event|2|||
164673154|NCT00838539|594829507|FG005|Overall Study|Adverse Event|1|||
164673155|NCT00838539|594829508|FG006|Overall Study|Adverse Event|0|||
164673156|NCT00838539|594829509|FG007|Overall Study|Adverse Event|2|||
164673157|NCT00838539|594829510|FG008|Overall Study|Adverse Event|0|||
164673158|NCT00838539|594829511|FG009|Overall Study|Adverse Event|1|||
164673159|NCT00838539|594829512|FG010|Overall Study|Adverse Event|2|||
164673160|NCT00838539|594829513|FG011|Overall Study|Adverse Event|0|||
164673161|NCT00838539|594829502|FG000|Overall Study|Withdrawal by Subject|0|||
164673162|NCT00838539|594829503|FG001|Overall Study|Withdrawal by Subject|1|||
164673163|NCT00838539|594829504|FG002|Overall Study|Withdrawal by Subject|0|||
164673164|NCT00838539|594829505|FG003|Overall Study|Withdrawal by Subject|0|||
164673165|NCT00838539|594829506|FG004|Overall Study|Withdrawal by Subject|0|||
164673166|NCT00838539|594829507|FG005|Overall Study|Withdrawal by Subject|0|||
164673167|NCT00838539|594829508|FG006|Overall Study|Withdrawal by Subject|0|||
164673168|NCT00838539|594829509|FG007|Overall Study|Withdrawal by Subject|0|||
164673169|NCT00838539|594829510|FG008|Overall Study|Withdrawal by Subject|0|||
164673170|NCT00838539|594829511|FG009|Overall Study|Withdrawal by Subject|1|||
164673171|NCT00838539|594829512|FG010|Overall Study|Withdrawal by Subject|2|||
164673172|NCT00838539|594829513|FG011|Overall Study|Withdrawal by Subject|0|||
164673173|NCT00838539|594829502|FG000|Overall Study|Death|0|||
164673174|NCT00838539|594829503|FG001|Overall Study|Death|0|||
164673175|NCT00838539|594829504|FG002|Overall Study|Death|0|||
164673176|NCT00838539|594829505|FG003|Overall Study|Death|0|||
164673177|NCT00838539|594829506|FG004|Overall Study|Death|0|||
164673178|NCT00838539|594829507|FG005|Overall Study|Death|0|||
164673179|NCT00838539|594829508|FG006|Overall Study|Death|1|||
164673180|NCT00838539|594829509|FG007|Overall Study|Death|0|||
164673181|NCT00838539|594829510|FG008|Overall Study|Death|0|||
164673182|NCT00838539|594829511|FG009|Overall Study|Death|0|||
164673183|NCT00838539|594829512|FG010|Overall Study|Death|0|||
164673184|NCT00838539|594829513|FG011|Overall Study|Death|0|||
164673185|NCT00838539|594829502|FG000|Overall Study|Physician Decision|0|||
164673186|NCT00838539|594829503|FG001|Overall Study|Physician Decision|0|||
164673187|NCT00838539|594829504|FG002|Overall Study|Physician Decision|0|||
164673188|NCT00838539|594829505|FG003|Overall Study|Physician Decision|0|||
164673189|NCT00838539|594829506|FG004|Overall Study|Physician Decision|0|||
164673190|NCT00838539|594829507|FG005|Overall Study|Physician Decision|0|||
164673191|NCT00838539|594829508|FG006|Overall Study|Physician Decision|0|||
164673192|NCT00838539|594829509|FG007|Overall Study|Physician Decision|0|||
164673193|NCT00838539|594829510|FG008|Overall Study|Physician Decision|1|||
164673194|NCT00838539|594829511|FG009|Overall Study|Physician Decision|0|||
164673195|NCT00838539|594829512|FG010|Overall Study|Physician Decision|0|||
164673196|NCT00838539|594829513|FG011|Overall Study|Physician Decision|0|||
164673197|NCT00838539|594829502|FG000|Overall Study|Clinical Progression|0|||
164673198|NCT00838539|594829503|FG001|Overall Study|Clinical Progression|0|||
164673199|NCT00838539|594829504|FG002|Overall Study|Clinical Progression|0|||
164673200|NCT00838539|594829505|FG003|Overall Study|Clinical Progression|0|||
164673201|NCT00838539|594829506|FG004|Overall Study|Clinical Progression|0|||
164673202|NCT00838539|594829507|FG005|Overall Study|Clinical Progression|0|||
164673203|NCT00838539|594829508|FG006|Overall Study|Clinical Progression|1|||
164673204|NCT00838539|594829509|FG007|Overall Study|Clinical Progression|0|||
164673205|NCT00838539|594829510|FG008|Overall Study|Clinical Progression|0|||
164673206|NCT00838539|594829511|FG009|Overall Study|Clinical Progression|0|||
164673207|NCT00838539|594829512|FG010|Overall Study|Clinical Progression|0|||
164673208|NCT00838539|594829513|FG011|Overall Study|Clinical Progression|0|||
164673209|NCT00838539|594829502|FG000|Overall Study|Symptomatic Deterioration|0|||
164673210|NCT00838539|594829503|FG001|Overall Study|Symptomatic Deterioration|0|||
164673211|NCT00838539|594829504|FG002|Overall Study|Symptomatic Deterioration|1|||
164673212|NCT00838539|594829505|FG003|Overall Study|Symptomatic Deterioration|1|||
164673213|NCT00838539|594829506|FG004|Overall Study|Symptomatic Deterioration|0|||
164673214|NCT00838539|594829507|FG005|Overall Study|Symptomatic Deterioration|1|||
164673215|NCT00838539|594829508|FG006|Overall Study|Symptomatic Deterioration|0|||
164673216|NCT00838539|594829509|FG007|Overall Study|Symptomatic Deterioration|0|||
164673217|NCT00838539|594829510|FG008|Overall Study|Symptomatic Deterioration|0|||
164673218|NCT00838539|594829511|FG009|Overall Study|Symptomatic Deterioration|1|||
164673219|NCT00838539|594829512|FG010|Overall Study|Symptomatic Deterioration|0|||
164673220|NCT00838539|594829513|FG011|Overall Study|Symptomatic Deterioration|0|||
164673221|NCT01908205|594829514|FG000|Overall Study|Lost to Follow-up|2|||
164673222|NCT01908205|594829515|FG001|Overall Study|Lost to Follow-up|0|||
164673223|NCT01908205|594829514|FG000|Overall Study|Withdrawal by Subject|3|||
164673224|NCT01908205|594829515|FG001|Overall Study|Withdrawal by Subject|1|||
164673225|NCT05323396|594829516|FG000|Overall Study|Lost to Follow-up|1|||
164673226|NCT05323396|594829517|FG001|Overall Study|Lost to Follow-up|35|||
164673227|NCT05323396|594829516|FG000|Overall Study|Pregnancy|1|||
164673228|NCT05323396|594829517|FG001|Overall Study|Pregnancy|0|||
164673229|NCT03238781|594829518|FG000|Overall Study|Adverse Event|1|||
164673230|NCT03238781|594829519|FG001|Overall Study|Adverse Event|1|||
164673231|NCT03238781|594829520|FG002|Overall Study|Adverse Event|2|||
164673232|NCT03238781|594829518|FG000|Overall Study|Lost to Follow-up|2|||
164673233|NCT03238781|594829519|FG001|Overall Study|Lost to Follow-up|1|||
164673234|NCT03238781|594829520|FG002|Overall Study|Lost to Follow-up|2|||
164673235|NCT03238781|594829518|FG000|Overall Study|Withdrawal by Subject|23|||
164673236|NCT03238781|594829519|FG001|Overall Study|Withdrawal by Subject|14|||
164673237|NCT03238781|594829520|FG002|Overall Study|Withdrawal by Subject|16|||
164673238|NCT03238781|594829518|FG000|Overall Study|Decision by sponsor|0|||
164673239|NCT03238781|594829519|FG001|Overall Study|Decision by sponsor|1|||
164673240|NCT03238781|594829520|FG002|Overall Study|Decision by sponsor|0|||
164673241|NCT02186821|594829524|FG000|Overall Study|Adverse Event|9|||
164673242|NCT02186821|594829524|FG000|Overall Study|Death|2|||
164673243|NCT02186821|594829524|FG000|Overall Study|Disease progression|32|||
164673244|NCT02186821|594829524|FG000|Overall Study|Protocol Violation|1|||
164673245|NCT02186821|594829524|FG000|Overall Study|Physician Decision|1|||
164673246|NCT02186821|594829524|FG000|Overall Study|Study terminated by sponsor|2|||
164673247|NCT04115293|594830900|FG000|Overall Study|Adverse Event|0|||
164673248|NCT04115293|594830901|FG001|Overall Study|Adverse Event|2|||
164673249|NCT04115293|594830900|FG000|Overall Study|Withdrawal by Subject|2|||
164673250|NCT04115293|594830901|FG001|Overall Study|Withdrawal by Subject|1|||
164673251|NCT04115293|594830900|FG000|Overall Study|Physician Decision|1|||
164673252|NCT04115293|594830901|FG001|Overall Study|Physician Decision|0|||
164673253|NCT04115293|594830900|FG000|Overall Study|Death|1|||
164673254|NCT04115293|594830901|FG001|Overall Study|Death|1|||
164673255|NCT02674152|594830902|FG000|Overall Study|Personal Reasons|1|||
164673256|NCT02674152|594830903|FG001|Overall Study|Personal Reasons|0|||
164673257|NCT02674152|594830904|FG002|Overall Study|Personal Reasons|0|||
164673258|NCT02674152|594830905|FG003|Overall Study|Personal Reasons|1|||
164673259|NCT02674152|594830906|FG004|Overall Study|Personal Reasons|1|||
164673260|NCT02674152|594830902|FG000|Overall Study|Other adverse event or clinical progression|0|||
164673261|NCT02674152|594830903|FG001|Overall Study|Other adverse event or clinical progression|1|||
164673262|NCT02674152|594830904|FG002|Overall Study|Other adverse event or clinical progression|0|||
164673263|NCT02674152|594830905|FG003|Overall Study|Other adverse event or clinical progression|3|||
164673264|NCT02674152|594830906|FG004|Overall Study|Other adverse event or clinical progression|0|||
164673265|NCT02674152|594830902|FG000|Overall Study|Dose-limiting toxicity|0|||
164673266|NCT02674152|594830903|FG001|Overall Study|Dose-limiting toxicity|0|||
164673267|NCT02674152|594830904|FG002|Overall Study|Dose-limiting toxicity|0|||
164673268|NCT02674152|594830905|FG003|Overall Study|Dose-limiting toxicity|0|||
164673269|NCT02674152|594830906|FG004|Overall Study|Dose-limiting toxicity|1|||
164673270|NCT02674152|594830902|FG000|Overall Study|Progressive Disease|2|||
164673271|NCT02674152|594830903|FG001|Overall Study|Progressive Disease|1|||
164673272|NCT02674152|594830904|FG002|Overall Study|Progressive Disease|1|||
164673273|NCT02674152|594830905|FG003|Overall Study|Progressive Disease|13|||
164673274|NCT02674152|594830906|FG004|Overall Study|Progressive Disease|2|||
164673275|NCT02674152|594830902|FG000|Overall Study|Adverse Event|0|||
164673276|NCT02674152|594830903|FG001|Overall Study|Adverse Event|0|||
164673277|NCT02674152|594830904|FG002|Overall Study|Adverse Event|1|||
164673278|NCT02674152|594830905|FG003|Overall Study|Adverse Event|0|||
164673279|NCT02674152|594830906|FG004|Overall Study|Adverse Event|1|||
164673280|NCT03772522|594830907|FG000|Pre-intervention|Withdrawal by Subject|3|||
164673281|NCT03772522|594830908|FG001|Pre-intervention|Withdrawal by Subject|4|||
164673282|NCT03772522|594830907|FG000|Intervention|Withdrawal by Subject|1|||
164673283|NCT03772522|594830908|FG001|Intervention|Withdrawal by Subject|0|||
164673284|NCT03772522|594830907|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
164673285|NCT03772522|594830908|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
164673286|NCT00070291|594830912|FG000|Step 1|Withdrawal by Subject|1|||
164673287|NCT00070291|594830912|FG000|Step 1|Adverse Event|1|||
164673288|NCT00070291|594830912|FG000|Step 2|Adverse Event|1|||
164673289|NCT03255733|594830913|FG000|Overall Study|Lost to Follow-up|4|||
164673290|NCT02533258|594830915|FG000|Overall Study|Adverse Event|1|||
164673291|NCT02533258|594830915|FG000|Overall Study|Death|2|||
164673292|NCT02533258|594830915|FG000|Overall Study|Other|1|||
164673293|NCT02533258|594830915|FG000|Overall Study|Economic factor|1|||
164673294|NCT02533258|594830915|FG000|Overall Study|Progression of pleural effusion|1|||
164673295|NCT02533258|594830915|FG000|Overall Study|Lack of Efficacy|2|||
164673296|NCT02096211|594830916|FG000|Overall Study|Death|2|||
164673297|NCT02096211|594830916|FG000|Overall Study|Withdrawal by Subject|8|||
164673298|NCT02096211|594830916|FG000|Overall Study|Revision of implant|7|||
164673299|NCT02096211|594830916|FG000|Overall Study|Lost to Follow-up|43|||
164673300|NCT01591785|594830920|FG000|Overall Study|worsening condition|1|||
164673301|NCT01591785|594830921|FG001|Overall Study|worsening condition|2|||
164673302|NCT01591785|594830920|FG000|Overall Study|Protocol Violation|2|||
164673303|NCT01591785|594830921|FG001|Overall Study|Protocol Violation|0|||
164673304|NCT01591785|594830920|FG000|Overall Study|Lost to Follow-up|1|||
164673305|NCT01591785|594830921|FG001|Overall Study|Lost to Follow-up|0|||
164673306|NCT02883452|594830922|FG000|Overall Study|Withdrawal by Subject|1|||
164673307|NCT02883452|594830923|FG001|Overall Study|Withdrawal by Subject|1|||
164673308|NCT02883452|594830924|FG002|Overall Study|Withdrawal by Subject|3|||
164673309|NCT02883452|594830925|FG003|Overall Study|Withdrawal by Subject|0|||
164673310|NCT02883452|594830926|FG004|Overall Study|Withdrawal by Subject|2|||
164673311|NCT02883452|594830927|FG005|Overall Study|Withdrawal by Subject|5|||
164673312|NCT02883452|594830922|FG000|Overall Study|Disease progression|1|||
164673313|NCT02883452|594830923|FG001|Overall Study|Disease progression|0|||
164673314|NCT02883452|594830924|FG002|Overall Study|Disease progression|0|||
164673315|NCT02883452|594830925|FG003|Overall Study|Disease progression|1|||
164673316|NCT02883452|594830926|FG004|Overall Study|Disease progression|4|||
164673317|NCT02883452|594830927|FG005|Overall Study|Disease progression|5|||
164673318|NCT02883452|594830922|FG000|Overall Study|Adverse Event|2|||
164673319|NCT02883452|594830923|FG001|Overall Study|Adverse Event|1|||
164673320|NCT02883452|594830924|FG002|Overall Study|Adverse Event|1|||
164673321|NCT02883452|594830925|FG003|Overall Study|Adverse Event|1|||
164673322|NCT02883452|594830926|FG004|Overall Study|Adverse Event|1|||
164673323|NCT02883452|594830927|FG005|Overall Study|Adverse Event|3|||
164673324|NCT02883452|594830922|FG000|Overall Study|Physician Decision|0|||
164673325|NCT02883452|594830923|FG001|Overall Study|Physician Decision|0|||
164673326|NCT02883452|594830924|FG002|Overall Study|Physician Decision|0|||
164673327|NCT02883452|594830925|FG003|Overall Study|Physician Decision|0|||
164673328|NCT02883452|594830926|FG004|Overall Study|Physician Decision|4|||
164673329|NCT02883452|594830927|FG005|Overall Study|Physician Decision|1|||
164673330|NCT02883452|594830922|FG000|Overall Study|Death|1|||
164673331|NCT02883452|594830923|FG001|Overall Study|Death|0|||
164673332|NCT02883452|594830924|FG002|Overall Study|Death|1|||
164673333|NCT02883452|594830925|FG003|Overall Study|Death|0|||
164673334|NCT02883452|594830926|FG004|Overall Study|Death|0|||
164673335|NCT02883452|594830927|FG005|Overall Study|Death|0|||
164673336|NCT02883452|594830922|FG000|Overall Study|Other|0|||
164673337|NCT02883452|594830923|FG001|Overall Study|Other|0|||
164673338|NCT02883452|594830924|FG002|Overall Study|Other|0|||
164673339|NCT02883452|594830925|FG003|Overall Study|Other|0|||
164673340|NCT02883452|594830926|FG004|Overall Study|Other|0|||
164673341|NCT02883452|594830927|FG005|Overall Study|Other|1|||
164673342|NCT02476994|594830935|FG000|Overall Study|Based on feedback from FDA|1|||
164673343|NCT02476994|594830936|FG001|Overall Study|Based on feedback from FDA|0|||
164673344|NCT02246166|594830937|FG000|Overall Study|Protocol Violation|1|||
164673345|NCT02246166|594830938|FG001|Overall Study|Protocol Violation|0|||
164673346|NCT02563561|594830939|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
164673347|NCT02563561|594830940|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
164673348|NCT02563561|594830941|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
164673349|NCT02563561|594830939|FG000|Overall Study|Withdrew of Consent|1|||
164673350|NCT02563561|594830940|FG001|Overall Study|Withdrew of Consent|1|||
164673351|NCT02563561|594830941|FG002|Overall Study|Withdrew of Consent|2|||
164673352|NCT02563561|594830939|FG000|Overall Study|Lost to Follow-up|1|||
164673353|NCT02563561|594830940|FG001|Overall Study|Lost to Follow-up|1|||
164673354|NCT02563561|594830941|FG002|Overall Study|Lost to Follow-up|0|||
164673355|NCT02563561|594830939|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
164673356|NCT02563561|594830940|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
164673357|NCT02563561|594830941|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
164673358|NCT02563561|594830939|FG000|Overall Study|Investigator Decision|3|||
164673359|NCT02563561|594830940|FG001|Overall Study|Investigator Decision|4|||
164673360|NCT02563561|594830941|FG002|Overall Study|Investigator Decision|2|||
164673361|NCT02563561|594830939|FG000|Overall Study|Sponsor Decision|5|||
164673362|NCT02563561|594830940|FG001|Overall Study|Sponsor Decision|2|||
164673363|NCT02563561|594830941|FG002|Overall Study|Sponsor Decision|4|||
164673364|NCT02563561|594830939|FG000|Overall Study|Other|1|||
164673365|NCT02563561|594830940|FG001|Overall Study|Other|5|||
164569228|NCT00224016|594451226|FG000|Maintenance Period|Withdrawal by Subject|2|||
164569229|NCT00224016|594451227|FG001|Maintenance Period|Withdrawal by Subject|0|||
164569230|NCT00224016|594451226|FG000|Maintenance Period|Lost to Follow-up|0|||
164569231|NCT00224016|594451227|FG001|Maintenance Period|Lost to Follow-up|1|||
164569232|NCT01252966|594451228|FG000|Overall Study|Lost to Follow-up|16|||
164569233|NCT01252966|594451229|FG001|Overall Study|Lost to Follow-up|10|||
164569234|NCT01252966|594451228|FG000|Overall Study|Withdrawal by Subject|7|||
164569235|NCT01252966|594451229|FG001|Overall Study|Withdrawal by Subject|3|||
164569236|NCT05019131|594451232|FG000|Overall Study|Lost to Follow-up|0|||
164569237|NCT05019131|594451233|FG001|Overall Study|Lost to Follow-up|3|||
164569238|NCT04684420|594451234|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164569239|NCT04684420|594451235|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164569240|NCT04684420|594451236|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
164569241|NCT04684420|594451237|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
164569242|NCT04684420|594451234|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
164569243|NCT04684420|594451235|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
164569244|NCT04684420|594451236|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
164569245|NCT04684420|594451237|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
164569246|NCT02360098|594451238|FG000|Overall Study|Physician Decision|7|||
164569247|NCT02771522|594451244|FG000|Overall Study|Lost to Follow-up|3|||
164569248|NCT02771522|594451244|FG000|Overall Study|Withdrawal by Subject|2|||
164673366|NCT02563561|594830941|FG002|Overall Study|Other|2|||
164673367|NCT00905840|594830945|FG000|Overall Study|Lost to Follow-up|11|||
164673368|NCT00905840|594830945|FG000|Overall Study|Death|3|||
164673369|NCT00905840|594830945|FG000|Overall Study|Withdrawal by Subject|1|||
164569249|NCT02771522|594451244|FG000|Overall Study|No white spot lesions|3|||
164569250|NCT02054702|594451250|FG000|Overall Study|Lost to Follow-up|3|||
164569251|NCT02054702|594451251|FG001|Overall Study|Lost to Follow-up|5|||
164569252|NCT02054702|594451250|FG000|Overall Study|Adverse Event|3|||
164569253|NCT02054702|594451251|FG001|Overall Study|Adverse Event|1|||
164569254|NCT02054702|594451250|FG000|Overall Study|Met Withdrawal Criteria|4|||
164569255|NCT02054702|594451251|FG001|Overall Study|Met Withdrawal Criteria|1|||
164569256|NCT02054702|594451250|FG000|Overall Study|Physician Decision|0|||
164569257|NCT02054702|594451251|FG001|Overall Study|Physician Decision|1|||
164569258|NCT02054702|594451250|FG000|Overall Study|Withdrawal by Subject|14|||
164673370|NCT00905840|594830945|FG000|Overall Study|Adverse Event|1|||
164329141|NCT03172910|593583233|FG001|Overall Study|Adverse Event|0|||
164329142|NCT03172910|593583234|FG002|Overall Study|Adverse Event|0|||
164569259|NCT02054702|594451251|FG001|Overall Study|Withdrawal by Subject|4|||
164569260|NCT03486392|594451252|FG000|Overall Study|Lost to Follow-up|0|||
164569261|NCT03486392|594451253|FG001|Overall Study|Lost to Follow-up|0|||
164569262|NCT03486392|594451254|FG002|Overall Study|Lost to Follow-up|8|||
164569263|NCT03486392|594451255|FG003|Overall Study|Lost to Follow-up|5|||
164569264|NCT03486392|594451256|FG004|Overall Study|Lost to Follow-up|2|||
164569265|NCT03486392|594451252|FG000|Overall Study|Withdrawal by Subject|3|||
164569266|NCT03486392|594451253|FG001|Overall Study|Withdrawal by Subject|0|||
164569267|NCT03486392|594451254|FG002|Overall Study|Withdrawal by Subject|6|||
164569268|NCT03486392|594451255|FG003|Overall Study|Withdrawal by Subject|4|||
164569269|NCT03486392|594451256|FG004|Overall Study|Withdrawal by Subject|1|||
164569270|NCT03486392|594451252|FG000|Overall Study|Death|0|||
164569271|NCT03486392|594451253|FG001|Overall Study|Death|0|||
164569272|NCT03486392|594451254|FG002|Overall Study|Death|0|||
164569273|NCT03486392|594451255|FG003|Overall Study|Death|0|||
164569274|NCT03486392|594451256|FG004|Overall Study|Death|1|||
164569275|NCT02347631|594451262|FG000|First Intervention (2 Months)|Adverse Event|1|||
164569276|NCT02347631|594451263|FG001|First Intervention (2 Months)|Adverse Event|1|||
164569277|NCT02347631|594451262|FG000|First Intervention (2 Months)|Pregnancy|1|||
164569278|NCT02347631|594451263|FG001|First Intervention (2 Months)|Pregnancy|0|||
164569279|NCT02347631|594451262|FG000|First Intervention (2 Months)|Moved out of area|0|||
164569280|NCT02347631|594451263|FG001|First Intervention (2 Months)|Moved out of area|2|||
164569281|NCT02347631|594451262|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
164569282|NCT02347631|594451263|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
164569283|NCT02347631|594451262|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
164569284|NCT02347631|594451263|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
164569285|NCT02347631|594451262|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
164569286|NCT02347631|594451263|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
164569287|NCT02347631|594451262|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
164569288|NCT02347631|594451263|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
164569289|NCT02347631|594451262|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
164569290|NCT02347631|594451263|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
164569291|NCT01262898|594451265|FG000|Overall Study|Protocol Violation|1|||
164569292|NCT01262898|594451266|FG001|Overall Study|Protocol Violation|1|||
164569293|NCT01262898|594451267|FG002|Overall Study|Protocol Violation|0|||
164569294|NCT01262898|594451268|FG003|Overall Study|Protocol Violation|0|||
164569295|NCT01262898|594451265|FG000|Overall Study|Lost to Follow-up|1|||
164569296|NCT01262898|594451266|FG001|Overall Study|Lost to Follow-up|0|||
164569297|NCT01262898|594451267|FG002|Overall Study|Lost to Follow-up|0|||
164569298|NCT01262898|594451268|FG003|Overall Study|Lost to Follow-up|0|||
164569299|NCT01262898|594451265|FG000|Overall Study|Withdrawal by Subject|1|||
164569300|NCT01262898|594451266|FG001|Overall Study|Withdrawal by Subject|1|||
164569301|NCT01262898|594451267|FG002|Overall Study|Withdrawal by Subject|0|||
164569302|NCT01262898|594451268|FG003|Overall Study|Withdrawal by Subject|0|||
164569303|NCT02304926|594451269|FG000|Overall Study|Lost to Follow-up|2|||
164569304|NCT02304926|594451270|FG001|Overall Study|Lost to Follow-up|1|||
164569305|NCT02388295|594451277|FG000|Dose Escalation Week 1|Adverse Event|1|||
164569306|NCT02388295|594451278|FG001|Dose Escalation Week 1|Adverse Event|2|||
164569307|NCT02388295|594451279|FG002|Dose Escalation Week 1|Adverse Event|1|||
164569308|NCT02388295|594451277|FG000|Dose Escalation Week 1|Determined not eligible|1|||
164569309|NCT02388295|594451278|FG001|Dose Escalation Week 1|Determined not eligible|1|||
164569310|NCT02388295|594451279|FG002|Dose Escalation Week 1|Determined not eligible|1|||
164569311|NCT02388295|594451277|FG000|Dose Escalation Week 2|Protocol Violation|0|||
164569312|NCT02388295|594451278|FG001|Dose Escalation Week 2|Protocol Violation|1|||
164569313|NCT02388295|594451279|FG002|Dose Escalation Week 2|Protocol Violation|0|||
164569314|NCT02388295|594451277|FG000|Dose Escalation Week 2|Determined not eligible|1|||
164569315|NCT02388295|594451278|FG001|Dose Escalation Week 2|Determined not eligible|1|||
164569316|NCT02388295|594451279|FG002|Dose Escalation Week 2|Determined not eligible|1|||
164569317|NCT02388295|594451277|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
164569318|NCT02388295|594451278|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
164569319|NCT02388295|594451279|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
164569320|NCT02076165|594451280|FG000|Overall Study|Lost to Follow-up|7|||
164569321|NCT02076165|594451281|FG001|Overall Study|Lost to Follow-up|5|||
164569322|NCT02076165|594451280|FG000|Overall Study|Refused follow-up assessment|1|||
164569323|NCT02076165|594451281|FG001|Overall Study|Refused follow-up assessment|1|||
164569324|NCT01551693|594451282|FG000|Overall Study|Disease Progression|1|||
164569325|NCT01551693|594451283|FG001|Overall Study|Disease Progression|0|||
164569326|NCT01551693|594451282|FG000|Overall Study|Adverse Event|0|||
164569327|NCT01551693|594451283|FG001|Overall Study|Adverse Event|1|||
164569328|NCT01551693|594451282|FG000|Overall Study|Withdrawal by Subject|0|||
164569329|NCT01551693|594451283|FG001|Overall Study|Withdrawal by Subject|1|||
164569330|NCT02429856|594451284|FG000|Overall Study|Death|12|||
164569331|NCT02429856|594451285|FG001|Overall Study|Death|13|||
164569332|NCT02429856|594451284|FG000|Overall Study|Lost to Follow-up|6|||
164569333|NCT02429856|594451285|FG001|Overall Study|Lost to Follow-up|5|||
164673371|NCT00448019|594830946|FG000|Overall Study|Withdrawal by Subject|3|||
164673372|NCT00448019|594830946|FG000|Overall Study|Disease progression|1|||
164673373|NCT00448019|594830946|FG000|Overall Study|Death|2|||
164673374|NCT00448019|594830946|FG000|Overall Study|Insurance Issues|1|||
164673375|NCT03020615|594830947|FG000|Overall Study|Physician Decision|3|||
164673376|NCT03020615|594830948|FG001|Overall Study|Physician Decision|1|||
164673377|NCT03020615|594830949|FG002|Overall Study|Physician Decision|2|||
164673378|NCT03020615|594830947|FG000|Overall Study|Parent/guardian/patient choice|3|||
164673379|NCT03020615|594830948|FG001|Overall Study|Parent/guardian/patient choice|0|||
164673380|NCT03020615|594830949|FG002|Overall Study|Parent/guardian/patient choice|4|||
164673381|NCT03020615|594830947|FG000|Overall Study|Screen failure|0|||
164673382|NCT03020615|594830948|FG001|Overall Study|Screen failure|0|||
164673383|NCT03020615|594830949|FG002|Overall Study|Screen failure|1|||
164673384|NCT03020615|594830947|FG000|Overall Study|Death|1|||
164673385|NCT03020615|594830948|FG001|Overall Study|Death|0|||
164673386|NCT03020615|594830949|FG002|Overall Study|Death|0|||
164673387|NCT03020615|594830947|FG000|Overall Study|Lost to Follow-up|0|||
164673388|NCT03020615|594830948|FG001|Overall Study|Lost to Follow-up|1|||
164673389|NCT03020615|594830949|FG002|Overall Study|Lost to Follow-up|0|||
164673390|NCT00089661|594830950|FG000|Overall Study|Adverse Event|0|||
164673391|NCT00089661|594830951|FG001|Overall Study|Adverse Event|2|||
164673392|NCT00089661|594830950|FG000|Overall Study|Death|1|||
164673393|NCT00089661|594830951|FG001|Overall Study|Death|0|||
164673394|NCT00089661|594830950|FG000|Overall Study|Lost to Follow-up|0|||
164673395|NCT00089661|594830951|FG001|Overall Study|Lost to Follow-up|3|||
164673396|NCT00089661|594830950|FG000|Overall Study|Withdrawal by Subject|11|||
164673397|NCT00089661|594830951|FG001|Overall Study|Withdrawal by Subject|9|||
164673398|NCT00089661|594830950|FG000|Overall Study|Disease progression|1|||
164673399|NCT00089661|594830951|FG001|Overall Study|Disease progression|3|||
164673400|NCT00089661|594830950|FG000|Overall Study|Ineligibility determined|4|||
164673401|NCT00089661|594830951|FG001|Overall Study|Ineligibility determined|4|||
164673402|NCT00089661|594830950|FG000|Overall Study|Noncompliance|2|||
164673403|NCT00089661|594830951|FG001|Overall Study|Noncompliance|4|||
164673404|NCT00089661|594830950|FG000|Overall Study|Other|2|||
164673405|NCT00089661|594830951|FG001|Overall Study|Other|1|||
164673406|NCT02760368|594830952|FG000|Overall Study|Withdrawal by Subject|8|||
164673407|NCT02760368|594830953|FG001|Overall Study|Withdrawal by Subject|12|||
164673408|NCT02760368|594830954|FG002|Overall Study|Withdrawal by Subject|9|||
164673409|NCT02760368|594830952|FG000|Overall Study|Screen Failure|0|||
164673410|NCT02760368|594830953|FG001|Overall Study|Screen Failure|0|||
164673411|NCT02760368|594830954|FG002|Overall Study|Screen Failure|1|||
164673412|NCT02760368|594830952|FG000|Overall Study|Death|0|||
164673413|NCT02760368|594830953|FG001|Overall Study|Death|1|||
164673414|NCT02760368|594830954|FG002|Overall Study|Death|0|||
164329143|NCT03172910|593583235|FG003|Overall Study|Adverse Event|0|||
164673415|NCT02760368|594830952|FG000|Overall Study|Withdrawal by Sponsor|0|||
164673416|NCT02760368|594830953|FG001|Overall Study|Withdrawal by Sponsor|0|||
164673417|NCT02760368|594830954|FG002|Overall Study|Withdrawal by Sponsor|1|||
164673418|NCT00794963|594830955|FG000|Overall Study|Withdrawal by Subject|1|||
164673419|NCT00794963|594830956|FG001|Overall Study|Withdrawal by Subject|4|||
164673420|NCT01037114|594830957|FG000|Year 20|Others|1|||
164673421|NCT01602419|594830958|FG000|Overall Study|Not treated with Wilate|9|||
164673422|NCT01602419|594830958|FG000|Overall Study|Adverse Drug Reaction|4|||
164673423|NCT01602419|594830958|FG000|Overall Study|Insurance issues|3|||
164673424|NCT01602419|594830958|FG000|Overall Study|Changed treatment centre|1|||
164673425|NCT01602419|594830958|FG000|Overall Study|Treatment centre closed|1|||
164673426|NCT01602419|594830958|FG000|Overall Study|Withdrawal by Subject|5|||
164673427|NCT01602419|594830958|FG000|Overall Study|Lost to Follow-up|6|||
164673428|NCT03620747|594830964|FG000|Overall Study|Participant decision|7|||
164673429|NCT03620747|594830964|FG000|Overall Study|Adverse Event|6|||
164673430|NCT03620747|594830964|FG000|Overall Study|Lack of Efficacy|1|||
164673431|NCT03620747|594830964|FG000|Overall Study|Poor compliance to protocol|2|||
164673432|NCT03620747|594830964|FG000|Overall Study|Other-unspecified|3|||
164673433|NCT00635492|594830967|FG000|Overall Study|Death|12|||
164673434|NCT00635492|594830968|FG001|Overall Study|Death|40|||
164673435|NCT00635492|594830967|FG000|Overall Study|Lost to Follow-up|151|||
164673436|NCT00635492|594830968|FG001|Overall Study|Lost to Follow-up|172|||
164673437|NCT00635492|594830967|FG000|Overall Study|Physician Decision|32|||
164673438|NCT00635492|594830968|FG001|Overall Study|Physician Decision|22|||
164673439|NCT00635492|594830967|FG000|Overall Study|Sponsor decision|2|||
164673440|NCT00635492|594830968|FG001|Overall Study|Sponsor decision|3|||
164673441|NCT00635492|594830967|FG000|Overall Study|Withdrawal by Subject|82|||
164673442|NCT00635492|594830968|FG001|Overall Study|Withdrawal by Subject|45|||
164673443|NCT04533594|594830973|FG000|Overall Study|Death|26|||
164673444|NCT02699866|594830979|FG000|Overall Study|Withdrawal by Subject|3|||
164673445|NCT02699866|594830979|FG000|Overall Study|Physician Decision|2|||
164329144|NCT03172910|593583236|FG004|Overall Study|Adverse Event|1|||
164673446|NCT02699866|594830979|FG000|Overall Study|Adverse Event|3|||
164673447|NCT02937870|594830980|FG000|Overall Study|Adverse Event|1|||
164329145|NCT01397201|593583237|FG000|Overall Study|Not treated|0|||
164673448|NCT02937870|594830980|FG000|Overall Study|Protocol Deviation|2|||
164673449|NCT01185821|594830981|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164673450|NCT01185821|594830982|FG001|Overall Study|Abnormal laboratory value(s)|2|||
164673451|NCT01185821|594830983|FG002|Overall Study|Abnormal laboratory value(s)|1|||
164673452|NCT01185821|594830984|FG003|Overall Study|Abnormal laboratory value(s)|0|||
164673453|NCT01185821|594830985|FG004|Overall Study|Abnormal laboratory value(s)|0|||
164673454|NCT01185821|594830981|FG000|Overall Study|Protocol Violation|0|||
164673455|NCT01185821|594830982|FG001|Overall Study|Protocol Violation|0|||
164673456|NCT01185821|594830983|FG002|Overall Study|Protocol Violation|0|||
164673457|NCT01185821|594830984|FG003|Overall Study|Protocol Violation|1|||
164673458|NCT01185821|594830985|FG004|Overall Study|Protocol Violation|1|||
164673459|NCT01185821|594830981|FG000|Overall Study|Abnormal test procedure result|0|||
164673460|NCT01185821|594830982|FG001|Overall Study|Abnormal test procedure result|0|||
164673461|NCT01185821|594830983|FG002|Overall Study|Abnormal test procedure result|0|||
164673462|NCT01185821|594830984|FG003|Overall Study|Abnormal test procedure result|0|||
164673463|NCT01185821|594830985|FG004|Overall Study|Abnormal test procedure result|1|||
164673464|NCT01185821|594830981|FG000|Overall Study|Death|0|||
164673465|NCT01185821|594830982|FG001|Overall Study|Death|1|||
164673466|NCT01185821|594830983|FG002|Overall Study|Death|0|||
164673467|NCT01185821|594830984|FG003|Overall Study|Death|0|||
164673468|NCT01185821|594830985|FG004|Overall Study|Death|0|||
164673469|NCT01185821|594830981|FG000|Overall Study|Condition no longer required study drug|0|||
164673470|NCT01185821|594830982|FG001|Overall Study|Condition no longer required study drug|0|||
164673471|NCT01185821|594830983|FG002|Overall Study|Condition no longer required study drug|0|||
164673472|NCT01185821|594830984|FG003|Overall Study|Condition no longer required study drug|0|||
164673473|NCT01185821|594830985|FG004|Overall Study|Condition no longer required study drug|1|||
164673474|NCT01185821|594830981|FG000|Overall Study|Adverse Event|2|||
164673475|NCT01185821|594830982|FG001|Overall Study|Adverse Event|3|||
164673476|NCT01185821|594830983|FG002|Overall Study|Adverse Event|1|||
164673477|NCT01185821|594830984|FG003|Overall Study|Adverse Event|2|||
164673478|NCT01185821|594830985|FG004|Overall Study|Adverse Event|5|||
164673479|NCT01185821|594830981|FG000|Overall Study|Lack of Efficacy|0|||
164673480|NCT01185821|594830982|FG001|Overall Study|Lack of Efficacy|0|||
164673481|NCT01185821|594830983|FG002|Overall Study|Lack of Efficacy|3|||
164673482|NCT01185821|594830984|FG003|Overall Study|Lack of Efficacy|0|||
164673483|NCT01185821|594830985|FG004|Overall Study|Lack of Efficacy|9|||
164673484|NCT01185821|594830981|FG000|Overall Study|Withdrawal by Subject|3|||
164673485|NCT01185821|594830982|FG001|Overall Study|Withdrawal by Subject|2|||
164673486|NCT01185821|594830983|FG002|Overall Study|Withdrawal by Subject|2|||
164673487|NCT01185821|594830984|FG003|Overall Study|Withdrawal by Subject|1|||
164673488|NCT01185821|594830985|FG004|Overall Study|Withdrawal by Subject|3|||
164673489|NCT01185821|594830981|FG000|Overall Study|Lost to Follow-up|1|||
164673490|NCT01185821|594830982|FG001|Overall Study|Lost to Follow-up|1|||
164673491|NCT01185821|594830983|FG002|Overall Study|Lost to Follow-up|2|||
164673492|NCT01185821|594830984|FG003|Overall Study|Lost to Follow-up|1|||
164673493|NCT01185821|594830985|FG004|Overall Study|Lost to Follow-up|2|||
164673494|NCT01185821|594830981|FG000|Overall Study|Administrative problems|0|||
164673495|NCT01185821|594830982|FG001|Overall Study|Administrative problems|0|||
164673496|NCT01185821|594830983|FG002|Overall Study|Administrative problems|1|||
164673497|NCT01185821|594830984|FG003|Overall Study|Administrative problems|1|||
164569334|NCT02429856|594451284|FG000|Overall Study|Withdrawal by Subject|1|||
164569335|NCT02429856|594451285|FG001|Overall Study|Withdrawal by Subject|1|||
164569336|NCT01950819|594451289|FG000|Overall Study|Graft Loss|35|||
164569337|NCT01950819|594451290|FG001|Overall Study|Graft Loss|30|||
164569338|NCT01950819|594451289|FG000|Overall Study|Death|29|||
164569339|NCT01950819|594451290|FG001|Overall Study|Death|34|||
164569340|NCT01950819|594451289|FG000|Overall Study|Subject / Gardian decision|54|||
164569341|NCT01950819|594451290|FG001|Overall Study|Subject / Gardian decision|51|||
164569342|NCT01950819|594451289|FG000|Overall Study|technical problems|2|||
164569343|NCT01950819|594451290|FG001|Overall Study|technical problems|0|||
164673498|NCT01185821|594830985|FG004|Overall Study|Administrative problems|2|||
164673499|NCT04263649|594830988|FG000|Overall Study|Adverse Event|53|||
164673500|NCT04263649|594830988|FG000|Overall Study|Lost to Follow-up|3|||
164673501|NCT04263649|594830988|FG000|Overall Study|Death|29|||
164673502|NCT04263649|594830988|FG000|Overall Study|Device deficiency|19|||
164673503|NCT04263649|594830988|FG000|Overall Study|other reasons|11|||
164673504|NCT05169710|594830989|FG000|Overall Study|Adverse Event|1|||
164673505|NCT05169710|594830990|FG001|Overall Study|Adverse Event|2|||
164673506|NCT05169710|594830991|FG002|Overall Study|Adverse Event|2|||
164569344|NCT01950819|594451289|FG000|Overall Study|Pregnancy|0|||
164569345|NCT01950819|594451290|FG001|Overall Study|Pregnancy|2|||
164569346|NCT01950819|594451289|FG000|Overall Study|Lost to Follow-up|9|||
164569347|NCT01950819|594451290|FG001|Overall Study|Lost to Follow-up|17|||
164569348|NCT04134494|594451292|FG000|Overall Study|Lost to Follow-up|2|||
164673507|NCT05169710|594830989|FG000|Overall Study|Lost to Follow-up|0|||
164673508|NCT05169710|594830990|FG001|Overall Study|Lost to Follow-up|0|||
164673509|NCT05169710|594830991|FG002|Overall Study|Lost to Follow-up|1|||
164673510|NCT05169710|594830989|FG000|Overall Study|Withdrawal by Subject|2|||
164673511|NCT05169710|594830990|FG001|Overall Study|Withdrawal by Subject|1|||
164673512|NCT05169710|594830991|FG002|Overall Study|Withdrawal by Subject|0|||
164673513|NCT05169710|594830989|FG000|Overall Study|Other Study Discontinuation Reason|0|||
164673514|NCT05169710|594830990|FG001|Overall Study|Other Study Discontinuation Reason|2|||
164673515|NCT05169710|594830991|FG002|Overall Study|Other Study Discontinuation Reason|0|||
164673516|NCT01208337|594830995|FG000|Overall Study|Death|3|||
164673517|NCT00836056|594830999|FG000|First Intervention|Adverse Event|1|||
164673518|NCT00836056|594831000|FG001|First Intervention|Adverse Event|0|||
164673519|NCT01001208|594831004|FG000|Overall Study|Adverse Event|10|||
164673520|NCT01001208|594831005|FG001|Overall Study|Adverse Event|5|||
164673521|NCT01001208|594831004|FG000|Overall Study|Lost to Follow-up|5|||
164673522|NCT01001208|594831005|FG001|Overall Study|Lost to Follow-up|9|||
164673523|NCT01001208|594831004|FG000|Overall Study|Physician Decision|1|||
164673524|NCT01001208|594831005|FG001|Overall Study|Physician Decision|0|||
164673525|NCT01001208|594831004|FG000|Overall Study|Withdrawal by Subject|4|||
164673526|NCT01001208|594831005|FG001|Overall Study|Withdrawal by Subject|5|||
164673527|NCT01001208|594831004|FG000|Overall Study|Ineligibility Determined|4|||
164673528|NCT01001208|594831005|FG001|Overall Study|Ineligibility Determined|2|||
164673529|NCT01001208|594831004|FG000|Overall Study|Noncompliance|4|||
164673530|NCT01001208|594831005|FG001|Overall Study|Noncompliance|7|||
164673531|NCT01001208|594831004|FG000|Overall Study|Disease Progression|0|||
164673532|NCT01001208|594831005|FG001|Overall Study|Disease Progression|3|||
164673533|NCT01001208|594831004|FG000|Overall Study|Other|0|||
164673534|NCT01001208|594831005|FG001|Overall Study|Other|2|||
164673535|NCT03197883|594831006|FG000|Overall Study|Adverse Event|1|||
164673536|NCT03197883|594831007|FG001|Overall Study|Adverse Event|1|||
164673537|NCT03197883|594831006|FG000|Overall Study|Lost to Follow-up|1|||
164673538|NCT03197883|594831007|FG001|Overall Study|Lost to Follow-up|0|||
164673539|NCT03197883|594831006|FG000|Overall Study|Protocol Violation|1|||
164673540|NCT03197883|594831007|FG001|Overall Study|Protocol Violation|0|||
164673541|NCT03197883|594831006|FG000|Overall Study|Other (Not Specified)|0|||
164673542|NCT03197883|594831007|FG001|Overall Study|Other (Not Specified)|5|||
164673543|NCT01353664|594831008|FG000|Overall Study|Other|3|||
164673544|NCT01353664|594831008|FG000|Overall Study|Disease Progression|16|||
164673545|NCT03420300|594831014|FG000|Overall Study|Death|2|||
164673546|NCT02066922|594831021|FG000|Overall Study|Adverse Event|1|||
164673547|NCT00440297|594831022|FG000|Overall Study|Adverse Event|8|||
164673548|NCT00440297|594831023|FG001|Overall Study|Adverse Event|5|||
164673549|NCT00440297|594831022|FG000|Overall Study|Lost to Follow-up|1|||
164673550|NCT00440297|594831023|FG001|Overall Study|Lost to Follow-up|0|||
164673551|NCT00440297|594831022|FG000|Overall Study|Physician Decision|1|||
164673552|NCT00440297|594831023|FG001|Overall Study|Physician Decision|0|||
164673553|NCT00440297|594831022|FG000|Overall Study|Protocol Violation|11|||
164673554|NCT00440297|594831023|FG001|Overall Study|Protocol Violation|7|||
164673555|NCT00440297|594831022|FG000|Overall Study|Withdrawal by Subject|1|||
164673556|NCT00440297|594831023|FG001|Overall Study|Withdrawal by Subject|6|||
164673557|NCT00440297|594831022|FG000|Overall Study|Randomized by mistake|1|||
164673558|NCT00440297|594831023|FG001|Overall Study|Randomized by mistake|0|||
164673559|NCT02024932|594831024|FG000|Overall Study|Adverse Event|2|||
164673560|NCT02024932|594831025|FG001|Overall Study|Adverse Event|3|||
164673561|NCT02024932|594831026|FG002|Overall Study|Adverse Event|0|||
164673562|NCT02024932|594831027|FG003|Overall Study|Adverse Event|0|||
164673563|NCT02024932|594831028|FG004|Overall Study|Adverse Event|2|||
164673564|NCT02024932|594831029|FG005|Overall Study|Adverse Event|0|||
164673565|NCT02024932|594831024|FG000|Overall Study|Abnormal laboratory value|0|||
164673566|NCT02024932|594831025|FG001|Overall Study|Abnormal laboratory value|0|||
164673567|NCT02024932|594831026|FG002|Overall Study|Abnormal laboratory value|0|||
164673568|NCT02024932|594831027|FG003|Overall Study|Abnormal laboratory value|2|||
164673569|NCT02024932|594831028|FG004|Overall Study|Abnormal laboratory value|0|||
164673570|NCT02024932|594831029|FG005|Overall Study|Abnormal laboratory value|0|||
164673571|NCT02445339|594831030|FG000|Overall Study|Physician Decision|1|||
164673572|NCT02445339|594831031|FG001|Overall Study|Physician Decision|0|||
164673573|NCT02445339|594831030|FG000|Overall Study|Lost to Follow-up|11|||
164673574|NCT02445339|594831031|FG001|Overall Study|Lost to Follow-up|15|||
164673575|NCT03206177|594831032|FG000|Overall Study|Withdrawal by Subject|1|||
164673576|NCT03020641|594831033|FG000|Overall Study|Lost to Follow-up|0|||
164673577|NCT03020641|594831034|FG001|Overall Study|Lost to Follow-up|1|||
164673578|NCT03020641|594831033|FG000|Overall Study|Converted to open surgery|2|||
164673579|NCT03020641|594831034|FG001|Overall Study|Converted to open surgery|1|||
164673580|NCT03020641|594831033|FG000|Overall Study|for surgery not performed|0|||
164673581|NCT03020641|594831034|FG001|Overall Study|for surgery not performed|1|||
164673582|NCT00727961|594831035|FG000|Overall Study|Lost to Follow-up|1|||
164673583|NCT00727961|594831035|FG000|Overall Study|Adverse Event|4|||
164673584|NCT00727961|594831035|FG000|Overall Study|Patient's refusal|2|||
164673585|NCT00727961|594831035|FG000|Overall Study|Progression|30|||
164673586|NCT03161405|594831036|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
164673587|NCT01421277|594831037|FG000|Overall Study|Lack of qualifying event|0|||
164673588|NCT01421277|594831038|FG001|Overall Study|Lack of qualifying event|61|||
164673589|NCT01421277|594831037|FG000|Overall Study|Incomplete baseline data|0|||
164673590|NCT01421277|594831038|FG001|Overall Study|Incomplete baseline data|31|||
164673591|NCT02039908|594831039|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
164673592|NCT02039908|594831040|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
164673593|NCT02039908|594831041|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
164673594|NCT02039908|594831042|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
164673595|NCT02039908|594831039|FG000|Phase 1-Summer|Protocol Violation|6|||
164673596|NCT02039908|594831040|FG001|Phase 1-Summer|Protocol Violation|0|||
164673597|NCT02039908|594831041|FG002|Phase 1-Summer|Protocol Violation|0|||
164673598|NCT02039908|594831042|FG003|Phase 1-Summer|Protocol Violation|0|||
164673599|NCT02039908|594831039|FG000|Phase 2-School Year|Lost to Follow-up|0|||
164673600|NCT02039908|594831040|FG001|Phase 2-School Year|Lost to Follow-up|0|||
164673601|NCT02039908|594831041|FG002|Phase 2-School Year|Lost to Follow-up|1|||
164673602|NCT02039908|594831042|FG003|Phase 2-School Year|Lost to Follow-up|3|||
164673603|NCT02039908|594831039|FG000|Phase 2-School Year|Protocol Violation|0|||
164673604|NCT02039908|594831040|FG001|Phase 2-School Year|Protocol Violation|0|||
164673605|NCT02039908|594831041|FG002|Phase 2-School Year|Protocol Violation|3|||
164673606|NCT02039908|594831042|FG003|Phase 2-School Year|Protocol Violation|0|||
164673607|NCT02039908|594831039|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
164673608|NCT02039908|594831040|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
164673609|NCT02039908|594831041|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
164673610|NCT02039908|594831042|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
164673611|NCT01597245|594831043|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
164673612|NCT01597245|594831044|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
164673613|NCT01597245|594831045|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
164673614|NCT01597245|594831046|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
164673615|NCT01597245|594831047|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164673616|NCT01597245|594831048|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164673617|NCT01597245|594831049|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164673618|NCT01597245|594831050|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164673619|NCT01597245|594831051|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164673620|NCT01597245|594831052|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164673621|NCT01597245|594831053|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164673622|NCT01597245|594831054|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164673623|NCT01597245|594831055|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164673624|NCT01597245|594831056|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164673625|NCT01597245|594831057|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164673626|NCT01597245|594831058|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164673627|NCT01597245|594831059|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164673628|NCT01597245|594831060|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164673629|NCT01597245|594831061|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164673630|NCT01597245|594831062|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164673631|NCT01597245|594831063|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164673632|NCT01597245|594831043|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
164673633|NCT01597245|594831044|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
164673634|NCT01597245|594831045|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
164673635|NCT01597245|594831046|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
164673636|NCT01597245|594831047|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164673637|NCT01597245|594831048|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164673638|NCT01597245|594831049|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164673639|NCT01597245|594831050|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164673640|NCT01597245|594831051|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164673641|NCT01597245|594831052|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164673642|NCT01597245|594831053|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164673643|NCT01597245|594831054|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164673644|NCT01597245|594831055|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164673645|NCT01597245|594831056|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164673646|NCT01597245|594831057|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164673647|NCT01597245|594831058|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164673648|NCT01597245|594831059|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164673649|NCT01597245|594831060|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164673650|NCT01597245|594831061|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164673651|NCT01597245|594831062|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164673652|NCT01597245|594831063|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164673653|NCT01597245|594831043|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
164673654|NCT01597245|594831044|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
164673655|NCT01597245|594831045|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
164673656|NCT01597245|594831046|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
164673657|NCT01597245|594831047|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164673658|NCT01597245|594831048|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164673659|NCT01597245|594831049|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164673660|NCT01597245|594831050|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164673661|NCT01597245|594831051|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164673662|NCT01597245|594831052|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164673663|NCT01597245|594831053|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164673664|NCT01597245|594831054|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164673665|NCT01597245|594831055|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164673666|NCT01597245|594831056|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164673667|NCT01597245|594831057|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164673668|NCT01597245|594831058|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164673669|NCT01597245|594831059|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164673670|NCT01597245|594831060|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164673671|NCT01597245|594831061|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164673672|NCT01597245|594831062|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164673673|NCT01597245|594831063|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164673674|NCT01597245|594831043|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
164673675|NCT01597245|594831044|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
164673676|NCT01597245|594831045|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
164673677|NCT01597245|594831046|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164673678|NCT01597245|594831047|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164673679|NCT01597245|594831048|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164673680|NCT01597245|594831049|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164673681|NCT01597245|594831050|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164673682|NCT01597245|594831051|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164673683|NCT01597245|594831052|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164673684|NCT01597245|594831053|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164673685|NCT01597245|594831054|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164673686|NCT01597245|594831055|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164329146|NCT01397201|593583238|FG001|Overall Study|Not treated|0|||
164569349|NCT00781365|594451293|FG000|Overall Study|Withdrawal by Subject|13|||
164569350|NCT00781365|594451294|FG001|Overall Study|Withdrawal by Subject|8|||
164569351|NCT00781365|594451293|FG000|Overall Study|Did Not Attend Visit|20|||
164569352|NCT00781365|594451294|FG001|Overall Study|Did Not Attend Visit|28|||
164569353|NCT00781365|594451293|FG000|Overall Study|Language barrier|1|||
164569354|NCT00781365|594451294|FG001|Overall Study|Language barrier|0|||
164569355|NCT01032629|594451299|FG000|Overall Study|Closed Site|21|||
164569356|NCT01032629|594451300|FG001|Overall Study|Closed Site|18|||
164569357|NCT01032629|594451301|FG002|Overall Study|Closed Site|16|||
164569358|NCT01032629|594451299|FG000|Overall Study|Withdrawal by Subject|50|||
164569359|NCT01032629|594451300|FG001|Overall Study|Withdrawal by Subject|36|||
164673687|NCT01597245|594831056|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164673688|NCT01597245|594831057|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164673689|NCT01597245|594831058|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164673690|NCT01597245|594831059|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164673691|NCT01597245|594831060|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164673692|NCT01597245|594831061|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164673693|NCT01597245|594831062|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164673694|NCT01597245|594831063|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164673695|NCT01597245|594831043|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
164673696|NCT01597245|594831044|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164673697|NCT01597245|594831045|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164673698|NCT01597245|594831046|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
164673699|NCT01597245|594831047|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164673700|NCT01597245|594831048|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164673701|NCT01597245|594831049|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164673702|NCT01597245|594831050|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164673703|NCT01597245|594831051|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164673704|NCT01597245|594831052|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164673705|NCT01597245|594831053|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164673706|NCT01597245|594831054|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164673707|NCT01597245|594831055|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164673708|NCT01597245|594831056|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164673709|NCT01597245|594831057|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164673710|NCT01597245|594831058|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164673711|NCT01597245|594831059|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164673712|NCT01597245|594831060|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164673713|NCT01597245|594831061|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164673714|NCT01597245|594831062|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164673715|NCT01597245|594831063|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164673716|NCT01597245|594831043|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
164673717|NCT01597245|594831044|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
164673718|NCT01597245|594831045|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
164673719|NCT01597245|594831046|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164673720|NCT01597245|594831047|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164673721|NCT01597245|594831048|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164673722|NCT01597245|594831049|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164673723|NCT01597245|594831050|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164673724|NCT01597245|594831051|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164673725|NCT01597245|594831052|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164673726|NCT01597245|594831053|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164673727|NCT01597245|594831054|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164673728|NCT01597245|594831055|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164673729|NCT01597245|594831056|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164673730|NCT01597245|594831057|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164673731|NCT01597245|594831058|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164673732|NCT01597245|594831059|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164673733|NCT01597245|594831060|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164673734|NCT01597245|594831061|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164673735|NCT01597245|594831062|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164673736|NCT01597245|594831063|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164673737|NCT01597245|594831043|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164673738|NCT01597245|594831044|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164673739|NCT01597245|594831045|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164673740|NCT01597245|594831046|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164673741|NCT01597245|594831047|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164673742|NCT01597245|594831048|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
164673743|NCT01597245|594831049|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
164673744|NCT01597245|594831050|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164673745|NCT01597245|594831051|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164673746|NCT01597245|594831052|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164673747|NCT01597245|594831053|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164673748|NCT01597245|594831054|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164673749|NCT01597245|594831055|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164673750|NCT01597245|594831056|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164673751|NCT01597245|594831057|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164673752|NCT01597245|594831058|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164673753|NCT01597245|594831059|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164673754|NCT01597245|594831060|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164673755|NCT01597245|594831061|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164673756|NCT01597245|594831062|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164673757|NCT01597245|594831063|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164673758|NCT01597245|594831043|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164673759|NCT01597245|594831044|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164673760|NCT01597245|594831045|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164673761|NCT01597245|594831046|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164673762|NCT01597245|594831047|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
164673763|NCT01597245|594831048|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
164673764|NCT01597245|594831049|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
164673765|NCT01597245|594831050|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
164673766|NCT01597245|594831051|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164673767|NCT01597245|594831052|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
164673768|NCT01597245|594831053|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164673769|NCT01597245|594831054|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164673770|NCT01597245|594831055|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164673771|NCT01597245|594831056|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164673772|NCT01597245|594831057|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164673773|NCT01597245|594831058|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164673774|NCT01597245|594831059|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164673775|NCT01597245|594831060|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164673776|NCT01597245|594831061|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164673777|NCT01597245|594831062|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164673778|NCT01597245|594831063|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164673779|NCT01597245|594831043|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164673780|NCT01597245|594831044|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164673781|NCT01597245|594831045|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164673782|NCT01597245|594831046|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164673783|NCT01597245|594831047|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164673784|NCT01597245|594831048|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
164673785|NCT01597245|594831049|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164673786|NCT01597245|594831050|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164673787|NCT01597245|594831051|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
164673788|NCT01597245|594831052|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164673789|NCT01597245|594831053|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
164673790|NCT01597245|594831054|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
164673791|NCT01597245|594831055|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
164673792|NCT01597245|594831056|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164673793|NCT01597245|594831057|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164673794|NCT01597245|594831058|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164673795|NCT01597245|594831059|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164673796|NCT01597245|594831060|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164673797|NCT01597245|594831061|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164673798|NCT01597245|594831062|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164673799|NCT01597245|594831063|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164673800|NCT01597245|594831043|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
164673801|NCT01597245|594831044|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
164673802|NCT01597245|594831045|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
164673803|NCT01597245|594831046|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
164673804|NCT01597245|594831047|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
164673805|NCT01597245|594831048|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
164673806|NCT01597245|594831049|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
164569360|NCT01032629|594451301|FG002|Overall Study|Withdrawal by Subject|35|||
164569361|NCT01032629|594451299|FG000|Overall Study|Lost to Follow-up|74|||
164569362|NCT01032629|594451300|FG001|Overall Study|Lost to Follow-up|47|||
164569363|NCT01032629|594451301|FG002|Overall Study|Lost to Follow-up|37|||
164569364|NCT01662648|594451302|FG000|Overall Study|Death|1|||
164569365|NCT01662648|594451303|FG001|Overall Study|Death|3|||
164569366|NCT01662648|594451302|FG000|Overall Study|Adverse Event|40|||
164569367|NCT01662648|594451303|FG001|Overall Study|Adverse Event|37|||
164421041|NCT02138747|593911085|FG001|Treatment Period 1|Withdrawal by Subject|4|||
164421042|NCT02138747|593911086|FG002|Treatment Period 1|Withdrawal by Subject|1|||
164569368|NCT01662648|594451302|FG000|Overall Study|Lack of Efficacy|17|||
164569369|NCT01662648|594451303|FG001|Overall Study|Lack of Efficacy|16|||
164569370|NCT01662648|594451302|FG000|Overall Study|Participant ineligible to continue trial|1|||
164569371|NCT01662648|594451303|FG001|Overall Study|Participant ineligible to continue trial|1|||
164569372|NCT01662648|594451302|FG000|Overall Study|Lost to Follow-up|24|||
164569373|NCT01662648|594451303|FG001|Overall Study|Lost to Follow-up|36|||
164569374|NCT01662648|594451302|FG000|Overall Study|Withdrawal by Subject|36|||
164569375|NCT01662648|594451303|FG001|Overall Study|Withdrawal by Subject|53|||
164569376|NCT01662648|594451302|FG000|Overall Study|Participant non-compliant|16|||
164569377|NCT01662648|594451303|FG001|Overall Study|Participant non-compliant|20|||
164569378|NCT01662648|594451302|FG000|Overall Study|Other|8|||
164569379|NCT01662648|594451303|FG001|Overall Study|Other|11|||
164569380|NCT01662648|594451302|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
164569381|NCT01662648|594451303|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
164569382|NCT01662648|594451302|FG000|Overall Study|LOE and other reason unspecified|1|||
164569383|NCT01662648|594451303|FG001|Overall Study|LOE and other reason unspecified|0|||
164569384|NCT01662648|594451302|FG000|Overall Study|LOE and Participant non-compliant|0|||
164569385|NCT01662648|594451303|FG001|Overall Study|LOE and Participant non-compliant|1|||
164569386|NCT00619957|594451305|FG000|Month 24 Double-Blind|Adverse Event|9|||
164569387|NCT00619957|594451306|FG001|Month 24 Double-Blind|Adverse Event|7|||
164569388|NCT00619957|594451305|FG000|Month 24 Double-Blind|Protocol Violation|1|||
164569389|NCT00619957|594451306|FG001|Month 24 Double-Blind|Protocol Violation|0|||
164569390|NCT00619957|594451305|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
164569391|NCT00619957|594451306|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
164569392|NCT00619957|594451305|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
164569393|NCT00619957|594451306|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
164569394|NCT00619957|594451305|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
164569395|NCT00619957|594451306|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
164569396|NCT00619957|594451305|FG000|Month 48 Open-Label|Adverse Event|4|||
164569397|NCT00619957|594451306|FG001|Month 48 Open-Label|Adverse Event|4|||
164569398|NCT00619957|594451305|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
164569399|NCT00619957|594451306|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
164569400|NCT00619957|594451305|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
164569401|NCT00619957|594451306|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
164569402|NCT00723957|594451307|FG000|Overall Study|Adverse event unrelated to study drug|1|||
164569403|NCT00723957|594451308|FG001|Overall Study|Adverse event unrelated to study drug|4|||
164569404|NCT00723957|594451307|FG000|Overall Study|Death|3|||
164569405|NCT00723957|594451308|FG001|Overall Study|Death|4|||
164569406|NCT00723957|594451307|FG000|Overall Study|Disease progression|27|||
164569407|NCT00723957|594451308|FG001|Overall Study|Disease progression|25|||
164569408|NCT00723957|594451307|FG000|Overall Study|Maximum clinical benefit|4|||
164569409|NCT00723957|594451308|FG001|Overall Study|Maximum clinical benefit|5|||
164569410|NCT00723957|594451307|FG000|Overall Study|Investigator decision|1|||
164569411|NCT00723957|594451308|FG001|Overall Study|Investigator decision|1|||
164569412|NCT00723957|594451307|FG000|Overall Study|Study drug toxicity|4|||
164569413|NCT00723957|594451308|FG001|Overall Study|Study drug toxicity|6|||
164569414|NCT00723957|594451307|FG000|Overall Study|Withdrawal by Subject|7|||
164569415|NCT00723957|594451308|FG001|Overall Study|Withdrawal by Subject|5|||
164569416|NCT00723957|594451307|FG000|Overall Study|Reason not analyzed|1|||
164569417|NCT00723957|594451308|FG001|Overall Study|Reason not analyzed|0|||
164569418|NCT00723957|594451307|FG000|Overall Study|Never received treatment|3|||
164569419|NCT00723957|594451308|FG001|Overall Study|Never received treatment|3|||
164569420|NCT00868790|594451309|FG000|Period 1|Adverse Event|1|||
164569421|NCT00868790|594451310|FG001|Period 1|Adverse Event|0|||
164569422|NCT00868790|594451311|FG002|Period 1|Adverse Event|0|||
164569423|NCT00868790|594451312|FG003|Period 1|Adverse Event|0|||
164569424|NCT00868790|594451313|FG004|Period 1|Adverse Event|0|||
164569425|NCT00868790|594451314|FG005|Period 1|Adverse Event|0|||
164569426|NCT00868790|594451315|FG006|Period 1|Adverse Event|0|||
164569427|NCT00868790|594451316|FG007|Period 1|Adverse Event|3|||
164569428|NCT00868790|594451317|FG008|Period 1|Adverse Event|1|||
164569429|NCT00868790|594451318|FG009|Period 1|Adverse Event|0|||
164569430|NCT00868790|594451319|FG010|Period 1|Adverse Event|0|||
164569431|NCT00868790|594451320|FG011|Period 1|Adverse Event|0|||
164569432|NCT00868790|594451321|FG012|Period 1|Adverse Event|0|||
164569433|NCT00868790|594451322|FG013|Period 1|Adverse Event|1|||
164569434|NCT00868790|594451309|FG000|Period 1|Protocol Violation|1|||
164569435|NCT00868790|594451310|FG001|Period 1|Protocol Violation|0|||
164569436|NCT00868790|594451311|FG002|Period 1|Protocol Violation|0|||
164569437|NCT00868790|594451312|FG003|Period 1|Protocol Violation|0|||
164569438|NCT00868790|594451313|FG004|Period 1|Protocol Violation|0|||
164569439|NCT00868790|594451314|FG005|Period 1|Protocol Violation|0|||
164569440|NCT00868790|594451315|FG006|Period 1|Protocol Violation|0|||
164569441|NCT00868790|594451316|FG007|Period 1|Protocol Violation|0|||
164569442|NCT00868790|594451317|FG008|Period 1|Protocol Violation|0|||
164569443|NCT00868790|594451318|FG009|Period 1|Protocol Violation|0|||
164569444|NCT00868790|594451319|FG010|Period 1|Protocol Violation|0|||
164569445|NCT00868790|594451320|FG011|Period 1|Protocol Violation|0|||
164569446|NCT00868790|594451321|FG012|Period 1|Protocol Violation|0|||
164569447|NCT00868790|594451322|FG013|Period 1|Protocol Violation|0|||
164569448|NCT00868790|594451309|FG000|Period 1|Withdrawal by Subject|0|||
164673807|NCT01597245|594831050|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
164673808|NCT01597245|594831051|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
164673809|NCT01597245|594831052|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
164569449|NCT00868790|594451310|FG001|Period 1|Withdrawal by Subject|1|||
164569450|NCT00868790|594451311|FG002|Period 1|Withdrawal by Subject|0|||
164569451|NCT00868790|594451312|FG003|Period 1|Withdrawal by Subject|0|||
164569452|NCT00868790|594451313|FG004|Period 1|Withdrawal by Subject|0|||
164569453|NCT00868790|594451314|FG005|Period 1|Withdrawal by Subject|0|||
164569454|NCT00868790|594451315|FG006|Period 1|Withdrawal by Subject|0|||
164569455|NCT00868790|594451316|FG007|Period 1|Withdrawal by Subject|0|||
164569456|NCT00868790|594451317|FG008|Period 1|Withdrawal by Subject|0|||
164569457|NCT00868790|594451318|FG009|Period 1|Withdrawal by Subject|0|||
164569458|NCT00868790|594451319|FG010|Period 1|Withdrawal by Subject|0|||
164569459|NCT00868790|594451320|FG011|Period 1|Withdrawal by Subject|0|||
164569460|NCT00868790|594451321|FG012|Period 1|Withdrawal by Subject|0|||
164569461|NCT00868790|594451322|FG013|Period 1|Withdrawal by Subject|1|||
164569462|NCT00868790|594451309|FG000|Period 1|Abnormal Triglycerides|0|||
164569463|NCT00868790|594451310|FG001|Period 1|Abnormal Triglycerides|0|||
164569464|NCT00868790|594451311|FG002|Period 1|Abnormal Triglycerides|0|||
164569465|NCT00868790|594451312|FG003|Period 1|Abnormal Triglycerides|0|||
164569466|NCT00868790|594451313|FG004|Period 1|Abnormal Triglycerides|1|||
164569467|NCT00868790|594451314|FG005|Period 1|Abnormal Triglycerides|0|||
164569468|NCT00868790|594451315|FG006|Period 1|Abnormal Triglycerides|0|||
164569469|NCT00868790|594451316|FG007|Period 1|Abnormal Triglycerides|0|||
164569470|NCT00868790|594451317|FG008|Period 1|Abnormal Triglycerides|0|||
164569471|NCT00868790|594451318|FG009|Period 1|Abnormal Triglycerides|0|||
164569472|NCT00868790|594451319|FG010|Period 1|Abnormal Triglycerides|0|||
164569473|NCT00868790|594451320|FG011|Period 1|Abnormal Triglycerides|0|||
164569474|NCT00868790|594451321|FG012|Period 1|Abnormal Triglycerides|0|||
164569475|NCT00868790|594451322|FG013|Period 1|Abnormal Triglycerides|0|||
164569476|NCT00868790|594451309|FG000|Period 1|Lost to Follow-up|0|||
164569477|NCT00868790|594451310|FG001|Period 1|Lost to Follow-up|0|||
164569478|NCT00868790|594451311|FG002|Period 1|Lost to Follow-up|0|||
164569479|NCT00868790|594451312|FG003|Period 1|Lost to Follow-up|0|||
164569480|NCT00868790|594451313|FG004|Period 1|Lost to Follow-up|0|||
164569481|NCT00868790|594451314|FG005|Period 1|Lost to Follow-up|1|||
164569482|NCT00868790|594451315|FG006|Period 1|Lost to Follow-up|0|||
164569483|NCT00868790|594451316|FG007|Period 1|Lost to Follow-up|0|||
164569484|NCT00868790|594451317|FG008|Period 1|Lost to Follow-up|0|||
164569485|NCT00868790|594451318|FG009|Period 1|Lost to Follow-up|0|||
164569486|NCT00868790|594451319|FG010|Period 1|Lost to Follow-up|0|||
164569487|NCT00868790|594451320|FG011|Period 1|Lost to Follow-up|0|||
164569488|NCT00868790|594451321|FG012|Period 1|Lost to Follow-up|0|||
164569489|NCT00868790|594451322|FG013|Period 1|Lost to Follow-up|0|||
164569490|NCT00868790|594451309|FG000|Period 2|Adverse Event|0|||
164569491|NCT00868790|594451310|FG001|Period 2|Adverse Event|0|||
164569492|NCT00868790|594451311|FG002|Period 2|Adverse Event|0|||
164569493|NCT00868790|594451312|FG003|Period 2|Adverse Event|0|||
164569494|NCT00868790|594451313|FG004|Period 2|Adverse Event|0|||
164569495|NCT00868790|594451314|FG005|Period 2|Adverse Event|0|||
164569496|NCT00868790|594451315|FG006|Period 2|Adverse Event|0|||
164569497|NCT00868790|594451316|FG007|Period 2|Adverse Event|0|||
164569498|NCT00868790|594451317|FG008|Period 2|Adverse Event|1|||
164569499|NCT00868790|594451318|FG009|Period 2|Adverse Event|0|||
164569500|NCT00868790|594451319|FG010|Period 2|Adverse Event|0|||
164569501|NCT00868790|594451320|FG011|Period 2|Adverse Event|0|||
164569502|NCT00868790|594451321|FG012|Period 2|Adverse Event|0|||
164569503|NCT00868790|594451322|FG013|Period 2|Adverse Event|0|||
164569504|NCT00868790|594451309|FG000|Period 2|Lost to Follow-up|0|||
164569505|NCT00868790|594451310|FG001|Period 2|Lost to Follow-up|1|||
164569506|NCT00868790|594451311|FG002|Period 2|Lost to Follow-up|0|||
164569507|NCT00868790|594451312|FG003|Period 2|Lost to Follow-up|0|||
164569508|NCT00868790|594451313|FG004|Period 2|Lost to Follow-up|0|||
164569509|NCT00868790|594451314|FG005|Period 2|Lost to Follow-up|1|||
164569510|NCT00868790|594451315|FG006|Period 2|Lost to Follow-up|0|||
164569511|NCT00868790|594451316|FG007|Period 2|Lost to Follow-up|0|||
164569512|NCT00868790|594451317|FG008|Period 2|Lost to Follow-up|0|||
164569513|NCT00868790|594451318|FG009|Period 2|Lost to Follow-up|0|||
164569514|NCT00868790|594451319|FG010|Period 2|Lost to Follow-up|0|||
164569515|NCT00868790|594451320|FG011|Period 2|Lost to Follow-up|0|||
164569516|NCT00868790|594451321|FG012|Period 2|Lost to Follow-up|0|||
164569517|NCT00868790|594451322|FG013|Period 2|Lost to Follow-up|0|||
164569518|NCT00868790|594451309|FG000|Period 2|Withdrawal by Subject|0|||
164569519|NCT00868790|594451310|FG001|Period 2|Withdrawal by Subject|0|||
164569520|NCT00868790|594451311|FG002|Period 2|Withdrawal by Subject|0|||
164569521|NCT00868790|594451312|FG003|Period 2|Withdrawal by Subject|0|||
164673810|NCT01597245|594831053|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
164673811|NCT01597245|594831054|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
164673812|NCT01597245|594831055|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
164673813|NCT01597245|594831056|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
164673814|NCT01597245|594831057|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
164673815|NCT01597245|594831058|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
164673816|NCT01597245|594831059|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
164673817|NCT01597245|594831060|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
164673818|NCT01597245|594831061|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
164673819|NCT01597245|594831062|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
164673820|NCT01597245|594831063|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
164673821|NCT01597245|594831043|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164673822|NCT01597245|594831044|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164673823|NCT01597245|594831045|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164673824|NCT01597245|594831046|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164673825|NCT01597245|594831047|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
164673826|NCT01597245|594831048|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
164673827|NCT01597245|594831049|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
164673828|NCT01597245|594831050|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164673829|NCT01597245|594831051|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
164673830|NCT01597245|594831052|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
164673831|NCT01597245|594831053|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
164673832|NCT01597245|594831054|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
164673833|NCT01597245|594831055|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
164673834|NCT01597245|594831056|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164673835|NCT01597245|594831057|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164673836|NCT01597245|594831058|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164673837|NCT01597245|594831059|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164673838|NCT01597245|594831060|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164673839|NCT01597245|594831061|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164673840|NCT01597245|594831062|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164673841|NCT01597245|594831063|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164673842|NCT01597245|594831043|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164673843|NCT01597245|594831044|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164673844|NCT01597245|594831045|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164673845|NCT01597245|594831046|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164673846|NCT01597245|594831047|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
164673847|NCT01597245|594831048|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164673848|NCT01597245|594831049|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164673849|NCT01597245|594831050|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164673850|NCT01597245|594831051|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
164673851|NCT01597245|594831052|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
164673852|NCT01597245|594831053|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
164673853|NCT01597245|594831054|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164673854|NCT01597245|594831055|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
164673855|NCT01597245|594831056|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164673856|NCT01597245|594831057|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164673857|NCT01597245|594831058|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164673858|NCT01597245|594831059|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164673859|NCT01597245|594831060|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164673860|NCT01597245|594831061|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164673861|NCT01597245|594831062|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164673862|NCT01597245|594831063|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164673863|NCT01597245|594831043|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164673864|NCT01597245|594831044|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164673865|NCT01597245|594831045|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164673866|NCT01597245|594831046|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164673867|NCT01597245|594831047|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
164673868|NCT01597245|594831048|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
164673869|NCT01597245|594831049|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
164673870|NCT01597245|594831050|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164673871|NCT01597245|594831051|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
164673872|NCT01597245|594831052|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
164673873|NCT01597245|594831053|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
164673874|NCT01597245|594831054|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
164673875|NCT01597245|594831055|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
164673876|NCT01597245|594831056|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164673877|NCT01597245|594831057|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164673878|NCT01597245|594831058|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164673879|NCT01597245|594831059|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164673880|NCT01597245|594831060|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164673881|NCT01597245|594831061|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164673882|NCT01597245|594831062|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164673883|NCT01597245|594831063|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164673884|NCT01597245|594831043|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164673885|NCT01597245|594831044|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164569522|NCT00868790|594451313|FG004|Period 2|Withdrawal by Subject|0|||
164569523|NCT00868790|594451314|FG005|Period 2|Withdrawal by Subject|0|||
164569524|NCT00868790|594451315|FG006|Period 2|Withdrawal by Subject|0|||
164569525|NCT00868790|594451316|FG007|Period 2|Withdrawal by Subject|0|||
164569526|NCT00868790|594451317|FG008|Period 2|Withdrawal by Subject|1|||
164569527|NCT00868790|594451318|FG009|Period 2|Withdrawal by Subject|0|||
164569528|NCT00868790|594451319|FG010|Period 2|Withdrawal by Subject|0|||
164569529|NCT00868790|594451320|FG011|Period 2|Withdrawal by Subject|0|||
164569530|NCT00868790|594451321|FG012|Period 2|Withdrawal by Subject|0|||
164569531|NCT00868790|594451322|FG013|Period 2|Withdrawal by Subject|1|||
164569532|NCT00868790|594451309|FG000|Period 3|Adverse Event|0|||
164569533|NCT00868790|594451310|FG001|Period 3|Adverse Event|0|||
164569534|NCT00868790|594451311|FG002|Period 3|Adverse Event|0|||
164569535|NCT00868790|594451312|FG003|Period 3|Adverse Event|0|||
164569536|NCT00868790|594451313|FG004|Period 3|Adverse Event|0|||
164569537|NCT00868790|594451314|FG005|Period 3|Adverse Event|0|||
164569538|NCT00868790|594451315|FG006|Period 3|Adverse Event|0|||
164569539|NCT00868790|594451316|FG007|Period 3|Adverse Event|0|||
164569540|NCT00868790|594451317|FG008|Period 3|Adverse Event|0|||
164569541|NCT00868790|594451318|FG009|Period 3|Adverse Event|1|||
164569542|NCT00868790|594451319|FG010|Period 3|Adverse Event|0|||
164569543|NCT00868790|594451320|FG011|Period 3|Adverse Event|0|||
164569544|NCT00868790|594451321|FG012|Period 3|Adverse Event|0|||
164569545|NCT00868790|594451322|FG013|Period 3|Adverse Event|0|||
164569546|NCT00868790|594451309|FG000|Period 3|Protocol Violation|0|||
164569547|NCT00868790|594451310|FG001|Period 3|Protocol Violation|0|||
164569548|NCT00868790|594451311|FG002|Period 3|Protocol Violation|0|||
164569549|NCT00868790|594451312|FG003|Period 3|Protocol Violation|0|||
164569550|NCT00868790|594451313|FG004|Period 3|Protocol Violation|0|||
164569551|NCT00868790|594451314|FG005|Period 3|Protocol Violation|0|||
164569552|NCT00868790|594451315|FG006|Period 3|Protocol Violation|0|||
164569553|NCT00868790|594451316|FG007|Period 3|Protocol Violation|0|||
164569554|NCT00868790|594451317|FG008|Period 3|Protocol Violation|0|||
164569555|NCT00868790|594451318|FG009|Period 3|Protocol Violation|0|||
164569556|NCT00868790|594451319|FG010|Period 3|Protocol Violation|1|||
164569557|NCT00868790|594451320|FG011|Period 3|Protocol Violation|0|||
164569558|NCT00868790|594451321|FG012|Period 3|Protocol Violation|0|||
164569559|NCT00868790|594451322|FG013|Period 3|Protocol Violation|0|||
164569560|NCT00868790|594451309|FG000|Period 3|Study Terminated by Sponsor|0|||
164569561|NCT00868790|594451310|FG001|Period 3|Study Terminated by Sponsor|0|||
164569562|NCT00868790|594451311|FG002|Period 3|Study Terminated by Sponsor|0|||
164569563|NCT00868790|594451312|FG003|Period 3|Study Terminated by Sponsor|1|||
164569564|NCT00868790|594451313|FG004|Period 3|Study Terminated by Sponsor|0|||
164569565|NCT00868790|594451314|FG005|Period 3|Study Terminated by Sponsor|0|||
164569566|NCT00868790|594451315|FG006|Period 3|Study Terminated by Sponsor|0|||
164569567|NCT00868790|594451316|FG007|Period 3|Study Terminated by Sponsor|0|||
164569568|NCT00868790|594451317|FG008|Period 3|Study Terminated by Sponsor|0|||
164569569|NCT00868790|594451318|FG009|Period 3|Study Terminated by Sponsor|0|||
164569570|NCT00868790|594451319|FG010|Period 3|Study Terminated by Sponsor|0|||
164569571|NCT00868790|594451320|FG011|Period 3|Study Terminated by Sponsor|0|||
164569572|NCT00868790|594451321|FG012|Period 3|Study Terminated by Sponsor|0|||
164569573|NCT00868790|594451322|FG013|Period 3|Study Terminated by Sponsor|0|||
164569574|NCT00868790|594451309|FG000|Period 4|Adverse Event|0|||
164569575|NCT00868790|594451310|FG001|Period 4|Adverse Event|0|||
164569576|NCT00868790|594451311|FG002|Period 4|Adverse Event|0|||
164569577|NCT00868790|594451312|FG003|Period 4|Adverse Event|0|||
164569578|NCT00868790|594451313|FG004|Period 4|Adverse Event|0|||
164569579|NCT00868790|594451314|FG005|Period 4|Adverse Event|0|||
164569580|NCT00868790|594451315|FG006|Period 4|Adverse Event|0|||
164569581|NCT00868790|594451316|FG007|Period 4|Adverse Event|1|||
164569582|NCT00868790|594451317|FG008|Period 4|Adverse Event|0|||
164569583|NCT00868790|594451318|FG009|Period 4|Adverse Event|0|||
164569584|NCT00868790|594451319|FG010|Period 4|Adverse Event|1|||
164569585|NCT00868790|594451320|FG011|Period 4|Adverse Event|0|||
164569586|NCT00868790|594451321|FG012|Period 4|Adverse Event|1|||
164569587|NCT00868790|594451322|FG013|Period 4|Adverse Event|0|||
164569588|NCT00868790|594451309|FG000|Period 4|Lost to Follow-up|0|||
164569589|NCT00868790|594451310|FG001|Period 4|Lost to Follow-up|0|||
164569590|NCT00868790|594451311|FG002|Period 4|Lost to Follow-up|0|||
164569591|NCT00868790|594451312|FG003|Period 4|Lost to Follow-up|0|||
164569592|NCT00868790|594451313|FG004|Period 4|Lost to Follow-up|0|||
164569593|NCT00868790|594451314|FG005|Period 4|Lost to Follow-up|0|||
164569594|NCT00868790|594451315|FG006|Period 4|Lost to Follow-up|0|||
164569595|NCT00868790|594451316|FG007|Period 4|Lost to Follow-up|1|||
164569596|NCT00868790|594451317|FG008|Period 4|Lost to Follow-up|0|||
164569597|NCT00868790|594451318|FG009|Period 4|Lost to Follow-up|0|||
164569598|NCT00868790|594451319|FG010|Period 4|Lost to Follow-up|0|||
164569599|NCT00868790|594451320|FG011|Period 4|Lost to Follow-up|0|||
164569600|NCT00868790|594451321|FG012|Period 4|Lost to Follow-up|0|||
164569601|NCT00868790|594451322|FG013|Period 4|Lost to Follow-up|0|||
164569602|NCT00868790|594451309|FG000|Period 4|Study Terminated by Sponsor|2|||
164224612|NCT00407030|593190311|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
164224613|NCT00407030|593190309|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
164673886|NCT01597245|594831045|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164673887|NCT01597245|594831046|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164673888|NCT01597245|594831047|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164673889|NCT01597245|594831048|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
164673890|NCT01597245|594831049|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164673891|NCT01597245|594831050|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164673892|NCT01597245|594831051|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
164673893|NCT01597245|594831052|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
164673894|NCT01597245|594831053|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
164673895|NCT01597245|594831054|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
164673896|NCT01597245|594831055|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164673897|NCT01597245|594831056|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164673898|NCT01597245|594831057|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164673899|NCT01597245|594831058|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164673900|NCT01597245|594831059|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164673901|NCT01597245|594831060|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164673902|NCT01597245|594831061|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164673903|NCT01597245|594831062|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164673904|NCT01597245|594831063|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164673905|NCT01597245|594831043|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164673906|NCT01597245|594831044|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164673907|NCT01597245|594831045|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164673908|NCT01597245|594831046|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164673909|NCT01597245|594831047|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164673910|NCT01597245|594831048|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164673911|NCT01597245|594831049|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164673912|NCT01597245|594831050|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164673913|NCT01597245|594831051|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164673914|NCT01597245|594831052|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164673915|NCT01597245|594831053|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
164673916|NCT01597245|594831054|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164673917|NCT01597245|594831055|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164673918|NCT01597245|594831056|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164673919|NCT01597245|594831057|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164673920|NCT01597245|594831058|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164673921|NCT01597245|594831059|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164673922|NCT01597245|594831060|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164673923|NCT01597245|594831061|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164673924|NCT01597245|594831062|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164673925|NCT01597245|594831063|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164673926|NCT01597245|594831043|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164673927|NCT01597245|594831044|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164673928|NCT01597245|594831045|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164673929|NCT01597245|594831046|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164673930|NCT01597245|594831047|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164673931|NCT01597245|594831048|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164673932|NCT01597245|594831049|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164673933|NCT01597245|594831050|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164673934|NCT01597245|594831051|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164673935|NCT01597245|594831052|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164673936|NCT01597245|594831053|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164673937|NCT01597245|594831054|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164673938|NCT01597245|594831055|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164673939|NCT01597245|594831056|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
164673940|NCT01597245|594831057|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
164673941|NCT01597245|594831058|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
164673942|NCT01597245|594831059|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164673943|NCT01597245|594831060|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164673944|NCT01597245|594831061|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164673945|NCT01597245|594831062|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164673946|NCT01597245|594831063|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164673947|NCT01597245|594831043|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164224614|NCT00407030|593190310|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
164224615|NCT00407030|593190311|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
164224616|NCT00407030|593190309|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
164224617|NCT00407030|593190310|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
164224618|NCT00407030|593190311|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
164224619|NCT00407030|593190309|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
164224620|NCT00407030|593190310|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
164224621|NCT00407030|593190311|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
164224622|NCT00407030|593190309|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
164224623|NCT00407030|593190310|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
164569603|NCT00868790|594451310|FG001|Period 4|Study Terminated by Sponsor|0|||
164569604|NCT00868790|594451311|FG002|Period 4|Study Terminated by Sponsor|0|||
164569605|NCT00868790|594451312|FG003|Period 4|Study Terminated by Sponsor|0|||
164569606|NCT00868790|594451313|FG004|Period 4|Study Terminated by Sponsor|0|||
164569607|NCT00868790|594451314|FG005|Period 4|Study Terminated by Sponsor|0|||
164569608|NCT00868790|594451315|FG006|Period 4|Study Terminated by Sponsor|0|||
164569609|NCT00868790|594451316|FG007|Period 4|Study Terminated by Sponsor|1|||
164569610|NCT00868790|594451317|FG008|Period 4|Study Terminated by Sponsor|2|||
164569611|NCT00868790|594451318|FG009|Period 4|Study Terminated by Sponsor|0|||
164569612|NCT00868790|594451319|FG010|Period 4|Study Terminated by Sponsor|2|||
164569613|NCT00868790|594451320|FG011|Period 4|Study Terminated by Sponsor|1|||
164569614|NCT00868790|594451321|FG012|Period 4|Study Terminated by Sponsor|0|||
164569615|NCT00868790|594451322|FG013|Period 4|Study Terminated by Sponsor|1|||
164569616|NCT00868790|594451309|FG000|Period 4|Abnormal ALT/AST|0|||
164569617|NCT00868790|594451310|FG001|Period 4|Abnormal ALT/AST|0|||
164569618|NCT00868790|594451311|FG002|Period 4|Abnormal ALT/AST|1|||
164569619|NCT00868790|594451312|FG003|Period 4|Abnormal ALT/AST|0|||
164569620|NCT00868790|594451313|FG004|Period 4|Abnormal ALT/AST|0|||
164569621|NCT00868790|594451314|FG005|Period 4|Abnormal ALT/AST|0|||
164569622|NCT00868790|594451315|FG006|Period 4|Abnormal ALT/AST|0|||
164569623|NCT00868790|594451316|FG007|Period 4|Abnormal ALT/AST|0|||
164569624|NCT00868790|594451317|FG008|Period 4|Abnormal ALT/AST|0|||
164569625|NCT00868790|594451318|FG009|Period 4|Abnormal ALT/AST|0|||
164569626|NCT00868790|594451319|FG010|Period 4|Abnormal ALT/AST|0|||
164569627|NCT00868790|594451320|FG011|Period 4|Abnormal ALT/AST|0|||
164569628|NCT00868790|594451321|FG012|Period 4|Abnormal ALT/AST|0|||
164569629|NCT00868790|594451322|FG013|Period 4|Abnormal ALT/AST|0|||
164569630|NCT00868790|594451309|FG000|Post-study|Withdrawal by Subject|0|||
164569631|NCT00868790|594451310|FG001|Post-study|Withdrawal by Subject|0|||
164569632|NCT00868790|594451311|FG002|Post-study|Withdrawal by Subject|0|||
164569633|NCT00868790|594451312|FG003|Post-study|Withdrawal by Subject|0|||
164569634|NCT00868790|594451313|FG004|Post-study|Withdrawal by Subject|1|||
164569635|NCT00868790|594451314|FG005|Post-study|Withdrawal by Subject|0|||
164569636|NCT00868790|594451315|FG006|Post-study|Withdrawal by Subject|0|||
164569637|NCT00868790|594451316|FG007|Post-study|Withdrawal by Subject|0|||
164569638|NCT00868790|594451317|FG008|Post-study|Withdrawal by Subject|0|||
164569639|NCT00868790|594451318|FG009|Post-study|Withdrawal by Subject|0|||
164569640|NCT00868790|594451319|FG010|Post-study|Withdrawal by Subject|0|||
164569641|NCT00868790|594451320|FG011|Post-study|Withdrawal by Subject|0|||
164569642|NCT00868790|594451321|FG012|Post-study|Withdrawal by Subject|0|||
164569643|NCT00868790|594451322|FG013|Post-study|Withdrawal by Subject|0|||
164569644|NCT00868790|594451309|FG000|Post-study|Excluded Medication|0|||
164569645|NCT00868790|594451310|FG001|Post-study|Excluded Medication|0|||
164569646|NCT00868790|594451311|FG002|Post-study|Excluded Medication|0|||
164569647|NCT00868790|594451312|FG003|Post-study|Excluded Medication|0|||
164569648|NCT00868790|594451313|FG004|Post-study|Excluded Medication|0|||
164569649|NCT00868790|594451314|FG005|Post-study|Excluded Medication|0|||
164569650|NCT00868790|594451315|FG006|Post-study|Excluded Medication|0|||
164569651|NCT00868790|594451316|FG007|Post-study|Excluded Medication|2|||
164569652|NCT00868790|594451317|FG008|Post-study|Excluded Medication|0|||
164569653|NCT00868790|594451318|FG009|Post-study|Excluded Medication|1|||
164569654|NCT00868790|594451319|FG010|Post-study|Excluded Medication|0|||
164569655|NCT00868790|594451320|FG011|Post-study|Excluded Medication|0|||
164569656|NCT00868790|594451321|FG012|Post-study|Excluded Medication|0|||
164569657|NCT00868790|594451322|FG013|Post-study|Excluded Medication|0|||
164569658|NCT01763164|594451323|FG000|Treatment Phase|Participant/Guardian decision|26|||
164569659|NCT01763164|594451324|FG001|Treatment Phase|Participant/Guardian decision|14|||
164569660|NCT01763164|594451323|FG000|Treatment Phase|Protocol Violation|1|||
164569661|NCT01763164|594451324|FG001|Treatment Phase|Protocol Violation|1|||
164329147|NCT01397201|593583239|FG002|Overall Study|Not treated|1|||
164569662|NCT01763164|594451323|FG000|Treatment Phase|Progressive Disease|142|||
164569663|NCT01763164|594451324|FG001|Treatment Phase|Progressive Disease|76|||
164569664|NCT01763164|594451323|FG000|Treatment Phase|Physician Decision|24|||
164569665|NCT01763164|594451324|FG001|Treatment Phase|Physician Decision|13|||
164569666|NCT01763164|594451323|FG000|Treatment Phase|Death|10|||
164569667|NCT01763164|594451324|FG001|Treatment Phase|Death|1|||
164569668|NCT01763164|594451323|FG000|Treatment Phase|Adverse Event|66|||
164569669|NCT01763164|594451324|FG001|Treatment Phase|Adverse Event|8|||
164673948|NCT01597245|594831044|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164673949|NCT01597245|594831045|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164673950|NCT01597245|594831046|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164673951|NCT01597245|594831047|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164673952|NCT01597245|594831048|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164673953|NCT01597245|594831049|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164673954|NCT01597245|594831050|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164673955|NCT01597245|594831051|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164673956|NCT01597245|594831052|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164673957|NCT01597245|594831053|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164673958|NCT01597245|594831054|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164673959|NCT01597245|594831055|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164673960|NCT01597245|594831056|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
164673961|NCT01597245|594831057|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
164673962|NCT01597245|594831058|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
164673963|NCT01597245|594831059|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164673964|NCT01597245|594831060|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164673965|NCT01597245|594831061|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164673966|NCT01597245|594831062|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164673967|NCT01597245|594831063|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164673968|NCT01597245|594831043|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164673969|NCT01597245|594831044|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164224624|NCT00407030|593190311|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
164224625|NCT00407030|593190309|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
164224626|NCT00407030|593190310|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
164224627|NCT00407030|593190311|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
164224628|NCT01340170|593190312|FG000|Overall Study|Lost to Follow-up|2|||
164224629|NCT01340170|593190313|FG001|Overall Study|Lost to Follow-up|4|||
164224630|NCT01340170|593190314|FG002|Overall Study|Lost to Follow-up|0|||
164224631|NCT01340170|593190312|FG000|Overall Study|Implant failure|1|||
164224632|NCT01340170|593190313|FG001|Overall Study|Implant failure|3|||
164569670|NCT01763164|594451323|FG000|Treatment Phase|Randomized but not Treated|0|||
164569671|NCT01763164|594451324|FG001|Treatment Phase|Randomized but not Treated|19|||
164569672|NCT01763164|594451323|FG000|Treatment Phase|Other|0|||
164569673|NCT01763164|594451324|FG001|Treatment Phase|Other|1|||
164569674|NCT01763164|594451323|FG000|Follow up Phase|New therapy for study indication|12|||
164569675|NCT01763164|594451324|FG001|Follow up Phase|New therapy for study indication|3|||
164569676|NCT01763164|594451323|FG000|Follow up Phase|Death|21|||
164569677|NCT01763164|594451324|FG001|Follow up Phase|Death|4|||
164569678|NCT01763164|594451323|FG000|Follow up Phase|Subject/guardian decision|9|||
164569679|NCT01763164|594451324|FG001|Follow up Phase|Subject/guardian decision|2|||
164569680|NCT01763164|594451323|FG000|Follow up Phase|Progressive disease|127|||
164569681|NCT01763164|594451324|FG001|Follow up Phase|Progressive disease|62|||
164569682|NCT01763164|594451323|FG000|Follow up Phase|Physician Decision|10|||
164569683|NCT01763164|594451324|FG001|Follow up Phase|Physician Decision|3|||
164569684|NCT01763164|594451323|FG000|Follow up Phase|Lost to Follow-up|1|||
164569685|NCT01763164|594451324|FG001|Follow up Phase|Lost to Follow-up|0|||
164569686|NCT01763164|594451323|FG000|Follow up Phase|Adverse Event|17|||
164569687|NCT01763164|594451324|FG001|Follow up Phase|Adverse Event|1|||
164569688|NCT01264939|594451325|FG000|Overall Study|Adverse Event|1|||
164569689|NCT01264939|594451326|FG001|Overall Study|Adverse Event|3|||
164569690|NCT01264939|594451325|FG000|Overall Study|Lost to Follow-up|0|||
164569691|NCT01264939|594451326|FG001|Overall Study|Lost to Follow-up|3|||
164569692|NCT01264939|594451325|FG000|Overall Study|Physician Decision|1|||
164569693|NCT01264939|594451326|FG001|Overall Study|Physician Decision|1|||
164569694|NCT01264939|594451325|FG000|Overall Study|Patient/Guardian Decision|8|||
164569695|NCT01264939|594451326|FG001|Overall Study|Patient/Guardian Decision|10|||
164569696|NCT01264939|594451325|FG000|Overall Study|Disease Progression|8|||
164569697|NCT01264939|594451326|FG001|Overall Study|Disease Progression|11|||
164569698|NCT04964258|594451327|FG000|Overall Study|Lost to Follow-up|1|||
164569699|NCT04964258|594451328|FG001|Overall Study|Lost to Follow-up|0|||
164569700|NCT04964258|594451329|FG002|Overall Study|Lost to Follow-up|0|||
164569701|NCT04964258|594451330|FG003|Overall Study|Lost to Follow-up|0|||
164569702|NCT04964258|594451331|FG004|Overall Study|Lost to Follow-up|0|||
164569703|NCT04964258|594451332|FG005|Overall Study|Lost to Follow-up|1|||
164673970|NCT01597245|594831045|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164673971|NCT01597245|594831046|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164673972|NCT01597245|594831047|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164673973|NCT01597245|594831048|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164673974|NCT01597245|594831049|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164673975|NCT01597245|594831050|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164673976|NCT01597245|594831051|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164673977|NCT01597245|594831052|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164673978|NCT01597245|594831053|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164673979|NCT01597245|594831054|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164673980|NCT01597245|594831055|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164673981|NCT01597245|594831056|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164673982|NCT01597245|594831057|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
164673983|NCT01597245|594831058|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
164673984|NCT01597245|594831059|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164673985|NCT01597245|594831060|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164673986|NCT01597245|594831061|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164673987|NCT01597245|594831062|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164673988|NCT01597245|594831063|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164673989|NCT01597245|594831043|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164673990|NCT01597245|594831044|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164569704|NCT04964258|594451333|FG006|Overall Study|Lost to Follow-up|0|||
164569705|NCT04964258|594451334|FG007|Overall Study|Lost to Follow-up|0|||
164569706|NCT04964258|594451335|FG008|Overall Study|Lost to Follow-up|0|||
164569707|NCT04964258|594451336|FG009|Overall Study|Lost to Follow-up|0|||
164569708|NCT04964258|594451337|FG010|Overall Study|Lost to Follow-up|0|||
164569709|NCT02965378|594451338|FG000|Overall Study|Progression|16|||
164569710|NCT02965378|594451339|FG001|Overall Study|Progression|4|||
164569711|NCT02965378|594451338|FG000|Overall Study|Adverse Event|5|||
164224633|NCT01340170|593190314|FG002|Overall Study|Implant failure|0|||
164224634|NCT03878602|593190315|FG000|Overall Study|cord blood donation|7|||
164224635|NCT03878602|593190316|FG001|Overall Study|cord blood donation|1|||
164224636|NCT03878602|593190315|FG000|Overall Study|incomplete data collection|2|||
164224637|NCT03878602|593190316|FG001|Overall Study|incomplete data collection|0|||
164224638|NCT00736476|593190317|FG000|Overall Study|Adverse Event|1|||
164224639|NCT00736476|593190318|FG001|Overall Study|Adverse Event|0|||
164224640|NCT02633527|593190319|FG000|Overall Study|Failed to meet eligibility|0|||
164224641|NCT02633527|593190320|FG001|Overall Study|Failed to meet eligibility|1|||
164224642|NCT02633527|593190321|FG002|Overall Study|Failed to meet eligibility|1|||
164224643|NCT02633527|593190322|FG003|Overall Study|Failed to meet eligibility|0|||
164224644|NCT02633527|593190323|FG004|Overall Study|Failed to meet eligibility|1|||
164224645|NCT02633527|593190319|FG000|Overall Study|Adverse Event|0|||
164224646|NCT02633527|593190320|FG001|Overall Study|Adverse Event|4|||
164224647|NCT02633527|593190321|FG002|Overall Study|Adverse Event|3|||
164224648|NCT02633527|593190322|FG003|Overall Study|Adverse Event|1|||
164224649|NCT02633527|593190323|FG004|Overall Study|Adverse Event|5|||
164224650|NCT02633527|593190319|FG000|Overall Study|Lost to Follow-up|1|||
164224651|NCT02633527|593190320|FG001|Overall Study|Lost to Follow-up|2|||
164224652|NCT02633527|593190321|FG002|Overall Study|Lost to Follow-up|5|||
164224653|NCT02633527|593190322|FG003|Overall Study|Lost to Follow-up|5|||
164224654|NCT02633527|593190323|FG004|Overall Study|Lost to Follow-up|4|||
164224655|NCT02633527|593190319|FG000|Overall Study|Withdrawal by Subject|0|||
164224656|NCT02633527|593190320|FG001|Overall Study|Withdrawal by Subject|3|||
164224657|NCT02633527|593190321|FG002|Overall Study|Withdrawal by Subject|5|||
164224658|NCT02633527|593190322|FG003|Overall Study|Withdrawal by Subject|4|||
164224659|NCT02633527|593190323|FG004|Overall Study|Withdrawal by Subject|4|||
164224660|NCT02633527|593190319|FG000|Overall Study|Protocol Violation|0|||
164224661|NCT02633527|593190320|FG001|Overall Study|Protocol Violation|1|||
164224662|NCT02633527|593190321|FG002|Overall Study|Protocol Violation|1|||
164224663|NCT02633527|593190322|FG003|Overall Study|Protocol Violation|1|||
164224664|NCT02633527|593190323|FG004|Overall Study|Protocol Violation|1|||
164224665|NCT02633527|593190319|FG000|Overall Study|Physician Decision|0|||
164224666|NCT02633527|593190320|FG001|Overall Study|Physician Decision|0|||
164224667|NCT02633527|593190321|FG002|Overall Study|Physician Decision|0|||
164224668|NCT02633527|593190322|FG003|Overall Study|Physician Decision|0|||
164224669|NCT02633527|593190323|FG004|Overall Study|Physician Decision|1|||
164224670|NCT02633527|593190319|FG000|Overall Study|Administrative reason|1|||
164224671|NCT02633527|593190320|FG001|Overall Study|Administrative reason|0|||
164224672|NCT02633527|593190321|FG002|Overall Study|Administrative reason|0|||
164224673|NCT02633527|593190322|FG003|Overall Study|Administrative reason|1|||
164224674|NCT02633527|593190323|FG004|Overall Study|Administrative reason|0|||
164224675|NCT02633527|593190319|FG000|Overall Study|Multiple reasons|1|||
164224676|NCT02633527|593190320|FG001|Overall Study|Multiple reasons|0|||
164224677|NCT02633527|593190321|FG002|Overall Study|Multiple reasons|2|||
164224678|NCT02633527|593190322|FG003|Overall Study|Multiple reasons|2|||
164224679|NCT02633527|593190323|FG004|Overall Study|Multiple reasons|1|||
164224680|NCT00452530|593190324|FG000|Overall Study|Death|1|||
164224681|NCT00452530|593190325|FG001|Overall Study|Death|0|||
164224682|NCT00452530|593190324|FG000|Overall Study|Adverse Event|40|||
164224683|NCT00452530|593190325|FG001|Overall Study|Adverse Event|44|||
164224684|NCT00452530|593190324|FG000|Overall Study|Withdrawal by Subject|68|||
164224685|NCT00452530|593190325|FG001|Overall Study|Withdrawal by Subject|57|||
164224686|NCT00452530|593190324|FG000|Overall Study|Lost to Follow-up|1|||
164224687|NCT00452530|593190325|FG001|Overall Study|Lost to Follow-up|0|||
164224688|NCT00452530|593190324|FG000|Overall Study|Poor compliance/noncompliance|1|||
164569712|NCT02965378|594451339|FG001|Overall Study|Adverse Event|2|||
164224689|NCT00452530|593190325|FG001|Overall Study|Poor compliance/noncompliance|2|||
164224690|NCT00452530|593190324|FG000|Overall Study|No longer met study criteria|18|||
164224691|NCT00452530|593190325|FG001|Overall Study|No longer met study criteria|22|||
164224692|NCT00452530|593190324|FG000|Overall Study|Other|7|||
164224693|NCT00452530|593190325|FG001|Overall Study|Other|11|||
164224694|NCT06091956|593190326|FG000|Overall Study|Withdrawal by Subject|1|||
164569713|NCT02965378|594451338|FG000|Overall Study|Death|2|||
164224695|NCT06091956|593190326|FG000|Overall Study|Complicating Disease|1|||
164224696|NCT02176525|593190329|FG000|Overall Study|Adverse Event|0|||
164224697|NCT02176525|593190330|FG001|Overall Study|Adverse Event|0|||
164224698|NCT02176525|593190331|FG002|Overall Study|Adverse Event|0|||
164224699|NCT02176525|593190332|FG003|Overall Study|Adverse Event|1|||
164224700|NCT02176525|593190333|FG004|Overall Study|Adverse Event|1|||
164224701|NCT02176525|593190334|FG005|Overall Study|Adverse Event|0|||
164224702|NCT02176525|593190335|FG006|Overall Study|Adverse Event|1|||
164224703|NCT02176525|593190336|FG007|Overall Study|Adverse Event|0|||
164224704|NCT02176525|593190329|FG000|Overall Study|not treated|1|||
164224705|NCT02176525|593190330|FG001|Overall Study|not treated|0|||
164569714|NCT02965378|594451339|FG001|Overall Study|Death|0|||
164569715|NCT02965378|594451338|FG000|Overall Study|Refusal|2|||
164569716|NCT02965378|594451339|FG001|Overall Study|Refusal|1|||
164569717|NCT02965378|594451338|FG000|Overall Study|Not protocol specified|0|||
164569718|NCT02965378|594451339|FG001|Overall Study|Not protocol specified|2|||
164569719|NCT01384292|594451347|FG000|Part B|Severe non-compliance to protocol|1|||
164569720|NCT01384292|594451348|FG001|Part B|Severe non-compliance to protocol|0|||
164569721|NCT01384292|594451349|FG002|Part B|Severe non-compliance to protocol|0|||
164569722|NCT01171612|594451351|FG000|Overall Study|Lost to Follow-up|51|||
164569723|NCT01285349|594451352|FG000|Overall Study|Lost to Follow-up|27|||
164569724|NCT01285349|594451353|FG001|Overall Study|Lost to Follow-up|20|||
164569725|NCT01285349|594451354|FG002|Overall Study|Lost to Follow-up|27|||
164569726|NCT00565617|594451355|FG000|Overall Study|Withdrawal by Subject|1|||
164569727|NCT03040024|594451356|FG000|Overall Study|Adverse Event|0|||
164569728|NCT03040024|594451357|FG001|Overall Study|Adverse Event|1|||
164569729|NCT03040024|594451358|FG002|Overall Study|Adverse Event|0|||
164569730|NCT03040024|594451356|FG000|Overall Study|Death|0|||
164569731|NCT03040024|594451357|FG001|Overall Study|Death|1|||
164569732|NCT03040024|594451358|FG002|Overall Study|Death|0|||
164569733|NCT03040024|594451356|FG000|Overall Study|Physician Decision|0|||
164569734|NCT03040024|594451357|FG001|Overall Study|Physician Decision|0|||
164569735|NCT03040024|594451358|FG002|Overall Study|Physician Decision|1|||
164569736|NCT01526148|594451360|FG000|Overall Study|Adverse Event|6|||
164569737|NCT01526148|594451361|FG001|Overall Study|Adverse Event|5|||
164569738|NCT01526148|594451360|FG000|Overall Study|Lost to Follow-up|3|||
164569739|NCT01526148|594451361|FG001|Overall Study|Lost to Follow-up|6|||
164569740|NCT01526148|594451360|FG000|Overall Study|Withdrawal by Subject|2|||
164569741|NCT01526148|594451361|FG001|Overall Study|Withdrawal by Subject|0|||
164569742|NCT01526148|594451360|FG000|Overall Study|Unstable Medical Condition|1|||
164569743|NCT01526148|594451361|FG001|Overall Study|Unstable Medical Condition|0|||
164569744|NCT01526148|594451360|FG000|Overall Study|Unable to discontinue concomitant med|1|||
164569745|NCT01526148|594451361|FG001|Overall Study|Unable to discontinue concomitant med|0|||
164569746|NCT01526148|594451360|FG000|Overall Study|Moved out of state|1|||
164569747|NCT01526148|594451361|FG001|Overall Study|Moved out of state|0|||
164569748|NCT01526148|594451360|FG000|Overall Study|Incarcerated|0|||
164569749|NCT01526148|594451361|FG001|Overall Study|Incarcerated|2|||
164569750|NCT01173653|594451362|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
164569751|NCT01173653|594451363|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
164569752|NCT02867761|594451366|FG000|Overall Study|Participant withdrawn by investigator|0|||
164569753|NCT02867761|594451367|FG001|Overall Study|Participant withdrawn by investigator|1|||
164569754|NCT02867761|594451366|FG000|Overall Study|Lost to Follow-up|25|||
164569755|NCT02867761|594451367|FG001|Overall Study|Lost to Follow-up|18|||
164569756|NCT02867761|594451366|FG000|Overall Study|Unable to complete protocol|3|||
164569757|NCT02867761|594451367|FG001|Overall Study|Unable to complete protocol|7|||
164569758|NCT01512264|594451368|FG000|Overall Study|Lost to Follow-up|0|||
164569759|NCT01512264|594451369|FG001|Overall Study|Lost to Follow-up|0|||
164569760|NCT01512264|594451370|FG002|Overall Study|Lost to Follow-up|0|||
164569761|NCT01512264|594451371|FG003|Overall Study|Lost to Follow-up|1|||
164569762|NCT01988090|594451384|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
164569763|NCT01988090|594451385|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
164569764|NCT01988090|594451384|FG000|Start Treament After Randomization|Protocol Violation|0|||
164569765|NCT01988090|594451385|FG001|Start Treament After Randomization|Protocol Violation|1|||
164569766|NCT01988090|594451384|FG000|Complete Study After Start|Withdrawal by Subject|2|||
164224706|NCT02176525|593190331|FG002|Overall Study|not treated|0|||
164224707|NCT02176525|593190332|FG003|Overall Study|not treated|0|||
164224708|NCT02176525|593190333|FG004|Overall Study|not treated|0|||
164224709|NCT02176525|593190334|FG005|Overall Study|not treated|1|||
164224710|NCT02176525|593190335|FG006|Overall Study|not treated|0|||
164569767|NCT01988090|594451385|FG001|Complete Study After Start|Withdrawal by Subject|0|||
164569768|NCT01988090|594451384|FG000|Complete Study After Start|Protocol Violation|1|||
164569769|NCT01988090|594451385|FG001|Complete Study After Start|Protocol Violation|1|||
164569770|NCT01439945|594451398|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
164569771|NCT01439945|594451399|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
164569772|NCT01439945|594451400|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
164569773|NCT01439945|594451401|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
164569774|NCT01439945|594451398|FG000|Double-Blind Treatment Phase|Ineligible|1|||
164673991|NCT01597245|594831045|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164673992|NCT01597245|594831046|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164673993|NCT01597245|594831047|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164673994|NCT01597245|594831048|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164673995|NCT01597245|594831049|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164673996|NCT01597245|594831050|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164673997|NCT01597245|594831051|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164673998|NCT01597245|594831052|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164224711|NCT02176525|593190336|FG007|Overall Study|not treated|0|||
164224712|NCT02100644|593190339|FG000|LTG Escalation Phase|Adverse Event|9|||
164224713|NCT02100644|593190340|FG001|LTG Escalation Phase|Adverse Event|0|||
164224714|NCT02100644|593190341|FG002|LTG Escalation Phase|Adverse Event|0|||
164224715|NCT02100644|593190339|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
164224716|NCT02100644|593190340|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
164224717|NCT02100644|593190341|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
164224718|NCT02100644|593190339|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
164224719|NCT02100644|593190340|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
164224720|NCT02100644|593190341|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
164224721|NCT03163264|593190349|FG000|Overall Study|Withdrawal by Subject|13|||
164224722|NCT03163264|593190350|FG001|Overall Study|Withdrawal by Subject|3|||
164224723|NCT03163264|593190351|FG002|Overall Study|Withdrawal by Subject|4|||
164224724|NCT03163264|593190352|FG003|Overall Study|Withdrawal by Subject|2|||
164224725|NCT03163264|593190349|FG000|Overall Study|Lost to Follow-up|17|||
164224726|NCT03163264|593190350|FG001|Overall Study|Lost to Follow-up|20|||
164224727|NCT03163264|593190351|FG002|Overall Study|Lost to Follow-up|0|||
164224728|NCT03163264|593190352|FG003|Overall Study|Lost to Follow-up|0|||
164224729|NCT03163264|593190349|FG000|Overall Study|Death|0|||
164224730|NCT03163264|593190350|FG001|Overall Study|Death|2|||
164224731|NCT03163264|593190351|FG002|Overall Study|Death|0|||
164224732|NCT03163264|593190352|FG003|Overall Study|Death|0|||
164224733|NCT03679884|593190353|FG000|Overall Study|Other|12|||
164224734|NCT03679884|593190354|FG001|Overall Study|Other|12|||
164224735|NCT03679884|593190355|FG002|Overall Study|Other|12|||
164224736|NCT03679884|593190356|FG003|Overall Study|Other|7|||
164224737|NCT03679884|593190357|FG004|Overall Study|Other|8|||
164224738|NCT03679884|593190353|FG000|Overall Study|Lack of Efficacy|15|||
164224739|NCT03679884|593190354|FG001|Overall Study|Lack of Efficacy|29|||
164224740|NCT03679884|593190355|FG002|Overall Study|Lack of Efficacy|13|||
164224741|NCT03679884|593190356|FG003|Overall Study|Lack of Efficacy|29|||
164224742|NCT03679884|593190357|FG004|Overall Study|Lack of Efficacy|10|||
164224743|NCT03679884|593190353|FG000|Overall Study|Death|1|||
164224744|NCT03679884|593190354|FG001|Overall Study|Death|0|||
164224745|NCT03679884|593190355|FG002|Overall Study|Death|0|||
164224746|NCT03679884|593190356|FG003|Overall Study|Death|0|||
164224747|NCT03679884|593190357|FG004|Overall Study|Death|0|||
164224748|NCT03679884|593190353|FG000|Overall Study|Adverse Event|2|||
164224749|NCT03679884|593190354|FG001|Overall Study|Adverse Event|10|||
164224750|NCT03679884|593190355|FG002|Overall Study|Adverse Event|9|||
164224751|NCT03679884|593190356|FG003|Overall Study|Adverse Event|6|||
164224752|NCT03679884|593190357|FG004|Overall Study|Adverse Event|6|||
164224753|NCT03679884|593190353|FG000|Overall Study|Withdrawal by Subject|12|||
164224754|NCT03679884|593190354|FG001|Overall Study|Withdrawal by Subject|23|||
164224755|NCT03679884|593190355|FG002|Overall Study|Withdrawal by Subject|8|||
164224756|NCT03679884|593190356|FG003|Overall Study|Withdrawal by Subject|8|||
164224757|NCT03679884|593190357|FG004|Overall Study|Withdrawal by Subject|9|||
164224758|NCT03679884|593190353|FG000|Overall Study|Lost to Follow-up|1|||
164224759|NCT03679884|593190354|FG001|Overall Study|Lost to Follow-up|4|||
164224760|NCT03679884|593190355|FG002|Overall Study|Lost to Follow-up|2|||
164673999|NCT01597245|594831053|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164674000|NCT01597245|594831054|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164674001|NCT01597245|594831055|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164674002|NCT01597245|594831056|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164674003|NCT01597245|594831057|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
164674004|NCT01597245|594831058|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
164674005|NCT01597245|594831059|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164674006|NCT01597245|594831060|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164674007|NCT01597245|594831061|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164674008|NCT01597245|594831062|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164674009|NCT01597245|594831063|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164674010|NCT01597245|594831043|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164674011|NCT01597245|594831044|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164674012|NCT01597245|594831045|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164674013|NCT01597245|594831046|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164674014|NCT01597245|594831047|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164674015|NCT01597245|594831048|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164674016|NCT01597245|594831049|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164674017|NCT01597245|594831050|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164224761|NCT03679884|593190356|FG003|Overall Study|Lost to Follow-up|0|||
164224762|NCT03679884|593190357|FG004|Overall Study|Lost to Follow-up|3|||
164674018|NCT01597245|594831051|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164674019|NCT01597245|594831052|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164674020|NCT01597245|594831053|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164674021|NCT01597245|594831054|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164674022|NCT01597245|594831055|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164674023|NCT01597245|594831056|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
164674024|NCT01597245|594831057|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
164224763|NCT01026038|593190358|FG000|Overall Study|Lost to Follow-up|1|||
164224764|NCT01026038|593190359|FG001|Overall Study|Lost to Follow-up|1|||
164224765|NCT01026038|593190360|FG002|Overall Study|Lost to Follow-up|0|||
164224766|NCT02792257|593190368|FG000|Overall Study|Lost to Follow-up|3|||
164224767|NCT02792257|593190369|FG001|Overall Study|Lost to Follow-up|4|||
164224768|NCT02792257|593190368|FG000|Overall Study|Allergy|0|||
164224769|NCT02792257|593190369|FG001|Overall Study|Allergy|1|||
164224770|NCT02792257|593190368|FG000|Overall Study|Protocol Violation|2|||
164224771|NCT02792257|593190369|FG001|Overall Study|Protocol Violation|0|||
164224772|NCT02792257|593190368|FG000|Overall Study|Excessive Agitation|0|||
164224773|NCT02792257|593190369|FG001|Overall Study|Excessive Agitation|1|||
164224774|NCT02792257|593190368|FG000|Overall Study|Not Feeling Well|0|||
164224775|NCT02792257|593190369|FG001|Overall Study|Not Feeling Well|1|||
164224776|NCT03760666|593190371|FG000|Overall Study|Adverse Event|2|||
164224777|NCT03760666|593190372|FG001|Overall Study|Adverse Event|4|||
164224778|NCT03760666|593190373|FG002|Overall Study|Adverse Event|1|||
164224779|NCT03760666|593190371|FG000|Overall Study|AML Disease Progression|3|||
164224780|NCT03760666|593190372|FG001|Overall Study|AML Disease Progression|3|||
164224781|NCT03760666|593190373|FG002|Overall Study|AML Disease Progression|0|||
164224782|NCT03760666|593190371|FG000|Overall Study|Physician Decision|0|||
164224783|NCT03760666|593190372|FG001|Overall Study|Physician Decision|3|||
164224784|NCT03760666|593190373|FG002|Overall Study|Physician Decision|0|||
164224785|NCT03760666|593190371|FG000|Overall Study|Withdrawal by Subject|0|||
164224786|NCT03760666|593190372|FG001|Overall Study|Withdrawal by Subject|1|||
164224787|NCT03760666|593190373|FG002|Overall Study|Withdrawal by Subject|0|||
164224788|NCT01800058|593190379|FG000|Overall Study|Lost to Follow-up|1|||
164224789|NCT01064622|593190380|FG000|Randomized Phase II|Withdrawal by Subject|2|||
164224790|NCT01064622|593190381|FG001|Randomized Phase II|Withdrawal by Subject|2|||
164224791|NCT01064622|593190380|FG000|Randomized Phase II|Protocol Violation|0|||
164224792|NCT01064622|593190381|FG001|Randomized Phase II|Protocol Violation|1|||
164224793|NCT02946996|593190384|FG000|Overall Study|non-evaluable|3|||
164224794|NCT02946996|593190385|FG001|Overall Study|non-evaluable|6|||
164224795|NCT02946996|593190386|FG002|Overall Study|non-evaluable|5|||
164224796|NCT00176254|593190387|FG000|Overall Study|Lost to Follow-up|1|||
164674025|NCT01597245|594831058|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
164674026|NCT01597245|594831059|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164674027|NCT01597245|594831060|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164674028|NCT01597245|594831061|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164674029|NCT01597245|594831062|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164674030|NCT01597245|594831063|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164674031|NCT01597245|594831043|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
164674032|NCT01597245|594831044|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
164674033|NCT01597245|594831045|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
164674034|NCT01597245|594831046|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
164674035|NCT01597245|594831047|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
164674036|NCT01597245|594831048|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
164674037|NCT01597245|594831049|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
164674038|NCT01597245|594831050|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
164674039|NCT01597245|594831051|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
164674040|NCT01597245|594831052|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
164674041|NCT01597245|594831053|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
164674042|NCT01597245|594831054|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
164674043|NCT01597245|594831055|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
164674044|NCT01597245|594831056|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
164674045|NCT01597245|594831057|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
164674046|NCT01597245|594831058|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
164674047|NCT01597245|594831059|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
164674048|NCT01597245|594831060|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
164674049|NCT01597245|594831061|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
164674050|NCT01597245|594831062|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
164674051|NCT01597245|594831063|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
164674052|NCT01597245|594831043|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164674053|NCT01597245|594831044|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164674054|NCT01597245|594831045|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164674055|NCT01597245|594831046|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164674056|NCT01597245|594831047|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164674057|NCT01597245|594831048|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164674058|NCT01597245|594831049|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164674059|NCT01597245|594831050|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164674060|NCT01597245|594831051|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164674061|NCT01597245|594831052|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164674062|NCT01597245|594831053|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164674063|NCT01597245|594831054|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164224797|NCT05330429|593190390|FG000|Overall Study|Study Terminated by Sponsor|4|||
164329148|NCT01397201|593583240|FG003|Overall Study|Not treated|0|||
164224798|NCT05330429|593190391|FG001|Overall Study|Study Terminated by Sponsor|33|||
164224799|NCT05330429|593190392|FG002|Overall Study|Study Terminated by Sponsor|12|||
164224800|NCT05330429|593190390|FG000|Overall Study|Death|5|||
164224801|NCT05330429|593190391|FG001|Overall Study|Death|2|||
164224802|NCT05330429|593190392|FG002|Overall Study|Death|4|||
164224803|NCT05330429|593190390|FG000|Overall Study|Withdrew Consent|0|||
164224804|NCT05330429|593190391|FG001|Overall Study|Withdrew Consent|5|||
164224805|NCT05330429|593190392|FG002|Overall Study|Withdrew Consent|4|||
164224806|NCT05330429|593190390|FG000|Overall Study|Investigator's Discretion|0|||
164224807|NCT05330429|593190391|FG001|Overall Study|Investigator's Discretion|1|||
164224808|NCT05330429|593190392|FG002|Overall Study|Investigator's Discretion|3|||
164224809|NCT05330429|593190390|FG000|Overall Study|Subject Decision|1|||
164224810|NCT05330429|593190391|FG001|Overall Study|Subject Decision|2|||
164224811|NCT05330429|593190392|FG002|Overall Study|Subject Decision|0|||
164224812|NCT05330429|593190390|FG000|Overall Study|Lost to Follow-up|0|||
164224813|NCT05330429|593190391|FG001|Overall Study|Lost to Follow-up|1|||
164224814|NCT05330429|593190392|FG002|Overall Study|Lost to Follow-up|0|||
164224815|NCT02568254|593190396|FG000|Period 2|Adverse Event|0|||
164224816|NCT02568254|593190397|FG001|Period 2|Adverse Event|0|||
164224817|NCT02568254|593190398|FG002|Period 2|Adverse Event|1|||
164224818|NCT02568254|593190399|FG003|Period 2|Adverse Event|0|||
164224819|NCT02568254|593190400|FG004|Period 2|Adverse Event|0|||
164224820|NCT02568254|593190401|FG005|Period 2|Adverse Event|0|||
164224821|NCT02568254|593190396|FG000|Period 3|Unstatisfactory Lens fitting|0|||
164224822|NCT02568254|593190397|FG001|Period 3|Unstatisfactory Lens fitting|0|||
164224823|NCT02568254|593190398|FG002|Period 3|Unstatisfactory Lens fitting|0|||
164224824|NCT02568254|593190399|FG003|Period 3|Unstatisfactory Lens fitting|0|||
164224825|NCT02568254|593190400|FG004|Period 3|Unstatisfactory Lens fitting|1|||
164224826|NCT02568254|593190401|FG005|Period 3|Unstatisfactory Lens fitting|0|||
164224827|NCT02113878|593192128|FG000|Overall Study|Adverse Event|1|||
164224828|NCT02113878|593192129|FG001|Overall Study|Adverse Event|0|||
164224829|NCT02113878|593192128|FG000|Overall Study|Withdrawal by Subject|1|||
164224830|NCT02113878|593192129|FG001|Overall Study|Withdrawal by Subject|0|||
164569775|NCT01439945|594451399|FG001|Double-Blind Treatment Phase|Ineligible|2|||
164569776|NCT01439945|594451400|FG002|Double-Blind Treatment Phase|Ineligible|0|||
164569777|NCT01439945|594451401|FG003|Double-Blind Treatment Phase|Ineligible|1|||
164569778|NCT04082663|594451402|FG000|Overall Study|Adverse Event|6|||
164569779|NCT04082663|594451402|FG000|Overall Study|Lost to Follow-up|1|||
164569780|NCT00927563|594451403|FG000|Overall Study|Lost to Follow-up|1|||
164569781|NCT00927563|594451403|FG000|Overall Study|Withdrawal by Subject|1|||
164569782|NCT03529409|594451406|FG000|Randomized|Lost to Follow-up|0|||
164569783|NCT03529409|594451407|FG001|Randomized|Lost to Follow-up|0|||
164569784|NCT03529409|594451408|FG002|Randomized|Lost to Follow-up|4|||
164569785|NCT03529409|594451406|FG000|Randomized|Excluded|0|||
164569786|NCT03529409|594451407|FG001|Randomized|Excluded|0|||
164569787|NCT03529409|594451408|FG002|Randomized|Excluded|1|||
164569788|NCT03529409|594451406|FG000|Post-treatment Assessment|Death|1|||
164569789|NCT03529409|594451407|FG001|Post-treatment Assessment|Death|0|||
164569790|NCT03529409|594451408|FG002|Post-treatment Assessment|Death|0|||
164569791|NCT03529409|594451406|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
164569792|NCT03529409|594451407|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
164569793|NCT03529409|594451408|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
164569794|NCT03529409|594451406|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
164569795|NCT03529409|594451407|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
164569796|NCT03529409|594451408|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
164569797|NCT03529409|594451406|FG000|Follow-up Assessment|Death|1|||
164569798|NCT03529409|594451407|FG001|Follow-up Assessment|Death|0|||
164569799|NCT03529409|594451408|FG002|Follow-up Assessment|Death|0|||
164569800|NCT03529409|594451406|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
164569801|NCT03529409|594451407|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
164569802|NCT03529409|594451408|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
164569803|NCT01497262|594451411|FG000|Overall Study|Abnormal Lab Values|4|||
164569804|NCT01497262|594451411|FG000|Overall Study|Abnormal Test Procedure Result|1|||
164569805|NCT01497262|594451411|FG000|Overall Study|Physician Decision|1|||
164674064|NCT01597245|594831055|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164569806|NCT01497262|594451411|FG000|Overall Study|Withdrawal by Subject|2|||
164569807|NCT01497262|594451411|FG000|Overall Study|Adverse Event|2|||
164569808|NCT01497262|594451411|FG000|Overall Study|Protocol Violation|1|||
164674065|NCT01597245|594831056|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164224831|NCT02113878|593192128|FG000|Overall Study|patient non-compliance|1|||
164329149|NCT01397201|593583241|FG004|Overall Study|Not treated|0|||
164569809|NCT05501119|594451412|FG000|Overall Study|Withdrawal by Subject|2|||
164569810|NCT05501119|594451412|FG000|Overall Study|Lost to Follow-up|5|||
164569811|NCT01752023|594451413|FG000|Overall Study|Physician Decision|2|||
164569812|NCT01752023|594451414|FG001|Overall Study|Physician Decision|1|||
164569813|NCT02542072|594451415|FG000|First Intervention (1 Month)|Adverse Event|1|||
164224832|NCT02113878|593192129|FG001|Overall Study|patient non-compliance|0|||
164224833|NCT03142451|593192130|FG000|Overall Study|Adverse Event|5|||
164224834|NCT03142451|593192131|FG001|Overall Study|Adverse Event|2|||
164224835|NCT03142451|593192130|FG000|Overall Study|Lost to Follow-up|25|||
164224836|NCT03142451|593192131|FG001|Overall Study|Lost to Follow-up|8|||
164224837|NCT03142451|593192130|FG000|Overall Study|Participant request|24|||
164224838|NCT03142451|593192131|FG001|Overall Study|Participant request|12|||
164224839|NCT03142451|593192130|FG000|Overall Study|Protocol Violation|3|||
164224840|NCT03142451|593192131|FG001|Overall Study|Protocol Violation|1|||
164224841|NCT03142451|593192130|FG000|Overall Study|Other|1|||
164224842|NCT03142451|593192131|FG001|Overall Study|Other|1|||
164224843|NCT02144337|593192132|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
164224844|NCT02144337|593192133|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
164224845|NCT02144337|593192132|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
164224846|NCT02144337|593192133|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
164224847|NCT02144337|593192132|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
164224848|NCT02144337|593192133|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
164224849|NCT02144337|593192132|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
164569814|NCT02542072|594451416|FG001|First Intervention (1 Month)|Adverse Event|1|||
164569815|NCT02542072|594451415|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
164569816|NCT02542072|594451416|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
164569817|NCT02542072|594451415|FG000|First Intervention (1 Month)|Lens discomfort|1|||
164224850|NCT02144337|593192133|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
164569818|NCT02542072|594451416|FG001|First Intervention (1 Month)|Lens discomfort|2|||
164569819|NCT02542072|594451415|FG000|First Intervention (1 Month)|Protocol Violation|1|||
164569820|NCT02542072|594451416|FG001|First Intervention (1 Month)|Protocol Violation|0|||
164569821|NCT02542072|594451415|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
164569822|NCT02542072|594451416|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
164569823|NCT02542072|594451415|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
164569824|NCT02542072|594451416|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
164569825|NCT02899156|594451417|FG000|Overall Study|Death|1|||
164569826|NCT02899156|594451418|FG001|Overall Study|Death|0|||
164569827|NCT02899156|594451417|FG000|Overall Study|Physician Decision|0|||
164569828|NCT02899156|594451418|FG001|Overall Study|Physician Decision|1|||
164569829|NCT02440581|594451424|FG000|Overall Study|Death|0|||
164569830|NCT02440581|594451425|FG001|Overall Study|Death|0|||
164569831|NCT02440581|594451426|FG002|Overall Study|Death|7|||
164569832|NCT02440581|594451427|FG003|Overall Study|Death|5|||
164569833|NCT02440581|594451424|FG000|Overall Study|Transplanted|1|||
164569834|NCT02440581|594451425|FG001|Overall Study|Transplanted|0|||
164569835|NCT02440581|594451426|FG002|Overall Study|Transplanted|3|||
164569836|NCT02440581|594451427|FG003|Overall Study|Transplanted|2|||
164569837|NCT02440581|594451424|FG000|Overall Study|Withdrawal by Subject|4|||
164569838|NCT02440581|594451425|FG001|Overall Study|Withdrawal by Subject|11|||
164569839|NCT02440581|594451426|FG002|Overall Study|Withdrawal by Subject|3|||
164569840|NCT02440581|594451427|FG003|Overall Study|Withdrawal by Subject|7|||
164569841|NCT00654498|594451428|FG000|Overall Study|Not Treated|1|||
164569842|NCT00654498|594451429|FG001|Overall Study|Not Treated|0|||
164569843|NCT00654498|594451428|FG000|Overall Study|Adverse Event|6|||
164569844|NCT00654498|594451429|FG001|Overall Study|Adverse Event|1|||
164569845|NCT00654498|594451428|FG000|Overall Study|Protocol Violation|1|||
164569846|NCT00654498|594451429|FG001|Overall Study|Protocol Violation|1|||
164569847|NCT00654498|594451428|FG000|Overall Study|Lost to Follow-up|1|||
164569848|NCT00654498|594451429|FG001|Overall Study|Lost to Follow-up|5|||
164569849|NCT00654498|594451428|FG000|Overall Study|Withdrawal by Subject|1|||
164569850|NCT00654498|594451429|FG001|Overall Study|Withdrawal by Subject|0|||
164569851|NCT00654498|594451428|FG000|Overall Study|Other reason not defined above|4|||
164569852|NCT00654498|594451429|FG001|Overall Study|Other reason not defined above|5|||
164224851|NCT02144337|593192132|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
164569853|NCT01468987|594451430|FG000|Overall Study|Adverse Event|12|||
164569854|NCT01468987|594451431|FG001|Overall Study|Adverse Event|9|||
164569855|NCT01468987|594451430|FG000|Overall Study|Death|4|||
164569856|NCT01468987|594451431|FG001|Overall Study|Death|1|||
164569857|NCT01468987|594451430|FG000|Overall Study|Lost to Follow-up|10|||
164569858|NCT01468987|594451431|FG001|Overall Study|Lost to Follow-up|5|||
164569859|NCT01468987|594451430|FG000|Overall Study|Protocol Violation|8|||
164569860|NCT01468987|594451431|FG001|Overall Study|Protocol Violation|2|||
164569861|NCT01468987|594451430|FG000|Overall Study|Withdrawal by Subject|28|||
164569862|NCT01468987|594451431|FG001|Overall Study|Withdrawal by Subject|28|||
164569863|NCT01468987|594451430|FG000|Overall Study|Physician Decision|8|||
164569864|NCT01468987|594451431|FG001|Overall Study|Physician Decision|15|||
164569865|NCT01468987|594451430|FG000|Overall Study|Sponsor Decision|1|||
164569866|NCT01468987|594451431|FG001|Overall Study|Sponsor Decision|0|||
164569867|NCT00787787|594451432|FG000|Overall Study|Lack of Efficacy|4|||
164569868|NCT00787787|594451432|FG000|Overall Study|Adverse Event|3|||
164569869|NCT00943683|594451433|FG000|Overall Study|Adverse Event|3|||
164569870|NCT00943683|594451434|FG001|Overall Study|Adverse Event|3|||
164569871|NCT00943683|594451433|FG000|Overall Study|Lost to Follow-up|1|||
164569872|NCT00943683|594451434|FG001|Overall Study|Lost to Follow-up|1|||
164569873|NCT00943683|594451433|FG000|Overall Study|Protocol Violation|1|||
164569874|NCT00943683|594451434|FG001|Overall Study|Protocol Violation|2|||
164569875|NCT00943683|594451433|FG000|Overall Study|Withdrawal by Subject|1|||
164569876|NCT00943683|594451434|FG001|Overall Study|Withdrawal by Subject|0|||
164569877|NCT00943683|594451433|FG000|Overall Study|Patient Moved|1|||
164569878|NCT00943683|594451434|FG001|Overall Study|Patient Moved|0|||
164569879|NCT06001307|594453121|FG000|Overall Study|Lost to Follow-up|1|||
164569880|NCT06001307|594453122|FG001|Overall Study|Lost to Follow-up|2|||
164569881|NCT03532100|594453125|FG000|Overall Study|Intervention malfunction|1|||
164569882|NCT03896581|594453126|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
164569883|NCT03896581|594453127|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
164569884|NCT03896581|594453126|FG000|Overall Study|Withdrawal by Subject|4|||
164569885|NCT03896581|594453127|FG001|Overall Study|Withdrawal by Subject|1|||
164569886|NCT03896581|594453126|FG000|Overall Study|Lost to Follow-up|1|||
164569887|NCT03896581|594453127|FG001|Overall Study|Lost to Follow-up|0|||
164569888|NCT03896581|594453126|FG000|Overall Study|Lack of Efficacy|2|||
164569889|NCT03896581|594453127|FG001|Overall Study|Lack of Efficacy|1|||
164569890|NCT03896581|594453126|FG000|Overall Study|Adverse event, non-fatal|0|||
164569891|NCT03896581|594453127|FG001|Overall Study|Adverse event, non-fatal|2|||
164569892|NCT02689492|594453130|FG000|Overall Study|Lost to Follow-up|61|||
164569893|NCT02689492|594453130|FG000|Overall Study|Withdrawal by Subject|11|||
164569894|NCT02689492|594453130|FG000|Overall Study|Death|9|||
164569895|NCT02689492|594453130|FG000|Overall Study|Physician Decision|2|||
164569896|NCT02689492|594453130|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
164569897|NCT02689492|594453130|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
164569898|NCT02689492|594453130|FG000|Overall Study|Other than listed|1|||
164569899|NCT01750918|594453131|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
164224852|NCT02144337|593192133|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
164569900|NCT01750918|594453132|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
164569901|NCT01750918|594453133|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
164569902|NCT01750918|594453134|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
164569903|NCT01750918|594453135|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
164569904|NCT01750918|594453136|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
164569905|NCT01750918|594453137|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
164569906|NCT01750918|594453138|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
164569907|NCT01750918|594453131|FG000|Overall Study|Lost to Follow-up|0|||
164569908|NCT01750918|594453132|FG001|Overall Study|Lost to Follow-up|0|||
164569909|NCT01750918|594453133|FG002|Overall Study|Lost to Follow-up|2|||
164569910|NCT01750918|594453134|FG003|Overall Study|Lost to Follow-up|2|||
164569911|NCT01750918|594453135|FG004|Overall Study|Lost to Follow-up|0|||
164569912|NCT01750918|594453136|FG005|Overall Study|Lost to Follow-up|0|||
164569913|NCT01750918|594453137|FG006|Overall Study|Lost to Follow-up|0|||
164569914|NCT01750918|594453138|FG007|Overall Study|Lost to Follow-up|1|||
164569915|NCT01750918|594453131|FG000|Overall Study|Withdrawal by Subject|0|||
164569916|NCT01750918|594453132|FG001|Overall Study|Withdrawal by Subject|0|||
164569917|NCT01750918|594453133|FG002|Overall Study|Withdrawal by Subject|1|||
164569918|NCT01750918|594453134|FG003|Overall Study|Withdrawal by Subject|2|||
164569919|NCT01750918|594453135|FG004|Overall Study|Withdrawal by Subject|1|||
164569920|NCT01750918|594453136|FG005|Overall Study|Withdrawal by Subject|1|||
164569921|NCT01750918|594453137|FG006|Overall Study|Withdrawal by Subject|2|||
164569922|NCT01750918|594453138|FG007|Overall Study|Withdrawal by Subject|2|||
164569923|NCT00162773|594453147|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
164224853|NCT05333965|593192134|FG000|First Intervention|Adverse Event|0|||
164224854|NCT05333965|593192135|FG001|First Intervention|Adverse Event|1|||
164224855|NCT05333965|593192134|FG000|First Intervention|Withdrawal by Subject|0|||
164224856|NCT05333965|593192135|FG001|First Intervention|Withdrawal by Subject|1|||
164224857|NCT00871000|593192138|FG000|Overall Study|Withdrawal by Subject|1|||
164224858|NCT00871000|593192139|FG001|Overall Study|Withdrawal by Subject|0|||
164224859|NCT01052428|593192140|FG000|Overall Study|Death|1|||
164224860|NCT01052428|593192141|FG001|Overall Study|Death|0|||
164224861|NCT01052428|593192140|FG000|Overall Study|Withdrawal by Subject|0|||
164224862|NCT01052428|593192141|FG001|Overall Study|Withdrawal by Subject|1|||
164224863|NCT03400787|593192142|FG000|Overall Study|Lost to Follow-up|1|||
164224864|NCT03400787|593192143|FG001|Overall Study|Lost to Follow-up|0|||
164224865|NCT03400787|593192142|FG000|Overall Study|Death|1|||
164224866|NCT03400787|593192143|FG001|Overall Study|Death|0|||
164224867|NCT03400787|593192142|FG000|Overall Study|Protocol Violation|0|||
164224868|NCT03400787|593192143|FG001|Overall Study|Protocol Violation|2|||
164224869|NCT03400787|593192142|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
164224870|NCT03400787|593192143|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
164569924|NCT02338843|594453149|FG000|Overall Study|Adverse Event|2|||
164569925|NCT02338843|594453150|FG001|Overall Study|Adverse Event|1|||
164224871|NCT02402907|593192146|FG000|Overall Study|Delivered vaginally|9|||
164569926|NCT02338843|594453149|FG000|Overall Study|Death|40|||
164224872|NCT02402907|593192147|FG001|Overall Study|Delivered vaginally|3|||
164569927|NCT02338843|594453150|FG001|Overall Study|Death|53|||
164224873|NCT02402907|593192146|FG000|Overall Study|Delivered outside of Sinai|1|||
164224874|NCT02402907|593192147|FG001|Overall Study|Delivered outside of Sinai|1|||
164224875|NCT02402907|593192146|FG000|Overall Study|Lost to follow up after C-Section|10|||
164224876|NCT02402907|593192147|FG001|Overall Study|Lost to follow up after C-Section|23|||
164569928|NCT02338843|594453149|FG000|Overall Study|Physician Decision|1|||
164569929|NCT02338843|594453150|FG001|Overall Study|Physician Decision|0|||
164569930|NCT02338843|594453149|FG000|Overall Study|Withdrawal by Subject|0|||
164569931|NCT02338843|594453150|FG001|Overall Study|Withdrawal by Subject|2|||
164569932|NCT02338843|594453149|FG000|Overall Study|Subject Recovered|0|||
164569933|NCT02338843|594453150|FG001|Overall Study|Subject Recovered|2|||
164569934|NCT02338843|594453149|FG000|Overall Study|Discontinued prior to randomizat|1|||
164569935|NCT02338843|594453150|FG001|Overall Study|Discontinued prior to randomizat|0|||
164569936|NCT02660580|594453157|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
164569937|NCT02660580|594453158|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
164569938|NCT02660580|594453159|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
164569939|NCT02660580|594453160|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
164569940|NCT02660580|594453161|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
164569941|NCT02660580|594453157|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
164569942|NCT02660580|594453158|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
164569943|NCT02660580|594453159|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
164569944|NCT02660580|594453160|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
164569945|NCT02660580|594453161|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
164569946|NCT02660580|594453157|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
164569947|NCT02660580|594453158|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
164569948|NCT02660580|594453159|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
164569949|NCT02660580|594453160|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
164569950|NCT02660580|594453161|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
164569951|NCT02660580|594453157|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
164569952|NCT02660580|594453158|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
164569953|NCT02660580|594453159|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
164569954|NCT02660580|594453160|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
164569955|NCT02660580|594453161|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
164569956|NCT02660580|594453157|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
164569957|NCT02660580|594453158|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
164569958|NCT02660580|594453159|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
164569959|NCT02660580|594453160|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
164569960|NCT02660580|594453161|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
164569961|NCT02660580|594453157|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
164569962|NCT02660580|594453158|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
164569963|NCT02660580|594453159|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
164569964|NCT02660580|594453160|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
164569965|NCT02660580|594453161|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
164569966|NCT02660580|594453157|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
164569967|NCT02660580|594453158|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
164569968|NCT02660580|594453159|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
164569969|NCT02660580|594453160|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
164569970|NCT02660580|594453161|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
164569971|NCT02660580|594453157|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
164569972|NCT02660580|594453158|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
164569973|NCT02660580|594453159|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
164569974|NCT02660580|594453160|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
164569975|NCT02660580|594453161|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
164569976|NCT02660580|594453157|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
164569977|NCT02660580|594453158|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
164569978|NCT02660580|594453159|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
164569979|NCT02660580|594453160|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
164569980|NCT02660580|594453161|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
164569981|NCT02660580|594453157|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
164569982|NCT02660580|594453158|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
164569983|NCT02660580|594453159|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
164569984|NCT02660580|594453160|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
164569985|NCT02660580|594453161|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
164569986|NCT02660580|594453157|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
164569987|NCT02660580|594453158|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
164569988|NCT02660580|594453159|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
164569989|NCT02660580|594453160|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
164569990|NCT02660580|594453161|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
164569991|NCT02660580|594453157|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
164569992|NCT02660580|594453158|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
164674066|NCT01597245|594831057|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
164674067|NCT01597245|594831058|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
164674068|NCT01597245|594831059|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164674069|NCT01597245|594831060|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164674070|NCT01597245|594831061|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164674071|NCT01597245|594831062|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164674072|NCT01597245|594831063|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164674073|NCT01597245|594831043|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164674074|NCT01597245|594831044|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164674075|NCT01597245|594831045|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164674076|NCT01597245|594831046|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164674077|NCT01597245|594831047|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164674078|NCT01597245|594831048|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164674079|NCT01597245|594831049|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164674080|NCT01597245|594831050|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164674081|NCT01597245|594831051|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164674082|NCT01597245|594831052|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164674083|NCT01597245|594831053|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164674084|NCT01597245|594831054|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164674085|NCT01597245|594831055|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164674086|NCT01597245|594831056|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164674087|NCT01597245|594831057|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
164674088|NCT01597245|594831058|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
164674089|NCT01597245|594831059|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164674090|NCT01597245|594831060|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164674091|NCT01597245|594831061|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164674092|NCT01597245|594831062|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164674093|NCT01597245|594831063|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164674094|NCT01597245|594831043|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164674095|NCT01597245|594831044|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164674096|NCT01597245|594831045|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164674097|NCT01597245|594831046|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164674098|NCT01597245|594831047|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164674099|NCT01597245|594831048|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164674100|NCT01597245|594831049|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164674101|NCT01597245|594831050|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164674102|NCT01597245|594831051|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164674103|NCT01597245|594831052|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164674104|NCT01597245|594831053|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164674105|NCT01597245|594831054|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164674106|NCT01597245|594831055|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164674107|NCT01597245|594831056|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164674108|NCT01597245|594831057|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
164674109|NCT01597245|594831058|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
164674110|NCT01597245|594831059|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164674111|NCT01597245|594831060|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164674112|NCT01597245|594831061|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164674113|NCT01597245|594831062|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164674114|NCT01597245|594831063|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164674115|NCT01597245|594831043|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164674116|NCT01597245|594831044|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164674117|NCT01597245|594831045|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164674118|NCT01597245|594831046|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164674119|NCT01597245|594831047|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164674120|NCT01597245|594831048|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164674121|NCT01597245|594831049|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164674122|NCT01597245|594831050|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164674123|NCT01597245|594831051|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164674124|NCT01597245|594831052|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164674125|NCT01597245|594831053|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164674126|NCT01597245|594831054|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164674127|NCT01597245|594831055|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164674128|NCT01597245|594831056|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
164674129|NCT01597245|594831057|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164569993|NCT02660580|594453159|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
164569994|NCT02660580|594453160|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
164569995|NCT02660580|594453161|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
164569996|NCT02660580|594453157|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
164569997|NCT02660580|594453158|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
164569998|NCT02660580|594453159|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
164569999|NCT02660580|594453160|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
164570000|NCT02660580|594453161|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
164570001|NCT05415449|594453162|FG000|Overall Study|Lost to Follow-up|2|||
164570002|NCT05415449|594453162|FG000|Overall Study|Withdrawal by Subject|4|||
164570003|NCT02185521|594453165|FG000|Overall Study|Withdrawal by Subject|1|||
164570004|NCT02185521|594453165|FG000|Overall Study|Protocol Violation|1|||
164570005|NCT00398112|594453182|FG000|Overall Study|Adverse Event|4|||
164570006|NCT00398112|594453182|FG000|Overall Study|Disease progression|9|||
164570007|NCT00398112|594453182|FG000|Overall Study|Alternative treatment|1|||
164570008|NCT00398112|594453182|FG000|Overall Study|Withdrawal by Subject|3|||
164570009|NCT00398112|594453182|FG000|Overall Study|Death|1|||
164570010|NCT00582556|594453183|FG000|Overall Study|Withdrawal by Subject|0|||
164570011|NCT00582556|594453184|FG001|Overall Study|Withdrawal by Subject|1|||
164570012|NCT00582556|594453185|FG002|Overall Study|Withdrawal by Subject|1|||
164570013|NCT00582556|594453183|FG000|Overall Study|Physician Decision|0|||
164329150|NCT01397201|593583237|FG000|Overall Study|Not yet defined|3|||
164570014|NCT00582556|594453184|FG001|Overall Study|Physician Decision|0|||
164570015|NCT00582556|594453185|FG002|Overall Study|Physician Decision|1|||
164224877|NCT02595437|593192149|FG000|Triferic Via IV|Withdrawal by Subject|1|||
164224878|NCT02837952|593192151|FG000|Overall Study|Adverse Event|0|||
164224879|NCT02837952|593192152|FG001|Overall Study|Adverse Event|1|||
164224880|NCT02837952|593192151|FG000|Overall Study|Withdrawal by Subject|4|||
164224881|NCT02837952|593192152|FG001|Overall Study|Withdrawal by Subject|5|||
164224882|NCT02837952|593192151|FG000|Overall Study|Medication Error|1|||
164224883|NCT02837952|593192152|FG001|Overall Study|Medication Error|0|||
164224884|NCT03439072|593192155|FG000|Overall Study|Withdrawal by Subject|2|||
164224885|NCT03439072|593192156|FG001|Overall Study|Withdrawal by Subject|3|||
164224886|NCT03439072|593192155|FG000|Overall Study|Physician Decision|0|||
164224887|NCT03439072|593192156|FG001|Overall Study|Physician Decision|1|||
164224888|NCT02003898|593192157|FG000|Overall Study|Death|3|||
164224889|NCT02003898|593192157|FG000|Overall Study|Lost to Follow-up|12|||
164224890|NCT02003898|593192157|FG000|Overall Study|Withdrawal by Subject|52|||
164224891|NCT01651208|593192158|FG000|Overall Study|Lost to Follow-up|14|||
164570016|NCT01993888|594453186|FG000|Overall Study|Death|1|||
164570017|NCT01993888|594453187|FG001|Overall Study|Death|1|||
164570018|NCT01993888|594453186|FG000|Overall Study|Lost to Follow-up|1|||
164570019|NCT01993888|594453187|FG001|Overall Study|Lost to Follow-up|1|||
164570020|NCT01993888|594453186|FG000|Overall Study|Withdrawal by Subject|0|||
164570021|NCT01993888|594453187|FG001|Overall Study|Withdrawal by Subject|1|||
164570022|NCT03124459|594453191|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
164570023|NCT03124459|594453192|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
164570024|NCT03124459|594453193|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
164570025|NCT03124459|594453194|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
164570026|NCT03124459|594453195|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
164570027|NCT03124459|594453196|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
164570028|NCT03124459|594453191|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
164570029|NCT03124459|594453192|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
164570030|NCT03124459|594453193|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
164570031|NCT03124459|594453194|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
164570032|NCT03124459|594453195|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
164224892|NCT01651208|593192159|FG001|Overall Study|Lost to Follow-up|16|||
164570033|NCT03124459|594453196|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
164570034|NCT03124459|594453191|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
164329151|NCT01397201|593583238|FG001|Overall Study|Not yet defined|6|||
164329152|NCT01397201|593583239|FG002|Overall Study|Not yet defined|5|||
164329153|NCT01397201|593583240|FG003|Overall Study|Not yet defined|5|||
164329154|NCT01397201|593583241|FG004|Overall Study|Not yet defined|4|||
164329155|NCT01397201|593583237|FG000|Overall Study|Adverse Event|2|||
164329156|NCT01397201|593583238|FG001|Overall Study|Adverse Event|0|||
164329157|NCT01397201|593583239|FG002|Overall Study|Adverse Event|0|||
164329158|NCT01397201|593583240|FG003|Overall Study|Adverse Event|0|||
164570035|NCT03124459|594453192|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
164570036|NCT03124459|594453193|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
164570037|NCT03124459|594453194|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
164570038|NCT03124459|594453195|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
164570039|NCT03124459|594453196|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
164570040|NCT03124459|594453191|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
164570041|NCT03124459|594453192|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
164570042|NCT03124459|594453193|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
164570043|NCT03124459|594453194|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
164570044|NCT03124459|594453195|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
164570045|NCT03124459|594453196|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
164570046|NCT03124459|594453191|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
164570047|NCT03124459|594453192|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
164570048|NCT03124459|594453193|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
164570049|NCT03124459|594453194|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
164570050|NCT03124459|594453195|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
164570051|NCT03124459|594453196|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
164570052|NCT03124459|594453191|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
164570053|NCT03124459|594453192|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
164570054|NCT03124459|594453193|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
164570055|NCT03124459|594453194|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
164570056|NCT03124459|594453195|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
164570057|NCT03124459|594453196|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
164570058|NCT01028352|594453197|FG000|Overall Study|Ineligible due to baseline average pain|5|||
164570059|NCT01028352|594453197|FG000|Overall Study|Withdrawal by Subject|1|||
164570060|NCT01903876|594453198|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
164570061|NCT01903876|594453199|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
164570062|NCT01903876|594453198|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
164570063|NCT01903876|594453199|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
164570064|NCT00826748|594453210|FG000|Overall Study|Withdrawal by Subject|0|||
164570065|NCT00826748|594453211|FG001|Overall Study|Withdrawal by Subject|0|||
164570066|NCT00826748|594453212|FG002|Overall Study|Withdrawal by Subject|2|||
164570067|NCT00826748|594453210|FG000|Overall Study|Physician Decision|0|||
164570068|NCT00826748|594453211|FG001|Overall Study|Physician Decision|0|||
164570069|NCT00826748|594453212|FG002|Overall Study|Physician Decision|1|||
164570070|NCT00826748|594453210|FG000|Overall Study|Samples Did Not pass QC|0|||
164570071|NCT00826748|594453211|FG001|Overall Study|Samples Did Not pass QC|0|||
164570072|NCT00826748|594453212|FG002|Overall Study|Samples Did Not pass QC|1|||
164570073|NCT02300129|594453214|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
164570074|NCT02300129|594453215|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
164570075|NCT02300129|594453216|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
164570076|NCT02300129|594453217|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
164570077|NCT02300129|594453214|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
164570078|NCT02300129|594453215|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
164570079|NCT02300129|594453216|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
164570080|NCT02300129|594453217|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
164570081|NCT02300129|594453214|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
164570082|NCT02300129|594453215|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
164570083|NCT02300129|594453216|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
164570084|NCT02300129|594453217|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
164570085|NCT01887912|594453218|FG000|Overall Study|Serious adverse event|400|||
164570086|NCT01887912|594453219|FG001|Overall Study|Serious adverse event|198|||
164570087|NCT01887912|594453218|FG000|Overall Study|Other Adverse Event|34|||
164570088|NCT01887912|594453219|FG001|Overall Study|Other Adverse Event|15|||
164570089|NCT01887912|594453218|FG000|Overall Study|Protocol Violation|67|||
164570090|NCT01887912|594453219|FG001|Overall Study|Protocol Violation|37|||
164570091|NCT01887912|594453218|FG000|Overall Study|Lost to Follow-up|163|||
164570092|NCT01887912|594453219|FG001|Overall Study|Lost to Follow-up|74|||
164570093|NCT01887912|594453218|FG000|Overall Study|Withdrawal by Subject|606|||
164570094|NCT01887912|594453219|FG001|Overall Study|Withdrawal by Subject|349|||
164570095|NCT01887912|594453218|FG000|Overall Study|Other|122|||
164570096|NCT01887912|594453219|FG001|Overall Study|Other|58|||
164329159|NCT01397201|593583241|FG004|Overall Study|Adverse Event|0|||
164674130|NCT01597245|594831058|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164674131|NCT01597245|594831059|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164674132|NCT01597245|594831060|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164674133|NCT01597245|594831061|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164674134|NCT01597245|594831062|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164674135|NCT01597245|594831063|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164674136|NCT01597245|594831043|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164674137|NCT01597245|594831044|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164674138|NCT01597245|594831045|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164674139|NCT01597245|594831046|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164674140|NCT01597245|594831047|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164674141|NCT01597245|594831048|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164674142|NCT01597245|594831049|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164674143|NCT01597245|594831050|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164674144|NCT01597245|594831051|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164674145|NCT01597245|594831052|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164674146|NCT01597245|594831053|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164674147|NCT01597245|594831054|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164674148|NCT01597245|594831055|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164674149|NCT01597245|594831056|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164674150|NCT01597245|594831057|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164674151|NCT01597245|594831058|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164674152|NCT01597245|594831059|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
164674153|NCT01597245|594831060|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
164224893|NCT00986102|593192176|FG000|Overall Study|Lost to Follow-up|0|||
164224894|NCT00986102|593192177|FG001|Overall Study|Lost to Follow-up|1|||
164224895|NCT00986102|593192178|FG002|Overall Study|Lost to Follow-up|0|||
164224896|NCT00986102|593192179|FG003|Overall Study|Lost to Follow-up|1|||
164224897|NCT00986102|593192176|FG000|Overall Study|Withdrawal by Subject|1|||
164224898|NCT00986102|593192177|FG001|Overall Study|Withdrawal by Subject|1|||
164224899|NCT00986102|593192178|FG002|Overall Study|Withdrawal by Subject|0|||
164224900|NCT00986102|593192179|FG003|Overall Study|Withdrawal by Subject|0|||
164224901|NCT02314247|593192180|FG000|Overall Study|Adverse Event|2|||
164224902|NCT02314247|593192181|FG001|Overall Study|Adverse Event|1|||
164224903|NCT02314247|593192182|FG002|Overall Study|Adverse Event|0|||
164224904|NCT02314247|593192180|FG000|Overall Study|Withdrawal by Subject|1|||
164224905|NCT02314247|593192181|FG001|Overall Study|Withdrawal by Subject|3|||
164224906|NCT02314247|593192182|FG002|Overall Study|Withdrawal by Subject|1|||
164224907|NCT02314247|593192180|FG000|Overall Study|Progression of Disease|6|||
164224908|NCT02314247|593192181|FG001|Overall Study|Progression of Disease|2|||
164224909|NCT02314247|593192182|FG002|Overall Study|Progression of Disease|0|||
164224910|NCT01260311|593192188|FG000|Overall Study|Adverse Event|11|||
164224911|NCT01260311|593192188|FG000|Overall Study|Lack of Efficacy|4|||
164224912|NCT01260311|593192188|FG000|Overall Study|Lost to Follow-up|25|||
164224913|NCT01260311|593192188|FG000|Overall Study|Withdrawal by Subject|6|||
164224914|NCT01260311|593192188|FG000|Overall Study|Financial Constraints|77|||
164224915|NCT01260311|593192188|FG000|Overall Study|Gone to Province|2|||
164224916|NCT01260311|593192188|FG000|Overall Study|Medication Stopped|1|||
164224917|NCT01260311|593192188|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
164224918|NCT00478140|593192189|FG000|Overall Study|Clinical Disease Progression|1|||
164224919|NCT00425854|593192192|FG000|Overall Study|Progressive Disease|19|||
164224920|NCT00425854|593192193|FG001|Overall Study|Progressive Disease|12|||
164224921|NCT00425854|593192192|FG000|Overall Study|Dose reduction toxicity AE|8|||
164224922|NCT00425854|593192193|FG001|Overall Study|Dose reduction toxicity AE|7|||
164224923|NCT00425854|593192192|FG000|Overall Study|Other Adverse Event|2|||
164224924|NCT00425854|593192193|FG001|Overall Study|Other Adverse Event|2|||
164224925|NCT01630811|593192194|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
164224926|NCT01630811|593192195|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
164224927|NCT01725308|593192198|FG000|Treatment Period I|Did Not Receive Drug|1|||
164224928|NCT01725308|593192199|FG001|Treatment Period I|Did Not Receive Drug|0|||
164224929|NCT01725308|593192200|FG002|Treatment Period I|Did Not Receive Drug|0|||
164224930|NCT01725308|593192198|FG000|Treatment Period I|Adverse Event|5|||
164224931|NCT01725308|593192199|FG001|Treatment Period I|Adverse Event|4|||
164224932|NCT01725308|593192200|FG002|Treatment Period I|Adverse Event|21|||
164224933|NCT01725308|593192198|FG000|Treatment Period I|Insufficient Response|7|||
164224934|NCT01725308|593192199|FG001|Treatment Period I|Insufficient Response|0|||
164224935|NCT01725308|593192200|FG002|Treatment Period I|Insufficient Response|5|||
164224936|NCT01725308|593192198|FG000|Treatment Period I|Worsening of the Target Disease|8|||
164224937|NCT01725308|593192199|FG001|Treatment Period I|Worsening of the Target Disease|0|||
164224938|NCT01725308|593192200|FG002|Treatment Period I|Worsening of the Target Disease|2|||
164224939|NCT01725308|593192198|FG000|Treatment Period I|Changes in the Episodes|3|||
164329160|NCT01229397|593583247|FG000|Overall Study|Withdrawal by Subject|3|||
164329161|NCT01229397|593583248|FG001|Overall Study|Withdrawal by Subject|3|||
164329162|NCT01229397|593583247|FG000|Overall Study|Lost to Follow-up|7|||
164329163|NCT01229397|593583248|FG001|Overall Study|Lost to Follow-up|6|||
164329164|NCT01229397|593583247|FG000|Overall Study|Migrated/moved from study area|1|||
164329165|NCT01229397|593583248|FG001|Overall Study|Migrated/moved from study area|0|||
164329166|NCT01810432|593583251|FG000|Washout|Protocol Violation|0|||
164329167|NCT01810432|593583252|FG001|Washout|Protocol Violation|1|||
164329168|NCT01810432|593583251|FG000|Washout|Adverse Event|1|||
164329169|NCT01810432|593583252|FG001|Washout|Adverse Event|0|||
164329170|NCT01810432|593583251|FG000|Period 2|Withdrawal by Subject|2|||
164329171|NCT01810432|593583252|FG001|Period 2|Withdrawal by Subject|1|||
164329172|NCT01810432|593583251|FG000|Period 2|Physician Decision|1|||
164329173|NCT01810432|593583252|FG001|Period 2|Physician Decision|0|||
164329174|NCT01810432|593583251|FG000|Period 2|Lost to Follow-up|1|||
164329175|NCT01810432|593583252|FG001|Period 2|Lost to Follow-up|1|||
164329176|NCT03343067|593583255|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
164329177|NCT03343067|593583256|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
164329178|NCT03343067|593583257|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
164329179|NCT00542451|593583258|FG000|Overall Study|Adverse Event|31|||
164329180|NCT00542451|593583258|FG000|Overall Study|Withdrawal by Subject|30|||
164329181|NCT00542451|593583258|FG000|Overall Study|Physician Decision|4|||
164329182|NCT00542451|593583258|FG000|Overall Study|Recurrent disease|1|||
164329183|NCT00542451|593583258|FG000|Overall Study|unknown reason|1|||
164329184|NCT00542451|593583258|FG000|Overall Study|Death|2|||
164329185|NCT00542451|593583258|FG000|Overall Study|Lost to Follow-up|10|||
164329186|NCT00116168|593583261|FG000|Overall Study|Lost to Follow-up|6|||
164329187|NCT00116168|593583262|FG001|Overall Study|Lost to Follow-up|5|||
164329188|NCT00116168|593583263|FG002|Overall Study|Lost to Follow-up|0|||
164329189|NCT00116168|593583264|FG003|Overall Study|Lost to Follow-up|0|||
164329190|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
164329191|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
164329192|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
164329193|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
164329194|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
164329195|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
164329196|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
164329197|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
164329198|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
164329199|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
164329200|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
164329201|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
164329202|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
164329203|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
164329204|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
164329205|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
164329206|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Program Termination|3|||
164329207|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Program Termination|0|||
164329208|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Program Termination|1|||
164329209|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Program Termination|1|||
164329210|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
164329211|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
164329212|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
164329213|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
164329214|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
164329215|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
164329216|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
164329217|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
164329218|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
164329219|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
164329220|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
164329221|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
164329222|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
164329223|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
164329224|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
164329225|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
164329226|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
164329227|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
164329228|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
164329229|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
164329230|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
164329231|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
164329232|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
164329233|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
164329234|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
164329235|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
164329236|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
164329237|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
164329238|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
164329239|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
164329240|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
164329241|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
164329242|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
164329243|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
164329244|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
164329245|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
164329246|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
164329247|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
164329248|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
164329249|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
164329250|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
164329251|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
164329252|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
164329253|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
164329254|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
164329255|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
164329256|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
164329257|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
164329258|NCT03739840|593583265|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
164329259|NCT03739840|593583266|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
164329260|NCT03739840|593583267|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
164329261|NCT03739840|593583268|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
164329262|NCT03739840|593583265|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
164329263|NCT03739840|593583266|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
164329264|NCT03739840|593583267|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
164329265|NCT03739840|593583268|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
164329266|NCT03739840|593583265|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
164329267|NCT03739840|593583266|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
164329268|NCT03739840|593583267|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
164329269|NCT03739840|593583268|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
164329270|NCT03739840|593583265|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
164329271|NCT03739840|593583266|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
164329272|NCT03739840|593583267|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
164329273|NCT03739840|593583268|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
164329274|NCT03739840|593583265|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
164329275|NCT03739840|593583266|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
164329276|NCT03739840|593583267|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
164329277|NCT03739840|593583268|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
164329278|NCT03739840|593583265|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
164329279|NCT03739840|593583266|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
164329280|NCT03739840|593583267|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
164329281|NCT03739840|593583268|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
164329282|NCT03739840|593583265|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
164329283|NCT03739840|593583266|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
164329284|NCT03739840|593583267|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
164329285|NCT03739840|593583268|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
164329286|NCT03739840|593583265|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
164329287|NCT03739840|593583266|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
164329288|NCT03739840|593583267|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
164329289|NCT03739840|593583268|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
164329290|NCT05153473|593583269|FG000|Overall Study|Death|46|||
164570097|NCT04462536|594453221|FG000|Overall Study|Withdrawal by Subject|3|||
164570098|NCT04462536|594453222|FG001|Overall Study|Withdrawal by Subject|9|||
164570099|NCT04462536|594453221|FG000|Overall Study|Lost to Follow-up|2|||
164570100|NCT04462536|594453222|FG001|Overall Study|Lost to Follow-up|4|||
164570101|NCT02747927|594453223|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|5|||
164570102|NCT02747927|594453224|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|14|||
164329291|NCT05153473|593583269|FG000|Overall Study|Lost to Follow-up|3|||
164224940|NCT01725308|593192199|FG001|Treatment Period I|Changes in the Episodes|0|||
164329292|NCT02788474|593583270|FG000|Double Blind Treatment Period|Not treated|1|||
164329293|NCT02788474|593583271|FG001|Double Blind Treatment Period|Not treated|0|||
164329294|NCT02788474|593583270|FG000|Double Blind Treatment Period|Patient's refusal|3|||
164329295|NCT02788474|593583271|FG001|Double Blind Treatment Period|Patient's refusal|0|||
164224941|NCT01725308|593192200|FG002|Treatment Period I|Changes in the Episodes|2|||
164224942|NCT01725308|593192198|FG000|Treatment Period I|Withdrawal of Consent|12|||
164224943|NCT01725308|593192199|FG001|Treatment Period I|Withdrawal of Consent|7|||
164224944|NCT01725308|593192200|FG002|Treatment Period I|Withdrawal of Consent|5|||
164224945|NCT01725308|593192198|FG000|Treatment Period I|Lost to Follow-up|3|||
164224946|NCT01725308|593192199|FG001|Treatment Period I|Lost to Follow-up|2|||
164224947|NCT01725308|593192200|FG002|Treatment Period I|Lost to Follow-up|2|||
164224948|NCT01725308|593192198|FG000|Treatment Period I|Protocol Deviations|3|||
164224949|NCT01725308|593192199|FG001|Treatment Period I|Protocol Deviations|1|||
164224950|NCT01725308|593192200|FG002|Treatment Period I|Protocol Deviations|1|||
164224951|NCT01725308|593192198|FG000|Treatment Period I|Miscellaneous|2|||
164224952|NCT01725308|593192199|FG001|Treatment Period I|Miscellaneous|0|||
164224953|NCT01725308|593192200|FG002|Treatment Period I|Miscellaneous|3|||
164224954|NCT01725308|593192198|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
164224955|NCT01725308|593192199|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
164224956|NCT01725308|593192200|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
164224957|NCT01725308|593192198|FG000|Treatment Period II|Did Not Receive Drug|4|||
164224958|NCT01725308|593192199|FG001|Treatment Period II|Did Not Receive Drug|0|||
164224959|NCT01725308|593192200|FG002|Treatment Period II|Did Not Receive Drug|0|||
164224960|NCT01725308|593192198|FG000|Treatment Period II|Adverse Event|13|||
164224961|NCT01725308|593192199|FG001|Treatment Period II|Adverse Event|8|||
164224962|NCT01725308|593192200|FG002|Treatment Period II|Adverse Event|20|||
164224963|NCT01725308|593192198|FG000|Treatment Period II|Insufficient Response|2|||
164224964|NCT01725308|593192199|FG001|Treatment Period II|Insufficient Response|4|||
164224965|NCT01725308|593192200|FG002|Treatment Period II|Insufficient Response|6|||
164224966|NCT01725308|593192198|FG000|Treatment Period II|Worsening of the Target Disease|1|||
164224967|NCT01725308|593192199|FG001|Treatment Period II|Worsening of the Target Disease|4|||
164224968|NCT01725308|593192200|FG002|Treatment Period II|Worsening of the Target Disease|2|||
164224969|NCT01725308|593192198|FG000|Treatment Period II|Changes in the Episodes|1|||
164224970|NCT01725308|593192199|FG001|Treatment Period II|Changes in the Episodes|0|||
164224971|NCT01725308|593192200|FG002|Treatment Period II|Changes in the Episodes|5|||
164224972|NCT01725308|593192198|FG000|Treatment Period II|Withdrawal of Consent|28|||
164224973|NCT01725308|593192199|FG001|Treatment Period II|Withdrawal of Consent|2|||
164224974|NCT01725308|593192200|FG002|Treatment Period II|Withdrawal of Consent|16|||
164224975|NCT01725308|593192198|FG000|Treatment Period II|Lost to Follow-up|1|||
164224976|NCT01725308|593192199|FG001|Treatment Period II|Lost to Follow-up|5|||
164224977|NCT01725308|593192200|FG002|Treatment Period II|Lost to Follow-up|3|||
164224978|NCT01725308|593192198|FG000|Treatment Period II|Protocol Deviations|0|||
164224979|NCT01725308|593192199|FG001|Treatment Period II|Protocol Deviations|0|||
164570103|NCT02747927|594453223|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|13|||
164674154|NCT01597245|594831061|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
164674155|NCT01597245|594831062|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
164674156|NCT01597245|594831063|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
164674157|NCT01597245|594831043|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164674158|NCT01597245|594831044|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164674159|NCT01597245|594831045|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164674160|NCT01597245|594831046|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164674161|NCT01597245|594831047|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164674162|NCT01597245|594831048|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164674163|NCT01597245|594831049|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164674164|NCT01597245|594831050|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164674165|NCT01597245|594831051|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164674166|NCT01597245|594831052|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164674167|NCT01597245|594831053|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164674168|NCT01597245|594831054|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164674169|NCT01597245|594831055|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164674170|NCT01597245|594831056|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164674171|NCT01597245|594831057|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164674172|NCT01597245|594831058|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164674173|NCT01597245|594831059|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164674174|NCT01597245|594831060|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
164674175|NCT01597245|594831061|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
164674176|NCT01597245|594831062|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
164224980|NCT01725308|593192200|FG002|Treatment Period II|Protocol Deviations|1|||
164224981|NCT01725308|593192198|FG000|Treatment Period II|Miscellaneous|5|||
164224982|NCT01725308|593192199|FG001|Treatment Period II|Miscellaneous|3|||
164224983|NCT01725308|593192200|FG002|Treatment Period II|Miscellaneous|7|||
164224984|NCT05652140|593192202|FG000|Overall Study|Lost to Follow-up|7|||
164224985|NCT05652140|593192203|FG001|Overall Study|Lost to Follow-up|16|||
164224986|NCT05652140|593192204|FG002|Overall Study|Lost to Follow-up|22|||
164224987|NCT05652140|593192205|FG003|Overall Study|Lost to Follow-up|31|||
164224988|NCT06048705|593192209|FG000|Overall Study|Physician Decision|1|||
164224989|NCT06048705|593192210|FG001|Overall Study|Physician Decision|0|||
164224990|NCT06048705|593192211|FG002|Overall Study|Physician Decision|0|||
164224991|NCT06048705|593192209|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
164224992|NCT06048705|593192210|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
164224993|NCT06048705|593192211|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
164224994|NCT06048705|593192209|FG000|Overall Study|Death prior to lymphodepletion|0|||
164224995|NCT06048705|593192210|FG001|Overall Study|Death prior to lymphodepletion|0|||
164224996|NCT06048705|593192211|FG002|Overall Study|Death prior to lymphodepletion|1|||
164224997|NCT02614066|593192212|FG000|Overall Study|Death|6|||
164224998|NCT02614066|593192213|FG001|Overall Study|Death|14|||
164224999|NCT02614066|593192214|FG002|Overall Study|Death|11|||
164225000|NCT02614066|593192215|FG003|Overall Study|Death|29|||
164225001|NCT02614066|593192212|FG000|Overall Study|Full consent withdrawn|0|||
164225002|NCT02614066|593192213|FG001|Overall Study|Full consent withdrawn|1|||
164225003|NCT02614066|593192214|FG002|Overall Study|Full consent withdrawn|0|||
164225004|NCT02614066|593192215|FG003|Overall Study|Full consent withdrawn|8|||
164225005|NCT02614066|593192212|FG000|Overall Study|Lost to Follow-up|0|||
164225006|NCT02614066|593192213|FG001|Overall Study|Lost to Follow-up|2|||
164225007|NCT02614066|593192214|FG002|Overall Study|Lost to Follow-up|2|||
164225008|NCT02614066|593192215|FG003|Overall Study|Lost to Follow-up|2|||
164225009|NCT02614066|593192212|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
164225010|NCT02614066|593192213|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
164225011|NCT02614066|593192214|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
164225012|NCT02614066|593192215|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
164225013|NCT02614066|593192212|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
164225014|NCT02614066|593192213|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
164225015|NCT02614066|593192214|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
164225016|NCT02614066|593192215|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
164225017|NCT02614066|593192212|FG000|Overall Study|Reason not specified|0|||
164225018|NCT02614066|593192213|FG001|Overall Study|Reason not specified|2|||
164225019|NCT02614066|593192214|FG002|Overall Study|Reason not specified|1|||
164225020|NCT02614066|593192215|FG003|Overall Study|Reason not specified|1|||
164225021|NCT04565756|593192216|FG000|Overall Study|Withdrawal by Subject|0|||
164225022|NCT04565756|593192217|FG001|Overall Study|Withdrawal by Subject|0|||
164225023|NCT04565756|593192218|FG002|Overall Study|Withdrawal by Subject|0|||
164225024|NCT04565756|593192219|FG003|Overall Study|Withdrawal by Subject|0|||
164225025|NCT04565756|593192220|FG004|Overall Study|Withdrawal by Subject|1|||
164329296|NCT02788474|593583270|FG000|Double Blind Treatment Period|Adverse Event|6|||
164329297|NCT02788474|593583271|FG001|Double Blind Treatment Period|Adverse Event|4|||
164329298|NCT02788474|593583270|FG000|Open Label Treatment Period|Adverse Event|29|||
164329299|NCT02788474|593583271|FG001|Open Label Treatment Period|Adverse Event|9|||
164329300|NCT02788474|593583270|FG000|Open Label Treatment Period|Other than reason specified|1|||
164329301|NCT02788474|593583271|FG001|Open Label Treatment Period|Other than reason specified|0|||
164329302|NCT02788474|593583270|FG000|Open Label Treatment Period|Patient's refusal|1|||
164329303|NCT02788474|593583271|FG001|Open Label Treatment Period|Patient's refusal|3|||
164329304|NCT02788474|593583270|FG000|Open Label Treatment Period|Non-compliance|1|||
164329305|NCT02788474|593583271|FG001|Open Label Treatment Period|Non-compliance|0|||
164329306|NCT03555435|593583272|FG000|Overall Study|Lost to Follow-up|17|||
164329307|NCT03555435|593583273|FG001|Overall Study|Lost to Follow-up|19|||
164329308|NCT03555435|593583274|FG002|Overall Study|Lost to Follow-up|8|||
164329309|NCT01243671|593583280|FG000|Overall Study|Adverse Event|3|||
164329310|NCT01243671|593583280|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
164329311|NCT01243671|593583280|FG000|Overall Study|Other|1|||
164329312|NCT02962765|593583281|FG000|Overall Study|Protocol Violation|9|||
164329313|NCT02962765|593583281|FG000|Overall Study|Withdrawal by Subject|3|||
164329314|NCT02962765|593583281|FG000|Overall Study|Lost to Follow-up|1|||
164329315|NCT02962765|593583281|FG000|Overall Study|Death|1|||
164329316|NCT02962765|593583281|FG000|Overall Study|Limited access to study medication|3|||
164329317|NCT00245583|593583285|FG000|Overall Study|Lost to Follow-up|1|||
164329318|NCT00245583|593583286|FG001|Overall Study|Lost to Follow-up|5|||
164329319|NCT00245583|593583285|FG000|Overall Study|Adverse Event|2|||
164329320|NCT00245583|593583286|FG001|Overall Study|Adverse Event|1|||
164329321|NCT00245583|593583285|FG000|Overall Study|Lack of Efficacy|1|||
164329322|NCT00245583|593583286|FG001|Overall Study|Lack of Efficacy|0|||
164329323|NCT00245583|593583285|FG000|Overall Study|Withdrawal by Subject|2|||
164329324|NCT00245583|593583286|FG001|Overall Study|Withdrawal by Subject|3|||
164329325|NCT01309893|593583287|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
164329326|NCT01309893|593583288|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
164329327|NCT01309893|593583287|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
164329328|NCT01309893|593583288|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
164329329|NCT02017171|593583289|FG000|Overall Study|Death|10|||
164329330|NCT02017171|593583290|FG001|Overall Study|Death|4|||
164329331|NCT02017171|593583289|FG000|Overall Study|Withdrawal by Subject|23|||
164329332|NCT02017171|593583290|FG001|Overall Study|Withdrawal by Subject|17|||
164329333|NCT02017171|593583289|FG000|Overall Study|Lost to Follow-up|21|||
164329334|NCT02017171|593583290|FG001|Overall Study|Lost to Follow-up|20|||
164329335|NCT02017171|593583289|FG000|Overall Study|ESKD|6|||
164329336|NCT02017171|593583290|FG001|Overall Study|ESKD|2|||
164329337|NCT02017171|593583289|FG000|Overall Study|Miscellaneous|2|||
164570104|NCT02747927|594453224|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|26|||
164570105|NCT02747927|594453223|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|19|||
164570106|NCT02747927|594453224|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|42|||
164570107|NCT02747927|594453223|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|2|||
164570108|NCT02747927|594453224|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|5|||
164570109|NCT02747927|594453223|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|131|||
164570110|NCT02747927|594453224|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|260|||
164570111|NCT02747927|594453223|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|1|||
164570112|NCT02747927|594453224|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|4|||
164570113|NCT02747927|594453223|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|7|||
164570114|NCT02747927|594453224|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|15|||
164570115|NCT02747927|594453223|FG000|Part 2: Additional VE (Months 16-21)|Adverse Event|0|||
164570116|NCT02747927|594453224|FG001|Part 2: Additional VE (Months 16-21)|Adverse Event|1|||
164570117|NCT02747927|594453223|FG000|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|4|||
164570118|NCT02747927|594453224|FG001|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|8|||
164570119|NCT02747927|594453223|FG000|Part 2: Additional VE (Months 16-21)|Pregnancy|11|||
164570120|NCT02747927|594453224|FG001|Part 2: Additional VE (Months 16-21)|Pregnancy|17|||
164570121|NCT02747927|594453223|FG000|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|13|||
164570122|NCT02747927|594453224|FG001|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|33|||
164570123|NCT02747927|594453223|FG000|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|1|||
164329338|NCT02017171|593583290|FG001|Overall Study|Miscellaneous|3|||
164329339|NCT02220998|593583291|FG000|Overall Study|Randomized but Never Treated|1|||
164329340|NCT02220998|593583292|FG001|Overall Study|Randomized but Never Treated|2|||
164329341|NCT02220998|593583291|FG000|Overall Study|Death|2|||
164329342|NCT02220998|593583292|FG001|Overall Study|Death|0|||
164329343|NCT02220998|593583291|FG000|Overall Study|Lack of Efficacy|0|||
164329344|NCT02220998|593583292|FG001|Overall Study|Lack of Efficacy|5|||
164329345|NCT02220998|593583291|FG000|Overall Study|Lost to Follow-up|4|||
164329346|NCT02220998|593583292|FG001|Overall Study|Lost to Follow-up|4|||
164329347|NCT00873860|593583293|FG000|Overall Study|Lost to Follow-up|1|||
164225026|NCT04565756|593192221|FG005|Overall Study|Withdrawal by Subject|0|||
164225027|NCT04565756|593192216|FG000|Overall Study|Protocol Violation|0|||
164225028|NCT04565756|593192217|FG001|Overall Study|Protocol Violation|0|||
164225029|NCT04565756|593192218|FG002|Overall Study|Protocol Violation|0|||
164225030|NCT04565756|593192219|FG003|Overall Study|Protocol Violation|0|||
164225031|NCT04565756|593192220|FG004|Overall Study|Protocol Violation|0|||
164225032|NCT04565756|593192221|FG005|Overall Study|Protocol Violation|1|||
164329348|NCT00873860|593583294|FG001|Overall Study|Lost to Follow-up|0|||
164329349|NCT00873860|593583295|FG002|Overall Study|Lost to Follow-up|0|||
164329350|NCT00873860|593583296|FG003|Overall Study|Lost to Follow-up|1|||
164329351|NCT00873860|593583293|FG000|Overall Study|Withdrawal by Subject|1|||
164329352|NCT00873860|593583294|FG001|Overall Study|Withdrawal by Subject|0|||
164329353|NCT00873860|593583295|FG002|Overall Study|Withdrawal by Subject|2|||
164329354|NCT00873860|593583296|FG003|Overall Study|Withdrawal by Subject|0|||
164329355|NCT00873860|593583293|FG000|Overall Study|Death|1|||
164329356|NCT00873860|593583294|FG001|Overall Study|Death|0|||
164329357|NCT00873860|593583295|FG002|Overall Study|Death|0|||
164329358|NCT00873860|593583296|FG003|Overall Study|Death|0|||
164329359|NCT00873860|593583293|FG000|Overall Study|Other|1|||
164329360|NCT00873860|593583294|FG001|Overall Study|Other|0|||
164329361|NCT00873860|593583295|FG002|Overall Study|Other|1|||
164329362|NCT00873860|593583296|FG003|Overall Study|Other|0|||
164329363|NCT01484938|593583297|FG000|Overall Study|Adverse Event|2|||
164329364|NCT01484938|593583297|FG000|Overall Study|Lost to Follow-up|1|||
164329365|NCT01484938|593583297|FG000|Overall Study|Noncompliance|1|||
164329366|NCT01172275|593583302|FG000|Overall Study|Lost to Follow-up|1|||
164329367|NCT01172275|593583303|FG001|Overall Study|Lost to Follow-up|0|||
164329368|NCT01172275|593583302|FG000|Overall Study|Protocol Violation|1|||
164329369|NCT01172275|593583303|FG001|Overall Study|Protocol Violation|0|||
164329370|NCT02862600|593583304|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
164329371|NCT02862600|593583304|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
164329372|NCT02862600|593583304|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
164329373|NCT02862600|593583304|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
164329374|NCT00194675|593583305|FG000|Overall Study|Lost to Follow-up|1|||
164329375|NCT00194675|593583306|FG001|Overall Study|Lost to Follow-up|1|||
164329376|NCT00194675|593583305|FG000|Overall Study|lack of interest|1|||
164329377|NCT00194675|593583306|FG001|Overall Study|lack of interest|1|||
164329378|NCT00194675|593583305|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
164329379|NCT00194675|593583306|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
164329380|NCT00194675|593583305|FG000|Overall Study|Protocol Violation|1|||
164329381|NCT00194675|593583306|FG001|Overall Study|Protocol Violation|0|||
164329382|NCT00194675|593583305|FG000|Overall Study|Death|1|||
164329383|NCT00194675|593583306|FG001|Overall Study|Death|0|||
164329384|NCT00667420|593583311|FG000|Overall Study|Adverse Event|2|||
164329385|NCT00667420|593583311|FG000|Overall Study|Lack of Efficacy|5|||
164329386|NCT00667420|593583311|FG000|Overall Study|Physician Decision|1|||
164329387|NCT00667420|593583311|FG000|Overall Study|Withdrawal by Subject|2|||
164329388|NCT04437368|593583312|FG000|Overall Study|Death|3|||
164329389|NCT04437368|593583313|FG001|Overall Study|Death|0|||
164329390|NCT04437368|593583314|FG002|Overall Study|Death|2|||
164329391|NCT04437368|593583312|FG000|Overall Study|Study terminated by sponsor|16|||
164329392|NCT04437368|593583313|FG001|Overall Study|Study terminated by sponsor|1|||
164329393|NCT04437368|593583314|FG002|Overall Study|Study terminated by sponsor|25|||
164329394|NCT04437368|593583312|FG000|Overall Study|Withdrawal by Subject|4|||
164329395|NCT04437368|593583313|FG001|Overall Study|Withdrawal by Subject|0|||
164329396|NCT04437368|593583314|FG002|Overall Study|Withdrawal by Subject|3|||
164329397|NCT04437368|593583312|FG000|Overall Study|Sponsor instructions|23|||
164570124|NCT02747927|594453224|FG001|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|7|||
164570125|NCT02747927|594453223|FG000|Part 2: Additional VE (Months 16-21)|Reason Not Specified|3|||
164570126|NCT02747927|594453224|FG001|Part 2: Additional VE (Months 16-21)|Reason Not Specified|6|||
164570127|NCT02747927|594453223|FG000|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|6|||
164570128|NCT02747927|594453224|FG001|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|10|||
164570129|NCT02747927|594453223|FG000|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|67|||
164570130|NCT02747927|594453224|FG001|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|149|||
164225033|NCT00968968|593192226|FG000|Overall Study|Study closed/terminated|10|||
164225034|NCT00968968|593192227|FG001|Overall Study|Study closed/terminated|10|||
164225035|NCT00968968|593192226|FG000|Overall Study|Protocol defined stopping criteria|3|||
164329398|NCT04437368|593583313|FG001|Overall Study|Sponsor instructions|0|||
164329399|NCT04437368|593583314|FG002|Overall Study|Sponsor instructions|0|||
164329400|NCT00095628|593583315|FG000|Overall Study|Disease progression prior to treatment|1|||
164225036|NCT00968968|593192227|FG001|Overall Study|Protocol defined stopping criteria|1|||
164329401|NCT04271280|593583316|FG000|Overall Study|Lost to Follow-up|300|||
164329402|NCT04271280|593583316|FG000|Overall Study|Death|153|||
164329403|NCT04271280|593583316|FG000|Overall Study|Withdrawal of consent by patient|59|||
164329404|NCT04271280|593583316|FG000|Overall Study|Other|51|||
164329405|NCT04271280|593583316|FG000|Overall Study|No end of study information|42|||
164329406|NCT00495131|593583317|FG000|Overall Study|Adverse Event|6|||
164674177|NCT01597245|594831063|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
164674178|NCT01597245|594831043|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164674179|NCT01597245|594831044|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164674180|NCT01597245|594831045|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164674181|NCT01597245|594831046|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164674182|NCT01597245|594831047|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164329407|NCT00495131|593583318|FG001|Overall Study|Adverse Event|2|||
164329408|NCT00495131|593583317|FG000|Overall Study|Lack of Efficacy|0|||
164329409|NCT00495131|593583318|FG001|Overall Study|Lack of Efficacy|2|||
164329410|NCT00495131|593583317|FG000|Overall Study|Lost to Follow-up|0|||
164329411|NCT00495131|593583318|FG001|Overall Study|Lost to Follow-up|2|||
164329412|NCT00495131|593583317|FG000|Overall Study|Withdrawal by Subject|1|||
164329413|NCT00495131|593583318|FG001|Overall Study|Withdrawal by Subject|0|||
164329414|NCT03224546|593583319|FG000|Overall Study|Lost to Follow-up|9|||
164329415|NCT03224546|593583320|FG001|Overall Study|Lost to Follow-up|8|||
164329416|NCT03224546|593583321|FG002|Overall Study|Lost to Follow-up|3|||
164329417|NCT03224546|593583319|FG000|Overall Study|Withdrawal by Subject|7|||
164329418|NCT03224546|593583320|FG001|Overall Study|Withdrawal by Subject|14|||
164329419|NCT03224546|593583321|FG002|Overall Study|Withdrawal by Subject|12|||
164329420|NCT01539317|593583324|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
164329421|NCT01539317|593583325|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
164329422|NCT04223232|593583326|FG000|Overall Study|Withdrawal by Subject|1|||
164329423|NCT00364130|593583327|FG000|Intervention Period|Lost to Follow-up|4|||
164329424|NCT00364130|593583328|FG001|Intervention Period|Lost to Follow-up|3|||
164329425|NCT00364130|593583327|FG000|Intervention Period|Pregnancy|1|||
164329426|NCT00364130|593583328|FG001|Intervention Period|Pregnancy|0|||
164329427|NCT00364130|593583327|FG000|Intervention Period|Withdrawal by Subject|4|||
164329428|NCT00364130|593583328|FG001|Intervention Period|Withdrawal by Subject|5|||
164329429|NCT00364130|593583327|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
164329430|NCT00364130|593583328|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
164329431|NCT00586846|593583336|FG000|Overall Study|Physician Decision|1|||
164329432|NCT00586846|593583336|FG000|Overall Study|Death|1|||
164329433|NCT00586846|593583336|FG000|Overall Study|Evaluable for Toxicity Only|4|||
164329434|NCT01702571|593583345|FG000|Overall Study|Death|1067|||
164329435|NCT01702571|593583346|FG001|Overall Study|Death|76|||
164329436|NCT01702571|593583345|FG000|Overall Study|Lost to Follow-up|144|||
164329437|NCT01702571|593583346|FG001|Overall Study|Lost to Follow-up|10|||
164329438|NCT01702571|593583345|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
164329439|NCT01702571|593583346|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
164329440|NCT01702571|593583345|FG000|Overall Study|Investigator Decision|5|||
164329441|NCT01702571|593583346|FG001|Overall Study|Investigator Decision|0|||
164329442|NCT01702571|593583345|FG000|Overall Study|Not Classifiable|1|||
164329443|NCT01702571|593583346|FG001|Overall Study|Not Classifiable|0|||
164329444|NCT01702571|593583345|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
164329445|NCT01702571|593583346|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
164329446|NCT01702571|593583345|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
164329447|NCT01702571|593583346|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
164329448|NCT01702571|593583345|FG000|Overall Study|Progressive Disease|3|||
164329449|NCT01702571|593583346|FG001|Overall Study|Progressive Disease|0|||
164329450|NCT01702571|593583345|FG000|Overall Study|Protocol Violation|2|||
164329451|NCT01702571|593583346|FG001|Overall Study|Protocol Violation|0|||
164329452|NCT01702571|593583345|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
164329453|NCT01702571|593583346|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
164329454|NCT01702571|593583345|FG000|Overall Study|Termination By Sponsor|4|||
164329455|NCT01702571|593583346|FG001|Overall Study|Termination By Sponsor|0|||
164329456|NCT01702571|593583345|FG000|Overall Study|Withdrawal by Subject|177|||
164329457|NCT01702571|593583346|FG001|Overall Study|Withdrawal by Subject|29|||
164329458|NCT03004443|593583347|FG000|Overall Study|Pregnancy|0|||
164329459|NCT03004443|593583348|FG001|Overall Study|Pregnancy|1|||
164329460|NCT00828854|593583349|FG000|Overall Study|Disease Progression|17|||
164329461|NCT00828854|593583349|FG000|Overall Study|Adverse Event|9|||
164329462|NCT00828854|593583349|FG000|Overall Study|Reason not Specified|1|||
164329463|NCT04221230|593583350|FG000|Overall Study|Lost to Follow-up|12|||
164329464|NCT04221230|593583351|FG001|Overall Study|Lost to Follow-up|12|||
164329465|NCT04221230|593583350|FG000|Overall Study|Protocol Violation|2|||
164329466|NCT04221230|593583351|FG001|Overall Study|Protocol Violation|2|||
164329467|NCT04221230|593583350|FG000|Overall Study|Adverse Event|0|||
164329468|NCT04221230|593583351|FG001|Overall Study|Adverse Event|8|||
164329469|NCT04221230|593583350|FG000|Overall Study|Physician Decision|1|||
164329470|NCT04221230|593583351|FG001|Overall Study|Physician Decision|0|||
164329471|NCT04221230|593583350|FG000|Overall Study|Withdrawal by Subject|13|||
164674183|NCT01597245|594831048|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164329472|NCT04221230|593583351|FG001|Overall Study|Withdrawal by Subject|11|||
164329473|NCT04221230|593583350|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164329474|NCT04221230|593583351|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164329475|NCT04221230|593583350|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
164329476|NCT04221230|593583351|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
164329477|NCT04221230|593583350|FG000|Overall Study|Pregnancy|0|||
164329478|NCT04221230|593583351|FG001|Overall Study|Pregnancy|1|||
164329479|NCT04221230|593583350|FG000|Overall Study|Other|1|||
164329480|NCT04221230|593583351|FG001|Overall Study|Other|2|||
164329481|NCT00915356|593583352|FG000|Overall Study|Withdrawal by Subject|1|||
164329482|NCT00915356|593583353|FG001|Overall Study|Withdrawal by Subject|0|||
164329483|NCT00915356|593583354|FG002|Overall Study|Withdrawal by Subject|0|||
164329484|NCT00915356|593583355|FG003|Overall Study|Withdrawal by Subject|0|||
164329485|NCT00915356|593583356|FG004|Overall Study|Withdrawal by Subject|0|||
164329486|NCT00191646|593583358|FG000|Overall Study|Toxicity|26|||
164329487|NCT00191646|593583359|FG001|Overall Study|Toxicity|37|||
164329488|NCT00191646|593583358|FG000|Overall Study|Disease Progression|5|||
164329489|NCT00191646|593583359|FG001|Overall Study|Disease Progression|6|||
164329490|NCT00191646|593583358|FG000|Overall Study|Physician Decision|20|||
164329491|NCT00191646|593583359|FG001|Overall Study|Physician Decision|11|||
164329492|NCT00191646|593583358|FG000|Overall Study|Withdrawal by Subject|58|||
164329493|NCT00191646|593583359|FG001|Overall Study|Withdrawal by Subject|39|||
164329494|NCT00191646|593583358|FG000|Overall Study|Protocol Violation|5|||
164329495|NCT00191646|593583359|FG001|Overall Study|Protocol Violation|7|||
164329496|NCT00191646|593583358|FG000|Overall Study|Death|6|||
164329497|NCT00191646|593583359|FG001|Overall Study|Death|8|||
164329498|NCT00191646|593583358|FG000|Overall Study|Other|33|||
164329499|NCT00191646|593583359|FG001|Overall Study|Other|34|||
164329500|NCT00191646|593583358|FG000|Overall Study|Missing Data|18|||
164329501|NCT00191646|593583359|FG001|Overall Study|Missing Data|11|||
164329502|NCT05211284|593583367|FG000|Overall Study|Study Terminated|3|||
164329503|NCT05211284|593583368|FG001|Overall Study|Study Terminated|1|||
164329504|NCT04090957|593583373|FG000|Overall Study|Lost to Follow-up|22|||
164329505|NCT04090957|593583374|FG001|Overall Study|Lost to Follow-up|25|||
164329506|NCT04090957|593583375|FG002|Overall Study|Lost to Follow-up|25|||
164329507|NCT04090957|593583376|FG003|Overall Study|Lost to Follow-up|36|||
164329508|NCT04090957|593583373|FG000|Overall Study|Withdrawal of Consent for Another Reason|15|||
164329509|NCT04090957|593583374|FG001|Overall Study|Withdrawal of Consent for Another Reason|17|||
164329510|NCT04090957|593583375|FG002|Overall Study|Withdrawal of Consent for Another Reason|21|||
164329511|NCT04090957|593583376|FG003|Overall Study|Withdrawal of Consent for Another Reason|39|||
164329512|NCT04090957|593583373|FG000|Overall Study|Adverse Event|19|||
164329513|NCT04090957|593583374|FG001|Overall Study|Adverse Event|25|||
164329514|NCT04090957|593583375|FG002|Overall Study|Adverse Event|8|||
164329515|NCT04090957|593583376|FG003|Overall Study|Adverse Event|104|||
164329516|NCT04090957|593583373|FG000|Overall Study|Other|10|||
164329517|NCT04090957|593583374|FG001|Overall Study|Other|6|||
164329518|NCT04090957|593583375|FG002|Overall Study|Other|5|||
164329519|NCT04090957|593583376|FG003|Overall Study|Other|12|||
164329520|NCT04090957|593583373|FG000|Overall Study|Serious Adverse Event|7|||
164329521|NCT04090957|593583374|FG001|Overall Study|Serious Adverse Event|11|||
164329522|NCT04090957|593583375|FG002|Overall Study|Serious Adverse Event|1|||
164329523|NCT04090957|593583376|FG003|Overall Study|Serious Adverse Event|32|||
164329524|NCT04090957|593583373|FG000|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|7|||
164329525|NCT04090957|593583374|FG001|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|9|||
164329526|NCT04090957|593583375|FG002|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|1|||
164329527|NCT04090957|593583376|FG003|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|26|||
164329528|NCT04090957|593583373|FG000|Overall Study|Lack of Efficacy|1|||
164329529|NCT04090957|593583374|FG001|Overall Study|Lack of Efficacy|1|||
164329530|NCT04090957|593583375|FG002|Overall Study|Lack of Efficacy|9|||
164329531|NCT04090957|593583376|FG003|Overall Study|Lack of Efficacy|0|||
164329532|NCT04090957|593583373|FG000|Overall Study|Protocol Violation|3|||
164329533|NCT04090957|593583374|FG001|Overall Study|Protocol Violation|5|||
164329534|NCT04090957|593583375|FG002|Overall Study|Protocol Violation|2|||
164329535|NCT04090957|593583376|FG003|Overall Study|Protocol Violation|1|||
164329536|NCT04090957|593583373|FG000|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
164329537|NCT04090957|593583374|FG001|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
164329538|NCT04090957|593583375|FG002|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|6|||
164329539|NCT04090957|593583376|FG003|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|3|||
164329540|NCT04090957|593583373|FG000|Overall Study|COVID-19|2|||
164329541|NCT04090957|593583374|FG001|Overall Study|COVID-19|2|||
164570131|NCT02747927|594453223|FG000|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|120|||
164329542|NCT04090957|593583375|FG002|Overall Study|COVID-19|3|||
164329543|NCT04090957|593583376|FG003|Overall Study|COVID-19|7|||
164329544|NCT04090957|593583373|FG000|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
164329545|NCT04090957|593583374|FG001|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
164329546|NCT04090957|593583375|FG002|Overall Study|Non-Compliance with Trial Protocol: Other|1|||
164329547|NCT04090957|593583376|FG003|Overall Study|Non-Compliance with Trial Protocol: Other|4|||
164329548|NCT04090957|593583373|FG000|Overall Study|Physician Decision|2|||
164570132|NCT02747927|594453224|FG001|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|228|||
164329549|NCT04090957|593583374|FG001|Overall Study|Physician Decision|1|||
164329550|NCT04090957|593583375|FG002|Overall Study|Physician Decision|1|||
164329551|NCT04090957|593583376|FG003|Overall Study|Physician Decision|5|||
164329552|NCT04090957|593583373|FG000|Overall Study|Sponsor Decision|1|||
164329553|NCT04090957|593583374|FG001|Overall Study|Sponsor Decision|1|||
164329554|NCT04090957|593583375|FG002|Overall Study|Sponsor Decision|1|||
164329555|NCT04090957|593583376|FG003|Overall Study|Sponsor Decision|3|||
164329556|NCT04090957|593583373|FG000|Overall Study|Endometrial Findings - Physician Decision|1|||
164329557|NCT04090957|593583374|FG001|Overall Study|Endometrial Findings - Physician Decision|1|||
164329558|NCT04090957|593583375|FG002|Overall Study|Endometrial Findings - Physician Decision|0|||
164329559|NCT04090957|593583376|FG003|Overall Study|Endometrial Findings - Physician Decision|5|||
164329560|NCT04090957|593583373|FG000|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
164329561|NCT04090957|593583374|FG001|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|0|||
164329562|NCT04090957|593583375|FG002|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
164329563|NCT04090957|593583376|FG003|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|4|||
164329564|NCT04090957|593583373|FG000|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
164329565|NCT04090957|593583374|FG001|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
164329566|NCT04090957|593583375|FG002|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|1|||
164329567|NCT04090957|593583376|FG003|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
164329568|NCT04090957|593583373|FG000|Overall Study|Death|1|||
164329569|NCT04090957|593583374|FG001|Overall Study|Death|0|||
164329570|NCT04090957|593583375|FG002|Overall Study|Death|0|||
164329571|NCT04090957|593583376|FG003|Overall Study|Death|0|||
164329572|NCT04090957|593583373|FG000|Overall Study|No Treatment Administered|2|||
164329573|NCT04090957|593583374|FG001|Overall Study|No Treatment Administered|1|||
164329574|NCT04090957|593583375|FG002|Overall Study|No Treatment Administered|2|||
164329575|NCT04090957|593583376|FG003|Overall Study|No Treatment Administered|1|||
164329576|NCT01909453|593583377|FG000|Overall Study|Ongoing|118|||
164329577|NCT01909453|593583378|FG001|Overall Study|Ongoing|103|||
164329578|NCT01909453|593583379|FG002|Overall Study|Ongoing|83|||
164329579|NCT01909453|593583380|FG003|Overall Study|Ongoing|164|||
164329580|NCT01909453|593583381|FG004|Overall Study|Ongoing|50|||
164329581|NCT01909453|593583377|FG000|Overall Study|Death|69|||
164329582|NCT01909453|593583378|FG001|Overall Study|Death|74|||
164329583|NCT01909453|593583379|FG002|Overall Study|Death|88|||
164329584|NCT01909453|593583380|FG003|Overall Study|Death|86|||
164329585|NCT01909453|593583381|FG004|Overall Study|Death|29|||
164329586|NCT01909453|593583377|FG000|Overall Study|Lost to Follow-up|3|||
164329587|NCT01909453|593583378|FG001|Overall Study|Lost to Follow-up|4|||
164329588|NCT01909453|593583379|FG002|Overall Study|Lost to Follow-up|4|||
164329589|NCT01909453|593583380|FG003|Overall Study|Lost to Follow-up|3|||
164329590|NCT01909453|593583381|FG004|Overall Study|Lost to Follow-up|3|||
164329591|NCT01909453|593583377|FG000|Overall Study|Withdrawal by Subject|2|||
164329592|NCT01909453|593583378|FG001|Overall Study|Withdrawal by Subject|13|||
164329593|NCT01909453|593583379|FG002|Overall Study|Withdrawal by Subject|16|||
164329594|NCT01909453|593583380|FG003|Overall Study|Withdrawal by Subject|5|||
164329595|NCT01909453|593583381|FG004|Overall Study|Withdrawal by Subject|4|||
164329596|NCT00122278|593584733|FG000|Overall Study|Lost to Follow-up|2|||
164329597|NCT00122278|593584734|FG001|Overall Study|Lost to Follow-up|0|||
164329598|NCT01002482|593584735|FG000|Overall Study|Withdrawal by Subject|14|||
164329599|NCT01002482|593584736|FG001|Overall Study|Withdrawal by Subject|21|||
164329600|NCT01002482|593584735|FG000|Overall Study|Included twice|1|||
164329601|NCT01002482|593584736|FG001|Overall Study|Included twice|0|||
164329602|NCT02598960|593584740|FG000|Treatment Period|Disease Progression|4|||
164329603|NCT02598960|593584741|FG001|Treatment Period|Disease Progression|4|||
164329604|NCT02598960|593584742|FG002|Treatment Period|Disease Progression|4|||
164329605|NCT02598960|593584743|FG003|Treatment Period|Disease Progression|6|||
164329606|NCT02598960|593584744|FG004|Treatment Period|Disease Progression|8|||
164329607|NCT02598960|593584745|FG005|Treatment Period|Disease Progression|2|||
164329608|NCT02598960|593584746|FG006|Treatment Period|Disease Progression|2|||
164329609|NCT02598960|593584747|FG007|Treatment Period|Disease Progression|3|||
164329610|NCT02598960|593584748|FG008|Treatment Period|Disease Progression|7|||
164329611|NCT02598960|593584749|FG009|Treatment Period|Disease Progression|9|||
164329612|NCT02598960|593584750|FG010|Treatment Period|Disease Progression|7|||
164329613|NCT02598960|593584751|FG011|Treatment Period|Disease Progression|143|||
164329614|NCT02598960|593584752|FG012|Treatment Period|Disease Progression|23|||
164570133|NCT02747927|594453223|FG000|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|1|||
164570134|NCT02747927|594453224|FG001|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|2|||
164329615|NCT02598960|593584740|FG000|Treatment Period|Study drug toxicity|0|||
164329616|NCT02598960|593584741|FG001|Treatment Period|Study drug toxicity|0|||
164329617|NCT02598960|593584742|FG002|Treatment Period|Study drug toxicity|0|||
164329618|NCT02598960|593584743|FG003|Treatment Period|Study drug toxicity|0|||
164329619|NCT02598960|593584744|FG004|Treatment Period|Study drug toxicity|0|||
164225037|NCT00968968|593192226|FG000|Overall Study|Withdrawal by Subject|2|||
164225038|NCT00968968|593192227|FG001|Overall Study|Withdrawal by Subject|0|||
164225039|NCT00968968|593192226|FG000|Overall Study|Physician Decision|1|||
164225040|NCT00968968|593192227|FG001|Overall Study|Physician Decision|2|||
164225041|NCT00968968|593192226|FG000|Overall Study|Lost to Follow-up|0|||
164329620|NCT02598960|593584745|FG005|Treatment Period|Study drug toxicity|0|||
164329621|NCT02598960|593584746|FG006|Treatment Period|Study drug toxicity|0|||
164329622|NCT02598960|593584747|FG007|Treatment Period|Study drug toxicity|0|||
164329623|NCT02598960|593584748|FG008|Treatment Period|Study drug toxicity|0|||
164329624|NCT02598960|593584749|FG009|Treatment Period|Study drug toxicity|1|||
164329625|NCT02598960|593584750|FG010|Treatment Period|Study drug toxicity|0|||
164329626|NCT02598960|593584751|FG011|Treatment Period|Study drug toxicity|3|||
164329627|NCT02598960|593584752|FG012|Treatment Period|Study drug toxicity|0|||
164329628|NCT02598960|593584740|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
164329629|NCT02598960|593584741|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
164329630|NCT02598960|593584742|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
164329631|NCT02598960|593584743|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
164329632|NCT02598960|593584744|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
164329633|NCT02598960|593584745|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
164329634|NCT02598960|593584746|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
164329635|NCT02598960|593584747|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
164329636|NCT02598960|593584748|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
164329637|NCT02598960|593584749|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
164329638|NCT02598960|593584750|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
164329639|NCT02598960|593584751|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
164329640|NCT02598960|593584752|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
164329641|NCT02598960|593584740|FG000|Treatment Period|participant request to discontinue|0|||
164329642|NCT02598960|593584741|FG001|Treatment Period|participant request to discontinue|1|||
164329643|NCT02598960|593584742|FG002|Treatment Period|participant request to discontinue|0|||
164329644|NCT02598960|593584743|FG003|Treatment Period|participant request to discontinue|0|||
164329645|NCT02598960|593584744|FG004|Treatment Period|participant request to discontinue|1|||
164329646|NCT02598960|593584745|FG005|Treatment Period|participant request to discontinue|0|||
164329647|NCT02598960|593584746|FG006|Treatment Period|participant request to discontinue|0|||
164329648|NCT02598960|593584747|FG007|Treatment Period|participant request to discontinue|0|||
164329649|NCT02598960|593584748|FG008|Treatment Period|participant request to discontinue|0|||
164329650|NCT02598960|593584749|FG009|Treatment Period|participant request to discontinue|0|||
164329651|NCT02598960|593584750|FG010|Treatment Period|participant request to discontinue|1|||
164329652|NCT02598960|593584751|FG011|Treatment Period|participant request to discontinue|4|||
164329653|NCT02598960|593584752|FG012|Treatment Period|participant request to discontinue|0|||
164329654|NCT02598960|593584740|FG000|Treatment Period|participant withdrew consent|0|||
164329655|NCT02598960|593584741|FG001|Treatment Period|participant withdrew consent|0|||
164329656|NCT02598960|593584742|FG002|Treatment Period|participant withdrew consent|0|||
164329657|NCT02598960|593584743|FG003|Treatment Period|participant withdrew consent|0|||
164329658|NCT02598960|593584744|FG004|Treatment Period|participant withdrew consent|0|||
164329659|NCT02598960|593584745|FG005|Treatment Period|participant withdrew consent|0|||
164225042|NCT00968968|593192227|FG001|Overall Study|Lost to Follow-up|1|||
164225043|NCT04401293|593192228|FG000|Overall Study|Withdrawal by Subject|1|||
164225044|NCT04401293|593192229|FG001|Overall Study|Withdrawal by Subject|3|||
164225045|NCT01783938|593192235|FG000|Overall Study|Disease Progression|18|||
164225046|NCT01783938|593192236|FG001|Overall Study|Disease Progression|41|||
164225047|NCT01783938|593192235|FG000|Overall Study|Study Drug Toxicity|27|||
164225048|NCT01783938|593192236|FG001|Overall Study|Study Drug Toxicity|14|||
164225049|NCT01783938|593192235|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
164225050|NCT01783938|593192236|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
164225051|NCT01783938|593192235|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
164225052|NCT01783938|593192236|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
164225053|NCT01783938|593192235|FG000|Overall Study|Participant Withdrew Consent|2|||
164225054|NCT01783938|593192236|FG001|Overall Study|Participant Withdrew Consent|0|||
164225055|NCT01783938|593192235|FG000|Overall Study|Maximum Clinical Benefit|1|||
164225056|NCT01783938|593192236|FG001|Overall Study|Maximum Clinical Benefit|0|||
164329660|NCT02598960|593584746|FG006|Treatment Period|participant withdrew consent|0|||
164329661|NCT02598960|593584747|FG007|Treatment Period|participant withdrew consent|0|||
164329662|NCT02598960|593584748|FG008|Treatment Period|participant withdrew consent|0|||
164329663|NCT02598960|593584749|FG009|Treatment Period|participant withdrew consent|0|||
164225057|NCT01783938|593192235|FG000|Overall Study|Other Reasons|3|||
164225058|NCT01783938|593192236|FG001|Overall Study|Other Reasons|1|||
164225059|NCT00930176|593192238|FG000|Overall Study|Death|1|||
164225060|NCT01712074|593192243|FG000|Placebo Run-in Period|Adverse Event|2|||
164225061|NCT01712074|593192244|FG001|Placebo Run-in Period|Adverse Event|0|||
164225062|NCT01712074|593192245|FG002|Placebo Run-in Period|Adverse Event|0|||
164329664|NCT02598960|593584750|FG010|Treatment Period|participant withdrew consent|0|||
164329665|NCT02598960|593584751|FG011|Treatment Period|participant withdrew consent|3|||
164329666|NCT02598960|593584752|FG012|Treatment Period|participant withdrew consent|0|||
164329667|NCT02598960|593584740|FG000|Treatment Period|No longer meets study criteria|0|||
164329668|NCT02598960|593584741|FG001|Treatment Period|No longer meets study criteria|0|||
164329669|NCT02598960|593584742|FG002|Treatment Period|No longer meets study criteria|0|||
164329670|NCT02598960|593584743|FG003|Treatment Period|No longer meets study criteria|0|||
164329671|NCT02598960|593584744|FG004|Treatment Period|No longer meets study criteria|0|||
164329672|NCT02598960|593584745|FG005|Treatment Period|No longer meets study criteria|0|||
164329673|NCT02598960|593584746|FG006|Treatment Period|No longer meets study criteria|0|||
164329674|NCT02598960|593584747|FG007|Treatment Period|No longer meets study criteria|0|||
164329675|NCT02598960|593584748|FG008|Treatment Period|No longer meets study criteria|0|||
164329676|NCT02598960|593584749|FG009|Treatment Period|No longer meets study criteria|0|||
164329677|NCT02598960|593584750|FG010|Treatment Period|No longer meets study criteria|0|||
164329678|NCT02598960|593584751|FG011|Treatment Period|No longer meets study criteria|1|||
164329679|NCT02598960|593584752|FG012|Treatment Period|No longer meets study criteria|0|||
164329680|NCT02598960|593584740|FG000|Treatment Period|Other Reasons|0|||
164329681|NCT02598960|593584741|FG001|Treatment Period|Other Reasons|0|||
164329682|NCT02598960|593584742|FG002|Treatment Period|Other Reasons|0|||
164329683|NCT02598960|593584743|FG003|Treatment Period|Other Reasons|0|||
164329684|NCT02598960|593584744|FG004|Treatment Period|Other Reasons|0|||
164329685|NCT02598960|593584745|FG005|Treatment Period|Other Reasons|0|||
164329686|NCT02598960|593584746|FG006|Treatment Period|Other Reasons|0|||
164329687|NCT02598960|593584747|FG007|Treatment Period|Other Reasons|0|||
164329688|NCT02598960|593584748|FG008|Treatment Period|Other Reasons|0|||
164329689|NCT02598960|593584749|FG009|Treatment Period|Other Reasons|0|||
164329690|NCT02598960|593584750|FG010|Treatment Period|Other Reasons|0|||
164329691|NCT02598960|593584751|FG011|Treatment Period|Other Reasons|0|||
164329692|NCT02598960|593584752|FG012|Treatment Period|Other Reasons|1|||
164329693|NCT02598960|593584740|FG000|Participants Entering Follow Up Period|Death|1|||
164329694|NCT02598960|593584741|FG001|Participants Entering Follow Up Period|Death|0|||
164329695|NCT02598960|593584742|FG002|Participants Entering Follow Up Period|Death|0|||
164329696|NCT02598960|593584743|FG003|Participants Entering Follow Up Period|Death|0|||
164329697|NCT02598960|593584744|FG004|Participants Entering Follow Up Period|Death|0|||
164329698|NCT02598960|593584745|FG005|Participants Entering Follow Up Period|Death|0|||
164329699|NCT02598960|593584746|FG006|Participants Entering Follow Up Period|Death|0|||
164329700|NCT02598960|593584747|FG007|Participants Entering Follow Up Period|Death|0|||
164329701|NCT02598960|593584748|FG008|Participants Entering Follow Up Period|Death|0|||
164329702|NCT02598960|593584749|FG009|Participants Entering Follow Up Period|Death|1|||
164329703|NCT02598960|593584750|FG010|Participants Entering Follow Up Period|Death|0|||
164329704|NCT02598960|593584751|FG011|Participants Entering Follow Up Period|Death|11|||
164329705|NCT02598960|593584752|FG012|Participants Entering Follow Up Period|Death|2|||
164329706|NCT02598960|593584740|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
164329707|NCT02598960|593584741|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
164329708|NCT02598960|593584742|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
164329709|NCT02598960|593584743|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
164329710|NCT02598960|593584744|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
164329711|NCT02598960|593584745|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
164329712|NCT02598960|593584746|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
164329713|NCT02598960|593584747|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
164329714|NCT02598960|593584748|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
164329715|NCT02598960|593584749|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
164329716|NCT02598960|593584750|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
164329717|NCT02598960|593584751|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
164329718|NCT02598960|593584752|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
164329719|NCT02598960|593584740|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
164329720|NCT02598960|593584741|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
164329721|NCT02598960|593584742|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
164329722|NCT02598960|593584743|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
164329723|NCT02598960|593584744|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
164329724|NCT02598960|593584745|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
164329725|NCT02598960|593584746|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
164570135|NCT02747927|594453223|FG000|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|119|||
164329726|NCT02598960|593584747|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
164329727|NCT02598960|593584748|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
164570136|NCT02747927|594453224|FG001|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|227|||
164329728|NCT02598960|593584749|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
164329729|NCT02598960|593584750|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
164329730|NCT02598960|593584751|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
164329731|NCT02598960|593584752|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
164329732|NCT02598960|593584740|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
164329733|NCT02598960|593584741|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
164329734|NCT02598960|593584742|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
164329735|NCT02598960|593584743|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
164329736|NCT02598960|593584744|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
164329737|NCT02598960|593584745|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
164329738|NCT02598960|593584746|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
164329739|NCT02598960|593584747|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
164329740|NCT02598960|593584748|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
164329741|NCT02598960|593584749|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
164329742|NCT02598960|593584750|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
164329743|NCT02598960|593584751|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
164329744|NCT02598960|593584752|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
164329745|NCT02598960|593584740|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
164329746|NCT02598960|593584741|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
164329747|NCT02598960|593584742|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
164329748|NCT02598960|593584743|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
164329749|NCT02598960|593584744|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
164329750|NCT02598960|593584745|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
164329751|NCT02598960|593584746|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
164329752|NCT02598960|593584747|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
164329753|NCT02598960|593584748|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
164329754|NCT02598960|593584749|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
164329755|NCT02598960|593584750|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
164329756|NCT02598960|593584751|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
164329757|NCT02598960|593584752|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
164329758|NCT00398411|593584753|FG000|Overall Study|Death|0|||
164329759|NCT00398411|593584754|FG001|Overall Study|Death|1|||
164329760|NCT00401531|593584755|FG000|Overall Study|Adverse Event|2|||
164329761|NCT00401531|593584756|FG001|Overall Study|Adverse Event|0|||
164329762|NCT00401531|593584755|FG000|Overall Study|Protocol Violation|3|||
164329763|NCT00401531|593584756|FG001|Overall Study|Protocol Violation|7|||
164329764|NCT00401531|593584755|FG000|Overall Study|Lost to Follow-up|1|||
164329765|NCT00401531|593584756|FG001|Overall Study|Lost to Follow-up|1|||
164329766|NCT00401531|593584755|FG000|Overall Study|Withdrawal by Subject|3|||
164329767|NCT00401531|593584756|FG001|Overall Study|Withdrawal by Subject|2|||
164329768|NCT01614600|593584761|FG000|Overall Study|Unacceptable fit|1|||
164329769|NCT01614600|593584761|FG000|Overall Study|Discomfort|1|||
164329770|NCT01614600|593584761|FG000|Overall Study|Unable to remove lens at the end of day|1|||
164329771|NCT01614600|593584761|FG000|Overall Study|Protocol deviation|1|||
164329772|NCT03403374|593584762|FG000|Overall Study|Lost to Follow-up|1|||
164329773|NCT00736957|593584768|FG000|Overall Study|Adverse Event|43|||
164329774|NCT00736957|593584768|FG000|Overall Study|Withdrawal by Subject|49|||
164329775|NCT00736957|593584768|FG000|Overall Study|violation of eligibility criteria|2|||
164329776|NCT00736957|593584768|FG000|Overall Study|did not attend hospital appointments|1|||
164329777|NCT00736957|593584768|FG000|Overall Study|not eligible for Treatment Period I|22|||
164329778|NCT00736957|593584768|FG000|Overall Study|Physician Decision|5|||
164329779|NCT02395666|593584769|FG000|Overall Study|Physician Decision|3|||
164329780|NCT02395666|593584770|FG001|Overall Study|Physician Decision|0|||
164329781|NCT02395666|593584769|FG000|Overall Study|Lost to Follow-up|1|||
164329782|NCT02395666|593584770|FG001|Overall Study|Lost to Follow-up|0|||
164329783|NCT02395666|593584769|FG000|Overall Study|Withdrawal by Subject|2|||
164329784|NCT02395666|593584770|FG001|Overall Study|Withdrawal by Subject|1|||
164329785|NCT03646643|593584771|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
164329786|NCT03646643|593584772|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
164329787|NCT03646643|593584771|FG000|Overall Study|Lost to Follow-up|0|||
164329788|NCT03646643|593584772|FG001|Overall Study|Lost to Follow-up|1|||
164329789|NCT02806973|593584773|FG000|Period 1|Withdrawal by Subject|0|||
164329790|NCT02806973|593584774|FG001|Period 1|Withdrawal by Subject|2|||
164329791|NCT02806973|593584775|FG002|Period 1|Withdrawal by Subject|1|||
164329792|NCT02806973|593584776|FG003|Period 1|Withdrawal by Subject|1|||
164329793|NCT02806973|593584773|FG000|Period 1|Adverse Event|0|||
164329794|NCT02806973|593584774|FG001|Period 1|Adverse Event|0|||
164329795|NCT02806973|593584775|FG002|Period 1|Adverse Event|0|||
164329796|NCT02806973|593584776|FG003|Period 1|Adverse Event|1|||
164674184|NCT01597245|594831049|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164329797|NCT02806973|593584773|FG000|Period 3|Withdrawal by Subject|0|||
164329798|NCT02806973|593584774|FG001|Period 3|Withdrawal by Subject|0|||
164329799|NCT02806973|593584775|FG002|Period 3|Withdrawal by Subject|0|||
164329800|NCT02806973|593584776|FG003|Period 3|Withdrawal by Subject|3|||
164329801|NCT02806973|593584773|FG000|Period 3|Adverse Event|0|||
164329802|NCT02806973|593584774|FG001|Period 3|Adverse Event|0|||
164329803|NCT02806973|593584775|FG002|Period 3|Adverse Event|1|||
164329804|NCT02806973|593584776|FG003|Period 3|Adverse Event|0|||
164329805|NCT04209426|593584779|FG000|Overall Study|Lost to Follow-up|3|||
164329806|NCT04209426|593584780|FG001|Overall Study|Lost to Follow-up|2|||
164329807|NCT04060862|593584781|FG000|Overall Study|Symptomatic Deterioration|1|||
164329808|NCT04060862|593584781|FG000|Overall Study|Un-specified|6|||
164329809|NCT04060862|593584781|FG000|Overall Study|Progressive disease|12|||
164329810|NCT04060862|593584781|FG000|Overall Study|Physician Decision|1|||
164329811|NCT01031381|593584786|FG000|Overall Study|Physician Decision|3|||
164329812|NCT01031381|593584786|FG000|Overall Study|Withdrawal by Subject|6|||
164329813|NCT02694523|593584787|FG000|Part A|Adverse Event|7|||
164329814|NCT02694523|593584788|FG001|Part A|Adverse Event|3|||
164329815|NCT02694523|593584789|FG002|Part A|Adverse Event|0|||
164329816|NCT02694523|593584790|FG003|Part A|Adverse Event|0|||
164329817|NCT02694523|593584791|FG004|Part A|Adverse Event|0|||
164329818|NCT02694523|593584792|FG005|Part A|Adverse Event|0|||
164329819|NCT02694523|593584793|FG006|Part A|Adverse Event|0|||
164225063|NCT01712074|593192243|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
164225064|NCT01712074|593192244|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
164225065|NCT01712074|593192245|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
164225066|NCT01712074|593192243|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
164225067|NCT01712074|593192244|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
164225068|NCT01712074|593192245|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
164225069|NCT01712074|593192243|FG000|Placebo Run-in Period|Other|1|||
164225070|NCT01712074|593192244|FG001|Placebo Run-in Period|Other|0|||
164225071|NCT01712074|593192245|FG002|Placebo Run-in Period|Other|0|||
164225072|NCT01712074|593192243|FG000|Placebo Run-in Period|No longer willing to participate|1|||
164225073|NCT01712074|593192244|FG001|Placebo Run-in Period|No longer willing to participate|0|||
164225074|NCT01712074|593192245|FG002|Placebo Run-in Period|No longer willing to participate|0|||
164225075|NCT01712074|593192243|FG000|Double Blind Period|Adverse Event|0|||
164225076|NCT01712074|593192244|FG001|Double Blind Period|Adverse Event|2|||
164225077|NCT01712074|593192245|FG002|Double Blind Period|Adverse Event|1|||
164225078|NCT01712074|593192243|FG000|Double Blind Period|No longer willing to participate|0|||
164225079|NCT01712074|593192244|FG001|Double Blind Period|No longer willing to participate|2|||
164225080|NCT01712074|593192245|FG002|Double Blind Period|No longer willing to participate|4|||
164225081|NCT01712074|593192243|FG000|Double Blind Period|Death|0|||
164225082|NCT01712074|593192244|FG001|Double Blind Period|Death|1|||
164225083|NCT01712074|593192245|FG002|Double Blind Period|Death|0|||
164225084|NCT01712074|593192243|FG000|Double Blind Period|Lost to Follow-up|0|||
164225085|NCT01712074|593192244|FG001|Double Blind Period|Lost to Follow-up|2|||
164225086|NCT01712074|593192245|FG002|Double Blind Period|Lost to Follow-up|1|||
164225087|NCT01712074|593192243|FG000|Double Blind Period|Other|0|||
164225088|NCT01712074|593192244|FG001|Double Blind Period|Other|4|||
164225089|NCT01712074|593192245|FG002|Double Blind Period|Other|1|||
164225090|NCT01712074|593192243|FG000|Double Blind Period|Protocol Violation|0|||
164225091|NCT01712074|593192244|FG001|Double Blind Period|Protocol Violation|0|||
164225092|NCT01712074|593192245|FG002|Double Blind Period|Protocol Violation|1|||
164225093|NCT01712074|593192243|FG000|Double Blind Period|No longer met eligibility criteria|0|||
164225094|NCT01712074|593192244|FG001|Double Blind Period|No longer met eligibility criteria|3|||
164225095|NCT01712074|593192245|FG002|Double Blind Period|No longer met eligibility criteria|0|||
164225096|NCT03478787|593192246|FG000|Overall Study|Adverse Event|5|||
164329820|NCT02694523|593584787|FG000|Part A|Protocol Violation|1|||
164329821|NCT02694523|593584788|FG001|Part A|Protocol Violation|0|||
164225097|NCT03478787|593192247|FG001|Overall Study|Adverse Event|1|||
164225098|NCT03478787|593192246|FG000|Overall Study|Protocol Violation|3|||
164225099|NCT03478787|593192247|FG001|Overall Study|Protocol Violation|0|||
164225100|NCT03478787|593192246|FG000|Overall Study|Lack of Efficacy|7|||
164225101|NCT03478787|593192247|FG001|Overall Study|Lack of Efficacy|1|||
164225102|NCT03478787|593192246|FG000|Overall Study|Lost to Follow-up|9|||
164225103|NCT03478787|593192247|FG001|Overall Study|Lost to Follow-up|5|||
164225104|NCT03478787|593192246|FG000|Overall Study|Withdrawal by Subject|2|||
164329822|NCT02694523|593584789|FG002|Part A|Protocol Violation|0|||
164329823|NCT02694523|593584790|FG003|Part A|Protocol Violation|0|||
164329824|NCT02694523|593584791|FG004|Part A|Protocol Violation|0|||
164225105|NCT03478787|593192247|FG001|Overall Study|Withdrawal by Subject|6|||
164329825|NCT02694523|593584792|FG005|Part A|Protocol Violation|0|||
164329826|NCT02694523|593584793|FG006|Part A|Protocol Violation|0|||
164225106|NCT03478787|593192246|FG000|Overall Study|Other, Not Specified|3|||
164225107|NCT03478787|593192247|FG001|Overall Study|Other, Not Specified|0|||
164225108|NCT02413346|593192248|FG000|Overall Study|Adverse Event|6|||
164225109|NCT02413346|593192249|FG001|Overall Study|Adverse Event|6|||
164329827|NCT02694523|593584787|FG000|Part A|Lost to Follow-up|1|||
164329828|NCT02694523|593584788|FG001|Part A|Lost to Follow-up|2|||
164570137|NCT02747927|594453223|FG000|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|82|||
164570138|NCT02747927|594453224|FG001|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|150|||
164570139|NCT02747927|594453223|FG000|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|13|||
164570140|NCT02747927|594453224|FG001|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|18|||
164570141|NCT02747927|594453223|FG000|Part 4: Booster VE & Safety (13 Months)|Adverse Event|1|||
164570142|NCT02747927|594453224|FG001|Part 4: Booster VE & Safety (13 Months)|Adverse Event|3|||
164570143|NCT02747927|594453223|FG000|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|4|||
164570144|NCT02747927|594453224|FG001|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|13|||
164225110|NCT02413346|593192248|FG000|Overall Study|Withdrawal by Subject|30|||
164225111|NCT02413346|593192249|FG001|Overall Study|Withdrawal by Subject|40|||
164225112|NCT02413346|593192248|FG000|Overall Study|Lost to Follow-up|17|||
164225113|NCT02413346|593192249|FG001|Overall Study|Lost to Follow-up|21|||
164225114|NCT02413346|593192248|FG000|Overall Study|Protocol Violation|2|||
164225115|NCT02413346|593192249|FG001|Overall Study|Protocol Violation|0|||
164225116|NCT02413346|593192248|FG000|Overall Study|Other Miscellaneous Reasons|4|||
164225117|NCT02413346|593192249|FG001|Overall Study|Other Miscellaneous Reasons|3|||
164225118|NCT02766478|593192254|FG000|Overall Study|Withdrawal by Subject|1|||
164225119|NCT02766478|593192255|FG001|Overall Study|Withdrawal by Subject|1|||
164225120|NCT05626686|593192256|FG000|Overall Study|Protocol Violation|3|||
164225121|NCT05626686|593192256|FG000|Overall Study|Withdrawal by Subject|3|||
164225122|NCT00682435|593192257|FG000|Overall Study|Insufficient data|5|||
164225123|NCT00682435|593192257|FG000|Overall Study|Erroneously enrolled twice|2|||
164225124|NCT00089583|593192258|FG000|Overall Study|Adverse Event|0|||
164225125|NCT00089583|593192259|FG001|Overall Study|Adverse Event|3|||
164225126|NCT00089583|593192258|FG000|Overall Study|Insufficient Viral Load Response|5|||
164225127|NCT00089583|593192259|FG001|Overall Study|Insufficient Viral Load Response|5|||
164225128|NCT00089583|593192258|FG000|Overall Study|Withdrawal by Subject|0|||
164225129|NCT00089583|593192259|FG001|Overall Study|Withdrawal by Subject|4|||
164225130|NCT00089583|593192258|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
164225131|NCT00089583|593192259|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
164225132|NCT00089583|593192258|FG000|Overall Study|Participant Refused Study Medication|0|||
164225133|NCT00089583|593192259|FG001|Overall Study|Participant Refused Study Medication|2|||
164225134|NCT00089583|593192258|FG000|Overall Study|Non-Compliance|0|||
164225135|NCT00089583|593192259|FG001|Overall Study|Non-Compliance|4|||
164225136|NCT00089583|593192258|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
164225137|NCT00089583|593192259|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
164225138|NCT00089583|593192258|FG000|Overall Study|Participant Management Criteria Met|0|||
164225139|NCT00089583|593192259|FG001|Overall Study|Participant Management Criteria Met|1|||
164225140|NCT00089583|593192258|FG000|Overall Study|Reason Not Provided|0|||
164225141|NCT00089583|593192259|FG001|Overall Study|Reason Not Provided|1|||
164225142|NCT00089583|593192258|FG000|Overall Study|Protocol Violation|0|||
164225143|NCT00089583|593192259|FG001|Overall Study|Protocol Violation|3|||
164225144|NCT00089583|593192258|FG000|Overall Study|Principal Investigator Decision|0|||
164225145|NCT00089583|593192259|FG001|Overall Study|Principal Investigator Decision|10|||
164225146|NCT00089583|593192258|FG000|Overall Study|Start of Disallowed Medication|0|||
164225147|NCT00089583|593192259|FG001|Overall Study|Start of Disallowed Medication|1|||
164225148|NCT00089583|593192258|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
164225149|NCT00089583|593192259|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
164225150|NCT00089583|593192258|FG000|Overall Study|Participant Incarcerated|0|||
164225151|NCT00089583|593192259|FG001|Overall Study|Participant Incarcerated|1|||
164225152|NCT03289741|593192260|FG000|Overall Study|Adverse Event|1|||
164225153|NCT03289741|593192261|FG001|Overall Study|Adverse Event|1|||
164225154|NCT03289741|593192260|FG000|Overall Study|Physician Decision|2|||
164225155|NCT03289741|593192261|FG001|Overall Study|Physician Decision|2|||
164225156|NCT03289741|593192260|FG000|Overall Study|Withdrawal by Subject|1|||
164225157|NCT03289741|593192261|FG001|Overall Study|Withdrawal by Subject|0|||
164225158|NCT00992394|593192265|FG000|Overall Study|Lack of Efficacy|6|||
164225159|NCT00992394|593192266|FG001|Overall Study|Lack of Efficacy|3|||
164225160|NCT00992394|593192265|FG000|Overall Study|Adverse Event|4|||
164225161|NCT00992394|593192266|FG001|Overall Study|Adverse Event|5|||
164225162|NCT00992394|593192265|FG000|Overall Study|Withdrawal by Subject|8|||
164225163|NCT00992394|593192266|FG001|Overall Study|Withdrawal by Subject|2|||
164225164|NCT00992394|593192265|FG000|Overall Study|Physician Decision|1|||
164225165|NCT00992394|593192266|FG001|Overall Study|Physician Decision|0|||
164225166|NCT00992394|593192265|FG000|Overall Study|Protocol Violation|2|||
164225167|NCT00992394|593192266|FG001|Overall Study|Protocol Violation|4|||
164225168|NCT00992394|593192265|FG000|Overall Study|Lost to Follow-up|2|||
164225169|NCT00992394|593192266|FG001|Overall Study|Lost to Follow-up|0|||
164225170|NCT00992394|593192265|FG000|Overall Study|Other event|1|||
164225171|NCT00992394|593192266|FG001|Overall Study|Other event|0|||
164225172|NCT01245049|593192267|FG000|Overall Study|Migrated/moved from study area|0|||
164225173|NCT01245049|593192268|FG001|Overall Study|Migrated/moved from study area|1|||
164225174|NCT01245049|593192267|FG000|Overall Study|Withdrawal by Subject|0|||
164225175|NCT01245049|593192268|FG001|Overall Study|Withdrawal by Subject|1|||
164329829|NCT02694523|593584789|FG002|Part A|Lost to Follow-up|0|||
164329830|NCT02694523|593584790|FG003|Part A|Lost to Follow-up|0|||
164329831|NCT02694523|593584791|FG004|Part A|Lost to Follow-up|0|||
164329832|NCT02694523|593584792|FG005|Part A|Lost to Follow-up|0|||
164570145|NCT02747927|594453223|FG000|Part 4: Booster VE & Safety (13 Months)|Pregnancy|8|||
164570146|NCT02747927|594453224|FG001|Part 4: Booster VE & Safety (13 Months)|Pregnancy|15|||
164570147|NCT02747927|594453223|FG000|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|29|||
164570148|NCT02747927|594453224|FG001|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|60|||
164570149|NCT02747927|594453223|FG000|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|0|||
164570150|NCT02747927|594453224|FG001|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|1|||
164570151|NCT02747927|594453223|FG000|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|4|||
164570152|NCT02747927|594453224|FG001|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|9|||
164570153|NCT02747927|594453223|FG000|Part 5: Booster VE & Safety (1 Year)|Adverse Event|0|||
164570154|NCT02747927|594453224|FG001|Part 5: Booster VE & Safety (1 Year)|Adverse Event|3|||
164570155|NCT02747927|594453223|FG000|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|8|||
164570156|NCT02747927|594453224|FG001|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|30|||
164570157|NCT02747927|594453223|FG000|Part 5: Booster VE & Safety (1 Year)|Pregnancy|18|||
164570158|NCT02747927|594453224|FG001|Part 5: Booster VE & Safety (1 Year)|Pregnancy|27|||
164570159|NCT02747927|594453223|FG000|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|18|||
164570160|NCT02747927|594453224|FG001|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|40|||
164570161|NCT02747927|594453223|FG000|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|14|||
164570162|NCT02747927|594453224|FG001|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|29|||
164570163|NCT02747927|594453223|FG000|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|40|||
164570164|NCT02747927|594453224|FG001|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|89|||
164570165|NCT01154101|594453234|FG000|Overall Study|Adverse Event|0|||
164570166|NCT01154101|594453235|FG001|Overall Study|Adverse Event|2|||
164570167|NCT01154101|594453236|FG002|Overall Study|Adverse Event|1|||
164570168|NCT01154101|594453237|FG003|Overall Study|Adverse Event|1|||
164570169|NCT01154101|594453238|FG004|Overall Study|Adverse Event|0|||
164570170|NCT01154101|594453234|FG000|Overall Study|Lost to Follow-up|0|||
164570171|NCT01154101|594453235|FG001|Overall Study|Lost to Follow-up|1|||
164570172|NCT01154101|594453236|FG002|Overall Study|Lost to Follow-up|0|||
164570173|NCT01154101|594453237|FG003|Overall Study|Lost to Follow-up|1|||
164570174|NCT01154101|594453238|FG004|Overall Study|Lost to Follow-up|0|||
164570175|NCT01154101|594453234|FG000|Overall Study|Withdrawal by Subject|0|||
164570176|NCT01154101|594453235|FG001|Overall Study|Withdrawal by Subject|1|||
164570177|NCT01154101|594453236|FG002|Overall Study|Withdrawal by Subject|2|||
164570178|NCT01154101|594453237|FG003|Overall Study|Withdrawal by Subject|0|||
164570179|NCT01154101|594453238|FG004|Overall Study|Withdrawal by Subject|1|||
164570180|NCT03575104|594453239|FG000|Overall Study|Adverse Event|4|||
164570181|NCT03575104|594453240|FG001|Overall Study|Adverse Event|3|||
164570182|NCT03575104|594453241|FG002|Overall Study|Adverse Event|4|||
164570183|NCT03575104|594453239|FG000|Overall Study|Withdrawal by Subject|13|||
164570184|NCT03575104|594453240|FG001|Overall Study|Withdrawal by Subject|16|||
164570185|NCT03575104|594453241|FG002|Overall Study|Withdrawal by Subject|11|||
164570186|NCT03575104|594453239|FG000|Overall Study|Other reasons|6|||
164570187|NCT03575104|594453240|FG001|Overall Study|Other reasons|8|||
164570188|NCT03575104|594453241|FG002|Overall Study|Other reasons|6|||
164570189|NCT03575104|594453239|FG000|Overall Study|Lost to Follow-up|1|||
164570190|NCT03575104|594453240|FG001|Overall Study|Lost to Follow-up|2|||
164570191|NCT03575104|594453241|FG002|Overall Study|Lost to Follow-up|1|||
164570192|NCT00332709|594453242|FG000|Overall Study|Adverse Event|11|||
164570193|NCT00332709|594453243|FG001|Overall Study|Adverse Event|14|||
164570194|NCT00332709|594453242|FG000|Overall Study|Withdrawal by Subject|2|||
164570195|NCT00332709|594453243|FG001|Overall Study|Withdrawal by Subject|3|||
164570196|NCT00332709|594453242|FG000|Overall Study|Lost to Follow-up|2|||
164570197|NCT00332709|594453243|FG001|Overall Study|Lost to Follow-up|0|||
164570198|NCT00332709|594453242|FG000|Overall Study|Administrative Problems|0|||
164570199|NCT00332709|594453243|FG001|Overall Study|Administrative Problems|3|||
164570200|NCT00332709|594453242|FG000|Overall Study|Abnormal test procedure result|1|||
164570201|NCT00332709|594453243|FG001|Overall Study|Abnormal test procedure result|0|||
164570202|NCT03293654|594453248|FG000|Overall Study|Lost to Follow-up|0|||
164570203|NCT03293654|594453249|FG001|Overall Study|Lost to Follow-up|1|||
164570204|NCT03293654|594453250|FG002|Overall Study|Lost to Follow-up|0|||
164570205|NCT01919307|594453251|FG000|Overall Study|Withdrawal by Subject|9|||
164570206|NCT05052723|594453253|FG000|Overall Study|Death|19|||
164674185|NCT01597245|594831050|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164674186|NCT01597245|594831051|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164570207|NCT03049449|594453254|FG000|Overall Study|Did not receive treatment.|0|||
164674187|NCT01597245|594831052|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164570208|NCT03049449|594453255|FG001|Overall Study|Did not receive treatment.|0|||
164570209|NCT03049449|594453256|FG002|Overall Study|Did not receive treatment.|0|||
164329833|NCT02694523|593584793|FG006|Part A|Lost to Follow-up|0|||
164225176|NCT01245049|593192267|FG000|Overall Study|Lost to Follow-up|1|||
164225177|NCT01245049|593192268|FG001|Overall Study|Lost to Follow-up|2|||
164225178|NCT00450749|593192269|FG000|Overall Study|Withdrawal by Subject|0|||
164225179|NCT00450749|593192270|FG001|Overall Study|Withdrawal by Subject|0|||
164225180|NCT00450749|593192271|FG002|Overall Study|Withdrawal by Subject|2|||
164225181|NCT00450749|593192269|FG000|Overall Study|Noncompliant|0|||
164225182|NCT00450749|593192270|FG001|Overall Study|Noncompliant|1|||
164225183|NCT00450749|593192271|FG002|Overall Study|Noncompliant|0|||
164225184|NCT02151604|593192272|FG000|Overall Study|Lost to Follow-up|3|||
164225185|NCT02151604|593192272|FG000|Overall Study|Withdrawal by Subject|2|||
164225186|NCT02151604|593192272|FG000|Overall Study|Physician Decision|3|||
164570210|NCT03049449|594453257|FG003|Overall Study|Did not receive treatment.|0|||
164570211|NCT03049449|594453258|FG004|Overall Study|Did not receive treatment.|0|||
164570212|NCT03049449|594453259|FG005|Overall Study|Did not receive treatment.|0|||
164570213|NCT03049449|594453260|FG006|Overall Study|Did not receive treatment.|0|||
164570214|NCT03049449|594453261|FG007|Overall Study|Did not receive treatment.|0|||
164225187|NCT02151604|593192272|FG000|Overall Study|Death|1|||
164225188|NCT00537082|593192274|FG000|Overall Study|Adverse Event|6|||
164225189|NCT00537082|593192275|FG001|Overall Study|Adverse Event|6|||
164570215|NCT03049449|594453262|FG008|Overall Study|Did not receive treatment.|1|||
164570216|NCT03049449|594453263|FG009|Overall Study|Did not receive treatment.|0|||
164570217|NCT03049449|594453254|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
164570218|NCT03049449|594453255|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
164225190|NCT00537082|593192276|FG002|Overall Study|Adverse Event|3|||
164225191|NCT00537082|593192274|FG000|Overall Study|Protocol Violation|0|||
164225192|NCT00537082|593192275|FG001|Overall Study|Protocol Violation|2|||
164225193|NCT00537082|593192276|FG002|Overall Study|Protocol Violation|1|||
164225194|NCT00537082|593192274|FG000|Overall Study|Lack of Efficacy|0|||
164225195|NCT00537082|593192275|FG001|Overall Study|Lack of Efficacy|0|||
164225196|NCT00537082|593192276|FG002|Overall Study|Lack of Efficacy|2|||
164225197|NCT00537082|593192274|FG000|Overall Study|Withdrawal by Subject|0|||
164225198|NCT00537082|593192275|FG001|Overall Study|Withdrawal by Subject|1|||
164225199|NCT00537082|593192276|FG002|Overall Study|Withdrawal by Subject|0|||
164225200|NCT00537082|593192274|FG000|Overall Study|Discontinued before initiating treatment|3|||
164225201|NCT00537082|593192275|FG001|Overall Study|Discontinued before initiating treatment|0|||
164225202|NCT00537082|593192276|FG002|Overall Study|Discontinued before initiating treatment|0|||
164225203|NCT04495478|593192277|FG000|Overall Study|Withdrawal by Subject|0|||
164225204|NCT04495478|593192278|FG001|Overall Study|Withdrawal by Subject|0|||
164225205|NCT04495478|593192279|FG002|Overall Study|Withdrawal by Subject|0|||
164225206|NCT04495478|593192280|FG003|Overall Study|Withdrawal by Subject|1|||
164225207|NCT04495478|593192281|FG004|Overall Study|Withdrawal by Subject|0|||
164225208|NCT04495478|593192282|FG005|Overall Study|Withdrawal by Subject|0|||
164225209|NCT04495478|593192283|FG006|Overall Study|Withdrawal by Subject|0|||
164225210|NCT04495478|593192277|FG000|Overall Study|Physician Decision|0|||
164225211|NCT04495478|593192278|FG001|Overall Study|Physician Decision|1|||
164225212|NCT04495478|593192279|FG002|Overall Study|Physician Decision|0|||
164225213|NCT04495478|593192280|FG003|Overall Study|Physician Decision|0|||
164225214|NCT04495478|593192281|FG004|Overall Study|Physician Decision|1|||
164225215|NCT04495478|593192282|FG005|Overall Study|Physician Decision|0|||
164225216|NCT04495478|593192283|FG006|Overall Study|Physician Decision|0|||
164225217|NCT00655746|593192284|FG000|Overall Study|Withdrawal by Subject|1|||
164225218|NCT00561821|593192285|FG000|Overall Study|Not treated|0|||
164225219|NCT00561821|593192286|FG001|Overall Study|Not treated|0|||
164225220|NCT00561821|593192287|FG002|Overall Study|Not treated|1|||
164225221|NCT00561821|593192288|FG003|Overall Study|Not treated|0|||
164225222|NCT00561821|593192285|FG000|Overall Study|Withdrawal by Subject|0|||
164225223|NCT00561821|593192286|FG001|Overall Study|Withdrawal by Subject|1|||
164225224|NCT00561821|593192287|FG002|Overall Study|Withdrawal by Subject|0|||
164225225|NCT00561821|593192288|FG003|Overall Study|Withdrawal by Subject|2|||
164225226|NCT00561821|593192285|FG000|Overall Study|Reasons not related to trial|2|||
164225227|NCT00561821|593192286|FG001|Overall Study|Reasons not related to trial|1|||
164225228|NCT00561821|593192287|FG002|Overall Study|Reasons not related to trial|0|||
164225229|NCT00561821|593192288|FG003|Overall Study|Reasons not related to trial|0|||
164225230|NCT00561821|593192285|FG000|Overall Study|Other (reason not specified)|1|||
164225231|NCT00561821|593192286|FG001|Overall Study|Other (reason not specified)|1|||
164225232|NCT00561821|593192287|FG002|Overall Study|Other (reason not specified)|0|||
164225233|NCT00561821|593192288|FG003|Overall Study|Other (reason not specified)|0|||
164225234|NCT00561821|593192285|FG000|Overall Study|Adverse Event|2|||
164225235|NCT00561821|593192286|FG001|Overall Study|Adverse Event|3|||
164225236|NCT00561821|593192287|FG002|Overall Study|Adverse Event|1|||
164225237|NCT00561821|593192288|FG003|Overall Study|Adverse Event|1|||
164225238|NCT03178942|593192289|FG000|Overall Study|Withdrawal by Subject|2|||
164225239|NCT03178942|593192290|FG001|Overall Study|Withdrawal by Subject|0|||
164225240|NCT03178942|593192289|FG000|Overall Study|Lost to Follow-up|1|||
164225241|NCT03178942|593192290|FG001|Overall Study|Lost to Follow-up|2|||
164225242|NCT01197300|593193950|FG000|Overall Study|Lost to Follow-up|0|||
164674188|NCT01597245|594831053|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164674189|NCT01597245|594831054|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164674190|NCT01597245|594831055|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164674191|NCT01597245|594831056|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164674192|NCT01597245|594831057|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164674193|NCT01597245|594831058|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164674194|NCT01597245|594831059|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
164674195|NCT01597245|594831060|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164674196|NCT01597245|594831061|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164674197|NCT01597245|594831062|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
164674198|NCT01597245|594831063|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
164674199|NCT01597245|594831043|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164674200|NCT01597245|594831044|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164674201|NCT01597245|594831045|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164674202|NCT01597245|594831046|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164674203|NCT01597245|594831047|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164674204|NCT01597245|594831048|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164674205|NCT01597245|594831049|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164674206|NCT01597245|594831050|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164674207|NCT01597245|594831051|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164674208|NCT01597245|594831052|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164674209|NCT01597245|594831053|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164674210|NCT01597245|594831054|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164674211|NCT01597245|594831055|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164674212|NCT01597245|594831056|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164674213|NCT01597245|594831057|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164674214|NCT01597245|594831058|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164674215|NCT01597245|594831059|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164674216|NCT01597245|594831060|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164674217|NCT01597245|594831061|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
164674218|NCT01597245|594831062|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
164674219|NCT01597245|594831063|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
164674220|NCT01597245|594831043|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164674221|NCT01597245|594831044|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164674222|NCT01597245|594831045|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164674223|NCT01597245|594831046|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164674224|NCT01597245|594831047|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164674225|NCT01597245|594831048|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164674226|NCT01597245|594831049|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164674227|NCT01597245|594831050|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164674228|NCT01597245|594831051|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164674229|NCT01597245|594831052|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164674230|NCT01597245|594831053|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164674231|NCT01597245|594831054|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164674232|NCT01597245|594831055|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164674233|NCT01597245|594831056|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164674234|NCT01597245|594831057|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164674235|NCT01597245|594831058|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164674236|NCT01597245|594831059|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
164674237|NCT01597245|594831060|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164674238|NCT01597245|594831061|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164674239|NCT01597245|594831062|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
164674240|NCT01597245|594831063|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
164674241|NCT01597245|594831043|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164674242|NCT01597245|594831044|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164674243|NCT01597245|594831045|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164674244|NCT01597245|594831046|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164674245|NCT01597245|594831047|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164674246|NCT01597245|594831048|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164674247|NCT01597245|594831049|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164674248|NCT01597245|594831050|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164674249|NCT01597245|594831051|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164225243|NCT01197300|593193951|FG001|Overall Study|Lost to Follow-up|1|||
164225244|NCT01197300|593193950|FG000|Overall Study|Protocol Violation|0|||
164225245|NCT01197300|593193951|FG001|Overall Study|Protocol Violation|1|||
164225246|NCT03443401|593193960|FG000|Overall Study|Lost to Follow-up|13|||
164225247|NCT03443401|593193960|FG000|Overall Study|Influential outlier|1|||
164225248|NCT02363283|593193961|FG000|Overall Study|Withdrawal by Subject|1|||
164225249|NCT02363283|593193961|FG000|Overall Study|Not eligible due to transaminitis|1|||
164225250|NCT00530257|593193967|FG000|Overall Study|Lost to Follow-up|1|||
164225251|NCT04110145|593193971|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
164225252|NCT04110145|593193972|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
164225253|NCT04110145|593193973|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
164225254|NCT04110145|593193974|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
164225255|NCT04110145|593193975|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
164225256|NCT05401409|593193976|FG000|Overall Study|Lost to Follow-up|1|||
164225257|NCT05401409|593193977|FG001|Overall Study|Lost to Follow-up|0|||
164225258|NCT02562040|593193978|FG000|Overall Study|Lost to Follow-up|20|||
164225259|NCT02562040|593193979|FG001|Overall Study|Lost to Follow-up|28|||
164674250|NCT01597245|594831052|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164674251|NCT01597245|594831053|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164674252|NCT01597245|594831054|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164225260|NCT02562040|593193978|FG000|Overall Study|Withdrawal by Subject|8|||
164225261|NCT02562040|593193979|FG001|Overall Study|Withdrawal by Subject|7|||
164225262|NCT02562040|593193978|FG000|Overall Study|Adverse Event|1|||
164225263|NCT02562040|593193979|FG001|Overall Study|Adverse Event|0|||
164225264|NCT02255279|593193981|FG000|Overall Study|Lost to Follow-up|2|||
164225265|NCT02255279|593193982|FG001|Overall Study|Lost to Follow-up|2|||
164225266|NCT02255279|593193981|FG000|Overall Study|Protocol Violation|0|||
164225267|NCT02255279|593193982|FG001|Overall Study|Protocol Violation|1|||
164225268|NCT02255279|593193981|FG000|Overall Study|Withdrawal by Subject|3|||
164225269|NCT02255279|593193982|FG001|Overall Study|Withdrawal by Subject|6|||
164225270|NCT00432991|593193987|FG000|Overall Study|Protocol Violation|7|||
164225271|NCT00432991|593193988|FG001|Overall Study|Protocol Violation|12|||
164225272|NCT00363467|593193989|FG000|Overall Study|Physician Decision|1|||
164225273|NCT03160573|593193992|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
164225274|NCT03160573|593193993|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
164225275|NCT03160573|593193994|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
164225276|NCT03160573|593193995|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
164225277|NCT02715856|593194020|FG000|Overall Study|Software Issues|12|||
164225278|NCT02715856|593194021|FG001|Overall Study|Software Issues|7|||
164225279|NCT02715856|593194020|FG000|Overall Study|Death|6|||
164225280|NCT02715856|593194021|FG001|Overall Study|Death|5|||
164225281|NCT02715856|593194020|FG000|Overall Study|Non- Compliant|0|||
164225282|NCT02715856|593194021|FG001|Overall Study|Non- Compliant|40|||
164225283|NCT00128492|593194022|FG000|Overall Study|AE unrelated to study|2|||
164225284|NCT00128492|593194023|FG001|Overall Study|AE unrelated to study|9|||
164225285|NCT00128492|593194022|FG000|Overall Study|Study drug intolerance (AE)|2|||
164225286|NCT00128492|593194023|FG001|Overall Study|Study drug intolerance (AE)|8|||
164225287|NCT00128492|593194022|FG000|Overall Study|AE related to study|1|||
164225288|NCT00128492|593194023|FG001|Overall Study|AE related to study|4|||
164225289|NCT00128492|593194022|FG000|Overall Study|Death|1|||
164225290|NCT00128492|593194023|FG001|Overall Study|Death|0|||
164225291|NCT00128492|593194022|FG000|Overall Study|Lost to Follow-up|1|||
164225292|NCT00128492|593194023|FG001|Overall Study|Lost to Follow-up|5|||
164225293|NCT00128492|593194022|FG000|Overall Study|Noncompliance|0|||
164225294|NCT00128492|593194023|FG001|Overall Study|Noncompliance|5|||
164225295|NCT00128492|593194022|FG000|Overall Study|Personal or administrative|10|||
164225296|NCT00128492|593194023|FG001|Overall Study|Personal or administrative|22|||
164225297|NCT00128492|593194022|FG000|Overall Study|Withdrawal by Subject|3|||
164225298|NCT00128492|593194023|FG001|Overall Study|Withdrawal by Subject|5|||
164225299|NCT00128492|593194022|FG000|Overall Study|Pregnancy|0|||
164225300|NCT00128492|593194023|FG001|Overall Study|Pregnancy|1|||
164225301|NCT03436420|593194024|FG000|Overall Study|Lack of Efficacy|3|||
164225302|NCT00756314|593194025|FG000|Overall Study|Lost to Follow-up|2|||
164225303|NCT00756314|593194026|FG001|Overall Study|Lost to Follow-up|59|||
164225304|NCT02605967|593194027|FG000|Overall Study|subject / guardian decision|1|||
164225305|NCT02605967|593194028|FG001|Overall Study|subject / guardian decision|2|||
164225306|NCT02605967|593194027|FG000|Overall Study|Physician Decision|10|||
164225307|NCT02605967|593194028|FG001|Overall Study|Physician Decision|1|||
164225308|NCT02605967|593194027|FG000|Overall Study|Death|4|||
164225309|NCT02605967|593194028|FG001|Overall Study|Death|2|||
164225310|NCT02605967|593194027|FG000|Overall Study|Adverse Event|1|||
164225311|NCT02605967|593194028|FG001|Overall Study|Adverse Event|0|||
164225312|NCT02605967|593194027|FG000|Overall Study|progressive disease|66|||
164225313|NCT02605967|593194028|FG001|Overall Study|progressive disease|35|||
164225314|NCT03627468|593194029|FG000|Overall Study|Adverse Event|5|||
164225315|NCT03627468|593194030|FG001|Overall Study|Adverse Event|33|||
164225316|NCT03627468|593194029|FG000|Overall Study|Withdrawal by Subject|13|||
164225317|NCT03627468|593194030|FG001|Overall Study|Withdrawal by Subject|23|||
164225318|NCT03627468|593194029|FG000|Overall Study|Physician Decision|1|||
164225319|NCT03627468|593194030|FG001|Overall Study|Physician Decision|0|||
164225320|NCT03627468|593194029|FG000|Overall Study|Protocol Violation|0|||
164674253|NCT01597245|594831055|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164674254|NCT01597245|594831056|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164225321|NCT03627468|593194030|FG001|Overall Study|Protocol Violation|2|||
164225322|NCT03627468|593194029|FG000|Overall Study|Lost to Follow-up|10|||
164674255|NCT01597245|594831057|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164674256|NCT01597245|594831058|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164674257|NCT01597245|594831059|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
164674258|NCT01597245|594831060|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164674259|NCT01597245|594831061|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164674260|NCT01597245|594831062|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
164674261|NCT01597245|594831063|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
164674262|NCT01597245|594831043|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164674263|NCT01597245|594831044|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164674264|NCT01597245|594831045|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164674265|NCT01597245|594831046|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164674266|NCT01597245|594831047|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164674267|NCT01597245|594831048|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164674268|NCT01597245|594831049|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164674269|NCT01597245|594831050|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164674270|NCT01597245|594831051|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164674271|NCT01597245|594831052|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164674272|NCT01597245|594831053|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164674273|NCT01597245|594831054|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164674274|NCT01597245|594831055|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164674275|NCT01597245|594831056|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164674276|NCT01597245|594831057|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164674277|NCT01597245|594831058|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164674278|NCT01597245|594831059|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
164674279|NCT01597245|594831060|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164674280|NCT01597245|594831061|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164674281|NCT01597245|594831062|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
164674282|NCT01597245|594831063|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164674283|NCT01597245|594831043|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164674284|NCT01597245|594831044|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164674285|NCT01597245|594831045|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164674286|NCT01597245|594831046|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164674287|NCT01597245|594831047|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164674288|NCT01597245|594831048|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164674289|NCT01597245|594831049|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164674290|NCT01597245|594831050|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164674291|NCT01597245|594831051|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164674292|NCT01597245|594831052|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164674293|NCT01597245|594831053|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164674294|NCT01597245|594831054|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164674295|NCT01597245|594831055|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164674296|NCT01597245|594831056|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164674297|NCT01597245|594831057|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164674298|NCT01597245|594831058|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164674299|NCT01597245|594831059|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
164225323|NCT03627468|593194030|FG001|Overall Study|Lost to Follow-up|16|||
164225324|NCT03627468|593194029|FG000|Overall Study|Death|1|||
164225325|NCT03627468|593194030|FG001|Overall Study|Death|0|||
164225326|NCT03627468|593194029|FG000|Overall Study|Pregnancy|1|||
164225327|NCT03627468|593194030|FG001|Overall Study|Pregnancy|1|||
164225328|NCT03627468|593194029|FG000|Overall Study|Lack of Efficacy|0|||
164674300|NCT01597245|594831060|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164674301|NCT01597245|594831061|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164225329|NCT03627468|593194030|FG001|Overall Study|Lack of Efficacy|2|||
164225330|NCT03627468|593194029|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
164225331|NCT03627468|593194030|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
164225332|NCT01475825|593194034|FG000|Overall Study|Adverse Event|41|||
164225333|NCT01475825|593194035|FG001|Overall Study|Adverse Event|15|||
164225334|NCT01475825|593194036|FG002|Overall Study|Adverse Event|27|||
164225335|NCT01475825|593194037|FG003|Overall Study|Adverse Event|11|||
164225336|NCT01475825|593194034|FG000|Overall Study|Death|1|||
164225337|NCT01475825|593194035|FG001|Overall Study|Death|0|||
164225338|NCT01475825|593194036|FG002|Overall Study|Death|1|||
164225339|NCT01475825|593194037|FG003|Overall Study|Death|0|||
164225340|NCT01475825|593194034|FG000|Overall Study|Lack of Efficacy|0|||
164225341|NCT01475825|593194035|FG001|Overall Study|Lack of Efficacy|0|||
164225342|NCT01475825|593194036|FG002|Overall Study|Lack of Efficacy|1|||
164225343|NCT01475825|593194037|FG003|Overall Study|Lack of Efficacy|0|||
164225344|NCT01475825|593194034|FG000|Overall Study|Lost to Follow-up|0|||
164225345|NCT01475825|593194035|FG001|Overall Study|Lost to Follow-up|0|||
164570219|NCT03049449|594453256|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
164570220|NCT03049449|594453257|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
164570221|NCT03049449|594453258|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
164570222|NCT03049449|594453259|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
164570223|NCT03049449|594453260|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
164570224|NCT03049449|594453261|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
164570225|NCT03049449|594453262|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
164570226|NCT03049449|594453263|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
164570227|NCT03049449|594453254|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
164570228|NCT03049449|594453255|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
164570229|NCT03049449|594453256|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
164570230|NCT03049449|594453257|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
164570231|NCT03049449|594453258|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
164570232|NCT03049449|594453259|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
164570233|NCT03049449|594453260|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
164570234|NCT03049449|594453261|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
164570235|NCT03049449|594453262|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
164570236|NCT03049449|594453263|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
164570237|NCT01295125|594453264|FG000|Overall Study|Study stopped prematurely|9|||
164570238|NCT00891735|594453265|FG000|Overall Study|Adverse Event|2|||
164570239|NCT00891735|594453266|FG001|Overall Study|Adverse Event|0|||
164570240|NCT00891735|594453267|FG002|Overall Study|Adverse Event|2|||
164570241|NCT00891735|594453268|FG003|Overall Study|Adverse Event|0|||
164570242|NCT00891735|594453265|FG000|Overall Study|Death|8|||
164570243|NCT00891735|594453266|FG001|Overall Study|Death|5|||
164570244|NCT00891735|594453267|FG002|Overall Study|Death|4|||
164570245|NCT00891735|594453268|FG003|Overall Study|Death|5|||
164570246|NCT00891735|594453265|FG000|Overall Study|Lost to Follow-up|2|||
164570247|NCT00891735|594453266|FG001|Overall Study|Lost to Follow-up|2|||
164570248|NCT00891735|594453267|FG002|Overall Study|Lost to Follow-up|2|||
164570249|NCT00891735|594453268|FG003|Overall Study|Lost to Follow-up|2|||
164570250|NCT00891735|594453265|FG000|Overall Study|Physician's decision to withdraw patient|1|||
164570251|NCT00891735|594453266|FG001|Overall Study|Physician's decision to withdraw patient|0|||
164570252|NCT00891735|594453267|FG002|Overall Study|Physician's decision to withdraw patient|0|||
164570253|NCT00891735|594453268|FG003|Overall Study|Physician's decision to withdraw patient|0|||
164570254|NCT00891735|594453265|FG000|Overall Study|Patient's decision to withdraw|4|||
164570255|NCT00891735|594453266|FG001|Overall Study|Patient's decision to withdraw|9|||
164570256|NCT00891735|594453267|FG002|Overall Study|Patient's decision to withdraw|4|||
164570257|NCT00891735|594453268|FG003|Overall Study|Patient's decision to withdraw|8|||
164570258|NCT01360645|594453269|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
164570259|NCT01360645|594453270|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
164570260|NCT01360645|594453271|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
164570261|NCT01360645|594453272|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
164570262|NCT01360645|594453269|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
164570263|NCT01360645|594453270|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
164570264|NCT01360645|594453271|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
164570265|NCT01360645|594453272|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
164570266|NCT01360645|594453269|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
164570267|NCT01360645|594453270|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
164570268|NCT01360645|594453271|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
164225346|NCT01475825|593194036|FG002|Overall Study|Lost to Follow-up|3|||
164225347|NCT01475825|593194037|FG003|Overall Study|Lost to Follow-up|1|||
164225348|NCT01475825|593194034|FG000|Overall Study|Non-compliance with Study Drug|1|||
164225349|NCT01475825|593194035|FG001|Overall Study|Non-compliance with Study Drug|2|||
164570269|NCT01360645|594453272|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
164570270|NCT01360645|594453269|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
164570271|NCT01360645|594453270|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
164570272|NCT01360645|594453271|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
164570273|NCT01360645|594453272|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
164570274|NCT01360645|594453269|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
164570275|NCT01360645|594453270|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
164570276|NCT01360645|594453271|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
164570277|NCT01360645|594453272|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
164570278|NCT01360645|594453269|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
164570279|NCT01360645|594453270|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
164570280|NCT01360645|594453271|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
164570281|NCT01360645|594453272|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
164570282|NCT01360645|594453269|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
164570283|NCT01360645|594453270|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
164570284|NCT01360645|594453271|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
164570285|NCT01360645|594453272|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
164570286|NCT01360645|594453269|FG000|Phase B (6 Weeks)|Adverse Event|0|||
164570287|NCT01360645|594453270|FG001|Phase B (6 Weeks)|Adverse Event|6|||
164570288|NCT01360645|594453271|FG002|Phase B (6 Weeks)|Adverse Event|0|||
164570289|NCT01360645|594453272|FG003|Phase B (6 Weeks)|Adverse Event|0|||
164570290|NCT01360645|594453269|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
164570291|NCT01360645|594453270|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
164570292|NCT01360645|594453271|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
164570293|NCT01360645|594453272|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
164570294|NCT01360645|594453269|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
164570295|NCT01360645|594453270|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
164570296|NCT01360645|594453271|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
164570297|NCT01360645|594453272|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
164570298|NCT01360645|594453269|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
164570299|NCT01360645|594453270|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
164570300|NCT01360645|594453271|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
164570301|NCT01360645|594453272|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
164570302|NCT01360645|594453269|FG000|Phase A+|Lost to Follow-up|0|||
164570303|NCT01360645|594453270|FG001|Phase A+|Lost to Follow-up|0|||
164570304|NCT01360645|594453271|FG002|Phase A+|Lost to Follow-up|0|||
164570305|NCT01360645|594453272|FG003|Phase A+|Lost to Follow-up|7|||
164570306|NCT01360645|594453269|FG000|Phase A+|Adverse Event|0|||
164570307|NCT01360645|594453270|FG001|Phase A+|Adverse Event|0|||
164570308|NCT01360645|594453271|FG002|Phase A+|Adverse Event|0|||
164570309|NCT01360645|594453272|FG003|Phase A+|Adverse Event|2|||
164570310|NCT01360645|594453269|FG000|Phase A+|Met Withdrawal Criteria|0|||
164570311|NCT01360645|594453270|FG001|Phase A+|Met Withdrawal Criteria|0|||
164570312|NCT01360645|594453271|FG002|Phase A+|Met Withdrawal Criteria|0|||
164570313|NCT01360645|594453272|FG003|Phase A+|Met Withdrawal Criteria|4|||
164570314|NCT01360645|594453269|FG000|Phase A+|Physician Decision|0|||
164570315|NCT01360645|594453270|FG001|Phase A+|Physician Decision|0|||
164570316|NCT01360645|594453271|FG002|Phase A+|Physician Decision|0|||
164570317|NCT01360645|594453272|FG003|Phase A+|Physician Decision|2|||
164570318|NCT01360645|594453269|FG000|Phase A+|Withdrawal by Subject|0|||
164570319|NCT01360645|594453270|FG001|Phase A+|Withdrawal by Subject|0|||
164570320|NCT01360645|594453271|FG002|Phase A+|Withdrawal by Subject|0|||
164570321|NCT01360645|594453272|FG003|Phase A+|Withdrawal by Subject|5|||
164570322|NCT01360645|594453269|FG000|Phase A+|Protocol Deviation|0|||
164570323|NCT01360645|594453270|FG001|Phase A+|Protocol Deviation|0|||
164570324|NCT01360645|594453271|FG002|Phase A+|Protocol Deviation|0|||
164570325|NCT01360645|594453272|FG003|Phase A+|Protocol Deviation|4|||
164570326|NCT00802360|594453273|FG000|Overall Study|Stimulation failure|4|||
164570327|NCT00802360|594453274|FG001|Overall Study|Stimulation failure|0|||
164570328|NCT00802360|594453275|FG002|Overall Study|Stimulation failure|3|||
164674302|NCT01597245|594831062|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
164674303|NCT01597245|594831063|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164674304|NCT01597245|594831043|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164674305|NCT01597245|594831044|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164674306|NCT01597245|594831045|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164674307|NCT01597245|594831046|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164674308|NCT01597245|594831047|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164674309|NCT01597245|594831048|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164674310|NCT01597245|594831049|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164674311|NCT01597245|594831050|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164674312|NCT01597245|594831051|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164674313|NCT01597245|594831052|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164674314|NCT01597245|594831053|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164674315|NCT01597245|594831054|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164674316|NCT01597245|594831055|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164674317|NCT01597245|594831056|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164674318|NCT01597245|594831057|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164674319|NCT01597245|594831058|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164674320|NCT01597245|594831059|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164674321|NCT01597245|594831060|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164674322|NCT01597245|594831061|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164674323|NCT01597245|594831062|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
164674324|NCT01597245|594831063|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164674325|NCT00731783|594831064|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
164674326|NCT00731783|594831065|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
164674327|NCT00731783|594831064|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
164674328|NCT00731783|594831065|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
164674329|NCT00731783|594831064|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
164674330|NCT00731783|594831065|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
164674331|NCT00731783|594831064|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
164674332|NCT00731783|594831065|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
164674333|NCT03071575|594832679|FG000|Overall Study|Death|0|||
164674334|NCT03071575|594832680|FG001|Overall Study|Death|1|||
164674335|NCT03071575|594832679|FG000|Overall Study|Lost to Follow-up|5|||
164674336|NCT03071575|594832680|FG001|Overall Study|Lost to Follow-up|11|||
164674337|NCT03071575|594832679|FG000|Overall Study|Withdrawal by Subject|4|||
164674338|NCT03071575|594832680|FG001|Overall Study|Withdrawal by Subject|2|||
164674339|NCT00218257|594832685|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
164674340|NCT00218257|594832686|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
164674341|NCT00579345|594832687|FG000|Overall Study|Withdrawal by Subject|2|||
164674342|NCT00579345|594832688|FG001|Overall Study|Withdrawal by Subject|0|||
164674343|NCT00579345|594832689|FG002|Overall Study|Withdrawal by Subject|0|||
164674344|NCT00579345|594832690|FG003|Overall Study|Withdrawal by Subject|0|||
164674345|NCT00579345|594832691|FG004|Overall Study|Withdrawal by Subject|0|||
164674346|NCT00579345|594832692|FG005|Overall Study|Withdrawal by Subject|0|||
164225350|NCT01475825|593194036|FG002|Overall Study|Non-compliance with Study Drug|4|||
164225351|NCT01475825|593194037|FG003|Overall Study|Non-compliance with Study Drug|0|||
164225352|NCT01475825|593194034|FG000|Overall Study|Other: Not available|0|||
164225353|NCT01475825|593194035|FG001|Overall Study|Other: Not available|0|||
164225354|NCT01475825|593194036|FG002|Overall Study|Other: Not available|2|||
164225355|NCT01475825|593194037|FG003|Overall Study|Other: Not available|0|||
164225356|NCT01475825|593194034|FG000|Overall Study|Protocol Violation|1|||
164674347|NCT00579345|594832693|FG006|Overall Study|Withdrawal by Subject|0|||
164674348|NCT00579345|594832694|FG007|Overall Study|Withdrawal by Subject|1|||
164674349|NCT00579345|594832687|FG000|Overall Study|Lost to Follow-up|1|||
164674350|NCT00579345|594832688|FG001|Overall Study|Lost to Follow-up|0|||
164674351|NCT00579345|594832689|FG002|Overall Study|Lost to Follow-up|0|||
164674352|NCT00579345|594832690|FG003|Overall Study|Lost to Follow-up|0|||
164674353|NCT00579345|594832691|FG004|Overall Study|Lost to Follow-up|0|||
164674354|NCT00579345|594832692|FG005|Overall Study|Lost to Follow-up|0|||
164674355|NCT00579345|594832693|FG006|Overall Study|Lost to Follow-up|0|||
164225357|NCT01475825|593194035|FG001|Overall Study|Protocol Violation|0|||
164225358|NCT01475825|593194036|FG002|Overall Study|Protocol Violation|0|||
164225359|NCT01475825|593194037|FG003|Overall Study|Protocol Violation|0|||
164674356|NCT00579345|594832694|FG007|Overall Study|Lost to Follow-up|0|||
164674357|NCT00579345|594832687|FG000|Overall Study|Adverse Event|0|||
164674358|NCT00579345|594832688|FG001|Overall Study|Adverse Event|0|||
164674359|NCT00579345|594832689|FG002|Overall Study|Adverse Event|1|||
164674360|NCT00579345|594832690|FG003|Overall Study|Adverse Event|0|||
164570329|NCT00802360|594453276|FG003|Overall Study|Stimulation failure|3|||
164570330|NCT00802360|594453273|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
164570331|NCT00802360|594453274|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
164570332|NCT00802360|594453275|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
164570333|NCT00802360|594453276|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
164570334|NCT00802360|594453273|FG000|Overall Study|Cycle cancelled|0|||
164570335|NCT00802360|594453274|FG001|Overall Study|Cycle cancelled|1|||
164570336|NCT00802360|594453275|FG002|Overall Study|Cycle cancelled|1|||
164570337|NCT00802360|594453276|FG003|Overall Study|Cycle cancelled|1|||
164570338|NCT00802360|594453273|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
164570339|NCT00802360|594453274|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
164570340|NCT00802360|594453275|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
164570341|NCT00802360|594453276|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
164570342|NCT00802360|594453273|FG000|Overall Study|No positive serum pregnancy|17|||
164570343|NCT00802360|594453274|FG001|Overall Study|No positive serum pregnancy|20|||
164570344|NCT00802360|594453275|FG002|Overall Study|No positive serum pregnancy|14|||
164570345|NCT00802360|594453276|FG003|Overall Study|No positive serum pregnancy|10|||
164570346|NCT00802360|594453273|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
164570347|NCT00802360|594453274|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
164570348|NCT00802360|594453275|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
164570349|NCT00802360|594453276|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
164570350|NCT00802360|594453273|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
164570351|NCT00802360|594453274|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
164570352|NCT00802360|594453275|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
164570353|NCT00802360|594453276|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
164570354|NCT00802360|594453273|FG000|Overall Study|Other|2|||
164570355|NCT00802360|594453274|FG001|Overall Study|Other|3|||
164570356|NCT00802360|594453275|FG002|Overall Study|Other|6|||
164570357|NCT00802360|594453276|FG003|Overall Study|Other|3|||
164570358|NCT03838484|594453277|FG000|Overall Study|Lost to Follow-up|0|||
164570359|NCT03838484|594453278|FG001|Overall Study|Lost to Follow-up|1|||
164570360|NCT03838484|594453279|FG002|Overall Study|Lost to Follow-up|0|||
164570361|NCT03838484|594453280|FG003|Overall Study|Lost to Follow-up|0|||
164570362|NCT01900002|594453281|FG000|Overall Study|Withdrawal by Subject|2|||
164570363|NCT01900002|594453281|FG000|Overall Study|ineligible for Y-90|4|||
164570364|NCT00860470|594453290|FG000|Overall Study|Death|6|||
164570365|NCT00860470|594453291|FG001|Overall Study|Death|10|||
164570366|NCT00860470|594453290|FG000|Overall Study|Moved away|8|||
164570367|NCT00860470|594453291|FG001|Overall Study|Moved away|10|||
164570368|NCT00860470|594453290|FG000|Overall Study|Lost to Follow-up|34|||
164570369|NCT00860470|594453291|FG001|Overall Study|Lost to Follow-up|39|||
164570370|NCT00888238|594453292|FG000|Washout Period After Period 2|Adverse Event|0|||
164570371|NCT00888238|594453293|FG001|Washout Period After Period 2|Adverse Event|0|||
164570372|NCT00888238|594453294|FG002|Washout Period After Period 2|Adverse Event|1|||
164570373|NCT01245673|594453296|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
164570374|NCT01459614|594453306|FG000|Overall Study|Adverse Event|1|||
164570375|NCT01459614|594453307|FG001|Overall Study|Adverse Event|0|||
164570376|NCT03283085|594453310|FG000|Overall Study|Adverse Event|18|||
164570377|NCT03283085|594453311|FG001|Overall Study|Adverse Event|3|||
164570378|NCT03283085|594453312|FG002|Overall Study|Adverse Event|13|||
164570379|NCT03283085|594453313|FG003|Overall Study|Adverse Event|0|||
164570380|NCT03283085|594453314|FG004|Overall Study|Adverse Event|0|||
164570381|NCT03283085|594453315|FG005|Overall Study|Adverse Event|5|||
164570382|NCT03283085|594453310|FG000|Overall Study|Death|0|||
164570383|NCT03283085|594453311|FG001|Overall Study|Death|0|||
164570384|NCT03283085|594453312|FG002|Overall Study|Death|3|||
164570385|NCT03283085|594453313|FG003|Overall Study|Death|1|||
164570386|NCT03283085|594453314|FG004|Overall Study|Death|0|||
164570387|NCT03283085|594453315|FG005|Overall Study|Death|0|||
164225360|NCT01475825|593194034|FG000|Overall Study|Physician Decision|0|||
164225361|NCT01475825|593194035|FG001|Overall Study|Physician Decision|1|||
164225362|NCT01475825|593194036|FG002|Overall Study|Physician Decision|0|||
164225363|NCT01475825|593194037|FG003|Overall Study|Physician Decision|0|||
164225364|NCT01475825|593194034|FG000|Overall Study|Withdrawal by Subject|8|||
164225365|NCT01475825|593194035|FG001|Overall Study|Withdrawal by Subject|3|||
164225366|NCT01475825|593194036|FG002|Overall Study|Withdrawal by Subject|11|||
164225367|NCT01475825|593194037|FG003|Overall Study|Withdrawal by Subject|7|||
164225368|NCT01475825|593194034|FG000|Overall Study|Did not enter OLC|15|||
164570388|NCT03283085|594453310|FG000|Overall Study|Withdrawal by Subject|42|||
164570389|NCT03283085|594453311|FG001|Overall Study|Withdrawal by Subject|21|||
164570390|NCT03283085|594453312|FG002|Overall Study|Withdrawal by Subject|66|||
164570391|NCT03283085|594453313|FG003|Overall Study|Withdrawal by Subject|3|||
164225369|NCT01475825|593194035|FG001|Overall Study|Did not enter OLC|11|||
164225370|NCT01475825|593194036|FG002|Overall Study|Did not enter OLC|15|||
164225371|NCT01475825|593194037|FG003|Overall Study|Did not enter OLC|11|||
164570392|NCT03283085|594453314|FG004|Overall Study|Withdrawal by Subject|3|||
164570393|NCT03283085|594453315|FG005|Overall Study|Withdrawal by Subject|5|||
164570394|NCT03283085|594453310|FG000|Overall Study|Physician Decision|14|||
164570395|NCT03283085|594453311|FG001|Overall Study|Physician Decision|8|||
164570396|NCT03283085|594453312|FG002|Overall Study|Physician Decision|19|||
164570397|NCT03283085|594453313|FG003|Overall Study|Physician Decision|0|||
164570398|NCT03283085|594453314|FG004|Overall Study|Physician Decision|0|||
164570399|NCT03283085|594453315|FG005|Overall Study|Physician Decision|2|||
164570400|NCT03283085|594453310|FG000|Overall Study|Site Terminated by Sponsor|1|||
164570401|NCT03283085|594453311|FG001|Overall Study|Site Terminated by Sponsor|0|||
164570402|NCT03283085|594453312|FG002|Overall Study|Site Terminated by Sponsor|3|||
164570403|NCT03283085|594453313|FG003|Overall Study|Site Terminated by Sponsor|0|||
164570404|NCT03283085|594453314|FG004|Overall Study|Site Terminated by Sponsor|0|||
164570405|NCT03283085|594453315|FG005|Overall Study|Site Terminated by Sponsor|0|||
164570406|NCT03283085|594453310|FG000|Overall Study|Lost to Follow-up|2|||
164570407|NCT03283085|594453311|FG001|Overall Study|Lost to Follow-up|0|||
164570408|NCT03283085|594453312|FG002|Overall Study|Lost to Follow-up|2|||
164570409|NCT03283085|594453313|FG003|Overall Study|Lost to Follow-up|0|||
164570410|NCT03283085|594453314|FG004|Overall Study|Lost to Follow-up|0|||
164570411|NCT03283085|594453315|FG005|Overall Study|Lost to Follow-up|1|||
164570412|NCT03283085|594453310|FG000|Overall Study|Pregnancy|0|||
164570413|NCT03283085|594453311|FG001|Overall Study|Pregnancy|0|||
164570414|NCT03283085|594453312|FG002|Overall Study|Pregnancy|1|||
164570415|NCT03283085|594453313|FG003|Overall Study|Pregnancy|0|||
164570416|NCT03283085|594453314|FG004|Overall Study|Pregnancy|0|||
164570417|NCT03283085|594453315|FG005|Overall Study|Pregnancy|0|||
164570418|NCT03283085|594453310|FG000|Overall Study|Lack of Efficacy|12|||
164570419|NCT03283085|594453311|FG001|Overall Study|Lack of Efficacy|6|||
164570420|NCT03283085|594453312|FG002|Overall Study|Lack of Efficacy|24|||
164570421|NCT03283085|594453313|FG003|Overall Study|Lack of Efficacy|1|||
164570422|NCT03283085|594453314|FG004|Overall Study|Lack of Efficacy|1|||
164570423|NCT03283085|594453315|FG005|Overall Study|Lack of Efficacy|0|||
164570424|NCT03283085|594453310|FG000|Overall Study|Reason not Specified|0|||
164570425|NCT03283085|594453311|FG001|Overall Study|Reason not Specified|4|||
164570426|NCT03283085|594453312|FG002|Overall Study|Reason not Specified|8|||
164570427|NCT03283085|594453313|FG003|Overall Study|Reason not Specified|0|||
164570428|NCT03283085|594453314|FG004|Overall Study|Reason not Specified|0|||
164570429|NCT03283085|594453315|FG005|Overall Study|Reason not Specified|1|||
164570430|NCT00450580|594454952|FG000|Overall Study|Adverse Event|5|||
164570431|NCT00450580|594454953|FG001|Overall Study|Adverse Event|7|||
164570432|NCT00450580|594454952|FG000|Overall Study|Lost to Follow-up|4|||
164570433|NCT00450580|594454953|FG001|Overall Study|Lost to Follow-up|5|||
164570434|NCT00450580|594454952|FG000|Overall Study|Withdrawal by Subject|2|||
164570435|NCT00450580|594454953|FG001|Overall Study|Withdrawal by Subject|2|||
164570436|NCT00450580|594454952|FG000|Overall Study|Protocol Violation|1|||
164570437|NCT00450580|594454953|FG001|Overall Study|Protocol Violation|1|||
164570438|NCT00450580|594454952|FG000|Overall Study|Protocol-defined virologic failure|1|||
164570439|NCT00450580|594454953|FG001|Overall Study|Protocol-defined virologic failure|0|||
164570440|NCT00450580|594454952|FG000|Overall Study|Could not comply with scheduled visits|1|||
164570441|NCT00450580|594454953|FG001|Overall Study|Could not comply with scheduled visits|0|||
164570442|NCT00450580|594454952|FG000|Overall Study|Patient went to Brazil|1|||
164570443|NCT00450580|594454953|FG001|Overall Study|Patient went to Brazil|0|||
164570444|NCT00450580|594454952|FG000|Overall Study|Patient could not swallow Norvir|1|||
164570445|NCT00450580|594454953|FG001|Overall Study|Patient could not swallow Norvir|0|||
164570446|NCT00450580|594454952|FG000|Overall Study|Withdrawal due to pregnancy|0|||
164570447|NCT00450580|594454953|FG001|Overall Study|Withdrawal due to pregnancy|1|||
164570448|NCT00522392|594454958|FG000|Overall Study|Disease progression|0|||
164570449|NCT00522392|594454959|FG001|Overall Study|Disease progression|3|||
164570450|NCT00522392|594454958|FG000|Overall Study|Adverse Event|7|||
164570451|NCT00522392|594454959|FG001|Overall Study|Adverse Event|7|||
164570452|NCT00522392|594454958|FG000|Overall Study|Withdrawal by Subject|1|||
164570453|NCT00522392|594454959|FG001|Overall Study|Withdrawal by Subject|1|||
164570454|NCT00522392|594454958|FG000|Overall Study|Physician Decision|0|||
164570455|NCT00522392|594454959|FG001|Overall Study|Physician Decision|1|||
164570456|NCT00522392|594454958|FG000|Overall Study|Non-compliance|0|||
164674361|NCT00579345|594832691|FG004|Overall Study|Adverse Event|0|||
164674362|NCT00579345|594832692|FG005|Overall Study|Adverse Event|0|||
164674363|NCT00579345|594832693|FG006|Overall Study|Adverse Event|0|||
164674364|NCT00579345|594832694|FG007|Overall Study|Adverse Event|0|||
164674365|NCT00579345|594832687|FG000|Overall Study|Protocol Violation|1|||
164674366|NCT00579345|594832688|FG001|Overall Study|Protocol Violation|0|||
164674367|NCT00579345|594832689|FG002|Overall Study|Protocol Violation|0|||
164674368|NCT00579345|594832690|FG003|Overall Study|Protocol Violation|0|||
164674369|NCT00579345|594832691|FG004|Overall Study|Protocol Violation|0|||
164674370|NCT00579345|594832692|FG005|Overall Study|Protocol Violation|0|||
164674371|NCT00579345|594832693|FG006|Overall Study|Protocol Violation|0|||
164674372|NCT00579345|594832694|FG007|Overall Study|Protocol Violation|1|||
164674373|NCT00579345|594832687|FG000|Overall Study|Death|1|||
164674374|NCT00579345|594832688|FG001|Overall Study|Death|1|||
164674375|NCT00579345|594832689|FG002|Overall Study|Death|1|||
164674376|NCT00579345|594832690|FG003|Overall Study|Death|1|||
164674377|NCT00579345|594832691|FG004|Overall Study|Death|0|||
164674378|NCT00579345|594832692|FG005|Overall Study|Death|0|||
164674379|NCT00579345|594832693|FG006|Overall Study|Death|0|||
164674380|NCT00579345|594832694|FG007|Overall Study|Death|0|||
164674381|NCT02267187|594832698|FG000|Overall Study|Physician Decision|2|||
164674382|NCT02267187|594832698|FG000|Overall Study|Screen fail|3|||
164674383|NCT00712959|594832703|FG000|Overall Study|Protocol Violation|3|||
164674384|NCT00712959|594832704|FG001|Overall Study|Protocol Violation|1|||
164674385|NCT00712959|594832703|FG000|Overall Study|Lost to Follow-up|13|||
164674386|NCT00712959|594832704|FG001|Overall Study|Lost to Follow-up|2|||
164674387|NCT00712959|594832703|FG000|Overall Study|Withdrawal by Subject|3|||
164674388|NCT00712959|594832704|FG001|Overall Study|Withdrawal by Subject|0|||
164674389|NCT00834067|594832705|FG000|Washout of 21 Days|Protocol Violation|0|||
164674390|NCT00834067|594832706|FG001|Washout of 21 Days|Protocol Violation|1|||
164674391|NCT00418561|594832707|FG000|Overall Study|Participant's (guardian's) decision|0|||
164674392|NCT00418561|594832708|FG001|Overall Study|Participant's (guardian's) decision|1|||
164329834|NCT02694523|593584787|FG000|Part A|Withdrawal by Subject|3|||
164329835|NCT02694523|593584788|FG001|Part A|Withdrawal by Subject|1|||
164329836|NCT02694523|593584789|FG002|Part A|Withdrawal by Subject|0|||
164329837|NCT02694523|593584790|FG003|Part A|Withdrawal by Subject|0|||
164329838|NCT02694523|593584791|FG004|Part A|Withdrawal by Subject|0|||
164329839|NCT02694523|593584792|FG005|Part A|Withdrawal by Subject|0|||
164329840|NCT02694523|593584793|FG006|Part A|Withdrawal by Subject|0|||
164329841|NCT02694523|593584787|FG000|Part A|Other|1|||
164329842|NCT02694523|593584788|FG001|Part A|Other|1|||
164329843|NCT02694523|593584789|FG002|Part A|Other|0|||
164329844|NCT02694523|593584790|FG003|Part A|Other|0|||
164674393|NCT00418561|594832709|FG002|Overall Study|Participant's (guardian's) decision|0|||
164674394|NCT01796171|594832710|FG000|Enrolled|Death|0|||
164674395|NCT01796171|594832711|FG001|Enrolled|Death|0|||
164674396|NCT01796171|594832712|FG002|Enrolled|Death|0|||
164674397|NCT01796171|594832713|FG003|Enrolled|Death|0|||
164674398|NCT01796171|594832714|FG004|Enrolled|Death|0|||
164674399|NCT01796171|594832715|FG005|Enrolled|Death|0|||
164674400|NCT01796171|594832716|FG006|Enrolled|Death|0|||
164674401|NCT01796171|594832717|FG007|Enrolled|Death|0|||
164674402|NCT01796171|594832718|FG008|Enrolled|Death|0|||
164674403|NCT01796171|594832719|FG009|Enrolled|Death|0|||
164674404|NCT01796171|594832720|FG010|Enrolled|Death|0|||
164674405|NCT01796171|594832721|FG011|Enrolled|Death|0|||
164674406|NCT01796171|594832722|FG012|Enrolled|Death|0|||
164329845|NCT02694523|593584791|FG004|Part A|Other|0|||
164329846|NCT02694523|593584792|FG005|Part A|Other|0|||
164329847|NCT02694523|593584793|FG006|Part A|Other|0|||
164329848|NCT02694523|593584787|FG000|Part B|Adverse Event|0|||
164329849|NCT02694523|593584788|FG001|Part B|Adverse Event|0|||
164674407|NCT01796171|594832723|FG013|Enrolled|Death|0|||
164674408|NCT01796171|594832724|FG014|Enrolled|Death|1|||
164674409|NCT01796171|594832710|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
164674410|NCT01796171|594832711|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
164674411|NCT01796171|594832712|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
164674412|NCT01796171|594832713|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
164329850|NCT02694523|593584789|FG002|Part B|Adverse Event|7|||
164674413|NCT01796171|594832714|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
164329851|NCT02694523|593584790|FG003|Part B|Adverse Event|1|||
164329852|NCT02694523|593584791|FG004|Part B|Adverse Event|1|||
164674414|NCT01796171|594832715|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
164674415|NCT01796171|594832716|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
164674416|NCT01796171|594832717|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
164329853|NCT02694523|593584792|FG005|Part B|Adverse Event|2|||
164329854|NCT02694523|593584793|FG006|Part B|Adverse Event|0|||
164329855|NCT02694523|593584787|FG000|Part B|Protocol Violation|0|||
164570457|NCT00522392|594454959|FG001|Overall Study|Non-compliance|1|||
164570458|NCT03932812|594454960|FG000|Overall Study|Lost to Follow-up|12|||
164570459|NCT03932812|594454961|FG001|Overall Study|Lost to Follow-up|14|||
164570460|NCT03932812|594454960|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
164570461|NCT03932812|594454961|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
164570462|NCT00430755|594454966|FG000|Overall Study|Withdrawal by Subject|53|||
164570463|NCT03480802|594454969|FG000|Overall Study|Lost to Follow-up|5|||
164570464|NCT03480802|594454970|FG001|Overall Study|Lost to Follow-up|1|||
164570465|NCT03480802|594454969|FG000|Overall Study|Withdrawal by Subject|2|||
164570466|NCT03480802|594454970|FG001|Overall Study|Withdrawal by Subject|1|||
164570467|NCT03480802|594454969|FG000|Overall Study|Relocated|0|||
164570468|NCT03480802|594454970|FG001|Overall Study|Relocated|1|||
164570469|NCT00988247|594454971|FG000|Overall Study|Adverse Event|17|||
164570470|NCT00988247|594454972|FG001|Overall Study|Adverse Event|3|||
164570471|NCT00988247|594454971|FG000|Overall Study|Withdrawal by Subject|44|||
164570472|NCT00988247|594454972|FG001|Overall Study|Withdrawal by Subject|13|||
164570473|NCT00988247|594454971|FG000|Overall Study|Pregnancy|1|||
164570474|NCT00988247|594454972|FG001|Overall Study|Pregnancy|2|||
164570475|NCT00988247|594454971|FG000|Overall Study|Lost to Follow-up|11|||
164570476|NCT00988247|594454972|FG001|Overall Study|Lost to Follow-up|2|||
164570477|NCT00988247|594454971|FG000|Overall Study|Protocol Violation|4|||
164570478|NCT00988247|594454972|FG001|Overall Study|Protocol Violation|5|||
164570479|NCT00988247|594454971|FG000|Overall Study|Sponsor requested withdrawal|3|||
164570480|NCT00988247|594454972|FG001|Overall Study|Sponsor requested withdrawal|1|||
164570481|NCT00988247|594454971|FG000|Overall Study|Other|3|||
164570482|NCT00988247|594454972|FG001|Overall Study|Other|0|||
164570483|NCT01409928|594454973|FG000|Overall Study|Physician Decision|12|||
164570484|NCT02661594|594454974|FG000|Overall Study|Protocol Violation|1|||
164570485|NCT02661594|594454975|FG001|Overall Study|Protocol Violation|0|||
164570486|NCT02661594|594454976|FG002|Overall Study|Protocol Violation|1|||
164570487|NCT02661594|594454977|FG003|Overall Study|Protocol Violation|0|||
164570488|NCT01169779|594454982|FG000|Overall Study|Adverse Event|3|||
164570489|NCT01169779|594454983|FG001|Overall Study|Adverse Event|11|||
164570490|NCT01169779|594454982|FG000|Overall Study|Lack of Efficacy|1|||
164570491|NCT01169779|594454983|FG001|Overall Study|Lack of Efficacy|0|||
164570492|NCT01169779|594454982|FG000|Overall Study|Protocol Violation|1|||
164570493|NCT01169779|594454983|FG001|Overall Study|Protocol Violation|1|||
164329856|NCT02694523|593584788|FG001|Part B|Protocol Violation|0|||
164329857|NCT02694523|593584789|FG002|Part B|Protocol Violation|1|||
164570494|NCT01169779|594454982|FG000|Overall Study|Withdrawal by Subject|3|||
164570495|NCT01169779|594454983|FG001|Overall Study|Withdrawal by Subject|2|||
164570496|NCT01169779|594454982|FG000|Overall Study|Familial and personal reasons|3|||
164570497|NCT01169779|594454983|FG001|Overall Study|Familial and personal reasons|3|||
164570498|NCT00432237|594454986|FG000|Overall Study|Adverse Event|0|||
164570499|NCT00432237|594454987|FG001|Overall Study|Adverse Event|0|||
164570500|NCT00432237|594454988|FG002|Overall Study|Adverse Event|0|||
164570501|NCT00432237|594454989|FG003|Overall Study|Adverse Event|1|||
164570502|NCT00432237|594454986|FG000|Overall Study|Lack of Efficacy|0|||
164570503|NCT00432237|594454987|FG001|Overall Study|Lack of Efficacy|0|||
164570504|NCT00432237|594454988|FG002|Overall Study|Lack of Efficacy|0|||
164674417|NCT01796171|594832718|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
164674418|NCT01796171|594832719|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
164674419|NCT01796171|594832720|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
164674420|NCT01796171|594832721|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
164674421|NCT01796171|594832722|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
164674422|NCT01796171|594832723|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
164674423|NCT01796171|594832724|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
164674424|NCT01796171|594832710|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164674425|NCT01796171|594832711|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164674426|NCT01796171|594832712|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164674427|NCT01796171|594832713|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164674428|NCT01796171|594832714|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164674429|NCT01796171|594832715|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164674430|NCT01796171|594832716|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164674431|NCT01796171|594832717|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164674432|NCT01796171|594832718|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164674433|NCT01796171|594832719|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164674434|NCT01796171|594832720|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164674435|NCT01796171|594832721|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164674436|NCT01796171|594832722|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164674437|NCT01796171|594832723|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
164674438|NCT01796171|594832724|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164674439|NCT01796171|594832710|FG000|Treatment Period With Betalutin|Progressive disease|0|||
164674440|NCT01796171|594832711|FG001|Treatment Period With Betalutin|Progressive disease|1|||
164674441|NCT01796171|594832712|FG002|Treatment Period With Betalutin|Progressive disease|0|||
164674442|NCT01796171|594832713|FG003|Treatment Period With Betalutin|Progressive disease|0|||
164674443|NCT01796171|594832714|FG004|Treatment Period With Betalutin|Progressive disease|0|||
164674444|NCT01796171|594832715|FG005|Treatment Period With Betalutin|Progressive disease|0|||
164674445|NCT01796171|594832716|FG006|Treatment Period With Betalutin|Progressive disease|0|||
164674446|NCT01796171|594832717|FG007|Treatment Period With Betalutin|Progressive disease|0|||
164674447|NCT01796171|594832718|FG008|Treatment Period With Betalutin|Progressive disease|0|||
164674448|NCT01796171|594832719|FG009|Treatment Period With Betalutin|Progressive disease|0|||
164674449|NCT01796171|594832720|FG010|Treatment Period With Betalutin|Progressive disease|0|||
164674450|NCT01796171|594832721|FG011|Treatment Period With Betalutin|Progressive disease|0|||
164674451|NCT01796171|594832722|FG012|Treatment Period With Betalutin|Progressive disease|0|||
164674452|NCT01796171|594832723|FG013|Treatment Period With Betalutin|Progressive disease|0|||
164674453|NCT01796171|594832724|FG014|Treatment Period With Betalutin|Progressive disease|0|||
164674454|NCT01796171|594832710|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
164674455|NCT01796171|594832711|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
164674456|NCT01796171|594832712|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
164674457|NCT01796171|594832713|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
164674458|NCT01796171|594832714|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
164674459|NCT01796171|594832715|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
164674460|NCT01796171|594832716|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
164674461|NCT01796171|594832717|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
164674462|NCT01796171|594832718|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
164329858|NCT02694523|593584790|FG003|Part B|Protocol Violation|0|||
164674463|NCT01796171|594832719|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
164674464|NCT01796171|594832720|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
164674465|NCT01796171|594832721|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
164674466|NCT01796171|594832722|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
164674467|NCT01796171|594832723|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
164674468|NCT01796171|594832724|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
164674469|NCT01796171|594832710|FG000|Treatment Period With Betalutin|Physician Decision|0|||
164674470|NCT01796171|594832711|FG001|Treatment Period With Betalutin|Physician Decision|0|||
164674471|NCT01796171|594832712|FG002|Treatment Period With Betalutin|Physician Decision|0|||
164674472|NCT01796171|594832713|FG003|Treatment Period With Betalutin|Physician Decision|0|||
164674473|NCT01796171|594832714|FG004|Treatment Period With Betalutin|Physician Decision|0|||
164674474|NCT01796171|594832715|FG005|Treatment Period With Betalutin|Physician Decision|0|||
164674475|NCT01796171|594832716|FG006|Treatment Period With Betalutin|Physician Decision|0|||
164674476|NCT01796171|594832717|FG007|Treatment Period With Betalutin|Physician Decision|0|||
164674477|NCT01796171|594832718|FG008|Treatment Period With Betalutin|Physician Decision|0|||
164674478|NCT01796171|594832719|FG009|Treatment Period With Betalutin|Physician Decision|0|||
164674479|NCT01796171|594832720|FG010|Treatment Period With Betalutin|Physician Decision|5|||
164329859|NCT02694523|593584791|FG004|Part B|Protocol Violation|0|||
164329860|NCT02694523|593584792|FG005|Part B|Protocol Violation|0|||
164674480|NCT01796171|594832721|FG011|Treatment Period With Betalutin|Physician Decision|1|||
164674481|NCT01796171|594832722|FG012|Treatment Period With Betalutin|Physician Decision|1|||
164674482|NCT01796171|594832723|FG013|Treatment Period With Betalutin|Physician Decision|0|||
164674483|NCT01796171|594832724|FG014|Treatment Period With Betalutin|Physician Decision|0|||
164674484|NCT01796171|594832710|FG000|Treatment Period With Betalutin|Death|0|||
164674485|NCT01796171|594832711|FG001|Treatment Period With Betalutin|Death|0|||
164674486|NCT01796171|594832712|FG002|Treatment Period With Betalutin|Death|0|||
164674487|NCT01796171|594832713|FG003|Treatment Period With Betalutin|Death|0|||
164674488|NCT01796171|594832714|FG004|Treatment Period With Betalutin|Death|0|||
164674489|NCT01796171|594832715|FG005|Treatment Period With Betalutin|Death|0|||
164674490|NCT01796171|594832716|FG006|Treatment Period With Betalutin|Death|0|||
164674491|NCT01796171|594832717|FG007|Treatment Period With Betalutin|Death|0|||
164674492|NCT01796171|594832718|FG008|Treatment Period With Betalutin|Death|0|||
164674493|NCT01796171|594832719|FG009|Treatment Period With Betalutin|Death|0|||
164674494|NCT01796171|594832720|FG010|Treatment Period With Betalutin|Death|2|||
164674495|NCT01796171|594832721|FG011|Treatment Period With Betalutin|Death|0|||
164674496|NCT01796171|594832722|FG012|Treatment Period With Betalutin|Death|0|||
164674497|NCT01796171|594832723|FG013|Treatment Period With Betalutin|Death|0|||
164674498|NCT01796171|594832724|FG014|Treatment Period With Betalutin|Death|0|||
164674499|NCT01796171|594832710|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
164674500|NCT01796171|594832711|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
164674501|NCT01796171|594832712|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
164674502|NCT01796171|594832713|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
164225372|NCT04157738|593194038|FG000|Overall Study|Moved out of state|0|||
164225373|NCT04157738|593194039|FG001|Overall Study|Moved out of state|2|||
164225374|NCT04157738|593194038|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
164225375|NCT04157738|593194039|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
164225376|NCT02244957|593194040|FG000|Overall Study|Lack of Efficacy|1|||
164225377|NCT02244957|593194041|FG001|Overall Study|Lack of Efficacy|0|||
164225378|NCT01725282|593194043|FG000|Overall Study|Adverse Event|1|||
164225379|NCT01725282|593194044|FG001|Overall Study|Adverse Event|3|||
164225380|NCT01725282|593194045|FG002|Overall Study|Adverse Event|6|||
164225381|NCT01725282|593194046|FG003|Overall Study|Adverse Event|4|||
164225382|NCT01725282|593194043|FG000|Overall Study|Exacerbation of Target Disease|1|||
164225383|NCT01725282|593194044|FG001|Overall Study|Exacerbation of Target Disease|0|||
164225384|NCT01725282|593194045|FG002|Overall Study|Exacerbation of Target Disease|0|||
164225385|NCT01725282|593194046|FG003|Overall Study|Exacerbation of Target Disease|1|||
164674503|NCT01796171|594832714|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
164674504|NCT01796171|594832715|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
164674505|NCT01796171|594832716|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
164674506|NCT01796171|594832717|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
164674507|NCT01796171|594832718|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
164674508|NCT01796171|594832719|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
164674509|NCT01796171|594832720|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
164225386|NCT01725282|593194043|FG000|Overall Study|Met Exclusion Criteria|0|||
164225387|NCT01725282|593194044|FG001|Overall Study|Met Exclusion Criteria|0|||
164225388|NCT01725282|593194045|FG002|Overall Study|Met Exclusion Criteria|1|||
164225389|NCT01725282|593194046|FG003|Overall Study|Met Exclusion Criteria|0|||
164225390|NCT01725282|593194043|FG000|Overall Study|Study Site Withdrawal|0|||
164225391|NCT01725282|593194044|FG001|Overall Study|Study Site Withdrawal|1|||
164674510|NCT01796171|594832721|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
164674511|NCT01796171|594832722|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
164674512|NCT01796171|594832723|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
164674513|NCT01796171|594832724|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
164674514|NCT01796171|594832710|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164674515|NCT01796171|594832711|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164225392|NCT01725282|593194045|FG002|Overall Study|Study Site Withdrawal|0|||
164225393|NCT01725282|593194046|FG003|Overall Study|Study Site Withdrawal|0|||
164225394|NCT01725282|593194043|FG000|Overall Study|Withdrawal by Subject|0|||
164674516|NCT01796171|594832712|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164674517|NCT01796171|594832713|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164674518|NCT01796171|594832714|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164674519|NCT01796171|594832715|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164674520|NCT01796171|594832716|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164674521|NCT01796171|594832717|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164225395|NCT01725282|593194044|FG001|Overall Study|Withdrawal by Subject|0|||
164225396|NCT01725282|593194045|FG002|Overall Study|Withdrawal by Subject|1|||
164225397|NCT01725282|593194046|FG003|Overall Study|Withdrawal by Subject|1|||
164329861|NCT02694523|593584793|FG006|Part B|Protocol Violation|0|||
164225398|NCT01725282|593194043|FG000|Overall Study|Lack of Efficacy|0|||
164225399|NCT01725282|593194044|FG001|Overall Study|Lack of Efficacy|1|||
164329862|NCT02694523|593584787|FG000|Part B|Lost to Follow-up|0|||
164329863|NCT02694523|593584788|FG001|Part B|Lost to Follow-up|0|||
164674522|NCT01796171|594832718|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164674523|NCT01796171|594832719|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164674524|NCT01796171|594832720|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
164674525|NCT01796171|594832721|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
164674526|NCT01796171|594832722|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164674527|NCT01796171|594832723|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164674528|NCT01796171|594832724|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164674529|NCT01796171|594832710|FG000|Follow-up Period|Start of further anticancer therapy|4|||
164674530|NCT01796171|594832711|FG001|Follow-up Period|Start of further anticancer therapy|25|||
164674531|NCT01796171|594832712|FG002|Follow-up Period|Start of further anticancer therapy|2|||
164674532|NCT01796171|594832713|FG003|Follow-up Period|Start of further anticancer therapy|1|||
164674533|NCT01796171|594832714|FG004|Follow-up Period|Start of further anticancer therapy|2|||
164674534|NCT01796171|594832715|FG005|Follow-up Period|Start of further anticancer therapy|2|||
164674535|NCT01796171|594832716|FG006|Follow-up Period|Start of further anticancer therapy|1|||
164674536|NCT01796171|594832717|FG007|Follow-up Period|Start of further anticancer therapy|15|||
164674537|NCT01796171|594832718|FG008|Follow-up Period|Start of further anticancer therapy|2|||
164674538|NCT01796171|594832719|FG009|Follow-up Period|Start of further anticancer therapy|0|||
164674539|NCT01796171|594832720|FG010|Follow-up Period|Start of further anticancer therapy|0|||
164674540|NCT01796171|594832721|FG011|Follow-up Period|Start of further anticancer therapy|0|||
164674541|NCT01796171|594832722|FG012|Follow-up Period|Start of further anticancer therapy|0|||
164674542|NCT01796171|594832723|FG013|Follow-up Period|Start of further anticancer therapy|0|||
164674543|NCT01796171|594832724|FG014|Follow-up Period|Start of further anticancer therapy|0|||
164674544|NCT01796171|594832710|FG000|Follow-up Period|Progressive disease|0|||
164674545|NCT01796171|594832711|FG001|Follow-up Period|Progressive disease|1|||
164674546|NCT01796171|594832712|FG002|Follow-up Period|Progressive disease|0|||
164674547|NCT01796171|594832713|FG003|Follow-up Period|Progressive disease|0|||
164674548|NCT01796171|594832714|FG004|Follow-up Period|Progressive disease|0|||
164674549|NCT01796171|594832715|FG005|Follow-up Period|Progressive disease|0|||
164674550|NCT01796171|594832716|FG006|Follow-up Period|Progressive disease|0|||
164674551|NCT01796171|594832717|FG007|Follow-up Period|Progressive disease|3|||
164674552|NCT01796171|594832718|FG008|Follow-up Period|Progressive disease|0|||
164674553|NCT01796171|594832719|FG009|Follow-up Period|Progressive disease|0|||
164674554|NCT01796171|594832720|FG010|Follow-up Period|Progressive disease|0|||
164674555|NCT01796171|594832721|FG011|Follow-up Period|Progressive disease|0|||
164674556|NCT01796171|594832722|FG012|Follow-up Period|Progressive disease|0|||
164674557|NCT01796171|594832723|FG013|Follow-up Period|Progressive disease|0|||
164674558|NCT01796171|594832724|FG014|Follow-up Period|Progressive disease|0|||
164674559|NCT01796171|594832710|FG000|Follow-up Period|Physician Decision|0|||
164674560|NCT01796171|594832711|FG001|Follow-up Period|Physician Decision|2|||
164674561|NCT01796171|594832712|FG002|Follow-up Period|Physician Decision|0|||
164674562|NCT01796171|594832713|FG003|Follow-up Period|Physician Decision|0|||
164674563|NCT01796171|594832714|FG004|Follow-up Period|Physician Decision|0|||
164674564|NCT01796171|594832715|FG005|Follow-up Period|Physician Decision|0|||
164674565|NCT01796171|594832716|FG006|Follow-up Period|Physician Decision|0|||
164674566|NCT01796171|594832717|FG007|Follow-up Period|Physician Decision|0|||
164674567|NCT01796171|594832718|FG008|Follow-up Period|Physician Decision|0|||
164225400|NCT01725282|593194045|FG002|Overall Study|Lack of Efficacy|0|||
164225401|NCT01725282|593194046|FG003|Overall Study|Lack of Efficacy|1|||
164225402|NCT05071027|593194047|FG000|Overall Study|Lost to Follow-up|1|||
164225403|NCT05071027|593194048|FG001|Overall Study|Lost to Follow-up|4|||
164225404|NCT04576481|593194049|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
164225405|NCT04576481|593194050|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
164225406|NCT04576481|593194051|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
164225407|NCT04576481|593194052|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
164225408|NCT05463952|593194056|FG000|Treatment|Progressive disease|4|||
164225409|NCT05463952|593194056|FG000|Treatment|Ongoing|2|||
164225410|NCT02739828|593194058|FG000|Overall Study|Adverse Event|1|||
164225411|NCT02739828|593194058|FG000|Overall Study|Lost to Follow-up|4|||
164225412|NCT00489359|593194061|FG000|Overall Study|Death|0|||
164225413|NCT00489359|593194062|FG001|Overall Study|Death|2|||
164225414|NCT00489359|593194061|FG000|Overall Study|Progressive Disease|5|||
164225415|NCT00489359|593194062|FG001|Overall Study|Progressive Disease|6|||
164225416|NCT00489359|593194061|FG000|Overall Study|Lost to Follow-up|1|||
164225417|NCT00489359|593194062|FG001|Overall Study|Lost to Follow-up|0|||
164225418|NCT00489359|593194061|FG000|Overall Study|Withdrawal by Subject|1|||
164570505|NCT00432237|594454989|FG003|Overall Study|Lack of Efficacy|1|||
164570506|NCT00432237|594454986|FG000|Overall Study|Lost to Follow-up|10|||
164570507|NCT00432237|594454987|FG001|Overall Study|Lost to Follow-up|10|||
164570508|NCT00432237|594454988|FG002|Overall Study|Lost to Follow-up|18|||
164570509|NCT00432237|594454989|FG003|Overall Study|Lost to Follow-up|18|||
164570510|NCT00432237|594454986|FG000|Overall Study|Physician Decision|1|||
164570511|NCT00432237|594454987|FG001|Overall Study|Physician Decision|3|||
164570512|NCT00432237|594454988|FG002|Overall Study|Physician Decision|2|||
164570513|NCT00432237|594454989|FG003|Overall Study|Physician Decision|1|||
164570514|NCT00432237|594454986|FG000|Overall Study|Pregnancy|0|||
164570515|NCT00432237|594454987|FG001|Overall Study|Pregnancy|1|||
164570516|NCT00432237|594454988|FG002|Overall Study|Pregnancy|0|||
164570517|NCT00432237|594454989|FG003|Overall Study|Pregnancy|0|||
164570518|NCT00432237|594454986|FG000|Overall Study|Protocol Violation|13|||
164570519|NCT00432237|594454987|FG001|Overall Study|Protocol Violation|10|||
164570520|NCT00432237|594454988|FG002|Overall Study|Protocol Violation|11|||
164570521|NCT00432237|594454989|FG003|Overall Study|Protocol Violation|8|||
164570522|NCT00432237|594454986|FG000|Overall Study|Withdrawal by Subject|5|||
164570523|NCT00432237|594454987|FG001|Overall Study|Withdrawal by Subject|6|||
164570524|NCT00432237|594454988|FG002|Overall Study|Withdrawal by Subject|9|||
164570525|NCT00432237|594454989|FG003|Overall Study|Withdrawal by Subject|11|||
164570526|NCT00432237|594454986|FG000|Overall Study|Lack of Qualifying Event|38|||
164570527|NCT00432237|594454987|FG001|Overall Study|Lack of Qualifying Event|71|||
164570528|NCT00432237|594454988|FG002|Overall Study|Lack of Qualifying Event|69|||
164570529|NCT00432237|594454989|FG003|Overall Study|Lack of Qualifying Event|84|||
164570530|NCT01354132|594454990|FG000|Randomization|Physician Decision|1|||
164570531|NCT01354132|594454991|FG001|Randomization|Physician Decision|0|||
164570532|NCT01354132|594454990|FG000|Randomization|Withdrawal by Subject|0|||
164570533|NCT01354132|594454991|FG001|Randomization|Withdrawal by Subject|1|||
164570534|NCT01354132|594454990|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
164570535|NCT01354132|594454991|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
164570536|NCT01354132|594454990|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
164570537|NCT01354132|594454991|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
164570538|NCT01354132|594454990|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
164570539|NCT01354132|594454991|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
164570540|NCT00191854|594454994|FG000|Overall Study|Death|26|||
164570541|NCT00191854|594454995|FG001|Overall Study|Death|23|||
164570542|NCT00191854|594454996|FG002|Overall Study|Death|29|||
164570543|NCT00191854|594454994|FG000|Overall Study|Lost to Follow-up|7|||
164570544|NCT00191854|594454995|FG001|Overall Study|Lost to Follow-up|5|||
164570545|NCT00191854|594454996|FG002|Overall Study|Lost to Follow-up|5|||
164570546|NCT00191854|594454994|FG000|Overall Study|Withdrawal by Subject|4|||
164570547|NCT00191854|594454995|FG001|Overall Study|Withdrawal by Subject|2|||
164570548|NCT00191854|594454996|FG002|Overall Study|Withdrawal by Subject|3|||
164570549|NCT00191854|594454994|FG000|Overall Study|Sponsor Decision|0|||
164570550|NCT00191854|594454995|FG001|Overall Study|Sponsor Decision|0|||
164570551|NCT00191854|594454996|FG002|Overall Study|Sponsor Decision|1|||
164570552|NCT00191854|594454994|FG000|Overall Study|Screen Failure|0|||
164570553|NCT00191854|594454995|FG001|Overall Study|Screen Failure|0|||
164570554|NCT00191854|594454996|FG002|Overall Study|Screen Failure|1|||
164570555|NCT01933932|594455001|FG000|Overall Study|Death|173|||
164570556|NCT01933932|594455002|FG001|Overall Study|Death|163|||
164570557|NCT01933932|594455001|FG000|Overall Study|Withdrawal by Subject|11|||
164570558|NCT01933932|594455002|FG001|Overall Study|Withdrawal by Subject|14|||
164570559|NCT01933932|594455001|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164570560|NCT01933932|594455002|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
164570561|NCT02601950|594455003|FG000|Overall Study|Participant enrolled in rollover study|0|||
164570562|NCT02601950|594455004|FG001|Overall Study|Participant enrolled in rollover study|0|||
164570563|NCT02601950|594455005|FG002|Overall Study|Participant enrolled in rollover study|1|||
164225419|NCT00489359|593194062|FG001|Overall Study|Withdrawal by Subject|5|||
164225420|NCT00489359|593194061|FG000|Overall Study|Adverse Event|0|||
164225421|NCT00489359|593194062|FG001|Overall Study|Adverse Event|16|||
164225422|NCT03180138|593194063|FG000|Overall Study|Mobile-phone could not be verified|2|||
164225423|NCT03180138|593194064|FG001|Overall Study|Mobile-phone could not be verified|13|||
164225424|NCT03180138|593194065|FG002|Overall Study|Mobile-phone could not be verified|15|||
164225425|NCT03180138|593194063|FG000|Overall Study|No prior immunization records|17|||
164674568|NCT01796171|594832719|FG009|Follow-up Period|Physician Decision|0|||
164674569|NCT01796171|594832720|FG010|Follow-up Period|Physician Decision|5|||
164674570|NCT01796171|594832721|FG011|Follow-up Period|Physician Decision|0|||
164674571|NCT01796171|594832722|FG012|Follow-up Period|Physician Decision|0|||
164674572|NCT01796171|594832723|FG013|Follow-up Period|Physician Decision|0|||
164674573|NCT01796171|594832724|FG014|Follow-up Period|Physician Decision|0|||
164674574|NCT01796171|594832710|FG000|Follow-up Period|Withdrawal by Subject|0|||
164674575|NCT01796171|594832711|FG001|Follow-up Period|Withdrawal by Subject|1|||
164674576|NCT01796171|594832712|FG002|Follow-up Period|Withdrawal by Subject|0|||
164674577|NCT01796171|594832713|FG003|Follow-up Period|Withdrawal by Subject|0|||
164674578|NCT01796171|594832714|FG004|Follow-up Period|Withdrawal by Subject|0|||
164674579|NCT01796171|594832715|FG005|Follow-up Period|Withdrawal by Subject|1|||
164674580|NCT01796171|594832716|FG006|Follow-up Period|Withdrawal by Subject|0|||
164674581|NCT01796171|594832717|FG007|Follow-up Period|Withdrawal by Subject|0|||
164674582|NCT01796171|594832718|FG008|Follow-up Period|Withdrawal by Subject|0|||
164674583|NCT01796171|594832719|FG009|Follow-up Period|Withdrawal by Subject|0|||
164674584|NCT01796171|594832720|FG010|Follow-up Period|Withdrawal by Subject|3|||
164674585|NCT01796171|594832721|FG011|Follow-up Period|Withdrawal by Subject|1|||
164674586|NCT01796171|594832722|FG012|Follow-up Period|Withdrawal by Subject|0|||
164674587|NCT01796171|594832723|FG013|Follow-up Period|Withdrawal by Subject|0|||
164674588|NCT01796171|594832724|FG014|Follow-up Period|Withdrawal by Subject|0|||
164674589|NCT01796171|594832710|FG000|Follow-up Period|Death|0|||
164674590|NCT01796171|594832711|FG001|Follow-up Period|Death|0|||
164674591|NCT01796171|594832712|FG002|Follow-up Period|Death|0|||
164674592|NCT01796171|594832713|FG003|Follow-up Period|Death|0|||
164674593|NCT01796171|594832714|FG004|Follow-up Period|Death|0|||
164674594|NCT01796171|594832715|FG005|Follow-up Period|Death|0|||
164674595|NCT01796171|594832716|FG006|Follow-up Period|Death|1|||
164674596|NCT01796171|594832717|FG007|Follow-up Period|Death|0|||
164674597|NCT01796171|594832718|FG008|Follow-up Period|Death|0|||
164674598|NCT01796171|594832719|FG009|Follow-up Period|Death|0|||
164674599|NCT01796171|594832720|FG010|Follow-up Period|Death|17|||
164674600|NCT01796171|594832721|FG011|Follow-up Period|Death|9|||
164674601|NCT01796171|594832722|FG012|Follow-up Period|Death|1|||
164674602|NCT01796171|594832723|FG013|Follow-up Period|Death|0|||
164674603|NCT01796171|594832724|FG014|Follow-up Period|Death|0|||
164674604|NCT01796171|594832710|FG000|Follow-up Period|Patient transferred to other hospital|0|||
164674605|NCT01796171|594832711|FG001|Follow-up Period|Patient transferred to other hospital|1|||
164674606|NCT01796171|594832712|FG002|Follow-up Period|Patient transferred to other hospital|0|||
164674607|NCT01796171|594832713|FG003|Follow-up Period|Patient transferred to other hospital|0|||
164674608|NCT01796171|594832714|FG004|Follow-up Period|Patient transferred to other hospital|0|||
164674609|NCT01796171|594832715|FG005|Follow-up Period|Patient transferred to other hospital|0|||
164674610|NCT01796171|594832716|FG006|Follow-up Period|Patient transferred to other hospital|0|||
164674611|NCT01796171|594832717|FG007|Follow-up Period|Patient transferred to other hospital|0|||
164674612|NCT01796171|594832718|FG008|Follow-up Period|Patient transferred to other hospital|0|||
164674613|NCT01796171|594832719|FG009|Follow-up Period|Patient transferred to other hospital|0|||
164674614|NCT01796171|594832720|FG010|Follow-up Period|Patient transferred to other hospital|0|||
164674615|NCT01796171|594832721|FG011|Follow-up Period|Patient transferred to other hospital|0|||
164674616|NCT01796171|594832722|FG012|Follow-up Period|Patient transferred to other hospital|0|||
164674617|NCT01796171|594832723|FG013|Follow-up Period|Patient transferred to other hospital|0|||
164674618|NCT01796171|594832724|FG014|Follow-up Period|Patient transferred to other hospital|0|||
164674619|NCT01796171|594832710|FG000|Follow-up Period|Sponsor Decision|0|||
164674620|NCT01796171|594832711|FG001|Follow-up Period|Sponsor Decision|0|||
164674621|NCT01796171|594832712|FG002|Follow-up Period|Sponsor Decision|0|||
164674622|NCT01796171|594832713|FG003|Follow-up Period|Sponsor Decision|0|||
164674623|NCT01796171|594832714|FG004|Follow-up Period|Sponsor Decision|0|||
164674624|NCT01796171|594832715|FG005|Follow-up Period|Sponsor Decision|0|||
164674625|NCT01796171|594832716|FG006|Follow-up Period|Sponsor Decision|0|||
164674626|NCT01796171|594832717|FG007|Follow-up Period|Sponsor Decision|0|||
164225426|NCT03180138|593194064|FG001|Overall Study|No prior immunization records|0|||
164329864|NCT02694523|593584789|FG002|Part B|Lost to Follow-up|2|||
164674627|NCT01796171|594832718|FG008|Follow-up Period|Sponsor Decision|0|||
164674628|NCT01796171|594832719|FG009|Follow-up Period|Sponsor Decision|0|||
164674629|NCT01796171|594832720|FG010|Follow-up Period|Sponsor Decision|40|||
164674630|NCT01796171|594832721|FG011|Follow-up Period|Sponsor Decision|15|||
164674631|NCT01796171|594832722|FG012|Follow-up Period|Sponsor Decision|7|||
164674632|NCT01796171|594832723|FG013|Follow-up Period|Sponsor Decision|0|||
164674633|NCT01796171|594832724|FG014|Follow-up Period|Sponsor Decision|0|||
164674634|NCT00829309|594832725|FG000|Washout: 7 Days|Protocol Violation|1|||
164674635|NCT00829309|594832726|FG001|Washout: 7 Days|Protocol Violation|0|||
164674636|NCT03699020|594832730|FG000|Overall Study|Withdrawal by Subject|3|||
164674637|NCT03699020|594832731|FG001|Overall Study|Withdrawal by Subject|2|||
164674638|NCT02678286|594832732|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
164674639|NCT02678286|594832733|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
164674640|NCT02678286|594832732|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
164674641|NCT02678286|594832733|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
164674642|NCT02678286|594832732|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
164674643|NCT02678286|594832733|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
164674644|NCT02678286|594832732|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
164674645|NCT02678286|594832733|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
164674646|NCT02678286|594832732|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
164674647|NCT02678286|594832733|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
164674648|NCT02077465|594832738|FG000|Overall Study|Withdrew Consent|0|||
164674649|NCT02077465|594832739|FG001|Overall Study|Withdrew Consent|1|||
164674650|NCT02077465|594832738|FG000|Overall Study|Lost to Follow-up|1|||
164674651|NCT02077465|594832739|FG001|Overall Study|Lost to Follow-up|0|||
164674652|NCT03375463|594832741|FG000|Period 1|Lost to Follow-up|0|||
164674653|NCT03375463|594832742|FG001|Period 1|Lost to Follow-up|0|||
164674654|NCT03375463|594832743|FG002|Period 1|Lost to Follow-up|1|||
164674655|NCT03375463|594832744|FG003|Period 1|Lost to Follow-up|0|||
164674656|NCT03375463|594832745|FG004|Period 1|Lost to Follow-up|0|||
164674657|NCT03375463|594832746|FG005|Period 1|Lost to Follow-up|0|||
164674658|NCT03375463|594832741|FG000|Period 1|Adverse Event|0|||
164674659|NCT03375463|594832742|FG001|Period 1|Adverse Event|0|||
164674660|NCT03375463|594832743|FG002|Period 1|Adverse Event|0|||
164674661|NCT03375463|594832744|FG003|Period 1|Adverse Event|0|||
164674662|NCT03375463|594832745|FG004|Period 1|Adverse Event|1|||
164674663|NCT03375463|594832746|FG005|Period 1|Adverse Event|0|||
164674664|NCT03375463|594832741|FG000|Period 2|Lost to Follow-up|1|||
164674665|NCT03375463|594832742|FG001|Period 2|Lost to Follow-up|1|||
164674666|NCT03375463|594832743|FG002|Period 2|Lost to Follow-up|0|||
164674667|NCT03375463|594832744|FG003|Period 2|Lost to Follow-up|0|||
164674668|NCT03375463|594832745|FG004|Period 2|Lost to Follow-up|0|||
164674669|NCT03375463|594832746|FG005|Period 2|Lost to Follow-up|0|||
164674670|NCT01827163|594832747|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
164674671|NCT01827163|594832747|FG000|Overall Study|Adverse Event|9|||
164674672|NCT01745120|594832749|FG000|Overall Study|Investigator decision|1|||
164674673|NCT01745120|594832750|FG001|Overall Study|Investigator decision|0|||
164674674|NCT00850174|594832757|FG000|Washout: One Week|Withdrawal by Subject|0|||
164674675|NCT00850174|594832758|FG001|Washout: One Week|Withdrawal by Subject|2|||
164674676|NCT00850174|594832757|FG000|Second Intervention|Withdrawal by Subject|1|||
164674677|NCT00850174|594832758|FG001|Second Intervention|Withdrawal by Subject|0|||
164674678|NCT01900626|594832761|FG000|Overall Study|study was closed due to low enrollment|1|||
164674679|NCT01900626|594832762|FG001|Overall Study|study was closed due to low enrollment|1|||
164674680|NCT03500341|594832766|FG000|Overall Study|Withdrawn prior to Completion|2|||
164674681|NCT01294917|594832767|FG000|Overall Study|Relocation|5|||
164674682|NCT01294917|594832767|FG000|Overall Study|Inconvenience|1|||
164674683|NCT03017885|594832768|FG000|Overall Study|Adverse Event|2|||
164674684|NCT03017885|594832769|FG001|Overall Study|Adverse Event|0|||
164674685|NCT03017885|594832770|FG002|Overall Study|Adverse Event|0|||
164674686|NCT03017885|594832771|FG003|Overall Study|Adverse Event|0|||
164674687|NCT03017885|594832772|FG004|Overall Study|Adverse Event|0|||
164674688|NCT03017885|594832773|FG005|Overall Study|Adverse Event|0|||
164674689|NCT03017885|594832768|FG000|Overall Study|Progression of disease|4|||
164674690|NCT03017885|594832769|FG001|Overall Study|Progression of disease|3|||
164674691|NCT03017885|594832770|FG002|Overall Study|Progression of disease|4|||
164674692|NCT03017885|594832771|FG003|Overall Study|Progression of disease|0|||
164674693|NCT03017885|594832772|FG004|Overall Study|Progression of disease|0|||
164674694|NCT03017885|594832773|FG005|Overall Study|Progression of disease|0|||
164674695|NCT03017885|594832768|FG000|Overall Study|Other than listed|1|||
164674696|NCT03017885|594832769|FG001|Overall Study|Other than listed|2|||
164674697|NCT03017885|594832770|FG002|Overall Study|Other than listed|1|||
164674698|NCT03017885|594832771|FG003|Overall Study|Other than listed|0|||
164674699|NCT03017885|594832772|FG004|Overall Study|Other than listed|0|||
164674700|NCT03017885|594832773|FG005|Overall Study|Other than listed|0|||
164674701|NCT03017885|594832768|FG000|Overall Study|Lost to Follow-up|2|||
164674702|NCT03017885|594832769|FG001|Overall Study|Lost to Follow-up|0|||
164674703|NCT03017885|594832770|FG002|Overall Study|Lost to Follow-up|3|||
164674704|NCT03017885|594832771|FG003|Overall Study|Lost to Follow-up|0|||
164674705|NCT03017885|594832772|FG004|Overall Study|Lost to Follow-up|0|||
164674706|NCT03017885|594832773|FG005|Overall Study|Lost to Follow-up|0|||
164674707|NCT03017885|594832768|FG000|Overall Study|Change to other anti-cancer therapy|0|||
164674708|NCT03017885|594832769|FG001|Overall Study|Change to other anti-cancer therapy|0|||
164674709|NCT03017885|594832770|FG002|Overall Study|Change to other anti-cancer therapy|1|||
164674710|NCT03017885|594832771|FG003|Overall Study|Change to other anti-cancer therapy|0|||
164674711|NCT03017885|594832772|FG004|Overall Study|Change to other anti-cancer therapy|0|||
164674712|NCT03017885|594832773|FG005|Overall Study|Change to other anti-cancer therapy|0|||
164674713|NCT03138967|594832775|FG000|Overall Study|Death|0|||
164674714|NCT03138967|594832776|FG001|Overall Study|Death|1|||
164674715|NCT03138967|594832775|FG000|Overall Study|Physician Decision|1|||
164674716|NCT03138967|594832776|FG001|Overall Study|Physician Decision|3|||
164674717|NCT04405570|594832783|FG000|Overall Study|Adverse Event|0|||
164674718|NCT04405570|594832784|FG001|Overall Study|Adverse Event|1|||
164674719|NCT04405570|594832785|FG002|Overall Study|Adverse Event|1|||
164674720|NCT04405570|594832786|FG003|Overall Study|Adverse Event|1|||
164674721|NCT04405570|594832783|FG000|Overall Study|Lost to Follow-up|0|||
164674722|NCT04405570|594832784|FG001|Overall Study|Lost to Follow-up|1|||
164674723|NCT04405570|594832785|FG002|Overall Study|Lost to Follow-up|0|||
164674724|NCT04405570|594832786|FG003|Overall Study|Lost to Follow-up|0|||
164674725|NCT04405570|594832783|FG000|Overall Study|Physician Decision|0|||
164674726|NCT04405570|594832784|FG001|Overall Study|Physician Decision|0|||
164674727|NCT04405570|594832785|FG002|Overall Study|Physician Decision|1|||
164674728|NCT04405570|594832786|FG003|Overall Study|Physician Decision|0|||
164674729|NCT04405570|594832783|FG000|Overall Study|Withdrawal by Subject|0|||
164329865|NCT02694523|593584790|FG003|Part B|Lost to Follow-up|3|||
164329866|NCT02694523|593584791|FG004|Part B|Lost to Follow-up|2|||
164329867|NCT02694523|593584792|FG005|Part B|Lost to Follow-up|0|||
164329868|NCT02694523|593584793|FG006|Part B|Lost to Follow-up|1|||
164329869|NCT02694523|593584787|FG000|Part B|Withdrawal by Subject|0|||
164329870|NCT02694523|593584788|FG001|Part B|Withdrawal by Subject|0|||
164329871|NCT02694523|593584789|FG002|Part B|Withdrawal by Subject|9|||
164329872|NCT02694523|593584790|FG003|Part B|Withdrawal by Subject|0|||
164329873|NCT02694523|593584791|FG004|Part B|Withdrawal by Subject|1|||
164329874|NCT02694523|593584792|FG005|Part B|Withdrawal by Subject|3|||
164329875|NCT02694523|593584793|FG006|Part B|Withdrawal by Subject|0|||
164329876|NCT02694523|593584787|FG000|Part B|Other|0|||
164329877|NCT02694523|593584788|FG001|Part B|Other|0|||
164329878|NCT02694523|593584789|FG002|Part B|Other|1|||
164329879|NCT02694523|593584790|FG003|Part B|Other|0|||
164329880|NCT02694523|593584791|FG004|Part B|Other|0|||
164329881|NCT02694523|593584792|FG005|Part B|Other|0|||
164329882|NCT02694523|593584793|FG006|Part B|Other|1|||
164329883|NCT01058265|593584794|FG000|Overall Study|Lost to Follow-up|11|||
164329884|NCT01058265|593584795|FG001|Overall Study|Lost to Follow-up|12|||
164329885|NCT02169284|593584796|FG000|Overall Study|Physician Decision|0|||
164329886|NCT02169284|593584797|FG001|Overall Study|Physician Decision|1|||
164329887|NCT01367119|593584798|FG000|Overall Study|Adverse Event|1|||
164329888|NCT01367119|593584799|FG001|Overall Study|Adverse Event|0|||
164329889|NCT01367119|593584798|FG000|Overall Study|Withdrawal by Subject|1|||
164329890|NCT01367119|593584799|FG001|Overall Study|Withdrawal by Subject|1|||
164329891|NCT02964507|593584802|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
164329892|NCT02964507|593584803|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
164329893|NCT02964507|593584804|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
164329894|NCT02964507|593584805|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
164329895|NCT02964507|593584806|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
164329896|NCT02964507|593584807|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
164329897|NCT02964507|593584808|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
164329898|NCT02964507|593584809|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
164329899|NCT02964507|593584802|FG000|Overall Study|Study terminated by Sponsor|9|||
164329900|NCT02964507|593584803|FG001|Overall Study|Study terminated by Sponsor|1|||
164329901|NCT02964507|593584804|FG002|Overall Study|Study terminated by Sponsor|9|||
164329902|NCT02964507|593584805|FG003|Overall Study|Study terminated by Sponsor|3|||
164674730|NCT04405570|594832784|FG001|Overall Study|Withdrawal by Subject|1|||
164674731|NCT04405570|594832785|FG002|Overall Study|Withdrawal by Subject|1|||
164674732|NCT04405570|594832786|FG003|Overall Study|Withdrawal by Subject|0|||
164674733|NCT04405570|594832783|FG000|Overall Study|Randomized not dosed|0|||
164674734|NCT04405570|594832784|FG001|Overall Study|Randomized not dosed|2|||
164674735|NCT04405570|594832785|FG002|Overall Study|Randomized not dosed|0|||
164674736|NCT04405570|594832786|FG003|Overall Study|Randomized not dosed|0|||
164674737|NCT04499963|594832787|FG000|Overall Study|Adverse Event|3|||
164674738|NCT04499963|594832788|FG001|Overall Study|Adverse Event|0|||
164674739|NCT04499963|594832787|FG000|Overall Study|Death|3|||
164674740|NCT04499963|594832788|FG001|Overall Study|Death|0|||
164674741|NCT04499963|594832787|FG000|Overall Study|Lack of Efficacy|7|||
164674742|NCT04499963|594832788|FG001|Overall Study|Lack of Efficacy|0|||
164674743|NCT04499963|594832787|FG000|Overall Study|Lost to Follow-up|2|||
164674744|NCT04499963|594832788|FG001|Overall Study|Lost to Follow-up|0|||
164674745|NCT02648347|594832794|FG000|Overall Study|Death|174|||
164674746|NCT02648347|594832795|FG001|Overall Study|Death|167|||
164674747|NCT02648347|594832794|FG000|Overall Study|Withdrawal by Subject|16|||
164674748|NCT02648347|594832795|FG001|Overall Study|Withdrawal by Subject|9|||
164329903|NCT02964507|593584806|FG004|Overall Study|Study terminated by Sponsor|3|||
164674749|NCT02648347|594832794|FG000|Overall Study|Lost to Follow-up|18|||
164674750|NCT02648347|594832795|FG001|Overall Study|Lost to Follow-up|21|||
164674751|NCT02648347|594832794|FG000|Overall Study|Missing|1|||
164674752|NCT02648347|594832795|FG001|Overall Study|Missing|0|||
164674753|NCT03546842|594832797|FG000|Overall Study|Protocol Violation|1|||
164674754|NCT03546842|594832797|FG000|Overall Study|Withdrawal by Subject|2|||
164674755|NCT01723397|594832798|FG000|Study Period 1|Protocol Violation|0|||
164674756|NCT01723397|594832799|FG001|Study Period 1|Protocol Violation|1|||
164674757|NCT01723397|594832798|FG000|Study Period 2|Protocol Violation|0|||
164674758|NCT01723397|594832799|FG001|Study Period 2|Protocol Violation|1|||
164674759|NCT02739997|594832800|FG000|Overall Study|Death|1|||
164674760|NCT02739997|594832800|FG000|Overall Study|Withdrawal by Subject|1|||
164674761|NCT02601625|594832805|FG000|Overall Study|Lost to Follow-up|0|||
164674762|NCT02601625|594832806|FG001|Overall Study|Lost to Follow-up|0|||
164674763|NCT02601625|594832807|FG002|Overall Study|Lost to Follow-up|1|||
164674764|NCT02601625|594832808|FG003|Overall Study|Lost to Follow-up|1|||
164674765|NCT00838279|594832809|FG000|Washout|Protocol Violation|1|||
164674766|NCT00838279|594832810|FG001|Washout|Protocol Violation|0|||
164674767|NCT00838279|594832809|FG000|Washout|Withdrawal by Subject|0|||
164674768|NCT00838279|594832810|FG001|Washout|Withdrawal by Subject|1|||
164674769|NCT04608188|594832811|FG000|Overall Study|Withdrawal by Subject|4|||
164674770|NCT04608188|594832812|FG001|Overall Study|Withdrawal by Subject|8|||
164674771|NCT04419311|594832814|FG000|Overall Study|Lost to Follow-up|1|||
164674772|NCT04419311|594832815|FG001|Overall Study|Lost to Follow-up|0|||
164674773|NCT00965185|594832816|FG000|Overall Study|Lost to Follow-up|2|||
164674774|NCT00965185|594832817|FG001|Overall Study|Lost to Follow-up|0|||
164674775|NCT00965185|594832816|FG000|Overall Study|Withdrawal by Subject|0|||
164674776|NCT00965185|594832817|FG001|Overall Study|Withdrawal by Subject|1|||
164674777|NCT01921062|594832818|FG000|Overall Study|Withdrawal by Subject|0|||
164674778|NCT01921062|594832819|FG001|Overall Study|Withdrawal by Subject|7|||
164674779|NCT01921062|594832818|FG000|Overall Study|Adverse Event|5|||
164674780|NCT01921062|594832819|FG001|Overall Study|Adverse Event|6|||
164674781|NCT01921062|594832818|FG000|Overall Study|Protocol Violation|0|||
164674782|NCT01921062|594832819|FG001|Overall Study|Protocol Violation|1|||
164674783|NCT01921062|594832818|FG000|Overall Study|VMIQ score > 72|4|||
164674784|NCT01921062|594832819|FG001|Overall Study|VMIQ score > 72|1|||
164674785|NCT01921062|594832818|FG000|Overall Study|Logistic error|0|||
164674786|NCT01921062|594832819|FG001|Overall Study|Logistic error|1|||
164674787|NCT03686033|594832820|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
164674788|NCT03686033|594832821|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
164674789|NCT03686033|594832822|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
164674790|NCT03686033|594832823|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
164674791|NCT03686033|594832824|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
164674792|NCT03686033|594832825|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
164674793|NCT01302548|594832827|FG000|Overall Study|Lost to Follow-up|2|||
164674794|NCT01302548|594832828|FG001|Overall Study|Lost to Follow-up|1|||
164674795|NCT00095212|594832842|FG000|Overall Study|Withdrawal by Subject|1|||
164674796|NCT00095212|594832843|FG001|Overall Study|Withdrawal by Subject|3|||
164674797|NCT02374853|594832848|FG000|Overall Study|Surgery Cancelled|5|||
164674798|NCT02374853|594832849|FG001|Overall Study|Surgery Cancelled|11|||
164674799|NCT03681470|594832851|FG000|Overall Study|Lack of Efficacy|3|||
164674800|NCT03681470|594832851|FG000|Overall Study|Lost to Follow-up|1|||
164674801|NCT03681470|594832851|FG000|Overall Study|Protocol Violation|3|||
164674802|NCT03681470|594832851|FG000|Overall Study|Withdrawal by Subject|1|||
164674803|NCT02335658|594832856|FG000|Overall Study|Adverse Event|18|||
164674804|NCT02335658|594832857|FG001|Overall Study|Adverse Event|12|||
164674805|NCT02335658|594832856|FG000|Overall Study|Lack of Efficacy|4|||
164674806|NCT02335658|594832857|FG001|Overall Study|Lack of Efficacy|5|||
164674807|NCT02335658|594832856|FG000|Overall Study|Pregnancy|1|||
164674808|NCT02335658|594832857|FG001|Overall Study|Pregnancy|0|||
164674809|NCT02335658|594832856|FG000|Overall Study|Withdrawal by Subject|13|||
164674810|NCT02335658|594832857|FG001|Overall Study|Withdrawal by Subject|21|||
164674811|NCT02335658|594832856|FG000|Overall Study|non-compliance|2|||
164674812|NCT02335658|594832857|FG001|Overall Study|non-compliance|3|||
164674813|NCT02335658|594832856|FG000|Overall Study|other reason|2|||
164674814|NCT02335658|594832857|FG001|Overall Study|other reason|3|||
164674815|NCT03500692|594832862|FG000|Overall Study|Death|163|||
164674816|NCT03500692|594832862|FG000|Overall Study|Lost to Follow-up|75|||
164674817|NCT03500692|594832862|FG000|Overall Study|Termination Reasons|3|||
164674818|NCT02305758|594832863|FG000|Overall Study|Death|27|||
164674819|NCT02305758|594832864|FG001|Overall Study|Death|27|||
164674820|NCT02305758|594832863|FG000|Overall Study|Withdrew consent|9|||
164674821|NCT02305758|594832864|FG001|Overall Study|Withdrew consent|2|||
164674822|NCT02305758|594832863|FG000|Overall Study|Lost to Follow-up|6|||
164674823|NCT02305758|594832864|FG001|Overall Study|Lost to Follow-up|1|||
164674824|NCT02305758|594832863|FG000|Overall Study|Study Terminated by Sponsor|21|||
164674825|NCT02305758|594832864|FG001|Overall Study|Study Terminated by Sponsor|34|||
164674826|NCT02305758|594832863|FG000|Overall Study|Other, not specified|2|||
164674827|NCT02305758|594832864|FG001|Overall Study|Other, not specified|1|||
164674828|NCT04149964|594832865|FG000|Overall Study|Lost to Follow-up|19|||
164674829|NCT04149964|594832866|FG001|Overall Study|Lost to Follow-up|18|||
164674830|NCT02032888|594832867|FG000|Treatment Period|Poor compliance/noncompliance|1|||
164674831|NCT02032888|594832868|FG001|Treatment Period|Poor compliance/noncompliance|1|||
164570564|NCT02601950|594455006|FG003|Overall Study|Participant enrolled in rollover study|0|||
164570565|NCT02601950|594455007|FG004|Overall Study|Participant enrolled in rollover study|1|||
164570566|NCT02601950|594455008|FG005|Overall Study|Participant enrolled in rollover study|1|||
164570567|NCT02601950|594455009|FG006|Overall Study|Participant enrolled in rollover study|1|||
164570568|NCT02601950|594455010|FG007|Overall Study|Participant enrolled in rollover study|0|||
164570569|NCT02601950|594455003|FG000|Overall Study|Disease progression - radiological|21|||
164570570|NCT02601950|594455004|FG001|Overall Study|Disease progression - radiological|26|||
164570571|NCT02601950|594455005|FG002|Overall Study|Disease progression - radiological|22|||
164570572|NCT02601950|594455006|FG003|Overall Study|Disease progression - radiological|11|||
164570573|NCT02601950|594455007|FG004|Overall Study|Disease progression - radiological|46|||
164570574|NCT02601950|594455008|FG005|Overall Study|Disease progression - radiological|52|||
164570575|NCT02601950|594455009|FG006|Overall Study|Disease progression - radiological|7|||
164570576|NCT02601950|594455010|FG007|Overall Study|Disease progression - radiological|5|||
164570577|NCT02601950|594455003|FG000|Overall Study|Disease progression - clinical|3|||
164570578|NCT02601950|594455004|FG001|Overall Study|Disease progression - clinical|5|||
164570579|NCT02601950|594455005|FG002|Overall Study|Disease progression - clinical|4|||
164570580|NCT02601950|594455006|FG003|Overall Study|Disease progression - clinical|2|||
164570581|NCT02601950|594455007|FG004|Overall Study|Disease progression - clinical|6|||
164570582|NCT02601950|594455008|FG005|Overall Study|Disease progression - clinical|6|||
164570583|NCT02601950|594455009|FG006|Overall Study|Disease progression - clinical|5|||
164570584|NCT02601950|594455010|FG007|Overall Study|Disease progression - clinical|1|||
164570585|NCT02601950|594455003|FG000|Overall Study|Death|6|||
164570586|NCT02601950|594455004|FG001|Overall Study|Death|0|||
164570587|NCT02601950|594455005|FG002|Overall Study|Death|3|||
164570588|NCT02601950|594455006|FG003|Overall Study|Death|1|||
164570589|NCT02601950|594455007|FG004|Overall Study|Death|4|||
164570590|NCT02601950|594455008|FG005|Overall Study|Death|1|||
164570591|NCT02601950|594455009|FG006|Overall Study|Death|0|||
164570592|NCT02601950|594455010|FG007|Overall Study|Death|0|||
164570593|NCT02601950|594455003|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
164570594|NCT02601950|594455004|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
164570595|NCT02601950|594455005|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
164570596|NCT02601950|594455006|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
164570597|NCT02601950|594455007|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
164570598|NCT02601950|594455008|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
164570599|NCT02601950|594455009|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
164570600|NCT02601950|594455010|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
164570601|NCT02601950|594455003|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
164570602|NCT02601950|594455004|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
164570603|NCT02601950|594455005|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
164570604|NCT02601950|594455006|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
164570605|NCT02601950|594455007|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
164570606|NCT02601950|594455008|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
164570607|NCT02601950|594455009|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
164570608|NCT02601950|594455010|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
164570609|NCT02601950|594455003|FG000|Overall Study|Non-compliance|0|||
164570610|NCT02601950|594455004|FG001|Overall Study|Non-compliance|1|||
164570611|NCT02601950|594455005|FG002|Overall Study|Non-compliance|0|||
164570612|NCT02601950|594455006|FG003|Overall Study|Non-compliance|0|||
164570613|NCT02601950|594455007|FG004|Overall Study|Non-compliance|0|||
164570614|NCT02601950|594455008|FG005|Overall Study|Non-compliance|1|||
164570615|NCT02601950|594455009|FG006|Overall Study|Non-compliance|1|||
164570616|NCT02601950|594455010|FG007|Overall Study|Non-compliance|0|||
164570617|NCT02601950|594455003|FG000|Overall Study|Participant refused further study treatment|0|||
164570618|NCT02601950|594455004|FG001|Overall Study|Participant refused further study treatment|1|||
164570619|NCT02601950|594455005|FG002|Overall Study|Participant refused further study treatment|1|||
164570620|NCT02601950|594455006|FG003|Overall Study|Participant refused further study treatment|0|||
164570621|NCT02601950|594455007|FG004|Overall Study|Participant refused further study treatment|2|||
164570622|NCT02601950|594455008|FG005|Overall Study|Participant refused further study treatment|2|||
164570623|NCT02601950|594455009|FG006|Overall Study|Participant refused further study treatment|2|||
164570624|NCT02601950|594455010|FG007|Overall Study|Participant refused further study treatment|1|||
164570625|NCT02601950|594455003|FG000|Overall Study|Investigator discretion|1|||
164570626|NCT02601950|594455004|FG001|Overall Study|Investigator discretion|0|||
164570627|NCT02601950|594455005|FG002|Overall Study|Investigator discretion|1|||
164570628|NCT02601950|594455006|FG003|Overall Study|Investigator discretion|0|||
164570629|NCT02601950|594455007|FG004|Overall Study|Investigator discretion|1|||
164570630|NCT02601950|594455008|FG005|Overall Study|Investigator discretion|1|||
164570631|NCT02601950|594455009|FG006|Overall Study|Investigator discretion|1|||
164570632|NCT02601950|594455010|FG007|Overall Study|Investigator discretion|0|||
164570633|NCT02601950|594455003|FG000|Overall Study|Other|0|||
164570634|NCT02601950|594455004|FG001|Overall Study|Other|0|||
164674832|NCT02032888|594832869|FG002|Treatment Period|Poor compliance/noncompliance|0|||
164674833|NCT02032888|594832867|FG000|Treatment Period|Other|1|||
164674834|NCT02032888|594832868|FG001|Treatment Period|Other|1|||
164674835|NCT02032888|594832869|FG002|Treatment Period|Other|0|||
164674836|NCT02032888|594832867|FG000|Follow-up Period|Lost to Follow-up|1|||
164674837|NCT02032888|594832868|FG001|Follow-up Period|Lost to Follow-up|1|||
164674838|NCT02032888|594832869|FG002|Follow-up Period|Lost to Follow-up|0|||
164674839|NCT02032888|594832867|FG000|Follow-up Period|Death|1|||
164674840|NCT02032888|594832868|FG001|Follow-up Period|Death|1|||
164674841|NCT02032888|594832869|FG002|Follow-up Period|Death|0|||
164674842|NCT02032888|594832867|FG000|Follow-up Period|Other|1|||
164674843|NCT02032888|594832868|FG001|Follow-up Period|Other|0|||
164674844|NCT02032888|594832869|FG002|Follow-up Period|Other|0|||
164674845|NCT01424644|594832870|FG000|Overall Study|Adverse Event|2|||
164674846|NCT01424644|594832871|FG001|Overall Study|Adverse Event|0|||
164674847|NCT01424644|594832870|FG000|Overall Study|Withdrawal by Subject|9|||
164674848|NCT01424644|594832871|FG001|Overall Study|Withdrawal by Subject|12|||
164674849|NCT01424644|594832870|FG000|Overall Study|Lost to Follow-up|16|||
164674850|NCT01424644|594832871|FG001|Overall Study|Lost to Follow-up|12|||
164674851|NCT01424644|594832870|FG000|Overall Study|Protocol Violation|4|||
164674852|NCT01424644|594832871|FG001|Overall Study|Protocol Violation|3|||
164674853|NCT01424644|594832870|FG000|Overall Study|Administrative Reason|1|||
164674854|NCT01424644|594832871|FG001|Overall Study|Administrative Reason|0|||
164674855|NCT01424644|594832870|FG000|Overall Study|Unable to Classify|1|||
164674856|NCT01424644|594832871|FG001|Overall Study|Unable to Classify|0|||
164674857|NCT05593965|594832872|FG000|1st Intervention (1 Day)|Technical error|1|||
164674858|NCT05593965|594832873|FG001|1st Intervention (1 Day)|Technical error|0|||
164674859|NCT02272777|594832874|FG000|Overall Study|Adverse Event|0|||
164674860|NCT02272777|594832875|FG001|Overall Study|Adverse Event|1|||
164674861|NCT02272777|594832874|FG000|Overall Study|Withdrawal by Subject|0|||
164674862|NCT02272777|594832875|FG001|Overall Study|Withdrawal by Subject|3|||
164674863|NCT02272777|594832874|FG000|Overall Study|Lost to Follow-up|2|||
164674864|NCT02272777|594832875|FG001|Overall Study|Lost to Follow-up|0|||
164674865|NCT02272777|594832874|FG000|Overall Study|Other|2|||
164674866|NCT02272777|594832875|FG001|Overall Study|Other|0|||
164674867|NCT00837486|594832877|FG000|Blinded-treatment Phase|Physician Decision|1|||
164674868|NCT00837486|594832878|FG001|Blinded-treatment Phase|Physician Decision|0|||
164674869|NCT00837486|594832877|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
164674870|NCT00837486|594832878|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
164674871|NCT00837486|594832877|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
164674872|NCT00837486|594832878|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
164674873|NCT00837486|594832877|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
164674874|NCT00837486|594832878|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
164674875|NCT01577381|594832879|FG000|Overall Study|Discontinued|2|||
164674876|NCT01577381|594832880|FG001|Overall Study|Discontinued|1|||
164225427|NCT03180138|593194065|FG002|Overall Study|No prior immunization records|6|||
164225428|NCT03180138|593194063|FG000|Overall Study|Found to be >24 mon after randomization|3|||
164225429|NCT03180138|593194064|FG001|Overall Study|Found to be >24 mon after randomization|0|||
164674877|NCT01577381|594832881|FG002|Overall Study|Discontinued|2|||
164674878|NCT01577381|594832882|FG003|Overall Study|Discontinued|2|||
164674879|NCT01577381|594832879|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
164674880|NCT01577381|594832880|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
164225430|NCT03180138|593194065|FG002|Overall Study|Found to be >24 mon after randomization|3|||
164674881|NCT01577381|594832881|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
164674882|NCT01577381|594832882|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
164674883|NCT02571907|594834788|FG000|Overall Study|Death|4|||
164674884|NCT02571907|594834788|FG000|Overall Study|Lost to Follow-up|3|||
164674885|NCT02571907|594834788|FG000|Overall Study|Withdrawal by Subject|3|||
164225431|NCT04191733|593194067|FG000|Overall Study|Withdrawn due to study closure|13|||
164674886|NCT03447353|594834789|FG000|Overall Study|Failure at Screening Visit|2|||
164674887|NCT03447353|594834789|FG000|Overall Study|Lost to Follow-up|4|||
164674888|NCT03447353|594834789|FG000|Overall Study|Scheduling Conflicts|3|||
164674889|NCT03447353|594834789|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
164674890|NCT02175095|594834792|FG000|Overall Study|Withdrawal by Subject|3|||
164674891|NCT02635750|594834793|FG000|Part 1, Period 2|Adverse Event|1|||
164674892|NCT02635750|594834794|FG001|Part 1, Period 2|Adverse Event|0|||
164674893|NCT02635750|594834795|FG002|Part 1, Period 2|Adverse Event|0|||
164674894|NCT00462345|594834796|FG000|Overall Study|Withdrawal by Subject|2|||
164674895|NCT00462345|594834796|FG000|Overall Study|Did not complete second course|1|||
164674896|NCT02642653|594834800|FG000|Overall Study|Adverse Event|2|||
164674897|NCT02642653|594834801|FG001|Overall Study|Adverse Event|0|||
164674898|NCT02875392|594834805|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
164674899|NCT02875392|594834806|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
164674900|NCT00834717|594834810|FG000|First Intervention|Adverse Event|1|||
164674901|NCT00834717|594834811|FG001|First Intervention|Adverse Event|0|||
164329904|NCT02964507|593584807|FG005|Overall Study|Study terminated by Sponsor|2|||
164329905|NCT02964507|593584808|FG006|Overall Study|Study terminated by Sponsor|0|||
164329906|NCT02964507|593584809|FG007|Overall Study|Study terminated by Sponsor|0|||
164329907|NCT02964507|593584802|FG000|Overall Study|Other|3|||
164329908|NCT02964507|593584803|FG001|Overall Study|Other|0|||
164329909|NCT02964507|593584804|FG002|Overall Study|Other|0|||
164329910|NCT02964507|593584805|FG003|Overall Study|Other|0|||
164329911|NCT02964507|593584806|FG004|Overall Study|Other|1|||
164329912|NCT02964507|593584807|FG005|Overall Study|Other|0|||
164329913|NCT02964507|593584808|FG006|Overall Study|Other|0|||
164329914|NCT02964507|593584809|FG007|Overall Study|Other|0|||
164329915|NCT02964507|593584802|FG000|Overall Study|Death|11|||
164329916|NCT02964507|593584803|FG001|Overall Study|Death|9|||
164329917|NCT02964507|593584804|FG002|Overall Study|Death|12|||
164329918|NCT02964507|593584805|FG003|Overall Study|Death|2|||
164329919|NCT02964507|593584806|FG004|Overall Study|Death|10|||
164329920|NCT02964507|593584807|FG005|Overall Study|Death|5|||
164329921|NCT02964507|593584808|FG006|Overall Study|Death|0|||
164329922|NCT02964507|593584809|FG007|Overall Study|Death|0|||
164329923|NCT02964507|593584802|FG000|Overall Study|Withdrawal by Subject|1|||
164329924|NCT02964507|593584803|FG001|Overall Study|Withdrawal by Subject|0|||
164329925|NCT02964507|593584804|FG002|Overall Study|Withdrawal by Subject|1|||
164329926|NCT02964507|593584805|FG003|Overall Study|Withdrawal by Subject|1|||
164329927|NCT02964507|593584806|FG004|Overall Study|Withdrawal by Subject|0|||
164329928|NCT02964507|593584807|FG005|Overall Study|Withdrawal by Subject|1|||
164329929|NCT02964507|593584808|FG006|Overall Study|Withdrawal by Subject|0|||
164329930|NCT02964507|593584809|FG007|Overall Study|Withdrawal by Subject|0|||
164329931|NCT02964507|593584802|FG000|Overall Study|Physician Decision|2|||
164329932|NCT02964507|593584803|FG001|Overall Study|Physician Decision|0|||
164329933|NCT02964507|593584804|FG002|Overall Study|Physician Decision|3|||
164329934|NCT02964507|593584805|FG003|Overall Study|Physician Decision|0|||
164329935|NCT02964507|593584806|FG004|Overall Study|Physician Decision|1|||
164329936|NCT02964507|593584807|FG005|Overall Study|Physician Decision|0|||
164570635|NCT02601950|594455005|FG002|Overall Study|Other|0|||
164570636|NCT02601950|594455006|FG003|Overall Study|Other|0|||
164570637|NCT02601950|594455007|FG004|Overall Study|Other|2|||
164570638|NCT02601950|594455008|FG005|Overall Study|Other|2|||
164570639|NCT02601950|594455009|FG006|Overall Study|Other|1|||
164570640|NCT02601950|594455010|FG007|Overall Study|Other|0|||
164570641|NCT02157883|594455011|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
164570642|NCT02157883|594455011|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
164570643|NCT02157883|594455011|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
164570644|NCT02157883|594455011|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
164570645|NCT02157883|594455011|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
164570646|NCT01701258|594455012|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
164570647|NCT01701258|594455013|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
164570648|NCT01701258|594455014|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
164570649|NCT01701258|594455015|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
164570650|NCT01701258|594455016|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
164570651|NCT01701258|594455017|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
164570652|NCT01701258|594455018|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
164570653|NCT01701258|594455019|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
164570654|NCT01701258|594455020|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
164570655|NCT01701258|594455021|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
164570656|NCT01701258|594455022|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
164570657|NCT01701258|594455023|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
164570658|NCT01701258|594455024|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
164570659|NCT01701258|594455012|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
164570660|NCT01701258|594455013|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
164570661|NCT01701258|594455014|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
164570662|NCT01701258|594455015|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
164570663|NCT01701258|594455016|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
164570664|NCT01701258|594455017|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
164570665|NCT01701258|594455018|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
164225432|NCT04191733|593194068|FG001|Overall Study|Withdrawn due to study closure|14|||
164225433|NCT04191733|593194067|FG000|Overall Study|Withdrawal by Subject|2|||
164225434|NCT04191733|593194068|FG001|Overall Study|Withdrawal by Subject|4|||
164225435|NCT04191733|593194067|FG000|Overall Study|Physician Decision|1|||
164225436|NCT04191733|593194068|FG001|Overall Study|Physician Decision|1|||
164225437|NCT04191733|593194067|FG000|Overall Study|Lost to Follow-up|5|||
164225438|NCT04191733|593194068|FG001|Overall Study|Lost to Follow-up|6|||
164225439|NCT04191733|593194067|FG000|Overall Study|Death|0|||
164225440|NCT04191733|593194068|FG001|Overall Study|Death|1|||
164225441|NCT01903733|593194071|FG000|Overall Study|Death|23|||
164329937|NCT02964507|593584808|FG006|Overall Study|Physician Decision|0|||
164329938|NCT02964507|593584809|FG007|Overall Study|Physician Decision|0|||
164329939|NCT04341662|593584810|FG000|Overall Study|Did not have source-verified blood loss data|423|||
164674902|NCT00834717|594834810|FG000|First Intervention|Withdrawal by Subject|0|||
164674903|NCT00834717|594834811|FG001|First Intervention|Withdrawal by Subject|1|||
164674904|NCT01660243|594834812|FG000|Overall Study|Adverse Event|1|||
164674905|NCT01660243|594834813|FG001|Overall Study|Adverse Event|0|||
164674906|NCT01660243|594834814|FG002|Overall Study|Adverse Event|1|||
164674907|NCT01660243|594834815|FG003|Overall Study|Adverse Event|0|||
164674908|NCT01660243|594834812|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
164674909|NCT01660243|594834813|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
164674910|NCT01660243|594834814|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
164674911|NCT01660243|594834815|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
164674912|NCT01660243|594834812|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
164674913|NCT01660243|594834813|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
164674914|NCT01660243|594834814|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
164674915|NCT01660243|594834815|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
164674916|NCT01660243|594834812|FG000|Overall Study|Randomization error|0|||
164674917|NCT01660243|594834813|FG001|Overall Study|Randomization error|0|||
164674918|NCT01660243|594834814|FG002|Overall Study|Randomization error|0|||
164674919|NCT01660243|594834815|FG003|Overall Study|Randomization error|1|||
164674920|NCT03025087|594834816|FG000|Overall Study|Physician Decision|3|||
164674921|NCT03025087|594834817|FG001|Overall Study|Physician Decision|3|||
164674922|NCT03025087|594834818|FG002|Overall Study|Physician Decision|0|||
164674923|NCT03025087|594834819|FG003|Overall Study|Physician Decision|0|||
164674924|NCT03025087|594834820|FG004|Overall Study|Physician Decision|0|||
164674925|NCT03025087|594834816|FG000|Overall Study|Withdrawal by Subject|1|||
164674926|NCT03025087|594834817|FG001|Overall Study|Withdrawal by Subject|1|||
164674927|NCT03025087|594834818|FG002|Overall Study|Withdrawal by Subject|0|||
164674928|NCT03025087|594834819|FG003|Overall Study|Withdrawal by Subject|0|||
164674929|NCT03025087|594834820|FG004|Overall Study|Withdrawal by Subject|0|||
164674930|NCT03025087|594834816|FG000|Overall Study|Unable to complete MRI|2|||
164674931|NCT03025087|594834817|FG001|Overall Study|Unable to complete MRI|2|||
164674932|NCT03025087|594834818|FG002|Overall Study|Unable to complete MRI|0|||
164674933|NCT03025087|594834819|FG003|Overall Study|Unable to complete MRI|0|||
164674934|NCT03025087|594834820|FG004|Overall Study|Unable to complete MRI|0|||
164674935|NCT04299087|594834821|FG000|Overall Study|Lost to Follow-up|2|||
164674936|NCT04299087|594834822|FG001|Overall Study|Lost to Follow-up|1|||
164674937|NCT00594035|594834823|FG000|Overall Study|Lost to Follow-up|1|||
164674938|NCT00594035|594834824|FG001|Overall Study|Lost to Follow-up|1|||
164674939|NCT00594035|594834823|FG000|Overall Study|Withdrawal by Subject|1|||
164674940|NCT00594035|594834824|FG001|Overall Study|Withdrawal by Subject|0|||
164674941|NCT00594035|594834823|FG000|Overall Study|Subject transferred to nursing home|0|||
164674942|NCT00594035|594834824|FG001|Overall Study|Subject transferred to nursing home|1|||
164674943|NCT00594035|594834823|FG000|Overall Study|Subject couldn't return due to job|0|||
164674944|NCT00594035|594834824|FG001|Overall Study|Subject couldn't return due to job|1|||
164674945|NCT00795821|594834825|FG000|Acute Treatment Phase|Adverse Event|23|||
164674946|NCT00795821|594834826|FG001|Acute Treatment Phase|Adverse Event|4|||
164674947|NCT00795821|594834825|FG000|Acute Treatment Phase|Death|1|||
164674948|NCT00795821|594834826|FG001|Acute Treatment Phase|Death|0|||
164674949|NCT00795821|594834825|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
164674950|NCT00795821|594834826|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
164674951|NCT00795821|594834825|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
164674952|NCT00795821|594834826|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
164674953|NCT00795821|594834825|FG000|Acute Treatment Phase|Physician Decision|1|||
164674954|NCT00795821|594834826|FG001|Acute Treatment Phase|Physician Decision|1|||
164674955|NCT00795821|594834825|FG000|Acute Treatment Phase|Protocol Violation|1|||
164674956|NCT00795821|594834826|FG001|Acute Treatment Phase|Protocol Violation|2|||
164674957|NCT00795821|594834825|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
164674958|NCT00795821|594834826|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
164674959|NCT00795821|594834825|FG000|Long-term Extension Phase|Adverse Event|25|||
164674960|NCT00795821|594834826|FG001|Long-term Extension Phase|Adverse Event|32|||
164674961|NCT00795821|594834825|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
164674962|NCT00795821|594834826|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
164674963|NCT00795821|594834825|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
164674964|NCT00795821|594834826|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
164674965|NCT00795821|594834825|FG000|Long-term Extension Phase|Physician Decision|1|||
164674966|NCT00795821|594834826|FG001|Long-term Extension Phase|Physician Decision|2|||
164674967|NCT00795821|594834825|FG000|Long-term Extension Phase|Protocol Violation|3|||
164225442|NCT01903733|593194072|FG001|Overall Study|Death|54|||
164225443|NCT01903733|593194073|FG002|Overall Study|Death|30|||
164674968|NCT00795821|594834826|FG001|Long-term Extension Phase|Protocol Violation|5|||
164674969|NCT00795821|594834825|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
164225444|NCT01903733|593194074|FG003|Overall Study|Death|98|||
164225445|NCT01903733|593194071|FG000|Overall Study|Participant refused further follow-up|35|||
164225446|NCT01903733|593194072|FG001|Overall Study|Participant refused further follow-up|38|||
164225447|NCT01903733|593194073|FG002|Overall Study|Participant refused further follow-up|13|||
164225448|NCT01903733|593194074|FG003|Overall Study|Participant refused further follow-up|9|||
164225449|NCT01903733|593194071|FG000|Overall Study|Lost to Follow-up|18|||
164225450|NCT01903733|593194072|FG001|Overall Study|Lost to Follow-up|19|||
164570666|NCT01701258|594455019|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
164570667|NCT01701258|594455020|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
164570668|NCT01701258|594455021|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
164570669|NCT01701258|594455022|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
164570670|NCT01701258|594455023|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
164570671|NCT01701258|594455024|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
164570672|NCT01701258|594455012|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
164570673|NCT01701258|594455013|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
164570674|NCT01701258|594455014|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
164570675|NCT01701258|594455015|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
164570676|NCT01701258|594455016|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
164570677|NCT01701258|594455017|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
164570678|NCT01701258|594455018|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
164570679|NCT01701258|594455019|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
164570680|NCT01701258|594455020|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
164570681|NCT01701258|594455021|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
164570682|NCT01701258|594455022|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
164570683|NCT01701258|594455023|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
164570684|NCT01701258|594455024|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
164570685|NCT01701258|594455012|FG000|Assessment and Scheduling|Investigator Terminated|2|||
164570686|NCT01701258|594455013|FG001|Assessment and Scheduling|Investigator Terminated|0|||
164570687|NCT01701258|594455014|FG002|Assessment and Scheduling|Investigator Terminated|0|||
164570688|NCT01701258|594455015|FG003|Assessment and Scheduling|Investigator Terminated|0|||
164570689|NCT01701258|594455016|FG004|Assessment and Scheduling|Investigator Terminated|0|||
164570690|NCT01701258|594455017|FG005|Assessment and Scheduling|Investigator Terminated|0|||
164570691|NCT01701258|594455018|FG006|Assessment and Scheduling|Investigator Terminated|0|||
164570692|NCT01701258|594455019|FG007|Assessment and Scheduling|Investigator Terminated|0|||
164570693|NCT01701258|594455020|FG008|Assessment and Scheduling|Investigator Terminated|0|||
164570694|NCT01701258|594455021|FG009|Assessment and Scheduling|Investigator Terminated|0|||
164570695|NCT01701258|594455022|FG010|Assessment and Scheduling|Investigator Terminated|0|||
164570696|NCT01701258|594455023|FG011|Assessment and Scheduling|Investigator Terminated|0|||
164570697|NCT01701258|594455024|FG012|Assessment and Scheduling|Investigator Terminated|0|||
164570698|NCT01323478|594455025|FG000|Overall Study|Adverse Event|7|||
164570699|NCT01323478|594455025|FG000|Overall Study|Lack of Efficacy|4|||
164570700|NCT01323478|594455025|FG000|Overall Study|Non-compliance With Study Product|3|||
164570701|NCT01323478|594455025|FG000|Overall Study|Protocol Violation|1|||
164570702|NCT01323478|594455025|FG000|Overall Study|Withdrawal of Consent|1|||
164570703|NCT01323478|594455025|FG000|Overall Study|Administrative or Other Reasons|8|||
164570704|NCT00934102|594455027|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
164570705|NCT00934102|594455028|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
164570706|NCT00934102|594455029|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
164570707|NCT00792298|594455030|FG000|Treatment Period 1|Adverse Event|0|||
164570708|NCT00792298|594455031|FG001|Treatment Period 1|Adverse Event|1|||
164329940|NCT04341662|593584811|FG001|Overall Study|Did not have source-verified blood loss data|514|||
164329941|NCT02675231|593584812|FG000|Overall Study|Withdrawal by Subject|2|||
164329942|NCT02675231|593584813|FG001|Overall Study|Withdrawal by Subject|4|||
164329943|NCT02675231|593584814|FG002|Overall Study|Withdrawal by Subject|2|||
164329944|NCT02675231|593584812|FG000|Overall Study|Lost to Follow-up|3|||
164329945|NCT02675231|593584813|FG001|Overall Study|Lost to Follow-up|4|||
164329946|NCT02675231|593584814|FG002|Overall Study|Lost to Follow-up|3|||
164329947|NCT00064298|593584815|FG000|Overall Study|Withdrawal by Subject|2|||
164329948|NCT00064298|593584816|FG001|Overall Study|Withdrawal by Subject|1|||
164329949|NCT00064298|593584815|FG000|Overall Study|Lost to Follow-up|2|||
164329950|NCT00064298|593584816|FG001|Overall Study|Lost to Follow-up|2|||
164329951|NCT00064298|593584815|FG000|Overall Study|Death|0|||
164329952|NCT00064298|593584816|FG001|Overall Study|Death|1|||
164329953|NCT00064298|593584815|FG000|Overall Study|Disease Progression|2|||
164329954|NCT00064298|593584816|FG001|Overall Study|Disease Progression|1|||
164329955|NCT03309046|593584817|FG000|Overall Study|Withdrawal by Subject|4|||
164329956|NCT03309046|593584818|FG001|Overall Study|Withdrawal by Subject|17|||
164329957|NCT02764190|593584819|FG000|Overall Study|Lost to Follow-up|17|||
164329958|NCT02764190|593584820|FG001|Overall Study|Lost to Follow-up|13|||
164329959|NCT00591266|593584821|FG000|Overall Study|Adverse Event|2|||
164329960|NCT00591266|593584822|FG001|Overall Study|Adverse Event|2|||
164329961|NCT00591266|593584823|FG002|Overall Study|Adverse Event|3|||
164329962|NCT00591266|593584821|FG000|Overall Study|Lost to Follow-up|0|||
164329963|NCT00591266|593584822|FG001|Overall Study|Lost to Follow-up|1|||
164329964|NCT00591266|593584823|FG002|Overall Study|Lost to Follow-up|0|||
164329965|NCT00591266|593584821|FG000|Overall Study|Protocol Violation|0|||
164329966|NCT00591266|593584822|FG001|Overall Study|Protocol Violation|0|||
164329967|NCT00591266|593584823|FG002|Overall Study|Protocol Violation|1|||
164329968|NCT00591266|593584821|FG000|Overall Study|Withdrawal by Subject|6|||
164329969|NCT00591266|593584822|FG001|Overall Study|Withdrawal by Subject|2|||
164329970|NCT00591266|593584823|FG002|Overall Study|Withdrawal by Subject|5|||
164329971|NCT00591266|593584821|FG000|Overall Study|Lack of Efficacy|0|||
164329972|NCT00591266|593584822|FG001|Overall Study|Lack of Efficacy|2|||
164329973|NCT00591266|593584823|FG002|Overall Study|Lack of Efficacy|0|||
164329974|NCT00591266|593584821|FG000|Overall Study|Other|1|||
164329975|NCT00591266|593584822|FG001|Overall Study|Other|4|||
164329976|NCT00591266|593584823|FG002|Overall Study|Other|5|||
164329977|NCT03488927|593584824|FG000|Overall Study|Withdrawal by Subject|44|||
164329978|NCT03488927|593584825|FG001|Overall Study|Withdrawal by Subject|118|||
164329979|NCT03488927|593584826|FG002|Overall Study|Withdrawal by Subject|217|||
164329980|NCT03497676|593584827|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
164329981|NCT03497676|593584828|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
164329982|NCT03497676|593584829|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
164329983|NCT03497676|593584830|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
164329984|NCT03497676|593584827|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
164329985|NCT03497676|593584828|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
164329986|NCT03497676|593584829|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
164329987|NCT03497676|593584830|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
164329988|NCT03497676|593584827|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
164329989|NCT03497676|593584828|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
164329990|NCT03497676|593584829|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
164329991|NCT03497676|593584830|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
164329992|NCT03497676|593584827|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
164329993|NCT03497676|593584828|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
164329994|NCT03497676|593584829|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
164329995|NCT03497676|593584830|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
164329996|NCT03497676|593584827|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
164329997|NCT03497676|593584828|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
164329998|NCT03497676|593584829|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
164570709|NCT00792298|594455032|FG002|Treatment Period 1|Adverse Event|0|||
164570710|NCT00792298|594455033|FG003|Treatment Period 1|Adverse Event|1|||
164570711|NCT00792298|594455034|FG004|Treatment Period 1|Adverse Event|0|||
164570712|NCT00792298|594455035|FG005|Treatment Period 1|Adverse Event|1|||
164570713|NCT00792298|594455036|FG006|Treatment Period 1|Adverse Event|1|||
164570714|NCT00792298|594455037|FG007|Treatment Period 1|Adverse Event|0|||
164570715|NCT00792298|594455030|FG000|Treatment Period 1|Lack of Efficacy|0|||
164570716|NCT00792298|594455031|FG001|Treatment Period 1|Lack of Efficacy|0|||
164570717|NCT00792298|594455032|FG002|Treatment Period 1|Lack of Efficacy|1|||
164570718|NCT00792298|594455033|FG003|Treatment Period 1|Lack of Efficacy|0|||
164570719|NCT00792298|594455034|FG004|Treatment Period 1|Lack of Efficacy|0|||
164570720|NCT00792298|594455035|FG005|Treatment Period 1|Lack of Efficacy|0|||
164570721|NCT00792298|594455036|FG006|Treatment Period 1|Lack of Efficacy|0|||
164570722|NCT00792298|594455037|FG007|Treatment Period 1|Lack of Efficacy|0|||
164570723|NCT00792298|594455030|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164329999|NCT03497676|593584830|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
164330000|NCT03497676|593584827|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
164330001|NCT03497676|593584828|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
164330002|NCT03497676|593584829|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
164330003|NCT03497676|593584830|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
164330004|NCT03497676|593584827|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
164330005|NCT03497676|593584828|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
164330006|NCT03497676|593584829|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
164225451|NCT01903733|593194073|FG002|Overall Study|Lost to Follow-up|6|||
164225452|NCT01903733|593194074|FG003|Overall Study|Lost to Follow-up|9|||
164225453|NCT01903733|593194071|FG000|Overall Study|Other|10|||
164225454|NCT01903733|593194072|FG001|Overall Study|Other|15|||
164225455|NCT01903733|593194073|FG002|Overall Study|Other|12|||
164225456|NCT01903733|593194074|FG003|Overall Study|Other|3|||
164330007|NCT03497676|593584830|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
164330008|NCT03497676|593584827|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
164330009|NCT03497676|593584828|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
164330010|NCT03497676|593584829|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
164330011|NCT03497676|593584830|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
164330012|NCT00880165|593584833|FG000|Overall Study|Withdrawal by Subject|27|||
164330013|NCT00880165|593584834|FG001|Overall Study|Withdrawal by Subject|23|||
164330014|NCT00880165|593584833|FG000|Overall Study|Not diagnosed with OSA|14|||
164330015|NCT00880165|593584834|FG001|Overall Study|Not diagnosed with OSA|8|||
164330016|NCT00880165|593584833|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
164330017|NCT00880165|593584834|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
164330018|NCT00880165|593584833|FG000|Overall Study|Lost to follow|9|||
164330019|NCT00880165|593584834|FG001|Overall Study|Lost to follow|15|||
164330020|NCT00395538|593584835|FG000|Overall Study|Did not re-consent to revised protocol|1|||
164330021|NCT00395538|593584836|FG001|Overall Study|Did not re-consent to revised protocol|10|||
164330022|NCT00395538|593584837|FG002|Overall Study|Did not re-consent to revised protocol|0|||
164330023|NCT00395538|593584835|FG000|Overall Study|FDA partial hold on PTH|0|||
164330024|NCT00395538|593584836|FG001|Overall Study|FDA partial hold on PTH|0|||
164330025|NCT00395538|593584837|FG002|Overall Study|FDA partial hold on PTH|11|||
164330026|NCT00395538|593584835|FG000|Overall Study|Failed screening|0|||
164330027|NCT00395538|593584836|FG001|Overall Study|Failed screening|0|||
164674970|NCT00795821|594834826|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
164330028|NCT00395538|593584837|FG002|Overall Study|Failed screening|4|||
164330029|NCT00395538|593584835|FG000|Overall Study|Switch to Natpara|0|||
164330030|NCT00395538|593584836|FG001|Overall Study|Switch to Natpara|0|||
164330031|NCT00395538|593584837|FG002|Overall Study|Switch to Natpara|3|||
164330032|NCT00395538|593584835|FG000|Overall Study|Adverse Event|1|||
164330033|NCT00395538|593584836|FG001|Overall Study|Adverse Event|0|||
164330034|NCT00395538|593584837|FG002|Overall Study|Adverse Event|2|||
164330035|NCT00395538|593584835|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
164330036|NCT00395538|593584836|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
164330037|NCT00395538|593584837|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
164330038|NCT00395538|593584835|FG000|Overall Study|Non-compliance with study protocol|0|||
164330039|NCT00395538|593584836|FG001|Overall Study|Non-compliance with study protocol|1|||
164330040|NCT00395538|593584837|FG002|Overall Study|Non-compliance with study protocol|0|||
164674971|NCT00795821|594834825|FG000|Taper Phase|Adverse Event|2|||
164674972|NCT00795821|594834826|FG001|Taper Phase|Adverse Event|0|||
164674973|NCT00795821|594834825|FG000|Taper Phase|Lost to Follow-up|1|||
164674974|NCT00795821|594834826|FG001|Taper Phase|Lost to Follow-up|0|||
164674975|NCT00795821|594834825|FG000|Taper Phase|Physician Decision|2|||
164674976|NCT00795821|594834826|FG001|Taper Phase|Physician Decision|0|||
164225457|NCT01903733|593194071|FG000|Overall Study|Missing|2|||
164225458|NCT01903733|593194072|FG001|Overall Study|Missing|0|||
164225459|NCT01903733|593194073|FG002|Overall Study|Missing|0|||
164225460|NCT01903733|593194074|FG003|Overall Study|Missing|0|||
164225461|NCT01903733|593194071|FG000|Overall Study|Investigator request|18|||
164225462|NCT01903733|593194072|FG001|Overall Study|Investigator request|0|||
164225463|NCT01903733|593194073|FG002|Overall Study|Investigator request|0|||
164225464|NCT01903733|593194074|FG003|Overall Study|Investigator request|0|||
164225465|NCT02202577|593194075|FG000|Overall Study|Lost to Follow-up|6|||
164225466|NCT02202577|593194076|FG001|Overall Study|Lost to Follow-up|16|||
164225467|NCT02202577|593194075|FG000|Overall Study|Protocol Violation|7|||
164225468|NCT02202577|593194076|FG001|Overall Study|Protocol Violation|3|||
164674977|NCT00795821|594834825|FG000|Taper Phase|Withdrawal by Subject|4|||
164674978|NCT00795821|594834826|FG001|Taper Phase|Withdrawal by Subject|0|||
164225469|NCT01714063|593194077|FG000|Overall Study|Equipment malfunction|2|||
164674979|NCT00508651|594834831|FG000|Overall Study|Lost to Follow-up|3|||
164225470|NCT01646216|593194078|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
164225471|NCT01646216|593194079|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
164225472|NCT01646216|593194078|FG000|Overall Study|Did not complete training|0|||
164330041|NCT00395538|593584835|FG000|Overall Study|PTH resistance|0|||
164330042|NCT00395538|593584836|FG001|Overall Study|PTH resistance|0|||
164330043|NCT00395538|593584837|FG002|Overall Study|PTH resistance|1|||
164330044|NCT00395538|593584835|FG000|Overall Study|Pregnancy|1|||
164330045|NCT00395538|593584836|FG001|Overall Study|Pregnancy|0|||
164330046|NCT00395538|593584837|FG002|Overall Study|Pregnancy|0|||
164330047|NCT00395538|593584835|FG000|Overall Study|Partial recovery of parathyroid function|0|||
164330048|NCT00395538|593584836|FG001|Overall Study|Partial recovery of parathyroid function|0|||
164330049|NCT00395538|593584837|FG002|Overall Study|Partial recovery of parathyroid function|1|||
164330050|NCT00395538|593584835|FG000|Overall Study|Participant elected to discontinue|0|||
164330051|NCT00395538|593584836|FG001|Overall Study|Participant elected to discontinue|0|||
164330052|NCT00395538|593584837|FG002|Overall Study|Participant elected to discontinue|1|||
164330053|NCT01074047|593584838|FG000|Treatment Phase|Adverse Event|89|||
164330054|NCT01074047|593584839|FG001|Treatment Phase|Adverse Event|66|||
164330055|NCT01074047|593584838|FG000|Treatment Phase|Disease Progression|16|||
164330056|NCT01074047|593584839|FG001|Treatment Phase|Disease Progression|21|||
164330057|NCT01074047|593584838|FG000|Treatment Phase|Withdrawal by Subject|27|||
164330058|NCT01074047|593584839|FG001|Treatment Phase|Withdrawal by Subject|48|||
164330059|NCT01074047|593584838|FG000|Treatment Phase|Death|53|||
164330060|NCT01074047|593584839|FG001|Treatment Phase|Death|58|||
164330061|NCT01074047|593584838|FG000|Treatment Phase|Lost to Follow-up|0|||
164330062|NCT01074047|593584839|FG001|Treatment Phase|Lost to Follow-up|1|||
164330063|NCT01074047|593584838|FG000|Treatment Phase|Protocol Violation|0|||
164330064|NCT01074047|593584839|FG001|Treatment Phase|Protocol Violation|1|||
164330065|NCT01074047|593584838|FG000|Treatment Phase|Miscellaneous|32|||
164330066|NCT01074047|593584839|FG001|Treatment Phase|Miscellaneous|39|||
164330067|NCT01074047|593584838|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
164330068|NCT01074047|593584839|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
164330069|NCT01074047|593584838|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
164330070|NCT01074047|593584839|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
164330071|NCT01074047|593584838|FG000|Survival Follow-Up Phase|Death|116|||
164330072|NCT01074047|593584839|FG001|Survival Follow-Up Phase|Death|124|||
164330073|NCT01074047|593584838|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
164330074|NCT01074047|593584839|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
164330075|NCT01074047|593584838|FG000|Extension Phase|Physician Decision|1|||
164330076|NCT01074047|593584839|FG001|Extension Phase|Physician Decision|0|||
164330077|NCT01074047|593584838|FG000|Extension Phase|Adverse Event|5|||
164330078|NCT01074047|593584839|FG001|Extension Phase|Adverse Event|0|||
164330079|NCT01074047|593584838|FG000|Extension Phase|Disease Progression|9|||
164330080|NCT01074047|593584839|FG001|Extension Phase|Disease Progression|0|||
164330081|NCT01074047|593584838|FG000|Extension Phase|Withdrawal by Subject|2|||
164330082|NCT01074047|593584839|FG001|Extension Phase|Withdrawal by Subject|0|||
164330083|NCT01074047|593584838|FG000|Extension Phase|Death|5|||
164330084|NCT01074047|593584839|FG001|Extension Phase|Death|0|||
164330085|NCT02211638|593584840|FG000|Overall Study|Case Report Forms Uncollected|291|||
164330086|NCT02211638|593584840|FG000|Overall Study|Protocol Violation|692|||
164330087|NCT05140382|593584842|FG000|Overall Study|Death|3|||
164330088|NCT05140382|593584843|FG001|Overall Study|Death|0|||
164330089|NCT05140382|593584844|FG002|Overall Study|Death|0|||
164330090|NCT05140382|593584842|FG000|Overall Study|Investigator decision|1|||
164330091|NCT05140382|593584843|FG001|Overall Study|Investigator decision|0|||
164330092|NCT05140382|593584844|FG002|Overall Study|Investigator decision|0|||
164330093|NCT05140382|593584842|FG000|Overall Study|Other|4|||
164330094|NCT05140382|593584843|FG001|Overall Study|Other|0|||
164225473|NCT01646216|593194079|FG001|Overall Study|Did not complete training|2|||
164225474|NCT01646216|593194078|FG000|Overall Study|Investigator decision|1|||
164225475|NCT01646216|593194079|FG001|Overall Study|Investigator decision|1|||
164225476|NCT03721107|593194080|FG000|Overall Study|Adverse Event|1|||
164225477|NCT03721107|593194081|FG001|Overall Study|Adverse Event|1|||
164225478|NCT03721107|593194082|FG002|Overall Study|Adverse Event|6|||
164225479|NCT03721107|593194083|FG003|Overall Study|Adverse Event|5|||
164225480|NCT03721107|593194080|FG000|Overall Study|Lost to Follow-up|2|||
164225481|NCT03721107|593194081|FG001|Overall Study|Lost to Follow-up|0|||
164225482|NCT03721107|593194082|FG002|Overall Study|Lost to Follow-up|3|||
164225483|NCT03721107|593194083|FG003|Overall Study|Lost to Follow-up|0|||
164330095|NCT05140382|593584844|FG002|Overall Study|Other|1|||
164330096|NCT05140382|593584842|FG000|Overall Study|Progressive disease|20|||
164330097|NCT05140382|593584843|FG001|Overall Study|Progressive disease|1|||
164225484|NCT03721107|593194080|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
164225485|NCT03721107|593194081|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
164330098|NCT05140382|593584844|FG002|Overall Study|Progressive disease|12|||
164330099|NCT05140382|593584842|FG000|Overall Study|Subjective disease progression|2|||
164330100|NCT05140382|593584843|FG001|Overall Study|Subjective disease progression|1|||
164330101|NCT05140382|593584844|FG002|Overall Study|Subjective disease progression|0|||
164330102|NCT05140382|593584842|FG000|Overall Study|Unknown at data cut-off|0|||
164330103|NCT05140382|593584843|FG001|Overall Study|Unknown at data cut-off|0|||
164330104|NCT05140382|593584844|FG002|Overall Study|Unknown at data cut-off|1|||
164330105|NCT05140382|593584842|FG000|Overall Study|Withdrawal by Subject|1|||
164330106|NCT05140382|593584843|FG001|Overall Study|Withdrawal by Subject|0|||
164330107|NCT05140382|593584844|FG002|Overall Study|Withdrawal by Subject|4|||
164330108|NCT05140382|593584842|FG000|Overall Study|Withdrawal of consent|0|||
164330109|NCT05140382|593584843|FG001|Overall Study|Withdrawal of consent|0|||
164330110|NCT05140382|593584844|FG002|Overall Study|Withdrawal of consent|1|||
164330111|NCT05419908|593584845|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
164330112|NCT05419908|593584846|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
164330113|NCT05419908|593584845|FG000|Overall Study|Serious Adverse Event|0|||
164330114|NCT05419908|593584846|FG001|Overall Study|Serious Adverse Event|2|||
164330115|NCT05419908|593584845|FG000|Overall Study|Withdrawal by Subject|2|||
164330116|NCT05419908|593584846|FG001|Overall Study|Withdrawal by Subject|0|||
164330117|NCT05419908|593584845|FG000|Overall Study|Miscellaneous|1|||
164330118|NCT05419908|593584846|FG001|Overall Study|Miscellaneous|1|||
164330119|NCT01659658|593586604|FG000|Overall Study|Withdrawal by Patient|18|||
164330120|NCT01659658|593586605|FG001|Overall Study|Withdrawal by Patient|4|||
164330121|NCT01659658|593586606|FG002|Overall Study|Withdrawal by Patient|2|||
164330122|NCT01659658|593586607|FG003|Overall Study|Withdrawal by Patient|0|||
164330123|NCT01659658|593586608|FG004|Overall Study|Withdrawal by Patient|11|||
164330124|NCT01659658|593586604|FG000|Overall Study|Study Terminated by Sponsor|9|||
164330125|NCT01659658|593586605|FG001|Overall Study|Study Terminated by Sponsor|7|||
164330126|NCT01659658|593586606|FG002|Overall Study|Study Terminated by Sponsor|0|||
164330127|NCT01659658|593586607|FG003|Overall Study|Study Terminated by Sponsor|1|||
164330128|NCT01659658|593586608|FG004|Overall Study|Study Terminated by Sponsor|4|||
164330129|NCT01659658|593586604|FG000|Overall Study|Reason not Specified|61|||
164330130|NCT01659658|593586605|FG001|Overall Study|Reason not Specified|15|||
164330131|NCT01659658|593586606|FG002|Overall Study|Reason not Specified|8|||
164330132|NCT01659658|593586607|FG003|Overall Study|Reason not Specified|1|||
164330133|NCT01659658|593586608|FG004|Overall Study|Reason not Specified|34|||
164330134|NCT01659658|593586604|FG000|Overall Study|Lost to Follow-up|2|||
164330135|NCT01659658|593586605|FG001|Overall Study|Lost to Follow-up|0|||
164330136|NCT01659658|593586606|FG002|Overall Study|Lost to Follow-up|0|||
164330137|NCT01659658|593586607|FG003|Overall Study|Lost to Follow-up|0|||
164330138|NCT01659658|593586608|FG004|Overall Study|Lost to Follow-up|0|||
164330139|NCT01927341|593586609|FG000|Phase 1b|Lost to Follow-up|1|||
164330140|NCT01927341|593586610|FG001|Phase 1b|Lost to Follow-up|0|||
164330141|NCT01927341|593586611|FG002|Phase 1b|Lost to Follow-up|0|||
164330142|NCT01927341|593586612|FG003|Phase 1b|Lost to Follow-up|0|||
164330143|NCT01927341|593586613|FG004|Phase 1b|Lost to Follow-up|0|||
164330144|NCT01927341|593586609|FG000|Phase 1b|Death|2|||
164330145|NCT01927341|593586610|FG001|Phase 1b|Death|0|||
164330146|NCT01927341|593586611|FG002|Phase 1b|Death|0|||
164330147|NCT01927341|593586612|FG003|Phase 1b|Death|0|||
164330148|NCT01927341|593586613|FG004|Phase 1b|Death|0|||
164330149|NCT01927341|593586609|FG000|Phase 1b|Follow-up completed|7|||
164330150|NCT01927341|593586610|FG001|Phase 1b|Follow-up completed|0|||
164330151|NCT01927341|593586611|FG002|Phase 1b|Follow-up completed|0|||
164330152|NCT01927341|593586612|FG003|Phase 1b|Follow-up completed|0|||
164330153|NCT01927341|593586613|FG004|Phase 1b|Follow-up completed|0|||
164330154|NCT01927341|593586609|FG000|Phase 2|Lost to Follow-up|0|||
164330155|NCT01927341|593586610|FG001|Phase 2|Lost to Follow-up|1|||
164330156|NCT01927341|593586611|FG002|Phase 2|Lost to Follow-up|0|||
164330157|NCT01927341|593586612|FG003|Phase 2|Lost to Follow-up|0|||
164330158|NCT01927341|593586613|FG004|Phase 2|Lost to Follow-up|0|||
164330159|NCT01927341|593586609|FG000|Phase 2|Participant withdrew consent|0|||
164330160|NCT01927341|593586610|FG001|Phase 2|Participant withdrew consent|2|||
164330161|NCT01927341|593586611|FG002|Phase 2|Participant withdrew consent|1|||
164330162|NCT01927341|593586612|FG003|Phase 2|Participant withdrew consent|2|||
164330163|NCT01927341|593586613|FG004|Phase 2|Participant withdrew consent|3|||
164330164|NCT01927341|593586609|FG000|Phase 2|Death|0|||
164330165|NCT01927341|593586610|FG001|Phase 2|Death|4|||
164330166|NCT01927341|593586611|FG002|Phase 2|Death|0|||
164330167|NCT01927341|593586612|FG003|Phase 2|Death|3|||
164330168|NCT01927341|593586613|FG004|Phase 2|Death|2|||
164330169|NCT01927341|593586609|FG000|Phase 2|New cancer therapy|0|||
164330170|NCT01927341|593586610|FG001|Phase 2|New cancer therapy|1|||
164330171|NCT01927341|593586611|FG002|Phase 2|New cancer therapy|0|||
164330172|NCT01927341|593586612|FG003|Phase 2|New cancer therapy|4|||
164330173|NCT01927341|593586613|FG004|Phase 2|New cancer therapy|1|||
164330174|NCT01927341|593586609|FG000|Phase 2|Disease progression|0|||
164330175|NCT01927341|593586610|FG001|Phase 2|Disease progression|1|||
164330176|NCT01927341|593586611|FG002|Phase 2|Disease progression|1|||
164330177|NCT01927341|593586612|FG003|Phase 2|Disease progression|1|||
164225486|NCT03721107|593194082|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
164225487|NCT03721107|593194083|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
164225488|NCT03721107|593194080|FG000|Overall Study|Physician Decision|0|||
164225489|NCT03721107|593194081|FG001|Overall Study|Physician Decision|1|||
164225490|NCT03721107|593194082|FG002|Overall Study|Physician Decision|0|||
164225491|NCT03721107|593194083|FG003|Overall Study|Physician Decision|0|||
164225492|NCT03721107|593194080|FG000|Overall Study|Pregnancy|0|||
164225493|NCT03721107|593194081|FG001|Overall Study|Pregnancy|0|||
164225494|NCT03721107|593194082|FG002|Overall Study|Pregnancy|1|||
164225495|NCT03721107|593194083|FG003|Overall Study|Pregnancy|0|||
164225496|NCT03721107|593194080|FG000|Overall Study|Withdrawal by Subject|1|||
164225497|NCT03721107|593194081|FG001|Overall Study|Withdrawal by Subject|1|||
164225498|NCT03721107|593194082|FG002|Overall Study|Withdrawal by Subject|5|||
164225499|NCT03721107|593194083|FG003|Overall Study|Withdrawal by Subject|5|||
164225500|NCT03721107|593194080|FG000|Overall Study|Other|1|||
164225501|NCT03721107|593194081|FG001|Overall Study|Other|0|||
164225502|NCT03721107|593194082|FG002|Overall Study|Other|0|||
164225503|NCT03721107|593194083|FG003|Overall Study|Other|1|||
164225504|NCT02369159|593194086|FG000|Overall Study|Adverse Event|0|||
164225505|NCT02369159|593194087|FG001|Overall Study|Adverse Event|1|||
164225506|NCT02369159|593194086|FG000|Overall Study|Lost to Follow-up|1|||
164225507|NCT02369159|593194087|FG001|Overall Study|Lost to Follow-up|1|||
164225508|NCT02369159|593194086|FG000|Overall Study|Withdrawal by Subject|7|||
164225509|NCT02369159|593194087|FG001|Overall Study|Withdrawal by Subject|0|||
164225510|NCT00563316|593194090|FG000|Overall Study|Adverse Event|2|||
164225511|NCT00563316|593194090|FG000|Overall Study|Physician Decision|1|||
164225512|NCT00563316|593194090|FG000|Overall Study|Lost to Follow-up|2|||
164225513|NCT00563316|593194090|FG000|Overall Study|Death|1|||
164570724|NCT00792298|594455031|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164570725|NCT00792298|594455032|FG002|Treatment Period 1|Withdrawal by Subject|1|||
164570726|NCT00792298|594455033|FG003|Treatment Period 1|Withdrawal by Subject|2|||
164570727|NCT00792298|594455034|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164570728|NCT00792298|594455035|FG005|Treatment Period 1|Withdrawal by Subject|2|||
164570729|NCT00792298|594455036|FG006|Treatment Period 1|Withdrawal by Subject|1|||
164570730|NCT00792298|594455037|FG007|Treatment Period 1|Withdrawal by Subject|0|||
164570731|NCT00792298|594455030|FG000|Treatment Period 1|Lost to Follow-up|0|||
164570732|NCT00792298|594455031|FG001|Treatment Period 1|Lost to Follow-up|0|||
164570733|NCT00792298|594455032|FG002|Treatment Period 1|Lost to Follow-up|0|||
164570734|NCT00792298|594455033|FG003|Treatment Period 1|Lost to Follow-up|0|||
164570735|NCT00792298|594455034|FG004|Treatment Period 1|Lost to Follow-up|0|||
164570736|NCT00792298|594455035|FG005|Treatment Period 1|Lost to Follow-up|0|||
164570737|NCT00792298|594455036|FG006|Treatment Period 1|Lost to Follow-up|1|||
164570738|NCT00792298|594455037|FG007|Treatment Period 1|Lost to Follow-up|0|||
164570739|NCT00792298|594455030|FG000|Treatment Period 1|Physician Decision|0|||
164570740|NCT00792298|594455031|FG001|Treatment Period 1|Physician Decision|0|||
164570741|NCT00792298|594455032|FG002|Treatment Period 1|Physician Decision|0|||
164570742|NCT00792298|594455033|FG003|Treatment Period 1|Physician Decision|1|||
164570743|NCT00792298|594455034|FG004|Treatment Period 1|Physician Decision|0|||
164570744|NCT00792298|594455035|FG005|Treatment Period 1|Physician Decision|0|||
164570745|NCT00792298|594455036|FG006|Treatment Period 1|Physician Decision|1|||
164570746|NCT00792298|594455037|FG007|Treatment Period 1|Physician Decision|0|||
164570747|NCT00792298|594455030|FG000|Treatment Period 1|Protocol Violation|0|||
164570748|NCT00792298|594455031|FG001|Treatment Period 1|Protocol Violation|0|||
164570749|NCT00792298|594455032|FG002|Treatment Period 1|Protocol Violation|0|||
164570750|NCT00792298|594455033|FG003|Treatment Period 1|Protocol Violation|0|||
164570751|NCT00792298|594455034|FG004|Treatment Period 1|Protocol Violation|0|||
164570752|NCT00792298|594455035|FG005|Treatment Period 1|Protocol Violation|0|||
164570753|NCT00792298|594455036|FG006|Treatment Period 1|Protocol Violation|0|||
164570754|NCT00792298|594455037|FG007|Treatment Period 1|Protocol Violation|1|||
164674980|NCT00508651|594834832|FG001|Overall Study|Lost to Follow-up|1|||
164674981|NCT00508651|594834831|FG000|Overall Study|Withdrawal by Subject|1|||
164674982|NCT00508651|594834832|FG001|Overall Study|Withdrawal by Subject|1|||
164674983|NCT03874715|594834837|FG000|Overall Study|Adverse Event|2|||
164674984|NCT03874715|594834838|FG001|Overall Study|Adverse Event|0|||
164674985|NCT03874715|594834837|FG000|Overall Study|Poor compliance to protocol|5|||
164674986|NCT03874715|594834838|FG001|Overall Study|Poor compliance to protocol|1|||
164674987|NCT03874715|594834837|FG000|Overall Study|Withdrawal by Subject|1|||
164674988|NCT03874715|594834838|FG001|Overall Study|Withdrawal by Subject|0|||
164674989|NCT03874715|594834837|FG000|Overall Study|Other-unspecified|1|||
164674990|NCT03874715|594834838|FG001|Overall Study|Other-unspecified|0|||
164674991|NCT00461786|594834839|FG000|Overall Study|Entry Criteria Not Met|2|||
164674992|NCT00461786|594834839|FG000|Overall Study|Inevaluable (Never Treated)|1|||
164674993|NCT00934050|594834840|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
164674994|NCT00934050|594834841|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
164674995|NCT00934050|594834842|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
164674996|NCT00934050|594834843|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
164674997|NCT00934050|594834844|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
164330178|NCT01927341|593586613|FG004|Phase 2|Disease progression|0|||
164330179|NCT01927341|593586609|FG000|Phase 2|Follow-up completed|0|||
164330180|NCT01927341|593586610|FG001|Phase 2|Follow-up completed|6|||
164330181|NCT01927341|593586611|FG002|Phase 2|Follow-up completed|3|||
164330182|NCT01927341|593586612|FG003|Phase 2|Follow-up completed|5|||
164330183|NCT01927341|593586613|FG004|Phase 2|Follow-up completed|2|||
164330184|NCT00674973|593586614|FG000|Overall Study|Insufficient Therapeutic Response|77|||
164330185|NCT00674973|593586615|FG001|Overall Study|Insufficient Therapeutic Response|72|||
164330186|NCT00674973|593586614|FG000|Overall Study|Refused Treatment|1|||
164330187|NCT00674973|593586615|FG001|Overall Study|Refused Treatment|5|||
164330188|NCT00674973|593586614|FG000|Overall Study|Failure to Return|1|||
164330189|NCT00674973|593586615|FG001|Overall Study|Failure to Return|0|||
164330190|NCT00674973|593586614|FG000|Overall Study|Adverse Event|2|||
164330191|NCT00674973|593586615|FG001|Overall Study|Adverse Event|9|||
164330192|NCT00674973|593586614|FG000|Overall Study|Death|19|||
164330193|NCT00674973|593586615|FG001|Overall Study|Death|15|||
164330194|NCT00674973|593586614|FG000|Overall Study|Protocol Violation|0|||
164330195|NCT00674973|593586615|FG001|Overall Study|Protocol Violation|1|||
164330196|NCT00451451|593586616|FG000|Overall Study|Adverse Event|11|||
164330197|NCT00451451|593586617|FG001|Overall Study|Adverse Event|21|||
164330198|NCT00451451|593586618|FG002|Overall Study|Adverse Event|26|||
164330199|NCT00451451|593586619|FG003|Overall Study|Adverse Event|10|||
164330200|NCT00451451|593586616|FG000|Overall Study|Lost to Follow-up|11|||
164330201|NCT00451451|593586617|FG001|Overall Study|Lost to Follow-up|9|||
164330202|NCT00451451|593586618|FG002|Overall Study|Lost to Follow-up|8|||
164330203|NCT00451451|593586619|FG003|Overall Study|Lost to Follow-up|11|||
164674998|NCT00934050|594834845|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
164674999|NCT00934050|594834840|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
164675000|NCT00934050|594834841|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
164675001|NCT00934050|594834842|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
164330204|NCT00451451|593586616|FG000|Overall Study|Consent Withdrawn|14|||
164330205|NCT00451451|593586617|FG001|Overall Study|Consent Withdrawn|9|||
164330206|NCT00451451|593586618|FG002|Overall Study|Consent Withdrawn|17|||
164330207|NCT00451451|593586619|FG003|Overall Study|Consent Withdrawn|17|||
164330208|NCT00451451|593586616|FG000|Overall Study|Investigator Decision|6|||
164330209|NCT00451451|593586617|FG001|Overall Study|Investigator Decision|2|||
164330210|NCT00451451|593586618|FG002|Overall Study|Investigator Decision|1|||
164330211|NCT00451451|593586619|FG003|Overall Study|Investigator Decision|2|||
164330212|NCT00451451|593586616|FG000|Overall Study|Subject Non-Compliance|8|||
164330213|NCT00451451|593586617|FG001|Overall Study|Subject Non-Compliance|4|||
164330214|NCT00451451|593586618|FG002|Overall Study|Subject Non-Compliance|3|||
164330215|NCT00451451|593586619|FG003|Overall Study|Subject Non-Compliance|3|||
164330216|NCT00451451|593586616|FG000|Overall Study|Death|1|||
164330217|NCT00451451|593586617|FG001|Overall Study|Death|0|||
164330218|NCT00451451|593586618|FG002|Overall Study|Death|0|||
164330219|NCT00451451|593586619|FG003|Overall Study|Death|1|||
164675002|NCT00934050|594834843|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
164675003|NCT00934050|594834844|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
164675004|NCT00934050|594834845|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
164330220|NCT00451451|593586616|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
164330221|NCT00451451|593586617|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
164330222|NCT00451451|593586618|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
164330223|NCT00451451|593586619|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
164570755|NCT00792298|594455030|FG000|Washout|Adverse Event|0|||
164570756|NCT00792298|594455031|FG001|Washout|Adverse Event|0|||
164570757|NCT00792298|594455032|FG002|Washout|Adverse Event|0|||
164570758|NCT00792298|594455033|FG003|Washout|Adverse Event|0|||
164570759|NCT00792298|594455034|FG004|Washout|Adverse Event|0|||
164570760|NCT00792298|594455035|FG005|Washout|Adverse Event|1|||
164570761|NCT00792298|594455036|FG006|Washout|Adverse Event|0|||
164570762|NCT00792298|594455037|FG007|Washout|Adverse Event|0|||
164570763|NCT00792298|594455030|FG000|Washout|Withdrawal by Subject|0|||
164570764|NCT00792298|594455031|FG001|Washout|Withdrawal by Subject|0|||
164570765|NCT00792298|594455032|FG002|Washout|Withdrawal by Subject|1|||
164570766|NCT00792298|594455033|FG003|Washout|Withdrawal by Subject|0|||
164570767|NCT00792298|594455034|FG004|Washout|Withdrawal by Subject|0|||
164570768|NCT00792298|594455035|FG005|Washout|Withdrawal by Subject|1|||
164330224|NCT00084838|593586622|FG000|Overall Study|Death|1|||
164330225|NCT00084838|593586622|FG000|Overall Study|Adverse Event|2|||
164330226|NCT00084838|593586622|FG000|Overall Study|Withdrawal by Subject|1|||
164330227|NCT00084838|593586622|FG000|Overall Study|Progressive Disease|4|||
164330228|NCT00084838|593586622|FG000|Overall Study|Pt Non-Compliance|1|||
164330229|NCT00084838|593586622|FG000|Overall Study|Ineligible|4|||
164330230|NCT00518687|593586623|FG000|Overall Study|Adverse Event|201|||
164330231|NCT00518687|593586624|FG001|Overall Study|Adverse Event|177|||
164330232|NCT00518687|593586623|FG000|Overall Study|Lost to Follow-up|144|||
164330233|NCT00518687|593586624|FG001|Overall Study|Lost to Follow-up|155|||
164330234|NCT00518687|593586623|FG000|Overall Study|Physician Decision|42|||
164570769|NCT00792298|594455036|FG006|Washout|Withdrawal by Subject|0|||
164330235|NCT00518687|593586624|FG001|Overall Study|Physician Decision|48|||
164330236|NCT00518687|593586623|FG000|Overall Study|Progressive disease|2|||
164330237|NCT00518687|593586624|FG001|Overall Study|Progressive disease|2|||
164330238|NCT00518687|593586623|FG000|Overall Study|Protocol Violation|8|||
164330239|NCT00518687|593586624|FG001|Overall Study|Protocol Violation|10|||
164330240|NCT00518687|593586623|FG000|Overall Study|Study terminated by sponsor|930|||
164330241|NCT00518687|593586624|FG001|Overall Study|Study terminated by sponsor|918|||
164330242|NCT00518687|593586623|FG000|Overall Study|Withdrawal by Subject|110|||
164330243|NCT00518687|593586624|FG001|Overall Study|Withdrawal by Subject|110|||
164330244|NCT01442038|593586627|FG000|Overall Study|Death|35|||
164330245|NCT01442038|593586628|FG001|Overall Study|Death|29|||
164330246|NCT01442038|593586627|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
164330247|NCT01442038|593586628|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
164330248|NCT01442038|593586627|FG000|Overall Study|Participant Withdrew Consent|137|||
164330249|NCT01442038|593586628|FG001|Overall Study|Participant Withdrew Consent|102|||
164330250|NCT01442038|593586627|FG000|Overall Study|Lost to Follow-up|37|||
164330251|NCT01442038|593586628|FG001|Overall Study|Lost to Follow-up|51|||
164330252|NCT01442038|593586627|FG000|Overall Study|Adverse Event|26|||
164330253|NCT01442038|593586628|FG001|Overall Study|Adverse Event|15|||
164330254|NCT01442038|593586627|FG000|Overall Study|Protocol Deviation|9|||
164330255|NCT01442038|593586628|FG001|Overall Study|Protocol Deviation|20|||
164330256|NCT01442038|593586627|FG000|Overall Study|Investigator's Discretion|13|||
164330257|NCT01442038|593586628|FG001|Overall Study|Investigator's Discretion|16|||
164330258|NCT01442038|593586627|FG000|Overall Study|Study Terminated By Sponsor|2|||
164330259|NCT01442038|593586628|FG001|Overall Study|Study Terminated By Sponsor|3|||
164330260|NCT00089284|593586629|FG000|Overall Study|Adverse event before starting treatment|0|||
164330261|NCT00089284|593586630|FG001|Overall Study|Adverse event before starting treatment|0|||
164330262|NCT00089284|593586631|FG002|Overall Study|Adverse event before starting treatment|0|||
164330263|NCT00089284|593586632|FG003|Overall Study|Adverse event before starting treatment|0|||
164330264|NCT00089284|593586633|FG004|Overall Study|Adverse event before starting treatment|0|||
164330265|NCT00089284|593586634|FG005|Overall Study|Adverse event before starting treatment|0|||
164330266|NCT00089284|593586635|FG006|Overall Study|Adverse event before starting treatment|1|||
164330267|NCT00137631|593586636|FG000|Overall Study|Lost to Follow-up|37|||
164330268|NCT00137631|593586637|FG001|Overall Study|Lost to Follow-up|41|||
164330269|NCT02611960|593586638|FG000|Overall Study|Adverse Event|7|||
164330270|NCT02611960|593586639|FG001|Overall Study|Adverse Event|8|||
164330271|NCT02611960|593586638|FG000|Overall Study|Death|98|||
164330272|NCT02611960|593586639|FG001|Overall Study|Death|92|||
164330273|NCT02611960|593586638|FG000|Overall Study|Withdrawal by Subject|1|||
164330274|NCT02611960|593586639|FG001|Overall Study|Withdrawal by Subject|5|||
164330275|NCT02611960|593586638|FG000|Overall Study|Sponsor Decision|11|||
164330276|NCT02611960|593586639|FG001|Overall Study|Sponsor Decision|11|||
164330277|NCT01092507|593586640|FG000|Overall Study|Withdrawal by Subject|2|||
164330278|NCT01092507|593586641|FG001|Overall Study|Withdrawal by Subject|0|||
164330279|NCT00085709|593586653|FG000|Overall Study|Adverse Event|8|||
164330280|NCT00085709|593586654|FG001|Overall Study|Adverse Event|0|||
164330281|NCT00085709|593586653|FG000|Overall Study|Death|8|||
164330282|NCT00085709|593586654|FG001|Overall Study|Death|2|||
164330283|NCT00085709|593586653|FG000|Overall Study|Refusal unrelated to adverse events|1|||
164330284|NCT00085709|593586654|FG001|Overall Study|Refusal unrelated to adverse events|2|||
164330285|NCT00085709|593586653|FG000|Overall Study|Progression|3|||
164330286|NCT00085709|593586654|FG001|Overall Study|Progression|4|||
164330287|NCT00085709|593586653|FG000|Overall Study|Not protocol specified|12|||
164330288|NCT00085709|593586654|FG001|Overall Study|Not protocol specified|22|||
164330289|NCT00085709|593586653|FG000|Overall Study|Not eligible|19|||
164330290|NCT00085709|593586654|FG001|Overall Study|Not eligible|19|||
164330291|NCT00085709|593586653|FG000|Overall Study|Withdrawal by Subject|2|||
164330292|NCT00085709|593586654|FG001|Overall Study|Withdrawal by Subject|1|||
164330293|NCT04131556|593586655|FG000|Overall Study|Adverse Event|1|||
164330294|NCT04131556|593586655|FG000|Overall Study|Withdrawal by Subject|1|||
164330295|NCT01229371|593586656|FG000|Overall Study|Withdrawal by Subject|0|||
164330296|NCT01229371|593586657|FG001|Overall Study|Withdrawal by Subject|1|||
164330297|NCT01229371|593586658|FG002|Overall Study|Withdrawal by Subject|0|||
164330298|NCT01229371|593586659|FG003|Overall Study|Withdrawal by Subject|0|||
164330299|NCT04622735|593586660|FG000|Overall Study|Lost to Follow-up|1|||
164330300|NCT04622735|593586661|FG001|Overall Study|Lost to Follow-up|2|||
164330301|NCT04622735|593586662|FG002|Overall Study|Lost to Follow-up|1|||
164330302|NCT04622735|593586660|FG000|Overall Study|Adverse Event|0|||
164330303|NCT04622735|593586661|FG001|Overall Study|Adverse Event|0|||
164330304|NCT04622735|593586662|FG002|Overall Study|Adverse Event|1|||
164330305|NCT04622735|593586660|FG000|Overall Study|Protocol Violation|1|||
164330306|NCT04622735|593586661|FG001|Overall Study|Protocol Violation|0|||
164330307|NCT04622735|593586662|FG002|Overall Study|Protocol Violation|0|||
164330308|NCT05314478|593586663|FG000|Overall Study|Physician Decision|1|||
164330309|NCT00145600|593586668|FG000|Overall Study|Death|1|||
164330310|NCT00145600|593586669|FG001|Overall Study|Death|2|||
164675005|NCT00934050|594834840|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
164675006|NCT00934050|594834841|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
164675007|NCT00934050|594834842|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
164675008|NCT00934050|594834843|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
164675009|NCT00934050|594834844|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
164675010|NCT00934050|594834845|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
164675011|NCT00934050|594834840|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
164675012|NCT00934050|594834841|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
164675013|NCT00934050|594834842|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
164675014|NCT00934050|594834843|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
164675015|NCT00934050|594834844|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
164675016|NCT00934050|594834845|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
164675017|NCT00934050|594834840|FG000|Enrolled After 15 Dec 2009|Death|0|||
164675018|NCT00934050|594834841|FG001|Enrolled After 15 Dec 2009|Death|0|||
164675019|NCT00934050|594834842|FG002|Enrolled After 15 Dec 2009|Death|0|||
164225514|NCT00563316|593194090|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
164225515|NCT00563316|593194090|FG000|Overall Study|Other|1|||
164225516|NCT02991859|593194094|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225517|NCT02991859|593194095|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
164225518|NCT02991859|593194096|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225519|NCT02991859|593194097|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225520|NCT02991859|593194098|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
164225521|NCT02991859|593194099|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225522|NCT02991859|593194100|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225523|NCT02991859|593194101|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225524|NCT02991859|593194102|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225525|NCT02991859|593194103|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225526|NCT02991859|593194104|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225527|NCT02991859|593194105|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225528|NCT02991859|593194106|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225529|NCT02991859|593194107|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225530|NCT02991859|593194108|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225531|NCT02991859|593194109|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225532|NCT02991859|593194110|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225533|NCT02991859|593194094|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225534|NCT02991859|593194095|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225535|NCT02991859|593194096|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225536|NCT02991859|593194097|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225537|NCT02991859|593194098|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225538|NCT02991859|593194099|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225539|NCT02991859|593194100|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225540|NCT02991859|593194101|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225541|NCT02991859|593194102|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225542|NCT02991859|593194103|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225543|NCT02991859|593194104|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225544|NCT02991859|593194105|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225545|NCT02991859|593194106|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
164225546|NCT02991859|593194107|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
164225547|NCT02991859|593194108|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225548|NCT02991859|593194109|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225549|NCT02991859|593194110|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225550|NCT02991859|593194094|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225551|NCT02991859|593194095|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225552|NCT02991859|593194096|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225553|NCT02991859|593194097|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225554|NCT02991859|593194098|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225555|NCT02991859|593194099|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
164225556|NCT02991859|593194100|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225557|NCT02991859|593194101|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225558|NCT02991859|593194102|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225559|NCT02991859|593194103|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225560|NCT02991859|593194104|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225561|NCT02991859|593194105|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164330311|NCT00145600|593586670|FG002|Overall Study|Death|2|||
164675020|NCT00934050|594834843|FG003|Enrolled After 15 Dec 2009|Death|0|||
164675021|NCT00934050|594834844|FG004|Enrolled After 15 Dec 2009|Death|0|||
164225562|NCT02991859|593194106|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225563|NCT02991859|593194107|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225564|NCT02991859|593194108|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225565|NCT02991859|593194109|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225566|NCT02991859|593194110|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225567|NCT02991859|593194094|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164225568|NCT02991859|593194095|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164225569|NCT02991859|593194096|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164225570|NCT02991859|593194097|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164330312|NCT00145600|593586671|FG003|Overall Study|Death|6|||
164330313|NCT00145600|593586668|FG000|Overall Study|Ineligible|3|||
164675022|NCT00934050|594834845|FG005|Enrolled After 15 Dec 2009|Death|1|||
164675023|NCT00934050|594834840|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
164675024|NCT00934050|594834841|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
164675025|NCT00934050|594834842|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
164675026|NCT00934050|594834843|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
164330314|NCT00145600|593586669|FG001|Overall Study|Ineligible|0|||
164330315|NCT00145600|593586670|FG002|Overall Study|Ineligible|1|||
164330316|NCT00145600|593586671|FG003|Overall Study|Ineligible|5|||
164330317|NCT00145600|593586668|FG000|Overall Study|Lost to Follow-up|2|||
164330318|NCT00145600|593586669|FG001|Overall Study|Lost to Follow-up|6|||
164330319|NCT00145600|593586670|FG002|Overall Study|Lost to Follow-up|2|||
164330320|NCT00145600|593586671|FG003|Overall Study|Lost to Follow-up|4|||
164330321|NCT00145600|593586668|FG000|Overall Study|Noncompliance|1|||
164330322|NCT00145600|593586669|FG001|Overall Study|Noncompliance|0|||
164330323|NCT00145600|593586670|FG002|Overall Study|Noncompliance|0|||
164330324|NCT00145600|593586671|FG003|Overall Study|Noncompliance|0|||
164330325|NCT00145600|593586668|FG000|Overall Study|Withdrawal by Subject|1|||
164330326|NCT00145600|593586669|FG001|Overall Study|Withdrawal by Subject|2|||
164330327|NCT00145600|593586670|FG002|Overall Study|Withdrawal by Subject|0|||
164330328|NCT00145600|593586671|FG003|Overall Study|Withdrawal by Subject|1|||
164330329|NCT00736879|593586675|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
164330330|NCT00736879|593586676|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
164330331|NCT00736879|593586677|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
164330332|NCT00736879|593586678|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
164330333|NCT00736879|593586675|FG000|Double Blind Treatment Period|Adverse Event|0|||
164330334|NCT00736879|593586676|FG001|Double Blind Treatment Period|Adverse Event|1|||
164330335|NCT00736879|593586677|FG002|Double Blind Treatment Period|Adverse Event|1|||
164330336|NCT00736879|593586678|FG003|Double Blind Treatment Period|Adverse Event|0|||
164330337|NCT00736879|593586675|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
164330338|NCT00736879|593586676|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
164330339|NCT00736879|593586677|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
164330340|NCT00736879|593586678|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
164330341|NCT00736879|593586675|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
164330342|NCT00736879|593586676|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
164330343|NCT00736879|593586677|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
164330344|NCT00736879|593586678|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
164330345|NCT00736879|593586675|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
164330346|NCT00736879|593586676|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
164330347|NCT00736879|593586677|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
164330348|NCT00736879|593586678|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
164330349|NCT00736879|593586675|FG000|Double Blind Treatment Period|No longer met criteria|0|||
164330350|NCT00736879|593586676|FG001|Double Blind Treatment Period|No longer met criteria|1|||
164330351|NCT00736879|593586677|FG002|Double Blind Treatment Period|No longer met criteria|0|||
164330352|NCT00736879|593586678|FG003|Double Blind Treatment Period|No longer met criteria|0|||
164330353|NCT00736879|593586675|FG000|Double Blind Treatment Period|non-specified|0|||
164330354|NCT00736879|593586676|FG001|Double Blind Treatment Period|non-specified|1|||
164330355|NCT00736879|593586677|FG002|Double Blind Treatment Period|non-specified|0|||
164330356|NCT00736879|593586678|FG003|Double Blind Treatment Period|non-specified|0|||
164330357|NCT00736879|593586675|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
164675027|NCT00934050|594834844|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
164675028|NCT00934050|594834845|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
164675029|NCT00934050|594834840|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
164330358|NCT00736879|593586676|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
164675030|NCT00934050|594834841|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
164675031|NCT00934050|594834842|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
164675032|NCT00934050|594834843|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
164675033|NCT00934050|594834844|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
164675034|NCT00934050|594834845|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
164675035|NCT03616535|594834849|FG000|Overall Study|Death|2|||
164675036|NCT03616535|594834850|FG001|Overall Study|Death|0|||
164225571|NCT02991859|593194098|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164675037|NCT03616535|594834851|FG002|Overall Study|Death|0|||
164675038|NCT03616535|594834852|FG003|Overall Study|Death|1|||
164675039|NCT03616535|594834849|FG000|Overall Study|Lost to Follow-up|2|||
164675040|NCT03616535|594834850|FG001|Overall Study|Lost to Follow-up|1|||
164675041|NCT03616535|594834851|FG002|Overall Study|Lost to Follow-up|0|||
164675042|NCT03616535|594834852|FG003|Overall Study|Lost to Follow-up|2|||
164330359|NCT00736879|593586677|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
164330360|NCT00736879|593586678|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
164330361|NCT00736879|593586675|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
164330362|NCT00736879|593586676|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
164330363|NCT00736879|593586677|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
164330364|NCT00736879|593586678|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
164330365|NCT03583164|593586685|FG000|Overall Study|Death in Main Phase|35|||
164330366|NCT03583164|593586685|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
164330367|NCT03583164|593586685|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
164330368|NCT03583164|593586685|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
164330369|NCT03583164|593586685|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
164330370|NCT03583164|593586685|FG000|Overall Study|Physician decision in Main Phase|1|||
164330371|NCT03583164|593586685|FG000|Overall Study|Physician decision in Extended Phase|2|||
164330372|NCT03583164|593586685|FG000|Overall Study|Death in Extended Phase|13|||
164330373|NCT03583164|593586685|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
164330374|NCT03583164|593586685|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
164330375|NCT03583164|593586685|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
164330376|NCT03583164|593586685|FG000|Overall Study|Treatment failure in Main Phase|2|||
164330377|NCT03583164|593586685|FG000|Overall Study|Treatment failure in Extended Phase|4|||
164330378|NCT03583164|593586685|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
164330379|NCT03583164|593586685|FG000|Overall Study|Other not specified reason in Main Phase|2|||
164330380|NCT02869438|593586693|FG000|Overall Study|Lost to Follow-up|1|||
164330381|NCT02869438|593586694|FG001|Overall Study|Lost to Follow-up|0|||
164330382|NCT02869438|593586693|FG000|Overall Study|Adverse Event|1|||
164330383|NCT02869438|593586694|FG001|Overall Study|Adverse Event|0|||
164330384|NCT02869438|593586693|FG000|Overall Study|Withdrawal by Subject|1|||
164330385|NCT02869438|593586694|FG001|Overall Study|Withdrawal by Subject|2|||
164330386|NCT00573248|593586701|FG000|Overall Study|scheduling conflicts|15|||
164330387|NCT00573248|593586702|FG001|Overall Study|scheduling conflicts|11|||
164330388|NCT05323656|593586703|FG000|Overall Study|Still On-Treatment|6|||
164330389|NCT05323656|593586704|FG001|Overall Study|Still On-Treatment|6|||
164330390|NCT05323656|593586703|FG000|Overall Study|Progressive Disease|15|||
164330391|NCT05323656|593586704|FG001|Overall Study|Progressive Disease|14|||
164330392|NCT05323656|593586703|FG000|Overall Study|Adverse Event|2|||
164330393|NCT05323656|593586704|FG001|Overall Study|Adverse Event|3|||
164330394|NCT05323656|593586703|FG000|Overall Study|Death|1|||
164330395|NCT05323656|593586704|FG001|Overall Study|Death|2|||
164330396|NCT05323656|593586703|FG000|Overall Study|Withdrawal by Subject|1|||
164330397|NCT05323656|593586704|FG001|Overall Study|Withdrawal by Subject|0|||
164330398|NCT05323656|593586703|FG000|Overall Study|Clinical disease progression|0|||
164330399|NCT05323656|593586704|FG001|Overall Study|Clinical disease progression|1|||
164330400|NCT05323656|593586703|FG000|Overall Study|Patient and Investigator decision|1|||
164330401|NCT05323656|593586704|FG001|Overall Study|Patient and Investigator decision|0|||
164330402|NCT05323656|593586703|FG000|Overall Study|Physician Decision|0|||
164330403|NCT05323656|593586704|FG001|Overall Study|Physician Decision|1|||
164330404|NCT03880461|593586705|FG000|Overall Study|Determined ineligible after enrollment|45|||
164330405|NCT03880461|593586706|FG001|Overall Study|Determined ineligible after enrollment|44|||
164330406|NCT03880461|593586705|FG000|Overall Study|No weight measurement after enrollment|24|||
164330407|NCT03880461|593586706|FG001|Overall Study|No weight measurement after enrollment|17|||
164330408|NCT03953183|593586708|FG000|Overall Study|Physician Decision|0|||
164330409|NCT03953183|593586709|FG001|Overall Study|Physician Decision|1|||
164330410|NCT03953183|593586708|FG000|Overall Study|Withdrawal by Subject|0|||
164330411|NCT03953183|593586709|FG001|Overall Study|Withdrawal by Subject|1|||
164330412|NCT01115803|593586723|FG000|Overall Study|Withdrawal by Subject|0|||
164330413|NCT01115803|593586724|FG001|Overall Study|Withdrawal by Subject|0|||
164330414|NCT01115803|593586725|FG002|Overall Study|Withdrawal by Subject|0|||
164330415|NCT01115803|593586726|FG003|Overall Study|Withdrawal by Subject|0|||
164330416|NCT01115803|593586727|FG004|Overall Study|Withdrawal by Subject|0|||
164330417|NCT01115803|593586728|FG005|Overall Study|Withdrawal by Subject|0|||
164421043|NCT02138747|593911087|FG003|Treatment Period 1|Withdrawal by Subject|3|||
164421044|NCT02138747|593911084|FG000|Treatment Period 1|Other - Miscellaneous|2|||
164675043|NCT03616535|594834849|FG000|Overall Study|Withdrawal by Subject|1|||
164675044|NCT03616535|594834850|FG001|Overall Study|Withdrawal by Subject|2|||
164675045|NCT03616535|594834851|FG002|Overall Study|Withdrawal by Subject|5|||
164675046|NCT03616535|594834852|FG003|Overall Study|Withdrawal by Subject|1|||
164675047|NCT03616535|594834849|FG000|Overall Study|Not specified or change in eligibility|2|||
164330418|NCT01115803|593586729|FG006|Overall Study|Withdrawal by Subject|1|||
164330419|NCT01115803|593586723|FG000|Overall Study|Lost to Follow-up|0|||
164330420|NCT01115803|593586724|FG001|Overall Study|Lost to Follow-up|0|||
164570770|NCT00792298|594455037|FG007|Washout|Withdrawal by Subject|0|||
164570771|NCT00792298|594455030|FG000|Treatment Period 2|Lack of Efficacy|0|||
164570772|NCT00792298|594455031|FG001|Treatment Period 2|Lack of Efficacy|0|||
164570773|NCT00792298|594455032|FG002|Treatment Period 2|Lack of Efficacy|0|||
164570774|NCT00792298|594455033|FG003|Treatment Period 2|Lack of Efficacy|0|||
164330421|NCT01115803|593586725|FG002|Overall Study|Lost to Follow-up|1|||
164330422|NCT01115803|593586726|FG003|Overall Study|Lost to Follow-up|0|||
164330423|NCT01115803|593586727|FG004|Overall Study|Lost to Follow-up|0|||
164330424|NCT01115803|593586728|FG005|Overall Study|Lost to Follow-up|0|||
164330425|NCT01115803|593586729|FG006|Overall Study|Lost to Follow-up|0|||
164330426|NCT01115803|593586723|FG000|Overall Study|Progressive Disease during Cycle1|0|||
164330427|NCT01115803|593586724|FG001|Overall Study|Progressive Disease during Cycle1|0|||
164330428|NCT01115803|593586725|FG002|Overall Study|Progressive Disease during Cycle1|0|||
164330429|NCT01115803|593586726|FG003|Overall Study|Progressive Disease during Cycle1|0|||
164330430|NCT01115803|593586727|FG004|Overall Study|Progressive Disease during Cycle1|0|||
164330431|NCT01115803|593586728|FG005|Overall Study|Progressive Disease during Cycle1|0|||
164330432|NCT01115803|593586729|FG006|Overall Study|Progressive Disease during Cycle1|1|||
164330433|NCT03063203|593586730|FG000|Overall Study|Chose alternative therapy|3|||
164330434|NCT03063203|593586730|FG000|Overall Study|Death|2|||
164330435|NCT03063203|593586730|FG000|Overall Study|Disease progression|4|||
164330436|NCT03063203|593586730|FG000|Overall Study|Physician Decision|5|||
164330437|NCT04718103|593586731|FG000|Overall Study|Adverse Event|1|||
164330438|NCT04718103|593586732|FG001|Overall Study|Adverse Event|1|||
164330439|NCT04718103|593586731|FG000|Overall Study|Lack of Efficacy|4|||
164330440|NCT04718103|593586732|FG001|Overall Study|Lack of Efficacy|1|||
164330441|NCT04718103|593586731|FG000|Overall Study|Lost to Follow-up|2|||
164330442|NCT04718103|593586732|FG001|Overall Study|Lost to Follow-up|2|||
164330443|NCT04718103|593586731|FG000|Overall Study|Physician Decision|2|||
164330444|NCT04718103|593586732|FG001|Overall Study|Physician Decision|0|||
164330445|NCT04718103|593586731|FG000|Overall Study|Pregnancy|0|||
164330446|NCT04718103|593586732|FG001|Overall Study|Pregnancy|1|||
164330447|NCT04718103|593586731|FG000|Overall Study|Withdrawal by Subject|10|||
164330448|NCT04718103|593586732|FG001|Overall Study|Withdrawal by Subject|6|||
164330449|NCT04718103|593586731|FG000|Overall Study|Randomized, not treated|4|||
164330450|NCT04718103|593586732|FG001|Overall Study|Randomized, not treated|1|||
164675048|NCT03616535|594834850|FG001|Overall Study|Not specified or change in eligibility|3|||
164675049|NCT03616535|594834851|FG002|Overall Study|Not specified or change in eligibility|3|||
164675050|NCT03616535|594834852|FG003|Overall Study|Not specified or change in eligibility|1|||
164675051|NCT01083693|594834855|FG000|Overall Study|Adverse Event|1|||
164330451|NCT04718103|593586731|FG000|Overall Study|GCP violations|7|||
164330452|NCT04718103|593586732|FG001|Overall Study|GCP violations|5|||
164330453|NCT02273739|593586733|FG000|Overall Study|Progression of Disease|3|||
164330454|NCT02273739|593586734|FG001|Overall Study|Progression of Disease|4|||
164330455|NCT02273739|593586735|FG002|Overall Study|Progression of Disease|5|||
164330456|NCT02273739|593586736|FG003|Overall Study|Progression of Disease|2|||
164330457|NCT02273739|593586733|FG000|Overall Study|Death|0|||
164330458|NCT02273739|593586734|FG001|Overall Study|Death|0|||
164330459|NCT02273739|593586735|FG002|Overall Study|Death|0|||
164330460|NCT02273739|593586736|FG003|Overall Study|Death|2|||
164330461|NCT02273739|593586733|FG000|Overall Study|Adverse Event|0|||
164330462|NCT02273739|593586734|FG001|Overall Study|Adverse Event|0|||
164330463|NCT02273739|593586735|FG002|Overall Study|Adverse Event|0|||
164330464|NCT02273739|593586736|FG003|Overall Study|Adverse Event|1|||
164330465|NCT02273739|593586733|FG000|Overall Study|Withdrawal by Subject|0|||
164330466|NCT02273739|593586734|FG001|Overall Study|Withdrawal by Subject|0|||
164330467|NCT02273739|593586735|FG002|Overall Study|Withdrawal by Subject|2|||
164330468|NCT02273739|593586736|FG003|Overall Study|Withdrawal by Subject|1|||
164330469|NCT02273739|593586733|FG000|Overall Study|Physician Decision|0|||
164330470|NCT02273739|593586734|FG001|Overall Study|Physician Decision|0|||
164330471|NCT02273739|593586735|FG002|Overall Study|Physician Decision|0|||
164330472|NCT02273739|593586736|FG003|Overall Study|Physician Decision|1|||
164330473|NCT02280473|593586738|FG000|Overall Study|Adverse Event|1|||
164330474|NCT02280473|593586739|FG001|Overall Study|Adverse Event|1|||
164330475|NCT02280473|593586738|FG000|Overall Study|Lack of Efficacy|0|||
164330476|NCT02280473|593586739|FG001|Overall Study|Lack of Efficacy|1|||
164330477|NCT02280473|593586738|FG000|Overall Study|Lost to Follow-up|0|||
164330478|NCT02280473|593586739|FG001|Overall Study|Lost to Follow-up|1|||
164330479|NCT02393690|593586740|FG000|Overall Study|Ineligible|0|||
164330480|NCT02393690|593586741|FG001|Overall Study|Ineligible|1|||
164330481|NCT05298306|593586742|FG000|Overall Study|Physician Decision|0|||
164330482|NCT05298306|593586743|FG001|Overall Study|Physician Decision|0|||
164330483|NCT05298306|593586744|FG002|Overall Study|Physician Decision|0|||
164330484|NCT05298306|593586745|FG003|Overall Study|Physician Decision|1|||
164330485|NCT05298306|593586746|FG004|Overall Study|Physician Decision|0|||
164330486|NCT05298306|593586747|FG005|Overall Study|Physician Decision|0|||
164330487|NCT05080660|593586749|FG000|Overall Study|Adverse Event|4|||
164330488|NCT05080660|593586750|FG001|Overall Study|Adverse Event|0|||
164330489|NCT05080660|593586749|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
164330490|NCT05080660|593586750|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
164330491|NCT05080660|593586749|FG000|Overall Study|Physician Decision|1|||
164330492|NCT05080660|593586750|FG001|Overall Study|Physician Decision|0|||
164330493|NCT05080660|593586749|FG000|Overall Study|Protocol Deviation|2|||
164330494|NCT05080660|593586750|FG001|Overall Study|Protocol Deviation|0|||
164330495|NCT05080660|593586749|FG000|Overall Study|Withdrawal by Subject|5|||
164330496|NCT05080660|593586750|FG001|Overall Study|Withdrawal by Subject|2|||
164330497|NCT00237185|593586751|FG000|Core|Adverse Event|3|||
164330498|NCT00237185|593586752|FG001|Core|Adverse Event|4|||
164330499|NCT00237185|593586751|FG000|Core|Abnormal laboratory value|0|||
164330500|NCT00237185|593586752|FG001|Core|Abnormal laboratory value|4|||
164330501|NCT00237185|593586751|FG000|Core|Abnormal test procedure results|1|||
164330502|NCT00237185|593586752|FG001|Core|Abnormal test procedure results|0|||
164330503|NCT00237185|593586751|FG000|Core|Lack of Efficacy|30|||
164330504|NCT00237185|593586752|FG001|Core|Lack of Efficacy|23|||
164330505|NCT00237185|593586751|FG000|Core|Protocol Violation|1|||
164330506|NCT00237185|593586752|FG001|Core|Protocol Violation|1|||
164330507|NCT00237185|593586751|FG000|Core|Withdrawal by Subject|4|||
164330508|NCT00237185|593586752|FG001|Core|Withdrawal by Subject|4|||
164330509|NCT00237185|593586751|FG000|Core|Administrative problems|0|||
164330510|NCT00237185|593586752|FG001|Core|Administrative problems|1|||
164330511|NCT00237185|593586751|FG000|Core|Death|4|||
164330512|NCT00237185|593586752|FG001|Core|Death|0|||
164330513|NCT00237185|593586751|FG000|Core|Determined ineligible post randomization|1|||
164330514|NCT00237185|593586752|FG001|Core|Determined ineligible post randomization|0|||
164330515|NCT00237185|593586751|FG000|Extension|Adverse Event|1|||
164330516|NCT00237185|593586752|FG001|Extension|Adverse Event|0|||
164675052|NCT01083693|594834856|FG001|Overall Study|Adverse Event|1|||
164330517|NCT00237185|593586751|FG000|Extension|Abnormal laboratory value|0|||
164330518|NCT00237185|593586752|FG001|Extension|Abnormal laboratory value|1|||
164330519|NCT00237185|593586751|FG000|Extension|Lack of Efficacy|9|||
164330520|NCT00237185|593586752|FG001|Extension|Lack of Efficacy|14|||
164330521|NCT00237185|593586751|FG000|Extension|Condition no longer required study drug|0|||
164330522|NCT00237185|593586752|FG001|Extension|Condition no longer required study drug|1|||
164330523|NCT00237185|593586751|FG000|Extension|Withdrawal by Subject|3|||
164330524|NCT00237185|593586752|FG001|Extension|Withdrawal by Subject|2|||
164675053|NCT01083693|594834857|FG002|Overall Study|Adverse Event|0|||
164675054|NCT01083693|594834855|FG000|Overall Study|Lost to Follow-up|2|||
164675055|NCT01083693|594834856|FG001|Overall Study|Lost to Follow-up|0|||
164675056|NCT01083693|594834857|FG002|Overall Study|Lost to Follow-up|2|||
164675057|NCT01083693|594834855|FG000|Overall Study|Lack of effectiveness|13|||
164675058|NCT01083693|594834856|FG001|Overall Study|Lack of effectiveness|2|||
164675059|NCT01083693|594834857|FG002|Overall Study|Lack of effectiveness|2|||
164675060|NCT01083693|594834855|FG000|Overall Study|Patient Moved|0|||
164675061|NCT01083693|594834856|FG001|Overall Study|Patient Moved|1|||
164675062|NCT01083693|594834857|FG002|Overall Study|Patient Moved|0|||
164675063|NCT01083693|594834855|FG000|Overall Study|Complete remission|0|||
164675064|NCT01083693|594834856|FG001|Overall Study|Complete remission|1|||
164675065|NCT01083693|594834857|FG002|Overall Study|Complete remission|0|||
164675066|NCT01083693|594834855|FG000|Overall Study|Other medical condition/surgery|1|||
164675067|NCT01083693|594834856|FG001|Overall Study|Other medical condition/surgery|1|||
164675068|NCT01083693|594834857|FG002|Overall Study|Other medical condition/surgery|0|||
164675069|NCT01083693|594834855|FG000|Overall Study|Withdrawal by Subject|3|||
164675070|NCT01083693|594834856|FG001|Overall Study|Withdrawal by Subject|0|||
164675071|NCT01083693|594834857|FG002|Overall Study|Withdrawal by Subject|2|||
164675072|NCT01083693|594834855|FG000|Overall Study|Reason unknown|0|||
164675073|NCT01083693|594834856|FG001|Overall Study|Reason unknown|0|||
164675074|NCT01083693|594834857|FG002|Overall Study|Reason unknown|1|||
164675075|NCT00834418|594834858|FG000|Overall Study|Adverse Event|0|||
164675076|NCT00834418|594834859|FG001|Overall Study|Adverse Event|2|||
164675077|NCT01705574|594834860|FG000|Double-Blind Phase|Lost to Follow-up|12|||
164675078|NCT01705574|594834861|FG001|Double-Blind Phase|Lost to Follow-up|16|||
164675079|NCT01705574|594834862|FG002|Double-Blind Phase|Lost to Follow-up|0|||
164675080|NCT01705574|594834863|FG003|Double-Blind Phase|Lost to Follow-up|0|||
164675081|NCT01705574|594834860|FG000|Double-Blind Phase|Adverse Event|3|||
164675082|NCT01705574|594834861|FG001|Double-Blind Phase|Adverse Event|10|||
164675083|NCT01705574|594834862|FG002|Double-Blind Phase|Adverse Event|0|||
164675084|NCT01705574|594834863|FG003|Double-Blind Phase|Adverse Event|0|||
164675085|NCT01705574|594834860|FG000|Double-Blind Phase|Withdrew Consent|8|||
164675086|NCT01705574|594834861|FG001|Double-Blind Phase|Withdrew Consent|5|||
164675087|NCT01705574|594834862|FG002|Double-Blind Phase|Withdrew Consent|0|||
164675088|NCT01705574|594834863|FG003|Double-Blind Phase|Withdrew Consent|0|||
164675089|NCT01705574|594834860|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
164675090|NCT01705574|594834861|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
164675091|NCT01705574|594834862|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
164570775|NCT00792298|594455034|FG004|Treatment Period 2|Lack of Efficacy|1|||
164570776|NCT00792298|594455035|FG005|Treatment Period 2|Lack of Efficacy|0|||
164570777|NCT00792298|594455036|FG006|Treatment Period 2|Lack of Efficacy|0|||
164570778|NCT00792298|594455037|FG007|Treatment Period 2|Lack of Efficacy|0|||
164570779|NCT00792298|594455030|FG000|Treatment Period 2|Physician Decision|0|||
164570780|NCT00792298|594455031|FG001|Treatment Period 2|Physician Decision|0|||
164570781|NCT00792298|594455032|FG002|Treatment Period 2|Physician Decision|0|||
164570782|NCT00792298|594455033|FG003|Treatment Period 2|Physician Decision|0|||
164570783|NCT00792298|594455034|FG004|Treatment Period 2|Physician Decision|0|||
164570784|NCT00792298|594455035|FG005|Treatment Period 2|Physician Decision|0|||
164570785|NCT00792298|594455036|FG006|Treatment Period 2|Physician Decision|1|||
164570786|NCT00792298|594455037|FG007|Treatment Period 2|Physician Decision|0|||
164570787|NCT00792298|594455030|FG000|Treatment Period 2|Pregnancy|0|||
164570788|NCT00792298|594455031|FG001|Treatment Period 2|Pregnancy|0|||
164570789|NCT00792298|594455032|FG002|Treatment Period 2|Pregnancy|1|||
164570790|NCT00792298|594455033|FG003|Treatment Period 2|Pregnancy|0|||
164570791|NCT00792298|594455034|FG004|Treatment Period 2|Pregnancy|0|||
164570792|NCT00792298|594455035|FG005|Treatment Period 2|Pregnancy|0|||
164570793|NCT00792298|594455036|FG006|Treatment Period 2|Pregnancy|0|||
164570794|NCT00792298|594455037|FG007|Treatment Period 2|Pregnancy|0|||
164570795|NCT00792298|594455030|FG000|Treatment Period 2|Withdrawal by Subject|1|||
164570796|NCT00792298|594455031|FG001|Treatment Period 2|Withdrawal by Subject|1|||
164570797|NCT00792298|594455032|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164570798|NCT00792298|594455033|FG003|Treatment Period 2|Withdrawal by Subject|2|||
164570799|NCT00792298|594455034|FG004|Treatment Period 2|Withdrawal by Subject|1|||
164570800|NCT00792298|594455035|FG005|Treatment Period 2|Withdrawal by Subject|0|||
164570801|NCT00792298|594455036|FG006|Treatment Period 2|Withdrawal by Subject|0|||
164570802|NCT00792298|594455037|FG007|Treatment Period 2|Withdrawal by Subject|2|||
164675092|NCT01705574|594834863|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
164675093|NCT01705574|594834860|FG000|Double-Blind Phase|Pregnancy|1|||
164675094|NCT01705574|594834861|FG001|Double-Blind Phase|Pregnancy|1|||
164675095|NCT01705574|594834862|FG002|Double-Blind Phase|Pregnancy|0|||
164675096|NCT01705574|594834863|FG003|Double-Blind Phase|Pregnancy|0|||
164675097|NCT01705574|594834860|FG000|Double-Blind Phase|Protocol Violation|1|||
164675098|NCT01705574|594834861|FG001|Double-Blind Phase|Protocol Violation|0|||
164675099|NCT01705574|594834862|FG002|Double-Blind Phase|Protocol Violation|0|||
164675100|NCT01705574|594834863|FG003|Double-Blind Phase|Protocol Violation|0|||
164675101|NCT01705574|594834860|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
164675102|NCT01705574|594834861|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
164675103|NCT01705574|594834862|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
164675104|NCT01705574|594834863|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
164675105|NCT01705574|594834860|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
164675106|NCT01705574|594834861|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
164675107|NCT01705574|594834862|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
164675108|NCT01705574|594834863|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
164675109|NCT01705574|594834860|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
164675110|NCT01705574|594834861|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
164675111|NCT01705574|594834862|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
164675112|NCT01705574|594834863|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
164675113|NCT01705574|594834860|FG000|Open-Label Extension Phase|Adverse Event|3|||
164675114|NCT01705574|594834861|FG001|Open-Label Extension Phase|Adverse Event|0|||
164675115|NCT01705574|594834862|FG002|Open-Label Extension Phase|Adverse Event|0|||
164675116|NCT01705574|594834863|FG003|Open-Label Extension Phase|Adverse Event|1|||
164675117|NCT01705574|594834860|FG000|Open-Label Extension Phase|Death|2|||
164675118|NCT01705574|594834861|FG001|Open-Label Extension Phase|Death|0|||
164675119|NCT01705574|594834862|FG002|Open-Label Extension Phase|Death|1|||
164675120|NCT01705574|594834863|FG003|Open-Label Extension Phase|Death|0|||
164675121|NCT01705574|594834860|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
164675122|NCT01705574|594834861|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
164675123|NCT01705574|594834862|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
164675124|NCT01705574|594834863|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
164675125|NCT01705574|594834860|FG000|Open-Label Extension Phase|Physician Decision|0|||
164675126|NCT01705574|594834861|FG001|Open-Label Extension Phase|Physician Decision|0|||
164675127|NCT01705574|594834862|FG002|Open-Label Extension Phase|Physician Decision|2|||
164675128|NCT01705574|594834863|FG003|Open-Label Extension Phase|Physician Decision|0|||
164675129|NCT01705574|594834860|FG000|Open-Label Extension Phase|Pregnancy|0|||
164675130|NCT01705574|594834861|FG001|Open-Label Extension Phase|Pregnancy|0|||
164675131|NCT01705574|594834862|FG002|Open-Label Extension Phase|Pregnancy|1|||
164675132|NCT01705574|594834863|FG003|Open-Label Extension Phase|Pregnancy|1|||
164675133|NCT00777023|594834864|FG000|Overall Study|Adverse Event|15|||
164675134|NCT00777023|594834865|FG001|Overall Study|Adverse Event|21|||
164675135|NCT00777023|594834866|FG002|Overall Study|Adverse Event|8|||
164675136|NCT00777023|594834864|FG000|Overall Study|Lack of Efficacy|1|||
164675137|NCT00777023|594834865|FG001|Overall Study|Lack of Efficacy|0|||
164675138|NCT00777023|594834866|FG002|Overall Study|Lack of Efficacy|14|||
164675139|NCT00777023|594834864|FG000|Overall Study|Protocol Violation|2|||
164675140|NCT00777023|594834865|FG001|Overall Study|Protocol Violation|1|||
164675141|NCT00777023|594834866|FG002|Overall Study|Protocol Violation|1|||
164675142|NCT00777023|594834864|FG000|Overall Study|Lost to Follow-up|2|||
164675143|NCT00777023|594834865|FG001|Overall Study|Lost to Follow-up|3|||
164675144|NCT00777023|594834866|FG002|Overall Study|Lost to Follow-up|3|||
164675145|NCT00777023|594834864|FG000|Overall Study|Death|0|||
164675146|NCT00777023|594834865|FG001|Overall Study|Death|1|||
164675147|NCT00777023|594834866|FG002|Overall Study|Death|0|||
164675148|NCT00777023|594834864|FG000|Overall Study|Withdrawal by Subject|7|||
164675149|NCT00777023|594834865|FG001|Overall Study|Withdrawal by Subject|7|||
164675150|NCT00777023|594834866|FG002|Overall Study|Withdrawal by Subject|8|||
164675151|NCT00777023|594834864|FG000|Overall Study|Missing data|1|||
164675152|NCT00777023|594834865|FG001|Overall Study|Missing data|1|||
164675153|NCT00777023|594834866|FG002|Overall Study|Missing data|0|||
164675154|NCT00777023|594834864|FG000|Overall Study|Reasons not specified|4|||
164675155|NCT00777023|594834865|FG001|Overall Study|Reasons not specified|4|||
164675156|NCT00777023|594834866|FG002|Overall Study|Reasons not specified|2|||
164675157|NCT00777023|594834864|FG000|Overall Study|Last dose date unknown|3|||
164675158|NCT00777023|594834865|FG001|Overall Study|Last dose date unknown|3|||
164675159|NCT00777023|594834866|FG002|Overall Study|Last dose date unknown|1|||
164675160|NCT02472366|594834867|FG000|Overall Study|Lost to Follow-up|1|||
164675161|NCT02472366|594834868|FG001|Overall Study|Lost to Follow-up|0|||
164675162|NCT04274686|594834869|FG000|Overall Study|Physician Decision|1|||
164330525|NCT00237185|593586751|FG000|Extension|Lost to Follow-up|1|||
164330526|NCT00237185|593586752|FG001|Extension|Lost to Follow-up|0|||
164330527|NCT00237185|593586751|FG000|Extension|Administrative problems|1|||
164330528|NCT00237185|593586752|FG001|Extension|Administrative problems|0|||
164330529|NCT00237185|593586751|FG000|Extension|Death|1|||
164330530|NCT00237185|593586752|FG001|Extension|Death|1|||
164330531|NCT02204007|593586753|FG000|Overall Study|Surgery Canceled|1|||
164330532|NCT02204007|593586754|FG001|Overall Study|Surgery Canceled|1|||
164330533|NCT03194490|593586755|FG000|Overall Study|Lost to Follow-up|1|||
164330534|NCT03194490|593586756|FG001|Overall Study|Lost to Follow-up|3|||
164330535|NCT03194490|593586755|FG000|Overall Study|participant developed specific neck pain|1|||
164330536|NCT03194490|593586756|FG001|Overall Study|participant developed specific neck pain|0|||
164330537|NCT03911843|593586757|FG000|Overall Study|Adverse Event|2|||
164330538|NCT03911843|593586758|FG001|Overall Study|Adverse Event|0|||
164330539|NCT03911843|593586757|FG000|Overall Study|Protocol Violation|2|||
164330540|NCT03911843|593586758|FG001|Overall Study|Protocol Violation|0|||
164330541|NCT03911843|593586757|FG000|Overall Study|Lost to Follow-up|0|||
164330542|NCT03911843|593586758|FG001|Overall Study|Lost to Follow-up|1|||
164330543|NCT02059005|593586761|FG000|Overall Study|Death|1|||
164330544|NCT02059005|593586762|FG001|Overall Study|Death|3|||
164330545|NCT02059005|593586761|FG000|Overall Study|Lost to Follow-up|19|||
164330546|NCT02059005|593586762|FG001|Overall Study|Lost to Follow-up|19|||
164330547|NCT02059005|593586761|FG000|Overall Study|Incarceration|0|||
164330548|NCT02059005|593586762|FG001|Overall Study|Incarceration|1|||
164330549|NCT02059005|593586761|FG000|Overall Study|Inpatient|0|||
164330550|NCT02059005|593586762|FG001|Overall Study|Inpatient|1|||
164330551|NCT02750943|593586765|FG000|Overall Study|Lost to Follow-up|1|||
164330552|NCT02750943|593586766|FG001|Overall Study|Lost to Follow-up|2|||
164330553|NCT02750943|593586765|FG000|Overall Study|Withdrawal by Subject|5|||
164330554|NCT02750943|593586766|FG001|Overall Study|Withdrawal by Subject|7|||
164330555|NCT00171054|593586767|FG000|Overall Study|Protocol Violation|1|||
164330556|NCT00171054|593586768|FG001|Overall Study|Protocol Violation|2|||
164330557|NCT00171054|593586767|FG000|Overall Study|Patient withdrew consent|1|||
164330558|NCT00171054|593586768|FG001|Overall Study|Patient withdrew consent|0|||
164330559|NCT00171054|593586767|FG000|Overall Study|Lost to Follow-up|0|||
164330560|NCT00171054|593586768|FG001|Overall Study|Lost to Follow-up|1|||
164330561|NCT00171054|593586767|FG000|Overall Study|Adverse Event|8|||
164330562|NCT00171054|593586768|FG001|Overall Study|Adverse Event|8|||
164570803|NCT02649634|594455038|FG000|Overall Study|Withdrawal by Subject|3|||
164570804|NCT02649634|594455039|FG001|Overall Study|Withdrawal by Subject|5|||
164570805|NCT02649634|594455038|FG000|Overall Study|Lost to Follow-up|0|||
164570806|NCT02649634|594455039|FG001|Overall Study|Lost to Follow-up|1|||
164570807|NCT00763009|594455042|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
164570808|NCT01111604|594455043|FG000|Overall Study|Lost to Follow-up|0|||
164570809|NCT01111604|594455044|FG001|Overall Study|Lost to Follow-up|0|||
164570810|NCT01111604|594455045|FG002|Overall Study|Lost to Follow-up|1|||
164570811|NCT01111604|594455043|FG000|Overall Study|Withdrew Consent|3|||
164570812|NCT01111604|594455044|FG001|Overall Study|Withdrew Consent|0|||
164570813|NCT01111604|594455045|FG002|Overall Study|Withdrew Consent|2|||
164570814|NCT01111604|594455043|FG000|Overall Study|Withdrawal by Subject|2|||
164570815|NCT01111604|594455044|FG001|Overall Study|Withdrawal by Subject|0|||
164570816|NCT01111604|594455045|FG002|Overall Study|Withdrawal by Subject|0|||
164570817|NCT01111604|594455043|FG000|Overall Study|Death|1|||
164570818|NCT01111604|594455044|FG001|Overall Study|Death|0|||
164570819|NCT01111604|594455045|FG002|Overall Study|Death|0|||
164570820|NCT01111604|594455043|FG000|Overall Study|Met Exclusion Criteria|2|||
164570821|NCT01111604|594455044|FG001|Overall Study|Met Exclusion Criteria|0|||
164570822|NCT01111604|594455045|FG002|Overall Study|Met Exclusion Criteria|0|||
164570823|NCT01355289|594455047|FG000|Core Study|Adverse Event, Non-Fatal|1|||
164570824|NCT01355289|594455048|FG001|Core Study|Adverse Event, Non-Fatal|0|||
164570825|NCT01355289|594455049|FG002|Core Study|Adverse Event, Non-Fatal|0|||
164570826|NCT01355289|594455050|FG003|Core Study|Adverse Event, Non-Fatal|0|||
164570827|NCT01355289|594455051|FG004|Core Study|Adverse Event, Non-Fatal|0|||
164570828|NCT01355289|594455047|FG000|Core Study|Inadequate Therapeutic Effect|0|||
164570829|NCT01355289|594455048|FG001|Core Study|Inadequate Therapeutic Effect|0|||
164570830|NCT01355289|594455049|FG002|Core Study|Inadequate Therapeutic Effect|0|||
164570831|NCT01355289|594455050|FG003|Core Study|Inadequate Therapeutic Effect|1|||
164570832|NCT01355289|594455051|FG004|Core Study|Inadequate Therapeutic Effect|0|||
164570833|NCT01355289|594455047|FG000|Core Study|Other|0|||
164570834|NCT01355289|594455048|FG001|Core Study|Other|0|||
164330563|NCT00171054|593586767|FG000|Overall Study|Condition no longer required study drug|0|||
164330564|NCT00171054|593586768|FG001|Overall Study|Condition no longer required study drug|1|||
164330565|NCT04597918|593586769|FG000|Overall Study|Withdrawal by Subject|6|||
164330566|NCT04597918|593586769|FG000|Overall Study|Lost to Follow-up|3|||
164330567|NCT04597918|593586769|FG000|Overall Study|Death|1|||
164330568|NCT04382755|593586778|FG000|Overall Study|Withdrawal by Subject|1|||
164570835|NCT01355289|594455049|FG002|Core Study|Other|0|||
164570836|NCT01355289|594455050|FG003|Core Study|Other|1|||
164570837|NCT01355289|594455051|FG004|Core Study|Other|0|||
164570838|NCT01355289|594455047|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
164330569|NCT04382755|593586779|FG001|Overall Study|Withdrawal by Subject|0|||
164330570|NCT04382755|593586778|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
164330571|NCT04382755|593586779|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
164330572|NCT04382755|593586778|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
164330573|NCT04382755|593586779|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
164330574|NCT04041700|593586784|FG000|Overall Study|Pregnancy|1|||
164330575|NCT04041700|593586784|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
164330576|NCT03120624|593586785|FG000|Overall Study|Withdrawal by Subject|0|||
164330577|NCT03120624|593586786|FG001|Overall Study|Withdrawal by Subject|1|||
164330578|NCT03120624|593586787|FG002|Overall Study|Withdrawal by Subject|0|||
164330579|NCT03120624|593586788|FG003|Overall Study|Withdrawal by Subject|0|||
164330580|NCT03120624|593586789|FG004|Overall Study|Withdrawal by Subject|0|||
164330581|NCT03120624|593586790|FG005|Overall Study|Withdrawal by Subject|0|||
164330582|NCT03120624|593586791|FG006|Overall Study|Withdrawal by Subject|0|||
164330583|NCT03120624|593586792|FG007|Overall Study|Withdrawal by Subject|0|||
164330584|NCT01104701|593588227|FG000|Overall Study|Withdrawal by Subject|0|||
164330585|NCT01104701|593588228|FG001|Overall Study|Withdrawal by Subject|1|||
164330586|NCT01104701|593588229|FG002|Overall Study|Withdrawal by Subject|2|||
164330587|NCT01104701|593588230|FG003|Overall Study|Withdrawal by Subject|1|||
164330588|NCT01104701|593588227|FG000|Overall Study|Adverse Event|0|||
164330589|NCT01104701|593588228|FG001|Overall Study|Adverse Event|0|||
164330590|NCT01104701|593588229|FG002|Overall Study|Adverse Event|0|||
164675163|NCT04274686|594834870|FG001|Overall Study|Physician Decision|0|||
164675164|NCT01273805|594834873|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
164675165|NCT01273805|594834874|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
164675166|NCT02647944|594834875|FG000|Overall Study|Withdrawal by Subject|0|||
164675167|NCT02647944|594834876|FG001|Overall Study|Withdrawal by Subject|3|||
164675168|NCT02647944|594834875|FG000|Overall Study|Adverse Event|2|||
164675169|NCT02647944|594834876|FG001|Overall Study|Adverse Event|0|||
164675170|NCT02909907|594834880|FG000|Overall Study|Withdrawal by Subject|0|||
164675171|NCT02909907|594834881|FG001|Overall Study|Withdrawal by Subject|1|||
164675172|NCT01513174|594834882|FG000|Overall Study|Inclusion Error|1|||
164675173|NCT01513174|594834883|FG001|Overall Study|Inclusion Error|7|||
164675174|NCT01513174|594834882|FG000|Overall Study|Not receive study treatment|3|||
164675175|NCT01513174|594834883|FG001|Overall Study|Not receive study treatment|1|||
164675176|NCT01200810|594834889|FG000|Overall Study|Physician Decision|1|||
164330591|NCT01104701|593588230|FG003|Overall Study|Adverse Event|1|||
164330592|NCT01104701|593588227|FG000|Overall Study|Physician Decision|0|||
164330593|NCT01104701|593588228|FG001|Overall Study|Physician Decision|2|||
164330594|NCT01104701|593588229|FG002|Overall Study|Physician Decision|0|||
164330595|NCT01104701|593588230|FG003|Overall Study|Physician Decision|0|||
164330596|NCT00891462|593588231|FG000|Overall Study|Withdrawal by Subject|9|||
164330597|NCT00891462|593588232|FG001|Overall Study|Withdrawal by Subject|6|||
164330598|NCT00891462|593588233|FG002|Overall Study|Withdrawal by Subject|7|||
164330599|NCT00891462|593588231|FG000|Overall Study|Adverse Event|7|||
164330600|NCT00891462|593588232|FG001|Overall Study|Adverse Event|8|||
164330601|NCT00891462|593588233|FG002|Overall Study|Adverse Event|7|||
164330602|NCT00891462|593588231|FG000|Overall Study|Lack of Efficacy|10|||
164330603|NCT00891462|593588232|FG001|Overall Study|Lack of Efficacy|5|||
164330604|NCT00891462|593588233|FG002|Overall Study|Lack of Efficacy|1|||
164330605|NCT00891462|593588231|FG000|Overall Study|COPD exacerbation|7|||
164330606|NCT00891462|593588232|FG001|Overall Study|COPD exacerbation|4|||
164330607|NCT00891462|593588233|FG002|Overall Study|COPD exacerbation|1|||
164330608|NCT00891462|593588231|FG000|Overall Study|Other Reason|2|||
164330609|NCT00891462|593588232|FG001|Overall Study|Other Reason|5|||
164330610|NCT00891462|593588233|FG002|Overall Study|Other Reason|3|||
164330611|NCT00891462|593588231|FG000|Overall Study|Protocol Violation|2|||
164330612|NCT00891462|593588232|FG001|Overall Study|Protocol Violation|1|||
164330613|NCT00891462|593588233|FG002|Overall Study|Protocol Violation|3|||
164330614|NCT00891462|593588231|FG000|Overall Study|Inclusion/exclusion criteria|0|||
164675177|NCT01200810|594834890|FG001|Overall Study|Physician Decision|0|||
164675178|NCT01200810|594834889|FG000|Overall Study|Withdrawal by Subject|1|||
164675179|NCT01200810|594834890|FG001|Overall Study|Withdrawal by Subject|2|||
164675180|NCT01200810|594834889|FG000|Overall Study|Sponsor stopped making study drug|3|||
164675181|NCT01200810|594834890|FG001|Overall Study|Sponsor stopped making study drug|3|||
164330615|NCT00891462|593588232|FG001|Overall Study|Inclusion/exclusion criteria|2|||
164330616|NCT00891462|593588233|FG002|Overall Study|Inclusion/exclusion criteria|2|||
164330617|NCT00891462|593588231|FG000|Overall Study|Lost to Follow-up|0|||
164570839|NCT01355289|594455048|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
164570840|NCT01355289|594455049|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
164570841|NCT01355289|594455050|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
164570842|NCT01355289|594455051|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
164570843|NCT01355289|594455047|FG000|Open Label Extension|Lost to Follow-up|0|||
164570844|NCT01355289|594455048|FG001|Open Label Extension|Lost to Follow-up|0|||
164570845|NCT01355289|594455049|FG002|Open Label Extension|Lost to Follow-up|0|||
164570846|NCT01355289|594455050|FG003|Open Label Extension|Lost to Follow-up|0|||
164570847|NCT01355289|594455051|FG004|Open Label Extension|Lost to Follow-up|1|||
164570848|NCT01355289|594455047|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
164570849|NCT01355289|594455048|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
164570850|NCT01355289|594455049|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
164570851|NCT01355289|594455050|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
164570852|NCT01355289|594455051|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
164570853|NCT01355289|594455047|FG000|Open Label Extension|Other|0|||
164570854|NCT01355289|594455048|FG001|Open Label Extension|Other|0|||
164570855|NCT01355289|594455049|FG002|Open Label Extension|Other|0|||
164570856|NCT01355289|594455050|FG003|Open Label Extension|Other|0|||
164570857|NCT01355289|594455051|FG004|Open Label Extension|Other|3|||
164570858|NCT01614964|594455060|FG000|Overall Study|Withdrawal by Subject|2|||
164570859|NCT01614964|594455061|FG001|Overall Study|Withdrawal by Subject|0|||
164570860|NCT01614964|594455060|FG000|Overall Study|Lost to Follow-up|3|||
164570861|NCT01614964|594455061|FG001|Overall Study|Lost to Follow-up|0|||
164570862|NCT01360996|594455066|FG000|Overall Study|Withdrawal by Subject|4|||
164570863|NCT01360996|594455067|FG001|Overall Study|Withdrawal by Subject|3|||
164570864|NCT01360996|594455068|FG002|Overall Study|Withdrawal by Subject|2|||
164570865|NCT01360996|594455066|FG000|Overall Study|Noncompliant|2|||
164570866|NCT01360996|594455067|FG001|Overall Study|Noncompliant|0|||
164570867|NCT01360996|594455068|FG002|Overall Study|Noncompliant|0|||
164570868|NCT03377634|594455069|FG000|Study Period|Adverse Event|1|||
164570869|NCT03377634|594455070|FG001|Study Period|Adverse Event|0|||
164570870|NCT03377634|594455069|FG000|Study Period|Withdrawal by Subject|1|||
164570871|NCT03377634|594455070|FG001|Study Period|Withdrawal by Subject|0|||
164570872|NCT01454076|594455071|FG000|Overall Study|Other|2|||
164570873|NCT01454076|594455072|FG001|Overall Study|Other|0|||
164570874|NCT01454076|594455073|FG002|Overall Study|Other|0|||
164570875|NCT01454076|594455074|FG003|Overall Study|Other|1|||
164570876|NCT01454076|594455075|FG004|Overall Study|Other|2|||
164570877|NCT01454076|594455071|FG000|Overall Study|Withdrawal by Subject|3|||
164570878|NCT01454076|594455072|FG001|Overall Study|Withdrawal by Subject|4|||
164570879|NCT01454076|594455073|FG002|Overall Study|Withdrawal by Subject|2|||
164570880|NCT01454076|594455074|FG003|Overall Study|Withdrawal by Subject|1|||
164570881|NCT01454076|594455075|FG004|Overall Study|Withdrawal by Subject|2|||
164570882|NCT01454076|594455071|FG000|Overall Study|Adverse Event|8|||
164570883|NCT01454076|594455072|FG001|Overall Study|Adverse Event|2|||
164570884|NCT01454076|594455073|FG002|Overall Study|Adverse Event|7|||
164570885|NCT01454076|594455074|FG003|Overall Study|Adverse Event|0|||
164570886|NCT01454076|594455075|FG004|Overall Study|Adverse Event|2|||
164570887|NCT00291551|594455081|FG000|Overall Study|Death|7|||
164570888|NCT00291551|594455081|FG000|Overall Study|Withdrawal by Subject|6|||
164570889|NCT02452762|594455082|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
164570890|NCT02452762|594455083|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
164570891|NCT02452762|594455082|FG000|Overall Study|Withdrawal by Subject|1|||
164570892|NCT02452762|594455083|FG001|Overall Study|Withdrawal by Subject|0|||
164570893|NCT03682120|594455084|FG000|Overall Study|Lost to Follow-up|11|||
164570894|NCT03682120|594455085|FG001|Overall Study|Lost to Follow-up|4|||
164570895|NCT03682120|594455086|FG002|Overall Study|Lost to Follow-up|5|||
164570896|NCT03682120|594455087|FG003|Overall Study|Lost to Follow-up|2|||
164570897|NCT03682120|594455084|FG000|Overall Study|Physician Decision|1|||
164570898|NCT03682120|594455085|FG001|Overall Study|Physician Decision|0|||
164570899|NCT03682120|594455086|FG002|Overall Study|Physician Decision|0|||
164570900|NCT03682120|594455087|FG003|Overall Study|Physician Decision|0|||
164570901|NCT03682120|594455084|FG000|Overall Study|Withdrawal by Subject|1|||
164570902|NCT03682120|594455085|FG001|Overall Study|Withdrawal by Subject|2|||
164570903|NCT03682120|594455086|FG002|Overall Study|Withdrawal by Subject|3|||
164570904|NCT03682120|594455087|FG003|Overall Study|Withdrawal by Subject|0|||
164570905|NCT03682120|594455084|FG000|Overall Study|Death|0|||
164570906|NCT03682120|594455085|FG001|Overall Study|Death|1|||
164330618|NCT00891462|593588232|FG001|Overall Study|Lost to Follow-up|2|||
164330619|NCT00891462|593588233|FG002|Overall Study|Lost to Follow-up|0|||
164570907|NCT03682120|594455086|FG002|Overall Study|Death|0|||
164570908|NCT03682120|594455087|FG003|Overall Study|Death|0|||
164570909|NCT03682120|594455084|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
164675182|NCT02576938|594834894|FG000|Overall Study|Adverse Event|5|||
164570910|NCT03682120|594455085|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
164330620|NCT00423722|593588234|FG000|Overall Study|Death|4|||
164330621|NCT00423722|593588235|FG001|Overall Study|Death|4|||
164330622|NCT00423722|593588234|FG000|Overall Study|Declined to participate|2|||
164330623|NCT00423722|593588235|FG001|Overall Study|Declined to participate|3|||
164330624|NCT00423722|593588234|FG000|Overall Study|Unable to complete questionnaires|4|||
164330625|NCT00423722|593588235|FG001|Overall Study|Unable to complete questionnaires|4|||
164330626|NCT00423722|593588234|FG000|Overall Study|Withdrawal by Subject|4|||
164330627|NCT00423722|593588235|FG001|Overall Study|Withdrawal by Subject|2|||
164330628|NCT00215683|593588236|FG000|Overall Study|Adverse Event|15|||
164330629|NCT00215683|593588237|FG001|Overall Study|Adverse Event|16|||
164330630|NCT00215683|593588238|FG002|Overall Study|Adverse Event|15|||
164330631|NCT00215683|593588236|FG000|Overall Study|Lack of Efficacy|5|||
164225572|NCT02991859|593194099|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164225573|NCT02991859|593194100|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164330632|NCT00215683|593588237|FG001|Overall Study|Lack of Efficacy|1|||
164330633|NCT00215683|593588238|FG002|Overall Study|Lack of Efficacy|2|||
164330634|NCT00215683|593588236|FG000|Overall Study|Lost to Follow-up|0|||
164330635|NCT00215683|593588237|FG001|Overall Study|Lost to Follow-up|2|||
164225574|NCT02991859|593194101|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164225575|NCT02991859|593194102|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164225576|NCT02991859|593194103|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
164225577|NCT02991859|593194104|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164330636|NCT00215683|593588238|FG002|Overall Study|Lost to Follow-up|1|||
164570911|NCT03682120|594455086|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
164225578|NCT02991859|593194105|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164225579|NCT02991859|593194106|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164225580|NCT02991859|593194107|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164225581|NCT02991859|593194108|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164225582|NCT02991859|593194109|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164225583|NCT02991859|593194110|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164225584|NCT02991859|593194094|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225585|NCT02991859|593194095|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225586|NCT02991859|593194096|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225587|NCT02991859|593194097|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225588|NCT02991859|593194098|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225589|NCT02991859|593194099|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225590|NCT02991859|593194100|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225591|NCT02991859|593194101|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225592|NCT02991859|593194102|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
164225593|NCT02991859|593194103|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225594|NCT02991859|593194104|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225595|NCT02991859|593194105|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225596|NCT02991859|593194106|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225597|NCT02991859|593194107|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225598|NCT02991859|593194108|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225599|NCT02991859|593194109|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225600|NCT02991859|593194110|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225601|NCT01514422|593194118|FG000|Overall Study|Lost to Follow-up|1|||
164225602|NCT03511209|593194119|FG000|Overall Study|Withdrawal by Subject|2|||
164225603|NCT03511209|593194120|FG001|Overall Study|Withdrawal by Subject|4|||
164225604|NCT03511209|593194119|FG000|Overall Study|Death|1|||
164225605|NCT03511209|593194120|FG001|Overall Study|Death|0|||
164225606|NCT03511209|593194119|FG000|Overall Study|Lost to Follow-up|0|||
164225607|NCT03511209|593194120|FG001|Overall Study|Lost to Follow-up|2|||
164570912|NCT03682120|594455087|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
164570913|NCT03898063|594455088|FG000|Overall Study|Withdrawal by Subject|10|||
164570914|NCT03898063|594455089|FG001|Overall Study|Withdrawal by Subject|8|||
164570915|NCT01889602|594455091|FG000|First Intervention|Adverse Event|1|||
164570916|NCT01889602|594455092|FG001|First Intervention|Adverse Event|1|||
164570917|NCT01889602|594455093|FG002|First Intervention|Adverse Event|1|||
164570918|NCT01889602|594455091|FG000|First Intervention|Protocol Violation|0|||
164675183|NCT02576938|594834895|FG001|Overall Study|Adverse Event|3|||
164225608|NCT00562861|593194121|FG000|Overall Study|Adverse Event|1|||
164225609|NCT00562861|593194122|FG001|Overall Study|Adverse Event|1|||
164225610|NCT00562861|593194121|FG000|Overall Study|Lack of Efficacy|5|||
164330637|NCT00215683|593588236|FG000|Overall Study|Withdrawal by Subject|9|||
164330638|NCT00215683|593588237|FG001|Overall Study|Withdrawal by Subject|4|||
164330639|NCT00215683|593588238|FG002|Overall Study|Withdrawal by Subject|13|||
164570919|NCT01889602|594455092|FG001|First Intervention|Protocol Violation|1|||
164225611|NCT00562861|593194122|FG001|Overall Study|Lack of Efficacy|5|||
164225612|NCT00562861|593194121|FG000|Overall Study|noncompliance, moved|7|||
164570920|NCT01889602|594455093|FG002|First Intervention|Protocol Violation|1|||
164225613|NCT00562861|593194122|FG001|Overall Study|noncompliance, moved|2|||
164225614|NCT00562861|593194121|FG000|Overall Study|Lost to Follow-up|7|||
164225615|NCT00562861|593194122|FG001|Overall Study|Lost to Follow-up|3|||
164225616|NCT00655356|593194123|FG000|Overall Study|Withdrawal by Subject|3|||
164225617|NCT00655356|593194124|FG001|Overall Study|Withdrawal by Subject|4|||
164225618|NCT00655356|593194123|FG000|Overall Study|Sponsor Request|10|||
164225619|NCT00655356|593194124|FG001|Overall Study|Sponsor Request|4|||
164225620|NCT00655356|593194123|FG000|Overall Study|Adverse Event|1|||
164225621|NCT00655356|593194124|FG001|Overall Study|Adverse Event|1|||
164225622|NCT00655356|593194123|FG000|Overall Study|Protocol Violation|2|||
164225623|NCT00655356|593194124|FG001|Overall Study|Protocol Violation|1|||
164330640|NCT00215683|593588236|FG000|Overall Study|Physician Decision|0|||
164330641|NCT00215683|593588237|FG001|Overall Study|Physician Decision|0|||
164330642|NCT00215683|593588238|FG002|Overall Study|Physician Decision|1|||
164330643|NCT00215683|593588236|FG000|Overall Study|Difficult to attend visits|0|||
164330644|NCT00215683|593588237|FG001|Overall Study|Difficult to attend visits|1|||
164330645|NCT00215683|593588238|FG002|Overall Study|Difficult to attend visits|0|||
164330646|NCT00215683|593588236|FG000|Overall Study|No study drug available|0|||
164330647|NCT00215683|593588237|FG001|Overall Study|No study drug available|1|||
164330648|NCT00215683|593588238|FG002|Overall Study|No study drug available|0|||
164330649|NCT00215683|593588236|FG000|Overall Study|Intermittent therapy required|0|||
164330650|NCT00215683|593588237|FG001|Overall Study|Intermittent therapy required|1|||
164330651|NCT00215683|593588238|FG002|Overall Study|Intermittent therapy required|0|||
164330652|NCT02437513|593588240|FG000|Overall Study|Withdrawal by Subject|2|||
164330653|NCT00595465|593588241|FG000|Overall Study|Adverse Event|4|||
164330654|NCT00595465|593588242|FG001|Overall Study|Adverse Event|3|||
164330655|NCT00595465|593588243|FG002|Overall Study|Adverse Event|3|||
164330656|NCT00595465|593588241|FG000|Overall Study|Pregnancy|0|||
164330657|NCT00595465|593588242|FG001|Overall Study|Pregnancy|0|||
164330658|NCT00595465|593588243|FG002|Overall Study|Pregnancy|1|||
164330659|NCT00595465|593588241|FG000|Overall Study|Protocol Violation|2|||
164330660|NCT00595465|593588242|FG001|Overall Study|Protocol Violation|1|||
164330661|NCT00595465|593588243|FG002|Overall Study|Protocol Violation|0|||
164330662|NCT00595465|593588241|FG000|Overall Study|Lost to Follow-up|0|||
164330663|NCT00595465|593588242|FG001|Overall Study|Lost to Follow-up|0|||
164330664|NCT00595465|593588243|FG002|Overall Study|Lost to Follow-up|2|||
164330665|NCT00595465|593588241|FG000|Overall Study|administrative reason|0|||
164330666|NCT00595465|593588242|FG001|Overall Study|administrative reason|0|||
164330667|NCT00595465|593588243|FG002|Overall Study|administrative reason|1|||
164330668|NCT00107783|593588244|FG000|Overall Study|Adverse Event|0|||
164330669|NCT00107783|593588245|FG001|Overall Study|Adverse Event|2|||
164330670|NCT00107783|593588244|FG000|Overall Study|Death|0|||
164330671|NCT00107783|593588245|FG001|Overall Study|Death|1|||
164570921|NCT01889602|594455091|FG000|First Intervention|Study ending|0|||
164225624|NCT00655356|593194123|FG000|Overall Study|Other Reason|1|||
164225625|NCT00655356|593194124|FG001|Overall Study|Other Reason|0|||
164225626|NCT01093573|593194129|FG000|Overall Study|Physician Decision|0|||
164225627|NCT01093573|593194130|FG001|Overall Study|Physician Decision|0|||
164225628|NCT01093573|593194131|FG002|Overall Study|Physician Decision|1|||
164225629|NCT01093573|593194129|FG000|Overall Study|Insurance Denied|0|||
164225630|NCT01093573|593194130|FG001|Overall Study|Insurance Denied|0|||
164225631|NCT01093573|593194131|FG002|Overall Study|Insurance Denied|1|||
164225632|NCT01623154|593194132|FG000|Overall Study|Did not drink Pranactin Citric|4|||
164225633|NCT01412983|593194133|FG000|1st Period|Ineligible|0|||
164225634|NCT01412983|593194134|FG001|1st Period|Ineligible|1|||
164225635|NCT01412983|593194133|FG000|1st Period|Positive slit lamp finding|0|||
164225636|NCT01412983|593194134|FG001|1st Period|Positive slit lamp finding|1|||
164225637|NCT01412983|593194133|FG000|1st Period|Unacceptable lens movement|0|||
164225638|NCT01412983|593194134|FG001|1st Period|Unacceptable lens movement|1|||
164225639|NCT01412983|593194133|FG000|1st Period|Inability to maintain wear|0|||
164225640|NCT01412983|593194134|FG001|1st Period|Inability to maintain wear|1|||
164330672|NCT00107783|593588244|FG000|Overall Study|Withdrawal by Subject|2|||
164330673|NCT00107783|593588245|FG001|Overall Study|Withdrawal by Subject|0|||
164570922|NCT01889602|594455092|FG001|First Intervention|Study ending|1|||
164570923|NCT01889602|594455093|FG002|First Intervention|Study ending|0|||
164570924|NCT01889602|594455091|FG000|Second Intervention|Adverse Event|0|||
164570925|NCT01889602|594455092|FG001|Second Intervention|Adverse Event|0|||
164570926|NCT01889602|594455093|FG002|Second Intervention|Adverse Event|1|||
164225641|NCT04349098|593194135|FG000|Overall Study|Death|16|||
164330674|NCT00107783|593588244|FG000|Overall Study|Second hip replacement|1|||
164330675|NCT00107783|593588245|FG001|Overall Study|Second hip replacement|1|||
164330676|NCT01298531|593588246|FG000|Overall Study|Lack of Efficacy|0|||
164570927|NCT01889602|594455091|FG000|Second Intervention|Study ending|1|||
164225642|NCT04349098|593194136|FG001|Overall Study|Death|8|||
164225643|NCT04349098|593194135|FG000|Overall Study|Lost to Follow-up|11|||
164225644|NCT04349098|593194136|FG001|Overall Study|Lost to Follow-up|8|||
164330677|NCT01298531|593588247|FG001|Overall Study|Lack of Efficacy|1|||
164330678|NCT01298531|593588246|FG000|Overall Study|Lost to Follow-up|2|||
164570928|NCT01889602|594455092|FG001|Second Intervention|Study ending|0|||
164225645|NCT04349098|593194135|FG000|Overall Study|Withdrawal by Subject|8|||
164225646|NCT04349098|593194136|FG001|Overall Study|Withdrawal by Subject|5|||
164225647|NCT04349098|593194135|FG000|Overall Study|Other|3|||
164225648|NCT04349098|593194136|FG001|Overall Study|Other|5|||
164225649|NCT00800384|593194137|FG000|Overall Study|Withdrawal by Subject|24|||
164225650|NCT00800384|593194138|FG001|Overall Study|Withdrawal by Subject|17|||
164225651|NCT00800384|593194137|FG000|Overall Study|Lost to Follow-up|17|||
164225652|NCT00800384|593194138|FG001|Overall Study|Lost to Follow-up|26|||
164225653|NCT04280783|593196134|FG000|Overall Study|Family issues unrelated to the study.|1|||
164225654|NCT04280783|593196135|FG001|Overall Study|Family issues unrelated to the study.|0|||
164225655|NCT04280783|593196134|FG000|Overall Study|Withdrawal by Subject|0|||
164225656|NCT04280783|593196135|FG001|Overall Study|Withdrawal by Subject|1|||
164225657|NCT01394185|593196136|FG000|Overall Study|Withdrawal by Subject|2|||
164225658|NCT01394185|593196137|FG001|Overall Study|Withdrawal by Subject|0|||
164570929|NCT01889602|594455093|FG002|Second Intervention|Study ending|0|||
164570930|NCT01889602|594455091|FG000|Second Intervention|Withdrawal by Subject|0|||
164570931|NCT01889602|594455092|FG001|Second Intervention|Withdrawal by Subject|0|||
164570932|NCT01889602|594455093|FG002|Second Intervention|Withdrawal by Subject|1|||
164570933|NCT01889602|594455091|FG000|Third Intervention|Protocol Violation|1|||
164570934|NCT01889602|594455092|FG001|Third Intervention|Protocol Violation|0|||
164570935|NCT01889602|594455093|FG002|Third Intervention|Protocol Violation|0|||
164570936|NCT01889602|594455091|FG000|Third Intervention|Withdrawal by Subject|2|||
164570937|NCT01889602|594455092|FG001|Third Intervention|Withdrawal by Subject|2|||
164570938|NCT01889602|594455093|FG002|Third Intervention|Withdrawal by Subject|0|||
164570939|NCT01412957|594455094|FG000|Overall Study|Withdrawal by Subject|6|||
164570940|NCT01412957|594455095|FG001|Overall Study|Withdrawal by Subject|22|||
164570941|NCT01412957|594455094|FG000|Overall Study|Lost to Follow-up|7|||
164570942|NCT01412957|594455095|FG001|Overall Study|Lost to Follow-up|2|||
164570943|NCT01412957|594455094|FG000|Overall Study|Death|136|||
164570944|NCT01412957|594455095|FG001|Overall Study|Death|133|||
164570945|NCT02040142|594455101|FG000|Overall Study|Lost to Follow-up|5|||
164570946|NCT02040142|594455101|FG000|Overall Study|Death|17|||
164570947|NCT02040142|594455101|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
164570948|NCT01926626|594455122|FG000|Overall Study|Withdrawal by Subject|15|||
164570949|NCT01926626|594455122|FG000|Overall Study|Lost to Follow-up|7|||
164570950|NCT03636906|594455123|FG000|Overall Study|Adverse Event|0|||
164570951|NCT03636906|594455124|FG001|Overall Study|Adverse Event|0|||
164570952|NCT03636906|594455125|FG002|Overall Study|Adverse Event|1|||
164570953|NCT03636906|594455123|FG000|Overall Study|Lost to Follow-up|1|||
164570954|NCT03636906|594455124|FG001|Overall Study|Lost to Follow-up|0|||
164570955|NCT03636906|594455125|FG002|Overall Study|Lost to Follow-up|0|||
164225659|NCT01394185|593196138|FG002|Overall Study|Withdrawal by Subject|0|||
164225660|NCT01394185|593196139|FG003|Overall Study|Withdrawal by Subject|0|||
164330679|NCT01298531|593588247|FG001|Overall Study|Lost to Follow-up|0|||
164330680|NCT01298531|593588246|FG000|Overall Study|Protocol Violation|1|||
164330681|NCT01298531|593588247|FG001|Overall Study|Protocol Violation|1|||
164330682|NCT01298531|593588246|FG000|Overall Study|Adverse Event|4|||
164330683|NCT01298531|593588247|FG001|Overall Study|Adverse Event|3|||
164330684|NCT01298531|593588246|FG000|Overall Study|Does not meet entrance criteria|0|||
164570956|NCT03636906|594455123|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
164570957|NCT03636906|594455124|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
164570958|NCT03636906|594455125|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
164675184|NCT02576938|594834896|FG002|Overall Study|Adverse Event|6|||
164225661|NCT01394185|593196140|FG004|Overall Study|Withdrawal by Subject|1|||
164225662|NCT01394185|593196141|FG005|Overall Study|Withdrawal by Subject|0|||
164225663|NCT01394185|593196136|FG000|Overall Study|Change in protocol|3|||
164225664|NCT01394185|593196137|FG001|Overall Study|Change in protocol|0|||
164330685|NCT01298531|593588247|FG001|Overall Study|Does not meet entrance criteria|1|||
164330686|NCT01298531|593588246|FG000|Overall Study|Other|2|||
164330687|NCT01298531|593588247|FG001|Overall Study|Other|1|||
164675185|NCT02576938|594834894|FG000|Overall Study|Protocol Violation|1|||
164675186|NCT02576938|594834895|FG001|Overall Study|Protocol Violation|1|||
164675187|NCT02576938|594834896|FG002|Overall Study|Protocol Violation|1|||
164675188|NCT02576938|594834894|FG000|Overall Study|Withdrawal by Subject|3|||
164675189|NCT02576938|594834895|FG001|Overall Study|Withdrawal by Subject|2|||
164675190|NCT02576938|594834896|FG002|Overall Study|Withdrawal by Subject|4|||
164675191|NCT02576938|594834894|FG000|Overall Study|Lack of Efficacy|9|||
164675192|NCT02576938|594834895|FG001|Overall Study|Lack of Efficacy|4|||
164675193|NCT02576938|594834896|FG002|Overall Study|Lack of Efficacy|0|||
164675194|NCT02576938|594834894|FG000|Overall Study|Lost to Follow-up|2|||
164675195|NCT02576938|594834895|FG001|Overall Study|Lost to Follow-up|0|||
164675196|NCT02576938|594834896|FG002|Overall Study|Lost to Follow-up|1|||
164675197|NCT02576938|594834894|FG000|Overall Study|Physician Decision|0|||
164675198|NCT02576938|594834895|FG001|Overall Study|Physician Decision|1|||
164675199|NCT02576938|594834896|FG002|Overall Study|Physician Decision|0|||
164675200|NCT02576938|594834894|FG000|Overall Study|Met Exclusion Criteria|0|||
164225665|NCT01394185|593196138|FG002|Overall Study|Change in protocol|0|||
164570959|NCT03636906|594455123|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
164570960|NCT03636906|594455124|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
164570961|NCT03636906|594455125|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
164570962|NCT03636906|594455123|FG000|Overall Study|Other|0|||
164570963|NCT03636906|594455124|FG001|Overall Study|Other|0|||
164570964|NCT03636906|594455125|FG002|Overall Study|Other|1|||
164570965|NCT02292771|594455126|FG000|Overall Study|Withdrawal by Subject|2|||
164570966|NCT02292771|594455127|FG001|Overall Study|Withdrawal by Subject|1|||
164570967|NCT02292771|594455126|FG000|Overall Study|Lost to Follow-up|2|||
164570968|NCT02292771|594455127|FG001|Overall Study|Lost to Follow-up|1|||
164570969|NCT04280081|594455128|FG000|Overall Study|Adverse Event|4|||
164570970|NCT04280081|594455128|FG000|Overall Study|Death|2|||
164570971|NCT04280081|594455128|FG000|Overall Study|Progressive Disease|6|||
164570972|NCT00023322|594456748|FG000|Overall Study|Lost to Follow-up|1|||
164570973|NCT05194345|594456758|FG000|Overall Study|Withdrawal by Subject|6|||
164570974|NCT05194345|594456759|FG001|Overall Study|Withdrawal by Subject|4|||
164570975|NCT05194345|594456760|FG002|Overall Study|Withdrawal by Subject|0|||
164570976|NCT05194345|594456758|FG000|Overall Study|Moved to another state, becoming ineligible.|0|||
164570977|NCT05194345|594456759|FG001|Overall Study|Moved to another state, becoming ineligible.|2|||
164570978|NCT05194345|594456760|FG002|Overall Study|Moved to another state, becoming ineligible.|0|||
164570979|NCT04854499|594456762|FG000|Overall Study|Study Terminated by Sponsor|5|||
164570980|NCT04854499|594456763|FG001|Overall Study|Study Terminated by Sponsor|27|||
164570981|NCT04854499|594456764|FG002|Overall Study|Study Terminated by Sponsor|28|||
164570982|NCT04854499|594456765|FG003|Overall Study|Study Terminated by Sponsor|19|||
164570983|NCT04854499|594456766|FG004|Overall Study|Study Terminated by Sponsor|1|||
164570984|NCT04854499|594456767|FG005|Overall Study|Study Terminated by Sponsor|10|||
164570985|NCT04854499|594456762|FG000|Overall Study|Death|1|||
164570986|NCT04854499|594456763|FG001|Overall Study|Death|23|||
164570987|NCT04854499|594456764|FG002|Overall Study|Death|21|||
164570988|NCT04854499|594456765|FG003|Overall Study|Death|7|||
164570989|NCT04854499|594456766|FG004|Overall Study|Death|6|||
164570990|NCT04854499|594456767|FG005|Overall Study|Death|24|||
164570991|NCT04854499|594456762|FG000|Overall Study|Investigator's Discretion|0|||
164570992|NCT04854499|594456763|FG001|Overall Study|Investigator's Discretion|1|||
164570993|NCT04854499|594456764|FG002|Overall Study|Investigator's Discretion|3|||
164570994|NCT04854499|594456765|FG003|Overall Study|Investigator's Discretion|4|||
164570995|NCT04854499|594456766|FG004|Overall Study|Investigator's Discretion|1|||
164570996|NCT04854499|594456767|FG005|Overall Study|Investigator's Discretion|5|||
164570997|NCT04854499|594456762|FG000|Overall Study|Withdrew Consent|0|||
164570998|NCT04854499|594456763|FG001|Overall Study|Withdrew Consent|1|||
164570999|NCT04854499|594456764|FG002|Overall Study|Withdrew Consent|2|||
164571000|NCT04854499|594456765|FG003|Overall Study|Withdrew Consent|2|||
164571001|NCT04854499|594456766|FG004|Overall Study|Withdrew Consent|0|||
164571002|NCT04854499|594456767|FG005|Overall Study|Withdrew Consent|1|||
164571003|NCT04854499|594456762|FG000|Overall Study|Lost to Follow-up|0|||
164571004|NCT04854499|594456763|FG001|Overall Study|Lost to Follow-up|0|||
164571005|NCT04854499|594456764|FG002|Overall Study|Lost to Follow-up|0|||
164571006|NCT04854499|594456765|FG003|Overall Study|Lost to Follow-up|0|||
164571007|NCT04854499|594456766|FG004|Overall Study|Lost to Follow-up|0|||
164571008|NCT04854499|594456767|FG005|Overall Study|Lost to Follow-up|1|||
164571009|NCT02612909|594456768|FG000|Phase 2|Withdrawal by Subject|2|||
164571010|NCT02612909|594456769|FG001|Phase 2|Withdrawal by Subject|5|||
164571011|NCT02612909|594456770|FG002|Phase 2|Withdrawal by Subject|0|||
164571012|NCT02612909|594456771|FG003|Phase 2|Withdrawal by Subject|0|||
164571013|NCT02612909|594456772|FG004|Phase 2|Withdrawal by Subject|0|||
164571014|NCT02612909|594456768|FG000|Phase 2|Pregnancy|0|||
164571015|NCT02612909|594456769|FG001|Phase 2|Pregnancy|0|||
164571016|NCT02612909|594456770|FG002|Phase 2|Pregnancy|1|||
164571017|NCT02612909|594456771|FG003|Phase 2|Pregnancy|0|||
164571018|NCT02612909|594456772|FG004|Phase 2|Pregnancy|0|||
164571019|NCT02612909|594456768|FG000|Phase 3|Withdrawal by Subject|0|||
164571020|NCT02612909|594456769|FG001|Phase 3|Withdrawal by Subject|0|||
164225666|NCT01394185|593196139|FG003|Overall Study|Change in protocol|0|||
164225667|NCT01394185|593196140|FG004|Overall Study|Change in protocol|3|||
164571021|NCT02612909|594456770|FG002|Phase 3|Withdrawal by Subject|0|||
164571022|NCT02612909|594456771|FG003|Phase 3|Withdrawal by Subject|1|||
164571023|NCT02612909|594456772|FG004|Phase 3|Withdrawal by Subject|0|||
164571024|NCT03615222|594456778|FG000|Overall Study|Ineligible|26|||
164225668|NCT01394185|593196141|FG005|Overall Study|Change in protocol|0|||
164571025|NCT03615222|594456778|FG000|Overall Study|Withdrawal by Subject|7|||
164571026|NCT03615222|594456778|FG000|Overall Study|Death|1|||
164571027|NCT03304522|594456783|FG000|Overall Study|Adverse Event|0|||
164571028|NCT03304522|594456784|FG001|Overall Study|Adverse Event|4|||
164571029|NCT03304522|594456783|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
164571030|NCT03304522|594456784|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
164571031|NCT03304522|594456783|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
164571032|NCT03304522|594456784|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
164225669|NCT01394185|593196136|FG000|Overall Study|Protocol Violation|1|||
164675201|NCT02576938|594834895|FG001|Overall Study|Met Exclusion Criteria|1|||
164675202|NCT02576938|594834896|FG002|Overall Study|Met Exclusion Criteria|0|||
164675203|NCT00640562|594834897|FG000|Overall Study|Adverse Event|8|||
164675204|NCT00640562|594834898|FG001|Overall Study|Adverse Event|5|||
164675205|NCT00640562|594834897|FG000|Overall Study|Lack of Efficacy|1|||
164675206|NCT00640562|594834898|FG001|Overall Study|Lack of Efficacy|4|||
164675207|NCT00640562|594834897|FG000|Overall Study|Protocol Violation|2|||
164675208|NCT00640562|594834898|FG001|Overall Study|Protocol Violation|4|||
164675209|NCT00640562|594834897|FG000|Overall Study|Withdrawal by Subject|6|||
164675210|NCT00640562|594834898|FG001|Overall Study|Withdrawal by Subject|10|||
164675211|NCT00640562|594834897|FG000|Overall Study|Known risperidone intolerance|0|||
164675212|NCT00640562|594834898|FG001|Overall Study|Known risperidone intolerance|1|||
164675213|NCT00640562|594834897|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
164675214|NCT00640562|594834898|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
164675215|NCT00640562|594834897|FG000|Overall Study|Low study drug dose|0|||
164675216|NCT00640562|594834898|FG001|Overall Study|Low study drug dose|1|||
164675217|NCT00640562|594834897|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
164225670|NCT01394185|593196137|FG001|Overall Study|Protocol Violation|0|||
164225671|NCT01394185|593196138|FG002|Overall Study|Protocol Violation|0|||
164225672|NCT01394185|593196139|FG003|Overall Study|Protocol Violation|1|||
164225673|NCT01394185|593196140|FG004|Overall Study|Protocol Violation|0|||
164421045|NCT02138747|593911085|FG001|Treatment Period 1|Other - Miscellaneous|4|||
164421046|NCT02138747|593911086|FG002|Treatment Period 1|Other - Miscellaneous|0|||
164421047|NCT02138747|593911087|FG003|Treatment Period 1|Other - Miscellaneous|0|||
164225674|NCT01394185|593196141|FG005|Overall Study|Protocol Violation|1|||
164225675|NCT02254460|593196142|FG000|Overall Study|Adverse Event|1|||
164225676|NCT02254460|593196143|FG001|Overall Study|Adverse Event|0|||
164225677|NCT01050218|593196144|FG000|Overall Study|Adverse Event|37|||
164225678|NCT01050218|593196144|FG000|Overall Study|Lack of Efficacy|8|||
164225679|NCT01050218|593196144|FG000|Overall Study|Protocol Violation|3|||
164225680|NCT01050218|593196144|FG000|Overall Study|Withdrawal by Subject|18|||
164225681|NCT01050218|593196144|FG000|Overall Study|Discontinued by sponsor|18|||
164225682|NCT01050218|593196144|FG000|Overall Study|Compliance|2|||
164225683|NCT01050218|593196144|FG000|Overall Study|Failed to return|7|||
164225684|NCT01050218|593196144|FG000|Overall Study|Serious Adverse Event|1|||
164225685|NCT01050218|593196144|FG000|Overall Study|Family emergency|1|||
164225686|NCT02336555|593196145|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164225687|NCT02336555|593196146|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
164225688|NCT02336555|593196145|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
164225689|NCT02336555|593196146|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
164225690|NCT02336555|593196145|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
164225691|NCT02336555|593196146|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
164225692|NCT01959919|593196147|FG000|Overall Study|Did not meet the eligibility criteria|2|||
164225693|NCT01537432|593196149|FG000|Overall Study|Lost to Follow-up|3|||
164225694|NCT01537432|593196150|FG001|Overall Study|Lost to Follow-up|1|||
164225695|NCT01537432|593196149|FG000|Overall Study|Withdrawal by Subject|0|||
164225696|NCT01537432|593196150|FG001|Overall Study|Withdrawal by Subject|1|||
164225697|NCT01537432|593196149|FG000|Overall Study|Administrative problems|1|||
164225698|NCT01537432|593196150|FG001|Overall Study|Administrative problems|0|||
164225699|NCT01537432|593196149|FG000|Overall Study|Adverse Event|1|||
164225700|NCT01537432|593196150|FG001|Overall Study|Adverse Event|0|||
164225701|NCT01537432|593196149|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164225702|NCT01537432|593196150|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164225703|NCT03682367|593196153|FG000|Overall Study|Protocol Violation|2|||
164225704|NCT03682367|593196154|FG001|Overall Study|Protocol Violation|1|||
164225705|NCT03682367|593196153|FG000|Overall Study|Closed Study Early|0|||
164225706|NCT03682367|593196154|FG001|Overall Study|Closed Study Early|3|||
164225707|NCT05166902|593196155|FG000|First Intervention|Lost to Follow-up|0|||
164225708|NCT05166902|593196156|FG001|First Intervention|Lost to Follow-up|1|||
164225709|NCT01550965|593196165|FG000|Overall Study|Adverse Event|26|||
164225710|NCT01550965|593196165|FG000|Overall Study|Withdrawal by Subject|10|||
164225711|NCT01550965|593196165|FG000|Overall Study|Lost to Follow-up|2|||
164225712|NCT01550965|593196165|FG000|Overall Study|Lack of Efficacy|59|||
164675218|NCT00640562|594834898|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
164675219|NCT03098394|594834902|FG000|Overall Study|Pregnancy|0|||
164675220|NCT03098394|594834903|FG001|Overall Study|Pregnancy|1|||
164225713|NCT01550965|593196165|FG000|Overall Study|Other|13|||
164225714|NCT00160563|593196168|FG000|Overall Study|Adverse Event|1|||
164225715|NCT00160563|593196169|FG001|Overall Study|Adverse Event|1|||
164225716|NCT00160563|593196170|FG002|Overall Study|Adverse Event|1|||
164225717|NCT00160563|593196168|FG000|Overall Study|Lost to Follow-up|1|||
164225718|NCT00160563|593196169|FG001|Overall Study|Lost to Follow-up|1|||
164225719|NCT00160563|593196170|FG002|Overall Study|Lost to Follow-up|2|||
164225720|NCT00160563|593196168|FG000|Overall Study|Protocol Violation|0|||
164675221|NCT04408794|594834904|FG000|Overall Study|Adverse Event|43|||
164675222|NCT04408794|594834904|FG000|Overall Study|Infrequent study drug usage|43|||
164421048|NCT02138747|593911084|FG000|Treatment Period 2|Adverse Event|6|||
164330688|NCT00422097|593588248|FG000|Dose Level 2|Still on treatment|0|||
164330689|NCT00422097|593588249|FG001|Dose Level 2|Still on treatment|1|||
164330690|NCT00422097|593588250|FG002|Dose Level 2|Still on treatment|0|||
164225721|NCT00160563|593196169|FG001|Overall Study|Protocol Violation|0|||
164225722|NCT00160563|593196170|FG002|Overall Study|Protocol Violation|3|||
164225723|NCT00160563|593196168|FG000|Overall Study|Withdrawal by Subject|1|||
164225724|NCT00160563|593196169|FG001|Overall Study|Withdrawal by Subject|2|||
164225725|NCT00160563|593196170|FG002|Overall Study|Withdrawal by Subject|3|||
164225726|NCT00160563|593196168|FG000|Overall Study|Other (listed in the study report)|48|||
164225727|NCT00160563|593196169|FG001|Overall Study|Other (listed in the study report)|40|||
164225728|NCT00160563|593196170|FG002|Overall Study|Other (listed in the study report)|81|||
164225729|NCT00160563|593196168|FG000|Overall Study|Missing reason|0|||
164225730|NCT00160563|593196169|FG001|Overall Study|Missing reason|1|||
164225731|NCT00160563|593196170|FG002|Overall Study|Missing reason|0|||
164225732|NCT00309946|593196171|FG000|Overall Study|Withdrawal by Subject|1|||
164225733|NCT01347086|593196175|FG000|Overall Study|failed screening visit|0|||
164225734|NCT01347086|593196176|FG001|Overall Study|failed screening visit|0|||
164225735|NCT01347086|593196177|FG002|Overall Study|failed screening visit|1|||
164225736|NCT01347086|593196178|FG003|Overall Study|failed screening visit|0|||
164225737|NCT01347086|593196179|FG004|Overall Study|failed screening visit|0|||
164225738|NCT01347086|593196180|FG005|Overall Study|failed screening visit|0|||
164225739|NCT01347086|593196181|FG006|Overall Study|failed screening visit|1|||
164225740|NCT01347086|593196182|FG007|Overall Study|failed screening visit|1|||
164225741|NCT01347086|593196183|FG008|Overall Study|failed screening visit|0|||
164225742|NCT01347086|593196184|FG009|Overall Study|failed screening visit|1|||
164225743|NCT03111108|593196186|FG000|Overall Study|Death|0|||
164330691|NCT00422097|593588251|FG003|Dose Level 2|Still on treatment|0|||
164330692|NCT00422097|593588252|FG004|Dose Level 2|Still on treatment|0|||
164330693|NCT00422097|593588253|FG005|Dose Level 2|Still on treatment|0|||
164330694|NCT00422097|593588254|FG006|Dose Level 2|Still on treatment|0|||
164330695|NCT00422097|593588255|FG007|Dose Level 2|Still on treatment|0|||
164330696|NCT02360995|593588256|FG000|Overall Study|Lost to Follow-up|2|||
164330697|NCT02360995|593588257|FG001|Overall Study|Lost to Follow-up|0|||
164330698|NCT02360995|593588258|FG002|Overall Study|Lost to Follow-up|2|||
164330699|NCT02360995|593588256|FG000|Overall Study|Withdrawal by Subject|0|||
164330700|NCT02360995|593588257|FG001|Overall Study|Withdrawal by Subject|1|||
164330701|NCT02360995|593588258|FG002|Overall Study|Withdrawal by Subject|0|||
164330702|NCT02476422|593588259|FG000|Overall Study|Subject/guardian decision|0|||
164330703|NCT02476422|593588260|FG001|Overall Study|Subject/guardian decision|1|||
164330704|NCT03960554|593588266|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
164330705|NCT03960554|593588267|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
164330706|NCT02545075|593588268|FG000|Randomization|Lost to Follow-up|0|||
164330707|NCT02545075|593588269|FG001|Randomization|Lost to Follow-up|1|||
164330708|NCT02545075|593588268|FG000|Randomization|Withdrawal by Subject|0|||
164330709|NCT02545075|593588269|FG001|Randomization|Withdrawal by Subject|6|||
164330710|NCT02545075|593588268|FG000|Treatment|Disease progression|71|||
164330711|NCT02545075|593588269|FG001|Treatment|Disease progression|32|||
164330712|NCT02545075|593588268|FG000|Treatment|Participant dicontinued study treatment|7|||
164421049|NCT02138747|593911085|FG001|Treatment Period 2|Adverse Event|3|||
164421050|NCT02138747|593911086|FG002|Treatment Period 2|Adverse Event|1|||
164421051|NCT02138747|593911087|FG003|Treatment Period 2|Adverse Event|1|||
164421052|NCT02138747|593911084|FG000|Treatment Period 2|Lost to Follow-up|2|||
164421053|NCT02138747|593911085|FG001|Treatment Period 2|Lost to Follow-up|0|||
164421054|NCT02138747|593911086|FG002|Treatment Period 2|Lost to Follow-up|0|||
164421055|NCT02138747|593911087|FG003|Treatment Period 2|Lost to Follow-up|0|||
164421056|NCT02138747|593911084|FG000|Treatment Period 2|Protocol Violation|1|||
164421057|NCT02138747|593911085|FG001|Treatment Period 2|Protocol Violation|0|||
164421058|NCT02138747|593911086|FG002|Treatment Period 2|Protocol Violation|0|||
164421059|NCT02138747|593911087|FG003|Treatment Period 2|Protocol Violation|0|||
164421060|NCT02138747|593911084|FG000|Treatment Period 2|Withdrawal by Subject|5|||
164421061|NCT02138747|593911085|FG001|Treatment Period 2|Withdrawal by Subject|4|||
164421062|NCT02138747|593911086|FG002|Treatment Period 2|Withdrawal by Subject|1|||
164421063|NCT02138747|593911087|FG003|Treatment Period 2|Withdrawal by Subject|2|||
164571033|NCT03304522|594456783|FG000|Overall Study|Other|0|||
164225744|NCT03111108|593196187|FG001|Overall Study|Death|1|||
164225745|NCT03111108|593196186|FG000|Overall Study|Withdrawal by Subject|1|||
164571034|NCT03304522|594456784|FG001|Overall Study|Other|1|||
164225746|NCT03111108|593196187|FG001|Overall Study|Withdrawal by Subject|0|||
164225747|NCT01514357|593196188|FG000|Overall Study|Screen failure|2|||
164225748|NCT01514357|593196189|FG001|Overall Study|Screen failure|0|||
164330713|NCT02545075|593588269|FG001|Treatment|Participant dicontinued study treatment|9|||
164330714|NCT02545075|593588268|FG000|Treatment|Withdrawal by Subject|1|||
164330715|NCT02545075|593588269|FG001|Treatment|Withdrawal by Subject|0|||
164330716|NCT02545075|593588268|FG000|Treatment|Adverse event not related to study drug|1|||
164330717|NCT02545075|593588269|FG001|Treatment|Adverse event not related to study drug|0|||
164330718|NCT02545075|593588268|FG000|Treatment|Death|1|||
164571035|NCT00486603|594456790|FG000|Overall Study|Withdrawal by Subject|1|||
164571036|NCT00486603|594456791|FG001|Overall Study|Withdrawal by Subject|0|||
164571037|NCT00486603|594456792|FG002|Overall Study|Withdrawal by Subject|0|||
164571038|NCT00486603|594456793|FG003|Overall Study|Withdrawal by Subject|0|||
164571039|NCT00486603|594456794|FG004|Overall Study|Withdrawal by Subject|0|||
164571040|NCT00486603|594456790|FG000|Overall Study|Physician Decision|0|||
164571041|NCT00486603|594456791|FG001|Overall Study|Physician Decision|1|||
164571042|NCT00486603|594456792|FG002|Overall Study|Physician Decision|0|||
164571043|NCT00486603|594456793|FG003|Overall Study|Physician Decision|0|||
164571044|NCT00486603|594456794|FG004|Overall Study|Physician Decision|0|||
164571045|NCT03367871|594456795|FG000|Overall Study|Lost to Follow-up|1|||
164571046|NCT01670994|594456796|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
164571047|NCT01670994|594456797|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
164571048|NCT01670994|594456796|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
164571049|NCT01670994|594456797|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
164571050|NCT01670994|594456796|FG000|Overall Study|Patient experienced DLT|0|||
164571051|NCT01670994|594456797|FG001|Overall Study|Patient experienced DLT|1|||
164571052|NCT02013544|594456799|FG000|Overall Study|Adverse Event|5|||
164571053|NCT02013544|594456800|FG001|Overall Study|Adverse Event|5|||
164571054|NCT02013544|594456799|FG000|Overall Study|Lost to Follow-up|2|||
164571055|NCT02013544|594456800|FG001|Overall Study|Lost to Follow-up|3|||
164571056|NCT02013544|594456799|FG000|Overall Study|Withdrawal by Subject|2|||
164571057|NCT02013544|594456800|FG001|Overall Study|Withdrawal by Subject|8|||
164225749|NCT01514357|593196188|FG000|Overall Study|Withdrawal by Subject|2|||
164225750|NCT01514357|593196189|FG001|Overall Study|Withdrawal by Subject|0|||
164571058|NCT02013544|594456799|FG000|Overall Study|Physician Decision|0|||
164571059|NCT02013544|594456800|FG001|Overall Study|Physician Decision|1|||
164571060|NCT02013544|594456799|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
164571061|NCT02013544|594456800|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
164571062|NCT00885365|594456803|FG000|4 Weeks ON Treatment|Adverse Event|2|||
164571063|NCT00885365|594456804|FG001|4 Weeks ON Treatment|Adverse Event|4|||
164571064|NCT00885365|594456803|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
164571065|NCT00885365|594456804|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
164571066|NCT00885365|594456803|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
164571067|NCT00885365|594456804|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
164571068|NCT01824979|594456805|FG000|Overall Study|Withdrawal by Subject|5|||
164571069|NCT01824979|594456806|FG001|Overall Study|Withdrawal by Subject|0|||
164571070|NCT01824979|594456805|FG000|Overall Study|Physician Decision|2|||
164571071|NCT01824979|594456806|FG001|Overall Study|Physician Decision|0|||
164571072|NCT01824979|594456805|FG000|Overall Study|Protocol Violation|6|||
164571073|NCT01824979|594456806|FG001|Overall Study|Protocol Violation|13|||
164571074|NCT01756456|594456814|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
164571075|NCT01756456|594456815|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
164571076|NCT01756456|594456816|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
164571077|NCT01756456|594456817|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
164571078|NCT01756456|594456818|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
164571079|NCT01756456|594456819|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
164571080|NCT01756456|594456814|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
164571081|NCT01756456|594456815|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
164571082|NCT01756456|594456816|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
164571083|NCT01756456|594456817|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
164571084|NCT01756456|594456818|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
164571085|NCT01756456|594456819|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
164571086|NCT01756456|594456814|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
164571087|NCT01756456|594456815|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
164571088|NCT01756456|594456816|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
164571089|NCT01756456|594456817|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
164571090|NCT01756456|594456818|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
164571091|NCT01756456|594456819|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
164571092|NCT01756456|594456814|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
164571093|NCT01756456|594456815|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
164225751|NCT04691115|593196190|FG000|Overall Study|Withdrawal by Subject|0|||
164225752|NCT04691115|593196191|FG001|Overall Study|Withdrawal by Subject|0|||
164225753|NCT04691115|593196192|FG002|Overall Study|Withdrawal by Subject|0|||
164225754|NCT04691115|593196193|FG003|Overall Study|Withdrawal by Subject|0|||
164225755|NCT04691115|593196194|FG004|Overall Study|Withdrawal by Subject|0|||
164225756|NCT04691115|593196195|FG005|Overall Study|Withdrawal by Subject|1|||
164225757|NCT04691115|593196196|FG006|Overall Study|Withdrawal by Subject|0|||
164225758|NCT04691115|593196197|FG007|Overall Study|Withdrawal by Subject|0|||
164225759|NCT04691115|593196198|FG008|Overall Study|Withdrawal by Subject|0|||
164225760|NCT04691115|593196199|FG009|Overall Study|Withdrawal by Subject|0|||
164225761|NCT04691115|593196200|FG010|Overall Study|Withdrawal by Subject|0|||
164225762|NCT04691115|593196201|FG011|Overall Study|Withdrawal by Subject|0|||
164225763|NCT04691115|593196202|FG012|Overall Study|Withdrawal by Subject|0|||
164225764|NCT04691115|593196203|FG013|Overall Study|Withdrawal by Subject|0|||
164225765|NCT00830336|593196207|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
164225766|NCT00830336|593196208|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
164225767|NCT00867334|593196209|FG000|Overall Study|Withdrawal by Subject|0|||
164225768|NCT00867334|593196210|FG001|Overall Study|Withdrawal by Subject|1|||
164571094|NCT01756456|594456816|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
164571095|NCT01756456|594456817|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
164571096|NCT01756456|594456818|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
164571097|NCT01756456|594456819|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
164571098|NCT01756456|594456814|FG000|Treatment Period: Phase I/II|Other causes|0|||
164571099|NCT01756456|594456815|FG001|Treatment Period: Phase I/II|Other causes|0|||
164571100|NCT01756456|594456816|FG002|Treatment Period: Phase I/II|Other causes|0|||
164571101|NCT01756456|594456817|FG003|Treatment Period: Phase I/II|Other causes|1|||
164571102|NCT01756456|594456818|FG004|Treatment Period: Phase I/II|Other causes|2|||
164571103|NCT01756456|594456819|FG005|Treatment Period: Phase I/II|Other causes|2|||
164571104|NCT01756456|594456814|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
164571105|NCT01756456|594456815|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
164571106|NCT01756456|594456816|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
164571107|NCT01756456|594456817|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
164571108|NCT01756456|594456818|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
164571109|NCT01756456|594456819|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
164571110|NCT01756456|594456814|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
164571111|NCT01756456|594456815|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
164571112|NCT01756456|594456816|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
164571113|NCT01756456|594456817|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
164571114|NCT01756456|594456818|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
164571115|NCT01756456|594456819|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
164571116|NCT01756456|594456814|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
164571117|NCT01756456|594456815|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
164571118|NCT01756456|594456816|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
164571119|NCT01756456|594456817|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
164571120|NCT01756456|594456818|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
164571121|NCT01756456|594456819|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
164571122|NCT01756456|594456814|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
164571123|NCT01756456|594456815|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
164571124|NCT01756456|594456816|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
164571125|NCT01756456|594456817|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
164571126|NCT01756456|594456818|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
164571127|NCT01756456|594456819|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
164571128|NCT01756456|594456814|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
164571129|NCT01756456|594456815|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
164571130|NCT01756456|594456816|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
164571131|NCT01756456|594456817|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
164571132|NCT01756456|594456818|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
164571133|NCT01756456|594456819|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
164571134|NCT01756456|594456814|FG000|Follow Up Period Phase I/II|Other causes|0|||
164571135|NCT01756456|594456815|FG001|Follow Up Period Phase I/II|Other causes|0|||
164571136|NCT01756456|594456816|FG002|Follow Up Period Phase I/II|Other causes|0|||
164571137|NCT01756456|594456817|FG003|Follow Up Period Phase I/II|Other causes|1|||
164571138|NCT01756456|594456818|FG004|Follow Up Period Phase I/II|Other causes|3|||
164571139|NCT01756456|594456819|FG005|Follow Up Period Phase I/II|Other causes|5|||
164571140|NCT02706938|594456820|FG000|First Period, 6 Weeks|Adverse Event|8|||
164571141|NCT02706938|594456821|FG001|First Period, 6 Weeks|Adverse Event|0|||
164571142|NCT02706938|594456820|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
164571143|NCT02706938|594456821|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
164571144|NCT02706938|594456820|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
164571145|NCT02706938|594456821|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
164571146|NCT02706938|594456820|FG000|Second Period, 6 Weeks|Adverse Event|0|||
164571147|NCT02706938|594456821|FG001|Second Period, 6 Weeks|Adverse Event|7|||
164571148|NCT02706938|594456820|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
164571149|NCT02706938|594456821|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
164675223|NCT04408794|594834904|FG000|Overall Study|Lack of Efficacy|61|||
164225769|NCT00867334|593196209|FG000|Overall Study|Withdrawal by Subject|1|||
164571150|NCT00813995|594456822|FG000|Overall Study|Clinical adverse event|9|||
164571151|NCT00813995|594456823|FG001|Overall Study|Clinical adverse event|3|||
164571152|NCT00813995|594456822|FG000|Overall Study|Laboratory adverse event|0|||
164225770|NCT00867334|593196210|FG001|Overall Study|Withdrawal by Subject|0|||
164225771|NCT00867334|593196209|FG000|Overall Study|Withdrawal by Subject|1|||
164225772|NCT00867334|593196210|FG001|Overall Study|Withdrawal by Subject|0|||
164225773|NCT01148771|593196211|FG000|Washout Period|Withdrawal by Subject|0|||
164225774|NCT01148771|593196212|FG001|Washout Period|Withdrawal by Subject|1|||
164225775|NCT01437189|593196217|FG000|Overall Study|Adverse Event|3|||
164225776|NCT01437189|593196217|FG000|Overall Study|Lack of Efficacy|4|||
164225777|NCT01437189|593196217|FG000|Overall Study|Withdrawal by Subject|8|||
164330719|NCT02545075|593588269|FG001|Treatment|Death|0|||
164330720|NCT02545075|593588268|FG000|Treatment|Participant drug toxicity|1|||
164330721|NCT02545075|593588269|FG001|Treatment|Participant drug toxicity|0|||
164330722|NCT02545075|593588268|FG000|Treatment|Completed treatment|40|||
164330723|NCT02545075|593588269|FG001|Treatment|Completed treatment|12|||
164225778|NCT00347269|593196218|FG000|Overall Study|Lost to Follow-up|74|||
164330724|NCT00735254|593588274|FG000|Overall Study|Protocol Violation|1|||
164330725|NCT00735254|593588275|FG001|Overall Study|Protocol Violation|1|||
164330726|NCT00735254|593588276|FG002|Overall Study|Protocol Violation|1|||
164330727|NCT00735254|593588277|FG003|Overall Study|Protocol Violation|0|||
164330728|NCT06400979|593588278|FG000|Overall Study|Lost to Follow-up|29|||
164330729|NCT06400979|593588278|FG000|Overall Study|Withdrawal by Subject|1|||
164330730|NCT00925990|593588283|FG000|Overall Study|Adverse Event|1|||
164330731|NCT00925990|593588284|FG001|Overall Study|Adverse Event|3|||
164330732|NCT00925990|593588283|FG000|Overall Study|Withdrawal by Subject|2|||
164330733|NCT00925990|593588284|FG001|Overall Study|Withdrawal by Subject|2|||
164330734|NCT00925990|593588283|FG000|Overall Study|Lost to Follow-up|1|||
164330735|NCT00925990|593588284|FG001|Overall Study|Lost to Follow-up|3|||
164330736|NCT00925990|593588283|FG000|Overall Study|Physician Decision|1|||
164330737|NCT00925990|593588284|FG001|Overall Study|Physician Decision|1|||
164330738|NCT00925990|593588283|FG000|Overall Study|moved out of state, missed medication|0|||
164330739|NCT00925990|593588284|FG001|Overall Study|moved out of state, missed medication|2|||
164330740|NCT00750880|593588288|FG000|Overall Study|Adverse Event|76|||
164330741|NCT00750880|593588288|FG000|Overall Study|Death|4|||
164330742|NCT00750880|593588288|FG000|Overall Study|Lack of Efficacy|46|||
164225779|NCT00347269|593196219|FG001|Overall Study|Lost to Follow-up|65|||
164225780|NCT00347269|593196218|FG000|Overall Study|Withdrawal by Subject|18|||
164225781|NCT00347269|593196219|FG001|Overall Study|Withdrawal by Subject|38|||
164225782|NCT00347269|593196218|FG000|Overall Study|Death|2|||
164225783|NCT00347269|593196219|FG001|Overall Study|Death|3|||
164225784|NCT00835549|593196220|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
164225785|NCT00835549|593196221|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
164225786|NCT03268499|593196222|FG000|Overall Study|Withdrawal by Subject|2|||
164225787|NCT03268499|593196223|FG001|Overall Study|Withdrawal by Subject|1|||
164225788|NCT04064567|593196228|FG000|Overall Study|Lost to Follow-up|23|||
164225789|NCT04064567|593196229|FG001|Overall Study|Lost to Follow-up|22|||
164225790|NCT04064567|593196228|FG000|Overall Study|Withdrawal by Subject|0|||
164225791|NCT04064567|593196229|FG001|Overall Study|Withdrawal by Subject|1|||
164225792|NCT04064567|593196228|FG000|Overall Study|Reincarcerated|7|||
164225793|NCT04064567|593196229|FG001|Overall Study|Reincarcerated|10|||
164225794|NCT04064567|593196228|FG000|Overall Study|Moved out of U.S.|0|||
164225795|NCT04064567|593196229|FG001|Overall Study|Moved out of U.S.|1|||
164225796|NCT03464461|593196232|FG000|Overall Study|exclusionary medication given ,|1|||
164330743|NCT00750880|593588288|FG000|Overall Study|Lost to Follow-up|10|||
164330744|NCT00750880|593588288|FG000|Overall Study|Protocol Violation|15|||
164330745|NCT00750880|593588288|FG000|Overall Study|Withdrawal by Subject|33|||
164330746|NCT00750880|593588288|FG000|Overall Study|Physician Decision|20|||
164330747|NCT00750880|593588288|FG000|Overall Study|Administrative|11|||
164330748|NCT00249288|593588294|FG000|Overall Study|Lost to Follow-up|3|||
164330749|NCT00249288|593588295|FG001|Overall Study|Lost to Follow-up|3|||
164330750|NCT00249288|593588294|FG000|Overall Study|Withdrawal by Subject|2|||
164330751|NCT00249288|593588295|FG001|Overall Study|Withdrawal by Subject|2|||
164225797|NCT03464461|593196233|FG001|Overall Study|exclusionary medication given ,|2|||
164225798|NCT03464461|593196234|FG002|Overall Study|exclusionary medication given ,|0|||
164225799|NCT03464461|593196232|FG000|Overall Study|Physician Decision|0|||
164225800|NCT03464461|593196233|FG001|Overall Study|Physician Decision|1|||
164225801|NCT03464461|593196234|FG002|Overall Study|Physician Decision|0|||
164225802|NCT05524948|593196235|FG000|Overall Study|Withdrawal by Subject|1|||
164225803|NCT05524948|593196236|FG001|Overall Study|Withdrawal by Subject|0|||
164225804|NCT05524948|593196235|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
164225805|NCT05524948|593196236|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
164225806|NCT03460704|593196239|FG000|Overall Study|Withdrawal by Subject|11|||
164330752|NCT03091777|593588296|FG000|Overall Study|Pregnancy|2|||
164330753|NCT03091777|593588297|FG001|Overall Study|Pregnancy|1|||
164225807|NCT03460704|593196240|FG001|Overall Study|Withdrawal by Subject|14|||
164225808|NCT03460704|593196239|FG000|Overall Study|Study terminated by the Sponsor|29|||
164225809|NCT03460704|593196240|FG001|Overall Study|Study terminated by the Sponsor|19|||
164330754|NCT03091777|593588298|FG002|Overall Study|Pregnancy|0|||
164330755|NCT03091777|593588296|FG000|Overall Study|Adverse Event|2|||
164330756|NCT03091777|593588297|FG001|Overall Study|Adverse Event|1|||
164330757|NCT03091777|593588298|FG002|Overall Study|Adverse Event|4|||
164330758|NCT03091777|593588296|FG000|Overall Study|Withdrawal by Subject|4|||
164225810|NCT03460704|593196239|FG000|Overall Study|Adverse Event|10|||
164225811|NCT03460704|593196240|FG001|Overall Study|Adverse Event|5|||
164225812|NCT03460704|593196239|FG000|Overall Study|Death|3|||
164225813|NCT03460704|593196240|FG001|Overall Study|Death|2|||
164225814|NCT03460704|593196239|FG000|Overall Study|Non-Compliance with Study Drug|3|||
164225815|NCT03460704|593196240|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164225816|NCT03460704|593196239|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164225817|NCT03460704|593196240|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
164225818|NCT03460704|593196239|FG000|Overall Study|Other|2|||
164225819|NCT03460704|593196240|FG001|Overall Study|Other|1|||
164225820|NCT02913326|593196241|FG000|Overall Study|Reason not listed|0|||
164225821|NCT02913326|593196242|FG001|Overall Study|Reason not listed|1|||
164225822|NCT02913326|593196241|FG000|Overall Study|Lost to Follow-up|0|||
164225823|NCT02913326|593196242|FG001|Overall Study|Lost to Follow-up|1|||
164225824|NCT02913326|593196241|FG000|Overall Study|Adverse Event|1|||
164225825|NCT02913326|593196242|FG001|Overall Study|Adverse Event|0|||
164225826|NCT01767857|593196243|FG000|Overall Study|Adverse Event|27|||
164225827|NCT01767857|593196244|FG001|Overall Study|Adverse Event|7|||
164225828|NCT01767857|593196243|FG000|Overall Study|Death|28|||
164225829|NCT01767857|593196244|FG001|Overall Study|Death|13|||
164225830|NCT01767857|593196243|FG000|Overall Study|Lack of Efficacy|299|||
164225831|NCT01767857|593196244|FG001|Overall Study|Lack of Efficacy|151|||
164225832|NCT01767857|593196243|FG000|Overall Study|Lost to Follow-up|1|||
164225833|NCT01767857|593196244|FG001|Overall Study|Lost to Follow-up|1|||
164225834|NCT01767857|593196243|FG000|Overall Study|Withdrawal by Subject|38|||
164225835|NCT01767857|593196244|FG001|Overall Study|Withdrawal by Subject|18|||
164225836|NCT01767857|593196243|FG000|Overall Study|Physician Decision|17|||
164225837|NCT01767857|593196244|FG001|Overall Study|Physician Decision|10|||
164225838|NCT01767857|593196243|FG000|Overall Study|Protocol Terminated|1|||
164225839|NCT01767857|593196244|FG001|Overall Study|Protocol Terminated|0|||
164225840|NCT01767857|593196243|FG000|Overall Study|Randomized But Never Treated|19|||
164225841|NCT01767857|593196244|FG001|Overall Study|Randomized But Never Treated|13|||
164225842|NCT01421459|593196245|FG000|Overall Study|Adverse Event|6|||
164225843|NCT01421459|593196246|FG001|Overall Study|Adverse Event|10|||
164225844|NCT01421459|593196245|FG000|Overall Study|Death|1|||
164225845|NCT01421459|593196246|FG001|Overall Study|Death|1|||
164225846|NCT01421459|593196245|FG000|Overall Study|Lack of Efficacy|1|||
164225847|NCT01421459|593196246|FG001|Overall Study|Lack of Efficacy|2|||
164225848|NCT01421459|593196245|FG000|Overall Study|Lost to Follow-up|8|||
164225849|NCT01421459|593196246|FG001|Overall Study|Lost to Follow-up|9|||
164225850|NCT01421459|593196245|FG000|Overall Study|Physician Decision|9|||
164225851|NCT01421459|593196246|FG001|Overall Study|Physician Decision|9|||
164225852|NCT01421459|593196245|FG000|Overall Study|Protocol Violation|8|||
164225853|NCT01421459|593196246|FG001|Overall Study|Protocol Violation|5|||
164225854|NCT01421459|593196245|FG000|Overall Study|Withdrawal by Subject|12|||
164225855|NCT01421459|593196246|FG001|Overall Study|Withdrawal by Subject|16|||
164330759|NCT03091777|593588297|FG001|Overall Study|Withdrawal by Subject|2|||
164330760|NCT03091777|593588298|FG002|Overall Study|Withdrawal by Subject|6|||
164330761|NCT03091777|593588296|FG000|Overall Study|Protocol Violation|2|||
164330762|NCT03091777|593588297|FG001|Overall Study|Protocol Violation|1|||
164330763|NCT03091777|593588298|FG002|Overall Study|Protocol Violation|1|||
164330764|NCT03091777|593588296|FG000|Overall Study|Lost to Follow-up|12|||
164330765|NCT03091777|593588297|FG001|Overall Study|Lost to Follow-up|14|||
164225856|NCT02899754|593196247|FG000|Overall Study|Lost to Follow-up|7|||
164225857|NCT02899754|593196248|FG001|Overall Study|Lost to Follow-up|9|||
164225858|NCT04818229|593196249|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
164225859|NCT04818229|593196250|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
164225860|NCT04818229|593196251|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
164225861|NCT04818229|593196249|FG000|Overall Study|Adverse Event|3|||
164225862|NCT04818229|593196250|FG001|Overall Study|Adverse Event|1|||
164225863|NCT04818229|593196251|FG002|Overall Study|Adverse Event|1|||
164225864|NCT04818229|593196249|FG000|Overall Study|Withdrawal by Subject|0|||
164225865|NCT04818229|593196250|FG001|Overall Study|Withdrawal by Subject|0|||
164225866|NCT04818229|593196251|FG002|Overall Study|Withdrawal by Subject|2|||
164225867|NCT04818229|593196249|FG000|Overall Study|Lost to Follow-up|0|||
164225868|NCT04818229|593196250|FG001|Overall Study|Lost to Follow-up|0|||
164225869|NCT04818229|593196251|FG002|Overall Study|Lost to Follow-up|1|||
164225870|NCT04082364|593196252|FG000|Overall Study|Death|23|||
164225871|NCT04082364|593196253|FG001|Overall Study|Death|1|||
164330766|NCT03091777|593588298|FG002|Overall Study|Lost to Follow-up|7|||
164330767|NCT03091777|593588296|FG000|Overall Study|Lack of Efficacy|0|||
164225872|NCT04082364|593196254|FG002|Overall Study|Death|1|||
164225873|NCT04082364|593196255|FG003|Overall Study|Death|2|||
164330768|NCT03091777|593588297|FG001|Overall Study|Lack of Efficacy|0|||
164330769|NCT03091777|593588298|FG002|Overall Study|Lack of Efficacy|5|||
164225874|NCT04082364|593196256|FG004|Overall Study|Death|1|||
164330770|NCT03091777|593588296|FG000|Overall Study|Noncompliance with study drug|2|||
164571153|NCT00813995|594456823|FG001|Overall Study|Laboratory adverse event|2|||
164225875|NCT04082364|593196252|FG000|Overall Study|Lost to Follow-up|1|||
164225876|NCT04082364|593196253|FG001|Overall Study|Lost to Follow-up|0|||
164225877|NCT04082364|593196254|FG002|Overall Study|Lost to Follow-up|0|||
164225878|NCT04082364|593196255|FG003|Overall Study|Lost to Follow-up|0|||
164225879|NCT04082364|593196256|FG004|Overall Study|Lost to Follow-up|1|||
164225880|NCT04082364|593196252|FG000|Overall Study|Physician Decision|1|||
164225881|NCT04082364|593196253|FG001|Overall Study|Physician Decision|1|||
164225882|NCT04082364|593196254|FG002|Overall Study|Physician Decision|0|||
164225883|NCT04082364|593196255|FG003|Overall Study|Physician Decision|2|||
164225884|NCT04082364|593196256|FG004|Overall Study|Physician Decision|1|||
164225885|NCT04082364|593196252|FG000|Overall Study|Withdrawal by Subject|1|||
164225886|NCT04082364|593196253|FG001|Overall Study|Withdrawal by Subject|1|||
164225887|NCT04082364|593196254|FG002|Overall Study|Withdrawal by Subject|0|||
164225888|NCT04082364|593196255|FG003|Overall Study|Withdrawal by Subject|0|||
164225889|NCT04082364|593196256|FG004|Overall Study|Withdrawal by Subject|1|||
164225890|NCT04082364|593196252|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
164225891|NCT04082364|593196253|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
164225892|NCT04082364|593196254|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
164225893|NCT04082364|593196255|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
164225894|NCT04082364|593196256|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
164225895|NCT04082364|593196252|FG000|Overall Study|Disease progression|0|||
164225896|NCT04082364|593196253|FG001|Overall Study|Disease progression|0|||
164225897|NCT04082364|593196254|FG002|Overall Study|Disease progression|0|||
164225898|NCT04082364|593196255|FG003|Overall Study|Disease progression|1|||
164225899|NCT04082364|593196256|FG004|Overall Study|Disease progression|0|||
164225900|NCT03186378|593196257|FG000|Overall Study|Lost to Follow-up|1|||
164225901|NCT03186378|593196258|FG001|Overall Study|Lost to Follow-up|0|||
164225902|NCT03247673|593196262|FG000|Overall Study|Withdrawal by Subject|1|||
164225903|NCT03247673|593196263|FG001|Overall Study|Withdrawal by Subject|0|||
164225904|NCT03247673|593196264|FG002|Overall Study|Withdrawal by Subject|3|||
164225905|NCT03247673|593196262|FG000|Overall Study|Lost to Follow-up|0|||
164225906|NCT03247673|593196263|FG001|Overall Study|Lost to Follow-up|0|||
164225907|NCT03247673|593196264|FG002|Overall Study|Lost to Follow-up|1|||
164225908|NCT02971137|593196269|FG000|Overall Study|Lost to Follow-up|44|||
164225909|NCT02971137|593196270|FG001|Overall Study|Lost to Follow-up|56|||
164225910|NCT02757963|593196271|FG000|Overall Study|Adverse Event|3|||
164225911|NCT02757963|593196271|FG000|Overall Study|Reached Stopping Criteria|1054|||
164225912|NCT02757963|593196271|FG000|Overall Study|Lost to Follow-up|5|||
164225913|NCT02757963|593196271|FG000|Overall Study|Physician Decision|1|||
164225914|NCT02757963|593196271|FG000|Overall Study|Withdrawal by Subject|34|||
164225915|NCT00215657|593196272|FG000|Overall Study|Adverse Event|5|||
164225916|NCT00215657|593196273|FG001|Overall Study|Adverse Event|1|||
164225917|NCT00215657|593196274|FG002|Overall Study|Adverse Event|3|||
164225918|NCT00215657|593196275|FG003|Overall Study|Adverse Event|0|||
164225919|NCT00215657|593196276|FG004|Overall Study|Adverse Event|3|||
164225920|NCT00215657|593196277|FG005|Overall Study|Adverse Event|1|||
164225921|NCT00215657|593196278|FG006|Overall Study|Adverse Event|0|||
164225922|NCT00215657|593196279|FG007|Overall Study|Adverse Event|3|||
164225923|NCT00215657|593196272|FG000|Overall Study|Withdrawal by Subject|6|||
164225924|NCT00215657|593196273|FG001|Overall Study|Withdrawal by Subject|3|||
164225925|NCT00215657|593196274|FG002|Overall Study|Withdrawal by Subject|3|||
164225926|NCT00215657|593196275|FG003|Overall Study|Withdrawal by Subject|1|||
164225927|NCT00215657|593196276|FG004|Overall Study|Withdrawal by Subject|6|||
164225928|NCT00215657|593196277|FG005|Overall Study|Withdrawal by Subject|1|||
164225929|NCT00215657|593196278|FG006|Overall Study|Withdrawal by Subject|10|||
164225930|NCT00215657|593196279|FG007|Overall Study|Withdrawal by Subject|3|||
164225931|NCT00215657|593196272|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
164225932|NCT00215657|593196273|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
164225933|NCT00215657|593196274|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
164225934|NCT00215657|593196275|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
164225935|NCT00215657|593196276|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
164225936|NCT00215657|593196277|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
164225937|NCT00215657|593196278|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
164225938|NCT00215657|593196279|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
164225939|NCT00215657|593196272|FG000|Overall Study|Insufficient testosterone response|5|||
164225940|NCT00215657|593196273|FG001|Overall Study|Insufficient testosterone response|4|||
164225941|NCT00215657|593196274|FG002|Overall Study|Insufficient testosterone response|1|||
164225942|NCT00215657|593196275|FG003|Overall Study|Insufficient testosterone response|12|||
164225943|NCT00215657|593196276|FG004|Overall Study|Insufficient testosterone response|8|||
164225944|NCT00215657|593196277|FG005|Overall Study|Insufficient testosterone response|12|||
164225945|NCT00215657|593196278|FG006|Overall Study|Insufficient testosterone response|4|||
164225946|NCT00215657|593196279|FG007|Overall Study|Insufficient testosterone response|7|||
164225947|NCT00215657|593196272|FG000|Overall Study|Other|3|||
164225948|NCT00215657|593196273|FG001|Overall Study|Other|1|||
164225949|NCT00215657|593196274|FG002|Overall Study|Other|2|||
164225950|NCT00215657|593196275|FG003|Overall Study|Other|3|||
164225951|NCT00215657|593196276|FG004|Overall Study|Other|5|||
164225952|NCT00215657|593196277|FG005|Overall Study|Other|4|||
164225953|NCT00215657|593196278|FG006|Overall Study|Other|6|||
164225954|NCT00215657|593196279|FG007|Overall Study|Other|1|||
164225955|NCT04755231|593196280|FG000|Overall Study|Lost to Follow-up|5|||
164225956|NCT04755231|593196280|FG000|Overall Study|Withdrawal by Subject|5|||
164225957|NCT03769467|593196281|FG000|Overall Study|Adverse Event|1|||
164225958|NCT03769467|593196282|FG001|Overall Study|Adverse Event|1|||
164225959|NCT03769467|593196283|FG002|Overall Study|Adverse Event|0|||
164225960|NCT03769467|593196281|FG000|Overall Study|Death|3|||
164225961|NCT03769467|593196282|FG001|Overall Study|Death|3|||
164225962|NCT03769467|593196283|FG002|Overall Study|Death|0|||
164225963|NCT03769467|593196281|FG000|Overall Study|Study Terminated By Sponsor|2|||
164225964|NCT03769467|593196282|FG001|Overall Study|Study Terminated By Sponsor|1|||
164225965|NCT03769467|593196283|FG002|Overall Study|Study Terminated By Sponsor|0|||
164225966|NCT03769467|593196281|FG000|Overall Study|Withdrawal by Subject|0|||
164225967|NCT03769467|593196282|FG001|Overall Study|Withdrawal by Subject|1|||
164225968|NCT03769467|593196283|FG002|Overall Study|Withdrawal by Subject|0|||
164225969|NCT04754399|593196284|FG000|Overall Study|Adverse Event|5|||
164225970|NCT04754399|593196284|FG000|Overall Study|Withdrawal by Subject|6|||
164225971|NCT05259722|593196287|FG000|Overall Study|Adverse Event|2|||
164225972|NCT05259722|593196288|FG001|Overall Study|Adverse Event|24|||
164225973|NCT05259722|593196287|FG000|Overall Study|Lost to Follow-up|5|||
164225974|NCT05259722|593196288|FG001|Overall Study|Lost to Follow-up|1|||
164225975|NCT05259722|593196287|FG000|Overall Study|Lack of Efficacy|8|||
164225976|NCT05259722|593196288|FG001|Overall Study|Lack of Efficacy|26|||
164225977|NCT05259722|593196287|FG000|Overall Study|Withdrawal by Subject|15|||
164225978|NCT05259722|593196288|FG001|Overall Study|Withdrawal by Subject|33|||
164225979|NCT05259722|593196287|FG000|Overall Study|Various reasons|3|||
164225980|NCT05259722|593196288|FG001|Overall Study|Various reasons|9|||
164225981|NCT05259722|593196287|FG000|Overall Study|Not exposed to IMP|1|||
164225982|NCT05259722|593196288|FG001|Overall Study|Not exposed to IMP|12|||
164225983|NCT05259722|593196287|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
164330771|NCT03091777|593588297|FG001|Overall Study|Noncompliance with study drug|3|||
164330772|NCT03091777|593588298|FG002|Overall Study|Noncompliance with study drug|1|||
164330773|NCT03091777|593588296|FG000|Overall Study|Physician Decision|1|||
164330774|NCT03091777|593588297|FG001|Overall Study|Physician Decision|0|||
164330775|NCT03091777|593588298|FG002|Overall Study|Physician Decision|1|||
164225984|NCT05259722|593196288|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
164330776|NCT03091777|593588296|FG000|Overall Study|Abnormal Laboratory Value|7|||
164330777|NCT03091777|593588297|FG001|Overall Study|Abnormal Laboratory Value|11|||
164330778|NCT03091777|593588298|FG002|Overall Study|Abnormal Laboratory Value|12|||
164330779|NCT02536833|593588299|FG000|Overall Study|Discontinued Before Treatment|0|||
164330780|NCT02536833|593588300|FG001|Overall Study|Discontinued Before Treatment|0|||
164330781|NCT02536833|593588301|FG002|Overall Study|Discontinued Before Treatment|1|||
164330782|NCT02536833|593588302|FG003|Overall Study|Discontinued Before Treatment|2|||
164330783|NCT02536833|593588299|FG000|Overall Study|Adverse Event|1|||
164330784|NCT02536833|593588300|FG001|Overall Study|Adverse Event|3|||
164330785|NCT02536833|593588301|FG002|Overall Study|Adverse Event|4|||
164330786|NCT02536833|593588302|FG003|Overall Study|Adverse Event|1|||
164330787|NCT02536833|593588299|FG000|Overall Study|Lost to Follow-up|2|||
164330788|NCT02536833|593588300|FG001|Overall Study|Lost to Follow-up|1|||
164330789|NCT02536833|593588301|FG002|Overall Study|Lost to Follow-up|2|||
164571154|NCT00813995|594456822|FG000|Overall Study|Lack of Efficacy|1|||
164225985|NCT01887600|593196289|FG000|Overall Study|Death|39|||
164225986|NCT01887600|593196290|FG001|Overall Study|Death|16|||
164225987|NCT01887600|593196289|FG000|Overall Study|Lack of Efficacy|3|||
164225988|NCT01887600|593196290|FG001|Overall Study|Lack of Efficacy|26|||
164225989|NCT01887600|593196289|FG000|Overall Study|Lost to Follow-up|5|||
164225990|NCT01887600|593196290|FG001|Overall Study|Lost to Follow-up|1|||
164225991|NCT01887600|593196289|FG000|Overall Study|Physician Decision|7|||
164571155|NCT00813995|594456823|FG001|Overall Study|Lack of Efficacy|0|||
164571156|NCT00813995|594456822|FG000|Overall Study|Lost to Follow-up|4|||
164571157|NCT00813995|594456823|FG001|Overall Study|Lost to Follow-up|2|||
164225992|NCT01887600|593196290|FG001|Overall Study|Physician Decision|8|||
164571158|NCT00813995|594456822|FG000|Overall Study|Other reason|2|||
164571159|NCT00813995|594456823|FG001|Overall Study|Other reason|2|||
164225993|NCT01887600|593196289|FG000|Overall Study|Protocol Deviation|3|||
164225994|NCT01887600|593196290|FG001|Overall Study|Protocol Deviation|0|||
164330790|NCT02536833|593588302|FG003|Overall Study|Lost to Follow-up|2|||
164225995|NCT01887600|593196289|FG000|Overall Study|Withdrawal by Subject|58|||
164225996|NCT01887600|593196290|FG001|Overall Study|Withdrawal by Subject|52|||
164225997|NCT01887600|593196289|FG000|Overall Study|Adverse Event|21|||
164330791|NCT02536833|593588299|FG000|Overall Study|Physician Decision|0|||
164330792|NCT02536833|593588300|FG001|Overall Study|Physician Decision|0|||
164330793|NCT02536833|593588301|FG002|Overall Study|Physician Decision|0|||
164330794|NCT02536833|593588302|FG003|Overall Study|Physician Decision|1|||
164330795|NCT02536833|593588299|FG000|Overall Study|Site Terminated by Sponsor|2|||
164330796|NCT02536833|593588300|FG001|Overall Study|Site Terminated by Sponsor|2|||
164225998|NCT01887600|593196290|FG001|Overall Study|Adverse Event|9|||
164225999|NCT01887600|593196289|FG000|Overall Study|Non-compliance with study drug|3|||
164226000|NCT01887600|593196290|FG001|Overall Study|Non-compliance with study drug|0|||
164226001|NCT01887600|593196289|FG000|Overall Study|Miscellaneous|6|||
164226002|NCT01887600|593196290|FG001|Overall Study|Miscellaneous|2|||
164226003|NCT01887600|593196289|FG000|Overall Study|Progressive Disease|1|||
164226004|NCT01887600|593196290|FG001|Overall Study|Progressive Disease|0|||
164226005|NCT00962650|593196291|FG000|Overall Study|Transgastric DP was not completed|2|||
164226006|NCT03688139|593196292|FG000|Overall Study|Lost to Follow-up|2|||
164226007|NCT03688139|593196293|FG001|Overall Study|Lost to Follow-up|0|||
164226008|NCT03688139|593196292|FG000|Overall Study|Physician Decision|0|||
164226009|NCT03688139|593196293|FG001|Overall Study|Physician Decision|1|||
164226010|NCT03688139|593196292|FG000|Overall Study|Withdrawal by Subject|2|||
164226011|NCT03688139|593196293|FG001|Overall Study|Withdrawal by Subject|3|||
164226012|NCT00231465|593196294|FG000|Overall Study|Completed only one cycle|1|||
164226013|NCT00231465|593196294|FG000|Overall Study|Did not have follow up CT scans|1|||
164226014|NCT00127933|593196297|FG000|Overall Study|Randomized but not dosed|1|||
164226015|NCT00127933|593196298|FG001|Overall Study|Randomized but not dosed|0|||
164226016|NCT00498485|593196299|FG000|Overall Study|Adverse Event|1|||
164226017|NCT00498485|593196300|FG001|Overall Study|Adverse Event|5|||
164226018|NCT03072875|593196301|FG000|Overall Study|Lost to Follow-up|1|||
164226019|NCT01943825|593196302|FG000|Overall Study|Lost to Follow-up|9|||
164226020|NCT01943825|593196303|FG001|Overall Study|Lost to Follow-up|3|||
164226021|NCT01943825|593196304|FG002|Overall Study|Lost to Follow-up|12|||
164226022|NCT01943825|593196305|FG003|Overall Study|Lost to Follow-up|8|||
164226023|NCT01943825|593196302|FG000|Overall Study|Withdrawal by Subject|1|||
164226024|NCT01943825|593196303|FG001|Overall Study|Withdrawal by Subject|0|||
164226025|NCT01943825|593196304|FG002|Overall Study|Withdrawal by Subject|3|||
164226026|NCT01943825|593196305|FG003|Overall Study|Withdrawal by Subject|2|||
164226027|NCT01943825|593196302|FG000|Overall Study|Other than specified above|0|||
164226028|NCT01943825|593196303|FG001|Overall Study|Other than specified above|1|||
164226029|NCT01943825|593196304|FG002|Overall Study|Other than specified above|0|||
164226030|NCT01943825|593196305|FG003|Overall Study|Other than specified above|1|||
164226031|NCT00452400|593196306|FG000|Overall Study|Adverse Event|1|||
164226032|NCT00452400|593196307|FG001|Overall Study|Adverse Event|1|||
164226033|NCT00452400|593196308|FG002|Overall Study|Adverse Event|5|||
164226034|NCT00452400|593196309|FG003|Overall Study|Adverse Event|0|||
164226035|NCT00452400|593196310|FG004|Overall Study|Adverse Event|2|||
164226036|NCT00452400|593196306|FG000|Overall Study|Protocol Violation|0|||
164226037|NCT00452400|593196307|FG001|Overall Study|Protocol Violation|0|||
164226038|NCT00452400|593196308|FG002|Overall Study|Protocol Violation|1|||
164226039|NCT00452400|593196309|FG003|Overall Study|Protocol Violation|0|||
164226040|NCT00452400|593196310|FG004|Overall Study|Protocol Violation|0|||
164571160|NCT00813995|594456822|FG000|Overall Study|Protocol Violation|3|||
164571161|NCT00813995|594456823|FG001|Overall Study|Protocol Violation|2|||
164571162|NCT00813995|594456822|FG000|Overall Study|Subject moved|4|||
164571163|NCT00813995|594456823|FG001|Overall Study|Subject moved|0|||
164571164|NCT00813995|594456822|FG000|Overall Study|Withdrawal by Subject|0|||
164571165|NCT00813995|594456823|FG001|Overall Study|Withdrawal by Subject|5|||
164571166|NCT02868892|594456824|FG000|Overall Study|Investigator left site and no follow-up|6|||
164571167|NCT00584870|594456831|FG000|Overall Study|Adverse Event|4|||
164571168|NCT00584870|594456832|FG001|Overall Study|Adverse Event|3|||
164571169|NCT00584870|594456833|FG002|Overall Study|Adverse Event|2|||
164571170|NCT00584870|594456831|FG000|Overall Study|Lost to Follow-up|4|||
164571171|NCT00584870|594456832|FG001|Overall Study|Lost to Follow-up|1|||
164571172|NCT00584870|594456833|FG002|Overall Study|Lost to Follow-up|1|||
164571173|NCT00584870|594456831|FG000|Overall Study|Lack of Efficacy|7|||
164571174|NCT00584870|594456832|FG001|Overall Study|Lack of Efficacy|14|||
164571175|NCT00584870|594456833|FG002|Overall Study|Lack of Efficacy|8|||
164571176|NCT00584870|594456831|FG000|Overall Study|Withdrawal by Subject|10|||
164571177|NCT00584870|594456832|FG001|Overall Study|Withdrawal by Subject|5|||
164571178|NCT00584870|594456833|FG002|Overall Study|Withdrawal by Subject|3|||
164571179|NCT00584870|594456831|FG000|Overall Study|Protocol Violation|1|||
164571180|NCT00584870|594456832|FG001|Overall Study|Protocol Violation|1|||
164571181|NCT00584870|594456833|FG002|Overall Study|Protocol Violation|2|||
164226041|NCT00452400|593196306|FG000|Overall Study|Lost to Follow-up|1|||
164571182|NCT00584870|594456831|FG000|Overall Study|Did not met entrance criteria|1|||
164675224|NCT04408794|594834904|FG000|Overall Study|Lost to Follow-up|33|||
164675225|NCT04408794|594834904|FG000|Overall Study|Non-compliance|6|||
164675226|NCT04408794|594834904|FG000|Overall Study|Physician Decision|1|||
164226042|NCT00452400|593196307|FG001|Overall Study|Lost to Follow-up|0|||
164226043|NCT00452400|593196308|FG002|Overall Study|Lost to Follow-up|0|||
164571183|NCT00584870|594456832|FG001|Overall Study|Did not met entrance criteria|0|||
164571184|NCT00584870|594456833|FG002|Overall Study|Did not met entrance criteria|0|||
164571185|NCT00584870|594456831|FG000|Overall Study|Other|2|||
164226044|NCT00452400|593196309|FG003|Overall Study|Lost to Follow-up|0|||
164226045|NCT00452400|593196310|FG004|Overall Study|Lost to Follow-up|0|||
164571186|NCT00584870|594456832|FG001|Overall Study|Other|0|||
164571187|NCT00584870|594456833|FG002|Overall Study|Other|0|||
164226046|NCT00452400|593196306|FG000|Overall Study|Withdrawal by Subject|1|||
164226047|NCT00452400|593196307|FG001|Overall Study|Withdrawal by Subject|0|||
164226048|NCT00452400|593196308|FG002|Overall Study|Withdrawal by Subject|1|||
164226049|NCT00452400|593196309|FG003|Overall Study|Withdrawal by Subject|0|||
164226050|NCT00452400|593196310|FG004|Overall Study|Withdrawal by Subject|0|||
164226051|NCT00452400|593196306|FG000|Overall Study|Lack of Efficacy|2|||
164226052|NCT00452400|593196307|FG001|Overall Study|Lack of Efficacy|0|||
164226053|NCT00452400|593196308|FG002|Overall Study|Lack of Efficacy|0|||
164226054|NCT00452400|593196309|FG003|Overall Study|Lack of Efficacy|0|||
164226055|NCT00452400|593196310|FG004|Overall Study|Lack of Efficacy|0|||
164226056|NCT00452400|593196306|FG000|Overall Study|Other reasons not listed above|0|||
164226057|NCT00452400|593196307|FG001|Overall Study|Other reasons not listed above|0|||
164226058|NCT00452400|593196308|FG002|Overall Study|Other reasons not listed above|0|||
164226059|NCT00452400|593196309|FG003|Overall Study|Other reasons not listed above|1|||
164226060|NCT00452400|593196310|FG004|Overall Study|Other reasons not listed above|1|||
164226061|NCT03378635|593196315|FG000|Overall Study|Adverse Event|1|||
164226062|NCT03378635|593196316|FG001|Overall Study|Adverse Event|0|||
164226063|NCT03378635|593196317|FG002|Overall Study|Adverse Event|0|||
164226064|NCT03378635|593196315|FG000|Overall Study|Withdrawal by Subject|1|||
164226065|NCT03378635|593196316|FG001|Overall Study|Withdrawal by Subject|0|||
164226066|NCT03378635|593196317|FG002|Overall Study|Withdrawal by Subject|0|||
164226067|NCT01472835|593196320|FG000|Overall Study|Lost to Follow-up|2|||
164226068|NCT01472835|593196321|FG001|Overall Study|Lost to Follow-up|0|||
164226069|NCT01835431|593196338|FG000|Overall Study|Adverse Event|1|||
164226070|NCT01835431|593196339|FG001|Overall Study|Adverse Event|0|||
164226071|NCT01835431|593196338|FG000|Overall Study|other|0|||
164226072|NCT01835431|593196339|FG001|Overall Study|other|2|||
164226073|NCT01835431|593196338|FG000|Overall Study|Withdrawal by Subject|6|||
164226074|NCT01835431|593196339|FG001|Overall Study|Withdrawal by Subject|10|||
164226075|NCT01835431|593196338|FG000|Overall Study|Protocol Violation|1|||
164226076|NCT01835431|593196339|FG001|Overall Study|Protocol Violation|0|||
164226077|NCT01316900|593196340|FG000|Overall Study|Adverse Event|10|||
164226078|NCT01316900|593196341|FG001|Overall Study|Adverse Event|10|||
164226079|NCT01316900|593196342|FG002|Overall Study|Adverse Event|15|||
164226080|NCT01316900|593196343|FG003|Overall Study|Adverse Event|9|||
164226081|NCT01316900|593196340|FG000|Overall Study|Lack of Efficacy|17|||
164226082|NCT01316900|593196341|FG001|Overall Study|Lack of Efficacy|9|||
164226083|NCT01316900|593196342|FG002|Overall Study|Lack of Efficacy|5|||
164226084|NCT01316900|593196343|FG003|Overall Study|Lack of Efficacy|7|||
164226085|NCT01316900|593196340|FG000|Overall Study|Protocol Violation|7|||
164226086|NCT01316900|593196341|FG001|Overall Study|Protocol Violation|1|||
164226087|NCT01316900|593196342|FG002|Overall Study|Protocol Violation|4|||
164226088|NCT01316900|593196343|FG003|Overall Study|Protocol Violation|0|||
164226089|NCT01316900|593196340|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
164226090|NCT01316900|593196341|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
164226091|NCT01316900|593196342|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
164226092|NCT01316900|593196343|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
164226093|NCT01316900|593196340|FG000|Overall Study|Lost to Follow-up|1|||
164226094|NCT01316900|593196341|FG001|Overall Study|Lost to Follow-up|0|||
164226095|NCT01316900|593196342|FG002|Overall Study|Lost to Follow-up|1|||
164226096|NCT01316900|593196343|FG003|Overall Study|Lost to Follow-up|1|||
164226097|NCT01316900|593196340|FG000|Overall Study|Withdrawal by Subject|7|||
164226098|NCT01316900|593196341|FG001|Overall Study|Withdrawal by Subject|8|||
164226099|NCT01316900|593196342|FG002|Overall Study|Withdrawal by Subject|6|||
164226100|NCT01316900|593196343|FG003|Overall Study|Withdrawal by Subject|9|||
164226101|NCT01684033|593196344|FG000|Period 1, First 30 Days|Adverse Event|1|||
164226102|NCT01684033|593196345|FG001|Period 1, First 30 Days|Adverse Event|1|||
164226103|NCT01684033|593196344|FG000|Period 1, First 30 Days|Noncompliance|1|||
164226104|NCT01684033|593196345|FG001|Period 1, First 30 Days|Noncompliance|0|||
164226105|NCT01684033|593196344|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
164330797|NCT02536833|593588301|FG002|Overall Study|Site Terminated by Sponsor|2|||
164330798|NCT02536833|593588302|FG003|Overall Study|Site Terminated by Sponsor|2|||
164330799|NCT02536833|593588299|FG000|Overall Study|Subject Non-Compliance|0|||
164330800|NCT02536833|593588300|FG001|Overall Study|Subject Non-Compliance|1|||
164330801|NCT02536833|593588301|FG002|Overall Study|Subject Non-Compliance|1|||
164226106|NCT01684033|593196345|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
164226107|NCT01684033|593196344|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
164226108|NCT01684033|593196345|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
164226109|NCT01684033|593196344|FG000|Period 2, Second 30 Days|Adverse Event|1|||
164226110|NCT01684033|593196345|FG001|Period 2, Second 30 Days|Adverse Event|0|||
164226111|NCT05346640|593196346|FG000|Overall Study|Lack of Efficacy|2|||
164226112|NCT05346640|593196346|FG000|Overall Study|Lost to Follow-up|14|||
164226113|NCT05346640|593196346|FG000|Overall Study|Protocol Violation|4|||
164226114|NCT05346640|593196346|FG000|Overall Study|Withdrawal by Subject|2|||
164330802|NCT02536833|593588302|FG003|Overall Study|Subject Non-Compliance|0|||
164330803|NCT02536833|593588299|FG000|Overall Study|Withdrawal by Subject|4|||
164330804|NCT02536833|593588300|FG001|Overall Study|Withdrawal by Subject|3|||
164226115|NCT05346640|593196346|FG000|Overall Study|Physiological Complications|3|||
164226116|NCT05346640|593196346|FG000|Overall Study|Other Reason|3|||
164226117|NCT03726879|593196347|FG000|Overall Study|Death|11|||
164226118|NCT03726879|593196348|FG001|Overall Study|Death|13|||
164226119|NCT03726879|593196347|FG000|Overall Study|Physician Decision|0|||
164226120|NCT03726879|593196348|FG001|Overall Study|Physician Decision|2|||
164226121|NCT03726879|593196347|FG000|Overall Study|Protocol Violation|0|||
164226122|NCT03726879|593196348|FG001|Overall Study|Protocol Violation|1|||
164226123|NCT03726879|593196347|FG000|Overall Study|Withdrawal by Subject|5|||
164226124|NCT03726879|593196348|FG001|Overall Study|Withdrawal by Subject|6|||
164226125|NCT03726879|593196347|FG000|Overall Study|TSH result is unstable|0|||
164226126|NCT03726879|593196348|FG001|Overall Study|TSH result is unstable|1|||
164226127|NCT03726879|593196347|FG000|Overall Study|Disease relapse|1|||
164226128|NCT03726879|593196348|FG001|Overall Study|Disease relapse|0|||
164226129|NCT03726879|593196347|FG000|Overall Study|Lost to Follow-up|3|||
164226130|NCT03726879|593196348|FG001|Overall Study|Lost to Follow-up|0|||
164226131|NCT02496156|593196349|FG000|Overall Study|Lost to Follow-up|5|||
164226132|NCT02496156|593196350|FG001|Overall Study|Lost to Follow-up|0|||
164226133|NCT02496156|593196349|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
164226134|NCT02496156|593196350|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
164226135|NCT00507507|593196351|FG000|Treatment Period|Lost to Follow-up|0|||
164226136|NCT00507507|593196352|FG001|Treatment Period|Lost to Follow-up|2|||
164226137|NCT00507507|593196351|FG000|Treatment Period|Physician Decision|4|||
164226138|NCT00507507|593196352|FG001|Treatment Period|Physician Decision|1|||
164226139|NCT00507507|593196351|FG000|Treatment Period|Protocol Violation|1|||
164226140|NCT00507507|593196352|FG001|Treatment Period|Protocol Violation|2|||
164226141|NCT00507507|593196351|FG000|Treatment Period|Adverse Event|1|||
164226142|NCT00507507|593196352|FG001|Treatment Period|Adverse Event|1|||
164226143|NCT00507507|593196351|FG000|Treatment Period|Withdrawal by Subject|46|||
164226144|NCT00507507|593196352|FG001|Treatment Period|Withdrawal by Subject|47|||
164226145|NCT00507507|593196351|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
164226146|NCT00507507|593196352|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
164330805|NCT02536833|593588301|FG002|Overall Study|Withdrawal by Subject|5|||
164330806|NCT02536833|593588302|FG003|Overall Study|Withdrawal by Subject|11|||
164330807|NCT00089674|593588303|FG000|Overall Study|Physician Decision|4|||
164226147|NCT00507507|593196351|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
164226148|NCT00507507|593196352|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
164226149|NCT00507507|593196351|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
164226150|NCT00507507|593196352|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
164226151|NCT02371889|593198384|FG000|Overall Study|Adverse medication effect|11|||
164226152|NCT02371889|593198385|FG001|Overall Study|Adverse medication effect|2|||
164226153|NCT02371889|593198384|FG000|Overall Study|Lost to Follow-up|6|||
164226154|NCT02371889|593198385|FG001|Overall Study|Lost to Follow-up|5|||
164226155|NCT02371889|593198384|FG000|Overall Study|Personal time constraints|2|||
164226156|NCT02371889|593198385|FG001|Overall Study|Personal time constraints|4|||
164226157|NCT02371889|593198384|FG000|Overall Study|Lack of Efficacy|0|||
164226158|NCT02371889|593198385|FG001|Overall Study|Lack of Efficacy|2|||
164571188|NCT00584870|594456831|FG000|Overall Study|Randomized but not treated|0|||
164330808|NCT00089674|593588304|FG001|Overall Study|Physician Decision|2|||
164571189|NCT00584870|594456832|FG001|Overall Study|Randomized but not treated|1|||
164571190|NCT00584870|594456833|FG002|Overall Study|Randomized but not treated|2|||
164571191|NCT00631137|594456834|FG000|Overall Study|Withdrawal by Subject|1|||
164571192|NCT00631137|594456835|FG001|Overall Study|Withdrawal by Subject|0|||
164571193|NCT01015833|594456836|FG000|Overall Study|Death|1|||
164571194|NCT01015833|594456837|FG001|Overall Study|Death|0|||
164571195|NCT01015833|594456836|FG000|Overall Study|Withdrawal by Subject|3|||
164571196|NCT01015833|594456837|FG001|Overall Study|Withdrawal by Subject|2|||
164571197|NCT01015833|594456836|FG000|Overall Study|Adverse Event|0|||
164571198|NCT01015833|594456837|FG001|Overall Study|Adverse Event|1|||
164571199|NCT01015833|594456836|FG000|Overall Study|Physician Decision|2|||
164226159|NCT02371889|593198384|FG000|Overall Study|Relapse|0|||
164226160|NCT02371889|593198385|FG001|Overall Study|Relapse|1|||
164226161|NCT05130281|593198386|FG000|Overall Study|Withdrawal by Subject|0|||
164226162|NCT05130281|593198387|FG001|Overall Study|Withdrawal by Subject|0|||
164571200|NCT01015833|594456837|FG001|Overall Study|Physician Decision|0|||
164226163|NCT05130281|593198388|FG002|Overall Study|Withdrawal by Subject|1|||
164226164|NCT06844812|593198389|FG000|Overall Study|Lost to Follow-up|5|||
164226165|NCT06844812|593198389|FG000|Overall Study|stigmatization concerns|2|||
164226166|NCT06844812|593198389|FG000|Overall Study|medication refusal|2|||
164226167|NCT06844812|593198389|FG000|Overall Study|concerns about possible side effects|2|||
164226168|NCT06844812|593198389|FG000|Overall Study|wanting to seek another specialist opinion|2|||
164226169|NCT06844812|593198389|FG000|Overall Study|side effects (dizziness)|1|||
164226170|NCT05520333|593198393|FG000|Overall Study|Lost to Follow-up|3|||
164226171|NCT05520333|593198394|FG001|Overall Study|Lost to Follow-up|6|||
164226172|NCT02410200|593198397|FG000|Overall Study|Adverse Event|2|||
164571201|NCT01015833|594456836|FG000|Overall Study|Symptomatic deterioration|0|||
164571202|NCT01015833|594456837|FG001|Overall Study|Symptomatic deterioration|1|||
164226173|NCT05069415|593198398|FG000|Overall Study|Withdrawal by Subject|2|||
164226174|NCT05069415|593198399|FG001|Overall Study|Withdrawal by Subject|0|||
164226175|NCT05069415|593198398|FG000|Overall Study|Adverse Event|2|||
164226176|NCT05069415|593198399|FG001|Overall Study|Adverse Event|0|||
164226177|NCT00101400|593198402|FG000|Survival Follow-Up|Alive|7|||
164226178|NCT03701074|593198403|FG000|Overall Study|Physician Decision|1|||
164226179|NCT03701074|593198404|FG001|Overall Study|Physician Decision|0|||
164226180|NCT01661595|593198410|FG000|Phase 1: Week 0-4|Adverse Event|1|||
164226181|NCT01661595|593198411|FG001|Phase 1: Week 0-4|Adverse Event|0|||
164226182|NCT01661595|593198412|FG002|Phase 1: Week 0-4|Adverse Event|0|||
164226183|NCT01661595|593198413|FG003|Phase 1: Week 0-4|Adverse Event|0|||
164226184|NCT01661595|593198410|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
164226185|NCT01661595|593198411|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
164226186|NCT01661595|593198412|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
164226187|NCT01661595|593198413|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
164226188|NCT01500135|593198414|FG000|Overall Study|Withdrawal of Consent|4|||
164226189|NCT01500135|593198415|FG001|Overall Study|Withdrawal of Consent|0|||
164226190|NCT01500135|593198414|FG000|Overall Study|Lost to Follow-up|6|||
164226191|NCT01500135|593198415|FG001|Overall Study|Lost to Follow-up|4|||
164226192|NCT01500135|593198414|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
164226193|NCT01500135|593198415|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
164226194|NCT01500135|593198414|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
164226195|NCT01500135|593198415|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
164226196|NCT01500135|593198414|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
164226197|NCT01500135|593198415|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
164226198|NCT01500135|593198414|FG000|Overall Study|Participant was a Safety Concern|1|||
164226199|NCT01500135|593198415|FG001|Overall Study|Participant was a Safety Concern|0|||
164226200|NCT01500135|593198414|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
164226201|NCT01500135|593198415|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
164226202|NCT00661687|593198416|FG000|Overall Study|Study related symptoms and complaints|5|||
164226203|NCT00661687|593198416|FG000|Overall Study|Positive slit lamp findings|4|||
164226204|NCT00661687|593198416|FG000|Overall Study|Inability to maintain wearing schedule|3|||
164226205|NCT00661687|593198416|FG000|Overall Study|Physician Decision|1|||
164226206|NCT00661687|593198416|FG000|Overall Study|Adverse Event|2|||
164226207|NCT00912509|593198417|FG000|Overall Study|Lost to Follow-up|1|||
164226208|NCT00912509|593198418|FG001|Overall Study|Lost to Follow-up|0|||
164226209|NCT00912509|593198417|FG000|Overall Study|Lack of Efficacy|4|||
164226210|NCT00912509|593198418|FG001|Overall Study|Lack of Efficacy|3|||
164226211|NCT05538728|593198419|FG000|Overall Study|Withdrawal by Subject|1|||
164226212|NCT05538728|593198420|FG001|Overall Study|Withdrawal by Subject|1|||
164226213|NCT01362530|593198422|FG000|Base Study (Cycle 1)|Adverse Event|2|||
164226214|NCT01362530|593198423|FG001|Base Study (Cycle 1)|Adverse Event|0|||
164226215|NCT01362530|593198422|FG000|Base Study (Cycle 1)|Physician Decision|0|||
164226216|NCT01362530|593198423|FG001|Base Study (Cycle 1)|Physician Decision|1|||
164226217|NCT01362530|593198422|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
164226218|NCT01362530|593198423|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
164226219|NCT01362530|593198422|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
164226220|NCT01362530|593198423|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
164226221|NCT01362530|593198422|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
164226222|NCT01362530|593198423|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
164226223|NCT01362530|593198422|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
164226224|NCT01362530|593198423|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
164571203|NCT01015833|594456836|FG000|Overall Study|Other|5|||
164226225|NCT01362530|593198422|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
164226226|NCT01362530|593198423|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
164226227|NCT01362530|593198422|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
164226228|NCT01362530|593198423|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
164226229|NCT01362530|593198422|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
164226230|NCT01362530|593198423|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
164226231|NCT01362530|593198422|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
164226232|NCT01362530|593198423|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
164226233|NCT01362530|593198422|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
164226234|NCT01362530|593198423|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
164226235|NCT01362530|593198422|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
164226236|NCT01362530|593198423|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
164226237|NCT01362530|593198422|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
164226238|NCT01362530|593198423|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
164226239|NCT01034657|593198424|FG000|Core Phase|Withdrawal by Subject|1|||
164226240|NCT01034657|593198425|FG001|Core Phase|Withdrawal by Subject|0|||
164226241|NCT01034657|593198426|FG002|Core Phase|Withdrawal by Subject|0|||
164226242|NCT01034657|593198424|FG000|Core Phase|Lack of Efficacy|2|||
164226243|NCT01034657|593198425|FG001|Core Phase|Lack of Efficacy|0|||
164226244|NCT01034657|593198426|FG002|Core Phase|Lack of Efficacy|0|||
164226245|NCT01034657|593198424|FG000|Core Phase|Abnormal laboratory value|1|||
164226246|NCT01034657|593198425|FG001|Core Phase|Abnormal laboratory value|0|||
164226247|NCT01034657|593198426|FG002|Core Phase|Abnormal laboratory value|0|||
164226248|NCT01034657|593198424|FG000|Core Phase|Adverse Event|8|||
164226249|NCT01034657|593198425|FG001|Core Phase|Adverse Event|0|||
164226250|NCT01034657|593198426|FG002|Core Phase|Adverse Event|0|||
164226251|NCT01034657|593198424|FG000|Core Phase|Protocol Violation|2|||
164226252|NCT01034657|593198425|FG001|Core Phase|Protocol Violation|0|||
164226253|NCT01034657|593198426|FG002|Core Phase|Protocol Violation|0|||
164226254|NCT01034657|593198424|FG000|Randomized Phase|Withdrawal by Subject|0|||
164226255|NCT01034657|593198425|FG001|Randomized Phase|Withdrawal by Subject|2|||
164226256|NCT01034657|593198426|FG002|Randomized Phase|Withdrawal by Subject|0|||
164226257|NCT01034657|593198424|FG000|Randomized Phase|Lack of Efficacy|5|||
164226258|NCT01034657|593198425|FG001|Randomized Phase|Lack of Efficacy|1|||
164226259|NCT01034657|593198426|FG002|Randomized Phase|Lack of Efficacy|0|||
164226260|NCT01034657|593198424|FG000|Randomized Phase|Abnormal laboratory value|0|||
164226261|NCT01034657|593198425|FG001|Randomized Phase|Abnormal laboratory value|1|||
164226262|NCT01034657|593198426|FG002|Randomized Phase|Abnormal laboratory value|0|||
164226263|NCT01034657|593198424|FG000|Randomized Phase|Adverse Event|0|||
164226264|NCT01034657|593198425|FG001|Randomized Phase|Adverse Event|2|||
164226265|NCT01034657|593198426|FG002|Randomized Phase|Adverse Event|1|||
164226266|NCT01517178|593198427|FG000|Period 1|Adverse Event|1|||
164226267|NCT01517178|593198428|FG001|Period 1|Adverse Event|2|||
164226268|NCT01517178|593198427|FG000|Period 1|Lack of Efficacy|0|||
164226269|NCT01517178|593198428|FG001|Period 1|Lack of Efficacy|1|||
164226270|NCT01517178|593198427|FG000|Period 1|E.g. study termination|3|||
164226271|NCT01517178|593198428|FG001|Period 1|E.g. study termination|1|||
164226272|NCT01517178|593198427|FG000|Period 1|Withdrawal by Subject|0|||
164226273|NCT01517178|593198428|FG001|Period 1|Withdrawal by Subject|1|||
164226274|NCT01517178|593198427|FG000|Period 2|Adverse Event|1|||
164226275|NCT01517178|593198428|FG001|Period 2|Adverse Event|0|||
164226276|NCT01517178|593198427|FG000|Period 2|Withdrawal by Subject|3|||
164226277|NCT01517178|593198428|FG001|Period 2|Withdrawal by Subject|0|||
164226278|NCT01517178|593198427|FG000|Period 2|E.g. study termination|2|||
164226279|NCT01517178|593198428|FG001|Period 2|E.g. study termination|2|||
164226280|NCT01557569|593198429|FG000|Overall Study|Adverse Event|2|||
164226281|NCT01557569|593198430|FG001|Overall Study|Adverse Event|0|||
164226282|NCT01557569|593198429|FG000|Overall Study|high blood pressure|0|||
164226283|NCT01557569|593198430|FG001|Overall Study|high blood pressure|1|||
164226284|NCT01557569|593198429|FG000|Overall Study|Withdrawal by Subject|3|||
164226285|NCT01557569|593198430|FG001|Overall Study|Withdrawal by Subject|5|||
164226286|NCT01557569|593198429|FG000|Overall Study|noncompliance with rules of residential|0|||
164226287|NCT01557569|593198430|FG001|Overall Study|noncompliance with rules of residential|1|||
164330809|NCT00089674|593588303|FG000|Overall Study|Adverse Event|23|||
164330810|NCT00089674|593588304|FG001|Overall Study|Adverse Event|29|||
164226288|NCT01772693|593198431|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
164226289|NCT01772693|593198432|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
164226290|NCT01772693|593198431|FG000|Overall Study|Withdrawal by Subject|2|||
164226291|NCT01772693|593198432|FG001|Overall Study|Withdrawal by Subject|0|||
164226292|NCT01772693|593198431|FG000|Overall Study|Alternative Treatment|2|||
164226293|NCT01772693|593198432|FG001|Overall Study|Alternative Treatment|0|||
164226294|NCT01633112|593198435|FG000|Overall Study|Lack of Efficacy|1|||
164226295|NCT01633112|593198436|FG001|Overall Study|Lack of Efficacy|6|||
164226296|NCT01633112|593198437|FG002|Overall Study|Lack of Efficacy|13|||
164226297|NCT01633112|593198435|FG000|Overall Study|Abnormal laboratory value(s)|3|||
164226298|NCT01633112|593198436|FG001|Overall Study|Abnormal laboratory value(s)|1|||
164226299|NCT01633112|593198437|FG002|Overall Study|Abnormal laboratory value(s)|0|||
164226300|NCT01633112|593198435|FG000|Overall Study|Abnormal test procedure result(s)|0|||
164226301|NCT01633112|593198436|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164226302|NCT01633112|593198437|FG002|Overall Study|Abnormal test procedure result(s)|0|||
164226303|NCT01633112|593198435|FG000|Overall Study|Administrative problems|1|||
164226304|NCT01633112|593198436|FG001|Overall Study|Administrative problems|2|||
164226305|NCT01633112|593198437|FG002|Overall Study|Administrative problems|5|||
164226306|NCT01633112|593198435|FG000|Overall Study|Adverse Event|16|||
164226307|NCT01633112|593198436|FG001|Overall Study|Adverse Event|18|||
164226308|NCT01633112|593198437|FG002|Overall Study|Adverse Event|20|||
164226309|NCT01633112|593198435|FG000|Overall Study|Lost to Follow-up|7|||
164226310|NCT01633112|593198436|FG001|Overall Study|Lost to Follow-up|19|||
164226311|NCT01633112|593198437|FG002|Overall Study|Lost to Follow-up|6|||
164226312|NCT01633112|593198435|FG000|Overall Study|Protocol Violation|4|||
164226313|NCT01633112|593198436|FG001|Overall Study|Protocol Violation|0|||
164226314|NCT01633112|593198437|FG002|Overall Study|Protocol Violation|2|||
164226315|NCT01633112|593198435|FG000|Overall Study|Subject no longer requires study drug|0|||
164226316|NCT01633112|593198436|FG001|Overall Study|Subject no longer requires study drug|0|||
164226317|NCT01633112|593198437|FG002|Overall Study|Subject no longer requires study drug|1|||
164226318|NCT01633112|593198435|FG000|Overall Study|Withdrawal by Subject|20|||
164226319|NCT01633112|593198436|FG001|Overall Study|Withdrawal by Subject|12|||
164226320|NCT01633112|593198437|FG002|Overall Study|Withdrawal by Subject|41|||
164226321|NCT01633112|593198435|FG000|Overall Study|missing Study Completion CRF|1|||
164226322|NCT01633112|593198436|FG001|Overall Study|missing Study Completion CRF|1|||
164226323|NCT01633112|593198437|FG002|Overall Study|missing Study Completion CRF|4|||
164226324|NCT01225952|593198439|FG000|Overall Study|Lost to Follow-up|1|||
164226325|NCT01225952|593198440|FG001|Overall Study|Lost to Follow-up|0|||
164226326|NCT01225952|593198441|FG002|Overall Study|Lost to Follow-up|0|||
164226327|NCT01225952|593198439|FG000|Overall Study|Study Eye Explanted|0|||
164226328|NCT01225952|593198440|FG001|Overall Study|Study Eye Explanted|0|||
164226329|NCT01225952|593198441|FG002|Overall Study|Study Eye Explanted|1|||
164226330|NCT01225952|593198439|FG000|Overall Study|Withdrawal by Subject|4|||
164226331|NCT01225952|593198440|FG001|Overall Study|Withdrawal by Subject|4|||
164226332|NCT01225952|593198441|FG002|Overall Study|Withdrawal by Subject|5|||
164226333|NCT01225952|593198439|FG000|Overall Study|Surgical complications|1|||
164226334|NCT01225952|593198440|FG001|Overall Study|Surgical complications|0|||
164226335|NCT01225952|593198441|FG002|Overall Study|Surgical complications|0|||
164330811|NCT00089674|593588303|FG000|Overall Study|Withdrawal by Subject|143|||
164330812|NCT00089674|593588304|FG001|Overall Study|Withdrawal by Subject|127|||
164330813|NCT00089674|593588303|FG000|Overall Study|Death|43|||
164330814|NCT00089674|593588304|FG001|Overall Study|Death|43|||
164330815|NCT00089674|593588303|FG000|Overall Study|Disease progression|21|||
164330816|NCT00089674|593588304|FG001|Overall Study|Disease progression|23|||
164330817|NCT00089674|593588303|FG000|Overall Study|Ineligibility determined|8|||
164330818|NCT00089674|593588304|FG001|Overall Study|Ineligibility determined|10|||
164330819|NCT00089674|593588303|FG000|Overall Study|Lost to Follow-up|21|||
164226336|NCT00889005|593198442|FG000|Overall Study|Lost to Follow-up|4|||
164226337|NCT00889005|593198443|FG001|Overall Study|Lost to Follow-up|2|||
164226338|NCT00889005|593198442|FG000|Overall Study|Withdrawal by Subject|4|||
164330820|NCT00089674|593588304|FG001|Overall Study|Lost to Follow-up|17|||
164330821|NCT00089674|593588303|FG000|Overall Study|Noncompliance|7|||
164330822|NCT00089674|593588304|FG001|Overall Study|Noncompliance|3|||
164330823|NCT00089674|593588303|FG000|Overall Study|Other|5|||
164226339|NCT00889005|593198443|FG001|Overall Study|Withdrawal by Subject|0|||
164226340|NCT02872142|593198447|FG000|Overall Study|Adverse Event|2|||
164226341|NCT02872142|593198447|FG000|Overall Study|Death|1|||
164226342|NCT02872142|593198447|FG000|Overall Study|Participant Decision|3|||
164226343|NCT05122143|593198448|FG000|Overall Study|Adverse Event|1|||
164330824|NCT00089674|593588304|FG001|Overall Study|Other|9|||
164330825|NCT00089674|593588303|FG000|Overall Study|Requirement for alternative therapy|14|||
164330826|NCT00089674|593588304|FG001|Overall Study|Requirement for alternative therapy|4|||
164330827|NCT01437878|593588305|FG000|Overall Study|Withdrawal by Subject|1|||
164330828|NCT01437878|593588306|FG001|Overall Study|Withdrawal by Subject|0|||
164330829|NCT01476644|593588313|FG000|Overall Study|Death|5|||
164226344|NCT05122143|593198449|FG001|Overall Study|Adverse Event|0|||
164330830|NCT01476644|593588313|FG000|Overall Study|moved to another state|2|||
164571204|NCT01015833|594456837|FG001|Overall Study|Other|1|||
164226345|NCT05122143|593198450|FG002|Overall Study|Adverse Event|0|||
164226346|NCT05122143|593198451|FG003|Overall Study|Adverse Event|0|||
164226347|NCT05122143|593198452|FG004|Overall Study|Adverse Event|1|||
164330831|NCT01476644|593588313|FG000|Overall Study|Lost to Follow-up|19|||
164330832|NCT01476644|593588313|FG000|Overall Study|Withdrawal by Subject|13|||
164330833|NCT01462227|593588315|FG000|Second Assignment|Lost to Follow-up|1|||
164226348|NCT05122143|593198453|FG005|Overall Study|Adverse Event|0|||
164226349|NCT05122143|593198448|FG000|Overall Study|Protocol non-compliance|0|||
164330834|NCT01462227|593588316|FG001|Second Assignment|Lost to Follow-up|0|||
164330835|NCT01462227|593588317|FG002|Second Assignment|Lost to Follow-up|0|||
164226350|NCT05122143|593198449|FG001|Overall Study|Protocol non-compliance|0|||
164226351|NCT05122143|593198450|FG002|Overall Study|Protocol non-compliance|1|||
164226352|NCT05122143|593198451|FG003|Overall Study|Protocol non-compliance|0|||
164226353|NCT05122143|593198452|FG004|Overall Study|Protocol non-compliance|0|||
164226354|NCT05122143|593198453|FG005|Overall Study|Protocol non-compliance|0|||
164226355|NCT05122143|593198448|FG000|Overall Study|Covid contact|0|||
164226356|NCT05122143|593198449|FG001|Overall Study|Covid contact|0|||
164226357|NCT05122143|593198450|FG002|Overall Study|Covid contact|0|||
164226358|NCT05122143|593198451|FG003|Overall Study|Covid contact|0|||
164226359|NCT05122143|593198452|FG004|Overall Study|Covid contact|1|||
164226360|NCT05122143|593198453|FG005|Overall Study|Covid contact|0|||
164226361|NCT00692237|593198456|FG000|Overall Study|Withdrawal by Subject|1|||
164226362|NCT00692237|593198457|FG001|Overall Study|Withdrawal by Subject|3|||
164226363|NCT00692237|593198456|FG000|Overall Study|Adverse Event|0|||
164226364|NCT00692237|593198457|FG001|Overall Study|Adverse Event|1|||
164226365|NCT00395447|593198460|FG000|Overall Study|Death|37|||
164226366|NCT00395447|593198461|FG001|Overall Study|Death|32|||
164226367|NCT00395447|593198460|FG000|Overall Study|Lost to Follow-up|52|||
164226368|NCT00395447|593198461|FG001|Overall Study|Lost to Follow-up|43|||
164226369|NCT00395447|593198460|FG000|Overall Study|Withdrawal by Subject|24|||
164226370|NCT00395447|593198461|FG001|Overall Study|Withdrawal by Subject|19|||
164226371|NCT00395447|593198460|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
164226372|NCT00395447|593198461|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
164226373|NCT03766906|593198462|FG000|Overall Study|Withdrawal by Subject|6|||
164226374|NCT02624687|593198463|FG000|Overall Study|Withdrawal by Subject|1|||
164226375|NCT02624687|593198464|FG001|Overall Study|Withdrawal by Subject|1|||
164226376|NCT02624687|593198463|FG000|Overall Study|medical leave from work|0|||
164226377|NCT02624687|593198464|FG001|Overall Study|medical leave from work|1|||
164226378|NCT00836901|593198467|FG000|First Intervention|Withdrawal by Subject|1|||
164226379|NCT00836901|593198468|FG001|First Intervention|Withdrawal by Subject|0|||
164226380|NCT01047540|593198469|FG000|Overall Study|Protocol Violation|1|||
164226381|NCT01047540|593198470|FG001|Overall Study|Protocol Violation|0|||
164226382|NCT01047540|593198471|FG002|Overall Study|Protocol Violation|0|||
164226383|NCT01047540|593198472|FG003|Overall Study|Protocol Violation|0|||
164226384|NCT01047540|593198473|FG004|Overall Study|Protocol Violation|0|||
164226385|NCT01047540|593198469|FG000|Overall Study|Lost to Follow-up|1|||
164226386|NCT01047540|593198470|FG001|Overall Study|Lost to Follow-up|0|||
164226387|NCT01047540|593198471|FG002|Overall Study|Lost to Follow-up|0|||
164226388|NCT01047540|593198472|FG003|Overall Study|Lost to Follow-up|0|||
164226389|NCT01047540|593198473|FG004|Overall Study|Lost to Follow-up|0|||
164226390|NCT01047540|593198469|FG000|Overall Study|Withdrawal by Subject|1|||
164226391|NCT01047540|593198470|FG001|Overall Study|Withdrawal by Subject|0|||
164226392|NCT01047540|593198471|FG002|Overall Study|Withdrawal by Subject|3|||
164226393|NCT01047540|593198472|FG003|Overall Study|Withdrawal by Subject|0|||
164226394|NCT01047540|593198473|FG004|Overall Study|Withdrawal by Subject|1|||
164226395|NCT01047540|593198469|FG000|Overall Study|Pregnancy|1|||
164226396|NCT01047540|593198470|FG001|Overall Study|Pregnancy|0|||
164226397|NCT01047540|593198471|FG002|Overall Study|Pregnancy|0|||
164226398|NCT01047540|593198472|FG003|Overall Study|Pregnancy|0|||
164226399|NCT01047540|593198473|FG004|Overall Study|Pregnancy|0|||
164226400|NCT01047540|593198469|FG000|Overall Study|Adverse Event|1|||
164226401|NCT01047540|593198470|FG001|Overall Study|Adverse Event|0|||
164226402|NCT01047540|593198471|FG002|Overall Study|Adverse Event|0|||
164226403|NCT01047540|593198472|FG003|Overall Study|Adverse Event|0|||
164226404|NCT01047540|593198473|FG004|Overall Study|Adverse Event|0|||
164226405|NCT03032484|593198479|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
164226406|NCT03032484|593198480|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
164226407|NCT03032484|593198479|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
164226408|NCT03032484|593198480|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
164226409|NCT01689649|593198481|FG000|Overall Study|Lack of Efficacy|3|||
164226410|NCT01689649|593198481|FG000|Overall Study|Non-compliance|11|||
164226411|NCT01689649|593198481|FG000|Overall Study|Protocol Violation|3|||
164226412|NCT01689649|593198481|FG000|Overall Study|Lost to Follow-up|5|||
164226413|NCT04893811|593198482|FG000|Vaccination Phase|Death|1|||
164571205|NCT01015833|594456836|FG000|Overall Study|Motor Vehicle Accidents|1|||
164571206|NCT01015833|594456837|FG001|Overall Study|Motor Vehicle Accidents|0|||
164226414|NCT04893811|593198483|FG001|Vaccination Phase|Death|0|||
164226415|NCT04893811|593198482|FG000|Vaccination Phase|Lost to Follow-up|1|||
164226416|NCT04893811|593198483|FG001|Vaccination Phase|Lost to Follow-up|1|||
164571207|NCT01015833|594456836|FG000|Overall Study|Did not start treatment|1|||
164226417|NCT04893811|593198482|FG000|Vaccination Phase|Protocol Violation|2|||
164421064|NCT02138747|593911084|FG000|Treatment Period 2|Other - Miscellaneous|3|||
164226418|NCT04893811|593198483|FG001|Vaccination Phase|Protocol Violation|0|||
164226419|NCT04893811|593198482|FG000|Vaccination Phase|Withdrawal by Subject|2|||
164226420|NCT04893811|593198483|FG001|Vaccination Phase|Withdrawal by Subject|1|||
164226421|NCT04893811|593198482|FG000|Vaccination Phase|Other|0|||
164226422|NCT04893811|593198483|FG001|Vaccination Phase|Other|1|||
164226423|NCT04893811|593198482|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
164226424|NCT04893811|593198483|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
164226425|NCT04893811|593198482|FG000|Follow-up Phase|Lost to Follow-up|0|||
164226426|NCT04893811|593198483|FG001|Follow-up Phase|Lost to Follow-up|1|||
164226427|NCT00595075|593198490|FG000|Overall Study|Withdrawal by Subject|1|||
164226428|NCT00595075|593198491|FG001|Overall Study|Withdrawal by Subject|0|||
164226429|NCT05261490|593198493|FG000|Overall Study|Other|1|||
164226430|NCT05261490|593198494|FG001|Overall Study|Other|0|||
164226431|NCT05261490|593198495|FG002|Overall Study|Other|0|||
164226432|NCT05261490|593198493|FG000|Overall Study|Study Terminated by Sponsor|1|||
164226433|NCT05261490|593198494|FG001|Overall Study|Study Terminated by Sponsor|1|||
164226434|NCT05261490|593198495|FG002|Overall Study|Study Terminated by Sponsor|4|||
164226435|NCT05261490|593198493|FG000|Overall Study|Death|1|||
164226436|NCT05261490|593198494|FG001|Overall Study|Death|2|||
164226437|NCT05261490|593198495|FG002|Overall Study|Death|0|||
164226438|NCT01335685|593198499|FG000|Overall Study|Study Terminated by Sponsor|2|||
164226439|NCT01335685|593198500|FG001|Overall Study|Study Terminated by Sponsor|1|||
164226440|NCT01335685|593198501|FG002|Overall Study|Study Terminated by Sponsor|1|||
164226441|NCT01335685|593198502|FG003|Overall Study|Study Terminated by Sponsor|10|||
164226442|NCT01335685|593198503|FG004|Overall Study|Study Terminated by Sponsor|0|||
164226443|NCT01335685|593198504|FG005|Overall Study|Study Terminated by Sponsor|4|||
164226444|NCT01335685|593198505|FG006|Overall Study|Study Terminated by Sponsor|2|||
164226445|NCT01335685|593198506|FG007|Overall Study|Study Terminated by Sponsor|3|||
164226446|NCT01335685|593198499|FG000|Overall Study|Withdrawal by Subject|1|||
164226447|NCT01335685|593198500|FG001|Overall Study|Withdrawal by Subject|0|||
164226448|NCT01335685|593198501|FG002|Overall Study|Withdrawal by Subject|0|||
164226449|NCT01335685|593198502|FG003|Overall Study|Withdrawal by Subject|1|||
164226450|NCT01335685|593198503|FG004|Overall Study|Withdrawal by Subject|0|||
164226451|NCT01335685|593198504|FG005|Overall Study|Withdrawal by Subject|0|||
164226452|NCT01335685|593198505|FG006|Overall Study|Withdrawal by Subject|0|||
164226453|NCT01335685|593198506|FG007|Overall Study|Withdrawal by Subject|0|||
164226454|NCT01335685|593198499|FG000|Overall Study|Reason not Specified|0|||
164226455|NCT01335685|593198500|FG001|Overall Study|Reason not Specified|0|||
164226456|NCT01335685|593198501|FG002|Overall Study|Reason not Specified|1|||
164226457|NCT01335685|593198502|FG003|Overall Study|Reason not Specified|0|||
164226458|NCT01335685|593198503|FG004|Overall Study|Reason not Specified|0|||
164330836|NCT01462227|593588318|FG003|Second Assignment|Lost to Follow-up|0|||
164330837|NCT01462227|593588315|FG000|Second Assignment|Protocol Violation|0|||
164330838|NCT01462227|593588316|FG001|Second Assignment|Protocol Violation|1|||
164330839|NCT01462227|593588317|FG002|Second Assignment|Protocol Violation|1|||
164330840|NCT01462227|593588318|FG003|Second Assignment|Protocol Violation|0|||
164330841|NCT00586066|593588321|FG000|Overall Study|Lost to Follow-up|6|||
164330842|NCT00586066|593588322|FG001|Overall Study|Lost to Follow-up|3|||
164330843|NCT00586066|593588321|FG000|Overall Study|Lack of Efficacy|5|||
164330844|NCT00586066|593588322|FG001|Overall Study|Lack of Efficacy|3|||
164330845|NCT00586066|593588321|FG000|Overall Study|Adverse Event|2|||
164330846|NCT00586066|593588322|FG001|Overall Study|Adverse Event|2|||
164330847|NCT00586066|593588321|FG000|Overall Study|Physician Decision|1|||
164330848|NCT00586066|593588322|FG001|Overall Study|Physician Decision|0|||
164330849|NCT00586066|593588321|FG000|Overall Study|Withdrawal of consent|4|||
164330850|NCT00586066|593588322|FG001|Overall Study|Withdrawal of consent|2|||
164330851|NCT00144027|593588323|FG000|Overall Study|Lost to Follow-up|1|||
164571208|NCT01015833|594456837|FG001|Overall Study|Did not start treatment|0|||
164571209|NCT03430986|594456840|FG000|24-week Control Period|Adverse Event|1|||
164571210|NCT03430986|594456841|FG001|24-week Control Period|Adverse Event|0|||
164571211|NCT03430986|594456840|FG000|24-week Control Period|Lost to Follow-up|2|||
164571212|NCT03430986|594456841|FG001|24-week Control Period|Lost to Follow-up|2|||
164571213|NCT03430986|594456840|FG000|24-week Control Period|Withdrawal by Participant|5|||
164571214|NCT03430986|594456841|FG001|24-week Control Period|Withdrawal by Participant|0|||
164571215|NCT03430986|594456840|FG000|24-week Control Period|Protocol Deviation|0|||
164571216|NCT03430986|594456841|FG001|24-week Control Period|Protocol Deviation|2|||
164571217|NCT03430986|594456840|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
164571218|NCT03430986|594456841|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
164226459|NCT01335685|593198504|FG005|Overall Study|Reason not Specified|1|||
164226460|NCT01335685|593198505|FG006|Overall Study|Reason not Specified|0|||
164226461|NCT01335685|593198506|FG007|Overall Study|Reason not Specified|0|||
164226462|NCT02554474|593198507|FG000|Overall Study|Protocol Violation|1|||
164226463|NCT02554474|593198508|FG001|Overall Study|Protocol Violation|1|||
164226464|NCT02554474|593198507|FG000|Overall Study|Health issue not related to the study|1|||
164330852|NCT00144027|593588324|FG001|Overall Study|Lost to Follow-up|3|||
164571219|NCT03430986|594456840|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
164571220|NCT03430986|594456841|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
164226465|NCT02554474|593198508|FG001|Overall Study|Health issue not related to the study|0|||
164330853|NCT00144027|593588323|FG000|Overall Study|Withdrawal by Subject|2|||
164330854|NCT00144027|593588324|FG001|Overall Study|Withdrawal by Subject|2|||
164330855|NCT00144027|593588323|FG000|Overall Study|did not complete baseline assessment|0|||
164571221|NCT00961961|594456844|FG000|Phase I|Withdrawal by Subject|7|||
164226466|NCT02554474|593198507|FG000|Overall Study|Withdrawal by Subject|1|||
164226467|NCT02554474|593198508|FG001|Overall Study|Withdrawal by Subject|1|||
164226468|NCT03211832|593198511|FG000|Overall Study|No longer with agency|32|||
164226469|NCT03211832|593198512|FG001|Overall Study|No longer with agency|49|||
164226470|NCT03211832|593198513|FG002|Overall Study|No longer with agency|30|||
164226471|NCT03211832|593198511|FG000|Overall Study|Declined survey|3|||
164226472|NCT03211832|593198512|FG001|Overall Study|Declined survey|3|||
164226473|NCT03211832|593198513|FG002|Overall Study|Declined survey|2|||
164226474|NCT03211832|593198511|FG000|Overall Study|Not available during data collection|1|||
164226475|NCT03211832|593198512|FG001|Overall Study|Not available during data collection|0|||
164226476|NCT03211832|593198513|FG002|Overall Study|Not available during data collection|2|||
164226477|NCT03777020|593198517|FG000|Overall Study|Withdrawal by Subject|4|||
164226478|NCT03777020|593198518|FG001|Overall Study|Withdrawal by Subject|4|||
164226479|NCT03777020|593198517|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
164226480|NCT03777020|593198518|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
164226481|NCT01422382|593198519|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
164226482|NCT00967499|593198520|FG000|Overall Study|Adverse Event|0|||
164226483|NCT00967499|593198521|FG001|Overall Study|Adverse Event|1|||
164226484|NCT00967499|593198520|FG000|Overall Study|Protocol Violation|1|||
164226485|NCT00967499|593198521|FG001|Overall Study|Protocol Violation|0|||
164226486|NCT00967499|593198520|FG000|Overall Study|Sponsor Decision|1|||
164571222|NCT00961961|594456845|FG001|Phase I|Withdrawal by Subject|0|||
164571223|NCT00961961|594456846|FG002|Phase I|Withdrawal by Subject|0|||
164226487|NCT00967499|593198521|FG001|Overall Study|Sponsor Decision|0|||
164226488|NCT00967499|593198520|FG000|Overall Study|Randomized but not treated|63|||
164226489|NCT00967499|593198521|FG001|Overall Study|Randomized but not treated|59|||
164226490|NCT00420056|593198528|FG000|Overall Study|Objective progression or relapse|17|||
164226491|NCT03111732|593198532|FG000|Overall Study|Enrolled in different study|1|||
164226492|NCT03111732|593198532|FG000|Overall Study|Progressive disease|3|||
164226493|NCT03111732|593198532|FG000|Overall Study|Withdrawal by Subject|1|||
164226494|NCT00289900|593198536|FG000|Overall Study|Adverse Event|28|||
164226495|NCT00289900|593198537|FG001|Overall Study|Adverse Event|40|||
164226496|NCT00289900|593198538|FG002|Overall Study|Adverse Event|13|||
164226497|NCT00289900|593198539|FG003|Overall Study|Adverse Event|19|||
164226498|NCT00289900|593198540|FG004|Overall Study|Adverse Event|20|||
164226499|NCT00289900|593198541|FG005|Overall Study|Adverse Event|33|||
164226500|NCT00289900|593198536|FG000|Overall Study|Lost to Follow-up|7|||
164226501|NCT00289900|593198537|FG001|Overall Study|Lost to Follow-up|7|||
164226502|NCT00289900|593198538|FG002|Overall Study|Lost to Follow-up|8|||
164226503|NCT00289900|593198539|FG003|Overall Study|Lost to Follow-up|8|||
164226504|NCT00289900|593198540|FG004|Overall Study|Lost to Follow-up|4|||
164226505|NCT00289900|593198541|FG005|Overall Study|Lost to Follow-up|8|||
164226506|NCT00289900|593198536|FG000|Overall Study|Participant had flushing|18|||
164226507|NCT00289900|593198537|FG001|Overall Study|Participant had flushing|42|||
164226508|NCT00289900|593198538|FG002|Overall Study|Participant had flushing|1|||
164226509|NCT00289900|593198539|FG003|Overall Study|Participant had flushing|2|||
164226510|NCT00289900|593198540|FG004|Overall Study|Participant had flushing|0|||
164226511|NCT00289900|593198541|FG005|Overall Study|Participant had flushing|4|||
164226512|NCT00289900|593198536|FG000|Overall Study|Other|0|||
164226513|NCT00289900|593198537|FG001|Overall Study|Other|0|||
164226514|NCT00289900|593198538|FG002|Overall Study|Other|0|||
164226515|NCT00289900|593198539|FG003|Overall Study|Other|5|||
164226516|NCT00289900|593198540|FG004|Overall Study|Other|1|||
164226517|NCT00289900|593198541|FG005|Overall Study|Other|0|||
164330856|NCT00144027|593588324|FG001|Overall Study|did not complete baseline assessment|6|||
164330857|NCT00910988|593588325|FG000|Overall Study|Lost to Follow-up|2|||
164330858|NCT00910988|593588326|FG001|Overall Study|Lost to Follow-up|4|||
164330859|NCT00910988|593588327|FG002|Overall Study|Lost to Follow-up|3|||
164330860|NCT00910988|593588328|FG003|Overall Study|Lost to Follow-up|0|||
164330861|NCT01977937|593588329|FG000|Overall Study|Withdrawal by Subject|2|||
164330862|NCT01977937|593588330|FG001|Overall Study|Withdrawal by Subject|1|||
164330863|NCT01977937|593588329|FG000|Overall Study|Adverse Event|1|||
164571224|NCT00961961|594456847|FG003|Phase I|Withdrawal by Subject|0|||
164226518|NCT00289900|593198536|FG000|Overall Study|Participant moved|1|||
164226519|NCT00289900|593198537|FG001|Overall Study|Participant moved|0|||
164226520|NCT00289900|593198538|FG002|Overall Study|Participant moved|0|||
164226521|NCT00289900|593198539|FG003|Overall Study|Participant moved|1|||
164226522|NCT00289900|593198540|FG004|Overall Study|Participant moved|1|||
164226523|NCT00289900|593198541|FG005|Overall Study|Participant moved|1|||
164226524|NCT00289900|593198536|FG000|Overall Study|Withdrawal by Subject|10|||
164226525|NCT00289900|593198537|FG001|Overall Study|Withdrawal by Subject|21|||
164571225|NCT00961961|594456844|FG000|Phase I|Lost to Follow-up|10|||
164571226|NCT00961961|594456845|FG001|Phase I|Lost to Follow-up|0|||
164226526|NCT00289900|593198538|FG002|Overall Study|Withdrawal by Subject|8|||
164226527|NCT00289900|593198539|FG003|Overall Study|Withdrawal by Subject|18|||
164330864|NCT01977937|593588330|FG001|Overall Study|Adverse Event|0|||
164330865|NCT01977937|593588329|FG000|Overall Study|Physician Decision|0|||
164571227|NCT00961961|594456846|FG002|Phase I|Lost to Follow-up|0|||
164226528|NCT00289900|593198540|FG004|Overall Study|Withdrawal by Subject|12|||
164226529|NCT00289900|593198541|FG005|Overall Study|Withdrawal by Subject|11|||
164226530|NCT00289900|593198536|FG000|Overall Study|Protocol Violation|3|||
164226531|NCT00289900|593198537|FG001|Overall Study|Protocol Violation|9|||
164226532|NCT00289900|593198538|FG002|Overall Study|Protocol Violation|2|||
164226533|NCT00289900|593198539|FG003|Overall Study|Protocol Violation|6|||
164226534|NCT00289900|593198540|FG004|Overall Study|Protocol Violation|7|||
164226535|NCT00289900|593198541|FG005|Overall Study|Protocol Violation|4|||
164226536|NCT00289900|593198536|FG000|Overall Study|site terminated|1|||
164226537|NCT00289900|593198537|FG001|Overall Study|site terminated|0|||
164226538|NCT00289900|593198538|FG002|Overall Study|site terminated|1|||
164226539|NCT00289900|593198539|FG003|Overall Study|site terminated|0|||
164226540|NCT00289900|593198540|FG004|Overall Study|site terminated|0|||
164226541|NCT00289900|593198541|FG005|Overall Study|site terminated|0|||
164226542|NCT00289900|593198536|FG000|Overall Study|Not treated|0|||
164226543|NCT00289900|593198537|FG001|Overall Study|Not treated|1|||
164226544|NCT00289900|593198538|FG002|Overall Study|Not treated|0|||
164226545|NCT00289900|593198539|FG003|Overall Study|Not treated|0|||
164226546|NCT00289900|593198540|FG004|Overall Study|Not treated|0|||
164226547|NCT00289900|593198541|FG005|Overall Study|Not treated|0|||
164226548|NCT01703221|593198542|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
164226549|NCT01703221|593198543|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
164226550|NCT01703221|593198544|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
164226551|NCT01703221|593198542|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
164226552|NCT01703221|593198543|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
164226553|NCT01703221|593198544|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
164226554|NCT01703221|593198542|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
164226555|NCT01703221|593198543|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
164226556|NCT01703221|593198544|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
164226557|NCT01703221|593198542|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
164226558|NCT01703221|593198543|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
164226559|NCT01703221|593198544|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
164226560|NCT01703221|593198542|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
164226561|NCT01703221|593198543|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
164226562|NCT01703221|593198544|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
164226563|NCT01703221|593198542|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
164226564|NCT01703221|593198543|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
164226565|NCT01703221|593198544|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
164226566|NCT01703221|593198542|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
164226567|NCT01703221|593198543|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
164226568|NCT01703221|593198544|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
164226569|NCT01703221|593198542|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
164226570|NCT01703221|593198543|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
164226571|NCT01703221|593198544|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
164226572|NCT01152385|593198545|FG000|Overall Study|Withdrawal by Subject|3|||
164226573|NCT01152385|593198546|FG001|Overall Study|Withdrawal by Subject|1|||
164226574|NCT01152385|593198547|FG002|Overall Study|Withdrawal by Subject|1|||
164226575|NCT01152385|593198548|FG003|Overall Study|Withdrawal by Subject|1|||
164226576|NCT01152385|593198545|FG000|Overall Study|Protocol Violation|0|||
164226577|NCT01152385|593198546|FG001|Overall Study|Protocol Violation|0|||
164226578|NCT01152385|593198547|FG002|Overall Study|Protocol Violation|0|||
164226579|NCT01152385|593198548|FG003|Overall Study|Protocol Violation|1|||
164226580|NCT01152385|593198545|FG000|Overall Study|Adverse Event|1|||
164226581|NCT01152385|593198546|FG001|Overall Study|Adverse Event|1|||
164226582|NCT01152385|593198547|FG002|Overall Study|Adverse Event|0|||
164226583|NCT01152385|593198548|FG003|Overall Study|Adverse Event|0|||
164226584|NCT01152385|593198545|FG000|Overall Study|Study-specific withdrawal criteria|1|||
164226585|NCT01152385|593198546|FG001|Overall Study|Study-specific withdrawal criteria|1|||
164226586|NCT01152385|593198547|FG002|Overall Study|Study-specific withdrawal criteria|2|||
164226587|NCT01152385|593198548|FG003|Overall Study|Study-specific withdrawal criteria|0|||
164226588|NCT01152385|593198545|FG000|Overall Study|Other|4|||
164226589|NCT01152385|593198546|FG001|Overall Study|Other|3|||
164226590|NCT01152385|593198547|FG002|Overall Study|Other|2|||
164226591|NCT01152385|593198548|FG003|Overall Study|Other|3|||
164226592|NCT03249558|593198549|FG000|Overall Study|Lost to Follow-up|2|||
164226593|NCT03249558|593198550|FG001|Overall Study|Lost to Follow-up|1|||
164226594|NCT03249558|593198551|FG002|Overall Study|Lost to Follow-up|4|||
164675227|NCT04408794|594834904|FG000|Overall Study|Pregnancy|6|||
164226595|NCT03249558|593198549|FG000|Overall Study|Physician Decision|1|||
164226596|NCT03249558|593198550|FG001|Overall Study|Physician Decision|0|||
164226597|NCT03249558|593198551|FG002|Overall Study|Physician Decision|0|||
164226598|NCT03249558|593198549|FG000|Overall Study|Withdrawal by Subject|6|||
164226599|NCT03249558|593198550|FG001|Overall Study|Withdrawal by Subject|5|||
164226600|NCT03249558|593198551|FG002|Overall Study|Withdrawal by Subject|7|||
164226601|NCT03249558|593198549|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
164226602|NCT03249558|593198550|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
164226603|NCT03249558|593198551|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
164226604|NCT03249558|593198549|FG000|Overall Study|Protocol Violation|1|||
164226605|NCT03249558|593198550|FG001|Overall Study|Protocol Violation|1|||
164226606|NCT03249558|593198551|FG002|Overall Study|Protocol Violation|2|||
164226607|NCT02656173|593198552|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
164226608|NCT02656173|593198553|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
164226609|NCT02656173|593198552|FG000|Overall Study|Adverse Event|7|||
164226610|NCT02656173|593198553|FG001|Overall Study|Adverse Event|5|||
164226611|NCT02656173|593198552|FG000|Overall Study|Withdrawal by Subject|1|||
164226612|NCT02656173|593198553|FG001|Overall Study|Withdrawal by Subject|3|||
164226613|NCT02656173|593198552|FG000|Overall Study|Protocol Violation|0|||
164226614|NCT02656173|593198553|FG001|Overall Study|Protocol Violation|1|||
164226615|NCT02656173|593198552|FG000|Overall Study|Miscellaneous|2|||
164226616|NCT02656173|593198553|FG001|Overall Study|Miscellaneous|0|||
164226617|NCT03927846|593198557|FG000|Overall Study|Lost to Follow-up|10|||
164226618|NCT03927846|593198558|FG001|Overall Study|Lost to Follow-up|11|||
164226619|NCT03449147|593198559|FG000|52-week Treatment Period|Death|0|||
164226620|NCT03449147|593198560|FG001|52-week Treatment Period|Death|1|||
164226621|NCT03449147|593198561|FG002|52-week Treatment Period|Death|0|||
164226622|NCT03449147|593198559|FG000|52-week Treatment Period|Lost to Follow-up|6|||
164226623|NCT03449147|593198560|FG001|52-week Treatment Period|Lost to Follow-up|2|||
164226624|NCT03449147|593198561|FG002|52-week Treatment Period|Lost to Follow-up|5|||
164226625|NCT03449147|593198559|FG000|52-week Treatment Period|Other|0|||
164226626|NCT03449147|593198560|FG001|52-week Treatment Period|Other|1|||
164226627|NCT03449147|593198561|FG002|52-week Treatment Period|Other|2|||
164226628|NCT03449147|593198559|FG000|52-week Treatment Period|Physician Decision|1|||
164226629|NCT03449147|593198560|FG001|52-week Treatment Period|Physician Decision|0|||
164226630|NCT03449147|593198561|FG002|52-week Treatment Period|Physician Decision|3|||
164226631|NCT03449147|593198559|FG000|52-week Treatment Period|Screen Failure|1|||
164226632|NCT03449147|593198560|FG001|52-week Treatment Period|Screen Failure|2|||
164226633|NCT03449147|593198561|FG002|52-week Treatment Period|Screen Failure|0|||
164226634|NCT03449147|593198559|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
164226635|NCT03449147|593198560|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
164226636|NCT03449147|593198561|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
164226637|NCT03449147|593198559|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
164226638|NCT03449147|593198560|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
164226639|NCT03449147|593198561|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
164226640|NCT03449147|593198559|FG000|12-Week Off-Treatment Durability Period|Other|0|||
164226641|NCT03449147|593198560|FG001|12-Week Off-Treatment Durability Period|Other|1|||
164226642|NCT03449147|593198561|FG002|12-Week Off-Treatment Durability Period|Other|0|||
164226643|NCT00954538|593198562|FG000|Part III|Withdrawal by Subject|0|||
164226644|NCT00954538|593198563|FG001|Part III|Withdrawal by Subject|0|||
164226645|NCT00954538|593198564|FG002|Part III|Withdrawal by Subject|0|||
164226646|NCT00954538|593198565|FG003|Part III|Withdrawal by Subject|0|||
164226647|NCT00954538|593198566|FG004|Part III|Withdrawal by Subject|1|||
164226648|NCT00954538|593198567|FG005|Part III|Withdrawal by Subject|0|||
164226649|NCT00974233|593198572|FG000|Induction Chemoimmunotherapy|Death|2|||
164226650|NCT00974233|593198572|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
164226651|NCT00974233|593198572|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
164226652|NCT00974233|593198572|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
164226653|NCT00974233|593198572|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
164226654|NCT00974233|593198572|FG000|Maintenance Lenalidomide|Adverse Event|8|||
164571228|NCT00961961|594456847|FG003|Phase I|Lost to Follow-up|0|||
164571229|NCT00961961|594456844|FG000|Phase I|Lack of Efficacy|94|||
164226655|NCT01657942|593198573|FG000|Overall Study|Alternative Treatment|7|||
164226656|NCT01657942|593198573|FG000|Overall Study|Lost to Follow-up|1|||
164226657|NCT03061214|593198576|FG000|Overall Study|Withdrawal by Subject|21|||
164226658|NCT03061214|593198577|FG001|Overall Study|Withdrawal by Subject|26|||
164226659|NCT03061214|593198578|FG002|Overall Study|Withdrawal by Subject|9|||
164226660|NCT03061214|593198576|FG000|Overall Study|Lost to Follow-up|3|||
164226661|NCT03061214|593198577|FG001|Overall Study|Lost to Follow-up|1|||
164226662|NCT03061214|593198578|FG002|Overall Study|Lost to Follow-up|1|||
164226663|NCT03061214|593198576|FG000|Overall Study|Death|1|||
164226664|NCT03061214|593198577|FG001|Overall Study|Death|1|||
164226665|NCT03061214|593198578|FG002|Overall Study|Death|0|||
164226666|NCT02904265|593199919|FG000|Overall Study|Physician Decision|1|||
164226667|NCT02904265|593199920|FG001|Overall Study|Physician Decision|2|||
164226668|NCT00185614|593199925|FG000|Inter-treatment Period|Physician Decision|1|||
164226669|NCT00185614|593199925|FG000|Inter-treatment Period|Relapse|2|||
164226670|NCT00185614|593199925|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
164226671|NCT00993473|593199929|FG000|Overall Study|Adverse Event|0|||
164226672|NCT00993473|593199930|FG001|Overall Study|Adverse Event|2|||
164226673|NCT00993473|593199929|FG000|Overall Study|Protocol Violation|1|||
164226674|NCT00993473|593199930|FG001|Overall Study|Protocol Violation|2|||
164226675|NCT00993473|593199929|FG000|Overall Study|Lost to Follow-up|1|||
164226676|NCT00993473|593199930|FG001|Overall Study|Lost to Follow-up|0|||
164226677|NCT00993473|593199929|FG000|Overall Study|Withdrawal by Subject|1|||
164226678|NCT00993473|593199930|FG001|Overall Study|Withdrawal by Subject|5|||
164226679|NCT00993473|593199929|FG000|Overall Study|Technical problem with CGM device|0|||
164226680|NCT00993473|593199930|FG001|Overall Study|Technical problem with CGM device|1|||
164226681|NCT00993473|593199929|FG000|Overall Study|Family event|1|||
164226682|NCT00993473|593199930|FG001|Overall Study|Family event|0|||
164226683|NCT00770679|593199941|FG000|Overall Study|Lost to Follow-up|3|||
164226684|NCT00770679|593199941|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
164226685|NCT01998477|593199942|FG000|Overall Study|Lost to Follow-up|4|||
164226686|NCT01998477|593199943|FG001|Overall Study|Lost to Follow-up|5|||
164226687|NCT01998477|593199942|FG000|Overall Study|Withdrawal by Subject|6|||
164226688|NCT01998477|593199943|FG001|Overall Study|Withdrawal by Subject|0|||
164226689|NCT00129974|593199944|FG000|Overall Study|Other|1|||
164226690|NCT00113373|593199949|FG000|Overall Study|Ineligible: wrong primary|1|||
164226691|NCT00113373|593199949|FG000|Overall Study|Ineligible: second primary|1|||
164226692|NCT00113373|593199949|FG000|Overall Study|Never Treated|1|||
164226693|NCT02395627|593199950|FG000|Overall Study|Withdrawal by Subject|0|||
164226694|NCT02395627|593199951|FG001|Overall Study|Withdrawal by Subject|2|||
164226695|NCT02395627|593199952|FG002|Overall Study|Withdrawal by Subject|0|||
164226696|NCT02395627|593199950|FG000|Overall Study|Did not receive pembrolizumab|3|||
164226697|NCT02395627|593199951|FG001|Overall Study|Did not receive pembrolizumab|1|||
164226698|NCT02395627|593199952|FG002|Overall Study|Did not receive pembrolizumab|0|||
164226699|NCT03253627|593199953|FG000|Overall Study|Lost to Follow-up|1|||
164226700|NCT03253627|593199954|FG001|Overall Study|Lost to Follow-up|2|||
164226701|NCT03253627|593199953|FG000|Overall Study|Withdrawal by Subject|0|||
164226702|NCT03253627|593199954|FG001|Overall Study|Withdrawal by Subject|2|||
164226703|NCT03253627|593199953|FG000|Overall Study|Inability to complete MRI|1|||
164226704|NCT03253627|593199954|FG001|Overall Study|Inability to complete MRI|0|||
164226705|NCT00979407|593199961|FG000|Overall Study|Withdrawal by Subject|3|||
164226706|NCT00979407|593199962|FG001|Overall Study|Withdrawal by Subject|4|||
164226707|NCT00979407|593199961|FG000|Overall Study|Lost to Follow-up|3|||
164226708|NCT00979407|593199962|FG001|Overall Study|Lost to Follow-up|3|||
164226709|NCT00855166|593199963|FG000|Overall Study|Adverse Event|0|||
164226710|NCT00855166|593199964|FG001|Overall Study|Adverse Event|2|||
164226711|NCT00855166|593199963|FG000|Overall Study|Death|0|||
164226712|NCT00855166|593199964|FG001|Overall Study|Death|1|||
164226713|NCT00855166|593199963|FG000|Overall Study|Withdrawal by Subject|1|||
164226714|NCT00855166|593199964|FG001|Overall Study|Withdrawal by Subject|4|||
164226715|NCT00855166|593199963|FG000|Overall Study|Poor/non-compliance|2|||
164226716|NCT00855166|593199964|FG001|Overall Study|Poor/non-compliance|0|||
164226717|NCT00855166|593199963|FG000|Overall Study|Administrative reasons by sponsor|1|||
164226718|NCT00855166|593199964|FG001|Overall Study|Administrative reasons by sponsor|0|||
164226719|NCT00855166|593199963|FG000|Overall Study|Subject no longer meets study criteria|1|||
164226720|NCT00855166|593199964|FG001|Overall Study|Subject no longer meets study criteria|1|||
164226721|NCT00489476|593199965|FG000|Overall Study|Lost to Follow-up|0|||
164226722|NCT00489476|593199966|FG001|Overall Study|Lost to Follow-up|1|||
164226723|NCT00489476|593199967|FG002|Overall Study|Lost to Follow-up|0|||
164226724|NCT00489476|593199968|FG003|Overall Study|Lost to Follow-up|0|||
164226725|NCT04003389|593199971|FG000|Overall Study|Adverse Event|27|||
164226726|NCT04003389|593199972|FG001|Overall Study|Adverse Event|34|||
164226727|NCT04003389|593199973|FG002|Overall Study|Adverse Event|28|||
164226728|NCT04003389|593199971|FG000|Overall Study|Lost to Follow-up|39|||
164330866|NCT01977937|593588330|FG001|Overall Study|Physician Decision|1|||
164330867|NCT02819518|593588333|FG000|Overall Study|Death|9|||
164330868|NCT02819518|593588334|FG001|Overall Study|Death|12|||
164330869|NCT02819518|593588335|FG002|Overall Study|Death|9|||
164330870|NCT02819518|593588336|FG003|Overall Study|Death|475|||
164330871|NCT02819518|593588337|FG004|Overall Study|Death|244|||
164330872|NCT02819518|593588333|FG000|Overall Study|Withdrawal by Subject|0|||
164330873|NCT02819518|593588334|FG001|Overall Study|Withdrawal by Subject|0|||
164330874|NCT02819518|593588335|FG002|Overall Study|Withdrawal by Subject|0|||
164330875|NCT02819518|593588336|FG003|Overall Study|Withdrawal by Subject|25|||
164330876|NCT02819518|593588337|FG004|Overall Study|Withdrawal by Subject|8|||
164330877|NCT02819518|593588333|FG000|Overall Study|Lost to Follow-up|0|||
164330878|NCT02819518|593588334|FG001|Overall Study|Lost to Follow-up|0|||
164421065|NCT02138747|593911085|FG001|Treatment Period 2|Other - Miscellaneous|0|||
164675228|NCT04408794|594834904|FG000|Overall Study|Protocol Deviation|9|||
164421066|NCT02138747|593911086|FG002|Treatment Period 2|Other - Miscellaneous|0|||
164226729|NCT04003389|593199972|FG001|Overall Study|Lost to Follow-up|30|||
164226730|NCT04003389|593199973|FG002|Overall Study|Lost to Follow-up|33|||
164226731|NCT04003389|593199971|FG000|Overall Study|Protocol Violation|1|||
164226732|NCT04003389|593199972|FG001|Overall Study|Protocol Violation|6|||
164226733|NCT04003389|593199973|FG002|Overall Study|Protocol Violation|5|||
164330879|NCT02819518|593588335|FG002|Overall Study|Lost to Follow-up|0|||
164330880|NCT02819518|593588336|FG003|Overall Study|Lost to Follow-up|0|||
164226734|NCT04003389|593199971|FG000|Overall Study|Withdrawal by Subject|119|||
164226735|NCT04003389|593199972|FG001|Overall Study|Withdrawal by Subject|79|||
164330881|NCT02819518|593588337|FG004|Overall Study|Lost to Follow-up|1|||
164330882|NCT02819518|593588333|FG000|Overall Study|Sponsor Decision|1|||
164226736|NCT04003389|593199973|FG002|Overall Study|Withdrawal by Subject|85|||
164226737|NCT04003389|593199971|FG000|Overall Study|Miscellaneous|14|||
164226738|NCT04003389|593199972|FG001|Overall Study|Miscellaneous|11|||
164226739|NCT04003389|593199973|FG002|Overall Study|Miscellaneous|14|||
164226740|NCT04003389|593199971|FG000|Overall Study|Participant did not receive study drug|1|||
164226741|NCT04003389|593199972|FG001|Overall Study|Participant did not receive study drug|0|||
164226742|NCT04003389|593199973|FG002|Overall Study|Participant did not receive study drug|0|||
164226743|NCT02514746|593199978|FG000|Overall Study|Chronically Ill|1|||
164226744|NCT02514746|593199979|FG001|Overall Study|Chronically Ill|2|||
164226745|NCT02514746|593199978|FG000|Overall Study|Physician Decision|4|||
164226746|NCT02514746|593199979|FG001|Overall Study|Physician Decision|2|||
164226747|NCT02514746|593199978|FG000|Overall Study|Withdrawal by Subject|12|||
164226748|NCT02514746|593199979|FG001|Overall Study|Withdrawal by Subject|10|||
164226749|NCT02514746|593199978|FG000|Overall Study|Other|5|||
164226750|NCT02514746|593199979|FG001|Overall Study|Other|1|||
164226751|NCT04003142|593199980|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
164226752|NCT04003142|593199981|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
164226753|NCT04003142|593199982|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
164226754|NCT04003142|593199983|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
164226755|NCT04003142|593199984|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
164226756|NCT04003142|593199980|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
164226757|NCT04003142|593199981|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
164226758|NCT04003142|593199982|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
164226759|NCT04003142|593199983|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
164226760|NCT04003142|593199984|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
164226761|NCT04003142|593199980|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
164226762|NCT04003142|593199981|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
164226763|NCT04003142|593199982|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
164226764|NCT04003142|593199983|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
164226765|NCT04003142|593199984|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
164226766|NCT04003142|593199980|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
164226767|NCT04003142|593199981|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
164226768|NCT04003142|593199982|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
164226769|NCT04003142|593199983|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
164226770|NCT04003142|593199984|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
164226771|NCT04003142|593199980|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
164226772|NCT04003142|593199981|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
164226773|NCT04003142|593199982|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
164226774|NCT04003142|593199983|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
164226775|NCT04003142|593199984|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
164226776|NCT04003142|593199980|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
164226777|NCT04003142|593199981|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
164226778|NCT04003142|593199982|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
164226779|NCT04003142|593199983|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
164226780|NCT04003142|593199984|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
164226781|NCT04003142|593199980|FG000|Extension Period (40 Weeks)|Death|0|||
164226782|NCT04003142|593199981|FG001|Extension Period (40 Weeks)|Death|0|||
164226783|NCT04003142|593199982|FG002|Extension Period (40 Weeks)|Death|0|||
164226784|NCT04003142|593199983|FG003|Extension Period (40 Weeks)|Death|0|||
164226785|NCT04003142|593199984|FG004|Extension Period (40 Weeks)|Death|1|||
164226786|NCT04003142|593199980|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
164226787|NCT04003142|593199981|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
164226788|NCT04003142|593199982|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
164226789|NCT04003142|593199983|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
164226790|NCT04003142|593199984|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
164226791|NCT04003142|593199980|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
164226792|NCT04003142|593199981|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
164226793|NCT04003142|593199982|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
164226794|NCT04003142|593199983|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
164226795|NCT04003142|593199984|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
164226796|NCT04003142|593199980|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
164226797|NCT04003142|593199981|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
164226798|NCT04003142|593199982|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
164226799|NCT04003142|593199983|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
164226800|NCT04003142|593199984|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
164226801|NCT04003142|593199980|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
164226802|NCT04003142|593199981|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
164226803|NCT04003142|593199982|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
164226804|NCT04003142|593199983|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
164226805|NCT04003142|593199984|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
164226806|NCT04806373|593199985|FG000|Overall Study|Withdrawal by Subject|1|||
164226807|NCT04806373|593199986|FG001|Overall Study|Withdrawal by Subject|1|||
164226808|NCT03382873|593199987|FG000|Overall Study|Lost to Follow-up|9|||
164226809|NCT03382873|593199988|FG001|Overall Study|Lost to Follow-up|10|||
164226810|NCT03382873|593199987|FG000|Overall Study|Withdrawal by Subject|6|||
164226811|NCT03382873|593199988|FG001|Overall Study|Withdrawal by Subject|11|||
164226812|NCT03382873|593199987|FG000|Overall Study|Visit not completed due to pandemic|16|||
164226813|NCT03382873|593199988|FG001|Overall Study|Visit not completed due to pandemic|41|||
164226814|NCT01450631|593199989|FG000|Overall Study|Lost to Follow-up|2|||
164226815|NCT01450631|593199990|FG001|Overall Study|Lost to Follow-up|4|||
164226816|NCT01450631|593199989|FG000|Overall Study|Withdrawal by Subject|1|||
164226817|NCT01450631|593199990|FG001|Overall Study|Withdrawal by Subject|0|||
164226818|NCT03624036|593199999|FG000|Overall Study|Death|2|||
164226819|NCT03624036|593200000|FG001|Overall Study|Death|3|||
164226820|NCT03624036|593200001|FG002|Overall Study|Death|0|||
164226821|NCT03624036|593200002|FG003|Overall Study|Death|1|||
164226822|NCT03624036|593199999|FG000|Overall Study|Withdrawal by Subject|1|||
164226823|NCT03624036|593200000|FG001|Overall Study|Withdrawal by Subject|0|||
164226824|NCT03624036|593200001|FG002|Overall Study|Withdrawal by Subject|1|||
164226825|NCT03624036|593200002|FG003|Overall Study|Withdrawal by Subject|0|||
164226826|NCT03624036|593199999|FG000|Overall Study|Enrolled but Never Treated|1|||
164226827|NCT03624036|593200000|FG001|Overall Study|Enrolled but Never Treated|0|||
164226828|NCT03624036|593200001|FG002|Overall Study|Enrolled but Never Treated|0|||
164226829|NCT03624036|593200002|FG003|Overall Study|Enrolled but Never Treated|0|||
164226830|NCT03624036|593199999|FG000|Overall Study|Reason not Specified|3|||
164226831|NCT03624036|593200000|FG001|Overall Study|Reason not Specified|0|||
164226832|NCT03624036|593200001|FG002|Overall Study|Reason not Specified|2|||
164226833|NCT03624036|593200002|FG003|Overall Study|Reason not Specified|2|||
164226834|NCT01185366|593200008|FG000|First Line Therapy|Insurance Coverage Denied|1|||
164226835|NCT01185366|593200009|FG001|First Line Therapy|Insurance Coverage Denied|1|||
164226836|NCT01185366|593200008|FG000|First Line Therapy|Withdrawal by Subject|1|||
164226837|NCT01185366|593200009|FG001|First Line Therapy|Withdrawal by Subject|0|||
164226838|NCT01185366|593200008|FG000|First Line Therapy|Lack of Metastatic Site|1|||
164226839|NCT01185366|593200009|FG001|First Line Therapy|Lack of Metastatic Site|0|||
164226840|NCT01185366|593200008|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
164226841|NCT01185366|593200009|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
164226842|NCT01185366|593200008|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
164226843|NCT01185366|593200009|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
164226844|NCT01185366|593200008|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
164226845|NCT01185366|593200009|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
164226846|NCT01185366|593200008|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
164226847|NCT01185366|593200009|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
164226848|NCT01390584|593200014|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
164226849|NCT01390584|593200015|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
164226850|NCT01390584|593200016|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
164226851|NCT00025233|593200017|FG000|Overall Study|Ineligible: wrong cell type|1|||
164226852|NCT00025233|593200017|FG000|Overall Study|Ineligible: wrong primary|1|||
164226853|NCT00025233|593200017|FG000|Overall Study|Ineligible: improper prior treatment|1|||
164226854|NCT00025233|593200017|FG000|Overall Study|Never treated|1|||
164226855|NCT00401830|593200018|FG000|Overall Study|Adverse Event|10|||
164226856|NCT00401830|593200019|FG001|Overall Study|Adverse Event|18|||
164226857|NCT00401830|593200018|FG000|Overall Study|Lack of Efficacy|11|||
164226858|NCT00401830|593200019|FG001|Overall Study|Lack of Efficacy|5|||
164226859|NCT00401830|593200018|FG000|Overall Study|Withdrawal by Subject|4|||
164226860|NCT00401830|593200019|FG001|Overall Study|Withdrawal by Subject|3|||
164226861|NCT00401830|593200018|FG000|Overall Study|Protocol Violation|3|||
164226862|NCT00401830|593200019|FG001|Overall Study|Protocol Violation|3|||
164226863|NCT00401830|593200018|FG000|Overall Study|Non-compliance with drug study|1|||
164226864|NCT00401830|593200019|FG001|Overall Study|Non-compliance with drug study|0|||
164226865|NCT00401830|593200018|FG000|Overall Study|Lost to Follow-up|1|||
164226866|NCT00401830|593200019|FG001|Overall Study|Lost to Follow-up|3|||
164226867|NCT00401830|593200018|FG000|Overall Study|Other: Personal / Family problems|1|||
164226868|NCT00401830|593200019|FG001|Overall Study|Other: Personal / Family problems|0|||
164226869|NCT01720602|593200020|FG000|Overall Study|Adverse Event|3|||
164226870|NCT01720602|593200020|FG000|Overall Study|Progressive disease on therapy|2|||
164226871|NCT02539394|593200021|FG000|Overall Study|Protocol Violation|1|||
164226872|NCT02539394|593200022|FG001|Overall Study|Protocol Violation|3|||
164226873|NCT02539394|593200021|FG000|Overall Study|Lost to Follow-up|1|||
164226874|NCT02539394|593200022|FG001|Overall Study|Lost to Follow-up|2|||
164226875|NCT02539394|593200021|FG000|Overall Study|Incomplete dataset|6|||
164226876|NCT02539394|593200022|FG001|Overall Study|Incomplete dataset|6|||
164226877|NCT02691494|593200025|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
164226878|NCT02691494|593200026|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
164226879|NCT02691494|593200027|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
164226880|NCT02691494|593200025|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
164226881|NCT02691494|593200026|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
164226882|NCT02691494|593200027|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
164226883|NCT02691494|593200025|FG000|Post-Treatment Follow-Up Period|Other|2|||
164226884|NCT02691494|593200026|FG001|Post-Treatment Follow-Up Period|Other|1|||
164226885|NCT02691494|593200027|FG002|Post-Treatment Follow-Up Period|Other|1|||
164226886|NCT02691494|593200025|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
164226887|NCT02691494|593200026|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
164226888|NCT02691494|593200027|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
164226889|NCT02691494|593200025|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
164226890|NCT02691494|593200026|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
164226891|NCT02691494|593200027|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
164226892|NCT04634331|593200028|FG000|Overall Study|Withdrawal by Subject|2|||
164226893|NCT04634331|593200029|FG001|Overall Study|Withdrawal by Subject|2|||
164226894|NCT00461812|593200034|FG000|Overall Study|study terminated|10|||
164226895|NCT02916433|593200035|FG000|Overall Study|Withdrawal by Subject|1|||
164226896|NCT02916433|593200036|FG001|Overall Study|Withdrawal by Subject|0|||
164226897|NCT02916433|593200035|FG000|Overall Study|Physician Decision|1|||
164226898|NCT02916433|593200036|FG001|Overall Study|Physician Decision|0|||
164226899|NCT01694771|593200037|FG000|Overall Study|Adverse Event|18|||
164226900|NCT01694771|593200038|FG001|Overall Study|Adverse Event|16|||
164226901|NCT01694771|593200037|FG000|Overall Study|Lack of Efficacy|1|||
164226902|NCT01694771|593200038|FG001|Overall Study|Lack of Efficacy|0|||
164226903|NCT01694771|593200037|FG000|Overall Study|Non compliance protocol|7|||
164226904|NCT01694771|593200038|FG001|Overall Study|Non compliance protocol|6|||
164226905|NCT01694771|593200037|FG000|Overall Study|Lost to Follow-up|2|||
164226906|NCT01694771|593200038|FG001|Overall Study|Lost to Follow-up|3|||
164226907|NCT01694771|593200037|FG000|Overall Study|Consent withdrawn|7|||
164226908|NCT01694771|593200038|FG001|Overall Study|Consent withdrawn|9|||
164226909|NCT01694771|593200037|FG000|Overall Study|Other reasons|5|||
164226910|NCT01694771|593200038|FG001|Overall Study|Other reasons|6|||
164226911|NCT00890097|593200039|FG000|Overall Study|Adverse Event|21|||
164226912|NCT00890097|593200040|FG001|Overall Study|Adverse Event|32|||
164226913|NCT00890097|593200041|FG002|Overall Study|Adverse Event|28|||
164226914|NCT00890097|593200039|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
164226915|NCT00890097|593200040|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
164226916|NCT00890097|593200041|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
164226917|NCT00890097|593200039|FG000|Overall Study|Withdrew Consent|9|||
164226918|NCT00890097|593200040|FG001|Overall Study|Withdrew Consent|6|||
164226919|NCT00890097|593200041|FG002|Overall Study|Withdrew Consent|9|||
164226920|NCT00890097|593200039|FG000|Overall Study|Lost to Follow-up|5|||
164226921|NCT00890097|593200040|FG001|Overall Study|Lost to Follow-up|5|||
164226922|NCT00890097|593200041|FG002|Overall Study|Lost to Follow-up|5|||
164226923|NCT00890097|593200039|FG000|Overall Study|Noncompliance|0|||
164226924|NCT00890097|593200040|FG001|Overall Study|Noncompliance|4|||
164226925|NCT00890097|593200041|FG002|Overall Study|Noncompliance|4|||
164226926|NCT00890097|593200039|FG000|Overall Study|Sponsor Decision|7|||
164226927|NCT00890097|593200040|FG001|Overall Study|Sponsor Decision|11|||
164226928|NCT00890097|593200041|FG002|Overall Study|Sponsor Decision|7|||
164226929|NCT00890097|593200039|FG000|Overall Study|Did not attend final visit|2|||
164226930|NCT00890097|593200040|FG001|Overall Study|Did not attend final visit|3|||
164226931|NCT00890097|593200041|FG002|Overall Study|Did not attend final visit|0|||
164226932|NCT00890097|593200039|FG000|Overall Study|Subject Decision|3|||
164226933|NCT00890097|593200040|FG001|Overall Study|Subject Decision|2|||
164226934|NCT00890097|593200041|FG002|Overall Study|Subject Decision|6|||
164226935|NCT00890097|593200039|FG000|Overall Study|Randomization Error|2|||
164226936|NCT00890097|593200040|FG001|Overall Study|Randomization Error|0|||
164226937|NCT00890097|593200041|FG002|Overall Study|Randomization Error|0|||
164226938|NCT00890097|593200039|FG000|Overall Study|Failed inclusion criteria|3|||
164226939|NCT00890097|593200040|FG001|Overall Study|Failed inclusion criteria|4|||
164226940|NCT00890097|593200041|FG002|Overall Study|Failed inclusion criteria|0|||
164226941|NCT00890097|593200039|FG000|Overall Study|Transportation|0|||
164226942|NCT00890097|593200040|FG001|Overall Study|Transportation|2|||
164226943|NCT00890097|593200041|FG002|Overall Study|Transportation|0|||
164226944|NCT00890097|593200039|FG000|Overall Study|Subject Moved|0|||
164226945|NCT00890097|593200040|FG001|Overall Study|Subject Moved|4|||
164330883|NCT02819518|593588334|FG001|Overall Study|Sponsor Decision|1|||
164226946|NCT00890097|593200041|FG002|Overall Study|Subject Moved|0|||
164226947|NCT00890097|593200039|FG000|Overall Study|Protocol Deviation|1|||
164675229|NCT04408794|594834904|FG000|Overall Study|Sheehan-STS Result|1|||
164330884|NCT02819518|593588335|FG002|Overall Study|Sponsor Decision|0|||
164330885|NCT02819518|593588336|FG003|Overall Study|Sponsor Decision|34|||
164226948|NCT00890097|593200040|FG001|Overall Study|Protocol Deviation|1|||
164226949|NCT00890097|593200041|FG002|Overall Study|Protocol Deviation|1|||
164226950|NCT03878069|593200048|FG000|Overall Study|Death|0|||
164226951|NCT03878069|593200049|FG001|Overall Study|Death|1|||
164226952|NCT03878069|593200050|FG002|Overall Study|Death|0|||
164226953|NCT00834587|593200051|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
164226954|NCT00834587|593200052|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
164226955|NCT02536339|593200054|FG000|Overall Study|Death|20|||
164330886|NCT02819518|593588337|FG004|Overall Study|Sponsor Decision|17|||
164226956|NCT02536339|593200054|FG000|Overall Study|Withdrawal by Subject|3|||
164226957|NCT02536339|593200054|FG000|Overall Study|Lost to Follow-up|2|||
164226958|NCT02536339|593200054|FG000|Overall Study|Treatment discontinued|2|||
164226959|NCT02536339|593200054|FG000|Overall Study|Physician Decision|1|||
164226960|NCT01691092|593200055|FG000|Overall Study|Lost to Follow-up|10|||
164226961|NCT01691092|593200055|FG000|Overall Study|Physician Decision|4|||
164226962|NCT01691092|593200055|FG000|Overall Study|Withdrawal by Subject|3|||
164226963|NCT01691092|593200055|FG000|Overall Study|non-compliance|3|||
164226964|NCT01691092|593200055|FG000|Overall Study|used for different study|2|||
164226965|NCT01691092|593200055|FG000|Overall Study|screen fail|19|||
164571230|NCT00961961|594456845|FG001|Phase I|Lack of Efficacy|0|||
164571231|NCT00961961|594456846|FG002|Phase I|Lack of Efficacy|0|||
164226966|NCT03727022|593201305|FG000|Phase A|Lost to Follow-up|2|||
164226967|NCT03727022|593201306|FG001|Phase A|Lost to Follow-up|3|||
164226968|NCT03727022|593201305|FG000|Phase A|Withdrawal by Subject|10|||
164226969|NCT03727022|593201306|FG001|Phase A|Withdrawal by Subject|9|||
164226970|NCT03727022|593201305|FG000|Phase B|Lost to Follow-up|0|||
164226971|NCT03727022|593201306|FG001|Phase B|Lost to Follow-up|1|||
164226972|NCT03727022|593201305|FG000|Phase B|Subject Non-Compliance|1|||
164226973|NCT03727022|593201306|FG001|Phase B|Subject Non-Compliance|0|||
164226974|NCT03727022|593201305|FG000|Phase B|Withdrawal by Subject|3|||
164226975|NCT03727022|593201306|FG001|Phase B|Withdrawal by Subject|3|||
164226976|NCT03727022|593201305|FG000|Phase B|Site Closure|4|||
164226977|NCT03727022|593201306|FG001|Phase B|Site Closure|0|||
164226978|NCT05550818|593201307|FG000|Overall Study|Protocol Violation|1|||
164226979|NCT05550818|593201308|FG001|Overall Study|Protocol Violation|1|||
164226980|NCT05550818|593201307|FG000|Overall Study|Withdrawal by Subject|2|||
164226981|NCT05550818|593201308|FG001|Overall Study|Withdrawal by Subject|1|||
164226982|NCT00581100|593201309|FG000|Overall Study|Death|1|||
164226983|NCT00581100|593201310|FG001|Overall Study|Death|0|||
164226984|NCT00581100|593201309|FG000|Overall Study|Adverse Event|2|||
164226985|NCT00581100|593201310|FG001|Overall Study|Adverse Event|1|||
164226986|NCT00581100|593201309|FG000|Overall Study|Withdrawal by Subject|1|||
164226987|NCT00581100|593201310|FG001|Overall Study|Withdrawal by Subject|4|||
164226988|NCT00581100|593201309|FG000|Overall Study|Other|3|||
164226989|NCT00581100|593201310|FG001|Overall Study|Other|0|||
164226990|NCT00590317|593201311|FG000|Overall Study|Lack of Efficacy|1|||
164226991|NCT00590317|593201312|FG001|Overall Study|Lack of Efficacy|5|||
164226992|NCT03031912|593201313|FG000|Overall Study|Lost to Follow-up|1|||
164226993|NCT03031912|593201314|FG001|Overall Study|Lost to Follow-up|1|||
164226994|NCT03031912|593201315|FG002|Overall Study|Lost to Follow-up|0|||
164226995|NCT03031912|593201316|FG003|Overall Study|Lost to Follow-up|1|||
164226996|NCT03031912|593201317|FG004|Overall Study|Lost to Follow-up|0|||
164226997|NCT03031912|593201318|FG005|Overall Study|Lost to Follow-up|0|||
164226998|NCT03031912|593201319|FG006|Overall Study|Lost to Follow-up|0|||
164226999|NCT03031912|593201320|FG007|Overall Study|Lost to Follow-up|0|||
164227000|NCT03031912|593201321|FG008|Overall Study|Lost to Follow-up|0|||
164227001|NCT03031912|593201322|FG009|Overall Study|Lost to Follow-up|0|||
164227002|NCT04097743|593201325|FG000|Overall Study|Non-compliance of the study instruction.|1|||
164227003|NCT04097743|593201326|FG001|Overall Study|Non-compliance of the study instruction.|0|||
164227004|NCT05562934|593201337|FG000|Overall Study|Adverse Event|0|||
164227005|NCT05562934|593201338|FG001|Overall Study|Adverse Event|2|||
164227006|NCT05562934|593201339|FG002|Overall Study|Adverse Event|0|||
164227007|NCT05562934|593201340|FG003|Overall Study|Adverse Event|0|||
164227008|NCT05562934|593201341|FG004|Overall Study|Adverse Event|2|||
164227009|NCT05562934|593201337|FG000|Overall Study|Lost to Follow-up|0|||
164227010|NCT05562934|593201338|FG001|Overall Study|Lost to Follow-up|0|||
164227011|NCT05562934|593201339|FG002|Overall Study|Lost to Follow-up|0|||
164227012|NCT05562934|593201340|FG003|Overall Study|Lost to Follow-up|0|||
164227013|NCT05562934|593201341|FG004|Overall Study|Lost to Follow-up|1|||
164227014|NCT05562934|593201337|FG000|Overall Study|Protocol Violation|0|||
164227015|NCT05562934|593201338|FG001|Overall Study|Protocol Violation|0|||
164227016|NCT05562934|593201339|FG002|Overall Study|Protocol Violation|0|||
164227017|NCT05562934|593201340|FG003|Overall Study|Protocol Violation|1|||
164330887|NCT02819518|593588333|FG000|Overall Study|Transferred to extension study|1|||
164330888|NCT02819518|593588334|FG001|Overall Study|Transferred to extension study|1|||
164227018|NCT05562934|593201341|FG004|Overall Study|Protocol Violation|1|||
164227019|NCT05562934|593201337|FG000|Overall Study|Withdrawal by Subject|0|||
164227020|NCT05562934|593201338|FG001|Overall Study|Withdrawal by Subject|0|||
164227021|NCT05562934|593201339|FG002|Overall Study|Withdrawal by Subject|1|||
164227022|NCT05562934|593201340|FG003|Overall Study|Withdrawal by Subject|1|||
164227023|NCT05562934|593201341|FG004|Overall Study|Withdrawal by Subject|0|||
164227024|NCT05365217|593201342|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164227025|NCT05365217|593201343|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164227026|NCT03997383|593201344|FG000|Double-blind Treatment Period|Adverse Event|4|||
164227027|NCT03997383|593201345|FG001|Double-blind Treatment Period|Adverse Event|3|||
164227028|NCT03997383|593201344|FG000|Double-blind Treatment Period|Death|4|||
164227029|NCT03997383|593201345|FG001|Double-blind Treatment Period|Death|4|||
164330889|NCT02819518|593588335|FG002|Overall Study|Transferred to extension study|1|||
164571232|NCT00961961|594456847|FG003|Phase I|Lack of Efficacy|0|||
164227030|NCT03997383|593201344|FG000|Double-blind Treatment Period|Physician Decision|2|||
164227031|NCT03997383|593201345|FG001|Double-blind Treatment Period|Physician Decision|0|||
164227032|NCT03997383|593201344|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
164227033|NCT03997383|593201345|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
164227034|NCT03997383|593201344|FG000|Open-label Extension Period|Ongoing|148|||
164227035|NCT03997383|593201345|FG001|Open-label Extension Period|Ongoing|151|||
164227036|NCT03997383|593201344|FG000|Open-label Extension Period|Adverse Event|4|||
164227037|NCT03997383|593201345|FG001|Open-label Extension Period|Adverse Event|1|||
164227038|NCT03997383|593201344|FG000|Open-label Extension Period|Death|8|||
164227039|NCT03997383|593201345|FG001|Open-label Extension Period|Death|9|||
164227040|NCT03997383|593201344|FG000|Open-label Extension Period|Physician Decision|1|||
164227041|NCT03997383|593201345|FG001|Open-label Extension Period|Physician Decision|1|||
164227042|NCT03997383|593201344|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
164227043|NCT03997383|593201345|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
164227044|NCT03997383|593201344|FG000|Open-label Extension Period|Reason Not Specified|2|||
164227045|NCT03997383|593201345|FG001|Open-label Extension Period|Reason Not Specified|0|||
164227046|NCT00069953|593201348|FG000|Overall Study|Protocol Violation|2|||
164227047|NCT02940223|593201349|FG000|Overall Study|Failed Requirement|2|||
164227048|NCT02940223|593201350|FG001|Overall Study|Failed Requirement|0|||
164227049|NCT05528510|593201352|FG000|Overall Study|Death|1|||
164227050|NCT05528510|593201353|FG001|Overall Study|Death|0|||
164227051|NCT05528510|593201354|FG002|Overall Study|Death|0|||
164227052|NCT05528510|593201352|FG000|Overall Study|Lost to Follow-up|1|||
164227053|NCT05528510|593201353|FG001|Overall Study|Lost to Follow-up|0|||
164227054|NCT05528510|593201354|FG002|Overall Study|Lost to Follow-up|0|||
164227055|NCT05528510|593201352|FG000|Overall Study|Withdrawal by Subject|4|||
164227056|NCT05528510|593201353|FG001|Overall Study|Withdrawal by Subject|1|||
164227057|NCT05528510|593201354|FG002|Overall Study|Withdrawal by Subject|3|||
164227058|NCT05528510|593201352|FG000|Overall Study|Other|2|||
164227059|NCT05528510|593201353|FG001|Overall Study|Other|2|||
164227060|NCT05528510|593201354|FG002|Overall Study|Other|1|||
164227061|NCT01856478|593201357|FG000|Overall Study|Not treated|0|||
164227062|NCT01856478|593201358|FG001|Overall Study|Not treated|8|||
164227063|NCT01856478|593201357|FG000|Overall Study|Progressive disease per RECIST|146|||
164227064|NCT01856478|593201358|FG001|Overall Study|Progressive disease per RECIST|49|||
164227065|NCT01856478|593201357|FG000|Overall Study|Worsening of underlying cancer|6|||
164227066|NCT01856478|593201358|FG001|Overall Study|Worsening of underlying cancer|2|||
164227067|NCT01856478|593201357|FG000|Overall Study|Adverse events|57|||
164227068|NCT01856478|593201358|FG001|Overall Study|Adverse events|30|||
164227069|NCT01856478|593201357|FG000|Overall Study|Non-compliant with protocol|1|||
164227070|NCT01856478|593201358|FG001|Overall Study|Non-compliant with protocol|1|||
164227071|NCT01856478|593201357|FG000|Overall Study|Lost to Follow-up|1|||
164227072|NCT01856478|593201358|FG001|Overall Study|Lost to Follow-up|1|||
164227073|NCT01856478|593201357|FG000|Overall Study|Refused to continue trial medication|13|||
164227074|NCT01856478|593201358|FG001|Overall Study|Refused to continue trial medication|11|||
164227075|NCT01856478|593201357|FG000|Overall Study|Other reason than listed|4|||
164227076|NCT01856478|593201358|FG001|Overall Study|Other reason than listed|10|||
164227077|NCT05032820|593201359|FG000|Overall Study|Lost to Follow-up|1|||
164227078|NCT05032820|593201359|FG000|Overall Study|Withdrawal by Subject|1|||
164227079|NCT04108208|593201360|FG000|Overall Study|Withdrawal by Subject|2|||
164227080|NCT04108208|593201361|FG001|Overall Study|Withdrawal by Subject|6|||
164227081|NCT04108208|593201360|FG000|Overall Study|other-ongoing|20|||
164227082|NCT04108208|593201361|FG001|Overall Study|other-ongoing|40|||
164227083|NCT04108208|593201360|FG000|Overall Study|Death|1|||
164227084|NCT04108208|593201361|FG001|Overall Study|Death|4|||
164227085|NCT04108208|593201360|FG000|Overall Study|Lost to Follow-up|2|||
164227086|NCT04108208|593201361|FG001|Overall Study|Lost to Follow-up|0|||
164227087|NCT04936308|593201362|FG000|Overall Study|Death|0|||
164227088|NCT04936308|593201363|FG001|Overall Study|Death|0|||
164227089|NCT04936308|593201364|FG002|Overall Study|Death|1|||
164227090|NCT04936308|593201362|FG000|Overall Study|Withdrawal by Subject|6|||
164227091|NCT04936308|593201363|FG001|Overall Study|Withdrawal by Subject|3|||
164227092|NCT04936308|593201364|FG002|Overall Study|Withdrawal by Subject|0|||
164227093|NCT04936308|593201362|FG000|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|0|||
164227094|NCT04936308|593201363|FG001|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
164227095|NCT04936308|593201364|FG002|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
164227096|NCT04936308|593201362|FG000|Overall Study|Completed protocol-required follow-up|1|||
164227097|NCT04936308|593201363|FG001|Overall Study|Completed protocol-required follow-up|2|||
164227098|NCT04936308|593201364|FG002|Overall Study|Completed protocol-required follow-up|2|||
164227099|NCT04936308|593201362|FG000|Overall Study|Discontinued study intervention and were being followed|2|||
164227100|NCT04936308|593201363|FG001|Overall Study|Discontinued study intervention and were being followed|2|||
164227101|NCT04936308|593201364|FG002|Overall Study|Discontinued study intervention and were being followed|4|||
164227102|NCT04936308|593201362|FG000|Overall Study|Other|3|||
164227103|NCT04936308|593201363|FG001|Overall Study|Other|0|||
164227104|NCT04936308|593201364|FG002|Overall Study|Other|2|||
164227105|NCT04770272|593201365|FG000|Overall Study|Death|1|||
164227106|NCT04770272|593201366|FG001|Overall Study|Death|0|||
164227107|NCT04770272|593201365|FG000|Overall Study|Withdrawal by Subject|11|||
164227108|NCT04770272|593201366|FG001|Overall Study|Withdrawal by Subject|12|||
164227109|NCT04770272|593201365|FG000|Overall Study|Protocol Violation|0|||
164227110|NCT04770272|593201366|FG001|Overall Study|Protocol Violation|2|||
164227111|NCT04770272|593201365|FG000|Overall Study|Adverse Event|23|||
164227112|NCT04770272|593201366|FG001|Overall Study|Adverse Event|21|||
164227113|NCT04770272|593201365|FG000|Overall Study|Physician Decision|7|||
164227114|NCT04770272|593201366|FG001|Overall Study|Physician Decision|3|||
164227115|NCT04770272|593201365|FG000|Overall Study|Disease progression|4|||
164227116|NCT04770272|593201366|FG001|Overall Study|Disease progression|8|||
164227117|NCT04770272|593201365|FG000|Overall Study|Switched to other therapy.|0|||
164227118|NCT04770272|593201366|FG001|Overall Study|Switched to other therapy.|2|||
164227119|NCT02363946|593201367|FG000|Overall Study|Lost to Follow-up|0|||
164227120|NCT02363946|593201368|FG001|Overall Study|Lost to Follow-up|0|||
164227121|NCT02363946|593201369|FG002|Overall Study|Lost to Follow-up|0|||
164227122|NCT02363946|593201370|FG003|Overall Study|Lost to Follow-up|0|||
164227123|NCT02363946|593201371|FG004|Overall Study|Lost to Follow-up|0|||
164227124|NCT02363946|593201372|FG005|Overall Study|Lost to Follow-up|0|||
164227125|NCT02363946|593201373|FG006|Overall Study|Lost to Follow-up|0|||
164227126|NCT02363946|593201374|FG007|Overall Study|Lost to Follow-up|1|||
164227127|NCT02363946|593201375|FG008|Overall Study|Lost to Follow-up|0|||
164227128|NCT02363946|593201376|FG009|Overall Study|Lost to Follow-up|0|||
164227129|NCT02363946|593201377|FG010|Overall Study|Lost to Follow-up|0|||
164227130|NCT02363946|593201378|FG011|Overall Study|Lost to Follow-up|0|||
164227131|NCT02363946|593201379|FG012|Overall Study|Lost to Follow-up|0|||
164227132|NCT03769116|593201382|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
164227133|NCT03769116|593201383|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
164227134|NCT03769116|593201382|FG000|Part 3 - Open Label|Physician Decision|1|||
164227135|NCT03769116|593201383|FG001|Part 3 - Open Label|Physician Decision|0|||
164227136|NCT03769116|593201382|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
164227137|NCT03769116|593201383|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
164227138|NCT03030261|593201385|FG000|Overall Study|Still receiving continuation therapy|5|||
164227139|NCT01615029|593201386|FG000|Overall Study|Adverse Event|1|||
164227140|NCT01615029|593201387|FG001|Overall Study|Adverse Event|0|||
164227141|NCT01615029|593201388|FG002|Overall Study|Adverse Event|3|||
164227142|NCT01615029|593201389|FG003|Overall Study|Adverse Event|0|||
164227143|NCT01615029|593201390|FG004|Overall Study|Adverse Event|4|||
164227144|NCT01615029|593201386|FG000|Overall Study|Progressive disease|1|||
164227145|NCT01615029|593201387|FG001|Overall Study|Progressive disease|1|||
164227146|NCT01615029|593201388|FG002|Overall Study|Progressive disease|1|||
164227147|NCT01615029|593201389|FG003|Overall Study|Progressive disease|1|||
164227148|NCT01615029|593201390|FG004|Overall Study|Progressive disease|10|||
164227149|NCT01615029|593201386|FG000|Overall Study|Physician Decision|0|||
164227150|NCT01615029|593201387|FG001|Overall Study|Physician Decision|0|||
164227151|NCT01615029|593201388|FG002|Overall Study|Physician Decision|0|||
164227152|NCT01615029|593201389|FG003|Overall Study|Physician Decision|0|||
164227153|NCT01615029|593201390|FG004|Overall Study|Physician Decision|2|||
164227154|NCT04903093|593201391|FG000|Overall Study|Withdrawal by Subject|0|||
164227155|NCT04903093|593201392|FG001|Overall Study|Withdrawal by Subject|0|||
164227156|NCT04903093|593201393|FG002|Overall Study|Withdrawal by Subject|0|||
164227157|NCT04903093|593201394|FG003|Overall Study|Withdrawal by Subject|1|||
164227158|NCT04903093|593201395|FG004|Overall Study|Withdrawal by Subject|0|||
164227159|NCT04903093|593201396|FG005|Overall Study|Withdrawal by Subject|0|||
164227160|NCT01539525|593201406|FG000|Overall Study|Lost to Follow-up|19|||
164227161|NCT01539525|593201407|FG001|Overall Study|Lost to Follow-up|12|||
164227162|NCT01539525|593201408|FG002|Overall Study|Lost to Follow-up|11|||
164227163|NCT01539525|593201406|FG000|Overall Study|Withdrawal by Subject|0|||
164227164|NCT01539525|593201407|FG001|Overall Study|Withdrawal by Subject|3|||
164227165|NCT01539525|593201408|FG002|Overall Study|Withdrawal by Subject|2|||
164227166|NCT01539525|593201406|FG000|Overall Study|Protocol Violation|1|||
164227167|NCT01539525|593201407|FG001|Overall Study|Protocol Violation|1|||
164227168|NCT01539525|593201408|FG002|Overall Study|Protocol Violation|4|||
164227169|NCT02268851|593201409|FG000|Overall Study|Death|0|||
164330890|NCT02819518|593588336|FG003|Overall Study|Transferred to extension study|32|||
164227170|NCT02268851|593201410|FG001|Overall Study|Death|0|||
164227171|NCT02268851|593201411|FG002|Overall Study|Death|0|||
164227172|NCT02268851|593201412|FG003|Overall Study|Death|1|||
164227173|NCT02268851|593201413|FG004|Overall Study|Death|2|||
164330891|NCT02819518|593588337|FG004|Overall Study|Transferred to extension study|11|||
164227174|NCT02268851|593201414|FG005|Overall Study|Death|1|||
164227175|NCT02268851|593201409|FG000|Overall Study|Adverse Event|0|||
164227176|NCT02268851|593201410|FG001|Overall Study|Adverse Event|0|||
164227177|NCT02268851|593201411|FG002|Overall Study|Adverse Event|0|||
164227178|NCT02268851|593201412|FG003|Overall Study|Adverse Event|0|||
164227179|NCT02268851|593201413|FG004|Overall Study|Adverse Event|2|||
164227180|NCT02268851|593201414|FG005|Overall Study|Adverse Event|2|||
164330892|NCT02766465|593588338|FG000|Overall Study|Withdrawal by Subject|0|||
164227181|NCT02268851|593201409|FG000|Overall Study|Withdrawal by Subject|0|||
164227182|NCT02268851|593201410|FG001|Overall Study|Withdrawal by Subject|0|||
164227183|NCT02268851|593201411|FG002|Overall Study|Withdrawal by Subject|0|||
164227184|NCT02268851|593201412|FG003|Overall Study|Withdrawal by Subject|2|||
164227185|NCT02268851|593201413|FG004|Overall Study|Withdrawal by Subject|0|||
164227186|NCT02268851|593201414|FG005|Overall Study|Withdrawal by Subject|1|||
164227187|NCT02268851|593201409|FG000|Overall Study|Progressive Disease|1|||
164227188|NCT02268851|593201410|FG001|Overall Study|Progressive Disease|3|||
164227189|NCT02268851|593201411|FG002|Overall Study|Progressive Disease|0|||
164227190|NCT02268851|593201412|FG003|Overall Study|Progressive Disease|0|||
164227191|NCT02268851|593201413|FG004|Overall Study|Progressive Disease|1|||
164227192|NCT02268851|593201414|FG005|Overall Study|Progressive Disease|4|||
164227193|NCT02268851|593201409|FG000|Overall Study|Physician Decision|0|||
164227194|NCT02268851|593201410|FG001|Overall Study|Physician Decision|0|||
164227195|NCT02268851|593201411|FG002|Overall Study|Physician Decision|1|||
164227196|NCT02268851|593201412|FG003|Overall Study|Physician Decision|0|||
164227197|NCT02268851|593201413|FG004|Overall Study|Physician Decision|0|||
164227198|NCT02268851|593201414|FG005|Overall Study|Physician Decision|1|||
164227199|NCT02268851|593201409|FG000|Overall Study|Patient Compliance|0|||
164227200|NCT02268851|593201410|FG001|Overall Study|Patient Compliance|0|||
164227201|NCT02268851|593201411|FG002|Overall Study|Patient Compliance|0|||
164227202|NCT02268851|593201412|FG003|Overall Study|Patient Compliance|0|||
164227203|NCT02268851|593201413|FG004|Overall Study|Patient Compliance|1|||
164227204|NCT02268851|593201414|FG005|Overall Study|Patient Compliance|1|||
164227205|NCT02268851|593201409|FG000|Overall Study|Co-Morbid Condition|0|||
164227206|NCT02268851|593201410|FG001|Overall Study|Co-Morbid Condition|0|||
164227207|NCT02268851|593201411|FG002|Overall Study|Co-Morbid Condition|0|||
164227208|NCT02268851|593201412|FG003|Overall Study|Co-Morbid Condition|0|||
164227209|NCT02268851|593201413|FG004|Overall Study|Co-Morbid Condition|1|||
164227210|NCT02268851|593201414|FG005|Overall Study|Co-Morbid Condition|1|||
164227211|NCT03425188|593201416|FG000|Overall Study|Withdrawal by Subject|1|||
164227212|NCT02184442|593201417|FG000|Overall Study|Death|61|||
164227213|NCT02184442|593201418|FG001|Overall Study|Death|65|||
164227214|NCT02184442|593201417|FG000|Overall Study|Withdrawal by Subject|3|||
164227215|NCT02184442|593201418|FG001|Overall Study|Withdrawal by Subject|11|||
164227216|NCT00787800|593201419|FG000|Overall Study|Withdrawal by Subject|3|||
164227217|NCT00787800|593201420|FG001|Overall Study|Withdrawal by Subject|5|||
164227218|NCT00787800|593201419|FG000|Overall Study|Death|0|||
164227219|NCT00787800|593201420|FG001|Overall Study|Death|2|||
164227220|NCT03810495|593201421|FG000|Overall Study|Lost to Follow-up|2|||
164227221|NCT03810495|593201421|FG000|Overall Study|Withdrawal by Subject|1|||
164227222|NCT01905683|593201424|FG000|Overall Study|Protocol Violation|1|||
164227223|NCT01905683|593201424|FG000|Overall Study|Re-injection criteria not met; others|13|||
164227224|NCT01905683|593201424|FG000|Overall Study|Physician Decision|1|||
164227225|NCT01905683|593201424|FG000|Overall Study|Lack of Efficacy|8|||
164227226|NCT01905683|593201424|FG000|Overall Study|Withdrawal by Subject|20|||
164227227|NCT01905683|593201424|FG000|Overall Study|Adverse Event|4|||
164227228|NCT01905683|593201424|FG000|Overall Study|Lost to Follow-up|4|||
164227229|NCT02037984|593201427|FG000|Overall Study|Lack of Efficacy|0|||
164227230|NCT02037984|593201428|FG001|Overall Study|Lack of Efficacy|0|||
164227231|NCT02037984|593201429|FG002|Overall Study|Lack of Efficacy|3|||
164227232|NCT02037984|593201430|FG003|Overall Study|Lack of Efficacy|10|||
164227233|NCT02037984|593201431|FG004|Overall Study|Lack of Efficacy|2|||
164227234|NCT02037984|593201432|FG005|Overall Study|Lack of Efficacy|2|||
164227235|NCT02037984|593201433|FG006|Overall Study|Lack of Efficacy|4|||
164227236|NCT02037984|593201434|FG007|Overall Study|Lack of Efficacy|3|||
164227237|NCT02037984|593201427|FG000|Overall Study|Lost to Follow-up|1|||
164227238|NCT02037984|593201428|FG001|Overall Study|Lost to Follow-up|0|||
164227239|NCT02037984|593201429|FG002|Overall Study|Lost to Follow-up|3|||
164227240|NCT02037984|593201430|FG003|Overall Study|Lost to Follow-up|5|||
164227241|NCT02037984|593201431|FG004|Overall Study|Lost to Follow-up|2|||
164227242|NCT02037984|593201432|FG005|Overall Study|Lost to Follow-up|2|||
164227243|NCT02037984|593201433|FG006|Overall Study|Lost to Follow-up|2|||
164227244|NCT02037984|593201434|FG007|Overall Study|Lost to Follow-up|4|||
164227245|NCT02037984|593201427|FG000|Overall Study|Physician Decision|0|||
164227246|NCT02037984|593201428|FG001|Overall Study|Physician Decision|0|||
164227247|NCT02037984|593201429|FG002|Overall Study|Physician Decision|0|||
164227248|NCT02037984|593201430|FG003|Overall Study|Physician Decision|0|||
164227249|NCT02037984|593201431|FG004|Overall Study|Physician Decision|0|||
164227250|NCT02037984|593201432|FG005|Overall Study|Physician Decision|0|||
164227251|NCT02037984|593201433|FG006|Overall Study|Physician Decision|1|||
164227252|NCT02037984|593201434|FG007|Overall Study|Physician Decision|0|||
164227253|NCT02037984|593201427|FG000|Overall Study|Protocol Violation|0|||
164227254|NCT02037984|593201428|FG001|Overall Study|Protocol Violation|0|||
164227255|NCT02037984|593201429|FG002|Overall Study|Protocol Violation|0|||
164227256|NCT02037984|593201430|FG003|Overall Study|Protocol Violation|0|||
164227257|NCT02037984|593201431|FG004|Overall Study|Protocol Violation|0|||
164227258|NCT02037984|593201432|FG005|Overall Study|Protocol Violation|1|||
164227259|NCT02037984|593201433|FG006|Overall Study|Protocol Violation|2|||
164227260|NCT02037984|593201434|FG007|Overall Study|Protocol Violation|0|||
164227261|NCT02037984|593201427|FG000|Overall Study|Technical Problems|0|||
164227262|NCT02037984|593201428|FG001|Overall Study|Technical Problems|0|||
164227263|NCT02037984|593201429|FG002|Overall Study|Technical Problems|3|||
164227264|NCT02037984|593201430|FG003|Overall Study|Technical Problems|3|||
164227265|NCT02037984|593201431|FG004|Overall Study|Technical Problems|2|||
164227266|NCT02037984|593201432|FG005|Overall Study|Technical Problems|3|||
164227267|NCT02037984|593201433|FG006|Overall Study|Technical Problems|4|||
164227268|NCT02037984|593201434|FG007|Overall Study|Technical Problems|2|||
164227269|NCT02037984|593201427|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164227270|NCT02037984|593201428|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164227271|NCT02037984|593201429|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
164227272|NCT02037984|593201430|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
164227273|NCT02037984|593201431|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
164227274|NCT02037984|593201432|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
164227275|NCT02037984|593201433|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
164227276|NCT02037984|593201434|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
164227277|NCT02037984|593201427|FG000|Overall Study|Withdrawal by Subject|0|||
164227278|NCT02037984|593201428|FG001|Overall Study|Withdrawal by Subject|0|||
164227279|NCT02037984|593201429|FG002|Overall Study|Withdrawal by Subject|0|||
164227280|NCT02037984|593201430|FG003|Overall Study|Withdrawal by Subject|1|||
164227281|NCT02037984|593201431|FG004|Overall Study|Withdrawal by Subject|1|||
164227282|NCT02037984|593201432|FG005|Overall Study|Withdrawal by Subject|3|||
164227283|NCT02037984|593201433|FG006|Overall Study|Withdrawal by Subject|0|||
164227284|NCT02037984|593201434|FG007|Overall Study|Withdrawal by Subject|1|||
164227285|NCT04924608|593202553|FG000|Overall Study|Adverse Event|10|||
164227286|NCT04924608|593202554|FG001|Overall Study|Adverse Event|6|||
164227287|NCT04924608|593202553|FG000|Overall Study|Lost to Follow-up|1|||
164227288|NCT04924608|593202554|FG001|Overall Study|Lost to Follow-up|1|||
164227289|NCT04924608|593202553|FG000|Overall Study|Ongoing at the data cut-off date|54|||
164227290|NCT04924608|593202554|FG001|Overall Study|Ongoing at the data cut-off date|60|||
164227291|NCT04924608|593202553|FG000|Overall Study|Progressive Disease|2|||
164227292|NCT04924608|593202554|FG001|Overall Study|Progressive Disease|0|||
164227293|NCT04924608|593202553|FG000|Overall Study|Withdrawal by Subject|3|||
164227294|NCT04924608|593202554|FG001|Overall Study|Withdrawal by Subject|6|||
164227295|NCT04924608|593202553|FG000|Overall Study|Other reason|1|||
164227296|NCT04924608|593202554|FG001|Overall Study|Other reason|1|||
164227297|NCT05415215|593202555|FG000|Neoadjuvant Phase|Adverse Event|0|||
164227298|NCT05415215|593202556|FG001|Neoadjuvant Phase|Adverse Event|8|||
164227299|NCT05415215|593202557|FG002|Neoadjuvant Phase|Adverse Event|0|||
164227300|NCT05415215|593202558|FG003|Neoadjuvant Phase|Adverse Event|0|||
164227301|NCT05415215|593202559|FG004|Neoadjuvant Phase|Adverse Event|0|||
164227302|NCT05415215|593202560|FG005|Neoadjuvant Phase|Adverse Event|0|||
164227303|NCT05415215|593202561|FG006|Neoadjuvant Phase|Adverse Event|0|||
164227304|NCT05415215|593202562|FG007|Neoadjuvant Phase|Adverse Event|0|||
164227305|NCT05415215|593202555|FG000|Neoadjuvant Phase|Death|0|||
164227306|NCT05415215|593202556|FG001|Neoadjuvant Phase|Death|4|||
164227307|NCT05415215|593202557|FG002|Neoadjuvant Phase|Death|0|||
164330893|NCT02766465|593588339|FG001|Overall Study|Withdrawal by Subject|10|||
164330894|NCT01505647|593588340|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
164330895|NCT01505647|593588341|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
164330896|NCT01505647|593588340|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
164330897|NCT01505647|593588341|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
164330898|NCT01505647|593588340|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
164330899|NCT01505647|593588341|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
164330900|NCT01505647|593588340|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
164330901|NCT01505647|593588341|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
164330902|NCT01505647|593588340|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
164330903|NCT01505647|593588341|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
164227308|NCT05415215|593202558|FG003|Neoadjuvant Phase|Death|0|||
164227309|NCT05415215|593202559|FG004|Neoadjuvant Phase|Death|0|||
164227310|NCT05415215|593202560|FG005|Neoadjuvant Phase|Death|0|||
164227311|NCT05415215|593202561|FG006|Neoadjuvant Phase|Death|0|||
164227312|NCT05415215|593202562|FG007|Neoadjuvant Phase|Death|0|||
164330904|NCT01907100|593588342|FG000|Overall Study|PD based on modified RECIST criteria|31|||
164227313|NCT05415215|593202555|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
164227314|NCT05415215|593202556|FG001|Neoadjuvant Phase|Withdrawal by Subject|11|||
164330905|NCT01907100|593588343|FG001|Overall Study|PD based on modified RECIST criteria|32|||
164227315|NCT05415215|593202557|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
164227316|NCT05415215|593202558|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
164227317|NCT05415215|593202559|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
164330906|NCT01907100|593588344|FG002|Overall Study|PD based on modified RECIST criteria|95|||
164330907|NCT01907100|593588345|FG003|Overall Study|PD based on modified RECIST criteria|92|||
164330908|NCT01907100|593588342|FG000|Overall Study|Withdrawal by Subject|2|||
164330909|NCT01907100|593588343|FG001|Overall Study|Withdrawal by Subject|5|||
164330910|NCT01907100|593588344|FG002|Overall Study|Withdrawal by Subject|10|||
164330911|NCT01907100|593588345|FG003|Overall Study|Withdrawal by Subject|13|||
164330912|NCT01907100|593588342|FG000|Overall Study|Protocol Violation|0|||
164330913|NCT01907100|593588343|FG001|Overall Study|Protocol Violation|0|||
164330914|NCT01907100|593588344|FG002|Overall Study|Protocol Violation|1|||
164330915|NCT01907100|593588345|FG003|Overall Study|Protocol Violation|1|||
164330916|NCT01907100|593588342|FG000|Overall Study|Lost to Follow-up|0|||
164330917|NCT01907100|593588343|FG001|Overall Study|Lost to Follow-up|0|||
164330918|NCT01907100|593588344|FG002|Overall Study|Lost to Follow-up|0|||
164330919|NCT01907100|593588345|FG003|Overall Study|Lost to Follow-up|1|||
164330920|NCT01907100|593588342|FG000|Overall Study|Not treated|2|||
164330921|NCT01907100|593588343|FG001|Overall Study|Not treated|0|||
164330922|NCT01907100|593588344|FG002|Overall Study|Not treated|1|||
164330923|NCT01907100|593588345|FG003|Overall Study|Not treated|2|||
164330924|NCT01907100|593588342|FG000|Overall Study|Other than reasons specified|1|||
164330925|NCT01907100|593588343|FG001|Overall Study|Other than reasons specified|0|||
164330926|NCT01907100|593588344|FG002|Overall Study|Other than reasons specified|10|||
164330927|NCT01907100|593588345|FG003|Overall Study|Other than reasons specified|6|||
164330928|NCT01907100|593588342|FG000|Overall Study|Adverse event (AE)|6|||
164227318|NCT05415215|593202560|FG005|Neoadjuvant Phase|Withdrawal by Subject|0|||
164227319|NCT05415215|593202561|FG006|Neoadjuvant Phase|Withdrawal by Subject|0|||
164227320|NCT05415215|593202562|FG007|Neoadjuvant Phase|Withdrawal by Subject|0|||
164227321|NCT05415215|593202555|FG000|Neoadjuvant Phase|Progressive Disease|0|||
164227322|NCT05415215|593202556|FG001|Neoadjuvant Phase|Progressive Disease|2|||
164227323|NCT05415215|593202557|FG002|Neoadjuvant Phase|Progressive Disease|0|||
164227324|NCT05415215|593202558|FG003|Neoadjuvant Phase|Progressive Disease|0|||
164227325|NCT05415215|593202559|FG004|Neoadjuvant Phase|Progressive Disease|0|||
164227326|NCT05415215|593202560|FG005|Neoadjuvant Phase|Progressive Disease|0|||
164227327|NCT05415215|593202561|FG006|Neoadjuvant Phase|Progressive Disease|0|||
164227328|NCT05415215|593202562|FG007|Neoadjuvant Phase|Progressive Disease|0|||
164227329|NCT05415215|593202555|FG000|Neoadjuvant Phase|Reason not Specified|1|||
164227330|NCT05415215|593202556|FG001|Neoadjuvant Phase|Reason not Specified|4|||
164227331|NCT05415215|593202557|FG002|Neoadjuvant Phase|Reason not Specified|0|||
164227332|NCT05415215|593202558|FG003|Neoadjuvant Phase|Reason not Specified|0|||
164227333|NCT05415215|593202559|FG004|Neoadjuvant Phase|Reason not Specified|0|||
164227334|NCT05415215|593202560|FG005|Neoadjuvant Phase|Reason not Specified|0|||
164227335|NCT05415215|593202561|FG006|Neoadjuvant Phase|Reason not Specified|0|||
164227336|NCT05415215|593202562|FG007|Neoadjuvant Phase|Reason not Specified|0|||
164227337|NCT05415215|593202555|FG000|Neoadjuvant Phase|Treatment Intolerance|1|||
164227338|NCT05415215|593202556|FG001|Neoadjuvant Phase|Treatment Intolerance|1|||
164227339|NCT05415215|593202557|FG002|Neoadjuvant Phase|Treatment Intolerance|0|||
164227340|NCT05415215|593202558|FG003|Neoadjuvant Phase|Treatment Intolerance|0|||
164227341|NCT05415215|593202559|FG004|Neoadjuvant Phase|Treatment Intolerance|0|||
164227342|NCT05415215|593202560|FG005|Neoadjuvant Phase|Treatment Intolerance|0|||
164227343|NCT05415215|593202561|FG006|Neoadjuvant Phase|Treatment Intolerance|0|||
164227344|NCT05415215|593202562|FG007|Neoadjuvant Phase|Treatment Intolerance|0|||
164227345|NCT05415215|593202555|FG000|Neoadjuvant Phase|Lost to Follow-up|1|||
164227346|NCT05415215|593202556|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
164227347|NCT05415215|593202557|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
164227348|NCT05415215|593202558|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
164227349|NCT05415215|593202559|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
164227350|NCT05415215|593202560|FG005|Neoadjuvant Phase|Lost to Follow-up|0|||
164227351|NCT05415215|593202561|FG006|Neoadjuvant Phase|Lost to Follow-up|0|||
164227352|NCT05415215|593202562|FG007|Neoadjuvant Phase|Lost to Follow-up|0|||
164227353|NCT05415215|593202555|FG000|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
164227354|NCT05415215|593202556|FG001|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
164227355|NCT05415215|593202557|FG002|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
164227356|NCT05415215|593202558|FG003|Adjuvant Phase: Cross-over Period|Adverse Event|1|||
164227357|NCT05415215|593202559|FG004|Adjuvant Phase: Cross-over Period|Adverse Event|1|||
164227358|NCT05415215|593202560|FG005|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
164227359|NCT05415215|593202561|FG006|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
164227360|NCT05415215|593202562|FG007|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
164227361|NCT05415215|593202555|FG000|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
164227362|NCT05415215|593202556|FG001|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
164227363|NCT05415215|593202557|FG002|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
164227364|NCT05415215|593202558|FG003|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|1|||
164227365|NCT05415215|593202559|FG004|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|1|||
164227366|NCT05415215|593202560|FG005|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
164227367|NCT05415215|593202561|FG006|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
164227368|NCT05415215|593202562|FG007|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
164227369|NCT05415215|593202555|FG000|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
164227370|NCT05415215|593202556|FG001|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
164227371|NCT05415215|593202557|FG002|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
164330929|NCT01907100|593588343|FG001|Overall Study|Adverse event (AE)|3|||
164227372|NCT05415215|593202558|FG003|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
164227373|NCT05415215|593202559|FG004|Adjuvant Phase: Cross-over Period|Treatment Intolerance|1|||
164330930|NCT01907100|593588344|FG002|Overall Study|Adverse event (AE)|22|||
164227374|NCT05415215|593202560|FG005|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
164227375|NCT05415215|593202561|FG006|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
164227376|NCT05415215|593202562|FG007|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
164227377|NCT05415215|593202555|FG000|Adjuvant Phase: Continuation Period|Adverse Event|0|||
164227378|NCT05415215|593202556|FG001|Adjuvant Phase: Continuation Period|Adverse Event|0|||
164227379|NCT05415215|593202557|FG002|Adjuvant Phase: Continuation Period|Adverse Event|0|||
164227380|NCT05415215|593202558|FG003|Adjuvant Phase: Continuation Period|Adverse Event|0|||
164227381|NCT05415215|593202559|FG004|Adjuvant Phase: Continuation Period|Adverse Event|0|||
164227382|NCT05415215|593202560|FG005|Adjuvant Phase: Continuation Period|Adverse Event|0|||
164227383|NCT05415215|593202561|FG006|Adjuvant Phase: Continuation Period|Adverse Event|1|||
164227384|NCT05415215|593202562|FG007|Adjuvant Phase: Continuation Period|Adverse Event|0|||
164227385|NCT05415215|593202555|FG000|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
164227386|NCT05415215|593202556|FG001|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
164227387|NCT05415215|593202557|FG002|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
164227388|NCT05415215|593202558|FG003|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
164227389|NCT05415215|593202559|FG004|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
164227390|NCT05415215|593202560|FG005|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|1|||
164227391|NCT05415215|593202561|FG006|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
164227392|NCT05415215|593202562|FG007|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
164227393|NCT05415215|593202555|FG000|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
164227394|NCT05415215|593202556|FG001|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
164227395|NCT05415215|593202557|FG002|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
164227396|NCT05415215|593202558|FG003|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
164227397|NCT05415215|593202559|FG004|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
164227398|NCT05415215|593202560|FG005|Adjuvant Phase: Continuation Period|Withdrawal by Subject|1|||
164227399|NCT05415215|593202561|FG006|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
164227400|NCT05415215|593202562|FG007|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
164227401|NCT05415215|593202555|FG000|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
164227402|NCT05415215|593202556|FG001|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
164227403|NCT05415215|593202557|FG002|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
164227404|NCT05415215|593202558|FG003|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
164227405|NCT05415215|593202559|FG004|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
164227406|NCT05415215|593202560|FG005|Adjuvant Phase: Continuation Period|Progressive Disease|1|||
164227407|NCT05415215|593202561|FG006|Adjuvant Phase: Continuation Period|Progressive Disease|1|||
164227408|NCT05415215|593202562|FG007|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
164227409|NCT05415215|593202555|FG000|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
164227410|NCT05415215|593202556|FG001|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
164227411|NCT05415215|593202557|FG002|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
164227412|NCT05415215|593202558|FG003|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
164227413|NCT05415215|593202559|FG004|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
164227414|NCT05415215|593202560|FG005|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
164227415|NCT05415215|593202561|FG006|Adjuvant Phase: Continuation Period|Reason not Specified|1|||
164227416|NCT05415215|593202562|FG007|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
164227417|NCT05415215|593202555|FG000|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
164227418|NCT05415215|593202556|FG001|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
164227419|NCT05415215|593202557|FG002|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
164227420|NCT05415215|593202558|FG003|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
164227421|NCT05415215|593202559|FG004|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
164227422|NCT05415215|593202560|FG005|Adjuvant Phase: Continuation Period|Ongoing in Treatment|11|||
164571233|NCT00961961|594456844|FG000|Phase I|Adverse Event|7|||
164571234|NCT00961961|594456845|FG001|Phase I|Adverse Event|0|||
164571235|NCT00961961|594456846|FG002|Phase I|Adverse Event|0|||
164571236|NCT00961961|594456847|FG003|Phase I|Adverse Event|0|||
164571237|NCT00961961|594456844|FG000|Phase I|Physician Decision|8|||
164571238|NCT00961961|594456845|FG001|Phase I|Physician Decision|0|||
164571239|NCT00961961|594456846|FG002|Phase I|Physician Decision|0|||
164571240|NCT00961961|594456847|FG003|Phase I|Physician Decision|0|||
164571241|NCT00961961|594456844|FG000|Phase II|Lost to Follow-up|0|||
164421067|NCT02138747|593911087|FG003|Treatment Period 2|Other - Miscellaneous|0|||
164227423|NCT05415215|593202561|FG006|Adjuvant Phase: Continuation Period|Ongoing in Treatment|9|||
164227424|NCT05415215|593202562|FG007|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
164571242|NCT00961961|594456845|FG001|Phase II|Lost to Follow-up|0|||
164571243|NCT00961961|594456846|FG002|Phase II|Lost to Follow-up|10|||
164571244|NCT00961961|594456847|FG003|Phase II|Lost to Follow-up|7|||
164227425|NCT05415215|593202555|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
164227426|NCT05415215|593202556|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
164227427|NCT05415215|593202557|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
164227428|NCT05415215|593202558|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
164227429|NCT05415215|593202559|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
164227430|NCT05415215|593202560|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
164227431|NCT05415215|593202561|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
164227432|NCT05415215|593202562|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|5|||
164227433|NCT05415215|593202555|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
164227434|NCT05415215|593202556|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
164227435|NCT05415215|593202557|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
164227436|NCT05415215|593202558|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
164227437|NCT05415215|593202559|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
164227438|NCT05415215|593202560|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
164227439|NCT05415215|593202561|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
164227440|NCT05415215|593202562|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Death|1|||
164227441|NCT05415215|593202555|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
164227442|NCT05415215|593202556|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
164227443|NCT05415215|593202557|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
164227444|NCT05415215|593202558|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
164227445|NCT05415215|593202559|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
164227446|NCT05415215|593202560|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
164227447|NCT05415215|593202561|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
164227448|NCT05415215|593202562|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|2|||
164227449|NCT05415215|593202555|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
164227450|NCT05415215|593202556|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
164227451|NCT05415215|593202557|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
164227452|NCT05415215|593202558|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
164421068|NCT02302066|593911088|FG000|Overall Study|Adverse Event|1|||
164421069|NCT02302066|593911089|FG001|Overall Study|Adverse Event|1|||
164421070|NCT02302066|593911090|FG002|Overall Study|Adverse Event|3|||
164421071|NCT02302066|593911091|FG003|Overall Study|Adverse Event|0|||
164421072|NCT02302066|593911088|FG000|Overall Study|Lost to Follow-up|4|||
164421073|NCT02302066|593911089|FG001|Overall Study|Lost to Follow-up|5|||
164421074|NCT02302066|593911090|FG002|Overall Study|Lost to Follow-up|24|||
164421075|NCT02302066|593911091|FG003|Overall Study|Lost to Follow-up|7|||
164421076|NCT02302066|593911088|FG000|Overall Study|Withdrawal by Subject|25|||
164421077|NCT02302066|593911089|FG001|Overall Study|Withdrawal by Subject|58|||
164421078|NCT02302066|593911090|FG002|Overall Study|Withdrawal by Subject|124|||
164421079|NCT02302066|593911091|FG003|Overall Study|Withdrawal by Subject|33|||
164421080|NCT02302066|593911088|FG000|Overall Study|Pregnancy|2|||
164227453|NCT05415215|593202559|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
164227454|NCT05415215|593202560|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
164227455|NCT05415215|593202561|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
164227456|NCT05415215|593202562|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|1|||
164227457|NCT05415215|593202555|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
164227458|NCT05415215|593202556|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
164227459|NCT05415215|593202557|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
164227460|NCT05415215|593202558|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
164227461|NCT05415215|593202559|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
164227462|NCT05415215|593202560|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
164227463|NCT05415215|593202561|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
164227464|NCT05415215|593202562|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|2|||
164227465|NCT05415215|593202555|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
164227466|NCT05415215|593202556|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
164227467|NCT05415215|593202557|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
164227468|NCT05415215|593202558|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
164227469|NCT05415215|593202559|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
164227470|NCT05415215|593202560|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
164227471|NCT05415215|593202561|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
164227472|NCT05415215|593202562|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|4|||
164421081|NCT02302066|593911089|FG001|Overall Study|Pregnancy|10|||
164421082|NCT02302066|593911090|FG002|Overall Study|Pregnancy|12|||
164421083|NCT02302066|593911091|FG003|Overall Study|Pregnancy|0|||
164421084|NCT02302066|593911088|FG000|Overall Study|Reason Not Specified|1|||
164421085|NCT02302066|593911089|FG001|Overall Study|Reason Not Specified|1|||
164421086|NCT02302066|593911090|FG002|Overall Study|Reason Not Specified|9|||
164571245|NCT00961961|594456844|FG000|Phase II|Adverse Event|0|||
164421087|NCT02302066|593911091|FG003|Overall Study|Reason Not Specified|1|||
164421088|NCT04793464|593911096|FG000|Overall Study|Lost to Follow-up|458|||
164330931|NCT01907100|593588345|FG003|Overall Study|Adverse event (AE)|23|||
164571246|NCT00961961|594456845|FG001|Phase II|Adverse Event|0|||
164421089|NCT04793464|593911097|FG001|Overall Study|Lost to Follow-up|168|||
164421090|NCT04793464|593911098|FG002|Overall Study|Lost to Follow-up|5|||
164421091|NCT04793464|593911096|FG000|Overall Study|Withdrawal by Subject|43|||
164421092|NCT04793464|593911097|FG001|Overall Study|Withdrawal by Subject|15|||
164421093|NCT04793464|593911098|FG002|Overall Study|Withdrawal by Subject|0|||
164421094|NCT00903786|593911099|FG000|Overall Study|Physician Decision|6|||
164571247|NCT00961961|594456846|FG002|Phase II|Adverse Event|0|||
164571248|NCT00961961|594456847|FG003|Phase II|Adverse Event|1|||
164571249|NCT00961961|594456844|FG000|Phase II|Physician Decision|0|||
164571250|NCT00961961|594456845|FG001|Phase II|Physician Decision|0|||
164571251|NCT00961961|594456846|FG002|Phase II|Physician Decision|1|||
164571252|NCT00961961|594456847|FG003|Phase II|Physician Decision|0|||
164571253|NCT00961961|594456844|FG000|Phase II|Withdrawal by Subject|0|||
164571254|NCT00961961|594456845|FG001|Phase II|Withdrawal by Subject|0|||
164571255|NCT00961961|594456846|FG002|Phase II|Withdrawal by Subject|1|||
164571256|NCT00961961|594456847|FG003|Phase II|Withdrawal by Subject|0|||
164571257|NCT04752384|594456848|FG000|Overall Study|Withdrawal by Subject|1|||
164571258|NCT04752384|594456848|FG000|Overall Study|Death|1|||
164571259|NCT04439331|594456849|FG000|Overall Study|Never Start Protocol Therapy|2|||
164571260|NCT04439331|594456849|FG000|Overall Study|Ineligible|2|||
164571261|NCT04439331|594456849|FG000|Overall Study|Mutation Status Not Confirmed|1|||
164571262|NCT04439331|594456849|FG000|Overall Study|Adverse Event|1|||
164571263|NCT04439331|594456849|FG000|Overall Study|Death|1|||
164571264|NCT04439331|594456849|FG000|Overall Study|Disease Progression|20|||
164571265|NCT04439331|594456849|FG000|Overall Study|Withdrawal by Subject|6|||
164571266|NCT04439331|594456849|FG000|Overall Study|Physician Decision|1|||
164571267|NCT04439331|594456849|FG000|Overall Study|Other Complicating Disease|1|||
164571268|NCT04370509|594456850|FG000|Overall Study|Adverse Event|1|||
164571269|NCT04370509|594456851|FG001|Overall Study|Adverse Event|0|||
164571270|NCT04370509|594456850|FG000|Overall Study|Did not receive post-op Pembrolizumab|1|||
164571271|NCT04370509|594456851|FG001|Overall Study|Did not receive post-op Pembrolizumab|0|||
164571272|NCT04743856|594456852|FG000|Overall Study|Lost to Follow-up|6|||
164571273|NCT04743856|594456853|FG001|Overall Study|Lost to Follow-up|7|||
164571274|NCT04743856|594456852|FG000|Overall Study|Withdrawal by Subject|1|||
164571275|NCT04743856|594456853|FG001|Overall Study|Withdrawal by Subject|0|||
164571276|NCT04696861|594456854|FG000|Overall Study|Death|1|||
164571277|NCT04696861|594456855|FG001|Overall Study|Death|0|||
164571278|NCT04696861|594456854|FG000|Overall Study|Lost to Follow-up|3|||
164571279|NCT04696861|594456855|FG001|Overall Study|Lost to Follow-up|0|||
164571280|NCT04439188|594456856|FG000|Overall Study|Ineligible|3|||
164571281|NCT04439188|594456856|FG000|Overall Study|Adverse Event|4|||
164571282|NCT04439188|594456856|FG000|Overall Study|Death|1|||
164571283|NCT04439188|594456856|FG000|Overall Study|Disease Progression|25|||
164571284|NCT04439188|594456856|FG000|Overall Study|Withdrawal by Subject|2|||
164571285|NCT00630331|594456857|FG000|Overall Study|Death|2|||
164571286|NCT00630331|594456858|FG001|Overall Study|Death|1|||
164571287|NCT00630331|594456859|FG002|Overall Study|Death|1|||
164571288|NCT00630331|594456857|FG000|Overall Study|Adverse Event|1|||
164571289|NCT00630331|594456858|FG001|Overall Study|Adverse Event|0|||
164571290|NCT00630331|594456859|FG002|Overall Study|Adverse Event|0|||
164571291|NCT00630331|594456857|FG000|Overall Study|Withdrawal by Subject|12|||
164571292|NCT00630331|594456858|FG001|Overall Study|Withdrawal by Subject|7|||
164571293|NCT00630331|594456859|FG002|Overall Study|Withdrawal by Subject|5|||
164571294|NCT00630331|594456857|FG000|Overall Study|Lost to Follow-up|175|||
164571295|NCT00630331|594456858|FG001|Overall Study|Lost to Follow-up|143|||
164571296|NCT00630331|594456859|FG002|Overall Study|Lost to Follow-up|170|||
164571297|NCT00630331|594456857|FG000|Overall Study|Inappropriate enrollment|3|||
164571298|NCT00630331|594456858|FG001|Overall Study|Inappropriate enrollment|6|||
164421095|NCT00903786|593911099|FG000|Overall Study|Lack of Efficacy|5|||
164571299|NCT00630331|594456859|FG002|Overall Study|Inappropriate enrollment|3|||
164571300|NCT00630331|594456857|FG000|Overall Study|Unable to classify|9|||
164571301|NCT00630331|594456858|FG001|Overall Study|Unable to classify|4|||
164421096|NCT00903786|593911099|FG000|Overall Study|Reason other than lack of efficacy|4|||
164421097|NCT02285595|593911101|FG000|Overall Study|Lost to Follow-up|14|||
164571302|NCT00630331|594456859|FG002|Overall Study|Unable to classify|3|||
164571303|NCT00630331|594456857|FG000|Overall Study|Protocol Violation|4|||
164571304|NCT00630331|594456858|FG001|Overall Study|Protocol Violation|5|||
164571305|NCT00630331|594456859|FG002|Overall Study|Protocol Violation|6|||
164571306|NCT01929135|594456860|FG000|Overall Study|Lost to Follow-up|1|||
164571307|NCT01929135|594456861|FG001|Overall Study|Lost to Follow-up|1|||
164571308|NCT02425098|594456862|FG000|Overall Study|Lost to Follow-up|7|||
164571309|NCT02425098|594456863|FG001|Overall Study|Lost to Follow-up|7|||
164571310|NCT02425098|594456862|FG000|Overall Study|Withdrawal by Subject|4|||
164571311|NCT02425098|594456863|FG001|Overall Study|Withdrawal by Subject|8|||
164571312|NCT02425098|594456862|FG000|Overall Study|Pregnancy|2|||
164571313|NCT02425098|594456863|FG001|Overall Study|Pregnancy|0|||
164227473|NCT05415215|593202555|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
164227474|NCT05415215|593202556|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
164227475|NCT05415215|593202557|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
164227476|NCT05415215|593202558|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
164571314|NCT02425098|594456862|FG000|Overall Study|Reason not Specified|0|||
164571315|NCT02425098|594456863|FG001|Overall Study|Reason not Specified|1|||
164571316|NCT01955707|594456864|FG000|Overall Study|Adverse Event|1|||
164571317|NCT01955707|594456865|FG001|Overall Study|Adverse Event|2|||
164571318|NCT01955707|594456864|FG000|Overall Study|Lost to Follow-up|2|||
164571319|NCT01955707|594456865|FG001|Overall Study|Lost to Follow-up|1|||
164571320|NCT01955707|594456864|FG000|Overall Study|Withdrawal by Subject|0|||
164571321|NCT01955707|594456865|FG001|Overall Study|Withdrawal by Subject|3|||
164227477|NCT05415215|593202559|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
164227478|NCT05415215|593202560|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
164227479|NCT05415215|593202561|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
164227480|NCT05415215|593202562|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|25|||
164227481|NCT05415215|593202555|FG000|Follow-up Period|Ongoing in Follow-up|0|||
164227482|NCT05415215|593202556|FG001|Follow-up Period|Ongoing in Follow-up|0|||
164227483|NCT05415215|593202557|FG002|Follow-up Period|Ongoing in Follow-up|0|||
164227484|NCT05415215|593202558|FG003|Follow-up Period|Ongoing in Follow-up|0|||
164227485|NCT05415215|593202559|FG004|Follow-up Period|Ongoing in Follow-up|0|||
164227486|NCT05415215|593202560|FG005|Follow-up Period|Ongoing in Follow-up|44|||
164227487|NCT05415215|593202561|FG006|Follow-up Period|Ongoing in Follow-up|45|||
164227488|NCT05415215|593202562|FG007|Follow-up Period|Ongoing in Follow-up|51|||
164227489|NCT05415215|593202555|FG000|Follow-up Period|Adverse Event|0|||
164227490|NCT05415215|593202556|FG001|Follow-up Period|Adverse Event|0|||
164227491|NCT05415215|593202557|FG002|Follow-up Period|Adverse Event|0|||
164227492|NCT05415215|593202558|FG003|Follow-up Period|Adverse Event|0|||
164227493|NCT05415215|593202559|FG004|Follow-up Period|Adverse Event|0|||
164227494|NCT05415215|593202560|FG005|Follow-up Period|Adverse Event|0|||
164227495|NCT05415215|593202561|FG006|Follow-up Period|Adverse Event|1|||
164227496|NCT05415215|593202562|FG007|Follow-up Period|Adverse Event|0|||
164227497|NCT05415215|593202555|FG000|Follow-up Period|Lost to Follow-up|0|||
164227498|NCT05415215|593202556|FG001|Follow-up Period|Lost to Follow-up|0|||
164227499|NCT05415215|593202557|FG002|Follow-up Period|Lost to Follow-up|0|||
164227500|NCT05415215|593202558|FG003|Follow-up Period|Lost to Follow-up|0|||
164227501|NCT05415215|593202559|FG004|Follow-up Period|Lost to Follow-up|0|||
164227502|NCT05415215|593202560|FG005|Follow-up Period|Lost to Follow-up|1|||
164227503|NCT05415215|593202561|FG006|Follow-up Period|Lost to Follow-up|1|||
164227504|NCT05415215|593202562|FG007|Follow-up Period|Lost to Follow-up|0|||
164227505|NCT05415215|593202555|FG000|Follow-up Period|Withdrawal by Subject|0|||
164227506|NCT05415215|593202556|FG001|Follow-up Period|Withdrawal by Subject|0|||
164227507|NCT05415215|593202557|FG002|Follow-up Period|Withdrawal by Subject|0|||
164227508|NCT05415215|593202558|FG003|Follow-up Period|Withdrawal by Subject|0|||
164227509|NCT05415215|593202559|FG004|Follow-up Period|Withdrawal by Subject|0|||
164227510|NCT05415215|593202560|FG005|Follow-up Period|Withdrawal by Subject|0|||
164227511|NCT05415215|593202561|FG006|Follow-up Period|Withdrawal by Subject|0|||
164227512|NCT05415215|593202562|FG007|Follow-up Period|Withdrawal by Subject|2|||
164227513|NCT02797522|593202563|FG000|Overall Study|Study Terminated by Sponsor|0|||
164227514|NCT02797522|593202564|FG001|Overall Study|Study Terminated by Sponsor|0|||
164227515|NCT02797522|593202565|FG002|Overall Study|Study Terminated by Sponsor|0|||
164227516|NCT02797522|593202566|FG003|Overall Study|Study Terminated by Sponsor|0|||
164227517|NCT02797522|593202567|FG004|Overall Study|Study Terminated by Sponsor|0|||
164227518|NCT02797522|593202568|FG005|Overall Study|Study Terminated by Sponsor|0|||
164227519|NCT02797522|593202569|FG006|Overall Study|Study Terminated by Sponsor|0|||
164227520|NCT02797522|593202570|FG007|Overall Study|Study Terminated by Sponsor|4|||
164227521|NCT02797522|593202571|FG008|Overall Study|Study Terminated by Sponsor|2|||
164227522|NCT02797522|593202572|FG009|Overall Study|Study Terminated by Sponsor|4|||
164227523|NCT02797522|593202573|FG010|Overall Study|Study Terminated by Sponsor|1|||
164227524|NCT04129398|593202574|FG000|Overall Study|Physician Decision|2|||
164227525|NCT02932410|593202575|FG000|Overall Study|Death|7|||
164227526|NCT02932410|593202576|FG001|Overall Study|Death|6|||
164227527|NCT02932410|593202577|FG002|Overall Study|Death|0|||
164227528|NCT02932410|593202578|FG003|Overall Study|Death|0|||
164227529|NCT02932410|593202575|FG000|Overall Study|Lost to Follow-up|1|||
164227530|NCT02932410|593202576|FG001|Overall Study|Lost to Follow-up|2|||
164227531|NCT02932410|593202577|FG002|Overall Study|Lost to Follow-up|0|||
164227532|NCT02932410|593202578|FG003|Overall Study|Lost to Follow-up|0|||
164227533|NCT02932410|593202575|FG000|Overall Study|Parent/Subjects decision|6|||
164227534|NCT02932410|593202576|FG001|Overall Study|Parent/Subjects decision|6|||
164571322|NCT01955707|594456864|FG000|Overall Study|Death|13|||
164571323|NCT01955707|594456865|FG001|Overall Study|Death|14|||
164227535|NCT02932410|593202577|FG002|Overall Study|Parent/Subjects decision|1|||
164571324|NCT01955707|594456864|FG000|Overall Study|Other|4|||
164571325|NCT01955707|594456865|FG001|Overall Study|Other|2|||
164571326|NCT01817790|594456868|FG000|Overall Study|Adverse Event|0|||
164330932|NCT01907100|593588342|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
164330933|NCT01907100|593588343|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
164330934|NCT01907100|593588344|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
164330935|NCT01907100|593588345|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
164330936|NCT01758289|593588346|FG000|Overall Study|Premature Study Termination|44|||
164330937|NCT01758289|593588346|FG000|Overall Study|Adverse Event|9|||
164330938|NCT01574079|593588347|FG000|Overall Study|Physician Decision|0|||
164330939|NCT01574079|593588348|FG001|Overall Study|Physician Decision|2|||
164330940|NCT01574079|593588347|FG000|Overall Study|Lost to Follow-up|1|||
164330941|NCT01574079|593588348|FG001|Overall Study|Lost to Follow-up|0|||
164330942|NCT00908011|593588349|FG000|Overall Study|Withdrawal by Subject|2|||
164330943|NCT00908011|593588350|FG001|Overall Study|Withdrawal by Subject|2|||
164330944|NCT00843726|593588351|FG000|Overall Study|Death|1|||
164330945|NCT00843726|593588352|FG001|Overall Study|Death|0|||
164330946|NCT00843726|593588351|FG000|Overall Study|Withdrawal by Subject|0|||
164330947|NCT00843726|593588352|FG001|Overall Study|Withdrawal by Subject|1|||
164330948|NCT00667602|593588353|FG000|Overall Study|Withdrawal by Subject|4|||
164330949|NCT00667602|593588354|FG001|Overall Study|Withdrawal by Subject|9|||
164330950|NCT00667602|593588355|FG002|Overall Study|Withdrawal by Subject|10|||
164330951|NCT00667602|593588353|FG000|Overall Study|Lost to Follow-up|4|||
164571327|NCT01817790|594456869|FG001|Overall Study|Adverse Event|2|||
164330952|NCT00667602|593588354|FG001|Overall Study|Lost to Follow-up|5|||
164330953|NCT00667602|593588355|FG002|Overall Study|Lost to Follow-up|6|||
164330954|NCT00667602|593588353|FG000|Overall Study|Administrative reason|0|||
164330955|NCT00667602|593588354|FG001|Overall Study|Administrative reason|0|||
164330956|NCT00667602|593588355|FG002|Overall Study|Administrative reason|2|||
164330957|NCT00667602|593588353|FG000|Overall Study|Protocol Violation|0|||
164330958|NCT00667602|593588354|FG001|Overall Study|Protocol Violation|1|||
164330959|NCT00667602|593588355|FG002|Overall Study|Protocol Violation|0|||
164330960|NCT03640559|593588359|FG000|Overall Study|Physician Decision|1|||
164571328|NCT01817790|594456868|FG000|Overall Study|Lost to Follow-up|0|||
164571329|NCT01817790|594456869|FG001|Overall Study|Lost to Follow-up|1|||
164571330|NCT01817790|594456868|FG000|Overall Study|Protocol Violation|2|||
164571331|NCT01817790|594456869|FG001|Overall Study|Protocol Violation|1|||
164421098|NCT02285595|593911101|FG000|Overall Study|Withdrawal by Subject|1|||
164421099|NCT02696902|593911104|FG000|Overall Study|Lost to Follow-up|0|||
164421100|NCT02696902|593911105|FG001|Overall Study|Lost to Follow-up|1|||
164421101|NCT02696902|593911106|FG002|Overall Study|Lost to Follow-up|1|||
164330961|NCT03640559|593588360|FG001|Overall Study|Physician Decision|1|||
164330962|NCT03640559|593588359|FG000|Overall Study|Withdrawal by Subject|1|||
164571332|NCT01817790|594456868|FG000|Overall Study|Withdrawal by Subject|1|||
164571333|NCT01817790|594456869|FG001|Overall Study|Withdrawal by Subject|3|||
164571334|NCT01817790|594456868|FG000|Overall Study|Other: Could not attend appointment|1|||
164571335|NCT01817790|594456869|FG001|Overall Study|Other: Could not attend appointment|1|||
164571336|NCT01671345|594456870|FG000|Overall Study|Lost to Follow-up|10|||
164571337|NCT01671345|594456871|FG001|Overall Study|Lost to Follow-up|6|||
164571338|NCT01671345|594456870|FG000|Overall Study|visit with non-participating physician|3|||
164571339|NCT01671345|594456871|FG001|Overall Study|visit with non-participating physician|3|||
164571340|NCT02847598|594456877|FG000|Overall Study|Adverse Event|0|||
164571341|NCT02847598|594456878|FG001|Overall Study|Adverse Event|0|||
164571342|NCT02847598|594456879|FG002|Overall Study|Adverse Event|0|||
164571343|NCT02847598|594456880|FG003|Overall Study|Adverse Event|0|||
164571344|NCT02847598|594456881|FG004|Overall Study|Adverse Event|0|||
164571345|NCT02847598|594456882|FG005|Overall Study|Adverse Event|0|||
164571346|NCT02847598|594456883|FG006|Overall Study|Adverse Event|0|||
164571347|NCT02847598|594456884|FG007|Overall Study|Adverse Event|1|||
164571348|NCT02847598|594456877|FG000|Overall Study|Consent withdrawn|2|||
164571349|NCT02847598|594456878|FG001|Overall Study|Consent withdrawn|0|||
164330963|NCT03640559|593588360|FG001|Overall Study|Withdrawal by Subject|0|||
164330964|NCT01436162|593588361|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
164330965|NCT01436162|593588362|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
164330966|NCT01436162|593588363|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
164330967|NCT01436162|593588361|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
164330968|NCT01436162|593588362|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
164571350|NCT02847598|594456879|FG002|Overall Study|Consent withdrawn|0|||
164571351|NCT02847598|594456880|FG003|Overall Study|Consent withdrawn|4|||
164571352|NCT02847598|594456881|FG004|Overall Study|Consent withdrawn|3|||
164571353|NCT02847598|594456882|FG005|Overall Study|Consent withdrawn|2|||
164571354|NCT02847598|594456883|FG006|Overall Study|Consent withdrawn|1|||
164571355|NCT02847598|594456884|FG007|Overall Study|Consent withdrawn|3|||
164571356|NCT02847598|594456877|FG000|Overall Study|Death|3|||
164571357|NCT02847598|594456878|FG001|Overall Study|Death|0|||
164571358|NCT02847598|594456879|FG002|Overall Study|Death|0|||
164571359|NCT02847598|594456880|FG003|Overall Study|Death|0|||
164571360|NCT02847598|594456881|FG004|Overall Study|Death|0|||
164571361|NCT02847598|594456882|FG005|Overall Study|Death|0|||
164571362|NCT02847598|594456883|FG006|Overall Study|Death|0|||
164571363|NCT02847598|594456884|FG007|Overall Study|Death|0|||
164675230|NCT04408794|594834904|FG000|Overall Study|Withdrawal by Subject|57|||
164675231|NCT04408794|594834904|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
164675232|NCT04408794|594834904|FG000|Overall Study|Never Treated Migraine|5|||
164675233|NCT00571064|594834907|FG000|Overall Study|Adverse Event|13|||
164675234|NCT00571064|594834907|FG000|Overall Study|Protocol Violation|4|||
164675235|NCT00571064|594834907|FG000|Overall Study|Withdrawal by Subject|2|||
164675236|NCT00571064|594834907|FG000|Overall Study|Other|2|||
164675237|NCT00244764|594834908|FG000|Overall Study|Adverse Event|37|||
164675238|NCT00244764|594834908|FG000|Overall Study|Lost to Follow-up|23|||
164675239|NCT00244764|594834908|FG000|Overall Study|Withdrawal by Subject|12|||
164675240|NCT00244764|594834908|FG000|Overall Study|Disease Progression|13|||
164675241|NCT00244764|594834908|FG000|Overall Study|Protocol Violation|2|||
164675242|NCT00244764|594834908|FG000|Overall Study|Death|1|||
164675243|NCT00244764|594834908|FG000|Overall Study|Off Study Medication for >21 Days|1|||
164675244|NCT00244764|594834908|FG000|Overall Study|Declining Performance Status|1|||
164675245|NCT00244764|594834908|FG000|Overall Study|Participant was Hospitalized until Death|1|||
164675246|NCT00244764|594834908|FG000|Overall Study|Primary Investigator Discretion|2|||
164675247|NCT00244764|594834908|FG000|Overall Study|Sponsor Terminated Study|2|||
164675248|NCT00244764|594834908|FG000|Overall Study|Developed Secondary Malignancy|1|||
164675249|NCT01518972|594834911|FG000|Overall Study|Lost to Follow-up|2|||
164675250|NCT01518972|594834912|FG001|Overall Study|Lost to Follow-up|1|||
164675251|NCT01518972|594834911|FG000|Overall Study|Withdrawal by Subject|1|||
164675252|NCT01518972|594834912|FG001|Overall Study|Withdrawal by Subject|0|||
164675253|NCT01518972|594834911|FG000|Overall Study|Moved from area|1|||
164675254|NCT01518972|594834912|FG001|Overall Study|Moved from area|0|||
164675255|NCT01518972|594834911|FG000|Overall Study|Transportation problems|1|||
164675256|NCT01518972|594834912|FG001|Overall Study|Transportation problems|0|||
164675257|NCT01518972|594834911|FG000|Overall Study|Exclusionary medical condition|1|||
164675258|NCT01518972|594834912|FG001|Overall Study|Exclusionary medical condition|0|||
164675259|NCT01518972|594834911|FG000|Overall Study|Missed safety visits|0|||
164675260|NCT01518972|594834912|FG001|Overall Study|Missed safety visits|1|||
164675261|NCT01518972|594834911|FG000|Overall Study|Exclusionary medication|0|||
164675262|NCT01518972|594834912|FG001|Overall Study|Exclusionary medication|1|||
164675263|NCT01518972|594834911|FG000|Overall Study|Declined medication starting on day 12|0|||
164675264|NCT01518972|594834912|FG001|Overall Study|Declined medication starting on day 12|1|||
164675265|NCT02159950|594834918|FG000|Overall Study|Adverse Event|0|||
164675266|NCT02159950|594834919|FG001|Overall Study|Adverse Event|1|||
164675267|NCT02159950|594834918|FG000|Overall Study|Progression|0|||
164675268|NCT02159950|594834919|FG001|Overall Study|Progression|1|||
164675269|NCT00003659|594834920|FG000|Overall Study|Withdrawal by Subject|3|||
164675270|NCT04022954|594834922|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
164675271|NCT04022954|594834922|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
164675272|NCT04022954|594834922|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
164675273|NCT03872128|594834925|FG000|Overall Study|Dropped out before treatment|1|||
164675274|NCT03872128|594834926|FG001|Overall Study|Dropped out before treatment|0|||
164675275|NCT03872128|594834927|FG002|Overall Study|Dropped out before treatment|4|||
164675276|NCT03872128|594834925|FG000|Overall Study|Lost to Follow-up|2|||
164675277|NCT03872128|594834926|FG001|Overall Study|Lost to Follow-up|5|||
164675278|NCT03872128|594834927|FG002|Overall Study|Lost to Follow-up|8|||
164675279|NCT03285594|594834932|FG000|Overall Study|At the Participant's Own Request|10|||
164675280|NCT03285594|594834933|FG001|Overall Study|At the Participant's Own Request|5|||
164675281|NCT03285594|594834934|FG002|Overall Study|At the Participant's Own Request|21|||
164227536|NCT02932410|593202578|FG003|Overall Study|Parent/Subjects decision|0|||
164227537|NCT02932410|593202575|FG000|Overall Study|Physician Decision|0|||
164227538|NCT02932410|593202576|FG001|Overall Study|Physician Decision|1|||
164227539|NCT02932410|593202577|FG002|Overall Study|Physician Decision|0|||
164227540|NCT02932410|593202578|FG003|Overall Study|Physician Decision|0|||
164227541|NCT04557735|593202581|FG000|Treatment Period (26 Weeks)|Withdrawal by Subject|1|||
164227542|NCT04557735|593202581|FG000|Treatment Period (26 Weeks)|Physician Decision|4|||
164675282|NCT03285594|594834932|FG000|Overall Study|Adverse Event|2|||
164675283|NCT03285594|594834933|FG001|Overall Study|Adverse Event|2|||
164675284|NCT03285594|594834934|FG002|Overall Study|Adverse Event|6|||
164675285|NCT03285594|594834932|FG000|Overall Study|Poor Compliance to Protocol|0|||
164227543|NCT04557735|593202581|FG000|Treatment Period (26 Weeks)|Death|5|||
164227544|NCT04557735|593202581|FG000|Treatment Period (26 Weeks)|Adverse Event|2|||
164421102|NCT02696902|593911104|FG000|Overall Study|Withdrawal by Subject|0|||
164675286|NCT03285594|594834933|FG001|Overall Study|Poor Compliance to Protocol|0|||
164675287|NCT03285594|594834934|FG002|Overall Study|Poor Compliance to Protocol|1|||
164675288|NCT03285594|594834932|FG000|Overall Study|Lost to Follow-up|0|||
164675289|NCT03285594|594834933|FG001|Overall Study|Lost to Follow-up|0|||
164675290|NCT03285594|594834934|FG002|Overall Study|Lost to Follow-up|1|||
164675291|NCT03285594|594834932|FG000|Overall Study|Reason Not Specified|3|||
164675292|NCT03285594|594834933|FG001|Overall Study|Reason Not Specified|4|||
164675293|NCT03285594|594834934|FG002|Overall Study|Reason Not Specified|8|||
164675294|NCT03733444|594834935|FG000|Overall Study|Adverse Event|8|||
164675295|NCT03733444|594834936|FG001|Overall Study|Adverse Event|10|||
164571364|NCT02847598|594456877|FG000|Overall Study|Lost to Follow-up|0|||
164571365|NCT02847598|594456878|FG001|Overall Study|Lost to Follow-up|0|||
164571366|NCT02847598|594456879|FG002|Overall Study|Lost to Follow-up|0|||
164571367|NCT02847598|594456880|FG003|Overall Study|Lost to Follow-up|0|||
164571368|NCT02847598|594456881|FG004|Overall Study|Lost to Follow-up|0|||
164571369|NCT02847598|594456882|FG005|Overall Study|Lost to Follow-up|1|||
164571370|NCT02847598|594456883|FG006|Overall Study|Lost to Follow-up|1|||
164227545|NCT04557735|593202581|FG000|Follow-Up Period (26 Weeks)|Physician Decision|1|||
164227546|NCT04557735|593202581|FG000|Follow-Up Period (26 Weeks)|Death|4|||
164227547|NCT05451329|593202588|FG000|Overall Study|Adverse Event|1|||
164227548|NCT05451329|593202589|FG001|Overall Study|Adverse Event|1|||
164227549|NCT05451329|593202590|FG002|Overall Study|Adverse Event|0|||
164227550|NCT05451329|593202588|FG000|Overall Study|Withdrawal by Subject|1|||
164227551|NCT05451329|593202589|FG001|Overall Study|Withdrawal by Subject|0|||
164227552|NCT05451329|593202590|FG002|Overall Study|Withdrawal by Subject|0|||
164227553|NCT05451329|593202588|FG000|Overall Study|Investigational Product Lot exchange|1|||
164227554|NCT05451329|593202589|FG001|Overall Study|Investigational Product Lot exchange|1|||
164227555|NCT05451329|593202590|FG002|Overall Study|Investigational Product Lot exchange|0|||
164227556|NCT04629521|593202593|FG000|Overall Study|Death|1|||
164227557|NCT04629521|593202593|FG000|Overall Study|Lost to Follow-up|3|||
164227558|NCT04629521|593202593|FG000|Overall Study|Subject withdrew consent|3|||
164227559|NCT04629521|593202593|FG000|Overall Study|Enrolled in error|1|||
164227560|NCT03019406|593202594|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
164227561|NCT03019406|593202595|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
164227562|NCT03019406|593202596|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
164227563|NCT03019406|593202597|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
164227564|NCT03163667|593202598|FG000|Overall Study|Death|15|||
164227565|NCT03163667|593202599|FG001|Overall Study|Death|27|||
164227566|NCT03163667|593202598|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
164227567|NCT03163667|593202599|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
164227568|NCT02556736|593202600|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
164227569|NCT02556736|593202601|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
164227570|NCT02556736|593202602|FG002|Open Label Treatment Period|Withdrawal by Subject|1|||
164227571|NCT02556736|593202603|FG003|Open Label Treatment Period|Withdrawal by Subject|1|||
164330969|NCT01436162|593588363|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
164330970|NCT01436162|593588361|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
164330971|NCT01436162|593588362|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
164330972|NCT01436162|593588363|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
164330973|NCT01436162|593588361|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
164227572|NCT02556736|593202600|FG000|Open Label Treatment Period|Adverse Event|0|||
164227573|NCT02556736|593202601|FG001|Open Label Treatment Period|Adverse Event|0|||
164227574|NCT02556736|593202602|FG002|Open Label Treatment Period|Adverse Event|0|||
164227575|NCT02556736|593202603|FG003|Open Label Treatment Period|Adverse Event|1|||
164227576|NCT02556736|593202600|FG000|Long-Term Follow-up|Lost to Follow-up|1|||
164227577|NCT02556736|593202601|FG001|Long-Term Follow-up|Lost to Follow-up|0|||
164330974|NCT01436162|593588362|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
164330975|NCT01436162|593588363|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
164330976|NCT01436162|593588361|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
164330977|NCT01436162|593588362|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
164330978|NCT01436162|593588363|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
164330979|NCT01436162|593588361|FG000|Single-blind Lead-in Phase|Other|107|||
164330980|NCT01436162|593588362|FG001|Single-blind Lead-in Phase|Other|0|||
164330981|NCT01436162|593588363|FG002|Single-blind Lead-in Phase|Other|0|||
164227578|NCT02556736|593202602|FG002|Long-Term Follow-up|Lost to Follow-up|0|||
164571371|NCT02847598|594456884|FG007|Overall Study|Lost to Follow-up|0|||
164571372|NCT03690869|594456888|FG000|Overall Study|Adverse Event|0|||
164227579|NCT02556736|593202603|FG003|Long-Term Follow-up|Lost to Follow-up|1|||
164227580|NCT01302834|593202611|FG000|Overall Study|Protocol Violation|17|||
164227581|NCT01302834|593202612|FG001|Overall Study|Protocol Violation|23|||
164227582|NCT01302834|593202611|FG000|Overall Study|HIV positive|1|||
164571373|NCT03690869|594456889|FG001|Overall Study|Adverse Event|0|||
164571374|NCT03690869|594456890|FG002|Overall Study|Adverse Event|0|||
164571375|NCT03690869|594456891|FG003|Overall Study|Adverse Event|1|||
164571376|NCT03690869|594456892|FG004|Overall Study|Adverse Event|0|||
164571377|NCT03690869|594456893|FG005|Overall Study|Adverse Event|0|||
164571378|NCT03690869|594456894|FG006|Overall Study|Adverse Event|0|||
164571379|NCT03690869|594456895|FG007|Overall Study|Adverse Event|1|||
164571380|NCT03690869|594456896|FG008|Overall Study|Adverse Event|0|||
164571381|NCT03690869|594456897|FG009|Overall Study|Adverse Event|1|||
164571382|NCT03690869|594456888|FG000|Overall Study|Death|1|||
164571383|NCT03690869|594456889|FG001|Overall Study|Death|1|||
164571384|NCT03690869|594456890|FG002|Overall Study|Death|1|||
164571385|NCT03690869|594456891|FG003|Overall Study|Death|4|||
164571386|NCT03690869|594456892|FG004|Overall Study|Death|2|||
164571387|NCT03690869|594456893|FG005|Overall Study|Death|5|||
164571388|NCT03690869|594456894|FG006|Overall Study|Death|3|||
164571389|NCT03690869|594456895|FG007|Overall Study|Death|2|||
164571390|NCT03690869|594456896|FG008|Overall Study|Death|0|||
164571391|NCT03690869|594456897|FG009|Overall Study|Death|3|||
164571392|NCT03690869|594456888|FG000|Overall Study|Lost to Follow-up|0|||
164571393|NCT03690869|594456889|FG001|Overall Study|Lost to Follow-up|0|||
164571394|NCT03690869|594456890|FG002|Overall Study|Lost to Follow-up|1|||
164571395|NCT03690869|594456891|FG003|Overall Study|Lost to Follow-up|0|||
164571396|NCT03690869|594456892|FG004|Overall Study|Lost to Follow-up|0|||
164571397|NCT03690869|594456893|FG005|Overall Study|Lost to Follow-up|0|||
164571398|NCT03690869|594456894|FG006|Overall Study|Lost to Follow-up|0|||
164571399|NCT03690869|594456895|FG007|Overall Study|Lost to Follow-up|0|||
164571400|NCT03690869|594456896|FG008|Overall Study|Lost to Follow-up|0|||
164571401|NCT03690869|594456897|FG009|Overall Study|Lost to Follow-up|0|||
164571402|NCT03690869|594456888|FG000|Overall Study|Other Treatment|1|||
164571403|NCT03690869|594456889|FG001|Overall Study|Other Treatment|1|||
164571404|NCT03690869|594456890|FG002|Overall Study|Other Treatment|1|||
164571405|NCT03690869|594456891|FG003|Overall Study|Other Treatment|2|||
164571406|NCT03690869|594456892|FG004|Overall Study|Other Treatment|3|||
164571407|NCT03690869|594456893|FG005|Overall Study|Other Treatment|1|||
164421103|NCT02696902|593911105|FG001|Overall Study|Withdrawal by Subject|0|||
164227583|NCT01302834|593202612|FG001|Overall Study|HIV positive|3|||
164227584|NCT05810597|593202613|FG000|Period 1|Adverse Event|2|||
164227585|NCT05810597|593202614|FG001|Period 1|Adverse Event|0|||
164421104|NCT02696902|593911106|FG002|Overall Study|Withdrawal by Subject|1|||
164421105|NCT02696902|593911104|FG000|Overall Study|Death|19|||
164421106|NCT02696902|593911105|FG001|Overall Study|Death|3|||
164421107|NCT02696902|593911106|FG002|Overall Study|Death|24|||
164421108|NCT02696902|593911104|FG000|Overall Study|Participant not fit post-randomization|0|||
164421109|NCT02696902|593911105|FG001|Overall Study|Participant not fit post-randomization|0|||
164227586|NCT05810597|593202613|FG000|Period 1|Physician Decision|1|||
164227587|NCT05810597|593202614|FG001|Period 1|Physician Decision|0|||
164227588|NCT05213624|593202615|FG000|Overall Study|Adverse Event|0|||
164227589|NCT05213624|593202616|FG001|Overall Study|Adverse Event|3|||
164227590|NCT05213624|593202617|FG002|Overall Study|Adverse Event|0|||
164227591|NCT05213624|593202618|FG003|Overall Study|Adverse Event|0|||
164227592|NCT05213624|593202615|FG000|Overall Study|Protocol deviation|0|||
164227593|NCT05213624|593202616|FG001|Overall Study|Protocol deviation|2|||
164227594|NCT05213624|593202617|FG002|Overall Study|Protocol deviation|0|||
164227595|NCT05213624|593202618|FG003|Overall Study|Protocol deviation|0|||
164227596|NCT05213624|593202615|FG000|Overall Study|Withdrawal by Subject|0|||
164227597|NCT05213624|593202616|FG001|Overall Study|Withdrawal by Subject|0|||
164227598|NCT05213624|593202617|FG002|Overall Study|Withdrawal by Subject|0|||
164330982|NCT01436162|593588361|FG000|Randomized Phase|Adverse Event|1|||
164421110|NCT02696902|593911106|FG002|Overall Study|Participant not fit post-randomization|1|||
164421111|NCT02696902|593911104|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
164421112|NCT02696902|593911105|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
164421113|NCT02696902|593911106|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
164421114|NCT02696902|593911104|FG000|Overall Study|Principal investigator's decision|1|||
164421115|NCT02696902|593911105|FG001|Overall Study|Principal investigator's decision|0|||
164421116|NCT02696902|593911106|FG002|Overall Study|Principal investigator's decision|0|||
164421117|NCT02696902|593911104|FG000|Overall Study|Sponsor's decision|1|||
164421118|NCT02696902|593911105|FG001|Overall Study|Sponsor's decision|0|||
164421119|NCT02696902|593911106|FG002|Overall Study|Sponsor's decision|0|||
164421120|NCT02696902|593911104|FG000|Overall Study|Transferred to other hospital|1|||
164421121|NCT02696902|593911105|FG001|Overall Study|Transferred to other hospital|0|||
164421122|NCT02696902|593911106|FG002|Overall Study|Transferred to other hospital|0|||
164421123|NCT00845871|593911110|FG000|Assessment Period|Adverse Event|2|||
164421124|NCT00845871|593911110|FG000|Assessment Period|Abnormal laboratory values|1|||
164421125|NCT00845871|593911110|FG000|Assessment Period|Abnormal test procedure results|1|||
164421126|NCT00845871|593911110|FG000|Assessment Period|Patient withdrew consent|3|||
164421127|NCT01857622|593911111|FG000|Overall Study|Adverse Event|5|||
164421128|NCT01857622|593911112|FG001|Overall Study|Adverse Event|0|||
164421129|NCT01857622|593911113|FG002|Overall Study|Adverse Event|2|||
164227599|NCT05213624|593202618|FG003|Overall Study|Withdrawal by Subject|1|||
164227600|NCT05213624|593202615|FG000|Overall Study|Not treated|0|||
164227601|NCT05213624|593202616|FG001|Overall Study|Not treated|1|||
164227602|NCT05213624|593202617|FG002|Overall Study|Not treated|2|||
164330983|NCT01436162|593588362|FG001|Randomized Phase|Adverse Event|5|||
164330984|NCT01436162|593588363|FG002|Randomized Phase|Adverse Event|6|||
164330985|NCT01436162|593588361|FG000|Randomized Phase|Protocol Violation|4|||
164571408|NCT03690869|594456894|FG006|Overall Study|Other Treatment|2|||
164571409|NCT03690869|594456895|FG007|Overall Study|Other Treatment|7|||
164571410|NCT03690869|594456896|FG008|Overall Study|Other Treatment|0|||
164421130|NCT01857622|593911111|FG000|Overall Study|Physician Decision|1|||
164421131|NCT01857622|593911112|FG001|Overall Study|Physician Decision|0|||
164421132|NCT01857622|593911113|FG002|Overall Study|Physician Decision|0|||
164421133|NCT01857622|593911111|FG000|Overall Study|Protocol Violation|4|||
164227603|NCT05213624|593202618|FG003|Overall Study|Not treated|2|||
164571411|NCT03690869|594456897|FG009|Overall Study|Other Treatment|3|||
164571412|NCT03690869|594456888|FG000|Overall Study|Physician Decision|0|||
164675296|NCT03733444|594834937|FG002|Overall Study|Adverse Event|5|||
164675297|NCT03733444|594834935|FG000|Overall Study|Death|20|||
164675298|NCT03733444|594834936|FG001|Overall Study|Death|19|||
164675299|NCT03733444|594834937|FG002|Overall Study|Death|11|||
164675300|NCT03733444|594834935|FG000|Overall Study|Lost to Follow-up|3|||
164675301|NCT03733444|594834936|FG001|Overall Study|Lost to Follow-up|0|||
164675302|NCT03733444|594834937|FG002|Overall Study|Lost to Follow-up|1|||
164675303|NCT03733444|594834935|FG000|Overall Study|Lack of Efficacy|0|||
164675304|NCT03733444|594834936|FG001|Overall Study|Lack of Efficacy|1|||
164675305|NCT03733444|594834937|FG002|Overall Study|Lack of Efficacy|1|||
164675306|NCT03733444|594834935|FG000|Overall Study|Physician Decision|2|||
164675307|NCT03733444|594834936|FG001|Overall Study|Physician Decision|1|||
164675308|NCT03733444|594834937|FG002|Overall Study|Physician Decision|0|||
164675309|NCT03733444|594834935|FG000|Overall Study|Protocol Violation|2|||
164675310|NCT03733444|594834936|FG001|Overall Study|Protocol Violation|1|||
164675311|NCT03733444|594834937|FG002|Overall Study|Protocol Violation|0|||
164675312|NCT03733444|594834935|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
164675313|NCT03733444|594834936|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
164675314|NCT03733444|594834937|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
164227604|NCT01602380|593202619|FG000|Overall Study|Death|147|||
164227605|NCT01602380|593202620|FG001|Overall Study|Death|145|||
164227606|NCT01602380|593202619|FG000|Overall Study|Withdrawal by Subject|39|||
164227607|NCT01602380|593202620|FG001|Overall Study|Withdrawal by Subject|41|||
164227608|NCT01602380|593202619|FG000|Overall Study|Lost to Follow-up|15|||
164675315|NCT03733444|594834935|FG000|Overall Study|Study Terminated by Sponsor|203|||
164675316|NCT03733444|594834936|FG001|Overall Study|Study Terminated by Sponsor|209|||
164675317|NCT03733444|594834937|FG002|Overall Study|Study Terminated by Sponsor|221|||
164675318|NCT03733444|594834935|FG000|Overall Study|Withdrawal by Subject|19|||
164675319|NCT03733444|594834936|FG001|Overall Study|Withdrawal by Subject|18|||
164675320|NCT03733444|594834937|FG002|Overall Study|Withdrawal by Subject|16|||
164675321|NCT03733444|594834935|FG000|Overall Study|Miscellaneous|1|||
164675322|NCT03733444|594834936|FG001|Overall Study|Miscellaneous|0|||
164675323|NCT03733444|594834937|FG002|Overall Study|Miscellaneous|1|||
164675324|NCT03733444|594834935|FG000|Overall Study|Not Treated|1|||
164675325|NCT03733444|594834936|FG001|Overall Study|Not Treated|2|||
164675326|NCT03733444|594834937|FG002|Overall Study|Not Treated|1|||
164675327|NCT03637764|594834938|FG000|Overall Study|Adverse Event|2|||
164675328|NCT03637764|594834939|FG001|Overall Study|Adverse Event|0|||
164675329|NCT03637764|594834940|FG002|Overall Study|Adverse Event|0|||
164675330|NCT03637764|594834941|FG003|Overall Study|Adverse Event|1|||
164675331|NCT03637764|594834938|FG000|Overall Study|Progressive Disease|23|||
164675332|NCT03637764|594834939|FG001|Overall Study|Progressive Disease|23|||
164675333|NCT03637764|594834940|FG002|Overall Study|Progressive Disease|18|||
164675334|NCT03637764|594834941|FG003|Overall Study|Progressive Disease|31|||
164675335|NCT03637764|594834938|FG000|Overall Study|Withdrawal by Subject|1|||
164675336|NCT03637764|594834939|FG001|Overall Study|Withdrawal by Subject|3|||
164675337|NCT03637764|594834940|FG002|Overall Study|Withdrawal by Subject|0|||
164675338|NCT03637764|594834941|FG003|Overall Study|Withdrawal by Subject|1|||
164675339|NCT02648438|594834942|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164675340|NCT02648438|594834943|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
164675341|NCT02648438|594834944|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
164675342|NCT02648438|594834942|FG000|Overall Study|Protocol Violation|2|||
164675343|NCT02648438|594834943|FG001|Overall Study|Protocol Violation|0|||
164675344|NCT02648438|594834944|FG002|Overall Study|Protocol Violation|0|||
164675345|NCT02648438|594834942|FG000|Overall Study|Withdrawal by Subject|1|||
164675346|NCT02648438|594834943|FG001|Overall Study|Withdrawal by Subject|1|||
164675347|NCT02648438|594834944|FG002|Overall Study|Withdrawal by Subject|0|||
164227609|NCT01602380|593202620|FG001|Overall Study|Lost to Follow-up|12|||
164227610|NCT01602380|593202619|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
164227611|NCT01602380|593202620|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
164227612|NCT01602380|593202619|FG000|Overall Study|Other|2|||
164675348|NCT04604275|594834945|FG000|Washout-1 Week|Withdrawal by Subject|1|||
164675349|NCT04604275|594834946|FG001|Washout-1 Week|Withdrawal by Subject|0|||
164675350|NCT01045161|594834949|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
164675351|NCT01045161|594834950|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
164675352|NCT01045161|594834951|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
164675353|NCT01045161|594834949|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
164227613|NCT01602380|593202620|FG001|Overall Study|Other|0|||
164227614|NCT01044459|593202621|FG000|Overall Study|Withdrawal by Subject|21|||
164227615|NCT01044459|593202622|FG001|Overall Study|Withdrawal by Subject|28|||
164227616|NCT01044459|593202621|FG000|Overall Study|Terminated by Sponsor|22|||
164227617|NCT01044459|593202622|FG001|Overall Study|Terminated by Sponsor|21|||
164227618|NCT01044459|593202621|FG000|Overall Study|Adverse Event|22|||
164675354|NCT01045161|594834950|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
164675355|NCT01045161|594834951|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
164675356|NCT01045161|594834949|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
164227619|NCT01044459|593202622|FG001|Overall Study|Adverse Event|20|||
164227620|NCT01044459|593202621|FG000|Overall Study|Lack of Efficacy|23|||
164227621|NCT01044459|593202622|FG001|Overall Study|Lack of Efficacy|12|||
164227622|NCT01044459|593202621|FG000|Overall Study|Protocol Violation|11|||
164227623|NCT01044459|593202622|FG001|Overall Study|Protocol Violation|16|||
164571413|NCT03690869|594456889|FG001|Overall Study|Physician Decision|1|||
164571414|NCT03690869|594456890|FG002|Overall Study|Physician Decision|0|||
164571415|NCT03690869|594456891|FG003|Overall Study|Physician Decision|0|||
164571416|NCT03690869|594456892|FG004|Overall Study|Physician Decision|0|||
164571417|NCT03690869|594456893|FG005|Overall Study|Physician Decision|0|||
164571418|NCT03690869|594456894|FG006|Overall Study|Physician Decision|0|||
164571419|NCT03690869|594456895|FG007|Overall Study|Physician Decision|0|||
164571420|NCT03690869|594456896|FG008|Overall Study|Physician Decision|0|||
164571421|NCT03690869|594456897|FG009|Overall Study|Physician Decision|0|||
164571422|NCT03690869|594456888|FG000|Overall Study|Progressive Disease|1|||
164571423|NCT03690869|594456889|FG001|Overall Study|Progressive Disease|2|||
164571424|NCT03690869|594456890|FG002|Overall Study|Progressive Disease|0|||
164571425|NCT03690869|594456891|FG003|Overall Study|Progressive Disease|1|||
164571426|NCT03690869|594456892|FG004|Overall Study|Progressive Disease|0|||
164571427|NCT03690869|594456893|FG005|Overall Study|Progressive Disease|0|||
164571428|NCT03690869|594456894|FG006|Overall Study|Progressive Disease|0|||
164571429|NCT03690869|594456895|FG007|Overall Study|Progressive Disease|0|||
164571430|NCT03690869|594456896|FG008|Overall Study|Progressive Disease|1|||
164571431|NCT03690869|594456897|FG009|Overall Study|Progressive Disease|1|||
164571432|NCT03690869|594456888|FG000|Overall Study|Subject Decision|0|||
164227624|NCT01044459|593202621|FG000|Overall Study|Other Reason|7|||
164227625|NCT01044459|593202622|FG001|Overall Study|Other Reason|14|||
164227626|NCT01044459|593202621|FG000|Overall Study|COPD exacerbation|9|||
164227627|NCT01044459|593202622|FG001|Overall Study|COPD exacerbation|8|||
164227628|NCT01044459|593202621|FG000|Overall Study|Lost to Follow-up|18|||
164227629|NCT01044459|593202622|FG001|Overall Study|Lost to Follow-up|12|||
164227630|NCT03369704|593202628|FG000|Treatment Epoch|technical problems|1|||
164227631|NCT03369704|593202629|FG001|Treatment Epoch|technical problems|0|||
164227632|NCT03369704|593202628|FG000|Treatment Epoch|Protocol Violation|1|||
164227633|NCT03369704|593202629|FG001|Treatment Epoch|Protocol Violation|0|||
164227634|NCT03369704|593202628|FG000|Treatment Epoch|Lost to Follow-up|0|||
164227635|NCT03369704|593202629|FG001|Treatment Epoch|Lost to Follow-up|1|||
164227636|NCT03369704|593202628|FG000|Treatment Epoch|Lack of Efficacy|0|||
164227637|NCT03369704|593202629|FG001|Treatment Epoch|Lack of Efficacy|2|||
164227638|NCT03369704|593202628|FG000|Treatment Epoch|Adverse Event|2|||
164227639|NCT03369704|593202629|FG001|Treatment Epoch|Adverse Event|0|||
164227640|NCT03369704|593202628|FG000|Follow-up Epoch|Lost to Follow-up|1|||
164227641|NCT03369704|593202629|FG001|Follow-up Epoch|Lost to Follow-up|0|||
164227642|NCT04153149|593202631|FG000|Double Blind Period|Death|63|||
164227643|NCT04153149|593202632|FG001|Double Blind Period|Death|49|||
164227644|NCT04153149|593202633|FG002|Double Blind Period|Death|0|||
164227645|NCT04153149|593202634|FG003|Double Blind Period|Death|0|||
164227646|NCT04153149|593202631|FG000|Double Blind Period|Withdrawal by Subject|16|||
164227647|NCT04153149|593202632|FG001|Double Blind Period|Withdrawal by Subject|11|||
164227648|NCT04153149|593202633|FG002|Double Blind Period|Withdrawal by Subject|0|||
164227649|NCT04153149|593202634|FG003|Double Blind Period|Withdrawal by Subject|0|||
164227650|NCT04153149|593202631|FG000|Double Blind Period|Adverse Event|6|||
164227651|NCT04153149|593202632|FG001|Double Blind Period|Adverse Event|2|||
164227652|NCT04153149|593202633|FG002|Double Blind Period|Adverse Event|0|||
164227653|NCT04153149|593202634|FG003|Double Blind Period|Adverse Event|0|||
164227654|NCT04153149|593202631|FG000|Double Blind Period|Lost to Follow-up|2|||
164227655|NCT04153149|593202632|FG001|Double Blind Period|Lost to Follow-up|1|||
164227656|NCT04153149|593202633|FG002|Double Blind Period|Lost to Follow-up|0|||
164227657|NCT04153149|593202634|FG003|Double Blind Period|Lost to Follow-up|0|||
164227658|NCT04153149|593202631|FG000|Double Blind Period|Withdrawal by guardian|0|||
164227659|NCT04153149|593202632|FG001|Double Blind Period|Withdrawal by guardian|2|||
164227660|NCT04153149|593202633|FG002|Double Blind Period|Withdrawal by guardian|0|||
164227661|NCT04153149|593202634|FG003|Double Blind Period|Withdrawal by guardian|0|||
164227662|NCT04153149|593202631|FG000|Double Blind Period|Reason Not Specified|5|||
164227663|NCT04153149|593202632|FG001|Double Blind Period|Reason Not Specified|4|||
164227664|NCT04153149|593202633|FG002|Double Blind Period|Reason Not Specified|0|||
164227665|NCT04153149|593202634|FG003|Double Blind Period|Reason Not Specified|0|||
164227666|NCT04153149|593202631|FG000|Double Blind Period|Physician Decision|2|||
164227667|NCT04153149|593202632|FG001|Double Blind Period|Physician Decision|0|||
164227668|NCT04153149|593202633|FG002|Double Blind Period|Physician Decision|0|||
164227669|NCT04153149|593202634|FG003|Double Blind Period|Physician Decision|0|||
164571433|NCT03690869|594456889|FG001|Overall Study|Subject Decision|0|||
164571434|NCT03690869|594456890|FG002|Overall Study|Subject Decision|0|||
164571435|NCT03690869|594456891|FG003|Overall Study|Subject Decision|1|||
164571436|NCT03690869|594456892|FG004|Overall Study|Subject Decision|0|||
164227670|NCT04153149|593202631|FG000|Open Label Extension Period|Death|0|||
164227671|NCT04153149|593202632|FG001|Open Label Extension Period|Death|0|||
164227672|NCT04153149|593202633|FG002|Open Label Extension Period|Death|7|||
164571437|NCT03690869|594456893|FG005|Overall Study|Subject Decision|0|||
164571438|NCT03690869|594456894|FG006|Overall Study|Subject Decision|0|||
164330986|NCT01436162|593588362|FG001|Randomized Phase|Protocol Violation|4|||
164330987|NCT01436162|593588363|FG002|Randomized Phase|Protocol Violation|2|||
164330988|NCT01436162|593588361|FG000|Randomized Phase|Withdrawal by Subject|16|||
164330989|NCT01436162|593588362|FG001|Randomized Phase|Withdrawal by Subject|9|||
164330990|NCT01436162|593588363|FG002|Randomized Phase|Withdrawal by Subject|8|||
164330991|NCT01436162|593588361|FG000|Randomized Phase|Lost to Follow-up|17|||
164330992|NCT01436162|593588362|FG001|Randomized Phase|Lost to Follow-up|5|||
164330993|NCT01436162|593588363|FG002|Randomized Phase|Lost to Follow-up|4|||
164330994|NCT01436162|593588361|FG000|Randomized Phase|Lack of Efficacy|0|||
164330995|NCT01436162|593588362|FG001|Randomized Phase|Lack of Efficacy|1|||
164330996|NCT01436162|593588363|FG002|Randomized Phase|Lack of Efficacy|1|||
164330997|NCT01436162|593588361|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
164330998|NCT01436162|593588362|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
164330999|NCT01436162|593588363|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
164331000|NCT01436162|593588361|FG000|Randomized Phase|Other|2|||
164331001|NCT01436162|593588362|FG001|Randomized Phase|Other|5|||
164331002|NCT01436162|593588363|FG002|Randomized Phase|Other|4|||
164331003|NCT02567552|593588364|FG000|Overall Study|Adverse Event|0|||
164331004|NCT02567552|593588365|FG001|Overall Study|Adverse Event|1|||
164331005|NCT04669535|593588370|FG000|Overall Study|Death|1|||
164331006|NCT04669535|593588371|FG001|Overall Study|Death|1|||
164331007|NCT04669535|593588372|FG002|Overall Study|Death|0|||
164331008|NCT04669535|593588373|FG003|Overall Study|Death|0|||
164331009|NCT01876810|593588374|FG000|Overall Study|Physician Decision|0|||
164331010|NCT01876810|593588375|FG001|Overall Study|Physician Decision|1|||
164331011|NCT00458536|593588380|FG000|Overall Study|Disease progression prior to treatment|7|||
164331012|NCT00458536|593588380|FG000|Overall Study|Unable to make vaccine|3|||
164331013|NCT00458536|593588380|FG000|Overall Study|No measurable disease after surgery|2|||
164331014|NCT00458536|593588380|FG000|Overall Study|Did not have renal cell carcinoma|2|||
164331015|NCT00458536|593588380|FG000|Overall Study|Patient did not have surgery|1|||
164331016|NCT00458536|593588380|FG000|Overall Study|Ineligible due to toxicity|1|||
164331017|NCT00458536|593588380|FG000|Overall Study|Withdrawal by Subject|1|||
164331018|NCT00458536|593588380|FG000|Overall Study|Progressive disease during treatment|2|||
164331019|NCT00285207|593588381|FG000|Overall Study|Lost to Follow-up|3|||
164331020|NCT00285207|593588382|FG001|Overall Study|Lost to Follow-up|2|||
164331021|NCT00285207|593588381|FG000|Overall Study|Withdrawal by Subject|5|||
164331022|NCT00285207|593588382|FG001|Overall Study|Withdrawal by Subject|2|||
164331023|NCT00285207|593588381|FG000|Overall Study|Pregnancy|1|||
164331024|NCT00285207|593588382|FG001|Overall Study|Pregnancy|1|||
164331025|NCT00285207|593588381|FG000|Overall Study|non-compliance|0|||
164331026|NCT00285207|593588382|FG001|Overall Study|non-compliance|1|||
164331027|NCT02160782|593589839|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
164331028|NCT02160782|593589840|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
164331029|NCT02160782|593589841|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
164331030|NCT02160782|593589842|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
164331031|NCT02160782|593589843|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
164675357|NCT01045161|594834950|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
164675358|NCT01045161|594834951|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
164227673|NCT04153149|593202634|FG003|Open Label Extension Period|Death|3|||
164227674|NCT04153149|593202631|FG000|Open Label Extension Period|Withdrawal by guardian|0|||
164227675|NCT04153149|593202632|FG001|Open Label Extension Period|Withdrawal by guardian|0|||
164227676|NCT04153149|593202633|FG002|Open Label Extension Period|Withdrawal by guardian|1|||
164227677|NCT04153149|593202634|FG003|Open Label Extension Period|Withdrawal by guardian|0|||
164227678|NCT04153149|593202631|FG000|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
164227679|NCT04153149|593202632|FG001|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
164227680|NCT04153149|593202633|FG002|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
164227681|NCT04153149|593202634|FG003|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|1|||
164227682|NCT04153149|593202631|FG000|Open Label Extension Period|Study Treatment Ongoing|0|||
164227683|NCT04153149|593202632|FG001|Open Label Extension Period|Study Treatment Ongoing|0|||
164227684|NCT04153149|593202633|FG002|Open Label Extension Period|Study Treatment Ongoing|213|||
164227685|NCT04153149|593202634|FG003|Open Label Extension Period|Study Treatment Ongoing|237|||
164227686|NCT03759379|593203779|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
164227687|NCT03759379|593203780|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
164227688|NCT03759379|593203779|FG000|Treatment Period|Death|2|||
164227689|NCT03759379|593203780|FG001|Treatment Period|Death|3|||
164227690|NCT03759379|593203779|FG000|Treatment Period|Lost to Follow-up|1|||
164227691|NCT03759379|593203780|FG001|Treatment Period|Lost to Follow-up|0|||
164227692|NCT03759379|593203779|FG000|Treatment Period|Physician Decision|0|||
164331032|NCT02160782|593589839|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
164331033|NCT02160782|593589840|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
164331034|NCT02160782|593589841|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
164331035|NCT02160782|593589842|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
164227693|NCT03759379|593203780|FG001|Treatment Period|Physician Decision|1|||
164227694|NCT00833703|593203781|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
164227695|NCT00833703|593203782|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
164227696|NCT00003907|593203783|FG000|Overall Study|Adverse Event|2|||
164227697|NCT00003907|593203784|FG001|Overall Study|Adverse Event|11|||
164227698|NCT00003907|593203783|FG000|Overall Study|Death|2|||
164227699|NCT00003907|593203784|FG001|Overall Study|Death|0|||
164227700|NCT00003907|593203783|FG000|Overall Study|Withdrawal by Subject|1|||
164227701|NCT00003907|593203784|FG001|Overall Study|Withdrawal by Subject|3|||
164227702|NCT00003907|593203783|FG000|Overall Study|Progressive disease|4|||
164227703|NCT00003907|593203784|FG001|Overall Study|Progressive disease|4|||
164227704|NCT00003907|593203783|FG000|Overall Study|Complicating disease|1|||
164227705|NCT00003907|593203784|FG001|Overall Study|Complicating disease|0|||
164227706|NCT00003907|593203783|FG000|Overall Study|Other|1|||
164227707|NCT00003907|593203784|FG001|Overall Study|Other|3|||
164227708|NCT00003907|593203783|FG000|Overall Study|ineligible or not treated|2|||
164227709|NCT00003907|593203784|FG001|Overall Study|ineligible or not treated|2|||
164227710|NCT00266032|593203785|FG000|Treatment|Adverse Event|42|||
164227711|NCT00266032|593203786|FG001|Treatment|Adverse Event|26|||
164227712|NCT00266032|593203787|FG002|Treatment|Adverse Event|10|||
164227713|NCT00266032|593203785|FG000|Treatment|Lost to Follow-up|19|||
164227714|NCT00266032|593203786|FG001|Treatment|Lost to Follow-up|4|||
164227715|NCT00266032|593203787|FG002|Treatment|Lost to Follow-up|2|||
164227716|NCT00266032|593203785|FG000|Treatment|Pregnancy|3|||
164227717|NCT00266032|593203786|FG001|Treatment|Pregnancy|2|||
164227718|NCT00266032|593203787|FG002|Treatment|Pregnancy|2|||
164227719|NCT00266032|593203785|FG000|Treatment|Protocol Violation|6|||
164227720|NCT00266032|593203786|FG001|Treatment|Protocol Violation|14|||
164571439|NCT03690869|594456895|FG007|Overall Study|Subject Decision|1|||
164421134|NCT01857622|593911112|FG001|Overall Study|Protocol Violation|1|||
164227721|NCT00266032|593203787|FG002|Treatment|Protocol Violation|13|||
164227722|NCT00266032|593203785|FG000|Treatment|Withdrawal by Subject|28|||
164571440|NCT03690869|594456896|FG008|Overall Study|Subject Decision|0|||
164571441|NCT03690869|594456897|FG009|Overall Study|Subject Decision|0|||
164571442|NCT01468311|594456899|FG000|Overall Study|mobilization failure|1|||
164571443|NCT01468311|594456899|FG000|Overall Study|Withdrawal by Subject|1|||
164571444|NCT03797001|594458278|FG000|Overall Study|Withdrawn due to COVID19|4|||
164571445|NCT03797001|594458279|FG001|Overall Study|Withdrawn due to COVID19|0|||
164571446|NCT03797001|594458278|FG000|Overall Study|Withdrawal by Subject|7|||
164571447|NCT03797001|594458279|FG001|Overall Study|Withdrawal by Subject|6|||
164571448|NCT03797001|594458278|FG000|Overall Study|Adverse Event|0|||
164571449|NCT03797001|594458279|FG001|Overall Study|Adverse Event|1|||
164571450|NCT00500266|594458280|FG000|Overall Study|Death|3|||
164571451|NCT00500266|594458280|FG000|Overall Study|Lost to Follow-up|3|||
164571452|NCT00500266|594458280|FG000|Overall Study|Withdrawal by Subject|3|||
164571453|NCT00500266|594458280|FG000|Overall Study|Assigned, not treated|4|||
164571454|NCT04840667|594458281|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
164571455|NCT05067127|594458282|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
164571456|NCT05067127|594458283|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
164571457|NCT05067127|594458284|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
164571458|NCT05067127|594458285|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
164571459|NCT05067127|594458282|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
164571460|NCT05067127|594458283|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
164571461|NCT05067127|594458284|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
164571462|NCT05067127|594458285|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
164571463|NCT05067127|594458282|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
164571464|NCT05067127|594458283|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
164571465|NCT05067127|594458284|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
164571466|NCT05067127|594458285|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
164571467|NCT05067127|594458282|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
164571468|NCT05067127|594458283|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
164571469|NCT05067127|594458284|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
164571470|NCT05067127|594458285|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
164571471|NCT05067127|594458282|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
164571472|NCT05067127|594458283|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
164571473|NCT05067127|594458284|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
164571474|NCT05067127|594458285|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
164571475|NCT05067127|594458282|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
164571476|NCT05067127|594458283|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
164227723|NCT00266032|593203786|FG001|Treatment|Withdrawal by Subject|13|||
164227724|NCT00266032|593203787|FG002|Treatment|Withdrawal by Subject|12|||
164227725|NCT00266032|593203785|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
164227726|NCT00266032|593203786|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
164421135|NCT01857622|593911113|FG002|Overall Study|Protocol Violation|0|||
164227727|NCT00266032|593203787|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
164571477|NCT05067127|594458284|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
164571478|NCT05067127|594458285|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
164571479|NCT05067127|594458282|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
164571480|NCT05067127|594458283|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
164571481|NCT05067127|594458284|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
164571482|NCT05067127|594458285|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
164571483|NCT04572633|594458286|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
164571484|NCT03155997|594458287|FG000|Overall Study|Withdrawal by Subject|119|||
164571485|NCT03155997|594458288|FG001|Overall Study|Withdrawal by Subject|134|||
164571486|NCT03155997|594458287|FG000|Overall Study|Lost to Follow-up|12|||
164571487|NCT03155997|594458288|FG001|Overall Study|Lost to Follow-up|13|||
164571488|NCT03155997|594458287|FG000|Overall Study|Missing disposition data|0|||
164571489|NCT03155997|594458288|FG001|Overall Study|Missing disposition data|1|||
164571490|NCT03155997|594458287|FG000|Overall Study|On study treatment|2027|||
164571491|NCT03155997|594458288|FG001|Overall Study|On study treatment|2074|||
164571492|NCT03514914|594458290|FG000|Overall Study|Death|3|||
164227728|NCT00266032|593203785|FG000|Open-label Safety Extension|Adverse Event|5|||
164227729|NCT00266032|593203786|FG001|Open-label Safety Extension|Adverse Event|0|||
164227730|NCT00266032|593203787|FG002|Open-label Safety Extension|Adverse Event|4|||
164227731|NCT00266032|593203785|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
164571493|NCT03514914|594458291|FG001|Overall Study|Death|3|||
164571494|NCT03514914|594458290|FG000|Overall Study|Lost to Follow-up|117|||
164571495|NCT03514914|594458291|FG001|Overall Study|Lost to Follow-up|89|||
164571496|NCT02507349|594458298|FG000|Overall Study|Death|12|||
164227732|NCT00266032|593203786|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
164227733|NCT00266032|593203787|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
164571497|NCT02507349|594458299|FG001|Overall Study|Death|16|||
164571498|NCT02507349|594458298|FG000|Overall Study|Withdrawal by Subject|1|||
164571499|NCT02507349|594458299|FG001|Overall Study|Withdrawal by Subject|1|||
164571500|NCT02507349|594458298|FG000|Overall Study|Lost to Follow-up|174|||
164571501|NCT02507349|594458299|FG001|Overall Study|Lost to Follow-up|144|||
164571502|NCT02700984|594458300|FG000|Overall Study|Death|2|||
164571503|NCT02700984|594458301|FG001|Overall Study|Death|1|||
164571504|NCT02700984|594458300|FG000|Overall Study|Lost to Follow-up|2|||
164571505|NCT02700984|594458301|FG001|Overall Study|Lost to Follow-up|1|||
164571506|NCT02700984|594458300|FG000|Overall Study|Physician Decision|0|||
164571507|NCT02700984|594458301|FG001|Overall Study|Physician Decision|1|||
164571508|NCT02700984|594458300|FG000|Overall Study|Withdrawal by Subject|8|||
164571509|NCT02700984|594458301|FG001|Overall Study|Withdrawal by Subject|9|||
164571510|NCT02700984|594458300|FG000|Overall Study|Reason not specified|3|||
164571511|NCT02700984|594458301|FG001|Overall Study|Reason not specified|2|||
164675359|NCT01045161|594834949|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
164675360|NCT01045161|594834950|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
164675361|NCT01045161|594834951|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
164675362|NCT01045161|594834949|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
164675363|NCT01045161|594834950|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
164675364|NCT01045161|594834951|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
164227734|NCT00266032|593203785|FG000|Open-label Safety Extension|Pregnancy|4|||
164227735|NCT00266032|593203786|FG001|Open-label Safety Extension|Pregnancy|1|||
164227736|NCT00266032|593203787|FG002|Open-label Safety Extension|Pregnancy|2|||
164227737|NCT00266032|593203785|FG000|Open-label Safety Extension|Protocol Violation|1|||
164227738|NCT00266032|593203786|FG001|Open-label Safety Extension|Protocol Violation|3|||
164227739|NCT00266032|593203787|FG002|Open-label Safety Extension|Protocol Violation|2|||
164227740|NCT00266032|593203785|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
164227741|NCT00266032|593203786|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
164227742|NCT00266032|593203787|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
164227743|NCT00266032|593203785|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
164227744|NCT00266032|593203786|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
164227745|NCT00266032|593203787|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
164675365|NCT01045161|594834949|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
164675366|NCT01045161|594834950|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
164675367|NCT01045161|594834951|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
164227746|NCT00124657|593203789|FG000|Overall Study|Toxicity|0|||
164571512|NCT00473876|594458302|FG000|Overall Study|Lost to Follow-up|3|||
164227747|NCT00124657|593203790|FG001|Overall Study|Toxicity|0|||
164227748|NCT00124657|593203791|FG002|Overall Study|Toxicity|1|||
164571513|NCT00473876|594458303|FG001|Overall Study|Lost to Follow-up|1|||
164571514|NCT00727402|594458304|FG000|Overall Study|Physician Decision|116|||
164571515|NCT04525703|594458307|FG000|Overall Study|Lost to Follow-up|6|||
164571516|NCT04525703|594458308|FG001|Overall Study|Lost to Follow-up|15|||
164571517|NCT04525703|594458309|FG002|Overall Study|Lost to Follow-up|8|||
164227749|NCT00124657|593203789|FG000|Overall Study|Non-compliance|1|||
164227750|NCT00124657|593203790|FG001|Overall Study|Non-compliance|0|||
164227751|NCT00124657|593203791|FG002|Overall Study|Non-compliance|4|||
164227752|NCT00124657|593203789|FG000|Overall Study|Progressive disease|14|||
164227753|NCT00124657|593203790|FG001|Overall Study|Progressive disease|5|||
164227754|NCT00124657|593203791|FG002|Overall Study|Progressive disease|27|||
164227755|NCT00124657|593203789|FG000|Overall Study|Intercurrent illness|1|||
164227756|NCT00124657|593203790|FG001|Overall Study|Intercurrent illness|0|||
164571518|NCT03094195|594458310|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
164571519|NCT03094195|594458311|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
164571520|NCT03094195|594458312|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
164571521|NCT03094195|594458313|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
164571522|NCT03094195|594458314|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
164571523|NCT03094195|594458315|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
164571524|NCT03094195|594458316|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
164571525|NCT03094195|594458317|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
164571526|NCT03094195|594458310|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
164571527|NCT03094195|594458311|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
164571528|NCT03094195|594458312|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
164571529|NCT03094195|594458313|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
164571530|NCT03094195|594458314|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
164571531|NCT03094195|594458315|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
164571532|NCT03094195|594458316|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
164571533|NCT03094195|594458317|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
164571534|NCT03094195|594458310|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
164571535|NCT03094195|594458311|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
164571536|NCT03094195|594458312|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
164571537|NCT03094195|594458313|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
164571538|NCT03094195|594458314|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
164571539|NCT03094195|594458315|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
164571540|NCT03094195|594458316|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
164571541|NCT03094195|594458317|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
164571542|NCT03094195|594458310|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
164571543|NCT03094195|594458311|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
164571544|NCT03094195|594458312|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
164571545|NCT03094195|594458313|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
164571546|NCT03094195|594458314|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
164571547|NCT03094195|594458315|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
164571548|NCT03094195|594458316|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
164571549|NCT03094195|594458317|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
164571550|NCT01651780|594458320|FG000|Overall Study|Physician decision: No 30-day visit|2|||
164571551|NCT01651780|594458321|FG001|Overall Study|Physician decision: No 30-day visit|1|||
164571552|NCT01651780|594458320|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
164571553|NCT01651780|594458321|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
164571554|NCT01651780|594458320|FG000|Overall Study|Withdrawal by Subject|2|||
164571555|NCT01651780|594458321|FG001|Overall Study|Withdrawal by Subject|0|||
164571556|NCT01651780|594458320|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
164571557|NCT01651780|594458321|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
164571558|NCT01651780|594458320|FG000|Overall Study|Lost to Follow-up|1|||
164571559|NCT01651780|594458321|FG001|Overall Study|Lost to Follow-up|2|||
164571560|NCT01651780|594458320|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
164571561|NCT01651780|594458321|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
164571562|NCT00054132|594458322|FG000|Overall Study|Not Treated|1|||
164571563|NCT01290887|594458323|FG000|Overall Study|Adverse Event|6|||
164571564|NCT01290887|594458324|FG001|Overall Study|Adverse Event|11|||
164571565|NCT01290887|594458323|FG000|Overall Study|Lack of Efficacy|4|||
164571566|NCT01290887|594458324|FG001|Overall Study|Lack of Efficacy|5|||
164571567|NCT01290887|594458323|FG000|Overall Study|Withdrawal by Subject|26|||
164571568|NCT01290887|594458324|FG001|Overall Study|Withdrawal by Subject|32|||
164571569|NCT01290887|594458323|FG000|Overall Study|Protocol Violation|2|||
164571570|NCT01290887|594458324|FG001|Overall Study|Protocol Violation|1|||
164571571|NCT01290887|594458323|FG000|Overall Study|Lost to Follow-up|4|||
164571572|NCT01290887|594458324|FG001|Overall Study|Lost to Follow-up|4|||
164571573|NCT01290887|594458323|FG000|Overall Study|Non-compliance to study procedures|0|||
164571574|NCT01290887|594458324|FG001|Overall Study|Non-compliance to study procedures|1|||
164571575|NCT01290887|594458323|FG000|Overall Study|Non-compliance to study medications|1|||
164571576|NCT01290887|594458324|FG001|Overall Study|Non-compliance to study medications|0|||
164571577|NCT01290887|594458323|FG000|Overall Study|Sponsor closure of study|420|||
164227757|NCT00124657|593203791|FG002|Overall Study|Intercurrent illness|0|||
164227758|NCT04693715|593203798|FG000|Overall Study|Adverse Events Leading to Death|2|||
164227759|NCT04693715|593203799|FG001|Overall Study|Adverse Events Leading to Death|2|||
164227760|NCT04693715|593203800|FG002|Overall Study|Adverse Events Leading to Death|4|||
164227761|NCT04693715|593203798|FG000|Overall Study|Lost to Follow-up|0|||
164227762|NCT04693715|593203799|FG001|Overall Study|Lost to Follow-up|2|||
164227763|NCT04693715|593203800|FG002|Overall Study|Lost to Follow-up|2|||
164227764|NCT04693715|593203798|FG000|Overall Study|Physician Decision|0|||
164227765|NCT04693715|593203799|FG001|Overall Study|Physician Decision|1|||
164227766|NCT04693715|593203800|FG002|Overall Study|Physician Decision|0|||
164227767|NCT04693715|593203798|FG000|Overall Study|Withdrawal by Legal Authorized Representative|0|||
164227768|NCT04693715|593203799|FG001|Overall Study|Withdrawal by Legal Authorized Representative|1|||
164227769|NCT04693715|593203800|FG002|Overall Study|Withdrawal by Legal Authorized Representative|0|||
164227770|NCT04693715|593203798|FG000|Overall Study|Withdrawal by Subject|0|||
164227771|NCT04693715|593203799|FG001|Overall Study|Withdrawal by Subject|0|||
164227772|NCT04693715|593203800|FG002|Overall Study|Withdrawal by Subject|1|||
164227773|NCT02367885|593203801|FG000|Overall Study|Lost to Follow-up|1|||
164227774|NCT02367885|593203802|FG001|Overall Study|Lost to Follow-up|0|||
164227775|NCT02367885|593203803|FG002|Overall Study|Lost to Follow-up|0|||
164227776|NCT02367885|593203801|FG000|Overall Study|Withdrawal by Subject|1|||
164227777|NCT02367885|593203802|FG001|Overall Study|Withdrawal by Subject|0|||
164227778|NCT02367885|593203803|FG002|Overall Study|Withdrawal by Subject|0|||
164227779|NCT01378195|593203804|FG000|Overall Study|Lost to Follow-up|29|||
164227780|NCT01378195|593203805|FG001|Overall Study|Lost to Follow-up|18|||
164227781|NCT00752219|593203806|FG000|Overall Study|Clinical failure|0|||
164227782|NCT00752219|593203807|FG001|Overall Study|Clinical failure|1|||
164227783|NCT00752219|593203806|FG000|Overall Study|Adverse Event|5|||
164227784|NCT00752219|593203807|FG001|Overall Study|Adverse Event|3|||
164227785|NCT00752219|593203806|FG000|Overall Study|Protocol deviation|1|||
164227786|NCT00752219|593203807|FG001|Overall Study|Protocol deviation|0|||
164227787|NCT00752219|593203806|FG000|Overall Study|Lost to Follow-up|1|||
164227788|NCT00752219|593203807|FG001|Overall Study|Lost to Follow-up|2|||
164227789|NCT00752219|593203806|FG000|Overall Study|Randomized but not treated|1|||
164227790|NCT00752219|593203807|FG001|Overall Study|Randomized but not treated|0|||
164227791|NCT00752219|593203806|FG000|Overall Study|Other|3|||
164227792|NCT00752219|593203807|FG001|Overall Study|Other|0|||
164227793|NCT03533491|593203809|FG000|Overall Study|Lost to Follow-up|2|||
164227794|NCT06433908|593203813|FG000|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|1|||
164227795|NCT06433908|593203814|FG001|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
164227796|NCT06433908|593203815|FG002|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
164227797|NCT06433908|593203816|FG003|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
164227798|NCT06433908|593203813|FG000|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
164227799|NCT06433908|593203814|FG001|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|1|||
164227800|NCT06433908|593203815|FG002|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
164227801|NCT06433908|593203816|FG003|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
164227802|NCT06433908|593203813|FG000|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
164227803|NCT06433908|593203814|FG001|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
164227804|NCT06433908|593203815|FG002|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|1|||
164227805|NCT06433908|593203816|FG003|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
164227806|NCT05418426|593203817|FG000|Overall Study|Adverse Event|0|||
164227807|NCT05418426|593203818|FG001|Overall Study|Adverse Event|1|||
164227808|NCT05418426|593203819|FG002|Overall Study|Adverse Event|0|||
164227809|NCT05418426|593203817|FG000|Overall Study|Withdrawal by Subject|0|||
164227810|NCT05418426|593203818|FG001|Overall Study|Withdrawal by Subject|1|||
164227811|NCT05418426|593203819|FG002|Overall Study|Withdrawal by Subject|0|||
164227812|NCT05418426|593203817|FG000|Overall Study|Protocol Violation|0|||
164227813|NCT05418426|593203818|FG001|Overall Study|Protocol Violation|0|||
164227814|NCT05418426|593203819|FG002|Overall Study|Protocol Violation|1|||
164227815|NCT04403880|593203822|FG000|Overall Study|Death|1|||
164227816|NCT04403880|593203823|FG001|Overall Study|Death|0|||
164227817|NCT04403880|593203824|FG002|Overall Study|Death|2|||
164227818|NCT04403880|593203825|FG003|Overall Study|Death|0|||
164227819|NCT04403880|593203826|FG004|Overall Study|Death|0|||
164571578|NCT01290887|594458324|FG001|Overall Study|Sponsor closure of study|476|||
164571579|NCT01290887|594458323|FG000|Overall Study|Other|3|||
164571580|NCT01290887|594458324|FG001|Overall Study|Other|6|||
164571581|NCT01412229|594458325|FG000|Overall Study|Physician Decision|1|||
164571582|NCT00454207|594458326|FG000|Overall Study|Adverse Event|3|||
164571583|NCT00454207|594458327|FG001|Overall Study|Adverse Event|1|||
164571584|NCT00454207|594458326|FG000|Overall Study|Lack of Efficacy|1|||
164571585|NCT00454207|594458327|FG001|Overall Study|Lack of Efficacy|0|||
164571586|NCT00454207|594458326|FG000|Overall Study|Protocol Violation|0|||
164571587|NCT00454207|594458327|FG001|Overall Study|Protocol Violation|1|||
164227820|NCT04403880|593203827|FG005|Overall Study|Death|0|||
164227821|NCT04403880|593203828|FG006|Overall Study|Death|0|||
164227822|NCT04403880|593203822|FG000|Overall Study|Physician Decision|0|||
164571588|NCT00642642|594458331|FG000|Treatment & Follow Up|Adverse Event|2|||
164571589|NCT00642642|594458331|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
164227823|NCT04403880|593203823|FG001|Overall Study|Physician Decision|0|||
164227824|NCT04403880|593203824|FG002|Overall Study|Physician Decision|0|||
164227825|NCT04403880|593203825|FG003|Overall Study|Physician Decision|0|||
164227826|NCT04403880|593203826|FG004|Overall Study|Physician Decision|1|||
164227827|NCT04403880|593203827|FG005|Overall Study|Physician Decision|0|||
164227828|NCT04403880|593203828|FG006|Overall Study|Physician Decision|0|||
164227829|NCT04403880|593203822|FG000|Overall Study|Lost to Follow-up|4|||
164227830|NCT04403880|593203823|FG001|Overall Study|Lost to Follow-up|3|||
164227831|NCT04403880|593203824|FG002|Overall Study|Lost to Follow-up|8|||
164227832|NCT04403880|593203825|FG003|Overall Study|Lost to Follow-up|7|||
164227833|NCT04403880|593203826|FG004|Overall Study|Lost to Follow-up|8|||
164227834|NCT04403880|593203827|FG005|Overall Study|Lost to Follow-up|1|||
164227835|NCT04403880|593203828|FG006|Overall Study|Lost to Follow-up|8|||
164227836|NCT04403880|593203822|FG000|Overall Study|Withdrawal by Subject|8|||
164227837|NCT04403880|593203823|FG001|Overall Study|Withdrawal by Subject|9|||
164227838|NCT04403880|593203824|FG002|Overall Study|Withdrawal by Subject|22|||
164227839|NCT04403880|593203825|FG003|Overall Study|Withdrawal by Subject|16|||
164227840|NCT04403880|593203826|FG004|Overall Study|Withdrawal by Subject|16|||
164227841|NCT04403880|593203827|FG005|Overall Study|Withdrawal by Subject|8|||
164227842|NCT04403880|593203828|FG006|Overall Study|Withdrawal by Subject|11|||
164227843|NCT04403880|593203822|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
164227844|NCT04403880|593203823|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|5|||
164227845|NCT04403880|593203824|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|12|||
164227846|NCT04403880|593203825|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|2|||
164227847|NCT04403880|593203826|FG004|Overall Study|Participant Unable to Adhere to Visit Schedule|8|||
164227848|NCT04403880|593203827|FG005|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
164227849|NCT04403880|593203828|FG006|Overall Study|Participant Unable to Adhere to Visit Schedule|2|||
164227850|NCT04403880|593203822|FG000|Overall Study|Participant Unable to Comply with Study Procedure|7|||
164227851|NCT04403880|593203823|FG001|Overall Study|Participant Unable to Comply with Study Procedure|1|||
164227852|NCT04403880|593203824|FG002|Overall Study|Participant Unable to Comply with Study Procedure|7|||
164227853|NCT04403880|593203825|FG003|Overall Study|Participant Unable to Comply with Study Procedure|9|||
164227854|NCT04403880|593203826|FG004|Overall Study|Participant Unable to Comply with Study Procedure|8|||
164227855|NCT04403880|593203827|FG005|Overall Study|Participant Unable to Comply with Study Procedure|8|||
164227856|NCT04403880|593203828|FG006|Overall Study|Participant Unable to Comply with Study Procedure|19|||
164227857|NCT04403880|593203822|FG000|Overall Study|Pregnancy|2|||
164227858|NCT04403880|593203823|FG001|Overall Study|Pregnancy|0|||
164227859|NCT04403880|593203824|FG002|Overall Study|Pregnancy|5|||
164227860|NCT04403880|593203825|FG003|Overall Study|Pregnancy|0|||
164227861|NCT04403880|593203826|FG004|Overall Study|Pregnancy|1|||
164227862|NCT04403880|593203827|FG005|Overall Study|Pregnancy|0|||
164227863|NCT04403880|593203828|FG006|Overall Study|Pregnancy|1|||
164227864|NCT04403880|593203822|FG000|Overall Study|Sponsor Decision|2|||
164227865|NCT04403880|593203823|FG001|Overall Study|Sponsor Decision|0|||
164227866|NCT04403880|593203824|FG002|Overall Study|Sponsor Decision|14|||
164227867|NCT04403880|593203825|FG003|Overall Study|Sponsor Decision|1|||
164227868|NCT04403880|593203826|FG004|Overall Study|Sponsor Decision|1|||
164227869|NCT04403880|593203827|FG005|Overall Study|Sponsor Decision|0|||
164227870|NCT04403880|593203828|FG006|Overall Study|Sponsor Decision|2|||
164227871|NCT04403880|593203822|FG000|Overall Study|Other|18|||
164227872|NCT04403880|593203823|FG001|Overall Study|Other|9|||
164675368|NCT01045161|594834949|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
164227873|NCT04403880|593203824|FG002|Overall Study|Other|14|||
164227874|NCT04403880|593203825|FG003|Overall Study|Other|10|||
164227875|NCT04403880|593203826|FG004|Overall Study|Other|11|||
164675369|NCT01045161|594834950|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
164675370|NCT01045161|594834951|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
164675371|NCT01045161|594834949|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
164675372|NCT01045161|594834950|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
164675373|NCT01045161|594834951|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
164675374|NCT01045161|594834949|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
164675375|NCT01045161|594834950|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
164675376|NCT01045161|594834951|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
164675377|NCT01045161|594834949|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
164227876|NCT04403880|593203827|FG005|Overall Study|Other|12|||
164227877|NCT04403880|593203828|FG006|Overall Study|Other|15|||
164227878|NCT04138277|593203831|FG000|Pretreatment|Withdrawal by Subject|1|||
164227879|NCT04138277|593203832|FG001|Pretreatment|Withdrawal by Subject|0|||
164227880|NCT04138277|593203831|FG000|Treatment|Adverse Event|6|||
164227881|NCT04138277|593203832|FG001|Treatment|Adverse Event|2|||
164227882|NCT04138277|593203831|FG000|Treatment|Lost to Follow-up|1|||
164227883|NCT04138277|593203832|FG001|Treatment|Lost to Follow-up|0|||
164227884|NCT04138277|593203831|FG000|Treatment|Pregnancy|3|||
164227885|NCT04138277|593203832|FG001|Treatment|Pregnancy|0|||
164227886|NCT04138277|593203831|FG000|Treatment|COVID-19 pandemic|1|||
164227887|NCT04138277|593203832|FG001|Treatment|COVID-19 pandemic|0|||
164227888|NCT04138277|593203831|FG000|Treatment|Withdrawal by Subject|9|||
164227889|NCT04138277|593203832|FG001|Treatment|Withdrawal by Subject|3|||
164227890|NCT04138277|593203831|FG000|Treatment|Sponsor decision|1|||
164227891|NCT04138277|593203832|FG001|Treatment|Sponsor decision|0|||
164227892|NCT04138277|593203831|FG000|Treatment|Physician Decision|1|||
164227893|NCT04138277|593203832|FG001|Treatment|Physician Decision|0|||
164227894|NCT04138277|593203831|FG000|Treatment|Worsening of condition|1|||
164227895|NCT04138277|593203832|FG001|Treatment|Worsening of condition|2|||
164227896|NCT03768414|593203833|FG000|Overall Study|Adverse Event or side effects|72|||
164227897|NCT03768414|593203834|FG001|Overall Study|Adverse Event or side effects|28|||
164227898|NCT03768414|593203833|FG000|Overall Study|Refusal unrelated to adverse event|33|||
164331036|NCT02160782|593589843|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
164331037|NCT02160782|593589839|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
164331038|NCT02160782|593589840|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
164331039|NCT02160782|593589841|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
164331040|NCT02160782|593589842|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
164331041|NCT02160782|593589843|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
164331042|NCT02160782|593589839|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
164331043|NCT02160782|593589840|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
164355620|NCT00512707|593676483|FG001|Overall Study|Developed skin irritation|1|||
164571590|NCT00642642|594458331|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
164571591|NCT02116621|594458332|FG000|Baseline|Withdrawal by Subject|0|||
164675378|NCT01045161|594834950|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
164675379|NCT01045161|594834951|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
164675380|NCT01045161|594834949|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
164675381|NCT01045161|594834950|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
164675382|NCT01045161|594834951|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
164675383|NCT01045161|594834949|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
164675384|NCT01045161|594834950|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
164675385|NCT01045161|594834951|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
164675386|NCT01045161|594834949|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
164675387|NCT01045161|594834950|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
164675388|NCT01045161|594834951|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
164675389|NCT01045161|594834949|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
164675390|NCT01045161|594834950|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
164675391|NCT01045161|594834951|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
164675392|NCT02089997|594834952|FG000|Overall Study|Case report forms uncollected|99|||
164227899|NCT03768414|593203834|FG001|Overall Study|Refusal unrelated to adverse event|33|||
164227900|NCT03768414|593203833|FG000|Overall Study|Progression/relapse|132|||
164227901|NCT03768414|593203834|FG001|Overall Study|Progression/relapse|60|||
164227902|NCT03768414|593203833|FG000|Overall Study|Death|9|||
164227903|NCT03768414|593203834|FG001|Overall Study|Death|6|||
164571592|NCT02116621|594458333|FG001|Baseline|Withdrawal by Subject|4|||
164571593|NCT02116621|594458332|FG000|Three Month Follow-up|Death|1|||
164571594|NCT02116621|594458333|FG001|Three Month Follow-up|Death|1|||
164571595|NCT02116621|594458332|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
164571596|NCT02116621|594458333|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
164571597|NCT02116621|594458332|FG000|Three Month Follow-up|Lost to Follow-up|0|||
164571598|NCT02116621|594458333|FG001|Three Month Follow-up|Lost to Follow-up|1|||
164571599|NCT02116621|594458332|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
164571600|NCT02116621|594458333|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
164571601|NCT02116621|594458332|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
164571602|NCT02116621|594458333|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
164571603|NCT02116621|594458332|FG000|Six Month Follow-up|Lost to Follow-up|2|||
164571604|NCT02116621|594458333|FG001|Six Month Follow-up|Lost to Follow-up|1|||
164571605|NCT02116621|594458332|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
164571606|NCT02116621|594458333|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
164571607|NCT02116621|594458332|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
164571608|NCT02116621|594458333|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
164571609|NCT02116621|594458332|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
164571610|NCT02116621|594458333|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
164571611|NCT02116621|594458332|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
164571612|NCT02116621|594458333|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
164571613|NCT02116621|594458332|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
164571614|NCT02116621|594458333|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
164571615|NCT00151892|594458334|FG000|Overall Study|Lack of Efficacy|50|||
164571616|NCT00151892|594458335|FG001|Overall Study|Lack of Efficacy|57|||
164571617|NCT00151892|594458334|FG000|Overall Study|Patient request|10|||
164227904|NCT03768414|593203833|FG000|Overall Study|Other - not protocol specified|45|||
164227905|NCT03768414|593203834|FG001|Overall Study|Other - not protocol specified|18|||
164227906|NCT03768414|593203833|FG000|Overall Study|Reason under review|3|||
164227907|NCT03768414|593203834|FG001|Overall Study|Reason under review|2|||
164227908|NCT02528305|593203839|FG000|Overall Study|Withdrawal by Subject|1|||
164227909|NCT02528305|593203839|FG000|Overall Study|Adverse Event|1|||
164227910|NCT02528305|593203839|FG000|Overall Study|Physician Decision|1|||
164571618|NCT00151892|594458335|FG001|Overall Study|Patient request|7|||
164571619|NCT00151892|594458334|FG000|Overall Study|Lost to Follow-up|5|||
164571620|NCT00151892|594458335|FG001|Overall Study|Lost to Follow-up|10|||
164571621|NCT00151892|594458334|FG000|Overall Study|Adverse Event|6|||
164571622|NCT00151892|594458335|FG001|Overall Study|Adverse Event|3|||
164571623|NCT00151892|594458334|FG000|Overall Study|Protocol Violation|3|||
164571624|NCT00151892|594458335|FG001|Overall Study|Protocol Violation|3|||
164571625|NCT00151892|594458334|FG000|Overall Study|Non-compliance|0|||
164571626|NCT00151892|594458335|FG001|Overall Study|Non-compliance|1|||
164571627|NCT00151892|594458334|FG000|Overall Study|Pregnancy|0|||
164571628|NCT00151892|594458335|FG001|Overall Study|Pregnancy|1|||
164571629|NCT00151892|594458334|FG000|Overall Study|Did not return for a visit|1|||
164571630|NCT00151892|594458335|FG001|Overall Study|Did not return for a visit|0|||
164571631|NCT00151892|594458334|FG000|Overall Study|Used prohibited corticosteroids|1|||
164571632|NCT00151892|594458335|FG001|Overall Study|Used prohibited corticosteroids|0|||
164571633|NCT00151892|594458334|FG000|Overall Study|Lack of study medication at center|0|||
164571634|NCT00151892|594458335|FG001|Overall Study|Lack of study medication at center|1|||
164571635|NCT03437447|594458336|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164571636|NCT03437447|594458337|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164571637|NCT03437447|594458338|FG002|Treatment Period 1|Withdrawal by Subject|1|||
164571638|NCT03440944|594458341|FG000|Overall Study|Physician Decision|1|||
164571639|NCT03440944|594458342|FG001|Overall Study|Physician Decision|0|||
164571640|NCT03440944|594458341|FG000|Overall Study|No Acceptable Vasculature|0|||
164571641|NCT03440944|594458342|FG001|Overall Study|No Acceptable Vasculature|1|||
164571642|NCT01661790|594458343|FG000|Overall Study|Lost to Follow-up|0|||
164571643|NCT01661790|594458344|FG001|Overall Study|Lost to Follow-up|2|||
164571644|NCT02764541|594458347|FG000|Overall Study|Withdrawal by Subject|0|||
164571645|NCT02764541|594458348|FG001|Overall Study|Withdrawal by Subject|0|||
164571646|NCT02764541|594458349|FG002|Overall Study|Withdrawal by Subject|0|||
164571647|NCT02764541|594458350|FG003|Overall Study|Withdrawal by Subject|0|||
164571648|NCT02764541|594458351|FG004|Overall Study|Withdrawal by Subject|1|||
164571649|NCT02764541|594458352|FG005|Overall Study|Withdrawal by Subject|1|||
164571650|NCT02764541|594458353|FG006|Overall Study|Withdrawal by Subject|0|||
164571651|NCT02764541|594458354|FG007|Overall Study|Withdrawal by Subject|1|||
164571652|NCT02764541|594458347|FG000|Overall Study|Adverse Event|1|||
164571653|NCT02764541|594458348|FG001|Overall Study|Adverse Event|0|||
164571654|NCT02764541|594458349|FG002|Overall Study|Adverse Event|0|||
164571655|NCT02764541|594458350|FG003|Overall Study|Adverse Event|0|||
164571656|NCT02764541|594458351|FG004|Overall Study|Adverse Event|0|||
164571657|NCT02764541|594458352|FG005|Overall Study|Adverse Event|0|||
164571658|NCT02764541|594458353|FG006|Overall Study|Adverse Event|1|||
164571659|NCT02764541|594458354|FG007|Overall Study|Adverse Event|0|||
164571660|NCT02764541|594458347|FG000|Overall Study|Metastasis|1|||
164571661|NCT02764541|594458348|FG001|Overall Study|Metastasis|0|||
164571662|NCT02764541|594458349|FG002|Overall Study|Metastasis|0|||
164571663|NCT02764541|594458350|FG003|Overall Study|Metastasis|0|||
164571664|NCT02764541|594458351|FG004|Overall Study|Metastasis|0|||
164571665|NCT02764541|594458352|FG005|Overall Study|Metastasis|0|||
164571666|NCT02764541|594458353|FG006|Overall Study|Metastasis|0|||
164571667|NCT02764541|594458354|FG007|Overall Study|Metastasis|0|||
164571668|NCT02764541|594458347|FG000|Overall Study|Disease progression|1|||
164571669|NCT02764541|594458348|FG001|Overall Study|Disease progression|1|||
164571670|NCT02764541|594458349|FG002|Overall Study|Disease progression|0|||
164571671|NCT02764541|594458350|FG003|Overall Study|Disease progression|0|||
164571672|NCT02764541|594458351|FG004|Overall Study|Disease progression|0|||
164571673|NCT02764541|594458352|FG005|Overall Study|Disease progression|0|||
164571674|NCT02764541|594458353|FG006|Overall Study|Disease progression|0|||
164571675|NCT02764541|594458354|FG007|Overall Study|Disease progression|1|||
164227911|NCT01308788|593203843|FG000|2-year Treatment|medication change by treating physician|4|||
164227912|NCT01308788|593203844|FG001|2-year Treatment|medication change by treating physician|11|||
164227913|NCT00322218|593203845|FG000|Overall Study|Death|3|||
164571676|NCT02764541|594458347|FG000|Overall Study|Protocol Violation|0|||
164571677|NCT02764541|594458348|FG001|Overall Study|Protocol Violation|0|||
164571678|NCT02764541|594458349|FG002|Overall Study|Protocol Violation|0|||
164571679|NCT02764541|594458350|FG003|Overall Study|Protocol Violation|1|||
164571680|NCT02764541|594458351|FG004|Overall Study|Protocol Violation|0|||
164571681|NCT02764541|594458352|FG005|Overall Study|Protocol Violation|1|||
164571682|NCT02764541|594458353|FG006|Overall Study|Protocol Violation|0|||
164571683|NCT02764541|594458354|FG007|Overall Study|Protocol Violation|0|||
164571684|NCT02764541|594458347|FG000|Overall Study|Physician Decision|0|||
164571685|NCT02764541|594458348|FG001|Overall Study|Physician Decision|0|||
164571686|NCT02764541|594458349|FG002|Overall Study|Physician Decision|0|||
164227914|NCT00322218|593203846|FG001|Overall Study|Death|6|||
164227915|NCT00124306|593203847|FG000|Overall Study|Adverse Event|7|||
164227916|NCT00124306|593203848|FG001|Overall Study|Adverse Event|2|||
164227917|NCT00124306|593203847|FG000|Overall Study|Lost to Follow-up|10|||
164227918|NCT00124306|593203848|FG001|Overall Study|Lost to Follow-up|6|||
164227919|NCT00124306|593203847|FG000|Overall Study|Lack of Efficacy|3|||
164227920|NCT00124306|593203848|FG001|Overall Study|Lack of Efficacy|6|||
164227921|NCT00124306|593203847|FG000|Overall Study|Personal constraints|0|||
164227922|NCT00124306|593203848|FG001|Overall Study|Personal constraints|2|||
164227923|NCT00124306|593203847|FG000|Overall Study|Use of unacceptable medication|1|||
164227924|NCT00124306|593203848|FG001|Overall Study|Use of unacceptable medication|0|||
164227925|NCT00124306|593203847|FG000|Overall Study|Abnormal lab result|0|||
164227926|NCT00124306|593203848|FG001|Overall Study|Abnormal lab result|1|||
164227927|NCT00124306|593203847|FG000|Overall Study|Other|2|||
164227928|NCT00124306|593203848|FG001|Overall Study|Other|0|||
164227929|NCT03596645|593203854|FG000|Overall Study|Adverse Event|17|||
164227930|NCT03596645|593203855|FG001|Overall Study|Adverse Event|0|||
164227931|NCT03596645|593203854|FG000|Overall Study|Lack of Efficacy|8|||
164227932|NCT03596645|593203855|FG001|Overall Study|Lack of Efficacy|0|||
164227933|NCT03596645|593203854|FG000|Overall Study|Lost to Follow-up|1|||
164227934|NCT03596645|593203855|FG001|Overall Study|Lost to Follow-up|1|||
164227935|NCT03596645|593203854|FG000|Overall Study|Physician Decision|1|||
164571687|NCT02764541|594458350|FG003|Overall Study|Physician Decision|1|||
164571688|NCT02764541|594458351|FG004|Overall Study|Physician Decision|0|||
164571689|NCT02764541|594458352|FG005|Overall Study|Physician Decision|0|||
164571690|NCT02764541|594458353|FG006|Overall Study|Physician Decision|0|||
164571691|NCT02764541|594458354|FG007|Overall Study|Physician Decision|1|||
164571692|NCT02764541|594458347|FG000|Overall Study|Three Cycles completed before surgery|0|||
164571693|NCT02764541|594458348|FG001|Overall Study|Three Cycles completed before surgery|0|||
164571694|NCT02764541|594458349|FG002|Overall Study|Three Cycles completed before surgery|0|||
164571695|NCT02764541|594458350|FG003|Overall Study|Three Cycles completed before surgery|1|||
164571696|NCT02764541|594458351|FG004|Overall Study|Three Cycles completed before surgery|0|||
164571697|NCT02764541|594458352|FG005|Overall Study|Three Cycles completed before surgery|0|||
164571698|NCT02764541|594458353|FG006|Overall Study|Three Cycles completed before surgery|0|||
164571699|NCT02764541|594458354|FG007|Overall Study|Three Cycles completed before surgery|0|||
164571700|NCT02764541|594458347|FG000|Overall Study|Patient Compliance|0|||
164571701|NCT02764541|594458348|FG001|Overall Study|Patient Compliance|0|||
164571702|NCT02764541|594458349|FG002|Overall Study|Patient Compliance|1|||
164571703|NCT02764541|594458350|FG003|Overall Study|Patient Compliance|0|||
164571704|NCT02764541|594458351|FG004|Overall Study|Patient Compliance|0|||
164571705|NCT02764541|594458352|FG005|Overall Study|Patient Compliance|0|||
164675393|NCT02089997|594834952|FG000|Overall Study|Protocol Violation|147|||
164675394|NCT02957942|594834956|FG000|Overall Study|Withdrawal by Subject|0|||
164675395|NCT02957942|594834957|FG001|Overall Study|Withdrawal by Subject|1|||
164675396|NCT02957942|594834956|FG000|Overall Study|Practicing experiment protocol|0|||
164675397|NCT02957942|594834957|FG001|Overall Study|Practicing experiment protocol|6|||
164675398|NCT02655679|594834960|FG000|Overall Study|Adverse Event|0|||
164675399|NCT02655679|594834961|FG001|Overall Study|Adverse Event|1|||
164675400|NCT02655679|594834962|FG002|Overall Study|Adverse Event|0|||
164675401|NCT02655679|594834963|FG003|Overall Study|Adverse Event|0|||
164675402|NCT02655679|594834964|FG004|Overall Study|Adverse Event|0|||
164675403|NCT02655679|594834960|FG000|Overall Study|Withdrawal by Subject|1|||
164675404|NCT02655679|594834961|FG001|Overall Study|Withdrawal by Subject|1|||
164675405|NCT02655679|594834962|FG002|Overall Study|Withdrawal by Subject|0|||
164675406|NCT02655679|594834963|FG003|Overall Study|Withdrawal by Subject|3|||
164675407|NCT02655679|594834964|FG004|Overall Study|Withdrawal by Subject|1|||
164675408|NCT02655679|594834960|FG000|Overall Study|Inability to Comply with the Protocol|1|||
164675409|NCT02655679|594834961|FG001|Overall Study|Inability to Comply with the Protocol|0|||
164675410|NCT02655679|594834962|FG002|Overall Study|Inability to Comply with the Protocol|0|||
164675411|NCT02655679|594834963|FG003|Overall Study|Inability to Comply with the Protocol|0|||
164675412|NCT02655679|594834964|FG004|Overall Study|Inability to Comply with the Protocol|0|||
164675413|NCT02655679|594834960|FG000|Overall Study|Lost to Follow-up|0|||
164675414|NCT02655679|594834961|FG001|Overall Study|Lost to Follow-up|1|||
164675415|NCT02655679|594834962|FG002|Overall Study|Lost to Follow-up|1|||
164675416|NCT02655679|594834963|FG003|Overall Study|Lost to Follow-up|1|||
164227936|NCT03596645|593203855|FG001|Overall Study|Physician Decision|1|||
164227937|NCT03596645|593203854|FG000|Overall Study|Protocol Violation|1|||
164227938|NCT03596645|593203855|FG001|Overall Study|Protocol Violation|0|||
164227939|NCT03596645|593203854|FG000|Overall Study|Initiated Prohibited Medication|1|||
164675417|NCT02655679|594834964|FG004|Overall Study|Lost to Follow-up|0|||
164227940|NCT03596645|593203855|FG001|Overall Study|Initiated Prohibited Medication|0|||
164227941|NCT03596645|593203854|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
164675418|NCT02655679|594834960|FG000|Overall Study|Other Miscellaneous Reasons|1|||
164571706|NCT02764541|594458353|FG006|Overall Study|Patient Compliance|0|||
164571707|NCT02764541|594458354|FG007|Overall Study|Patient Compliance|0|||
164571708|NCT02764541|594458347|FG000|Overall Study|Death|0|||
164331044|NCT02160782|593589841|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
164331045|NCT02160782|593589842|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
164331046|NCT02160782|593589843|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
164331047|NCT02160782|593589839|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
164331048|NCT02160782|593589840|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
164331049|NCT02160782|593589841|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
164331050|NCT02160782|593589842|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
164331051|NCT02160782|593589843|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
164331052|NCT02160782|593589839|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
164331053|NCT02160782|593589840|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
164331054|NCT02160782|593589841|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
164331055|NCT02160782|593589842|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
164331056|NCT02160782|593589843|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
164331057|NCT02160782|593589839|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
164331058|NCT02160782|593589840|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
164331059|NCT02160782|593589841|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
164571709|NCT02764541|594458348|FG001|Overall Study|Death|0|||
164571710|NCT02764541|594458349|FG002|Overall Study|Death|0|||
164571711|NCT02764541|594458350|FG003|Overall Study|Death|0|||
164571712|NCT02764541|594458351|FG004|Overall Study|Death|0|||
164571713|NCT02764541|594458352|FG005|Overall Study|Death|0|||
164571714|NCT02764541|594458353|FG006|Overall Study|Death|1|||
164571715|NCT02764541|594458354|FG007|Overall Study|Death|0|||
164571716|NCT02764541|594458347|FG000|Overall Study|Insurance reasons|0|||
164571717|NCT02764541|594458348|FG001|Overall Study|Insurance reasons|0|||
164571718|NCT02764541|594458349|FG002|Overall Study|Insurance reasons|0|||
164571719|NCT02764541|594458350|FG003|Overall Study|Insurance reasons|0|||
164571720|NCT02764541|594458351|FG004|Overall Study|Insurance reasons|0|||
164571721|NCT02764541|594458352|FG005|Overall Study|Insurance reasons|0|||
164571722|NCT02764541|594458353|FG006|Overall Study|Insurance reasons|1|||
164571723|NCT02764541|594458354|FG007|Overall Study|Insurance reasons|0|||
164571724|NCT02048904|594458355|FG000|Overall Study|Withdrawal by Subject|7|||
164571725|NCT02048904|594458355|FG000|Overall Study|Physician Decision|70|||
164571726|NCT00413959|594458358|FG000|Overall Study|Pt had only one cycle.|1|||
164571727|NCT01813890|594458361|FG000|Overall Study|Adverse Event|0|||
164571728|NCT01813890|594458362|FG001|Overall Study|Adverse Event|3|||
164571729|NCT01813890|594458363|FG002|Overall Study|Adverse Event|4|||
164571730|NCT01813890|594458361|FG000|Overall Study|Lack of Efficacy|9|||
164571731|NCT01813890|594458362|FG001|Overall Study|Lack of Efficacy|1|||
164571732|NCT01813890|594458363|FG002|Overall Study|Lack of Efficacy|2|||
164571733|NCT04482647|594458364|FG000|Overall Study|Time constraints|2|||
164571734|NCT04482647|594458364|FG000|Overall Study|Health issues|1|||
164571735|NCT04482647|594458364|FG000|Overall Study|Death in the family|1|||
164571736|NCT04482647|594458364|FG000|Overall Study|Disliked the intervention|1|||
164571737|NCT04482647|594458364|FG000|Overall Study|No reasons specified|7|||
164571738|NCT03952559|594458365|FG000|Double Blind Treatment Period|Adverse Event|0|||
164571739|NCT03952559|594458366|FG001|Double Blind Treatment Period|Adverse Event|2|||
164571740|NCT03952559|594458367|FG002|Double Blind Treatment Period|Adverse Event|1|||
164571741|NCT03952559|594458368|FG003|Double Blind Treatment Period|Adverse Event|0|||
164571742|NCT03952559|594458369|FG004|Double Blind Treatment Period|Adverse Event|1|||
164571743|NCT03952559|594458365|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
164571744|NCT03952559|594458366|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
164571745|NCT03952559|594458367|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
164571746|NCT03952559|594458368|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
164571747|NCT03952559|594458369|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
164571748|NCT03952559|594458365|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
164571749|NCT03952559|594458366|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
164571750|NCT03952559|594458367|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
164571751|NCT03952559|594458368|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
164571752|NCT03952559|594458369|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
164571753|NCT03952559|594458365|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
164571754|NCT03952559|594458366|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
164571755|NCT03952559|594458367|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
164571756|NCT03952559|594458368|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
164571757|NCT03952559|594458369|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
164571758|NCT01870739|594458372|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
164571759|NCT01870739|594458373|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
164571760|NCT01870739|594458372|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
164571761|NCT01870739|594458373|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
164571762|NCT01870739|594458372|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
164571763|NCT01870739|594458373|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
164331060|NCT02160782|593589842|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
164331061|NCT02160782|593589843|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
164227942|NCT03596645|593203855|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164227943|NCT03596645|593203854|FG000|Overall Study|No mucosal healing achieved|1|||
164227944|NCT03596645|593203855|FG001|Overall Study|No mucosal healing achieved|0|||
164227945|NCT03596645|593203854|FG000|Overall Study|Disease progression|1|||
164227946|NCT03596645|593203855|FG001|Overall Study|Disease progression|0|||
164227947|NCT03596645|593203854|FG000|Overall Study|Ongoing|37|||
164227948|NCT03596645|593203855|FG001|Overall Study|Ongoing|12|||
164227949|NCT03596645|593203854|FG000|Overall Study|Randomized but not treated|0|||
164227950|NCT03596645|593203855|FG001|Overall Study|Randomized but not treated|1|||
164227951|NCT00866775|593205361|FG000|Overall Study|Adverse Event|5|||
164227952|NCT00866775|593205362|FG001|Overall Study|Adverse Event|19|||
164227953|NCT00866775|593205361|FG000|Overall Study|Death|1|||
164227954|NCT00866775|593205362|FG001|Overall Study|Death|0|||
164227955|NCT00866775|593205361|FG000|Overall Study|Lost to Follow-up|0|||
164227956|NCT00866775|593205362|FG001|Overall Study|Lost to Follow-up|4|||
164227957|NCT00866775|593205361|FG000|Overall Study|Physician Decision|0|||
164227958|NCT00866775|593205362|FG001|Overall Study|Physician Decision|3|||
164227959|NCT00866775|593205361|FG000|Overall Study|Protocol Violation|3|||
164227960|NCT00866775|593205362|FG001|Overall Study|Protocol Violation|4|||
164227961|NCT00866775|593205361|FG000|Overall Study|Withdrawal by Subject|4|||
164227962|NCT00866775|593205362|FG001|Overall Study|Withdrawal by Subject|4|||
164227963|NCT00866775|593205361|FG000|Overall Study|met exit criteria|23|||
164227964|NCT00866775|593205362|FG001|Overall Study|met exit criteria|17|||
164227965|NCT00866775|593205361|FG000|Overall Study|discontinued due to communication error|0|||
164227966|NCT00866775|593205362|FG001|Overall Study|discontinued due to communication error|1|||
164227967|NCT01904279|593205367|FG000|Overall Study|Lack of Efficacy|2|||
164227968|NCT01904279|593205368|FG001|Overall Study|Lack of Efficacy|3|||
164227969|NCT01904279|593205367|FG000|Overall Study|Withdrawal by Subject|1|||
164227970|NCT01904279|593205368|FG001|Overall Study|Withdrawal by Subject|0|||
164227971|NCT03283241|593205371|FG000|Overall Study|Adverse Event|4|||
164227972|NCT03283241|593205372|FG001|Overall Study|Adverse Event|1|||
164227973|NCT03283241|593205371|FG000|Overall Study|Withdrawal by Subject|0|||
164227974|NCT03283241|593205372|FG001|Overall Study|Withdrawal by Subject|1|||
164227975|NCT03283241|593205371|FG000|Overall Study|Subject relocated to Finland|0|||
164227976|NCT03283241|593205372|FG001|Overall Study|Subject relocated to Finland|1|||
164227977|NCT00666263|593205373|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
164227978|NCT00666263|593205374|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
164227979|NCT00666263|593205373|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
164227980|NCT00666263|593205374|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
164227981|NCT00666263|593205373|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
164227982|NCT00666263|593205374|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
164227983|NCT02439957|593205375|FG000|Overall Study|Study Terminated|3|||
164227984|NCT02439957|593205376|FG001|Overall Study|Study Terminated|3|||
164227985|NCT00586157|593205377|FG000|First Intervention|Worsening behavior|1|||
164227986|NCT00586157|593205378|FG001|First Intervention|Worsening behavior|0|||
164227987|NCT00586157|593205377|FG000|Second Intervention|Withdrawal by Subject|1|||
164227988|NCT00586157|593205378|FG001|Second Intervention|Withdrawal by Subject|0|||
164227989|NCT00586157|593205377|FG000|Second Intervention|Worsening behavior|1|||
164227990|NCT00586157|593205378|FG001|Second Intervention|Worsening behavior|0|||
164227991|NCT00586157|593205377|FG000|Second Intervention|Adverse Event|0|||
164227992|NCT00586157|593205378|FG001|Second Intervention|Adverse Event|1|||
164331062|NCT01083485|593589849|FG000|Overall Study|Adverse Event|0|||
164331063|NCT01083485|593589850|FG001|Overall Study|Adverse Event|1|||
164331064|NCT01083485|593589849|FG000|Overall Study|Protocol Violation|1|||
164331065|NCT01083485|593589850|FG001|Overall Study|Protocol Violation|0|||
164331066|NCT01083485|593589849|FG000|Overall Study|Withdrawal by Subject|5|||
164331067|NCT01083485|593589850|FG001|Overall Study|Withdrawal by Subject|2|||
164227993|NCT00414609|593205379|FG000|Core Study|Adverse Event|9|||
164227994|NCT00414609|593205380|FG001|Core Study|Adverse Event|11|||
164331068|NCT01083485|593589849|FG000|Overall Study|Other|1|||
164227995|NCT00414609|593205381|FG002|Core Study|Adverse Event|0|||
164227996|NCT00414609|593205379|FG000|Core Study|Abnormal laboratory values|0|||
164227997|NCT00414609|593205380|FG001|Core Study|Abnormal laboratory values|1|||
164227998|NCT00414609|593205381|FG002|Core Study|Abnormal laboratory values|0|||
164571764|NCT01870739|594458372|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
164227999|NCT00414609|593205379|FG000|Core Study|Abnormal test procedure results|1|||
164228000|NCT00414609|593205380|FG001|Core Study|Abnormal test procedure results|1|||
164228001|NCT00414609|593205381|FG002|Core Study|Abnormal test procedure results|0|||
164228002|NCT00414609|593205379|FG000|Core Study|Protocol deviation|0|||
164228003|NCT00414609|593205380|FG001|Core Study|Protocol deviation|1|||
164228004|NCT00414609|593205381|FG002|Core Study|Protocol deviation|0|||
164228005|NCT00414609|593205379|FG000|Core Study|Patient withdrew consent|10|||
164228006|NCT00414609|593205380|FG001|Core Study|Patient withdrew consent|11|||
164228007|NCT00414609|593205381|FG002|Core Study|Patient withdrew consent|0|||
164228008|NCT00414609|593205379|FG000|Core Study|Lost to Follow-up|7|||
164228009|NCT00414609|593205380|FG001|Core Study|Lost to Follow-up|4|||
164228010|NCT00414609|593205381|FG002|Core Study|Lost to Follow-up|0|||
164228011|NCT00414609|593205379|FG000|Core Study|Administrative problems|0|||
164228012|NCT00414609|593205380|FG001|Core Study|Administrative problems|2|||
164228013|NCT00414609|593205381|FG002|Core Study|Administrative problems|0|||
164228014|NCT00414609|593205379|FG000|Core Study|Death|7|||
164228015|NCT00414609|593205380|FG001|Core Study|Death|14|||
164228016|NCT00414609|593205381|FG002|Core Study|Death|0|||
164228017|NCT00414609|593205379|FG000|Extension Study|Adverse Event|0|||
164228018|NCT00414609|593205380|FG001|Extension Study|Adverse Event|0|||
164228019|NCT00414609|593205381|FG002|Extension Study|Adverse Event|14|||
164228020|NCT00414609|593205379|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
164228021|NCT00414609|593205380|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
164228022|NCT00414609|593205381|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
164228023|NCT00414609|593205379|FG000|Extension Study|Withdrawal by Subject|0|||
164228024|NCT00414609|593205380|FG001|Extension Study|Withdrawal by Subject|0|||
164228025|NCT00414609|593205381|FG002|Extension Study|Withdrawal by Subject|13|||
164228026|NCT00414609|593205379|FG000|Extension Study|Lost to Follow-up|0|||
164228027|NCT00414609|593205380|FG001|Extension Study|Lost to Follow-up|0|||
164228028|NCT00414609|593205381|FG002|Extension Study|Lost to Follow-up|10|||
164228029|NCT00414609|593205379|FG000|Extension Study|Administrative problems|0|||
164228030|NCT00414609|593205380|FG001|Extension Study|Administrative problems|0|||
164228031|NCT00414609|593205381|FG002|Extension Study|Administrative problems|1|||
164228032|NCT00414609|593205379|FG000|Extension Study|Death|0|||
164228033|NCT00414609|593205380|FG001|Extension Study|Death|0|||
164228034|NCT00414609|593205381|FG002|Extension Study|Death|17|||
164228035|NCT02853136|593205384|FG000|Wash-out|Adverse Event|0|||
164228036|NCT02853136|593205385|FG001|Wash-out|Adverse Event|0|||
164228037|NCT02853136|593205386|FG002|Wash-out|Adverse Event|0|||
164228038|NCT02853136|593205387|FG003|Wash-out|Adverse Event|1|||
164228039|NCT00841815|593205388|FG000|Washout|Withdrawal by Subject|0|||
164228040|NCT00841815|593205389|FG001|Washout|Withdrawal by Subject|1|||
164228041|NCT01682720|593205397|FG000|Overall Study|Randomized but Not Treated|0|||
164228042|NCT01682720|593205398|FG001|Overall Study|Randomized but Not Treated|1|||
164228043|NCT01682720|593205399|FG002|Overall Study|Randomized but Not Treated|1|||
164228044|NCT01682720|593205400|FG003|Overall Study|Randomized but Not Treated|0|||
164228045|NCT01682720|593205397|FG000|Overall Study|Terminated by Sponsor|83|||
164228046|NCT01682720|593205398|FG001|Overall Study|Terminated by Sponsor|0|||
164228047|NCT01682720|593205399|FG002|Overall Study|Terminated by Sponsor|0|||
164228048|NCT01682720|593205400|FG003|Overall Study|Terminated by Sponsor|0|||
164228049|NCT01682720|593205397|FG000|Overall Study|Efficacy Failure|0|||
164228050|NCT01682720|593205398|FG001|Overall Study|Efficacy Failure|3|||
164228051|NCT01682720|593205399|FG002|Overall Study|Efficacy Failure|3|||
164228052|NCT01682720|593205400|FG003|Overall Study|Efficacy Failure|30|||
164228053|NCT01682720|593205397|FG000|Overall Study|Lost to Follow-up|1|||
164228054|NCT01682720|593205398|FG001|Overall Study|Lost to Follow-up|1|||
164228055|NCT01682720|593205399|FG002|Overall Study|Lost to Follow-up|0|||
164228056|NCT01682720|593205400|FG003|Overall Study|Lost to Follow-up|6|||
164228057|NCT01682720|593205397|FG000|Overall Study|Subject Withdrew Consent|0|||
164228058|NCT01682720|593205398|FG001|Overall Study|Subject Withdrew Consent|0|||
164228059|NCT01682720|593205399|FG002|Overall Study|Subject Withdrew Consent|2|||
164228060|NCT01682720|593205400|FG003|Overall Study|Subject Withdrew Consent|2|||
164228061|NCT01682720|593205397|FG000|Overall Study|Adverse Event|1|||
164228062|NCT01682720|593205398|FG001|Overall Study|Adverse Event|0|||
164228063|NCT01682720|593205399|FG002|Overall Study|Adverse Event|1|||
164228064|NCT01682720|593205400|FG003|Overall Study|Adverse Event|1|||
164228065|NCT01687595|593205401|FG000|Overall Study|Withdrawal by Subject|8|||
164228066|NCT01687595|593205402|FG001|Overall Study|Withdrawal by Subject|0|||
164228067|NCT01687595|593205401|FG000|Overall Study|Lost to Follow-up|3|||
164228068|NCT01687595|593205402|FG001|Overall Study|Lost to Follow-up|1|||
164228069|NCT01687595|593205401|FG000|Overall Study|Investigator's decision|1|||
164228070|NCT01687595|593205402|FG001|Overall Study|Investigator's decision|0|||
164228071|NCT01687595|593205401|FG000|Overall Study|Sponsor's decision|1|||
164228072|NCT01687595|593205402|FG001|Overall Study|Sponsor's decision|0|||
164228073|NCT01687595|593205401|FG000|Overall Study|Noncompliance|1|||
164228074|NCT01687595|593205402|FG001|Overall Study|Noncompliance|2|||
164228075|NCT01687595|593205401|FG000|Overall Study|Other than specified|56|||
164228076|NCT01687595|593205402|FG001|Overall Study|Other than specified|7|||
164228077|NCT04204902|593205403|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
164228078|NCT04204902|593205404|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
164228079|NCT03647137|593205406|FG000|Overall Study|Scan Limitation|2|||
164228080|NCT03647137|593205407|FG001|Overall Study|Scan Limitation|1|||
164228081|NCT03647137|593205408|FG002|Overall Study|Scan Limitation|1|||
164228082|NCT03647137|593205409|FG003|Overall Study|Scan Limitation|2|||
164228083|NCT03900650|593205410|FG000|Overall Study|Withdrawal by Subject|1|||
164228084|NCT03900650|593205411|FG001|Overall Study|Withdrawal by Subject|1|||
164228085|NCT03900650|593205412|FG002|Overall Study|Withdrawal by Subject|0|||
164228086|NCT03900650|593205413|FG003|Overall Study|Withdrawal by Subject|0|||
164331069|NCT01083485|593589850|FG001|Overall Study|Other|0|||
164331070|NCT02171065|593589851|FG000|Overall Study|Withdrawal by Subject|1|||
164331071|NCT02171065|593589852|FG001|Overall Study|Withdrawal by Subject|0|||
164331072|NCT02171065|593589853|FG002|Overall Study|Withdrawal by Subject|0|||
164331073|NCT02171065|593589851|FG000|Overall Study|Lost to Follow-up|0|||
164331074|NCT02171065|593589852|FG001|Overall Study|Lost to Follow-up|0|||
164331075|NCT02171065|593589853|FG002|Overall Study|Lost to Follow-up|1|||
164331076|NCT00851630|593589855|FG000|Overall Study|Death|2|||
164331077|NCT00851630|593589856|FG001|Overall Study|Death|1|||
164331078|NCT00851630|593589855|FG000|Overall Study|Clinical failure|0|||
164331079|NCT00851630|593589856|FG001|Overall Study|Clinical failure|1|||
164228087|NCT03900650|593205410|FG000|Overall Study|Withdrawn by staff|1|||
164228088|NCT03900650|593205411|FG001|Overall Study|Withdrawn by staff|0|||
164228089|NCT03900650|593205412|FG002|Overall Study|Withdrawn by staff|0|||
164228090|NCT03900650|593205413|FG003|Overall Study|Withdrawn by staff|0|||
164228091|NCT00829868|593205414|FG000|Washout|Physician Decision|1|||
164228092|NCT00829868|593205415|FG001|Washout|Physician Decision|0|||
164228093|NCT01554904|593205419|FG000|Overall Study|Withdrawal by Subject|3|||
164331080|NCT03906461|593589861|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
164331081|NCT03906461|593589861|FG000|Completed 12-month Follow-up|Missed Visit|6|||
164331082|NCT01795638|593589866|FG000|Overall Study|Death|0|||
164331083|NCT01795638|593589867|FG001|Overall Study|Death|3|||
164331084|NCT01795638|593589866|FG000|Overall Study|transferred to quaternary hospital|2|||
164331085|NCT01795638|593589867|FG001|Overall Study|transferred to quaternary hospital|3|||
164331086|NCT01795638|593589866|FG000|Overall Study|Protocol Violation|3|||
164331087|NCT01795638|593589867|FG001|Overall Study|Protocol Violation|0|||
164331088|NCT01795638|593589866|FG000|Overall Study|discharged from hospital|7|||
164331089|NCT01795638|593589867|FG001|Overall Study|discharged from hospital|5|||
164331090|NCT01795638|593589866|FG000|Overall Study|Withdrawal by Subject|1|||
164331091|NCT01795638|593589867|FG001|Overall Study|Withdrawal by Subject|0|||
164331092|NCT03061097|593589868|FG000|Overall Study|Withdrawal by Subject|0|||
164421136|NCT01857622|593911111|FG000|Overall Study|Withdrawal by Subject|1|||
164421137|NCT01857622|593911112|FG001|Overall Study|Withdrawal by Subject|0|||
164421138|NCT01857622|593911113|FG002|Overall Study|Withdrawal by Subject|0|||
164421139|NCT01291225|593911116|FG000|Overall Study|Lost to Follow-up|85|||
164421140|NCT01291225|593911117|FG001|Overall Study|Lost to Follow-up|39|||
164421141|NCT01163747|593911118|FG000|Overall Study|Adverse Event|0|||
164421142|NCT01163747|593911119|FG001|Overall Study|Adverse Event|5|||
164421143|NCT01163747|593911118|FG000|Overall Study|Insufficient Therapeutic Response|0|||
164421144|NCT01163747|593911119|FG001|Overall Study|Insufficient Therapeutic Response|1|||
164421145|NCT01163747|593911118|FG000|Overall Study|Protocol Violation|0|||
164421146|NCT01163747|593911119|FG001|Overall Study|Protocol Violation|1|||
164421147|NCT01163747|593911118|FG000|Overall Study|Refused Treatment|6|||
164421148|NCT01163747|593911119|FG001|Overall Study|Refused Treatment|4|||
164421149|NCT02924389|593911128|FG000|Overall Study|Lost to Follow-up|1|||
164421150|NCT02924389|593911129|FG001|Overall Study|Lost to Follow-up|0|||
164421151|NCT02924389|593911128|FG000|Overall Study|Physician Decision|2|||
164421152|NCT02924389|593911129|FG001|Overall Study|Physician Decision|0|||
164421153|NCT02924389|593911128|FG000|Overall Study|Withdrawal by Subject|3|||
164421154|NCT02924389|593911129|FG001|Overall Study|Withdrawal by Subject|0|||
164421155|NCT02924389|593911128|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
164421156|NCT02924389|593911129|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
164421157|NCT05220501|593912613|FG000|Overall Study|Withdrawal by Subject|11|||
164421158|NCT05220501|593912614|FG001|Overall Study|Withdrawal by Subject|21|||
164421159|NCT05220501|593912615|FG002|Overall Study|Withdrawal by Subject|32|||
164421160|NCT05220501|593912613|FG000|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|5|||
164421161|NCT05220501|593912614|FG001|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|16|||
164421162|NCT05220501|593912615|FG002|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|39|||
164421163|NCT03660943|593912616|FG000|Overall Study|Adverse Event|5|||
164228094|NCT01554904|593205419|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
164228095|NCT03829683|593205422|FG000|Overall Study|Lost to Follow-up|1|||
164228096|NCT03829683|593205423|FG001|Overall Study|Lost to Follow-up|0|||
164331093|NCT03061097|593589869|FG001|Overall Study|Withdrawal by Subject|3|||
164331094|NCT03956056|593589876|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
164331095|NCT03956056|593589876|FG000|Overall Study|Lack of Efficacy|1|||
164421164|NCT03660943|593912617|FG001|Overall Study|Adverse Event|3|||
164421165|NCT03660943|593912616|FG000|Overall Study|Death|0|||
164421166|NCT03660943|593912617|FG001|Overall Study|Death|2|||
164421167|NCT03660943|593912616|FG000|Overall Study|Lost to Follow-up|7|||
164421168|NCT03660943|593912617|FG001|Overall Study|Lost to Follow-up|3|||
164421169|NCT03660943|593912616|FG000|Overall Study|Protocol Violation|3|||
164228097|NCT03829683|593205422|FG000|Overall Study|Physician Decision|3|||
164228098|NCT03829683|593205423|FG001|Overall Study|Physician Decision|1|||
164331096|NCT02231918|593589877|FG000|Overall Study|Withdrawal by Subject|0|||
164331097|NCT02231918|593589878|FG001|Overall Study|Withdrawal by Subject|1|||
164331098|NCT02231918|593589879|FG002|Overall Study|Withdrawal by Subject|0|||
164228099|NCT03829683|593205422|FG000|Overall Study|Withdrawal by Subject|0|||
164228100|NCT03829683|593205423|FG001|Overall Study|Withdrawal by Subject|1|||
164228101|NCT03829683|593205422|FG000|Overall Study|Discharge from hospital|1|||
164228102|NCT03829683|593205423|FG001|Overall Study|Discharge from hospital|0|||
164228103|NCT01681849|593205426|FG000|Overall Study|Protocol Violation|2|||
164228104|NCT01681849|593205427|FG001|Overall Study|Protocol Violation|0|||
164228105|NCT01681849|593205428|FG002|Overall Study|Protocol Violation|0|||
164228106|NCT01681849|593205426|FG000|Overall Study|Withdrawal by Subject|3|||
164228107|NCT01681849|593205427|FG001|Overall Study|Withdrawal by Subject|5|||
164228108|NCT01681849|593205428|FG002|Overall Study|Withdrawal by Subject|33|||
164228109|NCT01681849|593205426|FG000|Overall Study|Lost to Follow-up|3|||
164228110|NCT01681849|593205427|FG001|Overall Study|Lost to Follow-up|2|||
164331099|NCT02231918|593589877|FG000|Overall Study|Adverse Event|0|||
164331100|NCT02231918|593589878|FG001|Overall Study|Adverse Event|0|||
164331101|NCT02231918|593589879|FG002|Overall Study|Adverse Event|1|||
164331102|NCT00293215|593589885|FG000|Overall Study|Progressive disease|3|||
164331103|NCT00293215|593589886|FG001|Overall Study|Progressive disease|1|||
164331104|NCT00293215|593589885|FG000|Overall Study|Adverse Event|2|||
164331105|NCT00293215|593589886|FG001|Overall Study|Adverse Event|2|||
164331106|NCT01409434|593589887|FG000|Overall Study|Protocol Violation|4|||
164331107|NCT04629508|593589891|FG000|Overall Study|Adverse Event|1|||
164331108|NCT04629508|593589891|FG000|Overall Study|Death|2|||
164331109|NCT04629508|593589891|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
164331110|NCT04073368|593589894|FG000|Overall Study|Adverse Event|2|||
164331111|NCT04073368|593589895|FG001|Overall Study|Adverse Event|0|||
164331112|NCT04073368|593589896|FG002|Overall Study|Adverse Event|1|||
164331113|NCT04073368|593589897|FG003|Overall Study|Adverse Event|1|||
164331114|NCT04073368|593589894|FG000|Overall Study|Withdrawal by Subject|2|||
164331115|NCT04073368|593589895|FG001|Overall Study|Withdrawal by Subject|2|||
164331116|NCT04073368|593589896|FG002|Overall Study|Withdrawal by Subject|1|||
164331117|NCT04073368|593589897|FG003|Overall Study|Withdrawal by Subject|1|||
164331118|NCT04073368|593589894|FG000|Overall Study|Lost to Follow-up|1|||
164331119|NCT04073368|593589895|FG001|Overall Study|Lost to Follow-up|1|||
164331120|NCT04073368|593589896|FG002|Overall Study|Lost to Follow-up|1|||
164331121|NCT04073368|593589897|FG003|Overall Study|Lost to Follow-up|0|||
164331122|NCT04073368|593589894|FG000|Overall Study|Protocol Violation|0|||
164331123|NCT04073368|593589895|FG001|Overall Study|Protocol Violation|1|||
164331124|NCT04073368|593589896|FG002|Overall Study|Protocol Violation|0|||
164331125|NCT04073368|593589897|FG003|Overall Study|Protocol Violation|0|||
164331126|NCT04073368|593589894|FG000|Overall Study|Subject noncompliance|7|||
164331127|NCT04073368|593589895|FG001|Overall Study|Subject noncompliance|4|||
164331128|NCT04073368|593589896|FG002|Overall Study|Subject noncompliance|0|||
164331129|NCT04073368|593589897|FG003|Overall Study|Subject noncompliance|0|||
164331130|NCT03026088|593589898|FG000|Overall Study|Study termination|20|||
164331131|NCT00761579|593589899|FG000|Overall Study|Adverse Event|10|||
164331132|NCT00761579|593589899|FG000|Overall Study|Death|2|||
164331133|NCT00761579|593589899|FG000|Overall Study|Lack of Efficacy|21|||
164331134|NCT00761579|593589899|FG000|Overall Study|Lost to Follow-up|16|||
164331135|NCT00761579|593589899|FG000|Overall Study|Pregnancy|1|||
164331136|NCT00761579|593589899|FG000|Overall Study|Withdrawal by Subject|34|||
164331137|NCT00761579|593589899|FG000|Overall Study|Lack of compliance|2|||
164331138|NCT00761579|593589899|FG000|Overall Study|Protocol deviation|1|||
164331139|NCT00761579|593589899|FG000|Overall Study|Drug overdose|1|||
164331140|NCT00761579|593589899|FG000|Overall Study|Aggravation of depression|1|||
164331141|NCT00761579|593589899|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
164331142|NCT00761579|593589899|FG000|Overall Study|Lost survey form|1|||
164331143|NCT00761579|593589899|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
164331144|NCT00950911|593589900|FG000|Overall Study|Adverse Event|0|||
164331145|NCT00950911|593589901|FG001|Overall Study|Adverse Event|2|||
164331146|NCT00950911|593589900|FG000|Overall Study|Death|4|||
164331147|NCT00950911|593589901|FG001|Overall Study|Death|6|||
164331148|NCT00950911|593589900|FG000|Overall Study|Disease progression|2|||
164331149|NCT00950911|593589901|FG001|Overall Study|Disease progression|2|||
164331150|NCT00950911|593589900|FG000|Overall Study|Consent withdrawn|1|||
164331151|NCT00950911|593589901|FG001|Overall Study|Consent withdrawn|3|||
164331152|NCT00950911|593589900|FG000|Overall Study|Administrative decision|3|||
164571765|NCT01870739|594458373|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
164331153|NCT00950911|593589901|FG001|Overall Study|Administrative decision|1|||
164331154|NCT00950911|593589900|FG000|Overall Study|Ineligibility determined|1|||
164331155|NCT00950911|593589901|FG001|Overall Study|Ineligibility determined|0|||
164228111|NCT01681849|593205428|FG002|Overall Study|Lost to Follow-up|6|||
164228112|NCT04525183|593205431|FG000|Overall Study|Withdrawal by Subject|0|||
164228113|NCT04525183|593205432|FG001|Overall Study|Withdrawal by Subject|0|||
164331156|NCT00950911|593589900|FG000|Overall Study|Noncompliance|1|||
164331157|NCT00950911|593589901|FG001|Overall Study|Noncompliance|0|||
164331158|NCT00950911|593589900|FG000|Overall Study|Poor performance status|0|||
164331159|NCT00950911|593589901|FG001|Overall Study|Poor performance status|1|||
164331160|NCT02063880|593589902|FG000|Overall Study|Death|21|||
164331161|NCT02063880|593589903|FG001|Overall Study|Death|18|||
164421170|NCT03660943|593912617|FG001|Overall Study|Protocol Violation|5|||
164331162|NCT02063880|593589902|FG000|Overall Study|Lost to Follow-up|7|||
164331163|NCT02063880|593589903|FG001|Overall Study|Lost to Follow-up|7|||
164331164|NCT02063880|593589902|FG000|Overall Study|Ineligible|0|||
164331165|NCT02063880|593589903|FG001|Overall Study|Ineligible|2|||
164331166|NCT02600351|593589904|FG000|Overall Study|Lack of Efficacy|3|||
164331167|NCT02600351|593589905|FG001|Overall Study|Lack of Efficacy|0|||
164331168|NCT02600351|593589906|FG002|Overall Study|Lack of Efficacy|5|||
164331169|NCT02600351|593589907|FG003|Overall Study|Lack of Efficacy|2|||
164331170|NCT02600351|593589904|FG000|Overall Study|Lost to Follow-up|1|||
164331171|NCT02600351|593589905|FG001|Overall Study|Lost to Follow-up|0|||
164331172|NCT02600351|593589906|FG002|Overall Study|Lost to Follow-up|0|||
164331173|NCT02600351|593589907|FG003|Overall Study|Lost to Follow-up|0|||
164331174|NCT02600351|593589904|FG000|Overall Study|Randomized but Not Treated|1|||
164331175|NCT02600351|593589905|FG001|Overall Study|Randomized but Not Treated|0|||
164331176|NCT02600351|593589906|FG002|Overall Study|Randomized but Not Treated|1|||
164331177|NCT02600351|593589907|FG003|Overall Study|Randomized but Not Treated|3|||
164331178|NCT00567593|593589910|FG000|Overall Study|Adverse Event|1|||
164331179|NCT00567593|593589910|FG000|Overall Study|Physician Decision|1|||
164331180|NCT02106910|593589911|FG000|Overall Study|Lost to Follow-up|1|||
164331181|NCT02106910|593589912|FG001|Overall Study|Lost to Follow-up|1|||
164331182|NCT04087213|593589913|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
164331183|NCT04087213|593589913|FG000|In-Facility Introduction|Adverse Event|1|||
164331184|NCT04087213|593589913|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
164331185|NCT04087213|593589913|FG000|Assisted Evaluable Period|Personal reasons|3|||
164331186|NCT04087213|593589913|FG000|Transition Period B|Renal Transplantation|1|||
164331187|NCT01272661|593589916|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
164331188|NCT01272661|593589917|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
164331189|NCT01272661|593589918|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
164331190|NCT01086423|593589919|FG000|Overall Study|Protocol Violation|0|||
164331191|NCT01086423|593589920|FG001|Overall Study|Protocol Violation|0|||
164331192|NCT01086423|593589921|FG002|Overall Study|Protocol Violation|1|||
164331193|NCT01086423|593589919|FG000|Overall Study|Migrated/moved from study area|2|||
164331194|NCT01086423|593589920|FG001|Overall Study|Migrated/moved from study area|0|||
164331195|NCT01086423|593589921|FG002|Overall Study|Migrated/moved from study area|4|||
164331196|NCT01086423|593589919|FG000|Overall Study|Adverse event, fatal|1|||
164331197|NCT01086423|593589920|FG001|Overall Study|Adverse event, fatal|1|||
164331198|NCT01086423|593589921|FG002|Overall Study|Adverse event, fatal|0|||
164331199|NCT01086423|593589919|FG000|Overall Study|Adverse event, non-fatal|2|||
164331200|NCT01086423|593589920|FG001|Overall Study|Adverse event, non-fatal|1|||
164331201|NCT01086423|593589921|FG002|Overall Study|Adverse event, non-fatal|0|||
164331202|NCT01086423|593589919|FG000|Overall Study|Withdrawal by Subject|5|||
164331203|NCT01086423|593589920|FG001|Overall Study|Withdrawal by Subject|1|||
164331204|NCT01086423|593589921|FG002|Overall Study|Withdrawal by Subject|3|||
164331205|NCT01086423|593589919|FG000|Overall Study|Lost to Follow-up|0|||
164331206|NCT01086423|593589920|FG001|Overall Study|Lost to Follow-up|0|||
164331207|NCT01086423|593589921|FG002|Overall Study|Lost to Follow-up|1|||
164331208|NCT02057393|593589922|FG000|Overall Study|Withdrawal by Subject|1|||
164331209|NCT02057393|593589922|FG000|Overall Study|Patient did not meet criteria|1|||
164331210|NCT02652767|593589923|FG000|Overall Study|Death|2|||
164331211|NCT02652767|593589923|FG000|Overall Study|Lost to Follow-up|1|||
164331212|NCT02652767|593589923|FG000|Overall Study|Withdrawal by Subject|1|||
164331213|NCT01130103|593589924|FG000|Randomized Treatment|Adverse Event|1|||
164331214|NCT01130103|593589925|FG001|Randomized Treatment|Adverse Event|1|||
164331215|NCT01130103|593589924|FG000|Randomized Treatment|Lost to Follow-up|1|||
164331216|NCT01130103|593589925|FG001|Randomized Treatment|Lost to Follow-up|0|||
164331217|NCT01130103|593589924|FG000|Randomized Treatment|Protocol Violation|3|||
164331218|NCT01130103|593589925|FG001|Randomized Treatment|Protocol Violation|2|||
164331219|NCT01130103|593589924|FG000|Randomized Treatment|Withdrawal by Subject|1|||
164331220|NCT01130103|593589925|FG001|Randomized Treatment|Withdrawal by Subject|2|||
164331221|NCT01130103|593589924|FG000|Maintenance Treatment|Lack of Efficacy|0|||
164331222|NCT01130103|593589925|FG001|Maintenance Treatment|Lack of Efficacy|1|||
164331223|NCT01130103|593589924|FG000|Maintenance Treatment|Lost to Follow-up|1|||
164331224|NCT01130103|593589925|FG001|Maintenance Treatment|Lost to Follow-up|1|||
164331225|NCT01130103|593589924|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
164331226|NCT01130103|593589925|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
164331227|NCT01028378|593589926|FG000|Overall Study|Lost to Follow-up|12|||
164331228|NCT01028378|593589926|FG000|Overall Study|Withdrawal by Subject|1|||
164331229|NCT01028378|593589926|FG000|Overall Study|Adminstrative Reasons|4|||
164331230|NCT00450385|593589927|FG000|Overall Study|Death|3|||
164331231|NCT00450385|593589927|FG000|Overall Study|Protocol Violation|1|||
164331232|NCT00450385|593589927|FG000|Overall Study|Withdrawal by Subject|2|||
164421171|NCT03660943|593912616|FG000|Overall Study|Withdrawal by Subject|8|||
164331233|NCT00450385|593589927|FG000|Overall Study|Lack of Efficacy|2|||
164331234|NCT00450385|593589927|FG000|Overall Study|Adverse Event|1|||
164331235|NCT00450385|593589927|FG000|Overall Study|Physician Decision|1|||
164331236|NCT00450385|593589927|FG000|Overall Study|Other|3|||
164228114|NCT04525183|593205433|FG002|Overall Study|Withdrawal by Subject|3|||
164228115|NCT04525183|593205431|FG000|Overall Study|Study non-compliance|0|||
164228116|NCT04525183|593205432|FG001|Overall Study|Study non-compliance|0|||
164228117|NCT04525183|593205433|FG002|Overall Study|Study non-compliance|1|||
164228118|NCT04525183|593205431|FG000|Overall Study|Recurrent disease before starting on study|0|||
164228119|NCT04525183|593205432|FG001|Overall Study|Recurrent disease before starting on study|0|||
164228120|NCT04525183|593205433|FG002|Overall Study|Recurrent disease before starting on study|1|||
164228121|NCT00803049|593205434|FG000|Overall Study|Adverse Event|21|||
164228122|NCT00803049|593205435|FG001|Overall Study|Adverse Event|33|||
164228123|NCT00803049|593205436|FG002|Overall Study|Adverse Event|13|||
164228124|NCT00803049|593205437|FG003|Overall Study|Adverse Event|27|||
164228125|NCT00803049|593205434|FG000|Overall Study|Lack of Efficacy|10|||
164228126|NCT00803049|593205435|FG001|Overall Study|Lack of Efficacy|19|||
164228127|NCT00803049|593205436|FG002|Overall Study|Lack of Efficacy|6|||
164228128|NCT00803049|593205437|FG003|Overall Study|Lack of Efficacy|13|||
164228129|NCT00803049|593205434|FG000|Overall Study|Lost to Follow-up|0|||
164228130|NCT00803049|593205435|FG001|Overall Study|Lost to Follow-up|2|||
164228131|NCT00803049|593205436|FG002|Overall Study|Lost to Follow-up|0|||
164421172|NCT03660943|593912617|FG001|Overall Study|Withdrawal by Subject|15|||
164421173|NCT03660943|593912616|FG000|Overall Study|Lack of Efficacy|9|||
164421174|NCT03660943|593912617|FG001|Overall Study|Lack of Efficacy|12|||
164228132|NCT00803049|593205437|FG003|Overall Study|Lost to Follow-up|3|||
164228133|NCT00803049|593205434|FG000|Overall Study|Death|2|||
164228134|NCT00803049|593205435|FG001|Overall Study|Death|1|||
164228135|NCT00803049|593205436|FG002|Overall Study|Death|0|||
164228136|NCT00803049|593205437|FG003|Overall Study|Death|2|||
164228137|NCT00803049|593205434|FG000|Overall Study|Progressive Disease|6|||
164228138|NCT00803049|593205435|FG001|Overall Study|Progressive Disease|10|||
164228139|NCT00803049|593205436|FG002|Overall Study|Progressive Disease|6|||
164228140|NCT00803049|593205437|FG003|Overall Study|Progressive Disease|6|||
164228141|NCT00803049|593205434|FG000|Overall Study|Withdrawal by Subject|19|||
164228142|NCT00803049|593205435|FG001|Overall Study|Withdrawal by Subject|43|||
164228143|NCT00803049|593205436|FG002|Overall Study|Withdrawal by Subject|16|||
164228144|NCT00803049|593205437|FG003|Overall Study|Withdrawal by Subject|44|||
164228145|NCT00803049|593205434|FG000|Overall Study|Protocol Violation|0|||
164228146|NCT00803049|593205435|FG001|Overall Study|Protocol Violation|1|||
164228147|NCT00803049|593205436|FG002|Overall Study|Protocol Violation|1|||
164228148|NCT00803049|593205437|FG003|Overall Study|Protocol Violation|0|||
164228149|NCT00803049|593205434|FG000|Overall Study|Randomized and Not Treated|0|||
164228150|NCT00803049|593205435|FG001|Overall Study|Randomized and Not Treated|0|||
164228151|NCT00803049|593205436|FG002|Overall Study|Randomized and Not Treated|0|||
164228152|NCT00803049|593205437|FG003|Overall Study|Randomized and Not Treated|2|||
164228153|NCT00803049|593205434|FG000|Overall Study|Other than Specified Above|3|||
164228154|NCT00803049|593205435|FG001|Overall Study|Other than Specified Above|9|||
164228155|NCT00803049|593205436|FG002|Overall Study|Other than Specified Above|2|||
164228156|NCT00803049|593205437|FG003|Overall Study|Other than Specified Above|5|||
164228157|NCT01272219|593205438|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
164228158|NCT01272219|593205439|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
164228159|NCT01272219|593205440|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
164228160|NCT01272219|593205441|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
164228161|NCT01272219|593205442|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
164228162|NCT01272219|593205443|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
164228163|NCT01272219|593205438|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
164228164|NCT01272219|593205439|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
164228165|NCT01272219|593205440|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
164228166|NCT01272219|593205441|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
164228167|NCT01272219|593205442|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
164228168|NCT01272219|593205443|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
164228169|NCT01272219|593205438|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
164228170|NCT01272219|593205439|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
164228171|NCT01272219|593205440|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
164228172|NCT01272219|593205441|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
164228173|NCT01272219|593205442|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
164228174|NCT01272219|593205443|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
164228175|NCT01272219|593205438|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
164228176|NCT01272219|593205439|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
164228177|NCT01272219|593205440|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
164228178|NCT01272219|593205441|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
164228179|NCT01272219|593205442|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
164228180|NCT01272219|593205443|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
164228181|NCT01272219|593205438|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
164228182|NCT01272219|593205439|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
164228183|NCT01272219|593205440|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
164228184|NCT01272219|593205441|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
164228185|NCT01272219|593205442|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
164228186|NCT01272219|593205443|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
164228187|NCT01272219|593205438|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
164228188|NCT01272219|593205439|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
164228189|NCT01272219|593205440|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
164228190|NCT01272219|593205441|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
164228191|NCT01272219|593205442|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
164228192|NCT01272219|593205443|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
164228193|NCT01272219|593205438|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
164228194|NCT01272219|593205439|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
164228195|NCT01272219|593205440|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
164228196|NCT01272219|593205441|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
164331237|NCT00471146|593589928|FG000|Overall Study|Adverse Event|32|||
164331238|NCT00471146|593589929|FG001|Overall Study|Adverse Event|33|||
164331239|NCT00471146|593589928|FG000|Overall Study|Withdrawal by Subject|14|||
164331240|NCT00471146|593589929|FG001|Overall Study|Withdrawal by Subject|11|||
164331241|NCT00471146|593589928|FG000|Overall Study|Death|11|||
164331242|NCT00471146|593589929|FG001|Overall Study|Death|12|||
164331243|NCT00471146|593589928|FG000|Overall Study|Lost to Follow-up|4|||
164331244|NCT00471146|593589929|FG001|Overall Study|Lost to Follow-up|2|||
164331245|NCT00471146|593589928|FG000|Overall Study|Protocol Violation|2|||
164331246|NCT00471146|593589929|FG001|Overall Study|Protocol Violation|2|||
164331247|NCT00471146|593589928|FG000|Overall Study|Objective progression or relapse|84|||
164421175|NCT03660943|593912616|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
164331248|NCT00471146|593589929|FG001|Overall Study|Objective progression or relapse|87|||
164331249|NCT00471146|593589928|FG000|Overall Study|Global deterioration of health status|12|||
164331250|NCT00471146|593589929|FG001|Overall Study|Global deterioration of health status|14|||
164331251|NCT00471146|593589928|FG000|Overall Study|Randomized but not treated|9|||
164331252|NCT00471146|593589929|FG001|Overall Study|Randomized but not treated|8|||
164421176|NCT03660943|593912617|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
164421177|NCT00867490|593912618|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
164421178|NCT00867490|593912618|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
164421179|NCT00867490|593912618|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
164421180|NCT00867490|593912618|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
164421181|NCT00867490|593912618|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
164421182|NCT02086552|593912621|FG000|Overall Study|Withdrawal by Subject|1|||
164421183|NCT02406261|593912622|FG000|Period 1|Lost to Follow-up|2|||
164421184|NCT02406261|593912623|FG001|Period 1|Lost to Follow-up|0|||
164421185|NCT02406261|593912622|FG000|Period 1|Adverse Event|1|||
164421186|NCT02406261|593912623|FG001|Period 1|Adverse Event|0|||
164421187|NCT02406261|593912622|FG000|Period 2|Physician Decision|0|||
164421188|NCT02406261|593912623|FG001|Period 2|Physician Decision|1|||
164421189|NCT02406261|593912622|FG000|Period 2|Protocol Violation|0|||
164421190|NCT02406261|593912623|FG001|Period 2|Protocol Violation|1|||
164421191|NCT02406261|593912622|FG000|Period 2|Withdrawal by Subject|0|||
164421192|NCT02406261|593912623|FG001|Period 2|Withdrawal by Subject|1|||
164421193|NCT01567163|593912624|FG000|Overall Study|Progressive Disease|2|||
164421194|NCT01567163|593912624|FG000|Overall Study|Lost to Follow-up|2|||
164421195|NCT01734850|593912625|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
164421196|NCT01734850|593912626|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
164421197|NCT01734850|593912627|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
164421198|NCT01734850|593912625|FG000|Overall Study|Not infused due to manufacturing failure|0|||
164421199|NCT01734850|593912626|FG001|Overall Study|Not infused due to manufacturing failure|0|||
164421200|NCT01734850|593912627|FG002|Overall Study|Not infused due to manufacturing failure|1|||
164421201|NCT03824938|593912628|FG000|Overall Study|Withdrawal by Subject|2|||
164421202|NCT03824938|593912629|FG001|Overall Study|Withdrawal by Subject|1|||
164421203|NCT03824938|593912630|FG002|Overall Study|Withdrawal by Subject|0|||
164421204|NCT03824938|593912631|FG003|Overall Study|Withdrawal by Subject|2|||
164421205|NCT03824938|593912632|FG004|Overall Study|Withdrawal by Subject|0|||
164421206|NCT03824938|593912633|FG005|Overall Study|Withdrawal by Subject|1|||
164421207|NCT03824938|593912628|FG000|Overall Study|Lost to Follow-up|0|||
164421208|NCT03824938|593912629|FG001|Overall Study|Lost to Follow-up|1|||
164228197|NCT01272219|593205442|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
164331253|NCT00471146|593589928|FG000|Overall Study|Other|4|||
164331254|NCT00471146|593589929|FG001|Overall Study|Other|5|||
164331255|NCT00467610|593589932|FG000|Overall Study|Withdrawal by Subject|1|||
164331256|NCT02676466|593589933|FG000|Overall Study|Death|0|||
164421209|NCT03824938|593912630|FG002|Overall Study|Lost to Follow-up|0|||
164421210|NCT03824938|593912631|FG003|Overall Study|Lost to Follow-up|0|||
164421211|NCT03824938|593912632|FG004|Overall Study|Lost to Follow-up|1|||
164421212|NCT03824938|593912633|FG005|Overall Study|Lost to Follow-up|0|||
164421213|NCT00393094|593912640|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
164421214|NCT00393094|593912640|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
164228198|NCT01272219|593205443|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
164228199|NCT01272219|593205438|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
164228200|NCT01272219|593205439|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
164228201|NCT01272219|593205440|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
164228202|NCT01272219|593205441|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
164228203|NCT01272219|593205442|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
164228204|NCT01272219|593205443|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
164228205|NCT01272219|593205438|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
164228206|NCT01272219|593205439|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
164228207|NCT01272219|593205440|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
164228208|NCT01272219|593205441|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
164228209|NCT01272219|593205442|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
164228210|NCT01272219|593205443|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
164228211|NCT01272219|593205438|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
164228212|NCT01272219|593205439|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
164228213|NCT01272219|593205440|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
164228214|NCT01272219|593205441|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
164228215|NCT01272219|593205442|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
164228216|NCT01272219|593205443|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
164228217|NCT01272219|593205438|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
164228218|NCT01272219|593205439|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
164228219|NCT01272219|593205440|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
164228220|NCT01272219|593205441|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
164228221|NCT01272219|593205442|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
164228222|NCT01272219|593205443|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
164228223|NCT01272219|593205438|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
164228224|NCT01272219|593205439|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
164228225|NCT01272219|593205440|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
164228226|NCT01272219|593205441|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
164228227|NCT01272219|593205442|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
164228228|NCT01272219|593205443|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
164228229|NCT01272219|593205438|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
164228230|NCT01272219|593205439|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
164228231|NCT01272219|593205440|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
164228232|NCT01272219|593205441|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
164228233|NCT01272219|593205442|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
164228234|NCT01272219|593205443|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
164228235|NCT01272219|593205438|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
164228236|NCT01272219|593205439|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
164228237|NCT01272219|593205440|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
164228238|NCT01272219|593205441|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
164228239|NCT01272219|593205442|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
164228240|NCT01272219|593205443|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
164228241|NCT01272219|593205438|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
164228242|NCT01272219|593205439|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
164228243|NCT01272219|593205440|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
164228244|NCT01272219|593205441|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
164228245|NCT01272219|593205442|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
164228246|NCT01272219|593205443|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
164228247|NCT01272219|593205438|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
164228248|NCT01272219|593205439|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
164228249|NCT01272219|593205440|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
164228250|NCT01272219|593205441|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
164228251|NCT01272219|593205442|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
164228252|NCT01272219|593205443|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
164228253|NCT05305651|593205444|FG000|Overall Study|Death|1|||
164228254|NCT05305651|593205444|FG000|Overall Study|Withdrawal by Subject|4|||
164228255|NCT05305651|593205444|FG000|Overall Study|Lost to Follow-up|4|||
164421215|NCT02019602|593912641|FG000|Screening Period|Ineligibility|4|||
164421216|NCT02019602|593912642|FG001|Screening Period|Ineligibility|0|||
164421217|NCT02019602|593912641|FG000|Screening Period|Adverse Event|1|||
164228256|NCT05021224|593205451|FG000|Overall Study|Did not complete all survey items|4|||
164421218|NCT02019602|593912642|FG001|Screening Period|Adverse Event|0|||
164228257|NCT05021224|593205452|FG001|Overall Study|Did not complete all survey items|1|||
164228258|NCT05021224|593205453|FG002|Overall Study|Did not complete all survey items|0|||
164228259|NCT05021224|593205454|FG003|Overall Study|Did not complete all survey items|2|||
164421219|NCT03653416|593912645|FG000|Overall Study|Protocol Violation|6|||
164228260|NCT03996395|593205455|FG000|Overall Study|Lost to Follow-up|4|||
164228261|NCT03996395|593205455|FG000|Overall Study|Withdrawal by Subject|1|||
164228262|NCT03996395|593205455|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
164228263|NCT05375929|593205458|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
164228264|NCT05375929|593205459|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
164228265|NCT05375929|593205460|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
164228266|NCT05375929|593205461|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
164228267|NCT05375929|593205458|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
164228268|NCT05375929|593205459|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
164228269|NCT05375929|593205460|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
164228270|NCT05375929|593205461|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
164228271|NCT05375929|593205458|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
164228272|NCT05375929|593205459|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
164228273|NCT05375929|593205460|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
164228274|NCT05375929|593205461|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
164228275|NCT05375929|593205458|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
164228276|NCT05375929|593205459|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
164228277|NCT05375929|593205460|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
164228278|NCT05375929|593205461|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
164228279|NCT05375929|593205458|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
164228280|NCT05375929|593205459|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
164228281|NCT05375929|593205460|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
164228282|NCT05375929|593205461|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
164228283|NCT05375929|593205458|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
164228284|NCT05375929|593205459|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
164228285|NCT05375929|593205460|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
164228286|NCT05375929|593205461|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
164228287|NCT05375929|593205458|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
164228288|NCT05375929|593205459|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
164228289|NCT05375929|593205460|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
164228290|NCT05375929|593205461|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
164228291|NCT05375929|593205458|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
164228292|NCT05375929|593205459|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
164228293|NCT05375929|593205460|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
164228294|NCT05375929|593205461|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
164228295|NCT05375929|593205458|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
164228296|NCT05375929|593205459|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
164228297|NCT05375929|593205460|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
164228298|NCT05375929|593205461|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
164228299|NCT05375929|593205458|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
164228300|NCT05375929|593205459|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
164228301|NCT05375929|593205460|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
164228302|NCT05375929|593205461|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
164228303|NCT03973489|593205467|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
164228304|NCT03973489|593205468|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
164228305|NCT03973489|593205469|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
164228306|NCT03973489|593205470|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
164228307|NCT03973489|593205471|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
164228308|NCT03973489|593205472|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
164228309|NCT03973489|593205473|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
164228310|NCT03973489|593205474|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
164228311|NCT03973489|593205467|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
164228312|NCT03973489|593205468|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
164228313|NCT03973489|593205469|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
164228314|NCT03973489|593205470|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
164228315|NCT03973489|593205471|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
164228316|NCT03973489|593205472|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
164228317|NCT03973489|593205473|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
164228318|NCT03973489|593205474|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
164228319|NCT03973489|593205467|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
164228320|NCT03973489|593205468|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
164228321|NCT03973489|593205469|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
164228322|NCT03973489|593205470|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
164228323|NCT03973489|593205471|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
164228324|NCT03973489|593205472|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
164421220|NCT03653416|593912646|FG001|Overall Study|Protocol Violation|1|||
164421221|NCT03207711|593912647|FG000|Overall Study|Withdrawal by Subject|1|||
164421222|NCT03207711|593912648|FG001|Overall Study|Withdrawal by Subject|2|||
164421223|NCT02372058|593912651|FG000|Overall Study|Withdrawal by Subject|3|||
164421224|NCT02788006|593912655|FG000|Overall Study|Patient not treated|1|||
164421225|NCT00318149|593912656|FG000|Overall Study|Adverse Event|0|||
164421226|NCT00318149|593912657|FG001|Overall Study|Adverse Event|0|||
164421227|NCT00318149|593912658|FG002|Overall Study|Adverse Event|0|||
164421228|NCT00318149|593912659|FG003|Overall Study|Adverse Event|0|||
164421229|NCT00318149|593912660|FG004|Overall Study|Adverse Event|0|||
164421230|NCT00318149|593912661|FG005|Overall Study|Adverse Event|2|||
164421231|NCT03541642|593912664|FG000|Overall Study|Withdrawal by Subject|1|||
164421232|NCT03541642|593912665|FG001|Overall Study|Withdrawal by Subject|2|||
164421233|NCT03541642|593912664|FG000|Overall Study|Lost to Follow-up|16|||
164571766|NCT01870739|594458372|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
164571767|NCT01870739|594458373|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
164228325|NCT03973489|593205473|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
164228326|NCT03973489|593205474|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
164228327|NCT03973489|593205467|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
164228328|NCT03973489|593205468|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
164228329|NCT03973489|593205469|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
164228330|NCT03973489|593205470|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
164228331|NCT03973489|593205471|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
164228332|NCT03973489|593205472|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
164228333|NCT03973489|593205473|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
164228334|NCT03973489|593205474|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
164228335|NCT03973489|593205467|FG000|Second Intervention (1 Day)|Adverse Event|0|||
164228336|NCT03973489|593205468|FG001|Second Intervention (1 Day)|Adverse Event|0|||
164228337|NCT03973489|593205469|FG002|Second Intervention (1 Day)|Adverse Event|0|||
164228338|NCT03973489|593205470|FG003|Second Intervention (1 Day)|Adverse Event|1|||
164228339|NCT03973489|593205471|FG004|Second Intervention (1 Day)|Adverse Event|0|||
164228340|NCT03973489|593205472|FG005|Second Intervention (1 Day)|Adverse Event|0|||
164228341|NCT03973489|593205473|FG006|Second Intervention (1 Day)|Adverse Event|0|||
164228342|NCT03973489|593205474|FG007|Second Intervention (1 Day)|Adverse Event|0|||
164228343|NCT03301415|593205475|FG000|Overall Study|Lost to Follow-up|2|||
164228344|NCT03301415|593205475|FG000|Overall Study|Unable to comply with visit schedule|2|||
164228345|NCT00392288|593205476|FG000|Overall Study|Adverse Event|17|||
164228346|NCT00392288|593205477|FG001|Overall Study|Adverse Event|7|||
164228347|NCT00392288|593205478|FG002|Overall Study|Adverse Event|8|||
164228348|NCT00392288|593205476|FG000|Overall Study|Lack of Efficacy|8|||
164228349|NCT00392288|593205477|FG001|Overall Study|Lack of Efficacy|5|||
164228350|NCT00392288|593205478|FG002|Overall Study|Lack of Efficacy|3|||
164228351|NCT00392288|593205476|FG000|Overall Study|Protocol Violation|1|||
164228352|NCT00392288|593205477|FG001|Overall Study|Protocol Violation|3|||
164228353|NCT00392288|593205478|FG002|Overall Study|Protocol Violation|1|||
164228354|NCT00392288|593205476|FG000|Overall Study|Lost to Follow-up|1|||
164228355|NCT00392288|593205477|FG001|Overall Study|Lost to Follow-up|1|||
164228356|NCT00392288|593205478|FG002|Overall Study|Lost to Follow-up|1|||
164228357|NCT00392288|593205476|FG000|Overall Study|Withdrawal by Subject|1|||
164228358|NCT00392288|593205477|FG001|Overall Study|Withdrawal by Subject|0|||
164228359|NCT00392288|593205478|FG002|Overall Study|Withdrawal by Subject|2|||
164228360|NCT00392288|593205476|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
164228361|NCT00392288|593205477|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
164228362|NCT00392288|593205478|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
164228363|NCT00392288|593205476|FG000|Overall Study|Other|3|||
164228364|NCT00392288|593205477|FG001|Overall Study|Other|4|||
164228365|NCT00392288|593205478|FG002|Overall Study|Other|1|||
164228366|NCT02544763|593205479|FG000|Overall Study|Adverse Event|8|||
164228367|NCT02544763|593205480|FG001|Overall Study|Adverse Event|8|||
164421234|NCT03541642|593912665|FG001|Overall Study|Lost to Follow-up|12|||
164421235|NCT03541642|593912664|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
164421236|NCT03541642|593912665|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
164421237|NCT03050398|593912668|FG000|Overall Study|Study terminated by sponsor|8|||
164421238|NCT05108649|593912669|FG000|Overall Study|Lost to Follow-up|0|||
164421239|NCT05108649|593912670|FG001|Overall Study|Lost to Follow-up|4|||
164228368|NCT02544763|593205481|FG002|Overall Study|Adverse Event|0|||
164228369|NCT02544763|593205479|FG000|Overall Study|Withdrawn by parent/guardian|1|||
164228370|NCT02544763|593205480|FG001|Overall Study|Withdrawn by parent/guardian|1|||
164228371|NCT02544763|593205481|FG002|Overall Study|Withdrawn by parent/guardian|1|||
164228372|NCT02544763|593205479|FG000|Overall Study|Met withdrawal criteria|0|||
164228373|NCT02544763|593205480|FG001|Overall Study|Met withdrawal criteria|2|||
164228374|NCT02544763|593205481|FG002|Overall Study|Met withdrawal criteria|0|||
164228375|NCT02544763|593205479|FG000|Overall Study|Physician Decision|0|||
164421240|NCT05108649|593912671|FG002|Overall Study|Lost to Follow-up|3|||
164228376|NCT02544763|593205480|FG001|Overall Study|Physician Decision|1|||
164228377|NCT02544763|593205481|FG002|Overall Study|Physician Decision|0|||
164228378|NCT02544763|593205479|FG000|Overall Study|Difficulties taking IMP|1|||
164228379|NCT02544763|593205480|FG001|Overall Study|Difficulties taking IMP|0|||
164228380|NCT02544763|593205481|FG002|Overall Study|Difficulties taking IMP|0|||
164228381|NCT02097225|593205482|FG000|Dose Level 4|Adverse Event|0|||
164228382|NCT02097225|593205483|FG001|Dose Level 4|Adverse Event|0|||
164228383|NCT02097225|593205484|FG002|Dose Level 4|Adverse Event|0|||
164228384|NCT02097225|593205485|FG003|Dose Level 4|Adverse Event|0|||
164228385|NCT02097225|593205486|FG004|Dose Level 4|Adverse Event|1|||
164228386|NCT03379870|593207304|FG000|Overall Study|Lost to Follow-up|1|||
164228387|NCT03379870|593207305|FG001|Overall Study|Lost to Follow-up|0|||
164228388|NCT03379870|593207304|FG000|Overall Study|Protocol Violation|1|||
164228389|NCT03379870|593207305|FG001|Overall Study|Protocol Violation|1|||
164228390|NCT00003645|593207306|FG000|Overall Study|Death|4|||
164228391|NCT00003645|593207307|FG001|Overall Study|Death|1|||
164228392|NCT00003645|593207306|FG000|Overall Study|Lost to Follow-up|7|||
164228393|NCT00003645|593207307|FG001|Overall Study|Lost to Follow-up|8|||
164228394|NCT00003645|593207306|FG000|Overall Study|Withdrawal by Subject|1|||
164228395|NCT00003645|593207307|FG001|Overall Study|Withdrawal by Subject|3|||
164228396|NCT04101331|593207308|FG000|Overall Study|Adverse Event|9|||
164228397|NCT04101331|593207308|FG000|Overall Study|Disease progression|82|||
164228398|NCT04101331|593207308|FG000|Overall Study|Withdrawal by Subject|1|||
164228399|NCT04101331|593207308|FG000|Overall Study|Investigator decision|6|||
164228400|NCT04101331|593207308|FG000|Overall Study|Death|6|||
164228401|NCT04101331|593207308|FG000|Overall Study|Allogenic transplant|1|||
164228402|NCT04616196|593207309|FG000|Overall Study|Progressive Disease|3|||
164228403|NCT04616196|593207310|FG001|Overall Study|Progressive Disease|0|||
164228404|NCT04616196|593207311|FG002|Overall Study|Progressive Disease|4|||
164228405|NCT04616196|593207312|FG003|Overall Study|Progressive Disease|1|||
164228406|NCT04616196|593207309|FG000|Overall Study|Death|2|||
164228407|NCT04616196|593207310|FG001|Overall Study|Death|4|||
164228408|NCT04616196|593207311|FG002|Overall Study|Death|1|||
164228409|NCT04616196|593207312|FG003|Overall Study|Death|0|||
164228410|NCT04616196|593207309|FG000|Overall Study|Withdrawal by Subject|0|||
164228411|NCT04616196|593207310|FG001|Overall Study|Withdrawal by Subject|2|||
164421241|NCT05108649|593912672|FG003|Overall Study|Lost to Follow-up|6|||
164421242|NCT05108649|593912669|FG000|Overall Study|Not Interested|1|||
164675419|NCT02655679|594834961|FG001|Overall Study|Other Miscellaneous Reasons|0|||
164675420|NCT02655679|594834962|FG002|Overall Study|Other Miscellaneous Reasons|0|||
164228412|NCT04616196|593207311|FG002|Overall Study|Withdrawal by Subject|0|||
164228413|NCT04616196|593207312|FG003|Overall Study|Withdrawal by Subject|0|||
164228414|NCT04616196|593207309|FG000|Overall Study|Lost to Follow-up|1|||
164228415|NCT04616196|593207310|FG001|Overall Study|Lost to Follow-up|0|||
164228416|NCT04616196|593207311|FG002|Overall Study|Lost to Follow-up|0|||
164228417|NCT04616196|593207312|FG003|Overall Study|Lost to Follow-up|0|||
164228418|NCT04616196|593207309|FG000|Overall Study|Sponsor request|2|||
164228419|NCT04616196|593207310|FG001|Overall Study|Sponsor request|1|||
164228420|NCT04616196|593207311|FG002|Overall Study|Sponsor request|1|||
164228421|NCT04616196|593207312|FG003|Overall Study|Sponsor request|2|||
164228422|NCT03502681|593207313|FG000|Overall Study|Adverse Event|1|||
164228423|NCT03502681|593207314|FG001|Overall Study|Adverse Event|1|||
164228424|NCT03502681|593207313|FG000|Overall Study|Disease Progression|2|||
164228425|NCT03502681|593207314|FG001|Overall Study|Disease Progression|1|||
164228426|NCT02254291|593207315|FG000|Overall Study|Withdrawal by Subject|0|||
164228427|NCT02254291|593207316|FG001|Overall Study|Withdrawal by Subject|3|||
164228428|NCT02254291|593207317|FG002|Overall Study|Withdrawal by Subject|1|||
164228429|NCT02254291|593207315|FG000|Overall Study|Missing follow-up information|0|||
164228430|NCT02254291|593207316|FG001|Overall Study|Missing follow-up information|0|||
164228431|NCT02254291|593207317|FG002|Overall Study|Missing follow-up information|1|||
164228432|NCT06790303|593207320|FG000|Overall Study|Study Terminated by sponsor|4|||
164228433|NCT06790303|593207320|FG000|Overall Study|Death|4|||
164421243|NCT05108649|593912670|FG001|Overall Study|Not Interested|1|||
164675421|NCT02655679|594834963|FG003|Overall Study|Other Miscellaneous Reasons|0|||
164228434|NCT02579759|593207323|FG000|Overall Study|Protocol Violation|2|||
164228435|NCT02579759|593207324|FG001|Overall Study|Protocol Violation|0|||
164228436|NCT02579759|593207325|FG002|Overall Study|Protocol Violation|0|||
164228437|NCT02579759|593207323|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
164228438|NCT02579759|593207324|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
164228439|NCT02579759|593207325|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
164228440|NCT02579759|593207323|FG000|Overall Study|BfArM hold|13|||
164228441|NCT02579759|593207324|FG001|Overall Study|BfArM hold|12|||
164228442|NCT02579759|593207325|FG002|Overall Study|BfArM hold|12|||
164228443|NCT02579759|593207323|FG000|Overall Study|Sponsor stopped Dose 2|0|||
164228444|NCT02579759|593207324|FG001|Overall Study|Sponsor stopped Dose 2|41|||
164228445|NCT02579759|593207325|FG002|Overall Study|Sponsor stopped Dose 2|0|||
164228446|NCT02579759|593207323|FG000|Overall Study|Non compliance|0|||
164228447|NCT02579759|593207324|FG001|Overall Study|Non compliance|1|||
164228448|NCT02579759|593207325|FG002|Overall Study|Non compliance|0|||
164421244|NCT05108649|593912671|FG002|Overall Study|Not Interested|0|||
164421245|NCT05108649|593912672|FG003|Overall Study|Not Interested|1|||
164675422|NCT02655679|594834964|FG004|Overall Study|Other Miscellaneous Reasons|0|||
164675423|NCT03801707|594834965|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
164675424|NCT01754597|594834966|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
164421246|NCT05108649|593912669|FG000|Overall Study|Out of area|0|||
164421247|NCT05108649|593912670|FG001|Overall Study|Out of area|0|||
164421248|NCT05108649|593912671|FG002|Overall Study|Out of area|0|||
164421249|NCT05108649|593912672|FG003|Overall Study|Out of area|1|||
164421250|NCT05108649|593912669|FG000|Overall Study|PI decision|1|||
164421251|NCT05108649|593912670|FG001|Overall Study|PI decision|0|||
164421252|NCT05108649|593912671|FG002|Overall Study|PI decision|0|||
164675425|NCT01754597|594834967|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
164421253|NCT05108649|593912672|FG003|Overall Study|PI decision|0|||
164421254|NCT05108649|593912669|FG000|Overall Study|Significant Non-Compliance|0|||
164421255|NCT05108649|593912670|FG001|Overall Study|Significant Non-Compliance|1|||
164421256|NCT05108649|593912671|FG002|Overall Study|Significant Non-Compliance|0|||
164421257|NCT05108649|593912672|FG003|Overall Study|Significant Non-Compliance|0|||
164421258|NCT05108649|593912669|FG000|Overall Study|Unable to adhere to study protocol|0|||
164421259|NCT05108649|593912670|FG001|Overall Study|Unable to adhere to study protocol|2|||
164421260|NCT05108649|593912671|FG002|Overall Study|Unable to adhere to study protocol|0|||
164421261|NCT05108649|593912672|FG003|Overall Study|Unable to adhere to study protocol|0|||
164421262|NCT03523871|593912673|FG000|Overall Study|Death|1|||
164421263|NCT01083160|593912674|FG000|Overall Study|Adverse Event|1|||
164421264|NCT00918749|593912675|FG000|Overall Study|Adverse Event|1|||
164421265|NCT00918749|593912676|FG001|Overall Study|Adverse Event|0|||
164421266|NCT00918749|593912677|FG002|Overall Study|Adverse Event|1|||
164421267|NCT00918749|593912675|FG000|Overall Study|Lost to Follow-up|0|||
164421268|NCT00918749|593912676|FG001|Overall Study|Lost to Follow-up|0|||
164421269|NCT00918749|593912677|FG002|Overall Study|Lost to Follow-up|1|||
164421270|NCT00918749|593912675|FG000|Overall Study|Withdrawal by Subject|5|||
164421271|NCT00918749|593912676|FG001|Overall Study|Withdrawal by Subject|3|||
164421272|NCT00918749|593912677|FG002|Overall Study|Withdrawal by Subject|5|||
164421273|NCT00918749|593912675|FG000|Overall Study|No Study Medication Taken|1|||
164421274|NCT00918749|593912676|FG001|Overall Study|No Study Medication Taken|0|||
164421275|NCT00918749|593912677|FG002|Overall Study|No Study Medication Taken|0|||
164421276|NCT03055832|593912678|FG000|Week 2|Withdrawal by Subject|1|||
164421277|NCT03055832|593912679|FG001|Week 2|Withdrawal by Subject|0|||
164421278|NCT03619174|593912680|FG000|Overall Study|Lost to Follow-up|3|||
164675426|NCT00819741|594834968|FG000|Overall Study|Adverse Event|5|||
164675427|NCT00819741|594834969|FG001|Overall Study|Adverse Event|2|||
164675428|NCT00819741|594834968|FG000|Overall Study|Lack of Efficacy|0|||
164675429|NCT00819741|594834969|FG001|Overall Study|Lack of Efficacy|2|||
164675430|NCT00819741|594834968|FG000|Overall Study|Lost to Follow-up|3|||
164675431|NCT00819741|594834969|FG001|Overall Study|Lost to Follow-up|1|||
164421279|NCT03619174|593912681|FG001|Overall Study|Lost to Follow-up|0|||
164421280|NCT03619174|593912680|FG000|Overall Study|Withdrawal by Subject|4|||
164421281|NCT03619174|593912681|FG001|Overall Study|Withdrawal by Subject|3|||
164421282|NCT03619174|593912680|FG000|Overall Study|Pregnancy|1|||
164421283|NCT03619174|593912681|FG001|Overall Study|Pregnancy|1|||
164421284|NCT03619174|593912680|FG000|Overall Study|Discomfort during treatment|1|||
164421285|NCT03619174|593912681|FG001|Overall Study|Discomfort during treatment|0|||
164421286|NCT01991197|593912682|FG000|Overall Study|Lost to Follow-up|1|||
164675432|NCT00819741|594834968|FG000|Overall Study|Protocol Violation|3|||
164421287|NCT01991197|593912683|FG001|Overall Study|Lost to Follow-up|1|||
164421288|NCT01991197|593912682|FG000|Overall Study|Physician Decision|0|||
164421289|NCT01991197|593912683|FG001|Overall Study|Physician Decision|2|||
164421290|NCT01991197|593912682|FG000|Overall Study|Withdrawal by Subject|2|||
164421291|NCT01991197|593912683|FG001|Overall Study|Withdrawal by Subject|0|||
164421292|NCT01012973|593912684|FG000|Overall Study|Adverse Event|5|||
164421293|NCT01012973|593912685|FG001|Overall Study|Adverse Event|5|||
164421294|NCT01012973|593912684|FG000|Overall Study|Lack of Efficacy|0|||
164421295|NCT01012973|593912685|FG001|Overall Study|Lack of Efficacy|5|||
164421296|NCT01012973|593912684|FG000|Overall Study|Lost to Follow-up|1|||
164421297|NCT01012973|593912685|FG001|Overall Study|Lost to Follow-up|0|||
164228449|NCT02579759|593207323|FG000|Overall Study|Pregnancy|0|||
164421298|NCT01012973|593912684|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
164675433|NCT00819741|594834969|FG001|Overall Study|Protocol Violation|4|||
164675434|NCT00819741|594834968|FG000|Overall Study|Withdrawal by Subject|2|||
164675435|NCT00819741|594834969|FG001|Overall Study|Withdrawal by Subject|2|||
164421299|NCT01012973|593912685|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
164228450|NCT02579759|593207324|FG001|Overall Study|Pregnancy|1|||
164421300|NCT01012973|593912684|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
164421301|NCT01012973|593912685|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
164421302|NCT01012973|593912684|FG000|Overall Study|Protocol Violation|5|||
164421303|NCT01012973|593912685|FG001|Overall Study|Protocol Violation|2|||
164421304|NCT01012973|593912684|FG000|Overall Study|Withdrawal by Subject|4|||
164421305|NCT01012973|593912685|FG001|Overall Study|Withdrawal by Subject|6|||
164421306|NCT01932996|593912686|FG000|Overall Study|Protocol Violation|2|||
164421307|NCT01932996|593912687|FG001|Overall Study|Protocol Violation|0|||
164421308|NCT00846742|593912690|FG000|Overall Study|Withdrawal by Subject|1|||
164228451|NCT02579759|593207325|FG002|Overall Study|Pregnancy|0|||
164228452|NCT02579759|593207323|FG000|Overall Study|Inclusion/exclusion criteria|0|||
164228453|NCT02579759|593207324|FG001|Overall Study|Inclusion/exclusion criteria|0|||
164228454|NCT02579759|593207325|FG002|Overall Study|Inclusion/exclusion criteria|1|||
164228455|NCT02579759|593207323|FG000|Overall Study|Adverse Event|4|||
164228456|NCT02579759|593207324|FG001|Overall Study|Adverse Event|3|||
164228457|NCT02579759|593207325|FG002|Overall Study|Adverse Event|1|||
164228458|NCT02579759|593207323|FG000|Overall Study|Withdrawal by Subject|3|||
164228459|NCT02579759|593207324|FG001|Overall Study|Withdrawal by Subject|3|||
164228460|NCT02579759|593207325|FG002|Overall Study|Withdrawal by Subject|5|||
164228461|NCT02579759|593207323|FG000|Overall Study|Lost to Follow-up|2|||
164228462|NCT02579759|593207324|FG001|Overall Study|Lost to Follow-up|2|||
164228463|NCT02579759|593207325|FG002|Overall Study|Lost to Follow-up|2|||
164228464|NCT03436732|593207326|FG000|Overall Study|Not treated-enrolled in different study|1|||
164228465|NCT03436732|593207327|FG001|Overall Study|Not treated-enrolled in different study|0|||
164228466|NCT03436732|593207326|FG000|Overall Study|Off study after cycle 1|1|||
164228467|NCT03436732|593207327|FG001|Overall Study|Off study after cycle 1|0|||
164228468|NCT03436732|593207326|FG000|Overall Study|Adverse Event|2|||
164228469|NCT03436732|593207327|FG001|Overall Study|Adverse Event|0|||
164228470|NCT03436732|593207326|FG000|Overall Study|Death|0|||
164228471|NCT03436732|593207327|FG001|Overall Study|Death|1|||
164228472|NCT02014467|593207330|FG000|Overall Study|Adverse Event|4|||
164228473|NCT02014467|593207331|FG001|Overall Study|Adverse Event|0|||
164228474|NCT02014467|593207330|FG000|Overall Study|Protocol Violation|3|||
164228475|NCT02014467|593207331|FG001|Overall Study|Protocol Violation|0|||
164331257|NCT02676466|593589934|FG001|Overall Study|Death|2|||
164331258|NCT02676466|593589935|FG002|Overall Study|Death|1|||
164331259|NCT02676466|593589936|FG003|Overall Study|Death|0|||
164331260|NCT02676466|593589937|FG004|Overall Study|Death|0|||
164331261|NCT02676466|593589938|FG005|Overall Study|Death|0|||
164421309|NCT01435798|593912695|FG000|Overall Study|Withdrawal by Subject|1|||
164331262|NCT02676466|593589939|FG006|Overall Study|Death|0|||
164331263|NCT02676466|593589940|FG007|Overall Study|Death|0|||
164331264|NCT02676466|593589933|FG000|Overall Study|Withdrawal by Subject|4|||
164331265|NCT02676466|593589934|FG001|Overall Study|Withdrawal by Subject|3|||
164331266|NCT02676466|593589935|FG002|Overall Study|Withdrawal by Subject|1|||
164331267|NCT02676466|593589936|FG003|Overall Study|Withdrawal by Subject|0|||
164331268|NCT02676466|593589937|FG004|Overall Study|Withdrawal by Subject|3|||
164331269|NCT02676466|593589938|FG005|Overall Study|Withdrawal by Subject|1|||
164331270|NCT02676466|593589939|FG006|Overall Study|Withdrawal by Subject|1|||
164331271|NCT02676466|593589940|FG007|Overall Study|Withdrawal by Subject|1|||
164331272|NCT02001181|593589942|FG000|Overall Study|Adverse Event|0|||
164331273|NCT02001181|593589943|FG001|Overall Study|Adverse Event|2|||
164331274|NCT02001181|593589942|FG000|Overall Study|Lost to Follow-up|1|||
164331275|NCT02001181|593589943|FG001|Overall Study|Lost to Follow-up|0|||
164331276|NCT02001181|593589942|FG000|Overall Study|Withdrawal by Subject|0|||
164331277|NCT02001181|593589943|FG001|Overall Study|Withdrawal by Subject|1|||
164331278|NCT02436681|593589945|FG000|Overall Study|Lost to Follow-up|10|||
164331279|NCT02436681|593589945|FG000|Overall Study|Withdrawal by Subject|2|||
164331280|NCT02436681|593589945|FG000|Overall Study|Death|2|||
164331281|NCT00739596|593589946|FG000|Overall Study|Adverse Event|12|||
164331282|NCT00739596|593589947|FG001|Overall Study|Adverse Event|6|||
164331283|NCT00739596|593589946|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
164421310|NCT03257995|593912699|FG000|Overall Study|Adverse Event|0|||
164421311|NCT03257995|593912700|FG001|Overall Study|Adverse Event|1|||
164675436|NCT00819741|594834968|FG000|Overall Study|Unclassified|6|||
164228476|NCT02014467|593207330|FG000|Overall Study|Physician Decision|2|||
164228477|NCT02014467|593207331|FG001|Overall Study|Physician Decision|3|||
164228478|NCT02014467|593207330|FG000|Overall Study|Withdrawal by Subject|16|||
164228479|NCT02014467|593207331|FG001|Overall Study|Withdrawal by Subject|4|||
164228480|NCT01217892|593207333|FG000|Overall Study|Adverse Event|1|||
164228481|NCT01217892|593207334|FG001|Overall Study|Adverse Event|1|||
164228482|NCT01217892|593207335|FG002|Overall Study|Adverse Event|1|||
164228483|NCT01217892|593207336|FG003|Overall Study|Adverse Event|0|||
164228484|NCT01217892|593207333|FG000|Overall Study|Withdrawal by Subject|0|||
164228485|NCT01217892|593207334|FG001|Overall Study|Withdrawal by Subject|2|||
164228486|NCT01217892|593207335|FG002|Overall Study|Withdrawal by Subject|1|||
164331284|NCT00739596|593589947|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
164331285|NCT00739596|593589946|FG000|Overall Study|Patient Withdrew Consent|8|||
164331286|NCT00739596|593589947|FG001|Overall Study|Patient Withdrew Consent|8|||
164331287|NCT00739596|593589946|FG000|Overall Study|Lost to Follow-up|0|||
164331288|NCT00739596|593589947|FG001|Overall Study|Lost to Follow-up|2|||
164228487|NCT01217892|593207336|FG003|Overall Study|Withdrawal by Subject|0|||
164228488|NCT01217892|593207333|FG000|Overall Study|Lab value|1|||
164421312|NCT03257995|593912701|FG002|Overall Study|Adverse Event|0|||
164421313|NCT03257995|593912702|FG003|Overall Study|Adverse Event|0|||
164228489|NCT01217892|593207334|FG001|Overall Study|Lab value|0|||
164228490|NCT01217892|593207335|FG002|Overall Study|Lab value|1|||
164228491|NCT01217892|593207336|FG003|Overall Study|Lab value|0|||
164228492|NCT01217892|593207333|FG000|Overall Study|Subject no longer meets study criteria|5|||
164228493|NCT01217892|593207334|FG001|Overall Study|Subject no longer meets study criteria|2|||
164228494|NCT01217892|593207335|FG002|Overall Study|Subject no longer meets study criteria|4|||
164228495|NCT01217892|593207336|FG003|Overall Study|Subject no longer meets study criteria|8|||
164228496|NCT01217892|593207333|FG000|Overall Study|Incorrect enrollment|0|||
164228497|NCT01217892|593207334|FG001|Overall Study|Incorrect enrollment|1|||
164228498|NCT01217892|593207335|FG002|Overall Study|Incorrect enrollment|1|||
164228499|NCT01217892|593207336|FG003|Overall Study|Incorrect enrollment|0|||
164228500|NCT01217892|593207333|FG000|Overall Study|Poor/Non-Compliance|0|||
164228501|NCT01217892|593207334|FG001|Overall Study|Poor/Non-Compliance|0|||
164228502|NCT01217892|593207335|FG002|Overall Study|Poor/Non-Compliance|1|||
164228503|NCT01217892|593207336|FG003|Overall Study|Poor/Non-Compliance|0|||
164228504|NCT00831389|593207338|FG000|Overall Study|Withdrawal by Subject|0|||
164228505|NCT00831389|593207339|FG001|Overall Study|Withdrawal by Subject|1|||
164228506|NCT00278161|593207341|FG000|Overall Study|Death|11|||
164228507|NCT01817777|593207342|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
164228508|NCT01817777|593207343|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
164228509|NCT01817777|593207344|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
164228510|NCT01817777|593207342|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
164228511|NCT01817777|593207343|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
164228512|NCT01817777|593207344|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
164228513|NCT01817777|593207342|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
164228514|NCT01817777|593207343|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
164228515|NCT01817777|593207344|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
164228516|NCT01817777|593207342|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
164228517|NCT01817777|593207343|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
164228518|NCT01817777|593207344|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
164228519|NCT01817777|593207342|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
164228520|NCT01817777|593207343|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
164228521|NCT01817777|593207344|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
164228522|NCT00443456|593207345|FG000|Overall Study|Adverse Event|16|||
164228523|NCT00443456|593207345|FG000|Overall Study|Move|1|||
164228524|NCT00443456|593207345|FG000|Overall Study|Withdrawal by Subject|1|||
164228525|NCT03242434|593207346|FG000|Overall Study|Death|0|||
164228526|NCT03242434|593207347|FG001|Overall Study|Death|2|||
164228527|NCT01592747|593207353|FG000|Overall Study|Loss of Therapeutic Response|107|||
164228528|NCT01592747|593207354|FG001|Overall Study|Loss of Therapeutic Response|108|||
164228529|NCT01592747|593207355|FG002|Overall Study|Loss of Therapeutic Response|100|||
164228530|NCT01592747|593207353|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
164228531|NCT01592747|593207354|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
164228532|NCT01592747|593207355|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
164228533|NCT01592747|593207353|FG000|Overall Study|Adverse Event|1|||
164228534|NCT01592747|593207354|FG001|Overall Study|Adverse Event|0|||
164228535|NCT01592747|593207355|FG002|Overall Study|Adverse Event|0|||
164228536|NCT01592747|593207353|FG000|Overall Study|Protocol Violation|4|||
164228537|NCT01592747|593207354|FG001|Overall Study|Protocol Violation|0|||
164228538|NCT01592747|593207355|FG002|Overall Study|Protocol Violation|4|||
164228539|NCT01592747|593207353|FG000|Overall Study|Lack of Efficacy|0|||
164228540|NCT01592747|593207354|FG001|Overall Study|Lack of Efficacy|1|||
164228541|NCT01592747|593207355|FG002|Overall Study|Lack of Efficacy|0|||
164228542|NCT01592747|593207353|FG000|Overall Study|Withdrawal by Subject|2|||
164228543|NCT01592747|593207354|FG001|Overall Study|Withdrawal by Subject|0|||
164228544|NCT01592747|593207355|FG002|Overall Study|Withdrawal by Subject|2|||
164228545|NCT01592747|593207353|FG000|Overall Study|Lost to Follow-up|1|||
164228546|NCT01592747|593207354|FG001|Overall Study|Lost to Follow-up|0|||
164228547|NCT01592747|593207355|FG002|Overall Study|Lost to Follow-up|1|||
164228548|NCT01592747|593207353|FG000|Overall Study|Other Reasons|1|||
164228549|NCT01592747|593207354|FG001|Overall Study|Other Reasons|1|||
164331289|NCT00739596|593589946|FG000|Overall Study|Protocol Deviation|1|||
164331290|NCT00739596|593589947|FG001|Overall Study|Protocol Deviation|1|||
164331291|NCT02520661|593589952|FG000|Overall Study|Lost to Follow-up|7|||
164331292|NCT02520661|593589953|FG001|Overall Study|Lost to Follow-up|3|||
164331293|NCT02520661|593589952|FG000|Overall Study|Admitted from ED|49|||
164331294|NCT02520661|593589953|FG001|Overall Study|Admitted from ED|48|||
164228550|NCT01592747|593207355|FG002|Overall Study|Other Reasons|0|||
164228551|NCT01935947|593207358|FG000|Overall Study|Adverse Event|0|||
164228552|NCT01935947|593207359|FG001|Overall Study|Adverse Event|2|||
164228553|NCT01935947|593207360|FG002|Overall Study|Adverse Event|0|||
164228554|NCT01935947|593207358|FG000|Overall Study|Diease Progression|2|||
164331295|NCT02520661|593589952|FG000|Overall Study|ED greater than 24 hours|29|||
164571768|NCT01870739|594458372|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
164331296|NCT02520661|593589953|FG001|Overall Study|ED greater than 24 hours|38|||
164421314|NCT03257995|593912703|FG004|Overall Study|Adverse Event|0|||
164421315|NCT03257995|593912704|FG005|Overall Study|Adverse Event|0|||
164421316|NCT03257995|593912699|FG000|Overall Study|Protocol deviation|0|||
164421317|NCT03257995|593912700|FG001|Overall Study|Protocol deviation|0|||
164421318|NCT03257995|593912701|FG002|Overall Study|Protocol deviation|0|||
164421319|NCT03257995|593912702|FG003|Overall Study|Protocol deviation|0|||
164421320|NCT03257995|593912703|FG004|Overall Study|Protocol deviation|0|||
164421321|NCT03257995|593912704|FG005|Overall Study|Protocol deviation|2|||
164421322|NCT01556763|593912710|FG000|Overall Study|Withdrawal by Subject|0|||
164421323|NCT01556763|593912711|FG001|Overall Study|Withdrawal by Subject|1|||
164421324|NCT01556763|593912712|FG002|Overall Study|Withdrawal by Subject|0|||
164675437|NCT00819741|594834969|FG001|Overall Study|Unclassified|0|||
164675438|NCT00819741|594834968|FG000|Overall Study|Reasons unknown|3|||
164675439|NCT00819741|594834969|FG001|Overall Study|Reasons unknown|3|||
164675440|NCT02222818|594836730|FG000|Period 1|Eligibility criteria not met|0|||
164675441|NCT02222818|594836731|FG001|Period 1|Eligibility criteria not met|3|||
164675442|NCT01376037|594836732|FG000|Overall Study|Lost to Follow-up|0|||
164675443|NCT01376037|594836733|FG001|Overall Study|Lost to Follow-up|2|||
164675444|NCT02328040|594836734|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
164675445|NCT02328040|594836735|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
164675446|NCT00835991|594836737|FG000|First Intervention|Adverse Event|0|||
164675447|NCT00835991|594836738|FG001|First Intervention|Adverse Event|1|||
164675448|NCT00835991|594836737|FG000|Washout|Protocol Violation|0|||
164675449|NCT00835991|594836738|FG001|Washout|Protocol Violation|2|||
164675450|NCT00835991|594836737|FG000|Washout|Withdrawal by Subject|3|||
164675451|NCT00835991|594836738|FG001|Washout|Withdrawal by Subject|1|||
164421325|NCT02258464|593912713|FG000|Overall Study|Progressive disease (PD)|9|||
164421326|NCT02258464|593912714|FG001|Overall Study|Progressive disease (PD)|17|||
164421327|NCT02258464|593912713|FG000|Overall Study|Study drug never administered|1|||
164421328|NCT02258464|593912714|FG001|Overall Study|Study drug never administered|1|||
164421329|NCT02258464|593912713|FG000|Overall Study|AE not related to clinical PD|1|||
164675452|NCT02149420|594836739|FG000|Core Study|Administrative problems|0|||
164675453|NCT02149420|594836740|FG001|Core Study|Administrative problems|1|||
164421330|NCT02258464|593912714|FG001|Overall Study|AE not related to clinical PD|3|||
164421331|NCT02258464|593912713|FG000|Overall Study|Withdrawal by Subject|5|||
164228555|NCT01935947|593207359|FG001|Overall Study|Diease Progression|2|||
164675454|NCT02149420|594836741|FG002|Core Study|Administrative problems|2|||
164421332|NCT02258464|593912714|FG001|Overall Study|Withdrawal by Subject|4|||
164421333|NCT02258464|593912713|FG000|Overall Study|AE related to clinical PD|1|||
164421334|NCT02258464|593912714|FG001|Overall Study|AE related to clinical PD|0|||
164421335|NCT00932646|593912715|FG000|Overall Study|Adverse Event|2|||
164421336|NCT00932646|593912716|FG001|Overall Study|Adverse Event|1|||
164421337|NCT00932646|593912717|FG002|Overall Study|Adverse Event|1|||
164421338|NCT00932646|593912718|FG003|Overall Study|Adverse Event|1|||
164421339|NCT00932646|593912715|FG000|Overall Study|Lost to Follow-up|2|||
164421340|NCT00932646|593912716|FG001|Overall Study|Lost to Follow-up|1|||
164421341|NCT00932646|593912717|FG002|Overall Study|Lost to Follow-up|0|||
164421342|NCT00932646|593912718|FG003|Overall Study|Lost to Follow-up|0|||
164421343|NCT00932646|593912715|FG000|Overall Study|Withdrawal by Subject|1|||
164421344|NCT00932646|593912716|FG001|Overall Study|Withdrawal by Subject|1|||
164421345|NCT00932646|593912717|FG002|Overall Study|Withdrawal by Subject|3|||
164421346|NCT00932646|593912718|FG003|Overall Study|Withdrawal by Subject|0|||
164421347|NCT04170296|593912719|FG000|Overall Study|Adverse Event|1|||
164421348|NCT04170296|593912720|FG001|Overall Study|Adverse Event|0|||
164421349|NCT04170296|593912719|FG000|Overall Study|Withdrawal by Subject|3|||
164421350|NCT04170296|593912720|FG001|Overall Study|Withdrawal by Subject|2|||
164421351|NCT04170296|593912719|FG000|Overall Study|Lost to Follow-up|4|||
164421352|NCT04170296|593912720|FG001|Overall Study|Lost to Follow-up|2|||
164421353|NCT00776100|593912721|FG000|Overall Study|Disease Progression|1|||
164421354|NCT00776100|593912722|FG001|Overall Study|Disease Progression|0|||
164421355|NCT03567993|593912723|FG000|Overall Study|Lost to Follow-up|4|||
164421356|NCT03567993|593912724|FG001|Overall Study|Lost to Follow-up|2|||
164421357|NCT03567993|593912723|FG000|Overall Study|Death|1|||
164421358|NCT03567993|593912724|FG001|Overall Study|Death|1|||
164421359|NCT03567993|593912723|FG000|Overall Study|Withdrawal by Subject|1|||
164228556|NCT01935947|593207360|FG002|Overall Study|Diease Progression|2|||
164675455|NCT02149420|594836739|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
164421360|NCT03567993|593912724|FG001|Overall Study|Withdrawal by Subject|0|||
164421361|NCT04759885|593912730|FG000|Overall Study|Other|1|||
164421362|NCT04759885|593912731|FG001|Overall Study|Other|0|||
164421363|NCT04759885|593912732|FG002|Overall Study|Other|2|||
164421364|NCT04759885|593912733|FG003|Overall Study|Other|0|||
164421365|NCT04759885|593912734|FG004|Overall Study|Other|0|||
164421366|NCT04759885|593912730|FG000|Overall Study|Withdrawal by Subject|0|||
164421367|NCT04759885|593912731|FG001|Overall Study|Withdrawal by Subject|0|||
164421368|NCT04759885|593912732|FG002|Overall Study|Withdrawal by Subject|1|||
164228557|NCT01935947|593207358|FG000|Overall Study|Death|1|||
164421369|NCT04759885|593912733|FG003|Overall Study|Withdrawal by Subject|9|||
164675456|NCT02149420|594836740|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
164675457|NCT02149420|594836741|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
164675458|NCT00440518|594836743|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
164675459|NCT00440518|594836744|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
164675460|NCT00440518|594836745|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
164675461|NCT00440518|594836743|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
164675462|NCT00440518|594836744|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
164675463|NCT00440518|594836745|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
164675464|NCT00440518|594836743|FG000|Randomized /Titration Period|Protocol Deviation|1|||
164675465|NCT00440518|594836744|FG001|Randomized /Titration Period|Protocol Deviation|0|||
164675466|NCT00440518|594836745|FG002|Randomized /Titration Period|Protocol Deviation|0|||
164675467|NCT00440518|594836743|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
164675468|NCT00440518|594836744|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
164675469|NCT00440518|594836745|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
164675470|NCT00440518|594836743|FG000|Randomized /Titration Period|Other|1|||
164675471|NCT00440518|594836744|FG001|Randomized /Titration Period|Other|0|||
164675472|NCT00440518|594836745|FG002|Randomized /Titration Period|Other|0|||
164675473|NCT00440518|594836743|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
164675474|NCT00440518|594836744|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
164675475|NCT00440518|594836745|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
164675476|NCT00440518|594836743|FG000|Randomized /Titration Period|Adverse Event|2|||
164675477|NCT00440518|594836744|FG001|Randomized /Titration Period|Adverse Event|3|||
164675478|NCT00440518|594836745|FG002|Randomized /Titration Period|Adverse Event|0|||
164675479|NCT00440518|594836743|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
164675480|NCT00440518|594836744|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
164675481|NCT00440518|594836745|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
164675482|NCT00440518|594836743|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
164675483|NCT00440518|594836744|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
164675484|NCT00440518|594836745|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
164675485|NCT00440518|594836743|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
164675486|NCT00440518|594836744|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
164421370|NCT04759885|593912734|FG004|Overall Study|Withdrawal by Subject|6|||
164421371|NCT04759885|593912730|FG000|Overall Study|Adverse Event|0|||
164421372|NCT04759885|593912731|FG001|Overall Study|Adverse Event|0|||
164421373|NCT04759885|593912732|FG002|Overall Study|Adverse Event|0|||
164421374|NCT04759885|593912733|FG003|Overall Study|Adverse Event|3|||
164421375|NCT04759885|593912734|FG004|Overall Study|Adverse Event|0|||
164421376|NCT04759885|593912730|FG000|Overall Study|Physician Decision|0|||
164421377|NCT04759885|593912731|FG001|Overall Study|Physician Decision|0|||
164421378|NCT04759885|593912732|FG002|Overall Study|Physician Decision|0|||
164421379|NCT04759885|593912733|FG003|Overall Study|Physician Decision|2|||
164421380|NCT04759885|593912734|FG004|Overall Study|Physician Decision|0|||
164421381|NCT01960790|593912735|FG000|Overall Study|Survey forms could not be recovered|3|||
164421382|NCT01960790|593912735|FG000|Overall Study|Treat with Humira outside survey period|3|||
164421383|NCT01960790|593912735|FG000|Overall Study|Transferred to another hospital|4|||
164331297|NCT02520661|593589952|FG000|Overall Study|other ineligibility|14|||
164331298|NCT02520661|593589953|FG001|Overall Study|other ineligibility|22|||
164331299|NCT02520661|593589952|FG000|Overall Study|Withdrawal by Subject|7|||
164331300|NCT02520661|593589953|FG001|Overall Study|Withdrawal by Subject|16|||
164331301|NCT01414608|593589961|FG000|Overall Study|Ineligible|5|||
164331302|NCT01414608|593589962|FG001|Overall Study|Ineligible|2|||
164421384|NCT01960790|593912735|FG000|Overall Study|Unevaluable for safety|1|||
164331303|NCT00760084|593589964|FG000|Overall Study|Physician Decision|5|||
164331304|NCT00760084|593589964|FG000|Overall Study|Withdrawal by Subject|2|||
164331305|NCT00760084|593589964|FG000|Overall Study|Progressive Disease|3|||
164331306|NCT02301988|593589965|FG000|Overall Study|Withdrawal by Subject|2|||
164331307|NCT02301988|593589966|FG001|Overall Study|Withdrawal by Subject|1|||
164331308|NCT02301988|593589965|FG000|Overall Study|Physician Decision|2|||
164331309|NCT02301988|593589966|FG001|Overall Study|Physician Decision|2|||
164331310|NCT02301988|593589965|FG000|Overall Study|Unknown Reason|1|||
164331311|NCT02301988|593589966|FG001|Overall Study|Unknown Reason|3|||
164331312|NCT02301988|593589965|FG000|Overall Study|Lack of Efficacy|3|||
164331313|NCT02301988|593589966|FG001|Overall Study|Lack of Efficacy|2|||
164331314|NCT02301988|593589965|FG000|Overall Study|Death|1|||
164331315|NCT02301988|593589966|FG001|Overall Study|Death|0|||
164331316|NCT02301988|593589965|FG000|Overall Study|Adverse Event|1|||
164331317|NCT02301988|593589966|FG001|Overall Study|Adverse Event|1|||
164331318|NCT02891161|593589967|FG000|Study Treatment|Disease Progression|2|||
164331319|NCT02891161|593589968|FG001|Study Treatment|Disease Progression|4|||
164421385|NCT04318093|593912737|FG000|Overall Study|Adverse Event|2|||
164421386|NCT04318093|593912738|FG001|Overall Study|Adverse Event|2|||
164421387|NCT04318093|593912737|FG000|Overall Study|Participant withdrew consent|1|||
164331320|NCT02891161|593589967|FG000|Study Treatment|AE/Side Effects/Complications|1|||
164228558|NCT01935947|593207359|FG001|Overall Study|Death|0|||
164228559|NCT01935947|593207360|FG002|Overall Study|Death|0|||
164228560|NCT04102514|593207361|FG000|Overall Study|Death|3|||
164228561|NCT04102514|593207362|FG001|Overall Study|Death|0|||
164228562|NCT04102514|593207363|FG002|Overall Study|Death|0|||
164228563|NCT04102514|593207364|FG003|Overall Study|Death|0|||
164228564|NCT04102514|593207361|FG000|Overall Study|Lost to Follow-up|0|||
164228565|NCT04102514|593207362|FG001|Overall Study|Lost to Follow-up|0|||
164228566|NCT04102514|593207363|FG002|Overall Study|Lost to Follow-up|3|||
164228567|NCT04102514|593207364|FG003|Overall Study|Lost to Follow-up|0|||
164228568|NCT04102514|593207361|FG000|Overall Study|Physician Decision|0|||
164228569|NCT04102514|593207362|FG001|Overall Study|Physician Decision|0|||
164228570|NCT04102514|593207363|FG002|Overall Study|Physician Decision|1|||
164228571|NCT04102514|593207364|FG003|Overall Study|Physician Decision|0|||
164571769|NCT01870739|594458373|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
164571770|NCT01870739|594458372|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
164571771|NCT01870739|594458373|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
164571772|NCT01986062|594458374|FG000|Overall Study|Lost to Follow-up|1|||
164571773|NCT01986062|594458375|FG001|Overall Study|Lost to Follow-up|0|||
164571774|NCT01986062|594458374|FG000|Overall Study|Withdrawal by Subject|0|||
164571775|NCT01986062|594458375|FG001|Overall Study|Withdrawal by Subject|1|||
164571776|NCT03538743|594458376|FG000|Overall Study|Adverse Event|0|||
164571777|NCT03538743|594458377|FG001|Overall Study|Adverse Event|0|||
164571778|NCT03538743|594458378|FG002|Overall Study|Adverse Event|1|||
164571779|NCT03538743|594458379|FG003|Overall Study|Adverse Event|1|||
164571780|NCT03538743|594458380|FG004|Overall Study|Adverse Event|0|||
164571781|NCT03538743|594458381|FG005|Overall Study|Adverse Event|0|||
164571782|NCT03538743|594458382|FG006|Overall Study|Adverse Event|0|||
164571783|NCT03538743|594458383|FG007|Overall Study|Adverse Event|0|||
164571784|NCT03538743|594458384|FG008|Overall Study|Adverse Event|0|||
164571785|NCT03538743|594458376|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
164571786|NCT03538743|594458377|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
164571787|NCT03538743|594458378|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
164571788|NCT03538743|594458379|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
164571789|NCT03538743|594458380|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
164571790|NCT03538743|594458381|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
164571791|NCT03538743|594458382|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
164571792|NCT03538743|594458383|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
164571793|NCT03538743|594458384|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
164228572|NCT04102514|593207361|FG000|Overall Study|Withdrawal by Subject|7|||
164228573|NCT04102514|593207362|FG001|Overall Study|Withdrawal by Subject|13|||
164228574|NCT04102514|593207363|FG002|Overall Study|Withdrawal by Subject|7|||
164228575|NCT04102514|593207364|FG003|Overall Study|Withdrawal by Subject|14|||
164228576|NCT04102514|593207361|FG000|Overall Study|Moved to longterm care facility|6|||
164228577|NCT04102514|593207362|FG001|Overall Study|Moved to longterm care facility|0|||
164228578|NCT04102514|593207363|FG002|Overall Study|Moved to longterm care facility|4|||
164228579|NCT04102514|593207364|FG003|Overall Study|Moved to longterm care facility|0|||
164228580|NCT00619918|593207365|FG000|Overall Study|Withdrawal by Subject|4|||
164228581|NCT00619918|593207366|FG001|Overall Study|Withdrawal by Subject|3|||
164228582|NCT00619918|593207365|FG000|Overall Study|Physician Decision|2|||
164228583|NCT00619918|593207366|FG001|Overall Study|Physician Decision|4|||
164228584|NCT00619918|593207365|FG000|Overall Study|Transfer to outside facility|3|||
164228585|NCT00619918|593207366|FG001|Overall Study|Transfer to outside facility|3|||
164228586|NCT00619918|593207365|FG000|Overall Study|Left before receiving first dose|7|||
164228587|NCT00619918|593207366|FG001|Overall Study|Left before receiving first dose|6|||
164228588|NCT00619918|593207365|FG000|Overall Study|ICU admission|4|||
164228589|NCT00619918|593207366|FG001|Overall Study|ICU admission|6|||
164228590|NCT02758626|593207373|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
164228591|NCT02758626|593207374|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
164228592|NCT02758626|593207373|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
164228593|NCT02758626|593207374|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
164331321|NCT02891161|593589968|FG001|Study Treatment|AE/Side Effects/Complications|5|||
164331322|NCT02891161|593589967|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
164421388|NCT04318093|593912738|FG001|Overall Study|Participant withdrew consent|0|||
164228594|NCT02758626|593207373|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
164228595|NCT02758626|593207374|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
164228596|NCT02758626|593207373|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
164228597|NCT02758626|593207374|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
164331323|NCT02891161|593589968|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
164228598|NCT00456365|593207377|FG000|Overall Study|Lost to Follow-up|1|||
164571794|NCT03538743|594458376|FG000|Overall Study|Withdrawal by Subject|0|||
164571795|NCT03538743|594458377|FG001|Overall Study|Withdrawal by Subject|0|||
164571796|NCT03538743|594458378|FG002|Overall Study|Withdrawal by Subject|0|||
164571797|NCT03538743|594458379|FG003|Overall Study|Withdrawal by Subject|1|||
164228599|NCT00456365|593207378|FG001|Overall Study|Lost to Follow-up|3|||
164228600|NCT00456365|593207377|FG000|Overall Study|Withdrawal by Subject|4|||
164228601|NCT00456365|593207378|FG001|Overall Study|Withdrawal by Subject|7|||
164228602|NCT00456365|593207377|FG000|Overall Study|Pregnancy|1|||
164228603|NCT00456365|593207378|FG001|Overall Study|Pregnancy|1|||
164228604|NCT00456365|593207377|FG000|Overall Study|oncologic diagnosis|1|||
164228605|NCT00456365|593207378|FG001|Overall Study|oncologic diagnosis|1|||
164228606|NCT02096354|593207382|FG000|Overall Study|Physician Decision|4|||
164228607|NCT02096354|593207383|FG001|Overall Study|Physician Decision|5|||
164228608|NCT02096354|593207384|FG002|Overall Study|Physician Decision|0|||
164228609|NCT02096354|593207382|FG000|Overall Study|Withdrawal by Subject|3|||
164228610|NCT02096354|593207383|FG001|Overall Study|Withdrawal by Subject|1|||
164228611|NCT02096354|593207384|FG002|Overall Study|Withdrawal by Subject|0|||
164228612|NCT02096354|593207382|FG000|Overall Study|Adverse Event|7|||
164228613|NCT02096354|593207383|FG001|Overall Study|Adverse Event|4|||
164228614|NCT02096354|593207384|FG002|Overall Study|Adverse Event|0|||
164228615|NCT02096354|593207382|FG000|Overall Study|Ineligible|0|||
164228616|NCT02096354|593207383|FG001|Overall Study|Ineligible|0|||
164228617|NCT02096354|593207384|FG002|Overall Study|Ineligible|11|||
164228618|NCT03715829|593207385|FG000|Dose Ranging Period|Adverse Event|2|||
164228619|NCT03715829|593207386|FG001|Dose Ranging Period|Adverse Event|4|||
164228620|NCT03715829|593207387|FG002|Dose Ranging Period|Adverse Event|5|||
164228621|NCT03715829|593207388|FG003|Dose Ranging Period|Adverse Event|2|||
164228622|NCT03715829|593207389|FG004|Dose Ranging Period|Adverse Event|3|||
164228623|NCT03715829|593207390|FG005|Dose Ranging Period|Adverse Event|3|||
164228624|NCT03715829|593207391|FG006|Dose Ranging Period|Adverse Event|0|||
164228625|NCT03715829|593207392|FG007|Dose Ranging Period|Adverse Event|0|||
164228626|NCT03715829|593207393|FG008|Dose Ranging Period|Adverse Event|0|||
164228627|NCT03715829|593207394|FG009|Dose Ranging Period|Adverse Event|0|||
164228628|NCT03715829|593207395|FG010|Dose Ranging Period|Adverse Event|0|||
164228629|NCT03715829|593207385|FG000|Dose Ranging Period|Lack of Efficacy|0|||
164228630|NCT03715829|593207386|FG001|Dose Ranging Period|Lack of Efficacy|1|||
164228631|NCT03715829|593207387|FG002|Dose Ranging Period|Lack of Efficacy|0|||
164228632|NCT03715829|593207388|FG003|Dose Ranging Period|Lack of Efficacy|1|||
164228633|NCT03715829|593207389|FG004|Dose Ranging Period|Lack of Efficacy|0|||
164228634|NCT03715829|593207390|FG005|Dose Ranging Period|Lack of Efficacy|0|||
164228635|NCT03715829|593207391|FG006|Dose Ranging Period|Lack of Efficacy|0|||
164228636|NCT03715829|593207392|FG007|Dose Ranging Period|Lack of Efficacy|0|||
164228637|NCT03715829|593207393|FG008|Dose Ranging Period|Lack of Efficacy|0|||
164228638|NCT03715829|593207394|FG009|Dose Ranging Period|Lack of Efficacy|0|||
164228639|NCT03715829|593207395|FG010|Dose Ranging Period|Lack of Efficacy|0|||
164228640|NCT03715829|593207385|FG000|Dose Ranging Period|Lost to Follow-up|2|||
164228641|NCT03715829|593207386|FG001|Dose Ranging Period|Lost to Follow-up|0|||
164228642|NCT03715829|593207387|FG002|Dose Ranging Period|Lost to Follow-up|1|||
164228643|NCT03715829|593207388|FG003|Dose Ranging Period|Lost to Follow-up|1|||
164228644|NCT03715829|593207389|FG004|Dose Ranging Period|Lost to Follow-up|1|||
164228645|NCT03715829|593207390|FG005|Dose Ranging Period|Lost to Follow-up|2|||
164228646|NCT03715829|593207391|FG006|Dose Ranging Period|Lost to Follow-up|0|||
164228647|NCT03715829|593207392|FG007|Dose Ranging Period|Lost to Follow-up|0|||
164228648|NCT03715829|593207393|FG008|Dose Ranging Period|Lost to Follow-up|0|||
164228649|NCT03715829|593207394|FG009|Dose Ranging Period|Lost to Follow-up|0|||
164228650|NCT03715829|593207395|FG010|Dose Ranging Period|Lost to Follow-up|0|||
164228651|NCT03715829|593207385|FG000|Dose Ranging Period|Protocol Violation|0|||
164228652|NCT03715829|593207386|FG001|Dose Ranging Period|Protocol Violation|0|||
164228653|NCT03715829|593207387|FG002|Dose Ranging Period|Protocol Violation|0|||
164228654|NCT03715829|593207388|FG003|Dose Ranging Period|Protocol Violation|1|||
164228655|NCT03715829|593207389|FG004|Dose Ranging Period|Protocol Violation|0|||
164228656|NCT03715829|593207390|FG005|Dose Ranging Period|Protocol Violation|0|||
164228657|NCT03715829|593207391|FG006|Dose Ranging Period|Protocol Violation|0|||
164228658|NCT03715829|593207392|FG007|Dose Ranging Period|Protocol Violation|0|||
164228659|NCT03715829|593207393|FG008|Dose Ranging Period|Protocol Violation|0|||
164228660|NCT03715829|593207394|FG009|Dose Ranging Period|Protocol Violation|0|||
164228661|NCT03715829|593207395|FG010|Dose Ranging Period|Protocol Violation|0|||
164228662|NCT03715829|593207385|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
164228663|NCT03715829|593207386|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
164228664|NCT03715829|593207387|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
164228665|NCT03715829|593207388|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
164228666|NCT03715829|593207389|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
164228667|NCT03715829|593207390|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
164228668|NCT03715829|593207391|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
164228669|NCT03715829|593207392|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
164228670|NCT03715829|593207393|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
164228671|NCT03715829|593207394|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
164228672|NCT03715829|593207395|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
164228673|NCT03715829|593207385|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
164228674|NCT03715829|593207386|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
164299708|NCT01217229|593472904|FG000|Overall Study|Disease progression not confirmed|2|||
164675487|NCT00440518|594836745|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
164675488|NCT00440518|594836743|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
164675489|NCT00440518|594836744|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
164675490|NCT00440518|594836745|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
164675491|NCT00440518|594836743|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
164675492|NCT00440518|594836744|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
164675493|NCT00440518|594836745|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
164228675|NCT03715829|593207387|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
164228676|NCT03715829|593207388|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
164228677|NCT03715829|593207389|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
164228678|NCT03715829|593207390|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
164228679|NCT03715829|593207391|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
164228680|NCT03715829|593207392|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
164228681|NCT03715829|593207393|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
164228682|NCT03715829|593207394|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
164228683|NCT03715829|593207395|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
164228684|NCT03715829|593207385|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
164228685|NCT03715829|593207386|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
164228686|NCT03715829|593207387|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
164228687|NCT03715829|593207388|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
164228688|NCT03715829|593207389|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
164228689|NCT03715829|593207390|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
164228690|NCT03715829|593207391|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
164228691|NCT03715829|593207392|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
164228692|NCT03715829|593207393|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
164228693|NCT03715829|593207394|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
164228694|NCT03715829|593207395|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
164228695|NCT03715829|593207385|FG000|Dose Ranging Period|Other|0|||
164228696|NCT03715829|593207386|FG001|Dose Ranging Period|Other|0|||
164228697|NCT03715829|593207387|FG002|Dose Ranging Period|Other|2|||
164228698|NCT03715829|593207388|FG003|Dose Ranging Period|Other|0|||
164228699|NCT03715829|593207389|FG004|Dose Ranging Period|Other|0|||
164228700|NCT03715829|593207390|FG005|Dose Ranging Period|Other|3|||
164228701|NCT03715829|593207391|FG006|Dose Ranging Period|Other|0|||
164228702|NCT03715829|593207392|FG007|Dose Ranging Period|Other|0|||
164228703|NCT03715829|593207393|FG008|Dose Ranging Period|Other|0|||
164228704|NCT03715829|593207394|FG009|Dose Ranging Period|Other|0|||
164228705|NCT03715829|593207395|FG010|Dose Ranging Period|Other|0|||
164228706|NCT03715829|593207385|FG000|Extension Period|Adverse Event|0|||
164228707|NCT03715829|593207386|FG001|Extension Period|Adverse Event|0|||
164228708|NCT03715829|593207387|FG002|Extension Period|Adverse Event|0|||
164228709|NCT03715829|593207388|FG003|Extension Period|Adverse Event|0|||
164228710|NCT03715829|593207389|FG004|Extension Period|Adverse Event|0|||
164228711|NCT03715829|593207390|FG005|Extension Period|Adverse Event|0|||
164228712|NCT03715829|593207391|FG006|Extension Period|Adverse Event|3|||
164228713|NCT03715829|593207392|FG007|Extension Period|Adverse Event|1|||
164228714|NCT03715829|593207393|FG008|Extension Period|Adverse Event|6|||
164228715|NCT03715829|593207394|FG009|Extension Period|Adverse Event|0|||
164228716|NCT03715829|593207395|FG010|Extension Period|Adverse Event|0|||
164228717|NCT03715829|593207385|FG000|Extension Period|Lack of Efficacy|0|||
164228718|NCT03715829|593207386|FG001|Extension Period|Lack of Efficacy|0|||
164228719|NCT03715829|593207387|FG002|Extension Period|Lack of Efficacy|0|||
164228720|NCT03715829|593207388|FG003|Extension Period|Lack of Efficacy|0|||
164228721|NCT03715829|593207389|FG004|Extension Period|Lack of Efficacy|0|||
164228722|NCT03715829|593207390|FG005|Extension Period|Lack of Efficacy|0|||
164228723|NCT03715829|593207391|FG006|Extension Period|Lack of Efficacy|1|||
164228724|NCT03715829|593207392|FG007|Extension Period|Lack of Efficacy|9|||
164228725|NCT03715829|593207393|FG008|Extension Period|Lack of Efficacy|2|||
164228726|NCT03715829|593207394|FG009|Extension Period|Lack of Efficacy|0|||
164228727|NCT03715829|593207395|FG010|Extension Period|Lack of Efficacy|0|||
164228728|NCT03715829|593207385|FG000|Extension Period|Lost to Follow-up|0|||
164228729|NCT03715829|593207386|FG001|Extension Period|Lost to Follow-up|0|||
164228730|NCT03715829|593207387|FG002|Extension Period|Lost to Follow-up|0|||
164675494|NCT00440518|594836743|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
164228731|NCT03715829|593207388|FG003|Extension Period|Lost to Follow-up|0|||
164228732|NCT03715829|593207389|FG004|Extension Period|Lost to Follow-up|0|||
164421389|NCT04318093|593912737|FG000|Overall Study|Other reasons|0|||
164228733|NCT03715829|593207390|FG005|Extension Period|Lost to Follow-up|0|||
164228734|NCT03715829|593207391|FG006|Extension Period|Lost to Follow-up|0|||
164228735|NCT03715829|593207392|FG007|Extension Period|Lost to Follow-up|0|||
164228736|NCT03715829|593207393|FG008|Extension Period|Lost to Follow-up|2|||
164228737|NCT03715829|593207394|FG009|Extension Period|Lost to Follow-up|0|||
164228738|NCT03715829|593207395|FG010|Extension Period|Lost to Follow-up|0|||
164228739|NCT03715829|593207385|FG000|Extension Period|Protocol Violation|0|||
164228740|NCT03715829|593207386|FG001|Extension Period|Protocol Violation|0|||
164228741|NCT03715829|593207387|FG002|Extension Period|Protocol Violation|0|||
164228742|NCT03715829|593207388|FG003|Extension Period|Protocol Violation|0|||
164228743|NCT03715829|593207389|FG004|Extension Period|Protocol Violation|0|||
164228744|NCT03715829|593207390|FG005|Extension Period|Protocol Violation|0|||
164228745|NCT03715829|593207391|FG006|Extension Period|Protocol Violation|0|||
164228746|NCT03715829|593207392|FG007|Extension Period|Protocol Violation|0|||
164228747|NCT03715829|593207393|FG008|Extension Period|Protocol Violation|1|||
164228748|NCT03715829|593207394|FG009|Extension Period|Protocol Violation|0|||
164228749|NCT03715829|593207395|FG010|Extension Period|Protocol Violation|0|||
164228750|NCT03715829|593207385|FG000|Extension Period|Withdrawal by Subject|0|||
164228751|NCT03715829|593207386|FG001|Extension Period|Withdrawal by Subject|0|||
164228752|NCT03715829|593207387|FG002|Extension Period|Withdrawal by Subject|0|||
164228753|NCT03715829|593207388|FG003|Extension Period|Withdrawal by Subject|0|||
164228754|NCT03715829|593207389|FG004|Extension Period|Withdrawal by Subject|0|||
164228755|NCT03715829|593207390|FG005|Extension Period|Withdrawal by Subject|0|||
164228756|NCT03715829|593207391|FG006|Extension Period|Withdrawal by Subject|3|||
164228757|NCT03715829|593207392|FG007|Extension Period|Withdrawal by Subject|3|||
164228758|NCT03715829|593207393|FG008|Extension Period|Withdrawal by Subject|12|||
164228759|NCT03715829|593207394|FG009|Extension Period|Withdrawal by Subject|3|||
164228760|NCT03715829|593207395|FG010|Extension Period|Withdrawal by Subject|0|||
164228761|NCT03715829|593207385|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
164228762|NCT03715829|593207386|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
164228763|NCT03715829|593207387|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
164228764|NCT03715829|593207388|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
164228765|NCT03715829|593207389|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
164228766|NCT03715829|593207390|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
164228767|NCT03715829|593207391|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
164228768|NCT03715829|593207392|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
164228769|NCT03715829|593207393|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
164228770|NCT03715829|593207394|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
164228771|NCT03715829|593207395|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
164228772|NCT03715829|593207385|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
164228773|NCT03715829|593207386|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
164228774|NCT03715829|593207387|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
164228775|NCT03715829|593207388|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
164228776|NCT03715829|593207389|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
164228777|NCT03715829|593207390|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
164228778|NCT03715829|593207391|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
164228779|NCT03715829|593207392|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
164228780|NCT03715829|593207393|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
164228781|NCT03715829|593207394|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
164228782|NCT03715829|593207395|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
164228783|NCT03715829|593207385|FG000|Extension Period|Other|0|||
164228784|NCT03715829|593207386|FG001|Extension Period|Other|0|||
164228785|NCT03715829|593207387|FG002|Extension Period|Other|0|||
164228786|NCT03715829|593207388|FG003|Extension Period|Other|0|||
164228787|NCT03715829|593207389|FG004|Extension Period|Other|0|||
164228788|NCT03715829|593207390|FG005|Extension Period|Other|0|||
164228789|NCT03715829|593207391|FG006|Extension Period|Other|1|||
164228790|NCT03715829|593207392|FG007|Extension Period|Other|2|||
164331324|NCT02891161|593589967|FG000|Follow up|Death|4|||
164331325|NCT02891161|593589968|FG001|Follow up|Death|8|||
164331326|NCT02891161|593589967|FG000|Follow up|Refused to Follow up|0|||
164331327|NCT02891161|593589968|FG001|Follow up|Refused to Follow up|2|||
164331328|NCT02891161|593589967|FG000|Follow up|Symptomatic deterioration|0|||
164331329|NCT02891161|593589968|FG001|Follow up|Symptomatic deterioration|1|||
164331330|NCT02891161|593589967|FG000|Follow up|Study terminated|0|||
164331331|NCT02891161|593589968|FG001|Follow up|Study terminated|6|||
164331332|NCT01931202|593589971|FG000|Overall Study|Withdrawal by Subject|0|||
164331333|NCT01931202|593589972|FG001|Overall Study|Withdrawal by Subject|0|||
164331334|NCT01931202|593589973|FG002|Overall Study|Withdrawal by Subject|2|||
164331335|NCT01931202|593589971|FG000|Overall Study|Lost to Follow-up|0|||
164228791|NCT03715829|593207393|FG008|Extension Period|Other|4|||
164228792|NCT03715829|593207394|FG009|Extension Period|Other|0|||
164228793|NCT03715829|593207395|FG010|Extension Period|Other|0|||
164228794|NCT03579719|593207397|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
164228795|NCT01443026|593207398|FG000|Overall Study|Physician Decision|1|||
164228796|NCT01443026|593207399|FG001|Overall Study|Physician Decision|0|||
164228797|NCT01443026|593207398|FG000|Overall Study|Death|0|||
164228798|NCT01443026|593207399|FG001|Overall Study|Death|1|||
164331336|NCT01931202|593589972|FG001|Overall Study|Lost to Follow-up|5|||
164228799|NCT01443026|593207398|FG000|Overall Study|Withdrawal by Subject|0|||
164228800|NCT01443026|593207399|FG001|Overall Study|Withdrawal by Subject|3|||
164228801|NCT01443026|593207398|FG000|Overall Study|Lost to Follow-up|2|||
164228802|NCT01443026|593207399|FG001|Overall Study|Lost to Follow-up|1|||
164228803|NCT01051661|593207404|FG000|Overall Study|Adverse Event|1|||
164228804|NCT01051661|593207405|FG001|Overall Study|Adverse Event|1|||
164228805|NCT01051661|593207406|FG002|Overall Study|Adverse Event|1|||
164228806|NCT01051661|593207407|FG003|Overall Study|Adverse Event|1|||
164228807|NCT01051661|593207408|FG004|Overall Study|Adverse Event|0|||
164228808|NCT01051661|593207409|FG005|Overall Study|Adverse Event|0|||
164421390|NCT04318093|593912738|FG001|Overall Study|Other reasons|1|||
164421391|NCT01370603|593912739|FG000|Period 1|Adverse Event|5|||
164421392|NCT01370603|593912740|FG001|Period 1|Adverse Event|3|||
164421393|NCT01370603|593912739|FG000|Period 1|Lost to Follow-up|2|||
164421394|NCT01370603|593912740|FG001|Period 1|Lost to Follow-up|0|||
164421395|NCT01370603|593912739|FG000|Period 1|Protocol Violation|2|||
164421396|NCT01370603|593912740|FG001|Period 1|Protocol Violation|2|||
164421397|NCT01370603|593912739|FG000|Period 1|Withdrawal by Subject|5|||
164421398|NCT01370603|593912740|FG001|Period 1|Withdrawal by Subject|5|||
164421399|NCT01370603|593912739|FG000|Crossover Washout|Adverse Event|2|||
164421400|NCT01370603|593912740|FG001|Crossover Washout|Adverse Event|1|||
164421401|NCT01370603|593912739|FG000|Crossover Washout|Lost to Follow-up|2|||
164421402|NCT01370603|593912740|FG001|Crossover Washout|Lost to Follow-up|0|||
164421403|NCT01370603|593912739|FG000|Crossover Washout|Protocol Violation|1|||
164421404|NCT01370603|593912740|FG001|Crossover Washout|Protocol Violation|0|||
164421405|NCT01370603|593912739|FG000|Crossover Washout|Withdrawal by Subject|4|||
164421406|NCT01370603|593912740|FG001|Crossover Washout|Withdrawal by Subject|1|||
164421407|NCT01370603|593912739|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
164421408|NCT01370603|593912740|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
164421409|NCT01370603|593912739|FG000|Period 2|Adverse Event|1|||
164421410|NCT01370603|593912740|FG001|Period 2|Adverse Event|4|||
164228809|NCT01051661|593207404|FG000|Overall Study|Lost to Follow-up|13|||
164228810|NCT01051661|593207405|FG001|Overall Study|Lost to Follow-up|22|||
164228811|NCT01051661|593207406|FG002|Overall Study|Lost to Follow-up|15|||
164228812|NCT01051661|593207407|FG003|Overall Study|Lost to Follow-up|17|||
164228813|NCT01051661|593207408|FG004|Overall Study|Lost to Follow-up|10|||
164228814|NCT01051661|593207409|FG005|Overall Study|Lost to Follow-up|24|||
164228815|NCT01051661|593207404|FG000|Overall Study|Migrated/moved from study area|1|||
164228816|NCT01051661|593207405|FG001|Overall Study|Migrated/moved from study area|6|||
164228817|NCT01051661|593207406|FG002|Overall Study|Migrated/moved from study area|6|||
164228818|NCT01051661|593207407|FG003|Overall Study|Migrated/moved from study area|8|||
164228819|NCT01051661|593207408|FG004|Overall Study|Migrated/moved from study area|7|||
164228820|NCT01051661|593207409|FG005|Overall Study|Migrated/moved from study area|3|||
164228821|NCT01051661|593207404|FG000|Overall Study|Refused blood sampling|0|||
164228822|NCT01051661|593207405|FG001|Overall Study|Refused blood sampling|0|||
164228823|NCT01051661|593207406|FG002|Overall Study|Refused blood sampling|0|||
164228824|NCT01051661|593207407|FG003|Overall Study|Refused blood sampling|0|||
164228825|NCT01051661|593207408|FG004|Overall Study|Refused blood sampling|0|||
164228826|NCT01051661|593207409|FG005|Overall Study|Refused blood sampling|1|||
164228827|NCT01051661|593207404|FG000|Overall Study|Data not reliable|1|||
164228828|NCT01051661|593207405|FG001|Overall Study|Data not reliable|0|||
164228829|NCT01051661|593207406|FG002|Overall Study|Data not reliable|0|||
164228830|NCT01051661|593207407|FG003|Overall Study|Data not reliable|0|||
164228831|NCT01051661|593207408|FG004|Overall Study|Data not reliable|0|||
164228832|NCT01051661|593207409|FG005|Overall Study|Data not reliable|1|||
164228833|NCT01051661|593207404|FG000|Overall Study|Unable to attend visit(s)|2|||
164228834|NCT01051661|593207405|FG001|Overall Study|Unable to attend visit(s)|4|||
164228835|NCT01051661|593207406|FG002|Overall Study|Unable to attend visit(s)|2|||
164228836|NCT01051661|593207407|FG003|Overall Study|Unable to attend visit(s)|1|||
164228837|NCT01051661|593207408|FG004|Overall Study|Unable to attend visit(s)|3|||
164228838|NCT01051661|593207409|FG005|Overall Study|Unable to attend visit(s)|2|||
164228839|NCT01051661|593207404|FG000|Overall Study|Consent not received from both parents|0|||
164228840|NCT01051661|593207405|FG001|Overall Study|Consent not received from both parents|0|||
164228841|NCT01051661|593207406|FG002|Overall Study|Consent not received from both parents|0|||
164228842|NCT01051661|593207407|FG003|Overall Study|Consent not received from both parents|0|||
164228843|NCT01051661|593207408|FG004|Overall Study|Consent not received from both parents|0|||
164228844|NCT01051661|593207409|FG005|Overall Study|Consent not received from both parents|1|||
164228845|NCT01051661|593207404|FG000|Overall Study|Failure to comply with protocol|0|||
164228846|NCT01051661|593207405|FG001|Overall Study|Failure to comply with protocol|0|||
164228847|NCT01051661|593207406|FG002|Overall Study|Failure to comply with protocol|2|||
164228848|NCT01051661|593207407|FG003|Overall Study|Failure to comply with protocol|0|||
164228849|NCT01051661|593207408|FG004|Overall Study|Failure to comply with protocol|0|||
164228850|NCT01051661|593207409|FG005|Overall Study|Failure to comply with protocol|0|||
164228851|NCT01051661|593207404|FG000|Overall Study|Subject lost legal representation|0|||
164228852|NCT01051661|593207405|FG001|Overall Study|Subject lost legal representation|0|||
164421411|NCT01370603|593912739|FG000|Period 2|Lost to Follow-up|1|||
164228853|NCT01051661|593207406|FG002|Overall Study|Subject lost legal representation|0|||
164228854|NCT01051661|593207407|FG003|Overall Study|Subject lost legal representation|0|||
164228855|NCT01051661|593207408|FG004|Overall Study|Subject lost legal representation|1|||
164228856|NCT01051661|593207409|FG005|Overall Study|Subject lost legal representation|0|||
164228857|NCT01051661|593207404|FG000|Overall Study|Protocol Violation|0|||
164228858|NCT01051661|593207405|FG001|Overall Study|Protocol Violation|0|||
164228859|NCT01051661|593207406|FG002|Overall Study|Protocol Violation|0|||
164228860|NCT01051661|593207407|FG003|Overall Study|Protocol Violation|1|||
164228861|NCT01051661|593207408|FG004|Overall Study|Protocol Violation|2|||
164228862|NCT01051661|593207409|FG005|Overall Study|Protocol Violation|1|||
164228863|NCT01051661|593207404|FG000|Overall Study|Withdrawal by Subject|16|||
164228864|NCT01051661|593207405|FG001|Overall Study|Withdrawal by Subject|30|||
164228865|NCT01051661|593207406|FG002|Overall Study|Withdrawal by Subject|13|||
164228866|NCT01051661|593207407|FG003|Overall Study|Withdrawal by Subject|28|||
164228867|NCT01051661|593207408|FG004|Overall Study|Withdrawal by Subject|12|||
164228868|NCT01051661|593207409|FG005|Overall Study|Withdrawal by Subject|34|||
164228869|NCT02852005|593207411|FG000|Overall Study|Lost to Follow-up|0|||
164228870|NCT02852005|593207412|FG001|Overall Study|Lost to Follow-up|0|||
164228871|NCT02852005|593207413|FG002|Overall Study|Lost to Follow-up|0|||
164228872|NCT02852005|593207414|FG003|Overall Study|Lost to Follow-up|0|||
164228873|NCT02852005|593207415|FG004|Overall Study|Lost to Follow-up|1|||
164228874|NCT02852005|593207411|FG000|Overall Study|Withdrawal by Subject|1|||
164228875|NCT02852005|593207412|FG001|Overall Study|Withdrawal by Subject|0|||
164228876|NCT02852005|593207413|FG002|Overall Study|Withdrawal by Subject|0|||
164228877|NCT02852005|593207414|FG003|Overall Study|Withdrawal by Subject|0|||
164228878|NCT02852005|593207415|FG004|Overall Study|Withdrawal by Subject|0|||
164228879|NCT04079920|593207418|FG000|Overall Study|Adverse event, not related to study drug|2|||
164228880|NCT04079920|593207418|FG000|Overall Study|Adverse event related to study drug|10|||
164228881|NCT04079920|593207418|FG000|Overall Study|Death|2|||
164228882|NCT04079920|593207418|FG000|Overall Study|Lost to Follow-up|22|||
164228883|NCT04079920|593207418|FG000|Overall Study|Physician Decision|1|||
164228884|NCT04079920|593207418|FG000|Overall Study|Withdrawal by Subject|11|||
164228885|NCT03760068|593207419|FG000|Overall Study|Withdrawal by Subject|7|||
164228886|NCT03760068|593207420|FG001|Overall Study|Withdrawal by Subject|8|||
164228887|NCT03760068|593207419|FG000|Overall Study|Adverse Event|1|||
164228888|NCT03760068|593207420|FG001|Overall Study|Adverse Event|2|||
164228889|NCT03760068|593207419|FG000|Overall Study|Administrative Decision by Sponsor|0|||
164228890|NCT03760068|593207420|FG001|Overall Study|Administrative Decision by Sponsor|2|||
164228891|NCT03760068|593207419|FG000|Overall Study|Physician Decision|1|||
164228892|NCT03760068|593207420|FG001|Overall Study|Physician Decision|2|||
164228893|NCT03760068|593207419|FG000|Overall Study|Lost to Follow-up|4|||
164228894|NCT03760068|593207420|FG001|Overall Study|Lost to Follow-up|9|||
164228895|NCT03760068|593207419|FG000|Overall Study|Subject Moved Out of State|1|||
164228896|NCT03760068|593207420|FG001|Overall Study|Subject Moved Out of State|0|||
164228897|NCT05014919|593207421|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
164228898|NCT05014919|593207422|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
164228899|NCT05014919|593207423|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
164228900|NCT05014919|593207421|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
164228901|NCT05014919|593207422|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
164228902|NCT05014919|593207423|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
164228903|NCT05014919|593207421|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
164228904|NCT05014919|593207422|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
164228905|NCT05014919|593207423|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
164228906|NCT05014919|593207421|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
164228907|NCT05014919|593207422|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
164228908|NCT05014919|593207423|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
164228909|NCT05014919|593207421|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
164228910|NCT05014919|593207422|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
164228911|NCT05014919|593207423|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
164228912|NCT05014919|593207421|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
164228913|NCT05014919|593207422|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
164228914|NCT05014919|593207423|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
164228915|NCT05014919|593207421|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
164228916|NCT05014919|593207422|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
164228917|NCT05014919|593207423|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
164228918|NCT05014919|593207421|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
164228919|NCT05014919|593207422|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
164228920|NCT05014919|593207423|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
164228921|NCT04126174|593207429|FG000|Overall Study|Lost to Follow-up|3|||
164228922|NCT04126174|593207430|FG001|Overall Study|Lost to Follow-up|3|||
164228923|NCT03773562|593207431|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
164228924|NCT03773562|593207431|FG000|Overall Study|Lost to Follow-up|10|||
164331337|NCT01931202|593589973|FG002|Overall Study|Lost to Follow-up|2|||
164228925|NCT03773562|593207431|FG000|Overall Study|Withdrawal by Subject|1|||
164228926|NCT01491919|593207432|FG000|Overall Study|Insufficient PK sampling|1|||
164228927|NCT01491919|593207433|FG001|Overall Study|Insufficient PK sampling|2|||
164228928|NCT01491919|593207434|FG002|Overall Study|Insufficient PK sampling|1|||
164228929|NCT03204812|593207444|FG000|Overall Study|Adverse Event|3|||
164228930|NCT01027351|593207445|FG000|Overall Study|Withdrawal by Subject|1|||
164228931|NCT01027351|593207446|FG001|Overall Study|Withdrawal by Subject|0|||
164228932|NCT01027351|593207447|FG002|Overall Study|Withdrawal by Subject|1|||
164228933|NCT01027351|593207448|FG003|Overall Study|Withdrawal by Subject|0|||
164228934|NCT01027351|593207449|FG004|Overall Study|Withdrawal by Subject|3|||
164228935|NCT01027351|593207450|FG005|Overall Study|Withdrawal by Subject|5|||
164228936|NCT01027351|593207445|FG000|Overall Study|Lost to Follow-up|1|||
164228937|NCT01027351|593207446|FG001|Overall Study|Lost to Follow-up|1|||
164228938|NCT01027351|593207447|FG002|Overall Study|Lost to Follow-up|0|||
164331338|NCT01857583|593589975|FG000|Overall Study|Adverse Event|0|||
164331339|NCT01857583|593589976|FG001|Overall Study|Adverse Event|0|||
164331340|NCT01857583|593589977|FG002|Overall Study|Adverse Event|1|||
164421412|NCT01370603|593912740|FG001|Period 2|Lost to Follow-up|0|||
164421413|NCT01370603|593912739|FG000|Period 2|Withdrawal by Subject|1|||
164421414|NCT01370603|593912740|FG001|Period 2|Withdrawal by Subject|0|||
164421415|NCT02133924|593912741|FG000|Overall Study|Death|38|||
164331341|NCT01857583|593589978|FG003|Overall Study|Adverse Event|1|||
164331342|NCT01857583|593589975|FG000|Overall Study|Death|0|||
164331343|NCT01857583|593589976|FG001|Overall Study|Death|1|||
164331344|NCT01857583|593589977|FG002|Overall Study|Death|1|||
164331345|NCT01857583|593589978|FG003|Overall Study|Death|0|||
164331346|NCT01857583|593589975|FG000|Overall Study|Physician Decision|0|||
164331347|NCT01857583|593589976|FG001|Overall Study|Physician Decision|0|||
164331348|NCT01857583|593589977|FG002|Overall Study|Physician Decision|0|||
164331349|NCT01857583|593589978|FG003|Overall Study|Physician Decision|1|||
164331350|NCT01857583|593589975|FG000|Overall Study|Withdrawal by Subject|1|||
164331351|NCT01857583|593589976|FG001|Overall Study|Withdrawal by Subject|0|||
164331352|NCT01857583|593589977|FG002|Overall Study|Withdrawal by Subject|1|||
164331353|NCT01857583|593589978|FG003|Overall Study|Withdrawal by Subject|2|||
164331354|NCT02775903|593589983|FG000|Overall Study|Death|7|||
164331355|NCT02775903|593589984|FG001|Overall Study|Death|11|||
164331356|NCT02775903|593589985|FG002|Overall Study|Death|12|||
164331357|NCT02775903|593589986|FG003|Overall Study|Death|11|||
164331358|NCT02775903|593589983|FG000|Overall Study|Adverse Event|0|||
164331359|NCT02775903|593589984|FG001|Overall Study|Adverse Event|1|||
164331360|NCT02775903|593589985|FG002|Overall Study|Adverse Event|12|||
164331361|NCT02775903|593589986|FG003|Overall Study|Adverse Event|3|||
164331362|NCT02775903|593589983|FG000|Overall Study|Progressive disease|15|||
164331363|NCT02775903|593589984|FG001|Overall Study|Progressive disease|14|||
164331364|NCT02775903|593589985|FG002|Overall Study|Progressive disease|30|||
164331365|NCT02775903|593589986|FG003|Overall Study|Progressive disease|20|||
164331366|NCT02775903|593589983|FG000|Overall Study|Lack of Efficacy|2|||
164331367|NCT02775903|593589984|FG001|Overall Study|Lack of Efficacy|2|||
164331368|NCT02775903|593589985|FG002|Overall Study|Lack of Efficacy|2|||
164331369|NCT02775903|593589986|FG003|Overall Study|Lack of Efficacy|6|||
164331370|NCT02775903|593589983|FG000|Overall Study|Withdrawal by Subject|7|||
164331371|NCT02775903|593589984|FG001|Overall Study|Withdrawal by Subject|5|||
164331372|NCT02775903|593589985|FG002|Overall Study|Withdrawal by Subject|5|||
164331373|NCT02775903|593589986|FG003|Overall Study|Withdrawal by Subject|8|||
164331374|NCT02775903|593589983|FG000|Overall Study|Other reasons|7|||
164331375|NCT02775903|593589984|FG001|Overall Study|Other reasons|8|||
164331376|NCT02775903|593589985|FG002|Overall Study|Other reasons|2|||
164331377|NCT02775903|593589986|FG003|Overall Study|Other reasons|12|||
164421416|NCT02133924|593912741|FG000|Overall Study|Physician Decision|1|||
164421417|NCT02133924|593912741|FG000|Overall Study|Withdrawal by Subject|3|||
164421418|NCT01644474|593912743|FG000|Overall Study|Poor compliance to protocol|1|||
164228939|NCT01027351|593207448|FG003|Overall Study|Lost to Follow-up|1|||
164228940|NCT01027351|593207449|FG004|Overall Study|Lost to Follow-up|6|||
164228941|NCT01027351|593207450|FG005|Overall Study|Lost to Follow-up|0|||
164228942|NCT01027351|593207445|FG000|Overall Study|Inappropriate enrollment|0|||
164331378|NCT03552965|593589990|FG000|Overall Study|Death|1|||
164331379|NCT03552965|593589991|FG001|Overall Study|Death|1|||
164331380|NCT03552965|593589990|FG000|Overall Study|Lost to Follow-up|1|||
164331381|NCT03552965|593589991|FG001|Overall Study|Lost to Follow-up|1|||
164331382|NCT03552965|593589990|FG000|Overall Study|Physician Decision|1|||
164228943|NCT01027351|593207446|FG001|Overall Study|Inappropriate enrollment|0|||
164228944|NCT01027351|593207447|FG002|Overall Study|Inappropriate enrollment|0|||
164228945|NCT01027351|593207448|FG003|Overall Study|Inappropriate enrollment|0|||
164331383|NCT03552965|593589991|FG001|Overall Study|Physician Decision|1|||
164228946|NCT01027351|593207449|FG004|Overall Study|Inappropriate enrollment|1|||
164228947|NCT01027351|593207450|FG005|Overall Study|Inappropriate enrollment|0|||
164331384|NCT03552965|593589990|FG000|Overall Study|Withdrawal by Subject|0|||
164331385|NCT03552965|593589991|FG001|Overall Study|Withdrawal by Subject|2|||
164331386|NCT03552965|593589990|FG000|Overall Study|Continuation not in patient best interest|1|||
164421419|NCT01644474|593912744|FG001|Overall Study|Poor compliance to protocol|0|||
164228948|NCT01027351|593207445|FG000|Overall Study|Protocol Violation|1|||
164228949|NCT01027351|593207446|FG001|Overall Study|Protocol Violation|0|||
164228950|NCT01027351|593207447|FG002|Overall Study|Protocol Violation|0|||
164228951|NCT01027351|593207448|FG003|Overall Study|Protocol Violation|1|||
164228952|NCT01027351|593207449|FG004|Overall Study|Protocol Violation|1|||
164228953|NCT01027351|593207450|FG005|Overall Study|Protocol Violation|0|||
164228954|NCT00911157|593207451|FG000|Overall Study|Adverse Event|4|||
164228955|NCT00911157|593207452|FG001|Overall Study|Adverse Event|1|||
164228956|NCT00911157|593207451|FG000|Overall Study|Withdrawal by Subject|1|||
164228957|NCT00911157|593207452|FG001|Overall Study|Withdrawal by Subject|1|||
164228958|NCT00911157|593207451|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
164228959|NCT00911157|593207452|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
164228960|NCT00911157|593207451|FG000|Overall Study|Need to treat for lung cancer|1|||
164228961|NCT00911157|593207452|FG001|Overall Study|Need to treat for lung cancer|0|||
164228962|NCT01852214|593207453|FG000|Period 1|Adverse Event|1|||
164228963|NCT01852214|593207454|FG001|Period 1|Adverse Event|2|||
164228964|NCT01852214|593207453|FG000|Period 1|Withdrawal by Subject|0|||
164228965|NCT01852214|593207454|FG001|Period 1|Withdrawal by Subject|1|||
164421420|NCT01644474|593912743|FG000|Overall Study|Consent withdrawn by participant|0|||
164421421|NCT01644474|593912744|FG001|Overall Study|Consent withdrawn by participant|1|||
164421422|NCT01644474|593912743|FG000|Overall Study|Participant moved|0|||
164421423|NCT01644474|593912744|FG001|Overall Study|Participant moved|1|||
164421424|NCT01644474|593912743|FG000|Overall Study|Adverse Event|4|||
164421425|NCT01644474|593912744|FG001|Overall Study|Adverse Event|5|||
164421426|NCT01644474|593912743|FG000|Overall Study|Site scheduling error|1|||
164421427|NCT01644474|593912744|FG001|Overall Study|Site scheduling error|1|||
164421428|NCT01644474|593912743|FG000|Overall Study|Protocol Violation|1|||
164421429|NCT01644474|593912744|FG001|Overall Study|Protocol Violation|0|||
164421430|NCT04039503|593912749|FG000|Overall Study|Adverse Event|3|||
164421431|NCT04039503|593912750|FG001|Overall Study|Adverse Event|0|||
164421432|NCT04039503|593912751|FG002|Overall Study|Adverse Event|2|||
164421433|NCT04039503|593912752|FG003|Overall Study|Adverse Event|0|||
164421434|NCT04039503|593912749|FG000|Overall Study|Lost to Follow-up|0|||
164421435|NCT04039503|593912750|FG001|Overall Study|Lost to Follow-up|0|||
164421436|NCT04039503|593912751|FG002|Overall Study|Lost to Follow-up|1|||
164421437|NCT04039503|593912752|FG003|Overall Study|Lost to Follow-up|0|||
164421438|NCT04039503|593912749|FG000|Overall Study|Protocol Violation|0|||
164421439|NCT04039503|593912750|FG001|Overall Study|Protocol Violation|1|||
164421440|NCT04039503|593912751|FG002|Overall Study|Protocol Violation|2|||
164421441|NCT04039503|593912752|FG003|Overall Study|Protocol Violation|1|||
164421442|NCT04039503|593912749|FG000|Overall Study|Withdrawal by Subject|4|||
164421443|NCT04039503|593912750|FG001|Overall Study|Withdrawal by Subject|3|||
164228966|NCT01852214|593207453|FG000|Washout Period|Withdrawal by Subject|0|||
164228967|NCT01852214|593207454|FG001|Washout Period|Withdrawal by Subject|1|||
164228968|NCT04091438|593207455|FG000|Treatment Period 1 (1 Day)|Other|1|||
164228969|NCT04091438|593207456|FG001|Treatment Period 1 (1 Day)|Other|0|||
164228970|NCT04091438|593207455|FG000|Washout Period (1 Day)|Protocol deviation|0|||
164228971|NCT04091438|593207456|FG001|Washout Period (1 Day)|Protocol deviation|1|||
164228972|NCT04091438|593207455|FG000|Washout Period (1 Day)|Other|0|||
164228973|NCT04091438|593207456|FG001|Washout Period (1 Day)|Other|1|||
164228974|NCT00421408|593207457|FG000|Overall Study|Lost to Follow-up|30|||
164228975|NCT00421408|593207458|FG001|Overall Study|Lost to Follow-up|20|||
164228976|NCT00421408|593207457|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
164228977|NCT00421408|593207458|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
164228978|NCT04105725|593207459|FG000|Primary Intervention|Lost to Follow-up|0|||
164228979|NCT04105725|593207460|FG001|Primary Intervention|Lost to Follow-up|2|||
164228980|NCT04105725|593207459|FG000|Primary Intervention|Withdrawal by Subject|0|||
164228981|NCT04105725|593207460|FG001|Primary Intervention|Withdrawal by Subject|1|||
164228982|NCT04573881|593207461|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
164228983|NCT03058952|593209216|FG000|Overall Study|Adverse Event|1|||
164228984|NCT03058952|593209217|FG001|Overall Study|Adverse Event|0|||
164228985|NCT03058952|593209216|FG000|Overall Study|Lost to Follow-up|15|||
164228986|NCT03058952|593209217|FG001|Overall Study|Lost to Follow-up|15|||
164228987|NCT03058952|593209216|FG000|Overall Study|Withdrawal by Subject|7|||
164228988|NCT03058952|593209217|FG001|Overall Study|Withdrawal by Subject|11|||
164228989|NCT01373281|593209220|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
164228990|NCT01373281|593209221|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
164228991|NCT01373281|593209220|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
164228992|NCT01373281|593209221|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
164228993|NCT01373281|593209220|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
164421444|NCT04039503|593912751|FG002|Overall Study|Withdrawal by Subject|5|||
164421445|NCT04039503|593912752|FG003|Overall Study|Withdrawal by Subject|2|||
164421446|NCT02044458|593912754|FG000|Overall Study|Protocol Violation|3|||
164421447|NCT02044458|593912755|FG001|Overall Study|Protocol Violation|8|||
164228994|NCT01373281|593209221|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
164228995|NCT01373281|593209220|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
164228996|NCT01373281|593209221|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
164228997|NCT01373281|593209220|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
164228998|NCT01373281|593209221|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
164228999|NCT01373281|593209220|FG000|Surveillance Expansion Period|Protocol Violation|9|||
164229000|NCT01373281|593209221|FG001|Surveillance Expansion Period|Protocol Violation|1|||
164229001|NCT01373281|593209220|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
164229002|NCT01373281|593209221|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
164229003|NCT01373281|593209220|FG000|Surveillance Expansion Period|Serious adverse event|3|||
164229004|NCT01373281|593209221|FG001|Surveillance Expansion Period|Serious adverse event|4|||
164229005|NCT02296476|593209222|FG000|Overall Study|Disease Progression|6|||
164229006|NCT02296476|593209223|FG001|Overall Study|Disease Progression|4|||
164331387|NCT03552965|593589991|FG001|Overall Study|Continuation not in patient best interest|0|||
164421448|NCT05567952|593914412|FG000|Overall Study|Lost to Follow-up|3|||
164421449|NCT05567952|593914413|FG001|Overall Study|Lost to Follow-up|2|||
164421450|NCT05567952|593914412|FG000|Overall Study|Withdrawal by Subject|6|||
164331388|NCT03552965|593589990|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
164331389|NCT03552965|593589991|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
164331390|NCT03670836|593589992|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
164331391|NCT03670836|593589993|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
164331392|NCT03670836|593589992|FG000|Per Protocol Population (PP)|Physician Decision|9|||
164331393|NCT03670836|593589993|FG001|Per Protocol Population (PP)|Physician Decision|10|||
164331394|NCT03670836|593589992|FG000|Per Protocol Population (PP)|Physician Decision|4|||
164331395|NCT03670836|593589993|FG001|Per Protocol Population (PP)|Physician Decision|6|||
164331396|NCT03670836|593589992|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
164331397|NCT03670836|593589993|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
164331398|NCT05108922|593591221|FG000|Overall Study|Adverse Event|2|||
164331399|NCT05108922|593591222|FG001|Overall Study|Adverse Event|3|||
164331400|NCT05108922|593591221|FG000|Overall Study|Lost to Follow-up|2|||
164331401|NCT05108922|593591222|FG001|Overall Study|Lost to Follow-up|1|||
164331402|NCT05108922|593591221|FG000|Overall Study|Inadvertent enrollment|0|||
164331403|NCT05108922|593591222|FG001|Overall Study|Inadvertent enrollment|1|||
164331404|NCT05108922|593591221|FG000|Overall Study|Physician Decision|2|||
164331405|NCT05108922|593591222|FG001|Overall Study|Physician Decision|3|||
164331406|NCT05108922|593591221|FG000|Overall Study|Protocol deviation|1|||
164331407|NCT05108922|593591222|FG001|Overall Study|Protocol deviation|0|||
164331408|NCT05108922|593591221|FG000|Overall Study|Screen failure|1|||
164331409|NCT05108922|593591222|FG001|Overall Study|Screen failure|0|||
164331410|NCT05108922|593591221|FG000|Overall Study|Withdrawal by Subject|11|||
164331411|NCT05108922|593591222|FG001|Overall Study|Withdrawal by Subject|8|||
164331412|NCT05036369|593591223|FG000|Overall Study|Run In non compliance|1|||
164331413|NCT05036369|593591224|FG001|Overall Study|Run In non compliance|2|||
164331414|NCT05036369|593591223|FG000|Overall Study|Change in eligibility criteria|0|||
164331415|NCT05036369|593591224|FG001|Overall Study|Change in eligibility criteria|1|||
164331416|NCT01846104|593591225|FG000|Overall Study|Withdrawal by Subject|1|||
164331417|NCT01854658|593591230|FG000|Overall Study|Protocol Violation|6|||
164331418|NCT01854658|593591231|FG001|Overall Study|Protocol Violation|2|||
164331419|NCT01854658|593591232|FG002|Overall Study|Protocol Violation|2|||
164331420|NCT01854658|593591233|FG003|Overall Study|Protocol Violation|1|||
164331421|NCT01854658|593591230|FG000|Overall Study|Physician Decision|7|||
164331422|NCT01854658|593591231|FG001|Overall Study|Physician Decision|5|||
164331423|NCT01854658|593591232|FG002|Overall Study|Physician Decision|2|||
164331424|NCT01854658|593591233|FG003|Overall Study|Physician Decision|4|||
164331425|NCT01854658|593591230|FG000|Overall Study|Lost to Follow-up|8|||
164331426|NCT01854658|593591231|FG001|Overall Study|Lost to Follow-up|9|||
164331427|NCT01854658|593591232|FG002|Overall Study|Lost to Follow-up|8|||
164421451|NCT05567952|593914413|FG001|Overall Study|Withdrawal by Subject|3|||
164229007|NCT02296476|593209224|FG002|Overall Study|Disease Progression|2|||
164229008|NCT03345550|593209230|FG000|Overall Study|Withdrawal by Subject|1|||
164229009|NCT03345550|593209231|FG001|Overall Study|Withdrawal by Subject|0|||
164229010|NCT03345550|593209230|FG000|Overall Study|Lost to Follow-up|4|||
164229011|NCT03345550|593209231|FG001|Overall Study|Lost to Follow-up|5|||
164229012|NCT01149460|593209234|FG000|Overall Study|Withdrawal by Subject|0|||
164229013|NCT01149460|593209235|FG001|Overall Study|Withdrawal by Subject|2|||
164331428|NCT01854658|593591233|FG003|Overall Study|Lost to Follow-up|4|||
164421452|NCT05567952|593914412|FG000|Overall Study|Other|3|||
164229014|NCT03257657|593209236|FG000|Overall Study|Lost to Follow-up|0|||
164331429|NCT01854658|593591230|FG000|Overall Study|Withdrawal by Subject|28|||
164331430|NCT01854658|593591231|FG001|Overall Study|Withdrawal by Subject|21|||
164331431|NCT01854658|593591232|FG002|Overall Study|Withdrawal by Subject|29|||
164331432|NCT01854658|593591233|FG003|Overall Study|Withdrawal by Subject|15|||
164331433|NCT01854658|593591230|FG000|Overall Study|Protocol-specified criteria|15|||
164331434|NCT01854658|593591231|FG001|Overall Study|Protocol-specified criteria|15|||
164331435|NCT01854658|593591232|FG002|Overall Study|Protocol-specified criteria|10|||
164421453|NCT05567952|593914413|FG001|Overall Study|Other|1|||
164421454|NCT02692235|593914414|FG000|Overall Study|Withdrawal by Subject|2|||
164571798|NCT03538743|594458380|FG004|Overall Study|Withdrawal by Subject|0|||
164571799|NCT03538743|594458381|FG005|Overall Study|Withdrawal by Subject|0|||
164571800|NCT03538743|594458382|FG006|Overall Study|Withdrawal by Subject|0|||
164571801|NCT03538743|594458383|FG007|Overall Study|Withdrawal by Subject|0|||
164571802|NCT03538743|594458384|FG008|Overall Study|Withdrawal by Subject|0|||
164229015|NCT03257657|593209237|FG001|Overall Study|Lost to Follow-up|3|||
164229016|NCT03257657|593209236|FG000|Overall Study|Withdrawn|0|||
164229017|NCT03257657|593209237|FG001|Overall Study|Withdrawn|1|||
164229018|NCT03257657|593209236|FG000|Overall Study|Noted not eligible right after enrolled|0|||
164229019|NCT03257657|593209237|FG001|Overall Study|Noted not eligible right after enrolled|1|||
164229020|NCT02801578|593209238|FG000|Overall Study|Adverse Event|2|||
164229021|NCT00668642|593209244|FG000|First Off-cycle|Cancer progression|1|||
164229022|NCT00668642|593209245|FG001|First Off-cycle|Cancer progression|0|||
164229023|NCT00668642|593209244|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
164229024|NCT00668642|593209245|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
164229025|NCT02272985|593209246|FG000|Overall Study|Withdrawal by Subject|1|||
164229026|NCT02272985|593209246|FG000|Overall Study|hip fracture|1|||
164229027|NCT02272985|593209246|FG000|Overall Study|kidney transplantation|1|||
164229028|NCT02489279|593209249|FG000|Overall Study|Lost to Follow-up|12|||
164229029|NCT02489279|593209250|FG001|Overall Study|Lost to Follow-up|10|||
164229030|NCT03440411|593209251|FG000|Overall Study|Adverse Event|0|||
164229031|NCT03440411|593209252|FG001|Overall Study|Adverse Event|0|||
164229032|NCT03440411|593209253|FG002|Overall Study|Adverse Event|1|||
164229033|NCT03440411|593209254|FG003|Overall Study|Adverse Event|0|||
164229034|NCT03440411|593209251|FG000|Overall Study|PD|2|||
164229035|NCT03440411|593209252|FG001|Overall Study|PD|1|||
164229036|NCT03440411|593209253|FG002|Overall Study|PD|1|||
164229037|NCT03440411|593209254|FG003|Overall Study|PD|1|||
164229038|NCT03440411|593209251|FG000|Overall Study|Withdrawal by Subject|1|||
164229039|NCT03440411|593209252|FG001|Overall Study|Withdrawal by Subject|0|||
164229040|NCT03440411|593209253|FG002|Overall Study|Withdrawal by Subject|0|||
164229041|NCT03440411|593209254|FG003|Overall Study|Withdrawal by Subject|0|||
164229042|NCT03440411|593209251|FG000|Overall Study|Closed study by sponsor|0|||
164229043|NCT03440411|593209252|FG001|Overall Study|Closed study by sponsor|0|||
164229044|NCT03440411|593209253|FG002|Overall Study|Closed study by sponsor|0|||
164229045|NCT03440411|593209254|FG003|Overall Study|Closed study by sponsor|1|||
164229046|NCT00505687|593209255|FG000|Overall Study|Important protocol violation|2|||
164229047|NCT00505687|593209255|FG000|Overall Study|Lack of Efficacy|15|||
164229048|NCT00505687|593209255|FG000|Overall Study|Adverse Event|48|||
164229049|NCT00505687|593209255|FG000|Overall Study|Subject withdrew consent|15|||
164229050|NCT00505687|593209255|FG000|Overall Study|Lost to Follow-up|1|||
164229051|NCT00505687|593209255|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
164229052|NCT00505687|593209255|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
164229053|NCT00505687|593209255|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
164229054|NCT00505687|593209255|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
164229055|NCT00505687|593209255|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
164229056|NCT00505687|593209255|FG000|Overall Study|Other: Disease Progression|1|||
164229057|NCT00505687|593209255|FG000|Overall Study|Other: As Per Sponsor|8|||
164229058|NCT03707821|593209256|FG000|Overall Study|Protocol Violation|0|||
164571803|NCT01827384|594458387|FG000|Overall Study|Switched to alternative treatment|0|||
164571804|NCT01827384|594458388|FG001|Overall Study|Switched to alternative treatment|0|||
164675495|NCT00440518|594836744|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
164229059|NCT03707821|593209257|FG001|Overall Study|Protocol Violation|1|||
164229060|NCT03707821|593209256|FG000|Overall Study|Unsatisfactory Visual Response|1|||
164229061|NCT03707821|593209257|FG001|Overall Study|Unsatisfactory Visual Response|0|||
164229062|NCT03707821|593209256|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
164229063|NCT03707821|593209257|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
164229064|NCT01432444|593209258|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
164229065|NCT01432444|593209259|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
164229066|NCT01432444|593209260|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
164229067|NCT01432444|593209258|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
164229068|NCT01432444|593209259|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
164229069|NCT01432444|593209260|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
164229070|NCT01432444|593209258|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
164229071|NCT01432444|593209259|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
164229072|NCT01432444|593209260|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
164421455|NCT02692235|593914415|FG001|Overall Study|Withdrawal by Subject|1|||
164229073|NCT01432444|593209258|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
164229074|NCT01432444|593209259|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
164229075|NCT01432444|593209260|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
164229076|NCT01432444|593209258|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
164229077|NCT01432444|593209259|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
164571805|NCT01827384|594458389|FG002|Overall Study|Switched to alternative treatment|0|||
164229078|NCT01432444|593209260|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
164229079|NCT01432444|593209258|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
164229080|NCT01432444|593209259|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
164229081|NCT01432444|593209260|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
164229082|NCT01432444|593209258|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
164229083|NCT01432444|593209259|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
164229084|NCT01432444|593209260|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
164229085|NCT01432444|593209258|FG000|Treatment Phase|Lost to Follow-up|0|||
164229086|NCT01432444|593209259|FG001|Treatment Phase|Lost to Follow-up|33|||
164571806|NCT01827384|594458390|FG003|Overall Study|Switched to alternative treatment|0|||
164571807|NCT01827384|594458391|FG004|Overall Study|Switched to alternative treatment|0|||
164571808|NCT01827384|594458392|FG005|Overall Study|Switched to alternative treatment|0|||
164571809|NCT01827384|594458393|FG006|Overall Study|Switched to alternative treatment|0|||
164229087|NCT01432444|593209260|FG002|Treatment Phase|Lost to Follow-up|0|||
164571810|NCT01827384|594458394|FG007|Overall Study|Switched to alternative treatment|0|||
164229088|NCT01432444|593209258|FG000|Treatment Phase|Adverse Event|0|||
164229089|NCT01432444|593209259|FG001|Treatment Phase|Adverse Event|37|||
164229090|NCT01432444|593209260|FG002|Treatment Phase|Adverse Event|0|||
164229091|NCT01432444|593209258|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
164229092|NCT01432444|593209259|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
164229093|NCT01432444|593209260|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
164229094|NCT01432444|593209258|FG000|Treatment Phase|Physician Decision|0|||
164571811|NCT01827384|594458395|FG008|Overall Study|Switched to alternative treatment|0|||
164571812|NCT01827384|594458396|FG009|Overall Study|Switched to alternative treatment|0|||
164229095|NCT01432444|593209259|FG001|Treatment Phase|Physician Decision|5|||
164229096|NCT01432444|593209260|FG002|Treatment Phase|Physician Decision|0|||
164229097|NCT01432444|593209258|FG000|Treatment Phase|Withdrawal by Subject|0|||
164229098|NCT01432444|593209259|FG001|Treatment Phase|Withdrawal by Subject|41|||
164229099|NCT01432444|593209260|FG002|Treatment Phase|Withdrawal by Subject|0|||
164229100|NCT01432444|593209258|FG000|Treatment Phase|Protocol Deviation|0|||
164229101|NCT01432444|593209259|FG001|Treatment Phase|Protocol Deviation|3|||
164229102|NCT01432444|593209260|FG002|Treatment Phase|Protocol Deviation|0|||
164229103|NCT01432444|593209258|FG000|Treatment Phase|Lack of Efficacy|0|||
164229104|NCT01432444|593209259|FG001|Treatment Phase|Lack of Efficacy|10|||
164229105|NCT01432444|593209260|FG002|Treatment Phase|Lack of Efficacy|0|||
164229106|NCT01432444|593209258|FG000|Extension Phase|Lost to Follow-up|0|||
164229107|NCT01432444|593209259|FG001|Extension Phase|Lost to Follow-up|0|||
164229108|NCT01432444|593209260|FG002|Extension Phase|Lost to Follow-up|17|||
164229109|NCT01432444|593209258|FG000|Extension Phase|Adverse Event|0|||
164229110|NCT01432444|593209259|FG001|Extension Phase|Adverse Event|0|||
164229111|NCT01432444|593209260|FG002|Extension Phase|Adverse Event|10|||
164229112|NCT01432444|593209258|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
164229113|NCT01432444|593209259|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
164229114|NCT01432444|593209260|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
164229115|NCT01432444|593209258|FG000|Extension Phase|Met Withdrawal Criteria|0|||
164229116|NCT01432444|593209259|FG001|Extension Phase|Met Withdrawal Criteria|0|||
164229117|NCT01432444|593209260|FG002|Extension Phase|Met Withdrawal Criteria|144|||
164229118|NCT01432444|593209258|FG000|Extension Phase|Physician Decision|0|||
164229119|NCT01432444|593209259|FG001|Extension Phase|Physician Decision|0|||
164229120|NCT01432444|593209260|FG002|Extension Phase|Physician Decision|1|||
164229121|NCT01432444|593209258|FG000|Extension Phase|Withdrawal by Subject|0|||
164229122|NCT01432444|593209259|FG001|Extension Phase|Withdrawal by Subject|0|||
164229123|NCT01432444|593209260|FG002|Extension Phase|Withdrawal by Subject|13|||
164229124|NCT03673176|593209261|FG000|Overall Study|Death prior to intervention|1|||
164229125|NCT03673176|593209261|FG000|Overall Study|Death following intervention|3|||
164229126|NCT03673176|593209261|FG000|Overall Study|Withdrawal by Subject|1|||
164229127|NCT02378480|593209262|FG000|Overall Study|Physician Decision|1|||
164229128|NCT02378480|593209263|FG001|Overall Study|Physician Decision|1|||
164421456|NCT02692235|593914414|FG000|Overall Study|Adverse Event|1|||
164229129|NCT02378480|593209262|FG000|Overall Study|Death|1|||
164229130|NCT02378480|593209263|FG001|Overall Study|Death|2|||
164229131|NCT02378480|593209262|FG000|Overall Study|Randomized, but Not Treated|6|||
164229132|NCT02378480|593209263|FG001|Overall Study|Randomized, but Not Treated|4|||
164229133|NCT02378480|593209262|FG000|Overall Study|Adverse Event|0|||
164229134|NCT02378480|593209263|FG001|Overall Study|Adverse Event|1|||
164229135|NCT02378480|593209262|FG000|Overall Study|Missed EOT/PTE Visit|1|||
164229136|NCT02378480|593209263|FG001|Overall Study|Missed EOT/PTE Visit|2|||
164229137|NCT02378480|593209262|FG000|Overall Study|Withdrawal by Subject|9|||
164229138|NCT02378480|593209263|FG001|Overall Study|Withdrawal by Subject|4|||
164229139|NCT02378480|593209262|FG000|Overall Study|Lost to Follow-up|10|||
164229140|NCT02378480|593209263|FG001|Overall Study|Lost to Follow-up|18|||
164229141|NCT01230060|593209267|FG000|Overall Study|Withdrawal by Subject|1|||
164229142|NCT03802916|593209268|FG000|Overall Study|Adverse Event|0|||
164229143|NCT03802916|593209269|FG001|Overall Study|Adverse Event|1|||
164571813|NCT01827384|594458397|FG010|Overall Study|Switched to alternative treatment|0|||
164229144|NCT03802916|593209268|FG000|Overall Study|Withdrawal by Subject|0|||
164229145|NCT03802916|593209269|FG001|Overall Study|Withdrawal by Subject|1|||
164229146|NCT01285102|593209270|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
164229147|NCT02157610|593209271|FG000|Overall Study|Death|4|||
164229148|NCT02157610|593209272|FG001|Overall Study|Death|4|||
164229149|NCT02327169|593209273|FG000|Overall Study|Progressive Disease|1|||
164229150|NCT02327169|593209274|FG001|Overall Study|Progressive Disease|3|||
164229151|NCT02327169|593209275|FG002|Overall Study|Progressive Disease|4|||
164229152|NCT02327169|593209276|FG003|Overall Study|Progressive Disease|3|||
164229153|NCT02327169|593209277|FG004|Overall Study|Progressive Disease|4|||
164229154|NCT02327169|593209278|FG005|Overall Study|Progressive Disease|3|||
164229155|NCT02327169|593209279|FG006|Overall Study|Progressive Disease|3|||
164229156|NCT02327169|593209280|FG007|Overall Study|Progressive Disease|3|||
164229157|NCT02327169|593209281|FG008|Overall Study|Progressive Disease|4|||
164229158|NCT02327169|593209282|FG009|Overall Study|Progressive Disease|4|||
164229159|NCT02327169|593209283|FG010|Overall Study|Progressive Disease|4|||
164229160|NCT02327169|593209284|FG011|Overall Study|Progressive Disease|3|||
164229161|NCT02327169|593209285|FG012|Overall Study|Progressive Disease|1|||
164229162|NCT02327169|593209286|FG013|Overall Study|Progressive Disease|3|||
164229163|NCT02327169|593209287|FG014|Overall Study|Progressive Disease|3|||
164229164|NCT02327169|593209273|FG000|Overall Study|Adverse Event|2|||
164229165|NCT02327169|593209274|FG001|Overall Study|Adverse Event|0|||
164229166|NCT02327169|593209275|FG002|Overall Study|Adverse Event|1|||
164229167|NCT02327169|593209276|FG003|Overall Study|Adverse Event|0|||
164229168|NCT02327169|593209277|FG004|Overall Study|Adverse Event|1|||
164229169|NCT02327169|593209278|FG005|Overall Study|Adverse Event|0|||
164229170|NCT02327169|593209279|FG006|Overall Study|Adverse Event|0|||
164229171|NCT02327169|593209280|FG007|Overall Study|Adverse Event|0|||
164229172|NCT02327169|593209281|FG008|Overall Study|Adverse Event|0|||
164229173|NCT02327169|593209282|FG009|Overall Study|Adverse Event|2|||
164229174|NCT02327169|593209283|FG010|Overall Study|Adverse Event|0|||
164229175|NCT02327169|593209284|FG011|Overall Study|Adverse Event|3|||
164229176|NCT02327169|593209285|FG012|Overall Study|Adverse Event|0|||
164229177|NCT02327169|593209286|FG013|Overall Study|Adverse Event|2|||
164229178|NCT02327169|593209287|FG014|Overall Study|Adverse Event|1|||
164229179|NCT02327169|593209273|FG000|Overall Study|Symptomatic Deterioration|0|||
164229180|NCT02327169|593209274|FG001|Overall Study|Symptomatic Deterioration|0|||
164229181|NCT02327169|593209275|FG002|Overall Study|Symptomatic Deterioration|1|||
164229182|NCT02327169|593209276|FG003|Overall Study|Symptomatic Deterioration|0|||
164229183|NCT02327169|593209277|FG004|Overall Study|Symptomatic Deterioration|1|||
164229184|NCT02327169|593209278|FG005|Overall Study|Symptomatic Deterioration|1|||
164229185|NCT02327169|593209279|FG006|Overall Study|Symptomatic Deterioration|0|||
164229186|NCT02327169|593209280|FG007|Overall Study|Symptomatic Deterioration|0|||
164229187|NCT02327169|593209281|FG008|Overall Study|Symptomatic Deterioration|2|||
164331436|NCT01854658|593591233|FG003|Overall Study|Protocol-specified criteria|7|||
164331437|NCT01854658|593591230|FG000|Overall Study|Lack of Efficacy|3|||
164331438|NCT01854658|593591231|FG001|Overall Study|Lack of Efficacy|8|||
164331439|NCT01854658|593591232|FG002|Overall Study|Lack of Efficacy|4|||
164331440|NCT01854658|593591233|FG003|Overall Study|Lack of Efficacy|7|||
164331441|NCT01854658|593591230|FG000|Overall Study|Adverse Event|21|||
164331442|NCT01854658|593591231|FG001|Overall Study|Adverse Event|14|||
164331443|NCT01854658|593591232|FG002|Overall Study|Adverse Event|23|||
164331444|NCT01854658|593591233|FG003|Overall Study|Adverse Event|19|||
164229188|NCT02327169|593209282|FG009|Overall Study|Symptomatic Deterioration|1|||
164229189|NCT02327169|593209283|FG010|Overall Study|Symptomatic Deterioration|0|||
164229190|NCT02327169|593209284|FG011|Overall Study|Symptomatic Deterioration|0|||
164229191|NCT02327169|593209285|FG012|Overall Study|Symptomatic Deterioration|0|||
164229192|NCT02327169|593209286|FG013|Overall Study|Symptomatic Deterioration|2|||
164229193|NCT02327169|593209287|FG014|Overall Study|Symptomatic Deterioration|1|||
164229194|NCT02327169|593209273|FG000|Overall Study|Reason Not Specified|0|||
164229195|NCT02327169|593209274|FG001|Overall Study|Reason Not Specified|0|||
164229196|NCT02327169|593209275|FG002|Overall Study|Reason Not Specified|1|||
164229197|NCT02327169|593209276|FG003|Overall Study|Reason Not Specified|0|||
164229198|NCT02327169|593209277|FG004|Overall Study|Reason Not Specified|0|||
164229199|NCT02327169|593209278|FG005|Overall Study|Reason Not Specified|0|||
164229200|NCT02327169|593209279|FG006|Overall Study|Reason Not Specified|0|||
164331445|NCT01854658|593591230|FG000|Overall Study|Administrative reasons|5|||
164421457|NCT02692235|593914415|FG001|Overall Study|Adverse Event|2|||
164229201|NCT02327169|593209280|FG007|Overall Study|Reason Not Specified|0|||
164229202|NCT02327169|593209281|FG008|Overall Study|Reason Not Specified|0|||
164229203|NCT02327169|593209282|FG009|Overall Study|Reason Not Specified|1|||
164229204|NCT02327169|593209283|FG010|Overall Study|Reason Not Specified|2|||
164229205|NCT02327169|593209284|FG011|Overall Study|Reason Not Specified|1|||
164229206|NCT02327169|593209285|FG012|Overall Study|Reason Not Specified|0|||
164229207|NCT02327169|593209286|FG013|Overall Study|Reason Not Specified|0|||
164229208|NCT02327169|593209287|FG014|Overall Study|Reason Not Specified|2|||
164331446|NCT01854658|593591231|FG001|Overall Study|Administrative reasons|1|||
164331447|NCT01854658|593591232|FG002|Overall Study|Administrative reasons|2|||
164229209|NCT02327169|593209273|FG000|Overall Study|Withdrawal by Subject|1|||
164229210|NCT02327169|593209274|FG001|Overall Study|Withdrawal by Subject|0|||
164229211|NCT02327169|593209275|FG002|Overall Study|Withdrawal by Subject|0|||
164229212|NCT02327169|593209276|FG003|Overall Study|Withdrawal by Subject|0|||
164229213|NCT02327169|593209277|FG004|Overall Study|Withdrawal by Subject|1|||
164229214|NCT02327169|593209278|FG005|Overall Study|Withdrawal by Subject|0|||
164229215|NCT02327169|593209279|FG006|Overall Study|Withdrawal by Subject|0|||
164229216|NCT02327169|593209280|FG007|Overall Study|Withdrawal by Subject|1|||
164229217|NCT02327169|593209281|FG008|Overall Study|Withdrawal by Subject|0|||
164229218|NCT02327169|593209282|FG009|Overall Study|Withdrawal by Subject|0|||
164229219|NCT02327169|593209283|FG010|Overall Study|Withdrawal by Subject|0|||
164229220|NCT02327169|593209284|FG011|Overall Study|Withdrawal by Subject|0|||
164229221|NCT02327169|593209285|FG012|Overall Study|Withdrawal by Subject|0|||
164229222|NCT02327169|593209286|FG013|Overall Study|Withdrawal by Subject|0|||
164229223|NCT02327169|593209287|FG014|Overall Study|Withdrawal by Subject|3|||
164229224|NCT02327169|593209273|FG000|Overall Study|Lost to Follow-up|0|||
164229225|NCT02327169|593209274|FG001|Overall Study|Lost to Follow-up|0|||
164229226|NCT02327169|593209275|FG002|Overall Study|Lost to Follow-up|0|||
164229227|NCT02327169|593209276|FG003|Overall Study|Lost to Follow-up|0|||
164229228|NCT02327169|593209277|FG004|Overall Study|Lost to Follow-up|1|||
164229229|NCT02327169|593209278|FG005|Overall Study|Lost to Follow-up|0|||
164229230|NCT02327169|593209279|FG006|Overall Study|Lost to Follow-up|0|||
164229231|NCT02327169|593209280|FG007|Overall Study|Lost to Follow-up|0|||
164229232|NCT02327169|593209281|FG008|Overall Study|Lost to Follow-up|0|||
164229233|NCT02327169|593209282|FG009|Overall Study|Lost to Follow-up|0|||
164229234|NCT02327169|593209283|FG010|Overall Study|Lost to Follow-up|0|||
164229235|NCT02327169|593209284|FG011|Overall Study|Lost to Follow-up|0|||
164229236|NCT02327169|593209285|FG012|Overall Study|Lost to Follow-up|0|||
164229237|NCT02327169|593209286|FG013|Overall Study|Lost to Follow-up|0|||
164229238|NCT02327169|593209287|FG014|Overall Study|Lost to Follow-up|0|||
164229239|NCT03787615|593209288|FG000|Overall Study|Withdrawal by Subject|2|||
164331448|NCT01854658|593591233|FG003|Overall Study|Administrative reasons|2|||
164331449|NCT00331864|593591236|FG000|Overall Study|Adverse Event|30|||
164331450|NCT00331864|593591237|FG001|Overall Study|Adverse Event|1|||
164331451|NCT00331864|593591236|FG000|Overall Study|Lack of Efficacy|4|||
164331452|NCT00331864|593591237|FG001|Overall Study|Lack of Efficacy|0|||
164331453|NCT00331864|593591236|FG000|Overall Study|Protocol Violation|3|||
164331454|NCT00331864|593591237|FG001|Overall Study|Protocol Violation|0|||
164331455|NCT00331864|593591236|FG000|Overall Study|Withdrawal by Subject|10|||
164331456|NCT00331864|593591237|FG001|Overall Study|Withdrawal by Subject|0|||
164331457|NCT00331864|593591236|FG000|Overall Study|Lost to Follow-up|4|||
164331458|NCT00331864|593591237|FG001|Overall Study|Lost to Follow-up|3|||
164331459|NCT00331864|593591236|FG000|Overall Study|Administrative Problems|1|||
164331460|NCT00331864|593591237|FG001|Overall Study|Administrative Problems|0|||
164331461|NCT00331864|593591236|FG000|Overall Study|Death|6|||
164331462|NCT00331864|593591237|FG001|Overall Study|Death|0|||
164331463|NCT02213042|593591239|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
164331464|NCT02213042|593591240|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
164331465|NCT02213042|593591241|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
164331466|NCT02213042|593591239|FG000|Overall Study|Adverse Event|2|||
164331467|NCT02213042|593591240|FG001|Overall Study|Adverse Event|1|||
164331468|NCT02213042|593591241|FG002|Overall Study|Adverse Event|0|||
164331469|NCT02213042|593591239|FG000|Overall Study|Withdrawal by Subject|0|||
164331470|NCT02213042|593591240|FG001|Overall Study|Withdrawal by Subject|1|||
164331471|NCT02213042|593591241|FG002|Overall Study|Withdrawal by Subject|1|||
164331472|NCT02213042|593591239|FG000|Overall Study|Protocol Violation|1|||
164331473|NCT02213042|593591240|FG001|Overall Study|Protocol Violation|0|||
164331474|NCT02213042|593591241|FG002|Overall Study|Protocol Violation|0|||
164331475|NCT02213042|593591239|FG000|Overall Study|Investigator discretion|0|||
164331476|NCT02213042|593591240|FG001|Overall Study|Investigator discretion|0|||
164331477|NCT02213042|593591241|FG002|Overall Study|Investigator discretion|1|||
164331478|NCT02007512|593591242|FG000|Double Blind Treatment Period|Adverse Event|4|||
164331479|NCT02007512|593591243|FG001|Double Blind Treatment Period|Adverse Event|6|||
164331480|NCT02007512|593591244|FG002|Double Blind Treatment Period|Adverse Event|2|||
164331481|NCT02007512|593591245|FG003|Double Blind Treatment Period|Adverse Event|2|||
164331482|NCT02007512|593591242|FG000|Double Blind Treatment Period|Death|1|||
164229240|NCT03787615|593209288|FG000|Overall Study|Lost to Follow-up|2|||
164229241|NCT01229111|593209290|FG000|Overall Study|Death|1|||
164229242|NCT01946880|593209291|FG000|Overall Study|Lost to Follow-up|1|||
164229243|NCT01946880|593209292|FG001|Overall Study|Lost to Follow-up|0|||
164229244|NCT01946880|593209291|FG000|Overall Study|Physician Decision|1|||
164331483|NCT02007512|593591243|FG001|Double Blind Treatment Period|Death|0|||
164331484|NCT02007512|593591244|FG002|Double Blind Treatment Period|Death|0|||
164331485|NCT02007512|593591245|FG003|Double Blind Treatment Period|Death|0|||
164331486|NCT02007512|593591242|FG000|Double Blind Treatment Period|Disease progression|51|||
164331487|NCT02007512|593591243|FG001|Double Blind Treatment Period|Disease progression|50|||
164421458|NCT00802841|593914416|FG000|Overall Study|Administrative problems|1|||
164421459|NCT00802841|593914417|FG001|Overall Study|Administrative problems|0|||
164421460|NCT00802841|593914416|FG000|Overall Study|Lost to Follow-up|2|||
164421461|NCT00802841|593914417|FG001|Overall Study|Lost to Follow-up|1|||
164421462|NCT00802841|593914416|FG000|Overall Study|Death|1|||
164421463|NCT00802841|593914417|FG001|Overall Study|Death|2|||
164421464|NCT00802841|593914416|FG000|Overall Study|Adverse Event|8|||
164421465|NCT00802841|593914417|FG001|Overall Study|Adverse Event|2|||
164421466|NCT00802841|593914416|FG000|Overall Study|Disease progression|7|||
164421467|NCT00802841|593914417|FG001|Overall Study|Disease progression|3|||
164421468|NCT00802841|593914416|FG000|Overall Study|Withdrawal by Subject|9|||
164421469|NCT00802841|593914417|FG001|Overall Study|Withdrawal by Subject|5|||
164421470|NCT00802841|593914416|FG000|Overall Study|Protocol deviation|2|||
164421471|NCT00802841|593914417|FG001|Overall Study|Protocol deviation|6|||
164421472|NCT00802841|593914416|FG000|Overall Study|Treatment duration completed|66|||
164421473|NCT00802841|593914417|FG001|Overall Study|Treatment duration completed|76|||
164421474|NCT01268059|593914418|FG000|Overall Study|Lost to Follow-up|0|||
164421475|NCT01268059|593914419|FG001|Overall Study|Lost to Follow-up|1|||
164421476|NCT01268059|593914420|FG002|Overall Study|Lost to Follow-up|0|||
164421477|NCT01268059|593914421|FG003|Overall Study|Lost to Follow-up|0|||
164421478|NCT01268059|593914418|FG000|Overall Study|Withdrawal by Subject|7|||
164421479|NCT01268059|593914419|FG001|Overall Study|Withdrawal by Subject|4|||
164421480|NCT01268059|593914420|FG002|Overall Study|Withdrawal by Subject|0|||
164421481|NCT01268059|593914421|FG003|Overall Study|Withdrawal by Subject|0|||
164421482|NCT01268059|593914418|FG000|Overall Study|Death|20|||
164421483|NCT01268059|593914419|FG001|Overall Study|Death|30|||
164421484|NCT01268059|593914420|FG002|Overall Study|Death|3|||
164331488|NCT02007512|593591244|FG002|Double Blind Treatment Period|Disease progression|57|||
164331489|NCT02007512|593591245|FG003|Double Blind Treatment Period|Disease progression|52|||
164331490|NCT02007512|593591242|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
164331491|NCT02007512|593591243|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
164421485|NCT01268059|593914421|FG003|Overall Study|Death|5|||
164571814|NCT01827384|594458398|FG011|Overall Study|Switched to alternative treatment|0|||
164571815|NCT01827384|594458399|FG012|Overall Study|Switched to alternative treatment|0|||
164571816|NCT01827384|594458400|FG013|Overall Study|Switched to alternative treatment|2|||
164331492|NCT02007512|593591244|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
164331493|NCT02007512|593591245|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
164331494|NCT02007512|593591242|FG000|Double Blind Treatment Period|Protocol Violation|1|||
164331495|NCT02007512|593591243|FG001|Double Blind Treatment Period|Protocol Violation|0|||
164331496|NCT02007512|593591244|FG002|Double Blind Treatment Period|Protocol Violation|0|||
164331497|NCT02007512|593591245|FG003|Double Blind Treatment Period|Protocol Violation|1|||
164331498|NCT02007512|593591242|FG000|Double Blind Treatment Period|Other|2|||
164331499|NCT02007512|593591243|FG001|Double Blind Treatment Period|Other|1|||
164331500|NCT02007512|593591244|FG002|Double Blind Treatment Period|Other|1|||
164421486|NCT01268059|593914418|FG000|Overall Study|Progression of disease|1|||
164421487|NCT01268059|593914419|FG001|Overall Study|Progression of disease|0|||
164421488|NCT01268059|593914420|FG002|Overall Study|Progression of disease|0|||
164421489|NCT01268059|593914421|FG003|Overall Study|Progression of disease|0|||
164421490|NCT03699124|593914422|FG000|Overall Study|Adverse Event|6|||
164421491|NCT03699124|593914423|FG001|Overall Study|Adverse Event|5|||
164571817|NCT01827384|594458387|FG000|Overall Study|Disease progression before treatment|0|||
164229245|NCT01946880|593209292|FG001|Overall Study|Physician Decision|1|||
164229246|NCT01946880|593209291|FG000|Overall Study|Withdrawal by Subject|3|||
164229247|NCT01946880|593209292|FG001|Overall Study|Withdrawal by Subject|2|||
164229248|NCT01946880|593209291|FG000|Overall Study|Met Primary Endpoint|1|||
164229249|NCT01946880|593209292|FG001|Overall Study|Met Primary Endpoint|0|||
164229250|NCT01946880|593209291|FG000|Overall Study|Personal and Family Issues|1|||
164229251|NCT01946880|593209292|FG001|Overall Study|Personal and Family Issues|0|||
164229252|NCT00721110|593209295|FG000|Overall Study|Ultram use|1|||
164229253|NCT00721110|593209296|FG001|Overall Study|Ultram use|0|||
164229254|NCT00721110|593209297|FG002|Overall Study|Ultram use|0|||
164229255|NCT00721110|593209298|FG003|Overall Study|Ultram use|0|||
164229256|NCT00721110|593209295|FG000|Overall Study|vertical incision|0|||
164229257|NCT00721110|593209296|FG001|Overall Study|vertical incision|0|||
164229258|NCT00721110|593209297|FG002|Overall Study|vertical incision|1|||
164229259|NCT00721110|593209298|FG003|Overall Study|vertical incision|0|||
164229260|NCT02799043|593209299|FG000|Overall Study|Adverse Event|0|||
164229261|NCT02799043|593209300|FG001|Overall Study|Adverse Event|1|||
164229262|NCT02799043|593209299|FG000|Overall Study|Death|1|||
164229263|NCT02799043|593209300|FG001|Overall Study|Death|1|||
164229264|NCT02799043|593209299|FG000|Overall Study|Lost to Follow-up|3|||
164229265|NCT02799043|593209300|FG001|Overall Study|Lost to Follow-up|6|||
164421492|NCT03699124|593914424|FG002|Overall Study|Adverse Event|2|||
164421493|NCT03699124|593914422|FG000|Overall Study|Death|0|||
164229266|NCT02799043|593209299|FG000|Overall Study|Withdrawal by Subject|4|||
164229267|NCT02799043|593209300|FG001|Overall Study|Withdrawal by Subject|4|||
164421494|NCT03699124|593914423|FG001|Overall Study|Death|2|||
164229268|NCT02799043|593209299|FG000|Overall Study|Moved to different country|0|||
164229269|NCT02799043|593209300|FG001|Overall Study|Moved to different country|1|||
164229270|NCT02799043|593209299|FG000|Overall Study|Trial Screen Failure|1|||
164229271|NCT02799043|593209300|FG001|Overall Study|Trial Screen Failure|0|||
164229272|NCT02799043|593209299|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
164229273|NCT02799043|593209300|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
164229274|NCT02226653|593209301|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
164229275|NCT02226653|593209302|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
164229276|NCT02226653|593209301|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
164229277|NCT02226653|593209302|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
164229278|NCT01922895|593209303|FG000|Overall Study|Death|0|||
164229279|NCT01922895|593209304|FG001|Overall Study|Death|1|||
164229280|NCT01922895|593209303|FG000|Overall Study|Withdrawal by Subject|1|||
164229281|NCT01922895|593209304|FG001|Overall Study|Withdrawal by Subject|2|||
164229282|NCT01922895|593209303|FG000|Overall Study|Lost to Follow-up|5|||
164229283|NCT01922895|593209304|FG001|Overall Study|Lost to Follow-up|11|||
164229284|NCT01916226|593209305|FG000|Overall Study|Adverse Event|1|||
164229285|NCT01916226|593209306|FG001|Overall Study|Adverse Event|0|||
164229286|NCT01916226|593209307|FG002|Overall Study|Adverse Event|1|||
164229287|NCT01916226|593209308|FG003|Overall Study|Adverse Event|1|||
164229288|NCT01916226|593209305|FG000|Overall Study|Lack of Efficacy|0|||
164229289|NCT01916226|593209306|FG001|Overall Study|Lack of Efficacy|0|||
164229290|NCT01916226|593209307|FG002|Overall Study|Lack of Efficacy|2|||
164229291|NCT01916226|593209308|FG003|Overall Study|Lack of Efficacy|1|||
164229292|NCT01916226|593209305|FG000|Overall Study|Protocol Violation|0|||
164229293|NCT01916226|593209306|FG001|Overall Study|Protocol Violation|1|||
164229294|NCT01916226|593209307|FG002|Overall Study|Protocol Violation|0|||
164229295|NCT01916226|593209308|FG003|Overall Study|Protocol Violation|1|||
164229296|NCT01916226|593209305|FG000|Overall Study|Physician Decision|0|||
164229297|NCT01916226|593209306|FG001|Overall Study|Physician Decision|0|||
164229298|NCT01916226|593209307|FG002|Overall Study|Physician Decision|0|||
164229299|NCT01916226|593209308|FG003|Overall Study|Physician Decision|1|||
164229300|NCT01166646|593209310|FG000|Overall Study|Protocol Violation|0|||
164229301|NCT01166646|593209311|FG001|Overall Study|Protocol Violation|1|||
164229302|NCT01166646|593209310|FG000|Overall Study|Adverse Event|1|||
164229303|NCT01166646|593209311|FG001|Overall Study|Adverse Event|0|||
164229304|NCT05142306|593209312|FG000|Overall Study|Withdrawal by Subject|0|||
164229305|NCT05142306|593209313|FG001|Overall Study|Withdrawal by Subject|0|||
164229306|NCT05142306|593209314|FG002|Overall Study|Withdrawal by Subject|1|||
164229307|NCT05430919|593209315|FG000|Overall Study|Protocol Violation|0|||
164229308|NCT05430919|593209316|FG001|Overall Study|Protocol Violation|0|||
164229309|NCT05430919|593209317|FG002|Overall Study|Protocol Violation|1|||
164229310|NCT05430919|593209318|FG003|Overall Study|Protocol Violation|0|||
164229311|NCT05430919|593209315|FG000|Overall Study|Lost to Follow-up|0|||
164229312|NCT05430919|593209316|FG001|Overall Study|Lost to Follow-up|1|||
164229313|NCT05430919|593209317|FG002|Overall Study|Lost to Follow-up|0|||
164229314|NCT05430919|593209318|FG003|Overall Study|Lost to Follow-up|0|||
164229315|NCT05430919|593209315|FG000|Overall Study|Withdrawal by Subject|3|||
164229316|NCT05430919|593209316|FG001|Overall Study|Withdrawal by Subject|0|||
164229317|NCT05430919|593209317|FG002|Overall Study|Withdrawal by Subject|0|||
164229318|NCT05430919|593209318|FG003|Overall Study|Withdrawal by Subject|1|||
164229319|NCT04650893|593209333|FG000|Overall Study|Lost to Follow-up|11|||
164229320|NCT04650893|593209334|FG001|Overall Study|Lost to Follow-up|10|||
164229321|NCT04650893|593209335|FG002|Overall Study|Lost to Follow-up|11|||
164675496|NCT00440518|594836745|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
164675497|NCT03570749|594836746|FG000|Overall Study|Ongoing|26|||
164675498|NCT03570749|594836747|FG001|Overall Study|Ongoing|25|||
164675499|NCT03570749|594836748|FG002|Overall Study|Ongoing|25|||
164675500|NCT03570749|594836749|FG003|Overall Study|Ongoing|26|||
164675501|NCT03570749|594836750|FG004|Overall Study|Ongoing|140|||
164675502|NCT03570749|594836751|FG005|Overall Study|Ongoing|142|||
164675503|NCT03570749|594836752|FG006|Overall Study|Ongoing|220|||
164675504|NCT03570749|594836746|FG000|Overall Study|Adverse Event|0|||
164675505|NCT03570749|594836747|FG001|Overall Study|Adverse Event|0|||
164675506|NCT03570749|594836748|FG002|Overall Study|Adverse Event|0|||
164675507|NCT03570749|594836749|FG003|Overall Study|Adverse Event|0|||
164675508|NCT03570749|594836750|FG004|Overall Study|Adverse Event|2|||
164675509|NCT03570749|594836751|FG005|Overall Study|Adverse Event|3|||
164675510|NCT03570749|594836752|FG006|Overall Study|Adverse Event|6|||
164229322|NCT04309500|593209340|FG000|Overall Study|Lost to Follow-up|1|||
164229323|NCT04309500|593209341|FG001|Overall Study|Lost to Follow-up|0|||
164229324|NCT04309500|593209342|FG002|Overall Study|Lost to Follow-up|0|||
164229325|NCT04309500|593209343|FG003|Overall Study|Lost to Follow-up|0|||
164229326|NCT00553475|593209344|FG000|Overall Study|Adverse Event|7|||
164229327|NCT00553475|593209345|FG001|Overall Study|Adverse Event|17|||
164675511|NCT03570749|594836746|FG000|Overall Study|Lack of Efficacy|0|||
164675512|NCT03570749|594836747|FG001|Overall Study|Lack of Efficacy|0|||
164229328|NCT00553475|593209346|FG002|Overall Study|Adverse Event|13|||
164675513|NCT03570749|594836748|FG002|Overall Study|Lack of Efficacy|0|||
164675514|NCT03570749|594836749|FG003|Overall Study|Lack of Efficacy|0|||
164421495|NCT03699124|593914424|FG002|Overall Study|Death|0|||
164421496|NCT03699124|593914422|FG000|Overall Study|Lost to Follow-up|20|||
164421497|NCT03699124|593914423|FG001|Overall Study|Lost to Follow-up|16|||
164421498|NCT03699124|593914424|FG002|Overall Study|Lost to Follow-up|15|||
164421499|NCT03699124|593914422|FG000|Overall Study|Protocol Violation|1|||
164421500|NCT03699124|593914423|FG001|Overall Study|Protocol Violation|0|||
164421501|NCT03699124|593914424|FG002|Overall Study|Protocol Violation|0|||
164421502|NCT03699124|593914422|FG000|Overall Study|Withdrawal by Subject|13|||
164421503|NCT03699124|593914423|FG001|Overall Study|Withdrawal by Subject|14|||
164421504|NCT03699124|593914424|FG002|Overall Study|Withdrawal by Subject|13|||
164421505|NCT03699124|593914422|FG000|Overall Study|Other reasons|5|||
164421506|NCT03699124|593914423|FG001|Overall Study|Other reasons|3|||
164421507|NCT03699124|593914424|FG002|Overall Study|Other reasons|10|||
164421508|NCT00472186|593914428|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
164421509|NCT00472186|593914429|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
164421510|NCT03468426|593914430|FG000|Overall Study|Progressive disease|3|||
164421511|NCT03468426|593914431|FG001|Overall Study|Progressive disease|0|||
164421512|NCT03468426|593914432|FG002|Overall Study|Progressive disease|4|||
164331501|NCT02007512|593591245|FG003|Double Blind Treatment Period|Other|2|||
164331502|NCT02007512|593591242|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
164331503|NCT02007512|593591243|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
164331504|NCT02007512|593591244|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
164331505|NCT02007512|593591245|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
164331506|NCT02007512|593591242|FG000|Open Label Treatment Period|Adverse Event|1|||
164331507|NCT02007512|593591243|FG001|Open Label Treatment Period|Adverse Event|0|||
164331508|NCT02007512|593591244|FG002|Open Label Treatment Period|Adverse Event|0|||
164331509|NCT02007512|593591245|FG003|Open Label Treatment Period|Adverse Event|0|||
164331510|NCT02007512|593591242|FG000|Open Label Treatment Period|Other|1|||
164331511|NCT02007512|593591243|FG001|Open Label Treatment Period|Other|1|||
164331512|NCT02007512|593591244|FG002|Open Label Treatment Period|Other|0|||
164331513|NCT02007512|593591245|FG003|Open Label Treatment Period|Other|0|||
164331514|NCT02007512|593591242|FG000|Open Label Treatment Period|Disease progression|23|||
164331515|NCT02007512|593591243|FG001|Open Label Treatment Period|Disease progression|11|||
164331516|NCT02007512|593591244|FG002|Open Label Treatment Period|Disease progression|0|||
164331517|NCT02007512|593591245|FG003|Open Label Treatment Period|Disease progression|0|||
164331518|NCT02360111|593591248|FG000|Overall Study|Death|2|||
164331519|NCT00611533|593591249|FG000|First Intervention (6 Weeks)|Never started study|0|||
164331520|NCT00611533|593591250|FG001|First Intervention (6 Weeks)|Never started study|1|||
164331521|NCT00611533|593591249|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
164331522|NCT00611533|593591250|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
164331523|NCT00611533|593591249|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
164331524|NCT00611533|593591250|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
164331525|NCT01933217|593591251|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
164331526|NCT01933217|593591252|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
164331527|NCT01933217|593591251|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
164331528|NCT01933217|593591252|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
164331529|NCT03923738|593591256|FG000|Period 1|Adverse Event|1|||
164331530|NCT03923738|593591256|FG000|Period 1|Withdrawal by Subject|1|||
164331531|NCT05246397|593591257|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
164331532|NCT03875768|593591259|FG000|Overall Study|Lost to Follow-up|16|||
164331533|NCT03875768|593591260|FG001|Overall Study|Lost to Follow-up|13|||
164331534|NCT03875768|593591259|FG000|Overall Study|Withdrawal by Subject|10|||
164331535|NCT03875768|593591260|FG001|Overall Study|Withdrawal by Subject|21|||
164331536|NCT03875768|593591259|FG000|Overall Study|Did not complete assessment|21|||
164331537|NCT03875768|593591260|FG001|Overall Study|Did not complete assessment|12|||
164331538|NCT03875768|593591259|FG000|Overall Study|Became ineligible|1|||
164331539|NCT03875768|593591260|FG001|Overall Study|Became ineligible|0|||
164331540|NCT01925274|593591261|FG000|Overall Study|Death|1|||
164331541|NCT01925274|593591262|FG001|Overall Study|Death|0|||
164421513|NCT03468426|593914433|FG003|Overall Study|Progressive disease|20|||
164331542|NCT01925274|593591263|FG002|Overall Study|Death|0|||
164331543|NCT01925274|593591261|FG000|Overall Study|Lost to Follow-up|0|||
164331544|NCT01925274|593591262|FG001|Overall Study|Lost to Follow-up|1|||
164421514|NCT03468426|593914434|FG004|Overall Study|Progressive disease|23|||
164331545|NCT01925274|593591263|FG002|Overall Study|Lost to Follow-up|0|||
164421515|NCT03468426|593914435|FG005|Overall Study|Progressive disease|15|||
164331546|NCT01925274|593591261|FG000|Overall Study|Withdrawal by Subject|1|||
164331547|NCT01925274|593591262|FG001|Overall Study|Withdrawal by Subject|2|||
164331548|NCT01925274|593591263|FG002|Overall Study|Withdrawal by Subject|0|||
164331549|NCT01925274|593591261|FG000|Overall Study|Study terminated by sponsor|4|||
164421516|NCT03468426|593914436|FG006|Overall Study|Progressive disease|24|||
164421517|NCT03468426|593914437|FG007|Overall Study|Progressive disease|27|||
164421518|NCT03468426|593914438|FG008|Overall Study|Progressive disease|13|||
164421519|NCT03468426|593914439|FG009|Overall Study|Progressive disease|13|||
164421520|NCT03468426|593914440|FG010|Overall Study|Progressive disease|0|||
164229329|NCT00553475|593209344|FG000|Overall Study|Lack of Efficacy|7|||
164229330|NCT00553475|593209345|FG001|Overall Study|Lack of Efficacy|1|||
164229331|NCT00553475|593209346|FG002|Overall Study|Lack of Efficacy|0|||
164229332|NCT00553475|593209344|FG000|Overall Study|Withdrawal by Subject|1|||
164229333|NCT00553475|593209345|FG001|Overall Study|Withdrawal by Subject|1|||
164229334|NCT00553475|593209346|FG002|Overall Study|Withdrawal by Subject|0|||
164229335|NCT00553475|593209344|FG000|Overall Study|Physician Decision|1|||
164229336|NCT00553475|593209345|FG001|Overall Study|Physician Decision|0|||
164229337|NCT00553475|593209346|FG002|Overall Study|Physician Decision|0|||
164229338|NCT00553475|593209344|FG000|Overall Study|Due to moving|0|||
164229339|NCT00553475|593209345|FG001|Overall Study|Due to moving|1|||
164229340|NCT00553475|593209346|FG002|Overall Study|Due to moving|0|||
164229341|NCT00913835|593209347|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
164229342|NCT00913835|593209348|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
164229343|NCT00913835|593209347|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
164331550|NCT01925274|593591262|FG001|Overall Study|Study terminated by sponsor|0|||
164331551|NCT01925274|593591263|FG002|Overall Study|Study terminated by sponsor|0|||
164331552|NCT01925274|593591261|FG000|Overall Study|Protocol amendment|1|||
164331553|NCT01925274|593591262|FG001|Overall Study|Protocol amendment|3|||
164331554|NCT01925274|593591263|FG002|Overall Study|Protocol amendment|6|||
164331555|NCT04327674|593591265|FG000|Overall Study|Protocol Violation|19|||
164331556|NCT00723398|593591270|FG000|Overall Study|Withdrawal by Subject|2|||
164331557|NCT00723398|593591271|FG001|Overall Study|Withdrawal by Subject|6|||
164331558|NCT00723398|593591272|FG002|Overall Study|Withdrawal by Subject|4|||
164331559|NCT00723398|593591273|FG003|Overall Study|Withdrawal by Subject|4|||
164331560|NCT00723398|593591274|FG004|Overall Study|Withdrawal by Subject|4|||
164331561|NCT00723398|593591270|FG000|Overall Study|Protocol Violation|2|||
164331562|NCT00723398|593591271|FG001|Overall Study|Protocol Violation|1|||
164331563|NCT00723398|593591272|FG002|Overall Study|Protocol Violation|5|||
164331564|NCT00723398|593591273|FG003|Overall Study|Protocol Violation|0|||
164331565|NCT00723398|593591274|FG004|Overall Study|Protocol Violation|0|||
164331566|NCT00723398|593591270|FG000|Overall Study|Physician Decision|2|||
164331567|NCT00723398|593591271|FG001|Overall Study|Physician Decision|2|||
164331568|NCT00723398|593591272|FG002|Overall Study|Physician Decision|5|||
164331569|NCT00723398|593591273|FG003|Overall Study|Physician Decision|0|||
164331570|NCT00723398|593591274|FG004|Overall Study|Physician Decision|1|||
164331571|NCT00723398|593591270|FG000|Overall Study|Adverse Event|0|||
164331572|NCT00723398|593591271|FG001|Overall Study|Adverse Event|5|||
164331573|NCT00723398|593591272|FG002|Overall Study|Adverse Event|3|||
164331574|NCT00723398|593591273|FG003|Overall Study|Adverse Event|1|||
164331575|NCT00723398|593591274|FG004|Overall Study|Adverse Event|4|||
164331576|NCT00723398|593591270|FG000|Overall Study|Lost to Follow-up|0|||
164331577|NCT00723398|593591271|FG001|Overall Study|Lost to Follow-up|1|||
164331578|NCT00723398|593591272|FG002|Overall Study|Lost to Follow-up|0|||
164331579|NCT00723398|593591273|FG003|Overall Study|Lost to Follow-up|0|||
164331580|NCT00723398|593591274|FG004|Overall Study|Lost to Follow-up|0|||
164331581|NCT00267189|593591275|FG000|Overall Study|Patient withdrew consent|1|||
164331582|NCT00267189|593591276|FG001|Overall Study|Patient withdrew consent|1|||
164331583|NCT00267189|593591275|FG000|Overall Study|Death|1|||
164331584|NCT00267189|593591276|FG001|Overall Study|Death|0|||
164331585|NCT00267189|593591275|FG000|Overall Study|Missing|3|||
164331586|NCT00267189|593591276|FG001|Overall Study|Missing|0|||
164331587|NCT00751621|593591277|FG000|Overall Study|Adverse Event|1|||
164331588|NCT00751621|593591277|FG000|Overall Study|Withdrawal by Subject|1|||
164331589|NCT00751621|593591277|FG000|Overall Study|Subject moved to another country|1|||
164331590|NCT00751621|593591277|FG000|Overall Study|Poor adherence to asthma treatment|1|||
164331591|NCT01225887|593591280|FG000|Overall Study|Ineligible:required test not done|2|||
164331592|NCT01225887|593591280|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
164331593|NCT01225887|593591280|FG000|Overall Study|Ineligible:inadequate pathology|2|||
164331594|NCT04505540|593591283|FG000|Baseline|Protocol Violation|10|||
164421521|NCT03468426|593914430|FG000|Overall Study|Other adverse event or clinical progression|0|||
164421522|NCT03468426|593914431|FG001|Overall Study|Other adverse event or clinical progression|1|||
164331595|NCT04505540|593591283|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
164331596|NCT04505540|593591283|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
164331597|NCT04505540|593591283|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
164331598|NCT04505540|593591283|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
164331599|NCT04505540|593591283|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
164331600|NCT04505540|593591283|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
164331601|NCT04505540|593591283|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
164331602|NCT04505540|593591283|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
164331603|NCT04505540|593591283|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
164229344|NCT00913835|593209348|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
164229345|NCT00913835|593209347|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
164331604|NCT04505540|593591283|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
164331605|NCT04505540|593591283|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
164229346|NCT00913835|593209348|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
164229347|NCT00913835|593209347|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
164229348|NCT00913835|593209348|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
164229349|NCT00913835|593209347|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
164229350|NCT00913835|593209348|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
164229351|NCT00773461|593209349|FG000|Overall Study|Adverse Event|1|||
164229352|NCT00773461|593209350|FG001|Overall Study|Adverse Event|3|||
164229353|NCT00773461|593209349|FG000|Overall Study|Withdrawal by Subject|4|||
164229354|NCT00773461|593209350|FG001|Overall Study|Withdrawal by Subject|1|||
164229355|NCT00637156|593209351|FG000|Overall Study|Withdrawal by Subject|0|||
164229356|NCT00637156|593209352|FG001|Overall Study|Withdrawal by Subject|7|||
164229357|NCT00637156|593209351|FG000|Overall Study|Death|0|||
164229358|NCT00637156|593209352|FG001|Overall Study|Death|1|||
164229359|NCT00637156|593209351|FG000|Overall Study|Lost to Follow-up|10|||
164229360|NCT00637156|593209352|FG001|Overall Study|Lost to Follow-up|16|||
164229361|NCT03193437|593209353|FG000|Overall Study|Adverse Event|4|||
164229362|NCT03193437|593209353|FG000|Overall Study|Withdrawal by Subject|2|||
164229363|NCT03193437|593209353|FG000|Overall Study|Disease Progression|2|||
164229364|NCT04976855|593209354|FG000|Part I|Withdrawal by Subject|0|||
164229365|NCT04976855|593209355|FG001|Part I|Withdrawal by Subject|1|||
164229366|NCT04976855|593209356|FG002|Part I|Withdrawal by Subject|0|||
164229367|NCT04976855|593209357|FG003|Part I|Withdrawal by Subject|0|||
164229368|NCT04976855|593209358|FG004|Part I|Withdrawal by Subject|0|||
164229369|NCT04976855|593209359|FG005|Part I|Withdrawal by Subject|0|||
164229370|NCT04976855|593209360|FG006|Part I|Withdrawal by Subject|0|||
164229371|NCT04976855|593209354|FG000|Part II|Adverse Event|0|||
164229372|NCT04976855|593209355|FG001|Part II|Adverse Event|0|||
164229373|NCT04976855|593209356|FG002|Part II|Adverse Event|0|||
164229374|NCT04976855|593209357|FG003|Part II|Adverse Event|1|||
164229375|NCT04976855|593209358|FG004|Part II|Adverse Event|0|||
164229376|NCT04976855|593209359|FG005|Part II|Adverse Event|0|||
164229377|NCT04976855|593209360|FG006|Part II|Adverse Event|0|||
164229378|NCT04976855|593209354|FG000|Part II|Withdrawal by Subject|0|||
164229379|NCT04976855|593209355|FG001|Part II|Withdrawal by Subject|0|||
164229380|NCT04976855|593209356|FG002|Part II|Withdrawal by Subject|0|||
164229381|NCT04976855|593209357|FG003|Part II|Withdrawal by Subject|0|||
164229382|NCT04976855|593209358|FG004|Part II|Withdrawal by Subject|1|||
164229383|NCT04976855|593209359|FG005|Part II|Withdrawal by Subject|0|||
164229384|NCT04976855|593209360|FG006|Part II|Withdrawal by Subject|0|||
164229385|NCT04976855|593209354|FG000|Part II|Lost to Follow-up|0|||
164229386|NCT04976855|593209355|FG001|Part II|Lost to Follow-up|0|||
164229387|NCT04976855|593209356|FG002|Part II|Lost to Follow-up|0|||
164229388|NCT04976855|593209357|FG003|Part II|Lost to Follow-up|0|||
164229389|NCT04976855|593209358|FG004|Part II|Lost to Follow-up|0|||
164229390|NCT04976855|593209359|FG005|Part II|Lost to Follow-up|1|||
164229391|NCT04976855|593209360|FG006|Part II|Lost to Follow-up|0|||
164229392|NCT02038036|593209361|FG000|Core Study|Adverse Event|7|||
164229393|NCT02038036|593209362|FG001|Core Study|Adverse Event|7|||
164229394|NCT02038036|593209361|FG000|Core Study|Death|1|||
164229395|NCT02038036|593209362|FG001|Core Study|Death|1|||
164229396|NCT02038036|593209361|FG000|Core Study|Disease progression|2|||
164229397|NCT02038036|593209362|FG001|Core Study|Disease progression|2|||
164229398|NCT02038036|593209361|FG000|Core Study|Lost to Follow-up|0|||
164229399|NCT02038036|593209362|FG001|Core Study|Lost to Follow-up|1|||
164229400|NCT02038036|593209361|FG000|Core Study|Physician Decision|2|||
164229401|NCT02038036|593209362|FG001|Core Study|Physician Decision|1|||
164229402|NCT02038036|593209361|FG000|Core Study|Subject/guardian decision|0|||
164229403|NCT02038036|593209362|FG001|Core Study|Subject/guardian decision|1|||
164331606|NCT04505540|593591283|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
164331607|NCT05342532|593591286|FG000|Overall Study|Adverse Event|5|||
164331608|NCT05342532|593591287|FG001|Overall Study|Adverse Event|20|||
164331609|NCT05342532|593591286|FG000|Overall Study|Lost to Follow-up|10|||
164331610|NCT05342532|593591287|FG001|Overall Study|Lost to Follow-up|15|||
164331611|NCT01123850|593591292|FG000|Overall Study|Slow enrollment|45|||
164331612|NCT03180684|593591293|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
164331613|NCT03180684|593591294|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
164331614|NCT03180684|593591293|FG000|Overall Study|Physician Decision|1|||
164331615|NCT03180684|593591294|FG001|Overall Study|Physician Decision|0|||
164229404|NCT02038036|593209361|FG000|Core Study|Withdrawal by Subject|3|||
164229405|NCT02038036|593209362|FG001|Core Study|Withdrawal by Subject|1|||
164229406|NCT02038036|593209361|FG000|Crossover Period|Withdrawal by Subject|0|||
164229407|NCT02038036|593209362|FG001|Crossover Period|Withdrawal by Subject|3|||
164229408|NCT02038036|593209361|FG000|Crossover Period|Adverse Event|0|||
164229409|NCT02038036|593209362|FG001|Crossover Period|Adverse Event|9|||
164229410|NCT02038036|593209361|FG000|Crossover Period|Death|0|||
164229411|NCT02038036|593209362|FG001|Crossover Period|Death|2|||
164229412|NCT02038036|593209361|FG000|Crossover Period|Disease progression|0|||
164229413|NCT02038036|593209362|FG001|Crossover Period|Disease progression|3|||
164229414|NCT02038036|593209361|FG000|Crossover Period|Lost to Follow-up|0|||
164229415|NCT02038036|593209362|FG001|Crossover Period|Lost to Follow-up|1|||
164229416|NCT02038036|593209361|FG000|Crossover Period|Physician Decision|0|||
164229417|NCT02038036|593209362|FG001|Crossover Period|Physician Decision|2|||
164229418|NCT00908141|593209373|FG000|Overall Study|Withdrawal by Subject|0|||
164421523|NCT03468426|593914432|FG002|Overall Study|Other adverse event or clinical progression|3|||
164229419|NCT00908141|593209374|FG001|Overall Study|Withdrawal by Subject|1|||
164229420|NCT02657356|593210753|FG000|Overall Study|Death|1|||
164229421|NCT02657356|593210754|FG001|Overall Study|Death|0|||
164229422|NCT02657356|593210753|FG000|Overall Study|Withdrawal by Subject|5|||
164229423|NCT02657356|593210754|FG001|Overall Study|Withdrawal by Subject|6|||
164229424|NCT02657356|593210753|FG000|Overall Study|Terminated by Sponsor|8|||
164229425|NCT02657356|593210754|FG001|Overall Study|Terminated by Sponsor|5|||
164229426|NCT02657356|593210753|FG000|Overall Study|Rolled over to EAP study|6|||
164229427|NCT02657356|593210754|FG001|Overall Study|Rolled over to EAP study|4|||
164229428|NCT03768336|593210755|FG000|Overall Study|Lost to Follow-up|3|||
164229429|NCT03768336|593210756|FG001|Overall Study|Lost to Follow-up|2|||
164229430|NCT03768336|593210755|FG000|Overall Study|Became Ineligible|2|||
164229431|NCT03768336|593210756|FG001|Overall Study|Became Ineligible|0|||
164229432|NCT03768336|593210755|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
164229433|NCT03768336|593210756|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
164229434|NCT03768336|593210755|FG000|Overall Study|Missed final survey (post-treatment|0|||
164229435|NCT03768336|593210756|FG001|Overall Study|Missed final survey (post-treatment|1|||
164229436|NCT02278003|593210757|FG000|Overall Study|Withdrawal by Subject|11|||
164229437|NCT02278003|593210758|FG001|Overall Study|Withdrawal by Subject|0|||
164229438|NCT02278003|593210757|FG000|Overall Study|Not Treated|1|||
164229439|NCT02278003|593210758|FG001|Overall Study|Not Treated|0|||
164229440|NCT02278003|593210757|FG000|Overall Study|Recognition task improperly completed|7|||
164229441|NCT02278003|593210758|FG001|Overall Study|Recognition task improperly completed|0|||
164229442|NCT00980044|593210759|FG000|Overall Study|Withdrawal by Subject|5|||
164229443|NCT00980044|593210760|FG001|Overall Study|Withdrawal by Subject|7|||
164229444|NCT00980044|593210761|FG002|Overall Study|Withdrawal by Subject|3|||
164229445|NCT00980044|593210759|FG000|Overall Study|Protocol Violation|0|||
164229446|NCT00980044|593210760|FG001|Overall Study|Protocol Violation|0|||
164229447|NCT00980044|593210761|FG002|Overall Study|Protocol Violation|2|||
164229448|NCT00442702|593210762|FG000|Titration Period|Adverse Event|2|||
164229449|NCT00442702|593210763|FG001|Titration Period|Adverse Event|0|||
164229450|NCT00442702|593210762|FG000|Titration Period|Death|3|||
164229451|NCT00442702|593210763|FG001|Titration Period|Death|2|||
164229452|NCT00442702|593210762|FG000|Titration Period|Insufficient Therapeutic Response|1|||
164229453|NCT00442702|593210763|FG001|Titration Period|Insufficient Therapeutic Response|0|||
164229454|NCT00442702|593210762|FG000|Titration Period|Refused Treatment|4|||
164229455|NCT00442702|593210763|FG001|Titration Period|Refused Treatment|1|||
164229456|NCT00442702|593210762|FG000|Titration Period|Failure to return|1|||
164229457|NCT00442702|593210763|FG001|Titration Period|Failure to return|0|||
164229458|NCT00442702|593210762|FG000|Titration Period|Hospitalized in another hospital|1|||
164229459|NCT00442702|593210763|FG001|Titration Period|Hospitalized in another hospital|0|||
164229460|NCT00442702|593210762|FG000|Evaluation Period|Adverse Event|1|||
164229461|NCT00442702|593210763|FG001|Evaluation Period|Adverse Event|0|||
164229462|NCT00442702|593210762|FG000|Evaluation Period|Death|1|||
164229463|NCT00442702|593210763|FG001|Evaluation Period|Death|1|||
164229464|NCT00442702|593210762|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
164229465|NCT00442702|593210763|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
164229466|NCT00442702|593210762|FG000|Evaluation Period|Refused treatment|1|||
164229467|NCT00442702|593210763|FG001|Evaluation Period|Refused treatment|1|||
164229468|NCT00442702|593210762|FG000|Evaluation Period|Renal transplant|0|||
164229469|NCT00442702|593210763|FG001|Evaluation Period|Renal transplant|1|||
164229470|NCT00442702|593210762|FG000|Evaluation Period|Failure to return|1|||
164229471|NCT00442702|593210763|FG001|Evaluation Period|Failure to return|0|||
164229472|NCT00442702|593210762|FG000|Evaluation Period|Site closure|0|||
164229473|NCT00442702|593210763|FG001|Evaluation Period|Site closure|1|||
164229474|NCT01444781|593210764|FG000|Overall Study|Lost to Follow-up|0|||
164421524|NCT03468426|593914433|FG003|Overall Study|Other adverse event or clinical progression|14|||
164421525|NCT03468426|593914434|FG004|Overall Study|Other adverse event or clinical progression|10|||
164229475|NCT01444781|593210765|FG001|Overall Study|Lost to Follow-up|3|||
164229476|NCT01444781|593210766|FG002|Overall Study|Lost to Follow-up|1|||
164229477|NCT01444781|593210764|FG000|Overall Study|Withdrawal by Subject|3|||
164229478|NCT01444781|593210765|FG001|Overall Study|Withdrawal by Subject|1|||
164229479|NCT01444781|593210766|FG002|Overall Study|Withdrawal by Subject|2|||
164229480|NCT00500331|593210768|FG000|Overall Study|Adverse Event|0|||
164229481|NCT00500331|593210769|FG001|Overall Study|Adverse Event|2|||
164229482|NCT00500331|593210770|FG002|Overall Study|Adverse Event|0|||
164229483|NCT00500331|593210771|FG003|Overall Study|Adverse Event|1|||
164229484|NCT00500331|593210772|FG004|Overall Study|Adverse Event|2|||
164229485|NCT00500331|593210773|FG005|Overall Study|Adverse Event|2|||
164229486|NCT00500331|593210774|FG006|Overall Study|Adverse Event|0|||
164229487|NCT00500331|593210768|FG000|Overall Study|Lost to Follow-up|1|||
164229488|NCT00500331|593210769|FG001|Overall Study|Lost to Follow-up|1|||
164675515|NCT03570749|594836750|FG004|Overall Study|Lack of Efficacy|8|||
164229489|NCT00500331|593210770|FG002|Overall Study|Lost to Follow-up|1|||
164229490|NCT00500331|593210771|FG003|Overall Study|Lost to Follow-up|2|||
164229491|NCT00500331|593210772|FG004|Overall Study|Lost to Follow-up|1|||
164229492|NCT00500331|593210773|FG005|Overall Study|Lost to Follow-up|0|||
164229493|NCT00500331|593210774|FG006|Overall Study|Lost to Follow-up|0|||
164229494|NCT00500331|593210768|FG000|Overall Study|Protocol Violation|3|||
164229495|NCT00500331|593210769|FG001|Overall Study|Protocol Violation|1|||
164229496|NCT00500331|593210770|FG002|Overall Study|Protocol Violation|1|||
164229497|NCT00500331|593210771|FG003|Overall Study|Protocol Violation|0|||
164229498|NCT00500331|593210772|FG004|Overall Study|Protocol Violation|1|||
164229499|NCT00500331|593210773|FG005|Overall Study|Protocol Violation|1|||
164229500|NCT00500331|593210774|FG006|Overall Study|Protocol Violation|1|||
164229501|NCT00500331|593210768|FG000|Overall Study|Withdrawal by Subject|4|||
164229502|NCT00500331|593210769|FG001|Overall Study|Withdrawal by Subject|0|||
164229503|NCT00500331|593210770|FG002|Overall Study|Withdrawal by Subject|1|||
164229504|NCT00500331|593210771|FG003|Overall Study|Withdrawal by Subject|5|||
164229505|NCT00500331|593210772|FG004|Overall Study|Withdrawal by Subject|0|||
164229506|NCT00500331|593210773|FG005|Overall Study|Withdrawal by Subject|1|||
164229507|NCT00500331|593210774|FG006|Overall Study|Withdrawal by Subject|1|||
164229508|NCT00500331|593210768|FG000|Overall Study|Lack of Efficacy|3|||
164229509|NCT00500331|593210769|FG001|Overall Study|Lack of Efficacy|1|||
164229510|NCT00500331|593210770|FG002|Overall Study|Lack of Efficacy|0|||
164229511|NCT00500331|593210771|FG003|Overall Study|Lack of Efficacy|0|||
164229512|NCT00500331|593210772|FG004|Overall Study|Lack of Efficacy|0|||
164229513|NCT00500331|593210773|FG005|Overall Study|Lack of Efficacy|0|||
164229514|NCT00500331|593210774|FG006|Overall Study|Lack of Efficacy|0|||
164229515|NCT00500331|593210768|FG000|Overall Study|Liver function test abnormality|0|||
164229516|NCT00500331|593210769|FG001|Overall Study|Liver function test abnormality|0|||
164229517|NCT00500331|593210770|FG002|Overall Study|Liver function test abnormality|1|||
164229518|NCT00500331|593210771|FG003|Overall Study|Liver function test abnormality|0|||
164229519|NCT00500331|593210772|FG004|Overall Study|Liver function test abnormality|0|||
164229520|NCT00500331|593210773|FG005|Overall Study|Liver function test abnormality|0|||
164229521|NCT00500331|593210774|FG006|Overall Study|Liver function test abnormality|0|||
164229522|NCT00500331|593210768|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
164229523|NCT00500331|593210769|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
164229524|NCT00500331|593210770|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
164229525|NCT00500331|593210771|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
164229526|NCT00500331|593210772|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
164229527|NCT00500331|593210773|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
164229528|NCT00500331|593210774|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
164229529|NCT00500331|593210768|FG000|Overall Study|Didn't return for continuation of study|1|||
164229530|NCT00500331|593210769|FG001|Overall Study|Didn't return for continuation of study|0|||
164229531|NCT00500331|593210770|FG002|Overall Study|Didn't return for continuation of study|0|||
164229532|NCT00500331|593210771|FG003|Overall Study|Didn't return for continuation of study|0|||
164229533|NCT00500331|593210772|FG004|Overall Study|Didn't return for continuation of study|0|||
164229534|NCT00500331|593210773|FG005|Overall Study|Didn't return for continuation of study|0|||
164229535|NCT00500331|593210774|FG006|Overall Study|Didn't return for continuation of study|0|||
164229536|NCT00500331|593210768|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
164229537|NCT00500331|593210769|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
164229538|NCT00500331|593210770|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
164229539|NCT00500331|593210771|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
164229540|NCT00500331|593210772|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
164229541|NCT00500331|593210773|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
164229542|NCT00500331|593210774|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
164229543|NCT00500331|593210768|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
164229544|NCT00500331|593210769|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
164229545|NCT00500331|593210770|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
164675516|NCT03570749|594836751|FG005|Overall Study|Lack of Efficacy|2|||
164675517|NCT03570749|594836752|FG006|Overall Study|Lack of Efficacy|7|||
164675518|NCT03570749|594836746|FG000|Overall Study|Lost to Follow-up|0|||
164229546|NCT00500331|593210771|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
164229547|NCT00500331|593210772|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
164229548|NCT00500331|593210773|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
164229549|NCT00500331|593210774|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
164229550|NCT00500331|593210768|FG000|Overall Study|Participant was randomized by mistake|1|||
164331616|NCT03180684|593591293|FG000|Overall Study|Lost to Follow-up|1|||
164331617|NCT03180684|593591294|FG001|Overall Study|Lost to Follow-up|0|||
164331618|NCT03180684|593591293|FG000|Overall Study|Progressive Disease|1|||
164331619|NCT03180684|593591294|FG001|Overall Study|Progressive Disease|0|||
164331620|NCT02495233|593591298|FG000|Overall Study|Miscellaneous|0|||
164331621|NCT02495233|593591299|FG001|Overall Study|Miscellaneous|1|||
164421526|NCT03468426|593914435|FG005|Overall Study|Other adverse event or clinical progression|8|||
164421527|NCT03468426|593914436|FG006|Overall Study|Other adverse event or clinical progression|5|||
164421528|NCT03468426|593914437|FG007|Overall Study|Other adverse event or clinical progression|4|||
164421529|NCT03468426|593914438|FG008|Overall Study|Other adverse event or clinical progression|6|||
164421530|NCT03468426|593914439|FG009|Overall Study|Other adverse event or clinical progression|11|||
164421531|NCT03468426|593914440|FG010|Overall Study|Other adverse event or clinical progression|0|||
164421532|NCT03468426|593914430|FG000|Overall Study|Refused to continue taking trial medication|0|||
164421533|NCT03468426|593914431|FG001|Overall Study|Refused to continue taking trial medication|0|||
164421534|NCT03468426|593914432|FG002|Overall Study|Refused to continue taking trial medication|0|||
164421535|NCT03468426|593914433|FG003|Overall Study|Refused to continue taking trial medication|2|||
164421536|NCT03468426|593914434|FG004|Overall Study|Refused to continue taking trial medication|0|||
164421537|NCT03468426|593914435|FG005|Overall Study|Refused to continue taking trial medication|3|||
164421538|NCT03468426|593914436|FG006|Overall Study|Refused to continue taking trial medication|0|||
164421539|NCT03468426|593914437|FG007|Overall Study|Refused to continue taking trial medication|0|||
164229551|NCT00500331|593210769|FG001|Overall Study|Participant was randomized by mistake|0|||
164229552|NCT00500331|593210770|FG002|Overall Study|Participant was randomized by mistake|0|||
164229553|NCT00500331|593210771|FG003|Overall Study|Participant was randomized by mistake|0|||
164229554|NCT00500331|593210772|FG004|Overall Study|Participant was randomized by mistake|0|||
164229555|NCT00500331|593210773|FG005|Overall Study|Participant was randomized by mistake|0|||
164229556|NCT00500331|593210774|FG006|Overall Study|Participant was randomized by mistake|0|||
164229557|NCT00500331|593210768|FG000|Overall Study|Diabetologist nurse in the study|0|||
164229558|NCT00500331|593210769|FG001|Overall Study|Diabetologist nurse in the study|0|||
164229559|NCT00500331|593210770|FG002|Overall Study|Diabetologist nurse in the study|1|||
164229560|NCT00500331|593210771|FG003|Overall Study|Diabetologist nurse in the study|0|||
164229561|NCT00500331|593210772|FG004|Overall Study|Diabetologist nurse in the study|0|||
164229562|NCT00500331|593210773|FG005|Overall Study|Diabetologist nurse in the study|0|||
164229563|NCT00500331|593210774|FG006|Overall Study|Diabetologist nurse in the study|0|||
164229564|NCT00500331|593210768|FG000|Overall Study|State ban of biological samples export|0|||
164229565|NCT00500331|593210769|FG001|Overall Study|State ban of biological samples export|0|||
164229566|NCT00500331|593210770|FG002|Overall Study|State ban of biological samples export|0|||
164229567|NCT00500331|593210771|FG003|Overall Study|State ban of biological samples export|1|||
164229568|NCT00500331|593210772|FG004|Overall Study|State ban of biological samples export|0|||
164229569|NCT00500331|593210773|FG005|Overall Study|State ban of biological samples export|0|||
164229570|NCT00500331|593210774|FG006|Overall Study|State ban of biological samples export|0|||
164229571|NCT00500331|593210768|FG000|Overall Study|Protocol violated|0|||
164229572|NCT00500331|593210769|FG001|Overall Study|Protocol violated|0|||
164229573|NCT00500331|593210770|FG002|Overall Study|Protocol violated|0|||
164229574|NCT00500331|593210771|FG003|Overall Study|Protocol violated|1|||
164229575|NCT00500331|593210772|FG004|Overall Study|Protocol violated|0|||
164229576|NCT00500331|593210773|FG005|Overall Study|Protocol violated|0|||
164229577|NCT00500331|593210774|FG006|Overall Study|Protocol violated|0|||
164229578|NCT03014089|593210780|FG000|Overall Study|Withdrawal by Subject|0|||
164229579|NCT03014089|593210781|FG001|Overall Study|Withdrawal by Subject|1|||
164229580|NCT03014089|593210782|FG002|Overall Study|Withdrawal by Subject|1|||
164229581|NCT03014089|593210783|FG003|Overall Study|Withdrawal by Subject|1|||
164229582|NCT03014089|593210780|FG000|Overall Study|Lost to Follow-up|1|||
164229583|NCT03014089|593210781|FG001|Overall Study|Lost to Follow-up|0|||
164229584|NCT03014089|593210782|FG002|Overall Study|Lost to Follow-up|0|||
164229585|NCT03014089|593210783|FG003|Overall Study|Lost to Follow-up|0|||
164229586|NCT03014089|593210780|FG000|Overall Study|Adverse Event|1|||
164229587|NCT03014089|593210781|FG001|Overall Study|Adverse Event|0|||
164229588|NCT03014089|593210782|FG002|Overall Study|Adverse Event|1|||
164421540|NCT03468426|593914438|FG008|Overall Study|Refused to continue taking trial medication|1|||
164571818|NCT01827384|594458388|FG001|Overall Study|Disease progression before treatment|0|||
164571819|NCT01827384|594458389|FG002|Overall Study|Disease progression before treatment|0|||
164571820|NCT01827384|594458390|FG003|Overall Study|Disease progression before treatment|0|||
164571821|NCT01827384|594458391|FG004|Overall Study|Disease progression before treatment|0|||
164571822|NCT01827384|594458392|FG005|Overall Study|Disease progression before treatment|0|||
164571823|NCT01827384|594458393|FG006|Overall Study|Disease progression before treatment|0|||
164571824|NCT01827384|594458394|FG007|Overall Study|Disease progression before treatment|0|||
164571825|NCT01827384|594458395|FG008|Overall Study|Disease progression before treatment|0|||
164571826|NCT01827384|594458396|FG009|Overall Study|Disease progression before treatment|0|||
164229589|NCT03014089|593210783|FG003|Overall Study|Adverse Event|0|||
164229590|NCT00321932|593210784|FG000|Overall Study|Death|3|||
164229591|NCT00321932|593210785|FG001|Overall Study|Death|6|||
164229592|NCT00321932|593210784|FG000|Overall Study|Withdrawal by Subject|3|||
164571827|NCT01827384|594458397|FG010|Overall Study|Disease progression before treatment|0|||
164229593|NCT00321932|593210785|FG001|Overall Study|Withdrawal by Subject|6|||
164229594|NCT00321932|593210784|FG000|Overall Study|Early relapse|2|||
164229595|NCT00321932|593210785|FG001|Overall Study|Early relapse|8|||
164229596|NCT00321932|593210784|FG000|Overall Study|Missing data|2|||
164229597|NCT00321932|593210785|FG001|Overall Study|Missing data|1|||
164229598|NCT00734032|593210786|FG000|Overall Study|Adverse Event|0|||
164229599|NCT00734032|593210787|FG001|Overall Study|Adverse Event|1|||
164229600|NCT00734032|593210788|FG002|Overall Study|Adverse Event|0|||
164229601|NCT00734032|593210789|FG003|Overall Study|Adverse Event|0|||
164229602|NCT03468998|593210792|FG000|Overall Study|Withdrawal by Subject|1|||
164229603|NCT03468998|593210793|FG001|Overall Study|Withdrawal by Subject|1|||
164229604|NCT03468998|593210794|FG002|Overall Study|Withdrawal by Subject|0|||
164229605|NCT03468998|593210795|FG003|Overall Study|Withdrawal by Subject|4|||
164229606|NCT03468998|593210796|FG004|Overall Study|Withdrawal by Subject|1|||
164229607|NCT03468998|593210797|FG005|Overall Study|Withdrawal by Subject|0|||
164229608|NCT00137449|593210798|FG000|Overall Study|Disease Progression|8|||
164229609|NCT00137449|593210799|FG001|Overall Study|Disease Progression|13|||
164229610|NCT00137449|593210798|FG000|Overall Study|Death|4|||
164229611|NCT00137449|593210799|FG001|Overall Study|Death|3|||
164229612|NCT00137449|593210798|FG000|Overall Study|Adverse Event|3|||
164229613|NCT00137449|593210799|FG001|Overall Study|Adverse Event|1|||
164229614|NCT00137449|593210798|FG000|Overall Study|Withdrawal by Subject|1|||
164229615|NCT00137449|593210799|FG001|Overall Study|Withdrawal by Subject|1|||
164229616|NCT01356940|593210802|FG000|First Intervention (28 Days)|Adverse Event|1|||
164229617|NCT01356940|593210803|FG001|First Intervention (28 Days)|Adverse Event|0|||
164229618|NCT01356940|593210802|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
164229619|NCT01356940|593210803|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
164229620|NCT03412591|593210804|FG000|Overall Study|Withdrawal by Subject|1|||
164229621|NCT03412591|593210805|FG001|Overall Study|Withdrawal by Subject|8|||
164229622|NCT03412591|593210804|FG000|Overall Study|Adverse Event|0|||
164229623|NCT03412591|593210805|FG001|Overall Study|Adverse Event|1|||
164229624|NCT00480532|593210812|FG000|Overall Study|Withdrawal by Subject|2|||
164229625|NCT00480532|593210813|FG001|Overall Study|Withdrawal by Subject|4|||
164229626|NCT00480532|593210814|FG002|Overall Study|Withdrawal by Subject|3|||
164229627|NCT00480532|593210815|FG003|Overall Study|Withdrawal by Subject|1|||
164229628|NCT00480532|593210812|FG000|Overall Study|Protocol Violation|0|||
164229629|NCT00480532|593210813|FG001|Overall Study|Protocol Violation|0|||
164229630|NCT00480532|593210814|FG002|Overall Study|Protocol Violation|1|||
164229631|NCT00480532|593210815|FG003|Overall Study|Protocol Violation|0|||
164229632|NCT03322566|593210816|FG000|Overall Study|Death|34|||
164229633|NCT03322566|593210817|FG001|Overall Study|Death|35|||
164229634|NCT03322566|593210818|FG002|Overall Study|Death|23|||
164229635|NCT03322566|593210816|FG000|Overall Study|Physician Decision|6|||
164229636|NCT03322566|593210817|FG001|Overall Study|Physician Decision|7|||
164229637|NCT03322566|593210818|FG002|Overall Study|Physician Decision|2|||
164229638|NCT03322566|593210816|FG000|Overall Study|Withdrawal by Subject|4|||
164229639|NCT03322566|593210817|FG001|Overall Study|Withdrawal by Subject|3|||
164229640|NCT03322566|593210818|FG002|Overall Study|Withdrawal by Subject|6|||
164675519|NCT03570749|594836747|FG001|Overall Study|Lost to Follow-up|0|||
164675520|NCT03570749|594836748|FG002|Overall Study|Lost to Follow-up|0|||
164675521|NCT03570749|594836749|FG003|Overall Study|Lost to Follow-up|0|||
164675522|NCT03570749|594836750|FG004|Overall Study|Lost to Follow-up|5|||
164229641|NCT03322566|593210816|FG000|Overall Study|Lost to Follow-up|0|||
164421541|NCT03468426|593914439|FG009|Overall Study|Refused to continue taking trial medication|0|||
164421542|NCT03468426|593914440|FG010|Overall Study|Refused to continue taking trial medication|0|||
164421543|NCT03468426|593914430|FG000|Overall Study|Other than listed|0|||
164421544|NCT03468426|593914431|FG001|Overall Study|Other than listed|1|||
164421545|NCT03468426|593914432|FG002|Overall Study|Other than listed|0|||
164229642|NCT03322566|593210817|FG001|Overall Study|Lost to Follow-up|0|||
164229643|NCT03322566|593210818|FG002|Overall Study|Lost to Follow-up|1|||
164229644|NCT03322566|593210816|FG000|Overall Study|Study terminated by sponsor|1|||
164229645|NCT03322566|593210817|FG001|Overall Study|Study terminated by sponsor|0|||
164229646|NCT03322566|593210818|FG002|Overall Study|Study terminated by sponsor|1|||
164229647|NCT01602484|593210819|FG000|Overall Study|Airway issues unrelated to study|0|||
164229648|NCT01602484|593210820|FG001|Overall Study|Airway issues unrelated to study|1|||
164229649|NCT00425555|593210823|FG000|Overall Study|Withdrawal by Subject|11|||
164229650|NCT00425555|593210824|FG001|Overall Study|Withdrawal by Subject|8|||
164229651|NCT00425555|593210823|FG000|Overall Study|Lost to Follow-up|0|||
164421546|NCT03468426|593914433|FG003|Overall Study|Other than listed|0|||
164229652|NCT00425555|593210824|FG001|Overall Study|Lost to Follow-up|1|||
164675523|NCT03570749|594836751|FG005|Overall Study|Lost to Follow-up|10|||
164229653|NCT00425555|593210823|FG000|Overall Study|Administrative problems|3|||
164675524|NCT03570749|594836752|FG006|Overall Study|Lost to Follow-up|10|||
164229654|NCT00425555|593210824|FG001|Overall Study|Administrative problems|0|||
164229655|NCT00425555|593210823|FG000|Overall Study|Death|1|||
164229656|NCT00425555|593210824|FG001|Overall Study|Death|2|||
164229657|NCT00425555|593210823|FG000|Overall Study|New cancer therapy|2|||
164229658|NCT00425555|593210824|FG001|Overall Study|New cancer therapy|1|||
164229659|NCT00425555|593210823|FG000|Overall Study|Disease progression|36|||
164229660|NCT00425555|593210824|FG001|Overall Study|Disease progression|33|||
164229661|NCT00425555|593210823|FG000|Overall Study|Adverse Event|25|||
164229662|NCT00425555|593210824|FG001|Overall Study|Adverse Event|15|||
164229663|NCT00425555|593210823|FG000|Overall Study|Protocol Violation|1|||
164229664|NCT00425555|593210824|FG001|Overall Study|Protocol Violation|0|||
164229665|NCT05763381|593210825|FG000|Overall Study|Lost to Follow-up|2|||
164229666|NCT05763381|593210826|FG001|Overall Study|Lost to Follow-up|3|||
164229667|NCT05763381|593210825|FG000|Overall Study|Withdrawal by Subject|1|||
164229668|NCT05763381|593210826|FG001|Overall Study|Withdrawal by Subject|2|||
164229669|NCT02697448|593210828|FG000|Overall Study|Protocol Violation|2|||
164229670|NCT02697448|593210829|FG001|Overall Study|Protocol Violation|4|||
164229671|NCT02697448|593210828|FG000|Overall Study|Clinical concerns during ablation|1|||
164229672|NCT02697448|593210829|FG001|Overall Study|Clinical concerns during ablation|1|||
164229673|NCT02697448|593210828|FG000|Overall Study|No data collected|2|||
164229674|NCT02697448|593210829|FG001|Overall Study|No data collected|0|||
164229675|NCT05473715|593210830|FG000|Overall Study|Trial terminate|2|||
164229676|NCT05473715|593210831|FG001|Overall Study|Trial terminate|1|||
164229677|NCT02592863|593210835|FG000|Overall Study|Withdrawal by Subject|2|||
164229678|NCT02592863|593210836|FG001|Overall Study|Withdrawal by Subject|2|||
164229679|NCT02592863|593210835|FG000|Overall Study|Lost to Follow-up|1|||
164229680|NCT02592863|593210836|FG001|Overall Study|Lost to Follow-up|1|||
164229681|NCT02743221|593210837|FG000|Overall Study|Progressive disease|29|||
164229682|NCT02743221|593210838|FG001|Overall Study|Progressive disease|38|||
164229683|NCT02743221|593210837|FG000|Overall Study|Adverse Event|17|||
164229684|NCT02743221|593210838|FG001|Overall Study|Adverse Event|14|||
164229685|NCT02743221|593210837|FG000|Overall Study|non medical reason|8|||
164229686|NCT02743221|593210838|FG001|Overall Study|non medical reason|2|||
164229687|NCT02743221|593210837|FG000|Overall Study|Physician Decision|2|||
164229688|NCT02743221|593210838|FG001|Overall Study|Physician Decision|5|||
164229689|NCT02743221|593210837|FG000|Overall Study|Patient not eligible, not treated|0|||
164229690|NCT02743221|593210838|FG001|Overall Study|Patient not eligible, not treated|1|||
164229691|NCT02609503|593210848|FG000|Overall Study|Adverse Event|1|||
164229692|NCT02609503|593210848|FG000|Overall Study|Death|1|||
164229693|NCT02609503|593210848|FG000|Overall Study|Withdrawal by Subject|1|||
164229694|NCT02609503|593210848|FG000|Overall Study|Disease progression|1|||
164229695|NCT01969409|593210849|FG000|Overall Study|Death|2|||
164229696|NCT01969409|593210850|FG001|Overall Study|Death|2|||
164229697|NCT01969409|593210849|FG000|Overall Study|Transplant|1|||
164229698|NCT01969409|593210850|FG001|Overall Study|Transplant|1|||
164229699|NCT01969409|593210849|FG000|Overall Study|Withdrawal by Subject|0|||
164229700|NCT01969409|593210850|FG001|Overall Study|Withdrawal by Subject|1|||
164229701|NCT04642079|593210851|FG000|Overall Study|Lost to Follow-up|2|||
164229702|NCT04642079|593210852|FG001|Overall Study|Lost to Follow-up|5|||
164229703|NCT04642079|593210853|FG002|Overall Study|Lost to Follow-up|2|||
164229704|NCT04642079|593210854|FG003|Overall Study|Lost to Follow-up|0|||
164229705|NCT04642079|593210851|FG000|Overall Study|Withdrawal by Subject|0|||
164229706|NCT04642079|593210852|FG001|Overall Study|Withdrawal by Subject|4|||
164229707|NCT04642079|593210853|FG002|Overall Study|Withdrawal by Subject|1|||
164229708|NCT04642079|593210854|FG003|Overall Study|Withdrawal by Subject|2|||
164229709|NCT04642079|593210851|FG000|Overall Study|Other|0|||
164229710|NCT04642079|593210852|FG001|Overall Study|Other|0|||
164229711|NCT04642079|593210853|FG002|Overall Study|Other|0|||
164229712|NCT04642079|593210854|FG003|Overall Study|Other|1|||
164229713|NCT04642079|593210851|FG000|Overall Study|No longer met eligibility criteria|1|||
164229714|NCT04642079|593210852|FG001|Overall Study|No longer met eligibility criteria|0|||
164229715|NCT04642079|593210853|FG002|Overall Study|No longer met eligibility criteria|1|||
164229716|NCT04642079|593210854|FG003|Overall Study|No longer met eligibility criteria|1|||
164229717|NCT00759395|593210858|FG000|Overall Study|Adverse Event|1|||
164229718|NCT00759395|593210859|FG001|Overall Study|Adverse Event|0|||
164229719|NCT00759395|593210858|FG000|Overall Study|Withdrawal by Subject|1|||
164229720|NCT00759395|593210859|FG001|Overall Study|Withdrawal by Subject|0|||
164229721|NCT00759395|593210858|FG000|Overall Study|Lack of Efficacy|0|||
164229722|NCT00759395|593210859|FG001|Overall Study|Lack of Efficacy|2|||
164229723|NCT00086515|593210860|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
164229724|NCT00086515|593210861|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
164229725|NCT00086515|593210860|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
164229726|NCT00086515|593210861|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
164229727|NCT00086515|593210860|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
164229728|NCT00086515|593210861|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
164229729|NCT00086515|593210860|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
164229730|NCT00086515|593210861|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
164229731|NCT00086515|593210860|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
164229732|NCT00086515|593210861|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
164229733|NCT00086515|593210860|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
164229734|NCT00086515|593210861|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
164229735|NCT00086515|593210860|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
164229736|NCT00086515|593210861|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
164229737|NCT00086515|593210860|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
164229738|NCT00086515|593210861|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
164229739|NCT00086515|593210860|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
164331622|NCT01638819|593591303|FG000|Overall Study|Lost to Follow-up|1|||
164229740|NCT00086515|593210861|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
164229741|NCT00086515|593210860|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
164229742|NCT00086515|593210861|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
164229743|NCT00086515|593210860|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
164229744|NCT00086515|593210861|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
164229745|NCT00086515|593210860|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
164229746|NCT00086515|593210861|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
164229747|NCT00086515|593210860|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
164229748|NCT00086515|593210861|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
164229749|NCT00086515|593210860|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
164229750|NCT00086515|593210861|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
164229751|NCT00086515|593210860|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
164331623|NCT01638819|593591304|FG001|Overall Study|Lost to Follow-up|0|||
164331624|NCT00923936|593591305|FG000|Overall Study|progressive disease on study|2|||
164331625|NCT00923936|593591306|FG001|Overall Study|progressive disease on study|1|||
164331626|NCT00923936|593591305|FG000|Overall Study|Adverse Event|2|||
164331627|NCT00923936|593591306|FG001|Overall Study|Adverse Event|1|||
164331628|NCT00923936|593591305|FG000|Overall Study|Lost to follow up|2|||
164331629|NCT00923936|593591306|FG001|Overall Study|Lost to follow up|0|||
164331630|NCT00923936|593591305|FG000|Overall Study|Continuing in follow up period|2|||
164331631|NCT00923936|593591306|FG001|Overall Study|Continuing in follow up period|1|||
164331632|NCT04263454|593591307|FG000|Overall Study|Adverse Event|0|||
164331633|NCT04263454|593591308|FG001|Overall Study|Adverse Event|2|||
164331634|NCT04263454|593591307|FG000|Overall Study|Physician Decision|3|||
164331635|NCT04263454|593591308|FG001|Overall Study|Physician Decision|5|||
164331636|NCT04263454|593591307|FG000|Overall Study|Poor Data Quality|0|||
164331637|NCT04263454|593591308|FG001|Overall Study|Poor Data Quality|1|||
164331638|NCT01231347|593591309|FG000|Overall Study|Full Consent withdrawn|19|||
164331639|NCT01231347|593591310|FG001|Overall Study|Full Consent withdrawn|19|||
164331640|NCT01231347|593591311|FG002|Overall Study|Full Consent withdrawn|11|||
164331641|NCT01231347|593591309|FG000|Overall Study|Lost to Follow-up|4|||
164331642|NCT01231347|593591310|FG001|Overall Study|Lost to Follow-up|2|||
164331643|NCT01231347|593591311|FG002|Overall Study|Lost to Follow-up|2|||
164331644|NCT01231347|593591309|FG000|Overall Study|Death|202|||
164331645|NCT01231347|593591310|FG001|Overall Study|Death|210|||
164331646|NCT01231347|593591311|FG002|Overall Study|Death|101|||
164331647|NCT01231347|593591309|FG000|Overall Study|other event|7|||
164331648|NCT01231347|593591310|FG001|Overall Study|other event|9|||
164331649|NCT01231347|593591311|FG002|Overall Study|other event|3|||
164331650|NCT01460368|593591312|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
164331651|NCT01460368|593591313|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
164331652|NCT01460368|593591314|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
164331653|NCT01460368|593591315|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
164331654|NCT01460368|593591316|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
164331655|NCT01460368|593591317|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
164331656|NCT01460368|593591318|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
164331657|NCT01460368|593591312|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
164331658|NCT01460368|593591313|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
164331659|NCT01460368|593591314|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
164331660|NCT01460368|593591315|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
164331661|NCT01460368|593591316|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
164331662|NCT01460368|593591317|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
164331663|NCT01460368|593591318|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
164331664|NCT01460368|593591312|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
164331665|NCT01460368|593591313|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
164331666|NCT01460368|593591314|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
164331667|NCT01460368|593591315|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
164331668|NCT01460368|593591316|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
164331669|NCT01460368|593591317|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
164331670|NCT01460368|593591318|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
164331671|NCT01460368|593591312|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
164331672|NCT01460368|593591313|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
164331673|NCT01460368|593591314|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
164331674|NCT01460368|593591315|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
164331675|NCT01460368|593591316|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
164331676|NCT01460368|593591317|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
164331677|NCT01460368|593591318|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
164229752|NCT00086515|593210861|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
164331678|NCT01460368|593591312|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
164421547|NCT03468426|593914434|FG004|Overall Study|Other than listed|2|||
164229753|NCT00086515|593210860|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
164229754|NCT00086515|593210861|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
164229755|NCT00086515|593210860|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
164229756|NCT00086515|593210861|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
164229757|NCT00086515|593210860|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
164229758|NCT00086515|593210861|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
164571828|NCT01827384|594458398|FG011|Overall Study|Disease progression before treatment|0|||
164571829|NCT01827384|594458399|FG012|Overall Study|Disease progression before treatment|0|||
164571830|NCT01827384|594458400|FG013|Overall Study|Disease progression before treatment|4|||
164571831|NCT01827384|594458387|FG000|Overall Study|Ineligible|0|||
164571832|NCT01827384|594458388|FG001|Overall Study|Ineligible|0|||
164571833|NCT01827384|594458389|FG002|Overall Study|Ineligible|0|||
164571834|NCT01827384|594458390|FG003|Overall Study|Ineligible|0|||
164571835|NCT01827384|594458391|FG004|Overall Study|Ineligible|0|||
164571836|NCT01827384|594458392|FG005|Overall Study|Ineligible|0|||
164571837|NCT01827384|594458393|FG006|Overall Study|Ineligible|0|||
164571838|NCT01827384|594458394|FG007|Overall Study|Ineligible|0|||
164571839|NCT01827384|594458395|FG008|Overall Study|Ineligible|0|||
164571840|NCT01827384|594458396|FG009|Overall Study|Ineligible|0|||
164571841|NCT01827384|594458397|FG010|Overall Study|Ineligible|0|||
164571842|NCT01827384|594458398|FG011|Overall Study|Ineligible|0|||
164571843|NCT01827384|594458399|FG012|Overall Study|Ineligible|0|||
164571844|NCT01827384|594458400|FG013|Overall Study|Ineligible|19|||
164571845|NCT01827384|594458387|FG000|Overall Study|Participant died before treatment|0|||
164571846|NCT01827384|594458388|FG001|Overall Study|Participant died before treatment|0|||
164571847|NCT01827384|594458389|FG002|Overall Study|Participant died before treatment|0|||
164571848|NCT01827384|594458390|FG003|Overall Study|Participant died before treatment|0|||
164229759|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
164571849|NCT01827384|594458391|FG004|Overall Study|Participant died before treatment|0|||
164571850|NCT01827384|594458392|FG005|Overall Study|Participant died before treatment|0|||
164571851|NCT01827384|594458393|FG006|Overall Study|Participant died before treatment|0|||
164571852|NCT01827384|594458394|FG007|Overall Study|Participant died before treatment|0|||
164571853|NCT01827384|594458395|FG008|Overall Study|Participant died before treatment|0|||
164571854|NCT01827384|594458396|FG009|Overall Study|Participant died before treatment|0|||
164571855|NCT01827384|594458397|FG010|Overall Study|Participant died before treatment|0|||
164571856|NCT01827384|594458398|FG011|Overall Study|Participant died before treatment|0|||
164571857|NCT01827384|594458399|FG012|Overall Study|Participant died before treatment|0|||
164571858|NCT01827384|594458400|FG013|Overall Study|Participant died before treatment|5|||
164571859|NCT01827384|594458387|FG000|Overall Study|Insufficient tumor cells|0|||
164571860|NCT01827384|594458388|FG001|Overall Study|Insufficient tumor cells|0|||
164571861|NCT01827384|594458389|FG002|Overall Study|Insufficient tumor cells|0|||
164571862|NCT01827384|594458390|FG003|Overall Study|Insufficient tumor cells|0|||
164571863|NCT01827384|594458391|FG004|Overall Study|Insufficient tumor cells|0|||
164229760|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
164229761|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
164229762|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
164229763|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
164229764|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
164229765|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
164229766|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
164229767|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
164229768|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
164229769|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
164229770|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
164229771|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
164229772|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
164229773|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
164229774|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
164229775|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
164229776|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
164229777|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
164229778|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
164229779|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
164421548|NCT03468426|593914435|FG005|Overall Study|Other than listed|2|||
164421549|NCT03468426|593914436|FG006|Overall Study|Other than listed|0|||
164571864|NCT01827384|594458392|FG005|Overall Study|Insufficient tumor cells|0|||
164571865|NCT01827384|594458393|FG006|Overall Study|Insufficient tumor cells|0|||
164571866|NCT01827384|594458394|FG007|Overall Study|Insufficient tumor cells|0|||
164571867|NCT01827384|594458395|FG008|Overall Study|Insufficient tumor cells|0|||
164571868|NCT01827384|594458396|FG009|Overall Study|Insufficient tumor cells|0|||
164571869|NCT01827384|594458397|FG010|Overall Study|Insufficient tumor cells|0|||
164571870|NCT01827384|594458398|FG011|Overall Study|Insufficient tumor cells|0|||
164571871|NCT01827384|594458399|FG012|Overall Study|Insufficient tumor cells|0|||
164421550|NCT03468426|593914437|FG007|Overall Study|Other than listed|0|||
164421551|NCT03468426|593914438|FG008|Overall Study|Other than listed|4|||
164421552|NCT03468426|593914439|FG009|Overall Study|Other than listed|4|||
164421553|NCT03468426|593914440|FG010|Overall Study|Other than listed|1|||
164421554|NCT03468426|593914430|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164421555|NCT03468426|593914431|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164421556|NCT03468426|593914432|FG002|Overall Study|Dose Limiting Toxicity (DLT)|1|||
164421557|NCT03468426|593914433|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164421558|NCT03468426|593914434|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164421559|NCT03468426|593914435|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164421560|NCT03468426|593914436|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164421561|NCT03468426|593914437|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164421562|NCT03468426|593914438|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164421563|NCT03468426|593914439|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164421564|NCT03468426|593914440|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164421565|NCT03468426|593914430|FG000|Overall Study|missing reason|0|||
164421566|NCT03468426|593914431|FG001|Overall Study|missing reason|0|||
164421567|NCT03468426|593914432|FG002|Overall Study|missing reason|0|||
164421568|NCT03468426|593914433|FG003|Overall Study|missing reason|0|||
164421569|NCT03468426|593914434|FG004|Overall Study|missing reason|0|||
164421570|NCT03468426|593914435|FG005|Overall Study|missing reason|0|||
164421571|NCT03468426|593914436|FG006|Overall Study|missing reason|0|||
164421572|NCT03468426|593914437|FG007|Overall Study|missing reason|0|||
164421573|NCT03468426|593914438|FG008|Overall Study|missing reason|0|||
164421574|NCT03468426|593914439|FG009|Overall Study|missing reason|1|||
164421575|NCT03468426|593914440|FG010|Overall Study|missing reason|0|||
164421576|NCT05876351|593914442|FG000|Overall Study|Other than specified|2|||
164421577|NCT05876351|593914442|FG000|Overall Study|Study specific discontinuation criteria|1|||
164421578|NCT00997243|593914443|FG000|Overall Study|Early termination of study by sponsor|7|||
164421579|NCT03415022|593914444|FG000|Overall Study|Withdrawal by Subject|1|||
164421580|NCT03415022|593914445|FG001|Overall Study|Withdrawal by Subject|2|||
164421581|NCT03415022|593914444|FG000|Overall Study|COVID-19 Suspension|2|||
164421582|NCT03415022|593914445|FG001|Overall Study|COVID-19 Suspension|3|||
164421583|NCT03415022|593914444|FG000|Overall Study|Lost to Follow-up|2|||
164421584|NCT03415022|593914445|FG001|Overall Study|Lost to Follow-up|0|||
164421585|NCT02206152|593914448|FG000|Pre-Randomization|Withdrawal by Subject|2|||
164421586|NCT00478608|593914449|FG000|Overall Study|Adverse Event|1|||
164571872|NCT01827384|594458400|FG013|Overall Study|Insufficient tumor cells|13|||
164571873|NCT01827384|594458387|FG000|Overall Study|No actionable mutation|0|||
164571874|NCT01827384|594458388|FG001|Overall Study|No actionable mutation|0|||
164571875|NCT01827384|594458389|FG002|Overall Study|No actionable mutation|0|||
164571876|NCT01827384|594458390|FG003|Overall Study|No actionable mutation|0|||
164571877|NCT01827384|594458391|FG004|Overall Study|No actionable mutation|0|||
164229780|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
164229781|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
164229782|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
164229783|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
164229784|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
164229785|NCT02420314|593210865|FG000|Overall Study|Withdrawal by Subject|1|||
164229786|NCT02420314|593210865|FG000|Overall Study|Protocol Violation|1|||
164229787|NCT02251041|593210866|FG000|Overall Study|Did not receive intervention|15|||
164229788|NCT02251041|593210867|FG001|Overall Study|Did not receive intervention|4|||
164229789|NCT01618708|593210870|FG000|Overall Study|Adverse Event|10|||
164229790|NCT01618708|593210871|FG001|Overall Study|Adverse Event|10|||
164229791|NCT01618708|593210870|FG000|Overall Study|Lost to Follow-up|3|||
164229792|NCT01618708|593210871|FG001|Overall Study|Lost to Follow-up|3|||
164229793|NCT01618708|593210870|FG000|Overall Study|Withdrawal by Subject|17|||
164571878|NCT01827384|594458392|FG005|Overall Study|No actionable mutation|0|||
164571879|NCT01827384|594458393|FG006|Overall Study|No actionable mutation|0|||
164571880|NCT01827384|594458394|FG007|Overall Study|No actionable mutation|0|||
164571881|NCT01827384|594458395|FG008|Overall Study|No actionable mutation|0|||
164571882|NCT01827384|594458396|FG009|Overall Study|No actionable mutation|0|||
164571883|NCT01827384|594458397|FG010|Overall Study|No actionable mutation|0|||
164229794|NCT01618708|593210871|FG001|Overall Study|Withdrawal by Subject|22|||
164229795|NCT01618708|593210870|FG000|Overall Study|Lack of Efficacy|8|||
164229796|NCT01618708|593210871|FG001|Overall Study|Lack of Efficacy|8|||
164421587|NCT00478608|593914449|FG000|Overall Study|Serious Adverse Event|14|||
164421588|NCT00478608|593914449|FG000|Overall Study|Withdrawal by Subject|2|||
164421589|NCT00478608|593914449|FG000|Overall Study|Protocol Violation|3|||
164421590|NCT01349907|593914452|FG000|Overall Study|Adverse Event|37|||
164229797|NCT01618708|593210870|FG000|Overall Study|Technical problems|2|||
164421591|NCT01349907|593914453|FG001|Overall Study|Adverse Event|11|||
164421592|NCT01349907|593914452|FG000|Overall Study|Treatment failure|13|||
164571884|NCT01827384|594458398|FG011|Overall Study|No actionable mutation|0|||
164571885|NCT01827384|594458399|FG012|Overall Study|No actionable mutation|0|||
164571886|NCT01827384|594458400|FG013|Overall Study|No actionable mutation|73|||
164421593|NCT01349907|593914453|FG001|Overall Study|Treatment failure|4|||
164421594|NCT01349907|593914452|FG000|Overall Study|Lost to Follow-up|25|||
164421595|NCT01349907|593914453|FG001|Overall Study|Lost to Follow-up|6|||
164421596|NCT01349907|593914452|FG000|Overall Study|Withdrawal by Subject|30|||
164421597|NCT01349907|593914453|FG001|Overall Study|Withdrawal by Subject|8|||
164421598|NCT01349907|593914452|FG000|Overall Study|Protocol Violation|33|||
164421599|NCT01349907|593914453|FG001|Overall Study|Protocol Violation|13|||
164421600|NCT01349907|593914452|FG000|Overall Study|Administrative|1|||
164421601|NCT01349907|593914453|FG001|Overall Study|Administrative|1|||
164421602|NCT03583541|593914456|FG000|Overall Study|Lost to Follow-up|31|||
164421603|NCT03583541|593914457|FG001|Overall Study|Lost to Follow-up|65|||
164421604|NCT00884286|593914458|FG000|Overall Study|Progressive disease|21|||
164421605|NCT00884286|593914459|FG001|Overall Study|Progressive disease|28|||
164421606|NCT00884286|593914458|FG000|Overall Study|Toxicity|4|||
164421607|NCT00884286|593914459|FG001|Overall Study|Toxicity|1|||
164421608|NCT00884286|593914458|FG000|Overall Study|Death|2|||
164421609|NCT00884286|593914459|FG001|Overall Study|Death|2|||
164421610|NCT00884286|593914458|FG000|Overall Study|Physician Decision|1|||
164421611|NCT00884286|593914459|FG001|Overall Study|Physician Decision|0|||
164421612|NCT00884286|593914458|FG000|Overall Study|Septic shock|1|||
164421613|NCT00884286|593914459|FG001|Overall Study|Septic shock|0|||
164421614|NCT00884286|593914458|FG000|Overall Study|Thrombus in right auricle|1|||
164421615|NCT00884286|593914459|FG001|Overall Study|Thrombus in right auricle|0|||
164421616|NCT00884286|593914458|FG000|Overall Study|Not treated|2|||
164421617|NCT00884286|593914459|FG001|Overall Study|Not treated|1|||
164421618|NCT00884286|593914458|FG000|Overall Study|Comprised lung carcinoma|0|||
164421619|NCT00884286|593914459|FG001|Overall Study|Comprised lung carcinoma|1|||
164421620|NCT00724061|593914461|FG000|Dose Escalation Phase|Adverse Event|2|||
164229798|NCT01618708|593210871|FG001|Overall Study|Technical problems|0|||
164229799|NCT01618708|593210870|FG000|Overall Study|Other than specified above|1|||
164229800|NCT01618708|593210871|FG001|Overall Study|Other than specified above|1|||
164229801|NCT01618708|593210870|FG000|Overall Study|Randomized but not treated|3|||
164421621|NCT00724061|593914461|FG000|Dose Escalation Phase|Disease Progression|3|||
164421622|NCT00594932|593914464|FG000|First 3 Months|Withdrawal by Subject|1|||
164421623|NCT00594932|593914465|FG001|First 3 Months|Withdrawal by Subject|3|||
164421624|NCT00594932|593914464|FG000|Final 3 Months|Withdrawal by Subject|4|||
164421625|NCT00594932|593914465|FG001|Final 3 Months|Withdrawal by Subject|3|||
164571887|NCT01827384|594458387|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
164571888|NCT01827384|594458388|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
164571889|NCT01827384|594458389|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
164229802|NCT01618708|593210871|FG001|Overall Study|Randomized but not treated|2|||
164229803|NCT00680914|593210874|FG000|Overall Study|Consent withdrawal|6|||
164229804|NCT00680914|593210875|FG001|Overall Study|Consent withdrawal|3|||
164229805|NCT00680914|593210874|FG000|Overall Study|Lost to Follow-up|4|||
164229806|NCT00680914|593210875|FG001|Overall Study|Lost to Follow-up|0|||
164229807|NCT00680914|593210874|FG000|Overall Study|serious adverse event (SAE)|0|||
164229808|NCT00680914|593210875|FG001|Overall Study|serious adverse event (SAE)|1|||
164229809|NCT01848457|593210876|FG000|Overall Study|Death|1|||
164229810|NCT01848457|593210877|FG001|Overall Study|Death|0|||
164229811|NCT01848457|593210878|FG002|Overall Study|Death|0|||
164229812|NCT01848457|593210879|FG003|Overall Study|Death|0|||
164229813|NCT03131479|593210880|FG000|Overall Study|Adverse Event|0|||
164229814|NCT03131479|593210881|FG001|Overall Study|Adverse Event|0|||
164571890|NCT01827384|594458390|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
164571891|NCT01827384|594458391|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
164571892|NCT01827384|594458392|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
164571893|NCT01827384|594458393|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
164571894|NCT01827384|594458394|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
164571895|NCT01827384|594458395|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
164571896|NCT01827384|594458396|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
164229815|NCT03131479|593210882|FG002|Overall Study|Adverse Event|1|||
164229816|NCT03131479|593210883|FG003|Overall Study|Adverse Event|1|||
164421626|NCT01536145|593914466|FG000|Overall Study|Progressive disease|3|||
164421627|NCT01536145|593914467|FG001|Overall Study|Progressive disease|4|||
164421628|NCT01536145|593914468|FG002|Overall Study|Progressive disease|1|||
164421629|NCT01536145|593914469|FG003|Overall Study|Progressive disease|2|||
164229817|NCT03131479|593210884|FG004|Overall Study|Adverse Event|0|||
164229818|NCT03131479|593210880|FG000|Overall Study|Subject/Guardian Decision|0|||
164229819|NCT03131479|593210881|FG001|Overall Study|Subject/Guardian Decision|0|||
164421630|NCT01536145|593914470|FG004|Overall Study|Progressive disease|1|||
164421631|NCT01536145|593914471|FG005|Overall Study|Progressive disease|2|||
164421632|NCT01536145|593914472|FG006|Overall Study|Progressive disease|1|||
164421633|NCT01536145|593914473|FG007|Overall Study|Progressive disease|2|||
164421634|NCT01536145|593914474|FG008|Overall Study|Progressive disease|1|||
164421635|NCT01536145|593914475|FG009|Overall Study|Progressive disease|3|||
164421636|NCT01536145|593914476|FG010|Overall Study|Progressive disease|3|||
164229820|NCT03131479|593210882|FG002|Overall Study|Subject/Guardian Decision|0|||
164229821|NCT03131479|593210883|FG003|Overall Study|Subject/Guardian Decision|1|||
164229822|NCT03131479|593210884|FG004|Overall Study|Subject/Guardian Decision|0|||
164229823|NCT04439903|593210885|FG000|Overall Study|Withdrawal by Subject|2|||
164229824|NCT04439903|593210885|FG000|Overall Study|Screen Failure|1|||
164229825|NCT02181413|593210887|FG000|Overall Study|Withdrawal by Subject|45|||
164229826|NCT02181413|593210888|FG001|Overall Study|Withdrawal by Subject|61|||
164229827|NCT02181413|593210887|FG000|Overall Study|Reason Not Specified|2|||
164229828|NCT02181413|593210888|FG001|Overall Study|Reason Not Specified|5|||
164229829|NCT02181413|593210887|FG000|Overall Study|Lost to Follow-up|8|||
164229830|NCT02181413|593210888|FG001|Overall Study|Lost to Follow-up|7|||
164229831|NCT02298946|593210890|FG000|Overall Study|Did not receive treatment|2|||
164229832|NCT02298946|593210891|FG001|Overall Study|Did not receive treatment|0|||
164229833|NCT02298946|593210890|FG000|Overall Study|Unevaluable|2|||
164229834|NCT02298946|593210891|FG001|Overall Study|Unevaluable|1|||
164229835|NCT00050011|593210892|FG000|Overall Study|Adverse Event|41|||
164229836|NCT00050011|593210893|FG001|Overall Study|Adverse Event|46|||
164229837|NCT00050011|593210892|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164229838|NCT00050011|593210893|FG001|Overall Study|Abnormal laboratory value(s)|1|||
164229839|NCT00050011|593210892|FG000|Overall Study|Abnormal test procedure results|0|||
164229840|NCT00050011|593210893|FG001|Overall Study|Abnormal test procedure results|1|||
164229841|NCT00050011|593210892|FG000|Overall Study|Lack of Efficacy|16|||
164229842|NCT00050011|593210893|FG001|Overall Study|Lack of Efficacy|21|||
164229843|NCT00050011|593210892|FG000|Overall Study|Participant condition no longer required|1|||
164229844|NCT00050011|593210893|FG001|Overall Study|Participant condition no longer required|0|||
164229845|NCT00050011|593210892|FG000|Overall Study|Protocol Violation|4|||
164229846|NCT00050011|593210893|FG001|Overall Study|Protocol Violation|10|||
164229847|NCT00050011|593210892|FG000|Overall Study|Withdrawal by Subject|34|||
164229848|NCT00050011|593210893|FG001|Overall Study|Withdrawal by Subject|26|||
164229849|NCT00050011|593210892|FG000|Overall Study|Lost to Follow-up|7|||
164229850|NCT00050011|593210893|FG001|Overall Study|Lost to Follow-up|9|||
164229851|NCT00050011|593210892|FG000|Overall Study|Administrative problems|10|||
164229852|NCT00050011|593210893|FG001|Overall Study|Administrative problems|6|||
164229853|NCT00050011|593210892|FG000|Overall Study|Death|7|||
164229854|NCT00050011|593210893|FG001|Overall Study|Death|4|||
164229855|NCT00050011|593210892|FG000|Overall Study|Unknown - Reason is missing|0|||
164229856|NCT00050011|593210893|FG001|Overall Study|Unknown - Reason is missing|2|||
164229857|NCT03034044|593210894|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
164229858|NCT02412436|593210895|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
164229859|NCT02412436|593210895|FG000|Overall Study|Lost to Follow-up|6|||
164229860|NCT02412436|593210895|FG000|Overall Study|Unable to get to clinic|3|||
164229861|NCT02412436|593210895|FG000|Overall Study|Death|1|||
164229862|NCT02412436|593210895|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
164229863|NCT01111552|593210896|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
164229864|NCT01111552|593210897|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
164229865|NCT01111552|593210898|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
164229866|NCT01111552|593210899|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
164229867|NCT01111552|593210900|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
164229868|NCT01111552|593210896|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
164229869|NCT01111552|593210897|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
164229870|NCT01111552|593210898|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
164229871|NCT01111552|593210899|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
164229872|NCT01111552|593210900|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
164229873|NCT01111552|593210896|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
164229874|NCT01111552|593210897|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
164229875|NCT01111552|593210898|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
164229876|NCT01111552|593210899|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
164229877|NCT01111552|593210900|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
164229878|NCT01111552|593210896|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
164331679|NCT01460368|593591313|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
164331680|NCT01460368|593591314|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
164571897|NCT01827384|594458397|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
164571898|NCT01827384|594458398|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
164571899|NCT01827384|594458399|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
164229879|NCT01111552|593210897|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
164421637|NCT01536145|593914466|FG000|Overall Study|Withdrawal by Subject|0|||
164229880|NCT01111552|593210898|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
164229881|NCT01111552|593210899|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
164229882|NCT01111552|593210900|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
164229883|NCT01111552|593210896|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
164421638|NCT01536145|593914467|FG001|Overall Study|Withdrawal by Subject|0|||
164229884|NCT01111552|593210897|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
164229885|NCT01111552|593210898|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
164229886|NCT01111552|593210899|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
164229887|NCT01111552|593210900|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
164229888|NCT01111552|593210896|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
164229889|NCT01111552|593210897|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
164229890|NCT01111552|593210898|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
164229891|NCT01111552|593210899|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
164229892|NCT01111552|593210900|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
164229893|NCT01111552|593210896|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
164229894|NCT01111552|593210897|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
164229895|NCT01111552|593210898|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
164229896|NCT01111552|593210899|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
164229897|NCT01111552|593210900|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
164229898|NCT01111552|593210896|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
164229899|NCT01111552|593210897|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
164229900|NCT01111552|593210898|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
164229901|NCT01111552|593210899|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
164229902|NCT01111552|593210900|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
164229903|NCT01111552|593210896|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
164229904|NCT01111552|593210897|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
164229905|NCT01111552|593210898|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
164229906|NCT01111552|593210899|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
164229907|NCT01111552|593210900|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
164229908|NCT01111552|593210896|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
164229909|NCT01111552|593210897|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
164229910|NCT01111552|593210898|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
164229911|NCT01111552|593210899|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
164229912|NCT01111552|593210900|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
164229913|NCT01111552|593210896|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
164229914|NCT01111552|593210897|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
164229915|NCT01111552|593210898|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
164229916|NCT01111552|593210899|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
164229917|NCT01111552|593210900|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
164229918|NCT01111552|593210896|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
164229919|NCT01111552|593210897|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
164229920|NCT01111552|593210898|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
164229921|NCT01111552|593210899|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
164229922|NCT01111552|593210900|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
164229923|NCT01111552|593210896|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
164229924|NCT01111552|593210897|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
164229925|NCT01111552|593210898|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
164229926|NCT01111552|593210899|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
164229927|NCT01111552|593210900|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
164229928|NCT01111552|593210896|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
164229929|NCT01111552|593210897|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
164229930|NCT01111552|593210898|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
164229931|NCT01111552|593210899|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
164229932|NCT01111552|593210900|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
164229933|NCT02679274|593210904|FG000|Overall Study|Withdrawal by Subject|1|||
164229934|NCT02679274|593210905|FG001|Overall Study|Withdrawal by Subject|0|||
164229935|NCT03514134|593212606|FG000|Overall Study|Lost to Follow-up|0|||
164229936|NCT03514134|593212607|FG001|Overall Study|Lost to Follow-up|1|||
164229937|NCT00462826|593212610|FG000|Overall Study|Ineligible - second primary|1|||
164229938|NCT00462826|593212610|FG000|Overall Study|Ineligible - wrong cell type|1|||
164229939|NCT00462826|593212610|FG000|Overall Study|Ineligible - wrong primary|2|||
164229940|NCT00462826|593212610|FG000|Overall Study|Never treated|1|||
164229941|NCT04976777|593212611|FG000|Overall Study|COVID-19 Infection|1|||
164229942|NCT04976777|593212612|FG001|Overall Study|COVID-19 Infection|0|||
164229943|NCT05654181|593212613|FG000|Overall Study|Adverse Event|1|||
164331681|NCT01460368|593591315|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
164331682|NCT01460368|593591316|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
164331683|NCT01460368|593591317|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
164331684|NCT01460368|593591318|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
164331685|NCT02047227|593591319|FG000|Overall Study|Adverse Event|2|||
164331686|NCT02047227|593591320|FG001|Overall Study|Adverse Event|4|||
164421639|NCT01536145|593914468|FG002|Overall Study|Withdrawal by Subject|1|||
164421640|NCT01536145|593914469|FG003|Overall Study|Withdrawal by Subject|0|||
164421641|NCT01536145|593914470|FG004|Overall Study|Withdrawal by Subject|0|||
164421642|NCT01536145|593914471|FG005|Overall Study|Withdrawal by Subject|1|||
164229944|NCT05654181|593212614|FG001|Overall Study|Adverse Event|0|||
164229945|NCT05654181|593212615|FG002|Overall Study|Adverse Event|0|||
164229946|NCT05654181|593212616|FG003|Overall Study|Adverse Event|0|||
164229947|NCT05654181|593212617|FG004|Overall Study|Adverse Event|0|||
164229948|NCT05654181|593212618|FG005|Overall Study|Adverse Event|0|||
164229949|NCT05654181|593212619|FG006|Overall Study|Adverse Event|0|||
164229950|NCT05654181|593212620|FG007|Overall Study|Adverse Event|1|||
164229951|NCT05654181|593212621|FG008|Overall Study|Adverse Event|0|||
164229952|NCT05654181|593212622|FG009|Overall Study|Adverse Event|0|||
164229953|NCT05654181|593212613|FG000|Overall Study|Withdrawal by Subject|0|||
164229954|NCT05654181|593212614|FG001|Overall Study|Withdrawal by Subject|0|||
164229955|NCT05654181|593212615|FG002|Overall Study|Withdrawal by Subject|0|||
164229956|NCT05654181|593212616|FG003|Overall Study|Withdrawal by Subject|0|||
164421643|NCT01536145|593914472|FG006|Overall Study|Withdrawal by Subject|0|||
164421644|NCT01536145|593914473|FG007|Overall Study|Withdrawal by Subject|0|||
164421645|NCT01536145|593914474|FG008|Overall Study|Withdrawal by Subject|2|||
164421646|NCT01536145|593914475|FG009|Overall Study|Withdrawal by Subject|0|||
164421647|NCT01536145|593914476|FG010|Overall Study|Withdrawal by Subject|2|||
164421648|NCT01536145|593914466|FG000|Overall Study|Other|0|||
164421649|NCT01536145|593914467|FG001|Overall Study|Other|0|||
164421650|NCT01536145|593914468|FG002|Overall Study|Other|0|||
164421651|NCT01536145|593914469|FG003|Overall Study|Other|0|||
164421652|NCT01536145|593914470|FG004|Overall Study|Other|1|||
164421653|NCT01536145|593914471|FG005|Overall Study|Other|0|||
164421654|NCT01536145|593914472|FG006|Overall Study|Other|0|||
164229957|NCT05654181|593212617|FG004|Overall Study|Withdrawal by Subject|0|||
164229958|NCT05654181|593212618|FG005|Overall Study|Withdrawal by Subject|0|||
164229959|NCT05654181|593212619|FG006|Overall Study|Withdrawal by Subject|0|||
164229960|NCT05654181|593212620|FG007|Overall Study|Withdrawal by Subject|1|||
164229961|NCT05654181|593212621|FG008|Overall Study|Withdrawal by Subject|0|||
164229962|NCT05654181|593212622|FG009|Overall Study|Withdrawal by Subject|0|||
164229963|NCT05654181|593212613|FG000|Overall Study|Other|0|||
164229964|NCT05654181|593212614|FG001|Overall Study|Other|0|||
164229965|NCT05654181|593212615|FG002|Overall Study|Other|0|||
164421655|NCT01536145|593914473|FG007|Overall Study|Other|0|||
164421656|NCT01536145|593914474|FG008|Overall Study|Other|0|||
164421657|NCT01536145|593914475|FG009|Overall Study|Other|3|||
164421658|NCT01536145|593914476|FG010|Overall Study|Other|2|||
164421659|NCT01536145|593914466|FG000|Overall Study|Death|0|||
164421660|NCT01536145|593914467|FG001|Overall Study|Death|0|||
164571900|NCT01827384|594458400|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
164571901|NCT04980391|594458413|FG000|Overall Study|Death|0|||
164571902|NCT04980391|594458414|FG001|Overall Study|Death|0|||
164571903|NCT04980391|594458415|FG002|Overall Study|Death|1|||
164571904|NCT04980391|594458416|FG003|Overall Study|Death|1|||
164571905|NCT04980391|594458413|FG000|Overall Study|Lost to Follow-up|3|||
164571906|NCT04980391|594458414|FG001|Overall Study|Lost to Follow-up|3|||
164571907|NCT04980391|594458415|FG002|Overall Study|Lost to Follow-up|2|||
164571908|NCT04980391|594458416|FG003|Overall Study|Lost to Follow-up|3|||
164571909|NCT04980391|594458413|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
164571910|NCT04980391|594458414|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
164571911|NCT04980391|594458415|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
164571912|NCT04980391|594458416|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
164571913|NCT04980391|594458413|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164571914|NCT04980391|594458414|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164571915|NCT04980391|594458415|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
164571916|NCT04980391|594458416|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164571917|NCT04980391|594458413|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
164571918|NCT04980391|594458414|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
164571919|NCT04980391|594458415|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
164421661|NCT01536145|593914468|FG002|Overall Study|Death|0|||
164421662|NCT01536145|593914469|FG003|Overall Study|Death|0|||
164421663|NCT01536145|593914470|FG004|Overall Study|Death|0|||
164421664|NCT01536145|593914471|FG005|Overall Study|Death|0|||
164421665|NCT01536145|593914472|FG006|Overall Study|Death|1|||
164571920|NCT04980391|594458416|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
164229966|NCT05654181|593212616|FG003|Overall Study|Other|0|||
164421666|NCT01536145|593914473|FG007|Overall Study|Death|0|||
164229967|NCT05654181|593212617|FG004|Overall Study|Other|1|||
164229968|NCT05654181|593212618|FG005|Overall Study|Other|1|||
164229969|NCT05654181|593212619|FG006|Overall Study|Other|0|||
164421667|NCT01536145|593914474|FG008|Overall Study|Death|0|||
164421668|NCT01536145|593914475|FG009|Overall Study|Death|0|||
164571921|NCT00960076|594460303|FG000|Overall Study|Adverse Event|1|||
164571922|NCT00960076|594460304|FG001|Overall Study|Adverse Event|7|||
164229970|NCT05654181|593212620|FG007|Overall Study|Other|0|||
164229971|NCT05654181|593212621|FG008|Overall Study|Other|0|||
164229972|NCT05654181|593212622|FG009|Overall Study|Other|0|||
164229973|NCT01397253|593212623|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
164229974|NCT01397253|593212624|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
164229975|NCT03033784|593212630|FG000|Overall Study|Anxiety related to MRI scanner|0|||
164229976|NCT03033784|593212631|FG001|Overall Study|Anxiety related to MRI scanner|1|||
164229977|NCT03033784|593212632|FG002|Overall Study|Anxiety related to MRI scanner|0|||
164229978|NCT03033784|593212633|FG003|Overall Study|Anxiety related to MRI scanner|0|||
164229979|NCT03033784|593212634|FG004|Overall Study|Anxiety related to MRI scanner|0|||
164421669|NCT01536145|593914476|FG010|Overall Study|Death|0|||
164421670|NCT01536145|593914466|FG000|Overall Study|Adverse Event|0|||
164229980|NCT03033784|593212635|FG005|Overall Study|Anxiety related to MRI scanner|0|||
164229981|NCT03033784|593212636|FG006|Overall Study|Anxiety related to MRI scanner|0|||
164229982|NCT03033784|593212637|FG007|Overall Study|Anxiety related to MRI scanner|0|||
164229983|NCT03033784|593212638|FG008|Overall Study|Anxiety related to MRI scanner|0|||
164229984|NCT03033784|593212639|FG009|Overall Study|Anxiety related to MRI scanner|0|||
164421671|NCT01536145|593914467|FG001|Overall Study|Adverse Event|0|||
164421672|NCT01536145|593914468|FG002|Overall Study|Adverse Event|0|||
164421673|NCT01536145|593914469|FG003|Overall Study|Adverse Event|0|||
164421674|NCT01536145|593914470|FG004|Overall Study|Adverse Event|0|||
164421675|NCT01536145|593914471|FG005|Overall Study|Adverse Event|0|||
164421676|NCT01536145|593914472|FG006|Overall Study|Adverse Event|0|||
164421677|NCT01536145|593914473|FG007|Overall Study|Adverse Event|2|||
164421678|NCT01536145|593914474|FG008|Overall Study|Adverse Event|0|||
164421679|NCT01536145|593914475|FG009|Overall Study|Adverse Event|0|||
164421680|NCT01536145|593914476|FG010|Overall Study|Adverse Event|3|||
164421681|NCT00688259|593914479|FG000|Overall Study|Lost to Follow-up|2|||
164421682|NCT00688259|593914480|FG001|Overall Study|Lost to Follow-up|4|||
164421683|NCT00688259|593914479|FG000|Overall Study|Physician Decision|1|||
164421684|NCT00688259|593914480|FG001|Overall Study|Physician Decision|0|||
164421685|NCT00688259|593914479|FG000|Overall Study|Withdrawal by Subject|2|||
164421686|NCT00688259|593914480|FG001|Overall Study|Withdrawal by Subject|0|||
164421687|NCT00688259|593914479|FG000|Overall Study|Declined Interview|2|||
164421688|NCT00688259|593914480|FG001|Overall Study|Declined Interview|3|||
164421689|NCT00688259|593914479|FG000|Overall Study|Hospitalized at Follow-up|0|||
164421690|NCT00688259|593914480|FG001|Overall Study|Hospitalized at Follow-up|1|||
164421691|NCT02982720|593914483|FG000|Overall Study|Adverse Event|3|||
164421692|NCT02982720|593914483|FG000|Overall Study|Death|1|||
164421693|NCT00287469|593914488|FG000|Overall Study|serious adverse event|1|||
164421694|NCT00287469|593914489|FG001|Overall Study|serious adverse event|6|||
164421695|NCT00287469|593914488|FG000|Overall Study|Adverse Event|1|||
164421696|NCT00287469|593914489|FG001|Overall Study|Adverse Event|1|||
164421697|NCT00287469|593914488|FG000|Overall Study|moved from area|144|||
164421698|NCT00287469|593914489|FG001|Overall Study|moved from area|138|||
164421699|NCT00287469|593914488|FG000|Overall Study|Lost to Follow-up|74|||
164421700|NCT00287469|593914489|FG001|Overall Study|Lost to Follow-up|69|||
164421701|NCT01058863|593914490|FG000|Overall Study|Lost to Follow-up|1|||
164421702|NCT01058863|593914490|FG000|Overall Study|Withdrawal by Subject|1|||
164421703|NCT01058863|593914490|FG000|Overall Study|Sponsor requested withdrawal|1|||
164421704|NCT01058863|593914490|FG000|Overall Study|Randomized in error|1|||
164421705|NCT00681187|593914491|FG000|Overall Study|Withdrawal by Subject|1|||
164421706|NCT00681187|593914492|FG001|Overall Study|Withdrawal by Subject|0|||
164421707|NCT00681187|593914491|FG000|Overall Study|Death|0|||
164421708|NCT00681187|593914492|FG001|Overall Study|Death|1|||
164421709|NCT00681187|593914491|FG000|Overall Study|Adverse Event|0|||
164421710|NCT00681187|593914492|FG001|Overall Study|Adverse Event|1|||
164421711|NCT02448719|593914494|FG000|Overall Study|Withdrawal by Subject|0|||
164229985|NCT03033784|593212640|FG010|Overall Study|Anxiety related to MRI scanner|0|||
164229986|NCT03033784|593212641|FG011|Overall Study|Anxiety related to MRI scanner|0|||
164421712|NCT02448719|593914495|FG001|Overall Study|Withdrawal by Subject|0|||
164229987|NCT03033784|593212642|FG012|Overall Study|Anxiety related to MRI scanner|0|||
164421713|NCT02448719|593914496|FG002|Overall Study|Withdrawal by Subject|0|||
164421714|NCT02448719|593914497|FG003|Overall Study|Withdrawal by Subject|0|||
164421715|NCT02448719|593914498|FG004|Overall Study|Withdrawal by Subject|1|||
164421716|NCT02448719|593914499|FG005|Overall Study|Withdrawal by Subject|0|||
164421717|NCT02448719|593914500|FG006|Overall Study|Withdrawal by Subject|0|||
164229988|NCT03033784|593212630|FG000|Overall Study|Withdrawal by Subject|0|||
164421718|NCT02448719|593914501|FG007|Overall Study|Withdrawal by Subject|0|||
164421719|NCT02448719|593914502|FG008|Overall Study|Withdrawal by Subject|0|||
164421720|NCT02448719|593914503|FG009|Overall Study|Withdrawal by Subject|0|||
164421721|NCT02448719|593914504|FG010|Overall Study|Withdrawal by Subject|0|||
164421722|NCT04707391|593914507|FG000|Overall Study|Adverse Event|5|||
164421723|NCT04707391|593914508|FG001|Overall Study|Adverse Event|8|||
164421724|NCT04707391|593914507|FG000|Overall Study|Lost to Follow-up|44|||
164421725|NCT04707391|593914508|FG001|Overall Study|Lost to Follow-up|31|||
164421726|NCT04707391|593914507|FG000|Overall Study|Protocol Violation|1|||
164421727|NCT04707391|593914508|FG001|Overall Study|Protocol Violation|5|||
164571923|NCT00960076|594460303|FG000|Overall Study|No longer met study criteria|1|||
164571924|NCT00960076|594460304|FG001|Overall Study|No longer met study criteria|5|||
164571925|NCT00960076|594460303|FG000|Overall Study|Withdrawal by Subject|1|||
164571926|NCT00960076|594460304|FG001|Overall Study|Withdrawal by Subject|2|||
164571927|NCT00960076|594460303|FG000|Overall Study|Lost to Follow-up|3|||
164571928|NCT00960076|594460304|FG001|Overall Study|Lost to Follow-up|3|||
164229989|NCT03033784|593212631|FG001|Overall Study|Withdrawal by Subject|0|||
164229990|NCT03033784|593212632|FG002|Overall Study|Withdrawal by Subject|0|||
164229991|NCT03033784|593212633|FG003|Overall Study|Withdrawal by Subject|0|||
164229992|NCT03033784|593212634|FG004|Overall Study|Withdrawal by Subject|0|||
164229993|NCT03033784|593212635|FG005|Overall Study|Withdrawal by Subject|0|||
164229994|NCT03033784|593212636|FG006|Overall Study|Withdrawal by Subject|0|||
164229995|NCT03033784|593212637|FG007|Overall Study|Withdrawal by Subject|0|||
164229996|NCT03033784|593212638|FG008|Overall Study|Withdrawal by Subject|0|||
164229997|NCT03033784|593212639|FG009|Overall Study|Withdrawal by Subject|0|||
164229998|NCT03033784|593212640|FG010|Overall Study|Withdrawal by Subject|0|||
164229999|NCT03033784|593212641|FG011|Overall Study|Withdrawal by Subject|0|||
164230000|NCT03033784|593212642|FG012|Overall Study|Withdrawal by Subject|2|||
164230001|NCT00267488|593212643|FG000|Overall Study|Sponsor Terminated Study|9|||
164230002|NCT00267488|593212643|FG000|Overall Study|Protocol Violation|1|||
164230003|NCT00267488|593212643|FG000|Overall Study|Other (Disease Progression)|1|||
164230004|NCT02093520|593212644|FG000|Overall Study|Not treated|6|||
164230005|NCT02093520|593212645|FG001|Overall Study|Not treated|22|||
164230006|NCT00851084|593212646|FG000|Overall Study|Randomized but not treated|1|||
164230007|NCT00851084|593212647|FG001|Overall Study|Randomized but not treated|0|||
164230008|NCT00851084|593212646|FG000|Overall Study|Adverse Event|26|||
164230009|NCT00851084|593212647|FG001|Overall Study|Adverse Event|36|||
164230010|NCT00851084|593212646|FG000|Overall Study|Disease progression|52|||
164230011|NCT00851084|593212647|FG001|Overall Study|Disease progression|47|||
164230012|NCT00851084|593212646|FG000|Overall Study|Poor compliance to protocol|1|||
164230013|NCT00851084|593212647|FG001|Overall Study|Poor compliance to protocol|1|||
164230014|NCT00851084|593212646|FG000|Overall Study|Physician Decision|13|||
164230015|NCT00851084|593212647|FG001|Overall Study|Physician Decision|14|||
164230016|NCT00851084|593212646|FG000|Overall Study|Consent withdrawn|0|||
164230017|NCT00851084|593212647|FG001|Overall Study|Consent withdrawn|2|||
164230018|NCT00851084|593212646|FG000|Overall Study|Withdrawal by Subject|11|||
164230019|NCT00851084|593212647|FG001|Overall Study|Withdrawal by Subject|12|||
164230020|NCT00851084|593212646|FG000|Overall Study|Metastatic surgery|6|||
164230021|NCT00851084|593212647|FG001|Overall Study|Metastatic surgery|6|||
164230022|NCT00851084|593212646|FG000|Overall Study|Other|7|||
164230023|NCT00851084|593212647|FG001|Overall Study|Other|1|||
164230024|NCT01892189|593212650|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
164230025|NCT01892189|593212651|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
164230026|NCT01892189|593212652|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
164230027|NCT01892189|593212653|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
164230028|NCT01892189|593212654|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
164230029|NCT01892189|593212655|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
164230030|NCT01892189|593212656|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
164230031|NCT01892189|593212657|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
164230032|NCT01892189|593212658|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
164331687|NCT02047227|593591319|FG000|Overall Study|Lost to Follow-up|0|||
164331688|NCT02047227|593591320|FG001|Overall Study|Lost to Follow-up|3|||
164331689|NCT02047227|593591319|FG000|Overall Study|Protocol Violation|1|||
164331690|NCT02047227|593591320|FG001|Overall Study|Protocol Violation|0|||
164331691|NCT02047227|593591319|FG000|Overall Study|Spontaneous pregnancy|1|||
164331692|NCT02047227|593591320|FG001|Overall Study|Spontaneous pregnancy|0|||
164331693|NCT02047227|593591319|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
164331694|NCT02047227|593591320|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
164331695|NCT02047227|593591319|FG000|Overall Study|No oocytes retrieved|21|||
164331696|NCT02047227|593591320|FG001|Overall Study|No oocytes retrieved|20|||
164331697|NCT02047227|593591319|FG000|Overall Study|No fertilization|61|||
164331698|NCT02047227|593591320|FG001|Overall Study|No fertilization|51|||
164331699|NCT02047227|593591319|FG000|Overall Study|Intention to freeze all embryos|1|||
164331700|NCT02047227|593591320|FG001|Overall Study|Intention to freeze all embryos|0|||
164331701|NCT02047227|593591319|FG000|Overall Study|All embryos discarded|12|||
164331702|NCT02047227|593591320|FG001|Overall Study|All embryos discarded|11|||
164230033|NCT01892189|593212650|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164230034|NCT01892189|593212651|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164230035|NCT01892189|593212652|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
164230036|NCT01892189|593212653|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
164230037|NCT01892189|593212654|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164230038|NCT01892189|593212655|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164331703|NCT02047227|593591319|FG000|Overall Study|Other|10|||
164331704|NCT02047227|593591320|FG001|Overall Study|Other|9|||
164331705|NCT01385371|593591333|FG000|Overall Study|Adverse Event|54|||
164331706|NCT01385371|593591334|FG001|Overall Study|Adverse Event|19|||
164675525|NCT03570749|594836746|FG000|Overall Study|Pregnancy|0|||
164230039|NCT01892189|593212656|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
164230040|NCT01892189|593212657|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164230041|NCT01892189|593212658|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
164230042|NCT01892189|593212650|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
164230043|NCT01892189|593212651|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
164230044|NCT01892189|593212652|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
164230045|NCT01892189|593212653|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
164230046|NCT01892189|593212654|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
164230047|NCT01892189|593212655|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
164230048|NCT01892189|593212656|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
164230049|NCT01892189|593212657|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
164230050|NCT01892189|593212658|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
164230051|NCT02263547|593212661|FG000|Overall Study|Adverse Event|1|||
164230052|NCT02263547|593212661|FG000|Overall Study|Lost to Follow-up|2|||
164230053|NCT00856557|593212662|FG000|Overall Study|No patients with contextual flags|12|||
164230054|NCT00856557|593212663|FG001|Overall Study|No patients with contextual flags|16|||
164230055|NCT02301897|593212664|FG000|Treatment Course 1|Non-Compliance|0|||
164230056|NCT02301897|593212665|FG001|Treatment Course 1|Non-Compliance|0|||
164230057|NCT02301897|593212666|FG002|Treatment Course 1|Non-Compliance|1|||
164230058|NCT02301897|593212664|FG000|Treatment Course 1|Adverse Event|1|||
164230059|NCT02301897|593212665|FG001|Treatment Course 1|Adverse Event|1|||
164230060|NCT02301897|593212666|FG002|Treatment Course 1|Adverse Event|0|||
164230061|NCT02301897|593212664|FG000|Treatment Course 1|Lost to Follow-up|1|||
164230062|NCT02301897|593212665|FG001|Treatment Course 1|Lost to Follow-up|2|||
164230063|NCT02301897|593212666|FG002|Treatment Course 1|Lost to Follow-up|1|||
164230064|NCT02301897|593212664|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
164230065|NCT02301897|593212665|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
164230066|NCT02301897|593212666|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
164230067|NCT02301897|593212664|FG000|Treatment Course 1|Withdrawal by Subject|0|||
164230068|NCT02301897|593212665|FG001|Treatment Course 1|Withdrawal by Subject|0|||
164230069|NCT02301897|593212666|FG002|Treatment Course 1|Withdrawal by Subject|2|||
164230070|NCT02301897|593212664|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
164675526|NCT03570749|594836747|FG001|Overall Study|Pregnancy|0|||
164675527|NCT03570749|594836748|FG002|Overall Study|Pregnancy|0|||
164675528|NCT03570749|594836749|FG003|Overall Study|Pregnancy|0|||
164230071|NCT02301897|593212665|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
164230072|NCT02301897|593212666|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
164230073|NCT02301897|593212664|FG000|Treatment Course 2|Lost to Follow-up|0|||
164230074|NCT02301897|593212665|FG001|Treatment Course 2|Lost to Follow-up|2|||
164230075|NCT02301897|593212666|FG002|Treatment Course 2|Lost to Follow-up|0|||
164230076|NCT02301897|593212664|FG000|Treatment Course 2|Pregnancy|0|||
164230077|NCT02301897|593212665|FG001|Treatment Course 2|Pregnancy|1|||
164230078|NCT02301897|593212666|FG002|Treatment Course 2|Pregnancy|1|||
164230079|NCT02301897|593212664|FG000|Treatment Course 2|Withdrawal by Subject|0|||
164230080|NCT02301897|593212665|FG001|Treatment Course 2|Withdrawal by Subject|2|||
164230081|NCT02301897|593212666|FG002|Treatment Course 2|Withdrawal by Subject|0|||
164230082|NCT02301897|593212664|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
164230083|NCT02301897|593212665|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
164230084|NCT02301897|593212666|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
164230085|NCT00337168|593212667|FG000|Overall Study|Death|5|||
164230086|NCT00337168|593212667|FG000|Overall Study|Not protocol specified|2|||
164230087|NCT00337168|593212667|FG000|Overall Study|Did not start therapy|1|||
164230088|NCT02684461|593212670|FG000|Overall Study|Adverse Event|1|||
164230089|NCT02684461|593212671|FG001|Overall Study|Adverse Event|0|||
164230090|NCT02684461|593212672|FG002|Overall Study|Adverse Event|0|||
164230091|NCT02684461|593212670|FG000|Overall Study|Lack of Efficacy|1|||
164230092|NCT02684461|593212671|FG001|Overall Study|Lack of Efficacy|2|||
164230093|NCT02684461|593212672|FG002|Overall Study|Lack of Efficacy|0|||
164230094|NCT03663582|593212673|FG000|Overall Study|Physician Decision|1|||
164230095|NCT00557440|593212685|FG000|Treatment Period 1|Adverse Event|0|||
164230096|NCT00557440|593212686|FG001|Treatment Period 1|Adverse Event|0|||
164230097|NCT00557440|593212687|FG002|Treatment Period 1|Adverse Event|1|||
164230098|NCT00814983|593212688|FG000|Overall Study|Screen failure|1|||
164230099|NCT00814983|593212689|FG001|Overall Study|Screen failure|0|||
164230100|NCT00814983|593212688|FG000|Overall Study|Withdrawal by Subject|1|||
164230101|NCT00814983|593212689|FG001|Overall Study|Withdrawal by Subject|0|||
164230102|NCT00814983|593212688|FG000|Overall Study|Graft failure|1|||
164230103|NCT00814983|593212689|FG001|Overall Study|Graft failure|0|||
164230104|NCT04507763|593212690|FG000|Overall Study|Participants did not meet entrance criteria|201|||
164230105|NCT06582732|593212691|FG000|Initial Study Period|Adverse Event|0|||
164230106|NCT06582732|593212692|FG001|Initial Study Period|Adverse Event|0|||
164230107|NCT06582732|593212693|FG002|Initial Study Period|Adverse Event|0|||
164230108|NCT06582732|593212694|FG003|Initial Study Period|Adverse Event|2|||
164230109|NCT06582732|593212695|FG004|Initial Study Period|Adverse Event|0|||
164230110|NCT06582732|593212696|FG005|Initial Study Period|Adverse Event|0|||
164421728|NCT04707391|593914507|FG000|Overall Study|Withdrawal by Subject|27|||
164421729|NCT04707391|593914508|FG001|Overall Study|Withdrawal by Subject|25|||
164421730|NCT04707391|593914507|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
164421731|NCT04707391|593914508|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
164421732|NCT04707391|593914507|FG000|Overall Study|Other|0|||
164421733|NCT04707391|593914508|FG001|Overall Study|Other|2|||
164421734|NCT01406717|593914511|FG000|Overall Study|Subject non-compliance|4|||
164421735|NCT01406717|593914512|FG001|Overall Study|Subject non-compliance|3|||
164421736|NCT01406717|593914511|FG000|Overall Study|Protocol Violation|5|||
164421737|NCT01406717|593914512|FG001|Overall Study|Protocol Violation|1|||
164421738|NCT01406717|593914511|FG000|Overall Study|Lost to Follow-up|14|||
164421739|NCT01406717|593914512|FG001|Overall Study|Lost to Follow-up|8|||
164421740|NCT01406717|593914511|FG000|Overall Study|Withdrawal by Subject|19|||
164421741|NCT01406717|593914512|FG001|Overall Study|Withdrawal by Subject|15|||
164421742|NCT01406717|593914511|FG000|Overall Study|Adverse Event|1|||
164421743|NCT01406717|593914512|FG001|Overall Study|Adverse Event|2|||
164421744|NCT01406717|593914511|FG000|Overall Study|Lack of Efficacy|0|||
164421745|NCT01406717|593914512|FG001|Overall Study|Lack of Efficacy|1|||
164421746|NCT01406717|593914511|FG000|Overall Study|Non-completion of visit activity|0|||
164421747|NCT01406717|593914512|FG001|Overall Study|Non-completion of visit activity|1|||
164421748|NCT02040090|593914513|FG000|Overall Study|Adverse Event|2|||
164421749|NCT02040090|593914514|FG001|Overall Study|Adverse Event|0|||
164421750|NCT02040090|593914513|FG000|Overall Study|Physician Decision|1|||
164421751|NCT02040090|593914514|FG001|Overall Study|Physician Decision|0|||
164421752|NCT02040090|593914513|FG000|Overall Study|Withdrawal by Subject|0|||
164421753|NCT02040090|593914514|FG001|Overall Study|Withdrawal by Subject|1|||
164421754|NCT02040090|593914513|FG000|Overall Study|Lost to Follow-up|0|||
164421755|NCT02040090|593914514|FG001|Overall Study|Lost to Follow-up|1|||
164421756|NCT02275533|593914517|FG000|Overall Study|Protocol Violation|2|||
164421757|NCT02275533|593914518|FG001|Overall Study|Protocol Violation|0|||
164421758|NCT02275533|593914517|FG000|Overall Study|Never received study treatment|1|||
164421759|NCT02275533|593914518|FG001|Overall Study|Never received study treatment|0|||
164421760|NCT00653263|593914519|FG000|Overall Study|Withdrawal by Subject|1|||
164421761|NCT00653263|593914519|FG000|Overall Study|Physician Decision|1|||
164421762|NCT00895843|593914520|FG000|Overall Study|Protocol Violation|12|||
164421763|NCT00895843|593914521|FG001|Overall Study|Protocol Violation|12|||
164421764|NCT02611830|593914522|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
164421765|NCT02611830|593914523|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
164421766|NCT02611830|593914524|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
164421767|NCT02611830|593914525|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
164421768|NCT02611830|593914522|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
164421769|NCT02611830|593914523|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
164421770|NCT02611830|593914524|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
164421771|NCT02611830|593914525|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
164421772|NCT02611830|593914522|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
164421773|NCT02611830|593914523|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
164421774|NCT02611830|593914524|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
164421775|NCT02611830|593914525|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
164421776|NCT02611830|593914522|FG000|OL Induction Phase|Lack of Efficacy|9|||
164421777|NCT02611830|593914523|FG001|OL Induction Phase|Lack of Efficacy|0|||
164421778|NCT02611830|593914524|FG002|OL Induction Phase|Lack of Efficacy|0|||
164421779|NCT02611830|593914525|FG003|OL Induction Phase|Lack of Efficacy|0|||
164421780|NCT02611830|593914522|FG000|OL Induction Phase|Reason not specified|3|||
164421781|NCT02611830|593914523|FG001|OL Induction Phase|Reason not specified|0|||
164421782|NCT02611830|593914524|FG002|OL Induction Phase|Reason not specified|0|||
164421783|NCT02611830|593914525|FG003|OL Induction Phase|Reason not specified|0|||
164421784|NCT02611830|593914522|FG000|Maintenance Phase|Lack of Efficacy|0|||
164421785|NCT02611830|593914523|FG001|Maintenance Phase|Lack of Efficacy|29|||
164421786|NCT02611830|593914524|FG002|Maintenance Phase|Lack of Efficacy|18|||
164421787|NCT02611830|593914525|FG003|Maintenance Phase|Lack of Efficacy|6|||
164421788|NCT02611830|593914522|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
164421789|NCT02611830|593914523|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
164421790|NCT02611830|593914524|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
164421791|NCT02611830|593914525|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
164421792|NCT02611830|593914522|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
164421793|NCT02611830|593914523|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
164421794|NCT02611830|593914524|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
164421795|NCT02611830|593914525|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
164421796|NCT02611830|593914522|FG000|Maintenance Phase|Lost to Follow-up|0|||
164421797|NCT02611830|593914523|FG001|Maintenance Phase|Lost to Follow-up|0|||
164421798|NCT02611830|593914524|FG002|Maintenance Phase|Lost to Follow-up|0|||
164421799|NCT02611830|593914525|FG003|Maintenance Phase|Lost to Follow-up|1|||
164421800|NCT02611830|593914522|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
164421801|NCT02611830|593914523|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
164675529|NCT03570749|594836750|FG004|Overall Study|Pregnancy|0|||
164421802|NCT02611830|593914524|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
164421803|NCT02611830|593914525|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
164421804|NCT02611830|593914522|FG000|Maintenance Phase|Pregnancy|0|||
164421805|NCT02611830|593914523|FG001|Maintenance Phase|Pregnancy|0|||
164421806|NCT02611830|593914524|FG002|Maintenance Phase|Pregnancy|1|||
164421807|NCT02611830|593914525|FG003|Maintenance Phase|Pregnancy|0|||
164421808|NCT02611830|593914522|FG000|Maintenance Phase|Reason not specified|0|||
164421809|NCT02611830|593914523|FG001|Maintenance Phase|Reason not specified|1|||
164421810|NCT02611830|593914524|FG002|Maintenance Phase|Reason not specified|4|||
164421811|NCT02611830|593914525|FG003|Maintenance Phase|Reason not specified|0|||
164421812|NCT00195715|593914530|FG000|Overall Study|Adverse Event|122|||
164421813|NCT00195715|593914530|FG000|Overall Study|Withdrawal by Subject|58|||
164421814|NCT00195715|593914530|FG000|Overall Study|Lost to Follow-up|27|||
164421815|NCT00195715|593914530|FG000|Overall Study|Protocol Violation|13|||
164421816|NCT00195715|593914530|FG000|Overall Study|Lack of Efficacy|93|||
164421817|NCT00195715|593914530|FG000|Overall Study|Pregnancy|14|||
164421818|NCT00195715|593914530|FG000|Overall Study|Investigative site closure|8|||
164421819|NCT00195715|593914530|FG000|Overall Study|Subject moved/relocated|7|||
164421820|NCT00195715|593914530|FG000|Overall Study|Subject non-compliance|6|||
164421821|NCT00195715|593914530|FG000|Overall Study|Subject started commercial Humira|5|||
164421822|NCT00195715|593914530|FG000|Overall Study|Subject choice|3|||
164421823|NCT00195715|593914530|FG000|Overall Study|Loss of response/no improvement|3|||
164421824|NCT00195715|593914530|FG000|Overall Study|Sponsor stopped study|1|||
164421825|NCT00195715|593914530|FG000|Overall Study|Administrative reasons|2|||
164421826|NCT00195715|593914530|FG000|Overall Study|Investigator's decision|2|||
164421827|NCT00195715|593914530|FG000|Overall Study|Subject wants to get pregnant|4|||
164421828|NCT00195715|593914530|FG000|Overall Study|Use of prohibited medication|2|||
164230111|NCT06582732|593212697|FG006|Initial Study Period|Adverse Event|0|||
164230112|NCT06582732|593212691|FG000|Initial Study Period|Death|1|||
164230113|NCT06582732|593212692|FG001|Initial Study Period|Death|0|||
164230114|NCT06582732|593212693|FG002|Initial Study Period|Death|0|||
164230115|NCT06582732|593212694|FG003|Initial Study Period|Death|0|||
164230116|NCT06582732|593212695|FG004|Initial Study Period|Death|1|||
164421829|NCT00195715|593914530|FG000|Overall Study|Planned surgery|2|||
164421830|NCT00195715|593914530|FG000|Overall Study|Increased infection rate|1|||
164421831|NCT00195715|593914530|FG000|Overall Study|Ineligible|1|||
164230117|NCT06582732|593212696|FG005|Initial Study Period|Death|0|||
164421832|NCT00195715|593914530|FG000|Overall Study|Colonic stricture|1|||
164421833|NCT00195715|593914530|FG000|Overall Study|Sponsor discontinued trial|1|||
164421834|NCT00195715|593914530|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
164421835|NCT05822921|593914535|FG000|Overall Study|Lost to Follow-up|1|||
164421836|NCT05822921|593914536|FG001|Overall Study|Lost to Follow-up|1|||
164421837|NCT01267253|593914539|FG000|Overall Study|Ineligible - required test not done|1|||
164421838|NCT01267253|593914539|FG000|Overall Study|Inevaluable-never received study treatme|2|||
164230118|NCT06582732|593212697|FG006|Initial Study Period|Death|0|||
164230119|NCT06582732|593212691|FG000|Initial Study Period|Lost to Follow-up|0|||
164230120|NCT06582732|593212692|FG001|Initial Study Period|Lost to Follow-up|0|||
164230121|NCT06582732|593212693|FG002|Initial Study Period|Lost to Follow-up|2|||
164230122|NCT06582732|593212694|FG003|Initial Study Period|Lost to Follow-up|0|||
164230123|NCT06582732|593212695|FG004|Initial Study Period|Lost to Follow-up|0|||
164230124|NCT06582732|593212696|FG005|Initial Study Period|Lost to Follow-up|0|||
164230125|NCT06582732|593212697|FG006|Initial Study Period|Lost to Follow-up|0|||
164230126|NCT06582732|593212691|FG000|Initial Study Period|Withdrawal by Subject|0|||
164230127|NCT06582732|593212692|FG001|Initial Study Period|Withdrawal by Subject|1|||
164230128|NCT06582732|593212693|FG002|Initial Study Period|Withdrawal by Subject|0|||
164230129|NCT06582732|593212694|FG003|Initial Study Period|Withdrawal by Subject|1|||
164230130|NCT06582732|593212695|FG004|Initial Study Period|Withdrawal by Subject|3|||
164230131|NCT06582732|593212696|FG005|Initial Study Period|Withdrawal by Subject|1|||
164230132|NCT06582732|593212697|FG006|Initial Study Period|Withdrawal by Subject|2|||
164230133|NCT06582732|593212691|FG000|Initial Study Period|Moved Away|0|||
164230134|NCT06582732|593212692|FG001|Initial Study Period|Moved Away|0|||
164230135|NCT06582732|593212693|FG002|Initial Study Period|Moved Away|0|||
164230136|NCT06582732|593212694|FG003|Initial Study Period|Moved Away|0|||
164230137|NCT06582732|593212695|FG004|Initial Study Period|Moved Away|1|||
164230138|NCT06582732|593212696|FG005|Initial Study Period|Moved Away|0|||
164230139|NCT06582732|593212697|FG006|Initial Study Period|Moved Away|0|||
164230140|NCT03931330|593212698|FG000|Overall Study|Physician Decision|1|||
164230141|NCT03412929|593212699|FG000|Overall Study|Protocol Violation|3|||
164230142|NCT01381679|593212704|FG000|Overall Study|Adverse Event|3|||
164230143|NCT01381679|593212704|FG000|Overall Study|Lost to Follow-up|885|||
164230144|NCT01674062|593212705|FG000|Overall Study|Insufficient Therapeutic Response|56|||
164230145|NCT01674062|593212706|FG001|Overall Study|Insufficient Therapeutic Response|26|||
164230146|NCT01674062|593212705|FG000|Overall Study|Other|8|||
164421839|NCT00996580|593914540|FG000|Overall Study|Adverse Event|466|||
164230147|NCT01674062|593212706|FG001|Overall Study|Other|1|||
164230148|NCT01674062|593212705|FG000|Overall Study|Adverse Event|1|||
164230149|NCT01674062|593212706|FG001|Overall Study|Adverse Event|1|||
164230150|NCT01674062|593212705|FG000|Overall Study|Death|0|||
164230151|NCT01674062|593212706|FG001|Overall Study|Death|1|||
164230152|NCT01674062|593212705|FG000|Overall Study|Programming Error|1|||
164230153|NCT01674062|593212706|FG001|Overall Study|Programming Error|0|||
164230154|NCT04661839|593212707|FG000|Overall Study|Not Treated|0|||
164230155|NCT04661839|593212708|FG001|Overall Study|Not Treated|0|||
164230156|NCT04661839|593212709|FG002|Overall Study|Not Treated|1|||
164230157|NCT04661839|593212710|FG003|Overall Study|Not Treated|0|||
164230158|NCT04661839|593212707|FG000|Overall Study|Lost to Follow-up|1|||
164230159|NCT04661839|593212708|FG001|Overall Study|Lost to Follow-up|0|||
164230160|NCT04661839|593212709|FG002|Overall Study|Lost to Follow-up|0|||
164230161|NCT04661839|593212710|FG003|Overall Study|Lost to Follow-up|1|||
164230162|NCT03895372|593212711|FG000|Investigational Treatment Period|Adverse Event|1|||
164230163|NCT03895372|593212712|FG001|Investigational Treatment Period|Adverse Event|0|||
164230164|NCT03895372|593212713|FG002|Investigational Treatment Period|Adverse Event|0|||
164230165|NCT03895372|593212714|FG003|Investigational Treatment Period|Adverse Event|0|||
164230166|NCT03895372|593212715|FG004|Investigational Treatment Period|Adverse Event|0|||
164230167|NCT03895372|593212716|FG005|Investigational Treatment Period|Adverse Event|0|||
164230168|NCT03895372|593212717|FG006|Investigational Treatment Period|Adverse Event|4|||
164230169|NCT03895372|593212718|FG007|Investigational Treatment Period|Adverse Event|3|||
164230170|NCT03895372|593212711|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
164230171|NCT03895372|593212712|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
164230172|NCT03895372|593212713|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
164230173|NCT03895372|593212714|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
164230174|NCT03895372|593212715|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
164230175|NCT03895372|593212716|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
164230176|NCT03895372|593212717|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
164230177|NCT03895372|593212718|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
164230178|NCT03895372|593212711|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
164230179|NCT03895372|593212712|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
164230180|NCT03895372|593212713|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
164230181|NCT03895372|593212714|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
164230182|NCT03895372|593212715|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
164230183|NCT03895372|593212716|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
164230184|NCT03895372|593212717|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
164230185|NCT03895372|593212718|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
164230186|NCT03895372|593212711|FG000|Investigational Treatment Period|Other|0|||
164230187|NCT03895372|593212712|FG001|Investigational Treatment Period|Other|0|||
164230188|NCT03895372|593212713|FG002|Investigational Treatment Period|Other|0|||
164230189|NCT03895372|593212714|FG003|Investigational Treatment Period|Other|0|||
164331707|NCT01385371|593591333|FG000|Overall Study|Lost to Follow-up|16|||
164331708|NCT01385371|593591334|FG001|Overall Study|Lost to Follow-up|16|||
164331709|NCT01385371|593591333|FG000|Overall Study|Withdrawal by Subject|52|||
164331710|NCT01385371|593591334|FG001|Overall Study|Withdrawal by Subject|39|||
164331711|NCT01385371|593591333|FG000|Overall Study|Protocol Violation|25|||
164331712|NCT01385371|593591334|FG001|Overall Study|Protocol Violation|21|||
164331713|NCT01385371|593591333|FG000|Overall Study|Administrative|2|||
164331714|NCT01385371|593591334|FG001|Overall Study|Administrative|2|||
164331715|NCT01090973|593591337|FG000|Overall Study|Disease progression|1|||
164331716|NCT03112590|593591340|FG000|Overall Study|Adverse Event|0|||
164331717|NCT03112590|593591341|FG001|Overall Study|Adverse Event|1|||
164331718|NCT03112590|593591342|FG002|Overall Study|Adverse Event|0|||
164331719|NCT03635788|593591343|FG000|Step 1|Death|1|||
164331720|NCT03635788|593591344|FG001|Step 1|Death|0|||
164331721|NCT03635788|593591345|FG002|Step 1|Death|0|||
164331722|NCT03635788|593591343|FG000|Step 1|Lost to Follow-up|31|||
164331723|NCT03635788|593591344|FG001|Step 1|Lost to Follow-up|0|||
164331724|NCT03635788|593591345|FG002|Step 1|Lost to Follow-up|0|||
164331725|NCT03635788|593591343|FG000|Step 1|Pregnancy|1|||
164421840|NCT00996580|593914540|FG000|Overall Study|Lost to Follow-up|480|||
164421841|NCT00996580|593914540|FG000|Overall Study|Noncompliance with the protocol|137|||
164230190|NCT03895372|593212715|FG004|Investigational Treatment Period|Other|0|||
164230191|NCT03895372|593212716|FG005|Investigational Treatment Period|Other|1|||
164230192|NCT03895372|593212717|FG006|Investigational Treatment Period|Other|0|||
164230193|NCT03895372|593212718|FG007|Investigational Treatment Period|Other|2|||
164230194|NCT03895372|593212711|FG000|Investigational Treatment Period|Protocol Violation|0|||
164230195|NCT03895372|593212712|FG001|Investigational Treatment Period|Protocol Violation|0|||
164230196|NCT03895372|593212713|FG002|Investigational Treatment Period|Protocol Violation|0|||
164230197|NCT03895372|593212714|FG003|Investigational Treatment Period|Protocol Violation|1|||
164331726|NCT03635788|593591344|FG001|Step 1|Pregnancy|0|||
164331727|NCT03635788|593591345|FG002|Step 1|Pregnancy|0|||
164331728|NCT03635788|593591343|FG000|Step 1|Protocol Violation|8|||
164331729|NCT03635788|593591344|FG001|Step 1|Protocol Violation|0|||
164331730|NCT03635788|593591345|FG002|Step 1|Protocol Violation|0|||
164331731|NCT03635788|593591343|FG000|Step 1|Withdrawal by Subject|13|||
164331732|NCT03635788|593591344|FG001|Step 1|Withdrawal by Subject|0|||
164331733|NCT03635788|593591345|FG002|Step 1|Withdrawal by Subject|0|||
164331734|NCT03635788|593591343|FG000|Step 1|Other reasons|12|||
164331735|NCT03635788|593591344|FG001|Step 1|Other reasons|0|||
164331736|NCT03635788|593591345|FG002|Step 1|Other reasons|0|||
164331737|NCT03635788|593591343|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
164331738|NCT03635788|593591344|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
164331739|NCT03635788|593591345|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
164331740|NCT03635788|593591343|FG000|Step 2|Lost to Follow-up|0|||
164331741|NCT03635788|593591344|FG001|Step 2|Lost to Follow-up|8|||
164331742|NCT03635788|593591345|FG002|Step 2|Lost to Follow-up|15|||
164331743|NCT03635788|593591343|FG000|Step 2|Withdrawal by Subject|0|||
164331744|NCT03635788|593591344|FG001|Step 2|Withdrawal by Subject|6|||
164331745|NCT03635788|593591345|FG002|Step 2|Withdrawal by Subject|6|||
164331746|NCT03635788|593591343|FG000|Step 2|Death|0|||
164331747|NCT03635788|593591344|FG001|Step 2|Death|2|||
164331748|NCT03635788|593591345|FG002|Step 2|Death|0|||
164331749|NCT03635788|593591343|FG000|Step 2|Incarceration|0|||
164331750|NCT03635788|593591344|FG001|Step 2|Incarceration|2|||
164331751|NCT03635788|593591345|FG002|Step 2|Incarceration|0|||
164331752|NCT03635788|593591343|FG000|Step 2|Non-Compliance With Study Requirements|0|||
164331753|NCT03635788|593591344|FG001|Step 2|Non-Compliance With Study Requirements|1|||
164331754|NCT03635788|593591345|FG002|Step 2|Non-Compliance With Study Requirements|1|||
164331755|NCT03635788|593591343|FG000|Step 2|Confounding Medical Condition|0|||
164331756|NCT03635788|593591344|FG001|Step 2|Confounding Medical Condition|0|||
164331757|NCT03635788|593591345|FG002|Step 2|Confounding Medical Condition|1|||
164331758|NCT03635788|593591343|FG000|Step 2|Out Of State With No Plan To Return|0|||
164331759|NCT03635788|593591344|FG001|Step 2|Out Of State With No Plan To Return|1|||
164331760|NCT03635788|593591345|FG002|Step 2|Out Of State With No Plan To Return|0|||
164331761|NCT03635788|593591343|FG000|Step 2|Switched To Injectables|0|||
164331762|NCT03635788|593591344|FG001|Step 2|Switched To Injectables|0|||
164331763|NCT03635788|593591345|FG002|Step 2|Switched To Injectables|1|||
164331764|NCT03635788|593591343|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
164331765|NCT03635788|593591344|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
164331766|NCT03635788|593591345|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
164331767|NCT04571515|593591349|FG000|Overall Study|Physician Decision|0|||
164331768|NCT04571515|593591350|FG001|Overall Study|Physician Decision|0|||
164331769|NCT04571515|593591351|FG002|Overall Study|Physician Decision|0|||
164331770|NCT04571515|593591352|FG003|Overall Study|Physician Decision|0|||
164331771|NCT04571515|593591353|FG004|Overall Study|Physician Decision|1|||
164331772|NCT04571515|593591349|FG000|Overall Study|Withdrawal by Subject|0|||
164331773|NCT04571515|593591350|FG001|Overall Study|Withdrawal by Subject|0|||
164331774|NCT04571515|593591351|FG002|Overall Study|Withdrawal by Subject|0|||
164331775|NCT04571515|593591352|FG003|Overall Study|Withdrawal by Subject|0|||
164331776|NCT04571515|593591353|FG004|Overall Study|Withdrawal by Subject|1|||
164331777|NCT04571515|593591349|FG000|Overall Study|insufficient pain|1|||
164331778|NCT04571515|593591350|FG001|Overall Study|insufficient pain|0|||
164331779|NCT04571515|593591351|FG002|Overall Study|insufficient pain|0|||
164331780|NCT04571515|593591352|FG003|Overall Study|insufficient pain|0|||
164331781|NCT04571515|593591353|FG004|Overall Study|insufficient pain|1|||
164331782|NCT05098938|593591362|FG000|Overall Study|Adverse Event|4|||
164331783|NCT05098938|593591363|FG001|Overall Study|Adverse Event|3|||
164331784|NCT05098938|593591362|FG000|Overall Study|inclusion/exclusion criteria change|11|||
164331785|NCT05098938|593591363|FG001|Overall Study|inclusion/exclusion criteria change|5|||
164331786|NCT05098938|593591362|FG000|Overall Study|lack of compliance|26|||
164331787|NCT05098938|593591363|FG001|Overall Study|lack of compliance|19|||
164331788|NCT05098938|593591362|FG000|Overall Study|Lost to Follow-up|37|||
164331789|NCT05098938|593591363|FG001|Overall Study|Lost to Follow-up|40|||
164331790|NCT05098938|593591362|FG000|Overall Study|Lost in treatment period|17|||
164331791|NCT05098938|593591363|FG001|Overall Study|Lost in treatment period|13|||
164331792|NCT05098938|593591362|FG000|Overall Study|Met an exclusion criterion|0|||
164331793|NCT05098938|593591363|FG001|Overall Study|Met an exclusion criterion|3|||
164571929|NCT00960076|594460303|FG000|Overall Study|Severe non-compliance to protocol|1|||
164571930|NCT00960076|594460304|FG001|Overall Study|Severe non-compliance to protocol|2|||
164571931|NCT00960076|594460303|FG000|Overall Study|Hyperglycemia|1|||
164571932|NCT00960076|594460304|FG001|Overall Study|Hyperglycemia|5|||
164571933|NCT00960076|594460303|FG000|Overall Study|Did not attend the termination visit|0|||
164331794|NCT05098938|593591362|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
164331795|NCT05098938|593591363|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
164331796|NCT05098938|593591362|FG000|Overall Study|Physician Decision|25|||
164331797|NCT05098938|593591363|FG001|Overall Study|Physician Decision|32|||
164331798|NCT05098938|593591362|FG000|Overall Study|Run in failure in treatment phase|1|||
164331799|NCT05098938|593591363|FG001|Overall Study|Run in failure in treatment phase|1|||
164331800|NCT05098938|593591362|FG000|Overall Study|Withdrawal by Subject|0|||
164331801|NCT05098938|593591363|FG001|Overall Study|Withdrawal by Subject|3|||
164331802|NCT05098938|593591362|FG000|Overall Study|Run-in Failure in early study|505|||
164331803|NCT05098938|593591363|FG001|Overall Study|Run-in Failure in early study|514|||
164331804|NCT05098938|593591362|FG000|Overall Study|IMP delivery missed|1|||
164331805|NCT05098938|593591363|FG001|Overall Study|IMP delivery missed|5|||
164571934|NCT00960076|594460304|FG001|Overall Study|Did not attend the termination visit|1|||
164421842|NCT00996580|593914540|FG000|Overall Study|Physician Decision|5|||
164331806|NCT05098938|593591362|FG000|Overall Study|6 months visit was missed|2|||
164331807|NCT05098938|593591363|FG001|Overall Study|6 months visit was missed|0|||
164331808|NCT05098938|593591362|FG000|Overall Study|fit for use was not completed within window|3|||
164331809|NCT05098938|593591363|FG001|Overall Study|fit for use was not completed within window|0|||
164331810|NCT05098938|593591362|FG000|Overall Study|V2 visit was not completed within window|0|||
164331811|NCT05098938|593591363|FG001|Overall Study|V2 visit was not completed within window|1|||
164331812|NCT05098938|593591362|FG000|Overall Study|exclusionary medication use|1|||
164331813|NCT05098938|593591363|FG001|Overall Study|exclusionary medication use|2|||
164331814|NCT05098938|593591362|FG000|Overall Study|change in medication|1|||
164331815|NCT05098938|593591363|FG001|Overall Study|change in medication|0|||
164331816|NCT05098938|593591362|FG000|Overall Study|treatment failure|2|||
164331817|NCT05098938|593591363|FG001|Overall Study|treatment failure|1|||
164331818|NCT02570074|593593099|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
164331819|NCT02570074|593593100|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
164331820|NCT01859143|593593101|FG000|Overall Study|Lost to Follow-up|2|||
164331821|NCT01859143|593593102|FG001|Overall Study|Lost to Follow-up|0|||
164331822|NCT00760214|593593103|FG000|Overall Study|Adverse Event|8|||
164331823|NCT00760214|593593104|FG001|Overall Study|Adverse Event|9|||
164331824|NCT00760214|593593105|FG002|Overall Study|Adverse Event|12|||
164331825|NCT00760214|593593103|FG000|Overall Study|Protocol Violation|3|||
164331826|NCT00760214|593593104|FG001|Overall Study|Protocol Violation|0|||
164331827|NCT00760214|593593105|FG002|Overall Study|Protocol Violation|3|||
164331828|NCT00760214|593593103|FG000|Overall Study|Lost to Follow-up|0|||
164331829|NCT00760214|593593104|FG001|Overall Study|Lost to Follow-up|0|||
164331830|NCT00760214|593593105|FG002|Overall Study|Lost to Follow-up|1|||
164331831|NCT00760214|593593103|FG000|Overall Study|Withdrawal by Subject|12|||
164331832|NCT00760214|593593104|FG001|Overall Study|Withdrawal by Subject|14|||
164331833|NCT00760214|593593105|FG002|Overall Study|Withdrawal by Subject|13|||
164331834|NCT00760214|593593103|FG000|Overall Study|Lack of Efficacy|3|||
164331835|NCT00760214|593593104|FG001|Overall Study|Lack of Efficacy|2|||
164331836|NCT00760214|593593105|FG002|Overall Study|Lack of Efficacy|4|||
164331837|NCT00760214|593593103|FG000|Overall Study|Pregnancy|0|||
164331838|NCT00760214|593593104|FG001|Overall Study|Pregnancy|0|||
164331839|NCT00760214|593593105|FG002|Overall Study|Pregnancy|1|||
164331840|NCT00760214|593593103|FG000|Overall Study|Physician Decision|1|||
164331841|NCT00760214|593593104|FG001|Overall Study|Physician Decision|1|||
164331842|NCT00760214|593593105|FG002|Overall Study|Physician Decision|1|||
164331843|NCT00760214|593593103|FG000|Overall Study|Other|3|||
164331844|NCT00760214|593593104|FG001|Overall Study|Other|4|||
164331845|NCT00760214|593593105|FG002|Overall Study|Other|6|||
164331846|NCT00700570|593593106|FG000|Overall Study|Adverse Event|2|||
164331847|NCT00700570|593593107|FG001|Overall Study|Adverse Event|6|||
164331848|NCT00700570|593593106|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
164331849|NCT00700570|593593107|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
164331850|NCT00700570|593593106|FG000|Overall Study|Disease Progression|8|||
164331851|NCT00700570|593593107|FG001|Overall Study|Disease Progression|11|||
164331852|NCT00700570|593593106|FG000|Overall Study|Withdrawal by Subject|1|||
164571935|NCT02029976|594460305|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
164571936|NCT02029976|594460306|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
164571937|NCT02029976|594460305|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
164571938|NCT02029976|594460306|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
164571939|NCT02029976|594460305|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
164571940|NCT02029976|594460306|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
164571941|NCT02029976|594460305|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
164571942|NCT02029976|594460306|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
164421843|NCT00996580|593914540|FG000|Overall Study|Pregnancy|68|||
164331853|NCT00700570|593593107|FG001|Overall Study|Withdrawal by Subject|6|||
164331854|NCT01134315|593593108|FG000|Overall Study|Adverse Event|1|||
164331855|NCT01134315|593593109|FG001|Overall Study|Adverse Event|2|||
164331856|NCT01134315|593593108|FG000|Overall Study|Other Reason|8|||
164331857|NCT01134315|593593109|FG001|Overall Study|Other Reason|17|||
164331858|NCT04587271|593593110|FG000|Overall Study|Lost to Follow-up|2|||
164571943|NCT03263806|594460307|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
164421844|NCT00996580|593914540|FG000|Overall Study|Protocol Violation|16|||
164421845|NCT00996580|593914540|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
164331859|NCT04587271|593593111|FG001|Overall Study|Lost to Follow-up|2|||
164331860|NCT04587271|593593112|FG002|Overall Study|Lost to Follow-up|0|||
164331861|NCT04587271|593593113|FG003|Overall Study|Lost to Follow-up|2|||
164331862|NCT04587271|593593114|FG004|Overall Study|Lost to Follow-up|2|||
164331863|NCT04587271|593593115|FG005|Overall Study|Lost to Follow-up|0|||
164331864|NCT04587271|593593110|FG000|Overall Study|Caregiver brought child to visits|0|||
164331865|NCT04587271|593593111|FG001|Overall Study|Caregiver brought child to visits|0|||
164331866|NCT04587271|593593112|FG002|Overall Study|Caregiver brought child to visits|0|||
164331867|NCT04587271|593593113|FG003|Overall Study|Caregiver brought child to visits|1|||
164331868|NCT04587271|593593114|FG004|Overall Study|Caregiver brought child to visits|0|||
164230198|NCT03895372|593212715|FG004|Investigational Treatment Period|Protocol Violation|0|||
164230199|NCT03895372|593212716|FG005|Investigational Treatment Period|Protocol Violation|0|||
164230200|NCT03895372|593212717|FG006|Investigational Treatment Period|Protocol Violation|0|||
164230201|NCT03895372|593212718|FG007|Investigational Treatment Period|Protocol Violation|0|||
164230202|NCT03895372|593212711|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
164230203|NCT03895372|593212712|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
164230204|NCT03895372|593212713|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
164230205|NCT03895372|593212714|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
164230206|NCT03895372|593212715|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
164230207|NCT03895372|593212716|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
164230208|NCT03895372|593212717|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
164230209|NCT03895372|593212718|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
164230210|NCT03895372|593212711|FG000|Extension Treatment Period|Adverse Event|0|||
164230211|NCT03895372|593212712|FG001|Extension Treatment Period|Adverse Event|1|||
164230212|NCT03895372|593212713|FG002|Extension Treatment Period|Adverse Event|0|||
164230213|NCT03895372|593212714|FG003|Extension Treatment Period|Adverse Event|1|||
164230214|NCT03895372|593212715|FG004|Extension Treatment Period|Adverse Event|0|||
164421846|NCT00996580|593914540|FG000|Overall Study|Withdrawal by Subject|217|||
164421847|NCT00996580|593914540|FG000|Overall Study|Other|29|||
164571944|NCT03263806|594460308|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
164571945|NCT03263806|594460307|FG000|Overall Study|Withdrawal by Subject|0|||
164571946|NCT03263806|594460308|FG001|Overall Study|Withdrawal by Subject|1|||
164571947|NCT03263806|594460307|FG000|Overall Study|Study Termination|5|||
164571948|NCT03263806|594460308|FG001|Overall Study|Study Termination|6|||
164571949|NCT01445171|594460309|FG000|Overall Study|Lost to Follow-up|11|||
164571950|NCT01445171|594460309|FG000|Overall Study|Withdrawal by Subject|16|||
164571951|NCT01445171|594460309|FG000|Overall Study|Death|51|||
164571952|NCT01445171|594460309|FG000|Overall Study|Subjects declined to return for followup|9|||
164571953|NCT01445171|594460309|FG000|Overall Study|Consented but did not receive device|8|||
164571954|NCT01552057|594460315|FG000|Overall Study|Adverse Event|14|||
164571955|NCT01552057|594460316|FG001|Overall Study|Adverse Event|15|||
164571956|NCT01552057|594460315|FG000|Overall Study|Lack of Efficacy|8|||
164571957|NCT01552057|594460316|FG001|Overall Study|Lack of Efficacy|23|||
164571958|NCT01552057|594460315|FG000|Overall Study|Withdrawal by Subject|5|||
164571959|NCT01552057|594460316|FG001|Overall Study|Withdrawal by Subject|8|||
164571960|NCT01552057|594460315|FG000|Overall Study|Entry Criteria Not Met|2|||
164571961|NCT01552057|594460316|FG001|Overall Study|Entry Criteria Not Met|2|||
164571962|NCT01552057|594460315|FG000|Overall Study|Physician Decision|1|||
164571963|NCT01552057|594460316|FG001|Overall Study|Physician Decision|0|||
164571964|NCT03895203|594460317|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
164571965|NCT03895203|594460318|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
164571966|NCT03895203|594460319|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
164571967|NCT03895203|594460320|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
164571968|NCT03895203|594460321|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
164571969|NCT03895203|594460322|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
164571970|NCT03895203|594460317|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
164571971|NCT03895203|594460318|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
164571972|NCT03895203|594460319|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
164571973|NCT03895203|594460320|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
164571974|NCT03895203|594460321|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
164571975|NCT03895203|594460322|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
164571976|NCT03895203|594460317|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
164571977|NCT03895203|594460318|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
164571978|NCT03895203|594460319|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
164571979|NCT03895203|594460320|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
164571980|NCT03895203|594460321|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
164571981|NCT03895203|594460322|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
164571982|NCT03895203|594460317|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
164571983|NCT03895203|594460318|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
164571984|NCT03895203|594460319|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
164571985|NCT03895203|594460320|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
164571986|NCT03895203|594460321|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
164675530|NCT03570749|594836751|FG005|Overall Study|Pregnancy|1|||
164421848|NCT00064025|593914541|FG000|Overall Study|Ineligible|4|||
164230215|NCT03895372|593212716|FG005|Extension Treatment Period|Adverse Event|0|||
164230216|NCT03895372|593212717|FG006|Extension Treatment Period|Adverse Event|3|||
164230217|NCT03895372|593212718|FG007|Extension Treatment Period|Adverse Event|3|||
164230218|NCT03895372|593212711|FG000|Extension Treatment Period|Other|1|||
164230219|NCT03895372|593212712|FG001|Extension Treatment Period|Other|3|||
164230220|NCT03895372|593212713|FG002|Extension Treatment Period|Other|0|||
164421849|NCT00064025|593914541|FG000|Overall Study|Inevaluable|3|||
164230221|NCT03895372|593212714|FG003|Extension Treatment Period|Other|0|||
164230222|NCT03895372|593212715|FG004|Extension Treatment Period|Other|1|||
164230223|NCT03895372|593212716|FG005|Extension Treatment Period|Other|0|||
164230224|NCT03895372|593212717|FG006|Extension Treatment Period|Other|0|||
164230225|NCT03895372|593212718|FG007|Extension Treatment Period|Other|2|||
164230226|NCT03895372|593212711|FG000|Extension Treatment Period|Pregnancy|0|||
164230227|NCT03895372|593212712|FG001|Extension Treatment Period|Pregnancy|0|||
164230228|NCT03895372|593212713|FG002|Extension Treatment Period|Pregnancy|0|||
164230229|NCT03895372|593212714|FG003|Extension Treatment Period|Pregnancy|0|||
164230230|NCT03895372|593212715|FG004|Extension Treatment Period|Pregnancy|1|||
164230231|NCT03895372|593212716|FG005|Extension Treatment Period|Pregnancy|0|||
164230232|NCT03895372|593212717|FG006|Extension Treatment Period|Pregnancy|0|||
164230233|NCT03895372|593212718|FG007|Extension Treatment Period|Pregnancy|0|||
164230234|NCT03895372|593212711|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
164230235|NCT03895372|593212712|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
164230236|NCT03895372|593212713|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
164230237|NCT03895372|593212714|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
164230238|NCT03895372|593212715|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
164230239|NCT03895372|593212716|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
164230240|NCT03895372|593212717|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
164230241|NCT03895372|593212718|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
164230242|NCT03685149|593212719|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
164230243|NCT03685149|593212720|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
164230244|NCT03685149|593212719|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
164230245|NCT03685149|593212720|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
164230246|NCT03685149|593212719|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
164230247|NCT03685149|593212720|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
164230248|NCT02951819|593212722|FG000|Overall Study|Death|9|||
164230249|NCT02951819|593212723|FG001|Overall Study|Death|7|||
164230250|NCT02951819|593212722|FG000|Overall Study|Withdrawal by Subject|3|||
164230251|NCT02951819|593212723|FG001|Overall Study|Withdrawal by Subject|0|||
164230252|NCT02951819|593212722|FG000|Overall Study|Adverse Event|1|||
164230253|NCT02951819|593212723|FG001|Overall Study|Adverse Event|0|||
164230254|NCT02951819|593212722|FG000|Overall Study|Lack of Efficacy|4|||
164230255|NCT02951819|593212723|FG001|Overall Study|Lack of Efficacy|0|||
164230256|NCT02951819|593212722|FG000|Overall Study|Lost to Follow-up|1|||
164230257|NCT02951819|593212723|FG001|Overall Study|Lost to Follow-up|0|||
164230258|NCT02951819|593212722|FG000|Overall Study|Progressive Disease|1|||
164230259|NCT02951819|593212723|FG001|Overall Study|Progressive Disease|0|||
164230260|NCT02951819|593212722|FG000|Overall Study|Other|9|||
164230261|NCT02951819|593212723|FG001|Overall Study|Other|0|||
164230262|NCT00581919|593212727|FG000|Overall Study|Adverse Event|8|||
164230263|NCT00581919|593212727|FG000|Overall Study|Death|1|||
164230264|NCT00581919|593212727|FG000|Overall Study|Disease Progression|10|||
164230265|NCT00581919|593212727|FG000|Overall Study|Physician Decision|1|||
164230266|NCT00581919|593212727|FG000|Overall Study|Other Complicating Disease|1|||
164230267|NCT00581919|593212727|FG000|Overall Study|Started Non-Protocol Therapy|2|||
164230268|NCT00581919|593212727|FG000|Overall Study|Withdrawal by Subject|1|||
164230269|NCT02034565|593212728|FG000|Overall Study|Adverse Event|1|||
164230270|NCT02034565|593212729|FG001|Overall Study|Adverse Event|0|||
164230271|NCT03232567|593212732|FG000|Overall Study|Withdrawal by Subject|0|||
164230272|NCT03232567|593212733|FG001|Overall Study|Withdrawal by Subject|1|||
164230273|NCT03232567|593212734|FG002|Overall Study|Withdrawal by Subject|0|||
164230274|NCT03232567|593212735|FG003|Overall Study|Withdrawal by Subject|0|||
164230275|NCT02655601|593212736|FG000|Overall Study|Adverse Event|0|||
164230276|NCT02655601|593212737|FG001|Overall Study|Adverse Event|0|||
164230277|NCT02655601|593212738|FG002|Overall Study|Adverse Event|0|||
164230278|NCT02655601|593212739|FG003|Overall Study|Adverse Event|1|||
164230279|NCT02655601|593212740|FG004|Overall Study|Adverse Event|1|||
164230280|NCT02655601|593212741|FG005|Overall Study|Adverse Event|0|||
164331869|NCT04587271|593593115|FG005|Overall Study|Caregiver brought child to visits|0|||
164571987|NCT03895203|594460322|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
164230281|NCT02655601|593212736|FG000|Overall Study|Physician Decision|0|||
164230282|NCT02655601|593212737|FG001|Overall Study|Physician Decision|0|||
164230283|NCT02655601|593212738|FG002|Overall Study|Physician Decision|0|||
164230284|NCT02655601|593212739|FG003|Overall Study|Physician Decision|0|||
164230285|NCT02655601|593212740|FG004|Overall Study|Physician Decision|1|||
164230286|NCT02655601|593212741|FG005|Overall Study|Physician Decision|1|||
164230287|NCT02655601|593212736|FG000|Overall Study|Withdrawal by Subject|0|||
164230288|NCT02655601|593212737|FG001|Overall Study|Withdrawal by Subject|0|||
164230289|NCT02655601|593212738|FG002|Overall Study|Withdrawal by Subject|0|||
164230290|NCT02655601|593212739|FG003|Overall Study|Withdrawal by Subject|0|||
164230291|NCT02655601|593212740|FG004|Overall Study|Withdrawal by Subject|4|||
164230292|NCT02655601|593212741|FG005|Overall Study|Withdrawal by Subject|8|||
164571988|NCT03895203|594460317|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
164230293|NCT02655601|593212736|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
164230294|NCT02655601|593212737|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
164230295|NCT02655601|593212738|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
164230296|NCT02655601|593212739|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
164230297|NCT02655601|593212740|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
164230298|NCT02655601|593212741|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
164230299|NCT05837481|593212742|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
164230300|NCT05837481|593212743|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
164230301|NCT02014376|593212744|FG000|Overall Study|Adverse Event|1|||
164230302|NCT02014376|593212745|FG001|Overall Study|Adverse Event|1|||
164230303|NCT02014376|593212746|FG002|Overall Study|Adverse Event|0|||
164230304|NCT02014376|593212744|FG000|Overall Study|Lost to Follow-up|2|||
164230305|NCT02014376|593212745|FG001|Overall Study|Lost to Follow-up|0|||
164230306|NCT02014376|593212746|FG002|Overall Study|Lost to Follow-up|0|||
164230307|NCT02135133|593212748|FG000|Overall Study|Adverse Event|10|||
164230308|NCT02135133|593212748|FG000|Overall Study|regulatory mandate|5|||
164230309|NCT03312543|593212759|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
164230310|NCT03312543|593212760|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
164230311|NCT03312543|593212759|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
164230312|NCT03312543|593212760|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
164230313|NCT03312543|593212759|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
164230314|NCT03312543|593212760|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
164230315|NCT03312543|593212759|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
164230316|NCT03312543|593212760|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
164230317|NCT03312543|593212759|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
164230318|NCT03312543|593212760|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
164230319|NCT03312543|593212759|FG000|Regression (Week 12 to Week 24)|Death|0|||
164230320|NCT03312543|593212760|FG001|Regression (Week 12 to Week 24)|Death|1|||
164230321|NCT04507269|593212761|FG000|Overall Study|Withdrawal by Subject|1|||
164230322|NCT04507269|593212762|FG001|Overall Study|Withdrawal by Subject|1|||
164230323|NCT04507269|593212763|FG002|Overall Study|Withdrawal by Subject|0|||
164230324|NCT04507269|593212764|FG003|Overall Study|Withdrawal by Subject|0|||
164230325|NCT04507269|593212765|FG004|Overall Study|Withdrawal by Subject|0|||
164230326|NCT04507269|593212766|FG005|Overall Study|Withdrawal by Subject|0|||
164230327|NCT04507269|593212761|FG000|Overall Study|Lost to Follow-up|0|||
164230328|NCT04507269|593212762|FG001|Overall Study|Lost to Follow-up|0|||
164230329|NCT04507269|593212763|FG002|Overall Study|Lost to Follow-up|0|||
164230330|NCT04507269|593212764|FG003|Overall Study|Lost to Follow-up|0|||
164230331|NCT04507269|593212765|FG004|Overall Study|Lost to Follow-up|1|||
164230332|NCT04507269|593212766|FG005|Overall Study|Lost to Follow-up|0|||
164230333|NCT05852340|593212767|FG000|Period 5|Not completing the meal|0|||
164331870|NCT03719586|593593116|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
164331871|NCT03719586|593593117|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
164331872|NCT03719586|593593118|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
164331873|NCT03719586|593593119|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
164331874|NCT02791594|593593120|FG000|Overall Study|Physician Decision|2|||
164331875|NCT02310321|593593121|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
164331876|NCT02310321|593593122|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
164331877|NCT02310321|593593123|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
164331878|NCT02310321|593593121|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
164331879|NCT02310321|593593122|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
164331880|NCT02310321|593593123|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
164331881|NCT02310321|593593121|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
164331882|NCT02310321|593593122|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
164331883|NCT02310321|593593123|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
164331884|NCT02310321|593593121|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
164331885|NCT02310321|593593122|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
164331886|NCT02310321|593593123|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
164331887|NCT02310321|593593121|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
164331888|NCT02310321|593593122|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
164331889|NCT02310321|593593123|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
164675531|NCT03570749|594836752|FG006|Overall Study|Pregnancy|1|||
164230334|NCT05852340|593212768|FG001|Period 5|Not completing the meal|1|||
164230335|NCT05852340|593212769|FG002|Period 5|Not completing the meal|0|||
164675532|NCT03570749|594836746|FG000|Overall Study|Screen Fail|0|||
164675533|NCT03570749|594836747|FG001|Overall Study|Screen Fail|0|||
164675534|NCT03570749|594836748|FG002|Overall Study|Screen Fail|0|||
164675535|NCT03570749|594836749|FG003|Overall Study|Screen Fail|0|||
164675536|NCT03570749|594836750|FG004|Overall Study|Screen Fail|0|||
164230336|NCT05852340|593212770|FG003|Period 5|Not completing the meal|0|||
164230337|NCT05852340|593212767|FG000|Period 5|Adverse Event|0|||
164230338|NCT05852340|593212768|FG001|Period 5|Adverse Event|0|||
164230339|NCT05852340|593212769|FG002|Period 5|Adverse Event|0|||
164230340|NCT05852340|593212770|FG003|Period 5|Adverse Event|1|||
164230341|NCT00071032|593212773|FG000|Overall Study|Lost to Follow-up|1|||
164230342|NCT00071032|593212774|FG001|Overall Study|Lost to Follow-up|1|||
164230343|NCT00071032|593212773|FG000|Overall Study|Withdrawal by Subject|8|||
164230344|NCT00071032|593212774|FG001|Overall Study|Withdrawal by Subject|6|||
164230345|NCT00071032|593212773|FG000|Overall Study|Missing Primary Outcome|0|||
164230346|NCT00071032|593212774|FG001|Overall Study|Missing Primary Outcome|1|||
164230347|NCT04197583|593212775|FG000|Overall Study|Study Stent Replacement|34|||
164230348|NCT04197583|593212776|FG001|Overall Study|Study Stent Replacement|8|||
164230349|NCT04197583|593212775|FG000|Overall Study|Lost to Follow-up|14|||
164331890|NCT02310321|593593121|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
164331891|NCT02310321|593593122|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
164331892|NCT02310321|593593123|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
164331893|NCT02310321|593593121|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
164331894|NCT02310321|593593122|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
164331895|NCT02310321|593593123|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
164331896|NCT02310321|593593121|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
164331897|NCT02310321|593593122|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
164331898|NCT02310321|593593123|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
164331899|NCT02310321|593593121|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
164331900|NCT02310321|593593122|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
164331901|NCT02310321|593593123|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
164331902|NCT02310321|593593121|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
164331903|NCT02310321|593593122|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
164331904|NCT02310321|593593123|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
164331905|NCT02310321|593593121|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
164331906|NCT02310321|593593122|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
164331907|NCT02310321|593593123|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
164331908|NCT02310321|593593121|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
164331909|NCT02310321|593593122|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
164331910|NCT02310321|593593123|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
164331911|NCT02310321|593593121|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
164331912|NCT02310321|593593122|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
164331913|NCT02310321|593593123|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
164331914|NCT02310321|593593121|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
164331915|NCT02310321|593593122|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
164331916|NCT02310321|593593123|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
164331917|NCT02310321|593593121|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
164331918|NCT02310321|593593122|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
164331919|NCT02310321|593593123|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
164331920|NCT02310321|593593121|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
164331921|NCT02310321|593593122|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
164331922|NCT02310321|593593123|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
164331923|NCT02310321|593593121|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
164331924|NCT02310321|593593122|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
164331925|NCT02310321|593593123|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
164331926|NCT02310321|593593121|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
164331927|NCT02310321|593593122|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
164331928|NCT02310321|593593123|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
164331929|NCT02310321|593593121|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
164331930|NCT02310321|593593122|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
164331931|NCT02310321|593593123|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
164331932|NCT02310321|593593121|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
164331933|NCT02310321|593593122|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
164331934|NCT02310321|593593123|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
164331935|NCT02310321|593593121|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
164230350|NCT04197583|593212776|FG001|Overall Study|Lost to Follow-up|3|||
164230351|NCT04197583|593212775|FG000|Overall Study|Death|3|||
164230352|NCT04197583|593212776|FG001|Overall Study|Death|0|||
164230353|NCT04197583|593212775|FG000|Overall Study|Physician Decision|1|||
164230354|NCT04197583|593212776|FG001|Overall Study|Physician Decision|0|||
164230355|NCT04197583|593212775|FG000|Overall Study|Withdrawal by Subject|1|||
164331936|NCT02310321|593593122|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
164230356|NCT04197583|593212776|FG001|Overall Study|Withdrawal by Subject|1|||
164230357|NCT04197583|593212775|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
164230358|NCT04197583|593212776|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
164230359|NCT04197583|593212775|FG000|Overall Study|Screen Failure|0|||
164230360|NCT04197583|593212776|FG001|Overall Study|Screen Failure|20|||
164230361|NCT04042311|593212783|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
164230362|NCT04042311|593212783|FG000|Overall Study|Unable to tolerate|4|||
164230363|NCT04042311|593212783|FG000|Overall Study|Concurrent illness|2|||
164571989|NCT03895203|594460318|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
164571990|NCT03895203|594460319|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
164571991|NCT03895203|594460320|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
164571992|NCT03895203|594460321|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
164571993|NCT03895203|594460322|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
164230364|NCT04042311|593212783|FG000|Overall Study|Adverse Event|2|||
164230365|NCT04042311|593212783|FG000|Overall Study|No longer meeting inclusion criteria|2|||
164230366|NCT04042311|593212783|FG000|Overall Study|No reason given|1|||
164331937|NCT02310321|593593123|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
164571994|NCT03895203|594460317|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
164571995|NCT03895203|594460318|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
164571996|NCT03895203|594460319|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
164571997|NCT03895203|594460320|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
164571998|NCT03895203|594460321|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
164571999|NCT03895203|594460322|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
164572000|NCT03895203|594460317|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
164572001|NCT03895203|594460318|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
164572002|NCT03895203|594460319|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
164572003|NCT03895203|594460320|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
164572004|NCT03895203|594460321|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
164572005|NCT03895203|594460322|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
164572006|NCT03895203|594460317|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
164572007|NCT03895203|594460318|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
164572008|NCT03895203|594460319|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
164572009|NCT03895203|594460320|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
164572010|NCT03895203|594460321|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
164572011|NCT03895203|594460322|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
164572012|NCT03895203|594460317|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
164572013|NCT03895203|594460318|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
164572014|NCT03895203|594460319|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
164572015|NCT03895203|594460320|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
164572016|NCT03895203|594460321|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
164572017|NCT03895203|594460322|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
164572018|NCT03895203|594460317|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
164572019|NCT03895203|594460318|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
164572020|NCT03895203|594460319|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
164572021|NCT03895203|594460320|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
164572022|NCT03895203|594460321|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
164572023|NCT03895203|594460322|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
164675537|NCT03570749|594836751|FG005|Overall Study|Screen Fail|0|||
164331938|NCT02310321|593593121|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
164331939|NCT02310321|593593122|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
164331940|NCT02310321|593593123|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
164331941|NCT02310321|593593121|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
164331942|NCT02310321|593593122|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
164331943|NCT02310321|593593123|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
164331944|NCT04950166|593593124|FG000|Overall Study|Withdrawal by Subject|1|||
164331945|NCT01698905|593593125|FG000|Overall Study|Adverse Event|4|||
164331946|NCT01698905|593593125|FG000|Overall Study|Physician Decision|2|||
164331947|NCT01698905|593593125|FG000|Overall Study|Pregnancy|1|||
164331948|NCT01698905|593593125|FG000|Overall Study|Protocol Violation|1|||
164331949|NCT01698905|593593125|FG000|Overall Study|Subject/guardian decision|2|||
164331950|NCT01698905|593593125|FG000|Overall Study|Death|1|||
164331951|NCT05896748|593593126|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
164331952|NCT05896748|593593126|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
164331953|NCT05896748|593593126|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
164331954|NCT05896748|593593126|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
164331955|NCT05896748|593593126|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
164331956|NCT00857415|593593134|FG000|Overall Study|Image acquisition failure|2|||
164331957|NCT00857415|593593135|FG001|Overall Study|Image acquisition failure|0|||
164331958|NCT00857415|593593134|FG000|Overall Study|Invalid image or not imaged|3|||
164331959|NCT00857415|593593135|FG001|Overall Study|Invalid image or not imaged|0|||
164331960|NCT00857415|593593134|FG000|Overall Study|Subject still living at end of study|110|||
164331961|NCT00857415|593593135|FG001|Overall Study|Subject still living at end of study|0|||
164331962|NCT00857415|593593134|FG000|Overall Study|Deceased with no autopsy|2|||
164331963|NCT00857415|593593135|FG001|Overall Study|Deceased with no autopsy|0|||
164331964|NCT04508140|593593136|FG000|Overall Study|Adverse Event|2|||
164331965|NCT04508140|593593137|FG001|Overall Study|Adverse Event|2|||
164331966|NCT04508140|593593136|FG000|Overall Study|Withdrawal by Subject|0|||
164331967|NCT04508140|593593137|FG001|Overall Study|Withdrawal by Subject|2|||
164331968|NCT04508140|593593136|FG000|Overall Study|progressive disease|9|||
164331969|NCT04508140|593593137|FG001|Overall Study|progressive disease|3|||
164331970|NCT01822678|593593138|FG000|Overall Study|Withdrawal by Subject|5|||
164331971|NCT01822678|593593139|FG001|Overall Study|Withdrawal by Subject|4|||
164331972|NCT01822678|593593140|FG002|Overall Study|Withdrawal by Subject|4|||
164331973|NCT01822678|593593138|FG000|Overall Study|Adverse Event|4|||
164331974|NCT01822678|593593139|FG001|Overall Study|Adverse Event|3|||
164331975|NCT01822678|593593140|FG002|Overall Study|Adverse Event|1|||
164331976|NCT01822678|593593138|FG000|Overall Study|Lack of Efficacy|3|||
164331977|NCT01822678|593593139|FG001|Overall Study|Lack of Efficacy|6|||
164331978|NCT01822678|593593140|FG002|Overall Study|Lack of Efficacy|5|||
164331979|NCT01822678|593593138|FG000|Overall Study|Lost to Follow-up|0|||
164331980|NCT01822678|593593139|FG001|Overall Study|Lost to Follow-up|2|||
164331981|NCT01822678|593593140|FG002|Overall Study|Lost to Follow-up|1|||
164331982|NCT00764504|593593141|FG000|Overall Study|Death|12|||
164331983|NCT00764504|593593142|FG001|Overall Study|Death|6|||
164331984|NCT00764504|593593143|FG002|Overall Study|Death|13|||
164331985|NCT00764504|593593141|FG000|Overall Study|Revision of Device|12|||
164331986|NCT00764504|593593142|FG001|Overall Study|Revision of Device|23|||
164331987|NCT00764504|593593143|FG002|Overall Study|Revision of Device|14|||
164331988|NCT00764504|593593141|FG000|Overall Study|Physician Decision|1|||
164572024|NCT03895203|594460317|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
164572025|NCT03895203|594460318|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
164572026|NCT03895203|594460319|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
164572027|NCT03895203|594460320|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
164572028|NCT03895203|594460321|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
164572029|NCT03895203|594460322|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
164572030|NCT03895203|594460317|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
164572031|NCT03895203|594460318|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
164572032|NCT03895203|594460319|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
164675538|NCT03570749|594836752|FG006|Overall Study|Screen Fail|1|||
164675539|NCT03570749|594836746|FG000|Overall Study|Withdrawal by Subject|2|||
164331989|NCT00764504|593593142|FG001|Overall Study|Physician Decision|0|||
164331990|NCT00764504|593593143|FG002|Overall Study|Physician Decision|0|||
164331991|NCT00764504|593593141|FG000|Overall Study|Withdrawal by Subject|1|||
164331992|NCT00764504|593593142|FG001|Overall Study|Withdrawal by Subject|7|||
164331993|NCT00764504|593593143|FG002|Overall Study|Withdrawal by Subject|4|||
164331994|NCT00764504|593593141|FG000|Overall Study|Lost to Follow-up|40|||
164331995|NCT00764504|593593142|FG001|Overall Study|Lost to Follow-up|34|||
164331996|NCT00764504|593593143|FG002|Overall Study|Lost to Follow-up|72|||
164331997|NCT02456103|593593147|FG000|Overall Study|Study Closure|207|||
164331998|NCT02456103|593593147|FG000|Overall Study|Physician Decision|1|||
164331999|NCT02456103|593593147|FG000|Overall Study|Required prohibited medications|5|||
164230367|NCT04042311|593212783|FG000|Overall Study|Withdrawal by Subject|4|||
164230368|NCT04134936|593212784|FG000|Overall Study|Adverse Event|3|||
164230369|NCT04134936|593212785|FG001|Overall Study|Adverse Event|2|||
164230370|NCT04134936|593212784|FG000|Overall Study|Withdrawal by Subject|2|||
164230371|NCT04134936|593212785|FG001|Overall Study|Withdrawal by Subject|3|||
164230372|NCT04134936|593212784|FG000|Overall Study|Physician Decision|0|||
164230373|NCT04134936|593212785|FG001|Overall Study|Physician Decision|1|||
164230374|NCT04134936|593212784|FG000|Overall Study|Progressive disease, joined another trial|1|||
164230375|NCT04134936|593212785|FG001|Overall Study|Progressive disease, joined another trial|0|||
164230376|NCT04134936|593212784|FG000|Overall Study|Progressive disease|1|||
164230377|NCT04134936|593212785|FG001|Overall Study|Progressive disease|0|||
164230378|NCT03518060|593212786|FG000|Overall Study|Death|1|||
164230379|NCT03518060|593212786|FG000|Overall Study|Poor adherence|1|||
164230380|NCT03518060|593212786|FG000|Overall Study|Withdrawal of informed consent|2|||
164230381|NCT03518060|593212786|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
164230382|NCT03518060|593212786|FG000|Overall Study|Physician Decision|7|||
164230383|NCT03518060|593212786|FG000|Overall Study|Adverse drug reactions|23|||
164230384|NCT03518060|593212786|FG000|Overall Study|Withdrawal by Subject|25|||
164230385|NCT03518060|593212786|FG000|Overall Study|Lost to Follow-up|13|||
164230386|NCT00323622|593212787|FG000|Overall Study|Other|30|||
164230387|NCT00323622|593212788|FG001|Overall Study|Other|91|||
164230388|NCT00323622|593212789|FG002|Overall Study|Other|4|||
164230389|NCT00323622|593212790|FG003|Overall Study|Other|12|||
164230390|NCT00323622|593212791|FG004|Overall Study|Other|32|||
164230391|NCT00323622|593212792|FG005|Overall Study|Other|74|||
164230392|NCT00323622|593212793|FG006|Overall Study|Other|5|||
164230393|NCT00323622|593212794|FG007|Overall Study|Other|13|||
164230394|NCT00323622|593212787|FG000|Overall Study|Death|1|||
164230395|NCT00323622|593212788|FG001|Overall Study|Death|1|||
164230396|NCT00323622|593212789|FG002|Overall Study|Death|0|||
164230397|NCT00323622|593212790|FG003|Overall Study|Death|0|||
164230398|NCT00323622|593212791|FG004|Overall Study|Death|7|||
164230399|NCT00323622|593212792|FG005|Overall Study|Death|0|||
164230400|NCT00323622|593212793|FG006|Overall Study|Death|0|||
164230401|NCT00323622|593212794|FG007|Overall Study|Death|2|||
164230402|NCT02613507|593212803|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
164230403|NCT02613507|593212804|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
164230404|NCT02613507|593212803|FG000|Pre-Treamtent|Participant withdrew consent|0|||
164230405|NCT02613507|593212804|FG001|Pre-Treamtent|Participant withdrew consent|4|||
164230406|NCT02613507|593212803|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
164230407|NCT02613507|593212804|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
164230408|NCT02613507|593212803|FG000|Treatment|Not reported|3|||
164230409|NCT02613507|593212804|FG001|Treatment|Not reported|0|||
164230410|NCT02613507|593212803|FG000|Treatment|Other reasons|8|||
164230411|NCT02613507|593212804|FG001|Treatment|Other reasons|0|||
164230412|NCT02613507|593212803|FG000|Treatment|Participant no longer meets criteria|3|||
164230413|NCT02613507|593212804|FG001|Treatment|Participant no longer meets criteria|0|||
164230414|NCT02613507|593212803|FG000|Treatment|Maximum clinical benefit|5|||
164230415|NCT02613507|593212804|FG001|Treatment|Maximum clinical benefit|10|||
164230416|NCT02613507|593212803|FG000|Treatment|Lost to Follow-up|1|||
164230417|NCT02613507|593212804|FG001|Treatment|Lost to Follow-up|0|||
164230418|NCT02613507|593212803|FG000|Treatment|Participant withdrew consent|0|||
164230419|NCT02613507|593212804|FG001|Treatment|Participant withdrew consent|2|||
164230420|NCT02613507|593212803|FG000|Treatment|Participant request to discontinue study treatment|13|||
164230421|NCT02613507|593212804|FG001|Treatment|Participant request to discontinue study treatment|17|||
164230422|NCT02613507|593212803|FG000|Treatment|Adverse event unrelated to study drug|20|||
164230423|NCT02613507|593212804|FG001|Treatment|Adverse event unrelated to study drug|3|||
164230424|NCT02613507|593212803|FG000|Treatment|Death|2|||
164230425|NCT02613507|593212804|FG001|Treatment|Death|0|||
164230426|NCT02613507|593212803|FG000|Treatment|Study drug toxicity|19|||
164230427|NCT02613507|593212804|FG001|Treatment|Study drug toxicity|14|||
164230428|NCT02613507|593212803|FG000|Treatment|Disease progression|263|||
164230429|NCT02613507|593212804|FG001|Treatment|Disease progression|110|||
164230430|NCT02471144|593214023|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
164230431|NCT02471144|593214024|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
164230432|NCT02471144|593214025|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
164230433|NCT02471144|593214026|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
164230434|NCT02471144|593214027|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
164230435|NCT02471144|593214028|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
164230436|NCT02471144|593214029|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
164230437|NCT02471144|593214030|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
164230438|NCT02471144|593214031|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
164230439|NCT02471144|593214032|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
164230440|NCT02471144|593214033|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
164230441|NCT02471144|593214023|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
164230442|NCT02471144|593214024|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
164230443|NCT02471144|593214025|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
164230444|NCT02471144|593214026|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
164230445|NCT02471144|593214027|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
164230446|NCT02471144|593214028|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
164230447|NCT02471144|593214029|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
164230448|NCT02471144|593214030|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
164230449|NCT02471144|593214031|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
164230450|NCT02471144|593214032|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
164230451|NCT02471144|593214033|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
164230452|NCT02471144|593214023|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
164230453|NCT02471144|593214024|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
164230454|NCT02471144|593214025|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
164230455|NCT02471144|593214026|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
164230456|NCT02471144|593214027|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
164230457|NCT02471144|593214028|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
164230458|NCT02471144|593214029|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
164230459|NCT02471144|593214030|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
164230460|NCT02471144|593214031|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
164230461|NCT02471144|593214032|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
164230462|NCT02471144|593214033|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
164230463|NCT02471144|593214023|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
164230464|NCT02471144|593214024|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
164230465|NCT02471144|593214025|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
164230466|NCT02471144|593214026|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
164230467|NCT02471144|593214027|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
164230468|NCT02471144|593214028|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
164230469|NCT02471144|593214029|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
164230470|NCT02471144|593214030|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
164230471|NCT02471144|593214031|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
164230472|NCT02471144|593214032|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
164230473|NCT02471144|593214033|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
164230474|NCT02471144|593214023|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
164230475|NCT02471144|593214024|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
164230476|NCT02471144|593214025|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
164230477|NCT02471144|593214026|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
164230478|NCT02471144|593214027|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
164230479|NCT02471144|593214028|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
164230480|NCT02471144|593214029|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
164230481|NCT02471144|593214030|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
164230482|NCT02471144|593214031|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
164332000|NCT02456103|593593147|FG000|Overall Study|Protocol Violation|1|||
164332001|NCT02456103|593593147|FG000|Overall Study|Adverse Event|5|||
164332002|NCT02456103|593593147|FG000|Overall Study|Abnormal Laboratory Value|2|||
164332003|NCT02456103|593593147|FG000|Overall Study|Lost to Follow-up|1|||
164332004|NCT02456103|593593147|FG000|Overall Study|Withdrawal by Subject|24|||
164332005|NCT01465191|593593148|FG000|Overall Study|Protocol Violation|6|||
164332006|NCT01465191|593593149|FG001|Overall Study|Protocol Violation|3|||
164332007|NCT01465191|593593150|FG002|Overall Study|Protocol Violation|3|||
164332008|NCT01465191|593593148|FG000|Overall Study|Lost to Follow-up|3|||
164332009|NCT01465191|593593149|FG001|Overall Study|Lost to Follow-up|6|||
164332010|NCT01465191|593593150|FG002|Overall Study|Lost to Follow-up|4|||
164332011|NCT03614975|593593151|FG000|Overall Study|Physician Decision|7|||
164332012|NCT03614975|593593152|FG001|Overall Study|Physician Decision|5|||
164332013|NCT03614975|593593151|FG000|Overall Study|Withdrawal by Subject|2|||
164332014|NCT03614975|593593152|FG001|Overall Study|Withdrawal by Subject|2|||
164332015|NCT03614975|593593151|FG000|Overall Study|Specimens not in lab batch shipment|1|||
164332016|NCT03614975|593593152|FG001|Overall Study|Specimens not in lab batch shipment|1|||
164332017|NCT01390220|593593153|FG000|Test Dose Phase|Adverse Event|17|||
164332018|NCT01390220|593593154|FG001|Test Dose Phase|Adverse Event|0|||
164332019|NCT01390220|593593155|FG002|Test Dose Phase|Adverse Event|0|||
164332020|NCT01390220|593593153|FG000|Test Dose Phase|Withdrawal by Subject|8|||
164332021|NCT01390220|593593154|FG001|Test Dose Phase|Withdrawal by Subject|0|||
164332022|NCT01390220|593593155|FG002|Test Dose Phase|Withdrawal by Subject|0|||
164332023|NCT01390220|593593153|FG000|Test Dose Phase|Lost to Follow-up|2|||
164332024|NCT01390220|593593154|FG001|Test Dose Phase|Lost to Follow-up|0|||
164332025|NCT01390220|593593155|FG002|Test Dose Phase|Lost to Follow-up|0|||
164332026|NCT01390220|593593153|FG000|Test Dose Phase|Protocol Violation|8|||
164332027|NCT01390220|593593154|FG001|Test Dose Phase|Protocol Violation|0|||
164332028|NCT01390220|593593155|FG002|Test Dose Phase|Protocol Violation|0|||
164332029|NCT01390220|593593153|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
164332030|NCT01390220|593593154|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
164332031|NCT01390220|593593155|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
164332032|NCT01390220|593593153|FG000|Test Dose Phase|Study/Site closure|6|||
164332033|NCT01390220|593593154|FG001|Test Dose Phase|Study/Site closure|0|||
164332034|NCT01390220|593593155|FG002|Test Dose Phase|Study/Site closure|0|||
164332035|NCT01390220|593593153|FG000|Test Dose Phase|Caregiver no longer available|5|||
164332036|NCT01390220|593593154|FG001|Test Dose Phase|Caregiver no longer available|0|||
164332037|NCT01390220|593593155|FG002|Test Dose Phase|Caregiver no longer available|0|||
164332038|NCT01390220|593593153|FG000|Test Dose Phase|Noncompliance|2|||
164332039|NCT01390220|593593154|FG001|Test Dose Phase|Noncompliance|0|||
164332040|NCT01390220|593593155|FG002|Test Dose Phase|Noncompliance|0|||
164332041|NCT01390220|593593153|FG000|Test Dose Phase|Logistical|6|||
164332042|NCT01390220|593593154|FG001|Test Dose Phase|Logistical|0|||
164332043|NCT01390220|593593155|FG002|Test Dose Phase|Logistical|0|||
164332044|NCT01390220|593593153|FG000|Comparative Phase|Withdrawal by Subject|0|||
164332045|NCT01390220|593593154|FG001|Comparative Phase|Withdrawal by Subject|1|||
164332046|NCT01390220|593593155|FG002|Comparative Phase|Withdrawal by Subject|0|||
164332047|NCT00943124|593593156|FG000|Period 1|Withdrawal by Subject|1|||
164332048|NCT00943124|593593157|FG001|Period 1|Withdrawal by Subject|1|||
164332049|NCT00943124|593593156|FG000|Period 1|Did Not Follow Study Procedures|1|||
164332050|NCT00943124|593593157|FG001|Period 1|Did Not Follow Study Procedures|0|||
164332051|NCT00943124|593593156|FG000|Period 1|Personal Reasons|0|||
164332052|NCT00943124|593593157|FG001|Period 1|Personal Reasons|1|||
164332053|NCT03059446|593593158|FG000|Overall Study|Adverse Event|11|||
164332054|NCT03059446|593593158|FG000|Overall Study|Withdrawal of Consent|16|||
164332055|NCT03059446|593593158|FG000|Overall Study|Lost to Follow-up|3|||
164332056|NCT03059446|593593158|FG000|Overall Study|Protocol Violation|1|||
164332057|NCT03059446|593593158|FG000|Overall Study|Study Terminated by Sponsor|131|||
164332058|NCT03059446|593593158|FG000|Overall Study|Reason not Specified|5|||
164332059|NCT02992132|593593159|FG000|Overall Study|Adverse Event|4|||
164332060|NCT02992132|593593160|FG001|Overall Study|Adverse Event|1|||
164332061|NCT02992132|593593161|FG002|Overall Study|Adverse Event|3|||
164332062|NCT02992132|593593159|FG000|Overall Study|Lack of Efficacy|2|||
164332063|NCT02992132|593593160|FG001|Overall Study|Lack of Efficacy|0|||
164332064|NCT02992132|593593161|FG002|Overall Study|Lack of Efficacy|0|||
164332065|NCT02992132|593593159|FG000|Overall Study|Non-compliance with study drug|2|||
164332066|NCT02992132|593593160|FG001|Overall Study|Non-compliance with study drug|0|||
164332067|NCT02992132|593593161|FG002|Overall Study|Non-compliance with study drug|0|||
164332068|NCT02992132|593593159|FG000|Overall Study|Progressive disease|1|||
164332069|NCT02992132|593593160|FG001|Overall Study|Progressive disease|0|||
164332070|NCT02992132|593593161|FG002|Overall Study|Progressive disease|0|||
164332071|NCT02992132|593593159|FG000|Overall Study|Protocol Violation|2|||
164332072|NCT02992132|593593160|FG001|Overall Study|Protocol Violation|2|||
164332073|NCT02992132|593593161|FG002|Overall Study|Protocol Violation|0|||
164332074|NCT02992132|593593159|FG000|Overall Study|Caregiver withdrew consent|2|||
164332075|NCT02992132|593593160|FG001|Overall Study|Caregiver withdrew consent|3|||
164332076|NCT02992132|593593161|FG002|Overall Study|Caregiver withdrew consent|2|||
164332077|NCT02992132|593593159|FG000|Overall Study|Withdrawal by Subject|0|||
164332078|NCT02992132|593593160|FG001|Overall Study|Withdrawal by Subject|2|||
164332079|NCT02992132|593593161|FG002|Overall Study|Withdrawal by Subject|1|||
164332080|NCT02992132|593593159|FG000|Overall Study|Physician Decision|0|||
164332081|NCT02992132|593593160|FG001|Overall Study|Physician Decision|0|||
164332082|NCT02992132|593593161|FG002|Overall Study|Physician Decision|1|||
164332083|NCT02448810|593593162|FG000|Overall Study|Adverse Event|0|||
164332084|NCT02448810|593593163|FG001|Overall Study|Adverse Event|0|||
164332085|NCT02448810|593593164|FG002|Overall Study|Adverse Event|1|||
164332086|NCT02448810|593593165|FG003|Overall Study|Adverse Event|0|||
164332087|NCT02448810|593593166|FG004|Overall Study|Adverse Event|0|||
164332088|NCT02448810|593593167|FG005|Overall Study|Adverse Event|0|||
164332089|NCT02448810|593593168|FG006|Overall Study|Adverse Event|0|||
164332090|NCT02448810|593593169|FG007|Overall Study|Adverse Event|0|||
164332091|NCT02448810|593593162|FG000|Overall Study|Withdrawal by Subject|0|||
164332092|NCT02448810|593593163|FG001|Overall Study|Withdrawal by Subject|0|||
164332093|NCT02448810|593593164|FG002|Overall Study|Withdrawal by Subject|1|||
164332094|NCT02448810|593593165|FG003|Overall Study|Withdrawal by Subject|0|||
164332095|NCT02448810|593593166|FG004|Overall Study|Withdrawal by Subject|3|||
164332096|NCT02448810|593593167|FG005|Overall Study|Withdrawal by Subject|5|||
164332097|NCT02448810|593593168|FG006|Overall Study|Withdrawal by Subject|0|||
164332098|NCT02448810|593593169|FG007|Overall Study|Withdrawal by Subject|2|||
164332099|NCT02448810|593593162|FG000|Overall Study|Other (study terminated by sponsor)|0|||
164332100|NCT02448810|593593163|FG001|Overall Study|Other (study terminated by sponsor)|0|||
164332101|NCT02448810|593593164|FG002|Overall Study|Other (study terminated by sponsor)|0|||
164332102|NCT02448810|593593165|FG003|Overall Study|Other (study terminated by sponsor)|0|||
164332103|NCT02448810|593593166|FG004|Overall Study|Other (study terminated by sponsor)|4|||
164332104|NCT02448810|593593167|FG005|Overall Study|Other (study terminated by sponsor)|2|||
164332105|NCT02448810|593593168|FG006|Overall Study|Other (study terminated by sponsor)|2|||
164332106|NCT02448810|593593169|FG007|Overall Study|Other (study terminated by sponsor)|1|||
164675540|NCT03570749|594836747|FG001|Overall Study|Withdrawal by Subject|3|||
164675541|NCT03570749|594836748|FG002|Overall Study|Withdrawal by Subject|2|||
164675542|NCT03570749|594836749|FG003|Overall Study|Withdrawal by Subject|1|||
164675543|NCT03570749|594836750|FG004|Overall Study|Withdrawal by Subject|17|||
164675544|NCT03570749|594836751|FG005|Overall Study|Withdrawal by Subject|12|||
164675545|NCT03570749|594836752|FG006|Overall Study|Withdrawal by Subject|15|||
164675546|NCT03570749|594836746|FG000|Overall Study|Other|0|||
164675547|NCT03570749|594836747|FG001|Overall Study|Other|0|||
164675548|NCT03570749|594836748|FG002|Overall Study|Other|0|||
164675549|NCT03570749|594836749|FG003|Overall Study|Other|0|||
164675550|NCT03570749|594836750|FG004|Overall Study|Other|17|||
164675551|NCT03570749|594836751|FG005|Overall Study|Other|14|||
164675552|NCT03570749|594836752|FG006|Overall Study|Other|21|||
164675553|NCT00561015|594836753|FG000|Overall Study|Adverse Event|0|||
164675554|NCT00561015|594836754|FG001|Overall Study|Adverse Event|0|||
164675555|NCT00561015|594836755|FG002|Overall Study|Adverse Event|0|||
164421850|NCT02468934|593914542|FG000|Overall Study|Withdrawal by Subject|4|||
164332107|NCT02448810|593593162|FG000|Overall Study|Death|1|||
164332108|NCT02448810|593593163|FG001|Overall Study|Death|0|||
164332109|NCT02448810|593593164|FG002|Overall Study|Death|1|||
164332110|NCT02448810|593593165|FG003|Overall Study|Death|0|||
164332111|NCT02448810|593593166|FG004|Overall Study|Death|1|||
164332112|NCT02448810|593593167|FG005|Overall Study|Death|0|||
164332113|NCT02448810|593593168|FG006|Overall Study|Death|0|||
164332114|NCT02448810|593593169|FG007|Overall Study|Death|0|||
164332115|NCT02448810|593593162|FG000|Overall Study|Other (Progressive disease)|2|||
164332116|NCT02448810|593593163|FG001|Overall Study|Other (Progressive disease)|2|||
164332117|NCT02448810|593593164|FG002|Overall Study|Other (Progressive disease)|0|||
164332118|NCT02448810|593593165|FG003|Overall Study|Other (Progressive disease)|3|||
164332119|NCT02448810|593593166|FG004|Overall Study|Other (Progressive disease)|23|||
164332120|NCT02448810|593593167|FG005|Overall Study|Other (Progressive disease)|9|||
164332121|NCT02448810|593593168|FG006|Overall Study|Other (Progressive disease)|14|||
164332122|NCT02448810|593593169|FG007|Overall Study|Other (Progressive disease)|5|||
164332123|NCT02448810|593593162|FG000|Overall Study|Lost to Follow-up|0|||
164332124|NCT02448810|593593163|FG001|Overall Study|Lost to Follow-up|1|||
164332125|NCT02448810|593593164|FG002|Overall Study|Lost to Follow-up|0|||
164332126|NCT02448810|593593165|FG003|Overall Study|Lost to Follow-up|0|||
164332127|NCT02448810|593593166|FG004|Overall Study|Lost to Follow-up|0|||
164332128|NCT02448810|593593167|FG005|Overall Study|Lost to Follow-up|0|||
164332129|NCT02448810|593593168|FG006|Overall Study|Lost to Follow-up|0|||
164332130|NCT02448810|593593169|FG007|Overall Study|Lost to Follow-up|0|||
164332131|NCT02448810|593593162|FG000|Overall Study|Other (unspecified)|0|||
164332132|NCT02448810|593593163|FG001|Overall Study|Other (unspecified)|0|||
164332133|NCT02448810|593593164|FG002|Overall Study|Other (unspecified)|0|||
164332134|NCT02448810|593593165|FG003|Overall Study|Other (unspecified)|0|||
164332135|NCT02448810|593593166|FG004|Overall Study|Other (unspecified)|0|||
164332136|NCT02448810|593593167|FG005|Overall Study|Other (unspecified)|0|||
164332137|NCT02448810|593593168|FG006|Overall Study|Other (unspecified)|2|||
164332138|NCT02448810|593593169|FG007|Overall Study|Other (unspecified)|0|||
164332139|NCT00136604|593593170|FG000|Overall Study|Lost to Follow-up|1|||
164332140|NCT00136604|593593171|FG001|Overall Study|Lost to Follow-up|0|||
164332141|NCT00136604|593593172|FG002|Overall Study|Lost to Follow-up|0|||
164332142|NCT00136604|593593173|FG003|Overall Study|Lost to Follow-up|0|||
164332143|NCT00136604|593593174|FG004|Overall Study|Lost to Follow-up|1|||
164332144|NCT00136604|593593170|FG000|Overall Study|Migrated/moved from study area|0|||
164332145|NCT00136604|593593171|FG001|Overall Study|Migrated/moved from study area|1|||
164332146|NCT00136604|593593172|FG002|Overall Study|Migrated/moved from study area|0|||
164332147|NCT00136604|593593173|FG003|Overall Study|Migrated/moved from study area|0|||
164332148|NCT00136604|593593174|FG004|Overall Study|Migrated/moved from study area|0|||
164332149|NCT04795622|593593175|FG000|Overall Study|Adverse Event|1|||
164332150|NCT04795622|593593176|FG001|Overall Study|Adverse Event|0|||
164332151|NCT04795622|593593175|FG000|Overall Study|Withdrawal by Subject|3|||
164332152|NCT04795622|593593176|FG001|Overall Study|Withdrawal by Subject|3|||
164332153|NCT04795622|593593175|FG000|Overall Study|Protocol Violation|0|||
164332154|NCT04795622|593593176|FG001|Overall Study|Protocol Violation|2|||
164332155|NCT04795622|593593175|FG000|Overall Study|Lost to Follow-up|2|||
164332156|NCT04795622|593593176|FG001|Overall Study|Lost to Follow-up|3|||
164332157|NCT04795622|593593175|FG000|Overall Study|Other|7|||
164332158|NCT04795622|593593176|FG001|Overall Study|Other|8|||
164332159|NCT00470847|593593177|FG000|Overall Study|Pt still receiving treatment|1|||
164332160|NCT03963401|593593179|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
164332161|NCT03963401|593593180|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
164332162|NCT03963401|593593181|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
164332163|NCT03963401|593593182|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
164332164|NCT03963401|593593183|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
164332165|NCT03963401|593593184|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
164332166|NCT03963401|593593179|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
164675556|NCT00561015|594836756|FG003|Overall Study|Adverse Event|0|||
164675557|NCT00561015|594836757|FG004|Overall Study|Adverse Event|1|||
164230483|NCT02471144|593214032|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
164230484|NCT02471144|593214033|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
164230485|NCT02471144|593214023|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
164230486|NCT02471144|593214024|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
164230487|NCT02471144|593214025|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
164230488|NCT02471144|593214026|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
164230489|NCT02471144|593214027|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
164230490|NCT02471144|593214028|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
164230491|NCT02471144|593214029|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
164230492|NCT02471144|593214030|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
164230493|NCT02471144|593214031|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
164230494|NCT02471144|593214032|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
164230495|NCT02471144|593214033|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
164230496|NCT02471144|593214023|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
164230497|NCT02471144|593214024|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
164230498|NCT02471144|593214025|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
164230499|NCT02471144|593214026|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
164230500|NCT02471144|593214027|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
164230501|NCT02471144|593214028|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
164230502|NCT02471144|593214029|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
164230503|NCT02471144|593214030|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
164230504|NCT02471144|593214031|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
164230505|NCT02471144|593214032|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
164230506|NCT02471144|593214033|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
164230507|NCT02471144|593214023|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
164230508|NCT02471144|593214024|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
164230509|NCT02471144|593214025|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
164230510|NCT02471144|593214026|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
164230511|NCT02471144|593214027|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
164230512|NCT02471144|593214028|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
164230513|NCT02471144|593214029|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
164230514|NCT02471144|593214030|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
164230515|NCT02471144|593214031|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
164230516|NCT02471144|593214032|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
164230517|NCT02471144|593214033|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
164230518|NCT02471144|593214023|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
164230519|NCT02471144|593214024|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
164230520|NCT02471144|593214025|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
164230521|NCT02471144|593214026|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
164230522|NCT02471144|593214027|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
164230523|NCT02471144|593214028|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
164230524|NCT02471144|593214029|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
164230525|NCT02471144|593214030|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
164230526|NCT02471144|593214031|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
164230527|NCT02471144|593214032|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
164230528|NCT02471144|593214033|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
164230529|NCT02471144|593214023|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
164230530|NCT02471144|593214024|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
164230531|NCT02471144|593214025|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
164230532|NCT02471144|593214026|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
164230533|NCT02471144|593214027|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
164230534|NCT02471144|593214028|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
164230535|NCT02471144|593214029|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
164230536|NCT02471144|593214030|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
164230537|NCT02471144|593214031|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
164230538|NCT02471144|593214032|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
164230539|NCT02471144|593214033|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
164230540|NCT02471144|593214023|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
164230541|NCT02471144|593214024|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
164230542|NCT02471144|593214025|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
164230543|NCT02471144|593214026|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
164230544|NCT02471144|593214027|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
164230545|NCT02471144|593214028|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
164230546|NCT02471144|593214029|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
164230547|NCT02471144|593214030|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
164230548|NCT02471144|593214031|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
164421851|NCT02468934|593914542|FG000|Overall Study|Screen Failure|3|||
164230549|NCT02471144|593214032|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
164230550|NCT02471144|593214033|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
164421852|NCT02036515|593914547|FG000|Overall Study|Adverse Event|1|||
164421853|NCT02036515|593914548|FG001|Overall Study|Adverse Event|1|||
164421854|NCT02036515|593914549|FG002|Overall Study|Adverse Event|2|||
164421855|NCT02036515|593914547|FG000|Overall Study|Lost to Follow-up|0|||
164421856|NCT02036515|593914548|FG001|Overall Study|Lost to Follow-up|2|||
164421857|NCT02036515|593914549|FG002|Overall Study|Lost to Follow-up|0|||
164421858|NCT02036515|593914547|FG000|Overall Study|Non-compliance with study drug|0|||
164421859|NCT02036515|593914548|FG001|Overall Study|Non-compliance with study drug|0|||
164421860|NCT02036515|593914549|FG002|Overall Study|Non-compliance with study drug|2|||
164421861|NCT02036515|593914547|FG000|Overall Study|Screen failure|0|||
164421862|NCT02036515|593914548|FG001|Overall Study|Screen failure|2|||
164421863|NCT02036515|593914549|FG002|Overall Study|Screen failure|0|||
164421864|NCT02036515|593914547|FG000|Overall Study|Withdrawal by Subject|4|||
164421865|NCT02036515|593914548|FG001|Overall Study|Withdrawal by Subject|7|||
164421866|NCT02036515|593914549|FG002|Overall Study|Withdrawal by Subject|9|||
164230551|NCT02471144|593214023|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
164230552|NCT02471144|593214024|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
164230553|NCT02471144|593214025|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
164230554|NCT02471144|593214026|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
164230555|NCT02471144|593214027|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
164230556|NCT02471144|593214028|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
164230557|NCT02471144|593214029|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
164230558|NCT02471144|593214030|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
164230559|NCT02471144|593214031|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
164230560|NCT02471144|593214032|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
164230561|NCT02471144|593214033|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
164230562|NCT02471144|593214023|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
164230563|NCT02471144|593214024|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
164230564|NCT02471144|593214025|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
164230565|NCT02471144|593214026|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
164230566|NCT02471144|593214027|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
164230567|NCT02471144|593214028|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
164230568|NCT02471144|593214029|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
164230569|NCT02471144|593214030|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
164230570|NCT02471144|593214031|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
164230571|NCT02471144|593214032|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
164230572|NCT02471144|593214033|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
164230573|NCT02471144|593214023|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
164332167|NCT03963401|593593180|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
164332168|NCT03963401|593593181|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
164332169|NCT03963401|593593182|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
164332170|NCT03963401|593593183|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
164332171|NCT03963401|593593184|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
164332172|NCT03963401|593593179|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
164332173|NCT03963401|593593180|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
164332174|NCT03963401|593593181|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
164332175|NCT03963401|593593182|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
164332176|NCT03963401|593593183|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
164332177|NCT03963401|593593184|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
164421867|NCT02036515|593914547|FG000|Overall Study|Hyperglycemia|0|||
164421868|NCT02036515|593914548|FG001|Overall Study|Hyperglycemia|0|||
164421869|NCT02036515|593914549|FG002|Overall Study|Hyperglycemia|1|||
164572033|NCT03895203|594460320|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
164572034|NCT03895203|594460321|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
164572035|NCT03895203|594460322|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
164572036|NCT03895203|594460317|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
164572037|NCT03895203|594460318|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
164572038|NCT03895203|594460319|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
164572039|NCT03895203|594460320|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
164572040|NCT03895203|594460321|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
164421870|NCT02218489|593914556|FG000|Overall Study|Withdrawal by Subject|4|||
164421871|NCT02218489|593914557|FG001|Overall Study|Withdrawal by Subject|3|||
164421872|NCT02218489|593914556|FG000|Overall Study|Lost to Follow-up|1|||
164421873|NCT02218489|593914557|FG001|Overall Study|Lost to Follow-up|0|||
164421874|NCT00547911|593914558|FG000|Overall Study|Adverse Event|0|||
164230574|NCT02471144|593214024|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
164230575|NCT02471144|593214025|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
164230576|NCT02471144|593214026|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
164230577|NCT02471144|593214027|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
164230578|NCT02471144|593214028|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
164230579|NCT02471144|593214029|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
164230580|NCT02471144|593214030|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
164230581|NCT02471144|593214031|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
164230582|NCT02471144|593214032|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
164230583|NCT02471144|593214033|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
164230584|NCT03977155|593214038|FG000|Overall Study|Adverse Event|3|||
164230585|NCT03977155|593214039|FG001|Overall Study|Adverse Event|0|||
164230586|NCT03977155|593214040|FG002|Overall Study|Adverse Event|0|||
164230587|NCT03977155|593214038|FG000|Overall Study|Lost to Follow-up|0|||
164230588|NCT03977155|593214039|FG001|Overall Study|Lost to Follow-up|1|||
164421875|NCT00547911|593914559|FG001|Overall Study|Adverse Event|0|||
164421876|NCT00547911|593914560|FG002|Overall Study|Adverse Event|0|||
164230589|NCT03977155|593214040|FG002|Overall Study|Lost to Follow-up|0|||
164230590|NCT03977155|593214038|FG000|Overall Study|Withdrawal by Subject|1|||
164230591|NCT03977155|593214039|FG001|Overall Study|Withdrawal by Subject|1|||
164230592|NCT03977155|593214040|FG002|Overall Study|Withdrawal by Subject|2|||
164230593|NCT03977155|593214038|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
164230594|NCT03977155|593214039|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
164230595|NCT03977155|593214040|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
164230596|NCT00936936|593214041|FG000|Overall Study|Adverse Event|7|||
164230597|NCT00936936|593214042|FG001|Overall Study|Adverse Event|1|||
164230598|NCT00936936|593214041|FG000|Overall Study|Disease Progression|2|||
164230599|NCT00936936|593214042|FG001|Overall Study|Disease Progression|2|||
164230600|NCT00936936|593214041|FG000|Overall Study|Unrelated|3|||
164230601|NCT00936936|593214042|FG001|Overall Study|Unrelated|1|||
164230602|NCT03440385|593214052|FG000|Overall Study|Other Reason|4|||
164230603|NCT03440385|593214053|FG001|Overall Study|Other Reason|1|||
164230604|NCT03440385|593214052|FG000|Overall Study|Site Closed|1|||
164230605|NCT03440385|593214053|FG001|Overall Study|Site Closed|0|||
164230606|NCT03440385|593214052|FG000|Overall Study|Lost to Follow-up|2|||
164230607|NCT03440385|593214053|FG001|Overall Study|Lost to Follow-up|0|||
164230608|NCT03440385|593214052|FG000|Overall Study|Withdrawal by Subject|12|||
164230609|NCT03440385|593214053|FG001|Overall Study|Withdrawal by Subject|6|||
164230610|NCT03440385|593214052|FG000|Overall Study|Lack of Efficacy|9|||
164230611|NCT03440385|593214053|FG001|Overall Study|Lack of Efficacy|2|||
164230612|NCT03440385|593214052|FG000|Overall Study|Adverse Event|15|||
164230613|NCT03440385|593214053|FG001|Overall Study|Adverse Event|11|||
164230614|NCT00488293|593214054|FG000|Overall Study|Lost to Follow-up|28|||
164230615|NCT00488293|593214055|FG001|Overall Study|Lost to Follow-up|25|||
164230616|NCT00488293|593214054|FG000|Overall Study|Withdrawal by Subject|5|||
164230617|NCT00488293|593214055|FG001|Overall Study|Withdrawal by Subject|3|||
164230618|NCT00488293|593214054|FG000|Overall Study|Death|2|||
164230619|NCT00488293|593214055|FG001|Overall Study|Death|1|||
164230620|NCT00488293|593214054|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
164332178|NCT03963401|593593179|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
164332179|NCT03963401|593593180|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
164332180|NCT03963401|593593181|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
164332181|NCT03963401|593593182|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
164332182|NCT03963401|593593183|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
164332183|NCT03963401|593593184|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
164332184|NCT03963401|593593179|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
164332185|NCT03963401|593593180|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
164332186|NCT03963401|593593181|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
164332187|NCT03963401|593593182|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
164332188|NCT03963401|593593183|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
164332189|NCT03963401|593593184|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
164332190|NCT03963401|593593179|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
164332191|NCT03963401|593593180|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
164421877|NCT00547911|593914561|FG003|Overall Study|Adverse Event|1|||
164230621|NCT00488293|593214055|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
164230622|NCT00939185|593214056|FG000|Overall Study|Adverse Event|3|||
164230623|NCT00939185|593214056|FG000|Overall Study|Lack of Efficacy|1|||
164230624|NCT00939185|593214056|FG000|Overall Study|Lost to Follow-up|6|||
164421878|NCT00547911|593914562|FG004|Overall Study|Adverse Event|0|||
164230625|NCT00939185|593214056|FG000|Overall Study|Other|3|||
164230626|NCT00939185|593214056|FG000|Overall Study|Withdrawal by Subject|2|||
164230627|NCT00939185|593214056|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
164230628|NCT00363298|593214057|FG000|First Study Week|Lack of Efficacy|6|||
164421879|NCT00547911|593914563|FG005|Overall Study|Adverse Event|0|||
164421880|NCT02601937|593914564|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
164230629|NCT00363298|593214058|FG001|First Study Week|Lack of Efficacy|5|||
164230630|NCT00363298|593214057|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
164230631|NCT00363298|593214058|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
164230632|NCT02374255|593214059|FG000|Overall Study|Withdrawal by Subject|2|||
164230633|NCT02374255|593214060|FG001|Overall Study|Withdrawal by Subject|0|||
164230634|NCT02374255|593214061|FG002|Overall Study|Withdrawal by Subject|0|||
164230635|NCT02374255|593214062|FG003|Overall Study|Withdrawal by Subject|0|||
164230636|NCT00730327|593214063|FG000|Overall Study|Lost to Follow-up|14|||
164230637|NCT00730327|593214064|FG001|Overall Study|Lost to Follow-up|16|||
164230638|NCT00730327|593214063|FG000|Overall Study|Adverse Event|8|||
164421881|NCT02601937|593914565|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
164421882|NCT02601937|593914566|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
164421883|NCT02601937|593914567|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
164421884|NCT02601937|593914568|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
164421885|NCT02601937|593914569|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
164421886|NCT02601937|593914570|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
164230639|NCT00730327|593214064|FG001|Overall Study|Adverse Event|1|||
164230640|NCT00730327|593214063|FG000|Overall Study|Withdrawal by Subject|3|||
164230641|NCT00730327|593214064|FG001|Overall Study|Withdrawal by Subject|13|||
164230642|NCT00730327|593214063|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
164230643|NCT00730327|593214064|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
164230644|NCT00095576|593214065|FG000|Overall Study|Adverse Event|5|||
164230645|NCT00095576|593214066|FG001|Overall Study|Adverse Event|3|||
164230646|NCT00095576|593214065|FG000|Overall Study|Lost to Follow-up|233|||
164230647|NCT00095576|593214066|FG001|Overall Study|Lost to Follow-up|229|||
164230648|NCT00095576|593214065|FG000|Overall Study|Protocol Violation|1|||
164230649|NCT00095576|593214066|FG001|Overall Study|Protocol Violation|0|||
164230650|NCT00095576|593214065|FG000|Overall Study|Withdrawal by Subject|34|||
164230651|NCT00095576|593214066|FG001|Overall Study|Withdrawal by Subject|47|||
164230652|NCT00095576|593214065|FG000|Overall Study|Option to switch to a rollover study|1097|||
164230653|NCT00095576|593214066|FG001|Overall Study|Option to switch to a rollover study|1099|||
164230654|NCT00095576|593214065|FG000|Overall Study|Site terminated|75|||
164230655|NCT00095576|593214066|FG001|Overall Study|Site terminated|67|||
164230656|NCT00095576|593214065|FG000|Overall Study|Subject moved|30|||
164230657|NCT00095576|593214066|FG001|Overall Study|Subject moved|36|||
164230658|NCT02332928|593214069|FG000|Overall Study|Withdrawal by Subject|0|||
164230659|NCT02332928|593214070|FG001|Overall Study|Withdrawal by Subject|2|||
164230660|NCT02332928|593214069|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
164230661|NCT02332928|593214070|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
164230662|NCT01497197|593214071|FG000|Overall Study|Lost to Follow-up|1|||
164230663|NCT01497197|593214072|FG001|Overall Study|Lost to Follow-up|0|||
164230664|NCT01497197|593214071|FG000|Overall Study|Protocol Violation|0|||
164230665|NCT01497197|593214072|FG001|Overall Study|Protocol Violation|2|||
164230666|NCT01497197|593214071|FG000|Overall Study|Withdrawal by Subject|2|||
164230667|NCT01497197|593214072|FG001|Overall Study|Withdrawal by Subject|1|||
164230668|NCT01497197|593214071|FG000|Overall Study|Excessive/lack of response to treatment|1|||
164230669|NCT01497197|593214072|FG001|Overall Study|Excessive/lack of response to treatment|0|||
164230670|NCT01497197|593214071|FG000|Overall Study|Risk of OHSS|1|||
164230671|NCT01497197|593214072|FG001|Overall Study|Risk of OHSS|0|||
164230672|NCT01497197|593214071|FG000|Overall Study|No oocytes retrieved|3|||
164230673|NCT01497197|593214072|FG001|Overall Study|No oocytes retrieved|2|||
164230674|NCT01497197|593214071|FG000|Overall Study|No fertilisation|6|||
164230675|NCT01497197|593214072|FG001|Overall Study|No fertilisation|5|||
164230676|NCT01497197|593214071|FG000|Overall Study|Intention to freeze all embryos|0|||
164230677|NCT01497197|593214072|FG001|Overall Study|Intention to freeze all embryos|1|||
164230678|NCT01497197|593214071|FG000|Overall Study|All embryos discarded|0|||
164230679|NCT01497197|593214072|FG001|Overall Study|All embryos discarded|3|||
164230680|NCT01497197|593214071|FG000|Overall Study|Other|3|||
164230681|NCT01497197|593214072|FG001|Overall Study|Other|1|||
164230682|NCT01425814|593214074|FG000|Period 1|Stability criteria not fulfilled|0|||
164230683|NCT01425814|593214075|FG001|Period 1|Stability criteria not fulfilled|1|||
164230684|NCT01425814|593214076|FG002|Period 1|Stability criteria not fulfilled|0|||
164230685|NCT01425814|593214077|FG003|Period 1|Stability criteria not fulfilled|0|||
164230686|NCT01425814|593214078|FG004|Period 1|Stability criteria not fulfilled|0|||
164230687|NCT01425814|593214079|FG005|Period 1|Stability criteria not fulfilled|0|||
164230688|NCT01425814|593214074|FG000|Period 2|Stability criteria not fulfilled|0|||
164230689|NCT01425814|593214075|FG001|Period 2|Stability criteria not fulfilled|1|||
164230690|NCT01425814|593214076|FG002|Period 2|Stability criteria not fulfilled|0|||
164230691|NCT01425814|593214077|FG003|Period 2|Stability criteria not fulfilled|0|||
164230692|NCT01425814|593214078|FG004|Period 2|Stability criteria not fulfilled|0|||
164230693|NCT01425814|593214079|FG005|Period 2|Stability criteria not fulfilled|0|||
164421887|NCT02601937|593914571|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
164421888|NCT02601937|593914572|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
164230694|NCT01425814|593214074|FG000|Period 3|Adverse Event|0|||
164230695|NCT01425814|593214075|FG001|Period 3|Adverse Event|0|||
164230696|NCT01425814|593214076|FG002|Period 3|Adverse Event|0|||
164230697|NCT01425814|593214077|FG003|Period 3|Adverse Event|0|||
164230698|NCT01425814|593214078|FG004|Period 3|Adverse Event|0|||
164230699|NCT01425814|593214079|FG005|Period 3|Adverse Event|1|||
164230700|NCT01425814|593214074|FG000|Period 4|Adverse Event|1|||
164230701|NCT01425814|593214075|FG001|Period 4|Adverse Event|0|||
164230702|NCT01425814|593214076|FG002|Period 4|Adverse Event|1|||
164230703|NCT01425814|593214077|FG003|Period 4|Adverse Event|0|||
164230704|NCT01425814|593214078|FG004|Period 4|Adverse Event|0|||
164230705|NCT01425814|593214079|FG005|Period 4|Adverse Event|0|||
164230706|NCT01425814|593214074|FG000|Period 5|Stability criteria not fulfilled|0|||
164230707|NCT01425814|593214075|FG001|Period 5|Stability criteria not fulfilled|0|||
164230708|NCT01425814|593214076|FG002|Period 5|Stability criteria not fulfilled|1|||
164230709|NCT01425814|593214077|FG003|Period 5|Stability criteria not fulfilled|0|||
164230710|NCT01425814|593214078|FG004|Period 5|Stability criteria not fulfilled|0|||
164230711|NCT01425814|593214079|FG005|Period 5|Stability criteria not fulfilled|1|||
164572041|NCT03895203|594460322|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
164572042|NCT03895203|594460317|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
164421889|NCT02601937|593914573|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
164230712|NCT01052779|593214080|FG000|Overall Study|Adverse Event|1|||
164230713|NCT01052779|593214081|FG001|Overall Study|Adverse Event|4|||
164230714|NCT01052779|593214080|FG000|Overall Study|Withdrawal by Subject|1|||
164230715|NCT01052779|593214081|FG001|Overall Study|Withdrawal by Subject|2|||
164230716|NCT01052779|593214080|FG000|Overall Study|Other-Protocol Violation|1|||
164230717|NCT01052779|593214081|FG001|Overall Study|Other-Protocol Violation|1|||
164230718|NCT01052779|593214080|FG000|Overall Study|Other-Surgery|0|||
164230719|NCT01052779|593214081|FG001|Overall Study|Other-Surgery|2|||
164230720|NCT01052779|593214080|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
164230721|NCT01052779|593214081|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
164230722|NCT03580044|593214082|FG000|Overall Study|Death|2|||
164230723|NCT03580044|593214083|FG001|Overall Study|Death|1|||
164230724|NCT03580044|593214082|FG000|Overall Study|Withdrawal by Subject|1|||
164230725|NCT03580044|593214083|FG001|Overall Study|Withdrawal by Subject|1|||
164230726|NCT03524157|593214084|FG000|Overall Study|cytology not readable|0|||
164230727|NCT03524157|593214085|FG001|Overall Study|cytology not readable|0|||
164230728|NCT03524157|593214086|FG002|Overall Study|cytology not readable|1|||
164230729|NCT01358734|593214087|FG000|Overall Study|Adverse Event|4|||
164230730|NCT01358734|593214088|FG001|Overall Study|Adverse Event|7|||
164230731|NCT01358734|593214089|FG002|Overall Study|Adverse Event|3|||
164230732|NCT01358734|593214087|FG000|Overall Study|Lack of Efficacy|0|||
164230733|NCT01358734|593214088|FG001|Overall Study|Lack of Efficacy|1|||
164230734|NCT01358734|593214089|FG002|Overall Study|Lack of Efficacy|3|||
164230735|NCT01358734|593214087|FG000|Overall Study|Withdrawal by Subject|1|||
164230736|NCT01358734|593214088|FG001|Overall Study|Withdrawal by Subject|6|||
164230737|NCT01358734|593214089|FG002|Overall Study|Withdrawal by Subject|3|||
164230738|NCT01358734|593214087|FG000|Overall Study|Death|3|||
164230739|NCT01358734|593214088|FG001|Overall Study|Death|7|||
164230740|NCT01358734|593214089|FG002|Overall Study|Death|2|||
164230741|NCT01358734|593214087|FG000|Overall Study|Progressive Disease|5|||
164230742|NCT01358734|593214088|FG001|Overall Study|Progressive Disease|13|||
164230743|NCT01358734|593214089|FG002|Overall Study|Progressive Disease|16|||
164230744|NCT01358734|593214087|FG000|Overall Study|Non-compliance with study drug|0|||
164230745|NCT01358734|593214088|FG001|Overall Study|Non-compliance with study drug|0|||
164230746|NCT01358734|593214089|FG002|Overall Study|Non-compliance with study drug|1|||
164230747|NCT01358734|593214087|FG000|Overall Study|Other|2|||
164230748|NCT01358734|593214088|FG001|Overall Study|Other|5|||
164230749|NCT01358734|593214089|FG002|Overall Study|Other|4|||
164572043|NCT03895203|594460318|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
164230750|NCT01358734|593214087|FG000|Overall Study|Protocol Violation|0|||
164230751|NCT01358734|593214088|FG001|Overall Study|Protocol Violation|0|||
164230752|NCT01358734|593214089|FG002|Overall Study|Protocol Violation|2|||
164230753|NCT03427619|593214092|FG000|Overall Study|Physician Decision|3|||
164230754|NCT03427619|593214092|FG000|Overall Study|Withdrawal by Subject|4|||
164230755|NCT03427619|593214092|FG000|Overall Study|Lost to Follow-up|5|||
164230756|NCT03427619|593214092|FG000|Overall Study|Administrative|4|||
164230757|NCT03427619|593214092|FG000|Overall Study|Other|2|||
164230758|NCT03427619|593214092|FG000|Overall Study|Unknown or Missing Completion Status|48|||
164230759|NCT02743962|593214099|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
164230760|NCT02743962|593214100|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
164230761|NCT01055028|593214106|FG000|Screening|Screen Failure|1|||
164230762|NCT01055028|593214107|FG001|Screening|Screen Failure|1|||
164230763|NCT01055028|593214106|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
164230764|NCT01055028|593214107|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
164230765|NCT01055028|593214106|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
164230766|NCT01055028|593214107|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
164230767|NCT01055028|593214106|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
164332192|NCT03963401|593593181|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
164332193|NCT03963401|593593182|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
164332194|NCT03963401|593593183|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
164332195|NCT03963401|593593184|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
164332196|NCT03963401|593593179|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
164332197|NCT03963401|593593180|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
164332198|NCT03963401|593593181|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
164332199|NCT03963401|593593182|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
164332200|NCT03963401|593593183|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
164332201|NCT03963401|593593184|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
164332202|NCT03963401|593593179|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
164332203|NCT03963401|593593180|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
164332204|NCT03963401|593593181|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
164332205|NCT03963401|593593182|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
164332206|NCT03963401|593593183|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
164332207|NCT03963401|593593184|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
164332208|NCT03963401|593593179|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
164332209|NCT03963401|593593180|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
164332210|NCT03963401|593593181|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
164332211|NCT03963401|593593182|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
164332212|NCT03963401|593593183|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
164332213|NCT03963401|593593184|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
164332214|NCT03963401|593593179|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
164332215|NCT03963401|593593180|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
164332216|NCT03963401|593593181|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
164332217|NCT03963401|593593182|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
164332218|NCT03963401|593593183|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
164332219|NCT03963401|593593184|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
164332220|NCT03963401|593593179|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
164332221|NCT03963401|593593180|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
164332222|NCT03963401|593593181|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
164332223|NCT03963401|593593182|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
164332224|NCT03963401|593593183|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
164332225|NCT03963401|593593184|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
164332226|NCT01916967|593593185|FG000|Overall Study|Adverse Event|0|||
164332227|NCT01916967|593593186|FG001|Overall Study|Adverse Event|0|||
164332228|NCT01916967|593593187|FG002|Overall Study|Adverse Event|2|||
164332229|NCT01916967|593593185|FG000|Overall Study|Lack of Efficacy|0|||
164332230|NCT01916967|593593186|FG001|Overall Study|Lack of Efficacy|0|||
164332231|NCT01916967|593593187|FG002|Overall Study|Lack of Efficacy|6|||
164332232|NCT01916967|593593185|FG000|Overall Study|Physician Decision|0|||
164332233|NCT01916967|593593186|FG001|Overall Study|Physician Decision|0|||
164332234|NCT01916967|593593187|FG002|Overall Study|Physician Decision|1|||
164332235|NCT01916967|593593185|FG000|Overall Study|Protocol Violation|0|||
164332236|NCT01916967|593593186|FG001|Overall Study|Protocol Violation|1|||
164332237|NCT01916967|593593187|FG002|Overall Study|Protocol Violation|0|||
164332238|NCT01070043|593593192|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
164332239|NCT01070043|593593193|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
164332240|NCT01070043|593593194|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
164332241|NCT01070043|593593192|FG000|Double-Blind Treatment|Adverse Event|0|||
164332242|NCT01070043|593593193|FG001|Double-Blind Treatment|Adverse Event|0|||
164332243|NCT01070043|593593194|FG002|Double-Blind Treatment|Adverse Event|2|||
164332244|NCT01610271|593593197|FG000|Overall Study|Surgery not complete|0|||
164332245|NCT01610271|593593198|FG001|Overall Study|Surgery not complete|1|||
164332246|NCT01610271|593593197|FG000|Overall Study|Prosthesis not implanted|2|||
164332247|NCT01610271|593593198|FG001|Overall Study|Prosthesis not implanted|3|||
164332248|NCT02038452|593593199|FG000|Overall Study|Withdrawal by Subject|7|||
164332249|NCT02038452|593593200|FG001|Overall Study|Withdrawal by Subject|9|||
164332250|NCT02038452|593593199|FG000|Overall Study|Lost to Follow-up|31|||
164332251|NCT02038452|593593200|FG001|Overall Study|Lost to Follow-up|28|||
164332252|NCT01369615|593593201|FG000|Overall Study|Withdrawal by Subject|0|||
164572044|NCT03895203|594460319|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
164421890|NCT02601937|593914574|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
164421891|NCT02601937|593914564|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
164332253|NCT01369615|593593202|FG001|Overall Study|Withdrawal by Subject|1|||
164332254|NCT01369615|593593201|FG000|Overall Study|Lost to Follow-up|0|||
164332255|NCT01369615|593593202|FG001|Overall Study|Lost to Follow-up|1|||
164332256|NCT02337738|593593203|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
164230768|NCT01055028|593214107|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
164230769|NCT03528902|593214111|FG000|Overall Study|Adverse Event|1|||
164230770|NCT03528902|593214112|FG001|Overall Study|Adverse Event|0|||
164230771|NCT04620668|593214113|FG000|Overall Study|Withdrawal by Subject|2|||
164230772|NCT04620668|593214114|FG001|Overall Study|Withdrawal by Subject|0|||
164572045|NCT03895203|594460320|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
164572046|NCT03895203|594460321|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
164572047|NCT03895203|594460322|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
164572048|NCT01389245|594460323|FG000|Overall Study|Protocol Violation|10|||
164572049|NCT01389245|594460323|FG000|Overall Study|Lost to Follow-up|3|||
164572050|NCT01389245|594460323|FG000|Overall Study|Withdrawal by Subject|2|||
164572051|NCT05540652|594460324|FG000|Overall Study|Withdrawal by Subject|1|||
164572052|NCT04454489|594460327|FG000|Overall Study|Disease progression|12|||
164572053|NCT04454489|594460327|FG000|Overall Study|Death|4|||
164572054|NCT04454489|594460327|FG000|Overall Study|Adverse Event|1|||
164572055|NCT04454489|594460327|FG000|Overall Study|Physician Decision|1|||
164572056|NCT00755079|594460332|FG000|Overall Study|Lost to Follow-up|1|||
164572057|NCT00755079|594460333|FG001|Overall Study|Lost to Follow-up|3|||
164572058|NCT00755079|594460332|FG000|Overall Study|Adverse Event|0|||
164572059|NCT00755079|594460333|FG001|Overall Study|Adverse Event|1|||
164572060|NCT00755079|594460332|FG000|Overall Study|Withdrawal by Subject|0|||
164421892|NCT02601937|593914565|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
164572061|NCT00755079|594460333|FG001|Overall Study|Withdrawal by Subject|2|||
164230773|NCT04620668|593214113|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
164230774|NCT04620668|593214114|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
164230775|NCT04620668|593214113|FG000|Overall Study|Removed before analysis: missing data|2|||
164230776|NCT04620668|593214114|FG001|Overall Study|Removed before analysis: missing data|0|||
164230777|NCT04620668|593214113|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
164230778|NCT04620668|593214114|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
164230779|NCT04620668|593214113|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
164230780|NCT04620668|593214114|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
164230781|NCT00427700|593214121|FG000|Overall Study|Lost to Follow-up|2|||
164230782|NCT00427700|593214122|FG001|Overall Study|Lost to Follow-up|5|||
164230783|NCT00427700|593214121|FG000|Overall Study|no induction of menses|1|||
164230784|NCT00427700|593214122|FG001|Overall Study|no induction of menses|4|||
164230785|NCT00427700|593214121|FG000|Overall Study|Pregnancy|0|||
164230786|NCT00427700|593214122|FG001|Overall Study|Pregnancy|2|||
164230787|NCT04581395|593214123|FG000|Overall Study|Protocol Violation|4|||
164230788|NCT04581395|593214124|FG001|Overall Study|Protocol Violation|3|||
164230789|NCT04581395|593214125|FG002|Overall Study|Protocol Violation|2|||
164230790|NCT04581395|593214123|FG000|Overall Study|Physician Decision|0|||
164230791|NCT04581395|593214124|FG001|Overall Study|Physician Decision|1|||
164230792|NCT04581395|593214125|FG002|Overall Study|Physician Decision|0|||
164230793|NCT03709472|593214132|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
164230794|NCT03709472|593214133|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
164230795|NCT03709472|593214132|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
164230796|NCT03709472|593214133|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
164230797|NCT00112385|593214136|FG000|Overall Study|Lost to Follow-up|1|||
164230798|NCT00112385|593214137|FG001|Overall Study|Lost to Follow-up|0|||
164230799|NCT00112385|593214136|FG000|Overall Study|Withdrawal by Subject|0|||
164230800|NCT00112385|593214137|FG001|Overall Study|Withdrawal by Subject|1|||
164230801|NCT00959049|593215634|FG000|Overall Study|Adverse Event|1|||
164230802|NCT00959049|593215635|FG001|Overall Study|Adverse Event|0|||
164230803|NCT00959049|593215636|FG002|Overall Study|Adverse Event|0|||
164230804|NCT00959049|593215637|FG003|Overall Study|Adverse Event|0|||
164230805|NCT00959049|593215638|FG004|Overall Study|Adverse Event|0|||
164230806|NCT00959049|593215639|FG005|Overall Study|Adverse Event|0|||
164230807|NCT00959049|593215634|FG000|Overall Study|Lost to Follow-up|17|||
164230808|NCT00959049|593215635|FG001|Overall Study|Lost to Follow-up|5|||
164230809|NCT00959049|593215636|FG002|Overall Study|Lost to Follow-up|1|||
164230810|NCT00959049|593215637|FG003|Overall Study|Lost to Follow-up|10|||
164230811|NCT00959049|593215638|FG004|Overall Study|Lost to Follow-up|9|||
164230812|NCT00959049|593215639|FG005|Overall Study|Lost to Follow-up|1|||
164230813|NCT00959049|593215634|FG000|Overall Study|Contraindicated medication|0|||
164230814|NCT00959049|593215635|FG001|Overall Study|Contraindicated medication|0|||
164572062|NCT01276288|594460334|FG000|Overall Study|Adverse Event|1|||
164572063|NCT01276288|594460335|FG001|Overall Study|Adverse Event|1|||
164572064|NCT01276288|594460336|FG002|Overall Study|Adverse Event|0|||
164572065|NCT01276288|594460337|FG003|Overall Study|Adverse Event|0|||
164572066|NCT01276288|594460334|FG000|Overall Study|not treated|1|||
164572067|NCT01276288|594460335|FG001|Overall Study|not treated|0|||
164230815|NCT00959049|593215636|FG002|Overall Study|Contraindicated medication|0|||
164230816|NCT00959049|593215637|FG003|Overall Study|Contraindicated medication|1|||
164230817|NCT00959049|593215638|FG004|Overall Study|Contraindicated medication|0|||
164230818|NCT00959049|593215639|FG005|Overall Study|Contraindicated medication|0|||
164332257|NCT02337738|593593204|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
164332258|NCT02337738|593593205|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
164332259|NCT02337738|593593203|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
164332260|NCT02337738|593593204|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
164332261|NCT02337738|593593205|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
164332262|NCT02337738|593593203|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
164332263|NCT02337738|593593204|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
164332264|NCT02337738|593593205|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
164332265|NCT02337738|593593203|FG000|Overall Study|Voluntary Withdrawal|10|||
164332266|NCT02337738|593593204|FG001|Overall Study|Voluntary Withdrawal|5|||
164332267|NCT02337738|593593205|FG002|Overall Study|Voluntary Withdrawal|2|||
164332268|NCT02337738|593593203|FG000|Overall Study|Lack of Efficacy|2|||
164332269|NCT02337738|593593204|FG001|Overall Study|Lack of Efficacy|4|||
164332270|NCT02337738|593593205|FG002|Overall Study|Lack of Efficacy|0|||
164332271|NCT02337738|593593203|FG000|Overall Study|Investigator's Judgment|1|||
164332272|NCT02337738|593593204|FG001|Overall Study|Investigator's Judgment|1|||
164332273|NCT02337738|593593205|FG002|Overall Study|Investigator's Judgment|3|||
164332274|NCT00986479|593593206|FG000|Period 1|Improved mood|1|||
164332275|NCT00986479|593593207|FG001|Period 1|Improved mood|0|||
164332276|NCT00986479|593593206|FG000|Period 1|Administrative reasons|1|||
164332277|NCT00986479|593593207|FG001|Period 1|Administrative reasons|0|||
164332278|NCT01721070|593593208|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
164332279|NCT02035475|593593209|FG000|Overall Study|Withdrawal by Subject|4|||
164332280|NCT02035475|593593209|FG000|Overall Study|Physician Decision|1|||
164332281|NCT02035475|593593209|FG000|Overall Study|Equipment Error|1|||
164332282|NCT01626495|593593217|FG000|Overall Study|Adverse Event|3|||
164332283|NCT01626495|593593217|FG000|Overall Study|Disease progression|27|||
164332284|NCT01626495|593593217|FG000|Overall Study|Withdrawal by Subject|1|||
164332285|NCT01626495|593593217|FG000|Overall Study|Administrative problem|1|||
164332286|NCT01626495|593593217|FG000|Overall Study|Death|2|||
164332287|NCT01626495|593593217|FG000|Overall Study|Physician Decision|1|||
164332288|NCT01626495|593593217|FG000|Overall Study|New cancer therapy|16|||
164332289|NCT01626495|593593217|FG000|Overall Study|Manufacturing failure|1|||
164332290|NCT00445978|593593218|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
164332291|NCT00445978|593593218|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
164332292|NCT00445978|593593218|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
164332293|NCT00445978|593593218|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
164332294|NCT00445978|593593218|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
164332295|NCT00445978|593593218|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
164332296|NCT00445978|593593218|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
164332297|NCT00445978|593593218|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
164332298|NCT00445978|593593218|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
164332299|NCT00304239|593593219|FG000|Overall Study|Protocol Deviations/Violations|15|||
164332300|NCT00304239|593593220|FG001|Overall Study|Protocol Deviations/Violations|0|||
164332301|NCT00304239|593593219|FG000|Overall Study|Adverse Event|2|||
164332302|NCT00304239|593593220|FG001|Overall Study|Adverse Event|0|||
164332303|NCT02979197|593593221|FG000|Overall Study|Adverse Event|4|||
164332304|NCT02979197|593593222|FG001|Overall Study|Adverse Event|2|||
164332305|NCT02979197|593593223|FG002|Overall Study|Adverse Event|0|||
164332306|NCT02979197|593593221|FG000|Overall Study|Protocol Violation|0|||
164332307|NCT02979197|593593222|FG001|Overall Study|Protocol Violation|1|||
164332308|NCT02979197|593593223|FG002|Overall Study|Protocol Violation|0|||
164332309|NCT02979197|593593221|FG000|Overall Study|Subject unable to commit to study dates|0|||
164332310|NCT02979197|593593222|FG001|Overall Study|Subject unable to commit to study dates|1|||
164332311|NCT02979197|593593223|FG002|Overall Study|Subject unable to commit to study dates|0|||
164332312|NCT02949700|593593224|FG000|Phase I|Withdrawal by Subject|1|||
164332313|NCT02949700|593593225|FG001|Phase I|Withdrawal by Subject|1|||
164332314|NCT02949700|593593226|FG002|Phase I|Withdrawal by Subject|0|||
164332315|NCT02949700|593593227|FG003|Phase I|Withdrawal by Subject|0|||
164332316|NCT02949700|593593224|FG000|Phase I|Protocol Violation|1|||
164332317|NCT02949700|593593225|FG001|Phase I|Protocol Violation|0|||
164572068|NCT01276288|594460336|FG002|Overall Study|not treated|0|||
164572069|NCT01276288|594460337|FG003|Overall Study|not treated|0|||
164572070|NCT00629083|594460342|FG000|Overall Study|Adverse Event|0|||
164572071|NCT00629083|594460343|FG001|Overall Study|Adverse Event|2|||
164332318|NCT02949700|593593226|FG002|Phase I|Protocol Violation|0|||
164572072|NCT00629083|594460342|FG000|Overall Study|Lack of Efficacy|3|||
164572073|NCT00629083|594460343|FG001|Overall Study|Lack of Efficacy|1|||
164572074|NCT00629083|594460342|FG000|Overall Study|Withdrawal by Subject|10|||
164572075|NCT00629083|594460343|FG001|Overall Study|Withdrawal by Subject|2|||
164675558|NCT00561015|594836758|FG005|Overall Study|Adverse Event|0|||
164675559|NCT00561015|594836753|FG000|Overall Study|Lost to Follow-up|2|||
164332319|NCT02949700|593593227|FG003|Phase I|Protocol Violation|0|||
164675560|NCT00561015|594836754|FG001|Overall Study|Lost to Follow-up|0|||
164572076|NCT00629083|594460342|FG000|Overall Study|Lost to Follow-up|12|||
164572077|NCT00629083|594460343|FG001|Overall Study|Lost to Follow-up|8|||
164421893|NCT02601937|593914566|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
164421894|NCT02601937|593914567|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
164421895|NCT02601937|593914568|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
164421896|NCT02601937|593914569|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
164421897|NCT02601937|593914570|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
164421898|NCT02601937|593914571|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
164421899|NCT02601937|593914572|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
164421900|NCT02601937|593914573|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
164421901|NCT02601937|593914574|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
164421902|NCT02601937|593914564|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
164421903|NCT02601937|593914565|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
164421904|NCT02601937|593914566|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
164421905|NCT02601937|593914567|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
164421906|NCT02601937|593914568|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
164421907|NCT02601937|593914569|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
164572078|NCT00629083|594460342|FG000|Overall Study|Moved out of country/state|2|||
164230819|NCT00959049|593215634|FG000|Overall Study|Withdrawal by Subject|0|||
164230820|NCT00959049|593215635|FG001|Overall Study|Withdrawal by Subject|2|||
164230821|NCT00959049|593215636|FG002|Overall Study|Withdrawal by Subject|0|||
164230822|NCT00959049|593215637|FG003|Overall Study|Withdrawal by Subject|0|||
164230823|NCT00959049|593215638|FG004|Overall Study|Withdrawal by Subject|0|||
164230824|NCT00959049|593215639|FG005|Overall Study|Withdrawal by Subject|0|||
164230825|NCT00565747|593215640|FG000|Overall Study|No embryo transfer|67|||
164230826|NCT00565747|593215641|FG001|Overall Study|No embryo transfer|73|||
164230827|NCT04507204|593215642|FG000|Overall Study|Adverse Event|8|||
164230828|NCT04507204|593215643|FG001|Overall Study|Adverse Event|13|||
164230829|NCT04507204|593215642|FG000|Overall Study|Death|0|||
164230830|NCT04507204|593215643|FG001|Overall Study|Death|1|||
164230831|NCT04507204|593215642|FG000|Overall Study|Lost to Follow-up|15|||
164230832|NCT04507204|593215643|FG001|Overall Study|Lost to Follow-up|14|||
164230833|NCT04507204|593215642|FG000|Overall Study|Poor Compliance with Protocol|2|||
164230834|NCT04507204|593215643|FG001|Overall Study|Poor Compliance with Protocol|4|||
164230835|NCT04507204|593215642|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
164230836|NCT04507204|593215643|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
164230837|NCT04507204|593215642|FG000|Overall Study|Withdrawal of Patient Consent|21|||
164230838|NCT04507204|593215643|FG001|Overall Study|Withdrawal of Patient Consent|13|||
164230839|NCT01905540|593215646|FG000|Period 3|Other|1|||
164230840|NCT01905540|593215647|FG001|Period 3|Other|0|||
164230841|NCT01905540|593215648|FG002|Period 3|Other|1|||
164230842|NCT01905540|593215649|FG003|Period 3|Other|1|||
164230843|NCT03729609|593215650|FG000|Overall Study|Protocol Violation|1|||
164230844|NCT02919618|593215653|FG000|Overall Study|Death|1|||
164230845|NCT04770285|593215654|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
164230846|NCT04770285|593215655|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
164230847|NCT04770285|593215654|FG000|Overall Study|Lack of Efficacy|0|||
164230848|NCT04770285|593215655|FG001|Overall Study|Lack of Efficacy|1|||
164230849|NCT04770285|593215654|FG000|Overall Study|Lost to Follow-up|11|||
164230850|NCT04770285|593215655|FG001|Overall Study|Lost to Follow-up|8|||
164230851|NCT04770285|593215654|FG000|Overall Study|Protocol Deviation|6|||
164230852|NCT04770285|593215655|FG001|Overall Study|Protocol Deviation|6|||
164230853|NCT04770285|593215654|FG000|Overall Study|Technical Problem|0|||
164230854|NCT04770285|593215655|FG001|Overall Study|Technical Problem|1|||
164230855|NCT04770285|593215654|FG000|Overall Study|Withdrawal by Subject|9|||
164230856|NCT04770285|593215655|FG001|Overall Study|Withdrawal by Subject|8|||
164230857|NCT04770285|593215654|FG000|Overall Study|Reason Not Specified|0|||
164230858|NCT04770285|593215655|FG001|Overall Study|Reason Not Specified|1|||
164230859|NCT03411044|593215656|FG000|Overall Study|Death|30|||
164230860|NCT03411044|593215656|FG000|Overall Study|Withdrawal by Subject|48|||
164230861|NCT03411044|593215656|FG000|Overall Study|Lost to Follow-up|78|||
164230862|NCT03411044|593215656|FG000|Overall Study|Adverse Event|30|||
164230863|NCT03411044|593215656|FG000|Overall Study|Missing status|4|||
164230864|NCT00645658|593215657|FG000|Overall Study|Withdrawal by Subject|1|||
164230865|NCT00645658|593215658|FG001|Overall Study|Withdrawal by Subject|0|||
164230866|NCT00645658|593215657|FG000|Overall Study|Did not complete all assesments|0|||
164230867|NCT00645658|593215658|FG001|Overall Study|Did not complete all assesments|2|||
164230868|NCT00815633|593215669|FG000|Overall Study|study terminated|1|||
164230869|NCT02457065|593215670|FG000|Overall Study|Lost to Follow-up|9|||
164230870|NCT02457065|593215671|FG001|Overall Study|Lost to Follow-up|11|||
164230871|NCT01362790|593215672|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
164230872|NCT01362790|593215673|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
164230873|NCT01362790|593215674|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
164230874|NCT01362790|593215675|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
164332320|NCT02949700|593593224|FG000|Phase II|Withdrawal by Subject|0|||
164332321|NCT02949700|593593225|FG001|Phase II|Withdrawal by Subject|0|||
164332322|NCT02949700|593593226|FG002|Phase II|Withdrawal by Subject|0|||
164332323|NCT02949700|593593227|FG003|Phase II|Withdrawal by Subject|2|||
164332324|NCT02949700|593593224|FG000|Phase II|Protocol Violation|0|||
164332325|NCT02949700|593593225|FG001|Phase II|Protocol Violation|0|||
164332326|NCT02949700|593593226|FG002|Phase II|Protocol Violation|1|||
164332327|NCT02949700|593593227|FG003|Phase II|Protocol Violation|3|||
164332328|NCT05430022|593593238|FG000|Overall Study|Withdrawal by Subject|4|||
164332329|NCT05430022|593593239|FG001|Overall Study|Withdrawal by Subject|4|||
164332330|NCT05521906|593593240|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
164332331|NCT05521906|593593241|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
164332332|NCT01828320|593593242|FG000|Overall Study|Lost to Follow-up|1|||
164332333|NCT01828320|593593243|FG001|Overall Study|Lost to Follow-up|3|||
164332334|NCT01828320|593593242|FG000|Overall Study|Withdrawal by Subject|7|||
164332335|NCT01828320|593593243|FG001|Overall Study|Withdrawal by Subject|2|||
164355621|NCT00512707|593676482|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
164355622|NCT00512707|593676483|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
164355623|NCT00512707|593676482|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
164355624|NCT00512707|593676483|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
164355625|NCT03720470|593678625|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
164355626|NCT03720470|593678626|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
164355627|NCT03720470|593678627|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
164355628|NCT03720470|593678628|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
164355629|NCT03720470|593678629|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
164355630|NCT03720470|593678630|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
164355631|NCT03720470|593678625|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
164355632|NCT03720470|593678626|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
164355633|NCT03720470|593678627|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
164355634|NCT03720470|593678628|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
164355635|NCT03720470|593678629|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
164355636|NCT03720470|593678630|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
164355637|NCT03720470|593678625|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
164355638|NCT03720470|593678626|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
164355639|NCT03720470|593678627|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
164355640|NCT03720470|593678628|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
164355641|NCT03720470|593678629|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
164355642|NCT03720470|593678630|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
164355643|NCT03720470|593678625|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
164355644|NCT03720470|593678626|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
164355645|NCT03720470|593678627|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
164355646|NCT03720470|593678628|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
164355647|NCT03720470|593678629|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
164355648|NCT03720470|593678630|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
164355649|NCT03720470|593678625|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
164355650|NCT03720470|593678626|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
164355651|NCT03720470|593678627|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
164355652|NCT03720470|593678628|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
164355653|NCT03720470|593678629|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
164355654|NCT03720470|593678630|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
164355655|NCT03720470|593678625|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
164355656|NCT03720470|593678626|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
164355657|NCT03720470|593678627|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
164355658|NCT03720470|593678628|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
164355659|NCT03720470|593678629|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
164355660|NCT03720470|593678630|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
164355661|NCT03720470|593678625|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
164355662|NCT03720470|593678626|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
164355663|NCT03720470|593678627|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
164355664|NCT03720470|593678628|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
164355665|NCT03720470|593678629|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
164355666|NCT03720470|593678630|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
164421908|NCT02601937|593914570|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
164355667|NCT03720470|593678625|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
164355668|NCT03720470|593678626|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
164355669|NCT03720470|593678627|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
164230875|NCT01362790|593215676|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
164230876|NCT01362790|593215677|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
164230877|NCT01362790|593215678|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
164230878|NCT01362790|593215672|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
164230879|NCT01362790|593215673|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
164230880|NCT01362790|593215674|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
164230881|NCT01362790|593215675|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
164230882|NCT01362790|593215676|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
164230883|NCT01362790|593215677|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
164230884|NCT01362790|593215678|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
164230885|NCT01362790|593215672|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
164230886|NCT01362790|593215673|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
164230887|NCT01362790|593215674|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
164230888|NCT01362790|593215675|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
164230889|NCT01362790|593215676|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
164230890|NCT01362790|593215677|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
164230891|NCT01362790|593215678|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
164230892|NCT01362790|593215672|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
164230893|NCT01362790|593215673|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
164230894|NCT01362790|593215674|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
164230895|NCT01362790|593215675|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
164230896|NCT01362790|593215676|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
164230897|NCT01362790|593215677|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
164230898|NCT01362790|593215678|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
164230899|NCT01362790|593215672|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
164230900|NCT01362790|593215673|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
164230901|NCT01362790|593215674|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
164230902|NCT01362790|593215675|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
164230903|NCT01362790|593215676|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
164230904|NCT01362790|593215677|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
164230905|NCT01362790|593215678|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
164230906|NCT01362790|593215672|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
164230907|NCT01362790|593215673|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
164230908|NCT01362790|593215674|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
164230909|NCT01362790|593215675|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
164230910|NCT01362790|593215676|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
164230911|NCT01362790|593215677|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
164230912|NCT01362790|593215678|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
164230913|NCT01362790|593215672|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
164230914|NCT01362790|593215673|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
164230915|NCT01362790|593215674|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
164230916|NCT01362790|593215675|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
164230917|NCT01362790|593215676|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
164230918|NCT01362790|593215677|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
164230919|NCT01362790|593215678|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
164230920|NCT01362790|593215672|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
164230921|NCT01362790|593215673|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
164230922|NCT01362790|593215674|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
164421909|NCT02601937|593914571|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
164421910|NCT02601937|593914572|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
164421911|NCT02601937|593914573|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
164421912|NCT02601937|593914574|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
164421913|NCT02601937|593914564|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
164421914|NCT02601937|593914565|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
164421915|NCT02601937|593914566|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
164421916|NCT02601937|593914567|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
164421917|NCT02601937|593914568|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
164421918|NCT02601937|593914569|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
164230923|NCT01362790|593215675|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
164230924|NCT01362790|593215676|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
164230925|NCT01362790|593215677|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
164230926|NCT01362790|593215678|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
164230927|NCT01362790|593215672|FG000|Pilot Phase & Phase 2|Death on study|0|||
164230928|NCT01362790|593215673|FG001|Pilot Phase & Phase 2|Death on study|0|||
164230929|NCT01362790|593215674|FG002|Pilot Phase & Phase 2|Death on study|0|||
164230930|NCT01362790|593215675|FG003|Pilot Phase & Phase 2|Death on study|1|||
164230931|NCT01362790|593215676|FG004|Pilot Phase & Phase 2|Death on study|0|||
164230932|NCT01362790|593215677|FG005|Pilot Phase & Phase 2|Death on study|0|||
164230933|NCT01362790|593215678|FG006|Pilot Phase & Phase 2|Death on study|0|||
164230934|NCT01362790|593215672|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
164230935|NCT01362790|593215673|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
164230936|NCT01362790|593215674|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
164230937|NCT01362790|593215675|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
164230938|NCT01362790|593215676|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
164230939|NCT01362790|593215677|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
164230940|NCT01362790|593215678|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
164230941|NCT01362790|593215672|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
164230942|NCT01362790|593215673|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
164230943|NCT01362790|593215674|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
164230944|NCT01362790|593215675|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
164230945|NCT01362790|593215676|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
164230946|NCT01362790|593215677|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
164230947|NCT01362790|593215678|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
164230948|NCT01362790|593215672|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
164230949|NCT01362790|593215673|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
164230950|NCT01362790|593215674|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
164230951|NCT01362790|593215675|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
164230952|NCT01362790|593215676|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
164230953|NCT01362790|593215677|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
164230954|NCT01362790|593215678|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
164230955|NCT03038087|593215679|FG000|Overall Study|lost data|1|||
164230956|NCT00654355|593215680|FG000|Overall Study|Lost to Follow-up|2|||
164230957|NCT00654355|593215681|FG001|Overall Study|Lost to Follow-up|2|||
164230958|NCT01435356|593215683|FG000|Overall Study|Adverse Event|2|||
164230959|NCT01435356|593215684|FG001|Overall Study|Adverse Event|0|||
164230960|NCT01435356|593215683|FG000|Overall Study|Disease progression/recurrence|17|||
164230961|NCT01435356|593215684|FG001|Overall Study|Disease progression/recurrence|10|||
164230962|NCT01435356|593215683|FG000|Overall Study|Protocol Violation|0|||
164230963|NCT01435356|593215684|FG001|Overall Study|Protocol Violation|1|||
164230964|NCT01435356|593215683|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
164230965|NCT01435356|593215684|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
164230966|NCT01435356|593215683|FG000|Overall Study|Withdrawal by Subject|1|||
164421919|NCT02601937|593914570|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
164230967|NCT01435356|593215684|FG001|Overall Study|Withdrawal by Subject|1|||
164230968|NCT01435356|593215683|FG000|Overall Study|Facial palsy|1|||
164230969|NCT01435356|593215684|FG001|Overall Study|Facial palsy|0|||
164230970|NCT01435356|593215683|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
164230971|NCT01435356|593215684|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
164230972|NCT01435356|593215683|FG000|Overall Study|Physician Decision|1|||
164230973|NCT01435356|593215684|FG001|Overall Study|Physician Decision|0|||
164230974|NCT01435356|593215683|FG000|Overall Study|Patient decision|3|||
164421920|NCT02601937|593914571|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
164421921|NCT02601937|593914572|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
164421922|NCT02601937|593914573|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
164421923|NCT02601937|593914574|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
164675561|NCT00561015|594836755|FG002|Overall Study|Lost to Follow-up|0|||
164230975|NCT01435356|593215684|FG001|Overall Study|Patient decision|0|||
164230976|NCT01435356|593215683|FG000|Overall Study|Patient moved to another city|1|||
164230977|NCT01435356|593215684|FG001|Overall Study|Patient moved to another city|1|||
164230978|NCT02796651|593215685|FG000|Overall Study|Adverse Event|6|||
164230979|NCT02796651|593215685|FG000|Overall Study|Lost to Follow-up|1|||
164230980|NCT02796651|593215685|FG000|Overall Study|Withdrawal by Subject|4|||
164230981|NCT02796651|593215685|FG000|Overall Study|Protocol Violation|4|||
164230982|NCT02796651|593215685|FG000|Overall Study|Lack of Efficacy|1|||
164230983|NCT02796651|593215685|FG000|Overall Study|Other|10|||
164230984|NCT00437073|593215686|FG000|Overall Study|Sponsor Terminated Study|1|||
164230985|NCT00437073|593215687|FG001|Overall Study|Sponsor Terminated Study|0|||
164230986|NCT00437073|593215686|FG000|Overall Study|Physician Decision|0|||
164230987|NCT00437073|593215687|FG001|Overall Study|Physician Decision|1|||
164230988|NCT03485157|593215688|FG000|Double Blind Phase|Lost to Follow-up|4|||
164230989|NCT03485157|593215689|FG001|Double Blind Phase|Lost to Follow-up|4|||
164230990|NCT03485157|593215688|FG000|Double Blind Phase|Adverse Event|2|||
164230991|NCT03485157|593215689|FG001|Double Blind Phase|Adverse Event|1|||
164230992|NCT03485157|593215688|FG000|Double Blind Phase|Withdrawal by Subject|6|||
164230993|NCT03485157|593215689|FG001|Double Blind Phase|Withdrawal by Subject|9|||
164332336|NCT00866788|593595546|FG000|Overall Study|Adverse Event|0|||
164332337|NCT00866788|593595547|FG001|Overall Study|Adverse Event|2|||
164332338|NCT00866788|593595548|FG002|Overall Study|Adverse Event|0|||
164332339|NCT00866788|593595549|FG003|Overall Study|Adverse Event|1|||
164332340|NCT00866788|593595546|FG000|Overall Study|Lost to Follow-up|1|||
164332341|NCT00866788|593595547|FG001|Overall Study|Lost to Follow-up|1|||
164332342|NCT00866788|593595548|FG002|Overall Study|Lost to Follow-up|0|||
164332343|NCT00866788|593595549|FG003|Overall Study|Lost to Follow-up|2|||
164332344|NCT00866788|593595546|FG000|Overall Study|Withdrawal by Subject|2|||
164230994|NCT03485157|593215688|FG000|Double Blind Phase|Removal by PI|3|||
164230995|NCT03485157|593215689|FG001|Double Blind Phase|Removal by PI|7|||
164230996|NCT03485157|593215688|FG000|Open Label Phase|Lost to Follow-up|1|||
164230997|NCT03485157|593215689|FG001|Open Label Phase|Lost to Follow-up|2|||
164230998|NCT03485157|593215688|FG000|Open Label Phase|Adverse Event|0|||
164230999|NCT03485157|593215689|FG001|Open Label Phase|Adverse Event|1|||
164231000|NCT03485157|593215688|FG000|Open Label Phase|Withdrawal by Subject|1|||
164231001|NCT03485157|593215689|FG001|Open Label Phase|Withdrawal by Subject|2|||
164231002|NCT03485157|593215688|FG000|Open Label Phase|Removal by PI|2|||
164231003|NCT03485157|593215689|FG001|Open Label Phase|Removal by PI|0|||
164231004|NCT04918771|593215693|FG000|Overall Study|Withdrawal by Subject|4|||
164231005|NCT04918771|593215694|FG001|Overall Study|Withdrawal by Subject|5|||
164231006|NCT04918771|593215693|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
164231007|NCT04918771|593215694|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
164231008|NCT01849276|593215695|FG000|Followed for Survival for 5 Years|Death|1|||
164231009|NCT01849276|593215695|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
164231010|NCT02657343|593215696|FG000|Overall Study|Death|0|||
164231011|NCT02657343|593215697|FG001|Overall Study|Death|2|||
164231012|NCT02657343|593215698|FG002|Overall Study|Death|0|||
164231013|NCT02657343|593215699|FG003|Overall Study|Death|0|||
164231014|NCT02657343|593215700|FG004|Overall Study|Death|0|||
164231015|NCT02657343|593215701|FG005|Overall Study|Death|0|||
164231016|NCT02657343|593215696|FG000|Overall Study|Patient went to hospice|1|||
164231017|NCT02657343|593215697|FG001|Overall Study|Patient went to hospice|0|||
164231018|NCT02657343|593215698|FG002|Overall Study|Patient went to hospice|0|||
164231019|NCT02657343|593215699|FG003|Overall Study|Patient went to hospice|0|||
164231020|NCT02657343|593215700|FG004|Overall Study|Patient went to hospice|0|||
164231021|NCT02657343|593215701|FG005|Overall Study|Patient went to hospice|0|||
164231022|NCT02657343|593215696|FG000|Overall Study|Withdrawal by Subject|0|||
164231023|NCT02657343|593215697|FG001|Overall Study|Withdrawal by Subject|0|||
164231024|NCT02657343|593215698|FG002|Overall Study|Withdrawal by Subject|0|||
164231025|NCT02657343|593215699|FG003|Overall Study|Withdrawal by Subject|0|||
164231026|NCT02657343|593215700|FG004|Overall Study|Withdrawal by Subject|1|||
164231027|NCT02657343|593215701|FG005|Overall Study|Withdrawal by Subject|0|||
164231028|NCT01813357|593215709|FG000|Overall Study|Lost to Follow-up|5|||
164231029|NCT01813357|593215710|FG001|Overall Study|Lost to Follow-up|6|||
164231030|NCT02607722|593215717|FG000|Overall Study|No data reliability|1|||
164231031|NCT02607722|593215717|FG000|Overall Study|no patient visit|18|||
164231032|NCT02607722|593215717|FG000|Overall Study|missing info in CRF|13|||
164231033|NCT02607722|593215717|FG000|Overall Study|Withdrawal by Subject|616|||
164231034|NCT02607722|593215717|FG000|Overall Study|Lost to Follow-up|312|||
164231035|NCT02607722|593215717|FG000|Overall Study|Improved|22|||
164231036|NCT02607722|593215717|FG000|Overall Study|Lack of Efficacy|316|||
164231037|NCT02607722|593215717|FG000|Overall Study|Adverse Event|2553|||
164231038|NCT02607722|593215717|FG000|Overall Study|Not treated|1|||
164231039|NCT02607722|593215717|FG000|Overall Study|No CRF collected|138|||
164231040|NCT02607722|593215717|FG000|Overall Study|without CRF|4225|||
164231041|NCT02607722|593215717|FG000|Overall Study|Physician Decision|367|||
164231042|NCT04347538|593215718|FG000|Overall Study|Lost to Follow-up|4|||
164231043|NCT04347538|593215719|FG001|Overall Study|Lost to Follow-up|5|||
164231044|NCT04347538|593215720|FG002|Overall Study|Lost to Follow-up|7|||
164231045|NCT02259231|593215721|FG000|Overall Study|Adverse Event|1|||
164421924|NCT02601937|593914564|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
164231046|NCT02259231|593215722|FG001|Overall Study|Adverse Event|1|||
164231047|NCT02259231|593215723|FG002|Overall Study|Adverse Event|2|||
164231048|NCT02259231|593215724|FG003|Overall Study|Adverse Event|0|||
164231049|NCT02259231|593215725|FG004|Overall Study|Adverse Event|0|||
164231050|NCT02259231|593215726|FG005|Overall Study|Adverse Event|0|||
164231051|NCT02259231|593215727|FG006|Overall Study|Adverse Event|0|||
164231052|NCT02259231|593215721|FG000|Overall Study|Progressive Disease|4|||
164231053|NCT02259231|593215722|FG001|Overall Study|Progressive Disease|5|||
164231054|NCT02259231|593215723|FG002|Overall Study|Progressive Disease|4|||
164231055|NCT02259231|593215724|FG003|Overall Study|Progressive Disease|5|||
164231056|NCT02259231|593215725|FG004|Overall Study|Progressive Disease|4|||
164231057|NCT02259231|593215726|FG005|Overall Study|Progressive Disease|5|||
164231058|NCT02259231|593215727|FG006|Overall Study|Progressive Disease|4|||
164231059|NCT02259231|593215721|FG000|Overall Study|Sponsor termination of study|1|||
164231060|NCT02259231|593215722|FG001|Overall Study|Sponsor termination of study|0|||
164231061|NCT02259231|593215723|FG002|Overall Study|Sponsor termination of study|0|||
164231062|NCT02259231|593215724|FG003|Overall Study|Sponsor termination of study|1|||
164231063|NCT02259231|593215725|FG004|Overall Study|Sponsor termination of study|2|||
164231064|NCT02259231|593215726|FG005|Overall Study|Sponsor termination of study|1|||
164231065|NCT02259231|593215727|FG006|Overall Study|Sponsor termination of study|1|||
164231066|NCT02871219|593215728|FG000|Overall Study|Adverse Event|15|||
164231067|NCT02871219|593215728|FG000|Overall Study|Death|3|||
164231068|NCT02871219|593215728|FG000|Overall Study|Progression|3|||
164231069|NCT02871219|593215728|FG000|Overall Study|Infections|7|||
164231070|NCT02871219|593215728|FG000|Overall Study|Infusion Related|4|||
164231071|NCT03238196|593215729|FG000|Overall Study|Adverse Event|3|||
164231072|NCT03238196|593215730|FG001|Overall Study|Adverse Event|0|||
164231073|NCT03238196|593215731|FG002|Overall Study|Adverse Event|2|||
164231074|NCT03238196|593215732|FG003|Overall Study|Adverse Event|2|||
164231075|NCT03238196|593215729|FG000|Overall Study|Withdrawal by Subject|4|||
164231076|NCT03238196|593215730|FG001|Overall Study|Withdrawal by Subject|1|||
164231077|NCT03238196|593215731|FG002|Overall Study|Withdrawal by Subject|1|||
164231078|NCT03238196|593215732|FG003|Overall Study|Withdrawal by Subject|0|||
164231079|NCT03238196|593215729|FG000|Overall Study|Disease progression|14|||
164231080|NCT03238196|593215730|FG001|Overall Study|Disease progression|2|||
164231081|NCT03238196|593215731|FG002|Overall Study|Disease progression|3|||
164231082|NCT03238196|593215732|FG003|Overall Study|Disease progression|2|||
164231083|NCT03238196|593215729|FG000|Overall Study|Still on treatment|1|||
164231084|NCT03238196|593215730|FG001|Overall Study|Still on treatment|0|||
164231085|NCT03238196|593215731|FG002|Overall Study|Still on treatment|0|||
164231086|NCT03238196|593215732|FG003|Overall Study|Still on treatment|0|||
164231087|NCT05081843|593215733|FG000|Overall Study|Lost to Follow-up|135|||
164231088|NCT05081843|593215734|FG001|Overall Study|Lost to Follow-up|145|||
164231089|NCT04938427|593215735|FG000|Overall Study|Adverse Event|5|||
164231090|NCT04938427|593215736|FG001|Overall Study|Adverse Event|19|||
164231091|NCT04938427|593215735|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
164231092|NCT04938427|593215736|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164231093|NCT04938427|593215735|FG000|Overall Study|Withdrawal by Subject|1|||
164231094|NCT04938427|593215736|FG001|Overall Study|Withdrawal by Subject|0|||
164231095|NCT04938427|593215735|FG000|Overall Study|Reason Not Specified|2|||
164231096|NCT04938427|593215736|FG001|Overall Study|Reason Not Specified|1|||
164231097|NCT04629196|593215737|FG000|Overall Study|Subject discontinued study drug|1|||
164231098|NCT04629196|593215738|FG001|Overall Study|Subject discontinued study drug|0|||
164231099|NCT04629196|593215737|FG000|Overall Study|Subject study drug dosing increased|1|||
164231100|NCT04629196|593215738|FG001|Overall Study|Subject study drug dosing increased|1|||
164231101|NCT04629196|593215737|FG000|Overall Study|Withdrawal by Subject|1|||
164231102|NCT04629196|593215738|FG001|Overall Study|Withdrawal by Subject|2|||
164231103|NCT00835354|593215742|FG000|First Intervention|Adverse Event|0|||
164231104|NCT00835354|593215743|FG001|First Intervention|Adverse Event|1|||
164231105|NCT02061085|593215746|FG000|Overall Study|Adverse Event|8|||
164231106|NCT05487378|593215747|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
164231107|NCT05487378|593215748|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
164231108|NCT05487378|593215747|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
164231109|NCT05487378|593215748|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
164231110|NCT01385995|593215750|FG000|Period 1, 2 Months|Physician Decision|1|||
164231111|NCT01385995|593215751|FG001|Period 1, 2 Months|Physician Decision|0|||
164231112|NCT02414841|593215752|FG000|Overall Study|Withdrawal by Subject|7|||
164231113|NCT02414841|593215753|FG001|Overall Study|Withdrawal by Subject|5|||
164231114|NCT02414841|593215752|FG000|Overall Study|Lost to Follow-up|13|||
164231115|NCT02414841|593215753|FG001|Overall Study|Lost to Follow-up|6|||
164231116|NCT02414841|593215752|FG000|Overall Study|Death|17|||
164231117|NCT02414841|593215753|FG001|Overall Study|Death|14|||
164231118|NCT02414841|593215752|FG000|Overall Study|Received a Kidney Transplant|13|||
164231119|NCT02414841|593215753|FG001|Overall Study|Received a Kidney Transplant|4|||
164231120|NCT02414841|593215752|FG000|Overall Study|Randomized But Not Treated|6|||
164231121|NCT02414841|593215753|FG001|Overall Study|Randomized But Not Treated|4|||
164231122|NCT03164356|593215760|FG000|Overall Study|Lost to Follow-up|1|||
164231123|NCT03164356|593215761|FG001|Overall Study|Lost to Follow-up|1|||
164231124|NCT03164356|593215762|FG002|Overall Study|Lost to Follow-up|2|||
164231125|NCT03164356|593215763|FG003|Overall Study|Lost to Follow-up|1|||
164231126|NCT03164356|593215760|FG000|Overall Study|Physician Decision|0|||
164231127|NCT03164356|593215761|FG001|Overall Study|Physician Decision|0|||
164231128|NCT03164356|593215762|FG002|Overall Study|Physician Decision|3|||
164231129|NCT03164356|593215763|FG003|Overall Study|Physician Decision|0|||
164231130|NCT03164356|593215760|FG000|Overall Study|Protocol Violation|2|||
164231131|NCT03164356|593215761|FG001|Overall Study|Protocol Violation|1|||
164231132|NCT03164356|593215762|FG002|Overall Study|Protocol Violation|0|||
164231133|NCT03164356|593215763|FG003|Overall Study|Protocol Violation|0|||
164231134|NCT03164356|593215760|FG000|Overall Study|Withdrawal by Subject|1|||
164231135|NCT03164356|593215761|FG001|Overall Study|Withdrawal by Subject|0|||
164231136|NCT03164356|593215762|FG002|Overall Study|Withdrawal by Subject|0|||
164231137|NCT03164356|593215763|FG003|Overall Study|Withdrawal by Subject|0|||
164231138|NCT03164356|593215760|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
164231139|NCT03164356|593215761|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
164231140|NCT03164356|593215762|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
164231141|NCT03164356|593215763|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
164231142|NCT03164356|593215760|FG000|Overall Study|Subject Incarcerated|0|||
164231143|NCT03164356|593215761|FG001|Overall Study|Subject Incarcerated|1|||
164231144|NCT03164356|593215762|FG002|Overall Study|Subject Incarcerated|0|||
164231145|NCT03164356|593215763|FG003|Overall Study|Subject Incarcerated|0|||
164675562|NCT00561015|594836756|FG003|Overall Study|Lost to Follow-up|1|||
164231146|NCT03164356|593215760|FG000|Overall Study|Prosthetist unable to participate|0|||
164231147|NCT03164356|593215761|FG001|Overall Study|Prosthetist unable to participate|2|||
164231148|NCT03164356|593215762|FG002|Overall Study|Prosthetist unable to participate|1|||
164231149|NCT03164356|593215763|FG003|Overall Study|Prosthetist unable to participate|0|||
164231150|NCT03648372|593215764|FG000|Overall Study|Withdrawal by Subject|2|||
164231151|NCT03648372|593215765|FG001|Overall Study|Withdrawal by Subject|0|||
164231152|NCT03648372|593215766|FG002|Overall Study|Withdrawal by Subject|0|||
164231153|NCT03648372|593215767|FG003|Overall Study|Withdrawal by Subject|0|||
164231154|NCT03648372|593215768|FG004|Overall Study|Withdrawal by Subject|0|||
164231155|NCT03648372|593215769|FG005|Overall Study|Withdrawal by Subject|1|||
164231156|NCT03648372|593215770|FG006|Overall Study|Withdrawal by Subject|2|||
164231157|NCT03648372|593215771|FG007|Overall Study|Withdrawal by Subject|0|||
164231158|NCT03648372|593215772|FG008|Overall Study|Withdrawal by Subject|0|||
164231159|NCT03648372|593215773|FG009|Overall Study|Withdrawal by Subject|0|||
164231160|NCT03648372|593215774|FG010|Overall Study|Withdrawal by Subject|2|||
164231161|NCT03648372|593215775|FG011|Overall Study|Withdrawal by Subject|0|||
164231162|NCT03648372|593215776|FG012|Overall Study|Withdrawal by Subject|2|||
164231163|NCT03648372|593215777|FG013|Overall Study|Withdrawal by Subject|0|||
164231164|NCT03648372|593215778|FG014|Overall Study|Withdrawal by Subject|0|||
164231165|NCT03648372|593215779|FG015|Overall Study|Withdrawal by Subject|0|||
164231166|NCT03648372|593215780|FG016|Overall Study|Withdrawal by Subject|1|||
164231167|NCT03648372|593215781|FG017|Overall Study|Withdrawal by Subject|0|||
164231168|NCT03648372|593215782|FG018|Overall Study|Withdrawal by Subject|0|||
164231169|NCT03648372|593215783|FG019|Overall Study|Withdrawal by Subject|0|||
164231170|NCT03648372|593215784|FG020|Overall Study|Withdrawal by Subject|0|||
164231171|NCT03648372|593215764|FG000|Overall Study|Progressive Disease|2|||
164231172|NCT03648372|593215765|FG001|Overall Study|Progressive Disease|3|||
164231173|NCT03648372|593215766|FG002|Overall Study|Progressive Disease|4|||
164231174|NCT03648372|593215767|FG003|Overall Study|Progressive Disease|3|||
164231175|NCT03648372|593215768|FG004|Overall Study|Progressive Disease|2|||
164231176|NCT03648372|593215769|FG005|Overall Study|Progressive Disease|2|||
164231177|NCT03648372|593215770|FG006|Overall Study|Progressive Disease|3|||
164231178|NCT03648372|593215771|FG007|Overall Study|Progressive Disease|3|||
164231179|NCT03648372|593215772|FG008|Overall Study|Progressive Disease|5|||
164231180|NCT03648372|593215773|FG009|Overall Study|Progressive Disease|5|||
164231181|NCT03648372|593215774|FG010|Overall Study|Progressive Disease|2|||
164231182|NCT03648372|593215775|FG011|Overall Study|Progressive Disease|3|||
164231183|NCT03648372|593215776|FG012|Overall Study|Progressive Disease|3|||
164231184|NCT03648372|593215777|FG013|Overall Study|Progressive Disease|3|||
164231185|NCT03648372|593215778|FG014|Overall Study|Progressive Disease|6|||
164231186|NCT03648372|593215779|FG015|Overall Study|Progressive Disease|0|||
164231187|NCT03648372|593215780|FG016|Overall Study|Progressive Disease|0|||
164231188|NCT03648372|593215781|FG017|Overall Study|Progressive Disease|0|||
164231189|NCT03648372|593215782|FG018|Overall Study|Progressive Disease|0|||
164231190|NCT03648372|593215783|FG019|Overall Study|Progressive Disease|0|||
164231191|NCT03648372|593215784|FG020|Overall Study|Progressive Disease|0|||
164231192|NCT03648372|593215764|FG000|Overall Study|Other|0|||
164231193|NCT03648372|593215765|FG001|Overall Study|Other|0|||
164231194|NCT03648372|593215766|FG002|Overall Study|Other|0|||
164231195|NCT03648372|593215767|FG003|Overall Study|Other|0|||
164231196|NCT03648372|593215768|FG004|Overall Study|Other|1|||
164231197|NCT03648372|593215769|FG005|Overall Study|Other|0|||
164231198|NCT03648372|593215770|FG006|Overall Study|Other|0|||
164231199|NCT03648372|593215771|FG007|Overall Study|Other|0|||
164231200|NCT03648372|593215772|FG008|Overall Study|Other|0|||
164231201|NCT03648372|593215773|FG009|Overall Study|Other|0|||
164231202|NCT03648372|593215774|FG010|Overall Study|Other|1|||
164231203|NCT03648372|593215775|FG011|Overall Study|Other|2|||
164231204|NCT03648372|593215776|FG012|Overall Study|Other|1|||
164231205|NCT03648372|593215777|FG013|Overall Study|Other|3|||
164231206|NCT03648372|593215778|FG014|Overall Study|Other|0|||
164231207|NCT03648372|593215779|FG015|Overall Study|Other|5|||
164231208|NCT03648372|593215780|FG016|Overall Study|Other|1|||
164332345|NCT00866788|593595547|FG001|Overall Study|Withdrawal by Subject|1|||
164675563|NCT00561015|594836757|FG004|Overall Study|Lost to Follow-up|0|||
164231209|NCT03648372|593215781|FG017|Overall Study|Other|5|||
164231210|NCT03648372|593215782|FG018|Overall Study|Other|0|||
164231211|NCT03648372|593215783|FG019|Overall Study|Other|1|||
164231212|NCT03648372|593215784|FG020|Overall Study|Other|0|||
164231213|NCT03648372|593215764|FG000|Overall Study|Lost to Follow-up|0|||
164231214|NCT03648372|593215765|FG001|Overall Study|Lost to Follow-up|0|||
164231215|NCT03648372|593215766|FG002|Overall Study|Lost to Follow-up|0|||
164231216|NCT03648372|593215767|FG003|Overall Study|Lost to Follow-up|0|||
164231217|NCT03648372|593215768|FG004|Overall Study|Lost to Follow-up|0|||
164231218|NCT03648372|593215769|FG005|Overall Study|Lost to Follow-up|0|||
164231219|NCT03648372|593215770|FG006|Overall Study|Lost to Follow-up|0|||
164231220|NCT03648372|593215771|FG007|Overall Study|Lost to Follow-up|0|||
164231221|NCT03648372|593215772|FG008|Overall Study|Lost to Follow-up|0|||
164231222|NCT03648372|593215773|FG009|Overall Study|Lost to Follow-up|0|||
164231223|NCT03648372|593215774|FG010|Overall Study|Lost to Follow-up|0|||
164231224|NCT03648372|593215775|FG011|Overall Study|Lost to Follow-up|0|||
164231225|NCT03648372|593215776|FG012|Overall Study|Lost to Follow-up|0|||
164231226|NCT03648372|593215777|FG013|Overall Study|Lost to Follow-up|1|||
164231227|NCT03648372|593215778|FG014|Overall Study|Lost to Follow-up|0|||
164231228|NCT03648372|593215779|FG015|Overall Study|Lost to Follow-up|1|||
164231229|NCT03648372|593215780|FG016|Overall Study|Lost to Follow-up|0|||
164231230|NCT03648372|593215781|FG017|Overall Study|Lost to Follow-up|1|||
164231231|NCT03648372|593215782|FG018|Overall Study|Lost to Follow-up|0|||
164231232|NCT03648372|593215783|FG019|Overall Study|Lost to Follow-up|0|||
164231233|NCT03648372|593215784|FG020|Overall Study|Lost to Follow-up|0|||
164231234|NCT03648372|593215764|FG000|Overall Study|Start of a New Systemic Treatment|0|||
164231235|NCT03648372|593215765|FG001|Overall Study|Start of a New Systemic Treatment|0|||
164231236|NCT03648372|593215766|FG002|Overall Study|Start of a New Systemic Treatment|0|||
164231237|NCT03648372|593215767|FG003|Overall Study|Start of a New Systemic Treatment|0|||
164231238|NCT03648372|593215768|FG004|Overall Study|Start of a New Systemic Treatment|0|||
164231239|NCT03648372|593215769|FG005|Overall Study|Start of a New Systemic Treatment|0|||
164231240|NCT03648372|593215770|FG006|Overall Study|Start of a New Systemic Treatment|0|||
164231241|NCT03648372|593215771|FG007|Overall Study|Start of a New Systemic Treatment|2|||
164231242|NCT03648372|593215772|FG008|Overall Study|Start of a New Systemic Treatment|0|||
164231243|NCT03648372|593215773|FG009|Overall Study|Start of a New Systemic Treatment|0|||
164231244|NCT03648372|593215774|FG010|Overall Study|Start of a New Systemic Treatment|1|||
164231245|NCT03648372|593215775|FG011|Overall Study|Start of a New Systemic Treatment|0|||
164231246|NCT03648372|593215776|FG012|Overall Study|Start of a New Systemic Treatment|0|||
164231247|NCT03648372|593215777|FG013|Overall Study|Start of a New Systemic Treatment|0|||
164231248|NCT03648372|593215778|FG014|Overall Study|Start of a New Systemic Treatment|0|||
164231249|NCT03648372|593215779|FG015|Overall Study|Start of a New Systemic Treatment|0|||
164231250|NCT03648372|593215780|FG016|Overall Study|Start of a New Systemic Treatment|0|||
164231251|NCT03648372|593215781|FG017|Overall Study|Start of a New Systemic Treatment|0|||
164231252|NCT03648372|593215782|FG018|Overall Study|Start of a New Systemic Treatment|0|||
164231253|NCT03648372|593215783|FG019|Overall Study|Start of a New Systemic Treatment|0|||
164231254|NCT03648372|593215784|FG020|Overall Study|Start of a New Systemic Treatment|0|||
164231255|NCT03396445|593218026|FG000|Treatment Period|Death|2|||
164231256|NCT03396445|593218027|FG001|Treatment Period|Death|2|||
164231257|NCT03396445|593218028|FG002|Treatment Period|Death|1|||
164231258|NCT03396445|593218029|FG003|Treatment Period|Death|1|||
164231259|NCT03396445|593218030|FG004|Treatment Period|Death|3|||
164231260|NCT03396445|593218031|FG005|Treatment Period|Death|2|||
164231261|NCT03396445|593218032|FG006|Treatment Period|Death|5|||
164231262|NCT03396445|593218033|FG007|Treatment Period|Death|3|||
164231263|NCT03396445|593218034|FG008|Treatment Period|Death|3|||
164231264|NCT03396445|593218035|FG009|Treatment Period|Death|3|||
164231265|NCT03396445|593218036|FG010|Treatment Period|Death|7|||
164231266|NCT03396445|593218037|FG011|Treatment Period|Death|12|||
164231267|NCT03396445|593218038|FG012|Treatment Period|Death|28|||
164231268|NCT03396445|593218039|FG013|Treatment Period|Death|14|||
164231269|NCT03396445|593218040|FG014|Treatment Period|Death|10|||
164231270|NCT03396445|593218041|FG015|Treatment Period|Death|8|||
164231271|NCT03396445|593218042|FG016|Treatment Period|Death|18|||
164231272|NCT03396445|593218043|FG017|Treatment Period|Death|0|||
164231273|NCT03396445|593218044|FG018|Treatment Period|Death|0|||
164231274|NCT03396445|593218045|FG019|Treatment Period|Death|0|||
164231275|NCT03396445|593218046|FG020|Treatment Period|Death|0|||
164231276|NCT03396445|593218047|FG021|Treatment Period|Death|0|||
164231277|NCT03396445|593218048|FG022|Treatment Period|Death|0|||
164231278|NCT03396445|593218049|FG023|Treatment Period|Death|0|||
164231279|NCT03396445|593218050|FG024|Treatment Period|Death|0|||
164231280|NCT03396445|593218051|FG025|Treatment Period|Death|0|||
164231281|NCT03396445|593218026|FG000|Treatment Period|Lost to Follow-up|0|||
164231282|NCT03396445|593218027|FG001|Treatment Period|Lost to Follow-up|0|||
164231283|NCT03396445|593218028|FG002|Treatment Period|Lost to Follow-up|0|||
164231284|NCT03396445|593218029|FG003|Treatment Period|Lost to Follow-up|0|||
164231285|NCT03396445|593218030|FG004|Treatment Period|Lost to Follow-up|0|||
164231286|NCT03396445|593218031|FG005|Treatment Period|Lost to Follow-up|0|||
164231287|NCT03396445|593218032|FG006|Treatment Period|Lost to Follow-up|0|||
164231288|NCT03396445|593218033|FG007|Treatment Period|Lost to Follow-up|0|||
164231289|NCT03396445|593218034|FG008|Treatment Period|Lost to Follow-up|0|||
164231290|NCT03396445|593218035|FG009|Treatment Period|Lost to Follow-up|0|||
164231291|NCT03396445|593218036|FG010|Treatment Period|Lost to Follow-up|0|||
164332346|NCT00866788|593595548|FG002|Overall Study|Withdrawal by Subject|0|||
164332347|NCT00866788|593595549|FG003|Overall Study|Withdrawal by Subject|1|||
164231292|NCT03396445|593218037|FG011|Treatment Period|Lost to Follow-up|0|||
164231293|NCT03396445|593218038|FG012|Treatment Period|Lost to Follow-up|1|||
164231294|NCT03396445|593218039|FG013|Treatment Period|Lost to Follow-up|0|||
164231295|NCT03396445|593218040|FG014|Treatment Period|Lost to Follow-up|1|||
164231296|NCT03396445|593218041|FG015|Treatment Period|Lost to Follow-up|0|||
164231297|NCT03396445|593218042|FG016|Treatment Period|Lost to Follow-up|0|||
164231298|NCT03396445|593218043|FG017|Treatment Period|Lost to Follow-up|0|||
164231299|NCT03396445|593218044|FG018|Treatment Period|Lost to Follow-up|0|||
164231300|NCT03396445|593218045|FG019|Treatment Period|Lost to Follow-up|0|||
164231301|NCT03396445|593218046|FG020|Treatment Period|Lost to Follow-up|0|||
164231302|NCT03396445|593218047|FG021|Treatment Period|Lost to Follow-up|0|||
164231303|NCT03396445|593218048|FG022|Treatment Period|Lost to Follow-up|0|||
164231304|NCT03396445|593218049|FG023|Treatment Period|Lost to Follow-up|0|||
164231305|NCT03396445|593218050|FG024|Treatment Period|Lost to Follow-up|0|||
164231306|NCT03396445|593218051|FG025|Treatment Period|Lost to Follow-up|0|||
164231307|NCT03396445|593218026|FG000|Treatment Period|Physician Decision|0|||
164231308|NCT03396445|593218027|FG001|Treatment Period|Physician Decision|0|||
164231309|NCT03396445|593218028|FG002|Treatment Period|Physician Decision|0|||
164231310|NCT03396445|593218029|FG003|Treatment Period|Physician Decision|0|||
164231311|NCT03396445|593218030|FG004|Treatment Period|Physician Decision|1|||
164231312|NCT03396445|593218031|FG005|Treatment Period|Physician Decision|0|||
164231313|NCT03396445|593218032|FG006|Treatment Period|Physician Decision|0|||
164231314|NCT03396445|593218033|FG007|Treatment Period|Physician Decision|0|||
164231315|NCT03396445|593218034|FG008|Treatment Period|Physician Decision|0|||
164231316|NCT03396445|593218035|FG009|Treatment Period|Physician Decision|1|||
164231317|NCT03396445|593218036|FG010|Treatment Period|Physician Decision|0|||
164231318|NCT03396445|593218037|FG011|Treatment Period|Physician Decision|0|||
164231319|NCT03396445|593218038|FG012|Treatment Period|Physician Decision|0|||
164231320|NCT03396445|593218039|FG013|Treatment Period|Physician Decision|0|||
164231321|NCT03396445|593218040|FG014|Treatment Period|Physician Decision|0|||
164231322|NCT03396445|593218041|FG015|Treatment Period|Physician Decision|0|||
164231323|NCT03396445|593218042|FG016|Treatment Period|Physician Decision|0|||
164231324|NCT03396445|593218043|FG017|Treatment Period|Physician Decision|0|||
164231325|NCT03396445|593218044|FG018|Treatment Period|Physician Decision|0|||
164231326|NCT03396445|593218045|FG019|Treatment Period|Physician Decision|0|||
164231327|NCT03396445|593218046|FG020|Treatment Period|Physician Decision|0|||
164675564|NCT00561015|594836758|FG005|Overall Study|Lost to Follow-up|3|||
164231328|NCT03396445|593218047|FG021|Treatment Period|Physician Decision|0|||
164231329|NCT03396445|593218048|FG022|Treatment Period|Physician Decision|0|||
164231330|NCT03396445|593218049|FG023|Treatment Period|Physician Decision|0|||
164231331|NCT03396445|593218050|FG024|Treatment Period|Physician Decision|0|||
164231332|NCT03396445|593218051|FG025|Treatment Period|Physician Decision|0|||
164231333|NCT03396445|593218026|FG000|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231334|NCT03396445|593218027|FG001|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164332348|NCT00866788|593595546|FG000|Overall Study|Pregnancy|0|||
164332349|NCT00866788|593595547|FG001|Overall Study|Pregnancy|1|||
164332350|NCT00866788|593595548|FG002|Overall Study|Pregnancy|0|||
164332351|NCT00866788|593595549|FG003|Overall Study|Pregnancy|0|||
164332352|NCT00866788|593595546|FG000|Overall Study|Disease progression|3|||
164332353|NCT00866788|593595547|FG001|Overall Study|Disease progression|1|||
164332354|NCT00866788|593595548|FG002|Overall Study|Disease progression|1|||
164332355|NCT00866788|593595549|FG003|Overall Study|Disease progression|0|||
164675565|NCT00561015|594836753|FG000|Overall Study|Participant non-compliance|2|||
164675566|NCT00561015|594836754|FG001|Overall Study|Participant non-compliance|0|||
164231335|NCT03396445|593218028|FG002|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231336|NCT03396445|593218029|FG003|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231337|NCT03396445|593218030|FG004|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164675567|NCT00561015|594836755|FG002|Overall Study|Participant non-compliance|0|||
164675568|NCT00561015|594836756|FG003|Overall Study|Participant non-compliance|0|||
164675569|NCT00561015|594836757|FG004|Overall Study|Participant non-compliance|0|||
164231338|NCT03396445|593218031|FG005|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231339|NCT03396445|593218032|FG006|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231340|NCT03396445|593218033|FG007|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164332356|NCT00866788|593595546|FG000|Overall Study|Physician Decision|0|||
164675570|NCT00561015|594836758|FG005|Overall Study|Participant non-compliance|0|||
164675571|NCT02545283|594836761|FG000|Overall Study|Lost to Follow-up|2|||
164675572|NCT02545283|594836762|FG001|Overall Study|Lost to Follow-up|4|||
164675573|NCT02545283|594836761|FG000|Overall Study|Withdrawal by Subject|5|||
164675574|NCT02545283|594836762|FG001|Overall Study|Withdrawal by Subject|9|||
164675575|NCT02545283|594836761|FG000|Overall Study|Death|109|||
164421925|NCT02601937|593914565|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
164231341|NCT03396445|593218034|FG008|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231342|NCT03396445|593218035|FG009|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231343|NCT03396445|593218036|FG010|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231344|NCT03396445|593218037|FG011|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231345|NCT03396445|593218038|FG012|Treatment Period|Randomized by Mistake without Study Treatment|1|||
164231346|NCT03396445|593218039|FG013|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164332357|NCT00866788|593595547|FG001|Overall Study|Physician Decision|0|||
164332358|NCT00866788|593595548|FG002|Overall Study|Physician Decision|1|||
164332359|NCT00866788|593595549|FG003|Overall Study|Physician Decision|1|||
164675576|NCT02545283|594836762|FG001|Overall Study|Death|211|||
164421926|NCT02601937|593914566|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
164421927|NCT02601937|593914567|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
164332360|NCT02349061|593595551|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
164332361|NCT02349061|593595552|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
164332362|NCT02349061|593595553|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
164332363|NCT02349061|593595551|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
164332364|NCT02349061|593595552|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
164332365|NCT02349061|593595553|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
164332366|NCT02349061|593595551|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
164332367|NCT02349061|593595552|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
164332368|NCT02349061|593595553|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
164332369|NCT02349061|593595551|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
164332370|NCT02349061|593595552|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
164332371|NCT02349061|593595553|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
164332372|NCT02349061|593595551|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
164332373|NCT02349061|593595552|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
164332374|NCT02349061|593595553|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
164332375|NCT02349061|593595551|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
164332376|NCT02349061|593595552|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
164332377|NCT02349061|593595553|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
164332378|NCT02349061|593595551|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
164332379|NCT02349061|593595552|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
164332380|NCT02349061|593595553|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
164332381|NCT02349061|593595551|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
164332382|NCT02349061|593595552|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
164332383|NCT02349061|593595553|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
164332384|NCT02349061|593595551|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
164332385|NCT02349061|593595552|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
164332386|NCT02349061|593595553|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
164332387|NCT02349061|593595551|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
164332388|NCT02349061|593595552|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
164332389|NCT02349061|593595553|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
164332390|NCT02349061|593595551|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
164332391|NCT02349061|593595552|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
164332392|NCT02349061|593595553|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
164332393|NCT02349061|593595551|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
164332394|NCT02349061|593595552|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
164332395|NCT02349061|593595553|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
164332396|NCT02349061|593595551|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
164332397|NCT02349061|593595552|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
164332398|NCT02349061|593595553|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
164332399|NCT02095223|593595554|FG000|Overall Study|Withdrawal by Subject|1|||
164332400|NCT02095223|593595555|FG001|Overall Study|Withdrawal by Subject|0|||
164332401|NCT01397162|593595556|FG000|Overall Study|Adverse Event|4|||
164332402|NCT01397162|593595557|FG001|Overall Study|Adverse Event|0|||
164332403|NCT01397162|593595558|FG002|Overall Study|Adverse Event|0|||
164332404|NCT01397162|593595559|FG003|Overall Study|Adverse Event|0|||
164332405|NCT01397162|593595560|FG004|Overall Study|Adverse Event|0|||
164332406|NCT01397162|593595556|FG000|Overall Study|Not yet defined|3|||
164332407|NCT01397162|593595557|FG001|Overall Study|Not yet defined|4|||
164332408|NCT01397162|593595558|FG002|Overall Study|Not yet defined|3|||
164332409|NCT01397162|593595559|FG003|Overall Study|Not yet defined|5|||
164332410|NCT01397162|593595560|FG004|Overall Study|Not yet defined|3|||
164332411|NCT02339285|593595561|FG000|Overall Study|Withdrawal by Subject|0|||
164332412|NCT02339285|593595562|FG001|Overall Study|Withdrawal by Subject|1|||
164332413|NCT02339285|593595563|FG002|Overall Study|Withdrawal by Subject|1|||
164332414|NCT02339285|593595561|FG000|Overall Study|Lost to Follow-up|1|||
164332415|NCT02339285|593595562|FG001|Overall Study|Lost to Follow-up|1|||
164332416|NCT02339285|593595563|FG002|Overall Study|Lost to Follow-up|1|||
164332417|NCT02339285|593595561|FG000|Overall Study|Protocol Deviation|0|||
164332418|NCT02339285|593595562|FG001|Overall Study|Protocol Deviation|1|||
164332419|NCT02339285|593595563|FG002|Overall Study|Protocol Deviation|0|||
164332420|NCT01507298|593595566|FG000|Overall Study|Protocol Violation|0|||
164332421|NCT01507298|593595567|FG001|Overall Study|Protocol Violation|6|||
164332422|NCT01920555|593595568|FG000|Overall Study|Physician Decision|1|||
164332423|NCT01920555|593595569|FG001|Overall Study|Physician Decision|2|||
164332424|NCT01920555|593595570|FG002|Overall Study|Physician Decision|1|||
164332425|NCT01920555|593595571|FG003|Overall Study|Physician Decision|2|||
164332426|NCT01920555|593595572|FG004|Overall Study|Physician Decision|0|||
164332427|NCT01920555|593595568|FG000|Overall Study|Lack of Efficacy|2|||
164332428|NCT01920555|593595569|FG001|Overall Study|Lack of Efficacy|0|||
164421928|NCT02601937|593914568|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
164332429|NCT01920555|593595570|FG002|Overall Study|Lack of Efficacy|0|||
164231347|NCT03396445|593218040|FG014|Treatment Period|Randomized by Mistake without Study Treatment|1|||
164572079|NCT00629083|594460343|FG001|Overall Study|Moved out of country/state|1|||
164572080|NCT00629083|594460342|FG000|Overall Study|Refused to return for 12 month visit|1|||
164572081|NCT00629083|594460343|FG001|Overall Study|Refused to return for 12 month visit|0|||
164572082|NCT01478958|594460344|FG000|Overall Study|Withdrawal by Subject|1|||
164231348|NCT03396445|593218041|FG015|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231349|NCT03396445|593218042|FG016|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231350|NCT03396445|593218043|FG017|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231351|NCT03396445|593218044|FG018|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231352|NCT03396445|593218045|FG019|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231353|NCT03396445|593218046|FG020|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231354|NCT03396445|593218047|FG021|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231355|NCT03396445|593218048|FG022|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231356|NCT03396445|593218049|FG023|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231357|NCT03396445|593218050|FG024|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231358|NCT03396445|593218051|FG025|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231359|NCT03396445|593218026|FG000|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
164231360|NCT03396445|593218027|FG001|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
164231361|NCT03396445|593218028|FG002|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
164231362|NCT03396445|593218029|FG003|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|2|||
164231363|NCT03396445|593218030|FG004|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
164231364|NCT03396445|593218031|FG005|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231365|NCT03396445|593218032|FG006|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|9|||
164231366|NCT03396445|593218033|FG007|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231367|NCT03396445|593218034|FG008|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231368|NCT03396445|593218035|FG009|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231369|NCT03396445|593218036|FG010|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231370|NCT03396445|593218037|FG011|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231371|NCT03396445|593218038|FG012|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231372|NCT03396445|593218039|FG013|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231373|NCT03396445|593218040|FG014|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231374|NCT03396445|593218041|FG015|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231375|NCT03396445|593218042|FG016|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231376|NCT03396445|593218043|FG017|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231377|NCT03396445|593218044|FG018|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231378|NCT03396445|593218045|FG019|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231379|NCT03396445|593218046|FG020|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164299709|NCT00888134|593472905|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
164299710|NCT00888134|593472905|FG000|Follow-up|being followed for long-term survival|1|||
164299711|NCT03783078|593472908|FG000|Overall Study|Death|31|||
164299712|NCT03783078|593472908|FG000|Overall Study|Sponsor Decision|23|||
164299713|NCT03783078|593472908|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
164299714|NCT01903460|593472911|FG000|Overall Study|Adverse Event|0|||
164299715|NCT01903460|593472912|FG001|Overall Study|Adverse Event|0|||
164299716|NCT01903460|593472913|FG002|Overall Study|Adverse Event|0|||
164299717|NCT01903460|593472914|FG003|Overall Study|Adverse Event|1|||
164299718|NCT03104868|593472915|FG000|6 Week Follow up|Lost to Follow-up|5|||
164421929|NCT02601937|593914569|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
164421930|NCT02601937|593914570|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
164299719|NCT03104868|593472916|FG001|6 Week Follow up|Lost to Follow-up|8|||
164299720|NCT03104868|593472915|FG000|6 Week Follow up|Death|1|||
164299721|NCT03104868|593472916|FG001|6 Week Follow up|Death|1|||
164299722|NCT03104868|593472915|FG000|6 Week Follow up|Withdrawal by Subject|7|||
164299723|NCT03104868|593472916|FG001|6 Week Follow up|Withdrawal by Subject|6|||
164299724|NCT03104868|593472915|FG000|6 Week Follow up|Completed Later Timepoint|24|||
164299725|NCT03104868|593472916|FG001|6 Week Follow up|Completed Later Timepoint|22|||
164299726|NCT03104868|593472915|FG000|6 Month Follow up|Lost to Follow-up|2|||
164299727|NCT03104868|593472916|FG001|6 Month Follow up|Lost to Follow-up|2|||
164299728|NCT03104868|593472915|FG000|6 Month Follow up|Death|0|||
164231380|NCT03396445|593218047|FG021|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231381|NCT03396445|593218048|FG022|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231382|NCT03396445|593218049|FG023|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231383|NCT03396445|593218050|FG024|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231384|NCT03396445|593218051|FG025|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231385|NCT03396445|593218026|FG000|Treatment Period|Withdrawal by Subject|0|||
164231386|NCT03396445|593218027|FG001|Treatment Period|Withdrawal by Subject|0|||
164231387|NCT03396445|593218028|FG002|Treatment Period|Withdrawal by Subject|0|||
164231388|NCT03396445|593218029|FG003|Treatment Period|Withdrawal by Subject|0|||
164231389|NCT03396445|593218030|FG004|Treatment Period|Withdrawal by Subject|0|||
164231390|NCT03396445|593218031|FG005|Treatment Period|Withdrawal by Subject|0|||
164231391|NCT03396445|593218032|FG006|Treatment Period|Withdrawal by Subject|0|||
164231392|NCT03396445|593218033|FG007|Treatment Period|Withdrawal by Subject|0|||
164231393|NCT03396445|593218034|FG008|Treatment Period|Withdrawal by Subject|0|||
164231394|NCT03396445|593218035|FG009|Treatment Period|Withdrawal by Subject|0|||
164231395|NCT03396445|593218036|FG010|Treatment Period|Withdrawal by Subject|0|||
164231396|NCT03396445|593218037|FG011|Treatment Period|Withdrawal by Subject|0|||
164231397|NCT03396445|593218038|FG012|Treatment Period|Withdrawal by Subject|0|||
164231398|NCT03396445|593218039|FG013|Treatment Period|Withdrawal by Subject|0|||
164231399|NCT03396445|593218040|FG014|Treatment Period|Withdrawal by Subject|1|||
164231400|NCT03396445|593218041|FG015|Treatment Period|Withdrawal by Subject|0|||
164231401|NCT03396445|593218042|FG016|Treatment Period|Withdrawal by Subject|1|||
164231402|NCT03396445|593218043|FG017|Treatment Period|Withdrawal by Subject|0|||
164231403|NCT03396445|593218044|FG018|Treatment Period|Withdrawal by Subject|0|||
164231404|NCT03396445|593218045|FG019|Treatment Period|Withdrawal by Subject|0|||
164231405|NCT03396445|593218046|FG020|Treatment Period|Withdrawal by Subject|0|||
164231406|NCT03396445|593218047|FG021|Treatment Period|Withdrawal by Subject|0|||
164231407|NCT03396445|593218048|FG022|Treatment Period|Withdrawal by Subject|0|||
164231408|NCT03396445|593218049|FG023|Treatment Period|Withdrawal by Subject|0|||
164231409|NCT03396445|593218050|FG024|Treatment Period|Withdrawal by Subject|0|||
164231410|NCT03396445|593218051|FG025|Treatment Period|Withdrawal by Subject|0|||
164572083|NCT01478958|594460345|FG001|Overall Study|Withdrawal by Subject|1|||
164572084|NCT01478958|594460346|FG002|Overall Study|Withdrawal by Subject|1|||
164572085|NCT01478958|594460344|FG000|Overall Study|Weight loss|1|||
164572086|NCT01478958|594460345|FG001|Overall Study|Weight loss|0|||
164572087|NCT01478958|594460346|FG002|Overall Study|Weight loss|0|||
164572088|NCT01478958|594460344|FG000|Overall Study|Re-located|0|||
164572089|NCT01478958|594460345|FG001|Overall Study|Re-located|1|||
164572090|NCT01478958|594460346|FG002|Overall Study|Re-located|0|||
164572091|NCT01478958|594460344|FG000|Overall Study|Unable to comply|0|||
164572092|NCT01478958|594460345|FG001|Overall Study|Unable to comply|0|||
164572093|NCT01478958|594460346|FG002|Overall Study|Unable to comply|2|||
164572094|NCT01193686|594460347|FG000|Overall Study|Withdrawal by Subject|4|||
164572095|NCT01193686|594460348|FG001|Overall Study|Withdrawal by Subject|1|||
164572096|NCT01193686|594460347|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
164572097|NCT01193686|594460348|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
164572098|NCT03401749|594460349|FG000|Overall Study|Lost to Follow-up|20|||
164572099|NCT03401749|594460350|FG001|Overall Study|Lost to Follow-up|16|||
164572100|NCT03401749|594460351|FG002|Overall Study|Lost to Follow-up|26|||
164572101|NCT01147809|594460354|FG000|Phase I (168 Days)|Adverse Event|0|||
164572102|NCT01147809|594460355|FG001|Phase I (168 Days)|Adverse Event|0|||
164572103|NCT01147809|594460356|FG002|Phase I (168 Days)|Adverse Event|0|||
164572104|NCT01147809|594460357|FG003|Phase I (168 Days)|Adverse Event|1|||
164572105|NCT01147809|594460358|FG004|Phase I (168 Days)|Adverse Event|0|||
164572106|NCT01147809|594460359|FG005|Phase I (168 Days)|Adverse Event|0|||
164572107|NCT01147809|594460354|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
164572108|NCT01147809|594460355|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
164572109|NCT01147809|594460356|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
164572110|NCT01147809|594460357|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
164572111|NCT01147809|594460358|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
164572112|NCT01147809|594460359|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
164572113|NCT01147809|594460354|FG000|Phase I (168 Days)|Physician Decision|0|||
164572114|NCT01147809|594460355|FG001|Phase I (168 Days)|Physician Decision|1|||
164572115|NCT01147809|594460356|FG002|Phase I (168 Days)|Physician Decision|2|||
164231411|NCT03396445|593218026|FG000|Switch-over Period|Death|0|||
164231412|NCT03396445|593218027|FG001|Switch-over Period|Death|0|||
164231413|NCT03396445|593218028|FG002|Switch-over Period|Death|0|||
164572116|NCT01147809|594460357|FG003|Phase I (168 Days)|Physician Decision|0|||
164572117|NCT01147809|594460358|FG004|Phase I (168 Days)|Physician Decision|0|||
164572118|NCT01147809|594460359|FG005|Phase I (168 Days)|Physician Decision|0|||
164572119|NCT01147809|594460354|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
164572120|NCT01147809|594460355|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
164572121|NCT01147809|594460356|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
164572122|NCT01147809|594460357|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
164332430|NCT01920555|593595571|FG003|Overall Study|Lack of Efficacy|0|||
164332431|NCT01920555|593595572|FG004|Overall Study|Lack of Efficacy|0|||
164332432|NCT01920555|593595568|FG000|Overall Study|Travel Difficulties|1|||
164332433|NCT01920555|593595569|FG001|Overall Study|Travel Difficulties|1|||
164332434|NCT01920555|593595570|FG002|Overall Study|Travel Difficulties|0|||
164332435|NCT01920555|593595571|FG003|Overall Study|Travel Difficulties|0|||
164332436|NCT01920555|593595572|FG004|Overall Study|Travel Difficulties|1|||
164572123|NCT01147809|594460358|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
164332437|NCT01920555|593595568|FG000|Overall Study|Lost to Follow-up|0|||
164332438|NCT01920555|593595569|FG001|Overall Study|Lost to Follow-up|1|||
164332439|NCT01920555|593595570|FG002|Overall Study|Lost to Follow-up|0|||
164332440|NCT01920555|593595571|FG003|Overall Study|Lost to Follow-up|1|||
164332441|NCT01920555|593595572|FG004|Overall Study|Lost to Follow-up|0|||
164572124|NCT01147809|594460359|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
164572125|NCT01147809|594460354|FG000|Phase II (168 Days)|Adverse Event|0|||
164572126|NCT01147809|594460355|FG001|Phase II (168 Days)|Adverse Event|0|||
164572127|NCT01147809|594460356|FG002|Phase II (168 Days)|Adverse Event|0|||
164572128|NCT01147809|594460357|FG003|Phase II (168 Days)|Adverse Event|0|||
164572129|NCT01147809|594460358|FG004|Phase II (168 Days)|Adverse Event|3|||
164572130|NCT01147809|594460359|FG005|Phase II (168 Days)|Adverse Event|6|||
164572131|NCT01147809|594460354|FG000|Phase II (168 Days)|Protocol Violation|0|||
164572132|NCT01147809|594460355|FG001|Phase II (168 Days)|Protocol Violation|0|||
164572133|NCT01147809|594460356|FG002|Phase II (168 Days)|Protocol Violation|0|||
164572134|NCT01147809|594460357|FG003|Phase II (168 Days)|Protocol Violation|0|||
164572135|NCT01147809|594460358|FG004|Phase II (168 Days)|Protocol Violation|0|||
164572136|NCT01147809|594460359|FG005|Phase II (168 Days)|Protocol Violation|1|||
164572137|NCT01147809|594460354|FG000|Phase II (168 Days)|Physician Decision|0|||
164572138|NCT01147809|594460355|FG001|Phase II (168 Days)|Physician Decision|0|||
164572139|NCT01147809|594460356|FG002|Phase II (168 Days)|Physician Decision|0|||
164572140|NCT01147809|594460357|FG003|Phase II (168 Days)|Physician Decision|0|||
164572141|NCT01147809|594460358|FG004|Phase II (168 Days)|Physician Decision|5|||
164572142|NCT01147809|594460359|FG005|Phase II (168 Days)|Physician Decision|11|||
164572143|NCT01147809|594460354|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
164572144|NCT01147809|594460355|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
164572145|NCT01147809|594460356|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
164572146|NCT01147809|594460357|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
164572147|NCT01147809|594460358|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
164572148|NCT01147809|594460359|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
164572149|NCT01147809|594460354|FG000|Phase II (168 Days)|Ongoing|0|||
164572150|NCT01147809|594460355|FG001|Phase II (168 Days)|Ongoing|0|||
164572151|NCT01147809|594460356|FG002|Phase II (168 Days)|Ongoing|0|||
164572152|NCT01147809|594460357|FG003|Phase II (168 Days)|Ongoing|0|||
164572153|NCT01147809|594460358|FG004|Phase II (168 Days)|Ongoing|1|||
164572154|NCT01147809|594460359|FG005|Phase II (168 Days)|Ongoing|0|||
164572155|NCT01307423|594460360|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
164572156|NCT01307423|594460361|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
164572157|NCT01307423|594460362|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
164675577|NCT02545283|594836761|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
164675578|NCT02545283|594836762|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
164675579|NCT02545283|594836761|FG000|Overall Study|Study Terminated By Sponsor|33|||
164675580|NCT02545283|594836762|FG001|Overall Study|Study Terminated By Sponsor|71|||
164675581|NCT02436005|594836763|FG000|Second Intervention|Adverse Event|0|||
164675582|NCT02436005|594836764|FG001|Second Intervention|Adverse Event|1|||
164675583|NCT00583453|594836765|FG000|Overall Study|discontinued intervention|0|||
164675584|NCT00583453|594836766|FG001|Overall Study|discontinued intervention|2|||
164675585|NCT00905606|594836767|FG000|Period 1|Adverse Event|0|||
164675586|NCT00905606|594836768|FG001|Period 1|Adverse Event|1|||
164675587|NCT00905606|594836767|FG000|Washout|Withdrawal by Subject|1|||
164675588|NCT00905606|594836768|FG001|Washout|Withdrawal by Subject|0|||
164675589|NCT03635320|594836769|FG000|Overall Study|not implanted the device|1|||
164675590|NCT03635320|594836770|FG001|Overall Study|not implanted the device|2|||
164675591|NCT03635320|594836769|FG000|Overall Study|Withdrawal by Subject|11|||
164675592|NCT03635320|594836770|FG001|Overall Study|Withdrawal by Subject|6|||
164675593|NCT01558635|594836771|FG000|Overall Study|Death|1|||
164675594|NCT01558635|594836771|FG000|Overall Study|Withdrawal by Subject|2|||
164675595|NCT01558635|594836771|FG000|Overall Study|Physician Decision|1|||
164675596|NCT01558635|594836771|FG000|Overall Study|Subject received other treatment|1|||
164675597|NCT01558635|594836771|FG000|Overall Study|Reveal XT was explanted|1|||
164675598|NCT00455312|594836774|FG000|Overall Study|Death|0|||
164675599|NCT00455312|594836775|FG001|Overall Study|Death|1|||
164675600|NCT02659150|594836776|FG000|Subject Enrollment|Physician Decision|3|||
164675601|NCT02659150|594836776|FG000|Subject Enrollment|Withdrawal by Subject|2|||
164675602|NCT02659150|594836776|FG000|Baseline Imaging|Withdrawal by Subject|1|||
164675603|NCT02659150|594836776|FG000|Baseline Imaging|Physician Decision|1|||
164332442|NCT00426231|593595573|FG000|Overall Study|Withdrawal by Subject|9|||
164572158|NCT01307423|594460363|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
164675604|NCT02659150|594836776|FG000|Study Drug Dosing|Adverse Event|1|||
164675605|NCT01363765|594836779|FG000|Overall Study|non-diagnostic|2621|||
164675606|NCT01363765|594836780|FG001|Overall Study|non-diagnostic|1124|||
164675607|NCT01363765|594836779|FG000|Overall Study|duplicate records|736|||
164675608|NCT01363765|594836780|FG001|Overall Study|duplicate records|3177|||
164675609|NCT01363765|594836779|FG000|Overall Study|non-resident|156|||
164675610|NCT01363765|594836780|FG001|Overall Study|non-resident|76|||
164675611|NCT01363765|594836779|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
164675612|NCT01363765|594836780|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
164675613|NCT01363765|594836779|FG000|Overall Study|smear during intervention|2170|||
164675614|NCT01363765|594836780|FG001|Overall Study|smear during intervention|0|||
164675615|NCT00448591|594836781|FG000|Overall Study|Withdrawal by Subject|178|||
164675616|NCT00448591|594836781|FG000|Overall Study|Progressive Disease|1382|||
164675617|NCT00448591|594836781|FG000|Overall Study|Adverse Event|382|||
164675618|NCT00448591|594836781|FG000|Overall Study|Protocol Violation|41|||
164675619|NCT00448591|594836781|FG000|Overall Study|Lost to Follow-up|19|||
164675620|NCT00448591|594836781|FG000|Overall Study|Treatment Regimen Completed|70|||
164675621|NCT00448591|594836781|FG000|Overall Study|Other|154|||
164675622|NCT00448591|594836781|FG000|Overall Study|Termination of Study|70|||
164675623|NCT00609674|594836782|FG000|Overall Study|Adverse Event|1|||
164675624|NCT00609674|594836783|FG001|Overall Study|Adverse Event|1|||
164675625|NCT00609674|594836782|FG000|Overall Study|Protocol Violation|3|||
164675626|NCT00609674|594836783|FG001|Overall Study|Protocol Violation|5|||
164675627|NCT00609674|594836782|FG000|Overall Study|Lost to Follow-up|1|||
164675628|NCT00609674|594836783|FG001|Overall Study|Lost to Follow-up|0|||
164675629|NCT00609674|594836782|FG000|Overall Study|Withdrew consent|2|||
164675630|NCT00609674|594836783|FG001|Overall Study|Withdrew consent|1|||
164675631|NCT00834431|594836786|FG000|First Intervention|Adverse Event|0|||
164675632|NCT00834431|594836787|FG001|First Intervention|Adverse Event|1|||
164675633|NCT00834431|594836786|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
164675634|NCT00834431|594836787|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
164675635|NCT00556322|594836792|FG000|Overall Study|Insufficient therapeutic response|158|||
164675636|NCT00556322|594836793|FG001|Overall Study|Insufficient therapeutic response|168|||
164675637|NCT00556322|594836792|FG000|Overall Study|Adverse Event|7|||
164675638|NCT00556322|594836793|FG001|Overall Study|Adverse Event|4|||
164675639|NCT00556322|594836792|FG000|Overall Study|Other|4|||
164675640|NCT00556322|594836793|FG001|Overall Study|Other|1|||
164675641|NCT00556322|594836792|FG000|Overall Study|Lost to Follow-up|5|||
164675642|NCT00556322|594836793|FG001|Overall Study|Lost to Follow-up|3|||
164675643|NCT00556322|594836792|FG000|Overall Study|Withdrawal by Subject|19|||
164675644|NCT00556322|594836793|FG001|Overall Study|Withdrawal by Subject|7|||
164675645|NCT00556322|594836792|FG000|Overall Study|Protocol Violation|5|||
164675646|NCT00556322|594836793|FG001|Overall Study|Protocol Violation|1|||
164675647|NCT00556322|594836792|FG000|Overall Study|Ongoing at data cutoff|3|||
164675648|NCT00556322|594836793|FG001|Overall Study|Ongoing at data cutoff|5|||
164675649|NCT00556322|594836792|FG000|Overall Study|Death|20|||
164675650|NCT00556322|594836793|FG001|Overall Study|Death|14|||
164675651|NCT01913405|594836794|FG000|Overall Study|Withdrawal by Subject|1|||
164675652|NCT01913405|594836794|FG000|Overall Study|Adverse Event|1|||
164675653|NCT04400890|594836795|FG000|Overall Study|Withdrawal by Subject|3|||
164332443|NCT00426231|593595574|FG001|Overall Study|Withdrawal by Subject|12|||
164332444|NCT00108433|593595575|FG000|Overall Study|Lack of Efficacy|1|||
164332445|NCT00108433|593595576|FG001|Overall Study|Lack of Efficacy|2|||
164332446|NCT00108433|593595575|FG000|Overall Study|Death|3|||
164332447|NCT00108433|593595576|FG001|Overall Study|Death|0|||
164332448|NCT00108433|593595575|FG000|Overall Study|Adverse Event|3|||
164332449|NCT00108433|593595576|FG001|Overall Study|Adverse Event|1|||
164332450|NCT00108433|593595575|FG000|Overall Study|Other|14|||
164332451|NCT00108433|593595576|FG001|Overall Study|Other|14|||
164332452|NCT01193660|593595577|FG000|Overall Study|Withdrawal by Subject|2|||
164332453|NCT01193660|593595578|FG001|Overall Study|Withdrawal by Subject|3|||
164332454|NCT01193660|593595579|FG002|Overall Study|Withdrawal by Subject|1|||
164332455|NCT01193660|593595577|FG000|Overall Study|Death|1|||
164332456|NCT01193660|593595578|FG001|Overall Study|Death|0|||
164332457|NCT01193660|593595579|FG002|Overall Study|Death|0|||
164675654|NCT04400890|594836796|FG001|Overall Study|Withdrawal by Subject|2|||
164675655|NCT03925532|594836797|FG000|Overall Study|Lost to Follow-up|1|||
164675656|NCT02258074|594836798|FG000|Overall Study|Withdrawal by Subject|1|||
164675657|NCT02258074|594836799|FG001|Overall Study|Withdrawal by Subject|0|||
164675658|NCT02258074|594836800|FG002|Overall Study|Withdrawal by Subject|0|||
164675659|NCT02258074|594836801|FG003|Overall Study|Withdrawal by Subject|0|||
164675660|NCT01615198|594836804|FG000|Overall Study|Withdrawal by Subject|5|||
164675661|NCT01615198|594836805|FG001|Overall Study|Withdrawal by Subject|5|||
164675662|NCT01615198|594836804|FG000|Overall Study|Protocol deviation|1|||
164675663|NCT01615198|594836805|FG001|Overall Study|Protocol deviation|1|||
164675664|NCT01615198|594836804|FG000|Overall Study|Physician Decision|5|||
164675665|NCT01615198|594836805|FG001|Overall Study|Physician Decision|1|||
164332458|NCT01193660|593595577|FG000|Overall Study|Physician Decision|1|||
164332459|NCT01193660|593595578|FG001|Overall Study|Physician Decision|0|||
164332460|NCT01193660|593595579|FG002|Overall Study|Physician Decision|1|||
164421931|NCT02601937|593914571|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
164421932|NCT02601937|593914572|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
164421933|NCT02601937|593914573|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
164421934|NCT02601937|593914574|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
164332461|NCT00195273|593595580|FG000|Overall Study|Adverse Event|9|||
164332462|NCT00195273|593595581|FG001|Overall Study|Adverse Event|9|||
164332463|NCT00195273|593595580|FG000|Overall Study|Protocol deviation|0|||
164332464|NCT00195273|593595581|FG001|Overall Study|Protocol deviation|1|||
164332465|NCT00195273|593595580|FG000|Overall Study|Lack of Efficacy|3|||
164332466|NCT00195273|593595581|FG001|Overall Study|Lack of Efficacy|1|||
164332467|NCT00195273|593595580|FG000|Overall Study|Procedural complications|9|||
164332468|NCT00195273|593595581|FG001|Overall Study|Procedural complications|3|||
164332469|NCT01886716|593595582|FG000|Week 1|Lost to Follow-up|0|||
164332470|NCT01886716|593595583|FG001|Week 1|Lost to Follow-up|0|||
164332471|NCT01886716|593595584|FG002|Week 1|Lost to Follow-up|2|||
164332472|NCT01886716|593595585|FG003|Week 1|Lost to Follow-up|2|||
164332473|NCT01886716|593595582|FG000|Week 2|Lost to Follow-up|3|||
164332474|NCT01886716|593595583|FG001|Week 2|Lost to Follow-up|2|||
164332475|NCT01886716|593595584|FG002|Week 2|Lost to Follow-up|1|||
164332476|NCT01886716|593595585|FG003|Week 2|Lost to Follow-up|3|||
164332477|NCT01886716|593595582|FG000|Week 3|Lost to Follow-up|1|||
164332478|NCT01886716|593595583|FG001|Week 3|Lost to Follow-up|1|||
164332479|NCT01886716|593595584|FG002|Week 3|Lost to Follow-up|0|||
164332480|NCT01886716|593595585|FG003|Week 3|Lost to Follow-up|1|||
164332481|NCT02367131|593595586|FG000|Overall Study|Adverse Event|64|||
164332482|NCT02367131|593595586|FG000|Overall Study|No visit since the first visit|3|||
164332483|NCT02367131|593595586|FG000|Overall Study|Request by patient|53|||
164332484|NCT02367131|593595586|FG000|Overall Study|Improvement/remission|2|||
164332485|NCT02367131|593595586|FG000|Overall Study|No change/progressive disease|78|||
164332486|NCT02367131|593595586|FG000|Overall Study|Other than stated above|20|||
164421935|NCT02601937|593914564|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
164421936|NCT02601937|593914565|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
164421937|NCT02601937|593914566|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
164675666|NCT01615198|594836804|FG000|Overall Study|Lost to Follow-up|1|||
164675667|NCT01615198|594836805|FG001|Overall Study|Lost to Follow-up|1|||
164675668|NCT01615198|594836804|FG000|Overall Study|Lack of Efficacy|1|||
164675669|NCT01615198|594836805|FG001|Overall Study|Lack of Efficacy|6|||
164675670|NCT01615198|594836804|FG000|Overall Study|Adverse Event|11|||
164675671|NCT01615198|594836805|FG001|Overall Study|Adverse Event|5|||
164675672|NCT01686438|594836806|FG000|Overall Study|Lost to Follow-up|8|||
164675673|NCT01686438|594836807|FG001|Overall Study|Lost to Follow-up|9|||
164675674|NCT01686438|594836808|FG002|Overall Study|Lost to Follow-up|10|||
164675675|NCT01686438|594836806|FG000|Overall Study|Adverse Event|0|||
164675676|NCT01686438|594836807|FG001|Overall Study|Adverse Event|0|||
164675677|NCT01686438|594836808|FG002|Overall Study|Adverse Event|1|||
164675678|NCT01686438|594836806|FG000|Overall Study|Protocol Violation|0|||
164675679|NCT01686438|594836807|FG001|Overall Study|Protocol Violation|0|||
164675680|NCT01686438|594836808|FG002|Overall Study|Protocol Violation|1|||
164675681|NCT01686438|594836806|FG000|Overall Study|Withdrawal by Subject|0|||
164675682|NCT01686438|594836807|FG001|Overall Study|Withdrawal by Subject|0|||
164675683|NCT01686438|594836808|FG002|Overall Study|Withdrawal by Subject|1|||
164675684|NCT00984126|594836809|FG000|Overall Study|Protocol Violation|0|||
164675685|NCT00984126|594836810|FG001|Overall Study|Protocol Violation|0|||
164675686|NCT00984126|594836811|FG002|Overall Study|Protocol Violation|1|||
164675687|NCT00984126|594836812|FG003|Overall Study|Protocol Violation|2|||
164675688|NCT00984126|594836809|FG000|Overall Study|Adverse Event|0|||
164675689|NCT00984126|594836810|FG001|Overall Study|Adverse Event|0|||
164675690|NCT00984126|594836811|FG002|Overall Study|Adverse Event|0|||
164675691|NCT00984126|594836812|FG003|Overall Study|Adverse Event|2|||
164675692|NCT00984126|594836809|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
164675693|NCT00984126|594836810|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
164675694|NCT00984126|594836811|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
164675695|NCT00984126|594836812|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
164675696|NCT00984126|594836809|FG000|Overall Study|Withdrawal criteria|0|||
164675697|NCT00984126|594836810|FG001|Overall Study|Withdrawal criteria|1|||
164675698|NCT00984126|594836811|FG002|Overall Study|Withdrawal criteria|3|||
164675699|NCT00984126|594836812|FG003|Overall Study|Withdrawal criteria|9|||
164675700|NCT01029340|594836815|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
164675701|NCT01029340|594836816|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
164675702|NCT01029340|594836817|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
164675703|NCT01029340|594836818|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
164675704|NCT01029340|594836819|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
164675705|NCT01029340|594836820|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
164675706|NCT01029340|594836815|FG000|Part B Treatment Period|Protocol Violation|0|||
164675707|NCT01029340|594836816|FG001|Part B Treatment Period|Protocol Violation|0|||
164675708|NCT01029340|594836817|FG002|Part B Treatment Period|Protocol Violation|1|||
164675709|NCT01029340|594836818|FG003|Part B Treatment Period|Protocol Violation|0|||
164231414|NCT03396445|593218029|FG003|Switch-over Period|Death|0|||
164231415|NCT03396445|593218030|FG004|Switch-over Period|Death|0|||
164231416|NCT03396445|593218031|FG005|Switch-over Period|Death|0|||
164231417|NCT03396445|593218032|FG006|Switch-over Period|Death|0|||
164231418|NCT03396445|593218033|FG007|Switch-over Period|Death|0|||
164332487|NCT02367131|593595586|FG000|Overall Study|Not treated|2|||
164332488|NCT01051466|593595593|FG000|Overall Study|Adverse Event|1|||
164332489|NCT01051466|593595594|FG001|Overall Study|Adverse Event|0|||
164332490|NCT01051466|593595593|FG000|Overall Study|Lost to Follow-up|1|||
164332491|NCT01051466|593595594|FG001|Overall Study|Lost to Follow-up|1|||
164332492|NCT01051466|593595593|FG000|Overall Study|Withdrawal by Subject|5|||
164332493|NCT01051466|593595594|FG001|Overall Study|Withdrawal by Subject|1|||
164332494|NCT01051466|593595593|FG000|Overall Study|Entry Criteria Not Met|0|||
164332495|NCT01051466|593595594|FG001|Overall Study|Entry Criteria Not Met|3|||
164332496|NCT01051466|593595593|FG000|Overall Study|Physician Decision|1|||
164332497|NCT01051466|593595594|FG001|Overall Study|Physician Decision|0|||
164332498|NCT00810108|593595595|FG000|Overall Study|Withdrawal by Subject|1|||
164332499|NCT00810108|593595596|FG001|Overall Study|Withdrawal by Subject|0|||
164332500|NCT04806503|593595600|FG000|Overall Study|Lost to Follow-up|0|||
164332501|NCT04806503|593595601|FG001|Overall Study|Lost to Follow-up|0|||
164332502|NCT04806503|593595602|FG002|Overall Study|Lost to Follow-up|1|||
164332503|NCT04806503|593595603|FG003|Overall Study|Lost to Follow-up|0|||
164332504|NCT04806503|593595604|FG004|Overall Study|Lost to Follow-up|0|||
164332505|NCT04806503|593595600|FG000|Overall Study|Withdrawal by Subject|1|||
164332506|NCT04806503|593595601|FG001|Overall Study|Withdrawal by Subject|0|||
164332507|NCT04806503|593595602|FG002|Overall Study|Withdrawal by Subject|1|||
164332508|NCT04806503|593595603|FG003|Overall Study|Withdrawal by Subject|1|||
164332509|NCT04806503|593595604|FG004|Overall Study|Withdrawal by Subject|1|||
164332510|NCT04806503|593595600|FG000|Overall Study|Adverse Event|1|||
164332511|NCT04806503|593595601|FG001|Overall Study|Adverse Event|1|||
164332512|NCT04806503|593595602|FG002|Overall Study|Adverse Event|0|||
164332513|NCT04806503|593595603|FG003|Overall Study|Adverse Event|1|||
164332514|NCT04806503|593595604|FG004|Overall Study|Adverse Event|0|||
164332515|NCT03589469|593595605|FG000|Overall Study|Withdrawal by Subject|8|||
164332516|NCT03589469|593595605|FG000|Overall Study|Physician Decision|20|||
164332517|NCT03589469|593595605|FG000|Overall Study|Death|97|||
164332518|NCT03589469|593595605|FG000|Overall Study|Lost to Follow-up|8|||
164332519|NCT03589469|593595605|FG000|Overall Study|Miscellaneous|1|||
164332520|NCT02556203|593595619|FG000|Overall Study|Withdrawal by Subject|21|||
164332521|NCT02556203|593595620|FG001|Overall Study|Withdrawal by Subject|21|||
164332522|NCT02556203|593595619|FG000|Overall Study|Lost to Follow-up|5|||
164332523|NCT02556203|593595620|FG001|Overall Study|Lost to Follow-up|5|||
164332524|NCT02556203|593595619|FG000|Overall Study|Adverse Event|1|||
164332525|NCT02556203|593595620|FG001|Overall Study|Adverse Event|0|||
164332526|NCT02180165|593595625|FG000|Overall Study|Not Treated|0|||
164332527|NCT02180165|593595626|FG001|Overall Study|Not Treated|0|||
164572159|NCT01307423|594460364|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
164231419|NCT03396445|593218034|FG008|Switch-over Period|Death|0|||
164231420|NCT03396445|593218035|FG009|Switch-over Period|Death|0|||
164231421|NCT03396445|593218036|FG010|Switch-over Period|Death|0|||
164231422|NCT03396445|593218037|FG011|Switch-over Period|Death|0|||
164231423|NCT03396445|593218038|FG012|Switch-over Period|Death|0|||
164231424|NCT03396445|593218039|FG013|Switch-over Period|Death|0|||
164231425|NCT03396445|593218040|FG014|Switch-over Period|Death|0|||
164231426|NCT03396445|593218041|FG015|Switch-over Period|Death|0|||
164231427|NCT03396445|593218042|FG016|Switch-over Period|Death|0|||
164231428|NCT03396445|593218043|FG017|Switch-over Period|Death|0|||
164231429|NCT03396445|593218044|FG018|Switch-over Period|Death|1|||
164231430|NCT03396445|593218045|FG019|Switch-over Period|Death|2|||
164332528|NCT02180165|593595627|FG002|Overall Study|Not Treated|1|||
164572160|NCT01307423|594460365|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
164572161|NCT01307423|594460366|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
164572162|NCT01307423|594460367|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
164572163|NCT01307423|594460368|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
164572164|NCT01307423|594460360|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
164231431|NCT03396445|593218046|FG020|Switch-over Period|Death|2|||
164332529|NCT02180165|593595628|FG003|Overall Study|Not Treated|0|||
164332530|NCT02180165|593595625|FG000|Overall Study|Adverse Event|7|||
164231432|NCT03396445|593218047|FG021|Switch-over Period|Death|1|||
164231433|NCT03396445|593218048|FG022|Switch-over Period|Death|2|||
164231434|NCT03396445|593218049|FG023|Switch-over Period|Death|0|||
164332531|NCT02180165|593595626|FG001|Overall Study|Adverse Event|0|||
164332532|NCT02180165|593595627|FG002|Overall Study|Adverse Event|18|||
164332533|NCT02180165|593595628|FG003|Overall Study|Adverse Event|3|||
164231435|NCT03396445|593218050|FG024|Switch-over Period|Death|1|||
164231436|NCT03396445|593218051|FG025|Switch-over Period|Death|6|||
164332534|NCT02180165|593595625|FG000|Overall Study|Lack of Efficacy|0|||
164332535|NCT02180165|593595626|FG001|Overall Study|Lack of Efficacy|1|||
164231437|NCT03396445|593218026|FG000|Switch-over Period|Lost to Follow-up|0|||
164231438|NCT03396445|593218027|FG001|Switch-over Period|Lost to Follow-up|0|||
164332536|NCT02180165|593595627|FG002|Overall Study|Lack of Efficacy|3|||
164421938|NCT02601937|593914567|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
164421939|NCT02601937|593914568|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
164421940|NCT02601937|593914569|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
164421941|NCT02601937|593914570|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
164421942|NCT02601937|593914571|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
164421943|NCT02601937|593914572|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
164421944|NCT02601937|593914573|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
164421945|NCT02601937|593914574|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
164421946|NCT02601937|593914564|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
164421947|NCT02601937|593914565|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
164421948|NCT02601937|593914566|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
164421949|NCT02601937|593914567|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
164421950|NCT02601937|593914568|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
164421951|NCT02601937|593914569|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
164421952|NCT02601937|593914570|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
164421953|NCT02601937|593914571|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
164421954|NCT02601937|593914572|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
164421955|NCT02601937|593914573|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
164421956|NCT02601937|593914574|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
164421957|NCT02601937|593914564|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
164421958|NCT02601937|593914565|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
164421959|NCT02601937|593914566|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
164421960|NCT02601937|593914567|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
164421961|NCT02601937|593914568|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
164421962|NCT02601937|593914569|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
164421963|NCT02601937|593914570|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
164421964|NCT02601937|593914571|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
164421965|NCT02601937|593914572|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
164421966|NCT02601937|593914573|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
164421967|NCT02601937|593914574|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
164421968|NCT02601937|593914564|FG000|Period 2: Dose Expansion Cohort|Other|0|||
164421969|NCT02601937|593914565|FG001|Period 2: Dose Expansion Cohort|Other|0|||
164421970|NCT02601937|593914566|FG002|Period 2: Dose Expansion Cohort|Other|0|||
164421971|NCT02601937|593914567|FG003|Period 2: Dose Expansion Cohort|Other|0|||
164421972|NCT02601937|593914568|FG004|Period 2: Dose Expansion Cohort|Other|0|||
164421973|NCT02601937|593914569|FG005|Period 2: Dose Expansion Cohort|Other|0|||
164421974|NCT02601937|593914570|FG006|Period 2: Dose Expansion Cohort|Other|0|||
164421975|NCT02601937|593914571|FG007|Period 2: Dose Expansion Cohort|Other|0|||
164421976|NCT02601937|593914572|FG008|Period 2: Dose Expansion Cohort|Other|2|||
164572165|NCT01307423|594460361|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
164572166|NCT01307423|594460362|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
164572167|NCT01307423|594460363|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
164572168|NCT01307423|594460364|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
164572169|NCT01307423|594460365|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
164572170|NCT01307423|594460366|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
164572171|NCT01307423|594460367|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
164572172|NCT01307423|594460368|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
164572173|NCT01307423|594460360|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
164572174|NCT01307423|594460361|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
164572175|NCT01307423|594460362|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
164572176|NCT01307423|594460363|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
164572177|NCT01307423|594460364|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
164572178|NCT01307423|594460365|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
164572179|NCT01307423|594460366|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
164572180|NCT01307423|594460367|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
164572181|NCT01307423|594460368|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
164572182|NCT01307423|594460360|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
164572183|NCT01307423|594460361|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
164572184|NCT01307423|594460362|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
164572185|NCT01307423|594460363|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
164572186|NCT01307423|594460364|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
164421977|NCT02601937|593914573|FG009|Period 2: Dose Expansion Cohort|Other|2|||
164421978|NCT02601937|593914574|FG010|Period 2: Dose Expansion Cohort|Other|0|||
164421979|NCT02601937|593914564|FG000|Period 2: Dose Expansion Cohort|Death|0|||
164421980|NCT02601937|593914565|FG001|Period 2: Dose Expansion Cohort|Death|0|||
164421981|NCT02601937|593914566|FG002|Period 2: Dose Expansion Cohort|Death|0|||
164421982|NCT02601937|593914567|FG003|Period 2: Dose Expansion Cohort|Death|0|||
164421983|NCT02601937|593914568|FG004|Period 2: Dose Expansion Cohort|Death|0|||
164421984|NCT02601937|593914569|FG005|Period 2: Dose Expansion Cohort|Death|0|||
164421985|NCT02601937|593914570|FG006|Period 2: Dose Expansion Cohort|Death|0|||
164421986|NCT02601937|593914571|FG007|Period 2: Dose Expansion Cohort|Death|0|||
164421987|NCT02601937|593914572|FG008|Period 2: Dose Expansion Cohort|Death|1|||
164421988|NCT02601937|593914573|FG009|Period 2: Dose Expansion Cohort|Death|0|||
164421989|NCT02601937|593914574|FG010|Period 2: Dose Expansion Cohort|Death|0|||
164421990|NCT04145349|593916241|FG000|Overall Study|Withdrawal by Subject|3|||
164421991|NCT04145349|593916242|FG001|Overall Study|Withdrawal by Subject|0|||
164421992|NCT04145349|593916241|FG000|Overall Study|Lost to Follow-up|0|||
164421993|NCT04145349|593916242|FG001|Overall Study|Lost to Follow-up|1|||
164421994|NCT04145349|593916241|FG000|Overall Study|On study treatment (Ongoing)|0|||
164421995|NCT04145349|593916242|FG001|Overall Study|On study treatment (Ongoing)|1|||
164421996|NCT03280563|593916244|FG000|Stage 1|Death|2|||
164421997|NCT03280563|593916245|FG001|Stage 1|Death|1|||
164421998|NCT03280563|593916246|FG002|Stage 1|Death|0|||
164421999|NCT03280563|593916247|FG003|Stage 1|Death|0|||
164422000|NCT03280563|593916248|FG004|Stage 1|Death|0|||
164422001|NCT03280563|593916249|FG005|Stage 1|Death|3|||
164422002|NCT03280563|593916250|FG006|Stage 1|Death|0|||
164422003|NCT03280563|593916251|FG007|Stage 1|Death|0|||
164422004|NCT03280563|593916252|FG008|Stage 1|Death|0|||
164422005|NCT03280563|593916244|FG000|Stage 1|Study Ended by Sponsor|0|||
164422006|NCT03280563|593916245|FG001|Stage 1|Study Ended by Sponsor|0|||
164422007|NCT03280563|593916246|FG002|Stage 1|Study Ended by Sponsor|1|||
164422008|NCT03280563|593916247|FG003|Stage 1|Study Ended by Sponsor|0|||
164422009|NCT03280563|593916248|FG004|Stage 1|Study Ended by Sponsor|0|||
164422010|NCT03280563|593916249|FG005|Stage 1|Study Ended by Sponsor|1|||
164422011|NCT03280563|593916250|FG006|Stage 1|Study Ended by Sponsor|0|||
164422012|NCT03280563|593916251|FG007|Stage 1|Study Ended by Sponsor|0|||
164422013|NCT03280563|593916252|FG008|Stage 1|Study Ended by Sponsor|0|||
164422014|NCT03280563|593916244|FG000|Stage 1|Withdrawal by Subject|5|||
164422015|NCT03280563|593916245|FG001|Stage 1|Withdrawal by Subject|1|||
164422016|NCT03280563|593916246|FG002|Stage 1|Withdrawal by Subject|2|||
164422017|NCT03280563|593916247|FG003|Stage 1|Withdrawal by Subject|0|||
164422018|NCT03280563|593916248|FG004|Stage 1|Withdrawal by Subject|0|||
164422019|NCT03280563|593916249|FG005|Stage 1|Withdrawal by Subject|2|||
164422020|NCT03280563|593916250|FG006|Stage 1|Withdrawal by Subject|0|||
164422021|NCT03280563|593916251|FG007|Stage 1|Withdrawal by Subject|0|||
164422022|NCT03280563|593916252|FG008|Stage 1|Withdrawal by Subject|0|||
164422023|NCT03280563|593916244|FG000|Stage 1|Reason Not Specified|0|||
164422024|NCT03280563|593916245|FG001|Stage 1|Reason Not Specified|0|||
164422025|NCT03280563|593916246|FG002|Stage 1|Reason Not Specified|0|||
164422026|NCT03280563|593916247|FG003|Stage 1|Reason Not Specified|0|||
164422027|NCT03280563|593916248|FG004|Stage 1|Reason Not Specified|0|||
164422028|NCT03280563|593916249|FG005|Stage 1|Reason Not Specified|1|||
164422029|NCT03280563|593916250|FG006|Stage 1|Reason Not Specified|0|||
164422030|NCT03280563|593916251|FG007|Stage 1|Reason Not Specified|0|||
164422031|NCT03280563|593916252|FG008|Stage 1|Reason Not Specified|0|||
164422032|NCT03280563|593916244|FG000|Stage 1|Physician Decision|0|||
164422033|NCT03280563|593916245|FG001|Stage 1|Physician Decision|1|||
164422034|NCT03280563|593916246|FG002|Stage 1|Physician Decision|0|||
164422035|NCT03280563|593916247|FG003|Stage 1|Physician Decision|0|||
164422036|NCT03280563|593916248|FG004|Stage 1|Physician Decision|0|||
164422037|NCT03280563|593916249|FG005|Stage 1|Physician Decision|0|||
164422038|NCT03280563|593916250|FG006|Stage 1|Physician Decision|0|||
164422039|NCT03280563|593916251|FG007|Stage 1|Physician Decision|0|||
164422040|NCT03280563|593916252|FG008|Stage 1|Physician Decision|0|||
164422041|NCT03280563|593916244|FG000|Stage 2|Death|0|||
164422042|NCT03280563|593916245|FG001|Stage 2|Death|0|||
164422043|NCT03280563|593916246|FG002|Stage 2|Death|0|||
164422044|NCT03280563|593916247|FG003|Stage 2|Death|0|||
164422045|NCT03280563|593916248|FG004|Stage 2|Death|0|||
164422046|NCT03280563|593916249|FG005|Stage 2|Death|0|||
164422047|NCT03280563|593916250|FG006|Stage 2|Death|0|||
164422048|NCT03280563|593916251|FG007|Stage 2|Death|1|||
164422049|NCT03280563|593916252|FG008|Stage 2|Death|0|||
164422050|NCT03280563|593916244|FG000|Stage 2|Progressive Disease|0|||
164422051|NCT03280563|593916245|FG001|Stage 2|Progressive Disease|0|||
164422052|NCT03280563|593916246|FG002|Stage 2|Progressive Disease|0|||
164422053|NCT03280563|593916247|FG003|Stage 2|Progressive Disease|0|||
164422054|NCT03280563|593916248|FG004|Stage 2|Progressive Disease|0|||
164422055|NCT03280563|593916249|FG005|Stage 2|Progressive Disease|0|||
164422056|NCT03280563|593916250|FG006|Stage 2|Progressive Disease|2|||
164422057|NCT03280563|593916251|FG007|Stage 2|Progressive Disease|0|||
164422058|NCT03280563|593916252|FG008|Stage 2|Progressive Disease|0|||
164422059|NCT03280563|593916244|FG000|Long-term Survival Follow-up|Death|10|||
164422060|NCT03280563|593916245|FG001|Long-term Survival Follow-up|Death|14|||
164422061|NCT03280563|593916246|FG002|Long-term Survival Follow-up|Death|15|||
164422062|NCT03280563|593916247|FG003|Long-term Survival Follow-up|Death|3|||
164422063|NCT03280563|593916248|FG004|Long-term Survival Follow-up|Death|6|||
164422064|NCT03280563|593916249|FG005|Long-term Survival Follow-up|Death|18|||
164422065|NCT03280563|593916250|FG006|Long-term Survival Follow-up|Death|11|||
164422066|NCT03280563|593916251|FG007|Long-term Survival Follow-up|Death|1|||
164422067|NCT03280563|593916252|FG008|Long-term Survival Follow-up|Death|3|||
164422068|NCT03280563|593916244|FG000|Long-term Survival Follow-up|Study Ended by Sponsor|4|||
164422069|NCT03280563|593916245|FG001|Long-term Survival Follow-up|Study Ended by Sponsor|9|||
164422070|NCT03280563|593916246|FG002|Long-term Survival Follow-up|Study Ended by Sponsor|3|||
164422071|NCT03280563|593916247|FG003|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
164422072|NCT03280563|593916248|FG004|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
164422073|NCT03280563|593916249|FG005|Long-term Survival Follow-up|Study Ended by Sponsor|13|||
164422074|NCT03280563|593916250|FG006|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
164422075|NCT03280563|593916251|FG007|Long-term Survival Follow-up|Study Ended by Sponsor|2|||
164422076|NCT03280563|593916252|FG008|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
164422077|NCT03280563|593916244|FG000|Long-term Survival Follow-up|Withdrawal by Subject|1|||
164422078|NCT03280563|593916245|FG001|Long-term Survival Follow-up|Withdrawal by Subject|1|||
164422079|NCT03280563|593916246|FG002|Long-term Survival Follow-up|Withdrawal by Subject|1|||
164422080|NCT03280563|593916247|FG003|Long-term Survival Follow-up|Withdrawal by Subject|0|||
164422081|NCT03280563|593916248|FG004|Long-term Survival Follow-up|Withdrawal by Subject|1|||
164422082|NCT03280563|593916249|FG005|Long-term Survival Follow-up|Withdrawal by Subject|0|||
164422083|NCT03280563|593916250|FG006|Long-term Survival Follow-up|Withdrawal by Subject|0|||
164422084|NCT03280563|593916251|FG007|Long-term Survival Follow-up|Withdrawal by Subject|0|||
164422085|NCT03280563|593916252|FG008|Long-term Survival Follow-up|Withdrawal by Subject|0|||
164422086|NCT03280563|593916244|FG000|Long-term Survival Follow-up|Lost to Follow-up|0|||
164422087|NCT03280563|593916245|FG001|Long-term Survival Follow-up|Lost to Follow-up|1|||
164422088|NCT03280563|593916246|FG002|Long-term Survival Follow-up|Lost to Follow-up|1|||
164422089|NCT03280563|593916247|FG003|Long-term Survival Follow-up|Lost to Follow-up|0|||
164422090|NCT03280563|593916248|FG004|Long-term Survival Follow-up|Lost to Follow-up|2|||
164422091|NCT03280563|593916249|FG005|Long-term Survival Follow-up|Lost to Follow-up|1|||
164422092|NCT03280563|593916250|FG006|Long-term Survival Follow-up|Lost to Follow-up|0|||
164422093|NCT03280563|593916251|FG007|Long-term Survival Follow-up|Lost to Follow-up|0|||
164422094|NCT03280563|593916252|FG008|Long-term Survival Follow-up|Lost to Follow-up|0|||
164422095|NCT03038672|593916253|FG000|Initial Treatment|Unacceptable chemistry|0|||
164422096|NCT03038672|593916254|FG001|Initial Treatment|Unacceptable chemistry|1|||
164422097|NCT03038672|593916253|FG000|Initial Treatment|Progression prior to treatment|1|||
164422098|NCT03038672|593916254|FG001|Initial Treatment|Progression prior to treatment|0|||
164422099|NCT03038672|593916253|FG000|Initial Treatment|No treatment per protocol|1|||
164422100|NCT03038672|593916254|FG001|Initial Treatment|No treatment per protocol|0|||
164422101|NCT04423393|593916255|FG000|Overall Study|Withdrawal by Subject|0|||
164422102|NCT04423393|593916256|FG001|Overall Study|Withdrawal by Subject|0|||
164332537|NCT02180165|593595628|FG003|Overall Study|Lack of Efficacy|2|||
164332538|NCT02180165|593595625|FG000|Overall Study|Physician Decision|1|||
164332539|NCT02180165|593595626|FG001|Overall Study|Physician Decision|0|||
164332540|NCT02180165|593595627|FG002|Overall Study|Physician Decision|5|||
164332541|NCT02180165|593595628|FG003|Overall Study|Physician Decision|0|||
164332542|NCT02180165|593595625|FG000|Overall Study|Withdrawal by Subject|3|||
164332543|NCT02180165|593595626|FG001|Overall Study|Withdrawal by Subject|0|||
164332544|NCT02180165|593595627|FG002|Overall Study|Withdrawal by Subject|2|||
164332545|NCT02180165|593595628|FG003|Overall Study|Withdrawal by Subject|1|||
164332546|NCT02943460|593595630|FG000|Blinded Study Phase|Adverse Event|3|||
164332547|NCT02943460|593595631|FG001|Blinded Study Phase|Adverse Event|0|||
164332548|NCT02943460|593595632|FG002|Blinded Study Phase|Adverse Event|0|||
164332549|NCT02943460|593595630|FG000|Blinded Study Phase|Withdrew Consent|0|||
164332550|NCT02943460|593595631|FG001|Blinded Study Phase|Withdrew Consent|1|||
164332551|NCT02943460|593595632|FG002|Blinded Study Phase|Withdrew Consent|0|||
164332552|NCT02943460|593595630|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
164332553|NCT02943460|593595631|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
164332554|NCT02943460|593595632|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
164332555|NCT02943460|593595630|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
164332556|NCT02943460|593595631|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
164332557|NCT02943460|593595632|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
164332558|NCT02943460|593595630|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
164332559|NCT02943460|593595631|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
164332560|NCT02943460|593595632|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
164332561|NCT00369122|593595633|FG000|Overall Study|Ineligible|10|||
164332562|NCT00369122|593595633|FG000|Overall Study|No protocol treatment|1|||
164332563|NCT04171765|593595634|FG000|Overall Study|Adverse Event|2|||
164422103|NCT04423393|593916257|FG002|Overall Study|Withdrawal by Subject|0|||
164332564|NCT04171765|593595635|FG001|Overall Study|Adverse Event|0|||
164332565|NCT04171765|593595636|FG002|Overall Study|Adverse Event|1|||
164332566|NCT04171765|593595637|FG003|Overall Study|Adverse Event|0|||
164422104|NCT04423393|593916258|FG003|Overall Study|Withdrawal by Subject|0|||
164422105|NCT04423393|593916259|FG004|Overall Study|Withdrawal by Subject|0|||
164422106|NCT04423393|593916260|FG005|Overall Study|Withdrawal by Subject|1|||
164422107|NCT04423393|593916261|FG006|Overall Study|Withdrawal by Subject|0|||
164422108|NCT04423393|593916262|FG007|Overall Study|Withdrawal by Subject|0|||
164422109|NCT04423393|593916263|FG008|Overall Study|Withdrawal by Subject|0|||
164422110|NCT04423393|593916264|FG009|Overall Study|Withdrawal by Subject|0|||
164422111|NCT04423393|593916265|FG010|Overall Study|Withdrawal by Subject|0|||
164422112|NCT04423393|593916266|FG011|Overall Study|Withdrawal by Subject|0|||
164422113|NCT04423393|593916267|FG012|Overall Study|Withdrawal by Subject|0|||
164422114|NCT04423393|593916268|FG013|Overall Study|Withdrawal by Subject|1|||
164422115|NCT04423393|593916269|FG014|Overall Study|Withdrawal by Subject|0|||
164422116|NCT04423393|593916270|FG015|Overall Study|Withdrawal by Subject|0|||
164422117|NCT04423393|593916271|FG016|Overall Study|Withdrawal by Subject|0|||
164422118|NCT04423393|593916272|FG017|Overall Study|Withdrawal by Subject|0|||
164422119|NCT04423393|593916255|FG000|Overall Study|Sponsor Decision|0|||
164422120|NCT04423393|593916256|FG001|Overall Study|Sponsor Decision|0|||
164422121|NCT04423393|593916257|FG002|Overall Study|Sponsor Decision|0|||
164422122|NCT04423393|593916258|FG003|Overall Study|Sponsor Decision|0|||
164422123|NCT04423393|593916259|FG004|Overall Study|Sponsor Decision|0|||
164422124|NCT04423393|593916260|FG005|Overall Study|Sponsor Decision|0|||
164422125|NCT04423393|593916261|FG006|Overall Study|Sponsor Decision|0|||
164422126|NCT04423393|593916262|FG007|Overall Study|Sponsor Decision|0|||
164422127|NCT04423393|593916263|FG008|Overall Study|Sponsor Decision|0|||
164422128|NCT04423393|593916264|FG009|Overall Study|Sponsor Decision|0|||
164422129|NCT04423393|593916265|FG010|Overall Study|Sponsor Decision|0|||
164422130|NCT04423393|593916266|FG011|Overall Study|Sponsor Decision|0|||
164422131|NCT04423393|593916267|FG012|Overall Study|Sponsor Decision|0|||
164422132|NCT04423393|593916268|FG013|Overall Study|Sponsor Decision|1|||
164422133|NCT04423393|593916269|FG014|Overall Study|Sponsor Decision|0|||
164422134|NCT04423393|593916270|FG015|Overall Study|Sponsor Decision|0|||
164422135|NCT04423393|593916271|FG016|Overall Study|Sponsor Decision|0|||
164422136|NCT04423393|593916272|FG017|Overall Study|Sponsor Decision|0|||
164422137|NCT00432159|593916273|FG000|Overall Study|Death|0|||
164422138|NCT00432159|593916274|FG001|Overall Study|Death|1|||
164422139|NCT00432159|593916275|FG002|Overall Study|Death|0|||
164422140|NCT00432159|593916276|FG003|Overall Study|Death|0|||
164422141|NCT00432159|593916277|FG004|Overall Study|Death|0|||
164422142|NCT00432159|593916273|FG000|Overall Study|Failure|9|||
164422143|NCT00432159|593916274|FG001|Overall Study|Failure|5|||
164422144|NCT00432159|593916275|FG002|Overall Study|Failure|3|||
164422145|NCT00432159|593916276|FG003|Overall Study|Failure|2|||
164422146|NCT00432159|593916277|FG004|Overall Study|Failure|3|||
164572187|NCT01307423|594460365|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
164572188|NCT01307423|594460366|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
164572189|NCT01307423|594460367|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
164572190|NCT01307423|594460368|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
164572191|NCT01307423|594460360|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
164572192|NCT01307423|594460361|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
164572193|NCT01307423|594460362|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
164572194|NCT01307423|594460363|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
164572195|NCT01307423|594460364|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
164572196|NCT01307423|594460365|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
164572197|NCT01307423|594460366|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
164572198|NCT01307423|594460367|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
164572199|NCT01307423|594460368|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
164572200|NCT01307423|594460360|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
164572201|NCT01307423|594460361|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
164572202|NCT01307423|594460362|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
164675710|NCT01029340|594836819|FG004|Part B Treatment Period|Protocol Violation|0|||
164422147|NCT00432159|593916273|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
164422148|NCT00432159|593916274|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
164572203|NCT01307423|594460363|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
164422149|NCT00432159|593916275|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
164422150|NCT00432159|593916276|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
164422151|NCT00432159|593916277|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
164422152|NCT01929993|593916279|FG000|Overall Study|Protocol Violation|4|||
164422153|NCT01929993|593916280|FG001|Overall Study|Protocol Violation|6|||
164422154|NCT01929993|593916279|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
164422155|NCT01929993|593916280|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
164422156|NCT00107380|593916281|FG000|Overall Study|Adverse Event|7|||
164422157|NCT00107380|593916281|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
164422158|NCT00107380|593916281|FG000|Overall Study|Progression/relapse|4|||
164422159|NCT00107380|593916281|FG000|Overall Study|Death|3|||
164572204|NCT01307423|594460364|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
164422160|NCT00107380|593916281|FG000|Overall Study|Other - not protocol specified|7|||
164572205|NCT01307423|594460365|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
164572206|NCT01307423|594460366|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
164572207|NCT01307423|594460367|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
164572208|NCT01307423|594460368|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
164572209|NCT01307423|594460360|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
164572210|NCT01307423|594460361|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
164572211|NCT01307423|594460362|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
164572212|NCT01307423|594460363|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
164572213|NCT01307423|594460364|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
164572214|NCT01307423|594460365|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
164572215|NCT01307423|594460366|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
164675711|NCT01029340|594836820|FG005|Part B Treatment Period|Protocol Violation|0|||
164675712|NCT01029340|594836815|FG000|Extension Period|Adverse Event|0|||
164231439|NCT03396445|593218028|FG002|Switch-over Period|Lost to Follow-up|0|||
164231440|NCT03396445|593218029|FG003|Switch-over Period|Lost to Follow-up|0|||
164231441|NCT03396445|593218030|FG004|Switch-over Period|Lost to Follow-up|0|||
164231442|NCT03396445|593218031|FG005|Switch-over Period|Lost to Follow-up|0|||
164231443|NCT03396445|593218032|FG006|Switch-over Period|Lost to Follow-up|0|||
164231444|NCT03396445|593218033|FG007|Switch-over Period|Lost to Follow-up|0|||
164231445|NCT03396445|593218034|FG008|Switch-over Period|Lost to Follow-up|0|||
164231446|NCT03396445|593218035|FG009|Switch-over Period|Lost to Follow-up|0|||
164231447|NCT03396445|593218036|FG010|Switch-over Period|Lost to Follow-up|0|||
164231448|NCT03396445|593218037|FG011|Switch-over Period|Lost to Follow-up|0|||
164231449|NCT03396445|593218038|FG012|Switch-over Period|Lost to Follow-up|0|||
164231450|NCT03396445|593218039|FG013|Switch-over Period|Lost to Follow-up|0|||
164231451|NCT03396445|593218040|FG014|Switch-over Period|Lost to Follow-up|0|||
164231452|NCT03396445|593218041|FG015|Switch-over Period|Lost to Follow-up|0|||
164231453|NCT03396445|593218042|FG016|Switch-over Period|Lost to Follow-up|0|||
164299729|NCT03104868|593472916|FG001|6 Month Follow up|Death|1|||
164299730|NCT03104868|593472915|FG000|6 Month Follow up|Completed Later Timepoint|22|||
164299731|NCT03104868|593472916|FG001|6 Month Follow up|Completed Later Timepoint|32|||
164299732|NCT03104868|593472915|FG000|12 Month Follow up|Lost to Follow-up|1|||
164299733|NCT03104868|593472916|FG001|12 Month Follow up|Lost to Follow-up|2|||
164299734|NCT03104868|593472915|FG000|12 Month Follow up|Death|0|||
164299735|NCT03104868|593472916|FG001|12 Month Follow up|Death|1|||
164299736|NCT03104868|593472915|FG000|12 Month Follow up|Withdrawal by Subject|0|||
164299737|NCT03104868|593472916|FG001|12 Month Follow up|Withdrawal by Subject|3|||
164299738|NCT03104868|593472915|FG000|12 Month Follow up|Completed Later Timepoint|32|||
164299739|NCT03104868|593472916|FG001|12 Month Follow up|Completed Later Timepoint|29|||
164299740|NCT03104868|593472915|FG000|18 Month Follow up|Lost to Follow-up|7|||
164299741|NCT03104868|593472916|FG001|18 Month Follow up|Lost to Follow-up|11|||
164299742|NCT03104868|593472915|FG000|18 Month Follow up|Death|2|||
164299743|NCT03104868|593472916|FG001|18 Month Follow up|Death|1|||
164299744|NCT03104868|593472915|FG000|18 Month Follow up|Withdrawal by Subject|1|||
164299745|NCT03104868|593472916|FG001|18 Month Follow up|Withdrawal by Subject|2|||
164299746|NCT03104868|593472915|FG000|18 Month Follow up|Graft Loss|1|||
164299747|NCT03104868|593472916|FG001|18 Month Follow up|Graft Loss|1|||
164299748|NCT03104868|593472915|FG000|18 Month Follow up|Completed Later Timepoint|19|||
164299749|NCT03104868|593472916|FG001|18 Month Follow up|Completed Later Timepoint|20|||
164299750|NCT03104868|593472915|FG000|24 Month Follow up|Lost to Follow-up|15|||
164299751|NCT03104868|593472916|FG001|24 Month Follow up|Lost to Follow-up|16|||
164299752|NCT03104868|593472915|FG000|24 Month Follow up|Death|3|||
164299753|NCT03104868|593472916|FG001|24 Month Follow up|Death|2|||
164299754|NCT03104868|593472915|FG000|24 Month Follow up|Withdrawal by Subject|1|||
164299755|NCT03104868|593472916|FG001|24 Month Follow up|Withdrawal by Subject|0|||
164299756|NCT03104868|593472915|FG000|24 Month Follow up|Graft Loss|2|||
164299757|NCT03104868|593472916|FG001|24 Month Follow up|Graft Loss|0|||
164299758|NCT02059278|593472920|FG000|Overall Study|Adverse Event|1|||
164299759|NCT02059278|593472921|FG001|Overall Study|Adverse Event|1|||
164299760|NCT02059278|593472920|FG000|Overall Study|Lost to Follow-up|1|||
164299761|NCT02059278|593472921|FG001|Overall Study|Lost to Follow-up|0|||
164299762|NCT02059278|593472920|FG000|Overall Study|Withdrawal by Subject|0|||
164299763|NCT02059278|593472921|FG001|Overall Study|Withdrawal by Subject|3|||
164299764|NCT02059278|593472920|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
164299765|NCT02059278|593472921|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
164299766|NCT00888173|593472922|FG000|Overall Study|Wrong Primary|1|||
164299767|NCT00888173|593472922|FG000|Overall Study|Ineligible: required test not done|1|||
164299768|NCT01488890|593472923|FG000|Overall Study|Serious adverse event|2|||
164299769|NCT01488890|593472924|FG001|Overall Study|Serious adverse event|0|||
164299770|NCT01488890|593472925|FG002|Overall Study|Serious adverse event|0|||
164299771|NCT01488890|593472926|FG003|Overall Study|Serious adverse event|0|||
164332567|NCT04171765|593595634|FG000|Overall Study|Lost to Follow-up|0|||
164332568|NCT04171765|593595635|FG001|Overall Study|Lost to Follow-up|2|||
164332569|NCT04171765|593595636|FG002|Overall Study|Lost to Follow-up|2|||
164332570|NCT04171765|593595637|FG003|Overall Study|Lost to Follow-up|2|||
164332571|NCT04171765|593595634|FG000|Overall Study|Week 58 visit missed|0|||
164332572|NCT04171765|593595635|FG001|Overall Study|Week 58 visit missed|0|||
164332573|NCT04171765|593595636|FG002|Overall Study|Week 58 visit missed|1|||
164332574|NCT04171765|593595637|FG003|Overall Study|Week 58 visit missed|0|||
164332575|NCT04171765|593595634|FG000|Overall Study|Study terminated by sponsor|2|||
164332576|NCT04171765|593595635|FG001|Overall Study|Study terminated by sponsor|0|||
164332577|NCT04171765|593595636|FG002|Overall Study|Study terminated by sponsor|0|||
164332578|NCT04171765|593595637|FG003|Overall Study|Study terminated by sponsor|0|||
164332579|NCT04171765|593595634|FG000|Overall Study|Withdrawal by Subject|1|||
164332580|NCT04171765|593595635|FG001|Overall Study|Withdrawal by Subject|0|||
164332581|NCT04171765|593595636|FG002|Overall Study|Withdrawal by Subject|0|||
164332582|NCT04171765|593595637|FG003|Overall Study|Withdrawal by Subject|3|||
164332583|NCT03633617|593595638|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
164332584|NCT03633617|593595639|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
164332585|NCT03633617|593595640|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
164332586|NCT03633617|593595641|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
164332587|NCT03633617|593595642|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
164332588|NCT03633617|593595643|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
164332589|NCT03633617|593595644|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
164332590|NCT03633617|593595645|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
164332591|NCT03633617|593595646|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
164332592|NCT03633617|593595647|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
164332593|NCT03633617|593595648|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
164332594|NCT03633617|593595638|FG000|Part A|Unconfirmed early termination visit|1|||
164332595|NCT03633617|593595639|FG001|Part A|Unconfirmed early termination visit|0|||
164332596|NCT03633617|593595640|FG002|Part A|Unconfirmed early termination visit|0|||
164332597|NCT03633617|593595641|FG003|Part A|Unconfirmed early termination visit|0|||
164332598|NCT03633617|593595642|FG004|Part A|Unconfirmed early termination visit|0|||
164332599|NCT03633617|593595643|FG005|Part A|Unconfirmed early termination visit|0|||
164332600|NCT03633617|593595644|FG006|Part A|Unconfirmed early termination visit|0|||
164332601|NCT03633617|593595645|FG007|Part A|Unconfirmed early termination visit|0|||
164332602|NCT03633617|593595646|FG008|Part A|Unconfirmed early termination visit|0|||
164332603|NCT03633617|593595647|FG009|Part A|Unconfirmed early termination visit|0|||
164332604|NCT03633617|593595648|FG010|Part A|Unconfirmed early termination visit|0|||
164332605|NCT03633617|593595638|FG000|Part A|Adverse Event|0|||
164332606|NCT03633617|593595639|FG001|Part A|Adverse Event|1|||
164332607|NCT03633617|593595640|FG002|Part A|Adverse Event|0|||
164332608|NCT03633617|593595641|FG003|Part A|Adverse Event|0|||
164332609|NCT03633617|593595642|FG004|Part A|Adverse Event|0|||
164332610|NCT03633617|593595643|FG005|Part A|Adverse Event|0|||
164332611|NCT03633617|593595644|FG006|Part A|Adverse Event|0|||
164332612|NCT03633617|593595645|FG007|Part A|Adverse Event|0|||
164332613|NCT03633617|593595646|FG008|Part A|Adverse Event|0|||
164332614|NCT03633617|593595647|FG009|Part A|Adverse Event|0|||
164332615|NCT03633617|593595648|FG010|Part A|Adverse Event|0|||
164332616|NCT03633617|593595638|FG000|Part A|Pregnancy|1|||
164332617|NCT03633617|593595639|FG001|Part A|Pregnancy|0|||
164332618|NCT03633617|593595640|FG002|Part A|Pregnancy|0|||
164332619|NCT03633617|593595641|FG003|Part A|Pregnancy|0|||
164332620|NCT03633617|593595642|FG004|Part A|Pregnancy|0|||
164332621|NCT03633617|593595643|FG005|Part A|Pregnancy|0|||
164332622|NCT03633617|593595644|FG006|Part A|Pregnancy|0|||
164332623|NCT03633617|593595645|FG007|Part A|Pregnancy|0|||
164332624|NCT03633617|593595646|FG008|Part A|Pregnancy|0|||
164332625|NCT03633617|593595647|FG009|Part A|Pregnancy|0|||
164332626|NCT03633617|593595648|FG010|Part A|Pregnancy|0|||
164332627|NCT03633617|593595638|FG000|Part A|Withdrawal by Subject|0|||
164332628|NCT03633617|593595639|FG001|Part A|Withdrawal by Subject|1|||
164332629|NCT03633617|593595640|FG002|Part A|Withdrawal by Subject|0|||
164332630|NCT03633617|593595641|FG003|Part A|Withdrawal by Subject|0|||
164422161|NCT00107380|593916281|FG000|Overall Study|Ineligible|2|||
164422162|NCT03673098|593916282|FG000|Overall Study|Lost to Follow-up|2|||
164332631|NCT03633617|593595642|FG004|Part A|Withdrawal by Subject|0|||
164332632|NCT03633617|593595643|FG005|Part A|Withdrawal by Subject|0|||
164332633|NCT03633617|593595644|FG006|Part A|Withdrawal by Subject|0|||
164332634|NCT03633617|593595645|FG007|Part A|Withdrawal by Subject|0|||
164332635|NCT03633617|593595646|FG008|Part A|Withdrawal by Subject|0|||
164332636|NCT03633617|593595647|FG009|Part A|Withdrawal by Subject|0|||
164332637|NCT03633617|593595648|FG010|Part A|Withdrawal by Subject|0|||
164332638|NCT03633617|593595638|FG000|Part B|Adverse Event|0|||
164332639|NCT03633617|593595639|FG001|Part B|Adverse Event|0|||
164332640|NCT03633617|593595640|FG002|Part B|Adverse Event|2|||
164422163|NCT03673098|593916283|FG001|Overall Study|Lost to Follow-up|3|||
164572216|NCT01307423|594460367|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
164572217|NCT01307423|594460368|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
164572218|NCT01307423|594460360|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
164572219|NCT01307423|594460361|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
164572220|NCT01307423|594460362|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
164572221|NCT01307423|594460363|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
164572222|NCT01307423|594460364|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
164572223|NCT01307423|594460365|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
164572224|NCT01307423|594460366|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
164572225|NCT01307423|594460367|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
164572226|NCT01307423|594460368|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
164572227|NCT01307423|594460360|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
164572228|NCT01307423|594460361|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
164231454|NCT03396445|593218043|FG017|Switch-over Period|Lost to Follow-up|0|||
164231455|NCT03396445|593218044|FG018|Switch-over Period|Lost to Follow-up|0|||
164422164|NCT03673098|593916282|FG000|Overall Study|Withdrawal by Subject|6|||
164422165|NCT03673098|593916283|FG001|Overall Study|Withdrawal by Subject|1|||
164422166|NCT03673098|593916282|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
164422167|NCT03673098|593916283|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
164422168|NCT03850444|593916284|FG000|Overall Study|Adverse Event|16|||
164422169|NCT03850444|593916285|FG001|Overall Study|Adverse Event|10|||
164422170|NCT03850444|593916284|FG000|Overall Study|Death|87|||
164422171|NCT03850444|593916285|FG001|Overall Study|Death|107|||
164422172|NCT03850444|593916284|FG000|Overall Study|Lost to Follow-up|1|||
164422173|NCT03850444|593916285|FG001|Overall Study|Lost to Follow-up|1|||
164422174|NCT03850444|593916284|FG000|Overall Study|Withdrawal by Subject|1|||
164422175|NCT03850444|593916285|FG001|Overall Study|Withdrawal by Subject|5|||
164422176|NCT03850444|593916284|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
164422177|NCT03850444|593916285|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
164422178|NCT03595683|593916286|FG000|Overall Study|Adverse Event|1|||
164422179|NCT03595683|593916287|FG001|Overall Study|Adverse Event|0|||
164422180|NCT03595683|593916286|FG000|Overall Study|Pursue alternative therapy|1|||
164422181|NCT03595683|593916287|FG001|Overall Study|Pursue alternative therapy|1|||
164422182|NCT03595683|593916286|FG000|Overall Study|Progressive disease|1|||
164422183|NCT03595683|593916287|FG001|Overall Study|Progressive disease|3|||
164422184|NCT01518257|593916290|FG000|Overall Study|Lost to Follow-up|1|||
164422185|NCT01518257|593916291|FG001|Overall Study|Lost to Follow-up|0|||
164422186|NCT01518257|593916290|FG000|Overall Study|Other Miscellaneous Reason|1|||
164422187|NCT01518257|593916291|FG001|Overall Study|Other Miscellaneous Reason|0|||
164422188|NCT01021878|593916293|FG000|Overall Study|Lost to Follow-up|4|||
164422189|NCT01021878|593916294|FG001|Overall Study|Lost to Follow-up|3|||
164422190|NCT01021878|593916293|FG000|Overall Study|Death|0|||
164422191|NCT01021878|593916294|FG001|Overall Study|Death|1|||
164422192|NCT01021878|593916293|FG000|Overall Study|Adverse Event|6|||
164422193|NCT01021878|593916294|FG001|Overall Study|Adverse Event|5|||
164422194|NCT01021878|593916293|FG000|Overall Study|Transplantation|6|||
164422195|NCT01021878|593916294|FG001|Overall Study|Transplantation|1|||
164422196|NCT01155726|593916296|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
164422197|NCT01155726|593916297|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
164422198|NCT01155726|593916298|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
164422199|NCT01155726|593916299|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
164422200|NCT03158948|593916300|FG000|Overall Study|Death|1|||
164422201|NCT03158948|593916301|FG001|Overall Study|Death|1|||
164422202|NCT03158948|593916302|FG002|Overall Study|Death|3|||
164422203|NCT03158948|593916303|FG003|Overall Study|Death|2|||
164422204|NCT03158948|593916300|FG000|Overall Study|Physician Decision|0|||
164422205|NCT03158948|593916301|FG001|Overall Study|Physician Decision|0|||
164422206|NCT03158948|593916302|FG002|Overall Study|Physician Decision|0|||
164422207|NCT03158948|593916303|FG003|Overall Study|Physician Decision|1|||
164422208|NCT05257837|593916307|FG000|Overall Study|Excluded (did not find the guns)|4|||
164422209|NCT05257837|593916308|FG001|Overall Study|Excluded (did not find the guns)|2|||
164422210|NCT05257837|593916309|FG002|Overall Study|Excluded (did not find the guns)|4|||
164422211|NCT05257837|593916310|FG003|Overall Study|Excluded (did not find the guns)|0|||
164422212|NCT05675709|593916313|FG000|Overall Study|incomplete outcome data|2|||
164422213|NCT05675709|593916314|FG001|Overall Study|incomplete outcome data|8|||
164675713|NCT01029340|594836816|FG001|Extension Period|Adverse Event|0|||
164675714|NCT01029340|594836817|FG002|Extension Period|Adverse Event|0|||
164422214|NCT01254565|593916318|FG000|Overall Study|Non-compliance to Study Procedures|0|||
164422215|NCT01254565|593916319|FG001|Overall Study|Non-compliance to Study Procedures|0|||
164422216|NCT01254565|593916320|FG002|Overall Study|Non-compliance to Study Procedures|0|||
164422217|NCT01254565|593916321|FG003|Overall Study|Non-compliance to Study Procedures|0|||
164422218|NCT01254565|593916322|FG004|Overall Study|Non-compliance to Study Procedures|1|||
164422219|NCT01254565|593916323|FG005|Overall Study|Non-compliance to Study Procedures|0|||
164675715|NCT01029340|594836818|FG003|Extension Period|Adverse Event|0|||
164675716|NCT01029340|594836819|FG004|Extension Period|Adverse Event|0|||
164675717|NCT01029340|594836820|FG005|Extension Period|Adverse Event|1|||
164675718|NCT01029340|594836815|FG000|Extension Period|starting another study|0|||
164675719|NCT01029340|594836816|FG001|Extension Period|starting another study|0|||
164675720|NCT01029340|594836817|FG002|Extension Period|starting another study|0|||
164675721|NCT01029340|594836818|FG003|Extension Period|starting another study|0|||
164675722|NCT01029340|594836819|FG004|Extension Period|starting another study|0|||
164231456|NCT03396445|593218045|FG019|Switch-over Period|Lost to Follow-up|0|||
164231457|NCT03396445|593218046|FG020|Switch-over Period|Lost to Follow-up|0|||
164231458|NCT03396445|593218047|FG021|Switch-over Period|Lost to Follow-up|0|||
164231459|NCT03396445|593218048|FG022|Switch-over Period|Lost to Follow-up|0|||
164231460|NCT03396445|593218049|FG023|Switch-over Period|Lost to Follow-up|1|||
164231461|NCT03396445|593218050|FG024|Switch-over Period|Lost to Follow-up|0|||
164231462|NCT03396445|593218051|FG025|Switch-over Period|Lost to Follow-up|0|||
164231463|NCT04123704|593218065|FG000|Overall Study|Disease progression|2|||
164231464|NCT03332056|593218071|FG000|Overall Study|Incomplete questionnaires|8|||
164231465|NCT03332056|593218072|FG001|Overall Study|Incomplete questionnaires|9|||
164231466|NCT03332056|593218071|FG000|Overall Study|Passed stone prior to surgery date|1|||
164231467|NCT03332056|593218072|FG001|Overall Study|Passed stone prior to surgery date|0|||
164231468|NCT03332056|593218071|FG000|Overall Study|Did not require a ureteral stent|0|||
164231469|NCT03332056|593218072|FG001|Overall Study|Did not require a ureteral stent|1|||
164231470|NCT03360344|593218075|FG000|Overall Study|Withdrawal by Subject|0|||
164231471|NCT03360344|593218076|FG001|Overall Study|Withdrawal by Subject|1|||
164231472|NCT03360344|593218077|FG002|Overall Study|Withdrawal by Subject|1|||
164231473|NCT00133705|593218082|FG000|Overall Study|Withdrawal by Subject|2|||
164231474|NCT00133705|593218083|FG001|Overall Study|Withdrawal by Subject|3|||
164231475|NCT00688740|593218094|FG000|Overall Study|Adverse Event|45|||
164231476|NCT00688740|593218095|FG001|Overall Study|Adverse Event|8|||
164231477|NCT00688740|593218094|FG000|Overall Study|Death|2|||
164231478|NCT00688740|593218095|FG001|Overall Study|Death|2|||
164231479|NCT00688740|593218094|FG000|Overall Study|Lost to Follow-up|0|||
164231480|NCT00688740|593218095|FG001|Overall Study|Lost to Follow-up|1|||
164231481|NCT00688740|593218094|FG000|Overall Study|Consent Withdrawn|17|||
164231482|NCT00688740|593218095|FG001|Overall Study|Consent Withdrawn|17|||
164231483|NCT00688740|593218094|FG000|Overall Study|Breast Cancer Relapse|1|||
164231484|NCT00688740|593218095|FG001|Overall Study|Breast Cancer Relapse|4|||
164332641|NCT03633617|593595641|FG003|Part B|Adverse Event|2|||
164332642|NCT03633617|593595642|FG004|Part B|Adverse Event|1|||
164332643|NCT03633617|593595643|FG005|Part B|Adverse Event|0|||
164332644|NCT03633617|593595644|FG006|Part B|Adverse Event|0|||
164332645|NCT03633617|593595645|FG007|Part B|Adverse Event|0|||
164332646|NCT03633617|593595646|FG008|Part B|Adverse Event|0|||
164332647|NCT03633617|593595647|FG009|Part B|Adverse Event|0|||
164332648|NCT03633617|593595648|FG010|Part B|Adverse Event|0|||
164332649|NCT03633617|593595638|FG000|Part B|Withdrawal by Subject|0|||
164332650|NCT03633617|593595639|FG001|Part B|Withdrawal by Subject|0|||
164332651|NCT03633617|593595640|FG002|Part B|Withdrawal by Subject|1|||
164332652|NCT03633617|593595641|FG003|Part B|Withdrawal by Subject|0|||
164332653|NCT03633617|593595642|FG004|Part B|Withdrawal by Subject|2|||
164332654|NCT03633617|593595643|FG005|Part B|Withdrawal by Subject|0|||
164332655|NCT03633617|593595644|FG006|Part B|Withdrawal by Subject|0|||
164332656|NCT03633617|593595645|FG007|Part B|Withdrawal by Subject|0|||
164332657|NCT03633617|593595646|FG008|Part B|Withdrawal by Subject|0|||
164332658|NCT03633617|593595647|FG009|Part B|Withdrawal by Subject|0|||
164332659|NCT03633617|593595648|FG010|Part B|Withdrawal by Subject|0|||
164332660|NCT03633617|593595638|FG000|Part B|Lost to Follow-up|0|||
164332661|NCT03633617|593595639|FG001|Part B|Lost to Follow-up|0|||
164332662|NCT03633617|593595640|FG002|Part B|Lost to Follow-up|0|||
164332663|NCT03633617|593595641|FG003|Part B|Lost to Follow-up|0|||
164332664|NCT03633617|593595642|FG004|Part B|Lost to Follow-up|1|||
164332665|NCT03633617|593595643|FG005|Part B|Lost to Follow-up|0|||
164332666|NCT03633617|593595644|FG006|Part B|Lost to Follow-up|0|||
164332667|NCT03633617|593595645|FG007|Part B|Lost to Follow-up|0|||
164332668|NCT03633617|593595646|FG008|Part B|Lost to Follow-up|0|||
164332669|NCT03633617|593595647|FG009|Part B|Lost to Follow-up|0|||
164332670|NCT03633617|593595648|FG010|Part B|Lost to Follow-up|0|||
164332671|NCT03633617|593595638|FG000|Part B|Physician Decision|0|||
164332672|NCT03633617|593595639|FG001|Part B|Physician Decision|0|||
164332673|NCT03633617|593595640|FG002|Part B|Physician Decision|0|||
164675723|NCT01029340|594836820|FG005|Extension Period|starting another study|8|||
164675724|NCT01029340|594836815|FG000|Extension Period|non-compliance|0|||
164231485|NCT00688740|593218094|FG000|Overall Study|Violation of Inclusion Criteria|1|||
164231486|NCT00688740|593218095|FG001|Overall Study|Violation of Inclusion Criteria|3|||
164675725|NCT01029340|594836816|FG001|Extension Period|non-compliance|0|||
164332674|NCT03633617|593595641|FG003|Part B|Physician Decision|0|||
164332675|NCT03633617|593595642|FG004|Part B|Physician Decision|1|||
164332676|NCT03633617|593595643|FG005|Part B|Physician Decision|0|||
164332677|NCT03633617|593595644|FG006|Part B|Physician Decision|0|||
164332678|NCT03633617|593595645|FG007|Part B|Physician Decision|0|||
164332679|NCT03633617|593595646|FG008|Part B|Physician Decision|0|||
164422220|NCT01254565|593916318|FG000|Overall Study|Did not Receive Treatment|1|||
164422221|NCT01254565|593916319|FG001|Overall Study|Did not Receive Treatment|1|||
164422222|NCT01254565|593916320|FG002|Overall Study|Did not Receive Treatment|0|||
164422223|NCT01254565|593916321|FG003|Overall Study|Did not Receive Treatment|0|||
164422224|NCT01254565|593916322|FG004|Overall Study|Did not Receive Treatment|3|||
164422225|NCT01254565|593916323|FG005|Overall Study|Did not Receive Treatment|4|||
164422226|NCT01254565|593916318|FG000|Overall Study|Other|0|||
164422227|NCT01254565|593916319|FG001|Overall Study|Other|0|||
164422228|NCT01254565|593916320|FG002|Overall Study|Other|0|||
164422229|NCT01254565|593916321|FG003|Overall Study|Other|1|||
164422230|NCT01254565|593916322|FG004|Overall Study|Other|0|||
164422231|NCT01254565|593916323|FG005|Overall Study|Other|0|||
164572229|NCT01307423|594460362|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
164572230|NCT01307423|594460363|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
164572231|NCT01307423|594460364|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
164572232|NCT01307423|594460365|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
164572233|NCT01307423|594460366|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
164572234|NCT01307423|594460367|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
164572235|NCT01307423|594460368|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
164572236|NCT01307423|594460360|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
164572237|NCT01307423|594460361|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
164572238|NCT01307423|594460362|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
164572239|NCT01307423|594460363|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
164572240|NCT01307423|594460364|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
164572241|NCT01307423|594460365|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
164572242|NCT01307423|594460366|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
164572243|NCT01307423|594460367|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
164572244|NCT01307423|594460368|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
164572245|NCT01307423|594460360|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
164572246|NCT01307423|594460361|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
164572247|NCT01307423|594460362|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
164572248|NCT01307423|594460363|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
164572249|NCT01307423|594460364|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
164572250|NCT01307423|594460365|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
164572251|NCT01307423|594460366|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
164572252|NCT01307423|594460367|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
164572253|NCT01307423|594460368|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
164572254|NCT01307423|594460360|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
164572255|NCT01307423|594460361|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
164572256|NCT01307423|594460362|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
164572257|NCT01307423|594460363|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
164572258|NCT01307423|594460364|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
164572259|NCT01307423|594460365|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
164572260|NCT01307423|594460366|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
164572261|NCT01307423|594460367|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
164572262|NCT01307423|594460368|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
164572263|NCT01307423|594460360|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
164572264|NCT01307423|594460361|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
164572265|NCT01307423|594460362|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
164572266|NCT01307423|594460363|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
164572267|NCT01307423|594460364|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
164572268|NCT01307423|594460365|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
164572269|NCT01307423|594460366|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
164572270|NCT01307423|594460367|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
164572271|NCT01307423|594460368|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
164572272|NCT01307423|594460360|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
164572273|NCT01307423|594460361|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
164572274|NCT01307423|594460362|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
164572275|NCT01307423|594460363|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
164572276|NCT01307423|594460364|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
164572277|NCT01307423|594460365|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
164572278|NCT01307423|594460366|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
164572279|NCT01307423|594460367|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
164572280|NCT01307423|594460368|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
164675726|NCT01029340|594836817|FG002|Extension Period|non-compliance|0|||
164675727|NCT01029340|594836818|FG003|Extension Period|non-compliance|0|||
164422232|NCT02726399|593916330|FG000|Overall Study|Participant Non-Compliance|1|||
164422233|NCT02726399|593916330|FG000|Overall Study|Adverse Event|2|||
164422234|NCT02726399|593916330|FG000|Overall Study|Progression of disease|4|||
164572281|NCT01307423|594460360|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
164572282|NCT01307423|594460361|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
164572283|NCT01307423|594460362|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
164572284|NCT01307423|594460363|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
164572285|NCT01307423|594460364|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
164572286|NCT01307423|594460365|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
164572287|NCT01307423|594460366|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
164572288|NCT01307423|594460367|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
164572289|NCT01307423|594460368|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
164572290|NCT01307423|594460360|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
164572291|NCT01307423|594460361|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
164572292|NCT01307423|594460362|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
164572293|NCT01307423|594460363|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
164572294|NCT01307423|594460364|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
164572295|NCT01307423|594460365|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
164572296|NCT01307423|594460366|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
164572297|NCT01307423|594460367|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
164572298|NCT01307423|594460368|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
164572299|NCT01307423|594460360|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
164572300|NCT01307423|594460361|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
164572301|NCT01307423|594460362|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
164572302|NCT01307423|594460363|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
164572303|NCT01307423|594460364|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
164572304|NCT01307423|594460365|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
164572305|NCT01307423|594460366|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
164572306|NCT01307423|594460367|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
164572307|NCT01307423|594460368|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
164572308|NCT01307423|594460360|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
164572309|NCT01307423|594460361|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
164332680|NCT03633617|593595647|FG009|Part B|Physician Decision|0|||
164332681|NCT03633617|593595648|FG010|Part B|Physician Decision|0|||
164332682|NCT03633617|593595638|FG000|Part B|COVID-19 Restrictions|0|||
164332683|NCT03633617|593595639|FG001|Part B|COVID-19 Restrictions|0|||
164332684|NCT03633617|593595640|FG002|Part B|COVID-19 Restrictions|1|||
164332685|NCT03633617|593595641|FG003|Part B|COVID-19 Restrictions|0|||
164332686|NCT03633617|593595642|FG004|Part B|COVID-19 Restrictions|0|||
164332687|NCT03633617|593595643|FG005|Part B|COVID-19 Restrictions|0|||
164332688|NCT03633617|593595644|FG006|Part B|COVID-19 Restrictions|0|||
164332689|NCT03633617|593595645|FG007|Part B|COVID-19 Restrictions|0|||
164332690|NCT03633617|593595646|FG008|Part B|COVID-19 Restrictions|0|||
164332691|NCT03633617|593595647|FG009|Part B|COVID-19 Restrictions|0|||
164332692|NCT03633617|593595648|FG010|Part B|COVID-19 Restrictions|0|||
164422235|NCT01440049|593916333|FG000|Overall Study|Adverse Event|5|||
164422236|NCT02268552|593916334|FG000|Part 1|Death|1|||
164422237|NCT02268552|593916335|FG001|Part 1|Death|1|||
164422238|NCT02268552|593916336|FG002|Part 1|Death|1|||
164422239|NCT02268552|593916337|FG003|Part 1|Death|2|||
164422240|NCT02268552|593916338|FG004|Part 1|Death|0|||
164422241|NCT02268552|593916339|FG005|Part 1|Death|0|||
164422242|NCT02268552|593916340|FG006|Part 1|Death|0|||
164422243|NCT02268552|593916334|FG000|Part 1|Subject/guardian decision|0|||
164422244|NCT02268552|593916335|FG001|Part 1|Subject/guardian decision|0|||
164422245|NCT02268552|593916336|FG002|Part 1|Subject/guardian decision|0|||
164422246|NCT02268552|593916337|FG003|Part 1|Subject/guardian decision|1|||
164422247|NCT02268552|593916338|FG004|Part 1|Subject/guardian decision|0|||
164422248|NCT02268552|593916339|FG005|Part 1|Subject/guardian decision|0|||
164572310|NCT01307423|594460362|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
164572311|NCT01307423|594460363|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
164572312|NCT01307423|594460364|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
164572313|NCT01307423|594460365|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
164572314|NCT01307423|594460366|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
164332693|NCT03633617|593595638|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
164332694|NCT03633617|593595639|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
164332695|NCT03633617|593595640|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
164332696|NCT03633617|593595641|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
164422249|NCT02268552|593916340|FG006|Part 1|Subject/guardian decision|0|||
164422250|NCT02268552|593916334|FG000|Part 2|Death|0|||
164422251|NCT02268552|593916335|FG001|Part 2|Death|0|||
164422252|NCT02268552|593916336|FG002|Part 2|Death|0|||
164422253|NCT02268552|593916337|FG003|Part 2|Death|0|||
164422254|NCT02268552|593916338|FG004|Part 2|Death|0|||
164422255|NCT02268552|593916339|FG005|Part 2|Death|0|||
164422256|NCT02268552|593916340|FG006|Part 2|Death|2|||
164422257|NCT02268552|593916334|FG000|Part 2|Subject/guardian decision|0|||
164231487|NCT00366457|593218099|FG000|Overall Study|never began study therapy|2|||
164231488|NCT02829996|593218100|FG000|Overall Study|Withdrawal by Subject|1|||
164231489|NCT02829996|593218101|FG001|Overall Study|Withdrawal by Subject|0|||
164231490|NCT02829996|593218102|FG002|Overall Study|Withdrawal by Subject|0|||
164231491|NCT02829996|593218103|FG003|Overall Study|Withdrawal by Subject|0|||
164231492|NCT02829996|593218104|FG004|Overall Study|Withdrawal by Subject|0|||
164231493|NCT04484857|593218110|FG000|Overall Study|Adverse Event|2|||
164231494|NCT04484857|593218110|FG000|Overall Study|Death|10|||
164231495|NCT04484857|593218110|FG000|Overall Study|Withdrawal by Subject|3|||
164231496|NCT04484857|593218110|FG000|Overall Study|Transferred/Relocation|5|||
164231497|NCT04484857|593218110|FG000|Overall Study|Kidney Transplant|7|||
164231498|NCT04484857|593218110|FG000|Overall Study|Other than specified|4|||
164231499|NCT04484857|593218110|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
164231500|NCT01206517|593218114|FG000|Overall Study|Withdrawal by Subject|0|||
164231501|NCT01206517|593218115|FG001|Overall Study|Withdrawal by Subject|0|||
164231502|NCT01206517|593218116|FG002|Overall Study|Withdrawal by Subject|2|||
164231503|NCT01206517|593218117|FG003|Overall Study|Withdrawal by Subject|0|||
164231504|NCT01206517|593218118|FG004|Overall Study|Withdrawal by Subject|1|||
164231505|NCT01206517|593218119|FG005|Overall Study|Withdrawal by Subject|0|||
164231506|NCT00725985|593218120|FG000|ITP- Treatment Disposition|Adverse Event|20|||
164231507|NCT00725985|593218121|FG001|ITP- Treatment Disposition|Adverse Event|10|||
164231508|NCT00725985|593218122|FG002|ITP- Treatment Disposition|Adverse Event|5|||
164231509|NCT00725985|593218123|FG003|ITP- Treatment Disposition|Adverse Event|0|||
164231510|NCT00725985|593218124|FG004|ITP- Treatment Disposition|Adverse Event|0|||
164231511|NCT00725985|593218125|FG005|ITP- Treatment Disposition|Adverse Event|0|||
164231512|NCT00725985|593218126|FG006|ITP- Treatment Disposition|Adverse Event|0|||
164422258|NCT02268552|593916335|FG001|Part 2|Subject/guardian decision|0|||
164422259|NCT02268552|593916336|FG002|Part 2|Subject/guardian decision|0|||
164422260|NCT02268552|593916337|FG003|Part 2|Subject/guardian decision|0|||
164231513|NCT00725985|593218127|FG007|ITP- Treatment Disposition|Adverse Event|0|||
164231514|NCT00725985|593218128|FG008|ITP- Treatment Disposition|Adverse Event|0|||
164231515|NCT00725985|593218129|FG009|ITP- Treatment Disposition|Adverse Event|0|||
164231516|NCT00725985|593218130|FG010|ITP- Treatment Disposition|Adverse Event|0|||
164231517|NCT00725985|593218131|FG011|ITP- Treatment Disposition|Adverse Event|0|||
164231518|NCT00725985|593218120|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
164231519|NCT00725985|593218121|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
164231520|NCT00725985|593218122|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
164231521|NCT00725985|593218123|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
164231522|NCT00725985|593218124|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
164231523|NCT00725985|593218125|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
164231524|NCT00725985|593218126|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
164231525|NCT00725985|593218127|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
164231526|NCT00725985|593218128|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
164231527|NCT00725985|593218129|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
164231528|NCT00725985|593218130|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
164231529|NCT00725985|593218131|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
164231530|NCT00725985|593218120|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
164231531|NCT00725985|593218121|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
164231532|NCT00725985|593218122|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
164231533|NCT00725985|593218123|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
164231534|NCT00725985|593218124|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
164231535|NCT00725985|593218125|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
164231536|NCT00725985|593218126|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
164231537|NCT00725985|593218127|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
164231538|NCT00725985|593218128|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
164231539|NCT00725985|593218129|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
164231540|NCT00725985|593218130|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
164231541|NCT00725985|593218131|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
164231542|NCT00725985|593218120|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
164231543|NCT00725985|593218121|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
164231544|NCT00725985|593218122|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
164231545|NCT00725985|593218123|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
164231546|NCT00725985|593218124|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
164231547|NCT00725985|593218125|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
164231548|NCT00725985|593218126|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
164231549|NCT00725985|593218127|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
164231550|NCT00725985|593218128|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
164231551|NCT00725985|593218129|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
164422261|NCT02268552|593916338|FG004|Part 2|Subject/guardian decision|0|||
164422262|NCT02268552|593916339|FG005|Part 2|Subject/guardian decision|0|||
164422263|NCT02268552|593916340|FG006|Part 2|Subject/guardian decision|1|||
164231552|NCT00725985|593218130|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
164231553|NCT00725985|593218131|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
164231554|NCT00725985|593218120|FG000|ITP- Treatment Disposition|Other|50|||
164231555|NCT00725985|593218121|FG001|ITP- Treatment Disposition|Other|38|||
164231556|NCT00725985|593218122|FG002|ITP- Treatment Disposition|Other|24|||
164231557|NCT00725985|593218123|FG003|ITP- Treatment Disposition|Other|0|||
164231558|NCT00725985|593218124|FG004|ITP- Treatment Disposition|Other|0|||
164422264|NCT02268552|593916334|FG000|Part 3 Extension|Death|0|||
164231559|NCT00725985|593218125|FG005|ITP- Treatment Disposition|Other|0|||
164231560|NCT00725985|593218126|FG006|ITP- Treatment Disposition|Other|0|||
164231561|NCT00725985|593218127|FG007|ITP- Treatment Disposition|Other|0|||
164231562|NCT00725985|593218128|FG008|ITP- Treatment Disposition|Other|0|||
164231563|NCT00725985|593218129|FG009|ITP- Treatment Disposition|Other|0|||
164231564|NCT00725985|593218130|FG010|ITP- Treatment Disposition|Other|0|||
164231565|NCT00725985|593218131|FG011|ITP- Treatment Disposition|Other|0|||
164231566|NCT00725985|593218120|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
164332697|NCT03633617|593595642|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
164332698|NCT03633617|593595643|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
164332699|NCT03633617|593595644|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
164332700|NCT03633617|593595645|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
164332701|NCT03633617|593595646|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
164332702|NCT03633617|593595647|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
164332703|NCT03633617|593595648|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
164332704|NCT03633617|593595638|FG000|Part C (& Follow-up)|Adverse Event|0|||
164332705|NCT03633617|593595639|FG001|Part C (& Follow-up)|Adverse Event|0|||
164332706|NCT03633617|593595640|FG002|Part C (& Follow-up)|Adverse Event|0|||
164332707|NCT03633617|593595641|FG003|Part C (& Follow-up)|Adverse Event|0|||
164332708|NCT03633617|593595642|FG004|Part C (& Follow-up)|Adverse Event|0|||
164332709|NCT03633617|593595643|FG005|Part C (& Follow-up)|Adverse Event|1|||
164332710|NCT03633617|593595644|FG006|Part C (& Follow-up)|Adverse Event|0|||
164332711|NCT03633617|593595645|FG007|Part C (& Follow-up)|Adverse Event|1|||
164332712|NCT03633617|593595646|FG008|Part C (& Follow-up)|Adverse Event|0|||
164332713|NCT03633617|593595647|FG009|Part C (& Follow-up)|Adverse Event|0|||
164332714|NCT03633617|593595648|FG010|Part C (& Follow-up)|Adverse Event|0|||
164332715|NCT03633617|593595638|FG000|Part C (& Follow-up)|Pregnancy|0|||
164332716|NCT03633617|593595639|FG001|Part C (& Follow-up)|Pregnancy|0|||
164332717|NCT03633617|593595640|FG002|Part C (& Follow-up)|Pregnancy|0|||
164332718|NCT03633617|593595641|FG003|Part C (& Follow-up)|Pregnancy|0|||
164332719|NCT03633617|593595642|FG004|Part C (& Follow-up)|Pregnancy|0|||
164332720|NCT03633617|593595643|FG005|Part C (& Follow-up)|Pregnancy|0|||
164332721|NCT03633617|593595644|FG006|Part C (& Follow-up)|Pregnancy|0|||
164332722|NCT03633617|593595645|FG007|Part C (& Follow-up)|Pregnancy|0|||
164332723|NCT03633617|593595646|FG008|Part C (& Follow-up)|Pregnancy|0|||
164332724|NCT03633617|593595647|FG009|Part C (& Follow-up)|Pregnancy|1|||
164332725|NCT03633617|593595648|FG010|Part C (& Follow-up)|Pregnancy|0|||
164332726|NCT03633617|593595638|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
164332727|NCT03633617|593595639|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
164332728|NCT03633617|593595640|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
164332729|NCT03633617|593595641|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
164332730|NCT03633617|593595642|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
164332731|NCT03633617|593595643|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
164231567|NCT00725985|593218121|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
164332732|NCT03633617|593595644|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
164332733|NCT03633617|593595645|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
164332734|NCT03633617|593595646|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
164332735|NCT03633617|593595647|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
164332736|NCT03633617|593595648|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
164422265|NCT02268552|593916335|FG001|Part 3 Extension|Death|1|||
164422266|NCT02268552|593916336|FG002|Part 3 Extension|Death|1|||
164231568|NCT00725985|593218122|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
164422267|NCT02268552|593916337|FG003|Part 3 Extension|Death|1|||
164422268|NCT02268552|593916338|FG004|Part 3 Extension|Death|1|||
164422269|NCT02268552|593916339|FG005|Part 3 Extension|Death|1|||
164231569|NCT00725985|593218123|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
164231570|NCT00725985|593218124|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
164231571|NCT00725985|593218125|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
164231572|NCT00725985|593218126|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
164231573|NCT00725985|593218127|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
164231574|NCT00725985|593218128|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
164231575|NCT00725985|593218129|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
164231576|NCT00725985|593218130|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
164231577|NCT00725985|593218131|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
164422270|NCT02268552|593916340|FG006|Part 3 Extension|Death|0|||
164422271|NCT02268552|593916334|FG000|Part 3 Extension|Early termination of trial|1|||
164231578|NCT00725985|593218120|FG000|OLMP (Up to 96 Weeks)|Death|0|||
164231579|NCT00725985|593218121|FG001|OLMP (Up to 96 Weeks)|Death|0|||
164231580|NCT00725985|593218122|FG002|OLMP (Up to 96 Weeks)|Death|0|||
164231581|NCT00725985|593218123|FG003|OLMP (Up to 96 Weeks)|Death|0|||
164231582|NCT00725985|593218124|FG004|OLMP (Up to 96 Weeks)|Death|1|||
164231583|NCT00725985|593218125|FG005|OLMP (Up to 96 Weeks)|Death|0|||
164231584|NCT00725985|593218126|FG006|OLMP (Up to 96 Weeks)|Death|0|||
164231585|NCT00725985|593218127|FG007|OLMP (Up to 96 Weeks)|Death|0|||
164231586|NCT00725985|593218128|FG008|OLMP (Up to 96 Weeks)|Death|0|||
164231587|NCT00725985|593218129|FG009|OLMP (Up to 96 Weeks)|Death|0|||
164231588|NCT00725985|593218130|FG010|OLMP (Up to 96 Weeks)|Death|0|||
164231589|NCT00725985|593218131|FG011|OLMP (Up to 96 Weeks)|Death|0|||
164231590|NCT00725985|593218120|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
164231591|NCT00725985|593218121|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
164231592|NCT00725985|593218122|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
164231593|NCT00725985|593218123|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
164231594|NCT00725985|593218124|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
164231595|NCT00725985|593218125|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
164231596|NCT00725985|593218126|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
164231597|NCT00725985|593218127|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
164231598|NCT00725985|593218128|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
164231599|NCT00725985|593218129|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
164231600|NCT00725985|593218130|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
164231601|NCT00725985|593218131|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
164231602|NCT00725985|593218120|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
164231603|NCT00725985|593218121|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
164231604|NCT00725985|593218122|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
164231605|NCT00725985|593218123|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
164231606|NCT00725985|593218124|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
164231607|NCT00725985|593218125|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
164572315|NCT01307423|594460367|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
164231608|NCT00725985|593218126|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
164231609|NCT00725985|593218127|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
164231610|NCT00725985|593218128|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
164231611|NCT00725985|593218129|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
164231612|NCT00725985|593218130|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
164231613|NCT00725985|593218131|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
164231614|NCT00725985|593218120|FG000|OLMP (Up to 96 Weeks)|Other|0|||
164231615|NCT00725985|593218121|FG001|OLMP (Up to 96 Weeks)|Other|0|||
164231616|NCT00725985|593218122|FG002|OLMP (Up to 96 Weeks)|Other|0|||
164231617|NCT00725985|593218123|FG003|OLMP (Up to 96 Weeks)|Other|15|||
164231618|NCT00725985|593218124|FG004|OLMP (Up to 96 Weeks)|Other|20|||
164231619|NCT00725985|593218125|FG005|OLMP (Up to 96 Weeks)|Other|44|||
164231620|NCT00725985|593218126|FG006|OLMP (Up to 96 Weeks)|Other|0|||
164231621|NCT00725985|593218127|FG007|OLMP (Up to 96 Weeks)|Other|0|||
164231622|NCT00725985|593218128|FG008|OLMP (Up to 96 Weeks)|Other|0|||
164231623|NCT00725985|593218129|FG009|OLMP (Up to 96 Weeks)|Other|0|||
164231624|NCT00725985|593218130|FG010|OLMP (Up to 96 Weeks)|Other|0|||
164231625|NCT00725985|593218131|FG011|OLMP (Up to 96 Weeks)|Other|0|||
164231626|NCT00725985|593218120|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
164231627|NCT00725985|593218121|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
164231628|NCT00725985|593218122|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
164231629|NCT00725985|593218123|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
164231630|NCT00725985|593218124|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
164231631|NCT00725985|593218125|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
164231632|NCT00725985|593218126|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
164231633|NCT00725985|593218127|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
164231634|NCT00725985|593218128|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
164231635|NCT00725985|593218129|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
164231636|NCT00725985|593218130|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
164332737|NCT03633617|593595638|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
164332738|NCT03633617|593595639|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
164332739|NCT03633617|593595640|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
164332740|NCT03633617|593595641|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
164332741|NCT03633617|593595642|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
164572316|NCT01307423|594460368|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
164332742|NCT03633617|593595643|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
164572317|NCT01307423|594460360|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
164231637|NCT00725985|593218131|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
164231638|NCT00725985|593218120|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
164231639|NCT00725985|593218121|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
164231640|NCT00725985|593218122|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
164231641|NCT00725985|593218123|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
164332743|NCT03633617|593595644|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
164422272|NCT02268552|593916335|FG001|Part 3 Extension|Early termination of trial|0|||
164422273|NCT02268552|593916336|FG002|Part 3 Extension|Early termination of trial|0|||
164422274|NCT02268552|593916337|FG003|Part 3 Extension|Early termination of trial|0|||
164422275|NCT02268552|593916338|FG004|Part 3 Extension|Early termination of trial|2|||
164422276|NCT02268552|593916339|FG005|Part 3 Extension|Early termination of trial|9|||
164422277|NCT02268552|593916340|FG006|Part 3 Extension|Early termination of trial|11|||
164422278|NCT02268552|593916334|FG000|Part 3 Extension|Subject/guardian decision|0|||
164422279|NCT02268552|593916335|FG001|Part 3 Extension|Subject/guardian decision|0|||
164422280|NCT02268552|593916336|FG002|Part 3 Extension|Subject/guardian decision|0|||
164422281|NCT02268552|593916337|FG003|Part 3 Extension|Subject/guardian decision|0|||
164422282|NCT02268552|593916338|FG004|Part 3 Extension|Subject/guardian decision|0|||
164422283|NCT02268552|593916339|FG005|Part 3 Extension|Subject/guardian decision|0|||
164422284|NCT02268552|593916340|FG006|Part 3 Extension|Subject/guardian decision|1|||
164332744|NCT03633617|593595645|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
164332745|NCT03633617|593595646|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
164422285|NCT04168385|593916342|FG000|Overall Study|Withdrawal by Subject|1|||
164422286|NCT04168385|593916343|FG001|Overall Study|Withdrawal by Subject|0|||
164422287|NCT04168385|593916342|FG000|Overall Study|Adverse Event|2|||
164332746|NCT03633617|593595647|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
164332747|NCT03633617|593595648|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
164332748|NCT03633617|593595638|FG000|Part C (& Follow-up)|Physician Decision|0|||
164332749|NCT03633617|593595639|FG001|Part C (& Follow-up)|Physician Decision|0|||
164422288|NCT04168385|593916343|FG001|Overall Study|Adverse Event|1|||
164422289|NCT04168385|593916342|FG000|Overall Study|Liver transplant|3|||
164422290|NCT04168385|593916343|FG001|Overall Study|Liver transplant|1|||
164422291|NCT04168385|593916342|FG000|Overall Study|Listed for liver transplant|1|||
164422292|NCT04168385|593916343|FG001|Overall Study|Listed for liver transplant|0|||
164422293|NCT02139982|593916344|FG000|Overall Study|Lack of Efficacy|0|||
164422294|NCT02139982|593916345|FG001|Overall Study|Lack of Efficacy|1|||
164422295|NCT02139982|593916346|FG002|Overall Study|Lack of Efficacy|0|||
164332750|NCT03633617|593595640|FG002|Part C (& Follow-up)|Physician Decision|0|||
164332751|NCT03633617|593595641|FG003|Part C (& Follow-up)|Physician Decision|0|||
164332752|NCT03633617|593595642|FG004|Part C (& Follow-up)|Physician Decision|0|||
164332753|NCT03633617|593595643|FG005|Part C (& Follow-up)|Physician Decision|0|||
164332754|NCT03633617|593595644|FG006|Part C (& Follow-up)|Physician Decision|0|||
164332755|NCT03633617|593595645|FG007|Part C (& Follow-up)|Physician Decision|1|||
164332756|NCT03633617|593595646|FG008|Part C (& Follow-up)|Physician Decision|0|||
164332757|NCT03633617|593595647|FG009|Part C (& Follow-up)|Physician Decision|0|||
164332758|NCT03633617|593595648|FG010|Part C (& Follow-up)|Physician Decision|1|||
164332759|NCT03633617|593595638|FG000|Part C (& Follow-up)|COVID-19 related|0|||
164332760|NCT03633617|593595639|FG001|Part C (& Follow-up)|COVID-19 related|0|||
164332761|NCT03633617|593595640|FG002|Part C (& Follow-up)|COVID-19 related|0|||
164332762|NCT03633617|593595641|FG003|Part C (& Follow-up)|COVID-19 related|0|||
164332763|NCT03633617|593595642|FG004|Part C (& Follow-up)|COVID-19 related|0|||
164332764|NCT03633617|593595643|FG005|Part C (& Follow-up)|COVID-19 related|1|||
164332765|NCT03633617|593595644|FG006|Part C (& Follow-up)|COVID-19 related|0|||
164332766|NCT03633617|593595645|FG007|Part C (& Follow-up)|COVID-19 related|0|||
164332767|NCT03633617|593595646|FG008|Part C (& Follow-up)|COVID-19 related|0|||
164332768|NCT03633617|593595647|FG009|Part C (& Follow-up)|COVID-19 related|0|||
164332769|NCT03633617|593595648|FG010|Part C (& Follow-up)|COVID-19 related|0|||
164332770|NCT03633617|593595638|FG000|Part C (& Follow-up)|Protocol Violation|0|||
164332771|NCT03633617|593595639|FG001|Part C (& Follow-up)|Protocol Violation|0|||
164332772|NCT03633617|593595640|FG002|Part C (& Follow-up)|Protocol Violation|0|||
164332773|NCT03633617|593595641|FG003|Part C (& Follow-up)|Protocol Violation|0|||
164332774|NCT03633617|593595642|FG004|Part C (& Follow-up)|Protocol Violation|0|||
164332775|NCT03633617|593595643|FG005|Part C (& Follow-up)|Protocol Violation|0|||
164422296|NCT02139982|593916347|FG003|Overall Study|Lack of Efficacy|1|||
164422297|NCT02139982|593916348|FG004|Overall Study|Lack of Efficacy|0|||
164422298|NCT02139982|593916349|FG005|Overall Study|Lack of Efficacy|0|||
164422299|NCT02139982|593916350|FG006|Overall Study|Lack of Efficacy|0|||
164422300|NCT02139982|593916351|FG007|Overall Study|Lack of Efficacy|0|||
164422301|NCT02139982|593916352|FG008|Overall Study|Lack of Efficacy|0|||
164422302|NCT02139982|593916353|FG009|Overall Study|Lack of Efficacy|0|||
164422303|NCT02748512|593916356|FG000|Overall Study|Lost to Follow-up|1|||
164422304|NCT02748512|593916357|FG001|Overall Study|Lost to Follow-up|1|||
164422305|NCT00088205|593916365|FG000|Overall Study|Adverse Event|4|||
164572318|NCT01307423|594460361|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
164572319|NCT01307423|594460362|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
164572320|NCT01307423|594460363|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
164422306|NCT00088205|593916365|FG000|Overall Study|Progressive Disease|51|||
164332776|NCT03633617|593595644|FG006|Part C (& Follow-up)|Protocol Violation|0|||
164332777|NCT03633617|593595645|FG007|Part C (& Follow-up)|Protocol Violation|0|||
164332778|NCT03633617|593595646|FG008|Part C (& Follow-up)|Protocol Violation|0|||
164422307|NCT00088205|593916365|FG000|Overall Study|Physician Decision|1|||
164422308|NCT00088205|593916365|FG000|Overall Study|Death Due to Study Disease|4|||
164231642|NCT00725985|593218124|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
164231643|NCT00725985|593218125|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
164231644|NCT00725985|593218126|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
164231645|NCT00725985|593218127|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
164231646|NCT00725985|593218128|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
164231647|NCT00725985|593218129|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
164231648|NCT00725985|593218130|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
164231649|NCT00725985|593218131|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
164231650|NCT00725985|593218120|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
164231651|NCT00725985|593218121|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
164231652|NCT00725985|593218122|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
164231653|NCT00725985|593218123|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
164231654|NCT00725985|593218124|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
164231655|NCT00725985|593218125|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
164231656|NCT00725985|593218126|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
164231657|NCT00725985|593218127|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
164231658|NCT00725985|593218128|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
164231659|NCT00725985|593218129|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
164231660|NCT00725985|593218130|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
164231661|NCT00725985|593218131|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
164231662|NCT00725985|593218120|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
164231663|NCT00725985|593218121|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
164231664|NCT00725985|593218122|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
164231665|NCT00725985|593218123|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
164231666|NCT00725985|593218124|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
164231667|NCT00725985|593218125|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
164231668|NCT00725985|593218126|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
164231669|NCT00725985|593218127|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
164231670|NCT00725985|593218128|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
164231671|NCT00725985|593218129|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
164231672|NCT00725985|593218130|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
164231673|NCT00725985|593218131|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
164231674|NCT02546323|593218132|FG000|Overall Study|Withdrawal by Subject|36|||
164231675|NCT02546323|593218133|FG001|Overall Study|Withdrawal by Subject|33|||
164231676|NCT02546323|593218132|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
164231677|NCT02546323|593218133|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
164231678|NCT02546323|593218132|FG000|Overall Study|Adverse Event|17|||
164231679|NCT02546323|593218133|FG001|Overall Study|Adverse Event|11|||
164231680|NCT02546323|593218132|FG000|Overall Study|Patient Specific Reasons|1|||
164231681|NCT02546323|593218133|FG001|Overall Study|Patient Specific Reasons|2|||
164231682|NCT02546323|593218132|FG000|Overall Study|Lost to Follow-up|2|||
164231683|NCT02546323|593218133|FG001|Overall Study|Lost to Follow-up|3|||
164231684|NCT02546323|593218132|FG000|Overall Study|Non-compliance with Study Drug|2|||
164231685|NCT02546323|593218133|FG001|Overall Study|Non-compliance with Study Drug|2|||
164231686|NCT02546323|593218132|FG000|Overall Study|Met Withdrawal Criteria|2|||
164231687|NCT02546323|593218133|FG001|Overall Study|Met Withdrawal Criteria|14|||
164231688|NCT04476784|593218134|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
164231689|NCT04476784|593218135|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
164231690|NCT00863304|593218142|FG000|Overall Study|Adverse Event|10|||
164231691|NCT00863304|593218143|FG001|Overall Study|Adverse Event|4|||
164231692|NCT00863304|593218144|FG002|Overall Study|Adverse Event|14|||
164231693|NCT00863304|593218145|FG003|Overall Study|Adverse Event|16|||
164231694|NCT00863304|593218142|FG000|Overall Study|Lost to Follow-up|1|||
164231695|NCT00863304|593218143|FG001|Overall Study|Lost to Follow-up|5|||
164231696|NCT00863304|593218144|FG002|Overall Study|Lost to Follow-up|4|||
164231697|NCT00863304|593218145|FG003|Overall Study|Lost to Follow-up|2|||
164231698|NCT00863304|593218142|FG000|Overall Study|Lack of Efficacy|57|||
164231699|NCT00863304|593218143|FG001|Overall Study|Lack of Efficacy|26|||
164231700|NCT00863304|593218144|FG002|Overall Study|Lack of Efficacy|30|||
164231701|NCT00863304|593218145|FG003|Overall Study|Lack of Efficacy|28|||
164231702|NCT00863304|593218142|FG000|Overall Study|Withdrawal by Subject|19|||
164231703|NCT00863304|593218143|FG001|Overall Study|Withdrawal by Subject|14|||
164231704|NCT00863304|593218144|FG002|Overall Study|Withdrawal by Subject|20|||
164231705|NCT00863304|593218145|FG003|Overall Study|Withdrawal by Subject|18|||
164231706|NCT00863304|593218142|FG000|Overall Study|Other|1|||
164231707|NCT00863304|593218143|FG001|Overall Study|Other|0|||
164332779|NCT03633617|593595647|FG009|Part C (& Follow-up)|Protocol Violation|3|||
164231708|NCT00863304|593218144|FG002|Overall Study|Other|0|||
164231709|NCT00863304|593218145|FG003|Overall Study|Other|1|||
164231710|NCT00863304|593218142|FG000|Overall Study|Protocol Violation|2|||
164231711|NCT00863304|593218143|FG001|Overall Study|Protocol Violation|6|||
164231712|NCT00863304|593218144|FG002|Overall Study|Protocol Violation|2|||
164231713|NCT00863304|593218145|FG003|Overall Study|Protocol Violation|0|||
164231714|NCT00863304|593218142|FG000|Overall Study|Randomized, but not Treated|3|||
164572321|NCT01307423|594460364|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
164572322|NCT01307423|594460365|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
164572323|NCT01307423|594460366|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
164572324|NCT01307423|594460367|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
164572325|NCT01307423|594460368|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
164572326|NCT01307423|594460360|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
164572327|NCT01307423|594460361|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
164572328|NCT01307423|594460362|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
164572329|NCT01307423|594460363|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
164572330|NCT01307423|594460364|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
164572331|NCT01307423|594460365|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
164572332|NCT01307423|594460366|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
164572333|NCT01307423|594460367|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
164572334|NCT01307423|594460368|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
164572335|NCT01307423|594460360|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
164572336|NCT01307423|594460361|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
164572337|NCT01307423|594460362|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
164572338|NCT01307423|594460363|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
164572339|NCT01307423|594460364|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
164572340|NCT01307423|594460365|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
164572341|NCT01307423|594460366|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
164572342|NCT01307423|594460367|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
164572343|NCT01307423|594460368|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
164572344|NCT01307423|594460360|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
164572345|NCT01307423|594460361|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
164572346|NCT01307423|594460362|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
164572347|NCT01307423|594460363|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
164572348|NCT01307423|594460364|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
164572349|NCT01307423|594460365|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
164572350|NCT01307423|594460366|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
164572351|NCT01307423|594460367|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
164572352|NCT01307423|594460368|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
164572353|NCT01307423|594460360|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
164572354|NCT01307423|594460361|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
164572355|NCT01307423|594460362|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
164572356|NCT01307423|594460363|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
164572357|NCT01307423|594460364|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
164572358|NCT01307423|594460365|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
164572359|NCT01307423|594460366|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
164572360|NCT01307423|594460367|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
164572361|NCT01307423|594460368|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
164572362|NCT01307423|594460360|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
164572363|NCT01307423|594460361|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
164572364|NCT01307423|594460362|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
164572365|NCT01307423|594460363|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
164572366|NCT01307423|594460364|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
164572367|NCT01307423|594460365|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
164572368|NCT01307423|594460366|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
164572369|NCT01307423|594460367|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
164572370|NCT01307423|594460368|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
164572371|NCT01307423|594460360|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
164572372|NCT01307423|594460361|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
164572373|NCT01307423|594460362|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
164572374|NCT01307423|594460363|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
164572375|NCT01307423|594460364|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
164572376|NCT01307423|594460365|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
164572377|NCT01307423|594460366|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
164572378|NCT01307423|594460367|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
164572379|NCT01307423|594460368|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
164572380|NCT01307423|594460360|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
164572381|NCT01307423|594460361|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
164572382|NCT01307423|594460362|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
164572383|NCT01307423|594460363|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
164572384|NCT01307423|594460364|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
164572385|NCT01307423|594460365|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
164572386|NCT01307423|594460366|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
164572387|NCT01307423|594460367|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
164572388|NCT01307423|594460368|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
164332780|NCT03633617|593595648|FG010|Part C (& Follow-up)|Protocol Violation|1|||
164332781|NCT03633617|593595638|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
164332782|NCT03633617|593595639|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
164332783|NCT03633617|593595640|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
164332784|NCT03633617|593595641|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
164332785|NCT03633617|593595642|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
164332786|NCT03633617|593595643|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
164332787|NCT03633617|593595644|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
164332788|NCT03633617|593595645|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
164332789|NCT03633617|593595646|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
164332790|NCT03633617|593595647|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
164332791|NCT03633617|593595648|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
164332792|NCT00809354|593595651|FG000|Overall Study|Adverse Event|32|||
164332793|NCT00809354|593595652|FG001|Overall Study|Adverse Event|45|||
164332794|NCT00809354|593595653|FG002|Overall Study|Adverse Event|37|||
164332795|NCT00809354|593595654|FG003|Overall Study|Adverse Event|53|||
164332796|NCT00809354|593595655|FG004|Overall Study|Adverse Event|26|||
164332797|NCT00809354|593595656|FG005|Overall Study|Adverse Event|33|||
164332798|NCT00809354|593595657|FG006|Overall Study|Adverse Event|44|||
164332799|NCT00809354|593595658|FG007|Overall Study|Adverse Event|40|||
164332800|NCT00809354|593595659|FG008|Overall Study|Adverse Event|46|||
164332801|NCT00809354|593595660|FG009|Overall Study|Adverse Event|26|||
164332802|NCT00809354|593595651|FG000|Overall Study|Lack of Efficacy|23|||
164332803|NCT00809354|593595652|FG001|Overall Study|Lack of Efficacy|23|||
164332804|NCT00809354|593595653|FG002|Overall Study|Lack of Efficacy|22|||
164332805|NCT00809354|593595654|FG003|Overall Study|Lack of Efficacy|15|||
164332806|NCT00809354|593595655|FG004|Overall Study|Lack of Efficacy|40|||
164332807|NCT00809354|593595656|FG005|Overall Study|Lack of Efficacy|19|||
164332808|NCT00809354|593595657|FG006|Overall Study|Lack of Efficacy|21|||
164332809|NCT00809354|593595658|FG007|Overall Study|Lack of Efficacy|15|||
164332810|NCT00809354|593595659|FG008|Overall Study|Lack of Efficacy|18|||
164332811|NCT00809354|593595660|FG009|Overall Study|Lack of Efficacy|38|||
164332812|NCT00809354|593595651|FG000|Overall Study|Lost to Follow-up|10|||
164332813|NCT00809354|593595652|FG001|Overall Study|Lost to Follow-up|11|||
164332814|NCT00809354|593595653|FG002|Overall Study|Lost to Follow-up|8|||
164332815|NCT00809354|593595654|FG003|Overall Study|Lost to Follow-up|13|||
164332816|NCT00809354|593595655|FG004|Overall Study|Lost to Follow-up|6|||
164332817|NCT00809354|593595656|FG005|Overall Study|Lost to Follow-up|2|||
164332818|NCT00809354|593595657|FG006|Overall Study|Lost to Follow-up|0|||
164332819|NCT00809354|593595658|FG007|Overall Study|Lost to Follow-up|5|||
164332820|NCT00809354|593595659|FG008|Overall Study|Lost to Follow-up|4|||
164332821|NCT00809354|593595660|FG009|Overall Study|Lost to Follow-up|0|||
164332822|NCT00809354|593595651|FG000|Overall Study|Protocol Violation|7|||
164332823|NCT00809354|593595652|FG001|Overall Study|Protocol Violation|14|||
164332824|NCT00809354|593595653|FG002|Overall Study|Protocol Violation|14|||
164332825|NCT00809354|593595654|FG003|Overall Study|Protocol Violation|12|||
164332826|NCT00809354|593595655|FG004|Overall Study|Protocol Violation|14|||
164332827|NCT00809354|593595656|FG005|Overall Study|Protocol Violation|6|||
164332828|NCT00809354|593595657|FG006|Overall Study|Protocol Violation|4|||
164332829|NCT00809354|593595658|FG007|Overall Study|Protocol Violation|6|||
164332830|NCT00809354|593595659|FG008|Overall Study|Protocol Violation|9|||
164332831|NCT00809354|593595660|FG009|Overall Study|Protocol Violation|3|||
164332832|NCT00809354|593595651|FG000|Overall Study|Withdrawal by Subject|32|||
164332833|NCT00809354|593595652|FG001|Overall Study|Withdrawal by Subject|27|||
164332834|NCT00809354|593595653|FG002|Overall Study|Withdrawal by Subject|31|||
164332835|NCT00809354|593595654|FG003|Overall Study|Withdrawal by Subject|33|||
164332836|NCT00809354|593595655|FG004|Overall Study|Withdrawal by Subject|34|||
164332837|NCT00809354|593595656|FG005|Overall Study|Withdrawal by Subject|29|||
164332838|NCT00809354|593595657|FG006|Overall Study|Withdrawal by Subject|27|||
164332839|NCT00809354|593595658|FG007|Overall Study|Withdrawal by Subject|19|||
164332840|NCT00809354|593595659|FG008|Overall Study|Withdrawal by Subject|18|||
164332841|NCT00809354|593595660|FG009|Overall Study|Withdrawal by Subject|20|||
164332842|NCT00809354|593595651|FG000|Overall Study|Other|10|||
164332843|NCT00809354|593595652|FG001|Overall Study|Other|2|||
164332844|NCT00809354|593595653|FG002|Overall Study|Other|7|||
164332845|NCT00809354|593595654|FG003|Overall Study|Other|10|||
164332846|NCT00809354|593595655|FG004|Overall Study|Other|5|||
164332847|NCT00809354|593595656|FG005|Overall Study|Other|3|||
164332848|NCT00809354|593595657|FG006|Overall Study|Other|2|||
164332849|NCT00809354|593595658|FG007|Overall Study|Other|3|||
164332850|NCT00809354|593595659|FG008|Overall Study|Other|4|||
164332851|NCT00809354|593595660|FG009|Overall Study|Other|3|||
164332852|NCT00809354|593595651|FG000|Overall Study|Study terminated by sponsor|138|||
164332853|NCT00809354|593595652|FG001|Overall Study|Study terminated by sponsor|134|||
164332854|NCT00809354|593595653|FG002|Overall Study|Study terminated by sponsor|129|||
164332855|NCT00809354|593595654|FG003|Overall Study|Study terminated by sponsor|120|||
164332856|NCT00809354|593595655|FG004|Overall Study|Study terminated by sponsor|126|||
164332857|NCT00809354|593595656|FG005|Overall Study|Study terminated by sponsor|133|||
164332858|NCT00809354|593595657|FG006|Overall Study|Study terminated by sponsor|124|||
164332859|NCT00809354|593595658|FG007|Overall Study|Study terminated by sponsor|148|||
164231715|NCT00863304|593218143|FG001|Overall Study|Randomized, but not Treated|1|||
164231716|NCT00863304|593218144|FG002|Overall Study|Randomized, but not Treated|4|||
164231717|NCT00863304|593218145|FG003|Overall Study|Randomized, but not Treated|1|||
164231718|NCT00863304|593218142|FG000|Overall Study|Entered extension study|101|||
164231719|NCT00863304|593218143|FG001|Overall Study|Entered extension study|129|||
164231720|NCT00863304|593218144|FG002|Overall Study|Entered extension study|113|||
164231721|NCT00863304|593218145|FG003|Overall Study|Entered extension study|125|||
164231722|NCT01182350|593218147|FG000|Overall Study|Adverse Event|5|||
164231723|NCT01182350|593218148|FG001|Overall Study|Adverse Event|0|||
164231724|NCT01182350|593218149|FG002|Overall Study|Adverse Event|0|||
164231725|NCT01182350|593218150|FG003|Overall Study|Adverse Event|0|||
164231726|NCT01182350|593218151|FG004|Overall Study|Adverse Event|0|||
164231727|NCT01182350|593218147|FG000|Overall Study|Disease Progression|15|||
164231728|NCT01182350|593218148|FG001|Overall Study|Disease Progression|12|||
164231729|NCT01182350|593218149|FG002|Overall Study|Disease Progression|0|||
164231730|NCT01182350|593218150|FG003|Overall Study|Disease Progression|1|||
164231731|NCT01182350|593218151|FG004|Overall Study|Disease Progression|0|||
164231732|NCT01182350|593218147|FG000|Overall Study|Death|0|||
164231733|NCT01182350|593218148|FG001|Overall Study|Death|1|||
164231734|NCT01182350|593218149|FG002|Overall Study|Death|1|||
164231735|NCT01182350|593218150|FG003|Overall Study|Death|0|||
164231736|NCT01182350|593218151|FG004|Overall Study|Death|0|||
164231737|NCT01182350|593218147|FG000|Overall Study|Withdrawal by Subject|3|||
164231738|NCT01182350|593218148|FG001|Overall Study|Withdrawal by Subject|1|||
164231739|NCT01182350|593218149|FG002|Overall Study|Withdrawal by Subject|0|||
164231740|NCT01182350|593218150|FG003|Overall Study|Withdrawal by Subject|1|||
164231741|NCT01182350|593218151|FG004|Overall Study|Withdrawal by Subject|0|||
164231742|NCT01182350|593218147|FG000|Overall Study|Alternative Therapy|2|||
164231743|NCT01182350|593218148|FG001|Overall Study|Alternative Therapy|0|||
164231744|NCT01182350|593218149|FG002|Overall Study|Alternative Therapy|1|||
164231745|NCT01182350|593218150|FG003|Overall Study|Alternative Therapy|0|||
164231746|NCT01182350|593218151|FG004|Overall Study|Alternative Therapy|0|||
164231747|NCT01182350|593218147|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
164231748|NCT01182350|593218148|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
164231749|NCT01182350|593218149|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
164231750|NCT01182350|593218150|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
164231751|NCT01182350|593218151|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
164231752|NCT01182350|593218147|FG000|Overall Study|Unevaluable for Biopsy|0|||
164231753|NCT01182350|593218148|FG001|Overall Study|Unevaluable for Biopsy|0|||
164572389|NCT01307423|594460360|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
164572390|NCT01307423|594460361|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
164572391|NCT01307423|594460362|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
164572392|NCT01307423|594460363|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
164572393|NCT01307423|594460364|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
164572394|NCT01307423|594460365|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
164572395|NCT01307423|594460366|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
164572396|NCT01307423|594460367|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
164572397|NCT01307423|594460368|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
164572398|NCT01307423|594460360|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
164572399|NCT01307423|594460361|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
164572400|NCT01307423|594460362|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
164572401|NCT01307423|594460363|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
164572402|NCT01307423|594460364|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
164231754|NCT01182350|593218149|FG002|Overall Study|Unevaluable for Biopsy|0|||
164231755|NCT01182350|593218150|FG003|Overall Study|Unevaluable for Biopsy|0|||
164231756|NCT01182350|593218151|FG004|Overall Study|Unevaluable for Biopsy|3|||
164231757|NCT04023487|593218152|FG000|Overall Study|Lost to Follow-up|5|||
164231758|NCT04023487|593218153|FG001|Overall Study|Lost to Follow-up|4|||
164231759|NCT04023487|593218152|FG000|Overall Study|Pregnancy|1|||
164332860|NCT00809354|593595659|FG008|Overall Study|Study terminated by sponsor|127|||
164332861|NCT00809354|593595660|FG009|Overall Study|Study terminated by sponsor|135|||
164332862|NCT00809354|593595651|FG000|Overall Study|Withdrawn due to pregnancy|0|||
164332863|NCT00809354|593595652|FG001|Overall Study|Withdrawn due to pregnancy|1|||
164332864|NCT00809354|593595653|FG002|Overall Study|Withdrawn due to pregnancy|0|||
164332865|NCT00809354|593595654|FG003|Overall Study|Withdrawn due to pregnancy|0|||
164572403|NCT01307423|594460365|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
164231760|NCT04023487|593218153|FG001|Overall Study|Pregnancy|2|||
164231761|NCT04023487|593218152|FG000|Overall Study|Withdrawal by Subject|4|||
164231762|NCT04023487|593218153|FG001|Overall Study|Withdrawal by Subject|5|||
164231763|NCT04023487|593218152|FG000|Overall Study|Partially completed testing|8|||
164332866|NCT00809354|593595655|FG004|Overall Study|Withdrawn due to pregnancy|0|||
164332867|NCT00809354|593595656|FG005|Overall Study|Withdrawn due to pregnancy|0|||
164572404|NCT01307423|594460366|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
164332868|NCT00809354|593595657|FG006|Overall Study|Withdrawn due to pregnancy|0|||
164675728|NCT01029340|594836819|FG004|Extension Period|non-compliance|0|||
164231764|NCT04023487|593218153|FG001|Overall Study|Partially completed testing|4|||
164231765|NCT00605189|593218154|FG000|Overall Study|Adverse Event|1|||
164231766|NCT00605189|593218155|FG001|Overall Study|Adverse Event|0|||
164231767|NCT00605189|593218156|FG002|Overall Study|Adverse Event|0|||
164231768|NCT00605189|593218154|FG000|Overall Study|Other|2|||
164231769|NCT00605189|593218155|FG001|Overall Study|Other|2|||
164231770|NCT00605189|593218156|FG002|Overall Study|Other|0|||
164231771|NCT03898180|593218157|FG000|Overall Study|Death|178|||
164231772|NCT03898180|593218158|FG001|Overall Study|Death|173|||
164231773|NCT03898180|593218157|FG000|Overall Study|Physician Decision|1|||
164231774|NCT03898180|593218158|FG001|Overall Study|Physician Decision|0|||
164231775|NCT03898180|593218157|FG000|Overall Study|Sponsor Decision|3|||
164231776|NCT03898180|593218158|FG001|Overall Study|Sponsor Decision|0|||
164231777|NCT03898180|593218157|FG000|Overall Study|Lost to Follow-up|1|||
164231778|NCT03898180|593218158|FG001|Overall Study|Lost to Follow-up|0|||
164231779|NCT03898180|593218157|FG000|Overall Study|Withdrawal by Subject|5|||
164231780|NCT03898180|593218158|FG001|Overall Study|Withdrawal by Subject|4|||
164231781|NCT05030766|593218160|FG000|Phase 1 Participants|Lost to Follow-up|12|||
164231782|NCT05030766|593218161|FG001|Phase 1 Participants|Lost to Follow-up|22|||
164231783|NCT05030766|593218162|FG002|Phase 1 Participants|Lost to Follow-up|0|||
164231784|NCT05030766|593218163|FG003|Phase 1 Participants|Lost to Follow-up|0|||
164231785|NCT05030766|593218160|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
164231786|NCT05030766|593218161|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
164231787|NCT05030766|593218162|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
164231788|NCT05030766|593218163|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
164231789|NCT05030766|593218160|FG000|Phase 2 Participants|Lost to Follow-up|0|||
164231790|NCT05030766|593218161|FG001|Phase 2 Participants|Lost to Follow-up|0|||
164231791|NCT05030766|593218162|FG002|Phase 2 Participants|Lost to Follow-up|6|||
164231792|NCT05030766|593218163|FG003|Phase 2 Participants|Lost to Follow-up|2|||
164231793|NCT03093415|593218164|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
164231794|NCT03093415|593218165|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
164231795|NCT03093415|593218166|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
164231796|NCT03093415|593218164|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
164231797|NCT03093415|593218165|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
164231798|NCT03093415|593218166|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
164231799|NCT03093415|593218164|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
164231800|NCT03093415|593218165|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
164231801|NCT03093415|593218166|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
164231802|NCT03093415|593218164|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
164231803|NCT03093415|593218165|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
164231804|NCT03093415|593218166|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
164231805|NCT03093415|593218164|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
164231806|NCT03093415|593218165|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
164231807|NCT03093415|593218166|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
164231808|NCT03093415|593218164|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
164231809|NCT03093415|593218165|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
164231810|NCT03093415|593218166|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
164231811|NCT03093415|593218164|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
164231812|NCT03093415|593218165|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
164231813|NCT03093415|593218166|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
164231814|NCT03093415|593218164|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
164231815|NCT03093415|593218165|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
164231816|NCT03093415|593218166|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
164231817|NCT03093415|593218164|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
164231818|NCT03093415|593218165|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
164231819|NCT03093415|593218166|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
164231820|NCT03093415|593218164|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
164231821|NCT03093415|593218165|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
164231822|NCT03093415|593218166|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
164231823|NCT03093415|593218164|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
164231824|NCT03093415|593218165|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
164231825|NCT03093415|593218166|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
164231826|NCT03559530|593218167|FG000|Overall Study|non-location of medical records|44|||
164231827|NCT03559530|593218168|FG001|Overall Study|non-location of medical records|0|||
164231828|NCT03559530|593218167|FG000|Overall Study|culture results not considered for treat|29|||
164422309|NCT05199233|593916366|FG000|Overall Study|Lack of Efficacy|1|||
164572405|NCT01307423|594460367|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
164231829|NCT03559530|593218168|FG001|Overall Study|culture results not considered for treat|0|||
164231830|NCT03559530|593218167|FG000|Overall Study|duplicate cases|8|||
164332869|NCT00809354|593595658|FG007|Overall Study|Withdrawn due to pregnancy|0|||
164332870|NCT00809354|593595659|FG008|Overall Study|Withdrawn due to pregnancy|0|||
164332871|NCT00809354|593595660|FG009|Overall Study|Withdrawn due to pregnancy|0|||
164332872|NCT00809354|593595651|FG000|Overall Study|Randomized but not Treated|3|||
164332873|NCT00809354|593595652|FG001|Overall Study|Randomized but not Treated|1|||
164332874|NCT00809354|593595653|FG002|Overall Study|Randomized but not Treated|6|||
164332875|NCT00809354|593595654|FG003|Overall Study|Randomized but not Treated|0|||
164332876|NCT00809354|593595655|FG004|Overall Study|Randomized but not Treated|5|||
164332877|NCT00809354|593595656|FG005|Overall Study|Randomized but not Treated|0|||
164332878|NCT00809354|593595657|FG006|Overall Study|Randomized but not Treated|1|||
164332879|NCT00809354|593595658|FG007|Overall Study|Randomized but not Treated|1|||
164332880|NCT00809354|593595659|FG008|Overall Study|Randomized but not Treated|2|||
164332881|NCT00809354|593595660|FG009|Overall Study|Randomized but not Treated|1|||
164332882|NCT00809354|593595651|FG000|Overall Study|Death|0|||
164332883|NCT00809354|593595652|FG001|Overall Study|Death|0|||
164332884|NCT00809354|593595653|FG002|Overall Study|Death|0|||
164332885|NCT00809354|593595654|FG003|Overall Study|Death|0|||
164332886|NCT00809354|593595655|FG004|Overall Study|Death|0|||
164332887|NCT00809354|593595656|FG005|Overall Study|Death|0|||
164332888|NCT00809354|593595657|FG006|Overall Study|Death|0|||
164332889|NCT00809354|593595658|FG007|Overall Study|Death|1|||
164231831|NCT03559530|593218168|FG001|Overall Study|duplicate cases|0|||
164231832|NCT03559530|593218167|FG000|Overall Study|other species of Acinetobacte|7|||
164231833|NCT03559530|593218168|FG001|Overall Study|other species of Acinetobacte|0|||
164231834|NCT03559530|593218167|FG000|Overall Study|contamination / colonization|3|||
164231835|NCT03559530|593218168|FG001|Overall Study|contamination / colonization|0|||
164231836|NCT01472185|593218169|FG000|Overall Study|Randomized but Not Treated|0|||
164231837|NCT01472185|593218170|FG001|Overall Study|Randomized but Not Treated|1|||
164231838|NCT01472185|593218169|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
164231839|NCT01472185|593218170|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
164231840|NCT01472185|593218169|FG000|Overall Study|Hyperglycemia|5|||
164231841|NCT01472185|593218170|FG001|Overall Study|Hyperglycemia|2|||
164231842|NCT01472185|593218169|FG000|Overall Study|Investigator's Discretion|3|||
164231843|NCT01472185|593218170|FG001|Overall Study|Investigator's Discretion|1|||
164231844|NCT01472185|593218169|FG000|Overall Study|Lost to Follow-up|4|||
164231845|NCT01472185|593218170|FG001|Overall Study|Lost to Follow-up|1|||
164231846|NCT01472185|593218169|FG000|Overall Study|Protocol Violation|5|||
164231847|NCT01472185|593218170|FG001|Overall Study|Protocol Violation|1|||
164231848|NCT01472185|593218169|FG000|Overall Study|Subject Noncompliance|8|||
164231849|NCT01472185|593218170|FG001|Overall Study|Subject Noncompliance|15|||
164231850|NCT01472185|593218169|FG000|Overall Study|Subject Withdrew Consent|6|||
164231851|NCT01472185|593218170|FG001|Overall Study|Subject Withdrew Consent|3|||
164231852|NCT02958865|593218171|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
164231853|NCT02958865|593218172|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
164231854|NCT02958865|593218173|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
164231855|NCT02958865|593218174|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
164231856|NCT02958865|593218175|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
164231857|NCT02958865|593218176|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
164231858|NCT02958865|593218177|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
164231859|NCT02958865|593218178|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
164231860|NCT02958865|593218179|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
164231861|NCT02958865|593218180|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
164231862|NCT02958865|593218181|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
164231863|NCT02958865|593218182|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
164231864|NCT02958865|593218183|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
164231865|NCT02958865|593218184|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
164231866|NCT02958865|593218185|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
164231867|NCT02958865|593218186|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
164231868|NCT02958865|593218171|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
164231869|NCT02958865|593218172|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
164332890|NCT00809354|593595659|FG008|Overall Study|Death|0|||
164231870|NCT02958865|593218173|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
164231871|NCT02958865|593218174|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
164231872|NCT02958865|593218175|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
164332891|NCT00809354|593595660|FG009|Overall Study|Death|0|||
164332892|NCT04137224|593595663|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
164332893|NCT04137224|593595664|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
164332894|NCT04137224|593595663|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
164332895|NCT04137224|593595664|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
164332896|NCT04137224|593595663|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
164332897|NCT04137224|593595664|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
164332898|NCT01199731|593595672|FG000|Overall Study|Adverse Event|0|||
164231873|NCT02958865|593218176|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
164231874|NCT02958865|593218177|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
164231875|NCT02958865|593218178|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
164231876|NCT02958865|593218179|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
164231877|NCT02958865|593218180|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
164231878|NCT02958865|593218181|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
164231879|NCT02958865|593218182|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
164231880|NCT02958865|593218183|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
164231881|NCT02958865|593218184|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
164231882|NCT02958865|593218185|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
164231883|NCT02958865|593218186|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
164231884|NCT02958865|593218171|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
164231885|NCT02958865|593218172|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
164231886|NCT02958865|593218173|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231887|NCT02958865|593218174|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231888|NCT02958865|593218175|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231889|NCT02958865|593218176|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231890|NCT02958865|593218177|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231891|NCT02958865|593218178|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231892|NCT02958865|593218179|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231893|NCT02958865|593218180|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231894|NCT02958865|593218181|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231895|NCT02958865|593218182|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231896|NCT02958865|593218183|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231897|NCT02958865|593218184|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231898|NCT02958865|593218185|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231899|NCT02958865|593218186|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231900|NCT02958865|593218171|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
164231901|NCT02958865|593218172|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164231902|NCT02958865|593218173|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
164231903|NCT02958865|593218174|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
164231904|NCT02958865|593218175|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
164231905|NCT02958865|593218176|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
164231906|NCT02958865|593218177|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
164231907|NCT02958865|593218178|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164231908|NCT02958865|593218179|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164231909|NCT02958865|593218180|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164231910|NCT02958865|593218181|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164231911|NCT02958865|593218182|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164231912|NCT02958865|593218183|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164231913|NCT02958865|593218184|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164231914|NCT02958865|593218185|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164231915|NCT02958865|593218186|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164231916|NCT02958865|593218171|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231917|NCT02958865|593218172|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231918|NCT02958865|593218173|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231919|NCT02958865|593218174|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
164231920|NCT02958865|593218175|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231921|NCT02958865|593218176|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231922|NCT02958865|593218177|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
164231923|NCT02958865|593218178|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231924|NCT02958865|593218179|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231925|NCT02958865|593218180|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231926|NCT02958865|593218181|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231927|NCT02958865|593218182|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231928|NCT02958865|593218183|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231929|NCT02958865|593218184|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231930|NCT02958865|593218185|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231931|NCT02958865|593218186|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231932|NCT02958865|593218171|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231933|NCT02958865|593218172|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231934|NCT02958865|593218173|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
164231935|NCT02958865|593218174|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231936|NCT02958865|593218175|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231937|NCT02958865|593218176|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231938|NCT02958865|593218177|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231939|NCT02958865|593218178|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231940|NCT02958865|593218179|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231941|NCT02958865|593218180|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231942|NCT02958865|593218181|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231943|NCT02958865|593218182|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231944|NCT02958865|593218183|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231945|NCT02958865|593218184|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231946|NCT02958865|593218185|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231947|NCT02958865|593218186|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231948|NCT02958865|593218171|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
164231949|NCT02958865|593218172|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
164231950|NCT02958865|593218173|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
164231951|NCT02958865|593218174|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231952|NCT02958865|593218175|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231953|NCT02958865|593218176|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231954|NCT02958865|593218177|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231955|NCT02958865|593218178|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231956|NCT02958865|593218179|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231957|NCT02958865|593218180|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231958|NCT02958865|593218181|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231959|NCT02958865|593218182|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231960|NCT02958865|593218183|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231961|NCT02958865|593218184|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231962|NCT02958865|593218185|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231963|NCT02958865|593218186|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231964|NCT02958865|593218171|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
164231965|NCT02958865|593218172|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
164231966|NCT02958865|593218173|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
164231967|NCT02958865|593218174|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
164231968|NCT02958865|593218175|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
164231969|NCT02958865|593218176|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
164231970|NCT02958865|593218177|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
164231971|NCT02958865|593218178|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
164231972|NCT02958865|593218179|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
164231973|NCT02958865|593218180|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
164231974|NCT02958865|593218181|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
164231975|NCT02958865|593218182|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
164231976|NCT02958865|593218183|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
164231977|NCT02958865|593218184|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
164231978|NCT02958865|593218185|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
164231979|NCT02958865|593218186|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
164231980|NCT02958865|593218171|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231981|NCT02958865|593218172|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231982|NCT02958865|593218173|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231983|NCT02958865|593218174|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231984|NCT02958865|593218175|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
164231985|NCT02958865|593218176|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231986|NCT02958865|593218177|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231987|NCT02958865|593218178|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231988|NCT02958865|593218179|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231989|NCT02958865|593218180|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231990|NCT02958865|593218181|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231991|NCT02958865|593218182|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231992|NCT02958865|593218183|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231993|NCT02958865|593218184|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231994|NCT02958865|593218185|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231995|NCT02958865|593218186|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231996|NCT02958865|593218171|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
164231997|NCT02958865|593218172|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
164231998|NCT02958865|593218173|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
164231999|NCT02958865|593218174|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
164232000|NCT02958865|593218175|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
164232001|NCT02958865|593218176|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
164232002|NCT02958865|593218177|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
164232003|NCT02958865|593218178|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
164232004|NCT02958865|593218179|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
164232005|NCT02958865|593218180|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
164232006|NCT02958865|593218181|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
164232007|NCT02958865|593218182|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
164232008|NCT02958865|593218183|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
164232009|NCT02958865|593218184|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
164232010|NCT02958865|593218185|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
164232011|NCT02958865|593218186|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
164232012|NCT02958865|593218171|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
164232013|NCT02958865|593218172|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
164232014|NCT02958865|593218173|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
164232015|NCT02958865|593218174|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
164232016|NCT02958865|593218175|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
164232017|NCT02958865|593218176|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
164232018|NCT02958865|593218177|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
164232019|NCT02958865|593218178|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
164232020|NCT02958865|593218179|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
164232021|NCT02958865|593218180|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
164232022|NCT02958865|593218181|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
164232023|NCT02958865|593218182|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
164232024|NCT02958865|593218183|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
164232025|NCT02958865|593218184|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
164232026|NCT02958865|593218185|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
164232027|NCT02958865|593218186|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
164332899|NCT01199731|593595673|FG001|Overall Study|Adverse Event|1|||
164332900|NCT01199731|593595674|FG002|Overall Study|Adverse Event|0|||
164332901|NCT01199731|593595672|FG000|Overall Study|Study closed/terminated|7|||
164332902|NCT01199731|593595673|FG001|Overall Study|Study closed/terminated|9|||
164332903|NCT01199731|593595674|FG002|Overall Study|Study closed/terminated|7|||
164332904|NCT01199731|593595672|FG000|Overall Study|Lost to Follow-up|0|||
164332905|NCT01199731|593595673|FG001|Overall Study|Lost to Follow-up|0|||
164332906|NCT01199731|593595674|FG002|Overall Study|Lost to Follow-up|2|||
164332907|NCT01199731|593595672|FG000|Overall Study|Physician Decision|0|||
164332908|NCT01199731|593595673|FG001|Overall Study|Physician Decision|1|||
164332909|NCT01199731|593595674|FG002|Overall Study|Physician Decision|1|||
164332910|NCT01199731|593595672|FG000|Overall Study|Withdrawal by Subject|2|||
164332911|NCT01199731|593595673|FG001|Overall Study|Withdrawal by Subject|0|||
164332912|NCT01199731|593595674|FG002|Overall Study|Withdrawal by Subject|0|||
164332913|NCT04010539|593595675|FG000|Overall Study|Withdrawal by Subject|4|||
164332914|NCT04010539|593595676|FG001|Overall Study|Withdrawal by Subject|1|||
164332915|NCT04010539|593595675|FG000|Overall Study|Physician Decision|0|||
164332916|NCT04010539|593595676|FG001|Overall Study|Physician Decision|2|||
164332917|NCT04010539|593595675|FG000|Overall Study|Lost to Follow-up|10|||
164332918|NCT04010539|593595676|FG001|Overall Study|Lost to Follow-up|14|||
164332919|NCT04010539|593595675|FG000|Overall Study|Adverse Event|3|||
164332920|NCT04010539|593595676|FG001|Overall Study|Adverse Event|0|||
164332921|NCT04010539|593595675|FG000|Overall Study|Participant Did Not Receive IP|0|||
164332922|NCT04010539|593595676|FG001|Overall Study|Participant Did Not Receive IP|1|||
164332923|NCT04010539|593595675|FG000|Overall Study|Protocol Deviation|0|||
164332924|NCT04010539|593595676|FG001|Overall Study|Protocol Deviation|1|||
164332925|NCT04010539|593595675|FG000|Overall Study|Randomized in Error/ Mistake|2|||
164422310|NCT02491892|593916371|FG000|Overall Study|Adverse Event|1|||
164422311|NCT02491892|593916372|FG001|Overall Study|Adverse Event|1|||
164422312|NCT02491892|593916371|FG000|Overall Study|Death|1|||
164422313|NCT02491892|593916372|FG001|Overall Study|Death|1|||
164572406|NCT01307423|594460368|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
164232028|NCT02958865|593218171|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232029|NCT02958865|593218172|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232030|NCT02958865|593218173|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232031|NCT02958865|593218174|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232032|NCT02958865|593218175|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232033|NCT02958865|593218176|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232034|NCT02958865|593218177|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232035|NCT02958865|593218178|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232036|NCT02958865|593218179|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164332926|NCT04010539|593595676|FG001|Overall Study|Randomized in Error/ Mistake|0|||
164332927|NCT04010539|593595675|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
164332928|NCT04010539|593595676|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
164332929|NCT02028871|593595677|FG000|Overall Study|Positive urine drug screen|1|||
164332930|NCT02028871|593595678|FG001|Overall Study|Positive urine drug screen|1|||
164332931|NCT02028871|593595677|FG000|Overall Study|Withdrawal by Subject|1|||
164332932|NCT02028871|593595678|FG001|Overall Study|Withdrawal by Subject|2|||
164422314|NCT02491892|593916371|FG000|Overall Study|Lack of Efficacy|37|||
164422315|NCT02491892|593916372|FG001|Overall Study|Lack of Efficacy|36|||
164572407|NCT01307423|594460360|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
164232037|NCT02958865|593218180|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
164232038|NCT02958865|593218181|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232039|NCT02958865|593218182|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232040|NCT02958865|593218183|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232041|NCT02958865|593218184|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232042|NCT02958865|593218185|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232043|NCT02958865|593218186|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
164232044|NCT02958865|593218171|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
164232045|NCT02958865|593218172|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
164232046|NCT02958865|593218173|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
164232047|NCT02958865|593218174|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
164232048|NCT02958865|593218175|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
164232049|NCT02958865|593218176|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
164232050|NCT02958865|593218177|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
164232051|NCT02958865|593218178|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
164232052|NCT02958865|593218179|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
164232053|NCT02958865|593218180|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
164232054|NCT02958865|593218181|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
164232055|NCT02958865|593218182|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
164232056|NCT02958865|593218183|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
164232057|NCT02958865|593218184|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
164232058|NCT02958865|593218185|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
164232059|NCT02958865|593218186|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
164232060|NCT02958865|593218171|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
164232061|NCT02958865|593218172|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
164232062|NCT02958865|593218173|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
164232063|NCT02958865|593218174|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
164232064|NCT02958865|593218175|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
164232065|NCT02958865|593218176|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
164232066|NCT02958865|593218177|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
164232067|NCT02958865|593218178|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
164232068|NCT02958865|593218179|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
164232069|NCT02958865|593218180|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
164232070|NCT02958865|593218181|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
164232071|NCT02958865|593218182|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
164232072|NCT02958865|593218183|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
164232073|NCT02958865|593218184|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
164232074|NCT02958865|593218185|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
164232075|NCT02958865|593218186|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
164232076|NCT02958865|593218171|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164232077|NCT02958865|593218172|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164232078|NCT02958865|593218173|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164232079|NCT02958865|593218174|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164232080|NCT02958865|593218175|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164232081|NCT02958865|593218176|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164232082|NCT02958865|593218177|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164232083|NCT02958865|593218178|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164232084|NCT02958865|593218179|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164232085|NCT02958865|593218180|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164332933|NCT02028871|593595677|FG000|Overall Study|IV placement difficulty|1|||
164332934|NCT02028871|593595678|FG001|Overall Study|IV placement difficulty|0|||
164572408|NCT01307423|594460361|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
164232086|NCT02958865|593218181|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164332935|NCT02028871|593595677|FG000|Overall Study|Current Illness|1|||
164572409|NCT01307423|594460362|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
164572410|NCT01307423|594460363|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
164572411|NCT01307423|594460364|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
164572412|NCT01307423|594460365|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
164422316|NCT02491892|593916371|FG000|Overall Study|Refused Treatment|1|||
164232087|NCT02958865|593218182|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164232088|NCT02958865|593218183|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164232089|NCT02958865|593218184|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
164232090|NCT02958865|593218185|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164332936|NCT02028871|593595678|FG001|Overall Study|Current Illness|0|||
164332937|NCT02314143|593595681|FG000|Overall Study|Adverse Event|0|||
164332938|NCT02314143|593595682|FG001|Overall Study|Adverse Event|6|||
164332939|NCT02314143|593595683|FG002|Overall Study|Adverse Event|4|||
164572413|NCT01307423|594460366|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
164675729|NCT01029340|594836820|FG005|Extension Period|non-compliance|1|||
164572414|NCT01307423|594460367|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
164572415|NCT01307423|594460368|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
164572416|NCT01307423|594460360|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
164572417|NCT01307423|594460361|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
164572418|NCT01307423|594460362|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
164232091|NCT02958865|593218186|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164232092|NCT02958865|593218171|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232093|NCT02958865|593218172|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232094|NCT02958865|593218173|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232095|NCT02958865|593218174|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232096|NCT02958865|593218175|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232097|NCT02958865|593218176|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232098|NCT02958865|593218177|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232099|NCT02958865|593218178|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232100|NCT02958865|593218179|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232101|NCT02958865|593218180|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232102|NCT02958865|593218181|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232103|NCT02958865|593218182|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232104|NCT02958865|593218183|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232105|NCT02958865|593218184|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
164232106|NCT02958865|593218185|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232107|NCT02958865|593218186|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232108|NCT02958865|593218171|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232109|NCT02958865|593218172|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232110|NCT02958865|593218173|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232111|NCT02958865|593218174|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232112|NCT02958865|593218175|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232113|NCT02958865|593218176|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232114|NCT02958865|593218177|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232115|NCT02958865|593218178|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232116|NCT02958865|593218179|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232117|NCT02958865|593218180|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
164572419|NCT01307423|594460363|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
164232118|NCT02958865|593218181|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232119|NCT02958865|593218182|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232120|NCT02958865|593218183|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232121|NCT02958865|593218184|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232122|NCT02958865|593218185|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232123|NCT02958865|593218186|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232124|NCT01309230|593218187|FG000|Overall Study|Withdrawal by Subject|0|||
164232125|NCT01309230|593218188|FG001|Overall Study|Withdrawal by Subject|2|||
164232126|NCT01309230|593218187|FG000|Overall Study|Observation arm closed|0|||
164232127|NCT01309230|593218188|FG001|Overall Study|Observation arm closed|2|||
164232128|NCT02661815|593218189|FG000|Overall Study|Withdrawal by Subject|1|||
164232129|NCT02661815|593218190|FG001|Overall Study|Withdrawal by Subject|0|||
164232130|NCT02661815|593218191|FG002|Overall Study|Withdrawal by Subject|0|||
164232131|NCT02661815|593218192|FG003|Overall Study|Withdrawal by Subject|0|||
164232132|NCT00209131|593218193|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
164232133|NCT00209131|593218194|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
164232134|NCT05360784|593218195|FG000|Overall Study|Discontinued|25|||
164232135|NCT05360784|593218196|FG001|Overall Study|Discontinued|11|||
164232136|NCT04875533|593218197|FG000|Overall Study|Adverse Event|6|||
164232137|NCT04875533|593218198|FG001|Overall Study|Adverse Event|4|||
164232138|NCT04875533|593218197|FG000|Overall Study|Protocol Violation|4|||
164232139|NCT04875533|593218198|FG001|Overall Study|Protocol Violation|0|||
164232140|NCT04875533|593218197|FG000|Overall Study|Withdrawal by Subject|8|||
164232141|NCT04875533|593218198|FG001|Overall Study|Withdrawal by Subject|5|||
164232142|NCT04875533|593218197|FG000|Overall Study|No longer meets eligibility criteria|1|||
164232143|NCT04875533|593218198|FG001|Overall Study|No longer meets eligibility criteria|0|||
164232144|NCT04875533|593218197|FG000|Overall Study|Other|0|||
164232145|NCT04875533|593218198|FG001|Overall Study|Other|2|||
164572420|NCT01307423|594460364|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
164422317|NCT02491892|593916372|FG001|Overall Study|Refused Treatment|0|||
164232146|NCT02971163|593218199|FG000|Overall Study|Lost to Follow-up|4|||
164232147|NCT02971163|593218200|FG001|Overall Study|Lost to Follow-up|2|||
164232148|NCT01299961|593218203|FG000|Overall Study|Adverse Event|3|||
164232149|NCT01299961|593218203|FG000|Overall Study|Lack of Efficacy|2|||
164232150|NCT01299961|593218203|FG000|Overall Study|Lost to Follow-up|1|||
164332940|NCT02314143|593595681|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
164332941|NCT02314143|593595682|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
164332942|NCT02314143|593595683|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
164332943|NCT02314143|593595681|FG000|Overall Study|Physician Decision|2|||
164332944|NCT02314143|593595682|FG001|Overall Study|Physician Decision|1|||
164332945|NCT02314143|593595683|FG002|Overall Study|Physician Decision|0|||
164332946|NCT02314143|593595681|FG000|Overall Study|Withdrawal by Subject|1|||
164332947|NCT02314143|593595682|FG001|Overall Study|Withdrawal by Subject|0|||
164422318|NCT02491892|593916371|FG000|Overall Study|Lost to Follow-up|1|||
164422319|NCT02491892|593916372|FG001|Overall Study|Lost to Follow-up|0|||
164422320|NCT00065468|593916373|FG000|Overall Study|Death|172|||
164422321|NCT00065468|593916374|FG001|Overall Study|Death|169|||
164422322|NCT00065468|593916375|FG002|Overall Study|Death|171|||
164422323|NCT00065468|593916373|FG000|Overall Study|Withdrawal by Subject|3|||
164422324|NCT00065468|593916374|FG001|Overall Study|Withdrawal by Subject|4|||
164422325|NCT00065468|593916375|FG002|Overall Study|Withdrawal by Subject|5|||
164422326|NCT00065468|593916373|FG000|Overall Study|Lost to Follow-up|5|||
164422327|NCT00065468|593916374|FG001|Overall Study|Lost to Follow-up|3|||
164422328|NCT00065468|593916375|FG002|Overall Study|Lost to Follow-up|2|||
164422329|NCT00065468|593916373|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
164422330|NCT00065468|593916374|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
164422331|NCT00065468|593916375|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
164422332|NCT00065468|593916373|FG000|Overall Study|Disease progression|0|||
164422333|NCT00065468|593916374|FG001|Overall Study|Disease progression|0|||
164422334|NCT00065468|593916375|FG002|Overall Study|Disease progression|1|||
164422335|NCT00065468|593916373|FG000|Overall Study|Other|14|||
164422336|NCT00065468|593916374|FG001|Overall Study|Other|24|||
164422337|NCT00065468|593916375|FG002|Overall Study|Other|18|||
164422338|NCT02117544|593916376|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
164422339|NCT02117544|593916377|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
164422340|NCT00231894|593916382|FG000|Overall Study|Withdrawal by Subject|1|||
164422341|NCT00231894|593916383|FG001|Overall Study|Withdrawal by Subject|1|||
164422342|NCT01848834|593916386|FG000|Overall Study|Adverse Event|3|||
164422343|NCT01848834|593916387|FG001|Overall Study|Adverse Event|11|||
164422344|NCT01848834|593916388|FG002|Overall Study|Adverse Event|3|||
164422345|NCT01848834|593916389|FG003|Overall Study|Adverse Event|5|||
164422346|NCT01848834|593916390|FG004|Overall Study|Adverse Event|9|||
164422347|NCT01848834|593916386|FG000|Overall Study|Death|2|||
164422348|NCT01848834|593916387|FG001|Overall Study|Death|11|||
164332948|NCT02314143|593595683|FG002|Overall Study|Withdrawal by Subject|1|||
164422349|NCT01848834|593916388|FG002|Overall Study|Death|1|||
164422350|NCT01848834|593916389|FG003|Overall Study|Death|8|||
164422351|NCT01848834|593916390|FG004|Overall Study|Death|27|||
164422352|NCT01848834|593916386|FG000|Overall Study|Excluded Medication|5|||
164422353|NCT01848834|593916387|FG001|Overall Study|Excluded Medication|4|||
164422354|NCT01848834|593916388|FG002|Overall Study|Excluded Medication|3|||
164422355|NCT01848834|593916389|FG003|Overall Study|Excluded Medication|6|||
164422356|NCT01848834|593916390|FG004|Overall Study|Excluded Medication|6|||
164422357|NCT01848834|593916386|FG000|Overall Study|Lost to Follow-up|5|||
164422358|NCT01848834|593916387|FG001|Overall Study|Lost to Follow-up|5|||
164422359|NCT01848834|593916388|FG002|Overall Study|Lost to Follow-up|3|||
164422360|NCT01848834|593916389|FG003|Overall Study|Lost to Follow-up|0|||
164422361|NCT01848834|593916390|FG004|Overall Study|Lost to Follow-up|3|||
164422362|NCT01848834|593916386|FG000|Overall Study|Physician Decision|1|||
164422363|NCT01848834|593916387|FG001|Overall Study|Physician Decision|3|||
164675730|NCT01029340|594836815|FG000|Extension Period|Withdrawal by Subject|0|||
164675731|NCT01029340|594836816|FG001|Extension Period|Withdrawal by Subject|0|||
164675732|NCT01029340|594836817|FG002|Extension Period|Withdrawal by Subject|0|||
164675733|NCT01029340|594836818|FG003|Extension Period|Withdrawal by Subject|0|||
164675734|NCT01029340|594836819|FG004|Extension Period|Withdrawal by Subject|0|||
164675735|NCT01029340|594836820|FG005|Extension Period|Withdrawal by Subject|1|||
164675736|NCT01029340|594836815|FG000|Extension Period|Physician Decision|0|||
164422364|NCT01848834|593916388|FG002|Overall Study|Physician Decision|4|||
164332949|NCT01528215|593595696|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
164332950|NCT01528215|593595697|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
164332951|NCT01528215|593595696|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
164422365|NCT01848834|593916389|FG003|Overall Study|Physician Decision|0|||
164422366|NCT01848834|593916390|FG004|Overall Study|Physician Decision|11|||
164422367|NCT01848834|593916386|FG000|Overall Study|Protocol Violation|0|||
164422368|NCT01848834|593916387|FG001|Overall Study|Protocol Violation|0|||
164422369|NCT01848834|593916388|FG002|Overall Study|Protocol Violation|0|||
164422370|NCT01848834|593916389|FG003|Overall Study|Protocol Violation|0|||
164422371|NCT01848834|593916390|FG004|Overall Study|Protocol Violation|1|||
164422372|NCT01848834|593916386|FG000|Overall Study|Sponsor Decision|1|||
164422373|NCT01848834|593916387|FG001|Overall Study|Sponsor Decision|1|||
164675737|NCT01029340|594836816|FG001|Extension Period|Physician Decision|0|||
164675738|NCT01029340|594836817|FG002|Extension Period|Physician Decision|0|||
164675739|NCT01029340|594836818|FG003|Extension Period|Physician Decision|0|||
164422374|NCT01848834|593916388|FG002|Overall Study|Sponsor Decision|0|||
164232151|NCT02904096|593218204|FG000|Overall Study|Adverse Event|1|||
164232152|NCT02904096|593218205|FG001|Overall Study|Adverse Event|0|||
164232153|NCT02904096|593218204|FG000|Overall Study|Withdrawal by Subject|4|||
164232154|NCT02904096|593218205|FG001|Overall Study|Withdrawal by Subject|3|||
164572421|NCT01307423|594460365|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
164572422|NCT01307423|594460366|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
164572423|NCT01307423|594460367|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
164572424|NCT01307423|594460368|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
164232155|NCT02904096|593218204|FG000|Overall Study|Lost to Follow-up|10|||
164232156|NCT02904096|593218205|FG001|Overall Study|Lost to Follow-up|17|||
164232157|NCT02904096|593218204|FG000|Overall Study|Non-compliant|3|||
164232158|NCT02904096|593218205|FG001|Overall Study|Non-compliant|1|||
164232159|NCT02904096|593218204|FG000|Overall Study|Sponsor instructed|1|||
164232160|NCT02904096|593218205|FG001|Overall Study|Sponsor instructed|0|||
164232161|NCT00526799|593218208|FG000|Overall Study|Withdrawal by Subject|1|||
164232162|NCT00526799|593218209|FG001|Overall Study|Withdrawal by Subject|0|||
164232163|NCT00526799|593218208|FG000|Overall Study|Intercurrent Complicating Disease|0|||
164232164|NCT00526799|593218209|FG001|Overall Study|Intercurrent Complicating Disease|1|||
164232165|NCT03633058|593218212|FG000|Overall Study|Adverse Event|0|||
164232166|NCT03633058|593218213|FG001|Overall Study|Adverse Event|0|||
164232167|NCT03633058|593218214|FG002|Overall Study|Adverse Event|1|||
164232168|NCT03633058|593218215|FG003|Overall Study|Adverse Event|0|||
164232169|NCT01107496|593218219|FG000|Overall Study|Adverse Event|1|||
164232170|NCT01107496|593218220|FG001|Overall Study|Adverse Event|0|||
164232171|NCT01107496|593218219|FG000|Overall Study|Lack of Efficacy|1|||
164232172|NCT01107496|593218220|FG001|Overall Study|Lack of Efficacy|0|||
164232173|NCT01107496|593218219|FG000|Overall Study|Protocol Violation|0|||
164232174|NCT01107496|593218220|FG001|Overall Study|Protocol Violation|1|||
164232175|NCT01107496|593218219|FG000|Overall Study|Lost to Follow-up|0|||
164232176|NCT01107496|593218220|FG001|Overall Study|Lost to Follow-up|1|||
164232177|NCT03559556|593218221|FG000|Overall Study|Withdrawal by Subject|1|||
164232178|NCT02496000|593218222|FG000|Overall Study|Withdrawal by Subject|1|||
164232179|NCT02496000|593218223|FG001|Overall Study|Withdrawal by Subject|2|||
164232180|NCT02496000|593218224|FG002|Overall Study|Withdrawal by Subject|0|||
164232181|NCT02496000|593218222|FG000|Overall Study|Lost to Follow-up|1|||
164232182|NCT02496000|593218223|FG001|Overall Study|Lost to Follow-up|0|||
164232183|NCT02496000|593218224|FG002|Overall Study|Lost to Follow-up|1|||
164232184|NCT02496000|593218222|FG000|Overall Study|Protocol Violation|0|||
164332952|NCT01528215|593595697|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
164332953|NCT01528215|593595696|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
164332954|NCT01528215|593595697|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
164332955|NCT01528215|593595696|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
164332956|NCT01528215|593595697|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
164332957|NCT02322021|593595698|FG000|Core Phase|Adverse Event|1|||
164332958|NCT02322021|593595699|FG001|Core Phase|Adverse Event|3|||
164332959|NCT02322021|593595700|FG002|Core Phase|Adverse Event|4|||
164332960|NCT02322021|593595701|FG003|Core Phase|Adverse Event|2|||
164332961|NCT02322021|593595702|FG004|Core Phase|Adverse Event|0|||
164332962|NCT02322021|593595698|FG000|Core Phase|Participant Choice|4|||
164332963|NCT02322021|593595699|FG001|Core Phase|Participant Choice|5|||
164332964|NCT02322021|593595700|FG002|Core Phase|Participant Choice|4|||
164332965|NCT02322021|593595701|FG003|Core Phase|Participant Choice|2|||
164332966|NCT02322021|593595702|FG004|Core Phase|Participant Choice|0|||
164332967|NCT02322021|593595698|FG000|Core Phase|Lost to Follow-up|0|||
164332968|NCT02322021|593595699|FG001|Core Phase|Lost to Follow-up|0|||
164332969|NCT02322021|593595700|FG002|Core Phase|Lost to Follow-up|0|||
164332970|NCT02322021|593595701|FG003|Core Phase|Lost to Follow-up|1|||
164332971|NCT02322021|593595702|FG004|Core Phase|Lost to Follow-up|0|||
164332972|NCT02322021|593595698|FG000|Core Phase|Other|0|||
164332973|NCT02322021|593595699|FG001|Core Phase|Other|0|||
164332974|NCT02322021|593595700|FG002|Core Phase|Other|1|||
164332975|NCT02322021|593595701|FG003|Core Phase|Other|0|||
164332976|NCT02322021|593595702|FG004|Core Phase|Other|0|||
164332977|NCT02322021|593595698|FG000|Extension Phase|Adverse Event|0|||
164332978|NCT02322021|593595699|FG001|Extension Phase|Adverse Event|0|||
164332979|NCT02322021|593595700|FG002|Extension Phase|Adverse Event|0|||
164332980|NCT02322021|593595701|FG003|Extension Phase|Adverse Event|0|||
164332981|NCT02322021|593595702|FG004|Extension Phase|Adverse Event|3|||
164332982|NCT02322021|593595698|FG000|Extension Phase|Participant Choice|0|||
164332983|NCT02322021|593595699|FG001|Extension Phase|Participant Choice|0|||
164332984|NCT02322021|593595700|FG002|Extension Phase|Participant Choice|0|||
164332985|NCT02322021|593595701|FG003|Extension Phase|Participant Choice|0|||
164332986|NCT02322021|593595702|FG004|Extension Phase|Participant Choice|6|||
164332987|NCT02322021|593595698|FG000|Extension Phase|Other|0|||
164332988|NCT02322021|593595699|FG001|Extension Phase|Other|0|||
164332989|NCT02322021|593595700|FG002|Extension Phase|Other|0|||
164332990|NCT02322021|593595701|FG003|Extension Phase|Other|0|||
164332991|NCT02322021|593595702|FG004|Extension Phase|Other|3|||
164332992|NCT02322021|593595698|FG000|Extension Phase|Lost to Follow-up|0|||
164232185|NCT02496000|593218223|FG001|Overall Study|Protocol Violation|0|||
164232186|NCT02496000|593218224|FG002|Overall Study|Protocol Violation|1|||
164232187|NCT02496000|593218222|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
164232188|NCT02496000|593218223|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
164232189|NCT02496000|593218224|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
164232190|NCT02496000|593218222|FG000|Overall Study|undetermined|0|||
164232191|NCT02496000|593218223|FG001|Overall Study|undetermined|1|||
164232192|NCT02496000|593218224|FG002|Overall Study|undetermined|0|||
164232193|NCT01877278|593218225|FG000|Overall Study|Lost to Follow-up|3|||
164232194|NCT01877278|593218226|FG001|Overall Study|Lost to Follow-up|3|||
164232195|NCT01969058|593218227|FG000|Overall Study|Withdrawal by Subject|2|||
164232196|NCT01969058|593218228|FG001|Overall Study|Withdrawal by Subject|0|||
164232197|NCT01969058|593218227|FG000|Overall Study|Adverse Event|1|||
164232198|NCT01969058|593218228|FG001|Overall Study|Adverse Event|0|||
164232199|NCT04090749|593218229|FG000|Open Label Pilot|Lost to Follow-up|1|||
164232200|NCT04090749|593218230|FG001|Open Label Pilot|Lost to Follow-up|0|||
164232201|NCT04090749|593218231|FG002|Open Label Pilot|Lost to Follow-up|0|||
164232202|NCT04090749|593218229|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
164232203|NCT04090749|593218230|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
164232204|NCT04090749|593218231|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
164232205|NCT04090749|593218229|FG000|Pilot Trial|Lost to Follow-up|0|||
164232206|NCT04090749|593218230|FG001|Pilot Trial|Lost to Follow-up|1|||
164232207|NCT04090749|593218231|FG002|Pilot Trial|Lost to Follow-up|1|||
164232208|NCT03510715|593218232|FG000|Overall Study|Adverse Event|1|||
164232209|NCT03510715|593218233|FG001|Overall Study|Adverse Event|0|||
164232210|NCT01972659|593218235|FG000|Overall Study|Protocol Violation|2|||
164232211|NCT01972659|593218236|FG001|Overall Study|Protocol Violation|2|||
164232212|NCT01972659|593218235|FG000|Overall Study|problems realted to acceleromyograph|2|||
164232213|NCT01972659|593218236|FG001|Overall Study|problems realted to acceleromyograph|1|||
164232214|NCT02457793|593218238|FG000|Overall Study|Reason not specified|0|||
164232215|NCT02457793|593218239|FG001|Overall Study|Reason not specified|0|||
164232216|NCT02457793|593218240|FG002|Overall Study|Reason not specified|0|||
164232217|NCT02457793|593218241|FG003|Overall Study|Reason not specified|1|||
164232218|NCT02457793|593218242|FG004|Overall Study|Reason not specified|1|||
164232219|NCT02457793|593218243|FG005|Overall Study|Reason not specified|1|||
164232220|NCT02457793|593218238|FG000|Overall Study|Withdrawal by Subject|0|||
164232221|NCT02457793|593218239|FG001|Overall Study|Withdrawal by Subject|4|||
164232222|NCT02457793|593218240|FG002|Overall Study|Withdrawal by Subject|2|||
164232223|NCT02457793|593218241|FG003|Overall Study|Withdrawal by Subject|2|||
164232224|NCT02457793|593218242|FG004|Overall Study|Withdrawal by Subject|2|||
164232225|NCT02457793|593218243|FG005|Overall Study|Withdrawal by Subject|2|||
164572425|NCT01307423|594460360|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
164572426|NCT01307423|594460361|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
164572427|NCT01307423|594460362|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
164572428|NCT01307423|594460363|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
164572429|NCT01307423|594460364|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
164572430|NCT01307423|594460365|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
164572431|NCT01307423|594460366|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
164232226|NCT02457793|593218238|FG000|Overall Study|Adverse Event|0|||
164232227|NCT02457793|593218239|FG001|Overall Study|Adverse Event|0|||
164232228|NCT02457793|593218240|FG002|Overall Study|Adverse Event|0|||
164232229|NCT02457793|593218241|FG003|Overall Study|Adverse Event|1|||
164232230|NCT02457793|593218242|FG004|Overall Study|Adverse Event|0|||
164232231|NCT02457793|593218243|FG005|Overall Study|Adverse Event|0|||
164232232|NCT02457793|593218238|FG000|Overall Study|Physician Decision|1|||
164232233|NCT02457793|593218239|FG001|Overall Study|Physician Decision|0|||
164232234|NCT02457793|593218240|FG002|Overall Study|Physician Decision|1|||
164232235|NCT02457793|593218241|FG003|Overall Study|Physician Decision|1|||
164232236|NCT02457793|593218242|FG004|Overall Study|Physician Decision|1|||
164232237|NCT02457793|593218243|FG005|Overall Study|Physician Decision|3|||
164232238|NCT00791648|593219892|FG000|Overall Study|Physician Decision|0|||
164232239|NCT00791648|593219893|FG001|Overall Study|Physician Decision|1|||
164232240|NCT00791648|593219892|FG000|Overall Study|Withdrawal by Subject|0|||
164232241|NCT00791648|593219893|FG001|Overall Study|Withdrawal by Subject|1|||
164232242|NCT00836706|593219894|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
164232243|NCT00836706|593219895|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
164232244|NCT02989857|593219896|FG000|Randomization Phase|Not Treated|3|||
164232245|NCT02989857|593219897|FG001|Randomization Phase|Not Treated|2|||
164232246|NCT02989857|593219898|FG002|Randomization Phase|Not Treated|0|||
164232247|NCT01992757|593219899|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
164232248|NCT01344356|593219903|FG000|Overall Study|Physician Decision|0|||
164232249|NCT01344356|593219904|FG001|Overall Study|Physician Decision|3|||
164232250|NCT01344356|593219903|FG000|Overall Study|Lost to Follow-up|0|||
164232251|NCT01344356|593219904|FG001|Overall Study|Lost to Follow-up|6|||
164232252|NCT02390076|593219909|FG000|Overall Study|Lost to Follow-up|2|||
164232253|NCT02390076|593219910|FG001|Overall Study|Lost to Follow-up|1|||
164232254|NCT02390076|593219911|FG002|Overall Study|Lost to Follow-up|4|||
164232255|NCT02095106|593219914|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
164232256|NCT02095106|593219915|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
164232257|NCT00635050|593219920|FG000|Overall Study|Withdrawal by Subject|1|||
164232258|NCT03038620|593219921|FG000|Overall Study|Lost to Follow-up|18|||
164232259|NCT03038620|593219922|FG001|Overall Study|Lost to Follow-up|23|||
164232260|NCT03038620|593219921|FG000|Overall Study|Withdrawal by Subject|0|||
164232261|NCT03038620|593219922|FG001|Overall Study|Withdrawal by Subject|15|||
164232262|NCT03038620|593219921|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
164232263|NCT03038620|593219922|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
164232264|NCT04380142|593219927|FG000|LD/CD Stabilization Period|Adverse Event|3|||
164232265|NCT04380142|593219928|FG001|LD/CD Stabilization Period|Adverse Event|0|||
164232266|NCT04380142|593219929|FG002|LD/CD Stabilization Period|Adverse Event|0|||
164232267|NCT04380142|593219927|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
164232268|NCT04380142|593219928|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
164232269|NCT04380142|593219929|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
164232270|NCT04380142|593219927|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
164232271|NCT04380142|593219928|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
164232272|NCT04380142|593219929|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
164232273|NCT04380142|593219927|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
164232274|NCT04380142|593219928|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
164232275|NCT04380142|593219929|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
164232276|NCT04380142|593219927|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
164232277|NCT04380142|593219928|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
164232278|NCT04380142|593219929|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
164232279|NCT04380142|593219927|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
164232280|NCT04380142|593219928|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
164232281|NCT04380142|593219929|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
164232282|NCT04380142|593219927|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164232283|NCT04380142|593219928|FG001|Double-Blind Treatment Period|Adverse Event|1|||
164232284|NCT04380142|593219929|FG002|Double-Blind Treatment Period|Adverse Event|14|||
164232285|NCT04380142|593219927|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
164232286|NCT04380142|593219928|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
164232287|NCT04380142|593219929|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
164232288|NCT04380142|593219927|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
164232289|NCT04380142|593219928|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
164232290|NCT04380142|593219929|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
164232291|NCT04380142|593219927|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
164232292|NCT04380142|593219928|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
164232293|NCT04380142|593219929|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
164232294|NCT04380142|593219927|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
164232295|NCT04380142|593219928|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
164232296|NCT04380142|593219929|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
164232297|NCT04380142|593219927|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
164232298|NCT04380142|593219928|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
164232299|NCT04380142|593219929|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
164232300|NCT00539500|593219935|FG000|Overall Study|Disease Progression|1|||
164232301|NCT00539500|593219935|FG000|Overall Study|Lost to Follow-up|2|||
164232302|NCT02011542|593219937|FG000|Overall Study|Physician Decision|1|||
164232303|NCT03261505|593219938|FG000|Overall Study|Withdrawal by Subject|2|||
164232304|NCT03261505|593219939|FG001|Overall Study|Withdrawal by Subject|3|||
164232305|NCT03261505|593219940|FG002|Overall Study|Withdrawal by Subject|4|||
164232306|NCT03261505|593219941|FG003|Overall Study|Withdrawal by Subject|3|||
164232307|NCT03261505|593219938|FG000|Overall Study|unrelated surgery preventing the subject participating the study|0|||
164232308|NCT03261505|593219939|FG001|Overall Study|unrelated surgery preventing the subject participating the study|0|||
164232309|NCT03261505|593219940|FG002|Overall Study|unrelated surgery preventing the subject participating the study|1|||
164232310|NCT03261505|593219941|FG003|Overall Study|unrelated surgery preventing the subject participating the study|0|||
164232311|NCT03261505|593219938|FG000|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
164232312|NCT03261505|593219939|FG001|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
164232313|NCT03261505|593219940|FG002|Overall Study|Claustrophobic or can not provide proof of diagnosis|2|||
164232314|NCT03261505|593219941|FG003|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
164232315|NCT03261505|593219938|FG000|Overall Study|the subject can not concentrate to complete the questionnaire|1|||
164232316|NCT03261505|593219939|FG001|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
164232317|NCT03261505|593219940|FG002|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
164232318|NCT03261505|593219941|FG003|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
164232319|NCT00663260|593219943|FG000|Overall Study|Lack of Efficacy|2|||
164422375|NCT01848834|593916389|FG003|Overall Study|Sponsor Decision|1|||
164572432|NCT01307423|594460367|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
164572433|NCT01307423|594460368|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
164675740|NCT01029340|594836819|FG004|Extension Period|Physician Decision|0|||
164675741|NCT01029340|594836820|FG005|Extension Period|Physician Decision|1|||
164675742|NCT02009163|594836828|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
164675743|NCT02009163|594836829|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
164675744|NCT02009163|594836830|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
164675745|NCT02009163|594836828|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
164675746|NCT02009163|594836829|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
164675747|NCT02009163|594836830|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
164675748|NCT02009163|594836828|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
164675749|NCT02009163|594836829|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
164572434|NCT01307423|594460360|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
164675750|NCT02009163|594836830|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
164332993|NCT02322021|593595699|FG001|Extension Phase|Lost to Follow-up|0|||
164332994|NCT02322021|593595700|FG002|Extension Phase|Lost to Follow-up|0|||
164332995|NCT02322021|593595701|FG003|Extension Phase|Lost to Follow-up|0|||
164332996|NCT02322021|593595702|FG004|Extension Phase|Lost to Follow-up|1|||
164332997|NCT02322021|593595698|FG000|Extension Phase|Study terminated by sponsor|0|||
164332998|NCT02322021|593595699|FG001|Extension Phase|Study terminated by sponsor|0|||
164332999|NCT02322021|593595700|FG002|Extension Phase|Study terminated by sponsor|0|||
164333000|NCT02322021|593595701|FG003|Extension Phase|Study terminated by sponsor|0|||
164333001|NCT02322021|593595702|FG004|Extension Phase|Study terminated by sponsor|28|||
164333002|NCT01934972|593595703|FG000|Overall Study|Withdrawal by Subject|9|||
164333003|NCT01934972|593595704|FG001|Overall Study|Withdrawal by Subject|6|||
164333004|NCT01278160|593595705|FG000|Overall Study|Adverse Event|1|||
164572435|NCT01307423|594460361|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
164572436|NCT01307423|594460362|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
164572437|NCT01307423|594460363|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
164572438|NCT01307423|594460364|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
164572439|NCT01307423|594460365|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
164572440|NCT01307423|594460366|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
164572441|NCT01307423|594460367|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
164572442|NCT01307423|594460368|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
164572443|NCT01307423|594460360|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
164572444|NCT01307423|594460361|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
164572445|NCT01307423|594460362|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
164572446|NCT01307423|594460363|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
164572447|NCT01307423|594460364|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
164572448|NCT01307423|594460365|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
164572449|NCT01307423|594460366|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
164572450|NCT01307423|594460367|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
164572451|NCT01307423|594460368|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
164572452|NCT01307423|594460360|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
164572453|NCT01307423|594460361|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
164572454|NCT01307423|594460362|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
164572455|NCT01307423|594460363|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
164572456|NCT01307423|594460364|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
164572457|NCT01307423|594460365|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
164572458|NCT01307423|594460366|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
164572459|NCT01307423|594460367|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
164572460|NCT01307423|594460368|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
164572461|NCT01307423|594460360|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
164572462|NCT01307423|594460361|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
164572463|NCT01307423|594460362|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
164572464|NCT01307423|594460363|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
164572465|NCT01307423|594460364|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
164572466|NCT01307423|594460365|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
164572467|NCT01307423|594460366|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
164572468|NCT01307423|594460367|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
164572469|NCT01307423|594460368|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
164572470|NCT01307423|594460360|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
164572471|NCT01307423|594460361|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
164572472|NCT01307423|594460362|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
164572473|NCT01307423|594460363|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
164675751|NCT02009163|594836828|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
164572474|NCT01307423|594460364|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
164572475|NCT01307423|594460365|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
164333005|NCT01278160|593595706|FG001|Overall Study|Adverse Event|1|||
164232320|NCT00663260|593219944|FG001|Overall Study|Lack of Efficacy|0|||
164232321|NCT00663260|593219945|FG002|Overall Study|Lack of Efficacy|0|||
164232322|NCT00663260|593219943|FG000|Overall Study|Adverse Event|12|||
164232323|NCT00663260|593219944|FG001|Overall Study|Adverse Event|7|||
164232324|NCT00663260|593219945|FG002|Overall Study|Adverse Event|6|||
164232325|NCT00663260|593219943|FG000|Overall Study|Withdrawal by Subject|3|||
164572476|NCT01307423|594460366|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
164572477|NCT01307423|594460367|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
164232326|NCT00663260|593219944|FG001|Overall Study|Withdrawal by Subject|1|||
164232327|NCT00663260|593219945|FG002|Overall Study|Withdrawal by Subject|6|||
164232328|NCT00663260|593219943|FG000|Overall Study|Death|1|||
164232329|NCT00663260|593219944|FG001|Overall Study|Death|0|||
164232330|NCT00663260|593219945|FG002|Overall Study|Death|1|||
164232331|NCT00663260|593219943|FG000|Overall Study|Lost to Follow-up|0|||
164232332|NCT00663260|593219944|FG001|Overall Study|Lost to Follow-up|1|||
164232333|NCT00663260|593219945|FG002|Overall Study|Lost to Follow-up|0|||
164299772|NCT01488890|593472923|FG000|Overall Study|Protocol Violation|3|||
164299773|NCT01488890|593472924|FG001|Overall Study|Protocol Violation|0|||
164299774|NCT01488890|593472925|FG002|Overall Study|Protocol Violation|4|||
164299775|NCT01488890|593472926|FG003|Overall Study|Protocol Violation|0|||
164299776|NCT01488890|593472923|FG000|Overall Study|Lost to Follow-up|13|||
164299777|NCT01488890|593472924|FG001|Overall Study|Lost to Follow-up|10|||
164299778|NCT01488890|593472925|FG002|Overall Study|Lost to Follow-up|20|||
164299779|NCT01488890|593472926|FG003|Overall Study|Lost to Follow-up|3|||
164299780|NCT01488890|593472923|FG000|Overall Study|Withdrawal by Subject|14|||
164299781|NCT01488890|593472924|FG001|Overall Study|Withdrawal by Subject|10|||
164299782|NCT01488890|593472925|FG002|Overall Study|Withdrawal by Subject|11|||
164299783|NCT01488890|593472926|FG003|Overall Study|Withdrawal by Subject|2|||
164299784|NCT00829426|593472927|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
164299785|NCT00829426|593472928|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
164299786|NCT02628873|593472929|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
164299787|NCT02628873|593472930|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
164299788|NCT02628873|593472929|FG000|Second Test (1 Hour)|Physician Decision|1|||
164299789|NCT02628873|593472930|FG001|Second Test (1 Hour)|Physician Decision|0|||
164299790|NCT03597347|593472933|FG000|Overall Study|Withdrawal by Subject|1|||
164299791|NCT03597347|593472934|FG001|Overall Study|Withdrawal by Subject|1|||
164299792|NCT03597347|593472935|FG002|Overall Study|Withdrawal by Subject|0|||
164299793|NCT03597347|593472933|FG000|Overall Study|Withdrawal due to Covid-19|3|||
164299794|NCT03597347|593472934|FG001|Overall Study|Withdrawal due to Covid-19|0|||
164299795|NCT03597347|593472935|FG002|Overall Study|Withdrawal due to Covid-19|0|||
164299796|NCT03597347|593472933|FG000|Overall Study|Sponsor decision to terminate study|3|||
164299797|NCT03597347|593472934|FG001|Overall Study|Sponsor decision to terminate study|2|||
164299798|NCT03597347|593472935|FG002|Overall Study|Sponsor decision to terminate study|4|||
164299799|NCT04606134|593472936|FG000|Overall Study|Adverse Event|0|||
164299800|NCT04606134|593472937|FG001|Overall Study|Adverse Event|1|||
164299801|NCT00107653|593472938|FG000|Overall Study|Adverse Event|24|||
164299802|NCT00107653|593472939|FG001|Overall Study|Adverse Event|43|||
164299803|NCT00107653|593472938|FG000|Overall Study|Insufficient Therapeutic Response|25|||
164299804|NCT00107653|593472939|FG001|Overall Study|Insufficient Therapeutic Response|11|||
164299805|NCT00107653|593472938|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
164299806|NCT00107653|593472939|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
164299807|NCT00107653|593472938|FG000|Overall Study|Protocol Violation|1|||
164299808|NCT00107653|593472939|FG001|Overall Study|Protocol Violation|0|||
164299809|NCT00107653|593472938|FG000|Overall Study|Withdrawal by Subject|12|||
164299810|NCT00107653|593472939|FG001|Overall Study|Withdrawal by Subject|13|||
164299811|NCT00107653|593472938|FG000|Overall Study|Lost to Follow-up|13|||
164299812|NCT00107653|593472939|FG001|Overall Study|Lost to Follow-up|5|||
164299813|NCT00107653|593472938|FG000|Overall Study|Administrative Reasons|3|||
164299814|NCT00107653|593472939|FG001|Overall Study|Administrative Reasons|3|||
164299815|NCT01099267|593472941|FG000|MDS-003 Study|Adverse Event|37|||
164299816|NCT01099267|593472941|FG000|MDS-003 Study|Lack of Efficacy|52|||
164299817|NCT01099267|593472941|FG000|MDS-003 Study|Withdrawal by Subject|8|||
164299818|NCT01099267|593472941|FG000|MDS-003 Study|Lost to Follow-up|1|||
164299819|NCT01099267|593472941|FG000|MDS-003 Study|Death|11|||
164299820|NCT01099267|593472941|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
164299821|NCT01099267|593472941|FG000|MDS-003 Study|Disease Progression|7|||
164299822|NCT01099267|593472941|FG000|MDS-003 Study|Investigator Decision|2|||
164299823|NCT01099267|593472941|FG000|MDS-003 Study|Non-Compliance|2|||
164299824|NCT01099267|593472941|FG000|MDS-003 Study|Loss of Response|1|||
164299825|NCT01099267|593472941|FG000|MDS-003 Study|Secondary Malign Disease|1|||
164299826|NCT04986904|593472942|FG000|Overall Study|Lost to Follow-up|11|||
164299827|NCT04986904|593472942|FG000|Overall Study|Withdrawal by Subject|1|||
164299828|NCT02532517|593472943|FG000|Overall Study|Did not complete 24-Month visit|4|||
164299829|NCT02532517|593472943|FG000|Overall Study|Failed Angiographic eligibility|1|||
164299830|NCT02532517|593472943|FG000|Overall Study|Lost to Follow-up|4|||
164422376|NCT01848834|593916390|FG004|Overall Study|Sponsor Decision|1|||
164422377|NCT01848834|593916386|FG000|Overall Study|Withdrawal by Subject|2|||
164422378|NCT01848834|593916387|FG001|Overall Study|Withdrawal by Subject|13|||
164422379|NCT01848834|593916388|FG002|Overall Study|Withdrawal by Subject|10|||
164422380|NCT01848834|593916389|FG003|Overall Study|Withdrawal by Subject|6|||
164422381|NCT01848834|593916390|FG004|Overall Study|Withdrawal by Subject|36|||
164422382|NCT01570868|593916391|FG000|Overall Study|Adverse Event|8|||
164422383|NCT01570868|593916392|FG001|Overall Study|Adverse Event|1|||
164422384|NCT01570868|593916391|FG000|Overall Study|FDA Recommendation|23|||
164422385|NCT01570868|593916392|FG001|Overall Study|FDA Recommendation|3|||
164422386|NCT01570868|593916391|FG000|Overall Study|Physician Decision|10|||
164232334|NCT00663260|593219943|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
164232335|NCT00663260|593219944|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
164232336|NCT00663260|593219945|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
164232337|NCT00980798|593219946|FG000|Overall Study|Adverse Event|7|||
164232338|NCT00980798|593219947|FG001|Overall Study|Adverse Event|36|||
164232339|NCT00980798|593219946|FG000|Overall Study|Lack of Efficacy|16|||
164232340|NCT00980798|593219947|FG001|Overall Study|Lack of Efficacy|5|||
164232341|NCT00980798|593219946|FG000|Overall Study|Lost to Follow-up|0|||
164232342|NCT00980798|593219947|FG001|Overall Study|Lost to Follow-up|1|||
164232343|NCT00980798|593219946|FG000|Overall Study|Physician Decision|2|||
164232344|NCT00980798|593219947|FG001|Overall Study|Physician Decision|1|||
164232345|NCT00980798|593219946|FG000|Overall Study|Withdrawal by Subject|8|||
164232346|NCT00980798|593219947|FG001|Overall Study|Withdrawal by Subject|11|||
164232347|NCT00980798|593219946|FG000|Overall Study|Other|0|||
164232348|NCT00980798|593219947|FG001|Overall Study|Other|1|||
164232349|NCT00522379|593219948|FG000|Overall Study|Adverse Event|12|||
164232350|NCT00522379|593219949|FG001|Overall Study|Adverse Event|15|||
164232351|NCT00522379|593219950|FG002|Overall Study|Adverse Event|12|||
164232352|NCT00522379|593219951|FG003|Overall Study|Adverse Event|5|||
164232353|NCT00522379|593219952|FG004|Overall Study|Adverse Event|17|||
164232354|NCT00522379|593219948|FG000|Overall Study|Lack of Efficacy|3|||
164232355|NCT00522379|593219949|FG001|Overall Study|Lack of Efficacy|0|||
164232356|NCT00522379|593219950|FG002|Overall Study|Lack of Efficacy|2|||
164232357|NCT00522379|593219951|FG003|Overall Study|Lack of Efficacy|2|||
164232358|NCT00522379|593219952|FG004|Overall Study|Lack of Efficacy|7|||
164232359|NCT00522379|593219948|FG000|Overall Study|Withdrawal by Subject|2|||
164232360|NCT00522379|593219949|FG001|Overall Study|Withdrawal by Subject|3|||
164232361|NCT00522379|593219950|FG002|Overall Study|Withdrawal by Subject|1|||
164232362|NCT00522379|593219951|FG003|Overall Study|Withdrawal by Subject|2|||
164232363|NCT00522379|593219952|FG004|Overall Study|Withdrawal by Subject|0|||
164232364|NCT00522379|593219948|FG000|Overall Study|Protocol Violation|1|||
164232365|NCT00522379|593219949|FG001|Overall Study|Protocol Violation|1|||
164232366|NCT00522379|593219950|FG002|Overall Study|Protocol Violation|2|||
164232367|NCT00522379|593219951|FG003|Overall Study|Protocol Violation|0|||
164232368|NCT00522379|593219952|FG004|Overall Study|Protocol Violation|0|||
164232369|NCT00522379|593219948|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
164232370|NCT00522379|593219949|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
164232371|NCT00522379|593219950|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
164232372|NCT00522379|593219951|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
164232373|NCT00522379|593219952|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
164232374|NCT00522379|593219948|FG000|Overall Study|Lost to Follow-up|1|||
164232375|NCT00522379|593219949|FG001|Overall Study|Lost to Follow-up|0|||
164232376|NCT00522379|593219950|FG002|Overall Study|Lost to Follow-up|4|||
164232377|NCT00522379|593219951|FG003|Overall Study|Lost to Follow-up|2|||
164232378|NCT00522379|593219952|FG004|Overall Study|Lost to Follow-up|2|||
164232379|NCT00522379|593219948|FG000|Overall Study|Randomization error|0|||
164232380|NCT00522379|593219949|FG001|Overall Study|Randomization error|0|||
164232381|NCT00522379|593219950|FG002|Overall Study|Randomization error|0|||
164232382|NCT00522379|593219951|FG003|Overall Study|Randomization error|0|||
164232383|NCT00522379|593219952|FG004|Overall Study|Randomization error|1|||
164232384|NCT00522379|593219948|FG000|Overall Study|Dispensing error|1|||
164232385|NCT00522379|593219949|FG001|Overall Study|Dispensing error|0|||
164232386|NCT00522379|593219950|FG002|Overall Study|Dispensing error|0|||
164232387|NCT00522379|593219951|FG003|Overall Study|Dispensing error|1|||
164232388|NCT00522379|593219952|FG004|Overall Study|Dispensing error|0|||
164232389|NCT00522379|593219948|FG000|Overall Study|Subject Moved|1|||
164232390|NCT00522379|593219949|FG001|Overall Study|Subject Moved|1|||
164422387|NCT01570868|593916392|FG001|Overall Study|Physician Decision|4|||
164232391|NCT00522379|593219950|FG002|Overall Study|Subject Moved|0|||
164232392|NCT00522379|593219951|FG003|Overall Study|Subject Moved|0|||
164232393|NCT00522379|593219952|FG004|Overall Study|Subject Moved|0|||
164422388|NCT01570868|593916391|FG000|Overall Study|Lost to Follow-up|1|||
164422389|NCT01570868|593916392|FG001|Overall Study|Lost to Follow-up|0|||
164232394|NCT00522379|593219948|FG000|Overall Study|Sponsor Request|0|||
164232395|NCT00522379|593219949|FG001|Overall Study|Sponsor Request|1|||
164232396|NCT00522379|593219950|FG002|Overall Study|Sponsor Request|0|||
164232397|NCT00522379|593219951|FG003|Overall Study|Sponsor Request|0|||
164232398|NCT00522379|593219952|FG004|Overall Study|Sponsor Request|0|||
164232399|NCT00522379|593219948|FG000|Overall Study|Family Problem|0|||
164232400|NCT00522379|593219949|FG001|Overall Study|Family Problem|0|||
164232401|NCT00522379|593219950|FG002|Overall Study|Family Problem|1|||
164232402|NCT00522379|593219951|FG003|Overall Study|Family Problem|0|||
164232403|NCT00522379|593219952|FG004|Overall Study|Family Problem|0|||
164232404|NCT00522379|593219948|FG000|Overall Study|Site Closed|0|||
164232405|NCT00522379|593219949|FG001|Overall Study|Site Closed|0|||
164232406|NCT00522379|593219950|FG002|Overall Study|Site Closed|0|||
164232407|NCT00522379|593219951|FG003|Overall Study|Site Closed|1|||
164232408|NCT00522379|593219952|FG004|Overall Study|Site Closed|0|||
164232409|NCT00522379|593219948|FG000|Overall Study|Subject Withdrawal|0|||
164232410|NCT00522379|593219949|FG001|Overall Study|Subject Withdrawal|0|||
164232411|NCT00522379|593219950|FG002|Overall Study|Subject Withdrawal|0|||
164232412|NCT00522379|593219951|FG003|Overall Study|Subject Withdrawal|1|||
164232413|NCT00522379|593219952|FG004|Overall Study|Subject Withdrawal|0|||
164232414|NCT03213509|593219953|FG000|Overall Study|Did not consent for verbal autopsy|4|||
164232415|NCT03213509|593219954|FG001|Overall Study|Did not consent for verbal autopsy|5|||
164232416|NCT04562090|593219955|FG000|Overall Study|Withdrawal by Subject|3|||
164232417|NCT04562090|593219956|FG001|Overall Study|Withdrawal by Subject|4|||
164232418|NCT04562090|593219955|FG000|Overall Study|Protocol Violation|2|||
164232419|NCT04562090|593219956|FG001|Overall Study|Protocol Violation|0|||
164232420|NCT04562090|593219955|FG000|Overall Study|Lack of Efficacy|0|||
164232421|NCT04562090|593219956|FG001|Overall Study|Lack of Efficacy|1|||
164232422|NCT04562090|593219955|FG000|Overall Study|Adverse Event|1|||
164232423|NCT04562090|593219956|FG001|Overall Study|Adverse Event|4|||
164232424|NCT04562090|593219955|FG000|Overall Study|Miscellaneous|0|||
164232425|NCT04562090|593219956|FG001|Overall Study|Miscellaneous|3|||
164232426|NCT00847730|593219957|FG000|Overall Study|Multiple interruptions in therapy|8|||
164232427|NCT00432965|593219958|FG000|Overall Study|Lost to Follow-up|22|||
164232428|NCT00432965|593219959|FG001|Overall Study|Lost to Follow-up|19|||
164232429|NCT00432965|593219958|FG000|Overall Study|Withdrawal by Subject|13|||
164232430|NCT00432965|593219959|FG001|Overall Study|Withdrawal by Subject|13|||
164232431|NCT00432965|593219958|FG000|Overall Study|Physician Decision|14|||
164232432|NCT00432965|593219959|FG001|Overall Study|Physician Decision|13|||
164232433|NCT00432965|593219958|FG000|Overall Study|Lack of Efficacy|8|||
164232434|NCT00432965|593219959|FG001|Overall Study|Lack of Efficacy|13|||
164232435|NCT00432965|593219958|FG000|Overall Study|Non-compliance|7|||
164232436|NCT00432965|593219959|FG001|Overall Study|Non-compliance|0|||
164232437|NCT00432965|593219958|FG000|Overall Study|Adverse Event|22|||
164232438|NCT00432965|593219959|FG001|Overall Study|Adverse Event|19|||
164232439|NCT00432965|593219958|FG000|Overall Study|Death|3|||
164232440|NCT00432965|593219959|FG001|Overall Study|Death|4|||
164232441|NCT00432965|593219958|FG000|Overall Study|Exclusionary Methods|1|||
164232442|NCT00432965|593219959|FG001|Overall Study|Exclusionary Methods|2|||
164232443|NCT00432965|593219958|FG000|Overall Study|Incomplete Data|4|||
164232444|NCT00432965|593219959|FG001|Overall Study|Incomplete Data|3|||
164232445|NCT01889251|593219960|FG000|Overall Study|Adverse Event|1|||
164232446|NCT01889251|593219961|FG001|Overall Study|Adverse Event|0|||
164232447|NCT01903863|593219962|FG000|Overall Study|Physician Decision|2|||
164232448|NCT01903863|593219963|FG001|Overall Study|Physician Decision|0|||
164232449|NCT01344226|593219970|FG000|Overall Study|Protocol Violation|2|||
164232450|NCT01344226|593219970|FG000|Overall Study|Withdrawal by Subject|3|||
164232451|NCT01344226|593219970|FG000|Overall Study|Lack of Efficacy|3|||
164232452|NCT03909971|593219977|FG000|Overall Study|Participant transition to rollover study|26|||
164333006|NCT01278160|593595705|FG000|Overall Study|Lost to Follow-up|0|||
164333007|NCT01278160|593595706|FG001|Overall Study|Lost to Follow-up|1|||
164675752|NCT02009163|594836829|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
164675753|NCT02009163|594836830|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
164675754|NCT02009163|594836828|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
164675755|NCT02009163|594836829|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
164333008|NCT01278160|593595705|FG000|Overall Study|Withdrawal by Subject|3|||
164675756|NCT02009163|594836830|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
164675757|NCT02009163|594836828|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
164232453|NCT03909971|593219978|FG001|Overall Study|Participant transition to rollover study|9|||
164232454|NCT03909971|593219977|FG000|Overall Study|Global Deterioration of Health Status|2|||
164232455|NCT03909971|593219978|FG001|Overall Study|Global Deterioration of Health Status|2|||
164232456|NCT03909971|593219977|FG000|Overall Study|Progressive Disease|28|||
164232457|NCT03909971|593219978|FG001|Overall Study|Progressive Disease|21|||
164232458|NCT03909971|593219977|FG000|Overall Study|Death|6|||
164232459|NCT03909971|593219978|FG001|Overall Study|Death|6|||
164232460|NCT03909971|593219977|FG000|Overall Study|Adverse Event|1|||
164333009|NCT01278160|593595706|FG001|Overall Study|Withdrawal by Subject|2|||
164232461|NCT03909971|593219978|FG001|Overall Study|Adverse Event|2|||
164232462|NCT03909971|593219977|FG000|Overall Study|Withdrawal by Subject|2|||
164232463|NCT03909971|593219978|FG001|Overall Study|Withdrawal by Subject|1|||
164232464|NCT03909971|593219977|FG000|Overall Study|Participant was unwilling to come to site visit|0|||
164232465|NCT03909971|593219978|FG001|Overall Study|Participant was unwilling to come to site visit|1|||
164232466|NCT03909971|593219977|FG000|Overall Study|No longer benefit from Lorlatinib|2|||
164232467|NCT03909971|593219978|FG001|Overall Study|No longer benefit from Lorlatinib|0|||
164232468|NCT04727151|593219982|FG000|Overall Study|Death|0|||
164232469|NCT04727151|593219983|FG001|Overall Study|Death|0|||
164232470|NCT04727151|593219984|FG002|Overall Study|Death|0|||
164232471|NCT04727151|593219985|FG003|Overall Study|Death|0|||
164232472|NCT04727151|593219986|FG004|Overall Study|Death|3|||
164232473|NCT04727151|593219982|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
164232474|NCT04727151|593219983|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
164232475|NCT04727151|593219984|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
164232476|NCT04727151|593219985|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
164232477|NCT04727151|593219986|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
164232478|NCT01587196|593219987|FG000|Overall Study|Lost to Follow-up|50|||
164232479|NCT01587196|593219987|FG000|Overall Study|Withdrawal by Subject|4|||
164232480|NCT00642759|593219988|FG000|Overall Study|Protocol Violation|1|||
164232481|NCT03612570|593219992|FG000|Overall Study|Lost to Follow-up|1|||
164232482|NCT05318287|593219997|FG000|Overall Study|Lost to Follow-up|8|||
164232483|NCT05185453|593219998|FG000|Overall Study|Lost to Follow-up|13|||
164232484|NCT05185453|593219999|FG001|Overall Study|Lost to Follow-up|3|||
164232485|NCT03537508|593220000|FG000|Overall Study|Adverse Event|2|||
164232486|NCT03537508|593220001|FG001|Overall Study|Adverse Event|1|||
164232487|NCT03537508|593220000|FG000|Overall Study|Protocol Violation|65|||
164232488|NCT03537508|593220001|FG001|Overall Study|Protocol Violation|48|||
164232489|NCT03537508|593220000|FG000|Overall Study|Lost to Follow-up|86|||
164232490|NCT03537508|593220001|FG001|Overall Study|Lost to Follow-up|60|||
164232491|NCT03537508|593220000|FG000|Overall Study|Withdrawal by parent/guardian|263|||
164232492|NCT03537508|593220001|FG001|Overall Study|Withdrawal by parent/guardian|149|||
164232493|NCT03814044|593220021|FG000|Overall Study|Protocol deviation|1|||
164232494|NCT02757768|593220022|FG000|Overall Study|Randomized Never Received Study Drug|3|||
164232495|NCT02757768|593220023|FG001|Overall Study|Randomized Never Received Study Drug|4|||
164232496|NCT02757768|593220022|FG000|Overall Study|Adverse Event|5|||
164232497|NCT02757768|593220023|FG001|Overall Study|Adverse Event|3|||
164232498|NCT02757768|593220022|FG000|Overall Study|Lack of Efficacy|2|||
164232499|NCT02757768|593220023|FG001|Overall Study|Lack of Efficacy|1|||
164232500|NCT02757768|593220022|FG000|Overall Study|Lost to Follow-up|1|||
164232501|NCT02757768|593220023|FG001|Overall Study|Lost to Follow-up|0|||
164232502|NCT02757768|593220022|FG000|Overall Study|Protocol Deviation|2|||
164232503|NCT02757768|593220023|FG001|Overall Study|Protocol Deviation|9|||
164232504|NCT02757768|593220022|FG000|Overall Study|Withdrawal by Subject|16|||
164232505|NCT02757768|593220023|FG001|Overall Study|Withdrawal by Subject|9|||
164232506|NCT02757768|593220022|FG000|Overall Study|Miscellaneous|4|||
164232507|NCT02757768|593220023|FG001|Overall Study|Miscellaneous|2|||
164232508|NCT00835367|593220035|FG000|Washout|Adverse Event|2|||
164232509|NCT00835367|593220036|FG001|Washout|Adverse Event|0|||
164232510|NCT00835367|593220035|FG000|Washout|Withdrawal by Subject|1|||
164232511|NCT00835367|593220036|FG001|Washout|Withdrawal by Subject|0|||
164232512|NCT00835367|593220035|FG000|Second Intervention|Adverse Event|1|||
164232513|NCT00835367|593220036|FG001|Second Intervention|Adverse Event|1|||
164232514|NCT00835172|593220037|FG000|Washout|Protocol Violation|0|||
164232515|NCT00835172|593220038|FG001|Washout|Protocol Violation|1|||
164232516|NCT02495883|593220039|FG000|Overall Study|Excessive head motion|1|||
164232517|NCT02495883|593220040|FG001|Overall Study|Excessive head motion|0|||
164232518|NCT00964678|593220044|FG000|Overall Study|Physician Decision|4|||
164232519|NCT03552029|593221650|FG000|Overall Study|Death|3|||
164232520|NCT03552029|593221651|FG001|Overall Study|Death|0|||
164232521|NCT03552029|593221650|FG000|Overall Study|Adverse Event|1|||
164232522|NCT03552029|593221651|FG001|Overall Study|Adverse Event|0|||
164232523|NCT03552029|593221650|FG000|Overall Study|Lack of Efficacy|0|||
164232524|NCT03552029|593221651|FG001|Overall Study|Lack of Efficacy|2|||
164675758|NCT02009163|594836829|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
164232525|NCT03552029|593221650|FG000|Overall Study|Physician Decision|0|||
164232526|NCT03552029|593221651|FG001|Overall Study|Physician Decision|1|||
164232527|NCT03552029|593221650|FG000|Overall Study|Study terminated by Sponsor|0|||
164232528|NCT03552029|593221651|FG001|Overall Study|Study terminated by Sponsor|1|||
164232529|NCT03552029|593221650|FG000|Overall Study|Other|0|||
164232530|NCT03552029|593221651|FG001|Overall Study|Other|2|||
164232531|NCT04490278|593221652|FG000|Overall Study|Lost to Follow-up|6|||
164232532|NCT00183248|593221655|FG000|Overall Study|Lost to Follow-up|0|||
164232533|NCT00183248|593221656|FG001|Overall Study|Lost to Follow-up|1|||
164232534|NCT00183248|593221655|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
164232535|NCT00183248|593221656|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
164232536|NCT03801525|593221657|FG000|Overall Study|Adverse Event|17|||
164232537|NCT03801525|593221658|FG001|Overall Study|Adverse Event|1|||
164232538|NCT03801525|593221659|FG002|Overall Study|Adverse Event|0|||
164232539|NCT03801525|593221657|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
164232540|NCT03801525|593221658|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
164299831|NCT02532517|593472943|FG000|Overall Study|Withdrawal by Subject|4|||
164232541|NCT03801525|593221659|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
164232542|NCT03801525|593221657|FG000|Overall Study|Death|29|||
164232543|NCT03801525|593221658|FG001|Overall Study|Death|1|||
164232544|NCT03801525|593221659|FG002|Overall Study|Death|4|||
164232545|NCT03801525|593221657|FG000|Overall Study|Disease Progression|6|||
164232546|NCT03801525|593221658|FG001|Overall Study|Disease Progression|0|||
164232547|NCT03801525|593221659|FG002|Overall Study|Disease Progression|1|||
164232548|NCT03801525|593221657|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
164232549|NCT03801525|593221658|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
164232550|NCT03801525|593221659|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
164232551|NCT03801525|593221657|FG000|Overall Study|Investigator Decision|18|||
164232552|NCT03801525|593221658|FG001|Overall Study|Investigator Decision|1|||
164232553|NCT03801525|593221659|FG002|Overall Study|Investigator Decision|0|||
164232554|NCT03801525|593221657|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
164232555|NCT03801525|593221658|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
164232556|NCT03801525|593221659|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
164232557|NCT03801525|593221657|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
164232558|NCT03801525|593221658|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
164232559|NCT03801525|593221659|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
164232560|NCT03801525|593221657|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
164232561|NCT03801525|593221658|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
164232562|NCT03801525|593221659|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
164232563|NCT03801525|593221657|FG000|Overall Study|Withdrawal of Subject Consent|38|||
164232564|NCT03801525|593221658|FG001|Overall Study|Withdrawal of Subject Consent|2|||
164232565|NCT03801525|593221659|FG002|Overall Study|Withdrawal of Subject Consent|1|||
164232566|NCT03801525|593221657|FG000|Overall Study|Reason not Specified|4|||
164232567|NCT03801525|593221658|FG001|Overall Study|Reason not Specified|0|||
164232568|NCT03801525|593221659|FG002|Overall Study|Reason not Specified|4|||
164232569|NCT03309202|593221660|FG000|Overall Study|Lost to Follow-up|1|||
164232570|NCT03309202|593221661|FG001|Overall Study|Lost to Follow-up|0|||
164232571|NCT03309202|593221662|FG002|Overall Study|Lost to Follow-up|0|||
164232572|NCT03309202|593221663|FG003|Overall Study|Lost to Follow-up|0|||
164232573|NCT04734210|593221664|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
164232574|NCT04734210|593221665|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
164232575|NCT04734210|593221666|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
164232576|NCT04734210|593221664|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
164232577|NCT04734210|593221665|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
164232578|NCT04734210|593221666|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
164232579|NCT04734210|593221664|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
164232580|NCT04734210|593221665|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
164232581|NCT04734210|593221666|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
164232582|NCT04734210|593221664|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
164232583|NCT04734210|593221665|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
164232584|NCT04734210|593221666|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
164232585|NCT00573768|593221667|FG000|Overall Study|Adverse Event|1|||
164333010|NCT01278160|593595705|FG000|Overall Study|Unclassified|1|||
164333011|NCT01278160|593595706|FG001|Overall Study|Unclassified|2|||
164333012|NCT00560885|593595707|FG000|Overall Study|Death|7|||
164333013|NCT00560885|593595707|FG000|Overall Study|Withdrawal by Subject|1|||
164333014|NCT03148275|593595708|FG000|Overall Study|Death|6|||
164333015|NCT03148275|593595708|FG000|Overall Study|Adverse Event|3|||
164333016|NCT03148275|593595708|FG000|Overall Study|Liver transplant|2|||
164333017|NCT03148275|593595708|FG000|Overall Study|Patient decision|5|||
164333018|NCT03148275|593595708|FG000|Overall Study|transition to commercial drug|1|||
164572478|NCT01307423|594460368|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
164572479|NCT03406962|594460371|FG000|Overall Study|Death|2|||
164572480|NCT03406962|594460371|FG000|Overall Study|Adverse Event|1|||
164572481|NCT03853694|594460372|FG000|Overall Study|Protocol Violation|3|||
164572482|NCT03853694|594460373|FG001|Overall Study|Protocol Violation|5|||
164572483|NCT03853694|594460374|FG002|Overall Study|Protocol Violation|3|||
164572484|NCT03853694|594460372|FG000|Overall Study|Delivered early|0|||
164572485|NCT03853694|594460373|FG001|Overall Study|Delivered early|1|||
164572486|NCT03853694|594460374|FG002|Overall Study|Delivered early|0|||
164422390|NCT01570868|593916391|FG000|Overall Study|Withdrawal by Subject|1|||
164422391|NCT01570868|593916392|FG001|Overall Study|Withdrawal by Subject|0|||
164422392|NCT03370276|593916393|FG000|Overall Study|Death|0|||
164572487|NCT03853694|594460372|FG000|Overall Study|not suitable to proceed|0|||
164572488|NCT03853694|594460373|FG001|Overall Study|not suitable to proceed|1|||
164232586|NCT00573768|593221668|FG001|Overall Study|Adverse Event|1|||
164232587|NCT00573768|593221669|FG002|Overall Study|Adverse Event|2|||
164232588|NCT00573768|593221667|FG000|Overall Study|Protocol Violation|1|||
164232589|NCT00573768|593221668|FG001|Overall Study|Protocol Violation|0|||
164232590|NCT00573768|593221669|FG002|Overall Study|Protocol Violation|1|||
164232591|NCT00573768|593221667|FG000|Overall Study|Withdrawal by Subject|0|||
164232592|NCT00573768|593221668|FG001|Overall Study|Withdrawal by Subject|1|||
164232593|NCT00573768|593221669|FG002|Overall Study|Withdrawal by Subject|0|||
164232594|NCT00573768|593221667|FG000|Overall Study|Lost to Follow-up|0|||
164232595|NCT00573768|593221668|FG001|Overall Study|Lost to Follow-up|0|||
164232596|NCT00573768|593221669|FG002|Overall Study|Lost to Follow-up|1|||
164232597|NCT00553254|593221675|FG000|Overall Study|Death|3|||
164232598|NCT00553254|593221676|FG001|Overall Study|Death|6|||
164232599|NCT00553254|593221677|FG002|Overall Study|Death|25|||
164232600|NCT00553254|593221675|FG000|Overall Study|Lost to Follow-up|0|||
164232601|NCT00553254|593221676|FG001|Overall Study|Lost to Follow-up|0|||
164232602|NCT00553254|593221677|FG002|Overall Study|Lost to Follow-up|2|||
164232603|NCT00553254|593221675|FG000|Overall Study|Withdrawal by Subject|2|||
164232604|NCT00553254|593221676|FG001|Overall Study|Withdrawal by Subject|0|||
164232605|NCT00553254|593221677|FG002|Overall Study|Withdrawal by Subject|2|||
164232606|NCT00553254|593221675|FG000|Overall Study|Study terminated by Sponsor|0|||
164232607|NCT00553254|593221676|FG001|Overall Study|Study terminated by Sponsor|0|||
164232608|NCT00553254|593221677|FG002|Overall Study|Study terminated by Sponsor|1|||
164232609|NCT00553254|593221675|FG000|Overall Study|Other|1|||
164232610|NCT00553254|593221676|FG001|Overall Study|Other|0|||
164232611|NCT00553254|593221677|FG002|Overall Study|Other|13|||
164232612|NCT02314923|593221680|FG000|Overall Study|Death|0|||
164232613|NCT02314923|593221681|FG001|Overall Study|Death|0|||
164232614|NCT02314923|593221682|FG002|Overall Study|Death|0|||
164232615|NCT02314923|593221683|FG003|Overall Study|Death|1|||
164232616|NCT02314923|593221684|FG004|Overall Study|Death|0|||
164232617|NCT02314923|593221685|FG005|Overall Study|Death|0|||
164232618|NCT02314923|593221686|FG006|Overall Study|Death|0|||
164232619|NCT02314923|593221687|FG007|Overall Study|Death|0|||
164232620|NCT02314923|593221688|FG008|Overall Study|Death|0|||
164333019|NCT03148275|593595708|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
164333020|NCT03803683|593595710|FG000|Overall Study|Lost to Follow-up|41|||
164333021|NCT03803683|593595711|FG001|Overall Study|Lost to Follow-up|18|||
164333022|NCT03803683|593595712|FG002|Overall Study|Lost to Follow-up|12|||
164333023|NCT03803683|593595710|FG000|Overall Study|Withdrawal by Subject|9|||
164333024|NCT03803683|593595711|FG001|Overall Study|Withdrawal by Subject|1|||
164333025|NCT03803683|593595712|FG002|Overall Study|Withdrawal by Subject|4|||
164333026|NCT04493333|593597303|FG000|Overall Study|Withdrawal by Subject|1|||
164333027|NCT04493333|593597304|FG001|Overall Study|Withdrawal by Subject|1|||
164333028|NCT04493333|593597303|FG000|Overall Study|Ineligible|0|||
164333029|NCT04493333|593597304|FG001|Overall Study|Ineligible|1|||
164333030|NCT04493333|593597303|FG000|Overall Study|Noncompliance|2|||
164333031|NCT04493333|593597304|FG001|Overall Study|Noncompliance|1|||
164333032|NCT02925923|593597305|FG000|Overall Study|blood samples hemolyzed|0|||
164333033|NCT02925923|593597306|FG001|Overall Study|blood samples hemolyzed|2|||
164333034|NCT00697073|593597307|FG000|Overall Study|Withdrawal by Subject|2|||
164333035|NCT00697073|593597307|FG000|Overall Study|Pregnancy|1|||
164333036|NCT00697073|593597307|FG000|Overall Study|non compliance and other|6|||
164333037|NCT03911713|593597308|FG000|Overall Study|Lost to Follow-up|0|||
164333038|NCT03911713|593597309|FG001|Overall Study|Lost to Follow-up|2|||
164333039|NCT03911713|593597310|FG002|Overall Study|Lost to Follow-up|0|||
164333040|NCT03911713|593597311|FG003|Overall Study|Lost to Follow-up|0|||
164675759|NCT02009163|594836830|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
164675760|NCT02009163|594836828|FG000|Open-label Period (Non-randomized)|Other|13|||
164333041|NCT03911713|593597312|FG004|Overall Study|Lost to Follow-up|0|||
164333042|NCT03911713|593597308|FG000|Overall Study|Other|0|||
164333043|NCT03911713|593597309|FG001|Overall Study|Other|0|||
164333044|NCT03911713|593597310|FG002|Overall Study|Other|0|||
164333045|NCT03911713|593597311|FG003|Overall Study|Other|1|||
164333046|NCT03911713|593597312|FG004|Overall Study|Other|0|||
164333047|NCT03911713|593597308|FG000|Overall Study|Randomized, Never Dosed|1|||
164333048|NCT03911713|593597309|FG001|Overall Study|Randomized, Never Dosed|0|||
164333049|NCT03911713|593597310|FG002|Overall Study|Randomized, Never Dosed|0|||
164333050|NCT03911713|593597311|FG003|Overall Study|Randomized, Never Dosed|1|||
164333051|NCT03911713|593597312|FG004|Overall Study|Randomized, Never Dosed|0|||
164333052|NCT01845818|593597315|FG000|Overall Study|Withdrawal by Subject|0|||
164232621|NCT02314923|593221689|FG009|Overall Study|Death|0|||
164232622|NCT02314923|593221680|FG000|Overall Study|Lost to Follow-up|2|||
164232623|NCT02314923|593221681|FG001|Overall Study|Lost to Follow-up|3|||
164232624|NCT02314923|593221682|FG002|Overall Study|Lost to Follow-up|1|||
164232625|NCT02314923|593221683|FG003|Overall Study|Lost to Follow-up|0|||
164232626|NCT02314923|593221684|FG004|Overall Study|Lost to Follow-up|0|||
164232627|NCT02314923|593221685|FG005|Overall Study|Lost to Follow-up|0|||
164232628|NCT02314923|593221686|FG006|Overall Study|Lost to Follow-up|3|||
164232629|NCT02314923|593221687|FG007|Overall Study|Lost to Follow-up|4|||
164422393|NCT03370276|593916394|FG001|Overall Study|Death|2|||
164422394|NCT03370276|593916395|FG002|Overall Study|Death|5|||
164422395|NCT02584855|593916401|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
164422396|NCT02584855|593916402|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
164422397|NCT02584855|593916403|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
164422398|NCT02584855|593916404|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
164422399|NCT02584855|593916405|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
164422400|NCT02584855|593916406|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
164422401|NCT02584855|593916401|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
164422402|NCT02584855|593916402|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
164422403|NCT02584855|593916403|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
164422404|NCT02584855|593916404|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
164422405|NCT02584855|593916405|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
164422406|NCT02584855|593916406|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
164422407|NCT02584855|593916401|FG000|Open-Label Treatment Period|Adverse Event|14|||
164422408|NCT02584855|593916402|FG001|Open-Label Treatment Period|Adverse Event|0|||
164422409|NCT02584855|593916403|FG002|Open-Label Treatment Period|Adverse Event|0|||
164422410|NCT02584855|593916404|FG003|Open-Label Treatment Period|Adverse Event|0|||
164422411|NCT02584855|593916405|FG004|Open-Label Treatment Period|Adverse Event|0|||
164422412|NCT02584855|593916406|FG005|Open-Label Treatment Period|Adverse Event|0|||
164422413|NCT02584855|593916401|FG000|Open-Label Treatment Period|Death|2|||
164422414|NCT02584855|593916402|FG001|Open-Label Treatment Period|Death|0|||
164422415|NCT02584855|593916403|FG002|Open-Label Treatment Period|Death|0|||
164422416|NCT02584855|593916404|FG003|Open-Label Treatment Period|Death|0|||
164422417|NCT02584855|593916405|FG004|Open-Label Treatment Period|Death|0|||
164422418|NCT02584855|593916406|FG005|Open-Label Treatment Period|Death|0|||
164422419|NCT02584855|593916401|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
164422420|NCT02584855|593916402|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
164422421|NCT02584855|593916403|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
164422422|NCT02584855|593916404|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
164422423|NCT02584855|593916405|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
164422424|NCT02584855|593916406|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
164422425|NCT02584855|593916401|FG000|Open-Label Treatment Period|Protocol Violation|1|||
164422426|NCT02584855|593916402|FG001|Open-Label Treatment Period|Protocol Violation|0|||
164422427|NCT02584855|593916403|FG002|Open-Label Treatment Period|Protocol Violation|0|||
164422428|NCT02584855|593916404|FG003|Open-Label Treatment Period|Protocol Violation|0|||
164422429|NCT02584855|593916405|FG004|Open-Label Treatment Period|Protocol Violation|0|||
164422430|NCT02584855|593916406|FG005|Open-Label Treatment Period|Protocol Violation|0|||
164422431|NCT02584855|593916401|FG000|Open-Label Treatment Period|No PI Available|2|||
164422432|NCT02584855|593916402|FG001|Open-Label Treatment Period|No PI Available|0|||
164422433|NCT02584855|593916403|FG002|Open-Label Treatment Period|No PI Available|0|||
164422434|NCT02584855|593916404|FG003|Open-Label Treatment Period|No PI Available|0|||
164422435|NCT02584855|593916405|FG004|Open-Label Treatment Period|No PI Available|0|||
164422436|NCT02584855|593916406|FG005|Open-Label Treatment Period|No PI Available|0|||
164422437|NCT02584855|593916401|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
164422438|NCT02584855|593916402|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
164422439|NCT02584855|593916403|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
164422440|NCT02584855|593916404|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
164422441|NCT02584855|593916405|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
164422442|NCT02584855|593916406|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
164422443|NCT02584855|593916401|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
164422444|NCT02584855|593916402|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
164422445|NCT02584855|593916403|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
164422446|NCT02584855|593916404|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
164422447|NCT02584855|593916405|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
164422448|NCT02584855|593916406|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
164422449|NCT02584855|593916401|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
164422450|NCT02584855|593916402|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
164422451|NCT02584855|593916403|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
164422452|NCT02584855|593916404|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
164422453|NCT02584855|593916405|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
164422454|NCT02584855|593916406|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
164422455|NCT02584855|593916401|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
164422456|NCT02584855|593916402|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
164422457|NCT02584855|593916403|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
164422458|NCT02584855|593916404|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
164422459|NCT02584855|593916405|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
164422460|NCT02584855|593916406|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
164422461|NCT02584855|593916401|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
164422462|NCT02584855|593916402|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
164422463|NCT02584855|593916403|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
164232630|NCT02314923|593221688|FG008|Overall Study|Lost to Follow-up|2|||
164232631|NCT02314923|593221689|FG009|Overall Study|Lost to Follow-up|0|||
164232632|NCT02314923|593221680|FG000|Overall Study|Withdrawal by Subject|0|||
164232633|NCT02314923|593221681|FG001|Overall Study|Withdrawal by Subject|0|||
164232634|NCT02314923|593221682|FG002|Overall Study|Withdrawal by Subject|1|||
164232635|NCT02314923|593221683|FG003|Overall Study|Withdrawal by Subject|0|||
164232636|NCT02314923|593221684|FG004|Overall Study|Withdrawal by Subject|1|||
164232637|NCT02314923|593221685|FG005|Overall Study|Withdrawal by Subject|0|||
164232638|NCT02314923|593221686|FG006|Overall Study|Withdrawal by Subject|1|||
164232639|NCT02314923|593221687|FG007|Overall Study|Withdrawal by Subject|0|||
164232640|NCT02314923|593221688|FG008|Overall Study|Withdrawal by Subject|0|||
164333053|NCT01845818|593597316|FG001|Overall Study|Withdrawal by Subject|1|||
164333054|NCT01845818|593597315|FG000|Overall Study|Lost to Follow-up|7|||
164333055|NCT01845818|593597316|FG001|Overall Study|Lost to Follow-up|5|||
164333056|NCT01845818|593597315|FG000|Overall Study|Administrative Reasons|3|||
164333057|NCT01845818|593597316|FG001|Overall Study|Administrative Reasons|1|||
164333058|NCT01845818|593597315|FG000|Overall Study|Serious Adverse Event|1|||
164333059|NCT01845818|593597316|FG001|Overall Study|Serious Adverse Event|1|||
164333060|NCT01845818|593597315|FG000|Overall Study|Other|25|||
164333061|NCT01845818|593597316|FG001|Overall Study|Other|8|||
164333062|NCT01845818|593597315|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
164333063|NCT01845818|593597316|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
164333064|NCT01845818|593597315|FG000|Overall Study|No Follow-Up Data Available|4|||
164333065|NCT01845818|593597316|FG001|Overall Study|No Follow-Up Data Available|1|||
164333066|NCT02595970|593597317|FG000|Overall Study|Withdrawal by Subject|2|||
164333067|NCT02595970|593597317|FG000|Overall Study|Physician Decision|2|||
164333068|NCT02595970|593597317|FG000|Overall Study|Protocol Violation|4|||
164333069|NCT02595970|593597317|FG000|Overall Study|Adverse Event|5|||
164333070|NCT02595970|593597317|FG000|Overall Study|Lack of Efficacy|7|||
164333071|NCT05061966|593597320|FG000|Overall Study|Lost to Follow-up|13|||
164333072|NCT05061966|593597321|FG001|Overall Study|Lost to Follow-up|13|||
164333073|NCT03793556|593597322|FG000|Overall Study|Withdrawal by Subject|12|||
164333074|NCT03793556|593597323|FG001|Overall Study|Withdrawal by Subject|1|||
164333075|NCT03793556|593597322|FG000|Overall Study|Lost to Follow-up|1|||
164333076|NCT03793556|593597323|FG001|Overall Study|Lost to Follow-up|1|||
164333077|NCT02923427|593597324|FG000|Overall Study|convert to laparatomy|2|||
164333078|NCT02923427|593597325|FG001|Overall Study|convert to laparatomy|2|||
164333079|NCT02923427|593597324|FG000|Overall Study|destaturation|1|||
164333080|NCT02923427|593597325|FG001|Overall Study|destaturation|0|||
164333081|NCT02923427|593597324|FG000|Overall Study|can not replace LMA|1|||
164333082|NCT02923427|593597325|FG001|Overall Study|can not replace LMA|0|||
164333083|NCT01325623|593597326|FG000|Overall Study|Withdrawal by Subject|3|||
164333084|NCT01539642|593597331|FG000|Overall Study|Lack of Efficacy|20|||
164333085|NCT01539642|593597332|FG001|Overall Study|Lack of Efficacy|18|||
164333086|NCT01539642|593597331|FG000|Overall Study|Patient ready for early discharge|8|||
164333087|NCT01539642|593597332|FG001|Overall Study|Patient ready for early discharge|7|||
164333088|NCT01539642|593597331|FG000|Overall Study|Adverse Event|6|||
164333089|NCT01539642|593597332|FG001|Overall Study|Adverse Event|4|||
164333090|NCT01539642|593597331|FG000|Overall Study|Withdrawal by Subject|2|||
164333091|NCT01539642|593597332|FG001|Overall Study|Withdrawal by Subject|2|||
164333092|NCT00598702|593597333|FG000|Overall Study|Other|0|||
164333093|NCT00598702|593597334|FG001|Overall Study|Other|2|||
164572489|NCT03853694|594460374|FG002|Overall Study|not suitable to proceed|0|||
164572490|NCT03853694|594460372|FG000|Overall Study|difficult surgery|0|||
164572491|NCT03853694|594460373|FG001|Overall Study|difficult surgery|0|||
164572492|NCT03853694|594460374|FG002|Overall Study|difficult surgery|1|||
164572493|NCT03853694|594460372|FG000|Overall Study|Lost to Follow-up|0|||
164572494|NCT03853694|594460373|FG001|Overall Study|Lost to Follow-up|1|||
164572495|NCT03853694|594460374|FG002|Overall Study|Lost to Follow-up|0|||
164572496|NCT03853694|594460372|FG000|Overall Study|Withdrawal by Subject|0|||
164572497|NCT03853694|594460373|FG001|Overall Study|Withdrawal by Subject|1|||
164572498|NCT03853694|594460374|FG002|Overall Study|Withdrawal by Subject|0|||
164572499|NCT02209766|594460375|FG000|Overall Study|Withdrawal by Subject|0|||
164572500|NCT02209766|594460376|FG001|Overall Study|Withdrawal by Subject|0|||
164572501|NCT02209766|594460377|FG002|Overall Study|Withdrawal by Subject|0|||
164572502|NCT02209766|594460378|FG003|Overall Study|Withdrawal by Subject|1|||
164572503|NCT02209766|594460379|FG004|Overall Study|Withdrawal by Subject|0|||
164572504|NCT00805207|594460380|FG000|Overall Study|Protocol Violation|0|||
164572505|NCT00805207|594460381|FG001|Overall Study|Protocol Violation|0|||
164572506|NCT00805207|594460382|FG002|Overall Study|Protocol Violation|1|||
164572507|NCT00805207|594460383|FG003|Overall Study|Protocol Violation|0|||
164572508|NCT00805207|594460384|FG004|Overall Study|Protocol Violation|0|||
164572509|NCT00805207|594460385|FG005|Overall Study|Protocol Violation|0|||
164437463|NCT02914522|593968185|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
164572510|NCT00805207|594460386|FG006|Overall Study|Protocol Violation|0|||
164572511|NCT00805207|594460387|FG007|Overall Study|Protocol Violation|0|||
164572512|NCT00805207|594460388|FG008|Overall Study|Protocol Violation|0|||
164232641|NCT02314923|593221689|FG009|Overall Study|Withdrawal by Subject|0|||
164232642|NCT02314923|593221680|FG000|Overall Study|Physician Decision|0|||
164232643|NCT02314923|593221681|FG001|Overall Study|Physician Decision|1|||
164232644|NCT02314923|593221682|FG002|Overall Study|Physician Decision|0|||
164232645|NCT02314923|593221683|FG003|Overall Study|Physician Decision|0|||
164232646|NCT02314923|593221684|FG004|Overall Study|Physician Decision|0|||
164232647|NCT02314923|593221685|FG005|Overall Study|Physician Decision|0|||
164232648|NCT02314923|593221686|FG006|Overall Study|Physician Decision|0|||
164232649|NCT02314923|593221687|FG007|Overall Study|Physician Decision|0|||
164232650|NCT02314923|593221688|FG008|Overall Study|Physician Decision|0|||
164232651|NCT02314923|593221689|FG009|Overall Study|Physician Decision|0|||
164232652|NCT02314923|593221680|FG000|Overall Study|Participant unavailable|0|||
164232653|NCT02314923|593221681|FG001|Overall Study|Participant unavailable|0|||
164232654|NCT02314923|593221682|FG002|Overall Study|Participant unavailable|0|||
164232655|NCT02314923|593221683|FG003|Overall Study|Participant unavailable|0|||
164232656|NCT02314923|593221684|FG004|Overall Study|Participant unavailable|0|||
164232657|NCT02314923|593221685|FG005|Overall Study|Participant unavailable|1|||
164232658|NCT02314923|593221686|FG006|Overall Study|Participant unavailable|0|||
164232659|NCT02314923|593221687|FG007|Overall Study|Participant unavailable|0|||
164232660|NCT02314923|593221688|FG008|Overall Study|Participant unavailable|0|||
164232661|NCT02314923|593221689|FG009|Overall Study|Participant unavailable|0|||
164232662|NCT02314923|593221680|FG000|Overall Study|Screen failure|0|||
164232663|NCT02314923|593221681|FG001|Overall Study|Screen failure|0|||
164232664|NCT02314923|593221682|FG002|Overall Study|Screen failure|0|||
164232665|NCT02314923|593221683|FG003|Overall Study|Screen failure|0|||
164232666|NCT02314923|593221684|FG004|Overall Study|Screen failure|0|||
164232667|NCT02314923|593221685|FG005|Overall Study|Screen failure|0|||
164232668|NCT02314923|593221686|FG006|Overall Study|Screen failure|1|||
164232669|NCT02314923|593221687|FG007|Overall Study|Screen failure|0|||
164232670|NCT02314923|593221688|FG008|Overall Study|Screen failure|0|||
164232671|NCT02314923|593221689|FG009|Overall Study|Screen failure|0|||
164232672|NCT02314923|593221680|FG000|Overall Study|Participant relocation|1|||
164232673|NCT02314923|593221681|FG001|Overall Study|Participant relocation|0|||
164232674|NCT02314923|593221682|FG002|Overall Study|Participant relocation|0|||
164232675|NCT02314923|593221683|FG003|Overall Study|Participant relocation|0|||
164232676|NCT02314923|593221684|FG004|Overall Study|Participant relocation|0|||
164232677|NCT02314923|593221685|FG005|Overall Study|Participant relocation|0|||
164232678|NCT02314923|593221686|FG006|Overall Study|Participant relocation|0|||
164232679|NCT02314923|593221687|FG007|Overall Study|Participant relocation|1|||
164232680|NCT02314923|593221688|FG008|Overall Study|Participant relocation|0|||
164232681|NCT02314923|593221689|FG009|Overall Study|Participant relocation|0|||
164232682|NCT00976456|593221692|FG000|Overall Study|Adverse Event|17|||
164232683|NCT00976456|593221693|FG001|Overall Study|Adverse Event|22|||
164232684|NCT00976456|593221692|FG000|Overall Study|Death|7|||
164232685|NCT00976456|593221693|FG001|Overall Study|Death|9|||
164232686|NCT00976456|593221692|FG000|Overall Study|Lack of Efficacy|5|||
164675761|NCT02009163|594836829|FG001|Open-label Period (Non-randomized)|Other|0|||
164675762|NCT02009163|594836830|FG002|Open-label Period (Non-randomized)|Other|0|||
164675763|NCT02009163|594836828|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
164675764|NCT02009163|594836829|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
164675765|NCT02009163|594836830|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
164675766|NCT02009163|594836828|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
164675767|NCT02009163|594836829|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
164232687|NCT00976456|593221693|FG001|Overall Study|Lack of Efficacy|2|||
164232688|NCT00976456|593221692|FG000|Overall Study|Withdrawal by Subject|3|||
164232689|NCT00976456|593221693|FG001|Overall Study|Withdrawal by Subject|1|||
164232690|NCT00976456|593221692|FG000|Overall Study|screening failure, unknown|11|||
164675768|NCT02009163|594836830|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
164675769|NCT02009163|594836828|FG000|Randomized-withdrawal Period|Adverse Event|0|||
164675770|NCT02009163|594836829|FG001|Randomized-withdrawal Period|Adverse Event|0|||
164675771|NCT02009163|594836830|FG002|Randomized-withdrawal Period|Adverse Event|6|||
164675772|NCT02009163|594836828|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
164675773|NCT02009163|594836829|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
164675774|NCT02009163|594836830|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
164675775|NCT02009163|594836828|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
164675776|NCT02009163|594836829|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
164675777|NCT02009163|594836830|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
164675778|NCT02009163|594836828|FG000|Randomized-withdrawal Period|Pregnancy|0|||
164675779|NCT02009163|594836829|FG001|Randomized-withdrawal Period|Pregnancy|0|||
164675780|NCT02009163|594836830|FG002|Randomized-withdrawal Period|Pregnancy|2|||
164437464|NCT02914522|593968186|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
164232691|NCT00976456|593221693|FG001|Overall Study|screening failure, unknown|4|||
164232692|NCT00478257|593221694|FG000|Overall Study|Withdrawal by Subject|8|||
164232693|NCT00478257|593221695|FG001|Overall Study|Withdrawal by Subject|3|||
164232694|NCT00806585|593221696|FG000|Overall Study|Study terminated by Sponsor|0|||
164232695|NCT00806585|593221697|FG001|Overall Study|Study terminated by Sponsor|0|||
164232696|NCT00806585|593221698|FG002|Overall Study|Study terminated by Sponsor|1|||
164232697|NCT00806585|593221699|FG003|Overall Study|Study terminated by Sponsor|2|||
164232698|NCT00806585|593221700|FG004|Overall Study|Study terminated by Sponsor|0|||
164232699|NCT00806585|593221696|FG000|Overall Study|Protocol Violation|3|||
164232700|NCT00806585|593221697|FG001|Overall Study|Protocol Violation|1|||
164232701|NCT00806585|593221698|FG002|Overall Study|Protocol Violation|2|||
164232702|NCT00806585|593221699|FG003|Overall Study|Protocol Violation|0|||
164232703|NCT00806585|593221700|FG004|Overall Study|Protocol Violation|0|||
164232704|NCT00806585|593221696|FG000|Overall Study|Physician Decision|0|||
164232705|NCT00806585|593221697|FG001|Overall Study|Physician Decision|2|||
164232706|NCT00806585|593221698|FG002|Overall Study|Physician Decision|3|||
164232707|NCT00806585|593221699|FG003|Overall Study|Physician Decision|0|||
164232708|NCT00806585|593221700|FG004|Overall Study|Physician Decision|1|||
164232709|NCT00806585|593221696|FG000|Overall Study|Lost to Follow-up|2|||
164232710|NCT00806585|593221697|FG001|Overall Study|Lost to Follow-up|1|||
164232711|NCT00806585|593221698|FG002|Overall Study|Lost to Follow-up|2|||
164232712|NCT00806585|593221699|FG003|Overall Study|Lost to Follow-up|2|||
164232713|NCT00806585|593221700|FG004|Overall Study|Lost to Follow-up|5|||
164232714|NCT00806585|593221696|FG000|Overall Study|Lack of Efficacy|1|||
164232715|NCT00806585|593221697|FG001|Overall Study|Lack of Efficacy|0|||
164232716|NCT00806585|593221698|FG002|Overall Study|Lack of Efficacy|0|||
164232717|NCT00806585|593221699|FG003|Overall Study|Lack of Efficacy|0|||
164232718|NCT00806585|593221700|FG004|Overall Study|Lack of Efficacy|0|||
164232719|NCT00806585|593221696|FG000|Overall Study|Adverse Event|1|||
164232720|NCT00806585|593221697|FG001|Overall Study|Adverse Event|5|||
164232721|NCT00806585|593221698|FG002|Overall Study|Adverse Event|3|||
164232722|NCT00806585|593221699|FG003|Overall Study|Adverse Event|4|||
164232723|NCT00806585|593221700|FG004|Overall Study|Adverse Event|2|||
164232724|NCT00806585|593221696|FG000|Overall Study|Withdrawal by Subject|10|||
164232725|NCT00806585|593221697|FG001|Overall Study|Withdrawal by Subject|8|||
164232726|NCT00806585|593221698|FG002|Overall Study|Withdrawal by Subject|9|||
164232727|NCT00806585|593221699|FG003|Overall Study|Withdrawal by Subject|3|||
164232728|NCT00806585|593221700|FG004|Overall Study|Withdrawal by Subject|11|||
164232729|NCT00806585|593221696|FG000|Overall Study|Completion status unknown|15|||
164232730|NCT00806585|593221697|FG001|Overall Study|Completion status unknown|14|||
164232731|NCT00806585|593221698|FG002|Overall Study|Completion status unknown|12|||
164232732|NCT00806585|593221699|FG003|Overall Study|Completion status unknown|4|||
164232733|NCT00806585|593221700|FG004|Overall Study|Completion status unknown|12|||
164232734|NCT02507934|593221701|FG000|Overall Study|Lost to Follow-up|2|||
164232735|NCT02507934|593221702|FG001|Overall Study|Lost to Follow-up|0|||
164232736|NCT02507934|593221701|FG000|Overall Study|Withdrawal by Subject|2|||
164232737|NCT02507934|593221702|FG001|Overall Study|Withdrawal by Subject|0|||
164232738|NCT03766399|593221703|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232739|NCT03766399|593221704|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232740|NCT03766399|593221705|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232741|NCT03766399|593221706|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232742|NCT03766399|593221707|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232743|NCT03766399|593221708|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232744|NCT03766399|593221709|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232745|NCT03766399|593221710|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232746|NCT03766399|593221711|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232747|NCT03766399|593221712|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232748|NCT03766399|593221713|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232749|NCT03766399|593221714|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232750|NCT03766399|593221715|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164333094|NCT00598702|593597335|FG002|Overall Study|Other|0|||
164333095|NCT00598702|593597336|FG003|Overall Study|Other|0|||
164333096|NCT00598702|593597337|FG004|Overall Study|Other|0|||
164333097|NCT00598702|593597338|FG005|Overall Study|Other|1|||
164333098|NCT00598702|593597339|FG006|Overall Study|Other|0|||
164333099|NCT00598702|593597340|FG007|Overall Study|Other|0|||
164333100|NCT00598702|593597333|FG000|Overall Study|Early discharge from hospital|0|||
164333101|NCT00598702|593597334|FG001|Overall Study|Early discharge from hospital|0|||
164333102|NCT00598702|593597335|FG002|Overall Study|Early discharge from hospital|2|||
164333103|NCT00598702|593597336|FG003|Overall Study|Early discharge from hospital|5|||
164232751|NCT03766399|593221716|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
164232752|NCT03766399|593221717|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232753|NCT03766399|593221718|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232754|NCT03766399|593221719|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232755|NCT03766399|593221720|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232756|NCT03331354|593221721|FG000|Overall Study|Withdrawal by Subject|1|||
164232757|NCT03331354|593221722|FG001|Overall Study|Withdrawal by Subject|3|||
164232758|NCT03331354|593221721|FG000|Overall Study|Lost to Follow-up|3|||
164333104|NCT00598702|593597337|FG004|Overall Study|Early discharge from hospital|0|||
164572513|NCT00805207|594460380|FG000|Overall Study|Physician Decision|0|||
164232759|NCT03331354|593221722|FG001|Overall Study|Lost to Follow-up|3|||
164675781|NCT02009163|594836828|FG000|Randomized-withdrawal Period|Other|0|||
164675782|NCT02009163|594836829|FG001|Randomized-withdrawal Period|Other|9|||
164675783|NCT02009163|594836830|FG002|Randomized-withdrawal Period|Other|5|||
164675784|NCT02453386|594836831|FG000|Overall Study|Adverse Event|22|||
164675785|NCT02453386|594836832|FG001|Overall Study|Adverse Event|30|||
164675786|NCT02453386|594836833|FG002|Overall Study|Adverse Event|15|||
164675787|NCT02453386|594836831|FG000|Overall Study|Protocol Violation|1|||
164675788|NCT02453386|594836832|FG001|Overall Study|Protocol Violation|0|||
164675789|NCT02453386|594836833|FG002|Overall Study|Protocol Violation|1|||
164675790|NCT02453386|594836831|FG000|Overall Study|Withdrawal by Subject|10|||
164675791|NCT02453386|594836832|FG001|Overall Study|Withdrawal by Subject|9|||
164675792|NCT02453386|594836833|FG002|Overall Study|Withdrawal by Subject|9|||
164675793|NCT02453386|594836831|FG000|Overall Study|Sponsor Terminated Study|14|||
164675794|NCT02453386|594836832|FG001|Overall Study|Sponsor Terminated Study|8|||
164675795|NCT02453386|594836833|FG002|Overall Study|Sponsor Terminated Study|11|||
164675796|NCT02453386|594836831|FG000|Overall Study|Subject Terminated by Sponsor|1|||
164675797|NCT02453386|594836832|FG001|Overall Study|Subject Terminated by Sponsor|1|||
164675798|NCT02453386|594836833|FG002|Overall Study|Subject Terminated by Sponsor|1|||
164675799|NCT02453386|594836831|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
164675800|NCT02453386|594836832|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
164675801|NCT02453386|594836833|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
164675802|NCT02453386|594836831|FG000|Overall Study|Lost to Follow-up|0|||
164675803|NCT02453386|594836832|FG001|Overall Study|Lost to Follow-up|0|||
164675804|NCT02453386|594836833|FG002|Overall Study|Lost to Follow-up|1|||
164675805|NCT02453386|594836831|FG000|Overall Study|Other|1|||
164675806|NCT02453386|594836832|FG001|Overall Study|Other|0|||
164675807|NCT02453386|594836833|FG002|Overall Study|Other|1|||
164675808|NCT00359281|594836834|FG000|Overall Study|Adverse Event|1|||
164675809|NCT00359281|594836835|FG001|Overall Study|Adverse Event|0|||
164675810|NCT00359281|594836836|FG002|Overall Study|Adverse Event|0|||
164675811|NCT00359281|594836837|FG003|Overall Study|Adverse Event|0|||
164675812|NCT00359281|594836838|FG004|Overall Study|Adverse Event|0|||
164675813|NCT00359281|594836839|FG005|Overall Study|Adverse Event|0|||
164675814|NCT00359281|594836840|FG006|Overall Study|Adverse Event|1|||
164675815|NCT00359281|594836841|FG007|Overall Study|Adverse Event|0|||
164675816|NCT00359281|594836842|FG008|Overall Study|Adverse Event|0|||
164675817|NCT00359281|594836834|FG000|Overall Study|Withdrawal by Subject|0|||
164675818|NCT00359281|594836835|FG001|Overall Study|Withdrawal by Subject|0|||
164675819|NCT00359281|594836836|FG002|Overall Study|Withdrawal by Subject|0|||
164675820|NCT00359281|594836837|FG003|Overall Study|Withdrawal by Subject|0|||
164675821|NCT00359281|594836838|FG004|Overall Study|Withdrawal by Subject|0|||
164675822|NCT00359281|594836839|FG005|Overall Study|Withdrawal by Subject|0|||
164675823|NCT00359281|594836840|FG006|Overall Study|Withdrawal by Subject|1|||
164675824|NCT00359281|594836841|FG007|Overall Study|Withdrawal by Subject|0|||
164675825|NCT00359281|594836842|FG008|Overall Study|Withdrawal by Subject|0|||
164675826|NCT01415986|594836845|FG000|Overall Study|Lost to Follow-up|1|||
164675827|NCT01474551|594836848|FG000|Overall Study|Death|1|||
164333105|NCT00598702|593597338|FG005|Overall Study|Early discharge from hospital|10|||
164333106|NCT00598702|593597339|FG006|Overall Study|Early discharge from hospital|1|||
164333107|NCT00598702|593597340|FG007|Overall Study|Early discharge from hospital|0|||
164333108|NCT00598702|593597333|FG000|Overall Study|Adverse Event|0|||
164333109|NCT00598702|593597334|FG001|Overall Study|Adverse Event|0|||
164675828|NCT03586726|594836856|FG000|Overall Study|Withdrawal by Subject|1|||
164675829|NCT03122457|594836857|FG000|Overall Study|Withdrawal by Subject|6|||
164675830|NCT01854047|594836859|FG000|Overall Study|Lack of Efficacy|1|||
164675831|NCT01854047|594836860|FG001|Overall Study|Lack of Efficacy|0|||
164675832|NCT01854047|594836861|FG002|Overall Study|Lack of Efficacy|0|||
164333110|NCT00598702|593597335|FG002|Overall Study|Adverse Event|0|||
164333111|NCT00598702|593597336|FG003|Overall Study|Adverse Event|1|||
164333112|NCT00598702|593597337|FG004|Overall Study|Adverse Event|0|||
164333113|NCT00598702|593597338|FG005|Overall Study|Adverse Event|0|||
164333114|NCT00598702|593597339|FG006|Overall Study|Adverse Event|0|||
164333115|NCT00598702|593597340|FG007|Overall Study|Adverse Event|0|||
164333116|NCT00598702|593597333|FG000|Overall Study|Withdrawal by Subject|0|||
164333117|NCT00598702|593597334|FG001|Overall Study|Withdrawal by Subject|0|||
164333118|NCT00598702|593597335|FG002|Overall Study|Withdrawal by Subject|0|||
164675833|NCT01854047|594836862|FG003|Overall Study|Lack of Efficacy|0|||
164675834|NCT01854047|594836863|FG004|Overall Study|Lack of Efficacy|0|||
164675835|NCT01854047|594836859|FG000|Overall Study|Poor compliance to protocol|3|||
164675836|NCT01854047|594836860|FG001|Overall Study|Poor compliance to protocol|0|||
164675837|NCT01854047|594836861|FG002|Overall Study|Poor compliance to protocol|2|||
164675838|NCT01854047|594836862|FG003|Overall Study|Poor compliance to protocol|0|||
164675839|NCT01854047|594836863|FG004|Overall Study|Poor compliance to protocol|0|||
164675840|NCT01854047|594836859|FG000|Overall Study|Adverse Event|5|||
164675841|NCT01854047|594836860|FG001|Overall Study|Adverse Event|4|||
164675842|NCT01854047|594836861|FG002|Overall Study|Adverse Event|6|||
164675843|NCT01854047|594836862|FG003|Overall Study|Adverse Event|10|||
164675844|NCT01854047|594836863|FG004|Overall Study|Adverse Event|7|||
164333119|NCT00598702|593597336|FG003|Overall Study|Withdrawal by Subject|1|||
164333120|NCT00598702|593597337|FG004|Overall Study|Withdrawal by Subject|1|||
164333121|NCT00598702|593597338|FG005|Overall Study|Withdrawal by Subject|0|||
164333122|NCT00598702|593597339|FG006|Overall Study|Withdrawal by Subject|0|||
164333123|NCT00598702|593597340|FG007|Overall Study|Withdrawal by Subject|0|||
164333124|NCT00598702|593597333|FG000|Overall Study|Physician Decision|0|||
164333125|NCT00598702|593597334|FG001|Overall Study|Physician Decision|0|||
164333126|NCT00598702|593597335|FG002|Overall Study|Physician Decision|0|||
164333127|NCT00598702|593597336|FG003|Overall Study|Physician Decision|0|||
164333128|NCT00598702|593597337|FG004|Overall Study|Physician Decision|1|||
164333129|NCT00598702|593597338|FG005|Overall Study|Physician Decision|0|||
164333130|NCT00598702|593597339|FG006|Overall Study|Physician Decision|0|||
164333131|NCT00598702|593597340|FG007|Overall Study|Physician Decision|0|||
164333132|NCT00598702|593597333|FG000|Overall Study|Dose limiting toxicity|0|||
164333133|NCT00598702|593597334|FG001|Overall Study|Dose limiting toxicity|0|||
164333134|NCT00598702|593597335|FG002|Overall Study|Dose limiting toxicity|0|||
164333135|NCT00598702|593597336|FG003|Overall Study|Dose limiting toxicity|1|||
164333136|NCT00598702|593597337|FG004|Overall Study|Dose limiting toxicity|1|||
164333137|NCT00598702|593597338|FG005|Overall Study|Dose limiting toxicity|1|||
164333138|NCT00598702|593597339|FG006|Overall Study|Dose limiting toxicity|0|||
164333139|NCT00598702|593597340|FG007|Overall Study|Dose limiting toxicity|0|||
164333140|NCT02413372|593597344|FG000|Treatment|Lost to Follow-up|0|||
164333141|NCT02413372|593597345|FG001|Treatment|Lost to Follow-up|2|||
164333142|NCT02413372|593597346|FG002|Treatment|Lost to Follow-up|1|||
164333143|NCT02413372|593597344|FG000|Treatment|Withdrawal by Subject|1|||
164675845|NCT01854047|594836859|FG000|Overall Study|Randomized but not treated|0|||
164333144|NCT02413372|593597345|FG001|Treatment|Withdrawal by Subject|0|||
164675846|NCT01854047|594836860|FG001|Overall Study|Randomized but not treated|1|||
164675847|NCT01854047|594836861|FG002|Overall Study|Randomized but not treated|2|||
164675848|NCT01854047|594836862|FG003|Overall Study|Randomized but not treated|0|||
164675849|NCT01854047|594836863|FG004|Overall Study|Randomized but not treated|4|||
164675850|NCT01854047|594836859|FG000|Overall Study|Other than specified above|3|||
164675851|NCT01854047|594836860|FG001|Overall Study|Other than specified above|3|||
164675852|NCT01854047|594836861|FG002|Overall Study|Other than specified above|3|||
164675853|NCT01854047|594836862|FG003|Overall Study|Other than specified above|5|||
164675854|NCT01854047|594836863|FG004|Overall Study|Other than specified above|8|||
164675855|NCT03769025|594836867|FG000|Overall Study|Withdrawal by Subject|1|||
164675856|NCT03769025|594836868|FG001|Overall Study|Withdrawal by Subject|1|||
164675857|NCT03769025|594836867|FG000|Overall Study|Lost to Follow-up|4|||
164675858|NCT03769025|594836868|FG001|Overall Study|Lost to Follow-up|3|||
164675859|NCT02911701|594836871|FG000|Overall Study|Withdrawal by Subject|2|||
164675860|NCT02911701|594836872|FG001|Overall Study|Withdrawal by Subject|4|||
164675861|NCT02911701|594836871|FG000|Overall Study|Adverse Event|1|||
164675862|NCT02911701|594836872|FG001|Overall Study|Adverse Event|0|||
164675863|NCT04659603|594836875|FG000|Overall Study|Study terminated by sponsor|0|||
164675864|NCT04659603|594836876|FG001|Overall Study|Study terminated by sponsor|0|||
164675865|NCT04659603|594836877|FG002|Overall Study|Study terminated by sponsor|2|||
164675866|NCT04659603|594836875|FG000|Overall Study|Withdrawal by Subject|0|||
164675867|NCT04659603|594836876|FG001|Overall Study|Withdrawal by Subject|5|||
164675868|NCT04659603|594836877|FG002|Overall Study|Withdrawal by Subject|0|||
164675869|NCT04659603|594836875|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
164675870|NCT04659603|594836876|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
164675871|NCT04659603|594836877|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
164675872|NCT01110005|594836878|FG000|Overall Study|ineligible|1|||
164675873|NCT01110005|594836879|FG001|Overall Study|ineligible|2|||
164675874|NCT01110005|594836878|FG000|Overall Study|missing consent|3|||
164675875|NCT01110005|594836879|FG001|Overall Study|missing consent|2|||
164675876|NCT01110005|594836878|FG000|Overall Study|Withdrawal by Subject|0|||
164675877|NCT01110005|594836879|FG001|Overall Study|Withdrawal by Subject|1|||
164675878|NCT04646213|594836880|FG000|Overall Study|Physician Decision|3|||
164675879|NCT04646213|594836880|FG000|Overall Study|Withdrawal by Subject|2|||
164675880|NCT02441309|594836881|FG000|Overall Study|Disease progression|2|||
164675881|NCT02441309|594836882|FG001|Overall Study|Disease progression|1|||
164675882|NCT02441309|594836883|FG002|Overall Study|Disease progression|2|||
164333145|NCT02413372|593597346|FG002|Treatment|Withdrawal by Subject|0|||
164333146|NCT02413372|593597344|FG000|Follow-up|Lost to Follow-up|1|||
164333147|NCT02413372|593597345|FG001|Follow-up|Lost to Follow-up|1|||
164675883|NCT02441309|594836881|FG000|Overall Study|Adverse Event|0|||
164675884|NCT02441309|594836882|FG001|Overall Study|Adverse Event|1|||
164675885|NCT02441309|594836883|FG002|Overall Study|Adverse Event|0|||
164675886|NCT02441309|594836881|FG000|Overall Study|Withdrawal by Subject|1|||
164675887|NCT02441309|594836882|FG001|Overall Study|Withdrawal by Subject|0|||
164675888|NCT02441309|594836883|FG002|Overall Study|Withdrawal by Subject|1|||
164675889|NCT02281084|594836884|FG000|Overall Study|Death|21|||
164333148|NCT02413372|593597346|FG002|Follow-up|Lost to Follow-up|0|||
164675890|NCT02281084|594836885|FG001|Overall Study|Death|18|||
164333149|NCT02413372|593597344|FG000|Follow-up|Subject Withdrew Consent|1|||
164675891|NCT02281084|594836886|FG002|Overall Study|Death|3|||
164232760|NCT03331354|593221721|FG000|Overall Study|Found employment before initiated active intervention|0|||
164232761|NCT03331354|593221722|FG001|Overall Study|Found employment before initiated active intervention|4|||
164232762|NCT01559935|593221725|FG000|Car Phase|Toxicity|4|||
164232763|NCT01559935|593221725|FG000|Car Phase|Death|1|||
164232764|NCT01559935|593221725|FG000|Car Phase|Lack of Efficacy|2|||
164232765|NCT01559935|593221725|FG000|Car Phase|Lost to Follow-up|1|||
164232766|NCT01559935|593221725|FG000|Car Phase|Physician Decision|1|||
164232767|NCT01559935|593221725|FG000|Car Phase|Withdrawal by Subject|2|||
164232768|NCT01559935|593221725|FG000|Car Phase|Per protocol|1|||
164232769|NCT01559935|593221725|FG000|Car Phase|Insurance|1|||
164232770|NCT01559935|593221725|FG000|Car Phase|non-compliance|1|||
164232771|NCT01559935|593221725|FG000|BiRD Phase|Toxicity|1|||
164232772|NCT01559935|593221725|FG000|BiRD Phase|Lack of Efficacy|1|||
164232773|NCT01559935|593221725|FG000|BiRD Phase|Withdrawal by Subject|2|||
164232774|NCT01559935|593221725|FG000|Maintenance Phase|Remains on study|28|||
164232775|NCT01559935|593221725|FG000|Maintenance Phase|Toxicity|1|||
164232776|NCT01559935|593221725|FG000|Maintenance Phase|Lack of Efficacy|18|||
164232777|NCT01559935|593221725|FG000|Maintenance Phase|Withdrawal by Subject|5|||
164232778|NCT01559935|593221725|FG000|Maintenance Phase|Non-compliance|2|||
164232779|NCT05889468|593221726|FG000|Overall Study|Lost to Follow-up|9|||
164232780|NCT05889468|593221727|FG001|Overall Study|Lost to Follow-up|2|||
164232781|NCT05889468|593221726|FG000|Overall Study|Withdrawal by Subject|2|||
164232782|NCT05889468|593221727|FG001|Overall Study|Withdrawal by Subject|2|||
164232783|NCT01767987|593221730|FG000|Overall Study|Physician Decision|4|||
164232784|NCT01767987|593221731|FG001|Overall Study|Physician Decision|1|||
164232785|NCT01153516|593221732|FG000|Overall Study|Both subjects refused surgery|2|||
164232786|NCT01153516|593221733|FG001|Overall Study|Both subjects refused surgery|0|||
164232787|NCT01605097|593221742|FG000|Overall Study|Protocol Violation|1|||
164232788|NCT02284893|593221750|FG000|26 Week (Short Term)|Adverse Event|1|||
164232789|NCT02284893|593221751|FG001|26 Week (Short Term)|Adverse Event|9|||
164232790|NCT02284893|593221750|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
164232791|NCT02284893|593221751|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
164232792|NCT02284893|593221750|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
164232793|NCT02284893|593221751|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
164232794|NCT02284893|593221750|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
164232795|NCT02284893|593221751|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
164232796|NCT02284893|593221750|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
164232797|NCT02284893|593221751|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
164232798|NCT02284893|593221750|FG000|26 Week (Short Term)|Other|1|||
164232799|NCT02284893|593221751|FG001|26 Week (Short Term)|Other|1|||
164232800|NCT02284893|593221750|FG000|52 Week (Long Term)|Adverse Event|3|||
164232801|NCT02284893|593221751|FG001|52 Week (Long Term)|Adverse Event|1|||
164232802|NCT02284893|593221750|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
164232803|NCT02284893|593221751|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
164232804|NCT02284893|593221750|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
164232805|NCT02284893|593221751|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
164232806|NCT02284893|593221750|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
164232807|NCT02284893|593221751|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
164572514|NCT00805207|594460381|FG001|Overall Study|Physician Decision|1|||
164572515|NCT00805207|594460382|FG002|Overall Study|Physician Decision|0|||
164572516|NCT00805207|594460383|FG003|Overall Study|Physician Decision|0|||
164572517|NCT00805207|594460384|FG004|Overall Study|Physician Decision|0|||
164572518|NCT00805207|594460385|FG005|Overall Study|Physician Decision|1|||
164572519|NCT00805207|594460386|FG006|Overall Study|Physician Decision|0|||
164572520|NCT00805207|594460387|FG007|Overall Study|Physician Decision|0|||
164572521|NCT00805207|594460388|FG008|Overall Study|Physician Decision|0|||
164572522|NCT00805207|594460380|FG000|Overall Study|Withdrawal by Subject|0|||
164572523|NCT00805207|594460381|FG001|Overall Study|Withdrawal by Subject|1|||
164572524|NCT00805207|594460382|FG002|Overall Study|Withdrawal by Subject|0|||
164572525|NCT00805207|594460383|FG003|Overall Study|Withdrawal by Subject|0|||
164572526|NCT00805207|594460384|FG004|Overall Study|Withdrawal by Subject|1|||
164572527|NCT00805207|594460385|FG005|Overall Study|Withdrawal by Subject|2|||
164572528|NCT00805207|594460386|FG006|Overall Study|Withdrawal by Subject|0|||
164572529|NCT00805207|594460387|FG007|Overall Study|Withdrawal by Subject|0|||
164572530|NCT00805207|594460388|FG008|Overall Study|Withdrawal by Subject|0|||
164572531|NCT00064701|594460389|FG000|One Year Post-transplant|Did not receive study drug|7|||
164572532|NCT00064701|594460390|FG001|One Year Post-transplant|Did not receive study drug|12|||
164572533|NCT00064701|594460391|FG002|One Year Post-transplant|Did not receive study drug|11|||
164572534|NCT00064701|594460389|FG000|One Year Post-transplant|Adverse Event|23|||
164572535|NCT00064701|594460390|FG001|One Year Post-transplant|Adverse Event|19|||
164572536|NCT00064701|594460391|FG002|One Year Post-transplant|Adverse Event|37|||
164572537|NCT00064701|594460389|FG000|One Year Post-transplant|Rejection|0|||
164572538|NCT00064701|594460390|FG001|One Year Post-transplant|Rejection|1|||
164572539|NCT00064701|594460391|FG002|One Year Post-transplant|Rejection|16|||
164572540|NCT00064701|594460389|FG000|One Year Post-transplant|Non-compliance|4|||
164675892|NCT02281084|594836887|FG003|Overall Study|Death|5|||
164675893|NCT02281084|594836884|FG000|Overall Study|Adverse Event|1|||
164675894|NCT02281084|594836885|FG001|Overall Study|Adverse Event|0|||
164675895|NCT02281084|594836886|FG002|Overall Study|Adverse Event|0|||
164675896|NCT02281084|594836887|FG003|Overall Study|Adverse Event|0|||
164422464|NCT02584855|593916404|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
164422465|NCT02584855|593916405|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
164422466|NCT02584855|593916406|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
164422467|NCT02584855|593916401|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
164422468|NCT02584855|593916402|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
164422469|NCT02584855|593916403|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
164422470|NCT02584855|593916404|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
164422471|NCT02584855|593916405|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
164422472|NCT02584855|593916406|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
164422473|NCT02584855|593916401|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
164422474|NCT02584855|593916402|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
164675897|NCT02281084|594836884|FG000|Overall Study|Withdrawal by Subject|2|||
164675898|NCT02281084|594836885|FG001|Overall Study|Withdrawal by Subject|2|||
164675899|NCT02281084|594836886|FG002|Overall Study|Withdrawal by Subject|0|||
164675900|NCT02281084|594836887|FG003|Overall Study|Withdrawal by Subject|0|||
164422475|NCT02584855|593916403|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
164675901|NCT02281084|594836884|FG000|Overall Study|Site Closure by Sponsor|5|||
164422476|NCT02584855|593916404|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
164422477|NCT02584855|593916405|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
164422478|NCT02584855|593916406|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
164422479|NCT04963062|593916410|FG000|Overall Study|withdrew by the study team|4|||
164422480|NCT04963062|593916411|FG001|Overall Study|withdrew by the study team|2|||
164422481|NCT02107274|593917953|FG000|Treatment vs. Placebo|Adverse Event|3|||
164422482|NCT02107274|593917954|FG001|Treatment vs. Placebo|Adverse Event|0|||
164422483|NCT02107274|593917953|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
164422484|NCT02107274|593917954|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
164422485|NCT02107274|593917953|FG000|Control Phase|Lost to Follow-up|1|||
164422486|NCT02107274|593917954|FG001|Control Phase|Lost to Follow-up|1|||
164422487|NCT02107274|593917953|FG000|Control Phase|Death|2|||
164422488|NCT02107274|593917954|FG001|Control Phase|Death|0|||
164422489|NCT02107274|593917953|FG000|Control Phase|Adverse Event|0|||
164422490|NCT02107274|593917954|FG001|Control Phase|Adverse Event|1|||
164422491|NCT05305040|593917957|FG000|Overall Study|Not Dosed|37|||
164422492|NCT05305040|593917958|FG001|Overall Study|Not Dosed|37|||
164422493|NCT05305040|593917957|FG000|Overall Study|Study Closure|34|||
164422494|NCT05305040|593917958|FG001|Overall Study|Study Closure|46|||
164422495|NCT05305040|593917957|FG000|Overall Study|Death|14|||
164422496|NCT05305040|593917958|FG001|Overall Study|Death|13|||
164422497|NCT05305040|593917957|FG000|Overall Study|Withdrawal by Subject|15|||
164422498|NCT05305040|593917958|FG001|Overall Study|Withdrawal by Subject|10|||
164422499|NCT05305040|593917957|FG000|Overall Study|Other|13|||
164422500|NCT05305040|593917958|FG001|Overall Study|Other|10|||
164422501|NCT05305040|593917957|FG000|Overall Study|Primary Malignancy Relapse|3|||
164422502|NCT05305040|593917958|FG001|Overall Study|Primary Malignancy Relapse|4|||
164422503|NCT05305040|593917957|FG000|Overall Study|Adverse Event|3|||
164422504|NCT05305040|593917958|FG001|Overall Study|Adverse Event|3|||
164422505|NCT05305040|593917957|FG000|Overall Study|Lost to Follow-up|2|||
164422506|NCT05305040|593917958|FG001|Overall Study|Lost to Follow-up|1|||
164422507|NCT05305040|593917957|FG000|Overall Study|Graft versus host disease|2|||
164422508|NCT05305040|593917958|FG001|Overall Study|Graft versus host disease|0|||
164422509|NCT05305040|593917957|FG000|Overall Study|Investigator's Decision|1|||
164422510|NCT05305040|593917958|FG001|Overall Study|Investigator's Decision|1|||
164422511|NCT05305040|593917957|FG000|Overall Study|COVID-19 Reasons|1|||
164422512|NCT05305040|593917958|FG001|Overall Study|COVID-19 Reasons|0|||
164422513|NCT02206685|593917959|FG000|Overall Study|Surgery cancelled/changed|2|||
164422514|NCT02206685|593917960|FG001|Overall Study|Surgery cancelled/changed|3|||
164422515|NCT02206685|593917959|FG000|Overall Study|Withdrawal by Subject|1|||
164422516|NCT02206685|593917960|FG001|Overall Study|Withdrawal by Subject|2|||
164422517|NCT02206685|593917959|FG000|Overall Study|Protocol Violation|2|||
164422518|NCT02206685|593917960|FG001|Overall Study|Protocol Violation|2|||
164422519|NCT01195675|593917961|FG000|Overall Study|Adverse Event|1|||
164422520|NCT01195675|593917961|FG000|Overall Study|Withdrawal by Subject|2|||
164422521|NCT04730947|593917962|FG000|Overall Study|Withdrawal by Subject|0|||
164422522|NCT04730947|593917963|FG001|Overall Study|Withdrawal by Subject|1|||
164422523|NCT01196104|593917975|FG000|Overall Study|Lost to Follow-up|1|||
164422524|NCT01196104|593917976|FG001|Overall Study|Lost to Follow-up|0|||
164675902|NCT02281084|594836885|FG001|Overall Study|Site Closure by Sponsor|1|||
164422525|NCT01196104|593917975|FG000|Overall Study|Physician Decision|0|||
164422526|NCT01196104|593917976|FG001|Overall Study|Physician Decision|1|||
164422527|NCT01196104|593917975|FG000|Overall Study|Withdrawal by Subject|3|||
164675903|NCT02281084|594836886|FG002|Overall Study|Site Closure by Sponsor|2|||
164675904|NCT02281084|594836887|FG003|Overall Study|Site Closure by Sponsor|0|||
164675905|NCT02658084|594836888|FG000|Overall Study|Withdrawal by Subject|1|||
164675906|NCT02658084|594836889|FG001|Overall Study|Withdrawal by Subject|0|||
164675907|NCT02658084|594836888|FG000|Overall Study|Study Termination|1|||
164422528|NCT01196104|593917976|FG001|Overall Study|Withdrawal by Subject|3|||
164422529|NCT01196104|593917975|FG000|Overall Study|Various|0|||
164422530|NCT01196104|593917976|FG001|Overall Study|Various|1|||
164422531|NCT01094171|593917983|FG000|Overall Study|Lost to Follow-up|2|||
164422532|NCT01094171|593917983|FG000|Overall Study|Informed consent withdrawal|4|||
164422533|NCT01094171|593917983|FG000|Overall Study|Migration from the study area|3|||
164422534|NCT01094171|593917983|FG000|Overall Study|Other|1|||
164422535|NCT01310868|593917984|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
164422536|NCT04496167|593917985|FG000|Overall Study|Adverse Event|6|||
164422537|NCT04496167|593917986|FG001|Overall Study|Adverse Event|2|||
164422538|NCT04496167|593917985|FG000|Overall Study|Withdrawal by Subject|7|||
164422539|NCT04496167|593917986|FG001|Overall Study|Withdrawal by Subject|6|||
164422540|NCT04496167|593917985|FG000|Overall Study|Lost to Follow-up|3|||
164422541|NCT04496167|593917986|FG001|Overall Study|Lost to Follow-up|5|||
164422542|NCT04496167|593917985|FG000|Overall Study|Not Treated|1|||
164422543|NCT04496167|593917986|FG001|Overall Study|Not Treated|2|||
164422544|NCT04496167|593917985|FG000|Overall Study|Other Than Specified|1|||
164422545|NCT04496167|593917986|FG001|Overall Study|Other Than Specified|1|||
164422546|NCT00598481|593917987|FG000|Treatment|Physician Decision|1|||
164422547|NCT01708187|593917990|FG000|Overall Study|Lost to Follow-up|0|||
164675908|NCT02658084|594836889|FG001|Overall Study|Study Termination|0|||
164675909|NCT03290781|594836890|FG000|Overall Study|Adverse Event|5|||
164675910|NCT03290781|594836891|FG001|Overall Study|Adverse Event|7|||
164422548|NCT01708187|593917991|FG001|Overall Study|Lost to Follow-up|1|||
164422549|NCT02408549|593917993|FG000|Overall Study|Adverse Event|15|||
164422550|NCT02408549|593917993|FG000|Overall Study|Death|4|||
164422551|NCT02408549|593917993|FG000|Overall Study|Lack of Efficacy|17|||
164422552|NCT02408549|593917993|FG000|Overall Study|Protocol Violation|4|||
164422553|NCT02408549|593917993|FG000|Overall Study|Lost to Follow-up|6|||
164422554|NCT02408549|593917993|FG000|Overall Study|Consent withdrawn|30|||
164422555|NCT02408549|593917993|FG000|Overall Study|Neurology research program closing at site|1|||
164422556|NCT02408549|593917993|FG000|Overall Study|Site closure|1|||
164422557|NCT02408549|593917993|FG000|Overall Study|Pregnancy|1|||
164422558|NCT02408549|593917993|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
164422559|NCT02408549|593917993|FG000|Overall Study|Subject moved to another place, far from site|1|||
164422560|NCT02408549|593917993|FG000|Overall Study|Study terminated at site|1|||
164422561|NCT02025205|593917994|FG000|Overall Study|Withdrawal by Subject|1|||
164422562|NCT02025205|593917995|FG001|Overall Study|Withdrawal by Subject|1|||
164422563|NCT02025205|593917994|FG000|Overall Study|Protocol Violation|2|||
164422564|NCT02025205|593917995|FG001|Overall Study|Protocol Violation|1|||
164422565|NCT02025205|593917994|FG000|Overall Study|Death|0|||
164422566|NCT02025205|593917995|FG001|Overall Study|Death|1|||
164422567|NCT01232556|593917998|FG000|Overall Study|Withdrawal by Subject|21|||
164422568|NCT01232556|593917999|FG001|Overall Study|Withdrawal by Subject|17|||
164422569|NCT01232556|593917998|FG000|Overall Study|Death|97|||
164422570|NCT01232556|593917999|FG001|Overall Study|Death|97|||
164422571|NCT01232556|593917998|FG000|Overall Study|Lost to Follow-up|0|||
164422572|NCT01232556|593917999|FG001|Overall Study|Lost to Follow-up|2|||
164422573|NCT01232556|593917998|FG000|Overall Study|Terminated by Sponsor|35|||
164422574|NCT01232556|593917999|FG001|Overall Study|Terminated by Sponsor|51|||
164422575|NCT01232556|593917998|FG000|Overall Study|Other|6|||
164675911|NCT03290781|594836892|FG002|Overall Study|Adverse Event|4|||
164675912|NCT03290781|594836893|FG003|Overall Study|Adverse Event|1|||
164675913|NCT03290781|594836894|FG004|Overall Study|Adverse Event|0|||
164675914|NCT03290781|594836895|FG005|Overall Study|Adverse Event|0|||
164675915|NCT03290781|594836896|FG006|Overall Study|Adverse Event|0|||
164232808|NCT02284893|593221750|FG000|52 Week (Long Term)|Non-Compliance|2|||
164232809|NCT02284893|593221751|FG001|52 Week (Long Term)|Non-Compliance|3|||
164232810|NCT00105066|593221757|FG000|Overall Study|Adverse Event|2|||
164675916|NCT03290781|594836890|FG000|Overall Study|Death|0|||
164675917|NCT03290781|594836891|FG001|Overall Study|Death|0|||
164675918|NCT03290781|594836892|FG002|Overall Study|Death|1|||
164675919|NCT03290781|594836893|FG003|Overall Study|Death|0|||
164422576|NCT01232556|593917999|FG001|Overall Study|Other|4|||
164422577|NCT04172987|593918002|FG000|Lead In Period|Adverse Event|1|||
164422578|NCT04172987|593918002|FG000|Lead In Period|Protocol Violation|1|||
164422579|NCT04172987|593918002|FG000|Period 1|Physician Decision|1|||
164422580|NCT04172987|593918002|FG000|Period 2|Adverse Event|5|||
164422581|NCT04172987|593918002|FG000|Period 2|Dosing Termination by Sponsor|4|||
164422582|NCT01603121|593918004|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
164422583|NCT01603121|593918005|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
164422584|NCT00738530|593918006|FG000|Overall Study|Death|220|||
164422585|NCT00738530|593918007|FG001|Overall Study|Death|224|||
164422586|NCT00738530|593918006|FG000|Overall Study|Lost to Follow-up|8|||
164422587|NCT00738530|593918007|FG001|Overall Study|Lost to Follow-up|6|||
164422588|NCT00738530|593918006|FG000|Overall Study|Withdrawal by Subject|6|||
164422589|NCT00738530|593918007|FG001|Overall Study|Withdrawal by Subject|8|||
164422590|NCT01628510|593918008|FG000|Overall Study|Withdrawal by Subject|0|||
164422591|NCT01628510|593918009|FG001|Overall Study|Withdrawal by Subject|4|||
164422592|NCT01628510|593918008|FG000|Overall Study|Death|3|||
164422593|NCT01628510|593918009|FG001|Overall Study|Death|1|||
164422594|NCT01656759|593918010|FG000|Overall Study|Protocol Violation|2|||
164422595|NCT01656759|593918011|FG001|Overall Study|Protocol Violation|3|||
164422596|NCT04179461|593918012|FG000|Overall Study|Lost to Follow-up|4|||
164422597|NCT03785340|593918016|FG000|Overall Study|Lost to Follow-up|2|||
164422598|NCT03785340|593918017|FG001|Overall Study|Lost to Follow-up|0|||
164422599|NCT03785340|593918016|FG000|Overall Study|Adverse Event|1|||
164422600|NCT03785340|593918017|FG001|Overall Study|Adverse Event|0|||
164422601|NCT03160079|593918022|FG000|Overall Study|Adverse Event|2|||
164422602|NCT03160079|593918023|FG001|Overall Study|Adverse Event|0|||
164422603|NCT03160079|593918022|FG000|Overall Study|Disease Progression|1|||
164422604|NCT03160079|593918023|FG001|Overall Study|Disease Progression|0|||
164422605|NCT03160079|593918022|FG000|Overall Study|Physician Decision|1|||
164422606|NCT03160079|593918023|FG001|Overall Study|Physician Decision|0|||
164422607|NCT02500316|593918024|FG000|Overall Study|Adverse Event|3|||
164422608|NCT02500316|593918024|FG000|Overall Study|Lost to Follow-up|2|||
164422609|NCT02500316|593918024|FG000|Overall Study|Protocol Violation|1|||
164422610|NCT02500316|593918024|FG000|Overall Study|Withdrawal by Subject|15|||
164422611|NCT02500316|593918024|FG000|Overall Study|Final height achieved|5|||
164422612|NCT02500316|593918024|FG000|Overall Study|Due to war activity|1|||
164422613|NCT02337478|593918025|FG000|Overall Study|Lack of Efficacy|5|||
164422614|NCT01513967|593918036|FG000|Overall Study|Pregnancy|0|||
164422615|NCT01513967|593918037|FG001|Overall Study|Pregnancy|0|||
164422616|NCT01513967|593918038|FG002|Overall Study|Pregnancy|0|||
164422617|NCT01513967|593918039|FG003|Overall Study|Pregnancy|0|||
164422618|NCT01513967|593918040|FG004|Overall Study|Pregnancy|0|||
164422619|NCT01513967|593918041|FG005|Overall Study|Pregnancy|0|||
164422620|NCT01513967|593918042|FG006|Overall Study|Pregnancy|1|||
164422621|NCT01513967|593918043|FG007|Overall Study|Pregnancy|0|||
164422622|NCT01513967|593918036|FG000|Overall Study|missed a study visit|0|||
164422623|NCT01513967|593918037|FG001|Overall Study|missed a study visit|0|||
164422624|NCT01513967|593918038|FG002|Overall Study|missed a study visit|0|||
164422625|NCT01513967|593918039|FG003|Overall Study|missed a study visit|0|||
164422626|NCT01513967|593918040|FG004|Overall Study|missed a study visit|0|||
164422627|NCT01513967|593918041|FG005|Overall Study|missed a study visit|0|||
164422628|NCT01513967|593918042|FG006|Overall Study|missed a study visit|1|||
164422629|NCT01513967|593918043|FG007|Overall Study|missed a study visit|0|||
164422630|NCT01513967|593918036|FG000|Overall Study|excluded due to positive drug screen|0|||
164422631|NCT01513967|593918037|FG001|Overall Study|excluded due to positive drug screen|0|||
164422632|NCT01513967|593918038|FG002|Overall Study|excluded due to positive drug screen|0|||
164422633|NCT01513967|593918039|FG003|Overall Study|excluded due to positive drug screen|0|||
164422634|NCT01513967|593918040|FG004|Overall Study|excluded due to positive drug screen|0|||
164422635|NCT01513967|593918041|FG005|Overall Study|excluded due to positive drug screen|0|||
164422636|NCT01513967|593918042|FG006|Overall Study|excluded due to positive drug screen|0|||
164422637|NCT01513967|593918043|FG007|Overall Study|excluded due to positive drug screen|2|||
164422638|NCT01513967|593918036|FG000|Overall Study|Physician Decision|0|||
164422639|NCT01513967|593918037|FG001|Overall Study|Physician Decision|0|||
164422640|NCT01513967|593918038|FG002|Overall Study|Physician Decision|0|||
164422641|NCT01513967|593918039|FG003|Overall Study|Physician Decision|0|||
164422642|NCT01513967|593918040|FG004|Overall Study|Physician Decision|0|||
164422643|NCT01513967|593918041|FG005|Overall Study|Physician Decision|1|||
164675920|NCT03290781|594836894|FG004|Overall Study|Death|1|||
164675921|NCT03290781|594836895|FG005|Overall Study|Death|0|||
164675922|NCT03290781|594836896|FG006|Overall Study|Death|0|||
164675923|NCT03290781|594836890|FG000|Overall Study|Withdrawal by Subject|6|||
164675924|NCT03290781|594836891|FG001|Overall Study|Withdrawal by Subject|5|||
164675925|NCT03290781|594836892|FG002|Overall Study|Withdrawal by Subject|9|||
164675926|NCT03290781|594836893|FG003|Overall Study|Withdrawal by Subject|10|||
164675927|NCT03290781|594836894|FG004|Overall Study|Withdrawal by Subject|1|||
164675928|NCT03290781|594836895|FG005|Overall Study|Withdrawal by Subject|2|||
164422644|NCT01513967|593918042|FG006|Overall Study|Physician Decision|0|||
164422645|NCT01513967|593918043|FG007|Overall Study|Physician Decision|0|||
164422646|NCT01987830|593918044|FG000|Overall Study|Never received baseline scan|1|||
164422647|NCT00057811|593918050|FG000|Overall Study|Lack of Efficacy|1|||
164422648|NCT00057811|593918051|FG001|Overall Study|Lack of Efficacy|4|||
164422649|NCT00057811|593918050|FG000|Overall Study|Physician Decision|1|||
164422650|NCT00057811|593918051|FG001|Overall Study|Physician Decision|0|||
164422651|NCT00057811|593918050|FG000|Overall Study|Withdrawal by Subject|3|||
164422652|NCT00057811|593918051|FG001|Overall Study|Withdrawal by Subject|4|||
164422653|NCT00057811|593918050|FG000|Overall Study|Ineligible|4|||
164422654|NCT00057811|593918051|FG001|Overall Study|Ineligible|2|||
164422655|NCT00057811|593918050|FG000|Overall Study|Inevaluable|1|||
164422656|NCT00057811|593918051|FG001|Overall Study|Inevaluable|2|||
164422657|NCT00556374|593918052|FG000|Overall Study|Withdrawal by Subject|235|||
164232811|NCT00105066|593221758|FG001|Overall Study|Adverse Event|5|||
164232812|NCT02231580|593221759|FG000|Overall Study|Adverse Event|5|||
164232813|NCT02231580|593221760|FG001|Overall Study|Adverse Event|0|||
164232814|NCT05552859|593221762|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
164232815|NCT05552859|593221763|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
164232816|NCT01722669|593221767|FG000|Overall Study|Withdrawal by Subject|0|||
164232817|NCT01722669|593221768|FG001|Overall Study|Withdrawal by Subject|0|||
164232818|NCT01722669|593221769|FG002|Overall Study|Withdrawal by Subject|0|||
164232819|NCT01722669|593221770|FG003|Overall Study|Withdrawal by Subject|0|||
164232820|NCT01722669|593221771|FG004|Overall Study|Withdrawal by Subject|0|||
164232821|NCT01722669|593221772|FG005|Overall Study|Withdrawal by Subject|2|||
164232822|NCT02255656|593221777|FG000|Overall Study|Adverse Event|11|||
164232823|NCT02255656|593221777|FG000|Overall Study|Poor compliance to protocol|3|||
164232824|NCT02255656|593221777|FG000|Overall Study|Lost to Follow-up|30|||
164232825|NCT02255656|593221777|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
164232826|NCT02255656|593221777|FG000|Overall Study|Other|126|||
164232827|NCT03734536|593221778|FG000|Overall Study|Withdrew Consent|1|||
164232828|NCT03734536|593221779|FG001|Overall Study|Withdrew Consent|5|||
164232829|NCT03734536|593221778|FG000|Overall Study|Lost to Follow-up|10|||
164232830|NCT03734536|593221779|FG001|Overall Study|Lost to Follow-up|7|||
164232831|NCT03448393|593221780|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
164232832|NCT03448393|593221781|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
164232833|NCT03448393|593221782|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
164232834|NCT03448393|593221783|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
164232835|NCT03448393|593221784|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
164232836|NCT03448393|593221785|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
164232837|NCT03448393|593221786|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
164232838|NCT03448393|593221787|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
164232839|NCT03448393|593221788|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
164232840|NCT03448393|593221780|FG000|Dose Expansion|Not treated - screen failure|0|||
164232841|NCT03448393|593221781|FG001|Dose Expansion|Not treated - screen failure|0|||
164232842|NCT03448393|593221782|FG002|Dose Expansion|Not treated - screen failure|0|||
164232843|NCT03448393|593221783|FG003|Dose Expansion|Not treated - screen failure|0|||
164232844|NCT03448393|593221784|FG004|Dose Expansion|Not treated - screen failure|0|||
164232845|NCT03448393|593221785|FG005|Dose Expansion|Not treated - screen failure|0|||
164232846|NCT03448393|593221786|FG006|Dose Expansion|Not treated - screen failure|0|||
164232847|NCT03448393|593221787|FG007|Dose Expansion|Not treated - screen failure|0|||
164232848|NCT03448393|593221788|FG008|Dose Expansion|Not treated - screen failure|7|||
164232849|NCT04144517|593221794|FG000|Overall Study|Physician Decision|0|||
164232850|NCT04144517|593221795|FG001|Overall Study|Physician Decision|1|||
164232851|NCT04144517|593221794|FG000|Overall Study|Other|2|||
164232852|NCT04144517|593221795|FG001|Overall Study|Other|2|||
164232853|NCT04144517|593221794|FG000|Overall Study|Death|6|||
164232854|NCT04144517|593221795|FG001|Overall Study|Death|3|||
164232855|NCT05929326|593221800|FG000|Overall Study|unqualified sample|2|||
164232856|NCT05929326|593221801|FG001|Overall Study|unqualified sample|3|||
164232857|NCT05929326|593221802|FG002|Overall Study|unqualified sample|7|||
164232858|NCT05212168|593221812|FG000|Overall Study|Lost to Follow-up|0|||
164232859|NCT05212168|593221813|FG001|Overall Study|Lost to Follow-up|3|||
164232860|NCT05212168|593221812|FG000|Overall Study|Study terminated by sponsor|30|||
164232861|NCT05212168|593221813|FG001|Overall Study|Study terminated by sponsor|27|||
164232862|NCT05212168|593221812|FG000|Overall Study|Other|4|||
164232863|NCT05212168|593221813|FG001|Overall Study|Other|7|||
164232864|NCT03941093|593221815|FG000|Overall Study|Protocol Violation|0|||
164232865|NCT03941093|593221816|FG001|Overall Study|Protocol Violation|1|||
164232866|NCT03941093|593221815|FG000|Overall Study|Withdrawal by Subject|9|||
164232867|NCT03941093|593221816|FG001|Overall Study|Withdrawal by Subject|6|||
164232868|NCT03359395|593221819|FG000|First Intervention A / B|Withdrawal by Subject|1|||
164232869|NCT03359395|593221820|FG001|First Intervention A / B|Withdrawal by Subject|0|||
164232870|NCT03359395|593221819|FG000|First Intervention A / B|Lost to Follow-up|2|||
164232871|NCT03359395|593221820|FG001|First Intervention A / B|Lost to Follow-up|3|||
164232872|NCT03359395|593221819|FG000|Second Intervention B/A|Exclusion criteria|0|||
164232873|NCT03359395|593221820|FG001|Second Intervention B/A|Exclusion criteria|1|||
164232874|NCT03359395|593221819|FG000|Second Intervention B/A|Lost to Follow-up|3|||
164232875|NCT03359395|593221820|FG001|Second Intervention B/A|Lost to Follow-up|2|||
164232876|NCT02333799|593223267|FG000|Treatment Period|Withdrawal by Subject|1|||
164232877|NCT02333799|593223267|FG000|Treatment Period|Death|6|||
164232878|NCT02333799|593223267|FG000|6 Month Follow Up Period|Physician Decision|1|||
164232879|NCT02333799|593223267|FG000|6 Month Follow Up Period|Death|1|||
164232880|NCT02333799|593223267|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
164232881|NCT02333799|593223267|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
164232882|NCT05484895|593223268|FG000|Overall Study|Lost to Follow-up|63|||
164232883|NCT05484895|593223269|FG001|Overall Study|Lost to Follow-up|64|||
164232884|NCT04795531|593223271|FG000|Overall Study|Withdrawal by Subject|4|||
164232885|NCT04795531|593223272|FG001|Overall Study|Withdrawal by Subject|4|||
164232886|NCT04795531|593223271|FG000|Overall Study|Lost to Follow-up|0|||
164333150|NCT02413372|593597345|FG001|Follow-up|Subject Withdrew Consent|0|||
164333151|NCT02413372|593597346|FG002|Follow-up|Subject Withdrew Consent|1|||
164333152|NCT02413372|593597344|FG000|Follow-up|Subject unable to return for visit|0|||
164333153|NCT02413372|593597345|FG001|Follow-up|Subject unable to return for visit|0|||
164333154|NCT02413372|593597346|FG002|Follow-up|Subject unable to return for visit|1|||
164333155|NCT03053271|593597356|FG000|Overall Study|Did not meet randomization criteria|3|||
164333156|NCT03053271|593597356|FG000|Overall Study|Withdrawal by Subject|1|||
164333157|NCT00580970|593597357|FG000|Pre-treatment|Non-compliance|1|||
164333158|NCT00580970|593597357|FG000|Treatment (Lovastatin)|Non-compliance|6|||
164333159|NCT00580970|593597357|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
164333160|NCT00580970|593597357|FG000|Treatment (Lovastatin)|Physician Decision|4|||
164333161|NCT00580970|593597357|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
164333162|NCT00580970|593597357|FG000|Treatment (Lovastatin)|Death|1|||
164333163|NCT03161093|593597360|FG000|Overall Study|Protocol Violation|11|||
164333164|NCT03161093|593597361|FG001|Overall Study|Protocol Violation|14|||
164333165|NCT03161093|593597362|FG002|Overall Study|Protocol Violation|6|||
164333166|NCT03161093|593597363|FG003|Overall Study|Protocol Violation|13|||
164333167|NCT03161093|593597364|FG004|Overall Study|Protocol Violation|1|||
164333168|NCT03161093|593597365|FG005|Overall Study|Protocol Violation|0|||
164333169|NCT03161093|593597360|FG000|Overall Study|Adverse Event|5|||
164422658|NCT00556374|593918053|FG001|Overall Study|Withdrawal by Subject|205|||
164422659|NCT00556374|593918052|FG000|Overall Study|Death|158|||
164422660|NCT00556374|593918053|FG001|Overall Study|Death|127|||
164232887|NCT04795531|593223272|FG001|Overall Study|Lost to Follow-up|1|||
164232888|NCT04795531|593223271|FG000|Overall Study|Physician Decision|0|||
164232889|NCT04795531|593223272|FG001|Overall Study|Physician Decision|2|||
164232890|NCT04795531|593223271|FG000|Overall Study|Death|2|||
164232891|NCT04795531|593223272|FG001|Overall Study|Death|1|||
164232892|NCT01323192|593223273|FG000|Overall Study|Adverse Event|6|||
164232893|NCT01323192|593223274|FG001|Overall Study|Adverse Event|1|||
164232894|NCT01323192|593223273|FG000|Overall Study|Withdrawal by Subject|3|||
164232895|NCT01323192|593223274|FG001|Overall Study|Withdrawal by Subject|1|||
164232896|NCT01323192|593223273|FG000|Overall Study|Noncompliance with study medication|0|||
164232897|NCT01323192|593223274|FG001|Overall Study|Noncompliance with study medication|3|||
164232898|NCT01323192|593223273|FG000|Overall Study|Nonmedical reasons|0|||
164232899|NCT01323192|593223274|FG001|Overall Study|Nonmedical reasons|1|||
164232900|NCT00633126|593223275|FG000|Overall Study|Did not receive full dose|1|||
164232901|NCT01276704|593223278|FG000|Overall Study|Lost to Follow-up|2|||
164232902|NCT01276704|593223279|FG001|Overall Study|Lost to Follow-up|3|||
164232903|NCT01276704|593223278|FG000|Overall Study|Non-compliant|2|||
164232904|NCT01276704|593223279|FG001|Overall Study|Non-compliant|2|||
164232905|NCT01276704|593223278|FG000|Overall Study|Withdrawal by Subject|7|||
164232906|NCT01276704|593223279|FG001|Overall Study|Withdrawal by Subject|1|||
164232907|NCT01276704|593223278|FG000|Overall Study|Physician Decision|3|||
164232908|NCT01276704|593223279|FG001|Overall Study|Physician Decision|5|||
164232909|NCT01168596|593223280|FG000|Overall Study|Withdrawal by Subject|3|||
164232910|NCT01168596|593223281|FG001|Overall Study|Withdrawal by Subject|1|||
164232911|NCT00710593|593223282|FG000|Overall Study|Incarceration|1|||
164232912|NCT00710593|593223283|FG001|Overall Study|Incarceration|0|||
164232913|NCT00710593|593223282|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
164232914|NCT00710593|593223283|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
164232915|NCT00710593|593223282|FG000|Overall Study|Lost to Follow-up|3|||
164232916|NCT00710593|593223283|FG001|Overall Study|Lost to Follow-up|1|||
164232917|NCT00710593|593223282|FG000|Overall Study|Moved out of area|1|||
164232918|NCT00710593|593223283|FG001|Overall Study|Moved out of area|0|||
164232919|NCT00710593|593223282|FG000|Overall Study|Failure to adhere or complete study eval|1|||
164232920|NCT00710593|593223283|FG001|Overall Study|Failure to adhere or complete study eval|1|||
164232921|NCT00710593|593223282|FG000|Overall Study|Protocol Violation|1|||
164232922|NCT00710593|593223283|FG001|Overall Study|Protocol Violation|1|||
164232923|NCT00710593|593223282|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
164333170|NCT03161093|593597361|FG001|Overall Study|Adverse Event|21|||
164422661|NCT00556374|593918052|FG000|Overall Study|Lost to Follow-up|24|||
164232924|NCT00710593|593223283|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
164232925|NCT01441960|593223284|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
164333171|NCT03161093|593597362|FG002|Overall Study|Adverse Event|16|||
164232926|NCT01441960|593223285|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
164232927|NCT01441960|593223284|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
164232928|NCT01441960|593223285|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
164232929|NCT01441960|593223284|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
164422662|NCT00556374|593918053|FG001|Overall Study|Lost to Follow-up|17|||
164232930|NCT01441960|593223285|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
164232931|NCT03243084|593223294|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
164232932|NCT03243084|593223295|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
164675929|NCT03290781|594836896|FG006|Overall Study|Withdrawal by Subject|0|||
164675930|NCT03290781|594836890|FG000|Overall Study|Physician Decision|0|||
164675931|NCT03290781|594836891|FG001|Overall Study|Physician Decision|1|||
164675932|NCT03290781|594836892|FG002|Overall Study|Physician Decision|0|||
164675933|NCT03290781|594836893|FG003|Overall Study|Physician Decision|0|||
164232933|NCT01500317|593223303|FG000|Overall Study|Withdrawal by Subject|3|||
164232934|NCT01500317|593223304|FG001|Overall Study|Withdrawal by Subject|2|||
164232935|NCT01500317|593223305|FG002|Overall Study|Withdrawal by Subject|0|||
164232936|NCT00335829|593223306|FG000|Overall Study|Withdrawal by Subject|1|||
164232937|NCT00335829|593223306|FG000|Overall Study|Lost to Follow-up|1|||
164232938|NCT00335829|593223306|FG000|Overall Study|Adverse Event|1|||
164232939|NCT02090764|593223307|FG000|Overall Study|Adverse Event|1|||
164232940|NCT02090764|593223308|FG001|Overall Study|Adverse Event|3|||
164232941|NCT02090764|593223307|FG000|Overall Study|Lack of Efficacy|0|||
164232942|NCT02090764|593223308|FG001|Overall Study|Lack of Efficacy|13|||
164232943|NCT02090764|593223307|FG000|Overall Study|Withdrawal by Subject|2|||
164232944|NCT02090764|593223308|FG001|Overall Study|Withdrawal by Subject|1|||
164232945|NCT02090764|593223307|FG000|Overall Study|Intercurrent illness and other|1|||
164232946|NCT02090764|593223308|FG001|Overall Study|Intercurrent illness and other|1|||
164232947|NCT02090764|593223307|FG000|Overall Study|Lost to Follow-up|2|||
164232948|NCT02090764|593223308|FG001|Overall Study|Lost to Follow-up|2|||
164232949|NCT00744861|593223309|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
164232950|NCT00744861|593223310|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
164232951|NCT00744861|593223311|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
164232952|NCT00744861|593223312|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
164232953|NCT00744861|593223309|FG000|Feasibility Stage 1|Pregnancy|0|||
164232954|NCT00744861|593223310|FG001|Feasibility Stage 1|Pregnancy|1|||
164232955|NCT00744861|593223311|FG002|Feasibility Stage 1|Pregnancy|0|||
164232956|NCT00744861|593223312|FG003|Feasibility Stage 1|Pregnancy|0|||
164232957|NCT00744861|593223309|FG000|Pivotal Stage 2|Adverse Event|0|||
164232958|NCT00744861|593223310|FG001|Pivotal Stage 2|Adverse Event|0|||
164232959|NCT00744861|593223311|FG002|Pivotal Stage 2|Adverse Event|6|||
164232960|NCT00744861|593223312|FG003|Pivotal Stage 2|Adverse Event|11|||
164232961|NCT00744861|593223309|FG000|Pivotal Stage 2|Death|0|||
164232962|NCT00744861|593223310|FG001|Pivotal Stage 2|Death|0|||
164232963|NCT00744861|593223311|FG002|Pivotal Stage 2|Death|0|||
164232964|NCT00744861|593223312|FG003|Pivotal Stage 2|Death|1|||
164232965|NCT00744861|593223309|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
164232966|NCT00744861|593223310|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
164232967|NCT00744861|593223311|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
164232968|NCT00744861|593223312|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
164232969|NCT00744861|593223309|FG000|Pivotal Stage 2|Physician Decision|0|||
164232970|NCT00744861|593223310|FG001|Pivotal Stage 2|Physician Decision|0|||
164232971|NCT00744861|593223311|FG002|Pivotal Stage 2|Physician Decision|3|||
164232972|NCT00744861|593223312|FG003|Pivotal Stage 2|Physician Decision|1|||
164232973|NCT00744861|593223309|FG000|Pivotal Stage 2|Protocol Violation|0|||
164232974|NCT00744861|593223310|FG001|Pivotal Stage 2|Protocol Violation|0|||
164232975|NCT00744861|593223311|FG002|Pivotal Stage 2|Protocol Violation|0|||
164232976|NCT00744861|593223312|FG003|Pivotal Stage 2|Protocol Violation|1|||
164232977|NCT00744861|593223309|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
164232978|NCT00744861|593223310|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
164232979|NCT00744861|593223311|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
164232980|NCT00744861|593223312|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
164232981|NCT00744861|593223309|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
164232982|NCT00744861|593223310|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
164232983|NCT00744861|593223311|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
164232984|NCT00744861|593223312|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
164232985|NCT04856527|593223313|FG000|Overall Study|Unable to complete experimental task|2|||
164232986|NCT04856527|593223314|FG001|Overall Study|Unable to complete experimental task|0|||
164232987|NCT04562116|593223317|FG000|Overall Study|Lost to Follow-up|1|||
164232988|NCT04562116|593223317|FG000|Overall Study|Withdrawal by Subject|3|||
164232989|NCT02038647|593223319|FG000|Overall Study|Progressive Disease|50|||
164232990|NCT02038647|593223320|FG001|Overall Study|Progressive Disease|59|||
164675934|NCT03290781|594836894|FG004|Overall Study|Physician Decision|0|||
164675935|NCT03290781|594836895|FG005|Overall Study|Physician Decision|0|||
164675936|NCT03290781|594836896|FG006|Overall Study|Physician Decision|0|||
164675937|NCT03290781|594836890|FG000|Overall Study|Site Terminated by Sponsor|1|||
164232991|NCT02038647|593223319|FG000|Overall Study|Adverse Event|18|||
164232992|NCT02038647|593223320|FG001|Overall Study|Adverse Event|10|||
164232993|NCT02038647|593223319|FG000|Overall Study|Symptomatic Deterioration|7|||
164232994|NCT02038647|593223320|FG001|Overall Study|Symptomatic Deterioration|7|||
164232995|NCT02038647|593223319|FG000|Overall Study|Withdrawal by Subject|5|||
164232996|NCT02038647|593223320|FG001|Overall Study|Withdrawal by Subject|2|||
164232997|NCT02038647|593223319|FG000|Overall Study|Not Reported|0|||
164232998|NCT02038647|593223320|FG001|Overall Study|Not Reported|1|||
164232999|NCT02038647|593223319|FG000|Overall Study|Ongoing at Datacut|9|||
164422663|NCT00556374|593918052|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
164422664|NCT00556374|593918053|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
164422665|NCT05294419|593918054|FG000|Overall Study|Protocol Violation|4|||
164422666|NCT05294419|593918055|FG001|Overall Study|Protocol Violation|0|||
164422667|NCT05294419|593918056|FG002|Overall Study|Protocol Violation|0|||
164422668|NCT05294419|593918054|FG000|Overall Study|Lost to Follow-up|6|||
164422669|NCT05294419|593918055|FG001|Overall Study|Lost to Follow-up|0|||
164422670|NCT05294419|593918056|FG002|Overall Study|Lost to Follow-up|0|||
164422671|NCT05294419|593918054|FG000|Overall Study|Results voided after publishing|2|||
164422672|NCT05294419|593918055|FG001|Overall Study|Results voided after publishing|0|||
164422673|NCT05294419|593918056|FG002|Overall Study|Results voided after publishing|0|||
164422674|NCT00544544|593918057|FG000|Overall Study|Withdrawal by Subject|1|||
164422675|NCT00544544|593918057|FG000|Overall Study|Adverse Event|1|||
164422676|NCT00544544|593918057|FG000|Overall Study|Lost to Follow-up|1|||
164422677|NCT00442286|593918061|FG000|Overall Study|Death|2|||
164422678|NCT00442286|593918062|FG001|Overall Study|Death|2|||
164422679|NCT00442286|593918061|FG000|Overall Study|Lost to Follow-up|1|||
164422680|NCT00442286|593918062|FG001|Overall Study|Lost to Follow-up|0|||
164422681|NCT00442286|593918061|FG000|Overall Study|Withdrawal by Subject|2|||
164422682|NCT00442286|593918062|FG001|Overall Study|Withdrawal by Subject|0|||
164422683|NCT00442286|593918061|FG000|Overall Study|System explanted|1|||
164422684|NCT00442286|593918062|FG001|Overall Study|System explanted|0|||
164422685|NCT00442286|593918061|FG000|Overall Study|Patient Injury|1|||
164422686|NCT00442286|593918062|FG001|Overall Study|Patient Injury|0|||
164422687|NCT03428815|593918063|FG000|Overall Study|Lost to Follow-up|2|||
164422688|NCT03428815|593918064|FG001|Overall Study|Lost to Follow-up|2|||
164422689|NCT03428815|593918063|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
164422690|NCT03428815|593918064|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
164422691|NCT03428815|593918063|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
164422692|NCT03428815|593918064|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
164422693|NCT05221749|593918065|FG000|Overall Study|Lost to Follow-up|2|||
164422694|NCT05221749|593918066|FG001|Overall Study|Lost to Follow-up|3|||
164422695|NCT04140890|593918069|FG000|Overall Study|Withdrawal by Subject|0|||
164422696|NCT04140890|593918070|FG001|Overall Study|Withdrawal by Subject|1|||
164422697|NCT02102464|593918071|FG000|Randomized Study|Withdrawal by Subject|0|||
164422698|NCT02102464|593918072|FG001|Randomized Study|Withdrawal by Subject|1|||
164422699|NCT02102464|593918073|FG002|Randomized Study|Withdrawal by Subject|0|||
164422700|NCT02404493|593918074|FG000|Overall Study|Adverse Event|1|||
164422701|NCT02404493|593918075|FG001|Overall Study|Adverse Event|1|||
164422702|NCT01700348|593918076|FG000|Overall Study|Withdrawal by Subject|22|||
164422703|NCT01700348|593918076|FG000|Overall Study|Lost to Follow-up|1|||
164422704|NCT02388074|593918077|FG000|Overall Study|Lost in Transit|2|||
164422705|NCT02388074|593918077|FG000|Overall Study|Sample Not Returned|1|||
164422706|NCT01778062|593918080|FG000|Overall Study|Adverse Event|1|||
164422707|NCT01778062|593918081|FG001|Overall Study|Adverse Event|3|||
164422708|NCT01778062|593918080|FG000|Overall Study|Consent Withdrawal|1|||
164422709|NCT01778062|593918081|FG001|Overall Study|Consent Withdrawal|5|||
164422710|NCT01778062|593918080|FG000|Overall Study|major protocol deviation|4|||
164422711|NCT01778062|593918081|FG001|Overall Study|major protocol deviation|3|||
164422712|NCT03958630|593918084|FG000|Overall Study|Withdrawal by Subject|0|||
164422713|NCT03958630|593918085|FG001|Overall Study|Withdrawal by Subject|0|||
164422714|NCT03958630|593918086|FG002|Overall Study|Withdrawal by Subject|1|||
164422715|NCT03958630|593918084|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
164422716|NCT03958630|593918085|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
164422717|NCT03958630|593918086|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
164422718|NCT03317379|593918092|FG000|Overall Study|Lost to Follow-up|0|||
164422719|NCT03317379|593918093|FG001|Overall Study|Lost to Follow-up|3|||
164422720|NCT03317379|593918094|FG002|Overall Study|Lost to Follow-up|2|||
164422721|NCT04157686|593918095|FG000|Overall Study|Adverse Event|1|||
164422722|NCT04157686|593918096|FG001|Overall Study|Adverse Event|0|||
164422723|NCT04157686|593918097|FG002|Overall Study|Adverse Event|1|||
164422724|NCT04157686|593918098|FG003|Overall Study|Adverse Event|0|||
164422725|NCT04157686|593918099|FG004|Overall Study|Adverse Event|1|||
164675938|NCT03290781|594836891|FG001|Overall Study|Site Terminated by Sponsor|0|||
164422726|NCT04157686|593918100|FG005|Overall Study|Adverse Event|0|||
164422727|NCT04157686|593918101|FG006|Overall Study|Adverse Event|0|||
164422728|NCT04157686|593918102|FG007|Overall Study|Adverse Event|0|||
164422729|NCT04157686|593918095|FG000|Overall Study|Pregnancy|0|||
164422730|NCT04157686|593918096|FG001|Overall Study|Pregnancy|1|||
164422731|NCT04157686|593918097|FG002|Overall Study|Pregnancy|3|||
164422732|NCT04157686|593918098|FG003|Overall Study|Pregnancy|0|||
164422733|NCT04157686|593918099|FG004|Overall Study|Pregnancy|0|||
164422734|NCT04157686|593918100|FG005|Overall Study|Pregnancy|0|||
164422735|NCT04157686|593918101|FG006|Overall Study|Pregnancy|3|||
164422736|NCT04157686|593918102|FG007|Overall Study|Pregnancy|0|||
164422737|NCT04157686|593918095|FG000|Overall Study|Lost to Follow-up|1|||
164675939|NCT03290781|594836892|FG002|Overall Study|Site Terminated by Sponsor|2|||
164233000|NCT02038647|593223320|FG001|Overall Study|Ongoing at Datacut|10|||
164233001|NCT02757430|593223321|FG000|Overall Study|Physician Decision|6|||
164233002|NCT02757430|593223321|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
164233003|NCT02757430|593223321|FG000|Overall Study|No informed consent|1|||
164233004|NCT02757430|593223321|FG000|Overall Study|No procedure performed|2|||
164233005|NCT03078868|593223324|FG000|Overall Study|Physician Decision|3|||
164233006|NCT01983111|593223325|FG000|Overall Study|Withdrawal by Subject|8|||
164233007|NCT01983111|593223326|FG001|Overall Study|Withdrawal by Subject|6|||
164233008|NCT01983111|593223325|FG000|Overall Study|Adverse Event|4|||
164233009|NCT01983111|593223326|FG001|Overall Study|Adverse Event|0|||
164233010|NCT01983111|593223325|FG000|Overall Study|Protocol Violation|0|||
164233011|NCT01983111|593223326|FG001|Overall Study|Protocol Violation|1|||
164233012|NCT03502200|593223327|FG000|Overall Study|Adverse Event|1|||
164233013|NCT03502200|593223328|FG001|Overall Study|Adverse Event|0|||
164233014|NCT03502200|593223327|FG000|Overall Study|Lost to Follow-up|36|||
164233015|NCT03502200|593223328|FG001|Overall Study|Lost to Follow-up|38|||
164233016|NCT03502200|593223327|FG000|Overall Study|Study Team Decision|1|||
164233017|NCT03502200|593223328|FG001|Overall Study|Study Team Decision|1|||
164233018|NCT03502200|593223327|FG000|Overall Study|Withdrawal by Subject|5|||
164233019|NCT03502200|593223328|FG001|Overall Study|Withdrawal by Subject|7|||
164233020|NCT03502200|593223327|FG000|Overall Study|Death|0|||
164233021|NCT03502200|593223328|FG001|Overall Study|Death|2|||
164233022|NCT00855335|593223329|FG000|Overall Study|Lost to Follow-up|0|||
164233023|NCT00855335|593223330|FG001|Overall Study|Lost to Follow-up|0|||
164233024|NCT00855335|593223331|FG002|Overall Study|Lost to Follow-up|3|||
164233025|NCT00855335|593223332|FG003|Overall Study|Lost to Follow-up|1|||
164233026|NCT00855335|593223333|FG004|Overall Study|Lost to Follow-up|0|||
164233027|NCT00855335|593223329|FG000|Overall Study|Withdrawal by Subject|0|||
164233028|NCT00855335|593223330|FG001|Overall Study|Withdrawal by Subject|0|||
164233029|NCT00855335|593223331|FG002|Overall Study|Withdrawal by Subject|0|||
164233030|NCT00855335|593223332|FG003|Overall Study|Withdrawal by Subject|1|||
164233031|NCT00855335|593223333|FG004|Overall Study|Withdrawal by Subject|0|||
164233032|NCT00855335|593223329|FG000|Overall Study|Adverse Event|2|||
164233033|NCT00855335|593223330|FG001|Overall Study|Adverse Event|0|||
164233034|NCT00855335|593223331|FG002|Overall Study|Adverse Event|0|||
164233035|NCT00855335|593223332|FG003|Overall Study|Adverse Event|0|||
164233036|NCT00855335|593223333|FG004|Overall Study|Adverse Event|0|||
164233037|NCT00855335|593223329|FG000|Overall Study|Physician Decision|1|||
164233038|NCT00855335|593223330|FG001|Overall Study|Physician Decision|1|||
164233039|NCT00855335|593223331|FG002|Overall Study|Physician Decision|0|||
164233040|NCT00855335|593223332|FG003|Overall Study|Physician Decision|0|||
164233041|NCT00855335|593223333|FG004|Overall Study|Physician Decision|0|||
164233042|NCT00855335|593223329|FG000|Overall Study|Other|2|||
164233043|NCT00855335|593223330|FG001|Overall Study|Other|1|||
164233044|NCT00855335|593223331|FG002|Overall Study|Other|2|||
164233045|NCT00855335|593223332|FG003|Overall Study|Other|5|||
164233046|NCT00855335|593223333|FG004|Overall Study|Other|1|||
164233047|NCT03097289|593223335|FG000|Overall Study|Adverse Event|1|||
164233048|NCT03097289|593223335|FG000|Overall Study|Equipment failure|2|||
164233049|NCT03097289|593223335|FG000|Overall Study|Collected platelet product unusable|3|||
164233050|NCT02526290|593223338|FG000|Overall Study|Adverse Event|3|||
164233051|NCT02526290|593223338|FG000|Overall Study|Withdrawal by Subject|4|||
164233052|NCT02526290|593223338|FG000|Overall Study|Physician Decision|1|||
164233053|NCT02082977|593223339|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
164233054|NCT02082977|593223340|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
164233055|NCT02082977|593223341|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
164233056|NCT02082977|593223342|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
164233057|NCT02082977|593223343|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
164233058|NCT02082977|593223344|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
164233059|NCT02082977|593223345|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
164233060|NCT02082977|593223346|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
164233061|NCT02082977|593223347|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
164233062|NCT02082977|593223348|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
164233063|NCT02082977|593223339|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
164233064|NCT02082977|593223340|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
164233065|NCT02082977|593223341|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
164233066|NCT02082977|593223342|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
164233067|NCT02082977|593223343|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
164233068|NCT02082977|593223344|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
164233069|NCT02082977|593223345|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
164233070|NCT02082977|593223346|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
164233071|NCT02082977|593223347|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
164233072|NCT02082977|593223348|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
164233073|NCT02082977|593223339|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
164233074|NCT02082977|593223340|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
164233075|NCT02082977|593223341|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
164233076|NCT02082977|593223342|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
164233077|NCT02082977|593223343|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
164233078|NCT02082977|593223344|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
164233079|NCT02082977|593223345|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
164233080|NCT02082977|593223346|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
164233081|NCT02082977|593223347|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
164233082|NCT02082977|593223348|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
164233083|NCT02082977|593223339|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
164233084|NCT02082977|593223340|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
164233085|NCT02082977|593223341|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
164233086|NCT02082977|593223342|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
164233087|NCT02082977|593223343|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
164233088|NCT02082977|593223344|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
164233089|NCT02082977|593223345|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
164233090|NCT02082977|593223346|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
164233091|NCT02082977|593223347|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
164233092|NCT02082977|593223348|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
164233093|NCT02082977|593223339|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
164233094|NCT02082977|593223340|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
164233095|NCT02082977|593223341|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
164233096|NCT02082977|593223342|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
164233097|NCT02082977|593223343|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
164233098|NCT02082977|593223344|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
164233099|NCT02082977|593223345|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
164233100|NCT02082977|593223346|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
164233101|NCT02082977|593223347|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
164233102|NCT02082977|593223348|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
164233103|NCT00049543|593223349|FG000|Overall Study|still on treatment|2|||
164233104|NCT00049543|593223350|FG001|Overall Study|still on treatment|9|||
164233105|NCT01506726|593223370|FG000|Overall Study|Adverse Event|1|||
164233106|NCT01506726|593223371|FG001|Overall Study|Adverse Event|2|||
164233107|NCT04079738|593223372|FG000|Study Treatment|Death|1|||
164233108|NCT04079738|593223373|FG001|Study Treatment|Death|0|||
164233109|NCT04079738|593223374|FG002|Study Treatment|Death|0|||
164233110|NCT04079738|593223375|FG003|Study Treatment|Death|0|||
164233111|NCT04079738|593223372|FG000|Study Treatment|Adverse Event|2|||
164233112|NCT04079738|593223373|FG001|Study Treatment|Adverse Event|0|||
164233113|NCT04079738|593223374|FG002|Study Treatment|Adverse Event|0|||
164233114|NCT04079738|593223375|FG003|Study Treatment|Adverse Event|0|||
164233115|NCT04079738|593223372|FG000|Study Treatment|withdrawal before treatment|1|||
164233116|NCT04079738|593223373|FG001|Study Treatment|withdrawal before treatment|0|||
164233117|NCT04079738|593223374|FG002|Study Treatment|withdrawal before treatment|0|||
164233118|NCT04079738|593223375|FG003|Study Treatment|withdrawal before treatment|0|||
164233119|NCT04079738|593223372|FG000|Study Treatment|symptomatic deterioration|2|||
164233120|NCT04079738|593223373|FG001|Study Treatment|symptomatic deterioration|0|||
164233121|NCT04079738|593223374|FG002|Study Treatment|symptomatic deterioration|0|||
164233122|NCT04079738|593223375|FG003|Study Treatment|symptomatic deterioration|0|||
164233123|NCT04079738|593223372|FG000|Study Treatment|Disease Progression|1|||
164233124|NCT04079738|593223373|FG001|Study Treatment|Disease Progression|0|||
164233125|NCT04079738|593223374|FG002|Study Treatment|Disease Progression|0|||
164233126|NCT04079738|593223375|FG003|Study Treatment|Disease Progression|0|||
164233127|NCT04079738|593223372|FG000|Study Treatment|withdrawal after treatment|1|||
164233128|NCT04079738|593223373|FG001|Study Treatment|withdrawal after treatment|0|||
164233129|NCT04079738|593223374|FG002|Study Treatment|withdrawal after treatment|0|||
164233130|NCT04079738|593223375|FG003|Study Treatment|withdrawal after treatment|0|||
164233131|NCT04079738|593223372|FG000|Follow up|Withdrawal by Subject|3|||
164233132|NCT04079738|593223373|FG001|Follow up|Withdrawal by Subject|0|||
164233133|NCT04079738|593223374|FG002|Follow up|Withdrawal by Subject|0|||
164233134|NCT04079738|593223375|FG003|Follow up|Withdrawal by Subject|0|||
164233135|NCT04079738|593223372|FG000|Follow up|Death|5|||
164233136|NCT04079738|593223373|FG001|Follow up|Death|0|||
164233137|NCT04079738|593223374|FG002|Follow up|Death|0|||
164233138|NCT04079738|593223375|FG003|Follow up|Death|0|||
164233139|NCT01380080|593223378|FG000|Overall Study|Death|36|||
164233140|NCT01380080|593223379|FG001|Overall Study|Death|44|||
164233141|NCT01380080|593223378|FG000|Overall Study|Site is closing|28|||
164233142|NCT01380080|593223379|FG001|Overall Study|Site is closing|31|||
164233143|NCT01380080|593223378|FG000|Overall Study|Not able to get to clinic|7|||
164233144|NCT01380080|593223379|FG001|Overall Study|Not able to get to clinic|1|||
164233145|NCT01380080|593223378|FG000|Overall Study|Not willing to adhere to requirements|6|||
164233146|NCT01380080|593223379|FG001|Overall Study|Not willing to adhere to requirements|2|||
164233147|NCT01380080|593223378|FG000|Overall Study|Withdrawal by Subject|5|||
164233148|NCT01380080|593223379|FG001|Overall Study|Withdrawal by Subject|2|||
164233149|NCT01380080|593223378|FG000|Overall Study|Lost to Follow-up|3|||
164233150|NCT01380080|593223379|FG001|Overall Study|Lost to Follow-up|3|||
164233151|NCT02303821|593223382|FG000|Overall Study|Withdrawal by Subject|0|||
164233152|NCT02303821|593223383|FG001|Overall Study|Withdrawal by Subject|0|||
164233153|NCT02303821|593223384|FG002|Overall Study|Withdrawal by Subject|0|||
164233154|NCT02303821|593223385|FG003|Overall Study|Withdrawal by Subject|0|||
164233155|NCT02303821|593223386|FG004|Overall Study|Withdrawal by Subject|0|||
164233156|NCT02303821|593223387|FG005|Overall Study|Withdrawal by Subject|0|||
164233157|NCT02303821|593223388|FG006|Overall Study|Withdrawal by Subject|0|||
164233158|NCT02303821|593223389|FG007|Overall Study|Withdrawal by Subject|2|||
164233159|NCT02303821|593223382|FG000|Overall Study|Death|0|||
164233160|NCT02303821|593223383|FG001|Overall Study|Death|2|||
164233161|NCT02303821|593223384|FG002|Overall Study|Death|0|||
164233162|NCT02303821|593223385|FG003|Overall Study|Death|0|||
164233163|NCT02303821|593223386|FG004|Overall Study|Death|0|||
164233164|NCT02303821|593223387|FG005|Overall Study|Death|3|||
164233165|NCT02303821|593223388|FG006|Overall Study|Death|41|||
164233166|NCT02303821|593223389|FG007|Overall Study|Death|29|||
164233167|NCT02303821|593223382|FG000|Overall Study|Lost to Follow-up|0|||
164233168|NCT02303821|593223383|FG001|Overall Study|Lost to Follow-up|0|||
164233169|NCT02303821|593223384|FG002|Overall Study|Lost to Follow-up|0|||
164233170|NCT02303821|593223385|FG003|Overall Study|Lost to Follow-up|0|||
164233171|NCT02303821|593223386|FG004|Overall Study|Lost to Follow-up|0|||
164233172|NCT02303821|593223387|FG005|Overall Study|Lost to Follow-up|0|||
164233173|NCT02303821|593223388|FG006|Overall Study|Lost to Follow-up|1|||
164233174|NCT02303821|593223389|FG007|Overall Study|Lost to Follow-up|0|||
164422738|NCT04157686|593918096|FG001|Overall Study|Lost to Follow-up|2|||
164233175|NCT02303821|593223382|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
164233176|NCT02303821|593223383|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
164233177|NCT02303821|593223384|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
164233178|NCT02303821|593223385|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
164233179|NCT02303821|593223386|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
164233180|NCT02303821|593223387|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
164233181|NCT02303821|593223388|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
164233182|NCT02303821|593223389|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
164233183|NCT02303821|593223382|FG000|Overall Study|Decision by sponsor|0|||
164233184|NCT02303821|593223383|FG001|Overall Study|Decision by sponsor|0|||
164233185|NCT02303821|593223384|FG002|Overall Study|Decision by sponsor|0|||
164233186|NCT02303821|593223385|FG003|Overall Study|Decision by sponsor|0|||
164233187|NCT02303821|593223386|FG004|Overall Study|Decision by sponsor|0|||
164233188|NCT02303821|593223387|FG005|Overall Study|Decision by sponsor|1|||
164233189|NCT02303821|593223388|FG006|Overall Study|Decision by sponsor|0|||
164233190|NCT02303821|593223389|FG007|Overall Study|Decision by sponsor|0|||
164233191|NCT02303821|593223382|FG000|Overall Study|Protocol-specified criteria|0|||
164233192|NCT02303821|593223383|FG001|Overall Study|Protocol-specified criteria|1|||
164233193|NCT02303821|593223384|FG002|Overall Study|Protocol-specified criteria|0|||
164233194|NCT02303821|593223385|FG003|Overall Study|Protocol-specified criteria|0|||
164233195|NCT02303821|593223386|FG004|Overall Study|Protocol-specified criteria|0|||
164233196|NCT02303821|593223387|FG005|Overall Study|Protocol-specified criteria|1|||
164233197|NCT02303821|593223388|FG006|Overall Study|Protocol-specified criteria|0|||
164233198|NCT02303821|593223389|FG007|Overall Study|Protocol-specified criteria|0|||
164233199|NCT00210132|593223390|FG000|Overall Study|Protocol Violation|1|||
164233200|NCT00210132|593223391|FG001|Overall Study|Protocol Violation|4|||
164233201|NCT02711202|593223394|FG000|Overall Study|Adverse Event|3|||
164233202|NCT02711202|593223395|FG001|Overall Study|Adverse Event|0|||
164422739|NCT04157686|593918097|FG002|Overall Study|Lost to Follow-up|8|||
164233203|NCT02711202|593223394|FG000|Overall Study|graft loss|1|||
164233204|NCT02711202|593223395|FG001|Overall Study|graft loss|0|||
164233205|NCT02402647|593223396|FG000|Overall Study|Lost to Follow-up|13|||
164233206|NCT02402647|593223397|FG001|Overall Study|Lost to Follow-up|7|||
164233207|NCT02402647|593223396|FG000|Overall Study|Protocol Violation|1|||
164233208|NCT02402647|593223397|FG001|Overall Study|Protocol Violation|1|||
164333172|NCT03161093|593597363|FG003|Overall Study|Adverse Event|35|||
164333173|NCT03161093|593597364|FG004|Overall Study|Adverse Event|2|||
164333174|NCT03161093|593597365|FG005|Overall Study|Adverse Event|1|||
164333175|NCT03161093|593597360|FG000|Overall Study|Lack of Efficacy|9|||
164333176|NCT03161093|593597361|FG001|Overall Study|Lack of Efficacy|13|||
164233209|NCT02402647|593223396|FG000|Overall Study|scheduled and timed out|2|||
164233210|NCT02402647|593223397|FG001|Overall Study|scheduled and timed out|1|||
164233211|NCT02402647|593223396|FG000|Overall Study|medical illness|2|||
164422740|NCT04157686|593918098|FG003|Overall Study|Lost to Follow-up|6|||
164333177|NCT03161093|593597362|FG002|Overall Study|Lack of Efficacy|9|||
164333178|NCT03161093|593597363|FG003|Overall Study|Lack of Efficacy|24|||
164422741|NCT04157686|593918099|FG004|Overall Study|Lost to Follow-up|6|||
164233212|NCT02402647|593223397|FG001|Overall Study|medical illness|4|||
164233213|NCT02402647|593223396|FG000|Overall Study|Moved|2|||
164233214|NCT02402647|593223397|FG001|Overall Study|Moved|0|||
164233215|NCT02402647|593223396|FG000|Overall Study|loved one illness|1|||
164233216|NCT02402647|593223397|FG001|Overall Study|loved one illness|0|||
164233217|NCT02402647|593223396|FG000|Overall Study|deceased preexisting condition|2|||
164233218|NCT02402647|593223397|FG001|Overall Study|deceased preexisting condition|0|||
164233219|NCT02402647|593223396|FG000|Overall Study|Other|2|||
164233220|NCT02402647|593223397|FG001|Overall Study|Other|1|||
164233221|NCT00618787|593223412|FG000|Overall Study|Adverse Event|0|||
164233222|NCT00618787|593223413|FG001|Overall Study|Adverse Event|1|||
164233223|NCT00618787|593223412|FG000|Overall Study|Withdrawal by Subject|2|||
164233224|NCT00618787|593223413|FG001|Overall Study|Withdrawal by Subject|1|||
164233225|NCT00618787|593223412|FG000|Overall Study|Lost to Follow-up|1|||
164233226|NCT00618787|593223413|FG001|Overall Study|Lost to Follow-up|0|||
164233227|NCT01994876|593223414|FG000|Test Period 1|Withdrawal by Subject|0|||
164233228|NCT01994876|593223415|FG001|Test Period 1|Withdrawal by Subject|1|||
164233229|NCT01994876|593223414|FG000|Test Period 1|Adverse Event|0|||
164233230|NCT01994876|593223415|FG001|Test Period 1|Adverse Event|1|||
164233231|NCT01994876|593223414|FG000|Test Period 2|Adverse Event|1|||
164233232|NCT01994876|593223415|FG001|Test Period 2|Adverse Event|0|||
164233233|NCT01994876|593223414|FG000|Test Period 2|Protocol Violation|0|||
164233234|NCT01994876|593223415|FG001|Test Period 2|Protocol Violation|1|||
164422742|NCT04157686|593918100|FG005|Overall Study|Lost to Follow-up|3|||
164233235|NCT06022107|593223416|FG000|Overall Study|Did not complete baseline questionnaire / did not begin using intervention|4|||
164572541|NCT00064701|594460390|FG001|One Year Post-transplant|Non-compliance|2|||
164572542|NCT00064701|594460391|FG002|One Year Post-transplant|Non-compliance|5|||
164572543|NCT00064701|594460389|FG000|One Year Post-transplant|Graft Failure|3|||
164572544|NCT00064701|594460390|FG001|One Year Post-transplant|Graft Failure|2|||
164572545|NCT00064701|594460391|FG002|One Year Post-transplant|Graft Failure|1|||
164572546|NCT00064701|594460389|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
164572547|NCT00064701|594460390|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
164572548|NCT00064701|594460391|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
164572549|NCT00064701|594460389|FG000|One Year Post-transplant|Lost to Follow-up|1|||
164572550|NCT00064701|594460390|FG001|One Year Post-transplant|Lost to Follow-up|0|||
164572551|NCT00064701|594460391|FG002|One Year Post-transplant|Lost to Follow-up|0|||
164572552|NCT00064701|594460389|FG000|One Year Post-transplant|Converted to rapamycin|1|||
164572553|NCT00064701|594460390|FG001|One Year Post-transplant|Converted to rapamycin|0|||
164572554|NCT00064701|594460391|FG002|One Year Post-transplant|Converted to rapamycin|0|||
164572555|NCT00064701|594460389|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
164572556|NCT00064701|594460390|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
164572557|NCT00064701|594460391|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
164572558|NCT00064701|594460389|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
164572559|NCT00064701|594460390|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
164572560|NCT00064701|594460391|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
164572561|NCT00064701|594460389|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
164572562|NCT00064701|594460390|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
164572563|NCT00064701|594460391|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
164572564|NCT00064701|594460389|FG000|One Year Post-transplant|Poor absorption|0|||
164572565|NCT00064701|594460390|FG001|One Year Post-transplant|Poor absorption|1|||
164572566|NCT00064701|594460391|FG002|One Year Post-transplant|Poor absorption|0|||
164572567|NCT00064701|594460389|FG000|One Year Post-transplant|Pancreas transplant|0|||
164572568|NCT00064701|594460390|FG001|One Year Post-transplant|Pancreas transplant|0|||
164572569|NCT00064701|594460391|FG002|One Year Post-transplant|Pancreas transplant|1|||
164572570|NCT00064701|594460389|FG000|Clinical Continuation Phase|Adverse Event|12|||
164572571|NCT00064701|594460390|FG001|Clinical Continuation Phase|Adverse Event|21|||
164572572|NCT00064701|594460391|FG002|Clinical Continuation Phase|Adverse Event|14|||
164572573|NCT00064701|594460389|FG000|Clinical Continuation Phase|Non-compliance|8|||
164572574|NCT00064701|594460390|FG001|Clinical Continuation Phase|Non-compliance|6|||
164572575|NCT00064701|594460391|FG002|Clinical Continuation Phase|Non-compliance|7|||
164572576|NCT00064701|594460389|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
164572577|NCT00064701|594460390|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
164572578|NCT00064701|594460391|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
164572579|NCT00064701|594460389|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
164572580|NCT00064701|594460390|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
164572581|NCT00064701|594460391|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
164572582|NCT00064701|594460389|FG000|Clinical Continuation Phase|Graft Failure|5|||
164572583|NCT00064701|594460390|FG001|Clinical Continuation Phase|Graft Failure|5|||
164572584|NCT00064701|594460391|FG002|Clinical Continuation Phase|Graft Failure|2|||
164572585|NCT00064701|594460389|FG000|Clinical Continuation Phase|Rejection|1|||
164572586|NCT00064701|594460390|FG001|Clinical Continuation Phase|Rejection|2|||
164572587|NCT00064701|594460391|FG002|Clinical Continuation Phase|Rejection|2|||
164572588|NCT00064701|594460389|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
164572589|NCT00064701|594460390|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
164572590|NCT00064701|594460391|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
164572591|NCT00064701|594460389|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
164233236|NCT06022107|593223416|FG000|Overall Study|Dropped out of study for higher level of care|1|||
164233237|NCT06022107|593223416|FG000|Overall Study|Lost to Follow-up|2|||
164233238|NCT05847686|593226011|FG000|Overall Study|Withdrawal by Subject|3|||
164233239|NCT03716830|593226012|FG000|Overall Study|Withdrawal by Subject|2|||
164299832|NCT02532517|593472943|FG000|Overall Study|Death|4|||
164233240|NCT03716830|593226013|FG001|Overall Study|Withdrawal by Subject|2|||
164233241|NCT03716830|593226014|FG002|Overall Study|Withdrawal by Subject|6|||
164233242|NCT03716830|593226015|FG003|Overall Study|Withdrawal by Subject|5|||
164233243|NCT03716830|593226012|FG000|Overall Study|Adverse Event|1|||
164233244|NCT03716830|593226013|FG001|Overall Study|Adverse Event|2|||
164233245|NCT03716830|593226014|FG002|Overall Study|Adverse Event|0|||
164233246|NCT03716830|593226015|FG003|Overall Study|Adverse Event|1|||
164233247|NCT03716830|593226012|FG000|Overall Study|Lost to Follow-up|1|||
164233248|NCT03716830|593226013|FG001|Overall Study|Lost to Follow-up|1|||
164333179|NCT03161093|593597364|FG004|Overall Study|Lack of Efficacy|4|||
164333180|NCT03161093|593597365|FG005|Overall Study|Lack of Efficacy|1|||
164333181|NCT03161093|593597360|FG000|Overall Study|Physician Decision|0|||
164333182|NCT03161093|593597361|FG001|Overall Study|Physician Decision|1|||
164333183|NCT03161093|593597362|FG002|Overall Study|Physician Decision|0|||
164333184|NCT03161093|593597363|FG003|Overall Study|Physician Decision|2|||
164333185|NCT03161093|593597364|FG004|Overall Study|Physician Decision|17|||
164333186|NCT03161093|593597365|FG005|Overall Study|Physician Decision|15|||
164333187|NCT03161093|593597360|FG000|Overall Study|Withdrawal by Subject|24|||
164422743|NCT04157686|593918101|FG006|Overall Study|Lost to Follow-up|7|||
164422744|NCT04157686|593918102|FG007|Overall Study|Lost to Follow-up|9|||
164422745|NCT04157686|593918095|FG000|Overall Study|Lack of Efficacy|0|||
164422746|NCT04157686|593918096|FG001|Overall Study|Lack of Efficacy|0|||
164422747|NCT04157686|593918097|FG002|Overall Study|Lack of Efficacy|0|||
164422748|NCT04157686|593918098|FG003|Overall Study|Lack of Efficacy|0|||
164422749|NCT04157686|593918099|FG004|Overall Study|Lack of Efficacy|0|||
164422750|NCT04157686|593918100|FG005|Overall Study|Lack of Efficacy|2|||
164422751|NCT04157686|593918101|FG006|Overall Study|Lack of Efficacy|0|||
164422752|NCT04157686|593918102|FG007|Overall Study|Lack of Efficacy|1|||
164422753|NCT04157686|593918095|FG000|Overall Study|Withdrawal by Subject|10|||
164422754|NCT04157686|593918096|FG001|Overall Study|Withdrawal by Subject|10|||
164422755|NCT04157686|593918097|FG002|Overall Study|Withdrawal by Subject|12|||
164422756|NCT04157686|593918098|FG003|Overall Study|Withdrawal by Subject|20|||
164422757|NCT04157686|593918099|FG004|Overall Study|Withdrawal by Subject|12|||
164422758|NCT04157686|593918100|FG005|Overall Study|Withdrawal by Subject|11|||
164422759|NCT04157686|593918101|FG006|Overall Study|Withdrawal by Subject|18|||
164422760|NCT04157686|593918102|FG007|Overall Study|Withdrawal by Subject|24|||
164422761|NCT04157686|593918095|FG000|Overall Study|Physician Decision|0|||
164422762|NCT04157686|593918096|FG001|Overall Study|Physician Decision|0|||
164422763|NCT04157686|593918097|FG002|Overall Study|Physician Decision|1|||
164422764|NCT04157686|593918098|FG003|Overall Study|Physician Decision|0|||
164422765|NCT04157686|593918099|FG004|Overall Study|Physician Decision|1|||
164422766|NCT04157686|593918100|FG005|Overall Study|Physician Decision|0|||
164422767|NCT04157686|593918101|FG006|Overall Study|Physician Decision|3|||
164422768|NCT04157686|593918102|FG007|Overall Study|Physician Decision|0|||
164422769|NCT04157686|593918095|FG000|Overall Study|Death|0|||
164422770|NCT04157686|593918096|FG001|Overall Study|Death|0|||
164422771|NCT04157686|593918097|FG002|Overall Study|Death|0|||
164422772|NCT04157686|593918098|FG003|Overall Study|Death|2|||
164422773|NCT04157686|593918099|FG004|Overall Study|Death|0|||
164422774|NCT04157686|593918100|FG005|Overall Study|Death|0|||
164422775|NCT04157686|593918101|FG006|Overall Study|Death|0|||
164422776|NCT04157686|593918102|FG007|Overall Study|Death|0|||
164422777|NCT04157686|593918095|FG000|Overall Study|Protocol Violation|0|||
164422778|NCT04157686|593918096|FG001|Overall Study|Protocol Violation|0|||
164422779|NCT04157686|593918097|FG002|Overall Study|Protocol Violation|0|||
164422780|NCT04157686|593918098|FG003|Overall Study|Protocol Violation|0|||
164422781|NCT04157686|593918099|FG004|Overall Study|Protocol Violation|1|||
164422782|NCT04157686|593918100|FG005|Overall Study|Protocol Violation|0|||
164422783|NCT04157686|593918101|FG006|Overall Study|Protocol Violation|0|||
164422784|NCT04157686|593918102|FG007|Overall Study|Protocol Violation|0|||
164422785|NCT04157686|593918095|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
164422786|NCT04157686|593918096|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
164422787|NCT04157686|593918097|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
164422788|NCT04157686|593918098|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
164422789|NCT04157686|593918099|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
164233249|NCT03716830|593226014|FG002|Overall Study|Lost to Follow-up|0|||
164422790|NCT04157686|593918100|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
164422791|NCT04157686|593918101|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
164333188|NCT03161093|593597361|FG001|Overall Study|Withdrawal by Subject|73|||
164333189|NCT03161093|593597362|FG002|Overall Study|Withdrawal by Subject|44|||
164422792|NCT04157686|593918102|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
164422793|NCT04445155|593918103|FG000|Overall Study|Lost to Follow-up|11|||
164422794|NCT04445155|593918104|FG001|Overall Study|Lost to Follow-up|2|||
164422795|NCT04445155|593918105|FG002|Overall Study|Lost to Follow-up|3|||
164422796|NCT04445155|593918106|FG003|Overall Study|Lost to Follow-up|0|||
164233250|NCT03716830|593226015|FG003|Overall Study|Lost to Follow-up|0|||
164233251|NCT04887831|593226016|FG000|Overall Study|Death|26|||
164233252|NCT04887831|593226017|FG001|Overall Study|Death|26|||
164233253|NCT04887831|593226016|FG000|Overall Study|Lost to Follow-up|0|||
164422797|NCT04445155|593918103|FG000|Overall Study|Withdrawal by Subject|8|||
164422798|NCT04445155|593918104|FG001|Overall Study|Withdrawal by Subject|0|||
164422799|NCT04445155|593918105|FG002|Overall Study|Withdrawal by Subject|0|||
164422800|NCT04445155|593918106|FG003|Overall Study|Withdrawal by Subject|0|||
164422801|NCT04445155|593918103|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
164422802|NCT04445155|593918104|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
164422803|NCT04445155|593918105|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
164422804|NCT04445155|593918106|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
164422805|NCT04445155|593918103|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
164422806|NCT04445155|593918104|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
164422807|NCT04445155|593918105|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
164422808|NCT04445155|593918106|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
164422809|NCT04191135|593918108|FG000|Induction Treatment|Not Treated|2|||
164422810|NCT04191135|593918109|FG001|Induction Treatment|Not Treated|0|||
164422811|NCT04191135|593918110|FG002|Induction Treatment|Not Treated|0|||
164422812|NCT04191135|593918108|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
164422813|NCT04191135|593918109|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
164422814|NCT04191135|593918110|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
164422815|NCT04191135|593918108|FG000|Induction Treatment|Adverse Event|25|||
164422816|NCT04191135|593918109|FG001|Induction Treatment|Adverse Event|0|||
164422817|NCT04191135|593918110|FG002|Induction Treatment|Adverse Event|0|||
164422818|NCT04191135|593918108|FG000|Induction Treatment|Clinical Progression|8|||
164422819|NCT04191135|593918109|FG001|Induction Treatment|Clinical Progression|0|||
164422820|NCT04191135|593918110|FG002|Induction Treatment|Clinical Progression|0|||
164422821|NCT04191135|593918108|FG000|Induction Treatment|Excluded Medication|1|||
164422822|NCT04191135|593918109|FG001|Induction Treatment|Excluded Medication|0|||
164422823|NCT04191135|593918110|FG002|Induction Treatment|Excluded Medication|0|||
164422824|NCT04191135|593918108|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
164422825|NCT04191135|593918109|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
164422826|NCT04191135|593918110|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
164422827|NCT04191135|593918108|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
164422828|NCT04191135|593918109|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
164422829|NCT04191135|593918110|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
164422830|NCT04191135|593918108|FG000|Induction Treatment|Physician Decision|2|||
164422831|NCT04191135|593918109|FG001|Induction Treatment|Physician Decision|0|||
164422832|NCT04191135|593918110|FG002|Induction Treatment|Physician Decision|0|||
164422833|NCT04191135|593918108|FG000|Induction Treatment|Progressive Disease|135|||
164422834|NCT04191135|593918109|FG001|Induction Treatment|Progressive Disease|0|||
164422835|NCT04191135|593918110|FG002|Induction Treatment|Progressive Disease|0|||
164422836|NCT04191135|593918108|FG000|Induction Treatment|Protocol Violation|10|||
164422837|NCT04191135|593918109|FG001|Induction Treatment|Protocol Violation|0|||
164422838|NCT04191135|593918110|FG002|Induction Treatment|Protocol Violation|0|||
164422839|NCT04191135|593918108|FG000|Induction Treatment|Withdrawal by Subject|4|||
164422840|NCT04191135|593918109|FG001|Induction Treatment|Withdrawal by Subject|0|||
164422841|NCT04191135|593918110|FG002|Induction Treatment|Withdrawal by Subject|0|||
164422842|NCT04191135|593918108|FG000|Randomized Treatment|Death|0|||
164422843|NCT04191135|593918109|FG001|Randomized Treatment|Death|50|||
164422844|NCT04191135|593918110|FG002|Randomized Treatment|Death|54|||
164422845|NCT04191135|593918108|FG000|Randomized Treatment|Lost to Follow-up|0|||
164422846|NCT04191135|593918109|FG001|Randomized Treatment|Lost to Follow-up|0|||
164422847|NCT04191135|593918110|FG002|Randomized Treatment|Lost to Follow-up|1|||
164422848|NCT04191135|593918108|FG000|Randomized Treatment|Withdrawal by Subject|0|||
164422849|NCT04191135|593918109|FG001|Randomized Treatment|Withdrawal by Subject|2|||
164422850|NCT04191135|593918110|FG002|Randomized Treatment|Withdrawal by Subject|0|||
164422851|NCT04191135|593918108|FG000|Randomized Treatment|Ongoing in Trial|0|||
164422852|NCT04191135|593918109|FG001|Randomized Treatment|Ongoing in Trial|83|||
164422853|NCT04191135|593918110|FG002|Randomized Treatment|Ongoing in Trial|81|||
164422854|NCT00394095|593919439|FG000|Screening|Withdrawal by Subject|1|||
164422855|NCT00394095|593919440|FG001|Screening|Withdrawal by Subject|0|||
164422856|NCT00394095|593919439|FG000|Randomized|Withdrawal by Subject|5|||
164233254|NCT04887831|593226017|FG001|Overall Study|Lost to Follow-up|1|||
164422857|NCT00394095|593919440|FG001|Randomized|Withdrawal by Subject|1|||
164233255|NCT04887831|593226016|FG000|Overall Study|Withdrawal by Subject|2|||
164422858|NCT00394095|593919439|FG000|Randomized|Adverse Event|1|||
164422859|NCT00394095|593919440|FG001|Randomized|Adverse Event|1|||
164422860|NCT00394095|593919439|FG000|Randomized|Overdose|1|||
164422861|NCT00394095|593919440|FG001|Randomized|Overdose|0|||
164422862|NCT00394095|593919439|FG000|Randomized|Lost to Follow-up|1|||
164422863|NCT00394095|593919440|FG001|Randomized|Lost to Follow-up|2|||
164422864|NCT02424344|593919441|FG000|Overall Study|Lack of Efficacy|0|||
164422865|NCT02424344|593919442|FG001|Overall Study|Lack of Efficacy|1|||
164422866|NCT02424344|593919441|FG000|Overall Study|Withdrawal by Subject|2|||
164233256|NCT04887831|593226017|FG001|Overall Study|Withdrawal by Subject|1|||
164233257|NCT04887831|593226016|FG000|Overall Study|Study Terminated by Sponsor|18|||
164233258|NCT04887831|593226017|FG001|Overall Study|Study Terminated by Sponsor|17|||
164233259|NCT04887831|593226016|FG000|Overall Study|Other|1|||
164233260|NCT04887831|593226017|FG001|Overall Study|Other|0|||
164233261|NCT03698279|593226018|FG000|Overall Study|Withdrawal by parent/guardian|1|||
164233262|NCT03698279|593226019|FG001|Overall Study|Withdrawal by parent/guardian|1|||
164233263|NCT03698279|593226020|FG002|Overall Study|Withdrawal by parent/guardian|1|||
164233264|NCT03698279|593226021|FG003|Overall Study|Withdrawal by parent/guardian|1|||
164233265|NCT03698279|593226022|FG004|Overall Study|Withdrawal by parent/guardian|0|||
164233266|NCT03698279|593226023|FG005|Overall Study|Withdrawal by parent/guardian|0|||
164233267|NCT03698279|593226018|FG000|Overall Study|Protocol deviation|1|||
164233268|NCT03698279|593226019|FG001|Overall Study|Protocol deviation|0|||
164233269|NCT03698279|593226020|FG002|Overall Study|Protocol deviation|1|||
164233270|NCT03698279|593226021|FG003|Overall Study|Protocol deviation|0|||
164233271|NCT03698279|593226022|FG004|Overall Study|Protocol deviation|0|||
164233272|NCT03698279|593226023|FG005|Overall Study|Protocol deviation|0|||
164233273|NCT03698279|593226018|FG000|Overall Study|Withdrawal by Subject|0|||
164233274|NCT03698279|593226019|FG001|Overall Study|Withdrawal by Subject|0|||
164233275|NCT03698279|593226020|FG002|Overall Study|Withdrawal by Subject|1|||
164233276|NCT03698279|593226021|FG003|Overall Study|Withdrawal by Subject|0|||
164233277|NCT03698279|593226022|FG004|Overall Study|Withdrawal by Subject|0|||
164233278|NCT03698279|593226023|FG005|Overall Study|Withdrawal by Subject|0|||
164233279|NCT03698279|593226018|FG000|Overall Study|Lost to Follow-up|3|||
164233280|NCT03698279|593226019|FG001|Overall Study|Lost to Follow-up|1|||
164233281|NCT03698279|593226020|FG002|Overall Study|Lost to Follow-up|4|||
164233282|NCT03698279|593226021|FG003|Overall Study|Lost to Follow-up|5|||
164233283|NCT03698279|593226022|FG004|Overall Study|Lost to Follow-up|0|||
164233284|NCT03698279|593226023|FG005|Overall Study|Lost to Follow-up|0|||
164233285|NCT02552225|593226024|FG000|Overall Study|Withdrawal by Subject|1|||
164233286|NCT02552225|593226025|FG001|Overall Study|Withdrawal by Subject|0|||
164233287|NCT03122184|593226029|FG000|Overall Study|Lost to Follow-up|4|||
164233288|NCT03122184|593226030|FG001|Overall Study|Lost to Follow-up|6|||
164233289|NCT03122184|593226029|FG000|Overall Study|Withdrawal by Subject|3|||
164233290|NCT03122184|593226030|FG001|Overall Study|Withdrawal by Subject|0|||
164233291|NCT03122184|593226029|FG000|Overall Study|Terminated due to cognitive problem|1|||
164233292|NCT03122184|593226030|FG001|Overall Study|Terminated due to cognitive problem|0|||
164233293|NCT02276040|593226033|FG000|Overall Study|Physician Decision|15|||
164233294|NCT00876447|593226034|FG000|Overall Study|Other miscellaneous reasons|3|||
164233295|NCT00876447|593226035|FG001|Overall Study|Other miscellaneous reasons|8|||
164233296|NCT00876447|593226034|FG000|Overall Study|Site closure|19|||
164233297|NCT00876447|593226035|FG001|Overall Study|Site closure|14|||
164233298|NCT00876447|593226034|FG000|Overall Study|Protocol Violation|9|||
164233299|NCT00876447|593226035|FG001|Overall Study|Protocol Violation|3|||
164233300|NCT00876447|593226034|FG000|Overall Study|Personal reasons|30|||
164233301|NCT00876447|593226035|FG001|Overall Study|Personal reasons|28|||
164233302|NCT00876447|593226034|FG000|Overall Study|Lost to Follow-up|6|||
164233303|NCT00876447|593226035|FG001|Overall Study|Lost to Follow-up|15|||
164233304|NCT00876447|593226034|FG000|Overall Study|Pregnancy|4|||
164233305|NCT00876447|593226035|FG001|Overall Study|Pregnancy|2|||
164233306|NCT00876447|593226034|FG000|Overall Study|Lack of Efficacy|5|||
164233307|NCT00876447|593226035|FG001|Overall Study|Lack of Efficacy|3|||
164233308|NCT00876447|593226034|FG000|Overall Study|Adverse Event|4|||
164233309|NCT00876447|593226035|FG001|Overall Study|Adverse Event|8|||
164233310|NCT00567502|593226036|FG000|Overall Study|Lost to Follow-up|91|||
164233311|NCT00567502|593226037|FG001|Overall Study|Lost to Follow-up|14|||
164233312|NCT00567502|593226038|FG002|Overall Study|Lost to Follow-up|351|||
164233313|NCT00567502|593226039|FG003|Overall Study|Lost to Follow-up|2|||
164233314|NCT00567502|593226036|FG000|Overall Study|Death|65|||
164333190|NCT03161093|593597363|FG003|Overall Study|Withdrawal by Subject|97|||
164333191|NCT03161093|593597364|FG004|Overall Study|Withdrawal by Subject|11|||
164333192|NCT03161093|593597365|FG005|Overall Study|Withdrawal by Subject|10|||
164333193|NCT03161093|593597360|FG000|Overall Study|Lost to Follow-up|3|||
164233315|NCT00567502|593226037|FG001|Overall Study|Death|16|||
164233316|NCT00567502|593226038|FG002|Overall Study|Death|360|||
164233317|NCT00567502|593226039|FG003|Overall Study|Death|5|||
164233318|NCT00567502|593226036|FG000|Overall Study|Other|64|||
164233319|NCT00567502|593226037|FG001|Overall Study|Other|2|||
164233320|NCT00567502|593226038|FG002|Overall Study|Other|134|||
164233321|NCT00567502|593226039|FG003|Overall Study|Other|6|||
164233322|NCT00567502|593226036|FG000|Overall Study|Participant request|12|||
164233323|NCT00567502|593226037|FG001|Overall Study|Participant request|1|||
164233324|NCT00567502|593226038|FG002|Overall Study|Participant request|33|||
164233325|NCT00567502|593226039|FG003|Overall Study|Participant request|1|||
164233326|NCT00567502|593226036|FG000|Overall Study|Sponsor request|9|||
164233327|NCT00567502|593226037|FG001|Overall Study|Sponsor request|0|||
164233328|NCT00567502|593226038|FG002|Overall Study|Sponsor request|30|||
164233329|NCT00567502|593226039|FG003|Overall Study|Sponsor request|1|||
164233330|NCT00567502|593226036|FG000|Overall Study|Never Initiated Treatment|0|||
164233331|NCT00567502|593226037|FG001|Overall Study|Never Initiated Treatment|0|||
164233332|NCT00567502|593226038|FG002|Overall Study|Never Initiated Treatment|0|||
164233333|NCT00567502|593226039|FG003|Overall Study|Never Initiated Treatment|72|||
164233334|NCT03728933|593226040|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
164233335|NCT03728933|593226041|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164233336|NCT03728933|593226042|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
164233337|NCT03728933|593226040|FG000|Overall Study|Withdrawal by Subject|0|||
164233338|NCT03728933|593226041|FG001|Overall Study|Withdrawal by Subject|0|||
164233339|NCT03728933|593226042|FG002|Overall Study|Withdrawal by Subject|1|||
164233340|NCT03728933|593226040|FG000|Overall Study|Lost to Follow-up|0|||
164233341|NCT03728933|593226041|FG001|Overall Study|Lost to Follow-up|1|||
164233342|NCT03728933|593226042|FG002|Overall Study|Lost to Follow-up|0|||
164233343|NCT03728933|593226040|FG000|Overall Study|Adverse Event|1|||
164233344|NCT03728933|593226041|FG001|Overall Study|Adverse Event|0|||
164233345|NCT03728933|593226042|FG002|Overall Study|Adverse Event|0|||
164233346|NCT02835690|593226043|FG000|Overall Study|Death|12|||
164233347|NCT02835690|593226044|FG001|Overall Study|Death|11|||
164233348|NCT02835690|593226045|FG002|Overall Study|Death|13|||
164233349|NCT02835690|593226043|FG000|Overall Study|Transferred to Extension Study|2|||
164233350|NCT02835690|593226044|FG001|Overall Study|Transferred to Extension Study|2|||
164233351|NCT02835690|593226045|FG002|Overall Study|Transferred to Extension Study|1|||
164233352|NCT02835690|593226043|FG000|Overall Study|Did Not Continue on Extension Study|0|||
164233353|NCT02835690|593226044|FG001|Overall Study|Did Not Continue on Extension Study|0|||
164233354|NCT02835690|593226045|FG002|Overall Study|Did Not Continue on Extension Study|1|||
164233355|NCT02835690|593226043|FG000|Overall Study|Not Treated|0|||
164233356|NCT02835690|593226044|FG001|Overall Study|Not Treated|2|||
164233357|NCT02835690|593226045|FG002|Overall Study|Not Treated|0|||
164233358|NCT02297516|593226046|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
164233359|NCT02297516|593226047|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
164233360|NCT02297516|593226046|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
164233361|NCT02297516|593226047|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
164233362|NCT02297516|593226046|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
164233363|NCT02297516|593226047|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
164233364|NCT03674281|593226048|FG000|Overall Study|screen failure|2|||
164233365|NCT03674281|593226049|FG001|Overall Study|screen failure|0|||
164233366|NCT03674281|593226050|FG002|Overall Study|screen failure|0|||
164233367|NCT03674281|593226048|FG000|Overall Study|Withdrawal by Subject|1|||
164233368|NCT03674281|593226049|FG001|Overall Study|Withdrawal by Subject|3|||
164233369|NCT03674281|593226050|FG002|Overall Study|Withdrawal by Subject|3|||
164233370|NCT00582907|593226053|FG000|1st Course|Withdrawal by Subject|1|||
164233371|NCT00582907|593226054|FG001|1st Course|Withdrawal by Subject|0|||
164233372|NCT00582907|593226055|FG002|1st Course|Withdrawal by Subject|0|||
164233373|NCT00582907|593226056|FG003|1st Course|Withdrawal by Subject|0|||
164233374|NCT00582907|593226053|FG000|1st Course|Lost to Follow-up|0|||
164233375|NCT00582907|593226054|FG001|1st Course|Lost to Follow-up|0|||
164233376|NCT00582907|593226055|FG002|1st Course|Lost to Follow-up|0|||
164233377|NCT00582907|593226056|FG003|1st Course|Lost to Follow-up|1|||
164233378|NCT00582907|593226053|FG000|2nd Course|Lack of Efficacy|1|||
164233379|NCT00582907|593226054|FG001|2nd Course|Lack of Efficacy|0|||
164233380|NCT00582907|593226055|FG002|2nd Course|Lack of Efficacy|0|||
164233381|NCT00582907|593226056|FG003|2nd Course|Lack of Efficacy|0|||
164333194|NCT03161093|593597361|FG001|Overall Study|Lost to Follow-up|12|||
164333195|NCT03161093|593597362|FG002|Overall Study|Lost to Follow-up|4|||
164333196|NCT03161093|593597363|FG003|Overall Study|Lost to Follow-up|7|||
164333197|NCT03161093|593597364|FG004|Overall Study|Lost to Follow-up|8|||
164333198|NCT03161093|593597365|FG005|Overall Study|Lost to Follow-up|13|||
164333199|NCT03161093|593597360|FG000|Overall Study|Death|3|||
164333200|NCT03161093|593597361|FG001|Overall Study|Death|9|||
164333201|NCT03161093|593597362|FG002|Overall Study|Death|7|||
164333202|NCT03161093|593597363|FG003|Overall Study|Death|9|||
164333203|NCT03161093|593597364|FG004|Overall Study|Death|0|||
164333204|NCT03161093|593597365|FG005|Overall Study|Death|0|||
164233382|NCT02538614|593226057|FG000|Overall Study|Progressive Disease|2|||
164233383|NCT00189423|593226064|FG000|Overall Study|Death|746|||
164233384|NCT00189423|593226065|FG001|Overall Study|Death|747|||
164233385|NCT00189423|593226064|FG000|Overall Study|Withdrawal by Subject|9|||
164233386|NCT00189423|593226065|FG001|Overall Study|Withdrawal by Subject|9|||
164233387|NCT00189423|593226064|FG000|Overall Study|Lost to Follow-up|10|||
164233388|NCT00189423|593226065|FG001|Overall Study|Lost to Follow-up|10|||
164233389|NCT04622592|593226066|FG000|Overall Study|Death|0|||
164233390|NCT04622592|593226067|FG001|Overall Study|Death|0|||
164233391|NCT04622592|593226068|FG002|Overall Study|Death|1|||
164233392|NCT04622592|593226069|FG003|Overall Study|Death|0|||
164233393|NCT04622592|593226070|FG004|Overall Study|Death|0|||
164233394|NCT04622592|593226071|FG005|Overall Study|Death|0|||
164233395|NCT04622592|593226072|FG006|Overall Study|Death|0|||
164233396|NCT04622592|593226073|FG007|Overall Study|Death|1|||
164233397|NCT04622592|593226066|FG000|Overall Study|Lost to Follow-up|0|||
164233398|NCT04622592|593226067|FG001|Overall Study|Lost to Follow-up|0|||
164233399|NCT04622592|593226068|FG002|Overall Study|Lost to Follow-up|0|||
164233400|NCT04622592|593226069|FG003|Overall Study|Lost to Follow-up|3|||
164233401|NCT04622592|593226070|FG004|Overall Study|Lost to Follow-up|1|||
164233402|NCT04622592|593226071|FG005|Overall Study|Lost to Follow-up|0|||
164233403|NCT04622592|593226072|FG006|Overall Study|Lost to Follow-up|2|||
164233404|NCT04622592|593226073|FG007|Overall Study|Lost to Follow-up|2|||
164233405|NCT04622592|593226066|FG000|Overall Study|Physician Decision|0|||
164233406|NCT04622592|593226067|FG001|Overall Study|Physician Decision|0|||
164233407|NCT04622592|593226068|FG002|Overall Study|Physician Decision|0|||
164233408|NCT04622592|593226069|FG003|Overall Study|Physician Decision|0|||
164233409|NCT04622592|593226070|FG004|Overall Study|Physician Decision|1|||
164233410|NCT04622592|593226071|FG005|Overall Study|Physician Decision|0|||
164233411|NCT04622592|593226072|FG006|Overall Study|Physician Decision|0|||
164233412|NCT04622592|593226073|FG007|Overall Study|Physician Decision|0|||
164233413|NCT04622592|593226066|FG000|Overall Study|Withdrawal by Subject|1|||
164233414|NCT04622592|593226067|FG001|Overall Study|Withdrawal by Subject|0|||
164233415|NCT04622592|593226068|FG002|Overall Study|Withdrawal by Subject|2|||
164233416|NCT04622592|593226069|FG003|Overall Study|Withdrawal by Subject|0|||
164233417|NCT04622592|593226070|FG004|Overall Study|Withdrawal by Subject|0|||
164233418|NCT04622592|593226071|FG005|Overall Study|Withdrawal by Subject|0|||
164233419|NCT04622592|593226072|FG006|Overall Study|Withdrawal by Subject|1|||
164233420|NCT04622592|593226073|FG007|Overall Study|Withdrawal by Subject|4|||
164233421|NCT04622592|593226066|FG000|Overall Study|Other than specified above|0|||
164233422|NCT04622592|593226067|FG001|Overall Study|Other than specified above|0|||
164233423|NCT04622592|593226068|FG002|Overall Study|Other than specified above|1|||
164233424|NCT04622592|593226069|FG003|Overall Study|Other than specified above|0|||
164233425|NCT04622592|593226070|FG004|Overall Study|Other than specified above|0|||
164233426|NCT04622592|593226071|FG005|Overall Study|Other than specified above|0|||
164233427|NCT04622592|593226072|FG006|Overall Study|Other than specified above|0|||
164233428|NCT04622592|593226073|FG007|Overall Study|Other than specified above|0|||
164233429|NCT00415636|593226074|FG000|Overall Study|Symptomatic deterioration|1|||
164233430|NCT00415636|593226075|FG001|Overall Study|Symptomatic deterioration|0|||
164233431|NCT00415636|593226076|FG002|Overall Study|Symptomatic deterioration|1|||
164233432|NCT00415636|593226077|FG003|Overall Study|Symptomatic deterioration|2|||
164233433|NCT00415636|593226078|FG004|Overall Study|Symptomatic deterioration|0|||
164233434|NCT00415636|593226079|FG005|Overall Study|Symptomatic deterioration|1|||
164233435|NCT00415636|593226074|FG000|Overall Study|Adverse Event|0|||
164233436|NCT00415636|593226075|FG001|Overall Study|Adverse Event|0|||
164233437|NCT00415636|593226076|FG002|Overall Study|Adverse Event|0|||
164233438|NCT00415636|593226077|FG003|Overall Study|Adverse Event|1|||
164233439|NCT00415636|593226078|FG004|Overall Study|Adverse Event|1|||
164233440|NCT00415636|593226079|FG005|Overall Study|Adverse Event|0|||
164233441|NCT00415636|593226074|FG000|Overall Study|Withdrawal by Subject|0|||
164233442|NCT00415636|593226075|FG001|Overall Study|Withdrawal by Subject|0|||
164233443|NCT00415636|593226076|FG002|Overall Study|Withdrawal by Subject|0|||
164233444|NCT00415636|593226077|FG003|Overall Study|Withdrawal by Subject|0|||
164233445|NCT00415636|593226078|FG004|Overall Study|Withdrawal by Subject|1|||
164233446|NCT00415636|593226079|FG005|Overall Study|Withdrawal by Subject|0|||
164233447|NCT00415636|593226074|FG000|Overall Study|Disease progression|0|||
164233448|NCT00415636|593226075|FG001|Overall Study|Disease progression|0|||
164233449|NCT00415636|593226076|FG002|Overall Study|Disease progression|0|||
164233450|NCT00415636|593226077|FG003|Overall Study|Disease progression|3|||
164233451|NCT00415636|593226078|FG004|Overall Study|Disease progression|0|||
164233452|NCT00415636|593226079|FG005|Overall Study|Disease progression|1|||
164233453|NCT01263119|593226080|FG000|Period 1|Protocol Violation|2|||
164233454|NCT01263119|593226080|FG000|Period 2|Adverse Event|2|||
164233455|NCT02138825|593226081|FG000|Main Study Treatment|Adverse Event|11|||
164233456|NCT02138825|593226082|FG001|Main Study Treatment|Adverse Event|3|||
164233457|NCT02138825|593226081|FG000|Main Study Treatment|Death|1|||
164233458|NCT02138825|593226082|FG001|Main Study Treatment|Death|2|||
164233459|NCT02138825|593226081|FG000|Main Study Treatment|Protocol Violation|2|||
164333205|NCT03161093|593597360|FG000|Overall Study|Unknown - Not reported|0|||
164333206|NCT03161093|593597361|FG001|Overall Study|Unknown - Not reported|1|||
164333207|NCT03161093|593597362|FG002|Overall Study|Unknown - Not reported|0|||
164233460|NCT02138825|593226082|FG001|Main Study Treatment|Protocol Violation|2|||
164233461|NCT02138825|593226081|FG000|Main Study Treatment|Sponsor decision|12|||
164233462|NCT02138825|593226082|FG001|Main Study Treatment|Sponsor decision|18|||
164233463|NCT02138825|593226081|FG000|Main Study Treatment|Study terminated by sponsor|10|||
164233464|NCT02138825|593226082|FG001|Main Study Treatment|Study terminated by sponsor|9|||
164233465|NCT02138825|593226081|FG000|Main Study Treatment|Withdrawal by Subject|3|||
164233466|NCT02138825|593226082|FG001|Main Study Treatment|Withdrawal by Subject|1|||
164233467|NCT02138825|593226081|FG000|Main Study Treatment|Medical decision|1|||
164233468|NCT02138825|593226082|FG001|Main Study Treatment|Medical decision|0|||
164233469|NCT02138825|593226081|FG000|Long-term Extension|Study termination by sponsor|32|||
164233470|NCT02138825|593226082|FG001|Long-term Extension|Study termination by sponsor|38|||
164233471|NCT02138825|593226081|FG000|Safety Follow-up|Adverse Event|4|||
164233472|NCT02138825|593226082|FG001|Safety Follow-up|Adverse Event|3|||
164572592|NCT00064701|594460390|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
164422867|NCT02424344|593919442|FG001|Overall Study|Withdrawal by Subject|1|||
164422868|NCT02424344|593919441|FG000|Overall Study|Lost to Follow-up|1|||
164422869|NCT02424344|593919442|FG001|Overall Study|Lost to Follow-up|0|||
164422870|NCT02424344|593919441|FG000|Overall Study|Adverse Event|4|||
164422871|NCT02424344|593919442|FG001|Overall Study|Adverse Event|8|||
164422872|NCT01174550|593919443|FG000|Overall Study|Death|75|||
164422873|NCT01174550|593919444|FG001|Overall Study|Death|74|||
164422874|NCT01174550|593919443|FG000|Overall Study|Lost to Follow-up|652|||
164422875|NCT01174550|593919444|FG001|Overall Study|Lost to Follow-up|510|||
164422876|NCT01174550|593919443|FG000|Overall Study|Withdrawal by Subject|543|||
164422877|NCT01174550|593919444|FG001|Overall Study|Withdrawal by Subject|289|||
164422878|NCT02123966|593919445|FG000|Overall Study|Intercurrent Illness|1|||
164422879|NCT01536262|593919446|FG000|Overall Study|Adverse Event|6|||
164422880|NCT01536262|593919447|FG001|Overall Study|Adverse Event|1|||
164422881|NCT01536262|593919448|FG002|Overall Study|Adverse Event|2|||
164422882|NCT01536262|593919446|FG000|Overall Study|Withdrawal by Subject|1|||
164422883|NCT01536262|593919447|FG001|Overall Study|Withdrawal by Subject|1|||
164422884|NCT01536262|593919448|FG002|Overall Study|Withdrawal by Subject|0|||
164422885|NCT01536262|593919446|FG000|Overall Study|Other than stated above|1|||
164422886|NCT01536262|593919447|FG001|Overall Study|Other than stated above|0|||
164422887|NCT01536262|593919448|FG002|Overall Study|Other than stated above|0|||
164422888|NCT01460381|593919452|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
164422889|NCT01460381|593919453|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
164422890|NCT01097655|593919454|FG000|Overall Study|Withdrawal by Subject|1|||
164422891|NCT01097655|593919454|FG000|Overall Study|Subject Documented Twice|1|||
164422892|NCT01097655|593919454|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
164422893|NCT02561455|593919455|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
164422894|NCT02561455|593919456|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
164422895|NCT02561455|593919457|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
164422896|NCT02561455|593919458|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
164422897|NCT02561455|593919455|FG000|Overall Study|Withdrawal by Subject|1|||
164422898|NCT02561455|593919456|FG001|Overall Study|Withdrawal by Subject|0|||
164422899|NCT02561455|593919457|FG002|Overall Study|Withdrawal by Subject|1|||
164422900|NCT02561455|593919458|FG003|Overall Study|Withdrawal by Subject|0|||
164422901|NCT02561455|593919455|FG000|Overall Study|Disease Progression|0|||
164422902|NCT02561455|593919456|FG001|Overall Study|Disease Progression|1|||
164422903|NCT02561455|593919457|FG002|Overall Study|Disease Progression|0|||
164422904|NCT02561455|593919458|FG003|Overall Study|Disease Progression|0|||
164422905|NCT03639675|593919459|FG000|Overall Study|Withdrawal by Subject|1|||
164422906|NCT01021332|593919460|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
164422907|NCT01021332|593919460|FG000|Overall Study|Adverse Event|43|||
164422908|NCT01021332|593919460|FG000|Overall Study|Lack of Efficacy|19|||
164422909|NCT01021332|593919460|FG000|Overall Study|Withdrawal of Consent|23|||
164422910|NCT01021332|593919460|FG000|Overall Study|Lost to Follow-up|4|||
164422911|NCT01021332|593919460|FG000|Overall Study|Protocol Violation|9|||
164422912|NCT01021332|593919460|FG000|Overall Study|Miscellaneous|3|||
164422913|NCT00826280|593919461|FG000|Overall Study|Randomized but drug not received|1|||
164422914|NCT00826280|593919462|FG001|Overall Study|Randomized but drug not received|0|||
164422915|NCT00826280|593919463|FG002|Overall Study|Randomized but drug not received|1|||
164422916|NCT00826280|593919461|FG000|Overall Study|Adverse Event|1|||
164422917|NCT00826280|593919462|FG001|Overall Study|Adverse Event|3|||
164422918|NCT00826280|593919463|FG002|Overall Study|Adverse Event|0|||
164422919|NCT00826280|593919461|FG000|Overall Study|Lost to Follow-up|0|||
164422920|NCT00826280|593919462|FG001|Overall Study|Lost to Follow-up|1|||
164422921|NCT00826280|593919463|FG002|Overall Study|Lost to Follow-up|0|||
164333208|NCT03161093|593597363|FG003|Overall Study|Unknown - Not reported|0|||
164333209|NCT03161093|593597364|FG004|Overall Study|Unknown - Not reported|0|||
164333210|NCT03161093|593597365|FG005|Overall Study|Unknown - Not reported|1|||
164333211|NCT00570765|593597366|FG000|DB Phase|Withdrawal by Subject|1|||
164333212|NCT00570765|593597367|FG001|DB Phase|Withdrawal by Subject|0|||
164333213|NCT00570765|593597368|FG002|DB Phase|Withdrawal by Subject|0|||
164333214|NCT00570765|593597369|FG003|DB Phase|Withdrawal by Subject|0|||
164422922|NCT00826280|593919461|FG000|Overall Study|Sponsor discontinued subject or study|1|||
164422923|NCT00826280|593919462|FG001|Overall Study|Sponsor discontinued subject or study|0|||
164422924|NCT00826280|593919463|FG002|Overall Study|Sponsor discontinued subject or study|0|||
164422925|NCT00826280|593919461|FG000|Overall Study|Reversible ischemic defect not present|43|||
164422926|NCT00826280|593919462|FG001|Overall Study|Reversible ischemic defect not present|40|||
164422927|NCT00826280|593919463|FG002|Overall Study|Reversible ischemic defect not present|44|||
164422928|NCT00826280|593919461|FG000|Overall Study|Interpretation Failure|1|||
164422929|NCT00826280|593919462|FG001|Overall Study|Interpretation Failure|0|||
164422930|NCT00826280|593919463|FG002|Overall Study|Interpretation Failure|0|||
164422931|NCT00826280|593919461|FG000|Overall Study|Machine Failure|1|||
164333215|NCT00570765|593597366|FG000|DB Phase|Protocol Violation|0|||
164422932|NCT00826280|593919462|FG001|Overall Study|Machine Failure|1|||
164333216|NCT00570765|593597367|FG001|DB Phase|Protocol Violation|1|||
164675940|NCT03290781|594836893|FG003|Overall Study|Site Terminated by Sponsor|1|||
164675941|NCT03290781|594836894|FG004|Overall Study|Site Terminated by Sponsor|0|||
164675942|NCT03290781|594836895|FG005|Overall Study|Site Terminated by Sponsor|0|||
164675943|NCT03290781|594836896|FG006|Overall Study|Site Terminated by Sponsor|0|||
164233473|NCT02138825|593226081|FG000|Safety Follow-up|Death|11|||
164675944|NCT03290781|594836890|FG000|Overall Study|Lost to Follow-up|0|||
164675945|NCT03290781|594836891|FG001|Overall Study|Lost to Follow-up|0|||
164675946|NCT03290781|594836892|FG002|Overall Study|Lost to Follow-up|0|||
164675947|NCT03290781|594836893|FG003|Overall Study|Lost to Follow-up|1|||
164675948|NCT03290781|594836894|FG004|Overall Study|Lost to Follow-up|0|||
164675949|NCT03290781|594836895|FG005|Overall Study|Lost to Follow-up|0|||
164675950|NCT03290781|594836896|FG006|Overall Study|Lost to Follow-up|0|||
164675951|NCT03290781|594836890|FG000|Overall Study|Protocol Deviation|2|||
164675952|NCT03290781|594836891|FG001|Overall Study|Protocol Deviation|0|||
164675953|NCT03290781|594836892|FG002|Overall Study|Protocol Deviation|0|||
164675954|NCT03290781|594836893|FG003|Overall Study|Protocol Deviation|1|||
164675955|NCT03290781|594836894|FG004|Overall Study|Protocol Deviation|0|||
164675956|NCT03290781|594836895|FG005|Overall Study|Protocol Deviation|0|||
164675957|NCT03290781|594836896|FG006|Overall Study|Protocol Deviation|0|||
164675958|NCT03290781|594836890|FG000|Overall Study|Disease Relapse|32|||
164675959|NCT03290781|594836891|FG001|Overall Study|Disease Relapse|5|||
164675960|NCT03290781|594836892|FG002|Overall Study|Disease Relapse|38|||
164675961|NCT03290781|594836893|FG003|Overall Study|Disease Relapse|7|||
164675962|NCT03290781|594836894|FG004|Overall Study|Disease Relapse|3|||
164675963|NCT03290781|594836895|FG005|Overall Study|Disease Relapse|1|||
164675964|NCT03290781|594836896|FG006|Overall Study|Disease Relapse|4|||
164675965|NCT03290781|594836890|FG000|Overall Study|Other|3|||
164675966|NCT03290781|594836891|FG001|Overall Study|Other|0|||
164675967|NCT03290781|594836892|FG002|Overall Study|Other|2|||
164675968|NCT03290781|594836893|FG003|Overall Study|Other|2|||
164675969|NCT03290781|594836894|FG004|Overall Study|Other|0|||
164675970|NCT03290781|594836895|FG005|Overall Study|Other|0|||
164675971|NCT03290781|594836896|FG006|Overall Study|Other|0|||
164675972|NCT02820350|594836913|FG000|Overall Study|Withdrawal by Subject|3|||
164675973|NCT02820350|594836913|FG000|Overall Study|Death|4|||
164675974|NCT03697109|594838020|FG000|Open-label (OL) Phase|Adverse Event|24|||
164675975|NCT03697109|594838021|FG001|Open-label (OL) Phase|Adverse Event|0|||
164675976|NCT03697109|594838022|FG002|Open-label (OL) Phase|Adverse Event|0|||
164675977|NCT03697109|594838020|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
164675978|NCT03697109|594838021|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
164675979|NCT03697109|594838022|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
164675980|NCT03697109|594838020|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
164675981|NCT03697109|594838021|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
164675982|NCT03697109|594838022|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
164675983|NCT03697109|594838020|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
164675984|NCT03697109|594838021|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
164675985|NCT03697109|594838022|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
164675986|NCT03697109|594838020|FG000|Open-label (OL) Phase|Physician Decision|2|||
164675987|NCT03697109|594838021|FG001|Open-label (OL) Phase|Physician Decision|0|||
164675988|NCT03697109|594838022|FG002|Open-label (OL) Phase|Physician Decision|0|||
164675989|NCT03697109|594838020|FG000|Open-label (OL) Phase|Death|2|||
164675990|NCT03697109|594838021|FG001|Open-label (OL) Phase|Death|0|||
164675991|NCT03697109|594838022|FG002|Open-label (OL) Phase|Death|0|||
164675992|NCT03697109|594838020|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
164675993|NCT03697109|594838021|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
164675994|NCT03697109|594838022|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
164422933|NCT00826280|593919463|FG002|Overall Study|Machine Failure|0|||
164675995|NCT03697109|594838020|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
164675996|NCT03697109|594838021|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
164675997|NCT03697109|594838022|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
164675998|NCT03697109|594838020|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
164675999|NCT03697109|594838021|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
164676000|NCT03697109|594838022|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
164676001|NCT02301975|594838025|FG000|Overall Study|Adverse Event|8|||
164676002|NCT02301975|594838026|FG001|Overall Study|Adverse Event|3|||
164676003|NCT02301975|594838027|FG002|Overall Study|Adverse Event|2|||
164676004|NCT02301975|594838025|FG000|Overall Study|Lack of Efficacy|1|||
164676005|NCT02301975|594838026|FG001|Overall Study|Lack of Efficacy|1|||
164676006|NCT02301975|594838027|FG002|Overall Study|Lack of Efficacy|1|||
164676007|NCT02301975|594838025|FG000|Overall Study|Protocol Violation|3|||
164676008|NCT02301975|594838026|FG001|Overall Study|Protocol Violation|5|||
164676009|NCT02301975|594838027|FG002|Overall Study|Protocol Violation|3|||
164676010|NCT02301975|594838025|FG000|Overall Study|Lost to Follow-up|0|||
164676011|NCT02301975|594838026|FG001|Overall Study|Lost to Follow-up|2|||
164676012|NCT02301975|594838027|FG002|Overall Study|Lost to Follow-up|2|||
164676013|NCT02301975|594838025|FG000|Overall Study|Physician Decision|4|||
164676014|NCT02301975|594838026|FG001|Overall Study|Physician Decision|2|||
164676015|NCT02301975|594838027|FG002|Overall Study|Physician Decision|3|||
164233474|NCT02138825|593226082|FG001|Safety Follow-up|Death|5|||
164233475|NCT02138825|593226081|FG000|Safety Follow-up|Withdrawal by Subject|5|||
164233476|NCT02138825|593226082|FG001|Safety Follow-up|Withdrawal by Subject|3|||
164233477|NCT02138825|593226081|FG000|Safety Follow-up|clinic worsening|1|||
164233478|NCT02138825|593226082|FG001|Safety Follow-up|clinic worsening|0|||
164233479|NCT02138825|593226081|FG000|Safety Follow-up|withdrawal by PI|1|||
164233480|NCT02138825|593226082|FG001|Safety Follow-up|withdrawal by PI|0|||
164233481|NCT02138825|593226081|FG000|Safety Follow-up|logistical difficulties|0|||
164233482|NCT02138825|593226082|FG001|Safety Follow-up|logistical difficulties|1|||
164233483|NCT02138825|593226081|FG000|Safety Follow-up|progressive disease|0|||
164233484|NCT02138825|593226082|FG001|Safety Follow-up|progressive disease|2|||
164233485|NCT02138825|593226081|FG000|Safety Follow-up|too unwell to attend the visit|0|||
164233486|NCT02138825|593226082|FG001|Safety Follow-up|too unwell to attend the visit|1|||
164233487|NCT02138825|593226081|FG000|Safety Follow-up|treatment unblinded|0|||
164233488|NCT02138825|593226082|FG001|Safety Follow-up|treatment unblinded|1|||
164233489|NCT02138825|593226081|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
164233490|NCT02138825|593226082|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
164233491|NCT01702298|593226088|FG000|Overall Study|Withdrawal by Subject|1|||
164233492|NCT00560508|593226092|FG000|12 Week Double-blind Period|Adverse Event|3|||
164233493|NCT00560508|593226093|FG001|12 Week Double-blind Period|Adverse Event|2|||
164233494|NCT00560508|593226092|FG000|12 Week Double-blind Period|Protocol Violation|1|||
164233495|NCT00560508|593226093|FG001|12 Week Double-blind Period|Protocol Violation|0|||
164233496|NCT00560508|593226092|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
164233497|NCT00560508|593226093|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
164233498|NCT00560508|593226092|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
164233499|NCT00560508|593226093|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
164233500|NCT00560508|593226092|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
164233501|NCT00560508|593226093|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
164233502|NCT00560508|593226092|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
164233503|NCT00560508|593226093|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
164233504|NCT00560508|593226092|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
164233505|NCT00560508|593226093|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
164233506|NCT01822925|593226098|FG000|Overall Study|Adverse Event|1|||
164333217|NCT00570765|593597368|FG002|DB Phase|Protocol Violation|0|||
164333218|NCT00570765|593597369|FG003|DB Phase|Protocol Violation|0|||
164333219|NCT00570765|593597366|FG000|DB Phase|Adverse Event|3|||
164333220|NCT00570765|593597367|FG001|DB Phase|Adverse Event|6|||
164333221|NCT00570765|593597368|FG002|DB Phase|Adverse Event|0|||
164333222|NCT00570765|593597369|FG003|DB Phase|Adverse Event|0|||
164333223|NCT00570765|593597366|FG000|DB Phase|Did Not Receive Study Drug|0|||
164333224|NCT00570765|593597367|FG001|DB Phase|Did Not Receive Study Drug|0|||
164333225|NCT00570765|593597368|FG002|DB Phase|Did Not Receive Study Drug|1|||
164333226|NCT00570765|593597369|FG003|DB Phase|Did Not Receive Study Drug|0|||
164333227|NCT00570765|593597366|FG000|LTSE Phase|Withdrawal by Subject|0|||
164333228|NCT00570765|593597367|FG001|LTSE Phase|Withdrawal by Subject|0|||
164333229|NCT00570765|593597368|FG002|LTSE Phase|Withdrawal by Subject|0|||
164333230|NCT00570765|593597369|FG003|LTSE Phase|Withdrawal by Subject|1|||
164333231|NCT00570765|593597366|FG000|LTSE Phase|Adverse Event|0|||
164333232|NCT00570765|593597367|FG001|LTSE Phase|Adverse Event|0|||
164333233|NCT00570765|593597368|FG002|LTSE Phase|Adverse Event|0|||
164333234|NCT00570765|593597369|FG003|LTSE Phase|Adverse Event|7|||
164333235|NCT00570765|593597366|FG000|LTSE Phase|Physician Decision|0|||
164333236|NCT00570765|593597367|FG001|LTSE Phase|Physician Decision|0|||
164333237|NCT00570765|593597368|FG002|LTSE Phase|Physician Decision|0|||
164333238|NCT00570765|593597369|FG003|LTSE Phase|Physician Decision|4|||
164333239|NCT01031706|593597370|FG000|Overall Study|Adverse Event|1|||
164333240|NCT01031706|593597371|FG001|Overall Study|Adverse Event|0|||
164422934|NCT00826280|593919461|FG000|Overall Study|One or more non-interpretable scan|0|||
164422935|NCT00826280|593919462|FG001|Overall Study|One or more non-interpretable scan|1|||
164676016|NCT02301975|594838025|FG000|Overall Study|Withdrawal by Subject|15|||
164676017|NCT02301975|594838026|FG001|Overall Study|Withdrawal by Subject|12|||
164676018|NCT02301975|594838027|FG002|Overall Study|Withdrawal by Subject|11|||
164233507|NCT01822925|593226099|FG001|Overall Study|Adverse Event|1|||
164233508|NCT01822925|593226100|FG002|Overall Study|Adverse Event|1|||
164233509|NCT01822925|593226101|FG003|Overall Study|Adverse Event|1|||
164233510|NCT01822925|593226098|FG000|Overall Study|Lost to Follow-up|0|||
164233511|NCT01822925|593226099|FG001|Overall Study|Lost to Follow-up|1|||
164233512|NCT01822925|593226100|FG002|Overall Study|Lost to Follow-up|0|||
164233513|NCT01822925|593226101|FG003|Overall Study|Lost to Follow-up|0|||
164233514|NCT01822925|593226098|FG000|Overall Study|Protocol Violation|1|||
164333241|NCT01031706|593597370|FG000|Overall Study|Withdrawal by Subject|1|||
164333242|NCT01031706|593597371|FG001|Overall Study|Withdrawal by Subject|1|||
164333243|NCT02124161|593597372|FG000|Overall Study|Other unspecified|0|||
164333244|NCT02124161|593597373|FG001|Overall Study|Other unspecified|1|||
164333245|NCT02124161|593597372|FG000|Overall Study|Death|1|||
164333246|NCT02124161|593597373|FG001|Overall Study|Death|0|||
164333247|NCT02124161|593597372|FG000|Overall Study|Protocol Violation|2|||
164333248|NCT02124161|593597373|FG001|Overall Study|Protocol Violation|1|||
164333249|NCT02124161|593597372|FG000|Overall Study|Withdrawal by Subject|1|||
164333250|NCT02124161|593597373|FG001|Overall Study|Withdrawal by Subject|2|||
164333251|NCT02124161|593597372|FG000|Overall Study|Adverse Event|2|||
164333252|NCT02124161|593597373|FG001|Overall Study|Adverse Event|0|||
164333253|NCT02124161|593597372|FG000|Overall Study|Does not meet entrance criteria|2|||
164333254|NCT02124161|593597373|FG001|Overall Study|Does not meet entrance criteria|3|||
164333255|NCT02124161|593597372|FG000|Overall Study|No longer meets eligibility criteria|5|||
164333256|NCT02124161|593597373|FG001|Overall Study|No longer meets eligibility criteria|4|||
164333257|NCT02124161|593597372|FG000|Overall Study|Lost to Follow-up|3|||
164333258|NCT02124161|593597373|FG001|Overall Study|Lost to Follow-up|4|||
164333259|NCT01669928|593597375|FG000|First Intervention|Withdrawal by Subject|3|||
164333260|NCT01669928|593597376|FG001|First Intervention|Withdrawal by Subject|5|||
164333261|NCT01954342|593597379|FG000|Overall Study|Missing data from 13-16week study visit|0|||
164333262|NCT01954342|593597380|FG001|Overall Study|Missing data from 13-16week study visit|0|||
164333263|NCT01954342|593597381|FG002|Overall Study|Missing data from 13-16week study visit|0|||
164333264|NCT01954342|593597382|FG003|Overall Study|Missing data from 13-16week study visit|1|||
164333265|NCT01954342|593597379|FG000|Overall Study|Miscarriage|0|||
164333266|NCT01954342|593597380|FG001|Overall Study|Miscarriage|0|||
164333267|NCT01954342|593597381|FG002|Overall Study|Miscarriage|0|||
164333268|NCT01954342|593597382|FG003|Overall Study|Miscarriage|3|||
164333269|NCT01954342|593597379|FG000|Overall Study|Lost to Follow-up|0|||
164333270|NCT01954342|593597380|FG001|Overall Study|Lost to Follow-up|0|||
164333271|NCT01954342|593597381|FG002|Overall Study|Lost to Follow-up|0|||
164333272|NCT01954342|593597382|FG003|Overall Study|Lost to Follow-up|5|||
164333273|NCT01954342|593597379|FG000|Overall Study|Preterm delivery|0|||
164333274|NCT01954342|593597380|FG001|Overall Study|Preterm delivery|0|||
164333275|NCT01954342|593597381|FG002|Overall Study|Preterm delivery|0|||
164333276|NCT01954342|593597382|FG003|Overall Study|Preterm delivery|3|||
164333277|NCT01954342|593597379|FG000|Overall Study|Pre-eclampsia|0|||
164572593|NCT00064701|594460391|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
164572594|NCT00064701|594460389|FG000|Clinical Continuation Phase|Physician Decision|1|||
164572595|NCT00064701|594460390|FG001|Clinical Continuation Phase|Physician Decision|3|||
164572596|NCT00064701|594460391|FG002|Clinical Continuation Phase|Physician Decision|0|||
164572597|NCT00064701|594460389|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
164572598|NCT00064701|594460390|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
164572599|NCT00064701|594460391|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
164572600|NCT00064701|594460389|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
164676019|NCT04278560|594838028|FG000|Overall Study|Adverse Event|1|||
164676020|NCT04278560|594838029|FG001|Overall Study|Adverse Event|2|||
164676021|NCT04278560|594838028|FG000|Overall Study|Withdrawal by Subject|0|||
164676022|NCT04278560|594838029|FG001|Overall Study|Withdrawal by Subject|1|||
164676023|NCT00163657|594838030|FG000|Overall Study|Death|12|||
164676024|NCT00163657|594838031|FG001|Overall Study|Death|14|||
164676025|NCT00163657|594838032|FG002|Overall Study|Death|19|||
164676026|NCT00163657|594838030|FG000|Overall Study|graft loss|4|||
164676027|NCT00163657|594838031|FG001|Overall Study|graft loss|1|||
164676028|NCT00163657|594838032|FG002|Overall Study|graft loss|2|||
164676029|NCT00163657|594838030|FG000|Overall Study|Withdrawal by Subject|2|||
164676030|NCT00163657|594838031|FG001|Overall Study|Withdrawal by Subject|3|||
164676031|NCT00163657|594838032|FG002|Overall Study|Withdrawal by Subject|2|||
164676032|NCT00163657|594838030|FG000|Overall Study|Physician Decision|0|||
164676033|NCT00163657|594838031|FG001|Overall Study|Physician Decision|1|||
164676034|NCT00163657|594838032|FG002|Overall Study|Physician Decision|1|||
164676035|NCT00163657|594838030|FG000|Overall Study|Non Compliance|1|||
164676036|NCT00163657|594838031|FG001|Overall Study|Non Compliance|0|||
164676037|NCT00163657|594838032|FG002|Overall Study|Non Compliance|0|||
164676038|NCT00163657|594838030|FG000|Overall Study|Lost to Follow-up|1|||
164676039|NCT00163657|594838031|FG001|Overall Study|Lost to Follow-up|3|||
164676040|NCT00163657|594838032|FG002|Overall Study|Lost to Follow-up|10|||
164676041|NCT00163657|594838030|FG000|Overall Study|Other reason|0|||
164676042|NCT00163657|594838031|FG001|Overall Study|Other reason|1|||
164676043|NCT00163657|594838032|FG002|Overall Study|Other reason|3|||
164676044|NCT02146105|594838033|FG000|Overall Study|Adverse Event|1|||
164333278|NCT01954342|593597380|FG001|Overall Study|Pre-eclampsia|0|||
164333279|NCT01954342|593597381|FG002|Overall Study|Pre-eclampsia|0|||
164333280|NCT01954342|593597382|FG003|Overall Study|Pre-eclampsia|4|||
164333281|NCT01954342|593597379|FG000|Overall Study|Unreliable Data|0|||
164333282|NCT01954342|593597380|FG001|Overall Study|Unreliable Data|0|||
164333283|NCT01954342|593597381|FG002|Overall Study|Unreliable Data|0|||
164333284|NCT01954342|593597382|FG003|Overall Study|Unreliable Data|2|||
164333285|NCT00984568|593597385|FG000|Overall Study|Withdrawal by Subject|1|||
164333286|NCT00984568|593597386|FG001|Overall Study|Withdrawal by Subject|2|||
164676045|NCT02146105|594838033|FG000|Overall Study|Withdrawal by Subject|5|||
164676046|NCT01319383|594838034|FG000|Overall Study|No ex vivo or in vivo response|4|||
164676047|NCT01319383|594838035|FG001|Overall Study|No ex vivo or in vivo response|0|||
164333287|NCT00984568|593597385|FG000|Overall Study|Lack of Efficacy|2|||
164333288|NCT00984568|593597386|FG001|Overall Study|Lack of Efficacy|0|||
164333289|NCT00984568|593597385|FG000|Overall Study|Adverse Event|2|||
164333290|NCT00984568|593597386|FG001|Overall Study|Adverse Event|0|||
164333291|NCT00984568|593597385|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
164333292|NCT00984568|593597386|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
164333293|NCT00984568|593597385|FG000|Overall Study|Lost to Follow-up|0|||
164333294|NCT00984568|593597386|FG001|Overall Study|Lost to Follow-up|1|||
164333295|NCT00984568|593597385|FG000|Overall Study|Opportunistic Infection|1|||
164676048|NCT01319383|594838034|FG000|Overall Study|Physician Decision|3|||
164676049|NCT01319383|594838035|FG001|Overall Study|Physician Decision|0|||
164676050|NCT01319383|594838034|FG000|Overall Study|Lack of Efficacy|5|||
164676051|NCT01319383|594838035|FG001|Overall Study|Lack of Efficacy|9|||
164676052|NCT01319383|594838034|FG000|Overall Study|No in vivo response to interval doses|0|||
164676053|NCT01319383|594838035|FG001|Overall Study|No in vivo response to interval doses|1|||
164676054|NCT01531894|594838038|FG000|Overall Study|Physician Decision|8|||
164676055|NCT01531894|594838038|FG000|Overall Study|Death|1|||
164676056|NCT03086460|594838039|FG000|Study Participants|Lost to Follow-up|2|||
164676057|NCT03086460|594838039|FG000|Study Participants|Protocol Violation|1|||
164676058|NCT03086460|594838039|FG000|Study Participants|Withdrawal by Subject|6|||
164676059|NCT03086460|594838039|FG000|Treatment A|Lost to Follow-up|1|||
164676060|NCT03086460|594838039|FG000|Treatment A|Protocol Violation|1|||
164676061|NCT03086460|594838039|FG000|Treatment A|Withdrawal by Subject|2|||
164676062|NCT03086460|594838039|FG000|Treatment C|Withdrawal by Subject|2|||
164676063|NCT03086460|594838039|FG000|Treatment E|Lost to Follow-up|1|||
164676064|NCT03086460|594838039|FG000|Treatment E|Withdrawal by Subject|3|||
164676065|NCT01735994|594838043|FG000|Overall Study|Withdrawal by Subject|6|||
164676066|NCT01735994|594838044|FG001|Overall Study|Withdrawal by Subject|4|||
164676067|NCT01735994|594838043|FG000|Overall Study|Injury|2|||
164676068|NCT01735994|594838044|FG001|Overall Study|Injury|0|||
164676069|NCT01735994|594838043|FG000|Overall Study|Kicked off team|5|||
164676070|NCT01735994|594838044|FG001|Overall Study|Kicked off team|0|||
164676071|NCT01735994|594838043|FG000|Overall Study|Lost to Follow-up|50|||
164676072|NCT01735994|594838044|FG001|Overall Study|Lost to Follow-up|62|||
164676073|NCT04994535|594838045|FG000|Overall Study|Lost to Follow-up|7|||
164676074|NCT04994535|594838046|FG001|Overall Study|Lost to Follow-up|7|||
164676075|NCT04994535|594838045|FG000|Overall Study|Withdrawal by Subject|10|||
164676076|NCT04994535|594838046|FG001|Overall Study|Withdrawal by Subject|7|||
164676077|NCT04994535|594838045|FG000|Overall Study|Other|1|||
164676078|NCT04994535|594838046|FG001|Overall Study|Other|1|||
164676079|NCT01158118|594838047|FG000|Overall Study|Screen failure|1|||
164676080|NCT01158118|594838048|FG001|Overall Study|Screen failure|0|||
164676081|NCT01158118|594838047|FG000|Overall Study|Donor match was a screen failure|0|||
164676082|NCT01158118|594838048|FG001|Overall Study|Donor match was a screen failure|1|||
164676083|NCT01158118|594838047|FG000|Overall Study|Suffered stroke prior to transplant|0|||
164676084|NCT01158118|594838048|FG001|Overall Study|Suffered stroke prior to transplant|1|||
164676085|NCT01158118|594838047|FG000|Overall Study|Death|0|||
164676086|NCT01158118|594838048|FG001|Overall Study|Death|1|||
164676087|NCT00604162|594838049|FG000|Overall Study|Physician Decision|3|||
164676088|NCT00604162|594838049|FG000|Overall Study|Withdrawal by Subject|1|||
164676089|NCT02246920|594838054|FG000|Overall Study|Adverse Event|3|||
164676090|NCT02246920|594838055|FG001|Overall Study|Adverse Event|1|||
164676091|NCT02246920|594838056|FG002|Overall Study|Adverse Event|1|||
164676092|NCT02246920|594838054|FG000|Overall Study|Lost to Follow-up|2|||
164676093|NCT02246920|594838055|FG001|Overall Study|Lost to Follow-up|1|||
164676094|NCT02246920|594838056|FG002|Overall Study|Lost to Follow-up|0|||
164676095|NCT02246920|594838054|FG000|Overall Study|Protocol Violation|2|||
164676096|NCT02246920|594838055|FG001|Overall Study|Protocol Violation|5|||
164676097|NCT02246920|594838056|FG002|Overall Study|Protocol Violation|1|||
164676098|NCT02246920|594838054|FG000|Overall Study|Withdrawal by Subject|0|||
164676099|NCT02246920|594838055|FG001|Overall Study|Withdrawal by Subject|0|||
164676100|NCT02246920|594838056|FG002|Overall Study|Withdrawal by Subject|1|||
164676101|NCT02902211|594838060|FG000|First Three Months|Withdrawal by Subject|7|||
164676102|NCT02902211|594838061|FG001|First Three Months|Withdrawal by Subject|3|||
164233515|NCT01822925|593226099|FG001|Overall Study|Protocol Violation|0|||
164233516|NCT01822925|593226100|FG002|Overall Study|Protocol Violation|0|||
164233517|NCT01822925|593226101|FG003|Overall Study|Protocol Violation|1|||
164233518|NCT01822925|593226098|FG000|Overall Study|Withdrawal by Subject|2|||
164233519|NCT01822925|593226099|FG001|Overall Study|Withdrawal by Subject|0|||
164233520|NCT01822925|593226100|FG002|Overall Study|Withdrawal by Subject|2|||
164233521|NCT01822925|593226101|FG003|Overall Study|Withdrawal by Subject|2|||
164233522|NCT01822925|593226098|FG000|Overall Study|Taking prohibited medication|2|||
164233523|NCT01822925|593226099|FG001|Overall Study|Taking prohibited medication|0|||
164233524|NCT01822925|593226100|FG002|Overall Study|Taking prohibited medication|0|||
164233525|NCT01822925|593226101|FG003|Overall Study|Taking prohibited medication|1|||
164233526|NCT03847519|593226102|FG000|Overall Study|Death|5|||
164233527|NCT03847519|593226103|FG001|Overall Study|Death|8|||
164676103|NCT00960297|594838062|FG000|Overall Study|Physician Decision|1|||
164233528|NCT03847519|593226104|FG002|Overall Study|Death|1|||
164233529|NCT03847519|593226102|FG000|Overall Study|Lost to Follow-up|1|||
164233530|NCT03847519|593226103|FG001|Overall Study|Lost to Follow-up|2|||
164233531|NCT03847519|593226104|FG002|Overall Study|Lost to Follow-up|0|||
164233532|NCT03847519|593226102|FG000|Overall Study|Study Terminated by Sponsor|0|||
164233533|NCT03847519|593226103|FG001|Overall Study|Study Terminated by Sponsor|3|||
164233534|NCT03847519|593226104|FG002|Overall Study|Study Terminated by Sponsor|2|||
164233535|NCT02300233|593226109|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
164233536|NCT02300233|593226110|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
164233537|NCT02300233|593226111|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
164233538|NCT02300233|593226109|FG000|Overall Study|Withdrawal by Subject|1|||
164233539|NCT02300233|593226110|FG001|Overall Study|Withdrawal by Subject|0|||
164233540|NCT02300233|593226111|FG002|Overall Study|Withdrawal by Subject|3|||
164233541|NCT02300233|593226109|FG000|Overall Study|Investigator Judgement|0|||
164233542|NCT02300233|593226110|FG001|Overall Study|Investigator Judgement|0|||
164233543|NCT02300233|593226111|FG002|Overall Study|Investigator Judgement|1|||
164233544|NCT02300233|593226109|FG000|Overall Study|Reason Not Specified|0|||
164233545|NCT02300233|593226110|FG001|Overall Study|Reason Not Specified|0|||
164233546|NCT02300233|593226111|FG002|Overall Study|Reason Not Specified|5|||
164233547|NCT00833690|593226112|FG000|Overall Study|Withdrawal by Subject|1|||
164233548|NCT00833690|593226113|FG001|Overall Study|Withdrawal by Subject|0|||
164233549|NCT00833690|593226114|FG002|Overall Study|Withdrawal by Subject|0|||
164233550|NCT00833690|593226112|FG000|Overall Study|Discontinued study drug|3|||
164233551|NCT00833690|593226113|FG001|Overall Study|Discontinued study drug|2|||
164233552|NCT00833690|593226114|FG002|Overall Study|Discontinued study drug|0|||
164233553|NCT02115321|593226115|FG000|Overall Study|Death|1|||
164233554|NCT02115321|593226116|FG001|Overall Study|Death|0|||
164233555|NCT04403919|593226117|FG000|Overall Study|Lost to Follow-up|0|||
164233556|NCT04403919|593226118|FG001|Overall Study|Lost to Follow-up|0|||
164233557|NCT04403919|593226119|FG002|Overall Study|Lost to Follow-up|0|||
164233558|NCT04403919|593226120|FG003|Overall Study|Lost to Follow-up|1|||
164233559|NCT03605693|593226121|FG000|Overall Study|Lost to Follow-up|4|||
164233560|NCT03605693|593226122|FG001|Overall Study|Lost to Follow-up|0|||
164233561|NCT03605693|593226121|FG000|Overall Study|Physician Decision|1|||
164233562|NCT03605693|593226122|FG001|Overall Study|Physician Decision|0|||
164233563|NCT04752566|593226123|FG000|Overall Study|Protocol Violation|0|||
164233564|NCT04752566|593226124|FG001|Overall Study|Protocol Violation|1|||
164233565|NCT04752566|593226123|FG000|Overall Study|Death|1|||
164233566|NCT04752566|593226124|FG001|Overall Study|Death|0|||
164233567|NCT04752566|593226123|FG000|Overall Study|Adverse Event|1|||
164233568|NCT04752566|593226124|FG001|Overall Study|Adverse Event|0|||
164676104|NCT00960297|594838062|FG000|Overall Study|Venous port infection|1|||
164233569|NCT04752566|593226123|FG000|Overall Study|Withdrawal by Subject|2|||
164233570|NCT04752566|593226124|FG001|Overall Study|Withdrawal by Subject|0|||
164233571|NCT04752566|593226123|FG000|Overall Study|Physician Decision|1|||
164233572|NCT04752566|593226124|FG001|Overall Study|Physician Decision|1|||
164333296|NCT00984568|593597386|FG001|Overall Study|Opportunistic Infection|0|||
164333297|NCT00984568|593597385|FG000|Overall Study|Unknown Reason|1|||
164333298|NCT00984568|593597386|FG001|Overall Study|Unknown Reason|3|||
164333299|NCT05085730|593597387|FG000|Overall Study|Withdrawal by Subject|4|||
164676105|NCT00960297|594838062|FG000|Overall Study|Disease progression|1|||
164676106|NCT03247972|594838063|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
164233573|NCT05134649|593226125|FG000|Overall Study|Lost to Follow-up|12|||
164233574|NCT05134649|593226125|FG000|Overall Study|Withdrawal by Subject|14|||
164233575|NCT05134649|593226125|FG000|Overall Study|Pregnancy|1|||
164233576|NCT05134649|593226125|FG000|Overall Study|Other, not specified|3|||
164233577|NCT04392154|593226128|FG000|Primary Treatment Period (100 Weeks)|Adverse Event|3|||
164233578|NCT04392154|593226129|FG001|Primary Treatment Period (100 Weeks)|Adverse Event|46|||
164233579|NCT04392154|593226130|FG002|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
164233580|NCT04392154|593226131|FG003|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
164233581|NCT04392154|593226128|FG000|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
164333300|NCT05085730|593597387|FG000|Overall Study|Physician Decision|1|||
164233582|NCT04392154|593226129|FG001|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|1|||
164233583|NCT04392154|593226130|FG002|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
164233584|NCT04392154|593226131|FG003|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
164233585|NCT04392154|593226128|FG000|Primary Treatment Period (100 Weeks)|Lack of Efficacy|1|||
164233586|NCT04392154|593226129|FG001|Primary Treatment Period (100 Weeks)|Lack of Efficacy|47|||
164233587|NCT04392154|593226130|FG002|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
164233588|NCT04392154|593226131|FG003|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
164233589|NCT04392154|593226128|FG000|Primary Treatment Period (100 Weeks)|Lost to Follow-up|11|||
164233590|NCT04392154|593226129|FG001|Primary Treatment Period (100 Weeks)|Lost to Follow-up|61|||
164233591|NCT04392154|593226130|FG002|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
164233592|NCT04392154|593226131|FG003|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
164233593|NCT04392154|593226128|FG000|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
164233594|NCT04392154|593226129|FG001|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
164233595|NCT04392154|593226130|FG002|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
164233596|NCT04392154|593226131|FG003|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
164233597|NCT04392154|593226128|FG000|Primary Treatment Period (100 Weeks)|Physician Decision|1|||
164233598|NCT04392154|593226129|FG001|Primary Treatment Period (100 Weeks)|Physician Decision|5|||
164233599|NCT04392154|593226130|FG002|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
164233600|NCT04392154|593226131|FG003|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
164233601|NCT04392154|593226128|FG000|Primary Treatment Period (100 Weeks)|Pregnancy|1|||
164233602|NCT04392154|593226129|FG001|Primary Treatment Period (100 Weeks)|Pregnancy|8|||
164233603|NCT04392154|593226130|FG002|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
164233604|NCT04392154|593226131|FG003|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
164233605|NCT04392154|593226128|FG000|Primary Treatment Period (100 Weeks)|Protocol deviation|1|||
164233606|NCT04392154|593226129|FG001|Primary Treatment Period (100 Weeks)|Protocol deviation|12|||
164233607|NCT04392154|593226130|FG002|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
164233608|NCT04392154|593226131|FG003|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
164233609|NCT04392154|593226128|FG000|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|18|||
164233610|NCT04392154|593226129|FG001|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|138|||
164233611|NCT04392154|593226130|FG002|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
164233612|NCT04392154|593226131|FG003|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
164233613|NCT04392154|593226128|FG000|Primary Treatment Period (100 Weeks)|Sponsor Decision|1|||
164233614|NCT04392154|593226129|FG001|Primary Treatment Period (100 Weeks)|Sponsor Decision|14|||
164233615|NCT04392154|593226130|FG002|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
164233616|NCT04392154|593226131|FG003|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
164233617|NCT04392154|593226128|FG000|Primary Treatment Period (100 Weeks)|Site Closure|0|||
164233618|NCT04392154|593226129|FG001|Primary Treatment Period (100 Weeks)|Site Closure|4|||
164233619|NCT04392154|593226130|FG002|Primary Treatment Period (100 Weeks)|Site Closure|0|||
164233620|NCT04392154|593226131|FG003|Primary Treatment Period (100 Weeks)|Site Closure|0|||
164233621|NCT04392154|593226128|FG000|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
164233622|NCT04392154|593226129|FG001|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
164233623|NCT04392154|593226130|FG002|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
164233624|NCT04392154|593226131|FG003|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|1|||
164233625|NCT04392154|593226128|FG000|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
164233626|NCT04392154|593226129|FG001|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
164233627|NCT04392154|593226130|FG002|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|1|||
164233628|NCT04392154|593226131|FG003|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
164233629|NCT04392154|593226128|FG000|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
164233630|NCT04392154|593226129|FG001|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
164233631|NCT04392154|593226130|FG002|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
164233632|NCT04392154|593226131|FG003|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|1|||
164233633|NCT00023595|593226134|FG000|5 Year Follow up|Lost to Follow-up|2|||
164233634|NCT00023595|593226135|FG001|5 Year Follow up|Lost to Follow-up|2|||
164233635|NCT00023595|593226136|FG002|5 Year Follow up|Lost to Follow-up|1|||
164233636|NCT00023595|593226137|FG003|5 Year Follow up|Lost to Follow-up|7|||
164233637|NCT00023595|593226138|FG004|5 Year Follow up|Lost to Follow-up|3|||
164572601|NCT00064701|594460390|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
164233638|NCT00023595|593226134|FG000|10 Year Follow up|Lost to Follow-up|12|||
164233639|NCT00023595|593226135|FG001|10 Year Follow up|Lost to Follow-up|10|||
164233640|NCT00023595|593226136|FG002|10 Year Follow up|Lost to Follow-up|3|||
164233641|NCT00023595|593226137|FG003|10 Year Follow up|Lost to Follow-up|0|||
164572602|NCT00064701|594460391|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
164572603|NCT00064701|594460389|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
164572604|NCT00064701|594460390|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
164422936|NCT00826280|593919463|FG002|Overall Study|One or more non-interpretable scan|1|||
164233642|NCT00023595|593226138|FG004|10 Year Follow up|Lost to Follow-up|0|||
164233643|NCT02106832|593226144|FG000|Overall Study|Adverse Event|1|||
164233644|NCT02106832|593226145|FG001|Overall Study|Adverse Event|2|||
164233645|NCT02106832|593226146|FG002|Overall Study|Adverse Event|3|||
164233646|NCT02106832|593226147|FG003|Overall Study|Adverse Event|0|||
164233647|NCT02106832|593226144|FG000|Overall Study|Death|4|||
164233648|NCT02106832|593226145|FG001|Overall Study|Death|4|||
164233649|NCT02106832|593226146|FG002|Overall Study|Death|1|||
164233650|NCT02106832|593226147|FG003|Overall Study|Death|4|||
164233651|NCT02106832|593226144|FG000|Overall Study|Deterioration of general conditions|0|||
164233652|NCT02106832|593226145|FG001|Overall Study|Deterioration of general conditions|0|||
164233653|NCT02106832|593226146|FG002|Overall Study|Deterioration of general conditions|1|||
164233654|NCT02106832|593226147|FG003|Overall Study|Deterioration of general conditions|0|||
164233655|NCT02106832|593226144|FG000|Overall Study|Lost to Follow-up|0|||
164233656|NCT02106832|593226145|FG001|Overall Study|Lost to Follow-up|1|||
164233657|NCT02106832|593226146|FG002|Overall Study|Lost to Follow-up|1|||
164233658|NCT02106832|593226147|FG003|Overall Study|Lost to Follow-up|3|||
164233659|NCT02106832|593226144|FG000|Overall Study|Physician Decision|1|||
164233660|NCT02106832|593226145|FG001|Overall Study|Physician Decision|0|||
164233661|NCT02106832|593226146|FG002|Overall Study|Physician Decision|0|||
164233662|NCT02106832|593226147|FG003|Overall Study|Physician Decision|0|||
164233663|NCT02106832|593226144|FG000|Overall Study|Protocol Violation|0|||
164233664|NCT02106832|593226145|FG001|Overall Study|Protocol Violation|0|||
164233665|NCT02106832|593226146|FG002|Overall Study|Protocol Violation|0|||
164233666|NCT02106832|593226147|FG003|Overall Study|Protocol Violation|1|||
164233667|NCT02106832|593226144|FG000|Overall Study|Withdrawal by Subject|17|||
164233668|NCT02106832|593226145|FG001|Overall Study|Withdrawal by Subject|17|||
164233669|NCT02106832|593226146|FG002|Overall Study|Withdrawal by Subject|10|||
164233670|NCT02106832|593226147|FG003|Overall Study|Withdrawal by Subject|7|||
164233671|NCT02106832|593226144|FG000|Overall Study|Technical problems|0|||
164233672|NCT02106832|593226145|FG001|Overall Study|Technical problems|1|||
164233673|NCT02106832|593226146|FG002|Overall Study|Technical problems|0|||
164233674|NCT02106832|593226147|FG003|Overall Study|Technical problems|0|||
164233675|NCT05205616|593226170|FG000|Overall Study|Lost to Follow-up|4|||
164233676|NCT05205616|593226171|FG001|Overall Study|Lost to Follow-up|4|||
164233677|NCT01467466|593226173|FG000|Overall Study|Withdrawal by Subject|15|||
164233678|NCT01467466|593226174|FG001|Overall Study|Withdrawal by Subject|18|||
164233679|NCT01467466|593226175|FG002|Overall Study|Withdrawal by Subject|13|||
164233680|NCT01467466|593226176|FG003|Overall Study|Withdrawal by Subject|11|||
164233681|NCT01467466|593226173|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
164233682|NCT01467466|593226174|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
164233683|NCT01467466|593226175|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
164233684|NCT01467466|593226176|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
164233685|NCT01467466|593226173|FG000|Overall Study|Procedure Cancelled|46|||
164233686|NCT01467466|593226174|FG001|Overall Study|Procedure Cancelled|45|||
164233687|NCT01467466|593226175|FG002|Overall Study|Procedure Cancelled|25|||
164233688|NCT01467466|593226176|FG003|Overall Study|Procedure Cancelled|29|||
164233689|NCT01467466|593226173|FG000|Overall Study|No Endpoint Blood Draw|38|||
164233690|NCT01467466|593226174|FG001|Overall Study|No Endpoint Blood Draw|32|||
164233691|NCT01467466|593226175|FG002|Overall Study|No Endpoint Blood Draw|51|||
164233692|NCT01467466|593226176|FG003|Overall Study|No Endpoint Blood Draw|43|||
164233693|NCT00787150|593226177|FG000|Overall Study|Adverse Event|4|||
164233694|NCT00787150|593226178|FG001|Overall Study|Adverse Event|4|||
164233695|NCT00787150|593226179|FG002|Overall Study|Adverse Event|4|||
164233696|NCT00787150|593226177|FG000|Overall Study|Physician Decision|1|||
164233697|NCT00787150|593226178|FG001|Overall Study|Physician Decision|2|||
164233698|NCT00787150|593226179|FG002|Overall Study|Physician Decision|1|||
164422937|NCT05343455|593919466|FG000|Overall Study|Withdrawal by Subject|4|||
164422938|NCT05343455|593919467|FG001|Overall Study|Withdrawal by Subject|9|||
164233699|NCT00787150|593226177|FG000|Overall Study|Withdrawal by Subject|2|||
164233700|NCT00787150|593226178|FG001|Overall Study|Withdrawal by Subject|1|||
164233701|NCT00787150|593226179|FG002|Overall Study|Withdrawal by Subject|0|||
164233702|NCT00787150|593226177|FG000|Overall Study|Dosing incorrect study durg|2|||
164233703|NCT00787150|593226178|FG001|Overall Study|Dosing incorrect study durg|0|||
164233704|NCT00787150|593226179|FG002|Overall Study|Dosing incorrect study durg|0|||
164233705|NCT00982280|593226187|FG000|Observation Period|Not eligible to be dosed|19|||
164233706|NCT00982280|593226187|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
164233707|NCT00982280|593226187|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
164233708|NCT00982280|593226187|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
164233709|NCT00982280|593226187|FG000|Maintenance Period|Adverse Event|1|||
164233710|NCT01979185|593226193|FG000|Period 2|Other|0|||
164233711|NCT01979185|593226194|FG001|Period 2|Other|1|||
164233712|NCT01121757|593226195|FG000|First Drug|Death|1|||
164233713|NCT01121757|593226196|FG001|First Drug|Death|0|||
164233714|NCT01121757|593226195|FG000|First Drug|Disease Progression|0|||
164233715|NCT01121757|593226196|FG001|First Drug|Disease Progression|2|||
164233716|NCT01121757|593226195|FG000|Combination|Physician Decision|0|||
164233717|NCT01121757|593226196|FG001|Combination|Physician Decision|1|||
164233718|NCT01121757|593226195|FG000|Combination|Disease Progression|2|||
164233719|NCT01121757|593226196|FG001|Combination|Disease Progression|0|||
164233720|NCT06028464|593226202|FG000|Washout|Positive drug test.|1|||
164233721|NCT03636022|593226203|FG000|Overall Study|Withdrawal by Subject|1|||
164233722|NCT03636022|593226204|FG001|Overall Study|Withdrawal by Subject|3|||
164233723|NCT03330847|593226205|FG000|Overall Study|Patients ongoing study|62|||
164233724|NCT03330847|593226206|FG001|Overall Study|Patients ongoing study|65|||
164233725|NCT03330847|593226207|FG002|Overall Study|Patients ongoing study|15|||
164233726|NCT01346592|593226210|FG000|Overall Study|Lost to Follow-up|62|||
164233727|NCT01346592|593226211|FG001|Overall Study|Lost to Follow-up|29|||
164233728|NCT01346592|593226212|FG002|Overall Study|Lost to Follow-up|29|||
164233729|NCT01346592|593226210|FG000|Overall Study|Protocol Violation|2|||
164233730|NCT01346592|593226211|FG001|Overall Study|Protocol Violation|1|||
164233731|NCT01346592|593226212|FG002|Overall Study|Protocol Violation|0|||
164233732|NCT01346592|593226210|FG000|Overall Study|Death|1|||
164233733|NCT01346592|593226211|FG001|Overall Study|Death|3|||
164233734|NCT01346592|593226212|FG002|Overall Study|Death|4|||
164333301|NCT01649804|593597388|FG000|Overall Study|Administrative/Other|8|||
164333302|NCT03845543|593597389|FG000|Overall Study|Death|25|||
164333303|NCT03845543|593597389|FG000|Overall Study|Withdrawal by Subject|2|||
164333304|NCT03845543|593597389|FG000|Overall Study|Lost to Follow-up|12|||
164333305|NCT03845543|593597389|FG000|Overall Study|Adverse Event|17|||
164333306|NCT01400815|593597390|FG000|Overall Study|Adverse Event|3|||
164333307|NCT01400815|593597391|FG001|Overall Study|Adverse Event|0|||
164333308|NCT01400815|593597390|FG000|Overall Study|Death|0|||
164333309|NCT01400815|593597391|FG001|Overall Study|Death|1|||
164333310|NCT01400815|593597390|FG000|Overall Study|Lost to Follow-up|18|||
164333311|NCT01400815|593597391|FG001|Overall Study|Lost to Follow-up|11|||
164333312|NCT01400815|593597390|FG000|Overall Study|Protocol Violation|0|||
164333313|NCT01400815|593597391|FG001|Overall Study|Protocol Violation|1|||
164333314|NCT01400815|593597390|FG000|Overall Study|Physician Decision|1|||
164333315|NCT01400815|593597391|FG001|Overall Study|Physician Decision|0|||
164333316|NCT01400815|593597390|FG000|Overall Study|Withdrawal by Subject|15|||
164333317|NCT01400815|593597391|FG001|Overall Study|Withdrawal by Subject|8|||
164333318|NCT01400815|593597390|FG000|Overall Study|Subject in jail|1|||
164333319|NCT01400815|593597391|FG001|Overall Study|Subject in jail|0|||
164333320|NCT01912963|593597397|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
164333321|NCT01912963|593597398|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
164333322|NCT01912963|593597399|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
164333323|NCT01912963|593597397|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
164333324|NCT01912963|593597398|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
164333325|NCT01912963|593597399|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
164333326|NCT01912963|593597397|FG000|Overall Study|Adverse Event|0|||
164333327|NCT01912963|593597398|FG001|Overall Study|Adverse Event|1|||
164333328|NCT01912963|593597399|FG002|Overall Study|Adverse Event|1|||
164333329|NCT01912963|593597397|FG000|Overall Study|Withdrawal by Subject|0|||
164333330|NCT01912963|593597398|FG001|Overall Study|Withdrawal by Subject|1|||
164333331|NCT01912963|593597399|FG002|Overall Study|Withdrawal by Subject|0|||
164333332|NCT01912963|593597397|FG000|Overall Study|Sought treatment locally|0|||
164333333|NCT01912963|593597398|FG001|Overall Study|Sought treatment locally|1|||
164333334|NCT01912963|593597399|FG002|Overall Study|Sought treatment locally|0|||
164333335|NCT01336569|593597403|FG000|Overall Study|Lost to Follow-up|4|||
164333336|NCT00406354|593597404|FG000|All Randomized Patients|Protocol Violation|0|||
164333337|NCT00406354|593597405|FG001|All Randomized Patients|Protocol Violation|0|||
164333338|NCT00406354|593597406|FG002|All Randomized Patients|Protocol Violation|1|||
164333339|NCT00406354|593597404|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
164333340|NCT00406354|593597405|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
164333341|NCT00406354|593597406|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
164572605|NCT00064701|594460391|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
164572606|NCT00064701|594460389|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
164233735|NCT01346592|593226210|FG000|Overall Study|Adverse Event|0|||
164233736|NCT01346592|593226211|FG001|Overall Study|Adverse Event|1|||
164233737|NCT01346592|593226212|FG002|Overall Study|Adverse Event|0|||
164233738|NCT01346592|593226210|FG000|Overall Study|Withdrawal by Subject|77|||
164233739|NCT01346592|593226211|FG001|Overall Study|Withdrawal by Subject|51|||
164233740|NCT01346592|593226212|FG002|Overall Study|Withdrawal by Subject|38|||
164233741|NCT01346592|593226210|FG000|Overall Study|Inappropriate enrollment|3|||
164333342|NCT00406354|593597404|FG000|All Randomized and Treated Patients|Adverse Event|6|||
164333343|NCT00406354|593597405|FG001|All Randomized and Treated Patients|Adverse Event|2|||
164333344|NCT00406354|593597406|FG002|All Randomized and Treated Patients|Adverse Event|1|||
164333345|NCT00406354|593597404|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
164333346|NCT00406354|593597405|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
164333347|NCT00406354|593597406|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
164233742|NCT01346592|593226211|FG001|Overall Study|Inappropriate enrollment|1|||
164233743|NCT01346592|593226212|FG002|Overall Study|Inappropriate enrollment|1|||
164233744|NCT01346592|593226210|FG000|Overall Study|Administrative reason|1|||
164233745|NCT01346592|593226211|FG001|Overall Study|Administrative reason|0|||
164233746|NCT01346592|593226212|FG002|Overall Study|Administrative reason|0|||
164233747|NCT01346592|593226210|FG000|Overall Study|Unable to Classify|7|||
164233748|NCT01346592|593226211|FG001|Overall Study|Unable to Classify|3|||
164233749|NCT01346592|593226212|FG002|Overall Study|Unable to Classify|6|||
164233750|NCT03557502|593226213|FG000|Protocol 2|Withdrawal by Subject|1|||
164233751|NCT03557502|593226214|FG001|Protocol 2|Withdrawal by Subject|1|||
164233752|NCT03557502|593226213|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
164233753|NCT03557502|593226214|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
164233754|NCT05819398|593226215|FG000|Overall Study|Withdrawal by Subject|11|||
164233755|NCT05819398|593226216|FG001|Overall Study|Withdrawal by Subject|7|||
164233756|NCT05819398|593226217|FG002|Overall Study|Withdrawal by Subject|6|||
164233757|NCT05819398|593226218|FG003|Overall Study|Withdrawal by Subject|6|||
164233758|NCT05819398|593226215|FG000|Overall Study|Lost to Follow-up|0|||
164233759|NCT05819398|593226216|FG001|Overall Study|Lost to Follow-up|2|||
164233760|NCT05819398|593226217|FG002|Overall Study|Lost to Follow-up|0|||
164233761|NCT05819398|593226218|FG003|Overall Study|Lost to Follow-up|1|||
164233762|NCT05819398|593226215|FG000|Overall Study|Adverse Event|1|||
164233763|NCT05819398|593226216|FG001|Overall Study|Adverse Event|3|||
164233764|NCT05819398|593226217|FG002|Overall Study|Adverse Event|4|||
164233765|NCT05819398|593226218|FG003|Overall Study|Adverse Event|5|||
164233766|NCT05819398|593226215|FG000|Overall Study|Other than listed|0|||
164233767|NCT05819398|593226216|FG001|Overall Study|Other than listed|2|||
164233768|NCT05819398|593226217|FG002|Overall Study|Other than listed|2|||
164233769|NCT05819398|593226218|FG003|Overall Study|Other than listed|0|||
164233770|NCT05819398|593226215|FG000|Overall Study|Lack of Efficacy|0|||
164233771|NCT05819398|593226216|FG001|Overall Study|Lack of Efficacy|1|||
164233772|NCT05819398|593226217|FG002|Overall Study|Lack of Efficacy|0|||
164233773|NCT05819398|593226218|FG003|Overall Study|Lack of Efficacy|0|||
164233774|NCT05819398|593226215|FG000|Overall Study|Study terminated by sponsor|20|||
164233775|NCT05819398|593226216|FG001|Overall Study|Study terminated by sponsor|18|||
164233776|NCT05819398|593226217|FG002|Overall Study|Study terminated by sponsor|20|||
164233777|NCT05819398|593226218|FG003|Overall Study|Study terminated by sponsor|22|||
164233778|NCT02520154|593226219|FG000|Overall Study|Death|1|||
164233779|NCT02520154|593226219|FG000|Overall Study|Withdrawal by Subject|2|||
164233780|NCT02520154|593226219|FG000|Overall Study|Physician Decision|2|||
164233781|NCT05943990|593226220|FG000|Overall Study|Study Terminated by Sponsor|0|||
164233782|NCT05943990|593226221|FG001|Overall Study|Study Terminated by Sponsor|0|||
164233783|NCT05943990|593226222|FG002|Overall Study|Study Terminated by Sponsor|1|||
164233784|NCT04696146|593227736|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
164233785|NCT04696146|593227737|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
164233786|NCT04696146|593227736|FG000|Overall Study|Off hours issue with product|1|||
164233787|NCT04696146|593227737|FG001|Overall Study|Off hours issue with product|0|||
164233788|NCT00276419|593227742|FG000|First Intervention|Adverse Event|1|||
164422939|NCT05343455|593919468|FG002|Overall Study|Withdrawal by Subject|7|||
164422940|NCT05343455|593919466|FG000|Overall Study|Adverse Event|2|||
164422941|NCT05343455|593919467|FG001|Overall Study|Adverse Event|1|||
164422942|NCT05343455|593919468|FG002|Overall Study|Adverse Event|2|||
164422943|NCT05343455|593919466|FG000|Overall Study|Lost to Follow-up|1|||
164422944|NCT05343455|593919467|FG001|Overall Study|Lost to Follow-up|1|||
164422945|NCT05343455|593919468|FG002|Overall Study|Lost to Follow-up|3|||
164422946|NCT05343455|593919466|FG000|Overall Study|Pregnancy|1|||
164422947|NCT05343455|593919467|FG001|Overall Study|Pregnancy|0|||
164422948|NCT05343455|593919468|FG002|Overall Study|Pregnancy|0|||
164422949|NCT05343455|593919466|FG000|Overall Study|Physician Decision|0|||
164422950|NCT05343455|593919467|FG001|Overall Study|Physician Decision|0|||
164422951|NCT05343455|593919468|FG002|Overall Study|Physician Decision|1|||
164422952|NCT05343455|593919466|FG000|Overall Study|Protocol Violation|0|||
164422953|NCT05343455|593919467|FG001|Overall Study|Protocol Violation|1|||
164572607|NCT00064701|594460390|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
164572608|NCT00064701|594460391|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
164422954|NCT05343455|593919468|FG002|Overall Study|Protocol Violation|1|||
164572609|NCT00064701|594460389|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
164233789|NCT00276419|593227743|FG001|First Intervention|Adverse Event|0|||
164233790|NCT00276419|593227742|FG000|First Intervention|Withdrawal by Subject|0|||
164233791|NCT00276419|593227743|FG001|First Intervention|Withdrawal by Subject|2|||
164233792|NCT03493958|593227744|FG000|Overall Study|Withdrawal by Subject|6|||
164233793|NCT03493958|593227744|FG000|Overall Study|Lost to Follow-up|7|||
164233794|NCT03493958|593227744|FG000|Overall Study|Did not complete all required study procedures|2|||
164233795|NCT02448381|593227747|FG000|Overall Study|Adverse Event|2|||
164233796|NCT02448381|593227748|FG001|Overall Study|Adverse Event|0|||
164233797|NCT02448381|593227747|FG000|Overall Study|Lost to Follow-up|16|||
164422955|NCT03354637|593919471|FG000|Double-blind Period|Protocol Violation|2|||
164422956|NCT03354637|593919472|FG001|Double-blind Period|Protocol Violation|0|||
164422957|NCT03354637|593919473|FG002|Double-blind Period|Protocol Violation|0|||
164422958|NCT03354637|593919471|FG000|Double-blind Period|Adverse Event|1|||
164422959|NCT03354637|593919472|FG001|Double-blind Period|Adverse Event|2|||
164422960|NCT03354637|593919473|FG002|Double-blind Period|Adverse Event|0|||
164233798|NCT02448381|593227748|FG001|Overall Study|Lost to Follow-up|9|||
164233799|NCT02448381|593227747|FG000|Overall Study|Physician Decision|1|||
164233800|NCT02448381|593227748|FG001|Overall Study|Physician Decision|1|||
164233801|NCT02448381|593227747|FG000|Overall Study|Pregnancy|1|||
164233802|NCT02448381|593227748|FG001|Overall Study|Pregnancy|0|||
164233803|NCT02448381|593227747|FG000|Overall Study|Withdrawal by Subject|13|||
164233804|NCT02448381|593227748|FG001|Overall Study|Withdrawal by Subject|9|||
164233805|NCT02448381|593227747|FG000|Overall Study|Noncompliance with Study Procedures|2|||
164233806|NCT02448381|593227748|FG001|Overall Study|Noncompliance with Study Procedures|0|||
164233807|NCT04617860|593227751|FG000|Overall Study|Adverse Event|0|||
164233808|NCT04617860|593227752|FG001|Overall Study|Adverse Event|2|||
164233809|NCT04617860|593227753|FG002|Overall Study|Adverse Event|2|||
164233810|NCT04617860|593227751|FG000|Overall Study|Withdrawal by Subject|0|||
164233811|NCT04617860|593227752|FG001|Overall Study|Withdrawal by Subject|0|||
164233812|NCT04617860|593227753|FG002|Overall Study|Withdrawal by Subject|2|||
164233813|NCT04617860|593227751|FG000|Overall Study|Physician Decision|0|||
164233814|NCT04617860|593227752|FG001|Overall Study|Physician Decision|1|||
164233815|NCT04617860|593227753|FG002|Overall Study|Physician Decision|0|||
164233816|NCT04617860|593227751|FG000|Overall Study|Sponsor Decision|0|||
164233817|NCT04617860|593227752|FG001|Overall Study|Sponsor Decision|3|||
164233818|NCT04617860|593227753|FG002|Overall Study|Sponsor Decision|1|||
164233819|NCT04617860|593227751|FG000|Overall Study|Termination of Study by Sponsor|8|||
164233820|NCT04617860|593227752|FG001|Overall Study|Termination of Study by Sponsor|4|||
164233821|NCT04617860|593227753|FG002|Overall Study|Termination of Study by Sponsor|13|||
164233822|NCT02735200|593227758|FG000|Overall Study|Lost to Follow-up|0|||
164233823|NCT02735200|593227759|FG001|Overall Study|Lost to Follow-up|5|||
164233824|NCT02735200|593227758|FG000|Overall Study|Withdrawal by Subject|8|||
164233825|NCT02735200|593227759|FG001|Overall Study|Withdrawal by Subject|0|||
164233826|NCT00619866|593227769|FG000|Weeks 1 - 12|Adverse Event|0|||
164233827|NCT00619866|593227770|FG001|Weeks 1 - 12|Adverse Event|1|||
164233828|NCT00619866|593227771|FG002|Weeks 1 - 12|Adverse Event|2|||
164233829|NCT00619866|593227772|FG003|Weeks 1 - 12|Adverse Event|0|||
164233830|NCT00619866|593227773|FG004|Weeks 1 - 12|Adverse Event|0|||
164233831|NCT00619866|593227769|FG000|Weeks 1 - 12|Non-compliance|0|||
164233832|NCT00619866|593227770|FG001|Weeks 1 - 12|Non-compliance|0|||
164233833|NCT00619866|593227771|FG002|Weeks 1 - 12|Non-compliance|1|||
164233834|NCT00619866|593227772|FG003|Weeks 1 - 12|Non-compliance|0|||
164233835|NCT00619866|593227773|FG004|Weeks 1 - 12|Non-compliance|0|||
164233836|NCT00619866|593227769|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
164233837|NCT00619866|593227770|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
164233838|NCT00619866|593227771|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
164233839|NCT00619866|593227772|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
164233840|NCT00619866|593227773|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
164233841|NCT00619866|593227769|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
164233842|NCT00619866|593227770|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
164233843|NCT00619866|593227771|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
164233844|NCT00619866|593227772|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
164233845|NCT00619866|593227773|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
164233846|NCT00619866|593227769|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
164233847|NCT00619866|593227770|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
164233848|NCT00619866|593227771|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
164572610|NCT00064701|594460390|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
164233849|NCT00619866|593227772|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
164233850|NCT00619866|593227773|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
164233851|NCT00619866|593227769|FG000|Weeks 1 - 12|Sponsor Decision|0|||
164233852|NCT00619866|593227770|FG001|Weeks 1 - 12|Sponsor Decision|1|||
164233853|NCT00619866|593227771|FG002|Weeks 1 - 12|Sponsor Decision|0|||
164233854|NCT00619866|593227772|FG003|Weeks 1 - 12|Sponsor Decision|0|||
164233855|NCT00619866|593227773|FG004|Weeks 1 - 12|Sponsor Decision|0|||
164233856|NCT00619866|593227769|FG000|Weeks 13 - 24|Adverse Event|0|||
164233857|NCT00619866|593227770|FG001|Weeks 13 - 24|Adverse Event|0|||
164572611|NCT00064701|594460391|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
164572612|NCT00064701|594460389|FG000|Clinical Continuation Phase|Patient opted out|0|||
164572613|NCT00064701|594460390|FG001|Clinical Continuation Phase|Patient opted out|0|||
164572614|NCT00064701|594460391|FG002|Clinical Continuation Phase|Patient opted out|1|||
164233858|NCT00619866|593227771|FG002|Weeks 13 - 24|Adverse Event|2|||
164233859|NCT00619866|593227772|FG003|Weeks 13 - 24|Adverse Event|1|||
164233860|NCT00619866|593227773|FG004|Weeks 13 - 24|Adverse Event|0|||
164233861|NCT00619866|593227769|FG000|Weeks 13 - 24|Protocol Deviation|0|||
164233862|NCT00619866|593227770|FG001|Weeks 13 - 24|Protocol Deviation|0|||
164233863|NCT00619866|593227771|FG002|Weeks 13 - 24|Protocol Deviation|0|||
164233864|NCT00619866|593227772|FG003|Weeks 13 - 24|Protocol Deviation|1|||
164233865|NCT00619866|593227773|FG004|Weeks 13 - 24|Protocol Deviation|0|||
164572615|NCT01818297|594460392|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
164233866|NCT00619866|593227769|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
164233867|NCT00619866|593227770|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
164233868|NCT00619866|593227771|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
164233869|NCT00619866|593227772|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
164233870|NCT00619866|593227773|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
164233871|NCT00619866|593227769|FG000|Weeks 13 - 24|Non-compliance|0|||
164233872|NCT00619866|593227770|FG001|Weeks 13 - 24|Non-compliance|1|||
164233873|NCT00619866|593227771|FG002|Weeks 13 - 24|Non-compliance|1|||
164233874|NCT00619866|593227772|FG003|Weeks 13 - 24|Non-compliance|0|||
164233875|NCT00619866|593227773|FG004|Weeks 13 - 24|Non-compliance|0|||
164233876|NCT00619866|593227769|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
164233877|NCT00619866|593227770|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
164233878|NCT00619866|593227771|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
164233879|NCT00619866|593227772|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
164233880|NCT00619866|593227773|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
164233881|NCT01656161|593227774|FG000|Overall Study|Death|3|||
164233882|NCT01656161|593227774|FG000|Overall Study|Adverse Event|2|||
164233883|NCT01656161|593227774|FG000|Overall Study|Protocol Violation|1|||
164233884|NCT01656161|593227774|FG000|Overall Study|Withdrawal by Subject|1|||
164233885|NCT03510273|593227779|FG000|Overall Study|Withdrawal by Subject|2|||
164233886|NCT03510273|593227779|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
164233887|NCT03510273|593227779|FG000|Overall Study|Moved away from study area|4|||
164233888|NCT02589938|593227783|FG000|Overall Study|Withdrawal by Subject|11|||
164233889|NCT02589938|593227784|FG001|Overall Study|Withdrawal by Subject|5|||
164233890|NCT02589938|593227785|FG002|Overall Study|Withdrawal by Subject|6|||
164233891|NCT02589938|593227783|FG000|Overall Study|Lost to Follow-up|3|||
164233892|NCT02589938|593227784|FG001|Overall Study|Lost to Follow-up|3|||
164233893|NCT02589938|593227785|FG002|Overall Study|Lost to Follow-up|3|||
164233894|NCT02589938|593227783|FG000|Overall Study|Death|1|||
164233895|NCT02589938|593227784|FG001|Overall Study|Death|0|||
164233896|NCT02589938|593227785|FG002|Overall Study|Death|1|||
164233897|NCT02589938|593227783|FG000|Overall Study|Protocol Violation|6|||
164233898|NCT02589938|593227784|FG001|Overall Study|Protocol Violation|2|||
164233899|NCT02589938|593227785|FG002|Overall Study|Protocol Violation|3|||
164233900|NCT02589938|593227783|FG000|Overall Study|Physician Decision|1|||
164233901|NCT02589938|593227784|FG001|Overall Study|Physician Decision|0|||
164233902|NCT02589938|593227785|FG002|Overall Study|Physician Decision|0|||
164233903|NCT02589938|593227783|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
164233904|NCT02589938|593227784|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
164233905|NCT02589938|593227785|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
164233906|NCT04716894|593227786|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
164233907|NCT04716894|593227786|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
164233908|NCT03773484|593227793|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
164233909|NCT04724837|593227794|FG000|Overall Study|Other|4|||
164233910|NCT04724837|593227795|FG001|Overall Study|Other|16|||
164233911|NCT04724837|593227796|FG002|Overall Study|Other|0|||
164233912|NCT04724837|593227794|FG000|Overall Study|Withdrawal by Subject|2|||
164233913|NCT04724837|593227795|FG001|Overall Study|Withdrawal by Subject|9|||
164233914|NCT04724837|593227796|FG002|Overall Study|Withdrawal by Subject|9|||
164233915|NCT04724837|593227794|FG000|Overall Study|Adverse Event|2|||
164233916|NCT04724837|593227795|FG001|Overall Study|Adverse Event|7|||
164233917|NCT04724837|593227796|FG002|Overall Study|Adverse Event|4|||
164233918|NCT04724837|593227794|FG000|Overall Study|Lost to Follow-up|0|||
164233919|NCT04724837|593227795|FG001|Overall Study|Lost to Follow-up|1|||
164422961|NCT03354637|593919471|FG000|Double-blind Period|Lost to Follow-up|3|||
164422962|NCT03354637|593919472|FG001|Double-blind Period|Lost to Follow-up|4|||
164422963|NCT03354637|593919473|FG002|Double-blind Period|Lost to Follow-up|3|||
164422964|NCT03354637|593919471|FG000|Double-blind Period|Withdrawal by Subject|10|||
164422965|NCT03354637|593919472|FG001|Double-blind Period|Withdrawal by Subject|6|||
164422966|NCT03354637|593919473|FG002|Double-blind Period|Withdrawal by Subject|4|||
164422967|NCT03354637|593919471|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
164422968|NCT03354637|593919472|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
164422969|NCT03354637|593919473|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
164233920|NCT04724837|593227796|FG002|Overall Study|Lost to Follow-up|3|||
164572616|NCT01818297|594460393|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
164572617|NCT01818297|594460392|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
164422970|NCT03354637|593919471|FG000|Open Label Extension|Adverse Event|0|||
164572618|NCT01818297|594460393|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
164233921|NCT04724837|593227794|FG000|Overall Study|Physician Decision|1|||
164233922|NCT04724837|593227795|FG001|Overall Study|Physician Decision|2|||
164233923|NCT04724837|593227796|FG002|Overall Study|Physician Decision|0|||
164233924|NCT04724837|593227794|FG000|Overall Study|Death|0|||
164233925|NCT04724837|593227795|FG001|Overall Study|Death|0|||
164233926|NCT04724837|593227796|FG002|Overall Study|Death|1|||
164233927|NCT04724837|593227794|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
164233928|NCT04724837|593227795|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
164233929|NCT04724837|593227796|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
164233930|NCT04724837|593227794|FG000|Overall Study|Study Terminated by Sponsor|0|||
164233931|NCT04724837|593227795|FG001|Overall Study|Study Terminated by Sponsor|1|||
164233932|NCT04724837|593227796|FG002|Overall Study|Study Terminated by Sponsor|0|||
164233933|NCT04222673|593227797|FG000|Overall Study|Lost to Follow-up|5|||
164233934|NCT03620981|593227808|FG000|Overall Study|Adverse Event|14|||
164233935|NCT03620981|593227809|FG001|Overall Study|Adverse Event|38|||
164233936|NCT03620981|593227810|FG002|Overall Study|Adverse Event|25|||
164233937|NCT03620981|593227808|FG000|Overall Study|Lack of Efficacy|2|||
164233938|NCT03620981|593227809|FG001|Overall Study|Lack of Efficacy|1|||
164233939|NCT03620981|593227810|FG002|Overall Study|Lack of Efficacy|1|||
164233940|NCT03620981|593227808|FG000|Overall Study|Physician Decision|7|||
164233941|NCT03620981|593227809|FG001|Overall Study|Physician Decision|4|||
164233942|NCT03620981|593227810|FG002|Overall Study|Physician Decision|4|||
164233943|NCT03620981|593227808|FG000|Overall Study|Protocol Violation|1|||
164233944|NCT03620981|593227809|FG001|Overall Study|Protocol Violation|2|||
164233945|NCT03620981|593227810|FG002|Overall Study|Protocol Violation|1|||
164233946|NCT03620981|593227808|FG000|Overall Study|Withdrawal by Legal Representative|2|||
164233947|NCT03620981|593227809|FG001|Overall Study|Withdrawal by Legal Representative|1|||
164233948|NCT03620981|593227810|FG002|Overall Study|Withdrawal by Legal Representative|1|||
164233949|NCT03620981|593227808|FG000|Overall Study|Withdrawal by Care Giver|2|||
164233950|NCT03620981|593227809|FG001|Overall Study|Withdrawal by Care Giver|0|||
164233951|NCT03620981|593227810|FG002|Overall Study|Withdrawal by Care Giver|1|||
164233952|NCT03620981|593227808|FG000|Overall Study|Non-compliance with Study Drug|1|||
164233953|NCT03620981|593227809|FG001|Overall Study|Non-compliance with Study Drug|1|||
164233954|NCT03620981|593227810|FG002|Overall Study|Non-compliance with Study Drug|0|||
164233955|NCT05852470|593227819|FG000|Overall Study|Withdrawal by Subject|0|||
164233956|NCT05852470|593227820|FG001|Overall Study|Withdrawal by Subject|1|||
164233957|NCT06071104|593227821|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
164233958|NCT02420717|593227826|FG000|Overall Study|Did not receive all study medication|2|||
164233959|NCT02420717|593227827|FG001|Overall Study|Did not receive all study medication|0|||
164233960|NCT02420717|593227828|FG002|Overall Study|Did not receive all study medication|0|||
164233961|NCT04116489|593227829|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
164233962|NCT04116489|593227829|FG000|Overall Study|Withdrawal by Subject|1|||
164233963|NCT03781570|593227830|FG000|Overall Study|Technical Issues (equipment failure)|31|||
164233964|NCT03781570|593227830|FG000|Overall Study|Withdrawal by Subject|7|||
164233965|NCT03781570|593227830|FG000|Overall Study|Physical Constraints|11|||
164233966|NCT03138564|593227831|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
164233967|NCT03138564|593227832|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
164233968|NCT03138564|593227831|FG000|Overall Study|Lost to Follow-up|16|||
164233969|NCT03138564|593227832|FG001|Overall Study|Lost to Follow-up|2|||
164233970|NCT03138564|593227831|FG000|Overall Study|Withdrawal by Subject|48|||
164233971|NCT03138564|593227832|FG001|Overall Study|Withdrawal by Subject|4|||
164233972|NCT03138564|593227831|FG000|Overall Study|No longer met eligibility criteria|2|||
164233973|NCT03138564|593227832|FG001|Overall Study|No longer met eligibility criteria|0|||
164233974|NCT03138564|593227831|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
164233975|NCT03138564|593227832|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
164233976|NCT03138564|593227831|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
164233977|NCT03138564|593227832|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
164233978|NCT03138564|593227831|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
164233979|NCT03138564|593227832|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
164233980|NCT03138564|593227831|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
164572619|NCT01818297|594460392|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
164572620|NCT01818297|594460393|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
164572621|NCT02949830|594460394|FG000|Overall Study|Adverse Event|1|||
164572622|NCT02949830|594460394|FG000|Overall Study|Withdrawal by Subject|1|||
164572623|NCT01628926|594460395|FG000|Overall Study|Adverse Event|13|||
164572624|NCT01628926|594460396|FG001|Overall Study|Adverse Event|11|||
164572625|NCT01628926|594460397|FG002|Overall Study|Adverse Event|9|||
164572626|NCT01628926|594460395|FG000|Overall Study|Lack of Efficacy|2|||
164572627|NCT01628926|594460396|FG001|Overall Study|Lack of Efficacy|1|||
164572628|NCT01628926|594460397|FG002|Overall Study|Lack of Efficacy|5|||
164233981|NCT03138564|593227832|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
164233982|NCT05177354|593227834|FG000|Implant to 30-day Visit|Physician Decision|1|||
164233983|NCT05177354|593227834|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
164233984|NCT05177354|593227834|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
164233985|NCT05177354|593227834|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
164233986|NCT02936323|593227835|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
164233987|NCT02936323|593227836|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
164233988|NCT02936323|593227837|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
164572629|NCT01628926|594460395|FG000|Overall Study|Withdrawal by Subject|6|||
164572630|NCT01628926|594460396|FG001|Overall Study|Withdrawal by Subject|4|||
164572631|NCT01628926|594460397|FG002|Overall Study|Withdrawal by Subject|2|||
164233989|NCT02936323|593227838|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
164233990|NCT02936323|593227839|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
164233991|NCT02936323|593227840|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
164233992|NCT02936323|593227841|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
164233993|NCT02936323|593227842|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
164233994|NCT02936323|593227843|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
164233995|NCT02936323|593227844|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
164233996|NCT02936323|593227835|FG000|Phase 1 Dose Escalation|Death|2|||
164233997|NCT02936323|593227836|FG001|Phase 1 Dose Escalation|Death|1|||
164233998|NCT02936323|593227837|FG002|Phase 1 Dose Escalation|Death|3|||
164233999|NCT02936323|593227838|FG003|Phase 1 Dose Escalation|Death|1|||
164234000|NCT02936323|593227839|FG004|Phase 1 Dose Escalation|Death|2|||
164234001|NCT02936323|593227840|FG005|Phase 1 Dose Escalation|Death|3|||
164234002|NCT02936323|593227841|FG006|Phase 1 Dose Escalation|Death|3|||
164234003|NCT02936323|593227842|FG007|Phase 1 Dose Escalation|Death|0|||
164234004|NCT02936323|593227843|FG008|Phase 1 Dose Escalation|Death|0|||
164234005|NCT02936323|593227844|FG009|Phase 1 Dose Escalation|Death|0|||
164234006|NCT02936323|593227835|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
164234007|NCT02936323|593227836|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
164234008|NCT02936323|593227837|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
164234009|NCT02936323|593227838|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
164234010|NCT02936323|593227839|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
164234011|NCT02936323|593227840|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
164234012|NCT02936323|593227841|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
164234013|NCT02936323|593227842|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
164234014|NCT02936323|593227843|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
164234015|NCT02936323|593227844|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
164234016|NCT02936323|593227835|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
164234017|NCT02936323|593227836|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
164234018|NCT02936323|593227837|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
164234019|NCT02936323|593227838|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
164234020|NCT02936323|593227839|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
164234021|NCT02936323|593227840|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
164234022|NCT02936323|593227841|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
164234023|NCT02936323|593227842|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
164234024|NCT02936323|593227843|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
164234025|NCT02936323|593227844|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
164234026|NCT02936323|593227835|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
164234027|NCT02936323|593227836|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
164572632|NCT01628926|594460395|FG000|Overall Study|Protocol Violation|0|||
164234028|NCT02936323|593227837|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
164234029|NCT02936323|593227838|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
164234030|NCT02936323|593227839|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
164234031|NCT02936323|593227840|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
164234032|NCT02936323|593227841|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
164234033|NCT02936323|593227842|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
164234034|NCT02936323|593227843|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
164234035|NCT02936323|593227844|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
164572633|NCT01628926|594460396|FG001|Overall Study|Protocol Violation|1|||
164572634|NCT01628926|594460397|FG002|Overall Study|Protocol Violation|0|||
164572635|NCT01628926|594460395|FG000|Overall Study|Discontinuation criteria|3|||
164572636|NCT01628926|594460396|FG001|Overall Study|Discontinuation criteria|4|||
164572637|NCT01628926|594460397|FG002|Overall Study|Discontinuation criteria|0|||
164572638|NCT01628926|594460395|FG000|Overall Study|Physician Decision|2|||
164572639|NCT01628926|594460396|FG001|Overall Study|Physician Decision|2|||
164572640|NCT01628926|594460397|FG002|Overall Study|Physician Decision|1|||
164572641|NCT03029832|594460398|FG000|Overall Study|Safety Follow-Up Completed|2|||
164572642|NCT03029832|594460399|FG001|Overall Study|Safety Follow-Up Completed|0|||
164572643|NCT03029832|594460398|FG000|Overall Study|Death due to Disease Progression|1|||
164572644|NCT03029832|594460399|FG001|Overall Study|Death due to Disease Progression|0|||
164234036|NCT02936323|593227835|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
164234037|NCT02936323|593227836|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
164234038|NCT02936323|593227837|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
164234039|NCT02936323|593227838|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
164572645|NCT03029832|594460398|FG000|Overall Study|Study Terminated By Sponsor|1|||
164234040|NCT02936323|593227839|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
164234041|NCT02936323|593227840|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
164234042|NCT02936323|593227841|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
164572646|NCT03029832|594460399|FG001|Overall Study|Study Terminated By Sponsor|1|||
164572647|NCT04373460|594460400|FG000|Overall Study|Did not receive tranfusion|18|||
164572648|NCT04373460|594460401|FG001|Overall Study|Did not receive tranfusion|26|||
164572649|NCT01672957|594460402|FG000|Overall Study|Protocol Violation|48|||
164234043|NCT02936323|593227842|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
164234044|NCT02936323|593227843|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
164234045|NCT02936323|593227844|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
164234046|NCT02936323|593227835|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
164234047|NCT02936323|593227836|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
164234048|NCT02936323|593227837|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
164234049|NCT02936323|593227838|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
164234050|NCT02936323|593227839|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
164234051|NCT02936323|593227840|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
164234052|NCT02936323|593227841|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
164234053|NCT02936323|593227842|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
164234054|NCT02936323|593227843|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
164234055|NCT02936323|593227844|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
164234056|NCT02936323|593227835|FG000|Phase 2a Dose Expansion|Death|0|||
164234057|NCT02936323|593227836|FG001|Phase 2a Dose Expansion|Death|0|||
164234058|NCT02936323|593227837|FG002|Phase 2a Dose Expansion|Death|0|||
164234059|NCT02936323|593227838|FG003|Phase 2a Dose Expansion|Death|0|||
164234060|NCT02936323|593227839|FG004|Phase 2a Dose Expansion|Death|0|||
164234061|NCT02936323|593227840|FG005|Phase 2a Dose Expansion|Death|0|||
164234062|NCT02936323|593227841|FG006|Phase 2a Dose Expansion|Death|0|||
164234063|NCT02936323|593227842|FG007|Phase 2a Dose Expansion|Death|4|||
164234064|NCT02936323|593227843|FG008|Phase 2a Dose Expansion|Death|8|||
164234065|NCT02936323|593227844|FG009|Phase 2a Dose Expansion|Death|10|||
164234066|NCT06272383|593227845|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
164234067|NCT06272383|593227846|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
164234068|NCT05715827|593227847|FG000|Overall Study|Physician Decision|0|||
164234069|NCT05715827|593227848|FG001|Overall Study|Physician Decision|1|||
164234070|NCT05715827|593227847|FG000|Overall Study|console communication error|0|||
164234071|NCT05715827|593227848|FG001|Overall Study|console communication error|1|||
164234072|NCT04846868|593227849|FG000|Overall Study|Adverse Event|12|||
164234073|NCT04846868|593227850|FG001|Overall Study|Adverse Event|11|||
164234074|NCT04846868|593227849|FG000|Overall Study|Protocol deviation|6|||
164234075|NCT04846868|593227850|FG001|Overall Study|Protocol deviation|2|||
164234076|NCT04846868|593227849|FG000|Overall Study|Perceived lack of efficacy|3|||
164234077|NCT04846868|593227850|FG001|Overall Study|Perceived lack of efficacy|2|||
164234078|NCT04846868|593227849|FG000|Overall Study|Change of residence|2|||
164234079|NCT04846868|593227850|FG001|Overall Study|Change of residence|3|||
164234080|NCT04846868|593227849|FG000|Overall Study|Burden of study procedures|1|||
164234081|NCT04846868|593227850|FG001|Overall Study|Burden of study procedures|1|||
164234082|NCT04846868|593227849|FG000|Overall Study|No reason available|2|||
164234083|NCT04846868|593227850|FG001|Overall Study|No reason available|5|||
164422971|NCT03354637|593919472|FG001|Open Label Extension|Adverse Event|0|||
164422972|NCT03354637|593919473|FG002|Open Label Extension|Adverse Event|1|||
164422973|NCT03354637|593919471|FG000|Open Label Extension|Lost to Follow-up|0|||
164422974|NCT03354637|593919472|FG001|Open Label Extension|Lost to Follow-up|0|||
164422975|NCT03354637|593919473|FG002|Open Label Extension|Lost to Follow-up|2|||
164422976|NCT03354637|593919471|FG000|Open Label Extension|Withdrawal by Subject|0|||
164234084|NCT04846868|593227849|FG000|Overall Study|Other reason listed|20|||
164234085|NCT04846868|593227850|FG001|Overall Study|Other reason listed|10|||
164234086|NCT04846868|593227849|FG000|Overall Study|Not treated|0|||
164234087|NCT04846868|593227850|FG001|Overall Study|Not treated|1|||
164234088|NCT04398706|593227851|FG000|Overall Study|Adverse Event|0|||
164234089|NCT04398706|593227852|FG001|Overall Study|Adverse Event|0|||
164234090|NCT04398706|593227853|FG002|Overall Study|Adverse Event|0|||
164234091|NCT04398706|593227854|FG003|Overall Study|Adverse Event|0|||
164234092|NCT04398706|593227855|FG004|Overall Study|Adverse Event|0|||
164234093|NCT04398706|593227856|FG005|Overall Study|Adverse Event|1|||
164234094|NCT04398706|593227857|FG006|Overall Study|Adverse Event|1|||
164572650|NCT01672957|594460402|FG000|Overall Study|Death|2|||
164572651|NCT01672957|594460402|FG000|Overall Study|ICF Signed After Transplantation|5|||
164572652|NCT01795547|594460405|FG000|Overall Study|Adverse Event|16|||
164572653|NCT01795547|594460406|FG001|Overall Study|Adverse Event|27|||
164572654|NCT01795547|594460405|FG000|Overall Study|Lack of Efficacy|8|||
164572655|NCT01795547|594460406|FG001|Overall Study|Lack of Efficacy|3|||
164572656|NCT01795547|594460405|FG000|Overall Study|Protocol Violation|6|||
164422977|NCT03354637|593919472|FG001|Open Label Extension|Withdrawal by Subject|0|||
164572657|NCT01795547|594460406|FG001|Overall Study|Protocol Violation|4|||
164572658|NCT01795547|594460405|FG000|Overall Study|Lost to Follow-up|2|||
164572659|NCT01795547|594460406|FG001|Overall Study|Lost to Follow-up|5|||
164234095|NCT04398706|593227858|FG007|Overall Study|Adverse Event|0|||
164234096|NCT04398706|593227851|FG000|Overall Study|Lost to Follow-up|0|||
164234097|NCT04398706|593227852|FG001|Overall Study|Lost to Follow-up|1|||
164234098|NCT04398706|593227853|FG002|Overall Study|Lost to Follow-up|2|||
164422978|NCT03354637|593919473|FG002|Open Label Extension|Withdrawal by Subject|5|||
164572660|NCT01795547|594460405|FG000|Overall Study|Withdrawal of consent|7|||
164234099|NCT04398706|593227854|FG003|Overall Study|Lost to Follow-up|1|||
164676107|NCT03247972|594838063|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
164676108|NCT00968812|594838064|FG000|Overall Study|Adverse Event|30|||
164676109|NCT00968812|594838065|FG001|Overall Study|Adverse Event|46|||
164676110|NCT00968812|594838066|FG002|Overall Study|Adverse Event|33|||
164676111|NCT00968812|594838064|FG000|Overall Study|Death|2|||
164676112|NCT00968812|594838065|FG001|Overall Study|Death|2|||
164676113|NCT00968812|594838066|FG002|Overall Study|Death|1|||
164676114|NCT00968812|594838064|FG000|Overall Study|Lack of Efficacy|9|||
164676115|NCT00968812|594838065|FG001|Overall Study|Lack of Efficacy|7|||
164676116|NCT00968812|594838066|FG002|Overall Study|Lack of Efficacy|16|||
164676117|NCT00968812|594838064|FG000|Overall Study|Lost to Follow-up|17|||
164234100|NCT04398706|593227855|FG004|Overall Study|Lost to Follow-up|6|||
164234101|NCT04398706|593227856|FG005|Overall Study|Lost to Follow-up|3|||
164234102|NCT04398706|593227857|FG006|Overall Study|Lost to Follow-up|8|||
164234103|NCT04398706|593227858|FG007|Overall Study|Lost to Follow-up|2|||
164234104|NCT04398706|593227851|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164234105|NCT04398706|593227852|FG001|Overall Study|Withdrawal by parent/guardian|2|||
164234106|NCT04398706|593227853|FG002|Overall Study|Withdrawal by parent/guardian|1|||
164234107|NCT04398706|593227854|FG003|Overall Study|Withdrawal by parent/guardian|2|||
164234108|NCT04398706|593227855|FG004|Overall Study|Withdrawal by parent/guardian|19|||
164234109|NCT04398706|593227856|FG005|Overall Study|Withdrawal by parent/guardian|23|||
164234110|NCT04398706|593227857|FG006|Overall Study|Withdrawal by parent/guardian|13|||
164234111|NCT04398706|593227858|FG007|Overall Study|Withdrawal by parent/guardian|11|||
164234112|NCT04398706|593227851|FG000|Overall Study|Protocol deviation|0|||
164234113|NCT04398706|593227852|FG001|Overall Study|Protocol deviation|1|||
164234114|NCT04398706|593227853|FG002|Overall Study|Protocol deviation|0|||
164234115|NCT04398706|593227854|FG003|Overall Study|Protocol deviation|0|||
164234116|NCT04398706|593227855|FG004|Overall Study|Protocol deviation|6|||
164234117|NCT04398706|593227856|FG005|Overall Study|Protocol deviation|4|||
164422979|NCT03354637|593919471|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
164234118|NCT04398706|593227857|FG006|Overall Study|Protocol deviation|6|||
164234119|NCT04398706|593227858|FG007|Overall Study|Protocol deviation|3|||
164234120|NCT04890509|593227859|FG000|Overall Study|Death|4|||
164234121|NCT04890509|593227860|FG001|Overall Study|Death|4|||
164422980|NCT03354637|593919472|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
164422981|NCT03354637|593919473|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
164422982|NCT03354637|593919471|FG000|Open Label Extension|Subject Noncompliance|0|||
164422983|NCT03354637|593919472|FG001|Open Label Extension|Subject Noncompliance|0|||
164422984|NCT03354637|593919473|FG002|Open Label Extension|Subject Noncompliance|1|||
164422985|NCT03354637|593919471|FG000|Open Label Extension|Lack of Efficacy|0|||
164422986|NCT03354637|593919472|FG001|Open Label Extension|Lack of Efficacy|0|||
164422987|NCT03354637|593919473|FG002|Open Label Extension|Lack of Efficacy|1|||
164676118|NCT00968812|594838065|FG001|Overall Study|Lost to Follow-up|12|||
164234122|NCT04116853|593227861|FG000|Overall Study|Adverse Event|1|||
164234123|NCT04116853|593227862|FG001|Overall Study|Adverse Event|3|||
164234124|NCT04116853|593227861|FG000|Overall Study|Lost to Follow-up|2|||
164234125|NCT04116853|593227862|FG001|Overall Study|Lost to Follow-up|0|||
164234126|NCT04116853|593227861|FG000|Overall Study|Incarceration|0|||
164234127|NCT04116853|593227862|FG001|Overall Study|Incarceration|1|||
164234128|NCT04116853|593227861|FG000|Overall Study|Pregnancy|1|||
164234129|NCT04116853|593227862|FG001|Overall Study|Pregnancy|1|||
164234130|NCT04116853|593227861|FG000|Overall Study|Began Other Weight Loss program|4|||
164234131|NCT04116853|593227862|FG001|Overall Study|Began Other Weight Loss program|8|||
164234132|NCT04116853|593227861|FG000|Overall Study|Began Anti-Obesity Medication|3|||
164234133|NCT04116853|593227862|FG001|Overall Study|Began Anti-Obesity Medication|3|||
164234134|NCT04116853|593227861|FG000|Overall Study|Protocol Violation|0|||
164234135|NCT04116853|593227862|FG001|Overall Study|Protocol Violation|1|||
164234136|NCT02581930|593227866|FG000|Overall Study|Withdrawal by Subject|1|||
164234137|NCT02581930|593227866|FG000|Overall Study|patient declined further treatment|1|||
164234138|NCT02776735|593227867|FG000|Overall Study|Adverse Event|0|||
164234139|NCT02776735|593227868|FG001|Overall Study|Adverse Event|0|||
164234140|NCT02776735|593227869|FG002|Overall Study|Adverse Event|0|||
164234141|NCT02776735|593227870|FG003|Overall Study|Adverse Event|1|||
164234142|NCT02776735|593227871|FG004|Overall Study|Adverse Event|0|||
164234143|NCT02776735|593227872|FG005|Overall Study|Adverse Event|1|||
164234144|NCT02776735|593227867|FG000|Overall Study|Lost to Follow-up|0|||
164422988|NCT03354637|593919471|FG000|Open Label Extension|Physician Decision|0|||
164422989|NCT03354637|593919472|FG001|Open Label Extension|Physician Decision|0|||
164422990|NCT03354637|593919473|FG002|Open Label Extension|Physician Decision|1|||
164676119|NCT00968812|594838066|FG002|Overall Study|Lost to Follow-up|11|||
164676120|NCT00968812|594838064|FG000|Overall Study|Physician Decision|8|||
164676121|NCT00968812|594838065|FG001|Overall Study|Physician Decision|5|||
164676122|NCT00968812|594838066|FG002|Overall Study|Physician Decision|9|||
164676123|NCT00968812|594838064|FG000|Overall Study|Protocol Violation|7|||
164676124|NCT00968812|594838065|FG001|Overall Study|Protocol Violation|4|||
164234145|NCT02776735|593227868|FG001|Overall Study|Lost to Follow-up|0|||
164422991|NCT04006366|593919474|FG000|Overall Study|Withdrawal by Subject|1|||
164234146|NCT02776735|593227869|FG002|Overall Study|Lost to Follow-up|0|||
164234147|NCT02776735|593227870|FG003|Overall Study|Lost to Follow-up|1|||
164234148|NCT02776735|593227871|FG004|Overall Study|Lost to Follow-up|0|||
164234149|NCT02776735|593227872|FG005|Overall Study|Lost to Follow-up|0|||
164234150|NCT02776735|593227867|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164234151|NCT02776735|593227868|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164234152|NCT02776735|593227869|FG002|Overall Study|Withdrawal by parent/guardian|2|||
164234153|NCT02776735|593227870|FG003|Overall Study|Withdrawal by parent/guardian|2|||
164422992|NCT01123161|593919479|FG000|Overall Study|Lost to Follow-up|1|||
164676125|NCT00968812|594838066|FG002|Overall Study|Protocol Violation|3|||
164676126|NCT00968812|594838064|FG000|Overall Study|Withdrawal by Subject|17|||
164234154|NCT02776735|593227871|FG004|Overall Study|Withdrawal by parent/guardian|0|||
164234155|NCT02776735|593227872|FG005|Overall Study|Withdrawal by parent/guardian|0|||
164234156|NCT02776735|593227867|FG000|Overall Study|Withdrawal by Subject|1|||
164234157|NCT02776735|593227868|FG001|Overall Study|Withdrawal by Subject|0|||
164234158|NCT02776735|593227869|FG002|Overall Study|Withdrawal by Subject|0|||
164234159|NCT02776735|593227870|FG003|Overall Study|Withdrawal by Subject|0|||
164234160|NCT02776735|593227871|FG004|Overall Study|Withdrawal by Subject|0|||
164234161|NCT02776735|593227872|FG005|Overall Study|Withdrawal by Subject|1|||
164234162|NCT02776735|593227867|FG000|Overall Study|Other|0|||
164234163|NCT02776735|593227868|FG001|Overall Study|Other|0|||
164234164|NCT02776735|593227869|FG002|Overall Study|Other|3|||
164234165|NCT02776735|593227870|FG003|Overall Study|Other|0|||
164234166|NCT02776735|593227871|FG004|Overall Study|Other|0|||
164234167|NCT02776735|593227872|FG005|Overall Study|Other|0|||
164234168|NCT03186638|593229140|FG000|Overall Study|Withdrawal by Subject|4|||
164234169|NCT03186638|593229141|FG001|Overall Study|Withdrawal by Subject|4|||
164234170|NCT03186638|593229140|FG000|Overall Study|Withdrawn due to medical problem|3|||
164234171|NCT03186638|593229141|FG001|Overall Study|Withdrawn due to medical problem|2|||
164234172|NCT03186638|593229140|FG000|Overall Study|Lost to Follow-up|1|||
164234173|NCT03186638|593229141|FG001|Overall Study|Lost to Follow-up|0|||
164234174|NCT04099277|593229142|FG000|Overall Study|Physician Decision|1|||
164234175|NCT04099277|593229142|FG000|Overall Study|Withdrawal by Subject|1|||
164234176|NCT02367456|593229143|FG000|Overall Study|Death|8|||
164234177|NCT02367456|593229144|FG001|Overall Study|Death|24|||
164234178|NCT02367456|593229145|FG002|Overall Study|Death|17|||
164234179|NCT02367456|593229143|FG000|Overall Study|Lost to Follow-up|1|||
164234180|NCT02367456|593229144|FG001|Overall Study|Lost to Follow-up|3|||
164234181|NCT02367456|593229145|FG002|Overall Study|Lost to Follow-up|1|||
164234182|NCT02367456|593229143|FG000|Overall Study|Other reason|3|||
164234183|NCT02367456|593229144|FG001|Overall Study|Other reason|3|||
164234184|NCT02367456|593229145|FG002|Overall Study|Other reason|9|||
164234185|NCT02367456|593229143|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
164234186|NCT02367456|593229144|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
164234187|NCT02367456|593229145|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
164234188|NCT01645176|593229150|FG000|Overall Study|Lack of Efficacy|4|||
164234189|NCT01645176|593229150|FG000|Overall Study|did not complete final MRI|1|||
164234190|NCT02569853|593229153|FG000|Overall Study|Adverse Event|2|||
164234191|NCT02569853|593229154|FG001|Overall Study|Adverse Event|0|||
164234192|NCT02569853|593229153|FG000|Overall Study|Withdrawal by Subject|3|||
164234193|NCT02569853|593229154|FG001|Overall Study|Withdrawal by Subject|2|||
164234194|NCT02569853|593229153|FG000|Overall Study|Lost to Follow-up|3|||
164234195|NCT02569853|593229154|FG001|Overall Study|Lost to Follow-up|3|||
164234196|NCT02569853|593229153|FG000|Overall Study|Protocol Violation|1|||
164234197|NCT02569853|593229154|FG001|Overall Study|Protocol Violation|1|||
164234198|NCT02569853|593229153|FG000|Overall Study|Did not experience migraine attack|10|||
164234199|NCT02569853|593229154|FG001|Overall Study|Did not experience migraine attack|7|||
164234200|NCT02569853|593229153|FG000|Overall Study|Physician Decision|1|||
164234201|NCT02569853|593229154|FG001|Overall Study|Physician Decision|1|||
164234202|NCT00402987|593229155|FG000|Overall Study|Lack of Efficacy|0|||
164234203|NCT00402987|593229156|FG001|Overall Study|Lack of Efficacy|0|||
164234204|NCT00402987|593229157|FG002|Overall Study|Lack of Efficacy|1|||
164234205|NCT00402987|593229158|FG003|Overall Study|Lack of Efficacy|0|||
164234206|NCT01668004|593229159|FG000|Overall Study|Adverse Event|7|||
164234207|NCT01668004|593229159|FG000|Overall Study|Withdrawal by Subject|2|||
164234208|NCT01668004|593229159|FG000|Overall Study|Lost to Follow-up|5|||
164234209|NCT01668004|593229159|FG000|Overall Study|Lack of Efficacy|9|||
164234210|NCT01668004|593229159|FG000|Overall Study|Non-compliance with treatment|2|||
164234211|NCT00754572|593229162|FG000|Overall Study|Adverse Event|19|||
164234212|NCT00754572|593229162|FG000|Overall Study|Other|39|||
164234213|NCT00754572|593229162|FG000|Overall Study|Protocol Violation|3|||
164572661|NCT01795547|594460406|FG001|Overall Study|Withdrawal of consent|12|||
164572662|NCT01795547|594460405|FG000|Overall Study|Not Treated|4|||
164572663|NCT01795547|594460406|FG001|Overall Study|Not Treated|10|||
164234214|NCT00754572|593229162|FG000|Overall Study|Withdrawal by Subject|3|||
164234215|NCT00754572|593229162|FG000|Overall Study|Lack of Efficacy|2|||
164234216|NCT00754572|593229162|FG000|Overall Study|Death|1|||
164234217|NCT00754572|593229162|FG000|Overall Study|Administrative Reason|3|||
164572664|NCT01795547|594460405|FG000|Overall Study|Non-compliance with IMP|1|||
164234218|NCT00754572|593229162|FG000|Overall Study|Lost to Follow-up|1|||
164234219|NCT01493414|593229168|FG000|Overall Study|Adverse Event|405|||
164234220|NCT01493414|593229168|FG000|Overall Study|Disease progression|204|||
164234221|NCT01493414|593229168|FG000|Overall Study|Death|101|||
164234222|NCT01493414|593229168|FG000|Overall Study|Physician Decision|93|||
164234223|NCT01493414|593229168|FG000|Overall Study|Withdrawal by Subject|79|||
164234224|NCT01493414|593229168|FG000|Overall Study|Protocol deviation|27|||
164234225|NCT01493414|593229168|FG000|Overall Study|Administrative problems|25|||
164234226|NCT01493414|593229168|FG000|Overall Study|Lost to Follow-up|16|||
164234227|NCT04846231|593229179|FG000|Overall Study|Lost to Follow-up|1|||
164234228|NCT04846231|593229180|FG001|Overall Study|Lost to Follow-up|0|||
164234229|NCT04846231|593229181|FG002|Overall Study|Lost to Follow-up|0|||
164234230|NCT04846231|593229182|FG003|Overall Study|Lost to Follow-up|0|||
164234231|NCT04846231|593229183|FG004|Overall Study|Lost to Follow-up|0|||
164234232|NCT04846231|593229184|FG005|Overall Study|Lost to Follow-up|0|||
164234233|NCT04846231|593229185|FG006|Overall Study|Lost to Follow-up|0|||
164234234|NCT04846231|593229186|FG007|Overall Study|Lost to Follow-up|1|||
164234235|NCT04846231|593229179|FG000|Overall Study|Withdrawal by Subject|0|||
164234236|NCT04846231|593229180|FG001|Overall Study|Withdrawal by Subject|1|||
164234237|NCT04846231|593229181|FG002|Overall Study|Withdrawal by Subject|2|||
164234238|NCT04846231|593229182|FG003|Overall Study|Withdrawal by Subject|1|||
164234239|NCT04846231|593229183|FG004|Overall Study|Withdrawal by Subject|0|||
164234240|NCT04846231|593229184|FG005|Overall Study|Withdrawal by Subject|0|||
164234241|NCT04846231|593229185|FG006|Overall Study|Withdrawal by Subject|0|||
164234242|NCT04846231|593229186|FG007|Overall Study|Withdrawal by Subject|0|||
164234243|NCT04846231|593229179|FG000|Overall Study|Protocol Violation|0|||
164234244|NCT04846231|593229180|FG001|Overall Study|Protocol Violation|1|||
164234245|NCT04846231|593229181|FG002|Overall Study|Protocol Violation|0|||
164234246|NCT04846231|593229182|FG003|Overall Study|Protocol Violation|0|||
164234247|NCT04846231|593229183|FG004|Overall Study|Protocol Violation|0|||
164234248|NCT04846231|593229184|FG005|Overall Study|Protocol Violation|0|||
164234249|NCT04846231|593229185|FG006|Overall Study|Protocol Violation|0|||
164234250|NCT04846231|593229186|FG007|Overall Study|Protocol Violation|0|||
164234251|NCT04846231|593229179|FG000|Overall Study|Adverse Event|0|||
164234252|NCT04846231|593229180|FG001|Overall Study|Adverse Event|0|||
164234253|NCT04846231|593229181|FG002|Overall Study|Adverse Event|0|||
164234254|NCT04846231|593229182|FG003|Overall Study|Adverse Event|0|||
164234255|NCT04846231|593229183|FG004|Overall Study|Adverse Event|0|||
164234256|NCT04846231|593229184|FG005|Overall Study|Adverse Event|0|||
164234257|NCT04846231|593229185|FG006|Overall Study|Adverse Event|1|||
164234258|NCT04846231|593229186|FG007|Overall Study|Adverse Event|1|||
164234259|NCT01143402|593229194|FG000|Overall Study|Rapid clinical decline|1|||
164234260|NCT01143402|593229195|FG001|Overall Study|Rapid clinical decline|1|||
164234261|NCT01143402|593229196|FG002|Overall Study|Rapid clinical decline|0|||
164234262|NCT01143402|593229194|FG000|Overall Study|Not Treated|0|||
164234263|NCT01143402|593229195|FG001|Overall Study|Not Treated|0|||
164234264|NCT01143402|593229196|FG002|Overall Study|Not Treated|1|||
164234265|NCT04462471|593229197|FG000|Overall Study|Adverse Event|0|||
164234266|NCT04462471|593229198|FG001|Overall Study|Adverse Event|1|||
164234267|NCT04462471|593229199|FG002|Overall Study|Adverse Event|0|||
164234268|NCT04462471|593229200|FG003|Overall Study|Adverse Event|0|||
164234269|NCT04462471|593229197|FG000|Overall Study|Disease progression|1|||
164234270|NCT04462471|593229198|FG001|Overall Study|Disease progression|0|||
164234271|NCT04462471|593229199|FG002|Overall Study|Disease progression|0|||
164234272|NCT04462471|593229200|FG003|Overall Study|Disease progression|0|||
164234273|NCT02706392|593229201|FG000|Overall Study|Death|1|||
164234274|NCT02706392|593229202|FG001|Overall Study|Death|0|||
164234275|NCT02706392|593229203|FG002|Overall Study|Death|2|||
164234276|NCT02706392|593229204|FG003|Overall Study|Death|2|||
164234277|NCT02706392|593229205|FG004|Overall Study|Death|5|||
164234278|NCT02706392|593229206|FG005|Overall Study|Death|2|||
164234279|NCT00265122|593229211|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
164234280|NCT00265122|593229212|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
164234281|NCT00265122|593229213|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
164234282|NCT00265122|593229214|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
164422993|NCT01123161|593919480|FG001|Overall Study|Lost to Follow-up|0|||
164422994|NCT01123161|593919479|FG000|Overall Study|Withdrawal by Subject|1|||
164422995|NCT01123161|593919480|FG001|Overall Study|Withdrawal by Subject|0|||
164422996|NCT04466618|593919485|FG000|Overall Study|Withdrawal by Subject|0|||
164422997|NCT04466618|593919486|FG001|Overall Study|Withdrawal by Subject|1|||
164422998|NCT02800928|593919487|FG000|Overall Study|Withdrawal by Subject|1|||
164234283|NCT00265122|593229215|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
164234284|NCT00265122|593229216|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
164234285|NCT00265122|593229211|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
164234286|NCT00265122|593229212|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
164234287|NCT00265122|593229213|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
164234288|NCT00265122|593229214|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
164234289|NCT00265122|593229215|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
164234290|NCT00265122|593229216|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
164234291|NCT00265122|593229211|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
164234292|NCT00265122|593229212|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
164234293|NCT00265122|593229213|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
164234294|NCT00265122|593229214|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
164234295|NCT00265122|593229215|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
164234296|NCT00265122|593229216|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
164299833|NCT02234843|593472944|FG000|Overall Study|Death|1|||
164422999|NCT02800928|593919488|FG001|Overall Study|Withdrawal by Subject|1|||
164234297|NCT00265122|593229211|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
164234298|NCT00265122|593229212|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
164234299|NCT00265122|593229213|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
164234300|NCT00265122|593229214|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
164234301|NCT00265122|593229215|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
164234302|NCT00265122|593229216|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
164234303|NCT00265122|593229211|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
164234304|NCT00265122|593229212|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
164234305|NCT00265122|593229213|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
164234306|NCT00265122|593229214|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
164234307|NCT00265122|593229215|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
164234308|NCT00265122|593229216|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
164234309|NCT00265122|593229211|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
164234310|NCT00265122|593229212|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
164234311|NCT00265122|593229213|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
164234312|NCT00265122|593229214|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
164234313|NCT00265122|593229215|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
164234314|NCT00265122|593229216|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
164234315|NCT01276106|593229217|FG000|Overall Study|Adverse Event|3|||
164234316|NCT01276106|593229218|FG001|Overall Study|Adverse Event|3|||
164234317|NCT01276106|593229219|FG002|Overall Study|Adverse Event|11|||
164234318|NCT01276106|593229220|FG003|Overall Study|Adverse Event|3|||
164234319|NCT01276106|593229217|FG000|Overall Study|Withdrawal by Subject|6|||
164234320|NCT01276106|593229218|FG001|Overall Study|Withdrawal by Subject|3|||
164234321|NCT01276106|593229219|FG002|Overall Study|Withdrawal by Subject|1|||
164234322|NCT01276106|593229220|FG003|Overall Study|Withdrawal by Subject|6|||
164234323|NCT01276106|593229217|FG000|Overall Study|Lack of Efficacy|0|||
164234324|NCT01276106|593229218|FG001|Overall Study|Lack of Efficacy|1|||
164234325|NCT01276106|593229219|FG002|Overall Study|Lack of Efficacy|0|||
164234326|NCT01276106|593229220|FG003|Overall Study|Lack of Efficacy|1|||
164234327|NCT01276106|593229217|FG000|Overall Study|Lost to Follow-up|2|||
164676127|NCT00968812|594838065|FG001|Overall Study|Withdrawal by Subject|23|||
164676128|NCT00968812|594838066|FG002|Overall Study|Withdrawal by Subject|25|||
164676129|NCT00968812|594838064|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
164676130|NCT00968812|594838065|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
164676131|NCT00968812|594838066|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
164676132|NCT00968812|594838064|FG000|Overall Study|Noncompliance with study drug|4|||
164676133|NCT00968812|594838065|FG001|Overall Study|Noncompliance with study drug|1|||
164676134|NCT00968812|594838066|FG002|Overall Study|Noncompliance with study drug|6|||
164676135|NCT00968812|594838064|FG000|Overall Study|Unable to take rescue therapy|12|||
164234328|NCT01276106|593229218|FG001|Overall Study|Lost to Follow-up|1|||
164234329|NCT01276106|593229219|FG002|Overall Study|Lost to Follow-up|1|||
164234330|NCT01276106|593229220|FG003|Overall Study|Lost to Follow-up|0|||
164234331|NCT01276106|593229217|FG000|Overall Study|Physician Decision|0|||
164234332|NCT01276106|593229218|FG001|Overall Study|Physician Decision|0|||
164234333|NCT01276106|593229219|FG002|Overall Study|Physician Decision|1|||
164234334|NCT01276106|593229220|FG003|Overall Study|Physician Decision|1|||
164234335|NCT01276106|593229217|FG000|Overall Study|Protocol Violation|1|||
164234336|NCT01276106|593229218|FG001|Overall Study|Protocol Violation|1|||
164234337|NCT01276106|593229219|FG002|Overall Study|Protocol Violation|0|||
164234338|NCT01276106|593229220|FG003|Overall Study|Protocol Violation|2|||
164234339|NCT01276106|593229217|FG000|Overall Study|Insufficient therapeutic effects|0|||
164234340|NCT01276106|593229218|FG001|Overall Study|Insufficient therapeutic effects|0|||
164234341|NCT01276106|593229219|FG002|Overall Study|Insufficient therapeutic effects|2|||
164234342|NCT01276106|593229220|FG003|Overall Study|Insufficient therapeutic effects|0|||
164234343|NCT00862940|593229224|FG000|Overall Study|Adverse Event|15|||
164234344|NCT00862940|593229225|FG001|Overall Study|Adverse Event|12|||
164234345|NCT00862940|593229224|FG000|Overall Study|Lack of Efficacy|1|||
164234346|NCT00862940|593229225|FG001|Overall Study|Lack of Efficacy|3|||
164234347|NCT00862940|593229224|FG000|Overall Study|Protocol Violation|2|||
164423000|NCT02800928|593919487|FG000|Overall Study|Protocol Violation|1|||
164423001|NCT02800928|593919488|FG001|Overall Study|Protocol Violation|1|||
164423002|NCT00873093|593919494|FG000|Overall Study|Adverse Event|0|||
164234348|NCT00862940|593229225|FG001|Overall Study|Protocol Violation|5|||
164234349|NCT00862940|593229224|FG000|Overall Study|Withdrawal by Subject|4|||
164234350|NCT00862940|593229225|FG001|Overall Study|Withdrawal by Subject|6|||
164234351|NCT00862940|593229224|FG000|Overall Study|Non-compliance|4|||
164234352|NCT00862940|593229225|FG001|Overall Study|Non-compliance|0|||
164234353|NCT00862940|593229224|FG000|Overall Study|Lost to Follow-up|0|||
164423003|NCT00873093|593919495|FG001|Overall Study|Adverse Event|2|||
164423004|NCT00873093|593919496|FG002|Overall Study|Adverse Event|0|||
164676136|NCT00968812|594838065|FG001|Overall Study|Unable to take rescue therapy|12|||
164423005|NCT00873093|593919497|FG003|Overall Study|Adverse Event|0|||
164423006|NCT00873093|593919498|FG004|Overall Study|Adverse Event|0|||
164333348|NCT00406354|593597404|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
164333349|NCT00406354|593597405|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
164333350|NCT00406354|593597406|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
164572665|NCT01795547|594460406|FG001|Overall Study|Non-compliance with IMP|1|||
164572666|NCT01795547|594460405|FG000|Overall Study|Others|4|||
164572667|NCT01795547|594460406|FG001|Overall Study|Others|1|||
164572668|NCT01795547|594460405|FG000|Overall Study|Not stated|0|||
164572669|NCT01795547|594460406|FG001|Overall Study|Not stated|1|||
164572670|NCT04223609|594460409|FG000|Overall Study|Adverse Event|0|||
164572671|NCT04223609|594460410|FG001|Overall Study|Adverse Event|1|||
164572672|NCT04223609|594460409|FG000|Overall Study|Missed last visit|0|||
164572673|NCT04223609|594460410|FG001|Overall Study|Missed last visit|1|||
164572674|NCT00591734|594460411|FG000|Overall Study|Lack of Efficacy|35|||
164572675|NCT00591734|594460411|FG000|Overall Study|Adverse Event|5|||
164572676|NCT00591734|594460411|FG000|Overall Study|Physician Decision|5|||
164572677|NCT00591734|594460411|FG000|Overall Study|Intercurrent Illness|8|||
164572678|NCT04672083|594460412|FG000|Overall Study|Lost to Follow-up|1|||
164572679|NCT04672083|594460413|FG001|Overall Study|Lost to Follow-up|0|||
164572680|NCT04672083|594460414|FG002|Overall Study|Lost to Follow-up|0|||
164572681|NCT04672083|594460415|FG003|Overall Study|Lost to Follow-up|0|||
164572682|NCT04672083|594460416|FG004|Overall Study|Lost to Follow-up|0|||
164572683|NCT01551745|594460417|FG000|Overall Study|Withdrawal by Subject|1|||
164572684|NCT01551745|594460417|FG000|Overall Study|Disease Progression|2|||
164572685|NCT00749190|594460420|FG000|Overall Study|Adverse Event|0|||
164572686|NCT00749190|594460421|FG001|Overall Study|Adverse Event|2|||
164572687|NCT00749190|594460422|FG002|Overall Study|Adverse Event|0|||
164572688|NCT00749190|594460423|FG003|Overall Study|Adverse Event|4|||
164572689|NCT00749190|594460424|FG004|Overall Study|Adverse Event|0|||
164572690|NCT00749190|594460425|FG005|Overall Study|Adverse Event|3|||
164572691|NCT00749190|594460426|FG006|Overall Study|Adverse Event|0|||
164572692|NCT00749190|594460420|FG000|Overall Study|Lack of Efficacy|3|||
164572693|NCT00749190|594460421|FG001|Overall Study|Lack of Efficacy|1|||
164572694|NCT00749190|594460422|FG002|Overall Study|Lack of Efficacy|1|||
164572695|NCT00749190|594460423|FG003|Overall Study|Lack of Efficacy|0|||
164572696|NCT00749190|594460424|FG004|Overall Study|Lack of Efficacy|0|||
164572697|NCT00749190|594460425|FG005|Overall Study|Lack of Efficacy|1|||
164572698|NCT00749190|594460426|FG006|Overall Study|Lack of Efficacy|0|||
164572699|NCT00749190|594460420|FG000|Overall Study|Withdrawal by Subject|2|||
164572700|NCT00749190|594460421|FG001|Overall Study|Withdrawal by Subject|1|||
164572701|NCT00749190|594460422|FG002|Overall Study|Withdrawal by Subject|0|||
164572702|NCT00749190|594460423|FG003|Overall Study|Withdrawal by Subject|0|||
164572703|NCT00749190|594460424|FG004|Overall Study|Withdrawal by Subject|0|||
164333351|NCT00406354|593597404|FG000|All Randomized and Treated Patients|Physician Decision|0|||
164333352|NCT00406354|593597405|FG001|All Randomized and Treated Patients|Physician Decision|0|||
164572704|NCT00749190|594460425|FG005|Overall Study|Withdrawal by Subject|1|||
164572705|NCT00749190|594460426|FG006|Overall Study|Withdrawal by Subject|0|||
164572706|NCT00749190|594460420|FG000|Overall Study|Protocol Violation|0|||
164572707|NCT00749190|594460421|FG001|Overall Study|Protocol Violation|1|||
164572708|NCT00749190|594460422|FG002|Overall Study|Protocol Violation|0|||
164572709|NCT00749190|594460423|FG003|Overall Study|Protocol Violation|0|||
164572710|NCT00749190|594460424|FG004|Overall Study|Protocol Violation|0|||
164572711|NCT00749190|594460425|FG005|Overall Study|Protocol Violation|0|||
164572712|NCT00749190|594460426|FG006|Overall Study|Protocol Violation|1|||
164572713|NCT00749190|594460420|FG000|Overall Study|Other reason not defined above|0|||
164572714|NCT00749190|594460421|FG001|Overall Study|Other reason not defined above|0|||
164572715|NCT00749190|594460422|FG002|Overall Study|Other reason not defined above|0|||
164572716|NCT00749190|594460423|FG003|Overall Study|Other reason not defined above|1|||
164572717|NCT00749190|594460424|FG004|Overall Study|Other reason not defined above|0|||
164572718|NCT00749190|594460425|FG005|Overall Study|Other reason not defined above|0|||
164572719|NCT00749190|594460426|FG006|Overall Study|Other reason not defined above|0|||
164572720|NCT00355121|594460427|FG000|Overall Study|Did not receive study vaccine|1|||
164572721|NCT00355121|594460428|FG001|Overall Study|Did not receive study vaccine|0|||
164572722|NCT00355121|594460429|FG002|Overall Study|Did not receive study vaccine|1|||
164572723|NCT00355121|594460427|FG000|Overall Study|Adverse Event|0|||
164572724|NCT00355121|594460428|FG001|Overall Study|Adverse Event|1|||
164572725|NCT00355121|594460429|FG002|Overall Study|Adverse Event|0|||
164572726|NCT00355121|594460427|FG000|Overall Study|Protocol Violation|7|||
164143353|NCT03597295|592886602|FG000|Overall Study|Lost to Follow-up|7|||
164423007|NCT00873093|593919494|FG000|Overall Study|Death|0|||
164333353|NCT00406354|593597406|FG002|All Randomized and Treated Patients|Physician Decision|1|||
164333354|NCT03438383|593597423|FG000|Overall Study|Protocol Violation|9|||
164333355|NCT03438383|593597424|FG001|Overall Study|Protocol Violation|3|||
164333356|NCT02435069|593597425|FG000|Dose Response - First Intervention|Adverse Event|0|||
164333357|NCT02435069|593597426|FG001|Dose Response - First Intervention|Adverse Event|1|||
164333358|NCT02435069|593597427|FG002|Dose Response - First Intervention|Adverse Event|1|||
164333359|NCT02435069|593597428|FG003|Dose Response - First Intervention|Adverse Event|0|||
164333360|NCT02435069|593597429|FG004|Dose Response - First Intervention|Adverse Event|0|||
164333361|NCT02435069|593597425|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
164333362|NCT02435069|593597426|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
164333363|NCT02435069|593597427|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
164333364|NCT02435069|593597428|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
164333365|NCT02435069|593597429|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
164333366|NCT02030938|593597434|FG000|Overall Study|Lost to Follow-up|4|||
164333367|NCT02030938|593597434|FG000|Overall Study|Withdrawal by Subject|1|||
164333368|NCT03954132|593597436|FG000|Overall Study|Adverse Event|2|||
164333369|NCT03954132|593597437|FG001|Overall Study|Adverse Event|0|||
164333370|NCT03954132|593597436|FG000|Overall Study|Patient's wish|5|||
164333371|NCT03954132|593597437|FG001|Overall Study|Patient's wish|0|||
164333372|NCT03954132|593597436|FG000|Overall Study|Lost to Follow-up|10|||
164333373|NCT03954132|593597437|FG001|Overall Study|Lost to Follow-up|0|||
164333374|NCT03954132|593597436|FG000|Overall Study|Screening failure|0|||
164333375|NCT03954132|593597437|FG001|Overall Study|Screening failure|1|||
164333376|NCT03954132|593597436|FG000|Overall Study|No registration after Visit 1|5|||
164333377|NCT03954132|593597437|FG001|Overall Study|No registration after Visit 1|2|||
164333378|NCT03954132|593597436|FG000|Overall Study|Other reason than listed|2|||
164333379|NCT03954132|593597437|FG001|Overall Study|Other reason than listed|2|||
164333380|NCT03954132|593597436|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
164333381|NCT03954132|593597437|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
164333382|NCT03954132|593597436|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
164333383|NCT03954132|593597437|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
164333384|NCT00932737|593597440|FG000|Overall Study|Not treated in second episode|1|||
164333385|NCT00932737|593597441|FG001|Overall Study|Not treated in second episode|0|||
164333386|NCT00932737|593597440|FG000|Overall Study|Adverse Event|0|||
164333387|NCT00932737|593597441|FG001|Overall Study|Adverse Event|1|||
164333388|NCT05156073|593597444|FG000|Overall Study|Patient canceled appointment with PCP|1|||
164333389|NCT00973349|593597445|FG000|Overall Study|Adverse Event|0|||
164333390|NCT00973349|593597446|FG001|Overall Study|Adverse Event|0|||
164333391|NCT00973349|593597447|FG002|Overall Study|Adverse Event|0|||
164333392|NCT00973349|593597448|FG003|Overall Study|Adverse Event|0|||
164333393|NCT00973349|593597449|FG004|Overall Study|Adverse Event|1|||
164333394|NCT00973349|593597450|FG005|Overall Study|Adverse Event|0|||
164333395|NCT00973349|593597451|FG006|Overall Study|Adverse Event|0|||
164333396|NCT00973349|593597452|FG007|Overall Study|Adverse Event|0|||
164333397|NCT00973349|593597453|FG008|Overall Study|Adverse Event|1|||
164333398|NCT00973349|593597454|FG009|Overall Study|Adverse Event|0|||
164333399|NCT00973349|593597455|FG010|Overall Study|Adverse Event|0|||
164333400|NCT00973349|593597456|FG011|Overall Study|Adverse Event|0|||
164333401|NCT00973349|593597457|FG012|Overall Study|Adverse Event|0|||
164333402|NCT00973349|593597458|FG013|Overall Study|Adverse Event|0|||
164333403|NCT00973349|593597459|FG014|Overall Study|Adverse Event|1|||
164333404|NCT00973349|593597460|FG015|Overall Study|Adverse Event|0|||
164333405|NCT00973349|593597445|FG000|Overall Study|Withdrawal by Subject|1|||
164333406|NCT00973349|593597446|FG001|Overall Study|Withdrawal by Subject|2|||
164423008|NCT00873093|593919495|FG001|Overall Study|Death|3|||
164572727|NCT00355121|594460428|FG001|Overall Study|Protocol Violation|9|||
164572728|NCT00355121|594460429|FG002|Overall Study|Protocol Violation|1|||
164572729|NCT00355121|594460427|FG000|Overall Study|Lost to Follow-up|4|||
164572730|NCT00355121|594460428|FG001|Overall Study|Lost to Follow-up|7|||
164572731|NCT00355121|594460429|FG002|Overall Study|Lost to Follow-up|1|||
164572732|NCT00355121|594460427|FG000|Overall Study|Withdrawal by Subject|9|||
164572733|NCT00355121|594460428|FG001|Overall Study|Withdrawal by Subject|10|||
164572734|NCT00355121|594460429|FG002|Overall Study|Withdrawal by Subject|2|||
164572735|NCT00355121|594460427|FG000|Overall Study|Serious adverse events|0|||
164572736|NCT00355121|594460428|FG001|Overall Study|Serious adverse events|2|||
164572737|NCT00355121|594460429|FG002|Overall Study|Serious adverse events|0|||
164572738|NCT00784758|594460431|FG000|Overall Study|Withdrawal by Subject|3|||
164572739|NCT00784758|594460432|FG001|Overall Study|Withdrawal by Subject|0|||
164572740|NCT00784758|594460431|FG000|Overall Study|Adverse Event|1|||
164572741|NCT00784758|594460432|FG001|Overall Study|Adverse Event|0|||
164572742|NCT03726268|594460433|FG000|Overall Study|Physician Decision|2|||
164572743|NCT03726268|594460434|FG001|Overall Study|Physician Decision|8|||
164572744|NCT03726268|594460435|FG002|Overall Study|Physician Decision|6|||
164572745|NCT03726268|594460436|FG003|Overall Study|Physician Decision|3|||
164572746|NCT03726268|594460433|FG000|Overall Study|Withdrawal by Subject|11|||
164333407|NCT00973349|593597447|FG002|Overall Study|Withdrawal by Subject|2|||
164333408|NCT00973349|593597448|FG003|Overall Study|Withdrawal by Subject|3|||
164333409|NCT00973349|593597449|FG004|Overall Study|Withdrawal by Subject|2|||
164333410|NCT00973349|593597450|FG005|Overall Study|Withdrawal by Subject|0|||
164333411|NCT00973349|593597451|FG006|Overall Study|Withdrawal by Subject|2|||
164333412|NCT00973349|593597452|FG007|Overall Study|Withdrawal by Subject|2|||
164333413|NCT00973349|593597453|FG008|Overall Study|Withdrawal by Subject|0|||
164333414|NCT00973349|593597454|FG009|Overall Study|Withdrawal by Subject|2|||
164333415|NCT00973349|593597455|FG010|Overall Study|Withdrawal by Subject|0|||
164333416|NCT00973349|593597456|FG011|Overall Study|Withdrawal by Subject|1|||
164333417|NCT00973349|593597457|FG012|Overall Study|Withdrawal by Subject|0|||
164333418|NCT00973349|593597458|FG013|Overall Study|Withdrawal by Subject|0|||
164333419|NCT00973349|593597459|FG014|Overall Study|Withdrawal by Subject|0|||
164333420|NCT00973349|593597460|FG015|Overall Study|Withdrawal by Subject|0|||
164333421|NCT00973349|593597445|FG000|Overall Study|Lost to Follow-up|3|||
164333422|NCT00973349|593597446|FG001|Overall Study|Lost to Follow-up|1|||
164234354|NCT00862940|593229225|FG001|Overall Study|Lost to Follow-up|1|||
164234355|NCT00862940|593229224|FG000|Overall Study|Administrative or other reason(s)|4|||
164234356|NCT00862940|593229225|FG001|Overall Study|Administrative or other reason(s)|3|||
164234357|NCT00485173|593229226|FG000|Overall Study|Death|4|||
164234358|NCT00485173|593229227|FG001|Overall Study|Death|3|||
164234359|NCT00485173|593229226|FG000|Overall Study|Lost to Follow-up|32|||
164234360|NCT00485173|593229227|FG001|Overall Study|Lost to Follow-up|61|||
164234361|NCT00879398|593229230|FG000|Overall Study|Visit Stop|399|||
164234362|NCT00879398|593229230|FG000|Overall Study|Lack of Efficacy|64|||
164234363|NCT00879398|593229230|FG000|Overall Study|Adverse Event|41|||
164234364|NCT00879398|593229230|FG000|Overall Study|Other Reasons|171|||
164234365|NCT00829244|593229231|FG000|Overall Study|Adverse Event|1|||
164234366|NCT00829244|593229232|FG001|Overall Study|Adverse Event|3|||
164234367|NCT00829244|593229231|FG000|Overall Study|Protocol Violation|1|||
164234368|NCT00829244|593229232|FG001|Overall Study|Protocol Violation|0|||
164234369|NCT00829244|593229231|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
164234370|NCT00829244|593229232|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
164234371|NCT00829244|593229231|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
164234372|NCT00829244|593229232|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
164234373|NCT00829244|593229231|FG000|Overall Study|No fertilization|2|||
164234374|NCT00829244|593229232|FG001|Overall Study|No fertilization|2|||
164234375|NCT00829244|593229231|FG000|Overall Study|All embryos discarded|0|||
164234376|NCT00829244|593229232|FG001|Overall Study|All embryos discarded|3|||
164234377|NCT00829244|593229231|FG000|Overall Study|No embryo cleavage|0|||
164234378|NCT00829244|593229232|FG001|Overall Study|No embryo cleavage|2|||
164234379|NCT04251533|593229237|FG000|Overall Study|Progressive disease|33|||
164234380|NCT04251533|593229238|FG001|Overall Study|Progressive disease|29|||
164234381|NCT04251533|593229239|FG002|Overall Study|Progressive disease|22|||
164234382|NCT04251533|593229237|FG000|Overall Study|Death|5|||
164234383|NCT04251533|593229238|FG001|Overall Study|Death|1|||
164234384|NCT04251533|593229239|FG002|Overall Study|Death|3|||
164234385|NCT04251533|593229237|FG000|Overall Study|Physician Decision|3|||
164234386|NCT04251533|593229238|FG001|Overall Study|Physician Decision|2|||
164234387|NCT04251533|593229239|FG002|Overall Study|Physician Decision|4|||
164234388|NCT04251533|593229237|FG000|Overall Study|Participant decision|1|||
164234389|NCT04251533|593229238|FG001|Overall Study|Participant decision|3|||
164234390|NCT04251533|593229239|FG002|Overall Study|Participant decision|1|||
164234391|NCT04251533|593229237|FG000|Overall Study|Adverse Event|2|||
164234392|NCT04251533|593229238|FG001|Overall Study|Adverse Event|1|||
164234393|NCT04251533|593229239|FG002|Overall Study|Adverse Event|1|||
164234394|NCT04583618|593229247|FG000|Overall Study|Adverse Event|0|||
164234395|NCT04583618|593229248|FG001|Overall Study|Adverse Event|0|||
164234396|NCT04583618|593229249|FG002|Overall Study|Adverse Event|1|||
164234397|NCT04583618|593229250|FG003|Overall Study|Adverse Event|0|||
164234398|NCT04583618|593229251|FG004|Overall Study|Adverse Event|0|||
164423009|NCT00873093|593919496|FG002|Overall Study|Death|2|||
164676137|NCT00968812|594838066|FG002|Overall Study|Unable to take rescue therapy|17|||
164676138|NCT00968812|594838064|FG000|Overall Study|Other|25|||
164676139|NCT00968812|594838065|FG001|Overall Study|Other|37|||
164676140|NCT00968812|594838066|FG002|Overall Study|Other|40|||
164676141|NCT00834340|594838067|FG000|Washout|Adverse Event|1|||
164676142|NCT00834340|594838068|FG001|Washout|Adverse Event|0|||
164676143|NCT00834340|594838067|FG000|Washout|Withdrawal by Subject|1|||
164676144|NCT00834340|594838068|FG001|Washout|Withdrawal by Subject|0|||
164234399|NCT04583618|593229247|FG000|Overall Study|Protocol deviation|1|||
164333423|NCT00973349|593597447|FG002|Overall Study|Lost to Follow-up|2|||
164333424|NCT00973349|593597448|FG003|Overall Study|Lost to Follow-up|2|||
164333425|NCT00973349|593597449|FG004|Overall Study|Lost to Follow-up|1|||
164333426|NCT00973349|593597450|FG005|Overall Study|Lost to Follow-up|3|||
164234400|NCT04583618|593229248|FG001|Overall Study|Protocol deviation|1|||
164234401|NCT04583618|593229249|FG002|Overall Study|Protocol deviation|1|||
164234402|NCT04583618|593229250|FG003|Overall Study|Protocol deviation|0|||
164676145|NCT00395694|594838069|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
164333427|NCT00973349|593597451|FG006|Overall Study|Lost to Follow-up|0|||
164333428|NCT00973349|593597452|FG007|Overall Study|Lost to Follow-up|1|||
164333429|NCT00973349|593597453|FG008|Overall Study|Lost to Follow-up|2|||
164333430|NCT00973349|593597454|FG009|Overall Study|Lost to Follow-up|1|||
164333431|NCT00973349|593597455|FG010|Overall Study|Lost to Follow-up|0|||
164333432|NCT00973349|593597456|FG011|Overall Study|Lost to Follow-up|1|||
164333433|NCT00973349|593597457|FG012|Overall Study|Lost to Follow-up|0|||
164333434|NCT00973349|593597458|FG013|Overall Study|Lost to Follow-up|0|||
164333435|NCT00973349|593597459|FG014|Overall Study|Lost to Follow-up|0|||
164333436|NCT00973349|593597460|FG015|Overall Study|Lost to Follow-up|1|||
164333437|NCT00973349|593597445|FG000|Overall Study|Inappropriate enrolment|0|||
164333438|NCT00973349|593597446|FG001|Overall Study|Inappropriate enrolment|0|||
164333439|NCT00973349|593597447|FG002|Overall Study|Inappropriate enrolment|1|||
164333440|NCT00973349|593597448|FG003|Overall Study|Inappropriate enrolment|0|||
164333441|NCT00973349|593597449|FG004|Overall Study|Inappropriate enrolment|0|||
164333442|NCT00973349|593597450|FG005|Overall Study|Inappropriate enrolment|0|||
164333443|NCT00973349|593597451|FG006|Overall Study|Inappropriate enrolment|0|||
164333444|NCT00973349|593597452|FG007|Overall Study|Inappropriate enrolment|0|||
164333445|NCT00973349|593597453|FG008|Overall Study|Inappropriate enrolment|0|||
164333446|NCT00973349|593597454|FG009|Overall Study|Inappropriate enrolment|2|||
164333447|NCT00973349|593597455|FG010|Overall Study|Inappropriate enrolment|0|||
164333448|NCT00973349|593597456|FG011|Overall Study|Inappropriate enrolment|0|||
164333449|NCT00973349|593597457|FG012|Overall Study|Inappropriate enrolment|1|||
164333450|NCT00973349|593597458|FG013|Overall Study|Inappropriate enrolment|0|||
164333451|NCT00973349|593597459|FG014|Overall Study|Inappropriate enrolment|1|||
164333452|NCT00973349|593597460|FG015|Overall Study|Inappropriate enrolment|1|||
164333453|NCT00973349|593597445|FG000|Overall Study|Protocol Violation|0|||
164572747|NCT03726268|594460434|FG001|Overall Study|Withdrawal by Subject|5|||
164572748|NCT03726268|594460435|FG002|Overall Study|Withdrawal by Subject|9|||
164572749|NCT03726268|594460436|FG003|Overall Study|Withdrawal by Subject|8|||
164572750|NCT00490542|594460437|FG000|Overall Study|Lost to Follow-up|3|||
164572751|NCT00490542|594460438|FG001|Overall Study|Lost to Follow-up|0|||
164572752|NCT00490542|594460437|FG000|Overall Study|Adverse Event|3|||
164572753|NCT00490542|594460438|FG001|Overall Study|Adverse Event|3|||
164572754|NCT00490542|594460437|FG000|Overall Study|Lack of Efficacy|1|||
164572755|NCT00490542|594460438|FG001|Overall Study|Lack of Efficacy|1|||
164572756|NCT02875223|594460439|FG000|Overall Study|Other reasons|0|||
164572757|NCT02875223|594460440|FG001|Overall Study|Other reasons|0|||
164572758|NCT02875223|594460441|FG002|Overall Study|Other reasons|1|||
164572759|NCT02875223|594460442|FG003|Overall Study|Other reasons|0|||
164572760|NCT02875223|594460443|FG004|Overall Study|Other reasons|1|||
164572761|NCT02875223|594460444|FG005|Overall Study|Other reasons|2|||
164572762|NCT02875223|594460445|FG006|Overall Study|Other reasons|0|||
164572763|NCT02875223|594460446|FG007|Overall Study|Other reasons|2|||
164572764|NCT02875223|594460447|FG008|Overall Study|Other reasons|0|||
164572765|NCT02875223|594460448|FG009|Overall Study|Other reasons|0|||
164572766|NCT02875223|594460449|FG010|Overall Study|Other reasons|0|||
164572767|NCT02875223|594460450|FG011|Overall Study|Other reasons|0|||
164572768|NCT02875223|594460451|FG012|Overall Study|Other reasons|0|||
164572769|NCT02875223|594460439|FG000|Overall Study|Withdrawal by Subject|0|||
164572770|NCT02875223|594460440|FG001|Overall Study|Withdrawal by Subject|0|||
164572771|NCT02875223|594460441|FG002|Overall Study|Withdrawal by Subject|0|||
164572772|NCT02875223|594460442|FG003|Overall Study|Withdrawal by Subject|0|||
164572773|NCT02875223|594460443|FG004|Overall Study|Withdrawal by Subject|1|||
164572774|NCT02875223|594460444|FG005|Overall Study|Withdrawal by Subject|1|||
164572775|NCT02875223|594460445|FG006|Overall Study|Withdrawal by Subject|0|||
164572776|NCT02875223|594460446|FG007|Overall Study|Withdrawal by Subject|0|||
164572777|NCT02875223|594460447|FG008|Overall Study|Withdrawal by Subject|1|||
164572778|NCT02875223|594460448|FG009|Overall Study|Withdrawal by Subject|0|||
164572779|NCT02875223|594460449|FG010|Overall Study|Withdrawal by Subject|0|||
164572780|NCT02875223|594460450|FG011|Overall Study|Withdrawal by Subject|0|||
164572781|NCT02875223|594460451|FG012|Overall Study|Withdrawal by Subject|0|||
164572782|NCT02875223|594460439|FG000|Overall Study|Progressive disease|0|||
164572783|NCT02875223|594460440|FG001|Overall Study|Progressive disease|0|||
164572784|NCT02875223|594460441|FG002|Overall Study|Progressive disease|1|||
164572785|NCT02875223|594460442|FG003|Overall Study|Progressive disease|0|||
164572786|NCT02875223|594460443|FG004|Overall Study|Progressive disease|0|||
164572787|NCT02875223|594460444|FG005|Overall Study|Progressive disease|0|||
164572788|NCT02875223|594460445|FG006|Overall Study|Progressive disease|0|||
164572789|NCT02875223|594460446|FG007|Overall Study|Progressive disease|0|||
164572790|NCT02875223|594460447|FG008|Overall Study|Progressive disease|0|||
164676146|NCT00395694|594838070|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
164676147|NCT00395694|594838069|FG000|Continuation Phase|Adverse Event|1|||
164676148|NCT00395694|594838070|FG001|Continuation Phase|Adverse Event|0|||
164676149|NCT00395694|594838069|FG000|Continuation Phase|Lack of Efficacy|12|||
164333454|NCT00973349|593597446|FG001|Overall Study|Protocol Violation|0|||
164333455|NCT00973349|593597447|FG002|Overall Study|Protocol Violation|0|||
164572791|NCT02875223|594460448|FG009|Overall Study|Progressive disease|12|||
164676150|NCT00395694|594838070|FG001|Continuation Phase|Lack of Efficacy|11|||
164676151|NCT00395694|594838069|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
164676152|NCT00395694|594838070|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
164676153|NCT00395694|594838069|FG000|Continuation Phase|Poor Compliance|1|||
164676154|NCT00395694|594838070|FG001|Continuation Phase|Poor Compliance|0|||
164676155|NCT00395694|594838069|FG000|Continuation Phase|Withdrawal by Subject|0|||
164676156|NCT00395694|594838070|FG001|Continuation Phase|Withdrawal by Subject|2|||
164676157|NCT03249454|594838075|FG000|Overall Study|Withdrawal by Subject|0|||
164676158|NCT03249454|594838076|FG001|Overall Study|Withdrawal by Subject|0|||
164676159|NCT03249454|594838077|FG002|Overall Study|Withdrawal by Subject|0|||
164676160|NCT03249454|594838078|FG003|Overall Study|Withdrawal by Subject|0|||
164676161|NCT03249454|594838079|FG004|Overall Study|Withdrawal by Subject|0|||
164676162|NCT03249454|594838080|FG005|Overall Study|Withdrawal by Subject|0|||
164676163|NCT03249454|594838081|FG006|Overall Study|Withdrawal by Subject|0|||
164676164|NCT03249454|594838082|FG007|Overall Study|Withdrawal by Subject|0|||
164676165|NCT03249454|594838083|FG008|Overall Study|Withdrawal by Subject|0|||
164676166|NCT03249454|594838084|FG009|Overall Study|Withdrawal by Subject|1|||
164676167|NCT03249454|594838085|FG010|Overall Study|Withdrawal by Subject|1|||
164676168|NCT03987191|594838086|FG000|Overall Study|COVID-19 related research disruption|0|||
164676169|NCT03987191|594838087|FG001|Overall Study|COVID-19 related research disruption|2|||
164676170|NCT05446870|594838088|FG000|Overall Study|Death|6|||
164676171|NCT05446870|594838089|FG001|Overall Study|Death|5|||
164676172|NCT05446870|594838088|FG000|Overall Study|Lost to Follow-up|0|||
164676173|NCT05446870|594838089|FG001|Overall Study|Lost to Follow-up|1|||
164676174|NCT05446870|594838088|FG000|Overall Study|Physician Decision|52|||
164676175|NCT05446870|594838089|FG001|Overall Study|Physician Decision|53|||
164676176|NCT05446870|594838088|FG000|Overall Study|Withdrawal by Subject|3|||
164676177|NCT05446870|594838089|FG001|Overall Study|Withdrawal by Subject|3|||
164676178|NCT04108858|594838090|FG000|Overall Study|Adverse Event|1|||
164676179|NCT03663179|594838091|FG000|Overall Study|Withdrawal by Subject|2|||
164676180|NCT03663179|594838092|FG001|Overall Study|Withdrawal by Subject|0|||
164676181|NCT03663179|594838091|FG000|Overall Study|Lost to Follow-up|1|||
164676182|NCT03663179|594838092|FG001|Overall Study|Lost to Follow-up|1|||
164676183|NCT03663179|594838091|FG000|Overall Study|Revealed exclusionary condition|1|||
164676184|NCT03663179|594838092|FG001|Overall Study|Revealed exclusionary condition|0|||
164676185|NCT01940341|594838093|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
164676186|NCT01940341|594838094|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
164676187|NCT01940341|594838095|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
164676188|NCT01940341|594838096|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
164676189|NCT01940341|594838093|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
164676190|NCT01940341|594838094|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
164676191|NCT01940341|594838095|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
164676192|NCT01940341|594838096|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
164676193|NCT01940341|594838093|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
164676194|NCT01940341|594838094|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
164676195|NCT01940341|594838095|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
164676196|NCT01940341|594838096|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
164676197|NCT01940341|594838093|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
164676198|NCT01940341|594838094|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
164676199|NCT01940341|594838095|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
164676200|NCT01940341|594838096|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
164676201|NCT01940341|594838093|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
164676202|NCT01940341|594838094|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
164676203|NCT01940341|594838095|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
164676204|NCT01940341|594838096|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
164676205|NCT01940341|594838093|FG000|Period 1: Double-blind Phase|Death|0|||
164676206|NCT01940341|594838094|FG001|Period 1: Double-blind Phase|Death|1|||
164676207|NCT01940341|594838095|FG002|Period 1: Double-blind Phase|Death|0|||
164676208|NCT01940341|594838096|FG003|Period 1: Double-blind Phase|Death|0|||
164676209|NCT01940341|594838093|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
164676210|NCT01940341|594838094|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
164676211|NCT01940341|594838095|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
164676212|NCT01940341|594838096|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
164676213|NCT01940341|594838093|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
164676214|NCT01940341|594838094|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
164676215|NCT01940341|594838095|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
164676216|NCT01940341|594838096|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
164676217|NCT01940341|594838093|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
164676218|NCT01940341|594838094|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
164676219|NCT01940341|594838095|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
164423010|NCT00873093|593919497|FG003|Overall Study|Death|0|||
164676220|NCT01940341|594838096|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
164676221|NCT01940341|594838093|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
164676222|NCT01940341|594838094|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
164676223|NCT01940341|594838095|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
164676224|NCT01940341|594838096|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
164676225|NCT01940341|594838093|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
164676226|NCT01940341|594838094|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
164676227|NCT01940341|594838095|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
164676228|NCT01940341|594838096|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
164676229|NCT01940341|594838093|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
164676230|NCT01940341|594838094|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
164676231|NCT01940341|594838095|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
164676232|NCT01940341|594838096|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
164676233|NCT01940341|594838093|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
164676234|NCT01940341|594838094|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
164234403|NCT04583618|593229251|FG004|Overall Study|Protocol deviation|0|||
164234404|NCT04583618|593229247|FG000|Overall Study|Withdrawal by Subject|2|||
164234405|NCT04583618|593229248|FG001|Overall Study|Withdrawal by Subject|1|||
164234406|NCT04583618|593229249|FG002|Overall Study|Withdrawal by Subject|3|||
164234407|NCT04583618|593229250|FG003|Overall Study|Withdrawal by Subject|1|||
164234408|NCT04583618|593229251|FG004|Overall Study|Withdrawal by Subject|1|||
164234409|NCT04583618|593229247|FG000|Overall Study|Lost to Follow-up|0|||
164234410|NCT04583618|593229248|FG001|Overall Study|Lost to Follow-up|1|||
164234411|NCT04583618|593229249|FG002|Overall Study|Lost to Follow-up|3|||
164234412|NCT04583618|593229250|FG003|Overall Study|Lost to Follow-up|1|||
164234413|NCT04583618|593229251|FG004|Overall Study|Lost to Follow-up|1|||
164234414|NCT02302222|593229254|FG000|Overall Study|Physician Decision|0|||
164234415|NCT02302222|593229255|FG001|Overall Study|Physician Decision|4|||
164234416|NCT02302222|593229254|FG000|Overall Study|Lost to Follow-up|1|||
164234417|NCT02302222|593229255|FG001|Overall Study|Lost to Follow-up|0|||
164234418|NCT02302222|593229254|FG000|Overall Study|Treatment discontinued before day 5|0|||
164234419|NCT02302222|593229255|FG001|Overall Study|Treatment discontinued before day 5|1|||
164234420|NCT02302222|593229254|FG000|Overall Study|Withdrawn prior to any treatment|0|||
164234421|NCT02302222|593229255|FG001|Overall Study|Withdrawn prior to any treatment|1|||
164234422|NCT00016354|593229256|FG000|Overall Study|Lack of Efficacy|0|||
164234423|NCT00016354|593229257|FG001|Overall Study|Lack of Efficacy|0|||
164676235|NCT01940341|594838095|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
164676236|NCT01940341|594838096|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
164676237|NCT01940341|594838093|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
164676238|NCT01940341|594838094|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
164234424|NCT00016354|593229258|FG002|Overall Study|Lack of Efficacy|0|||
164234425|NCT00016354|593229259|FG003|Overall Study|Lack of Efficacy|0|||
164234426|NCT00016354|593229260|FG004|Overall Study|Lack of Efficacy|0|||
164234427|NCT00016354|593229261|FG005|Overall Study|Lack of Efficacy|0|||
164234428|NCT00016354|593229262|FG006|Overall Study|Lack of Efficacy|0|||
164234429|NCT00016354|593229263|FG007|Overall Study|Lack of Efficacy|1|||
164234430|NCT02769481|593229266|FG000|Overall Study|Protocol Violation|1|||
164676239|NCT01940341|594838095|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
164234431|NCT02769481|593229267|FG001|Overall Study|Protocol Violation|0|||
164234432|NCT02769481|593229266|FG000|Overall Study|Adverse Event|3|||
164234433|NCT02769481|593229267|FG001|Overall Study|Adverse Event|6|||
164234434|NCT02769481|593229266|FG000|Overall Study|Entry Criteria Not Met|1|||
164234435|NCT02769481|593229267|FG001|Overall Study|Entry Criteria Not Met|2|||
164234436|NCT02769481|593229266|FG000|Overall Study|Withdrawal by Subject|14|||
164234437|NCT02769481|593229267|FG001|Overall Study|Withdrawal by Subject|16|||
164234438|NCT02769481|593229266|FG000|Overall Study|Lost to Follow-up|9|||
164234439|NCT02769481|593229267|FG001|Overall Study|Lost to Follow-up|9|||
164234440|NCT02769481|593229266|FG000|Overall Study|Physician Decision|0|||
164234441|NCT02769481|593229267|FG001|Overall Study|Physician Decision|1|||
164234442|NCT02769481|593229266|FG000|Overall Study|Terminated by Sponsor|1|||
164234443|NCT02769481|593229267|FG001|Overall Study|Terminated by Sponsor|0|||
164234444|NCT02769481|593229266|FG000|Overall Study|Death|0|||
164333456|NCT00973349|593597448|FG003|Overall Study|Protocol Violation|0|||
164234445|NCT02769481|593229267|FG001|Overall Study|Death|1|||
164234446|NCT02769481|593229266|FG000|Overall Study|Undefined|4|||
164234447|NCT02769481|593229267|FG001|Overall Study|Undefined|1|||
164234448|NCT02781558|593229268|FG000|Overall Study|Lost to Follow-up|2|||
164676240|NCT01940341|594838096|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
164676241|NCT01940341|594838093|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
164676242|NCT01940341|594838094|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
164676243|NCT01940341|594838095|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
164234449|NCT02781558|593229269|FG001|Overall Study|Lost to Follow-up|2|||
164234450|NCT02781558|593229268|FG000|Overall Study|Adverse Event|1|||
164234451|NCT02781558|593229269|FG001|Overall Study|Adverse Event|0|||
164234452|NCT00643279|593229272|FG000|Overall Study|Death|13|||
164234453|NCT00643279|593229273|FG001|Overall Study|Death|11|||
164234454|NCT00643279|593229272|FG000|Overall Study|Withdrawal by Subject|3|||
164234455|NCT00643279|593229273|FG001|Overall Study|Withdrawal by Subject|0|||
164234456|NCT00643279|593229272|FG000|Overall Study|Lost to Follow-up|0|||
164234457|NCT00643279|593229273|FG001|Overall Study|Lost to Follow-up|1|||
164234458|NCT00643279|593229272|FG000|Overall Study|Physician Decision|0|||
164234459|NCT00643279|593229273|FG001|Overall Study|Physician Decision|1|||
164234460|NCT03274466|593229274|FG000|Overall Study|Withdrawal by Subject|7|||
164234461|NCT03274466|593229275|FG001|Overall Study|Withdrawal by Subject|3|||
164234462|NCT03274466|593229274|FG000|Overall Study|Protocol Specified Withdrawal|5|||
164234463|NCT03274466|593229275|FG001|Overall Study|Protocol Specified Withdrawal|11|||
164234464|NCT03274466|593229274|FG000|Overall Study|Lost to Follow-up|5|||
164234465|NCT03274466|593229275|FG001|Overall Study|Lost to Follow-up|7|||
164234466|NCT03274466|593229274|FG000|Overall Study|Subject Non-compliance|0|||
164234467|NCT03274466|593229275|FG001|Overall Study|Subject Non-compliance|1|||
164234468|NCT03274466|593229274|FG000|Overall Study|Adverse Event|3|||
164234469|NCT03274466|593229275|FG001|Overall Study|Adverse Event|3|||
164333457|NCT00973349|593597449|FG004|Overall Study|Protocol Violation|0|||
164333458|NCT00973349|593597450|FG005|Overall Study|Protocol Violation|0|||
164333459|NCT00973349|593597451|FG006|Overall Study|Protocol Violation|0|||
164333460|NCT00973349|593597452|FG007|Overall Study|Protocol Violation|0|||
164333461|NCT00973349|593597453|FG008|Overall Study|Protocol Violation|1|||
164676244|NCT01940341|594838096|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
164676245|NCT01940341|594838093|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
164676246|NCT01940341|594838094|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
164676247|NCT01940341|594838095|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
164676248|NCT01940341|594838096|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
164676249|NCT01940341|594838093|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
164676250|NCT01940341|594838094|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
164676251|NCT01940341|594838095|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
164676252|NCT01940341|594838096|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
164676253|NCT01940341|594838093|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
164676254|NCT01940341|594838094|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
164676255|NCT01940341|594838095|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
164676256|NCT01940341|594838096|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
164676257|NCT01940341|594838093|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
164676258|NCT01940341|594838094|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
164676259|NCT01940341|594838095|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
164676260|NCT01940341|594838096|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
164676261|NCT01289262|594838099|FG000|Overall Study|Lost to Follow-up|29|||
164676262|NCT01289262|594838100|FG001|Overall Study|Lost to Follow-up|16|||
164676263|NCT01289262|594838099|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
164676264|NCT01289262|594838100|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
164676265|NCT03792477|594838103|FG000|Overall Study|Adverse Event|0|||
164676266|NCT03792477|594838104|FG001|Overall Study|Adverse Event|0|||
164676267|NCT03792477|594838105|FG002|Overall Study|Adverse Event|0|||
164676268|NCT03792477|594838106|FG003|Overall Study|Adverse Event|1|||
164676269|NCT03792477|594838107|FG004|Overall Study|Adverse Event|0|||
164676270|NCT03792477|594838103|FG000|Overall Study|Lost to Follow-up|0|||
164676271|NCT03792477|594838104|FG001|Overall Study|Lost to Follow-up|0|||
164676272|NCT03792477|594838105|FG002|Overall Study|Lost to Follow-up|2|||
164676273|NCT03792477|594838106|FG003|Overall Study|Lost to Follow-up|0|||
164676274|NCT03792477|594838107|FG004|Overall Study|Lost to Follow-up|0|||
164676275|NCT03792477|594838103|FG000|Overall Study|Other|0|||
164676276|NCT03792477|594838104|FG001|Overall Study|Other|0|||
164676277|NCT03792477|594838105|FG002|Overall Study|Other|0|||
164676278|NCT03792477|594838106|FG003|Overall Study|Other|0|||
164676279|NCT03792477|594838107|FG004|Overall Study|Other|1|||
164676280|NCT00446563|594838110|FG000|Overall Study|Adverse Event|4|||
164676281|NCT00446563|594838111|FG001|Overall Study|Adverse Event|3|||
164676282|NCT00446563|594838110|FG000|Overall Study|Abnormal laboratory value(s)|0|||
164676283|NCT00446563|594838111|FG001|Overall Study|Abnormal laboratory value(s)|1|||
164333462|NCT00973349|593597454|FG009|Overall Study|Protocol Violation|0|||
164676284|NCT00446563|594838110|FG000|Overall Study|Abnormal test procedure result(s)|1|||
164676285|NCT00446563|594838111|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164234470|NCT03274466|593229274|FG000|Overall Study|Physician Decision|0|||
164676286|NCT00446563|594838110|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164234471|NCT03274466|593229275|FG001|Overall Study|Physician Decision|1|||
164234472|NCT03274466|593229274|FG000|Overall Study|Protocol Violation|3|||
164333463|NCT00973349|593597455|FG010|Overall Study|Protocol Violation|0|||
164333464|NCT00973349|593597456|FG011|Overall Study|Protocol Violation|0|||
164234473|NCT03274466|593229275|FG001|Overall Study|Protocol Violation|3|||
164234474|NCT01107886|593229281|FG000|Overall Study|Lost to Follow-up|15|||
164234475|NCT01107886|593229282|FG001|Overall Study|Lost to Follow-up|13|||
164234476|NCT01107886|593229281|FG000|Overall Study|Withdrawal by Subject|180|||
164234477|NCT01107886|593229282|FG001|Overall Study|Withdrawal by Subject|196|||
164234478|NCT01107886|593229281|FG000|Overall Study|Administrative withdrawal of consent|7|||
164234479|NCT01107886|593229282|FG001|Overall Study|Administrative withdrawal of consent|5|||
164234480|NCT01346176|593229283|FG000|Recruited|Protocol Violation|1|||
164423011|NCT00873093|593919498|FG004|Overall Study|Death|0|||
164423012|NCT00873093|593919494|FG000|Overall Study|Physician Decision|0|||
164423013|NCT00873093|593919495|FG001|Overall Study|Physician Decision|17|||
164423014|NCT00873093|593919496|FG002|Overall Study|Physician Decision|10|||
164423015|NCT00873093|593919497|FG003|Overall Study|Physician Decision|10|||
164423016|NCT00873093|593919498|FG004|Overall Study|Physician Decision|2|||
164423017|NCT00873093|593919494|FG000|Overall Study|Withdrawal by Subject|1|||
164423018|NCT00873093|593919495|FG001|Overall Study|Withdrawal by Subject|4|||
164423019|NCT00873093|593919496|FG002|Overall Study|Withdrawal by Subject|4|||
164423020|NCT00873093|593919497|FG003|Overall Study|Withdrawal by Subject|0|||
164423021|NCT00873093|593919498|FG004|Overall Study|Withdrawal by Subject|0|||
164423022|NCT00873093|593919494|FG000|Overall Study|Ineligible|0|||
164423023|NCT00873093|593919495|FG001|Overall Study|Ineligible|1|||
164423024|NCT00873093|593919496|FG002|Overall Study|Ineligible|0|||
164423025|NCT00873093|593919497|FG003|Overall Study|Ineligible|1|||
164423026|NCT00873093|593919498|FG004|Overall Study|Ineligible|0|||
164423027|NCT01152554|593919500|FG000|Overall Study|Withdrawal by Subject|73|||
164423028|NCT01152554|593919501|FG001|Overall Study|Withdrawal by Subject|28|||
164423029|NCT01152554|593919500|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
164423030|NCT01152554|593919501|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
164423031|NCT01152554|593919500|FG000|Overall Study|Adverse Event|67|||
164423032|NCT01152554|593919501|FG001|Overall Study|Adverse Event|14|||
164423033|NCT01152554|593919500|FG000|Overall Study|Severe non-compliance to protocol|36|||
164423034|NCT01152554|593919501|FG001|Overall Study|Severe non-compliance to protocol|14|||
164423035|NCT01152554|593919500|FG000|Overall Study|Condition under investigation worsened|5|||
164423036|NCT01152554|593919501|FG001|Overall Study|Condition under investigation worsened|2|||
164423037|NCT01152554|593919500|FG000|Overall Study|Lack of Efficacy|20|||
164423038|NCT01152554|593919501|FG001|Overall Study|Lack of Efficacy|3|||
164423039|NCT01152554|593919500|FG000|Overall Study|Study-specific withdrawal criteria|17|||
164423040|NCT01152554|593919501|FG001|Overall Study|Study-specific withdrawal criteria|8|||
164423041|NCT01152554|593919500|FG000|Overall Study|Lost to Follow-up|87|||
164423042|NCT01152554|593919501|FG001|Overall Study|Lost to Follow-up|32|||
164423043|NCT01152554|593919500|FG000|Overall Study|Other|28|||
164423044|NCT01152554|593919501|FG001|Overall Study|Other|8|||
164423045|NCT01152554|593919500|FG000|Overall Study|Death|1|||
164423046|NCT01152554|593919501|FG001|Overall Study|Death|1|||
164423047|NCT00146640|593919504|FG000|Overall Study|Adverse Event|12|||
164423048|NCT00146640|593919505|FG001|Overall Study|Adverse Event|10|||
164423049|NCT00146640|593919504|FG000|Overall Study|Medical Reasons|3|||
164423050|NCT00146640|593919505|FG001|Overall Study|Medical Reasons|0|||
164423051|NCT00146640|593919504|FG000|Overall Study|Non-Medical Reasons|8|||
164423052|NCT00146640|593919505|FG001|Overall Study|Non-Medical Reasons|4|||
164423053|NCT03486899|593919506|FG000|Overall Study|Lost to Follow-up|4|||
164423054|NCT03486899|593919507|FG001|Overall Study|Lost to Follow-up|1|||
164423055|NCT03486899|593919508|FG002|Overall Study|Lost to Follow-up|4|||
164423056|NCT03486899|593919509|FG003|Overall Study|Lost to Follow-up|3|||
164423057|NCT03486899|593919506|FG000|Overall Study|Death|1|||
164423058|NCT03486899|593919507|FG001|Overall Study|Death|0|||
164572792|NCT02875223|594460449|FG010|Overall Study|Progressive disease|2|||
164423059|NCT03486899|593919508|FG002|Overall Study|Death|0|||
164423060|NCT03486899|593919509|FG003|Overall Study|Death|1|||
164423061|NCT03486899|593919506|FG000|Overall Study|Adverse Event|0|||
164234481|NCT01346176|593229284|FG001|Recruited|Protocol Violation|0|||
164234482|NCT01346176|593229285|FG002|Recruited|Protocol Violation|0|||
164234483|NCT01346176|593229283|FG000|Completed Advance Directive|Death|3|||
164234484|NCT01346176|593229284|FG001|Completed Advance Directive|Death|2|||
164234485|NCT01346176|593229285|FG002|Completed Advance Directive|Death|2|||
164423062|NCT03486899|593919507|FG001|Overall Study|Adverse Event|2|||
164423063|NCT03486899|593919508|FG002|Overall Study|Adverse Event|0|||
164234486|NCT01346176|593229283|FG000|Completed Advance Directive|Became Ineligible|3|||
164234487|NCT01346176|593229284|FG001|Completed Advance Directive|Became Ineligible|0|||
164423064|NCT03486899|593919509|FG003|Overall Study|Adverse Event|2|||
164423065|NCT03486899|593919506|FG000|Overall Study|Withdrawal by Subject|3|||
164423066|NCT03486899|593919507|FG001|Overall Study|Withdrawal by Subject|7|||
164423067|NCT03486899|593919508|FG002|Overall Study|Withdrawal by Subject|4|||
164423068|NCT03486899|593919509|FG003|Overall Study|Withdrawal by Subject|3|||
164423069|NCT03486899|593919506|FG000|Overall Study|Other Reasons|0|||
164423070|NCT03486899|593919507|FG001|Overall Study|Other Reasons|1|||
164423071|NCT03486899|593919508|FG002|Overall Study|Other Reasons|0|||
164423072|NCT03486899|593919509|FG003|Overall Study|Other Reasons|1|||
164423073|NCT01439711|593919510|FG000|Overall Study|Ineligible|13|||
164333465|NCT00973349|593597457|FG012|Overall Study|Protocol Violation|0|||
164333466|NCT00973349|593597458|FG013|Overall Study|Protocol Violation|0|||
164333467|NCT00973349|593597459|FG014|Overall Study|Protocol Violation|0|||
164333468|NCT00973349|593597460|FG015|Overall Study|Protocol Violation|0|||
164333469|NCT00973349|593597445|FG000|Overall Study|Unable to classify|0|||
164333470|NCT00973349|593597446|FG001|Overall Study|Unable to classify|0|||
164333471|NCT00973349|593597447|FG002|Overall Study|Unable to classify|0|||
164333472|NCT00973349|593597448|FG003|Overall Study|Unable to classify|0|||
164333473|NCT00973349|593597449|FG004|Overall Study|Unable to classify|1|||
164333474|NCT00973349|593597450|FG005|Overall Study|Unable to classify|1|||
164333475|NCT00973349|593597451|FG006|Overall Study|Unable to classify|0|||
164333476|NCT00973349|593597452|FG007|Overall Study|Unable to classify|0|||
164333477|NCT00973349|593597453|FG008|Overall Study|Unable to classify|0|||
164333478|NCT00973349|593597454|FG009|Overall Study|Unable to classify|1|||
164333479|NCT00973349|593597455|FG010|Overall Study|Unable to classify|0|||
164333480|NCT00973349|593597456|FG011|Overall Study|Unable to classify|0|||
164333481|NCT00973349|593597457|FG012|Overall Study|Unable to classify|0|||
164333482|NCT00973349|593597458|FG013|Overall Study|Unable to classify|0|||
164333483|NCT00973349|593597459|FG014|Overall Study|Unable to classify|0|||
164333484|NCT00973349|593597460|FG015|Overall Study|Unable to classify|0|||
164333485|NCT02898116|593597465|FG000|Overall Study|Adverse Event|1|||
164333486|NCT02898116|593597465|FG000|Overall Study|Progressive disease|1|||
164333487|NCT02130024|593597466|FG000|Overall Study|Adverse Event|10|||
164676287|NCT00446563|594838111|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
164676288|NCT00446563|594838110|FG000|Overall Study|Withdrawal by Subject|2|||
164676289|NCT00446563|594838111|FG001|Overall Study|Withdrawal by Subject|1|||
164676290|NCT00446563|594838110|FG000|Overall Study|Administrative problems|0|||
164676291|NCT00446563|594838111|FG001|Overall Study|Administrative problems|1|||
164676292|NCT01169558|594838112|FG000|Overall Study|Disease progression|98|||
164676293|NCT01169558|594838112|FG000|Overall Study|Adverse Event|25|||
164676294|NCT01169558|594838112|FG000|Overall Study|Withdrawal of Consent|8|||
164676295|NCT01169558|594838112|FG000|Overall Study|Medical Decision|7|||
164676296|NCT01169558|594838112|FG000|Overall Study|Stable Disease|4|||
164676297|NCT01169558|594838112|FG000|Overall Study|Lost to Follow-up|4|||
164676298|NCT01169558|594838112|FG000|Overall Study|Need for Surgery|4|||
164676299|NCT01169558|594838112|FG000|Overall Study|Non-compliance|2|||
164676300|NCT01169558|594838112|FG000|Overall Study|Protocol Violation|2|||
164676301|NCT01169558|594838112|FG000|Overall Study|Partial response|2|||
164676302|NCT03134222|594838115|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
164676303|NCT03134222|594838116|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
164676304|NCT03134222|594838117|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
164676305|NCT03134222|594838118|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
164676306|NCT03134222|594838119|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
164676307|NCT03134222|594838115|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
164676308|NCT03134222|594838116|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
164676309|NCT03134222|594838117|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
164676310|NCT03134222|594838118|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
164676311|NCT03134222|594838119|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
164676312|NCT03134222|594838115|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
164676313|NCT03134222|594838116|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
164676314|NCT03134222|594838117|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
164676315|NCT03134222|594838118|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
164676316|NCT03134222|594838119|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
164676317|NCT03134222|594838115|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
164676318|NCT03134222|594838116|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
164676319|NCT03134222|594838117|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
164676320|NCT03134222|594838118|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
164676321|NCT03134222|594838119|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
164676322|NCT03134222|594838115|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
164676323|NCT03134222|594838116|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
164676324|NCT03134222|594838117|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
164676325|NCT03134222|594838118|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
164676326|NCT03134222|594838119|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
164676327|NCT03134222|594838115|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
164676328|NCT03134222|594838116|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
164676329|NCT03134222|594838117|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
164676330|NCT03134222|594838118|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
164676331|NCT03134222|594838119|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
164333488|NCT02130024|593597467|FG001|Overall Study|Adverse Event|11|||
164333489|NCT02130024|593597466|FG000|Overall Study|Death|2|||
164333490|NCT02130024|593597467|FG001|Overall Study|Death|2|||
164333491|NCT02130024|593597466|FG000|Overall Study|Lost to Follow-up|1|||
164333492|NCT02130024|593597467|FG001|Overall Study|Lost to Follow-up|1|||
164333493|NCT02130024|593597466|FG000|Overall Study|Physician Decision|1|||
164333494|NCT02130024|593597467|FG001|Overall Study|Physician Decision|3|||
164234488|NCT01346176|593229285|FG002|Completed Advance Directive|Became Ineligible|1|||
164234489|NCT01346176|593229283|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
164333495|NCT02130024|593597466|FG000|Overall Study|Protocol Deviation|4|||
164333496|NCT02130024|593597467|FG001|Overall Study|Protocol Deviation|0|||
164333497|NCT02130024|593597466|FG000|Overall Study|Site Administration Problems|1|||
164333498|NCT02130024|593597467|FG001|Overall Study|Site Administration Problems|0|||
164333499|NCT02130024|593597466|FG000|Overall Study|Subject Withdrew Consent|6|||
164333500|NCT02130024|593597467|FG001|Overall Study|Subject Withdrew Consent|14|||
164333501|NCT05597020|593597471|FG000|Washout|Forbidden medication|2|||
164333502|NCT05597020|593597472|FG001|Washout|Forbidden medication|0|||
164333503|NCT05597020|593597471|FG000|Treatment Period II|Advice from primary care physician|1|||
164333504|NCT05597020|593597472|FG001|Treatment Period II|Advice from primary care physician|0|||
164333505|NCT05597020|593597471|FG000|Treatment Period II|Subject lost investigational product|1|||
164234490|NCT01346176|593229284|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
164234491|NCT01346176|593229285|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
164234492|NCT01346176|593229283|FG000|Completed Satisfaction Survey|Death|3|||
164234493|NCT01346176|593229284|FG001|Completed Satisfaction Survey|Death|0|||
164234494|NCT01346176|593229285|FG002|Completed Satisfaction Survey|Death|2|||
164234495|NCT01346176|593229283|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
164234496|NCT01346176|593229284|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
164234497|NCT01346176|593229285|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
164333506|NCT05597020|593597472|FG001|Treatment Period II|Subject lost investigational product|0|||
164333507|NCT05597020|593597471|FG000|Treatment Period II|Private reasons|0|||
164333508|NCT05597020|593597472|FG001|Treatment Period II|Private reasons|1|||
164333509|NCT05736224|593597473|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
164333510|NCT01015131|593597474|FG000|Overall Study|Physician Decision|1|||
164333511|NCT01015131|593597474|FG000|Overall Study|Protocol Violation|1|||
164676332|NCT03134222|594838115|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
164234498|NCT01334918|593231338|FG000|Overall Study|Did not receive study drug|6|||
164234499|NCT01334918|593231339|FG001|Overall Study|Did not receive study drug|0|||
164234500|NCT01334918|593231338|FG000|Overall Study|Adverse Event|2|||
164234501|NCT01334918|593231339|FG001|Overall Study|Adverse Event|0|||
164234502|NCT01334918|593231338|FG000|Overall Study|Withdrawal by Subject|0|||
164234503|NCT01334918|593231339|FG001|Overall Study|Withdrawal by Subject|1|||
164234504|NCT01576783|593231343|FG000|Overall Study|Change in Medical Care|1|||
164234505|NCT01576783|593231344|FG001|Overall Study|Change in Medical Care|0|||
164234506|NCT01576783|593231343|FG000|Overall Study|Lost to Follow-up|14|||
164234507|NCT01576783|593231344|FG001|Overall Study|Lost to Follow-up|16|||
164234508|NCT01576783|593231343|FG000|Overall Study|Withdrawal by Subject|5|||
164234509|NCT01576783|593231344|FG001|Overall Study|Withdrawal by Subject|1|||
164234510|NCT05489328|593231345|FG000|Overall Study|Lost to Follow-up|0|||
164234511|NCT05489328|593231346|FG001|Overall Study|Lost to Follow-up|0|||
164234512|NCT05489328|593231347|FG002|Overall Study|Lost to Follow-up|1|||
164234513|NCT05489328|593231348|FG003|Overall Study|Lost to Follow-up|0|||
164234514|NCT05489328|593231349|FG004|Overall Study|Lost to Follow-up|2|||
164234515|NCT05489328|593231350|FG005|Overall Study|Lost to Follow-up|0|||
164234516|NCT05489328|593231351|FG006|Overall Study|Lost to Follow-up|0|||
164234517|NCT05489328|593231352|FG007|Overall Study|Lost to Follow-up|1|||
164234518|NCT05489328|593231353|FG008|Overall Study|Lost to Follow-up|0|||
164234519|NCT05489328|593231345|FG000|Overall Study|Withdrawal by Subject|0|||
164234520|NCT05489328|593231346|FG001|Overall Study|Withdrawal by Subject|0|||
164234521|NCT05489328|593231347|FG002|Overall Study|Withdrawal by Subject|0|||
164234522|NCT05489328|593231348|FG003|Overall Study|Withdrawal by Subject|0|||
164234523|NCT05489328|593231349|FG004|Overall Study|Withdrawal by Subject|0|||
164234524|NCT05489328|593231350|FG005|Overall Study|Withdrawal by Subject|0|||
164234525|NCT05489328|593231351|FG006|Overall Study|Withdrawal by Subject|1|||
164234526|NCT05489328|593231352|FG007|Overall Study|Withdrawal by Subject|1|||
164234527|NCT05489328|593231353|FG008|Overall Study|Withdrawal by Subject|0|||
164234528|NCT05489328|593231345|FG000|Overall Study|Other|0|||
164333512|NCT01015131|593597474|FG000|Overall Study|Withdrawal by Subject|2|||
164423074|NCT01439711|593919510|FG000|Overall Study|Cancel|3|||
164676333|NCT03134222|594838116|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
164676334|NCT03134222|594838117|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
164676335|NCT03134222|594838118|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
164676336|NCT03134222|594838119|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
164676337|NCT03134222|594838115|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
164333513|NCT01015131|593597474|FG000|Overall Study|Other Protocol Specified Criteria|4|||
164234529|NCT05489328|593231346|FG001|Overall Study|Other|0|||
164234530|NCT05489328|593231347|FG002|Overall Study|Other|0|||
164234531|NCT05489328|593231348|FG003|Overall Study|Other|0|||
164234532|NCT05489328|593231349|FG004|Overall Study|Other|0|||
164234533|NCT05489328|593231350|FG005|Overall Study|Other|0|||
164234534|NCT05489328|593231351|FG006|Overall Study|Other|0|||
164423075|NCT01439711|593919510|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
164423076|NCT01439711|593919510|FG000|Overall Study|Adverse Event|5|||
164423077|NCT01439711|593919510|FG000|Overall Study|Withdrawal by Subject|3|||
164423078|NCT01439711|593919510|FG000|Overall Study|Progression During Active Tx|3|||
164423079|NCT01439711|593919510|FG000|Overall Study|Noncompliance|3|||
164423080|NCT01439711|593919510|FG000|Overall Study|No MRI|9|||
164423081|NCT04242875|593919511|FG000|Overall Study|Adverse Event|2|||
164423082|NCT02397460|593919512|FG000|Treatment Period 2|Adverse Event|0|||
164423083|NCT02397460|593919513|FG001|Treatment Period 2|Adverse Event|0|||
164423084|NCT02397460|593919514|FG002|Treatment Period 2|Adverse Event|0|||
164423085|NCT02397460|593919515|FG003|Treatment Period 2|Adverse Event|0|||
164423086|NCT02397460|593919516|FG004|Treatment Period 2|Adverse Event|0|||
164423087|NCT02397460|593919517|FG005|Treatment Period 2|Adverse Event|0|||
164423088|NCT02397460|593919518|FG006|Treatment Period 2|Adverse Event|0|||
164423089|NCT02397460|593919519|FG007|Treatment Period 2|Adverse Event|1|||
164423090|NCT02397460|593919512|FG000|Treatment Period 4|Adverse Event|0|||
164423091|NCT02397460|593919513|FG001|Treatment Period 4|Adverse Event|1|||
164423092|NCT02397460|593919514|FG002|Treatment Period 4|Adverse Event|0|||
164423093|NCT02397460|593919515|FG003|Treatment Period 4|Adverse Event|0|||
164423094|NCT02397460|593919516|FG004|Treatment Period 4|Adverse Event|0|||
164423095|NCT02397460|593919517|FG005|Treatment Period 4|Adverse Event|0|||
164423096|NCT02397460|593919518|FG006|Treatment Period 4|Adverse Event|0|||
164423097|NCT02397460|593919519|FG007|Treatment Period 4|Adverse Event|0|||
164423098|NCT02397460|593919512|FG000|Treatment Period 4|Physician Decision|0|||
164423099|NCT02397460|593919513|FG001|Treatment Period 4|Physician Decision|0|||
164423100|NCT02397460|593919514|FG002|Treatment Period 4|Physician Decision|0|||
164423101|NCT02397460|593919515|FG003|Treatment Period 4|Physician Decision|0|||
164423102|NCT02397460|593919516|FG004|Treatment Period 4|Physician Decision|1|||
164423103|NCT02397460|593919517|FG005|Treatment Period 4|Physician Decision|0|||
164423104|NCT02397460|593919518|FG006|Treatment Period 4|Physician Decision|0|||
164423105|NCT02397460|593919519|FG007|Treatment Period 4|Physician Decision|0|||
164423106|NCT01723826|593919523|FG000|Overall Study|Adverse Event|4|||
164423107|NCT01723826|593919524|FG001|Overall Study|Adverse Event|1|||
164423108|NCT01723826|593919525|FG002|Overall Study|Adverse Event|4|||
164423109|NCT01723826|593919526|FG003|Overall Study|Adverse Event|5|||
164423110|NCT01723826|593919523|FG000|Overall Study|Death according to AE eCRF|2|||
164423111|NCT01723826|593919524|FG001|Overall Study|Death according to AE eCRF|3|||
164423112|NCT01723826|593919525|FG002|Overall Study|Death according to AE eCRF|3|||
164423113|NCT01723826|593919526|FG003|Overall Study|Death according to AE eCRF|7|||
164423114|NCT01723826|593919523|FG000|Overall Study|Lost to Follow-up|1|||
164423115|NCT01723826|593919524|FG001|Overall Study|Lost to Follow-up|3|||
164423116|NCT01723826|593919525|FG002|Overall Study|Lost to Follow-up|1|||
164423117|NCT01723826|593919526|FG003|Overall Study|Lost to Follow-up|1|||
164423118|NCT01723826|593919523|FG000|Overall Study|Non-compliance|0|||
164423119|NCT01723826|593919524|FG001|Overall Study|Non-compliance|1|||
164423120|NCT01723826|593919525|FG002|Overall Study|Non-compliance|3|||
164423121|NCT01723826|593919526|FG003|Overall Study|Non-compliance|3|||
164423122|NCT01723826|593919523|FG000|Overall Study|Non-compliance With Study Drug|0|||
164423123|NCT01723826|593919524|FG001|Overall Study|Non-compliance With Study Drug|1|||
164423124|NCT01723826|593919525|FG002|Overall Study|Non-compliance With Study Drug|0|||
164423125|NCT01723826|593919526|FG003|Overall Study|Non-compliance With Study Drug|0|||
164423126|NCT01723826|593919523|FG000|Overall Study|Other Reason|8|||
164423127|NCT01723826|593919524|FG001|Overall Study|Other Reason|6|||
164423128|NCT01723826|593919525|FG002|Overall Study|Other Reason|12|||
164423129|NCT01723826|593919526|FG003|Overall Study|Other Reason|14|||
164423130|NCT01723826|593919523|FG000|Overall Study|Physician Decision|1|||
164423131|NCT01723826|593919524|FG001|Overall Study|Physician Decision|3|||
164423132|NCT01723826|593919525|FG002|Overall Study|Physician Decision|4|||
164423133|NCT01723826|593919526|FG003|Overall Study|Physician Decision|11|||
164423134|NCT01723826|593919523|FG000|Overall Study|Protocol Violation|1|||
164423135|NCT01723826|593919524|FG001|Overall Study|Protocol Violation|1|||
164423136|NCT01723826|593919525|FG002|Overall Study|Protocol Violation|3|||
164423137|NCT01723826|593919526|FG003|Overall Study|Protocol Violation|1|||
164423138|NCT01723826|593919523|FG000|Overall Study|Withdrawal by Subject|10|||
164423139|NCT01723826|593919524|FG001|Overall Study|Withdrawal by Subject|17|||
164423140|NCT01723826|593919525|FG002|Overall Study|Withdrawal by Subject|27|||
164423141|NCT01723826|593919526|FG003|Overall Study|Withdrawal by Subject|48|||
164423142|NCT01767129|593919527|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
164234535|NCT05489328|593231352|FG007|Overall Study|Other|1|||
164234536|NCT05489328|593231353|FG008|Overall Study|Other|1|||
164234537|NCT01083602|593231354|FG000|Overall Study|Adverse Event|11|||
164234538|NCT01083602|593231354|FG000|Overall Study|New Cancer Therapy|2|||
164234539|NCT01083602|593231354|FG000|Overall Study|Death|1|||
164234540|NCT01083602|593231354|FG000|Overall Study|Withdrawal by Subject|5|||
164234541|NCT01083602|593231354|FG000|Overall Study|Lack of Efficacy|36|||
164423143|NCT01767129|593919528|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
164423144|NCT01473420|593919530|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
164234542|NCT01657370|593231358|FG000|Overall Study|Withdrawal by Subject|0|||
164234543|NCT01657370|593231359|FG001|Overall Study|Withdrawal by Subject|0|||
164423145|NCT01473420|593919531|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
164423146|NCT01473420|593919530|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
164423147|NCT01473420|593919531|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
164423148|NCT01473420|593919530|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
164423149|NCT01473420|593919531|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
164423150|NCT01473420|593919530|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
164423151|NCT01473420|593919531|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
164423152|NCT01473420|593919530|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
164423153|NCT01473420|593919531|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
164423154|NCT01473420|593919530|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
164423155|NCT01473420|593919531|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
164423156|NCT01473420|593919530|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
164423157|NCT01473420|593919531|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
164423158|NCT01473420|593919530|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
164423159|NCT01473420|593919531|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
164423160|NCT01473420|593919530|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
164423161|NCT01473420|593919531|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
164423162|NCT01473420|593919530|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
164423163|NCT01473420|593919531|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
164423164|NCT01473420|593919530|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
164423165|NCT01473420|593919531|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
164423166|NCT01473420|593919530|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
164423167|NCT01473420|593919531|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
164423168|NCT01473420|593919530|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
164423169|NCT01473420|593919531|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
164423170|NCT03259373|593919545|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
164423171|NCT03259373|593919546|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
164423172|NCT03259373|593919545|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
164423173|NCT03259373|593919546|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
164423174|NCT03259373|593919545|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
164423175|NCT03259373|593919546|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
164423176|NCT03259373|593919545|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
164423177|NCT03259373|593919546|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
164423178|NCT03259373|593919545|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
164423179|NCT03259373|593919546|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
164423180|NCT03259373|593919545|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
164423181|NCT03259373|593919546|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
164423182|NCT02906202|593919551|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
164423183|NCT05764239|593919552|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
164423184|NCT05764239|593919552|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
164423185|NCT05764239|593919552|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
164423186|NCT05764239|593919552|FG000|DEP (Part 1)|Adverse Event|1|||
164423187|NCT05764239|593919552|FG000|DEP (Part 1)|Lost to Follow-up|1|||
164423188|NCT05764239|593919552|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
164423189|NCT05764239|593919552|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
164423190|NCT05764239|593919552|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
164234544|NCT01657370|593231360|FG002|Overall Study|Withdrawal by Subject|1|||
164234545|NCT01657370|593231361|FG003|Overall Study|Withdrawal by Subject|0|||
164234546|NCT01657370|593231362|FG004|Overall Study|Withdrawal by Subject|0|||
164234547|NCT01657370|593231363|FG005|Overall Study|Withdrawal by Subject|1|||
164234548|NCT01657370|593231358|FG000|Overall Study|Physician Decision|2|||
164234549|NCT01657370|593231359|FG001|Overall Study|Physician Decision|3|||
164234550|NCT01657370|593231360|FG002|Overall Study|Physician Decision|1|||
164234551|NCT01657370|593231361|FG003|Overall Study|Physician Decision|2|||
164234552|NCT01657370|593231362|FG004|Overall Study|Physician Decision|5|||
164234553|NCT01657370|593231363|FG005|Overall Study|Physician Decision|0|||
164234554|NCT01657370|593231358|FG000|Overall Study|Lack of Qualifying Event|1|||
164234555|NCT01657370|593231359|FG001|Overall Study|Lack of Qualifying Event|0|||
164234556|NCT01657370|593231360|FG002|Overall Study|Lack of Qualifying Event|3|||
164234557|NCT01657370|593231361|FG003|Overall Study|Lack of Qualifying Event|2|||
164234558|NCT01657370|593231362|FG004|Overall Study|Lack of Qualifying Event|1|||
164234559|NCT01657370|593231363|FG005|Overall Study|Lack of Qualifying Event|2|||
164234560|NCT01657370|593231358|FG000|Overall Study|Adverse Event|0|||
164423191|NCT05764239|593919552|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
164234561|NCT01657370|593231359|FG001|Overall Study|Adverse Event|0|||
164234562|NCT01657370|593231360|FG002|Overall Study|Adverse Event|0|||
164234563|NCT01657370|593231361|FG003|Overall Study|Adverse Event|0|||
164234564|NCT01657370|593231362|FG004|Overall Study|Adverse Event|1|||
164676338|NCT03134222|594838116|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
164676339|NCT03134222|594838117|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
164676340|NCT03134222|594838118|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
164676341|NCT03134222|594838119|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
164676342|NCT02605928|594838120|FG000|Overall Study|Model tuning phase|28|||
164676343|NCT02605928|594838120|FG000|Overall Study|Lack of Efficacy|5|||
164676344|NCT03482882|594838123|FG000|Overall Study|Adverse Event|3|||
164676345|NCT03482882|594838123|FG000|Overall Study|Lost to Follow-up|1|||
164676346|NCT03482882|594838123|FG000|Overall Study|Protocol Violation|2|||
164676347|NCT03482882|594838123|FG000|Overall Study|Not further specified|1|||
164676348|NCT05341622|594838128|FG000|Overall Study|Death|0|||
164676349|NCT05341622|594838129|FG001|Overall Study|Death|0|||
164676350|NCT05341622|594838130|FG002|Overall Study|Death|0|||
164676351|NCT05341622|594838131|FG003|Overall Study|Death|0|||
164676352|NCT05341622|594838132|FG004|Overall Study|Death|1|||
164676353|NCT05341622|594838133|FG005|Overall Study|Death|0|||
164676354|NCT05341622|594838134|FG006|Overall Study|Death|0|||
164676355|NCT05341622|594838135|FG007|Overall Study|Death|1|||
164676356|NCT05341622|594838128|FG000|Overall Study|Invalid Address|0|||
164676357|NCT05341622|594838129|FG001|Overall Study|Invalid Address|1|||
164676358|NCT05341622|594838130|FG002|Overall Study|Invalid Address|0|||
164676359|NCT05341622|594838131|FG003|Overall Study|Invalid Address|0|||
164676360|NCT05341622|594838132|FG004|Overall Study|Invalid Address|0|||
164676361|NCT05341622|594838133|FG005|Overall Study|Invalid Address|0|||
164676362|NCT05341622|594838134|FG006|Overall Study|Invalid Address|0|||
164676363|NCT05341622|594838135|FG007|Overall Study|Invalid Address|0|||
164676364|NCT05341622|594838128|FG000|Overall Study|Ineligible|26|||
164676365|NCT05341622|594838129|FG001|Overall Study|Ineligible|21|||
164676366|NCT05341622|594838130|FG002|Overall Study|Ineligible|28|||
164676367|NCT05341622|594838131|FG003|Overall Study|Ineligible|24|||
164676368|NCT05341622|594838132|FG004|Overall Study|Ineligible|29|||
164676369|NCT05341622|594838133|FG005|Overall Study|Ineligible|31|||
164676370|NCT05341622|594838134|FG006|Overall Study|Ineligible|28|||
164676371|NCT05341622|594838135|FG007|Overall Study|Ineligible|26|||
164676372|NCT04611789|594838136|FG000|Overall Study|Lost to Follow-up|1|||
164676373|NCT04611789|594838137|FG001|Overall Study|Lost to Follow-up|0|||
164676374|NCT04611789|594838138|FG002|Overall Study|Lost to Follow-up|0|||
164676375|NCT05152576|594838140|FG000|Overall Study|Lost to Follow-up|3|||
164676376|NCT05152576|594838141|FG001|Overall Study|Lost to Follow-up|0|||
164676377|NCT05152576|594838142|FG002|Overall Study|Lost to Follow-up|0|||
164676378|NCT05152576|594838143|FG003|Overall Study|Lost to Follow-up|1|||
164333514|NCT04526509|593597475|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
164333515|NCT04526509|593597476|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
164333516|NCT04526509|593597477|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
164333517|NCT04526509|593597478|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
164333518|NCT04526509|593597479|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
164333519|NCT04526509|593597480|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
164355670|NCT03720470|593678628|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
164676379|NCT05152576|594838140|FG000|Overall Study|Withdrawal by Subject|0|||
164676380|NCT05152576|594838141|FG001|Overall Study|Withdrawal by Subject|1|||
164676381|NCT05152576|594838142|FG002|Overall Study|Withdrawal by Subject|0|||
164676382|NCT05152576|594838143|FG003|Overall Study|Withdrawal by Subject|1|||
164676383|NCT05152576|594838140|FG000|Overall Study|Other|2|||
164676384|NCT05152576|594838141|FG001|Overall Study|Other|0|||
164676385|NCT05152576|594838142|FG002|Overall Study|Other|0|||
164676386|NCT05152576|594838143|FG003|Overall Study|Other|0|||
164676387|NCT00859430|594838144|FG000|First Intervention|Withdrawal by Subject|0|||
164676388|NCT00859430|594838145|FG001|First Intervention|Withdrawal by Subject|1|||
164676389|NCT01952691|594840076|FG000|Overall Study|Lost to Follow-up|2|||
164676390|NCT00001703|594840077|FG000|Overall Study|progressed disease|2|||
164676391|NCT00001703|594840077|FG000|Overall Study|No evidence of disease|1|||
164676392|NCT00001703|594840077|FG000|Overall Study|recurrent disease|2|||
164676393|NCT02286739|594840078|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
164676394|NCT02286739|594840079|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
164676395|NCT02286739|594840078|FG000|Overall Study|No Verasense type documented|0|||
164676396|NCT02286739|594840079|FG001|Overall Study|No Verasense type documented|23|||
164676397|NCT02286739|594840078|FG000|Overall Study|Adverse Event|1|||
164676398|NCT02286739|594840079|FG001|Overall Study|Adverse Event|2|||
164676399|NCT02286739|594840078|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
164676400|NCT02286739|594840079|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
164676401|NCT00834795|594840080|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
164676402|NCT00834795|594840081|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
164676403|NCT00834795|594840080|FG000|Second Intervention|Adverse Event|1|||
164676404|NCT00834795|594840081|FG001|Second Intervention|Adverse Event|0|||
164676405|NCT02057835|594840086|FG000|Overall Study|Withdrawal by Subject|0|||
164572793|NCT02875223|594460450|FG011|Overall Study|Progressive disease|3|||
164333520|NCT04526509|593597481|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
164333521|NCT04526509|593597475|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
164333522|NCT04526509|593597476|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
164333523|NCT04526509|593597477|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
164333524|NCT04526509|593597478|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
164333525|NCT04526509|593597479|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
164333526|NCT04526509|593597480|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
164333527|NCT04526509|593597481|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
164333528|NCT04526509|593597475|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
164333529|NCT04526509|593597476|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
164333530|NCT04526509|593597477|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
164333531|NCT04526509|593597478|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
164333532|NCT04526509|593597479|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
164333533|NCT04526509|593597480|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
164333534|NCT04526509|593597481|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
164333535|NCT04526509|593597475|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
164333536|NCT04526509|593597476|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
164333537|NCT04526509|593597477|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
164333538|NCT04526509|593597478|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
164333539|NCT04526509|593597479|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
164333540|NCT04526509|593597480|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
164333541|NCT04526509|593597481|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
164333542|NCT04526509|593597475|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
164333543|NCT04526509|593597476|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
164333544|NCT04526509|593597477|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
164333545|NCT04526509|593597478|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
164333546|NCT04526509|593597479|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
164333547|NCT04526509|593597480|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
164333548|NCT04526509|593597481|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
164333549|NCT04526509|593597475|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
164333550|NCT04526509|593597476|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
164333551|NCT04526509|593597477|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
164333552|NCT04526509|593597478|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
164333553|NCT04526509|593597479|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
164333554|NCT04526509|593597480|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
164333555|NCT04526509|593597481|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
164333556|NCT04526509|593597475|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
164333557|NCT04526509|593597476|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
164423192|NCT04131907|593919553|FG000|Overall Study|Adverse Event|2|||
164423193|NCT04131907|593919554|FG001|Overall Study|Adverse Event|0|||
164423194|NCT04131907|593919555|FG002|Overall Study|Adverse Event|0|||
164572794|NCT02875223|594460451|FG012|Overall Study|Progressive disease|6|||
164572795|NCT02875223|594460439|FG000|Overall Study|Death|4|||
164572796|NCT02875223|594460440|FG001|Overall Study|Death|4|||
164572797|NCT02875223|594460441|FG002|Overall Study|Death|3|||
164572798|NCT02875223|594460442|FG003|Overall Study|Death|4|||
164572799|NCT02875223|594460443|FG004|Overall Study|Death|2|||
164572800|NCT02875223|594460444|FG005|Overall Study|Death|3|||
164572801|NCT02875223|594460445|FG006|Overall Study|Death|5|||
164572802|NCT02875223|594460446|FG007|Overall Study|Death|7|||
164572803|NCT02875223|594460447|FG008|Overall Study|Death|3|||
164572804|NCT02875223|594460448|FG009|Overall Study|Death|2|||
164572805|NCT02875223|594460449|FG010|Overall Study|Death|0|||
164572806|NCT02875223|594460450|FG011|Overall Study|Death|0|||
164234565|NCT01657370|593231363|FG005|Overall Study|Adverse Event|0|||
164234566|NCT01657370|593231358|FG000|Overall Study|Protocol Violation|1|||
164234567|NCT01657370|593231359|FG001|Overall Study|Protocol Violation|1|||
164234568|NCT01657370|593231360|FG002|Overall Study|Protocol Violation|1|||
164234569|NCT01657370|593231361|FG003|Overall Study|Protocol Violation|1|||
164234570|NCT01657370|593231362|FG004|Overall Study|Protocol Violation|0|||
164234571|NCT01657370|593231363|FG005|Overall Study|Protocol Violation|0|||
164234572|NCT01657370|593231358|FG000|Overall Study|Lost to Follow-up|2|||
164234573|NCT01657370|593231359|FG001|Overall Study|Lost to Follow-up|0|||
164234574|NCT01657370|593231360|FG002|Overall Study|Lost to Follow-up|1|||
164234575|NCT01657370|593231361|FG003|Overall Study|Lost to Follow-up|0|||
164234576|NCT01657370|593231362|FG004|Overall Study|Lost to Follow-up|0|||
164234577|NCT01657370|593231363|FG005|Overall Study|Lost to Follow-up|1|||
164234578|NCT02777086|593231364|FG000|Overall Study|Lost to Follow-up|96|||
164234579|NCT02777086|593231365|FG001|Overall Study|Lost to Follow-up|99|||
164234580|NCT01133665|593231366|FG000|Overall Study|Physician Decision|2|||
164234581|NCT01819272|593231367|FG000|Overall Study|Adverse Event|1|||
164234582|NCT01819272|593231368|FG001|Overall Study|Adverse Event|0|||
164234583|NCT01819272|593231369|FG002|Overall Study|Adverse Event|0|||
164234584|NCT01819272|593231370|FG003|Overall Study|Adverse Event|2|||
164234585|NCT01819272|593231371|FG004|Overall Study|Adverse Event|0|||
164234586|NCT01819272|593231372|FG005|Overall Study|Adverse Event|0|||
164234587|NCT01819272|593231367|FG000|Overall Study|Lost to Follow-up|3|||
164234588|NCT01819272|593231368|FG001|Overall Study|Lost to Follow-up|0|||
164234589|NCT01819272|593231369|FG002|Overall Study|Lost to Follow-up|1|||
164234590|NCT01819272|593231370|FG003|Overall Study|Lost to Follow-up|0|||
164234591|NCT01819272|593231371|FG004|Overall Study|Lost to Follow-up|0|||
164234592|NCT01819272|593231372|FG005|Overall Study|Lost to Follow-up|3|||
164234593|NCT01819272|593231367|FG000|Overall Study|Protocol Violation|0|||
164234594|NCT01819272|593231368|FG001|Overall Study|Protocol Violation|0|||
164234595|NCT01819272|593231369|FG002|Overall Study|Protocol Violation|0|||
164234596|NCT01819272|593231370|FG003|Overall Study|Protocol Violation|1|||
164234597|NCT01819272|593231371|FG004|Overall Study|Protocol Violation|2|||
164234598|NCT01819272|593231372|FG005|Overall Study|Protocol Violation|3|||
164234599|NCT01819272|593231367|FG000|Overall Study|Physician Decision|0|||
164234600|NCT01819272|593231368|FG001|Overall Study|Physician Decision|1|||
164234601|NCT01819272|593231369|FG002|Overall Study|Physician Decision|0|||
164234602|NCT01819272|593231370|FG003|Overall Study|Physician Decision|0|||
164234603|NCT01819272|593231371|FG004|Overall Study|Physician Decision|0|||
164234604|NCT01819272|593231372|FG005|Overall Study|Physician Decision|0|||
164234605|NCT01819272|593231367|FG000|Overall Study|Withdrawal of Consent|0|||
164234606|NCT01819272|593231368|FG001|Overall Study|Withdrawal of Consent|1|||
164234607|NCT01819272|593231369|FG002|Overall Study|Withdrawal of Consent|2|||
164234608|NCT01819272|593231370|FG003|Overall Study|Withdrawal of Consent|1|||
164234609|NCT01819272|593231371|FG004|Overall Study|Withdrawal of Consent|0|||
164234610|NCT01819272|593231372|FG005|Overall Study|Withdrawal of Consent|1|||
164234611|NCT01819272|593231367|FG000|Overall Study|Loss of Glucose Control|2|||
164234612|NCT01819272|593231368|FG001|Overall Study|Loss of Glucose Control|1|||
164234613|NCT01819272|593231369|FG002|Overall Study|Loss of Glucose Control|0|||
164234614|NCT01819272|593231370|FG003|Overall Study|Loss of Glucose Control|1|||
164234615|NCT01819272|593231371|FG004|Overall Study|Loss of Glucose Control|2|||
164234616|NCT01819272|593231372|FG005|Overall Study|Loss of Glucose Control|0|||
164234617|NCT03021486|593231373|FG000|Overall Study|Withdrawal by Subject|1|||
164234618|NCT03021486|593231374|FG001|Overall Study|Withdrawal by Subject|1|||
164234619|NCT03021486|593231375|FG002|Overall Study|Withdrawal by Subject|3|||
164234620|NCT03021486|593231373|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
164234621|NCT03021486|593231374|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
164234622|NCT03021486|593231375|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
164234623|NCT04043286|593231376|FG000|Overall Study|Withdrawal by Subject|2|||
164234624|NCT04043286|593231377|FG001|Overall Study|Withdrawal by Subject|2|||
164234625|NCT01732536|593231378|FG000|Overall Study|Withdrawal by Subject|1|||
164234626|NCT01732536|593231379|FG001|Overall Study|Withdrawal by Subject|1|||
164234627|NCT00805389|593231380|FG000|Overall Study|Adverse Event|0|||
164234628|NCT00805389|593231381|FG001|Overall Study|Adverse Event|0|||
164234629|NCT00805389|593231382|FG002|Overall Study|Adverse Event|1|||
164234630|NCT00805389|593231383|FG003|Overall Study|Adverse Event|2|||
164234631|NCT00805389|593231384|FG004|Overall Study|Adverse Event|0|||
164234632|NCT00805389|593231380|FG000|Overall Study|Lost to Follow-up|4|||
164234633|NCT00805389|593231381|FG001|Overall Study|Lost to Follow-up|3|||
164234634|NCT00805389|593231382|FG002|Overall Study|Lost to Follow-up|6|||
164234635|NCT00805389|593231383|FG003|Overall Study|Lost to Follow-up|10|||
164234636|NCT00805389|593231384|FG004|Overall Study|Lost to Follow-up|9|||
164423195|NCT04131907|593919553|FG000|Overall Study|Physician Decision|4|||
164234637|NCT00805389|593231380|FG000|Overall Study|Protocol Violation|0|||
164234638|NCT00805389|593231381|FG001|Overall Study|Protocol Violation|0|||
164234639|NCT00805389|593231382|FG002|Overall Study|Protocol Violation|1|||
164423196|NCT04131907|593919554|FG001|Overall Study|Physician Decision|22|||
164333558|NCT04526509|593597477|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
164333559|NCT04526509|593597478|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
164333560|NCT04526509|593597479|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
164333561|NCT04526509|593597480|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
164333562|NCT04526509|593597481|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
164333563|NCT04526509|593597475|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
164333564|NCT04526509|593597476|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
164333565|NCT04526509|593597477|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
164333566|NCT04526509|593597478|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
164333567|NCT04526509|593597479|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
164333568|NCT04526509|593597480|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
164333569|NCT04526509|593597481|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
164333570|NCT04526509|593597475|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
164333571|NCT04526509|593597476|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
164333572|NCT04526509|593597477|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
164333573|NCT04526509|593597478|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
164333574|NCT04526509|593597479|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
164333575|NCT04526509|593597480|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
164333576|NCT04526509|593597481|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
164333577|NCT04526509|593597475|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
164333578|NCT04526509|593597476|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
164333579|NCT04526509|593597477|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
164333580|NCT04526509|593597478|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
164333581|NCT04526509|593597479|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
164333582|NCT04526509|593597480|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
164333583|NCT04526509|593597481|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
164333584|NCT04526509|593597475|FG000|Enrolled|Study Terminated by Sponsor|0|||
164333585|NCT04526509|593597476|FG001|Enrolled|Study Terminated by Sponsor|0|||
164333586|NCT04526509|593597477|FG002|Enrolled|Study Terminated by Sponsor|0|||
164333587|NCT04526509|593597478|FG003|Enrolled|Study Terminated by Sponsor|0|||
164333588|NCT04526509|593597479|FG004|Enrolled|Study Terminated by Sponsor|0|||
164333589|NCT04526509|593597480|FG005|Enrolled|Study Terminated by Sponsor|0|||
164333590|NCT04526509|593597481|FG006|Enrolled|Study Terminated by Sponsor|1|||
164333591|NCT04526509|593597475|FG000|Enrolled|Death prior to lymphodepletion|0|||
164333592|NCT04526509|593597476|FG001|Enrolled|Death prior to lymphodepletion|0|||
164333593|NCT04526509|593597477|FG002|Enrolled|Death prior to lymphodepletion|0|||
164333594|NCT04526509|593597478|FG003|Enrolled|Death prior to lymphodepletion|1|||
164333595|NCT04526509|593597479|FG004|Enrolled|Death prior to lymphodepletion|0|||
164333596|NCT04526509|593597480|FG005|Enrolled|Death prior to lymphodepletion|0|||
164333597|NCT04526509|593597481|FG006|Enrolled|Death prior to lymphodepletion|0|||
164333598|NCT04526509|593597475|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
164423197|NCT04131907|593919555|FG002|Overall Study|Physician Decision|0|||
164676406|NCT02057835|594840087|FG001|Overall Study|Withdrawal by Subject|2|||
164676407|NCT02057835|594840088|FG002|Overall Study|Withdrawal by Subject|0|||
164676408|NCT02057835|594840089|FG003|Overall Study|Withdrawal by Subject|0|||
164676409|NCT02057835|594840090|FG004|Overall Study|Withdrawal by Subject|0|||
164676410|NCT02057835|594840091|FG005|Overall Study|Withdrawal by Subject|0|||
164676411|NCT02057835|594840092|FG006|Overall Study|Withdrawal by Subject|0|||
164676412|NCT02057835|594840093|FG007|Overall Study|Withdrawal by Subject|0|||
164676413|NCT02057835|594840094|FG008|Overall Study|Withdrawal by Subject|0|||
164676414|NCT02057835|594840095|FG009|Overall Study|Withdrawal by Subject|0|||
164676415|NCT00665925|594840096|FG000|Overall Study|Lack of Efficacy|10|||
164676416|NCT00665925|594840097|FG001|Overall Study|Lack of Efficacy|8|||
164676417|NCT00665925|594840098|FG002|Overall Study|Lack of Efficacy|9|||
164676418|NCT00665925|594840099|FG003|Overall Study|Lack of Efficacy|8|||
164676419|NCT00665925|594840096|FG000|Overall Study|Lost to Follow-up|1|||
164676420|NCT00665925|594840097|FG001|Overall Study|Lost to Follow-up|2|||
164676421|NCT00665925|594840098|FG002|Overall Study|Lost to Follow-up|2|||
164676422|NCT00665925|594840099|FG003|Overall Study|Lost to Follow-up|2|||
164676423|NCT00665925|594840096|FG000|Overall Study|Withdrawal by Subject|2|||
164676424|NCT00665925|594840097|FG001|Overall Study|Withdrawal by Subject|2|||
164676425|NCT00665925|594840098|FG002|Overall Study|Withdrawal by Subject|3|||
164676426|NCT00665925|594840099|FG003|Overall Study|Withdrawal by Subject|2|||
164676427|NCT00665925|594840096|FG000|Overall Study|Physician Decision|0|||
164676428|NCT00665925|594840097|FG001|Overall Study|Physician Decision|0|||
164676429|NCT00665925|594840098|FG002|Overall Study|Physician Decision|1|||
164676430|NCT00665925|594840099|FG003|Overall Study|Physician Decision|2|||
164676431|NCT00665925|594840096|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
164676432|NCT00665925|594840097|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
164676433|NCT00665925|594840098|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
164676434|NCT00665925|594840099|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
164676435|NCT00665925|594840096|FG000|Overall Study|Adverse Event|1|||
164676436|NCT00665925|594840097|FG001|Overall Study|Adverse Event|5|||
164234640|NCT00805389|593231383|FG003|Overall Study|Protocol Violation|0|||
164234641|NCT00805389|593231384|FG004|Overall Study|Protocol Violation|0|||
164234642|NCT00805389|593231380|FG000|Overall Study|Withdrawal by Subject|3|||
164234643|NCT00805389|593231381|FG001|Overall Study|Withdrawal by Subject|2|||
164234644|NCT00805389|593231382|FG002|Overall Study|Withdrawal by Subject|4|||
164234645|NCT00805389|593231383|FG003|Overall Study|Withdrawal by Subject|5|||
164234646|NCT00805389|593231384|FG004|Overall Study|Withdrawal by Subject|4|||
164234647|NCT01246960|593231385|FG000|Overall Study|Lost to Follow-up|3|||
164234648|NCT01246960|593231386|FG001|Overall Study|Lost to Follow-up|1|||
164234649|NCT01246960|593231385|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
164234650|NCT01246960|593231386|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
164234651|NCT03376516|593231391|FG000|Overall Study|Not treated|1|||
164234652|NCT03376516|593231391|FG000|Overall Study|Consent withdrawn|1|||
164234653|NCT01581684|593231392|FG000|Overall Study|Other reason not defined|0|||
164234654|NCT01581684|593231393|FG001|Overall Study|Other reason not defined|0|||
164234655|NCT01581684|593231394|FG002|Overall Study|Other reason not defined|0|||
164234656|NCT01581684|593231395|FG003|Overall Study|Other reason not defined|0|||
164234657|NCT01581684|593231396|FG004|Overall Study|Other reason not defined|0|||
164234658|NCT01581684|593231397|FG005|Overall Study|Other reason not defined|0|||
164234659|NCT01581684|593231398|FG006|Overall Study|Other reason not defined|0|||
164234660|NCT01581684|593231399|FG007|Overall Study|Other reason not defined|0|||
164234661|NCT01581684|593231400|FG008|Overall Study|Other reason not defined|1|||
164234662|NCT01581684|593231401|FG009|Overall Study|Other reason not defined|0|||
164234663|NCT02986074|593231402|FG000|First Trial Period|Adverse Event|1|||
164234664|NCT02986074|593231403|FG001|First Trial Period|Adverse Event|0|||
164234665|NCT02986074|593231404|FG002|First Trial Period|Adverse Event|0|||
164234666|NCT02986074|593231405|FG003|First Trial Period|Adverse Event|0|||
164234667|NCT02986074|593231402|FG000|Follow up Period|system explant|0|||
164234668|NCT02986074|593231403|FG001|Follow up Period|system explant|0|||
164234669|NCT02986074|593231404|FG002|Follow up Period|system explant|1|||
164234670|NCT02986074|593231405|FG003|Follow up Period|system explant|2|||
164234671|NCT02986074|593231402|FG000|Follow up Period|Physician Decision|0|||
164234672|NCT02986074|593231403|FG001|Follow up Period|Physician Decision|0|||
164234673|NCT02986074|593231404|FG002|Follow up Period|Physician Decision|0|||
164234674|NCT02986074|593231405|FG003|Follow up Period|Physician Decision|1|||
164234675|NCT02239926|593231408|FG000|Overall Study|Withdrawal by Subject|0|||
164234676|NCT02239926|593231409|FG001|Overall Study|Withdrawal by Subject|1|||
164234677|NCT00598650|593231412|FG000|Overall Study|Withdrawal by Subject|3|||
164234678|NCT00598650|593231412|FG000|Overall Study|Adverse Event|18|||
164234679|NCT00598650|593231412|FG000|Overall Study|No treatment for 3 weeks|1|||
164234680|NCT00598650|593231412|FG000|Overall Study|Not eligible|1|||
164234681|NCT00598650|593231412|FG000|Overall Study|Prohibited Concomitant Medication|2|||
164234682|NCT00598650|593231412|FG000|Overall Study|Physician Decision|2|||
164234683|NCT01628913|593231413|FG000|Overall Study|Adverse Event|12|||
164234684|NCT01628913|593231414|FG001|Overall Study|Adverse Event|5|||
164234685|NCT01628913|593231413|FG000|Overall Study|Disease Progression|11|||
164234686|NCT01628913|593231414|FG001|Overall Study|Disease Progression|14|||
164234687|NCT01628913|593231413|FG000|Overall Study|Protocol Violation|1|||
164234688|NCT01628913|593231414|FG001|Overall Study|Protocol Violation|0|||
164234689|NCT01628913|593231413|FG000|Overall Study|Death|1|||
164234690|NCT01628913|593231414|FG001|Overall Study|Death|0|||
164234691|NCT01628913|593231413|FG000|Overall Study|study terminated by Sponsor|4|||
164234692|NCT01628913|593231414|FG001|Overall Study|study terminated by Sponsor|9|||
164234693|NCT01628913|593231413|FG000|Overall Study|Withdrawal by Subject|1|||
164333599|NCT04526509|593597476|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
164333600|NCT04526509|593597477|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
164676437|NCT00665925|594840098|FG002|Overall Study|Adverse Event|10|||
164676438|NCT00665925|594840099|FG003|Overall Study|Adverse Event|5|||
164676439|NCT00665925|594840096|FG000|Overall Study|Enrolled by mistake|0|||
164676440|NCT00665925|594840097|FG001|Overall Study|Enrolled by mistake|0|||
164676441|NCT00665925|594840098|FG002|Overall Study|Enrolled by mistake|0|||
164423198|NCT04131907|593919553|FG000|Overall Study|Withdrawal by Subject|2|||
164423199|NCT04131907|593919554|FG001|Overall Study|Withdrawal by Subject|0|||
164423200|NCT04131907|593919555|FG002|Overall Study|Withdrawal by Subject|1|||
164423201|NCT04131907|593919553|FG000|Overall Study|Treatment failure|2|||
164423202|NCT04131907|593919554|FG001|Overall Study|Treatment failure|0|||
164423203|NCT04131907|593919555|FG002|Overall Study|Treatment failure|1|||
164423204|NCT00847301|593919556|FG000|Overall Study|Adverse Event|35|||
164423205|NCT00847301|593919556|FG000|Overall Study|Switch to other anticoagulants|16|||
164423206|NCT00847301|593919556|FG000|Overall Study|Lost to Follow-up|1|||
164423207|NCT00847301|593919556|FG000|Overall Study|No prescription after hospital discharge|1|||
164423208|NCT00847301|593919556|FG000|Overall Study|Other reason not defined above|1|||
164423209|NCT00641186|593919557|FG000|Overall Study|Adverse Event|3|||
164423210|NCT01388543|593919562|FG000|Day 14|Adverse Event|1|||
164423211|NCT01388543|593919563|FG001|Day 14|Adverse Event|4|||
164423212|NCT03363659|593919564|FG000|Overall Study|Adverse Event|1|||
164423213|NCT03363659|593919564|FG000|Overall Study|Screen fail|1|||
164423214|NCT03363659|593919564|FG000|Overall Study|Withdrawal by Subject|1|||
164423215|NCT00904150|593919565|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
164423216|NCT00904150|593919566|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
164423217|NCT00904150|593919565|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
164423218|NCT00904150|593919566|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
164423219|NCT01671748|593919567|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
164423220|NCT01671748|593919568|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
164423221|NCT01671748|593919567|FG000|4 Week run-in Phase|Adverse Event|1|||
164423222|NCT01671748|593919568|FG001|4 Week run-in Phase|Adverse Event|0|||
164423223|NCT01671748|593919567|FG000|4 Week run-in Phase|Not eligible|9|||
164423224|NCT01671748|593919568|FG001|4 Week run-in Phase|Not eligible|0|||
164423225|NCT03872388|593919569|FG000|Overall Study|Disease Progression|0|||
164423226|NCT03872388|593919570|FG001|Overall Study|Disease Progression|0|||
164423227|NCT03872388|593919571|FG002|Overall Study|Disease Progression|0|||
164423228|NCT03872388|593919572|FG003|Overall Study|Disease Progression|0|||
164423229|NCT03872388|593919573|FG004|Overall Study|Disease Progression|0|||
164423230|NCT03872388|593919574|FG005|Overall Study|Disease Progression|0|||
164423231|NCT03872388|593919575|FG006|Overall Study|Disease Progression|1|||
164423232|NCT03872388|593919576|FG007|Overall Study|Disease Progression|1|||
164423233|NCT04213846|593921387|FG000|Overall Study|Withdrawal by Subject|7|||
164423234|NCT04213846|593921388|FG001|Overall Study|Withdrawal by Subject|6|||
164423235|NCT04213846|593921387|FG000|Overall Study|Lost to Follow-up|15|||
164423236|NCT04213846|593921388|FG001|Overall Study|Lost to Follow-up|21|||
164423237|NCT04096365|593921407|FG000|Overall Study|Adverse Event|1|||
164423238|NCT02401529|593921410|FG000|Overall Study|Lost to Follow-up|2|||
164423239|NCT02401529|593921411|FG001|Overall Study|Lost to Follow-up|1|||
164423240|NCT02401529|593921410|FG000|Overall Study|Physician Decision|2|||
164423241|NCT02401529|593921411|FG001|Overall Study|Physician Decision|6|||
164423242|NCT02401529|593921410|FG000|Overall Study|Protocol Violation|5|||
164423243|NCT02401529|593921411|FG001|Overall Study|Protocol Violation|0|||
164423244|NCT01939158|593921414|FG000|Overall Study|Adverse Event|1|||
164423245|NCT01939158|593921415|FG001|Overall Study|Adverse Event|0|||
164423246|NCT01939158|593921416|FG002|Overall Study|Adverse Event|0|||
164423247|NCT01939158|593921417|FG003|Overall Study|Adverse Event|0|||
164423248|NCT01939158|593921414|FG000|Overall Study|Withdrawal by Subject|22|||
164423249|NCT01939158|593921415|FG001|Overall Study|Withdrawal by Subject|25|||
164423250|NCT01939158|593921416|FG002|Overall Study|Withdrawal by Subject|15|||
164423251|NCT01939158|593921417|FG003|Overall Study|Withdrawal by Subject|17|||
164423252|NCT01939158|593921414|FG000|Overall Study|Migrated/moved from study area|5|||
164423253|NCT01939158|593921415|FG001|Overall Study|Migrated/moved from study area|7|||
164423254|NCT01939158|593921416|FG002|Overall Study|Migrated/moved from study area|3|||
164423255|NCT01939158|593921417|FG003|Overall Study|Migrated/moved from study area|6|||
164423256|NCT01939158|593921414|FG000|Overall Study|Lost to Follow-up|18|||
164676442|NCT00665925|594840099|FG003|Overall Study|Enrolled by mistake|1|||
164676443|NCT00665925|594840096|FG000|Overall Study|Due to exclusion criteria|1|||
164676444|NCT00665925|594840097|FG001|Overall Study|Due to exclusion criteria|0|||
164676445|NCT00665925|594840098|FG002|Overall Study|Due to exclusion criteria|0|||
164676446|NCT00665925|594840099|FG003|Overall Study|Due to exclusion criteria|0|||
164676447|NCT04035187|594840102|FG000|Overall Study|Withdrawal by Subject|2|||
164676448|NCT04035187|594840103|FG001|Overall Study|Withdrawal by Subject|1|||
164676449|NCT04035187|594840104|FG002|Overall Study|Withdrawal by Subject|0|||
164676450|NCT04035187|594840105|FG003|Overall Study|Withdrawal by Subject|0|||
164423257|NCT01939158|593921415|FG001|Overall Study|Lost to Follow-up|17|||
164423258|NCT01939158|593921416|FG002|Overall Study|Lost to Follow-up|17|||
164423259|NCT01939158|593921417|FG003|Overall Study|Lost to Follow-up|17|||
164423260|NCT01939158|593921414|FG000|Overall Study|Death|0|||
164423261|NCT01939158|593921415|FG001|Overall Study|Death|0|||
164423262|NCT01939158|593921416|FG002|Overall Study|Death|1|||
164423263|NCT01939158|593921417|FG003|Overall Study|Death|1|||
164423264|NCT01939158|593921414|FG000|Overall Study|No longer meets eligibility criteria|0|||
164423265|NCT01939158|593921415|FG001|Overall Study|No longer meets eligibility criteria|0|||
164234694|NCT01628913|593231414|FG001|Overall Study|Withdrawal by Subject|0|||
164234695|NCT01628913|593231413|FG000|Overall Study|Physician Decision|1|||
164234696|NCT01628913|593231414|FG001|Overall Study|Physician Decision|3|||
164234697|NCT05201807|593231418|FG000|Overall Study|Adverse Event|1|||
164234698|NCT05201807|593231418|FG000|Overall Study|COVID-19 Related|1|||
164234699|NCT01664624|593231421|FG000|Overall Study|Adverse Event|0|||
164234700|NCT01664624|593231422|FG001|Overall Study|Adverse Event|1|||
164234701|NCT01664624|593231423|FG002|Overall Study|Adverse Event|0|||
164234702|NCT01664624|593231424|FG003|Overall Study|Adverse Event|0|||
164234703|NCT01029535|593231427|FG000|Overall Study|Lost to Follow-up|24|||
164234704|NCT01029535|593231427|FG000|Overall Study|Protocol Violation|2|||
164234705|NCT01029535|593231427|FG000|Overall Study|Participant Withdrew Consent|2|||
164234706|NCT01029535|593231427|FG000|Overall Study|Adverse Event|1|||
164234707|NCT01029535|593231427|FG000|Overall Study|Use of Another Treatment|1|||
164234708|NCT01029535|593231427|FG000|Overall Study|Death|1|||
164234709|NCT00524121|593231430|FG000|Overall Study|Disease progression|6|||
164234710|NCT00524121|593231430|FG000|Overall Study|Adverse Event|4|||
164234711|NCT00524121|593231430|FG000|Overall Study|Patient refused|2|||
164234712|NCT00524121|593231430|FG000|Overall Study|Other|1|||
164234713|NCT00524121|593231430|FG000|Overall Study|Death|1|||
164234714|NCT00524121|593231430|FG000|Overall Study|Not treated (became ineligible)|4|||
164234715|NCT00524121|593231430|FG000|Overall Study|Not treated (changed mind)|1|||
164234716|NCT02410772|593231434|FG000|Overall Study|Death|3|||
164234717|NCT02410772|593231435|FG001|Overall Study|Death|4|||
164234718|NCT02410772|593231436|FG002|Overall Study|Death|8|||
164234719|NCT02410772|593231434|FG000|Overall Study|Lost to Follow-up|31|||
164234720|NCT02410772|593231435|FG001|Overall Study|Lost to Follow-up|23|||
164234721|NCT02410772|593231436|FG002|Overall Study|Lost to Follow-up|22|||
164234722|NCT02410772|593231434|FG000|Overall Study|Pregnancy|8|||
164234723|NCT02410772|593231435|FG001|Overall Study|Pregnancy|4|||
164234724|NCT02410772|593231436|FG002|Overall Study|Pregnancy|5|||
164234725|NCT02410772|593231434|FG000|Overall Study|Protocol Violation|8|||
164234726|NCT02410772|593231435|FG001|Overall Study|Protocol Violation|8|||
164234727|NCT02410772|593231436|FG002|Overall Study|Protocol Violation|4|||
164234728|NCT02410772|593231434|FG000|Overall Study|Baseline Drug Resistance|49|||
164234729|NCT02410772|593231435|FG001|Overall Study|Baseline Drug Resistance|40|||
164234730|NCT02410772|593231436|FG002|Overall Study|Baseline Drug Resistance|51|||
164234731|NCT02410772|593231434|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
164234732|NCT02410772|593231435|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
164234733|NCT02410772|593231436|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
164234734|NCT02410772|593231434|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
164234735|NCT02410772|593231435|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
164234736|NCT02410772|593231436|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
164234737|NCT02164864|593231442|FG000|Overall Study|Trial disease worsening|7|||
164234738|NCT02164864|593231443|FG001|Overall Study|Trial disease worsening|5|||
164234739|NCT02164864|593231444|FG002|Overall Study|Trial disease worsening|1|||
164234740|NCT02164864|593231442|FG000|Overall Study|Other pre-existing disease worsening|6|||
164234741|NCT02164864|593231443|FG001|Overall Study|Other pre-existing disease worsening|4|||
164234742|NCT02164864|593231444|FG002|Overall Study|Other pre-existing disease worsening|9|||
164234743|NCT02164864|593231442|FG000|Overall Study|Other Adverse Event (AE)|52|||
164234744|NCT02164864|593231443|FG001|Overall Study|Other Adverse Event (AE)|32|||
164234745|NCT02164864|593231444|FG002|Overall Study|Other Adverse Event (AE)|49|||
164234746|NCT02164864|593231442|FG000|Overall Study|Protocol Violation|2|||
164234747|NCT02164864|593231443|FG001|Overall Study|Protocol Violation|4|||
164234748|NCT02164864|593231444|FG002|Overall Study|Protocol Violation|1|||
164234749|NCT02164864|593231442|FG000|Overall Study|Lost to Follow-up|4|||
164234750|NCT02164864|593231443|FG001|Overall Study|Lost to Follow-up|3|||
164234751|NCT02164864|593231444|FG002|Overall Study|Lost to Follow-up|2|||
164234752|NCT02164864|593231442|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
164234753|NCT02164864|593231443|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
164234754|NCT02164864|593231444|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
164234755|NCT02164864|593231442|FG000|Overall Study|Other than stated|3|||
164234756|NCT02164864|593231443|FG001|Overall Study|Other than stated|4|||
164234757|NCT02164864|593231444|FG002|Overall Study|Other than stated|14|||
164234758|NCT01870869|593231445|FG000|Overall Study|Implanted with nonstudy device|1|||
164234759|NCT01870869|593231446|FG001|Overall Study|Implanted with nonstudy device|3|||
164234760|NCT01870869|593231447|FG002|Overall Study|Implanted with nonstudy device|14|||
164234761|NCT01870869|593231448|FG003|Overall Study|Implanted with nonstudy device|4|||
164234762|NCT01870869|593231445|FG000|Overall Study|Death|0|||
164234763|NCT01870869|593231446|FG001|Overall Study|Death|0|||
164234764|NCT01870869|593231447|FG002|Overall Study|Death|7|||
164234765|NCT01870869|593231448|FG003|Overall Study|Death|1|||
164234766|NCT01870869|593231445|FG000|Overall Study|Subject choice|6|||
164234767|NCT01870869|593231446|FG001|Overall Study|Subject choice|2|||
164234768|NCT01870869|593231447|FG002|Overall Study|Subject choice|22|||
164234769|NCT01870869|593231448|FG003|Overall Study|Subject choice|8|||
164234770|NCT01870869|593231445|FG000|Overall Study|Lost to Follow-up|10|||
164423266|NCT01939158|593921416|FG002|Overall Study|No longer meets eligibility criteria|1|||
164423267|NCT01939158|593921417|FG003|Overall Study|No longer meets eligibility criteria|0|||
164423268|NCT01939158|593921414|FG000|Overall Study|Other|1|||
164423269|NCT01939158|593921415|FG001|Overall Study|Other|3|||
164423270|NCT01939158|593921416|FG002|Overall Study|Other|4|||
164423271|NCT01939158|593921417|FG003|Overall Study|Other|3|||
164423272|NCT05310084|593921418|FG000|Overall Study|Withdrawal by Subject|2|||
164234771|NCT01870869|593231446|FG001|Overall Study|Lost to Follow-up|2|||
164234772|NCT01870869|593231447|FG002|Overall Study|Lost to Follow-up|25|||
164234773|NCT01870869|593231448|FG003|Overall Study|Lost to Follow-up|3|||
164234774|NCT01870869|593231445|FG000|Overall Study|Reason not Specified|1|||
164234775|NCT01870869|593231446|FG001|Overall Study|Reason not Specified|2|||
164234776|NCT01870869|593231447|FG002|Overall Study|Reason not Specified|20|||
164234777|NCT01870869|593231448|FG003|Overall Study|Reason not Specified|4|||
164234778|NCT01870869|593231445|FG000|Overall Study|Not evaluable|10|||
164234779|NCT01870869|593231446|FG001|Overall Study|Not evaluable|5|||
164234780|NCT01870869|593231447|FG002|Overall Study|Not evaluable|42|||
164234781|NCT01870869|593231448|FG003|Overall Study|Not evaluable|10|||
164234782|NCT00904371|593231449|FG000|Overall Study|Adverse Event|2|||
164234783|NCT00904371|593231449|FG000|Overall Study|Lost to Follow-up|4|||
164234784|NCT00904371|593231449|FG000|Overall Study|Discontinued at target blood pressure|2|||
164234785|NCT00904371|593231449|FG000|Overall Study|Continued with Tritace|1|||
164234786|NCT02493764|593231450|FG000|Overall Study|Adverse Event|2|||
164234787|NCT02493764|593231451|FG001|Overall Study|Adverse Event|2|||
164234788|NCT02493764|593231450|FG000|Overall Study|Death|44|||
164234789|NCT02493764|593231451|FG001|Overall Study|Death|58|||
164234790|NCT02493764|593231450|FG000|Overall Study|Lost to Follow-up|2|||
164234791|NCT02493764|593231451|FG001|Overall Study|Lost to Follow-up|1|||
164234792|NCT02493764|593231450|FG000|Overall Study|Protocol Violation|6|||
164234793|NCT02493764|593231451|FG001|Overall Study|Protocol Violation|7|||
164234794|NCT02493764|593231450|FG000|Overall Study|Physician Decision|1|||
164234795|NCT02493764|593231451|FG001|Overall Study|Physician Decision|1|||
164234796|NCT02493764|593231450|FG000|Overall Study|Participant moved|17|||
164234797|NCT02493764|593231451|FG001|Overall Study|Participant moved|5|||
164234798|NCT02493764|593231450|FG000|Overall Study|Withdrawal parent/guardian|0|||
164234799|NCT02493764|593231451|FG001|Overall Study|Withdrawal parent/guardian|1|||
164234800|NCT02493764|593231450|FG000|Overall Study|Withdrawal by Subject|11|||
164234801|NCT02493764|593231451|FG001|Overall Study|Withdrawal by Subject|7|||
164234802|NCT05448950|593231454|FG000|Overall Study|Death|2|||
164234803|NCT05448950|593231454|FG000|Overall Study|Withdrawal by Subject|1|||
164234804|NCT05448950|593231454|FG000|Overall Study|AVG abandoned|4|||
164234805|NCT01646827|593231455|FG000|Overall Study|Lost to Follow-up|0|||
164234806|NCT01646827|593231456|FG001|Overall Study|Lost to Follow-up|3|||
164234807|NCT01646827|593231455|FG000|Overall Study|Physician Decision|1|||
164234808|NCT01646827|593231456|FG001|Overall Study|Physician Decision|2|||
164234809|NCT01646827|593231455|FG000|Overall Study|Withdrawal by Subject|1|||
164234810|NCT01646827|593231456|FG001|Overall Study|Withdrawal by Subject|0|||
164234811|NCT01242514|593231461|FG000|Overall Study|e.g., project closure|1042|||
164234812|NCT01242514|593231462|FG001|Overall Study|e.g., project closure|305|||
164234813|NCT01242514|593231463|FG002|Overall Study|e.g., project closure|171|||
164234814|NCT01242514|593231461|FG000|Overall Study|Subject decision|33|||
164234815|NCT01242514|593231462|FG001|Overall Study|Subject decision|8|||
164234816|NCT01242514|593231463|FG002|Overall Study|Subject decision|2|||
164234817|NCT01242514|593231461|FG000|Overall Study|Severe non-compliance to protocol|5|||
164234818|NCT01242514|593231462|FG001|Overall Study|Severe non-compliance to protocol|2|||
164234819|NCT01242514|593231463|FG002|Overall Study|Severe non-compliance to protocol|1|||
164234820|NCT01242514|593231461|FG000|Overall Study|Lack of therapeutic response|99|||
164234821|NCT01242514|593231462|FG001|Overall Study|Lack of therapeutic response|16|||
164234822|NCT01242514|593231463|FG002|Overall Study|Lack of therapeutic response|10|||
164234823|NCT01242514|593231461|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
164234824|NCT01242514|593231462|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
164234825|NCT01242514|593231463|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
164234826|NCT01242514|593231461|FG000|Overall Study|Lost to Follow-up|14|||
164423273|NCT05310084|593921419|FG001|Overall Study|Withdrawal by Subject|3|||
164234827|NCT01242514|593231462|FG001|Overall Study|Lost to Follow-up|5|||
164423274|NCT05310084|593921418|FG000|Overall Study|Participant availability|0|||
164234828|NCT01242514|593231463|FG002|Overall Study|Lost to Follow-up|4|||
164234829|NCT01242514|593231461|FG000|Overall Study|Adverse Event|129|||
164234830|NCT01242514|593231462|FG001|Overall Study|Adverse Event|18|||
164234831|NCT01242514|593231463|FG002|Overall Study|Adverse Event|19|||
164234832|NCT05901636|593231469|FG000|Overall Study|Lost to Follow-up|0|||
164234833|NCT05901636|593231470|FG001|Overall Study|Lost to Follow-up|1|||
164234834|NCT05901636|593231471|FG002|Overall Study|Lost to Follow-up|0|||
164234835|NCT05901636|593231472|FG003|Overall Study|Lost to Follow-up|1|||
164234836|NCT05901636|593231473|FG004|Overall Study|Lost to Follow-up|1|||
164234837|NCT05901636|593231474|FG005|Overall Study|Lost to Follow-up|3|||
164234838|NCT05901636|593231475|FG006|Overall Study|Lost to Follow-up|1|||
164299834|NCT02234843|593472945|FG001|Overall Study|Death|0|||
164333601|NCT04526509|593597478|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
164333602|NCT04526509|593597479|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
164423275|NCT05310084|593921419|FG001|Overall Study|Participant availability|4|||
164423276|NCT05310084|593921418|FG000|Overall Study|Lost to Follow-up|1|||
164423277|NCT05310084|593921419|FG001|Overall Study|Lost to Follow-up|1|||
164423278|NCT05310084|593921418|FG000|Overall Study|Adverse Event|1|||
164423279|NCT05310084|593921419|FG001|Overall Study|Adverse Event|1|||
164423280|NCT05310084|593921418|FG000|Overall Study|Randomized but not vaccinated|4|||
164423281|NCT05310084|593921419|FG001|Overall Study|Randomized but not vaccinated|2|||
164423282|NCT02065245|593921421|FG000|Infusion 1|Lost to Follow-up|0|||
164423283|NCT02065245|593921422|FG001|Infusion 1|Lost to Follow-up|0|||
164423284|NCT02065245|593921423|FG002|Infusion 1|Lost to Follow-up|0|||
164423285|NCT02065245|593921424|FG003|Infusion 1|Lost to Follow-up|0|||
164423286|NCT02065245|593921425|FG004|Infusion 1|Lost to Follow-up|0|||
164423287|NCT02065245|593921426|FG005|Infusion 1|Lost to Follow-up|0|||
164423288|NCT02065245|593921427|FG006|Infusion 1|Lost to Follow-up|1|||
164423289|NCT02065245|593921421|FG000|Infusion 1|Death|0|||
164423290|NCT02065245|593921422|FG001|Infusion 1|Death|0|||
164423291|NCT02065245|593921423|FG002|Infusion 1|Death|1|||
164423292|NCT02065245|593921424|FG003|Infusion 1|Death|0|||
164423293|NCT02065245|593921425|FG004|Infusion 1|Death|1|||
164423294|NCT02065245|593921426|FG005|Infusion 1|Death|0|||
164423295|NCT02065245|593921427|FG006|Infusion 1|Death|0|||
164423296|NCT02065245|593921421|FG000|Infusion 2|Death|0|||
164423297|NCT02065245|593921422|FG001|Infusion 2|Death|0|||
164423298|NCT02065245|593921423|FG002|Infusion 2|Death|0|||
164423299|NCT02065245|593921424|FG003|Infusion 2|Death|0|||
164423300|NCT02065245|593921425|FG004|Infusion 2|Death|0|||
164423301|NCT02065245|593921426|FG005|Infusion 2|Death|0|||
164423302|NCT02065245|593921427|FG006|Infusion 2|Death|1|||
164423303|NCT02065245|593921421|FG000|Infusion 3|Lost to Follow-up|1|||
164423304|NCT02065245|593921422|FG001|Infusion 3|Lost to Follow-up|1|||
164423305|NCT02065245|593921423|FG002|Infusion 3|Lost to Follow-up|0|||
164423306|NCT02065245|593921424|FG003|Infusion 3|Lost to Follow-up|0|||
164423307|NCT02065245|593921425|FG004|Infusion 3|Lost to Follow-up|0|||
164423308|NCT02065245|593921426|FG005|Infusion 3|Lost to Follow-up|0|||
164423309|NCT02065245|593921427|FG006|Infusion 3|Lost to Follow-up|0|||
164423310|NCT00924664|593921428|FG000|Overall Study|Adverse Event|23|||
164423311|NCT00924664|593921429|FG001|Overall Study|Adverse Event|39|||
164423312|NCT00924664|593921428|FG000|Overall Study|Lack of Efficacy|10|||
164423313|NCT00924664|593921429|FG001|Overall Study|Lack of Efficacy|15|||
164423314|NCT00924664|593921428|FG000|Overall Study|Lost to Follow-up|10|||
164423315|NCT00924664|593921429|FG001|Overall Study|Lost to Follow-up|12|||
164423316|NCT00924664|593921428|FG000|Overall Study|Withdrawal by Subject|47|||
164423317|NCT00924664|593921429|FG001|Overall Study|Withdrawal by Subject|71|||
164423318|NCT00924664|593921428|FG000|Overall Study|Protocol Violation|2|||
164423319|NCT00924664|593921429|FG001|Overall Study|Protocol Violation|5|||
164423320|NCT00924664|593921428|FG000|Overall Study|Pregnancy|1|||
164423321|NCT00924664|593921429|FG001|Overall Study|Pregnancy|1|||
164423322|NCT00924664|593921428|FG000|Overall Study|Death|0|||
164423323|NCT00924664|593921429|FG001|Overall Study|Death|2|||
164333603|NCT04526509|593597480|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
164333604|NCT04526509|593597481|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
164333605|NCT04526509|593597475|FG000|Enrolled|Physician Decision|0|||
164333606|NCT04526509|593597476|FG001|Enrolled|Physician Decision|1|||
164572807|NCT02875223|594460451|FG012|Overall Study|Death|0|||
164572808|NCT02875223|594460439|FG000|Overall Study|Lost to Follow-up|0|||
164572809|NCT02875223|594460440|FG001|Overall Study|Lost to Follow-up|1|||
164572810|NCT02875223|594460441|FG002|Overall Study|Lost to Follow-up|1|||
164572811|NCT02875223|594460442|FG003|Overall Study|Lost to Follow-up|0|||
164423324|NCT00924664|593921428|FG000|Overall Study|Study terminated by sponsor|199|||
164423325|NCT00924664|593921429|FG001|Overall Study|Study terminated by sponsor|330|||
164423326|NCT00924664|593921428|FG000|Overall Study|Other|29|||
164423327|NCT00924664|593921429|FG001|Overall Study|Other|52|||
164423328|NCT00924664|593921428|FG000|Overall Study|Randomized but not Treated|1|||
164423329|NCT00924664|593921429|FG001|Overall Study|Randomized but not Treated|0|||
164423330|NCT01598987|593921430|FG000|Baseline to Month 12|Administrative problems|2|||
164423331|NCT01598987|593921430|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
164423332|NCT01598987|593921430|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
164423333|NCT01598987|593921430|FG000|Baseline to 24 Month|Administrative problems|2|||
164423334|NCT01598987|593921430|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
164333607|NCT04526509|593597477|FG002|Enrolled|Physician Decision|0|||
164423335|NCT03531905|593921431|FG000|Overall Study|Withdrawal by Subject|3|||
164572812|NCT02875223|594460443|FG004|Overall Study|Lost to Follow-up|1|||
164423336|NCT03531905|593921432|FG001|Overall Study|Withdrawal by Subject|3|||
164423337|NCT03531905|593921433|FG002|Overall Study|Withdrawal by Subject|2|||
164423338|NCT03531905|593921431|FG000|Overall Study|Lost to Follow-up|2|||
164423339|NCT03531905|593921432|FG001|Overall Study|Lost to Follow-up|2|||
164423340|NCT03531905|593921433|FG002|Overall Study|Lost to Follow-up|1|||
164423341|NCT03531905|593921431|FG000|Overall Study|Participant was out of town|1|||
164572813|NCT02875223|594460444|FG005|Overall Study|Lost to Follow-up|0|||
164423342|NCT03531905|593921432|FG001|Overall Study|Participant was out of town|0|||
164423343|NCT03531905|593921433|FG002|Overall Study|Participant was out of town|0|||
164423344|NCT03531905|593921431|FG000|Overall Study|Could not speak with the participant|1|||
164423345|NCT03531905|593921432|FG001|Overall Study|Could not speak with the participant|0|||
164423346|NCT03531905|593921433|FG002|Overall Study|Could not speak with the participant|0|||
164423347|NCT01036087|593921434|FG000|Overall Study|Adverse Event|2|||
164423348|NCT01036087|593921434|FG000|Overall Study|Lack of Efficacy|1|||
164423349|NCT03527277|593921437|FG000|Overall Study|Withdrawal by Subject|5|||
164333608|NCT04526509|593597478|FG003|Enrolled|Physician Decision|0|||
164333609|NCT04526509|593597479|FG004|Enrolled|Physician Decision|0|||
164333610|NCT04526509|593597480|FG005|Enrolled|Physician Decision|0|||
164333611|NCT04526509|593597481|FG006|Enrolled|Physician Decision|0|||
164333612|NCT02206048|593599581|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
164333613|NCT00282412|593599582|FG000|Overall Study|Death|2|||
164333614|NCT02203071|593599584|FG000|Overall Study|Lost to Follow-up|3|||
164333615|NCT02203071|593599585|FG001|Overall Study|Lost to Follow-up|1|||
164333616|NCT02572388|593599586|FG000|Overall Study|Withdrawal by Subject|1|||
164333617|NCT02572388|593599587|FG001|Overall Study|Withdrawal by Subject|1|||
164333618|NCT02572388|593599588|FG002|Overall Study|Withdrawal by Subject|2|||
164333619|NCT02572388|593599589|FG003|Overall Study|Withdrawal by Subject|2|||
164333620|NCT02202837|593599592|FG000|Overall Study|Enbrel treatment discontinued|36|||
164333621|NCT02202837|593599593|FG001|Overall Study|Enbrel treatment discontinued|4|||
164333622|NCT02202837|593599592|FG000|Overall Study|Other|10|||
164333623|NCT02202837|593599593|FG001|Overall Study|Other|0|||
164333624|NCT02202837|593599592|FG000|Overall Study|Lost to Follow-up|7|||
164333625|NCT02202837|593599593|FG001|Overall Study|Lost to Follow-up|1|||
164333626|NCT01871142|593599594|FG000|Overall Study|Adverse Event|1|||
164333627|NCT00231842|593599604|FG000|Overall Study|Withdrawal by Subject|3|||
164333628|NCT00231842|593599604|FG000|Overall Study|Did not complete the last 3 cycle|8|||
164333629|NCT02422303|593599605|FG000|Overall Study|Lost to Follow-up|1|||
164333630|NCT02422303|593599606|FG001|Overall Study|Lost to Follow-up|1|||
164333631|NCT00428792|593599608|FG000|Overall Study|Lack of Efficacy|1|||
164333632|NCT00428792|593599609|FG001|Overall Study|Lack of Efficacy|3|||
164333633|NCT00428792|593599608|FG000|Overall Study|Lost to Follow-up|0|||
164333634|NCT00428792|593599609|FG001|Overall Study|Lost to Follow-up|1|||
164572814|NCT02875223|594460445|FG006|Overall Study|Lost to Follow-up|1|||
164572815|NCT02875223|594460446|FG007|Overall Study|Lost to Follow-up|1|||
164572816|NCT02875223|594460447|FG008|Overall Study|Lost to Follow-up|0|||
164572817|NCT02875223|594460448|FG009|Overall Study|Lost to Follow-up|0|||
164572818|NCT02875223|594460449|FG010|Overall Study|Lost to Follow-up|0|||
164572819|NCT02875223|594460450|FG011|Overall Study|Lost to Follow-up|0|||
164572820|NCT02875223|594460451|FG012|Overall Study|Lost to Follow-up|0|||
164572821|NCT03136107|594460452|FG000|Overall Study|Other (Not specified)|1|||
164572822|NCT01707992|594460454|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
164572823|NCT01707992|594460455|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
164572824|NCT01707992|594460456|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
164676451|NCT04035187|594840102|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
164676452|NCT04035187|594840103|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
164676453|NCT04035187|594840104|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
164676454|NCT04035187|594840105|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
164676455|NCT02255149|594840118|FG000|Overall Study|Lost to Follow-up|2|||
164676456|NCT02255149|594840118|FG000|Overall Study|Withdrawal by Subject|1|||
164676457|NCT02255149|594840118|FG000|Overall Study|Withdrawal by PI|1|||
164676458|NCT02255149|594840118|FG000|Overall Study|Implant Failure|1|||
164676459|NCT00373256|594840119|FG000|Overall Study|Adverse Event (AE)|1|||
164676460|NCT00373256|594840120|FG001|Overall Study|Adverse Event (AE)|5|||
164676461|NCT00373256|594840119|FG000|Overall Study|Lost to Follow-up|2|||
164676462|NCT00373256|594840120|FG001|Overall Study|Lost to Follow-up|1|||
164676463|NCT00373256|594840119|FG000|Overall Study|Death|9|||
164676464|NCT00373256|594840120|FG001|Overall Study|Death|8|||
164676465|NCT00373256|594840119|FG000|Overall Study|Objective Progression or Relapse|111|||
164676466|NCT00373256|594840120|FG001|Overall Study|Objective Progression or Relapse|104|||
164676467|NCT00373256|594840119|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
164676468|NCT00373256|594840120|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
164676469|NCT00373256|594840119|FG000|Overall Study|Other|73|||
164676470|NCT00373256|594840120|FG001|Overall Study|Other|107|||
164676471|NCT00373256|594840119|FG000|Overall Study|Protocol Violation|0|||
164676472|NCT00373256|594840120|FG001|Overall Study|Protocol Violation|2|||
164676473|NCT00373256|594840119|FG000|Overall Study|Study Terminated by Sponsor|41|||
164676474|NCT00373256|594840120|FG001|Overall Study|Study Terminated by Sponsor|13|||
164676475|NCT03032172|594840124|FG000|Treatment Period|Adverse Event|0|||
164676476|NCT03032172|594840125|FG001|Treatment Period|Adverse Event|1|||
164676477|NCT03032172|594840126|FG002|Treatment Period|Adverse Event|0|||
164676478|NCT03032172|594840127|FG003|Treatment Period|Adverse Event|0|||
164423350|NCT03527277|593921438|FG001|Overall Study|Withdrawal by Subject|0|||
164676479|NCT03032172|594840128|FG004|Treatment Period|Adverse Event|0|||
164676480|NCT03032172|594840129|FG005|Treatment Period|Adverse Event|0|||
164676481|NCT03032172|594840130|FG006|Treatment Period|Adverse Event|0|||
164676482|NCT03032172|594840131|FG007|Treatment Period|Adverse Event|0|||
164676483|NCT03032172|594840124|FG000|Treatment Period|Lack of Efficacy|0|||
164676484|NCT03032172|594840125|FG001|Treatment Period|Lack of Efficacy|1|||
164676485|NCT03032172|594840126|FG002|Treatment Period|Lack of Efficacy|0|||
164676486|NCT03032172|594840127|FG003|Treatment Period|Lack of Efficacy|0|||
164676487|NCT03032172|594840128|FG004|Treatment Period|Lack of Efficacy|0|||
164676488|NCT03032172|594840129|FG005|Treatment Period|Lack of Efficacy|0|||
164676489|NCT03032172|594840130|FG006|Treatment Period|Lack of Efficacy|0|||
164676490|NCT03032172|594840131|FG007|Treatment Period|Lack of Efficacy|0|||
164676491|NCT03032172|594840124|FG000|Treatment Period|Non-compliance With Study Drug|0|||
164676492|NCT03032172|594840125|FG001|Treatment Period|Non-compliance With Study Drug|1|||
164676493|NCT03032172|594840126|FG002|Treatment Period|Non-compliance With Study Drug|0|||
164676494|NCT03032172|594840127|FG003|Treatment Period|Non-compliance With Study Drug|0|||
164676495|NCT03032172|594840128|FG004|Treatment Period|Non-compliance With Study Drug|0|||
164676496|NCT03032172|594840129|FG005|Treatment Period|Non-compliance With Study Drug|0|||
164676497|NCT03032172|594840130|FG006|Treatment Period|Non-compliance With Study Drug|0|||
164676498|NCT03032172|594840131|FG007|Treatment Period|Non-compliance With Study Drug|0|||
164676499|NCT03032172|594840124|FG000|Treatment Period|Reason Not Specified|0|||
164676500|NCT03032172|594840125|FG001|Treatment Period|Reason Not Specified|4|||
164676501|NCT03032172|594840126|FG002|Treatment Period|Reason Not Specified|1|||
164676502|NCT03032172|594840127|FG003|Treatment Period|Reason Not Specified|0|||
164676503|NCT03032172|594840128|FG004|Treatment Period|Reason Not Specified|0|||
164676504|NCT03032172|594840129|FG005|Treatment Period|Reason Not Specified|0|||
164676505|NCT03032172|594840130|FG006|Treatment Period|Reason Not Specified|0|||
164676506|NCT03032172|594840131|FG007|Treatment Period|Reason Not Specified|0|||
164676507|NCT03032172|594840124|FG000|Treatment Period|Physician Decision|0|||
164676508|NCT03032172|594840125|FG001|Treatment Period|Physician Decision|2|||
164676509|NCT03032172|594840126|FG002|Treatment Period|Physician Decision|1|||
164676510|NCT03032172|594840127|FG003|Treatment Period|Physician Decision|0|||
164676511|NCT03032172|594840128|FG004|Treatment Period|Physician Decision|0|||
164676512|NCT03032172|594840129|FG005|Treatment Period|Physician Decision|0|||
164676513|NCT03032172|594840130|FG006|Treatment Period|Physician Decision|0|||
164676514|NCT03032172|594840131|FG007|Treatment Period|Physician Decision|0|||
164676515|NCT03032172|594840124|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
164676516|NCT03032172|594840125|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
164676517|NCT03032172|594840126|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
164234839|NCT05901636|593231469|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
164234840|NCT05901636|593231470|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
164234841|NCT05901636|593231471|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
164234842|NCT05901636|593231472|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
164234843|NCT05901636|593231473|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
164234844|NCT05901636|593231474|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
164234845|NCT05901636|593231475|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
164234846|NCT05901636|593231469|FG000|Overall Study|Withdrawal by Subject|1|||
164234847|NCT05901636|593231470|FG001|Overall Study|Withdrawal by Subject|1|||
164234848|NCT05901636|593231471|FG002|Overall Study|Withdrawal by Subject|0|||
164234849|NCT05901636|593231472|FG003|Overall Study|Withdrawal by Subject|0|||
164234850|NCT05901636|593231473|FG004|Overall Study|Withdrawal by Subject|1|||
164234851|NCT05901636|593231474|FG005|Overall Study|Withdrawal by Subject|1|||
164234852|NCT05901636|593231475|FG006|Overall Study|Withdrawal by Subject|0|||
164234853|NCT05901636|593231469|FG000|Overall Study|Other|0|||
164234854|NCT05901636|593231470|FG001|Overall Study|Other|0|||
164234855|NCT05901636|593231471|FG002|Overall Study|Other|1|||
164234856|NCT05901636|593231472|FG003|Overall Study|Other|1|||
164234857|NCT05901636|593231473|FG004|Overall Study|Other|0|||
164234858|NCT05901636|593231474|FG005|Overall Study|Other|0|||
164234859|NCT05901636|593231475|FG006|Overall Study|Other|0|||
164234860|NCT03193801|593231476|FG000|Overall Study|Physician Decision|2|||
164234861|NCT03193801|593231476|FG000|Overall Study|Withdrawal by Subject|1|||
164234862|NCT03110562|593231477|FG000|Initial Treatment Period|Disease Progression|1|||
164234863|NCT03110562|593231478|FG001|Initial Treatment Period|Disease Progression|1|||
164234864|NCT03110562|593231479|FG002|Initial Treatment Period|Disease Progression|0|||
164234865|NCT03110562|593231480|FG003|Initial Treatment Period|Disease Progression|0|||
164234866|NCT03110562|593231477|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
164234867|NCT03110562|593231478|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
164234868|NCT03110562|593231479|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
164234869|NCT03110562|593231480|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
164234870|NCT03110562|593231477|FG000|Initial Treatment Period|Adverse Event|1|||
164234871|NCT03110562|593231478|FG001|Initial Treatment Period|Adverse Event|0|||
164234872|NCT03110562|593231479|FG002|Initial Treatment Period|Adverse Event|0|||
164234873|NCT03110562|593231480|FG003|Initial Treatment Period|Adverse Event|0|||
164333635|NCT00850343|593599610|FG000|Overall Study|Withdrawal by Subject|11|||
164333636|NCT00850343|593599611|FG001|Overall Study|Withdrawal by Subject|0|||
164333637|NCT00850343|593599612|FG002|Overall Study|Withdrawal by Subject|3|||
164333638|NCT00850343|593599613|FG003|Overall Study|Withdrawal by Subject|2|||
164333639|NCT00850343|593599610|FG000|Overall Study|Adverse Event|15|||
164333640|NCT00850343|593599611|FG001|Overall Study|Adverse Event|2|||
164333641|NCT00850343|593599612|FG002|Overall Study|Adverse Event|6|||
164333642|NCT00850343|593599613|FG003|Overall Study|Adverse Event|6|||
164333643|NCT00850343|593599610|FG000|Overall Study|Pregnancy|0|||
164333644|NCT00850343|593599611|FG001|Overall Study|Pregnancy|0|||
164333645|NCT00850343|593599612|FG002|Overall Study|Pregnancy|0|||
164333646|NCT00850343|593599613|FG003|Overall Study|Pregnancy|1|||
164333647|NCT00850343|593599610|FG000|Overall Study|Lack of Efficacy|17|||
164333648|NCT00850343|593599611|FG001|Overall Study|Lack of Efficacy|0|||
164333649|NCT00850343|593599612|FG002|Overall Study|Lack of Efficacy|3|||
164333650|NCT00850343|593599613|FG003|Overall Study|Lack of Efficacy|2|||
164333651|NCT00850343|593599610|FG000|Overall Study|Non-compliance with Study Procedures|1|||
164333652|NCT00850343|593599611|FG001|Overall Study|Non-compliance with Study Procedures|0|||
164333653|NCT00850343|593599612|FG002|Overall Study|Non-compliance with Study Procedures|1|||
164333654|NCT00850343|593599613|FG003|Overall Study|Non-compliance with Study Procedures|1|||
164333655|NCT00850343|593599610|FG000|Overall Study|Physician Decision|2|||
164333656|NCT00850343|593599611|FG001|Overall Study|Physician Decision|1|||
164333657|NCT00850343|593599612|FG002|Overall Study|Physician Decision|1|||
164333658|NCT00850343|593599613|FG003|Overall Study|Physician Decision|1|||
164333659|NCT02468232|593599614|FG000|Core Part of Study|Adverse Event|0|||
164333660|NCT02468232|593599615|FG001|Core Part of Study|Adverse Event|1|||
164333661|NCT02468232|593599616|FG002|Core Part of Study|Adverse Event|0|||
164333662|NCT02468232|593599617|FG003|Core Part of Study|Adverse Event|0|||
164333663|NCT02468232|593599614|FG000|Core Part of Study|Death|20|||
164333664|NCT02468232|593599615|FG001|Core Part of Study|Death|17|||
164333665|NCT02468232|593599616|FG002|Core Part of Study|Death|0|||
164333666|NCT02468232|593599617|FG003|Core Part of Study|Death|0|||
164333667|NCT02468232|593599614|FG000|Core Part of Study|Technical Problems|1|||
164333668|NCT02468232|593599615|FG001|Core Part of Study|Technical Problems|1|||
164333669|NCT02468232|593599616|FG002|Core Part of Study|Technical Problems|0|||
164333670|NCT02468232|593599617|FG003|Core Part of Study|Technical Problems|0|||
164333671|NCT02468232|593599614|FG000|OLE Part of Study|Adverse Event|0|||
164333672|NCT02468232|593599615|FG001|OLE Part of Study|Adverse Event|0|||
164333673|NCT02468232|593599616|FG002|OLE Part of Study|Adverse Event|4|||
164333674|NCT02468232|593599617|FG003|OLE Part of Study|Adverse Event|5|||
164333675|NCT02468232|593599614|FG000|OLE Part of Study|Death|0|||
164333676|NCT02468232|593599615|FG001|OLE Part of Study|Death|0|||
164423351|NCT03527277|593921437|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
164572825|NCT01707992|594460457|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
164572826|NCT01707992|594460458|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
164572827|NCT01707992|594460459|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
164333677|NCT02468232|593599616|FG002|OLE Part of Study|Death|4|||
164333678|NCT02468232|593599617|FG003|OLE Part of Study|Death|2|||
164333679|NCT02468232|593599614|FG000|OLE Part of Study|Physician Decision|0|||
164333680|NCT02468232|593599615|FG001|OLE Part of Study|Physician Decision|0|||
164333681|NCT02468232|593599616|FG002|OLE Part of Study|Physician Decision|4|||
164333682|NCT02468232|593599617|FG003|OLE Part of Study|Physician Decision|0|||
164333683|NCT02468232|593599614|FG000|OLE Part of Study|Subject/Guardian decision|0|||
164333684|NCT02468232|593599615|FG001|OLE Part of Study|Subject/Guardian decision|0|||
164333685|NCT02468232|593599616|FG002|OLE Part of Study|Subject/Guardian decision|2|||
164333686|NCT02468232|593599617|FG003|OLE Part of Study|Subject/Guardian decision|5|||
164333687|NCT01973569|593599618|FG000|Overall Study|Adverse Event|9|||
164333688|NCT01973569|593599619|FG001|Overall Study|Adverse Event|2|||
164333689|NCT01973569|593599620|FG002|Overall Study|Adverse Event|4|||
164333690|NCT01973569|593599618|FG000|Overall Study|Protocol Violation|2|||
164333691|NCT01973569|593599619|FG001|Overall Study|Protocol Violation|1|||
164333692|NCT01973569|593599620|FG002|Overall Study|Protocol Violation|3|||
164333693|NCT01973569|593599618|FG000|Overall Study|Withdrawal by Subject|7|||
164333694|NCT01973569|593599619|FG001|Overall Study|Withdrawal by Subject|5|||
164333695|NCT01973569|593599620|FG002|Overall Study|Withdrawal by Subject|2|||
164572828|NCT01707992|594460454|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
164333696|NCT01973569|593599618|FG000|Overall Study|Invasive dental treatment|3|||
164333697|NCT01973569|593599619|FG001|Overall Study|Invasive dental treatment|5|||
164333698|NCT01973569|593599620|FG002|Overall Study|Invasive dental treatment|6|||
164333699|NCT01973569|593599618|FG000|Overall Study|Prohibited concomitant d|1|||
164333700|NCT01973569|593599619|FG001|Overall Study|Prohibited concomitant d|5|||
164333701|NCT01973569|593599620|FG002|Overall Study|Prohibited concomitant d|0|||
164333702|NCT01973569|593599618|FG000|Overall Study|Disease progression|0|||
164333703|NCT01973569|593599619|FG001|Overall Study|Disease progression|3|||
164333704|NCT01973569|593599620|FG002|Overall Study|Disease progression|0|||
164333705|NCT01973569|593599618|FG000|Overall Study|Other|1|||
164333706|NCT01973569|593599619|FG001|Overall Study|Other|1|||
164423352|NCT03527277|593921438|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
164423353|NCT03527277|593921437|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
164423354|NCT03527277|593921438|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
164234874|NCT03110562|593231477|FG000|Initial Treatment Period|Death|74|||
164234875|NCT03110562|593231478|FG001|Initial Treatment Period|Death|82|||
164234876|NCT03110562|593231479|FG002|Initial Treatment Period|Death|0|||
164234877|NCT03110562|593231480|FG003|Initial Treatment Period|Death|0|||
164234878|NCT03110562|593231477|FG000|Initial Treatment Period|Lost to Follow-up|13|||
164234879|NCT03110562|593231478|FG001|Initial Treatment Period|Lost to Follow-up|8|||
164234880|NCT03110562|593231479|FG002|Initial Treatment Period|Lost to Follow-up|0|||
164234881|NCT03110562|593231480|FG003|Initial Treatment Period|Lost to Follow-up|0|||
164234882|NCT03110562|593231477|FG000|Initial Treatment Period|Protocol Deviation|1|||
164234883|NCT03110562|593231478|FG001|Initial Treatment Period|Protocol Deviation|0|||
164234884|NCT03110562|593231479|FG002|Initial Treatment Period|Protocol Deviation|0|||
164234885|NCT03110562|593231480|FG003|Initial Treatment Period|Protocol Deviation|0|||
164234886|NCT03110562|593231477|FG000|Initial Treatment Period|Physician Decision|2|||
164234887|NCT03110562|593231478|FG001|Initial Treatment Period|Physician Decision|1|||
164234888|NCT03110562|593231479|FG002|Initial Treatment Period|Physician Decision|0|||
164234889|NCT03110562|593231480|FG003|Initial Treatment Period|Physician Decision|0|||
164234890|NCT03110562|593231477|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
164234891|NCT03110562|593231478|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
164234892|NCT03110562|593231479|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
164234893|NCT03110562|593231480|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
164234894|NCT03110562|593231477|FG000|Initial Treatment Period|Other|5|||
164234895|NCT03110562|593231478|FG001|Initial Treatment Period|Other|4|||
164234896|NCT03110562|593231479|FG002|Initial Treatment Period|Other|0|||
164234897|NCT03110562|593231480|FG003|Initial Treatment Period|Other|0|||
164234898|NCT03110562|593231477|FG000|Initial Treatment Period|Randomized but never treated|0|||
164234899|NCT03110562|593231478|FG001|Initial Treatment Period|Randomized but never treated|3|||
164234900|NCT03110562|593231479|FG002|Initial Treatment Period|Randomized but never treated|0|||
164234901|NCT03110562|593231480|FG003|Initial Treatment Period|Randomized but never treated|0|||
164234902|NCT03110562|593231477|FG000|Crossover Period|Disease Progression|0|||
164234903|NCT03110562|593231478|FG001|Crossover Period|Disease Progression|0|||
164234904|NCT03110562|593231479|FG002|Crossover Period|Disease Progression|1|||
164234905|NCT03110562|593231480|FG003|Crossover Period|Disease Progression|0|||
164234906|NCT03110562|593231477|FG000|Crossover Period|Withdrawal by Subject|0|||
164234907|NCT03110562|593231478|FG001|Crossover Period|Withdrawal by Subject|0|||
164234908|NCT03110562|593231479|FG002|Crossover Period|Withdrawal by Subject|8|||
164234909|NCT03110562|593231480|FG003|Crossover Period|Withdrawal by Subject|6|||
164234910|NCT03110562|593231477|FG000|Crossover Period|Death|0|||
164234911|NCT03110562|593231478|FG001|Crossover Period|Death|0|||
164234912|NCT03110562|593231479|FG002|Crossover Period|Death|37|||
164234913|NCT03110562|593231480|FG003|Crossover Period|Death|3|||
164234914|NCT03110562|593231477|FG000|Crossover Period|Lost to Follow-up|0|||
164234915|NCT03110562|593231478|FG001|Crossover Period|Lost to Follow-up|0|||
164333707|NCT01973569|593599620|FG002|Overall Study|Other|0|||
164333708|NCT01973569|593599618|FG000|Overall Study|Did not receive study drug|6|||
164333709|NCT01973569|593599619|FG001|Overall Study|Did not receive study drug|3|||
164333710|NCT01973569|593599620|FG002|Overall Study|Did not receive study drug|3|||
164333711|NCT00371826|593599621|FG000|Core Phase (12 Months)|Adverse Event|15|||
164333712|NCT00371826|593599622|FG001|Core Phase (12 Months)|Adverse Event|4|||
164333713|NCT00371826|593599623|FG002|Core Phase (12 Months)|Adverse Event|9|||
164333714|NCT00371826|593599621|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
164333715|NCT00371826|593599622|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
164333716|NCT00371826|593599623|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
164234916|NCT03110562|593231479|FG002|Crossover Period|Lost to Follow-up|0|||
164234917|NCT03110562|593231480|FG003|Crossover Period|Lost to Follow-up|1|||
164333717|NCT00371826|593599621|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
164333718|NCT00371826|593599622|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
164333719|NCT00371826|593599623|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
164333720|NCT00371826|593599621|FG000|Core Phase (12 Months)|Protocol Violation|1|||
164423355|NCT01781611|593921442|FG000|Overall Study|Adverse Event|4|||
164234918|NCT03110562|593231477|FG000|Crossover Period|Other|0|||
164234919|NCT03110562|593231478|FG001|Crossover Period|Other|0|||
164234920|NCT03110562|593231479|FG002|Crossover Period|Other|1|||
164234921|NCT03110562|593231480|FG003|Crossover Period|Other|1|||
164234922|NCT03110562|593231477|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
164234923|NCT03110562|593231478|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
164234924|NCT03110562|593231479|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
164234925|NCT03110562|593231480|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
164333721|NCT00371826|593599622|FG001|Core Phase (12 Months)|Protocol Violation|0|||
164333722|NCT00371826|593599623|FG002|Core Phase (12 Months)|Protocol Violation|1|||
164234926|NCT05239221|593231486|FG000|Overall Study|Adverse Event|0|||
164234927|NCT05239221|593231487|FG001|Overall Study|Adverse Event|0|||
164234928|NCT05239221|593231488|FG002|Overall Study|Adverse Event|0|||
164234929|NCT05239221|593231489|FG003|Overall Study|Adverse Event|0|||
164234930|NCT05239221|593231490|FG004|Overall Study|Adverse Event|0|||
164234931|NCT05239221|593231491|FG005|Overall Study|Adverse Event|0|||
164234932|NCT05239221|593231492|FG006|Overall Study|Adverse Event|1|||
164234933|NCT05239221|593231493|FG007|Overall Study|Adverse Event|0|||
164234934|NCT05239221|593231494|FG008|Overall Study|Adverse Event|0|||
164234935|NCT05239221|593231495|FG009|Overall Study|Adverse Event|0|||
164234936|NCT05239221|593231496|FG010|Overall Study|Adverse Event|1|||
164234937|NCT05239221|593231497|FG011|Overall Study|Adverse Event|1|||
164234938|NCT05239221|593231498|FG012|Overall Study|Adverse Event|0|||
164234939|NCT05239221|593231499|FG013|Overall Study|Adverse Event|0|||
164234940|NCT05239221|593231500|FG014|Overall Study|Adverse Event|0|||
164234941|NCT05239221|593231501|FG015|Overall Study|Adverse Event|0|||
164234942|NCT05239221|593231486|FG000|Overall Study|Withdrawal by Subject|0|||
164234943|NCT05239221|593231487|FG001|Overall Study|Withdrawal by Subject|0|||
164234944|NCT05239221|593231488|FG002|Overall Study|Withdrawal by Subject|0|||
164234945|NCT05239221|593231489|FG003|Overall Study|Withdrawal by Subject|0|||
164234946|NCT05239221|593231490|FG004|Overall Study|Withdrawal by Subject|0|||
164234947|NCT05239221|593231491|FG005|Overall Study|Withdrawal by Subject|0|||
164234948|NCT05239221|593231492|FG006|Overall Study|Withdrawal by Subject|0|||
164234949|NCT05239221|593231493|FG007|Overall Study|Withdrawal by Subject|0|||
164234950|NCT05239221|593231494|FG008|Overall Study|Withdrawal by Subject|0|||
164234951|NCT05239221|593231495|FG009|Overall Study|Withdrawal by Subject|0|||
164234952|NCT05239221|593231496|FG010|Overall Study|Withdrawal by Subject|1|||
164234953|NCT05239221|593231497|FG011|Overall Study|Withdrawal by Subject|0|||
164234954|NCT05239221|593231498|FG012|Overall Study|Withdrawal by Subject|0|||
164234955|NCT05239221|593231499|FG013|Overall Study|Withdrawal by Subject|0|||
164234956|NCT05239221|593231500|FG014|Overall Study|Withdrawal by Subject|0|||
164234957|NCT05239221|593231501|FG015|Overall Study|Withdrawal by Subject|1|||
164234958|NCT02114177|593233379|FG000|Overall Study|Lost to Follow-up|1|||
164234959|NCT02114177|593233380|FG001|Overall Study|Lost to Follow-up|2|||
164234960|NCT02114177|593233379|FG000|Overall Study|Withdrawal by Subject|6|||
164234961|NCT02114177|593233380|FG001|Overall Study|Withdrawal by Subject|1|||
164234962|NCT02114177|593233379|FG000|Overall Study|Other|2|||
164234963|NCT02114177|593233380|FG001|Overall Study|Other|1|||
164676518|NCT03032172|594840127|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
164234964|NCT05111145|593233381|FG000|Overall Study|Commercial drug is available for participant|76|||
164234965|NCT05111145|593233381|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
164234966|NCT02336815|593233382|FG000|Overall Study|Disease Progression|45|||
164234967|NCT02336815|593233383|FG001|Overall Study|Disease Progression|70|||
164234968|NCT02336815|593233382|FG000|Overall Study|Adverse Event|18|||
164234969|NCT02336815|593233383|FG001|Overall Study|Adverse Event|39|||
164234970|NCT02336815|593233382|FG000|Overall Study|Physician Decision|11|||
164234971|NCT02336815|593233383|FG001|Overall Study|Physician Decision|4|||
164234972|NCT02336815|593233382|FG000|Overall Study|Withdrawal by Subject|3|||
164234973|NCT02336815|593233383|FG001|Overall Study|Withdrawal by Subject|2|||
164234974|NCT02336815|593233382|FG000|Overall Study|Lost to Follow-up|1|||
164234975|NCT02336815|593233383|FG001|Overall Study|Lost to Follow-up|3|||
164234976|NCT02336815|593233382|FG000|Overall Study|Other|1|||
164234977|NCT02336815|593233383|FG001|Overall Study|Other|5|||
164234978|NCT01359956|593233384|FG000|Overall Study|Death|58|||
164234979|NCT01359956|593233385|FG001|Overall Study|Death|60|||
164234980|NCT01359956|593233386|FG002|Overall Study|Death|66|||
164234981|NCT01359956|593233387|FG003|Overall Study|Death|57|||
164333723|NCT00371826|593599621|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
164333724|NCT00371826|593599622|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
164676519|NCT03032172|594840128|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
164676520|NCT03032172|594840129|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
164694666|NCT03250299|594905309|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
164234982|NCT01359956|593233384|FG000|Overall Study|Lost to Follow-up|3|||
164234983|NCT01359956|593233385|FG001|Overall Study|Lost to Follow-up|4|||
164234984|NCT01359956|593233386|FG002|Overall Study|Lost to Follow-up|1|||
164234985|NCT01359956|593233387|FG003|Overall Study|Lost to Follow-up|1|||
164234986|NCT01784029|593233388|FG000|Overall Study|Lost to Follow-up|19|||
164234987|NCT01784029|593233389|FG001|Overall Study|Lost to Follow-up|20|||
164234988|NCT01784029|593233390|FG002|Overall Study|Lost to Follow-up|22|||
164333725|NCT00371826|593599623|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
164234989|NCT02415556|593233393|FG000|Overall Study|Adverse Event|3|||
164234990|NCT02415556|593233394|FG001|Overall Study|Adverse Event|4|||
164234991|NCT02415556|593233395|FG002|Overall Study|Adverse Event|2|||
164234992|NCT02415556|593233396|FG003|Overall Study|Adverse Event|4|||
164234993|NCT02415556|593233393|FG000|Overall Study|Lost to Follow-up|4|||
164234994|NCT02415556|593233394|FG001|Overall Study|Lost to Follow-up|5|||
164234995|NCT02415556|593233395|FG002|Overall Study|Lost to Follow-up|4|||
164234996|NCT02415556|593233396|FG003|Overall Study|Lost to Follow-up|1|||
164234997|NCT02415556|593233393|FG000|Overall Study|Withdrawal by Subject|13|||
164234998|NCT02415556|593233394|FG001|Overall Study|Withdrawal by Subject|4|||
164234999|NCT02415556|593233395|FG002|Overall Study|Withdrawal by Subject|14|||
164235000|NCT02415556|593233396|FG003|Overall Study|Withdrawal by Subject|12|||
164235001|NCT02415556|593233393|FG000|Overall Study|Physician Decision|1|||
164235002|NCT02415556|593233394|FG001|Overall Study|Physician Decision|3|||
164235003|NCT02415556|593233395|FG002|Overall Study|Physician Decision|1|||
164235004|NCT02415556|593233396|FG003|Overall Study|Physician Decision|2|||
164235005|NCT02415556|593233393|FG000|Overall Study|Censored - study completion|4|||
164235006|NCT02415556|593233394|FG001|Overall Study|Censored - study completion|5|||
164235007|NCT02415556|593233395|FG002|Overall Study|Censored - study completion|1|||
164235008|NCT02415556|593233396|FG003|Overall Study|Censored - study completion|0|||
164235009|NCT02415556|593233393|FG000|Overall Study|Family-related issues|0|||
164235010|NCT02415556|593233394|FG001|Overall Study|Family-related issues|0|||
164235011|NCT02415556|593233395|FG002|Overall Study|Family-related issues|0|||
164235012|NCT02415556|593233396|FG003|Overall Study|Family-related issues|1|||
164676521|NCT03032172|594840130|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
164235013|NCT01209767|593233397|FG000|Overall Study|Withdrawal by Subject|1|||
164235014|NCT01209767|593233397|FG000|Overall Study|Lost to Follow-up|3|||
164235015|NCT01621178|593233398|FG000|Overall Study|Adverse Event|5|||
164235016|NCT01621178|593233399|FG001|Overall Study|Adverse Event|2|||
164235017|NCT01621178|593233400|FG002|Overall Study|Adverse Event|8|||
164235018|NCT01621178|593233398|FG000|Overall Study|Death|6|||
164235019|NCT01621178|593233399|FG001|Overall Study|Death|7|||
164235020|NCT01621178|593233400|FG002|Overall Study|Death|2|||
164235021|NCT01621178|593233398|FG000|Overall Study|Lost to Follow-up|1|||
164235022|NCT01621178|593233399|FG001|Overall Study|Lost to Follow-up|2|||
164235023|NCT01621178|593233400|FG002|Overall Study|Lost to Follow-up|1|||
164235024|NCT01621178|593233398|FG000|Overall Study|Withdrawal by Subject|14|||
164235025|NCT01621178|593233399|FG001|Overall Study|Withdrawal by Subject|17|||
164235026|NCT01621178|593233400|FG002|Overall Study|Withdrawal by Subject|18|||
164235027|NCT01621178|593233398|FG000|Overall Study|Physician Decision|5|||
164235028|NCT01621178|593233399|FG001|Overall Study|Physician Decision|2|||
164235029|NCT01621178|593233400|FG002|Overall Study|Physician Decision|7|||
164235030|NCT00105534|593233401|FG000|Overall Study|Adverse Event|2|||
164235031|NCT00105534|593233402|FG001|Overall Study|Adverse Event|5|||
164235032|NCT00105534|593233401|FG000|Overall Study|Protocol Violation|1|||
164235033|NCT00105534|593233402|FG001|Overall Study|Protocol Violation|4|||
164235034|NCT00105534|593233401|FG000|Overall Study|Withdrawal by Subject|6|||
164235035|NCT00105534|593233402|FG001|Overall Study|Withdrawal by Subject|6|||
164235036|NCT00105534|593233401|FG000|Overall Study|Lost to Follow-up|5|||
164235037|NCT00105534|593233402|FG001|Overall Study|Lost to Follow-up|1|||
164235038|NCT00105534|593233401|FG000|Overall Study|Lack of Efficacy|7|||
164235039|NCT00105534|593233402|FG001|Overall Study|Lack of Efficacy|15|||
164235040|NCT00105534|593233401|FG000|Overall Study|Treatment unmasked|1|||
164235041|NCT00105534|593233402|FG001|Overall Study|Treatment unmasked|0|||
164235042|NCT00105534|593233401|FG000|Overall Study|Other Reason|0|||
164235043|NCT00105534|593233402|FG001|Overall Study|Other Reason|2|||
164235044|NCT02465931|593233403|FG000|Overall Study|Lost to Follow-up|9|||
164235045|NCT02465931|593233404|FG001|Overall Study|Lost to Follow-up|11|||
164235046|NCT02465931|593233403|FG000|Overall Study|Protocol Violation|1|||
164235047|NCT02465931|593233404|FG001|Overall Study|Protocol Violation|0|||
164235048|NCT02465931|593233403|FG000|Overall Study|Withdrawal by Subject|1|||
164235049|NCT02465931|593233404|FG001|Overall Study|Withdrawal by Subject|0|||
164235050|NCT00730756|593233406|FG000|Overall Study|Adverse Event|2|||
164235051|NCT00730756|593233407|FG001|Overall Study|Adverse Event|0|||
164235052|NCT00730756|593233406|FG000|Overall Study|Lack of Efficacy|1|||
164235053|NCT00730756|593233407|FG001|Overall Study|Lack of Efficacy|1|||
164235054|NCT00730756|593233406|FG000|Overall Study|Protocol Deviation|1|||
164235055|NCT00730756|593233407|FG001|Overall Study|Protocol Deviation|2|||
164235056|NCT00730756|593233406|FG000|Overall Study|Lost to Follow-up|0|||
164235057|NCT00730756|593233407|FG001|Overall Study|Lost to Follow-up|1|||
164235058|NCT00730756|593233406|FG000|Overall Study|Withdrew Consent|0|||
164235059|NCT00730756|593233407|FG001|Overall Study|Withdrew Consent|1|||
164235060|NCT04388826|593233408|FG000|Overall Study|Lost to Follow-up|3|||
164235061|NCT04388826|593233409|FG001|Overall Study|Lost to Follow-up|2|||
164235062|NCT04388826|593233408|FG000|Overall Study|Adverse Event|1|||
164235063|NCT04388826|593233409|FG001|Overall Study|Adverse Event|0|||
164235064|NCT01840943|593233410|FG000|Overall Study|Withdrawal by Subject|5|||
164235065|NCT01840943|593233411|FG001|Overall Study|Withdrawal by Subject|6|||
164235066|NCT01840943|593233410|FG000|Overall Study|Physician Decision|4|||
164235067|NCT01840943|593233411|FG001|Overall Study|Physician Decision|2|||
164235068|NCT01840943|593233410|FG000|Overall Study|Lost to Follow-up|4|||
164235069|NCT01840943|593233411|FG001|Overall Study|Lost to Follow-up|4|||
164235070|NCT02862574|593233412|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164235071|NCT02862574|593233413|FG001|Double-Blind Treatment Period|Adverse Event|1|||
164235072|NCT02862574|593233414|FG002|Double-Blind Treatment Period|Adverse Event|0|||
164423356|NCT01781611|593921443|FG001|Overall Study|Adverse Event|0|||
164423357|NCT01333943|593921444|FG000|Overall Study|Known neuropathy|1|||
164423358|NCT01333943|593921445|FG001|Overall Study|Known neuropathy|0|||
164423359|NCT02459587|593921452|FG000|3-Month Follow-up Assessment|Death|0|||
164423360|NCT02459587|593921453|FG001|3-Month Follow-up Assessment|Death|2|||
164423361|NCT02459587|593921452|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
164423362|NCT02459587|593921453|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
164423363|NCT02459587|593921452|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
164423364|NCT02459587|593921453|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
164423365|NCT02459587|593921452|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
164423366|NCT02459587|593921453|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
164423367|NCT02459587|593921452|FG000|6-month Follow-up Assessment|Death|2|||
164423368|NCT02459587|593921453|FG001|6-month Follow-up Assessment|Death|1|||
164423369|NCT02459587|593921452|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
164423370|NCT02459587|593921453|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
164423371|NCT02459587|593921452|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
164423372|NCT02459587|593921453|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
164423373|NCT02459587|593921452|FG000|12-month Follow-up Assessment|Death|2|||
164423374|NCT02459587|593921453|FG001|12-month Follow-up Assessment|Death|0|||
164423375|NCT02459587|593921452|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
164423376|NCT02459587|593921453|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
164423377|NCT02459587|593921452|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
164423378|NCT02459587|593921453|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
164423379|NCT02459587|593921452|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
164423380|NCT02459587|593921453|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
164423381|NCT02652130|593921456|FG000|Overall Study|Death|1|||
164423382|NCT02028884|593921457|FG000|Double-blind Period|Adverse Event|5|||
164423383|NCT02028884|593921458|FG001|Double-blind Period|Adverse Event|3|||
164423384|NCT02028884|593921459|FG002|Double-blind Period|Adverse Event|0|||
164423385|NCT02028884|593921457|FG000|Double-blind Period|Eligibility Violation|1|||
164423386|NCT02028884|593921458|FG001|Double-blind Period|Eligibility Violation|0|||
164423387|NCT02028884|593921459|FG002|Double-blind Period|Eligibility Violation|0|||
164423388|NCT02028884|593921457|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
164423389|NCT02028884|593921458|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
164423390|NCT02028884|593921459|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
164423391|NCT02028884|593921457|FG000|Double-blind Period|Withdrawal by Subject|2|||
164423392|NCT02028884|593921458|FG001|Double-blind Period|Withdrawal by Subject|0|||
164423393|NCT02028884|593921459|FG002|Double-blind Period|Withdrawal by Subject|0|||
164423394|NCT02028884|593921457|FG000|Open-label Extension Period|Adverse Event|3|||
164235073|NCT02862574|593233412|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
164235074|NCT02862574|593233413|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
164235075|NCT02862574|593233414|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
164235076|NCT02862574|593233412|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
164235077|NCT02862574|593233413|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
164333726|NCT00371826|593599621|FG000|Core Phase (12 Months)|Administrative problems|1|||
164333727|NCT00371826|593599622|FG001|Core Phase (12 Months)|Administrative problems|0|||
164333728|NCT00371826|593599623|FG002|Core Phase (12 Months)|Administrative problems|8|||
164423395|NCT02028884|593921458|FG001|Open-label Extension Period|Adverse Event|1|||
164423396|NCT02028884|593921459|FG002|Open-label Extension Period|Adverse Event|0|||
164423397|NCT02028884|593921457|FG000|Open-label Extension Period|Lack of Efficacy|3|||
164235078|NCT02862574|593233414|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
164235079|NCT01446874|593233415|FG000|Overall Study|Not eligible|1|||
164235080|NCT01446874|593233416|FG001|Overall Study|Not eligible|0|||
164333729|NCT00371826|593599621|FG000|Core Phase (12 Months)|Graft Loss|0|||
164333730|NCT00371826|593599622|FG001|Core Phase (12 Months)|Graft Loss|1|||
164333731|NCT00371826|593599623|FG002|Core Phase (12 Months)|Graft Loss|0|||
164333732|NCT00371826|593599621|FG000|Extension Phase (24 Months)|Adverse Event|4|||
164333733|NCT00371826|593599622|FG001|Extension Phase (24 Months)|Adverse Event|5|||
164423398|NCT02028884|593921458|FG001|Open-label Extension Period|Lack of Efficacy|0|||
164423399|NCT02028884|593921459|FG002|Open-label Extension Period|Lack of Efficacy|0|||
164333734|NCT00371826|593599623|FG002|Extension Phase (24 Months)|Adverse Event|0|||
164423400|NCT02028884|593921457|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
164423401|NCT02028884|593921458|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
164423402|NCT02028884|593921459|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
164333735|NCT00371826|593599621|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
164333736|NCT00371826|593599622|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
164333737|NCT00371826|593599623|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
164333738|NCT00371826|593599621|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
164572829|NCT01707992|594460455|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
164235081|NCT01446874|593233417|FG002|Overall Study|Not eligible|0|||
164333739|NCT00371826|593599622|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
164235082|NCT01446874|593233415|FG000|Overall Study|No surgery/No qualifying surgery|1|||
164235083|NCT01446874|593233416|FG001|Overall Study|No surgery/No qualifying surgery|0|||
164235084|NCT01446874|593233417|FG002|Overall Study|No surgery/No qualifying surgery|12|||
164235085|NCT01446874|593233415|FG000|Overall Study|Non-compliance|0|||
164235086|NCT01446874|593233416|FG001|Overall Study|Non-compliance|4|||
164235087|NCT01446874|593233417|FG002|Overall Study|Non-compliance|0|||
164235088|NCT01446874|593233415|FG000|Overall Study|Antibiotics for pre-op infection|0|||
164235089|NCT01446874|593233416|FG001|Overall Study|Antibiotics for pre-op infection|0|||
164235090|NCT01446874|593233417|FG002|Overall Study|Antibiotics for pre-op infection|2|||
164235091|NCT01446874|593233415|FG000|Overall Study|Withdrawal by Subject|0|||
164235092|NCT01446874|593233416|FG001|Overall Study|Withdrawal by Subject|0|||
164235093|NCT01446874|593233417|FG002|Overall Study|Withdrawal by Subject|4|||
164235094|NCT03639610|593233421|FG000|Overall Study|Adverse Event|7|||
164235095|NCT03639610|593233422|FG001|Overall Study|Adverse Event|1|||
164235096|NCT03639610|593233423|FG002|Overall Study|Adverse Event|0|||
164235097|NCT03639610|593233421|FG000|Overall Study|Physician Decision|3|||
164235098|NCT03639610|593233422|FG001|Overall Study|Physician Decision|1|||
164235099|NCT03639610|593233423|FG002|Overall Study|Physician Decision|0|||
164235100|NCT03639610|593233421|FG000|Overall Study|Disease progression|8|||
164235101|NCT03639610|593233422|FG001|Overall Study|Disease progression|5|||
164235102|NCT03639610|593233423|FG002|Overall Study|Disease progression|3|||
164235103|NCT03639610|593233421|FG000|Overall Study|Study terminated by sponsor|2|||
164235104|NCT03639610|593233422|FG001|Overall Study|Study terminated by sponsor|1|||
164235105|NCT03639610|593233423|FG002|Overall Study|Study terminated by sponsor|1|||
164235106|NCT03639610|593233421|FG000|Overall Study|Patient request to stop treatment|1|||
164235107|NCT03639610|593233422|FG001|Overall Study|Patient request to stop treatment|2|||
164235108|NCT03639610|593233423|FG002|Overall Study|Patient request to stop treatment|0|||
164235109|NCT05067335|593233426|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
164235110|NCT05067335|593233427|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
164235111|NCT05067335|593233428|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
164235112|NCT05067335|593233429|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
164235113|NCT05067335|593233426|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
164235114|NCT05067335|593233427|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
164235115|NCT05067335|593233428|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
164235116|NCT05067335|593233429|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
164235117|NCT05067335|593233426|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
164235118|NCT05067335|593233427|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
164235119|NCT05067335|593233428|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
164235120|NCT05067335|593233429|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
164235121|NCT05067335|593233426|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
164235122|NCT05067335|593233427|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
164235123|NCT05067335|593233428|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
164235124|NCT05067335|593233429|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
164235125|NCT05067335|593233426|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
164235126|NCT05067335|593233427|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
164235127|NCT05067335|593233428|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
164235128|NCT05067335|593233429|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
164235129|NCT05067335|593233426|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
164235130|NCT05067335|593233427|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
164235131|NCT05067335|593233428|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
164676522|NCT03032172|594840131|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
164676523|NCT03032172|594840124|FG000|Treatment Period|Withdrawal by Subject|2|||
164235132|NCT05067335|593233429|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
164235133|NCT05067335|593233426|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
164235134|NCT05067335|593233427|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
164235135|NCT05067335|593233428|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
164235136|NCT05067335|593233429|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
164235137|NCT05067335|593233426|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
164235138|NCT05067335|593233427|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
164235139|NCT05067335|593233428|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
164235140|NCT05067335|593233429|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
164235141|NCT05067335|593233426|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
164235142|NCT05067335|593233427|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
164235143|NCT05067335|593233428|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
164299835|NCT02234843|593472946|FG002|Overall Study|Death|0|||
164299836|NCT02234843|593472947|FG003|Overall Study|Death|0|||
164676524|NCT03032172|594840125|FG001|Treatment Period|Withdrawal by Subject|0|||
164676525|NCT03032172|594840126|FG002|Treatment Period|Withdrawal by Subject|3|||
164676526|NCT03032172|594840127|FG003|Treatment Period|Withdrawal by Subject|0|||
164676527|NCT03032172|594840128|FG004|Treatment Period|Withdrawal by Subject|0|||
164676528|NCT03032172|594840129|FG005|Treatment Period|Withdrawal by Subject|0|||
164676529|NCT03032172|594840130|FG006|Treatment Period|Withdrawal by Subject|0|||
164676530|NCT03032172|594840131|FG007|Treatment Period|Withdrawal by Subject|0|||
164676531|NCT03032172|594840124|FG000|Open-label Extension Period|Death|0|||
164676532|NCT03032172|594840125|FG001|Open-label Extension Period|Death|0|||
164676533|NCT03032172|594840126|FG002|Open-label Extension Period|Death|0|||
164676534|NCT03032172|594840127|FG003|Open-label Extension Period|Death|0|||
164676535|NCT03032172|594840128|FG004|Open-label Extension Period|Death|0|||
164235144|NCT05067335|593233429|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
164235145|NCT05067335|593233426|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
164235146|NCT05067335|593233427|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
164235147|NCT05067335|593233428|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
164235148|NCT05067335|593233429|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
164235149|NCT03610048|593233430|FG000|Overall Study|Study terminated by sponsor|84|||
164235150|NCT03610048|593233430|FG000|Overall Study|Adverse Event|32|||
164235151|NCT03610048|593233430|FG000|Overall Study|Withdrawal by Subject|31|||
164235152|NCT03610048|593233430|FG000|Overall Study|Lost to Follow-up|8|||
164235153|NCT03610048|593233430|FG000|Overall Study|Other|4|||
164235154|NCT03610048|593233430|FG000|Overall Study|Physician Decision|1|||
164235155|NCT03610048|593233430|FG000|Overall Study|Pregnancy|1|||
164235156|NCT01146613|593233431|FG000|Overall Study|Lost to Follow-up|3|||
164235157|NCT01146613|593233432|FG001|Overall Study|Lost to Follow-up|8|||
164235158|NCT01146613|593233431|FG000|Overall Study|Lack of Efficacy|0|||
164235159|NCT01146613|593233432|FG001|Overall Study|Lack of Efficacy|1|||
164235160|NCT01146613|593233431|FG000|Overall Study|Death|1|||
164235161|NCT01146613|593233432|FG001|Overall Study|Death|0|||
164235162|NCT01146613|593233431|FG000|Overall Study|Physician Decision|1|||
164235163|NCT01146613|593233432|FG001|Overall Study|Physician Decision|0|||
164235164|NCT01146613|593233431|FG000|Overall Study|Withdrawal by Subject|0|||
164235165|NCT01146613|593233432|FG001|Overall Study|Withdrawal by Subject|3|||
164235166|NCT01146613|593233431|FG000|Overall Study|schedule conflict|1|||
164235167|NCT01146613|593233432|FG001|Overall Study|schedule conflict|0|||
164235168|NCT01146613|593233431|FG000|Overall Study|Outpatient detox|1|||
164235169|NCT01146613|593233432|FG001|Overall Study|Outpatient detox|0|||
164235170|NCT02136914|593233433|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
164235171|NCT02136914|593233434|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
164235172|NCT02136914|593233433|FG000|Overall Study|Withdrawal by Subject|3|||
164235173|NCT02136914|593233434|FG001|Overall Study|Withdrawal by Subject|10|||
164235174|NCT02136914|593233433|FG000|Overall Study|Subject Unwilling to Proceed|7|||
164235175|NCT02136914|593233434|FG001|Overall Study|Subject Unwilling to Proceed|2|||
164235176|NCT02136914|593233433|FG000|Overall Study|Lost to Follow-up|1|||
164235177|NCT02136914|593233434|FG001|Overall Study|Lost to Follow-up|1|||
164235178|NCT02136914|593233433|FG000|Overall Study|Did Not Receive Study Drug|2|||
164235179|NCT02136914|593233434|FG001|Overall Study|Did Not Receive Study Drug|0|||
164235180|NCT02136914|593233433|FG000|Overall Study|Lack of Efficacy|1|||
164235181|NCT02136914|593233434|FG001|Overall Study|Lack of Efficacy|0|||
164235182|NCT02136914|593233433|FG000|Overall Study|Death|0|||
164235183|NCT02136914|593233434|FG001|Overall Study|Death|1|||
164676536|NCT03032172|594840129|FG005|Open-label Extension Period|Death|0|||
164676537|NCT03032172|594840130|FG006|Open-label Extension Period|Death|0|||
164235184|NCT05878067|593233435|FG000|Overall Study|Lost to Follow-up|2|||
164235185|NCT00949533|593233436|FG000|Overall Study|Lost to Follow-up|0|||
164235186|NCT00949533|593233437|FG001|Overall Study|Lost to Follow-up|1|||
164235187|NCT01493089|593233438|FG000|Overall Study|Protocol Violation|2|||
164235188|NCT01493089|593233439|FG001|Overall Study|Protocol Violation|2|||
164235189|NCT01493089|593233438|FG000|Overall Study|Withdrawal by Subject|1|||
164235190|NCT01493089|593233439|FG001|Overall Study|Withdrawal by Subject|0|||
164235191|NCT01493089|593233438|FG000|Overall Study|Physician Decision|0|||
164235192|NCT01493089|593233439|FG001|Overall Study|Physician Decision|1|||
164235193|NCT02234362|593233440|FG000|Overall Study|Not eligible after first screening visit|17|||
164235194|NCT02234362|593233440|FG000|Overall Study|Lost to Follow-up|6|||
164235195|NCT02234362|593233440|FG000|Overall Study|Withdrawal by Subject|3|||
164235196|NCT00261833|593233441|FG000|Overall Study|Death|1|||
164235197|NCT00261833|593233442|FG001|Overall Study|Death|3|||
164235198|NCT00261833|593233441|FG000|Overall Study|Adverse Event|1|||
164235199|NCT00261833|593233442|FG001|Overall Study|Adverse Event|4|||
164235200|NCT00261833|593233441|FG000|Overall Study|Withdrawal by Subject|5|||
164235201|NCT00261833|593233442|FG001|Overall Study|Withdrawal by Subject|7|||
164235202|NCT00261833|593233441|FG000|Overall Study|Protocol Violation|0|||
164235203|NCT00261833|593233442|FG001|Overall Study|Protocol Violation|1|||
164235204|NCT00261833|593233441|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
164235205|NCT00261833|593233442|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
164235206|NCT00261833|593233441|FG000|Overall Study|Lung transplantation|1|||
164235207|NCT00261833|593233442|FG001|Overall Study|Lung transplantation|1|||
164235208|NCT00261833|593233441|FG000|Overall Study|Missing reason|1|||
164235209|NCT00261833|593233442|FG001|Overall Study|Missing reason|0|||
164333740|NCT00371826|593599623|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
164333741|NCT00371826|593599621|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
164333742|NCT00371826|593599622|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
164333743|NCT00371826|593599623|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
164333744|NCT00371826|593599621|FG000|Extension Phase (24 Months)|Administrative problems|0|||
164235210|NCT00261833|593233441|FG000|Overall Study|Not interested in being participant|0|||
164235211|NCT00261833|593233442|FG001|Overall Study|Not interested in being participant|1|||
164235212|NCT00419744|593233443|FG000|Overall Study|Adverse Event|39|||
164235213|NCT00419744|593233444|FG001|Overall Study|Adverse Event|40|||
164235214|NCT00419744|593233445|FG002|Overall Study|Adverse Event|50|||
164235215|NCT00419744|593233443|FG000|Overall Study|Withdrawal by Subject|45|||
164235216|NCT00419744|593233444|FG001|Overall Study|Withdrawal by Subject|49|||
164235217|NCT00419744|593233445|FG002|Overall Study|Withdrawal by Subject|52|||
164235218|NCT00419744|593233443|FG000|Overall Study|Lost to Follow-up|8|||
164235219|NCT00419744|593233444|FG001|Overall Study|Lost to Follow-up|10|||
164235220|NCT00419744|593233445|FG002|Overall Study|Lost to Follow-up|6|||
164235221|NCT00419744|593233443|FG000|Overall Study|Protocol Violation|4|||
164235222|NCT00419744|593233444|FG001|Overall Study|Protocol Violation|7|||
164235223|NCT00419744|593233445|FG002|Overall Study|Protocol Violation|8|||
164235224|NCT00419744|593233443|FG000|Overall Study|Randomized in error|9|||
164235225|NCT00419744|593233444|FG001|Overall Study|Randomized in error|6|||
164235226|NCT00419744|593233445|FG002|Overall Study|Randomized in error|7|||
164235227|NCT00419744|593233443|FG000|Overall Study|Moving out of state|2|||
164235228|NCT00419744|593233444|FG001|Overall Study|Moving out of state|0|||
164235229|NCT00419744|593233445|FG002|Overall Study|Moving out of state|1|||
164235230|NCT00419744|593233443|FG000|Overall Study|Physician Decision|10|||
164235231|NCT00419744|593233444|FG001|Overall Study|Physician Decision|5|||
164235232|NCT00419744|593233445|FG002|Overall Study|Physician Decision|6|||
164235233|NCT00419744|593233443|FG000|Overall Study|Spirometry mouthpiece issues|0|||
164235234|NCT00419744|593233444|FG001|Overall Study|Spirometry mouthpiece issues|1|||
164235235|NCT00419744|593233445|FG002|Overall Study|Spirometry mouthpiece issues|2|||
164235236|NCT00419744|593233443|FG000|Overall Study|Incorrect medication kit dispensed|0|||
164235237|NCT00419744|593233444|FG001|Overall Study|Incorrect medication kit dispensed|0|||
164235238|NCT00419744|593233445|FG002|Overall Study|Incorrect medication kit dispensed|1|||
164235239|NCT00583219|593233448|FG000|Phase 2|Withdrawal by Subject|1|||
164235240|NCT02131766|593233449|FG000|Overall Study|Withdrawal by Subject|4|||
164235241|NCT02271880|593233451|FG000|Overall Study|Premature discontinuation of study|3|||
164235242|NCT02271880|593233452|FG001|Overall Study|Premature discontinuation of study|4|||
164333745|NCT00371826|593599622|FG001|Extension Phase (24 Months)|Administrative problems|0|||
164333746|NCT00371826|593599623|FG002|Extension Phase (24 Months)|Administrative problems|2|||
164333747|NCT02436304|593599624|FG000|Overall Study|Lost to Follow-up|0|||
164423403|NCT02028884|593921457|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
164235243|NCT00474903|593233454|FG000|Overall Study|Protocol Violation|1|||
164235244|NCT00474903|593233455|FG001|Overall Study|Protocol Violation|5|||
164235245|NCT00474903|593233456|FG002|Overall Study|Protocol Violation|2|||
164235246|NCT02006927|593233457|FG000|Overall Study|Adverse Event|2|||
164235247|NCT02006927|593233457|FG000|Overall Study|Withdrawal by Subject|1|||
164235248|NCT00673920|593233460|FG000|Baseline up to Week 48|Withdrew consent|1|||
164235249|NCT00673920|593233461|FG001|Baseline up to Week 48|Withdrew consent|0|||
164235250|NCT00673920|593233462|FG002|Baseline up to Week 48|Withdrew consent|2|||
164235251|NCT00673920|593233463|FG003|Baseline up to Week 48|Withdrew consent|0|||
164235252|NCT00673920|593233464|FG004|Baseline up to Week 48|Withdrew consent|0|||
164235253|NCT00673920|593233465|FG005|Baseline up to Week 48|Withdrew consent|0|||
164235254|NCT00673920|593233466|FG006|Baseline up to Week 48|Withdrew consent|0|||
164235255|NCT00673920|593233467|FG007|Baseline up to Week 48|Withdrew consent|0|||
164235256|NCT00673920|593233460|FG000|Baseline up to Week 48|Refused treatment|1|||
164235257|NCT00673920|593233461|FG001|Baseline up to Week 48|Refused treatment|0|||
164235258|NCT00673920|593233462|FG002|Baseline up to Week 48|Refused treatment|0|||
164235259|NCT00673920|593233463|FG003|Baseline up to Week 48|Refused treatment|0|||
164235260|NCT00673920|593233464|FG004|Baseline up to Week 48|Refused treatment|0|||
164235261|NCT00673920|593233465|FG005|Baseline up to Week 48|Refused treatment|0|||
164235262|NCT00673920|593233466|FG006|Baseline up to Week 48|Refused treatment|0|||
164235263|NCT00673920|593233467|FG007|Baseline up to Week 48|Refused treatment|0|||
164235264|NCT00673920|593233460|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
164235265|NCT00673920|593233461|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
164235266|NCT00673920|593233462|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
164235267|NCT00673920|593233463|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
164235268|NCT00673920|593233464|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
164235269|NCT00673920|593233465|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
164235270|NCT00673920|593233466|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
164235271|NCT00673920|593233467|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
164235272|NCT00673920|593233460|FG000|Baseline up to Week 48|Protocol Violation|0|||
164235273|NCT00673920|593233461|FG001|Baseline up to Week 48|Protocol Violation|0|||
164235274|NCT00673920|593233462|FG002|Baseline up to Week 48|Protocol Violation|1|||
164235275|NCT00673920|593233463|FG003|Baseline up to Week 48|Protocol Violation|0|||
164235276|NCT00673920|593233464|FG004|Baseline up to Week 48|Protocol Violation|0|||
164235277|NCT00673920|593233465|FG005|Baseline up to Week 48|Protocol Violation|0|||
164235278|NCT00673920|593233466|FG006|Baseline up to Week 48|Protocol Violation|0|||
164235279|NCT00673920|593233467|FG007|Baseline up to Week 48|Protocol Violation|0|||
164235280|NCT00673920|593233460|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
164235281|NCT00673920|593233461|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
164235282|NCT00673920|593233462|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
164235283|NCT00673920|593233463|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
164235284|NCT00673920|593233464|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
164235285|NCT00673920|593233465|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
164235286|NCT00673920|593233466|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
164235287|NCT00673920|593233467|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
164235288|NCT00673920|593233460|FG000|Baseline up to Week 48|Administrative/Other|0|||
164235289|NCT00673920|593233461|FG001|Baseline up to Week 48|Administrative/Other|1|||
164235290|NCT00673920|593233462|FG002|Baseline up to Week 48|Administrative/Other|2|||
164235291|NCT00673920|593233463|FG003|Baseline up to Week 48|Administrative/Other|0|||
164235292|NCT00673920|593233464|FG004|Baseline up to Week 48|Administrative/Other|0|||
164235293|NCT00673920|593233465|FG005|Baseline up to Week 48|Administrative/Other|0|||
164235294|NCT00673920|593233466|FG006|Baseline up to Week 48|Administrative/Other|0|||
164235295|NCT00673920|593233467|FG007|Baseline up to Week 48|Administrative/Other|0|||
164235296|NCT00673920|593233460|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
164235297|NCT00673920|593233461|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
164235298|NCT00673920|593233462|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
164235299|NCT00673920|593233463|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
164235300|NCT00673920|593233464|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
164235301|NCT00673920|593233465|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
164235302|NCT00673920|593233466|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
164235303|NCT00673920|593233467|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
164235304|NCT00673920|593233460|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
164235305|NCT00673920|593233461|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
164235306|NCT00673920|593233462|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
164235307|NCT00673920|593233463|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
164235308|NCT00673920|593233464|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
164676538|NCT03032172|594840131|FG007|Open-label Extension Period|Death|2|||
164676539|NCT03032172|594840124|FG000|Open-label Extension Period|Reason Not Specified|0|||
164676540|NCT03032172|594840125|FG001|Open-label Extension Period|Reason Not Specified|0|||
164676541|NCT03032172|594840126|FG002|Open-label Extension Period|Reason Not Specified|0|||
164676542|NCT03032172|594840127|FG003|Open-label Extension Period|Reason Not Specified|0|||
164235309|NCT00673920|593233465|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
164235310|NCT00673920|593233466|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
164235311|NCT00673920|593233467|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
164235312|NCT00673920|593233460|FG000|Week 24 to Week 48|Failure to return|0|||
164676543|NCT03032172|594840128|FG004|Open-label Extension Period|Reason Not Specified|0|||
164235313|NCT00673920|593233461|FG001|Week 24 to Week 48|Failure to return|0|||
164235314|NCT00673920|593233462|FG002|Week 24 to Week 48|Failure to return|0|||
164235315|NCT00673920|593233463|FG003|Week 24 to Week 48|Failure to return|0|||
164235316|NCT00673920|593233464|FG004|Week 24 to Week 48|Failure to return|0|||
164235317|NCT00673920|593233465|FG005|Week 24 to Week 48|Failure to return|1|||
164235318|NCT00673920|593233466|FG006|Week 24 to Week 48|Failure to return|0|||
164235319|NCT00673920|593233467|FG007|Week 24 to Week 48|Failure to return|0|||
164235320|NCT00673920|593233460|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
164235321|NCT00673920|593233461|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
164235322|NCT00673920|593233462|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
164235323|NCT00673920|593233463|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
164235324|NCT00673920|593233464|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
164235325|NCT00673920|593233465|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
164235326|NCT00673920|593233466|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
164235327|NCT00673920|593233467|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
164235328|NCT00673920|593233460|FG000|Week 24 to Week 48|Death|0|||
164235329|NCT00673920|593233461|FG001|Week 24 to Week 48|Death|0|||
164235330|NCT00673920|593233462|FG002|Week 24 to Week 48|Death|0|||
164235331|NCT00673920|593233463|FG003|Week 24 to Week 48|Death|0|||
164235332|NCT00673920|593233464|FG004|Week 24 to Week 48|Death|0|||
164235333|NCT00673920|593233465|FG005|Week 24 to Week 48|Death|1|||
164235334|NCT00673920|593233466|FG006|Week 24 to Week 48|Death|0|||
164235335|NCT00673920|593233467|FG007|Week 24 to Week 48|Death|0|||
164235336|NCT00673920|593233460|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
164235337|NCT00673920|593233461|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
164235338|NCT00673920|593233462|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
164235339|NCT00673920|593233463|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
164235340|NCT00673920|593233464|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
164235341|NCT00673920|593233465|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
164235342|NCT00673920|593233466|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
164235343|NCT00673920|593233467|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
164235344|NCT02519842|593233468|FG000|Base Study: Cycle 1|Screening Failure|1|||
164235345|NCT02519842|593233469|FG001|Base Study: Cycle 1|Screening Failure|1|||
164235346|NCT02519842|593233470|FG002|Base Study: Cycle 1|Screening Failure|0|||
164235347|NCT02519842|593233468|FG000|Base Study: Cycle 1|Adverse Event|1|||
164235348|NCT02519842|593233469|FG001|Base Study: Cycle 1|Adverse Event|0|||
164235349|NCT02519842|593233470|FG002|Base Study: Cycle 1|Adverse Event|0|||
164235350|NCT02519842|593233468|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
164235351|NCT02519842|593233469|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
164235352|NCT02519842|593233470|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
164235353|NCT02519842|593233468|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
164235354|NCT02519842|593233469|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
164235355|NCT02519842|593233470|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
164235356|NCT02519842|593233468|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
164235357|NCT02519842|593233469|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
164235358|NCT02519842|593233470|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
164235359|NCT02519842|593233468|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
164235360|NCT02519842|593233469|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
164235361|NCT02519842|593233470|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
164235362|NCT02519842|593233468|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
164235363|NCT02519842|593233469|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
164235364|NCT02519842|593233470|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
164235365|NCT02519842|593233468|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
164235366|NCT02519842|593233469|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
164235367|NCT02519842|593233470|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
164235368|NCT02519842|593233468|FG000|Optional Extension: Cycles 2-6|Death|0|||
164235369|NCT02519842|593233469|FG001|Optional Extension: Cycles 2-6|Death|0|||
164235370|NCT02519842|593233470|FG002|Optional Extension: Cycles 2-6|Death|1|||
164235371|NCT02519842|593233468|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
164235372|NCT02519842|593233469|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
164235373|NCT02519842|593233470|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
164235374|NCT02519842|593233468|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
164235375|NCT02519842|593233469|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
164235376|NCT02519842|593233470|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
164235377|NCT02519842|593233468|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
164235378|NCT02519842|593233469|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
164235379|NCT02519842|593233470|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
164235380|NCT02519842|593233468|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
164235381|NCT02519842|593233469|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
164235382|NCT02519842|593233470|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
164235383|NCT01561976|593233475|FG000|Period 1|Adverse Event|0|||
164235384|NCT01561976|593233476|FG001|Period 1|Adverse Event|0|||
164235385|NCT01561976|593233477|FG002|Period 1|Adverse Event|1|||
164235386|NCT01561976|593233478|FG003|Period 1|Adverse Event|0|||
164235387|NCT01561976|593233479|FG004|Period 1|Adverse Event|0|||
164235388|NCT01561976|593233480|FG005|Period 1|Adverse Event|0|||
164235389|NCT01561976|593233475|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
164235390|NCT01561976|593233476|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
164235391|NCT01561976|593233477|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
164235392|NCT01561976|593233478|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
164235393|NCT01561976|593233479|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
164235394|NCT01561976|593233480|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
164235395|NCT01561976|593233475|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164235396|NCT01561976|593233476|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164235397|NCT01561976|593233477|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164235398|NCT01561976|593233478|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164235399|NCT01561976|593233479|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164235400|NCT01561976|593233480|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
164235401|NCT01561976|593233475|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
164235402|NCT01561976|593233476|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
164235403|NCT01561976|593233477|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
164235404|NCT01561976|593233478|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
164676544|NCT03032172|594840129|FG005|Open-label Extension Period|Reason Not Specified|5|||
164676545|NCT03032172|594840130|FG006|Open-label Extension Period|Reason Not Specified|3|||
164676546|NCT03032172|594840131|FG007|Open-label Extension Period|Reason Not Specified|0|||
164676547|NCT03032172|594840124|FG000|Open-label Extension Period|Pregnancy|0|||
164676548|NCT03032172|594840125|FG001|Open-label Extension Period|Pregnancy|0|||
164676549|NCT03032172|594840126|FG002|Open-label Extension Period|Pregnancy|0|||
164676550|NCT03032172|594840127|FG003|Open-label Extension Period|Pregnancy|0|||
164676551|NCT03032172|594840128|FG004|Open-label Extension Period|Pregnancy|0|||
164676552|NCT03032172|594840129|FG005|Open-label Extension Period|Pregnancy|0|||
164676553|NCT03032172|594840130|FG006|Open-label Extension Period|Pregnancy|1|||
164676554|NCT03032172|594840131|FG007|Open-label Extension Period|Pregnancy|0|||
164676555|NCT03032172|594840124|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
164676556|NCT03032172|594840125|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
164676557|NCT03032172|594840126|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
164676558|NCT03032172|594840127|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
164676559|NCT03032172|594840128|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
164235405|NCT01561976|593233479|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
164235406|NCT01561976|593233480|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
164235407|NCT02639390|593233481|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
164333748|NCT02436304|593599625|FG001|Overall Study|Lost to Follow-up|1|||
164333749|NCT02436304|593599626|FG002|Overall Study|Lost to Follow-up|0|||
164333750|NCT02436304|593599624|FG000|Overall Study|Withdrawal by Subject|0|||
164333751|NCT02436304|593599625|FG001|Overall Study|Withdrawal by Subject|1|||
164333752|NCT02436304|593599626|FG002|Overall Study|Withdrawal by Subject|0|||
164333753|NCT02436304|593599624|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
164333754|NCT02436304|593599625|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
164333755|NCT02436304|593599626|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
164333756|NCT04540497|593599631|FG000|Overall Study|Adverse Event|0|||
164333757|NCT04540497|593599632|FG001|Overall Study|Adverse Event|2|||
164333758|NCT04540497|593599631|FG000|Overall Study|Lost to Follow-up|1|||
164333759|NCT04540497|593599632|FG001|Overall Study|Lost to Follow-up|0|||
164333760|NCT04540497|593599631|FG000|Overall Study|Withdrawal by Subject|1|||
164333761|NCT04540497|593599632|FG001|Overall Study|Withdrawal by Subject|1|||
164333762|NCT04540497|593599631|FG000|Overall Study|Miscellaneous|2|||
164333763|NCT04540497|593599632|FG001|Overall Study|Miscellaneous|1|||
164333764|NCT05274815|593599636|FG000|Overall Study|Adverse Event|1|||
164333765|NCT05274815|593599636|FG000|Overall Study|Death|2|||
164333766|NCT05274815|593599636|FG000|Overall Study|Lost to Follow-up|4|||
164333767|NCT05274815|593599636|FG000|Overall Study|Withdrawn from study due to investigator's decision|1|||
164333768|NCT05274815|593599636|FG000|Overall Study|Withdrawn from study due to participant's decision to withdraw|1|||
164676560|NCT03032172|594840129|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
164676561|NCT03032172|594840130|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
164676562|NCT03032172|594840131|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
164676563|NCT02718326|594840132|FG000|Overall Study|Adverse Event|4|||
164676564|NCT02718326|594840133|FG001|Overall Study|Adverse Event|9|||
164676565|NCT02718326|594840134|FG002|Overall Study|Adverse Event|0|||
164676566|NCT02718326|594840132|FG000|Overall Study|Death|8|||
164676567|NCT02718326|594840133|FG001|Overall Study|Death|1|||
164676568|NCT02718326|594840134|FG002|Overall Study|Death|2|||
164676569|NCT02718326|594840132|FG000|Overall Study|Withdrawal by Subject|4|||
164676570|NCT02718326|594840133|FG001|Overall Study|Withdrawal by Subject|9|||
164676571|NCT02718326|594840134|FG002|Overall Study|Withdrawal by Subject|6|||
164676572|NCT02718326|594840132|FG000|Overall Study|Lost to Follow-up|18|||
164676573|NCT02718326|594840133|FG001|Overall Study|Lost to Follow-up|5|||
164676574|NCT02718326|594840134|FG002|Overall Study|Lost to Follow-up|14|||
164676575|NCT02718326|594840132|FG000|Overall Study|Protocol Deviation|1|||
164676576|NCT02718326|594840133|FG001|Overall Study|Protocol Deviation|0|||
164676577|NCT02718326|594840134|FG002|Overall Study|Protocol Deviation|0|||
164676578|NCT02718326|594840132|FG000|Overall Study|Pregnancy|1|||
164676579|NCT02718326|594840133|FG001|Overall Study|Pregnancy|0|||
164676580|NCT02718326|594840134|FG002|Overall Study|Pregnancy|0|||
164676581|NCT06195579|594840135|FG000|Overall Study|Withdrawal by Subject|1|||
164676582|NCT03868891|594840136|FG000|Overall Study|Adverse Event|1|||
164676583|NCT03868891|594840137|FG001|Overall Study|Adverse Event|0|||
164676584|NCT03868891|594840136|FG000|Overall Study|Lost to Follow-up|2|||
164676585|NCT03868891|594840137|FG001|Overall Study|Lost to Follow-up|1|||
164676586|NCT03868891|594840136|FG000|Overall Study|COVID-19 Restrictions|1|||
164676587|NCT03868891|594840137|FG001|Overall Study|COVID-19 Restrictions|2|||
164676588|NCT03049748|594840138|FG000|Overall Study|Lost to Follow-up|1|||
164676589|NCT03049748|594840139|FG001|Overall Study|Lost to Follow-up|0|||
164676590|NCT03049748|594840138|FG000|Overall Study|Death|3|||
164423404|NCT02028884|593921458|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
164423405|NCT02028884|593921459|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
164333769|NCT05274815|593599636|FG000|Overall Study|Withdrawn from study due to severe non-compliance with the protocol|1|||
164333770|NCT05274815|593599636|FG000|Overall Study|Withdrawn from study due to subject decision|1|||
164333771|NCT05274815|593599636|FG000|Overall Study|Withdrawn due to participant's decision not to continue for personal and family reasons|1|||
164333772|NCT05274815|593599636|FG000|Overall Study|Withdrawn from study due to the participant stopped visit; agreed to a telephone contact at Week 52|1|||
164333773|NCT05274815|593599636|FG000|Overall Study|Withdrawn from study due to randomization into closed cohort by mistake|1|||
164333774|NCT05274815|593599636|FG000|Overall Study|Withdrawal by Subject|11|||
164333775|NCT03914326|593599637|FG000|Overall Study|Withdrawal by Subject|27|||
164333776|NCT03914326|593599638|FG001|Overall Study|Withdrawal by Subject|34|||
164333777|NCT03914326|593599637|FG000|Overall Study|Lost to Follow-up|43|||
164333778|NCT03914326|593599638|FG001|Overall Study|Lost to Follow-up|51|||
164333779|NCT03914326|593599637|FG000|Overall Study|Randomised more than once|0|||
164333780|NCT03914326|593599638|FG001|Overall Study|Randomised more than once|1|||
164333781|NCT04612790|593599639|FG000|DB Period (Up to 36 Weeks)|Death|1|||
164333782|NCT04612790|593599640|FG001|DB Period (Up to 36 Weeks)|Death|1|||
164333783|NCT04612790|593599641|FG002|DB Period (Up to 36 Weeks)|Death|0|||
164333784|NCT04612790|593599642|FG003|DB Period (Up to 36 Weeks)|Death|0|||
164333785|NCT04612790|593599639|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
164333786|NCT04612790|593599640|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
164333787|NCT04612790|593599641|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
164333788|NCT04612790|593599642|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
164333789|NCT04612790|593599639|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
164333790|NCT04612790|593599640|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
164333791|NCT04612790|593599641|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
164333792|NCT04612790|593599642|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
164333793|NCT04612790|593599639|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
164333794|NCT04612790|593599640|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
164333795|NCT04612790|593599641|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
164333796|NCT04612790|593599642|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
164333797|NCT04612790|593599639|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
164333798|NCT04612790|593599640|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
164333799|NCT04612790|593599641|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
164333800|NCT04612790|593599642|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
164333801|NCT04612790|593599639|FG000|DB Period (Up to 36 Weeks)|Other|1|||
164333802|NCT04612790|593599640|FG001|DB Period (Up to 36 Weeks)|Other|0|||
164333803|NCT04612790|593599641|FG002|DB Period (Up to 36 Weeks)|Other|0|||
164333804|NCT04612790|593599642|FG003|DB Period (Up to 36 Weeks)|Other|0|||
164676591|NCT03049748|594840139|FG001|Overall Study|Death|0|||
164676592|NCT03049748|594840138|FG000|Overall Study|Withdrawal by Subject|0|||
164676593|NCT03049748|594840139|FG001|Overall Study|Withdrawal by Subject|3|||
164676594|NCT03049748|594840138|FG000|Overall Study|Protocol Violation|0|||
164676595|NCT03049748|594840139|FG001|Overall Study|Protocol Violation|2|||
164676596|NCT03049748|594840138|FG000|Overall Study|Moved out of state (relocation)|0|||
164676597|NCT03049748|594840139|FG001|Overall Study|Moved out of state (relocation)|1|||
164676598|NCT01667679|594840159|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
164676599|NCT01667679|594840160|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
164676600|NCT01667679|594840159|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
164676601|NCT01667679|594840160|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
164676602|NCT01667679|594840159|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
164676603|NCT01667679|594840160|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
164676604|NCT01667679|594840159|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
164676605|NCT01667679|594840160|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
164676606|NCT01667679|594840159|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
164676607|NCT01667679|594840160|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
164676608|NCT01667679|594840159|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
164676609|NCT01667679|594840160|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
164676610|NCT01667679|594840159|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
164676611|NCT01667679|594840160|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
164676612|NCT01667679|594840159|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
164676613|NCT01667679|594840160|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
164676614|NCT01667679|594840159|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
164676615|NCT01667679|594840160|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
164676616|NCT01667679|594840159|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
164676617|NCT01667679|594840160|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
164676618|NCT01667679|594840159|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
164676619|NCT01667679|594840160|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
164676620|NCT01667679|594840159|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
164676621|NCT01667679|594840160|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
164676622|NCT01667679|594840159|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
164676623|NCT01667679|594840160|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
164676624|NCT01667679|594840159|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
164676625|NCT01667679|594840160|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
164235408|NCT02639390|593233482|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
164235409|NCT01463527|593233483|FG000|Overall Study|Protocol Violation|1|||
164235410|NCT01463527|593233484|FG001|Overall Study|Protocol Violation|1|||
164235411|NCT01463527|593233483|FG000|Overall Study|Crying >20% of sedation|5|||
164235412|NCT01463527|593233484|FG001|Overall Study|Crying >20% of sedation|6|||
164235413|NCT01977222|593233487|FG000|Overall Study|Withdrawal by Subject|1|||
164235414|NCT02980107|593233488|FG000|Overall Study|Withdrawal by Subject|51|||
164235415|NCT02980107|593233489|FG001|Overall Study|Withdrawal by Subject|62|||
164235416|NCT03746015|593233490|FG000|Overall Study|Withdrawal of Consent|1|||
164235417|NCT03746015|593233491|FG001|Overall Study|Withdrawal of Consent|0|||
164235418|NCT03746015|593233492|FG002|Overall Study|Withdrawal of Consent|0|||
164235419|NCT02836249|593233493|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
164235420|NCT02836249|593233494|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
164235421|NCT02836249|593233495|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
164235422|NCT02836249|593233496|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
164572830|NCT01707992|594460456|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
164235423|NCT02836249|593233493|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
164235424|NCT02836249|593233494|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
164235425|NCT02836249|593233495|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
164235426|NCT02836249|593233496|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
164333805|NCT04612790|593599639|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
164572831|NCT01707992|594460457|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
164572832|NCT01707992|594460458|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
164572833|NCT01707992|594460459|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
164572834|NCT01707992|594460454|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
164572835|NCT01707992|594460455|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
164572836|NCT01707992|594460456|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
164572837|NCT01707992|594460457|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
164572838|NCT01707992|594460458|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
164572839|NCT01707992|594460459|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
164572840|NCT01707992|594460454|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
164572841|NCT01707992|594460455|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
164572842|NCT01707992|594460456|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
164572843|NCT01707992|594460457|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
164333806|NCT04612790|593599640|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
164333807|NCT04612790|593599641|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
164333808|NCT04612790|593599642|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
164333809|NCT04612790|593599639|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
164333810|NCT04612790|593599640|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
164676626|NCT01667679|594840159|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
164676627|NCT01667679|594840160|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
164676628|NCT01667679|594840159|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
164676629|NCT01667679|594840160|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
164676630|NCT01667679|594840159|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
164676631|NCT01667679|594840160|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
164676632|NCT01667679|594840159|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
164676633|NCT01667679|594840160|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
164676634|NCT01667679|594840159|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
164676635|NCT01667679|594840160|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
164676636|NCT01667679|594840159|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
164676637|NCT01667679|594840160|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
164676638|NCT01667679|594840159|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
164676639|NCT01667679|594840160|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
164676640|NCT01175018|594840161|FG000|Overall Study|Adverse Event|3|||
164676641|NCT01175018|594840162|FG001|Overall Study|Adverse Event|1|||
164676642|NCT02911792|594840163|FG000|Overall Study|Lost to Follow-up|3|||
164676643|NCT02911792|594840164|FG001|Overall Study|Lost to Follow-up|3|||
164676644|NCT02911792|594840165|FG002|Overall Study|Lost to Follow-up|3|||
164676645|NCT02911792|594840166|FG003|Overall Study|Lost to Follow-up|3|||
164676646|NCT00840073|594840171|FG000|Second Intervention|Missed 72 hour blood draw|1|||
164676647|NCT00840073|594840172|FG001|Second Intervention|Missed 72 hour blood draw|1|||
164423406|NCT02028884|593921457|FG000|Open-label Extension Period|Switched to another treatment option|3|||
164423407|NCT02028884|593921458|FG001|Open-label Extension Period|Switched to another treatment option|0|||
164423408|NCT02028884|593921459|FG002|Open-label Extension Period|Switched to another treatment option|0|||
164423409|NCT00354029|593921460|FG000|Overall Study|Protocol Violation|4|||
164423410|NCT00354029|593921461|FG001|Overall Study|Protocol Violation|2|||
164423411|NCT00765362|593921464|FG000|Overall Study|Death|9|||
164423412|NCT00765362|593921464|FG000|Overall Study|Adverse Event|2|||
164423413|NCT00765362|593921464|FG000|Overall Study|Protocol Violation|18|||
164423414|NCT00765362|593921464|FG000|Overall Study|Withdrawal by Subject|13|||
164423415|NCT00765362|593921464|FG000|Overall Study|Lost to Follow-up|95|||
164423416|NCT00519779|593921467|FG000|Overall Study|Withdrawal by Subject|0|||
164423417|NCT00519779|593921468|FG001|Overall Study|Withdrawal by Subject|1|||
164423418|NCT02886728|593921474|FG000|Overall Study|Withdrew Consent|31|||
164423419|NCT02886728|593921475|FG001|Overall Study|Withdrew Consent|13|||
164423420|NCT02886728|593921476|FG002|Overall Study|Withdrew Consent|11|||
164423421|NCT02886728|593921477|FG003|Overall Study|Withdrew Consent|47|||
164423422|NCT02886728|593921474|FG000|Overall Study|Lost to Follow-up|12|||
164423423|NCT02886728|593921475|FG001|Overall Study|Lost to Follow-up|6|||
164423424|NCT02886728|593921476|FG002|Overall Study|Lost to Follow-up|13|||
164423425|NCT02886728|593921477|FG003|Overall Study|Lost to Follow-up|12|||
164423426|NCT02886728|593921474|FG000|Overall Study|Adverse Event|13|||
164423427|NCT02886728|593921475|FG001|Overall Study|Adverse Event|5|||
164423428|NCT02886728|593921476|FG002|Overall Study|Adverse Event|5|||
164423429|NCT02886728|593921477|FG003|Overall Study|Adverse Event|11|||
164423430|NCT02886728|593921474|FG000|Overall Study|Investigator's Discretion|11|||
164423431|NCT02886728|593921475|FG001|Overall Study|Investigator's Discretion|7|||
164423432|NCT02886728|593921476|FG002|Overall Study|Investigator's Discretion|5|||
164423433|NCT02886728|593921477|FG003|Overall Study|Investigator's Discretion|11|||
164423434|NCT02886728|593921474|FG000|Overall Study|Death|3|||
164423435|NCT02886728|593921475|FG001|Overall Study|Death|1|||
164423436|NCT02886728|593921476|FG002|Overall Study|Death|0|||
164423437|NCT02886728|593921477|FG003|Overall Study|Death|0|||
164676648|NCT01788423|594840174|FG000|Overall Study|See Comments in Completed (above)|0|||
164423438|NCT02886728|593921474|FG000|Overall Study|Protocol Violation|0|||
164423439|NCT02886728|593921475|FG001|Overall Study|Protocol Violation|0|||
164423440|NCT02886728|593921476|FG002|Overall Study|Protocol Violation|0|||
164235427|NCT02836249|593233493|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
164235428|NCT02836249|593233494|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
164235429|NCT02836249|593233495|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
164235430|NCT02836249|593233496|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
164235431|NCT02836249|593233493|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164235432|NCT02836249|593233494|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
164235433|NCT02836249|593233495|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164235434|NCT02836249|593233496|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164235435|NCT02836249|593233493|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
164235436|NCT02836249|593233494|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
164235437|NCT02836249|593233495|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
164235438|NCT02836249|593233496|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
164333811|NCT04612790|593599641|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
164333812|NCT04612790|593599642|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
164423441|NCT02886728|593921477|FG003|Overall Study|Protocol Violation|4|||
164423442|NCT02886728|593921474|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164423443|NCT02886728|593921475|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164572844|NCT01707992|594460458|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
164333813|NCT04612790|593599639|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
164333814|NCT04612790|593599640|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
164333815|NCT04612790|593599641|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
164333816|NCT04612790|593599642|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
164572845|NCT01707992|594460459|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
164333817|NCT04612790|593599639|FG000|OLE Period (Up to 1 Year)|Other|0|||
164333818|NCT04612790|593599640|FG001|OLE Period (Up to 1 Year)|Other|0|||
164333819|NCT04612790|593599641|FG002|OLE Period (Up to 1 Year)|Other|0|||
164333820|NCT04612790|593599642|FG003|OLE Period (Up to 1 Year)|Other|1|||
164333821|NCT00785928|593599643|FG000|Treatment Phase|Adverse Event|1|||
164333822|NCT00785928|593599644|FG001|Treatment Phase|Adverse Event|1|||
164333823|NCT00785928|593599645|FG002|Treatment Phase|Adverse Event|2|||
164572846|NCT01707992|594460454|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
164572847|NCT01707992|594460455|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
164572848|NCT01707992|594460456|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
164572849|NCT01707992|594460457|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
164572850|NCT01707992|594460458|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
164572851|NCT01707992|594460459|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
164572852|NCT01707992|594460454|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
164572853|NCT01707992|594460455|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
164572854|NCT01707992|594460456|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
164572855|NCT01707992|594460457|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
164572856|NCT01707992|594460458|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
164572857|NCT01707992|594460459|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
164572858|NCT01707992|594460454|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
164572859|NCT01707992|594460455|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
164572860|NCT01707992|594460456|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
164572861|NCT01707992|594460457|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
164572862|NCT01707992|594460458|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
164572863|NCT01707992|594460459|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
164572864|NCT01707992|594460454|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
164572865|NCT01707992|594460455|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
164572866|NCT01707992|594460456|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
164572867|NCT01707992|594460457|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
164572868|NCT01707992|594460458|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
164572869|NCT01707992|594460459|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
164572870|NCT01707992|594460454|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
164572871|NCT01707992|594460455|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
164572872|NCT01707992|594460456|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
164572873|NCT01707992|594460457|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
164572874|NCT01707992|594460458|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
164572875|NCT01707992|594460459|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
164572876|NCT01707992|594460454|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
164572877|NCT01707992|594460455|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
164572878|NCT01707992|594460456|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
164572879|NCT01707992|594460457|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
164572880|NCT01707992|594460458|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
164572881|NCT01707992|594460459|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
164572882|NCT01707992|594460454|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
164572883|NCT01707992|594460455|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
164572884|NCT01707992|594460456|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
164572885|NCT01707992|594460457|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
164572886|NCT01707992|594460458|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
164572887|NCT01707992|594460459|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
164572888|NCT01707992|594460454|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
164572889|NCT01707992|594460455|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
164572890|NCT01707992|594460456|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
164572891|NCT01707992|594460457|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
164572892|NCT01707992|594460458|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
164572893|NCT01707992|594460459|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
164572894|NCT01707992|594460454|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
164572895|NCT01707992|594460455|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
164676649|NCT01788423|594840175|FG001|Overall Study|See Comments in Completed (above)|4|||
164572896|NCT01707992|594460456|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
164333824|NCT00785928|593599646|FG003|Treatment Phase|Adverse Event|0|||
164333825|NCT00785928|593599647|FG004|Treatment Phase|Adverse Event|0|||
164676650|NCT01788423|594840176|FG002|Overall Study|See Comments in Completed (above)|5|||
164676651|NCT00835263|594840177|FG000|Second Intervention|Adverse Event|1|||
164676652|NCT00835263|594840178|FG001|Second Intervention|Adverse Event|0|||
164676653|NCT01020474|594840181|FG000|Overall Study|Adverse Event|4|||
164676654|NCT01020474|594840182|FG001|Overall Study|Adverse Event|4|||
164676655|NCT01020474|594840181|FG000|Overall Study|Protocol Violation|0|||
164676656|NCT01020474|594840182|FG001|Overall Study|Protocol Violation|2|||
164676657|NCT01020474|594840181|FG000|Overall Study|Withdrawal by Subject|5|||
164676658|NCT01020474|594840182|FG001|Overall Study|Withdrawal by Subject|7|||
164676659|NCT01020474|594840181|FG000|Overall Study|Other Reasons|1|||
164235439|NCT02836249|593233493|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
164235440|NCT02836249|593233494|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
164235441|NCT02836249|593233495|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
164235442|NCT02836249|593233496|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
164333826|NCT00785928|593599648|FG005|Treatment Phase|Adverse Event|0|||
164333827|NCT00785928|593599649|FG006|Treatment Phase|Adverse Event|2|||
164333828|NCT00785928|593599643|FG000|Treatment Phase|Inadequate Response|0|||
164333829|NCT00785928|593599644|FG001|Treatment Phase|Inadequate Response|1|||
164333830|NCT00785928|593599645|FG002|Treatment Phase|Inadequate Response|0|||
164333831|NCT00785928|593599646|FG003|Treatment Phase|Inadequate Response|0|||
164333832|NCT00785928|593599647|FG004|Treatment Phase|Inadequate Response|0|||
164333833|NCT00785928|593599648|FG005|Treatment Phase|Inadequate Response|0|||
164333834|NCT00785928|593599649|FG006|Treatment Phase|Inadequate Response|0|||
164333835|NCT00785928|593599643|FG000|Treatment Phase|Lack of Efficacy|0|||
164333836|NCT00785928|593599644|FG001|Treatment Phase|Lack of Efficacy|1|||
164333837|NCT00785928|593599645|FG002|Treatment Phase|Lack of Efficacy|1|||
164333838|NCT00785928|593599646|FG003|Treatment Phase|Lack of Efficacy|0|||
164333839|NCT00785928|593599647|FG004|Treatment Phase|Lack of Efficacy|0|||
164333840|NCT00785928|593599648|FG005|Treatment Phase|Lack of Efficacy|0|||
164333841|NCT00785928|593599649|FG006|Treatment Phase|Lack of Efficacy|0|||
164333842|NCT00785928|593599643|FG000|Treatment Phase|Physician Decision|0|||
164333843|NCT00785928|593599644|FG001|Treatment Phase|Physician Decision|0|||
164333844|NCT00785928|593599645|FG002|Treatment Phase|Physician Decision|0|||
164333845|NCT00785928|593599646|FG003|Treatment Phase|Physician Decision|0|||
164333846|NCT00785928|593599647|FG004|Treatment Phase|Physician Decision|1|||
164333847|NCT00785928|593599648|FG005|Treatment Phase|Physician Decision|0|||
164333848|NCT00785928|593599649|FG006|Treatment Phase|Physician Decision|0|||
164333849|NCT00785928|593599643|FG000|Treatment Phase|Sponsor Decision|1|||
164333850|NCT00785928|593599644|FG001|Treatment Phase|Sponsor Decision|0|||
164333851|NCT00785928|593599645|FG002|Treatment Phase|Sponsor Decision|0|||
164333852|NCT00785928|593599646|FG003|Treatment Phase|Sponsor Decision|0|||
164333853|NCT00785928|593599647|FG004|Treatment Phase|Sponsor Decision|0|||
164235443|NCT02836249|593233493|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
164235444|NCT02836249|593233494|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
164235445|NCT02836249|593233495|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
164235446|NCT02836249|593233496|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
164235447|NCT02836249|593233493|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
164235448|NCT02836249|593233494|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
164235449|NCT02836249|593233495|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
164235450|NCT02836249|593233496|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
164235451|NCT02836249|593233493|FG000|Open-Label TAF Treatment Phase|Death|0|||
164235452|NCT02836249|593233494|FG001|Open-Label TAF Treatment Phase|Death|0|||
164235453|NCT02836249|593233495|FG002|Open-Label TAF Treatment Phase|Death|1|||
164235454|NCT02836249|593233496|FG003|Open-Label TAF Treatment Phase|Death|0|||
164235455|NCT02836249|593233493|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
164235456|NCT02836249|593233494|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
164235457|NCT02836249|593233495|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
164235458|NCT02836249|593233496|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
164235459|NCT02836249|593233493|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
164235460|NCT02836249|593233494|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
164235461|NCT02836249|593233495|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
164235462|NCT02836249|593233496|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
164333854|NCT00785928|593599648|FG005|Treatment Phase|Sponsor Decision|0|||
164235463|NCT05200845|593233497|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
164235464|NCT05200845|593233498|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
164333855|NCT00785928|593599649|FG006|Treatment Phase|Sponsor Decision|1|||
164333856|NCT00785928|593599643|FG000|Treatment Phase|Withdrawal by Subject|1|||
164333857|NCT00785928|593599644|FG001|Treatment Phase|Withdrawal by Subject|2|||
164333858|NCT00785928|593599645|FG002|Treatment Phase|Withdrawal by Subject|0|||
164333859|NCT00785928|593599646|FG003|Treatment Phase|Withdrawal by Subject|0|||
164333860|NCT00785928|593599647|FG004|Treatment Phase|Withdrawal by Subject|1|||
164676660|NCT01020474|594840182|FG001|Overall Study|Other Reasons|1|||
164676661|NCT01020474|594840181|FG000|Overall Study|Insufficient Clinical Response|0|||
164333861|NCT00785928|593599648|FG005|Treatment Phase|Withdrawal by Subject|0|||
164676662|NCT01020474|594840182|FG001|Overall Study|Insufficient Clinical Response|3|||
164676663|NCT00107991|594840183|FG000|Eligibility Assessment|Disease not severe enough|7|||
164676664|NCT00107991|594840183|FG000|Eligibility Assessment|Unwilling to participate|7|||
164676665|NCT00107991|594840183|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
164676666|NCT00107991|594840183|FG000|Eligibility Assessment|Abnormal labs|2|||
164676667|NCT00107991|594840183|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
164676668|NCT00107991|594840183|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
164676669|NCT00107991|594840183|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
164676670|NCT00107991|594840183|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
164676671|NCT00107991|594840183|FG000|12 Week Treatment Period|Adverse Event|1|||
164676672|NCT00107991|594840183|FG000|12 Week Treatment Period|Protocol Violation|1|||
164676673|NCT00107991|594840183|FG000|12 Week Treatment Period|Incarcerated|1|||
164676674|NCT00107991|594840183|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
164676675|NCT03669861|594840184|FG000|Overall Study|Disease Flare|5|||
164676676|NCT03669861|594840184|FG000|Overall Study|Lack of Efficacy|2|||
164676677|NCT02760927|594840185|FG000|Overall Study|Tube Slippage from Device|1|||
164676678|NCT03256695|594840187|FG000|Overall Study|Adverse Event|8|||
164676679|NCT03256695|594840187|FG000|Overall Study|Death|2|||
164676680|NCT03256695|594840187|FG000|Overall Study|Withdrawal by Subject|14|||
164676681|NCT03256695|594840187|FG000|Overall Study|Non-compliance with study drug|1|||
164676682|NCT03256695|594840187|FG000|Overall Study|Lost to Follow-up|3|||
164676683|NCT03256695|594840187|FG000|Overall Study|Lack of Efficacy|3|||
164676684|NCT03256695|594840187|FG000|Overall Study|Protocol Violation|5|||
164676685|NCT03256695|594840187|FG000|Overall Study|Other than specified|3|||
164676686|NCT02964039|594840193|FG000|Overall Study|Medical reason unrelated to study participation|1|||
164676687|NCT02964039|594840194|FG001|Overall Study|Medical reason unrelated to study participation|0|||
164676688|NCT02964039|594840195|FG002|Overall Study|Medical reason unrelated to study participation|3|||
164676689|NCT02964039|594840193|FG000|Overall Study|Research shutdown due to pandemic|2|||
164676690|NCT02964039|594840194|FG001|Overall Study|Research shutdown due to pandemic|0|||
164676691|NCT02964039|594840195|FG002|Overall Study|Research shutdown due to pandemic|1|||
164676692|NCT02964039|594840193|FG000|Overall Study|Withdrawal by Subject|0|||
164676693|NCT02964039|594840194|FG001|Overall Study|Withdrawal by Subject|1|||
164676694|NCT02964039|594840195|FG002|Overall Study|Withdrawal by Subject|0|||
164676695|NCT02964039|594840193|FG000|Overall Study|Lost to Follow-up|1|||
164676696|NCT02964039|594840194|FG001|Overall Study|Lost to Follow-up|0|||
164676697|NCT02964039|594840195|FG002|Overall Study|Lost to Follow-up|1|||
164676698|NCT02689505|594840196|FG000|Overall Study|Progressive disease|2|||
164676699|NCT02689505|594840197|FG001|Overall Study|Progressive disease|2|||
164676700|NCT02689505|594840198|FG002|Overall Study|Progressive disease|3|||
164676701|NCT02689505|594840199|FG003|Overall Study|Progressive disease|9|||
164676702|NCT02689505|594840200|FG004|Overall Study|Progressive disease|1|||
164676703|NCT02689505|594840196|FG000|Overall Study|Dose Limiting Toxicity|0|||
164676704|NCT02689505|594840197|FG001|Overall Study|Dose Limiting Toxicity|1|||
164676705|NCT02689505|594840198|FG002|Overall Study|Dose Limiting Toxicity|0|||
164235465|NCT05200845|593233499|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
164235466|NCT05200845|593233500|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
164235467|NCT05200845|593233497|FG000|Overall Study|Withdrawal by Subject|0|||
164235468|NCT05200845|593233498|FG001|Overall Study|Withdrawal by Subject|1|||
164235469|NCT05200845|593233499|FG002|Overall Study|Withdrawal by Subject|1|||
164235470|NCT05200845|593233500|FG003|Overall Study|Withdrawal by Subject|0|||
164235471|NCT00928668|593233503|FG000|Overall Study|Adverse Event|1|||
164235472|NCT00928668|593233504|FG001|Overall Study|Adverse Event|0|||
164235473|NCT00928668|593233505|FG002|Overall Study|Adverse Event|0|||
164235474|NCT00928668|593233506|FG003|Overall Study|Adverse Event|0|||
164235475|NCT00928668|593233507|FG004|Overall Study|Adverse Event|0|||
164235476|NCT00928668|593233503|FG000|Overall Study|Protocol Violation|0|||
164235477|NCT00928668|593233504|FG001|Overall Study|Protocol Violation|0|||
164235478|NCT00928668|593233505|FG002|Overall Study|Protocol Violation|0|||
164235479|NCT00928668|593233506|FG003|Overall Study|Protocol Violation|0|||
164235480|NCT00928668|593233507|FG004|Overall Study|Protocol Violation|1|||
164235481|NCT00928668|593233503|FG000|Overall Study|Withdrawal by Subject|0|||
164235482|NCT00928668|593233504|FG001|Overall Study|Withdrawal by Subject|1|||
164235483|NCT00928668|593233505|FG002|Overall Study|Withdrawal by Subject|1|||
164235484|NCT00928668|593233506|FG003|Overall Study|Withdrawal by Subject|0|||
164235485|NCT00928668|593233507|FG004|Overall Study|Withdrawal by Subject|0|||
164235486|NCT00928668|593233503|FG000|Overall Study|Other reasons not listed above|0|||
164235487|NCT00928668|593233504|FG001|Overall Study|Other reasons not listed above|0|||
164235488|NCT00928668|593233505|FG002|Overall Study|Other reasons not listed above|0|||
164235489|NCT00928668|593233506|FG003|Overall Study|Other reasons not listed above|1|||
164676706|NCT02689505|594840199|FG003|Overall Study|Dose Limiting Toxicity|0|||
164676707|NCT02689505|594840200|FG004|Overall Study|Dose Limiting Toxicity|2|||
164676708|NCT02689505|594840196|FG000|Overall Study|Other AE or clinical progression|0|||
164676709|NCT02689505|594840197|FG001|Overall Study|Other AE or clinical progression|2|||
164676710|NCT02689505|594840198|FG002|Overall Study|Other AE or clinical progression|0|||
164676711|NCT02689505|594840199|FG003|Overall Study|Other AE or clinical progression|2|||
164676712|NCT02689505|594840200|FG004|Overall Study|Other AE or clinical progression|0|||
164676713|NCT01103713|594840201|FG000|Overall Study|Lost to Follow-up|2|||
164235490|NCT00928668|593233507|FG004|Overall Study|Other reasons not listed above|0|||
164235491|NCT02412670|593233508|FG000|Overall Study|Adverse Event|4|||
164423444|NCT02886728|593921476|FG002|Overall Study|Non-Compliance with Study Drug|1|||
164423445|NCT02886728|593921477|FG003|Overall Study|Non-Compliance with Study Drug|0|||
164423446|NCT02886728|593921474|FG000|Overall Study|Pregnancy|0|||
164423447|NCT02886728|593921475|FG001|Overall Study|Pregnancy|0|||
164423448|NCT02886728|593921476|FG002|Overall Study|Pregnancy|1|||
164423449|NCT02886728|593921477|FG003|Overall Study|Pregnancy|0|||
164423450|NCT02886728|593921474|FG000|Overall Study|Randomized but Not Dosed|1|||
164423451|NCT02886728|593921475|FG001|Overall Study|Randomized but Not Dosed|0|||
164423452|NCT02886728|593921476|FG002|Overall Study|Randomized but Not Dosed|0|||
164423453|NCT02886728|593921477|FG003|Overall Study|Randomized but Not Dosed|2|||
164423454|NCT00109928|593921478|FG000|Overall Study|Adverse Event|2|||
164235492|NCT02412670|593233509|FG001|Overall Study|Adverse Event|1|||
164235493|NCT02412670|593233508|FG000|Overall Study|Physician Decision|1|||
164235494|NCT02412670|593233509|FG001|Overall Study|Physician Decision|0|||
164423455|NCT00109928|593921478|FG000|Overall Study|Progression|6|||
164423456|NCT00109928|593921478|FG000|Overall Study|Death|2|||
164676714|NCT01103713|594840201|FG000|Overall Study|Withdrawal by Subject|8|||
164676715|NCT01103713|594840201|FG000|Overall Study|Study terminated by sponsor|2|||
164676716|NCT01103713|594840201|FG000|Overall Study|Other|1|||
164676717|NCT02089685|594840202|FG000|Overall Study|Adverse Event|1|||
164676718|NCT02089685|594840203|FG001|Overall Study|Adverse Event|0|||
164676719|NCT02089685|594840204|FG002|Overall Study|Adverse Event|0|||
164676720|NCT02089685|594840205|FG003|Overall Study|Adverse Event|0|||
164676721|NCT02089685|594840206|FG004|Overall Study|Adverse Event|1|||
164676722|NCT02089685|594840207|FG005|Overall Study|Adverse Event|0|||
164676723|NCT02089685|594840202|FG000|Overall Study|Clinical Progression|4|||
164676724|NCT02089685|594840203|FG001|Overall Study|Clinical Progression|0|||
164676725|NCT02089685|594840204|FG002|Overall Study|Clinical Progression|0|||
164676726|NCT02089685|594840205|FG003|Overall Study|Clinical Progression|5|||
164676727|NCT02089685|594840206|FG004|Overall Study|Clinical Progression|1|||
164676728|NCT02089685|594840207|FG005|Overall Study|Clinical Progression|2|||
164676729|NCT02089685|594840202|FG000|Overall Study|Excluded Medication|1|||
164676730|NCT02089685|594840203|FG001|Overall Study|Excluded Medication|0|||
164676731|NCT02089685|594840204|FG002|Overall Study|Excluded Medication|0|||
164676732|NCT02089685|594840205|FG003|Overall Study|Excluded Medication|11|||
164676733|NCT02089685|594840206|FG004|Overall Study|Excluded Medication|2|||
164676734|NCT02089685|594840207|FG005|Overall Study|Excluded Medication|1|||
164676735|NCT02089685|594840202|FG000|Overall Study|Progressive disease|13|||
164676736|NCT02089685|594840203|FG001|Overall Study|Progressive disease|10|||
164676737|NCT02089685|594840204|FG002|Overall Study|Progressive disease|3|||
164676738|NCT02089685|594840205|FG003|Overall Study|Progressive disease|51|||
164676739|NCT02089685|594840206|FG004|Overall Study|Progressive disease|17|||
164676740|NCT02089685|594840207|FG005|Overall Study|Progressive disease|12|||
164676741|NCT02089685|594840202|FG000|Overall Study|Follow up ended by sponsor|2|||
164676742|NCT02089685|594840203|FG001|Overall Study|Follow up ended by sponsor|2|||
164676743|NCT02089685|594840204|FG002|Overall Study|Follow up ended by sponsor|0|||
164676744|NCT02089685|594840205|FG003|Overall Study|Follow up ended by sponsor|70|||
164676745|NCT02089685|594840206|FG004|Overall Study|Follow up ended by sponsor|26|||
164676746|NCT02089685|594840207|FG005|Overall Study|Follow up ended by sponsor|26|||
164676747|NCT02089685|594840202|FG000|Overall Study|Withdrawal by Subject|0|||
164676748|NCT02089685|594840203|FG001|Overall Study|Withdrawal by Subject|2|||
164676749|NCT02089685|594840204|FG002|Overall Study|Withdrawal by Subject|0|||
164676750|NCT02089685|594840205|FG003|Overall Study|Withdrawal by Subject|8|||
164676751|NCT02089685|594840206|FG004|Overall Study|Withdrawal by Subject|1|||
164676752|NCT02089685|594840207|FG005|Overall Study|Withdrawal by Subject|1|||
164676753|NCT02089685|594840202|FG000|Overall Study|Status not recorded|1|||
164676754|NCT02089685|594840203|FG001|Overall Study|Status not recorded|0|||
164676755|NCT02089685|594840204|FG002|Overall Study|Status not recorded|0|||
164676756|NCT02089685|594840205|FG003|Overall Study|Status not recorded|0|||
164676757|NCT02089685|594840206|FG004|Overall Study|Status not recorded|1|||
164676758|NCT02089685|594840207|FG005|Overall Study|Status not recorded|0|||
164676759|NCT02089685|594840202|FG000|Overall Study|Death|0|||
164423457|NCT00109928|593921478|FG000|Overall Study|not protocol specified|2|||
164423458|NCT00109928|593921478|FG000|Overall Study|not eligible|1|||
164423459|NCT01364727|593921482|FG000|Overall Study|Not Eligible|2|||
164423460|NCT01676220|593921483|FG000|Overall Study|Randomized But Not Treated|4|||
164676760|NCT02089685|594840203|FG001|Overall Study|Death|0|||
164676761|NCT02089685|594840204|FG002|Overall Study|Death|0|||
164676762|NCT02089685|594840205|FG003|Overall Study|Death|7|||
164676763|NCT02089685|594840206|FG004|Overall Study|Death|2|||
164676764|NCT02089685|594840207|FG005|Overall Study|Death|5|||
164676765|NCT02089685|594840202|FG000|Overall Study|Lost to Follow-up|0|||
164676766|NCT02089685|594840203|FG001|Overall Study|Lost to Follow-up|0|||
164676767|NCT02089685|594840204|FG002|Overall Study|Lost to Follow-up|0|||
164676768|NCT02089685|594840205|FG003|Overall Study|Lost to Follow-up|1|||
164676769|NCT02089685|594840206|FG004|Overall Study|Lost to Follow-up|0|||
164676770|NCT02089685|594840207|FG005|Overall Study|Lost to Follow-up|0|||
164676771|NCT02089685|594840202|FG000|Overall Study|Physician Decision|0|||
164676772|NCT02089685|594840203|FG001|Overall Study|Physician Decision|0|||
164676773|NCT02089685|594840204|FG002|Overall Study|Physician Decision|0|||
164676774|NCT02089685|594840205|FG003|Overall Study|Physician Decision|0|||
164676775|NCT02089685|594840206|FG004|Overall Study|Physician Decision|0|||
164676776|NCT02089685|594840207|FG005|Overall Study|Physician Decision|4|||
164676777|NCT02089685|594840202|FG000|Overall Study|Screen failure|1|||
164676778|NCT02089685|594840203|FG001|Overall Study|Screen failure|0|||
164676779|NCT02089685|594840204|FG002|Overall Study|Screen failure|0|||
164676780|NCT02089685|594840205|FG003|Overall Study|Screen failure|0|||
164676781|NCT02089685|594840206|FG004|Overall Study|Screen failure|0|||
164676782|NCT02089685|594840207|FG005|Overall Study|Screen failure|0|||
164676783|NCT04887415|594840210|FG000|Overall Study|Lost to Follow-up|2|||
164676784|NCT00840411|594840211|FG000|First Intervention|Adverse Event|1|||
164676785|NCT00840411|594840212|FG001|First Intervention|Adverse Event|0|||
164676786|NCT00840411|594840211|FG000|Washout|Withdrawal by Subject|1|||
164676787|NCT00840411|594840212|FG001|Washout|Withdrawal by Subject|0|||
164676788|NCT01576042|594840214|FG000|Overall Study|Physician Decision|2|||
164676789|NCT01576042|594840215|FG001|Overall Study|Physician Decision|0|||
164676790|NCT03233724|594840216|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
164676791|NCT03233724|594840217|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
164423461|NCT01676220|593921484|FG001|Overall Study|Randomized But Not Treated|1|||
164423462|NCT01676220|593921483|FG000|Overall Study|Adverse Event|10|||
164423463|NCT01676220|593921484|FG001|Overall Study|Adverse Event|8|||
164423464|NCT01676220|593921483|FG000|Overall Study|Lack of Efficacy|2|||
164423465|NCT01676220|593921484|FG001|Overall Study|Lack of Efficacy|5|||
164423466|NCT01676220|593921483|FG000|Overall Study|Protocol Violation|11|||
164423467|NCT01676220|593921484|FG001|Overall Study|Protocol Violation|12|||
164423468|NCT01676220|593921483|FG000|Overall Study|Received Rescue Therapy|14|||
164423469|NCT01676220|593921484|FG001|Overall Study|Received Rescue Therapy|22|||
164423470|NCT01676220|593921483|FG000|Overall Study|Personal Reason|34|||
164423471|NCT01676220|593921484|FG001|Overall Study|Personal Reason|45|||
164423472|NCT01676220|593921483|FG000|Overall Study|Lost to Follow-up|11|||
164423473|NCT01676220|593921484|FG001|Overall Study|Lost to Follow-up|18|||
164423474|NCT01676220|593921483|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
164423475|NCT01676220|593921484|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
164423476|NCT01676220|593921483|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
164423477|NCT01676220|593921484|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
164423478|NCT01676220|593921483|FG000|Overall Study|Perceived Lack of Efficacy|3|||
164423479|NCT01676220|593921484|FG001|Overall Study|Perceived Lack of Efficacy|1|||
164423480|NCT01676220|593921483|FG000|Overall Study|Non Serious Hypoglycemia|2|||
164423481|NCT01676220|593921484|FG001|Overall Study|Non Serious Hypoglycemia|0|||
164423482|NCT01676220|593921483|FG000|Overall Study|No More Need of Insulin|1|||
164423483|NCT01676220|593921484|FG001|Overall Study|No More Need of Insulin|0|||
164423484|NCT02411591|593921485|FG000|Overall Study|Adverse Event|0|||
164423485|NCT02411591|593921486|FG001|Overall Study|Adverse Event|4|||
164423486|NCT02411591|593921487|FG002|Overall Study|Adverse Event|2|||
164423487|NCT02411591|593921485|FG000|Overall Study|Withdrawal by Subject|0|||
164423488|NCT02411591|593921486|FG001|Overall Study|Withdrawal by Subject|3|||
164423489|NCT02411591|593921487|FG002|Overall Study|Withdrawal by Subject|0|||
164423490|NCT02411591|593921485|FG000|Overall Study|Physician Decision|0|||
164423491|NCT02411591|593921486|FG001|Overall Study|Physician Decision|3|||
164423492|NCT02411591|593921487|FG002|Overall Study|Physician Decision|1|||
164423493|NCT00750893|593921490|FG000|Overall Study|Adverse Event|5|||
164423494|NCT00750893|593921490|FG000|Overall Study|Withdrawal by Subject|10|||
164423495|NCT00750893|593921490|FG000|Overall Study|Lost to Follow-up|510|||
164423496|NCT00750893|593921490|FG000|Overall Study|Other|17|||
164423497|NCT00661258|593921498|FG000|Overall Study|Death|1|||
164423498|NCT00661258|593921499|FG001|Overall Study|Death|0|||
164423499|NCT00661258|593921498|FG000|Overall Study|caught by police and in detox center|2|||
164423500|NCT00661258|593921499|FG001|Overall Study|caught by police and in detox center|1|||
164423501|NCT01628874|593921500|FG000|Overall Study|Physician Decision|1|||
164423502|NCT01628874|593921501|FG001|Overall Study|Physician Decision|1|||
164423503|NCT01628874|593921500|FG000|Overall Study|Age >4 months|4|||
164423504|NCT01628874|593921501|FG001|Overall Study|Age >4 months|2|||
164423505|NCT03990363|593921503|FG000|Overall Study|Withdrawal by Subject|10|||
164423506|NCT03990363|593921504|FG001|Overall Study|Withdrawal by Subject|9|||
164423507|NCT03990363|593921505|FG002|Overall Study|Withdrawal by Subject|18|||
164423508|NCT03990363|593921506|FG003|Overall Study|Withdrawal by Subject|11|||
164423509|NCT03990363|593921507|FG004|Overall Study|Withdrawal by Subject|9|||
164676792|NCT03233724|594840218|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
164676793|NCT03233724|594840219|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
164235495|NCT02412670|593233508|FG000|Overall Study|Withdrawal by Subject|1|||
164235496|NCT02412670|593233509|FG001|Overall Study|Withdrawal by Subject|0|||
164235497|NCT02412670|593233508|FG000|Overall Study|Ineligible|1|||
164235498|NCT02412670|593233509|FG001|Overall Study|Ineligible|0|||
164235499|NCT02943473|593233513|FG000|Overall Study|enrolled but not dosed|1|||
164676794|NCT03233724|594840220|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
164676795|NCT03233724|594840216|FG000|Phase I Dose Escalation|Best interest of participant|1|||
164676796|NCT03233724|594840217|FG001|Phase I Dose Escalation|Best interest of participant|1|||
164676797|NCT03233724|594840218|FG002|Phase I Dose Escalation|Best interest of participant|1|||
164676798|NCT03233724|594840219|FG003|Phase I Dose Escalation|Best interest of participant|0|||
164676799|NCT03233724|594840220|FG004|Phase I Dose Escalation|Best interest of participant|0|||
164676800|NCT03233724|594840216|FG000|Phase I Dose Escalation|Physician Decision|0|||
164676801|NCT03233724|594840217|FG001|Phase I Dose Escalation|Physician Decision|0|||
164676802|NCT03233724|594840218|FG002|Phase I Dose Escalation|Physician Decision|1|||
164676803|NCT03233724|594840219|FG003|Phase I Dose Escalation|Physician Decision|0|||
164676804|NCT03233724|594840220|FG004|Phase I Dose Escalation|Physician Decision|0|||
164676805|NCT03233724|594840216|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
164676806|NCT03233724|594840217|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
164676807|NCT03233724|594840218|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
164676808|NCT03233724|594840219|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
164676809|NCT03233724|594840220|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
164676810|NCT00651820|594840223|FG000|Overall Study|Lost to Follow-up|2|||
164676811|NCT01911676|594840224|FG000|Period 1 of Study|Withdrawal by Subject|4|||
164676812|NCT01911676|594840225|FG001|Period 1 of Study|Withdrawal by Subject|2|||
164676813|NCT01911676|594840226|FG002|Period 1 of Study|Withdrawal by Subject|1|||
164676814|NCT01911676|594840227|FG003|Period 1 of Study|Withdrawal by Subject|2|||
164676815|NCT01911676|594840224|FG000|Period 1 of Study|Physician Decision|2|||
164676816|NCT01911676|594840225|FG001|Period 1 of Study|Physician Decision|0|||
164676817|NCT01911676|594840226|FG002|Period 1 of Study|Physician Decision|0|||
164676818|NCT01911676|594840227|FG003|Period 1 of Study|Physician Decision|1|||
164676819|NCT01911676|594840224|FG000|Period 2 of Study|Physician Decision|2|||
164676820|NCT01911676|594840225|FG001|Period 2 of Study|Physician Decision|0|||
164676821|NCT01911676|594840226|FG002|Period 2 of Study|Physician Decision|0|||
164676822|NCT01911676|594840227|FG003|Period 2 of Study|Physician Decision|1|||
164676823|NCT01911676|594840224|FG000|Period 2 of Study|Lost to Follow-up|0|||
164676824|NCT01911676|594840225|FG001|Period 2 of Study|Lost to Follow-up|0|||
164676825|NCT01911676|594840226|FG002|Period 2 of Study|Lost to Follow-up|0|||
164676826|NCT01911676|594840227|FG003|Period 2 of Study|Lost to Follow-up|1|||
164676827|NCT00773253|594840228|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
164676828|NCT00773253|594840229|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
164676829|NCT00657553|594840233|FG000|Overall Study|low accrual, no analysis run|5|||
164676830|NCT00657553|594840234|FG001|Overall Study|low accrual, no analysis run|5|||
164676831|NCT03173547|594840235|FG000|Overall Study|Adverse Event|2|||
164676832|NCT03173547|594840236|FG001|Overall Study|Adverse Event|0|||
164676833|NCT03173547|594840235|FG000|Overall Study|Withdrawal by Subject|2|||
164676834|NCT03173547|594840236|FG001|Overall Study|Withdrawal by Subject|2|||
164676835|NCT01566721|594840237|FG000|Treatment Period|Withdrawal by Subject|35|||
164676836|NCT01566721|594840238|FG001|Treatment Period|Withdrawal by Subject|9|||
164676837|NCT01566721|594840237|FG000|Treatment Period|Disease Progression/Recurrence|37|||
164676838|NCT01566721|594840238|FG001|Treatment Period|Disease Progression/Recurrence|13|||
164676839|NCT01566721|594840237|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
164676840|NCT01566721|594840238|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
164676841|NCT01566721|594840237|FG000|Treatment Period|Other|13|||
164676842|NCT01566721|594840238|FG001|Treatment Period|Other|2|||
164676843|NCT01566721|594840237|FG000|Treatment Period|Lack of Compliance|5|||
164676844|NCT01566721|594840238|FG001|Treatment Period|Lack of Compliance|1|||
164676845|NCT01566721|594840237|FG000|Treatment Period|Adverse Event|100|||
164676846|NCT01566721|594840238|FG001|Treatment Period|Adverse Event|30|||
164676847|NCT01566721|594840237|FG000|Treatment Period|Pregnancy|1|||
164676848|NCT01566721|594840238|FG001|Treatment Period|Pregnancy|0|||
164676849|NCT01566721|594840237|FG000|Safety Follow-up|Physician Decision|6|||
164676850|NCT01566721|594840238|FG001|Safety Follow-up|Physician Decision|4|||
164235500|NCT02943473|593233513|FG000|Overall Study|screen failure|1|||
164235501|NCT02943473|593233513|FG000|Overall Study|Physician Decision|4|||
164235502|NCT01728246|593233514|FG000|Overall Study|Participant needed rescue medication|1|||
164676851|NCT01566721|594840237|FG000|Safety Follow-up|Lost to Follow-up|101|||
164676852|NCT01566721|594840238|FG001|Safety Follow-up|Lost to Follow-up|48|||
164676853|NCT01566721|594840237|FG000|Safety Follow-up|Withdrawal by Subject|155|||
164676854|NCT01566721|594840238|FG001|Safety Follow-up|Withdrawal by Subject|49|||
164676855|NCT01566721|594840237|FG000|Safety Follow-up|Death|28|||
164676856|NCT01566721|594840238|FG001|Safety Follow-up|Death|4|||
164676857|NCT01566721|594840237|FG000|Safety Follow-up|Non-compliance|7|||
164299837|NCT02234843|593472948|FG004|Overall Study|Death|0|||
164676858|NCT01566721|594840238|FG001|Safety Follow-up|Non-compliance|3|||
164676859|NCT01566721|594840237|FG000|Safety Follow-up|Protocol Violation|7|||
164676860|NCT01566721|594840238|FG001|Safety Follow-up|Protocol Violation|0|||
164676861|NCT01566721|594840237|FG000|Safety Follow-up|Site closure|2|||
164676862|NCT01566721|594840238|FG001|Safety Follow-up|Site closure|3|||
164676863|NCT01566721|594840237|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
164676864|NCT01566721|594840238|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
164235503|NCT01728246|593233515|FG001|Overall Study|Participant needed rescue medication|5|||
164235504|NCT01728246|593233514|FG000|Overall Study|Protocol Violation|1|||
164235505|NCT01728246|593233515|FG001|Overall Study|Protocol Violation|0|||
164235506|NCT01728246|593233514|FG000|Overall Study|Withdrawal by Subject|2|||
164235507|NCT01728246|593233515|FG001|Overall Study|Withdrawal by Subject|3|||
164235508|NCT01728246|593233514|FG000|Overall Study|Lost to Follow-up|23|||
164235509|NCT01728246|593233515|FG001|Overall Study|Lost to Follow-up|22|||
164235510|NCT01728246|593233514|FG000|Overall Study|Lack of Efficacy|1|||
164676865|NCT01566721|594840237|FG000|Safety Follow-up|Missing|7|||
164676866|NCT01566721|594840238|FG001|Safety Follow-up|Missing|2|||
164676867|NCT01566721|594840237|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
164676868|NCT01566721|594840238|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
164676869|NCT01566721|594840237|FG000|Safety Follow-up|Sponsor decision|1|||
164676870|NCT01566721|594840238|FG001|Safety Follow-up|Sponsor decision|0|||
164676871|NCT01566721|594840237|FG000|Safety Follow-up|Adverse Event|8|||
164676872|NCT01566721|594840238|FG001|Safety Follow-up|Adverse Event|4|||
164676873|NCT00811655|594840245|FG000|Overall Study|Physician Decision|1|||
164676874|NCT00787254|594840247|FG000|Overall Study|Adverse Event|24|||
164676875|NCT00787254|594840248|FG001|Overall Study|Adverse Event|23|||
164676876|NCT00787254|594840247|FG000|Overall Study|Protocol Violation|26|||
164676877|NCT00787254|594840248|FG001|Overall Study|Protocol Violation|23|||
164676878|NCT00787254|594840247|FG000|Overall Study|Withdrawal by Subject|16|||
164676879|NCT00787254|594840248|FG001|Overall Study|Withdrawal by Subject|11|||
164676880|NCT00787254|594840247|FG000|Overall Study|Lack of Efficacy|4|||
164235511|NCT01728246|593233515|FG001|Overall Study|Lack of Efficacy|1|||
164235512|NCT01728246|593233514|FG000|Overall Study|Adverse Event|8|||
164235513|NCT01728246|593233515|FG001|Overall Study|Adverse Event|5|||
164235514|NCT05805150|593233516|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
164235515|NCT05805150|593233517|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
164235516|NCT00431964|593233520|FG000|Overall Study|Adverse Event|1|||
164235517|NCT00431964|593233521|FG001|Overall Study|Adverse Event|0|||
164235518|NCT00431964|593233520|FG000|Overall Study|Lost to Follow-up|1|||
164235519|NCT00431964|593233521|FG001|Overall Study|Lost to Follow-up|2|||
164235520|NCT00431964|593233520|FG000|Overall Study|Physician Decision|2|||
164235521|NCT00431964|593233521|FG001|Overall Study|Physician Decision|2|||
164235522|NCT00431964|593233520|FG000|Overall Study|Withdrawal by Subject|2|||
164235523|NCT00431964|593233521|FG001|Overall Study|Withdrawal by Subject|1|||
164235524|NCT00431964|593233520|FG000|Overall Study|Parental Consent Withdrawn|0|||
164235525|NCT00431964|593233521|FG001|Overall Study|Parental Consent Withdrawn|2|||
164235526|NCT00431964|593233520|FG000|Overall Study|Due to Unstable Health|0|||
164235527|NCT00431964|593233521|FG001|Overall Study|Due to Unstable Health|1|||
164235528|NCT04138056|593233522|FG000|Primary Study|Lost to Follow-up|3|||
164235529|NCT04138056|593233523|FG001|Primary Study|Lost to Follow-up|4|||
164235530|NCT04138056|593233524|FG002|Primary Study|Lost to Follow-up|1|||
164676881|NCT00787254|594840248|FG001|Overall Study|Lack of Efficacy|15|||
164676882|NCT00787254|594840247|FG000|Overall Study|NSAIDs discontinuation|1|||
164676883|NCT00787254|594840248|FG001|Overall Study|NSAIDs discontinuation|2|||
164676884|NCT00787254|594840247|FG000|Overall Study|Institution closed|1|||
164676885|NCT00787254|594840248|FG001|Overall Study|Institution closed|0|||
164676886|NCT00787254|594840247|FG000|Overall Study|Physician Decision|4|||
164676887|NCT00787254|594840248|FG001|Overall Study|Physician Decision|8|||
164676888|NCT00119015|594840251|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
164676889|NCT00119015|594840252|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
164676890|NCT00119015|594840253|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
164235531|NCT04138056|593233525|FG003|Primary Study|Lost to Follow-up|1|||
164235532|NCT04138056|593233526|FG004|Primary Study|Lost to Follow-up|4|||
164299838|NCT02234843|593472949|FG005|Overall Study|Death|0|||
164299839|NCT02234843|593472950|FG006|Overall Study|Death|0|||
164299840|NCT02234843|593472951|FG007|Overall Study|Death|0|||
164299841|NCT02234843|593472952|FG008|Overall Study|Death|0|||
164299842|NCT02234843|593472953|FG009|Overall Study|Death|0|||
164299843|NCT02234843|593472944|FG000|Overall Study|Protocol Violation|1|||
164299844|NCT02234843|593472945|FG001|Overall Study|Protocol Violation|0|||
164299845|NCT02234843|593472946|FG002|Overall Study|Protocol Violation|1|||
164299846|NCT02234843|593472947|FG003|Overall Study|Protocol Violation|0|||
164299847|NCT02234843|593472948|FG004|Overall Study|Protocol Violation|0|||
164299848|NCT02234843|593472949|FG005|Overall Study|Protocol Violation|0|||
164299849|NCT02234843|593472950|FG006|Overall Study|Protocol Violation|0|||
164299850|NCT02234843|593472951|FG007|Overall Study|Protocol Violation|0|||
164299851|NCT02234843|593472952|FG008|Overall Study|Protocol Violation|0|||
164235533|NCT04138056|593233522|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
164235534|NCT04138056|593233523|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
164235535|NCT04138056|593233524|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
164676891|NCT05776901|594841689|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
164676892|NCT01958294|594841692|FG000|Overall Study|Clinical Circumstances|2|||
164676893|NCT06144424|594841701|FG000|Overall Study|Withdrawal by Subject|2|||
164676894|NCT06144424|594841702|FG001|Overall Study|Withdrawal by Subject|0|||
164676895|NCT06144424|594841701|FG000|Overall Study|Incarceration|1|||
164676896|NCT06144424|594841702|FG001|Overall Study|Incarceration|0|||
164676897|NCT06284525|594841703|FG000|Overall Study|Withdrawal by Subject|1|||
164676898|NCT00834522|594841704|FG000|Washout|Adverse Event|1|||
164676899|NCT00834522|594841705|FG001|Washout|Adverse Event|0|||
164676900|NCT00834522|594841704|FG000|Washout|Withdrawal by Subject|2|||
164235536|NCT04138056|593233525|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
164676901|NCT00834522|594841705|FG001|Washout|Withdrawal by Subject|1|||
164676902|NCT00519194|594841706|FG000|Overall Study|Withdrawal by Subject|9|||
164235537|NCT04138056|593233526|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
164235538|NCT04138056|593233522|FG000|Extension Study|Lost to Follow-up|1|||
164235539|NCT04138056|593233523|FG001|Extension Study|Lost to Follow-up|2|||
164235540|NCT04138056|593233524|FG002|Extension Study|Lost to Follow-up|1|||
164235541|NCT04138056|593233525|FG003|Extension Study|Lost to Follow-up|0|||
164235542|NCT04138056|593233526|FG004|Extension Study|Lost to Follow-up|1|||
164235543|NCT01968980|593233530|FG000|Overall Study|Death|0|||
164676903|NCT00519194|594841706|FG000|Overall Study|Death|9|||
164676904|NCT00519194|594841706|FG000|Overall Study|Lost to Follow-up|3|||
164676905|NCT01111461|594841707|FG000|Overall Study|Adverse Event|32|||
164676906|NCT01111461|594841707|FG000|Overall Study|Participant choice|11|||
164676907|NCT01111461|594841707|FG000|Overall Study|Lost to Follow-up|1|||
164676908|NCT01111461|594841707|FG000|Overall Study|Withdrawal by Subject|1|||
164423510|NCT03990363|593921503|FG000|Overall Study|Physician Decision|1|||
164423511|NCT03990363|593921504|FG001|Overall Study|Physician Decision|0|||
164423512|NCT03990363|593921505|FG002|Overall Study|Physician Decision|0|||
164423513|NCT03990363|593921506|FG003|Overall Study|Physician Decision|0|||
164423514|NCT03990363|593921507|FG004|Overall Study|Physician Decision|0|||
164423515|NCT03990363|593921503|FG000|Overall Study|Adverse Event|1|||
164423516|NCT03990363|593921504|FG001|Overall Study|Adverse Event|3|||
164423517|NCT03990363|593921505|FG002|Overall Study|Adverse Event|2|||
164423518|NCT03990363|593921506|FG003|Overall Study|Adverse Event|2|||
164423519|NCT03990363|593921507|FG004|Overall Study|Adverse Event|0|||
164423520|NCT03990363|593921503|FG000|Overall Study|Death|14|||
164423521|NCT03990363|593921504|FG001|Overall Study|Death|8|||
164423522|NCT03990363|593921505|FG002|Overall Study|Death|14|||
164423523|NCT03990363|593921506|FG003|Overall Study|Death|10|||
164423524|NCT03990363|593921507|FG004|Overall Study|Death|11|||
164235544|NCT01968980|593233531|FG001|Overall Study|Death|1|||
164333862|NCT00785928|593599649|FG006|Treatment Phase|Withdrawal by Subject|0|||
164333863|NCT03611010|593599656|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
164333864|NCT03611010|593599657|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
164333865|NCT03611010|593599658|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
164333866|NCT03611010|593599659|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
164333867|NCT01675427|593599660|FG000|Overall Study|Withdrawal by Subject|7|||
164333868|NCT01675427|593599660|FG000|Overall Study|Participant Refused Sample Collection|18|||
164333869|NCT01675427|593599660|FG000|Overall Study|Sample not Collected by Mistake|2|||
164333870|NCT01675427|593599660|FG000|Overall Study|Lost to Follow-up|5|||
164333871|NCT01675427|593599660|FG000|Overall Study|Other|2|||
164333872|NCT05021081|593599664|FG000|Phase 2|Subject enrolled in error|1|||
164333873|NCT05021081|593599665|FG001|Phase 2|Subject enrolled in error|1|||
164676909|NCT01111461|594841707|FG000|Overall Study|Other|6|||
164676910|NCT03600805|594841720|FG000|Overall Study|Adverse Event|2|||
164676911|NCT03600805|594841721|FG001|Overall Study|Adverse Event|1|||
164423525|NCT03990363|593921503|FG000|Overall Study|Failure to meet randomization criteria|0|||
164333874|NCT05021081|593599666|FG002|Phase 2|Subject enrolled in error|0|||
164333875|NCT03257371|593599671|FG000|Overall Study|Lost to Follow-up|1|||
164676912|NCT03600805|594841722|FG002|Overall Study|Adverse Event|1|||
164676913|NCT03600805|594841723|FG003|Overall Study|Adverse Event|7|||
164676914|NCT03600805|594841720|FG000|Overall Study|Lack of Efficacy|2|||
164333876|NCT03387683|593599672|FG000|Overall Study|In receipt of disallowed medication|1|||
164423526|NCT03990363|593921504|FG001|Overall Study|Failure to meet randomization criteria|1|||
164423527|NCT03990363|593921505|FG002|Overall Study|Failure to meet randomization criteria|1|||
164423528|NCT03990363|593921506|FG003|Overall Study|Failure to meet randomization criteria|0|||
164333877|NCT03387683|593599673|FG001|Overall Study|In receipt of disallowed medication|0|||
164333878|NCT03387683|593599672|FG000|Overall Study|Did not receive treatment|1|||
164423529|NCT03990363|593921507|FG004|Overall Study|Failure to meet randomization criteria|0|||
164423530|NCT03990363|593921503|FG000|Overall Study|Lost to Follow-up|0|||
164423531|NCT03990363|593921504|FG001|Overall Study|Lost to Follow-up|0|||
164676915|NCT03600805|594841721|FG001|Overall Study|Lack of Efficacy|1|||
164235545|NCT01968980|593233530|FG000|Overall Study|Adverse Event|1|||
164235546|NCT01968980|593233531|FG001|Overall Study|Adverse Event|3|||
164235547|NCT01968980|593233530|FG000|Overall Study|Does not meet entry criteria|1|||
164235548|NCT01968980|593233531|FG001|Overall Study|Does not meet entry criteria|3|||
164235549|NCT01968980|593233530|FG000|Overall Study|Withdrawal by Subject|13|||
164235550|NCT01968980|593233531|FG001|Overall Study|Withdrawal by Subject|5|||
164235551|NCT01968980|593233530|FG000|Overall Study|Other unspecified|1|||
164235552|NCT01968980|593233531|FG001|Overall Study|Other unspecified|2|||
164235553|NCT03189719|593233532|FG000|Overall Study|Death|325|||
164235554|NCT03189719|593233533|FG001|Overall Study|Death|361|||
164235555|NCT03189719|593233532|FG000|Overall Study|Physician Decision|1|||
164676916|NCT03600805|594841722|FG002|Overall Study|Lack of Efficacy|0|||
164676917|NCT03600805|594841723|FG003|Overall Study|Lack of Efficacy|0|||
164676918|NCT03600805|594841720|FG000|Overall Study|Withdrawal by Subject|1|||
164676919|NCT03600805|594841721|FG001|Overall Study|Withdrawal by Subject|0|||
164676920|NCT03600805|594841722|FG002|Overall Study|Withdrawal by Subject|0|||
164676921|NCT03600805|594841723|FG003|Overall Study|Withdrawal by Subject|1|||
164676922|NCT03600805|594841720|FG000|Overall Study|Other unspecified|14|||
164676923|NCT03600805|594841721|FG001|Overall Study|Other unspecified|6|||
164676924|NCT03600805|594841722|FG002|Overall Study|Other unspecified|7|||
164676925|NCT03600805|594841723|FG003|Overall Study|Other unspecified|11|||
164676926|NCT00804856|594841728|FG000|Overall Study|Progressive Disease|3|||
164676927|NCT00804856|594841729|FG001|Overall Study|Progressive Disease|2|||
164676928|NCT00804856|594841730|FG002|Overall Study|Progressive Disease|4|||
164676929|NCT00804856|594841731|FG003|Overall Study|Progressive Disease|6|||
164676930|NCT00804856|594841732|FG004|Overall Study|Progressive Disease|4|||
164676931|NCT00804856|594841733|FG005|Overall Study|Progressive Disease|1|||
164676932|NCT00804856|594841734|FG006|Overall Study|Progressive Disease|8|||
164676933|NCT00804856|594841735|FG007|Overall Study|Progressive Disease|2|||
164676934|NCT00804856|594841736|FG008|Overall Study|Progressive Disease|4|||
164676935|NCT00804856|594841737|FG009|Overall Study|Progressive Disease|5|||
164676936|NCT00804856|594841738|FG010|Overall Study|Progressive Disease|12|||
164676937|NCT00804856|594841739|FG011|Overall Study|Progressive Disease|2|||
164676938|NCT00804856|594841740|FG012|Overall Study|Progressive Disease|2|||
164676939|NCT00804856|594841741|FG013|Overall Study|Progressive Disease|26|||
164676940|NCT00804856|594841742|FG014|Overall Study|Progressive Disease|20|||
164423532|NCT03990363|593921505|FG002|Overall Study|Lost to Follow-up|0|||
164235556|NCT03189719|593233533|FG001|Overall Study|Physician Decision|0|||
164235557|NCT03189719|593233532|FG000|Overall Study|Sponsor Decision|40|||
164235558|NCT03189719|593233533|FG001|Overall Study|Sponsor Decision|12|||
164235559|NCT03189719|593233532|FG000|Overall Study|Withdrawal by Subject|7|||
164235560|NCT03189719|593233533|FG001|Overall Study|Withdrawal by Subject|3|||
164235561|NCT03012880|593233534|FG000|Overall Study|Withdrawal by Subject|1|||
164235562|NCT03012880|593233535|FG001|Overall Study|Withdrawal by Subject|0|||
164235563|NCT03012880|593233534|FG000|Overall Study|Ineligible|1|||
164235564|NCT03012880|593233535|FG001|Overall Study|Ineligible|0|||
164235565|NCT05211596|593233536|FG000|Baseline to 6 Months|Lost to Follow-up|11|||
164235566|NCT05211596|593233536|FG000|Baseline to 6 Months|Death|1|||
164235567|NCT05211596|593233536|FG000|Baseline to 6 Months|Withdrawal by Subject|1|||
164235568|NCT05211596|593233536|FG000|6 Months to 18 Months|Lost to Follow-up|9|||
164235569|NCT02293551|593233537|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
164235570|NCT02293551|593233538|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
164235571|NCT02293551|593233539|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
164235572|NCT02293551|593233540|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
164235573|NCT02293551|593233541|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
164235574|NCT02293551|593233542|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
164235575|NCT02293551|593233537|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
164235576|NCT02293551|593233538|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
164235577|NCT02293551|593233539|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
164235578|NCT02293551|593233540|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
164235579|NCT02293551|593233541|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
164235580|NCT02293551|593233542|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
164235581|NCT02293551|593233537|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
164235582|NCT02293551|593233538|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
164235583|NCT02293551|593233539|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
164235584|NCT02293551|593233540|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
164235585|NCT02293551|593233541|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
164235586|NCT02293551|593233542|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
164235587|NCT04532749|593233543|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
164235588|NCT04532749|593233544|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
164235589|NCT04532749|593233543|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
164235590|NCT04532749|593233544|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
164235591|NCT04532749|593233543|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
164235592|NCT04532749|593233544|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
164676941|NCT00804856|594841728|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164423533|NCT03990363|593921506|FG003|Overall Study|Lost to Follow-up|1|||
164423534|NCT03990363|593921507|FG004|Overall Study|Lost to Follow-up|2|||
164423535|NCT03990363|593921503|FG000|Overall Study|Non-compliance with study drug|2|||
164423536|NCT03990363|593921504|FG001|Overall Study|Non-compliance with study drug|1|||
164423537|NCT03990363|593921505|FG002|Overall Study|Non-compliance with study drug|2|||
164423538|NCT03990363|593921506|FG003|Overall Study|Non-compliance with study drug|0|||
164423539|NCT03990363|593921507|FG004|Overall Study|Non-compliance with study drug|0|||
164423540|NCT03990363|593921503|FG000|Overall Study|Study terminated by sponsor|0|||
164423541|NCT03990363|593921504|FG001|Overall Study|Study terminated by sponsor|1|||
164423542|NCT03990363|593921505|FG002|Overall Study|Study terminated by sponsor|0|||
164423543|NCT03990363|593921506|FG003|Overall Study|Study terminated by sponsor|0|||
164423544|NCT03990363|593921507|FG004|Overall Study|Study terminated by sponsor|0|||
164423545|NCT03990363|593921503|FG000|Overall Study|Site terminated by sponsor|2|||
164423546|NCT03990363|593921504|FG001|Overall Study|Site terminated by sponsor|1|||
164423547|NCT03990363|593921505|FG002|Overall Study|Site terminated by sponsor|2|||
164423548|NCT03990363|593921506|FG003|Overall Study|Site terminated by sponsor|0|||
164423549|NCT03990363|593921507|FG004|Overall Study|Site terminated by sponsor|2|||
164423550|NCT03990363|593921503|FG000|Overall Study|Not categorized|5|||
164423551|NCT03990363|593921504|FG001|Overall Study|Not categorized|5|||
164423552|NCT03990363|593921505|FG002|Overall Study|Not categorized|3|||
164423553|NCT03990363|593921506|FG003|Overall Study|Not categorized|2|||
164423554|NCT03990363|593921507|FG004|Overall Study|Not categorized|2|||
164423555|NCT01563978|593921513|FG000|Overall Study|Physician Decision|1|||
164423556|NCT01563978|593921514|FG001|Overall Study|Physician Decision|0|||
164423557|NCT01563978|593921513|FG000|Overall Study|Lost to Follow-up|1|||
164423558|NCT01563978|593921514|FG001|Overall Study|Lost to Follow-up|0|||
164423559|NCT01563978|593921513|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
164423560|NCT01563978|593921514|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
164423561|NCT01563978|593921513|FG000|Overall Study|Adverse Event|1|||
164423562|NCT01563978|593921514|FG001|Overall Study|Adverse Event|2|||
164423563|NCT04630756|593921515|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
164423564|NCT04630756|593921516|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
164423565|NCT04630756|593921517|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
164423566|NCT01824472|593921521|FG000|Overall Study|Lost to Follow-up|0|||
164423567|NCT01824472|593921522|FG001|Overall Study|Lost to Follow-up|0|||
164423568|NCT01824472|593921523|FG002|Overall Study|Lost to Follow-up|1|||
164423569|NCT01824472|593921521|FG000|Overall Study|Withdrawal by Subject|1|||
164423570|NCT01824472|593921522|FG001|Overall Study|Withdrawal by Subject|5|||
164423571|NCT01824472|593921523|FG002|Overall Study|Withdrawal by Subject|3|||
164423572|NCT01824472|593921521|FG000|Overall Study|Ineligible post randomization&screening|0|||
164676942|NCT00804856|594841729|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164676943|NCT00804856|594841730|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164676944|NCT00804856|594841731|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164676945|NCT00804856|594841732|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
164676946|NCT00804856|594841733|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164676947|NCT00804856|594841734|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164676948|NCT00804856|594841735|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164676949|NCT00804856|594841736|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164676950|NCT00804856|594841737|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164676951|NCT00804856|594841738|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164676952|NCT00804856|594841739|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164676953|NCT00804856|594841740|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164676954|NCT00804856|594841741|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164676955|NCT00804856|594841742|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
164676956|NCT00804856|594841728|FG000|Overall Study|Other Adverse Event|1|||
164676957|NCT00804856|594841729|FG001|Overall Study|Other Adverse Event|1|||
164676958|NCT00804856|594841730|FG002|Overall Study|Other Adverse Event|1|||
164676959|NCT00804856|594841731|FG003|Overall Study|Other Adverse Event|2|||
164676960|NCT00804856|594841732|FG004|Overall Study|Other Adverse Event|2|||
164676961|NCT00804856|594841733|FG005|Overall Study|Other Adverse Event|1|||
164423573|NCT01824472|593921522|FG001|Overall Study|Ineligible post randomization&screening|2|||
164423574|NCT01824472|593921523|FG002|Overall Study|Ineligible post randomization&screening|0|||
164423575|NCT01815736|593921524|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
164423576|NCT01815736|593921525|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
164423577|NCT01815736|593921524|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
164423578|NCT01815736|593921525|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
164423579|NCT01815736|593921524|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
164423580|NCT01815736|593921525|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
164676962|NCT00804856|594841734|FG006|Overall Study|Other Adverse Event|3|||
164676963|NCT00804856|594841735|FG007|Overall Study|Other Adverse Event|0|||
164676964|NCT00804856|594841736|FG008|Overall Study|Other Adverse Event|0|||
164676965|NCT00804856|594841737|FG009|Overall Study|Other Adverse Event|1|||
164676966|NCT00804856|594841738|FG010|Overall Study|Other Adverse Event|5|||
164676967|NCT00804856|594841739|FG011|Overall Study|Other Adverse Event|2|||
164676968|NCT00804856|594841740|FG012|Overall Study|Other Adverse Event|0|||
164676969|NCT00804856|594841741|FG013|Overall Study|Other Adverse Event|6|||
164676970|NCT00804856|594841742|FG014|Overall Study|Other Adverse Event|13|||
164676971|NCT00804856|594841728|FG000|Overall Study|Non compliance with protocol|0|||
164676972|NCT00804856|594841729|FG001|Overall Study|Non compliance with protocol|0|||
164676973|NCT00804856|594841730|FG002|Overall Study|Non compliance with protocol|0|||
164676974|NCT00804856|594841731|FG003|Overall Study|Non compliance with protocol|0|||
164423581|NCT01815736|593921524|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
164423582|NCT01815736|593921525|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
164235593|NCT04532749|593233543|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
164235594|NCT04532749|593233544|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
164235595|NCT04532749|593233543|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
164235596|NCT04532749|593233544|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
164235597|NCT04532749|593233543|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
164235598|NCT04532749|593233544|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
164235599|NCT04532749|593233543|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
164235600|NCT04532749|593233544|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
164235601|NCT04532749|593233543|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
164235602|NCT04532749|593233544|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
164235603|NCT04532749|593233543|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
164235604|NCT04532749|593233544|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
164235605|NCT04532749|593233543|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
164235606|NCT04532749|593233544|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
164235607|NCT00529633|593235449|FG000|Overall Study|Withdrawal by Subject|1|||
164235608|NCT00529633|593235450|FG001|Overall Study|Withdrawal by Subject|1|||
164235609|NCT01897493|593235452|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
164235610|NCT03235050|593235455|FG000|Overall Study|Adverse Event|0|||
164235611|NCT03235050|593235456|FG001|Overall Study|Adverse Event|0|||
164235612|NCT03235050|593235457|FG002|Overall Study|Adverse Event|1|||
164235613|NCT03235050|593235458|FG003|Overall Study|Adverse Event|4|||
164235614|NCT03235050|593235459|FG004|Overall Study|Adverse Event|1|||
164235615|NCT03235050|593235455|FG000|Overall Study|Death|0|||
164235616|NCT03235050|593235456|FG001|Overall Study|Death|0|||
164235617|NCT03235050|593235457|FG002|Overall Study|Death|0|||
164235618|NCT03235050|593235458|FG003|Overall Study|Death|2|||
164235619|NCT03235050|593235459|FG004|Overall Study|Death|1|||
164235620|NCT03235050|593235455|FG000|Overall Study|Lost to Follow-up|1|||
164235621|NCT03235050|593235456|FG001|Overall Study|Lost to Follow-up|2|||
164235622|NCT03235050|593235457|FG002|Overall Study|Lost to Follow-up|1|||
164235623|NCT03235050|593235458|FG003|Overall Study|Lost to Follow-up|2|||
164235624|NCT03235050|593235459|FG004|Overall Study|Lost to Follow-up|0|||
164235625|NCT03235050|593235455|FG000|Overall Study|Withdrawal by Subject|3|||
164235626|NCT03235050|593235456|FG001|Overall Study|Withdrawal by Subject|2|||
164235627|NCT03235050|593235457|FG002|Overall Study|Withdrawal by Subject|2|||
164235628|NCT03235050|593235458|FG003|Overall Study|Withdrawal by Subject|5|||
164235629|NCT03235050|593235459|FG004|Overall Study|Withdrawal by Subject|7|||
164235630|NCT03235050|593235455|FG000|Overall Study|Other reasons|0|||
164235631|NCT03235050|593235456|FG001|Overall Study|Other reasons|1|||
164235632|NCT03235050|593235457|FG002|Overall Study|Other reasons|0|||
164235633|NCT03235050|593235458|FG003|Overall Study|Other reasons|1|||
164235634|NCT03235050|593235459|FG004|Overall Study|Other reasons|2|||
164235635|NCT00370292|593235460|FG000|Overall Study|Disease Progression|4|||
164235636|NCT00370292|593235460|FG000|Overall Study|Adverse Event|7|||
164235637|NCT00370292|593235460|FG000|Overall Study|Physician Decision|2|||
164235638|NCT02704208|593235461|FG000|Overall Study|Lost to Follow-up|42|||
164235639|NCT02704208|593235462|FG001|Overall Study|Lost to Follow-up|37|||
164235640|NCT03545672|593235463|FG000|Overall Study|Uncertain diagnosis|2|||
164235641|NCT03545672|593235464|FG001|Overall Study|Uncertain diagnosis|1|||
164235642|NCT03545672|593235463|FG000|Overall Study|Protocol Violation|2|||
164235643|NCT03545672|593235464|FG001|Overall Study|Protocol Violation|2|||
164235644|NCT02935192|593235465|FG000|Overall Study|Withdrawal by Subject|8|||
164235645|NCT02935192|593235466|FG001|Overall Study|Withdrawal by Subject|4|||
164235646|NCT00492557|593235468|FG000|Overall Study|Subject request|12|||
164235647|NCT00492557|593235469|FG001|Overall Study|Subject request|11|||
164676975|NCT00804856|594841732|FG004|Overall Study|Non compliance with protocol|0|||
164235648|NCT00492557|593235468|FG000|Overall Study|Protocol Violation|7|||
164235649|NCT00492557|593235469|FG001|Overall Study|Protocol Violation|8|||
164235650|NCT00492557|593235468|FG000|Overall Study|Other|2|||
164235651|NCT00492557|593235469|FG001|Overall Study|Other|2|||
164235652|NCT00492557|593235468|FG000|Overall Study|Death|1|||
164676976|NCT00804856|594841733|FG005|Overall Study|Non compliance with protocol|0|||
164235653|NCT00492557|593235469|FG001|Overall Study|Death|1|||
164235654|NCT00492557|593235468|FG000|Overall Study|Adverse Event|1|||
164235655|NCT00492557|593235469|FG001|Overall Study|Adverse Event|0|||
164235656|NCT00492557|593235468|FG000|Overall Study|Failed to return|1|||
164235657|NCT00492557|593235469|FG001|Overall Study|Failed to return|0|||
164235658|NCT00492557|593235468|FG000|Overall Study|Lost to Follow-up|0|||
164235659|NCT00492557|593235469|FG001|Overall Study|Lost to Follow-up|1|||
164235660|NCT03423121|593235473|FG000|Overall Study|Lost to Follow-up|2|||
164235661|NCT03423121|593235474|FG001|Overall Study|Lost to Follow-up|6|||
164235662|NCT03423121|593235473|FG000|Overall Study|Adverse Event|1|||
164235663|NCT03423121|593235474|FG001|Overall Study|Adverse Event|0|||
164235664|NCT04102007|593235479|FG000|Overall Study|Adverse Event|4|||
164235665|NCT04102007|593235479|FG000|Overall Study|Lost to Follow-up|3|||
164235666|NCT04102007|593235479|FG000|Overall Study|Withdrawal by Subject|12|||
164235667|NCT04102007|593235479|FG000|Overall Study|Eligibility Violation|5|||
164235668|NCT04102007|593235479|FG000|Overall Study|Lack of Efficacy|6|||
164235669|NCT04102007|593235479|FG000|Overall Study|Protocol Deviation|5|||
164235670|NCT04102007|593235479|FG000|Overall Study|Protocol Compliance|1|||
164235671|NCT04102007|593235479|FG000|Overall Study|Withdrew Treatment|2|||
164235672|NCT04102007|593235479|FG000|Overall Study|Pregnancy|1|||
164235673|NCT05173974|593235480|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
164235674|NCT05173974|593235481|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
164235675|NCT05173974|593235482|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
164235676|NCT05173974|593235483|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
164235677|NCT05173974|593235480|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
164235678|NCT05173974|593235481|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
164235679|NCT05173974|593235482|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
164235680|NCT05173974|593235483|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
164235681|NCT03289143|593235484|FG000|Overall Study|Caregiver Unavailability|1|||
164235682|NCT03289143|593235485|FG001|Overall Study|Caregiver Unavailability|1|||
164235683|NCT03289143|593235486|FG002|Overall Study|Caregiver Unavailability|0|||
164235684|NCT03289143|593235487|FG003|Overall Study|Caregiver Unavailability|0|||
164235685|NCT03289143|593235484|FG000|Overall Study|Research Department Closure|0|||
164235686|NCT03289143|593235485|FG001|Overall Study|Research Department Closure|0|||
164235687|NCT03289143|593235486|FG002|Overall Study|Research Department Closure|1|||
164235688|NCT03289143|593235487|FG003|Overall Study|Research Department Closure|0|||
164235689|NCT03289143|593235484|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
164235690|NCT03289143|593235485|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
164235691|NCT03289143|593235486|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
164235692|NCT03289143|593235487|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
164235693|NCT03289143|593235484|FG000|Overall Study|Medical Monitor Decision|1|||
164235694|NCT03289143|593235485|FG001|Overall Study|Medical Monitor Decision|0|||
164235695|NCT03289143|593235486|FG002|Overall Study|Medical Monitor Decision|0|||
164235696|NCT03289143|593235487|FG003|Overall Study|Medical Monitor Decision|0|||
164235697|NCT03289143|593235484|FG000|Overall Study|Participant Non-Compliance|0|||
164235698|NCT03289143|593235485|FG001|Overall Study|Participant Non-Compliance|0|||
164235699|NCT03289143|593235486|FG002|Overall Study|Participant Non-Compliance|1|||
164235700|NCT03289143|593235487|FG003|Overall Study|Participant Non-Compliance|0|||
164235701|NCT03289143|593235484|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
164235702|NCT03289143|593235485|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
164235703|NCT03289143|593235486|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
164235704|NCT03289143|593235487|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
164235705|NCT03289143|593235484|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
164235706|NCT03289143|593235485|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
164235707|NCT03289143|593235486|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
164235708|NCT03289143|593235487|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
164235709|NCT03289143|593235484|FG000|Overall Study|Caregiver Passed Away|1|||
164235710|NCT03289143|593235485|FG001|Overall Study|Caregiver Passed Away|0|||
164235711|NCT03289143|593235486|FG002|Overall Study|Caregiver Passed Away|0|||
164235712|NCT03289143|593235487|FG003|Overall Study|Caregiver Passed Away|0|||
164235713|NCT03289143|593235484|FG000|Overall Study|Physician Decision|0|||
164235714|NCT03289143|593235485|FG001|Overall Study|Physician Decision|2|||
164676977|NCT00804856|594841734|FG006|Overall Study|Non compliance with protocol|0|||
164676978|NCT00804856|594841735|FG007|Overall Study|Non compliance with protocol|0|||
164676979|NCT00804856|594841736|FG008|Overall Study|Non compliance with protocol|0|||
164676980|NCT00804856|594841737|FG009|Overall Study|Non compliance with protocol|0|||
164676981|NCT00804856|594841738|FG010|Overall Study|Non compliance with protocol|0|||
164676982|NCT00804856|594841739|FG011|Overall Study|Non compliance with protocol|0|||
164676983|NCT00804856|594841740|FG012|Overall Study|Non compliance with protocol|0|||
164676984|NCT00804856|594841741|FG013|Overall Study|Non compliance with protocol|2|||
164676985|NCT00804856|594841742|FG014|Overall Study|Non compliance with protocol|0|||
164676986|NCT00804856|594841728|FG000|Overall Study|Refused to continue medication|0|||
164676987|NCT00804856|594841729|FG001|Overall Study|Refused to continue medication|0|||
164676988|NCT00804856|594841730|FG002|Overall Study|Refused to continue medication|0|||
164676989|NCT00804856|594841731|FG003|Overall Study|Refused to continue medication|1|||
164676990|NCT00804856|594841732|FG004|Overall Study|Refused to continue medication|1|||
164235715|NCT03289143|593235486|FG002|Overall Study|Physician Decision|2|||
164235716|NCT03289143|593235487|FG003|Overall Study|Physician Decision|2|||
164572897|NCT01707992|594460457|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
164572898|NCT01707992|594460458|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
164572899|NCT01707992|594460459|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
164572900|NCT01707992|594460454|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
164572901|NCT01707992|594460455|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
164572902|NCT01707992|594460456|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
164572903|NCT01707992|594460457|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
164572904|NCT01707992|594460458|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
164572905|NCT01707992|594460459|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
164572906|NCT01707992|594460454|FG000|Active Treatment Phase (24 Months)|Death|0|||
164572907|NCT01707992|594460455|FG001|Active Treatment Phase (24 Months)|Death|0|||
164572908|NCT01707992|594460456|FG002|Active Treatment Phase (24 Months)|Death|0|||
164572909|NCT01707992|594460457|FG003|Active Treatment Phase (24 Months)|Death|2|||
164572910|NCT01707992|594460458|FG004|Active Treatment Phase (24 Months)|Death|0|||
164572911|NCT01707992|594460459|FG005|Active Treatment Phase (24 Months)|Death|0|||
164572912|NCT01707992|594460454|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
164572913|NCT01707992|594460455|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
164572914|NCT01707992|594460456|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
164572915|NCT01707992|594460457|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
164572916|NCT01707992|594460458|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
164572917|NCT01707992|594460459|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
164572918|NCT01707992|594460454|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
164572919|NCT01707992|594460455|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
164572920|NCT01707992|594460456|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
164572921|NCT01707992|594460457|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
164572922|NCT01707992|594460458|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
164572923|NCT01707992|594460459|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
164572924|NCT01707992|594460454|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
164572925|NCT01707992|594460455|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
164572926|NCT01707992|594460456|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
164572927|NCT01707992|594460457|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
164572928|NCT01707992|594460458|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
164572929|NCT01707992|594460459|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
164572930|NCT01707992|594460454|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
164572931|NCT01707992|594460455|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
164572932|NCT01707992|594460456|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
164572933|NCT01707992|594460457|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
164572934|NCT01707992|594460458|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
164572935|NCT01707992|594460459|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
164572936|NCT00998738|594460460|FG000|Overall Study|Uknown|1|||
164572937|NCT03498521|594460461|FG000|Overall Study|Death|227|||
164572938|NCT03498521|594460462|FG001|Overall Study|Death|79|||
164572939|NCT03498521|594460463|FG002|Overall Study|Death|84|||
164572940|NCT03498521|594460461|FG000|Overall Study|Exclusion criteria|1|||
164572941|NCT03498521|594460462|FG001|Overall Study|Exclusion criteria|0|||
164572942|NCT03498521|594460463|FG002|Overall Study|Exclusion criteria|0|||
164572943|NCT03498521|594460461|FG000|Overall Study|Lost to Follow-up|4|||
164572944|NCT03498521|594460462|FG001|Overall Study|Lost to Follow-up|3|||
164572945|NCT03498521|594460463|FG002|Overall Study|Lost to Follow-up|3|||
164572946|NCT03498521|594460461|FG000|Overall Study|No profile due to technical failure|1|||
164572947|NCT03498521|594460462|FG001|Overall Study|No profile due to technical failure|0|||
164572948|NCT03498521|594460463|FG002|Overall Study|No profile due to technical failure|0|||
164572949|NCT03498521|594460461|FG000|Overall Study|Physician Decision|3|||
164572950|NCT03498521|594460462|FG001|Overall Study|Physician Decision|1|||
164572951|NCT03498521|594460463|FG002|Overall Study|Physician Decision|0|||
164572952|NCT03498521|594460461|FG000|Overall Study|Withdrawal by Subject|11|||
164572953|NCT03498521|594460462|FG001|Overall Study|Withdrawal by Subject|6|||
164572954|NCT03498521|594460463|FG002|Overall Study|Withdrawal by Subject|2|||
164572955|NCT03498521|594460461|FG000|Overall Study|Study terminated by sponsor|79|||
164572956|NCT03498521|594460462|FG001|Overall Study|Study terminated by sponsor|21|||
164572957|NCT03498521|594460463|FG002|Overall Study|Study terminated by sponsor|4|||
164572958|NCT02848833|594460472|FG000|Overall Study|subject who are duplicated|1|||
164572959|NCT02848833|594460472|FG000|Overall Study|have not taken the study drug|11|||
164572960|NCT02848833|594460472|FG000|Overall Study|follow-up failure|6|||
164572961|NCT02848833|594460472|FG000|Overall Study|Protocol Violation|119|||
164572962|NCT04167345|594460473|FG000|Overall Study|Other|1|||
164572963|NCT04167345|594460474|FG001|Overall Study|Other|1|||
164572964|NCT04167345|594460475|FG002|Overall Study|Other|0|||
164572965|NCT04167345|594460476|FG003|Overall Study|Other|0|||
164235717|NCT03289143|593235484|FG000|Overall Study|Protocol Deviation|2|||
164235718|NCT03289143|593235485|FG001|Overall Study|Protocol Deviation|1|||
164235719|NCT03289143|593235486|FG002|Overall Study|Protocol Deviation|3|||
164235720|NCT03289143|593235487|FG003|Overall Study|Protocol Deviation|1|||
164235721|NCT03289143|593235484|FG000|Overall Study|Study Terminated By Sponsor|101|||
164235722|NCT03289143|593235485|FG001|Overall Study|Study Terminated By Sponsor|75|||
164235723|NCT03289143|593235486|FG002|Overall Study|Study Terminated By Sponsor|100|||
164235724|NCT03289143|593235487|FG003|Overall Study|Study Terminated By Sponsor|69|||
164235725|NCT03289143|593235484|FG000|Overall Study|Withdrawal by Subject|14|||
164235726|NCT03289143|593235485|FG001|Overall Study|Withdrawal by Subject|6|||
164235727|NCT03289143|593235486|FG002|Overall Study|Withdrawal by Subject|14|||
164235728|NCT03289143|593235487|FG003|Overall Study|Withdrawal by Subject|12|||
164235729|NCT03289143|593235484|FG000|Overall Study|Adverse Event|10|||
164235730|NCT03289143|593235485|FG001|Overall Study|Adverse Event|7|||
164235731|NCT03289143|593235486|FG002|Overall Study|Adverse Event|6|||
164235732|NCT03289143|593235487|FG003|Overall Study|Adverse Event|5|||
164235733|NCT03289143|593235484|FG000|Overall Study|Death|2|||
164235734|NCT03289143|593235485|FG001|Overall Study|Death|0|||
164235735|NCT03289143|593235486|FG002|Overall Study|Death|2|||
164235736|NCT03289143|593235487|FG003|Overall Study|Death|1|||
164235737|NCT03289143|593235484|FG000|Overall Study|Lost to Follow-up|2|||
164235738|NCT03289143|593235485|FG001|Overall Study|Lost to Follow-up|1|||
164235739|NCT03289143|593235486|FG002|Overall Study|Lost to Follow-up|1|||
164235740|NCT03289143|593235487|FG003|Overall Study|Lost to Follow-up|0|||
164235741|NCT03289143|593235484|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
164235742|NCT03289143|593235485|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
164235743|NCT03289143|593235486|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
164235744|NCT03289143|593235487|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
164235745|NCT03289143|593235484|FG000|Overall Study|Withdrawal by Caregiver|0|||
164235746|NCT03289143|593235485|FG001|Overall Study|Withdrawal by Caregiver|1|||
164235747|NCT03289143|593235486|FG002|Overall Study|Withdrawal by Caregiver|0|||
164235748|NCT03289143|593235487|FG003|Overall Study|Withdrawal by Caregiver|0|||
164235749|NCT03289143|593235484|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
164235750|NCT03289143|593235485|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
164572966|NCT04167345|594460477|FG004|Overall Study|Other|0|||
164572967|NCT04375761|594463241|FG000|Overall Study|Death|1|||
164572968|NCT04375761|594463242|FG001|Overall Study|Death|2|||
164572969|NCT04375761|594463241|FG000|Overall Study|Lost to Follow-up|203|||
164572970|NCT04375761|594463242|FG001|Overall Study|Lost to Follow-up|380|||
164572971|NCT04375761|594463241|FG000|Overall Study|Withdrawal by Subject|47|||
164572972|NCT04375761|594463242|FG001|Overall Study|Withdrawal by Subject|98|||
164572973|NCT04375761|594463241|FG000|Overall Study|Noncompliance with study procedure|121|||
164572974|NCT04375761|594463242|FG001|Overall Study|Noncompliance with study procedure|251|||
164572975|NCT04375761|594463241|FG000|Overall Study|Reimbursement not enough|1|||
164572976|NCT04375761|594463242|FG001|Overall Study|Reimbursement not enough|2|||
164572977|NCT04375761|594463241|FG000|Overall Study|Unforeseen family circumstances|1|||
164572978|NCT04375761|594463242|FG001|Overall Study|Unforeseen family circumstances|3|||
164572979|NCT04375761|594463241|FG000|Overall Study|Test too painful|1|||
164572980|NCT04375761|594463242|FG001|Overall Study|Test too painful|1|||
164572981|NCT04375761|594463241|FG000|Overall Study|Moved|0|||
164572982|NCT04375761|594463242|FG001|Overall Study|Moved|2|||
164572983|NCT04375761|594463241|FG000|Overall Study|Nonresponsive|0|||
164572984|NCT04375761|594463242|FG001|Overall Study|Nonresponsive|5|||
164572985|NCT02251743|594463254|FG000|Overall Study|Withdrawal by Subject|1|||
164572986|NCT02251743|594463255|FG001|Overall Study|Withdrawal by Subject|1|||
164572987|NCT00824564|594463256|FG000|Overall Study|Lost to Follow-up|5|||
164572988|NCT00824564|594463257|FG001|Overall Study|Lost to Follow-up|7|||
164572989|NCT00824564|594463256|FG000|Overall Study|Withdrawal by Subject|1|||
164572990|NCT00824564|594463257|FG001|Overall Study|Withdrawal by Subject|1|||
164676991|NCT00804856|594841733|FG005|Overall Study|Refused to continue medication|0|||
164676992|NCT00804856|594841734|FG006|Overall Study|Refused to continue medication|0|||
164235751|NCT03289143|593235486|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
164235752|NCT03289143|593235487|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
164235753|NCT03289143|593235484|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
164235754|NCT03289143|593235485|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
164299852|NCT02234843|593472953|FG009|Overall Study|Protocol Violation|0|||
164299853|NCT02234843|593472944|FG000|Overall Study|Efficacy outcome reached|2|||
164299854|NCT02234843|593472945|FG001|Overall Study|Efficacy outcome reached|0|||
164299855|NCT02234843|593472946|FG002|Overall Study|Efficacy outcome reached|0|||
164299856|NCT02234843|593472947|FG003|Overall Study|Efficacy outcome reached|0|||
164299857|NCT02234843|593472948|FG004|Overall Study|Efficacy outcome reached|0|||
164299858|NCT02234843|593472949|FG005|Overall Study|Efficacy outcome reached|2|||
164299859|NCT02234843|593472950|FG006|Overall Study|Efficacy outcome reached|0|||
164299860|NCT02234843|593472951|FG007|Overall Study|Efficacy outcome reached|0|||
164299861|NCT02234843|593472952|FG008|Overall Study|Efficacy outcome reached|0|||
164235755|NCT03289143|593235486|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
164235756|NCT03289143|593235487|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
164235757|NCT00948688|593235488|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
164235758|NCT00948688|593235489|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
164235759|NCT00948688|593235488|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
164235760|NCT00948688|593235489|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
164235761|NCT00948688|593235488|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
164235762|NCT00948688|593235489|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
164235763|NCT04047446|593235490|FG000|Overall Study|Physician Decision|1|||
164235764|NCT04047446|593235491|FG001|Overall Study|Physician Decision|0|||
164235765|NCT00329420|593235492|FG000|Re-induction Phase|Lack of Efficacy|0|||
164235766|NCT00329420|593235493|FG001|Re-induction Phase|Lack of Efficacy|1|||
164235767|NCT00329420|593235494|FG002|Re-induction Phase|Lack of Efficacy|0|||
164235768|NCT00329420|593235492|FG000|Re-induction Phase|Withdrawal of Consent|0|||
164235769|NCT00329420|593235493|FG001|Re-induction Phase|Withdrawal of Consent|0|||
164235770|NCT00329420|593235494|FG002|Re-induction Phase|Withdrawal of Consent|1|||
164235771|NCT00329420|593235492|FG000|Re-induction Phase|Did not respond to re-induction|6|||
164235772|NCT00329420|593235493|FG001|Re-induction Phase|Did not respond to re-induction|5|||
164235773|NCT00329420|593235494|FG002|Re-induction Phase|Did not respond to re-induction|7|||
164235774|NCT00329420|593235492|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
164235775|NCT00329420|593235493|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
164235776|NCT00329420|593235494|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
164235777|NCT00329420|593235492|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
164235778|NCT00329420|593235493|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
164235779|NCT00329420|593235494|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
164235780|NCT00329420|593235492|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
164235781|NCT00329420|593235493|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
164235782|NCT00329420|593235494|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
164235783|NCT02660229|593235496|FG000|Overall Study|Adverse Event|2|||
164235784|NCT02660229|593235497|FG001|Overall Study|Adverse Event|0|||
164235785|NCT02660229|593235496|FG000|Overall Study|Withdrawal by Subject|0|||
164235786|NCT02660229|593235497|FG001|Overall Study|Withdrawal by Subject|1|||
164235787|NCT02727322|593235501|FG000|Overall Study|Withdrawal by Subject|1|||
164235788|NCT02727322|593235502|FG001|Overall Study|Withdrawal by Subject|1|||
164235789|NCT02727322|593235501|FG000|Overall Study|Protocol Violation|1|||
164235790|NCT02727322|593235502|FG001|Overall Study|Protocol Violation|0|||
164235791|NCT00329030|593235508|FG000|Overall Study|Withdrawal by Subject|1|||
164235792|NCT00329030|593235509|FG001|Overall Study|Withdrawal by Subject|3|||
164235793|NCT00329030|593235508|FG000|Overall Study|Progressive Disease|6|||
164235794|NCT00329030|593235509|FG001|Overall Study|Progressive Disease|2|||
164235795|NCT00329030|593235508|FG000|Overall Study|Ineligible Pathology|1|||
164235796|NCT00329030|593235509|FG001|Overall Study|Ineligible Pathology|1|||
164235797|NCT00560417|593235510|FG000|Overall Study|Adverse Event|3|||
164235798|NCT00560417|593235511|FG001|Overall Study|Adverse Event|2|||
164235799|NCT00560417|593235510|FG000|Overall Study|Entry Criteria Not Met|1|||
164235800|NCT00560417|593235511|FG001|Overall Study|Entry Criteria Not Met|0|||
164235801|NCT00560417|593235510|FG000|Overall Study|Lost to Follow-up|0|||
164235802|NCT00560417|593235511|FG001|Overall Study|Lost to Follow-up|1|||
164235803|NCT00560417|593235510|FG000|Overall Study|Physician Decision|2|||
164235804|NCT00560417|593235511|FG001|Overall Study|Physician Decision|6|||
164235805|NCT00560417|593235510|FG000|Overall Study|Protocol Violation|6|||
164235806|NCT00560417|593235511|FG001|Overall Study|Protocol Violation|5|||
164235807|NCT00560417|593235510|FG000|Overall Study|Sponsor Decision|2|||
164235808|NCT00560417|593235511|FG001|Overall Study|Sponsor Decision|0|||
164235809|NCT00560417|593235510|FG000|Overall Study|Withdrawal by Subject|3|||
164235810|NCT00560417|593235511|FG001|Overall Study|Withdrawal by Subject|3|||
164235811|NCT00320606|593235512|FG000|Overall Study|Adverse Event|1|||
164235812|NCT00320606|593235512|FG000|Overall Study|Protocol Violation|1|||
164235813|NCT00320606|593235512|FG000|Overall Study|Withdrawal by Subject|1|||
164235814|NCT01948427|593235515|FG000|Overall Study|Serious Adverse Event|3|||
164235815|NCT01948427|593235516|FG001|Overall Study|Serious Adverse Event|0|||
164235816|NCT01948427|593235517|FG002|Overall Study|Serious Adverse Event|0|||
164676993|NCT00804856|594841735|FG007|Overall Study|Refused to continue medication|0|||
164235817|NCT01948427|593235518|FG003|Overall Study|Serious Adverse Event|0|||
164235818|NCT01948427|593235519|FG004|Overall Study|Serious Adverse Event|1|||
164235819|NCT01948427|593235515|FG000|Overall Study|Investigator Request|0|||
164235820|NCT01948427|593235516|FG001|Overall Study|Investigator Request|8|||
164235821|NCT01948427|593235517|FG002|Overall Study|Investigator Request|0|||
164235822|NCT01948427|593235518|FG003|Overall Study|Investigator Request|0|||
164235823|NCT01948427|593235519|FG004|Overall Study|Investigator Request|6|||
164235824|NCT01948427|593235515|FG000|Overall Study|Lost to Follow-up|1|||
164235825|NCT01948427|593235516|FG001|Overall Study|Lost to Follow-up|0|||
164676994|NCT00804856|594841736|FG008|Overall Study|Refused to continue medication|0|||
164235826|NCT01948427|593235517|FG002|Overall Study|Lost to Follow-up|0|||
164235827|NCT01948427|593235518|FG003|Overall Study|Lost to Follow-up|0|||
164235828|NCT01948427|593235519|FG004|Overall Study|Lost to Follow-up|4|||
164235829|NCT01948427|593235515|FG000|Overall Study|Withdrawal by Subject|2|||
164235830|NCT01948427|593235516|FG001|Overall Study|Withdrawal by Subject|0|||
164235831|NCT01948427|593235517|FG002|Overall Study|Withdrawal by Subject|0|||
164235832|NCT01948427|593235518|FG003|Overall Study|Withdrawal by Subject|0|||
164235833|NCT01948427|593235519|FG004|Overall Study|Withdrawal by Subject|1|||
164235834|NCT01948427|593235515|FG000|Overall Study|Other, Not Specified|1|||
164235835|NCT01948427|593235516|FG001|Overall Study|Other, Not Specified|9|||
164235836|NCT01948427|593235517|FG002|Overall Study|Other, Not Specified|0|||
164235837|NCT01948427|593235518|FG003|Overall Study|Other, Not Specified|0|||
164235838|NCT01948427|593235519|FG004|Overall Study|Other, Not Specified|2|||
164235839|NCT00256126|593235520|FG000|Overall Study|Adverse Event|1|||
164235840|NCT00256126|593235521|FG001|Overall Study|Adverse Event|0|||
164235841|NCT00256126|593235520|FG000|Overall Study|Other|1|||
164235842|NCT00256126|593235521|FG001|Overall Study|Other|2|||
164235843|NCT02434081|593235522|FG000|Overall Study|Death (never started treatment)|2|||
164235844|NCT02434081|593235522|FG000|Overall Study|Death|2|||
164235845|NCT02434081|593235522|FG000|Overall Study|Progression|20|||
164235846|NCT02434081|593235522|FG000|Overall Study|Adverse Event|20|||
164235847|NCT02434081|593235522|FG000|Overall Study|Physician Decision|2|||
164235848|NCT02434081|593235522|FG000|Overall Study|Withdrawal by Subject|1|||
164235849|NCT02434081|593235522|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
164235850|NCT00854360|593235529|FG000|Overall Study|Adverse Event|0|||
164235851|NCT00854360|593235530|FG001|Overall Study|Adverse Event|1|||
164235852|NCT00854360|593235531|FG002|Overall Study|Adverse Event|2|||
164235853|NCT00854360|593235532|FG003|Overall Study|Adverse Event|6|||
164235854|NCT00854360|593235529|FG000|Overall Study|Withdrawal by Subject|0|||
164235855|NCT00854360|593235530|FG001|Overall Study|Withdrawal by Subject|0|||
164235856|NCT00854360|593235531|FG002|Overall Study|Withdrawal by Subject|0|||
164333879|NCT03387683|593599673|FG001|Overall Study|Did not receive treatment|0|||
164333880|NCT00566501|593599676|FG000|Overall Study|Adverse Event|68|||
164333881|NCT00566501|593599677|FG001|Overall Study|Adverse Event|59|||
164333882|NCT00566501|593599676|FG000|Overall Study|Medication Non-compliance|5|||
164333883|NCT00566501|593599677|FG001|Overall Study|Medication Non-compliance|0|||
164333884|NCT00566501|593599676|FG000|Overall Study|Protocol Violation|2|||
164333885|NCT00566501|593599677|FG001|Overall Study|Protocol Violation|2|||
164333886|NCT00566501|593599676|FG000|Overall Study|Request of Investigator or Sponsor|6|||
164333887|NCT00566501|593599677|FG001|Overall Study|Request of Investigator or Sponsor|7|||
164333888|NCT00566501|593599676|FG000|Overall Study|Withdrawal by Subject|33|||
164333889|NCT00566501|593599677|FG001|Overall Study|Withdrawal by Subject|30|||
164333890|NCT00566501|593599676|FG000|Overall Study|Lack of Efficacy|8|||
164333891|NCT00566501|593599677|FG001|Overall Study|Lack of Efficacy|3|||
164333892|NCT00566501|593599676|FG000|Overall Study|Other|25|||
164333893|NCT00566501|593599677|FG001|Overall Study|Other|21|||
164333894|NCT05095454|593599678|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
164333895|NCT05095454|593599679|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
164333896|NCT00057876|593599680|FG000|Overall Study|Adverse Event|8|||
164333897|NCT00057876|593599681|FG001|Overall Study|Adverse Event|8|||
164333898|NCT00057876|593599680|FG000|Overall Study|Death|2|||
164333899|NCT00057876|593599681|FG001|Overall Study|Death|1|||
164333900|NCT00057876|593599680|FG000|Overall Study|Withdrawal by Subject|5|||
164333901|NCT00057876|593599681|FG001|Overall Study|Withdrawal by Subject|6|||
164333902|NCT00057876|593599680|FG000|Overall Study|Lack of Efficacy|10|||
164333903|NCT00057876|593599681|FG001|Overall Study|Lack of Efficacy|8|||
164333904|NCT00057876|593599680|FG000|Overall Study|Ineligible|1|||
164333905|NCT00057876|593599681|FG001|Overall Study|Ineligible|2|||
164333906|NCT00057876|593599680|FG000|Overall Study|other reason|2|||
164676995|NCT00804856|594841737|FG009|Overall Study|Refused to continue medication|0|||
164676996|NCT00804856|594841738|FG010|Overall Study|Refused to continue medication|3|||
164676997|NCT00804856|594841739|FG011|Overall Study|Refused to continue medication|0|||
164235857|NCT00854360|593235532|FG003|Overall Study|Withdrawal by Subject|1|||
164235858|NCT00854360|593235529|FG000|Overall Study|Pregnancy|0|||
164333907|NCT00057876|593599681|FG001|Overall Study|other reason|2|||
164333908|NCT00057876|593599680|FG000|Overall Study|other complicating disease|1|||
164333909|NCT00057876|593599681|FG001|Overall Study|other complicating disease|0|||
164333910|NCT01368432|593599682|FG000|Overall Study|Lost to Follow-up|0|||
164676998|NCT00804856|594841740|FG012|Overall Study|Refused to continue medication|1|||
164676999|NCT00804856|594841741|FG013|Overall Study|Refused to continue medication|1|||
164235859|NCT00854360|593235530|FG001|Overall Study|Pregnancy|1|||
164235860|NCT00854360|593235531|FG002|Overall Study|Pregnancy|0|||
164235861|NCT00854360|593235532|FG003|Overall Study|Pregnancy|0|||
164235862|NCT00854360|593235529|FG000|Overall Study|Lack of Efficacy|2|||
164235863|NCT00854360|593235530|FG001|Overall Study|Lack of Efficacy|1|||
164235864|NCT00854360|593235531|FG002|Overall Study|Lack of Efficacy|0|||
164333911|NCT01368432|593599683|FG001|Overall Study|Lost to Follow-up|1|||
164235865|NCT00854360|593235532|FG003|Overall Study|Lack of Efficacy|0|||
164235866|NCT00854360|593235529|FG000|Overall Study|Other|0|||
164235867|NCT00854360|593235530|FG001|Overall Study|Other|0|||
164235868|NCT00854360|593235531|FG002|Overall Study|Other|0|||
164235869|NCT00854360|593235532|FG003|Overall Study|Other|3|||
164235870|NCT02037529|593235533|FG000|Overall Study|Withdrawal by Subject|1|||
164235871|NCT02037529|593235534|FG001|Overall Study|Withdrawal by Subject|3|||
164235872|NCT02037529|593235533|FG000|Overall Study|Adverse Event|0|||
164235873|NCT02037529|593235534|FG001|Overall Study|Adverse Event|1|||
164235874|NCT00718315|593235535|FG000|Overall Study|Adverse Event|1|||
164235875|NCT00718315|593235536|FG001|Overall Study|Adverse Event|2|||
164235876|NCT00718315|593235537|FG002|Overall Study|Adverse Event|3|||
164677000|NCT00804856|594841742|FG014|Overall Study|Refused to continue medication|5|||
164677001|NCT00804856|594841728|FG000|Overall Study|Other reason than listed above|0|||
164677002|NCT00804856|594841729|FG001|Overall Study|Other reason than listed above|0|||
164677003|NCT00804856|594841730|FG002|Overall Study|Other reason than listed above|0|||
164677004|NCT00804856|594841731|FG003|Overall Study|Other reason than listed above|0|||
164677005|NCT00804856|594841732|FG004|Overall Study|Other reason than listed above|0|||
164677006|NCT00804856|594841733|FG005|Overall Study|Other reason than listed above|1|||
164677007|NCT00804856|594841734|FG006|Overall Study|Other reason than listed above|0|||
164677008|NCT00804856|594841735|FG007|Overall Study|Other reason than listed above|0|||
164677009|NCT00804856|594841736|FG008|Overall Study|Other reason than listed above|1|||
164677010|NCT00804856|594841737|FG009|Overall Study|Other reason than listed above|0|||
164677011|NCT00804856|594841738|FG010|Overall Study|Other reason than listed above|3|||
164677012|NCT00804856|594841739|FG011|Overall Study|Other reason than listed above|1|||
164677013|NCT00804856|594841740|FG012|Overall Study|Other reason than listed above|1|||
164677014|NCT00804856|594841741|FG013|Overall Study|Other reason than listed above|10|||
164677015|NCT00804856|594841742|FG014|Overall Study|Other reason than listed above|3|||
164235877|NCT00718315|593235535|FG000|Overall Study|Death|6|||
164235878|NCT00718315|593235536|FG001|Overall Study|Death|6|||
164235879|NCT00718315|593235537|FG002|Overall Study|Death|5|||
164235880|NCT00718315|593235535|FG000|Overall Study|Lost to Follow-up|2|||
164235881|NCT00718315|593235536|FG001|Overall Study|Lost to Follow-up|3|||
164677016|NCT03343535|594841743|FG000|Overall Study|Lost to Follow-up|1|||
164677017|NCT03343535|594841743|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
164677018|NCT03343535|594841743|FG000|Overall Study|Death|12|||
164677019|NCT03415308|594841750|FG000|Overall Study|Lost to Follow-up|0|||
164677020|NCT03415308|594841751|FG001|Overall Study|Lost to Follow-up|0|||
164677021|NCT03415308|594841752|FG002|Overall Study|Lost to Follow-up|1|||
164677022|NCT03415308|594841750|FG000|Overall Study|Scheduling Conflicts|0|||
164677023|NCT03415308|594841751|FG001|Overall Study|Scheduling Conflicts|0|||
164677024|NCT03415308|594841752|FG002|Overall Study|Scheduling Conflicts|7|||
164677025|NCT01471353|594841755|FG000|Overall Study|remain on study|3|||
164677026|NCT03123094|594841757|FG000|Overall Study|Withdrawal by Subject|0|||
164677027|NCT03123094|594841758|FG001|Overall Study|Withdrawal by Subject|2|||
164677028|NCT03123094|594841759|FG002|Overall Study|Withdrawal by Subject|1|||
164677029|NCT03123094|594841760|FG003|Overall Study|Withdrawal by Subject|0|||
164677030|NCT03123094|594841761|FG004|Overall Study|Withdrawal by Subject|1|||
164677031|NCT03437265|594841767|FG000|Overall Study|Protocol Violation|6|||
164677032|NCT04238754|594841772|FG000|Washout - 1 Week|Lost to Follow-up|1|||
164677033|NCT04238754|594841773|FG001|Washout - 1 Week|Lost to Follow-up|0|||
164677034|NCT01444378|594841778|FG000|Overall Study|Lost to Follow-up|1|||
164677035|NCT01444378|594841778|FG000|Overall Study|Withdrawal by Subject|1|||
164677036|NCT01444378|594841778|FG000|Overall Study|Death|3|||
164235882|NCT00718315|593235537|FG002|Overall Study|Lost to Follow-up|4|||
164235883|NCT00718315|593235535|FG000|Overall Study|Protocol Violation|5|||
164333912|NCT02758171|593599684|FG000|Wash-out|Withdrawal by Subject|1|||
164333913|NCT02758171|593599685|FG001|Wash-out|Withdrawal by Subject|0|||
164333914|NCT02758171|593599684|FG000|Wash-out|Other reason|1|||
164333915|NCT02758171|593599685|FG001|Wash-out|Other reason|0|||
164333916|NCT00853073|593599686|FG000|Overall Study|Withdrawal by Subject|3|||
164333917|NCT00853073|593599687|FG001|Overall Study|Withdrawal by Subject|2|||
164333918|NCT01999114|593599688|FG000|Overall Study|Adverse Event|8|||
164333919|NCT01999114|593599689|FG001|Overall Study|Adverse Event|7|||
164333920|NCT01999114|593599690|FG002|Overall Study|Adverse Event|2|||
164677037|NCT01444378|594841778|FG000|Overall Study|Administrative Closure Of The Study|2|||
164677038|NCT01444378|594841778|FG000|Overall Study|Missed Visits|10|||
164677039|NCT00705666|594841779|FG000|Overall Study|No post-treatment questionnaire|279|||
164677040|NCT00705666|594841779|FG000|Overall Study|Withdrawal by Subject|21|||
164677041|NCT00705666|594841779|FG000|Overall Study|Physician Decision|7|||
164235884|NCT00718315|593235536|FG001|Overall Study|Protocol Violation|5|||
164235885|NCT00718315|593235537|FG002|Overall Study|Protocol Violation|3|||
164235886|NCT00718315|593235535|FG000|Overall Study|Erlotinib dose decreased|4|||
164235887|NCT00718315|593235536|FG001|Overall Study|Erlotinib dose decreased|3|||
164235888|NCT00718315|593235537|FG002|Overall Study|Erlotinib dose decreased|1|||
164333921|NCT01999114|593599691|FG003|Overall Study|Adverse Event|2|||
164333922|NCT01999114|593599692|FG004|Overall Study|Adverse Event|1|||
164333923|NCT01999114|593599688|FG000|Overall Study|Withdrawal by Subject|0|||
164235889|NCT00718315|593235535|FG000|Overall Study|Use of Minocyclin|1|||
164235890|NCT00718315|593235536|FG001|Overall Study|Use of Minocyclin|1|||
164235891|NCT00718315|593235537|FG002|Overall Study|Use of Minocyclin|1|||
164235892|NCT00718315|593235535|FG000|Overall Study|Disease progression|0|||
164235893|NCT00718315|593235536|FG001|Overall Study|Disease progression|1|||
164235894|NCT00718315|593235537|FG002|Overall Study|Disease progression|1|||
164235895|NCT00718315|593235535|FG000|Overall Study|Other|0|||
164235896|NCT00718315|593235536|FG001|Overall Study|Other|0|||
164235897|NCT00718315|593235537|FG002|Overall Study|Other|1|||
164235898|NCT00718315|593235535|FG000|Overall Study|Use of ATB and Corticoids|0|||
164235899|NCT00718315|593235536|FG001|Overall Study|Use of ATB and Corticoids|1|||
164235900|NCT00718315|593235537|FG002|Overall Study|Use of ATB and Corticoids|2|||
164235901|NCT00399529|593235539|FG000|Overall Study|Off Study Prior to Treatment|2|||
164235902|NCT03435380|593235540|FG000|Overall Study|Death|1|||
164235903|NCT03435380|593235541|FG001|Overall Study|Death|2|||
164235904|NCT03435380|593235542|FG002|Overall Study|Death|1|||
164235905|NCT03435380|593235540|FG000|Overall Study|Lost to Follow-up|12|||
164235906|NCT03435380|593235541|FG001|Overall Study|Lost to Follow-up|8|||
164235907|NCT03435380|593235542|FG002|Overall Study|Lost to Follow-up|6|||
164235908|NCT03435380|593235540|FG000|Overall Study|Physician Decision|1|||
164235909|NCT03435380|593235541|FG001|Overall Study|Physician Decision|0|||
164333924|NCT01999114|593599689|FG001|Overall Study|Withdrawal by Subject|0|||
164333925|NCT01999114|593599690|FG002|Overall Study|Withdrawal by Subject|1|||
164333926|NCT01999114|593599691|FG003|Overall Study|Withdrawal by Subject|0|||
164333927|NCT01999114|593599692|FG004|Overall Study|Withdrawal by Subject|1|||
164333928|NCT01999114|593599688|FG000|Overall Study|Lost to Follow-up|0|||
164333929|NCT01999114|593599689|FG001|Overall Study|Lost to Follow-up|0|||
164572991|NCT00824564|594463256|FG000|Overall Study|Other|1|||
164572992|NCT00824564|594463257|FG001|Overall Study|Other|2|||
164572993|NCT00824564|594463256|FG000|Overall Study|Randomized, but not treated|1|||
164572994|NCT00824564|594463257|FG001|Overall Study|Randomized, but not treated|0|||
164572995|NCT04607408|594463258|FG000|Overall Study|Lost to Follow-up|0|||
164572996|NCT04607408|594463259|FG001|Overall Study|Lost to Follow-up|0|||
164572997|NCT04607408|594463260|FG002|Overall Study|Lost to Follow-up|0|||
164572998|NCT04607408|594463261|FG003|Overall Study|Lost to Follow-up|1|||
164572999|NCT04607408|594463262|FG004|Overall Study|Lost to Follow-up|0|||
164573000|NCT04607408|594463258|FG000|Overall Study|Withdrawal by Subject|0|||
164573001|NCT04607408|594463259|FG001|Overall Study|Withdrawal by Subject|1|||
164573002|NCT04607408|594463260|FG002|Overall Study|Withdrawal by Subject|0|||
164573003|NCT04607408|594463261|FG003|Overall Study|Withdrawal by Subject|1|||
164573004|NCT04607408|594463262|FG004|Overall Study|Withdrawal by Subject|0|||
164573005|NCT05113940|594463267|FG000|Part A (18 Days)|Adverse Event|0|||
164573006|NCT05113940|594463268|FG001|Part A (18 Days)|Adverse Event|0|||
164573007|NCT05113940|594463269|FG002|Part A (18 Days)|Adverse Event|1|||
164573008|NCT05113940|594463270|FG003|Part A (18 Days)|Adverse Event|1|||
164573009|NCT05113940|594463271|FG004|Part A (18 Days)|Adverse Event|1|||
164573010|NCT05113940|594463272|FG005|Part A (18 Days)|Adverse Event|0|||
164573011|NCT05113940|594463273|FG006|Part A (18 Days)|Adverse Event|0|||
164573012|NCT05113940|594463274|FG007|Part A (18 Days)|Adverse Event|0|||
164573013|NCT05113940|594463275|FG008|Part A (18 Days)|Adverse Event|0|||
164573014|NCT05113940|594463276|FG009|Part A (18 Days)|Adverse Event|0|||
164573015|NCT05113940|594463277|FG010|Part A (18 Days)|Adverse Event|0|||
164573016|NCT05113940|594463278|FG011|Part A (18 Days)|Adverse Event|2|||
164573017|NCT05113940|594463279|FG012|Part A (18 Days)|Adverse Event|0|||
164573018|NCT05113940|594463280|FG013|Part A (18 Days)|Adverse Event|0|||
164573019|NCT05113940|594463281|FG014|Part A (18 Days)|Adverse Event|0|||
164573020|NCT05113940|594463267|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
164573021|NCT05113940|594463268|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
164573022|NCT05113940|594463269|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
164573023|NCT05113940|594463270|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
164573024|NCT05113940|594463271|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
164573025|NCT05113940|594463272|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
164573026|NCT05113940|594463273|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
164573027|NCT05113940|594463274|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
164573028|NCT05113940|594463275|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
164235910|NCT03435380|593235542|FG002|Overall Study|Physician Decision|0|||
164235911|NCT03435380|593235540|FG000|Overall Study|Withdrawal by Subject|0|||
164573029|NCT05113940|594463276|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
164573030|NCT05113940|594463277|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
164573031|NCT05113940|594463278|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
164573032|NCT05113940|594463279|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
164235912|NCT03435380|593235541|FG001|Overall Study|Withdrawal by Subject|1|||
164235913|NCT03435380|593235542|FG002|Overall Study|Withdrawal by Subject|1|||
164235914|NCT03435380|593235540|FG000|Overall Study|Ineligible|0|||
164235915|NCT03435380|593235541|FG001|Overall Study|Ineligible|1|||
164235916|NCT03435380|593235542|FG002|Overall Study|Ineligible|1|||
164573033|NCT05113940|594463280|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
164573034|NCT05113940|594463281|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
164573035|NCT03619213|594463283|FG000|Overall Study|Lost to Follow-up|2|||
164677042|NCT00705666|594841779|FG000|Overall Study|Lost to Follow-up|5|||
164677043|NCT00705666|594841779|FG000|Overall Study|Death|1|||
164677044|NCT00705666|594841779|FG000|Overall Study|Adverse Event|4|||
164677045|NCT00705666|594841779|FG000|Overall Study|Other|12|||
164677046|NCT00705666|594841779|FG000|Overall Study|Other|2|||
164677047|NCT00705666|594841779|FG000|Overall Study|Lack of data|3|||
164677048|NCT00705666|594841779|FG000|Overall Study|Untreated|5|||
164677049|NCT02645409|594841781|FG000|Overall Study|Withdrawal by Subject|3|||
164677050|NCT02645409|594841782|FG001|Overall Study|Withdrawal by Subject|0|||
164677051|NCT02645409|594841781|FG000|Overall Study|Physician Decision|1|||
164677052|NCT02645409|594841782|FG001|Overall Study|Physician Decision|0|||
164677053|NCT03552393|594841785|FG000|Core Period|Kidney Transplant|1|||
164677054|NCT03552393|594841785|FG000|Core Period|Prohibited Medication|1|||
164677055|NCT03552393|594841785|FG000|Safety Extension Period|Kidney Transplant|4|||
164677056|NCT05646251|594841788|FG000|Overall Study|Physician Decision|1|||
164677057|NCT05646251|594841789|FG001|Overall Study|Physician Decision|0|||
164677058|NCT05646251|594841790|FG002|Overall Study|Physician Decision|2|||
164677059|NCT00465270|594841791|FG000|Overall Study|Death|7|||
164677060|NCT00465270|594841792|FG001|Overall Study|Death|11|||
164677061|NCT00465270|594841791|FG000|Overall Study|Withdrawal by Subject|34|||
164677062|NCT00465270|594841792|FG001|Overall Study|Withdrawal by Subject|78|||
164677063|NCT00465270|594841791|FG000|Overall Study|Lost to Follow-up|60|||
164677064|NCT00465270|594841792|FG001|Overall Study|Lost to Follow-up|67|||
164677065|NCT00465270|594841791|FG000|Overall Study|Investigator request|3|||
164677066|NCT00465270|594841792|FG001|Overall Study|Investigator request|4|||
164677067|NCT02388191|594841793|FG000|Overall Study|Patient did not receive IUD|1|||
164677068|NCT02388191|594841794|FG001|Overall Study|Patient did not receive IUD|0|||
164677069|NCT02530905|594841795|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
164677070|NCT02530905|594841796|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
164677071|NCT02530905|594841797|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
164677072|NCT01136174|594841798|FG000|Overall Study|Adverse Event|0|||
164677073|NCT01136174|594841799|FG001|Overall Study|Adverse Event|0|||
164677074|NCT01136174|594841800|FG002|Overall Study|Adverse Event|0|||
164677075|NCT01136174|594841801|FG003|Overall Study|Adverse Event|4|||
164677076|NCT01249651|594841804|FG000|Overall Study|Withdrawal by Subject|4|||
164677077|NCT01249651|594841804|FG000|Overall Study|Adverse Event|1|||
164677078|NCT01249651|594841804|FG000|Overall Study|Protocol Violation|1|||
164677079|NCT01249651|594841804|FG000|Overall Study|Sponsor Decision|1|||
164677080|NCT03873272|594841812|FG000|Overall Study|Withdrawal by Subject|2|||
164677081|NCT03873272|594841813|FG001|Overall Study|Withdrawal by Subject|0|||
164333930|NCT01999114|593599690|FG002|Overall Study|Lost to Follow-up|1|||
164333931|NCT01999114|593599691|FG003|Overall Study|Lost to Follow-up|0|||
164333932|NCT01999114|593599692|FG004|Overall Study|Lost to Follow-up|0|||
164677082|NCT03873272|594841814|FG002|Overall Study|Withdrawal by Subject|1|||
164677083|NCT03873272|594841812|FG000|Overall Study|Death|0|||
164677084|NCT03873272|594841813|FG001|Overall Study|Death|2|||
164677085|NCT03873272|594841814|FG002|Overall Study|Death|1|||
164677086|NCT03761173|594841815|FG000|Overall Study|Lost to Follow-up|93|||
164677087|NCT03761173|594841815|FG000|Overall Study|Withdrawal by Subject|74|||
164677088|NCT03761173|594841815|FG000|Overall Study|Death|45|||
164677089|NCT03761173|594841815|FG000|Overall Study|Withdrawal for Other Reasons|29|||
164677090|NCT03761173|594841815|FG000|Overall Study|Protocol Violation|1|||
164677091|NCT00316186|594841817|FG000|Overall Study|Adverse Event|6|||
164423583|NCT01815736|593921524|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
164423584|NCT01815736|593921525|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
164423585|NCT01815736|593921524|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
164423586|NCT01815736|593921525|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
164423587|NCT01815736|593921524|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
164423588|NCT01815736|593921525|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
164423589|NCT01815736|593921524|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
164423590|NCT01815736|593921525|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
164423591|NCT01815736|593921524|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
164423592|NCT01815736|593921525|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
164423593|NCT01815736|593921524|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
164423594|NCT01815736|593921525|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
164423595|NCT01815736|593921524|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
164423596|NCT01815736|593921525|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
164333933|NCT01999114|593599688|FG000|Overall Study|Administrative|0|||
164333934|NCT01999114|593599689|FG001|Overall Study|Administrative|0|||
164333935|NCT01999114|593599690|FG002|Overall Study|Administrative|1|||
164333936|NCT01999114|593599691|FG003|Overall Study|Administrative|1|||
164333937|NCT01999114|593599692|FG004|Overall Study|Administrative|2|||
164333938|NCT03840174|593599693|FG000|Overall Study|Withdrawal by Subject|1|||
164333939|NCT03840174|593599694|FG001|Overall Study|Withdrawal by Subject|0|||
164333940|NCT03840174|593599695|FG002|Overall Study|Withdrawal by Subject|0|||
164333941|NCT03840174|593599696|FG003|Overall Study|Withdrawal by Subject|0|||
164333942|NCT01008150|593599697|FG000|Overall Study|did not receive study drug|1|||
164333943|NCT01008150|593599698|FG001|Overall Study|did not receive study drug|1|||
164333944|NCT01008150|593599699|FG002|Overall Study|did not receive study drug|1|||
164333945|NCT01008150|593599700|FG003|Overall Study|did not receive study drug|0|||
164333946|NCT00178633|593599708|FG000|Overall Study|Lost to Follow-up|6|||
164573036|NCT03619213|594463284|FG001|Overall Study|Lost to Follow-up|1|||
164573037|NCT03619213|594463283|FG000|Overall Study|Withdrawal by Subject|8|||
164573038|NCT03619213|594463284|FG001|Overall Study|Withdrawal by Subject|10|||
164573039|NCT00442598|594463285|FG000|Overall Study|Adverse Event|1|||
164573040|NCT00442598|594463286|FG001|Overall Study|Adverse Event|0|||
164573041|NCT00442598|594463287|FG002|Overall Study|Adverse Event|0|||
164573042|NCT00442598|594463285|FG000|Overall Study|Tumor progression|3|||
164573043|NCT00442598|594463286|FG001|Overall Study|Tumor progression|4|||
164573044|NCT00442598|594463287|FG002|Overall Study|Tumor progression|0|||
164573045|NCT00442598|594463285|FG000|Overall Study|Clinical deterioration|1|||
164573046|NCT00442598|594463286|FG001|Overall Study|Clinical deterioration|2|||
164573047|NCT00442598|594463287|FG002|Overall Study|Clinical deterioration|0|||
164573048|NCT00442598|594463285|FG000|Overall Study|CA125 progression|0|||
164573049|NCT00442598|594463286|FG001|Overall Study|CA125 progression|1|||
164573050|NCT00442598|594463287|FG002|Overall Study|CA125 progression|0|||
164573051|NCT00442598|594463285|FG000|Overall Study|Reduced creatinine clearance|1|||
164573052|NCT00442598|594463286|FG001|Overall Study|Reduced creatinine clearance|0|||
164573053|NCT00442598|594463287|FG002|Overall Study|Reduced creatinine clearance|0|||
164573054|NCT00442598|594463285|FG000|Overall Study|Death|0|||
164573055|NCT00442598|594463286|FG001|Overall Study|Death|1|||
164573056|NCT00442598|594463287|FG002|Overall Study|Death|0|||
164573057|NCT02886702|594463288|FG000|Overall Study|Other|4|||
164573058|NCT02886702|594463289|FG001|Overall Study|Other|3|||
164573059|NCT02886702|594463290|FG002|Overall Study|Other|9|||
164573060|NCT02886702|594463288|FG000|Overall Study|Withdrawal by Subject|24|||
164573061|NCT02886702|594463289|FG001|Overall Study|Withdrawal by Subject|18|||
164573062|NCT02886702|594463290|FG002|Overall Study|Withdrawal by Subject|22|||
164573063|NCT02886702|594463288|FG000|Overall Study|Significant Worsening of Condition|0|||
164573064|NCT02886702|594463289|FG001|Overall Study|Significant Worsening of Condition|1|||
164573065|NCT02886702|594463290|FG002|Overall Study|Significant Worsening of Condition|0|||
164573066|NCT02886702|594463288|FG000|Overall Study|Protocol Violation|2|||
164573067|NCT02886702|594463289|FG001|Overall Study|Protocol Violation|2|||
164573068|NCT02886702|594463290|FG002|Overall Study|Protocol Violation|1|||
164573069|NCT02886702|594463288|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164573070|NCT02886702|594463289|FG001|Overall Study|Non-Compliance With Study Drug|1|||
164573071|NCT02886702|594463290|FG002|Overall Study|Non-Compliance With Study Drug|4|||
164573072|NCT02886702|594463288|FG000|Overall Study|Lost to Follow-up|11|||
164573073|NCT02886702|594463289|FG001|Overall Study|Lost to Follow-up|13|||
164573074|NCT02886702|594463290|FG002|Overall Study|Lost to Follow-up|8|||
164333947|NCT04810481|593599710|FG000|Overall Study|Disqualified data sets|10|||
164333948|NCT04810481|593599711|FG001|Overall Study|Disqualified data sets|28|||
164573075|NCT02886702|594463288|FG000|Overall Study|Lack of Efficacy|3|||
164573076|NCT02886702|594463289|FG001|Overall Study|Lack of Efficacy|4|||
164573077|NCT02886702|594463290|FG002|Overall Study|Lack of Efficacy|5|||
164573078|NCT02886702|594463288|FG000|Overall Study|Adverse Event|4|||
164573079|NCT02886702|594463289|FG001|Overall Study|Adverse Event|9|||
164677092|NCT00316186|594841817|FG000|Overall Study|Disease Progression|4|||
164677093|NCT00316186|594841817|FG000|Overall Study|Lost to Follow-up|1|||
164677094|NCT00316186|594841817|FG000|Overall Study|Other|1|||
164677095|NCT01802320|594841819|FG000|Overall Study|Death|1|||
164235917|NCT01164007|593235543|FG000|Overall Study|Adverse Event|5|||
164235918|NCT01164007|593235543|FG000|Overall Study|Progression of Disease|30|||
164235919|NCT01164007|593235543|FG000|Overall Study|Protocol Violation|1|||
164235920|NCT01164007|593235543|FG000|Overall Study|Withdrawal by Subject|1|||
164235921|NCT01164007|593235543|FG000|Overall Study|Medical Decision|3|||
164235922|NCT03218917|593235545|FG000|Overall Study|Adverse Event|3|||
164235923|NCT03218917|593235546|FG001|Overall Study|Adverse Event|3|||
164235924|NCT03218917|593235547|FG002|Overall Study|Adverse Event|2|||
164235925|NCT03218917|593235545|FG000|Overall Study|Subject withdrew consent|2|||
164235926|NCT03218917|593235546|FG001|Overall Study|Subject withdrew consent|4|||
164235927|NCT03218917|593235547|FG002|Overall Study|Subject withdrew consent|10|||
164235928|NCT03218917|593235545|FG000|Overall Study|Physician Decision|0|||
164333949|NCT00381381|593599719|FG000|Overall Study|Adverse Event|3|||
164333950|NCT00381381|593599719|FG000|Overall Study|Lost to Follow-up|52|||
164333951|NCT00381381|593599719|FG000|Overall Study|Withdrawal by Subject|9|||
164333952|NCT00568685|593599720|FG000|Overall Study|Adverse Event|2|||
164333953|NCT00568685|593599721|FG001|Overall Study|Adverse Event|3|||
164423597|NCT01815736|593921524|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
164423598|NCT01815736|593921525|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
164423599|NCT01815736|593921524|FG000|Extension Treatment Phase- After Week 96|Death|1|||
164423600|NCT01815736|593921525|FG001|Extension Treatment Phase- After Week 96|Death|0|||
164423601|NCT03387514|593921526|FG000|Overall Study|Withdrawal by Subject|2|||
164423602|NCT03387514|593921526|FG000|Overall Study|Physician Decision|1|||
164423603|NCT03387514|593921526|FG000|Overall Study|Lost to Follow-up|2|||
164423604|NCT03040687|593921529|FG000|Overall Study|Withdrawal by Subject|1|||
164423605|NCT03040687|593921530|FG001|Overall Study|Withdrawal by Subject|0|||
164423606|NCT03040687|593921531|FG002|Overall Study|Withdrawal by Subject|0|||
164423607|NCT02846558|593921532|FG000|Overall Study|Adverse Event|1|||
164423608|NCT02846558|593921533|FG001|Overall Study|Adverse Event|0|||
164423609|NCT02846558|593921534|FG002|Overall Study|Adverse Event|0|||
164573080|NCT02886702|594463290|FG002|Overall Study|Adverse Event|3|||
164573081|NCT02886702|594463288|FG000|Overall Study|Administrative Reasons|0|||
164573082|NCT02886702|594463289|FG001|Overall Study|Administrative Reasons|0|||
164573083|NCT02886702|594463290|FG002|Overall Study|Administrative Reasons|1|||
164573084|NCT00501228|594463296|FG000|Overall Study|Withdrawal by Subject|1|||
164333954|NCT00568685|593599722|FG002|Overall Study|Adverse Event|3|||
164333955|NCT00568685|593599720|FG000|Overall Study|Withdrawal by Subject|7|||
164333956|NCT00568685|593599721|FG001|Overall Study|Withdrawal by Subject|2|||
164333957|NCT00568685|593599722|FG002|Overall Study|Withdrawal by Subject|2|||
164333958|NCT00568685|593599720|FG000|Overall Study|Protocol Violation|1|||
164333959|NCT00568685|593599721|FG001|Overall Study|Protocol Violation|0|||
164333960|NCT00568685|593599722|FG002|Overall Study|Protocol Violation|0|||
164333961|NCT02787551|593599723|FG000|Core Period: 26 Weeks|Adverse Event|10|||
164333962|NCT02787551|593599724|FG001|Core Period: 26 Weeks|Adverse Event|0|||
164333963|NCT02787551|593599723|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
164333964|NCT02787551|593599724|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
164333965|NCT02787551|593599723|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
164333966|NCT02787551|593599724|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
164333967|NCT02787551|593599723|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
164333968|NCT02787551|593599724|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
164573085|NCT01756274|594463299|FG000|Overall Study|Protocol Violation|2|||
164573086|NCT01756274|594463299|FG000|Overall Study|Laboratory error|1|||
164573087|NCT01147926|594463300|FG000|Overall Study|Subject Withdrew Consent|9|||
164573088|NCT01147926|594463301|FG001|Overall Study|Subject Withdrew Consent|10|||
164573089|NCT01147926|594463300|FG000|Overall Study|Adverse Event|7|||
164573090|NCT01147926|594463301|FG001|Overall Study|Adverse Event|6|||
164573091|NCT01147926|594463300|FG000|Overall Study|Subject Non-Compliant|5|||
164573092|NCT01147926|594463301|FG001|Overall Study|Subject Non-Compliant|4|||
164573093|NCT01147926|594463300|FG000|Overall Study|Principal investigator left hospital|1|||
164573094|NCT01147926|594463301|FG001|Overall Study|Principal investigator left hospital|3|||
164573095|NCT01147926|594463300|FG000|Overall Study|Selection criteria not met|3|||
164573096|NCT01147926|594463301|FG001|Overall Study|Selection criteria not met|1|||
164573097|NCT01147926|594463300|FG000|Overall Study|Lost to Follow-up|0|||
164573098|NCT01147926|594463301|FG001|Overall Study|Lost to Follow-up|2|||
164573099|NCT01147926|594463300|FG000|Overall Study|Sponsor's Decision|0|||
164573100|NCT01147926|594463301|FG001|Overall Study|Sponsor's Decision|1|||
164677096|NCT01802320|594841819|FG000|Overall Study|Withdrawal by Subject|1|||
164677097|NCT00199901|594842989|FG000|Overall Study|Protocol Violation|2|||
164333969|NCT02787551|593599723|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
164333970|NCT02787551|593599724|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
164423610|NCT02846558|593921535|FG003|Overall Study|Adverse Event|0|||
164423611|NCT02846558|593921532|FG000|Overall Study|Withdrawal by Subject|5|||
164423612|NCT02846558|593921533|FG001|Overall Study|Withdrawal by Subject|4|||
164235929|NCT03218917|593235546|FG001|Overall Study|Physician Decision|1|||
164235930|NCT03218917|593235547|FG002|Overall Study|Physician Decision|1|||
164235931|NCT03218917|593235545|FG000|Overall Study|Lost to Follow-up|1|||
164235932|NCT03218917|593235546|FG001|Overall Study|Lost to Follow-up|0|||
164235933|NCT03218917|593235547|FG002|Overall Study|Lost to Follow-up|0|||
164235934|NCT03218917|593235545|FG000|Overall Study|Reason Missing|0|||
164235935|NCT03218917|593235546|FG001|Overall Study|Reason Missing|2|||
164235936|NCT03218917|593235547|FG002|Overall Study|Reason Missing|0|||
164235937|NCT03218917|593235545|FG000|Overall Study|Death|0|||
164235938|NCT03218917|593235546|FG001|Overall Study|Death|1|||
164235939|NCT03218917|593235547|FG002|Overall Study|Death|0|||
164333971|NCT02787551|593599723|FG000|Core Period: 26 Weeks|Other than specified|3|||
164333972|NCT02787551|593599724|FG001|Core Period: 26 Weeks|Other than specified|1|||
164333973|NCT02787551|593599723|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
164333974|NCT02787551|593599724|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
164333975|NCT02787551|593599723|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
164333976|NCT02787551|593599724|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
164333977|NCT02787551|593599723|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
164333978|NCT02787551|593599724|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
164333979|NCT03799211|593599725|FG000|Overall Study|Lost to Follow-up|2|||
164333980|NCT03799211|593599726|FG001|Overall Study|Lost to Follow-up|13|||
164333981|NCT03799211|593599725|FG000|Overall Study|Withdrawal by Subject|2|||
164333982|NCT03799211|593599726|FG001|Overall Study|Withdrawal by Subject|0|||
164333983|NCT00764491|593599727|FG000|Overall Study|Lost to Follow-up|35|||
164333984|NCT00764491|593599728|FG001|Overall Study|Lost to Follow-up|17|||
164333985|NCT03139279|593599731|FG000|Overall Study|Physician Decision|2|||
164333986|NCT03139279|593599732|FG001|Overall Study|Physician Decision|0|||
164333987|NCT03139279|593599731|FG000|Overall Study|Protocol Violation|5|||
164333988|NCT03139279|593599732|FG001|Overall Study|Protocol Violation|4|||
164333989|NCT03139279|593599731|FG000|Overall Study|Withdrawal by Subject|0|||
164333990|NCT03139279|593599732|FG001|Overall Study|Withdrawal by Subject|2|||
164333991|NCT02027376|593599735|FG000|Overall Study|Death|1|||
164333992|NCT02027376|593599736|FG001|Overall Study|Death|0|||
164333993|NCT02027376|593599737|FG002|Overall Study|Death|0|||
164333994|NCT01565642|593599738|FG000|Overall Study|Withdrawal by Subject|2|||
164333995|NCT01565642|593599739|FG001|Overall Study|Withdrawal by Subject|1|||
164333996|NCT01528033|593599743|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
164333997|NCT01528033|593599744|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
164333998|NCT01528033|593599743|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
164333999|NCT01528033|593599744|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
164334000|NCT01528033|593599743|FG000|Primary Endpoint Assessment ITT|Death|2|||
164334001|NCT01528033|593599744|FG001|Primary Endpoint Assessment ITT|Death|2|||
164334002|NCT01528033|593599743|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
164334003|NCT01528033|593599744|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
164334004|NCT01528033|593599743|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
164334005|NCT01528033|593599744|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
164334006|NCT01528033|593599743|FG000|Follow Up|No data available|46|||
164334007|NCT01528033|593599744|FG001|Follow Up|No data available|44|||
164334008|NCT02452697|593599749|FG000|Overall Study|Physician Decision|4|||
164334009|NCT02452697|593599750|FG001|Overall Study|Physician Decision|4|||
164334010|NCT02452697|593599751|FG002|Overall Study|Physician Decision|3|||
164334011|NCT02452697|593599752|FG003|Overall Study|Physician Decision|2|||
164334012|NCT02452697|593599749|FG000|Overall Study|Withdrawal by Subject|1|||
164334013|NCT02452697|593599750|FG001|Overall Study|Withdrawal by Subject|0|||
164334014|NCT02452697|593599751|FG002|Overall Study|Withdrawal by Subject|0|||
164334015|NCT02452697|593599752|FG003|Overall Study|Withdrawal by Subject|0|||
164334016|NCT02452697|593599749|FG000|Overall Study|still in follow-up|2|||
164334017|NCT02452697|593599750|FG001|Overall Study|still in follow-up|2|||
164334018|NCT02452697|593599751|FG002|Overall Study|still in follow-up|1|||
164334019|NCT02452697|593599752|FG003|Overall Study|still in follow-up|3|||
164334020|NCT01554397|593599753|FG000|Overall Study|Withdrawal by Subject|1|||
164334021|NCT01554397|593599754|FG001|Overall Study|Withdrawal by Subject|0|||
164334022|NCT01554397|593599753|FG000|Overall Study|Ineligible|7|||
164334023|NCT01554397|593599754|FG001|Overall Study|Ineligible|0|||
164334024|NCT04246372|593601438|FG000|Overall Study|Adverse Event|1|||
164334025|NCT04246372|593601438|FG000|Overall Study|Withdrawal by Subject|1|||
164334026|NCT04246372|593601438|FG000|Overall Study|Protocol Violation|2|||
164334027|NCT04246372|593601438|FG000|Overall Study|Physician Decision|1|||
164334028|NCT00257608|593601440|FG000|Chemotherapy Phase|Adverse Event|138|||
164235940|NCT03218917|593235545|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164235941|NCT03218917|593235546|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164235942|NCT03218917|593235547|FG002|Overall Study|Non-Compliance with Study Drug|0|||
164334029|NCT00257608|593601441|FG001|Chemotherapy Phase|Adverse Event|0|||
164334030|NCT00257608|593601442|FG002|Chemotherapy Phase|Adverse Event|0|||
164334031|NCT00257608|593601440|FG000|Chemotherapy Phase|Disease progression|139|||
164235943|NCT02581891|593235550|FG000|Overall Study|Adverse Event|4|||
164573101|NCT01147926|594463300|FG000|Overall Study|Lack of Efficacy|1|||
164573102|NCT01147926|594463301|FG001|Overall Study|Lack of Efficacy|0|||
164573103|NCT01147926|594463300|FG000|Overall Study|Too busy, no time for study|1|||
164423613|NCT02846558|593921534|FG002|Overall Study|Withdrawal by Subject|2|||
164423614|NCT02846558|593921535|FG003|Overall Study|Withdrawal by Subject|2|||
164235944|NCT02581891|593235551|FG001|Overall Study|Adverse Event|6|||
164235945|NCT02581891|593235550|FG000|Overall Study|Death|3|||
164235946|NCT02581891|593235551|FG001|Overall Study|Death|4|||
164235947|NCT02581891|593235550|FG000|Overall Study|Lost to Follow-up|1|||
164235948|NCT02581891|593235551|FG001|Overall Study|Lost to Follow-up|2|||
164235949|NCT02581891|593235550|FG000|Overall Study|Physician Decision|0|||
164235950|NCT02581891|593235551|FG001|Overall Study|Physician Decision|1|||
164235951|NCT02581891|593235550|FG000|Overall Study|Withdrawal by Subject|4|||
164235952|NCT02581891|593235551|FG001|Overall Study|Withdrawal by Subject|5|||
164235953|NCT02581891|593235550|FG000|Overall Study|Other Reasons|3|||
164235954|NCT02581891|593235551|FG001|Overall Study|Other Reasons|1|||
164235955|NCT02581891|593235550|FG000|Overall Study|Discontinued during followup|1|||
164235956|NCT02581891|593235551|FG001|Overall Study|Discontinued during followup|0|||
164235957|NCT01612676|593235552|FG000|Overall Study|Adverse Event|2|||
164235958|NCT01612676|593235553|FG001|Overall Study|Adverse Event|3|||
164235959|NCT01612676|593235554|FG002|Overall Study|Adverse Event|1|||
164235960|NCT01612676|593235555|FG003|Overall Study|Adverse Event|3|||
164235961|NCT01612676|593235552|FG000|Overall Study|Protocol Violation|0|||
164235962|NCT01612676|593235553|FG001|Overall Study|Protocol Violation|1|||
164235963|NCT01612676|593235554|FG002|Overall Study|Protocol Violation|0|||
164235964|NCT01612676|593235555|FG003|Overall Study|Protocol Violation|0|||
164235965|NCT00181844|593235562|FG000|Signed Consent|Withdrawal by Subject|5|||
164235966|NCT00181844|593235562|FG000|Signed Consent|Did not meet entrance criteria|7|||
164235967|NCT00181844|593235562|FG000|Exposed to Study Medication|Adverse Event|10|||
164423615|NCT02846558|593921532|FG000|Overall Study|Lost to Follow-up|2|||
164423616|NCT02846558|593921533|FG001|Overall Study|Lost to Follow-up|0|||
164423617|NCT02846558|593921534|FG002|Overall Study|Lost to Follow-up|0|||
164423618|NCT02846558|593921535|FG003|Overall Study|Lost to Follow-up|0|||
164423619|NCT01556243|593921539|FG000|Overall Study|Ineligible|34|||
164423620|NCT01556243|593921539|FG000|Overall Study|Converted to mastectomy|14|||
164423621|NCT01556243|593921539|FG000|Overall Study|Unable to achieve negative margins|2|||
164423622|NCT01556243|593921539|FG000|Overall Study|Withdrawal by Subject|16|||
164423623|NCT04684914|593921540|FG000|Overall Study|Withdrawal by Subject|1|||
164423624|NCT04684914|593921541|FG001|Overall Study|Withdrawal by Subject|0|||
164423625|NCT04684914|593921540|FG000|Overall Study|Discontinued before receiving study treatment|1|||
164423626|NCT04684914|593921541|FG001|Overall Study|Discontinued before receiving study treatment|2|||
164423627|NCT02353832|593921542|FG000|Overall Study|Ineligible after enrollment|1|||
164423628|NCT02353832|593921542|FG000|Overall Study|Lost to Follow-up|1|||
164423629|NCT01616563|593923142|FG000|Overall Study|Lost to Follow-up|40|||
164423630|NCT00072475|593923143|FG000|Overall Study|Adverse Event|44|||
164423631|NCT00072475|593923143|FG000|Overall Study|Death|3|||
164573104|NCT01147926|594463301|FG001|Overall Study|Too busy, no time for study|0|||
164235968|NCT00181844|593235562|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
164235969|NCT00181844|593235562|FG000|Exposed to Study Medication|Non-compliance|2|||
164235970|NCT00181844|593235562|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
164235971|NCT00181844|593235562|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
164235972|NCT02303262|593235565|FG000|Overall Study|Withdrawal by Subject|2|||
164235973|NCT01959932|593235570|FG000|Overall Study|Withdrawal by Subject|1|||
164235974|NCT01959932|593235571|FG001|Overall Study|Withdrawal by Subject|0|||
164235975|NCT01959932|593235572|FG002|Overall Study|Withdrawal by Subject|0|||
164235976|NCT00060944|593235575|FG000|Overall Study|Adverse Event|12|||
164235977|NCT00060944|593235576|FG001|Overall Study|Adverse Event|10|||
164573105|NCT01147926|594463300|FG000|Overall Study|Went on holiday|0|||
164573106|NCT01147926|594463301|FG001|Overall Study|Went on holiday|1|||
164235978|NCT00060944|593235575|FG000|Overall Study|Death|2|||
164235979|NCT00060944|593235576|FG001|Overall Study|Death|3|||
164235980|NCT00060944|593235575|FG000|Overall Study|Withdrawal by Subject|18|||
164235981|NCT00060944|593235576|FG001|Overall Study|Withdrawal by Subject|5|||
164235982|NCT00060944|593235575|FG000|Overall Study|Disease Progression|93|||
164235983|NCT00060944|593235576|FG001|Overall Study|Disease Progression|94|||
164235984|NCT00060944|593235575|FG000|Overall Study|Lost to Follow-up|1|||
164235985|NCT00060944|593235576|FG001|Overall Study|Lost to Follow-up|0|||
164235986|NCT00060944|593235575|FG000|Overall Study|Subject Ineligible To Continue|2|||
164235987|NCT00060944|593235576|FG001|Overall Study|Subject Ineligible To Continue|1|||
164235988|NCT00060944|593235575|FG000|Overall Study|Treatment Switch|0|||
164423632|NCT00072475|593923143|FG000|Overall Study|Withdrawal by Subject|46|||
164423633|NCT00072475|593923143|FG000|Overall Study|Patient/Investigator Decision|4|||
164423634|NCT03303105|593923146|FG000|Overall Study|Adverse Event|0|||
164423635|NCT03303105|593923147|FG001|Overall Study|Adverse Event|2|||
164423636|NCT03303105|593923146|FG000|Overall Study|Lack of Efficacy|1|||
164423637|NCT03303105|593923147|FG001|Overall Study|Lack of Efficacy|0|||
164423638|NCT03303105|593923146|FG000|Overall Study|Protocol Violation|1|||
164573107|NCT01147926|594463300|FG000|Overall Study|Colonoscopy result|0|||
164334032|NCT00257608|593601441|FG001|Chemotherapy Phase|Disease progression|0|||
164334033|NCT00257608|593601442|FG002|Chemotherapy Phase|Disease progression|0|||
164334034|NCT00257608|593601440|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
164334035|NCT00257608|593601441|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
164334036|NCT00257608|593601442|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
164334037|NCT00257608|593601440|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
164334038|NCT00257608|593601441|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
164334039|NCT00257608|593601442|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
164334040|NCT00257608|593601440|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
164334041|NCT00257608|593601441|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
164334042|NCT00257608|593601442|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
164334043|NCT00257608|593601440|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
164334044|NCT00257608|593601441|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
164334045|NCT00257608|593601442|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
164334046|NCT00257608|593601440|FG000|Chemotherapy Phase|Physician Decision|28|||
164334047|NCT00257608|593601441|FG001|Chemotherapy Phase|Physician Decision|0|||
164334048|NCT00257608|593601442|FG002|Chemotherapy Phase|Physician Decision|0|||
164334049|NCT00257608|593601440|FG000|Post Chemotherapy Phase|Adverse Event|0|||
164334050|NCT00257608|593601441|FG001|Post Chemotherapy Phase|Adverse Event|34|||
164334051|NCT00257608|593601442|FG002|Post Chemotherapy Phase|Adverse Event|38|||
164334052|NCT00257608|593601440|FG000|Post Chemotherapy Phase|Disease progression|0|||
164334053|NCT00257608|593601441|FG001|Post Chemotherapy Phase|Disease progression|204|||
164334054|NCT00257608|593601442|FG002|Post Chemotherapy Phase|Disease progression|168|||
164334055|NCT00257608|593601440|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
164334056|NCT00257608|593601441|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
164334057|NCT00257608|593601442|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
164334058|NCT00257608|593601440|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
164334059|NCT00257608|593601441|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
164334060|NCT00257608|593601442|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
164334061|NCT00257608|593601440|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
164334062|NCT00257608|593601441|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
164334063|NCT00257608|593601442|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
164334064|NCT00257608|593601440|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
164334065|NCT00257608|593601441|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
164334066|NCT00257608|593601442|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
164334067|NCT00257608|593601440|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
164334068|NCT00257608|593601441|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
164334069|NCT00257608|593601442|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
164334070|NCT00257608|593601440|FG000|Post Chemotherapy Phase|Physician Decision|0|||
164334071|NCT00257608|593601441|FG001|Post Chemotherapy Phase|Physician Decision|8|||
164334072|NCT00257608|593601442|FG002|Post Chemotherapy Phase|Physician Decision|11|||
164334073|NCT00257608|593601440|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
164334074|NCT00257608|593601441|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
164334075|NCT00257608|593601442|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
164334076|NCT00257608|593601440|FG000|Post Chemotherapy Phase|Not treated|0|||
164334077|NCT00257608|593601441|FG001|Post Chemotherapy Phase|Not treated|4|||
164334078|NCT00257608|593601442|FG002|Post Chemotherapy Phase|Not treated|7|||
164334079|NCT03673046|593601443|FG000|Overall Study|Adverse Event|1|||
164334080|NCT03673046|593601444|FG001|Overall Study|Adverse Event|1|||
164334081|NCT03673046|593601443|FG000|Overall Study|Withdrawal by Subject|8|||
164334082|NCT03673046|593601444|FG001|Overall Study|Withdrawal by Subject|2|||
164334083|NCT03817879|593601445|FG000|Overall Study|Drop out|5|||
164334084|NCT03817879|593601446|FG001|Overall Study|Drop out|12|||
164334085|NCT03817879|593601445|FG000|Overall Study|Withdrawal by Subject|0|||
164334086|NCT03817879|593601446|FG001|Overall Study|Withdrawal by Subject|1|||
164334087|NCT01896050|593601447|FG000|Overall Study|Adverse Event|37|||
164334088|NCT01896050|593601448|FG001|Overall Study|Adverse Event|2|||
164334089|NCT01896050|593601447|FG000|Overall Study|Death|1|||
164334090|NCT01896050|593601448|FG001|Overall Study|Death|0|||
164334091|NCT00392015|593601450|FG000|Overall Study|Lost to Follow-up|2|||
164334092|NCT00392015|593601451|FG001|Overall Study|Lost to Follow-up|0|||
164334093|NCT00392015|593601452|FG002|Overall Study|Lost to Follow-up|2|||
164334094|NCT00392015|593601453|FG003|Overall Study|Lost to Follow-up|1|||
164334095|NCT00392015|593601454|FG004|Overall Study|Lost to Follow-up|1|||
164334096|NCT00392015|593601455|FG005|Overall Study|Lost to Follow-up|0|||
164334097|NCT00392015|593601450|FG000|Overall Study|Withdrawal by Subject|0|||
164334098|NCT00392015|593601451|FG001|Overall Study|Withdrawal by Subject|0|||
164334099|NCT00392015|593601452|FG002|Overall Study|Withdrawal by Subject|2|||
164334100|NCT00392015|593601453|FG003|Overall Study|Withdrawal by Subject|0|||
164334101|NCT00392015|593601454|FG004|Overall Study|Withdrawal by Subject|0|||
164677098|NCT00199901|594842990|FG001|Overall Study|Protocol Violation|0|||
164677099|NCT00199901|594842989|FG000|Overall Study|Withdrawal by Subject|1|||
164235989|NCT00060944|593235576|FG001|Overall Study|Treatment Switch|13|||
164235990|NCT00060944|593235575|FG000|Overall Study|Other|2|||
164235991|NCT00060944|593235576|FG001|Overall Study|Other|4|||
164235992|NCT00060944|593235575|FG000|Overall Study|randomized but not treated|6|||
164423639|NCT03303105|593923147|FG001|Overall Study|Protocol Violation|0|||
164423640|NCT03303105|593923146|FG000|Overall Study|Withdrawal by Subject|0|||
164423641|NCT03303105|593923147|FG001|Overall Study|Withdrawal by Subject|2|||
164423642|NCT01033643|593923151|FG000|Overall Study|Withdrew Consent|0|||
164423643|NCT01033643|593923152|FG001|Overall Study|Withdrew Consent|3|||
164423644|NCT01033643|593923153|FG002|Overall Study|Withdrew Consent|0|||
164423645|NCT01033643|593923154|FG003|Overall Study|Withdrew Consent|0|||
164423646|NCT01033643|593923155|FG004|Overall Study|Withdrew Consent|0|||
164423647|NCT01033643|593923156|FG005|Overall Study|Withdrew Consent|1|||
164423648|NCT00839917|593923158|FG000|Overall Study|Lost to Follow-up|1|||
164423649|NCT00839917|593923159|FG001|Overall Study|Lost to Follow-up|0|||
164423650|NCT00839917|593923158|FG000|Overall Study|Did not receive vaccine|0|||
164423651|NCT00839917|593923159|FG001|Overall Study|Did not receive vaccine|1|||
164423652|NCT02297503|593923160|FG000|Overall Study|Withdrawal by Subject|1|||
164423653|NCT02297503|593923161|FG001|Overall Study|Withdrawal by Subject|1|||
164423654|NCT02297503|593923160|FG000|Overall Study|Protocol Violation|1|||
164423655|NCT02297503|593923161|FG001|Overall Study|Protocol Violation|0|||
164423656|NCT02297503|593923160|FG000|Overall Study|Pregnancy|0|||
164423657|NCT02297503|593923161|FG001|Overall Study|Pregnancy|1|||
164423658|NCT02297503|593923160|FG000|Overall Study|Lost to Follow-up|0|||
164423659|NCT02297503|593923161|FG001|Overall Study|Lost to Follow-up|1|||
164423660|NCT02297503|593923160|FG000|Overall Study|Medical reason|0|||
164423661|NCT02297503|593923161|FG001|Overall Study|Medical reason|1|||
164423662|NCT00550732|593923162|FG000|Overall Study|Death|4|||
164423663|NCT00550732|593923162|FG000|Overall Study|Withdrawal by Subject|2|||
164423664|NCT00550732|593923162|FG000|Overall Study|Physician Decision|2|||
164423665|NCT00550732|593923162|FG000|Overall Study|Lost to Follow-up|1|||
164423666|NCT00550732|593923162|FG000|Overall Study|Palliative care|1|||
164423667|NCT00550732|593923162|FG000|Overall Study|Adverse Event|1|||
164423668|NCT02724020|593923174|FG000|Overall Study|Death|16|||
164423669|NCT02724020|593923175|FG001|Overall Study|Death|18|||
164423670|NCT02724020|593923176|FG002|Overall Study|Death|19|||
164423671|NCT02724020|593923174|FG000|Overall Study|Lost to Follow-up|0|||
164423672|NCT02724020|593923175|FG001|Overall Study|Lost to Follow-up|3|||
164423673|NCT02724020|593923176|FG002|Overall Study|Lost to Follow-up|0|||
164423674|NCT02724020|593923174|FG000|Overall Study|Site Terminated by Sponsor|15|||
164423675|NCT02724020|593923175|FG001|Overall Study|Site Terminated by Sponsor|8|||
164423676|NCT02724020|593923176|FG002|Overall Study|Site Terminated by Sponsor|8|||
164423677|NCT02724020|593923174|FG000|Overall Study|Withdrawal by Subject|1|||
164423678|NCT02724020|593923175|FG001|Overall Study|Withdrawal by Subject|3|||
164423679|NCT02724020|593923176|FG002|Overall Study|Withdrawal by Subject|5|||
164423680|NCT02179918|593923177|FG000|Overall Study|Death|0|||
164423681|NCT02179918|593923178|FG001|Overall Study|Death|0|||
164423682|NCT02179918|593923179|FG002|Overall Study|Death|0|||
164423683|NCT02179918|593923180|FG003|Overall Study|Death|1|||
164423684|NCT02179918|593923181|FG004|Overall Study|Death|0|||
164423685|NCT02179918|593923177|FG000|Overall Study|Lost to Follow-up|0|||
164573108|NCT01147926|594463301|FG001|Overall Study|Colonoscopy result|1|||
164573109|NCT01085682|594463302|FG000|Overall Study|Withdrawal by Subject|25|||
164235993|NCT00060944|593235576|FG001|Overall Study|randomized but not treated|4|||
164235994|NCT00776230|593235580|FG000|Overall Study|Lost to Follow-up|2|||
164235995|NCT00776230|593235581|FG001|Overall Study|Lost to Follow-up|1|||
164235996|NCT00776230|593235582|FG002|Overall Study|Lost to Follow-up|5|||
164235997|NCT00776230|593235580|FG000|Overall Study|Not vaccinated at Day 0|1|||
164235998|NCT00776230|593235581|FG001|Overall Study|Not vaccinated at Day 0|0|||
164235999|NCT00776230|593235582|FG002|Overall Study|Not vaccinated at Day 0|0|||
164236000|NCT00776230|593235580|FG000|Overall Study|Withdrawal by Subject|0|||
164236001|NCT00776230|593235581|FG001|Overall Study|Withdrawal by Subject|1|||
164236002|NCT00776230|593235582|FG002|Overall Study|Withdrawal by Subject|0|||
164236003|NCT00776230|593235580|FG000|Overall Study|Subject missed Visit 4|0|||
164236004|NCT00776230|593235581|FG001|Overall Study|Subject missed Visit 4|1|||
164236005|NCT00776230|593235582|FG002|Overall Study|Subject missed Visit 4|0|||
164236006|NCT01215851|593235583|FG000|Treatment Period|Adverse Event|1|||
164423686|NCT02179918|593923178|FG001|Overall Study|Lost to Follow-up|0|||
164423687|NCT02179918|593923179|FG002|Overall Study|Lost to Follow-up|1|||
164423688|NCT02179918|593923180|FG003|Overall Study|Lost to Follow-up|0|||
164423689|NCT02179918|593923181|FG004|Overall Study|Lost to Follow-up|0|||
164423690|NCT02179918|593923177|FG000|Overall Study|Progressive Disease|4|||
164423691|NCT02179918|593923178|FG001|Overall Study|Progressive Disease|1|||
164423692|NCT02179918|593923179|FG002|Overall Study|Progressive Disease|1|||
164423693|NCT02179918|593923180|FG003|Overall Study|Progressive Disease|2|||
164423694|NCT02179918|593923181|FG004|Overall Study|Progressive Disease|6|||
164423695|NCT02179918|593923177|FG000|Overall Study|Other|0|||
164423696|NCT02179918|593923178|FG001|Overall Study|Other|1|||
164423697|NCT02179918|593923179|FG002|Overall Study|Other|0|||
164423698|NCT02179918|593923180|FG003|Overall Study|Other|0|||
164334102|NCT00392015|593601455|FG005|Overall Study|Withdrawal by Subject|0|||
164334103|NCT00392015|593601450|FG000|Overall Study|Adverse Event|0|||
164334104|NCT00392015|593601451|FG001|Overall Study|Adverse Event|0|||
164334105|NCT00392015|593601452|FG002|Overall Study|Adverse Event|0|||
164334106|NCT00392015|593601453|FG003|Overall Study|Adverse Event|0|||
164334107|NCT00392015|593601454|FG004|Overall Study|Adverse Event|1|||
164334108|NCT00392015|593601455|FG005|Overall Study|Adverse Event|0|||
164334109|NCT00392015|593601450|FG000|Overall Study|Previous trial recipient|0|||
164334110|NCT00392015|593601451|FG001|Overall Study|Previous trial recipient|0|||
164334111|NCT00392015|593601452|FG002|Overall Study|Previous trial recipient|0|||
164334112|NCT00392015|593601453|FG003|Overall Study|Previous trial recipient|0|||
164334113|NCT00392015|593601454|FG004|Overall Study|Previous trial recipient|1|||
164334114|NCT00392015|593601455|FG005|Overall Study|Previous trial recipient|0|||
164334115|NCT03693300|593601456|FG000|Overall Study|Withdrawal by Subject|6|||
164334116|NCT03693300|593601457|FG001|Overall Study|Withdrawal by Subject|0|||
164334117|NCT03693300|593601456|FG000|Overall Study|Death|50|||
164334118|NCT03693300|593601457|FG001|Overall Study|Death|2|||
164334119|NCT03693300|593601456|FG000|Overall Study|Lost to Follow-up|2|||
164334120|NCT03693300|593601457|FG001|Overall Study|Lost to Follow-up|0|||
164334121|NCT02742441|593601458|FG000|Overall Study|Lost to Follow-up|4|||
164334122|NCT02742441|593601459|FG001|Overall Study|Lost to Follow-up|4|||
164677100|NCT00199901|594842990|FG001|Overall Study|Withdrawal by Subject|0|||
164423699|NCT02179918|593923181|FG004|Overall Study|Other|1|||
164423700|NCT02179918|593923177|FG000|Overall Study|Subject refused further follow-up|0|||
164423701|NCT02179918|593923178|FG001|Overall Study|Subject refused further follow-up|1|||
164423702|NCT02179918|593923179|FG002|Overall Study|Subject refused further follow-up|0|||
164423703|NCT02179918|593923180|FG003|Overall Study|Subject refused further follow-up|0|||
164423704|NCT02179918|593923181|FG004|Overall Study|Subject refused further follow-up|1|||
164423705|NCT02954575|593923183|FG000|Overall Study|Withdrawal by Subject|2|||
164423706|NCT02954575|593923183|FG000|Overall Study|Adverse Event|1|||
164423707|NCT00570661|593923186|FG000|Overall Study|Disease worsening|5|||
164423708|NCT00570661|593923186|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
164423709|NCT00570661|593923186|FG000|Overall Study|Adverse Event|1|||
164423710|NCT01734382|593923190|FG000|Part 1|Adverse Event|2|||
164423711|NCT01734382|593923191|FG001|Part 1|Adverse Event|0|||
164423712|NCT01734382|593923192|FG002|Part 1|Adverse Event|0|||
164423713|NCT01734382|593923190|FG000|Part 2|Adverse Event|0|||
164423714|NCT01734382|593923191|FG001|Part 2|Adverse Event|0|||
164423715|NCT01734382|593923192|FG002|Part 2|Adverse Event|1|||
164423716|NCT01734382|593923190|FG000|Part 2|Lack of Efficacy|0|||
164423717|NCT01734382|593923191|FG001|Part 2|Lack of Efficacy|1|||
164423718|NCT01734382|593923192|FG002|Part 2|Lack of Efficacy|1|||
164423719|NCT01734382|593923190|FG000|Part 2|Other|0|||
164423720|NCT01734382|593923191|FG001|Part 2|Other|0|||
164423721|NCT01734382|593923192|FG002|Part 2|Other|1|||
164423722|NCT01734382|593923190|FG000|Part 2|Physician Decision|0|||
164423723|NCT01734382|593923191|FG001|Part 2|Physician Decision|0|||
164423724|NCT01734382|593923192|FG002|Part 2|Physician Decision|3|||
164423725|NCT01734382|593923190|FG000|Part 2|Protocol Violation|0|||
164423726|NCT01734382|593923191|FG001|Part 2|Protocol Violation|1|||
164423727|NCT01734382|593923192|FG002|Part 2|Protocol Violation|0|||
164423728|NCT01734382|593923190|FG000|Part 2|Withdrawal by Subject|0|||
164423729|NCT01734382|593923191|FG001|Part 2|Withdrawal by Subject|0|||
164423730|NCT01734382|593923192|FG002|Part 2|Withdrawal by Subject|1|||
164334123|NCT02742441|593601458|FG000|Overall Study|Withdrawal by Subject|2|||
164334124|NCT02742441|593601459|FG001|Overall Study|Withdrawal by Subject|2|||
164334125|NCT02742441|593601458|FG000|Overall Study|Adverse Event|0|||
164334126|NCT02742441|593601459|FG001|Overall Study|Adverse Event|2|||
164423731|NCT04537949|593923193|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
164677101|NCT00199901|594842989|FG000|Overall Study|Progressive Disease|24|||
164677102|NCT00199901|594842990|FG001|Overall Study|Progressive Disease|24|||
164677103|NCT05265624|594842997|FG000|Overall Study|Lost to Follow-up|3|||
164677104|NCT05265624|594842998|FG001|Overall Study|Lost to Follow-up|0|||
164677105|NCT05265624|594842997|FG000|Overall Study|Withdrawal by Subject|1|||
164677106|NCT05265624|594842998|FG001|Overall Study|Withdrawal by Subject|0|||
164677107|NCT06137781|594843001|FG000|Baseline measurements|Lost to Follow-up|2|||
164677108|NCT06137781|594843001|FG000|Baseline measurements|Withdrawal by Subject|1|||
164677109|NCT06137781|594843001|FG000|Baseline measurements|Expedited surgery|1|||
164677110|NCT06137781|594843001|FG000|Intervention period|Lost to Follow-up|2|||
164677111|NCT06137781|594843001|FG000|Intervention period|Withdrawal by Subject|3|||
164677112|NCT06137781|594843001|FG000|Intervention period|Expedited surgery|1|||
164677113|NCT06137781|594843001|FG000|Intervention period|Adverse Event|1|||
164677114|NCT03165994|594843007|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
164677115|NCT03165994|594843007|FG000|Overall Study|Death|2|||
164694667|NCT03250299|594905310|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
164423732|NCT04537949|593923194|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
164423733|NCT04537949|593923195|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
164423734|NCT04537949|593923196|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
164423735|NCT04537949|593923197|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
164573110|NCT01085682|594463303|FG001|Overall Study|Withdrawal by Subject|25|||
164236007|NCT01215851|593235584|FG001|Treatment Period|Adverse Event|1|||
164236008|NCT01215851|593235585|FG002|Treatment Period|Adverse Event|1|||
164236009|NCT01215851|593235586|FG003|Treatment Period|Adverse Event|3|||
164236010|NCT01215851|593235587|FG004|Treatment Period|Adverse Event|0|||
164236011|NCT01215851|593235588|FG005|Treatment Period|Adverse Event|1|||
164236012|NCT01215851|593235583|FG000|Follow up Period|Lost to Follow-up|0|||
164236013|NCT01215851|593235584|FG001|Follow up Period|Lost to Follow-up|0|||
164236014|NCT01215851|593235585|FG002|Follow up Period|Lost to Follow-up|0|||
164236015|NCT01215851|593235586|FG003|Follow up Period|Lost to Follow-up|0|||
164236016|NCT01215851|593235587|FG004|Follow up Period|Lost to Follow-up|0|||
164573111|NCT03926143|594463307|FG000|Overall Study|Physician Decision|3|||
164573112|NCT03926143|594463307|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
164236017|NCT01215851|593235588|FG005|Follow up Period|Lost to Follow-up|1|||
164236018|NCT03961308|593235589|FG000|Overall Study|Withdrawal by Subject|1|||
164236019|NCT03961308|593235590|FG001|Overall Study|Withdrawal by Subject|0|||
164236020|NCT03961308|593235589|FG000|Overall Study|Other|1|||
164236021|NCT03961308|593235590|FG001|Overall Study|Other|0|||
164236022|NCT03961308|593235589|FG000|Overall Study|Lost to Follow-up|0|||
164236023|NCT03961308|593235590|FG001|Overall Study|Lost to Follow-up|1|||
164236024|NCT03961308|593235589|FG000|Overall Study|Adverse Event|0|||
164236025|NCT03961308|593235590|FG001|Overall Study|Adverse Event|1|||
164236026|NCT02297412|593235596|FG000|Overall Study|Canceled|1|||
164236027|NCT02297412|593235597|FG001|Overall Study|Canceled|1|||
164236028|NCT04549454|593235598|FG000|T1 to T2|Lost to Follow-up|22|||
164236029|NCT04549454|593235599|FG001|T1 to T2|Lost to Follow-up|26|||
164236030|NCT04549454|593235598|FG000|T1 to T3|Lost to Follow-up|31|||
164236031|NCT04549454|593235599|FG001|T1 to T3|Lost to Follow-up|36|||
164236032|NCT00545779|593235610|FG000|Overall Study|Violation of selection criteria at entry|8|||
164236033|NCT00545779|593235610|FG000|Overall Study|Other protocol violation|1|||
164236034|NCT00545779|593235610|FG000|Overall Study|Did not cooperate|7|||
164236035|NCT00545779|593235610|FG000|Overall Study|Withdrawal by Subject|20|||
164236036|NCT00545779|593235610|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
164236037|NCT00545779|593235610|FG000|Overall Study|Failure to return|3|||
164236038|NCT01405196|593235611|FG000|Overall Study|Study Terminated by Sponsor|0|||
164236039|NCT01405196|593235612|FG001|Overall Study|Study Terminated by Sponsor|0|||
164236040|NCT01405196|593235613|FG002|Overall Study|Study Terminated by Sponsor|9|||
164236041|NCT01405196|593235614|FG003|Overall Study|Study Terminated by Sponsor|0|||
164236042|NCT01405196|593235611|FG000|Overall Study|Other|2|||
164236043|NCT01405196|593235612|FG001|Overall Study|Other|2|||
164236044|NCT01405196|593235613|FG002|Overall Study|Other|5|||
164236045|NCT01405196|593235614|FG003|Overall Study|Other|0|||
164236046|NCT01405196|593235611|FG000|Overall Study|Withdrawal by Subject|4|||
164236047|NCT01405196|593235612|FG001|Overall Study|Withdrawal by Subject|6|||
164236048|NCT01405196|593235613|FG002|Overall Study|Withdrawal by Subject|3|||
164236049|NCT01405196|593235614|FG003|Overall Study|Withdrawal by Subject|6|||
164236050|NCT01405196|593235611|FG000|Overall Study|Adverse Event|2|||
164236051|NCT01405196|593235612|FG001|Overall Study|Adverse Event|2|||
164236052|NCT01405196|593235613|FG002|Overall Study|Adverse Event|0|||
164236053|NCT01405196|593235614|FG003|Overall Study|Adverse Event|2|||
164236054|NCT01405196|593235611|FG000|Overall Study|Death|1|||
164236055|NCT01405196|593235612|FG001|Overall Study|Death|0|||
164236056|NCT01405196|593235613|FG002|Overall Study|Death|3|||
164236057|NCT01405196|593235614|FG003|Overall Study|Death|0|||
164236058|NCT01405196|593235611|FG000|Overall Study|Lost to Follow-up|2|||
164236059|NCT01405196|593235612|FG001|Overall Study|Lost to Follow-up|2|||
164236060|NCT01405196|593235613|FG002|Overall Study|Lost to Follow-up|3|||
164236061|NCT01405196|593235614|FG003|Overall Study|Lost to Follow-up|1|||
164236062|NCT01542788|593235615|FG000|Overall Study|Randomized but Not Treated|2|||
164236063|NCT01542788|593235616|FG001|Overall Study|Randomized but Not Treated|0|||
164236064|NCT01542788|593235615|FG000|Overall Study|Lack of Efficacy|41|||
164236065|NCT01542788|593235616|FG001|Overall Study|Lack of Efficacy|71|||
164236066|NCT01542788|593235615|FG000|Overall Study|Lost to Follow-up|5|||
164236067|NCT01542788|593235616|FG001|Overall Study|Lost to Follow-up|0|||
164236068|NCT01542788|593235615|FG000|Overall Study|Death|3|||
164236069|NCT01542788|593235616|FG001|Overall Study|Death|0|||
164236070|NCT01542788|593235615|FG000|Overall Study|Protocol Violation|2|||
164236071|NCT01542788|593235616|FG001|Overall Study|Protocol Violation|0|||
164236072|NCT01542788|593235615|FG000|Overall Study|Physician Decision|1|||
164236073|NCT01542788|593235616|FG001|Overall Study|Physician Decision|0|||
164236074|NCT01542788|593235615|FG000|Overall Study|Withdrawal by Subject|1|||
164236075|NCT01542788|593235616|FG001|Overall Study|Withdrawal by Subject|0|||
164236076|NCT01400412|593235617|FG000|Overall Study|Lost to Follow-up|4|||
164236077|NCT01400412|593235618|FG001|Overall Study|Lost to Follow-up|7|||
164236078|NCT01400412|593235617|FG000|Overall Study|Withdrawal by Subject|3|||
164236079|NCT01400412|593235618|FG001|Overall Study|Withdrawal by Subject|4|||
164236080|NCT01400412|593235617|FG000|Overall Study|Unable to complete|3|||
164236081|NCT01400412|593235618|FG001|Overall Study|Unable to complete|3|||
164236082|NCT01400412|593235617|FG000|Overall Study|Never started study treatment|0|||
164423736|NCT04537949|593923198|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
164423737|NCT04537949|593923199|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
164423738|NCT04537949|593923200|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
164423739|NCT04537949|593923193|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
164423740|NCT04537949|593923194|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
164423741|NCT04537949|593923195|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
164423742|NCT04537949|593923196|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
164423743|NCT04537949|593923197|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
164423744|NCT04537949|593923198|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
164423745|NCT04537949|593923199|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
164423746|NCT04537949|593923200|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
164423747|NCT04537949|593923193|FG000|Follow-up Phase|Lost to Follow-up|0|||
164423748|NCT04537949|593923194|FG001|Follow-up Phase|Lost to Follow-up|3|||
164423749|NCT04537949|593923195|FG002|Follow-up Phase|Lost to Follow-up|0|||
164423750|NCT04537949|593923196|FG003|Follow-up Phase|Lost to Follow-up|0|||
164423751|NCT04537949|593923197|FG004|Follow-up Phase|Lost to Follow-up|0|||
164423752|NCT04537949|593923198|FG005|Follow-up Phase|Lost to Follow-up|0|||
164236083|NCT01400412|593235618|FG001|Overall Study|Never started study treatment|3|||
164423753|NCT04537949|593923199|FG006|Follow-up Phase|Lost to Follow-up|0|||
164423754|NCT04537949|593923200|FG007|Follow-up Phase|Lost to Follow-up|0|||
164236084|NCT01649869|593235619|FG000|Overall Study|Family member illness|1|||
164236085|NCT01649869|593235620|FG001|Overall Study|Family member illness|0|||
164236086|NCT01649869|593235619|FG000|Overall Study|Required treatment outside protocol|1|||
164236087|NCT01649869|593235620|FG001|Overall Study|Required treatment outside protocol|0|||
164236088|NCT01649869|593235619|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
164236089|NCT01649869|593235620|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
164236090|NCT00069641|593236774|FG000|Overall Study|Death|1|||
164236091|NCT00069641|593236775|FG001|Overall Study|Death|0|||
164236092|NCT00069641|593236776|FG002|Overall Study|Death|1|||
164236093|NCT04778592|593236777|FG000|Overall Study|Adverse Event|1|||
164236094|NCT04778592|593236778|FG001|Overall Study|Adverse Event|2|||
164236095|NCT04778592|593236777|FG000|Overall Study|Withdrawal by Subject|1|||
164236096|NCT04778592|593236778|FG001|Overall Study|Withdrawal by Subject|2|||
164236097|NCT01354223|593236780|FG000|Overall Study|Withdrawal by Subject|3|||
164236098|NCT01354223|593236781|FG001|Overall Study|Withdrawal by Subject|1|||
164236099|NCT01126190|593236785|FG000|Double-Blind Phase|Death|0|||
164236100|NCT01126190|593236786|FG001|Double-Blind Phase|Death|1|||
164236101|NCT01126190|593236787|FG002|Double-Blind Phase|Death|0|||
164236102|NCT01126190|593236785|FG000|Double-Blind Phase|Adverse Event|1|||
164236103|NCT01126190|593236786|FG001|Double-Blind Phase|Adverse Event|2|||
164236104|NCT01126190|593236787|FG002|Double-Blind Phase|Adverse Event|0|||
164236105|NCT01126190|593236785|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
164236106|NCT01126190|593236786|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
164236107|NCT01126190|593236787|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
164236108|NCT01126190|593236785|FG000|Double-Blind Phase|Request of Investigator|1|||
164236109|NCT01126190|593236786|FG001|Double-Blind Phase|Request of Investigator|0|||
164236110|NCT01126190|593236787|FG002|Double-Blind Phase|Request of Investigator|0|||
164236111|NCT01126190|593236785|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
164236112|NCT01126190|593236786|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
164236113|NCT01126190|593236787|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
164236114|NCT01126190|593236785|FG000|Double-Blind Phase|Non-compliance|1|||
164236115|NCT01126190|593236786|FG001|Double-Blind Phase|Non-compliance|0|||
164236116|NCT01126190|593236787|FG002|Double-Blind Phase|Non-compliance|0|||
164236117|NCT01126190|593236785|FG000|Double-Blind Phase|Lost to Follow-up|1|||
164236118|NCT01126190|593236786|FG001|Double-Blind Phase|Lost to Follow-up|3|||
164236119|NCT01126190|593236787|FG002|Double-Blind Phase|Lost to Follow-up|0|||
164236120|NCT01126190|593236785|FG000|Open-Label Phase|Death|0|||
164236121|NCT01126190|593236786|FG001|Open-Label Phase|Death|0|||
164236122|NCT01126190|593236787|FG002|Open-Label Phase|Death|1|||
164236123|NCT01126190|593236785|FG000|Open-Label Phase|Adverse Event|0|||
164236124|NCT01126190|593236786|FG001|Open-Label Phase|Adverse Event|0|||
164236125|NCT01126190|593236787|FG002|Open-Label Phase|Adverse Event|4|||
164236126|NCT01126190|593236785|FG000|Open-Label Phase|Withdrawal by Subject|0|||
164236127|NCT01126190|593236786|FG001|Open-Label Phase|Withdrawal by Subject|0|||
164236128|NCT01126190|593236787|FG002|Open-Label Phase|Withdrawal by Subject|6|||
164236129|NCT01135992|593236788|FG000|Overall Study|Adverse Event|1|||
164236130|NCT01135992|593236788|FG000|Overall Study|Lack of Efficacy|1|||
164236131|NCT01135992|593236788|FG000|Overall Study|Protocol Violation|2|||
164236132|NCT01135992|593236788|FG000|Overall Study|Withdrawal criteria|10|||
164423755|NCT04537949|593923193|FG000|Follow-up Phase|personal reasons|0|||
164423756|NCT04537949|593923194|FG001|Follow-up Phase|personal reasons|0|||
164423757|NCT04537949|593923195|FG002|Follow-up Phase|personal reasons|0|||
164236133|NCT01135992|593236788|FG000|Overall Study|Unclassified|7|||
164236134|NCT01977898|593236789|FG000|Overall Study|Non functioning catheter|1|||
164236135|NCT01977898|593236790|FG001|Overall Study|Non functioning catheter|1|||
164423758|NCT04537949|593923196|FG003|Follow-up Phase|personal reasons|1|||
164423759|NCT04537949|593923197|FG004|Follow-up Phase|personal reasons|1|||
164423760|NCT04537949|593923198|FG005|Follow-up Phase|personal reasons|0|||
164423761|NCT04537949|593923199|FG006|Follow-up Phase|personal reasons|0|||
164423762|NCT04537949|593923200|FG007|Follow-up Phase|personal reasons|0|||
164423763|NCT04537949|593923193|FG000|Follow-up Phase|Withdrawal by Subject|0|||
164423764|NCT04537949|593923194|FG001|Follow-up Phase|Withdrawal by Subject|0|||
164423765|NCT04537949|593923195|FG002|Follow-up Phase|Withdrawal by Subject|0|||
164423766|NCT04537949|593923196|FG003|Follow-up Phase|Withdrawal by Subject|0|||
164423767|NCT04537949|593923197|FG004|Follow-up Phase|Withdrawal by Subject|1|||
164423768|NCT04537949|593923198|FG005|Follow-up Phase|Withdrawal by Subject|0|||
164423769|NCT04537949|593923199|FG006|Follow-up Phase|Withdrawal by Subject|0|||
164423770|NCT04537949|593923200|FG007|Follow-up Phase|Withdrawal by Subject|0|||
164423771|NCT05893797|593923203|FG000|Study Period 1 (Weeks 1 to 6)|Adverse Event|1|||
164423772|NCT05893797|593923203|FG000|Study Period 1 (Weeks 1 to 6)|Lost to Follow-up|1|||
164423773|NCT05893797|593923203|FG000|Study Period 1 (Weeks 1 to 6)|Withdrawal by Subject|2|||
164423774|NCT05893797|593923203|FG000|Study Period 2 (Weeks 7 to 18)|Physician Decision|2|||
164423775|NCT04770220|593923204|FG000|Overall Study|Adverse Event|2|||
164423776|NCT04770220|593923205|FG001|Overall Study|Adverse Event|11|||
164423777|NCT04770220|593923204|FG000|Overall Study|Withdrawal by Subject|5|||
164423778|NCT04770220|593923205|FG001|Overall Study|Withdrawal by Subject|11|||
164423779|NCT04770220|593923204|FG000|Overall Study|Lost to Follow-up|4|||
164423780|NCT04770220|593923205|FG001|Overall Study|Lost to Follow-up|3|||
164423781|NCT04770220|593923204|FG000|Overall Study|not otherwise specified|2|||
164423782|NCT04770220|593923205|FG001|Overall Study|not otherwise specified|3|||
164423783|NCT04770220|593923204|FG000|Overall Study|Physician Decision|1|||
164423784|NCT04770220|593923205|FG001|Overall Study|Physician Decision|3|||
164423785|NCT04894903|593923206|FG000|Overall Study|Death|1|||
164423786|NCT04894903|593923207|FG001|Overall Study|Death|0|||
164423787|NCT04894903|593923206|FG000|Overall Study|Pregnancy|1|||
164423788|NCT04894903|593923207|FG001|Overall Study|Pregnancy|0|||
164423789|NCT04894903|593923206|FG000|Overall Study|Withdrawal by Subject|1|||
164423790|NCT04894903|593923207|FG001|Overall Study|Withdrawal by Subject|1|||
164423791|NCT04894903|593923206|FG000|Overall Study|moved or exited health system|1|||
164423792|NCT04894903|593923207|FG001|Overall Study|moved or exited health system|3|||
164423793|NCT01923428|593923209|FG000|Overall Study|Adverse Event|8|||
164423794|NCT01923428|593923210|FG001|Overall Study|Adverse Event|6|||
164423795|NCT01923428|593923211|FG002|Overall Study|Adverse Event|3|||
164423796|NCT01923428|593923212|FG003|Overall Study|Adverse Event|3|||
164423797|NCT01923428|593923209|FG000|Overall Study|Withdrawal by Subject|5|||
164423798|NCT01923428|593923210|FG001|Overall Study|Withdrawal by Subject|3|||
164423799|NCT01923428|593923211|FG002|Overall Study|Withdrawal by Subject|0|||
164423800|NCT01923428|593923212|FG003|Overall Study|Withdrawal by Subject|4|||
164423801|NCT01923428|593923209|FG000|Overall Study|Lost to Follow-up|2|||
164423802|NCT01923428|593923210|FG001|Overall Study|Lost to Follow-up|1|||
164423803|NCT01923428|593923211|FG002|Overall Study|Lost to Follow-up|5|||
164423804|NCT01923428|593923212|FG003|Overall Study|Lost to Follow-up|0|||
164423805|NCT01923428|593923209|FG000|Overall Study|Protocol Violation|3|||
164423806|NCT01923428|593923210|FG001|Overall Study|Protocol Violation|0|||
164423807|NCT01923428|593923211|FG002|Overall Study|Protocol Violation|2|||
164423808|NCT01923428|593923212|FG003|Overall Study|Protocol Violation|1|||
164423809|NCT01923428|593923209|FG000|Overall Study|Non Compliance to treatment|1|||
164423810|NCT01923428|593923210|FG001|Overall Study|Non Compliance to treatment|2|||
164423811|NCT01923428|593923211|FG002|Overall Study|Non Compliance to treatment|0|||
164423812|NCT01923428|593923212|FG003|Overall Study|Non Compliance to treatment|1|||
164423813|NCT01923428|593923209|FG000|Overall Study|Lack of Efficacy|0|||
164423814|NCT01923428|593923210|FG001|Overall Study|Lack of Efficacy|0|||
164423815|NCT01923428|593923211|FG002|Overall Study|Lack of Efficacy|1|||
164423816|NCT01923428|593923212|FG003|Overall Study|Lack of Efficacy|1|||
164423817|NCT01822353|593923213|FG000|Overall Study|Adverse Event|1|||
164423818|NCT01822353|593923214|FG001|Overall Study|Adverse Event|3|||
164423819|NCT01822353|593923215|FG002|Overall Study|Adverse Event|1|||
164573113|NCT03926143|594463307|FG000|Overall Study|Adverse Event|2|||
164423820|NCT01822353|593923213|FG000|Overall Study|Pregnancy|0|||
164423821|NCT01822353|593923214|FG001|Overall Study|Pregnancy|1|||
164423822|NCT01822353|593923215|FG002|Overall Study|Pregnancy|0|||
164423823|NCT01822353|593923213|FG000|Overall Study|Withdrawal by Subject|3|||
164423824|NCT01822353|593923214|FG001|Overall Study|Withdrawal by Subject|1|||
164423825|NCT01822353|593923215|FG002|Overall Study|Withdrawal by Subject|0|||
164423826|NCT02550873|593923216|FG000|Randomized Double Blind|Adverse Event|3|||
164423827|NCT02550873|593923217|FG001|Randomized Double Blind|Adverse Event|1|||
164423828|NCT02550873|593923218|FG002|Randomized Double Blind|Adverse Event|0|||
164423829|NCT02550873|593923216|FG000|Randomized Double Blind|Disease progression|1|||
164423830|NCT02550873|593923217|FG001|Randomized Double Blind|Disease progression|1|||
164573114|NCT03926143|594463307|FG000|Overall Study|Progressive disease|3|||
164423831|NCT02550873|593923218|FG002|Randomized Double Blind|Disease progression|0|||
164423832|NCT02550873|593923216|FG000|Open Label Extension|Study ongoing|0|||
164423833|NCT02550873|593923217|FG001|Open Label Extension|Study ongoing|0|||
164423834|NCT02550873|593923218|FG002|Open Label Extension|Study ongoing|111|||
164423835|NCT03873246|593923220|FG000|Overall Study|Adverse Event|1|||
164423836|NCT03873246|593923221|FG001|Overall Study|Adverse Event|3|||
164423837|NCT03873246|593923222|FG002|Overall Study|Adverse Event|3|||
164423838|NCT03873246|593923220|FG000|Overall Study|Lost to Follow-up|4|||
164423839|NCT03873246|593923221|FG001|Overall Study|Lost to Follow-up|4|||
164423840|NCT03873246|593923222|FG002|Overall Study|Lost to Follow-up|5|||
164423841|NCT03873246|593923220|FG000|Overall Study|Protocol Violation|0|||
164423842|NCT03873246|593923221|FG001|Overall Study|Protocol Violation|1|||
164423843|NCT03873246|593923222|FG002|Overall Study|Protocol Violation|0|||
164423844|NCT03873246|593923220|FG000|Overall Study|Withdrawal by Subject|0|||
164423845|NCT03873246|593923221|FG001|Overall Study|Withdrawal by Subject|4|||
164423846|NCT03873246|593923222|FG002|Overall Study|Withdrawal by Subject|1|||
164423847|NCT02107443|593923223|FG000|Overall Study|Death|42|||
164423848|NCT02107443|593923224|FG001|Overall Study|Death|30|||
164423849|NCT02107443|593923223|FG000|Overall Study|Study Protocol Violation|3|||
164423850|NCT02107443|593923224|FG001|Overall Study|Study Protocol Violation|1|||
164423851|NCT02107443|593923223|FG000|Overall Study|Registered but Not Eligible|0|||
164423852|NCT02107443|593923224|FG001|Overall Study|Registered but Not Eligible|1|||
164423853|NCT02107443|593923223|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
164423854|NCT02107443|593923224|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
164423855|NCT02107443|593923223|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
164423856|NCT02107443|593923224|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
164423857|NCT02107443|593923223|FG000|Overall Study|Withdrawal: Changed Mind|2|||
164423858|NCT02107443|593923224|FG001|Overall Study|Withdrawal: Changed Mind|0|||
164423859|NCT02107443|593923223|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
164423860|NCT02107443|593923224|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
164423861|NCT02107443|593923223|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
164423862|NCT02107443|593923224|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
164423863|NCT02107443|593923223|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
164423864|NCT02107443|593923224|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
164423865|NCT02107443|593923223|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
164423866|NCT02107443|593923224|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
164423867|NCT02107443|593923223|FG000|Overall Study|Withdrawal: Other Medical|9|||
164423868|NCT02107443|593923224|FG001|Overall Study|Withdrawal: Other Medical|5|||
164423869|NCT02107443|593923223|FG000|Overall Study|Withdrawal: Disease Progression|4|||
164423870|NCT02107443|593923224|FG001|Overall Study|Withdrawal: Disease Progression|2|||
164423871|NCT02107443|593923223|FG000|Overall Study|Withdrawal: Personal Issues|0|||
164236136|NCT03983421|593236791|FG000|Overall Study|Lost to Follow-up|1|||
164236137|NCT01049373|593236792|FG000|Overall Study|Protocol Violation|9|||
164236138|NCT01049373|593236793|FG001|Overall Study|Protocol Violation|9|||
164236139|NCT01049373|593236792|FG000|Overall Study|Withdrawal by Subject|8|||
164236140|NCT01049373|593236793|FG001|Overall Study|Withdrawal by Subject|5|||
164236141|NCT01049373|593236792|FG000|Overall Study|Adverse Event|3|||
164236142|NCT01049373|593236793|FG001|Overall Study|Adverse Event|3|||
164236143|NCT01049373|593236792|FG000|Overall Study|Lost to Follow-up|9|||
164236144|NCT01049373|593236793|FG001|Overall Study|Lost to Follow-up|4|||
164236145|NCT01049373|593236792|FG000|Overall Study|no evaluable study values|9|||
164236146|NCT01049373|593236793|FG001|Overall Study|no evaluable study values|21|||
164236147|NCT01049373|593236792|FG000|Overall Study|Other|1|||
164236148|NCT01049373|593236793|FG001|Overall Study|Other|1|||
164236149|NCT01049373|593236792|FG000|Overall Study|Non-cooperation|0|||
164236150|NCT01049373|593236793|FG001|Overall Study|Non-cooperation|1|||
164236151|NCT04573972|593236794|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
164236152|NCT04573972|593236795|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
164236153|NCT01517984|593236796|FG000|Overall Study|Lost to Follow-up|0|||
164236154|NCT01517984|593236797|FG001|Overall Study|Lost to Follow-up|1|||
164236155|NCT01517984|593236798|FG002|Overall Study|Lost to Follow-up|0|||
164236156|NCT01517984|593236799|FG003|Overall Study|Lost to Follow-up|0|||
164236157|NCT01517984|593236796|FG000|Overall Study|Withdrawal by Subject|1|||
164236158|NCT01517984|593236797|FG001|Overall Study|Withdrawal by Subject|8|||
164236159|NCT01517984|593236798|FG002|Overall Study|Withdrawal by Subject|4|||
164236160|NCT01517984|593236799|FG003|Overall Study|Withdrawal by Subject|1|||
164236161|NCT01517984|593236796|FG000|Overall Study|Screen Failure|4|||
164236162|NCT01517984|593236797|FG001|Overall Study|Screen Failure|0|||
164236163|NCT01517984|593236798|FG002|Overall Study|Screen Failure|0|||
164236164|NCT01517984|593236799|FG003|Overall Study|Screen Failure|0|||
164423872|NCT02107443|593923224|FG001|Overall Study|Withdrawal: Personal Issues|3|||
164423873|NCT00885495|593923225|FG000|Overall Study|Adverse Event|1|||
164423874|NCT00885495|593923226|FG001|Overall Study|Adverse Event|2|||
164423875|NCT00885495|593923225|FG000|Overall Study|Protocol Violation|0|||
164423876|NCT00885495|593923226|FG001|Overall Study|Protocol Violation|1|||
164423877|NCT00885495|593923225|FG000|Overall Study|Withdrawal by Subject|1|||
164423878|NCT00885495|593923226|FG001|Overall Study|Withdrawal by Subject|0|||
164236165|NCT01517984|593236796|FG000|Overall Study|Ineligible for randomization|0|||
164236166|NCT01517984|593236797|FG001|Overall Study|Ineligible for randomization|14|||
164236167|NCT01517984|593236798|FG002|Overall Study|Ineligible for randomization|0|||
164423879|NCT00946647|593923227|FG000|Phase 1 Part|Adverse Event|2|||
164423880|NCT00946647|593923228|FG001|Phase 1 Part|Adverse Event|5|||
164423881|NCT00946647|593923229|FG002|Phase 1 Part|Adverse Event|3|||
164423882|NCT00946647|593923230|FG003|Phase 1 Part|Adverse Event|0|||
164423883|NCT00946647|593923231|FG004|Phase 1 Part|Adverse Event|0|||
164423884|NCT00946647|593923227|FG000|Phase 1 Part|Disease progression|3|||
164423885|NCT00946647|593923228|FG001|Phase 1 Part|Disease progression|6|||
164423886|NCT00946647|593923229|FG002|Phase 1 Part|Disease progression|1|||
164423887|NCT00946647|593923230|FG003|Phase 1 Part|Disease progression|0|||
164423888|NCT00946647|593923231|FG004|Phase 1 Part|Disease progression|0|||
164423889|NCT00946647|593923227|FG000|Phase 1 Part|Withdrawal by Subject|1|||
164423890|NCT00946647|593923228|FG001|Phase 1 Part|Withdrawal by Subject|4|||
164423891|NCT00946647|593923229|FG002|Phase 1 Part|Withdrawal by Subject|3|||
164423892|NCT00946647|593923230|FG003|Phase 1 Part|Withdrawal by Subject|0|||
164423893|NCT00946647|593923231|FG004|Phase 1 Part|Withdrawal by Subject|0|||
164423894|NCT00946647|593923227|FG000|Phase 1 Part|Abnormal values|0|||
164423895|NCT00946647|593923228|FG001|Phase 1 Part|Abnormal values|2|||
164423896|NCT00946647|593923229|FG002|Phase 1 Part|Abnormal values|0|||
164423897|NCT00946647|593923230|FG003|Phase 1 Part|Abnormal values|0|||
164423898|NCT00946647|593923231|FG004|Phase 1 Part|Abnormal values|0|||
164423899|NCT00946647|593923227|FG000|Phase 1 Part|Reason missing|0|||
164423900|NCT00946647|593923228|FG001|Phase 1 Part|Reason missing|1|||
164423901|NCT00946647|593923229|FG002|Phase 1 Part|Reason missing|0|||
164423902|NCT00946647|593923230|FG003|Phase 1 Part|Reason missing|0|||
164423903|NCT00946647|593923231|FG004|Phase 1 Part|Reason missing|0|||
164423904|NCT00946647|593923227|FG000|Phase ll Part|Untreated|0|||
164423905|NCT00946647|593923228|FG001|Phase ll Part|Untreated|0|||
164423906|NCT00946647|593923229|FG002|Phase ll Part|Untreated|0|||
164423907|NCT00946647|593923230|FG003|Phase ll Part|Untreated|0|||
164423908|NCT00946647|593923231|FG004|Phase ll Part|Untreated|2|||
164423909|NCT00946647|593923227|FG000|Phase ll Part|Adverse Event|0|||
164423910|NCT00946647|593923228|FG001|Phase ll Part|Adverse Event|0|||
164423911|NCT00946647|593923229|FG002|Phase ll Part|Adverse Event|0|||
164423912|NCT00946647|593923230|FG003|Phase ll Part|Adverse Event|10|||
164423913|NCT00946647|593923231|FG004|Phase ll Part|Adverse Event|6|||
164423914|NCT00946647|593923227|FG000|Phase ll Part|Withdrawal by Subject|0|||
164423915|NCT00946647|593923228|FG001|Phase ll Part|Withdrawal by Subject|0|||
164423916|NCT00946647|593923229|FG002|Phase ll Part|Withdrawal by Subject|0|||
164423917|NCT00946647|593923230|FG003|Phase ll Part|Withdrawal by Subject|8|||
164423918|NCT00946647|593923231|FG004|Phase ll Part|Withdrawal by Subject|6|||
164423919|NCT00946647|593923227|FG000|Phase ll Part|Administrative problems|0|||
164423920|NCT00946647|593923228|FG001|Phase ll Part|Administrative problems|0|||
164423921|NCT00946647|593923229|FG002|Phase ll Part|Administrative problems|0|||
164423922|NCT00946647|593923230|FG003|Phase ll Part|Administrative problems|3|||
164423923|NCT00946647|593923231|FG004|Phase ll Part|Administrative problems|8|||
164423924|NCT00946647|593923227|FG000|Phase ll Part|Death|0|||
164423925|NCT00946647|593923228|FG001|Phase ll Part|Death|0|||
164423926|NCT00946647|593923229|FG002|Phase ll Part|Death|0|||
164423927|NCT00946647|593923230|FG003|Phase ll Part|Death|7|||
164423928|NCT00946647|593923231|FG004|Phase ll Part|Death|4|||
164423929|NCT00946647|593923227|FG000|Phase ll Part|Disease progression|0|||
164423930|NCT00946647|593923228|FG001|Phase ll Part|Disease progression|0|||
164423931|NCT00946647|593923229|FG002|Phase ll Part|Disease progression|0|||
164423932|NCT00946647|593923230|FG003|Phase ll Part|Disease progression|6|||
164423933|NCT00946647|593923231|FG004|Phase ll Part|Disease progression|14|||
164423934|NCT00946647|593923227|FG000|Phase ll Part|Protocol Violation|0|||
164423935|NCT00946647|593923228|FG001|Phase ll Part|Protocol Violation|0|||
164423936|NCT00946647|593923229|FG002|Phase ll Part|Protocol Violation|0|||
164423937|NCT00946647|593923230|FG003|Phase ll Part|Protocol Violation|4|||
164423938|NCT00946647|593923231|FG004|Phase ll Part|Protocol Violation|2|||
164423939|NCT00946647|593923227|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
164423940|NCT00946647|593923228|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
164423941|NCT00946647|593923229|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
164423942|NCT00946647|593923230|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
164573115|NCT02561156|594463312|FG000|Part 2|Adverse Event|0|||
164573116|NCT02561156|594463313|FG001|Part 2|Adverse Event|0|||
164573117|NCT02561156|594463314|FG002|Part 2|Adverse Event|0|||
164423943|NCT00946647|593923231|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
164423944|NCT01368211|593923232|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
164423945|NCT01368211|593923233|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
164573118|NCT02561156|594463315|FG003|Part 2|Adverse Event|0|||
164423946|NCT01349660|593923236|FG000|Overall Study|Still Receiving Study Treatment|0|||
164423947|NCT01349660|593923237|FG001|Overall Study|Still Receiving Study Treatment|0|||
164423948|NCT01349660|593923238|FG002|Overall Study|Still Receiving Study Treatment|1|||
164423949|NCT01349660|593923236|FG000|Overall Study|Disease Progression|2|||
164573119|NCT02561156|594463316|FG004|Part 2|Adverse Event|0|||
164423950|NCT01349660|593923237|FG001|Overall Study|Disease Progression|4|||
164423951|NCT01349660|593923238|FG002|Overall Study|Disease Progression|50|||
164573120|NCT02561156|594463317|FG005|Part 2|Adverse Event|0|||
164236168|NCT01517984|593236799|FG003|Overall Study|Ineligible for randomization|0|||
164236169|NCT02724839|593236802|FG000|Overall Study|Withdrawal by Subject|1|||
164236170|NCT02724839|593236803|FG001|Overall Study|Withdrawal by Subject|1|||
164236171|NCT02724839|593236804|FG002|Overall Study|Withdrawal by Subject|0|||
164236172|NCT02724839|593236802|FG000|Overall Study|Lost to Follow-up|0|||
164236173|NCT02724839|593236803|FG001|Overall Study|Lost to Follow-up|3|||
164236174|NCT02724839|593236804|FG002|Overall Study|Lost to Follow-up|2|||
164236175|NCT02724839|593236802|FG000|Overall Study|Physician Decision|0|||
164236176|NCT02724839|593236803|FG001|Overall Study|Physician Decision|0|||
164236177|NCT02724839|593236804|FG002|Overall Study|Physician Decision|3|||
164236178|NCT01155050|593236805|FG000|Overall Study|Lost to Follow-up|15|||
164236179|NCT01155050|593236806|FG001|Overall Study|Lost to Follow-up|20|||
164236180|NCT01155050|593236807|FG002|Overall Study|Lost to Follow-up|19|||
164236181|NCT01155050|593236808|FG003|Overall Study|Lost to Follow-up|22|||
164236182|NCT01198587|593236809|FG000|Overall Study|Lost to Follow-up|8|||
164236183|NCT01198587|593236810|FG001|Overall Study|Lost to Follow-up|0|||
164236184|NCT01198587|593236811|FG002|Overall Study|Lost to Follow-up|9|||
164236185|NCT01198587|593236812|FG003|Overall Study|Lost to Follow-up|0|||
164423952|NCT01349660|593923236|FG000|Overall Study|Adverse Event|1|||
164236186|NCT01496287|593236813|FG000|Overall Study|Lost to Follow-up|1|||
164236187|NCT01496287|593236813|FG000|Overall Study|Incomplete anesthesia|5|||
164236188|NCT01959529|593236814|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
164236189|NCT01959529|593236815|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
164236190|NCT01959529|593236814|FG000|Overall Study|Lost to Follow-up|4|||
164236191|NCT01959529|593236815|FG001|Overall Study|Lost to Follow-up|1|||
164236192|NCT01959529|593236814|FG000|Overall Study|Other|70|||
164236193|NCT01959529|593236815|FG001|Overall Study|Other|68|||
164236194|NCT01959529|593236814|FG000|Overall Study|Hypoglycaemia|1|||
164236195|NCT01959529|593236815|FG001|Overall Study|Hypoglycaemia|1|||
164236196|NCT01959529|593236814|FG000|Overall Study|Lack of glycaemic control|1|||
164236197|NCT01959529|593236815|FG001|Overall Study|Lack of glycaemic control|1|||
164236198|NCT00557193|593236825|FG000|Induction|Adverse Event|2|||
164236199|NCT00557193|593236826|FG001|Induction|Adverse Event|0|||
164236200|NCT00557193|593236827|FG002|Induction|Adverse Event|0|||
164236201|NCT00557193|593236828|FG003|Induction|Adverse Event|0|||
164236202|NCT00557193|593236829|FG004|Induction|Adverse Event|0|||
164236203|NCT00557193|593236830|FG005|Induction|Adverse Event|0|||
164236204|NCT00557193|593236825|FG000|Induction|Death|6|||
164236205|NCT00557193|593236826|FG001|Induction|Death|0|||
164236206|NCT00557193|593236827|FG002|Induction|Death|0|||
164236207|NCT00557193|593236828|FG003|Induction|Death|0|||
164236208|NCT00557193|593236829|FG004|Induction|Death|0|||
164236209|NCT00557193|593236830|FG005|Induction|Death|0|||
164236210|NCT00557193|593236825|FG000|Induction|Physician Decision|3|||
164236211|NCT00557193|593236826|FG001|Induction|Physician Decision|0|||
164236212|NCT00557193|593236827|FG002|Induction|Physician Decision|0|||
164236213|NCT00557193|593236828|FG003|Induction|Physician Decision|0|||
164236214|NCT00557193|593236829|FG004|Induction|Physician Decision|0|||
164236215|NCT00557193|593236830|FG005|Induction|Physician Decision|0|||
164236216|NCT00557193|593236825|FG000|Induction|Withdrawal by Subject|1|||
164236217|NCT00557193|593236826|FG001|Induction|Withdrawal by Subject|0|||
164236218|NCT00557193|593236827|FG002|Induction|Withdrawal by Subject|0|||
164236219|NCT00557193|593236828|FG003|Induction|Withdrawal by Subject|0|||
164236220|NCT00557193|593236829|FG004|Induction|Withdrawal by Subject|0|||
164236221|NCT00557193|593236830|FG005|Induction|Withdrawal by Subject|0|||
164236222|NCT00557193|593236825|FG000|Induction|Refusal of Further Protocol Therapy|2|||
164236223|NCT00557193|593236826|FG001|Induction|Refusal of Further Protocol Therapy|0|||
164236224|NCT00557193|593236827|FG002|Induction|Refusal of Further Protocol Therapy|0|||
164236225|NCT00557193|593236828|FG003|Induction|Refusal of Further Protocol Therapy|0|||
164236226|NCT00557193|593236829|FG004|Induction|Refusal of Further Protocol Therapy|0|||
164236227|NCT00557193|593236830|FG005|Induction|Refusal of Further Protocol Therapy|0|||
164236228|NCT00557193|593236825|FG000|Induction|Ineligible|8|||
164236229|NCT00557193|593236826|FG001|Induction|Ineligible|0|||
164236230|NCT00557193|593236827|FG002|Induction|Ineligible|0|||
164236231|NCT00557193|593236828|FG003|Induction|Ineligible|0|||
164236232|NCT00557193|593236829|FG004|Induction|Ineligible|0|||
164236233|NCT00557193|593236830|FG005|Induction|Ineligible|0|||
164236234|NCT00557193|593236825|FG000|Induction|Inevaluable for post Induction|2|||
164236235|NCT00557193|593236826|FG001|Induction|Inevaluable for post Induction|0|||
164236236|NCT00557193|593236827|FG002|Induction|Inevaluable for post Induction|0|||
164236237|NCT00557193|593236828|FG003|Induction|Inevaluable for post Induction|0|||
164236238|NCT00557193|593236829|FG004|Induction|Inevaluable for post Induction|0|||
164423953|NCT01349660|593923237|FG001|Overall Study|Adverse Event|1|||
164236239|NCT00557193|593236830|FG005|Induction|Inevaluable for post Induction|0|||
164236240|NCT00557193|593236825|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
164573121|NCT02561156|594463318|FG006|Part 2|Adverse Event|0|||
164236241|NCT00557193|593236826|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
164236242|NCT00557193|593236827|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
164236243|NCT00557193|593236828|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
164236244|NCT00557193|593236829|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
164423954|NCT01349660|593923238|FG002|Overall Study|Adverse Event|12|||
164423955|NCT01349660|593923236|FG000|Overall Study|Withdrawal by Subject|2|||
164423956|NCT01349660|593923237|FG001|Overall Study|Withdrawal by Subject|0|||
164423957|NCT01349660|593923238|FG002|Overall Study|Withdrawal by Subject|9|||
164423958|NCT01349660|593923236|FG000|Overall Study|Death|1|||
164423959|NCT01349660|593923237|FG001|Overall Study|Death|1|||
164423960|NCT01349660|593923238|FG002|Overall Study|Death|0|||
164423961|NCT01349660|593923236|FG000|Overall Study|Non-Permitted Interventions|0|||
164423962|NCT01349660|593923237|FG001|Overall Study|Non-Permitted Interventions|0|||
164423963|NCT01349660|593923238|FG002|Overall Study|Non-Permitted Interventions|2|||
164423964|NCT01349660|593923236|FG000|Overall Study|Study Compliance|0|||
164423965|NCT01349660|593923237|FG001|Overall Study|Study Compliance|0|||
164423966|NCT01349660|593923238|FG002|Overall Study|Study Compliance|1|||
164423967|NCT01349660|593923236|FG000|Overall Study|Declining Performance Status|0|||
164423968|NCT01349660|593923237|FG001|Overall Study|Declining Performance Status|0|||
164423969|NCT01349660|593923238|FG002|Overall Study|Declining Performance Status|1|||
164423970|NCT05593211|593923240|FG000|Overall Study|Withdrawal by Subject|1|||
164423971|NCT03225846|593923241|FG000|Overall Study|Adverse Event|0|||
164423972|NCT03225846|593923242|FG001|Overall Study|Adverse Event|0|||
164423973|NCT03225846|593923243|FG002|Overall Study|Adverse Event|0|||
164423974|NCT03225846|593923244|FG003|Overall Study|Adverse Event|0|||
164423975|NCT03225846|593923245|FG004|Overall Study|Adverse Event|0|||
164423976|NCT03225846|593923246|FG005|Overall Study|Adverse Event|0|||
164423977|NCT03225846|593923247|FG006|Overall Study|Adverse Event|6|||
164423978|NCT03225846|593923241|FG000|Overall Study|Withdrawal by Subject|0|||
164423979|NCT03225846|593923242|FG001|Overall Study|Withdrawal by Subject|1|||
164423980|NCT03225846|593923243|FG002|Overall Study|Withdrawal by Subject|0|||
164423981|NCT03225846|593923244|FG003|Overall Study|Withdrawal by Subject|0|||
164423982|NCT03225846|593923245|FG004|Overall Study|Withdrawal by Subject|0|||
164423983|NCT03225846|593923246|FG005|Overall Study|Withdrawal by Subject|0|||
164423984|NCT03225846|593923247|FG006|Overall Study|Withdrawal by Subject|0|||
164423985|NCT03225846|593923241|FG000|Overall Study|Death|0|||
164423986|NCT03225846|593923242|FG001|Overall Study|Death|1|||
164423987|NCT03225846|593923243|FG002|Overall Study|Death|0|||
164423988|NCT03225846|593923244|FG003|Overall Study|Death|0|||
164423989|NCT03225846|593923245|FG004|Overall Study|Death|0|||
164423990|NCT03225846|593923246|FG005|Overall Study|Death|0|||
164423991|NCT03225846|593923247|FG006|Overall Study|Death|0|||
164423992|NCT03225846|593923241|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
164423993|NCT03225846|593923242|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
164423994|NCT03225846|593923243|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
164423995|NCT03225846|593923244|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
164423996|NCT03225846|593923245|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
164423997|NCT03225846|593923246|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
164423998|NCT03225846|593923247|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
164423999|NCT03225846|593923241|FG000|Overall Study|Patient decision|0|||
164424000|NCT03225846|593923242|FG001|Overall Study|Patient decision|0|||
164424001|NCT03225846|593923243|FG002|Overall Study|Patient decision|0|||
164424002|NCT03225846|593923244|FG003|Overall Study|Patient decision|0|||
164424003|NCT03225846|593923245|FG004|Overall Study|Patient decision|0|||
164424004|NCT03225846|593923246|FG005|Overall Study|Patient decision|0|||
164424005|NCT03225846|593923247|FG006|Overall Study|Patient decision|1|||
164424006|NCT04248465|593923248|FG000|Randomized-Controlled Period|Death|12|||
164424007|NCT04248465|593923249|FG001|Randomized-Controlled Period|Death|5|||
164424008|NCT04248465|593923248|FG000|Randomized-Controlled Period|Adverse Event|2|||
164424009|NCT04248465|593923249|FG001|Randomized-Controlled Period|Adverse Event|0|||
164424010|NCT04248465|593923248|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
164424011|NCT04248465|593923249|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
164424012|NCT04248465|593923248|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
164424013|NCT04248465|593923249|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
164424014|NCT04248465|593923248|FG000|Randomized-Controlled Period|Physician Decision|1|||
164424015|NCT04248465|593923249|FG001|Randomized-Controlled Period|Physician Decision|1|||
164424016|NCT04248465|593923248|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
164424017|NCT04248465|593923249|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
164424018|NCT04248465|593923248|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
164424019|NCT04248465|593923249|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
164424020|NCT04248465|593923248|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
164424021|NCT04248465|593923249|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
164424022|NCT00810641|593923257|FG000|Overall Study|Withdrawal by Subject|0|||
164424023|NCT00810641|593923258|FG001|Overall Study|Withdrawal by Subject|1|||
164424024|NCT00810641|593923259|FG002|Overall Study|Withdrawal by Subject|2|||
164424025|NCT01213173|593923263|FG000|Overall Study|Protocol Violation|2|||
164424026|NCT01213173|593923264|FG001|Overall Study|Protocol Violation|0|||
164424027|NCT01213173|593923263|FG000|Overall Study|Adverse Event|4|||
164424028|NCT01213173|593923264|FG001|Overall Study|Adverse Event|8|||
164424029|NCT01213173|593923263|FG000|Overall Study|Withdrawal by Subject|5|||
164334127|NCT03265665|593601460|FG000|24-week Data Collection|Withdrawal by Subject|2|||
164334128|NCT03265665|593601461|FG001|24-week Data Collection|Withdrawal by Subject|2|||
164334129|NCT03265665|593601460|FG000|24-week Data Collection|Lost to Follow-up|4|||
164334130|NCT03265665|593601461|FG001|24-week Data Collection|Lost to Follow-up|5|||
164334131|NCT03265665|593601460|FG000|36-week Data Collection|Lost to Follow-up|6|||
164334132|NCT03265665|593601461|FG001|36-week Data Collection|Lost to Follow-up|8|||
164334133|NCT01858376|593601462|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
164334134|NCT01680965|593601465|FG000|Overall Study|Death|0|||
164334135|NCT01680965|593601466|FG001|Overall Study|Death|0|||
164334136|NCT01680965|593601467|FG002|Overall Study|Death|0|||
164334137|NCT01680965|593601468|FG003|Overall Study|Death|6|||
164334138|NCT02486302|593601480|FG000|Overall Study|Discontinued prematurely|410|||
164334139|NCT02486302|593601480|FG000|Overall Study|Documentation not completed|255|||
164334140|NCT02486302|593601480|FG000|Overall Study|Excluded due to legal reasons|8|||
164334141|NCT02486302|593601480|FG000|Overall Study|Not treated|3|||
164334142|NCT00734474|593601483|FG000|Overall Study|Entry Criteria Not Met|0|||
164334143|NCT00734474|593601484|FG001|Overall Study|Entry Criteria Not Met|0|||
164334144|NCT00734474|593601485|FG002|Overall Study|Entry Criteria Not Met|5|||
164334145|NCT00734474|593601486|FG003|Overall Study|Entry Criteria Not Met|0|||
164334146|NCT00734474|593601487|FG004|Overall Study|Entry Criteria Not Met|3|||
164334147|NCT00734474|593601488|FG005|Overall Study|Entry Criteria Not Met|1|||
164334148|NCT00734474|593601489|FG006|Overall Study|Entry Criteria Not Met|0|||
164334149|NCT00734474|593601490|FG007|Overall Study|Entry Criteria Not Met|1|||
164334150|NCT00734474|593601491|FG008|Overall Study|Entry Criteria Not Met|1|||
164334151|NCT00734474|593601483|FG000|Overall Study|Lost to Follow-up|1|||
164334152|NCT00734474|593601484|FG001|Overall Study|Lost to Follow-up|0|||
164334153|NCT00734474|593601485|FG002|Overall Study|Lost to Follow-up|13|||
164334154|NCT00734474|593601486|FG003|Overall Study|Lost to Follow-up|0|||
164334155|NCT00734474|593601487|FG004|Overall Study|Lost to Follow-up|11|||
164334156|NCT00734474|593601488|FG005|Overall Study|Lost to Follow-up|1|||
164334157|NCT00734474|593601489|FG006|Overall Study|Lost to Follow-up|0|||
164334158|NCT00734474|593601490|FG007|Overall Study|Lost to Follow-up|9|||
164334159|NCT00734474|593601491|FG008|Overall Study|Lost to Follow-up|4|||
164334160|NCT00734474|593601483|FG000|Overall Study|Withdrawal by Subject|2|||
164334161|NCT00734474|593601484|FG001|Overall Study|Withdrawal by Subject|1|||
164334162|NCT00734474|593601485|FG002|Overall Study|Withdrawal by Subject|18|||
164334163|NCT00734474|593601486|FG003|Overall Study|Withdrawal by Subject|0|||
164334164|NCT00734474|593601487|FG004|Overall Study|Withdrawal by Subject|24|||
164334165|NCT00734474|593601488|FG005|Overall Study|Withdrawal by Subject|2|||
164334166|NCT00734474|593601489|FG006|Overall Study|Withdrawal by Subject|0|||
164334167|NCT00734474|593601490|FG007|Overall Study|Withdrawal by Subject|36|||
164334168|NCT00734474|593601491|FG008|Overall Study|Withdrawal by Subject|21|||
164334169|NCT00734474|593601483|FG000|Overall Study|Physician Decision|0|||
164334170|NCT00734474|593601484|FG001|Overall Study|Physician Decision|0|||
164334171|NCT00734474|593601485|FG002|Overall Study|Physician Decision|4|||
164334172|NCT00734474|593601486|FG003|Overall Study|Physician Decision|1|||
164334173|NCT00734474|593601487|FG004|Overall Study|Physician Decision|11|||
164334174|NCT00734474|593601488|FG005|Overall Study|Physician Decision|0|||
164334175|NCT00734474|593601489|FG006|Overall Study|Physician Decision|0|||
164334176|NCT00734474|593601490|FG007|Overall Study|Physician Decision|9|||
164334177|NCT00734474|593601491|FG008|Overall Study|Physician Decision|9|||
164334178|NCT00734474|593601483|FG000|Overall Study|Adverse Event|4|||
164334179|NCT00734474|593601484|FG001|Overall Study|Adverse Event|4|||
164334180|NCT00734474|593601485|FG002|Overall Study|Adverse Event|63|||
164334181|NCT00734474|593601486|FG003|Overall Study|Adverse Event|1|||
164334182|NCT00734474|593601487|FG004|Overall Study|Adverse Event|64|||
164334183|NCT00734474|593601488|FG005|Overall Study|Adverse Event|0|||
164334184|NCT00734474|593601489|FG006|Overall Study|Adverse Event|1|||
164334185|NCT00734474|593601490|FG007|Overall Study|Adverse Event|65|||
164334186|NCT00734474|593601491|FG008|Overall Study|Adverse Event|39|||
164334187|NCT00734474|593601483|FG000|Overall Study|Protocol Violation|0|||
164334188|NCT00734474|593601484|FG001|Overall Study|Protocol Violation|0|||
164334189|NCT00734474|593601485|FG002|Overall Study|Protocol Violation|4|||
164573122|NCT02561156|594463319|FG007|Part 2|Adverse Event|0|||
164334190|NCT00734474|593601486|FG003|Overall Study|Protocol Violation|0|||
164334191|NCT00734474|593601487|FG004|Overall Study|Protocol Violation|3|||
164334192|NCT00734474|593601488|FG005|Overall Study|Protocol Violation|0|||
164334193|NCT00734474|593601489|FG006|Overall Study|Protocol Violation|0|||
164334194|NCT00734474|593601490|FG007|Overall Study|Protocol Violation|3|||
164334195|NCT00734474|593601491|FG008|Overall Study|Protocol Violation|1|||
164334196|NCT00734474|593601483|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
164573123|NCT02561156|594463320|FG008|Part 2|Adverse Event|0|||
164573124|NCT02561156|594463321|FG009|Part 2|Adverse Event|0|||
164573125|NCT02561156|594463322|FG010|Part 2|Adverse Event|0|||
164334197|NCT00734474|593601484|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
164334198|NCT00734474|593601485|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
164334199|NCT00734474|593601486|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
164573126|NCT02561156|594463323|FG011|Part 2|Adverse Event|1|||
164334200|NCT00734474|593601487|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
164424030|NCT01213173|593923264|FG001|Overall Study|Withdrawal by Subject|5|||
164424031|NCT01213173|593923263|FG000|Overall Study|Incorrect Enrollment|1|||
164424032|NCT01213173|593923264|FG001|Overall Study|Incorrect Enrollment|3|||
164424033|NCT02253316|593923265|FG000|Consolidation|Progression|4|||
164424034|NCT02253316|593923266|FG001|Consolidation|Progression|0|||
164424035|NCT02253316|593923267|FG002|Consolidation|Progression|0|||
164424036|NCT02253316|593923265|FG000|Consolidation|Non-Compliance|1|||
164424037|NCT02253316|593923266|FG001|Consolidation|Non-Compliance|0|||
164424038|NCT02253316|593923267|FG002|Consolidation|Non-Compliance|0|||
164424039|NCT02253316|593923265|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
164424040|NCT02253316|593923266|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
164424041|NCT02253316|593923267|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
164424042|NCT02253316|593923265|FG000|Consolidation|Secondary Malignancy|2|||
164424043|NCT02253316|593923266|FG001|Consolidation|Secondary Malignancy|0|||
164424044|NCT02253316|593923267|FG002|Consolidation|Secondary Malignancy|0|||
164424045|NCT02253316|593923265|FG000|Consolidation|Adverse Event|7|||
164424046|NCT02253316|593923266|FG001|Consolidation|Adverse Event|0|||
164424047|NCT02253316|593923267|FG002|Consolidation|Adverse Event|0|||
164424048|NCT02253316|593923265|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
164424049|NCT02253316|593923266|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
164424050|NCT02253316|593923267|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
164424051|NCT02253316|593923265|FG000|Maintenance|Physician Decision|0|||
164424052|NCT02253316|593923266|FG001|Maintenance|Physician Decision|7|||
164424053|NCT02253316|593923267|FG002|Maintenance|Physician Decision|16|||
164424054|NCT02253316|593923265|FG000|Maintenance|Non-Compliance|0|||
164424055|NCT02253316|593923266|FG001|Maintenance|Non-Compliance|1|||
164424056|NCT02253316|593923267|FG002|Maintenance|Non-Compliance|1|||
164424057|NCT02253316|593923265|FG000|Maintenance|Secondary Malignancy|0|||
164424058|NCT02253316|593923266|FG001|Maintenance|Secondary Malignancy|2|||
164424059|NCT02253316|593923267|FG002|Maintenance|Secondary Malignancy|6|||
164424060|NCT02253316|593923265|FG000|Maintenance|Adverse Event|0|||
164236245|NCT00557193|593236830|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
164236246|NCT00557193|593236825|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
164236247|NCT00557193|593236826|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
164236248|NCT00557193|593236827|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
164236249|NCT00557193|593236828|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
164236250|NCT00557193|593236829|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
164236251|NCT00557193|593236830|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
164236252|NCT00557193|593236825|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
164236253|NCT00557193|593236826|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
164236254|NCT00557193|593236827|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
164236255|NCT00557193|593236828|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
164236256|NCT00557193|593236829|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
164236257|NCT00557193|593236830|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
164236258|NCT00557193|593236825|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
164236259|NCT00557193|593236826|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
164236260|NCT00557193|593236827|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
164236261|NCT00557193|593236828|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
164236262|NCT00557193|593236829|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
164236263|NCT00557193|593236830|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
164236264|NCT00557193|593236825|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
164236265|NCT00557193|593236826|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
164236266|NCT00557193|593236827|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
164236267|NCT00557193|593236828|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
164236268|NCT00557193|593236829|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
164236269|NCT00557193|593236830|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
164236270|NCT00557193|593236825|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
164236271|NCT00557193|593236826|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
164236272|NCT00557193|593236827|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
164236273|NCT00557193|593236828|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
164236274|NCT00557193|593236829|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
164424061|NCT02253316|593923266|FG001|Maintenance|Adverse Event|8|||
164424062|NCT02253316|593923267|FG002|Maintenance|Adverse Event|12|||
164424063|NCT02253316|593923265|FG000|Maintenance|Still receiving active treatment|0|||
164424064|NCT02253316|593923266|FG001|Maintenance|Still receiving active treatment|4|||
164424065|NCT02253316|593923267|FG002|Maintenance|Still receiving active treatment|0|||
164424066|NCT02684903|593923268|FG000|Overall Study|COVID-19 shutdown of lab|4|||
164424067|NCT02684903|593923269|FG001|Overall Study|COVID-19 shutdown of lab|6|||
164424068|NCT02684903|593923268|FG000|Overall Study|Lost to Follow-up|31|||
164677116|NCT03165994|594843007|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
164677117|NCT03165994|594843007|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
164236275|NCT00557193|593236830|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
164236276|NCT00557193|593236825|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
164236277|NCT00557193|593236826|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
164236278|NCT00557193|593236827|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
164236279|NCT00557193|593236828|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
164236280|NCT00557193|593236829|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
164236281|NCT00557193|593236830|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
164236282|NCT00557193|593236825|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
164236283|NCT00557193|593236826|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
164236284|NCT00557193|593236827|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
164236285|NCT00557193|593236828|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
164236286|NCT00557193|593236829|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
164236287|NCT00557193|593236830|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
164236288|NCT00557193|593236825|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
164236289|NCT00557193|593236826|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
164236290|NCT00557193|593236827|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
164236291|NCT00557193|593236828|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
164236292|NCT00557193|593236829|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
164236293|NCT00557193|593236830|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
164236294|NCT03036852|593236831|FG000|Overall Study|Death|2|||
164236295|NCT03036852|593236831|FG000|Overall Study|Lack of Efficacy|2|||
164236296|NCT03036852|593236831|FG000|Overall Study|Adverse Event|1|||
164236297|NCT03036852|593236831|FG000|Overall Study|Lost to Follow-up|1|||
164236298|NCT00652834|593236832|FG000|Overall Study|Withdrawal by Subject|3|||
164236299|NCT00652834|593236832|FG000|Overall Study|Lost to Follow-up|2|||
164236300|NCT03984825|593236835|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
164236301|NCT03984825|593236835|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
164236302|NCT03984825|593236835|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
164236303|NCT00742625|593236838|FG000|Remission Induction|Progression|6|||
164236304|NCT00742625|593236838|FG000|Remission Induction|Failed induction|8|||
164236305|NCT00742625|593236838|FG000|Remission Induction|Adverse Event|3|||
164236306|NCT00742625|593236838|FG000|Remission Induction|Death|10|||
164236307|NCT00742625|593236838|FG000|Remission Induction|Refusal|5|||
164236308|NCT00742625|593236838|FG000|Remission Induction|Non protocol treatment|17|||
164236309|NCT00742625|593236838|FG000|Remission Induction|Other, not specified|5|||
164236310|NCT00742625|593236838|FG000|Consolidation|Progression|5|||
164236311|NCT00742625|593236838|FG000|Consolidation|Adverse Event|1|||
164236312|NCT00742625|593236838|FG000|Consolidation|Death|1|||
164236313|NCT00742625|593236838|FG000|Consolidation|Refused|1|||
164236314|NCT00742625|593236838|FG000|Consolidation|Non protocol therapy|13|||
164236315|NCT01908140|593236843|FG000|Overall Study|Other or Progressive Disease|5|||
164236316|NCT01908140|593236844|FG001|Overall Study|Other or Progressive Disease|12|||
164236317|NCT01908140|593236843|FG000|Overall Study|Lack of Efficacy|7|||
164236318|NCT01908140|593236844|FG001|Overall Study|Lack of Efficacy|5|||
164236319|NCT01908140|593236843|FG000|Overall Study|Withdrawal by Subject|23|||
164236320|NCT01908140|593236844|FG001|Overall Study|Withdrawal by Subject|24|||
164236321|NCT01908140|593236843|FG000|Overall Study|Lost to Follow-up|1|||
164236322|NCT01908140|593236844|FG001|Overall Study|Lost to Follow-up|6|||
164236323|NCT01908140|593236843|FG000|Overall Study|Protocol Violation|8|||
164236324|NCT01908140|593236844|FG001|Overall Study|Protocol Violation|9|||
164236325|NCT01908140|593236843|FG000|Overall Study|Adverse Event|22|||
164236326|NCT01908140|593236844|FG001|Overall Study|Adverse Event|23|||
164236327|NCT01307449|593236845|FG000|Overall Study|Adverse Event|1|||
164236328|NCT01307449|593236846|FG001|Overall Study|Adverse Event|0|||
164236329|NCT01307449|593236847|FG002|Overall Study|Adverse Event|0|||
164236330|NCT01307449|593236848|FG003|Overall Study|Adverse Event|0|||
164236331|NCT02927795|593236851|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
164236332|NCT02927795|593236851|FG000|Overall Study|Not Treated|4|||
164236333|NCT01076010|593236852|FG000|Overall Study|Death|15|||
164236334|NCT01076010|593236853|FG001|Overall Study|Death|1|||
164236335|NCT01076010|593236854|FG002|Overall Study|Death|0|||
164236336|NCT01076010|593236852|FG000|Overall Study|Adverse Event|7|||
164236337|NCT01076010|593236853|FG001|Overall Study|Adverse Event|2|||
164236338|NCT01076010|593236854|FG002|Overall Study|Adverse Event|0|||
164236339|NCT01076010|593236852|FG000|Overall Study|Progressive disease|90|||
164236340|NCT01076010|593236853|FG001|Overall Study|Progressive disease|30|||
164236341|NCT01076010|593236854|FG002|Overall Study|Progressive disease|1|||
164236342|NCT01076010|593236852|FG000|Overall Study|Lack of Efficacy|4|||
164236343|NCT01076010|593236853|FG001|Overall Study|Lack of Efficacy|0|||
164236344|NCT01076010|593236854|FG002|Overall Study|Lack of Efficacy|0|||
164236345|NCT01076010|593236852|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
164236346|NCT01076010|593236853|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
164236347|NCT01076010|593236854|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
164236348|NCT01076010|593236852|FG000|Overall Study|Significant Surgical Procedure|0|||
164236349|NCT01076010|593236853|FG001|Overall Study|Significant Surgical Procedure|1|||
164424069|NCT02684903|593923269|FG001|Overall Study|Lost to Follow-up|41|||
164424070|NCT06403605|593923274|FG000|Follow-up|Withdrawn per protocol with PAR <50% at week 6|17|||
164424071|NCT06403605|593923275|FG001|Follow-up|Withdrawn per protocol with PAR <50% at week 6|19|||
164424072|NCT06403605|593923274|FG000|Follow-up|Adverse Event|4|||
164424073|NCT06403605|593923275|FG001|Follow-up|Adverse Event|2|||
164424074|NCT06403605|593923274|FG000|Follow-up|Withdrawal by Subject|2|||
164424075|NCT06403605|593923275|FG001|Follow-up|Withdrawal by Subject|3|||
164424076|NCT06403605|593923274|FG000|Follow-up|Lost to Follow-up|1|||
164424077|NCT06403605|593923275|FG001|Follow-up|Lost to Follow-up|0|||
164424078|NCT06403605|593923274|FG000|Follow-up|Death|1|||
164424079|NCT06403605|593923275|FG001|Follow-up|Death|0|||
164424080|NCT06403605|593923274|FG000|Follow-up|Other reasons|0|||
164424081|NCT06403605|593923275|FG001|Follow-up|Other reasons|4|||
164424082|NCT07083843|593923276|FG000|Intervention period.|Withdrawal by Subject|1|||
164424083|NCT07083843|593923277|FG001|Intervention period.|Withdrawal by Subject|0|||
164424084|NCT07083843|593923276|FG000|Intervention period.|Death|0|||
164424085|NCT07083843|593923277|FG001|Intervention period.|Death|1|||
164424086|NCT02153788|593924929|FG000|Overall Study|Physician Decision|2|||
164424087|NCT02153788|593924930|FG001|Overall Study|Physician Decision|1|||
164424088|NCT01106287|593924931|FG000|Overall Study|Adverse Event|1|||
164424089|NCT01106287|593924932|FG001|Overall Study|Adverse Event|0|||
164424090|NCT01106287|593924933|FG002|Overall Study|Adverse Event|0|||
164236350|NCT01076010|593236854|FG002|Overall Study|Significant Surgical Procedure|0|||
164236351|NCT01076010|593236852|FG000|Overall Study|Protocol Violation|0|||
164236352|NCT01076010|593236853|FG001|Overall Study|Protocol Violation|1|||
164236353|NCT01076010|593236854|FG002|Overall Study|Protocol Violation|0|||
164236354|NCT01076010|593236852|FG000|Overall Study|Noncompliance|1|||
164236355|NCT01076010|593236853|FG001|Overall Study|Noncompliance|1|||
164236356|NCT01076010|593236854|FG002|Overall Study|Noncompliance|0|||
164236357|NCT01076010|593236852|FG000|Overall Study|Withdrawal by Subject|3|||
164236358|NCT01076010|593236853|FG001|Overall Study|Withdrawal by Subject|0|||
164236359|NCT01076010|593236854|FG002|Overall Study|Withdrawal by Subject|1|||
164236360|NCT01076010|593236852|FG000|Overall Study|Other|5|||
164236361|NCT01076010|593236853|FG001|Overall Study|Other|2|||
164236362|NCT01076010|593236854|FG002|Overall Study|Other|0|||
164236363|NCT00397540|593236863|FG000|Overall Study|short follow-up duration < 12 months|1|||
164236364|NCT00397540|593236864|FG001|Overall Study|short follow-up duration < 12 months|0|||
164236365|NCT00956293|593236866|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
164236366|NCT00956293|593236867|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
164236367|NCT00956293|593236868|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
164236368|NCT00956293|593236866|FG000|Main Period (Pre-randomization)|Death|0|||
164236369|NCT00956293|593236867|FG001|Main Period (Pre-randomization)|Death|0|||
164236370|NCT00956293|593236868|FG002|Main Period (Pre-randomization)|Death|1|||
164236371|NCT00956293|593236866|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
164236372|NCT00956293|593236867|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
164236373|NCT00956293|593236868|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
164236374|NCT00956293|593236866|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
164236375|NCT00956293|593236867|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
164236376|NCT00956293|593236868|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
164236377|NCT00956293|593236866|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
164236378|NCT00956293|593236867|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
164236379|NCT00956293|593236868|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
164236380|NCT00956293|593236866|FG000|Main Period (Pre-randomization)|Graft loss|0|||
164236381|NCT00956293|593236867|FG001|Main Period (Pre-randomization)|Graft loss|0|||
164236382|NCT00956293|593236868|FG002|Main Period (Pre-randomization)|Graft loss|7|||
164236383|NCT00956293|593236866|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
164236384|NCT00956293|593236867|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
164236385|NCT00956293|593236868|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
164236386|NCT00956293|593236866|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
164236387|NCT00956293|593236867|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
164236388|NCT00956293|593236868|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
164236389|NCT00956293|593236866|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
164424091|NCT01106287|593924934|FG003|Overall Study|Adverse Event|0|||
164424092|NCT01450943|593924937|FG000|Overall Study|Screen failure, loss to follow-up|2|||
164424093|NCT01450943|593924938|FG001|Overall Study|Screen failure, loss to follow-up|7|||
164424094|NCT01450943|593924939|FG002|Overall Study|Screen failure, loss to follow-up|6|||
164424095|NCT00557505|593924940|FG000|Overall Study|Death|0|||
164424096|NCT00557505|593924941|FG001|Overall Study|Death|0|||
164424097|NCT00557505|593924942|FG002|Overall Study|Death|0|||
164424098|NCT00557505|593924943|FG003|Overall Study|Death|0|||
164677118|NCT03165994|594843007|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
164424099|NCT00557505|593924944|FG004|Overall Study|Death|0|||
164424100|NCT00557505|593924945|FG005|Overall Study|Death|0|||
164424101|NCT00557505|593924946|FG006|Overall Study|Death|0|||
164424102|NCT00557505|593924947|FG007|Overall Study|Death|0|||
164424103|NCT00557505|593924948|FG008|Overall Study|Death|1|||
164424104|NCT00557505|593924940|FG000|Overall Study|Adverse Event|0|||
164424105|NCT00557505|593924941|FG001|Overall Study|Adverse Event|0|||
164424106|NCT00557505|593924942|FG002|Overall Study|Adverse Event|1|||
164424107|NCT00557505|593924943|FG003|Overall Study|Adverse Event|0|||
164424108|NCT00557505|593924944|FG004|Overall Study|Adverse Event|0|||
164424109|NCT00557505|593924945|FG005|Overall Study|Adverse Event|0|||
164424110|NCT00557505|593924946|FG006|Overall Study|Adverse Event|1|||
164424111|NCT00557505|593924947|FG007|Overall Study|Adverse Event|0|||
164424112|NCT00557505|593924948|FG008|Overall Study|Adverse Event|0|||
164424113|NCT00557505|593924940|FG000|Overall Study|Global deterioration of health|1|||
164424114|NCT00557505|593924941|FG001|Overall Study|Global deterioration of health|0|||
164424115|NCT00557505|593924942|FG002|Overall Study|Global deterioration of health|0|||
164424116|NCT00557505|593924943|FG003|Overall Study|Global deterioration of health|0|||
164424117|NCT00557505|593924944|FG004|Overall Study|Global deterioration of health|0|||
164424118|NCT00557505|593924945|FG005|Overall Study|Global deterioration of health|0|||
164424119|NCT00557505|593924946|FG006|Overall Study|Global deterioration of health|0|||
164424120|NCT00557505|593924947|FG007|Overall Study|Global deterioration of health|0|||
164424121|NCT00557505|593924948|FG008|Overall Study|Global deterioration of health|0|||
164424122|NCT00557505|593924940|FG000|Overall Study|Objective progression or relapse|2|||
164424123|NCT00557505|593924941|FG001|Overall Study|Objective progression or relapse|3|||
164424124|NCT00557505|593924942|FG002|Overall Study|Objective progression or relapse|3|||
164424125|NCT00557505|593924943|FG003|Overall Study|Objective progression or relapse|2|||
164424126|NCT00557505|593924944|FG004|Overall Study|Objective progression or relapse|2|||
164424127|NCT00557505|593924945|FG005|Overall Study|Objective progression or relapse|3|||
164424128|NCT00557505|593924946|FG006|Overall Study|Objective progression or relapse|2|||
164424129|NCT00557505|593924947|FG007|Overall Study|Objective progression or relapse|5|||
164424130|NCT00557505|593924948|FG008|Overall Study|Objective progression or relapse|15|||
164424131|NCT00557505|593924940|FG000|Overall Study|Withdrawal by Subject|0|||
164424132|NCT00557505|593924941|FG001|Overall Study|Withdrawal by Subject|0|||
164424133|NCT00557505|593924942|FG002|Overall Study|Withdrawal by Subject|0|||
164424134|NCT00557505|593924943|FG003|Overall Study|Withdrawal by Subject|1|||
164424135|NCT00557505|593924944|FG004|Overall Study|Withdrawal by Subject|0|||
164424136|NCT00557505|593924945|FG005|Overall Study|Withdrawal by Subject|0|||
164424137|NCT00557505|593924946|FG006|Overall Study|Withdrawal by Subject|0|||
164424138|NCT00557505|593924947|FG007|Overall Study|Withdrawal by Subject|0|||
164424139|NCT00557505|593924948|FG008|Overall Study|Withdrawal by Subject|1|||
164424140|NCT01244763|593924949|FG000|Overall Study|Adverse Event|1|||
164424141|NCT01244763|593924950|FG001|Overall Study|Adverse Event|0|||
164424142|NCT01244763|593924951|FG002|Overall Study|Adverse Event|0|||
164424143|NCT01244763|593924952|FG003|Overall Study|Adverse Event|0|||
164424144|NCT01244763|593924953|FG004|Overall Study|Adverse Event|0|||
164424145|NCT01244763|593924954|FG005|Overall Study|Adverse Event|1|||
164424146|NCT01244763|593924949|FG000|Overall Study|Death|1|||
164236390|NCT00956293|593236867|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
164236391|NCT00956293|593236868|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
164424147|NCT01244763|593924950|FG001|Overall Study|Death|0|||
164424148|NCT01244763|593924951|FG002|Overall Study|Death|1|||
164677119|NCT03165994|594843007|FG000|Overall Study|Miscellaneous|1|||
164677120|NCT05014828|594843014|FG000|Overall Study|Study Completed by Sponsor|16|||
164677121|NCT05014828|594843015|FG001|Overall Study|Study Completed by Sponsor|16|||
164677122|NCT05014828|594843016|FG002|Overall Study|Study Completed by Sponsor|3|||
164677123|NCT05014828|594843017|FG003|Overall Study|Study Completed by Sponsor|3|||
164677124|NCT05014828|594843014|FG000|Overall Study|Death|11|||
164677125|NCT05014828|594843015|FG001|Overall Study|Death|6|||
164677126|NCT05014828|594843016|FG002|Overall Study|Death|0|||
164677127|NCT05014828|594843017|FG003|Overall Study|Death|0|||
164677128|NCT05014828|594843014|FG000|Overall Study|Lost to Follow-up|0|||
164677129|NCT05014828|594843015|FG001|Overall Study|Lost to Follow-up|0|||
164677130|NCT05014828|594843016|FG002|Overall Study|Lost to Follow-up|2|||
164677131|NCT05014828|594843017|FG003|Overall Study|Lost to Follow-up|0|||
164677132|NCT05014828|594843014|FG000|Overall Study|Miscellaneous.|0|||
164677133|NCT05014828|594843015|FG001|Overall Study|Miscellaneous.|1|||
164677134|NCT05014828|594843016|FG002|Overall Study|Miscellaneous.|0|||
164677135|NCT05014828|594843017|FG003|Overall Study|Miscellaneous.|0|||
164677136|NCT02682238|594843020|FG000|Overall Study|Lost to Follow-up|0|||
164677137|NCT02682238|594843021|FG001|Overall Study|Lost to Follow-up|2|||
164677138|NCT02682238|594843020|FG000|Overall Study|Withdrawal by Subject|1|||
164677139|NCT02682238|594843021|FG001|Overall Study|Withdrawal by Subject|0|||
164677140|NCT02682238|594843020|FG000|Overall Study|Adverse Event|1|||
164424149|NCT01244763|593924952|FG003|Overall Study|Death|0|||
164677141|NCT02682238|594843021|FG001|Overall Study|Adverse Event|0|||
164677142|NCT02682238|594843020|FG000|Overall Study|Non-compliance with Study Drug|1|||
164677143|NCT02682238|594843021|FG001|Overall Study|Non-compliance with Study Drug|0|||
164424150|NCT01244763|593924953|FG004|Overall Study|Death|2|||
164424151|NCT01244763|593924954|FG005|Overall Study|Death|0|||
164424152|NCT01244763|593924949|FG000|Overall Study|Physician Decision|0|||
164424153|NCT01244763|593924950|FG001|Overall Study|Physician Decision|0|||
164424154|NCT01244763|593924951|FG002|Overall Study|Physician Decision|1|||
164424155|NCT01244763|593924952|FG003|Overall Study|Physician Decision|0|||
164424156|NCT01244763|593924953|FG004|Overall Study|Physician Decision|0|||
164424157|NCT01244763|593924954|FG005|Overall Study|Physician Decision|0|||
164424158|NCT01244763|593924949|FG000|Overall Study|Withdrawal by Subject|1|||
164424159|NCT01244763|593924950|FG001|Overall Study|Withdrawal by Subject|2|||
164424160|NCT01244763|593924951|FG002|Overall Study|Withdrawal by Subject|0|||
164424161|NCT01244763|593924952|FG003|Overall Study|Withdrawal by Subject|1|||
164424162|NCT01244763|593924953|FG004|Overall Study|Withdrawal by Subject|1|||
164424163|NCT01244763|593924954|FG005|Overall Study|Withdrawal by Subject|2|||
164424164|NCT01244763|593924949|FG000|Overall Study|Lost to Follow-up|0|||
164424165|NCT01244763|593924950|FG001|Overall Study|Lost to Follow-up|1|||
164424166|NCT01244763|593924951|FG002|Overall Study|Lost to Follow-up|0|||
164424167|NCT01244763|593924952|FG003|Overall Study|Lost to Follow-up|0|||
164424168|NCT01244763|593924953|FG004|Overall Study|Lost to Follow-up|0|||
164424169|NCT01244763|593924954|FG005|Overall Study|Lost to Follow-up|0|||
164424170|NCT01244763|593924949|FG000|Overall Study|Enrolled into the Extension Study|0|||
164424171|NCT01244763|593924950|FG001|Overall Study|Enrolled into the Extension Study|0|||
164424172|NCT01244763|593924951|FG002|Overall Study|Enrolled into the Extension Study|0|||
164424173|NCT01244763|593924952|FG003|Overall Study|Enrolled into the Extension Study|0|||
164424174|NCT01244763|593924953|FG004|Overall Study|Enrolled into the Extension Study|0|||
164424175|NCT01244763|593924954|FG005|Overall Study|Enrolled into the Extension Study|1|||
164424176|NCT01323660|593924959|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
164424177|NCT01323660|593924960|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
164424178|NCT01323660|593924961|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
164424179|NCT01323660|593924962|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
164424180|NCT01323660|593924963|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
164424181|NCT01323660|593924964|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
164424182|NCT01323660|593924959|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
164424183|NCT01323660|593924960|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
164424184|NCT01323660|593924961|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
164424185|NCT01323660|593924962|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
164424186|NCT01323660|593924963|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
164424187|NCT01323660|593924964|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
164424188|NCT01323660|593924959|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
164424189|NCT01323660|593924960|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
164424190|NCT01323660|593924961|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
164424191|NCT01323660|593924962|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
164424192|NCT01323660|593924963|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
164424193|NCT01323660|593924964|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
164424194|NCT01323660|593924959|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
164334201|NCT00734474|593601488|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
164334202|NCT00734474|593601489|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
164334203|NCT00734474|593601490|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
164334204|NCT00734474|593601491|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
164334205|NCT00734474|593601483|FG000|Overall Study|Sponsor Decision|0|||
164334206|NCT00734474|593601484|FG001|Overall Study|Sponsor Decision|0|||
164334207|NCT00734474|593601485|FG002|Overall Study|Sponsor Decision|0|||
164334208|NCT00734474|593601486|FG003|Overall Study|Sponsor Decision|0|||
164334209|NCT00734474|593601487|FG004|Overall Study|Sponsor Decision|2|||
164334210|NCT00734474|593601488|FG005|Overall Study|Sponsor Decision|0|||
164334211|NCT00734474|593601489|FG006|Overall Study|Sponsor Decision|0|||
164334212|NCT00734474|593601490|FG007|Overall Study|Sponsor Decision|0|||
164334213|NCT00734474|593601491|FG008|Overall Study|Sponsor Decision|0|||
164334214|NCT00734474|593601483|FG000|Overall Study|Death|0|||
164334215|NCT00734474|593601484|FG001|Overall Study|Death|0|||
164334216|NCT00734474|593601485|FG002|Overall Study|Death|1|||
164424195|NCT01323660|593924960|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
164424196|NCT01323660|593924961|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
164424197|NCT01323660|593924962|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
164424198|NCT01323660|593924963|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
164437465|NCT02914522|593968187|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
164334217|NCT00734474|593601486|FG003|Overall Study|Death|0|||
164334218|NCT00734474|593601487|FG004|Overall Study|Death|0|||
164334219|NCT00734474|593601488|FG005|Overall Study|Death|0|||
164334220|NCT00734474|593601489|FG006|Overall Study|Death|0|||
164334221|NCT00734474|593601490|FG007|Overall Study|Death|2|||
164334222|NCT00734474|593601491|FG008|Overall Study|Death|1|||
164334223|NCT00734474|593601483|FG000|Overall Study|Lack of Efficacy|0|||
164334224|NCT00734474|593601484|FG001|Overall Study|Lack of Efficacy|0|||
164334225|NCT00734474|593601485|FG002|Overall Study|Lack of Efficacy|4|||
164334226|NCT00734474|593601486|FG003|Overall Study|Lack of Efficacy|0|||
164334227|NCT00734474|593601487|FG004|Overall Study|Lack of Efficacy|0|||
164334228|NCT00734474|593601488|FG005|Overall Study|Lack of Efficacy|0|||
164334229|NCT00734474|593601489|FG006|Overall Study|Lack of Efficacy|0|||
164334230|NCT00734474|593601490|FG007|Overall Study|Lack of Efficacy|4|||
164334231|NCT00734474|593601491|FG008|Overall Study|Lack of Efficacy|6|||
164334232|NCT02104752|593601494|FG000|Overall Study|Withdrawal by Subject|1|||
164334233|NCT02104752|593601495|FG001|Overall Study|Withdrawal by Subject|0|||
164334234|NCT02104752|593601494|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
164334235|NCT02104752|593601495|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
164334236|NCT02899299|593601496|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
164334237|NCT02899299|593601497|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
164334238|NCT02899299|593601496|FG000|Pre-treatment|Participant withdrew consent|1|||
164334239|NCT02899299|593601497|FG001|Pre-treatment|Participant withdrew consent|11|||
164334240|NCT02899299|593601496|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
164334241|NCT02899299|593601497|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
164334242|NCT02899299|593601496|FG000|Pre-treatment|Not reported|0|||
164334243|NCT02899299|593601497|FG001|Pre-treatment|Not reported|1|||
164334244|NCT02899299|593601496|FG000|Treatment|Disease Progression|182|||
164334245|NCT02899299|593601497|FG001|Treatment|Disease Progression|43|||
164334246|NCT02899299|593601496|FG000|Treatment|Study Drug Toxicity|60|||
164334247|NCT02899299|593601497|FG001|Treatment|Study Drug Toxicity|24|||
164334248|NCT02899299|593601496|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
164334249|NCT02899299|593601497|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
164334250|NCT02899299|593601496|FG000|Treatment|Participant request to discontinue Study treatment|4|||
164334251|NCT02899299|593601497|FG001|Treatment|Participant request to discontinue Study treatment|10|||
164334252|NCT02899299|593601496|FG000|Treatment|Participant withdrew consent|6|||
164334253|NCT02899299|593601497|FG001|Treatment|Participant withdrew consent|3|||
164334254|NCT02899299|593601496|FG000|Treatment|Lost to Follow-up|0|||
164334255|NCT02899299|593601497|FG001|Treatment|Lost to Follow-up|2|||
164334256|NCT02899299|593601496|FG000|Treatment|Maximum Clinical Benefit|11|||
164334257|NCT02899299|593601497|FG001|Treatment|Maximum Clinical Benefit|2|||
164334258|NCT02899299|593601496|FG000|Treatment|Poor/Non-compliance|1|||
164334259|NCT02899299|593601497|FG001|Treatment|Poor/Non-compliance|0|||
164334260|NCT02899299|593601496|FG000|Treatment|Participant no longer meets Study criteria|4|||
164334261|NCT02899299|593601497|FG001|Treatment|Participant no longer meets Study criteria|0|||
164334262|NCT02899299|593601496|FG000|Treatment|Administrative reason by Sponsor|2|||
164334263|NCT02899299|593601497|FG001|Treatment|Administrative reason by Sponsor|0|||
164334264|NCT02899299|593601496|FG000|Treatment|Other reasons|12|||
164334265|NCT02899299|593601497|FG001|Treatment|Other reasons|2|||
164334266|NCT02899299|593601496|FG000|Treatment|Not reported|7|||
164334267|NCT02899299|593601497|FG001|Treatment|Not reported|0|||
164334268|NCT00313300|593601498|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
164334269|NCT00313300|593601499|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
164334270|NCT00313300|593601500|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
164334271|NCT00313300|593601501|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
164334272|NCT00313300|593601502|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
164334273|NCT00313300|593601498|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
164334274|NCT00313300|593601499|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
164334275|NCT00313300|593601500|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
164334276|NCT00313300|593601501|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
164334277|NCT00313300|593601502|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
164334278|NCT00313300|593601498|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
164334279|NCT00313300|593601499|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
164334280|NCT00313300|593601500|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
164334281|NCT00313300|593601501|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
164334282|NCT00313300|593601502|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
164334283|NCT00313300|593601498|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
164334284|NCT00313300|593601499|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
164334285|NCT00313300|593601500|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
164573127|NCT02561156|594463324|FG012|Part 2|Adverse Event|0|||
164334286|NCT00313300|593601501|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
164334287|NCT00313300|593601502|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
164334288|NCT00313300|593601498|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
164334289|NCT00313300|593601499|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
164334290|NCT00313300|593601500|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
164334291|NCT00313300|593601501|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
164334292|NCT00313300|593601502|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
164334293|NCT00313300|593601498|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
164334294|NCT00313300|593601499|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
164334295|NCT00313300|593601500|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
164334296|NCT00313300|593601501|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
164334297|NCT00313300|593601502|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
164334298|NCT00313300|593601498|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
164334299|NCT00313300|593601499|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
164334300|NCT00313300|593601500|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
164334301|NCT00313300|593601501|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
164334302|NCT00313300|593601502|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
164334303|NCT00313300|593601498|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
164334304|NCT00313300|593601499|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
164334305|NCT00313300|593601500|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
164334306|NCT00313300|593601501|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
164334307|NCT00313300|593601502|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
164334308|NCT00313300|593601498|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
164334309|NCT00313300|593601499|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
164334310|NCT00313300|593601500|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
164334311|NCT00313300|593601501|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
164334312|NCT00313300|593601502|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
164334313|NCT00313300|593601498|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
164334314|NCT00313300|593601499|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
164334315|NCT00313300|593601500|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
164334316|NCT00313300|593601501|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
164334317|NCT00313300|593601502|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
164334318|NCT00313300|593601498|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
164334319|NCT00313300|593601499|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
164334320|NCT00313300|593601500|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
164334321|NCT00313300|593601501|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
164334322|NCT00313300|593601502|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
164334323|NCT00313300|593601498|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
164334324|NCT00313300|593601499|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
164334325|NCT00313300|593601500|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
164334326|NCT00313300|593601501|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
164334327|NCT00313300|593601502|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
164334328|NCT00313300|593601498|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
164334329|NCT00313300|593601499|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
164334330|NCT00313300|593601500|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
164334331|NCT00313300|593601501|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
164334332|NCT00313300|593601502|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
164334333|NCT00313300|593601498|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
164334334|NCT00313300|593601499|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
164334335|NCT00313300|593601500|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
164334336|NCT00313300|593601501|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
164334337|NCT00313300|593601502|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
164334338|NCT00313300|593601498|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
164334339|NCT00313300|593601499|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
164334340|NCT00313300|593601500|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
164334341|NCT00313300|593601501|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
164334342|NCT00313300|593601502|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
164334343|NCT00313300|593601498|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
164334344|NCT00313300|593601499|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
164334345|NCT00313300|593601500|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
164334346|NCT00313300|593601501|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
164334347|NCT00313300|593601502|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
164334348|NCT00313300|593601498|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
164334349|NCT00313300|593601499|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
164334350|NCT00313300|593601500|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
164334351|NCT00313300|593601501|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
164334352|NCT00313300|593601502|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
164334353|NCT00313300|593601498|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
164334354|NCT00313300|593601499|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
164334355|NCT00313300|593601500|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
164334356|NCT00313300|593601501|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
164334357|NCT00313300|593601502|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
164334358|NCT00313300|593601498|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
164334359|NCT00313300|593601499|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
164334360|NCT00313300|593601500|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
164334361|NCT00313300|593601501|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
164334362|NCT00313300|593601502|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
164424199|NCT01323660|593924964|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
164424200|NCT01323660|593924959|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164424201|NCT01323660|593924960|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164424202|NCT01323660|593924961|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164424203|NCT01323660|593924962|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164424204|NCT01323660|593924963|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
164424205|NCT01323660|593924964|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164424206|NCT01323660|593924959|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
164424207|NCT01323660|593924960|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
164424208|NCT01323660|593924961|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
164424209|NCT01323660|593924962|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
164424210|NCT01323660|593924963|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
164424211|NCT01323660|593924964|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
164424212|NCT01323660|593924959|FG000|Washout Period (14 Days)|Adverse Event|0|||
164424213|NCT01323660|593924960|FG001|Washout Period (14 Days)|Adverse Event|0|||
164424214|NCT01323660|593924961|FG002|Washout Period (14 Days)|Adverse Event|0|||
164424215|NCT01323660|593924962|FG003|Washout Period (14 Days)|Adverse Event|0|||
164424216|NCT01323660|593924963|FG004|Washout Period (14 Days)|Adverse Event|1|||
164424217|NCT01323660|593924964|FG005|Washout Period (14 Days)|Adverse Event|0|||
164424218|NCT01323660|593924959|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
164424219|NCT01323660|593924960|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
164424220|NCT01323660|593924961|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
164424221|NCT01323660|593924962|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
164424222|NCT01323660|593924963|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
164424223|NCT01323660|593924964|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
164424224|NCT01323660|593924959|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
164424225|NCT01323660|593924960|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
164424226|NCT01323660|593924961|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
164424227|NCT01323660|593924962|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
164424228|NCT01323660|593924963|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
164424229|NCT01323660|593924964|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
164424230|NCT01323660|593924959|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
164424231|NCT01323660|593924960|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
164424232|NCT01323660|593924961|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
164424233|NCT01323660|593924962|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
164424234|NCT01323660|593924963|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
164424235|NCT01323660|593924964|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
164424236|NCT01323660|593924959|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
164424237|NCT01323660|593924960|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
164424238|NCT01323660|593924961|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
164424239|NCT01323660|593924962|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
164424240|NCT01323660|593924963|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
164424241|NCT01323660|593924964|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
164424242|NCT01323660|593924959|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
164424243|NCT01323660|593924960|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
164424244|NCT01323660|593924961|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
164424245|NCT01323660|593924962|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
164424246|NCT01323660|593924963|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
164424247|NCT01323660|593924964|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
164424248|NCT01323660|593924959|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
164424249|NCT01323660|593924960|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
164424250|NCT01323660|593924961|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
164424251|NCT01323660|593924962|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
164424252|NCT01323660|593924963|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
164424253|NCT01323660|593924964|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
164424254|NCT01403987|593924968|FG000|Overall Study|Residents forgot their secret PIN|18|||
164424255|NCT01403987|593924969|FG001|Overall Study|Residents forgot their secret PIN|17|||
164424256|NCT01403987|593924970|FG002|Overall Study|Residents forgot their secret PIN|18|||
164424257|NCT00751790|593924975|FG000|Overall Study|Lost to Follow-up|1|||
164424258|NCT00751790|593924975|FG000|Overall Study|Death|3|||
164424259|NCT00751790|593924975|FG000|Overall Study|Withdrawal by Subject|1|||
164424260|NCT00180674|593924976|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
164424261|NCT00180674|593924976|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
164424262|NCT03302910|593924977|FG000|Overall Study|Protocol Violation|1|||
164424263|NCT03302910|593924978|FG001|Overall Study|Protocol Violation|0|||
164424264|NCT01106976|593924979|FG000|Overall Study|Lost to Follow-up|8|||
164424265|NCT01477749|593924982|FG000|Overall Study|Physician Decision|4|||
164424266|NCT04227340|593924986|FG000|Overall Study|Withdrawal by Subject|3|||
164424267|NCT01066156|593924987|FG000|Overall Study|ineligible|2|||
164424268|NCT01066156|593924987|FG000|Overall Study|Lost to Follow-up|7|||
164424269|NCT01066156|593924987|FG000|Overall Study|Withdrawal by Subject|1|||
164334363|NCT00313300|593601498|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
164334364|NCT00313300|593601499|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
164334365|NCT00313300|593601500|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
164334366|NCT00313300|593601501|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
164334367|NCT00313300|593601502|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
164334368|NCT00313300|593601498|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
164334369|NCT00313300|593601499|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
164334370|NCT00313300|593601500|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
164334371|NCT00313300|593601501|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
164334372|NCT00313300|593601502|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
164334373|NCT00639678|593601505|FG000|Overall Study|Withdrawal by Subject|3|||
164334374|NCT00639678|593601506|FG001|Overall Study|Withdrawal by Subject|0|||
164334375|NCT00639678|593601507|FG002|Overall Study|Withdrawal by Subject|4|||
164334376|NCT00639678|593601508|FG003|Overall Study|Withdrawal by Subject|0|||
164334377|NCT00639678|593601505|FG000|Overall Study|Lost to Follow-up|1|||
164334378|NCT00639678|593601506|FG001|Overall Study|Lost to Follow-up|0|||
164334379|NCT00639678|593601507|FG002|Overall Study|Lost to Follow-up|6|||
164334380|NCT00639678|593601508|FG003|Overall Study|Lost to Follow-up|0|||
164334381|NCT00639678|593601505|FG000|Overall Study|Adverse Event|0|||
164334382|NCT00639678|593601506|FG001|Overall Study|Adverse Event|1|||
164334383|NCT00639678|593601507|FG002|Overall Study|Adverse Event|0|||
164334384|NCT00639678|593601508|FG003|Overall Study|Adverse Event|0|||
164334385|NCT00639678|593601505|FG000|Overall Study|Lack of Compliance|0|||
164334386|NCT00639678|593601506|FG001|Overall Study|Lack of Compliance|0|||
164334387|NCT00639678|593601507|FG002|Overall Study|Lack of Compliance|1|||
164334388|NCT00639678|593601508|FG003|Overall Study|Lack of Compliance|0|||
164334389|NCT01926015|593601509|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164334390|NCT01926015|593601510|FG001|Overall Study|Withdrawal by parent/guardian|1|||
164334391|NCT01926015|593601509|FG000|Overall Study|Randomized not treated|2|||
164334392|NCT01926015|593601510|FG001|Overall Study|Randomized not treated|0|||
164334393|NCT01364649|593601511|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
164334394|NCT01364649|593601512|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
164334395|NCT01364649|593601511|FG000|Overall Study|Lack of Efficacy|6|||
164334396|NCT01364649|593601512|FG001|Overall Study|Lack of Efficacy|0|||
164334397|NCT01364649|593601511|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
164334398|NCT01364649|593601512|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
164334399|NCT01364649|593601511|FG000|Overall Study|Protocol Deviations|4|||
164334400|NCT01364649|593601512|FG001|Overall Study|Protocol Deviations|8|||
164334401|NCT01364649|593601511|FG000|Overall Study|Withdrawal of Consent|9|||
164334402|NCT01364649|593601512|FG001|Overall Study|Withdrawal of Consent|7|||
164334403|NCT01364649|593601511|FG000|Overall Study|Lost to Follow-up|12|||
164334404|NCT01364649|593601512|FG001|Overall Study|Lost to Follow-up|13|||
164334405|NCT01364649|593601511|FG000|Overall Study|Other|4|||
164334406|NCT01364649|593601512|FG001|Overall Study|Other|1|||
164334407|NCT01826604|593601513|FG000|Overall Study|Lost to Follow-up|8|||
164334408|NCT01826604|593601514|FG001|Overall Study|Lost to Follow-up|9|||
164334409|NCT04416633|593601515|FG000|Overall Study|Death|1|||
164334410|NCT04416633|593601515|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
164334411|NCT04416633|593601515|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
164334412|NCT04416633|593601515|FG000|Overall Study|Adverse Event|6|||
164334413|NCT04416633|593601515|FG000|Overall Study|Withdrawal by Subject|6|||
164334414|NCT03323502|593601516|FG000|Overall Study|Resident could not be linked to CMS data|594|||
164334415|NCT03323502|593601517|FG001|Overall Study|Resident could not be linked to CMS data|435|||
164334416|NCT03323502|593601516|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
164334417|NCT03323502|593601517|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
164334418|NCT03323502|593601516|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
164334419|NCT03323502|593601517|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
164334420|NCT03323502|593601516|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
164334421|NCT03323502|593601517|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
164334422|NCT03323502|593601516|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
164334423|NCT03323502|593601517|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
164334424|NCT00902668|593601528|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
164334425|NCT01914757|593601529|FG000|Overall Study|Severe non-compliance to protocol|3|||
164334426|NCT01914757|593601530|FG001|Overall Study|Severe non-compliance to protocol|1|||
164334427|NCT01914757|593601531|FG002|Overall Study|Severe non-compliance to protocol|2|||
164334428|NCT01914757|593601529|FG000|Overall Study|Lost to Follow-up|5|||
164334429|NCT01914757|593601530|FG001|Overall Study|Lost to Follow-up|8|||
164334430|NCT01914757|593601531|FG002|Overall Study|Lost to Follow-up|6|||
164334431|NCT01914757|593601529|FG000|Overall Study|Withdrawal by Subject|15|||
164334432|NCT01914757|593601530|FG001|Overall Study|Withdrawal by Subject|27|||
164236392|NCT00956293|593236866|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
164236393|NCT00956293|593236867|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
164236394|NCT00956293|593236868|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
164236395|NCT00956293|593236866|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
164236396|NCT00956293|593236867|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
164236397|NCT00956293|593236868|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
164236398|NCT00956293|593236866|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
164236399|NCT00956293|593236867|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
164236400|NCT00956293|593236868|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
164236401|NCT00956293|593236866|FG000|Main Period (Randomization)|Adverse Event|0|||
164236402|NCT00956293|593236867|FG001|Main Period (Randomization)|Adverse Event|15|||
164236403|NCT00956293|593236868|FG002|Main Period (Randomization)|Adverse Event|0|||
164236404|NCT00956293|593236866|FG000|Follow-up Period|Follow-up period was terminated.|20|||
164236405|NCT00956293|593236867|FG001|Follow-up Period|Follow-up period was terminated.|32|||
164236406|NCT00956293|593236868|FG002|Follow-up Period|Follow-up period was terminated.|0|||
164236407|NCT02536664|593236869|FG000|Overall Study|Inadequate completion of documentation|2|||
164236408|NCT02536664|593236870|FG001|Overall Study|Inadequate completion of documentation|4|||
164236409|NCT02536664|593236869|FG000|Overall Study|Progression|13|||
164236410|NCT02536664|593236870|FG001|Overall Study|Progression|18|||
164236411|NCT02536664|593236869|FG000|Overall Study|Death due to lymphoma|2|||
164236412|NCT02536664|593236870|FG001|Overall Study|Death due to lymphoma|1|||
164236413|NCT02536664|593236869|FG000|Overall Study|Death due to other reason|3|||
164236414|NCT02536664|593236870|FG001|Overall Study|Death due to other reason|2|||
164236415|NCT02536664|593236869|FG000|Overall Study|Intolerability|8|||
164236416|NCT02536664|593236870|FG001|Overall Study|Intolerability|6|||
164236417|NCT02536664|593236869|FG000|Overall Study|Withdrawal by Subject|8|||
164236418|NCT02536664|593236870|FG001|Overall Study|Withdrawal by Subject|5|||
164236419|NCT02536664|593236869|FG000|Overall Study|Other|18|||
164334433|NCT01914757|593601531|FG002|Overall Study|Withdrawal by Subject|19|||
164334434|NCT01914757|593601529|FG000|Overall Study|Death|2|||
164334435|NCT01914757|593601530|FG001|Overall Study|Death|2|||
164334436|NCT01914757|593601531|FG002|Overall Study|Death|1|||
164334437|NCT01914757|593601529|FG000|Overall Study|Adverse Event|4|||
164334438|NCT01914757|593601530|FG001|Overall Study|Adverse Event|3|||
164334439|NCT01914757|593601531|FG002|Overall Study|Adverse Event|4|||
164334440|NCT01914757|593601529|FG000|Overall Study|Study specific withdrawal criteria|0|||
164334441|NCT01914757|593601530|FG001|Overall Study|Study specific withdrawal criteria|1|||
164334442|NCT01914757|593601531|FG002|Overall Study|Study specific withdrawal criteria|0|||
164334443|NCT01914757|593601529|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
164334444|NCT01914757|593601530|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164334445|NCT01914757|593601531|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
164334446|NCT01914757|593601529|FG000|Overall Study|Other reasons|5|||
164334447|NCT01914757|593601530|FG001|Overall Study|Other reasons|9|||
164334448|NCT01914757|593601531|FG002|Overall Study|Other reasons|4|||
164334449|NCT00408629|593601536|FG000|Overall Study|Adverse Event|13|||
164334450|NCT00408629|593601537|FG001|Overall Study|Adverse Event|27|||
164334451|NCT00408629|593601536|FG000|Overall Study|Withdrawal by Subject|8|||
164334452|NCT00408629|593601537|FG001|Overall Study|Withdrawal by Subject|4|||
164334453|NCT00408629|593601536|FG000|Overall Study|Lost to Follow-up|1|||
164334454|NCT00408629|593601537|FG001|Overall Study|Lost to Follow-up|1|||
164334455|NCT00408629|593601536|FG000|Overall Study|Lack of Efficacy|63|||
164334456|NCT00408629|593601537|FG001|Overall Study|Lack of Efficacy|73|||
164334457|NCT00408629|593601536|FG000|Overall Study|Protocol Violation|1|||
164334458|NCT00408629|593601537|FG001|Overall Study|Protocol Violation|5|||
164334459|NCT00408629|593601536|FG000|Overall Study|Miscellaneous|11|||
164334460|NCT00408629|593601537|FG001|Overall Study|Miscellaneous|15|||
164334461|NCT01461980|593601538|FG000|Overall Study|Other|9|||
164334462|NCT01461980|593601539|FG001|Overall Study|Other|8|||
164334463|NCT01461980|593601540|FG002|Overall Study|Other|6|||
164334464|NCT01461980|593601538|FG000|Overall Study|Medication error|7|||
164334465|NCT01461980|593601539|FG001|Overall Study|Medication error|5|||
164334466|NCT01461980|593601540|FG002|Overall Study|Medication error|6|||
164334467|NCT01461980|593601538|FG000|Overall Study|Adverse Event|12|||
164334468|NCT01461980|593601539|FG001|Overall Study|Adverse Event|5|||
164334469|NCT01461980|593601540|FG002|Overall Study|Adverse Event|6|||
164334470|NCT01461980|593601538|FG000|Overall Study|Protocol Violation|12|||
164334471|NCT01461980|593601539|FG001|Overall Study|Protocol Violation|19|||
164334472|NCT01461980|593601540|FG002|Overall Study|Protocol Violation|16|||
164334473|NCT01461980|593601538|FG000|Overall Study|No longer meets eligibility criteria|18|||
164334474|NCT01461980|593601539|FG001|Overall Study|No longer meets eligibility criteria|9|||
164334475|NCT01461980|593601540|FG002|Overall Study|No longer meets eligibility criteria|19|||
164334476|NCT01461980|593601538|FG000|Overall Study|Lost to Follow-up|52|||
164334477|NCT01461980|593601539|FG001|Overall Study|Lost to Follow-up|53|||
164236420|NCT02536664|593236870|FG001|Overall Study|Other|24|||
164236421|NCT02536664|593236869|FG000|Overall Study|Missing|53|||
164236422|NCT02536664|593236870|FG001|Overall Study|Missing|20|||
164334478|NCT01461980|593601540|FG002|Overall Study|Lost to Follow-up|51|||
164424270|NCT02015663|593924989|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
164424271|NCT02015663|593924990|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
164424272|NCT02015663|593924989|FG000|Overall Study|Withdrawal by Subject|1|||
164424273|NCT02015663|593924990|FG001|Overall Study|Withdrawal by Subject|0|||
164424274|NCT02015663|593924989|FG000|Overall Study|Protocol Violation|0|||
164424275|NCT02015663|593924990|FG001|Overall Study|Protocol Violation|1|||
164424276|NCT02015663|593924989|FG000|Overall Study|Adverse Event|3|||
164424277|NCT02015663|593924990|FG001|Overall Study|Adverse Event|0|||
164424278|NCT02015663|593924989|FG000|Overall Study|Administrative problems|10|||
164424279|NCT02015663|593924990|FG001|Overall Study|Administrative problems|11|||
164424280|NCT02059161|593924991|FG000|Overall Study|Pregnancy|0|||
164424281|NCT02059161|593924992|FG001|Overall Study|Pregnancy|2|||
164424282|NCT02059161|593924991|FG000|Overall Study|Adverse Event|2|||
164424283|NCT02059161|593924992|FG001|Overall Study|Adverse Event|6|||
164424284|NCT02059161|593924991|FG000|Overall Study|Lost to Follow-up|20|||
164424285|NCT02059161|593924992|FG001|Overall Study|Lost to Follow-up|12|||
164424286|NCT02059161|593924991|FG000|Overall Study|Physician Decision|4|||
164424287|NCT02059161|593924992|FG001|Overall Study|Physician Decision|4|||
164424288|NCT02059161|593924991|FG000|Overall Study|Protocol Violation|1|||
164424289|NCT02059161|593924992|FG001|Overall Study|Protocol Violation|1|||
164424290|NCT02059161|593924991|FG000|Overall Study|Withdrawal by Subject|16|||
164424291|NCT02059161|593924992|FG001|Overall Study|Withdrawal by Subject|13|||
164424292|NCT02059161|593924991|FG000|Overall Study|Randomized in error, no study drug|0|||
164424293|NCT02059161|593924992|FG001|Overall Study|Randomized in error, no study drug|1|||
164424294|NCT02059161|593924991|FG000|Overall Study|Non-compliance with study drug|6|||
164424295|NCT02059161|593924992|FG001|Overall Study|Non-compliance with study drug|2|||
164424296|NCT01719861|593924996|FG000|Cycle 1|Death|4|||
164424297|NCT01719861|593924996|FG000|Cycle 2|Death|1|||
164424298|NCT00958009|593924997|FG000|Overall Study|Adverse Event|1|||
164424299|NCT00958009|593924997|FG000|Overall Study|Subject found device difficult to use|1|||
164424300|NCT00087490|593925010|FG000|Overall Study|Death|6|||
164573128|NCT01071070|594463325|FG000|Overall Study|Adverse Event|0|||
164573129|NCT01071070|594463326|FG001|Overall Study|Adverse Event|3|||
164334479|NCT01461980|593601538|FG000|Overall Study|No longer willing to participate|52|||
164334480|NCT01461980|593601539|FG001|Overall Study|No longer willing to participate|38|||
164334481|NCT01461980|593601540|FG002|Overall Study|No longer willing to participate|54|||
164334482|NCT01461980|593601538|FG000|Overall Study|Randomized but not vaccinated|4|||
164334483|NCT01461980|593601539|FG001|Overall Study|Randomized but not vaccinated|8|||
164334484|NCT01461980|593601540|FG002|Overall Study|Randomized but not vaccinated|7|||
164334485|NCT00122109|593601541|FG000|Overall Study|Did not meet criteria|6|||
164334486|NCT00122109|593601542|FG001|Overall Study|Did not meet criteria|7|||
164334487|NCT01890746|593601543|FG000|Overall Study|Death|39|||
164334488|NCT01890746|593601544|FG001|Overall Study|Death|30|||
164334489|NCT01890746|593601543|FG000|Overall Study|Adverse Event|1|||
164334490|NCT01890746|593601544|FG001|Overall Study|Adverse Event|0|||
164334491|NCT01890746|593601543|FG000|Overall Study|Lost to Follow-up|4|||
164334492|NCT01890746|593601544|FG001|Overall Study|Lost to Follow-up|1|||
164334493|NCT01890746|593601543|FG000|Overall Study|Physician Decision|3|||
164424301|NCT00087490|593925011|FG001|Overall Study|Death|4|||
164573130|NCT01071070|594463325|FG000|Overall Study|Withdrawal by Subject|1|||
164573131|NCT01071070|594463326|FG001|Overall Study|Withdrawal by Subject|0|||
164573132|NCT01071070|594463325|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
164573133|NCT01071070|594463326|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
164573134|NCT01071070|594463325|FG000|Overall Study|Hypercalcemia|1|||
164573135|NCT01071070|594463326|FG001|Overall Study|Hypercalcemia|0|||
164573136|NCT02207907|594463336|FG000|Overall Study|Lost to Follow-up|3|||
164573137|NCT02207907|594463337|FG001|Overall Study|Lost to Follow-up|1|||
164573138|NCT02207907|594463336|FG000|Overall Study|Withdrawal by Subject|5|||
164573139|NCT02207907|594463337|FG001|Overall Study|Withdrawal by Subject|6|||
164573140|NCT02207907|594463336|FG000|Overall Study|Did not meet study criteria|3|||
164573141|NCT02207907|594463337|FG001|Overall Study|Did not meet study criteria|0|||
164573142|NCT02207907|594463336|FG000|Overall Study|Pregnancy|0|||
164573143|NCT02207907|594463337|FG001|Overall Study|Pregnancy|1|||
164573144|NCT00158184|594463338|FG000|Overall Study|personal issues|3|||
164573145|NCT00158184|594463339|FG001|Overall Study|personal issues|1|||
164573146|NCT00158184|594463338|FG000|Overall Study|failed for follow unit/study rules|2|||
164573147|NCT00158184|594463339|FG001|Overall Study|failed for follow unit/study rules|0|||
164573148|NCT00158184|594463338|FG000|Overall Study|Adverse Event|1|||
164573149|NCT00158184|594463339|FG001|Overall Study|Adverse Event|1|||
164573150|NCT01025635|594463345|FG000|Overall Study|Withdrawal by Subject|6|||
164573151|NCT01025635|594463346|FG001|Overall Study|Withdrawal by Subject|7|||
164573152|NCT01025635|594463345|FG000|Overall Study|Protocol Violation|4|||
164573153|NCT01025635|594463346|FG001|Overall Study|Protocol Violation|2|||
164573154|NCT01025635|594463345|FG000|Overall Study|Lack of Efficacy|0|||
164573155|NCT01025635|594463346|FG001|Overall Study|Lack of Efficacy|1|||
164334494|NCT01890746|593601544|FG001|Overall Study|Physician Decision|2|||
164424302|NCT00087490|593925010|FG000|Overall Study|Adverse Event|3|||
164573156|NCT01025635|594463345|FG000|Overall Study|Lost to Follow-up|9|||
164424303|NCT00087490|593925011|FG001|Overall Study|Adverse Event|8|||
164424304|NCT00087490|593925010|FG000|Overall Study|Lack of Efficacy|0|||
164424305|NCT00087490|593925011|FG001|Overall Study|Lack of Efficacy|2|||
164424306|NCT00087490|593925010|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
164424307|NCT00087490|593925011|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
164424308|NCT00087490|593925010|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
164424309|NCT00087490|593925011|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
164424310|NCT00087490|593925010|FG000|Overall Study|Randomized but not treated|7|||
164424311|NCT00087490|593925011|FG001|Overall Study|Randomized but not treated|18|||
164424312|NCT01925170|593925012|FG000|Overall Study|Unverified cancer status|53|||
164424313|NCT02300311|593925017|FG000|Overall Study|Other than the reason specified|1|||
164424314|NCT02300311|593925018|FG001|Overall Study|Other than the reason specified|0|||
164424315|NCT02300311|593925017|FG000|Overall Study|Refused to continue taking medication|18|||
164424316|NCT02300311|593925018|FG001|Overall Study|Refused to continue taking medication|0|||
164424317|NCT02839681|593925019|FG000|Overall Study|Death|2|||
164424318|NCT00848211|593925020|FG000|Overall Study|Protocol Violation|0|||
164424319|NCT00848211|593925021|FG001|Overall Study|Protocol Violation|1|||
164424320|NCT00848211|593925022|FG002|Overall Study|Protocol Violation|1|||
164424321|NCT00848211|593925023|FG003|Overall Study|Protocol Violation|0|||
164424322|NCT00848211|593925020|FG000|Overall Study|Adverse Event|0|||
164424323|NCT00848211|593925021|FG001|Overall Study|Adverse Event|0|||
164424324|NCT00848211|593925022|FG002|Overall Study|Adverse Event|0|||
164424325|NCT00848211|593925023|FG003|Overall Study|Adverse Event|0|||
164424326|NCT00772928|593925024|FG000|Overall Study|Lost to Follow-up|9|||
164424327|NCT00772928|593925025|FG001|Overall Study|Lost to Follow-up|6|||
164424328|NCT00772928|593925024|FG000|Overall Study|Protocol Violation|10|||
164424329|NCT00772928|593925025|FG001|Overall Study|Protocol Violation|12|||
164424330|NCT00772928|593925024|FG000|Overall Study|Withdrawal by Subject|25|||
164424331|NCT00772928|593925025|FG001|Overall Study|Withdrawal by Subject|22|||
164424332|NCT00772928|593925024|FG000|Overall Study|Did not receive vaccine|0|||
164424333|NCT00772928|593925025|FG001|Overall Study|Did not receive vaccine|1|||
164424334|NCT00801242|593925030|FG000|Overall Study|Adverse Event|10|||
164424335|NCT00801242|593925030|FG000|Overall Study|Withdrawal by Subject|13|||
164424336|NCT00801242|593925030|FG000|Overall Study|Protocol Violation|5|||
164236423|NCT03507127|593236873|FG000|Overall Study|Withdrawal by Subject|1|||
164236424|NCT03507127|593236874|FG001|Overall Study|Withdrawal by Subject|0|||
164236425|NCT03507127|593236873|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
164236426|NCT03507127|593236874|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
164236427|NCT02081586|593236876|FG000|Overall Study|Lost to Follow-up|0|||
164236428|NCT02081586|593236877|FG001|Overall Study|Lost to Follow-up|1|||
164236429|NCT02081586|593236878|FG002|Overall Study|Lost to Follow-up|0|||
164236430|NCT02081586|593236879|FG003|Overall Study|Lost to Follow-up|1|||
164236431|NCT02081586|593236876|FG000|Overall Study|Head injury not related to study|0|||
164236432|NCT02081586|593236877|FG001|Overall Study|Head injury not related to study|0|||
164236433|NCT02081586|593236878|FG002|Overall Study|Head injury not related to study|1|||
164236434|NCT02081586|593236879|FG003|Overall Study|Head injury not related to study|0|||
164236435|NCT01355627|593236881|FG000|Overall Study|Request By the Patient to Discontinue|5|||
164236436|NCT01355627|593236882|FG001|Overall Study|Request By the Patient to Discontinue|7|||
164236437|NCT01355627|593236881|FG000|Overall Study|Lost to Follow-up|8|||
164236438|NCT01355627|593236882|FG001|Overall Study|Lost to Follow-up|7|||
164236439|NCT01355627|593236881|FG000|Overall Study|Fatal Adverse Event|19|||
164236440|NCT01355627|593236882|FG001|Overall Study|Fatal Adverse Event|23|||
164236441|NCT01355627|593236881|FG000|Overall Study|Other|1|||
164236442|NCT01355627|593236882|FG001|Overall Study|Other|1|||
164236443|NCT00789555|593236891|FG000|Overall Study|Protocol Amendment|78|||
164236444|NCT00789555|593236892|FG001|Overall Study|Protocol Amendment|76|||
164236445|NCT00789555|593236893|FG002|Overall Study|Protocol Amendment|80|||
164236446|NCT00789555|593236891|FG000|Overall Study|Adverse Event|17|||
164236447|NCT00789555|593236892|FG001|Overall Study|Adverse Event|7|||
164424337|NCT00801242|593925030|FG000|Overall Study|Physician Decision|3|||
164424338|NCT00801242|593925030|FG000|Overall Study|Lost to Follow-up|1|||
164424339|NCT00801242|593925030|FG000|Overall Study|Miscellaneous reasons|20|||
164424340|NCT00184028|593925031|FG000|Overall Study|Death|1|||
164424341|NCT00184028|593925031|FG000|Overall Study|Lack of Efficacy|4|||
164236448|NCT00789555|593236893|FG002|Overall Study|Adverse Event|10|||
164236449|NCT00789555|593236891|FG000|Overall Study|Lost to Follow-up|9|||
164236450|NCT00789555|593236892|FG001|Overall Study|Lost to Follow-up|10|||
164424342|NCT00184028|593925031|FG000|Overall Study|Adverse Event|2|||
164424343|NCT00184028|593925031|FG000|Overall Study|Withdrawal by Subject|1|||
164424344|NCT00184028|593925031|FG000|Overall Study|Non-compliance|2|||
164424345|NCT01347645|593925032|FG000|Overall Study|Death|1|||
164424346|NCT01347645|593925033|FG001|Overall Study|Death|5|||
164424347|NCT01347645|593925034|FG002|Overall Study|Death|2|||
164236451|NCT00789555|593236893|FG002|Overall Study|Lost to Follow-up|18|||
164236452|NCT00789555|593236891|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
164236453|NCT00789555|593236892|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
164424348|NCT01347645|593925035|FG003|Overall Study|Death|7|||
164334495|NCT01890746|593601543|FG000|Overall Study|Withdrawal by Subject|5|||
164334496|NCT01890746|593601544|FG001|Overall Study|Withdrawal by Subject|8|||
164334497|NCT00100178|593601545|FG000|Overall Study|Lost to Follow-up|0|||
164334498|NCT00100178|593601546|FG001|Overall Study|Lost to Follow-up|6|||
164334499|NCT00100178|593601547|FG002|Overall Study|Lost to Follow-up|5|||
164334500|NCT00100178|593601545|FG000|Overall Study|Adverse Event|2|||
164334501|NCT00100178|593601546|FG001|Overall Study|Adverse Event|2|||
164677144|NCT02682238|594843020|FG000|Overall Study|Non-compliance with Protocol|0|||
164334502|NCT00100178|593601547|FG002|Overall Study|Adverse Event|1|||
164334503|NCT00100178|593601545|FG000|Overall Study|Withdrawal by Subject|1|||
164334504|NCT00100178|593601546|FG001|Overall Study|Withdrawal by Subject|1|||
164334505|NCT00100178|593601547|FG002|Overall Study|Withdrawal by Subject|1|||
164334506|NCT00100178|593601545|FG000|Overall Study|Physician Decision|6|||
164334507|NCT00100178|593601546|FG001|Overall Study|Physician Decision|1|||
164334508|NCT00100178|593601547|FG002|Overall Study|Physician Decision|3|||
164334509|NCT00631696|593601548|FG000|Overall Study|Entered, not randomized to treatment|1|||
164334510|NCT00631696|593601549|FG001|Overall Study|Entered, not randomized to treatment|1|||
164334511|NCT00631696|593601548|FG000|Overall Study|Discontinued after database release date|1|||
164334512|NCT00631696|593601549|FG001|Overall Study|Discontinued after database release date|0|||
164334513|NCT00631696|593601548|FG000|Overall Study|Follow up after database release date|1|||
164334514|NCT00631696|593601549|FG001|Overall Study|Follow up after database release date|0|||
164334515|NCT00631696|593601548|FG000|Overall Study|Lost to Follow-up|7|||
164334516|NCT00631696|593601549|FG001|Overall Study|Lost to Follow-up|10|||
164334517|NCT00631696|593601548|FG000|Overall Study|Withdrawal by Subject|2|||
164334518|NCT00631696|593601549|FG001|Overall Study|Withdrawal by Subject|9|||
164334519|NCT00631696|593601548|FG000|Overall Study|Other|8|||
164334520|NCT00631696|593601549|FG001|Overall Study|Other|8|||
164334521|NCT00631696|593601548|FG000|Overall Study|Protocol Violation|9|||
164334522|NCT00631696|593601549|FG001|Overall Study|Protocol Violation|9|||
164334523|NCT00631696|593601548|FG000|Overall Study|Study terminated by sponsor|3|||
164334524|NCT00631696|593601549|FG001|Overall Study|Study terminated by sponsor|3|||
164334525|NCT00631696|593601548|FG000|Overall Study|Adverse Event|5|||
164334526|NCT00631696|593601549|FG001|Overall Study|Adverse Event|0|||
164334527|NCT03198078|593601552|FG000|Overall Study|Adverse Event|0|||
164334528|NCT03198078|593601553|FG001|Overall Study|Adverse Event|1|||
164334529|NCT03198078|593601554|FG002|Overall Study|Adverse Event|2|||
164334530|NCT03198078|593601552|FG000|Overall Study|Lack of Efficacy|0|||
164334531|NCT03198078|593601553|FG001|Overall Study|Lack of Efficacy|0|||
164334532|NCT03198078|593601554|FG002|Overall Study|Lack of Efficacy|3|||
164334533|NCT03198078|593601552|FG000|Overall Study|Lost to Follow-up|1|||
164334534|NCT03198078|593601553|FG001|Overall Study|Lost to Follow-up|0|||
164334535|NCT03198078|593601554|FG002|Overall Study|Lost to Follow-up|0|||
164334536|NCT03198078|593601552|FG000|Overall Study|Pregnancy|0|||
164334537|NCT03198078|593601553|FG001|Overall Study|Pregnancy|1|||
164334538|NCT03198078|593601554|FG002|Overall Study|Pregnancy|0|||
164334539|NCT03198078|593601552|FG000|Overall Study|Withdrawal by Subject|1|||
164334540|NCT03198078|593601553|FG001|Overall Study|Withdrawal by Subject|0|||
164334541|NCT03198078|593601554|FG002|Overall Study|Withdrawal by Subject|2|||
164334542|NCT03198078|593601552|FG000|Overall Study|Withdrawal by Caregiver|1|||
164334543|NCT03198078|593601553|FG001|Overall Study|Withdrawal by Caregiver|3|||
164334544|NCT03198078|593601554|FG002|Overall Study|Withdrawal by Caregiver|5|||
164334545|NCT01676727|593601555|FG000|Overall Study|Death|18|||
164334546|NCT01676727|593601555|FG000|Overall Study|Withdrawal by Subject|6|||
164334547|NCT01676727|593601555|FG000|Overall Study|Screening failure|5|||
164334548|NCT01676727|593601555|FG000|Overall Study|Not willing to attend 1-year visit|2|||
164334549|NCT01676727|593601555|FG000|Overall Study|Valve explanted|1|||
164334550|NCT01578330|593601556|FG000|Overall Study|Adverse Event|2|||
164334551|NCT01578330|593601556|FG000|Overall Study|Protocol Violation|5|||
164334552|NCT02517866|593601558|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
164334553|NCT02517866|593601559|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
164334554|NCT02517866|593601560|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
164334555|NCT02517866|593601558|FG000|Overall Study|Significant Protocol Deviation|4|||
164334556|NCT02517866|593601559|FG001|Overall Study|Significant Protocol Deviation|1|||
164334557|NCT02517866|593601560|FG002|Overall Study|Significant Protocol Deviation|0|||
164334558|NCT02517866|593601558|FG000|Overall Study|Lost to Follow-up|1|||
164334559|NCT02517866|593601559|FG001|Overall Study|Lost to Follow-up|0|||
164334560|NCT02517866|593601560|FG002|Overall Study|Lost to Follow-up|0|||
164334561|NCT02517866|593601558|FG000|Overall Study|Voluntary Withdrawal|2|||
164334562|NCT02517866|593601559|FG001|Overall Study|Voluntary Withdrawal|2|||
164334563|NCT02517866|593601560|FG002|Overall Study|Voluntary Withdrawal|0|||
164334564|NCT02517866|593601558|FG000|Overall Study|Investigator Decision|2|||
164334565|NCT02517866|593601559|FG001|Overall Study|Investigator Decision|1|||
164334566|NCT02517866|593601560|FG002|Overall Study|Investigator Decision|0|||
164334567|NCT02517866|593601558|FG000|Overall Study|Reason not specified|2|||
164334568|NCT02517866|593601559|FG001|Overall Study|Reason not specified|0|||
164334569|NCT02517866|593601560|FG002|Overall Study|Reason not specified|0|||
164334570|NCT03114488|593601561|FG000|Time Period 2|Withdrawal by Subject|1|||
164573157|NCT01025635|594463346|FG001|Overall Study|Lost to Follow-up|13|||
164573158|NCT01025635|594463345|FG000|Overall Study|Reason not known|4|||
164573159|NCT01025635|594463346|FG001|Overall Study|Reason not known|2|||
164236454|NCT00789555|593236893|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
164236455|NCT00789555|593236891|FG000|Overall Study|Treatment failure|11|||
164236456|NCT00789555|593236892|FG001|Overall Study|Treatment failure|8|||
164236457|NCT00789555|593236893|FG002|Overall Study|Treatment failure|12|||
164236458|NCT00789555|593236891|FG000|Overall Study|Protocol Violation|6|||
164236459|NCT00789555|593236892|FG001|Overall Study|Protocol Violation|9|||
164236460|NCT00789555|593236893|FG002|Overall Study|Protocol Violation|13|||
164236461|NCT04712669|593236894|FG000|Double Blind Phase|Adverse Event|4|||
164236462|NCT04712669|593236895|FG001|Double Blind Phase|Adverse Event|4|||
164236463|NCT04712669|593236896|FG002|Double Blind Phase|Adverse Event|3|||
164236464|NCT04712669|593236897|FG003|Double Blind Phase|Adverse Event|0|||
164236465|NCT04712669|593236898|FG004|Double Blind Phase|Adverse Event|0|||
164236466|NCT04712669|593236899|FG005|Double Blind Phase|Adverse Event|0|||
164236467|NCT04712669|593236900|FG006|Double Blind Phase|Adverse Event|0|||
164236468|NCT04712669|593236901|FG007|Double Blind Phase|Adverse Event|0|||
164236469|NCT04712669|593236894|FG000|Double Blind Phase|Physician Decision|1|||
164236470|NCT04712669|593236895|FG001|Double Blind Phase|Physician Decision|0|||
164236471|NCT04712669|593236896|FG002|Double Blind Phase|Physician Decision|0|||
164236472|NCT04712669|593236897|FG003|Double Blind Phase|Physician Decision|0|||
164236473|NCT04712669|593236898|FG004|Double Blind Phase|Physician Decision|0|||
164236474|NCT04712669|593236899|FG005|Double Blind Phase|Physician Decision|0|||
164236475|NCT04712669|593236900|FG006|Double Blind Phase|Physician Decision|0|||
164236476|NCT04712669|593236901|FG007|Double Blind Phase|Physician Decision|0|||
164236477|NCT04712669|593236894|FG000|Double Blind Phase|Withdrawal by Subject|3|||
164236478|NCT04712669|593236895|FG001|Double Blind Phase|Withdrawal by Subject|6|||
164236479|NCT04712669|593236896|FG002|Double Blind Phase|Withdrawal by Subject|0|||
164236480|NCT04712669|593236897|FG003|Double Blind Phase|Withdrawal by Subject|0|||
164236481|NCT04712669|593236898|FG004|Double Blind Phase|Withdrawal by Subject|0|||
164334571|NCT03114488|593601562|FG001|Time Period 2|Withdrawal by Subject|3|||
164334572|NCT03711266|593601564|FG000|Overall Study|Lost to Follow-up|10|||
164334573|NCT01646073|593601567|FG000|Period A (12 Weeks)|Adverse Event|0|||
164334574|NCT01646073|593601568|FG001|Period A (12 Weeks)|Adverse Event|2|||
164334575|NCT01646073|593601567|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
164334576|NCT01646073|593601568|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
164334577|NCT01646073|593601567|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
164334578|NCT01646073|593601568|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
164334579|NCT01646073|593601567|FG000|Period A (12 Weeks)|Protocol Violation|0|||
164334580|NCT01646073|593601568|FG001|Period A (12 Weeks)|Protocol Violation|1|||
164334581|NCT01646073|593601567|FG000|Period A (12 Weeks)|Other|0|||
164334582|NCT01646073|593601568|FG001|Period A (12 Weeks)|Other|1|||
164334583|NCT01646073|593601567|FG000|Period B (12 Weeks)|Adverse Event|0|||
164334584|NCT01646073|593601568|FG001|Period B (12 Weeks)|Adverse Event|7|||
164334585|NCT01646073|593601567|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
164334586|NCT01646073|593601568|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
164334587|NCT01646073|593601567|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
164334588|NCT01646073|593601568|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
164334589|NCT00679055|593601571|FG000|Overall Study|Adverse Event|0|||
164334590|NCT00679055|593601572|FG001|Overall Study|Adverse Event|1|||
164334591|NCT00679055|593601571|FG000|Overall Study|Other|0|||
164334592|NCT00679055|593601572|FG001|Overall Study|Other|3|||
164334593|NCT00679055|593601571|FG000|Overall Study|Study Terminated|2|||
164334594|NCT00679055|593601572|FG001|Overall Study|Study Terminated|1|||
164334595|NCT00629772|593601573|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
164334596|NCT00629772|593601574|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
164334597|NCT00629772|593601573|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
164334598|NCT00629772|593601574|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
164334599|NCT01393301|593601577|FG000|Overall Study|Lost to Follow-up|5|||
164334600|NCT01393301|593601578|FG001|Overall Study|Lost to Follow-up|3|||
164334601|NCT01393301|593601577|FG000|Overall Study|Withdrawal by Subject|2|||
164334602|NCT01393301|593601578|FG001|Overall Study|Withdrawal by Subject|0|||
164334603|NCT01393301|593601577|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
164334604|NCT01393301|593601578|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
164334605|NCT03342963|593601581|FG000|Overall Study|Adverse Event|1|||
164334606|NCT03342963|593601582|FG001|Overall Study|Adverse Event|2|||
164334607|NCT03342963|593601583|FG002|Overall Study|Adverse Event|0|||
164334608|NCT03342963|593601584|FG003|Overall Study|Adverse Event|0|||
164334609|NCT03342963|593601581|FG000|Overall Study|Withdrawal by Subject|1|||
164334610|NCT03342963|593601582|FG001|Overall Study|Withdrawal by Subject|0|||
164573160|NCT02393209|594463347|FG000|Overall Study|Study Terminated by Sponsor|1|||
164236482|NCT04712669|593236899|FG005|Double Blind Phase|Withdrawal by Subject|0|||
164236483|NCT04712669|593236900|FG006|Double Blind Phase|Withdrawal by Subject|0|||
164334611|NCT03342963|593601583|FG002|Overall Study|Withdrawal by Subject|0|||
164334612|NCT03342963|593601584|FG003|Overall Study|Withdrawal by Subject|0|||
164334613|NCT01309165|593601586|FG000|Overall Study|Lost to Follow-up|4|||
164424349|NCT01347645|593925036|FG004|Overall Study|Death|7|||
164424350|NCT01347645|593925032|FG000|Overall Study|Lost to Follow-up|1|||
164424351|NCT01347645|593925033|FG001|Overall Study|Lost to Follow-up|1|||
164424352|NCT01347645|593925034|FG002|Overall Study|Lost to Follow-up|0|||
164424353|NCT01347645|593925035|FG003|Overall Study|Lost to Follow-up|1|||
164424354|NCT01347645|593925036|FG004|Overall Study|Lost to Follow-up|1|||
164424355|NCT01347645|593925032|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
164424356|NCT01347645|593925033|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
164424357|NCT01347645|593925034|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
164424358|NCT01347645|593925035|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
164424359|NCT01347645|593925036|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
164424360|NCT01347645|593925032|FG000|Overall Study|Other|1|||
164424361|NCT01347645|593925033|FG001|Overall Study|Other|0|||
164424362|NCT01347645|593925034|FG002|Overall Study|Other|0|||
164424363|NCT01347645|593925035|FG003|Overall Study|Other|0|||
164424364|NCT01347645|593925036|FG004|Overall Study|Other|1|||
164424365|NCT01347645|593925032|FG000|Overall Study|Withdrawal by Subject|0|||
164424366|NCT01347645|593925033|FG001|Overall Study|Withdrawal by Subject|0|||
164424367|NCT01347645|593925034|FG002|Overall Study|Withdrawal by Subject|0|||
164424368|NCT01347645|593925035|FG003|Overall Study|Withdrawal by Subject|3|||
164424369|NCT01347645|593925036|FG004|Overall Study|Withdrawal by Subject|3|||
164424370|NCT01347645|593925032|FG000|Overall Study|Physician Decision|0|||
164424371|NCT01347645|593925033|FG001|Overall Study|Physician Decision|0|||
164424372|NCT01347645|593925034|FG002|Overall Study|Physician Decision|0|||
164424373|NCT01347645|593925035|FG003|Overall Study|Physician Decision|0|||
164424374|NCT01347645|593925036|FG004|Overall Study|Physician Decision|1|||
164424375|NCT01347645|593925032|FG000|Overall Study|Adverse Event|0|||
164424376|NCT01347645|593925033|FG001|Overall Study|Adverse Event|0|||
164424377|NCT01347645|593925034|FG002|Overall Study|Adverse Event|0|||
164424378|NCT01347645|593925035|FG003|Overall Study|Adverse Event|1|||
164424379|NCT01347645|593925036|FG004|Overall Study|Adverse Event|1|||
164424380|NCT00388362|593925037|FG000|Enrolled|Ineligible|1|||
164424381|NCT00388362|593925037|FG000|Enrolled|Adverse Event|9|||
164424382|NCT00388362|593925037|FG000|Enrolled|Death|1|||
164424383|NCT00388362|593925037|FG000|Enrolled|Loss insurance|1|||
164424384|NCT00388362|593925037|FG000|Enrolled|Withdrawal by Subject|1|||
164424385|NCT00388362|593925037|FG000|Remained on Study Median of 514 Days|Death|2|||
164424386|NCT01141660|593925038|FG000|Overall Study|Physician Decision|0|||
164424387|NCT01141660|593925039|FG001|Overall Study|Physician Decision|12|||
164424388|NCT00209027|593925041|FG000|Overall Study|study terminated|10|||
164424389|NCT00209027|593925042|FG001|Overall Study|study terminated|0|||
164424390|NCT02335268|593925043|FG000|Overall Study|Physician Decision|5|||
164424391|NCT02335268|593925044|FG001|Overall Study|Physician Decision|1|||
164424392|NCT02335268|593925043|FG000|Overall Study|Lack of Efficacy|2|||
164424393|NCT02335268|593925044|FG001|Overall Study|Lack of Efficacy|1|||
164424394|NCT02335268|593925043|FG000|Overall Study|Adverse Event|5|||
164424395|NCT02335268|593925044|FG001|Overall Study|Adverse Event|2|||
164424396|NCT02335268|593925043|FG000|Overall Study|increase blasts|2|||
164424397|NCT02335268|593925044|FG001|Overall Study|increase blasts|0|||
164424398|NCT02335268|593925043|FG000|Overall Study|Withdrawal by Subject|3|||
164424399|NCT02335268|593925044|FG001|Overall Study|Withdrawal by Subject|2|||
164424400|NCT04320615|593925046|FG000|Overall Study|Withdrawal by Subject|4|||
164424401|NCT04320615|593925047|FG001|Overall Study|Withdrawal by Subject|10|||
164424402|NCT04320615|593925046|FG000|Overall Study|Physician Decision|2|||
164424403|NCT04320615|593925047|FG001|Overall Study|Physician Decision|0|||
164424404|NCT04320615|593925046|FG000|Overall Study|Other|2|||
164424405|NCT04320615|593925047|FG001|Overall Study|Other|0|||
164424406|NCT04320615|593925046|FG000|Overall Study|Lost to Follow-up|5|||
164424407|NCT04320615|593925047|FG001|Overall Study|Lost to Follow-up|23|||
164573161|NCT02393209|594463348|FG001|Overall Study|Study Terminated by Sponsor|1|||
164424408|NCT04320615|593925046|FG000|Overall Study|Death|35|||
164424409|NCT04320615|593925047|FG001|Overall Study|Death|71|||
164424410|NCT01857323|593925048|FG000|Overall Study|Adverse Event|1|||
164424411|NCT01857323|593925048|FG000|Overall Study|Withdrawal by Subject|3|||
164424412|NCT01857323|593925048|FG000|Overall Study|Non-compliance|1|||
164424413|NCT01857323|593925048|FG000|Overall Study|Protocol Violation|6|||
164424414|NCT01857323|593925048|FG000|Overall Study|Lost to Follow-up|1|||
164424415|NCT01857323|593925048|FG000|Overall Study|Other|4|||
164424416|NCT01857323|593925048|FG000|Overall Study|Did not complete 180 doses|48|||
164424417|NCT04504916|593925049|FG000|Overall Study|Study terminated|7|||
164424418|NCT04504916|593925050|FG001|Overall Study|Study terminated|8|||
164424419|NCT04504916|593925049|FG000|Overall Study|Death|54|||
164424420|NCT04504916|593925050|FG001|Overall Study|Death|18|||
164573162|NCT02393209|594463349|FG002|Overall Study|Study Terminated by Sponsor|0|||
164424421|NCT04504916|593925049|FG000|Overall Study|Lost to Follow-up|1|||
164424422|NCT04504916|593925050|FG001|Overall Study|Lost to Follow-up|1|||
164424423|NCT04504916|593925049|FG000|Overall Study|Withdrawal by Subject|8|||
164334614|NCT01309165|593601587|FG001|Overall Study|Lost to Follow-up|3|||
164334615|NCT01309165|593601586|FG000|Overall Study|Return to work|1|||
164334616|NCT01309165|593601587|FG001|Overall Study|Return to work|2|||
164334617|NCT01309165|593601586|FG000|Overall Study|Left country|0|||
164334618|NCT01309165|593601587|FG001|Overall Study|Left country|1|||
164334619|NCT01309165|593601586|FG000|Overall Study|No transportation|0|||
164334620|NCT01309165|593601587|FG001|Overall Study|No transportation|1|||
164334621|NCT01309165|593601586|FG000|Overall Study|Admitted to hospital for second stroke|1|||
164334622|NCT01309165|593601587|FG001|Overall Study|Admitted to hospital for second stroke|0|||
164334623|NCT01497275|593601588|FG000|Overall Study|Death|1|||
164334624|NCT01497275|593601588|FG000|Overall Study|Adverse Event|1|||
164334625|NCT01484132|593601589|FG000|Overall Study|Lost to Follow-up|8|||
164334626|NCT01484132|593601589|FG000|Overall Study|Difficulty with time commitment|2|||
164334627|NCT01484132|593601589|FG000|Overall Study|Ineligible|1|||
164334628|NCT01484132|593601589|FG000|Overall Study|No pre-treatment urine sample collected|1|||
164334629|NCT01484132|593601589|FG000|Overall Study|No post-treatment urine sample collected|10|||
164334630|NCT03538431|593601590|FG000|Overall Study|Physician Decision|0|||
164334631|NCT03538431|593601591|FG001|Overall Study|Physician Decision|1|||
164334632|NCT03538431|593601590|FG000|Overall Study|Withdrawal by Subject|1|||
164334633|NCT03538431|593601591|FG001|Overall Study|Withdrawal by Subject|0|||
164334634|NCT00620464|593601592|FG000|Overall Study|Adverse Event|15|||
164334635|NCT00620464|593601593|FG001|Overall Study|Adverse Event|17|||
164334636|NCT00620464|593601592|FG000|Overall Study|Lost to Follow-up|1|||
164334637|NCT00620464|593601593|FG001|Overall Study|Lost to Follow-up|1|||
164334638|NCT00620464|593601592|FG000|Overall Study|Planning Pregnancy|1|||
164334639|NCT00620464|593601593|FG001|Overall Study|Planning Pregnancy|4|||
164334640|NCT00620464|593601592|FG000|Overall Study|Personal|2|||
164334641|NCT00620464|593601593|FG001|Overall Study|Personal|2|||
164334642|NCT00620464|593601592|FG000|Overall Study|Used prohibited medication|1|||
164334643|NCT00620464|593601593|FG001|Overall Study|Used prohibited medication|0|||
164334644|NCT05394350|593601594|FG000|Overall Study|Death|2|||
164334645|NCT05394350|593601595|FG001|Overall Study|Death|2|||
164334646|NCT05394350|593601596|FG002|Overall Study|Death|4|||
164334647|NCT05394350|593601597|FG003|Overall Study|Death|0|||
164334648|NCT05394350|593601598|FG004|Overall Study|Death|1|||
164334649|NCT05394350|593601599|FG005|Overall Study|Death|0|||
164334650|NCT05394350|593601594|FG000|Overall Study|Study terminated by sponsor|1|||
164334651|NCT05394350|593601595|FG001|Overall Study|Study terminated by sponsor|1|||
164334652|NCT05394350|593601596|FG002|Overall Study|Study terminated by sponsor|7|||
164334653|NCT05394350|593601597|FG003|Overall Study|Study terminated by sponsor|3|||
164334654|NCT05394350|593601598|FG004|Overall Study|Study terminated by sponsor|2|||
164334655|NCT05394350|593601599|FG005|Overall Study|Study terminated by sponsor|4|||
164334656|NCT02024555|593601600|FG000|Overall Study|Lost to Follow-up|1|||
164334657|NCT02024555|593601601|FG001|Overall Study|Lost to Follow-up|1|||
164334658|NCT02024555|593601600|FG000|Overall Study|Withdrawal by Subject|5|||
164334659|NCT02024555|593601601|FG001|Overall Study|Withdrawal by Subject|1|||
164334660|NCT02887859|593601602|FG000|Overall Study|Ongoing|6|||
164334661|NCT02887859|593601602|FG000|Overall Study|Adverse Event|7|||
164334662|NCT02887859|593601602|FG000|Overall Study|Death|1|||
164334663|NCT02887859|593601602|FG000|Overall Study|Physician Decision|1|||
164334664|NCT00492050|593601603|FG000|Overall Study|Adverse Event|1|||
164334665|NCT00492050|593601603|FG000|Overall Study|Lack of Efficacy|1|||
164334666|NCT00492050|593601603|FG000|Overall Study|Withdrawal by Subject|3|||
164334667|NCT00492050|593601603|FG000|Overall Study|Unable to collect SCT|2|||
164334668|NCT00492050|593601603|FG000|Overall Study|Progressive Disease|2|||
164334669|NCT04063384|593603187|FG000|Overall Study|placebo manipulation issue|1|||
164334670|NCT04063384|593603188|FG001|Overall Study|placebo manipulation issue|2|||
164334671|NCT04063384|593603189|FG002|Overall Study|placebo manipulation issue|1|||
164334672|NCT04063384|593603190|FG003|Overall Study|placebo manipulation issue|1|||
164334673|NCT00537238|593603191|FG000|Overall Study|Death|1|||
164334674|NCT00537238|593603192|FG001|Overall Study|Death|2|||
164573163|NCT02393209|594463350|FG003|Overall Study|Study Terminated by Sponsor|0|||
164334675|NCT00537238|593603191|FG000|Overall Study|Adverse Event|31|||
164334676|NCT00537238|593603192|FG001|Overall Study|Adverse Event|22|||
164573164|NCT02393209|594463347|FG000|Overall Study|Withdrawal by Patient|1|||
164573165|NCT02393209|594463348|FG001|Overall Study|Withdrawal by Patient|0|||
164334677|NCT00537238|593603191|FG000|Overall Study|Lack of Efficacy|20|||
164334678|NCT00537238|593603192|FG001|Overall Study|Lack of Efficacy|21|||
164334679|NCT00537238|593603191|FG000|Overall Study|Lost to Follow-up|12|||
164334680|NCT00537238|593603192|FG001|Overall Study|Lost to Follow-up|8|||
164334681|NCT00537238|593603191|FG000|Overall Study|Withdrawal by Subject|51|||
164424424|NCT04504916|593925050|FG001|Overall Study|Withdrawal by Subject|4|||
164334682|NCT00537238|593603192|FG001|Overall Study|Withdrawal by Subject|47|||
164334683|NCT00537238|593603191|FG000|Overall Study|Protocol Violation|15|||
164334684|NCT00537238|593603192|FG001|Overall Study|Protocol Violation|19|||
164334685|NCT00537238|593603191|FG000|Overall Study|Does not meet entrance criteria|0|||
164334686|NCT00537238|593603192|FG001|Overall Study|Does not meet entrance criteria|2|||
164334687|NCT00537238|593603191|FG000|Overall Study|Other|44|||
164334688|NCT00537238|593603192|FG001|Overall Study|Other|52|||
164334689|NCT01824342|593603200|FG000|Overall Study|Withdrawal by Subject|0|||
164334690|NCT01824342|593603201|FG001|Overall Study|Withdrawal by Subject|3|||
164334691|NCT01824342|593603200|FG000|Overall Study|Adverse Event|1|||
164334692|NCT01824342|593603201|FG001|Overall Study|Adverse Event|1|||
164334693|NCT01824342|593603200|FG000|Overall Study|Disease Progression|1|||
164334694|NCT01824342|593603201|FG001|Overall Study|Disease Progression|1|||
164334695|NCT01824342|593603200|FG000|Overall Study|Physician Decision|5|||
164334696|NCT01824342|593603201|FG001|Overall Study|Physician Decision|0|||
164334697|NCT01824342|593603200|FG000|Overall Study|Death|2|||
164334698|NCT01824342|593603201|FG001|Overall Study|Death|0|||
164334699|NCT06132659|593603202|FG000|Overall Study|Lost to Follow-up|0|||
164334700|NCT06132659|593603203|FG001|Overall Study|Lost to Follow-up|1|||
164334701|NCT06132659|593603204|FG002|Overall Study|Lost to Follow-up|0|||
164334702|NCT03615326|593603205|FG000|Overall Study|Death|266|||
164334703|NCT03615326|593603206|FG001|Overall Study|Death|286|||
164334704|NCT03615326|593603207|FG002|Overall Study|Death|14|||
164334705|NCT03615326|593603208|FG003|Overall Study|Death|17|||
164334706|NCT03615326|593603205|FG000|Overall Study|Lost to Follow-up|0|||
164334707|NCT03615326|593603206|FG001|Overall Study|Lost to Follow-up|1|||
164334708|NCT03615326|593603207|FG002|Overall Study|Lost to Follow-up|0|||
164334709|NCT03615326|593603208|FG003|Overall Study|Lost to Follow-up|0|||
164334710|NCT03615326|593603205|FG000|Overall Study|Withdrawal by Subject|1|||
164334711|NCT03615326|593603206|FG001|Overall Study|Withdrawal by Subject|3|||
164334712|NCT03615326|593603207|FG002|Overall Study|Withdrawal by Subject|0|||
164334713|NCT03615326|593603208|FG003|Overall Study|Withdrawal by Subject|0|||
164334714|NCT03615326|593603205|FG000|Overall Study|Participants Ongoing|83|||
164334715|NCT03615326|593603206|FG001|Overall Study|Participants Ongoing|58|||
164334716|NCT03615326|593603207|FG002|Overall Study|Participants Ongoing|6|||
164334717|NCT03615326|593603208|FG003|Overall Study|Participants Ongoing|3|||
164334718|NCT03794583|593603209|FG000|Overall Study|Death|8|||
164334719|NCT03794583|593603209|FG000|Overall Study|Study Terminated by Sponsor|24|||
164334720|NCT03794583|593603209|FG000|Overall Study|Withdrawal by Subject|9|||
164334721|NCT02497612|593603210|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
164334722|NCT02497612|593603211|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
164334723|NCT02497612|593603212|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
164334724|NCT02497612|593603213|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
164334725|NCT02497612|593603210|FG000|Overall Study|Participant's request|2|||
164334726|NCT02497612|593603211|FG001|Overall Study|Participant's request|3|||
164334727|NCT02497612|593603212|FG002|Overall Study|Participant's request|4|||
164334728|NCT02497612|593603213|FG003|Overall Study|Participant's request|1|||
164334729|NCT02497612|593603210|FG000|Overall Study|Investigator's judgement|1|||
164334730|NCT02497612|593603211|FG001|Overall Study|Investigator's judgement|0|||
164334731|NCT02497612|593603212|FG002|Overall Study|Investigator's judgement|0|||
164334732|NCT02497612|593603213|FG003|Overall Study|Investigator's judgement|2|||
164334733|NCT02497612|593603210|FG000|Overall Study|Adverse Event|3|||
164334734|NCT02497612|593603211|FG001|Overall Study|Adverse Event|1|||
164334735|NCT02497612|593603212|FG002|Overall Study|Adverse Event|4|||
164334736|NCT02497612|593603213|FG003|Overall Study|Adverse Event|1|||
164334737|NCT02497612|593603210|FG000|Overall Study|Lost to Follow-up|1|||
164334738|NCT02497612|593603211|FG001|Overall Study|Lost to Follow-up|1|||
164334739|NCT02497612|593603212|FG002|Overall Study|Lost to Follow-up|0|||
164334740|NCT02497612|593603213|FG003|Overall Study|Lost to Follow-up|1|||
164334741|NCT02497612|593603210|FG000|Overall Study|Other unspecified|1|||
164334742|NCT02497612|593603211|FG001|Overall Study|Other unspecified|1|||
164334743|NCT02497612|593603212|FG002|Overall Study|Other unspecified|2|||
164334744|NCT02497612|593603213|FG003|Overall Study|Other unspecified|0|||
164334745|NCT02497612|593603210|FG000|Overall Study|Not eligible|1|||
164334746|NCT02497612|593603211|FG001|Overall Study|Not eligible|0|||
164334747|NCT02497612|593603212|FG002|Overall Study|Not eligible|0|||
164334748|NCT02497612|593603213|FG003|Overall Study|Not eligible|1|||
164334749|NCT02651467|593603214|FG000|Overall Study|Withdrawal by Subject|0|||
164424425|NCT04504916|593925049|FG000|Overall Study|Did not agree to follow-up|0|||
164334750|NCT02651467|593603215|FG001|Overall Study|Withdrawal by Subject|0|||
164334751|NCT02651467|593603216|FG002|Overall Study|Withdrawal by Subject|2|||
164334752|NCT02651467|593603214|FG000|Overall Study|Other (Not specified)|1|||
164334753|NCT02651467|593603215|FG001|Overall Study|Other (Not specified)|0|||
164334754|NCT02651467|593603216|FG002|Overall Study|Other (Not specified)|2|||
164334755|NCT02477839|593603219|FG000|Overall Study|Adverse Event|0|||
164334756|NCT02477839|593603220|FG001|Overall Study|Adverse Event|1|||
164334757|NCT02477839|593603219|FG000|Overall Study|Protocol Violation|0|||
164334758|NCT02477839|593603220|FG001|Overall Study|Protocol Violation|2|||
164334759|NCT02477839|593603219|FG000|Overall Study|Withdrawal by Subject|3|||
164334760|NCT02477839|593603220|FG001|Overall Study|Withdrawal by Subject|3|||
164334761|NCT02477839|593603219|FG000|Overall Study|Participant had PGS during V6|0|||
164334762|NCT02477839|593603220|FG001|Overall Study|Participant had PGS during V6|1|||
164334763|NCT02477839|593603219|FG000|Overall Study|Parents decided to stop medication|0|||
164334764|NCT02477839|593603220|FG001|Overall Study|Parents decided to stop medication|1|||
164236484|NCT04712669|593236901|FG007|Double Blind Phase|Withdrawal by Subject|0|||
164236485|NCT04712669|593236894|FG000|Double Blind Phase|Termination by Sponsor|0|||
164236486|NCT04712669|593236895|FG001|Double Blind Phase|Termination by Sponsor|0|||
164236487|NCT04712669|593236896|FG002|Double Blind Phase|Termination by Sponsor|1|||
164236488|NCT04712669|593236897|FG003|Double Blind Phase|Termination by Sponsor|0|||
164236489|NCT04712669|593236898|FG004|Double Blind Phase|Termination by Sponsor|0|||
164236490|NCT04712669|593236899|FG005|Double Blind Phase|Termination by Sponsor|0|||
164236491|NCT04712669|593236900|FG006|Double Blind Phase|Termination by Sponsor|0|||
164236492|NCT04712669|593236901|FG007|Double Blind Phase|Termination by Sponsor|0|||
164236493|NCT04712669|593236894|FG000|Open Label Phase|Adverse Event|0|||
164236494|NCT04712669|593236895|FG001|Open Label Phase|Adverse Event|0|||
164236495|NCT04712669|593236896|FG002|Open Label Phase|Adverse Event|0|||
164236496|NCT04712669|593236897|FG003|Open Label Phase|Adverse Event|1|||
164236497|NCT04712669|593236898|FG004|Open Label Phase|Adverse Event|1|||
164236498|NCT04712669|593236899|FG005|Open Label Phase|Adverse Event|3|||
164236499|NCT04712669|593236900|FG006|Open Label Phase|Adverse Event|1|||
164236500|NCT04712669|593236901|FG007|Open Label Phase|Adverse Event|2|||
164236501|NCT04712669|593236894|FG000|Open Label Phase|Death|0|||
164236502|NCT04712669|593236895|FG001|Open Label Phase|Death|0|||
164236503|NCT04712669|593236896|FG002|Open Label Phase|Death|0|||
164236504|NCT04712669|593236897|FG003|Open Label Phase|Death|1|||
164236505|NCT04712669|593236898|FG004|Open Label Phase|Death|0|||
164236506|NCT04712669|593236899|FG005|Open Label Phase|Death|0|||
164236507|NCT04712669|593236900|FG006|Open Label Phase|Death|0|||
164236508|NCT04712669|593236901|FG007|Open Label Phase|Death|0|||
164236509|NCT04712669|593236894|FG000|Open Label Phase|Lack of Efficacy|0|||
164236510|NCT04712669|593236895|FG001|Open Label Phase|Lack of Efficacy|0|||
164236511|NCT04712669|593236896|FG002|Open Label Phase|Lack of Efficacy|0|||
164236512|NCT04712669|593236897|FG003|Open Label Phase|Lack of Efficacy|0|||
164236513|NCT04712669|593236898|FG004|Open Label Phase|Lack of Efficacy|1|||
164236514|NCT04712669|593236899|FG005|Open Label Phase|Lack of Efficacy|0|||
164236515|NCT04712669|593236900|FG006|Open Label Phase|Lack of Efficacy|0|||
164236516|NCT04712669|593236901|FG007|Open Label Phase|Lack of Efficacy|0|||
164236517|NCT04712669|593236894|FG000|Open Label Phase|Lost to Follow-up|0|||
164236518|NCT04712669|593236895|FG001|Open Label Phase|Lost to Follow-up|0|||
164236519|NCT04712669|593236896|FG002|Open Label Phase|Lost to Follow-up|0|||
164236520|NCT04712669|593236897|FG003|Open Label Phase|Lost to Follow-up|0|||
164236521|NCT04712669|593236898|FG004|Open Label Phase|Lost to Follow-up|0|||
164236522|NCT04712669|593236899|FG005|Open Label Phase|Lost to Follow-up|0|||
164236523|NCT04712669|593236900|FG006|Open Label Phase|Lost to Follow-up|1|||
164236524|NCT04712669|593236901|FG007|Open Label Phase|Lost to Follow-up|1|||
164236525|NCT04712669|593236894|FG000|Open Label Phase|Physician Decision|0|||
164236526|NCT04712669|593236895|FG001|Open Label Phase|Physician Decision|0|||
164236527|NCT04712669|593236896|FG002|Open Label Phase|Physician Decision|0|||
164236528|NCT04712669|593236897|FG003|Open Label Phase|Physician Decision|1|||
164236529|NCT04712669|593236898|FG004|Open Label Phase|Physician Decision|0|||
164236530|NCT04712669|593236899|FG005|Open Label Phase|Physician Decision|0|||
164236531|NCT04712669|593236900|FG006|Open Label Phase|Physician Decision|0|||
164236532|NCT04712669|593236901|FG007|Open Label Phase|Physician Decision|0|||
164236533|NCT04712669|593236894|FG000|Open Label Phase|Withdrawal by Subject|0|||
164236534|NCT04712669|593236895|FG001|Open Label Phase|Withdrawal by Subject|0|||
164236535|NCT04712669|593236896|FG002|Open Label Phase|Withdrawal by Subject|0|||
164236536|NCT04712669|593236897|FG003|Open Label Phase|Withdrawal by Subject|1|||
164236537|NCT04712669|593236898|FG004|Open Label Phase|Withdrawal by Subject|5|||
164236538|NCT04712669|593236899|FG005|Open Label Phase|Withdrawal by Subject|5|||
164236539|NCT04712669|593236900|FG006|Open Label Phase|Withdrawal by Subject|0|||
164236540|NCT04712669|593236901|FG007|Open Label Phase|Withdrawal by Subject|4|||
164236541|NCT04712669|593236894|FG000|Open Label Phase|Termination by Sponsor|0|||
164236542|NCT04712669|593236895|FG001|Open Label Phase|Termination by Sponsor|0|||
164236543|NCT04712669|593236896|FG002|Open Label Phase|Termination by Sponsor|0|||
164236544|NCT04712669|593236897|FG003|Open Label Phase|Termination by Sponsor|11|||
164236545|NCT04712669|593236898|FG004|Open Label Phase|Termination by Sponsor|9|||
164236546|NCT04712669|593236899|FG005|Open Label Phase|Termination by Sponsor|14|||
164236547|NCT04712669|593236900|FG006|Open Label Phase|Termination by Sponsor|0|||
164236548|NCT04712669|593236901|FG007|Open Label Phase|Termination by Sponsor|14|||
164236549|NCT00639457|593238824|FG000|Overall Study|Withdrawal by Subject|2|||
164236550|NCT00639457|593238825|FG001|Overall Study|Withdrawal by Subject|3|||
164236551|NCT03386773|593238826|FG000|Overall Study|Lost to Follow-up|24|||
164334765|NCT02477839|593603219|FG000|Overall Study|Lack of tolerability|0|||
164334766|NCT02477839|593603220|FG001|Overall Study|Lack of tolerability|1|||
164236552|NCT03386773|593238827|FG001|Overall Study|Lost to Follow-up|33|||
164236553|NCT03386773|593238826|FG000|Overall Study|Withdrawal by Subject|3|||
164236554|NCT03386773|593238827|FG001|Overall Study|Withdrawal by Subject|2|||
164236555|NCT00892008|593238828|FG000|Overall Study|Death|5|||
164236556|NCT00892008|593238828|FG000|Overall Study|Lack of Efficacy|3|||
164236557|NCT00892008|593238828|FG000|Overall Study|Lost to Follow-up|142|||
164236558|NCT00892008|593238828|FG000|Overall Study|Other|378|||
164236559|NCT00892008|593238828|FG000|Overall Study|Adverse Event|37|||
164424426|NCT04504916|593925050|FG001|Overall Study|Did not agree to follow-up|1|||
164424427|NCT03057834|593925051|FG000|Overall Study|Withdrawal by Subject|25|||
164424428|NCT03057834|593925052|FG001|Overall Study|Withdrawal by Subject|29|||
164424429|NCT00003509|593925053|FG000|Overall Study|Not evaluable|5|||
164424430|NCT03803774|593925054|FG000|Dose Escalation|Withdrawal by Subject|0|||
164424431|NCT03803774|593925055|FG001|Dose Escalation|Withdrawal by Subject|0|||
164424432|NCT03803774|593925056|FG002|Dose Escalation|Withdrawal by Subject|0|||
164424433|NCT03803774|593925057|FG003|Dose Escalation|Withdrawal by Subject|1|||
164424434|NCT03803774|593925058|FG004|Dose Escalation|Withdrawal by Subject|0|||
164424435|NCT05708846|593925059|FG000|Overall Study|Death|5|||
164424436|NCT05708846|593925059|FG000|Overall Study|Withdrawal by Subject|20|||
164424437|NCT03621982|593925060|FG000|Overall Study|Withdrawal by Subject|1|||
164424438|NCT03621982|593925061|FG001|Overall Study|Withdrawal by Subject|0|||
164424439|NCT03621982|593925062|FG002|Overall Study|Withdrawal by Subject|0|||
164677145|NCT02682238|594843021|FG001|Overall Study|Non-compliance with Protocol|2|||
164677146|NCT01370317|594843022|FG000|Overall Study|Participant withdrew consent|1|||
164677147|NCT01370317|594843023|FG001|Overall Study|Participant withdrew consent|0|||
164677148|NCT01370317|594843022|FG000|Overall Study|Protocol deviation|0|||
164677149|NCT01370317|594843023|FG001|Overall Study|Protocol deviation|1|||
164677150|NCT00075478|594843024|FG000|Overall Study|not eligible|1|||
164677151|NCT00075478|594843025|FG001|Overall Study|not eligible|0|||
164677152|NCT00075478|594843024|FG000|Overall Study|Physician Decision|0|||
164677153|NCT00075478|594843025|FG001|Overall Study|Physician Decision|1|||
164677154|NCT00824291|594843031|FG000|Overall Study|Adverse Event|15|||
164677155|NCT00824291|594843032|FG001|Overall Study|Adverse Event|6|||
164677156|NCT00824291|594843031|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
164677157|NCT00824291|594843032|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
164677158|NCT00824291|594843031|FG000|Overall Study|Lost to Follow-up|11|||
164677159|NCT00824291|594843032|FG001|Overall Study|Lost to Follow-up|9|||
164677160|NCT00824291|594843031|FG000|Overall Study|Non-compliance|1|||
164677161|NCT00824291|594843032|FG001|Overall Study|Non-compliance|1|||
164677162|NCT00824291|594843031|FG000|Overall Study|Protocol Violation|4|||
164677163|NCT00824291|594843032|FG001|Overall Study|Protocol Violation|1|||
164677164|NCT00824291|594843031|FG000|Overall Study|Withdrawal by Subject|14|||
164677165|NCT00824291|594843032|FG001|Overall Study|Withdrawal by Subject|8|||
164677166|NCT00824291|594843031|FG000|Overall Study|Lack of Efficacy|7|||
164677167|NCT00824291|594843032|FG001|Overall Study|Lack of Efficacy|8|||
164677168|NCT00824291|594843031|FG000|Overall Study|Participant on prohibited medication|1|||
164677169|NCT00824291|594843032|FG001|Overall Study|Participant on prohibited medication|0|||
164677170|NCT00123734|594843037|FG000|Overall Study|Death|3|||
164677171|NCT00123734|594843037|FG000|Overall Study|Lost to Follow-up|3|||
164677172|NCT00123734|594843037|FG000|Overall Study|Dropout|1|||
164677173|NCT00123734|594843037|FG000|Overall Study|Withdrawal by Subject|1|||
164677174|NCT00113386|594843038|FG000|Overall Study|Withdrawal by Subject|1|||
164677175|NCT00113386|594843039|FG001|Overall Study|Withdrawal by Subject|0|||
164677176|NCT00113386|594843038|FG000|Overall Study|Physician Decision|0|||
164677177|NCT00113386|594843039|FG001|Overall Study|Physician Decision|1|||
164677178|NCT00113386|594843038|FG000|Overall Study|Toxicity|3|||
164677179|NCT00113386|594843039|FG001|Overall Study|Toxicity|0|||
164677180|NCT00113386|594843038|FG000|Overall Study|Ineligible|1|||
164677181|NCT00113386|594843039|FG001|Overall Study|Ineligible|2|||
164677182|NCT00113386|594843038|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
164677183|NCT00113386|594843039|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
164677184|NCT02849457|594843040|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
164677185|NCT02849457|594843041|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
164677186|NCT02849457|594843042|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
164677187|NCT02849457|594843043|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
164677188|NCT03673670|594843045|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
164677189|NCT03673670|594843046|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
164677190|NCT03673670|594843047|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
164677191|NCT03673670|594843048|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
164677192|NCT03673670|594843049|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
164677193|NCT03673670|594843050|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
164677194|NCT03673670|594843045|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
164677195|NCT03673670|594843046|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
164677196|NCT03673670|594843047|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
164677197|NCT03673670|594843048|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
164677198|NCT03673670|594843049|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
164677199|NCT03673670|594843050|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
164677200|NCT03673670|594843045|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
164677201|NCT03673670|594843046|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
164677202|NCT03673670|594843047|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
164677203|NCT03673670|594843048|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
164236560|NCT00355030|593238829|FG000|Study Period 1 Treatment|Adverse Event|1|||
164236561|NCT00355030|593238830|FG001|Study Period 1 Treatment|Adverse Event|1|||
164236562|NCT00355030|593238829|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
164236563|NCT00355030|593238830|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
164236564|NCT00355030|593238829|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
164236565|NCT00355030|593238830|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
164236566|NCT00355030|593238829|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
164236567|NCT00355030|593238830|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
164236568|NCT00355030|593238829|FG000|Study Period 1 Treatment|Physician Decision|0|||
164236569|NCT00355030|593238830|FG001|Study Period 1 Treatment|Physician Decision|1|||
164236570|NCT00355030|593238829|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
164236571|NCT00355030|593238830|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
164236572|NCT00355030|593238829|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
164236573|NCT00355030|593238830|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
164236574|NCT00355030|593238829|FG000|Study Period 1 Treatment|Other|2|||
164236575|NCT00355030|593238830|FG001|Study Period 1 Treatment|Other|6|||
164236576|NCT00355030|593238829|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
164236577|NCT00355030|593238830|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
164236578|NCT00355030|593238829|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
164236579|NCT00355030|593238830|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
164236580|NCT01693367|593238833|FG000|Overall Study|Withdrawal by Subject|1|||
164236581|NCT01693367|593238834|FG001|Overall Study|Withdrawal by Subject|1|||
164236582|NCT01693367|593238833|FG000|Overall Study|Physician Decision|0|||
164236583|NCT01693367|593238834|FG001|Overall Study|Physician Decision|1|||
164236584|NCT00622726|593238835|FG000|March, 2008 to August, 2010|Death|5|||
164236585|NCT00622726|593238836|FG001|March, 2008 to August, 2010|Death|2|||
164236586|NCT00622726|593238835|FG000|August, 2010 to April, 2013|Death|1|||
164236587|NCT00622726|593238836|FG001|August, 2010 to April, 2013|Death|5|||
164236588|NCT00399035|593238837|FG000|Overall Study|Death|289|||
164236589|NCT00399035|593238838|FG001|Overall Study|Death|141|||
164236590|NCT00399035|593238839|FG002|Overall Study|Death|234|||
164236591|NCT00399035|593238837|FG000|Overall Study|Lost to Follow-up|2|||
164236592|NCT00399035|593238838|FG001|Overall Study|Lost to Follow-up|1|||
164236593|NCT00399035|593238839|FG002|Overall Study|Lost to Follow-up|5|||
164236594|NCT00399035|593238837|FG000|Overall Study|Withdrawal by Subject|19|||
164236595|NCT00399035|593238838|FG001|Overall Study|Withdrawal by Subject|15|||
164236596|NCT00399035|593238839|FG002|Overall Study|Withdrawal by Subject|12|||
164236597|NCT00399035|593238837|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
164236598|NCT00399035|593238838|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
164236599|NCT00399035|593238839|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
164236600|NCT00399035|593238837|FG000|Overall Study|Severe non-compliance with protocol|2|||
164236601|NCT00399035|593238838|FG001|Overall Study|Severe non-compliance with protocol|1|||
164236602|NCT00399035|593238839|FG002|Overall Study|Severe non-compliance with protocol|0|||
164236603|NCT02746809|593238842|FG000|Enrollment|Inclusion Exclusion not met|9|||
164236604|NCT02746809|593238842|FG000|Enrollment|Withdrawal by Subject|1|||
164236605|NCT02746809|593238842|FG000|Enrollment|Expected Enrollment Met|2|||
164236606|NCT02746809|593238842|FG000|Procedure|Death|1|||
164236607|NCT02746809|593238842|FG000|1-Month|Death|5|||
164236608|NCT02746809|593238842|FG000|6-Month|Death|2|||
164236609|NCT02746809|593238842|FG000|6-Month|Withdrawal by Subject|1|||
164236610|NCT02746809|593238842|FG000|12-Month|Death|3|||
164236611|NCT02746809|593238842|FG000|12-Month|Withdrawal by Subject|2|||
164236612|NCT02746809|593238842|FG000|24-Month|Death|1|||
164236613|NCT02746809|593238842|FG000|24-Month|Withdrawal by Subject|1|||
164236614|NCT02746809|593238842|FG000|36-Month|Death|8|||
164236615|NCT02746809|593238842|FG000|36-Month|Withdrawal by Subject|1|||
164236616|NCT02746809|593238842|FG000|48-Month|Death|7|||
164236617|NCT02746809|593238842|FG000|48-Month|Withdrawal by Subject|1|||
164236618|NCT02746809|593238842|FG000|60-Month|Death|1|||
164236619|NCT02746809|593238842|FG000|60-Month|Lost to Follow-up|2|||
164236620|NCT03500211|593238845|FG000|Overall Study|Withdrawal by Subject|1|||
164236621|NCT03500211|593238846|FG001|Overall Study|Withdrawal by Subject|1|||
164236622|NCT02431325|593238847|FG000|Overall Study|Adverse Event|3|||
164334767|NCT02477839|593603219|FG000|Overall Study|Exclusion criterion|0|||
164334768|NCT02477839|593603220|FG001|Overall Study|Exclusion criterion|1|||
164334769|NCT01439568|593603224|FG000|Overall Study|Lost to Follow-up|1|||
164334770|NCT01439568|593603225|FG001|Overall Study|Lost to Follow-up|0|||
164334771|NCT01439568|593603224|FG000|Overall Study|Withdrawal by Subject|2|||
164334772|NCT01439568|593603225|FG001|Overall Study|Withdrawal by Subject|2|||
164236623|NCT02431325|593238848|FG001|Overall Study|Adverse Event|0|||
164236624|NCT02431325|593238847|FG000|Overall Study|Lost to Follow-up|0|||
164236625|NCT02431325|593238848|FG001|Overall Study|Lost to Follow-up|1|||
164236626|NCT02431325|593238847|FG000|Overall Study|Withdrawal by Subject|1|||
164236627|NCT02431325|593238848|FG001|Overall Study|Withdrawal by Subject|2|||
164236628|NCT02431325|593238847|FG000|Overall Study|Declined to take study medication|1|||
164236629|NCT02431325|593238848|FG001|Overall Study|Declined to take study medication|0|||
164334773|NCT02607930|593603226|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
164236630|NCT02431325|593238847|FG000|Overall Study|Withdrew before starting study medication|1|||
164236631|NCT02431325|593238848|FG001|Overall Study|Withdrew before starting study medication|0|||
164236632|NCT02431325|593238847|FG000|Overall Study|Placebo shortage|2|||
164236633|NCT02431325|593238848|FG001|Overall Study|Placebo shortage|0|||
164236634|NCT01865487|593238849|FG000|Overall Study|Lost to Follow-up|0|||
164236635|NCT01865487|593238850|FG001|Overall Study|Lost to Follow-up|0|||
164236636|NCT01865487|593238851|FG002|Overall Study|Lost to Follow-up|0|||
164236637|NCT01865487|593238852|FG003|Overall Study|Lost to Follow-up|1|||
164236638|NCT01865487|593238853|FG004|Overall Study|Lost to Follow-up|0|||
164236639|NCT01865487|593238854|FG005|Overall Study|Lost to Follow-up|0|||
164236640|NCT01865487|593238855|FG006|Overall Study|Lost to Follow-up|1|||
164236641|NCT01865487|593238856|FG007|Overall Study|Lost to Follow-up|0|||
164236642|NCT01865487|593238857|FG008|Overall Study|Lost to Follow-up|0|||
164236643|NCT01865487|593238858|FG009|Overall Study|Lost to Follow-up|0|||
164236644|NCT01865487|593238849|FG000|Overall Study|Withdrawal by Subject|0|||
164236645|NCT01865487|593238850|FG001|Overall Study|Withdrawal by Subject|0|||
164236646|NCT01865487|593238851|FG002|Overall Study|Withdrawal by Subject|0|||
164236647|NCT01865487|593238852|FG003|Overall Study|Withdrawal by Subject|0|||
164236648|NCT01865487|593238853|FG004|Overall Study|Withdrawal by Subject|1|||
164236649|NCT01865487|593238854|FG005|Overall Study|Withdrawal by Subject|0|||
164236650|NCT01865487|593238855|FG006|Overall Study|Withdrawal by Subject|0|||
164236651|NCT01865487|593238856|FG007|Overall Study|Withdrawal by Subject|0|||
164236652|NCT01865487|593238857|FG008|Overall Study|Withdrawal by Subject|0|||
164236653|NCT01865487|593238858|FG009|Overall Study|Withdrawal by Subject|0|||
164236654|NCT01213082|593238862|FG000|Overall Study|Lost to Follow-up|6|||
164236655|NCT01213082|593238863|FG001|Overall Study|Lost to Follow-up|7|||
164236656|NCT01213082|593238864|FG002|Overall Study|Lost to Follow-up|4|||
164236657|NCT01213082|593238862|FG000|Overall Study|Physician Decision|0|||
164236658|NCT01213082|593238863|FG001|Overall Study|Physician Decision|0|||
164236659|NCT01213082|593238864|FG002|Overall Study|Physician Decision|1|||
164236660|NCT01627691|593238865|FG000|Overall Study|Death|11|||
164236661|NCT01627691|593238865|FG000|Overall Study|Lost to Follow-up|3|||
164236662|NCT01627691|593238865|FG000|Overall Study|Withdrawal by Subject|1|||
164236663|NCT01627691|593238865|FG000|Overall Study|Missed the visit|3|||
164236664|NCT00698828|593238871|FG000|Overall Study|Adverse Event|3|||
164236665|NCT00698828|593238872|FG001|Overall Study|Adverse Event|4|||
164236666|NCT00698828|593238873|FG002|Overall Study|Adverse Event|4|||
164236667|NCT00698828|593238871|FG000|Overall Study|Death|0|||
164236668|NCT00698828|593238872|FG001|Overall Study|Death|0|||
164334774|NCT02607930|593603227|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
164334775|NCT02607930|593603228|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
164334776|NCT02607930|593603229|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
164334777|NCT02607930|593603226|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
164334778|NCT02607930|593603227|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
164334779|NCT02607930|593603228|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
164334780|NCT02607930|593603229|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
164334781|NCT02607930|593603226|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
164334782|NCT02607930|593603227|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
164334783|NCT02607930|593603228|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
164334784|NCT02607930|593603229|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
164334785|NCT02607930|593603226|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
164334786|NCT02607930|593603227|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
164334787|NCT02607930|593603228|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
164334788|NCT02607930|593603229|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
164334789|NCT02607930|593603226|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
164334790|NCT02607930|593603227|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
164334791|NCT02607930|593603228|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
164334792|NCT02607930|593603229|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
164334793|NCT02607930|593603226|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
164334794|NCT02607930|593603227|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
164334795|NCT02607930|593603228|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
164334796|NCT02607930|593603229|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
164236669|NCT00698828|593238873|FG002|Overall Study|Death|1|||
164334797|NCT02607930|593603226|FG000|Double-Blinded Treatment Phase|Death|2|||
164334798|NCT02607930|593603227|FG001|Double-Blinded Treatment Phase|Death|1|||
164334799|NCT02607930|593603228|FG002|Double-Blinded Treatment Phase|Death|0|||
164236670|NCT00698828|593238871|FG000|Overall Study|Exacerbation of COPD|1|||
164236671|NCT00698828|593238872|FG001|Overall Study|Exacerbation of COPD|3|||
164236672|NCT00698828|593238873|FG002|Overall Study|Exacerbation of COPD|0|||
164236673|NCT00698828|593238871|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
164236674|NCT00698828|593238872|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
164236675|NCT00698828|593238873|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
164236676|NCT00698828|593238871|FG000|Overall Study|Investigator/Sponsor decision|1|||
164236677|NCT00698828|593238872|FG001|Overall Study|Investigator/Sponsor decision|0|||
164424440|NCT03621982|593925063|FG003|Overall Study|Withdrawal by Subject|1|||
164424441|NCT03621982|593925064|FG004|Overall Study|Withdrawal by Subject|0|||
164424442|NCT03621982|593925065|FG005|Overall Study|Withdrawal by Subject|1|||
164424443|NCT03621982|593925066|FG006|Overall Study|Withdrawal by Subject|1|||
164424444|NCT03621982|593925067|FG007|Overall Study|Withdrawal by Subject|0|||
164424445|NCT03621982|593925068|FG008|Overall Study|Withdrawal by Subject|1|||
164424446|NCT03621982|593925069|FG009|Overall Study|Withdrawal by Subject|0|||
164424447|NCT03621982|593925070|FG010|Overall Study|Withdrawal by Subject|2|||
164424448|NCT03621982|593925071|FG011|Overall Study|Withdrawal by Subject|1|||
164424449|NCT03621982|593925072|FG012|Overall Study|Withdrawal by Subject|2|||
164424450|NCT03621982|593925073|FG013|Overall Study|Withdrawal by Subject|2|||
164424451|NCT03621982|593925060|FG000|Overall Study|Investigator/Sponsor decision|0|||
164424452|NCT03621982|593925061|FG001|Overall Study|Investigator/Sponsor decision|0|||
164424453|NCT03621982|593925062|FG002|Overall Study|Investigator/Sponsor decision|0|||
164424454|NCT03621982|593925063|FG003|Overall Study|Investigator/Sponsor decision|0|||
164424455|NCT03621982|593925064|FG004|Overall Study|Investigator/Sponsor decision|0|||
164424456|NCT03621982|593925065|FG005|Overall Study|Investigator/Sponsor decision|0|||
164424457|NCT03621982|593925066|FG006|Overall Study|Investigator/Sponsor decision|0|||
164424458|NCT03621982|593925067|FG007|Overall Study|Investigator/Sponsor decision|0|||
164424459|NCT03621982|593925068|FG008|Overall Study|Investigator/Sponsor decision|0|||
164424460|NCT03621982|593925069|FG009|Overall Study|Investigator/Sponsor decision|0|||
164424461|NCT03621982|593925070|FG010|Overall Study|Investigator/Sponsor decision|0|||
164424462|NCT03621982|593925071|FG011|Overall Study|Investigator/Sponsor decision|4|||
164424463|NCT03621982|593925072|FG012|Overall Study|Investigator/Sponsor decision|0|||
164424464|NCT03621982|593925073|FG013|Overall Study|Investigator/Sponsor decision|2|||
164424465|NCT03621982|593925060|FG000|Overall Study|Death|2|||
164424466|NCT03621982|593925061|FG001|Overall Study|Death|4|||
164424467|NCT03621982|593925062|FG002|Overall Study|Death|4|||
164424468|NCT03621982|593925063|FG003|Overall Study|Death|3|||
164424469|NCT03621982|593925064|FG004|Overall Study|Death|8|||
164424470|NCT03621982|593925065|FG005|Overall Study|Death|4|||
164424471|NCT03621982|593925066|FG006|Overall Study|Death|6|||
164424472|NCT03621982|593925067|FG007|Overall Study|Death|3|||
164424473|NCT03621982|593925068|FG008|Overall Study|Death|0|||
164424474|NCT03621982|593925069|FG009|Overall Study|Death|3|||
164424475|NCT03621982|593925070|FG010|Overall Study|Death|8|||
164424476|NCT03621982|593925071|FG011|Overall Study|Death|4|||
164424477|NCT03621982|593925072|FG012|Overall Study|Death|2|||
164424478|NCT03621982|593925073|FG013|Overall Study|Death|2|||
164424479|NCT03621982|593925060|FG000|Overall Study|Lost to Follow-up|0|||
164424480|NCT03621982|593925061|FG001|Overall Study|Lost to Follow-up|0|||
164424481|NCT03621982|593925062|FG002|Overall Study|Lost to Follow-up|1|||
164424482|NCT03621982|593925063|FG003|Overall Study|Lost to Follow-up|0|||
164424483|NCT03621982|593925064|FG004|Overall Study|Lost to Follow-up|0|||
164424484|NCT03621982|593925065|FG005|Overall Study|Lost to Follow-up|0|||
164424485|NCT03621982|593925066|FG006|Overall Study|Lost to Follow-up|1|||
164424486|NCT03621982|593925067|FG007|Overall Study|Lost to Follow-up|0|||
164424487|NCT03621982|593925068|FG008|Overall Study|Lost to Follow-up|0|||
164424488|NCT03621982|593925069|FG009|Overall Study|Lost to Follow-up|1|||
164424489|NCT03621982|593925070|FG010|Overall Study|Lost to Follow-up|0|||
164424490|NCT03621982|593925071|FG011|Overall Study|Lost to Follow-up|0|||
164424491|NCT03621982|593925072|FG012|Overall Study|Lost to Follow-up|0|||
164424492|NCT03621982|593925073|FG013|Overall Study|Lost to Follow-up|0|||
164424493|NCT00238420|593925074|FG000|Overall Study|Protocol Violation|1|||
164424494|NCT00238420|593925075|FG001|Overall Study|Protocol Violation|1|||
164424495|NCT01254890|593925076|FG000|Overall Study|Ineligible|0|||
164424496|NCT01254890|593925077|FG001|Overall Study|Ineligible|3|||
164424497|NCT01254890|593925076|FG000|Overall Study|Withdrawal by Subject|1|||
164424498|NCT01254890|593925077|FG001|Overall Study|Withdrawal by Subject|2|||
164424499|NCT01254890|593925076|FG000|Overall Study|Disease Progression|0|||
164424500|NCT01254890|593925077|FG001|Overall Study|Disease Progression|5|||
164424501|NCT02419755|593925085|FG000|Overall Study|Death|1|||
164424502|NCT02419755|593925086|FG001|Overall Study|Death|3|||
164424503|NCT02419755|593925085|FG000|Overall Study|Relapse|0|||
164424504|NCT02419755|593925086|FG001|Overall Study|Relapse|1|||
164424505|NCT02419755|593925085|FG000|Overall Study|Ineligible|1|||
164424506|NCT02419755|593925086|FG001|Overall Study|Ineligible|0|||
164424507|NCT02419755|593925085|FG000|Overall Study|Withdrawal by Subject|1|||
164424508|NCT02419755|593925086|FG001|Overall Study|Withdrawal by Subject|0|||
164424509|NCT02325713|593925087|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
164424510|NCT02325713|593925088|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
164424511|NCT02325713|593925089|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
164424512|NCT02325713|593925090|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
164424513|NCT02325713|593925091|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
164424514|NCT02325713|593925092|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
164424515|NCT02325713|593925093|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
164424516|NCT02325713|593925094|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
164236678|NCT00698828|593238873|FG002|Overall Study|Investigator/Sponsor decision|2|||
164236679|NCT00698828|593238871|FG000|Overall Study|Lost to Follow-up|1|||
164236680|NCT00698828|593238872|FG001|Overall Study|Lost to Follow-up|1|||
164236681|NCT00698828|593238873|FG002|Overall Study|Lost to Follow-up|0|||
164236682|NCT00698828|593238871|FG000|Overall Study|Withdrew consent|0|||
164236683|NCT00698828|593238872|FG001|Overall Study|Withdrew consent|7|||
164236684|NCT00698828|593238873|FG002|Overall Study|Withdrew consent|4|||
164236685|NCT00698828|593238871|FG000|Overall Study|Withdrew consent (not treated)|2|||
164236686|NCT00698828|593238872|FG001|Overall Study|Withdrew consent (not treated)|0|||
164236687|NCT00698828|593238873|FG002|Overall Study|Withdrew consent (not treated)|0|||
164236688|NCT02013609|593238876|FG000|Overall Study|Withdrawal by Subject|9|||
164236689|NCT02013609|593238876|FG000|Overall Study|Lost to Follow-up|3|||
164236690|NCT02013609|593238876|FG000|Overall Study|Adverse Event|3|||
164236691|NCT02013609|593238876|FG000|Overall Study|Met Withdrawal Criteria|3|||
164236692|NCT01531998|593238878|FG000|Overall Study|Withdrawal by Subject|3|||
164236693|NCT01156844|593238880|FG000|Overall Study|Adverse Event|0|||
164236694|NCT01156844|593238881|FG001|Overall Study|Adverse Event|0|||
164236695|NCT01156844|593238882|FG002|Overall Study|Adverse Event|1|||
164236696|NCT01156844|593238883|FG003|Overall Study|Adverse Event|1|||
164236697|NCT01156844|593238880|FG000|Overall Study|Abnormal test procedure result(s)|0|||
164236698|NCT01156844|593238881|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164236699|NCT01156844|593238882|FG002|Overall Study|Abnormal test procedure result(s)|2|||
164236700|NCT01156844|593238883|FG003|Overall Study|Abnormal test procedure result(s)|2|||
164236701|NCT01156844|593238880|FG000|Overall Study|Withdrawal by Subject|0|||
164236702|NCT01156844|593238881|FG001|Overall Study|Withdrawal by Subject|0|||
164236703|NCT01156844|593238882|FG002|Overall Study|Withdrawal by Subject|2|||
164236704|NCT01156844|593238883|FG003|Overall Study|Withdrawal by Subject|2|||
164236705|NCT01156844|593238880|FG000|Overall Study|Lost to Follow-up|0|||
164236706|NCT01156844|593238881|FG001|Overall Study|Lost to Follow-up|0|||
164236707|NCT01156844|593238882|FG002|Overall Study|Lost to Follow-up|1|||
164236708|NCT01156844|593238883|FG003|Overall Study|Lost to Follow-up|0|||
164236709|NCT01156844|593238880|FG000|Overall Study|Administrative problems|0|||
164236710|NCT01156844|593238881|FG001|Overall Study|Administrative problems|1|||
164236711|NCT01156844|593238882|FG002|Overall Study|Administrative problems|0|||
164236712|NCT01156844|593238883|FG003|Overall Study|Administrative problems|1|||
164236713|NCT01156844|593238880|FG000|Overall Study|Protocol deviation|2|||
164236714|NCT01156844|593238881|FG001|Overall Study|Protocol deviation|0|||
164236715|NCT01156844|593238882|FG002|Overall Study|Protocol deviation|0|||
164236716|NCT01156844|593238883|FG003|Overall Study|Protocol deviation|0|||
164236717|NCT04067011|593238886|FG000|Overall Study|Not Treated|8|||
164236718|NCT04067011|593238887|FG001|Overall Study|Not Treated|7|||
164236719|NCT04067011|593238888|FG002|Overall Study|Not Treated|5|||
164236720|NCT04067011|593238886|FG000|Overall Study|Adverse Event|2|||
164236721|NCT04067011|593238887|FG001|Overall Study|Adverse Event|1|||
164236722|NCT04067011|593238888|FG002|Overall Study|Adverse Event|0|||
164236723|NCT04067011|593238886|FG000|Overall Study|Withdrawal by Subject|6|||
164236724|NCT04067011|593238887|FG001|Overall Study|Withdrawal by Subject|2|||
164236725|NCT04067011|593238888|FG002|Overall Study|Withdrawal by Subject|1|||
164236726|NCT04067011|593238886|FG000|Overall Study|Lost to Follow-up|0|||
164236727|NCT04067011|593238887|FG001|Overall Study|Lost to Follow-up|0|||
164236728|NCT04067011|593238888|FG002|Overall Study|Lost to Follow-up|1|||
164236729|NCT04067011|593238886|FG000|Overall Study|Physician Decision|1|||
164236730|NCT04067011|593238887|FG001|Overall Study|Physician Decision|1|||
164236731|NCT04067011|593238888|FG002|Overall Study|Physician Decision|0|||
164236732|NCT04067011|593238886|FG000|Overall Study|Other Reasons|2|||
164236733|NCT04067011|593238887|FG001|Overall Study|Other Reasons|0|||
164236734|NCT04067011|593238888|FG002|Overall Study|Other Reasons|1|||
164236735|NCT04067011|593238886|FG000|Overall Study|Missing|0|||
164236736|NCT04067011|593238887|FG001|Overall Study|Missing|2|||
164236737|NCT04067011|593238888|FG002|Overall Study|Missing|0|||
164236738|NCT05209386|593238889|FG000|Overall Study|Withdrawal by Subject|8|||
164236739|NCT05209386|593238889|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
164334800|NCT02607930|593603229|FG003|Double-Blinded Treatment Phase|Death|0|||
164334801|NCT02607930|593603226|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
164677204|NCT03673670|594843049|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
164677205|NCT03673670|594843050|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
164677206|NCT03673670|594843045|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
164236740|NCT04661033|593238890|FG000|Overall Study|Adverse Event|0|||
164236741|NCT04661033|593238891|FG001|Overall Study|Adverse Event|0|||
164236742|NCT04661033|593238892|FG002|Overall Study|Adverse Event|1|||
164236743|NCT04661033|593238893|FG003|Overall Study|Adverse Event|0|||
164236744|NCT04661033|593238890|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
164236745|NCT04661033|593238891|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
164236746|NCT04661033|593238892|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
164236747|NCT04661033|593238893|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
164236748|NCT04661033|593238890|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
164236749|NCT04661033|593238891|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
164236750|NCT04661033|593238892|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
164236751|NCT04661033|593238893|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
164236752|NCT04661033|593238890|FG000|Overall Study|Early discontinuation as per PI|1|||
164236753|NCT04661033|593238891|FG001|Overall Study|Early discontinuation as per PI|0|||
164236754|NCT04661033|593238892|FG002|Overall Study|Early discontinuation as per PI|0|||
164236755|NCT04661033|593238893|FG003|Overall Study|Early discontinuation as per PI|0|||
164236756|NCT03440008|593238894|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
164236757|NCT03440008|593238895|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
164236758|NCT03440008|593238894|FG000|Overall Study|Withdrawal by Subject|1|||
164236759|NCT03440008|593238895|FG001|Overall Study|Withdrawal by Subject|0|||
164236760|NCT02284191|593238896|FG000|Overall Study|Withdrawal by Subject|1|||
164236761|NCT02284191|593238897|FG001|Overall Study|Withdrawal by Subject|3|||
164236762|NCT02284191|593238896|FG000|Overall Study|Lost to Follow-up|1|||
164236763|NCT02284191|593238897|FG001|Overall Study|Lost to Follow-up|0|||
164236764|NCT04064905|593238900|FG000|Overall Study|Lost to Follow-up|0|||
164236765|NCT04064905|593238901|FG001|Overall Study|Lost to Follow-up|3|||
164236766|NCT04064905|593238902|FG002|Overall Study|Lost to Follow-up|1|||
164236767|NCT04064905|593238903|FG003|Overall Study|Lost to Follow-up|4|||
164236768|NCT04064905|593238904|FG004|Overall Study|Lost to Follow-up|2|||
164236769|NCT01734902|593238905|FG000|Overall Study|Other than listed|0|||
164236770|NCT01734902|593238906|FG001|Overall Study|Other than listed|2|||
164236771|NCT04436744|593238907|FG000|Overall Study|Adverse Event|1|||
164236772|NCT04436744|593238908|FG001|Overall Study|Adverse Event|1|||
164236773|NCT04436744|593238907|FG000|Overall Study|Death|1|||
164236774|NCT04436744|593238908|FG001|Overall Study|Death|0|||
164236775|NCT04436744|593238907|FG000|Overall Study|Lost to Follow-up|0|||
164236776|NCT04436744|593238908|FG001|Overall Study|Lost to Follow-up|2|||
164236777|NCT04436744|593238907|FG000|Overall Study|Physician Decision|0|||
164236778|NCT04436744|593238908|FG001|Overall Study|Physician Decision|1|||
164236779|NCT04436744|593238907|FG000|Overall Study|Progressive Disease|0|||
164236780|NCT04436744|593238908|FG001|Overall Study|Progressive Disease|4|||
164236781|NCT04436744|593238907|FG000|Overall Study|Protocol Deviation|1|||
164236782|NCT04436744|593238908|FG001|Overall Study|Protocol Deviation|1|||
164236783|NCT04436744|593238907|FG000|Overall Study|Withdrawal by Subject|1|||
164236784|NCT04436744|593238908|FG001|Overall Study|Withdrawal by Subject|2|||
164236785|NCT01463033|593238909|FG000|Overall Study|Lost to Follow-up|4|||
164236786|NCT01463033|593238910|FG001|Overall Study|Lost to Follow-up|4|||
164236787|NCT01463033|593238909|FG000|Overall Study|Death|3|||
164236788|NCT01463033|593238910|FG001|Overall Study|Death|2|||
164236789|NCT02359903|593238914|FG000|Overall Study|Adverse Event|0|||
164236790|NCT02359903|593238915|FG001|Overall Study|Adverse Event|2|||
164236791|NCT03383666|593238916|FG000|Overall Study|Withdrawal by Subject|2|||
164236792|NCT03383666|593238916|FG000|Overall Study|Lost to Follow-up|2|||
164236793|NCT01240863|593238918|FG000|Open-label Titration Period|Adverse Event|47|||
164236794|NCT01240863|593238919|FG001|Open-label Titration Period|Adverse Event|0|||
164236795|NCT01240863|593238920|FG002|Open-label Titration Period|Adverse Event|0|||
164236796|NCT01240863|593238918|FG000|Open-label Titration Period|Lack of Efficacy|19|||
164236797|NCT01240863|593238919|FG001|Open-label Titration Period|Lack of Efficacy|0|||
164236798|NCT01240863|593238920|FG002|Open-label Titration Period|Lack of Efficacy|0|||
164236799|NCT01240863|593238918|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
164236800|NCT01240863|593238919|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
164236801|NCT01240863|593238920|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
164236802|NCT01240863|593238918|FG000|Open-label Titration Period|Protocol Violation|7|||
164236803|NCT01240863|593238919|FG001|Open-label Titration Period|Protocol Violation|0|||
164236804|NCT01240863|593238920|FG002|Open-label Titration Period|Protocol Violation|0|||
164236805|NCT01240863|593238918|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
164236806|NCT01240863|593238919|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
164236807|NCT01240863|593238920|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
164236808|NCT01240863|593238918|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
164236809|NCT01240863|593238919|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
164236810|NCT01240863|593238920|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
164236811|NCT01240863|593238918|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
164236812|NCT01240863|593238919|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
164236813|NCT01240863|593238920|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
164236814|NCT01240863|593238918|FG000|Open-label Titration Period|Other|7|||
164236815|NCT01240863|593238919|FG001|Open-label Titration Period|Other|0|||
164236816|NCT01240863|593238920|FG002|Open-label Titration Period|Other|0|||
164236817|NCT01240863|593238918|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
164236818|NCT01240863|593238919|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
164236819|NCT01240863|593238920|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
164236820|NCT01240863|593238918|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
164334802|NCT02607930|593603227|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
164334803|NCT02607930|593603228|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
164334804|NCT02607930|593603229|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
164334805|NCT02607930|593603226|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
164424517|NCT02325713|593925095|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
164424518|NCT02325713|593925096|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
164424519|NCT02325713|593925097|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
164424520|NCT02325713|593925098|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
164334806|NCT02607930|593603227|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
164677207|NCT03673670|594843046|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
164424521|NCT02325713|593925099|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
164424522|NCT02325713|593925100|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
164424523|NCT02325713|593925101|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
164424524|NCT02325713|593925102|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
164424525|NCT02325713|593925087|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
164424526|NCT02325713|593925088|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
164424527|NCT02325713|593925089|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
164424528|NCT02325713|593925090|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
164424529|NCT02325713|593925091|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
164424530|NCT02325713|593925092|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
164424531|NCT02325713|593925093|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
164424532|NCT02325713|593925094|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
164424533|NCT02325713|593925095|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
164424534|NCT02325713|593925096|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
164424535|NCT02325713|593925097|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
164424536|NCT02325713|593925098|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
164424537|NCT02325713|593925099|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
164424538|NCT02325713|593925100|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
164424539|NCT02325713|593925101|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
164334807|NCT02607930|593603228|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
164334808|NCT02607930|593603229|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
164677208|NCT03673670|594843047|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
164677209|NCT03673670|594843048|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
164677210|NCT03673670|594843049|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
164677211|NCT03673670|594843050|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
164677212|NCT03673670|594843045|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
164677213|NCT03673670|594843046|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
164677214|NCT03673670|594843047|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
164677215|NCT03673670|594843048|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
164677216|NCT03673670|594843049|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
164677217|NCT03673670|594843050|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
164677218|NCT03673670|594843045|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
164677219|NCT03673670|594843046|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
164677220|NCT03673670|594843047|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
164677221|NCT03673670|594843048|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
164677222|NCT03673670|594843049|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
164677223|NCT03673670|594843050|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
164677224|NCT03673670|594843045|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
164677225|NCT03673670|594843046|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
164677226|NCT03673670|594843047|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
164677227|NCT03673670|594843048|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
164677228|NCT03673670|594843049|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
164677229|NCT03673670|594843050|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
164677230|NCT01058668|594843051|FG000|Double-blind Treatment Phase|Adverse Event|8|||
164677231|NCT01058668|594843052|FG001|Double-blind Treatment Phase|Adverse Event|15|||
164677232|NCT01058668|594843053|FG002|Double-blind Treatment Phase|Adverse Event|25|||
164677233|NCT01058668|594843051|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
164677234|NCT01058668|594843052|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
164677235|NCT01058668|594843053|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
164677236|NCT01058668|594843051|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
164677237|NCT01058668|594843052|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
164677238|NCT01058668|594843053|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
164677239|NCT01058668|594843051|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
164424540|NCT02325713|593925102|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
164424541|NCT02325713|593925087|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
164236821|NCT01240863|593238919|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
164236822|NCT01240863|593238920|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
164236823|NCT01240863|593238918|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164236824|NCT01240863|593238919|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
164236825|NCT01240863|593238920|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
164236826|NCT01240863|593238918|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
164236827|NCT01240863|593238919|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
164236828|NCT01240863|593238920|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
164236829|NCT01240863|593238918|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
164236830|NCT01240863|593238919|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
164236831|NCT01240863|593238920|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
164236832|NCT01240863|593238918|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
164334809|NCT02607930|593603226|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
164334810|NCT02607930|593603227|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
164334811|NCT02607930|593603228|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
164334812|NCT02607930|593603229|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
164334813|NCT02607930|593603226|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
164334814|NCT02607930|593603227|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
164334815|NCT02607930|593603228|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
164334816|NCT02607930|593603229|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
164236833|NCT01240863|593238919|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
164236834|NCT01240863|593238920|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
164236835|NCT01240863|593238918|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
164236836|NCT01240863|593238919|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
164236837|NCT01240863|593238920|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
164236838|NCT01240863|593238918|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
164236839|NCT01240863|593238919|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
164236840|NCT01240863|593238920|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
164236841|NCT00746811|593238921|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
164236842|NCT00746811|593238922|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
164236843|NCT01538199|593238923|FG000|Overall Study|Lost to Follow-up|1|||
164236844|NCT01538199|593238924|FG001|Overall Study|Lost to Follow-up|2|||
164236845|NCT01538199|593238925|FG002|Overall Study|Lost to Follow-up|1|||
164236846|NCT01538199|593238926|FG003|Overall Study|Lost to Follow-up|0|||
164236847|NCT01538199|593238923|FG000|Overall Study|participant did not have time|1|||
164236848|NCT01538199|593238924|FG001|Overall Study|participant did not have time|0|||
164236849|NCT01538199|593238925|FG002|Overall Study|participant did not have time|0|||
164236850|NCT01538199|593238926|FG003|Overall Study|participant did not have time|2|||
164236851|NCT01538199|593238923|FG000|Overall Study|Lack of Efficacy|0|||
164236852|NCT01538199|593238924|FG001|Overall Study|Lack of Efficacy|1|||
164236853|NCT01538199|593238925|FG002|Overall Study|Lack of Efficacy|0|||
164236854|NCT01538199|593238926|FG003|Overall Study|Lack of Efficacy|0|||
164236855|NCT03358030|593238927|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
164236856|NCT03358030|593238928|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
164334817|NCT02607930|593603226|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
164334818|NCT02607930|593603227|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
164334819|NCT02607930|593603228|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
164334820|NCT02607930|593603229|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
164334821|NCT02607930|593603226|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
164334822|NCT02607930|593603227|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
164334823|NCT02607930|593603228|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
164334824|NCT02607930|593603229|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
164334825|NCT02607930|593603226|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
164334826|NCT02607930|593603227|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
164334827|NCT02607930|593603228|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
164334828|NCT02607930|593603229|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
164334829|NCT02607930|593603226|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
164334830|NCT02607930|593603227|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
164334831|NCT02607930|593603228|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
164334832|NCT02607930|593603229|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
164334833|NCT02607930|593603226|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
164334834|NCT02607930|593603227|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
164334835|NCT02607930|593603228|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
164334836|NCT02607930|593603229|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
164334837|NCT01134731|593603230|FG000|Overall Study|Adverse Event|3|||
164334838|NCT01134731|593603231|FG001|Overall Study|Adverse Event|2|||
164334839|NCT01134731|593603232|FG002|Overall Study|Adverse Event|1|||
164334840|NCT01134731|593603230|FG000|Overall Study|Physician Decision|2|||
164334841|NCT01134731|593603231|FG001|Overall Study|Physician Decision|2|||
164334842|NCT01134731|593603232|FG002|Overall Study|Physician Decision|2|||
164334843|NCT01134731|593603230|FG000|Overall Study|Lack of Efficacy|0|||
164334844|NCT01134731|593603231|FG001|Overall Study|Lack of Efficacy|0|||
164424542|NCT02325713|593925088|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
164424543|NCT02325713|593925089|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
164424544|NCT02325713|593925090|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
164424545|NCT02325713|593925091|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
164424546|NCT02325713|593925092|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
164424547|NCT02325713|593925093|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
164424548|NCT02325713|593925094|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
164424549|NCT02325713|593925095|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
164424550|NCT02325713|593925096|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
164424551|NCT02325713|593925097|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
164424552|NCT02325713|593925098|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
164424553|NCT02325713|593925099|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
164424554|NCT02325713|593925100|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
164424555|NCT02325713|593925101|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
164424556|NCT02325713|593925102|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
164424557|NCT04988477|593925105|FG000|Overall Study|Death|1|||
164424558|NCT04988477|593925106|FG001|Overall Study|Death|0|||
164424559|NCT04988477|593925107|FG002|Overall Study|Death|0|||
164424560|NCT04988477|593925105|FG000|Overall Study|Lost to Follow-up|5|||
164424561|NCT04988477|593925106|FG001|Overall Study|Lost to Follow-up|2|||
164424562|NCT04988477|593925107|FG002|Overall Study|Lost to Follow-up|0|||
164424563|NCT04988477|593925105|FG000|Overall Study|Withdrawal by Subject|2|||
164424564|NCT04988477|593925106|FG001|Overall Study|Withdrawal by Subject|0|||
164424565|NCT04988477|593925107|FG002|Overall Study|Withdrawal by Subject|0|||
164424566|NCT04034238|593926463|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
164424567|NCT04034238|593926464|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
164424568|NCT04034238|593926465|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
164424569|NCT04034238|593926466|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
164424570|NCT04034238|593926463|FG000|Dose Escalation Phase|Screen failures|0|||
164424571|NCT04034238|593926464|FG001|Dose Escalation Phase|Screen failures|0|||
164424572|NCT04034238|593926465|FG002|Dose Escalation Phase|Screen failures|0|||
164424573|NCT04034238|593926466|FG003|Dose Escalation Phase|Screen failures|2|||
164424574|NCT04034238|593926463|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
164424575|NCT04034238|593926464|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
164424576|NCT04034238|593926465|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
164424577|NCT04034238|593926466|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
164424578|NCT04034238|593926463|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
164424579|NCT04034238|593926464|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
164424580|NCT04034238|593926465|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
164424581|NCT04034238|593926466|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
164424582|NCT04822298|593926467|FG000|Overall Study|Death|3|||
164424583|NCT00465361|593926468|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
164424584|NCT05406791|593926469|FG000|Overall Study|Lost to Follow-up|13|||
164424585|NCT05406791|593926470|FG001|Overall Study|Lost to Follow-up|10|||
164424586|NCT01625338|593926471|FG000|Overall Study|Enrolled but not Treated|0|||
164424587|NCT01625338|593926472|FG001|Overall Study|Enrolled but not Treated|0|||
164424588|NCT01625338|593926473|FG002|Overall Study|Enrolled but not Treated|1|||
164424589|NCT01625338|593926471|FG000|Overall Study|Efficacy Failure|27|||
164424590|NCT01625338|593926472|FG001|Overall Study|Efficacy Failure|39|||
164424591|NCT01625338|593926473|FG002|Overall Study|Efficacy Failure|31|||
164424592|NCT01625338|593926471|FG000|Overall Study|Lost to Follow-up|3|||
164424593|NCT01625338|593926472|FG001|Overall Study|Lost to Follow-up|3|||
164424594|NCT01625338|593926473|FG002|Overall Study|Lost to Follow-up|2|||
164424595|NCT01625338|593926471|FG000|Overall Study|Investigator Decision|0|||
164424596|NCT01625338|593926472|FG001|Overall Study|Investigator Decision|2|||
164424597|NCT01625338|593926473|FG002|Overall Study|Investigator Decision|1|||
164334845|NCT01134731|593603232|FG002|Overall Study|Lack of Efficacy|1|||
164334846|NCT01134731|593603230|FG000|Overall Study|Withdrawal by Subject|3|||
164334847|NCT01134731|593603231|FG001|Overall Study|Withdrawal by Subject|3|||
164424598|NCT01625338|593926471|FG000|Overall Study|Subject Withdrew Consent|1|||
164424599|NCT01625338|593926472|FG001|Overall Study|Subject Withdrew Consent|0|||
164424600|NCT01625338|593926473|FG002|Overall Study|Subject Withdrew Consent|2|||
164424601|NCT01625338|593926471|FG000|Overall Study|Adverse Event|1|||
164424602|NCT01625338|593926472|FG001|Overall Study|Adverse Event|0|||
164424603|NCT01625338|593926473|FG002|Overall Study|Adverse Event|1|||
164424604|NCT01625338|593926471|FG000|Overall Study|Study Discontinued by Sponsor|0|||
164424605|NCT01625338|593926472|FG001|Overall Study|Study Discontinued by Sponsor|0|||
164424606|NCT01625338|593926473|FG002|Overall Study|Study Discontinued by Sponsor|1|||
164424607|NCT01789203|593926474|FG000|Overall Study|Adverse Event|2|||
164424608|NCT01789203|593926475|FG001|Overall Study|Adverse Event|2|||
164424609|NCT01789203|593926474|FG000|Overall Study|Withdrawal by Subject|1|||
164424610|NCT01789203|593926475|FG001|Overall Study|Withdrawal by Subject|0|||
164424611|NCT01789203|593926474|FG000|Overall Study|Death|1|||
164424612|NCT01789203|593926475|FG001|Overall Study|Death|0|||
164424613|NCT01789203|593926474|FG000|Overall Study|Protocol Violation|2|||
164424614|NCT01789203|593926475|FG001|Overall Study|Protocol Violation|1|||
164424615|NCT01789203|593926474|FG000|Overall Study|Other|1|||
164334848|NCT01134731|593603232|FG002|Overall Study|Withdrawal by Subject|1|||
164334849|NCT01134731|593603230|FG000|Overall Study|Lost to Follow-up|5|||
164334850|NCT01134731|593603231|FG001|Overall Study|Lost to Follow-up|4|||
164334851|NCT01134731|593603232|FG002|Overall Study|Lost to Follow-up|3|||
164334852|NCT01050543|593603233|FG000|Overall Study|Withdrawal by Subject|0|||
164334853|NCT01050543|593603234|FG001|Overall Study|Withdrawal by Subject|2|||
164334854|NCT01050543|593603233|FG000|Overall Study|Protocol Violation|0|||
164334855|NCT01050543|593603234|FG001|Overall Study|Protocol Violation|1|||
164334856|NCT01050543|593603233|FG000|Overall Study|Administrative|4|||
164334857|NCT01050543|593603234|FG001|Overall Study|Administrative|1|||
164334858|NCT01950169|593603237|FG000|Overall Study|Withdrawal by Subject|2|||
164334859|NCT01950169|593603238|FG001|Overall Study|Withdrawal by Subject|8|||
164334860|NCT01950169|593603239|FG002|Overall Study|Withdrawal by Subject|1|||
164334861|NCT01950169|593603237|FG000|Overall Study|Death|1|||
164334862|NCT01950169|593603238|FG001|Overall Study|Death|0|||
164334863|NCT01950169|593603239|FG002|Overall Study|Death|0|||
164334864|NCT00437320|593603240|FG000|Overall Study|Participant request|2|||
164334865|NCT00437320|593603241|FG001|Overall Study|Participant request|1|||
164334866|NCT00437320|593603242|FG002|Overall Study|Participant request|4|||
164334867|NCT01938573|593603243|FG000|Overall Study|Lack of Efficacy|1|||
164334868|NCT01938573|593603244|FG001|Overall Study|Lack of Efficacy|0|||
164334869|NCT01938573|593603243|FG000|Overall Study|Operation at other hospital|1|||
164334870|NCT01938573|593603244|FG001|Overall Study|Operation at other hospital|0|||
164334871|NCT00737438|593603245|FG000|Overall Study|Withdrawal by Subject|2|||
164334872|NCT00737438|593603245|FG000|Overall Study|Patient ineligible|1|||
164334873|NCT02410551|593603246|FG000|Overall Study|Adverse Event|1|||
164334874|NCT02410551|593603246|FG000|Overall Study|Withdrawal by Subject|1|||
164334875|NCT02410551|593603246|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
164334876|NCT01739309|593603247|FG000|Overall Study|Adverse Event|1|||
164334877|NCT01739309|593603247|FG000|Overall Study|Withdrawal by Subject|1|||
164334878|NCT05469113|593603248|FG000|Period 2|Adverse Event|0|||
164334879|NCT05469113|593603249|FG001|Period 2|Adverse Event|3|||
164334880|NCT05447897|593603250|FG000|Overall Study|Did not participate in survey|2|||
164334881|NCT04553679|593603251|FG000|Overall Study|Withdrawal by Subject|2|||
164334882|NCT04553679|593603252|FG001|Overall Study|Withdrawal by Subject|0|||
164334883|NCT04553679|593603251|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
164334884|NCT04553679|593603252|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
164334885|NCT01230710|593603254|FG000|Overall Study|Disease Progression|41|||
164334886|NCT01230710|593603254|FG000|Overall Study|Lost to Follow-up|3|||
164334887|NCT01230710|593603254|FG000|Overall Study|Death|4|||
164334888|NCT01230710|593603254|FG000|Overall Study|Withdrawal of Consent|1|||
164334889|NCT02905149|593603255|FG000|Overall Study|Lost to Follow-up|2|||
164334890|NCT02905149|593603256|FG001|Overall Study|Lost to Follow-up|0|||
164334891|NCT00747812|593603257|FG000|Overall Study|Research Site Staff Relocation|5|||
164334892|NCT00747812|593603258|FG001|Overall Study|Research Site Staff Relocation|3|||
164334893|NCT01708161|593603261|FG000|Overall Study|Adverse Event|1|||
164334894|NCT01708161|593603262|FG001|Overall Study|Adverse Event|3|||
164334895|NCT01708161|593603263|FG002|Overall Study|Adverse Event|4|||
164334896|NCT01708161|593603264|FG003|Overall Study|Adverse Event|2|||
164334897|NCT01708161|593603265|FG004|Overall Study|Adverse Event|3|||
164334898|NCT01708161|593603266|FG005|Overall Study|Adverse Event|0|||
164334899|NCT01708161|593603261|FG000|Overall Study|Death|0|||
164334900|NCT01708161|593603262|FG001|Overall Study|Death|0|||
164334901|NCT01708161|593603263|FG002|Overall Study|Death|0|||
164334902|NCT01708161|593603264|FG003|Overall Study|Death|1|||
164334903|NCT01708161|593603265|FG004|Overall Study|Death|0|||
164424616|NCT01789203|593926475|FG001|Overall Study|Other|1|||
164424617|NCT01789203|593926474|FG000|Overall Study|patient non-adherent|2|||
164677240|NCT01058668|594843052|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
164677241|NCT01058668|594843053|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
164677242|NCT01058668|594843051|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
164334904|NCT01708161|593603266|FG005|Overall Study|Death|1|||
164334905|NCT01708161|593603261|FG000|Overall Study|Withdrawal by Subject|0|||
164334906|NCT01708161|593603262|FG001|Overall Study|Withdrawal by Subject|1|||
164334907|NCT01708161|593603263|FG002|Overall Study|Withdrawal by Subject|1|||
164334908|NCT01708161|593603264|FG003|Overall Study|Withdrawal by Subject|0|||
164424618|NCT01789203|593926475|FG001|Overall Study|patient non-adherent|0|||
164236857|NCT03358030|593238929|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
164236858|NCT03358030|593238930|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
164236859|NCT03358030|593238927|FG000|Overall Study|Ineligibility|0|||
164236860|NCT03358030|593238928|FG001|Overall Study|Ineligibility|0|||
164236861|NCT03358030|593238929|FG002|Overall Study|Ineligibility|0|||
164236862|NCT03358030|593238930|FG003|Overall Study|Ineligibility|2|||
164236863|NCT03358030|593238927|FG000|Overall Study|Voluntary Withdrawal|1|||
164236864|NCT03358030|593238928|FG001|Overall Study|Voluntary Withdrawal|1|||
164236865|NCT03358030|593238929|FG002|Overall Study|Voluntary Withdrawal|3|||
164236866|NCT03358030|593238930|FG003|Overall Study|Voluntary Withdrawal|1|||
164236867|NCT03358030|593238927|FG000|Overall Study|Other|0|||
164236868|NCT03358030|593238928|FG001|Overall Study|Other|0|||
164236869|NCT03358030|593238929|FG002|Overall Study|Other|1|||
164236870|NCT03358030|593238930|FG003|Overall Study|Other|0|||
164236871|NCT03770286|593238931|FG000|Overall Study|Lost to Follow-up|6|||
164236872|NCT03770286|593238932|FG001|Overall Study|Lost to Follow-up|4|||
164236873|NCT03770286|593238933|FG002|Overall Study|Lost to Follow-up|3|||
164236874|NCT03770286|593238931|FG000|Overall Study|Protocol Violation|1|||
164236875|NCT03770286|593238932|FG001|Overall Study|Protocol Violation|0|||
164236876|NCT03770286|593238933|FG002|Overall Study|Protocol Violation|2|||
164236877|NCT02505425|593238934|FG000|Overall Study|Lost to Follow-up|41|||
164236878|NCT02505425|593238935|FG001|Overall Study|Lost to Follow-up|61|||
164236879|NCT02505425|593238936|FG002|Overall Study|Lost to Follow-up|31|||
164236880|NCT02505425|593238937|FG003|Overall Study|Lost to Follow-up|19|||
164236881|NCT02505425|593238934|FG000|Overall Study|Withdrawal by Subject|39|||
164236882|NCT02505425|593238935|FG001|Overall Study|Withdrawal by Subject|9|||
164236883|NCT02505425|593238936|FG002|Overall Study|Withdrawal by Subject|19|||
164236884|NCT02505425|593238937|FG003|Overall Study|Withdrawal by Subject|7|||
164236885|NCT02505425|593238934|FG000|Overall Study|Death|8|||
164236886|NCT02505425|593238935|FG001|Overall Study|Death|12|||
164236887|NCT02505425|593238936|FG002|Overall Study|Death|0|||
164236888|NCT02505425|593238937|FG003|Overall Study|Death|0|||
164236889|NCT04756531|593238944|FG000|Overall Study|Adverse Event|0|||
164236890|NCT04756531|593238945|FG001|Overall Study|Adverse Event|0|||
164236891|NCT04756531|593238946|FG002|Overall Study|Adverse Event|0|||
164236892|NCT04756531|593238947|FG003|Overall Study|Adverse Event|0|||
164236893|NCT04756531|593238948|FG004|Overall Study|Adverse Event|1|||
164236894|NCT04756531|593238949|FG005|Overall Study|Adverse Event|0|||
164334909|NCT01708161|593603265|FG004|Overall Study|Withdrawal by Subject|0|||
164334910|NCT01708161|593603266|FG005|Overall Study|Withdrawal by Subject|0|||
164334911|NCT01708161|593603261|FG000|Overall Study|Administrative problems|0|||
164334912|NCT01708161|593603262|FG001|Overall Study|Administrative problems|1|||
164334913|NCT01708161|593603263|FG002|Overall Study|Administrative problems|0|||
164334914|NCT01708161|593603264|FG003|Overall Study|Administrative problems|0|||
164334915|NCT01708161|593603265|FG004|Overall Study|Administrative problems|0|||
164334916|NCT01708161|593603266|FG005|Overall Study|Administrative problems|0|||
164334917|NCT01708161|593603261|FG000|Overall Study|Disease progression|3|||
164334918|NCT01708161|593603262|FG001|Overall Study|Disease progression|5|||
164334919|NCT01708161|593603263|FG002|Overall Study|Disease progression|5|||
164334920|NCT01708161|593603264|FG003|Overall Study|Disease progression|13|||
164334921|NCT01708161|593603265|FG004|Overall Study|Disease progression|3|||
164334922|NCT01708161|593603266|FG005|Overall Study|Disease progression|0|||
164334923|NCT01986140|593603268|FG000|Overall Study|Withdrawal by Subject|31|||
164334924|NCT01986140|593603269|FG001|Overall Study|Withdrawal by Subject|25|||
164334925|NCT01986140|593603268|FG000|Overall Study|alternative treatment|1|||
164334926|NCT01986140|593603269|FG001|Overall Study|alternative treatment|1|||
164334927|NCT01986140|593603268|FG000|Overall Study|found not eligible|3|||
164334928|NCT01986140|593603269|FG001|Overall Study|found not eligible|0|||
164334929|NCT01986140|593603268|FG000|Overall Study|Adverse Event|0|||
164334930|NCT01986140|593603269|FG001|Overall Study|Adverse Event|1|||
164334931|NCT01986140|593603268|FG000|Overall Study|progression disease|0|||
164334932|NCT01986140|593603269|FG001|Overall Study|progression disease|1|||
164334933|NCT01069627|593603285|FG000|Overall Study|Disease progression|7|||
164334934|NCT01069627|593603285|FG000|Overall Study|Adverse Event|12|||
164334935|NCT01069627|593603285|FG000|Overall Study|Protocol Violation|1|||
164236895|NCT04756531|593238950|FG006|Overall Study|Adverse Event|0|||
164334936|NCT02963935|593603286|FG000|Overall Study|Adverse Event|12|||
164334937|NCT02963935|593603287|FG001|Overall Study|Adverse Event|6|||
164236896|NCT04756531|593238951|FG007|Overall Study|Adverse Event|0|||
164334938|NCT02963935|593603286|FG000|Overall Study|Protocol Violation|2|||
164334939|NCT02963935|593603287|FG001|Overall Study|Protocol Violation|1|||
164334940|NCT02963935|593603286|FG000|Overall Study|Lack of Efficacy|0|||
164334941|NCT02963935|593603287|FG001|Overall Study|Lack of Efficacy|2|||
164334942|NCT02963935|593603286|FG000|Overall Study|Lost to Follow-up|1|||
164236897|NCT04756531|593238952|FG008|Overall Study|Adverse Event|0|||
164236898|NCT04756531|593238953|FG009|Overall Study|Adverse Event|0|||
164236899|NCT04756531|593238954|FG010|Overall Study|Adverse Event|0|||
164236900|NCT04756531|593238955|FG011|Overall Study|Adverse Event|0|||
164236901|NCT04756531|593238956|FG012|Overall Study|Adverse Event|0|||
164334943|NCT02963935|593603287|FG001|Overall Study|Lost to Follow-up|6|||
164236902|NCT04756531|593238957|FG013|Overall Study|Adverse Event|0|||
164236903|NCT04756531|593238958|FG014|Overall Study|Adverse Event|0|||
164236904|NCT04756531|593238959|FG015|Overall Study|Adverse Event|0|||
164236905|NCT04756531|593238960|FG016|Overall Study|Adverse Event|0|||
164236906|NCT04756531|593238961|FG017|Overall Study|Adverse Event|0|||
164236907|NCT04756531|593238944|FG000|Overall Study|Withdrawal by Subject|0|||
164236908|NCT04756531|593238945|FG001|Overall Study|Withdrawal by Subject|0|||
164236909|NCT04756531|593238946|FG002|Overall Study|Withdrawal by Subject|0|||
164236910|NCT04756531|593238947|FG003|Overall Study|Withdrawal by Subject|0|||
164236911|NCT04756531|593238948|FG004|Overall Study|Withdrawal by Subject|0|||
164236912|NCT04756531|593238949|FG005|Overall Study|Withdrawal by Subject|0|||
164236913|NCT04756531|593238950|FG006|Overall Study|Withdrawal by Subject|1|||
164236914|NCT04756531|593238951|FG007|Overall Study|Withdrawal by Subject|0|||
164236915|NCT04756531|593238952|FG008|Overall Study|Withdrawal by Subject|0|||
164236916|NCT04756531|593238953|FG009|Overall Study|Withdrawal by Subject|0|||
164236917|NCT04756531|593238954|FG010|Overall Study|Withdrawal by Subject|0|||
164236918|NCT04756531|593238955|FG011|Overall Study|Withdrawal by Subject|0|||
164236919|NCT04756531|593238956|FG012|Overall Study|Withdrawal by Subject|0|||
164236920|NCT04756531|593238957|FG013|Overall Study|Withdrawal by Subject|0|||
164236921|NCT04756531|593238958|FG014|Overall Study|Withdrawal by Subject|0|||
164236922|NCT04756531|593238959|FG015|Overall Study|Withdrawal by Subject|0|||
164236923|NCT04756531|593238960|FG016|Overall Study|Withdrawal by Subject|0|||
164236924|NCT04756531|593238961|FG017|Overall Study|Withdrawal by Subject|0|||
164236925|NCT05643495|593238962|FG000|Overall Study|Adverse Event|0|||
164236926|NCT05643495|593238963|FG001|Overall Study|Adverse Event|1|||
164236927|NCT05643495|593238962|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
164236928|NCT05643495|593238963|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
164236929|NCT02257528|593238964|FG000|Overall Study|Never received study treatment|1|||
164236930|NCT01729039|593238965|FG000|Overall Study|disqualified|2|||
164236931|NCT01729039|593238966|FG001|Overall Study|disqualified|5|||
164236932|NCT01729039|593238965|FG000|Overall Study|Withdrawal by Subject|8|||
164236933|NCT01729039|593238966|FG001|Overall Study|Withdrawal by Subject|7|||
164236934|NCT00404248|593238969|FG000|Overall Study|pts declining status|0|||
164334944|NCT02963935|593603286|FG000|Overall Study|Unclassified|13|||
164334945|NCT02963935|593603287|FG001|Overall Study|Unclassified|22|||
164334946|NCT00464269|593603288|FG000|Overall Study|Lack of Efficacy|1|||
164334947|NCT00464269|593603289|FG001|Overall Study|Lack of Efficacy|0|||
164334948|NCT00464269|593603290|FG002|Overall Study|Lack of Efficacy|0|||
164334949|NCT00464269|593603291|FG003|Overall Study|Lack of Efficacy|0|||
164334950|NCT00464269|593603288|FG000|Overall Study|Lost to Follow-up|0|||
164573166|NCT02393209|594463349|FG002|Overall Study|Withdrawal by Patient|0|||
164236935|NCT00404248|593238970|FG001|Overall Study|pts declining status|1|||
164236936|NCT00404248|593238971|FG002|Overall Study|pts declining status|0|||
164236937|NCT00404248|593238972|FG003|Overall Study|pts declining status|0|||
164236938|NCT00404248|593238973|FG004|Overall Study|pts declining status|0|||
164236939|NCT00404248|593238974|FG005|Overall Study|pts declining status|0|||
164236940|NCT00404248|593238975|FG006|Overall Study|pts declining status|0|||
164334951|NCT00464269|593603289|FG001|Overall Study|Lost to Follow-up|4|||
164334952|NCT00464269|593603290|FG002|Overall Study|Lost to Follow-up|0|||
164334953|NCT00464269|593603291|FG003|Overall Study|Lost to Follow-up|1|||
164334954|NCT00464269|593603288|FG000|Overall Study|Withdrawal by Subject|0|||
164334955|NCT00464269|593603289|FG001|Overall Study|Withdrawal by Subject|2|||
164334956|NCT00464269|593603290|FG002|Overall Study|Withdrawal by Subject|1|||
164334957|NCT00464269|593603291|FG003|Overall Study|Withdrawal by Subject|1|||
164334958|NCT00464269|593603288|FG000|Overall Study|Other reason|3|||
164334959|NCT00464269|593603289|FG001|Overall Study|Other reason|3|||
164334960|NCT00464269|593603290|FG002|Overall Study|Other reason|1|||
164334961|NCT00464269|593603291|FG003|Overall Study|Other reason|1|||
164334962|NCT00464269|593603288|FG000|Overall Study|AE, serious fatal|0|||
164334963|NCT00464269|593603289|FG001|Overall Study|AE, serious fatal|0|||
164334964|NCT00464269|593603290|FG002|Overall Study|AE, serious fatal|1|||
164334965|NCT00464269|593603291|FG003|Overall Study|AE, serious fatal|1|||
164334966|NCT00464269|593603288|FG000|Overall Study|SAE, non-fatal|0|||
164334967|NCT00464269|593603289|FG001|Overall Study|SAE, non-fatal|0|||
164334968|NCT00464269|593603290|FG002|Overall Study|SAE, non-fatal|0|||
164334969|NCT00464269|593603291|FG003|Overall Study|SAE, non-fatal|1|||
164334970|NCT00464269|593603288|FG000|Overall Study|AE, non-serious non-fatal|2|||
164334971|NCT00464269|593603289|FG001|Overall Study|AE, non-serious non-fatal|8|||
164573167|NCT02393209|594463350|FG003|Overall Study|Withdrawal by Patient|0|||
164236941|NCT00404248|593238976|FG007|Overall Study|pts declining status|0|||
164236942|NCT00404248|593238977|FG008|Overall Study|pts declining status|0|||
164236943|NCT00698841|593238978|FG000|Overall Study|Withdrawal by Subject|2|||
164236944|NCT00698841|593238978|FG000|Overall Study|Adverse Event|3|||
164334972|NCT00464269|593603290|FG002|Overall Study|AE, non-serious non-fatal|3|||
164334973|NCT00464269|593603291|FG003|Overall Study|AE, non-serious non-fatal|4|||
164334974|NCT00464269|593603288|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
164334975|NCT00464269|593603289|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
164236945|NCT00698841|593238978|FG000|Overall Study|Disease progression|7|||
164236946|NCT00698841|593238978|FG000|Overall Study|Failure to meet eligibility criteria|2|||
164236947|NCT00698841|593238978|FG000|Overall Study|Study drug toxicity|2|||
164236948|NCT00698841|593238978|FG000|Overall Study|Other|2|||
164236949|NCT04646005|593238982|FG000|Overall Study|Adverse Event|1|||
164236950|NCT04646005|593238982|FG000|Overall Study|Progressive Disease|71|||
164236951|NCT04646005|593238982|FG000|Overall Study|Death|20|||
164236952|NCT04646005|593238982|FG000|Overall Study|Withdrawal by Subject|12|||
164236953|NCT04646005|593238982|FG000|Overall Study|Sponsor Request|9|||
164236954|NCT05788991|593238984|FG000|Overall Study|Not treated with study medication|1|||
164334976|NCT00464269|593603290|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
164334977|NCT00464269|593603291|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
164334978|NCT03911154|593603292|FG000|Overall Study|Withdrawal by Subject|1|||
164334979|NCT00299182|593603293|FG000|Overall Study|Withdrawal by Subject|0|||
164334980|NCT00299182|593603294|FG001|Overall Study|Withdrawal by Subject|0|||
164334981|NCT00299182|593603295|FG002|Overall Study|Withdrawal by Subject|1|||
164334982|NCT00299182|593603296|FG003|Overall Study|Withdrawal by Subject|0|||
164334983|NCT00299182|593603297|FG004|Overall Study|Withdrawal by Subject|1|||
164334984|NCT00299182|593603298|FG005|Overall Study|Withdrawal by Subject|2|||
164334985|NCT00299182|593603299|FG006|Overall Study|Withdrawal by Subject|0|||
164334986|NCT00299182|593603293|FG000|Overall Study|Chemotherapy Changed|0|||
164334987|NCT00299182|593603294|FG001|Overall Study|Chemotherapy Changed|0|||
164334988|NCT00299182|593603295|FG002|Overall Study|Chemotherapy Changed|1|||
164334989|NCT00299182|593603296|FG003|Overall Study|Chemotherapy Changed|0|||
164334990|NCT00299182|593603297|FG004|Overall Study|Chemotherapy Changed|1|||
164334991|NCT00299182|593603298|FG005|Overall Study|Chemotherapy Changed|0|||
164334992|NCT00299182|593603299|FG006|Overall Study|Chemotherapy Changed|1|||
164334993|NCT00299182|593603293|FG000|Overall Study|Adverse Event|0|||
164334994|NCT00299182|593603294|FG001|Overall Study|Adverse Event|0|||
164334995|NCT00299182|593603295|FG002|Overall Study|Adverse Event|0|||
164334996|NCT00299182|593603296|FG003|Overall Study|Adverse Event|0|||
164334997|NCT00299182|593603297|FG004|Overall Study|Adverse Event|0|||
164334998|NCT00299182|593603298|FG005|Overall Study|Adverse Event|1|||
164334999|NCT00299182|593603299|FG006|Overall Study|Adverse Event|0|||
164335000|NCT00299182|593603293|FG000|Overall Study|Not Eligible|0|||
164335001|NCT00299182|593603294|FG001|Overall Study|Not Eligible|0|||
164335002|NCT00299182|593603295|FG002|Overall Study|Not Eligible|0|||
164335003|NCT00299182|593603296|FG003|Overall Study|Not Eligible|0|||
164335004|NCT00299182|593603297|FG004|Overall Study|Not Eligible|1|||
164335005|NCT00299182|593603298|FG005|Overall Study|Not Eligible|0|||
164335006|NCT00299182|593603299|FG006|Overall Study|Not Eligible|0|||
164335007|NCT00292318|593603301|FG000|Overall Study|Study terminated by officials|2|||
164335008|NCT00292318|593603302|FG001|Overall Study|Study terminated by officials|1|||
164335009|NCT00771316|593603303|FG000|Overall Study|Adverse Event|0|||
164335010|NCT00771316|593603304|FG001|Overall Study|Adverse Event|1|||
164335011|NCT00771316|593603303|FG000|Overall Study|Patient withdrew consent|1|||
164335012|NCT00771316|593603304|FG001|Overall Study|Patient withdrew consent|0|||
164335013|NCT00771316|593603303|FG000|Overall Study|Discontinued due to early termination|1|||
164335014|NCT00771316|593603304|FG001|Overall Study|Discontinued due to early termination|0|||
164335015|NCT01822496|593603305|FG000|Overall Study|Protocol Violation|2|||
164335016|NCT01822496|593603306|FG001|Overall Study|Protocol Violation|2|||
164335017|NCT01822496|593603307|FG002|Overall Study|Protocol Violation|0|||
164335018|NCT01822496|593603308|FG003|Overall Study|Protocol Violation|1|||
164335019|NCT01822496|593603305|FG000|Overall Study|Withdrawal by Subject|0|||
164335020|NCT01822496|593603306|FG001|Overall Study|Withdrawal by Subject|0|||
164335021|NCT01822496|593603307|FG002|Overall Study|Withdrawal by Subject|0|||
164335022|NCT01822496|593603308|FG003|Overall Study|Withdrawal by Subject|3|||
164335023|NCT01631812|593603309|FG000|Overall Study|Adverse Event|25|||
164335024|NCT01631812|593603309|FG000|Overall Study|Lack of Efficacy|5|||
164335025|NCT01631812|593603309|FG000|Overall Study|Withdrawal by Subject|4|||
164335026|NCT01631812|593603309|FG000|Overall Study|Physician Decision|3|||
164335027|NCT00543543|593603310|FG000|Base Study|Adverse Event|1|||
164335028|NCT00543543|593603311|FG001|Base Study|Adverse Event|11|||
164335029|NCT00543543|593603312|FG002|Base Study|Adverse Event|0|||
164335030|NCT00543543|593603313|FG003|Base Study|Adverse Event|5|||
164335031|NCT00543543|593603310|FG000|Base Study|Lost to Follow-up|12|||
164335032|NCT00543543|593603311|FG001|Base Study|Lost to Follow-up|749|||
164335033|NCT00543543|593603312|FG002|Base Study|Lost to Follow-up|9|||
164335034|NCT00543543|593603313|FG003|Base Study|Lost to Follow-up|701|||
164335035|NCT00543543|593603310|FG000|Base Study|Physician Decision|0|||
164335036|NCT00543543|593603311|FG001|Base Study|Physician Decision|4|||
164335037|NCT00543543|593603312|FG002|Base Study|Physician Decision|0|||
164335038|NCT00543543|593603313|FG003|Base Study|Physician Decision|7|||
164335039|NCT00543543|593603310|FG000|Base Study|Protocol Violation|0|||
164335040|NCT00543543|593603311|FG001|Base Study|Protocol Violation|6|||
164236955|NCT05788991|593238985|FG001|Overall Study|Not treated with study medication|3|||
164236956|NCT05788991|593238984|FG000|Overall Study|Withdrawal by Subject|1|||
164335041|NCT00543543|593603312|FG002|Base Study|Protocol Violation|0|||
164236957|NCT05788991|593238985|FG001|Overall Study|Withdrawal by Subject|0|||
164236958|NCT05788991|593238984|FG000|Overall Study|Lack of Efficacy|0|||
164236959|NCT05788991|593238985|FG001|Overall Study|Lack of Efficacy|1|||
164236960|NCT05788991|593238984|FG000|Overall Study|Protocol Violation|1|||
164236961|NCT05788991|593238985|FG001|Overall Study|Protocol Violation|2|||
164236962|NCT04464473|593238986|FG000|Overall Study|New piercing could not be removed for scanning|0|||
164236963|NCT04464473|593238987|FG001|Overall Study|New piercing could not be removed for scanning|0|||
164236964|NCT04464473|593238988|FG002|Overall Study|New piercing could not be removed for scanning|0|||
164236965|NCT04464473|593238989|FG003|Overall Study|New piercing could not be removed for scanning|1|||
164236966|NCT04464473|593238990|FG004|Overall Study|New piercing could not be removed for scanning|0|||
164236967|NCT04464473|593238991|FG005|Overall Study|New piercing could not be removed for scanning|0|||
164236968|NCT04464473|593238986|FG000|Overall Study|Adverse Event|0|||
164236969|NCT04464473|593238987|FG001|Overall Study|Adverse Event|0|||
164236970|NCT04464473|593238988|FG002|Overall Study|Adverse Event|0|||
164236971|NCT04464473|593238989|FG003|Overall Study|Adverse Event|1|||
164236972|NCT04464473|593238990|FG004|Overall Study|Adverse Event|0|||
164236973|NCT04464473|593238991|FG005|Overall Study|Adverse Event|0|||
164236974|NCT04464473|593238986|FG000|Overall Study|Lost to Follow-up|0|||
164236975|NCT04464473|593238987|FG001|Overall Study|Lost to Follow-up|0|||
164236976|NCT04464473|593238988|FG002|Overall Study|Lost to Follow-up|0|||
164236977|NCT04464473|593238989|FG003|Overall Study|Lost to Follow-up|1|||
164236978|NCT04464473|593238990|FG004|Overall Study|Lost to Follow-up|0|||
164236979|NCT04464473|593238991|FG005|Overall Study|Lost to Follow-up|0|||
164236980|NCT03802396|593238992|FG000|Overall Study|Withdrawal by Subject|2|||
164236981|NCT03802396|593238993|FG001|Overall Study|Withdrawal by Subject|0|||
164236982|NCT03802396|593238992|FG000|Overall Study|Surgery Cancelled|1|||
164236983|NCT03802396|593238993|FG001|Overall Study|Surgery Cancelled|0|||
164236984|NCT04237584|593239004|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
164236985|NCT04237584|593239005|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
164236986|NCT04237584|593239006|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
164236987|NCT04237584|593239007|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
164236988|NCT04237584|593239004|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
164236989|NCT04237584|593239005|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
164236990|NCT04237584|593239006|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
164236991|NCT04237584|593239007|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
164573168|NCT02393209|594463347|FG000|Overall Study|Death|2|||
164573169|NCT02393209|594463348|FG001|Overall Study|Death|2|||
164573170|NCT02393209|594463349|FG002|Overall Study|Death|0|||
164236992|NCT04237584|593239004|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
164236993|NCT04237584|593239005|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
164335042|NCT00543543|593603313|FG003|Base Study|Protocol Violation|6|||
164335043|NCT00543543|593603310|FG000|Base Study|Withdrawal by Subject|7|||
164335044|NCT00543543|593603311|FG001|Base Study|Withdrawal by Subject|482|||
164335045|NCT00543543|593603312|FG002|Base Study|Withdrawal by Subject|5|||
164335046|NCT00543543|593603313|FG003|Base Study|Withdrawal by Subject|503|||
164335047|NCT00543543|593603310|FG000|Extension Study|Adverse Event|0|||
164335048|NCT00543543|593603311|FG001|Extension Study|Adverse Event|0|||
164335049|NCT00543543|593603312|FG002|Extension Study|Adverse Event|0|||
164335050|NCT00543543|593603313|FG003|Extension Study|Adverse Event|5|||
164335051|NCT00543543|593603310|FG000|Extension Study|Lost to Follow-up|0|||
164335052|NCT00543543|593603311|FG001|Extension Study|Lost to Follow-up|0|||
164335053|NCT00543543|593603312|FG002|Extension Study|Lost to Follow-up|0|||
164335054|NCT00543543|593603313|FG003|Extension Study|Lost to Follow-up|77|||
164335055|NCT00543543|593603310|FG000|Extension Study|Physician Decision|0|||
164335056|NCT00543543|593603311|FG001|Extension Study|Physician Decision|0|||
164335057|NCT00543543|593603312|FG002|Extension Study|Physician Decision|0|||
164335058|NCT00543543|593603313|FG003|Extension Study|Physician Decision|7|||
164335059|NCT00543543|593603310|FG000|Extension Study|Pregnancy|0|||
164335060|NCT00543543|593603311|FG001|Extension Study|Pregnancy|0|||
164335061|NCT00543543|593603312|FG002|Extension Study|Pregnancy|0|||
164335062|NCT00543543|593603313|FG003|Extension Study|Pregnancy|6|||
164335063|NCT00543543|593603310|FG000|Extension Study|Protocol Violation|0|||
164335064|NCT00543543|593603311|FG001|Extension Study|Protocol Violation|0|||
164335065|NCT00543543|593603312|FG002|Extension Study|Protocol Violation|0|||
164335066|NCT00543543|593603313|FG003|Extension Study|Protocol Violation|11|||
164335067|NCT00543543|593603310|FG000|Extension Study|Withdrawal by Subject|0|||
164335068|NCT00543543|593603311|FG001|Extension Study|Withdrawal by Subject|0|||
164335069|NCT00543543|593603312|FG002|Extension Study|Withdrawal by Subject|0|||
164335070|NCT00543543|593603313|FG003|Extension Study|Withdrawal by Subject|120|||
164335071|NCT00945555|593603314|FG000|Overall Study|Referred to another hospital|5|||
164335072|NCT00945555|593603314|FG000|Overall Study|Worsening condition, intensive care unit|1|||
164335073|NCT00945555|593603314|FG000|Overall Study|Withdrawal by Subject|2|||
164335074|NCT00945555|593603314|FG000|Overall Study|Participant continued treatment at home|1|||
164335075|NCT00945555|593603314|FG000|Overall Study|Death|18|||
164573171|NCT02393209|594463350|FG003|Overall Study|Death|0|||
164236994|NCT04237584|593239006|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
164236995|NCT04237584|593239007|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
164236996|NCT04237584|593239004|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
164236997|NCT04237584|593239005|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
164236998|NCT04237584|593239006|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
164236999|NCT04237584|593239007|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
164237000|NCT04237584|593239004|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
164237001|NCT04237584|593239005|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
164237002|NCT04237584|593239006|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
164237003|NCT04237584|593239007|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
164237004|NCT03549338|593240459|FG000|Overall Study|Progressive Disease|1|||
164237005|NCT03549338|593240460|FG001|Overall Study|Progressive Disease|0|||
164237006|NCT03549338|593240461|FG002|Overall Study|Progressive Disease|0|||
164237007|NCT03549338|593240459|FG000|Overall Study|Clinical Progression|0|||
164237008|NCT03549338|593240460|FG001|Overall Study|Clinical Progression|1|||
164237009|NCT03549338|593240461|FG002|Overall Study|Clinical Progression|0|||
164237010|NCT01492426|593240462|FG000|Treatment|Death|0|||
164237011|NCT01492426|593240463|FG001|Treatment|Death|1|||
164237012|NCT01492426|593240462|FG000|Treatment|Other|1|||
164237013|NCT01492426|593240463|FG001|Treatment|Other|0|||
164237014|NCT01492426|593240462|FG000|Treatment|Adverse Event|25|||
164237015|NCT01492426|593240463|FG001|Treatment|Adverse Event|25|||
164237016|NCT01492426|593240462|FG000|Treatment|Lack of Efficacy|38|||
164237017|NCT01492426|593240463|FG001|Treatment|Lack of Efficacy|5|||
164237018|NCT01492426|593240462|FG000|Treatment|Participant withdrew consent|1|||
164237019|NCT01492426|593240463|FG001|Treatment|Participant withdrew consent|2|||
164237020|NCT01492426|593240462|FG000|Treatment|Poor compliance/noncompliance|1|||
164237021|NCT01492426|593240463|FG001|Treatment|Poor compliance/noncompliance|0|||
164237022|NCT01492426|593240462|FG000|Treatment|Subject requested discontinue study drug|7|||
164237023|NCT01492426|593240463|FG001|Treatment|Subject requested discontinue study drug|3|||
164237024|NCT01492426|593240462|FG000|Treatment|Lost to Follow-up|9|||
164237025|NCT01492426|593240463|FG001|Treatment|Lost to Follow-up|4|||
164237026|NCT01492426|593240462|FG000|Treatment|Participant does not meet study criteria|1|||
164237027|NCT01492426|593240463|FG001|Treatment|Participant does not meet study criteria|0|||
164237028|NCT01492426|593240462|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
164237029|NCT01492426|593240463|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
164237030|NCT01492426|593240462|FG000|Follow-Up|Death|1|||
164237031|NCT01492426|593240463|FG001|Follow-Up|Death|0|||
164237032|NCT01492426|593240462|FG000|Follow-Up|Other|4|||
164237033|NCT01492426|593240463|FG001|Follow-Up|Other|2|||
164237034|NCT01492426|593240462|FG000|Follow-Up|Participant Withdrew Consent|6|||
164237035|NCT01492426|593240463|FG001|Follow-Up|Participant Withdrew Consent|1|||
164237036|NCT01492426|593240462|FG000|Follow-Up|Lost to Follow-up|12|||
164237037|NCT01492426|593240463|FG001|Follow-Up|Lost to Follow-up|6|||
164237038|NCT00269113|593240464|FG000|Overall Study|Adverse Event|14|||
164237039|NCT00269113|593240465|FG001|Overall Study|Adverse Event|7|||
164237040|NCT00269113|593240464|FG000|Overall Study|Lack of Efficacy|35|||
164237041|NCT00269113|593240465|FG001|Overall Study|Lack of Efficacy|18|||
164237042|NCT00269113|593240464|FG000|Overall Study|Early Improvement|2|||
164237043|NCT00269113|593240465|FG001|Overall Study|Early Improvement|0|||
164237044|NCT00269113|593240464|FG000|Overall Study|Withdrawal by Subject|0|||
164237045|NCT00269113|593240465|FG001|Overall Study|Withdrawal by Subject|2|||
164237046|NCT00269113|593240464|FG000|Overall Study|Death|6|||
164237047|NCT00269113|593240465|FG001|Overall Study|Death|2|||
164335076|NCT00945555|593603314|FG000|Overall Study|Other|1|||
164335077|NCT04502979|593603315|FG000|Overall Study|Lost to Follow-up|1|||
164335078|NCT04502979|593603316|FG001|Overall Study|Lost to Follow-up|3|||
164335079|NCT04502979|593603315|FG000|Overall Study|Withdrawal by Subject|2|||
164335080|NCT04502979|593603316|FG001|Overall Study|Withdrawal by Subject|1|||
164335081|NCT00586625|593603320|FG000|Overall Study|Adverse Event|6|||
164335082|NCT00586625|593603321|FG001|Overall Study|Adverse Event|6|||
164424619|NCT00515086|593926482|FG000|Overall Study|Adverse Event|1|||
164237048|NCT00269113|593240464|FG000|Overall Study|Lost to Follow-up|2|||
164237049|NCT00269113|593240465|FG001|Overall Study|Lost to Follow-up|1|||
164237050|NCT00269113|593240464|FG000|Overall Study|Protocol Violation|15|||
164237051|NCT00269113|593240465|FG001|Overall Study|Protocol Violation|5|||
164237052|NCT00269113|593240464|FG000|Overall Study|Other|0|||
164237053|NCT00269113|593240465|FG001|Overall Study|Other|2|||
164237054|NCT00652743|593240466|FG000|Months 12-18|Lost to Follow-up|1|||
164237055|NCT00652743|593240467|FG001|Months 12-18|Lost to Follow-up|2|||
164237056|NCT00652743|593240468|FG002|Months 12-18|Lost to Follow-up|7|||
164237057|NCT00652743|593240466|FG000|Months 24-30|Other|5|||
164237058|NCT00652743|593240467|FG001|Months 24-30|Other|1|||
164237059|NCT00652743|593240468|FG002|Months 24-30|Other|11|||
164237060|NCT00652743|593240466|FG000|Months 36-42|Serious Adverse Events|0|||
164335083|NCT00586625|593603320|FG000|Overall Study|Protocol Violation|3|||
164335084|NCT00586625|593603321|FG001|Overall Study|Protocol Violation|0|||
164335085|NCT00586625|593603320|FG000|Overall Study|Withdrawal by Subject|32|||
164237061|NCT00652743|593240467|FG001|Months 36-42|Serious Adverse Events|1|||
164237062|NCT00652743|593240468|FG002|Months 36-42|Serious Adverse Events|1|||
164237063|NCT00652743|593240466|FG000|Months 36-42|Withdrawal by Subject|1|||
164237064|NCT00652743|593240467|FG001|Months 36-42|Withdrawal by Subject|1|||
164237065|NCT00652743|593240468|FG002|Months 36-42|Withdrawal by Subject|0|||
164237066|NCT00652743|593240466|FG000|Months 36-42|Lost to Follow-up|0|||
164237067|NCT00652743|593240467|FG001|Months 36-42|Lost to Follow-up|1|||
164237068|NCT00652743|593240468|FG002|Months 36-42|Lost to Follow-up|0|||
164237069|NCT00652743|593240466|FG000|Months 36-42|Migrated/moved from study area|1|||
164237070|NCT00652743|593240467|FG001|Months 36-42|Migrated/moved from study area|0|||
164237071|NCT00652743|593240468|FG002|Months 36-42|Migrated/moved from study area|0|||
164237072|NCT00652743|593240466|FG000|Months 36-42|Other|4|||
164424620|NCT00515086|593926483|FG001|Overall Study|Adverse Event|1|||
164237073|NCT00652743|593240467|FG001|Months 36-42|Other|2|||
164335086|NCT00586625|593603321|FG001|Overall Study|Withdrawal by Subject|10|||
164335087|NCT00586625|593603320|FG000|Overall Study|Subject non-compliance|0|||
164335088|NCT00586625|593603321|FG001|Overall Study|Subject non-compliance|1|||
164335089|NCT00586625|593603320|FG000|Overall Study|Subject unable to return for visit|2|||
164335090|NCT00586625|593603321|FG001|Overall Study|Subject unable to return for visit|0|||
164335091|NCT02906332|593603323|FG000|Overall Study|Withdrawal by Subject|1|||
164335092|NCT00165984|593603324|FG000|Overall Study|Death|15|||
164335093|NCT01686828|593603328|FG000|Overall Study|Physician Decision|1|||
164335094|NCT01686828|593603329|FG001|Overall Study|Physician Decision|0|||
164335095|NCT01686828|593603330|FG002|Overall Study|Physician Decision|0|||
164335096|NCT01686828|593603331|FG003|Overall Study|Physician Decision|0|||
164335097|NCT01686828|593603328|FG000|Overall Study|New Job|0|||
164335098|NCT01686828|593603329|FG001|Overall Study|New Job|1|||
164335099|NCT01686828|593603330|FG002|Overall Study|New Job|0|||
164335100|NCT01686828|593603331|FG003|Overall Study|New Job|0|||
164335101|NCT01686828|593603328|FG000|Overall Study|Weight Loss|0|||
164335102|NCT01686828|593603329|FG001|Overall Study|Weight Loss|0|||
164335103|NCT01686828|593603330|FG002|Overall Study|Weight Loss|1|||
164335104|NCT01686828|593603331|FG003|Overall Study|Weight Loss|0|||
164335105|NCT02734433|593603332|FG000|Overall Study|Disease progression|1|||
164335106|NCT02734433|593603333|FG001|Overall Study|Disease progression|5|||
164335107|NCT02734433|593603332|FG000|Overall Study|Clinical progression|0|||
164335108|NCT02734433|593603333|FG001|Overall Study|Clinical progression|1|||
164335109|NCT02734433|593603332|FG000|Overall Study|Withdrawal by Subject|1|||
164335110|NCT02734433|593603333|FG001|Overall Study|Withdrawal by Subject|2|||
164335111|NCT03698331|593603336|FG000|Overall Study|Adverse Event|2|||
164335112|NCT03698331|593603337|FG001|Overall Study|Adverse Event|3|||
164335113|NCT03698331|593603336|FG000|Overall Study|Withdrawal by Subject|1|||
164335114|NCT03698331|593603337|FG001|Overall Study|Withdrawal by Subject|1|||
164335115|NCT03698331|593603336|FG000|Overall Study|Lost to Follow-up|0|||
164335116|NCT03698331|593603337|FG001|Overall Study|Lost to Follow-up|2|||
164335117|NCT03698331|593603336|FG000|Overall Study|Non-compliance with study drug|1|||
164335118|NCT03698331|593603337|FG001|Overall Study|Non-compliance with study drug|0|||
164335119|NCT04916769|593603339|FG000|Period 1|Physician Decision|0|||
164335120|NCT04916769|593603340|FG001|Period 1|Physician Decision|0|||
164335121|NCT04916769|593603341|FG002|Period 1|Physician Decision|0|||
164335122|NCT04916769|593603342|FG003|Period 1|Physician Decision|0|||
164335123|NCT04916769|593603343|FG004|Period 1|Physician Decision|0|||
164335124|NCT04916769|593603344|FG005|Period 1|Physician Decision|1|||
164335125|NCT04916769|593603339|FG000|Period 2|Physician Decision|0|||
164335126|NCT04916769|593603340|FG001|Period 2|Physician Decision|1|||
164335127|NCT04916769|593603341|FG002|Period 2|Physician Decision|0|||
164335128|NCT04916769|593603342|FG003|Period 2|Physician Decision|0|||
164335129|NCT04916769|593603343|FG004|Period 2|Physician Decision|0|||
164335130|NCT04916769|593603344|FG005|Period 2|Physician Decision|0|||
164335131|NCT04941456|593603345|FG000|Overall Study|Withdrawal by Subject|1|||
164335132|NCT04941456|593603346|FG001|Overall Study|Withdrawal by Subject|0|||
164335133|NCT04941456|593603345|FG000|Overall Study|Protocol Violation|1|||
164335134|NCT04941456|593603346|FG001|Overall Study|Protocol Violation|0|||
164335135|NCT03894046|593604814|FG000|Overall Study|Protocol Violation|1|||
164237074|NCT00652743|593240468|FG002|Months 36-42|Other|8|||
164237075|NCT00140140|593240469|FG000|Overall Study|Unacceptable toxicity|1|||
164237076|NCT00140140|593240470|FG001|Overall Study|Unacceptable toxicity|1|||
164237077|NCT00140140|593240471|FG002|Overall Study|Unacceptable toxicity|2|||
164237078|NCT00140140|593240469|FG000|Overall Study|Physician Decision|1|||
164237079|NCT00140140|593240470|FG001|Overall Study|Physician Decision|1|||
164237080|NCT00140140|593240471|FG002|Overall Study|Physician Decision|0|||
164237081|NCT00690794|593240472|FG000|Overall Study|Adverse Event|12|||
164335136|NCT03894046|593604815|FG001|Overall Study|Protocol Violation|0|||
164335137|NCT03894046|593604816|FG002|Overall Study|Protocol Violation|0|||
164335138|NCT03894046|593604814|FG000|Overall Study|Adverse Event|0|||
164335139|NCT03894046|593604815|FG001|Overall Study|Adverse Event|1|||
164335140|NCT03894046|593604816|FG002|Overall Study|Adverse Event|0|||
164335141|NCT03894046|593604814|FG000|Overall Study|Withdrawal by Subject|2|||
164335142|NCT03894046|593604815|FG001|Overall Study|Withdrawal by Subject|3|||
164424621|NCT00515086|593926484|FG002|Overall Study|Adverse Event|2|||
164424622|NCT00515086|593926485|FG003|Overall Study|Adverse Event|3|||
164424623|NCT00515086|593926482|FG000|Overall Study|Administrative|1|||
164424624|NCT00515086|593926483|FG001|Overall Study|Administrative|1|||
164424625|NCT00515086|593926484|FG002|Overall Study|Administrative|0|||
164424626|NCT00515086|593926485|FG003|Overall Study|Administrative|0|||
164424627|NCT00515086|593926482|FG000|Overall Study|Withdrawal by Subject|1|||
164424628|NCT00515086|593926483|FG001|Overall Study|Withdrawal by Subject|0|||
164424629|NCT00515086|593926484|FG002|Overall Study|Withdrawal by Subject|0|||
164424630|NCT00515086|593926485|FG003|Overall Study|Withdrawal by Subject|1|||
164424631|NCT00515086|593926482|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
164424632|NCT00515086|593926483|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
164424633|NCT00515086|593926484|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
164424634|NCT00515086|593926485|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
164424635|NCT00515086|593926482|FG000|Overall Study|Lost to Follow-up|1|||
164424636|NCT00515086|593926483|FG001|Overall Study|Lost to Follow-up|0|||
164424637|NCT00515086|593926484|FG002|Overall Study|Lost to Follow-up|0|||
164424638|NCT00515086|593926485|FG003|Overall Study|Lost to Follow-up|0|||
164424639|NCT00515086|593926482|FG000|Overall Study|Study drug no longer required|0|||
164424640|NCT00515086|593926483|FG001|Overall Study|Study drug no longer required|1|||
164424641|NCT00515086|593926484|FG002|Overall Study|Study drug no longer required|0|||
164424642|NCT00515086|593926485|FG003|Overall Study|Study drug no longer required|0|||
164424643|NCT00515086|593926482|FG000|Overall Study|Death|2|||
164424644|NCT00515086|593926483|FG001|Overall Study|Death|0|||
164424645|NCT00515086|593926484|FG002|Overall Study|Death|0|||
164424646|NCT00515086|593926485|FG003|Overall Study|Death|0|||
164424647|NCT02403674|593926488|FG000|Base Study|Death|1|||
164424648|NCT02403674|593926489|FG001|Base Study|Death|4|||
164424649|NCT02403674|593926488|FG000|Base Study|Adverse Event|11|||
164424650|NCT02403674|593926489|FG001|Base Study|Adverse Event|26|||
164424651|NCT02403674|593926488|FG000|Base Study|Lack of Efficacy|31|||
164424652|NCT02403674|593926489|FG001|Base Study|Lack of Efficacy|23|||
164424653|NCT02403674|593926488|FG000|Base Study|Lost to Follow-up|6|||
164424654|NCT02403674|593926489|FG001|Base Study|Lost to Follow-up|8|||
164424655|NCT02403674|593926488|FG000|Base Study|Withdrawal by Subject|10|||
164424656|NCT02403674|593926489|FG001|Base Study|Withdrawal by Subject|17|||
164424657|NCT02403674|593926488|FG000|Base Study|Physician Decision|2|||
164424658|NCT02403674|593926489|FG001|Base Study|Physician Decision|2|||
164424659|NCT02403674|593926488|FG000|Base Study|Pregnancy|2|||
164424660|NCT02403674|593926489|FG001|Base Study|Pregnancy|2|||
164424661|NCT02403674|593926488|FG000|Base Study|Protocol Violation|8|||
164424662|NCT02403674|593926489|FG001|Base Study|Protocol Violation|4|||
164424663|NCT02403674|593926488|FG000|Base Study|Non-Compliance with study drug|1|||
164424664|NCT02403674|593926489|FG001|Base Study|Non-Compliance with study drug|4|||
164424665|NCT02403674|593926488|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
164424666|NCT02403674|593926489|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
164424667|NCT02403674|593926488|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
164424668|NCT02403674|593926489|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
164424669|NCT02403674|593926488|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
164424670|NCT02403674|593926489|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
164424671|NCT02403674|593926488|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
164424672|NCT02403674|593926489|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
164424673|NCT02403674|593926488|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
164424674|NCT02403674|593926489|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
164424675|NCT02403674|593926488|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
164424676|NCT02403674|593926489|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
164424677|NCT02403674|593926488|FG000|Study Extension 1 (Open-Label)|Death|1|||
164237082|NCT00690794|593240473|FG001|Overall Study|Adverse Event|10|||
164237083|NCT00690794|593240472|FG000|Overall Study|Lost to Follow-up|1|||
164237084|NCT00690794|593240473|FG001|Overall Study|Lost to Follow-up|4|||
164237085|NCT00690794|593240472|FG000|Overall Study|Withdrawal by Subject|0|||
164237086|NCT00690794|593240473|FG001|Overall Study|Withdrawal by Subject|9|||
164237087|NCT00690794|593240472|FG000|Overall Study|Protocol Violation|6|||
164237088|NCT00690794|593240473|FG001|Overall Study|Protocol Violation|7|||
164424678|NCT02403674|593926489|FG001|Study Extension 1 (Open-Label)|Death|0|||
164424679|NCT02403674|593926488|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
164424680|NCT02403674|593926489|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
164424681|NCT02403674|593926488|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
164424682|NCT02403674|593926489|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
164424683|NCT02403674|593926488|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
164424684|NCT02403674|593926489|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
164424685|NCT02403674|593926488|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
164237089|NCT00690794|593240472|FG000|Overall Study|Noncompliance|1|||
164237090|NCT00690794|593240473|FG001|Overall Study|Noncompliance|2|||
164237091|NCT00690794|593240472|FG000|Overall Study|Other not specified|1|||
164237092|NCT00690794|593240473|FG001|Overall Study|Other not specified|3|||
164424686|NCT02403674|593926489|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
164237093|NCT00325143|593240474|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
164237094|NCT00325143|593240474|FG000|Overall Study|Migrated/moved from study area|1|||
164237095|NCT00325143|593240474|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
164237096|NCT00325143|593240474|FG000|Overall Study|Withdrawal by Subject|8|||
164237097|NCT02286895|593240475|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
164237098|NCT02286895|593240476|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
164237099|NCT02286895|593240475|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
164237100|NCT02286895|593240476|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
164237101|NCT02286895|593240475|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
164237102|NCT02286895|593240476|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
164335143|NCT03894046|593604816|FG002|Overall Study|Withdrawal by Subject|1|||
164335144|NCT03894046|593604814|FG000|Overall Study|Death|15|||
164335145|NCT03894046|593604815|FG001|Overall Study|Death|21|||
164335146|NCT03894046|593604816|FG002|Overall Study|Death|4|||
164335147|NCT03894046|593604814|FG000|Overall Study|No growth of ABC|2|||
164335148|NCT03894046|593604815|FG001|Overall Study|No growth of ABC|1|||
164335149|NCT03894046|593604816|FG002|Overall Study|No growth of ABC|0|||
164335150|NCT03894046|593604814|FG000|Overall Study|Physician Decision|1|||
164335151|NCT03894046|593604815|FG001|Overall Study|Physician Decision|1|||
164335152|NCT03894046|593604816|FG002|Overall Study|Physician Decision|1|||
164335153|NCT03894046|593604814|FG000|Overall Study|Prohibited concomitant medication|1|||
164335154|NCT03894046|593604815|FG001|Overall Study|Prohibited concomitant medication|0|||
164335155|NCT03894046|593604816|FG002|Overall Study|Prohibited concomitant medication|0|||
164335156|NCT03894046|593604814|FG000|Overall Study|Transferred to other arm/group|1|||
164335157|NCT03894046|593604815|FG001|Overall Study|Transferred to other arm/group|1|||
164335158|NCT03894046|593604816|FG002|Overall Study|Transferred to other arm/group|0|||
164335159|NCT03270644|593604817|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
164335160|NCT03270644|593604817|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
164335161|NCT00333801|593604818|FG000|Overall Study|Moved to another state|5|||
164335162|NCT00333801|593604819|FG001|Overall Study|Moved to another state|3|||
164335163|NCT00333801|593604818|FG000|Overall Study|Lost to Follow-up|2|||
164335164|NCT00333801|593604819|FG001|Overall Study|Lost to Follow-up|0|||
164335165|NCT00333801|593604818|FG000|Overall Study|Incarcerated|1|||
164335166|NCT00333801|593604819|FG001|Overall Study|Incarcerated|2|||
164335167|NCT00333801|593604818|FG000|Overall Study|Withdrawal by Subject|0|||
164335168|NCT00333801|593604819|FG001|Overall Study|Withdrawal by Subject|1|||
164335169|NCT02476201|593604820|FG000|Overall Study|Unable to program MPP|9|||
164335170|NCT02476201|593604820|FG000|Overall Study|Study echo not performed|5|||
164335171|NCT02476201|593604820|FG000|Overall Study|Adverse Event|4|||
164335172|NCT02476201|593604820|FG000|Overall Study|Death|2|||
164335173|NCT02476201|593604820|FG000|Overall Study|Lost to Follow-up|2|||
164335174|NCT02476201|593604820|FG000|Overall Study|MPP programmed to OFF|2|||
164335175|NCT02476201|593604820|FG000|Overall Study|Withdrawal by Subject|1|||
164335176|NCT02476201|593604820|FG000|Overall Study|Unsuccessful implant|1|||
164335177|NCT00777205|593604821|FG000|Overall Study|Lost to Follow-up|25|||
164335178|NCT00777205|593604822|FG001|Overall Study|Lost to Follow-up|9|||
164335179|NCT00777205|593604821|FG000|Overall Study|Withdrawal by Subject|6|||
164335180|NCT00777205|593604822|FG001|Overall Study|Withdrawal by Subject|4|||
164335181|NCT00777205|593604821|FG000|Overall Study|Death|0|||
164335182|NCT00777205|593604822|FG001|Overall Study|Death|2|||
164335183|NCT00777205|593604821|FG000|Overall Study|Protocol Violation|0|||
164335184|NCT00777205|593604822|FG001|Overall Study|Protocol Violation|56|||
164335185|NCT05055128|593604826|FG000|Overall Study|Adverse Event|0|||
164335186|NCT05055128|593604827|FG001|Overall Study|Adverse Event|0|||
164335187|NCT05055128|593604828|FG002|Overall Study|Adverse Event|0|||
164335188|NCT05055128|593604829|FG003|Overall Study|Adverse Event|1|||
164335189|NCT05055128|593604830|FG004|Overall Study|Adverse Event|1|||
164335190|NCT05055128|593604826|FG000|Overall Study|Protocol Violation|0|||
164335191|NCT05055128|593604827|FG001|Overall Study|Protocol Violation|0|||
164335192|NCT05055128|593604828|FG002|Overall Study|Protocol Violation|0|||
164335193|NCT05055128|593604829|FG003|Overall Study|Protocol Violation|1|||
164335194|NCT05055128|593604830|FG004|Overall Study|Protocol Violation|0|||
164335195|NCT05055128|593604826|FG000|Overall Study|Withdrawal by Subject|5|||
164237103|NCT02949011|593240478|FG000|Overall Study|Adverse Event|6|||
164335196|NCT05055128|593604827|FG001|Overall Study|Withdrawal by Subject|2|||
164335197|NCT05055128|593604828|FG002|Overall Study|Withdrawal by Subject|2|||
164335198|NCT05055128|593604829|FG003|Overall Study|Withdrawal by Subject|4|||
164335199|NCT05055128|593604830|FG004|Overall Study|Withdrawal by Subject|2|||
164335200|NCT05055128|593604826|FG000|Overall Study|Randomized By Mistake|0|||
164424687|NCT02403674|593926488|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
164424688|NCT02403674|593926489|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
164424689|NCT02403674|593926488|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
164335201|NCT05055128|593604827|FG001|Overall Study|Randomized By Mistake|1|||
164335202|NCT05055128|593604828|FG002|Overall Study|Randomized By Mistake|0|||
164335203|NCT05055128|593604829|FG003|Overall Study|Randomized By Mistake|0|||
164335204|NCT05055128|593604830|FG004|Overall Study|Randomized By Mistake|0|||
164573172|NCT02393209|594463347|FG000|Overall Study|Death due to Disease Progression|2|||
164237104|NCT02949011|593240479|FG001|Overall Study|Adverse Event|7|||
164237105|NCT02949011|593240480|FG002|Overall Study|Adverse Event|3|||
164237106|NCT02949011|593240478|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
164237107|NCT02949011|593240479|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
164237108|NCT02949011|593240480|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
164237109|NCT02949011|593240478|FG000|Overall Study|Protocol Deviation|5|||
164237110|NCT02949011|593240479|FG001|Overall Study|Protocol Deviation|3|||
164237111|NCT02949011|593240480|FG002|Overall Study|Protocol Deviation|3|||
164237112|NCT02949011|593240478|FG000|Overall Study|Lack of Efficacy|0|||
164237113|NCT02949011|593240479|FG001|Overall Study|Lack of Efficacy|2|||
164237114|NCT02949011|593240480|FG002|Overall Study|Lack of Efficacy|0|||
164237115|NCT02949011|593240478|FG000|Overall Study|Withdrawal by Subject|13|||
164237116|NCT02949011|593240479|FG001|Overall Study|Withdrawal by Subject|13|||
164237117|NCT02949011|593240480|FG002|Overall Study|Withdrawal by Subject|21|||
164237118|NCT02949011|593240478|FG000|Overall Study|Lost to Follow-up|7|||
164237119|NCT02949011|593240479|FG001|Overall Study|Lost to Follow-up|5|||
164237120|NCT02949011|593240480|FG002|Overall Study|Lost to Follow-up|5|||
164237121|NCT02949011|593240478|FG000|Overall Study|Death|0|||
164237122|NCT02949011|593240479|FG001|Overall Study|Death|0|||
164237123|NCT02949011|593240480|FG002|Overall Study|Death|1|||
164237124|NCT02949011|593240478|FG000|Overall Study|Miscellaneous|2|||
164237125|NCT02949011|593240479|FG001|Overall Study|Miscellaneous|4|||
164237126|NCT02949011|593240480|FG002|Overall Study|Miscellaneous|6|||
164237127|NCT00163189|593240482|FG000|Overall Study|Other|6|||
164237128|NCT00163189|593240482|FG000|Overall Study|Lost to Follow-up|1|||
164237129|NCT00163189|593240482|FG000|Overall Study|Protocol Violation|2|||
164237130|NCT00163189|593240482|FG000|Overall Study|Death|3|||
164237131|NCT00163189|593240482|FG000|Overall Study|Adverse Event|6|||
164237132|NCT00163189|593240482|FG000|Overall Study|Lack of Efficacy|7|||
164335205|NCT05055128|593604826|FG000|Overall Study|Other|1|||
164335206|NCT05055128|593604827|FG001|Overall Study|Other|0|||
164335207|NCT05055128|593604828|FG002|Overall Study|Other|0|||
164335208|NCT05055128|593604829|FG003|Overall Study|Other|0|||
164335209|NCT05055128|593604830|FG004|Overall Study|Other|0|||
164335210|NCT00747461|593604831|FG000|Overall Study|study terminated by sponsor|5|||
164335211|NCT02149875|593604832|FG000|Overall Study|Lost to Follow-up|3|||
164335212|NCT02149875|593604833|FG001|Overall Study|Lost to Follow-up|4|||
164335213|NCT02149875|593604834|FG002|Overall Study|Lost to Follow-up|5|||
164335214|NCT02149875|593604832|FG000|Overall Study|Withdrawal by Subject|3|||
164335215|NCT02149875|593604833|FG001|Overall Study|Withdrawal by Subject|2|||
164335216|NCT02149875|593604834|FG002|Overall Study|Withdrawal by Subject|2|||
164335217|NCT02149875|593604832|FG000|Overall Study|Physician Decision|1|||
164335218|NCT02149875|593604833|FG001|Overall Study|Physician Decision|2|||
164335219|NCT02149875|593604834|FG002|Overall Study|Physician Decision|2|||
164335220|NCT03643159|593604838|FG000|Overall Study|Adverse Event|1|||
164335221|NCT03643159|593604838|FG000|Overall Study|Withdrawal by Subject|1|||
164335222|NCT04308304|593604841|FG000|Overall Study|Withdrawal by Subject|4|||
164335223|NCT04308304|593604842|FG001|Overall Study|Withdrawal by Subject|0|||
164335224|NCT04308304|593604841|FG000|Overall Study|Protocol Violation|1|||
164335225|NCT04308304|593604842|FG001|Overall Study|Protocol Violation|0|||
164335226|NCT02840721|593604843|FG000|Treatment Period|Adverse Event|1|||
164335227|NCT02840721|593604843|FG000|Follow-Up|Lack of Efficacy|1|||
164335228|NCT02840721|593604843|FG000|Follow-Up|Withdrawal by Subject|4|||
164335229|NCT02840721|593604843|FG000|Follow-Up|Withdrawal of Consent|2|||
164335230|NCT05535972|593604845|FG000|Overall Study|Withdrawal by Subject|31|||
164335231|NCT05535972|593604845|FG000|Overall Study|Lost to Follow-up|5|||
164237133|NCT00163189|593240482|FG000|Overall Study|Study terminated by sponsor|11|||
164237134|NCT00163189|593240482|FG000|Overall Study|Withdrawal by Subject|11|||
164237135|NCT00163189|593240482|FG000|Overall Study|Did not meet continuation criterion|16|||
164335232|NCT05535972|593604845|FG000|Overall Study|Adverse Event|6|||
164335233|NCT05535972|593604845|FG000|Overall Study|Protocol Deviation|2|||
164573173|NCT02393209|594463348|FG001|Overall Study|Death due to Disease Progression|2|||
164573174|NCT02393209|594463349|FG002|Overall Study|Death due to Disease Progression|0|||
164237136|NCT01170663|593240483|FG000|Overall Study|Lost to Follow-up|3|||
164335234|NCT03945266|593604850|FG000|Overall Study|Withdrawal by Subject|1|||
164335235|NCT03945266|593604851|FG001|Overall Study|Withdrawal by Subject|0|||
164335236|NCT03945266|593604850|FG000|Overall Study|Miscarriage|0|||
164237137|NCT01170663|593240484|FG001|Overall Study|Lost to Follow-up|9|||
164237138|NCT01170663|593240483|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
164237139|NCT01170663|593240484|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
164237140|NCT00454116|593240485|FG000|Overall Study|Adverse Event|5|||
164237141|NCT00454116|593240486|FG001|Overall Study|Adverse Event|11|||
164237142|NCT00454116|593240487|FG002|Overall Study|Adverse Event|9|||
164335237|NCT03945266|593604851|FG001|Overall Study|Miscarriage|2|||
164335238|NCT03945266|593604850|FG000|Overall Study|Lost to Follow-up|1|||
164335239|NCT03945266|593604851|FG001|Overall Study|Lost to Follow-up|0|||
164335240|NCT03805646|593604869|FG000|Overall Study|Death|40|||
164335241|NCT03805646|593604870|FG001|Overall Study|Death|49|||
164237143|NCT00454116|593240485|FG000|Overall Study|Condition under investigation worsened|17|||
164237144|NCT00454116|593240486|FG001|Overall Study|Condition under investigation worsened|13|||
164237145|NCT00454116|593240487|FG002|Overall Study|Condition under investigation worsened|18|||
164237146|NCT00454116|593240485|FG000|Overall Study|Withdrawal by Subject|3|||
164237147|NCT00454116|593240486|FG001|Overall Study|Withdrawal by Subject|3|||
164237148|NCT00454116|593240487|FG002|Overall Study|Withdrawal by Subject|1|||
164237149|NCT00454116|593240485|FG000|Overall Study|Other|2|||
164237150|NCT00454116|593240486|FG001|Overall Study|Other|2|||
164237151|NCT00454116|593240487|FG002|Overall Study|Other|0|||
164237152|NCT01917318|593240488|FG000|First Treatment|Withdrawal by Subject|0|||
164237153|NCT01917318|593240489|FG001|First Treatment|Withdrawal by Subject|1|||
164237154|NCT01008618|593240490|FG000|Period 1 (Titration Period)|Physician Decision|2|||
164237155|NCT01008618|593240491|FG001|Period 1 (Titration Period)|Physician Decision|0|||
164237156|NCT01008618|593240492|FG002|Period 1 (Titration Period)|Physician Decision|0|||
164237157|NCT01008618|593240490|FG000|Period 1 (Titration Period)|Adverse Event|33|||
164237158|NCT01008618|593240491|FG001|Period 1 (Titration Period)|Adverse Event|0|||
164237159|NCT01008618|593240492|FG002|Period 1 (Titration Period)|Adverse Event|0|||
164237160|NCT01008618|593240490|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
164237161|NCT01008618|593240491|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
164237162|NCT01008618|593240492|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
164237163|NCT01008618|593240490|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
164237164|NCT01008618|593240491|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
164237165|NCT01008618|593240492|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
164237166|NCT01008618|593240490|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
164237167|NCT01008618|593240491|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
164237168|NCT01008618|593240492|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
164237169|NCT01008618|593240490|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
164237170|NCT01008618|593240491|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
164237171|NCT01008618|593240492|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
164237172|NCT01008618|593240490|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
164237173|NCT01008618|593240491|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
164237174|NCT01008618|593240492|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
164237175|NCT01008618|593240490|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
164237176|NCT01008618|593240491|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
164237177|NCT01008618|593240492|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
164237178|NCT01008618|593240490|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
164237179|NCT01008618|593240491|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
164237180|NCT01008618|593240492|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
164237181|NCT01008618|593240490|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
164237182|NCT01008618|593240491|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
164237183|NCT01008618|593240492|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
164237184|NCT01008618|593240490|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
164237185|NCT01008618|593240491|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
164237186|NCT01008618|593240492|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
164237187|NCT01008618|593240490|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
164237188|NCT01008618|593240491|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
164237189|NCT01008618|593240492|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
164237190|NCT04460183|593240496|FG000|Overall Study|Lost to Follow-up|3|||
164237191|NCT04460183|593240497|FG001|Overall Study|Lost to Follow-up|1|||
164237192|NCT04460183|593240496|FG000|Overall Study|Withdrawal by Subject|1|||
164237193|NCT04460183|593240497|FG001|Overall Study|Withdrawal by Subject|0|||
164237194|NCT00894387|593240498|FG000|Overall Study|Adverse Event|44|||
164237195|NCT00894387|593240499|FG001|Overall Study|Adverse Event|45|||
164237196|NCT00894387|593240498|FG000|Overall Study|Abnormal Laboratory values|2|||
164237197|NCT00894387|593240499|FG001|Overall Study|Abnormal Laboratory values|2|||
164237198|NCT00894387|593240498|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164237199|NCT00894387|593240499|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
164237200|NCT00894387|593240498|FG000|Overall Study|Lost to Follow-up|3|||
164237201|NCT00894387|593240499|FG001|Overall Study|Lost to Follow-up|5|||
164237202|NCT00894387|593240498|FG000|Overall Study|Administrative problems|2|||
164237203|NCT00894387|593240499|FG001|Overall Study|Administrative problems|2|||
164335242|NCT03805646|593604869|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
164335243|NCT03805646|593604870|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
164335244|NCT04452344|593604872|FG000|Overall Study|Withdrawal by Subject|3|||
164335245|NCT04452344|593604873|FG001|Overall Study|Withdrawal by Subject|6|||
164335246|NCT04452344|593604872|FG000|Overall Study|Adverse Event|1|||
164335247|NCT04452344|593604873|FG001|Overall Study|Adverse Event|2|||
164335248|NCT04452344|593604872|FG000|Overall Study|Lost to Follow-up|2|||
164335249|NCT04452344|593604873|FG001|Overall Study|Lost to Follow-up|2|||
164335250|NCT04452344|593604872|FG000|Overall Study|No Post-Op Visit|6|||
164237204|NCT00894387|593240498|FG000|Overall Study|Death|77|||
164237205|NCT00894387|593240499|FG001|Overall Study|Death|76|||
164237206|NCT00894387|593240498|FG000|Overall Study|Protocol Deviation|4|||
164237207|NCT00894387|593240499|FG001|Overall Study|Protocol Deviation|0|||
164237208|NCT00894387|593240498|FG000|Overall Study|Patient's request|25|||
164237209|NCT00894387|593240499|FG001|Overall Study|Patient's request|30|||
164424690|NCT02403674|593926489|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
164424691|NCT02403674|593926488|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
164424692|NCT02403674|593926489|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
164424693|NCT02403674|593926488|FG000|Study Extension 2 (Open-Label)|Death|2|||
164424694|NCT02403674|593926489|FG001|Study Extension 2 (Open-Label)|Death|2|||
164424695|NCT02403674|593926488|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
164237210|NCT00894387|593240498|FG000|Overall Study|Other (Missing)|5|||
164237211|NCT00894387|593240499|FG001|Overall Study|Other (Missing)|3|||
164237212|NCT00894387|593240498|FG000|Overall Study|Mis-randomized|13|||
164237213|NCT00894387|593240499|FG001|Overall Study|Mis-randomized|9|||
164237214|NCT00894387|593240498|FG000|Overall Study|GCP non-compliance|0|||
164237215|NCT00894387|593240499|FG001|Overall Study|GCP non-compliance|2|||
164237216|NCT01128569|593240500|FG000|Washout Period 1|Adverse Event|0|||
164237217|NCT01128569|593240501|FG001|Washout Period 1|Adverse Event|0|||
164237218|NCT01128569|593240502|FG002|Washout Period 1|Adverse Event|1|||
164237219|NCT01128569|593240503|FG003|Washout Period 1|Adverse Event|0|||
164237220|NCT01128569|593240504|FG004|Washout Period 1|Adverse Event|0|||
164237221|NCT01128569|593240505|FG005|Washout Period 1|Adverse Event|0|||
164237222|NCT01128569|593240500|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164237223|NCT01128569|593240501|FG001|Treatment Period 2|Withdrawal by Subject|1|||
164335251|NCT04452344|593604873|FG001|Overall Study|No Post-Op Visit|7|||
164335252|NCT05171777|593604874|FG000|Treatment Crossover Period|Adverse Event|9|||
164335253|NCT05171777|593604875|FG001|Treatment Crossover Period|Adverse Event|6|||
164335254|NCT05171777|593604876|FG002|Treatment Crossover Period|Adverse Event|0|||
164335255|NCT05171777|593604877|FG003|Treatment Crossover Period|Adverse Event|0|||
164335256|NCT05171777|593604874|FG000|Treatment Crossover Period|Death|5|||
164335257|NCT05171777|593604875|FG001|Treatment Crossover Period|Death|5|||
164335258|NCT05171777|593604876|FG002|Treatment Crossover Period|Death|0|||
164335259|NCT05171777|593604877|FG003|Treatment Crossover Period|Death|0|||
164335260|NCT05171777|593604874|FG000|Treatment Crossover Period|Disease Relapse|1|||
164335261|NCT05171777|593604875|FG001|Treatment Crossover Period|Disease Relapse|0|||
164335262|NCT05171777|593604876|FG002|Treatment Crossover Period|Disease Relapse|0|||
164335263|NCT05171777|593604877|FG003|Treatment Crossover Period|Disease Relapse|0|||
164335264|NCT05171777|593604874|FG000|Treatment Crossover Period|Reason not Specified|1|||
164335265|NCT05171777|593604875|FG001|Treatment Crossover Period|Reason not Specified|1|||
164335266|NCT05171777|593604876|FG002|Treatment Crossover Period|Reason not Specified|0|||
164335267|NCT05171777|593604877|FG003|Treatment Crossover Period|Reason not Specified|0|||
164335268|NCT05171777|593604874|FG000|Treatment Crossover Period|Physician Decision|0|||
164335269|NCT05171777|593604875|FG001|Treatment Crossover Period|Physician Decision|1|||
164335270|NCT05171777|593604876|FG002|Treatment Crossover Period|Physician Decision|0|||
164335271|NCT05171777|593604877|FG003|Treatment Crossover Period|Physician Decision|0|||
164335272|NCT05171777|593604874|FG000|Treatment Crossover Period|Progressive Disease|14|||
164335273|NCT05171777|593604875|FG001|Treatment Crossover Period|Progressive Disease|10|||
164335274|NCT05171777|593604876|FG002|Treatment Crossover Period|Progressive Disease|0|||
164335275|NCT05171777|593604877|FG003|Treatment Crossover Period|Progressive Disease|0|||
164335276|NCT05171777|593604874|FG000|Treatment Crossover Period|Protocol Violation|0|||
164335277|NCT05171777|593604875|FG001|Treatment Crossover Period|Protocol Violation|2|||
164335278|NCT05171777|593604876|FG002|Treatment Crossover Period|Protocol Violation|0|||
164335279|NCT05171777|593604877|FG003|Treatment Crossover Period|Protocol Violation|0|||
164335280|NCT05171777|593604874|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
164335281|NCT05171777|593604875|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
164335282|NCT05171777|593604876|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
164335283|NCT05171777|593604877|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
164335284|NCT05171777|593604874|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
164335285|NCT05171777|593604875|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
164335286|NCT05171777|593604876|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
164573175|NCT02393209|594463350|FG003|Overall Study|Death due to Disease Progression|0|||
164335287|NCT05171777|593604877|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
164237224|NCT01128569|593240502|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164335288|NCT05171777|593604874|FG000|Treatment Continuation Period|Adverse Event|0|||
164335289|NCT05171777|593604875|FG001|Treatment Continuation Period|Adverse Event|0|||
164424696|NCT02403674|593926489|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
164237225|NCT01128569|593240503|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164237226|NCT01128569|593240504|FG004|Treatment Period 2|Withdrawal by Subject|0|||
164237227|NCT01128569|593240505|FG005|Treatment Period 2|Withdrawal by Subject|0|||
164237228|NCT03338400|593240506|FG000|Overall Study|Lost to Follow-up|1|||
164237229|NCT03338400|593240507|FG001|Overall Study|Lost to Follow-up|2|||
164237230|NCT00487981|593240508|FG000|Overall Study|Hypothyroidism diagnosis|1|||
164237231|NCT00856609|593240513|FG000|Overall Study|Adverse Event|1|||
164237232|NCT00856609|593240514|FG001|Overall Study|Adverse Event|0|||
164237233|NCT01788943|593240515|FG000|Overall Study|Withdrawal by Subject|1|||
164237234|NCT01788943|593240516|FG001|Overall Study|Withdrawal by Subject|0|||
164237235|NCT01816295|593240517|FG000|Double Blind Phase|Adverse Event|11|||
164237236|NCT01816295|593240518|FG001|Double Blind Phase|Adverse Event|8|||
164237237|NCT01816295|593240517|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
164237238|NCT01816295|593240518|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
164237239|NCT01816295|593240517|FG000|Double Blind Phase|Lost to Follow-up|3|||
164237240|NCT01816295|593240518|FG001|Double Blind Phase|Lost to Follow-up|5|||
164237241|NCT01816295|593240517|FG000|Double Blind Phase|Physician Decision|2|||
164237242|NCT01816295|593240518|FG001|Double Blind Phase|Physician Decision|2|||
164237243|NCT01816295|593240517|FG000|Double Blind Phase|Protocol Violation|17|||
164237244|NCT01816295|593240518|FG001|Double Blind Phase|Protocol Violation|11|||
164237245|NCT01816295|593240517|FG000|Double Blind Phase|Sponsor Decision|8|||
164237246|NCT01816295|593240518|FG001|Double Blind Phase|Sponsor Decision|8|||
164237247|NCT01816295|593240517|FG000|Double Blind Phase|Withdrawal by Subject|22|||
164237248|NCT01816295|593240518|FG001|Double Blind Phase|Withdrawal by Subject|20|||
164237249|NCT01816295|593240517|FG000|OLE Phase|Adverse Event|17|||
164237250|NCT01816295|593240518|FG001|OLE Phase|Adverse Event|15|||
164237251|NCT01816295|593240517|FG000|OLE Phase|Death|1|||
164237252|NCT01816295|593240518|FG001|OLE Phase|Death|0|||
164237253|NCT01816295|593240517|FG000|OLE Phase|Entry Criteria Not Met|3|||
164237254|NCT01816295|593240518|FG001|OLE Phase|Entry Criteria Not Met|5|||
164237255|NCT01816295|593240517|FG000|OLE Phase|Lost to Follow-up|5|||
164237256|NCT01816295|593240518|FG001|OLE Phase|Lost to Follow-up|5|||
164237257|NCT01816295|593240517|FG000|OLE Phase|Physician Decision|3|||
164237258|NCT01816295|593240518|FG001|OLE Phase|Physician Decision|1|||
164237259|NCT01816295|593240517|FG000|OLE Phase|Protocol Violation|4|||
164237260|NCT01816295|593240518|FG001|OLE Phase|Protocol Violation|4|||
164237261|NCT01816295|593240517|FG000|OLE Phase|Sponsor Decision|7|||
164237262|NCT01816295|593240518|FG001|OLE Phase|Sponsor Decision|9|||
164237263|NCT01816295|593240517|FG000|OLE Phase|Withdrawal by Subject|10|||
164237264|NCT01816295|593240518|FG001|OLE Phase|Withdrawal by Subject|10|||
164237265|NCT01816295|593240517|FG000|OLE Phase|Lack of Efficacy|3|||
164237266|NCT01816295|593240518|FG001|OLE Phase|Lack of Efficacy|7|||
164237267|NCT01119287|593240519|FG000|Overall Study|Patient Decision, not related to AE|0|||
164237268|NCT01119287|593240520|FG001|Overall Study|Patient Decision, not related to AE|0|||
164237269|NCT01119287|593240521|FG002|Overall Study|Patient Decision, not related to AE|2|||
164237270|NCT01119287|593240522|FG003|Overall Study|Patient Decision, not related to AE|2|||
164237271|NCT01119287|593240523|FG004|Overall Study|Patient Decision, not related to AE|1|||
164237272|NCT01119287|593240524|FG005|Overall Study|Patient Decision, not related to AE|0|||
164237273|NCT00783432|593240525|FG000|Overall Study|Adverse Event|22|||
164237274|NCT00783432|593240526|FG001|Overall Study|Adverse Event|17|||
164237275|NCT00783432|593240525|FG000|Overall Study|Lack of Efficacy|20|||
164237276|NCT00783432|593240526|FG001|Overall Study|Lack of Efficacy|21|||
164237277|NCT00783432|593240525|FG000|Overall Study|Lost to Follow-up|11|||
164237278|NCT00783432|593240526|FG001|Overall Study|Lost to Follow-up|6|||
164237279|NCT00783432|593240525|FG000|Overall Study|Withdrawal by Subject|23|||
164237280|NCT00783432|593240526|FG001|Overall Study|Withdrawal by Subject|20|||
164237281|NCT00783432|593240525|FG000|Overall Study|subject moved|3|||
164237282|NCT00783432|593240526|FG001|Overall Study|subject moved|5|||
164237283|NCT00783432|593240525|FG000|Overall Study|Protocol Violation|6|||
164237284|NCT00783432|593240526|FG001|Overall Study|Protocol Violation|9|||
164237285|NCT00186628|593240527|FG000|Overall Study|Death|2|||
164237286|NCT00186628|593240527|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
164237287|NCT01331681|593240529|FG000|Overall Study|Adverse Event|10|||
164237288|NCT01331681|593240530|FG001|Overall Study|Adverse Event|13|||
164237289|NCT01331681|593240531|FG002|Overall Study|Adverse Event|10|||
164237290|NCT01331681|593240529|FG000|Overall Study|Death|6|||
164237291|NCT01331681|593240530|FG001|Overall Study|Death|6|||
164237292|NCT01331681|593240531|FG002|Overall Study|Death|2|||
164237293|NCT01331681|593240529|FG000|Overall Study|Lack of Efficacy|0|||
164237294|NCT01331681|593240530|FG001|Overall Study|Lack of Efficacy|1|||
164237295|NCT01331681|593240531|FG002|Overall Study|Lack of Efficacy|0|||
164237296|NCT01331681|593240529|FG000|Overall Study|Withdrawal by Subject|12|||
164237297|NCT01331681|593240530|FG001|Overall Study|Withdrawal by Subject|8|||
164237298|NCT01331681|593240531|FG002|Overall Study|Withdrawal by Subject|15|||
164237299|NCT01331681|593240529|FG000|Overall Study|Protocol Violation|1|||
164237300|NCT01331681|593240530|FG001|Overall Study|Protocol Violation|1|||
164237301|NCT01331681|593240531|FG002|Overall Study|Protocol Violation|0|||
164237302|NCT01331681|593240529|FG000|Overall Study|Lost to Follow-up|2|||
164237303|NCT01331681|593240530|FG001|Overall Study|Lost to Follow-up|4|||
164237304|NCT01331681|593240531|FG002|Overall Study|Lost to Follow-up|1|||
164237305|NCT01331681|593240529|FG000|Overall Study|Physician Decision|2|||
164237306|NCT01331681|593240530|FG001|Overall Study|Physician Decision|0|||
164237307|NCT01331681|593240531|FG002|Overall Study|Physician Decision|4|||
164237308|NCT01331681|593240529|FG000|Overall Study|Therapeutic procedure required|1|||
164237309|NCT01331681|593240530|FG001|Overall Study|Therapeutic procedure required|0|||
164237310|NCT01331681|593240531|FG002|Overall Study|Therapeutic procedure required|0|||
164237311|NCT01331681|593240529|FG000|Overall Study|Sponsor decision|1|||
164237312|NCT01331681|593240530|FG001|Overall Study|Sponsor decision|1|||
164237313|NCT01331681|593240531|FG002|Overall Study|Sponsor decision|0|||
164237314|NCT01331681|593240529|FG000|Overall Study|Switching to other therapy|0|||
164335290|NCT05171777|593604876|FG002|Treatment Continuation Period|Adverse Event|3|||
164335291|NCT05171777|593604877|FG003|Treatment Continuation Period|Adverse Event|6|||
164335292|NCT05171777|593604874|FG000|Treatment Continuation Period|Death|0|||
164237315|NCT01331681|593240530|FG001|Overall Study|Switching to other therapy|0|||
164237316|NCT01331681|593240531|FG002|Overall Study|Switching to other therapy|1|||
164237317|NCT01331681|593240529|FG000|Overall Study|Not Received Study Treatment|0|||
164237318|NCT01331681|593240530|FG001|Overall Study|Not Received Study Treatment|0|||
164237319|NCT01331681|593240531|FG002|Overall Study|Not Received Study Treatment|2|||
164237320|NCT01130337|593240532|FG000|Overall Study|Withdrawal by Subject|3|||
164237321|NCT01130337|593240532|FG000|Overall Study|Principal investigator decision|1|||
164237322|NCT01130337|593240532|FG000|Overall Study|Death|1|||
164237323|NCT01130337|593240532|FG000|Overall Study|Disease progression|1|||
164237324|NCT01130337|593240532|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
164237325|NCT01130337|593240532|FG000|Overall Study|Surgical resection (R2)|1|||
164237326|NCT05525910|593240533|FG000|Period 4|Per sponsor due to study timelines|0|||
164237327|NCT05525910|593240534|FG001|Period 4|Per sponsor due to study timelines|0|||
164237328|NCT05525910|593240535|FG002|Period 4|Per sponsor due to study timelines|1|||
164237329|NCT05525910|593240536|FG003|Period 4|Per sponsor due to study timelines|1|||
164237330|NCT05525910|593240537|FG004|Period 4|Per sponsor due to study timelines|1|||
164237331|NCT03886493|593240538|FG000|Overall Study|Adverse Event|1|||
164237332|NCT00107276|593240539|FG000|Overall Study|Progression|46|||
164237333|NCT00107276|593240539|FG000|Overall Study|Adverse Event|6|||
164237334|NCT00107276|593240539|FG000|Overall Study|M.D. decision|2|||
164237335|NCT00107276|593240539|FG000|Overall Study|Patient refusal|1|||
164237336|NCT00107276|593240539|FG000|Overall Study|Death|1|||
164237337|NCT00107276|593240539|FG000|Overall Study|Ineligible|16|||
164237338|NCT03498716|593240549|FG000|Overall Study|Withdrawal by Subject|88|||
164237339|NCT03498716|593240550|FG001|Overall Study|Withdrawal by Subject|73|||
164237340|NCT03498716|593240549|FG000|Overall Study|Study Terminated By Sponsor|933|||
164237341|NCT03498716|593240550|FG001|Overall Study|Study Terminated By Sponsor|927|||
164237342|NCT03498716|593240549|FG000|Overall Study|Lost to Follow-up|15|||
164237343|NCT03498716|593240550|FG001|Overall Study|Lost to Follow-up|26|||
164237344|NCT03498716|593240549|FG000|Overall Study|Disease Relapse|0|||
164237345|NCT03498716|593240550|FG001|Overall Study|Disease Relapse|1|||
164237346|NCT03498716|593240549|FG000|Overall Study|Death|58|||
164237347|NCT03498716|593240550|FG001|Overall Study|Death|72|||
164237348|NCT03498716|593240549|FG000|Overall Study|Physician Decision|4|||
164237349|NCT03498716|593240550|FG001|Overall Study|Physician Decision|2|||
164237350|NCT02257684|593240551|FG000|Overall Study|Adverse Event|2|||
164237351|NCT02257684|593240551|FG000|Overall Study|Lack of Efficacy|1|||
164237352|NCT02257684|593240551|FG000|Overall Study|Sponsor's Decision|1|||
164237353|NCT03139448|593240555|FG000|Overall Study|Lack of Efficacy|6|||
164237354|NCT03139448|593240556|FG001|Overall Study|Lack of Efficacy|7|||
164237355|NCT03139448|593240555|FG000|Overall Study|Location of procedure changed|2|||
164237356|NCT03139448|593240556|FG001|Overall Study|Location of procedure changed|8|||
164237357|NCT03139448|593240555|FG000|Overall Study|Withdrawal by Subject|3|||
164237358|NCT03139448|593240556|FG001|Overall Study|Withdrawal by Subject|6|||
164237359|NCT03139448|593240555|FG000|Overall Study|Screen fail|1|||
164237360|NCT03139448|593240556|FG001|Overall Study|Screen fail|3|||
164237361|NCT03139448|593240555|FG000|Overall Study|Physician Decision|0|||
164237362|NCT03139448|593240556|FG001|Overall Study|Physician Decision|2|||
164237363|NCT01987557|593240557|FG000|Overall Study|Protocol Violation|1|||
164237364|NCT01987557|593240558|FG001|Overall Study|Protocol Violation|0|||
164237365|NCT01987557|593240559|FG002|Overall Study|Protocol Violation|1|||
164237366|NCT01987557|593240557|FG000|Overall Study|Withdrawal by Subject|2|||
164237367|NCT01987557|593240558|FG001|Overall Study|Withdrawal by Subject|1|||
164237368|NCT01987557|593240559|FG002|Overall Study|Withdrawal by Subject|2|||
164237369|NCT01987557|593240557|FG000|Overall Study|Adverse Event|0|||
164237370|NCT01987557|593240558|FG001|Overall Study|Adverse Event|2|||
164237371|NCT01987557|593240559|FG002|Overall Study|Adverse Event|0|||
164237372|NCT00760552|593240560|FG000|Overall Study|Death|2|||
164237373|NCT00760552|593240561|FG001|Overall Study|Death|0|||
164237374|NCT00760552|593240560|FG000|Overall Study|Lost to Follow-up|11|||
164237375|NCT00760552|593240561|FG001|Overall Study|Lost to Follow-up|10|||
164237376|NCT01038323|593240562|FG000|Overall Study|Withdrawal by Subject|3|||
164237377|NCT01038323|593240563|FG001|Overall Study|Withdrawal by Subject|2|||
164237378|NCT01038323|593240564|FG002|Overall Study|Withdrawal by Subject|4|||
164237379|NCT01832727|593240575|FG000|Overall Study|Adverse Event|4|||
164335293|NCT05171777|593604875|FG001|Treatment Continuation Period|Death|0|||
164237380|NCT01832727|593240576|FG001|Overall Study|Adverse Event|6|||
164237381|NCT01832727|593240577|FG002|Overall Study|Adverse Event|1|||
164237382|NCT01832727|593240578|FG003|Overall Study|Adverse Event|0|||
164335294|NCT05171777|593604876|FG002|Treatment Continuation Period|Death|1|||
164335295|NCT05171777|593604877|FG003|Treatment Continuation Period|Death|3|||
164335296|NCT05171777|593604874|FG000|Treatment Continuation Period|Disease Relapse|0|||
164335297|NCT05171777|593604875|FG001|Treatment Continuation Period|Disease Relapse|0|||
164335298|NCT05171777|593604876|FG002|Treatment Continuation Period|Disease Relapse|1|||
164335299|NCT05171777|593604877|FG003|Treatment Continuation Period|Disease Relapse|0|||
164335300|NCT05171777|593604874|FG000|Treatment Continuation Period|Lack of Efficacy|0|||
164335301|NCT05171777|593604875|FG001|Treatment Continuation Period|Lack of Efficacy|0|||
164335302|NCT05171777|593604876|FG002|Treatment Continuation Period|Lack of Efficacy|0|||
164335303|NCT05171777|593604877|FG003|Treatment Continuation Period|Lack of Efficacy|1|||
164335304|NCT05171777|593604874|FG000|Treatment Continuation Period|Physician Decision|0|||
164335305|NCT05171777|593604875|FG001|Treatment Continuation Period|Physician Decision|0|||
164335306|NCT05171777|593604876|FG002|Treatment Continuation Period|Physician Decision|0|||
164335307|NCT05171777|593604877|FG003|Treatment Continuation Period|Physician Decision|4|||
164335308|NCT05171777|593604874|FG000|Treatment Continuation Period|Progressive Disease|0|||
164335309|NCT05171777|593604875|FG001|Treatment Continuation Period|Progressive Disease|0|||
164335310|NCT05171777|593604876|FG002|Treatment Continuation Period|Progressive Disease|6|||
164335311|NCT05171777|593604877|FG003|Treatment Continuation Period|Progressive Disease|20|||
164335312|NCT05171777|593604874|FG000|Treatment Continuation Period|Study Ended by Sponsor|0|||
164335313|NCT05171777|593604875|FG001|Treatment Continuation Period|Study Ended by Sponsor|0|||
164335314|NCT05171777|593604876|FG002|Treatment Continuation Period|Study Ended by Sponsor|4|||
164335315|NCT05171777|593604877|FG003|Treatment Continuation Period|Study Ended by Sponsor|15|||
164335316|NCT05171777|593604874|FG000|Treatment Continuation Period|Symptomatic Deterioration|0|||
164335317|NCT05171777|593604875|FG001|Treatment Continuation Period|Symptomatic Deterioration|0|||
164335318|NCT05171777|593604876|FG002|Treatment Continuation Period|Symptomatic Deterioration|0|||
164335319|NCT05171777|593604877|FG003|Treatment Continuation Period|Symptomatic Deterioration|2|||
164335320|NCT05171777|593604874|FG000|Treatment Continuation Period|Withdrawal by Subject|0|||
164335321|NCT05171777|593604875|FG001|Treatment Continuation Period|Withdrawal by Subject|0|||
164335322|NCT05171777|593604876|FG002|Treatment Continuation Period|Withdrawal by Subject|0|||
164335323|NCT05171777|593604877|FG003|Treatment Continuation Period|Withdrawal by Subject|6|||
164335324|NCT02364713|593604878|FG000|Overall Study|Ineligible|2|||
164335325|NCT02364713|593604879|FG001|Overall Study|Ineligible|2|||
164335326|NCT04686786|593604882|FG000|Overall Study|Adverse Event|9|||
164335327|NCT04686786|593604882|FG000|Overall Study|Death|1|||
164335328|NCT04686786|593604882|FG000|Overall Study|Lack of Efficacy|25|||
164335329|NCT04686786|593604882|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
164335330|NCT04686786|593604882|FG000|Overall Study|Study Terminated by Sponsor|14|||
164335331|NCT04686786|593604882|FG000|Overall Study|Withdrawal by Subject|15|||
164335332|NCT04686786|593604882|FG000|Overall Study|Other than specified|1|||
164335333|NCT05628103|593604885|FG000|Overall Study|Adverse Event|7|||
164335334|NCT05628103|593604885|FG000|Overall Study|Withdrawal by Subject|3|||
164335335|NCT05628103|593604885|FG000|Overall Study|Lost to Follow-up|3|||
164335336|NCT05628103|593604885|FG000|Overall Study|Lack of Efficacy|1|||
164335337|NCT05628103|593604885|FG000|Overall Study|Non-Compliance With Study Drug|4|||
164335338|NCT04840888|593604886|FG000|Period 1|Withdrawal by Subject|0|||
164335339|NCT04840888|593604887|FG001|Period 1|Withdrawal by Subject|0|||
164335340|NCT04840888|593604888|FG002|Period 1|Withdrawal by Subject|0|||
164335341|NCT04840888|593604889|FG003|Period 1|Withdrawal by Subject|0|||
164335342|NCT04840888|593604890|FG004|Period 1|Withdrawal by Subject|1|||
164335343|NCT04840888|593604891|FG005|Period 1|Withdrawal by Subject|0|||
164335344|NCT04840888|593604886|FG000|Period 1|Adverse Event|0|||
164335345|NCT04840888|593604887|FG001|Period 1|Adverse Event|0|||
164335346|NCT04840888|593604888|FG002|Period 1|Adverse Event|1|||
164335347|NCT04840888|593604889|FG003|Period 1|Adverse Event|1|||
164335348|NCT04840888|593604890|FG004|Period 1|Adverse Event|10|||
164335349|NCT04840888|593604891|FG005|Period 1|Adverse Event|1|||
164335350|NCT04340193|593604894|FG000|Overall Study|Other reason|0|||
164335351|NCT04340193|593604895|FG001|Overall Study|Other reason|0|||
164335352|NCT04340193|593604896|FG002|Overall Study|Other reason|1|||
164335353|NCT04340193|593604894|FG000|Overall Study|Disease recurrence|0|||
164335354|NCT04340193|593604895|FG001|Overall Study|Disease recurrence|1|||
164335355|NCT04340193|593604896|FG002|Overall Study|Disease recurrence|0|||
164335356|NCT04340193|593604894|FG000|Overall Study|Study drug toxicity|1|||
164335357|NCT04340193|593604895|FG001|Overall Study|Study drug toxicity|0|||
164335358|NCT04340193|593604896|FG002|Overall Study|Study drug toxicity|0|||
164335359|NCT04340193|593604894|FG000|Overall Study|Disease progression|1|||
164335360|NCT04340193|593604895|FG001|Overall Study|Disease progression|2|||
164335361|NCT04340193|593604896|FG002|Overall Study|Disease progression|3|||
164335362|NCT04340193|593604894|FG000|Overall Study|Administrative reasons by sponsor|0|||
164424697|NCT02403674|593926488|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
164335363|NCT04340193|593604895|FG001|Overall Study|Administrative reasons by sponsor|1|||
164335364|NCT04340193|593604896|FG002|Overall Study|Administrative reasons by sponsor|0|||
164335365|NCT04340193|593604894|FG000|Overall Study|Adverse Event|1|||
164335366|NCT04340193|593604895|FG001|Overall Study|Adverse Event|1|||
164335367|NCT04340193|593604896|FG002|Overall Study|Adverse Event|0|||
164335368|NCT03924869|593604897|FG000|Overall Study|Death|73|||
164424698|NCT02403674|593926489|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
164424699|NCT02403674|593926488|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
164424700|NCT02403674|593926489|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
164424701|NCT02403674|593926488|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
164424702|NCT02403674|593926489|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
164424703|NCT02403674|593926488|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
164424704|NCT02403674|593926489|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
164424705|NCT02403674|593926488|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
164424706|NCT02403674|593926489|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
164424707|NCT02403674|593926488|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
164424708|NCT02403674|593926489|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
164424709|NCT03487666|593926492|FG000|Overall Study|Disease progression|4|||
164424710|NCT03487666|593926493|FG001|Overall Study|Disease progression|2|||
164424711|NCT03487666|593926494|FG002|Overall Study|Disease progression|0|||
164424712|NCT03487666|593926492|FG000|Overall Study|Adverse Event|0|||
164424713|NCT03487666|593926493|FG001|Overall Study|Adverse Event|0|||
164424714|NCT03487666|593926494|FG002|Overall Study|Adverse Event|1|||
164424715|NCT03201757|593926495|FG000|Overall Study|Withdrawal by Subject|133|||
164424716|NCT03201757|593926495|FG000|Overall Study|Adverse Event|44|||
164424717|NCT03201757|593926495|FG000|Overall Study|Lost to Follow-up|37|||
164424718|NCT03201757|593926495|FG000|Overall Study|Pregnancy|2|||
164424719|NCT03201757|593926495|FG000|Overall Study|Lack of Efficacy|1|||
164424720|NCT03201757|593926495|FG000|Overall Study|Protocol Violation|20|||
164424721|NCT03201757|593926495|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
164424722|NCT03201757|593926495|FG000|Overall Study|Not Yet Determined|5|||
164424723|NCT03201757|593926495|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
164424724|NCT03201757|593926495|FG000|Overall Study|Other|20|||
164424725|NCT01254305|593926499|FG000|Overall Study|Adverse Event|6|||
164424726|NCT01254305|593926500|FG001|Overall Study|Adverse Event|3|||
164424727|NCT01254305|593926501|FG002|Overall Study|Adverse Event|2|||
164424728|NCT01254305|593926499|FG000|Overall Study|Lack of Efficacy|1|||
164424729|NCT01254305|593926500|FG001|Overall Study|Lack of Efficacy|0|||
164424730|NCT01254305|593926501|FG002|Overall Study|Lack of Efficacy|1|||
164424731|NCT01254305|593926499|FG000|Overall Study|Protocol Violation|1|||
164424732|NCT01254305|593926500|FG001|Overall Study|Protocol Violation|7|||
164424733|NCT01254305|593926501|FG002|Overall Study|Protocol Violation|3|||
164424734|NCT01254305|593926499|FG000|Overall Study|Withdrawal by Subject|4|||
164424735|NCT01254305|593926500|FG001|Overall Study|Withdrawal by Subject|2|||
164424736|NCT01254305|593926501|FG002|Overall Study|Withdrawal by Subject|4|||
164424737|NCT01254305|593926499|FG000|Overall Study|Lost to Follow-up|10|||
164424738|NCT01254305|593926500|FG001|Overall Study|Lost to Follow-up|6|||
164424739|NCT01254305|593926501|FG002|Overall Study|Lost to Follow-up|5|||
164424740|NCT01254305|593926499|FG000|Overall Study|Other Reasons|0|||
164424741|NCT01254305|593926500|FG001|Overall Study|Other Reasons|0|||
164424742|NCT01254305|593926501|FG002|Overall Study|Other Reasons|2|||
164424743|NCT03930186|593926502|FG000|Weeks 0 to 16|Adverse Event|6|||
164424744|NCT03930186|593926502|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
164424745|NCT03930186|593926502|FG000|Weeks 16 to 32|Adverse Event|1|||
164424746|NCT03930186|593926502|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
164424747|NCT03019458|593926505|FG000|Overall Study|Death|0|||
164424748|NCT03019458|593926506|FG001|Overall Study|Death|1|||
164424749|NCT00031447|593926507|FG000|Overall Study|Lost to Follow-up|0|||
164424750|NCT00031447|593926508|FG001|Overall Study|Lost to Follow-up|1|||
164424751|NCT00031447|593926507|FG000|Overall Study|Non-compliant|1|||
164424752|NCT00031447|593926508|FG001|Overall Study|Non-compliant|1|||
164424753|NCT00031447|593926507|FG000|Overall Study|Re-activation of Disease|2|||
164424754|NCT00031447|593926508|FG001|Overall Study|Re-activation of Disease|1|||
164424755|NCT00031447|593926507|FG000|Overall Study|Disruption of blinded study drug supply|7|||
164424756|NCT00031447|593926508|FG001|Overall Study|Disruption of blinded study drug supply|4|||
164424757|NCT01636362|593926512|FG000|Overall Study|Physician Decision|6|||
164424758|NCT01636362|593926512|FG000|Overall Study|Subject healed, not returning|1|||
164424759|NCT01636362|593926512|FG000|Overall Study|Withdrawal by Subject|1|||
164424760|NCT02271594|593926513|FG000|Overall Study|Study closed; recruiting failure|19|||
164424761|NCT02271594|593926514|FG001|Overall Study|Study closed; recruiting failure|12|||
164424762|NCT03330119|593926517|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
164573176|NCT02393209|594463347|FG000|Overall Study|Death from Legionella Infection|0|||
164573177|NCT02393209|594463348|FG001|Overall Study|Death from Legionella Infection|1|||
164424763|NCT03330119|593926518|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
164573178|NCT02393209|594463349|FG002|Overall Study|Death from Legionella Infection|0|||
164424764|NCT01561079|593926519|FG000|Overall Study|Physician Decision|17|||
164424765|NCT01561079|593926519|FG000|Overall Study|Withdrawal by Subject|59|||
164424766|NCT01561079|593926519|FG000|Overall Study|Protocol Violation|2|||
164424767|NCT03566680|593926531|FG000|Overall Study|Pregnancy|1|||
164424768|NCT03566680|593926531|FG000|Overall Study|Lost to Follow-up|13|||
164424769|NCT03566680|593926531|FG000|Overall Study|Withdrawal by Subject|3|||
164237383|NCT01832727|593240579|FG004|Overall Study|Adverse Event|1|||
164573179|NCT02393209|594463350|FG003|Overall Study|Death from Legionella Infection|0|||
164237384|NCT01832727|593240580|FG005|Overall Study|Adverse Event|1|||
164237385|NCT01832727|593240581|FG006|Overall Study|Adverse Event|2|||
164237386|NCT01832727|593240582|FG007|Overall Study|Adverse Event|1|||
164237387|NCT01832727|593240583|FG008|Overall Study|Adverse Event|9|||
164237388|NCT01832727|593240575|FG000|Overall Study|Disease progression|3|||
164237389|NCT01832727|593240576|FG001|Overall Study|Disease progression|0|||
164237390|NCT01832727|593240577|FG002|Overall Study|Disease progression|2|||
164237391|NCT01832727|593240578|FG003|Overall Study|Disease progression|1|||
164237392|NCT01832727|593240579|FG004|Overall Study|Disease progression|3|||
164237393|NCT01832727|593240580|FG005|Overall Study|Disease progression|3|||
164237394|NCT01832727|593240581|FG006|Overall Study|Disease progression|6|||
164237395|NCT01832727|593240582|FG007|Overall Study|Disease progression|2|||
164237396|NCT01832727|593240583|FG008|Overall Study|Disease progression|7|||
164237397|NCT01832727|593240575|FG000|Overall Study|Lost to Follow-up|0|||
164237398|NCT01832727|593240576|FG001|Overall Study|Lost to Follow-up|0|||
164237399|NCT01832727|593240577|FG002|Overall Study|Lost to Follow-up|0|||
164237400|NCT01832727|593240578|FG003|Overall Study|Lost to Follow-up|1|||
164237401|NCT01832727|593240579|FG004|Overall Study|Lost to Follow-up|0|||
164237402|NCT01832727|593240580|FG005|Overall Study|Lost to Follow-up|0|||
164237403|NCT01832727|593240581|FG006|Overall Study|Lost to Follow-up|0|||
164237404|NCT01832727|593240582|FG007|Overall Study|Lost to Follow-up|0|||
164237405|NCT01832727|593240583|FG008|Overall Study|Lost to Follow-up|0|||
164237406|NCT01832727|593240575|FG000|Overall Study|Physician Decision|1|||
164237407|NCT01832727|593240576|FG001|Overall Study|Physician Decision|0|||
164237408|NCT01832727|593240577|FG002|Overall Study|Physician Decision|0|||
164237409|NCT01832727|593240578|FG003|Overall Study|Physician Decision|1|||
164237410|NCT01832727|593240579|FG004|Overall Study|Physician Decision|0|||
164237411|NCT01832727|593240580|FG005|Overall Study|Physician Decision|1|||
164237412|NCT01832727|593240581|FG006|Overall Study|Physician Decision|0|||
164237413|NCT01832727|593240582|FG007|Overall Study|Physician Decision|0|||
164237414|NCT01832727|593240583|FG008|Overall Study|Physician Decision|0|||
164237415|NCT01832727|593240575|FG000|Overall Study|Withdrawal by Subject|1|||
164237416|NCT01832727|593240576|FG001|Overall Study|Withdrawal by Subject|1|||
164237417|NCT01832727|593240577|FG002|Overall Study|Withdrawal by Subject|0|||
164237418|NCT01832727|593240578|FG003|Overall Study|Withdrawal by Subject|1|||
164237419|NCT01832727|593240579|FG004|Overall Study|Withdrawal by Subject|0|||
164237420|NCT01832727|593240580|FG005|Overall Study|Withdrawal by Subject|1|||
164237421|NCT01832727|593240581|FG006|Overall Study|Withdrawal by Subject|0|||
164237422|NCT01832727|593240582|FG007|Overall Study|Withdrawal by Subject|2|||
164237423|NCT01832727|593240583|FG008|Overall Study|Withdrawal by Subject|1|||
164237424|NCT01832727|593240575|FG000|Overall Study|Study terminated by sponsor|0|||
164237425|NCT01832727|593240576|FG001|Overall Study|Study terminated by sponsor|0|||
164237426|NCT01832727|593240577|FG002|Overall Study|Study terminated by sponsor|0|||
164237427|NCT01832727|593240578|FG003|Overall Study|Study terminated by sponsor|0|||
164237428|NCT01832727|593240579|FG004|Overall Study|Study terminated by sponsor|0|||
164237429|NCT01832727|593240580|FG005|Overall Study|Study terminated by sponsor|0|||
164237430|NCT01832727|593240581|FG006|Overall Study|Study terminated by sponsor|0|||
164237431|NCT01832727|593240582|FG007|Overall Study|Study terminated by sponsor|1|||
164237432|NCT01832727|593240583|FG008|Overall Study|Study terminated by sponsor|1|||
164237433|NCT03323164|593240584|FG000|Overall Study|Poor quality imaging/scans|2|||
164237434|NCT03323164|593240585|FG001|Overall Study|Poor quality imaging/scans|2|||
164237435|NCT00461708|593240586|FG000|Overall Study|Adverse Event|17|||
164237436|NCT00461708|593240587|FG001|Overall Study|Adverse Event|7|||
164237437|NCT00461708|593240586|FG000|Overall Study|Lack of Efficacy|68|||
164237438|NCT00461708|593240587|FG001|Overall Study|Lack of Efficacy|20|||
164237439|NCT00461708|593240586|FG000|Overall Study|Physician Decision|10|||
164237440|NCT00461708|593240587|FG001|Overall Study|Physician Decision|4|||
164237441|NCT00461708|593240586|FG000|Overall Study|Withdrawal by Subject|8|||
164237442|NCT00461708|593240587|FG001|Overall Study|Withdrawal by Subject|2|||
164237443|NCT00461708|593240586|FG000|Overall Study|Other|4|||
164237444|NCT00461708|593240587|FG001|Overall Study|Other|4|||
164237445|NCT00461708|593240586|FG000|Overall Study|Death|8|||
164237446|NCT00461708|593240587|FG001|Overall Study|Death|1|||
164237447|NCT00501644|593240588|FG000|Overall Study|Adverse Event|4|||
164424770|NCT04003974|593926532|FG000|Overall Study|Missing|1|||
164237448|NCT00501644|593240588|FG000|Overall Study|Withdrawal by Subject|1|||
164237449|NCT02394561|593240589|FG000|CORE Phase|Adverse Event|7|||
164237450|NCT02394561|593240590|FG001|CORE Phase|Adverse Event|9|||
164237451|NCT02394561|593240589|FG000|CORE Phase|Death|0|||
164237452|NCT02394561|593240590|FG001|CORE Phase|Death|1|||
164237453|NCT02394561|593240589|FG000|CORE Phase|Pregnancy|1|||
164237454|NCT02394561|593240590|FG001|CORE Phase|Pregnancy|0|||
164237455|NCT02394561|593240589|FG000|CORE Phase|Lost to Follow-up|1|||
164237456|NCT02394561|593240590|FG001|CORE Phase|Lost to Follow-up|0|||
164237457|NCT02394561|593240589|FG000|CORE Phase|Physician Decision|1|||
164237458|NCT02394561|593240590|FG001|CORE Phase|Physician Decision|1|||
164237459|NCT02394561|593240589|FG000|CORE Phase|Withdrawal by Subject|2|||
164237460|NCT02394561|593240590|FG001|CORE Phase|Withdrawal by Subject|2|||
164424771|NCT04003974|593926533|FG001|Overall Study|Missing|0|||
164424772|NCT04003974|593926532|FG000|Overall Study|Withdrawal by Subject|0|||
164424773|NCT04003974|593926533|FG001|Overall Study|Withdrawal by Subject|2|||
164424774|NCT02400307|593926534|FG000|Overall Study|Enrolled and Never Dosed|1|||
164237461|NCT02394561|593240589|FG000|CORE Phase|Lack of Efficacy|1|||
164237462|NCT02394561|593240590|FG001|CORE Phase|Lack of Efficacy|6|||
164237463|NCT02394561|593240589|FG000|Extension Phase|Adverse Event|6|||
164237464|NCT02394561|593240590|FG001|Extension Phase|Adverse Event|1|||
164237465|NCT02394561|593240589|FG000|Extension Phase|Death|0|||
164237466|NCT02394561|593240590|FG001|Extension Phase|Death|1|||
164424775|NCT02400307|593926535|FG001|Overall Study|Enrolled and Never Dosed|0|||
164424776|NCT01272011|593926541|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
164237467|NCT02394561|593240589|FG000|Extension Phase|Protocol Violation|1|||
164237468|NCT02394561|593240590|FG001|Extension Phase|Protocol Violation|0|||
164237469|NCT02394561|593240589|FG000|Extension Phase|Lost to Follow-up|1|||
164237470|NCT02394561|593240590|FG001|Extension Phase|Lost to Follow-up|0|||
164237471|NCT02394561|593240589|FG000|Extension Phase|Physician Decision|0|||
164237472|NCT02394561|593240590|FG001|Extension Phase|Physician Decision|2|||
164237473|NCT02394561|593240589|FG000|Extension Phase|Withdrawal by Subject|0|||
164424777|NCT01272011|593926542|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
164424778|NCT01272011|593926543|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
164424779|NCT02013687|593926544|FG000|Overall Study|Lost to Follow-up|0|||
164424780|NCT02013687|593926545|FG001|Overall Study|Lost to Follow-up|0|||
164424781|NCT02013687|593926546|FG002|Overall Study|Lost to Follow-up|1|||
164424782|NCT02013687|593926547|FG003|Overall Study|Lost to Follow-up|0|||
164424783|NCT02013687|593926544|FG000|Overall Study|Protocol Violation|0|||
164424784|NCT02013687|593926545|FG001|Overall Study|Protocol Violation|0|||
164424785|NCT02013687|593926546|FG002|Overall Study|Protocol Violation|0|||
164424786|NCT02013687|593926547|FG003|Overall Study|Protocol Violation|1|||
164424787|NCT02013687|593926544|FG000|Overall Study|Withdrawal by Subject|0|||
164424788|NCT02013687|593926545|FG001|Overall Study|Withdrawal by Subject|0|||
164424789|NCT02013687|593926546|FG002|Overall Study|Withdrawal by Subject|0|||
164573180|NCT02393209|594463347|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
164573181|NCT02393209|594463348|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
164237474|NCT02394561|593240590|FG001|Extension Phase|Withdrawal by Subject|5|||
164237475|NCT02394561|593240589|FG000|Extension Phase|Lack of Efficacy|3|||
164237476|NCT02394561|593240590|FG001|Extension Phase|Lack of Efficacy|3|||
164237477|NCT02553629|593240591|FG000|Overall Study|Logistic reasons|3|||
164237478|NCT02553629|593240592|FG001|Overall Study|Logistic reasons|6|||
164335369|NCT03924869|593604898|FG001|Overall Study|Death|62|||
164335370|NCT03924869|593604897|FG000|Overall Study|Lost to Follow-up|3|||
164335371|NCT03924869|593604898|FG001|Overall Study|Lost to Follow-up|0|||
164335372|NCT03924869|593604897|FG000|Overall Study|Physician Decision|0|||
164335373|NCT03924869|593604898|FG001|Overall Study|Physician Decision|3|||
164335374|NCT03924869|593604897|FG000|Overall Study|Withdrawal by Subject|7|||
164335375|NCT03924869|593604898|FG001|Overall Study|Withdrawal by Subject|3|||
164335376|NCT03924869|593604897|FG000|Overall Study|Study Terminated By Sponsor|144|||
164335377|NCT03924869|593604898|FG001|Overall Study|Study Terminated By Sponsor|153|||
164335378|NCT03001882|593604901|FG000|Overall Study|Death|1|||
164335379|NCT03001882|593604902|FG001|Overall Study|Death|0|||
164335380|NCT03001882|593604903|FG002|Overall Study|Death|0|||
164335381|NCT03001882|593604904|FG003|Overall Study|Death|3|||
164335382|NCT03001882|593604901|FG000|Overall Study|Participant withdrew consent|0|||
164335383|NCT03001882|593604902|FG001|Overall Study|Participant withdrew consent|1|||
164335384|NCT03001882|593604903|FG002|Overall Study|Participant withdrew consent|0|||
164335385|NCT03001882|593604904|FG003|Overall Study|Participant withdrew consent|5|||
164335386|NCT03001882|593604901|FG000|Overall Study|Other reasons|1|||
164335387|NCT03001882|593604902|FG001|Overall Study|Other reasons|2|||
164335388|NCT03001882|593604903|FG002|Overall Study|Other reasons|0|||
164335389|NCT03001882|593604904|FG003|Overall Study|Other reasons|5|||
164335390|NCT03001882|593604901|FG000|Overall Study|Administrative reason by sponsor|0|||
164335391|NCT03001882|593604902|FG001|Overall Study|Administrative reason by sponsor|0|||
164335392|NCT03001882|593604903|FG002|Overall Study|Administrative reason by sponsor|0|||
164335393|NCT03001882|593604904|FG003|Overall Study|Administrative reason by sponsor|1|||
164335394|NCT03001882|593604901|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
164335395|NCT03001882|593604902|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
164335396|NCT03001882|593604903|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
164335397|NCT03001882|593604904|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
164424790|NCT02013687|593926547|FG003|Overall Study|Withdrawal by Subject|1|||
164424791|NCT02013687|593926544|FG000|Overall Study|Missed visits due to patient travel|0|||
164424792|NCT02013687|593926545|FG001|Overall Study|Missed visits due to patient travel|0|||
164424793|NCT02013687|593926546|FG002|Overall Study|Missed visits due to patient travel|1|||
164237479|NCT01880957|593240593|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
164237480|NCT01880957|593240594|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
164237481|NCT01880957|593240593|FG000|Overall Study|Lost to Follow-up|11|||
164237482|NCT01880957|593240594|FG001|Overall Study|Lost to Follow-up|0|||
164237483|NCT01880957|593240593|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
164237484|NCT01880957|593240594|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
164237485|NCT03342560|593240595|FG000|Overall Study|Lost to Follow-up|2|||
164237486|NCT02604511|593240596|FG000|Overall Study|Adverse Event|3|||
164237487|NCT02604511|593240596|FG000|Overall Study|Disease Progression|4|||
164237488|NCT02604511|593240596|FG000|Overall Study|Withdrawal by Subject|3|||
164237489|NCT02604511|593240596|FG000|Overall Study|Participant ineligible|1|||
164237490|NCT02604511|593240596|FG000|Overall Study|Intercurrent illness|1|||
164237491|NCT03586973|593240597|FG000|Overall Study|Death|15|||
164237492|NCT03586973|593240598|FG001|Overall Study|Death|8|||
164237493|NCT03586973|593240597|FG000|Overall Study|Site Terminated by Sponsor|3|||
164237494|NCT03586973|593240598|FG001|Overall Study|Site Terminated by Sponsor|6|||
164237495|NCT03586973|593240597|FG000|Overall Study|Withdrawal by Subject|1|||
164237496|NCT03586973|593240598|FG001|Overall Study|Withdrawal by Subject|0|||
164237497|NCT03586973|593240597|FG000|Overall Study|Lost to Follow-up|1|||
164237498|NCT03586973|593240598|FG001|Overall Study|Lost to Follow-up|0|||
164237499|NCT01150357|593240599|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
164237500|NCT01150357|593240600|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
164237501|NCT01150357|593240601|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
164237502|NCT01150357|593240599|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
164237503|NCT01150357|593240600|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
164237504|NCT01150357|593240601|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
164237505|NCT01150357|593240599|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
164237506|NCT01150357|593240600|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
164237507|NCT01150357|593240601|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
164237508|NCT01150357|593240599|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
164237509|NCT01150357|593240600|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
164237510|NCT01150357|593240601|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
164237511|NCT01150357|593240599|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
164237512|NCT01150357|593240600|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
164237513|NCT01150357|593240601|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
164237514|NCT01150357|593240599|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
164237515|NCT01150357|593240600|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
164237516|NCT01150357|593240601|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
164237517|NCT01150357|593240599|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
164237518|NCT01150357|593240600|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
164237519|NCT01150357|593240601|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
164237520|NCT02661672|593240602|FG000|Overall Study|Lost to Follow-up|1|||
164237521|NCT02661672|593240602|FG000|Overall Study|Death|4|||
164237522|NCT01248793|593242323|FG000|Overall Study|Lost to Follow-up|0|||
164424794|NCT02013687|593926547|FG003|Overall Study|Missed visits due to patient travel|0|||
164424795|NCT01627340|593926548|FG000|Overall Study|Adverse Event|1|||
164237523|NCT01248793|593242324|FG001|Overall Study|Lost to Follow-up|1|||
164237524|NCT01248793|593242323|FG000|Overall Study|Adverse Event|1|||
164237525|NCT01248793|593242324|FG001|Overall Study|Adverse Event|1|||
164237526|NCT01248793|593242323|FG000|Overall Study|Protocol Violation|0|||
164237527|NCT01248793|593242324|FG001|Overall Study|Protocol Violation|1|||
164237528|NCT01248793|593242323|FG000|Overall Study|Withdrawal by Subject|3|||
164237529|NCT01248793|593242324|FG001|Overall Study|Withdrawal by Subject|3|||
164237530|NCT00517699|593242325|FG000|Overall Study|Withdrawal by Subject|1|||
164237531|NCT00517699|593242325|FG000|Overall Study|Lack of Efficacy|1|||
164237532|NCT00517699|593242325|FG000|Overall Study|Administrative error|1|||
164237533|NCT00517699|593242325|FG000|Overall Study|Study terminated by Sponsor|2|||
164237534|NCT01114737|593242326|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
164237535|NCT01114737|593242327|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
164237536|NCT01114737|593242326|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
164237537|NCT01114737|593242327|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
164237538|NCT01114737|593242326|FG000|Randomized Treatment Period|Pregnancy|1|||
164237539|NCT01114737|593242327|FG001|Randomized Treatment Period|Pregnancy|0|||
164237540|NCT01114737|593242326|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
164237541|NCT01114737|593242327|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
164237542|NCT01114737|593242326|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
164424796|NCT01627340|593926549|FG001|Overall Study|Adverse Event|0|||
164424797|NCT01627340|593926548|FG000|Overall Study|Lost to Follow-up|8|||
164237543|NCT01114737|593242327|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
164237544|NCT01114737|593242326|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
164237545|NCT01114737|593242327|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
164237546|NCT02580877|593242330|FG000|Overall Study|Withdrawal by Subject|1|||
164237547|NCT02580877|593242331|FG001|Overall Study|Withdrawal by Subject|3|||
164237548|NCT02580877|593242330|FG000|Overall Study|Adverse Event|0|||
164237549|NCT02580877|593242331|FG001|Overall Study|Adverse Event|1|||
164424798|NCT01627340|593926549|FG001|Overall Study|Lost to Follow-up|4|||
164424799|NCT01627340|593926548|FG000|Overall Study|Pregnancy|1|||
164424800|NCT01627340|593926549|FG001|Overall Study|Pregnancy|0|||
164424801|NCT01627340|593926548|FG000|Overall Study|Withdrawal by Subject|2|||
164424802|NCT01627340|593926549|FG001|Overall Study|Withdrawal by Subject|0|||
164424803|NCT02240680|593926552|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
164424804|NCT02240680|593926553|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
164424805|NCT02240680|593926554|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
164424806|NCT02240680|593926555|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
164424807|NCT02240680|593926552|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
164424808|NCT02240680|593926553|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
164424809|NCT02240680|593926554|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
164424810|NCT02240680|593926555|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
164424811|NCT02240680|593926552|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
164424812|NCT02240680|593926553|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
164424813|NCT02240680|593926554|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
164237550|NCT01466491|593242332|FG000|Overall Study|Protocol Violation|0|||
164237551|NCT01466491|593242333|FG001|Overall Study|Protocol Violation|3|||
164237552|NCT01466491|593242334|FG002|Overall Study|Protocol Violation|2|||
164237553|NCT01466491|593242335|FG003|Overall Study|Protocol Violation|0|||
164237554|NCT01466491|593242332|FG000|Overall Study|Missing Data|0|||
164237555|NCT01466491|593242333|FG001|Overall Study|Missing Data|0|||
164237556|NCT01466491|593242334|FG002|Overall Study|Missing Data|1|||
164237557|NCT01466491|593242335|FG003|Overall Study|Missing Data|0|||
164237558|NCT01123148|593242336|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
164237559|NCT01123148|593242336|FG000|Overall Study|Didn't meet milestone criteria|1|||
164237560|NCT03604497|593242340|FG000|Overall Study|Protocol Violation|52|||
164237561|NCT00811954|593242341|FG000|Overall Study|Death|10|||
164237562|NCT00811954|593242342|FG001|Overall Study|Death|6|||
164237563|NCT00811954|593242343|FG002|Overall Study|Death|13|||
164237564|NCT00811954|593242341|FG000|Overall Study|Lost to Follow-up|29|||
164237565|NCT00811954|593242342|FG001|Overall Study|Lost to Follow-up|23|||
164237566|NCT00811954|593242343|FG002|Overall Study|Lost to Follow-up|34|||
164237567|NCT00811954|593242341|FG000|Overall Study|Not able to get to clinic|28|||
164237568|NCT00811954|593242342|FG001|Overall Study|Not able to get to clinic|35|||
164237569|NCT00811954|593242343|FG002|Overall Study|Not able to get to clinic|30|||
164237570|NCT00811954|593242341|FG000|Overall Study|Not willing to adhere to requirements|12|||
164237571|NCT00811954|593242342|FG001|Overall Study|Not willing to adhere to requirements|2|||
164237572|NCT00811954|593242343|FG002|Overall Study|Not willing to adhere to requirements|16|||
164237573|NCT00811954|593242341|FG000|Overall Study|Withdraw consent prior study completion|4|||
164237574|NCT00811954|593242342|FG001|Overall Study|Withdraw consent prior study completion|6|||
164237575|NCT00811954|593242343|FG002|Overall Study|Withdraw consent prior study completion|5|||
164237576|NCT00811954|593242341|FG000|Overall Study|Site Closure|4|||
164237577|NCT00811954|593242342|FG001|Overall Study|Site Closure|0|||
164237578|NCT00811954|593242343|FG002|Overall Study|Site Closure|1|||
164237579|NCT00811954|593242341|FG000|Overall Study|Severe Debilitation|2|||
164237580|NCT00811954|593242342|FG001|Overall Study|Severe Debilitation|0|||
164237581|NCT00811954|593242343|FG002|Overall Study|Severe Debilitation|1|||
164424814|NCT02240680|593926555|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
164424815|NCT02240680|593926552|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
164424816|NCT02240680|593926553|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
164424817|NCT02240680|593926554|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
164237582|NCT00811954|593242341|FG000|Overall Study|Complete Protocol: No follow-up|0|||
164237583|NCT00811954|593242342|FG001|Overall Study|Complete Protocol: No follow-up|0|||
164237584|NCT00811954|593242343|FG002|Overall Study|Complete Protocol: No follow-up|1|||
164237585|NCT01534481|593242350|FG000|Overall Study|Lost to Follow-up|29|||
164237586|NCT01534481|593242351|FG001|Overall Study|Lost to Follow-up|24|||
164237587|NCT01534481|593242350|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
164237588|NCT01534481|593242351|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
164237589|NCT01664247|593242355|FG000|Overall Study|Adverse Event|5|||
164237590|NCT01664247|593242356|FG001|Overall Study|Adverse Event|3|||
164237591|NCT01664247|593242355|FG000|Overall Study|Protocol Violation|3|||
164424818|NCT02240680|593926555|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
164424819|NCT02240680|593926552|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
164424820|NCT02240680|593926553|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
164237592|NCT01664247|593242356|FG001|Overall Study|Protocol Violation|5|||
164237593|NCT01664247|593242355|FG000|Overall Study|Withdrawal Criteria|1|||
164237594|NCT01664247|593242356|FG001|Overall Study|Withdrawal Criteria|4|||
164237595|NCT01664247|593242355|FG000|Overall Study|Unclassified|5|||
164237596|NCT01664247|593242356|FG001|Overall Study|Unclassified|29|||
164424821|NCT02240680|593926554|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
164237597|NCT00945659|593242357|FG000|Overall Study|Lost to Follow-up|7|||
164237598|NCT00945659|593242358|FG001|Overall Study|Lost to Follow-up|20|||
164237599|NCT00945659|593242359|FG002|Overall Study|Lost to Follow-up|17|||
164237600|NCT00658541|593242360|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
164237601|NCT00658541|593242361|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
164237602|NCT00658541|593242360|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
164237603|NCT00658541|593242361|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
164237604|NCT03179761|593242362|FG000|Overall Study|Death|2|||
164237605|NCT03179761|593242363|FG001|Overall Study|Death|5|||
164237606|NCT03179761|593242362|FG000|Overall Study|Lost to Follow-up|2|||
164237607|NCT03179761|593242363|FG001|Overall Study|Lost to Follow-up|2|||
164237608|NCT03179761|593242362|FG000|Overall Study|Protocol Violation|1|||
164237609|NCT03179761|593242363|FG001|Overall Study|Protocol Violation|0|||
164237610|NCT03179761|593242362|FG000|Overall Study|Withdrawal by Subject|1|||
164237611|NCT03179761|593242363|FG001|Overall Study|Withdrawal by Subject|4|||
164237612|NCT03179761|593242362|FG000|Overall Study|Investigator Request|0|||
164237613|NCT03179761|593242363|FG001|Overall Study|Investigator Request|2|||
164237614|NCT00565409|593242364|FG000|Period 1 Open Label|Adverse Event|17|||
164237615|NCT00565409|593242365|FG001|Period 1 Open Label|Adverse Event|0|||
164237616|NCT00565409|593242366|FG002|Period 1 Open Label|Adverse Event|0|||
164237617|NCT00565409|593242367|FG003|Period 1 Open Label|Adverse Event|0|||
164237618|NCT00565409|593242364|FG000|Period 1 Open Label|Death|2|||
164237619|NCT00565409|593242365|FG001|Period 1 Open Label|Death|0|||
164237620|NCT00565409|593242366|FG002|Period 1 Open Label|Death|0|||
164237621|NCT00565409|593242367|FG003|Period 1 Open Label|Death|0|||
164237622|NCT00565409|593242364|FG000|Period 1 Open Label|Lost to Follow-up|1|||
164237623|NCT00565409|593242365|FG001|Period 1 Open Label|Lost to Follow-up|0|||
164237624|NCT00565409|593242366|FG002|Period 1 Open Label|Lost to Follow-up|0|||
164237625|NCT00565409|593242367|FG003|Period 1 Open Label|Lost to Follow-up|0|||
164237626|NCT00565409|593242364|FG000|Period 1 Open Label|Other|21|||
164237627|NCT00565409|593242365|FG001|Period 1 Open Label|Other|0|||
164237628|NCT00565409|593242366|FG002|Period 1 Open Label|Other|0|||
164237629|NCT00565409|593242367|FG003|Period 1 Open Label|Other|0|||
164237630|NCT00565409|593242364|FG000|Period 1 Open Label|Protocol Violation|14|||
164237631|NCT00565409|593242365|FG001|Period 1 Open Label|Protocol Violation|0|||
164237632|NCT00565409|593242366|FG002|Period 1 Open Label|Protocol Violation|0|||
164237633|NCT00565409|593242367|FG003|Period 1 Open Label|Protocol Violation|0|||
164237634|NCT00565409|593242364|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
164237635|NCT00565409|593242365|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
164237636|NCT00565409|593242366|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
164237637|NCT00565409|593242367|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
164237638|NCT00565409|593242364|FG000|Period 1 Open Label|no conclusion of participation record|1|||
164237639|NCT00565409|593242365|FG001|Period 1 Open Label|no conclusion of participation record|0|||
164237640|NCT00565409|593242366|FG002|Period 1 Open Label|no conclusion of participation record|0|||
164237641|NCT00565409|593242367|FG003|Period 1 Open Label|no conclusion of participation record|0|||
164237642|NCT00565409|593242364|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
164237643|NCT00565409|593242365|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
164237644|NCT00565409|593242366|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
164237645|NCT00565409|593242367|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
164237646|NCT00565409|593242364|FG000|Period 2 Double-Blind|Adverse Event|0|||
164237647|NCT00565409|593242365|FG001|Period 2 Double-Blind|Adverse Event|7|||
164237648|NCT00565409|593242366|FG002|Period 2 Double-Blind|Adverse Event|4|||
164237649|NCT00565409|593242367|FG003|Period 2 Double-Blind|Adverse Event|5|||
164237650|NCT00565409|593242364|FG000|Period 2 Double-Blind|Death|0|||
164237651|NCT00565409|593242365|FG001|Period 2 Double-Blind|Death|2|||
164237652|NCT00565409|593242366|FG002|Period 2 Double-Blind|Death|0|||
164237653|NCT00565409|593242367|FG003|Period 2 Double-Blind|Death|0|||
164237654|NCT00565409|593242364|FG000|Period 2 Double-Blind|Protocol Violation|0|||
164237655|NCT00565409|593242365|FG001|Period 2 Double-Blind|Protocol Violation|4|||
164237656|NCT00565409|593242366|FG002|Period 2 Double-Blind|Protocol Violation|6|||
164237657|NCT00565409|593242367|FG003|Period 2 Double-Blind|Protocol Violation|2|||
164237658|NCT00565409|593242364|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
164237659|NCT00565409|593242365|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
164237660|NCT00565409|593242366|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
164237661|NCT00565409|593242367|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
164237662|NCT00565409|593242364|FG000|Period 2 Double-Blind|Other|0|||
164237663|NCT00565409|593242365|FG001|Period 2 Double-Blind|Other|4|||
164335398|NCT03001882|593604901|FG000|Overall Study|Not reported|0|||
164335399|NCT03001882|593604902|FG001|Overall Study|Not reported|0|||
164335400|NCT03001882|593604903|FG002|Overall Study|Not reported|0|||
164237664|NCT00565409|593242366|FG002|Period 2 Double-Blind|Other|5|||
164237665|NCT00565409|593242367|FG003|Period 2 Double-Blind|Other|9|||
164237666|NCT00565409|593242364|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
164237667|NCT00565409|593242365|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
164237668|NCT00565409|593242366|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
164237669|NCT00565409|593242367|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
164237670|NCT04828707|593242368|FG000|Overall Study|Lost to Follow-up|3|||
164335401|NCT03001882|593604904|FG003|Overall Study|Not reported|6|||
164237671|NCT04828707|593242369|FG001|Overall Study|Lost to Follow-up|2|||
164237672|NCT04828707|593242368|FG000|Overall Study|Withdrawal by Subject|2|||
164237673|NCT04828707|593242369|FG001|Overall Study|Withdrawal by Subject|1|||
164237674|NCT04211363|593242378|FG000|Overall Study|Adverse Event|5|||
164237675|NCT04211363|593242379|FG001|Overall Study|Adverse Event|2|||
164237676|NCT04211363|593242378|FG000|Overall Study|Physician Decision|0|||
164237677|NCT04211363|593242379|FG001|Overall Study|Physician Decision|1|||
164237678|NCT04211363|593242378|FG000|Overall Study|Protocol Violation|1|||
164237679|NCT04211363|593242379|FG001|Overall Study|Protocol Violation|0|||
164237680|NCT04211363|593242378|FG000|Overall Study|Pregnancy|1|||
164237681|NCT04211363|593242379|FG001|Overall Study|Pregnancy|0|||
164237682|NCT04211363|593242378|FG000|Overall Study|Lost to Follow-up|12|||
164237683|NCT04211363|593242379|FG001|Overall Study|Lost to Follow-up|4|||
164237684|NCT04211363|593242378|FG000|Overall Study|Withdrawal by Subject|11|||
164237685|NCT04211363|593242379|FG001|Overall Study|Withdrawal by Subject|11|||
164237686|NCT04211363|593242378|FG000|Overall Study|Other|1|||
164237687|NCT04211363|593242379|FG001|Overall Study|Other|2|||
164237688|NCT03434834|593242382|FG000|Overall Study|unable to swallow OCT probe|16|||
164237689|NCT01823289|593242383|FG000|Overall Study|Lost to Follow-up|5|||
164237690|NCT01823289|593242383|FG000|Overall Study|Adverse Event|5|||
164237691|NCT01823289|593242383|FG000|Overall Study|Lack of Efficacy|1|||
164237692|NCT01823289|593242383|FG000|Overall Study|Physician Decision|9|||
164237693|NCT01823289|593242383|FG000|Overall Study|Administered contraindicated medicine|1|||
164237694|NCT01823289|593242383|FG000|Overall Study|Transaminase increased more than 3 times|1|||
164237695|NCT01823289|593242383|FG000|Overall Study|Drug affected efficacy and safety|1|||
164237696|NCT01823289|593242383|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
164237697|NCT01812057|593242391|FG000|Overall Study|Protocol Violation|1|||
164237698|NCT01812057|593242392|FG001|Overall Study|Protocol Violation|0|||
164237699|NCT01812057|593242391|FG000|Overall Study|Physician Decision|1|||
164237700|NCT01812057|593242392|FG001|Overall Study|Physician Decision|0|||
164237701|NCT01736917|593242393|FG000|Overall Study|Adverse Event|1|||
164237702|NCT01736917|593242393|FG000|Overall Study|Protocol Violation|10|||
164424822|NCT02240680|593926555|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
164237703|NCT00654732|593242398|FG000|Overall Study|Adverse Event|4|||
164237704|NCT00654732|593242399|FG001|Overall Study|Adverse Event|6|||
164237705|NCT01133847|593242406|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
164237706|NCT01133847|593242407|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
164237707|NCT01133847|593242408|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
164237708|NCT01133847|593242406|FG000|Follow-Up Phase|Lost to Follow-up|1|||
164237709|NCT01133847|593242407|FG001|Follow-Up Phase|Lost to Follow-up|3|||
164237710|NCT01133847|593242408|FG002|Follow-Up Phase|Lost to Follow-up|7|||
164237711|NCT01378117|593242409|FG000|Overall Study|withdrawal|2|||
164237712|NCT01378117|593242410|FG001|Overall Study|withdrawal|1|||
164237713|NCT01378117|593242411|FG002|Overall Study|withdrawal|2|||
164237714|NCT01378117|593242409|FG000|Overall Study|discharged before med given|2|||
164237715|NCT01378117|593242410|FG001|Overall Study|discharged before med given|0|||
164237716|NCT01378117|593242411|FG002|Overall Study|discharged before med given|1|||
164237717|NCT02961244|593242412|FG000|Overall Study|Protocol Violation|0|||
164237718|NCT02961244|593242413|FG001|Overall Study|Protocol Violation|1|||
164237719|NCT02961244|593242412|FG000|Overall Study|Withdrawal by Subject|1|||
164237720|NCT02961244|593242413|FG001|Overall Study|Withdrawal by Subject|2|||
164237721|NCT02961244|593242412|FG000|Overall Study|Surgery plan change after study approval|0|||
164237722|NCT02961244|593242413|FG001|Overall Study|Surgery plan change after study approval|2|||
164237723|NCT02961244|593242412|FG000|Overall Study|Lost to Follow-up|0|||
164237724|NCT02961244|593242413|FG001|Overall Study|Lost to Follow-up|2|||
164237725|NCT02961244|593242412|FG000|Overall Study|İnadequate data|0|||
164237726|NCT02961244|593242413|FG001|Overall Study|İnadequate data|2|||
164237727|NCT01854528|593242414|FG000|Overall Study|Adverse Event|0|||
164237728|NCT01854528|593242415|FG001|Overall Study|Adverse Event|4|||
164237729|NCT01854528|593242414|FG000|Overall Study|Withdrawal by Subject|0|||
164237730|NCT01854528|593242415|FG001|Overall Study|Withdrawal by Subject|2|||
164237731|NCT01854528|593242414|FG000|Overall Study|Virologic Failure|0|||
164237732|NCT01854528|593242415|FG001|Overall Study|Virologic Failure|9|||
164237733|NCT01368614|593242417|FG000|Screening Period|Screen Failure|58|||
164237734|NCT01368614|593242418|FG001|Screening Period|Screen Failure|0|||
164237735|NCT01368614|593242419|FG002|Screening Period|Screen Failure|0|||
164237736|NCT01368614|593242420|FG003|Screening Period|Screen Failure|0|||
164237737|NCT01368614|593242417|FG000|Study Period|Withdrawal by Subject|0|||
164424823|NCT02240680|593926552|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
164237738|NCT01368614|593242418|FG001|Study Period|Withdrawal by Subject|1|||
164237739|NCT01368614|593242419|FG002|Study Period|Withdrawal by Subject|1|||
164424824|NCT02240680|593926553|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
164237740|NCT01368614|593242420|FG003|Study Period|Withdrawal by Subject|3|||
164237741|NCT01368614|593242417|FG000|Study Period|Lost to Follow-up|0|||
164237742|NCT01368614|593242418|FG001|Study Period|Lost to Follow-up|0|||
164237743|NCT01368614|593242419|FG002|Study Period|Lost to Follow-up|1|||
164237744|NCT01368614|593242420|FG003|Study Period|Lost to Follow-up|0|||
164237745|NCT00518180|593242421|FG000|Overall Study|Withdrawal by Subject|29|||
164237746|NCT00518180|593242422|FG001|Overall Study|Withdrawal by Subject|30|||
164237747|NCT00518180|593242423|FG002|Overall Study|Withdrawal by Subject|42|||
164237748|NCT00518180|593242421|FG000|Overall Study|Lost to Follow-up|30|||
164237749|NCT00518180|593242422|FG001|Overall Study|Lost to Follow-up|28|||
164237750|NCT00518180|593242423|FG002|Overall Study|Lost to Follow-up|34|||
164237751|NCT00518180|593242421|FG000|Overall Study|Administrative reason|0|||
164237752|NCT00518180|593242422|FG001|Overall Study|Administrative reason|2|||
164237753|NCT00518180|593242423|FG002|Overall Study|Administrative reason|2|||
164237754|NCT00518180|593242421|FG000|Overall Study|Protocol Violation|5|||
164237755|NCT00518180|593242422|FG001|Overall Study|Protocol Violation|7|||
164237756|NCT00518180|593242423|FG002|Overall Study|Protocol Violation|4|||
164237757|NCT00518180|593242421|FG000|Overall Study|Unable to classify|0|||
164237758|NCT00518180|593242422|FG001|Overall Study|Unable to classify|2|||
164237759|NCT00518180|593242423|FG002|Overall Study|Unable to classify|0|||
164237760|NCT00518180|593242421|FG000|Overall Study|Adverse Event|1|||
164237761|NCT00518180|593242422|FG001|Overall Study|Adverse Event|0|||
164237762|NCT00518180|593242423|FG002|Overall Study|Adverse Event|0|||
164237763|NCT02347085|593242430|FG000|Overall Study|Adverse Event|2|||
164237764|NCT02347085|593242430|FG000|Overall Study|Lack of Efficacy|1|||
164237765|NCT02347085|593242430|FG000|Overall Study|Withdrawal by Subject|4|||
164237766|NCT02347085|593242430|FG000|Overall Study|Lost to Follow-up|1|||
164237767|NCT02347085|593242430|FG000|Overall Study|Protocol Criteria|2|||
164237768|NCT01957865|593242431|FG000|Overall Study|Found HIV negative|0|||
164237769|NCT01957865|593242432|FG001|Overall Study|Found HIV negative|0|||
164237770|NCT01957865|593242433|FG002|Overall Study|Found HIV negative|1|||
164237771|NCT01957865|593242431|FG000|Overall Study|Lost to Follow-up|0|||
164237772|NCT01957865|593242432|FG001|Overall Study|Lost to Follow-up|2|||
164237773|NCT01957865|593242433|FG002|Overall Study|Lost to Follow-up|2|||
164237774|NCT01082614|593242434|FG000|Overall Study|Adverse Event|1|||
164237775|NCT01082614|593242435|FG001|Overall Study|Adverse Event|4|||
164237776|NCT01082614|593242434|FG000|Overall Study|Equipment Malfunction|0|||
164237777|NCT01082614|593242435|FG001|Overall Study|Equipment Malfunction|1|||
164237778|NCT01082614|593242434|FG000|Overall Study|Physician Decision|2|||
164237779|NCT01082614|593242435|FG001|Overall Study|Physician Decision|0|||
164237780|NCT00950651|593242443|FG000|Overall Study|Adverse Event|17|||
164237781|NCT00950651|593242444|FG001|Overall Study|Adverse Event|20|||
164237782|NCT00950651|593242443|FG000|Overall Study|Death|1|||
164237783|NCT00950651|593242444|FG001|Overall Study|Death|0|||
164237784|NCT00950651|593242443|FG000|Overall Study|Lack of Efficacy|2|||
164237785|NCT00950651|593242444|FG001|Overall Study|Lack of Efficacy|2|||
164237786|NCT00950651|593242443|FG000|Overall Study|Protocol Violation|3|||
164237787|NCT00950651|593242444|FG001|Overall Study|Protocol Violation|4|||
164237788|NCT00950651|593242443|FG000|Overall Study|Withdrawal by Subject|8|||
164237789|NCT00950651|593242444|FG001|Overall Study|Withdrawal by Subject|9|||
164237790|NCT03783780|593242445|FG000|Overall Study|Withdrawn prior to completion|1|||
164237791|NCT03768427|593242446|FG000|Overall Study|Death|0|||
164237792|NCT03768427|593242447|FG001|Overall Study|Death|0|||
164237793|NCT03768427|593242448|FG002|Overall Study|Death|1|||
164237794|NCT03768427|593242449|FG003|Overall Study|Death|0|||
164237795|NCT03768427|593242446|FG000|Overall Study|Lost to Follow-up|2|||
164237796|NCT03768427|593242447|FG001|Overall Study|Lost to Follow-up|0|||
164237797|NCT03768427|593242448|FG002|Overall Study|Lost to Follow-up|0|||
164237798|NCT03768427|593242449|FG003|Overall Study|Lost to Follow-up|0|||
164237799|NCT03768427|593242446|FG000|Overall Study|Physician Decision|3|||
164237800|NCT03768427|593242447|FG001|Overall Study|Physician Decision|2|||
164237801|NCT03768427|593242448|FG002|Overall Study|Physician Decision|4|||
164237802|NCT03768427|593242449|FG003|Overall Study|Physician Decision|4|||
164237803|NCT03768427|593242446|FG000|Overall Study|Withdrawal by Subject|7|||
164237804|NCT03768427|593242447|FG001|Overall Study|Withdrawal by Subject|2|||
164237805|NCT03768427|593242448|FG002|Overall Study|Withdrawal by Subject|6|||
164237806|NCT03768427|593242449|FG003|Overall Study|Withdrawal by Subject|7|||
164237807|NCT03710889|593242452|FG000|Overall Study|Adverse Event|2|||
164237808|NCT03710889|593242452|FG000|Overall Study|Protocol Deviation|1|||
164237809|NCT00659425|593242456|FG000|Overall Study|Disease progression|1|||
164237810|NCT00659425|593242457|FG001|Overall Study|Disease progression|0|||
164237811|NCT00659425|593242458|FG002|Overall Study|Disease progression|0|||
164237812|NCT00659425|593242459|FG003|Overall Study|Disease progression|1|||
164237813|NCT00659425|593242460|FG004|Overall Study|Disease progression|0|||
164237814|NCT00659425|593242461|FG005|Overall Study|Disease progression|2|||
164237815|NCT00659425|593242462|FG006|Overall Study|Disease progression|4|||
164237816|NCT00659425|593242463|FG007|Overall Study|Disease progression|3|||
164237817|NCT00659425|593242464|FG008|Overall Study|Disease progression|5|||
164424825|NCT02240680|593926554|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
164237818|NCT00659425|593242465|FG009|Overall Study|Disease progression|3|||
164237819|NCT00659425|593242456|FG000|Overall Study|Death|0|||
164237820|NCT00659425|593242457|FG001|Overall Study|Death|0|||
164237821|NCT00659425|593242458|FG002|Overall Study|Death|0|||
164237822|NCT00659425|593242459|FG003|Overall Study|Death|1|||
164237823|NCT00659425|593242460|FG004|Overall Study|Death|0|||
164237824|NCT00659425|593242461|FG005|Overall Study|Death|0|||
164237825|NCT00659425|593242462|FG006|Overall Study|Death|1|||
164424826|NCT02240680|593926555|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
164424827|NCT02240680|593926552|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
164424828|NCT02240680|593926553|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
164424829|NCT02240680|593926554|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
164424830|NCT02240680|593926555|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
164424831|NCT02240680|593926552|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
164424832|NCT02240680|593926553|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
164424833|NCT02240680|593926554|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
164424834|NCT02240680|593926555|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
164424835|NCT01657032|593926556|FG000|Overall Study|Lost to Follow-up|0|||
164424836|NCT01657032|593926557|FG001|Overall Study|Lost to Follow-up|7|||
164424837|NCT01782326|593926558|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
164424838|NCT01782326|593926559|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
164424839|NCT01782326|593926558|FG000|Planned Treatment Epoch|Death|29|||
164424840|NCT01782326|593926559|FG001|Planned Treatment Epoch|Death|30|||
164424841|NCT01782326|593926558|FG000|Planned Treatment Epoch|Physician Decision|18|||
164424842|NCT01782326|593926559|FG001|Planned Treatment Epoch|Physician Decision|16|||
164424843|NCT01782326|593926558|FG000|Planned Treatment Epoch|Protocol deviation|2|||
164424844|NCT01782326|593926559|FG001|Planned Treatment Epoch|Protocol deviation|3|||
164424845|NCT01782326|593926558|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
164424846|NCT01782326|593926559|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
164424847|NCT01782326|593926558|FG000|Planned Treatment Epoch|Technical problems|0|||
164424848|NCT01782326|593926559|FG001|Planned Treatment Epoch|Technical problems|4|||
164424849|NCT01782326|593926558|FG000|Double-blind Treatment|Adverse Event|129|||
164424850|NCT01782326|593926559|FG001|Double-blind Treatment|Adverse Event|145|||
164424851|NCT01782326|593926558|FG000|Double-blind Treatment|Subject/guardian decision|111|||
164424852|NCT01782326|593926559|FG001|Double-blind Treatment|Subject/guardian decision|125|||
164424853|NCT01782326|593926558|FG000|Double-blind Treatment|Lack of Efficacy|17|||
164424854|NCT01782326|593926559|FG001|Double-blind Treatment|Lack of Efficacy|22|||
164424855|NCT01782326|593926558|FG000|Double-blind Treatment|Physician Decision|13|||
164424856|NCT01782326|593926559|FG001|Double-blind Treatment|Physician Decision|16|||
164424857|NCT01782326|593926558|FG000|Double-blind Treatment|Protocol deviation|8|||
164424858|NCT01782326|593926559|FG001|Double-blind Treatment|Protocol deviation|7|||
164424859|NCT01782326|593926558|FG000|Double-blind Treatment|Technical problems|0|||
164424860|NCT01782326|593926559|FG001|Double-blind Treatment|Technical problems|5|||
164424861|NCT02559817|593926560|FG000|Treatment Period|Adverse Event|1|||
164424862|NCT02559817|593926561|FG001|Treatment Period|Adverse Event|0|||
164424863|NCT02559817|593926562|FG002|Treatment Period|Adverse Event|1|||
164424864|NCT02559817|593926563|FG003|Treatment Period|Adverse Event|0|||
164424865|NCT02559817|593926564|FG004|Treatment Period|Adverse Event|0|||
164424866|NCT02559817|593926560|FG000|Treatment Period|Lack of Efficacy|0|||
164424867|NCT02559817|593926561|FG001|Treatment Period|Lack of Efficacy|1|||
164424868|NCT02559817|593926562|FG002|Treatment Period|Lack of Efficacy|0|||
164424869|NCT02559817|593926563|FG003|Treatment Period|Lack of Efficacy|0|||
164424870|NCT02559817|593926564|FG004|Treatment Period|Lack of Efficacy|0|||
164424871|NCT02559817|593926560|FG000|Treatment Period|Lost to Follow-up|0|||
164424872|NCT02559817|593926561|FG001|Treatment Period|Lost to Follow-up|1|||
164424873|NCT02559817|593926562|FG002|Treatment Period|Lost to Follow-up|0|||
164424874|NCT02559817|593926563|FG003|Treatment Period|Lost to Follow-up|1|||
164424875|NCT02559817|593926564|FG004|Treatment Period|Lost to Follow-up|0|||
164424876|NCT02559817|593926560|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
164424877|NCT02559817|593926561|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
164424878|NCT02559817|593926562|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
164424879|NCT02559817|593926563|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
164424880|NCT02559817|593926564|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
164424881|NCT02559817|593926560|FG000|Treatment Period|Protocol Violation|0|||
164237826|NCT00659425|593242463|FG007|Overall Study|Death|0|||
164237827|NCT00659425|593242464|FG008|Overall Study|Death|0|||
164237828|NCT00659425|593242465|FG009|Overall Study|Death|0|||
164237829|NCT00659425|593242456|FG000|Overall Study|Adverse Event|0|||
164424882|NCT02559817|593926561|FG001|Treatment Period|Protocol Violation|0|||
164424883|NCT02559817|593926562|FG002|Treatment Period|Protocol Violation|0|||
164424884|NCT02559817|593926563|FG003|Treatment Period|Protocol Violation|1|||
164424885|NCT02559817|593926564|FG004|Treatment Period|Protocol Violation|0|||
164424886|NCT03389893|593926565|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
164424887|NCT03389893|593926566|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
164424888|NCT03389893|593926567|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
164424889|NCT03389893|593926568|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
164424890|NCT03389893|593926565|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
164424891|NCT03389893|593926566|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
164424892|NCT03389893|593926567|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
164424893|NCT03389893|593926568|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
164424894|NCT03389893|593926565|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
164424895|NCT03389893|593926566|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
164424896|NCT03389893|593926567|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
164335402|NCT03001882|593604901|FG000|Overall Study|Maximum clinical benefit|2|||
164335403|NCT03001882|593604902|FG001|Overall Study|Maximum clinical benefit|3|||
164335404|NCT03001882|593604903|FG002|Overall Study|Maximum clinical benefit|0|||
164335405|NCT03001882|593604904|FG003|Overall Study|Maximum clinical benefit|10|||
164335406|NCT03001882|593604901|FG000|Overall Study|AE unrelated to study drug|3|||
164335407|NCT03001882|593604902|FG001|Overall Study|AE unrelated to study drug|3|||
164335408|NCT03001882|593604903|FG002|Overall Study|AE unrelated to study drug|0|||
164335409|NCT03001882|593604904|FG003|Overall Study|AE unrelated to study drug|11|||
164335410|NCT03001882|593604901|FG000|Overall Study|Study Drug Toxicity|8|||
164335411|NCT03001882|593604902|FG001|Overall Study|Study Drug Toxicity|5|||
164335412|NCT03001882|593604903|FG002|Overall Study|Study Drug Toxicity|0|||
164335413|NCT03001882|593604904|FG003|Overall Study|Study Drug Toxicity|37|||
164335414|NCT03001882|593604901|FG000|Overall Study|Disease progression|16|||
164335415|NCT03001882|593604902|FG001|Overall Study|Disease progression|14|||
164335416|NCT03001882|593604903|FG002|Overall Study|Disease progression|1|||
164335417|NCT03001882|593604904|FG003|Overall Study|Disease progression|90|||
164335418|NCT02718300|593604905|FG000|Overall Study|Death|4|||
164335419|NCT02718300|593604906|FG001|Overall Study|Death|5|||
164335420|NCT02718300|593604907|FG002|Overall Study|Death|17|||
164335421|NCT02718300|593604905|FG000|Overall Study|Lost to Follow-up|1|||
164335422|NCT02718300|593604906|FG001|Overall Study|Lost to Follow-up|0|||
164335423|NCT02718300|593604907|FG002|Overall Study|Lost to Follow-up|2|||
164335424|NCT02718300|593604905|FG000|Overall Study|Physician Decision|1|||
164335425|NCT02718300|593604906|FG001|Overall Study|Physician Decision|0|||
164335426|NCT02718300|593604907|FG002|Overall Study|Physician Decision|2|||
164335427|NCT02718300|593604905|FG000|Overall Study|Study Terminated by Sponsor|6|||
164335428|NCT02718300|593604906|FG001|Overall Study|Study Terminated by Sponsor|3|||
164335429|NCT02718300|593604907|FG002|Overall Study|Study Terminated by Sponsor|4|||
164335430|NCT02718300|593604905|FG000|Overall Study|Withdrawal by Subject|0|||
164335431|NCT02718300|593604906|FG001|Overall Study|Withdrawal by Subject|4|||
164335432|NCT02718300|593604907|FG002|Overall Study|Withdrawal by Subject|3|||
164335433|NCT02718300|593604905|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
164335434|NCT02718300|593604906|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
164335435|NCT02718300|593604907|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
164335436|NCT05268055|593604909|FG000|Overall Study|Lost to Follow-up|68|||
164335437|NCT05268055|593604910|FG001|Overall Study|Lost to Follow-up|68|||
164335438|NCT05268055|593604909|FG000|Overall Study|Withdrawal by Subject|12|||
164335439|NCT05268055|593604910|FG001|Overall Study|Withdrawal by Subject|8|||
164335440|NCT03507400|593604911|FG000|Overall Study|discontinued|5|||
164424897|NCT03389893|593926568|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
164424898|NCT03389893|593926565|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
164424899|NCT03389893|593926566|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
164424900|NCT03389893|593926567|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
164424901|NCT03389893|593926568|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
164424902|NCT01077024|593926569|FG000|Overall Study|Lost to Follow-up|20|||
164424903|NCT01077024|593926570|FG001|Overall Study|Lost to Follow-up|14|||
164424904|NCT01077024|593926569|FG000|Overall Study|Withdrawal by Subject|0|||
164424905|NCT01077024|593926570|FG001|Overall Study|Withdrawal by Subject|2|||
164424906|NCT01077024|593926569|FG000|Overall Study|Incarcerated|7|||
164424907|NCT01077024|593926570|FG001|Overall Study|Incarcerated|8|||
164424908|NCT01077024|593926569|FG000|Overall Study|Other|4|||
164424909|NCT01077024|593926570|FG001|Overall Study|Other|4|||
164424910|NCT02034435|593926571|FG000|Overall Study|Withdrawal by Subject|1|||
164424911|NCT02034435|593926572|FG001|Overall Study|Withdrawal by Subject|0|||
164424912|NCT02034435|593926573|FG002|Overall Study|Withdrawal by Subject|0|||
164424913|NCT02034435|593926574|FG003|Overall Study|Withdrawal by Subject|0|||
164424914|NCT02034435|593926571|FG000|Overall Study|Illness|0|||
164424915|NCT02034435|593926572|FG001|Overall Study|Illness|2|||
164424916|NCT02034435|593926573|FG002|Overall Study|Illness|0|||
164424917|NCT02034435|593926574|FG003|Overall Study|Illness|0|||
164424918|NCT02034435|593926571|FG000|Overall Study|Inadequate IV access|1|||
164424919|NCT02034435|593926572|FG001|Overall Study|Inadequate IV access|0|||
164335441|NCT03507400|593604912|FG001|Overall Study|discontinued|1|||
164335442|NCT03507400|593604911|FG000|Overall Study|Lost to Follow-up|8|||
164335443|NCT03507400|593604912|FG001|Overall Study|Lost to Follow-up|6|||
164335444|NCT03507400|593604911|FG000|Overall Study|Protocol Violation|0|||
164335445|NCT03507400|593604912|FG001|Overall Study|Protocol Violation|1|||
164335446|NCT01555983|593604913|FG000|Overall Study|Withdrawal by Subject|1|||
164335447|NCT01555983|593604914|FG001|Overall Study|Withdrawal by Subject|0|||
164424920|NCT02034435|593926573|FG002|Overall Study|Inadequate IV access|0|||
164424921|NCT02034435|593926574|FG003|Overall Study|Inadequate IV access|1|||
164424922|NCT00419003|593926578|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
164424923|NCT00419003|593926579|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
164677243|NCT01058668|594843052|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
164677244|NCT01058668|594843053|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
164677245|NCT01058668|594843051|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
164677246|NCT01058668|594843052|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
164677247|NCT01058668|594843053|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
164677248|NCT01778010|594843056|FG000|Overall Study|Withdrawal by Subject|2|||
164677249|NCT01778010|594843056|FG000|Overall Study|abnormal ECG before meds|1|||
164677250|NCT01778010|594843056|FG000|Overall Study|Arrested|1|||
164677251|NCT01778010|594843056|FG000|Overall Study|rash while on placebo|1|||
164677252|NCT02159183|594843059|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
164237830|NCT00659425|593242457|FG001|Overall Study|Adverse Event|0|||
164237831|NCT00659425|593242458|FG002|Overall Study|Adverse Event|0|||
164237832|NCT00659425|593242459|FG003|Overall Study|Adverse Event|0|||
164237833|NCT00659425|593242460|FG004|Overall Study|Adverse Event|0|||
164237834|NCT00659425|593242461|FG005|Overall Study|Adverse Event|1|||
164237835|NCT00659425|593242462|FG006|Overall Study|Adverse Event|0|||
164237836|NCT00659425|593242463|FG007|Overall Study|Adverse Event|3|||
164677253|NCT02159183|594843060|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
164237837|NCT00659425|593242464|FG008|Overall Study|Adverse Event|1|||
164237838|NCT00659425|593242465|FG009|Overall Study|Adverse Event|4|||
164237839|NCT00659425|593242456|FG000|Overall Study|Investigator Discretion|0|||
164237840|NCT00659425|593242457|FG001|Overall Study|Investigator Discretion|0|||
164237841|NCT00659425|593242458|FG002|Overall Study|Investigator Discretion|0|||
164677254|NCT02159183|594843059|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
164677255|NCT02159183|594843060|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
164677256|NCT02159183|594843059|FG000|Analysis After the 36 Months Follow-up|Death|0|||
164677257|NCT02159183|594843060|FG001|Analysis After the 36 Months Follow-up|Death|1|||
164677258|NCT02159183|594843059|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
164677259|NCT02159183|594843060|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
164677260|NCT02159183|594843059|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
164677261|NCT02159183|594843060|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
164677262|NCT02558491|594843064|FG000|First Invention|Withdrawal by Subject|3|||
164677263|NCT02558491|594843065|FG001|First Invention|Withdrawal by Subject|1|||
164677264|NCT02558491|594843064|FG000|First Invention|Data collection issues|1|||
164677265|NCT02558491|594843065|FG001|First Invention|Data collection issues|0|||
164677266|NCT02558491|594843064|FG000|First Invention|Stopping criteria|0|||
164677267|NCT02558491|594843065|FG001|First Invention|Stopping criteria|1|||
164677268|NCT02558491|594843064|FG000|First Invention|Changed parameters during trial|1|||
164677269|NCT02558491|594843065|FG001|First Invention|Changed parameters during trial|0|||
164677270|NCT02558491|594843064|FG000|Second Intervention|Withdrawal by Subject|1|||
164677271|NCT02558491|594843065|FG001|Second Intervention|Withdrawal by Subject|0|||
164335448|NCT01555983|593604915|FG002|Overall Study|Withdrawal by Subject|0|||
164335449|NCT01555983|593604916|FG003|Overall Study|Withdrawal by Subject|0|||
164335450|NCT01555983|593604917|FG004|Overall Study|Withdrawal by Subject|1|||
164335451|NCT01555983|593604918|FG005|Overall Study|Withdrawal by Subject|1|||
164335452|NCT04026711|593604922|FG000|Overall Study|Withdrawal by Subject|1|||
164335453|NCT04026711|593604923|FG001|Overall Study|Withdrawal by Subject|0|||
164335454|NCT04026711|593604922|FG000|Overall Study|mental health crisis|1|||
164335455|NCT04026711|593604923|FG001|Overall Study|mental health crisis|0|||
164335456|NCT05985395|593604928|FG000|Overall Study|Physician Decision|2|||
164335457|NCT05985395|593604929|FG001|Overall Study|Physician Decision|1|||
164335458|NCT05985395|593604928|FG000|Overall Study|Withdrawal by Subject|1|||
164335459|NCT05985395|593604929|FG001|Overall Study|Withdrawal by Subject|0|||
164335460|NCT05741528|593604930|FG000|Overall Study|Withdrawal by Subject|11|||
164335461|NCT05741528|593604930|FG000|Overall Study|Lost to Follow-up|3|||
164335462|NCT05741528|593604930|FG000|Overall Study|Adverse Event|2|||
164335463|NCT05741528|593604930|FG000|Overall Study|Non-Compliance With Study Drug|2|||
164335464|NCT05741528|593604930|FG000|Overall Study|Reason Not Specified|1|||
164335465|NCT04823650|593604931|FG000|Overall Study|Withdrawal by Subject|0|||
164335466|NCT04823650|593604932|FG001|Overall Study|Withdrawal by Subject|0|||
164677272|NCT02558491|594843064|FG000|Second Intervention|Stopping Criteria|1|||
164677273|NCT02558491|594843065|FG001|Second Intervention|Stopping Criteria|0|||
164677274|NCT00796328|594843066|FG000|Overall Study|experienced hypotension requiring tx|6|||
164237842|NCT00659425|593242459|FG003|Overall Study|Investigator Discretion|0|||
164237843|NCT00659425|593242460|FG004|Overall Study|Investigator Discretion|0|||
164237844|NCT00659425|593242461|FG005|Overall Study|Investigator Discretion|1|||
164335467|NCT04823650|593604933|FG002|Overall Study|Withdrawal by Subject|0|||
164335468|NCT04823650|593604934|FG003|Overall Study|Withdrawal by Subject|0|||
164335469|NCT04823650|593604935|FG004|Overall Study|Withdrawal by Subject|1|||
164237845|NCT00659425|593242462|FG006|Overall Study|Investigator Discretion|0|||
164237846|NCT00659425|593242463|FG007|Overall Study|Investigator Discretion|3|||
164335470|NCT04823650|593604936|FG005|Overall Study|Withdrawal by Subject|0|||
164335471|NCT02699697|593605977|FG000|Overall Study|Death|18|||
164335472|NCT02699697|593605978|FG001|Overall Study|Death|15|||
164335473|NCT02699697|593605977|FG000|Overall Study|Physician Decision|0|||
164237847|NCT00659425|593242464|FG008|Overall Study|Investigator Discretion|0|||
164237848|NCT00659425|593242465|FG009|Overall Study|Investigator Discretion|0|||
164237849|NCT00659425|593242456|FG000|Overall Study|Other|0|||
164237850|NCT00659425|593242457|FG001|Overall Study|Other|1|||
164237851|NCT00659425|593242458|FG002|Overall Study|Other|1|||
164424924|NCT00419003|593926578|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
164237852|NCT00659425|593242459|FG003|Overall Study|Other|2|||
164237853|NCT00659425|593242460|FG004|Overall Study|Other|4|||
164237854|NCT00659425|593242461|FG005|Overall Study|Other|0|||
164237855|NCT00659425|593242462|FG006|Overall Study|Other|3|||
164237856|NCT00659425|593242463|FG007|Overall Study|Other|2|||
164237857|NCT00659425|593242464|FG008|Overall Study|Other|0|||
164237858|NCT00659425|593242465|FG009|Overall Study|Other|6|||
164237859|NCT02121509|593242469|FG000|Washout Period (35 Days)|Adverse Event|1|||
164237860|NCT02121509|593242470|FG001|Washout Period (35 Days)|Adverse Event|1|||
164237861|NCT02121509|593242471|FG002|Washout Period (35 Days)|Adverse Event|0|||
164237862|NCT02121509|593242472|FG003|Washout Period (35 Days)|Adverse Event|0|||
164237863|NCT02121509|593242469|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
164237864|NCT02121509|593242470|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
164237865|NCT02121509|593242471|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
164237866|NCT02121509|593242472|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
164237867|NCT02121509|593242469|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
164237868|NCT02121509|593242470|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
164237869|NCT02121509|593242471|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
164237870|NCT02121509|593242472|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
164237871|NCT00636181|593242475|FG000|Overall Study|Withdrawal by Subject|8|||
164237872|NCT00636181|593242476|FG001|Overall Study|Withdrawal by Subject|6|||
164237873|NCT00636181|593242477|FG002|Overall Study|Withdrawal by Subject|10|||
164237874|NCT02993263|593242479|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
164237875|NCT02561962|593242480|FG000|Overall Study|Withdrawal by Subject|1|||
164237876|NCT02561962|593242481|FG001|Overall Study|Withdrawal by Subject|0|||
164237877|NCT02561962|593242482|FG002|Overall Study|Withdrawal by Subject|0|||
164237878|NCT02561962|593242483|FG003|Overall Study|Withdrawal by Subject|0|||
164237879|NCT02561962|593242484|FG004|Overall Study|Withdrawal by Subject|1|||
164237880|NCT02561962|593242485|FG005|Overall Study|Withdrawal by Subject|1|||
164237881|NCT02561962|593242486|FG006|Overall Study|Withdrawal by Subject|2|||
164237882|NCT02561962|593242487|FG007|Overall Study|Withdrawal by Subject|1|||
164237883|NCT02561962|593242488|FG008|Overall Study|Withdrawal by Subject|0|||
164237884|NCT02561962|593242480|FG000|Overall Study|Decision by sponsor|0|||
164237885|NCT02561962|593242481|FG001|Overall Study|Decision by sponsor|0|||
164237886|NCT02561962|593242482|FG002|Overall Study|Decision by sponsor|0|||
164237887|NCT02561962|593242483|FG003|Overall Study|Decision by sponsor|0|||
164237888|NCT02561962|593242484|FG004|Overall Study|Decision by sponsor|1|||
164237889|NCT02561962|593242485|FG005|Overall Study|Decision by sponsor|1|||
164237890|NCT02561962|593242486|FG006|Overall Study|Decision by sponsor|0|||
164237891|NCT02561962|593242487|FG007|Overall Study|Decision by sponsor|3|||
164237892|NCT02561962|593242488|FG008|Overall Study|Decision by sponsor|0|||
164237893|NCT02561962|593242480|FG000|Overall Study|Lost to Follow-up|0|||
164237894|NCT02561962|593242481|FG001|Overall Study|Lost to Follow-up|0|||
164237895|NCT02561962|593242482|FG002|Overall Study|Lost to Follow-up|0|||
164237896|NCT02561962|593242483|FG003|Overall Study|Lost to Follow-up|0|||
164237897|NCT02561962|593242484|FG004|Overall Study|Lost to Follow-up|0|||
164237898|NCT02561962|593242485|FG005|Overall Study|Lost to Follow-up|1|||
164237899|NCT02561962|593242486|FG006|Overall Study|Lost to Follow-up|0|||
164237900|NCT02561962|593242487|FG007|Overall Study|Lost to Follow-up|0|||
164335474|NCT02699697|593605978|FG001|Overall Study|Physician Decision|1|||
164573182|NCT02393209|594463349|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
164573183|NCT02393209|594463350|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
164573184|NCT02393209|594463347|FG000|Overall Study|Lost to Follow-up|0|||
164573185|NCT02393209|594463348|FG001|Overall Study|Lost to Follow-up|1|||
164573186|NCT02393209|594463349|FG002|Overall Study|Lost to Follow-up|0|||
164573187|NCT02393209|594463350|FG003|Overall Study|Lost to Follow-up|0|||
164573188|NCT03545282|594463351|FG000|Overall Study|Lost to Follow-up|15|||
164573189|NCT03545282|594463352|FG001|Overall Study|Lost to Follow-up|10|||
164573190|NCT03545282|594463351|FG000|Overall Study|Withdrawal by Subject|2|||
164573191|NCT03545282|594463352|FG001|Overall Study|Withdrawal by Subject|2|||
164573192|NCT03751111|594463353|FG000|Overall Study|Lack of Efficacy|9|||
164573193|NCT03751111|594463354|FG001|Overall Study|Lack of Efficacy|30|||
164573194|NCT03751111|594463353|FG000|Overall Study|Adverse Event|3|||
164573195|NCT03751111|594463354|FG001|Overall Study|Adverse Event|2|||
164573196|NCT00929240|594463355|FG000|Initial Treatment Phase|Adverse Event|31|||
164573197|NCT00929240|594463356|FG001|Initial Treatment Phase|Adverse Event|0|||
164573198|NCT00929240|594463357|FG002|Initial Treatment Phase|Adverse Event|0|||
164573199|NCT00929240|594463355|FG000|Initial Treatment Phase|Disease progression|41|||
164573200|NCT00929240|594463356|FG001|Initial Treatment Phase|Disease progression|0|||
164573201|NCT00929240|594463357|FG002|Initial Treatment Phase|Disease progression|0|||
164573202|NCT00929240|594463355|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
164237901|NCT02561962|593242488|FG008|Overall Study|Lost to Follow-up|0|||
164237902|NCT02735421|593244089|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
164237903|NCT02735421|593244089|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
164237904|NCT02735421|593244089|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
164237905|NCT02735421|593244089|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
164237906|NCT02735421|593244089|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
164237907|NCT02735421|593244089|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
164237908|NCT02735421|593244089|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
164237909|NCT00322049|593244091|FG000|Overall Study|Moved out of area|0|||
164237910|NCT00322049|593244092|FG001|Overall Study|Moved out of area|0|||
164237911|NCT00322049|593244093|FG002|Overall Study|Moved out of area|0|||
164237912|NCT00322049|593244094|FG003|Overall Study|Moved out of area|1|||
164237913|NCT00322049|593244091|FG000|Overall Study|Infected with Dengue during study|0|||
164237914|NCT00322049|593244092|FG001|Overall Study|Infected with Dengue during study|1|||
164237915|NCT00322049|593244093|FG002|Overall Study|Infected with Dengue during study|0|||
164237916|NCT00322049|593244094|FG003|Overall Study|Infected with Dengue during study|0|||
164237917|NCT01978145|593244095|FG000|Treatment Period 1|Adverse Event|1|||
164237918|NCT01978145|593244096|FG001|Treatment Period 1|Adverse Event|9|||
164677275|NCT03406156|594843073|FG000|Overall Study|Death|9|||
164677276|NCT03406156|594843074|FG001|Overall Study|Death|3|||
164677277|NCT03406156|594843073|FG000|Overall Study|Withdrawal by Subject|1|||
164677278|NCT03406156|594843074|FG001|Overall Study|Withdrawal by Subject|2|||
164677279|NCT03406156|594843073|FG000|Overall Study|COVID-19 infection|1|||
164677280|NCT03406156|594843074|FG001|Overall Study|COVID-19 infection|0|||
164677281|NCT03406156|594843073|FG000|Overall Study|Non-compliance with study procedures|1|||
164677282|NCT03406156|594843074|FG001|Overall Study|Non-compliance with study procedures|1|||
164677283|NCT03406156|594843073|FG000|Overall Study|Lost to Follow-up|0|||
164677284|NCT03406156|594843074|FG001|Overall Study|Lost to Follow-up|2|||
164677285|NCT03406156|594843073|FG000|Overall Study|Other, not specified|72|||
164677286|NCT03406156|594843074|FG001|Overall Study|Other, not specified|28|||
164677287|NCT05479058|594843077|FG000|Overall Study|Withdrawal by Subject|1|||
164677288|NCT05479058|594843078|FG001|Overall Study|Withdrawal by Subject|1|||
164677289|NCT05479058|594843077|FG000|Overall Study|Study terminated by sponsor|10|||
164677290|NCT05479058|594843078|FG001|Overall Study|Study terminated by sponsor|10|||
164677291|NCT05630885|594843079|FG000|Study Completion|Took prohibited medications|2|||
164677292|NCT05630885|594843080|FG001|Study Completion|Took prohibited medications|0|||
164677293|NCT05630885|594843079|FG000|Study Completion|Non-compliance with study drug|1|||
164677294|NCT05630885|594843080|FG001|Study Completion|Non-compliance with study drug|0|||
164237919|NCT01978145|593244095|FG000|Treatment Period 1|Physician Decision|1|||
164237920|NCT01978145|593244096|FG001|Treatment Period 1|Physician Decision|0|||
164237921|NCT01978145|593244095|FG000|Treatment Period 1|Withdrawal by Subject|5|||
164237922|NCT01978145|593244096|FG001|Treatment Period 1|Withdrawal by Subject|4|||
164237923|NCT01978145|593244095|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
164237924|NCT01978145|593244096|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
164237925|NCT01978145|593244095|FG000|Washout Period 1|Adverse Event|0|||
164237926|NCT01978145|593244096|FG001|Washout Period 1|Adverse Event|1|||
164237927|NCT01978145|593244095|FG000|Washout Period 1|Withdrawal by Subject|1|||
164237928|NCT01978145|593244096|FG001|Washout Period 1|Withdrawal by Subject|1|||
164237929|NCT01978145|593244095|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
164237930|NCT01978145|593244096|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
164677295|NCT05630885|594843079|FG000|Study Completion|Adverse Event|1|||
164677296|NCT05630885|594843080|FG001|Study Completion|Adverse Event|0|||
164677297|NCT05630885|594843079|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
164677298|NCT05630885|594843080|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
164677299|NCT05630885|594843079|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
164677300|NCT05630885|594843080|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
164677301|NCT03419403|594843081|FG000|Overall Study|Withdrawal by Subject|5|||
164677302|NCT03419403|594843082|FG001|Overall Study|Withdrawal by Subject|2|||
164677303|NCT03419403|594843083|FG002|Overall Study|Withdrawal by Subject|5|||
164677304|NCT03419403|594843084|FG003|Overall Study|Withdrawal by Subject|1|||
164677305|NCT03419403|594843081|FG000|Overall Study|Progressive disease (per protocol)|0|||
164677306|NCT03419403|594843082|FG001|Overall Study|Progressive disease (per protocol)|2|||
164237931|NCT01978145|593244095|FG000|Treatment Period 2|Adverse Event|3|||
164237932|NCT01978145|593244096|FG001|Treatment Period 2|Adverse Event|3|||
164237933|NCT01978145|593244095|FG000|Treatment Period 2|Protocol Violation|0|||
164237934|NCT01978145|593244096|FG001|Treatment Period 2|Protocol Violation|1|||
164237935|NCT01978145|593244095|FG000|Treatment Period 2|Lost to Follow-up|1|||
164237936|NCT01978145|593244096|FG001|Treatment Period 2|Lost to Follow-up|1|||
164677307|NCT03419403|594843083|FG002|Overall Study|Progressive disease (per protocol)|2|||
164677308|NCT03419403|594843084|FG003|Overall Study|Progressive disease (per protocol)|0|||
164677309|NCT03419403|594843081|FG000|Overall Study|Other, not specified|6|||
164677310|NCT03419403|594843082|FG001|Overall Study|Other, not specified|4|||
164677311|NCT03419403|594843083|FG002|Overall Study|Other, not specified|5|||
164677312|NCT03419403|594843084|FG003|Overall Study|Other, not specified|1|||
164677313|NCT03419403|594843081|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
164677314|NCT03419403|594843082|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
164677315|NCT03419403|594843083|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
164677316|NCT03419403|594843084|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
164677317|NCT03084471|594843089|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
164677318|NCT03084471|594843089|FG000|Overall Study|Condition under investigation worsened|84|||
164677319|NCT03084471|594843089|FG000|Overall Study|Lack of therapeutic response|2|||
164677320|NCT03084471|594843089|FG000|Overall Study|Protocol Violation|1|||
164677321|NCT03084471|594843089|FG000|Overall Study|Adverse Event|73|||
164677322|NCT03084471|594843089|FG000|Overall Study|Withdrawal by Subject|12|||
164677323|NCT03084471|594843089|FG000|Overall Study|Disease relapse|181|||
164677324|NCT03084471|594843089|FG000|Overall Study|Subjective disease progression|359|||
164677325|NCT03084471|594843089|FG000|Overall Study|Other (as recorded)|33|||
164677326|NCT03084471|594843089|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
164677327|NCT00251979|594843090|FG000|Overall Study|Protocol Violation|3|||
164677328|NCT00251979|594843091|FG001|Overall Study|Protocol Violation|5|||
164677329|NCT00251979|594843090|FG000|Overall Study|Adverse Event|11|||
164677330|NCT00251979|594843091|FG001|Overall Study|Adverse Event|17|||
164677331|NCT00251979|594843090|FG000|Overall Study|Withdrawal by Subject|13|||
164677332|NCT00251979|594843091|FG001|Overall Study|Withdrawal by Subject|7|||
164677333|NCT00251979|594843090|FG000|Overall Study|Lost to Follow-up|8|||
164677334|NCT00251979|594843091|FG001|Overall Study|Lost to Follow-up|6|||
164677335|NCT00251979|594843090|FG000|Overall Study|Death|3|||
164677336|NCT00251979|594843091|FG001|Overall Study|Death|5|||
164677337|NCT01878292|594843096|FG000|Randomized|Protocol Violation|1|||
164677338|NCT01878292|594843097|FG001|Randomized|Protocol Violation|0|||
164677339|NCT01878292|594843098|FG002|Randomized|Protocol Violation|0|||
164677340|NCT01878292|594843096|FG000|Randomized|Lost to Follow-up|1|||
164677341|NCT01878292|594843097|FG001|Randomized|Lost to Follow-up|0|||
164677342|NCT01878292|594843098|FG002|Randomized|Lost to Follow-up|0|||
164677343|NCT01878292|594843096|FG000|Randomized|Adverse Event|1|||
164677344|NCT01878292|594843097|FG001|Randomized|Adverse Event|0|||
164677345|NCT01878292|594843098|FG002|Randomized|Adverse Event|0|||
164677346|NCT01878292|594843096|FG000|Double-blind Treatment Period|Other Reasons|2|||
164677347|NCT01878292|594843097|FG001|Double-blind Treatment Period|Other Reasons|0|||
164677348|NCT01878292|594843098|FG002|Double-blind Treatment Period|Other Reasons|0|||
164677349|NCT01878292|594843096|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
164677350|NCT01878292|594843097|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
164677351|NCT01878292|594843098|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
164677352|NCT01878292|594843096|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
164677353|NCT01878292|594843097|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
164677354|NCT01878292|594843098|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
164677355|NCT01878292|594843096|FG000|Double-blind Treatment Period|Protocol Violation|3|||
164677356|NCT01878292|594843097|FG001|Double-blind Treatment Period|Protocol Violation|4|||
164677357|NCT01878292|594843098|FG002|Double-blind Treatment Period|Protocol Violation|2|||
164424925|NCT00419003|593926579|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
164424926|NCT02687919|593926580|FG000|Overall Study|Withdrawal by Subject|6|||
164424927|NCT02687919|593926581|FG001|Overall Study|Withdrawal by Subject|6|||
164424928|NCT02687919|593926580|FG000|Overall Study|Protocol Violation|2|||
164424929|NCT02687919|593926581|FG001|Overall Study|Protocol Violation|0|||
164424930|NCT02531438|593926582|FG000|Overall Study|Adverse Event|7|||
164424931|NCT02531438|593926583|FG001|Overall Study|Adverse Event|9|||
164424932|NCT02531438|593926582|FG000|Overall Study|Lost to Follow-up|0|||
164424933|NCT02531438|593926583|FG001|Overall Study|Lost to Follow-up|3|||
164424934|NCT02531438|593926582|FG000|Overall Study|Withdrawal by Subject|7|||
164424935|NCT02531438|593926583|FG001|Overall Study|Withdrawal by Subject|8|||
164424936|NCT02531438|593926582|FG000|Overall Study|Physician Decision|0|||
164424937|NCT02531438|593926583|FG001|Overall Study|Physician Decision|1|||
164424938|NCT02531438|593926582|FG000|Overall Study|Death|6|||
164424939|NCT02531438|593926583|FG001|Overall Study|Death|3|||
164424940|NCT02531438|593926582|FG000|Overall Study|Randomized, but Not Treated|4|||
164424941|NCT02531438|593926583|FG001|Overall Study|Randomized, but Not Treated|0|||
164424942|NCT02531438|593926582|FG000|Overall Study|Missed EOT/PTE Visit|5|||
164424943|NCT02531438|593926583|FG001|Overall Study|Missed EOT/PTE Visit|2|||
164677358|NCT01878292|594843096|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
164677359|NCT01878292|594843097|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
164677360|NCT01878292|594843098|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
164677361|NCT01878292|594843096|FG000|Double-blind Treatment Period|Adverse Event|4|||
164677362|NCT01878292|594843097|FG001|Double-blind Treatment Period|Adverse Event|9|||
164677363|NCT01878292|594843098|FG002|Double-blind Treatment Period|Adverse Event|8|||
164677364|NCT01878292|594843096|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
164424944|NCT02531438|593926582|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
164677365|NCT01878292|594843097|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
164424945|NCT02531438|593926583|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
164424946|NCT01653847|593926584|FG000|Overall Study|Withdrawal by Subject|1|||
164424947|NCT01653847|593926585|FG001|Overall Study|Withdrawal by Subject|0|||
164424948|NCT03100838|593926586|FG000|Overall Study|Adverse Event|1|||
164424949|NCT03100838|593926587|FG001|Overall Study|Adverse Event|0|||
164424950|NCT03100838|593926588|FG002|Overall Study|Adverse Event|0|||
164424951|NCT03100838|593926589|FG003|Overall Study|Adverse Event|0|||
164424952|NCT03100838|593926586|FG000|Overall Study|Physician Decision|1|||
164424953|NCT03100838|593926587|FG001|Overall Study|Physician Decision|1|||
164424954|NCT03100838|593926588|FG002|Overall Study|Physician Decision|1|||
164424955|NCT03100838|593926589|FG003|Overall Study|Physician Decision|1|||
164424956|NCT03100838|593926586|FG000|Overall Study|Pregnancy|0|||
164424957|NCT03100838|593926587|FG001|Overall Study|Pregnancy|1|||
164424958|NCT03100838|593926588|FG002|Overall Study|Pregnancy|0|||
164424959|NCT03100838|593926589|FG003|Overall Study|Pregnancy|0|||
164424960|NCT03100838|593926586|FG000|Overall Study|Lost to Follow-up|0|||
164424961|NCT03100838|593926587|FG001|Overall Study|Lost to Follow-up|0|||
164424962|NCT03100838|593926588|FG002|Overall Study|Lost to Follow-up|1|||
164424963|NCT03100838|593926589|FG003|Overall Study|Lost to Follow-up|0|||
164424964|NCT01653743|593926590|FG000|Overall Study|Withdrawal by Subject|1|||
164424965|NCT01653743|593926591|FG001|Overall Study|Withdrawal by Subject|0|||
164573203|NCT00929240|594463356|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
164573204|NCT00929240|594463357|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
164573205|NCT00929240|594463355|FG000|Initial Treatment Phase|Protocol Violation|5|||
164573206|NCT00929240|594463356|FG001|Initial Treatment Phase|Protocol Violation|0|||
164573207|NCT00929240|594463357|FG002|Initial Treatment Phase|Protocol Violation|0|||
164573208|NCT00929240|594463355|FG000|Initial Treatment Phase|Death|2|||
164573209|NCT00929240|594463356|FG001|Initial Treatment Phase|Death|0|||
164573210|NCT00929240|594463357|FG002|Initial Treatment Phase|Death|0|||
164573211|NCT00929240|594463355|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
164573212|NCT00929240|594463356|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
164573213|NCT00929240|594463357|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
164573214|NCT00929240|594463355|FG000|Initial Treatment Phase|Physician Decision|4|||
164573215|NCT00929240|594463356|FG001|Initial Treatment Phase|Physician Decision|0|||
164573216|NCT00929240|594463357|FG002|Initial Treatment Phase|Physician Decision|0|||
164573217|NCT00929240|594463355|FG000|Maintenance Phase|Disease progression|0|||
164573218|NCT00929240|594463356|FG001|Maintenance Phase|Disease progression|73|||
164573219|NCT00929240|594463357|FG002|Maintenance Phase|Disease progression|60|||
164573220|NCT00929240|594463355|FG000|Maintenance Phase|Adverse Event|0|||
164573221|NCT00929240|594463356|FG001|Maintenance Phase|Adverse Event|9|||
164573222|NCT00929240|594463357|FG002|Maintenance Phase|Adverse Event|12|||
164573223|NCT00929240|594463355|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164573224|NCT00929240|594463356|FG001|Maintenance Phase|Withdrawal by Subject|2|||
164573225|NCT00929240|594463357|FG002|Maintenance Phase|Withdrawal by Subject|6|||
164573226|NCT00929240|594463355|FG000|Maintenance Phase|Protocol Violation|0|||
164573227|NCT00929240|594463356|FG001|Maintenance Phase|Protocol Violation|1|||
164573228|NCT00929240|594463357|FG002|Maintenance Phase|Protocol Violation|0|||
164573229|NCT00929240|594463355|FG000|Maintenance Phase|Health authority/Study termination|0|||
164573230|NCT00929240|594463356|FG001|Maintenance Phase|Health authority/Study termination|1|||
164573231|NCT00929240|594463357|FG002|Maintenance Phase|Health authority/Study termination|2|||
164573232|NCT00929240|594463355|FG000|Maintenance Phase|Physician Decision|0|||
164573233|NCT00929240|594463356|FG001|Maintenance Phase|Physician Decision|2|||
164573234|NCT00929240|594463357|FG002|Maintenance Phase|Physician Decision|1|||
164573235|NCT00929240|594463355|FG000|Maintenance Phase|Change of treatment|0|||
164573236|NCT00929240|594463356|FG001|Maintenance Phase|Change of treatment|4|||
164573237|NCT00929240|594463357|FG002|Maintenance Phase|Change of treatment|0|||
164573238|NCT00929240|594463355|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
164573239|NCT00929240|594463356|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
164573240|NCT00929240|594463357|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
164573241|NCT00929240|594463355|FG000|Maintenance Phase|Participant not treated|0|||
164573242|NCT00929240|594463356|FG001|Maintenance Phase|Participant not treated|2|||
164573243|NCT00929240|594463357|FG002|Maintenance Phase|Participant not treated|0|||
164573244|NCT02582671|594463358|FG000|Overall Study|Failure to return|1|||
164573245|NCT02582671|594463358|FG000|Overall Study|Other, not specified|1|||
164573246|NCT01287104|594463363|FG000|Overall Study|Patient developed progressive disease|1|||
164573247|NCT01287104|594463364|FG001|Overall Study|Patient developed progressive disease|1|||
164573248|NCT01287104|594463365|FG002|Overall Study|Patient developed progressive disease|3|||
164573249|NCT01287104|594463366|FG003|Overall Study|Patient developed progressive disease|2|||
164573250|NCT01287104|594463363|FG000|Overall Study|Donor anaphylaxis|0|||
164573251|NCT01287104|594463364|FG001|Overall Study|Donor anaphylaxis|1|||
164573252|NCT01287104|594463365|FG002|Overall Study|Donor anaphylaxis|0|||
164573253|NCT01287104|594463366|FG003|Overall Study|Donor anaphylaxis|1|||
164573254|NCT01287104|594463363|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
164424966|NCT01653743|593926590|FG000|Overall Study|Investigator discretion|3|||
164677366|NCT01878292|594843098|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
164677367|NCT00323882|594843099|FG000|Overall Study|Adverse Event|2|||
164677368|NCT00323882|594843100|FG001|Overall Study|Adverse Event|1|||
164677369|NCT00323882|594843101|FG002|Overall Study|Adverse Event|1|||
164677370|NCT00323882|594843102|FG003|Overall Study|Adverse Event|1|||
164677371|NCT00323882|594843103|FG004|Overall Study|Adverse Event|3|||
164677372|NCT00323882|594843099|FG000|Overall Study|Disease Progression|6|||
164677373|NCT00323882|594843100|FG001|Overall Study|Disease Progression|4|||
164677374|NCT00323882|594843101|FG002|Overall Study|Disease Progression|10|||
164677375|NCT00323882|594843102|FG003|Overall Study|Disease Progression|5|||
164424967|NCT01653743|593926591|FG001|Overall Study|Investigator discretion|0|||
164424968|NCT00994279|593926592|FG000|Overall Study|Withdrawal by Subject|2|||
164424969|NCT00994279|593926593|FG001|Overall Study|Withdrawal by Subject|2|||
164424970|NCT00994279|593926592|FG000|Overall Study|Toxicity|1|||
164424971|NCT00994279|593926593|FG001|Overall Study|Toxicity|0|||
164424972|NCT00994279|593926592|FG000|Overall Study|Multiple reasons|1|||
164424973|NCT00994279|593926593|FG001|Overall Study|Multiple reasons|3|||
164424974|NCT01606189|593926594|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
164424975|NCT01606189|593926595|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
164424976|NCT01606189|593926596|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
164424977|NCT01606189|593926597|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
164424978|NCT01606189|593926598|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
164424979|NCT01606189|593926599|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
164424980|NCT01606189|593926594|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
164424981|NCT01606189|593926595|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
164424982|NCT01606189|593926596|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
164424983|NCT01606189|593926597|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
164424984|NCT01606189|593926598|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
164424985|NCT01606189|593926599|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
164677376|NCT00323882|594843103|FG004|Overall Study|Disease Progression|22|||
164677377|NCT00323882|594843099|FG000|Overall Study|Death|0|||
164677378|NCT00323882|594843100|FG001|Overall Study|Death|1|||
164677379|NCT00323882|594843101|FG002|Overall Study|Death|1|||
164677380|NCT00323882|594843102|FG003|Overall Study|Death|0|||
164677381|NCT00323882|594843103|FG004|Overall Study|Death|5|||
164677382|NCT00323882|594843099|FG000|Overall Study|Lost to Follow-up|0|||
164677383|NCT00323882|594843100|FG001|Overall Study|Lost to Follow-up|0|||
164677384|NCT00323882|594843101|FG002|Overall Study|Lost to Follow-up|1|||
164677385|NCT00323882|594843102|FG003|Overall Study|Lost to Follow-up|0|||
164677386|NCT00323882|594843103|FG004|Overall Study|Lost to Follow-up|1|||
164677387|NCT00323882|594843099|FG000|Overall Study|Other|0|||
164677388|NCT00323882|594843100|FG001|Overall Study|Other|0|||
164677389|NCT00323882|594843101|FG002|Overall Study|Other|0|||
164677390|NCT00323882|594843102|FG003|Overall Study|Other|1|||
164677391|NCT00323882|594843103|FG004|Overall Study|Other|1|||
164677392|NCT00429416|594843106|FG000|Overall Study|Death|1|||
164677393|NCT02152163|594843108|FG000|Overall Study|Physician Decision|12|||
164677394|NCT02152163|594843109|FG001|Overall Study|Physician Decision|13|||
164677395|NCT00730691|594843111|FG000|Overall Study|Adverse Event|4|||
164677396|NCT00730691|594843112|FG001|Overall Study|Adverse Event|8|||
164677397|NCT00730691|594843113|FG002|Overall Study|Adverse Event|11|||
164677398|NCT00730691|594843114|FG003|Overall Study|Adverse Event|11|||
164677399|NCT00730691|594843115|FG004|Overall Study|Adverse Event|23|||
164677400|NCT00730691|594843111|FG000|Overall Study|Lack of Efficacy|4|||
164677401|NCT00730691|594843112|FG001|Overall Study|Lack of Efficacy|4|||
164677402|NCT00730691|594843113|FG002|Overall Study|Lack of Efficacy|2|||
164677403|NCT00730691|594843114|FG003|Overall Study|Lack of Efficacy|1|||
164677404|NCT00730691|594843115|FG004|Overall Study|Lack of Efficacy|1|||
164677405|NCT00730691|594843111|FG000|Overall Study|Non-compliance with Study Drug|6|||
164677406|NCT00730691|594843112|FG001|Overall Study|Non-compliance with Study Drug|1|||
164677407|NCT00730691|594843113|FG002|Overall Study|Non-compliance with Study Drug|6|||
164677408|NCT00730691|594843114|FG003|Overall Study|Non-compliance with Study Drug|3|||
164677409|NCT00730691|594843115|FG004|Overall Study|Non-compliance with Study Drug|3|||
164677410|NCT00730691|594843111|FG000|Overall Study|Protocol Deviations|3|||
164424986|NCT01400893|593926600|FG000|Overall Study|Death|27|||
164677411|NCT00730691|594843112|FG001|Overall Study|Protocol Deviations|5|||
164677412|NCT00730691|594843113|FG002|Overall Study|Protocol Deviations|3|||
164677413|NCT00730691|594843114|FG003|Overall Study|Protocol Deviations|7|||
164677414|NCT00730691|594843115|FG004|Overall Study|Protocol Deviations|5|||
164677415|NCT00730691|594843111|FG000|Overall Study|Withdrawal of Consent|7|||
164677416|NCT00730691|594843112|FG001|Overall Study|Withdrawal of Consent|9|||
164677417|NCT00730691|594843113|FG002|Overall Study|Withdrawal of Consent|3|||
164677418|NCT00730691|594843114|FG003|Overall Study|Withdrawal of Consent|6|||
164677419|NCT00730691|594843115|FG004|Overall Study|Withdrawal of Consent|3|||
164424987|NCT01400893|593926601|FG001|Overall Study|Death|21|||
164677420|NCT00730691|594843111|FG000|Overall Study|Lost to Follow-up|11|||
164677421|NCT00730691|594843112|FG001|Overall Study|Lost to Follow-up|8|||
164677422|NCT00730691|594843113|FG002|Overall Study|Lost to Follow-up|13|||
164237937|NCT01978145|593244095|FG000|Treatment Period 2|Withdrawal by Subject|7|||
164237938|NCT01978145|593244096|FG001|Treatment Period 2|Withdrawal by Subject|4|||
164237939|NCT01978145|593244095|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
164237940|NCT01978145|593244096|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
164237941|NCT01173679|593244097|FG000|Overall Study|Death|1|||
164573255|NCT01287104|594463364|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
164573256|NCT01287104|594463365|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
164573257|NCT01287104|594463366|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
164573258|NCT01287104|594463363|FG000|Overall Study|Low donor chimerism|0|||
164573259|NCT01287104|594463364|FG001|Overall Study|Low donor chimerism|1|||
164573260|NCT01287104|594463365|FG002|Overall Study|Low donor chimerism|0|||
164573261|NCT01287104|594463366|FG003|Overall Study|Low donor chimerism|0|||
164573262|NCT01287104|594463363|FG000|Overall Study|NK cells did not meet release criteria|0|||
164573263|NCT01287104|594463364|FG001|Overall Study|NK cells did not meet release criteria|1|||
164573264|NCT01287104|594463365|FG002|Overall Study|NK cells did not meet release criteria|0|||
164573265|NCT01287104|594463366|FG003|Overall Study|NK cells did not meet release criteria|0|||
164573266|NCT00195650|594463373|FG000|Overall Study|Adverse Event|194|||
164573267|NCT00195650|594463373|FG000|Overall Study|Lack of Efficacy|99|||
164573268|NCT00195650|594463373|FG000|Overall Study|Withdrawal by Subject|67|||
164573269|NCT00195650|594463373|FG000|Overall Study|Lost to Follow-up|44|||
164573270|NCT00195650|594463373|FG000|Overall Study|Death|23|||
164573271|NCT00195650|594463373|FG000|Overall Study|Protocol Violation|15|||
164573272|NCT00195650|594463373|FG000|Overall Study|Administrative reasons|83|||
164573273|NCT00432809|594463374|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
164573274|NCT00432809|594463375|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
164573275|NCT00432809|594463376|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
164573276|NCT00432809|594463374|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
164573277|NCT00432809|594463375|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
164573278|NCT00432809|594463376|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
164573279|NCT01499290|594463377|FG000|Overall Study|Withdrawal by Subject|22|||
164573280|NCT01499290|594463378|FG001|Overall Study|Withdrawal by Subject|15|||
164573281|NCT01499290|594463377|FG000|Overall Study|Not specified in study report|11|||
164573282|NCT01499290|594463378|FG001|Overall Study|Not specified in study report|5|||
164573283|NCT01499290|594463377|FG000|Overall Study|Condition improved/subject recovered|1|||
164573284|NCT01499290|594463378|FG001|Overall Study|Condition improved/subject recovered|0|||
164573285|NCT01499290|594463377|FG000|Overall Study|Lack of Efficacy|7|||
164573286|NCT01499290|594463378|FG001|Overall Study|Lack of Efficacy|8|||
164573287|NCT01499290|594463377|FG000|Overall Study|Adverse Event|14|||
164573288|NCT01499290|594463378|FG001|Overall Study|Adverse Event|7|||
164573289|NCT03308188|594463379|FG000|Overall Study|Withdrawal by Subject|0|||
164573290|NCT03308188|594463380|FG001|Overall Study|Withdrawal by Subject|3|||
164573291|NCT03308188|594463379|FG000|Overall Study|Death|0|||
164573292|NCT03308188|594463380|FG001|Overall Study|Death|1|||
164573293|NCT01791855|594463381|FG000|Overall Study|Adverse Event|0|||
164573294|NCT01791855|594463382|FG001|Overall Study|Adverse Event|0|||
164573295|NCT01791855|594463383|FG002|Overall Study|Adverse Event|0|||
164573296|NCT01791855|594463384|FG003|Overall Study|Adverse Event|1|||
164573297|NCT01791855|594463381|FG000|Overall Study|Randomized, not treated|0|||
164573298|NCT01791855|594463382|FG001|Overall Study|Randomized, not treated|1|||
164573299|NCT01791855|594463383|FG002|Overall Study|Randomized, not treated|0|||
164573300|NCT01791855|594463384|FG003|Overall Study|Randomized, not treated|0|||
164573301|NCT00481065|594463385|FG000|Overall Study|Adverse event or death|1|||
164573302|NCT00481065|594463386|FG001|Overall Study|Adverse event or death|1|||
164573303|NCT00481065|594463387|FG002|Overall Study|Adverse event or death|3|||
164573304|NCT00481065|594463388|FG003|Overall Study|Adverse event or death|0|||
164573305|NCT00481065|594463389|FG004|Overall Study|Adverse event or death|2|||
164573306|NCT00481065|594463390|FG005|Overall Study|Adverse event or death|0|||
164573307|NCT00481065|594463391|FG006|Overall Study|Adverse event or death|1|||
164573308|NCT00481065|594463392|FG007|Overall Study|Adverse event or death|1|||
164573309|NCT00481065|594463385|FG000|Overall Study|Withdrawal by Subject|11|||
164573310|NCT00481065|594463386|FG001|Overall Study|Withdrawal by Subject|12|||
164573311|NCT00481065|594463387|FG002|Overall Study|Withdrawal by Subject|7|||
164573312|NCT00481065|594463388|FG003|Overall Study|Withdrawal by Subject|11|||
164573313|NCT00481065|594463389|FG004|Overall Study|Withdrawal by Subject|13|||
164573314|NCT00481065|594463390|FG005|Overall Study|Withdrawal by Subject|12|||
164573315|NCT00481065|594463391|FG006|Overall Study|Withdrawal by Subject|9|||
164573316|NCT00481065|594463392|FG007|Overall Study|Withdrawal by Subject|10|||
164573317|NCT00481065|594463385|FG000|Overall Study|Lost to Follow-up|4|||
164573318|NCT00481065|594463386|FG001|Overall Study|Lost to Follow-up|2|||
164573319|NCT00481065|594463387|FG002|Overall Study|Lost to Follow-up|4|||
164573320|NCT00481065|594463388|FG003|Overall Study|Lost to Follow-up|3|||
164573321|NCT00481065|594463389|FG004|Overall Study|Lost to Follow-up|3|||
164573322|NCT00481065|594463390|FG005|Overall Study|Lost to Follow-up|3|||
164573323|NCT00481065|594463391|FG006|Overall Study|Lost to Follow-up|2|||
164573324|NCT00481065|594463392|FG007|Overall Study|Lost to Follow-up|5|||
164573325|NCT00481065|594463385|FG000|Overall Study|Inappropriate enrollment|4|||
164677423|NCT00730691|594843114|FG003|Overall Study|Lost to Follow-up|15|||
164677424|NCT00730691|594843115|FG004|Overall Study|Lost to Follow-up|13|||
164677425|NCT00730691|594843111|FG000|Overall Study|Other|1|||
164677426|NCT00730691|594843112|FG001|Overall Study|Other|1|||
164677427|NCT00730691|594843113|FG002|Overall Study|Other|1|||
164677428|NCT00730691|594843114|FG003|Overall Study|Other|2|||
164677429|NCT00730691|594843115|FG004|Overall Study|Other|2|||
164677430|NCT01097577|594843116|FG000|Overall Study|Adverse Event|0|||
164677431|NCT01097577|594843117|FG001|Overall Study|Adverse Event|1|||
164677432|NCT02566850|594844799|FG000|Overall Study|Protocol Violation|1|||
164677433|NCT00682461|594844801|FG000|Overall Study|Adverse Event|5|||
164677434|NCT00682461|594844802|FG001|Overall Study|Adverse Event|7|||
164677435|NCT00682461|594844801|FG000|Overall Study|Lost to Follow-up|8|||
164677436|NCT00682461|594844802|FG001|Overall Study|Lost to Follow-up|5|||
164677437|NCT00682461|594844801|FG000|Overall Study|Withdrawal by Subject|12|||
164677438|NCT00682461|594844802|FG001|Overall Study|Withdrawal by Subject|19|||
164677439|NCT06298396|594844812|FG000|Default MAP|Protocol Violation|1|||
164677440|NCT01528696|594844815|FG000|Overall Study|See detailed description|18|||
164677441|NCT01528696|594844816|FG001|Overall Study|See detailed description|19|||
164677442|NCT01547286|594844820|FG000|Overall Study|Did not meet all eligibility criteria|1|||
164677443|NCT01547286|594844820|FG000|Overall Study|Physician Decision|1|||
164677444|NCT00836472|594844821|FG000|Washout|Adverse Event|1|||
164677445|NCT00836472|594844822|FG001|Washout|Adverse Event|2|||
164677446|NCT00836472|594844821|FG000|Washout|Withdrawal by Subject|1|||
164677447|NCT00836472|594844822|FG001|Washout|Withdrawal by Subject|1|||
164677448|NCT01695239|594844823|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
164677449|NCT01695239|594844824|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
164677450|NCT01695239|594844825|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
164677451|NCT01695239|594844826|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
164677452|NCT01695239|594844827|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
164677453|NCT01695239|594844828|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
164677454|NCT01695239|594844829|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
164677455|NCT01695239|594844830|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
164677456|NCT01695239|594844831|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
164335475|NCT02699697|593605977|FG000|Overall Study|Lost to Follow-up|2|||
164335476|NCT02699697|593605978|FG001|Overall Study|Lost to Follow-up|3|||
164335477|NCT02699697|593605977|FG000|Overall Study|Refused to follow up|1|||
164677457|NCT01695239|594844832|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
164677458|NCT01695239|594844833|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
164677459|NCT01695239|594844834|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
164677460|NCT01695239|594844835|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
164677461|NCT01695239|594844836|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
164677462|NCT01695239|594844823|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
164677463|NCT01695239|594844824|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
164335478|NCT02699697|593605978|FG001|Overall Study|Refused to follow up|1|||
164335479|NCT02699697|593605977|FG000|Overall Study|Entered hospice care|5|||
164677464|NCT01695239|594844825|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
164677465|NCT01695239|594844826|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
164677466|NCT01695239|594844827|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
164335480|NCT02699697|593605978|FG001|Overall Study|Entered hospice care|2|||
164335481|NCT02699697|593605977|FG000|Overall Study|Missing reason for discontinuation|6|||
164335482|NCT02699697|593605978|FG001|Overall Study|Missing reason for discontinuation|5|||
164335483|NCT02362035|593605979|FG000|Overall Study|Death|67|||
164335484|NCT02362035|593605979|FG000|Overall Study|Lost to Follow-up|3|||
164335485|NCT02362035|593605979|FG000|Overall Study|Adverse Event|1|||
164335486|NCT02362035|593605979|FG000|Overall Study|Physician Decision|1|||
164335487|NCT02362035|593605979|FG000|Overall Study|Subject started another cancer therapy|10|||
164335488|NCT02362035|593605979|FG000|Overall Study|Study terminated by sponsor|45|||
164335489|NCT02362035|593605979|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
164335490|NCT02362035|593605979|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
164335491|NCT02362035|593605979|FG000|Overall Study|Disease progression|11|||
164335492|NCT02362035|593605979|FG000|Overall Study|Withdrawal by Subject|20|||
164335493|NCT00004635|593605980|FG000|Period One|refused|2|||
164335494|NCT00004635|593605981|FG001|Period One|refused|1|||
164335495|NCT00004635|593605980|FG000|Period One|Withdrawal by Subject|1|||
164335496|NCT00004635|593605981|FG001|Period One|Withdrawal by Subject|1|||
164677467|NCT01695239|594844828|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
164677468|NCT01695239|594844829|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
164677469|NCT01695239|594844830|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
164677470|NCT01695239|594844831|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
164677471|NCT01695239|594844832|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
164677472|NCT01695239|594844833|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
164677473|NCT01695239|594844834|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
164677474|NCT01695239|594844835|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
164677475|NCT01695239|594844836|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
164677476|NCT01695239|594844823|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
164677477|NCT01695239|594844824|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164677478|NCT01695239|594844825|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
164677479|NCT01695239|594844826|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164677480|NCT01695239|594844827|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164677481|NCT01695239|594844828|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164677482|NCT01695239|594844829|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164677483|NCT01695239|594844830|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164677484|NCT01695239|594844831|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164677485|NCT01695239|594844832|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164677486|NCT01695239|594844833|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164677487|NCT01695239|594844834|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164677488|NCT01695239|594844835|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164677489|NCT01695239|594844836|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164677490|NCT01695239|594844823|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
164677491|NCT01695239|594844824|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
164677492|NCT01695239|594844825|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
164677493|NCT01695239|594844826|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164677494|NCT01695239|594844827|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164677495|NCT01695239|594844828|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164677496|NCT01695239|594844829|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164335497|NCT00004635|593605980|FG000|Period One|Protocol Violation|1|||
164335498|NCT00004635|593605981|FG001|Period One|Protocol Violation|0|||
164335499|NCT00004635|593605980|FG000|Period One|PSA did not go <5 ng/mL|1|||
164335500|NCT00004635|593605981|FG001|Period One|PSA did not go <5 ng/mL|0|||
164335501|NCT00004635|593605980|FG000|Period One|second malignancy|1|||
164335502|NCT00004635|593605981|FG001|Period One|second malignancy|0|||
164335503|NCT00004635|593605980|FG000|Period One|progressed|0|||
164335504|NCT00004635|593605981|FG001|Period One|progressed|2|||
164335505|NCT00004635|593605980|FG000|Period One|health problem|0|||
164335506|NCT00004635|593605981|FG001|Period One|health problem|1|||
164335507|NCT00004635|593605980|FG000|Period One|discrepancy in data entry|0|||
164335508|NCT00004635|593605981|FG001|Period One|discrepancy in data entry|1|||
164335509|NCT00004635|593605980|FG000|Period Two|progression|2|||
164335510|NCT00004635|593605981|FG001|Period Two|progression|3|||
164335511|NCT00004635|593605980|FG000|Period Two|Adverse Event|1|||
164335512|NCT00004635|593605981|FG001|Period Two|Adverse Event|0|||
164335513|NCT00004635|593605980|FG000|Period Two|refused|0|||
164335514|NCT00004635|593605981|FG001|Period Two|refused|2|||
164335515|NCT00004635|593605980|FG000|Period Two|health problem|1|||
164335516|NCT00004635|593605981|FG001|Period Two|health problem|1|||
164335517|NCT00004635|593605980|FG000|Period Two|travel issues|0|||
164335518|NCT00004635|593605981|FG001|Period Two|travel issues|1|||
164335519|NCT00004635|593605980|FG000|Period Two|secondary malignancy|1|||
164335520|NCT00004635|593605981|FG001|Period Two|secondary malignancy|1|||
164335521|NCT00004635|593605980|FG000|Period Two|Lost to Follow-up|1|||
164335522|NCT00004635|593605981|FG001|Period Two|Lost to Follow-up|0|||
164335523|NCT00004635|593605980|FG000|Period Two|discrepancy in data entry|0|||
164335524|NCT00004635|593605981|FG001|Period Two|discrepancy in data entry|1|||
164335525|NCT00354614|593605982|FG000|Overall Study|Lack of Efficacy|28|||
164335526|NCT00191906|593605983|FG000|Study Period II|Adverse Event|0|||
164335527|NCT00191906|593605984|FG001|Study Period II|Adverse Event|1|||
164335528|NCT00191906|593605985|FG002|Study Period II|Adverse Event|0|||
164335529|NCT00191906|593605986|FG003|Study Period II|Adverse Event|0|||
164335530|NCT00191906|593605983|FG000|Study Period II|Withdrawal by Subject|0|||
164335531|NCT00191906|593605984|FG001|Study Period II|Withdrawal by Subject|3|||
164335532|NCT00191906|593605985|FG002|Study Period II|Withdrawal by Subject|0|||
164335533|NCT00191906|593605986|FG003|Study Period II|Withdrawal by Subject|0|||
164335534|NCT00191906|593605983|FG000|Study Period II|Parent/Caregiver Decision|0|||
164424988|NCT01400893|593926600|FG000|Overall Study|Lost to Follow-up|0|||
164424989|NCT01400893|593926601|FG001|Overall Study|Lost to Follow-up|6|||
164677497|NCT01695239|594844830|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164335535|NCT00191906|593605984|FG001|Study Period II|Parent/Caregiver Decision|1|||
164335536|NCT00191906|593605985|FG002|Study Period II|Parent/Caregiver Decision|0|||
164335537|NCT00191906|593605986|FG003|Study Period II|Parent/Caregiver Decision|0|||
164335538|NCT00191906|593605983|FG000|Study Period II|Entry Criteria Exclusion|0|||
164335539|NCT00191906|593605984|FG001|Study Period II|Entry Criteria Exclusion|0|||
164335540|NCT00191906|593605985|FG002|Study Period II|Entry Criteria Exclusion|1|||
164335541|NCT00191906|593605986|FG003|Study Period II|Entry Criteria Exclusion|0|||
164335542|NCT00191906|593605983|FG000|Study Period III|Adverse Event|1|||
164424990|NCT00519636|593926602|FG000|Treatment Period 1|Adverse Event|1|||
164335543|NCT00191906|593605984|FG001|Study Period III|Adverse Event|0|||
164677498|NCT01695239|594844831|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164677499|NCT01695239|594844832|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164424991|NCT00519636|593926603|FG001|Treatment Period 1|Adverse Event|0|||
164424992|NCT00519636|593926604|FG002|Treatment Period 1|Adverse Event|1|||
164424993|NCT00519636|593926605|FG003|Treatment Period 1|Adverse Event|0|||
164424994|NCT00519636|593926602|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
164424995|NCT00519636|593926603|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
164424996|NCT00519636|593926604|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
164424997|NCT00519636|593926605|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
164424998|NCT00519636|593926602|FG000|Washout Period|Adverse Event|2|||
164424999|NCT00519636|593926603|FG001|Washout Period|Adverse Event|1|||
164425000|NCT00519636|593926604|FG002|Washout Period|Adverse Event|1|||
164425001|NCT00519636|593926605|FG003|Washout Period|Adverse Event|0|||
164425002|NCT00519636|593926602|FG000|Washout Period|Lost to Follow-up|1|||
164677500|NCT01695239|594844833|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164237942|NCT01250054|593244098|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
164237943|NCT01250054|593244099|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
164237944|NCT02026011|593244100|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
164677501|NCT01695239|594844834|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164677502|NCT01695239|594844835|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164677503|NCT01695239|594844836|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164677504|NCT01695239|594844823|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
164677505|NCT01695239|594844824|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
164677506|NCT01695239|594844825|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
164677507|NCT01695239|594844826|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
164677508|NCT01695239|594844827|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
164677509|NCT01695239|594844828|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
164677510|NCT01695239|594844829|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
164677511|NCT01695239|594844830|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
164677512|NCT01695239|594844831|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
164677513|NCT01695239|594844832|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
164237945|NCT02026011|593244101|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
164237946|NCT02026011|593244100|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
164237947|NCT02026011|593244101|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
164237948|NCT02026011|593244100|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
164237949|NCT02026011|593244101|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
164237950|NCT02026011|593244100|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
164677514|NCT01695239|594844833|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
164425003|NCT00519636|593926603|FG001|Washout Period|Lost to Follow-up|0|||
164425004|NCT00519636|593926604|FG002|Washout Period|Lost to Follow-up|0|||
164425005|NCT00519636|593926605|FG003|Washout Period|Lost to Follow-up|0|||
164677515|NCT01695239|594844834|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
164677516|NCT01695239|594844835|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
164677517|NCT01695239|594844836|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
164677518|NCT01695239|594844823|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
164677519|NCT01695239|594844824|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164677520|NCT01695239|594844825|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
164677521|NCT01695239|594844826|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164677522|NCT01695239|594844827|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164677523|NCT01695239|594844828|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164677524|NCT01695239|594844829|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164677525|NCT01695239|594844830|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164677526|NCT01695239|594844831|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164677527|NCT01695239|594844832|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164677528|NCT01695239|594844833|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164677529|NCT01695239|594844834|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164677530|NCT01695239|594844835|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164677531|NCT01695239|594844836|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164677532|NCT01695239|594844823|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
164677533|NCT01695239|594844824|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164677534|NCT01695239|594844825|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164677535|NCT01695239|594844826|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164677536|NCT01695239|594844827|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164677537|NCT01695239|594844828|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164425006|NCT00519636|593926602|FG000|Washout Period|Protocol Violation|0|||
164237951|NCT02026011|593244101|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
164237952|NCT01770743|593244102|FG000|Overall Study|Adverse Event|1|||
164237953|NCT01770743|593244103|FG001|Overall Study|Adverse Event|0|||
164425007|NCT00519636|593926603|FG001|Washout Period|Protocol Violation|0|||
164425008|NCT00519636|593926604|FG002|Washout Period|Protocol Violation|1|||
164335544|NCT00191906|593605985|FG002|Study Period III|Adverse Event|0|||
164335545|NCT00191906|593605986|FG003|Study Period III|Adverse Event|0|||
164335546|NCT00191906|593605983|FG000|Study Period III|Lost to Follow-up|0|||
164335547|NCT00191906|593605984|FG001|Study Period III|Lost to Follow-up|1|||
164335548|NCT00191906|593605985|FG002|Study Period III|Lost to Follow-up|0|||
164335549|NCT00191906|593605986|FG003|Study Period III|Lost to Follow-up|0|||
164335550|NCT00191906|593605983|FG000|Study Period III|Parent/Caregiver Decision|1|||
164335551|NCT00191906|593605984|FG001|Study Period III|Parent/Caregiver Decision|0|||
164335552|NCT00191906|593605985|FG002|Study Period III|Parent/Caregiver Decision|0|||
164335553|NCT00191906|593605986|FG003|Study Period III|Parent/Caregiver Decision|0|||
164335554|NCT00191906|593605983|FG000|Study Period III|Lack of Efficacy|3|||
164335555|NCT00191906|593605984|FG001|Study Period III|Lack of Efficacy|3|||
164335556|NCT00191906|593605985|FG002|Study Period III|Lack of Efficacy|0|||
164335557|NCT00191906|593605986|FG003|Study Period III|Lack of Efficacy|0|||
164335558|NCT00573937|593605987|FG000|Overall Study|Study Terminated|0|||
164335559|NCT00573937|593605988|FG001|Overall Study|Study Terminated|1|||
164335560|NCT01797731|593605994|FG000|Overall Study|Didn't have proper radiographs required|3|||
164335561|NCT01797731|593605995|FG001|Overall Study|Didn't have proper radiographs required|3|||
164335562|NCT01604408|593605996|FG000|Treatment Period 1|Protocol Violation|0|||
164335563|NCT01604408|593605997|FG001|Treatment Period 1|Protocol Violation|1|||
164335564|NCT01604408|593605996|FG000|Treatment Period 2|Withdrawal by Subject|1|||
164335565|NCT01604408|593605997|FG001|Treatment Period 2|Withdrawal by Subject|1|||
164335566|NCT01604408|593605996|FG000|Treatment Period 2|Protocol Violation|1|||
164335567|NCT01604408|593605997|FG001|Treatment Period 2|Protocol Violation|0|||
164335568|NCT01604408|593605996|FG000|Treatment Period 2|Adverse Event|0|||
164335569|NCT01604408|593605997|FG001|Treatment Period 2|Adverse Event|1|||
164335570|NCT01604408|593605996|FG000|Treatment Period 3|Protocol Violation|1|||
164335571|NCT01604408|593605997|FG001|Treatment Period 3|Protocol Violation|1|||
164335572|NCT01604408|593605996|FG000|Treatment Period 3|Adverse Event|0|||
164335573|NCT01604408|593605997|FG001|Treatment Period 3|Adverse Event|3|||
164335574|NCT01604408|593605996|FG000|Treatment Period 3|Withdrawal by Subject|3|||
164335575|NCT01604408|593605997|FG001|Treatment Period 3|Withdrawal by Subject|1|||
164335576|NCT01604408|593605996|FG000|Treatment Period 3|Sponsor Decision|1|||
164335577|NCT01604408|593605997|FG001|Treatment Period 3|Sponsor Decision|0|||
164335578|NCT01604408|593605996|FG000|Treatment Period 4|Death|1|||
164335579|NCT01604408|593605997|FG001|Treatment Period 4|Death|0|||
164335580|NCT01604408|593605996|FG000|Treatment Period 4|Withdrawal by Subject|2|||
164335581|NCT01604408|593605997|FG001|Treatment Period 4|Withdrawal by Subject|1|||
164335582|NCT01604408|593605996|FG000|Treatment Period 4|Adverse Event|0|||
164335583|NCT01604408|593605997|FG001|Treatment Period 4|Adverse Event|1|||
164335584|NCT01604408|593605996|FG000|Treatment Period 5|Adverse Event|4|||
164335585|NCT01604408|593605997|FG001|Treatment Period 5|Adverse Event|0|||
164335586|NCT01604408|593605996|FG000|Treatment Period 6|Lost to Follow-up|0|||
164335587|NCT01604408|593605997|FG001|Treatment Period 6|Lost to Follow-up|1|||
164335588|NCT01604408|593605996|FG000|Treatment Period 6|Adverse Event|2|||
164335589|NCT01604408|593605997|FG001|Treatment Period 6|Adverse Event|0|||
164335590|NCT01604408|593605996|FG000|Treatment Period 6|Sponsor decision|0|||
164335591|NCT01604408|593605997|FG001|Treatment Period 6|Sponsor decision|1|||
164335592|NCT01604408|593605996|FG000|Observation Period|Adverse Event|1|||
164335593|NCT01604408|593605997|FG001|Observation Period|Adverse Event|1|||
164335594|NCT01604408|593605996|FG000|Observation Period|Withdrawal by Subject|0|||
164335595|NCT01604408|593605997|FG001|Observation Period|Withdrawal by Subject|2|||
164335596|NCT00722423|593606003|FG000|Overall Study|Protocol Violation|0|||
164335597|NCT00722423|593606004|FG001|Overall Study|Protocol Violation|1|||
164335598|NCT01189604|593606006|FG000|Overall Study|Impossible to visit|0|||
164335599|NCT01189604|593606007|FG001|Overall Study|Impossible to visit|0|||
164335600|NCT01189604|593606008|FG002|Overall Study|Impossible to visit|0|||
164335601|NCT01189604|593606009|FG003|Overall Study|Impossible to visit|0|||
164425009|NCT00519636|593926605|FG003|Washout Period|Protocol Violation|2|||
164425010|NCT00519636|593926602|FG000|Washout Period|Withdrawal by Subject|1|||
164425011|NCT00519636|593926603|FG001|Washout Period|Withdrawal by Subject|0|||
164335602|NCT01189604|593606010|FG004|Overall Study|Impossible to visit|0|||
164335603|NCT01189604|593606011|FG005|Overall Study|Impossible to visit|1|||
164425012|NCT00519636|593926604|FG002|Washout Period|Withdrawal by Subject|1|||
164335604|NCT01189604|593606012|FG006|Overall Study|Impossible to visit|0|||
164335605|NCT01189604|593606006|FG000|Overall Study|Adverse Event|0|||
164335606|NCT01189604|593606007|FG001|Overall Study|Adverse Event|1|||
164335607|NCT01189604|593606008|FG002|Overall Study|Adverse Event|0|||
164335608|NCT01189604|593606009|FG003|Overall Study|Adverse Event|0|||
164335609|NCT01189604|593606010|FG004|Overall Study|Adverse Event|2|||
164335610|NCT01189604|593606011|FG005|Overall Study|Adverse Event|0|||
164335611|NCT01189604|593606012|FG006|Overall Study|Adverse Event|1|||
164335612|NCT01189604|593606006|FG000|Overall Study|Withdrawal by Subject|1|||
164335613|NCT01189604|593606007|FG001|Overall Study|Withdrawal by Subject|0|||
164335614|NCT01189604|593606008|FG002|Overall Study|Withdrawal by Subject|0|||
164335615|NCT01189604|593606009|FG003|Overall Study|Withdrawal by Subject|0|||
164335616|NCT01189604|593606010|FG004|Overall Study|Withdrawal by Subject|0|||
164335617|NCT01189604|593606011|FG005|Overall Study|Withdrawal by Subject|0|||
164237954|NCT01770743|593244104|FG002|Overall Study|Adverse Event|0|||
164237955|NCT01770743|593244105|FG003|Overall Study|Adverse Event|0|||
164237956|NCT01770743|593244106|FG004|Overall Study|Adverse Event|0|||
164237957|NCT01770743|593244102|FG000|Overall Study|Withdrawal by Subject|0|||
164237958|NCT01770743|593244103|FG001|Overall Study|Withdrawal by Subject|0|||
164237959|NCT01770743|593244104|FG002|Overall Study|Withdrawal by Subject|1|||
164237960|NCT01770743|593244105|FG003|Overall Study|Withdrawal by Subject|1|||
164237961|NCT01770743|593244106|FG004|Overall Study|Withdrawal by Subject|1|||
164237962|NCT01770743|593244102|FG000|Overall Study|Lost to Follow-up|0|||
164237963|NCT01770743|593244103|FG001|Overall Study|Lost to Follow-up|2|||
164237964|NCT01770743|593244104|FG002|Overall Study|Lost to Follow-up|0|||
164237965|NCT01770743|593244105|FG003|Overall Study|Lost to Follow-up|0|||
164237966|NCT01770743|593244106|FG004|Overall Study|Lost to Follow-up|1|||
164237967|NCT01770743|593244102|FG000|Overall Study|Sponsor Terminated Subject|1|||
164237968|NCT01770743|593244103|FG001|Overall Study|Sponsor Terminated Subject|0|||
164237969|NCT01770743|593244104|FG002|Overall Study|Sponsor Terminated Subject|0|||
164237970|NCT01770743|593244105|FG003|Overall Study|Sponsor Terminated Subject|1|||
164237971|NCT01770743|593244106|FG004|Overall Study|Sponsor Terminated Subject|0|||
164237972|NCT01770743|593244102|FG000|Overall Study|Moving Out of State|0|||
164237973|NCT01770743|593244103|FG001|Overall Study|Moving Out of State|1|||
164237974|NCT01770743|593244104|FG002|Overall Study|Moving Out of State|0|||
164237975|NCT01770743|593244105|FG003|Overall Study|Moving Out of State|0|||
164573326|NCT00481065|594463386|FG001|Overall Study|Inappropriate enrollment|0|||
164237976|NCT01770743|593244106|FG004|Overall Study|Moving Out of State|0|||
164237977|NCT00755807|593244111|FG000|Acute Phase|Adverse Event|16|||
164237978|NCT00755807|593244112|FG001|Acute Phase|Adverse Event|5|||
164237979|NCT00755807|593244111|FG000|Acute Phase|Protocol Violation|1|||
164237980|NCT00755807|593244112|FG001|Acute Phase|Protocol Violation|3|||
164237981|NCT00755807|593244111|FG000|Acute Phase|Withdrawal by Subject|1|||
164237982|NCT00755807|593244112|FG001|Acute Phase|Withdrawal by Subject|2|||
164335618|NCT01189604|593606012|FG006|Overall Study|Withdrawal by Subject|0|||
164335619|NCT03945214|593606013|FG000|Overall Study|Lost to Follow-up|3|||
164335620|NCT03945214|593606014|FG001|Overall Study|Lost to Follow-up|4|||
164335621|NCT03945214|593606015|FG002|Overall Study|Lost to Follow-up|7|||
164335622|NCT03945214|593606016|FG003|Overall Study|Lost to Follow-up|4|||
164335623|NCT04102098|593606022|FG000|Main Study Period|Ongoing in study|302|||
164335624|NCT04102098|593606023|FG001|Main Study Period|Ongoing in study|291|||
164335625|NCT04102098|593606022|FG000|Main Study Period|Death|20|||
164335626|NCT04102098|593606023|FG001|Main Study Period|Death|27|||
164335627|NCT04102098|593606022|FG000|Main Study Period|Lost to Follow-up|1|||
164335628|NCT04102098|593606023|FG001|Main Study Period|Lost to Follow-up|1|||
164335629|NCT04102098|593606022|FG000|Main Study Period|Physician Decision|0|||
164335630|NCT04102098|593606023|FG001|Main Study Period|Physician Decision|1|||
164335631|NCT04102098|593606022|FG000|Main Study Period|Withdrawal by Subject|11|||
164335632|NCT04102098|593606023|FG001|Main Study Period|Withdrawal by Subject|14|||
164335633|NCT04102098|593606022|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
164335634|NCT04102098|593606023|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
164335635|NCT04102098|593606022|FG000|Crossover: AS Who Crossed Over|Death|11|||
164335636|NCT04102098|593606023|FG001|Crossover: AS Who Crossed Over|Death|0|||
164573327|NCT00481065|594463387|FG002|Overall Study|Inappropriate enrollment|2|||
164573328|NCT00481065|594463388|FG003|Overall Study|Inappropriate enrollment|0|||
164573329|NCT00481065|594463389|FG004|Overall Study|Inappropriate enrollment|2|||
164573330|NCT00481065|594463390|FG005|Overall Study|Inappropriate enrollment|1|||
164573331|NCT00481065|594463391|FG006|Overall Study|Inappropriate enrollment|0|||
164573332|NCT00481065|594463392|FG007|Overall Study|Inappropriate enrollment|1|||
164573333|NCT00481065|594463385|FG000|Overall Study|Administrative reason|0|||
164573334|NCT00481065|594463386|FG001|Overall Study|Administrative reason|0|||
164573335|NCT00481065|594463387|FG002|Overall Study|Administrative reason|0|||
164573336|NCT00481065|594463388|FG003|Overall Study|Administrative reason|0|||
164573337|NCT00481065|594463389|FG004|Overall Study|Administrative reason|0|||
164573338|NCT00481065|594463390|FG005|Overall Study|Administrative reason|2|||
164573339|NCT00481065|594463391|FG006|Overall Study|Administrative reason|1|||
164573340|NCT00481065|594463392|FG007|Overall Study|Administrative reason|0|||
164573341|NCT00481065|594463385|FG000|Overall Study|Protocol Violation|2|||
164573342|NCT00481065|594463386|FG001|Overall Study|Protocol Violation|1|||
164573343|NCT00481065|594463387|FG002|Overall Study|Protocol Violation|1|||
164573344|NCT00481065|594463388|FG003|Overall Study|Protocol Violation|1|||
164573345|NCT00481065|594463389|FG004|Overall Study|Protocol Violation|2|||
164573346|NCT00481065|594463390|FG005|Overall Study|Protocol Violation|6|||
164573347|NCT00481065|594463391|FG006|Overall Study|Protocol Violation|3|||
164573348|NCT00481065|594463392|FG007|Overall Study|Protocol Violation|2|||
164573349|NCT00481065|594463385|FG000|Overall Study|Unable to classify|0|||
164573350|NCT00481065|594463386|FG001|Overall Study|Unable to classify|1|||
164573351|NCT00481065|594463387|FG002|Overall Study|Unable to classify|2|||
164573352|NCT00481065|594463388|FG003|Overall Study|Unable to classify|0|||
164573353|NCT00481065|594463389|FG004|Overall Study|Unable to classify|1|||
164573354|NCT00481065|594463390|FG005|Overall Study|Unable to classify|0|||
164573355|NCT00481065|594463391|FG006|Overall Study|Unable to classify|0|||
164237983|NCT00755807|593244111|FG000|Acute Phase|Lack of Efficacy|0|||
164237984|NCT00755807|593244112|FG001|Acute Phase|Lack of Efficacy|1|||
164237985|NCT00755807|593244111|FG000|Acute Phase|Physician Decision|0|||
164237986|NCT00755807|593244112|FG001|Acute Phase|Physician Decision|1|||
164237987|NCT00755807|593244111|FG000|Open-label Extension Phase|Adverse Event|7|||
164237988|NCT00755807|593244112|FG001|Open-label Extension Phase|Adverse Event|7|||
164237989|NCT00755807|593244111|FG000|Open-label Extension Phase|Protocol Violation|5|||
164237990|NCT00755807|593244112|FG001|Open-label Extension Phase|Protocol Violation|2|||
164237991|NCT00755807|593244111|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
164237992|NCT00755807|593244112|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
164237993|NCT00755807|593244111|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
164237994|NCT00755807|593244112|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
164237995|NCT00755807|593244111|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
164237996|NCT00755807|593244112|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
164237997|NCT00755807|593244111|FG000|Open-label Extension Phase|Sponsor Decision|0|||
164237998|NCT00755807|593244112|FG001|Open-label Extension Phase|Sponsor Decision|1|||
164237999|NCT00939107|593244113|FG000|Overall Study|Lost to Follow-up|14|||
164238000|NCT00939107|593244114|FG001|Overall Study|Lost to Follow-up|12|||
164238001|NCT05010070|593244115|FG000|Overall Study|Lost to Follow-up|1|||
164238002|NCT05010070|593244115|FG000|Overall Study|Withdrawal by Subject|1|||
164677538|NCT01695239|594844829|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164677539|NCT01695239|594844830|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164677540|NCT01695239|594844831|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164677541|NCT01695239|594844832|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164677542|NCT01695239|594844833|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164677543|NCT01695239|594844834|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164677544|NCT01695239|594844835|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164677545|NCT01695239|594844836|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164677546|NCT01695239|594844823|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164677547|NCT01695239|594844824|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164677548|NCT01695239|594844825|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164677549|NCT01695239|594844826|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164677550|NCT01695239|594844827|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164677551|NCT01695239|594844828|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164677552|NCT01695239|594844829|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164677553|NCT01695239|594844830|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
164677554|NCT01695239|594844831|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164677555|NCT01695239|594844832|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164677556|NCT01695239|594844833|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164677557|NCT01695239|594844834|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164677558|NCT01695239|594844835|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164677559|NCT01695239|594844836|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164677560|NCT01695239|594844823|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164677561|NCT01695239|594844824|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164677562|NCT01695239|594844825|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164677563|NCT01695239|594844826|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164677564|NCT01695239|594844827|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164677565|NCT01695239|594844828|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164677566|NCT01695239|594844829|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164677567|NCT01695239|594844830|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
164677568|NCT01695239|594844831|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164677569|NCT01695239|594844832|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164677570|NCT01695239|594844833|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164238003|NCT01585025|593244122|FG000|Overall Study|Withdrawal by Subject|0|||
164238004|NCT01585025|593244123|FG001|Overall Study|Withdrawal by Subject|3|||
164238005|NCT01585025|593244124|FG002|Overall Study|Withdrawal by Subject|4|||
164238006|NCT00503984|593244125|FG000|Overall Study|Protocol Violation|0|||
164238007|NCT00503984|593244126|FG001|Overall Study|Protocol Violation|1|||
164238008|NCT00503984|593244127|FG002|Overall Study|Protocol Violation|0|||
164238009|NCT00503984|593244128|FG003|Overall Study|Protocol Violation|0|||
164238010|NCT00503984|593244129|FG004|Overall Study|Protocol Violation|0|||
164238011|NCT00503984|593244130|FG005|Overall Study|Protocol Violation|0|||
164425013|NCT00519636|593926605|FG003|Washout Period|Withdrawal by Subject|0|||
164238012|NCT00503984|593244125|FG000|Overall Study|Adverse Event|0|||
164238013|NCT00503984|593244126|FG001|Overall Study|Adverse Event|1|||
164238014|NCT00503984|593244127|FG002|Overall Study|Adverse Event|0|||
164238015|NCT00503984|593244128|FG003|Overall Study|Adverse Event|0|||
164238016|NCT00503984|593244129|FG004|Overall Study|Adverse Event|0|||
164238017|NCT00503984|593244130|FG005|Overall Study|Adverse Event|0|||
164238018|NCT00503984|593244125|FG000|Overall Study|Death|0|||
164238019|NCT00503984|593244126|FG001|Overall Study|Death|0|||
164238020|NCT00503984|593244127|FG002|Overall Study|Death|0|||
164238021|NCT00503984|593244128|FG003|Overall Study|Death|0|||
164238022|NCT00503984|593244129|FG004|Overall Study|Death|1|||
164238023|NCT00503984|593244130|FG005|Overall Study|Death|0|||
164238024|NCT02122380|593244133|FG000|First Intervention (30 Days)|Adverse Event|1|||
164238025|NCT02122380|593244134|FG001|First Intervention (30 Days)|Adverse Event|0|||
164238026|NCT02122380|593244133|FG000|First Intervention (30 Days)|Physician Decision|0|||
164238027|NCT02122380|593244134|FG001|First Intervention (30 Days)|Physician Decision|1|||
164238028|NCT02122380|593244133|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
164238029|NCT02122380|593244134|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
164238030|NCT02122380|593244133|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
164238031|NCT02122380|593244134|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
164238032|NCT02122380|593244133|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
164238033|NCT02122380|593244134|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
164238034|NCT00441272|593244136|FG000|Overall Study|Study terminated prior to enrollment|25|||
164238035|NCT00441272|593244137|FG001|Overall Study|Study terminated prior to enrollment|25|||
164238036|NCT00427011|593244138|FG000|Overall Study|Adverse Event|10|||
164238037|NCT00427011|593244138|FG000|Overall Study|Withdrawal by Subject|1|||
164238038|NCT00427011|593244138|FG000|Overall Study|Lack of Efficacy|2|||
164238039|NCT00427011|593244138|FG000|Overall Study|Other|12|||
164238040|NCT00952705|593244139|FG000|Overall Study|Lost to Follow-up|24|||
164238041|NCT00952705|593244140|FG001|Overall Study|Lost to Follow-up|8|||
164238042|NCT00952705|593244141|FG002|Overall Study|Lost to Follow-up|9|||
164238043|NCT00952705|593244139|FG000|Overall Study|Withdrawal by Subject|2|||
164238044|NCT00952705|593244140|FG001|Overall Study|Withdrawal by Subject|1|||
164238045|NCT00952705|593244141|FG002|Overall Study|Withdrawal by Subject|1|||
164238046|NCT00952705|593244139|FG000|Overall Study|Death|2|||
164238047|NCT00952705|593244140|FG001|Overall Study|Death|0|||
164238048|NCT00952705|593244141|FG002|Overall Study|Death|0|||
164238049|NCT00952705|593244139|FG000|Overall Study|Incarcerated post dose|5|||
164238050|NCT00952705|593244140|FG001|Overall Study|Incarcerated post dose|0|||
164238051|NCT00952705|593244141|FG002|Overall Study|Incarcerated post dose|0|||
164238052|NCT00952705|593244139|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
164238053|NCT00952705|593244140|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
164238054|NCT00952705|593244141|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
164238055|NCT02921789|593244145|FG000|Overall Study|Adverse Event|0|||
164238056|NCT02921789|593244146|FG001|Overall Study|Adverse Event|1|||
164238057|NCT02921789|593244145|FG000|Overall Study|Lost to Follow-up|1|||
164238058|NCT02921789|593244146|FG001|Overall Study|Lost to Follow-up|0|||
164238059|NCT02921789|593244145|FG000|Overall Study|Protocol Deviation|2|||
164238060|NCT02921789|593244146|FG001|Overall Study|Protocol Deviation|0|||
164238061|NCT02921789|593244145|FG000|Overall Study|Withdrawal by Subject|2|||
164238062|NCT02921789|593244146|FG001|Overall Study|Withdrawal by Subject|1|||
164238063|NCT02921789|593244145|FG000|Overall Study|Miscellaneous|3|||
164238064|NCT02921789|593244146|FG001|Overall Study|Miscellaneous|2|||
164238065|NCT01944020|593244147|FG000|Overall Study|Withdrawal by Subject|5|||
164238066|NCT01944020|593244148|FG001|Overall Study|Withdrawal by Subject|0|||
164238067|NCT01192126|593244149|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
164238068|NCT01192126|593244150|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
164238069|NCT01192126|593244149|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
164238070|NCT01192126|593244150|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
164238071|NCT01669902|593244151|FG000|Overall Study|Adverse Event|11|||
164238072|NCT01669902|593244151|FG000|Overall Study|Lack of Efficacy|10|||
164238073|NCT01669902|593244151|FG000|Overall Study|Other|8|||
164238074|NCT02391311|593244154|FG000|Overall Study|Lost to Follow-up|2|||
164238075|NCT02391311|593244155|FG001|Overall Study|Lost to Follow-up|1|||
164238076|NCT02391311|593244154|FG000|Overall Study|deemed ineligible after baseline|1|||
164238077|NCT02391311|593244155|FG001|Overall Study|deemed ineligible after baseline|1|||
164238078|NCT00688467|593244158|FG000|Treatment Period 1|Adverse Event|2|||
164238079|NCT00688467|593244159|FG001|Treatment Period 1|Adverse Event|1|||
164238080|NCT00688467|593244158|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
164238081|NCT00688467|593244159|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
164238082|NCT00688467|593244158|FG000|Treatment Period 2|Protocol Violation|0|||
164238083|NCT00688467|593244159|FG001|Treatment Period 2|Protocol Violation|1|||
164238084|NCT00688467|593244158|FG000|Treatment Period 2|Adverse Event|0|||
164238085|NCT00688467|593244159|FG001|Treatment Period 2|Adverse Event|1|||
164238086|NCT02808897|593244160|FG000|Overall Study|Lost to Follow-up|9|||
164238087|NCT02808897|593244161|FG001|Overall Study|Lost to Follow-up|11|||
164238088|NCT00305448|593244162|FG000|Overall Study|Protocol Violation|0|||
164238089|NCT00305448|593244163|FG001|Overall Study|Protocol Violation|1|||
164238090|NCT00305448|593244164|FG002|Overall Study|Protocol Violation|0|||
164238091|NCT00305448|593244162|FG000|Overall Study|Withdrawal by Subject|2|||
164238092|NCT00305448|593244163|FG001|Overall Study|Withdrawal by Subject|0|||
164238093|NCT00305448|593244164|FG002|Overall Study|Withdrawal by Subject|1|||
164238094|NCT00305448|593244162|FG000|Overall Study|Adverse Event|1|||
164238095|NCT00305448|593244163|FG001|Overall Study|Adverse Event|0|||
164238096|NCT00305448|593244164|FG002|Overall Study|Adverse Event|1|||
164238097|NCT00305448|593244162|FG000|Overall Study|Disease Progression|27|||
164238098|NCT00305448|593244163|FG001|Overall Study|Disease Progression|31|||
164238099|NCT00305448|593244164|FG002|Overall Study|Disease Progression|28|||
164238100|NCT00305448|593244162|FG000|Overall Study|Subjective Disease Progression|1|||
164238101|NCT00305448|593244163|FG001|Overall Study|Subjective Disease Progression|2|||
164238102|NCT00305448|593244164|FG002|Overall Study|Subjective Disease Progression|2|||
164238103|NCT00305448|593244162|FG000|Overall Study|Tumor Marker Elevation|0|||
164238104|NCT00305448|593244163|FG001|Overall Study|Tumor Marker Elevation|0|||
164238105|NCT00305448|593244164|FG002|Overall Study|Tumor Marker Elevation|1|||
164238106|NCT00002766|593244165|FG000|Overall Study|Withdrawal by Subject|0|||
164238107|NCT00002766|593244166|FG001|Overall Study|Withdrawal by Subject|1|||
164238108|NCT00002766|593244165|FG000|Overall Study|Patient Not Treated|1|||
164238109|NCT00002766|593244166|FG001|Overall Study|Patient Not Treated|2|||
164238110|NCT00002766|593244165|FG000|Overall Study|Adverse Event|1|||
164238111|NCT00002766|593244166|FG001|Overall Study|Adverse Event|1|||
164238112|NCT00002766|593244165|FG000|Overall Study|Protocol Violation|1|||
164238113|NCT00002766|593244166|FG001|Overall Study|Protocol Violation|0|||
164238114|NCT00387088|593244177|FG000|Overall Study|Adverse Event|143|||
164238115|NCT00387088|593244178|FG001|Overall Study|Adverse Event|156|||
164238116|NCT00387088|593244177|FG000|Overall Study|Protocol Violation|47|||
164238117|NCT00387088|593244178|FG001|Overall Study|Protocol Violation|35|||
164238118|NCT00387088|593244177|FG000|Overall Study|Withdrawal by Subject|20|||
164238119|NCT00387088|593244178|FG001|Overall Study|Withdrawal by Subject|35|||
164238120|NCT00387088|593244177|FG000|Overall Study|Lack of Efficacy|28|||
164238121|NCT00387088|593244178|FG001|Overall Study|Lack of Efficacy|67|||
164238122|NCT00387088|593244177|FG000|Overall Study|Lost to Follow-up|22|||
164238123|NCT00387088|593244178|FG001|Overall Study|Lost to Follow-up|28|||
164238124|NCT00387088|593244177|FG000|Overall Study|Other|58|||
164238125|NCT00387088|593244178|FG001|Overall Study|Other|52|||
164238126|NCT04108273|593244179|FG000|Overall Study|COVID Pandemic|1|||
164238127|NCT04108273|593244180|FG001|Overall Study|COVID Pandemic|0|||
164238128|NCT02441218|593244181|FG000|Overall Study|Death|503|||
164238129|NCT02441218|593244182|FG001|Overall Study|Death|553|||
164238130|NCT02441218|593244181|FG000|Overall Study|Withdrawal by Subject|73|||
164238131|NCT02441218|593244182|FG001|Overall Study|Withdrawal by Subject|58|||
164238132|NCT02441218|593244181|FG000|Overall Study|Lost to Follow-up|2|||
164238133|NCT02441218|593244182|FG001|Overall Study|Lost to Follow-up|1|||
164238134|NCT01541371|593244183|FG000|Overall Study|Withdrawal by Subject|14|||
164238135|NCT01541371|593244183|FG000|Overall Study|Lost to Follow-up|21|||
164238136|NCT01541371|593244183|FG000|Overall Study|Adverse Event|15|||
164238137|NCT01541371|593244183|FG000|Overall Study|Lack of Efficacy|12|||
164238138|NCT01541371|593244183|FG000|Overall Study|Protocol Violation|6|||
164238139|NCT01541371|593244183|FG000|Overall Study|Study medication non-compliance|3|||
164238140|NCT01541371|593244183|FG000|Overall Study|Other|6|||
164238141|NCT02154061|593244184|FG000|Overall Study|Pregnancy|1|||
164238142|NCT02154061|593244185|FG001|Overall Study|Pregnancy|0|||
164238143|NCT02154061|593244184|FG000|Overall Study|enrolled but not vaccinated|1|||
164238144|NCT02154061|593244185|FG001|Overall Study|enrolled but not vaccinated|0|||
164238145|NCT01936831|593244186|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
164238146|NCT01936831|593244187|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
164238147|NCT01936831|593244188|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
164238148|NCT01936831|593244189|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
164238149|NCT01936831|593244190|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
164238150|NCT01936831|593244191|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
164238151|NCT01936831|593244192|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
164238152|NCT01936831|593244193|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
164238153|NCT01936831|593244194|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
164238154|NCT01570387|593244200|FG000|Overall Study|Adverse Event|1|||
164238155|NCT01570387|593244201|FG001|Overall Study|Adverse Event|0|||
164425014|NCT00519636|593926602|FG000|Washout Period|Failed to meet continuation criteria|14|||
164425015|NCT00519636|593926603|FG001|Washout Period|Failed to meet continuation criteria|11|||
164238156|NCT01570387|593244202|FG002|Overall Study|Adverse Event|0|||
164238157|NCT01570387|593244203|FG003|Overall Study|Adverse Event|0|||
164238158|NCT01570387|593244200|FG000|Overall Study|Death|0|||
164238159|NCT01570387|593244201|FG001|Overall Study|Death|0|||
164238160|NCT01570387|593244202|FG002|Overall Study|Death|0|||
164238161|NCT01570387|593244203|FG003|Overall Study|Death|1|||
164238162|NCT01570387|593244200|FG000|Overall Study|Withdrawal by Subject|0|||
164238163|NCT01570387|593244201|FG001|Overall Study|Withdrawal by Subject|0|||
164238164|NCT01570387|593244202|FG002|Overall Study|Withdrawal by Subject|0|||
164238165|NCT01570387|593244203|FG003|Overall Study|Withdrawal by Subject|1|||
164238166|NCT01876381|593244204|FG000|Overall Study|Lack of Efficacy|5|||
164238167|NCT01876381|593244204|FG000|Overall Study|Physician Decision|1|||
164238168|NCT01876381|593244204|FG000|Overall Study|Withdrawal by Subject|1|||
164238169|NCT00523978|593244207|FG000|Overall Study|Withdrawal by Subject|3|||
164425016|NCT00519636|593926604|FG002|Washout Period|Failed to meet continuation criteria|9|||
164425017|NCT00519636|593926605|FG003|Washout Period|Failed to meet continuation criteria|3|||
164425018|NCT00519636|593926602|FG000|Washout Period|Out of pollen area > 48 hours|1|||
164425019|NCT00519636|593926603|FG001|Washout Period|Out of pollen area > 48 hours|0|||
164425020|NCT00519636|593926604|FG002|Washout Period|Out of pollen area > 48 hours|0|||
164425021|NCT00519636|593926605|FG003|Washout Period|Out of pollen area > 48 hours|0|||
164425022|NCT00519636|593926602|FG000|Washout Period|Participating in study at another site|1|||
164425023|NCT00519636|593926603|FG001|Washout Period|Participating in study at another site|0|||
164425024|NCT00519636|593926604|FG002|Washout Period|Participating in study at another site|0|||
164425025|NCT00519636|593926605|FG003|Washout Period|Participating in study at another site|0|||
164425026|NCT00519636|593926602|FG000|Washout Period|Non-compliant|0|||
164425027|NCT00519636|593926603|FG001|Washout Period|Non-compliant|1|||
164425028|NCT00519636|593926604|FG002|Washout Period|Non-compliant|0|||
164425029|NCT00519636|593926605|FG003|Washout Period|Non-compliant|0|||
164425030|NCT00519636|593926602|FG000|Washout Period|Per doctors request|0|||
164425031|NCT00519636|593926603|FG001|Washout Period|Per doctors request|1|||
164425032|NCT00519636|593926604|FG002|Washout Period|Per doctors request|0|||
164425033|NCT00519636|593926605|FG003|Washout Period|Per doctors request|0|||
164425034|NCT00519636|593926602|FG000|Washout Period|Subject randomized in error|0|||
164425035|NCT00519636|593926603|FG001|Washout Period|Subject randomized in error|0|||
164425036|NCT00519636|593926604|FG002|Washout Period|Subject randomized in error|1|||
164425037|NCT00519636|593926605|FG003|Washout Period|Subject randomized in error|0|||
164425038|NCT00519636|593926602|FG000|Washout Period|Prohibited medications|0|||
164425039|NCT00519636|593926603|FG001|Washout Period|Prohibited medications|0|||
164425040|NCT00519636|593926604|FG002|Washout Period|Prohibited medications|1|||
164425041|NCT00519636|593926605|FG003|Washout Period|Prohibited medications|0|||
164425042|NCT00519636|593926602|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
164425043|NCT00519636|593926603|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
164425044|NCT00519636|593926604|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
164425045|NCT00519636|593926605|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
164425046|NCT00519636|593926602|FG000|Treatment Period 2|Subject randomized in error|0|||
164425047|NCT00519636|593926603|FG001|Treatment Period 2|Subject randomized in error|1|||
164425048|NCT00519636|593926604|FG002|Treatment Period 2|Subject randomized in error|0|||
164425049|NCT00519636|593926605|FG003|Treatment Period 2|Subject randomized in error|0|||
164425050|NCT00519636|593926602|FG000|Treatment Period 2|Per doctors request|0|||
164425051|NCT00519636|593926603|FG001|Treatment Period 2|Per doctors request|0|||
164425052|NCT00519636|593926604|FG002|Treatment Period 2|Per doctors request|1|||
164425053|NCT00519636|593926605|FG003|Treatment Period 2|Per doctors request|0|||
164425054|NCT00519636|593926602|FG000|Treatment Period 2|Subject misrandomized|0|||
164425055|NCT00519636|593926603|FG001|Treatment Period 2|Subject misrandomized|0|||
164425056|NCT00519636|593926604|FG002|Treatment Period 2|Subject misrandomized|0|||
164425057|NCT00519636|593926605|FG003|Treatment Period 2|Subject misrandomized|1|||
164425058|NCT00519636|593926602|FG000|Post Study Period|Subject randomized in error|0|||
164425059|NCT00519636|593926603|FG001|Post Study Period|Subject randomized in error|0|||
164425060|NCT00519636|593926604|FG002|Post Study Period|Subject randomized in error|0|||
164425061|NCT00519636|593926605|FG003|Post Study Period|Subject randomized in error|1|||
164425062|NCT03077620|593926611|FG000|Overall Study|Unable to place lumbar catheter|1|||
164425063|NCT03077620|593926612|FG001|Overall Study|Unable to place lumbar catheter|0|||
164425064|NCT03077620|593926613|FG002|Overall Study|Unable to place lumbar catheter|1|||
164425065|NCT03077620|593926614|FG003|Overall Study|Unable to place lumbar catheter|0|||
164425066|NCT03077620|593926611|FG000|Overall Study|Withdrawal by Subject|0|||
164425067|NCT03077620|593926612|FG001|Overall Study|Withdrawal by Subject|1|||
164425068|NCT03077620|593926613|FG002|Overall Study|Withdrawal by Subject|0|||
164425069|NCT03077620|593926614|FG003|Overall Study|Withdrawal by Subject|0|||
164425070|NCT03077620|593926611|FG000|Overall Study|Physician Decision|0|||
164425071|NCT03077620|593926612|FG001|Overall Study|Physician Decision|0|||
164425072|NCT03077620|593926613|FG002|Overall Study|Physician Decision|1|||
164425073|NCT03077620|593926614|FG003|Overall Study|Physician Decision|0|||
164425074|NCT00245011|593926616|FG000|Overall Study|Lack of Efficacy|1|||
164425075|NCT00550173|593926617|FG000|Overall Study|Death|45|||
164425076|NCT00550173|593926618|FG001|Overall Study|Death|38|||
164425077|NCT00550173|593926619|FG002|Overall Study|Death|50|||
164425078|NCT00550173|593926617|FG000|Overall Study|Physician Decision|1|||
164425079|NCT00550173|593926618|FG001|Overall Study|Physician Decision|2|||
164425080|NCT00550173|593926619|FG002|Overall Study|Physician Decision|2|||
164425081|NCT00550173|593926617|FG000|Overall Study|Withdrawal by Subject|9|||
164425082|NCT00550173|593926618|FG001|Overall Study|Withdrawal by Subject|12|||
164425083|NCT00550173|593926619|FG002|Overall Study|Withdrawal by Subject|17|||
164425084|NCT00550173|593926617|FG000|Overall Study|Sponsor Decision|13|||
164425085|NCT00550173|593926618|FG001|Overall Study|Sponsor Decision|7|||
164425086|NCT00550173|593926619|FG002|Overall Study|Sponsor Decision|1|||
164425087|NCT00550173|593926617|FG000|Overall Study|Lost to Follow-up|4|||
164425088|NCT00550173|593926618|FG001|Overall Study|Lost to Follow-up|4|||
164425089|NCT00550173|593926619|FG002|Overall Study|Lost to Follow-up|3|||
164425090|NCT00940017|593928374|FG000|Overall Study|did not meet entrance criteria|3|||
164425091|NCT00940017|593928374|FG000|Overall Study|Adverse Event|1|||
164238170|NCT00523978|593244208|FG001|Overall Study|Withdrawal by Subject|7|||
164238171|NCT00523978|593244207|FG000|Overall Study|Screen Failures|5|||
164238172|NCT00523978|593244208|FG001|Overall Study|Screen Failures|1|||
164238173|NCT00523978|593244207|FG000|Overall Study|Death|1|||
164238174|NCT00523978|593244208|FG001|Overall Study|Death|0|||
164238175|NCT02170064|593244209|FG000|Overall Study|Withdrawal by Subject|5|||
164238176|NCT02170064|593244210|FG001|Overall Study|Withdrawal by Subject|1|||
164238177|NCT02170064|593244211|FG002|Overall Study|Withdrawal by Subject|1|||
164238178|NCT02170064|593244209|FG000|Overall Study|Physician Decision|1|||
164238179|NCT02170064|593244210|FG001|Overall Study|Physician Decision|1|||
164238180|NCT02170064|593244211|FG002|Overall Study|Physician Decision|0|||
164238181|NCT01696643|593244216|FG000|Overall Study|Adverse Event|15|||
164238182|NCT01696643|593244217|FG001|Overall Study|Adverse Event|7|||
164238183|NCT01696643|593244216|FG000|Overall Study|Death|1|||
164238184|NCT01696643|593244217|FG001|Overall Study|Death|2|||
164238185|NCT01696643|593244216|FG000|Overall Study|Lack of Efficacy|3|||
164238186|NCT01696643|593244217|FG001|Overall Study|Lack of Efficacy|0|||
164238187|NCT01696643|593244216|FG000|Overall Study|Lost to Follow-up|67|||
164238188|NCT01696643|593244217|FG001|Overall Study|Lost to Follow-up|67|||
164238189|NCT01696643|593244216|FG000|Overall Study|Physician Decision|3|||
164238190|NCT01696643|593244217|FG001|Overall Study|Physician Decision|2|||
164238191|NCT01696643|593244216|FG000|Overall Study|Pregnancy|0|||
164238192|NCT01696643|593244217|FG001|Overall Study|Pregnancy|1|||
164238193|NCT01696643|593244216|FG000|Overall Study|Protocol Violation|7|||
164238194|NCT01696643|593244217|FG001|Overall Study|Protocol Violation|7|||
164238195|NCT01696643|593244216|FG000|Overall Study|Study Terminated by Sponsor|286|||
164238196|NCT01696643|593244217|FG001|Overall Study|Study Terminated by Sponsor|294|||
164238197|NCT01696643|593244216|FG000|Overall Study|Withdrawal by Subject|142|||
164238198|NCT01696643|593244217|FG001|Overall Study|Withdrawal by Subject|149|||
164238199|NCT01696643|593244216|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
164238200|NCT01696643|593244217|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
164238201|NCT01696643|593244216|FG000|Overall Study|Site Error|2|||
164238202|NCT01696643|593244217|FG001|Overall Study|Site Error|1|||
164238203|NCT01696643|593244216|FG000|Overall Study|Participant Incarcerated|0|||
164238204|NCT01696643|593244217|FG001|Overall Study|Participant Incarcerated|1|||
164238205|NCT01696643|593244216|FG000|Overall Study|Medical Monitor Decision|0|||
164238206|NCT01696643|593244217|FG001|Overall Study|Medical Monitor Decision|2|||
164238207|NCT01696643|593244216|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
164238208|NCT01696643|593244217|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
164238209|NCT01193101|593244221|FG000|Overall Study|Adverse Event|0|||
164238210|NCT01193101|593244222|FG001|Overall Study|Adverse Event|1|||
164238211|NCT01193101|593244223|FG002|Overall Study|Adverse Event|1|||
164238212|NCT01193101|593244224|FG003|Overall Study|Adverse Event|3|||
164238213|NCT01193101|593244221|FG000|Overall Study|Lack of Efficacy|3|||
164238214|NCT01193101|593244222|FG001|Overall Study|Lack of Efficacy|1|||
164238215|NCT01193101|593244223|FG002|Overall Study|Lack of Efficacy|0|||
164238216|NCT01193101|593244224|FG003|Overall Study|Lack of Efficacy|8|||
164238217|NCT01193101|593244221|FG000|Overall Study|Withdrawal by Subject|2|||
164238218|NCT01193101|593244222|FG001|Overall Study|Withdrawal by Subject|4|||
164238219|NCT01193101|593244223|FG002|Overall Study|Withdrawal by Subject|1|||
164335637|NCT04102098|593606022|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
164335638|NCT04102098|593606023|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
164335639|NCT03150173|593606026|FG000|Overall Study|Lost to Follow-up|13|||
164335640|NCT03150173|593606027|FG001|Overall Study|Lost to Follow-up|5|||
164335641|NCT01756053|593606029|FG000|Period 1 (10 Days)|Protocol Violation|1|||
164238220|NCT01193101|593244224|FG003|Overall Study|Withdrawal by Subject|1|||
164238221|NCT01193101|593244221|FG000|Overall Study|Administrative problems|0|||
164238222|NCT01193101|593244222|FG001|Overall Study|Administrative problems|0|||
164238223|NCT01193101|593244223|FG002|Overall Study|Administrative problems|1|||
164335642|NCT01756053|593606030|FG001|Period 1 (10 Days)|Protocol Violation|1|||
164335643|NCT01756053|593606029|FG000|Period 2 (10 Days)|Protocol Violation|0|||
164425092|NCT01345292|593928375|FG000|Overall Study|Withdrawal by Subject|2|||
164238224|NCT01193101|593244224|FG003|Overall Study|Administrative problems|0|||
164238225|NCT01193101|593244221|FG000|Overall Study|Abnormal test procedure results|0|||
164238226|NCT01193101|593244222|FG001|Overall Study|Abnormal test procedure results|1|||
164238227|NCT01193101|593244223|FG002|Overall Study|Abnormal test procedure results|0|||
164238228|NCT01193101|593244224|FG003|Overall Study|Abnormal test procedure results|0|||
164238229|NCT03508050|593244225|FG000|Overall Study|Pleural adhesions|1|||
164238230|NCT03508050|593244226|FG001|Overall Study|Pleural adhesions|0|||
164335644|NCT01756053|593606030|FG001|Period 2 (10 Days)|Protocol Violation|2|||
164238231|NCT03508050|593244225|FG000|Overall Study|Mucus plug|1|||
164238232|NCT03508050|593244226|FG001|Overall Study|Mucus plug|0|||
164238233|NCT03508050|593244225|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
164238234|NCT03508050|593244226|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
164238235|NCT03508050|593244225|FG000|Overall Study|Sustained desaturation|0|||
164238236|NCT03508050|593244226|FG001|Overall Study|Sustained desaturation|1|||
164238237|NCT04389866|593244227|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
164238238|NCT04389866|593244228|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
164238239|NCT00776789|593244231|FG000|Overall Study|Consent refusal|2|||
164425093|NCT01345292|593928376|FG001|Overall Study|Withdrawal by Subject|0|||
164425094|NCT01345292|593928377|FG002|Overall Study|Withdrawal by Subject|1|||
164238240|NCT00776789|593244232|FG001|Overall Study|Consent refusal|2|||
164238241|NCT00776789|593244231|FG000|Overall Study|Poor quality video|1|||
164238242|NCT00776789|593244232|FG001|Overall Study|Poor quality video|1|||
164425095|NCT05458102|593928381|FG000|Overall Study|Withdrew consent|2|||
164425096|NCT05458102|593928382|FG001|Overall Study|Withdrew consent|0|||
164425097|NCT05458102|593928381|FG000|Overall Study|Adverse Event|1|||
164425098|NCT05458102|593928382|FG001|Overall Study|Adverse Event|0|||
164425099|NCT05458102|593928381|FG000|Overall Study|Enrolled but never treated|1|||
164425100|NCT05458102|593928382|FG001|Overall Study|Enrolled but never treated|0|||
164425101|NCT05458102|593928381|FG000|Overall Study|Protocol Violation|1|||
164425102|NCT05458102|593928382|FG001|Overall Study|Protocol Violation|0|||
164425103|NCT00852475|593928387|FG000|Overall Study|Lost to Follow-up|3|||
164425104|NCT00852475|593928388|FG001|Overall Study|Lost to Follow-up|4|||
164425105|NCT02373813|593928389|FG000|Run-In Period|Other, Not Specified|5|||
164425106|NCT02373813|593928390|FG001|Run-In Period|Other, Not Specified|0|||
164238243|NCT00401843|593244233|FG000|Overall Study|Achieved Complete Response|1|||
164238244|NCT00401843|593244234|FG001|Overall Study|Achieved Complete Response|5|||
164238245|NCT00401843|593244235|FG002|Overall Study|Achieved Complete Response|11|||
164238246|NCT00401843|593244233|FG000|Overall Study|Adverse Event|7|||
164238247|NCT00401843|593244234|FG001|Overall Study|Adverse Event|26|||
164238248|NCT00401843|593244235|FG002|Overall Study|Adverse Event|27|||
164238249|NCT00401843|593244233|FG000|Overall Study|Death|0|||
164238250|NCT00401843|593244234|FG001|Overall Study|Death|8|||
164238251|NCT00401843|593244235|FG002|Overall Study|Death|10|||
164238252|NCT00401843|593244233|FG000|Overall Study|Disease progression|10|||
164238253|NCT00401843|593244234|FG001|Overall Study|Disease progression|60|||
164238254|NCT00401843|593244235|FG002|Overall Study|Disease progression|49|||
164238255|NCT00401843|593244233|FG000|Overall Study|End of Study|1|||
164238256|NCT00401843|593244234|FG001|Overall Study|End of Study|1|||
164238257|NCT00401843|593244235|FG002|Overall Study|End of Study|2|||
164425107|NCT02373813|593928391|FG002|Run-In Period|Other, Not Specified|0|||
164425108|NCT02373813|593928392|FG003|Run-In Period|Other, Not Specified|0|||
164425109|NCT02373813|593928389|FG000|Run-In Period|Withdrawal by Subject|16|||
164425110|NCT02373813|593928390|FG001|Run-In Period|Withdrawal by Subject|0|||
164425111|NCT02373813|593928391|FG002|Run-In Period|Withdrawal by Subject|0|||
164425112|NCT02373813|593928392|FG003|Run-In Period|Withdrawal by Subject|0|||
164425113|NCT02373813|593928389|FG000|Run-In Period|Decision by Sponsor|11|||
164425114|NCT02373813|593928390|FG001|Run-In Period|Decision by Sponsor|0|||
164425115|NCT02373813|593928391|FG002|Run-In Period|Decision by Sponsor|0|||
164425116|NCT02373813|593928392|FG003|Run-In Period|Decision by Sponsor|0|||
164238258|NCT00401843|593244233|FG000|Overall Study|Lost to Follow-up|0|||
164238259|NCT00401843|593244234|FG001|Overall Study|Lost to Follow-up|0|||
164238260|NCT00401843|593244235|FG002|Overall Study|Lost to Follow-up|2|||
164238261|NCT00401843|593244233|FG000|Overall Study|Other Unspecified|0|||
164238262|NCT00401843|593244234|FG001|Overall Study|Other Unspecified|3|||
164238263|NCT00401843|593244235|FG002|Overall Study|Other Unspecified|5|||
164238264|NCT00401843|593244233|FG000|Overall Study|Physician Decision|0|||
164238265|NCT00401843|593244234|FG001|Overall Study|Physician Decision|16|||
164238266|NCT00401843|593244235|FG002|Overall Study|Physician Decision|10|||
164238267|NCT00401843|593244233|FG000|Overall Study|Protocol Violation|0|||
164238268|NCT00401843|593244234|FG001|Overall Study|Protocol Violation|0|||
164238269|NCT00401843|593244235|FG002|Overall Study|Protocol Violation|1|||
164238270|NCT00401843|593244233|FG000|Overall Study|Withdrawal by Subject|1|||
164238271|NCT00401843|593244234|FG001|Overall Study|Withdrawal by Subject|5|||
164238272|NCT00401843|593244235|FG002|Overall Study|Withdrawal by Subject|5|||
164238273|NCT00401843|593244233|FG000|Overall Study|Withdrawal of consent to study agent|1|||
164238274|NCT00401843|593244234|FG001|Overall Study|Withdrawal of consent to study agent|15|||
164425117|NCT02373813|593928389|FG000|Run-In Period|Protocol Violation|75|||
164425118|NCT02373813|593928390|FG001|Run-In Period|Protocol Violation|0|||
164425119|NCT02373813|593928391|FG002|Run-In Period|Protocol Violation|0|||
164425120|NCT02373813|593928392|FG003|Run-In Period|Protocol Violation|0|||
164425121|NCT02373813|593928389|FG000|Run-In Period|Lost to Follow-up|2|||
164573356|NCT00481065|594463392|FG007|Overall Study|Unable to classify|0|||
164238275|NCT00401843|593244235|FG002|Overall Study|Withdrawal of consent to study agent|17|||
164238276|NCT00401843|593244233|FG000|Overall Study|Randomized but not Treated|0|||
164238277|NCT00401843|593244234|FG001|Overall Study|Randomized but not Treated|2|||
164425122|NCT02373813|593928390|FG001|Run-In Period|Lost to Follow-up|0|||
164425123|NCT02373813|593928391|FG002|Run-In Period|Lost to Follow-up|0|||
164573357|NCT01709331|594463393|FG000|Overall Study|Adverse Event|1|||
164238278|NCT00401843|593244235|FG002|Overall Study|Randomized but not Treated|3|||
164238279|NCT00401843|593244233|FG000|Overall Study|Received incorrect treatment|0|||
164425124|NCT02373813|593928392|FG003|Run-In Period|Lost to Follow-up|0|||
164238280|NCT00401843|593244234|FG001|Overall Study|Received incorrect treatment|3|||
164238281|NCT00401843|593244235|FG002|Overall Study|Received incorrect treatment|0|||
164425125|NCT02373813|593928389|FG000|Run-In Period|Adverse Event|3|||
164425126|NCT02373813|593928390|FG001|Run-In Period|Adverse Event|0|||
164425127|NCT02373813|593928391|FG002|Run-In Period|Adverse Event|0|||
164425128|NCT02373813|593928392|FG003|Run-In Period|Adverse Event|0|||
164425129|NCT02373813|593928389|FG000|Run-In Period|Noncompliance|1|||
164425130|NCT02373813|593928390|FG001|Run-In Period|Noncompliance|0|||
164238282|NCT01182298|593244238|FG000|Overall Study|Lack of Efficacy|4|||
164238283|NCT01182298|593244238|FG000|Overall Study|Withdrawal by Subject|2|||
164238284|NCT04881760|593244239|FG000|Overall Study|Adverse Event|0|||
164238285|NCT04881760|593244240|FG001|Overall Study|Adverse Event|1|||
164238286|NCT04881760|593244241|FG002|Overall Study|Adverse Event|1|||
164238287|NCT04881760|593244242|FG003|Overall Study|Adverse Event|0|||
164238288|NCT04881760|593244243|FG004|Overall Study|Adverse Event|1|||
164238289|NCT04881760|593244244|FG005|Overall Study|Adverse Event|1|||
164238290|NCT04881760|593244245|FG006|Overall Study|Adverse Event|2|||
164238291|NCT04881760|593244239|FG000|Overall Study|Death|0|||
164238292|NCT04881760|593244240|FG001|Overall Study|Death|0|||
164238293|NCT04881760|593244241|FG002|Overall Study|Death|0|||
164238294|NCT04881760|593244242|FG003|Overall Study|Death|1|||
164238295|NCT04881760|593244243|FG004|Overall Study|Death|0|||
164238296|NCT04881760|593244244|FG005|Overall Study|Death|0|||
164238297|NCT04881760|593244245|FG006|Overall Study|Death|0|||
164238298|NCT04881760|593244239|FG000|Overall Study|Lost to Follow-up|5|||
164238299|NCT04881760|593244240|FG001|Overall Study|Lost to Follow-up|7|||
164238300|NCT04881760|593244241|FG002|Overall Study|Lost to Follow-up|5|||
164238301|NCT04881760|593244242|FG003|Overall Study|Lost to Follow-up|1|||
164238302|NCT04881760|593244243|FG004|Overall Study|Lost to Follow-up|2|||
164238303|NCT04881760|593244244|FG005|Overall Study|Lost to Follow-up|4|||
164425131|NCT02373813|593928391|FG002|Run-In Period|Noncompliance|0|||
164425132|NCT02373813|593928392|FG003|Run-In Period|Noncompliance|0|||
164425133|NCT02373813|593928389|FG000|Run-In Period|Ineligibility Determined|3|||
164425134|NCT02373813|593928390|FG001|Run-In Period|Ineligibility Determined|0|||
164425135|NCT02373813|593928391|FG002|Run-In Period|Ineligibility Determined|0|||
164238304|NCT04881760|593244245|FG006|Overall Study|Lost to Follow-up|4|||
164238305|NCT04881760|593244239|FG000|Overall Study|Withdrawal by Subject|13|||
164238306|NCT04881760|593244240|FG001|Overall Study|Withdrawal by Subject|1|||
164238307|NCT04881760|593244241|FG002|Overall Study|Withdrawal by Subject|1|||
164238308|NCT04881760|593244242|FG003|Overall Study|Withdrawal by Subject|4|||
164238309|NCT04881760|593244243|FG004|Overall Study|Withdrawal by Subject|2|||
164238310|NCT04881760|593244244|FG005|Overall Study|Withdrawal by Subject|1|||
164238311|NCT04881760|593244245|FG006|Overall Study|Withdrawal by Subject|2|||
164238312|NCT04881760|593244239|FG000|Overall Study|Randomized but Never Treated|0|||
164238313|NCT04881760|593244240|FG001|Overall Study|Randomized but Never Treated|0|||
164238314|NCT04881760|593244241|FG002|Overall Study|Randomized but Never Treated|0|||
164238315|NCT04881760|593244242|FG003|Overall Study|Randomized but Never Treated|1|||
164238316|NCT04881760|593244243|FG004|Overall Study|Randomized but Never Treated|0|||
164238317|NCT04881760|593244244|FG005|Overall Study|Randomized but Never Treated|0|||
164238318|NCT04881760|593244245|FG006|Overall Study|Randomized but Never Treated|0|||
164238319|NCT04881760|593244239|FG000|Overall Study|Inadvertent Enrollment|2|||
164238320|NCT04881760|593244240|FG001|Overall Study|Inadvertent Enrollment|0|||
164238321|NCT04881760|593244241|FG002|Overall Study|Inadvertent Enrollment|0|||
164238322|NCT04881760|593244242|FG003|Overall Study|Inadvertent Enrollment|0|||
164238323|NCT04881760|593244243|FG004|Overall Study|Inadvertent Enrollment|0|||
164238324|NCT04881760|593244244|FG005|Overall Study|Inadvertent Enrollment|0|||
164238325|NCT04881760|593244245|FG006|Overall Study|Inadvertent Enrollment|0|||
164238326|NCT04881760|593244239|FG000|Overall Study|Site Closure|0|||
164238327|NCT04881760|593244240|FG001|Overall Study|Site Closure|0|||
164238328|NCT04881760|593244241|FG002|Overall Study|Site Closure|0|||
164238329|NCT04881760|593244242|FG003|Overall Study|Site Closure|1|||
164238330|NCT04881760|593244243|FG004|Overall Study|Site Closure|0|||
164238331|NCT04881760|593244244|FG005|Overall Study|Site Closure|0|||
164238332|NCT04881760|593244245|FG006|Overall Study|Site Closure|0|||
164238333|NCT01508910|593244246|FG000|Treatment|Death|2|||
164238334|NCT01508910|593244247|FG001|Treatment|Death|3|||
164238335|NCT01508910|593244248|FG002|Treatment|Death|2|||
164238336|NCT01508910|593244249|FG003|Treatment|Death|0|||
164238337|NCT01508910|593244246|FG000|Treatment|Lost to Follow-up|0|||
164238338|NCT01508910|593244247|FG001|Treatment|Lost to Follow-up|0|||
164238339|NCT01508910|593244248|FG002|Treatment|Lost to Follow-up|2|||
164238340|NCT01508910|593244249|FG003|Treatment|Lost to Follow-up|1|||
164238341|NCT01508910|593244246|FG000|Treatment|Withdrawal by Subject|0|||
164238342|NCT01508910|593244247|FG001|Treatment|Withdrawal by Subject|1|||
164238343|NCT01508910|593244248|FG002|Treatment|Withdrawal by Subject|6|||
164238344|NCT01508910|593244249|FG003|Treatment|Withdrawal by Subject|1|||
164238345|NCT01508910|593244246|FG000|Treatment|Sponsor Decision|0|||
164238346|NCT01508910|593244247|FG001|Treatment|Sponsor Decision|0|||
164238347|NCT01508910|593244248|FG002|Treatment|Sponsor Decision|0|||
164238348|NCT01508910|593244249|FG003|Treatment|Sponsor Decision|1|||
164238349|NCT01595529|593244250|FG000|Overall Study|Adverse Event|2|||
164238350|NCT01595529|593244251|FG001|Overall Study|Adverse Event|0|||
164238351|NCT01595529|593244250|FG000|Overall Study|Subject Non-Compliant|2|||
164238352|NCT01595529|593244251|FG001|Overall Study|Subject Non-Compliant|0|||
164238353|NCT01595529|593244250|FG000|Overall Study|Lost to Follow-up|8|||
164238354|NCT01595529|593244251|FG001|Overall Study|Lost to Follow-up|14|||
164238355|NCT01595529|593244250|FG000|Overall Study|Protocol Violation|1|||
164425136|NCT02373813|593928392|FG003|Run-In Period|Ineligibility Determined|0|||
164238356|NCT01595529|593244251|FG001|Overall Study|Protocol Violation|2|||
164238357|NCT01595529|593244250|FG000|Overall Study|Physician Decision|1|||
164238358|NCT01595529|593244251|FG001|Overall Study|Physician Decision|0|||
164238359|NCT01595529|593244250|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
164238360|NCT01595529|593244251|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
164238361|NCT01595529|593244250|FG000|Overall Study|Administrative Decision|1|||
164238362|NCT01595529|593244251|FG001|Overall Study|Administrative Decision|0|||
164238363|NCT01595529|593244250|FG000|Overall Study|Entry Failure/Screening Failure|6|||
164238364|NCT01595529|593244251|FG001|Overall Study|Entry Failure/Screening Failure|1|||
164238365|NCT04016714|593244252|FG000|Overall Study|Death|1|||
164238366|NCT04016714|593244253|FG001|Overall Study|Death|0|||
164238367|NCT04016714|593244252|FG000|Overall Study|Lost to Follow-up|3|||
164238368|NCT04016714|593244253|FG001|Overall Study|Lost to Follow-up|1|||
164238369|NCT04016714|593244252|FG000|Overall Study|Physician Decision|3|||
164238370|NCT04016714|593244253|FG001|Overall Study|Physician Decision|3|||
164238371|NCT04016714|593244252|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
164238372|NCT04016714|593244253|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
164238373|NCT01822665|593244254|FG000|Overall Study|Adverse Event|3|||
164238374|NCT01822665|593244254|FG000|Overall Study|Other Reason|5|||
164238375|NCT00867035|593244255|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
164238376|NCT00867035|593244256|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
164238377|NCT00867035|593244255|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
164238378|NCT00867035|593244256|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
164238379|NCT00542178|593244258|FG000|Overall Study|did not complete year 4 follow-up|75|||
164238380|NCT00542178|593244259|FG001|Overall Study|did not complete year 4 follow-up|80|||
164238381|NCT00542178|593244260|FG002|Overall Study|did not complete year 4 follow-up|74|||
164238382|NCT00542178|593244261|FG003|Overall Study|did not complete year 4 follow-up|62|||
164238383|NCT00542178|593244262|FG004|Overall Study|did not complete year 4 follow-up|64|||
164238384|NCT00542178|593244263|FG005|Overall Study|did not complete year 4 follow-up|89|||
164238385|NCT00542178|593244264|FG006|Overall Study|did not complete year 4 follow-up|87|||
164238386|NCT00542178|593244265|FG007|Overall Study|did not complete year 4 follow-up|85|||
164238387|NCT00829998|593244266|FG000|Washout|Adverse Event|0|||
164238388|NCT00829998|593244267|FG001|Washout|Adverse Event|1|||
164238389|NCT06164691|593246407|FG000|Overall Study|Withdrawal by Subject|2|||
164238390|NCT06164691|593246408|FG001|Overall Study|Withdrawal by Subject|0|||
164238391|NCT06164691|593246409|FG002|Overall Study|Withdrawal by Subject|0|||
164238392|NCT00812955|593246410|FG000|Overall Study|Adverse Event|7|||
164238393|NCT00812955|593246411|FG001|Overall Study|Adverse Event|6|||
164238394|NCT00812955|593246412|FG002|Overall Study|Adverse Event|3|||
164238395|NCT00812955|593246413|FG003|Overall Study|Adverse Event|4|||
164238396|NCT00812955|593246410|FG000|Overall Study|Lost to Follow-up|2|||
164238397|NCT00812955|593246411|FG001|Overall Study|Lost to Follow-up|1|||
164238398|NCT00812955|593246412|FG002|Overall Study|Lost to Follow-up|1|||
164238399|NCT00812955|593246413|FG003|Overall Study|Lost to Follow-up|2|||
164238400|NCT00812955|593246410|FG000|Overall Study|Withdrawal by Subject|1|||
164238401|NCT00812955|593246411|FG001|Overall Study|Withdrawal by Subject|0|||
164238402|NCT00812955|593246412|FG002|Overall Study|Withdrawal by Subject|1|||
164238403|NCT00812955|593246413|FG003|Overall Study|Withdrawal by Subject|2|||
164238404|NCT00812955|593246410|FG000|Overall Study|randomized in error|0|||
164238405|NCT00812955|593246411|FG001|Overall Study|randomized in error|0|||
164238406|NCT00812955|593246412|FG002|Overall Study|randomized in error|1|||
164238407|NCT00812955|593246413|FG003|Overall Study|randomized in error|0|||
164238408|NCT03046446|593246414|FG000|Overall Study|Lack of Efficacy|7|||
164238409|NCT03046446|593246414|FG000|Overall Study|Adverse Event|6|||
164238410|NCT03046446|593246414|FG000|Overall Study|Lost to Follow-up|3|||
164238411|NCT03046446|593246414|FG000|Overall Study|Withdrawal by Subject|14|||
164238412|NCT03046446|593246414|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
164238413|NCT03046446|593246414|FG000|Overall Study|Disease Progression (see caveats)|25|||
164238414|NCT03046446|593246414|FG000|Overall Study|Non OA related knee surgery|1|||
164335645|NCT03277690|593606031|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
164335646|NCT03277690|593606032|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
164335647|NCT03277690|593606031|FG000|Dose Titration and Maintenance|Physician Decision|1|||
164335648|NCT03277690|593606032|FG001|Dose Titration and Maintenance|Physician Decision|0|||
164335649|NCT03277690|593606031|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
164335650|NCT03277690|593606032|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
164335651|NCT03277690|593606031|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
164335652|NCT03277690|593606032|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
164238415|NCT03183063|593246415|FG000|Overall Study|Withdrawal by Subject|2|||
164238416|NCT03183063|593246416|FG001|Overall Study|Withdrawal by Subject|0|||
164238417|NCT03183063|593246417|FG002|Overall Study|Withdrawal by Subject|0|||
164238418|NCT03183063|593246415|FG000|Overall Study|Physician Decision|3|||
164238419|NCT03183063|593246416|FG001|Overall Study|Physician Decision|4|||
164238420|NCT03183063|593246417|FG002|Overall Study|Physician Decision|4|||
164238421|NCT00399568|593246418|FG000|Overall Study|Adverse Event|1|||
164238422|NCT00399568|593246419|FG001|Overall Study|Adverse Event|2|||
164238423|NCT00399568|593246418|FG000|Overall Study|Withdrawal by Subject|7|||
164238424|NCT00399568|593246419|FG001|Overall Study|Withdrawal by Subject|3|||
164238425|NCT00399568|593246418|FG000|Overall Study|Protocol non-compliance|2|||
164238426|NCT00399568|593246419|FG001|Overall Study|Protocol non-compliance|2|||
164238427|NCT00399568|593246418|FG000|Overall Study|Lost to Follow-up|2|||
164238428|NCT00399568|593246419|FG001|Overall Study|Lost to Follow-up|2|||
164238429|NCT00925002|593246420|FG000|Overall Study|Other|1|||
164238430|NCT00925002|593246421|FG001|Overall Study|Other|4|||
164238431|NCT00925002|593246422|FG002|Overall Study|Other|0|||
164238432|NCT00925002|593246420|FG000|Overall Study|Death|1|||
164238433|NCT00925002|593246421|FG001|Overall Study|Death|1|||
164238434|NCT00925002|593246422|FG002|Overall Study|Death|5|||
164238435|NCT00925002|593246420|FG000|Overall Study|Adverse Event|3|||
164238436|NCT00925002|593246421|FG001|Overall Study|Adverse Event|1|||
164238437|NCT00925002|593246422|FG002|Overall Study|Adverse Event|2|||
164238438|NCT00925002|593246420|FG000|Overall Study|Participant withdrew consent|1|||
164238439|NCT00925002|593246421|FG001|Overall Study|Participant withdrew consent|3|||
164238440|NCT00925002|593246422|FG002|Overall Study|Participant withdrew consent|3|||
164238441|NCT01343888|593246425|FG000|Overall Study|Adverse Event|12|||
164238442|NCT01343888|593246426|FG001|Overall Study|Adverse Event|22|||
164238443|NCT01343888|593246427|FG002|Overall Study|Adverse Event|5|||
164238444|NCT01343888|593246425|FG000|Overall Study|Lack of Efficacy|9|||
164238445|NCT01343888|593246426|FG001|Overall Study|Lack of Efficacy|9|||
164238446|NCT01343888|593246427|FG002|Overall Study|Lack of Efficacy|13|||
164238447|NCT01343888|593246425|FG000|Overall Study|Lost to Follow-up|0|||
164238448|NCT01343888|593246426|FG001|Overall Study|Lost to Follow-up|2|||
164238449|NCT01343888|593246427|FG002|Overall Study|Lost to Follow-up|1|||
164238450|NCT01343888|593246425|FG000|Overall Study|Protocol Violation|0|||
164238451|NCT01343888|593246426|FG001|Overall Study|Protocol Violation|2|||
164238452|NCT01343888|593246427|FG002|Overall Study|Protocol Violation|0|||
164238453|NCT01343888|593246425|FG000|Overall Study|Withdrawal by Subject|4|||
164238454|NCT01343888|593246426|FG001|Overall Study|Withdrawal by Subject|4|||
164238455|NCT01343888|593246427|FG002|Overall Study|Withdrawal by Subject|2|||
164238456|NCT01343888|593246425|FG000|Overall Study|other than stated above|0|||
164238457|NCT01343888|593246426|FG001|Overall Study|other than stated above|0|||
164238458|NCT01343888|593246427|FG002|Overall Study|other than stated above|1|||
164238459|NCT00558636|593246428|FG000|Treatment|Adverse Event|9|||
164238460|NCT00558636|593246429|FG001|Treatment|Adverse Event|2|||
164238461|NCT00558636|593246428|FG000|Treatment|Withdrawal by Subject|2|||
164238462|NCT00558636|593246429|FG001|Treatment|Withdrawal by Subject|0|||
164238463|NCT00558636|593246428|FG000|Treatment|Premature termination of the study|35|||
164238464|NCT00558636|593246429|FG001|Treatment|Premature termination of the study|37|||
164238465|NCT00558636|593246428|FG000|Treatment|Disease progression|1|||
164238466|NCT00558636|593246429|FG001|Treatment|Disease progression|5|||
164238467|NCT00558636|593246428|FG000|Follow-up|Premature termination of the study|12|||
164238468|NCT00558636|593246429|FG001|Follow-up|Premature termination of the study|7|||
164238469|NCT01990742|593246430|FG000|Overall Study|Withdrawal by facility|407|||
164238470|NCT01990742|593246431|FG001|Overall Study|Withdrawal by facility|1083|||
164238471|NCT01990742|593246430|FG000|Overall Study|Facility closed|0|||
164238472|NCT01990742|593246431|FG001|Overall Study|Facility closed|270|||
164238473|NCT00800735|593246432|FG000|Overall Study|Administrative/Other|2|||
164238474|NCT00800735|593246432|FG000|Overall Study|Insufficient Therapeutic Response|2|||
164238475|NCT00800735|593246432|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
164238476|NCT00800735|593246432|FG000|Overall Study|Withdrew Consent|3|||
164238477|NCT00506142|593246433|FG000|Overall Study|Adverse Event|8|||
164238478|NCT00506142|593246434|FG001|Overall Study|Adverse Event|7|||
164238479|NCT00506142|593246433|FG000|Overall Study|Lack of Efficacy|21|||
164238480|NCT00506142|593246434|FG001|Overall Study|Lack of Efficacy|7|||
164238481|NCT00506142|593246433|FG000|Overall Study|Withdrawal by Subject|4|||
164238482|NCT00506142|593246434|FG001|Overall Study|Withdrawal by Subject|5|||
164238483|NCT00506142|593246433|FG000|Overall Study|Physician Decision|1|||
164238484|NCT00506142|593246434|FG001|Overall Study|Physician Decision|0|||
164238485|NCT00506142|593246433|FG000|Overall Study|New health condition|1|||
164238486|NCT00506142|593246434|FG001|Overall Study|New health condition|0|||
164238487|NCT02133573|593246440|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
164238488|NCT02133573|593246441|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
164238489|NCT02133573|593246440|FG000|Overall Study|Child Deaths|3|||
164238490|NCT02133573|593246441|FG001|Overall Study|Child Deaths|5|||
164335653|NCT03277690|593606031|FG000|Dose Titration and Maintenance|Adverse Event|15|||
164335654|NCT03277690|593606032|FG001|Dose Titration and Maintenance|Adverse Event|0|||
164335655|NCT03277690|593606031|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
164335656|NCT03277690|593606032|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
164335657|NCT03277690|593606031|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
164238491|NCT02133573|593246440|FG000|Overall Study|Child Declined Follow Ups|2|||
164238492|NCT02133573|593246441|FG001|Overall Study|Child Declined Follow Ups|1|||
164238493|NCT02133573|593246440|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
164238494|NCT02133573|593246441|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
164238495|NCT03848416|593246453|FG000|Overall Study|Withdrawal by Subject|1|||
164238496|NCT03848416|593246454|FG001|Overall Study|Withdrawal by Subject|0|||
164238497|NCT03848416|593246455|FG002|Overall Study|Withdrawal by Subject|0|||
164238498|NCT03848416|593246453|FG000|Overall Study|Death|0|||
164238499|NCT03848416|593246454|FG001|Overall Study|Death|0|||
164238500|NCT03848416|593246455|FG002|Overall Study|Death|1|||
164238501|NCT02808429|593246456|FG000|Overall Study|Lost to Follow-up|1|||
164238502|NCT02808429|593246457|FG001|Overall Study|Lost to Follow-up|0|||
164238503|NCT02808429|593246458|FG002|Overall Study|Lost to Follow-up|0|||
164238504|NCT02808429|593246456|FG000|Overall Study|Protocol Violation|0|||
164238505|NCT02808429|593246457|FG001|Overall Study|Protocol Violation|1|||
164238506|NCT02808429|593246458|FG002|Overall Study|Protocol Violation|0|||
164238507|NCT02808429|593246456|FG000|Overall Study|Premature study termination by sponsor|2|||
164238508|NCT02808429|593246457|FG001|Overall Study|Premature study termination by sponsor|0|||
164238509|NCT02808429|593246458|FG002|Overall Study|Premature study termination by sponsor|1|||
164238510|NCT02808429|593246456|FG000|Overall Study|Relocation|0|||
164238511|NCT02808429|593246457|FG001|Overall Study|Relocation|0|||
164238512|NCT02808429|593246458|FG002|Overall Study|Relocation|1|||
164238513|NCT01436110|593246459|FG000|Overall Study|Lack of Efficacy|23|||
164238514|NCT01436110|593246460|FG001|Overall Study|Lack of Efficacy|14|||
164238515|NCT01436110|593246461|FG002|Overall Study|Lack of Efficacy|9|||
164238516|NCT01436110|593246459|FG000|Overall Study|Withdrawal by Subject|6|||
164238517|NCT01436110|593246460|FG001|Overall Study|Withdrawal by Subject|8|||
164238518|NCT01436110|593246461|FG002|Overall Study|Withdrawal by Subject|4|||
164238519|NCT01436110|593246459|FG000|Overall Study|Adverse Event|2|||
164238520|NCT01436110|593246460|FG001|Overall Study|Adverse Event|1|||
164238521|NCT01436110|593246461|FG002|Overall Study|Adverse Event|2|||
164238522|NCT01436110|593246459|FG000|Overall Study|Physician Decision|3|||
164238523|NCT01436110|593246460|FG001|Overall Study|Physician Decision|1|||
164238524|NCT01436110|593246461|FG002|Overall Study|Physician Decision|1|||
164238525|NCT01436110|593246459|FG000|Overall Study|Lost to Follow-up|1|||
164238526|NCT01436110|593246460|FG001|Overall Study|Lost to Follow-up|1|||
164238527|NCT01436110|593246461|FG002|Overall Study|Lost to Follow-up|3|||
164238528|NCT01436110|593246459|FG000|Overall Study|Protocol Violation|3|||
164238529|NCT01436110|593246460|FG001|Overall Study|Protocol Violation|1|||
164238530|NCT01436110|593246461|FG002|Overall Study|Protocol Violation|1|||
164238531|NCT01436110|593246459|FG000|Overall Study|Did Not Receive Trial Medication|1|||
164238532|NCT01436110|593246460|FG001|Overall Study|Did Not Receive Trial Medication|0|||
164238533|NCT01436110|593246461|FG002|Overall Study|Did Not Receive Trial Medication|3|||
164238534|NCT03273907|593246463|FG000|Overall Study|Death|1|||
164238535|NCT03273907|593246463|FG000|Overall Study|Lost to Follow-up|4|||
164238536|NCT03273907|593246463|FG000|Overall Study|Withdrawal by Subject|2|||
164238537|NCT03273907|593246463|FG000|Overall Study|COVID 19|2|||
164238538|NCT00110214|593246464|FG000|Overall Study|Never started treatment|21|||
164238539|NCT00110214|593246465|FG001|Overall Study|Never started treatment|20|||
164238540|NCT00110214|593246464|FG000|Overall Study|Disease progression or death|260|||
164238541|NCT00110214|593246465|FG001|Overall Study|Disease progression or death|151|||
164238542|NCT00110214|593246464|FG000|Overall Study|Adverse Event|115|||
164238543|NCT00110214|593246465|FG001|Overall Study|Adverse Event|192|||
164238544|NCT00110214|593246464|FG000|Overall Study|Refused further treatment|52|||
164238545|NCT00110214|593246465|FG001|Overall Study|Refused further treatment|65|||
164238546|NCT00110214|593246464|FG000|Overall Study|Other (not specified)|61|||
164238547|NCT00110214|593246465|FG001|Overall Study|Other (not specified)|75|||
164238548|NCT01088503|593246466|FG000|Overall Study|Withdrawal by Subject|118|||
164335658|NCT03277690|593606032|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
164335659|NCT03109847|593606033|FG000|Overall Study|Withdrawal by Subject|1|||
164335660|NCT03109847|593606034|FG001|Overall Study|Withdrawal by Subject|0|||
164335661|NCT02633501|593606035|FG000|Overall Study|Adverse Event|0|||
164335662|NCT02633501|593606036|FG001|Overall Study|Adverse Event|0|||
164335663|NCT02633501|593606037|FG002|Overall Study|Adverse Event|1|||
164335664|NCT02633501|593606038|FG003|Overall Study|Adverse Event|0|||
164573358|NCT00772447|594463394|FG000|Overall Study|Withdrawal by Subject|9|||
164238549|NCT01088503|593246467|FG001|Overall Study|Withdrawal by Subject|327|||
164238550|NCT01088503|593246468|FG002|Overall Study|Withdrawal by Subject|10|||
164238551|NCT01088503|593246466|FG000|Overall Study|Death|64|||
164238552|NCT01088503|593246467|FG001|Overall Study|Death|358|||
164238553|NCT01088503|593246468|FG002|Overall Study|Death|7|||
164238554|NCT01847092|593246469|FG000|Overall Study|Adverse Event|12|||
164238555|NCT01847092|593246470|FG001|Overall Study|Adverse Event|3|||
164238556|NCT01847092|593246469|FG000|Overall Study|Withdrawal by Subject|5|||
164238557|NCT01847092|593246470|FG001|Overall Study|Withdrawal by Subject|5|||
164238558|NCT01847092|593246469|FG000|Overall Study|Protocol Specified|8|||
164238559|NCT01847092|593246470|FG001|Overall Study|Protocol Specified|0|||
164238560|NCT01847092|593246469|FG000|Overall Study|Physician Decision|1|||
164335665|NCT02633501|593606039|FG004|Overall Study|Adverse Event|1|||
164238561|NCT01847092|593246470|FG001|Overall Study|Physician Decision|1|||
164238562|NCT01847092|593246469|FG000|Overall Study|Protocol Violation|0|||
164238563|NCT01847092|593246470|FG001|Overall Study|Protocol Violation|2|||
164238564|NCT01016067|593246471|FG000|Overall Study|Lost to Follow-up|1|||
164238565|NCT01016067|593246472|FG001|Overall Study|Lost to Follow-up|2|||
164238566|NCT01016067|593246471|FG000|Overall Study|Physician Decision|1|||
164238567|NCT01016067|593246472|FG001|Overall Study|Physician Decision|1|||
164238568|NCT01016067|593246471|FG000|Overall Study|Withdrew due to Relocation|0|||
164238569|NCT01016067|593246472|FG001|Overall Study|Withdrew due to Relocation|1|||
164238570|NCT01673646|593246475|FG000|Overall Study|Adverse Event|2|||
164238571|NCT01673646|593246476|FG001|Overall Study|Adverse Event|1|||
164238572|NCT01673646|593246477|FG002|Overall Study|Adverse Event|1|||
164238573|NCT01673646|593246475|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164238574|NCT01673646|593246476|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164238575|NCT01673646|593246477|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
164238576|NCT01673646|593246475|FG000|Overall Study|Condition no longer requires study drug|0|||
164238577|NCT01673646|593246476|FG001|Overall Study|Condition no longer requires study drug|1|||
164238578|NCT01673646|593246477|FG002|Overall Study|Condition no longer requires study drug|0|||
164238579|NCT01673646|593246475|FG000|Overall Study|Withdrawal by Subject|0|||
164238580|NCT01673646|593246476|FG001|Overall Study|Withdrawal by Subject|2|||
164238581|NCT01673646|593246477|FG002|Overall Study|Withdrawal by Subject|2|||
164238582|NCT01673646|593246475|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
164238583|NCT01673646|593246476|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
164238584|NCT01673646|593246477|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
164238585|NCT01000506|593246478|FG000|Overall Study|Adverse Event|6|||
164238586|NCT01000506|593246479|FG001|Overall Study|Adverse Event|5|||
164238587|NCT01000506|593246480|FG002|Overall Study|Adverse Event|8|||
164238588|NCT01000506|593246481|FG003|Overall Study|Adverse Event|9|||
164238589|NCT01000506|593246478|FG000|Overall Study|Lack of Efficacy|8|||
164238590|NCT01000506|593246479|FG001|Overall Study|Lack of Efficacy|6|||
164238591|NCT01000506|593246480|FG002|Overall Study|Lack of Efficacy|4|||
164238592|NCT01000506|593246481|FG003|Overall Study|Lack of Efficacy|4|||
164238593|NCT01000506|593246478|FG000|Overall Study|Protocol Violation|1|||
164238594|NCT01000506|593246479|FG001|Overall Study|Protocol Violation|1|||
164238595|NCT01000506|593246480|FG002|Overall Study|Protocol Violation|0|||
164238596|NCT01000506|593246481|FG003|Overall Study|Protocol Violation|0|||
164238597|NCT01000506|593246478|FG000|Overall Study|Lost to Follow-up|1|||
164238598|NCT01000506|593246479|FG001|Overall Study|Lost to Follow-up|1|||
164238599|NCT01000506|593246480|FG002|Overall Study|Lost to Follow-up|4|||
164238600|NCT01000506|593246481|FG003|Overall Study|Lost to Follow-up|0|||
164238601|NCT01000506|593246478|FG000|Overall Study|Physician Decision|1|||
164238602|NCT01000506|593246479|FG001|Overall Study|Physician Decision|3|||
164238603|NCT01000506|593246480|FG002|Overall Study|Physician Decision|3|||
164238604|NCT01000506|593246481|FG003|Overall Study|Physician Decision|3|||
164238605|NCT01000506|593246478|FG000|Overall Study|Withdrawal by Subject|11|||
164573359|NCT00772447|594463395|FG001|Overall Study|Withdrawal by Subject|5|||
164238606|NCT01000506|593246479|FG001|Overall Study|Withdrawal by Subject|8|||
164238607|NCT01000506|593246480|FG002|Overall Study|Withdrawal by Subject|2|||
164238608|NCT01000506|593246481|FG003|Overall Study|Withdrawal by Subject|7|||
164238609|NCT03064074|593246482|FG000|Overall Study|Physician Decision|0|||
164238610|NCT03064074|593246483|FG001|Overall Study|Physician Decision|0|||
164238611|NCT03064074|593246484|FG002|Overall Study|Physician Decision|0|||
164238612|NCT03064074|593246485|FG003|Overall Study|Physician Decision|1|||
164238613|NCT00269087|593246489|FG000|Overall Study|Adverse Event|20|||
164238614|NCT00269087|593246489|FG000|Overall Study|Withdrawal by Subject|1|||
164238615|NCT00269087|593246489|FG000|Overall Study|Exacerbation of COPD|13|||
164238616|NCT01188967|593246495|FG000|Overall Study|Withdrawal by Subject|1|||
164238617|NCT01188967|593246496|FG001|Overall Study|Withdrawal by Subject|1|||
164238618|NCT01188967|593246495|FG000|Overall Study|Physician Decision|1|||
164238619|NCT01188967|593246496|FG001|Overall Study|Physician Decision|1|||
164238620|NCT01188967|593246495|FG000|Overall Study|Lost to Follow-up|3|||
164238621|NCT01188967|593246496|FG001|Overall Study|Lost to Follow-up|2|||
164238622|NCT01448616|593246497|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
164238623|NCT01448616|593246498|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
164238624|NCT01448616|593246499|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
164238625|NCT01448616|593246500|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
164238626|NCT01448616|593246497|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
164238627|NCT01448616|593246498|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
164238628|NCT01448616|593246499|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
164238629|NCT01448616|593246500|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
164238630|NCT01448616|593246497|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
164238631|NCT01448616|593246498|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
164238632|NCT01448616|593246499|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
164238633|NCT01448616|593246500|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
164335666|NCT02633501|593606040|FG005|Overall Study|Adverse Event|1|||
164238634|NCT01448616|593246497|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
164238635|NCT01448616|593246498|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
164238636|NCT01448616|593246499|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
164238637|NCT01448616|593246500|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
164238638|NCT01448616|593246497|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
164238639|NCT01448616|593246498|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
164238640|NCT01448616|593246499|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
164238641|NCT01448616|593246500|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
164238642|NCT04577781|593246501|FG000|Overall Study|Adverse Event|2|||
164238643|NCT04577781|593246502|FG001|Overall Study|Adverse Event|2|||
164238644|NCT04577781|593246501|FG000|Overall Study|Physician Decision|1|||
164238645|NCT04577781|593246502|FG001|Overall Study|Physician Decision|0|||
164238646|NCT01464879|593246503|FG000|Overall Study|Physician Decision|1|||
164238647|NCT01464879|593246503|FG000|Overall Study|Non-compliance|1|||
164238648|NCT02951780|593246508|FG000|Period 1|Adverse Event|0|||
164238649|NCT02951780|593246509|FG001|Period 1|Adverse Event|0|||
164238650|NCT02951780|593246510|FG002|Period 1|Adverse Event|0|||
164238651|NCT02951780|593246511|FG003|Period 1|Adverse Event|1|||
164238652|NCT02951780|593246512|FG004|Period 1|Adverse Event|0|||
164238653|NCT02951780|593246513|FG005|Period 1|Adverse Event|0|||
164238654|NCT02951780|593246514|FG006|Period 1|Adverse Event|0|||
164238655|NCT02951780|593246515|FG007|Period 1|Adverse Event|0|||
164238656|NCT02951780|593246516|FG008|Period 1|Adverse Event|0|||
164238657|NCT02951780|593246508|FG000|Period 1|Scheduling Conflicts|0|||
164238658|NCT02951780|593246509|FG001|Period 1|Scheduling Conflicts|0|||
164238659|NCT02951780|593246510|FG002|Period 1|Scheduling Conflicts|0|||
164238660|NCT02951780|593246511|FG003|Period 1|Scheduling Conflicts|0|||
164238661|NCT02951780|593246512|FG004|Period 1|Scheduling Conflicts|0|||
164238662|NCT02951780|593246513|FG005|Period 1|Scheduling Conflicts|0|||
164238663|NCT02951780|593246514|FG006|Period 1|Scheduling Conflicts|0|||
164238664|NCT02951780|593246515|FG007|Period 1|Scheduling Conflicts|1|||
164238665|NCT02951780|593246516|FG008|Period 1|Scheduling Conflicts|0|||
164238666|NCT02951780|593246508|FG000|Period 2|Scheduling Conflicts|0|||
164238667|NCT02951780|593246509|FG001|Period 2|Scheduling Conflicts|0|||
164238668|NCT02951780|593246510|FG002|Period 2|Scheduling Conflicts|0|||
164238669|NCT02951780|593246511|FG003|Period 2|Scheduling Conflicts|0|||
164238670|NCT02951780|593246512|FG004|Period 2|Scheduling Conflicts|0|||
164238671|NCT02951780|593246513|FG005|Period 2|Scheduling Conflicts|0|||
164238672|NCT02951780|593246514|FG006|Period 2|Scheduling Conflicts|0|||
164238673|NCT02951780|593246515|FG007|Period 2|Scheduling Conflicts|1|||
164238674|NCT02951780|593246516|FG008|Period 2|Scheduling Conflicts|0|||
164238675|NCT00508482|593246517|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
164238676|NCT00508482|593246518|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
164238677|NCT00508482|593246519|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
164238678|NCT00508482|593246517|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
164238679|NCT00508482|593246518|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
164238680|NCT00508482|593246519|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
164238681|NCT00508482|593246517|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
164238682|NCT00508482|593246518|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
164238683|NCT00508482|593246519|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
164238684|NCT00546481|593246520|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
164238685|NCT00546481|593246521|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
164238686|NCT00546481|593246522|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
164238687|NCT00546481|593246520|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
164238688|NCT00546481|593246521|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
164238689|NCT00546481|593246522|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
164238690|NCT00546481|593246520|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
164238691|NCT00546481|593246521|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
164238692|NCT00546481|593246522|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
164238693|NCT00546481|593246520|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
164238694|NCT00546481|593246521|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
164238695|NCT00546481|593246522|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
164238696|NCT00546481|593246520|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
164238697|NCT00546481|593246521|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
164238698|NCT00546481|593246522|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
164677571|NCT01695239|594844834|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164238699|NCT00546481|593246520|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
164238700|NCT00546481|593246521|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
164238701|NCT00546481|593246522|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
164238702|NCT00546481|593246520|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
164238703|NCT00546481|593246521|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
164238704|NCT00546481|593246522|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
164425137|NCT02373813|593928389|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
164425138|NCT02373813|593928390|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
164425139|NCT02373813|593928391|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
164425140|NCT02373813|593928392|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
164425141|NCT02373813|593928389|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
164425142|NCT02373813|593928390|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
164425143|NCT02373813|593928391|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
164425144|NCT02373813|593928392|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
164425145|NCT02373813|593928389|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
164425146|NCT02373813|593928390|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
164425147|NCT02373813|593928391|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
164425148|NCT02373813|593928392|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
164425149|NCT02373813|593928389|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164425150|NCT02373813|593928390|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
164425151|NCT02373813|593928391|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
164425152|NCT02373813|593928392|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
164425153|NCT01511536|593928393|FG000|Phase 1|Other|0|||
164425154|NCT01511536|593928394|FG001|Phase 1|Other|1|||
164425155|NCT01511536|593928395|FG002|Phase 1|Other|0|||
164425156|NCT01511536|593928393|FG000|Phase 2|Other|0|||
164425157|NCT01511536|593928394|FG001|Phase 2|Other|0|||
164425158|NCT01511536|593928395|FG002|Phase 2|Other|9|||
164425159|NCT02703532|593928397|FG000|Overall Study|Withdrawal by Subject|0|||
164425160|NCT02703532|593928398|FG001|Overall Study|Withdrawal by Subject|1|||
164425161|NCT02703532|593928399|FG002|Overall Study|Withdrawal by Subject|0|||
164425162|NCT02703532|593928400|FG003|Overall Study|Withdrawal by Subject|1|||
164425163|NCT02703532|593928397|FG000|Overall Study|Lost to Follow-up|2|||
164425164|NCT02703532|593928398|FG001|Overall Study|Lost to Follow-up|0|||
164425165|NCT02703532|593928399|FG002|Overall Study|Lost to Follow-up|2|||
164425166|NCT02703532|593928400|FG003|Overall Study|Lost to Follow-up|0|||
164425167|NCT00495469|593928401|FG000|Overall Study|Adverse Event|0|||
164425168|NCT00495469|593928402|FG001|Overall Study|Adverse Event|1|||
164425169|NCT00495469|593928403|FG002|Overall Study|Adverse Event|3|||
164425170|NCT00495469|593928404|FG003|Overall Study|Adverse Event|0|||
164425171|NCT00495469|593928405|FG004|Overall Study|Adverse Event|1|||
164425172|NCT00495469|593928406|FG005|Overall Study|Adverse Event|1|||
164573360|NCT00772447|594463394|FG000|Overall Study|Physician Decision|4|||
164573361|NCT00772447|594463395|FG001|Overall Study|Physician Decision|8|||
164573362|NCT00772447|594463394|FG000|Overall Study|Lost to Follow-up|2|||
164573363|NCT00772447|594463395|FG001|Overall Study|Lost to Follow-up|4|||
164425173|NCT00495469|593928407|FG006|Overall Study|Adverse Event|1|||
164425174|NCT00495469|593928401|FG000|Overall Study|Lost to Follow-up|1|||
164425175|NCT00495469|593928402|FG001|Overall Study|Lost to Follow-up|1|||
164425176|NCT00495469|593928403|FG002|Overall Study|Lost to Follow-up|3|||
164425177|NCT00495469|593928404|FG003|Overall Study|Lost to Follow-up|1|||
164425178|NCT00495469|593928405|FG004|Overall Study|Lost to Follow-up|0|||
164425179|NCT00495469|593928406|FG005|Overall Study|Lost to Follow-up|0|||
164425180|NCT00495469|593928407|FG006|Overall Study|Lost to Follow-up|0|||
164425181|NCT00495469|593928401|FG000|Overall Study|Protocol Violation|0|||
164425182|NCT00495469|593928402|FG001|Overall Study|Protocol Violation|0|||
164425183|NCT00495469|593928403|FG002|Overall Study|Protocol Violation|0|||
164425184|NCT00495469|593928404|FG003|Overall Study|Protocol Violation|0|||
164425185|NCT00495469|593928405|FG004|Overall Study|Protocol Violation|1|||
164425186|NCT00495469|593928406|FG005|Overall Study|Protocol Violation|2|||
164425187|NCT00495469|593928407|FG006|Overall Study|Protocol Violation|0|||
164425188|NCT00495469|593928401|FG000|Overall Study|Withdrawal by Subject|5|||
164425189|NCT00495469|593928402|FG001|Overall Study|Withdrawal by Subject|3|||
164425190|NCT00495469|593928403|FG002|Overall Study|Withdrawal by Subject|1|||
164425191|NCT00495469|593928404|FG003|Overall Study|Withdrawal by Subject|3|||
164425192|NCT00495469|593928405|FG004|Overall Study|Withdrawal by Subject|3|||
164425193|NCT00495469|593928406|FG005|Overall Study|Withdrawal by Subject|2|||
164425194|NCT00495469|593928407|FG006|Overall Study|Withdrawal by Subject|3|||
164425195|NCT00495469|593928401|FG000|Overall Study|Lack of Efficacy|0|||
164425196|NCT00495469|593928402|FG001|Overall Study|Lack of Efficacy|0|||
164425197|NCT00495469|593928403|FG002|Overall Study|Lack of Efficacy|0|||
164425198|NCT00495469|593928404|FG003|Overall Study|Lack of Efficacy|0|||
164425199|NCT00495469|593928405|FG004|Overall Study|Lack of Efficacy|0|||
164425200|NCT00495469|593928406|FG005|Overall Study|Lack of Efficacy|0|||
164425201|NCT00495469|593928407|FG006|Overall Study|Lack of Efficacy|1|||
164425202|NCT00495469|593928401|FG000|Overall Study|Liver function test abnormality|0|||
164425203|NCT00495469|593928402|FG001|Overall Study|Liver function test abnormality|1|||
164425204|NCT00495469|593928403|FG002|Overall Study|Liver function test abnormality|0|||
164425205|NCT00495469|593928404|FG003|Overall Study|Liver function test abnormality|0|||
164425206|NCT00495469|593928405|FG004|Overall Study|Liver function test abnormality|0|||
164238705|NCT00546481|593246520|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
164238706|NCT00546481|593246521|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
164238707|NCT00546481|593246522|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
164238708|NCT00546481|593246520|FG000|Maintenance Phase (CERA)|Other Reason|0|||
164238709|NCT00546481|593246521|FG001|Maintenance Phase (CERA)|Other Reason|0|||
164238710|NCT00546481|593246522|FG002|Maintenance Phase (CERA)|Other Reason|1|||
164238711|NCT00244621|593246523|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
164238712|NCT00244621|593246524|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
164238713|NCT00244621|593246525|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
164238714|NCT00244621|593246523|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
164238715|NCT00244621|593246524|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
164238716|NCT00244621|593246525|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
164238717|NCT00244621|593246523|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
164238718|NCT00244621|593246524|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
164238719|NCT00244621|593246525|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
164238720|NCT00244621|593246523|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
164238721|NCT00244621|593246524|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
164238722|NCT00244621|593246525|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
164238723|NCT00244621|593246523|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
164238724|NCT00244621|593246524|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
164238725|NCT00244621|593246525|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
164238726|NCT00244621|593246523|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
164238727|NCT00244621|593246524|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
164238728|NCT00244621|593246525|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
164238729|NCT00244621|593246523|FG000|Open-label Treatment Period|Adverse Event|0|||
164238730|NCT00244621|593246524|FG001|Open-label Treatment Period|Adverse Event|0|||
164238731|NCT00244621|593246525|FG002|Open-label Treatment Period|Adverse Event|1|||
164238732|NCT00244621|593246523|FG000|Open-label Treatment Period|Moved abroad|0|||
164238733|NCT00244621|593246524|FG001|Open-label Treatment Period|Moved abroad|0|||
164238734|NCT00244621|593246525|FG002|Open-label Treatment Period|Moved abroad|1|||
164238735|NCT02271529|593246528|FG000|Overall Study|Withdrawal by Subject|1|||
164238736|NCT00811720|593246532|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
164238737|NCT00811720|593246533|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
164238738|NCT00811720|593246532|FG000|All Treated Patients|Adverse Event|20|||
164238739|NCT00811720|593246533|FG001|All Treated Patients|Adverse Event|62|||
164238740|NCT00811720|593246532|FG000|All Treated Patients|Lack of Efficacy|22|||
164238741|NCT00811720|593246533|FG001|All Treated Patients|Lack of Efficacy|18|||
164238742|NCT00811720|593246532|FG000|All Treated Patients|Non-compliance|0|||
164238743|NCT00811720|593246533|FG001|All Treated Patients|Non-compliance|14|||
164238744|NCT00811720|593246532|FG000|All Treated Patients|Protocol Violation|9|||
164238745|NCT00811720|593246533|FG001|All Treated Patients|Protocol Violation|16|||
164238746|NCT00811720|593246532|FG000|All Treated Patients|Withdrawal by Subject|28|||
164238747|NCT00811720|593246533|FG001|All Treated Patients|Withdrawal by Subject|34|||
164238748|NCT00811720|593246532|FG000|All Treated Patients|Lost to Follow-up|10|||
164238749|NCT00811720|593246533|FG001|All Treated Patients|Lost to Follow-up|16|||
164238750|NCT00811720|593246532|FG000|All Treated Patients|Other Reason|7|||
164238751|NCT00811720|593246533|FG001|All Treated Patients|Other Reason|4|||
164238752|NCT03894891|593246534|FG000|Overall Study|Withdrawal by Subject|1|||
164238753|NCT03894891|593246534|FG000|Overall Study|Completed protocol treatment per protocol|5|||
164238754|NCT01644643|593246542|FG000|Overall Study|Death|1|||
164238755|NCT01644643|593246543|FG001|Overall Study|Death|0|||
164238756|NCT01644643|593246544|FG002|Overall Study|Death|3|||
164335667|NCT02633501|593606035|FG000|Overall Study|Withdrawal by Subject|2|||
164335668|NCT02633501|593606036|FG001|Overall Study|Withdrawal by Subject|1|||
164335669|NCT02633501|593606037|FG002|Overall Study|Withdrawal by Subject|2|||
164335670|NCT02633501|593606038|FG003|Overall Study|Withdrawal by Subject|2|||
164335671|NCT02633501|593606039|FG004|Overall Study|Withdrawal by Subject|1|||
164335672|NCT02633501|593606040|FG005|Overall Study|Withdrawal by Subject|3|||
164335673|NCT02633501|593606035|FG000|Overall Study|Various other reasons|0|||
164238757|NCT01644643|593246545|FG003|Overall Study|Death|3|||
164335674|NCT02633501|593606036|FG001|Overall Study|Various other reasons|2|||
164335675|NCT02633501|593606037|FG002|Overall Study|Various other reasons|4|||
164335676|NCT02633501|593606038|FG003|Overall Study|Various other reasons|1|||
164335677|NCT02633501|593606039|FG004|Overall Study|Various other reasons|7|||
164335678|NCT02633501|593606040|FG005|Overall Study|Various other reasons|11|||
164335679|NCT02633501|593606035|FG000|Overall Study|Lost to Follow-up|0|||
164335680|NCT02633501|593606036|FG001|Overall Study|Lost to Follow-up|0|||
164335681|NCT02633501|593606037|FG002|Overall Study|Lost to Follow-up|0|||
164335682|NCT02633501|593606038|FG003|Overall Study|Lost to Follow-up|1|||
164238758|NCT01644643|593246542|FG000|Overall Study|Lost to Follow-up|0|||
164238759|NCT01644643|593246543|FG001|Overall Study|Lost to Follow-up|0|||
164335683|NCT02633501|593606039|FG004|Overall Study|Lost to Follow-up|2|||
164335684|NCT02633501|593606040|FG005|Overall Study|Lost to Follow-up|0|||
164335685|NCT01104155|593606042|FG000|Overall Study|Adverse Event|15|||
164238760|NCT01644643|593246544|FG002|Overall Study|Lost to Follow-up|0|||
164238761|NCT01644643|593246545|FG003|Overall Study|Lost to Follow-up|4|||
164238762|NCT01644643|593246542|FG000|Overall Study|Withdrawal by Subject|1|||
164238763|NCT01644643|593246543|FG001|Overall Study|Withdrawal by Subject|0|||
164238764|NCT01644643|593246544|FG002|Overall Study|Withdrawal by Subject|2|||
164238765|NCT01644643|593246545|FG003|Overall Study|Withdrawal by Subject|1|||
164238766|NCT01644643|593246542|FG000|Overall Study|Other Eligibility criteria|0|||
164238767|NCT01644643|593246543|FG001|Overall Study|Other Eligibility criteria|0|||
164238768|NCT01644643|593246544|FG002|Overall Study|Other Eligibility criteria|0|||
164238769|NCT01644643|593246545|FG003|Overall Study|Other Eligibility criteria|2|||
164238770|NCT04940130|593246546|FG000|Overall Study|Travel|1|||
164238771|NCT04940130|593246547|FG001|Overall Study|Travel|0|||
164238772|NCT04940130|593246548|FG002|Overall Study|Travel|2|||
164238773|NCT04940130|593246546|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
164238774|NCT04940130|593246547|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
164238775|NCT04940130|593246548|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
164238776|NCT04940130|593246546|FG000|Overall Study|Adverse Event|0|||
164238777|NCT04940130|593246547|FG001|Overall Study|Adverse Event|0|||
164238778|NCT04940130|593246548|FG002|Overall Study|Adverse Event|2|||
164238779|NCT04940130|593246546|FG000|Overall Study|Disease progression/treatment failure|0|||
164238780|NCT04940130|593246547|FG001|Overall Study|Disease progression/treatment failure|0|||
164238781|NCT04940130|593246548|FG002|Overall Study|Disease progression/treatment failure|1|||
164238782|NCT04940130|593246546|FG000|Overall Study|Participant refusal|0|||
164238783|NCT04940130|593246547|FG001|Overall Study|Participant refusal|0|||
164238784|NCT04940130|593246548|FG002|Overall Study|Participant refusal|1|||
164238785|NCT00421148|593246551|FG000|Overall Study|Lost to Follow-up|0|||
164238786|NCT00421148|593246552|FG001|Overall Study|Lost to Follow-up|0|||
164238787|NCT00421148|593246553|FG002|Overall Study|Lost to Follow-up|0|||
164238788|NCT00421148|593246554|FG003|Overall Study|Lost to Follow-up|0|||
164238789|NCT00421148|593246555|FG004|Overall Study|Lost to Follow-up|0|||
164238790|NCT00421148|593246556|FG005|Overall Study|Lost to Follow-up|0|||
164238791|NCT00421148|593246557|FG006|Overall Study|Lost to Follow-up|0|||
164238792|NCT00421148|593246558|FG007|Overall Study|Lost to Follow-up|0|||
164238793|NCT00421148|593246559|FG008|Overall Study|Lost to Follow-up|0|||
164238794|NCT00421148|593246560|FG009|Overall Study|Lost to Follow-up|0|||
164238795|NCT00421148|593246561|FG010|Overall Study|Lost to Follow-up|0|||
164238796|NCT00421148|593246562|FG011|Overall Study|Lost to Follow-up|0|||
164238797|NCT00421148|593246563|FG012|Overall Study|Lost to Follow-up|0|||
164238798|NCT00421148|593246564|FG013|Overall Study|Lost to Follow-up|0|||
164238799|NCT00421148|593246565|FG014|Overall Study|Lost to Follow-up|0|||
164238800|NCT00421148|593246566|FG015|Overall Study|Lost to Follow-up|0|||
164238801|NCT00421148|593246567|FG016|Overall Study|Lost to Follow-up|0|||
164238802|NCT00421148|593246568|FG017|Overall Study|Lost to Follow-up|1|||
164238803|NCT00421148|593246569|FG018|Overall Study|Lost to Follow-up|0|||
164238804|NCT00421148|593246570|FG019|Overall Study|Lost to Follow-up|0|||
164238805|NCT00421148|593246551|FG000|Overall Study|Withdrawal by Subject|0|||
164238806|NCT00421148|593246552|FG001|Overall Study|Withdrawal by Subject|0|||
164238807|NCT00421148|593246553|FG002|Overall Study|Withdrawal by Subject|0|||
164238808|NCT00421148|593246554|FG003|Overall Study|Withdrawal by Subject|0|||
164238809|NCT00421148|593246555|FG004|Overall Study|Withdrawal by Subject|0|||
164238810|NCT00421148|593246556|FG005|Overall Study|Withdrawal by Subject|0|||
164425207|NCT00495469|593928406|FG005|Overall Study|Liver function test abnormality|0|||
164238811|NCT00421148|593246557|FG006|Overall Study|Withdrawal by Subject|0|||
164238812|NCT00421148|593246558|FG007|Overall Study|Withdrawal by Subject|0|||
164238813|NCT00421148|593246559|FG008|Overall Study|Withdrawal by Subject|0|||
164238814|NCT00421148|593246560|FG009|Overall Study|Withdrawal by Subject|0|||
164238815|NCT00421148|593246561|FG010|Overall Study|Withdrawal by Subject|0|||
164238816|NCT00421148|593246562|FG011|Overall Study|Withdrawal by Subject|0|||
164238817|NCT00421148|593246563|FG012|Overall Study|Withdrawal by Subject|0|||
164238818|NCT00421148|593246564|FG013|Overall Study|Withdrawal by Subject|0|||
164238819|NCT00421148|593246565|FG014|Overall Study|Withdrawal by Subject|0|||
164238820|NCT00421148|593246566|FG015|Overall Study|Withdrawal by Subject|0|||
164238821|NCT00421148|593246567|FG016|Overall Study|Withdrawal by Subject|0|||
164238822|NCT00421148|593246568|FG017|Overall Study|Withdrawal by Subject|1|||
164238823|NCT00421148|593246569|FG018|Overall Study|Withdrawal by Subject|0|||
164238824|NCT00421148|593246570|FG019|Overall Study|Withdrawal by Subject|0|||
164238825|NCT00421148|593246551|FG000|Overall Study|Protocol Violation|0|||
164238826|NCT00421148|593246552|FG001|Overall Study|Protocol Violation|0|||
164238827|NCT00421148|593246553|FG002|Overall Study|Protocol Violation|0|||
164238828|NCT00421148|593246554|FG003|Overall Study|Protocol Violation|0|||
164238829|NCT00421148|593246555|FG004|Overall Study|Protocol Violation|0|||
164238830|NCT00421148|593246556|FG005|Overall Study|Protocol Violation|1|||
164238831|NCT00421148|593246557|FG006|Overall Study|Protocol Violation|0|||
164238832|NCT00421148|593246558|FG007|Overall Study|Protocol Violation|0|||
164238833|NCT00421148|593246559|FG008|Overall Study|Protocol Violation|0|||
164238834|NCT00421148|593246560|FG009|Overall Study|Protocol Violation|0|||
164238835|NCT00421148|593246561|FG010|Overall Study|Protocol Violation|0|||
164238836|NCT00421148|593246562|FG011|Overall Study|Protocol Violation|0|||
164238837|NCT00421148|593246563|FG012|Overall Study|Protocol Violation|0|||
164238838|NCT00421148|593246564|FG013|Overall Study|Protocol Violation|0|||
164238839|NCT00421148|593246565|FG014|Overall Study|Protocol Violation|0|||
164238840|NCT00421148|593246566|FG015|Overall Study|Protocol Violation|0|||
164238841|NCT00421148|593246567|FG016|Overall Study|Protocol Violation|0|||
164238842|NCT00421148|593246568|FG017|Overall Study|Protocol Violation|0|||
164238843|NCT00421148|593246569|FG018|Overall Study|Protocol Violation|1|||
164238844|NCT00421148|593246570|FG019|Overall Study|Protocol Violation|0|||
164238845|NCT03289533|593246571|FG000|Overall Study|Death|12|||
164238846|NCT03289533|593246571|FG000|Overall Study|Terminated from study by sponsor|10|||
164238847|NCT00539240|593246572|FG000|Overall Study|Withdrawal by Subject|0|||
164238848|NCT00539240|593246573|FG001|Overall Study|Withdrawal by Subject|2|||
164238849|NCT00539240|593246574|FG002|Overall Study|Withdrawal by Subject|0|||
164238850|NCT00539240|593246572|FG000|Overall Study|Protocol Violation|1|||
164335686|NCT01104155|593606043|FG001|Overall Study|Adverse Event|8|||
164335687|NCT01104155|593606042|FG000|Overall Study|Participant choice|6|||
164335688|NCT01104155|593606043|FG001|Overall Study|Participant choice|5|||
164335689|NCT01104155|593606042|FG000|Overall Study|Withdrawal of consent|1|||
164335690|NCT01104155|593606043|FG001|Overall Study|Withdrawal of consent|1|||
164335691|NCT01104155|593606042|FG000|Overall Study|Other|3|||
164335692|NCT01104155|593606043|FG001|Overall Study|Other|4|||
164335693|NCT01672736|593606044|FG000|Overall Study|Available drug expired on 31 May 16|3|||
164335694|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
164335695|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
164335696|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|Death|1|||
164335697|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|Death|0|||
164335698|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
164335699|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
164335700|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
164335701|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
164335702|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
164335703|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
164335704|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
164335705|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
164335706|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
164335707|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
164335708|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
164335709|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
164335710|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
164335711|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
164335712|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
164335713|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
164335714|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
164335715|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
164335716|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
164335717|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
164335718|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
164335719|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
164335720|NCT02927262|593606047|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
164335721|NCT02927262|593606048|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
164335722|NCT02927262|593606047|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
164335723|NCT02927262|593606048|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
164335724|NCT02927262|593606047|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
164335725|NCT02927262|593606048|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
164335726|NCT02853344|593606051|FG000|Overall Study|Lost to Follow-up|1|||
164335727|NCT02853344|593606052|FG001|Overall Study|Lost to Follow-up|1|||
164335728|NCT02853344|593606051|FG000|Overall Study|Withdrawal by Subject|2|||
164335729|NCT02853344|593606052|FG001|Overall Study|Withdrawal by Subject|4|||
164573364|NCT00772447|594463394|FG000|Overall Study|incorrect enrolment|3|||
164573365|NCT00772447|594463395|FG001|Overall Study|incorrect enrolment|4|||
164573366|NCT00772447|594463394|FG000|Overall Study|Protocol Violation|0|||
164573367|NCT00772447|594463395|FG001|Overall Study|Protocol Violation|1|||
164573368|NCT00772447|594463394|FG000|Overall Study|all others|2|||
164573369|NCT00772447|594463395|FG001|Overall Study|all others|2|||
164573370|NCT04439344|594463396|FG000|Overall Study|Never started threapy|3|||
164238851|NCT00539240|593246573|FG001|Overall Study|Protocol Violation|1|||
164238852|NCT00539240|593246574|FG002|Overall Study|Protocol Violation|4|||
164238853|NCT00539240|593246572|FG000|Overall Study|Lost to Follow-up|2|||
164238854|NCT00539240|593246573|FG001|Overall Study|Lost to Follow-up|3|||
164238855|NCT00539240|593246574|FG002|Overall Study|Lost to Follow-up|1|||
164238856|NCT00539240|593246572|FG000|Overall Study|Adverse Event|3|||
164238857|NCT00539240|593246573|FG001|Overall Study|Adverse Event|1|||
164238858|NCT00539240|593246574|FG002|Overall Study|Adverse Event|10|||
164238859|NCT01284959|593246575|FG000|Overall Study|Withdrawal by Subject|1|||
164238860|NCT01284959|593246576|FG001|Overall Study|Withdrawal by Subject|0|||
164677572|NCT01695239|594844835|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164238861|NCT01284959|593246577|FG002|Overall Study|Withdrawal by Subject|0|||
164238862|NCT01284959|593246575|FG000|Overall Study|Adverse Event|0|||
164238863|NCT01284959|593246576|FG001|Overall Study|Adverse Event|0|||
164238864|NCT01284959|593246577|FG002|Overall Study|Adverse Event|1|||
164238865|NCT01055613|593246578|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
164238866|NCT01055613|593246579|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
164238867|NCT01055613|593246578|FG000|Overall Study|Unacceptable lens fit|1|||
164238868|NCT01055613|593246579|FG001|Overall Study|Unacceptable lens fit|0|||
164238869|NCT01055613|593246578|FG000|Overall Study|Discomfort|2|||
164238870|NCT01055613|593246579|FG001|Overall Study|Discomfort|1|||
164238871|NCT01055613|593246578|FG000|Overall Study|Lost to Follow-up|1|||
164238872|NCT01055613|593246579|FG001|Overall Study|Lost to Follow-up|1|||
164238873|NCT01055613|593246578|FG000|Overall Study|Protocol Violation|1|||
164238874|NCT01055613|593246579|FG001|Overall Study|Protocol Violation|1|||
164238875|NCT01055613|593246578|FG000|Overall Study|Subject Disinterest|1|||
164238876|NCT01055613|593246579|FG001|Overall Study|Subject Disinterest|1|||
164238877|NCT00363311|593246580|FG000|Overall Study|Adverse Event|6|||
164238878|NCT00363311|593246581|FG001|Overall Study|Adverse Event|4|||
164238879|NCT00363311|593246580|FG000|Overall Study|Lost to Follow-up|3|||
164238880|NCT00363311|593246581|FG001|Overall Study|Lost to Follow-up|0|||
164238881|NCT00363311|593246580|FG000|Overall Study|Protocol Violation|1|||
164238882|NCT00363311|593246581|FG001|Overall Study|Protocol Violation|2|||
164238883|NCT00363311|593246580|FG000|Overall Study|Withdrawal by Subject|12|||
164238884|NCT00363311|593246581|FG001|Overall Study|Withdrawal by Subject|6|||
164238885|NCT00363311|593246580|FG000|Overall Study|Physician Decision|1|||
164238886|NCT00363311|593246581|FG001|Overall Study|Physician Decision|1|||
164238887|NCT00363311|593246580|FG000|Overall Study|Sponsor Terminated Study|2|||
164238888|NCT00363311|593246581|FG001|Overall Study|Sponsor Terminated Study|2|||
164238889|NCT00363311|593246580|FG000|Overall Study|Disease Progression|46|||
164238890|NCT00363311|593246581|FG001|Overall Study|Disease Progression|26|||
164238891|NCT00363311|593246580|FG000|Overall Study|Non-Compliance|1|||
164238892|NCT00363311|593246581|FG001|Overall Study|Non-Compliance|1|||
164238893|NCT00363311|593246580|FG000|Overall Study|Participant Refused Biopsy|1|||
164238894|NCT00363311|593246581|FG001|Overall Study|Participant Refused Biopsy|0|||
164238895|NCT00363311|593246580|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
164238896|NCT00363311|593246581|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
164238897|NCT00363311|593246580|FG000|Overall Study|Participant Opted for Treatment|1|||
164238898|NCT00363311|593246581|FG001|Overall Study|Participant Opted for Treatment|0|||
164238899|NCT00363311|593246580|FG000|Overall Study|Participant Moved to Another Country|1|||
164238900|NCT00363311|593246581|FG001|Overall Study|Participant Moved to Another Country|0|||
164238901|NCT00363311|593246580|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
164238902|NCT00363311|593246581|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
164238903|NCT00363311|593246580|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
164238904|NCT00363311|593246581|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
164238905|NCT00363311|593246580|FG000|Overall Study|Participant Moved to Louisiana|0|||
164238906|NCT00363311|593246581|FG001|Overall Study|Participant Moved to Louisiana|1|||
164238907|NCT01677988|593246587|FG000|Overall Study|Lack of Efficacy|2|||
164238908|NCT02629861|593246604|FG000|Overall Study|Adverse Event|7|||
164238909|NCT02629861|593246605|FG001|Overall Study|Adverse Event|5|||
164238910|NCT02629861|593246606|FG002|Overall Study|Adverse Event|4|||
164335730|NCT02853344|593606051|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
164335731|NCT02853344|593606052|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
164335732|NCT02853344|593606051|FG000|Overall Study|Death|70|||
164335733|NCT02853344|593606052|FG001|Overall Study|Death|112|||
164335734|NCT02913612|593606053|FG000|Overall Study|Lost to Follow-up|6|||
164335735|NCT02913612|593606054|FG001|Overall Study|Lost to Follow-up|5|||
164335736|NCT02913612|593606055|FG002|Overall Study|Lost to Follow-up|2|||
164335737|NCT02913612|593606056|FG003|Overall Study|Lost to Follow-up|0|||
164677573|NCT01695239|594844836|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164238911|NCT02629861|593246604|FG000|Overall Study|Withdrawal by Subject|5|||
164238912|NCT02629861|593246605|FG001|Overall Study|Withdrawal by Subject|8|||
164238913|NCT02629861|593246606|FG002|Overall Study|Withdrawal by Subject|13|||
164238914|NCT02629861|593246604|FG000|Overall Study|Protocol Violation|2|||
164238915|NCT02629861|593246605|FG001|Overall Study|Protocol Violation|3|||
164335738|NCT02913612|593606053|FG000|Overall Study|Physician Decision|1|||
164238916|NCT02629861|593246606|FG002|Overall Study|Protocol Violation|7|||
164238917|NCT02629861|593246604|FG000|Overall Study|Lost to Follow-up|12|||
164335739|NCT02913612|593606054|FG001|Overall Study|Physician Decision|4|||
164335740|NCT02913612|593606055|FG002|Overall Study|Physician Decision|1|||
164238918|NCT02629861|593246605|FG001|Overall Study|Lost to Follow-up|9|||
164238919|NCT02629861|593246606|FG002|Overall Study|Lost to Follow-up|4|||
164238920|NCT02629861|593246604|FG000|Overall Study|Other|1|||
164238921|NCT02629861|593246605|FG001|Overall Study|Other|1|||
164238922|NCT02629861|593246606|FG002|Overall Study|Other|0|||
164238923|NCT02629861|593246604|FG000|Overall Study|Pregnancy|2|||
164238924|NCT02629861|593246605|FG001|Overall Study|Pregnancy|1|||
164238925|NCT02629861|593246606|FG002|Overall Study|Pregnancy|0|||
164238926|NCT00271544|593246607|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
164238927|NCT00271544|593246607|FG000|Overall Study|Model 4196 lead not attempted|9|||
164238928|NCT00271544|593246607|FG000|Overall Study|Implant not attempted|4|||
164238929|NCT00902330|593246614|FG000|Overall Study|Too overwhelmed by treatment|2|||
164238930|NCT00902330|593246615|FG001|Overall Study|Too overwhelmed by treatment|5|||
164238931|NCT00902330|593246614|FG000|Overall Study|Adverse Event|1|||
164238932|NCT00902330|593246615|FG001|Overall Study|Adverse Event|0|||
164238933|NCT00902330|593246614|FG000|Overall Study|No post baseline data|1|||
164238934|NCT00902330|593246615|FG001|Overall Study|No post baseline data|0|||
164238935|NCT00165789|593246616|FG000|Overall Study|Adverse Event|0|||
164238936|NCT00165789|593246617|FG001|Overall Study|Adverse Event|3|||
164238937|NCT00165789|593246618|FG002|Overall Study|Adverse Event|0|||
164238938|NCT00165789|593246619|FG003|Overall Study|Adverse Event|12|||
164238939|NCT00165789|593246616|FG000|Overall Study|Withdrawal by Subject|0|||
164238940|NCT00165789|593246617|FG001|Overall Study|Withdrawal by Subject|1|||
164238941|NCT00165789|593246618|FG002|Overall Study|Withdrawal by Subject|1|||
164238942|NCT00165789|593246619|FG003|Overall Study|Withdrawal by Subject|2|||
164238943|NCT03571971|593246620|FG000|Overall Study|Lost to Follow-up|2|||
164238944|NCT03571971|593246621|FG001|Overall Study|Lost to Follow-up|2|||
164238945|NCT03571971|593246620|FG000|Overall Study|Protocol Violation|2|||
164238946|NCT03571971|593246621|FG001|Overall Study|Protocol Violation|3|||
164238947|NCT03571971|593246620|FG000|Overall Study|Withdrawal by Subject|2|||
164238948|NCT03571971|593246621|FG001|Overall Study|Withdrawal by Subject|0|||
164238949|NCT03571971|593246620|FG000|Overall Study|Incomplete primary outcome data|2|||
164238950|NCT03571971|593246621|FG001|Overall Study|Incomplete primary outcome data|0|||
164238951|NCT03950856|593246625|FG000|Overall Study|Death|1|||
164238952|NCT03950856|593246626|FG001|Overall Study|Death|2|||
164238953|NCT03950856|593246627|FG002|Overall Study|Death|0|||
164238954|NCT03950856|593246628|FG003|Overall Study|Death|0|||
164238955|NCT03950856|593246625|FG000|Overall Study|Lost to Follow-up|5|||
164238956|NCT03950856|593246626|FG001|Overall Study|Lost to Follow-up|6|||
164238957|NCT03950856|593246627|FG002|Overall Study|Lost to Follow-up|8|||
164238958|NCT03950856|593246628|FG003|Overall Study|Lost to Follow-up|2|||
164238959|NCT03950856|593246625|FG000|Overall Study|Protocol Violation|2|||
164238960|NCT03950856|593246626|FG001|Overall Study|Protocol Violation|0|||
164238961|NCT03950856|593246627|FG002|Overall Study|Protocol Violation|0|||
164238962|NCT03950856|593246628|FG003|Overall Study|Protocol Violation|1|||
164238963|NCT03950856|593246625|FG000|Overall Study|Withdrawal by Subject|4|||
164238964|NCT03950856|593246626|FG001|Overall Study|Withdrawal by Subject|1|||
164238965|NCT03950856|593246627|FG002|Overall Study|Withdrawal by Subject|3|||
164238966|NCT03950856|593246628|FG003|Overall Study|Withdrawal by Subject|1|||
164238967|NCT03950856|593246625|FG000|Overall Study|Unable to phone|7|||
164238968|NCT03950856|593246626|FG001|Overall Study|Unable to phone|6|||
164238969|NCT03950856|593246627|FG002|Overall Study|Unable to phone|7|||
164238970|NCT03950856|593246628|FG003|Overall Study|Unable to phone|2|||
164238971|NCT01816984|593246629|FG000|Overall Study|declining health status|1|||
164238972|NCT00810277|593247737|FG000|Overall Study|Adverse Event|1|||
164238973|NCT00529243|593247741|FG000|Overall Study|Adverse Event|1|||
164238974|NCT00529243|593247741|FG000|Overall Study|Death|1|||
164238975|NCT00529243|593247741|FG000|Overall Study|Relocated|1|||
164238976|NCT01856322|593247742|FG000|Overall Study|off study due to lack of accrual|0|||
164238977|NCT01856322|593247743|FG001|Overall Study|off study due to lack of accrual|0|||
164238978|NCT01856322|593247744|FG002|Overall Study|off study due to lack of accrual|3|||
164238979|NCT04592341|593247745|FG000|Overall Study|Physician Decision|5|||
164238980|NCT04592341|593247745|FG000|Overall Study|Study Terminated by Sponsor|5|||
164238981|NCT04592341|593247745|FG000|Overall Study|Withdrawal by Subject|53|||
164238982|NCT04592341|593247745|FG000|Overall Study|Lost to Follow-up|3|||
164238983|NCT04592341|593247745|FG000|Overall Study|Death|1|||
164238984|NCT04592341|593247745|FG000|Overall Study|Adverse Event|5|||
164238985|NCT04592341|593247745|FG000|Overall Study|other|4|||
164238986|NCT02896257|593247746|FG000|Providers|Without eligible patients|21|||
164238987|NCT02896257|593247747|FG001|Providers|Without eligible patients|28|||
164238988|NCT02896257|593247746|FG000|Patients|PFT entry criteria not met|43|||
164238989|NCT02896257|593247747|FG001|Patients|PFT entry criteria not met|50|||
164238990|NCT02896257|593247746|FG000|Patients|No capacity to review|8|||
164238991|NCT02896257|593247747|FG001|Patients|No capacity to review|11|||
164238992|NCT02896257|593247746|FG000|Patients|Appointment rescheduled/cancelled|5|||
164238993|NCT02896257|593247747|FG001|Patients|Appointment rescheduled/cancelled|7|||
164238994|NCT02896257|593247746|FG000|Patients|PCP not assigned a clinic|4|||
164238995|NCT02896257|593247747|FG001|Patients|PCP not assigned a clinic|0|||
164238996|NCT02896257|593247746|FG000|Patients|No history of COPD|0|||
164238997|NCT02896257|593247747|FG001|Patients|No history of COPD|1|||
164238998|NCT02896257|593247746|FG000|Patients|Deceased between review and index date|0|||
164238999|NCT02896257|593247747|FG001|Patients|Deceased between review and index date|1|||
164239000|NCT02896257|593247746|FG000|Patients|No ICS Rx upon review|1|||
164239001|NCT02896257|593247747|FG001|Patients|No ICS Rx upon review|1|||
164239002|NCT02896257|593247746|FG000|Patients|Protocol Violation|2|||
164239003|NCT02896257|593247747|FG001|Patients|Protocol Violation|1|||
164239004|NCT02896257|593247746|FG000|Patients|Hospice care|0|||
164239005|NCT02896257|593247747|FG001|Patients|Hospice care|1|||
164239006|NCT03423602|593247752|FG000|Overall Study|Death|1|||
164239007|NCT03423602|593247752|FG000|Overall Study|Lost to Follow-up|6|||
164239008|NCT03423602|593247752|FG000|Overall Study|Protocol Violation|1|||
164239009|NCT03423602|593247752|FG000|Overall Study|Withdrawal by Subject|4|||
164239010|NCT00692003|593247753|FG000|Overall Study|Sponsor Decision|5|||
164239011|NCT00692003|593247754|FG001|Overall Study|Sponsor Decision|1|||
164239012|NCT03257358|593247755|FG000|Overall Study|Adverse Event|25|||
164239013|NCT03257358|593247756|FG001|Overall Study|Adverse Event|12|||
164239014|NCT03257358|593247755|FG000|Overall Study|Lack of Efficacy|1|||
164239015|NCT03257358|593247756|FG001|Overall Study|Lack of Efficacy|1|||
164239016|NCT03257358|593247755|FG000|Overall Study|Lost to Follow-up|12|||
164239017|NCT03257358|593247756|FG001|Overall Study|Lost to Follow-up|4|||
164239018|NCT03257358|593247755|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
164239019|NCT03257358|593247756|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
164239020|NCT03257358|593247755|FG000|Overall Study|Physician Decision|2|||
164239021|NCT03257358|593247756|FG001|Overall Study|Physician Decision|2|||
164239022|NCT03257358|593247755|FG000|Overall Study|Protocol Violation|5|||
164239023|NCT03257358|593247756|FG001|Overall Study|Protocol Violation|3|||
164239024|NCT03257358|593247755|FG000|Overall Study|Technical problems|4|||
164239025|NCT03257358|593247756|FG001|Overall Study|Technical problems|1|||
164239026|NCT03257358|593247755|FG000|Overall Study|Withdrawal by Subject|8|||
164239027|NCT03257358|593247756|FG001|Overall Study|Withdrawal by Subject|3|||
164239028|NCT03257358|593247755|FG000|Overall Study|Withdrawal of informed consent|9|||
164239029|NCT03257358|593247756|FG001|Overall Study|Withdrawal of informed consent|5|||
164239030|NCT03257358|593247755|FG000|Overall Study|New therapy for study indication|1|||
164239031|NCT03257358|593247756|FG001|Overall Study|New therapy for study indication|0|||
164239032|NCT03257358|593247755|FG000|Overall Study|No longer requires treatment|0|||
164239033|NCT03257358|593247756|FG001|Overall Study|No longer requires treatment|1|||
164239034|NCT02332187|593247757|FG000|Overall Study|Withdrawal by Subject|2|||
164239035|NCT02332187|593247758|FG001|Overall Study|Withdrawal by Subject|2|||
164239036|NCT02332187|593247757|FG000|Overall Study|Adverse Event|0|||
164239037|NCT02332187|593247758|FG001|Overall Study|Adverse Event|1|||
164239038|NCT01747915|593247759|FG000|Overall Study|Other|1|||
164239039|NCT01747915|593247760|FG001|Overall Study|Other|1|||
164239040|NCT01747915|593247761|FG002|Overall Study|Other|1|||
164239041|NCT01747915|593247759|FG000|Overall Study|Adverse Event|8|||
164239042|NCT01747915|593247760|FG001|Overall Study|Adverse Event|5|||
164239043|NCT01747915|593247761|FG002|Overall Study|Adverse Event|2|||
164239044|NCT01747915|593247759|FG000|Overall Study|Death|0|||
164239045|NCT01747915|593247760|FG001|Overall Study|Death|0|||
164239046|NCT01747915|593247761|FG002|Overall Study|Death|1|||
164239047|NCT01747915|593247759|FG000|Overall Study|Lack of Efficacy|0|||
164239048|NCT01747915|593247760|FG001|Overall Study|Lack of Efficacy|1|||
164239049|NCT01747915|593247761|FG002|Overall Study|Lack of Efficacy|0|||
164239050|NCT01747915|593247759|FG000|Overall Study|Lost to Follow-up|1|||
164239051|NCT01747915|593247760|FG001|Overall Study|Lost to Follow-up|0|||
164239052|NCT01747915|593247761|FG002|Overall Study|Lost to Follow-up|0|||
164239053|NCT01747915|593247759|FG000|Overall Study|Withdrawal by Subject|4|||
164239054|NCT01747915|593247760|FG001|Overall Study|Withdrawal by Subject|4|||
164239055|NCT01747915|593247761|FG002|Overall Study|Withdrawal by Subject|1|||
164239056|NCT01747915|593247759|FG000|Overall Study|Protocol Violation|1|||
164239057|NCT01747915|593247760|FG001|Overall Study|Protocol Violation|0|||
164239058|NCT01747915|593247761|FG002|Overall Study|Protocol Violation|0|||
164239059|NCT01747915|593247759|FG000|Overall Study|Pregnancy|0|||
164239060|NCT01747915|593247760|FG001|Overall Study|Pregnancy|0|||
164239061|NCT01747915|593247761|FG002|Overall Study|Pregnancy|1|||
164239062|NCT03443687|593247766|FG000|Overall Study|Lost to Follow-up|3|||
164239063|NCT03443687|593247767|FG001|Overall Study|Lost to Follow-up|5|||
164239064|NCT03443687|593247766|FG000|Overall Study|Withdrawal by Subject|1|||
164239065|NCT03443687|593247767|FG001|Overall Study|Withdrawal by Subject|0|||
164239066|NCT03443687|593247766|FG000|Overall Study|Discontinued intervention|1|||
164239067|NCT03443687|593247767|FG001|Overall Study|Discontinued intervention|1|||
164239068|NCT02805790|593247768|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
164239069|NCT02805790|593247769|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
164239070|NCT02266147|593247772|FG000|PART 1: Dose Escalation|Physician Decision|0|||
164239071|NCT02266147|593247773|FG001|PART 1: Dose Escalation|Physician Decision|0|||
164239072|NCT02266147|593247774|FG002|PART 1: Dose Escalation|Physician Decision|1|||
164239073|NCT02266147|593247775|FG003|PART 1: Dose Escalation|Physician Decision|0|||
164239074|NCT02266147|593247772|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
164677574|NCT01695239|594844823|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164677575|NCT01695239|594844824|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164677576|NCT01695239|594844825|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164677577|NCT01695239|594844826|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164677578|NCT01695239|594844827|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164677579|NCT01695239|594844828|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164677580|NCT01695239|594844829|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164677581|NCT01695239|594844830|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
164677582|NCT01695239|594844831|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164677583|NCT01695239|594844832|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164677584|NCT01695239|594844833|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164677585|NCT01695239|594844834|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164677586|NCT01695239|594844835|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164677587|NCT01695239|594844836|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164677588|NCT01695239|594844823|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
164677589|NCT01695239|594844824|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
164677590|NCT01695239|594844825|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
164677591|NCT01695239|594844826|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
164677592|NCT01695239|594844827|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
164677593|NCT01695239|594844828|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
164677594|NCT01695239|594844829|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
164677595|NCT01695239|594844830|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
164677596|NCT01695239|594844831|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
164677597|NCT01695239|594844832|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
164677598|NCT01695239|594844833|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
164239075|NCT02266147|593247773|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
164239076|NCT02266147|593247774|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
164239077|NCT02266147|593247775|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
164239078|NCT02266147|593247772|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
164239079|NCT02266147|593247773|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
164239080|NCT02266147|593247774|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
164239081|NCT02266147|593247775|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
164239082|NCT02266147|593247772|FG000|PART 1: Dose Escalation|Other|1|||
164239083|NCT02266147|593247773|FG001|PART 1: Dose Escalation|Other|1|||
164239084|NCT02266147|593247774|FG002|PART 1: Dose Escalation|Other|0|||
164239085|NCT02266147|593247775|FG003|PART 1: Dose Escalation|Other|0|||
164239086|NCT02266147|593247772|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
164239087|NCT02266147|593247773|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
164239088|NCT02266147|593247774|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
164239089|NCT02266147|593247775|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
164239090|NCT02266147|593247772|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
164239091|NCT02266147|593247773|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
164239092|NCT02266147|593247774|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
164239093|NCT02266147|593247775|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
164239094|NCT00382174|593247776|FG000|Overall Study|Lost to Follow-up|1|||
164239095|NCT00382174|593247777|FG001|Overall Study|Lost to Follow-up|4|||
164239096|NCT00382174|593247778|FG002|Overall Study|Lost to Follow-up|5|||
164239097|NCT00382174|593247776|FG000|Overall Study|Adverse Event|1|||
164239098|NCT00382174|593247777|FG001|Overall Study|Adverse Event|4|||
164239099|NCT00382174|593247778|FG002|Overall Study|Adverse Event|5|||
164239100|NCT00382174|593247776|FG000|Overall Study|Withdrawal by Subject|1|||
164239101|NCT00382174|593247777|FG001|Overall Study|Withdrawal by Subject|4|||
164239102|NCT00382174|593247778|FG002|Overall Study|Withdrawal by Subject|5|||
164239103|NCT00382174|593247776|FG000|Overall Study|Non compliance|1|||
164239104|NCT00382174|593247777|FG001|Overall Study|Non compliance|0|||
164239105|NCT00382174|593247778|FG002|Overall Study|Non compliance|1|||
164239106|NCT00382174|593247776|FG000|Overall Study|Physician Decision|0|||
164239107|NCT00382174|593247777|FG001|Overall Study|Physician Decision|2|||
164239108|NCT00382174|593247778|FG002|Overall Study|Physician Decision|2|||
164239109|NCT00382174|593247776|FG000|Overall Study|Failed to meet criteria|0|||
164239110|NCT00382174|593247777|FG001|Overall Study|Failed to meet criteria|1|||
164239111|NCT00382174|593247778|FG002|Overall Study|Failed to meet criteria|1|||
164239112|NCT00382174|593247776|FG000|Overall Study|Wounds merged|0|||
164239113|NCT00382174|593247777|FG001|Overall Study|Wounds merged|2|||
164239114|NCT00382174|593247778|FG002|Overall Study|Wounds merged|2|||
164239115|NCT01911260|593247779|FG000|Supplementation Period|transference or evasion of school|7|||
164239116|NCT01911260|593247780|FG001|Supplementation Period|transference or evasion of school|9|||
164239117|NCT01911260|593247781|FG002|Supplementation Period|transference or evasion of school|7|||
164239118|NCT01911260|593247782|FG003|Supplementation Period|transference or evasion of school|6|||
164239119|NCT01911260|593247779|FG000|Supplementation Period|Adverse Event|2|||
164239120|NCT01911260|593247780|FG001|Supplementation Period|Adverse Event|0|||
164239121|NCT01911260|593247781|FG002|Supplementation Period|Adverse Event|1|||
164239122|NCT01911260|593247782|FG003|Supplementation Period|Adverse Event|0|||
164239123|NCT01911260|593247779|FG000|Supplementation Period|refused to receive supplement|1|||
164239124|NCT01911260|593247780|FG001|Supplementation Period|refused to receive supplement|0|||
164239125|NCT01911260|593247781|FG002|Supplementation Period|refused to receive supplement|1|||
164239126|NCT01911260|593247782|FG003|Supplementation Period|refused to receive supplement|0|||
164239127|NCT01911260|593247779|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
164239128|NCT01911260|593247780|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
164239129|NCT01911260|593247781|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
164239130|NCT01911260|593247782|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
164239131|NCT01911260|593247779|FG000|Follow-up Period|transference or evasion of school|13|||
164335741|NCT02913612|593606056|FG003|Overall Study|Physician Decision|0|||
164335742|NCT02913612|593606053|FG000|Overall Study|Withdrawal by Subject|2|||
164335743|NCT02913612|593606054|FG001|Overall Study|Withdrawal by Subject|4|||
164335744|NCT02913612|593606055|FG002|Overall Study|Withdrawal by Subject|0|||
164335745|NCT02913612|593606056|FG003|Overall Study|Withdrawal by Subject|0|||
164335746|NCT02913612|593606053|FG000|Overall Study|Hemangioma resolved|1|||
164335747|NCT02913612|593606054|FG001|Overall Study|Hemangioma resolved|0|||
164335748|NCT02913612|593606055|FG002|Overall Study|Hemangioma resolved|0|||
164239132|NCT01911260|593247780|FG001|Follow-up Period|transference or evasion of school|20|||
164239133|NCT01911260|593247781|FG002|Follow-up Period|transference or evasion of school|15|||
164239134|NCT01911260|593247782|FG003|Follow-up Period|transference or evasion of school|12|||
164239135|NCT01657305|593247783|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
164335749|NCT02913612|593606056|FG003|Overall Study|Hemangioma resolved|0|||
164239136|NCT01657305|593247783|FG000|Overall Study|Withdrawal by Subject|4|||
164239137|NCT01657305|593247783|FG000|Overall Study|Adverse Event|1|||
164239138|NCT01657305|593247783|FG000|Overall Study|Lost to Follow-up|1|||
164335750|NCT02913612|593606053|FG000|Overall Study|Local IRB decision|1|||
164239139|NCT01657305|593247783|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
164239140|NCT00940602|593247784|FG000|Overall Study|Administrative problems|1|||
164239141|NCT00940602|593247785|FG001|Overall Study|Administrative problems|1|||
164239142|NCT00940602|593247784|FG000|Overall Study|Patient/guardian decision|13|||
164239143|NCT00940602|593247785|FG001|Overall Study|Patient/guardian decision|28|||
164239144|NCT00940602|593247784|FG000|Overall Study|Physician Decision|8|||
164239145|NCT00940602|593247785|FG001|Overall Study|Physician Decision|5|||
164239146|NCT00940602|593247784|FG000|Overall Study|Pregnancy|1|||
164239147|NCT00940602|593247785|FG001|Overall Study|Pregnancy|0|||
164239148|NCT00940602|593247784|FG000|Overall Study|Protocol Deviation (untreated)|1|||
164239149|NCT00940602|593247785|FG001|Overall Study|Protocol Deviation (untreated)|0|||
164239150|NCT00940602|593247784|FG000|Overall Study|Disease progression|8|||
164239151|NCT00940602|593247785|FG001|Overall Study|Disease progression|2|||
164239152|NCT00940602|593247784|FG000|Overall Study|Death|38|||
164239153|NCT00940602|593247785|FG001|Overall Study|Death|19|||
164239154|NCT00940602|593247784|FG000|Overall Study|Lost to Follow-up|3|||
164239155|NCT00940602|593247785|FG001|Overall Study|Lost to Follow-up|1|||
164239156|NCT00940602|593247784|FG000|Overall Study|Patient withdrew consent|26|||
164239157|NCT00940602|593247785|FG001|Overall Study|Patient withdrew consent|13|||
164239158|NCT00940602|593247784|FG000|Overall Study|Adverse Event|7|||
164239159|NCT00940602|593247785|FG001|Overall Study|Adverse Event|2|||
164239160|NCT00940602|593247784|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
164239161|NCT00940602|593247785|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
164239162|NCT00575666|593247786|FG000|Overall Study|Withdrawal by Subject|3|||
164239163|NCT00575666|593247787|FG001|Overall Study|Withdrawal by Subject|2|||
164239164|NCT00575666|593247786|FG000|Overall Study|Physician Decision|1|||
164239165|NCT00575666|593247787|FG001|Overall Study|Physician Decision|1|||
164239166|NCT01374425|593247788|FG000|Overall Study|Radiographic Disease Progression|86|||
164239167|NCT01374425|593247789|FG001|Overall Study|Radiographic Disease Progression|81|||
164239168|NCT01374425|593247788|FG000|Overall Study|Clinical Disease Progression|9|||
164239169|NCT01374425|593247789|FG001|Overall Study|Clinical Disease Progression|6|||
164239170|NCT01374425|593247788|FG000|Overall Study|Adverse Event|29|||
164239171|NCT01374425|593247789|FG001|Overall Study|Adverse Event|18|||
164239172|NCT01374425|593247788|FG000|Overall Study|Death (Progression of Disease)|1|||
164239173|NCT01374425|593247789|FG001|Overall Study|Death (Progression of Disease)|0|||
164239174|NCT01374425|593247788|FG000|Overall Study|Death (Adverse Event)|2|||
164239175|NCT01374425|593247789|FG001|Overall Study|Death (Adverse Event)|4|||
164239176|NCT01374425|593247788|FG000|Overall Study|Withdrawal by Subject|6|||
164239177|NCT01374425|593247789|FG001|Overall Study|Withdrawal by Subject|7|||
164239178|NCT01374425|593247788|FG000|Overall Study|Refused Treatment|10|||
164239179|NCT01374425|593247789|FG001|Overall Study|Refused Treatment|24|||
164239180|NCT01374425|593247788|FG000|Overall Study|Protocol Violation|2|||
164239181|NCT01374425|593247789|FG001|Overall Study|Protocol Violation|3|||
164239182|NCT01374425|593247788|FG000|Overall Study|Sponsor Decision|0|||
164239183|NCT01374425|593247789|FG001|Overall Study|Sponsor Decision|1|||
164239184|NCT01374425|593247788|FG000|Overall Study|Lost to Follow-up|2|||
164239185|NCT01374425|593247789|FG001|Overall Study|Lost to Follow-up|1|||
164239186|NCT01374425|593247788|FG000|Overall Study|Other|41|||
164239187|NCT01374425|593247789|FG001|Overall Study|Other|43|||
164239188|NCT02289469|593247790|FG000|Overall Study|Unable to match a control|6|||
164239189|NCT02289469|593247791|FG001|Overall Study|Unable to match a control|0|||
164239190|NCT01904721|593247793|FG000|Overall Study|Other Reasons|0|||
164239191|NCT01904721|593247794|FG001|Overall Study|Other Reasons|0|||
164239192|NCT01904721|593247795|FG002|Overall Study|Other Reasons|1|||
164239193|NCT01904721|593247796|FG003|Overall Study|Other Reasons|1|||
164239194|NCT01904721|593247797|FG004|Overall Study|Other Reasons|2|||
164239195|NCT01904721|593247798|FG005|Overall Study|Other Reasons|2|||
164239196|NCT01904721|593247799|FG006|Overall Study|Other Reasons|2|||
164239197|NCT01904721|593247793|FG000|Overall Study|Personal Reasons|0|||
164239198|NCT01904721|593247794|FG001|Overall Study|Personal Reasons|0|||
164239199|NCT01904721|593247795|FG002|Overall Study|Personal Reasons|0|||
164239200|NCT01904721|593247796|FG003|Overall Study|Personal Reasons|0|||
164239201|NCT01904721|593247797|FG004|Overall Study|Personal Reasons|2|||
164425208|NCT00495469|593928407|FG006|Overall Study|Liver function test abnormality|0|||
164239202|NCT01904721|593247798|FG005|Overall Study|Personal Reasons|3|||
164239203|NCT01904721|593247799|FG006|Overall Study|Personal Reasons|3|||
164239204|NCT01904721|593247793|FG000|Overall Study|Lost to Follow-up|0|||
164239205|NCT01904721|593247794|FG001|Overall Study|Lost to Follow-up|0|||
164239206|NCT01904721|593247795|FG002|Overall Study|Lost to Follow-up|0|||
164239207|NCT01904721|593247796|FG003|Overall Study|Lost to Follow-up|0|||
164239208|NCT01904721|593247797|FG004|Overall Study|Lost to Follow-up|1|||
164573371|NCT04439344|594463396|FG000|Overall Study|Ineligible|3|||
164239209|NCT01904721|593247798|FG005|Overall Study|Lost to Follow-up|3|||
164239210|NCT01904721|593247799|FG006|Overall Study|Lost to Follow-up|1|||
164239211|NCT01904721|593247793|FG000|Overall Study|Lack of Efficacy|0|||
164239212|NCT01904721|593247794|FG001|Overall Study|Lack of Efficacy|0|||
164239213|NCT01904721|593247795|FG002|Overall Study|Lack of Efficacy|0|||
164677599|NCT01695239|594844834|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
164677600|NCT01695239|594844835|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
164677601|NCT01695239|594844836|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
164677602|NCT01695239|594844823|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
164677603|NCT01695239|594844824|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
164677604|NCT01695239|594844825|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
164677605|NCT01695239|594844826|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
164677606|NCT01695239|594844827|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
164677607|NCT01695239|594844828|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
164677608|NCT01695239|594844829|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
164677609|NCT01695239|594844830|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
164677610|NCT01695239|594844831|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
164677611|NCT01695239|594844832|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
164677612|NCT01695239|594844833|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
164677613|NCT01695239|594844834|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
164677614|NCT01695239|594844835|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
164677615|NCT01695239|594844836|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
164677616|NCT01695239|594844823|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
164677617|NCT01695239|594844824|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
164335751|NCT02913612|593606054|FG001|Overall Study|Local IRB decision|0|||
164425209|NCT00495469|593928401|FG000|Overall Study|ST depression at randomisation in ECG|0|||
164239214|NCT01904721|593247796|FG003|Overall Study|Lack of Efficacy|0|||
164239215|NCT01904721|593247797|FG004|Overall Study|Lack of Efficacy|0|||
164239216|NCT01904721|593247798|FG005|Overall Study|Lack of Efficacy|0|||
164239217|NCT01904721|593247799|FG006|Overall Study|Lack of Efficacy|1|||
164239218|NCT01904721|593247793|FG000|Overall Study|Adverse Event|0|||
164239219|NCT01904721|593247794|FG001|Overall Study|Adverse Event|0|||
164239220|NCT01904721|593247795|FG002|Overall Study|Adverse Event|0|||
164239221|NCT01904721|593247796|FG003|Overall Study|Adverse Event|0|||
164239222|NCT01904721|593247797|FG004|Overall Study|Adverse Event|3|||
164239223|NCT01904721|593247798|FG005|Overall Study|Adverse Event|1|||
164239224|NCT01904721|593247799|FG006|Overall Study|Adverse Event|0|||
164239225|NCT00532844|593247800|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
164239226|NCT00532844|593247801|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
164239227|NCT00532844|593247800|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
164239228|NCT00532844|593247801|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
164239229|NCT00532844|593247800|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
164239230|NCT00532844|593247801|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
164239231|NCT00532844|593247800|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
164239232|NCT00532844|593247801|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
164239233|NCT00532844|593247800|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
164239234|NCT00532844|593247801|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
164239235|NCT01077063|593247803|FG000|Overall Study|Adverse Event|3|||
164239236|NCT01077063|593247804|FG001|Overall Study|Adverse Event|0|||
164239237|NCT01077063|593247803|FG000|Overall Study|Death|1|||
164239238|NCT01077063|593247804|FG001|Overall Study|Death|1|||
164239239|NCT01077063|593247803|FG000|Overall Study|Withdrawal by Subject|0|||
164239240|NCT01077063|593247804|FG001|Overall Study|Withdrawal by Subject|2|||
164239241|NCT02750930|593247805|FG000|Overall Study|Study closed/terminated|8|||
164239242|NCT00553631|593247807|FG000|Overall Study|Withdrawal by Subject|0|||
164239243|NCT00553631|593247808|FG001|Overall Study|Withdrawal by Subject|1|||
164239244|NCT00553631|593247807|FG000|Overall Study|Lost to Follow-up|1|||
164239245|NCT00553631|593247808|FG001|Overall Study|Lost to Follow-up|0|||
164239246|NCT02761642|593247809|FG000|Overall Study|Did not Receive Study Treatment|3|||
164239247|NCT02761642|593247809|FG000|Overall Study|Adverse Event|13|||
164239248|NCT02761642|593247809|FG000|Overall Study|Withdrawal by Subject|2|||
164239249|NCT02761642|593247809|FG000|Overall Study|Non-compliant|7|||
164239250|NCT02761642|593247809|FG000|Overall Study|Death|3|||
164239251|NCT02761642|593247809|FG000|Overall Study|Lack of Efficacy|20|||
164239252|NCT02761642|593247809|FG000|Overall Study|Physician Decision|1|||
164239253|NCT02761642|593247809|FG000|Overall Study|Reason Unspecified|21|||
164239254|NCT02850978|593247810|FG000|Overall Study|Uncollectable CRF|27|||
164239255|NCT02850978|593247810|FG000|Overall Study|No visit since the first visit|35|||
164239256|NCT02850978|593247810|FG000|Overall Study|Adverse Event|81|||
164239257|NCT02850978|593247810|FG000|Overall Study|Lack of Efficacy|40|||
164239258|NCT02850978|593247810|FG000|Overall Study|Improvement in condition|34|||
164239259|NCT02850978|593247810|FG000|Overall Study|Lost to Follow-up|121|||
164239260|NCT02850978|593247810|FG000|Overall Study|Reason not listed|88|||
164239261|NCT00114127|593247811|FG000|Overall Study|Adverse Event|2|||
164239262|NCT00114127|593247812|FG001|Overall Study|Adverse Event|1|||
164239263|NCT00114127|593247811|FG000|Overall Study|Lost to Follow-up|1|||
164239264|NCT00114127|593247812|FG001|Overall Study|Lost to Follow-up|0|||
164239265|NCT00114127|593247811|FG000|Overall Study|Withdrawal by Subject|1|||
164239266|NCT00114127|593247812|FG001|Overall Study|Withdrawal by Subject|3|||
164239267|NCT00251693|593247813|FG000|Overall Study|Adverse Event|17|||
164239268|NCT00251693|593247814|FG001|Overall Study|Adverse Event|9|||
164239269|NCT00251693|593247815|FG002|Overall Study|Adverse Event|9|||
164239270|NCT00251693|593247813|FG000|Overall Study|Protocol Violation|2|||
164239271|NCT00251693|593247814|FG001|Overall Study|Protocol Violation|0|||
164239272|NCT00251693|593247815|FG002|Overall Study|Protocol Violation|2|||
164239273|NCT00251693|593247813|FG000|Overall Study|Lost to Follow-up|12|||
164239274|NCT00251693|593247814|FG001|Overall Study|Lost to Follow-up|7|||
164239275|NCT00251693|593247815|FG002|Overall Study|Lost to Follow-up|8|||
164239276|NCT00251693|593247813|FG000|Overall Study|Withdrawal by Subject|11|||
164239277|NCT00251693|593247814|FG001|Overall Study|Withdrawal by Subject|17|||
164239278|NCT00251693|593247815|FG002|Overall Study|Withdrawal by Subject|14|||
164239279|NCT00251693|593247813|FG000|Overall Study|Lack of Efficacy|0|||
164239280|NCT00251693|593247814|FG001|Overall Study|Lack of Efficacy|1|||
164239281|NCT00251693|593247815|FG002|Overall Study|Lack of Efficacy|0|||
164239282|NCT00251693|593247813|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
164239283|NCT00251693|593247814|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
164239284|NCT00251693|593247815|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
164239285|NCT00251693|593247813|FG000|Overall Study|Noncompliant|0|||
164239286|NCT00251693|593247814|FG001|Overall Study|Noncompliant|0|||
164239287|NCT00251693|593247815|FG002|Overall Study|Noncompliant|2|||
164239288|NCT00251693|593247813|FG000|Overall Study|Possible Barrett's esophagus|3|||
164239289|NCT00251693|593247814|FG001|Overall Study|Possible Barrett's esophagus|5|||
164239290|NCT00251693|593247815|FG002|Overall Study|Possible Barrett's esophagus|2|||
164239291|NCT00251693|593247813|FG000|Overall Study|Subject request/subject unavailable|1|||
164239292|NCT00251693|593247814|FG001|Overall Study|Subject request/subject unavailable|2|||
164239293|NCT00251693|593247815|FG002|Overall Study|Subject request/subject unavailable|0|||
164239294|NCT00251693|593247813|FG000|Overall Study|Abnormal laboratory findings|0|||
164239295|NCT00251693|593247814|FG001|Overall Study|Abnormal laboratory findings|0|||
164239296|NCT00251693|593247815|FG002|Overall Study|Abnormal laboratory findings|1|||
164239297|NCT00570713|593247816|FG000|Overall Study|Adverse Event|16|||
164239298|NCT00570713|593247817|FG001|Overall Study|Adverse Event|9|||
164239299|NCT00570713|593247816|FG000|Overall Study|Death|7|||
164239300|NCT00570713|593247817|FG001|Overall Study|Death|7|||
164239301|NCT00570713|593247816|FG000|Overall Study|Lack of Efficacy|40|||
164239302|NCT00570713|593247817|FG001|Overall Study|Lack of Efficacy|49|||
164239303|NCT00570713|593247816|FG000|Overall Study|Physician Decision|2|||
164239304|NCT00570713|593247817|FG001|Overall Study|Physician Decision|2|||
164239305|NCT00570713|593247816|FG000|Overall Study|Withdrawal by Subject|3|||
164239306|NCT00570713|593247817|FG001|Overall Study|Withdrawal by Subject|3|||
164239307|NCT00570713|593247816|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
164239308|NCT00570713|593247817|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
164239309|NCT00469833|593247819|FG000|Overall Study|No IV access|2|||
164239310|NCT01816048|593247823|FG000|Overall Study|Adverse Event|1|||
164239311|NCT01816048|593247823|FG000|Overall Study|Death|1|||
164239312|NCT01816048|593247823|FG000|Overall Study|Withdrawal by Subject|1|||
164239313|NCT01816048|593247823|FG000|Overall Study|Disease Progression|3|||
164239314|NCT04422431|593247824|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
164239315|NCT04422431|593247824|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
164239316|NCT04422431|593247824|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
164239317|NCT04422431|593247824|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
164239318|NCT04422431|593247824|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
164239319|NCT04422431|593247824|FG000|Extension Period (48 Weeks)|Other than specified|2|||
164239320|NCT01174563|593247825|FG000|Overall Study|Progressive Disease|45|||
164239321|NCT01174563|593247825|FG000|Overall Study|Death|5|||
164239322|NCT01174563|593247825|FG000|Overall Study|Investigator's Discretion|5|||
164239323|NCT01174563|593247825|FG000|Overall Study|Participant Withdrew Consent|3|||
164239324|NCT01174563|593247825|FG000|Overall Study|Rash Adverse Event|1|||
164239325|NCT01174563|593247825|FG000|Overall Study|Sponsor's decision|1|||
164239326|NCT03402841|593247826|FG000|Overall Study|Withdrawal by Subject|3|||
164239327|NCT03402841|593247826|FG000|Overall Study|Lost to Follow-up|2|||
164239328|NCT03402841|593247826|FG000|Overall Study|Death|146|||
164335752|NCT02913612|593606055|FG002|Overall Study|Local IRB decision|0|||
164335753|NCT02913612|593606056|FG003|Overall Study|Local IRB decision|0|||
164335754|NCT02913612|593606053|FG000|Overall Study|Study drug non-compliance|1|||
164335755|NCT02913612|593606054|FG001|Overall Study|Study drug non-compliance|1|||
164335756|NCT02913612|593606055|FG002|Overall Study|Study drug non-compliance|0|||
164335757|NCT02913612|593606056|FG003|Overall Study|Study drug non-compliance|0|||
164335758|NCT02913612|593606053|FG000|Overall Study|Insurance issues|0|||
164335759|NCT02913612|593606054|FG001|Overall Study|Insurance issues|1|||
164335760|NCT02913612|593606055|FG002|Overall Study|Insurance issues|0|||
164335761|NCT02913612|593606056|FG003|Overall Study|Insurance issues|0|||
164335762|NCT02913612|593606053|FG000|Overall Study|Needed to treat second hemangioma|0|||
164677618|NCT01695239|594844825|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
164677619|NCT01695239|594844826|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
164677620|NCT01695239|594844827|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
164677621|NCT01695239|594844828|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
164677622|NCT01695239|594844829|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
164677623|NCT01695239|594844830|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
164677624|NCT01695239|594844831|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
164677625|NCT01695239|594844832|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
164677626|NCT01695239|594844833|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
164677627|NCT01695239|594844834|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
164677628|NCT01695239|594844835|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
164677629|NCT01695239|594844836|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
164677630|NCT01695239|594844823|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
164677631|NCT01695239|594844824|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
164677632|NCT01695239|594844825|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
164677633|NCT01695239|594844826|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
164677634|NCT01695239|594844827|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
164677635|NCT01695239|594844828|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
164677636|NCT01695239|594844829|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
164677637|NCT01695239|594844830|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
164677638|NCT01695239|594844831|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
164335763|NCT02913612|593606054|FG001|Overall Study|Needed to treat second hemangioma|1|||
164239329|NCT00444106|593247829|FG000|Overall Study|Lost to Follow-up|2|||
164239330|NCT00444106|593247830|FG001|Overall Study|Lost to Follow-up|1|||
164239331|NCT00444106|593247831|FG002|Overall Study|Lost to Follow-up|0|||
164239332|NCT00444106|593247829|FG000|Overall Study|Abnormal Test Procedure Results|0|||
164239333|NCT00444106|593247830|FG001|Overall Study|Abnormal Test Procedure Results|0|||
164239334|NCT00444106|593247831|FG002|Overall Study|Abnormal Test Procedure Results|1|||
164239335|NCT00038948|593247832|FG000|Overall Study|Adverse Event|131|||
164239336|NCT00038948|593247833|FG001|Overall Study|Adverse Event|43|||
164239337|NCT00038948|593247832|FG000|Overall Study|Lost to Follow-up|4|||
164239338|NCT00038948|593247833|FG001|Overall Study|Lost to Follow-up|4|||
164239339|NCT00038948|593247832|FG000|Overall Study|Nonmedical event|5|||
164239340|NCT00038948|593247833|FG001|Overall Study|Nonmedical event|7|||
164239341|NCT00038948|593247832|FG000|Overall Study|Withdrawal by Subject|23|||
164239342|NCT00038948|593247833|FG001|Overall Study|Withdrawal by Subject|10|||
164239343|NCT00038948|593247832|FG000|Overall Study|Protocol Violation|3|||
164239344|NCT00038948|593247833|FG001|Overall Study|Protocol Violation|7|||
164239345|NCT00038948|593247832|FG000|Overall Study|Lack of Efficacy|3|||
164239346|NCT00038948|593247833|FG001|Overall Study|Lack of Efficacy|6|||
164239347|NCT05270863|593247834|FG000|Visit 2 First Intervention|Randomization error|0|||
164239348|NCT05270863|593247835|FG001|Visit 2 First Intervention|Randomization error|0|||
164239349|NCT05270863|593247836|FG002|Visit 2 First Intervention|Randomization error|0|||
164239350|NCT05270863|593247837|FG003|Visit 2 First Intervention|Randomization error|1|||
164239351|NCT05270863|593247838|FG004|Visit 2 First Intervention|Randomization error|0|||
164239352|NCT05270863|593247839|FG005|Visit 2 First Intervention|Randomization error|0|||
164239353|NCT05270863|593247834|FG000|First Washout|Withdrawal by Subject|0|||
164239354|NCT05270863|593247835|FG001|First Washout|Withdrawal by Subject|0|||
164239355|NCT05270863|593247836|FG002|First Washout|Withdrawal by Subject|0|||
164239356|NCT05270863|593247837|FG003|First Washout|Withdrawal by Subject|0|||
164239357|NCT05270863|593247838|FG004|First Washout|Withdrawal by Subject|1|||
164239358|NCT05270863|593247839|FG005|First Washout|Withdrawal by Subject|1|||
164239359|NCT05270863|593247834|FG000|First Washout|Lost to Follow-up|0|||
164239360|NCT05270863|593247835|FG001|First Washout|Lost to Follow-up|0|||
164239361|NCT05270863|593247836|FG002|First Washout|Lost to Follow-up|0|||
164239362|NCT05270863|593247837|FG003|First Washout|Lost to Follow-up|0|||
164239363|NCT05270863|593247838|FG004|First Washout|Lost to Follow-up|0|||
164239364|NCT05270863|593247839|FG005|First Washout|Lost to Follow-up|1|||
164239365|NCT05270863|593247834|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
164239366|NCT05270863|593247835|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
164239367|NCT05270863|593247836|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
164239368|NCT05270863|593247837|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
164239369|NCT05270863|593247838|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
164239370|NCT05270863|593247839|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
164239371|NCT05270863|593247834|FG000|Second Washout|Withdrawal by Subject|1|||
164239372|NCT05270863|593247835|FG001|Second Washout|Withdrawal by Subject|1|||
164239373|NCT05270863|593247836|FG002|Second Washout|Withdrawal by Subject|0|||
164239374|NCT05270863|593247837|FG003|Second Washout|Withdrawal by Subject|0|||
164239375|NCT05270863|593247838|FG004|Second Washout|Withdrawal by Subject|0|||
164239376|NCT05270863|593247839|FG005|Second Washout|Withdrawal by Subject|0|||
164239377|NCT05270863|593247834|FG000|Second Washout|Lost to Follow-up|0|||
164239378|NCT05270863|593247835|FG001|Second Washout|Lost to Follow-up|0|||
164239379|NCT05270863|593247836|FG002|Second Washout|Lost to Follow-up|0|||
164239380|NCT05270863|593247837|FG003|Second Washout|Lost to Follow-up|1|||
164239381|NCT05270863|593247838|FG004|Second Washout|Lost to Follow-up|0|||
164239382|NCT05270863|593247839|FG005|Second Washout|Lost to Follow-up|0|||
164239383|NCT03984188|593247840|FG000|Overall Study|Death|2|||
164239384|NCT03984188|593247841|FG001|Overall Study|Death|4|||
164239385|NCT03984188|593247840|FG000|Overall Study|Physician Decision|0|||
164239386|NCT03984188|593247841|FG001|Overall Study|Physician Decision|2|||
164239387|NCT03984188|593247840|FG000|Overall Study|Lost to Follow-up|3|||
164239388|NCT03984188|593247841|FG001|Overall Study|Lost to Follow-up|2|||
164239389|NCT03984188|593247840|FG000|Overall Study|Withdrawal by Subject|6|||
164239390|NCT03984188|593247841|FG001|Overall Study|Withdrawal by Subject|0|||
164239391|NCT00552071|593250013|FG000|Overall Study|Adverse Event|1|||
164239392|NCT00552071|593250014|FG001|Overall Study|Adverse Event|0|||
164239393|NCT00552071|593250013|FG000|Overall Study|Lack of Efficacy|1|||
164239394|NCT00552071|593250014|FG001|Overall Study|Lack of Efficacy|0|||
164239395|NCT00552071|593250013|FG000|Overall Study|Physician Decision|1|||
164239396|NCT00552071|593250014|FG001|Overall Study|Physician Decision|0|||
164239397|NCT00552071|593250013|FG000|Overall Study|Pregnancy|1|||
164239398|NCT00552071|593250014|FG001|Overall Study|Pregnancy|0|||
164239399|NCT00552071|593250013|FG000|Overall Study|Death|0|||
164239400|NCT00552071|593250014|FG001|Overall Study|Death|1|||
164239401|NCT00552071|593250013|FG000|Overall Study|Withdrawal by Subject|0|||
164239402|NCT00552071|593250014|FG001|Overall Study|Withdrawal by Subject|1|||
164239403|NCT00272792|593250015|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
164239404|NCT00272792|593250016|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
164239405|NCT00272792|593250015|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
164239406|NCT00272792|593250016|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
164239407|NCT00272792|593250015|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
164239408|NCT00272792|593250016|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
164239409|NCT00272792|593250015|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
164239410|NCT00272792|593250016|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
164239411|NCT00937495|593250021|FG000|Overall Study|Protocol Violation|2|||
164239412|NCT02549989|593250022|FG000|Overall Study|Adverse Event|4|||
164239413|NCT02549989|593250022|FG000|Overall Study|Death|1|||
164239414|NCT02549989|593250022|FG000|Overall Study|Lack of Efficacy|19|||
164239415|NCT02549989|593250022|FG000|Overall Study|Withdrawal by Subject|3|||
164239416|NCT02628444|593250026|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
164239417|NCT02628444|593250027|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
164239418|NCT02628444|593250028|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
164239419|NCT02628444|593250029|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
164239420|NCT02628444|593250030|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
164239421|NCT02628444|593250031|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
164239422|NCT02628444|593250032|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
164239423|NCT02628444|593250033|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
164239424|NCT02628444|593250034|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
164239425|NCT02628444|593250026|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
164239426|NCT02628444|593250027|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
164239427|NCT02628444|593250028|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
164239428|NCT02628444|593250029|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
164239429|NCT02628444|593250030|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
164239430|NCT02628444|593250031|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
164239431|NCT02628444|593250032|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
164239432|NCT02628444|593250033|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
164239433|NCT02628444|593250034|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
164239434|NCT02628444|593250026|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
164239435|NCT02628444|593250027|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
164239436|NCT02628444|593250028|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
164239437|NCT02628444|593250029|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
164239438|NCT02628444|593250030|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
164239439|NCT02628444|593250031|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
164239440|NCT02628444|593250032|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
164239441|NCT02628444|593250033|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
164239442|NCT02628444|593250034|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
164239443|NCT02628444|593250026|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
164239444|NCT02628444|593250027|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
164239445|NCT02628444|593250028|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
164239446|NCT02628444|593250029|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
164239447|NCT02628444|593250030|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
164239448|NCT02628444|593250031|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
164239449|NCT02628444|593250032|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
164239450|NCT02628444|593250033|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
164239451|NCT02628444|593250034|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
164425210|NCT00495469|593928402|FG001|Overall Study|ST depression at randomisation in ECG|1|||
164425211|NCT00495469|593928403|FG002|Overall Study|ST depression at randomisation in ECG|0|||
164425212|NCT00495469|593928404|FG003|Overall Study|ST depression at randomisation in ECG|0|||
164425213|NCT00495469|593928405|FG004|Overall Study|ST depression at randomisation in ECG|0|||
164239452|NCT02628444|593250026|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
164239453|NCT02628444|593250027|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
164239454|NCT02628444|593250028|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
164239455|NCT02628444|593250029|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
164239456|NCT02628444|593250030|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
164239457|NCT02628444|593250031|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
164425214|NCT00495469|593928406|FG005|Overall Study|ST depression at randomisation in ECG|0|||
164425215|NCT00495469|593928407|FG006|Overall Study|ST depression at randomisation in ECG|0|||
164425216|NCT00926393|593928408|FG000|Overall Study|Withdrawal by Subject|1|||
164425217|NCT00926393|593928409|FG001|Overall Study|Withdrawal by Subject|2|||
164239458|NCT02628444|593250032|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
164239459|NCT02628444|593250033|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
164239460|NCT02628444|593250034|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
164239461|NCT02628444|593250026|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
164239462|NCT02628444|593250027|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
164239463|NCT02628444|593250028|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
164239464|NCT02628444|593250029|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
164239465|NCT02628444|593250030|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
164239466|NCT02628444|593250031|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
164239467|NCT02628444|593250032|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
164239468|NCT02628444|593250033|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
164573372|NCT04439344|594463396|FG000|Overall Study|Adverse Event|13|||
164573373|NCT04439344|594463396|FG000|Overall Study|Death|2|||
164239469|NCT02628444|593250034|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
164239470|NCT02628444|593250026|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
164239471|NCT02628444|593250027|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
164239472|NCT02628444|593250028|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
164239473|NCT02628444|593250029|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
164239474|NCT02628444|593250030|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
164239475|NCT02628444|593250031|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
164239476|NCT02628444|593250032|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
164239477|NCT02628444|593250033|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
164239478|NCT02628444|593250034|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
164239479|NCT02628444|593250026|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
164239480|NCT02628444|593250027|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
164239481|NCT02628444|593250028|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
164239482|NCT02628444|593250029|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
164239483|NCT02628444|593250030|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
164239484|NCT02628444|593250031|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
164239485|NCT02628444|593250032|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
164239486|NCT02628444|593250033|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
164239487|NCT02628444|593250034|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
164239488|NCT02628444|593250026|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
164239489|NCT02628444|593250027|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
164239490|NCT02628444|593250028|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
164239491|NCT02628444|593250029|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
164239492|NCT02628444|593250030|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
164239493|NCT02628444|593250031|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
164239494|NCT02628444|593250032|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
164239495|NCT02628444|593250033|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
164239496|NCT02628444|593250034|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
164239497|NCT02628444|593250026|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
164239498|NCT02628444|593250027|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
164239499|NCT02628444|593250028|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
164239500|NCT02628444|593250029|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
164239501|NCT02628444|593250030|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
164239502|NCT02628444|593250031|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
164239503|NCT02628444|593250032|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
164239504|NCT02628444|593250033|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
164239505|NCT02628444|593250034|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
164239506|NCT00288015|593250035|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
164239507|NCT00288015|593250035|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
164239508|NCT00288015|593250035|FG000|First Response Assessment|Withdrawal by Subject|1|||
164239509|NCT00288015|593250035|FG000|First Response Assessment|Death|1|||
164239510|NCT00288015|593250035|FG000|First Response Assessment|Physician Decision|2|||
164239511|NCT00288015|593250035|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
164239512|NCT00288015|593250035|FG000|Follow up for Survival x 2 Years|Death|13|||
164239513|NCT00288015|593250035|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
164239514|NCT00288015|593250035|FG000|Follow up for Survival x 2 Years|Other|9|||
164239515|NCT00443703|593250036|FG000|Overall Study|Never Treated|3|||
164239516|NCT00443703|593250037|FG001|Overall Study|Never Treated|1|||
164239517|NCT00443703|593250036|FG000|Overall Study|Adverse Event|7|||
164573374|NCT04439344|594463396|FG000|Overall Study|Disease progression|29|||
164573375|NCT04439344|594463396|FG000|Overall Study|Withdrawal by Subject|2|||
164573376|NCT04439344|594463396|FG000|Overall Study|Alternative therapy|1|||
164239518|NCT00443703|593250037|FG001|Overall Study|Adverse Event|3|||
164239519|NCT00443703|593250036|FG000|Overall Study|Lack of Efficacy|3|||
164239520|NCT00443703|593250037|FG001|Overall Study|Lack of Efficacy|1|||
164239521|NCT00443703|593250036|FG000|Overall Study|Lost to Follow-up|0|||
164239522|NCT00443703|593250037|FG001|Overall Study|Lost to Follow-up|4|||
164239523|NCT00443703|593250036|FG000|Overall Study|Physician Decision|4|||
164239524|NCT00443703|593250037|FG001|Overall Study|Physician Decision|2|||
164239525|NCT00443703|593250036|FG000|Overall Study|Protocol Violation|1|||
164239526|NCT00443703|593250037|FG001|Overall Study|Protocol Violation|1|||
164239527|NCT00443703|593250036|FG000|Overall Study|Withdrawal by Subject|9|||
164239528|NCT00443703|593250037|FG001|Overall Study|Withdrawal by Subject|6|||
164239529|NCT00443703|593250036|FG000|Overall Study|Progressive Disease|1|||
164239530|NCT00443703|593250037|FG001|Overall Study|Progressive Disease|0|||
164239531|NCT01333722|593250038|FG000|Overall Study|Lack of Efficacy|0|||
164239532|NCT01333722|593250039|FG001|Overall Study|Lack of Efficacy|2|||
164239533|NCT01333722|593250038|FG000|Overall Study|Withdrawal by Subject|0|||
164239534|NCT01333722|593250039|FG001|Overall Study|Withdrawal by Subject|1|||
164239535|NCT00784368|593250042|FG000|Overall Study|Physician Decision|0|||
164239536|NCT00784368|593250043|FG001|Overall Study|Physician Decision|0|||
164239537|NCT00784368|593250044|FG002|Overall Study|Physician Decision|6|||
164239538|NCT00784368|593250042|FG000|Overall Study|Lack of Efficacy|2|||
164239539|NCT00784368|593250043|FG001|Overall Study|Lack of Efficacy|0|||
164239540|NCT00784368|593250044|FG002|Overall Study|Lack of Efficacy|1|||
164239541|NCT00784368|593250042|FG000|Overall Study|Adverse Event|6|||
164239542|NCT00784368|593250043|FG001|Overall Study|Adverse Event|9|||
164239543|NCT00784368|593250044|FG002|Overall Study|Adverse Event|2|||
164239544|NCT00784368|593250042|FG000|Overall Study|Diagnosis of fever|0|||
164239545|NCT00784368|593250043|FG001|Overall Study|Diagnosis of fever|0|||
164239546|NCT00784368|593250044|FG002|Overall Study|Diagnosis of fever|1|||
164239547|NCT00784368|593250042|FG000|Overall Study|Worsening of complications|0|||
164239548|NCT00784368|593250043|FG001|Overall Study|Worsening of complications|0|||
164239549|NCT00784368|593250044|FG002|Overall Study|Worsening of complications|1|||
164239550|NCT00784368|593250042|FG000|Overall Study|Worsening of symptoms|0|||
164239551|NCT00784368|593250043|FG001|Overall Study|Worsening of symptoms|1|||
164239552|NCT00784368|593250044|FG002|Overall Study|Worsening of symptoms|0|||
164239553|NCT00784368|593250042|FG000|Overall Study|Withdrawal of informed consent|0|||
164239554|NCT00784368|593250043|FG001|Overall Study|Withdrawal of informed consent|1|||
164239555|NCT00784368|593250044|FG002|Overall Study|Withdrawal of informed consent|0|||
164239556|NCT02079909|593250045|FG000|Overall Study|Adverse Event|23|||
164239557|NCT02079909|593250046|FG001|Overall Study|Adverse Event|23|||
164239558|NCT02079909|593250047|FG002|Overall Study|Adverse Event|7|||
164239559|NCT02079909|593250045|FG000|Overall Study|Withdrawal by Subject|9|||
164239560|NCT02079909|593250046|FG001|Overall Study|Withdrawal by Subject|17|||
164239561|NCT02079909|593250047|FG002|Overall Study|Withdrawal by Subject|4|||
164239562|NCT02079909|593250045|FG000|Overall Study|Lost to Follow-up|2|||
164573377|NCT03770403|594463402|FG000|Overall Study|Adverse Event|8|||
164239563|NCT02079909|593250046|FG001|Overall Study|Lost to Follow-up|3|||
164239564|NCT02079909|593250047|FG002|Overall Study|Lost to Follow-up|1|||
164239565|NCT02079909|593250045|FG000|Overall Study|Death|2|||
164239566|NCT02079909|593250046|FG001|Overall Study|Death|2|||
164239567|NCT02079909|593250047|FG002|Overall Study|Death|0|||
164239568|NCT02079909|593250045|FG000|Overall Study|Lack of Efficacy|0|||
164239569|NCT02079909|593250046|FG001|Overall Study|Lack of Efficacy|0|||
164239570|NCT02079909|593250047|FG002|Overall Study|Lack of Efficacy|1|||
164239571|NCT02079909|593250045|FG000|Overall Study|Protocol Violation|0|||
164239572|NCT02079909|593250046|FG001|Overall Study|Protocol Violation|1|||
164239573|NCT02079909|593250047|FG002|Overall Study|Protocol Violation|1|||
164239574|NCT02079909|593250045|FG000|Overall Study|Physician Decision|0|||
164239575|NCT02079909|593250046|FG001|Overall Study|Physician Decision|1|||
164239576|NCT02079909|593250047|FG002|Overall Study|Physician Decision|1|||
164239577|NCT02079909|593250045|FG000|Overall Study|Relocation etc.|2|||
164239578|NCT02079909|593250046|FG001|Overall Study|Relocation etc.|2|||
164239579|NCT02079909|593250047|FG002|Overall Study|Relocation etc.|3|||
164239580|NCT00720356|593250052|FG000|Registration to Study|Determined to have methylated MGMT|67|||
164239581|NCT00720356|593250052|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
164239582|NCT00720356|593250052|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
164239583|NCT00720356|593250052|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
164573378|NCT03770403|594463402|FG000|Overall Study|Death|5|||
164425218|NCT00926393|593928408|FG000|Overall Study|Adverse Event|1|||
164425219|NCT00926393|593928409|FG001|Overall Study|Adverse Event|1|||
164239584|NCT00720356|593250052|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
164239585|NCT00720356|593250052|FG000|Follow up Until Death|Withdrawal by Subject|1|||
164239586|NCT00720356|593250052|FG000|Follow up Until Death|Alive at last data collection|4|||
164239587|NCT02237001|593250055|FG000|Overall Study|Lost to Follow-up|2|||
164239588|NCT02237001|593250055|FG000|Overall Study|Withdrawal by Subject|1|||
164239589|NCT02237001|593250055|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
164239590|NCT02237001|593250055|FG000|Overall Study|Re-operation|4|||
164239591|NCT02237001|593250055|FG000|Overall Study|Incarceration|1|||
164239592|NCT01047007|593250056|FG000|Overall Study|Adverse Event|0|||
164239593|NCT01047007|593250057|FG001|Overall Study|Adverse Event|2|||
164239594|NCT01047007|593250058|FG002|Overall Study|Adverse Event|1|||
164239595|NCT01047007|593250059|FG003|Overall Study|Adverse Event|0|||
164239596|NCT01047007|593250056|FG000|Overall Study|Progressive Disease|2|||
164239597|NCT01047007|593250057|FG001|Overall Study|Progressive Disease|4|||
164239598|NCT01047007|593250058|FG002|Overall Study|Progressive Disease|1|||
164239599|NCT01047007|593250059|FG003|Overall Study|Progressive Disease|0|||
164239600|NCT03759600|593250062|FG000|Overall Study|Adverse Event|2|||
164239601|NCT03759600|593250062|FG000|Overall Study|Progressive Disease|15|||
164239602|NCT03759600|593250062|FG000|Overall Study|Site Terminated by Sponsor|3|||
164239603|NCT00457392|593250064|FG000|Overall Study|Objective Progression or Relapse|229|||
164239604|NCT00457392|593250065|FG001|Overall Study|Objective Progression or Relapse|296|||
164239605|NCT00457392|593250064|FG000|Overall Study|Death|106|||
164239606|NCT00457392|593250065|FG001|Overall Study|Death|106|||
164239607|NCT00457392|593250064|FG000|Overall Study|Adverse Event|84|||
164239608|NCT00457392|593250065|FG001|Overall Study|Adverse Event|41|||
164239609|NCT00457392|593250064|FG000|Overall Study|Global Deterioration of Health Status|22|||
164239610|NCT00457392|593250065|FG001|Overall Study|Global Deterioration of Health Status|8|||
164239611|NCT00457392|593250064|FG000|Overall Study|Withdrawal by Subject|14|||
164239612|NCT00457392|593250065|FG001|Overall Study|Withdrawal by Subject|8|||
164239613|NCT00457392|593250064|FG000|Overall Study|Lost to Follow-up|6|||
164239614|NCT00457392|593250065|FG001|Overall Study|Lost to Follow-up|7|||
164239615|NCT00457392|593250064|FG000|Overall Study|Protocol Violation|4|||
164239616|NCT00457392|593250065|FG001|Overall Study|Protocol Violation|3|||
164239617|NCT00457392|593250064|FG000|Overall Study|Other|7|||
164239618|NCT00457392|593250065|FG001|Overall Study|Other|4|||
164239619|NCT00457392|593250064|FG000|Overall Study|Study Terminated by Sponsor|1|||
164239620|NCT00457392|593250065|FG001|Overall Study|Study Terminated by Sponsor|4|||
164239621|NCT00457392|593250064|FG000|Overall Study|Randomized, Not Treated|7|||
164239622|NCT00457392|593250065|FG001|Overall Study|Randomized, Not Treated|3|||
164239623|NCT00756275|593250066|FG000|Overall Study|Lost to Follow-up|25|||
164239624|NCT00756275|593250067|FG001|Overall Study|Lost to Follow-up|21|||
164239625|NCT00756275|593250066|FG000|Overall Study|Withdrawal by Subject|4|||
164239626|NCT00756275|593250067|FG001|Overall Study|Withdrawal by Subject|7|||
164239627|NCT00980148|593250068|FG000|Overall Study|Discharged from facility|89|||
164239628|NCT00980148|593250069|FG001|Overall Study|Discharged from facility|96|||
164239629|NCT00980148|593250068|FG000|Overall Study|Received other antichlamydia treatment|20|||
164239630|NCT00980148|593250069|FG001|Overall Study|Received other antichlamydia treatment|14|||
164239631|NCT00980148|593250068|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
164239632|NCT00980148|593250069|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
164239633|NCT00980148|593250068|FG000|Overall Study|Various other reasons|8|||
164239634|NCT00980148|593250069|FG001|Overall Study|Various other reasons|9|||
164239635|NCT02903823|593250070|FG000|Overall Study|Physician Decision|5|||
164239636|NCT02903823|593250070|FG000|Overall Study|Could not advance catheter|1|||
164239637|NCT02903823|593250070|FG000|Overall Study|Catheter dislodgement|1|||
164239638|NCT02852967|593250071|FG000|Overall Study|Adverse Event|3|||
164239639|NCT02852967|593250072|FG001|Overall Study|Adverse Event|1|||
164239640|NCT02852967|593250073|FG002|Overall Study|Adverse Event|0|||
164573379|NCT03770403|594463402|FG000|Overall Study|Physician Decision|1|||
164573380|NCT03770403|594463402|FG000|Overall Study|Sponsor decision|1|||
164573381|NCT03770403|594463402|FG000|Overall Study|Study terminated by Sponsor|1|||
164573382|NCT03770403|594463402|FG000|Overall Study|Withdrawal by Subject|13|||
164573383|NCT03770403|594463402|FG000|Overall Study|Other|88|||
164239641|NCT02852967|593250074|FG003|Overall Study|Adverse Event|1|||
164239642|NCT02852967|593250075|FG004|Overall Study|Adverse Event|0|||
164239643|NCT02852967|593250071|FG000|Overall Study|Death|1|||
164239644|NCT02852967|593250072|FG001|Overall Study|Death|0|||
164239645|NCT02852967|593250073|FG002|Overall Study|Death|0|||
164239646|NCT02852967|593250074|FG003|Overall Study|Death|0|||
164239647|NCT02852967|593250075|FG004|Overall Study|Death|0|||
164239648|NCT02852967|593250071|FG000|Overall Study|Lost to Follow-up|1|||
164239649|NCT02852967|593250072|FG001|Overall Study|Lost to Follow-up|2|||
164239650|NCT02852967|593250073|FG002|Overall Study|Lost to Follow-up|3|||
164239651|NCT02852967|593250074|FG003|Overall Study|Lost to Follow-up|4|||
164239652|NCT02852967|593250075|FG004|Overall Study|Lost to Follow-up|4|||
164239653|NCT02852967|593250071|FG000|Overall Study|Withdrawal by Subject|6|||
164239654|NCT02852967|593250072|FG001|Overall Study|Withdrawal by Subject|12|||
164239655|NCT02852967|593250073|FG002|Overall Study|Withdrawal by Subject|7|||
164239656|NCT02852967|593250074|FG003|Overall Study|Withdrawal by Subject|10|||
164239657|NCT02852967|593250075|FG004|Overall Study|Withdrawal by Subject|10|||
164239658|NCT02852967|593250071|FG000|Overall Study|SAE|0|||
164239659|NCT02852967|593250072|FG001|Overall Study|SAE|0|||
164239660|NCT02852967|593250073|FG002|Overall Study|SAE|0|||
164239661|NCT02852967|593250074|FG003|Overall Study|SAE|3|||
164239662|NCT02852967|593250075|FG004|Overall Study|SAE|0|||
164239663|NCT02852967|593250071|FG000|Overall Study|Elevated Liver Enzymes|2|||
164425220|NCT01094743|593928415|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
164425221|NCT02851511|593928416|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
164425222|NCT02851511|593928417|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
164425223|NCT02851511|593928418|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
164425224|NCT02851511|593928419|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
164425225|NCT02851511|593928416|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
164425226|NCT02851511|593928417|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
164425227|NCT02851511|593928418|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
164425228|NCT02851511|593928419|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
164425229|NCT02851511|593928416|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
164425230|NCT02851511|593928417|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
164425231|NCT02851511|593928418|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
164425232|NCT02851511|593928419|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
164425233|NCT02851511|593928416|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
164425234|NCT02851511|593928417|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
164425235|NCT02851511|593928418|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
164425236|NCT02851511|593928419|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
164425237|NCT02851511|593928416|FG000|Phase I|Physician Decision|0|||
164425238|NCT02851511|593928417|FG001|Phase I|Physician Decision|0|||
164425239|NCT02851511|593928418|FG002|Phase I|Physician Decision|0|||
164425240|NCT02851511|593928419|FG003|Phase I|Physician Decision|1|||
164425241|NCT02851511|593928416|FG000|Phase I|Withdrawal by Subject|2|||
164425242|NCT02851511|593928417|FG001|Phase I|Withdrawal by Subject|1|||
164425243|NCT02851511|593928418|FG002|Phase I|Withdrawal by Subject|0|||
164425244|NCT02851511|593928419|FG003|Phase I|Withdrawal by Subject|3|||
164425245|NCT02851511|593928416|FG000|Phase II|Physician Decision|18|||
164425246|NCT02851511|593928417|FG001|Phase II|Physician Decision|16|||
164425247|NCT02851511|593928418|FG002|Phase II|Physician Decision|0|||
164425248|NCT02851511|593928419|FG003|Phase II|Physician Decision|0|||
164425249|NCT02851511|593928416|FG000|Phase II|Withdrawal by Subject|18|||
164425250|NCT02851511|593928417|FG001|Phase II|Withdrawal by Subject|16|||
164425251|NCT02851511|593928418|FG002|Phase II|Withdrawal by Subject|0|||
164425252|NCT02851511|593928419|FG003|Phase II|Withdrawal by Subject|0|||
164425253|NCT02851511|593928416|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
164425254|NCT02851511|593928417|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
164425255|NCT02851511|593928418|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
164425256|NCT02851511|593928419|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
164425257|NCT02851511|593928416|FG000|Phase II|Lost to Follow-up|0|||
164425258|NCT02851511|593928417|FG001|Phase II|Lost to Follow-up|1|||
164425259|NCT02851511|593928418|FG002|Phase II|Lost to Follow-up|0|||
164425260|NCT02851511|593928419|FG003|Phase II|Lost to Follow-up|0|||
164425261|NCT04004208|593928422|FG000|Overall Study|Withdrawal by parent/guardian|1|||
164425262|NCT04004208|593928423|FG001|Overall Study|Withdrawal by parent/guardian|1|||
164425263|NCT04004208|593928422|FG000|Overall Study|Death|3|||
164425264|NCT04004208|593928423|FG001|Overall Study|Death|0|||
164425265|NCT04004208|593928422|FG000|Overall Study|COVID-19 pandemic|1|||
164425266|NCT04004208|593928423|FG001|Overall Study|COVID-19 pandemic|0|||
164425267|NCT04004208|593928422|FG000|Overall Study|Physician Decision|1|||
164425268|NCT04004208|593928423|FG001|Overall Study|Physician Decision|0|||
164425269|NCT04004208|593928422|FG000|Overall Study|Adverse Event|1|||
164425270|NCT04004208|593928423|FG001|Overall Study|Adverse Event|1|||
164425271|NCT00051311|593928424|FG000|Overall Study|Starting new study|0|||
164425272|NCT00051311|593928425|FG001|Overall Study|Starting new study|1|||
164425273|NCT00051311|593928424|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
164425274|NCT00051311|593928425|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
164425275|NCT00051311|593928424|FG000|Overall Study|Death of recipient|8|||
164425276|NCT00051311|593928425|FG001|Overall Study|Death of recipient|8|||
164425277|NCT00051311|593928424|FG000|Overall Study|Recipient taken off study|4|||
164425278|NCT00051311|593928425|FG001|Overall Study|Recipient taken off study|4|||
164425279|NCT04990440|593928426|FG000|Overall Study|Sponsor's Decision|0|||
164425280|NCT04990440|593928427|FG001|Overall Study|Sponsor's Decision|0|||
164425281|NCT04990440|593928428|FG002|Overall Study|Sponsor's Decision|1|||
164425282|NCT04170023|593928429|FG000|LTE Period|Withdrawal by Subject|1|||
164573384|NCT03896295|594463403|FG000|Overall Study|Adverse Event|0|||
164573385|NCT03896295|594463404|FG001|Overall Study|Adverse Event|1|||
164573386|NCT03896295|594463403|FG000|Overall Study|COVID-19|7|||
164425283|NCT04170023|593928430|FG001|LTE Period|Withdrawal by Subject|0|||
164425284|NCT04170023|593928431|FG002|LTE Period|Withdrawal by Subject|0|||
164425285|NCT04170023|593928429|FG000|LTE Period|Study Termination|11|||
164425286|NCT04170023|593928430|FG001|LTE Period|Study Termination|11|||
164425287|NCT04170023|593928431|FG002|LTE Period|Study Termination|5|||
164425288|NCT03712098|593928432|FG000|Overall Study|Lost to Follow-up|3|||
164573387|NCT03896295|594463404|FG001|Overall Study|COVID-19|29|||
164573388|NCT01957137|594463405|FG000|Randomized Portion|Adverse Event|1|||
164425289|NCT03712098|593928433|FG001|Overall Study|Lost to Follow-up|7|||
164573389|NCT01957137|594463405|FG000|Randomized Portion|Withdrawal by Subject|1|||
164239664|NCT02852967|593250072|FG001|Overall Study|Elevated Liver Enzymes|0|||
164239665|NCT02852967|593250073|FG002|Overall Study|Elevated Liver Enzymes|0|||
164239666|NCT02852967|593250074|FG003|Overall Study|Elevated Liver Enzymes|2|||
164239667|NCT02852967|593250075|FG004|Overall Study|Elevated Liver Enzymes|2|||
164239668|NCT02852967|593250071|FG000|Overall Study|Physician Decision|0|||
164239669|NCT02852967|593250072|FG001|Overall Study|Physician Decision|0|||
164239670|NCT02852967|593250073|FG002|Overall Study|Physician Decision|0|||
164239671|NCT02852967|593250074|FG003|Overall Study|Physician Decision|1|||
164239672|NCT02852967|593250075|FG004|Overall Study|Physician Decision|0|||
164239673|NCT02852967|593250071|FG000|Overall Study|Lack of Efficacy|0|||
164239674|NCT02852967|593250072|FG001|Overall Study|Lack of Efficacy|1|||
164239675|NCT02852967|593250073|FG002|Overall Study|Lack of Efficacy|0|||
164239676|NCT02852967|593250074|FG003|Overall Study|Lack of Efficacy|0|||
164239677|NCT02852967|593250075|FG004|Overall Study|Lack of Efficacy|0|||
164239678|NCT02852967|593250071|FG000|Overall Study|Non-compliance|0|||
164239679|NCT02852967|593250072|FG001|Overall Study|Non-compliance|0|||
164239680|NCT02852967|593250073|FG002|Overall Study|Non-compliance|1|||
164239681|NCT02852967|593250074|FG003|Overall Study|Non-compliance|1|||
164239682|NCT02852967|593250075|FG004|Overall Study|Non-compliance|0|||
164239683|NCT02852967|593250071|FG000|Overall Study|Dispensing Drug Violation|0|||
164239684|NCT02852967|593250072|FG001|Overall Study|Dispensing Drug Violation|0|||
164239685|NCT02852967|593250073|FG002|Overall Study|Dispensing Drug Violation|1|||
164239686|NCT02852967|593250074|FG003|Overall Study|Dispensing Drug Violation|0|||
164239687|NCT02852967|593250075|FG004|Overall Study|Dispensing Drug Violation|0|||
164239688|NCT02852967|593250071|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
164239689|NCT02852967|593250072|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
164239690|NCT02852967|593250073|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
164239691|NCT02852967|593250074|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
164239692|NCT02852967|593250075|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
164239693|NCT00339040|593250082|FG000|Stage I|Not able to attend clinic|1|||
164239694|NCT00339040|593250083|FG001|Stage I|Not able to attend clinic|0|||
164239695|NCT00339040|593250082|FG000|Stage I|Protocol Violation|1|||
164239696|NCT00339040|593250083|FG001|Stage I|Protocol Violation|1|||
164239697|NCT00339040|593250082|FG000|Stage II|Lost to Follow-up|3|||
164239698|NCT00339040|593250083|FG001|Stage II|Lost to Follow-up|0|||
164239699|NCT00339040|593250082|FG000|Stage II|Withdrawal by Subject|1|||
164239700|NCT00339040|593250083|FG001|Stage II|Withdrawal by Subject|2|||
164239701|NCT00339040|593250082|FG000|Stage II|Protocol Violation|3|||
164239702|NCT00339040|593250083|FG001|Stage II|Protocol Violation|0|||
164239703|NCT00339040|593250082|FG000|Stage II|Not able to attend clinic|1|||
164239704|NCT00339040|593250083|FG001|Stage II|Not able to attend clinic|0|||
164239705|NCT00339040|593250082|FG000|Stage II|Site closing|2|||
164239706|NCT00339040|593250083|FG001|Stage II|Site closing|0|||
164239707|NCT03341637|593250084|FG000|Overall Study|Lost to Follow-up|1|||
164239708|NCT03341637|593250085|FG001|Overall Study|Lost to Follow-up|0|||
164239709|NCT03341637|593250084|FG000|Overall Study|Withdrawal by Subject|3|||
164239710|NCT03341637|593250085|FG001|Overall Study|Withdrawal by Subject|3|||
164239711|NCT03341637|593250084|FG000|Overall Study|Reason not Specified|1|||
164239712|NCT03341637|593250085|FG001|Overall Study|Reason not Specified|1|||
164239713|NCT01462929|593250092|FG000|Overall Study|Adverse Event|3|||
164239714|NCT01462929|593250093|FG001|Overall Study|Adverse Event|3|||
164239715|NCT01462929|593250094|FG002|Overall Study|Adverse Event|4|||
164239716|NCT01462929|593250092|FG000|Overall Study|Withdrawal by Subject|2|||
164239717|NCT01462929|593250093|FG001|Overall Study|Withdrawal by Subject|1|||
164239718|NCT01462929|593250094|FG002|Overall Study|Withdrawal by Subject|0|||
164239719|NCT01462929|593250092|FG000|Overall Study|Lack of Efficacy|0|||
164239720|NCT01462929|593250093|FG001|Overall Study|Lack of Efficacy|0|||
164239721|NCT01462929|593250094|FG002|Overall Study|Lack of Efficacy|1|||
164239722|NCT00887159|593250095|FG000|Overall Study|Disease progression|6|||
164239723|NCT00887159|593250096|FG001|Overall Study|Disease progression|39|||
164239724|NCT00887159|593250097|FG002|Overall Study|Disease progression|33|||
164239725|NCT00887159|593250095|FG000|Overall Study|Adverse Event|3|||
164239726|NCT00887159|593250096|FG001|Overall Study|Adverse Event|4|||
164239727|NCT00887159|593250097|FG002|Overall Study|Adverse Event|17|||
164239728|NCT00887159|593250095|FG000|Overall Study|Death|2|||
164239729|NCT00887159|593250096|FG001|Overall Study|Death|2|||
164239730|NCT00887159|593250097|FG002|Overall Study|Death|0|||
164239731|NCT00887159|593250095|FG000|Overall Study|Withdrawal by Subject|4|||
164239732|NCT00887159|593250096|FG001|Overall Study|Withdrawal by Subject|4|||
164239733|NCT00887159|593250097|FG002|Overall Study|Withdrawal by Subject|2|||
164239734|NCT00887159|593250095|FG000|Overall Study|Alternative therapy|2|||
164239735|NCT00887159|593250096|FG001|Overall Study|Alternative therapy|0|||
164239736|NCT00887159|593250097|FG002|Overall Study|Alternative therapy|0|||
164239737|NCT00887159|593250095|FG000|Overall Study|Physician Decision|1|||
164239738|NCT00887159|593250096|FG001|Overall Study|Physician Decision|1|||
164239739|NCT00887159|593250097|FG002|Overall Study|Physician Decision|0|||
164239740|NCT00887159|593250095|FG000|Overall Study|Sympomatic deterioration|1|||
164239741|NCT00887159|593250096|FG001|Overall Study|Sympomatic deterioration|0|||
164239742|NCT00887159|593250097|FG002|Overall Study|Sympomatic deterioration|0|||
164239743|NCT00887159|593250095|FG000|Overall Study|Treatment delayed|1|||
164239744|NCT00887159|593250096|FG001|Overall Study|Treatment delayed|1|||
164239745|NCT00887159|593250097|FG002|Overall Study|Treatment delayed|0|||
164239746|NCT00887159|593250095|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
164239747|NCT00887159|593250096|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
164239748|NCT00887159|593250097|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
164239749|NCT00887159|593250095|FG000|Overall Study|Received more tx instead of observation|1|||
164239750|NCT00887159|593250096|FG001|Overall Study|Received more tx instead of observation|0|||
164239751|NCT00887159|593250097|FG002|Overall Study|Received more tx instead of observation|0|||
164239752|NCT00887159|593250095|FG000|Overall Study|Ineligible|5|||
164239753|NCT00887159|593250096|FG001|Overall Study|Ineligible|1|||
164239754|NCT00887159|593250097|FG002|Overall Study|Ineligible|0|||
164239755|NCT00887159|593250095|FG000|Overall Study|Never started assigned therapy|3|||
164239756|NCT00887159|593250096|FG001|Overall Study|Never started assigned therapy|3|||
164239757|NCT00887159|593250097|FG002|Overall Study|Never started assigned therapy|4|||
164239758|NCT02071771|593250102|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
164239759|NCT02071771|593250103|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
164239760|NCT02071771|593250102|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
164239761|NCT02071771|593250103|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
164239762|NCT02078752|593250104|FG000|Overall Study|Death|0|||
164239763|NCT02078752|593250105|FG001|Overall Study|Death|3|||
164239764|NCT02078752|593250106|FG002|Overall Study|Death|0|||
164239765|NCT02078752|593250107|FG003|Overall Study|Death|0|||
164239766|NCT02078752|593250108|FG004|Overall Study|Death|0|||
164239767|NCT02078752|593250109|FG005|Overall Study|Death|1|||
164239768|NCT02078752|593250110|FG006|Overall Study|Death|0|||
164239769|NCT02078752|593250111|FG007|Overall Study|Death|1|||
164239770|NCT02078752|593250112|FG008|Overall Study|Death|0|||
164239771|NCT02078752|593250113|FG009|Overall Study|Death|4|||
164239772|NCT02078752|593250104|FG000|Overall Study|Lost to Follow-up|1|||
164239773|NCT02078752|593250105|FG001|Overall Study|Lost to Follow-up|0|||
164239774|NCT02078752|593250106|FG002|Overall Study|Lost to Follow-up|0|||
164239775|NCT02078752|593250107|FG003|Overall Study|Lost to Follow-up|1|||
164239776|NCT02078752|593250108|FG004|Overall Study|Lost to Follow-up|0|||
164239777|NCT02078752|593250109|FG005|Overall Study|Lost to Follow-up|0|||
164239778|NCT02078752|593250110|FG006|Overall Study|Lost to Follow-up|0|||
164239779|NCT02078752|593250111|FG007|Overall Study|Lost to Follow-up|0|||
164239780|NCT02078752|593250112|FG008|Overall Study|Lost to Follow-up|0|||
164239781|NCT02078752|593250113|FG009|Overall Study|Lost to Follow-up|0|||
164239782|NCT02078752|593250104|FG000|Overall Study|Withdrawal by Subject|1|||
164239783|NCT02078752|593250105|FG001|Overall Study|Withdrawal by Subject|1|||
164239784|NCT02078752|593250106|FG002|Overall Study|Withdrawal by Subject|1|||
164239785|NCT02078752|593250107|FG003|Overall Study|Withdrawal by Subject|1|||
164239786|NCT02078752|593250108|FG004|Overall Study|Withdrawal by Subject|0|||
164239787|NCT02078752|593250109|FG005|Overall Study|Withdrawal by Subject|3|||
164239788|NCT02078752|593250110|FG006|Overall Study|Withdrawal by Subject|2|||
164239789|NCT02078752|593250111|FG007|Overall Study|Withdrawal by Subject|1|||
164239790|NCT02078752|593250112|FG008|Overall Study|Withdrawal by Subject|0|||
164239791|NCT02078752|593250113|FG009|Overall Study|Withdrawal by Subject|1|||
164239792|NCT02078752|593250104|FG000|Overall Study|Other|0|||
164239793|NCT02078752|593250105|FG001|Overall Study|Other|3|||
164239794|NCT02078752|593250106|FG002|Overall Study|Other|0|||
164239795|NCT02078752|593250107|FG003|Overall Study|Other|0|||
164239796|NCT02078752|593250108|FG004|Overall Study|Other|1|||
164239797|NCT02078752|593250109|FG005|Overall Study|Other|0|||
164239798|NCT02078752|593250110|FG006|Overall Study|Other|0|||
164239799|NCT02078752|593250111|FG007|Overall Study|Other|1|||
164239800|NCT02078752|593250112|FG008|Overall Study|Other|0|||
164239801|NCT02078752|593250113|FG009|Overall Study|Other|0|||
164239802|NCT02078752|593250104|FG000|Overall Study|Study terminated by sponsor|0|||
164239803|NCT02078752|593250105|FG001|Overall Study|Study terminated by sponsor|0|||
164239804|NCT02078752|593250106|FG002|Overall Study|Study terminated by sponsor|0|||
164239805|NCT02078752|593250107|FG003|Overall Study|Study terminated by sponsor|0|||
164239806|NCT02078752|593250108|FG004|Overall Study|Study terminated by sponsor|0|||
164239807|NCT02078752|593250109|FG005|Overall Study|Study terminated by sponsor|0|||
164239808|NCT02078752|593250110|FG006|Overall Study|Study terminated by sponsor|0|||
164239809|NCT02078752|593250111|FG007|Overall Study|Study terminated by sponsor|0|||
164239810|NCT02078752|593250112|FG008|Overall Study|Study terminated by sponsor|0|||
164239811|NCT02078752|593250113|FG009|Overall Study|Study terminated by sponsor|5|||
164239812|NCT00592631|593250119|FG000|Overall Study|Lost to Follow-up|0|||
164239813|NCT00592631|593250120|FG001|Overall Study|Lost to Follow-up|2|||
164239814|NCT01244035|593250121|FG000|Part 1: Period 1|Adverse Event|0|||
164239815|NCT01244035|593250122|FG001|Part 1: Period 1|Adverse Event|0|||
164239816|NCT01244035|593250123|FG002|Part 1: Period 1|Adverse Event|0|||
164239817|NCT01244035|593250124|FG003|Part 1: Period 1|Adverse Event|0|||
164239818|NCT01244035|593250125|FG004|Part 1: Period 1|Adverse Event|0|||
164239819|NCT01244035|593250126|FG005|Part 1: Period 1|Adverse Event|1|||
164239820|NCT01244035|593250121|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
164239821|NCT01244035|593250122|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
164239822|NCT01244035|593250123|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
164239823|NCT01244035|593250124|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
164239824|NCT01244035|593250125|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
164239825|NCT01244035|593250126|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
164239826|NCT01244035|593250121|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
164239827|NCT01244035|593250122|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
164239828|NCT01244035|593250123|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
164239829|NCT01244035|593250124|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
164239830|NCT01244035|593250125|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
164239831|NCT01244035|593250126|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
164239832|NCT01244035|593250121|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
164239833|NCT01244035|593250122|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
164239834|NCT01244035|593250123|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
164239835|NCT01244035|593250124|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
164239836|NCT01244035|593250125|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
164239837|NCT01244035|593250126|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
164239838|NCT01244035|593250121|FG000|Part 1: Period 3|Adverse Event|0|||
164239839|NCT01244035|593250122|FG001|Part 1: Period 3|Adverse Event|0|||
164239840|NCT01244035|593250123|FG002|Part 1: Period 3|Adverse Event|0|||
164239841|NCT01244035|593250124|FG003|Part 1: Period 3|Adverse Event|0|||
164239842|NCT01244035|593250125|FG004|Part 1: Period 3|Adverse Event|0|||
164239843|NCT01244035|593250126|FG005|Part 1: Period 3|Adverse Event|1|||
164239844|NCT01244035|593250121|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
164239845|NCT01244035|593250122|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
164239846|NCT01244035|593250123|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
164239847|NCT01244035|593250124|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
164239848|NCT01244035|593250125|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
164239849|NCT01244035|593250126|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
164239850|NCT01244035|593250121|FG000|Part 1: Period 3|Protocol Deviation|0|||
164239851|NCT01244035|593250122|FG001|Part 1: Period 3|Protocol Deviation|1|||
164239852|NCT01244035|593250123|FG002|Part 1: Period 3|Protocol Deviation|0|||
164239853|NCT01244035|593250124|FG003|Part 1: Period 3|Protocol Deviation|0|||
164239854|NCT01244035|593250125|FG004|Part 1: Period 3|Protocol Deviation|0|||
164239855|NCT01244035|593250126|FG005|Part 1: Period 3|Protocol Deviation|0|||
164239856|NCT02776683|593250128|FG000|Pre-switch Period|Protocol Violation|1|||
164239857|NCT02776683|593250129|FG001|Pre-switch Period|Protocol Violation|0|||
164239858|NCT02776683|593250128|FG000|Pre-switch Period|Adverse Event|21|||
164239859|NCT02776683|593250129|FG001|Pre-switch Period|Adverse Event|0|||
164239860|NCT02776683|593250128|FG000|Pre-switch Period|Withdrawal by Subject|9|||
164239861|NCT02776683|593250129|FG001|Pre-switch Period|Withdrawal by Subject|0|||
164239862|NCT02776683|593250128|FG000|Pre-switch Period|Physician Decision|7|||
164239863|NCT02776683|593250129|FG001|Pre-switch Period|Physician Decision|0|||
164239864|NCT02776683|593250128|FG000|Pre-switch Period|Progressive disease|39|||
164239865|NCT02776683|593250129|FG001|Pre-switch Period|Progressive disease|0|||
164239866|NCT02776683|593250128|FG000|Pre-switch Period|Other than listed|3|||
164239867|NCT02776683|593250129|FG001|Pre-switch Period|Other than listed|0|||
164239868|NCT02776683|593250128|FG000|Post-switch Period|Adverse Event|0|||
164239869|NCT02776683|593250129|FG001|Post-switch Period|Adverse Event|3|||
164239870|NCT02776683|593250128|FG000|Post-switch Period|Withdrawal by Subject|0|||
164239871|NCT02776683|593250129|FG001|Post-switch Period|Withdrawal by Subject|2|||
164239872|NCT02776683|593250128|FG000|Post-switch Period|Physician Decision|0|||
164239873|NCT02776683|593250129|FG001|Post-switch Period|Physician Decision|3|||
164239874|NCT02776683|593250128|FG000|Post-switch Period|Progressive disease|0|||
164239875|NCT02776683|593250129|FG001|Post-switch Period|Progressive disease|20|||
164239876|NCT02776683|593250128|FG000|Post-switch Period|Other than listed|0|||
164239877|NCT02776683|593250129|FG001|Post-switch Period|Other than listed|15|||
164239878|NCT00616642|593250131|FG000|Overall Study|Withdrawal by Subject|0|||
164239879|NCT00616642|593250132|FG001|Overall Study|Withdrawal by Subject|1|||
164239880|NCT00570323|593250133|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
164239881|NCT00570323|593250134|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
164239882|NCT00570323|593250133|FG000|Started Treatment After Randomization|Protocol Violation|1|||
164239883|NCT00570323|593250134|FG001|Started Treatment After Randomization|Protocol Violation|0|||
164239884|NCT00570323|593250133|FG000|Started Treatment After Randomization|Physician Decision|1|||
164239885|NCT00570323|593250134|FG001|Started Treatment After Randomization|Physician Decision|0|||
164239886|NCT00570323|593250133|FG000|Complete Study After Start|Lost to Follow-up|0|||
164239887|NCT00570323|593250134|FG001|Complete Study After Start|Lost to Follow-up|1|||
164239888|NCT00570323|593250133|FG000|Complete Study After Start|Withdrawal by Subject|2|||
164239889|NCT00570323|593250134|FG001|Complete Study After Start|Withdrawal by Subject|0|||
164239890|NCT00570323|593250133|FG000|Complete Study After Start|Physician Decision|1|||
164239891|NCT00570323|593250134|FG001|Complete Study After Start|Physician Decision|0|||
164239892|NCT01023217|593250136|FG000|Overall Study|Withdrawal by Subject|1|||
164239893|NCT01023217|593250137|FG001|Overall Study|Withdrawal by Subject|0|||
164335764|NCT02913612|593606055|FG002|Overall Study|Needed to treat second hemangioma|0|||
164335765|NCT02913612|593606056|FG003|Overall Study|Needed to treat second hemangioma|0|||
164335766|NCT02913612|593606053|FG000|Overall Study|Study completion criteria not met|0|||
164335767|NCT02913612|593606054|FG001|Overall Study|Study completion criteria not met|1|||
164335768|NCT02913612|593606055|FG002|Overall Study|Study completion criteria not met|0|||
164335769|NCT02913612|593606056|FG003|Overall Study|Study completion criteria not met|0|||
164335770|NCT02913612|593606053|FG000|Overall Study|Ineligible|0|||
164335771|NCT02913612|593606054|FG001|Overall Study|Ineligible|1|||
164335772|NCT02913612|593606055|FG002|Overall Study|Ineligible|0|||
164335773|NCT02913612|593606056|FG003|Overall Study|Ineligible|0|||
164335774|NCT04251273|593606057|FG000|Overall Study|Lost to Follow-up|331|||
164335775|NCT04251273|593606058|FG001|Overall Study|Lost to Follow-up|290|||
164335776|NCT04402060|593606059|FG000|Overall Study|Death|1|||
164335777|NCT04402060|593606060|FG001|Overall Study|Death|12|||
164335778|NCT04402060|593606061|FG002|Overall Study|Death|7|||
164335779|NCT04402060|593606059|FG000|Overall Study|Adverse Event|0|||
164335780|NCT04402060|593606060|FG001|Overall Study|Adverse Event|0|||
164335781|NCT04402060|593606061|FG002|Overall Study|Adverse Event|1|||
164335782|NCT04402060|593606059|FG000|Overall Study|Withdrawal by Subject|0|||
164335783|NCT04402060|593606060|FG001|Overall Study|Withdrawal by Subject|1|||
164335784|NCT04402060|593606061|FG002|Overall Study|Withdrawal by Subject|2|||
164335785|NCT04402060|593606059|FG000|Overall Study|Sponsor Request|0|||
164335786|NCT04402060|593606060|FG001|Overall Study|Sponsor Request|2|||
164335787|NCT04402060|593606061|FG002|Overall Study|Sponsor Request|0|||
164335788|NCT04402060|593606059|FG000|Overall Study|Physician Decision|0|||
164335789|NCT04402060|593606060|FG001|Overall Study|Physician Decision|0|||
164335790|NCT04402060|593606061|FG002|Overall Study|Physician Decision|1|||
164335791|NCT04402060|593606059|FG000|Overall Study|Other|0|||
164335792|NCT04402060|593606060|FG001|Overall Study|Other|1|||
164335793|NCT04402060|593606061|FG002|Overall Study|Other|0|||
164335794|NCT00936611|593606069|FG000|Overall Study|Progressive Disease|3|||
164335795|NCT00936611|593606069|FG000|Overall Study|New Systemic Therapy|22|||
164335796|NCT00936611|593606069|FG000|Overall Study|Lost to Follow-up|1|||
164335797|NCT00936611|593606069|FG000|Overall Study|Withdrawal by Subject|2|||
164335798|NCT00936611|593606069|FG000|Overall Study|Still on Follow-up|1|||
164335799|NCT00936611|593606069|FG000|Overall Study|Still on Active Therapy|7|||
164335800|NCT00936611|593606069|FG000|Overall Study|Ineligible for Study Drug|3|||
164335801|NCT02955797|593606070|FG000|Overall Study|Protocol Violation|1|||
164335802|NCT02955797|593606071|FG001|Overall Study|Protocol Violation|0|||
164335803|NCT02955797|593606072|FG002|Overall Study|Protocol Violation|0|||
164335804|NCT02955797|593606073|FG003|Overall Study|Protocol Violation|1|||
164335805|NCT02955797|593606070|FG000|Overall Study|Withdrawal by Subject|2|||
164335806|NCT02955797|593606071|FG001|Overall Study|Withdrawal by Subject|2|||
164335807|NCT02955797|593606072|FG002|Overall Study|Withdrawal by Subject|0|||
164335808|NCT02955797|593606073|FG003|Overall Study|Withdrawal by Subject|1|||
164335809|NCT02955797|593606070|FG000|Overall Study|Lost to Follow-up|0|||
164335810|NCT02955797|593606071|FG001|Overall Study|Lost to Follow-up|1|||
164335811|NCT02955797|593606072|FG002|Overall Study|Lost to Follow-up|0|||
164335812|NCT02955797|593606073|FG003|Overall Study|Lost to Follow-up|0|||
164335813|NCT03131453|593606075|FG000|Overall Study|Study terminated by Sponsor|424|||
164335814|NCT03131453|593606076|FG001|Overall Study|Study terminated by Sponsor|222|||
164335815|NCT03131453|593606077|FG002|Overall Study|Study terminated by Sponsor|438|||
164335816|NCT03131453|593606075|FG000|Overall Study|Withdrawal by Subject|18|||
164335817|NCT03131453|593606076|FG001|Overall Study|Withdrawal by Subject|7|||
164335818|NCT03131453|593606077|FG002|Overall Study|Withdrawal by Subject|13|||
164335819|NCT03131453|593606075|FG000|Overall Study|Adverse Event|10|||
164335820|NCT03131453|593606076|FG001|Overall Study|Adverse Event|3|||
164335821|NCT03131453|593606077|FG002|Overall Study|Adverse Event|3|||
164335822|NCT03131453|593606075|FG000|Overall Study|Lost to Follow-up|1|||
164335823|NCT03131453|593606076|FG001|Overall Study|Lost to Follow-up|0|||
164335824|NCT03131453|593606077|FG002|Overall Study|Lost to Follow-up|1|||
164335825|NCT03131453|593606075|FG000|Overall Study|Physician Decision|1|||
164335826|NCT03131453|593606076|FG001|Overall Study|Physician Decision|0|||
164335827|NCT03131453|593606077|FG002|Overall Study|Physician Decision|1|||
164425290|NCT03712098|593928432|FG000|Overall Study|Withdrawal by Subject|9|||
164335828|NCT03131453|593606075|FG000|Overall Study|Non-compliance with study treatment|1|||
164335829|NCT03131453|593606076|FG001|Overall Study|Non-compliance with study treatment|0|||
164335830|NCT03131453|593606077|FG002|Overall Study|Non-compliance with study treatment|0|||
164335831|NCT03131453|593606075|FG000|Overall Study|Technical problems|1|||
164335832|NCT03131453|593606076|FG001|Overall Study|Technical problems|0|||
164335833|NCT03131453|593606077|FG002|Overall Study|Technical problems|0|||
164335834|NCT03131453|593606075|FG000|Overall Study|Protocol deviation|0|||
164335835|NCT03131453|593606076|FG001|Overall Study|Protocol deviation|1|||
164335836|NCT03131453|593606077|FG002|Overall Study|Protocol deviation|0|||
164335837|NCT02081183|593606078|FG000|Overall Study|Lost to Follow-up|0|||
164335838|NCT02081183|593606079|FG001|Overall Study|Lost to Follow-up|1|||
164425291|NCT03712098|593928433|FG001|Overall Study|Withdrawal by Subject|4|||
164335839|NCT02081183|593606078|FG000|Overall Study|Protocol Violation|1|||
164335840|NCT02081183|593606079|FG001|Overall Study|Protocol Violation|0|||
164239894|NCT01567722|593250146|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
164239895|NCT01567722|593250147|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
164239896|NCT01567722|593250148|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
164425292|NCT03712098|593928432|FG000|Overall Study|Protocol Violation|2|||
164425293|NCT03712098|593928433|FG001|Overall Study|Protocol Violation|1|||
164239897|NCT01567722|593250146|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
164425294|NCT02256969|593928434|FG000|Overall Study|Screenfailed or withdrew|2|||
164239898|NCT01567722|593250147|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
164239899|NCT01567722|593250148|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
164239900|NCT01567722|593250146|FG000|Overall Study|Protocol closure by the OCG|2|||
164335841|NCT02081183|593606078|FG000|Overall Study|Other|3|||
164335842|NCT02081183|593606079|FG001|Overall Study|Other|3|||
164335843|NCT02282358|593606086|FG000|Overall Study|Nonevaluable|1|||
164335844|NCT01898208|593606087|FG000|Overall Study|Positive blood culture|17|||
164335845|NCT01898208|593606088|FG001|Overall Study|Positive blood culture|23|||
164335846|NCT01898208|593606089|FG002|Overall Study|Positive blood culture|15|||
164335847|NCT01898208|593606087|FG000|Overall Study|Death/comfort care within 24 hours|10|||
164335848|NCT01898208|593606088|FG001|Overall Study|Death/comfort care within 24 hours|9|||
164335849|NCT01898208|593606089|FG002|Overall Study|Death/comfort care within 24 hours|8|||
164335850|NCT01898208|593606087|FG000|Overall Study|Negative Gram Stain|6|||
164335851|NCT01898208|593606088|FG001|Overall Study|Negative Gram Stain|9|||
164335852|NCT01898208|593606089|FG002|Overall Study|Negative Gram Stain|6|||
164335853|NCT01898208|593606087|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
164335854|NCT01898208|593606088|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
164335855|NCT01898208|593606089|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
164335856|NCT01898208|593606087|FG000|Overall Study|System/Technical Error|1|||
164335857|NCT01898208|593606088|FG001|Overall Study|System/Technical Error|2|||
164335858|NCT01898208|593606089|FG002|Overall Study|System/Technical Error|3|||
164335859|NCT01898208|593606087|FG000|Overall Study|Lost to Follow-up|3|||
164335860|NCT01898208|593606088|FG001|Overall Study|Lost to Follow-up|1|||
164335861|NCT01898208|593606089|FG002|Overall Study|Lost to Follow-up|1|||
164335862|NCT04043728|593606090|FG000|Overall Study|Lost to Follow-up|1|||
164335863|NCT04043728|593606091|FG001|Overall Study|Lost to Follow-up|2|||
164335864|NCT04043728|593606092|FG002|Overall Study|Lost to Follow-up|0|||
164335865|NCT03780543|593606094|FG000|Overall Study|Adverse Event|1|||
164335866|NCT03780543|593606095|FG001|Overall Study|Adverse Event|0|||
164335867|NCT03780543|593606096|FG002|Overall Study|Adverse Event|2|||
164335868|NCT03780543|593606094|FG000|Overall Study|Lost to Follow-up|2|||
164335869|NCT03780543|593606095|FG001|Overall Study|Lost to Follow-up|0|||
164335870|NCT03780543|593606096|FG002|Overall Study|Lost to Follow-up|1|||
164335871|NCT03780543|593606094|FG000|Overall Study|Study terminated by Sponsor|8|||
164335872|NCT03780543|593606095|FG001|Overall Study|Study terminated by Sponsor|7|||
164335873|NCT03780543|593606096|FG002|Overall Study|Study terminated by Sponsor|13|||
164335874|NCT03780543|593606094|FG000|Overall Study|Withdrawal by Subject|1|||
164335875|NCT03780543|593606095|FG001|Overall Study|Withdrawal by Subject|8|||
164335876|NCT03780543|593606096|FG002|Overall Study|Withdrawal by Subject|1|||
164335877|NCT03780543|593606094|FG000|Overall Study|Noncompliance with study drug|1|||
164335878|NCT03780543|593606095|FG001|Overall Study|Noncompliance with study drug|0|||
164335879|NCT03780543|593606096|FG002|Overall Study|Noncompliance with study drug|0|||
164335880|NCT02649894|593606099|FG000|Overall Study|Adverse Event|1|||
164425295|NCT02256969|593928435|FG001|Overall Study|Screenfailed or withdrew|1|||
164425296|NCT02256969|593928436|FG002|Overall Study|Screenfailed or withdrew|1|||
164335881|NCT02649894|593606100|FG001|Overall Study|Adverse Event|0|||
164335882|NCT02649894|593606099|FG000|Overall Study|Physician Decision|0|||
164335883|NCT02649894|593606100|FG001|Overall Study|Physician Decision|1|||
164335884|NCT02649894|593606099|FG000|Overall Study|Withdrawal by Subject|5|||
164335885|NCT02649894|593606100|FG001|Overall Study|Withdrawal by Subject|2|||
164335886|NCT02649894|593606099|FG000|Overall Study|Lost to Follow-up|2|||
164335887|NCT02649894|593606100|FG001|Overall Study|Lost to Follow-up|1|||
164335888|NCT02649894|593606099|FG000|Overall Study|Death|30|||
164335889|NCT02649894|593606100|FG001|Overall Study|Death|7|||
164425297|NCT00372567|593928439|FG000|Phase 3 Study|Adverse Event|5|||
164335890|NCT02649894|593606099|FG000|Overall Study|Other, not specified|6|||
164335891|NCT02649894|593606100|FG001|Overall Study|Other, not specified|0|||
164335892|NCT01736124|593606101|FG000|Post-intervention Assessment|Death|2|||
164335893|NCT01736124|593606102|FG001|Post-intervention Assessment|Death|2|||
164335894|NCT01736124|593606101|FG000|Post-intervention Assessment|lost computer access|1|||
164335895|NCT01736124|593606102|FG001|Post-intervention Assessment|lost computer access|1|||
164335896|NCT01736124|593606101|FG000|Post-intervention Assessment|Moved away|3|||
164335897|NCT01736124|593606102|FG001|Post-intervention Assessment|Moved away|1|||
164335898|NCT01736124|593606101|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
164425298|NCT00372567|593928440|FG001|Phase 3 Study|Adverse Event|1|||
164425299|NCT00372567|593928441|FG002|Phase 3 Study|Adverse Event|1|||
164425300|NCT00372567|593928439|FG000|Phase 3 Study|Death|1|||
164239901|NCT01567722|593250147|FG001|Overall Study|Protocol closure by the OCG|0|||
164239902|NCT01567722|593250148|FG002|Overall Study|Protocol closure by the OCG|0|||
164239903|NCT01567722|593250146|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
164239904|NCT01567722|593250147|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
164239905|NCT01567722|593250148|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
164239906|NCT00332696|593250149|FG000|Overall Study|Death|24|||
164239907|NCT00332696|593250150|FG001|Overall Study|Death|14|||
164239908|NCT00332696|593250149|FG000|Overall Study|Insufficient therapeutic effect|4|||
164239909|NCT00332696|593250150|FG001|Overall Study|Insufficient therapeutic effect|11|||
164239910|NCT00332696|593250149|FG000|Overall Study|Adverse Event|1|||
164239911|NCT00332696|593250150|FG001|Overall Study|Adverse Event|2|||
164239912|NCT00332696|593250149|FG000|Overall Study|Condition does not justify treatment|0|||
164239913|NCT00332696|593250150|FG001|Overall Study|Condition does not justify treatment|2|||
164239914|NCT00332696|593250149|FG000|Overall Study|Lost to Follow-up|0|||
164239915|NCT00332696|593250150|FG001|Overall Study|Lost to Follow-up|1|||
164239916|NCT00332696|593250149|FG000|Overall Study|Withdrawal by Subject|1|||
164239917|NCT00332696|593250150|FG001|Overall Study|Withdrawal by Subject|0|||
164239918|NCT02216526|593250151|FG000|Overall Study|Adverse Event|1|||
164239919|NCT02216526|593250152|FG001|Overall Study|Adverse Event|1|||
164239920|NCT02216526|593250153|FG002|Overall Study|Adverse Event|0|||
164239921|NCT02216526|593250151|FG000|Overall Study|Death|0|||
164239922|NCT02216526|593250152|FG001|Overall Study|Death|1|||
164239923|NCT02216526|593250153|FG002|Overall Study|Death|3|||
164239924|NCT02216526|593250151|FG000|Overall Study|Protocol Violation|2|||
164239925|NCT02216526|593250152|FG001|Overall Study|Protocol Violation|0|||
164239926|NCT02216526|593250153|FG002|Overall Study|Protocol Violation|2|||
164239927|NCT02216526|593250151|FG000|Overall Study|Hospitalization|2|||
164239928|NCT02216526|593250152|FG001|Overall Study|Hospitalization|1|||
164239929|NCT02216526|593250153|FG002|Overall Study|Hospitalization|3|||
164239930|NCT04103450|593250158|FG000|Overall Study|Adverse Event|4|||
164239931|NCT04103450|593250159|FG001|Overall Study|Adverse Event|2|||
164239932|NCT04103450|593250158|FG000|Overall Study|Lack of Efficacy|3|||
164239933|NCT04103450|593250159|FG001|Overall Study|Lack of Efficacy|0|||
164239934|NCT04103450|593250158|FG000|Overall Study|Withdrawal by Subject|5|||
164239935|NCT04103450|593250159|FG001|Overall Study|Withdrawal by Subject|3|||
164239936|NCT04103450|593250158|FG000|Overall Study|Lost to Follow-up|1|||
164239937|NCT04103450|593250159|FG001|Overall Study|Lost to Follow-up|2|||
164239938|NCT04103450|593250158|FG000|Overall Study|Physician Decision|1|||
164239939|NCT04103450|593250159|FG001|Overall Study|Physician Decision|2|||
164239940|NCT04103450|593250158|FG000|Overall Study|Protocol Violation|1|||
164239941|NCT04103450|593250159|FG001|Overall Study|Protocol Violation|0|||
164239942|NCT04103450|593250158|FG000|Overall Study|Other|1|||
164239943|NCT04103450|593250159|FG001|Overall Study|Other|1|||
164239944|NCT02259114|593250161|FG000|Overall Study|Progressive Disease|14|||
164239945|NCT02259114|593250162|FG001|Overall Study|Progressive Disease|2|||
164239946|NCT02259114|593250163|FG002|Overall Study|Progressive Disease|10|||
164239947|NCT02259114|593250164|FG003|Overall Study|Progressive Disease|2|||
164239948|NCT02259114|593250165|FG004|Overall Study|Progressive Disease|5|||
164239949|NCT02259114|593250161|FG000|Overall Study|Adverse Event|2|||
164239950|NCT02259114|593250162|FG001|Overall Study|Adverse Event|1|||
164239951|NCT02259114|593250163|FG002|Overall Study|Adverse Event|0|||
164239952|NCT02259114|593250164|FG003|Overall Study|Adverse Event|0|||
164239953|NCT02259114|593250165|FG004|Overall Study|Adverse Event|1|||
164239954|NCT02259114|593250161|FG000|Overall Study|Death|3|||
164239955|NCT02259114|593250162|FG001|Overall Study|Death|0|||
164239956|NCT02259114|593250163|FG002|Overall Study|Death|1|||
164239957|NCT02259114|593250164|FG003|Overall Study|Death|0|||
164239958|NCT02259114|593250165|FG004|Overall Study|Death|0|||
164239959|NCT02259114|593250161|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
164239960|NCT02259114|593250162|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
164239961|NCT02259114|593250163|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
164239962|NCT02259114|593250164|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
164239963|NCT02259114|593250165|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
164239964|NCT02259114|593250161|FG000|Overall Study|Withdrawal by Subject|0|||
164239965|NCT02259114|593250162|FG001|Overall Study|Withdrawal by Subject|0|||
164239966|NCT02259114|593250163|FG002|Overall Study|Withdrawal by Subject|1|||
164239967|NCT02259114|593250164|FG003|Overall Study|Withdrawal by Subject|1|||
164239968|NCT02259114|593250165|FG004|Overall Study|Withdrawal by Subject|0|||
164239969|NCT02259114|593250161|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
164239970|NCT02259114|593250162|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
164239971|NCT02259114|593250163|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
164239972|NCT02259114|593250164|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
164239973|NCT02259114|593250165|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
164239974|NCT02259114|593250161|FG000|Overall Study|Not Treated|1|||
164239975|NCT02259114|593250162|FG001|Overall Study|Not Treated|0|||
164239976|NCT02259114|593250163|FG002|Overall Study|Not Treated|0|||
164239977|NCT02259114|593250164|FG003|Overall Study|Not Treated|0|||
164239978|NCT02259114|593250165|FG004|Overall Study|Not Treated|0|||
164425301|NCT00372567|593928440|FG001|Phase 3 Study|Death|1|||
164239979|NCT03937479|593250166|FG000|Overall Study|Adverse Event|2|||
164239980|NCT03937479|593250167|FG001|Overall Study|Adverse Event|3|||
164239981|NCT03937479|593250168|FG002|Overall Study|Adverse Event|0|||
164239982|NCT03937479|593250169|FG003|Overall Study|Adverse Event|0|||
164239983|NCT03937479|593250170|FG004|Overall Study|Adverse Event|1|||
164239984|NCT03937479|593250166|FG000|Overall Study|Withdrawal by Subject|3|||
164239985|NCT03937479|593250167|FG001|Overall Study|Withdrawal by Subject|5|||
164239986|NCT03937479|593250168|FG002|Overall Study|Withdrawal by Subject|2|||
164239987|NCT03937479|593250169|FG003|Overall Study|Withdrawal by Subject|2|||
164425302|NCT00372567|593928441|FG002|Phase 3 Study|Death|0|||
164239988|NCT03937479|593250170|FG004|Overall Study|Withdrawal by Subject|1|||
164239989|NCT03937479|593250166|FG000|Overall Study|Protocol Violation|5|||
164239990|NCT03937479|593250167|FG001|Overall Study|Protocol Violation|6|||
164239991|NCT03937479|593250168|FG002|Overall Study|Protocol Violation|4|||
164239992|NCT03937479|593250169|FG003|Overall Study|Protocol Violation|3|||
164239993|NCT03937479|593250170|FG004|Overall Study|Protocol Violation|2|||
164239994|NCT03937479|593250166|FG000|Overall Study|Lost to Follow-up|0|||
164239995|NCT03937479|593250167|FG001|Overall Study|Lost to Follow-up|1|||
164239996|NCT03937479|593250168|FG002|Overall Study|Lost to Follow-up|0|||
164239997|NCT03937479|593250169|FG003|Overall Study|Lost to Follow-up|1|||
164239998|NCT03937479|593250170|FG004|Overall Study|Lost to Follow-up|0|||
164239999|NCT03937479|593250166|FG000|Overall Study|Physician Decision|0|||
164240000|NCT03937479|593250167|FG001|Overall Study|Physician Decision|0|||
164240001|NCT03937479|593250168|FG002|Overall Study|Physician Decision|1|||
164240002|NCT03937479|593250169|FG003|Overall Study|Physician Decision|0|||
164240003|NCT03937479|593250170|FG004|Overall Study|Physician Decision|1|||
164240004|NCT02712788|593250173|FG000|Overall Study|Physician Decision|1|||
164240005|NCT02712788|593250174|FG001|Overall Study|Physician Decision|0|||
164240006|NCT02712788|593250173|FG000|Overall Study|Protocol Violation|1|||
164240007|NCT02712788|593250174|FG001|Overall Study|Protocol Violation|0|||
164240008|NCT03789292|593250179|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
164240009|NCT03789292|593250180|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
164240010|NCT03789292|593250181|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
164240011|NCT03789292|593250179|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
164240012|NCT03789292|593250180|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
164240013|NCT03789292|593250181|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
164240014|NCT03789292|593250179|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
164240015|NCT03789292|593250180|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
164240016|NCT03789292|593250181|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
164240017|NCT03789292|593250179|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
164240018|NCT03789292|593250180|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
164240019|NCT03789292|593250181|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
164240020|NCT03789292|593250179|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
164240021|NCT03789292|593250180|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
164240022|NCT03789292|593250181|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
164240023|NCT03789292|593250179|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
164240024|NCT03789292|593250180|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
164240025|NCT03789292|593250181|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
164240026|NCT03789292|593250179|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
164240027|NCT03789292|593250180|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
164240028|NCT03789292|593250181|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
164240029|NCT03789292|593250179|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
164335899|NCT01736124|593606102|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
164335900|NCT01736124|593606101|FG000|Post-intervention Assessment|Illness|3|||
164335901|NCT01736124|593606102|FG001|Post-intervention Assessment|Illness|2|||
164335902|NCT01736124|593606101|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
164335903|NCT01736124|593606102|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
164335904|NCT01736124|593606101|FG000|Post-intervention Assessment|Temporarily away|3|||
164335905|NCT01736124|593606102|FG001|Post-intervention Assessment|Temporarily away|1|||
164335906|NCT01736124|593606101|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
164335907|NCT01736124|593606102|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
164335908|NCT01736124|593606101|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
164335909|NCT01736124|593606102|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
164573390|NCT00700804|594463418|FG000|Overall Study|Withdrawal by Subject|1|||
164240030|NCT03789292|593250180|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
164240031|NCT03789292|593250181|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
164240032|NCT03789292|593250179|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
164240033|NCT03789292|593250180|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
164240034|NCT03789292|593250181|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
164335910|NCT01736124|593606101|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
164573391|NCT00700804|594463419|FG001|Overall Study|Withdrawal by Subject|2|||
164240035|NCT03789292|593250179|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
164240036|NCT03789292|593250180|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
164240037|NCT03789292|593250181|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
164240038|NCT03789292|593250179|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
164240039|NCT03789292|593250180|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
164240040|NCT03789292|593250181|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
164240041|NCT03789292|593250179|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
164240042|NCT03789292|593250180|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
164240043|NCT03789292|593250181|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
164240044|NCT03789292|593250179|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
164240045|NCT03789292|593250180|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
164240046|NCT03789292|593250181|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
164240047|NCT02230189|593250182|FG000|Overall Study|Withdrawal by Subject|3|||
164240048|NCT02230189|593250183|FG001|Overall Study|Withdrawal by Subject|0|||
164240049|NCT02230189|593250184|FG002|Overall Study|Withdrawal by Subject|1|||
164240050|NCT02230189|593250182|FG000|Overall Study|Lost to Follow-up|1|||
164240051|NCT02230189|593250183|FG001|Overall Study|Lost to Follow-up|0|||
164240052|NCT02230189|593250184|FG002|Overall Study|Lost to Follow-up|0|||
164240053|NCT02230189|593250182|FG000|Overall Study|Physician Decision|1|||
164240054|NCT02230189|593250183|FG001|Overall Study|Physician Decision|0|||
164240055|NCT02230189|593250184|FG002|Overall Study|Physician Decision|0|||
164240056|NCT00699413|593250189|FG000|Overall Study|Withdrawal by Subject|0|||
164240057|NCT00699413|593250190|FG001|Overall Study|Withdrawal by Subject|2|||
164240058|NCT00699413|593250189|FG000|Overall Study|Study terminated by sponsor|4|||
164240059|NCT00699413|593250190|FG001|Overall Study|Study terminated by sponsor|2|||
164240060|NCT02779777|593250191|FG000|Overall Study|Disease Progression|1|||
164240061|NCT02779777|593250192|FG001|Overall Study|Disease Progression|0|||
164240062|NCT02779777|593250193|FG002|Overall Study|Disease Progression|0|||
164240063|NCT02779777|593250191|FG000|Overall Study|Adverse Event|3|||
164240064|NCT02779777|593250192|FG001|Overall Study|Adverse Event|1|||
164240065|NCT02779777|593250193|FG002|Overall Study|Adverse Event|0|||
164240066|NCT02779777|593250191|FG000|Overall Study|Physician Decision|9|||
164240067|NCT02779777|593250192|FG001|Overall Study|Physician Decision|0|||
164240068|NCT02779777|593250193|FG002|Overall Study|Physician Decision|1|||
164240069|NCT02779777|593250191|FG000|Overall Study|Withdrawal by Subject|1|||
164240070|NCT02779777|593250192|FG001|Overall Study|Withdrawal by Subject|0|||
164240071|NCT02779777|593250193|FG002|Overall Study|Withdrawal by Subject|0|||
164240072|NCT00730886|593250194|FG000|Overall Study|Lost to Follow-up|1|||
164240073|NCT00730886|593250195|FG001|Overall Study|Lost to Follow-up|0|||
164240074|NCT00730886|593250194|FG000|Overall Study|Physician Decision|1|||
164240075|NCT00730886|593250195|FG001|Overall Study|Physician Decision|0|||
164240076|NCT02031302|593250196|FG000|Overall Study|Death|115|||
164240077|NCT02031302|593250197|FG001|Overall Study|Death|0|||
164240078|NCT02031302|593250196|FG000|Overall Study|Not treated with study valve system|18|||
164240079|NCT02031302|593250197|FG001|Overall Study|Not treated with study valve system|0|||
164240080|NCT02031302|593250196|FG000|Overall Study|Missed Follow Up|27|||
164240081|NCT02031302|593250197|FG001|Overall Study|Missed Follow Up|0|||
164240082|NCT02031302|593250196|FG000|Overall Study|Lost to Follow-up|4|||
164240083|NCT02031302|593250197|FG001|Overall Study|Lost to Follow-up|0|||
164240084|NCT01847443|593250198|FG000|Study Period 1|Withdrawal by Subject|0|||
164240085|NCT01847443|593250199|FG001|Study Period 1|Withdrawal by Subject|1|||
164240086|NCT01847443|593250200|FG002|Study Period 1|Withdrawal by Subject|0|||
164240087|NCT01847443|593250201|FG003|Study Period 1|Withdrawal by Subject|0|||
164240088|NCT01847443|593250198|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
164240089|NCT01847443|593250199|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
164240090|NCT01847443|593250200|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
164240091|NCT01847443|593250201|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
164240092|NCT01847443|593250198|FG000|Washout Period Before Study Period 2|Other reason|1|||
164240093|NCT01847443|593250199|FG001|Washout Period Before Study Period 2|Other reason|0|||
164240094|NCT01847443|593250200|FG002|Washout Period Before Study Period 2|Other reason|0|||
164240095|NCT01847443|593250201|FG003|Washout Period Before Study Period 2|Other reason|0|||
164240096|NCT01847443|593250198|FG000|Washout Period Before Study Period 3|Other reason|1|||
164240097|NCT01847443|593250199|FG001|Washout Period Before Study Period 3|Other reason|0|||
164240098|NCT01847443|593250200|FG002|Washout Period Before Study Period 3|Other reason|0|||
164240099|NCT01847443|593250201|FG003|Washout Period Before Study Period 3|Other reason|0|||
164240100|NCT01847443|593250198|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
164240101|NCT01847443|593250199|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
164240102|NCT01847443|593250200|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
164240103|NCT01847443|593250201|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
164240104|NCT01847443|593250198|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
164240105|NCT01847443|593250199|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
164240106|NCT01847443|593250200|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
164240107|NCT01847443|593250201|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
164240108|NCT04067492|593250202|FG000|Overall Study|Lost to Follow-up|0|||
164240109|NCT04067492|593250203|FG001|Overall Study|Lost to Follow-up|0|||
164240110|NCT04067492|593250204|FG002|Overall Study|Lost to Follow-up|0|||
164240111|NCT04067492|593250205|FG003|Overall Study|Lost to Follow-up|0|||
164240112|NCT04067492|593250206|FG004|Overall Study|Lost to Follow-up|0|||
164240113|NCT04067492|593250207|FG005|Overall Study|Lost to Follow-up|1|||
164240114|NCT04067492|593250202|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
164240115|NCT04067492|593250203|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
164335911|NCT01736124|593606102|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
164335912|NCT01736124|593606101|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
164425303|NCT00372567|593928439|FG000|Phase 3 Study|Protocol Violation|0|||
164425304|NCT00372567|593928440|FG001|Phase 3 Study|Protocol Violation|0|||
164335913|NCT01736124|593606102|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
164335914|NCT01736124|593606101|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
164335915|NCT01736124|593606102|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
164335916|NCT01736124|593606101|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
164335917|NCT01736124|593606102|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
164335918|NCT01736124|593606101|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
164335919|NCT01736124|593606102|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
164335920|NCT01736124|593606101|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
164335921|NCT01736124|593606102|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
164335922|NCT01736124|593606101|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
164335923|NCT01736124|593606102|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
164335924|NCT01467583|593606103|FG000|Overall Study|Death|1|||
164335925|NCT01467583|593606104|FG001|Overall Study|Death|1|||
164335926|NCT01467583|593606105|FG002|Overall Study|Death|0|||
164335927|NCT01467583|593606103|FG000|Overall Study|Withdrawal by Subject|1|||
164335928|NCT01467583|593606104|FG001|Overall Study|Withdrawal by Subject|0|||
164335929|NCT01467583|593606105|FG002|Overall Study|Withdrawal by Subject|0|||
164335930|NCT01467583|593606103|FG000|Overall Study|Protocol Violation|0|||
164335931|NCT01467583|593606104|FG001|Overall Study|Protocol Violation|0|||
164335932|NCT01467583|593606105|FG002|Overall Study|Protocol Violation|2|||
164335933|NCT05274165|593606107|FG000|Overall Study|Withdrawal by Subject|3|||
164335934|NCT05274165|593606108|FG001|Overall Study|Withdrawal by Subject|3|||
164335935|NCT02719327|593606110|FG000|Overall Study|Withdrawal by Subject|11|||
164335936|NCT02719327|593606111|FG001|Overall Study|Withdrawal by Subject|8|||
164335937|NCT00717093|593607773|FG000|Overall Study|Adverse Event|19|||
164335938|NCT00717093|593607774|FG001|Overall Study|Adverse Event|9|||
164335939|NCT00717093|593607773|FG000|Overall Study|Lack of Efficacy|3|||
164335940|NCT00717093|593607774|FG001|Overall Study|Lack of Efficacy|13|||
164335941|NCT00717093|593607773|FG000|Overall Study|Lost to Follow-up|9|||
164335942|NCT00717093|593607774|FG001|Overall Study|Lost to Follow-up|6|||
164335943|NCT00717093|593607773|FG000|Overall Study|Withdrawal by Subject|12|||
164335944|NCT00717093|593607774|FG001|Overall Study|Withdrawal by Subject|19|||
164335945|NCT00717093|593607773|FG000|Overall Study|Other|0|||
164335946|NCT00717093|593607774|FG001|Overall Study|Other|1|||
164335947|NCT00717093|593607773|FG000|Overall Study|Randomized but not treated|1|||
164335948|NCT00717093|593607774|FG001|Overall Study|Randomized but not treated|0|||
164335949|NCT00217620|593607775|FG000|Overall Study|Adverse Event|2|||
164335950|NCT00217620|593607775|FG000|Overall Study|Progression|31|||
164335951|NCT00217620|593607775|FG000|Overall Study|Not Protocol Specified|4|||
164335952|NCT00217620|593607775|FG000|Overall Study|Ineligible|13|||
164335953|NCT00217620|593607775|FG000|Overall Study|Never received treatment|1|||
164335954|NCT01314703|593607791|FG000|Overall Study|screen failure and closed enrollment|8|||
164335955|NCT04195906|593607795|FG000|Part 1|Adverse Event|3|||
164335956|NCT04195906|593607796|FG001|Part 1|Adverse Event|7|||
164335957|NCT04195906|593607795|FG000|Part 1|Withdrawal by Subject|0|||
164335958|NCT04195906|593607796|FG001|Part 1|Withdrawal by Subject|1|||
164335959|NCT04195906|593607795|FG000|Part 2|Adverse Event|1|||
164335960|NCT04195906|593607796|FG001|Part 2|Adverse Event|1|||
164335961|NCT04195906|593607795|FG000|Part 2|Withdrawal by Subject|0|||
164335962|NCT04195906|593607796|FG001|Part 2|Withdrawal by Subject|3|||
164335963|NCT04195906|593607795|FG000|Part 2|Other|1|||
164335964|NCT04195906|593607796|FG001|Part 2|Other|3|||
164335965|NCT01823146|593607798|FG000|Overall Study|Withdrawal by Subject|0|||
164335966|NCT01823146|593607799|FG001|Overall Study|Withdrawal by Subject|1|||
164335967|NCT01823146|593607798|FG000|Overall Study|Lost to Follow-up|2|||
164335968|NCT01823146|593607799|FG001|Overall Study|Lost to Follow-up|1|||
164425305|NCT00372567|593928441|FG002|Phase 3 Study|Protocol Violation|1|||
164573392|NCT00700804|594463418|FG000|Overall Study|Protocol Violation|1|||
164573393|NCT00700804|594463419|FG001|Overall Study|Protocol Violation|1|||
164573394|NCT00700804|594463418|FG000|Overall Study|Loose Stools|1|||
164573395|NCT00700804|594463419|FG001|Overall Study|Loose Stools|1|||
164573396|NCT02901431|594463420|FG000|PK Part|Adverse Event|0|||
164573397|NCT02901431|594463421|FG001|PK Part|Adverse Event|1|||
164240116|NCT04067492|593250204|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
164677639|NCT01695239|594844832|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
164677640|NCT01695239|594844833|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
164677641|NCT01695239|594844834|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
164677642|NCT01695239|594844835|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
164677643|NCT01695239|594844836|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
164677644|NCT01695239|594844823|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
164677645|NCT01695239|594844824|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
164677646|NCT01695239|594844825|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
164677647|NCT01695239|594844826|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
164677648|NCT01695239|594844827|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
164677649|NCT01695239|594844828|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
164677650|NCT01695239|594844829|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
164677651|NCT01695239|594844830|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
164677652|NCT01695239|594844831|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
164677653|NCT01695239|594844832|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
164677654|NCT01695239|594844833|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
164677655|NCT01695239|594844834|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
164677656|NCT01695239|594844835|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
164677657|NCT01695239|594844836|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
164677658|NCT01695239|594844823|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
164677659|NCT01695239|594844824|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
164677660|NCT01695239|594844825|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
164677661|NCT01695239|594844826|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
164677662|NCT01695239|594844827|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
164677663|NCT01695239|594844828|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
164677664|NCT01695239|594844829|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
164677665|NCT01695239|594844830|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
164677666|NCT01695239|594844831|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
164677667|NCT01695239|594844832|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
164677668|NCT01695239|594844833|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
164677669|NCT01695239|594844834|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
164677670|NCT01695239|594844835|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
164677671|NCT01695239|594844836|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
164677672|NCT01695239|594844823|FG000|Extension Long-Term Extension Periods|Death|0|||
164677673|NCT01695239|594844824|FG001|Extension Long-Term Extension Periods|Death|0|||
164677674|NCT01695239|594844825|FG002|Extension Long-Term Extension Periods|Death|0|||
164677675|NCT01695239|594844826|FG003|Extension Long-Term Extension Periods|Death|0|||
164677676|NCT01695239|594844827|FG004|Extension Long-Term Extension Periods|Death|0|||
164677677|NCT01695239|594844828|FG005|Extension Long-Term Extension Periods|Death|0|||
164677678|NCT01695239|594844829|FG006|Extension Long-Term Extension Periods|Death|0|||
164677679|NCT01695239|594844830|FG007|Extension Long-Term Extension Periods|Death|0|||
164677680|NCT01695239|594844831|FG008|Extension Long-Term Extension Periods|Death|1|||
164677681|NCT01695239|594844832|FG009|Extension Long-Term Extension Periods|Death|0|||
164677682|NCT01695239|594844833|FG010|Extension Long-Term Extension Periods|Death|0|||
164677683|NCT01695239|594844834|FG011|Extension Long-Term Extension Periods|Death|0|||
164677684|NCT01695239|594844835|FG012|Extension Long-Term Extension Periods|Death|0|||
164677685|NCT01695239|594844836|FG013|Extension Long-Term Extension Periods|Death|0|||
164677686|NCT01695239|594844823|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164677687|NCT01695239|594844824|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164677688|NCT01695239|594844825|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164677689|NCT01695239|594844826|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164677690|NCT01695239|594844827|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164677691|NCT01695239|594844828|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164677692|NCT01695239|594844829|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164677693|NCT01695239|594844830|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164677694|NCT01695239|594844831|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164677695|NCT01695239|594844832|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164677696|NCT01695239|594844833|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164677697|NCT01695239|594844834|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
164677698|NCT01695239|594844835|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
164677699|NCT01695239|594844836|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
164677700|NCT01695239|594844823|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164677701|NCT01695239|594844824|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164677702|NCT01695239|594844825|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164677703|NCT01695239|594844826|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164425306|NCT00372567|593928439|FG000|Phase 3 Study|Objective progression or relapse|10|||
164425307|NCT00372567|593928440|FG001|Phase 3 Study|Objective progression or relapse|13|||
164425308|NCT00372567|593928441|FG002|Phase 3 Study|Objective progression or relapse|4|||
164240117|NCT04067492|593250205|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
164240118|NCT04067492|593250206|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
164240119|NCT04067492|593250207|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
164240120|NCT04067492|593250202|FG000|Overall Study|COVID-19 epidemiological situation|0|||
164240121|NCT04067492|593250203|FG001|Overall Study|COVID-19 epidemiological situation|0|||
164240122|NCT04067492|593250204|FG002|Overall Study|COVID-19 epidemiological situation|0|||
164240123|NCT04067492|593250205|FG003|Overall Study|COVID-19 epidemiological situation|1|||
164240124|NCT04067492|593250206|FG004|Overall Study|COVID-19 epidemiological situation|0|||
164240125|NCT04067492|593250207|FG005|Overall Study|COVID-19 epidemiological situation|0|||
164240126|NCT05899829|593250212|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
164240127|NCT05899829|593250213|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
164240128|NCT05899829|593250212|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
164240129|NCT05899829|593250213|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
164240130|NCT04021290|593250216|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
164240131|NCT04021290|593250217|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
164240132|NCT04021290|593250218|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
164240133|NCT04021290|593250216|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
164240134|NCT04021290|593250217|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
164240135|NCT04021290|593250218|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
164240136|NCT04021290|593250216|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
164240137|NCT04021290|593250217|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
164240138|NCT04021290|593250218|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
164240139|NCT04021290|593250216|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
164240140|NCT04021290|593250217|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
164335969|NCT01426438|593607800|FG000|Overall Study|Lost to Follow-up|1|||
164335970|NCT01426438|593607801|FG001|Overall Study|Lost to Follow-up|3|||
164335971|NCT01426438|593607800|FG000|Overall Study|Off study Treatment|9|||
164335972|NCT01426438|593607801|FG001|Overall Study|Off study Treatment|3|||
164335973|NCT01426438|593607800|FG000|Overall Study|Poor scan quality|3|||
164425309|NCT00372567|593928439|FG000|Phase 3 Study|Global deterioration of health status|0|||
164425310|NCT00372567|593928440|FG001|Phase 3 Study|Global deterioration of health status|1|||
164425311|NCT00372567|593928441|FG002|Phase 3 Study|Global deterioration of health status|0|||
164425312|NCT00372567|593928439|FG000|Phase 3 Study|Other|2|||
164425313|NCT00372567|593928440|FG001|Phase 3 Study|Other|2|||
164425314|NCT00372567|593928441|FG002|Phase 3 Study|Other|1|||
164425315|NCT00372567|593928439|FG000|Phase 3 Study|study terminated by sponsor|13|||
164425316|NCT00372567|593928440|FG001|Phase 3 Study|study terminated by sponsor|8|||
164425317|NCT00372567|593928441|FG002|Phase 3 Study|study terminated by sponsor|5|||
164425318|NCT00953160|593928442|FG000|Overall Study|Lost to Follow-up|23|||
164425319|NCT00953160|593928442|FG000|Overall Study|Withdrawal by Subject|4|||
164425320|NCT03836664|593928453|FG000|Overall Study|Didn't complete forms and lost drug|3|||
164425321|NCT03836664|593928454|FG001|Overall Study|Didn't complete forms and lost drug|3|||
164425322|NCT01427907|593928455|FG000|Overall Study|Withdrawal by Subject|3|||
164425323|NCT01427907|593928456|FG001|Overall Study|Withdrawal by Subject|4|||
164425324|NCT00425503|593928459|FG000|Overall Study|Adverse Event|2|||
164425325|NCT00425503|593928459|FG000|Overall Study|Protocol Violation|1|||
164425326|NCT03278028|593928461|FG000|Overall Study|Lost to Follow-up|1|||
164677704|NCT01695239|594844827|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164240141|NCT04021290|593250218|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
164240142|NCT04021290|593250216|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
164335974|NCT01426438|593607801|FG001|Overall Study|Poor scan quality|2|||
164335975|NCT01426438|593607800|FG000|Overall Study|Missed Scan|2|||
164335976|NCT01426438|593607801|FG001|Overall Study|Missed Scan|2|||
164335977|NCT02122458|593607802|FG000|Overall Study|Withdrawal by Subject|0|||
164335978|NCT02122458|593607803|FG001|Overall Study|Withdrawal by Subject|0|||
164335979|NCT02122458|593607804|FG002|Overall Study|Withdrawal by Subject|0|||
164335980|NCT02122458|593607805|FG003|Overall Study|Withdrawal by Subject|4|||
164335981|NCT02122458|593607806|FG004|Overall Study|Withdrawal by Subject|4|||
164335982|NCT02122458|593607807|FG005|Overall Study|Withdrawal by Subject|4|||
164335983|NCT02122458|593607808|FG006|Overall Study|Withdrawal by Subject|0|||
164335984|NCT02122458|593607802|FG000|Overall Study|Lost to Follow-up|1|||
164335985|NCT02122458|593607803|FG001|Overall Study|Lost to Follow-up|3|||
164335986|NCT02122458|593607804|FG002|Overall Study|Lost to Follow-up|0|||
164425327|NCT03278028|593928462|FG001|Overall Study|Lost to Follow-up|0|||
164335987|NCT02122458|593607805|FG003|Overall Study|Lost to Follow-up|7|||
164335988|NCT02122458|593607806|FG004|Overall Study|Lost to Follow-up|5|||
164425328|NCT03278028|593928461|FG000|Overall Study|Withdrawal by Subject|3|||
164425329|NCT03278028|593928462|FG001|Overall Study|Withdrawal by Subject|1|||
164425330|NCT03278028|593928461|FG000|Overall Study|Pregnancy|0|||
164425331|NCT03278028|593928462|FG001|Overall Study|Pregnancy|1|||
164240143|NCT04021290|593250217|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
164240144|NCT04021290|593250218|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
164240145|NCT04021290|593250216|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
164240146|NCT04021290|593250217|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
164240147|NCT04021290|593250218|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
164240148|NCT04021290|593250216|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
164240149|NCT04021290|593250217|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
164240150|NCT04021290|593250218|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
164240151|NCT04021290|593250216|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
164240152|NCT04021290|593250217|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
164240153|NCT04021290|593250218|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
164240154|NCT04021290|593250216|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
164240155|NCT04021290|593250217|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
164240156|NCT04021290|593250218|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
164240157|NCT04021290|593250216|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
164240158|NCT04021290|593250217|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
164240159|NCT04021290|593250218|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
164240160|NCT04021290|593250216|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
164240161|NCT04021290|593250217|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
164240162|NCT04021290|593250218|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
164240163|NCT04021290|593250216|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
164240164|NCT04021290|593250217|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
164240165|NCT04021290|593250218|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
164240166|NCT05076045|593250219|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
164240167|NCT05076045|593250220|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
164240168|NCT03391882|593250221|FG000|Study Overall|Adverse Event|3|||
164240169|NCT03391882|593250222|FG001|Study Overall|Adverse Event|6|||
164240170|NCT03391882|593250223|FG002|Study Overall|Adverse Event|1|||
164240171|NCT03391882|593250224|FG003|Study Overall|Adverse Event|1|||
164240172|NCT03391882|593250225|FG004|Study Overall|Adverse Event|3|||
164240173|NCT03391882|593250226|FG005|Study Overall|Adverse Event|1|||
164240174|NCT03391882|593250221|FG000|Study Overall|Lack of Efficacy|13|||
164240175|NCT03391882|593250222|FG001|Study Overall|Lack of Efficacy|9|||
164240176|NCT03391882|593250223|FG002|Study Overall|Lack of Efficacy|0|||
164240177|NCT03391882|593250224|FG003|Study Overall|Lack of Efficacy|0|||
164240178|NCT03391882|593250225|FG004|Study Overall|Lack of Efficacy|0|||
164240179|NCT03391882|593250226|FG005|Study Overall|Lack of Efficacy|0|||
164240180|NCT03391882|593250221|FG000|Study Overall|Withdrawal by Subject|3|||
164240181|NCT03391882|593250222|FG001|Study Overall|Withdrawal by Subject|3|||
164240182|NCT03391882|593250223|FG002|Study Overall|Withdrawal by Subject|2|||
164240183|NCT03391882|593250224|FG003|Study Overall|Withdrawal by Subject|2|||
164240184|NCT03391882|593250225|FG004|Study Overall|Withdrawal by Subject|1|||
164240185|NCT03391882|593250226|FG005|Study Overall|Withdrawal by Subject|3|||
164240186|NCT03391882|593250221|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
164240187|NCT03391882|593250222|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
164240188|NCT03391882|593250223|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
164240189|NCT03391882|593250224|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
164240190|NCT03391882|593250225|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
164240191|NCT03391882|593250226|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
164240192|NCT03391882|593250221|FG000|Study Overall|Protocol Violation|1|||
164240193|NCT03391882|593250222|FG001|Study Overall|Protocol Violation|0|||
164240194|NCT03391882|593250223|FG002|Study Overall|Protocol Violation|0|||
164240195|NCT03391882|593250224|FG003|Study Overall|Protocol Violation|0|||
164240196|NCT03391882|593250225|FG004|Study Overall|Protocol Violation|0|||
164240197|NCT03391882|593250226|FG005|Study Overall|Protocol Violation|0|||
164240198|NCT03391882|593250221|FG000|Part A - Titration Phase|Adverse Event|3|||
164240199|NCT03391882|593250222|FG001|Part A - Titration Phase|Adverse Event|6|||
164240200|NCT03391882|593250223|FG002|Part A - Titration Phase|Adverse Event|0|||
164240201|NCT03391882|593250224|FG003|Part A - Titration Phase|Adverse Event|0|||
164240202|NCT03391882|593250225|FG004|Part A - Titration Phase|Adverse Event|0|||
164240203|NCT03391882|593250226|FG005|Part A - Titration Phase|Adverse Event|0|||
164240204|NCT03391882|593250221|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
164240205|NCT03391882|593250222|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
164240206|NCT03391882|593250223|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
164240207|NCT03391882|593250224|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
164240208|NCT03391882|593250225|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
164240209|NCT03391882|593250226|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
164240210|NCT03391882|593250221|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
164240211|NCT03391882|593250222|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
164240212|NCT03391882|593250223|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
164240213|NCT03391882|593250224|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
164335989|NCT02122458|593607807|FG005|Overall Study|Lost to Follow-up|15|||
164240214|NCT03391882|593250225|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
164240215|NCT03391882|593250226|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
164240216|NCT03391882|593250221|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
164240217|NCT03391882|593250222|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
164240218|NCT03391882|593250223|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
164240219|NCT03391882|593250224|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
164240220|NCT03391882|593250225|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
164335990|NCT02122458|593607808|FG006|Overall Study|Lost to Follow-up|1|||
164335991|NCT02122458|593607802|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
164335992|NCT02122458|593607803|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
164335993|NCT02122458|593607804|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
164335994|NCT02122458|593607805|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
164335995|NCT02122458|593607806|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
164335996|NCT02122458|593607807|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
164335997|NCT02122458|593607808|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
164335998|NCT02122458|593607802|FG000|Overall Study|Adverse Event|1|||
164335999|NCT02122458|593607803|FG001|Overall Study|Adverse Event|0|||
164336000|NCT02122458|593607804|FG002|Overall Study|Adverse Event|0|||
164336001|NCT02122458|593607805|FG003|Overall Study|Adverse Event|0|||
164336002|NCT02122458|593607806|FG004|Overall Study|Adverse Event|0|||
164336003|NCT02122458|593607807|FG005|Overall Study|Adverse Event|0|||
164336004|NCT02122458|593607808|FG006|Overall Study|Adverse Event|0|||
164336005|NCT02122458|593607802|FG000|Overall Study|Experimental Error|0|||
164336006|NCT02122458|593607803|FG001|Overall Study|Experimental Error|0|||
164336007|NCT02122458|593607804|FG002|Overall Study|Experimental Error|0|||
164336008|NCT02122458|593607805|FG003|Overall Study|Experimental Error|0|||
164336009|NCT02122458|593607806|FG004|Overall Study|Experimental Error|3|||
164336010|NCT02122458|593607807|FG005|Overall Study|Experimental Error|0|||
164336011|NCT02122458|593607808|FG006|Overall Study|Experimental Error|0|||
164336012|NCT02122458|593607802|FG000|Overall Study|Deployed or Moved|0|||
164336013|NCT02122458|593607803|FG001|Overall Study|Deployed or Moved|0|||
164336014|NCT02122458|593607804|FG002|Overall Study|Deployed or Moved|0|||
164336015|NCT02122458|593607805|FG003|Overall Study|Deployed or Moved|0|||
164336016|NCT02122458|593607806|FG004|Overall Study|Deployed or Moved|1|||
164336017|NCT02122458|593607807|FG005|Overall Study|Deployed or Moved|0|||
164336018|NCT02122458|593607808|FG006|Overall Study|Deployed or Moved|0|||
164336019|NCT02122458|593607802|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
164336020|NCT02122458|593607803|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
164336021|NCT02122458|593607804|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
164336022|NCT02122458|593607805|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
164336023|NCT02122458|593607806|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
164336024|NCT02122458|593607807|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
164336025|NCT02122458|593607808|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
164677705|NCT01695239|594844828|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164677706|NCT01695239|594844829|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164677707|NCT01695239|594844830|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164677708|NCT01695239|594844831|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164677709|NCT01695239|594844832|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164677710|NCT01695239|594844833|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164336026|NCT02122458|593607802|FG000|Overall Study|Noncompliance|0|||
164677711|NCT01695239|594844834|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164677712|NCT01695239|594844835|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
164677713|NCT01695239|594844836|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
164336027|NCT02122458|593607803|FG001|Overall Study|Noncompliance|1|||
164336028|NCT02122458|593607804|FG002|Overall Study|Noncompliance|0|||
164240221|NCT03391882|593250226|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
164240222|NCT03391882|593250221|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
164240223|NCT03391882|593250222|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
164240224|NCT03391882|593250223|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
164240225|NCT03391882|593250224|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
164240226|NCT03391882|593250225|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
164240227|NCT03391882|593250226|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
164240228|NCT03391882|593250221|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
164336029|NCT02122458|593607805|FG003|Overall Study|Noncompliance|0|||
164336030|NCT02122458|593607806|FG004|Overall Study|Noncompliance|0|||
164336031|NCT02122458|593607807|FG005|Overall Study|Noncompliance|0|||
164336032|NCT02122458|593607808|FG006|Overall Study|Noncompliance|0|||
164336033|NCT00412542|593607809|FG000|Overall Study|Withdrawal by Subject|0|||
164336034|NCT00412542|593607810|FG001|Overall Study|Withdrawal by Subject|2|||
164336035|NCT00412542|593607809|FG000|Overall Study|Not Eligible|0|||
164336036|NCT00412542|593607810|FG001|Overall Study|Not Eligible|1|||
164425332|NCT02118714|593928466|FG000|Overall Study|Lost to Follow-up|2|||
164240229|NCT03391882|593250222|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
164240230|NCT03391882|593250223|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
164240231|NCT03391882|593250224|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
164240232|NCT03391882|593250225|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
164240233|NCT03391882|593250226|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
164240234|NCT03391882|593250221|FG000|Part B - Treatment Phase|Adverse Event|0|||
164240235|NCT03391882|593250222|FG001|Part B - Treatment Phase|Adverse Event|0|||
164240236|NCT03391882|593250223|FG002|Part B - Treatment Phase|Adverse Event|1|||
164240237|NCT03391882|593250224|FG003|Part B - Treatment Phase|Adverse Event|1|||
164240238|NCT03391882|593250225|FG004|Part B - Treatment Phase|Adverse Event|3|||
164240239|NCT03391882|593250226|FG005|Part B - Treatment Phase|Adverse Event|1|||
164240240|NCT03391882|593250221|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
164240241|NCT03391882|593250222|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
164240242|NCT03391882|593250223|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
164240243|NCT03391882|593250224|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
164240244|NCT03391882|593250225|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
164240245|NCT03391882|593250226|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
164240246|NCT03092479|593250227|FG000|Overall Study|Lost to Follow-up|3|||
164240247|NCT03092479|593250228|FG001|Overall Study|Lost to Follow-up|2|||
164240248|NCT03092479|593250227|FG000|Overall Study|Withdrawal by Subject|4|||
164240249|NCT03092479|593250228|FG001|Overall Study|Withdrawal by Subject|0|||
164240250|NCT03913130|593250231|FG000|Overall Study|Sponsor Decision|1|||
164240251|NCT04046939|593250240|FG000|Primary Assessment Period|Adverse Event|1|||
164240252|NCT04046939|593250241|FG001|Primary Assessment Period|Adverse Event|0|||
164240253|NCT04046939|593250242|FG002|Primary Assessment Period|Adverse Event|0|||
164240254|NCT04046939|593250243|FG003|Primary Assessment Period|Adverse Event|0|||
164240255|NCT04046939|593250240|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
164240256|NCT04046939|593250241|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
164240257|NCT04046939|593250242|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
164240258|NCT04046939|593250243|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
164240259|NCT04046939|593250240|FG000|Primary Assessment Period|Physician Decision|0|||
164240260|NCT04046939|593250241|FG001|Primary Assessment Period|Physician Decision|0|||
164240261|NCT04046939|593250242|FG002|Primary Assessment Period|Physician Decision|1|||
164240262|NCT04046939|593250243|FG003|Primary Assessment Period|Physician Decision|0|||
164240263|NCT04046939|593250240|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
164240264|NCT04046939|593250241|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
164240265|NCT04046939|593250242|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
164240266|NCT04046939|593250243|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
164240267|NCT04704193|593250244|FG000|Overall Study|Withdrawal by Subject|1|||
164240268|NCT03384875|593250245|FG000|Overall Study|Death|1|||
164240269|NCT03384875|593250246|FG001|Overall Study|Death|1|||
164240270|NCT03384875|593250247|FG002|Overall Study|Death|0|||
164240271|NCT03384875|593250245|FG000|Overall Study|Reason not provided|1|||
164240272|NCT03384875|593250246|FG001|Overall Study|Reason not provided|0|||
164240273|NCT03384875|593250247|FG002|Overall Study|Reason not provided|0|||
164240274|NCT04790279|593252345|FG000|Overall Study|Did not meet medication start criteria|27|||
164240275|NCT04790279|593252346|FG001|Overall Study|Did not meet medication start criteria|15|||
164240276|NCT04790279|593252345|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
164240277|NCT04790279|593252346|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
164240278|NCT04790279|593252345|FG000|Overall Study|Protocol Violation|8|||
164240279|NCT04790279|593252346|FG001|Overall Study|Protocol Violation|3|||
164240280|NCT04790279|593252345|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
164240281|NCT04790279|593252346|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
164240282|NCT00678288|593252349|FG000|Overall Study|Adverse Event|0|||
164240283|NCT00678288|593252350|FG001|Overall Study|Adverse Event|2|||
164240284|NCT00678288|593252349|FG000|Overall Study|Withdrawal by Subject|1|||
164240285|NCT00678288|593252350|FG001|Overall Study|Withdrawal by Subject|1|||
164240286|NCT00678288|593252349|FG000|Overall Study|Study terminated by the sponsor|2|||
164240287|NCT00678288|593252350|FG001|Overall Study|Study terminated by the sponsor|0|||
164240288|NCT00678288|593252349|FG000|Overall Study|Not compliant with study medication|0|||
164240289|NCT00678288|593252350|FG001|Overall Study|Not compliant with study medication|1|||
164240290|NCT00678288|593252349|FG000|Overall Study|Switch to commercial drug|0|||
164240291|NCT00678288|593252350|FG001|Overall Study|Switch to commercial drug|1|||
164240292|NCT00678288|593252349|FG000|Overall Study|Reason not reported|1|||
164240293|NCT00678288|593252350|FG001|Overall Study|Reason not reported|0|||
164240294|NCT00678288|593252349|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
164240295|NCT00678288|593252350|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
164425333|NCT02118714|593928466|FG000|Overall Study|Protocol Violation|1|||
164240296|NCT04472650|593252359|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
164240297|NCT04472650|593252360|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
164240298|NCT03247829|593252363|FG000|Overall Study|Death|3|||
164240299|NCT03247829|593252364|FG001|Overall Study|Death|4|||
164573398|NCT02901431|594463422|FG002|PK Part|Adverse Event|0|||
164240300|NCT03247829|593252363|FG000|Overall Study|Enter Hospice Care|1|||
164240301|NCT03247829|593252364|FG001|Overall Study|Enter Hospice Care|0|||
164240302|NCT03247829|593252363|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
164240303|NCT03247829|593252364|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
164240304|NCT03247829|593252363|FG000|Overall Study|LVAD Explant|1|||
164240305|NCT03247829|593252364|FG001|Overall Study|LVAD Explant|1|||
164240306|NCT03247829|593252363|FG000|Overall Study|Transplant|1|||
164240307|NCT03247829|593252364|FG001|Overall Study|Transplant|1|||
164240308|NCT01783444|593252365|FG000|Treatment Phase|Adverse Event|9|||
164240309|NCT01783444|593252366|FG001|Treatment Phase|Adverse Event|20|||
164240310|NCT01783444|593252367|FG002|Treatment Phase|Adverse Event|19|||
164240311|NCT01783444|593252365|FG000|Treatment Phase|Disease Progression|76|||
164240312|NCT01783444|593252366|FG001|Treatment Phase|Disease Progression|66|||
164240313|NCT01783444|593252367|FG002|Treatment Phase|Disease Progression|64|||
164240314|NCT01783444|593252365|FG000|Treatment Phase|Death|2|||
164240315|NCT01783444|593252366|FG001|Treatment Phase|Death|2|||
164240316|NCT01783444|593252367|FG002|Treatment Phase|Death|2|||
164240317|NCT01783444|593252365|FG000|Treatment Phase|Protocol Violation|1|||
164240318|NCT01783444|593252366|FG001|Treatment Phase|Protocol Violation|1|||
164240319|NCT01783444|593252367|FG002|Treatment Phase|Protocol Violation|2|||
164240320|NCT01783444|593252365|FG000|Treatment Phase|Withdrawal by Subject|6|||
164240321|NCT01783444|593252366|FG001|Treatment Phase|Withdrawal by Subject|8|||
164240322|NCT01783444|593252367|FG002|Treatment Phase|Withdrawal by Subject|9|||
164240323|NCT01783444|593252365|FG000|Treatment Phase|Administrative problems|2|||
164240324|NCT01783444|593252366|FG001|Treatment Phase|Administrative problems|0|||
164240325|NCT01783444|593252367|FG002|Treatment Phase|Administrative problems|1|||
164240326|NCT01783444|593252365|FG000|Treatment Phase|Physician Decision|8|||
164240327|NCT01783444|593252366|FG001|Treatment Phase|Physician Decision|6|||
164240328|NCT01783444|593252367|FG002|Treatment Phase|Physician Decision|5|||
164240329|NCT01783444|593252365|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
164240330|NCT01783444|593252366|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
164240331|NCT01783444|593252367|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
164240332|NCT01783444|593252365|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
164240333|NCT01783444|593252366|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
164240334|NCT01783444|593252367|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
164240335|NCT01783444|593252365|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
164240336|NCT01783444|593252366|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
164240337|NCT01783444|593252367|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
164240338|NCT01783444|593252365|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
164240339|NCT01783444|593252366|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
164240340|NCT01783444|593252367|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
164240341|NCT01783444|593252365|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
164240342|NCT01783444|593252366|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
164240343|NCT01783444|593252367|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
164240344|NCT01783444|593252365|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
164240345|NCT01783444|593252366|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
164240346|NCT01783444|593252367|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
164240347|NCT01713582|593252371|FG000|Overall Study|Disease progression|3|||
164240348|NCT01713582|593252372|FG001|Overall Study|Disease progression|3|||
164240349|NCT01713582|593252373|FG002|Overall Study|Disease progression|3|||
164240350|NCT01713582|593252374|FG003|Overall Study|Disease progression|2|||
164240351|NCT01713582|593252375|FG004|Overall Study|Disease progression|3|||
164240352|NCT01713582|593252376|FG005|Overall Study|Disease progression|3|||
164240353|NCT01713582|593252377|FG006|Overall Study|Disease progression|3|||
164240354|NCT01713582|593252378|FG007|Overall Study|Disease progression|3|||
164573399|NCT02901431|594463423|FG003|PK Part|Adverse Event|0|||
164240355|NCT01713582|593252379|FG008|Overall Study|Disease progression|3|||
164240356|NCT01713582|593252380|FG009|Overall Study|Disease progression|11|||
164240357|NCT01713582|593252381|FG010|Overall Study|Disease progression|10|||
164240358|NCT01713582|593252382|FG011|Overall Study|Disease progression|5|||
164240359|NCT01713582|593252383|FG012|Overall Study|Disease progression|3|||
164240360|NCT01713582|593252384|FG013|Overall Study|Disease progression|3|||
164240361|NCT01713582|593252385|FG014|Overall Study|Disease progression|6|||
164240362|NCT01713582|593252386|FG015|Overall Study|Disease progression|6|||
164240363|NCT01713582|593252387|FG016|Overall Study|Disease progression|5|||
164240364|NCT01713582|593252388|FG017|Overall Study|Disease progression|2|||
164240365|NCT01713582|593252389|FG018|Overall Study|Disease progression|3|||
164240366|NCT01713582|593252390|FG019|Overall Study|Disease progression|5|||
164240367|NCT01713582|593252391|FG020|Overall Study|Disease progression|15|||
164240368|NCT01713582|593252371|FG000|Overall Study|Death|0|||
164240369|NCT01713582|593252372|FG001|Overall Study|Death|0|||
164240370|NCT01713582|593252373|FG002|Overall Study|Death|0|||
164240371|NCT01713582|593252374|FG003|Overall Study|Death|1|||
164240372|NCT01713582|593252375|FG004|Overall Study|Death|1|||
164240373|NCT01713582|593252376|FG005|Overall Study|Death|3|||
164240374|NCT01713582|593252377|FG006|Overall Study|Death|3|||
164240375|NCT01713582|593252378|FG007|Overall Study|Death|2|||
164240376|NCT01713582|593252379|FG008|Overall Study|Death|3|||
164240377|NCT01713582|593252380|FG009|Overall Study|Death|4|||
164240378|NCT01713582|593252381|FG010|Overall Study|Death|3|||
164240379|NCT01713582|593252382|FG011|Overall Study|Death|0|||
164240380|NCT01713582|593252383|FG012|Overall Study|Death|0|||
164240381|NCT01713582|593252384|FG013|Overall Study|Death|0|||
164240382|NCT01713582|593252385|FG014|Overall Study|Death|0|||
164240383|NCT01713582|593252386|FG015|Overall Study|Death|0|||
164240384|NCT01713582|593252387|FG016|Overall Study|Death|0|||
164240385|NCT01713582|593252388|FG017|Overall Study|Death|0|||
164240386|NCT01713582|593252389|FG018|Overall Study|Death|0|||
164240387|NCT01713582|593252390|FG019|Overall Study|Death|0|||
164240388|NCT01713582|593252391|FG020|Overall Study|Death|0|||
164240389|NCT01713582|593252371|FG000|Overall Study|Adverse event-related|0|||
164240390|NCT01713582|593252372|FG001|Overall Study|Adverse event-related|0|||
164240391|NCT01713582|593252373|FG002|Overall Study|Adverse event-related|0|||
164240392|NCT01713582|593252374|FG003|Overall Study|Adverse event-related|0|||
164240393|NCT01713582|593252375|FG004|Overall Study|Adverse event-related|0|||
164240394|NCT01713582|593252376|FG005|Overall Study|Adverse event-related|0|||
164240395|NCT01713582|593252377|FG006|Overall Study|Adverse event-related|0|||
164240396|NCT01713582|593252378|FG007|Overall Study|Adverse event-related|0|||
164240397|NCT01713582|593252379|FG008|Overall Study|Adverse event-related|0|||
164240398|NCT01713582|593252380|FG009|Overall Study|Adverse event-related|1|||
164240399|NCT01713582|593252381|FG010|Overall Study|Adverse event-related|1|||
164240400|NCT01713582|593252382|FG011|Overall Study|Adverse event-related|0|||
164240401|NCT01713582|593252383|FG012|Overall Study|Adverse event-related|0|||
164240402|NCT01713582|593252384|FG013|Overall Study|Adverse event-related|0|||
164240403|NCT01713582|593252385|FG014|Overall Study|Adverse event-related|0|||
164240404|NCT01713582|593252386|FG015|Overall Study|Adverse event-related|0|||
164240405|NCT01713582|593252387|FG016|Overall Study|Adverse event-related|0|||
164240406|NCT01713582|593252388|FG017|Overall Study|Adverse event-related|0|||
164240407|NCT01713582|593252389|FG018|Overall Study|Adverse event-related|1|||
164240408|NCT01713582|593252390|FG019|Overall Study|Adverse event-related|0|||
164240409|NCT01713582|593252391|FG020|Overall Study|Adverse event-related|0|||
164240410|NCT01713582|593252371|FG000|Overall Study|Adverse event-unrelated|0|||
164240411|NCT01713582|593252372|FG001|Overall Study|Adverse event-unrelated|0|||
164240412|NCT01713582|593252373|FG002|Overall Study|Adverse event-unrelated|0|||
164240413|NCT01713582|593252374|FG003|Overall Study|Adverse event-unrelated|0|||
164240414|NCT01713582|593252375|FG004|Overall Study|Adverse event-unrelated|0|||
164240415|NCT01713582|593252376|FG005|Overall Study|Adverse event-unrelated|1|||
164240416|NCT01713582|593252377|FG006|Overall Study|Adverse event-unrelated|1|||
164240417|NCT01713582|593252378|FG007|Overall Study|Adverse event-unrelated|1|||
164240418|NCT01713582|593252379|FG008|Overall Study|Adverse event-unrelated|0|||
164240419|NCT01713582|593252380|FG009|Overall Study|Adverse event-unrelated|0|||
164240420|NCT01713582|593252381|FG010|Overall Study|Adverse event-unrelated|0|||
164240421|NCT01713582|593252382|FG011|Overall Study|Adverse event-unrelated|0|||
164336037|NCT02833350|593607811|FG000|Overall Study|Adverse Event|0|||
164240422|NCT01713582|593252383|FG012|Overall Study|Adverse event-unrelated|0|||
164240423|NCT01713582|593252384|FG013|Overall Study|Adverse event-unrelated|1|||
164336038|NCT02833350|593607812|FG001|Overall Study|Adverse Event|3|||
164336039|NCT02833350|593607813|FG002|Overall Study|Adverse Event|4|||
164336040|NCT02833350|593607814|FG003|Overall Study|Adverse Event|4|||
164336041|NCT02833350|593607815|FG004|Overall Study|Adverse Event|1|||
164336042|NCT02833350|593607816|FG005|Overall Study|Adverse Event|0|||
164336043|NCT02833350|593607817|FG006|Overall Study|Adverse Event|1|||
164336044|NCT02833350|593607811|FG000|Overall Study|Death|0|||
164336045|NCT02833350|593607812|FG001|Overall Study|Death|0|||
164336046|NCT02833350|593607813|FG002|Overall Study|Death|1|||
164336047|NCT02833350|593607814|FG003|Overall Study|Death|0|||
164336048|NCT02833350|593607815|FG004|Overall Study|Death|0|||
164336049|NCT02833350|593607816|FG005|Overall Study|Death|0|||
164336050|NCT02833350|593607817|FG006|Overall Study|Death|0|||
164677714|NCT01695239|594844823|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
164240424|NCT01713582|593252385|FG014|Overall Study|Adverse event-unrelated|1|||
164240425|NCT01713582|593252386|FG015|Overall Study|Adverse event-unrelated|0|||
164240426|NCT01713582|593252387|FG016|Overall Study|Adverse event-unrelated|0|||
164336051|NCT02833350|593607811|FG000|Overall Study|Lack of Efficacy|0|||
164336052|NCT02833350|593607812|FG001|Overall Study|Lack of Efficacy|2|||
164336053|NCT02833350|593607813|FG002|Overall Study|Lack of Efficacy|1|||
164336054|NCT02833350|593607814|FG003|Overall Study|Lack of Efficacy|4|||
164336055|NCT02833350|593607815|FG004|Overall Study|Lack of Efficacy|0|||
164240427|NCT01713582|593252388|FG017|Overall Study|Adverse event-unrelated|0|||
164240428|NCT01713582|593252389|FG018|Overall Study|Adverse event-unrelated|0|||
164240429|NCT01713582|593252390|FG019|Overall Study|Adverse event-unrelated|0|||
164240430|NCT01713582|593252391|FG020|Overall Study|Adverse event-unrelated|0|||
164336056|NCT02833350|593607816|FG005|Overall Study|Lack of Efficacy|1|||
164336057|NCT02833350|593607817|FG006|Overall Study|Lack of Efficacy|1|||
164240431|NCT01713582|593252371|FG000|Overall Study|Withdrawal of consent|0|||
164240432|NCT01713582|593252372|FG001|Overall Study|Withdrawal of consent|0|||
164240433|NCT01713582|593252373|FG002|Overall Study|Withdrawal of consent|1|||
164240434|NCT01713582|593252374|FG003|Overall Study|Withdrawal of consent|0|||
164240435|NCT01713582|593252375|FG004|Overall Study|Withdrawal of consent|0|||
164240436|NCT01713582|593252376|FG005|Overall Study|Withdrawal of consent|1|||
164240437|NCT01713582|593252377|FG006|Overall Study|Withdrawal of consent|0|||
164240438|NCT01713582|593252378|FG007|Overall Study|Withdrawal of consent|0|||
164240439|NCT01713582|593252379|FG008|Overall Study|Withdrawal of consent|0|||
164240440|NCT01713582|593252380|FG009|Overall Study|Withdrawal of consent|1|||
164240441|NCT01713582|593252381|FG010|Overall Study|Withdrawal of consent|0|||
164240442|NCT01713582|593252382|FG011|Overall Study|Withdrawal of consent|0|||
164240443|NCT01713582|593252383|FG012|Overall Study|Withdrawal of consent|0|||
164240444|NCT01713582|593252384|FG013|Overall Study|Withdrawal of consent|0|||
164240445|NCT01713582|593252385|FG014|Overall Study|Withdrawal of consent|0|||
164240446|NCT01713582|593252386|FG015|Overall Study|Withdrawal of consent|0|||
164240447|NCT01713582|593252387|FG016|Overall Study|Withdrawal of consent|0|||
164240448|NCT01713582|593252388|FG017|Overall Study|Withdrawal of consent|0|||
164240449|NCT01713582|593252389|FG018|Overall Study|Withdrawal of consent|1|||
164240450|NCT01713582|593252390|FG019|Overall Study|Withdrawal of consent|0|||
164240451|NCT01713582|593252391|FG020|Overall Study|Withdrawal of consent|0|||
164240452|NCT01713582|593252371|FG000|Overall Study|Lack of Efficacy|0|||
164240453|NCT01713582|593252372|FG001|Overall Study|Lack of Efficacy|0|||
164240454|NCT01713582|593252373|FG002|Overall Study|Lack of Efficacy|0|||
164240455|NCT01713582|593252374|FG003|Overall Study|Lack of Efficacy|0|||
164240456|NCT01713582|593252375|FG004|Overall Study|Lack of Efficacy|0|||
164240457|NCT01713582|593252376|FG005|Overall Study|Lack of Efficacy|0|||
164240458|NCT01713582|593252377|FG006|Overall Study|Lack of Efficacy|0|||
164240459|NCT01713582|593252378|FG007|Overall Study|Lack of Efficacy|0|||
164240460|NCT01713582|593252379|FG008|Overall Study|Lack of Efficacy|0|||
164240461|NCT01713582|593252380|FG009|Overall Study|Lack of Efficacy|1|||
164240462|NCT01713582|593252381|FG010|Overall Study|Lack of Efficacy|2|||
164240463|NCT01713582|593252382|FG011|Overall Study|Lack of Efficacy|0|||
164240464|NCT01713582|593252383|FG012|Overall Study|Lack of Efficacy|0|||
164240465|NCT01713582|593252384|FG013|Overall Study|Lack of Efficacy|0|||
164240466|NCT01713582|593252385|FG014|Overall Study|Lack of Efficacy|0|||
164240467|NCT01713582|593252386|FG015|Overall Study|Lack of Efficacy|0|||
164240468|NCT01713582|593252387|FG016|Overall Study|Lack of Efficacy|0|||
164240469|NCT01713582|593252388|FG017|Overall Study|Lack of Efficacy|0|||
164240470|NCT01713582|593252389|FG018|Overall Study|Lack of Efficacy|0|||
164240471|NCT01713582|593252390|FG019|Overall Study|Lack of Efficacy|0|||
164240472|NCT01713582|593252391|FG020|Overall Study|Lack of Efficacy|0|||
164240473|NCT01713582|593252371|FG000|Overall Study|Withdrawal by Subject|0|||
164240474|NCT01713582|593252372|FG001|Overall Study|Withdrawal by Subject|0|||
164240475|NCT01713582|593252373|FG002|Overall Study|Withdrawal by Subject|0|||
164240476|NCT01713582|593252374|FG003|Overall Study|Withdrawal by Subject|0|||
164240477|NCT01713582|593252375|FG004|Overall Study|Withdrawal by Subject|0|||
164240478|NCT01713582|593252376|FG005|Overall Study|Withdrawal by Subject|0|||
164240479|NCT01713582|593252377|FG006|Overall Study|Withdrawal by Subject|0|||
164240480|NCT01713582|593252378|FG007|Overall Study|Withdrawal by Subject|0|||
164240481|NCT01713582|593252379|FG008|Overall Study|Withdrawal by Subject|0|||
164240482|NCT01713582|593252380|FG009|Overall Study|Withdrawal by Subject|0|||
164336058|NCT02833350|593607811|FG000|Overall Study|Lost to Follow-up|0|||
164336059|NCT02833350|593607812|FG001|Overall Study|Lost to Follow-up|1|||
164336060|NCT02833350|593607813|FG002|Overall Study|Lost to Follow-up|0|||
164336061|NCT02833350|593607814|FG003|Overall Study|Lost to Follow-up|0|||
164336062|NCT02833350|593607815|FG004|Overall Study|Lost to Follow-up|0|||
164336063|NCT02833350|593607816|FG005|Overall Study|Lost to Follow-up|0|||
164336064|NCT02833350|593607817|FG006|Overall Study|Lost to Follow-up|1|||
164336065|NCT02833350|593607811|FG000|Overall Study|Withdrawal by Subject|3|||
164336066|NCT02833350|593607812|FG001|Overall Study|Withdrawal by Subject|3|||
164336067|NCT02833350|593607813|FG002|Overall Study|Withdrawal by Subject|2|||
164425334|NCT03890120|593928469|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
164425335|NCT03890120|593928470|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
164573400|NCT02901431|594463424|FG004|PK Part|Adverse Event|0|||
164240483|NCT01713582|593252381|FG010|Overall Study|Withdrawal by Subject|0|||
164240484|NCT01713582|593252382|FG011|Overall Study|Withdrawal by Subject|0|||
164240485|NCT01713582|593252383|FG012|Overall Study|Withdrawal by Subject|0|||
164240486|NCT01713582|593252384|FG013|Overall Study|Withdrawal by Subject|0|||
164240487|NCT01713582|593252385|FG014|Overall Study|Withdrawal by Subject|0|||
164336068|NCT02833350|593607814|FG003|Overall Study|Withdrawal by Subject|0|||
164240488|NCT01713582|593252386|FG015|Overall Study|Withdrawal by Subject|0|||
164240489|NCT01713582|593252387|FG016|Overall Study|Withdrawal by Subject|0|||
164240490|NCT01713582|593252388|FG017|Overall Study|Withdrawal by Subject|1|||
164240491|NCT01713582|593252389|FG018|Overall Study|Withdrawal by Subject|0|||
164240492|NCT01713582|593252390|FG019|Overall Study|Withdrawal by Subject|0|||
164240493|NCT01713582|593252391|FG020|Overall Study|Withdrawal by Subject|0|||
164240494|NCT01713582|593252371|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
164240495|NCT01713582|593252372|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
164240496|NCT01713582|593252373|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
164240497|NCT01713582|593252374|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
164240498|NCT01713582|593252375|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
164240499|NCT01713582|593252376|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
164240500|NCT01713582|593252377|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
164240501|NCT01713582|593252378|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
164240502|NCT01713582|593252379|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
164240503|NCT01713582|593252380|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
164240504|NCT01713582|593252381|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
164240505|NCT01713582|593252382|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
164240506|NCT01713582|593252383|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
164240507|NCT01713582|593252384|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
164240508|NCT01713582|593252385|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
164240509|NCT01713582|593252386|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
164240510|NCT01713582|593252387|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
164240511|NCT01713582|593252388|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
164240512|NCT01713582|593252389|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
164240513|NCT01713582|593252390|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
164240514|NCT01713582|593252391|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
164240515|NCT01713582|593252371|FG000|Overall Study|Disease progression and adverse event|0|||
164240516|NCT01713582|593252372|FG001|Overall Study|Disease progression and adverse event|0|||
164240517|NCT01713582|593252373|FG002|Overall Study|Disease progression and adverse event|0|||
164240518|NCT01713582|593252374|FG003|Overall Study|Disease progression and adverse event|0|||
164240519|NCT01713582|593252375|FG004|Overall Study|Disease progression and adverse event|0|||
164240520|NCT01713582|593252376|FG005|Overall Study|Disease progression and adverse event|0|||
164240521|NCT01713582|593252377|FG006|Overall Study|Disease progression and adverse event|0|||
164240522|NCT01713582|593252378|FG007|Overall Study|Disease progression and adverse event|0|||
164240523|NCT01713582|593252379|FG008|Overall Study|Disease progression and adverse event|0|||
164240524|NCT01713582|593252380|FG009|Overall Study|Disease progression and adverse event|0|||
164240525|NCT01713582|593252381|FG010|Overall Study|Disease progression and adverse event|0|||
164240526|NCT01713582|593252382|FG011|Overall Study|Disease progression and adverse event|0|||
164240527|NCT01713582|593252383|FG012|Overall Study|Disease progression and adverse event|0|||
164240528|NCT01713582|593252384|FG013|Overall Study|Disease progression and adverse event|0|||
164240529|NCT01713582|593252385|FG014|Overall Study|Disease progression and adverse event|0|||
164240530|NCT01713582|593252386|FG015|Overall Study|Disease progression and adverse event|0|||
164240531|NCT01713582|593252387|FG016|Overall Study|Disease progression and adverse event|1|||
164240532|NCT01713582|593252388|FG017|Overall Study|Disease progression and adverse event|0|||
164240533|NCT01713582|593252389|FG018|Overall Study|Disease progression and adverse event|0|||
164240534|NCT01713582|593252390|FG019|Overall Study|Disease progression and adverse event|0|||
164240535|NCT01713582|593252391|FG020|Overall Study|Disease progression and adverse event|0|||
164240536|NCT04551898|593252392|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
164240537|NCT04551898|593252393|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
164240538|NCT04551898|593252394|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
164240539|NCT04551898|593252395|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
164240540|NCT04551898|593252392|FG000|Overall Study|Withdrawal by Subject|5|||
164240541|NCT04551898|593252393|FG001|Overall Study|Withdrawal by Subject|1|||
164240542|NCT04551898|593252394|FG002|Overall Study|Withdrawal by Subject|2|||
164240543|NCT04551898|593252395|FG003|Overall Study|Withdrawal by Subject|2|||
164240544|NCT04551898|593252392|FG000|Overall Study|Lost to Follow-up|2|||
164240545|NCT04551898|593252393|FG001|Overall Study|Lost to Follow-up|1|||
164240546|NCT04551898|593252394|FG002|Overall Study|Lost to Follow-up|2|||
164240547|NCT04551898|593252395|FG003|Overall Study|Lost to Follow-up|2|||
164240548|NCT04551898|593252392|FG000|Overall Study|Death|1|||
164573401|NCT02901431|594463425|FG005|PK Part|Adverse Event|0|||
164573402|NCT02901431|594463426|FG006|PK Part|Adverse Event|0|||
164240549|NCT04551898|593252393|FG001|Overall Study|Death|0|||
164240550|NCT04551898|593252394|FG002|Overall Study|Death|0|||
164240551|NCT04551898|593252395|FG003|Overall Study|Death|0|||
164573403|NCT02901431|594463427|FG007|PK Part|Adverse Event|0|||
164573404|NCT02901431|594463428|FG008|PK Part|Adverse Event|0|||
164573405|NCT02901431|594463429|FG009|PK Part|Adverse Event|0|||
164573406|NCT02901431|594463430|FG010|PK Part|Adverse Event|0|||
164573407|NCT02901431|594463431|FG011|PK Part|Adverse Event|0|||
164240552|NCT04551898|593252392|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
164240553|NCT04551898|593252393|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
164573408|NCT02901431|594463432|FG012|PK Part|Adverse Event|0|||
164573409|NCT02901431|594463420|FG000|PK Part|Lost to Follow-up|0|||
164240554|NCT04551898|593252394|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
164240555|NCT04551898|593252395|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
164240556|NCT03427814|593252396|FG000|Overall Study|Withdrawal by Subject|4|||
164240557|NCT03427814|593252397|FG001|Overall Study|Withdrawal by Subject|4|||
164240558|NCT03427814|593252396|FG000|Overall Study|Lost to Follow-up|0|||
164240559|NCT03427814|593252397|FG001|Overall Study|Lost to Follow-up|2|||
164240560|NCT03427814|593252396|FG000|Overall Study|Death|42|||
164240561|NCT03427814|593252397|FG001|Overall Study|Death|31|||
164240562|NCT03427814|593252396|FG000|Overall Study|Sponsor's Decision|1|||
164240563|NCT03427814|593252397|FG001|Overall Study|Sponsor's Decision|0|||
164240564|NCT03427814|593252396|FG000|Overall Study|Investigator's Decision|1|||
164240565|NCT03427814|593252397|FG001|Overall Study|Investigator's Decision|2|||
164240566|NCT03427814|593252396|FG000|Overall Study|Disease progression|1|||
164240567|NCT03427814|593252397|FG001|Overall Study|Disease progression|0|||
164240568|NCT03427814|593252396|FG000|Overall Study|Treatment Completed|0|||
164240569|NCT03427814|593252397|FG001|Overall Study|Treatment Completed|1|||
164240570|NCT03427814|593252396|FG000|Overall Study|Sponsor's Decision to End study|21|||
164240571|NCT03427814|593252397|FG001|Overall Study|Sponsor's Decision to End study|25|||
164240572|NCT03427814|593252396|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
164240573|NCT03427814|593252397|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
164240574|NCT03846427|593252398|FG000|Overall Study|Death|13|||
164240575|NCT03846427|593252398|FG000|Overall Study|Withdrawal by Subject|3|||
164240576|NCT03846427|593252398|FG000|Overall Study|Physician Decision|1|||
164240577|NCT01334554|593252399|FG000|Overall Study|Adverse Event|4|||
164240578|NCT01334554|593252400|FG001|Overall Study|Adverse Event|2|||
164240579|NCT02393859|593252402|FG000|Overall Study|Decision by Sponsor|2|||
164240580|NCT02393859|593252403|FG001|Overall Study|Decision by Sponsor|4|||
164240581|NCT02393859|593252402|FG000|Overall Study|Withdrawal by Subject|11|||
164240582|NCT02393859|593252403|FG001|Overall Study|Withdrawal by Subject|6|||
164240583|NCT02393859|593252402|FG000|Overall Study|Death|27|||
164240584|NCT02393859|593252403|FG001|Overall Study|Death|10|||
164240585|NCT02393859|593252402|FG000|Overall Study|Lost to Follow-up|1|||
164240586|NCT02393859|593252403|FG001|Overall Study|Lost to Follow-up|1|||
164240587|NCT00954447|593252404|FG000|Overall Study|Adverse Event|33|||
164240588|NCT00954447|593252405|FG001|Overall Study|Adverse Event|25|||
164240589|NCT00954447|593252404|FG000|Overall Study|Lack of Efficacy|17|||
164240590|NCT00954447|593252405|FG001|Overall Study|Lack of Efficacy|3|||
164240591|NCT00954447|593252404|FG000|Overall Study|Protocol Violation|5|||
164240592|NCT00954447|593252405|FG001|Overall Study|Protocol Violation|7|||
164240593|NCT00954447|593252404|FG000|Overall Study|Lost to Follow-up|8|||
164240594|NCT00954447|593252405|FG001|Overall Study|Lost to Follow-up|14|||
164240595|NCT00954447|593252404|FG000|Overall Study|Withdrawal by Subject|26|||
164240596|NCT00954447|593252405|FG001|Overall Study|Withdrawal by Subject|21|||
164240597|NCT00954447|593252404|FG000|Overall Study|Other|21|||
164240598|NCT00954447|593252405|FG001|Overall Study|Other|18|||
164240599|NCT01979614|593252406|FG000|Overall Study|Adverse Event|1|||
164240600|NCT01979614|593252407|FG001|Overall Study|Adverse Event|1|||
164240601|NCT00488514|593252408|FG000|Overall Study|Adverse Event|41|||
164240602|NCT00488514|593252408|FG000|Overall Study|Lost to Follow-up|44|||
164240603|NCT00488514|593252408|FG000|Overall Study|Protocol Violation|32|||
164240604|NCT00488514|593252408|FG000|Overall Study|Withdrawal by Subject|106|||
164240605|NCT00488514|593252408|FG000|Overall Study|Lack of Efficacy|28|||
164240606|NCT00488514|593252408|FG000|Overall Study|Did not meet criteria for treatment|30|||
164240607|NCT00488514|593252408|FG000|Overall Study|Postive drug screen|1|||
164240608|NCT00488514|593252408|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
164240609|NCT00488514|593252408|FG000|Overall Study|Investigator decision|1|||
164240610|NCT00488514|593252408|FG000|Overall Study|Participant had too few migraines|5|||
164240611|NCT00488514|593252408|FG000|Overall Study|Increase in number of migraines|2|||
164240612|NCT00488514|593252408|FG000|Overall Study|Increased use of concomitant medication|1|||
164240613|NCT00305877|593252409|FG000|Overall Study|Lack of Efficacy|6|||
164240614|NCT00305877|593252410|FG001|Overall Study|Lack of Efficacy|9|||
164240615|NCT00305877|593252409|FG000|Overall Study|Adverse Event|9|||
164240616|NCT00305877|593252410|FG001|Overall Study|Adverse Event|14|||
164240617|NCT00305877|593252409|FG000|Overall Study|Death|0|||
164240618|NCT00305877|593252410|FG001|Overall Study|Death|1|||
164240619|NCT00305877|593252409|FG000|Overall Study|Withdrawal by Subject|4|||
164240620|NCT00305877|593252410|FG001|Overall Study|Withdrawal by Subject|2|||
164240621|NCT00305877|593252409|FG000|Overall Study|Physician Decision|1|||
164240622|NCT00305877|593252410|FG001|Overall Study|Physician Decision|1|||
164240623|NCT00305877|593252409|FG000|Overall Study|Never start treatment|2|||
164240624|NCT00305877|593252410|FG001|Overall Study|Never start treatment|5|||
164240625|NCT00305877|593252409|FG000|Overall Study|Ineligible|2|||
164240626|NCT00305877|593252410|FG001|Overall Study|Ineligible|1|||
164240627|NCT00305877|593252409|FG000|Overall Study|Transportation issue with daily RT|0|||
164240628|NCT00305877|593252410|FG001|Overall Study|Transportation issue with daily RT|1|||
164240629|NCT01535287|593252411|FG000|Overall Study|drug not prepared in time|5|||
164240630|NCT01535287|593252412|FG001|Overall Study|drug not prepared in time|6|||
164240631|NCT00628446|593252415|FG000|Overall Study|Lost to Follow-up|3|||
164240632|NCT00628446|593252415|FG000|Overall Study|Withdrawal by Subject|1|||
164240633|NCT00628446|593252415|FG000|Overall Study|Protocol Violation|3|||
164240634|NCT04971967|593252418|FG000|Overall Study|Lost to Follow-up|6|||
164240635|NCT04971967|593252419|FG001|Overall Study|Lost to Follow-up|7|||
164240636|NCT00682929|593252422|FG000|Overall Study|Adverse Event|4|||
164240637|NCT00682929|593252423|FG001|Overall Study|Adverse Event|1|||
164240638|NCT00682929|593252424|FG002|Overall Study|Adverse Event|1|||
164240639|NCT00682929|593252422|FG000|Overall Study|Withdrawal by Subject|1|||
164240640|NCT00682929|593252423|FG001|Overall Study|Withdrawal by Subject|2|||
164240641|NCT00682929|593252424|FG002|Overall Study|Withdrawal by Subject|1|||
164240642|NCT00682929|593252422|FG000|Overall Study|dosing compliance < 80%|0|||
164240643|NCT00682929|593252423|FG001|Overall Study|dosing compliance < 80%|2|||
164240644|NCT00682929|593252424|FG002|Overall Study|dosing compliance < 80%|0|||
164240645|NCT00682929|593252422|FG000|Overall Study|lag in DEA renewal|1|||
164240646|NCT00682929|593252423|FG001|Overall Study|lag in DEA renewal|0|||
164240647|NCT00682929|593252424|FG002|Overall Study|lag in DEA renewal|0|||
164240648|NCT00938912|593252425|FG000|Overall Study|Withdrawal by Subject|28|||
164240649|NCT00938912|593252425|FG000|Overall Study|Lost to Follow-up|4|||
164240650|NCT00938912|593252425|FG000|Overall Study|Lack of Efficacy|43|||
164240651|NCT00938912|593252425|FG000|Overall Study|Adverse event, non-fatal|24|||
164240652|NCT00938912|593252425|FG000|Overall Study|Adverse event, fatal|1|||
164240653|NCT00938912|593252425|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
164240654|NCT00938912|593252425|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
164240655|NCT00938912|593252425|FG000|Overall Study|Participant needed prohibit medication|1|||
164240656|NCT00938912|593252425|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
164240657|NCT00938912|593252425|FG000|Overall Study|Did not meet Eligibility criteria|1|||
164240658|NCT00938912|593252425|FG000|Overall Study|Participant relocated not related to AE|1|||
164240659|NCT00938912|593252425|FG000|Overall Study|Participant moved to another city|1|||
164240660|NCT00938912|593252425|FG000|Overall Study|Participant experienced break through seizures|1|||
164240661|NCT00938912|593252425|FG000|Overall Study|No longer wished to participate in the study|1|||
164240662|NCT00938912|593252425|FG000|Overall Study|Protocol Deviation|2|||
164240663|NCT00803738|593252431|FG000|Overall Study|Adverse Event|3|||
164240664|NCT00803738|593252432|FG001|Overall Study|Adverse Event|5|||
164240665|NCT00803738|593252431|FG000|Overall Study|Lost to Follow-up|4|||
164240666|NCT00803738|593252432|FG001|Overall Study|Lost to Follow-up|4|||
164240667|NCT00803738|593252431|FG000|Overall Study|Protocol Violation|18|||
164240668|NCT00803738|593252432|FG001|Overall Study|Protocol Violation|10|||
164240669|NCT00803738|593252431|FG000|Overall Study|Withdrawal by Subject|1|||
164240670|NCT00803738|593252432|FG001|Overall Study|Withdrawal by Subject|4|||
164240671|NCT00803738|593252431|FG000|Overall Study|Lack of Efficacy|10|||
164240672|NCT00803738|593252432|FG001|Overall Study|Lack of Efficacy|16|||
164240673|NCT00803738|593252431|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
164240674|NCT00803738|593252432|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
164240675|NCT00803738|593252431|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
164240676|NCT00803738|593252432|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
164240677|NCT02964273|593252433|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
164240678|NCT02964273|593252434|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
164240679|NCT02964273|593252435|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
164240680|NCT02964273|593252436|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
164240681|NCT02964273|593252433|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
164240682|NCT02964273|593252434|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
164240683|NCT02964273|593252435|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
164240684|NCT02964273|593252436|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
164240685|NCT02964273|593252433|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
164240686|NCT02964273|593252434|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
164336069|NCT02833350|593607815|FG004|Overall Study|Withdrawal by Subject|2|||
164336070|NCT02833350|593607816|FG005|Overall Study|Withdrawal by Subject|0|||
164240687|NCT02964273|593252435|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
164240688|NCT02964273|593252436|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
164240689|NCT02964273|593252433|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
164336071|NCT02833350|593607817|FG006|Overall Study|Withdrawal by Subject|2|||
164336072|NCT00131508|593607820|FG000|Overall Study|Disease progression|0|||
164336073|NCT00131508|593607821|FG001|Overall Study|Disease progression|2|||
164336074|NCT00131508|593607820|FG000|Overall Study|Non-Compliance|2|||
164336075|NCT00131508|593607821|FG001|Overall Study|Non-Compliance|4|||
164336076|NCT00131508|593607820|FG000|Overall Study|Withdrawal by Subject|1|||
164336077|NCT00131508|593607821|FG001|Overall Study|Withdrawal by Subject|2|||
164425336|NCT03890120|593928471|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
164240690|NCT02964273|593252434|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
164336078|NCT01495975|593607823|FG000|Overall Study|Lost to Follow-up|1|||
164336079|NCT01495975|593607824|FG001|Overall Study|Lost to Follow-up|0|||
164573410|NCT02901431|594463421|FG001|PK Part|Lost to Follow-up|0|||
164425337|NCT03890120|593928472|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
164425338|NCT03890120|593928469|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
164425339|NCT03890120|593928470|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
164425340|NCT03890120|593928471|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
164425341|NCT03890120|593928472|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
164425342|NCT03890120|593928469|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
164425343|NCT03890120|593928470|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
164425344|NCT03890120|593928471|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
164425345|NCT03890120|593928472|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
164425346|NCT03890120|593928469|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
164677715|NCT01695239|594844824|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
164677716|NCT01695239|594844825|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
164677717|NCT01695239|594844826|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
164677718|NCT01695239|594844827|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
164677719|NCT01695239|594844828|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
164677720|NCT01695239|594844829|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
164677721|NCT01695239|594844830|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
164677722|NCT01695239|594844831|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
164677723|NCT01695239|594844832|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
164677724|NCT01695239|594844833|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
164677725|NCT01695239|594844834|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
164677726|NCT01695239|594844835|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
164677727|NCT01695239|594844836|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
164677728|NCT01695239|594844823|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164677729|NCT01695239|594844824|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164677730|NCT01695239|594844825|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164677731|NCT01695239|594844826|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164677732|NCT01695239|594844827|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164677733|NCT01695239|594844828|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164677734|NCT01695239|594844829|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164677735|NCT01695239|594844830|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164677736|NCT01695239|594844831|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164677737|NCT01695239|594844832|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164677738|NCT01695239|594844833|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164677739|NCT01695239|594844834|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164677740|NCT01695239|594844835|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164677741|NCT01695239|594844836|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
164677742|NCT03502811|594844838|FG000|Overall Study|Death|157|||
164677743|NCT03502811|594844838|FG000|Overall Study|Withdrawal by Subject|105|||
164677744|NCT03502811|594844838|FG000|Overall Study|Lost to Follow-up|26|||
164677745|NCT03502811|594844838|FG000|Overall Study|No Visits (Missed)|31|||
164677746|NCT03913377|594844839|FG000|Period 1|Test Article no longer available|0|||
164677747|NCT03913377|594844840|FG001|Period 1|Test Article no longer available|1|||
164677748|NCT03913377|594844841|FG002|Period 1|Test Article no longer available|0|||
164677749|NCT03913377|594844839|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
164677750|NCT03913377|594844840|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
164677751|NCT03913377|594844841|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
164677752|NCT05239195|594844842|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
164677753|NCT05239195|594844843|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
164677754|NCT00081653|594844844|FG000|Overall Study|Adverse Event|23|||
164677755|NCT00081653|594844845|FG001|Overall Study|Adverse Event|17|||
164677756|NCT00081653|594844844|FG000|Overall Study|Lost to Follow-up|2|||
164677757|NCT00081653|594844845|FG001|Overall Study|Lost to Follow-up|4|||
164677758|NCT00081653|594844844|FG000|Overall Study|Refused Treatment|18|||
164677759|NCT00081653|594844845|FG001|Overall Study|Refused Treatment|14|||
164677760|NCT00081653|594844844|FG000|Overall Study|Low bone mineral density|1|||
164677761|NCT00081653|594844845|FG001|Overall Study|Low bone mineral density|0|||
164677762|NCT00081653|594844844|FG000|Overall Study|Bone loss|2|||
164677763|NCT00081653|594844845|FG001|Overall Study|Bone loss|0|||
164677764|NCT00081653|594844844|FG000|Overall Study|Participant leaving country|1|||
164677765|NCT00081653|594844845|FG001|Overall Study|Participant leaving country|0|||
164677766|NCT00081653|594844844|FG000|Overall Study|Loss of bone mass|0|||
164677767|NCT00081653|594844845|FG001|Overall Study|Loss of bone mass|2|||
164677768|NCT00736190|594844848|FG000|Overall Study|Pregnancy|1|||
164677769|NCT00736190|594844848|FG000|Overall Study|Withdrawal by Subject|1|||
164677770|NCT00736190|594844848|FG000|Overall Study|Adverse Event|1|||
164677771|NCT03246503|594844849|FG000|Overall Study|Lost to Follow-up|23|||
164677772|NCT03246503|594844849|FG000|Overall Study|Withdrawal by Subject|20|||
164677773|NCT03246503|594844849|FG000|Overall Study|Physician Decision|5|||
164677774|NCT03246503|594844849|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
164240691|NCT02964273|593252435|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
164240692|NCT02964273|593252436|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
164240693|NCT02964273|593252433|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
164240694|NCT02964273|593252434|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
164240695|NCT02964273|593252435|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
164240696|NCT02964273|593252436|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
164240697|NCT02964273|593252433|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
164240698|NCT02964273|593252434|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
164240699|NCT02964273|593252435|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
164240700|NCT02964273|593252436|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
164240701|NCT03012334|593252437|FG000|Period 1|Withdrawal by Subject|0|||
164240702|NCT03012334|593252438|FG001|Period 1|Withdrawal by Subject|0|||
164240703|NCT03012334|593252439|FG002|Period 1|Withdrawal by Subject|0|||
164240704|NCT03012334|593252440|FG003|Period 1|Withdrawal by Subject|0|||
164677775|NCT02197416|594844850|FG000|Overall Study|Other reasons|0|||
164677776|NCT02197416|594844851|FG001|Overall Study|Other reasons|2|||
164677777|NCT02197416|594844852|FG002|Overall Study|Other reasons|5|||
164677778|NCT02197416|594844850|FG000|Overall Study|Withdrawal by Subject|0|||
164677779|NCT02197416|594844851|FG001|Overall Study|Withdrawal by Subject|2|||
164677780|NCT02197416|594844852|FG002|Overall Study|Withdrawal by Subject|1|||
164677781|NCT02197416|594844850|FG000|Overall Study|Protocol Violation|1|||
164677782|NCT02197416|594844851|FG001|Overall Study|Protocol Violation|0|||
164677783|NCT02197416|594844852|FG002|Overall Study|Protocol Violation|1|||
164677784|NCT02197416|594844850|FG000|Overall Study|Adverse Event|0|||
164677785|NCT02197416|594844851|FG001|Overall Study|Adverse Event|0|||
164240705|NCT03012334|593252441|FG004|Period 1|Withdrawal by Subject|0|||
164240706|NCT03012334|593252442|FG005|Period 1|Withdrawal by Subject|0|||
164240707|NCT03012334|593252443|FG006|Period 1|Withdrawal by Subject|0|||
164336080|NCT00808483|593607827|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
164336081|NCT00808483|593607828|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
164336082|NCT00808483|593607827|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
164336083|NCT00808483|593607828|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
164336084|NCT00808483|593607827|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
164336085|NCT00808483|593607828|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
164336086|NCT02038881|593607829|FG000|Overall Study|Withdrawal by Subject|0|||
164336087|NCT02038881|593607830|FG001|Overall Study|Withdrawal by Subject|0|||
164336088|NCT02038881|593607831|FG002|Overall Study|Withdrawal by Subject|1|||
164336089|NCT02038881|593607829|FG000|Overall Study|Lost to Follow-up|2|||
164336090|NCT02038881|593607830|FG001|Overall Study|Lost to Follow-up|0|||
164336091|NCT02038881|593607831|FG002|Overall Study|Lost to Follow-up|0|||
164336092|NCT02038881|593607829|FG000|Overall Study|incarcerated|1|||
164336093|NCT02038881|593607830|FG001|Overall Study|incarcerated|0|||
164336094|NCT02038881|593607831|FG002|Overall Study|incarcerated|0|||
164336095|NCT00333840|593607832|FG000|First-line Treatment Period|Adverse Event|38|||
164336096|NCT00333840|593607833|FG001|First-line Treatment Period|Adverse Event|37|||
164336097|NCT00333840|593607834|FG002|First-line Treatment Period|Adverse Event|0|||
164336098|NCT00333840|593607835|FG003|First-line Treatment Period|Adverse Event|0|||
164336099|NCT00333840|593607832|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
164336100|NCT00333840|593607833|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
164336101|NCT00333840|593607834|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
164336102|NCT00333840|593607835|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
164336103|NCT00333840|593607832|FG000|First-line Treatment Period|Abnormal procedure|2|||
164336104|NCT00333840|593607833|FG001|First-line Treatment Period|Abnormal procedure|0|||
164336105|NCT00333840|593607834|FG002|First-line Treatment Period|Abnormal procedure|0|||
164336106|NCT00333840|593607835|FG003|First-line Treatment Period|Abnormal procedure|0|||
164336107|NCT00333840|593607832|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
164336108|NCT00333840|593607833|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
164336109|NCT00333840|593607834|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
164336110|NCT00333840|593607835|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
164336111|NCT00333840|593607832|FG000|First-line Treatment Period|No longer required study drug|21|||
164677786|NCT02197416|594844852|FG002|Overall Study|Adverse Event|1|||
164240708|NCT03012334|593252444|FG007|Period 1|Withdrawal by Subject|0|||
164240709|NCT03012334|593252445|FG008|Period 1|Withdrawal by Subject|0|||
164336112|NCT00333840|593607833|FG001|First-line Treatment Period|No longer required study drug|8|||
164336113|NCT00333840|593607834|FG002|First-line Treatment Period|No longer required study drug|0|||
164336114|NCT00333840|593607835|FG003|First-line Treatment Period|No longer required study drug|0|||
164336115|NCT00333840|593607832|FG000|First-line Treatment Period|Protocol Violation|17|||
164336116|NCT00333840|593607833|FG001|First-line Treatment Period|Protocol Violation|17|||
164677787|NCT03689400|594844853|FG000|Overall Study|Lost to Follow-up|4|||
164677788|NCT01204294|594844854|FG000|Overall Study|Adverse Event|2|||
164677789|NCT01204294|594844855|FG001|Overall Study|Adverse Event|6|||
164677790|NCT01204294|594844856|FG002|Overall Study|Adverse Event|0|||
164240710|NCT03012334|593252446|FG009|Period 1|Withdrawal by Subject|1|||
164240711|NCT03012334|593252437|FG000|Period 2|Withdrawal by Subject|0|||
164240712|NCT03012334|593252438|FG001|Period 2|Withdrawal by Subject|1|||
164240713|NCT03012334|593252439|FG002|Period 2|Withdrawal by Subject|0|||
164240714|NCT03012334|593252440|FG003|Period 2|Withdrawal by Subject|0|||
164240715|NCT03012334|593252441|FG004|Period 2|Withdrawal by Subject|0|||
164240716|NCT03012334|593252442|FG005|Period 2|Withdrawal by Subject|0|||
164240717|NCT03012334|593252443|FG006|Period 2|Withdrawal by Subject|0|||
164240718|NCT03012334|593252444|FG007|Period 2|Withdrawal by Subject|0|||
164240719|NCT03012334|593252445|FG008|Period 2|Withdrawal by Subject|0|||
164240720|NCT03012334|593252446|FG009|Period 2|Withdrawal by Subject|0|||
164240721|NCT03012334|593252437|FG000|Period 2|Protocol Violation|0|||
164240722|NCT03012334|593252438|FG001|Period 2|Protocol Violation|0|||
164240723|NCT03012334|593252439|FG002|Period 2|Protocol Violation|1|||
164240724|NCT03012334|593252440|FG003|Period 2|Protocol Violation|0|||
164240725|NCT03012334|593252441|FG004|Period 2|Protocol Violation|0|||
164240726|NCT03012334|593252442|FG005|Period 2|Protocol Violation|0|||
164240727|NCT03012334|593252443|FG006|Period 2|Protocol Violation|0|||
164240728|NCT03012334|593252444|FG007|Period 2|Protocol Violation|1|||
164240729|NCT03012334|593252445|FG008|Period 2|Protocol Violation|0|||
164240730|NCT03012334|593252446|FG009|Period 2|Protocol Violation|0|||
164240731|NCT03012334|593252437|FG000|Period 4|Non-Compliance|0|||
164240732|NCT03012334|593252438|FG001|Period 4|Non-Compliance|0|||
164240733|NCT03012334|593252439|FG002|Period 4|Non-Compliance|0|||
164240734|NCT03012334|593252440|FG003|Period 4|Non-Compliance|0|||
164240735|NCT03012334|593252441|FG004|Period 4|Non-Compliance|0|||
164240736|NCT03012334|593252442|FG005|Period 4|Non-Compliance|0|||
164240737|NCT03012334|593252443|FG006|Period 4|Non-Compliance|1|||
164240738|NCT03012334|593252444|FG007|Period 4|Non-Compliance|0|||
164240739|NCT03012334|593252445|FG008|Period 4|Non-Compliance|0|||
164240740|NCT03012334|593252446|FG009|Period 4|Non-Compliance|0|||
164240741|NCT03012334|593252437|FG000|Period 4|Adverse Event|0|||
164240742|NCT03012334|593252438|FG001|Period 4|Adverse Event|0|||
164240743|NCT03012334|593252439|FG002|Period 4|Adverse Event|0|||
164240744|NCT03012334|593252440|FG003|Period 4|Adverse Event|0|||
164240745|NCT03012334|593252441|FG004|Period 4|Adverse Event|0|||
164240746|NCT03012334|593252442|FG005|Period 4|Adverse Event|0|||
164240747|NCT03012334|593252443|FG006|Period 4|Adverse Event|0|||
164240748|NCT03012334|593252444|FG007|Period 4|Adverse Event|0|||
164240749|NCT03012334|593252445|FG008|Period 4|Adverse Event|1|||
164240750|NCT03012334|593252446|FG009|Period 4|Adverse Event|0|||
164240751|NCT01823107|593252447|FG000|Overall Study|Withdrawal by Subject|1|||
164240752|NCT00328172|593252450|FG000|Overall Study|Adverse Event|3|||
164240753|NCT00328172|593252451|FG001|Overall Study|Adverse Event|2|||
164240754|NCT00328172|593252452|FG002|Overall Study|Adverse Event|1|||
164240755|NCT00328172|593252453|FG003|Overall Study|Adverse Event|2|||
164425347|NCT03890120|593928470|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
164425348|NCT03890120|593928471|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
164425349|NCT03890120|593928472|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
164425350|NCT03890120|593928469|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
164425351|NCT03890120|593928470|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
164425352|NCT03890120|593928471|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
164425353|NCT03890120|593928472|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
164425354|NCT03890120|593928469|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
164425355|NCT03890120|593928470|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
164425356|NCT03890120|593928471|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
164425357|NCT03890120|593928472|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
164425358|NCT03890120|593928469|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
164425359|NCT03890120|593928470|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
164425360|NCT03890120|593928471|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
164240756|NCT00328172|593252454|FG004|Overall Study|Adverse Event|1|||
164240757|NCT00328172|593252450|FG000|Overall Study|Protocol Violation|0|||
164240758|NCT00328172|593252451|FG001|Overall Study|Protocol Violation|1|||
164240759|NCT00328172|593252452|FG002|Overall Study|Protocol Violation|1|||
164240760|NCT00328172|593252453|FG003|Overall Study|Protocol Violation|0|||
164240761|NCT00328172|593252454|FG004|Overall Study|Protocol Violation|0|||
164240762|NCT00328172|593252450|FG000|Overall Study|Lost to Follow-up|1|||
164240763|NCT00328172|593252451|FG001|Overall Study|Lost to Follow-up|1|||
164240764|NCT00328172|593252452|FG002|Overall Study|Lost to Follow-up|2|||
164240765|NCT00328172|593252453|FG003|Overall Study|Lost to Follow-up|1|||
164240766|NCT00328172|593252454|FG004|Overall Study|Lost to Follow-up|1|||
164240767|NCT00328172|593252450|FG000|Overall Study|Withdrawal by Subject|1|||
164240768|NCT00328172|593252451|FG001|Overall Study|Withdrawal by Subject|1|||
164240769|NCT00328172|593252452|FG002|Overall Study|Withdrawal by Subject|1|||
164240770|NCT00328172|593252453|FG003|Overall Study|Withdrawal by Subject|6|||
164240771|NCT00328172|593252454|FG004|Overall Study|Withdrawal by Subject|0|||
164240772|NCT00328172|593252450|FG000|Overall Study|Lack of Efficacy|14|||
164240773|NCT00328172|593252451|FG001|Overall Study|Lack of Efficacy|9|||
164240774|NCT00328172|593252452|FG002|Overall Study|Lack of Efficacy|4|||
164240775|NCT00328172|593252453|FG003|Overall Study|Lack of Efficacy|4|||
164240776|NCT00328172|593252454|FG004|Overall Study|Lack of Efficacy|3|||
164240777|NCT00328172|593252450|FG000|Overall Study|Other reason (not specified)|3|||
164240778|NCT00328172|593252451|FG001|Overall Study|Other reason (not specified)|0|||
164240779|NCT00328172|593252452|FG002|Overall Study|Other reason (not specified)|1|||
164240780|NCT00328172|593252453|FG003|Overall Study|Other reason (not specified)|0|||
164240781|NCT00328172|593252454|FG004|Overall Study|Other reason (not specified)|0|||
164240782|NCT00077974|593252455|FG000|Overall Study|Adverse Event|22|||
164240783|NCT00077974|593252455|FG000|Overall Study|Protocol Violation|1|||
164240784|NCT00077974|593252455|FG000|Overall Study|Withdrawal by Subject|3|||
164240785|NCT00077974|593252455|FG000|Overall Study|Lack of Efficacy|76|||
164240786|NCT00077974|593252455|FG000|Overall Study|Decision of Sponsor|2|||
164240787|NCT02897115|593252458|FG000|Overall Study|Early termination of study by sponsor|11|||
164240788|NCT02897115|593252459|FG001|Overall Study|Early termination of study by sponsor|8|||
164240789|NCT00420381|593252460|FG000|Overall Study|Protocol Violation|1|||
164240790|NCT04512001|593252468|FG000|Week 0 to Week 24|Adverse Event|14|||
164240791|NCT04512001|593252469|FG001|Week 0 to Week 24|Adverse Event|10|||
164240792|NCT04512001|593252470|FG002|Week 0 to Week 24|Adverse Event|0|||
164240793|NCT04512001|593252471|FG003|Week 0 to Week 24|Adverse Event|0|||
164240794|NCT04512001|593252472|FG004|Week 0 to Week 24|Adverse Event|0|||
164240795|NCT04512001|593252468|FG000|Week 0 to Week 24|Death|0|||
164240796|NCT04512001|593252469|FG001|Week 0 to Week 24|Death|2|||
164240797|NCT04512001|593252470|FG002|Week 0 to Week 24|Death|0|||
164240798|NCT04512001|593252471|FG003|Week 0 to Week 24|Death|0|||
164240799|NCT04512001|593252472|FG004|Week 0 to Week 24|Death|0|||
164240800|NCT04512001|593252468|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
164240801|NCT04512001|593252469|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
164240802|NCT04512001|593252470|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
164240803|NCT04512001|593252471|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
164240804|NCT04512001|593252472|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
164240805|NCT04512001|593252468|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
164240806|NCT04512001|593252469|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
164240807|NCT04512001|593252470|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
164240808|NCT04512001|593252471|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
164240809|NCT04512001|593252472|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
164240810|NCT04512001|593252468|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
164240811|NCT04512001|593252469|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
164240812|NCT04512001|593252470|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
164240813|NCT04512001|593252471|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
164240814|NCT04512001|593252472|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
164240815|NCT04512001|593252468|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
164240816|NCT04512001|593252469|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
164240817|NCT04512001|593252470|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
164240818|NCT04512001|593252471|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
164240819|NCT04512001|593252472|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
164240820|NCT04512001|593252468|FG000|Week 24 to Week 63|Adverse Event|0|||
164240821|NCT04512001|593252469|FG001|Week 24 to Week 63|Adverse Event|0|||
164240822|NCT04512001|593252470|FG002|Week 24 to Week 63|Adverse Event|13|||
164240823|NCT04512001|593252471|FG003|Week 24 to Week 63|Adverse Event|8|||
164240824|NCT04512001|593252472|FG004|Week 24 to Week 63|Adverse Event|6|||
164240825|NCT04512001|593252468|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
164240826|NCT04512001|593252469|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
164240827|NCT04512001|593252470|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
164240828|NCT04512001|593252471|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
164240829|NCT04512001|593252472|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
164240830|NCT04512001|593252468|FG000|Week 24 to Week 63|Death|0|||
164240831|NCT04512001|593252469|FG001|Week 24 to Week 63|Death|0|||
164240832|NCT04512001|593252470|FG002|Week 24 to Week 63|Death|0|||
164240833|NCT04512001|593252471|FG003|Week 24 to Week 63|Death|1|||
164336117|NCT00333840|593607834|FG002|First-line Treatment Period|Protocol Violation|0|||
164336118|NCT00333840|593607835|FG003|First-line Treatment Period|Protocol Violation|0|||
164336119|NCT00333840|593607832|FG000|First-line Treatment Period|Subject withdrew consent|57|||
164336120|NCT00333840|593607833|FG001|First-line Treatment Period|Subject withdrew consent|77|||
164336121|NCT00333840|593607834|FG002|First-line Treatment Period|Subject withdrew consent|0|||
164336122|NCT00333840|593607835|FG003|First-line Treatment Period|Subject withdrew consent|0|||
164336123|NCT00333840|593607832|FG000|First-line Treatment Period|Lost to Follow-up|15|||
164240834|NCT04512001|593252472|FG004|Week 24 to Week 63|Death|1|||
164240835|NCT04512001|593252468|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
164240836|NCT04512001|593252469|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
164240837|NCT04512001|593252470|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
164240838|NCT04512001|593252471|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
164425361|NCT03890120|593928472|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
164573411|NCT02901431|594463422|FG002|PK Part|Lost to Follow-up|1|||
164425362|NCT03890120|593928469|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
164425363|NCT03890120|593928470|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
164425364|NCT03890120|593928471|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
164425365|NCT03890120|593928472|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
164425366|NCT03890120|593928469|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
164425367|NCT03890120|593928470|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
164425368|NCT03890120|593928471|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
164240839|NCT04512001|593252472|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
164240840|NCT04512001|593252468|FG000|Week 24 to Week 63|Miscellaneous|0|||
164240841|NCT04512001|593252469|FG001|Week 24 to Week 63|Miscellaneous|0|||
164240842|NCT04512001|593252470|FG002|Week 24 to Week 63|Miscellaneous|3|||
164240843|NCT04512001|593252471|FG003|Week 24 to Week 63|Miscellaneous|2|||
164240844|NCT04512001|593252472|FG004|Week 24 to Week 63|Miscellaneous|1|||
164240845|NCT03389308|593252473|FG000|Overall Study|Withdrawal by Subject|5|||
164240846|NCT03389308|593252473|FG000|Overall Study|Lost to Follow-up|3|||
164240847|NCT03389308|593252473|FG000|Overall Study|Adverse Event|2|||
164240848|NCT03389308|593252473|FG000|Overall Study|Sponsor Request|2|||
164240849|NCT03896477|593252481|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
164240850|NCT03896477|593252482|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
164240851|NCT03896477|593252483|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
164240852|NCT03896477|593252481|FG000|Overall Study|Parent Requested Withdrawal|8|||
164240853|NCT03896477|593252482|FG001|Overall Study|Parent Requested Withdrawal|12|||
164240854|NCT03896477|593252483|FG002|Overall Study|Parent Requested Withdrawal|9|||
164240855|NCT03896477|593252481|FG000|Overall Study|Adverse Event|0|||
164240856|NCT03896477|593252482|FG001|Overall Study|Adverse Event|0|||
164240857|NCT03896477|593252483|FG002|Overall Study|Adverse Event|1|||
164240858|NCT03896477|593252481|FG000|Overall Study|Death|1|||
164240859|NCT03896477|593252482|FG001|Overall Study|Death|0|||
164240860|NCT03896477|593252483|FG002|Overall Study|Death|0|||
164240861|NCT03896477|593252481|FG000|Overall Study|Other|5|||
164240862|NCT03896477|593252482|FG001|Overall Study|Other|6|||
164240863|NCT03896477|593252483|FG002|Overall Study|Other|7|||
164240864|NCT03896477|593252481|FG000|Overall Study|Lost to Follow-up|2|||
164240865|NCT03896477|593252482|FG001|Overall Study|Lost to Follow-up|1|||
164240866|NCT03896477|593252483|FG002|Overall Study|Lost to Follow-up|1|||
164240867|NCT01106157|593252488|FG000|Overall Study|Withdrawal by Subject|1|||
164240868|NCT01106157|593252489|FG001|Overall Study|Withdrawal by Subject|0|||
164240869|NCT02298868|593252493|FG000|Overall Study|Adverse Event|1|||
164425369|NCT03890120|593928472|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
164425370|NCT03890120|593928469|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
164425371|NCT03890120|593928470|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
164425372|NCT03890120|593928471|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
164425373|NCT03890120|593928472|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
164425374|NCT03890120|593928469|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
164425375|NCT03890120|593928470|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
164425376|NCT03890120|593928471|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
164425377|NCT03890120|593928472|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
164425378|NCT03890120|593928469|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
164425379|NCT03890120|593928470|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
164425380|NCT03890120|593928471|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
164425381|NCT03890120|593928472|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
164425382|NCT03890120|593928469|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
164425383|NCT03890120|593928470|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
164425384|NCT03890120|593928471|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
164425385|NCT03890120|593928472|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
164425386|NCT01052662|593928473|FG000|Overall Study|Lost to Follow-up|15|||
164425387|NCT01052662|593928474|FG001|Overall Study|Lost to Follow-up|13|||
164425388|NCT01052662|593928475|FG002|Overall Study|Lost to Follow-up|18|||
164425389|NCT01052662|593928473|FG000|Overall Study|Withdrawal by Subject|3|||
164425390|NCT01052662|593928474|FG001|Overall Study|Withdrawal by Subject|2|||
164425391|NCT01052662|593928475|FG002|Overall Study|Withdrawal by Subject|1|||
164573412|NCT02901431|594463423|FG003|PK Part|Lost to Follow-up|0|||
164240870|NCT02298868|593252493|FG000|Overall Study|Death|1|||
164240871|NCT02298868|593252493|FG000|Overall Study|Patient underwent transplant|1|||
164240872|NCT01063348|593252494|FG000|Overall Study|Lost to Follow-up|3|||
164425392|NCT01052662|593928473|FG000|Overall Study|Pharmacy issue|1|||
164240873|NCT01063348|593252495|FG001|Overall Study|Lost to Follow-up|10|||
164240874|NCT00696878|593252496|FG000|Overall Study|Adverse Event|8|||
164240875|NCT00696878|593252496|FG000|Overall Study|Withdrawal by Subject|87|||
164425393|NCT01052662|593928474|FG001|Overall Study|Pharmacy issue|3|||
164240876|NCT00696878|593252496|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
164240877|NCT00696878|593252496|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
164240878|NCT00696878|593252496|FG000|Overall Study|Trial stopped|32|||
164573413|NCT02901431|594463424|FG004|PK Part|Lost to Follow-up|0|||
164240879|NCT00696878|593252496|FG000|Overall Study|Other reason (not specified)|55|||
164240880|NCT03824392|593252499|FG000|Overall Study|Adverse Event|1|||
164240881|NCT03824392|593252500|FG001|Overall Study|Adverse Event|0|||
164240882|NCT03824392|593252501|FG002|Overall Study|Adverse Event|0|||
164240883|NCT03824392|593252502|FG003|Overall Study|Adverse Event|0|||
164240884|NCT03824392|593252499|FG000|Overall Study|Investigator Decision|0|||
164240885|NCT03824392|593252500|FG001|Overall Study|Investigator Decision|1|||
164240886|NCT03824392|593252501|FG002|Overall Study|Investigator Decision|0|||
164240887|NCT03824392|593252502|FG003|Overall Study|Investigator Decision|0|||
164240888|NCT03824392|593252499|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
164240889|NCT03824392|593252500|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
164240890|NCT03824392|593252501|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
164240891|NCT03824392|593252502|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
164240892|NCT00967616|593252503|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
164240893|NCT00967616|593252504|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
164240894|NCT00967616|593252503|FG000|Overall Study|Death|0|||
164240895|NCT00967616|593252504|FG001|Overall Study|Death|3|||
164240896|NCT00967616|593252503|FG000|Overall Study|Withdrawal by Subject|8|||
164240897|NCT00967616|593252504|FG001|Overall Study|Withdrawal by Subject|4|||
164240898|NCT00967616|593252503|FG000|Overall Study|Progressive Disease|31|||
164573414|NCT02901431|594463425|FG005|PK Part|Lost to Follow-up|0|||
164573415|NCT02901431|594463426|FG006|PK Part|Lost to Follow-up|0|||
164573416|NCT02901431|594463427|FG007|PK Part|Lost to Follow-up|0|||
164573417|NCT02901431|594463428|FG008|PK Part|Lost to Follow-up|0|||
164573418|NCT02901431|594463429|FG009|PK Part|Lost to Follow-up|0|||
164573419|NCT02901431|594463430|FG010|PK Part|Lost to Follow-up|0|||
164573420|NCT02901431|594463431|FG011|PK Part|Lost to Follow-up|0|||
164573421|NCT02901431|594463432|FG012|PK Part|Lost to Follow-up|0|||
164573422|NCT02901431|594463420|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
164573423|NCT02901431|594463421|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
164573424|NCT02901431|594463422|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
164573425|NCT02901431|594463423|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
164573426|NCT02901431|594463424|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
164573427|NCT02901431|594463425|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
164573428|NCT02901431|594463426|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
164573429|NCT02901431|594463427|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
164677791|NCT01204294|594844857|FG003|Overall Study|Adverse Event|7|||
164677792|NCT01204294|594844858|FG004|Overall Study|Adverse Event|1|||
164240899|NCT00967616|593252504|FG001|Overall Study|Progressive Disease|18|||
164677793|NCT01204294|594844859|FG005|Overall Study|Adverse Event|4|||
164677794|NCT01204294|594844860|FG006|Overall Study|Adverse Event|0|||
164677795|NCT01204294|594844854|FG000|Overall Study|Protocol Violation|1|||
164677796|NCT01204294|594844855|FG001|Overall Study|Protocol Violation|0|||
164677797|NCT01204294|594844856|FG002|Overall Study|Protocol Violation|2|||
164677798|NCT01204294|594844857|FG003|Overall Study|Protocol Violation|1|||
164677799|NCT01204294|594844858|FG004|Overall Study|Protocol Violation|0|||
164677800|NCT01204294|594844859|FG005|Overall Study|Protocol Violation|0|||
164677801|NCT01204294|594844860|FG006|Overall Study|Protocol Violation|0|||
164677802|NCT01204294|594844854|FG000|Overall Study|Withdrawal by Subject|0|||
164677803|NCT01204294|594844855|FG001|Overall Study|Withdrawal by Subject|2|||
164677804|NCT01204294|594844856|FG002|Overall Study|Withdrawal by Subject|2|||
164677805|NCT01204294|594844857|FG003|Overall Study|Withdrawal by Subject|1|||
164677806|NCT01204294|594844858|FG004|Overall Study|Withdrawal by Subject|1|||
164677807|NCT01204294|594844859|FG005|Overall Study|Withdrawal by Subject|1|||
164677808|NCT01204294|594844860|FG006|Overall Study|Withdrawal by Subject|2|||
164677809|NCT01204294|594844854|FG000|Overall Study|Lack of Efficacy|0|||
164677810|NCT01204294|594844855|FG001|Overall Study|Lack of Efficacy|0|||
164677811|NCT01204294|594844856|FG002|Overall Study|Lack of Efficacy|0|||
164240900|NCT00967616|593252503|FG000|Overall Study|Other|8|||
164240901|NCT00967616|593252504|FG001|Overall Study|Other|8|||
164573430|NCT02901431|594463428|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
164573431|NCT02901431|594463429|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
164573432|NCT02901431|594463430|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
164677812|NCT01204294|594844857|FG003|Overall Study|Lack of Efficacy|2|||
164240902|NCT00967616|593252503|FG000|Overall Study|Protocol Violation|1|||
164240903|NCT00967616|593252504|FG001|Overall Study|Protocol Violation|0|||
164573433|NCT02901431|594463431|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
164573434|NCT02901431|594463432|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
164573435|NCT02901431|594463420|FG000|PK Part|Pending dose confirmation|0|||
164677813|NCT01204294|594844858|FG004|Overall Study|Lack of Efficacy|0|||
164677814|NCT01204294|594844859|FG005|Overall Study|Lack of Efficacy|0|||
164677815|NCT01204294|594844860|FG006|Overall Study|Lack of Efficacy|0|||
164677816|NCT01204294|594844854|FG000|Overall Study|Other (house moving)|0|||
164573436|NCT02901431|594463421|FG001|PK Part|Pending dose confirmation|1|||
164573437|NCT02901431|594463422|FG002|PK Part|Pending dose confirmation|0|||
164677817|NCT01204294|594844855|FG001|Overall Study|Other (house moving)|0|||
164240904|NCT01847755|593252505|FG000|Overall Study|Adverse Event|2|||
164240905|NCT01847755|593252505|FG000|Overall Study|Withdrawal by Subject|2|||
164240906|NCT01847755|593252505|FG000|Overall Study|Physician Decision|1|||
164240907|NCT03188263|593252514|FG000|Overall Study|Withdrawal by Subject|3|||
164240908|NCT03188263|593252515|FG001|Overall Study|Withdrawal by Subject|0|||
164240909|NCT03188263|593252514|FG000|Overall Study|Physician Decision|1|||
164240910|NCT03188263|593252515|FG001|Overall Study|Physician Decision|0|||
164240911|NCT01030822|593252516|FG000|Overall Study|Moved/migrated from study area|6|||
164240912|NCT01030822|593252517|FG001|Overall Study|Moved/migrated from study area|7|||
164240913|NCT01030822|593252518|FG002|Overall Study|Moved/migrated from study area|3|||
164240914|NCT01030822|593252516|FG000|Overall Study|Withdrawal by Subject|16|||
164240915|NCT01030822|593252517|FG001|Overall Study|Withdrawal by Subject|13|||
164240916|NCT01030822|593252518|FG002|Overall Study|Withdrawal by Subject|16|||
164240917|NCT01030822|593252516|FG000|Overall Study|Lost to Follow-up|9|||
164240918|NCT01030822|593252517|FG001|Overall Study|Lost to Follow-up|4|||
164240919|NCT01030822|593252518|FG002|Overall Study|Lost to Follow-up|7|||
164240920|NCT00120627|593252526|FG000|Overall Study|Withdrawal by Subject|5|||
164240921|NCT00120627|593252527|FG001|Overall Study|Withdrawal by Subject|5|||
164240922|NCT03386435|593252528|FG000|Overall Study|Protocol Violation|5|||
164240923|NCT03386435|593252529|FG001|Overall Study|Protocol Violation|7|||
164240924|NCT04068922|593252530|FG000|Overall Study|Lost to Follow-up|5|||
164240925|NCT04068922|593252530|FG000|Overall Study|Withdrawal by Subject|7|||
164240926|NCT04068922|593252530|FG000|Overall Study|Adverse Event|1|||
164240927|NCT04540367|593252531|FG000|Overall Study|Withdrawal by Subject|0|||
164240928|NCT04540367|593252532|FG001|Overall Study|Withdrawal by Subject|0|||
164240929|NCT04540367|593252533|FG002|Overall Study|Withdrawal by Subject|0|||
164240930|NCT04540367|593252534|FG003|Overall Study|Withdrawal by Subject|2|||
164240931|NCT04540367|593252531|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
164240932|NCT04540367|593252532|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
164240933|NCT04540367|593252533|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
164240934|NCT04540367|593252534|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
164240935|NCT04540367|593252531|FG000|Overall Study|Adverse Event|0|||
164240936|NCT04540367|593252532|FG001|Overall Study|Adverse Event|0|||
164240937|NCT04540367|593252533|FG002|Overall Study|Adverse Event|1|||
164240938|NCT04540367|593252534|FG003|Overall Study|Adverse Event|1|||
164240939|NCT00907621|593252536|FG000|Overall Study|Lost to Follow-up|6|||
164240940|NCT00907621|593252537|FG001|Overall Study|Lost to Follow-up|3|||
164240941|NCT00907621|593252536|FG000|Overall Study|intercurrent febrile illness|1|||
164240942|NCT00907621|593252537|FG001|Overall Study|intercurrent febrile illness|1|||
164240943|NCT01815424|593254346|FG000|Week 0 to 16|Adverse Event|1|||
164240944|NCT01815424|593254347|FG001|Week 0 to 16|Adverse Event|3|||
164240945|NCT01815424|593254348|FG002|Week 0 to 16|Adverse Event|3|||
164240946|NCT01815424|593254349|FG003|Week 0 to 16|Adverse Event|0|||
164240947|NCT01815424|593254350|FG004|Week 0 to 16|Adverse Event|0|||
164240948|NCT01815424|593254346|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
164240949|NCT01815424|593254347|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
164240950|NCT01815424|593254348|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
164240951|NCT01815424|593254349|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
164240952|NCT01815424|593254350|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
164240953|NCT01815424|593254346|FG000|Week 0 to 16|Lost to Follow-up|0|||
164240954|NCT01815424|593254347|FG001|Week 0 to 16|Lost to Follow-up|1|||
164240955|NCT01815424|593254348|FG002|Week 0 to 16|Lost to Follow-up|0|||
164240956|NCT01815424|593254349|FG003|Week 0 to 16|Lost to Follow-up|0|||
164240957|NCT01815424|593254350|FG004|Week 0 to 16|Lost to Follow-up|0|||
164240958|NCT01815424|593254346|FG000|Week 0 to 16|Withdrawal by Subject|0|||
164240959|NCT01815424|593254347|FG001|Week 0 to 16|Withdrawal by Subject|0|||
164240960|NCT01815424|593254348|FG002|Week 0 to 16|Withdrawal by Subject|1|||
164240961|NCT01815424|593254349|FG003|Week 0 to 16|Withdrawal by Subject|0|||
164240962|NCT01815424|593254350|FG004|Week 0 to 16|Withdrawal by Subject|0|||
164240963|NCT01815424|593254346|FG000|Week 0 to 16|Other|1|||
164240964|NCT01815424|593254347|FG001|Week 0 to 16|Other|0|||
164240965|NCT01815424|593254348|FG002|Week 0 to 16|Other|3|||
164240966|NCT01815424|593254349|FG003|Week 0 to 16|Other|0|||
164240967|NCT01815424|593254350|FG004|Week 0 to 16|Other|0|||
164240968|NCT01815424|593254346|FG000|Week 0 to 16|Protocol Violation|1|||
164240969|NCT01815424|593254347|FG001|Week 0 to 16|Protocol Violation|0|||
164240970|NCT01815424|593254348|FG002|Week 0 to 16|Protocol Violation|0|||
164240971|NCT01815424|593254349|FG003|Week 0 to 16|Protocol Violation|0|||
164240972|NCT01815424|593254350|FG004|Week 0 to 16|Protocol Violation|0|||
164240973|NCT01815424|593254346|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
164240974|NCT01815424|593254347|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
164240975|NCT01815424|593254348|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
164240976|NCT01815424|593254349|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
164240977|NCT01815424|593254350|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
164240978|NCT01815424|593254346|FG000|Week 16 to 52|Other|0|||
164240979|NCT01815424|593254347|FG001|Week 16 to 52|Other|1|||
164240980|NCT01815424|593254348|FG002|Week 16 to 52|Other|0|||
164240981|NCT01815424|593254349|FG003|Week 16 to 52|Other|0|||
164240982|NCT01815424|593254350|FG004|Week 16 to 52|Other|0|||
164240983|NCT01815424|593254346|FG000|Week 16 to 52|Adverse Event|0|||
164240984|NCT01815424|593254347|FG001|Week 16 to 52|Adverse Event|0|||
164240985|NCT01815424|593254348|FG002|Week 16 to 52|Adverse Event|0|||
164240986|NCT01815424|593254349|FG003|Week 16 to 52|Adverse Event|0|||
164240987|NCT01815424|593254350|FG004|Week 16 to 52|Adverse Event|1|||
164240988|NCT01815424|593254346|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
164240989|NCT01815424|593254347|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
164240990|NCT01815424|593254348|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
164240991|NCT01815424|593254349|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
164240992|NCT01815424|593254350|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
164240993|NCT01815424|593254346|FG000|Week 16 to 52|Lost to Follow-up|0|||
164240994|NCT01815424|593254347|FG001|Week 16 to 52|Lost to Follow-up|2|||
164240995|NCT01815424|593254348|FG002|Week 16 to 52|Lost to Follow-up|0|||
164240996|NCT01815424|593254349|FG003|Week 16 to 52|Lost to Follow-up|2|||
164240997|NCT01815424|593254350|FG004|Week 16 to 52|Lost to Follow-up|1|||
164240998|NCT01815424|593254346|FG000|Week 16 to 52|Withdrawal by Subject|1|||
164240999|NCT01815424|593254347|FG001|Week 16 to 52|Withdrawal by Subject|2|||
164241000|NCT01815424|593254348|FG002|Week 16 to 52|Withdrawal by Subject|0|||
164241001|NCT01815424|593254349|FG003|Week 16 to 52|Withdrawal by Subject|0|||
164241002|NCT01815424|593254350|FG004|Week 16 to 52|Withdrawal by Subject|0|||
164241003|NCT01309204|593254351|FG000|Overall Study|Adverse Event|48|||
164241004|NCT01309204|593254352|FG001|Overall Study|Adverse Event|58|||
164241005|NCT01309204|593254351|FG000|Overall Study|Lost to Follow-up|2|||
164241006|NCT01309204|593254352|FG001|Overall Study|Lost to Follow-up|2|||
164241007|NCT01309204|593254351|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
164241008|NCT01309204|593254352|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
164241009|NCT01309204|593254351|FG000|Overall Study|Inadequate control of IOP|4|||
164241010|NCT01309204|593254352|FG001|Overall Study|Inadequate control of IOP|4|||
164241011|NCT01309204|593254351|FG000|Overall Study|Other|4|||
164241012|NCT01309204|593254352|FG001|Overall Study|Other|1|||
164336124|NCT00333840|593607833|FG001|First-line Treatment Period|Lost to Follow-up|6|||
164336125|NCT00333840|593607834|FG002|First-line Treatment Period|Lost to Follow-up|0|||
164336126|NCT00333840|593607835|FG003|First-line Treatment Period|Lost to Follow-up|0|||
164336127|NCT00333840|593607832|FG000|First-line Treatment Period|Administrative problems|12|||
164336128|NCT00333840|593607833|FG001|First-line Treatment Period|Administrative problems|6|||
164336129|NCT00333840|593607834|FG002|First-line Treatment Period|Administrative problems|0|||
164336130|NCT00333840|593607835|FG003|First-line Treatment Period|Administrative problems|0|||
164336131|NCT00333840|593607832|FG000|First-line Treatment Period|Death|19|||
164336132|NCT00333840|593607833|FG001|First-line Treatment Period|Death|2|||
164336133|NCT00333840|593607834|FG002|First-line Treatment Period|Death|0|||
164336134|NCT00333840|593607835|FG003|First-line Treatment Period|Death|0|||
164336135|NCT00333840|593607832|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
164336136|NCT00333840|593607833|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
164336137|NCT00333840|593607834|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
164336138|NCT00333840|593607835|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
164336139|NCT00333840|593607832|FG000|Second-line Treatment Period|Adverse Event|0|||
164336140|NCT00333840|593607833|FG001|Second-line Treatment Period|Adverse Event|0|||
164336141|NCT00333840|593607834|FG002|Second-line Treatment Period|Adverse Event|3|||
164336142|NCT00333840|593607835|FG003|Second-line Treatment Period|Adverse Event|34|||
164336143|NCT00333840|593607832|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
164336144|NCT00333840|593607833|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
164336145|NCT00333840|593607834|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
164336146|NCT00333840|593607835|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
164336147|NCT00333840|593607832|FG000|Second-line Treatment Period|Abnormal procedure|0|||
164336148|NCT00333840|593607833|FG001|Second-line Treatment Period|Abnormal procedure|0|||
164336149|NCT00333840|593607834|FG002|Second-line Treatment Period|Abnormal procedure|0|||
164336150|NCT00333840|593607835|FG003|Second-line Treatment Period|Abnormal procedure|1|||
164336151|NCT00333840|593607832|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
164336152|NCT00333840|593607833|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
164336153|NCT00333840|593607834|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
164336154|NCT00333840|593607835|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
164677818|NCT01204294|594844856|FG002|Overall Study|Other (house moving)|1|||
164336155|NCT00333840|593607832|FG000|Second-line Treatment Period|No longer required study drug|0|||
164677819|NCT01204294|594844857|FG003|Overall Study|Other (house moving)|0|||
164677820|NCT01204294|594844858|FG004|Overall Study|Other (house moving)|0|||
164677821|NCT01204294|594844859|FG005|Overall Study|Other (house moving)|0|||
164677822|NCT01204294|594844860|FG006|Overall Study|Other (house moving)|0|||
164677823|NCT03128723|594844861|FG000|Overall Study|Withdrawal by Subject|2|||
164677824|NCT02075463|594844862|FG000|Overall Study|Adverse Event|3|||
164677825|NCT02075463|594844862|FG000|Overall Study|Par. reached stopping criteria|4|||
164241013|NCT04723355|593254353|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
164241014|NCT04723355|593254353|FG000|Overall Study|Errors in the informed consent form|2|||
164241015|NCT03374358|593254354|FG000|Overall Study|Withdrawal by Subject|0|||
164241016|NCT03374358|593254355|FG001|Overall Study|Withdrawal by Subject|2|||
164241017|NCT01127633|593254357|FG000|Overall Study|Adverse Event|74|||
164241018|NCT01127633|593254358|FG001|Overall Study|Adverse Event|73|||
164241019|NCT01127633|593254357|FG000|Overall Study|Death|40|||
164241020|NCT01127633|593254358|FG001|Overall Study|Death|43|||
164241021|NCT01127633|593254357|FG000|Overall Study|Lost to Follow-up|4|||
164241022|NCT01127633|593254358|FG001|Overall Study|Lost to Follow-up|0|||
164241023|NCT01127633|593254357|FG000|Overall Study|Parent/Caregiver Decision|246|||
164241024|NCT01127633|593254358|FG001|Overall Study|Parent/Caregiver Decision|228|||
164241025|NCT01127633|593254357|FG000|Overall Study|Physician Decision|60|||
164241026|NCT01127633|593254358|FG001|Overall Study|Physician Decision|45|||
164241027|NCT01127633|593254357|FG000|Overall Study|Withdrawal by Subject|57|||
164241028|NCT01127633|593254358|FG001|Overall Study|Withdrawal by Subject|72|||
164241029|NCT01127633|593254357|FG000|Overall Study|Sponsor Decision|163|||
164241030|NCT01127633|593254358|FG001|Overall Study|Sponsor Decision|195|||
164336156|NCT00333840|593607833|FG001|Second-line Treatment Period|No longer required study drug|0|||
164336157|NCT00333840|593607834|FG002|Second-line Treatment Period|No longer required study drug|1|||
164336158|NCT00333840|593607835|FG003|Second-line Treatment Period|No longer required study drug|14|||
164241031|NCT01127633|593254357|FG000|Overall Study|Protocol Violation|8|||
164241032|NCT01127633|593254358|FG001|Overall Study|Protocol Violation|16|||
164241033|NCT01127633|593254357|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
164241034|NCT01127633|593254358|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
164241035|NCT01127633|593254357|FG000|Overall Study|Not treated|1|||
164241036|NCT01127633|593254358|FG001|Overall Study|Not treated|0|||
164241037|NCT01073293|593254360|FG000|Overall Study|Lost to Follow-up|0|||
164241038|NCT01073293|593254361|FG001|Overall Study|Lost to Follow-up|1|||
164241039|NCT01073293|593254360|FG000|Overall Study|Withdrawal by Subject|5|||
164241040|NCT01073293|593254361|FG001|Overall Study|Withdrawal by Subject|10|||
164241041|NCT02168101|593254363|FG000|Overall Study|Death|2|||
164241042|NCT02168101|593254364|FG001|Overall Study|Death|2|||
164241043|NCT02168101|593254365|FG002|Overall Study|Death|1|||
164241044|NCT00400517|593254366|FG000|Overall Study|Withdrawal by Subject|1|||
164241045|NCT00400517|593254366|FG000|Overall Study|Physician Decision|1|||
164241046|NCT01194245|593254367|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
164241047|NCT01194245|593254368|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
164241048|NCT01194245|593254369|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
164241049|NCT01194245|593254370|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
164241050|NCT01194245|593254371|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
164241051|NCT01194245|593254367|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
164241052|NCT01194245|593254368|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
164241053|NCT01194245|593254369|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
164241054|NCT01194245|593254370|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
164241055|NCT01194245|593254371|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
164241056|NCT01194245|593254367|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
164241057|NCT01194245|593254368|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
164241058|NCT01194245|593254369|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
164241059|NCT01194245|593254370|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
164241060|NCT01194245|593254371|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
164241061|NCT01194245|593254367|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
164241062|NCT01194245|593254368|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
164241063|NCT01194245|593254369|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
164241064|NCT01194245|593254370|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
164241065|NCT01194245|593254371|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
164241066|NCT01194245|593254367|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164241067|NCT01194245|593254368|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164241068|NCT01194245|593254369|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164241069|NCT01194245|593254370|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164241070|NCT01194245|593254371|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
164241071|NCT01194245|593254367|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164241072|NCT01194245|593254368|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164241073|NCT01194245|593254369|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
164241074|NCT01194245|593254370|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
164241075|NCT01194245|593254371|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
164241076|NCT05518461|593254372|FG000|Overall Study|Lost to Follow-up|25|||
164336159|NCT00333840|593607832|FG000|Second-line Treatment Period|Protocol Violation|0|||
164241077|NCT02457247|593254373|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
164241078|NCT02457247|593254374|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
164241079|NCT02457247|593254375|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
164241080|NCT02457247|593254376|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
164241081|NCT02457247|593254373|FG000|Period 1|Significant Protocol Deviation|1|||
164241082|NCT02457247|593254374|FG001|Period 1|Significant Protocol Deviation|1|||
164241083|NCT02457247|593254375|FG002|Period 1|Significant Protocol Deviation|0|||
164241084|NCT02457247|593254376|FG003|Period 1|Significant Protocol Deviation|0|||
164241085|NCT02457247|593254373|FG000|Period 1|Voluntary Withdrawal|1|||
164241086|NCT02457247|593254374|FG001|Period 1|Voluntary Withdrawal|0|||
164336160|NCT00333840|593607833|FG001|Second-line Treatment Period|Protocol Violation|0|||
164677826|NCT02075463|594844862|FG000|Overall Study|Withdrawal by Subject|1|||
164677827|NCT00392665|594844863|FG000|Overall Study|Death|16|||
164677828|NCT00392665|594844864|FG001|Overall Study|Death|14|||
164677829|NCT00392665|594844863|FG000|Overall Study|Lost to Follow-up|1|||
164677830|NCT00392665|594844864|FG001|Overall Study|Lost to Follow-up|1|||
164241087|NCT02457247|593254375|FG002|Period 1|Voluntary Withdrawal|0|||
164241088|NCT02457247|593254376|FG003|Period 1|Voluntary Withdrawal|0|||
164241089|NCT02457247|593254373|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
164241090|NCT02457247|593254374|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
164241091|NCT02457247|593254375|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
164241092|NCT02457247|593254376|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
164241093|NCT02457247|593254373|FG000|Period 2|Significant Protocol Deviation|1|||
164241094|NCT02457247|593254374|FG001|Period 2|Significant Protocol Deviation|0|||
164241095|NCT02457247|593254375|FG002|Period 2|Significant Protocol Deviation|0|||
164241096|NCT02457247|593254376|FG003|Period 2|Significant Protocol Deviation|0|||
164241097|NCT02457247|593254373|FG000|Period 2|Lost to Follow-up|0|||
164241098|NCT02457247|593254374|FG001|Period 2|Lost to Follow-up|1|||
164241099|NCT02457247|593254375|FG002|Period 2|Lost to Follow-up|0|||
164241100|NCT02457247|593254376|FG003|Period 2|Lost to Follow-up|0|||
164241101|NCT02457247|593254373|FG000|Period 2|Voluntary Withdrawal|1|||
164241102|NCT02457247|593254374|FG001|Period 2|Voluntary Withdrawal|1|||
164241103|NCT02457247|593254375|FG002|Period 2|Voluntary Withdrawal|0|||
164241104|NCT02457247|593254376|FG003|Period 2|Voluntary Withdrawal|0|||
164241105|NCT00739310|593254377|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
164241106|NCT00739310|593254377|FG000|Overall Study|Withdrawal by Subject|1|||
164241107|NCT00739310|593254377|FG000|Overall Study|Lost to Follow-up|2|||
164241108|NCT02954887|593254378|FG000|Overall Study|Withdrawal by Subject|3|||
164241109|NCT02954887|593254378|FG000|Overall Study|Lack of Efficacy|3|||
164241110|NCT02954887|593254378|FG000|Overall Study|Other|1|||
164241111|NCT01882465|593254380|FG000|Period 1|Lens Discomfort|0|||
164241112|NCT01882465|593254381|FG001|Period 1|Lens Discomfort|0|||
164241113|NCT01882465|593254382|FG002|Period 1|Lens Discomfort|0|||
164241114|NCT01882465|593254383|FG003|Period 1|Lens Discomfort|1|||
164241115|NCT01882465|593254384|FG004|Period 1|Lens Discomfort|0|||
164241116|NCT01882465|593254385|FG005|Period 1|Lens Discomfort|0|||
164241117|NCT01882465|593254386|FG006|Period 1|Lens Discomfort|0|||
164241118|NCT01882465|593254380|FG000|Period 1|Withdrawal by Subject|0|||
164241119|NCT01882465|593254381|FG001|Period 1|Withdrawal by Subject|0|||
164241120|NCT01882465|593254382|FG002|Period 1|Withdrawal by Subject|0|||
164241121|NCT01882465|593254383|FG003|Period 1|Withdrawal by Subject|0|||
164241122|NCT01882465|593254384|FG004|Period 1|Withdrawal by Subject|0|||
164241123|NCT01882465|593254385|FG005|Period 1|Withdrawal by Subject|0|||
164241124|NCT01882465|593254386|FG006|Period 1|Withdrawal by Subject|1|||
164241125|NCT01882465|593254380|FG000|Period 2|Protocol Violation|0|||
164241126|NCT01882465|593254381|FG001|Period 2|Protocol Violation|0|||
164241127|NCT01882465|593254382|FG002|Period 2|Protocol Violation|0|||
164241128|NCT01882465|593254383|FG003|Period 2|Protocol Violation|0|||
164241129|NCT01882465|593254384|FG004|Period 2|Protocol Violation|1|||
164241130|NCT01882465|593254385|FG005|Period 2|Protocol Violation|0|||
164241131|NCT01882465|593254386|FG006|Period 2|Protocol Violation|0|||
164241132|NCT01824290|593254389|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
164241133|NCT01824290|593254390|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
164241134|NCT01824290|593254391|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
164241135|NCT01824290|593254392|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
164241136|NCT01824290|593254389|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
164241137|NCT01824290|593254390|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
164241138|NCT01824290|593254391|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
164241139|NCT01824290|593254392|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
164241140|NCT01824290|593254389|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
164241141|NCT01824290|593254390|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
164241142|NCT01824290|593254391|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
164241143|NCT01824290|593254392|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
164241144|NCT01824290|593254389|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
164241145|NCT01824290|593254390|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
164241146|NCT01824290|593254391|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
164677831|NCT02294786|594844867|FG000|Overall Study|Withdrawal by Subject|0|||
164241147|NCT01824290|593254392|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
164241148|NCT01824290|593254389|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
164677832|NCT02294786|594844868|FG001|Overall Study|Withdrawal by Subject|1|||
164241149|NCT01824290|593254390|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
164241150|NCT01824290|593254391|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
164241151|NCT01824290|593254392|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
164241152|NCT01824290|593254389|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
164241153|NCT01824290|593254390|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
164241154|NCT01824290|593254391|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
164241155|NCT01824290|593254392|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
164241156|NCT00800982|593254393|FG000|Overall Study|Lost to Follow-up|1|||
164241157|NCT00800982|593254394|FG001|Overall Study|Lost to Follow-up|2|||
164241158|NCT00800982|593254393|FG000|Overall Study|Withdrawal by Subject|0|||
164241159|NCT00800982|593254394|FG001|Overall Study|Withdrawal by Subject|1|||
164241160|NCT00800982|593254393|FG000|Overall Study|Patient moved out of state|1|||
164241161|NCT00800982|593254394|FG001|Overall Study|Patient moved out of state|0|||
164241162|NCT01490918|593254395|FG000|Overall Study|Lost to Follow-up|2|||
164241163|NCT01490918|593254396|FG001|Overall Study|Lost to Follow-up|1|||
164241164|NCT01490918|593254397|FG002|Overall Study|Lost to Follow-up|0|||
164241165|NCT01490918|593254395|FG000|Overall Study|Withdrawal by Subject|7|||
164241166|NCT01490918|593254396|FG001|Overall Study|Withdrawal by Subject|8|||
164241167|NCT01490918|593254397|FG002|Overall Study|Withdrawal by Subject|3|||
164241168|NCT01490918|593254395|FG000|Overall Study|Adverse Event|0|||
164241169|NCT01490918|593254396|FG001|Overall Study|Adverse Event|0|||
164241170|NCT01490918|593254397|FG002|Overall Study|Adverse Event|1|||
164241171|NCT01490918|593254395|FG000|Overall Study|other cause|4|||
164241172|NCT01490918|593254396|FG001|Overall Study|other cause|5|||
164241173|NCT01490918|593254397|FG002|Overall Study|other cause|8|||
164241174|NCT00003631|593254411|FG000|Overall Study|Patient not treated|1|||
164241175|NCT00003631|593254412|FG001|Overall Study|Patient not treated|0|||
164241176|NCT00003631|593254413|FG002|Overall Study|Patient not treated|1|||
164241177|NCT00003631|593254411|FG000|Overall Study|Protocol Violation|1|||
164241178|NCT00003631|593254412|FG001|Overall Study|Protocol Violation|0|||
164241179|NCT00003631|593254413|FG002|Overall Study|Protocol Violation|0|||
164241180|NCT00003631|593254411|FG000|Overall Study|Adverse Event|1|||
164241181|NCT00003631|593254412|FG001|Overall Study|Adverse Event|1|||
164241182|NCT00003631|593254413|FG002|Overall Study|Adverse Event|5|||
164241183|NCT00003631|593254411|FG000|Overall Study|Death|0|||
164241184|NCT00003631|593254412|FG001|Overall Study|Death|0|||
164241185|NCT00003631|593254413|FG002|Overall Study|Death|1|||
164241186|NCT00003631|593254411|FG000|Overall Study|Evaluable for toxicity only|0|||
164241187|NCT00003631|593254412|FG001|Overall Study|Evaluable for toxicity only|0|||
164241188|NCT00003631|593254413|FG002|Overall Study|Evaluable for toxicity only|2|||
164241189|NCT00959907|593254414|FG000|Overall Study|Protocol Violation|0|||
164241190|NCT00959907|593254415|FG001|Overall Study|Protocol Violation|1|||
164241191|NCT00959907|593254414|FG000|Overall Study|Adverse Event|1|||
164241192|NCT00959907|593254415|FG001|Overall Study|Adverse Event|0|||
164241193|NCT00959907|593254414|FG000|Overall Study|Withdrawal by Subject|2|||
164241194|NCT00959907|593254415|FG001|Overall Study|Withdrawal by Subject|0|||
164241195|NCT01261975|593254420|FG000|Overall Study|Surgical complication|1|||
164241196|NCT00716274|593254422|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
164241197|NCT00716274|593254423|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
164241198|NCT00716274|593254424|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
164241199|NCT00716274|593254425|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
164241200|NCT00716274|593254426|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
164241201|NCT00716274|593254427|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
164241202|NCT00716274|593254422|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
164241203|NCT00716274|593254423|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
164241204|NCT00716274|593254424|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
164241205|NCT00716274|593254425|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
164241206|NCT00716274|593254426|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
164241207|NCT00716274|593254427|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
164241208|NCT00716274|593254422|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
164241209|NCT00716274|593254423|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
164241210|NCT00716274|593254424|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
164241211|NCT00716274|593254425|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
164241212|NCT00716274|593254426|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
164336161|NCT00333840|593607834|FG002|Second-line Treatment Period|Protocol Violation|1|||
164241213|NCT00716274|593254427|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
164241214|NCT00716274|593254422|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
164241215|NCT00716274|593254423|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
164241216|NCT00716274|593254424|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
164241217|NCT00716274|593254425|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
164241218|NCT00716274|593254426|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
164241219|NCT00716274|593254427|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
164241220|NCT00716274|593254422|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
164241221|NCT00716274|593254423|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
164573438|NCT02901431|594463423|FG003|PK Part|Pending dose confirmation|0|||
164573439|NCT02901431|594463424|FG004|PK Part|Pending dose confirmation|0|||
164573440|NCT02901431|594463425|FG005|PK Part|Pending dose confirmation|0|||
164573441|NCT02901431|594463426|FG006|PK Part|Pending dose confirmation|0|||
164573442|NCT02901431|594463427|FG007|PK Part|Pending dose confirmation|0|||
164573443|NCT02901431|594463428|FG008|PK Part|Pending dose confirmation|0|||
164573444|NCT02901431|594463429|FG009|PK Part|Pending dose confirmation|0|||
164573445|NCT02901431|594463430|FG010|PK Part|Pending dose confirmation|0|||
164573446|NCT02901431|594463431|FG011|PK Part|Pending dose confirmation|0|||
164573447|NCT02901431|594463432|FG012|PK Part|Pending dose confirmation|0|||
164573448|NCT02901431|594463420|FG000|PK Part|8 weeks of treatment ran out|2|||
164573449|NCT02901431|594463421|FG001|PK Part|8 weeks of treatment ran out|0|||
164573450|NCT02901431|594463422|FG002|PK Part|8 weeks of treatment ran out|0|||
164573451|NCT02901431|594463423|FG003|PK Part|8 weeks of treatment ran out|0|||
164573452|NCT02901431|594463424|FG004|PK Part|8 weeks of treatment ran out|0|||
164573453|NCT02901431|594463425|FG005|PK Part|8 weeks of treatment ran out|0|||
164573454|NCT02901431|594463426|FG006|PK Part|8 weeks of treatment ran out|0|||
164573455|NCT02901431|594463427|FG007|PK Part|8 weeks of treatment ran out|0|||
164573456|NCT02901431|594463428|FG008|PK Part|8 weeks of treatment ran out|0|||
164573457|NCT02901431|594463429|FG009|PK Part|8 weeks of treatment ran out|0|||
164573458|NCT02901431|594463430|FG010|PK Part|8 weeks of treatment ran out|0|||
164573459|NCT02901431|594463431|FG011|PK Part|8 weeks of treatment ran out|0|||
164573460|NCT02901431|594463432|FG012|PK Part|8 weeks of treatment ran out|0|||
164573461|NCT02901431|594463420|FG000|PK Part|Stopped treatment after 8 weeks|1|||
164573462|NCT02901431|594463421|FG001|PK Part|Stopped treatment after 8 weeks|0|||
164573463|NCT02901431|594463422|FG002|PK Part|Stopped treatment after 8 weeks|1|||
164573464|NCT02901431|594463423|FG003|PK Part|Stopped treatment after 8 weeks|0|||
164573465|NCT02901431|594463424|FG004|PK Part|Stopped treatment after 8 weeks|0|||
164573466|NCT02901431|594463425|FG005|PK Part|Stopped treatment after 8 weeks|0|||
164573467|NCT02901431|594463426|FG006|PK Part|Stopped treatment after 8 weeks|0|||
164573468|NCT02901431|594463427|FG007|PK Part|Stopped treatment after 8 weeks|0|||
164573469|NCT02901431|594463428|FG008|PK Part|Stopped treatment after 8 weeks|0|||
164573470|NCT02901431|594463429|FG009|PK Part|Stopped treatment after 8 weeks|0|||
164573471|NCT02901431|594463430|FG010|PK Part|Stopped treatment after 8 weeks|0|||
164573472|NCT02901431|594463431|FG011|PK Part|Stopped treatment after 8 weeks|0|||
164573473|NCT02901431|594463432|FG012|PK Part|Stopped treatment after 8 weeks|0|||
164573474|NCT02901431|594463420|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
164573475|NCT02901431|594463421|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
164573476|NCT02901431|594463422|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
164573477|NCT02901431|594463423|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
164573478|NCT02901431|594463424|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
164573479|NCT02901431|594463425|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
164573480|NCT02901431|594463426|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
164573481|NCT02901431|594463427|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
164573482|NCT02901431|594463428|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
164573483|NCT02901431|594463429|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
164573484|NCT02901431|594463430|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
164573485|NCT02901431|594463431|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
164573486|NCT02901431|594463432|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
164573487|NCT02901431|594463420|FG000|PK Part|Discontinued per Sponsor|0|||
164573488|NCT02901431|594463421|FG001|PK Part|Discontinued per Sponsor|3|||
164573489|NCT02901431|594463422|FG002|PK Part|Discontinued per Sponsor|0|||
164573490|NCT02901431|594463423|FG003|PK Part|Discontinued per Sponsor|0|||
164573491|NCT02901431|594463424|FG004|PK Part|Discontinued per Sponsor|0|||
164573492|NCT02901431|594463425|FG005|PK Part|Discontinued per Sponsor|0|||
164573493|NCT02901431|594463426|FG006|PK Part|Discontinued per Sponsor|0|||
164573494|NCT02901431|594463427|FG007|PK Part|Discontinued per Sponsor|0|||
164573495|NCT02901431|594463428|FG008|PK Part|Discontinued per Sponsor|0|||
164573496|NCT02901431|594463429|FG009|PK Part|Discontinued per Sponsor|0|||
164241222|NCT00716274|593254424|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
164573497|NCT02901431|594463430|FG010|PK Part|Discontinued per Sponsor|0|||
164573498|NCT02901431|594463431|FG011|PK Part|Discontinued per Sponsor|0|||
164573499|NCT02901431|594463432|FG012|PK Part|Discontinued per Sponsor|0|||
164573500|NCT02901431|594463420|FG000|PK Part|Withdrawal by Subject|1|||
164573501|NCT02901431|594463421|FG001|PK Part|Withdrawal by Subject|1|||
164573502|NCT02901431|594463422|FG002|PK Part|Withdrawal by Subject|3|||
164241223|NCT00716274|593254425|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
164241224|NCT00716274|593254426|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
164573503|NCT02901431|594463423|FG003|PK Part|Withdrawal by Subject|0|||
164573504|NCT02901431|594463424|FG004|PK Part|Withdrawal by Subject|0|||
164573505|NCT02901431|594463425|FG005|PK Part|Withdrawal by Subject|0|||
164573506|NCT02901431|594463426|FG006|PK Part|Withdrawal by Subject|0|||
164573507|NCT02901431|594463427|FG007|PK Part|Withdrawal by Subject|0|||
164573508|NCT02901431|594463428|FG008|PK Part|Withdrawal by Subject|0|||
164573509|NCT02901431|594463429|FG009|PK Part|Withdrawal by Subject|0|||
164573510|NCT02901431|594463430|FG010|PK Part|Withdrawal by Subject|0|||
164573511|NCT02901431|594463431|FG011|PK Part|Withdrawal by Subject|0|||
164573512|NCT02901431|594463432|FG012|PK Part|Withdrawal by Subject|0|||
164573513|NCT02901431|594463420|FG000|Main Treatment Part|Adverse Event|0|||
164573514|NCT02901431|594463421|FG001|Main Treatment Part|Adverse Event|0|||
164573515|NCT02901431|594463422|FG002|Main Treatment Part|Adverse Event|0|||
164573516|NCT02901431|594463423|FG003|Main Treatment Part|Adverse Event|3|||
164573517|NCT02901431|594463424|FG004|Main Treatment Part|Adverse Event|3|||
164573518|NCT02901431|594463425|FG005|Main Treatment Part|Adverse Event|4|||
164573519|NCT02901431|594463426|FG006|Main Treatment Part|Adverse Event|1|||
164573520|NCT02901431|594463427|FG007|Main Treatment Part|Adverse Event|0|||
164573521|NCT02901431|594463428|FG008|Main Treatment Part|Adverse Event|0|||
164573522|NCT02901431|594463429|FG009|Main Treatment Part|Adverse Event|0|||
164573523|NCT02901431|594463430|FG010|Main Treatment Part|Adverse Event|0|||
164573524|NCT02901431|594463431|FG011|Main Treatment Part|Adverse Event|0|||
164573525|NCT02901431|594463432|FG012|Main Treatment Part|Adverse Event|0|||
164573526|NCT02901431|594463420|FG000|Main Treatment Part|Lack of Efficacy|0|||
164573527|NCT02901431|594463421|FG001|Main Treatment Part|Lack of Efficacy|0|||
164573528|NCT02901431|594463422|FG002|Main Treatment Part|Lack of Efficacy|0|||
164573529|NCT02901431|594463423|FG003|Main Treatment Part|Lack of Efficacy|1|||
164573530|NCT02901431|594463424|FG004|Main Treatment Part|Lack of Efficacy|0|||
164573531|NCT02901431|594463425|FG005|Main Treatment Part|Lack of Efficacy|0|||
164573532|NCT02901431|594463426|FG006|Main Treatment Part|Lack of Efficacy|0|||
164241225|NCT00716274|593254427|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
164241226|NCT00716274|593254422|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
164241227|NCT00716274|593254423|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
164241228|NCT00716274|593254424|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
164241229|NCT00716274|593254425|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
164241230|NCT00716274|593254426|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
164241231|NCT00716274|593254427|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
164241232|NCT00716274|593254422|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
164241233|NCT00716274|593254423|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
164425394|NCT01052662|593928475|FG002|Overall Study|Pharmacy issue|3|||
164425395|NCT01052662|593928473|FG000|Overall Study|Adverse Event|1|||
164425396|NCT01052662|593928474|FG001|Overall Study|Adverse Event|1|||
164425397|NCT01052662|593928475|FG002|Overall Study|Adverse Event|0|||
164425398|NCT01052662|593928473|FG000|Overall Study|Legal Problem|2|||
164425399|NCT01052662|593928474|FG001|Overall Study|Legal Problem|0|||
164425400|NCT01052662|593928475|FG002|Overall Study|Legal Problem|0|||
164425401|NCT01052662|593928473|FG000|Overall Study|Administrative|0|||
164241234|NCT00716274|593254424|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
164241235|NCT00716274|593254425|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
164241236|NCT00716274|593254426|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
164241237|NCT00716274|593254427|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
164241238|NCT00716274|593254422|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
164241239|NCT00716274|593254423|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
164241240|NCT00716274|593254424|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
164241241|NCT00716274|593254425|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
164241242|NCT00716274|593254426|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
164241243|NCT00716274|593254427|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
164241244|NCT00716274|593254422|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
164241245|NCT00716274|593254423|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
164241246|NCT00716274|593254424|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
164425402|NCT01052662|593928474|FG001|Overall Study|Administrative|3|||
164425403|NCT01052662|593928475|FG002|Overall Study|Administrative|0|||
164573533|NCT02901431|594463427|FG007|Main Treatment Part|Lack of Efficacy|0|||
164573534|NCT02901431|594463428|FG008|Main Treatment Part|Lack of Efficacy|0|||
164573535|NCT02901431|594463429|FG009|Main Treatment Part|Lack of Efficacy|0|||
164677833|NCT02294786|594844867|FG000|Overall Study|Physician Decision|6|||
164241247|NCT00716274|593254425|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
164425404|NCT00479674|593928476|FG000|Overall Study|Adverse Event|18|||
164425405|NCT00479674|593928476|FG000|Overall Study|Withdrawal by Subject|6|||
164425406|NCT00479674|593928476|FG000|Overall Study|Physician Decision|14|||
164425407|NCT00479674|593928476|FG000|Overall Study|none provided|3|||
164573536|NCT02901431|594463430|FG010|Main Treatment Part|Lack of Efficacy|0|||
164573537|NCT02901431|594463431|FG011|Main Treatment Part|Lack of Efficacy|0|||
164573538|NCT02901431|594463432|FG012|Main Treatment Part|Lack of Efficacy|0|||
164573539|NCT02901431|594463420|FG000|Main Treatment Part|Lost to Follow-up|0|||
164573540|NCT02901431|594463421|FG001|Main Treatment Part|Lost to Follow-up|0|||
164573541|NCT02901431|594463422|FG002|Main Treatment Part|Lost to Follow-up|0|||
164573542|NCT02901431|594463423|FG003|Main Treatment Part|Lost to Follow-up|3|||
164677834|NCT02294786|594844868|FG001|Overall Study|Physician Decision|7|||
164573543|NCT02901431|594463424|FG004|Main Treatment Part|Lost to Follow-up|1|||
164573544|NCT02901431|594463425|FG005|Main Treatment Part|Lost to Follow-up|2|||
164241248|NCT00716274|593254426|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
164241249|NCT00716274|593254427|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
164241250|NCT00716274|593254422|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
164241251|NCT00716274|593254423|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
164241252|NCT00716274|593254424|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
164241253|NCT00716274|593254425|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
164241254|NCT00716274|593254426|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
164241255|NCT00716274|593254427|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
164241256|NCT01932788|593254428|FG000|Overall Study|Protocol Violation|18|||
164241257|NCT01932788|593254429|FG001|Overall Study|Protocol Violation|0|||
164241258|NCT01932788|593254428|FG000|Overall Study|Lost to Follow-up|18|||
164241259|NCT01932788|593254429|FG001|Overall Study|Lost to Follow-up|46|||
164336162|NCT00333840|593607835|FG003|Second-line Treatment Period|Protocol Violation|10|||
164336163|NCT00333840|593607832|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
164336164|NCT00333840|593607833|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
164336165|NCT00333840|593607834|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
164336166|NCT00333840|593607835|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
164336167|NCT00333840|593607832|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
164336168|NCT00333840|593607833|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
164336169|NCT00333840|593607834|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
164336170|NCT00333840|593607835|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
164336171|NCT00333840|593607832|FG000|Second-line Treatment Period|Administrative problems|0|||
164336172|NCT00333840|593607833|FG001|Second-line Treatment Period|Administrative problems|0|||
164336173|NCT00333840|593607834|FG002|Second-line Treatment Period|Administrative problems|0|||
164336174|NCT00333840|593607835|FG003|Second-line Treatment Period|Administrative problems|7|||
164336175|NCT00333840|593607832|FG000|Second-line Treatment Period|Death|0|||
164336176|NCT00333840|593607833|FG001|Second-line Treatment Period|Death|0|||
164336177|NCT00333840|593607834|FG002|Second-line Treatment Period|Death|0|||
164336178|NCT00333840|593607835|FG003|Second-line Treatment Period|Death|9|||
164336179|NCT02357979|593607836|FG000|Overall Study|Lost to Follow-up|5|||
164336180|NCT02357979|593607837|FG001|Overall Study|Lost to Follow-up|5|||
164336181|NCT01453725|593607838|FG000|Overall Study|Adverse Event|3|||
164336182|NCT01453725|593607839|FG001|Overall Study|Adverse Event|3|||
164336183|NCT01453725|593607838|FG000|Overall Study|Lost to Follow-up|4|||
164336184|NCT01453725|593607839|FG001|Overall Study|Lost to Follow-up|0|||
164336185|NCT01453725|593607838|FG000|Overall Study|Non-compliance With Protocol|1|||
164336186|NCT01453725|593607839|FG001|Overall Study|Non-compliance With Protocol|2|||
164336187|NCT01453725|593607838|FG000|Overall Study|Protocol Violation|1|||
164336188|NCT01453725|593607839|FG001|Overall Study|Protocol Violation|0|||
164336189|NCT01453725|593607838|FG000|Overall Study|Withdrawal by Subject|2|||
164336190|NCT01453725|593607839|FG001|Overall Study|Withdrawal by Subject|3|||
164336191|NCT01453725|593607838|FG000|Overall Study|Pregnancy Wish|0|||
164336192|NCT01453725|593607839|FG001|Overall Study|Pregnancy Wish|2|||
164336193|NCT01453725|593607838|FG000|Overall Study|Pregnancy|1|||
164336194|NCT01453725|593607839|FG001|Overall Study|Pregnancy|0|||
164336195|NCT01453725|593607838|FG000|Overall Study|Physician Decision|1|||
164336196|NCT01453725|593607839|FG001|Overall Study|Physician Decision|1|||
164336197|NCT03449901|593607850|FG000|Overall Study|Progression|57|||
164336198|NCT03449901|593607851|FG001|Overall Study|Progression|12|||
164336199|NCT03449901|593607850|FG000|Overall Study|Adverse Event|3|||
164336200|NCT03449901|593607851|FG001|Overall Study|Adverse Event|0|||
164336201|NCT03449901|593607850|FG000|Overall Study|Death|6|||
164336202|NCT03449901|593607851|FG001|Overall Study|Death|2|||
164336203|NCT03449901|593607850|FG000|Overall Study|Withdrawal by Subject|12|||
164336204|NCT03449901|593607851|FG001|Overall Study|Withdrawal by Subject|1|||
164336205|NCT03449901|593607850|FG000|Overall Study|Physician Decision|1|||
164573545|NCT02901431|594463426|FG006|Main Treatment Part|Lost to Follow-up|3|||
164573546|NCT02901431|594463427|FG007|Main Treatment Part|Lost to Follow-up|0|||
164573547|NCT02901431|594463428|FG008|Main Treatment Part|Lost to Follow-up|0|||
164573548|NCT02901431|594463429|FG009|Main Treatment Part|Lost to Follow-up|0|||
164241260|NCT01932788|593254428|FG000|Overall Study|Lack of Efficacy|2|||
164241261|NCT01932788|593254429|FG001|Overall Study|Lack of Efficacy|0|||
164336206|NCT03449901|593607851|FG001|Overall Study|Physician Decision|0|||
164336207|NCT03449901|593607850|FG000|Overall Study|Patient elected for surgical intervention|1|||
164336208|NCT03449901|593607851|FG001|Overall Study|Patient elected for surgical intervention|0|||
164336209|NCT03449901|593607850|FG000|Overall Study|Patient off for other complicating disease|1|||
164336210|NCT03449901|593607851|FG001|Overall Study|Patient off for other complicating disease|0|||
164336211|NCT03755791|593607854|FG000|Overall Study|Did not receive any study treatment|3|||
164336212|NCT03755791|593607855|FG001|Overall Study|Did not receive any study treatment|0|||
164336213|NCT03755791|593607856|FG002|Overall Study|Did not receive any study treatment|10|||
164336214|NCT03755791|593607854|FG000|Overall Study|Radiographic progression|204|||
164336215|NCT03755791|593607855|FG001|Overall Study|Radiographic progression|92|||
164241262|NCT01932788|593254428|FG000|Overall Study|Withdrawal by Subject|0|||
164241263|NCT01932788|593254429|FG001|Overall Study|Withdrawal by Subject|5|||
164241264|NCT04290624|593254430|FG000|Overall Study|Adverse Event|1|||
164241265|NCT04290624|593254431|FG001|Overall Study|Adverse Event|0|||
164241266|NCT01171677|593254432|FG000|Overall Study|Withdrawal by Subject|0|||
164241267|NCT01171677|593254433|FG001|Overall Study|Withdrawal by Subject|3|||
164241268|NCT01171677|593254432|FG000|Overall Study|Adverse Event|1|||
164241269|NCT01171677|593254433|FG001|Overall Study|Adverse Event|0|||
164241270|NCT01171677|593254432|FG000|Overall Study|completed <70% IntenSati classes|5|||
164241271|NCT01171677|593254433|FG001|Overall Study|completed <70% IntenSati classes|0|||
164241272|NCT00656370|593254436|FG000|Overall Study|Screen Failures|7|||
164241273|NCT00656370|593254436|FG000|Overall Study|Alternates|3|||
164241274|NCT01342094|593254437|FG000|Overall Study|Adverse Event|5|||
164241275|NCT01342094|593254438|FG001|Overall Study|Adverse Event|0|||
164241276|NCT01342094|593254437|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
164241277|NCT01342094|593254438|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
164241278|NCT01342094|593254437|FG000|Overall Study|Withdrawal by Subject|0|||
164241279|NCT01342094|593254438|FG001|Overall Study|Withdrawal by Subject|2|||
164241280|NCT02806414|593254443|FG000|Overall Study|Lost to Follow-up|2|||
164241281|NCT05653700|593254459|FG000|Overall Study|Non Responders|9|||
164241282|NCT05653700|593254460|FG001|Overall Study|Non Responders|0|||
164241283|NCT00543985|593254465|FG000|Overall Study|Withdrawal by Subject|4|||
164241284|NCT01634152|593254466|FG000|Overall Study|Adverse Event|2|||
164241285|NCT01634152|593254467|FG001|Overall Study|Adverse Event|0|||
164241286|NCT01634152|593254468|FG002|Overall Study|Adverse Event|2|||
164241287|NCT01634152|593254466|FG000|Overall Study|Consent withdrawn not due to AE|1|||
164241288|NCT01634152|593254467|FG001|Overall Study|Consent withdrawn not due to AE|0|||
164241289|NCT01634152|593254468|FG002|Overall Study|Consent withdrawn not due to AE|1|||
164241290|NCT01634152|593254466|FG000|Overall Study|Not treated|0|||
164241291|NCT01634152|593254467|FG001|Overall Study|Not treated|1|||
164241292|NCT01634152|593254468|FG002|Overall Study|Not treated|0|||
164241293|NCT01634152|593254466|FG000|Overall Study|Other reason not defined above|1|||
164241294|NCT01634152|593254467|FG001|Overall Study|Other reason not defined above|0|||
164241295|NCT01634152|593254468|FG002|Overall Study|Other reason not defined above|1|||
164241296|NCT01900665|593254475|FG000|Placebo Controlled Period|Death|9|||
164241297|NCT01900665|593254476|FG001|Placebo Controlled Period|Death|16|||
164241298|NCT01900665|593254475|FG000|Placebo Controlled Period|Adverse Event|48|||
164241299|NCT01900665|593254476|FG001|Placebo Controlled Period|Adverse Event|39|||
164241300|NCT01900665|593254475|FG000|Placebo Controlled Period|Protocol Violation|1|||
164241301|NCT01900665|593254476|FG001|Placebo Controlled Period|Protocol Violation|7|||
164241302|NCT01900665|593254475|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
164241303|NCT01900665|593254476|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
164241304|NCT01900665|593254475|FG000|Placebo Controlled Period|Physician Decision|11|||
164241305|NCT01900665|593254476|FG001|Placebo Controlled Period|Physician Decision|7|||
164241306|NCT01900665|593254475|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
164241307|NCT01900665|593254476|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
164241308|NCT01900665|593254475|FG000|Placebo Controlled Period|Caregiver Decision|33|||
164241309|NCT01900665|593254476|FG001|Placebo Controlled Period|Caregiver Decision|41|||
164241310|NCT01900665|593254475|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
164241311|NCT01900665|593254476|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
164241312|NCT01900665|593254475|FG000|Open Label Period|Adverse Event|16|||
164241313|NCT01900665|593254476|FG001|Open Label Period|Adverse Event|20|||
164241314|NCT01900665|593254475|FG000|Open Label Period|Death|5|||
164241315|NCT01900665|593254476|FG001|Open Label Period|Death|6|||
164241316|NCT01900665|593254475|FG000|Open Label Period|Lost to Follow-up|1|||
164336216|NCT03755791|593607856|FG002|Overall Study|Radiographic progression|115|||
164336217|NCT03755791|593607854|FG000|Overall Study|Adverse Event|140|||
164336218|NCT03755791|593607855|FG001|Overall Study|Adverse Event|60|||
164336219|NCT03755791|593607856|FG002|Overall Study|Adverse Event|51|||
164336220|NCT03755791|593607854|FG000|Overall Study|Lack of Efficacy|12|||
164336221|NCT03755791|593607855|FG001|Overall Study|Lack of Efficacy|6|||
164336222|NCT03755791|593607856|FG002|Overall Study|Lack of Efficacy|6|||
164241317|NCT01900665|593254476|FG001|Open Label Period|Lost to Follow-up|1|||
164241318|NCT01900665|593254475|FG000|Open Label Period|Parent/Caregiver Decision|33|||
164241319|NCT01900665|593254476|FG001|Open Label Period|Parent/Caregiver Decision|34|||
164241320|NCT01900665|593254475|FG000|Open Label Period|Physician Decision|4|||
164241321|NCT01900665|593254476|FG001|Open Label Period|Physician Decision|4|||
164241322|NCT01900665|593254475|FG000|Open Label Period|Protocol Violation|0|||
164241323|NCT01900665|593254476|FG001|Open Label Period|Protocol Violation|1|||
164241324|NCT01900665|593254475|FG000|Open Label Period|Sponsor Decision|802|||
164241325|NCT01900665|593254476|FG001|Open Label Period|Sponsor Decision|765|||
164241326|NCT01900665|593254475|FG000|Open Label Period|Withdrawal by Subject|20|||
164241327|NCT01900665|593254476|FG001|Open Label Period|Withdrawal by Subject|28|||
164336223|NCT03755791|593607854|FG000|Overall Study|Withdrawal by Subject|26|||
164336224|NCT03755791|593607855|FG001|Overall Study|Withdrawal by Subject|23|||
164336225|NCT03755791|593607856|FG002|Overall Study|Withdrawal by Subject|24|||
164241328|NCT02317627|593254478|FG000|Overall Study|Withdrawal by Subject|0|||
164241329|NCT02317627|593254479|FG001|Overall Study|Withdrawal by Subject|1|||
164241330|NCT02317627|593254480|FG002|Overall Study|Withdrawal by Subject|1|||
164241331|NCT02317627|593254478|FG000|Overall Study|Lost to Follow-up|2|||
164241332|NCT02317627|593254479|FG001|Overall Study|Lost to Follow-up|0|||
164241333|NCT02317627|593254480|FG002|Overall Study|Lost to Follow-up|0|||
164241334|NCT02317627|593254478|FG000|Overall Study|Stopped by Investigator|0|||
164241335|NCT02317627|593254479|FG001|Overall Study|Stopped by Investigator|1|||
164241336|NCT02317627|593254480|FG002|Overall Study|Stopped by Investigator|0|||
164241337|NCT02317627|593254478|FG000|Overall Study|Adverse Event|0|||
164241338|NCT02317627|593254479|FG001|Overall Study|Adverse Event|2|||
164241339|NCT02317627|593254480|FG002|Overall Study|Adverse Event|3|||
164241340|NCT02317627|593254478|FG000|Overall Study|Non-compliance with study drug|0|||
164241341|NCT02317627|593254479|FG001|Overall Study|Non-compliance with study drug|1|||
164241342|NCT02317627|593254480|FG002|Overall Study|Non-compliance with study drug|0|||
164241343|NCT04749914|593254481|FG000|Period 1|Adverse Event|1|||
164241344|NCT04749914|593254482|FG001|Period 1|Adverse Event|0|||
164241345|NCT04749914|593254483|FG002|Period 1|Adverse Event|0|||
164241346|NCT04749914|593254484|FG003|Period 1|Adverse Event|0|||
164241347|NCT04749914|593254481|FG000|Period 1|Withdrawal by Subject|1|||
164241348|NCT04749914|593254482|FG001|Period 1|Withdrawal by Subject|0|||
164241349|NCT04749914|593254483|FG002|Period 1|Withdrawal by Subject|1|||
164241350|NCT04749914|593254484|FG003|Period 1|Withdrawal by Subject|0|||
164241351|NCT00279214|593254485|FG000|Overall Study|Physician Decision|3|||
164241352|NCT00279214|593254486|FG001|Overall Study|Physician Decision|2|||
164241353|NCT00403130|593254487|FG000|2 Years From Start of Treatment|Not Eligible|3|||
164241354|NCT00403130|593254487|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
164241355|NCT00403130|593254487|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
164241356|NCT00403130|593254487|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
164241357|NCT01280968|593254488|FG000|Overall Study|Lost to Follow-up|8|||
164241358|NCT01280968|593254489|FG001|Overall Study|Lost to Follow-up|2|||
164241359|NCT01280968|593254488|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
164241360|NCT01280968|593254489|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
164241361|NCT01280968|593254488|FG000|Overall Study|Commuting Problems|2|||
164241362|NCT01280968|593254489|FG001|Overall Study|Commuting Problems|0|||
164241363|NCT01280968|593254488|FG000|Overall Study|Anxiety|2|||
164241364|NCT01280968|593254489|FG001|Overall Study|Anxiety|0|||
164241365|NCT01280968|593254488|FG000|Overall Study|Adverse Event|1|||
164241366|NCT01280968|593254489|FG001|Overall Study|Adverse Event|0|||
164241367|NCT01280968|593254488|FG000|Overall Study|Scheduling Conflicts|1|||
164241368|NCT01280968|593254489|FG001|Overall Study|Scheduling Conflicts|1|||
164241369|NCT01280968|593254488|FG000|Overall Study|Pre-existing Neurological Condition|1|||
164241370|NCT01280968|593254489|FG001|Overall Study|Pre-existing Neurological Condition|0|||
164241371|NCT01280968|593254488|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
164241372|NCT01280968|593254489|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
164241373|NCT00806260|593254490|FG000|Period 1 (1 Day)|Adverse Event|0|||
164336226|NCT03755791|593607854|FG000|Overall Study|Sponsor decision,|41|||
164336227|NCT03755791|593607855|FG001|Overall Study|Sponsor decision,|5|||
164336228|NCT03755791|593607856|FG002|Overall Study|Sponsor decision,|7|||
164336229|NCT03755791|593607854|FG000|Overall Study|Lost to Follow-up|1|||
164336230|NCT03755791|593607855|FG001|Overall Study|Lost to Follow-up|0|||
164336231|NCT03755791|593607856|FG002|Overall Study|Lost to Follow-up|2|||
164336232|NCT03755791|593607854|FG000|Overall Study|Protocol Violation|0|||
164336233|NCT03755791|593607855|FG001|Overall Study|Protocol Violation|0|||
164336234|NCT03755791|593607856|FG002|Overall Study|Protocol Violation|2|||
164336235|NCT03755791|593607854|FG000|Overall Study|Other than specified|5|||
164336236|NCT03755791|593607855|FG001|Overall Study|Other than specified|2|||
164336237|NCT03755791|593607856|FG002|Overall Study|Other than specified|0|||
164336238|NCT03605212|593607862|FG000|Treatment Period|Adverse Event|1|||
164336239|NCT03605212|593607863|FG001|Treatment Period|Adverse Event|0|||
164336240|NCT03605212|593607864|FG002|Treatment Period|Adverse Event|0|||
164336241|NCT03605212|593607865|FG003|Treatment Period|Adverse Event|0|||
164336242|NCT03605212|593607866|FG004|Treatment Period|Adverse Event|0|||
164336243|NCT03605212|593607862|FG000|Treatment Period|Physician Decision|0|||
164241374|NCT00806260|593254491|FG001|Period 1 (1 Day)|Adverse Event|0|||
164241375|NCT00806260|593254492|FG002|Period 1 (1 Day)|Adverse Event|0|||
164241376|NCT00806260|593254493|FG003|Period 1 (1 Day)|Adverse Event|0|||
164241377|NCT00806260|593254494|FG004|Period 1 (1 Day)|Adverse Event|3|||
164241378|NCT00806260|593254495|FG005|Period 1 (1 Day)|Adverse Event|0|||
164336244|NCT03605212|593607863|FG001|Treatment Period|Physician Decision|0|||
164336245|NCT03605212|593607864|FG002|Treatment Period|Physician Decision|0|||
164241379|NCT00806260|593254490|FG000|Period 2|Adverse Event|0|||
164241380|NCT00806260|593254491|FG001|Period 2|Adverse Event|0|||
164241381|NCT00806260|593254492|FG002|Period 2|Adverse Event|0|||
164241382|NCT00806260|593254493|FG003|Period 2|Adverse Event|1|||
164336246|NCT03605212|593607865|FG003|Treatment Period|Physician Decision|0|||
164573549|NCT02901431|594463430|FG010|Main Treatment Part|Lost to Follow-up|0|||
164573550|NCT02901431|594463431|FG011|Main Treatment Part|Lost to Follow-up|0|||
164241383|NCT00806260|593254494|FG004|Period 2|Adverse Event|0|||
164241384|NCT00806260|593254495|FG005|Period 2|Adverse Event|0|||
164241385|NCT00806260|593254490|FG000|Period 2|Protocol Violation|1|||
164241386|NCT00806260|593254491|FG001|Period 2|Protocol Violation|0|||
164241387|NCT00806260|593254492|FG002|Period 2|Protocol Violation|1|||
164241388|NCT00806260|593254493|FG003|Period 2|Protocol Violation|0|||
164241389|NCT00806260|593254494|FG004|Period 2|Protocol Violation|0|||
164241390|NCT00806260|593254495|FG005|Period 2|Protocol Violation|0|||
164241391|NCT00806260|593254490|FG000|Period 2|Need to take concomitant medication|1|||
164677835|NCT02294786|594844867|FG000|Overall Study|Lost to Follow-up|1|||
164677836|NCT02294786|594844868|FG001|Overall Study|Lost to Follow-up|2|||
164677837|NCT02294786|594844867|FG000|Overall Study|Protocol Violation|1|||
164241392|NCT00806260|593254491|FG001|Period 2|Need to take concomitant medication|0|||
164241393|NCT00806260|593254492|FG002|Period 2|Need to take concomitant medication|0|||
164241394|NCT00806260|593254493|FG003|Period 2|Need to take concomitant medication|0|||
164241395|NCT00806260|593254494|FG004|Period 2|Need to take concomitant medication|0|||
164241396|NCT00806260|593254495|FG005|Period 2|Need to take concomitant medication|0|||
164241397|NCT00806260|593254490|FG000|Period 2|sponsor request|0|||
164336247|NCT03605212|593607866|FG004|Treatment Period|Physician Decision|1|||
164336248|NCT01254292|593607867|FG000|Comparative Phase|Adverse Event|25|||
164241398|NCT00806260|593254491|FG001|Period 2|sponsor request|0|||
164336249|NCT01254292|593607868|FG001|Comparative Phase|Adverse Event|25|||
164336250|NCT01254292|593607867|FG000|Comparative Phase|Lost to Follow-up|3|||
164336251|NCT01254292|593607868|FG001|Comparative Phase|Lost to Follow-up|21|||
164336252|NCT01254292|593607867|FG000|Comparative Phase|Pregnancy|2|||
164336253|NCT01254292|593607868|FG001|Comparative Phase|Pregnancy|6|||
164336254|NCT01254292|593607867|FG000|Comparative Phase|Withdrawal by Subject|20|||
164336255|NCT01254292|593607868|FG001|Comparative Phase|Withdrawal by Subject|21|||
164336256|NCT01254292|593607867|FG000|Comparative Phase|Protocol Violation|1|||
164336257|NCT01254292|593607868|FG001|Comparative Phase|Protocol Violation|2|||
164336258|NCT01254292|593607867|FG000|Comparative Phase|Wish for pregnancy|4|||
164336259|NCT01254292|593607868|FG001|Comparative Phase|Wish for pregnancy|6|||
164336260|NCT01254292|593607867|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
164336261|NCT01254292|593607868|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
164336262|NCT01254292|593607867|FG000|LCS12 Extension Phase|Adverse Event|9|||
164336263|NCT01254292|593607868|FG001|LCS12 Extension Phase|Adverse Event|0|||
164336264|NCT01254292|593607867|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
164336265|NCT01254292|593607868|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
164336266|NCT01254292|593607867|FG000|LCS12 Extension Phase|Other unknown|4|||
164336267|NCT01254292|593607868|FG001|LCS12 Extension Phase|Other unknown|0|||
164336268|NCT01254292|593607867|FG000|LCS12 Extension Phase|Pregnancy|2|||
164336269|NCT01254292|593607868|FG001|LCS12 Extension Phase|Pregnancy|0|||
164336270|NCT01254292|593607867|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
164336271|NCT01254292|593607868|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
164336272|NCT02083081|593607869|FG000|Overall Study|Lost to Follow-up|31|||
164336273|NCT02083081|593607870|FG001|Overall Study|Lost to Follow-up|9|||
164336274|NCT00285818|593607871|FG000|Overall Study|Withdrawal by Subject|3|||
164336275|NCT00285818|593607872|FG001|Overall Study|Withdrawal by Subject|2|||
164336276|NCT00285818|593607871|FG000|Overall Study|Lost to Follow-up|1|||
164336277|NCT00285818|593607872|FG001|Overall Study|Lost to Follow-up|0|||
164336278|NCT01268150|593607880|FG000|Treatment Phase|Progression of disease|18|||
164336279|NCT01268150|593607880|FG000|Treatment Phase|Adverse Event|3|||
164336280|NCT01268150|593607880|FG000|Treatment Phase|Withdrawal by Subject|3|||
164336281|NCT01268150|593607880|FG000|Treatment Phase|Other|4|||
164336282|NCT01268150|593607880|FG000|Extension Phase|Adverse Event|3|||
164336283|NCT01268150|593607880|FG000|Extension Phase|Disease progression|18|||
164336284|NCT01268150|593607880|FG000|Extension Phase|Other|6|||
164336285|NCT04209348|593607881|FG000|Overall Study|Lost to Follow-up|1|||
164336286|NCT04209348|593607882|FG001|Overall Study|Lost to Follow-up|0|||
164241399|NCT00806260|593254492|FG002|Period 2|sponsor request|1|||
164241400|NCT00806260|593254493|FG003|Period 2|sponsor request|1|||
164336287|NCT02507973|593607884|FG000|Overall Study|Adverse Event|1|||
164336288|NCT01033851|593607887|FG000|Overall Study|Withdrawal by Subject|3|||
164336289|NCT01033851|593607888|FG001|Overall Study|Withdrawal by Subject|7|||
164336290|NCT04068610|593607889|FG000|Overall Study|Death|4|||
164336291|NCT04068610|593607890|FG001|Overall Study|Death|8|||
164336292|NCT04068610|593607891|FG002|Overall Study|Death|13|||
164336293|NCT04068610|593607889|FG000|Overall Study|Lost to Follow-up|0|||
164336294|NCT04068610|593607890|FG001|Overall Study|Lost to Follow-up|2|||
164336295|NCT04068610|593607891|FG002|Overall Study|Lost to Follow-up|0|||
164336296|NCT04068610|593607889|FG000|Overall Study|Withdrawal by Subject|0|||
164336297|NCT04068610|593607890|FG001|Overall Study|Withdrawal by Subject|4|||
164336298|NCT04068610|593607891|FG002|Overall Study|Withdrawal by Subject|2|||
164677838|NCT02294786|594844868|FG001|Overall Study|Protocol Violation|0|||
164677839|NCT02294786|594844867|FG000|Overall Study|Adverse Event|1|||
164241401|NCT00806260|593254494|FG004|Period 2|sponsor request|0|||
164241402|NCT00806260|593254495|FG005|Period 2|sponsor request|0|||
164241403|NCT00806260|593254490|FG000|Period 3|Protocol Violation|0|||
164241404|NCT00806260|593254491|FG001|Period 3|Protocol Violation|1|||
164241405|NCT00806260|593254492|FG002|Period 3|Protocol Violation|1|||
164241406|NCT00806260|593254493|FG003|Period 3|Protocol Violation|0|||
164241407|NCT00806260|593254494|FG004|Period 3|Protocol Violation|0|||
164241408|NCT00806260|593254495|FG005|Period 3|Protocol Violation|0|||
164241409|NCT00806260|593254490|FG000|Period 3|Pregnancy|1|||
164241410|NCT00806260|593254491|FG001|Period 3|Pregnancy|0|||
164241411|NCT00806260|593254492|FG002|Period 3|Pregnancy|0|||
164241412|NCT00806260|593254493|FG003|Period 3|Pregnancy|0|||
164241413|NCT00806260|593254494|FG004|Period 3|Pregnancy|0|||
164241414|NCT00806260|593254495|FG005|Period 3|Pregnancy|0|||
164241415|NCT00953706|593254499|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
164241416|NCT00953706|593254500|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
164241417|NCT00953706|593254501|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
164241418|NCT00953706|593254502|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
164241419|NCT00953706|593254499|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
164241420|NCT00953706|593254500|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
164241421|NCT00953706|593254501|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
164241422|NCT00953706|593254502|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
164241423|NCT00953706|593254499|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
164241424|NCT00953706|593254500|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
164241425|NCT00953706|593254501|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
164241426|NCT00953706|593254502|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
164241427|NCT00953706|593254499|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
164241428|NCT00953706|593254500|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
164241429|NCT00953706|593254501|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
164241430|NCT00953706|593254502|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
164241431|NCT00953706|593254499|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
164241432|NCT00953706|593254500|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
164241433|NCT00953706|593254501|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
164241434|NCT00953706|593254502|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
164241435|NCT00953706|593254499|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
164241436|NCT00953706|593254500|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
164241437|NCT00953706|593254501|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
164241438|NCT00953706|593254502|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
164241439|NCT00953706|593254499|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
164241440|NCT00953706|593254500|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
164241441|NCT00953706|593254501|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
164241442|NCT00953706|593254502|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
164241443|NCT00953706|593254499|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
164241444|NCT00953706|593254500|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
164241445|NCT00953706|593254501|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
164241446|NCT00953706|593254502|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
164241447|NCT00953706|593254499|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
164241448|NCT00953706|593254500|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
164241449|NCT00953706|593254501|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
164241450|NCT00953706|593254502|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
164241451|NCT00953706|593254499|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
164241452|NCT00953706|593254500|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
164241453|NCT00953706|593254501|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
164241454|NCT00953706|593254502|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
164241455|NCT00953706|593254499|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
164241456|NCT00953706|593254500|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
164241457|NCT00953706|593254501|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
164241458|NCT00953706|593254502|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
164241459|NCT02670473|593254503|FG000|Overall Study|Withdrawal by Subject|1|||
164241460|NCT01404234|593254504|FG000|Overall Study|Withdrawal by Subject|2|||
164241461|NCT01214837|593254505|FG000|Overall Study|Death|0|||
164241462|NCT01214837|593254506|FG001|Overall Study|Death|0|||
164241463|NCT01214837|593254507|FG002|Overall Study|Death|1|||
164241464|NCT01214837|593254505|FG000|Overall Study|Adverse Event|1|||
164241465|NCT01214837|593254506|FG001|Overall Study|Adverse Event|2|||
164241466|NCT01214837|593254507|FG002|Overall Study|Adverse Event|1|||
164241467|NCT01214837|593254505|FG000|Overall Study|Withdrawal by Subject|27|||
164241468|NCT01214837|593254506|FG001|Overall Study|Withdrawal by Subject|36|||
164241469|NCT01214837|593254507|FG002|Overall Study|Withdrawal by Subject|28|||
164336299|NCT04068610|593607889|FG000|Overall Study|Other|3|||
164336300|NCT04068610|593607890|FG001|Overall Study|Other|12|||
164241470|NCT01214837|593254505|FG000|Overall Study|Lost to Follow-up|20|||
164241471|NCT01214837|593254506|FG001|Overall Study|Lost to Follow-up|15|||
164241472|NCT01214837|593254507|FG002|Overall Study|Lost to Follow-up|21|||
164241473|NCT01214837|593254505|FG000|Overall Study|Inappropriate Enrolment|0|||
164241474|NCT01214837|593254506|FG001|Overall Study|Inappropriate Enrolment|1|||
164241475|NCT01214837|593254507|FG002|Overall Study|Inappropriate Enrolment|2|||
164241476|NCT01214837|593254505|FG000|Overall Study|Administrative Reason|2|||
164241477|NCT01214837|593254506|FG001|Overall Study|Administrative Reason|6|||
164241478|NCT01214837|593254507|FG002|Overall Study|Administrative Reason|4|||
164241479|NCT01214837|593254505|FG000|Overall Study|Protocol Violation|3|||
164241480|NCT01214837|593254506|FG001|Overall Study|Protocol Violation|1|||
164241481|NCT01214837|593254507|FG002|Overall Study|Protocol Violation|5|||
164241482|NCT01214837|593254505|FG000|Overall Study|Unable to Classify|1|||
164241483|NCT01214837|593254506|FG001|Overall Study|Unable to Classify|3|||
164241484|NCT01214837|593254507|FG002|Overall Study|Unable to Classify|0|||
164241485|NCT05414175|593254508|FG000|Overall Study|Withdrawal by Subject|1|||
164241486|NCT05414175|593254508|FG000|Overall Study|Other Reasons|1|||
164241487|NCT00027560|593254511|FG000|Overall Study|Withdrawal by Subject|1|||
164241488|NCT03559270|593254515|FG000|Overall Study|Adverse Event|6|||
164241489|NCT03559270|593254516|FG001|Overall Study|Adverse Event|5|||
164241490|NCT03559270|593254517|FG002|Overall Study|Adverse Event|3|||
164241491|NCT03559270|593254518|FG003|Overall Study|Adverse Event|0|||
164241492|NCT03559270|593254515|FG000|Overall Study|Lack of Efficacy|34|||
164241493|NCT03559270|593254516|FG001|Overall Study|Lack of Efficacy|52|||
164241494|NCT03559270|593254517|FG002|Overall Study|Lack of Efficacy|37|||
164241495|NCT03559270|593254518|FG003|Overall Study|Lack of Efficacy|2|||
164241496|NCT03559270|593254515|FG000|Overall Study|Death|0|||
164241497|NCT03559270|593254516|FG001|Overall Study|Death|2|||
164241498|NCT03559270|593254517|FG002|Overall Study|Death|0|||
164241499|NCT03559270|593254518|FG003|Overall Study|Death|0|||
164241500|NCT03559270|593254515|FG000|Overall Study|Lost to Follow-up|16|||
164241501|NCT03559270|593254516|FG001|Overall Study|Lost to Follow-up|4|||
164241502|NCT03559270|593254517|FG002|Overall Study|Lost to Follow-up|12|||
164241503|NCT03559270|593254518|FG003|Overall Study|Lost to Follow-up|3|||
164241504|NCT03559270|593254515|FG000|Overall Study|Sponsor Decision|38|||
164241505|NCT03559270|593254516|FG001|Overall Study|Sponsor Decision|31|||
164241506|NCT03559270|593254517|FG002|Overall Study|Sponsor Decision|35|||
164241507|NCT03559270|593254518|FG003|Overall Study|Sponsor Decision|18|||
164241508|NCT03559270|593254515|FG000|Overall Study|Withdrawal by Subject|19|||
164241509|NCT03559270|593254516|FG001|Overall Study|Withdrawal by Subject|21|||
164241510|NCT03559270|593254517|FG002|Overall Study|Withdrawal by Subject|18|||
164241511|NCT03559270|593254518|FG003|Overall Study|Withdrawal by Subject|7|||
164241512|NCT03559270|593254515|FG000|Overall Study|Physician Decision|3|||
164241513|NCT03559270|593254516|FG001|Overall Study|Physician Decision|2|||
164241514|NCT03559270|593254517|FG002|Overall Study|Physician Decision|1|||
164241515|NCT03559270|593254518|FG003|Overall Study|Physician Decision|0|||
164241516|NCT03559270|593254515|FG000|Overall Study|Pregnancy|0|||
164241517|NCT03559270|593254516|FG001|Overall Study|Pregnancy|1|||
164241518|NCT03559270|593254517|FG002|Overall Study|Pregnancy|0|||
164241519|NCT03559270|593254518|FG003|Overall Study|Pregnancy|0|||
164241520|NCT03559270|593254515|FG000|Overall Study|Protocol Violation|1|||
164241521|NCT03559270|593254516|FG001|Overall Study|Protocol Violation|0|||
164241522|NCT03559270|593254517|FG002|Overall Study|Protocol Violation|2|||
164573551|NCT02901431|594463432|FG012|Main Treatment Part|Lost to Follow-up|0|||
164241523|NCT03559270|593254518|FG003|Overall Study|Protocol Violation|0|||
164241524|NCT04776161|593255951|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
164241525|NCT04776161|593255952|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
164241526|NCT04776161|593255953|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
164241527|NCT04776161|593255951|FG000|Overall Study|Withdrawal by Subject|1|||
164241528|NCT04776161|593255952|FG001|Overall Study|Withdrawal by Subject|0|||
164241529|NCT04776161|593255953|FG002|Overall Study|Withdrawal by Subject|1|||
164241530|NCT04776161|593255951|FG000|Overall Study|Adverse Event|0|||
164241531|NCT04776161|593255952|FG001|Overall Study|Adverse Event|1|||
164241532|NCT04776161|593255953|FG002|Overall Study|Adverse Event|1|||
164241533|NCT00342628|593255954|FG000|Overall Study|Withdrawal by Subject|19|||
164241534|NCT00342628|593255955|FG001|Overall Study|Withdrawal by Subject|19|||
164241535|NCT00342628|593255956|FG002|Overall Study|Withdrawal by Subject|18|||
164241536|NCT00342628|593255954|FG000|Overall Study|Death|1|||
164241537|NCT00342628|593255955|FG001|Overall Study|Death|1|||
164241538|NCT00342628|593255956|FG002|Overall Study|Death|0|||
164241539|NCT00342628|593255954|FG000|Overall Study|moved residence|0|||
164241540|NCT00342628|593255955|FG001|Overall Study|moved residence|1|||
164241541|NCT00342628|593255956|FG002|Overall Study|moved residence|1|||
164425408|NCT03023332|593928477|FG000|Overall Study|Withdrawal by Subject|10|||
164241542|NCT00456755|593255961|FG000|Overall Study|Lost to Follow-up|2|||
164241543|NCT00456755|593255962|FG001|Overall Study|Lost to Follow-up|1|||
164241544|NCT01475721|593255965|FG000|Overall Study|Death|3|||
164241545|NCT01475721|593255966|FG001|Overall Study|Death|6|||
164425409|NCT03023332|593928478|FG001|Overall Study|Withdrawal by Subject|5|||
164241546|NCT01475721|593255965|FG000|Overall Study|Withdrawal by Subject|8|||
164241547|NCT01475721|593255966|FG001|Overall Study|Withdrawal by Subject|8|||
164241548|NCT01048242|593255967|FG000|Overall Study|See study flow chart|4|||
164241549|NCT01048242|593255968|FG001|Overall Study|See study flow chart|2|||
164241550|NCT01772550|593255971|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
164241551|NCT01772550|593255972|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
164241552|NCT01772550|593255973|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
164241553|NCT01772550|593255971|FG000|Overall Study|Adverse Event|0|||
164241554|NCT01772550|593255972|FG001|Overall Study|Adverse Event|0|||
164241555|NCT01772550|593255973|FG002|Overall Study|Adverse Event|1|||
164241556|NCT00559104|593255974|FG000|Overall Study|Lack of Efficacy|9|||
164241557|NCT00559104|593255975|FG001|Overall Study|Lack of Efficacy|0|||
164241558|NCT04567524|593255976|FG000|Overall Study|Adverse Event|1|||
164241559|NCT04567524|593255977|FG001|Overall Study|Adverse Event|1|||
164241560|NCT04567524|593255978|FG002|Overall Study|Adverse Event|0|||
164241561|NCT04567524|593255979|FG003|Overall Study|Adverse Event|0|||
164241562|NCT04567524|593255976|FG000|Overall Study|Withdrawal by Subject|2|||
164241563|NCT04567524|593255977|FG001|Overall Study|Withdrawal by Subject|0|||
164241564|NCT04567524|593255978|FG002|Overall Study|Withdrawal by Subject|0|||
164241565|NCT04567524|593255979|FG003|Overall Study|Withdrawal by Subject|1|||
164241566|NCT01147393|593255980|FG000|Dose Level 1|Dose limiting Toxicity|2|||
164241567|NCT01147393|593255980|FG000|Dose Level -1|Dose Limited Toxicity|1|||
164241568|NCT03432494|593255989|FG000|Overall Study|Death|1|||
164241569|NCT03432494|593255989|FG000|Overall Study|Noncompliance|1|||
164241570|NCT00775268|593255990|FG000|Baseline|Drug not synthesize dose|1|||
164241571|NCT00775268|593255991|FG001|Baseline|Drug not synthesize dose|0|||
164241572|NCT00775268|593255990|FG000|Baseline|Not treated-ineligible per CT|0|||
164241573|NCT00775268|593255991|FG001|Baseline|Not treated-ineligible per CT|1|||
164241574|NCT00775268|593255990|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
164241575|NCT00775268|593255991|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
164241576|NCT00775268|593255990|FG000|After Completion|Participant missed scan appointment|1|||
164241577|NCT00775268|593255991|FG001|After Completion|Participant missed scan appointment|0|||
164241578|NCT00825994|593255992|FG000|Overall Study|Withdrawal by Subject|2|||
164241579|NCT00825994|593255992|FG000|Overall Study|Lost to Follow-up|1|||
164241580|NCT00825994|593255992|FG000|Overall Study|Protocol Violation|1|||
164241581|NCT00825994|593255992|FG000|Overall Study|Placebo Responder at V2|1|||
164241582|NCT01833494|593255995|FG000|Overall Study|Adverse Event|24|||
164241583|NCT01833494|593255995|FG000|Overall Study|Physician Decision|6|||
164241584|NCT01833494|593255995|FG000|Overall Study|Withdrawal by Subject|6|||
164241585|NCT01833494|593255995|FG000|Overall Study|Decrease in serum phosphorus|4|||
164241586|NCT01833494|593255995|FG000|Overall Study|Decrease in serum calcium|4|||
164241587|NCT01833494|593255995|FG000|Overall Study|Increase in serum ferritin|1|||
164241588|NCT03745768|593256000|FG000|Overall Study|discontinued study|2|||
164241589|NCT03745768|593256001|FG001|Overall Study|discontinued study|0|||
164241590|NCT00443118|593256002|FG000|Overall Study|unknown primary outcome|3|||
164241591|NCT00443118|593256003|FG001|Overall Study|unknown primary outcome|1|||
164241592|NCT00443118|593256004|FG002|Overall Study|unknown primary outcome|0|||
164241593|NCT00443118|593256002|FG000|Overall Study|Withdrawal by Subject|1|||
164241594|NCT00443118|593256003|FG001|Overall Study|Withdrawal by Subject|0|||
164241595|NCT00443118|593256004|FG002|Overall Study|Withdrawal by Subject|0|||
164241596|NCT00506779|593256009|FG000|Overall Study|Withdrawal by Subject|1|||
164241597|NCT00506779|593256010|FG001|Overall Study|Withdrawal by Subject|0|||
164241598|NCT00506779|593256011|FG002|Overall Study|Withdrawal by Subject|1|||
164336301|NCT04068610|593607891|FG002|Overall Study|Other|11|||
164336302|NCT00072176|593607892|FG000|Overall Study|Withdrawal by Subject|1|||
164336303|NCT00072176|593607893|FG001|Overall Study|Withdrawal by Subject|0|||
164336304|NCT00072176|593607892|FG000|Overall Study|Protocol Violation|0|||
164336305|NCT00072176|593607893|FG001|Overall Study|Protocol Violation|1|||
164336306|NCT02586064|593607894|FG000|Overall Study|Other Obligations|6|||
164336307|NCT02586064|593607895|FG001|Overall Study|Other Obligations|6|||
164336308|NCT02586064|593607894|FG000|Overall Study|Other|3|||
164336309|NCT02586064|593607895|FG001|Overall Study|Other|7|||
164241599|NCT00506779|593256012|FG003|Overall Study|Withdrawal by Subject|0|||
164241600|NCT00506779|593256009|FG000|Overall Study|Adverse Event|0|||
164241601|NCT00506779|593256010|FG001|Overall Study|Adverse Event|1|||
164241602|NCT00506779|593256011|FG002|Overall Study|Adverse Event|1|||
164241603|NCT00506779|593256012|FG003|Overall Study|Adverse Event|1|||
164241604|NCT04263766|593256013|FG000|Overall Study|Withdrawal by Subject|6|||
164241605|NCT04263766|593256014|FG001|Overall Study|Withdrawal by Subject|4|||
164336310|NCT02586064|593607894|FG000|Overall Study|Never Started|3|||
164336311|NCT02586064|593607895|FG001|Overall Study|Never Started|3|||
164241606|NCT04263766|593256013|FG000|Overall Study|Lack of Efficacy|1|||
164241607|NCT04263766|593256014|FG001|Overall Study|Lack of Efficacy|3|||
164241608|NCT04232943|593256015|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
164241609|NCT04232943|593256016|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
164241610|NCT04232943|593256017|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
164241611|NCT04232943|593256015|FG000|Overall Study|Withdrawal by Subject|1|||
164241612|NCT04232943|593256016|FG001|Overall Study|Withdrawal by Subject|1|||
164241613|NCT04232943|593256017|FG002|Overall Study|Withdrawal by Subject|0|||
164241614|NCT02639247|593256018|FG000|Overall Study|Lost to Follow-up|2|||
164241615|NCT02639247|593256019|FG001|Overall Study|Lost to Follow-up|1|||
164241616|NCT02639247|593256018|FG000|Overall Study|Death|2|||
164241617|NCT02639247|593256019|FG001|Overall Study|Death|0|||
164241618|NCT02639247|593256018|FG000|Overall Study|Withdrew Consent|0|||
164241619|NCT02639247|593256019|FG001|Overall Study|Withdrew Consent|1|||
164241620|NCT02639247|593256018|FG000|Overall Study|Protocol Violation|1|||
164241621|NCT02639247|593256019|FG001|Overall Study|Protocol Violation|0|||
164241622|NCT01891396|593256020|FG000|Overall Study|Withdrawal by Subject|4|||
164241623|NCT01891396|593256021|FG001|Overall Study|Withdrawal by Subject|4|||
164241624|NCT01891396|593256022|FG002|Overall Study|Withdrawal by Subject|3|||
164241625|NCT01891396|593256020|FG000|Overall Study|Lost to Follow-up|0|||
164241626|NCT01891396|593256021|FG001|Overall Study|Lost to Follow-up|1|||
164241627|NCT01891396|593256022|FG002|Overall Study|Lost to Follow-up|0|||
164241628|NCT00573391|593256023|FG000|Overall Study|study stopped|2|||
164241629|NCT00573391|593256024|FG001|Overall Study|study stopped|2|||
164241630|NCT00573391|593256023|FG000|Overall Study|Death|1|||
164241631|NCT00573391|593256024|FG001|Overall Study|Death|0|||
164241632|NCT04011735|593256027|FG000|Overall Study|Withdrawal by Subject|1|||
164241633|NCT04011735|593256028|FG001|Overall Study|Withdrawal by Subject|0|||
164241634|NCT04011735|593256029|FG002|Overall Study|Withdrawal by Subject|1|||
164241635|NCT04011735|593256027|FG000|Overall Study|Met exclusion criteria after study entry|0|||
164241636|NCT04011735|593256028|FG001|Overall Study|Met exclusion criteria after study entry|1|||
164241637|NCT04011735|593256029|FG002|Overall Study|Met exclusion criteria after study entry|0|||
164241638|NCT02831855|593256030|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
164241639|NCT02831855|593256031|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
164241640|NCT02831855|593256032|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
164241641|NCT02831855|593256030|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
164241642|NCT02831855|593256031|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
164241643|NCT02831855|593256032|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
164241644|NCT02831855|593256030|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
164241645|NCT02831855|593256031|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
164241646|NCT02831855|593256032|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
164241647|NCT02831855|593256030|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
164241648|NCT02831855|593256031|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
164241649|NCT02831855|593256032|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
164241650|NCT02831855|593256030|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
164241651|NCT02831855|593256031|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
164241652|NCT02831855|593256032|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
164241653|NCT02831855|593256030|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
164241654|NCT02831855|593256031|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
164241655|NCT02831855|593256032|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
164241656|NCT02831855|593256030|FG000|Open Label Phase (24 Weeks)|Other|4|||
164241657|NCT02831855|593256031|FG001|Open Label Phase (24 Weeks)|Other|0|||
164241658|NCT02831855|593256032|FG002|Open Label Phase (24 Weeks)|Other|0|||
164241659|NCT02831855|593256030|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
164241660|NCT02831855|593256031|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
164241661|NCT02831855|593256032|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
164336312|NCT02586064|593607894|FG000|Overall Study|Lost Interest|1|||
164336313|NCT02586064|593607895|FG001|Overall Study|Lost Interest|4|||
164336314|NCT02586064|593607894|FG000|Overall Study|Miscellaneous Life Issues|0|||
164336315|NCT02586064|593607895|FG001|Overall Study|Miscellaneous Life Issues|5|||
164336316|NCT02586064|593607894|FG000|Overall Study|Infrequent Attendance|2|||
164336317|NCT02586064|593607895|FG001|Overall Study|Infrequent Attendance|1|||
164336318|NCT02586064|593607894|FG000|Overall Study|Timed Out|2|||
164336319|NCT02586064|593607895|FG001|Overall Study|Timed Out|0|||
164336320|NCT02586064|593607894|FG000|Overall Study|AUD relapse|0|||
164336321|NCT02586064|593607895|FG001|Overall Study|AUD relapse|2|||
164336322|NCT02586064|593607894|FG000|Overall Study|Legal Issue|1|||
164336323|NCT02586064|593607895|FG001|Overall Study|Legal Issue|0|||
164336324|NCT02158975|593607896|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
164336325|NCT02728596|593607899|FG000|Overall Study|Refusal unrelated to adverse event|3|||
164677840|NCT02294786|594844868|FG001|Overall Study|Adverse Event|1|||
164241662|NCT02831855|593256030|FG000|Double Blind Phase (24 Weeks)|Death|0|||
164241663|NCT02831855|593256031|FG001|Double Blind Phase (24 Weeks)|Death|0|||
164336326|NCT02728596|593607900|FG001|Overall Study|Refusal unrelated to adverse event|6|||
164336327|NCT02728596|593607901|FG002|Overall Study|Refusal unrelated to adverse event|7|||
164336328|NCT02728596|593607902|FG003|Overall Study|Refusal unrelated to adverse event|7|||
164677841|NCT02294786|594844867|FG000|Overall Study|Death|2|||
164677842|NCT02294786|594844868|FG001|Overall Study|Death|3|||
164677843|NCT01663233|594844869|FG000|Overall Study|Withdrawal by Subject|3|||
164677844|NCT01663233|594844870|FG001|Overall Study|Withdrawal by Subject|2|||
164425410|NCT03023332|593928479|FG002|Overall Study|Withdrawal by Subject|4|||
164425411|NCT03023332|593928480|FG003|Overall Study|Withdrawal by Subject|7|||
164425412|NCT03023332|593928477|FG000|Overall Study|Lost to Follow-up|13|||
164573552|NCT02901431|594463420|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
164573553|NCT02901431|594463421|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
164573554|NCT02901431|594463422|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
164573555|NCT02901431|594463423|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
164573556|NCT02901431|594463424|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
164241664|NCT02831855|593256032|FG002|Double Blind Phase (24 Weeks)|Death|2|||
164241665|NCT02831855|593256030|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
164241666|NCT02831855|593256031|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
164241667|NCT02831855|593256032|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
164241668|NCT02831855|593256030|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
164241669|NCT02831855|593256031|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
164241670|NCT02831855|593256032|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
164241671|NCT02831855|593256030|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
164241672|NCT02831855|593256031|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
164241673|NCT02831855|593256032|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
164241674|NCT02831855|593256030|FG000|Double Blind Phase (24 Weeks)|Other|0|||
164241675|NCT02831855|593256031|FG001|Double Blind Phase (24 Weeks)|Other|2|||
164241676|NCT02831855|593256032|FG002|Double Blind Phase (24 Weeks)|Other|5|||
164241677|NCT02831855|593256030|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
164241678|NCT02831855|593256031|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
164241679|NCT02831855|593256032|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
164241680|NCT02831855|593256030|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
164241681|NCT02831855|593256031|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
164241682|NCT02831855|593256032|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
164241683|NCT02831855|593256030|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
164241684|NCT02831855|593256031|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
164241685|NCT02831855|593256032|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
164241686|NCT01118780|593256034|FG000|Overall Study|Adverse Event|15|||
164241687|NCT01118780|593256035|FG001|Overall Study|Adverse Event|15|||
164241688|NCT01118780|593256034|FG000|Overall Study|Death|1|||
164241689|NCT01118780|593256035|FG001|Overall Study|Death|0|||
164241690|NCT01118780|593256034|FG000|Overall Study|Lack of Efficacy|2|||
164241691|NCT01118780|593256035|FG001|Overall Study|Lack of Efficacy|6|||
164241692|NCT01118780|593256034|FG000|Overall Study|Physician Decision|2|||
164241693|NCT01118780|593256035|FG001|Overall Study|Physician Decision|0|||
164241694|NCT01118780|593256034|FG000|Overall Study|Protocol Violation|3|||
164241695|NCT01118780|593256035|FG001|Overall Study|Protocol Violation|6|||
164241696|NCT01118780|593256034|FG000|Overall Study|Withdrawal by Subject|13|||
164241697|NCT01118780|593256035|FG001|Overall Study|Withdrawal by Subject|8|||
164241698|NCT03962855|593256036|FG000|Overall Study|Death|0|||
164241699|NCT03962855|593256037|FG001|Overall Study|Death|1|||
164241700|NCT03962855|593256036|FG000|Overall Study|Lost to Follow-up|0|||
164241701|NCT03962855|593256037|FG001|Overall Study|Lost to Follow-up|1|||
164241702|NCT03962855|593256036|FG000|Overall Study|Adverse Event|0|||
164241703|NCT03962855|593256037|FG001|Overall Study|Adverse Event|1|||
164241704|NCT03962855|593256036|FG000|Overall Study|Physician Decision|0|||
164241705|NCT03962855|593256037|FG001|Overall Study|Physician Decision|2|||
164241706|NCT03326063|593256038|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
164241707|NCT03326063|593256039|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
164241708|NCT02750514|593256040|FG000|Track 1|Disease progression|20|||
164241709|NCT02750514|593256041|FG001|Track 1|Disease progression|1|||
164241710|NCT02750514|593256042|FG002|Track 1|Disease progression|0|||
164241711|NCT02750514|593256043|FG003|Track 1|Disease progression|1|||
164241712|NCT02750514|593256044|FG004|Track 1|Disease progression|0|||
164241713|NCT02750514|593256040|FG000|Track 1|Adverse event unrelated to study drug|1|||
164241714|NCT02750514|593256041|FG001|Track 1|Adverse event unrelated to study drug|0|||
164241715|NCT02750514|593256042|FG002|Track 1|Adverse event unrelated to study drug|0|||
164241716|NCT02750514|593256043|FG003|Track 1|Adverse event unrelated to study drug|0|||
164241717|NCT02750514|593256044|FG004|Track 1|Adverse event unrelated to study drug|0|||
164241718|NCT02750514|593256040|FG000|Track 1|Study drug toxicity|4|||
164241719|NCT02750514|593256041|FG001|Track 1|Study drug toxicity|1|||
164336329|NCT02728596|593607899|FG000|Overall Study|Death|44|||
164336330|NCT02728596|593607900|FG001|Overall Study|Death|42|||
164336331|NCT02728596|593607901|FG002|Overall Study|Death|123|||
164336332|NCT02728596|593607902|FG003|Overall Study|Death|68|||
164336333|NCT04590963|593607903|FG000|Overall Study|Death|118|||
164336334|NCT04590963|593607904|FG001|Overall Study|Death|59|||
164336335|NCT04590963|593607903|FG000|Overall Study|Lost to Follow-up|1|||
164336336|NCT04590963|593607904|FG001|Overall Study|Lost to Follow-up|1|||
164336337|NCT04590963|593607903|FG000|Overall Study|Progressive disease|0|||
164336338|NCT04590963|593607904|FG001|Overall Study|Progressive disease|1|||
164425413|NCT03023332|593928478|FG001|Overall Study|Lost to Follow-up|16|||
164573557|NCT02901431|594463425|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
164573558|NCT02901431|594463426|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
164573559|NCT02901431|594463427|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
164573560|NCT02901431|594463428|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
164573561|NCT02901431|594463429|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
164573562|NCT02901431|594463430|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
164241720|NCT02750514|593256042|FG002|Track 1|Study drug toxicity|0|||
164241721|NCT02750514|593256043|FG003|Track 1|Study drug toxicity|1|||
164241722|NCT02750514|593256044|FG004|Track 1|Study drug toxicity|0|||
164241723|NCT02750514|593256040|FG000|Track 1|Participant request to discontinue|1|||
164241724|NCT02750514|593256041|FG001|Track 1|Participant request to discontinue|0|||
164241725|NCT02750514|593256042|FG002|Track 1|Participant request to discontinue|0|||
164241726|NCT02750514|593256043|FG003|Track 1|Participant request to discontinue|0|||
164241727|NCT02750514|593256044|FG004|Track 1|Participant request to discontinue|0|||
164241728|NCT02750514|593256040|FG000|Track 1|Other reasons|1|||
164241729|NCT02750514|593256041|FG001|Track 1|Other reasons|0|||
164241730|NCT02750514|593256042|FG002|Track 1|Other reasons|0|||
164241731|NCT02750514|593256043|FG003|Track 1|Other reasons|0|||
164241732|NCT02750514|593256044|FG004|Track 1|Other reasons|0|||
164241733|NCT02750514|593256040|FG000|Track 2|Disease progression|4|||
164241734|NCT02750514|593256041|FG001|Track 2|Disease progression|5|||
164241735|NCT02750514|593256042|FG002|Track 2|Disease progression|2|||
164241736|NCT02750514|593256043|FG003|Track 2|Disease progression|5|||
164241737|NCT02750514|593256044|FG004|Track 2|Disease progression|0|||
164241738|NCT02750514|593256040|FG000|Track 2|Adverse event unrelated to study drug|1|||
164241739|NCT02750514|593256041|FG001|Track 2|Adverse event unrelated to study drug|0|||
164241740|NCT02750514|593256042|FG002|Track 2|Adverse event unrelated to study drug|0|||
164241741|NCT02750514|593256043|FG003|Track 2|Adverse event unrelated to study drug|0|||
164241742|NCT02750514|593256044|FG004|Track 2|Adverse event unrelated to study drug|0|||
164241743|NCT02750514|593256040|FG000|Track 2|Study drug toxicity|1|||
164241744|NCT02750514|593256041|FG001|Track 2|Study drug toxicity|2|||
164241745|NCT02750514|593256042|FG002|Track 2|Study drug toxicity|0|||
164241746|NCT02750514|593256043|FG003|Track 2|Study drug toxicity|2|||
164241747|NCT02750514|593256044|FG004|Track 2|Study drug toxicity|0|||
164241748|NCT02750514|593256040|FG000|Track 2|Participant withdrew consent|0|||
164241749|NCT02750514|593256041|FG001|Track 2|Participant withdrew consent|1|||
164241750|NCT02750514|593256042|FG002|Track 2|Participant withdrew consent|0|||
164241751|NCT02750514|593256043|FG003|Track 2|Participant withdrew consent|0|||
164241752|NCT02750514|593256044|FG004|Track 2|Participant withdrew consent|0|||
164241753|NCT02750514|593256040|FG000|Track 3|Disease progression|0|||
164241754|NCT02750514|593256041|FG001|Track 3|Disease progression|24|||
164241755|NCT02750514|593256042|FG002|Track 3|Disease progression|13|||
164241756|NCT02750514|593256043|FG003|Track 3|Disease progression|14|||
164241757|NCT02750514|593256044|FG004|Track 3|Disease progression|0|||
164241758|NCT02750514|593256040|FG000|Track 3|Adverse event unrelated to study drug|0|||
164241759|NCT02750514|593256041|FG001|Track 3|Adverse event unrelated to study drug|1|||
164241760|NCT02750514|593256042|FG002|Track 3|Adverse event unrelated to study drug|1|||
164241761|NCT02750514|593256043|FG003|Track 3|Adverse event unrelated to study drug|1|||
164241762|NCT02750514|593256044|FG004|Track 3|Adverse event unrelated to study drug|0|||
164241763|NCT02750514|593256040|FG000|Track 3|Study drug toxicity|0|||
164241764|NCT02750514|593256041|FG001|Track 3|Study drug toxicity|3|||
164241765|NCT02750514|593256042|FG002|Track 3|Study drug toxicity|0|||
164241766|NCT02750514|593256043|FG003|Track 3|Study drug toxicity|1|||
164241767|NCT02750514|593256044|FG004|Track 3|Study drug toxicity|0|||
164241768|NCT02750514|593256040|FG000|Track 3|Participant request to discontinue|0|||
164573563|NCT02901431|594463431|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
164573564|NCT02901431|594463432|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
164573565|NCT02901431|594463420|FG000|Main Treatment Part|Physician Decision|0|||
164573566|NCT02901431|594463421|FG001|Main Treatment Part|Physician Decision|0|||
164573567|NCT02901431|594463422|FG002|Main Treatment Part|Physician Decision|0|||
164241769|NCT02750514|593256041|FG001|Track 3|Participant request to discontinue|2|||
164241770|NCT02750514|593256042|FG002|Track 3|Participant request to discontinue|0|||
164241771|NCT02750514|593256043|FG003|Track 3|Participant request to discontinue|0|||
164573568|NCT02901431|594463423|FG003|Main Treatment Part|Physician Decision|1|||
164573569|NCT02901431|594463424|FG004|Main Treatment Part|Physician Decision|0|||
164241772|NCT02750514|593256044|FG004|Track 3|Participant request to discontinue|0|||
164241773|NCT02750514|593256040|FG000|Track 3|Participant withdrew consent|0|||
164241774|NCT02750514|593256041|FG001|Track 3|Participant withdrew consent|3|||
164573570|NCT02901431|594463425|FG005|Main Treatment Part|Physician Decision|0|||
164573571|NCT02901431|594463426|FG006|Main Treatment Part|Physician Decision|1|||
164573572|NCT02901431|594463427|FG007|Main Treatment Part|Physician Decision|0|||
164573573|NCT02901431|594463428|FG008|Main Treatment Part|Physician Decision|0|||
164573574|NCT02901431|594463429|FG009|Main Treatment Part|Physician Decision|0|||
164573575|NCT02901431|594463430|FG010|Main Treatment Part|Physician Decision|0|||
164241775|NCT02750514|593256042|FG002|Track 3|Participant withdrew consent|1|||
164573576|NCT02901431|594463431|FG011|Main Treatment Part|Physician Decision|0|||
164241776|NCT02750514|593256043|FG003|Track 3|Participant withdrew consent|0|||
164241777|NCT02750514|593256044|FG004|Track 3|Participant withdrew consent|0|||
164241778|NCT02750514|593256040|FG000|Track 3|Other reasons|0|||
164241779|NCT02750514|593256041|FG001|Track 3|Other reasons|3|||
164677845|NCT01663233|594844869|FG000|Overall Study|Protocol Deviation|1|||
164241780|NCT02750514|593256042|FG002|Track 3|Other reasons|0|||
164241781|NCT02750514|593256043|FG003|Track 3|Other reasons|0|||
164241782|NCT02750514|593256044|FG004|Track 3|Other reasons|0|||
164241783|NCT02750514|593256040|FG000|Track 4|Study drug toxicity|0|||
164241784|NCT02750514|593256041|FG001|Track 4|Study drug toxicity|6|||
164241785|NCT02750514|593256042|FG002|Track 4|Study drug toxicity|0|||
164241786|NCT02750514|593256043|FG003|Track 4|Study drug toxicity|5|||
164241787|NCT02750514|593256044|FG004|Track 4|Study drug toxicity|0|||
164241788|NCT02750514|593256040|FG000|Track 4|Participant request to discontinue|0|||
164241789|NCT02750514|593256041|FG001|Track 4|Participant request to discontinue|1|||
164241790|NCT02750514|593256042|FG002|Track 4|Participant request to discontinue|0|||
164241791|NCT02750514|593256043|FG003|Track 4|Participant request to discontinue|1|||
164241792|NCT02750514|593256044|FG004|Track 4|Participant request to discontinue|0|||
164241793|NCT02750514|593256040|FG000|Track 4|Participant withdrew consent|0|||
164241794|NCT02750514|593256041|FG001|Track 4|Participant withdrew consent|1|||
164241795|NCT02750514|593256042|FG002|Track 4|Participant withdrew consent|0|||
164241796|NCT02750514|593256043|FG003|Track 4|Participant withdrew consent|0|||
164241797|NCT02750514|593256044|FG004|Track 4|Participant withdrew consent|0|||
164241798|NCT02750514|593256040|FG000|Track 4|Other reasons|0|||
164241799|NCT02750514|593256041|FG001|Track 4|Other reasons|5|||
164241800|NCT02750514|593256042|FG002|Track 4|Other reasons|0|||
164241801|NCT02750514|593256043|FG003|Track 4|Other reasons|3|||
164241802|NCT02750514|593256044|FG004|Track 4|Other reasons|0|||
164241803|NCT02750514|593256040|FG000|Track 4|Disease progression|0|||
164241804|NCT02750514|593256041|FG001|Track 4|Disease progression|33|||
164241805|NCT02750514|593256042|FG002|Track 4|Disease progression|0|||
164241806|NCT02750514|593256043|FG003|Track 4|Disease progression|32|||
164241807|NCT02750514|593256044|FG004|Track 4|Disease progression|0|||
164241808|NCT02750514|593256040|FG000|Track 4|Adverse event unrelated to study drug|0|||
164241809|NCT02750514|593256041|FG001|Track 4|Adverse event unrelated to study drug|5|||
164241810|NCT02750514|593256042|FG002|Track 4|Adverse event unrelated to study drug|0|||
164241811|NCT02750514|593256043|FG003|Track 4|Adverse event unrelated to study drug|0|||
164241812|NCT02750514|593256044|FG004|Track 4|Adverse event unrelated to study drug|0|||
164241813|NCT02750514|593256040|FG000|Track 4|Death|0|||
164241814|NCT02750514|593256041|FG001|Track 4|Death|0|||
164241815|NCT02750514|593256042|FG002|Track 4|Death|0|||
164241816|NCT02750514|593256043|FG003|Track 4|Death|1|||
164241817|NCT02750514|593256044|FG004|Track 4|Death|0|||
164241818|NCT02750514|593256040|FG000|Track 5|Disease progression|0|||
164241819|NCT02750514|593256041|FG001|Track 5|Disease progression|0|||
164241820|NCT02750514|593256042|FG002|Track 5|Disease progression|0|||
164241821|NCT02750514|593256043|FG003|Track 5|Disease progression|0|||
164241822|NCT02750514|593256044|FG004|Track 5|Disease progression|34|||
164241823|NCT02750514|593256040|FG000|Track 5|Adverse event unrelated to study drug|0|||
164241824|NCT02750514|593256041|FG001|Track 5|Adverse event unrelated to study drug|0|||
164241825|NCT02750514|593256042|FG002|Track 5|Adverse event unrelated to study drug|0|||
164241826|NCT02750514|593256043|FG003|Track 5|Adverse event unrelated to study drug|0|||
164241827|NCT02750514|593256044|FG004|Track 5|Adverse event unrelated to study drug|2|||
164241828|NCT02750514|593256040|FG000|Track 5|Study drug toxicity|0|||
164241829|NCT02750514|593256041|FG001|Track 5|Study drug toxicity|0|||
164241830|NCT02750514|593256042|FG002|Track 5|Study drug toxicity|0|||
164241831|NCT02750514|593256043|FG003|Track 5|Study drug toxicity|0|||
164241832|NCT02750514|593256044|FG004|Track 5|Study drug toxicity|2|||
164241833|NCT02750514|593256040|FG000|Track 5|Participant request to discontinue|0|||
164241834|NCT02750514|593256041|FG001|Track 5|Participant request to discontinue|0|||
164241835|NCT02750514|593256042|FG002|Track 5|Participant request to discontinue|0|||
164241836|NCT02750514|593256043|FG003|Track 5|Participant request to discontinue|0|||
164241837|NCT02750514|593256044|FG004|Track 5|Participant request to discontinue|3|||
164241838|NCT02750514|593256040|FG000|Track 5|Other reasons|0|||
164241839|NCT02750514|593256041|FG001|Track 5|Other reasons|0|||
164241840|NCT02750514|593256042|FG002|Track 5|Other reasons|0|||
164241841|NCT02750514|593256043|FG003|Track 5|Other reasons|0|||
164241842|NCT02750514|593256044|FG004|Track 5|Other reasons|2|||
164241843|NCT02756403|593256046|FG000|Overall Study|Unable to swallow medication|0|||
164241844|NCT02756403|593256047|FG001|Overall Study|Unable to swallow medication|1|||
164241845|NCT02756403|593256048|FG002|Overall Study|Unable to swallow medication|1|||
164241846|NCT02756403|593256049|FG003|Overall Study|Unable to swallow medication|1|||
164241847|NCT02756403|593256046|FG000|Overall Study|Did not complete Procedure|0|||
164241848|NCT02756403|593256047|FG001|Overall Study|Did not complete Procedure|1|||
164241849|NCT02756403|593256048|FG002|Overall Study|Did not complete Procedure|0|||
164336339|NCT04590963|593607903|FG000|Overall Study|Study terminated by sponsor|103|||
164241850|NCT02756403|593256049|FG003|Overall Study|Did not complete Procedure|0|||
164241851|NCT02756403|593256046|FG000|Overall Study|Changed Mind About Procedure|0|||
164241852|NCT02756403|593256047|FG001|Overall Study|Changed Mind About Procedure|0|||
164241853|NCT02756403|593256048|FG002|Overall Study|Changed Mind About Procedure|1|||
164241854|NCT02756403|593256049|FG003|Overall Study|Changed Mind About Procedure|0|||
164241855|NCT02756403|593256046|FG000|Overall Study|Protocol Violation|0|||
164241856|NCT02756403|593256047|FG001|Overall Study|Protocol Violation|1|||
164241857|NCT02756403|593256048|FG002|Overall Study|Protocol Violation|0|||
164241858|NCT02756403|593256049|FG003|Overall Study|Protocol Violation|1|||
164241859|NCT00527618|593256050|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
164241860|NCT00527618|593256051|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
164241861|NCT00527618|593256050|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
164241862|NCT00527618|593256051|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
164241863|NCT00527618|593256050|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
164241864|NCT00527618|593256051|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
164241865|NCT00527618|593256050|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
164241866|NCT00527618|593256051|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
164241867|NCT00527618|593256050|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
164241868|NCT00527618|593256051|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
164241869|NCT00527618|593256050|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
164241870|NCT00527618|593256051|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
164336340|NCT04590963|593607904|FG001|Overall Study|Study terminated by sponsor|50|||
164336341|NCT04590963|593607903|FG000|Overall Study|Withdrawal by Subject|15|||
164336342|NCT04590963|593607904|FG001|Overall Study|Withdrawal by Subject|8|||
164336343|NCT04590963|593607903|FG000|Overall Study|Ongoing at data cut-off|9|||
164336344|NCT04590963|593607904|FG001|Overall Study|Ongoing at data cut-off|4|||
164336345|NCT04590963|593607903|FG000|Overall Study|Screen failure|1|||
164336346|NCT04590963|593607904|FG001|Overall Study|Screen failure|0|||
164336347|NCT04430738|593607905|FG000|Phase 1: Dose Escalation|Death|1|||
164336348|NCT04430738|593607906|FG001|Phase 1: Dose Escalation|Death|4|||
164336349|NCT04430738|593607907|FG002|Phase 1: Dose Escalation|Death|4|||
164336350|NCT04430738|593607908|FG003|Phase 1: Dose Escalation|Death|1|||
164336351|NCT04430738|593607909|FG004|Phase 1: Dose Escalation|Death|6|||
164336352|NCT04430738|593607910|FG005|Phase 1: Dose Escalation|Death|0|||
164336353|NCT04430738|593607905|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
164336354|NCT04430738|593607906|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
164336355|NCT04430738|593607907|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
164336356|NCT04430738|593607908|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
164336357|NCT04430738|593607909|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
164336358|NCT04430738|593607910|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
164336359|NCT04430738|593607905|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
164336360|NCT04430738|593607906|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
164336361|NCT04430738|593607907|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
164336362|NCT04430738|593607908|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
164336363|NCT04430738|593607909|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
164336364|NCT04430738|593607910|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
164336365|NCT04430738|593607905|FG000|Phase 1: Dose Escalation|Other|1|||
164336366|NCT04430738|593607906|FG001|Phase 1: Dose Escalation|Other|0|||
164336367|NCT04430738|593607907|FG002|Phase 1: Dose Escalation|Other|0|||
164336368|NCT04430738|593607908|FG003|Phase 1: Dose Escalation|Other|0|||
164336369|NCT04430738|593607909|FG004|Phase 1: Dose Escalation|Other|0|||
164336370|NCT04430738|593607910|FG005|Phase 1: Dose Escalation|Other|0|||
164336371|NCT04430738|593607905|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
164336372|NCT04430738|593607906|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
164336373|NCT04430738|593607907|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
164336374|NCT04430738|593607908|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
164336375|NCT04430738|593607909|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
164336376|NCT04430738|593607910|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
164336377|NCT04430738|593607905|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
164336378|NCT04430738|593607906|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
164336379|NCT04430738|593607907|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
164336380|NCT04430738|593607908|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
164336381|NCT04430738|593607909|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
164336382|NCT04430738|593607910|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
164336383|NCT04176705|593607912|FG000|Overall Study|Withdrawal by Subject|4|||
164336384|NCT04176705|593607913|FG001|Overall Study|Withdrawal by Subject|4|||
164336385|NCT04176705|593607912|FG000|Overall Study|Death|1|||
164336386|NCT04176705|593607913|FG001|Overall Study|Death|1|||
164336387|NCT04176705|593607912|FG000|Overall Study|Lost to Follow-up|3|||
164241871|NCT02240121|593256056|FG000|Overall Study|Protocol Violation|1|||
164336388|NCT04176705|593607913|FG001|Overall Study|Lost to Follow-up|3|||
164677846|NCT01663233|594844870|FG001|Overall Study|Protocol Deviation|4|||
164336389|NCT02628769|593607914|FG000|First Intervention|Adverse Event|1|||
164241872|NCT02240121|593256057|FG001|Overall Study|Protocol Violation|2|||
164241873|NCT02240121|593256056|FG000|Overall Study|Physician Decision|0|||
164241874|NCT02240121|593256057|FG001|Overall Study|Physician Decision|1|||
164241875|NCT02240121|593256056|FG000|Overall Study|Change in protocol interpretation|1|||
164241876|NCT02240121|593256057|FG001|Overall Study|Change in protocol interpretation|0|||
164241877|NCT02240121|593256056|FG000|Overall Study|Lack of Efficacy|2|||
164241878|NCT02240121|593256057|FG001|Overall Study|Lack of Efficacy|3|||
164241879|NCT02240121|593256056|FG000|Overall Study|Site closed|1|||
164241880|NCT02240121|593256057|FG001|Overall Study|Site closed|1|||
164241881|NCT02240121|593256056|FG000|Overall Study|Pregnancy|1|||
164241882|NCT02240121|593256057|FG001|Overall Study|Pregnancy|0|||
164241883|NCT02240121|593256056|FG000|Overall Study|Adverse Event|2|||
164241884|NCT02240121|593256057|FG001|Overall Study|Adverse Event|4|||
164241885|NCT02240121|593256056|FG000|Overall Study|Withdrawal by Subject|6|||
164241886|NCT02240121|593256057|FG001|Overall Study|Withdrawal by Subject|2|||
164241887|NCT02240121|593256056|FG000|Overall Study|Lost to Follow-up|3|||
164241888|NCT02240121|593256057|FG001|Overall Study|Lost to Follow-up|4|||
164241889|NCT02240121|593256056|FG000|Overall Study|Other than specified|1|||
164241890|NCT02240121|593256057|FG001|Overall Study|Other than specified|3|||
164425414|NCT03023332|593928479|FG002|Overall Study|Lost to Follow-up|8|||
164425415|NCT03023332|593928480|FG003|Overall Study|Lost to Follow-up|13|||
164425416|NCT03023332|593928477|FG000|Overall Study|Death|1|||
164241891|NCT02967679|593256058|FG000|Overall Study|Adverse Event|1|||
164241892|NCT04571060|593256063|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
164336390|NCT02628769|593607915|FG001|First Intervention|Adverse Event|0|||
164336391|NCT02628769|593607914|FG000|First Intervention|Withdrawal by Subject|0|||
164336392|NCT02628769|593607915|FG001|First Intervention|Withdrawal by Subject|1|||
164336393|NCT02628769|593607914|FG000|Second Intervention|Adverse Event|2|||
164336394|NCT02628769|593607915|FG001|Second Intervention|Adverse Event|0|||
164336395|NCT02628769|593607914|FG000|Second Intervention|Physician Decision|0|||
164336396|NCT02628769|593607915|FG001|Second Intervention|Physician Decision|1|||
164336397|NCT04102189|593607917|FG000|Overall Study|Withdrawal by Subject|1|||
164336398|NCT04102189|593607918|FG001|Overall Study|Withdrawal by Subject|2|||
164336399|NCT04102189|593607917|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164336400|NCT04102189|593607918|FG001|Overall Study|Withdrawal by parent/guardian|1|||
164336401|NCT04102189|593607917|FG000|Overall Study|Lost to Follow-up|1|||
164336402|NCT04102189|593607918|FG001|Overall Study|Lost to Follow-up|0|||
164336403|NCT01543698|593609720|FG000|Phase 1b|Disease progression|2|||
164336404|NCT01543698|593609721|FG001|Phase 1b|Disease progression|4|||
164336405|NCT01543698|593609722|FG002|Phase 1b|Disease progression|3|||
164336406|NCT01543698|593609723|FG003|Phase 1b|Disease progression|2|||
164336407|NCT01543698|593609724|FG004|Phase 1b|Disease progression|10|||
164336408|NCT01543698|593609725|FG005|Phase 1b|Disease progression|6|||
164336409|NCT01543698|593609726|FG006|Phase 1b|Disease progression|5|||
164336410|NCT01543698|593609727|FG007|Phase 1b|Disease progression|3|||
164336411|NCT01543698|593609728|FG008|Phase 1b|Disease progression|4|||
164336412|NCT01543698|593609729|FG009|Phase 1b|Disease progression|5|||
164336413|NCT01543698|593609730|FG010|Phase 1b|Disease progression|1|||
164336414|NCT01543698|593609731|FG011|Phase 1b|Disease progression|0|||
164336415|NCT01543698|593609732|FG012|Phase 1b|Disease progression|0|||
164336416|NCT01543698|593609733|FG013|Phase 1b|Disease progression|0|||
164336417|NCT01543698|593609734|FG014|Phase 1b|Disease progression|0|||
164336418|NCT01543698|593609720|FG000|Phase 1b|Death|0|||
164336419|NCT01543698|593609721|FG001|Phase 1b|Death|0|||
164336420|NCT01543698|593609722|FG002|Phase 1b|Death|1|||
164336421|NCT01543698|593609723|FG003|Phase 1b|Death|1|||
164336422|NCT01543698|593609724|FG004|Phase 1b|Death|0|||
164336423|NCT01543698|593609725|FG005|Phase 1b|Death|0|||
164336424|NCT01543698|593609726|FG006|Phase 1b|Death|0|||
164336425|NCT01543698|593609727|FG007|Phase 1b|Death|0|||
164336426|NCT01543698|593609728|FG008|Phase 1b|Death|0|||
164336427|NCT01543698|593609729|FG009|Phase 1b|Death|0|||
164241893|NCT04571060|593256064|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
164241894|NCT04571060|593256063|FG000|Overall Study|Never treated migraine|47|||
164241895|NCT04571060|593256064|FG001|Overall Study|Never treated migraine|36|||
164336428|NCT01543698|593609730|FG010|Phase 1b|Death|1|||
164336429|NCT01543698|593609731|FG011|Phase 1b|Death|0|||
164336430|NCT01543698|593609732|FG012|Phase 1b|Death|0|||
164336431|NCT01543698|593609733|FG013|Phase 1b|Death|0|||
164241896|NCT04571060|593256063|FG000|Overall Study|Protocol Violation|4|||
164425417|NCT03023332|593928478|FG001|Overall Study|Death|0|||
164336432|NCT01543698|593609734|FG014|Phase 1b|Death|0|||
164336433|NCT01543698|593609720|FG000|Phase 1b|Withdrawal by Subject|0|||
164336434|NCT01543698|593609721|FG001|Phase 1b|Withdrawal by Subject|1|||
164241897|NCT04571060|593256064|FG001|Overall Study|Protocol Violation|2|||
164241898|NCT04571060|593256063|FG000|Overall Study|Withdrawal by Subject|6|||
164336435|NCT01543698|593609722|FG002|Phase 1b|Withdrawal by Subject|0|||
164336436|NCT01543698|593609723|FG003|Phase 1b|Withdrawal by Subject|1|||
164336437|NCT01543698|593609724|FG004|Phase 1b|Withdrawal by Subject|0|||
164336438|NCT01543698|593609725|FG005|Phase 1b|Withdrawal by Subject|0|||
164336439|NCT01543698|593609726|FG006|Phase 1b|Withdrawal by Subject|1|||
164425418|NCT03023332|593928479|FG002|Overall Study|Death|0|||
164241899|NCT04571060|593256064|FG001|Overall Study|Withdrawal by Subject|2|||
164241900|NCT04571060|593256063|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
164241901|NCT04571060|593256064|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
164241902|NCT01253369|593256065|FG000|Overall Study|Adverse Event|4|||
164241903|NCT01253369|593256065|FG000|Overall Study|Withdrawal by Subject|2|||
164241904|NCT01253369|593256065|FG000|Overall Study|Death|1|||
164241905|NCT01253369|593256065|FG000|Overall Study|Progressive disease|23|||
164241906|NCT01253369|593256065|FG000|Overall Study|Not Evaluable|3|||
164241907|NCT01220401|593256070|FG000|Overall Study|Withdrawal by Subject|2|||
164241908|NCT01220401|593256070|FG000|Overall Study|Protocol Violation|1|||
164241909|NCT01853462|593256071|FG000|Overall Study|Withdrawal by Subject|1|||
164241910|NCT01853462|593256072|FG001|Overall Study|Withdrawal by Subject|1|||
164241911|NCT02030821|593256074|FG000|Overall Study|Physician Decision|2|||
164241912|NCT02030821|593256075|FG001|Overall Study|Physician Decision|2|||
164241913|NCT02030821|593256076|FG002|Overall Study|Physician Decision|5|||
164241914|NCT02030821|593256077|FG003|Overall Study|Physician Decision|2|||
164241915|NCT03132467|593256078|FG000|Overall Study|Adverse Event|2|||
164241916|NCT03132467|593256078|FG000|Overall Study|Withdrawal by Subject|2|||
164241917|NCT01088906|593256079|FG000|Overall Study|Inclusion error|1|||
164241918|NCT01088906|593256079|FG000|Overall Study|Did not receive study treatment|3|||
164241919|NCT01088906|593256079|FG000|Overall Study|Missing data|1|||
164241920|NCT00457626|593256082|FG000|Overall Study|Adverse Event|3|||
164241921|NCT00457626|593256082|FG000|Overall Study|Administrative Problems|2|||
164241922|NCT00457626|593256082|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
164241923|NCT03965403|593256083|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
164241924|NCT02364037|593257129|FG000|Overall Study|Withdrawal by Subject|7|||
164241925|NCT02364037|593257130|FG001|Overall Study|Withdrawal by Subject|4|||
164241926|NCT02364037|593257129|FG000|Overall Study|Lost to Follow-up|37|||
164241927|NCT02364037|593257130|FG001|Overall Study|Lost to Follow-up|49|||
164241928|NCT01453036|593257131|FG000|Overall Study|Lost to Follow-up|26|||
164241929|NCT01453036|593257132|FG001|Overall Study|Lost to Follow-up|115|||
164241930|NCT01453036|593257133|FG002|Overall Study|Lost to Follow-up|31|||
164241931|NCT04072835|593257134|FG000|Overall Study|Overall trial ended|603|||
164241932|NCT04072835|593257134|FG000|Overall Study|Ablation|97|||
164241933|NCT04072835|593257134|FG000|Overall Study|Withdrawal of consent|66|||
164241934|NCT04072835|593257134|FG000|Overall Study|Physician Decision|50|||
164241935|NCT04072835|593257134|FG000|Overall Study|Lost to Follow-up|39|||
164241936|NCT04072835|593257134|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
164241937|NCT04072835|593257134|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
164241938|NCT04072835|593257134|FG000|Overall Study|Adverse Event|25|||
164241939|NCT04072835|593257134|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
164241940|NCT04072835|593257134|FG000|Overall Study|Death|11|||
164241941|NCT04072835|593257134|FG000|Overall Study|Participant felt the drug did not work|8|||
164241942|NCT04072835|593257134|FG000|Overall Study|Participant tolerability|5|||
164241943|NCT04072835|593257134|FG000|Overall Study|Missing|5|||
164241944|NCT04072835|593257134|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
164241945|NCT04072835|593257134|FG000|Overall Study|Pregnancy|3|||
164241946|NCT01336712|593257135|FG000|Overall Study|Death|2|||
164241947|NCT01336712|593257135|FG000|Overall Study|Lack of Efficacy|1|||
164241948|NCT00841776|593257136|FG000|Overall Study|Lack of Efficacy|0|||
164241949|NCT00841776|593257137|FG001|Overall Study|Lack of Efficacy|1|||
164241950|NCT00841776|593257136|FG000|Overall Study|Lost to Follow-up|2|||
164241951|NCT00841776|593257137|FG001|Overall Study|Lost to Follow-up|1|||
164241952|NCT00841776|593257136|FG000|Overall Study|Withdrawal by Subject|0|||
164241953|NCT00841776|593257137|FG001|Overall Study|Withdrawal by Subject|1|||
164241954|NCT02848092|593257138|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
164241955|NCT02848092|593257139|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
164241956|NCT02848092|593257138|FG000|1-month Post-training Follow-up|Adverse Event|2|||
164241957|NCT02848092|593257139|FG001|1-month Post-training Follow-up|Adverse Event|1|||
164241958|NCT02848092|593257138|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
164241959|NCT02848092|593257139|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
164241960|NCT02848092|593257138|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
164241961|NCT02848092|593257139|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
164241962|NCT02848092|593257138|FG000|1-month Post-training Follow-up|fatigue|0|||
164241963|NCT02848092|593257139|FG001|1-month Post-training Follow-up|fatigue|1|||
164241964|NCT02848092|593257138|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
164241965|NCT02848092|593257139|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
164241966|NCT02848092|593257138|FG000|6-month Post-training Follow-up|Adverse Event|1|||
164241967|NCT02848092|593257139|FG001|6-month Post-training Follow-up|Adverse Event|1|||
164241968|NCT02848092|593257138|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
164241969|NCT02848092|593257139|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
164241970|NCT02848092|593257138|FG000|6-month Post-training Follow-up|frustrated with task|1|||
164573577|NCT02901431|594463432|FG012|Main Treatment Part|Physician Decision|0|||
164573578|NCT02901431|594463420|FG000|Main Treatment Part|Withdrawal by Subject|0|||
164573579|NCT02901431|594463421|FG001|Main Treatment Part|Withdrawal by Subject|0|||
164573580|NCT02901431|594463422|FG002|Main Treatment Part|Withdrawal by Subject|0|||
164241971|NCT02848092|593257139|FG001|6-month Post-training Follow-up|frustrated with task|0|||
164241972|NCT02848092|593257138|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
164241973|NCT02848092|593257139|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
164241974|NCT02848092|593257138|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
164241975|NCT02848092|593257139|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
164241976|NCT01428219|593257145|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
164573581|NCT02901431|594463423|FG003|Main Treatment Part|Withdrawal by Subject|18|||
164573582|NCT02901431|594463424|FG004|Main Treatment Part|Withdrawal by Subject|3|||
164573583|NCT02901431|594463425|FG005|Main Treatment Part|Withdrawal by Subject|5|||
164573584|NCT02901431|594463426|FG006|Main Treatment Part|Withdrawal by Subject|6|||
164573585|NCT02901431|594463427|FG007|Main Treatment Part|Withdrawal by Subject|0|||
164573586|NCT02901431|594463428|FG008|Main Treatment Part|Withdrawal by Subject|0|||
164573587|NCT02901431|594463429|FG009|Main Treatment Part|Withdrawal by Subject|0|||
164573588|NCT02901431|594463430|FG010|Main Treatment Part|Withdrawal by Subject|0|||
164573589|NCT02901431|594463431|FG011|Main Treatment Part|Withdrawal by Subject|0|||
164573590|NCT02901431|594463432|FG012|Main Treatment Part|Withdrawal by Subject|0|||
164573591|NCT02901431|594463420|FG000|Open Label Part|Adverse Event|0|||
164573592|NCT02901431|594463421|FG001|Open Label Part|Adverse Event|0|||
164573593|NCT02901431|594463422|FG002|Open Label Part|Adverse Event|0|||
164573594|NCT02901431|594463423|FG003|Open Label Part|Adverse Event|0|||
164573595|NCT02901431|594463424|FG004|Open Label Part|Adverse Event|0|||
164573596|NCT02901431|594463425|FG005|Open Label Part|Adverse Event|0|||
164573597|NCT02901431|594463426|FG006|Open Label Part|Adverse Event|0|||
164573598|NCT02901431|594463427|FG007|Open Label Part|Adverse Event|0|||
164241977|NCT00355368|593257148|FG000|Overall Study|Protocol Violation|8|||
164241978|NCT00355368|593257149|FG001|Overall Study|Protocol Violation|7|||
164241979|NCT00355368|593257148|FG000|Overall Study|cardiac arrest prior to intubation|2|||
164241980|NCT00355368|593257149|FG001|Overall Study|cardiac arrest prior to intubation|2|||
164241981|NCT01694433|593257151|FG000|Overall Study|Adverse Event|7|||
164241982|NCT01694433|593257152|FG001|Overall Study|Adverse Event|0|||
164241983|NCT01694433|593257151|FG000|Overall Study|Physician Decision|1|||
164241984|NCT01694433|593257152|FG001|Overall Study|Physician Decision|0|||
164241985|NCT01694433|593257151|FG000|Overall Study|Withdrawal by Subject|3|||
164241986|NCT01694433|593257152|FG001|Overall Study|Withdrawal by Subject|4|||
164241987|NCT00374595|593257155|FG000|Overall Study|Death|23|||
164241988|NCT00374595|593257155|FG000|Overall Study|Withdrawal by Subject|39|||
164241989|NCT00374595|593257155|FG000|Overall Study|Lost to Follow-up|3|||
164241990|NCT00374595|593257155|FG000|Overall Study|too much time commitment|1|||
164241991|NCT00374595|593257155|FG000|Overall Study|transfer care to other clinical site|1|||
164425419|NCT03023332|593928480|FG003|Overall Study|Death|0|||
164573599|NCT02901431|594463428|FG008|Open Label Part|Adverse Event|4|||
164573600|NCT02901431|594463429|FG009|Open Label Part|Adverse Event|4|||
164573601|NCT02901431|594463430|FG010|Open Label Part|Adverse Event|0|||
164573602|NCT02901431|594463431|FG011|Open Label Part|Adverse Event|4|||
164573603|NCT02901431|594463432|FG012|Open Label Part|Adverse Event|1|||
164573604|NCT02901431|594463420|FG000|Open Label Part|Lost to Follow-up|0|||
164573605|NCT02901431|594463421|FG001|Open Label Part|Lost to Follow-up|0|||
164573606|NCT02901431|594463422|FG002|Open Label Part|Lost to Follow-up|0|||
164573607|NCT02901431|594463423|FG003|Open Label Part|Lost to Follow-up|0|||
164573608|NCT02901431|594463424|FG004|Open Label Part|Lost to Follow-up|0|||
164573609|NCT02901431|594463425|FG005|Open Label Part|Lost to Follow-up|0|||
164573610|NCT02901431|594463426|FG006|Open Label Part|Lost to Follow-up|0|||
164573611|NCT02901431|594463427|FG007|Open Label Part|Lost to Follow-up|0|||
164573612|NCT02901431|594463428|FG008|Open Label Part|Lost to Follow-up|2|||
164573613|NCT02901431|594463429|FG009|Open Label Part|Lost to Follow-up|2|||
164241992|NCT00374595|593257155|FG000|Overall Study|relocation|3|||
164241993|NCT01665911|593257159|FG000|Overall Study|Protocol Violation|4|||
164241994|NCT01665911|593257159|FG000|Overall Study|Withdrawal by Subject|1|||
164241995|NCT01665911|593257159|FG000|Overall Study|Adverse Event|1|||
164241996|NCT01881009|593257160|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
164241997|NCT01881009|593257161|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
164241998|NCT01151020|593257162|FG000|Overall Study|Death|25|||
164241999|NCT01151020|593257162|FG000|Overall Study|Conversion to open repair|1|||
164242000|NCT01151020|593257162|FG000|Overall Study|Lost to Follow-up|4|||
164242001|NCT01151020|593257162|FG000|Overall Study|Withdrawal by Subject|22|||
164242002|NCT01151020|593257162|FG000|Overall Study|Patients did not receive the device|2|||
164242003|NCT00648037|593257163|FG000|Overall Study|Not Treated|1|||
164242004|NCT00648037|593257163|FG000|Overall Study|Withdrawal by Subject|1|||
164242005|NCT00648037|593257163|FG000|Overall Study|Adverse Event|11|||
164242006|NCT00648037|593257163|FG000|Overall Study|Relapse|2|||
164425420|NCT01818700|593928481|FG000|Overall Study|Adverse Event|67|||
164425421|NCT01818700|593928481|FG000|Overall Study|Lack of Efficacy|2|||
164573614|NCT02901431|594463430|FG010|Open Label Part|Lost to Follow-up|1|||
164242007|NCT00648037|593257163|FG000|Overall Study|Other|1|||
164242008|NCT01635998|593257164|FG000|Overall Study|Death|1|||
164242009|NCT01635998|593257165|FG001|Overall Study|Death|1|||
164242010|NCT01635998|593257164|FG000|Overall Study|Lost to Follow-up|2|||
164242011|NCT01635998|593257165|FG001|Overall Study|Lost to Follow-up|1|||
164242012|NCT01635998|593257164|FG000|Overall Study|Withdrawal by Subject|1|||
164242013|NCT01635998|593257165|FG001|Overall Study|Withdrawal by Subject|5|||
164242014|NCT00846846|593257166|FG000|Overall Study|Death|56|||
164242015|NCT00846846|593257166|FG000|Overall Study|Withdrawal by Subject|19|||
164242016|NCT04419467|593257167|FG000|Overall Study|Not treated with IP|0|||
164242017|NCT04419467|593257168|FG001|Overall Study|Not treated with IP|0|||
164242018|NCT04419467|593257169|FG002|Overall Study|Not treated with IP|2|||
164242019|NCT04419467|593257167|FG000|Overall Study|Adverse Event|0|||
164242020|NCT04419467|593257168|FG001|Overall Study|Adverse Event|2|||
164242021|NCT04419467|593257169|FG002|Overall Study|Adverse Event|0|||
164242022|NCT04419467|593257167|FG000|Overall Study|Death|1|||
164242023|NCT04419467|593257168|FG001|Overall Study|Death|0|||
164242024|NCT04419467|593257169|FG002|Overall Study|Death|0|||
164242025|NCT04419467|593257167|FG000|Overall Study|Lost to Follow-up|0|||
164242026|NCT04419467|593257168|FG001|Overall Study|Lost to Follow-up|1|||
164242027|NCT04419467|593257169|FG002|Overall Study|Lost to Follow-up|2|||
164242028|NCT04419467|593257167|FG000|Overall Study|Withdrawal by Subject|0|||
164242029|NCT04419467|593257168|FG001|Overall Study|Withdrawal by Subject|0|||
164242030|NCT04419467|593257169|FG002|Overall Study|Withdrawal by Subject|4|||
164242031|NCT04419467|593257167|FG000|Overall Study|Pandemic related|0|||
164242032|NCT04419467|593257168|FG001|Overall Study|Pandemic related|0|||
164242033|NCT04419467|593257169|FG002|Overall Study|Pandemic related|1|||
164242034|NCT04419467|593257167|FG000|Overall Study|Reason not known|1|||
164242035|NCT04419467|593257168|FG001|Overall Study|Reason not known|0|||
164242036|NCT04419467|593257169|FG002|Overall Study|Reason not known|0|||
164242037|NCT00600067|593257173|FG000|Overall Study|Adverse Event|0|||
164242038|NCT00600067|593257174|FG001|Overall Study|Adverse Event|1|||
164242039|NCT00600067|593257173|FG000|Overall Study|Lost to Follow-up|2|||
164242040|NCT00600067|593257174|FG001|Overall Study|Lost to Follow-up|3|||
164242041|NCT00600067|593257173|FG000|Overall Study|protocol non-compliance|0|||
164242042|NCT00600067|593257174|FG001|Overall Study|protocol non-compliance|3|||
164242043|NCT00600067|593257173|FG000|Overall Study|Lack of Efficacy|1|||
164242044|NCT00600067|593257174|FG001|Overall Study|Lack of Efficacy|0|||
164242045|NCT00881894|593257177|FG000|Overall Study|Consent withdrawn|0|||
164242046|NCT00881894|593257178|FG001|Overall Study|Consent withdrawn|1|||
164242047|NCT00881894|593257177|FG000|Overall Study|Other reasons for premature termination|1|||
164242048|NCT00881894|593257178|FG001|Overall Study|Other reasons for premature termination|2|||
164242049|NCT03943290|593257180|FG000|Overall Study|Sponsor Terminated Study|6|||
164242050|NCT03943290|593257181|FG001|Overall Study|Sponsor Terminated Study|1|||
164242051|NCT03943290|593257182|FG002|Overall Study|Sponsor Terminated Study|11|||
164242052|NCT03943290|593257183|FG003|Overall Study|Sponsor Terminated Study|6|||
164242053|NCT03943290|593257184|FG004|Overall Study|Sponsor Terminated Study|7|||
164242054|NCT03943290|593257185|FG005|Overall Study|Sponsor Terminated Study|6|||
164242055|NCT03943290|593257186|FG006|Overall Study|Sponsor Terminated Study|6|||
164242056|NCT03943290|593257187|FG007|Overall Study|Sponsor Terminated Study|7|||
164242057|NCT03943290|593257188|FG008|Overall Study|Sponsor Terminated Study|8|||
164242058|NCT03943290|593257180|FG000|Overall Study|Lost to Follow-up|1|||
164242059|NCT03943290|593257181|FG001|Overall Study|Lost to Follow-up|0|||
164242060|NCT03943290|593257182|FG002|Overall Study|Lost to Follow-up|1|||
164242061|NCT03943290|593257183|FG003|Overall Study|Lost to Follow-up|0|||
164242062|NCT03943290|593257184|FG004|Overall Study|Lost to Follow-up|0|||
164242063|NCT03943290|593257185|FG005|Overall Study|Lost to Follow-up|0|||
164242064|NCT03943290|593257186|FG006|Overall Study|Lost to Follow-up|0|||
164242065|NCT03943290|593257187|FG007|Overall Study|Lost to Follow-up|1|||
164242066|NCT03943290|593257188|FG008|Overall Study|Lost to Follow-up|0|||
164242067|NCT03943290|593257180|FG000|Overall Study|Withdrawal by Subject|0|||
164242068|NCT03943290|593257181|FG001|Overall Study|Withdrawal by Subject|0|||
164242069|NCT03943290|593257182|FG002|Overall Study|Withdrawal by Subject|1|||
164242070|NCT03943290|593257183|FG003|Overall Study|Withdrawal by Subject|0|||
164242071|NCT03943290|593257184|FG004|Overall Study|Withdrawal by Subject|0|||
164242072|NCT03943290|593257185|FG005|Overall Study|Withdrawal by Subject|0|||
164242073|NCT03943290|593257186|FG006|Overall Study|Withdrawal by Subject|0|||
164242074|NCT03943290|593257187|FG007|Overall Study|Withdrawal by Subject|0|||
164242075|NCT03943290|593257188|FG008|Overall Study|Withdrawal by Subject|0|||
164242076|NCT02765399|593257189|FG000|Overall Study|Nausea|1|||
164242077|NCT02765399|593257190|FG001|Overall Study|Nausea|0|||
164242078|NCT02103062|593257191|FG000|Overall Study|Adverse Event|1|||
164242079|NCT02103062|593257192|FG001|Overall Study|Adverse Event|2|||
164242080|NCT02103062|593257191|FG000|Overall Study|Progressive Disease|17|||
164242081|NCT02103062|593257192|FG001|Overall Study|Progressive Disease|20|||
164242082|NCT02103062|593257191|FG000|Overall Study|Death|0|||
164242083|NCT02103062|593257192|FG001|Overall Study|Death|1|||
164242084|NCT03958331|593257193|FG000|Overall Study|Withdrawal by Subject|3|||
164242085|NCT03958331|593257194|FG001|Overall Study|Withdrawal by Subject|1|||
164242086|NCT03958331|593257195|FG002|Overall Study|Withdrawal by Subject|5|||
164242087|NCT03958331|593257193|FG000|Overall Study|Weaned from medicine|2|||
164242088|NCT03958331|593257194|FG001|Overall Study|Weaned from medicine|0|||
164242089|NCT03958331|593257195|FG002|Overall Study|Weaned from medicine|0|||
164242090|NCT03958331|593257193|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
164242091|NCT03958331|593257194|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
164242092|NCT03958331|593257195|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
164242093|NCT01991483|593257196|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
164242094|NCT01991483|593257197|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
164242095|NCT01991483|593257198|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
164242096|NCT01991483|593257199|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
164242097|NCT01991483|593257196|FG000|Dose Level 600 mg|Physician Decision|0|||
164242098|NCT01991483|593257197|FG001|Dose Level 600 mg|Physician Decision|0|||
164242099|NCT01991483|593257198|FG002|Dose Level 600 mg|Physician Decision|1|||
164242100|NCT01991483|593257199|FG003|Dose Level 600 mg|Physician Decision|0|||
164242101|NCT01991483|593257196|FG000|Dose Level 1000 mg|Protocol Violation|0|||
164242102|NCT01991483|593257197|FG001|Dose Level 1000 mg|Protocol Violation|0|||
164242103|NCT01991483|593257198|FG002|Dose Level 1000 mg|Protocol Violation|0|||
164242104|NCT01991483|593257199|FG003|Dose Level 1000 mg|Protocol Violation|1|||
164242105|NCT03192137|593257200|FG000|Overall Study|Adverse Event|10|||
164242106|NCT03192137|593257201|FG001|Overall Study|Adverse Event|11|||
164242107|NCT03192137|593257200|FG000|Overall Study|Physician Decision|1|||
164242108|NCT03192137|593257201|FG001|Overall Study|Physician Decision|0|||
164242109|NCT03192137|593257200|FG000|Overall Study|Lack of Efficacy|20|||
164242110|NCT03192137|593257201|FG001|Overall Study|Lack of Efficacy|37|||
164242111|NCT03192137|593257200|FG000|Overall Study|Withdrawal by Subject|3|||
164242112|NCT03192137|593257201|FG001|Overall Study|Withdrawal by Subject|3|||
164242113|NCT03192137|593257200|FG000|Overall Study|Protocol Violation|4|||
164242114|NCT03192137|593257201|FG001|Overall Study|Protocol Violation|3|||
164242115|NCT03192137|593257200|FG000|Overall Study|Surgery Cancelled|4|||
164242116|NCT03192137|593257201|FG001|Overall Study|Surgery Cancelled|1|||
164242117|NCT03192137|593257200|FG000|Overall Study|Other - Various Administrative Reasons|8|||
164242118|NCT03192137|593257201|FG001|Overall Study|Other - Various Administrative Reasons|3|||
164242119|NCT01070979|593257202|FG000|Overall Study|Adverse Event|2|||
164242120|NCT01070979|593257203|FG001|Overall Study|Adverse Event|3|||
164242121|NCT01070979|593257204|FG002|Overall Study|Adverse Event|3|||
164242122|NCT01070979|593257202|FG000|Overall Study|Lost to Follow-up|2|||
164242123|NCT01070979|593257203|FG001|Overall Study|Lost to Follow-up|1|||
164242124|NCT01070979|593257204|FG002|Overall Study|Lost to Follow-up|1|||
164242125|NCT01070979|593257202|FG000|Overall Study|Protocol Violation|0|||
164242126|NCT01070979|593257203|FG001|Overall Study|Protocol Violation|2|||
164242127|NCT01070979|593257204|FG002|Overall Study|Protocol Violation|6|||
164242128|NCT01070979|593257202|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
164242129|NCT01070979|593257203|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
164242130|NCT01070979|593257204|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
164242131|NCT01070979|593257202|FG000|Overall Study|Withdrawal by Subject|3|||
164242132|NCT01070979|593257203|FG001|Overall Study|Withdrawal by Subject|1|||
164573615|NCT02901431|594463431|FG011|Open Label Part|Lost to Follow-up|1|||
164573616|NCT02901431|594463432|FG012|Open Label Part|Lost to Follow-up|1|||
164242133|NCT01070979|593257204|FG002|Overall Study|Withdrawal by Subject|1|||
164242134|NCT01070979|593257202|FG000|Overall Study|No study drug taken|0|||
164242135|NCT01070979|593257203|FG001|Overall Study|No study drug taken|1|||
164242136|NCT01070979|593257204|FG002|Overall Study|No study drug taken|0|||
164242137|NCT00437268|593257205|FG000|Overall Study|Adverse Event|1|||
164242138|NCT00437268|593257206|FG001|Overall Study|Adverse Event|1|||
164242139|NCT00437268|593257205|FG000|Overall Study|Withdrawal by Subject|2|||
164242140|NCT00437268|593257206|FG001|Overall Study|Withdrawal by Subject|2|||
164242141|NCT00437268|593257205|FG000|Overall Study|Progressive disease|9|||
164242142|NCT00437268|593257206|FG001|Overall Study|Progressive disease|9|||
164242143|NCT00437268|593257205|FG000|Overall Study|Physician Decision|1|||
164242144|NCT00437268|593257206|FG001|Overall Study|Physician Decision|0|||
164242145|NCT00437268|593257205|FG000|Overall Study|Death|0|||
164242146|NCT00437268|593257206|FG001|Overall Study|Death|1|||
164242147|NCT04417257|593257211|FG000|Pilot Phase 2|Adverse Event|2|||
164242148|NCT04417257|593257212|FG001|Pilot Phase 2|Adverse Event|0|||
164573617|NCT02901431|594463420|FG000|Open Label Part|Physician Decision|0|||
164573618|NCT02901431|594463421|FG001|Open Label Part|Physician Decision|0|||
164242149|NCT04417257|593257211|FG000|Pilot Phase 2|Death|14|||
164573619|NCT02901431|594463422|FG002|Open Label Part|Physician Decision|0|||
164573620|NCT02901431|594463423|FG003|Open Label Part|Physician Decision|0|||
164242150|NCT04417257|593257212|FG001|Pilot Phase 2|Death|11|||
164242151|NCT04417257|593257211|FG000|Pilot Phase 2|Lost to Follow-up|3|||
164242152|NCT04417257|593257212|FG001|Pilot Phase 2|Lost to Follow-up|5|||
164242153|NCT04417257|593257211|FG000|Pilot Phase 2|Withdrawal by Subject|7|||
164242154|NCT04417257|593257212|FG001|Pilot Phase 2|Withdrawal by Subject|6|||
164336440|NCT01543698|593609727|FG007|Phase 1b|Withdrawal by Subject|0|||
164242155|NCT04417257|593257211|FG000|Pilot Phase 2|Hepatic impairment|1|||
164242156|NCT04417257|593257212|FG001|Pilot Phase 2|Hepatic impairment|0|||
164242157|NCT04417257|593257211|FG000|Pilot Phase 2|Unblinding|1|||
164242158|NCT04417257|593257212|FG001|Pilot Phase 2|Unblinding|0|||
164242159|NCT04417257|593257211|FG000|Pilot Phase 2|All other|0|||
164242160|NCT04417257|593257212|FG001|Pilot Phase 2|All other|2|||
164242161|NCT04417257|593257211|FG000|Phase 3 Extension|Death|3|||
164242162|NCT04417257|593257212|FG001|Phase 3 Extension|Death|1|||
164242163|NCT04417257|593257211|FG000|Phase 3 Extension|Lost to Follow-up|4|||
164242164|NCT04417257|593257212|FG001|Phase 3 Extension|Lost to Follow-up|2|||
164242165|NCT04417257|593257211|FG000|Phase 3 Extension|Patient withdrawal|2|||
164242166|NCT04417257|593257212|FG001|Phase 3 Extension|Patient withdrawal|2|||
164242167|NCT04417257|593257211|FG000|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|3|||
164242168|NCT04417257|593257212|FG001|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|1|||
164242169|NCT03484429|593257216|FG000|Overall Study|Withdrawal by Subject|1|||
164242170|NCT03484429|593257217|FG001|Overall Study|Withdrawal by Subject|0|||
164242171|NCT03484429|593257216|FG000|Overall Study|Adverse Event|2|||
164242172|NCT03484429|593257217|FG001|Overall Study|Adverse Event|0|||
164242173|NCT04466384|593257218|FG000|First Phase|Protocol Violation|1|||
164242174|NCT04466384|593257219|FG001|First Phase|Protocol Violation|0|||
164242175|NCT04466384|593257218|FG000|First Phase|Missing data|1|||
164242176|NCT04466384|593257219|FG001|First Phase|Missing data|0|||
164242177|NCT04466384|593257218|FG000|Cross Over Phase|Physician Decision|1|||
164242178|NCT04466384|593257219|FG001|Cross Over Phase|Physician Decision|0|||
164242179|NCT04466384|593257218|FG000|Cross Over Phase|Withdrawal by Subject|0|||
164242180|NCT04466384|593257219|FG001|Cross Over Phase|Withdrawal by Subject|1|||
164242181|NCT01152437|593257223|FG000|Overall Study|Other Adverse Event|8|||
164242182|NCT01152437|593257224|FG001|Overall Study|Other Adverse Event|1|||
164242183|NCT01152437|593257225|FG002|Overall Study|Other Adverse Event|7|||
164242184|NCT01152437|593257223|FG000|Overall Study|Not treated|0|||
164242185|NCT01152437|593257224|FG001|Overall Study|Not treated|1|||
164242186|NCT01152437|593257225|FG002|Overall Study|Not treated|2|||
164242187|NCT01152437|593257223|FG000|Overall Study|Progressive disease|27|||
164242188|NCT01152437|593257224|FG001|Overall Study|Progressive disease|13|||
164242189|NCT01152437|593257225|FG002|Overall Study|Progressive disease|32|||
164242190|NCT01152437|593257223|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
164242191|NCT01152437|593257224|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
164242192|NCT01152437|593257225|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
164242193|NCT02015039|593257226|FG000|Overall Study|Not eligible|0|||
164242194|NCT02015039|593257227|FG001|Overall Study|Not eligible|1|||
164242195|NCT01897532|593257228|FG000|Discontinuation From Treatment|Not Treated|7|||
164242196|NCT01897532|593257229|FG001|Discontinuation From Treatment|Not Treated|5|||
164242197|NCT01897532|593257228|FG000|Discontinuation From Treatment|Other reason than specified|196|||
164242198|NCT01897532|593257229|FG001|Discontinuation From Treatment|Other reason than specified|176|||
164242199|NCT01897532|593257228|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
164336441|NCT01543698|593609728|FG008|Phase 1b|Withdrawal by Subject|0|||
164336442|NCT01543698|593609729|FG009|Phase 1b|Withdrawal by Subject|0|||
164336443|NCT01543698|593609730|FG010|Phase 1b|Withdrawal by Subject|0|||
164336444|NCT01543698|593609731|FG011|Phase 1b|Withdrawal by Subject|0|||
164336445|NCT01543698|593609732|FG012|Phase 1b|Withdrawal by Subject|0|||
164336446|NCT01543698|593609733|FG013|Phase 1b|Withdrawal by Subject|0|||
164336447|NCT01543698|593609734|FG014|Phase 1b|Withdrawal by Subject|0|||
164336448|NCT01543698|593609720|FG000|Phase 1b|Adverse Event|1|||
164336449|NCT01543698|593609721|FG001|Phase 1b|Adverse Event|0|||
164336450|NCT01543698|593609722|FG002|Phase 1b|Adverse Event|0|||
164336451|NCT01543698|593609723|FG003|Phase 1b|Adverse Event|1|||
164336452|NCT01543698|593609724|FG004|Phase 1b|Adverse Event|2|||
164336453|NCT01543698|593609725|FG005|Phase 1b|Adverse Event|2|||
164336454|NCT01543698|593609726|FG006|Phase 1b|Adverse Event|0|||
164336455|NCT01543698|593609727|FG007|Phase 1b|Adverse Event|0|||
164336456|NCT01543698|593609728|FG008|Phase 1b|Adverse Event|1|||
164336457|NCT01543698|593609729|FG009|Phase 1b|Adverse Event|1|||
164336458|NCT01543698|593609730|FG010|Phase 1b|Adverse Event|2|||
164242200|NCT01897532|593257229|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
164242201|NCT01897532|593257228|FG000|Discontinuation From Treatment|Non compliance|24|||
164242202|NCT01897532|593257229|FG001|Discontinuation From Treatment|Non compliance|15|||
164242203|NCT01897532|593257228|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
164336459|NCT01543698|593609731|FG011|Phase 1b|Adverse Event|0|||
164336460|NCT01543698|593609732|FG012|Phase 1b|Adverse Event|0|||
164336461|NCT01543698|593609733|FG013|Phase 1b|Adverse Event|0|||
164336462|NCT01543698|593609734|FG014|Phase 1b|Adverse Event|0|||
164242204|NCT01897532|593257229|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
164242205|NCT01897532|593257228|FG000|Discontinuation From Trial|Not Treated|7|||
164242206|NCT01897532|593257229|FG001|Discontinuation From Trial|Not Treated|5|||
164242207|NCT01897532|593257228|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
164242208|NCT01897532|593257229|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
164336463|NCT01543698|593609720|FG000|Phase 1b|Administrative problems|1|||
164336464|NCT01543698|593609721|FG001|Phase 1b|Administrative problems|0|||
164242209|NCT01074931|593257234|FG000|Overall Study|Economic reasons|1|||
164242210|NCT01074931|593257234|FG000|Overall Study|Death|5|||
164242211|NCT00972023|593258443|FG000|Overall Study|Withdrawal by Subject|1|||
164242212|NCT03052608|593258444|FG000|Treatment Phase|Adverse Event|10|||
164242213|NCT03052608|593258445|FG001|Treatment Phase|Adverse Event|12|||
164242214|NCT03052608|593258444|FG000|Treatment Phase|Death|6|||
164242215|NCT03052608|593258445|FG001|Treatment Phase|Death|4|||
164242216|NCT03052608|593258444|FG000|Treatment Phase|Withdrawal by Subject|4|||
164242217|NCT03052608|593258445|FG001|Treatment Phase|Withdrawal by Subject|12|||
164242218|NCT03052608|593258444|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
164242219|NCT03052608|593258445|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
164242220|NCT03052608|593258444|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
164242221|NCT03052608|593258445|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
164242222|NCT03052608|593258444|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
164242223|NCT03052608|593258445|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
164242224|NCT03052608|593258444|FG000|Treatment Phase|Ongoing|103|||
164242225|NCT03052608|593258445|FG001|Treatment Phase|Ongoing|31|||
164242226|NCT03052608|593258444|FG000|Long-Term Follow-up Phase|Death|23|||
164242227|NCT03052608|593258445|FG001|Long-Term Follow-up Phase|Death|28|||
164242228|NCT03052608|593258444|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
164242229|NCT03052608|593258445|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
164242230|NCT03052608|593258444|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
164242231|NCT03052608|593258445|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
164242232|NCT03052608|593258444|FG000|Long-Term Follow-up Phase|Ongoing|122|||
164242233|NCT03052608|593258445|FG001|Long-Term Follow-up Phase|Ongoing|99|||
164242234|NCT05554146|593258452|FG000|Overall Study|Adverse Event|0|||
164242235|NCT05554146|593258453|FG001|Overall Study|Adverse Event|1|||
164242236|NCT05554146|593258454|FG002|Overall Study|Adverse Event|0|||
164242237|NCT05554146|593258455|FG003|Overall Study|Adverse Event|0|||
164242238|NCT05554146|593258452|FG000|Overall Study|Protocol Violation|0|||
164242239|NCT05554146|593258453|FG001|Overall Study|Protocol Violation|1|||
164242240|NCT05554146|593258454|FG002|Overall Study|Protocol Violation|0|||
164242241|NCT05554146|593258455|FG003|Overall Study|Protocol Violation|0|||
164242242|NCT05554146|593258452|FG000|Overall Study|No longer interested in participating|0|||
164242243|NCT05554146|593258453|FG001|Overall Study|No longer interested in participating|0|||
164242244|NCT05554146|593258454|FG002|Overall Study|No longer interested in participating|1|||
164242245|NCT05554146|593258455|FG003|Overall Study|No longer interested in participating|0|||
164242246|NCT05554146|593258452|FG000|Overall Study|Lost to Follow-up|1|||
164242247|NCT05554146|593258453|FG001|Overall Study|Lost to Follow-up|0|||
164242248|NCT05554146|593258454|FG002|Overall Study|Lost to Follow-up|0|||
164242249|NCT05554146|593258455|FG003|Overall Study|Lost to Follow-up|0|||
164242250|NCT03073525|593258458|FG000|Overall Study|Withdrawal by Subject|0|||
164242251|NCT03073525|593258459|FG001|Overall Study|Withdrawal by Subject|0|||
164242252|NCT03073525|593258460|FG002|Overall Study|Withdrawal by Subject|3|||
164242253|NCT01976299|593258461|FG000|Overall Study|Withdrawal by Subject|3|||
164242254|NCT01976299|593258462|FG001|Overall Study|Withdrawal by Subject|1|||
164242255|NCT01976299|593258461|FG000|Overall Study|Death|4|||
164242256|NCT01976299|593258462|FG001|Overall Study|Death|2|||
164242257|NCT01976299|593258461|FG000|Overall Study|Lost to Follow-up|7|||
164242258|NCT01976299|593258462|FG001|Overall Study|Lost to Follow-up|1|||
164242259|NCT01976299|593258461|FG000|Overall Study|See clarification above in comments|9|||
164242260|NCT01976299|593258462|FG001|Overall Study|See clarification above in comments|2|||
164242261|NCT00856323|593258464|FG000|Overall Study|Withdrawal by Subject|2|||
164242262|NCT01639469|593258465|FG000|Overall Study|Death|4|||
164242263|NCT01639469|593258466|FG001|Overall Study|Death|2|||
164242264|NCT01639469|593258465|FG000|Overall Study|Lost to Follow-up|1|||
164242265|NCT01639469|593258466|FG001|Overall Study|Lost to Follow-up|1|||
164242266|NCT01119443|593258467|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
164242267|NCT01119443|593258468|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
164242268|NCT02329743|593258471|FG000|Overall Study|Adverse Event|1|||
164242269|NCT02329743|593258472|FG001|Overall Study|Adverse Event|1|||
164242270|NCT02329743|593258473|FG002|Overall Study|Adverse Event|3|||
164242271|NCT02329743|593258471|FG000|Overall Study|Lost to Follow-up|1|||
164242272|NCT02329743|593258472|FG001|Overall Study|Lost to Follow-up|0|||
164242273|NCT02329743|593258473|FG002|Overall Study|Lost to Follow-up|1|||
164242274|NCT02329743|593258471|FG000|Overall Study|Withdrawal by Subject|4|||
164242275|NCT02329743|593258472|FG001|Overall Study|Withdrawal by Subject|4|||
164242276|NCT02329743|593258473|FG002|Overall Study|Withdrawal by Subject|1|||
164242277|NCT02329743|593258471|FG000|Overall Study|Other|0|||
164242278|NCT02329743|593258472|FG001|Overall Study|Other|2|||
164242279|NCT02329743|593258473|FG002|Overall Study|Other|3|||
164242280|NCT00347932|593258484|FG000|Overall Study|Adverse Event|4|||
164242281|NCT00347932|593258485|FG001|Overall Study|Adverse Event|5|||
164242282|NCT00347932|593258484|FG000|Overall Study|Lack of Efficacy|3|||
164242283|NCT00347932|593258485|FG001|Overall Study|Lack of Efficacy|14|||
164242284|NCT00347932|593258484|FG000|Overall Study|Lost to Follow-up|10|||
164242285|NCT00347932|593258485|FG001|Overall Study|Lost to Follow-up|9|||
164242286|NCT00347932|593258484|FG000|Overall Study|Withdrawal by Subject|10|||
164242287|NCT00347932|593258485|FG001|Overall Study|Withdrawal by Subject|16|||
164242288|NCT00347932|593258484|FG000|Overall Study|Did not meet inclusion criteria|4|||
164242289|NCT00347932|593258485|FG001|Overall Study|Did not meet inclusion criteria|8|||
164242290|NCT01484496|593258486|FG000|Period 1|Protocol Violation|3|||
164242291|NCT01484496|593258487|FG001|Period 1|Protocol Violation|4|||
164242292|NCT01484496|593258488|FG002|Period 1|Protocol Violation|0|||
164242293|NCT01484496|593258489|FG003|Period 1|Protocol Violation|0|||
164242294|NCT01484496|593258486|FG000|Period 1|Physician Decision|5|||
164242295|NCT01484496|593258487|FG001|Period 1|Physician Decision|1|||
164242296|NCT01484496|593258488|FG002|Period 1|Physician Decision|0|||
164242297|NCT01484496|593258489|FG003|Period 1|Physician Decision|0|||
164242298|NCT01484496|593258486|FG000|Period 1|Lack of Efficacy|10|||
164242299|NCT01484496|593258487|FG001|Period 1|Lack of Efficacy|15|||
164242300|NCT01484496|593258488|FG002|Period 1|Lack of Efficacy|0|||
164242301|NCT01484496|593258489|FG003|Period 1|Lack of Efficacy|0|||
164242302|NCT01484496|593258486|FG000|Period 1|Adverse Event|25|||
164242303|NCT01484496|593258487|FG001|Period 1|Adverse Event|40|||
164242304|NCT01484496|593258488|FG002|Period 1|Adverse Event|0|||
164242305|NCT01484496|593258489|FG003|Period 1|Adverse Event|0|||
164242306|NCT01484496|593258486|FG000|Period 1|Withdrawal by Subject|15|||
164242307|NCT01484496|593258487|FG001|Period 1|Withdrawal by Subject|12|||
164242308|NCT01484496|593258488|FG002|Period 1|Withdrawal by Subject|0|||
164242309|NCT01484496|593258489|FG003|Period 1|Withdrawal by Subject|0|||
164242310|NCT01484496|593258486|FG000|Period 1|Lost to Follow-up|2|||
164242311|NCT01484496|593258487|FG001|Period 1|Lost to Follow-up|6|||
164242312|NCT01484496|593258488|FG002|Period 1|Lost to Follow-up|0|||
164242313|NCT01484496|593258489|FG003|Period 1|Lost to Follow-up|0|||
164242314|NCT01484496|593258486|FG000|Period 1|Positive Pregnancy|1|||
164242315|NCT01484496|593258487|FG001|Period 1|Positive Pregnancy|6|||
164242316|NCT01484496|593258488|FG002|Period 1|Positive Pregnancy|0|||
164242317|NCT01484496|593258489|FG003|Period 1|Positive Pregnancy|0|||
164242318|NCT01484496|593258486|FG000|Period 1|Treatment Failure|3|||
164242319|NCT01484496|593258487|FG001|Period 1|Treatment Failure|6|||
164242320|NCT01484496|593258488|FG002|Period 1|Treatment Failure|0|||
164242321|NCT01484496|593258489|FG003|Period 1|Treatment Failure|0|||
164242322|NCT01484496|593258486|FG000|Period 1|Lack of Compliance|2|||
164242323|NCT01484496|593258487|FG001|Period 1|Lack of Compliance|1|||
164242324|NCT01484496|593258488|FG002|Period 1|Lack of Compliance|0|||
164242325|NCT01484496|593258489|FG003|Period 1|Lack of Compliance|0|||
164242326|NCT01484496|593258486|FG000|Period 1|Unable to Visit Site|0|||
164242327|NCT01484496|593258487|FG001|Period 1|Unable to Visit Site|2|||
164242328|NCT01484496|593258488|FG002|Period 1|Unable to Visit Site|0|||
164242329|NCT01484496|593258489|FG003|Period 1|Unable to Visit Site|0|||
164242330|NCT01484496|593258486|FG000|Period 2|Lack of Efficacy|0|||
164242331|NCT01484496|593258487|FG001|Period 2|Lack of Efficacy|0|||
164242332|NCT01484496|593258488|FG002|Period 2|Lack of Efficacy|1|||
164242333|NCT01484496|593258489|FG003|Period 2|Lack of Efficacy|3|||
164242334|NCT01484496|593258486|FG000|Period 2|Adverse Event|0|||
164242335|NCT01484496|593258487|FG001|Period 2|Adverse Event|0|||
164242336|NCT01484496|593258488|FG002|Period 2|Adverse Event|5|||
164242337|NCT01484496|593258489|FG003|Period 2|Adverse Event|13|||
164242338|NCT01484496|593258486|FG000|Period 2|Other|0|||
164242339|NCT01484496|593258487|FG001|Period 2|Other|0|||
164242340|NCT01484496|593258488|FG002|Period 2|Other|9|||
164425422|NCT01818700|593928481|FG000|Overall Study|Lost to Follow-up|5|||
164425423|NCT01818700|593928481|FG000|Overall Study|Withdrawal by Subject|27|||
164425424|NCT01818700|593928481|FG000|Overall Study|Protocol Violation|2|||
164425425|NCT01818700|593928481|FG000|Overall Study|Other|1|||
164573621|NCT02901431|594463424|FG004|Open Label Part|Physician Decision|0|||
164242341|NCT01484496|593258489|FG003|Period 2|Other|6|||
164573622|NCT02901431|594463425|FG005|Open Label Part|Physician Decision|0|||
164242342|NCT01645735|593258490|FG000|Overall Study|Physician Decision|2|||
164242343|NCT01645735|593258491|FG001|Overall Study|Physician Decision|0|||
164242344|NCT01645735|593258490|FG000|Overall Study|Withdrawal by Subject|1|||
164242345|NCT01645735|593258491|FG001|Overall Study|Withdrawal by Subject|0|||
164242346|NCT01645735|593258490|FG000|Overall Study|Protocol Violation|1|||
164242347|NCT01645735|593258491|FG001|Overall Study|Protocol Violation|0|||
164242348|NCT01645735|593258490|FG000|Overall Study|Adverse Event|0|||
164242349|NCT01645735|593258491|FG001|Overall Study|Adverse Event|1|||
164242350|NCT04860869|593258496|FG000|Overall Study|Withdrawal by Subject|1|||
164425426|NCT02412761|593928482|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
164425427|NCT02412761|593928483|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
164242351|NCT04860869|593258497|FG001|Overall Study|Withdrawal by Subject|0|||
164573623|NCT02901431|594463426|FG006|Open Label Part|Physician Decision|0|||
164242352|NCT01775553|593258498|FG000|Overall Study|Adverse Event|1|||
164677847|NCT01663233|594844869|FG000|Overall Study|Lost to Follow-up|0|||
164242353|NCT01775553|593258498|FG000|Overall Study|Disease Progression|12|||
164242354|NCT01492088|593258508|FG000|Overall Study|Withdrawal by Patient|0|||
164242355|NCT01492088|593258509|FG001|Overall Study|Withdrawal by Patient|2|||
164242356|NCT01492088|593258510|FG002|Overall Study|Withdrawal by Patient|0|||
164573624|NCT02901431|594463427|FG007|Open Label Part|Physician Decision|0|||
164573625|NCT02901431|594463428|FG008|Open Label Part|Physician Decision|1|||
164573626|NCT02901431|594463429|FG009|Open Label Part|Physician Decision|1|||
164573627|NCT02901431|594463430|FG010|Open Label Part|Physician Decision|0|||
164573628|NCT02901431|594463431|FG011|Open Label Part|Physician Decision|0|||
164573629|NCT02901431|594463432|FG012|Open Label Part|Physician Decision|0|||
164573630|NCT02901431|594463420|FG000|Open Label Part|Study Terminated By Sponsor|0|||
164573631|NCT02901431|594463421|FG001|Open Label Part|Study Terminated By Sponsor|0|||
164573632|NCT02901431|594463422|FG002|Open Label Part|Study Terminated By Sponsor|0|||
164573633|NCT02901431|594463423|FG003|Open Label Part|Study Terminated By Sponsor|0|||
164573634|NCT02901431|594463424|FG004|Open Label Part|Study Terminated By Sponsor|0|||
164573635|NCT02901431|594463425|FG005|Open Label Part|Study Terminated By Sponsor|0|||
164573636|NCT02901431|594463426|FG006|Open Label Part|Study Terminated By Sponsor|0|||
164573637|NCT02901431|594463427|FG007|Open Label Part|Study Terminated By Sponsor|0|||
164573638|NCT02901431|594463428|FG008|Open Label Part|Study Terminated By Sponsor|35|||
164573639|NCT02901431|594463429|FG009|Open Label Part|Study Terminated By Sponsor|12|||
164573640|NCT02901431|594463430|FG010|Open Label Part|Study Terminated By Sponsor|21|||
164573641|NCT02901431|594463431|FG011|Open Label Part|Study Terminated By Sponsor|31|||
164573642|NCT02901431|594463432|FG012|Open Label Part|Study Terminated By Sponsor|0|||
164573643|NCT02901431|594463420|FG000|Open Label Part|Withdrawal by Subject|0|||
164573644|NCT02901431|594463421|FG001|Open Label Part|Withdrawal by Subject|0|||
164573645|NCT02901431|594463422|FG002|Open Label Part|Withdrawal by Subject|0|||
164573646|NCT02901431|594463423|FG003|Open Label Part|Withdrawal by Subject|0|||
164573647|NCT02901431|594463424|FG004|Open Label Part|Withdrawal by Subject|0|||
164573648|NCT02901431|594463425|FG005|Open Label Part|Withdrawal by Subject|0|||
164573649|NCT02901431|594463426|FG006|Open Label Part|Withdrawal by Subject|0|||
164573650|NCT02901431|594463427|FG007|Open Label Part|Withdrawal by Subject|0|||
164573651|NCT02901431|594463428|FG008|Open Label Part|Withdrawal by Subject|6|||
164573652|NCT02901431|594463429|FG009|Open Label Part|Withdrawal by Subject|5|||
164242357|NCT01492088|593258508|FG000|Overall Study|Death|1|||
164242358|NCT01492088|593258509|FG001|Overall Study|Death|6|||
164242359|NCT01492088|593258510|FG002|Overall Study|Death|2|||
164242360|NCT01492088|593258508|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
164242361|NCT01492088|593258509|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
164242362|NCT01492088|593258510|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
164242363|NCT01492088|593258508|FG000|Overall Study|Alive at Last Follow-up|0|||
164242364|NCT01492088|593258509|FG001|Overall Study|Alive at Last Follow-up|6|||
164242365|NCT01492088|593258510|FG002|Overall Study|Alive at Last Follow-up|11|||
164242366|NCT00590967|593258511|FG000|Overall Study|Withdrawal by Subject|1|||
164242367|NCT00590967|593258512|FG001|Overall Study|Withdrawal by Subject|1|||
164242368|NCT00590967|593258511|FG000|Overall Study|Ineligible|1|||
164242369|NCT00590967|593258512|FG001|Overall Study|Ineligible|0|||
164242370|NCT00590967|593258511|FG000|Overall Study|Poor performance status|0|||
164242371|NCT00590967|593258512|FG001|Overall Study|Poor performance status|1|||
164242372|NCT00590967|593258511|FG000|Overall Study|Non-compliant|0|||
164242373|NCT00590967|593258512|FG001|Overall Study|Non-compliant|2|||
164242374|NCT00590967|593258511|FG000|Overall Study|Did not sign consent form|0|||
164242375|NCT00590967|593258512|FG001|Overall Study|Did not sign consent form|1|||
164242376|NCT00590967|593258511|FG000|Overall Study|Did not receive chemo per protocol|1|||
164242377|NCT00590967|593258512|FG001|Overall Study|Did not receive chemo per protocol|0|||
164242378|NCT01881789|593258513|FG000|Overall Study|Withdrawal by Subject|0|||
164242379|NCT01881789|593258514|FG001|Overall Study|Withdrawal by Subject|2|||
164242380|NCT01881789|593258515|FG002|Overall Study|Withdrawal by Subject|1|||
164242381|NCT01881789|593258516|FG003|Overall Study|Withdrawal by Subject|0|||
164242382|NCT01881789|593258517|FG004|Overall Study|Withdrawal by Subject|1|||
164242383|NCT01881789|593258518|FG005|Overall Study|Withdrawal by Subject|1|||
164242384|NCT01881789|593258513|FG000|Overall Study|Study Terminated by Sponsor|0|||
164242385|NCT01881789|593258514|FG001|Overall Study|Study Terminated by Sponsor|0|||
164242386|NCT01881789|593258515|FG002|Overall Study|Study Terminated by Sponsor|0|||
164242387|NCT01881789|593258516|FG003|Overall Study|Study Terminated by Sponsor|0|||
164242388|NCT01881789|593258517|FG004|Overall Study|Study Terminated by Sponsor|0|||
164242389|NCT01881789|593258518|FG005|Overall Study|Study Terminated by Sponsor|1|||
164242390|NCT01881789|593258513|FG000|Overall Study|Other|3|||
164242391|NCT01881789|593258514|FG001|Overall Study|Other|5|||
164242392|NCT01881789|593258515|FG002|Overall Study|Other|2|||
164242393|NCT01881789|593258516|FG003|Overall Study|Other|3|||
164242394|NCT01881789|593258517|FG004|Overall Study|Other|1|||
164242395|NCT01881789|593258518|FG005|Overall Study|Other|1|||
164242396|NCT00920556|593258519|FG000|Overall Study|Adverse Event|16|||
164242397|NCT00920556|593258519|FG000|Overall Study|Physician Decision|7|||
164242398|NCT00920556|593258519|FG000|Overall Study|Withdrawal by Subject|1|||
164242399|NCT01299389|593258520|FG000|Double-blind|Adverse Event|45|||
164242400|NCT01299389|593258521|FG001|Double-blind|Adverse Event|27|||
164242401|NCT01299389|593258522|FG002|Double-blind|Adverse Event|0|||
164242402|NCT01299389|593258523|FG003|Double-blind|Adverse Event|0|||
164573653|NCT02901431|594463430|FG010|Open Label Part|Withdrawal by Subject|7|||
164336465|NCT01543698|593609722|FG002|Phase 1b|Administrative problems|0|||
164336466|NCT01543698|593609723|FG003|Phase 1b|Administrative problems|0|||
164336467|NCT01543698|593609724|FG004|Phase 1b|Administrative problems|1|||
164336468|NCT01543698|593609725|FG005|Phase 1b|Administrative problems|0|||
164336469|NCT01543698|593609726|FG006|Phase 1b|Administrative problems|0|||
164336470|NCT01543698|593609727|FG007|Phase 1b|Administrative problems|1|||
164336471|NCT01543698|593609728|FG008|Phase 1b|Administrative problems|0|||
164336472|NCT01543698|593609729|FG009|Phase 1b|Administrative problems|0|||
164336473|NCT01543698|593609730|FG010|Phase 1b|Administrative problems|2|||
164336474|NCT01543698|593609731|FG011|Phase 1b|Administrative problems|0|||
164336475|NCT01543698|593609732|FG012|Phase 1b|Administrative problems|0|||
164336476|NCT01543698|593609733|FG013|Phase 1b|Administrative problems|0|||
164336477|NCT01543698|593609734|FG014|Phase 1b|Administrative problems|0|||
164336478|NCT01543698|593609720|FG000|Phase 1b|Protocol Violation|2|||
164336479|NCT01543698|593609721|FG001|Phase 1b|Protocol Violation|0|||
164336480|NCT01543698|593609722|FG002|Phase 1b|Protocol Violation|0|||
164336481|NCT01543698|593609723|FG003|Phase 1b|Protocol Violation|0|||
164336482|NCT01543698|593609724|FG004|Phase 1b|Protocol Violation|0|||
164336483|NCT01543698|593609725|FG005|Phase 1b|Protocol Violation|0|||
164336484|NCT01543698|593609726|FG006|Phase 1b|Protocol Violation|0|||
164336485|NCT01543698|593609727|FG007|Phase 1b|Protocol Violation|0|||
164336486|NCT01543698|593609728|FG008|Phase 1b|Protocol Violation|0|||
164336487|NCT01543698|593609729|FG009|Phase 1b|Protocol Violation|0|||
164677848|NCT01663233|594844870|FG001|Overall Study|Lost to Follow-up|1|||
164677849|NCT02105272|594844877|FG000|Overall Study|Adverse Event|1|||
164242403|NCT01299389|593258520|FG000|Double-blind|Lack of Efficacy|45|||
164242404|NCT01299389|593258521|FG001|Double-blind|Lack of Efficacy|21|||
164242405|NCT01299389|593258522|FG002|Double-blind|Lack of Efficacy|0|||
164242406|NCT01299389|593258523|FG003|Double-blind|Lack of Efficacy|0|||
164242407|NCT01299389|593258520|FG000|Double-blind|Lost to Follow-up|2|||
164242408|NCT01299389|593258521|FG001|Double-blind|Lost to Follow-up|1|||
164242409|NCT01299389|593258522|FG002|Double-blind|Lost to Follow-up|0|||
164242410|NCT01299389|593258523|FG003|Double-blind|Lost to Follow-up|0|||
164242411|NCT01299389|593258520|FG000|Double-blind|Withdrawal by Subject|16|||
164242412|NCT01299389|593258521|FG001|Double-blind|Withdrawal by Subject|13|||
164242413|NCT01299389|593258522|FG002|Double-blind|Withdrawal by Subject|0|||
164242414|NCT01299389|593258523|FG003|Double-blind|Withdrawal by Subject|0|||
164242415|NCT01299389|593258520|FG000|Double-blind|Other|1|||
164242416|NCT01299389|593258521|FG001|Double-blind|Other|1|||
164242417|NCT01299389|593258522|FG002|Double-blind|Other|0|||
164242418|NCT01299389|593258523|FG003|Double-blind|Other|0|||
164242419|NCT01299389|593258520|FG000|Double-blind|"fail to meet study population criteria"|0|||
164242420|NCT01299389|593258521|FG001|Double-blind|"fail to meet study population criteria"|1|||
164242421|NCT01299389|593258522|FG002|Double-blind|"fail to meet study population criteria"|0|||
164242422|NCT01299389|593258523|FG003|Double-blind|"fail to meet study population criteria"|0|||
164242423|NCT01299389|593258520|FG000|Post-observational|Other|0|||
164242424|NCT01299389|593258521|FG001|Post-observational|Other|0|||
164242425|NCT01299389|593258522|FG002|Post-observational|Other|12|||
164242426|NCT01299389|593258523|FG003|Post-observational|Other|6|||
164242427|NCT02834819|593258524|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
164242428|NCT02834819|593258525|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
164242429|NCT03637491|593258526|FG000|Overall Study|Death|9|||
164242430|NCT03637491|593258527|FG001|Overall Study|Death|9|||
164242431|NCT03637491|593258528|FG002|Overall Study|Death|5|||
164242432|NCT03637491|593258529|FG003|Overall Study|Death|3|||
164242433|NCT03637491|593258526|FG000|Overall Study|Lost to Follow-up|0|||
164242434|NCT03637491|593258527|FG001|Overall Study|Lost to Follow-up|1|||
164242435|NCT03637491|593258528|FG002|Overall Study|Lost to Follow-up|0|||
164242436|NCT03637491|593258529|FG003|Overall Study|Lost to Follow-up|1|||
164242437|NCT03637491|593258526|FG000|Overall Study|Study Terminated By Sponsor|0|||
164242438|NCT03637491|593258527|FG001|Overall Study|Study Terminated By Sponsor|2|||
164242439|NCT03637491|593258528|FG002|Overall Study|Study Terminated By Sponsor|1|||
164242440|NCT03637491|593258529|FG003|Overall Study|Study Terminated By Sponsor|0|||
164242441|NCT03637491|593258526|FG000|Overall Study|Withdrawal by Subject|1|||
164336488|NCT01543698|593609730|FG010|Phase 1b|Protocol Violation|0|||
164336489|NCT01543698|593609731|FG011|Phase 1b|Protocol Violation|0|||
164336490|NCT01543698|593609732|FG012|Phase 1b|Protocol Violation|0|||
164336491|NCT01543698|593609733|FG013|Phase 1b|Protocol Violation|0|||
164242442|NCT03637491|593258527|FG001|Overall Study|Withdrawal by Subject|0|||
164336492|NCT01543698|593609734|FG014|Phase 1b|Protocol Violation|0|||
164336493|NCT01543698|593609720|FG000|Phase 2|Protocol Violation|0|||
164677850|NCT02105272|594844878|FG001|Overall Study|Adverse Event|2|||
164336494|NCT01543698|593609721|FG001|Phase 2|Protocol Violation|0|||
164677851|NCT02105272|594844877|FG000|Overall Study|Physician Decision|0|||
164242443|NCT03637491|593258528|FG002|Overall Study|Withdrawal by Subject|1|||
164336495|NCT01543698|593609722|FG002|Phase 2|Protocol Violation|0|||
164336496|NCT01543698|593609723|FG003|Phase 2|Protocol Violation|0|||
164336497|NCT01543698|593609724|FG004|Phase 2|Protocol Violation|0|||
164336498|NCT01543698|593609725|FG005|Phase 2|Protocol Violation|0|||
164677852|NCT02105272|594844878|FG001|Overall Study|Physician Decision|1|||
164242444|NCT03637491|593258529|FG003|Overall Study|Withdrawal by Subject|2|||
164242445|NCT00889707|593258530|FG000|Overall Study|Adverse Event|1|||
164242446|NCT00889707|593258531|FG001|Overall Study|Adverse Event|0|||
164242447|NCT00889707|593258530|FG000|Overall Study|Withdrawal by Subject|4|||
164242448|NCT00889707|593258531|FG001|Overall Study|Withdrawal by Subject|3|||
164242449|NCT00889707|593258530|FG000|Overall Study|Lost to Follow-up|0|||
164242450|NCT00889707|593258531|FG001|Overall Study|Lost to Follow-up|2|||
164242451|NCT00889707|593258530|FG000|Overall Study|Lack of Efficacy|2|||
164242452|NCT00889707|593258531|FG001|Overall Study|Lack of Efficacy|5|||
164242453|NCT02185534|593258532|FG000|First Period|Withdrawal by Subject|0|||
164242454|NCT02185534|593258533|FG001|First Period|Withdrawal by Subject|0|||
164242455|NCT02185534|593258534|FG002|First Period|Withdrawal by Subject|0|||
164242456|NCT02185534|593258535|FG003|First Period|Withdrawal by Subject|1|||
164242457|NCT02185534|593258536|FG004|First Period|Withdrawal by Subject|0|||
164242458|NCT02185534|593258537|FG005|First Period|Withdrawal by Subject|0|||
164242459|NCT02185534|593258532|FG000|First Washout Period|Withdrawal by Subject|1|||
164242460|NCT02185534|593258533|FG001|First Washout Period|Withdrawal by Subject|0|||
164242461|NCT02185534|593258534|FG002|First Washout Period|Withdrawal by Subject|0|||
164242462|NCT02185534|593258535|FG003|First Washout Period|Withdrawal by Subject|0|||
164242463|NCT02185534|593258536|FG004|First Washout Period|Withdrawal by Subject|1|||
164242464|NCT02185534|593258537|FG005|First Washout Period|Withdrawal by Subject|0|||
164242465|NCT02185534|593258532|FG000|First Washout Period|Protocol Violation|0|||
164242466|NCT02185534|593258533|FG001|First Washout Period|Protocol Violation|0|||
164242467|NCT02185534|593258534|FG002|First Washout Period|Protocol Violation|0|||
164242468|NCT02185534|593258535|FG003|First Washout Period|Protocol Violation|0|||
164242469|NCT02185534|593258536|FG004|First Washout Period|Protocol Violation|0|||
164242470|NCT02185534|593258537|FG005|First Washout Period|Protocol Violation|1|||
164242471|NCT02737501|593258547|FG000|Randomized Phase|Died|41|||
164242472|NCT02737501|593258548|FG001|Randomized Phase|Died|29|||
164242473|NCT02737501|593258549|FG002|Randomized Phase|Died|0|||
164242474|NCT02737501|593258547|FG000|Randomized Phase|Withdrawal by Subject|16|||
164242475|NCT02737501|593258548|FG001|Randomized Phase|Withdrawal by Subject|6|||
164242476|NCT02737501|593258549|FG002|Randomized Phase|Withdrawal by Subject|0|||
164242477|NCT02737501|593258547|FG000|Randomized Phase|Lost to Follow-up|0|||
164242478|NCT02737501|593258548|FG001|Randomized Phase|Lost to Follow-up|1|||
164242479|NCT02737501|593258549|FG002|Randomized Phase|Lost to Follow-up|0|||
164242480|NCT02737501|593258547|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
164242481|NCT02737501|593258548|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
164242482|NCT02737501|593258549|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
164242483|NCT02737501|593258547|FG000|Randomized Phase|Reason not Specified|1|||
164242484|NCT02737501|593258548|FG001|Randomized Phase|Reason not Specified|1|||
164242485|NCT02737501|593258549|FG002|Randomized Phase|Reason not Specified|0|||
164242486|NCT02737501|593258547|FG000|Randomized Phase|Never Treated|1|||
164242487|NCT02737501|593258548|FG001|Randomized Phase|Never Treated|1|||
164242488|NCT02737501|593258549|FG002|Randomized Phase|Never Treated|0|||
164242489|NCT02737501|593258547|FG000|Crossover Phase|Died|0|||
164242490|NCT02737501|593258548|FG001|Crossover Phase|Died|0|||
164242491|NCT02737501|593258549|FG002|Crossover Phase|Died|22|||
164242492|NCT02737501|593258547|FG000|Crossover Phase|Withdrew Consent|0|||
164242493|NCT02737501|593258548|FG001|Crossover Phase|Withdrew Consent|0|||
164242494|NCT02737501|593258549|FG002|Crossover Phase|Withdrew Consent|9|||
164242495|NCT02737501|593258547|FG000|Crossover Phase|Physician Decision|0|||
164425428|NCT02412761|593928484|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
164425429|NCT02412761|593928485|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
164425430|NCT02412761|593928486|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
164425431|NCT02412761|593928487|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
164425432|NCT05968482|593928488|FG000|First Crossover Period|Withdrawal by Subject|0|||
164425433|NCT05968482|593928489|FG001|First Crossover Period|Withdrawal by Subject|0|||
164425434|NCT05968482|593928490|FG002|First Crossover Period|Withdrawal by Subject|1|||
164425435|NCT05968482|593928491|FG003|First Crossover Period|Withdrawal by Subject|0|||
164425436|NCT05968482|593928492|FG004|First Crossover Period|Withdrawal by Subject|0|||
164425437|NCT05968482|593928493|FG005|First Crossover Period|Withdrawal by Subject|0|||
164573654|NCT02901431|594463431|FG011|Open Label Part|Withdrawal by Subject|3|||
164573655|NCT02901431|594463432|FG012|Open Label Part|Withdrawal by Subject|1|||
164242496|NCT02737501|593258548|FG001|Crossover Phase|Physician Decision|0|||
164242497|NCT02737501|593258549|FG002|Crossover Phase|Physician Decision|1|||
164242498|NCT02737501|593258547|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
164242499|NCT02737501|593258548|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
164242500|NCT02737501|593258549|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
164242501|NCT02012218|593258550|FG000|Overall Study|Withdrawal by Subject|1|||
164242502|NCT02012218|593258551|FG001|Overall Study|Withdrawal by Subject|0|||
164242503|NCT02012218|593258552|FG002|Overall Study|Withdrawal by Subject|1|||
164425438|NCT05968482|593928488|FG000|First Crossover Period|Adverse Event|0|||
164425439|NCT05968482|593928489|FG001|First Crossover Period|Adverse Event|0|||
164425440|NCT05968482|593928490|FG002|First Crossover Period|Adverse Event|0|||
164242504|NCT02012218|593258553|FG003|Overall Study|Withdrawal by Subject|1|||
164242505|NCT02012218|593258554|FG004|Overall Study|Withdrawal by Subject|1|||
164242506|NCT02012218|593258550|FG000|Overall Study|Adverse Event|1|||
164242507|NCT02012218|593258551|FG001|Overall Study|Adverse Event|0|||
164242508|NCT02012218|593258552|FG002|Overall Study|Adverse Event|0|||
164242509|NCT02012218|593258553|FG003|Overall Study|Adverse Event|1|||
164242510|NCT02012218|593258554|FG004|Overall Study|Adverse Event|0|||
164242511|NCT02012218|593258550|FG000|Overall Study|Lost to Follow-up|0|||
164242512|NCT02012218|593258551|FG001|Overall Study|Lost to Follow-up|1|||
164242513|NCT02012218|593258552|FG002|Overall Study|Lost to Follow-up|1|||
164242514|NCT02012218|593258553|FG003|Overall Study|Lost to Follow-up|0|||
164242515|NCT02012218|593258554|FG004|Overall Study|Lost to Follow-up|0|||
164242516|NCT02012218|593258550|FG000|Overall Study|Protocol Specified|1|||
164242517|NCT02012218|593258551|FG001|Overall Study|Protocol Specified|0|||
164242518|NCT02012218|593258552|FG002|Overall Study|Protocol Specified|0|||
164242519|NCT02012218|593258553|FG003|Overall Study|Protocol Specified|0|||
164242520|NCT02012218|593258554|FG004|Overall Study|Protocol Specified|0|||
164242521|NCT02012218|593258550|FG000|Overall Study|Protocol Deviation|1|||
164242522|NCT02012218|593258551|FG001|Overall Study|Protocol Deviation|0|||
164242523|NCT02012218|593258552|FG002|Overall Study|Protocol Deviation|0|||
164242524|NCT02012218|593258553|FG003|Overall Study|Protocol Deviation|0|||
164242525|NCT02012218|593258554|FG004|Overall Study|Protocol Deviation|0|||
164242526|NCT04819113|593258555|FG000|Overall Study|Withdrawal by parent/guardian|3|||
164242527|NCT04819113|593258555|FG000|Overall Study|Lost to Follow-up|1|||
164242528|NCT04819113|593258555|FG000|Overall Study|Withdrawn before vaccination|2|||
164242529|NCT00786422|593258556|FG000|Rivaroxaban Treatment|Death|2|||
164242530|NCT00786422|593258556|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
164242531|NCT00786422|593258556|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
164242532|NCT00786422|593258556|FG000|Rivaroxaban Treatment|Physician Decision|1|||
164242533|NCT00786422|593258556|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
164242534|NCT00786422|593258556|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
164242535|NCT00786422|593258556|FG000|Rivaroxaban Treatment|Adverse Event|2|||
164242536|NCT00786422|593258556|FG000|Follow-up Period|Death|1|||
164242537|NCT00786422|593258556|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
164242538|NCT01085214|593258559|FG000|Overall Study|Alternate treatment required|1|||
164242539|NCT01985022|593258573|FG000|Overall Study|Lost to Follow-up|0|||
164242540|NCT01985022|593258574|FG001|Overall Study|Lost to Follow-up|1|||
164336499|NCT01543698|593609726|FG006|Phase 2|Protocol Violation|0|||
164336500|NCT01543698|593609727|FG007|Phase 2|Protocol Violation|0|||
164336501|NCT01543698|593609728|FG008|Phase 2|Protocol Violation|0|||
164336502|NCT01543698|593609729|FG009|Phase 2|Protocol Violation|0|||
164336503|NCT01543698|593609730|FG010|Phase 2|Protocol Violation|0|||
164336504|NCT01543698|593609731|FG011|Phase 2|Protocol Violation|0|||
164336505|NCT01543698|593609732|FG012|Phase 2|Protocol Violation|1|||
164336506|NCT01543698|593609733|FG013|Phase 2|Protocol Violation|0|||
164336507|NCT01543698|593609734|FG014|Phase 2|Protocol Violation|0|||
164336508|NCT01543698|593609720|FG000|Phase 2|Disease progression|0|||
164336509|NCT01543698|593609721|FG001|Phase 2|Disease progression|0|||
164336510|NCT01543698|593609722|FG002|Phase 2|Disease progression|0|||
164336511|NCT01543698|593609723|FG003|Phase 2|Disease progression|0|||
164336512|NCT01543698|593609724|FG004|Phase 2|Disease progression|0|||
164336513|NCT01543698|593609725|FG005|Phase 2|Disease progression|0|||
164336514|NCT01543698|593609726|FG006|Phase 2|Disease progression|0|||
164336515|NCT01543698|593609727|FG007|Phase 2|Disease progression|0|||
164336516|NCT01543698|593609728|FG008|Phase 2|Disease progression|0|||
164425441|NCT05968482|593928491|FG003|First Crossover Period|Adverse Event|0|||
164425442|NCT05968482|593928492|FG004|First Crossover Period|Adverse Event|0|||
164425443|NCT05968482|593928493|FG005|First Crossover Period|Adverse Event|1|||
164425444|NCT05968482|593928488|FG000|Second Crossover Period|Withdrawal by Subject|0|||
164677853|NCT02105272|594844877|FG000|Overall Study|Protocol Violation|2|||
164677854|NCT02105272|594844878|FG001|Overall Study|Protocol Violation|0|||
164677855|NCT02105272|594844877|FG000|Overall Study|Withdrawal by Subject|2|||
164242541|NCT01985022|593258573|FG000|Overall Study|Protocol Violation|0|||
164242542|NCT01985022|593258574|FG001|Overall Study|Protocol Violation|1|||
164242543|NCT01985022|593258573|FG000|Overall Study|Withdrawal by Subject|4|||
164242544|NCT01985022|593258574|FG001|Overall Study|Withdrawal by Subject|1|||
164242545|NCT03761056|593258579|FG000|Overall Study|Death|8|||
164242546|NCT03761056|593258579|FG000|Overall Study|Enrolled but never treated|2|||
164242547|NCT03761056|593258579|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
164242548|NCT03761056|593258579|FG000|Overall Study|Investigator decision|1|||
164242549|NCT00996658|593258580|FG000|Overall Study|Adverse Event|2|||
164336517|NCT01543698|593609729|FG009|Phase 2|Disease progression|0|||
164336518|NCT01543698|593609730|FG010|Phase 2|Disease progression|0|||
164336519|NCT01543698|593609731|FG011|Phase 2|Disease progression|10|||
164336520|NCT01543698|593609732|FG012|Phase 2|Disease progression|21|||
164336521|NCT01543698|593609733|FG013|Phase 2|Disease progression|30|||
164336522|NCT01543698|593609734|FG014|Phase 2|Disease progression|25|||
164336523|NCT01543698|593609720|FG000|Phase 2|Death|0|||
164677856|NCT02105272|594844878|FG001|Overall Study|Withdrawal by Subject|0|||
164677857|NCT00318461|594844881|FG000|Double-Blind, 6 Months|Adverse Event|11|||
164677858|NCT00318461|594844882|FG001|Double-Blind, 6 Months|Adverse Event|23|||
164677859|NCT00318461|594844883|FG002|Double-Blind, 6 Months|Adverse Event|29|||
164677860|NCT00318461|594844884|FG003|Double-Blind, 6 Months|Adverse Event|2|||
164677861|NCT00318461|594844885|FG004|Double-Blind, 6 Months|Adverse Event|8|||
164677862|NCT00318461|594844881|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
164677863|NCT00318461|594844882|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
164677864|NCT00318461|594844883|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
164677865|NCT00318461|594844884|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
164677866|NCT00318461|594844885|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
164677867|NCT00318461|594844881|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
164677868|NCT00318461|594844882|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
164677869|NCT00318461|594844883|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
164677870|NCT00318461|594844884|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
164677871|NCT00318461|594844885|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
164677872|NCT00318461|594844881|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
164677873|NCT00318461|594844882|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
164677874|NCT00318461|594844883|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
164677875|NCT00318461|594844884|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
164677876|NCT00318461|594844885|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
164677877|NCT00318461|594844881|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
164677878|NCT00318461|594844882|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
164677879|NCT00318461|594844883|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
164677880|NCT00318461|594844884|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
164677881|NCT00318461|594844885|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
164677882|NCT00318461|594844881|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
164677883|NCT00318461|594844882|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
164677884|NCT00318461|594844883|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
164677885|NCT00318461|594844884|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
164677886|NCT00318461|594844885|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
164677887|NCT00318461|594844881|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
164677888|NCT00318461|594844882|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
164677889|NCT00318461|594844883|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
164677890|NCT00318461|594844884|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
164677891|NCT00318461|594844885|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
164677892|NCT00318461|594844881|FG000|Double-Blind, 6 Months|Move|0|||
164677893|NCT00318461|594844882|FG001|Double-Blind, 6 Months|Move|1|||
164677894|NCT00318461|594844883|FG002|Double-Blind, 6 Months|Move|0|||
164677895|NCT00318461|594844884|FG003|Double-Blind, 6 Months|Move|0|||
164677896|NCT00318461|594844885|FG004|Double-Blind, 6 Months|Move|0|||
164677897|NCT00318461|594844881|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
164677898|NCT00318461|594844882|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
164677899|NCT00318461|594844883|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
164677900|NCT00318461|594844884|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
164677901|NCT00318461|594844885|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
164677902|NCT00318461|594844881|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
164677903|NCT00318461|594844882|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
164677904|NCT00318461|594844883|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
164677905|NCT00318461|594844884|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
164677906|NCT00318461|594844885|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
164677907|NCT00318461|594844881|FG000|Double-Blind, 6 Months|Work commitment|0|||
164677908|NCT00318461|594844882|FG001|Double-Blind, 6 Months|Work commitment|0|||
164677909|NCT00318461|594844883|FG002|Double-Blind, 6 Months|Work commitment|0|||
164677910|NCT00318461|594844884|FG003|Double-Blind, 6 Months|Work commitment|0|||
164677911|NCT00318461|594844885|FG004|Double-Blind, 6 Months|Work commitment|1|||
164677912|NCT00318461|594844881|FG000|Double-Blind, 6 Months|Investigator decision|0|||
164677913|NCT00318461|594844882|FG001|Double-Blind, 6 Months|Investigator decision|0|||
164677914|NCT00318461|594844883|FG002|Double-Blind, 6 Months|Investigator decision|0|||
164677915|NCT00318461|594844884|FG003|Double-Blind, 6 Months|Investigator decision|0|||
164677916|NCT00318461|594844885|FG004|Double-Blind, 6 Months|Investigator decision|1|||
164677917|NCT00318461|594844881|FG000|Double-Blind, 6 Months|Lack of time|1|||
164677918|NCT00318461|594844882|FG001|Double-Blind, 6 Months|Lack of time|0|||
164677919|NCT00318461|594844883|FG002|Double-Blind, 6 Months|Lack of time|0|||
164677920|NCT00318461|594844884|FG003|Double-Blind, 6 Months|Lack of time|0|||
164677921|NCT00318461|594844885|FG004|Double-Blind, 6 Months|Lack of time|0|||
164677922|NCT00318461|594844881|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
164677923|NCT00318461|594844882|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
164677924|NCT00318461|594844883|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
164677925|NCT00318461|594844884|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
164677926|NCT00318461|594844885|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
164677927|NCT00318461|594844881|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
164677928|NCT00318461|594844882|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
164677929|NCT00318461|594844883|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
164677930|NCT00318461|594844884|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
164677931|NCT00318461|594844885|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
164677932|NCT00318461|594844881|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
164677933|NCT00318461|594844882|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
164336524|NCT01543698|593609721|FG001|Phase 2|Death|0|||
164336525|NCT01543698|593609722|FG002|Phase 2|Death|0|||
164336526|NCT01543698|593609723|FG003|Phase 2|Death|0|||
164573656|NCT02500537|594463433|FG000|Overall Study|Death|2|||
164573657|NCT02500537|594463434|FG001|Overall Study|Death|0|||
164573658|NCT02500537|594463433|FG000|Overall Study|Lost to Follow-up|0|||
164573659|NCT02500537|594463434|FG001|Overall Study|Lost to Follow-up|1|||
164573660|NCT02500537|594463433|FG000|Overall Study|Withdrawal by Subject|1|||
164573661|NCT02500537|594463434|FG001|Overall Study|Withdrawal by Subject|0|||
164573662|NCT03832387|594463437|FG000|Overall Study|Protocol Violation|2|||
164573663|NCT03832387|594463438|FG001|Overall Study|Protocol Violation|6|||
164573664|NCT03832387|594463437|FG000|Overall Study|EXCLUSION CRITERIA|3|||
164573665|NCT03832387|594463438|FG001|Overall Study|EXCLUSION CRITERIA|1|||
164573666|NCT05775289|594463439|FG000|Overall Study|Study Ongoing|20|||
164573667|NCT05775289|594463440|FG001|Overall Study|Study Ongoing|53|||
164573668|NCT05775289|594463441|FG002|Overall Study|Study Ongoing|15|||
164573669|NCT05775289|594463442|FG003|Overall Study|Study Ongoing|55|||
164573670|NCT05775289|594463439|FG000|Overall Study|Death|4|||
164573671|NCT05775289|594463440|FG001|Overall Study|Death|11|||
164573672|NCT05775289|594463441|FG002|Overall Study|Death|8|||
164573673|NCT05775289|594463442|FG003|Overall Study|Death|12|||
164573674|NCT05775289|594463439|FG000|Overall Study|Lost to Follow-up|0|||
164573675|NCT05775289|594463440|FG001|Overall Study|Lost to Follow-up|1|||
164573676|NCT05775289|594463441|FG002|Overall Study|Lost to Follow-up|0|||
164573677|NCT05775289|594463442|FG003|Overall Study|Lost to Follow-up|0|||
164573678|NCT05775289|594463439|FG000|Overall Study|Progressive Disease|0|||
164573679|NCT05775289|594463440|FG001|Overall Study|Progressive Disease|0|||
164573680|NCT05775289|594463441|FG002|Overall Study|Progressive Disease|1|||
164573681|NCT05775289|594463442|FG003|Overall Study|Progressive Disease|0|||
164573682|NCT05775289|594463439|FG000|Overall Study|Withdrawal by Subject|1|||
164573683|NCT05775289|594463440|FG001|Overall Study|Withdrawal by Subject|1|||
164573684|NCT05775289|594463441|FG002|Overall Study|Withdrawal by Subject|0|||
164573685|NCT05775289|594463442|FG003|Overall Study|Withdrawal by Subject|0|||
164573686|NCT01291017|594463444|FG000|Overall Study|Lost to Follow-up|2|||
164573687|NCT01291017|594463444|FG000|Overall Study|Withdrawal by Subject|3|||
164573688|NCT00215150|594465480|FG000|Open Label Phase|Lost to Follow-up|7|||
164573689|NCT00215150|594465480|FG000|Open Label Phase|Withdrawal by Subject|1|||
164573690|NCT00215150|594465480|FG000|Open Label Phase|Did not complete a post base visit|13|||
164573691|NCT00215150|594465480|FG000|Open Label Phase|Did not meet randomization criteria|9|||
164573692|NCT00215150|594465480|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
164573693|NCT00215150|594465480|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
164573694|NCT00215150|594465480|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
164573695|NCT00783289|594465483|FG000|Overall Study|Protocol Violation|0|||
164573696|NCT00783289|594465484|FG001|Overall Study|Protocol Violation|1|||
164573697|NCT00783289|594465485|FG002|Overall Study|Protocol Violation|0|||
164573698|NCT00783289|594465486|FG003|Overall Study|Protocol Violation|0|||
164573699|NCT00506389|594465487|FG000|In-treatment Period|Other|3|||
164573700|NCT00506389|594465488|FG001|In-treatment Period|Other|3|||
164336527|NCT01543698|593609724|FG004|Phase 2|Death|0|||
164336528|NCT01543698|593609725|FG005|Phase 2|Death|0|||
164573701|NCT00506389|594465489|FG002|In-treatment Period|Other|4|||
164573702|NCT00506389|594465487|FG000|In-treatment Period|Lost to Follow-up|0|||
164573703|NCT00506389|594465488|FG001|In-treatment Period|Lost to Follow-up|0|||
164573704|NCT00506389|594465489|FG002|In-treatment Period|Lost to Follow-up|1|||
164573705|NCT00506389|594465487|FG000|In-treatment Period|Lack of compliance|1|||
164573706|NCT00506389|594465488|FG001|In-treatment Period|Lack of compliance|0|||
164573707|NCT00506389|594465489|FG002|In-treatment Period|Lack of compliance|0|||
164677934|NCT00318461|594844883|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
164336529|NCT01543698|593609726|FG006|Phase 2|Death|0|||
164573708|NCT00506389|594465487|FG000|In-treatment Period|Reasons not related to trial|4|||
164573709|NCT00506389|594465488|FG001|In-treatment Period|Reasons not related to trial|1|||
164573710|NCT00506389|594465489|FG002|In-treatment Period|Reasons not related to trial|0|||
164573711|NCT00506389|594465487|FG000|In-treatment Period|Withdrawal by Subject|3|||
164573712|NCT00506389|594465488|FG001|In-treatment Period|Withdrawal by Subject|3|||
164336530|NCT01543698|593609727|FG007|Phase 2|Death|0|||
164336531|NCT01543698|593609728|FG008|Phase 2|Death|0|||
164336532|NCT01543698|593609729|FG009|Phase 2|Death|0|||
164336533|NCT01543698|593609730|FG010|Phase 2|Death|0|||
164336534|NCT01543698|593609731|FG011|Phase 2|Death|0|||
164336535|NCT01543698|593609732|FG012|Phase 2|Death|1|||
164336536|NCT01543698|593609733|FG013|Phase 2|Death|1|||
164336537|NCT01543698|593609734|FG014|Phase 2|Death|1|||
164336538|NCT01543698|593609720|FG000|Phase 2|Administrative problems|0|||
164573713|NCT00506389|594465489|FG002|In-treatment Period|Withdrawal by Subject|4|||
164336539|NCT01543698|593609721|FG001|Phase 2|Administrative problems|0|||
164336540|NCT01543698|593609722|FG002|Phase 2|Administrative problems|0|||
164336541|NCT01543698|593609723|FG003|Phase 2|Administrative problems|0|||
164336542|NCT01543698|593609724|FG004|Phase 2|Administrative problems|0|||
164336543|NCT01543698|593609725|FG005|Phase 2|Administrative problems|0|||
164336544|NCT01543698|593609726|FG006|Phase 2|Administrative problems|0|||
164336545|NCT01543698|593609727|FG007|Phase 2|Administrative problems|0|||
164336546|NCT01543698|593609728|FG008|Phase 2|Administrative problems|0|||
164336547|NCT01543698|593609729|FG009|Phase 2|Administrative problems|0|||
164336548|NCT01543698|593609730|FG010|Phase 2|Administrative problems|0|||
164336549|NCT01543698|593609731|FG011|Phase 2|Administrative problems|0|||
164336550|NCT01543698|593609732|FG012|Phase 2|Administrative problems|0|||
164573714|NCT00506389|594465487|FG000|In-treatment Period|Lack of Efficacy|0|||
164573715|NCT00506389|594465488|FG001|In-treatment Period|Lack of Efficacy|2|||
164573716|NCT00506389|594465489|FG002|In-treatment Period|Lack of Efficacy|0|||
164573717|NCT00506389|594465487|FG000|In-treatment Period|Adverse Event|11|||
164573718|NCT00506389|594465488|FG001|In-treatment Period|Adverse Event|5|||
164573719|NCT00506389|594465489|FG002|In-treatment Period|Adverse Event|2|||
164573720|NCT00506389|594465487|FG000|In-treatment Period|Randomized but not treated|4|||
164573721|NCT00506389|594465488|FG001|In-treatment Period|Randomized but not treated|1|||
164573722|NCT00506389|594465489|FG002|In-treatment Period|Randomized but not treated|1|||
164573723|NCT05224258|594465491|FG000|Overall Study|Withdrawal by Subject|1|||
164573724|NCT05224258|594465492|FG001|Overall Study|Withdrawal by Subject|1|||
164573725|NCT05224258|594465491|FG000|Overall Study|Physician Decision|1|||
164573726|NCT05224258|594465492|FG001|Overall Study|Physician Decision|1|||
164573727|NCT05224258|594465491|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
164573728|NCT05224258|594465492|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164573729|NCT05224258|594465491|FG000|Overall Study|Study Product No Longer in Use|1|||
164573730|NCT05224258|594465492|FG001|Overall Study|Study Product No Longer in Use|0|||
164573731|NCT05224258|594465491|FG000|Overall Study|Adverse Event|0|||
164573732|NCT05224258|594465492|FG001|Overall Study|Adverse Event|1|||
164573733|NCT05224258|594465491|FG000|Overall Study|Protocol Deviation|0|||
164573734|NCT05224258|594465492|FG001|Overall Study|Protocol Deviation|1|||
164573735|NCT03095703|594465494|FG000|Overall Study|Withdrawal by Subject|1|||
164573736|NCT00476086|594465501|FG000|Overall Study|Alternative therapy|1|||
164573737|NCT00476086|594465501|FG000|Overall Study|Progressive Disease|4|||
164573738|NCT02900092|594465502|FG000|Overall Study|Adverse Event|1|||
164573739|NCT02292849|594465503|FG000|Overall Study|Lost to Follow-up|0|||
164573740|NCT02292849|594465504|FG001|Overall Study|Lost to Follow-up|2|||
164573741|NCT02292849|594465505|FG002|Overall Study|Lost to Follow-up|2|||
164573742|NCT02292849|594465503|FG000|Overall Study|Physician Decision|4|||
164573743|NCT02292849|594465504|FG001|Overall Study|Physician Decision|0|||
164573744|NCT02292849|594465505|FG002|Overall Study|Physician Decision|0|||
164573745|NCT01562028|594465506|FG000|Overall Study|Withdrawal by Subject|1|||
164573746|NCT01562028|594465507|FG001|Overall Study|Withdrawal by Subject|1|||
164573747|NCT01562028|594465506|FG000|Overall Study|Lost to Follow-up|2|||
164573748|NCT01562028|594465507|FG001|Overall Study|Lost to Follow-up|1|||
164573749|NCT00775021|594465511|FG000|First Intervention|Lost to Follow-up|1|||
164573750|NCT00775021|594465512|FG001|First Intervention|Lost to Follow-up|0|||
164573751|NCT00775021|594465511|FG000|Second Intervention|Adverse Event|0|||
164573752|NCT00775021|594465512|FG001|Second Intervention|Adverse Event|1|||
164336551|NCT01543698|593609733|FG013|Phase 2|Administrative problems|3|||
164336552|NCT01543698|593609734|FG014|Phase 2|Administrative problems|1|||
164336553|NCT01543698|593609720|FG000|Phase 2|Withdrawal by Subject|0|||
164573753|NCT00363415|594465513|FG000|Overall Study|Progressive Disease|196|||
164573754|NCT00363415|594465514|FG001|Overall Study|Progressive Disease|107|||
164573755|NCT00363415|594465513|FG000|Overall Study|Sponsor Decision|67|||
164573756|NCT00363415|594465514|FG001|Overall Study|Sponsor Decision|31|||
164573757|NCT00363415|594465513|FG000|Overall Study|Death|32|||
164573758|NCT00363415|594465514|FG001|Overall Study|Death|29|||
164336554|NCT01543698|593609721|FG001|Phase 2|Withdrawal by Subject|0|||
164336555|NCT01543698|593609722|FG002|Phase 2|Withdrawal by Subject|0|||
164336556|NCT01543698|593609723|FG003|Phase 2|Withdrawal by Subject|0|||
164336557|NCT01543698|593609724|FG004|Phase 2|Withdrawal by Subject|0|||
164573759|NCT00363415|594465513|FG000|Overall Study|Adverse Event|24|||
164573760|NCT00363415|594465514|FG001|Overall Study|Adverse Event|15|||
164336558|NCT01543698|593609725|FG005|Phase 2|Withdrawal by Subject|0|||
164336559|NCT01543698|593609726|FG006|Phase 2|Withdrawal by Subject|0|||
164336560|NCT01543698|593609727|FG007|Phase 2|Withdrawal by Subject|0|||
164336561|NCT01543698|593609728|FG008|Phase 2|Withdrawal by Subject|0|||
164336562|NCT01543698|593609729|FG009|Phase 2|Withdrawal by Subject|0|||
164677935|NCT00318461|594844884|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
164677936|NCT00318461|594844885|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
164677937|NCT00318461|594844881|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
164677938|NCT00318461|594844882|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
164677939|NCT00318461|594844883|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
164677940|NCT00318461|594844884|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
164677941|NCT00318461|594844885|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
164677942|NCT00318461|594844881|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
164677943|NCT00318461|594844882|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
164677944|NCT00318461|594844883|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
164677945|NCT00318461|594844884|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
164677946|NCT00318461|594844885|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
164677947|NCT00318461|594844881|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
164677948|NCT00318461|594844882|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
164677949|NCT00318461|594844883|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
164677950|NCT00318461|594844884|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
164677951|NCT00318461|594844885|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
164677952|NCT00318461|594844881|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
164677953|NCT00318461|594844882|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
164677954|NCT00318461|594844883|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
164677955|NCT00318461|594844884|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
164677956|NCT00318461|594844885|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
164677957|NCT00318461|594844881|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
164677958|NCT00318461|594844882|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
164677959|NCT00318461|594844883|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
164242550|NCT00996658|593258581|FG001|Overall Study|Adverse Event|5|||
164242551|NCT00996658|593258580|FG000|Overall Study|Protocol Violation|0|||
164242552|NCT00996658|593258581|FG001|Overall Study|Protocol Violation|1|||
164242553|NCT00996658|593258580|FG000|Overall Study|Lost to Follow-up|2|||
164242554|NCT00996658|593258581|FG001|Overall Study|Lost to Follow-up|5|||
164242555|NCT00996658|593258580|FG000|Overall Study|Non-compliance issues|3|||
164242556|NCT00996658|593258581|FG001|Overall Study|Non-compliance issues|3|||
164242557|NCT00996658|593258580|FG000|Overall Study|Other|9|||
164242558|NCT00996658|593258581|FG001|Overall Study|Other|7|||
164242559|NCT04267926|593260283|FG000|Overall Study|abnormal labs. No longer eligible|0|||
164242560|NCT04267926|593260284|FG001|Overall Study|abnormal labs. No longer eligible|0|||
164242561|NCT04267926|593260285|FG002|Overall Study|abnormal labs. No longer eligible|1|||
164242562|NCT04267926|593260283|FG000|Overall Study|Iron infusion for fatigue. No longer eligible for study.|1|||
164242563|NCT04267926|593260284|FG001|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
164242564|NCT04267926|593260285|FG002|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
164242565|NCT00532129|593260286|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
164242566|NCT00532129|593260286|FG000|Treatment Period|Physician Decision|15|||
164242567|NCT00532129|593260286|FG000|Treatment Period|Disease progression|3|||
164242568|NCT00532129|593260286|FG000|Treatment Period|Protocol Violation|1|||
164242569|NCT00532129|593260286|FG000|Treatment Period|Other|5|||
164242570|NCT00532129|593260286|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
164242571|NCT00532129|593260286|FG000|Follow-up Period|Disease progression|57|||
164242572|NCT00532129|593260286|FG000|Follow-up Period|Lost to Follow-up|1|||
164242573|NCT00532129|593260286|FG000|Follow-up Period|Other|6|||
164242574|NCT01396187|593260287|FG000|Overall Study|Adverse Event|0|||
164242575|NCT01396187|593260288|FG001|Overall Study|Adverse Event|1|||
164242576|NCT01396187|593260289|FG002|Overall Study|Adverse Event|0|||
164242577|NCT01396187|593260290|FG003|Overall Study|Adverse Event|0|||
164242578|NCT01396187|593260291|FG004|Overall Study|Adverse Event|0|||
164242579|NCT01396187|593260287|FG000|Overall Study|Withdrawal by Subject|0|||
164242580|NCT01396187|593260288|FG001|Overall Study|Withdrawal by Subject|1|||
164242581|NCT01396187|593260289|FG002|Overall Study|Withdrawal by Subject|1|||
164242582|NCT01396187|593260290|FG003|Overall Study|Withdrawal by Subject|0|||
164242583|NCT01396187|593260291|FG004|Overall Study|Withdrawal by Subject|0|||
164242584|NCT01396187|593260287|FG000|Overall Study|Other|1|||
164242585|NCT01396187|593260288|FG001|Overall Study|Other|1|||
164242586|NCT01396187|593260289|FG002|Overall Study|Other|0|||
164242587|NCT01396187|593260290|FG003|Overall Study|Other|0|||
164242588|NCT01396187|593260291|FG004|Overall Study|Other|1|||
164242589|NCT00551031|593260292|FG000|Overall Study|Adverse Event|0|||
164242590|NCT00551031|593260293|FG001|Overall Study|Adverse Event|1|||
164242591|NCT00551031|593260294|FG002|Overall Study|Adverse Event|0|||
164242592|NCT00551031|593260295|FG003|Overall Study|Adverse Event|0|||
164242593|NCT00551031|593260296|FG004|Overall Study|Adverse Event|0|||
164336563|NCT01543698|593609730|FG010|Phase 2|Withdrawal by Subject|0|||
164242594|NCT00551031|593260292|FG000|Overall Study|Protocol Violation|1|||
164242595|NCT00551031|593260293|FG001|Overall Study|Protocol Violation|1|||
164677960|NCT00318461|594844884|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
164677961|NCT00318461|594844885|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
164677962|NCT00505622|594844886|FG000|Overall Study|Adverse Event|5|||
164677963|NCT00505622|594844887|FG001|Overall Study|Adverse Event|6|||
164677964|NCT00505622|594844888|FG002|Overall Study|Adverse Event|4|||
164677965|NCT00505622|594844886|FG000|Overall Study|Protocol Violation|1|||
164677966|NCT00505622|594844887|FG001|Overall Study|Protocol Violation|1|||
164677967|NCT00505622|594844888|FG002|Overall Study|Protocol Violation|0|||
164677968|NCT00505622|594844886|FG000|Overall Study|Withdrawal by Subject|0|||
164677969|NCT00505622|594844887|FG001|Overall Study|Withdrawal by Subject|3|||
164677970|NCT00505622|594844888|FG002|Overall Study|Withdrawal by Subject|2|||
164677971|NCT00505622|594844886|FG000|Overall Study|Study termination by sponsor|115|||
164677972|NCT00505622|594844887|FG001|Overall Study|Study termination by sponsor|98|||
164677973|NCT00505622|594844888|FG002|Overall Study|Study termination by sponsor|90|||
164677974|NCT00796653|594844889|FG000|Overall Study|Adverse Event|19|||
164677975|NCT00796653|594844890|FG001|Overall Study|Adverse Event|16|||
164677976|NCT00796653|594844891|FG002|Overall Study|Adverse Event|16|||
164677977|NCT00796653|594844892|FG003|Overall Study|Adverse Event|16|||
164677978|NCT00796653|594844889|FG000|Overall Study|Lost to Follow-up|2|||
164677979|NCT00796653|594844890|FG001|Overall Study|Lost to Follow-up|1|||
164677980|NCT00796653|594844891|FG002|Overall Study|Lost to Follow-up|2|||
164677981|NCT00796653|594844892|FG003|Overall Study|Lost to Follow-up|3|||
164677982|NCT00796653|594844889|FG000|Overall Study|Withdrawal by Subject|16|||
164677983|NCT00796653|594844890|FG001|Overall Study|Withdrawal by Subject|8|||
164677984|NCT00796653|594844891|FG002|Overall Study|Withdrawal by Subject|8|||
164677985|NCT00796653|594844892|FG003|Overall Study|Withdrawal by Subject|13|||
164677986|NCT00796653|594844889|FG000|Overall Study|Lack of Efficacy|8|||
164677987|NCT00796653|594844890|FG001|Overall Study|Lack of Efficacy|1|||
164677988|NCT00796653|594844891|FG002|Overall Study|Lack of Efficacy|3|||
164677989|NCT00796653|594844892|FG003|Overall Study|Lack of Efficacy|2|||
164677990|NCT00796653|594844889|FG000|Overall Study|Non compliance with protocol|2|||
164677991|NCT00796653|594844890|FG001|Overall Study|Non compliance with protocol|2|||
164677992|NCT00796653|594844891|FG002|Overall Study|Non compliance with protocol|0|||
164677993|NCT00796653|594844892|FG003|Overall Study|Non compliance with protocol|2|||
164677994|NCT00796653|594844889|FG000|Overall Study|Other reason not described above|4|||
164677995|NCT00796653|594844890|FG001|Overall Study|Other reason not described above|9|||
164677996|NCT00796653|594844891|FG002|Overall Study|Other reason not described above|7|||
164677997|NCT00796653|594844892|FG003|Overall Study|Other reason not described above|4|||
164677998|NCT02414152|594844897|FG000|Overall Study|Withdrawal by Subject|1|||
164677999|NCT02414152|594844897|FG000|Overall Study|Lack of Efficacy|1|||
164678000|NCT01757392|594844898|FG000|Overall Study|Withdrawal by Subject|1|||
164678001|NCT01757392|594844898|FG000|Overall Study|Screen Fail|3|||
164678002|NCT00841698|594844905|FG000|First Intervention|Withdrawal by Subject|1|||
164678003|NCT00841698|594844906|FG001|First Intervention|Withdrawal by Subject|0|||
164678004|NCT04078022|594844913|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
164678005|NCT04078022|594844914|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
164678006|NCT01250912|594844915|FG000|Overall Study|Lost to Follow-up|1|||
164678007|NCT00191815|594844916|FG000|Overall Study|Adverse Event|2|||
164678008|NCT00191815|594844916|FG000|Overall Study|Disease progression or relapse|24|||
164678009|NCT00191815|594844916|FG000|Overall Study|Death|2|||
164678010|NCT00191815|594844916|FG000|Overall Study|Protocol Violation|3|||
164678011|NCT00191815|594844916|FG000|Overall Study|Physician Decision|2|||
164678012|NCT00191815|594844916|FG000|Overall Study|Withdrawal by Subject|7|||
164678013|NCT01929863|594844919|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
164678014|NCT01929863|594844920|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
164678015|NCT01929863|594844919|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
164678016|NCT01929863|594844920|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
164678017|NCT01929863|594844919|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
164678018|NCT01929863|594844920|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
164336564|NCT01543698|593609731|FG011|Phase 2|Withdrawal by Subject|0|||
164336565|NCT01543698|593609732|FG012|Phase 2|Withdrawal by Subject|0|||
164336566|NCT01543698|593609733|FG013|Phase 2|Withdrawal by Subject|3|||
164336567|NCT01543698|593609734|FG014|Phase 2|Withdrawal by Subject|1|||
164336568|NCT01543698|593609720|FG000|Phase 2|Adverse Event|0|||
164336569|NCT01543698|593609721|FG001|Phase 2|Adverse Event|0|||
164336570|NCT01543698|593609722|FG002|Phase 2|Adverse Event|0|||
164336571|NCT01543698|593609723|FG003|Phase 2|Adverse Event|0|||
164336572|NCT01543698|593609724|FG004|Phase 2|Adverse Event|0|||
164336573|NCT01543698|593609725|FG005|Phase 2|Adverse Event|0|||
164336574|NCT01543698|593609726|FG006|Phase 2|Adverse Event|0|||
164336575|NCT01543698|593609727|FG007|Phase 2|Adverse Event|0|||
164336576|NCT01543698|593609728|FG008|Phase 2|Adverse Event|0|||
164336577|NCT01543698|593609729|FG009|Phase 2|Adverse Event|0|||
164336578|NCT01543698|593609730|FG010|Phase 2|Adverse Event|0|||
164678019|NCT01348789|594844926|FG000|Overall Study|Protocol Violation|2|||
164678020|NCT01348789|594844926|FG000|Overall Study|Withdrawal by Subject|2|||
164678021|NCT00415363|594844933|FG000|Overall Study|Withdrawal by Subject|4|||
164678022|NCT00415363|594844934|FG001|Overall Study|Withdrawal by Subject|4|||
164678023|NCT00415363|594844933|FG000|Overall Study|Adverse Event|4|||
164678024|NCT00415363|594844934|FG001|Overall Study|Adverse Event|4|||
164678025|NCT00415363|594844933|FG000|Overall Study|Lost to Follow-up|2|||
164678026|NCT00415363|594844934|FG001|Overall Study|Lost to Follow-up|1|||
164678027|NCT00415363|594844933|FG000|Overall Study|Physician Decision|3|||
164678028|NCT00415363|594844934|FG001|Overall Study|Physician Decision|1|||
164678029|NCT00415363|594844933|FG000|Overall Study|Death|16|||
164678030|NCT00415363|594844934|FG001|Overall Study|Death|12|||
164678031|NCT00415363|594844933|FG000|Overall Study|Progressive disease|26|||
164678032|NCT00415363|594844934|FG001|Overall Study|Progressive disease|32|||
164678033|NCT03123471|594844935|FG000|Placebo-controlled Phase|Adverse Event|3|||
164678034|NCT03123471|594844936|FG001|Placebo-controlled Phase|Adverse Event|8|||
164678035|NCT03123471|594844935|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
164678036|NCT03123471|594844936|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
164678037|NCT03123471|594844935|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
164678038|NCT03123471|594844936|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
164678039|NCT03123471|594844935|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
164678040|NCT03123471|594844936|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
164678041|NCT03123471|594844935|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
164678042|NCT03123471|594844936|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
164678043|NCT03123471|594844935|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
164678044|NCT03123471|594844936|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
164678045|NCT03123471|594844935|FG000|Placebo-controlled Phase|Miscellaneous|0|||
164678046|NCT03123471|594844936|FG001|Placebo-controlled Phase|Miscellaneous|1|||
164678047|NCT03123471|594844935|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
164678048|NCT03123471|594844936|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
164678049|NCT03123471|594844935|FG000|Apremilast Extension Phase|Adverse Event|1|||
164678050|NCT03123471|594844936|FG001|Apremilast Extension Phase|Adverse Event|5|||
164678051|NCT03123471|594844935|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
164678052|NCT03123471|594844936|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
164678053|NCT03123471|594844935|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
164678054|NCT03123471|594844936|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
164678055|NCT02358538|594844939|FG000|Through Week 26|Adverse Event|0|||
164678056|NCT02358538|594844940|FG001|Through Week 26|Adverse Event|1|||
164678057|NCT02358538|594844941|FG002|Through Week 26|Adverse Event|1|||
164678058|NCT02358538|594844942|FG003|Through Week 26|Adverse Event|2|||
164678059|NCT02358538|594844939|FG000|Through Week 26|Lack of Efficacy|1|||
164678060|NCT02358538|594844940|FG001|Through Week 26|Lack of Efficacy|1|||
164678061|NCT02358538|594844941|FG002|Through Week 26|Lack of Efficacy|3|||
164678062|NCT02358538|594844942|FG003|Through Week 26|Lack of Efficacy|3|||
164678063|NCT02358538|594844939|FG000|Through Week 26|Withdrawal by Subject|1|||
164678064|NCT02358538|594844940|FG001|Through Week 26|Withdrawal by Subject|0|||
164678065|NCT02358538|594844941|FG002|Through Week 26|Withdrawal by Subject|0|||
164678066|NCT02358538|594844942|FG003|Through Week 26|Withdrawal by Subject|0|||
164678067|NCT02358538|594844939|FG000|Through Week 26|Non-Compliance|0|||
164678068|NCT02358538|594844940|FG001|Through Week 26|Non-Compliance|0|||
164678069|NCT02358538|594844941|FG002|Through Week 26|Non-Compliance|1|||
164678070|NCT02358538|594844942|FG003|Through Week 26|Non-Compliance|0|||
164678071|NCT02358538|594844939|FG000|Through Week 26|Family did not see benefit from IP|1|||
164678072|NCT02358538|594844940|FG001|Through Week 26|Family did not see benefit from IP|0|||
164678073|NCT02358538|594844941|FG002|Through Week 26|Family did not see benefit from IP|0|||
164678074|NCT02358538|594844942|FG003|Through Week 26|Family did not see benefit from IP|0|||
164678075|NCT02358538|594844939|FG000|52 Week Extension Period|Lack of Efficacy|0|||
164678076|NCT02358538|594844940|FG001|52 Week Extension Period|Lack of Efficacy|0|||
164678077|NCT02358538|594844941|FG002|52 Week Extension Period|Lack of Efficacy|2|||
164678078|NCT02358538|594844942|FG003|52 Week Extension Period|Lack of Efficacy|4|||
164336579|NCT01543698|593609731|FG011|Phase 2|Adverse Event|1|||
164336580|NCT01543698|593609732|FG012|Phase 2|Adverse Event|3|||
164336581|NCT01543698|593609733|FG013|Phase 2|Adverse Event|5|||
164336582|NCT01543698|593609734|FG014|Phase 2|Adverse Event|14|||
164336583|NCT00316719|593609735|FG000|Overall Study|Adverse Event|0|||
164678079|NCT01686477|594844943|FG000|Feeding Intervention|Death|1|||
164678080|NCT01686477|594844944|FG001|Feeding Intervention|Death|0|||
164678081|NCT01686477|594844945|FG002|Feeding Intervention|Death|1|||
164336584|NCT00316719|593609736|FG001|Overall Study|Adverse Event|6|||
164336585|NCT00316719|593609735|FG000|Overall Study|Consent withdrawn|2|||
164678082|NCT01686477|594844943|FG000|Feeding Intervention|Withdrawal by Subject|0|||
164678083|NCT01686477|594844944|FG001|Feeding Intervention|Withdrawal by Subject|6|||
164678084|NCT01686477|594844945|FG002|Feeding Intervention|Withdrawal by Subject|0|||
164336586|NCT00316719|593609736|FG001|Overall Study|Consent withdrawn|0|||
164336587|NCT01863953|593609737|FG000|Overall Study|Adverse Event|0|||
164678085|NCT01686477|594844943|FG000|Feeding Intervention|Physician Decision|1|||
164678086|NCT01686477|594844944|FG001|Feeding Intervention|Physician Decision|2|||
164678087|NCT01686477|594844945|FG002|Feeding Intervention|Physician Decision|0|||
164678088|NCT01686477|594844943|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
164678089|NCT01686477|594844944|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
164678090|NCT01686477|594844945|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
164678091|NCT01686477|594844943|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
164678092|NCT01686477|594844944|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
164678093|NCT01686477|594844945|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
164678094|NCT01686477|594844943|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
164678095|NCT01686477|594844944|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
164678096|NCT01686477|594844945|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
164678097|NCT01686477|594844943|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
164678098|NCT01686477|594844944|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
164678099|NCT01686477|594844945|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
164678100|NCT01686477|594844943|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
164678101|NCT01686477|594844944|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
164678102|NCT01686477|594844945|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
164678103|NCT01686477|594844943|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
164678104|NCT01686477|594844944|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
164678105|NCT01686477|594844945|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
164678106|NCT01686477|594844943|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
164678107|NCT01686477|594844944|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
164678108|NCT01686477|594844945|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
164678109|NCT06999265|594844947|FG000|Overall Study|Lost to Follow-up|1|||
164678110|NCT06999265|594844948|FG001|Overall Study|Lost to Follow-up|1|||
164678111|NCT02178787|594844949|FG000|Overall Study|Lost to Follow-up|1|||
164678112|NCT02178787|594844950|FG001|Overall Study|Lost to Follow-up|0|||
164678113|NCT02178787|594844949|FG000|Overall Study|Withdrawal by Subject|0|||
164678114|NCT02178787|594844950|FG001|Overall Study|Withdrawal by Subject|2|||
164678115|NCT02178787|594844949|FG000|Overall Study|No TCD window|3|||
164678116|NCT02178787|594844950|FG001|Overall Study|No TCD window|7|||
164678117|NCT02178787|594844949|FG000|Overall Study|Physician Decision|1|||
164678118|NCT02178787|594844950|FG001|Overall Study|Physician Decision|0|||
164678119|NCT00813592|594844951|FG000|Overall Study|Disease assessment was not completed per|2|||
164678120|NCT05710718|594846629|FG000|Overall Study|Withdrawal by Subject|5|||
164678121|NCT05710718|594846630|FG001|Overall Study|Withdrawal by Subject|1|||
164678122|NCT05710718|594846629|FG000|Overall Study|Lost to Follow-up|0|||
164678123|NCT05710718|594846630|FG001|Overall Study|Lost to Follow-up|1|||
164678124|NCT05710718|594846629|FG000|Overall Study|Death|0|||
164678125|NCT05710718|594846630|FG001|Overall Study|Death|1|||
164678126|NCT04372238|594846631|FG000|Overall Study|Duplicate|3|||
164678127|NCT04372238|594846632|FG001|Overall Study|Duplicate|3|||
164678128|NCT04372238|594846631|FG000|Overall Study|Did not consent for data linkage|6|||
164678129|NCT04372238|594846632|FG001|Overall Study|Did not consent for data linkage|10|||
164678130|NCT05005442|594846633|FG000|Overall Study|Death|14|||
164678131|NCT05005442|594846634|FG001|Overall Study|Death|10|||
164678132|NCT05005442|594846635|FG002|Overall Study|Death|8|||
164678133|NCT05005442|594846636|FG003|Overall Study|Death|22|||
164678134|NCT05005442|594846637|FG004|Overall Study|Death|13|||
164678135|NCT05005442|594846638|FG005|Overall Study|Death|15|||
164678136|NCT05005442|594846633|FG000|Overall Study|Lost to Follow-up|0|||
164678137|NCT05005442|594846634|FG001|Overall Study|Lost to Follow-up|2|||
164678138|NCT05005442|594846635|FG002|Overall Study|Lost to Follow-up|0|||
164678139|NCT05005442|594846636|FG003|Overall Study|Lost to Follow-up|0|||
164678140|NCT05005442|594846637|FG004|Overall Study|Lost to Follow-up|1|||
164678141|NCT05005442|594846638|FG005|Overall Study|Lost to Follow-up|0|||
164678142|NCT05005442|594846633|FG000|Overall Study|Physician Decision|0|||
164678143|NCT05005442|594846634|FG001|Overall Study|Physician Decision|0|||
164678144|NCT05005442|594846635|FG002|Overall Study|Physician Decision|1|||
164678145|NCT05005442|594846636|FG003|Overall Study|Physician Decision|0|||
164678146|NCT05005442|594846637|FG004|Overall Study|Physician Decision|2|||
164678147|NCT05005442|594846638|FG005|Overall Study|Physician Decision|0|||
164336588|NCT01863953|593609738|FG001|Overall Study|Adverse Event|0|||
164678148|NCT05005442|594846633|FG000|Overall Study|Sponsor decision|26|||
164678149|NCT05005442|594846634|FG001|Overall Study|Sponsor decision|26|||
164678150|NCT05005442|594846635|FG002|Overall Study|Sponsor decision|10|||
164678151|NCT05005442|594846636|FG003|Overall Study|Sponsor decision|5|||
164678152|NCT05005442|594846637|FG004|Overall Study|Sponsor decision|9|||
164336589|NCT01863953|593609739|FG002|Overall Study|Adverse Event|1|||
164336590|NCT00573183|593609740|FG000|Overall Study|Lost to Follow-up|52|||
164678153|NCT05005442|594846638|FG005|Overall Study|Sponsor decision|12|||
164678154|NCT05005442|594846633|FG000|Overall Study|Withdrawal by Subject|2|||
164678155|NCT05005442|594846634|FG001|Overall Study|Withdrawal by Subject|2|||
164678156|NCT05005442|594846635|FG002|Overall Study|Withdrawal by Subject|1|||
164678157|NCT05005442|594846636|FG003|Overall Study|Withdrawal by Subject|3|||
164678158|NCT05005442|594846637|FG004|Overall Study|Withdrawal by Subject|0|||
164678159|NCT05005442|594846638|FG005|Overall Study|Withdrawal by Subject|5|||
164678160|NCT05005442|594846633|FG000|Overall Study|Site terminated by sponsor|0|||
164678161|NCT05005442|594846634|FG001|Overall Study|Site terminated by sponsor|2|||
164678162|NCT05005442|594846635|FG002|Overall Study|Site terminated by sponsor|0|||
164678163|NCT05005442|594846636|FG003|Overall Study|Site terminated by sponsor|0|||
164678164|NCT05005442|594846637|FG004|Overall Study|Site terminated by sponsor|0|||
164678165|NCT05005442|594846638|FG005|Overall Study|Site terminated by sponsor|1|||
164678166|NCT03696160|594846639|FG000|Overall Study|Withdrew before IMP dosing|2|||
164678167|NCT03696160|594846640|FG001|Overall Study|Withdrew before IMP dosing|3|||
164678168|NCT00334815|594846641|FG000|Overall Study|Adverse Event|3|||
164678169|NCT00334815|594846642|FG001|Overall Study|Adverse Event|2|||
164678170|NCT00334815|594846641|FG000|Overall Study|Death|0|||
164678171|NCT00334815|594846642|FG001|Overall Study|Death|2|||
164678172|NCT00334815|594846641|FG000|Overall Study|Progression|1|||
164678173|NCT00334815|594846642|FG001|Overall Study|Progression|0|||
164678174|NCT00334815|594846641|FG000|Overall Study|ineligible|1|||
164678175|NCT00334815|594846642|FG001|Overall Study|ineligible|1|||
164678176|NCT00334815|594846641|FG000|Overall Study|patient refused treatment|0|||
164678177|NCT00334815|594846642|FG001|Overall Study|patient refused treatment|1|||
164678178|NCT00334815|594846641|FG000|Overall Study|Physician Decision|2|||
164678179|NCT00334815|594846642|FG001|Overall Study|Physician Decision|4|||
164678180|NCT03317899|594846648|FG000|Overall Study|Death|6|||
164678181|NCT03317899|594846649|FG001|Overall Study|Death|9|||
164678182|NCT01056484|594846651|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
164678183|NCT01056484|594846652|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
164678184|NCT01056484|594846651|FG000|Randomized Controlled Trial|Physician Decision|1|||
164678185|NCT01056484|594846652|FG001|Randomized Controlled Trial|Physician Decision|0|||
164678186|NCT01056484|594846651|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
164678187|NCT01056484|594846652|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
164678188|NCT00446966|594846655|FG000|Overall Study|Lost to Follow-up|10|||
164678189|NCT00446966|594846656|FG001|Overall Study|Lost to Follow-up|7|||
164678190|NCT01440803|594846657|FG000|Overall Study|Met study stopping rule|2|||
164678191|NCT01440803|594846658|FG001|Overall Study|Met study stopping rule|1|||
164678192|NCT01440803|594846657|FG000|Overall Study|Lost to Follow-up|0|||
164242596|NCT00551031|593260294|FG002|Overall Study|Protocol Violation|0|||
164242597|NCT00551031|593260295|FG003|Overall Study|Protocol Violation|0|||
164242598|NCT00551031|593260296|FG004|Overall Study|Protocol Violation|0|||
164242599|NCT00551031|593260292|FG000|Overall Study|Lost to Follow-up|0|||
164242600|NCT00551031|593260293|FG001|Overall Study|Lost to Follow-up|1|||
164678193|NCT01440803|594846658|FG001|Overall Study|Lost to Follow-up|2|||
164678194|NCT01440803|594846657|FG000|Overall Study|Withdrawal by Subject|0|||
164678195|NCT01440803|594846658|FG001|Overall Study|Withdrawal by Subject|1|||
164678196|NCT01492439|594846660|FG000|Overall Study|Withdrew from RTE|4|||
164678197|NCT01492439|594846661|FG001|Overall Study|Withdrew from RTE|9|||
164678198|NCT00673660|594846662|FG000|Overall Study|Lost to Follow-up|107|||
164678199|NCT01527006|594846663|FG000|Core Study|Adverse Event|0|||
164678200|NCT01527006|594846664|FG001|Core Study|Adverse Event|2|||
164678201|NCT01527006|594846663|FG000|Core Study|Lost to Follow-up|0|||
164678202|NCT01527006|594846664|FG001|Core Study|Lost to Follow-up|1|||
164678203|NCT01527006|594846663|FG000|Core Study|Subject Choice|1|||
164678204|NCT01527006|594846664|FG001|Core Study|Subject Choice|0|||
164678205|NCT01527006|594846663|FG000|Core Study|Inadequate Therapeutic Effect|1|||
164678206|NCT01527006|594846664|FG001|Core Study|Inadequate Therapeutic Effect|0|||
164678207|NCT01527006|594846663|FG000|Core Study|Withdrawal by Subject|0|||
164678208|NCT01527006|594846664|FG001|Core Study|Withdrawal by Subject|1|||
164678209|NCT01527006|594846663|FG000|Core Study|Other|0|||
164678210|NCT01527006|594846664|FG001|Core Study|Other|2|||
164678211|NCT01527006|594846663|FG000|Extension Phase|Adverse Event|4|||
164242601|NCT00551031|593260294|FG002|Overall Study|Lost to Follow-up|0|||
164242602|NCT00551031|593260295|FG003|Overall Study|Lost to Follow-up|1|||
164242603|NCT00551031|593260296|FG004|Overall Study|Lost to Follow-up|1|||
164242604|NCT00551031|593260292|FG000|Overall Study|Withdrawal by Subject|0|||
164242605|NCT00551031|593260293|FG001|Overall Study|Withdrawal by Subject|4|||
164242606|NCT00551031|593260294|FG002|Overall Study|Withdrawal by Subject|1|||
164242607|NCT00551031|593260295|FG003|Overall Study|Withdrawal by Subject|2|||
164242608|NCT00551031|593260296|FG004|Overall Study|Withdrawal by Subject|0|||
164242609|NCT00551031|593260292|FG000|Overall Study|Serious Adverse Event|0|||
164242610|NCT00551031|593260293|FG001|Overall Study|Serious Adverse Event|2|||
164242611|NCT00551031|593260294|FG002|Overall Study|Serious Adverse Event|1|||
164242612|NCT00551031|593260295|FG003|Overall Study|Serious Adverse Event|0|||
164242613|NCT00551031|593260296|FG004|Overall Study|Serious Adverse Event|0|||
164242614|NCT00551031|593260292|FG000|Overall Study|Did not receive vaccine|1|||
164242615|NCT00551031|593260293|FG001|Overall Study|Did not receive vaccine|2|||
164242616|NCT00551031|593260294|FG002|Overall Study|Did not receive vaccine|0|||
164242617|NCT00551031|593260295|FG003|Overall Study|Did not receive vaccine|0|||
164242618|NCT00551031|593260296|FG004|Overall Study|Did not receive vaccine|0|||
164242619|NCT01273038|593260297|FG000|Second Intervention (14 Days)|Adverse Event|0|||
164242620|NCT01273038|593260298|FG001|Second Intervention (14 Days)|Adverse Event|1|||
164242621|NCT01273038|593260297|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
164242622|NCT01273038|593260298|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
164242623|NCT00413660|593260299|FG000|Up To Week 12|Adverse Event|1|||
164242624|NCT00413660|593260300|FG001|Up To Week 12|Adverse Event|3|||
164242625|NCT00413660|593260301|FG002|Up To Week 12|Adverse Event|1|||
164242626|NCT00413660|593260302|FG003|Up To Week 12|Adverse Event|4|||
164242627|NCT00413660|593260303|FG004|Up To Week 12|Adverse Event|6|||
164242628|NCT00413660|593260304|FG005|Up To Week 12|Adverse Event|4|||
164242629|NCT00413660|593260305|FG006|Up To Week 12|Adverse Event|1|||
164242630|NCT00413660|593260306|FG007|Up To Week 12|Adverse Event|0|||
164242631|NCT00413660|593260307|FG008|Up To Week 12|Adverse Event|0|||
164242632|NCT00413660|593260308|FG009|Up To Week 12|Adverse Event|0|||
164242633|NCT00413660|593260309|FG010|Up To Week 12|Adverse Event|0|||
164242634|NCT00413660|593260299|FG000|Up To Week 12|Lack of Efficacy|2|||
164242635|NCT00413660|593260300|FG001|Up To Week 12|Lack of Efficacy|0|||
164242636|NCT00413660|593260301|FG002|Up To Week 12|Lack of Efficacy|0|||
164242637|NCT00413660|593260302|FG003|Up To Week 12|Lack of Efficacy|0|||
164242638|NCT00413660|593260303|FG004|Up To Week 12|Lack of Efficacy|0|||
164242639|NCT00413660|593260304|FG005|Up To Week 12|Lack of Efficacy|0|||
164242640|NCT00413660|593260305|FG006|Up To Week 12|Lack of Efficacy|5|||
164573761|NCT00363415|594465513|FG000|Overall Study|Physician Decision|18|||
164573762|NCT00363415|594465514|FG001|Overall Study|Physician Decision|35|||
164573763|NCT00363415|594465513|FG000|Overall Study|Entry Criteria Not Met|11|||
164573764|NCT00363415|594465514|FG001|Overall Study|Entry Criteria Not Met|10|||
164573765|NCT00363415|594465513|FG000|Overall Study|Withdrawal by Subject|9|||
164573766|NCT00363415|594465514|FG001|Overall Study|Withdrawal by Subject|15|||
164573767|NCT00363415|594465513|FG000|Overall Study|Lost to Follow-up|3|||
164573768|NCT00363415|594465514|FG001|Overall Study|Lost to Follow-up|3|||
164573769|NCT00363415|594465513|FG000|Overall Study|Protocol Violation|1|||
164678212|NCT01527006|594846664|FG001|Extension Phase|Adverse Event|2|||
164678213|NCT01527006|594846663|FG000|Extension Phase|Lost to Follow-up|0|||
164678214|NCT01527006|594846664|FG001|Extension Phase|Lost to Follow-up|1|||
164678215|NCT01527006|594846663|FG000|Extension Phase|Subject Choice|1|||
164678216|NCT01527006|594846664|FG001|Extension Phase|Subject Choice|1|||
164678217|NCT01527006|594846663|FG000|Extension Phase|Inadequate therapeutic effect|1|||
164678218|NCT01527006|594846664|FG001|Extension Phase|Inadequate therapeutic effect|1|||
164678219|NCT01527006|594846663|FG000|Extension Phase|Other|0|||
164678220|NCT01527006|594846664|FG001|Extension Phase|Other|3|||
164678221|NCT00933686|594846665|FG000|Overall Study|Protocol Violation|0|||
164678222|NCT00933686|594846666|FG001|Overall Study|Protocol Violation|1|||
164678223|NCT00933686|594846665|FG000|Overall Study|Lost to Follow-up|2|||
164678224|NCT00933686|594846666|FG001|Overall Study|Lost to Follow-up|2|||
164678225|NCT00933686|594846665|FG000|Overall Study|Withdrawal by Subject|6|||
164678226|NCT00933686|594846666|FG001|Overall Study|Withdrawal by Subject|5|||
164678227|NCT00933686|594846665|FG000|Overall Study|Adverse Event|1|||
164678228|NCT00933686|594846666|FG001|Overall Study|Adverse Event|1|||
164678229|NCT00933686|594846665|FG000|Overall Study|Physician Decision|1|||
164678230|NCT00933686|594846666|FG001|Overall Study|Physician Decision|0|||
164678231|NCT00933686|594846665|FG000|Overall Study|Failure to show up at endpoint visits|0|||
164678232|NCT00933686|594846666|FG001|Overall Study|Failure to show up at endpoint visits|2|||
164678233|NCT01383486|594846667|FG000|Overall Study|Lost to Follow-up|10|||
164678234|NCT01383486|594846667|FG000|Overall Study|Incomplete information for analysis|2|||
164678235|NCT01383486|594846667|FG000|Overall Study|Did not take any product|6|||
164678236|NCT00245063|594846668|FG000|Overall Study|Adverse Event|6|||
164678237|NCT00245063|594846669|FG001|Overall Study|Adverse Event|5|||
164678238|NCT00245063|594846668|FG000|Overall Study|Death|1|||
164678239|NCT00245063|594846669|FG001|Overall Study|Death|0|||
164678240|NCT01839279|594846672|FG000|Overall Study|Adverse Event|4|||
164678241|NCT01839279|594846673|FG001|Overall Study|Adverse Event|1|||
164678242|NCT01839279|594846674|FG002|Overall Study|Adverse Event|1|||
164678243|NCT01839279|594846672|FG000|Overall Study|Withdrawal by Subject|4|||
164678244|NCT01839279|594846673|FG001|Overall Study|Withdrawal by Subject|1|||
164678245|NCT01839279|594846674|FG002|Overall Study|Withdrawal by Subject|1|||
164678246|NCT01839279|594846672|FG000|Overall Study|Classified as 'Other'|5|||
164678247|NCT01839279|594846673|FG001|Overall Study|Classified as 'Other'|0|||
164678248|NCT01839279|594846674|FG002|Overall Study|Classified as 'Other'|0|||
164678249|NCT05919823|594846678|FG000|Pre-Treatment Period|Screen failure|1|||
164678250|NCT05919823|594846679|FG001|Pre-Treatment Period|Screen failure|0|||
164678251|NCT05919823|594846680|FG002|Pre-Treatment Period|Screen failure|0|||
164678252|NCT05919823|594846681|FG003|Pre-Treatment Period|Screen failure|0|||
164678253|NCT05919823|594846678|FG000|Pre-Treatment Period|Protocol Violation|0|||
164678254|NCT05919823|594846679|FG001|Pre-Treatment Period|Protocol Violation|1|||
164678255|NCT05919823|594846680|FG002|Pre-Treatment Period|Protocol Violation|0|||
164678256|NCT05919823|594846681|FG003|Pre-Treatment Period|Protocol Violation|0|||
164678257|NCT05919823|594846678|FG000|Double-Blind Period|Adverse Event|8|||
164678258|NCT05919823|594846679|FG001|Double-Blind Period|Adverse Event|9|||
164678259|NCT05919823|594846680|FG002|Double-Blind Period|Adverse Event|0|||
164678260|NCT05919823|594846681|FG003|Double-Blind Period|Adverse Event|0|||
164678261|NCT05919823|594846678|FG000|Double-Blind Period|Protocol Violation|2|||
164678262|NCT05919823|594846679|FG001|Double-Blind Period|Protocol Violation|1|||
164678263|NCT05919823|594846680|FG002|Double-Blind Period|Protocol Violation|0|||
164678264|NCT05919823|594846681|FG003|Double-Blind Period|Protocol Violation|0|||
164678265|NCT05919823|594846678|FG000|Double-Blind Period|Participant withdrew consent|11|||
164678266|NCT05919823|594846679|FG001|Double-Blind Period|Participant withdrew consent|7|||
164678267|NCT05919823|594846680|FG002|Double-Blind Period|Participant withdrew consent|0|||
164678268|NCT05919823|594846681|FG003|Double-Blind Period|Participant withdrew consent|0|||
164678269|NCT05919823|594846678|FG000|Double-Blind Period|Other reasons|2|||
164678270|NCT05919823|594846679|FG001|Double-Blind Period|Other reasons|3|||
164678271|NCT05919823|594846680|FG002|Double-Blind Period|Other reasons|0|||
164678272|NCT05919823|594846681|FG003|Double-Blind Period|Other reasons|0|||
164678273|NCT05919823|594846678|FG000|Open Label Period|Adverse Event|0|||
164678274|NCT05919823|594846679|FG001|Open Label Period|Adverse Event|0|||
164678275|NCT05919823|594846680|FG002|Open Label Period|Adverse Event|2|||
164678276|NCT05919823|594846681|FG003|Open Label Period|Adverse Event|4|||
164242641|NCT00413660|593260306|FG007|Up To Week 12|Lack of Efficacy|0|||
164242642|NCT00413660|593260307|FG008|Up To Week 12|Lack of Efficacy|0|||
164242643|NCT00413660|593260308|FG009|Up To Week 12|Lack of Efficacy|0|||
164242644|NCT00413660|593260309|FG010|Up To Week 12|Lack of Efficacy|0|||
164242645|NCT00413660|593260299|FG000|Up To Week 12|Lost to Follow-up|0|||
164678277|NCT05919823|594846678|FG000|Open Label Period|Lost to Follow-up|0|||
164678278|NCT05919823|594846679|FG001|Open Label Period|Lost to Follow-up|0|||
164678279|NCT05919823|594846680|FG002|Open Label Period|Lost to Follow-up|1|||
164242646|NCT00413660|593260300|FG001|Up To Week 12|Lost to Follow-up|1|||
164678280|NCT05919823|594846681|FG003|Open Label Period|Lost to Follow-up|0|||
164678281|NCT05919823|594846678|FG000|Open Label Period|Protocol Violation|0|||
164678282|NCT05919823|594846679|FG001|Open Label Period|Protocol Violation|0|||
164678283|NCT05919823|594846680|FG002|Open Label Period|Protocol Violation|0|||
164678284|NCT05919823|594846681|FG003|Open Label Period|Protocol Violation|1|||
164678285|NCT05919823|594846678|FG000|Open Label Period|Participant withdrew consent|0|||
164242647|NCT00413660|593260301|FG002|Up To Week 12|Lost to Follow-up|0|||
164242648|NCT00413660|593260302|FG003|Up To Week 12|Lost to Follow-up|0|||
164242649|NCT00413660|593260303|FG004|Up To Week 12|Lost to Follow-up|1|||
164242650|NCT00413660|593260304|FG005|Up To Week 12|Lost to Follow-up|0|||
164242651|NCT00413660|593260305|FG006|Up To Week 12|Lost to Follow-up|0|||
164242652|NCT00413660|593260306|FG007|Up To Week 12|Lost to Follow-up|0|||
164242653|NCT00413660|593260307|FG008|Up To Week 12|Lost to Follow-up|0|||
164242654|NCT00413660|593260308|FG009|Up To Week 12|Lost to Follow-up|0|||
164242655|NCT00413660|593260309|FG010|Up To Week 12|Lost to Follow-up|0|||
164242656|NCT00413660|593260299|FG000|Up To Week 12|Withdrawal by Subject|0|||
164242657|NCT00413660|593260300|FG001|Up To Week 12|Withdrawal by Subject|2|||
164242658|NCT00413660|593260301|FG002|Up To Week 12|Withdrawal by Subject|0|||
164336591|NCT00573183|593609741|FG001|Overall Study|Lost to Follow-up|50|||
164336592|NCT00573183|593609740|FG000|Overall Study|Withdrawal by Subject|8|||
164336593|NCT00573183|593609741|FG001|Overall Study|Withdrawal by Subject|2|||
164336594|NCT00573183|593609740|FG000|Overall Study|Death|0|||
164336595|NCT00573183|593609741|FG001|Overall Study|Death|1|||
164336596|NCT00573183|593609740|FG000|Overall Study|Adverse Event|2|||
164573770|NCT00363415|594465514|FG001|Overall Study|Protocol Violation|4|||
164573771|NCT01287754|594465517|FG000|Overall Study|Death|2|||
164573772|NCT01287754|594465518|FG001|Overall Study|Death|12|||
164573773|NCT01287754|594465517|FG000|Overall Study|Lost to Follow-up|1|||
164573774|NCT01287754|594465518|FG001|Overall Study|Lost to Follow-up|6|||
164573775|NCT01287754|594465517|FG000|Overall Study|Protocol Violation|0|||
164573776|NCT01287754|594465518|FG001|Overall Study|Protocol Violation|3|||
164573777|NCT04439266|594465529|FG000|Overall Study|Ineligible|1|||
164573778|NCT04439266|594465529|FG000|Overall Study|Adverse Event|1|||
164573779|NCT04439266|594465529|FG000|Overall Study|Death|1|||
164573780|NCT04439266|594465529|FG000|Overall Study|Disease progression|1|||
164573781|NCT04439266|594465529|FG000|Overall Study|Still on treatment|1|||
164573782|NCT05027802|594465531|FG000|Overall Study|Adverse Event|2|||
164573783|NCT05027802|594465531|FG000|Overall Study|Withdrawal by Subject|18|||
164573784|NCT05027802|594465531|FG000|Overall Study|Death|2|||
164573785|NCT05027802|594465531|FG000|Overall Study|Other|1|||
164573786|NCT00001337|594465538|FG000|Overall Study|Switched to alternate treatment|2|||
164573787|NCT00001337|594465539|FG001|Overall Study|Switched to alternate treatment|2|||
164573788|NCT00001337|594465540|FG002|Overall Study|Switched to alternate treatment|0|||
164573789|NCT00001337|594465538|FG000|Overall Study|Refused further treatment|2|||
164573790|NCT00001337|594465539|FG001|Overall Study|Refused further treatment|1|||
164573791|NCT00001337|594465540|FG002|Overall Study|Refused further treatment|0|||
164573792|NCT00001337|594465538|FG000|Overall Study|Began other Tx|1|||
164573793|NCT00001337|594465539|FG001|Overall Study|Began other Tx|0|||
164573794|NCT00001337|594465540|FG002|Overall Study|Began other Tx|0|||
164573795|NCT00001337|594465538|FG000|Overall Study|Physician Decision|3|||
164573796|NCT00001337|594465539|FG001|Overall Study|Physician Decision|1|||
164573797|NCT00001337|594465540|FG002|Overall Study|Physician Decision|0|||
164573798|NCT00001337|594465538|FG000|Overall Study|Doesn't have NHL|0|||
164573799|NCT00001337|594465539|FG001|Overall Study|Doesn't have NHL|1|||
164573800|NCT00001337|594465540|FG002|Overall Study|Doesn't have NHL|0|||
164573801|NCT00001337|594465538|FG000|Overall Study|Non protocol tx needed|3|||
164573802|NCT00001337|594465539|FG001|Overall Study|Non protocol tx needed|1|||
164573803|NCT00001337|594465540|FG002|Overall Study|Non protocol tx needed|0|||
164573804|NCT00001337|594465538|FG000|Overall Study|Protocol change|1|||
164573805|NCT00001337|594465539|FG001|Overall Study|Protocol change|0|||
164573806|NCT00001337|594465540|FG002|Overall Study|Protocol change|0|||
164573807|NCT00001337|594465538|FG000|Overall Study|2nd primary disease|0|||
164573808|NCT00001337|594465539|FG001|Overall Study|2nd primary disease|0|||
164573809|NCT00001337|594465540|FG002|Overall Study|2nd primary disease|1|||
164573810|NCT00001337|594465538|FG000|Overall Study|Death during follow up period|9|||
164573811|NCT00001337|594465539|FG001|Overall Study|Death during follow up period|4|||
164573812|NCT00001337|594465540|FG002|Overall Study|Death during follow up period|0|||
164573813|NCT00001337|594465538|FG000|Overall Study|Death on study|19|||
164573814|NCT00001337|594465539|FG001|Overall Study|Death on study|9|||
164573815|NCT00001337|594465540|FG002|Overall Study|Death on study|0|||
164573816|NCT00001337|594465538|FG000|Overall Study|Disease progression during follow-up period|3|||
164573817|NCT00001337|594465539|FG001|Overall Study|Disease progression during follow-up period|1|||
164573818|NCT00001337|594465540|FG002|Overall Study|Disease progression during follow-up period|0|||
164573819|NCT00001337|594465538|FG000|Overall Study|Disease progression on study|33|||
164336597|NCT00573183|593609741|FG001|Overall Study|Adverse Event|0|||
164336598|NCT00573183|593609740|FG000|Overall Study|Incarceration|5|||
164336599|NCT00573183|593609741|FG001|Overall Study|Incarceration|8|||
164573820|NCT00001337|594465539|FG001|Overall Study|Disease progression on study|41|||
164573821|NCT00001337|594465540|FG002|Overall Study|Disease progression on study|0|||
164573822|NCT00001337|594465538|FG000|Overall Study|Lost to further follow-up|10|||
164573823|NCT00001337|594465539|FG001|Overall Study|Lost to further follow-up|6|||
164242659|NCT00413660|593260302|FG003|Up To Week 12|Withdrawal by Subject|2|||
164242660|NCT00413660|593260303|FG004|Up To Week 12|Withdrawal by Subject|0|||
164242661|NCT00413660|593260304|FG005|Up To Week 12|Withdrawal by Subject|2|||
164242662|NCT00413660|593260305|FG006|Up To Week 12|Withdrawal by Subject|2|||
164242663|NCT00413660|593260306|FG007|Up To Week 12|Withdrawal by Subject|0|||
164242664|NCT00413660|593260307|FG008|Up To Week 12|Withdrawal by Subject|0|||
164242665|NCT00413660|593260308|FG009|Up To Week 12|Withdrawal by Subject|0|||
164242666|NCT00413660|593260309|FG010|Up To Week 12|Withdrawal by Subject|0|||
164242667|NCT00413660|593260299|FG000|Up To Week 12|Randomized, Not Treated|1|||
164242668|NCT00413660|593260300|FG001|Up To Week 12|Randomized, Not Treated|0|||
164242669|NCT00413660|593260301|FG002|Up To Week 12|Randomized, Not Treated|0|||
164242670|NCT00413660|593260302|FG003|Up To Week 12|Randomized, Not Treated|1|||
164242671|NCT00413660|593260303|FG004|Up To Week 12|Randomized, Not Treated|0|||
164242672|NCT00413660|593260304|FG005|Up To Week 12|Randomized, Not Treated|0|||
164336600|NCT00573183|593609740|FG000|Overall Study|Other|5|||
164573824|NCT00001337|594465540|FG002|Overall Study|Lost to further follow-up|0|||
164573825|NCT00001337|594465538|FG000|Overall Study|2nd malignancy|1|||
164573826|NCT00001337|594465539|FG001|Overall Study|2nd malignancy|0|||
164573827|NCT00001337|594465540|FG002|Overall Study|2nd malignancy|0|||
164573828|NCT00001337|594465538|FG000|Overall Study|Treatment for second lymphoma|0|||
164573829|NCT00001337|594465539|FG001|Overall Study|Treatment for second lymphoma|1|||
164573830|NCT00001337|594465540|FG002|Overall Study|Treatment for second lymphoma|0|||
164573831|NCT00001337|594465538|FG000|Overall Study|Transfer to transplant|0|||
164573832|NCT00001337|594465539|FG001|Overall Study|Transfer to transplant|1|||
164573833|NCT00001337|594465540|FG002|Overall Study|Transfer to transplant|0|||
164573834|NCT06161012|594465541|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
164573835|NCT06161012|594465542|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
164573836|NCT00408005|594465547|FG000|Induction|Adverse Event|19|||
164573837|NCT00408005|594465548|FG001|Induction|Adverse Event|3|||
164573838|NCT00408005|594465549|FG002|Induction|Adverse Event|0|||
164573839|NCT00408005|594465550|FG003|Induction|Adverse Event|0|||
164573840|NCT00408005|594465551|FG004|Induction|Adverse Event|0|||
164573841|NCT00408005|594465552|FG005|Induction|Adverse Event|0|||
164573842|NCT00408005|594465553|FG006|Induction|Adverse Event|0|||
164573843|NCT00408005|594465554|FG007|Induction|Adverse Event|0|||
164573844|NCT00408005|594465547|FG000|Induction|Death|6|||
164573845|NCT00408005|594465548|FG001|Induction|Death|0|||
164573846|NCT00408005|594465549|FG002|Induction|Death|0|||
164573847|NCT00408005|594465550|FG003|Induction|Death|0|||
164573848|NCT00408005|594465551|FG004|Induction|Death|0|||
164573849|NCT00408005|594465552|FG005|Induction|Death|0|||
164573850|NCT00408005|594465553|FG006|Induction|Death|0|||
164573851|NCT00408005|594465554|FG007|Induction|Death|0|||
164573852|NCT00408005|594465547|FG000|Induction|Physician Decision|83|||
164573853|NCT00408005|594465548|FG001|Induction|Physician Decision|9|||
164573854|NCT00408005|594465549|FG002|Induction|Physician Decision|0|||
164573855|NCT00408005|594465550|FG003|Induction|Physician Decision|0|||
164573856|NCT00408005|594465551|FG004|Induction|Physician Decision|0|||
164573857|NCT00408005|594465552|FG005|Induction|Physician Decision|0|||
164573858|NCT00408005|594465553|FG006|Induction|Physician Decision|0|||
164573859|NCT00408005|594465554|FG007|Induction|Physician Decision|0|||
164573860|NCT00408005|594465547|FG000|Induction|Withdrawal by Subject|2|||
164573861|NCT00408005|594465548|FG001|Induction|Withdrawal by Subject|4|||
164573862|NCT00408005|594465549|FG002|Induction|Withdrawal by Subject|0|||
164573863|NCT00408005|594465550|FG003|Induction|Withdrawal by Subject|0|||
164573864|NCT00408005|594465551|FG004|Induction|Withdrawal by Subject|0|||
164573865|NCT00408005|594465552|FG005|Induction|Withdrawal by Subject|0|||
164573866|NCT00408005|594465553|FG006|Induction|Withdrawal by Subject|0|||
164573867|NCT00408005|594465554|FG007|Induction|Withdrawal by Subject|0|||
164573868|NCT00408005|594465547|FG000|Induction|Ineligible|33|||
164573869|NCT00408005|594465548|FG001|Induction|Ineligible|14|||
164573870|NCT00408005|594465549|FG002|Induction|Ineligible|0|||
164573871|NCT00408005|594465550|FG003|Induction|Ineligible|0|||
164573872|NCT00408005|594465551|FG004|Induction|Ineligible|0|||
164573873|NCT00408005|594465552|FG005|Induction|Ineligible|0|||
164573874|NCT00408005|594465553|FG006|Induction|Ineligible|0|||
164573875|NCT00408005|594465554|FG007|Induction|Ineligible|0|||
164573876|NCT00408005|594465547|FG000|Induction|Refusal of Further Protocol Therapy|225|||
164573877|NCT00408005|594465548|FG001|Induction|Refusal of Further Protocol Therapy|44|||
164573878|NCT00408005|594465549|FG002|Induction|Refusal of Further Protocol Therapy|0|||
164242673|NCT00413660|593260305|FG006|Up To Week 12|Randomized, Not Treated|0|||
164242674|NCT00413660|593260306|FG007|Up To Week 12|Randomized, Not Treated|0|||
164242675|NCT00413660|593260307|FG008|Up To Week 12|Randomized, Not Treated|0|||
164242676|NCT00413660|593260308|FG009|Up To Week 12|Randomized, Not Treated|0|||
164336601|NCT00573183|593609741|FG001|Overall Study|Other|2|||
164573879|NCT00408005|594465550|FG003|Induction|Refusal of Further Protocol Therapy|0|||
164573880|NCT00408005|594465551|FG004|Induction|Refusal of Further Protocol Therapy|0|||
164573881|NCT00408005|594465552|FG005|Induction|Refusal of Further Protocol Therapy|0|||
164573882|NCT00408005|594465553|FG006|Induction|Refusal of Further Protocol Therapy|0|||
164573883|NCT00408005|594465554|FG007|Induction|Refusal of Further Protocol Therapy|0|||
164573884|NCT00408005|594465547|FG000|Induction|Entered another COG therapeutic protocol|4|||
164573885|NCT00408005|594465548|FG001|Induction|Entered another COG therapeutic protocol|0|||
164425445|NCT05968482|593928489|FG001|Second Crossover Period|Withdrawal by Subject|0|||
164425446|NCT05968482|593928490|FG002|Second Crossover Period|Withdrawal by Subject|0|||
164425447|NCT05968482|593928491|FG003|Second Crossover Period|Withdrawal by Subject|0|||
164425448|NCT05968482|593928492|FG004|Second Crossover Period|Withdrawal by Subject|1|||
164425449|NCT05968482|593928493|FG005|Second Crossover Period|Withdrawal by Subject|0|||
164678286|NCT05919823|594846679|FG001|Open Label Period|Participant withdrew consent|0|||
164678287|NCT05919823|594846680|FG002|Open Label Period|Participant withdrew consent|8|||
164678288|NCT05919823|594846681|FG003|Open Label Period|Participant withdrew consent|6|||
164678289|NCT05919823|594846678|FG000|Open Label Period|Death|0|||
164678290|NCT05919823|594846679|FG001|Open Label Period|Death|0|||
164678291|NCT05919823|594846680|FG002|Open Label Period|Death|0|||
164678292|NCT05919823|594846681|FG003|Open Label Period|Death|1|||
164678293|NCT05919823|594846678|FG000|Open Label Period|Other reasons|0|||
164678294|NCT05919823|594846679|FG001|Open Label Period|Other reasons|0|||
164678295|NCT05919823|594846680|FG002|Open Label Period|Other reasons|9|||
164678296|NCT05919823|594846681|FG003|Open Label Period|Other reasons|5|||
164678297|NCT01648582|594846682|FG000|Overall Study|Adverse Event|6|||
164678298|NCT01648582|594846683|FG001|Overall Study|Adverse Event|11|||
164678299|NCT01648582|594846684|FG002|Overall Study|Adverse Event|2|||
164678300|NCT01648582|594846682|FG000|Overall Study|Lost to Follow-up|9|||
164678301|NCT01648582|594846683|FG001|Overall Study|Lost to Follow-up|6|||
164678302|NCT01648582|594846684|FG002|Overall Study|Lost to Follow-up|8|||
164678303|NCT01648582|594846682|FG000|Overall Study|Protocol Violation|1|||
164678304|NCT01648582|594846683|FG001|Overall Study|Protocol Violation|2|||
164678305|NCT01648582|594846684|FG002|Overall Study|Protocol Violation|1|||
164678306|NCT01648582|594846682|FG000|Overall Study|Withdrawal by Subject|15|||
164678307|NCT01648582|594846683|FG001|Overall Study|Withdrawal by Subject|17|||
164678308|NCT01648582|594846684|FG002|Overall Study|Withdrawal by Subject|17|||
164678309|NCT01648582|594846682|FG000|Overall Study|Physician Decision|0|||
164425450|NCT05968482|593928488|FG000|Third Crossover Period|Adverse Event|0|||
164678310|NCT01648582|594846683|FG001|Overall Study|Physician Decision|1|||
164678311|NCT01648582|594846684|FG002|Overall Study|Physician Decision|3|||
164678312|NCT01648582|594846682|FG000|Overall Study|Death|1|||
164678313|NCT01648582|594846683|FG001|Overall Study|Death|0|||
164678314|NCT01648582|594846684|FG002|Overall Study|Death|0|||
164678315|NCT01648582|594846682|FG000|Overall Study|Sponsor Decision|0|||
164242677|NCT00413660|593260309|FG010|Up To Week 12|Randomized, Not Treated|0|||
164242678|NCT00413660|593260299|FG000|Up To Week 12|Other|3|||
164242679|NCT00413660|593260300|FG001|Up To Week 12|Other|1|||
164242680|NCT00413660|593260301|FG002|Up To Week 12|Other|6|||
164242681|NCT00413660|593260302|FG003|Up To Week 12|Other|1|||
164242682|NCT00413660|593260303|FG004|Up To Week 12|Other|2|||
164242683|NCT00413660|593260304|FG005|Up To Week 12|Other|4|||
164242684|NCT00413660|593260305|FG006|Up To Week 12|Other|3|||
164242685|NCT00413660|593260306|FG007|Up To Week 12|Other|0|||
164242686|NCT00413660|593260307|FG008|Up To Week 12|Other|0|||
164242687|NCT00413660|593260308|FG009|Up To Week 12|Other|0|||
164242688|NCT00413660|593260309|FG010|Up To Week 12|Other|0|||
164242689|NCT00413660|593260299|FG000|Post Week 12|Adverse Event|2|||
164242690|NCT00413660|593260300|FG001|Post Week 12|Adverse Event|0|||
164242691|NCT00413660|593260301|FG002|Post Week 12|Adverse Event|2|||
164242692|NCT00413660|593260302|FG003|Post Week 12|Adverse Event|1|||
164242693|NCT00413660|593260303|FG004|Post Week 12|Adverse Event|4|||
164242694|NCT00413660|593260304|FG005|Post Week 12|Adverse Event|2|||
164242695|NCT00413660|593260305|FG006|Post Week 12|Adverse Event|2|||
164242696|NCT00413660|593260306|FG007|Post Week 12|Adverse Event|0|||
164242697|NCT00413660|593260307|FG008|Post Week 12|Adverse Event|0|||
164242698|NCT00413660|593260308|FG009|Post Week 12|Adverse Event|0|||
164242699|NCT00413660|593260309|FG010|Post Week 12|Adverse Event|0|||
164242700|NCT00413660|593260299|FG000|Post Week 12|Lack of Efficacy|0|||
164242701|NCT00413660|593260300|FG001|Post Week 12|Lack of Efficacy|0|||
164242702|NCT00413660|593260301|FG002|Post Week 12|Lack of Efficacy|1|||
164242703|NCT00413660|593260302|FG003|Post Week 12|Lack of Efficacy|0|||
164425451|NCT05968482|593928489|FG001|Third Crossover Period|Adverse Event|0|||
164678316|NCT01648582|594846683|FG001|Overall Study|Sponsor Decision|1|||
164678317|NCT01648582|594846684|FG002|Overall Study|Sponsor Decision|1|||
164678318|NCT02321098|594846689|FG000|12 Weeks Treament|Lost to Follow-up|1|||
164242704|NCT00413660|593260303|FG004|Post Week 12|Lack of Efficacy|0|||
164242705|NCT00413660|593260304|FG005|Post Week 12|Lack of Efficacy|0|||
164242706|NCT00413660|593260305|FG006|Post Week 12|Lack of Efficacy|0|||
164242707|NCT00413660|593260306|FG007|Post Week 12|Lack of Efficacy|0|||
164242708|NCT00413660|593260307|FG008|Post Week 12|Lack of Efficacy|0|||
164242709|NCT00413660|593260308|FG009|Post Week 12|Lack of Efficacy|1|||
164242710|NCT00413660|593260309|FG010|Post Week 12|Lack of Efficacy|0|||
164242711|NCT00413660|593260299|FG000|Post Week 12|Lost to Follow-up|0|||
164242712|NCT00413660|593260300|FG001|Post Week 12|Lost to Follow-up|1|||
164425452|NCT05968482|593928490|FG002|Third Crossover Period|Adverse Event|0|||
164678319|NCT02321098|594846690|FG001|12 Weeks Treament|Lost to Follow-up|1|||
164678320|NCT02321098|594846691|FG002|12 Weeks Treament|Lost to Follow-up|0|||
164678321|NCT02321098|594846689|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
164678322|NCT02321098|594846690|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
164678323|NCT02321098|594846691|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
164678324|NCT02321098|594846689|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
164678325|NCT02321098|594846690|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
164678326|NCT02321098|594846691|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
164678327|NCT02321098|594846689|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
164678328|NCT02321098|594846690|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
164678329|NCT02321098|594846691|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
164678330|NCT03261167|594846696|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
164678331|NCT03261167|594846697|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
164678332|NCT03261167|594846696|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
164678333|NCT03261167|594846697|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
164678334|NCT03261167|594846696|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
164678335|NCT03261167|594846697|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
164678336|NCT03261167|594846696|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
164678337|NCT03261167|594846697|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
164678338|NCT03261167|594846696|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
164678339|NCT03261167|594846697|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
164678340|NCT03199963|594846701|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
164678341|NCT03199963|594846702|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
164678342|NCT03199963|594846701|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
164678343|NCT03199963|594846702|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
164678344|NCT03199963|594846701|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
164678345|NCT03199963|594846702|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
164678346|NCT03199963|594846701|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
164678347|NCT03199963|594846702|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
164678348|NCT03199963|594846701|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
164678349|NCT03199963|594846702|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
164678350|NCT03199963|594846701|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
164678351|NCT03199963|594846702|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
164678352|NCT03930732|594846703|FG000|Overall Study|Adverse Event|9|||
164678353|NCT03930732|594846704|FG001|Overall Study|Adverse Event|7|||
164678354|NCT03930732|594846703|FG000|Overall Study|Poor compliance to protocol|0|||
164678355|NCT03930732|594846704|FG001|Overall Study|Poor compliance to protocol|1|||
164678356|NCT03930732|594846703|FG000|Overall Study|Withdrawal by Subject|23|||
164678357|NCT03930732|594846704|FG001|Overall Study|Withdrawal by Subject|11|||
164678358|NCT03930732|594846703|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
164678359|NCT03930732|594846704|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
164678360|NCT03930732|594846703|FG000|Overall Study|Other reason not related to COVID-19|5|||
164678361|NCT03930732|594846704|FG001|Overall Study|Other reason not related to COVID-19|8|||
164678362|NCT00835692|594846708|FG000|First Intervention|Withdrawal by Subject|1|||
164678363|NCT00835692|594846709|FG001|First Intervention|Withdrawal by Subject|0|||
164678364|NCT03644550|594846710|FG000|Overall Study|Withdrawal by Subject|3|||
164678365|NCT03644550|594846710|FG000|Overall Study|Progressive disease|15|||
164678366|NCT01218867|594846711|FG000|Overall Study|Death during treatment|0|||
164678367|NCT01218867|594846712|FG001|Overall Study|Death during treatment|0|||
164678368|NCT01218867|594846713|FG002|Overall Study|Death during treatment|0|||
164678369|NCT01218867|594846714|FG003|Overall Study|Death during treatment|0|||
164678370|NCT01218867|594846715|FG004|Overall Study|Death during treatment|0|||
164678371|NCT01218867|594846716|FG005|Overall Study|Death during treatment|0|||
164678372|NCT01218867|594846717|FG006|Overall Study|Death during treatment|1|||
164678373|NCT01218867|594846718|FG007|Overall Study|Death during treatment|0|||
164678374|NCT01218867|594846719|FG008|Overall Study|Death during treatment|0|||
164678375|NCT01218867|594846720|FG009|Overall Study|Death during treatment|0|||
164678376|NCT01218867|594846721|FG010|Overall Study|Death during treatment|0|||
164678377|NCT01588236|594846726|FG000|Overall Study|Adverse Event|5|||
164678378|NCT01588236|594846727|FG001|Overall Study|Adverse Event|4|||
164678379|NCT01588236|594846728|FG002|Overall Study|Adverse Event|1|||
164678380|NCT01588236|594846726|FG000|Overall Study|Lost to Follow-up|8|||
164678381|NCT01588236|594846727|FG001|Overall Study|Lost to Follow-up|13|||
164242713|NCT00413660|593260301|FG002|Post Week 12|Lost to Follow-up|1|||
164242714|NCT00413660|593260302|FG003|Post Week 12|Lost to Follow-up|0|||
164242715|NCT00413660|593260303|FG004|Post Week 12|Lost to Follow-up|0|||
164242716|NCT00413660|593260304|FG005|Post Week 12|Lost to Follow-up|0|||
164242717|NCT00413660|593260305|FG006|Post Week 12|Lost to Follow-up|0|||
164678382|NCT01588236|594846728|FG002|Overall Study|Lost to Follow-up|6|||
164242718|NCT00413660|593260306|FG007|Post Week 12|Lost to Follow-up|0|||
164242719|NCT00413660|593260307|FG008|Post Week 12|Lost to Follow-up|0|||
164678383|NCT01588236|594846726|FG000|Overall Study|Physician Decision|1|||
164336602|NCT05439941|593609742|FG000|Overall Study|Lack of Efficacy|8|||
164336603|NCT05439941|593609743|FG001|Overall Study|Lack of Efficacy|5|||
164336604|NCT05439941|593609744|FG002|Overall Study|Lack of Efficacy|3|||
164336605|NCT05439941|593609742|FG000|Overall Study|Treatment Failure|0|||
164336606|NCT05439941|593609743|FG001|Overall Study|Treatment Failure|1|||
164336607|NCT05439941|593609744|FG002|Overall Study|Treatment Failure|0|||
164336608|NCT05439941|593609742|FG000|Overall Study|Adverse Event|1|||
164573886|NCT00408005|594465549|FG002|Induction|Entered another COG therapeutic protocol|0|||
164573887|NCT00408005|594465550|FG003|Induction|Entered another COG therapeutic protocol|0|||
164573888|NCT00408005|594465551|FG004|Induction|Entered another COG therapeutic protocol|0|||
164573889|NCT00408005|594465552|FG005|Induction|Entered another COG therapeutic protocol|0|||
164573890|NCT00408005|594465553|FG006|Induction|Entered another COG therapeutic protocol|0|||
164573891|NCT00408005|594465554|FG007|Induction|Entered another COG therapeutic protocol|0|||
164573892|NCT00408005|594465547|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
164573893|NCT00408005|594465548|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
164573894|NCT00408005|594465549|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
164573895|NCT00408005|594465550|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
164573896|NCT00408005|594465551|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
164573897|NCT00408005|594465552|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
164573898|NCT00408005|594465553|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
164573899|NCT00408005|594465554|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
164573900|NCT00408005|594465547|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
164573901|NCT00408005|594465548|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
164573902|NCT00408005|594465549|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
164573903|NCT00408005|594465550|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
164573904|NCT00408005|594465551|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
164573905|NCT00408005|594465552|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
164573906|NCT00408005|594465553|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
164573907|NCT00408005|594465554|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
164573908|NCT00408005|594465547|FG000|Induction|Progressive Disease|0|||
164573909|NCT00408005|594465548|FG001|Induction|Progressive Disease|1|||
164573910|NCT00408005|594465549|FG002|Induction|Progressive Disease|0|||
164573911|NCT00408005|594465550|FG003|Induction|Progressive Disease|0|||
164573912|NCT00408005|594465551|FG004|Induction|Progressive Disease|0|||
164573913|NCT00408005|594465552|FG005|Induction|Progressive Disease|0|||
164573914|NCT00408005|594465553|FG006|Induction|Progressive Disease|0|||
164573915|NCT00408005|594465554|FG007|Induction|Progressive Disease|0|||
164573916|NCT00408005|594465547|FG000|Induction|Inevaluable|18|||
164573917|NCT00408005|594465548|FG001|Induction|Inevaluable|14|||
164573918|NCT00408005|594465549|FG002|Induction|Inevaluable|0|||
164573919|NCT00408005|594465550|FG003|Induction|Inevaluable|0|||
164573920|NCT00408005|594465551|FG004|Induction|Inevaluable|0|||
164573921|NCT00408005|594465552|FG005|Induction|Inevaluable|0|||
164573922|NCT00408005|594465553|FG006|Induction|Inevaluable|0|||
164573923|NCT00408005|594465554|FG007|Induction|Inevaluable|0|||
164573924|NCT00408005|594465547|FG000|Induction|Failed to Complete Randomization|3|||
164573925|NCT00408005|594465548|FG001|Induction|Failed to Complete Randomization|2|||
164573926|NCT00408005|594465549|FG002|Induction|Failed to Complete Randomization|0|||
164573927|NCT00408005|594465550|FG003|Induction|Failed to Complete Randomization|0|||
164573928|NCT00408005|594465551|FG004|Induction|Failed to Complete Randomization|0|||
164573929|NCT00408005|594465552|FG005|Induction|Failed to Complete Randomization|0|||
164573930|NCT00408005|594465553|FG006|Induction|Failed to Complete Randomization|0|||
164573931|NCT00408005|594465554|FG007|Induction|Failed to Complete Randomization|0|||
164573932|NCT00408005|594465547|FG000|Induction|Protocol Deviation|3|||
164573933|NCT00408005|594465548|FG001|Induction|Protocol Deviation|1|||
164573934|NCT00408005|594465549|FG002|Induction|Protocol Deviation|0|||
164573935|NCT00408005|594465550|FG003|Induction|Protocol Deviation|0|||
164573936|NCT00408005|594465551|FG004|Induction|Protocol Deviation|0|||
164573937|NCT00408005|594465552|FG005|Induction|Protocol Deviation|0|||
164573938|NCT00408005|594465553|FG006|Induction|Protocol Deviation|0|||
164573939|NCT00408005|594465554|FG007|Induction|Protocol Deviation|0|||
164573940|NCT00408005|594465547|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
164573941|NCT00408005|594465548|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
164573942|NCT00408005|594465549|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
164573943|NCT00408005|594465550|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
164573944|NCT00408005|594465551|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
164573945|NCT00408005|594465552|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
164678384|NCT01588236|594846727|FG001|Overall Study|Physician Decision|2|||
164678385|NCT01588236|594846728|FG002|Overall Study|Physician Decision|0|||
164678386|NCT01588236|594846726|FG000|Overall Study|Protocol Violation|0|||
164678387|NCT01588236|594846727|FG001|Overall Study|Protocol Violation|1|||
164678388|NCT01588236|594846728|FG002|Overall Study|Protocol Violation|1|||
164678389|NCT01588236|594846726|FG000|Overall Study|Withdrawal by Subject|14|||
164336609|NCT05439941|593609743|FG001|Overall Study|Adverse Event|3|||
164336610|NCT05439941|593609744|FG002|Overall Study|Adverse Event|0|||
164242720|NCT00413660|593260308|FG009|Post Week 12|Lost to Follow-up|0|||
164242721|NCT00413660|593260309|FG010|Post Week 12|Lost to Follow-up|0|||
164242722|NCT00413660|593260299|FG000|Post Week 12|Withdrawal by Subject|0|||
164242723|NCT00413660|593260300|FG001|Post Week 12|Withdrawal by Subject|1|||
164242724|NCT00413660|593260301|FG002|Post Week 12|Withdrawal by Subject|1|||
164242725|NCT00413660|593260302|FG003|Post Week 12|Withdrawal by Subject|0|||
164242726|NCT00413660|593260303|FG004|Post Week 12|Withdrawal by Subject|1|||
164242727|NCT00413660|593260304|FG005|Post Week 12|Withdrawal by Subject|0|||
164242728|NCT00413660|593260305|FG006|Post Week 12|Withdrawal by Subject|0|||
164242729|NCT00413660|593260306|FG007|Post Week 12|Withdrawal by Subject|0|||
164242730|NCT00413660|593260307|FG008|Post Week 12|Withdrawal by Subject|0|||
164242731|NCT00413660|593260308|FG009|Post Week 12|Withdrawal by Subject|0|||
164242732|NCT00413660|593260309|FG010|Post Week 12|Withdrawal by Subject|1|||
164242733|NCT00413660|593260299|FG000|Post Week 12|Other|1|||
164242734|NCT00413660|593260300|FG001|Post Week 12|Other|2|||
164242735|NCT00413660|593260301|FG002|Post Week 12|Other|3|||
164242736|NCT00413660|593260302|FG003|Post Week 12|Other|0|||
164242737|NCT00413660|593260303|FG004|Post Week 12|Other|1|||
164242738|NCT00413660|593260304|FG005|Post Week 12|Other|1|||
164242739|NCT00413660|593260305|FG006|Post Week 12|Other|1|||
164242740|NCT00413660|593260306|FG007|Post Week 12|Other|0|||
164242741|NCT00413660|593260307|FG008|Post Week 12|Other|0|||
164242742|NCT00413660|593260308|FG009|Post Week 12|Other|0|||
164242743|NCT00413660|593260309|FG010|Post Week 12|Other|0|||
164242744|NCT01791517|593260310|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
164573946|NCT00408005|594465553|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
164573947|NCT00408005|594465554|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
164573948|NCT00408005|594465547|FG000|Induction|Recurrent leukemia|1|||
164573949|NCT00408005|594465548|FG001|Induction|Recurrent leukemia|0|||
164573950|NCT00408005|594465549|FG002|Induction|Recurrent leukemia|0|||
164242745|NCT01791517|593260311|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
164242746|NCT01791517|593260312|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
164242747|NCT01791517|593260313|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
164573951|NCT00408005|594465550|FG003|Induction|Recurrent leukemia|0|||
164573952|NCT00408005|594465551|FG004|Induction|Recurrent leukemia|0|||
164573953|NCT00408005|594465552|FG005|Induction|Recurrent leukemia|0|||
164573954|NCT00408005|594465553|FG006|Induction|Recurrent leukemia|0|||
164573955|NCT00408005|594465554|FG007|Induction|Recurrent leukemia|0|||
164573956|NCT00408005|594465547|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
164573957|NCT00408005|594465548|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
164573958|NCT00408005|594465549|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
164573959|NCT00408005|594465550|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
164573960|NCT00408005|594465551|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
164573961|NCT00408005|594465552|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
164573962|NCT00408005|594465553|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
164573963|NCT00408005|594465554|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
164573964|NCT00408005|594465547|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
164573965|NCT00408005|594465548|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
164573966|NCT00408005|594465549|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
164573967|NCT00408005|594465550|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
164573968|NCT00408005|594465551|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
164573969|NCT00408005|594465552|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
164573970|NCT00408005|594465553|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
164573971|NCT00408005|594465554|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
164573972|NCT00408005|594465547|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
164573973|NCT00408005|594465548|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
164573974|NCT00408005|594465549|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
164242748|NCT01791517|593260314|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
164242749|NCT01791517|593260315|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
164242750|NCT01791517|593260316|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
164242751|NCT01791517|593260317|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
164242752|NCT01791517|593260318|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
164242753|NCT01791517|593260319|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
164242754|NCT01791517|593260320|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
164242755|NCT01791517|593260321|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
164336611|NCT05439941|593609742|FG000|Overall Study|Adverse Event - Parent Study|1|||
164336612|NCT05439941|593609743|FG001|Overall Study|Adverse Event - Parent Study|0|||
164573975|NCT00408005|594465550|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
164573976|NCT00408005|594465551|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
164573977|NCT00408005|594465552|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
164242756|NCT01791517|593260310|FG000|Phase I: Period 1|Adverse Event|0|||
164242757|NCT01791517|593260311|FG001|Phase I: Period 1|Adverse Event|0|||
164242758|NCT01791517|593260312|FG002|Phase I: Period 1|Adverse Event|1|||
164242759|NCT01791517|593260313|FG003|Phase I: Period 1|Adverse Event|1|||
164425453|NCT05968482|593928491|FG003|Third Crossover Period|Adverse Event|0|||
164425454|NCT05968482|593928492|FG004|Third Crossover Period|Adverse Event|1|||
164425455|NCT05968482|593928493|FG005|Third Crossover Period|Adverse Event|0|||
164425456|NCT05968482|593928488|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
164425457|NCT05968482|593928489|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
164336613|NCT05439941|593609744|FG002|Overall Study|Adverse Event - Parent Study|0|||
164336614|NCT05439941|593609742|FG000|Overall Study|Pregnancy|1|||
164336615|NCT05439941|593609743|FG001|Overall Study|Pregnancy|0|||
164336616|NCT05439941|593609744|FG002|Overall Study|Pregnancy|0|||
164336617|NCT05439941|593609742|FG000|Overall Study|Withdrawal by Subject|9|||
164336618|NCT05439941|593609743|FG001|Overall Study|Withdrawal by Subject|6|||
164425458|NCT05968482|593928490|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
164336619|NCT05439941|593609744|FG002|Overall Study|Withdrawal by Subject|10|||
164336620|NCT05439941|593609742|FG000|Overall Study|Non-Compliance|1|||
164336621|NCT05439941|593609743|FG001|Overall Study|Non-Compliance|1|||
164336622|NCT05439941|593609744|FG002|Overall Study|Non-Compliance|1|||
164336623|NCT05439941|593609742|FG000|Overall Study|Lost to Follow-up|2|||
164336624|NCT05439941|593609743|FG001|Overall Study|Lost to Follow-up|2|||
164336625|NCT05439941|593609744|FG002|Overall Study|Lost to Follow-up|0|||
164336626|NCT05439941|593609742|FG000|Overall Study|Physician Decision|1|||
164336627|NCT05439941|593609743|FG001|Overall Study|Physician Decision|0|||
164425459|NCT05968482|593928491|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
164425460|NCT05968482|593928492|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
164425461|NCT05968482|593928493|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
164425462|NCT03379233|593928500|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
164425463|NCT03379233|593928501|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
164425464|NCT00965484|593928502|FG000|Overall Study|Protocol Violation|1|||
164425465|NCT00965484|593928502|FG000|Overall Study|Withdrawal by Subject|1|||
164425466|NCT02015195|593928504|FG000|Overall Study|Adverse Event|0|||
164425467|NCT02015195|593928505|FG001|Overall Study|Adverse Event|0|||
164425468|NCT02015195|593928506|FG002|Overall Study|Adverse Event|0|||
164425469|NCT02015195|593928507|FG003|Overall Study|Adverse Event|1|||
164425470|NCT02015195|593928508|FG004|Overall Study|Adverse Event|0|||
164425471|NCT02015195|593928509|FG005|Overall Study|Adverse Event|0|||
164425472|NCT02015195|593928510|FG006|Overall Study|Adverse Event|0|||
164425473|NCT02554513|593928511|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
164573978|NCT00408005|594465553|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
164573979|NCT00408005|594465554|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
164573980|NCT00408005|594465547|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
164573981|NCT00408005|594465548|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
164573982|NCT00408005|594465549|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
164573983|NCT00408005|594465550|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
164573984|NCT00408005|594465551|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
164573985|NCT00408005|594465552|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
164573986|NCT00408005|594465553|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
164573987|NCT00408005|594465554|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
164573988|NCT00408005|594465547|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
164573989|NCT00408005|594465548|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
164573990|NCT00408005|594465549|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
164573991|NCT00408005|594465550|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
164425474|NCT02554513|593928512|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
164425475|NCT02303574|593928516|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
164425476|NCT02303574|593928517|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
164425477|NCT02303574|593928518|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
164425478|NCT02303574|593928519|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
164425479|NCT02303574|593928520|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
164678390|NCT01588236|594846727|FG001|Overall Study|Withdrawal by Subject|16|||
164678391|NCT01588236|594846728|FG002|Overall Study|Withdrawal by Subject|18|||
164678392|NCT01588236|594846726|FG000|Overall Study|Exclusion Criteria met during study|2|||
164678393|NCT01588236|594846727|FG001|Overall Study|Exclusion Criteria met during study|1|||
164678394|NCT01588236|594846728|FG002|Overall Study|Exclusion Criteria met during study|0|||
164678395|NCT01588236|594846726|FG000|Overall Study|sponsor decision|1|||
164678396|NCT01588236|594846727|FG001|Overall Study|sponsor decision|6|||
164678397|NCT01588236|594846728|FG002|Overall Study|sponsor decision|2|||
164678398|NCT02430480|594846729|FG000|Overall Study|Death|1|||
164678399|NCT02430480|594846729|FG000|Overall Study|Anesthesia concerns|1|||
164678400|NCT02430480|594846729|FG000|Overall Study|Progressed on treatment|1|||
164678401|NCT01030133|594846730|FG000|Overall Study|failed to experience pain at level 7/10|2|||
164678402|NCT01030133|594846731|FG001|Overall Study|failed to experience pain at level 7/10|2|||
164678403|NCT04493684|594846732|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
164678404|NCT04493684|594846733|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164678405|NCT04493684|594846734|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
164678406|NCT04493684|594846735|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164678407|NCT04493684|594846736|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164678408|NCT04493684|594846737|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
164678409|NCT04493684|594846738|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164678410|NCT04493684|594846739|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164678411|NCT04493684|594846740|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164678412|NCT04493684|594846741|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164678413|NCT04493684|594846742|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164678414|NCT04493684|594846743|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164678415|NCT04493684|594846744|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164678416|NCT04493684|594846745|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164678417|NCT04493684|594846746|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164678418|NCT04493684|594846747|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164678419|NCT04493684|594846748|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164678420|NCT04493684|594846732|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
164678421|NCT04493684|594846733|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164678422|NCT04493684|594846734|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164678423|NCT04493684|594846735|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164678424|NCT04493684|594846736|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164678425|NCT04493684|594846737|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164678426|NCT04493684|594846738|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164678427|NCT04493684|594846739|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164678428|NCT04493684|594846740|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164678429|NCT04493684|594846741|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164678430|NCT04493684|594846742|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164678431|NCT04493684|594846743|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164678432|NCT04493684|594846744|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164678433|NCT04493684|594846745|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164678434|NCT04493684|594846746|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164678435|NCT04493684|594846747|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164678436|NCT04493684|594846748|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164678437|NCT04493684|594846732|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164678438|NCT04493684|594846733|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164678439|NCT04493684|594846734|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164678440|NCT04493684|594846735|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164678441|NCT04493684|594846736|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164678442|NCT04493684|594846737|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164678443|NCT04493684|594846738|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
164678444|NCT04493684|594846739|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164678445|NCT04493684|594846740|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164678446|NCT04493684|594846741|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164425480|NCT02303574|593928521|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
164242760|NCT01791517|593260314|FG004|Phase I: Period 1|Adverse Event|0|||
164242761|NCT01791517|593260315|FG005|Phase I: Period 1|Adverse Event|0|||
164242762|NCT01791517|593260316|FG006|Phase I: Period 1|Adverse Event|0|||
164242763|NCT01791517|593260317|FG007|Phase I: Period 1|Adverse Event|0|||
164242764|NCT01791517|593260318|FG008|Phase I: Period 1|Adverse Event|0|||
164242765|NCT01791517|593260319|FG009|Phase I: Period 1|Adverse Event|0|||
164242766|NCT01791517|593260320|FG010|Phase I: Period 1|Adverse Event|0|||
164242767|NCT01791517|593260321|FG011|Phase I: Period 1|Adverse Event|0|||
164242768|NCT01791517|593260310|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
164242769|NCT01791517|593260311|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
164242770|NCT01791517|593260312|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
164242771|NCT01791517|593260313|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
164242772|NCT01791517|593260314|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
164242773|NCT01791517|593260315|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
164242774|NCT01791517|593260316|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
164242775|NCT01791517|593260317|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
164242776|NCT01791517|593260318|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
164242777|NCT01791517|593260319|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
164242778|NCT01791517|593260320|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
164242779|NCT01791517|593260321|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
164242780|NCT01791517|593260310|FG000|Phase I: Period 1|Protocol Violation|0|||
164242781|NCT01791517|593260311|FG001|Phase I: Period 1|Protocol Violation|1|||
164242782|NCT01791517|593260312|FG002|Phase I: Period 1|Protocol Violation|0|||
164242783|NCT01791517|593260313|FG003|Phase I: Period 1|Protocol Violation|0|||
164242784|NCT01791517|593260314|FG004|Phase I: Period 1|Protocol Violation|0|||
164242785|NCT01791517|593260315|FG005|Phase I: Period 1|Protocol Violation|0|||
164242786|NCT01791517|593260316|FG006|Phase I: Period 1|Protocol Violation|0|||
164242787|NCT01791517|593260317|FG007|Phase I: Period 1|Protocol Violation|0|||
164242788|NCT01791517|593260318|FG008|Phase I: Period 1|Protocol Violation|0|||
164242789|NCT01791517|593260319|FG009|Phase I: Period 1|Protocol Violation|0|||
164242790|NCT01791517|593260320|FG010|Phase I: Period 1|Protocol Violation|0|||
164242791|NCT01791517|593260321|FG011|Phase I: Period 1|Protocol Violation|0|||
164242792|NCT01791517|593260310|FG000|Phase I: Period 1|Lost to Follow-up|0|||
164242793|NCT01791517|593260311|FG001|Phase I: Period 1|Lost to Follow-up|0|||
164242794|NCT01791517|593260312|FG002|Phase I: Period 1|Lost to Follow-up|0|||
164242795|NCT01791517|593260313|FG003|Phase I: Period 1|Lost to Follow-up|1|||
164242796|NCT01791517|593260314|FG004|Phase I: Period 1|Lost to Follow-up|0|||
164242797|NCT01791517|593260315|FG005|Phase I: Period 1|Lost to Follow-up|0|||
164242798|NCT01791517|593260316|FG006|Phase I: Period 1|Lost to Follow-up|1|||
164242799|NCT01791517|593260317|FG007|Phase I: Period 1|Lost to Follow-up|0|||
164242800|NCT01791517|593260318|FG008|Phase I: Period 1|Lost to Follow-up|1|||
164242801|NCT01791517|593260319|FG009|Phase I: Period 1|Lost to Follow-up|1|||
164242802|NCT01791517|593260320|FG010|Phase I: Period 1|Lost to Follow-up|0|||
164242803|NCT01791517|593260321|FG011|Phase I: Period 1|Lost to Follow-up|0|||
164242804|NCT01791517|593260310|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
164242805|NCT01791517|593260311|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
164242806|NCT01791517|593260312|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
164242807|NCT01791517|593260313|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
164242808|NCT01791517|593260314|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
164242809|NCT01791517|593260315|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
164242810|NCT01791517|593260316|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
164242811|NCT01791517|593260317|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
164242812|NCT01791517|593260318|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
164242813|NCT01791517|593260319|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
164242814|NCT01791517|593260320|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
164242815|NCT01791517|593260321|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
164242816|NCT01791517|593260310|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
164242817|NCT01791517|593260311|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
164242818|NCT01791517|593260312|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
164242819|NCT01791517|593260313|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
164242820|NCT01791517|593260314|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
164242821|NCT01791517|593260315|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
164242822|NCT01791517|593260316|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
164336628|NCT05439941|593609744|FG002|Overall Study|Physician Decision|0|||
164336629|NCT05439941|593609742|FG000|Overall Study|Trial Termination by Sponsor|78|||
164336630|NCT05439941|593609743|FG001|Overall Study|Trial Termination by Sponsor|83|||
164242823|NCT01791517|593260317|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
164242824|NCT01791517|593260318|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
164242825|NCT01791517|593260319|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
164242826|NCT01791517|593260320|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
164242827|NCT01791517|593260321|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
164242828|NCT01791517|593260310|FG000|Phase I: Period 2|Protocol Violation|0|||
164242829|NCT01791517|593260311|FG001|Phase I: Period 2|Protocol Violation|0|||
164336631|NCT05439941|593609744|FG002|Overall Study|Trial Termination by Sponsor|65|||
164242830|NCT01791517|593260312|FG002|Phase I: Period 2|Protocol Violation|0|||
164242831|NCT01791517|593260313|FG003|Phase I: Period 2|Protocol Violation|1|||
164242832|NCT01791517|593260314|FG004|Phase I: Period 2|Protocol Violation|0|||
164242833|NCT01791517|593260315|FG005|Phase I: Period 2|Protocol Violation|0|||
164242834|NCT01791517|593260316|FG006|Phase I: Period 2|Protocol Violation|0|||
164242835|NCT01791517|593260317|FG007|Phase I: Period 2|Protocol Violation|0|||
164242836|NCT01791517|593260318|FG008|Phase I: Period 2|Protocol Violation|0|||
164242837|NCT01791517|593260319|FG009|Phase I: Period 2|Protocol Violation|0|||
164242838|NCT01791517|593260320|FG010|Phase I: Period 2|Protocol Violation|0|||
164242839|NCT01791517|593260321|FG011|Phase I: Period 2|Protocol Violation|0|||
164242840|NCT01791517|593260310|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
164242841|NCT01791517|593260311|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
164242842|NCT01791517|593260312|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
164242843|NCT01791517|593260313|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
164242844|NCT01791517|593260314|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
164242845|NCT01791517|593260315|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
164242846|NCT01791517|593260316|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
164242847|NCT01791517|593260317|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
164242848|NCT01791517|593260318|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
164242849|NCT01791517|593260319|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
164242850|NCT01791517|593260320|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
164242851|NCT01791517|593260321|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
164242852|NCT01791517|593260310|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
164242853|NCT01791517|593260311|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
164242854|NCT01791517|593260312|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
164242855|NCT01791517|593260313|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
164242856|NCT01791517|593260314|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
164242857|NCT01791517|593260315|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
164242858|NCT01791517|593260316|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
164242859|NCT01791517|593260317|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
164242860|NCT01791517|593260318|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
164242861|NCT01791517|593260319|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
164242862|NCT01791517|593260320|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
164242863|NCT01791517|593260321|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
164242864|NCT01791517|593260310|FG000|Phase I: Period 2|Lens Discomfort|0|||
164242865|NCT01791517|593260311|FG001|Phase I: Period 2|Lens Discomfort|0|||
164242866|NCT01791517|593260312|FG002|Phase I: Period 2|Lens Discomfort|0|||
164242867|NCT01791517|593260313|FG003|Phase I: Period 2|Lens Discomfort|0|||
164242868|NCT01791517|593260314|FG004|Phase I: Period 2|Lens Discomfort|0|||
164242869|NCT01791517|593260315|FG005|Phase I: Period 2|Lens Discomfort|1|||
164242870|NCT01791517|593260316|FG006|Phase I: Period 2|Lens Discomfort|0|||
164242871|NCT01791517|593260317|FG007|Phase I: Period 2|Lens Discomfort|0|||
164242872|NCT01791517|593260318|FG008|Phase I: Period 2|Lens Discomfort|0|||
164336632|NCT05439941|593609742|FG000|Overall Study|Other than Reasons Listed|2|||
164336633|NCT05439941|593609743|FG001|Overall Study|Other than Reasons Listed|1|||
164336634|NCT05439941|593609744|FG002|Overall Study|Other than Reasons Listed|0|||
164336635|NCT02336373|593609747|FG000|Overall Study|Protocol closed early|4|||
164336636|NCT02336373|593609747|FG000|Overall Study|Physician Decision|14|||
164336637|NCT04798781|593609750|FG000|Overall Study|Withdrawal by Subject|1|||
164336638|NCT00615108|593609753|FG000|Overall Study|Adverse Event|122|||
164336639|NCT00615108|593609753|FG000|Overall Study|Other|370|||
164336640|NCT00615108|593609753|FG000|Overall Study|Lost to Follow-up|15|||
164336641|NCT02024529|593609754|FG000|Overall Study|Withdrawal by Subject|11|||
164336642|NCT02024529|593609755|FG001|Overall Study|Withdrawal by Subject|21|||
164336643|NCT02024529|593609754|FG000|Overall Study|Lost to Follow-up|2|||
164425481|NCT02303574|593928522|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
164425482|NCT02303574|593928523|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
164678447|NCT04493684|594846742|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164678448|NCT04493684|594846743|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164678449|NCT04493684|594846744|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164678450|NCT04493684|594846745|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164678451|NCT04493684|594846746|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164678452|NCT04493684|594846747|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164242873|NCT01791517|593260319|FG009|Phase I: Period 2|Lens Discomfort|0|||
164242874|NCT01791517|593260320|FG010|Phase I: Period 2|Lens Discomfort|0|||
164242875|NCT01791517|593260321|FG011|Phase I: Period 2|Lens Discomfort|0|||
164242876|NCT01791517|593260310|FG000|Phase I: Period 2|Lost to Follow-up|0|||
164242877|NCT01791517|593260311|FG001|Phase I: Period 2|Lost to Follow-up|3|||
164242878|NCT01791517|593260312|FG002|Phase I: Period 2|Lost to Follow-up|2|||
164242879|NCT01791517|593260313|FG003|Phase I: Period 2|Lost to Follow-up|0|||
164336644|NCT02024529|593609755|FG001|Overall Study|Lost to Follow-up|4|||
164336645|NCT00691301|593609756|FG000|Overall Study|Adverse Event|10|||
164336646|NCT00691301|593609756|FG000|Overall Study|Death|2|||
164336647|NCT00691301|593609756|FG000|Overall Study|Lack of Efficacy|32|||
164242880|NCT01791517|593260314|FG004|Phase I: Period 2|Lost to Follow-up|0|||
164242881|NCT01791517|593260315|FG005|Phase I: Period 2|Lost to Follow-up|0|||
164242882|NCT01791517|593260316|FG006|Phase I: Period 2|Lost to Follow-up|0|||
164242883|NCT01791517|593260317|FG007|Phase I: Period 2|Lost to Follow-up|0|||
164242884|NCT01791517|593260318|FG008|Phase I: Period 2|Lost to Follow-up|0|||
164242885|NCT01791517|593260319|FG009|Phase I: Period 2|Lost to Follow-up|0|||
164242886|NCT01791517|593260320|FG010|Phase I: Period 2|Lost to Follow-up|0|||
164242887|NCT01791517|593260321|FG011|Phase I: Period 2|Lost to Follow-up|0|||
164242888|NCT01791517|593260310|FG000|Phase I: Period 3|Lens Discomfort|0|||
164242889|NCT01791517|593260311|FG001|Phase I: Period 3|Lens Discomfort|0|||
164242890|NCT01791517|593260312|FG002|Phase I: Period 3|Lens Discomfort|0|||
164242891|NCT01791517|593260313|FG003|Phase I: Period 3|Lens Discomfort|0|||
164242892|NCT01791517|593260314|FG004|Phase I: Period 3|Lens Discomfort|0|||
164242893|NCT01791517|593260315|FG005|Phase I: Period 3|Lens Discomfort|0|||
164242894|NCT01791517|593260316|FG006|Phase I: Period 3|Lens Discomfort|0|||
164242895|NCT01791517|593260317|FG007|Phase I: Period 3|Lens Discomfort|0|||
164242896|NCT01791517|593260318|FG008|Phase I: Period 3|Lens Discomfort|0|||
164242897|NCT01791517|593260319|FG009|Phase I: Period 3|Lens Discomfort|0|||
164242898|NCT01791517|593260320|FG010|Phase I: Period 3|Lens Discomfort|0|||
164242899|NCT01791517|593260321|FG011|Phase I: Period 3|Lens Discomfort|1|||
164242900|NCT01791517|593260310|FG000|Phase I: Period 3|Lost to Follow-up|0|||
164242901|NCT01791517|593260311|FG001|Phase I: Period 3|Lost to Follow-up|1|||
164242902|NCT01791517|593260312|FG002|Phase I: Period 3|Lost to Follow-up|0|||
164242903|NCT01791517|593260313|FG003|Phase I: Period 3|Lost to Follow-up|0|||
164242904|NCT01791517|593260314|FG004|Phase I: Period 3|Lost to Follow-up|1|||
164242905|NCT01791517|593260315|FG005|Phase I: Period 3|Lost to Follow-up|0|||
164242906|NCT01791517|593260316|FG006|Phase I: Period 3|Lost to Follow-up|0|||
164242907|NCT01791517|593260317|FG007|Phase I: Period 3|Lost to Follow-up|0|||
164242908|NCT01791517|593260318|FG008|Phase I: Period 3|Lost to Follow-up|0|||
164242909|NCT01791517|593260319|FG009|Phase I: Period 3|Lost to Follow-up|0|||
164242910|NCT01791517|593260320|FG010|Phase I: Period 3|Lost to Follow-up|0|||
164242911|NCT01791517|593260321|FG011|Phase I: Period 3|Lost to Follow-up|0|||
164242912|NCT01791517|593260310|FG000|Phase I: Period 3|Adverse Event|0|||
164242913|NCT01791517|593260311|FG001|Phase I: Period 3|Adverse Event|0|||
164242914|NCT01791517|593260312|FG002|Phase I: Period 3|Adverse Event|0|||
164242915|NCT01791517|593260313|FG003|Phase I: Period 3|Adverse Event|1|||
164242916|NCT01791517|593260314|FG004|Phase I: Period 3|Adverse Event|0|||
164242917|NCT01791517|593260315|FG005|Phase I: Period 3|Adverse Event|0|||
164242918|NCT01791517|593260316|FG006|Phase I: Period 3|Adverse Event|0|||
164242919|NCT01791517|593260317|FG007|Phase I: Period 3|Adverse Event|0|||
164242920|NCT01791517|593260318|FG008|Phase I: Period 3|Adverse Event|0|||
164242921|NCT01791517|593260319|FG009|Phase I: Period 3|Adverse Event|0|||
164242922|NCT01791517|593260320|FG010|Phase I: Period 3|Adverse Event|0|||
164573992|NCT00408005|594465551|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
164573993|NCT00408005|594465552|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
164573994|NCT00408005|594465553|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
164573995|NCT00408005|594465554|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
164573996|NCT00408005|594465547|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
164573997|NCT00408005|594465548|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
164573998|NCT00408005|594465549|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
164573999|NCT00408005|594465550|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
164574000|NCT00408005|594465551|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
164574001|NCT00408005|594465552|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
164574002|NCT00408005|594465553|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
164574003|NCT00408005|594465554|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
164574004|NCT00408005|594465547|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
164574005|NCT00408005|594465548|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
164574006|NCT00408005|594465549|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
164574007|NCT00408005|594465550|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
164678453|NCT04493684|594846748|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164678454|NCT04493684|594846732|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
164242923|NCT01791517|593260321|FG011|Phase I: Period 3|Adverse Event|0|||
164242924|NCT01791517|593260310|FG000|Phase II|Lost to Follow-up|1|||
164242925|NCT01791517|593260311|FG001|Phase II|Lost to Follow-up|0|||
164242926|NCT01791517|593260312|FG002|Phase II|Lost to Follow-up|1|||
164242927|NCT01791517|593260313|FG003|Phase II|Lost to Follow-up|0|||
164425483|NCT02303574|593928524|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
164242928|NCT01791517|593260314|FG004|Phase II|Lost to Follow-up|1|||
164242929|NCT01791517|593260315|FG005|Phase II|Lost to Follow-up|2|||
164242930|NCT01791517|593260316|FG006|Phase II|Lost to Follow-up|0|||
164242931|NCT01791517|593260317|FG007|Phase II|Lost to Follow-up|1|||
164242932|NCT01791517|593260318|FG008|Phase II|Lost to Follow-up|1|||
164242933|NCT01791517|593260319|FG009|Phase II|Lost to Follow-up|1|||
164242934|NCT01791517|593260320|FG010|Phase II|Lost to Follow-up|0|||
164242935|NCT01791517|593260321|FG011|Phase II|Lost to Follow-up|0|||
164242936|NCT01791517|593260310|FG000|Phase II|Withdrawal by Subject|1|||
164242937|NCT01791517|593260311|FG001|Phase II|Withdrawal by Subject|0|||
164242938|NCT01791517|593260312|FG002|Phase II|Withdrawal by Subject|0|||
164242939|NCT01791517|593260313|FG003|Phase II|Withdrawal by Subject|0|||
164242940|NCT01791517|593260314|FG004|Phase II|Withdrawal by Subject|0|||
164242941|NCT01791517|593260315|FG005|Phase II|Withdrawal by Subject|2|||
164242942|NCT01791517|593260316|FG006|Phase II|Withdrawal by Subject|0|||
164242943|NCT01791517|593260317|FG007|Phase II|Withdrawal by Subject|1|||
164242944|NCT01791517|593260318|FG008|Phase II|Withdrawal by Subject|0|||
164242945|NCT01791517|593260319|FG009|Phase II|Withdrawal by Subject|0|||
164242946|NCT01791517|593260320|FG010|Phase II|Withdrawal by Subject|1|||
164242947|NCT01791517|593260321|FG011|Phase II|Withdrawal by Subject|0|||
164242948|NCT01791517|593260310|FG000|Phase II|Lack of Efficacy|0|||
164242949|NCT01791517|593260311|FG001|Phase II|Lack of Efficacy|0|||
164242950|NCT01791517|593260312|FG002|Phase II|Lack of Efficacy|0|||
164242951|NCT01791517|593260313|FG003|Phase II|Lack of Efficacy|0|||
164242952|NCT01791517|593260314|FG004|Phase II|Lack of Efficacy|1|||
164242953|NCT01791517|593260315|FG005|Phase II|Lack of Efficacy|0|||
164242954|NCT01791517|593260316|FG006|Phase II|Lack of Efficacy|0|||
164242955|NCT01791517|593260317|FG007|Phase II|Lack of Efficacy|0|||
164242956|NCT01791517|593260318|FG008|Phase II|Lack of Efficacy|0|||
164242957|NCT01791517|593260319|FG009|Phase II|Lack of Efficacy|0|||
164242958|NCT01791517|593260320|FG010|Phase II|Lack of Efficacy|0|||
164242959|NCT01791517|593260321|FG011|Phase II|Lack of Efficacy|0|||
164242960|NCT01791517|593260310|FG000|Phase II|Adverse Event|0|||
164242961|NCT01791517|593260311|FG001|Phase II|Adverse Event|0|||
164242962|NCT01791517|593260312|FG002|Phase II|Adverse Event|0|||
164242963|NCT01791517|593260313|FG003|Phase II|Adverse Event|0|||
164242964|NCT01791517|593260314|FG004|Phase II|Adverse Event|0|||
164242965|NCT01791517|593260315|FG005|Phase II|Adverse Event|0|||
164242966|NCT01791517|593260316|FG006|Phase II|Adverse Event|2|||
164242967|NCT01791517|593260317|FG007|Phase II|Adverse Event|1|||
164242968|NCT01791517|593260318|FG008|Phase II|Adverse Event|0|||
164425484|NCT02303574|593928525|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
164574008|NCT00408005|594465551|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
164574009|NCT00408005|594465552|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
164574010|NCT00408005|594465553|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
164574011|NCT00408005|594465554|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
164574012|NCT00408005|594465547|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
164574013|NCT00408005|594465548|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
164574014|NCT00408005|594465549|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
164574015|NCT00408005|594465550|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
164574016|NCT00408005|594465551|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
164574017|NCT00408005|594465552|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
164574018|NCT00408005|594465553|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
164574019|NCT00408005|594465554|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
164574020|NCT00408005|594465547|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
164574021|NCT00408005|594465548|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
164574022|NCT00408005|594465549|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
164574023|NCT00408005|594465550|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
164574024|NCT00408005|594465551|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
164574025|NCT00408005|594465552|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
164574026|NCT00408005|594465553|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
164574027|NCT00408005|594465554|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
164574028|NCT00408005|594465547|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
164574029|NCT00408005|594465548|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
164574030|NCT00408005|594465549|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
164574031|NCT00408005|594465550|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
164242969|NCT01791517|593260319|FG009|Phase II|Adverse Event|1|||
164242970|NCT01791517|593260320|FG010|Phase II|Adverse Event|0|||
164242971|NCT01791517|593260321|FG011|Phase II|Adverse Event|0|||
164242972|NCT01791517|593260310|FG000|Phase II|Lens Handling Difficulties|0|||
164242973|NCT01791517|593260311|FG001|Phase II|Lens Handling Difficulties|0|||
164242974|NCT01791517|593260312|FG002|Phase II|Lens Handling Difficulties|0|||
164242975|NCT01791517|593260313|FG003|Phase II|Lens Handling Difficulties|0|||
164242976|NCT01791517|593260314|FG004|Phase II|Lens Handling Difficulties|0|||
164242977|NCT01791517|593260315|FG005|Phase II|Lens Handling Difficulties|0|||
164242978|NCT01791517|593260316|FG006|Phase II|Lens Handling Difficulties|0|||
164425485|NCT02303574|593928516|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
164242979|NCT01791517|593260317|FG007|Phase II|Lens Handling Difficulties|0|||
164242980|NCT01791517|593260318|FG008|Phase II|Lens Handling Difficulties|1|||
164242981|NCT01791517|593260319|FG009|Phase II|Lens Handling Difficulties|0|||
164242982|NCT01791517|593260320|FG010|Phase II|Lens Handling Difficulties|0|||
164242983|NCT01791517|593260321|FG011|Phase II|Lens Handling Difficulties|0|||
164242984|NCT01791517|593260310|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
164242985|NCT01791517|593260311|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
164242986|NCT01791517|593260312|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
164242987|NCT01791517|593260313|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
164242988|NCT01791517|593260314|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
164242989|NCT01791517|593260315|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
164242990|NCT01791517|593260316|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
164242991|NCT01791517|593260317|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
164242992|NCT01791517|593260318|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
164242993|NCT01791517|593260319|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
164678455|NCT04493684|594846733|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164678456|NCT04493684|594846734|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164678457|NCT04493684|594846735|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164678458|NCT04493684|594846736|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164678459|NCT04493684|594846737|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164678460|NCT04493684|594846738|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164678461|NCT04493684|594846739|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164678462|NCT04493684|594846740|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164678463|NCT04493684|594846741|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164678464|NCT04493684|594846742|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164678465|NCT04493684|594846743|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164678466|NCT04493684|594846744|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164678467|NCT04493684|594846745|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164678468|NCT04493684|594846746|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164678469|NCT04493684|594846747|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164678470|NCT04493684|594846748|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164678471|NCT04493684|594846732|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164678472|NCT04493684|594846733|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164678473|NCT04493684|594846734|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164678474|NCT04493684|594846735|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164678475|NCT04493684|594846736|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164678476|NCT04493684|594846737|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
164678477|NCT04493684|594846738|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164678478|NCT04493684|594846739|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164678479|NCT04493684|594846740|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164678480|NCT04493684|594846741|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164678481|NCT04493684|594846742|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164678482|NCT04493684|594846743|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164678483|NCT04493684|594846744|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164678484|NCT04493684|594846745|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164678485|NCT04493684|594846746|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164678486|NCT04493684|594846747|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164678487|NCT04493684|594846748|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164678488|NCT04493684|594846732|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164678489|NCT04493684|594846733|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164678490|NCT04493684|594846734|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164678491|NCT04493684|594846735|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164678492|NCT04493684|594846736|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164678493|NCT04493684|594846737|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164678494|NCT04493684|594846738|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164678495|NCT04493684|594846739|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164678496|NCT04493684|594846740|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164242994|NCT01791517|593260320|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
164242995|NCT01791517|593260321|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
164242996|NCT01791517|593260310|FG000|Phase II|Pre-Existing Ocular Issue|0|||
164242997|NCT01791517|593260311|FG001|Phase II|Pre-Existing Ocular Issue|0|||
164242998|NCT01791517|593260312|FG002|Phase II|Pre-Existing Ocular Issue|0|||
164242999|NCT01791517|593260313|FG003|Phase II|Pre-Existing Ocular Issue|0|||
164243000|NCT01791517|593260314|FG004|Phase II|Pre-Existing Ocular Issue|0|||
164243001|NCT01791517|593260315|FG005|Phase II|Pre-Existing Ocular Issue|0|||
164243002|NCT01791517|593260316|FG006|Phase II|Pre-Existing Ocular Issue|0|||
164678497|NCT04493684|594846741|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164678498|NCT04493684|594846742|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164678499|NCT04493684|594846743|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
164678500|NCT04493684|594846744|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164678501|NCT04493684|594846745|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164678502|NCT04493684|594846746|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164243003|NCT01791517|593260317|FG007|Phase II|Pre-Existing Ocular Issue|0|||
164243004|NCT01791517|593260318|FG008|Phase II|Pre-Existing Ocular Issue|0|||
164243005|NCT01791517|593260319|FG009|Phase II|Pre-Existing Ocular Issue|0|||
164243006|NCT01791517|593260320|FG010|Phase II|Pre-Existing Ocular Issue|0|||
164243007|NCT01791517|593260321|FG011|Phase II|Pre-Existing Ocular Issue|1|||
164243008|NCT00589797|593260322|FG000|Overall Study|Death|1|||
164243009|NCT00589797|593260323|FG001|Overall Study|Death|0|||
164243010|NCT00589797|593260322|FG000|Overall Study|Lost to Follow-up|12|||
164243011|NCT00589797|593260323|FG001|Overall Study|Lost to Follow-up|9|||
164243012|NCT00589797|593260322|FG000|Overall Study|Physician Decision|8|||
164243013|NCT00589797|593260323|FG001|Overall Study|Physician Decision|3|||
164243014|NCT00589797|593260322|FG000|Overall Study|Withdrawal by Subject|6|||
164243015|NCT00589797|593260323|FG001|Overall Study|Withdrawal by Subject|5|||
164243016|NCT00589797|593260322|FG000|Overall Study|Non-Randomized Training Subjects|46|||
164243017|NCT00589797|593260323|FG001|Overall Study|Non-Randomized Training Subjects|6|||
164243018|NCT02141672|593260325|FG000|Overall Study|Adverse Event|0|||
164243019|NCT02141672|593260326|FG001|Overall Study|Adverse Event|1|||
164243020|NCT02141672|593260327|FG002|Overall Study|Adverse Event|0|||
164243021|NCT02141672|593260325|FG000|Overall Study|Death|10|||
164243022|NCT02141672|593260326|FG001|Overall Study|Death|2|||
164243023|NCT02141672|593260327|FG002|Overall Study|Death|1|||
164243024|NCT02141672|593260325|FG000|Overall Study|Lack of Efficacy|0|||
164243025|NCT02141672|593260326|FG001|Overall Study|Lack of Efficacy|0|||
164243026|NCT02141672|593260327|FG002|Overall Study|Lack of Efficacy|2|||
164243027|NCT02141672|593260325|FG000|Overall Study|Lost to Follow-up|1|||
164243028|NCT02141672|593260326|FG001|Overall Study|Lost to Follow-up|1|||
164243029|NCT02141672|593260327|FG002|Overall Study|Lost to Follow-up|3|||
164243030|NCT02141672|593260325|FG000|Overall Study|Physician Decision|1|||
164243031|NCT02141672|593260326|FG001|Overall Study|Physician Decision|2|||
164243032|NCT02141672|593260327|FG002|Overall Study|Physician Decision|5|||
164243033|NCT02141672|593260325|FG000|Overall Study|Protocol Violation|0|||
164243034|NCT02141672|593260326|FG001|Overall Study|Protocol Violation|0|||
164336648|NCT00691301|593609756|FG000|Overall Study|Withdrawal by Subject|4|||
164336649|NCT00691301|593609756|FG000|Overall Study|Concurrent illness|2|||
164336650|NCT00691301|593609756|FG000|Overall Study|other reason|3|||
164574032|NCT00408005|594465551|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
164574033|NCT00408005|594465552|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
164574034|NCT00408005|594465553|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
164574035|NCT00408005|594465554|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
164574036|NCT00408005|594465547|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
164574037|NCT00408005|594465548|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
164574038|NCT00408005|594465549|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
164574039|NCT00408005|594465550|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
164574040|NCT00408005|594465551|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
164574041|NCT00408005|594465552|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
164574042|NCT00408005|594465553|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
164574043|NCT00408005|594465554|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
164574044|NCT00408005|594465547|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
164574045|NCT00408005|594465548|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
164574046|NCT00408005|594465549|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
164574047|NCT00408005|594465550|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
164574048|NCT00408005|594465551|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
164574049|NCT00408005|594465552|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
164243035|NCT02141672|593260327|FG002|Overall Study|Protocol Violation|1|||
164243036|NCT02141672|593260325|FG000|Overall Study|Withdrawal by Subject|3|||
164243037|NCT02141672|593260326|FG001|Overall Study|Withdrawal by Subject|2|||
164243038|NCT02141672|593260327|FG002|Overall Study|Withdrawal by Subject|5|||
164243039|NCT02141672|593260325|FG000|Overall Study|refused to follow-up|1|||
164243040|NCT02141672|593260326|FG001|Overall Study|refused to follow-up|0|||
164243041|NCT02141672|593260327|FG002|Overall Study|refused to follow-up|1|||
164243042|NCT02688192|593260328|FG000|Overall Study|Lost to Follow-up|11|||
164243043|NCT02688192|593260329|FG001|Overall Study|Lost to Follow-up|5|||
164243044|NCT02688192|593260328|FG000|Overall Study|Physician Decision|1|||
164243045|NCT02688192|593260329|FG001|Overall Study|Physician Decision|0|||
164336651|NCT00691301|593609756|FG000|Overall Study|Did not initiate study treatment|1|||
164243046|NCT02817594|593260333|FG000|Overall Study|Withdrawal by Subject|1|||
164243047|NCT02817594|593260333|FG000|Overall Study|Other|1|||
164243048|NCT02817594|593260333|FG000|Overall Study|Did Not Receive Treatment|1|||
164243049|NCT02010593|593260334|FG000|Overall Study|Lost to Follow-up|1|||
164243050|NCT02010593|593260335|FG001|Overall Study|Lost to Follow-up|0|||
164243051|NCT02010593|593260334|FG000|Overall Study|Physician Decision|1|||
164243052|NCT02010593|593260335|FG001|Overall Study|Physician Decision|0|||
164243053|NCT02010593|593260334|FG000|Overall Study|Unable to adhere to visit schedule|0|||
164243054|NCT02010593|593260335|FG001|Overall Study|Unable to adhere to visit schedule|2|||
164243055|NCT01773967|593260336|FG000|Overall Study|Lost to Follow-up|15|||
164243056|NCT01773967|593260337|FG001|Overall Study|Lost to Follow-up|13|||
164243057|NCT01135459|593260338|FG000|Overall Study|Adverse Event|8|||
164243058|NCT01135459|593260339|FG001|Overall Study|Adverse Event|10|||
164243059|NCT01135459|593260338|FG000|Overall Study|Lack of Efficacy|3|||
164243060|NCT01135459|593260339|FG001|Overall Study|Lack of Efficacy|1|||
164243061|NCT01135459|593260338|FG000|Overall Study|Withdrawal by Subject|2|||
164243062|NCT01135459|593260339|FG001|Overall Study|Withdrawal by Subject|3|||
164243063|NCT01135459|593260338|FG000|Overall Study|Protocol Violation|5|||
164243064|NCT01135459|593260339|FG001|Overall Study|Protocol Violation|3|||
164243065|NCT01135459|593260338|FG000|Overall Study|Lost to Follow-up|2|||
164243066|NCT01135459|593260339|FG001|Overall Study|Lost to Follow-up|1|||
164243067|NCT01135459|593260338|FG000|Overall Study|Non-compliance to study procedures|0|||
164243068|NCT01135459|593260339|FG001|Overall Study|Non-compliance to study procedures|1|||
164243069|NCT01135459|593260338|FG000|Overall Study|Other than specified|1|||
164243070|NCT01135459|593260339|FG001|Overall Study|Other than specified|1|||
164243071|NCT01803880|593260340|FG000|Overall Study|Adverse Event|1|||
164243072|NCT01803880|593260341|FG001|Overall Study|Adverse Event|0|||
164243073|NCT01803880|593260342|FG002|Overall Study|Adverse Event|0|||
164243074|NCT01803880|593260340|FG000|Overall Study|Withdrawal by Subject|1|||
164243075|NCT01803880|593260341|FG001|Overall Study|Withdrawal by Subject|1|||
164243076|NCT01803880|593260342|FG002|Overall Study|Withdrawal by Subject|4|||
164243077|NCT01803880|593260340|FG000|Overall Study|Physician Decision|0|||
164243078|NCT01803880|593260341|FG001|Overall Study|Physician Decision|0|||
164243079|NCT01803880|593260342|FG002|Overall Study|Physician Decision|1|||
164243080|NCT01803880|593260340|FG000|Overall Study|Unable to return for follow-up visits|0|||
164243081|NCT01803880|593260341|FG001|Overall Study|Unable to return for follow-up visits|1|||
164243082|NCT01803880|593260342|FG002|Overall Study|Unable to return for follow-up visits|2|||
164243083|NCT01803880|593260340|FG000|Overall Study|Lost to Follow-up|1|||
164243084|NCT01803880|593260341|FG001|Overall Study|Lost to Follow-up|2|||
164243085|NCT01803880|593260342|FG002|Overall Study|Lost to Follow-up|3|||
164243086|NCT01803880|593260340|FG000|Overall Study|Protocol Violation|1|||
164243087|NCT01803880|593260341|FG001|Overall Study|Protocol Violation|0|||
164243088|NCT01803880|593260342|FG002|Overall Study|Protocol Violation|0|||
164243089|NCT01803880|593260340|FG000|Overall Study|Early study termination|0|||
164243090|NCT01803880|593260341|FG001|Overall Study|Early study termination|6|||
164243091|NCT01803880|593260342|FG002|Overall Study|Early study termination|5|||
164243092|NCT01803880|593260340|FG000|Overall Study|Incomplete data entry by sites|2|||
164243093|NCT01803880|593260341|FG001|Overall Study|Incomplete data entry by sites|0|||
164243094|NCT01803880|593260342|FG002|Overall Study|Incomplete data entry by sites|0|||
164243095|NCT00579553|593260353|FG000|Overall Study|Lost to Follow-up|16|||
164243096|NCT00579553|593260354|FG001|Overall Study|Lost to Follow-up|13|||
164243097|NCT02651116|593260359|FG000|Overall Study|Adverse Event|0|||
164243098|NCT02651116|593260360|FG001|Overall Study|Adverse Event|1|||
164243099|NCT02651116|593260359|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
164243100|NCT02651116|593260360|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
164243101|NCT02803203|593260361|FG000|Overall Study|Adverse Event|4|||
164243102|NCT02803203|593260361|FG000|Overall Study|Death|4|||
164243103|NCT02803203|593260361|FG000|Overall Study|Progressive disease|29|||
164243104|NCT02803203|593260361|FG000|Overall Study|Withdrawal by Subject|8|||
164243105|NCT02803203|593260361|FG000|Overall Study|Complete resection of target disease|2|||
164243106|NCT02803203|593260361|FG000|Overall Study|Switched to commercial Osi|1|||
164243107|NCT02803203|593260361|FG000|Overall Study|Participant moved away|1|||
164243108|NCT01887717|593260362|FG000|Overall Study|Withdrawal by Subject|1|||
164243109|NCT01887717|593260363|FG001|Overall Study|Withdrawal by Subject|7|||
164243110|NCT01887717|593260362|FG000|Overall Study|Physician Decision|0|||
164243111|NCT01887717|593260363|FG001|Overall Study|Physician Decision|2|||
164243112|NCT01887717|593260362|FG000|Overall Study|Administrative reasons|5|||
164243113|NCT01887717|593260363|FG001|Overall Study|Administrative reasons|2|||
164243114|NCT02041299|593260369|FG000|Overall Study|Adverse Event|9|||
164243115|NCT02041299|593260370|FG001|Overall Study|Adverse Event|3|||
164243116|NCT02041299|593260369|FG000|Overall Study|Lost to Follow-up|4|||
164243117|NCT02041299|593260370|FG001|Overall Study|Lost to Follow-up|1|||
164243118|NCT02041299|593260369|FG000|Overall Study|Physician Decision|1|||
164243119|NCT02041299|593260370|FG001|Overall Study|Physician Decision|1|||
164243120|NCT02041299|593260369|FG000|Overall Study|Withdrawal by Subject|13|||
164243121|NCT02041299|593260370|FG001|Overall Study|Withdrawal by Subject|7|||
164243122|NCT02041299|593260369|FG000|Overall Study|Protocol Violation|11|||
164243123|NCT02041299|593260370|FG001|Overall Study|Protocol Violation|4|||
164243124|NCT02041299|593260369|FG000|Overall Study|Termination of the study|7|||
164243125|NCT02041299|593260370|FG001|Overall Study|Termination of the study|3|||
164243126|NCT02041299|593260369|FG000|Overall Study|Required bone marrow transplant|0|||
164678503|NCT04493684|594846747|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164678504|NCT04493684|594846748|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164678505|NCT04493684|594846732|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164678506|NCT04493684|594846733|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164678507|NCT04493684|594846734|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164678508|NCT04493684|594846735|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164678509|NCT04493684|594846736|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164678510|NCT04493684|594846737|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164678511|NCT04493684|594846738|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164678512|NCT04493684|594846739|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164678513|NCT04493684|594846740|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164678514|NCT04493684|594846741|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164678515|NCT04493684|594846742|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164678516|NCT04493684|594846743|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164678517|NCT04493684|594846744|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164678518|NCT04493684|594846745|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164678519|NCT04493684|594846746|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164678520|NCT04493684|594846747|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
164678521|NCT04493684|594846748|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164678522|NCT04493684|594846732|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164678523|NCT04493684|594846733|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164678524|NCT04493684|594846734|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164678525|NCT04493684|594846735|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164678526|NCT04493684|594846736|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164678527|NCT04493684|594846737|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164678528|NCT04493684|594846738|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164678529|NCT04493684|594846739|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164678530|NCT04493684|594846740|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164678531|NCT04493684|594846741|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164678532|NCT04493684|594846742|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164678533|NCT04493684|594846743|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164678534|NCT04493684|594846744|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164678535|NCT04493684|594846745|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164678536|NCT04493684|594846746|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164243127|NCT02041299|593260370|FG001|Overall Study|Required bone marrow transplant|1|||
164243128|NCT02041299|593260369|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
164243129|NCT02041299|593260370|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
164243130|NCT02389465|593260371|FG000|Overall Study|Lost to Follow-up|1|||
164243131|NCT02389465|593260372|FG001|Overall Study|Lost to Follow-up|3|||
164243132|NCT02389465|593260373|FG002|Overall Study|Lost to Follow-up|3|||
164243133|NCT02389465|593260374|FG003|Overall Study|Lost to Follow-up|0|||
164243134|NCT02389465|593260371|FG000|Overall Study|Physician Decision|0|||
164243135|NCT02389465|593260372|FG001|Overall Study|Physician Decision|0|||
164243136|NCT02389465|593260373|FG002|Overall Study|Physician Decision|0|||
164243137|NCT02389465|593260374|FG003|Overall Study|Physician Decision|1|||
164243138|NCT02389465|593260371|FG000|Overall Study|Withdrawal by Subject|0|||
164243139|NCT02389465|593260372|FG001|Overall Study|Withdrawal by Subject|1|||
164243140|NCT02389465|593260373|FG002|Overall Study|Withdrawal by Subject|2|||
164243141|NCT02389465|593260374|FG003|Overall Study|Withdrawal by Subject|2|||
164243142|NCT01925768|593260375|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
164243143|NCT01925768|593260376|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
164243144|NCT01925768|593260375|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
164243145|NCT01925768|593260376|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
164243146|NCT01925768|593260375|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
164243147|NCT01925768|593260376|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
164243148|NCT01925768|593260375|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
164336652|NCT02642029|593609757|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
164243149|NCT01925768|593260376|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
164243150|NCT01925768|593260375|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
164678537|NCT04493684|594846747|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
164678538|NCT04493684|594846748|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164678539|NCT02591420|594847949|FG000|Overall Study|Lost to Follow-up|0|||
164678540|NCT02591420|594847950|FG001|Overall Study|Lost to Follow-up|1|||
164678541|NCT02591420|594847951|FG002|Overall Study|Lost to Follow-up|2|||
164678542|NCT04241458|594847952|FG000|Overall Study|Withdrawal by Subject|0|||
164678543|NCT04241458|594847953|FG001|Overall Study|Withdrawal by Subject|0|||
164678544|NCT04241458|594847954|FG002|Overall Study|Withdrawal by Subject|0|||
164678545|NCT04241458|594847955|FG003|Overall Study|Withdrawal by Subject|0|||
164678546|NCT04241458|594847956|FG004|Overall Study|Withdrawal by Subject|1|||
164678547|NCT05604170|594847959|FG000|Overall Study|Lack of Efficacy|5|||
164678548|NCT05604170|594847959|FG000|Overall Study|Adverse Event|6|||
164678549|NCT05604170|594847959|FG000|Overall Study|Physician Decision|6|||
164678550|NCT05604170|594847959|FG000|Overall Study|Lost to Follow-up|6|||
164678551|NCT05604170|594847959|FG000|Overall Study|Withdrawal by Subject|11|||
164678552|NCT05604170|594847959|FG000|Overall Study|Early study termination by sponsor|77|||
164678553|NCT05604170|594847959|FG000|Overall Study|Other|6|||
164678554|NCT04970810|594847960|FG000|Overall Study|deemed ineligible after randomization|3|||
164678555|NCT04970810|594847961|FG001|Overall Study|deemed ineligible after randomization|0|||
164678556|NCT04970810|594847962|FG002|Overall Study|deemed ineligible after randomization|4|||
164678557|NCT04742491|594847963|FG000|Overall Study|Death|2|||
164678558|NCT04742491|594847964|FG001|Overall Study|Death|0|||
164678559|NCT04742491|594847963|FG000|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
164336653|NCT02642029|593609758|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
164336654|NCT02642029|593609759|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
164336655|NCT02642029|593609760|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
164336656|NCT02642029|593609761|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
164336657|NCT02642029|593609762|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
164336658|NCT02642029|593609757|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
164336659|NCT02642029|593609758|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
164336660|NCT02642029|593609759|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
164336661|NCT02642029|593609760|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
164336662|NCT02642029|593609761|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
164336663|NCT02642029|593609762|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
164336664|NCT02642029|593609757|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
164336665|NCT02642029|593609758|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
164336666|NCT02642029|593609759|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
164336667|NCT02642029|593609760|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
164336668|NCT02642029|593609761|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
164425486|NCT02303574|593928517|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
164425487|NCT02303574|593928518|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
164425488|NCT02303574|593928519|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
164425489|NCT02303574|593928520|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
164425490|NCT02303574|593928521|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
164425491|NCT02303574|593928522|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
164425492|NCT02303574|593928523|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
164425493|NCT02303574|593928524|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
164425494|NCT02303574|593928525|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
164425495|NCT00859014|593928530|FG000|Overall Study|Death|4|||
164425496|NCT00859014|593928530|FG000|Overall Study|Lost to Follow-up|1|||
164574050|NCT00408005|594465553|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
164574051|NCT00408005|594465554|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
164574052|NCT00408005|594465547|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
164574053|NCT00408005|594465548|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
164574054|NCT00408005|594465549|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
164574055|NCT00408005|594465550|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
164574056|NCT00408005|594465551|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
164574057|NCT00408005|594465552|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
164574058|NCT00408005|594465553|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
164574059|NCT00408005|594465554|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
164574060|NCT00408005|594465547|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
164574061|NCT00408005|594465548|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
164574062|NCT00408005|594465549|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
164574063|NCT00408005|594465550|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
164678560|NCT04742491|594847964|FG001|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
164425497|NCT00162942|593928531|FG000|Overall Study|Adverse Event|10|||
164425498|NCT00162942|593928532|FG001|Overall Study|Adverse Event|6|||
164425499|NCT00162942|593928531|FG000|Overall Study|Death|1|||
164574064|NCT00408005|594465551|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
164574065|NCT00408005|594465552|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
164574066|NCT00408005|594465553|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
164574067|NCT00408005|594465554|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
164574068|NCT01506141|594465555|FG000|Overall Study|Adverse Event|0|||
164574069|NCT01506141|594465556|FG001|Overall Study|Adverse Event|2|||
164574070|NCT01506141|594465555|FG000|Overall Study|Participation Terminated by Investigator|1|||
164574071|NCT01506141|594465556|FG001|Overall Study|Participation Terminated by Investigator|1|||
164574072|NCT01506141|594465555|FG000|Overall Study|Site Terminated by Sponsor|2|||
164574073|NCT01506141|594465556|FG001|Overall Study|Site Terminated by Sponsor|0|||
164574074|NCT01506141|594465555|FG000|Overall Study|Reason Not Specified|4|||
164574075|NCT01506141|594465556|FG001|Overall Study|Reason Not Specified|2|||
164574076|NCT04889209|594465557|FG000|All Cohorts Except 15E|Adverse Event|0|||
164574077|NCT04889209|594465558|FG001|All Cohorts Except 15E|Adverse Event|0|||
164574078|NCT04889209|594465559|FG002|All Cohorts Except 15E|Adverse Event|0|||
164574079|NCT04889209|594465560|FG003|All Cohorts Except 15E|Adverse Event|0|||
164574080|NCT04889209|594465561|FG004|All Cohorts Except 15E|Adverse Event|0|||
164574081|NCT04889209|594465562|FG005|All Cohorts Except 15E|Adverse Event|0|||
164574082|NCT04889209|594465563|FG006|All Cohorts Except 15E|Adverse Event|1|||
164574083|NCT04889209|594465564|FG007|All Cohorts Except 15E|Adverse Event|0|||
164574084|NCT04889209|594465565|FG008|All Cohorts Except 15E|Adverse Event|0|||
164574085|NCT04889209|594465566|FG009|All Cohorts Except 15E|Adverse Event|0|||
164574086|NCT04889209|594465567|FG010|All Cohorts Except 15E|Adverse Event|0|||
164574087|NCT04889209|594465568|FG011|All Cohorts Except 15E|Adverse Event|0|||
164574088|NCT04889209|594465569|FG012|All Cohorts Except 15E|Adverse Event|0|||
164574089|NCT04889209|594465570|FG013|All Cohorts Except 15E|Adverse Event|0|||
164574090|NCT04889209|594465571|FG014|All Cohorts Except 15E|Adverse Event|0|||
164574091|NCT04889209|594465572|FG015|All Cohorts Except 15E|Adverse Event|0|||
164574092|NCT04889209|594465573|FG016|All Cohorts Except 15E|Adverse Event|0|||
164574093|NCT04889209|594465574|FG017|All Cohorts Except 15E|Adverse Event|0|||
164574094|NCT04889209|594465557|FG000|All Cohorts Except 15E|Death|0|||
164574095|NCT04889209|594465558|FG001|All Cohorts Except 15E|Death|1|||
164574096|NCT04889209|594465559|FG002|All Cohorts Except 15E|Death|0|||
164574097|NCT04889209|594465560|FG003|All Cohorts Except 15E|Death|0|||
164574098|NCT04889209|594465561|FG004|All Cohorts Except 15E|Death|0|||
164574099|NCT04889209|594465562|FG005|All Cohorts Except 15E|Death|0|||
164574100|NCT04889209|594465563|FG006|All Cohorts Except 15E|Death|0|||
164574101|NCT04889209|594465564|FG007|All Cohorts Except 15E|Death|0|||
164574102|NCT04889209|594465565|FG008|All Cohorts Except 15E|Death|0|||
164574103|NCT04889209|594465566|FG009|All Cohorts Except 15E|Death|0|||
164574104|NCT04889209|594465567|FG010|All Cohorts Except 15E|Death|0|||
164574105|NCT04889209|594465568|FG011|All Cohorts Except 15E|Death|0|||
164574106|NCT04889209|594465569|FG012|All Cohorts Except 15E|Death|0|||
164574107|NCT04889209|594465570|FG013|All Cohorts Except 15E|Death|0|||
164574108|NCT04889209|594465571|FG014|All Cohorts Except 15E|Death|0|||
164574109|NCT04889209|594465572|FG015|All Cohorts Except 15E|Death|0|||
164574110|NCT04889209|594465573|FG016|All Cohorts Except 15E|Death|0|||
164574111|NCT04889209|594465574|FG017|All Cohorts Except 15E|Death|0|||
164574112|NCT04889209|594465557|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
164574113|NCT04889209|594465558|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
164574114|NCT04889209|594465559|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
164574115|NCT04889209|594465560|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
164574116|NCT04889209|594465561|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
164574117|NCT04889209|594465562|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
164574118|NCT04889209|594465563|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
164574119|NCT04889209|594465564|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
164574120|NCT04889209|594465565|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
164574121|NCT04889209|594465566|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
164574122|NCT04889209|594465567|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
164574123|NCT04889209|594465568|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
164574124|NCT04889209|594465569|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
164574125|NCT04889209|594465570|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
164574126|NCT04889209|594465571|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
164678561|NCT04742491|594847963|FG000|Overall Study|Lost to Follow-up|6|||
164678562|NCT04742491|594847964|FG001|Overall Study|Lost to Follow-up|8|||
164425500|NCT00162942|593928532|FG001|Overall Study|Death|0|||
164425501|NCT00162942|593928531|FG000|Overall Study|Withdrawal by Subject|3|||
164425502|NCT00162942|593928532|FG001|Overall Study|Withdrawal by Subject|6|||
164574127|NCT04889209|594465572|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
164574128|NCT04889209|594465573|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
164574129|NCT04889209|594465574|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
164574130|NCT04889209|594465557|FG000|All Cohorts Except 15E|Physician Decision|0|||
164574131|NCT04889209|594465558|FG001|All Cohorts Except 15E|Physician Decision|0|||
164243151|NCT01925768|593260376|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
164243152|NCT01925768|593260375|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
164243153|NCT01925768|593260376|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
164243154|NCT01925768|593260375|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
164243155|NCT01925768|593260376|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
164243156|NCT01925768|593260375|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
164243157|NCT01925768|593260376|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
164243158|NCT01925768|593260375|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
164243159|NCT01925768|593260376|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
164243160|NCT01925768|593260375|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
164243161|NCT01925768|593260376|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
164336669|NCT02642029|593609762|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
164336670|NCT02642029|593609757|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
164336671|NCT02642029|593609758|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
164336672|NCT02642029|593609759|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
164336673|NCT02642029|593609760|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
164336674|NCT02642029|593609761|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
164336675|NCT02642029|593609762|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
164336676|NCT02642029|593609757|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
164336677|NCT02642029|593609758|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
164336678|NCT02642029|593609759|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
164336679|NCT02642029|593609760|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
164336680|NCT02642029|593609761|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
164336681|NCT02642029|593609762|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
164336682|NCT02642029|593609757|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
164336683|NCT02642029|593609758|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
164336684|NCT02642029|593609759|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
164336685|NCT02642029|593609760|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
164336686|NCT02642029|593609761|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
164336687|NCT02642029|593609762|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
164336688|NCT00463580|593609763|FG000|Overall Study|Lost to Follow-up|1|||
164336689|NCT00463580|593609764|FG001|Overall Study|Lost to Follow-up|0|||
164336690|NCT00463580|593609763|FG000|Overall Study|Schedule conflict|2|||
164336691|NCT00463580|593609764|FG001|Overall Study|Schedule conflict|0|||
164336692|NCT00463580|593609763|FG000|Overall Study|Medical/psychiatric complications|0|||
164336693|NCT00463580|593609764|FG001|Overall Study|Medical/psychiatric complications|2|||
164336694|NCT00676338|593609765|FG000|Overall Study|Adverse Event|6|||
164336695|NCT00676338|593609766|FG001|Overall Study|Adverse Event|6|||
164336696|NCT00676338|593609767|FG002|Overall Study|Adverse Event|5|||
164336697|NCT00676338|593609768|FG003|Overall Study|Adverse Event|1|||
164336698|NCT00676338|593609765|FG000|Overall Study|Lost to Follow-up|4|||
164336699|NCT00676338|593609766|FG001|Overall Study|Lost to Follow-up|1|||
164336700|NCT00676338|593609767|FG002|Overall Study|Lost to Follow-up|3|||
164336701|NCT00676338|593609768|FG003|Overall Study|Lost to Follow-up|4|||
164336702|NCT00676338|593609765|FG000|Overall Study|Physician Decision|3|||
164336703|NCT00676338|593609766|FG001|Overall Study|Physician Decision|3|||
164336704|NCT00676338|593609767|FG002|Overall Study|Physician Decision|2|||
164336705|NCT00676338|593609768|FG003|Overall Study|Physician Decision|3|||
164336706|NCT00676338|593609765|FG000|Overall Study|Protocol Violation|5|||
164336707|NCT00676338|593609766|FG001|Overall Study|Protocol Violation|9|||
164336708|NCT00676338|593609767|FG002|Overall Study|Protocol Violation|2|||
164336709|NCT00676338|593609768|FG003|Overall Study|Protocol Violation|5|||
164336710|NCT00676338|593609765|FG000|Overall Study|Withdrawal by Subject|17|||
164336711|NCT00676338|593609766|FG001|Overall Study|Withdrawal by Subject|9|||
164336712|NCT00676338|593609767|FG002|Overall Study|Withdrawal by Subject|12|||
164336713|NCT00676338|593609768|FG003|Overall Study|Withdrawal by Subject|6|||
164336714|NCT00676338|593609765|FG000|Overall Study|Entry Criteria Not Met|0|||
164336715|NCT00676338|593609766|FG001|Overall Study|Entry Criteria Not Met|2|||
164336716|NCT00676338|593609767|FG002|Overall Study|Entry Criteria Not Met|1|||
164336717|NCT00676338|593609768|FG003|Overall Study|Entry Criteria Not Met|1|||
164336718|NCT00676338|593609765|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
164336719|NCT00676338|593609766|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
164336720|NCT00676338|593609767|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
164336721|NCT00676338|593609768|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
164336722|NCT01788046|593609769|FG000|Overall Study|Withdrawal by Subject|12|||
164336723|NCT01788046|593609770|FG001|Overall Study|Withdrawal by Subject|12|||
164336724|NCT01788046|593609769|FG000|Overall Study|Lost to Follow-up|12|||
164336725|NCT01788046|593609770|FG001|Overall Study|Lost to Follow-up|19|||
164336726|NCT01788046|593609769|FG000|Overall Study|Death|7|||
164336727|NCT01788046|593609770|FG001|Overall Study|Death|5|||
164336728|NCT01788046|593609769|FG000|Overall Study|Protocol Specified Criteria|25|||
164425503|NCT00162942|593928531|FG000|Overall Study|Physician Decision|1|||
164425504|NCT00162942|593928532|FG001|Overall Study|Physician Decision|0|||
164425505|NCT00162942|593928531|FG000|Overall Study|Enter Open-Label Study|76|||
164425506|NCT00162942|593928532|FG001|Overall Study|Enter Open-Label Study|35|||
164425507|NCT00162942|593928531|FG000|Overall Study|Alternate Therapy|6|||
164425508|NCT00162942|593928532|FG001|Overall Study|Alternate Therapy|2|||
164425509|NCT00162942|593928531|FG000|Overall Study|Lack of Efficacy|1|||
164425510|NCT00162942|593928532|FG001|Overall Study|Lack of Efficacy|0|||
164425511|NCT00162942|593928531|FG000|Overall Study|Flare During Active Treatment|7|||
164425512|NCT00162942|593928532|FG001|Overall Study|Flare During Active Treatment|3|||
164425513|NCT00162942|593928531|FG000|Overall Study|2 or more consecutive treatments missed|1|||
164425514|NCT00162942|593928532|FG001|Overall Study|2 or more consecutive treatments missed|0|||
164678563|NCT04742491|594847963|FG000|Overall Study|Withdrawal by Subject|4|||
164678564|NCT04742491|594847964|FG001|Overall Study|Withdrawal by Subject|2|||
164678565|NCT04742491|594847963|FG000|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|2|||
164678566|NCT04742491|594847964|FG001|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|1|||
164678567|NCT04742491|594847963|FG000|Overall Study|Participant refused further participation|2|||
164678568|NCT04742491|594847964|FG001|Overall Study|Participant refused further participation|7|||
164678569|NCT04742491|594847963|FG000|Overall Study|Participant unable to adhere to visit schedule|3|||
164678570|NCT04742491|594847964|FG001|Overall Study|Participant unable to adhere to visit schedule|4|||
164678571|NCT04742491|594847963|FG000|Overall Study|Other reasons|3|||
164678572|NCT04742491|594847964|FG001|Overall Study|Other reasons|4|||
164678573|NCT04349267|594847965|FG000|Overall Study|Adverse Event|0|||
164678574|NCT04349267|594847966|FG001|Overall Study|Adverse Event|0|||
164678575|NCT04349267|594847967|FG002|Overall Study|Adverse Event|0|||
164678576|NCT04349267|594847968|FG003|Overall Study|Adverse Event|0|||
164678577|NCT04349267|594847969|FG004|Overall Study|Adverse Event|0|||
164678578|NCT04349267|594847970|FG005|Overall Study|Adverse Event|1|||
164678579|NCT04349267|594847971|FG006|Overall Study|Adverse Event|0|||
164678580|NCT04349267|594847965|FG000|Overall Study|Other reason|0|||
164678581|NCT04349267|594847966|FG001|Overall Study|Other reason|1|||
164678582|NCT04349267|594847967|FG002|Overall Study|Other reason|0|||
164678583|NCT04349267|594847968|FG003|Overall Study|Other reason|0|||
164678584|NCT04349267|594847969|FG004|Overall Study|Other reason|1|||
164678585|NCT04349267|594847970|FG005|Overall Study|Other reason|1|||
164678586|NCT04349267|594847971|FG006|Overall Study|Other reason|1|||
164678587|NCT04349267|594847965|FG000|Overall Study|Disease Progression|2|||
164678588|NCT04349267|594847966|FG001|Overall Study|Disease Progression|0|||
164678589|NCT04349267|594847967|FG002|Overall Study|Disease Progression|2|||
164678590|NCT04349267|594847968|FG003|Overall Study|Disease Progression|3|||
164678591|NCT04349267|594847969|FG004|Overall Study|Disease Progression|3|||
164678592|NCT04349267|594847970|FG005|Overall Study|Disease Progression|7|||
164678593|NCT04349267|594847971|FG006|Overall Study|Disease Progression|10|||
164678594|NCT04349267|594847965|FG000|Overall Study|Participant withdrew consent|0|||
164678595|NCT04349267|594847966|FG001|Overall Study|Participant withdrew consent|1|||
164678596|NCT04349267|594847967|FG002|Overall Study|Participant withdrew consent|0|||
164678597|NCT04349267|594847968|FG003|Overall Study|Participant withdrew consent|0|||
164678598|NCT04349267|594847969|FG004|Overall Study|Participant withdrew consent|0|||
164678599|NCT04349267|594847970|FG005|Overall Study|Participant withdrew consent|0|||
164678600|NCT04349267|594847971|FG006|Overall Study|Participant withdrew consent|1|||
164678601|NCT04618211|594847972|FG000|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
164678602|NCT04618211|594847973|FG001|Part I (Non-Attack, Safety)|Withdrawal by Subject|1|||
164678603|NCT04618211|594847974|FG002|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
164678604|NCT04618211|594847972|FG000|Part II (Self-administration, Efficacy)|Withdrawal by Subject|2|||
164678605|NCT04618211|594847973|FG001|Part II (Self-administration, Efficacy)|Withdrawal by Subject|3|||
164678606|NCT04618211|594847974|FG002|Part II (Self-administration, Efficacy)|Withdrawal by Subject|5|||
164678607|NCT04618211|594847972|FG000|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|6|||
164678608|NCT04618211|594847973|FG001|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|9|||
164678609|NCT04618211|594847974|FG002|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|8|||
164678610|NCT01244620|594847977|FG000|Overall Study|Study terminated|4|||
164678611|NCT01244620|594847978|FG001|Overall Study|Study terminated|4|||
164678612|NCT01244620|594847979|FG002|Overall Study|Study terminated|4|||
164678613|NCT01244620|594847980|FG003|Overall Study|Study terminated|4|||
164425515|NCT04796935|593928533|FG000|Overall Study|Withdrawal by Subject|0|||
164425516|NCT04796935|593928534|FG001|Overall Study|Withdrawal by Subject|1|||
164425517|NCT04796935|593928533|FG000|Overall Study|Physician Decision|0|||
164425518|NCT04796935|593928534|FG001|Overall Study|Physician Decision|1|||
164678614|NCT00848536|594847981|FG000|Overall Study|Adverse Event|2|||
164678615|NCT00848536|594847982|FG001|Overall Study|Adverse Event|2|||
164678616|NCT00848536|594847981|FG000|Overall Study|Withdrawal by Subject|0|||
164678617|NCT00848536|594847982|FG001|Overall Study|Withdrawal by Subject|1|||
164425519|NCT04796935|593928533|FG000|Overall Study|Device not available|1|||
164425520|NCT04796935|593928534|FG001|Overall Study|Device not available|0|||
164425521|NCT04796935|593928533|FG000|Overall Study|Trained provider not available|1|||
164425522|NCT04796935|593928534|FG001|Overall Study|Trained provider not available|0|||
164425523|NCT00783718|593928537|FG000|Induction Phase|Adverse Event|4|||
164425524|NCT00783718|593928538|FG001|Induction Phase|Adverse Event|0|||
164425525|NCT00783718|593928539|FG002|Induction Phase|Adverse Event|7|||
164425526|NCT00783718|593928540|FG003|Induction Phase|Adverse Event|0|||
164425527|NCT00783718|593928541|FG004|Induction Phase|Adverse Event|0|||
164425528|NCT00783718|593928542|FG005|Induction Phase|Adverse Event|0|||
164425529|NCT00783718|593928543|FG006|Induction Phase|Adverse Event|0|||
164425530|NCT00783718|593928537|FG000|Induction Phase|Protocol Violation|1|||
164425531|NCT00783718|593928538|FG001|Induction Phase|Protocol Violation|1|||
164425532|NCT00783718|593928539|FG002|Induction Phase|Protocol Violation|6|||
164425533|NCT00783718|593928540|FG003|Induction Phase|Protocol Violation|0|||
164425534|NCT00783718|593928541|FG004|Induction Phase|Protocol Violation|0|||
164425535|NCT00783718|593928542|FG005|Induction Phase|Protocol Violation|0|||
164425536|NCT00783718|593928543|FG006|Induction Phase|Protocol Violation|0|||
164425537|NCT00783718|593928537|FG000|Induction Phase|Lack of Efficacy|5|||
164425538|NCT00783718|593928538|FG001|Induction Phase|Lack of Efficacy|2|||
164425539|NCT00783718|593928539|FG002|Induction Phase|Lack of Efficacy|14|||
164425540|NCT00783718|593928540|FG003|Induction Phase|Lack of Efficacy|0|||
164425541|NCT00783718|593928541|FG004|Induction Phase|Lack of Efficacy|0|||
164425542|NCT00783718|593928542|FG005|Induction Phase|Lack of Efficacy|0|||
164425543|NCT00783718|593928543|FG006|Induction Phase|Lack of Efficacy|0|||
164425544|NCT00783718|593928537|FG000|Induction Phase|Withdrawal by Subject|3|||
164425545|NCT00783718|593928538|FG001|Induction Phase|Withdrawal by Subject|4|||
164425546|NCT00783718|593928539|FG002|Induction Phase|Withdrawal by Subject|8|||
164425547|NCT00783718|593928540|FG003|Induction Phase|Withdrawal by Subject|0|||
164425548|NCT00783718|593928541|FG004|Induction Phase|Withdrawal by Subject|0|||
164425549|NCT00783718|593928542|FG005|Induction Phase|Withdrawal by Subject|0|||
164425550|NCT00783718|593928543|FG006|Induction Phase|Withdrawal by Subject|0|||
164425551|NCT00783718|593928537|FG000|Induction Phase|Lost to Follow-up|1|||
164425552|NCT00783718|593928538|FG001|Induction Phase|Lost to Follow-up|0|||
164425553|NCT00783718|593928539|FG002|Induction Phase|Lost to Follow-up|1|||
164425554|NCT00783718|593928540|FG003|Induction Phase|Lost to Follow-up|0|||
164425555|NCT00783718|593928541|FG004|Induction Phase|Lost to Follow-up|0|||
164425556|NCT00783718|593928542|FG005|Induction Phase|Lost to Follow-up|0|||
164425557|NCT00783718|593928543|FG006|Induction Phase|Lost to Follow-up|0|||
164425558|NCT00783718|593928537|FG000|Maintenance Phase|Adverse Event|12|||
164425559|NCT00783718|593928538|FG001|Maintenance Phase|Adverse Event|0|||
164425560|NCT00783718|593928539|FG002|Maintenance Phase|Adverse Event|0|||
164425561|NCT00783718|593928540|FG003|Maintenance Phase|Adverse Event|15|||
164425562|NCT00783718|593928541|FG004|Maintenance Phase|Adverse Event|7|||
164425563|NCT00783718|593928542|FG005|Maintenance Phase|Adverse Event|6|||
164425564|NCT00783718|593928543|FG006|Maintenance Phase|Adverse Event|16|||
164425565|NCT00783718|593928537|FG000|Maintenance Phase|Protocol Violation|1|||
164425566|NCT00783718|593928538|FG001|Maintenance Phase|Protocol Violation|0|||
164425567|NCT00783718|593928539|FG002|Maintenance Phase|Protocol Violation|0|||
164425568|NCT00783718|593928540|FG003|Maintenance Phase|Protocol Violation|0|||
164425569|NCT00783718|593928541|FG004|Maintenance Phase|Protocol Violation|0|||
164425570|NCT00783718|593928542|FG005|Maintenance Phase|Protocol Violation|0|||
164425571|NCT00783718|593928543|FG006|Maintenance Phase|Protocol Violation|2|||
164425572|NCT00783718|593928537|FG000|Maintenance Phase|Lack of Efficacy|83|||
164425573|NCT00783718|593928538|FG001|Maintenance Phase|Lack of Efficacy|0|||
164243162|NCT01925768|593260375|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
164243163|NCT01925768|593260376|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
164243164|NCT00087698|593260382|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
164243165|NCT00087698|593260382|FG000|Overall Study|Death from Other Causes|3|||
164243166|NCT00087698|593260382|FG000|Overall Study|Adverse Event|4|||
164243167|NCT00087698|593260382|FG000|Overall Study|Withdrawal by Subject|4|||
164243168|NCT00087698|593260382|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
164243169|NCT00087698|593260382|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
164243170|NCT00087698|593260382|FG000|Overall Study|Clinical Relapse|1|||
164243171|NCT00087698|593260382|FG000|Overall Study|Death from Study Disease|2|||
164243172|NCT00087698|593260382|FG000|Overall Study|Death from Study Drug Toxicity|2|||
164243173|NCT00087698|593260382|FG000|Overall Study|Protocol Violation|1|||
164243174|NCT04179305|593260387|FG000|Overall Study|Death|1|||
164425574|NCT00783718|593928539|FG002|Maintenance Phase|Lack of Efficacy|0|||
164425575|NCT00783718|593928540|FG003|Maintenance Phase|Lack of Efficacy|61|||
164425576|NCT00783718|593928541|FG004|Maintenance Phase|Lack of Efficacy|31|||
164425577|NCT00783718|593928542|FG005|Maintenance Phase|Lack of Efficacy|33|||
164425578|NCT00783718|593928543|FG006|Maintenance Phase|Lack of Efficacy|155|||
164425579|NCT00783718|593928537|FG000|Maintenance Phase|Withdrawal by Subject|6|||
164425580|NCT00783718|593928538|FG001|Maintenance Phase|Withdrawal by Subject|0|||
164425581|NCT00783718|593928539|FG002|Maintenance Phase|Withdrawal by Subject|0|||
164243175|NCT04179305|593260388|FG001|Overall Study|Death|1|||
164425582|NCT00783718|593928540|FG003|Maintenance Phase|Withdrawal by Subject|2|||
164425583|NCT00783718|593928541|FG004|Maintenance Phase|Withdrawal by Subject|5|||
164425584|NCT00783718|593928542|FG005|Maintenance Phase|Withdrawal by Subject|2|||
164425585|NCT00783718|593928543|FG006|Maintenance Phase|Withdrawal by Subject|20|||
164425586|NCT00783718|593928537|FG000|Maintenance Phase|Lost to Follow-up|3|||
164425587|NCT00783718|593928538|FG001|Maintenance Phase|Lost to Follow-up|0|||
164425588|NCT00783718|593928539|FG002|Maintenance Phase|Lost to Follow-up|0|||
164425589|NCT00783718|593928540|FG003|Maintenance Phase|Lost to Follow-up|0|||
164425590|NCT00783718|593928541|FG004|Maintenance Phase|Lost to Follow-up|2|||
164425591|NCT00783718|593928542|FG005|Maintenance Phase|Lost to Follow-up|0|||
164425592|NCT00783718|593928543|FG006|Maintenance Phase|Lost to Follow-up|2|||
164425593|NCT01192295|593928544|FG000|Overall Study|Adverse Event|3|||
164425594|NCT01192295|593928545|FG001|Overall Study|Adverse Event|7|||
164425595|NCT01192295|593928544|FG000|Overall Study|Withdrawal by Subject|3|||
164425596|NCT01192295|593928545|FG001|Overall Study|Withdrawal by Subject|4|||
164425597|NCT01192295|593928544|FG000|Overall Study|Lost to Follow-up|0|||
164425598|NCT01192295|593928545|FG001|Overall Study|Lost to Follow-up|1|||
164425599|NCT01192295|593928544|FG000|Overall Study|Lack of Efficacy|0|||
164425600|NCT01192295|593928545|FG001|Overall Study|Lack of Efficacy|5|||
164425601|NCT01192295|593928544|FG000|Overall Study|Administrative|4|||
164425602|NCT01192295|593928545|FG001|Overall Study|Administrative|6|||
164425603|NCT00630539|593928546|FG000|Overall Study|Adverse Event|1|||
164425604|NCT00630539|593928547|FG001|Overall Study|Adverse Event|3|||
164425605|NCT00630539|593928548|FG002|Overall Study|Adverse Event|1|||
164425606|NCT00630539|593928549|FG003|Overall Study|Adverse Event|2|||
164425607|NCT00630539|593928546|FG000|Overall Study|Withdrawal by Subject|0|||
164425608|NCT00630539|593928547|FG001|Overall Study|Withdrawal by Subject|1|||
164425609|NCT00630539|593928548|FG002|Overall Study|Withdrawal by Subject|0|||
164425610|NCT00630539|593928549|FG003|Overall Study|Withdrawal by Subject|1|||
164425611|NCT02929108|593928554|FG000|Overall Study|Hospice patient death|100|||
164425612|NCT02929108|593928555|FG001|Overall Study|Hospice patient death|64|||
164425613|NCT02929108|593928556|FG002|Overall Study|Hospice patient death|28|||
164425614|NCT02929108|593928557|FG003|Overall Study|Hospice patient death|46|||
164425615|NCT02929108|593928558|FG004|Overall Study|Hospice patient death|55|||
164425616|NCT02929108|593928559|FG005|Overall Study|Hospice patient death|28|||
164425617|NCT02929108|593928560|FG006|Overall Study|Hospice patient death|78|||
164425618|NCT01027871|593928561|FG000|Overall Study|Physician Decision|1|||
164425619|NCT01027871|593928562|FG001|Overall Study|Physician Decision|5|||
164425620|NCT01027871|593928563|FG002|Overall Study|Physician Decision|0|||
164425621|NCT01027871|593928561|FG000|Overall Study|Protocol Violation|0|||
164425622|NCT01027871|593928562|FG001|Overall Study|Protocol Violation|2|||
164425623|NCT01027871|593928563|FG002|Overall Study|Protocol Violation|2|||
164425624|NCT01027871|593928561|FG000|Overall Study|Withdrawal by Subject|1|||
164425625|NCT01027871|593928562|FG001|Overall Study|Withdrawal by Subject|2|||
164425626|NCT01027871|593928563|FG002|Overall Study|Withdrawal by Subject|2|||
164425627|NCT01027871|593928561|FG000|Overall Study|Adverse Event|0|||
164425628|NCT01027871|593928562|FG001|Overall Study|Adverse Event|2|||
164425629|NCT01027871|593928563|FG002|Overall Study|Adverse Event|2|||
164425630|NCT01027871|593928561|FG000|Overall Study|Sponsor Decision|0|||
164425631|NCT01027871|593928562|FG001|Overall Study|Sponsor Decision|2|||
164425632|NCT01027871|593928563|FG002|Overall Study|Sponsor Decision|0|||
164425633|NCT01027871|593928561|FG000|Overall Study|Discontinued Prior to Treatment|0|||
164425634|NCT01027871|593928562|FG001|Overall Study|Discontinued Prior to Treatment|0|||
164425635|NCT01027871|593928563|FG002|Overall Study|Discontinued Prior to Treatment|1|||
164425636|NCT00052962|593928564|FG000|Overall Study|Not evaluable|0|||
164425637|NCT00052962|593928565|FG001|Overall Study|Not evaluable|2|||
164425638|NCT00052962|593928564|FG000|Overall Study|Not randomized/not evaluable|1|||
164425639|NCT00052962|593928565|FG001|Overall Study|Not randomized/not evaluable|0|||
164425640|NCT01414166|593928566|FG000|Overall Study|Adverse Event|10|||
164425641|NCT01414166|593928567|FG001|Overall Study|Adverse Event|2|||
164425642|NCT01414166|593928566|FG000|Overall Study|Lost to Follow-up|4|||
164425643|NCT01414166|593928567|FG001|Overall Study|Lost to Follow-up|1|||
164425644|NCT01414166|593928566|FG000|Overall Study|Non-compliance with study drug|2|||
164425645|NCT01414166|593928567|FG001|Overall Study|Non-compliance with study drug|0|||
164425646|NCT01414166|593928566|FG000|Overall Study|Physician Decision|2|||
164425647|NCT01414166|593928567|FG001|Overall Study|Physician Decision|0|||
164425648|NCT01414166|593928566|FG000|Overall Study|Protocol Violation|2|||
164425649|NCT01414166|593928567|FG001|Overall Study|Protocol Violation|0|||
164425650|NCT01414166|593928566|FG000|Overall Study|Study terminated by Sponsor|68|||
164425651|NCT01414166|593928567|FG001|Overall Study|Study terminated by Sponsor|75|||
164425652|NCT01414166|593928566|FG000|Overall Study|Withdrawal by Subject|3|||
164425653|NCT01414166|593928567|FG001|Overall Study|Withdrawal by Subject|5|||
164425654|NCT03782727|593928568|FG000|Overall Study|Lost to Follow-up|32|||
164425655|NCT03658811|593928569|FG000|Overall Study|Lost to Follow-up|3|||
164425656|NCT04209790|593928570|FG000|Overall Study|Physician Decision|1|||
164425657|NCT04060680|593928571|FG000|Overall Study|Unsuccessful implant|17|||
164425658|NCT04060680|593928572|FG001|Overall Study|Unsuccessful implant|2|||
164425659|NCT04060680|593928571|FG000|Overall Study|Adverse Event|3|||
164425660|NCT04060680|593928572|FG001|Overall Study|Adverse Event|0|||
164425661|NCT04060680|593928571|FG000|Overall Study|Death|2|||
164243176|NCT04179305|593260389|FG002|Overall Study|Death|0|||
164243177|NCT04179305|593260390|FG003|Overall Study|Death|0|||
164243178|NCT04179305|593260387|FG000|Overall Study|Lost to Follow-up|1|||
164243179|NCT04179305|593260388|FG001|Overall Study|Lost to Follow-up|1|||
164243180|NCT04179305|593260389|FG002|Overall Study|Lost to Follow-up|0|||
164243181|NCT04179305|593260390|FG003|Overall Study|Lost to Follow-up|0|||
164243182|NCT04179305|593260387|FG000|Overall Study|Withdrawal by Subject|0|||
164243183|NCT04179305|593260388|FG001|Overall Study|Withdrawal by Subject|1|||
164243184|NCT04179305|593260389|FG002|Overall Study|Withdrawal by Subject|0|||
164243185|NCT04179305|593260390|FG003|Overall Study|Withdrawal by Subject|0|||
164243186|NCT04179305|593260387|FG000|Overall Study|Did not have scan|1|||
164243187|NCT04179305|593260388|FG001|Overall Study|Did not have scan|0|||
164243188|NCT04179305|593260389|FG002|Overall Study|Did not have scan|0|||
164243189|NCT04179305|593260390|FG003|Overall Study|Did not have scan|0|||
164243190|NCT04179305|593260387|FG000|Overall Study|In hospice care|3|||
164243191|NCT04179305|593260388|FG001|Overall Study|In hospice care|0|||
164243192|NCT04179305|593260389|FG002|Overall Study|In hospice care|0|||
164243193|NCT04179305|593260390|FG003|Overall Study|In hospice care|0|||
164243194|NCT01737762|593260393|FG000|Overall Study|Adverse Event|2|||
164336729|NCT01788046|593609770|FG001|Overall Study|Protocol Specified Criteria|1|||
164336730|NCT00075218|593609771|FG000|Double-Blind Treatment|Adverse Event|23|||
164336731|NCT00075218|593609772|FG001|Double-Blind Treatment|Adverse Event|4|||
164336732|NCT00075218|593609773|FG002|Double-Blind Treatment|Adverse Event|0|||
164336733|NCT00075218|593609771|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
164336734|NCT00075218|593609772|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
164336735|NCT00075218|593609773|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
164336736|NCT00075218|593609771|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
164336737|NCT00075218|593609772|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
164336738|NCT00075218|593609773|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
164336739|NCT00075218|593609771|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
164336740|NCT00075218|593609772|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
164336741|NCT00075218|593609773|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
164336742|NCT00075218|593609771|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
164336743|NCT00075218|593609772|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
164336744|NCT00075218|593609773|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
164336745|NCT00075218|593609771|FG000|Double-Blind Treatment|No study medication taken|2|||
164336746|NCT00075218|593609772|FG001|Double-Blind Treatment|No study medication taken|0|||
164336747|NCT00075218|593609773|FG002|Double-Blind Treatment|No study medication taken|0|||
164336748|NCT00075218|593609771|FG000|Open-Label Treatment|Lack of Efficacy|0|||
164336749|NCT00075218|593609772|FG001|Open-Label Treatment|Lack of Efficacy|0|||
164336750|NCT00075218|593609773|FG002|Open-Label Treatment|Lack of Efficacy|174|||
164336751|NCT00075218|593609771|FG000|Open-Label Treatment|Adverse Event|0|||
164336752|NCT00075218|593609772|FG001|Open-Label Treatment|Adverse Event|0|||
164336753|NCT00075218|593609773|FG002|Open-Label Treatment|Adverse Event|51|||
164336754|NCT00075218|593609771|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
164336755|NCT00075218|593609772|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
164336756|NCT00075218|593609773|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
164336757|NCT00075218|593609771|FG000|Open-Label Treatment|Decision of Sponsor|0|||
164336758|NCT00075218|593609772|FG001|Open-Label Treatment|Decision of Sponsor|0|||
164336759|NCT00075218|593609773|FG002|Open-Label Treatment|Decision of Sponsor|8|||
164336760|NCT00075218|593609771|FG000|Open-Label Treatment|Protocol Violation|0|||
164336761|NCT00075218|593609772|FG001|Open-Label Treatment|Protocol Violation|0|||
164336762|NCT00075218|593609773|FG002|Open-Label Treatment|Protocol Violation|1|||
164336763|NCT00075218|593609771|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
164336764|NCT00075218|593609772|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
164336765|NCT00075218|593609773|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
164336766|NCT03643575|593609774|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
164336767|NCT03643575|593609775|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
164336768|NCT03643575|593609776|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
164336769|NCT03643575|593609777|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
164336770|NCT03643575|593609778|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
164336771|NCT03643575|593609779|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
164336772|NCT03643575|593609774|FG000|Washout: 7 Days|Adverse Event|1|||
164336773|NCT03643575|593609775|FG001|Washout: 7 Days|Adverse Event|0|||
164336774|NCT03643575|593609776|FG002|Washout: 7 Days|Adverse Event|0|||
164336775|NCT03643575|593609777|FG003|Washout: 7 Days|Adverse Event|0|||
164243195|NCT01737762|593260394|FG001|Overall Study|Adverse Event|2|||
164336776|NCT03643575|593609778|FG004|Washout: 7 Days|Adverse Event|0|||
164336777|NCT03643575|593609779|FG005|Washout: 7 Days|Adverse Event|0|||
164336778|NCT03643575|593609774|FG000|Washout: 7 Days|Non compliance check in|0|||
164336779|NCT03643575|593609775|FG001|Washout: 7 Days|Non compliance check in|1|||
164336780|NCT03643575|593609776|FG002|Washout: 7 Days|Non compliance check in|0|||
164243196|NCT01737762|593260393|FG000|Overall Study|Lost to Follow-up|1|||
164243197|NCT01737762|593260394|FG001|Overall Study|Lost to Follow-up|0|||
164336781|NCT03643575|593609777|FG003|Washout: 7 Days|Non compliance check in|0|||
164243198|NCT01737762|593260393|FG000|Overall Study|Withdrawal by Subject|2|||
164243199|NCT01737762|593260394|FG001|Overall Study|Withdrawal by Subject|2|||
164243200|NCT01737762|593260393|FG000|Overall Study|Progressive disease|1|||
164243201|NCT01737762|593260394|FG001|Overall Study|Progressive disease|2|||
164243202|NCT01737762|593260393|FG000|Overall Study|Physician Decision|1|||
164243203|NCT01737762|593260394|FG001|Overall Study|Physician Decision|1|||
164243204|NCT01737762|593260393|FG000|Overall Study|Moved from area|2|||
164243205|NCT01737762|593260394|FG001|Overall Study|Moved from area|1|||
164243206|NCT01737762|593260393|FG000|Overall Study|Trial termination|11|||
164243207|NCT01737762|593260394|FG001|Overall Study|Trial termination|9|||
164243208|NCT00326599|593260395|FG000|Overall Study|Withdrawal by Subject|1|||
164243209|NCT00326599|593260396|FG001|Overall Study|Withdrawal by Subject|0|||
164243210|NCT00326599|593260397|FG002|Overall Study|Withdrawal by Subject|5|||
164243211|NCT00326599|593260398|FG003|Overall Study|Withdrawal by Subject|2|||
164425662|NCT04060680|593928572|FG001|Overall Study|Death|0|||
164425663|NCT04060680|593928571|FG000|Overall Study|Study product no longer in use|1|||
164425664|NCT04060680|593928572|FG001|Overall Study|Study product no longer in use|0|||
164425665|NCT04060680|593928571|FG000|Overall Study|Withdrawal by Subject|1|||
164425666|NCT04060680|593928572|FG001|Overall Study|Withdrawal by Subject|0|||
164425667|NCT04091672|593930710|FG000|Overall Study|Death|6|||
164425668|NCT04091672|593930711|FG001|Overall Study|Death|6|||
164425669|NCT04091672|593930710|FG000|Overall Study|Lost to Follow-up|7|||
164425670|NCT04091672|593930711|FG001|Overall Study|Lost to Follow-up|7|||
164425671|NCT04091672|593930710|FG000|Overall Study|Withdrawal by Subject|3|||
164425672|NCT04091672|593930711|FG001|Overall Study|Withdrawal by Subject|3|||
164425673|NCT04091672|593930710|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
164425674|NCT04091672|593930711|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
164425675|NCT01256476|593930712|FG000|Overall Study|Adverse Event|2|||
164425676|NCT01256476|593930713|FG001|Overall Study|Adverse Event|1|||
164425677|NCT01256476|593930712|FG000|Overall Study|Withdrawal by Subject|2|||
164425678|NCT01256476|593930713|FG001|Overall Study|Withdrawal by Subject|1|||
164243212|NCT00326599|593260395|FG000|Overall Study|Adverse Event|1|||
164243213|NCT00326599|593260396|FG001|Overall Study|Adverse Event|0|||
164243214|NCT00326599|593260397|FG002|Overall Study|Adverse Event|32|||
164425679|NCT01256476|593930712|FG000|Overall Study|Lost to Follow-up|1|||
164243215|NCT00326599|593260398|FG003|Overall Study|Adverse Event|3|||
164243216|NCT00326599|593260395|FG000|Overall Study|Disease Progression|3|||
164243217|NCT00326599|593260396|FG001|Overall Study|Disease Progression|1|||
164243218|NCT00326599|593260397|FG002|Overall Study|Disease Progression|13|||
164243219|NCT00326599|593260398|FG003|Overall Study|Disease Progression|11|||
164243220|NCT00326599|593260395|FG000|Overall Study|Alternate Treatment|1|||
164243221|NCT00326599|593260396|FG001|Overall Study|Alternate Treatment|0|||
164243222|NCT00326599|593260397|FG002|Overall Study|Alternate Treatment|0|||
164243223|NCT00326599|593260398|FG003|Overall Study|Alternate Treatment|0|||
164243224|NCT00326599|593260395|FG000|Overall Study|Death|0|||
164243225|NCT00326599|593260396|FG001|Overall Study|Death|0|||
164243226|NCT00326599|593260397|FG002|Overall Study|Death|1|||
164243227|NCT00326599|593260398|FG003|Overall Study|Death|2|||
164243228|NCT00326599|593260395|FG000|Overall Study|Other Unspecified Reason|0|||
164243229|NCT00326599|593260396|FG001|Overall Study|Other Unspecified Reason|0|||
164243230|NCT00326599|593260397|FG002|Overall Study|Other Unspecified Reason|2|||
164243231|NCT00326599|593260398|FG003|Overall Study|Other Unspecified Reason|1|||
164243232|NCT03542266|593260399|FG000|Treatment Phase|Withdrawal by Subject|1|||
164243233|NCT03542266|593260399|FG000|Treatment Phase|Adverse Event|1|||
164243234|NCT03542266|593260399|FG000|Treatment Phase|PD|1|||
164243235|NCT00625586|593260400|FG000|Overall Study|Adverse Event|1|||
164243236|NCT00625586|593260400|FG000|Overall Study|Progressive disease|1|||
164243237|NCT04721158|593260408|FG000|Overall Study|Lost to Follow-up|4|||
164243238|NCT04721158|593260408|FG000|Overall Study|Device did not connect|1|||
164243239|NCT00142792|593260411|FG000|Overall Study|Death|0|||
164243240|NCT00142792|593260412|FG001|Overall Study|Death|0|||
164243241|NCT00142792|593260413|FG002|Overall Study|Death|1|||
164243242|NCT00142792|593260411|FG000|Overall Study|Withdrawal by Subject|3|||
164243243|NCT00142792|593260412|FG001|Overall Study|Withdrawal by Subject|2|||
164243244|NCT00142792|593260413|FG002|Overall Study|Withdrawal by Subject|3|||
164243245|NCT00142792|593260411|FG000|Overall Study|Lost to Follow-up|8|||
164243246|NCT00142792|593260412|FG001|Overall Study|Lost to Follow-up|11|||
164243247|NCT00142792|593260413|FG002|Overall Study|Lost to Follow-up|7|||
164243248|NCT00142792|593260411|FG000|Overall Study|No category|1|||
164425680|NCT01256476|593930713|FG001|Overall Study|Lost to Follow-up|2|||
164425681|NCT01256476|593930712|FG000|Overall Study|Persistent ALT or AST elevation|1|||
164243249|NCT00142792|593260412|FG001|Overall Study|No category|2|||
164243250|NCT00142792|593260413|FG002|Overall Study|No category|1|||
164243251|NCT00833027|593260415|FG000|Overall Study|Adverse Event|33|||
164243252|NCT00833027|593260415|FG000|Overall Study|Death|1|||
164243253|NCT00833027|593260415|FG000|Overall Study|Lack of Efficacy|12|||
164243254|NCT00833027|593260415|FG000|Overall Study|Lost to Follow-up|24|||
164243255|NCT00833027|593260415|FG000|Overall Study|Protocol Violation|115|||
164243256|NCT00833027|593260415|FG000|Overall Study|Withdrawal by Subject|16|||
164336782|NCT03643575|593609778|FG004|Washout: 7 Days|Non compliance check in|0|||
164336783|NCT03643575|593609779|FG005|Washout: 7 Days|Non compliance check in|0|||
164336784|NCT00875979|593609780|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
164336785|NCT00875979|593609781|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
164336786|NCT00875979|593609780|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
164336787|NCT00875979|593609781|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
164336788|NCT00875979|593609780|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
164336789|NCT00875979|593609781|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
164336790|NCT00875979|593609780|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
164336791|NCT00875979|593609781|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
164336792|NCT00875979|593609780|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
164336793|NCT00875979|593609781|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
164336794|NCT00875979|593609780|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
164336795|NCT00875979|593609781|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
164336796|NCT00875979|593609780|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
164574132|NCT04889209|594465559|FG002|All Cohorts Except 15E|Physician Decision|0|||
164574133|NCT04889209|594465560|FG003|All Cohorts Except 15E|Physician Decision|0|||
164574134|NCT04889209|594465561|FG004|All Cohorts Except 15E|Physician Decision|1|||
164574135|NCT04889209|594465562|FG005|All Cohorts Except 15E|Physician Decision|0|||
164574136|NCT04889209|594465563|FG006|All Cohorts Except 15E|Physician Decision|0|||
164574137|NCT04889209|594465564|FG007|All Cohorts Except 15E|Physician Decision|1|||
164574138|NCT04889209|594465565|FG008|All Cohorts Except 15E|Physician Decision|0|||
164574139|NCT04889209|594465566|FG009|All Cohorts Except 15E|Physician Decision|1|||
164574140|NCT04889209|594465567|FG010|All Cohorts Except 15E|Physician Decision|0|||
164574141|NCT04889209|594465568|FG011|All Cohorts Except 15E|Physician Decision|1|||
164574142|NCT04889209|594465569|FG012|All Cohorts Except 15E|Physician Decision|1|||
164574143|NCT04889209|594465570|FG013|All Cohorts Except 15E|Physician Decision|0|||
164574144|NCT04889209|594465571|FG014|All Cohorts Except 15E|Physician Decision|0|||
164574145|NCT04889209|594465572|FG015|All Cohorts Except 15E|Physician Decision|0|||
164574146|NCT04889209|594465573|FG016|All Cohorts Except 15E|Physician Decision|0|||
164574147|NCT04889209|594465574|FG017|All Cohorts Except 15E|Physician Decision|0|||
164574148|NCT04889209|594465557|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
164574149|NCT04889209|594465558|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
164574150|NCT04889209|594465559|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
164574151|NCT04889209|594465560|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
164574152|NCT04889209|594465561|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
164574153|NCT04889209|594465562|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
164574154|NCT04889209|594465563|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
164574155|NCT04889209|594465564|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
164574156|NCT04889209|594465565|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
164574157|NCT04889209|594465566|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
164574158|NCT04889209|594465567|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
164574159|NCT04889209|594465568|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
164574160|NCT04889209|594465569|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
164574161|NCT04889209|594465570|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
164574162|NCT04889209|594465571|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
164574163|NCT04889209|594465572|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
164574164|NCT04889209|594465573|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
164574165|NCT04889209|594465574|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
164574166|NCT04889209|594465557|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
164574167|NCT04889209|594465558|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
164574168|NCT04889209|594465559|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
164574169|NCT04889209|594465560|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
164574170|NCT04889209|594465561|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
164574171|NCT04889209|594465562|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
164574172|NCT04889209|594465563|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
164574173|NCT04889209|594465564|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
164574174|NCT04889209|594465565|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
164574175|NCT04889209|594465566|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
164574176|NCT04889209|594465567|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
164574177|NCT04889209|594465568|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
164574178|NCT04889209|594465569|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
164574179|NCT04889209|594465570|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
164574180|NCT04889209|594465571|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
164574181|NCT04889209|594465572|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
164678618|NCT00848536|594847981|FG000|Overall Study|Protocol Violation|0|||
164678619|NCT00848536|594847982|FG001|Overall Study|Protocol Violation|1|||
164425682|NCT01256476|593930713|FG001|Overall Study|Persistent ALT or AST elevation|0|||
164425683|NCT01256476|593930712|FG000|Overall Study|Physician Decision|0|||
164425684|NCT01256476|593930713|FG001|Overall Study|Physician Decision|1|||
164425685|NCT01256476|593930712|FG000|Overall Study|Subject non-compliance|0|||
164425686|NCT01256476|593930713|FG001|Overall Study|Subject non-compliance|1|||
164425687|NCT01256476|593930712|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
164425688|NCT01256476|593930713|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
164425689|NCT05296629|593930714|FG000|Overall Study|Withdrawal by Subject|3|||
164425690|NCT05296629|593930715|FG001|Overall Study|Withdrawal by Subject|10|||
164425691|NCT05296629|593930716|FG002|Overall Study|Withdrawal by Subject|4|||
164425692|NCT05296629|593930714|FG000|Overall Study|Lost to Follow-up|2|||
164425693|NCT05296629|593930715|FG001|Overall Study|Lost to Follow-up|7|||
164425694|NCT05296629|593930716|FG002|Overall Study|Lost to Follow-up|1|||
164425695|NCT05296629|593930714|FG000|Overall Study|Adverse Event|0|||
164425696|NCT05296629|593930715|FG001|Overall Study|Adverse Event|4|||
164425697|NCT05296629|593930716|FG002|Overall Study|Adverse Event|2|||
164425698|NCT05296629|593930714|FG000|Overall Study|Protocol Violation|0|||
164425699|NCT05296629|593930715|FG001|Overall Study|Protocol Violation|2|||
164425700|NCT05296629|593930716|FG002|Overall Study|Protocol Violation|0|||
164425701|NCT04531540|593930723|FG000|Overall Study|Adverse Event|1|||
164425702|NCT04531540|593930723|FG000|Overall Study|Protocol Violation|3|||
164425703|NCT04531540|593930723|FG000|Overall Study|Withdrawal by Subject|4|||
164425704|NCT04531540|593930723|FG000|Overall Study|Found to be Ineligible|1|||
164425705|NCT02688621|593930724|FG000|Overall Study|Pregnancy|1|||
164425706|NCT02688621|593930725|FG001|Overall Study|Pregnancy|3|||
164425707|NCT02688621|593930724|FG000|Overall Study|Lost to Follow-up|38|||
164425708|NCT02688621|593930725|FG001|Overall Study|Lost to Follow-up|15|||
164425709|NCT02688621|593930724|FG000|Overall Study|Withdrawal by Subject|1|||
164425710|NCT02688621|593930725|FG001|Overall Study|Withdrawal by Subject|0|||
164425711|NCT03239210|593930730|FG000|Overall Study|Lost to Follow-up|2|||
164425712|NCT03239210|593930731|FG001|Overall Study|Lost to Follow-up|2|||
164425713|NCT03239210|593930730|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
164425714|NCT03239210|593930731|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
164425715|NCT03239210|593930730|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
164425716|NCT03239210|593930731|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
164425717|NCT05349864|593930736|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
164425718|NCT05349864|593930737|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
164425719|NCT02478359|593930740|FG000|Overall Study|Disenrolled from health plan|106|||
164425720|NCT02478359|593930741|FG001|Overall Study|Disenrolled from health plan|65|||
164425721|NCT03293485|593930743|FG000|Overall Study|Death|1|||
164425722|NCT03293485|593930743|FG000|Overall Study|Screen Failure|2|||
164425723|NCT03293485|593930743|FG000|Overall Study|Withdrawal by Subject|2|||
164425724|NCT03633903|593930746|FG000|Overall Study|Withdrawal by Subject|1|||
164425725|NCT03633903|593930747|FG001|Overall Study|Withdrawal by Subject|2|||
164425726|NCT03633903|593930746|FG000|Overall Study|Lost to Follow-up|5|||
164243257|NCT00833027|593260415|FG000|Overall Study|Missing|10|||
164243258|NCT00444925|593260416|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
164243259|NCT00444925|593260417|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
164243260|NCT00444925|593260418|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
164243261|NCT00444925|593260416|FG000|Double-blind Treatment Period|Death|2|||
164243262|NCT00444925|593260417|FG001|Double-blind Treatment Period|Death|0|||
164243263|NCT00444925|593260418|FG002|Double-blind Treatment Period|Death|0|||
164243264|NCT00444925|593260416|FG000|Double-blind Treatment Period|Adverse Event|6|||
164243265|NCT00444925|593260417|FG001|Double-blind Treatment Period|Adverse Event|28|||
164243266|NCT00444925|593260418|FG002|Double-blind Treatment Period|Adverse Event|44|||
164243267|NCT00444925|593260416|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
164243268|NCT00444925|593260417|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
164243269|NCT00444925|593260418|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
164243270|NCT00444925|593260416|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
164243271|NCT00444925|593260417|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
164243272|NCT00444925|593260418|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
164243273|NCT00444925|593260416|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
164243274|NCT00444925|593260417|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
164425727|NCT03633903|593930747|FG001|Overall Study|Lost to Follow-up|5|||
164425728|NCT01813422|593930748|FG000|Overall Study|Withdrawal by Subject|14|||
164425729|NCT01813422|593930749|FG001|Overall Study|Withdrawal by Subject|8|||
164425730|NCT01813422|593930748|FG000|Overall Study|Death|2|||
164425731|NCT01813422|593930749|FG001|Overall Study|Death|3|||
164243275|NCT00444925|593260418|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
164425732|NCT01813422|593930748|FG000|Overall Study|Sponsor Decision|2|||
164425733|NCT01813422|593930749|FG001|Overall Study|Sponsor Decision|1|||
164425734|NCT01813422|593930748|FG000|Overall Study|Lost to Follow-up|2|||
164425735|NCT01813422|593930749|FG001|Overall Study|Lost to Follow-up|4|||
164425736|NCT03582137|593930752|FG000|Overall Study|Adverse Event|1|||
164425737|NCT03582137|593930753|FG001|Overall Study|Adverse Event|0|||
164243276|NCT00444925|593260416|FG000|Double-blind Treatment Period|Other|7|||
164243277|NCT00444925|593260417|FG001|Double-blind Treatment Period|Other|7|||
164243278|NCT00444925|593260418|FG002|Double-blind Treatment Period|Other|12|||
164243279|NCT03069716|593260422|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
164243280|NCT03069716|593260423|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
164243281|NCT03069716|593260424|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
164243282|NCT03069716|593260422|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
164243283|NCT03069716|593260423|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
164243284|NCT03069716|593260424|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
164243285|NCT03069716|593260422|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
164243286|NCT03069716|593260423|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
164243287|NCT03069716|593260424|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
164243288|NCT03069716|593260422|FG000|Randomized Treatment|Withdrawal by Subject|0|||
164243289|NCT03069716|593260423|FG001|Randomized Treatment|Withdrawal by Subject|2|||
164243290|NCT03069716|593260424|FG002|Randomized Treatment|Withdrawal by Subject|0|||
164243291|NCT00714948|593260425|FG000|Overall Study|Adverse Event|2|||
164243292|NCT01673126|593260426|FG000|Overall Study|change of diagnosis|4|||
164243293|NCT01673126|593260427|FG001|Overall Study|change of diagnosis|3|||
164243294|NCT00237042|593260430|FG000|Treatment|Became ineligible post-randomization|0|||
164243295|NCT00237042|593260431|FG001|Treatment|Became ineligible post-randomization|1|||
164243296|NCT00237042|593260432|FG002|Treatment|Became ineligible post-randomization|16|||
164336797|NCT00875979|593609781|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
164336798|NCT00875979|593609780|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
164336799|NCT00875979|593609781|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
164336800|NCT00875979|593609780|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
164336801|NCT00875979|593609781|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
164336802|NCT01696695|593609783|FG000|Overall Study|Disease progression|373|||
164336803|NCT01696695|593609783|FG000|Overall Study|Death|29|||
164336804|NCT01696695|593609783|FG000|Overall Study|Adverse Event|74|||
164336805|NCT01696695|593609783|FG000|Overall Study|Withdrawal by Subject|92|||
164336806|NCT01696695|593609783|FG000|Overall Study|Lost to Follow-up|48|||
164336807|NCT01696695|593609783|FG000|Overall Study|Other|74|||
164336808|NCT01696695|593609783|FG000|Overall Study|Major Protocol Violation|192|||
164336809|NCT01904058|593609791|FG000|Overall Study|Adverse Event|2|||
164336810|NCT01904058|593609792|FG001|Overall Study|Adverse Event|0|||
164336811|NCT01904058|593609793|FG002|Overall Study|Adverse Event|0|||
164336812|NCT01904058|593609794|FG003|Overall Study|Adverse Event|0|||
164336813|NCT01904058|593609791|FG000|Overall Study|Withdrawal by Subject|1|||
164336814|NCT01904058|593609792|FG001|Overall Study|Withdrawal by Subject|0|||
164336815|NCT01904058|593609793|FG002|Overall Study|Withdrawal by Subject|1|||
164336816|NCT01904058|593609794|FG003|Overall Study|Withdrawal by Subject|0|||
164336817|NCT01904058|593609791|FG000|Overall Study|Pregnancy|0|||
164336818|NCT01904058|593609792|FG001|Overall Study|Pregnancy|0|||
164336819|NCT01904058|593609793|FG002|Overall Study|Pregnancy|0|||
164336820|NCT01904058|593609794|FG003|Overall Study|Pregnancy|1|||
164336821|NCT04041375|593609796|FG000|Intervention Phase|Withdrawal by Subject|2|||
164336822|NCT04041375|593609797|FG001|Intervention Phase|Withdrawal by Subject|2|||
164336823|NCT04041375|593609796|FG000|Follow-up Phase|Death|2|||
164336824|NCT04041375|593609797|FG001|Follow-up Phase|Death|0|||
164336825|NCT04041375|593609796|FG000|Follow-up Phase|Lost to Follow-up|2|||
164336826|NCT04041375|593609797|FG001|Follow-up Phase|Lost to Follow-up|1|||
164336827|NCT04041375|593609796|FG000|Follow-up Phase|Too ill|3|||
164336828|NCT04041375|593609797|FG001|Follow-up Phase|Too ill|0|||
164336829|NCT02404220|593609803|FG000|Overall Study|Adverse Event|0|||
164336830|NCT02404220|593609804|FG001|Overall Study|Adverse Event|0|||
164336831|NCT02404220|593609805|FG002|Overall Study|Adverse Event|1|||
164336832|NCT02404220|593609806|FG003|Overall Study|Adverse Event|0|||
164336833|NCT02404220|593609803|FG000|Overall Study|Death|5|||
164336834|NCT02404220|593609804|FG001|Overall Study|Death|5|||
164336835|NCT02404220|593609805|FG002|Overall Study|Death|3|||
164336836|NCT02404220|593609806|FG003|Overall Study|Death|8|||
164336837|NCT02404220|593609803|FG000|Overall Study|Progressive Disease|0|||
164336838|NCT02404220|593609804|FG001|Overall Study|Progressive Disease|0|||
164336839|NCT02404220|593609805|FG002|Overall Study|Progressive Disease|1|||
164336840|NCT02404220|593609806|FG003|Overall Study|Progressive Disease|1|||
164336841|NCT02404220|593609803|FG000|Overall Study|Study Terminated by Sponsor|0|||
164336842|NCT02404220|593609804|FG001|Overall Study|Study Terminated by Sponsor|0|||
164336843|NCT02404220|593609805|FG002|Overall Study|Study Terminated by Sponsor|2|||
164336844|NCT02404220|593609806|FG003|Overall Study|Study Terminated by Sponsor|1|||
164336845|NCT02404220|593609803|FG000|Overall Study|Withdrawal by Subject|0|||
164336846|NCT02404220|593609804|FG001|Overall Study|Withdrawal by Subject|1|||
164336847|NCT02404220|593609805|FG002|Overall Study|Withdrawal by Subject|0|||
164336848|NCT02404220|593609806|FG003|Overall Study|Withdrawal by Subject|0|||
164336849|NCT02404220|593609803|FG000|Overall Study|Enrolled but Never Treated|0|||
164336850|NCT02404220|593609804|FG001|Overall Study|Enrolled but Never Treated|2|||
164243297|NCT00237042|593260430|FG000|Treatment|Moved out of state|1|||
164243298|NCT00237042|593260431|FG001|Treatment|Moved out of state|1|||
164243299|NCT00237042|593260432|FG002|Treatment|Moved out of state|1|||
164243300|NCT00237042|593260430|FG000|Treatment|Completed no treatment|5|||
164243301|NCT00237042|593260431|FG001|Treatment|Completed no treatment|5|||
164243302|NCT00237042|593260432|FG002|Treatment|Completed no treatment|21|||
164243303|NCT00237042|593260430|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
164243304|NCT00237042|593260431|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
164243305|NCT00237042|593260432|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
164243306|NCT00237042|593260430|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
164243307|NCT00237042|593260431|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
164243308|NCT00237042|593260432|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
164243309|NCT01913327|593260439|FG000|Overall Study|Withdrawal by Subject|0|||
164243310|NCT01913327|593260440|FG001|Overall Study|Withdrawal by Subject|1|||
164243311|NCT02151786|593260441|FG000|Overall Study|Unavailability of Case Report Form|26|||
164243312|NCT02151786|593260441|FG000|Overall Study|Outside the Contract Period|1|||
164243313|NCT02151786|593260441|FG000|Overall Study|Randomized, not Treated|1|||
164243314|NCT02151786|593260441|FG000|Overall Study|Unavailability of Information|8|||
164243315|NCT02112656|593260442|FG000|Overall Study|Death|78|||
164243316|NCT02112656|593260443|FG001|Overall Study|Death|82|||
164243317|NCT02112656|593260442|FG000|Overall Study|Withdrawal by Subject|9|||
164243318|NCT02112656|593260443|FG001|Overall Study|Withdrawal by Subject|11|||
164243319|NCT02112656|593260442|FG000|Overall Study|Lost to Follow-up|2|||
164243320|NCT02112656|593260443|FG001|Overall Study|Lost to Follow-up|4|||
164574182|NCT04889209|594465573|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
164574183|NCT04889209|594465574|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
164574184|NCT04889209|594465557|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164574185|NCT04889209|594465558|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164574186|NCT04889209|594465559|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164574187|NCT04889209|594465560|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
164574188|NCT04889209|594465561|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164574189|NCT04889209|594465562|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164574190|NCT04889209|594465563|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164574191|NCT04889209|594465564|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164574192|NCT04889209|594465565|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164574193|NCT04889209|594465566|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164574194|NCT04889209|594465567|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164574195|NCT04889209|594465568|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164574196|NCT04889209|594465569|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164574197|NCT04889209|594465570|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164574198|NCT04889209|594465571|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164574199|NCT04889209|594465572|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164574200|NCT04889209|594465573|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164574201|NCT04889209|594465574|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164574202|NCT04889209|594465557|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
164574203|NCT04889209|594465558|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
164574204|NCT04889209|594465559|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
164574205|NCT04889209|594465560|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
164574206|NCT04889209|594465561|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
164574207|NCT04889209|594465562|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
164574208|NCT04889209|594465563|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
164574209|NCT04889209|594465564|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
164574210|NCT04889209|594465565|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
164574211|NCT04889209|594465566|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
164574212|NCT04889209|594465567|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
164574213|NCT04889209|594465568|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
164243321|NCT02112656|593260442|FG000|Overall Study|Noncompliance|1|||
164243322|NCT02112656|593260443|FG001|Overall Study|Noncompliance|2|||
164243323|NCT04749745|593260444|FG000|Overall Study|Withdrawal by Subject|1|||
164243324|NCT04749745|593260445|FG001|Overall Study|Withdrawal by Subject|0|||
164243325|NCT01365455|593260446|FG000|Induction Period|Adverse Event|5|||
164243326|NCT01365455|593260447|FG001|Induction Period|Adverse Event|3|||
164243327|NCT01365455|593260448|FG002|Induction Period|Adverse Event|4|||
164243328|NCT01365455|593260449|FG003|Induction Period|Adverse Event|0|||
164243329|NCT01365455|593260450|FG004|Induction Period|Adverse Event|0|||
164243330|NCT01365455|593260446|FG000|Induction Period|Lack of Efficacy|1|||
164243331|NCT01365455|593260447|FG001|Induction Period|Lack of Efficacy|1|||
164243332|NCT01365455|593260448|FG002|Induction Period|Lack of Efficacy|0|||
164243333|NCT01365455|593260449|FG003|Induction Period|Lack of Efficacy|0|||
164243334|NCT01365455|593260450|FG004|Induction Period|Lack of Efficacy|0|||
164243335|NCT01365455|593260446|FG000|Induction Period|Pregnancy|0|||
164243336|NCT01365455|593260447|FG001|Induction Period|Pregnancy|1|||
164243337|NCT01365455|593260448|FG002|Induction Period|Pregnancy|0|||
164243338|NCT01365455|593260449|FG003|Induction Period|Pregnancy|0|||
164243339|NCT01365455|593260450|FG004|Induction Period|Pregnancy|0|||
164243340|NCT01365455|593260446|FG000|Induction Period|Protocol deviation|0|||
164243341|NCT01365455|593260447|FG001|Induction Period|Protocol deviation|1|||
164243342|NCT01365455|593260448|FG002|Induction Period|Protocol deviation|1|||
164243343|NCT01365455|593260449|FG003|Induction Period|Protocol deviation|0|||
164243344|NCT01365455|593260450|FG004|Induction Period|Protocol deviation|0|||
164243345|NCT01365455|593260446|FG000|Induction Period|Subject/guardian decision|9|||
164243346|NCT01365455|593260447|FG001|Induction Period|Subject/guardian decision|1|||
164243347|NCT01365455|593260448|FG002|Induction Period|Subject/guardian decision|8|||
164243348|NCT01365455|593260449|FG003|Induction Period|Subject/guardian decision|0|||
164243349|NCT01365455|593260450|FG004|Induction Period|Subject/guardian decision|0|||
164243350|NCT01365455|593260446|FG000|Induction Period|Lost to Follow-up|0|||
164425738|NCT03704298|593930758|FG000|Overall Study|Death|3|||
164425739|NCT03704298|593930759|FG001|Overall Study|Death|1|||
164425740|NCT03704298|593930760|FG002|Overall Study|Death|1|||
164425741|NCT03704298|593930761|FG003|Overall Study|Death|0|||
164425742|NCT03704298|593930758|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
164425743|NCT03704298|593930759|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
164425744|NCT03704298|593930760|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
164425745|NCT03704298|593930761|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
164425746|NCT03704298|593930758|FG000|Overall Study|Withdrawal by Subject|1|||
164425747|NCT03704298|593930759|FG001|Overall Study|Withdrawal by Subject|0|||
164425748|NCT03704298|593930760|FG002|Overall Study|Withdrawal by Subject|0|||
164425749|NCT03704298|593930761|FG003|Overall Study|Withdrawal by Subject|0|||
164425750|NCT03704298|593930758|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
164425751|NCT03704298|593930759|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
164425752|NCT03704298|593930760|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
164425753|NCT03704298|593930761|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
164425754|NCT00558753|593930762|FG000|Overall Study|Lost to Follow-up|5|||
164425755|NCT00558753|593930763|FG001|Overall Study|Lost to Follow-up|7|||
164425756|NCT01167023|593930767|FG000|Overall Study|Lost to Follow-up|0|||
164425757|NCT01167023|593930768|FG001|Overall Study|Lost to Follow-up|1|||
164425758|NCT01167023|593930769|FG002|Overall Study|Lost to Follow-up|1|||
164425759|NCT01167023|593930767|FG000|Overall Study|Screen Failure|0|||
164425760|NCT01167023|593930768|FG001|Overall Study|Screen Failure|1|||
164425761|NCT01167023|593930769|FG002|Overall Study|Screen Failure|0|||
164425762|NCT01167023|593930767|FG000|Overall Study|Sponsor Decision|0|||
164425763|NCT01167023|593930768|FG001|Overall Study|Sponsor Decision|1|||
164425764|NCT01167023|593930769|FG002|Overall Study|Sponsor Decision|0|||
164425765|NCT01167023|593930767|FG000|Overall Study|Withdrawal by Subject|0|||
164425766|NCT01167023|593930768|FG001|Overall Study|Withdrawal by Subject|0|||
164425767|NCT01167023|593930769|FG002|Overall Study|Withdrawal by Subject|1|||
164425768|NCT00410384|593930770|FG000|Overall Study|Withdrawal by Subject|28|||
164425769|NCT00410384|593930771|FG001|Overall Study|Withdrawal by Subject|17|||
164425770|NCT00410384|593930772|FG002|Overall Study|Withdrawal by Subject|20|||
164425771|NCT00410384|593930770|FG000|Overall Study|Adverse Event|23|||
164425772|NCT00410384|593930771|FG001|Overall Study|Adverse Event|18|||
164425773|NCT00410384|593930772|FG002|Overall Study|Adverse Event|23|||
164425774|NCT00410384|593930770|FG000|Overall Study|Lack of Efficacy|20|||
164425775|NCT00410384|593930771|FG001|Overall Study|Lack of Efficacy|12|||
164574214|NCT04889209|594465569|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
164574215|NCT04889209|594465570|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
164425776|NCT00410384|593930772|FG002|Overall Study|Lack of Efficacy|17|||
164425777|NCT00410384|593930770|FG000|Overall Study|Lack of Compliance|2|||
164574216|NCT04889209|594465571|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
164574217|NCT04889209|594465572|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
164243351|NCT01365455|593260447|FG001|Induction Period|Lost to Follow-up|0|||
164243352|NCT01365455|593260448|FG002|Induction Period|Lost to Follow-up|3|||
164425778|NCT00410384|593930771|FG001|Overall Study|Lack of Compliance|2|||
164425779|NCT00410384|593930772|FG002|Overall Study|Lack of Compliance|2|||
164243353|NCT01365455|593260449|FG003|Induction Period|Lost to Follow-up|0|||
164243354|NCT01365455|593260450|FG004|Induction Period|Lost to Follow-up|0|||
164243355|NCT01365455|593260446|FG000|Maintenance Period|Adverse Event|12|||
164243356|NCT01365455|593260447|FG001|Maintenance Period|Adverse Event|5|||
164243357|NCT01365455|593260448|FG002|Maintenance Period|Adverse Event|1|||
164243358|NCT01365455|593260449|FG003|Maintenance Period|Adverse Event|2|||
164243359|NCT01365455|593260450|FG004|Maintenance Period|Adverse Event|4|||
164243360|NCT01365455|593260446|FG000|Maintenance Period|Lack of Efficacy|10|||
164243361|NCT01365455|593260447|FG001|Maintenance Period|Lack of Efficacy|2|||
164243362|NCT01365455|593260448|FG002|Maintenance Period|Lack of Efficacy|0|||
164243363|NCT01365455|593260449|FG003|Maintenance Period|Lack of Efficacy|2|||
164243364|NCT01365455|593260450|FG004|Maintenance Period|Lack of Efficacy|2|||
164243365|NCT01365455|593260446|FG000|Maintenance Period|Lost to Follow-up|2|||
164243366|NCT01365455|593260447|FG001|Maintenance Period|Lost to Follow-up|4|||
164243367|NCT01365455|593260448|FG002|Maintenance Period|Lost to Follow-up|0|||
164243368|NCT01365455|593260449|FG003|Maintenance Period|Lost to Follow-up|0|||
164243369|NCT01365455|593260450|FG004|Maintenance Period|Lost to Follow-up|3|||
164243370|NCT01365455|593260446|FG000|Maintenance Period|Non-compliance with study treatment|0|||
164243371|NCT01365455|593260447|FG001|Maintenance Period|Non-compliance with study treatment|0|||
164243372|NCT01365455|593260448|FG002|Maintenance Period|Non-compliance with study treatment|0|||
164243373|NCT01365455|593260449|FG003|Maintenance Period|Non-compliance with study treatment|1|||
164243374|NCT01365455|593260450|FG004|Maintenance Period|Non-compliance with study treatment|0|||
164243375|NCT01365455|593260446|FG000|Maintenance Period|Physician Decision|0|||
164243376|NCT01365455|593260447|FG001|Maintenance Period|Physician Decision|1|||
164243377|NCT01365455|593260448|FG002|Maintenance Period|Physician Decision|0|||
164243378|NCT01365455|593260449|FG003|Maintenance Period|Physician Decision|0|||
164243379|NCT01365455|593260450|FG004|Maintenance Period|Physician Decision|1|||
164243380|NCT01365455|593260446|FG000|Maintenance Period|Pregnancy|0|||
164243381|NCT01365455|593260447|FG001|Maintenance Period|Pregnancy|4|||
164243382|NCT01365455|593260448|FG002|Maintenance Period|Pregnancy|0|||
164243383|NCT01365455|593260449|FG003|Maintenance Period|Pregnancy|0|||
164243384|NCT01365455|593260450|FG004|Maintenance Period|Pregnancy|2|||
164243385|NCT01365455|593260446|FG000|Maintenance Period|Protocol deviation|1|||
164243386|NCT01365455|593260447|FG001|Maintenance Period|Protocol deviation|1|||
164243387|NCT01365455|593260448|FG002|Maintenance Period|Protocol deviation|0|||
164243388|NCT01365455|593260449|FG003|Maintenance Period|Protocol deviation|0|||
164243389|NCT01365455|593260450|FG004|Maintenance Period|Protocol deviation|0|||
164243390|NCT01365455|593260446|FG000|Maintenance Period|Subject/guardian decision|4|||
164243391|NCT01365455|593260447|FG001|Maintenance Period|Subject/guardian decision|6|||
164243392|NCT01365455|593260448|FG002|Maintenance Period|Subject/guardian decision|2|||
164243393|NCT01365455|593260449|FG003|Maintenance Period|Subject/guardian decision|4|||
164243394|NCT01365455|593260450|FG004|Maintenance Period|Subject/guardian decision|1|||
164243395|NCT01234480|593261993|FG000|Overall Study|Pregnancy|88|||
164243396|NCT01234480|593261993|FG000|Overall Study|>36/Normal History|50|||
164243397|NCT01234480|593261993|FG000|Overall Study|Age|3|||
164243398|NCT01234480|593261993|FG000|Overall Study|HPV Vaccine History|28|||
164243399|NCT01234480|593261993|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
164243400|NCT01234480|593261993|FG000|Overall Study|Hysterectomy|2|||
164243401|NCT01234480|593261993|FG000|Overall Study|Hysterectomy post enrollment|1|||
164243402|NCT01234480|593261993|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
164243403|NCT01234480|593261993|FG000|Overall Study|Informed Consent Form Violation|30|||
164243404|NCT01234480|593261993|FG000|Overall Study|Incorrect Visit|3|||
164243405|NCT01234480|593261993|FG000|Overall Study|No Florida Lab License|20|||
164243406|NCT01234480|593261993|FG000|Overall Study|Out of Window|42|||
164243407|NCT01234480|593261993|FG000|Overall Study|Sample Processing/Storage|92|||
164243408|NCT01234480|593261993|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
164243409|NCT01234480|593261993|FG000|Overall Study|Site/Subject non-compliance|44|||
164243410|NCT01234480|593261993|FG000|Overall Study|Missing Sample|9|||
164243411|NCT03370419|593261994|FG000|Overall Study|Lost to Follow-up|16|||
164243412|NCT02595879|593262000|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
164243413|NCT02595879|593262001|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
164243414|NCT03145064|593262002|FG000|Overall Study|Death|24|||
164243415|NCT03145064|593262002|FG000|Overall Study|Lost to Follow-up|3|||
164243416|NCT03145064|593262002|FG000|Overall Study|Withdrawal by Subject|6|||
164243417|NCT03145064|593262002|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
164243418|NCT03145064|593262002|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
164243419|NCT00661830|593262003|FG000|Overall Study|Death|37|||
164243420|NCT00661830|593262004|FG001|Overall Study|Death|33|||
164243421|NCT00661830|593262003|FG000|Overall Study|Lost to Follow-up|1|||
164243422|NCT00661830|593262004|FG001|Overall Study|Lost to Follow-up|3|||
164243423|NCT00661830|593262003|FG000|Overall Study|Withdrawal by Subject|1|||
164243424|NCT00661830|593262004|FG001|Overall Study|Withdrawal by Subject|1|||
164243425|NCT00661830|593262003|FG000|Overall Study|Other reason|1|||
164243426|NCT00661830|593262004|FG001|Overall Study|Other reason|5|||
164243427|NCT01898286|593262005|FG000|Overall Study|Withdrawal by Subject|1|||
164243428|NCT01898286|593262005|FG000|Overall Study|Protocol Violation|1|||
164243429|NCT01898286|593262005|FG000|Overall Study|Lost to Follow-up|1|||
164243430|NCT01650831|593262006|FG000|Overall Study|Screen failure|1|||
164243431|NCT01897727|593262009|FG000|Overall Study|Exclusion: central sleep apnea|0|||
164243432|NCT01897727|593262010|FG001|Overall Study|Exclusion: central sleep apnea|1|||
164243433|NCT04245449|593262011|FG000|Overall Study|COVID shutdown|7|||
164243434|NCT02477527|593262012|FG000|Overall Study|Lost to Follow-up|2|||
164243435|NCT02477527|593262012|FG000|Overall Study|Withdrawal by Subject|1|||
164243436|NCT02477527|593262012|FG000|Overall Study|Screen Failure|3|||
164243437|NCT03692403|593262013|FG000|Overall Study|Withdrawal by Subject|1|||
164243438|NCT03692403|593262014|FG001|Overall Study|Withdrawal by Subject|0|||
164243439|NCT03692403|593262015|FG002|Overall Study|Withdrawal by Subject|1|||
164243440|NCT03692403|593262016|FG003|Overall Study|Withdrawal by Subject|0|||
164243441|NCT03692403|593262013|FG000|Overall Study|Adverse Event|0|||
164243442|NCT03692403|593262014|FG001|Overall Study|Adverse Event|0|||
164336851|NCT02404220|593609805|FG002|Overall Study|Enrolled but Never Treated|0|||
164336852|NCT02404220|593609806|FG003|Overall Study|Enrolled but Never Treated|0|||
164336853|NCT00395733|593609807|FG000|Period 2|Withdrawal by Subject|1|||
164336854|NCT00395733|593609808|FG001|Period 2|Withdrawal by Subject|2|||
164336855|NCT00395733|593609807|FG000|Period 2|Protocol Violation|0|||
164336856|NCT00395733|593609808|FG001|Period 2|Protocol Violation|1|||
164336857|NCT00395733|593609807|FG000|Period 2|Adverse Event|0|||
164336858|NCT00395733|593609808|FG001|Period 2|Adverse Event|2|||
164336859|NCT00395733|593609807|FG000|Period 2|Technical problems|1|||
164336860|NCT00395733|593609808|FG001|Period 2|Technical problems|0|||
164336861|NCT01147172|593609814|FG000|Overall Study|Withdrawal by Subject|2|||
164336862|NCT01147172|593609814|FG000|Overall Study|Lost to Follow-up|2|||
164336863|NCT01697358|593609815|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
164336864|NCT01697358|593609816|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
164336865|NCT01697358|593609815|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
164336866|NCT01697358|593609816|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
164574218|NCT04889209|594465573|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
164425780|NCT00410384|593930770|FG000|Overall Study|Lost to Follow-up|4|||
164425781|NCT00410384|593930771|FG001|Overall Study|Lost to Follow-up|6|||
164425782|NCT00410384|593930772|FG002|Overall Study|Lost to Follow-up|6|||
164425783|NCT00410384|593930770|FG000|Overall Study|Protocol Violation|6|||
164425784|NCT00410384|593930771|FG001|Overall Study|Protocol Violation|6|||
164425785|NCT00410384|593930772|FG002|Overall Study|Protocol Violation|6|||
164425786|NCT00410384|593930770|FG000|Overall Study|Physician Decision|3|||
164425787|NCT00410384|593930771|FG001|Overall Study|Physician Decision|3|||
164425788|NCT00410384|593930772|FG002|Overall Study|Physician Decision|4|||
164425789|NCT00410384|593930770|FG000|Overall Study|Other|3|||
164425790|NCT00410384|593930771|FG001|Overall Study|Other|8|||
164425791|NCT00410384|593930772|FG002|Overall Study|Other|4|||
164425792|NCT00577629|593930782|FG000|Treatment Period|Death|1|||
164425793|NCT00577629|593930782|FG000|Long Term Follow-Up|Death|15|||
164425794|NCT00577629|593930782|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
164425795|NCT00577629|593930782|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
164425796|NCT00577629|593930782|FG000|Long Term Follow-Up|Physician Decision|1|||
164425797|NCT05489224|593930783|FG000|Treatment Period I|Withdrawal by Subject|6|||
164425798|NCT05489224|593930784|FG001|Treatment Period I|Withdrawal by Subject|5|||
164425799|NCT05489224|593930785|FG002|Treatment Period I|Withdrawal by Subject|0|||
164425800|NCT05489224|593930783|FG000|Treatment Period I|Adverse Event|3|||
164425801|NCT05489224|593930784|FG001|Treatment Period I|Adverse Event|11|||
164425802|NCT05489224|593930785|FG002|Treatment Period I|Adverse Event|0|||
164425803|NCT05489224|593930783|FG000|Treatment Period I|Lost to Follow-up|0|||
164425804|NCT05489224|593930784|FG001|Treatment Period I|Lost to Follow-up|1|||
164425805|NCT05489224|593930785|FG002|Treatment Period I|Lost to Follow-up|0|||
164425806|NCT05489224|593930783|FG000|Treatment Period I|Physician Decision|0|||
164425807|NCT05489224|593930784|FG001|Treatment Period I|Physician Decision|1|||
164425808|NCT05489224|593930785|FG002|Treatment Period I|Physician Decision|0|||
164425809|NCT05489224|593930783|FG000|Treatment Period II up to Week 32|Ongoing|222|||
164425810|NCT05489224|593930784|FG001|Treatment Period II up to Week 32|Ongoing|107|||
164425811|NCT05489224|593930785|FG002|Treatment Period II up to Week 32|Ongoing|107|||
164425812|NCT05489224|593930783|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
164425813|NCT05489224|593930784|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
164425814|NCT05489224|593930785|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
164425815|NCT05489224|593930783|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
164425816|NCT05489224|593930784|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
164425817|NCT05489224|593930785|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
164425818|NCT04887285|593930786|FG000|Overall Study|Lost to Follow-up|0|||
164425819|NCT04887285|593930787|FG001|Overall Study|Lost to Follow-up|2|||
164425820|NCT04887285|593930788|FG002|Overall Study|Lost to Follow-up|3|||
164425821|NCT04640571|593930789|FG000|Overall Study|Withdrawal by Subject|0|||
164425822|NCT04640571|593930790|FG001|Overall Study|Withdrawal by Subject|0|||
164425823|NCT04640571|593930791|FG002|Overall Study|Withdrawal by Subject|0|||
164678620|NCT00848536|594847981|FG000|Overall Study|Noncompliance|1|||
164425824|NCT04640571|593930792|FG003|Overall Study|Withdrawal by Subject|0|||
164425825|NCT04640571|593930793|FG004|Overall Study|Withdrawal by Subject|0|||
164425826|NCT04640571|593930794|FG005|Overall Study|Withdrawal by Subject|2|||
164425827|NCT00832780|593930799|FG000|Overall Study|Death|16|||
164425828|NCT00832780|593930799|FG000|Overall Study|Lost to Follow-up|4|||
164425829|NCT00832780|593930799|FG000|Overall Study|no reason given|2|||
164425830|NCT00832780|593930799|FG000|Overall Study|other complicating condition|2|||
164678621|NCT00848536|594847982|FG001|Overall Study|Noncompliance|0|||
164678622|NCT00848536|594847981|FG000|Overall Study|Inadequate Control of IOP|1|||
164678623|NCT00848536|594847982|FG001|Overall Study|Inadequate Control of IOP|1|||
164678624|NCT00848536|594847981|FG000|Overall Study|Patient Moved|0|||
164678625|NCT00848536|594847982|FG001|Overall Study|Patient Moved|2|||
164678626|NCT01175135|594847983|FG000|Overall Study|Adverse Event|2|||
164678627|NCT01175135|594847984|FG001|Overall Study|Adverse Event|5|||
164678628|NCT01175135|594847985|FG002|Overall Study|Adverse Event|3|||
164678629|NCT01175135|594847986|FG003|Overall Study|Adverse Event|4|||
164425831|NCT00832780|593930799|FG000|Overall Study|Physician Decision|1|||
164425832|NCT05705167|593930800|FG000|Overall Study|Randomised but not Treated|0|||
164678630|NCT01175135|594847983|FG000|Overall Study|Death|1|||
164678631|NCT01175135|594847984|FG001|Overall Study|Death|0|||
164678632|NCT01175135|594847985|FG002|Overall Study|Death|0|||
164425833|NCT05705167|593930801|FG001|Overall Study|Randomised but not Treated|2|||
164425834|NCT05705167|593930802|FG002|Overall Study|Randomised but not Treated|0|||
164425835|NCT05705167|593930803|FG003|Overall Study|Randomised but not Treated|7|||
164425836|NCT05705167|593930804|FG004|Overall Study|Randomised but not Treated|0|||
164678633|NCT01175135|594847986|FG003|Overall Study|Death|0|||
164678634|NCT01175135|594847983|FG000|Overall Study|Lack of Efficacy|4|||
164678635|NCT01175135|594847984|FG001|Overall Study|Lack of Efficacy|5|||
164678636|NCT01175135|594847985|FG002|Overall Study|Lack of Efficacy|0|||
164678637|NCT01175135|594847986|FG003|Overall Study|Lack of Efficacy|5|||
164425837|NCT05705167|593930805|FG005|Overall Study|Randomised but not Treated|0|||
164425838|NCT05705167|593930806|FG006|Overall Study|Randomised but not Treated|0|||
164425839|NCT05705167|593930800|FG000|Overall Study|Death|0|||
164425840|NCT05705167|593930801|FG001|Overall Study|Death|0|||
164425841|NCT05705167|593930802|FG002|Overall Study|Death|3|||
164678638|NCT01175135|594847983|FG000|Overall Study|Lost to Follow-up|1|||
164678639|NCT01175135|594847984|FG001|Overall Study|Lost to Follow-up|2|||
164678640|NCT01175135|594847985|FG002|Overall Study|Lost to Follow-up|0|||
164678641|NCT01175135|594847986|FG003|Overall Study|Lost to Follow-up|0|||
164678642|NCT01175135|594847983|FG000|Overall Study|Protocol Violation|1|||
164678643|NCT01175135|594847984|FG001|Overall Study|Protocol Violation|1|||
164678644|NCT01175135|594847985|FG002|Overall Study|Protocol Violation|0|||
164678645|NCT01175135|594847986|FG003|Overall Study|Protocol Violation|0|||
164678646|NCT01175135|594847983|FG000|Overall Study|Withdrawal by Subject|4|||
164678647|NCT01175135|594847984|FG001|Overall Study|Withdrawal by Subject|8|||
164678648|NCT01175135|594847985|FG002|Overall Study|Withdrawal by Subject|5|||
164678649|NCT01175135|594847986|FG003|Overall Study|Withdrawal by Subject|5|||
164678650|NCT01175135|594847983|FG000|Overall Study|Other|3|||
164678651|NCT01175135|594847984|FG001|Overall Study|Other|1|||
164678652|NCT01175135|594847985|FG002|Overall Study|Other|3|||
164678653|NCT01175135|594847986|FG003|Overall Study|Other|0|||
164678654|NCT01175135|594847983|FG000|Overall Study|Randomized But Not Treated|0|||
164678655|NCT01175135|594847984|FG001|Overall Study|Randomized But Not Treated|0|||
164678656|NCT01175135|594847985|FG002|Overall Study|Randomized But Not Treated|1|||
164678657|NCT01175135|594847986|FG003|Overall Study|Randomized But Not Treated|0|||
164678658|NCT00466167|594847989|FG000|Overall Study|Adverse Event|8|||
164678659|NCT00466167|594847990|FG001|Overall Study|Adverse Event|8|||
164678660|NCT00466167|594847991|FG002|Overall Study|Adverse Event|7|||
164678661|NCT00466167|594847989|FG000|Overall Study|Lack of Efficacy|2|||
164678662|NCT00466167|594847990|FG001|Overall Study|Lack of Efficacy|0|||
164678663|NCT00466167|594847991|FG002|Overall Study|Lack of Efficacy|3|||
164678664|NCT00466167|594847989|FG000|Overall Study|Protocol Violation|1|||
164678665|NCT00466167|594847990|FG001|Overall Study|Protocol Violation|1|||
164678666|NCT00466167|594847991|FG002|Overall Study|Protocol Violation|2|||
164678667|NCT00466167|594847989|FG000|Overall Study|Lost to Follow-up|3|||
164678668|NCT00466167|594847990|FG001|Overall Study|Lost to Follow-up|2|||
164678669|NCT00466167|594847991|FG002|Overall Study|Lost to Follow-up|2|||
164678670|NCT00466167|594847989|FG000|Overall Study|Withdrawal by Subject|4|||
164678671|NCT00466167|594847990|FG001|Overall Study|Withdrawal by Subject|1|||
164678672|NCT00466167|594847991|FG002|Overall Study|Withdrawal by Subject|6|||
164678673|NCT00466167|594847989|FG000|Overall Study|patient did not meet inclusion criteria|1|||
164678674|NCT00466167|594847990|FG001|Overall Study|patient did not meet inclusion criteria|0|||
164678675|NCT00466167|594847991|FG002|Overall Study|patient did not meet inclusion criteria|1|||
164678676|NCT00466167|594847989|FG000|Overall Study|Not treated|1|||
164678677|NCT00466167|594847990|FG001|Overall Study|Not treated|0|||
164678678|NCT00466167|594847991|FG002|Overall Study|Not treated|0|||
164678679|NCT03534193|594847994|FG000|Overall Study|Lost to Follow-up|1|||
164678680|NCT03534193|594847995|FG001|Overall Study|Lost to Follow-up|3|||
164678681|NCT04414930|594847996|FG000|Overall Study|Withdrawal by Subject|1|||
164678682|NCT04414930|594847997|FG001|Overall Study|Withdrawal by Subject|3|||
164678683|NCT05470699|594847998|FG000|Overall Study|Did not receive intervention|13|||
164678684|NCT05470699|594847998|FG000|Overall Study|Ineligible|1|||
164678685|NCT03325881|594847999|FG000|Overall Study|Protocol Violation|0|||
164678686|NCT03325881|594848000|FG001|Overall Study|Protocol Violation|1|||
164678687|NCT03325881|594847999|FG000|Overall Study|Withdrawal by Subject|0|||
164678688|NCT03325881|594848000|FG001|Overall Study|Withdrawal by Subject|2|||
164678689|NCT03325881|594847999|FG000|Overall Study|Lack of Efficacy|2|||
164678690|NCT03325881|594848000|FG001|Overall Study|Lack of Efficacy|0|||
164678691|NCT03325881|594847999|FG000|Overall Study|Not treated|1|||
164678692|NCT03325881|594848000|FG001|Overall Study|Not treated|0|||
164678693|NCT03676634|594848001|FG000|Overall Study|Red blood cell loss|1|||
164678694|NCT03676634|594848001|FG000|Overall Study|Out-of-limit pulse|2|||
164678695|NCT00829712|594848006|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
164678696|NCT00829712|594848007|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
164678697|NCT02294981|594848008|FG000|Overall Study|Lost to Follow-up|1|||
164678698|NCT04128761|594848009|FG000|Overall Study|Lost to Follow-up|5|||
164678699|NCT04128761|594848010|FG001|Overall Study|Lost to Follow-up|6|||
164678700|NCT06539676|594848011|FG000|Overall Study|Early study termination|1|||
164678701|NCT06539676|594848012|FG001|Overall Study|Early study termination|0|||
164678702|NCT06539676|594848013|FG002|Overall Study|Early study termination|6|||
164678703|NCT00909038|594848020|FG000|Overall Study|Protocol Violation|187|||
164678704|NCT00909038|594848020|FG000|Overall Study|Non-evaluable Subjects|230|||
164678705|NCT00207090|594848021|FG000|Overall Study|Study drug toxicity|3|||
164425842|NCT05705167|593930803|FG003|Overall Study|Death|0|||
164678706|NCT00207090|594848021|FG000|Overall Study|Chest wall mass larger|1|||
164243443|NCT03692403|593262015|FG002|Overall Study|Adverse Event|0|||
164243444|NCT03692403|593262016|FG003|Overall Study|Adverse Event|1|||
164243445|NCT03692403|593262013|FG000|Overall Study|Pregnancy|0|||
164243446|NCT03692403|593262014|FG001|Overall Study|Pregnancy|1|||
164243447|NCT03692403|593262015|FG002|Overall Study|Pregnancy|0|||
164243448|NCT03692403|593262016|FG003|Overall Study|Pregnancy|0|||
164243449|NCT03692403|593262013|FG000|Overall Study|Other|0|||
164243450|NCT03692403|593262014|FG001|Overall Study|Other|0|||
164243451|NCT03692403|593262015|FG002|Overall Study|Other|1|||
164243452|NCT03692403|593262016|FG003|Overall Study|Other|0|||
164243453|NCT02479880|593262017|FG000|Overall Study|Study Terminated by Sponsor|13|||
164243454|NCT02479880|593262018|FG001|Overall Study|Study Terminated by Sponsor|12|||
164243455|NCT02479880|593262017|FG000|Overall Study|Pregnancy|0|||
164243456|NCT02479880|593262018|FG001|Overall Study|Pregnancy|1|||
164243457|NCT02840253|593262019|FG000|Overall Study|Unsuccessful block|4|||
164243458|NCT00856635|593262020|FG000|Overall Study|Lost to Follow-up|2|||
164243459|NCT00856635|593262021|FG001|Overall Study|Lost to Follow-up|5|||
164243460|NCT00856635|593262020|FG000|Overall Study|Pregnancy|1|||
164243461|NCT00856635|593262021|FG001|Overall Study|Pregnancy|0|||
164243462|NCT00856635|593262020|FG000|Overall Study|Withdrawal by Subject|3|||
164243463|NCT00856635|593262021|FG001|Overall Study|Withdrawal by Subject|1|||
164243464|NCT00856635|593262020|FG000|Overall Study|Serious Adverse Event|1|||
164243465|NCT00856635|593262021|FG001|Overall Study|Serious Adverse Event|0|||
164243466|NCT00856635|593262020|FG000|Overall Study|Other|1|||
164243467|NCT00856635|593262021|FG001|Overall Study|Other|0|||
164243468|NCT00856635|593262020|FG000|Overall Study|Discontinued at Randomization|2|||
164243469|NCT00856635|593262021|FG001|Overall Study|Discontinued at Randomization|2|||
164243470|NCT01349673|593262022|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
164243471|NCT01349673|593262022|FG000|Overall Study|No Longer Qualified For Study|1|||
164243472|NCT01349673|593262022|FG000|Overall Study|Site Closure|10|||
164243473|NCT01349673|593262022|FG000|Overall Study|Withdrawal by Subject|21|||
164243474|NCT01349673|593262022|FG000|Overall Study|Lost to Follow-up|6|||
164243475|NCT01349673|593262022|FG000|Overall Study|Adverse Event|17|||
164243476|NCT01349673|593262022|FG000|Overall Study|Study Terminated By Sponsor|50|||
164243477|NCT01349673|593262022|FG000|Overall Study|Lack of Efficacy|8|||
164243478|NCT03688919|593262023|FG000|Overall Study|Lost to Follow-up|2|||
164243479|NCT03688919|593262024|FG001|Overall Study|Lost to Follow-up|1|||
164243480|NCT03688919|593262023|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
164243481|NCT03688919|593262024|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
164243482|NCT00564733|593262029|FG000|Overall Study|Withdrawal by Subject|4|||
164243483|NCT00564733|593262029|FG000|Overall Study|Ineligible|5|||
164243484|NCT03198767|593262034|FG000|Overall Study|Protocol Violation|0|||
164243485|NCT03198767|593262035|FG001|Overall Study|Protocol Violation|0|||
164243486|NCT03198767|593262036|FG002|Overall Study|Protocol Violation|0|||
164243487|NCT03198767|593262037|FG003|Overall Study|Protocol Violation|6|||
164243488|NCT03198767|593262038|FG004|Overall Study|Protocol Violation|0|||
164243489|NCT03198767|593262039|FG005|Overall Study|Protocol Violation|0|||
164243490|NCT03198767|593262040|FG006|Overall Study|Protocol Violation|0|||
164243491|NCT03462758|593262041|FG000|Overall Study|Chose no or other method of contraception|20|||
164243492|NCT03462758|593262042|FG001|Overall Study|Chose no or other method of contraception|23|||
164243493|NCT03462758|593262041|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
164243494|NCT03462758|593262042|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
164243495|NCT03462758|593262041|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
164243496|NCT03462758|593262042|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
164243497|NCT03462758|593262041|FG000|Overall Study|Medical contraindication|2|||
164243498|NCT03462758|593262042|FG001|Overall Study|Medical contraindication|2|||
164243499|NCT03462758|593262041|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
164243500|NCT03462758|593262042|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
164243501|NCT02820844|593262043|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
164243502|NCT02820844|593262044|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
164243503|NCT02820844|593262045|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
164243504|NCT02820844|593262046|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
164243505|NCT02820844|593262047|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
164243506|NCT02820844|593262048|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
164243507|NCT02820844|593262043|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
164243508|NCT02820844|593262044|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
164243509|NCT02820844|593262045|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
164243510|NCT02820844|593262046|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
164243511|NCT02820844|593262047|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
164243512|NCT02820844|593262048|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
164243513|NCT02820844|593262043|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
164243514|NCT02820844|593262044|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
164243515|NCT02820844|593262045|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
164243516|NCT02820844|593262046|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
164243517|NCT02820844|593262047|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
164243518|NCT02820844|593262048|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
164243519|NCT02820844|593262043|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
164243520|NCT02820844|593262044|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
164243521|NCT02820844|593262045|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
164243522|NCT02820844|593262046|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
164243523|NCT02820844|593262047|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
164243524|NCT02820844|593262048|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
164243525|NCT02820844|593262043|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
164243526|NCT02820844|593262044|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
164243527|NCT02820844|593262045|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
164243528|NCT02820844|593262046|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
164243529|NCT02820844|593262047|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
164243530|NCT02820844|593262048|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
164243531|NCT02820844|593262043|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
164243532|NCT02820844|593262044|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
164243533|NCT02820844|593262045|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
164243534|NCT02820844|593262046|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
164243535|NCT02820844|593262047|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
164243536|NCT02820844|593262048|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
164243537|NCT02820844|593262043|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
164243538|NCT02820844|593262044|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
164243539|NCT02820844|593262045|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
164243540|NCT02820844|593262046|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
164243541|NCT02820844|593262047|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
164243542|NCT02820844|593262048|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
164243543|NCT02820844|593262043|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
164243544|NCT02820844|593262044|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
164243545|NCT02820844|593262045|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
164243546|NCT02820844|593262046|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
164243547|NCT02820844|593262047|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
164243548|NCT02820844|593262048|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
164243549|NCT02820844|593262043|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
164243550|NCT02820844|593262044|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
164243551|NCT02820844|593262045|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
164243552|NCT02820844|593262046|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
164574219|NCT04889209|594465574|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
164574220|NCT04889209|594465557|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164243553|NCT02820844|593262047|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
164243554|NCT02820844|593262048|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
164243555|NCT02820844|593262043|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
164243556|NCT02820844|593262044|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
164243557|NCT02820844|593262045|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
164243558|NCT02820844|593262046|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
164243559|NCT02820844|593262047|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
164243560|NCT02820844|593262048|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
164243561|NCT04423939|593262049|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
164243562|NCT04423939|593262050|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
164243563|NCT04423939|593262049|FG000|Overall Study|Death|3|||
164243564|NCT04423939|593262050|FG001|Overall Study|Death|0|||
164243565|NCT04423939|593262049|FG000|Overall Study|Withdrawal by Subject|3|||
164243566|NCT04423939|593262050|FG001|Overall Study|Withdrawal by Subject|0|||
164243567|NCT04423939|593262049|FG000|Overall Study|Caregiver to patient who died|0|||
164243568|NCT04423939|593262050|FG001|Overall Study|Caregiver to patient who died|3|||
164243569|NCT04423939|593262049|FG000|Overall Study|Caregiver to patient who withdrew|0|||
164243570|NCT04423939|593262050|FG001|Overall Study|Caregiver to patient who withdrew|3|||
164243571|NCT01722994|593262055|FG000|Overall Study|Missing data|25|||
164243572|NCT01722994|593262056|FG001|Overall Study|Missing data|17|||
164243573|NCT01206140|593262057|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
164243574|NCT01206140|593262058|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
164243575|NCT02655887|593262059|FG000|Overall Study|Lost to Follow-up|3|||
164243576|NCT02655887|593262059|FG000|Overall Study|Death|4|||
164243577|NCT02655887|593262059|FG000|Overall Study|Withdrawal by Subject|3|||
164243578|NCT02655887|593262059|FG000|Overall Study|Missed 12-month follow-up visit|4|||
164336867|NCT01697358|593609815|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
164574221|NCT04889209|594465558|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164574222|NCT04889209|594465559|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164574223|NCT04889209|594465560|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164243579|NCT04245709|593262062|FG000|Overall Study|Adverse Event|13|||
164243580|NCT04245709|593262062|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
164243581|NCT04339413|593262063|FG000|Overall Study|Reason Not Specified|2|||
164243582|NCT04339413|593262064|FG001|Overall Study|Reason Not Specified|7|||
164243583|NCT04339413|593262063|FG000|Overall Study|Study Terminated by Sponsor|30|||
164243584|NCT04339413|593262064|FG001|Overall Study|Study Terminated by Sponsor|33|||
164243585|NCT04339413|593262063|FG000|Overall Study|Progressive Disease|9|||
164243586|NCT04339413|593262064|FG001|Overall Study|Progressive Disease|6|||
164243587|NCT04339413|593262063|FG000|Overall Study|Withdrawal by Subject|9|||
164243588|NCT04339413|593262064|FG001|Overall Study|Withdrawal by Subject|10|||
164243589|NCT04339413|593262063|FG000|Overall Study|Physician Decision|3|||
164243590|NCT04339413|593262064|FG001|Overall Study|Physician Decision|1|||
164243591|NCT04339413|593262063|FG000|Overall Study|Death|2|||
164243592|NCT04339413|593262064|FG001|Overall Study|Death|0|||
164243593|NCT04339413|593262063|FG000|Overall Study|Adverse Event|3|||
164243594|NCT04339413|593262064|FG001|Overall Study|Adverse Event|0|||
164243595|NCT00442416|593262065|FG000|Overall Study|Adverse Event|4|||
164243596|NCT00442416|593262066|FG001|Overall Study|Adverse Event|1|||
164243597|NCT00442416|593262065|FG000|Overall Study|Death|1|||
164243598|NCT00442416|593262066|FG001|Overall Study|Death|0|||
164243599|NCT00442416|593262065|FG000|Overall Study|Lack of Efficacy|2|||
164243600|NCT00442416|593262066|FG001|Overall Study|Lack of Efficacy|0|||
164243601|NCT00442416|593262065|FG000|Overall Study|Protocol Violation|2|||
164243602|NCT00442416|593262066|FG001|Overall Study|Protocol Violation|3|||
164243603|NCT00442416|593262065|FG000|Overall Study|Withdrew consent|1|||
164243604|NCT00442416|593262066|FG001|Overall Study|Withdrew consent|2|||
164243605|NCT00442416|593262065|FG000|Overall Study|Administrative/Other|27|||
164243606|NCT00442416|593262066|FG001|Overall Study|Administrative/Other|33|||
164243607|NCT01964378|593262070|FG000|Overall Study|Disc. due to death before first dosing|0|||
164243608|NCT01964378|593262071|FG001|Overall Study|Disc. due to death before first dosing|1|||
164243609|NCT01964378|593262070|FG000|Overall Study|Disc. due to AE before first dosing|1|||
164243610|NCT01964378|593262071|FG001|Overall Study|Disc. due to AE before first dosing|0|||
164243611|NCT01964378|593262070|FG000|Overall Study|Death|3|||
164243612|NCT01964378|593262071|FG001|Overall Study|Death|2|||
164243613|NCT01964378|593262070|FG000|Overall Study|Adverse Event|12|||
164243614|NCT01964378|593262071|FG001|Overall Study|Adverse Event|5|||
164243615|NCT01964378|593262070|FG000|Overall Study|Lack of Efficacy|0|||
164243616|NCT01964378|593262071|FG001|Overall Study|Lack of Efficacy|1|||
164243617|NCT01964378|593262070|FG000|Overall Study|Protocol Violation|0|||
164243618|NCT01964378|593262071|FG001|Overall Study|Protocol Violation|1|||
164243619|NCT01964378|593262070|FG000|Overall Study|Lost to Follow-up|0|||
164243620|NCT01964378|593262071|FG001|Overall Study|Lost to Follow-up|1|||
164243621|NCT01964378|593262070|FG000|Overall Study|Withdrawal by Subject|7|||
164243622|NCT01964378|593262071|FG001|Overall Study|Withdrawal by Subject|5|||
164243623|NCT01964378|593262070|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
164243624|NCT01964378|593262071|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
164243625|NCT01964378|593262070|FG000|Overall Study|Other|1|||
164243626|NCT01964378|593262071|FG001|Overall Study|Other|2|||
164243627|NCT00657267|593262079|FG000|Overall Study|Progressive disease|45|||
164243628|NCT00657267|593262079|FG000|Overall Study|Adverse Event|9|||
164243629|NCT04872569|593262080|FG000|Overall Study|Withdrawal by Subject|2|||
164243630|NCT02382991|593262086|FG000|Overall Study|Adverse Event|1|||
164243631|NCT02382991|593262087|FG001|Overall Study|Adverse Event|2|||
164243632|NCT02382991|593262086|FG000|Overall Study|Lost to Follow-up|1|||
164574224|NCT04889209|594465561|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164243633|NCT02382991|593262087|FG001|Overall Study|Lost to Follow-up|0|||
164243634|NCT02382991|593262086|FG000|Overall Study|Withdrawal by Subject|0|||
164243635|NCT02382991|593262087|FG001|Overall Study|Withdrawal by Subject|1|||
164243636|NCT04951622|593262088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
164336868|NCT01697358|593609816|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
164336869|NCT01697358|593609815|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
164243637|NCT04951622|593262089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
164243638|NCT04951622|593262090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
164243639|NCT04951622|593262091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
164243640|NCT04951622|593262092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
164243641|NCT04951622|593262088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
164243642|NCT04951622|593262089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
164243643|NCT04951622|593262090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
164243644|NCT04951622|593262091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
164243645|NCT04951622|593262092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
164243646|NCT04951622|593262088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
164243647|NCT04951622|593262089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
164425843|NCT05705167|593930804|FG004|Overall Study|Death|1|||
164243648|NCT04951622|593262090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
164243649|NCT04951622|593262091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
164243650|NCT04951622|593262092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
164243651|NCT04951622|593262088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
164243652|NCT04951622|593262089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
164243653|NCT04951622|593262090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
164243654|NCT04951622|593262091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
164243655|NCT04951622|593262092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
164243656|NCT04951622|593262088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
164243657|NCT04951622|593262089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
164243658|NCT04951622|593262090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
164243659|NCT04951622|593262091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
164243660|NCT04951622|593262092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
164243661|NCT04951622|593262088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
164243662|NCT04951622|593262089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
164243663|NCT04951622|593262090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
164243664|NCT04951622|593262091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
164243665|NCT04951622|593262092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
164243666|NCT04951622|593262088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
164243667|NCT04951622|593262089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
164243668|NCT04951622|593262090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
164243669|NCT04951622|593262091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
164243670|NCT04951622|593262092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
164243671|NCT04951622|593262088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
164243672|NCT04951622|593262089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
164243673|NCT04951622|593262090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
164243674|NCT04951622|593262091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
164243675|NCT04951622|593262092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
164243676|NCT04951622|593262088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
164243677|NCT04951622|593262089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
164243678|NCT04951622|593262090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
164243679|NCT04951622|593262091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
164243680|NCT04951622|593262092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
164243681|NCT04951622|593262088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
164243682|NCT04951622|593262089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
164243683|NCT04951622|593262090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
164243684|NCT04951622|593262091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
164243685|NCT04951622|593262092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
164243686|NCT04951622|593262088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
164243687|NCT04951622|593262089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
164243688|NCT04951622|593262090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
164243689|NCT04951622|593262091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
164336870|NCT01697358|593609816|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
164336871|NCT01697358|593609815|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
164243690|NCT04951622|593262092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
164336872|NCT01697358|593609816|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
164336873|NCT01697358|593609815|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
164336874|NCT01697358|593609816|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
164336875|NCT01697358|593609815|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
164336876|NCT01697358|593609816|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
164336877|NCT01697358|593609815|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
164336878|NCT01697358|593609816|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
164336879|NCT01697358|593609815|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
164336880|NCT01697358|593609816|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
164336881|NCT01697358|593609815|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
164336882|NCT01697358|593609816|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
164336883|NCT02711345|593609819|FG000|Overall Study|Adverse Event|0|||
164574225|NCT04889209|594465562|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164574226|NCT04889209|594465563|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164574227|NCT04889209|594465564|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164574228|NCT04889209|594465565|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164574229|NCT04889209|594465566|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164574230|NCT04889209|594465567|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164574231|NCT04889209|594465568|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164574232|NCT04889209|594465569|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164678707|NCT00207090|594848021|FG000|Overall Study|Disease progression/relapse|2|||
164243691|NCT04951622|593262088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
164243692|NCT04951622|593262089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
164243693|NCT04951622|593262090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
164243694|NCT04951622|593262091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
164243695|NCT04951622|593262092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
164243696|NCT04951622|593262088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
164243697|NCT04951622|593262089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
164243698|NCT04951622|593262090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
164243699|NCT04951622|593262091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
164243700|NCT04951622|593262092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
164243701|NCT04951622|593262088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
164243702|NCT04951622|593262089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
164243703|NCT04951622|593262090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
164336884|NCT02711345|593609820|FG001|Overall Study|Adverse Event|0|||
164336885|NCT02711345|593609821|FG002|Overall Study|Adverse Event|0|||
164336886|NCT02711345|593609822|FG003|Overall Study|Adverse Event|1|||
164336887|NCT02711345|593609823|FG004|Overall Study|Adverse Event|1|||
164336888|NCT02711345|593609824|FG005|Overall Study|Adverse Event|2|||
164336889|NCT02711345|593609825|FG006|Overall Study|Adverse Event|1|||
164336890|NCT02711345|593609826|FG007|Overall Study|Adverse Event|0|||
164336891|NCT02711345|593609827|FG008|Overall Study|Adverse Event|0|||
164336892|NCT02711345|593609828|FG009|Overall Study|Adverse Event|2|||
164336893|NCT02711345|593609819|FG000|Overall Study|Physician Decision|0|||
164336894|NCT02711345|593609820|FG001|Overall Study|Physician Decision|0|||
164336895|NCT02711345|593609821|FG002|Overall Study|Physician Decision|1|||
164336896|NCT02711345|593609822|FG003|Overall Study|Physician Decision|0|||
164336897|NCT02711345|593609823|FG004|Overall Study|Physician Decision|0|||
164336898|NCT02711345|593609824|FG005|Overall Study|Physician Decision|0|||
164336899|NCT02711345|593609825|FG006|Overall Study|Physician Decision|0|||
164336900|NCT02711345|593609826|FG007|Overall Study|Physician Decision|0|||
164336901|NCT02711345|593609827|FG008|Overall Study|Physician Decision|1|||
164336902|NCT02711345|593609828|FG009|Overall Study|Physician Decision|0|||
164336903|NCT02711345|593609819|FG000|Overall Study|Progressive disease|1|||
164336904|NCT02711345|593609820|FG001|Overall Study|Progressive disease|3|||
164336905|NCT02711345|593609821|FG002|Overall Study|Progressive disease|5|||
164336906|NCT02711345|593609822|FG003|Overall Study|Progressive disease|3|||
164336907|NCT02711345|593609823|FG004|Overall Study|Progressive disease|7|||
164336908|NCT02711345|593609824|FG005|Overall Study|Progressive disease|2|||
164336909|NCT02711345|593609825|FG006|Overall Study|Progressive disease|8|||
164336910|NCT02711345|593609826|FG007|Overall Study|Progressive disease|4|||
164336911|NCT02711345|593609827|FG008|Overall Study|Progressive disease|5|||
164336912|NCT02711345|593609828|FG009|Overall Study|Progressive disease|6|||
164336913|NCT02711345|593609819|FG000|Overall Study|Subject/guardian decision|0|||
164336914|NCT02711345|593609820|FG001|Overall Study|Subject/guardian decision|0|||
164336915|NCT02711345|593609821|FG002|Overall Study|Subject/guardian decision|0|||
164336916|NCT02711345|593609822|FG003|Overall Study|Subject/guardian decision|0|||
164336917|NCT02711345|593609823|FG004|Overall Study|Subject/guardian decision|0|||
164336918|NCT02711345|593609824|FG005|Overall Study|Subject/guardian decision|2|||
164336919|NCT02711345|593609825|FG006|Overall Study|Subject/guardian decision|3|||
164336920|NCT02711345|593609826|FG007|Overall Study|Subject/guardian decision|1|||
164336921|NCT02711345|593609827|FG008|Overall Study|Subject/guardian decision|0|||
164336922|NCT02711345|593609828|FG009|Overall Study|Subject/guardian decision|4|||
164336923|NCT02711345|593609819|FG000|Overall Study|Death|1|||
164336924|NCT02711345|593609820|FG001|Overall Study|Death|0|||
164336925|NCT02711345|593609821|FG002|Overall Study|Death|0|||
164425844|NCT05705167|593930805|FG005|Overall Study|Death|1|||
164425845|NCT05705167|593930806|FG006|Overall Study|Death|1|||
164425846|NCT05705167|593930800|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
164425847|NCT05705167|593930801|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
164336926|NCT02711345|593609822|FG003|Overall Study|Death|0|||
164336927|NCT02711345|593609823|FG004|Overall Study|Death|0|||
164336928|NCT02711345|593609824|FG005|Overall Study|Death|0|||
164336929|NCT02711345|593609825|FG006|Overall Study|Death|0|||
164336930|NCT02711345|593609826|FG007|Overall Study|Death|1|||
164425848|NCT05705167|593930802|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
164678708|NCT00207090|594848021|FG000|Overall Study|Physician Decision|1|||
164336931|NCT02711345|593609827|FG008|Overall Study|Death|0|||
164336932|NCT02711345|593609828|FG009|Overall Study|Death|0|||
164336933|NCT00961649|593609829|FG000|Overall Study|Adverse Event|4|||
164336934|NCT00961649|593609830|FG001|Overall Study|Adverse Event|0|||
164336935|NCT00961649|593609831|FG002|Overall Study|Adverse Event|0|||
164336936|NCT00961649|593609832|FG003|Overall Study|Adverse Event|2|||
164336937|NCT00961649|593609829|FG000|Overall Study|Inadequate control of IOP|0|||
164336938|NCT00961649|593609830|FG001|Overall Study|Inadequate control of IOP|0|||
164336939|NCT00961649|593609831|FG002|Overall Study|Inadequate control of IOP|0|||
164425849|NCT05705167|593930803|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
164243704|NCT04951622|593262091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
164243705|NCT04951622|593262092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
164243706|NCT04951622|593262088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
164243707|NCT04951622|593262089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
164243708|NCT04951622|593262090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
164243709|NCT04951622|593262091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
164243710|NCT04951622|593262092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
164243711|NCT04951622|593262088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
164243712|NCT04951622|593262089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
164243713|NCT04951622|593262090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
164243714|NCT04951622|593262091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
164243715|NCT04951622|593262092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
164243716|NCT04951622|593262088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
164243717|NCT04951622|593262089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
164243718|NCT04951622|593262090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
164243719|NCT04951622|593262091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
164243720|NCT04951622|593262092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
164243721|NCT04951622|593262088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
164243722|NCT04951622|593262089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
164243723|NCT04951622|593262090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
164243724|NCT04951622|593262091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
164243725|NCT04951622|593262092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
164243726|NCT04951622|593262088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
164243727|NCT04951622|593262089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
164243728|NCT04951622|593262090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
164243729|NCT04951622|593262091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
164243730|NCT04951622|593262092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
164243731|NCT04951622|593262088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
164243732|NCT04951622|593262089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
164243733|NCT04951622|593262090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
164243734|NCT04951622|593262091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
164243735|NCT04951622|593262092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
164243736|NCT02891226|593262097|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
164243737|NCT02891226|593262098|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
164243738|NCT02891226|593262099|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
164243739|NCT02891226|593262100|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243740|NCT02891226|593262101|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243741|NCT02891226|593262102|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243742|NCT02891226|593262103|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243743|NCT02891226|593262104|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243744|NCT02891226|593262105|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243745|NCT02891226|593262106|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243746|NCT02891226|593262107|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243747|NCT02891226|593262108|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243748|NCT02891226|593262109|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243749|NCT02891226|593262110|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243750|NCT02891226|593262111|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243751|NCT02891226|593262112|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243752|NCT02891226|593262097|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
164243753|NCT02891226|593262098|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
164336940|NCT00961649|593609832|FG003|Overall Study|Inadequate control of IOP|1|||
164336941|NCT00961649|593609829|FG000|Overall Study|Patient has travel plans during holidays|0|||
164336942|NCT00961649|593609830|FG001|Overall Study|Patient has travel plans during holidays|0|||
164336943|NCT00961649|593609831|FG002|Overall Study|Patient has travel plans during holidays|1|||
164336944|NCT00961649|593609832|FG003|Overall Study|Patient has travel plans during holidays|0|||
164336945|NCT00961649|593609829|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
164336946|NCT00961649|593609830|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
164336947|NCT00961649|593609831|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
164336948|NCT00961649|593609832|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
164336949|NCT00961649|593609829|FG000|Overall Study|Study terminated by sponsor|4|||
164243754|NCT02891226|593262099|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164243755|NCT02891226|593262100|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164243756|NCT02891226|593262101|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164243757|NCT02891226|593262102|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164243758|NCT02891226|593262103|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164336950|NCT00961649|593609830|FG001|Overall Study|Study terminated by sponsor|4|||
164574233|NCT04889209|594465570|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164574234|NCT04889209|594465571|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164243759|NCT02891226|593262104|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164243760|NCT02891226|593262105|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164243761|NCT02891226|593262106|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164243762|NCT02891226|593262107|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164243763|NCT02891226|593262108|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164243764|NCT02891226|593262109|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164243765|NCT02891226|593262110|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164243766|NCT02891226|593262111|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164574235|NCT04889209|594465572|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164574236|NCT04889209|594465573|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164243767|NCT02891226|593262112|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164243768|NCT02891226|593262097|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243769|NCT02891226|593262098|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243770|NCT02891226|593262099|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243771|NCT02891226|593262100|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
164243772|NCT02891226|593262101|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243773|NCT02891226|593262102|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243774|NCT02891226|593262103|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243775|NCT02891226|593262104|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243776|NCT02891226|593262105|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243777|NCT02891226|593262106|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243778|NCT02891226|593262107|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243779|NCT02891226|593262108|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243780|NCT02891226|593262109|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243781|NCT02891226|593262110|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243782|NCT02891226|593262111|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243783|NCT02891226|593262112|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243784|NCT02891226|593262097|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243785|NCT02891226|593262098|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243786|NCT02891226|593262099|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
164243787|NCT02891226|593262100|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243788|NCT02891226|593262101|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243789|NCT02891226|593262102|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243790|NCT02891226|593262103|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243791|NCT02891226|593262104|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243792|NCT02891226|593262105|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243793|NCT02891226|593262106|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243794|NCT02891226|593262107|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243795|NCT02891226|593262108|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243796|NCT02891226|593262109|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243797|NCT02891226|593262110|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243798|NCT02891226|593262111|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243799|NCT02891226|593262112|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243800|NCT02891226|593262097|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243801|NCT02891226|593262098|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164336951|NCT00961649|593609831|FG002|Overall Study|Study terminated by sponsor|4|||
164336952|NCT00961649|593609832|FG003|Overall Study|Study terminated by sponsor|1|||
164336953|NCT02155881|593609833|FG000|Overall Study|Withdrawal by Subject|0|||
164574237|NCT04889209|594465574|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
164574238|NCT04889209|594465557|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164574239|NCT04889209|594465558|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164574240|NCT04889209|594465559|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164574241|NCT04889209|594465560|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164574242|NCT04889209|594465561|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164574243|NCT04889209|594465562|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164574244|NCT04889209|594465563|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164574245|NCT04889209|594465564|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164574246|NCT04889209|594465565|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164574247|NCT04889209|594465566|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164678709|NCT01895335|594848022|FG000|Overall Study|Adverse Event|106|||
164243802|NCT02891226|593262099|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243803|NCT02891226|593262100|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
164243804|NCT02891226|593262101|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243805|NCT02891226|593262102|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243806|NCT02891226|593262103|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164678710|NCT01895335|594848022|FG000|Overall Study|Lack of Efficacy|53|||
164678711|NCT01895335|594848022|FG000|Overall Study|Poor Compliance to Protocol|11|||
164678712|NCT01895335|594848022|FG000|Overall Study|Included But Not treated|1|||
164243807|NCT02891226|593262104|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243808|NCT02891226|593262105|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243809|NCT02891226|593262106|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243810|NCT02891226|593262107|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243811|NCT02891226|593262108|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243812|NCT02891226|593262109|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243813|NCT02891226|593262110|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243814|NCT02891226|593262111|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243815|NCT02891226|593262112|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243816|NCT02891226|593262097|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243817|NCT02891226|593262098|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243818|NCT02891226|593262099|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243819|NCT02891226|593262100|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
164243820|NCT02891226|593262101|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243821|NCT02891226|593262102|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243822|NCT02891226|593262103|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243823|NCT02891226|593262104|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243824|NCT02891226|593262105|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243825|NCT02891226|593262106|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243826|NCT02891226|593262107|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243827|NCT02891226|593262108|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243828|NCT02891226|593262109|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243829|NCT02891226|593262110|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243830|NCT02891226|593262111|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243831|NCT02891226|593262112|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243832|NCT02891226|593262097|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
164243833|NCT02891226|593262098|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
164243834|NCT02891226|593262099|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
164243835|NCT02891226|593262100|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
164243836|NCT02891226|593262101|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
164243837|NCT02891226|593262102|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
164243838|NCT02891226|593262103|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
164243839|NCT02891226|593262104|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
164243840|NCT02891226|593262105|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
164243841|NCT02891226|593262106|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
164243842|NCT02891226|593262107|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
164243843|NCT02891226|593262108|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
164243844|NCT02891226|593262109|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
164243845|NCT02891226|593262110|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
164243846|NCT02891226|593262111|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
164243847|NCT02891226|593262112|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
164243848|NCT02891226|593262097|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243849|NCT02891226|593262098|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243850|NCT02891226|593262099|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243851|NCT02891226|593262100|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243852|NCT02891226|593262101|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243853|NCT02891226|593262102|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
164243854|NCT02891226|593262103|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243855|NCT02891226|593262104|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243856|NCT02891226|593262105|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243857|NCT02891226|593262106|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
164243858|NCT02891226|593262107|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243859|NCT02891226|593262108|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243860|NCT02891226|593262109|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243861|NCT02891226|593262110|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243862|NCT02891226|593262111|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243863|NCT02891226|593262112|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243864|NCT02891226|593262097|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
164243865|NCT02891226|593262098|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
164243866|NCT02891226|593262099|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
164243867|NCT02891226|593262100|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
164243868|NCT02891226|593262101|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
164243869|NCT02891226|593262102|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
164243870|NCT02891226|593262103|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
164243871|NCT02891226|593262104|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
164243872|NCT02891226|593262105|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
164243873|NCT02891226|593262106|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
164243874|NCT02891226|593262107|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
164243875|NCT02891226|593262108|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
164243876|NCT02891226|593262109|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
164425850|NCT05705167|593930804|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
164243877|NCT02891226|593262110|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
164243878|NCT02891226|593262111|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
164574248|NCT04889209|594465567|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164574249|NCT04889209|594465568|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164574250|NCT04889209|594465569|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164574251|NCT04889209|594465570|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164574252|NCT04889209|594465571|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164574253|NCT04889209|594465572|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164574254|NCT04889209|594465573|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164574255|NCT04889209|594465574|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
164574256|NCT04889209|594465557|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164574257|NCT04889209|594465558|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164574258|NCT04889209|594465559|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164574259|NCT04889209|594465560|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164574260|NCT04889209|594465561|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164574261|NCT04889209|594465562|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164574262|NCT04889209|594465563|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164574263|NCT04889209|594465564|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164574264|NCT04889209|594465565|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164574265|NCT04889209|594465566|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164574266|NCT04889209|594465567|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164574267|NCT04889209|594465568|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164574268|NCT04889209|594465569|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164574269|NCT04889209|594465570|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164574270|NCT04889209|594465571|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
164574271|NCT04889209|594465572|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164574272|NCT04889209|594465573|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164574273|NCT04889209|594465574|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164574274|NCT05424276|594465579|FG000|Overall Study|Adverse Event|1|||
164574275|NCT05424276|594465580|FG001|Overall Study|Adverse Event|0|||
164574276|NCT05424276|594465581|FG002|Overall Study|Adverse Event|0|||
164574277|NCT05424276|594465582|FG003|Overall Study|Adverse Event|2|||
164574278|NCT05424276|594465579|FG000|Overall Study|Withdrawal by Subject|0|||
164574279|NCT05424276|594465580|FG001|Overall Study|Withdrawal by Subject|0|||
164574280|NCT05424276|594465581|FG002|Overall Study|Withdrawal by Subject|2|||
164574281|NCT05424276|594465582|FG003|Overall Study|Withdrawal by Subject|0|||
164574282|NCT05424276|594465579|FG000|Overall Study|Protocol Violation|0|||
164574283|NCT05424276|594465580|FG001|Overall Study|Protocol Violation|1|||
164574284|NCT05424276|594465581|FG002|Overall Study|Protocol Violation|0|||
164574285|NCT05424276|594465582|FG003|Overall Study|Protocol Violation|0|||
164574286|NCT05424276|594465579|FG000|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
164574287|NCT05424276|594465580|FG001|Overall Study|Subjects Withdrawn due to regulatory hold|2|||
164574288|NCT05424276|594465581|FG002|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
164574289|NCT05424276|594465582|FG003|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
164574290|NCT01725165|594465583|FG000|Overall Study|Death|11|||
164574291|NCT01725165|594465584|FG001|Overall Study|Death|18|||
164574292|NCT00382967|594465587|FG000|Overall Study|Protocol Violation|1|||
164574293|NCT00382967|594465588|FG001|Overall Study|Protocol Violation|1|||
164574294|NCT02731742|594465590|FG000|Overall Study|Death|1|||
164243879|NCT02891226|593262112|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
164243880|NCT02891226|593262097|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243881|NCT02891226|593262098|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243882|NCT02891226|593262099|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243883|NCT02891226|593262100|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243884|NCT02891226|593262101|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
164243885|NCT02891226|593262102|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243886|NCT02891226|593262103|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243887|NCT02891226|593262104|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243888|NCT02891226|593262105|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243889|NCT02891226|593262106|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243890|NCT02891226|593262107|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243891|NCT02891226|593262108|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243892|NCT02891226|593262109|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164574295|NCT02731742|594465591|FG001|Overall Study|Death|2|||
164574296|NCT02731742|594465592|FG002|Overall Study|Death|5|||
164574297|NCT02731742|594465593|FG003|Overall Study|Death|0|||
164574298|NCT02731742|594465590|FG000|Overall Study|Physician Decision|0|||
164574299|NCT02731742|594465591|FG001|Overall Study|Physician Decision|0|||
164574300|NCT02731742|594465592|FG002|Overall Study|Physician Decision|0|||
164574301|NCT02731742|594465593|FG003|Overall Study|Physician Decision|1|||
164574302|NCT02731742|594465590|FG000|Overall Study|Study Terminated by Sponsor|2|||
164574303|NCT02731742|594465591|FG001|Overall Study|Study Terminated by Sponsor|1|||
164574304|NCT02731742|594465592|FG002|Overall Study|Study Terminated by Sponsor|1|||
164574305|NCT02731742|594465593|FG003|Overall Study|Study Terminated by Sponsor|1|||
164574306|NCT04026568|594465594|FG000|Overall Study|study terminated|0|||
164574307|NCT04026568|594465595|FG001|Overall Study|study terminated|1|||
164574308|NCT00461175|594465596|FG000|Overall Study|Protocol Violation|522|||
164574309|NCT00461175|594465597|FG001|Overall Study|Protocol Violation|365|||
164574310|NCT00833092|594465601|FG000|Overall Study|Withdrawal by Subject|2|||
164574311|NCT00833092|594465602|FG001|Overall Study|Withdrawal by Subject|3|||
164574312|NCT00833092|594465601|FG000|Overall Study|Protocol Violation|2|||
164574313|NCT00833092|594465602|FG001|Overall Study|Protocol Violation|1|||
164574314|NCT00833092|594465601|FG000|Overall Study|Diarrhea|0|||
164574315|NCT00833092|594465602|FG001|Overall Study|Diarrhea|2|||
164574316|NCT00833092|594465601|FG000|Overall Study|constipation|0|||
164574317|NCT00833092|594465602|FG001|Overall Study|constipation|1|||
164574318|NCT00619229|594465603|FG000|Overall Study|Withdrawal by Subject|1|||
164574319|NCT00619229|594465604|FG001|Overall Study|Withdrawal by Subject|1|||
164574320|NCT00619229|594465603|FG000|Overall Study|Lost to Follow-up|1|||
164574321|NCT00619229|594465604|FG001|Overall Study|Lost to Follow-up|0|||
164574322|NCT00619229|594465603|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
164574323|NCT00619229|594465604|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
164574324|NCT00619229|594465603|FG000|Overall Study|Investigator planned Cataract Operation|1|||
164574325|NCT00619229|594465604|FG001|Overall Study|Investigator planned Cataract Operation|0|||
164574326|NCT03417440|594465605|FG000|Overall Study|Lost to Follow-up|0|||
164574327|NCT03417440|594465606|FG001|Overall Study|Lost to Follow-up|1|||
164574328|NCT03417440|594465607|FG002|Overall Study|Lost to Follow-up|0|||
164574329|NCT03417440|594465608|FG003|Overall Study|Lost to Follow-up|0|||
164574330|NCT03417440|594465609|FG004|Overall Study|Lost to Follow-up|1|||
164574331|NCT03417440|594465610|FG005|Overall Study|Lost to Follow-up|0|||
164574332|NCT03417440|594465611|FG006|Overall Study|Lost to Follow-up|0|||
164574333|NCT03417440|594465612|FG007|Overall Study|Lost to Follow-up|0|||
164574334|NCT03417440|594465605|FG000|Overall Study|Withdrawal by Subject|2|||
164574335|NCT03417440|594465606|FG001|Overall Study|Withdrawal by Subject|0|||
164574336|NCT03417440|594465607|FG002|Overall Study|Withdrawal by Subject|2|||
164574337|NCT03417440|594465608|FG003|Overall Study|Withdrawal by Subject|1|||
164574338|NCT03417440|594465609|FG004|Overall Study|Withdrawal by Subject|1|||
164574339|NCT03417440|594465610|FG005|Overall Study|Withdrawal by Subject|0|||
164574340|NCT03417440|594465611|FG006|Overall Study|Withdrawal by Subject|0|||
164574341|NCT03417440|594465612|FG007|Overall Study|Withdrawal by Subject|1|||
164574342|NCT00316264|594465613|FG000|Overall Study|Lost to Follow-up|0|||
164574343|NCT00316264|594465614|FG001|Overall Study|Lost to Follow-up|1|||
164574344|NCT00316264|594465615|FG002|Overall Study|Lost to Follow-up|0|||
164574345|NCT00316264|594465613|FG000|Overall Study|Withdrawal of Consent|3|||
164574346|NCT00316264|594465614|FG001|Overall Study|Withdrawal of Consent|5|||
164574347|NCT00316264|594465615|FG002|Overall Study|Withdrawal of Consent|6|||
164574348|NCT00316264|594465613|FG000|Overall Study|Death|2|||
164574349|NCT00316264|594465614|FG001|Overall Study|Death|0|||
164574350|NCT00316264|594465615|FG002|Overall Study|Death|0|||
164574351|NCT00316264|594465613|FG000|Overall Study|Other|1|||
164574352|NCT00316264|594465614|FG001|Overall Study|Other|1|||
164574353|NCT00316264|594465615|FG002|Overall Study|Other|0|||
164574354|NCT00355264|594465616|FG000|Extension (Variable Duration)|Adverse Event|1|||
164574355|NCT00355264|594465616|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
164574356|NCT01451645|594465617|FG000|Overall Study|Protocol Violation|1|||
164574357|NCT01451645|594465618|FG001|Overall Study|Protocol Violation|0|||
164574358|NCT01451645|594465617|FG000|Overall Study|Adverse Event|0|||
164574359|NCT01451645|594465618|FG001|Overall Study|Adverse Event|3|||
164574360|NCT01451645|594465617|FG000|Overall Study|Withdrawal by Subject|4|||
164574361|NCT01451645|594465618|FG001|Overall Study|Withdrawal by Subject|2|||
164574362|NCT01451645|594465617|FG000|Overall Study|Lost to Follow-up|4|||
164574363|NCT01451645|594465618|FG001|Overall Study|Lost to Follow-up|3|||
164574364|NCT02209506|594465621|FG000|Overall Study|Withdrawal by Subject|0|||
164574365|NCT02209506|594465622|FG001|Overall Study|Withdrawal by Subject|0|||
164574366|NCT02209506|594465623|FG002|Overall Study|Withdrawal by Subject|0|||
164574367|NCT02209506|594465624|FG003|Overall Study|Withdrawal by Subject|0|||
164574368|NCT02209506|594465625|FG004|Overall Study|Withdrawal by Subject|1|||
164678713|NCT01895335|594848022|FG000|Overall Study|Other than Specified Above|44|||
164678714|NCT03480763|594848023|FG000|Overall Study|Withdrawal by Subject|18|||
164678715|NCT03480763|594848024|FG001|Overall Study|Withdrawal by Subject|10|||
164678716|NCT03480763|594848023|FG000|Overall Study|Lost to Follow-up|4|||
164678717|NCT03480763|594848024|FG001|Overall Study|Lost to Follow-up|7|||
164678718|NCT03480763|594848023|FG000|Overall Study|non-study pneumococcal vaccine|1|||
164678719|NCT03480763|594848024|FG001|Overall Study|non-study pneumococcal vaccine|0|||
164678720|NCT03480763|594848023|FG000|Overall Study|oncological treatment|0|||
164678721|NCT03480763|594848024|FG001|Overall Study|oncological treatment|2|||
164574369|NCT02203149|594465626|FG000|Part 1|Adverse Event|0|||
164678722|NCT03480763|594848023|FG000|Overall Study|pain with vaccination|1|||
164243893|NCT02891226|593262110|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243894|NCT02891226|593262111|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243895|NCT02891226|593262112|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243896|NCT02891226|593262097|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243897|NCT02891226|593262098|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243898|NCT02891226|593262099|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243899|NCT02891226|593262100|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243900|NCT02891226|593262101|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243901|NCT02891226|593262102|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243902|NCT02891226|593262103|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
164243903|NCT02891226|593262104|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243904|NCT02891226|593262105|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243905|NCT02891226|593262106|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243906|NCT02891226|593262107|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243907|NCT02891226|593262108|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243908|NCT02891226|593262109|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243909|NCT02891226|593262110|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243910|NCT02891226|593262111|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243911|NCT02891226|593262112|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243912|NCT02891226|593262097|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164243913|NCT02891226|593262098|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164243914|NCT02891226|593262099|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164243915|NCT02891226|593262100|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164243916|NCT02891226|593262101|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164678723|NCT03480763|594848024|FG001|Overall Study|pain with vaccination|0|||
164678724|NCT01647828|594848027|FG000|Overall Study|Death|3|||
164678725|NCT01647828|594848028|FG001|Overall Study|Death|4|||
164678726|NCT01647828|594848029|FG002|Overall Study|Death|4|||
164678727|NCT01647828|594848030|FG003|Overall Study|Death|5|||
164678728|NCT01647828|594848031|FG004|Overall Study|Death|6|||
164678729|NCT01647828|594848032|FG005|Overall Study|Death|3|||
164243917|NCT02891226|593262102|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164243918|NCT02891226|593262103|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164243919|NCT02891226|593262104|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
164243920|NCT02891226|593262105|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
164243921|NCT02891226|593262106|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
164243922|NCT02891226|593262107|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164243923|NCT02891226|593262108|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164243924|NCT02891226|593262109|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164243925|NCT02891226|593262110|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164243926|NCT02891226|593262111|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164243927|NCT02891226|593262112|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164243928|NCT02891226|593262097|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243929|NCT02891226|593262098|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243930|NCT02891226|593262099|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243931|NCT02891226|593262100|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243932|NCT02891226|593262101|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243933|NCT02891226|593262102|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243934|NCT02891226|593262103|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243935|NCT02891226|593262104|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
164243936|NCT02891226|593262105|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243937|NCT02891226|593262106|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243938|NCT02891226|593262107|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243939|NCT02891226|593262108|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243940|NCT02891226|593262109|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243941|NCT02891226|593262110|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243942|NCT02891226|593262111|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243943|NCT02891226|593262112|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164336954|NCT02155881|593609834|FG001|Overall Study|Withdrawal by Subject|2|||
164336955|NCT02155881|593609833|FG000|Overall Study|Inappropriately randomized|2|||
164336956|NCT02155881|593609834|FG001|Overall Study|Inappropriately randomized|2|||
164336957|NCT04357782|593609835|FG000|Overall Study|Discharged from hospital|1|||
164336958|NCT04357782|593609836|FG001|Overall Study|Discharged from hospital|0|||
164678730|NCT01647828|594848033|FG006|Overall Study|Death|10|||
164678731|NCT01647828|594848034|FG007|Overall Study|Death|60|||
164678732|NCT01647828|594848035|FG008|Overall Study|Death|71|||
164243944|NCT02891226|593262097|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243945|NCT02891226|593262098|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243946|NCT02891226|593262099|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243947|NCT02891226|593262100|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243948|NCT02891226|593262101|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243949|NCT02891226|593262102|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243950|NCT02891226|593262103|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243951|NCT02891226|593262104|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243952|NCT02891226|593262105|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
164243953|NCT02891226|593262106|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243954|NCT02891226|593262107|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243955|NCT02891226|593262108|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243956|NCT02891226|593262109|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243957|NCT02891226|593262110|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243958|NCT02891226|593262111|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243959|NCT02891226|593262112|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243960|NCT02891226|593262097|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243961|NCT02891226|593262098|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243962|NCT02891226|593262099|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243963|NCT02891226|593262100|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243964|NCT02891226|593262101|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243965|NCT02891226|593262102|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243966|NCT02891226|593262103|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243967|NCT02891226|593262104|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243968|NCT02891226|593262105|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243969|NCT02891226|593262106|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
164243970|NCT02891226|593262107|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243971|NCT02891226|593262108|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243972|NCT02891226|593262109|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243973|NCT02891226|593262110|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243974|NCT02891226|593262111|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243975|NCT02891226|593262112|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243976|NCT02891226|593262097|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243977|NCT02891226|593262098|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243978|NCT02891226|593262099|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243979|NCT02891226|593262100|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243980|NCT02891226|593262101|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243981|NCT02891226|593262102|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243982|NCT02891226|593262103|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243983|NCT02891226|593262104|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243984|NCT02891226|593262105|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243985|NCT02891226|593262106|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
164243986|NCT02891226|593262107|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243987|NCT02891226|593262108|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243988|NCT02891226|593262109|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243989|NCT02891226|593262110|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243990|NCT02891226|593262111|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243991|NCT02891226|593262112|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243992|NCT02891226|593262097|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164243993|NCT02891226|593262098|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164243994|NCT02891226|593262099|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164243995|NCT02891226|593262100|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164243996|NCT02891226|593262101|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164243997|NCT02891226|593262102|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164243998|NCT02891226|593262103|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164243999|NCT02891226|593262104|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164244000|NCT02891226|593262105|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164244001|NCT02891226|593262106|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164244002|NCT02891226|593262107|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
164244003|NCT02891226|593262108|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164244004|NCT02891226|593262109|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164244005|NCT02891226|593262110|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164425851|NCT05705167|593930805|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
164425852|NCT05705167|593930806|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
164574370|NCT02203149|594465627|FG001|Part 1|Adverse Event|1|||
164574371|NCT02203149|594465628|FG002|Part 1|Adverse Event|0|||
164574372|NCT02203149|594465629|FG003|Part 1|Adverse Event|0|||
164574373|NCT02203149|594465630|FG004|Part 1|Adverse Event|0|||
164574374|NCT02203149|594465626|FG000|Part 2|Death|0|||
164574375|NCT02203149|594465627|FG001|Part 2|Death|0|||
164574376|NCT02203149|594465628|FG002|Part 2|Death|1|||
164574377|NCT02203149|594465629|FG003|Part 2|Death|1|||
164574378|NCT02203149|594465630|FG004|Part 2|Death|0|||
164574379|NCT02203149|594465626|FG000|Part 2|Withdrawal by Subject|0|||
164574380|NCT02203149|594465627|FG001|Part 2|Withdrawal by Subject|0|||
164574381|NCT02203149|594465628|FG002|Part 2|Withdrawal by Subject|0|||
164574382|NCT02203149|594465629|FG003|Part 2|Withdrawal by Subject|1|||
164574383|NCT02203149|594465630|FG004|Part 2|Withdrawal by Subject|0|||
164574384|NCT02203149|594465626|FG000|Part 2|Adverse Event|0|||
164574385|NCT02203149|594465627|FG001|Part 2|Adverse Event|0|||
164574386|NCT02203149|594465628|FG002|Part 2|Adverse Event|0|||
164574387|NCT02203149|594465629|FG003|Part 2|Adverse Event|1|||
164574388|NCT02203149|594465630|FG004|Part 2|Adverse Event|1|||
164574389|NCT02537678|594465631|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
164244006|NCT02891226|593262111|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164244007|NCT02891226|593262112|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164244008|NCT02891226|593262097|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244009|NCT02891226|593262098|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244010|NCT02891226|593262099|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244011|NCT02891226|593262100|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244012|NCT02891226|593262101|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244013|NCT02891226|593262102|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244014|NCT02891226|593262103|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244015|NCT02891226|593262104|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244016|NCT02891226|593262105|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244017|NCT02891226|593262106|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244018|NCT02891226|593262107|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
164244019|NCT02891226|593262108|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244020|NCT02891226|593262109|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244021|NCT02891226|593262110|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244022|NCT02891226|593262111|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244023|NCT02891226|593262112|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244024|NCT02891226|593262097|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244025|NCT02891226|593262098|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244026|NCT02891226|593262099|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244027|NCT02891226|593262100|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244028|NCT02891226|593262101|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244029|NCT02891226|593262102|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244030|NCT02891226|593262103|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244031|NCT02891226|593262104|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244032|NCT02891226|593262105|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244033|NCT02891226|593262106|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244034|NCT02891226|593262107|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
164244035|NCT02891226|593262108|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244036|NCT02891226|593262109|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244037|NCT02891226|593262110|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244038|NCT02891226|593262111|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244039|NCT02891226|593262112|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244040|NCT02891226|593262097|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244041|NCT02891226|593262098|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244042|NCT02891226|593262099|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244043|NCT02891226|593262100|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244044|NCT02891226|593262101|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244045|NCT02891226|593262102|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244046|NCT02891226|593262103|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244047|NCT02891226|593262104|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244048|NCT02891226|593262105|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244049|NCT02891226|593262106|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164574390|NCT02537678|594465632|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
164574391|NCT02537678|594465631|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
164574392|NCT02537678|594465632|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
164574393|NCT02537678|594465631|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
164574394|NCT02537678|594465632|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
164574395|NCT02537678|594465631|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
164574396|NCT02537678|594465632|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
164574397|NCT02537678|594465631|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
164574398|NCT02537678|594465632|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
164244050|NCT02891226|593262107|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
164244051|NCT02891226|593262108|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244052|NCT02891226|593262109|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244053|NCT02891226|593262110|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244054|NCT02891226|593262111|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244055|NCT02891226|593262112|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244056|NCT02891226|593262097|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164678733|NCT01647828|594848027|FG000|Overall Study|Withdrawal by Subject|2|||
164678734|NCT01647828|594848028|FG001|Overall Study|Withdrawal by Subject|0|||
164244057|NCT02891226|593262098|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244058|NCT02891226|593262099|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244059|NCT02891226|593262100|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244060|NCT02891226|593262101|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244061|NCT02891226|593262102|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244062|NCT02891226|593262103|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244063|NCT02891226|593262104|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244064|NCT02891226|593262105|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244065|NCT02891226|593262106|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244066|NCT02891226|593262107|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
164244067|NCT02891226|593262108|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244068|NCT02891226|593262109|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244069|NCT02891226|593262110|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244070|NCT02891226|593262111|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244071|NCT02891226|593262112|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164336959|NCT04357782|593609835|FG000|Overall Study|Death|0|||
164336960|NCT04357782|593609836|FG001|Overall Study|Death|2|||
164678735|NCT01647828|594848029|FG002|Overall Study|Withdrawal by Subject|0|||
164678736|NCT01647828|594848030|FG003|Overall Study|Withdrawal by Subject|1|||
164678737|NCT01647828|594848031|FG004|Overall Study|Withdrawal by Subject|0|||
164678738|NCT01647828|594848032|FG005|Overall Study|Withdrawal by Subject|0|||
164678739|NCT01647828|594848033|FG006|Overall Study|Withdrawal by Subject|1|||
164678740|NCT01647828|594848034|FG007|Overall Study|Withdrawal by Subject|0|||
164678741|NCT01647828|594848035|FG008|Overall Study|Withdrawal by Subject|2|||
164678742|NCT01647828|594848027|FG000|Overall Study|Study terminated by Sponsor|0|||
164678743|NCT01647828|594848028|FG001|Overall Study|Study terminated by Sponsor|0|||
164678744|NCT01647828|594848029|FG002|Overall Study|Study terminated by Sponsor|0|||
164678745|NCT01647828|594848030|FG003|Overall Study|Study terminated by Sponsor|0|||
164336961|NCT01786148|593609837|FG000|Overall Study|Lost to Follow-up|21|||
164336962|NCT01786148|593609838|FG001|Overall Study|Lost to Follow-up|13|||
164336963|NCT01786148|593609837|FG000|Overall Study|Death|0|||
164336964|NCT01786148|593609838|FG001|Overall Study|Death|1|||
164336965|NCT01786148|593609837|FG000|Overall Study|Withdrawal by Subject|0|||
164336966|NCT01786148|593609838|FG001|Overall Study|Withdrawal by Subject|7|||
164336967|NCT01786148|593609837|FG000|Overall Study|Incarceration|1|||
164336968|NCT01786148|593609838|FG001|Overall Study|Incarceration|1|||
164336969|NCT00338104|593609839|FG000|Overall Study|Protocol Violation|2|||
164336970|NCT00338104|593609840|FG001|Overall Study|Protocol Violation|1|||
164336971|NCT00338104|593609841|FG002|Overall Study|Protocol Violation|3|||
164336972|NCT02362269|593609844|FG000|Overall Study|Moved|1|||
164336973|NCT02362269|593609845|FG001|Overall Study|Moved|0|||
164336974|NCT02362269|593609844|FG000|Overall Study|Lost to Follow-up|0|||
164336975|NCT02362269|593609845|FG001|Overall Study|Lost to Follow-up|6|||
164336976|NCT02349542|593609846|FG000|Overall Study|Withdrawal by Subject|5|||
164336977|NCT03841448|593609849|FG000|Double-blind Treatment (DBT) Period|Death|1|||
164336978|NCT03841448|593609850|FG001|Double-blind Treatment (DBT) Period|Death|1|||
164336979|NCT03841448|593609851|FG002|Double-blind Treatment (DBT) Period|Death|0|||
164336980|NCT03841448|593609852|FG003|Double-blind Treatment (DBT) Period|Death|0|||
164336981|NCT03841448|593609849|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
164336982|NCT03841448|593609850|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
164336983|NCT03841448|593609851|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
164336984|NCT03841448|593609852|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
164336985|NCT03841448|593609849|FG000|Open-Label Extension (OLE) Period|Death|0|||
164336986|NCT03841448|593609850|FG001|Open-Label Extension (OLE) Period|Death|0|||
164336987|NCT03841448|593609851|FG002|Open-Label Extension (OLE) Period|Death|0|||
164336988|NCT03841448|593609852|FG003|Open-Label Extension (OLE) Period|Death|1|||
164678746|NCT01647828|594848031|FG004|Overall Study|Study terminated by Sponsor|0|||
164678747|NCT01647828|594848032|FG005|Overall Study|Study terminated by Sponsor|0|||
164678748|NCT01647828|594848033|FG006|Overall Study|Study terminated by Sponsor|1|||
164678749|NCT01647828|594848034|FG007|Overall Study|Study terminated by Sponsor|26|||
164244072|NCT02891226|593262097|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244073|NCT02891226|593262098|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244074|NCT02891226|593262099|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244075|NCT02891226|593262100|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244076|NCT02891226|593262101|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244077|NCT02891226|593262102|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244078|NCT02891226|593262103|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244079|NCT02891226|593262104|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244080|NCT02891226|593262105|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244081|NCT02891226|593262106|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244082|NCT02891226|593262107|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
164244083|NCT02891226|593262108|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244084|NCT02891226|593262109|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244085|NCT02891226|593262110|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244086|NCT02891226|593262111|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244087|NCT02891226|593262112|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244088|NCT02891226|593262097|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244089|NCT02891226|593262098|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244090|NCT02891226|593262099|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244091|NCT02891226|593262100|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244092|NCT02891226|593262101|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244093|NCT02891226|593262102|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244094|NCT02891226|593262103|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244095|NCT02891226|593262104|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244096|NCT02891226|593262105|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244097|NCT02891226|593262106|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244098|NCT02891226|593262107|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
164244099|NCT02891226|593262108|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244100|NCT02891226|593262109|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244101|NCT02891226|593262110|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244102|NCT02891226|593262111|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244103|NCT02891226|593262112|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244104|NCT02891226|593262097|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244105|NCT02891226|593262098|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244106|NCT02891226|593262099|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244107|NCT02891226|593262100|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244108|NCT02891226|593262101|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244109|NCT02891226|593262102|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244110|NCT02891226|593262103|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244111|NCT02891226|593262104|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244112|NCT02891226|593262105|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244113|NCT02891226|593262106|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244114|NCT02891226|593262107|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
164244115|NCT02891226|593262108|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244116|NCT02891226|593262109|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244117|NCT02891226|593262110|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244118|NCT02891226|593262111|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244119|NCT02891226|593262112|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244120|NCT02891226|593262097|FG000|Follow-up Period|Withdrawal by Subject|0|||
164244121|NCT02891226|593262098|FG001|Follow-up Period|Withdrawal by Subject|0|||
164244122|NCT02891226|593262099|FG002|Follow-up Period|Withdrawal by Subject|0|||
164244123|NCT02891226|593262100|FG003|Follow-up Period|Withdrawal by Subject|0|||
164244124|NCT02891226|593262101|FG004|Follow-up Period|Withdrawal by Subject|0|||
164244125|NCT02891226|593262102|FG005|Follow-up Period|Withdrawal by Subject|0|||
164244126|NCT02891226|593262103|FG006|Follow-up Period|Withdrawal by Subject|0|||
164244127|NCT02891226|593262104|FG007|Follow-up Period|Withdrawal by Subject|0|||
164244128|NCT02891226|593262105|FG008|Follow-up Period|Withdrawal by Subject|0|||
164244129|NCT02891226|593262106|FG009|Follow-up Period|Withdrawal by Subject|0|||
164336989|NCT03841448|593609849|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
164336990|NCT03841448|593609850|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
164336991|NCT03841448|593609851|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
164336992|NCT03841448|593609852|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
164244130|NCT02891226|593262107|FG010|Follow-up Period|Withdrawal by Subject|0|||
164244131|NCT02891226|593262108|FG011|Follow-up Period|Withdrawal by Subject|1|||
164244132|NCT02891226|593262109|FG012|Follow-up Period|Withdrawal by Subject|0|||
164244133|NCT02891226|593262110|FG013|Follow-up Period|Withdrawal by Subject|0|||
164244134|NCT02891226|593262111|FG014|Follow-up Period|Withdrawal by Subject|1|||
164244135|NCT02891226|593262112|FG015|Follow-up Period|Withdrawal by Subject|1|||
164244136|NCT01445847|593262115|FG000|Overall Study|Protocol Violation|13|||
164244137|NCT01445847|593262116|FG001|Overall Study|Protocol Violation|14|||
164244138|NCT01445847|593262115|FG000|Overall Study|Missed Data|1|||
164244139|NCT01445847|593262116|FG001|Overall Study|Missed Data|0|||
164244140|NCT04570384|593262117|FG000|Overall Study|Adverse Event|2|||
164244141|NCT04570384|593262118|FG001|Overall Study|Adverse Event|1|||
164244142|NCT04570384|593262117|FG000|Overall Study|Death|2|||
164244143|NCT04570384|593262118|FG001|Overall Study|Death|5|||
164244144|NCT04570384|593262117|FG000|Overall Study|Lost to Follow-up|1|||
164244145|NCT04570384|593262118|FG001|Overall Study|Lost to Follow-up|0|||
164244146|NCT04570384|593262117|FG000|Overall Study|Other|1|||
164244147|NCT04570384|593262118|FG001|Overall Study|Other|0|||
164244148|NCT04570384|593262117|FG000|Overall Study|Protocol Violation|0|||
164244149|NCT04570384|593262118|FG001|Overall Study|Protocol Violation|1|||
164244150|NCT04570384|593262117|FG000|Overall Study|Sponsor Decision|1|||
164244151|NCT04570384|593262118|FG001|Overall Study|Sponsor Decision|0|||
164244152|NCT04570384|593262117|FG000|Overall Study|Withdrawal by Subject|4|||
164244153|NCT04570384|593262118|FG001|Overall Study|Withdrawal by Subject|2|||
164244154|NCT03654274|593262119|FG000|Overall Study|Adverse Event|19|||
164244155|NCT03654274|593262120|FG001|Overall Study|Adverse Event|23|||
164244156|NCT03654274|593262121|FG002|Overall Study|Adverse Event|24|||
164244157|NCT03654274|593262119|FG000|Overall Study|Protocol Deviation|0|||
164244158|NCT03654274|593262120|FG001|Overall Study|Protocol Deviation|2|||
164244159|NCT03654274|593262121|FG002|Overall Study|Protocol Deviation|0|||
164244160|NCT03654274|593262119|FG000|Overall Study|Lost to Follow-up|8|||
164244161|NCT03654274|593262120|FG001|Overall Study|Lost to Follow-up|6|||
164244162|NCT03654274|593262121|FG002|Overall Study|Lost to Follow-up|5|||
164244163|NCT03654274|593262119|FG000|Overall Study|Withdrawal by Subject|46|||
164244164|NCT03654274|593262120|FG001|Overall Study|Withdrawal by Subject|25|||
164244165|NCT03654274|593262121|FG002|Overall Study|Withdrawal by Subject|33|||
164244166|NCT03654274|593262119|FG000|Overall Study|Lack of Efficacy|4|||
164244167|NCT03654274|593262120|FG001|Overall Study|Lack of Efficacy|5|||
164244168|NCT03654274|593262121|FG002|Overall Study|Lack of Efficacy|7|||
164244169|NCT03654274|593262119|FG000|Overall Study|Pregnancy|2|||
164244170|NCT03654274|593262120|FG001|Overall Study|Pregnancy|2|||
164244171|NCT03654274|593262121|FG002|Overall Study|Pregnancy|1|||
164244172|NCT03654274|593262119|FG000|Overall Study|Other|27|||
164244173|NCT03654274|593262120|FG001|Overall Study|Other|29|||
164244174|NCT03654274|593262121|FG002|Overall Study|Other|32|||
164244175|NCT03654274|593262119|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
164244176|NCT03654274|593262120|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
164244177|NCT03654274|593262121|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
164244178|NCT02454530|593262122|FG000|Overall Study|Other|8|||
164244179|NCT02454530|593262123|FG001|Overall Study|Other|13|||
164244180|NCT02454530|593262122|FG000|Overall Study|Missing information|56|||
164244181|NCT02454530|593262123|FG001|Overall Study|Missing information|69|||
164244182|NCT02454530|593262122|FG000|Overall Study|Death|2|||
164244183|NCT02454530|593262123|FG001|Overall Study|Death|41|||
164244184|NCT02454530|593262122|FG000|Overall Study|Lost to Follow-up|4|||
164244185|NCT02454530|593262123|FG001|Overall Study|Lost to Follow-up|4|||
164244186|NCT00326001|593262124|FG000|Overall Study|Adverse Event|4|||
164244187|NCT00326001|593262125|FG001|Overall Study|Adverse Event|5|||
164244188|NCT00326001|593262124|FG000|Overall Study|Physician Decision|3|||
164244189|NCT00326001|593262125|FG001|Overall Study|Physician Decision|3|||
164244190|NCT03265145|593262126|FG000|Overall Study|Protocol Violation|2|||
164244191|NCT03265145|593262127|FG001|Overall Study|Protocol Violation|0|||
164244192|NCT03265145|593262126|FG000|Overall Study|Adverse Event|1|||
164244193|NCT03265145|593262127|FG001|Overall Study|Adverse Event|0|||
164244194|NCT03265145|593262126|FG000|Overall Study|Withdrawal by Subject|23|||
164244195|NCT03265145|593262127|FG001|Overall Study|Withdrawal by Subject|19|||
164244196|NCT03265145|593262126|FG000|Overall Study|Death|12|||
164244197|NCT03265145|593262127|FG001|Overall Study|Death|12|||
164244198|NCT03265145|593262126|FG000|Overall Study|Lost to Follow-up|13|||
164244199|NCT03265145|593262127|FG001|Overall Study|Lost to Follow-up|9|||
164244200|NCT03265145|593262126|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
164244201|NCT03265145|593262127|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
164244202|NCT03265145|593262126|FG000|Overall Study|Switched back to previous medication|1|||
164244203|NCT03265145|593262127|FG001|Overall Study|Switched back to previous medication|0|||
164244204|NCT03265145|593262126|FG000|Overall Study|Did not want to take medication|1|||
164244205|NCT03265145|593262127|FG001|Overall Study|Did not want to take medication|0|||
164244206|NCT03265145|593262126|FG000|Overall Study|Subject could not afford medication|0|||
164244207|NCT03265145|593262127|FG001|Overall Study|Subject could not afford medication|1|||
164678750|NCT01647828|594848035|FG008|Overall Study|Study terminated by Sponsor|16|||
164678751|NCT01647828|594848027|FG000|Overall Study|Lost to Follow-up|0|||
164678752|NCT01647828|594848028|FG001|Overall Study|Lost to Follow-up|0|||
164678753|NCT01647828|594848029|FG002|Overall Study|Lost to Follow-up|0|||
164678754|NCT01647828|594848030|FG003|Overall Study|Lost to Follow-up|0|||
164678755|NCT01647828|594848031|FG004|Overall Study|Lost to Follow-up|0|||
164678756|NCT01647828|594848032|FG005|Overall Study|Lost to Follow-up|0|||
164678757|NCT01647828|594848033|FG006|Overall Study|Lost to Follow-up|0|||
164244208|NCT03265145|593262126|FG000|Overall Study|Site closed|2|||
164244209|NCT03265145|593262127|FG001|Overall Study|Site closed|3|||
164244210|NCT03265145|593262126|FG000|Overall Study|Incorrectly randomized|16|||
164244211|NCT03265145|593262127|FG001|Overall Study|Incorrectly randomized|6|||
164244212|NCT03265145|593262126|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
164244213|NCT03265145|593262127|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
164244214|NCT03265145|593262126|FG000|Overall Study|Physician Decision|0|||
164244215|NCT03265145|593262127|FG001|Overall Study|Physician Decision|3|||
164244216|NCT03265145|593262126|FG000|Overall Study|Subject transferred to another facility|0|||
164244217|NCT03265145|593262127|FG001|Overall Study|Subject transferred to another facility|1|||
164244218|NCT03640325|593263808|FG000|Overall Study|Withdrawal by Subject|4|||
164244219|NCT03640325|593263809|FG001|Overall Study|Withdrawal by Subject|1|||
164244220|NCT03640325|593263810|FG002|Overall Study|Withdrawal by Subject|0|||
164244221|NCT03640325|593263808|FG000|Overall Study|Lost to Follow-up|4|||
164244222|NCT03640325|593263809|FG001|Overall Study|Lost to Follow-up|5|||
164244223|NCT03640325|593263810|FG002|Overall Study|Lost to Follow-up|21|||
164244224|NCT03640325|593263808|FG000|Overall Study|Death|5|||
164244225|NCT03640325|593263809|FG001|Overall Study|Death|5|||
164244226|NCT03640325|593263810|FG002|Overall Study|Death|0|||
164244227|NCT01566149|593263813|FG000|Overall Study|Adverse Event|0|||
164244228|NCT01566149|593263814|FG001|Overall Study|Adverse Event|1|||
164244229|NCT01566149|593263813|FG000|Overall Study|Non-compliance with study medication|2|||
164244230|NCT01566149|593263814|FG001|Overall Study|Non-compliance with study medication|0|||
164244231|NCT01566149|593263813|FG000|Overall Study|Protocol Violation|0|||
164244232|NCT01566149|593263814|FG001|Overall Study|Protocol Violation|1|||
164244233|NCT01566149|593263813|FG000|Overall Study|Withdrawal by Subject|1|||
164244234|NCT01566149|593263814|FG001|Overall Study|Withdrawal by Subject|0|||
164244235|NCT03687957|593263816|FG000|Overall Study|Withdrawal by Subject|0|||
164244236|NCT03687957|593263817|FG001|Overall Study|Withdrawal by Subject|0|||
164244237|NCT03687957|593263818|FG002|Overall Study|Withdrawal by Subject|0|||
164244238|NCT03687957|593263819|FG003|Overall Study|Withdrawal by Subject|2|||
164244239|NCT03687957|593263820|FG004|Overall Study|Withdrawal by Subject|0|||
164244240|NCT03687957|593263821|FG005|Overall Study|Withdrawal by Subject|0|||
164244241|NCT03687957|593263822|FG006|Overall Study|Withdrawal by Subject|3|||
164244242|NCT03687957|593263823|FG007|Overall Study|Withdrawal by Subject|1|||
164244243|NCT03687957|593263824|FG008|Overall Study|Withdrawal by Subject|1|||
164244244|NCT03687957|593263825|FG009|Overall Study|Withdrawal by Subject|0|||
164678758|NCT01647828|594848034|FG007|Overall Study|Lost to Follow-up|2|||
164244245|NCT03687957|593263816|FG000|Overall Study|Disease progression|0|||
164244246|NCT03687957|593263817|FG001|Overall Study|Disease progression|1|||
164244247|NCT03687957|593263818|FG002|Overall Study|Disease progression|1|||
164244248|NCT03687957|593263819|FG003|Overall Study|Disease progression|2|||
164244249|NCT03687957|593263820|FG004|Overall Study|Disease progression|2|||
164244250|NCT03687957|593263821|FG005|Overall Study|Disease progression|0|||
164244251|NCT03687957|593263822|FG006|Overall Study|Disease progression|2|||
164244252|NCT03687957|593263823|FG007|Overall Study|Disease progression|1|||
164244253|NCT03687957|593263824|FG008|Overall Study|Disease progression|0|||
164244254|NCT03687957|593263825|FG009|Overall Study|Disease progression|0|||
164244255|NCT03687957|593263816|FG000|Overall Study|Physician Decision|0|||
164244256|NCT03687957|593263817|FG001|Overall Study|Physician Decision|0|||
164244257|NCT03687957|593263818|FG002|Overall Study|Physician Decision|0|||
164244258|NCT03687957|593263819|FG003|Overall Study|Physician Decision|2|||
164244259|NCT03687957|593263820|FG004|Overall Study|Physician Decision|1|||
164244260|NCT03687957|593263821|FG005|Overall Study|Physician Decision|0|||
164244261|NCT03687957|593263822|FG006|Overall Study|Physician Decision|1|||
164244262|NCT03687957|593263823|FG007|Overall Study|Physician Decision|0|||
164244263|NCT03687957|593263824|FG008|Overall Study|Physician Decision|0|||
164244264|NCT03687957|593263825|FG009|Overall Study|Physician Decision|0|||
164244265|NCT03687957|593263816|FG000|Overall Study|New malignancy|0|||
164244266|NCT03687957|593263817|FG001|Overall Study|New malignancy|0|||
164244267|NCT03687957|593263818|FG002|Overall Study|New malignancy|0|||
164244268|NCT03687957|593263819|FG003|Overall Study|New malignancy|0|||
164244269|NCT03687957|593263820|FG004|Overall Study|New malignancy|1|||
164244270|NCT03687957|593263821|FG005|Overall Study|New malignancy|0|||
164678759|NCT01647828|594848035|FG008|Overall Study|Lost to Follow-up|0|||
164244271|NCT03687957|593263822|FG006|Overall Study|New malignancy|0|||
164244272|NCT03687957|593263823|FG007|Overall Study|New malignancy|0|||
164244273|NCT03687957|593263824|FG008|Overall Study|New malignancy|0|||
164244274|NCT03687957|593263825|FG009|Overall Study|New malignancy|0|||
164244275|NCT03687957|593263816|FG000|Overall Study|Adverse Event|0|||
164244276|NCT03687957|593263817|FG001|Overall Study|Adverse Event|0|||
164244277|NCT03687957|593263818|FG002|Overall Study|Adverse Event|0|||
164244278|NCT03687957|593263819|FG003|Overall Study|Adverse Event|0|||
164244279|NCT03687957|593263820|FG004|Overall Study|Adverse Event|0|||
164244280|NCT03687957|593263821|FG005|Overall Study|Adverse Event|2|||
164244281|NCT03687957|593263822|FG006|Overall Study|Adverse Event|0|||
164244282|NCT03687957|593263823|FG007|Overall Study|Adverse Event|3|||
164244283|NCT03687957|593263824|FG008|Overall Study|Adverse Event|0|||
164244284|NCT03687957|593263825|FG009|Overall Study|Adverse Event|0|||
164244285|NCT03687957|593263816|FG000|Overall Study|Patient went on hospice|0|||
164244286|NCT03687957|593263817|FG001|Overall Study|Patient went on hospice|0|||
164244287|NCT03687957|593263818|FG002|Overall Study|Patient went on hospice|0|||
164244288|NCT03687957|593263819|FG003|Overall Study|Patient went on hospice|0|||
164244289|NCT03687957|593263820|FG004|Overall Study|Patient went on hospice|0|||
164244290|NCT03687957|593263821|FG005|Overall Study|Patient went on hospice|0|||
164244291|NCT03687957|593263822|FG006|Overall Study|Patient went on hospice|1|||
164244292|NCT03687957|593263823|FG007|Overall Study|Patient went on hospice|0|||
164244293|NCT03687957|593263824|FG008|Overall Study|Patient went on hospice|0|||
164244294|NCT03687957|593263825|FG009|Overall Study|Patient went on hospice|0|||
164244295|NCT03687957|593263816|FG000|Overall Study|Death|0|||
164244296|NCT03687957|593263817|FG001|Overall Study|Death|0|||
164244297|NCT03687957|593263818|FG002|Overall Study|Death|0|||
164244298|NCT03687957|593263819|FG003|Overall Study|Death|0|||
164244299|NCT03687957|593263820|FG004|Overall Study|Death|0|||
164244300|NCT03687957|593263821|FG005|Overall Study|Death|0|||
164244301|NCT03687957|593263822|FG006|Overall Study|Death|0|||
164244302|NCT03687957|593263823|FG007|Overall Study|Death|1|||
164244303|NCT03687957|593263824|FG008|Overall Study|Death|0|||
164244304|NCT03687957|593263825|FG009|Overall Study|Death|0|||
164244305|NCT03718325|593263826|FG000|Overall Study|Externalized leads were removed independent of the research protocol|2|||
164244306|NCT03718325|593263827|FG001|Overall Study|Externalized leads were removed independent of the research protocol|0|||
164244307|NCT03718325|593263828|FG002|Overall Study|Externalized leads were removed independent of the research protocol|0|||
164244308|NCT03718325|593263826|FG000|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|1|||
164244309|NCT03718325|593263827|FG001|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
164244310|NCT03718325|593263828|FG002|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
164244311|NCT02197572|593263829|FG000|Overall Study|Progressive Disease|28|||
164244312|NCT02197572|593263829|FG000|Overall Study|Withdrawal by Subject|9|||
164244313|NCT02197572|593263829|FG000|Overall Study|Adverse Event|3|||
164244314|NCT02197572|593263829|FG000|Overall Study|Reason Not Specified|4|||
164244315|NCT02383862|593263834|FG000|3 Month Follow up|Lost to Follow-up|23|||
164244316|NCT02383862|593263835|FG001|3 Month Follow up|Lost to Follow-up|21|||
164244317|NCT02630693|593263838|FG000|Overall Study|No receive treatment|0|||
164244318|NCT02630693|593263839|FG001|Overall Study|No receive treatment|1|||
164244319|NCT03801928|593263840|FG000|Overall Study|Adverse Event|1|||
164244320|NCT03801928|593263841|FG001|Overall Study|Adverse Event|0|||
164244321|NCT03801928|593263842|FG002|Overall Study|Adverse Event|1|||
164244322|NCT03801928|593263843|FG003|Overall Study|Adverse Event|2|||
164244323|NCT03801928|593263844|FG004|Overall Study|Adverse Event|0|||
164244324|NCT03801928|593263845|FG005|Overall Study|Adverse Event|2|||
164244325|NCT03801928|593263840|FG000|Overall Study|Lack of Efficacy|0|||
164244326|NCT03801928|593263841|FG001|Overall Study|Lack of Efficacy|0|||
164244327|NCT03801928|593263842|FG002|Overall Study|Lack of Efficacy|1|||
164244328|NCT03801928|593263843|FG003|Overall Study|Lack of Efficacy|0|||
164244329|NCT03801928|593263844|FG004|Overall Study|Lack of Efficacy|0|||
164244330|NCT03801928|593263845|FG005|Overall Study|Lack of Efficacy|0|||
164244331|NCT03801928|593263840|FG000|Overall Study|Lost to Follow-up|5|||
164244332|NCT03801928|593263841|FG001|Overall Study|Lost to Follow-up|1|||
164244333|NCT03801928|593263842|FG002|Overall Study|Lost to Follow-up|1|||
164244334|NCT03801928|593263843|FG003|Overall Study|Lost to Follow-up|4|||
164244335|NCT03801928|593263844|FG004|Overall Study|Lost to Follow-up|4|||
164244336|NCT03801928|593263845|FG005|Overall Study|Lost to Follow-up|2|||
164244337|NCT03801928|593263840|FG000|Overall Study|Withdrawal by Subject|0|||
164244338|NCT03801928|593263841|FG001|Overall Study|Withdrawal by Subject|0|||
164244339|NCT03801928|593263842|FG002|Overall Study|Withdrawal by Subject|2|||
164244340|NCT03801928|593263843|FG003|Overall Study|Withdrawal by Subject|1|||
164244341|NCT03801928|593263844|FG004|Overall Study|Withdrawal by Subject|0|||
164244342|NCT03801928|593263845|FG005|Overall Study|Withdrawal by Subject|0|||
164244343|NCT03801928|593263840|FG000|Overall Study|Other|0|||
164244344|NCT03801928|593263841|FG001|Overall Study|Other|2|||
164244345|NCT03801928|593263842|FG002|Overall Study|Other|0|||
164244346|NCT03801928|593263843|FG003|Overall Study|Other|1|||
164244347|NCT03801928|593263844|FG004|Overall Study|Other|0|||
164244348|NCT03801928|593263845|FG005|Overall Study|Other|1|||
164244349|NCT02763059|593263846|FG000|Overall Study|Lost to Follow-up|4|||
164244350|NCT02763059|593263847|FG001|Overall Study|Lost to Follow-up|1|||
164244351|NCT02763059|593263848|FG002|Overall Study|Lost to Follow-up|6|||
164244352|NCT02763059|593263846|FG000|Overall Study|Withdrawal by Subject|1|||
164244353|NCT02763059|593263847|FG001|Overall Study|Withdrawal by Subject|0|||
164244354|NCT02763059|593263848|FG002|Overall Study|Withdrawal by Subject|3|||
164244355|NCT01724216|593263849|FG000|Overall Study|Scan was not completed|1|||
164244356|NCT00175916|593263850|FG000|Overall Study|Death|19|||
164244357|NCT00175916|593263850|FG000|Overall Study|Adverse Event|81|||
164244358|NCT00175916|593263850|FG000|Overall Study|Lack of Efficacy|354|||
164244359|NCT00175916|593263850|FG000|Overall Study|Lost to Follow-up|17|||
164244360|NCT00175916|593263850|FG000|Overall Study|Subject Choice|98|||
164244361|NCT00175916|593263850|FG000|Overall Study|Lack of compliance|8|||
164244362|NCT00175916|593263850|FG000|Overall Study|Patient cannot record seizures|1|||
164244363|NCT00175916|593263850|FG000|Overall Study|Sponsor decision|17|||
164244364|NCT00175916|593263850|FG000|Overall Study|Vigabatrin intake|1|||
164244365|NCT00175916|593263850|FG000|Overall Study|Suicidal behaviour|1|||
164244366|NCT00175916|593263850|FG000|Overall Study|Withdrawal by Subject|1|||
164244367|NCT00175916|593263850|FG000|Overall Study|Seizure - free|4|||
164244368|NCT00175916|593263850|FG000|Overall Study|Administrative reason|1|||
164244369|NCT00175916|593263850|FG000|Overall Study|Pregnancy|1|||
164244370|NCT00175916|593263850|FG000|Overall Study|Patient's request|2|||
164244371|NCT00175916|593263850|FG000|Overall Study|Treating physiciant's choice|1|||
164244372|NCT00175916|593263850|FG000|Overall Study|Moved overseas|1|||
164244373|NCT00175916|593263850|FG000|Overall Study|Loss of job and economic burden|1|||
164244374|NCT00175916|593263850|FG000|Overall Study|Site was closed|9|||
164244375|NCT00175916|593263850|FG000|Overall Study|Patient went to prison|1|||
164244376|NCT01456130|593263852|FG000|Overall Study|Adverse Event|4|||
164244377|NCT01456130|593263852|FG000|Overall Study|Voluntary Withdrawal|1|||
164244378|NCT01456130|593263852|FG000|Overall Study|Lack of Efficacy|4|||
164244379|NCT01456130|593263852|FG000|Overall Study|Other|1|||
164244380|NCT03369665|593263857|FG000|Overall Study|Adverse Event|3|||
164244381|NCT03369665|593263857|FG000|Overall Study|Lost to Follow-up|7|||
164244382|NCT03369665|593263857|FG000|Overall Study|Withdrawal by Subject|15|||
164244383|NCT03369665|593263857|FG000|Overall Study|Progression Disease|2|||
164244384|NCT03369665|593263857|FG000|Overall Study|Not classified|3|||
164244385|NCT03230318|593263858|FG000|Overall Study|Radiographic disease progression|72|||
164244386|NCT03230318|593263859|FG001|Overall Study|Radiographic disease progression|19|||
164244387|NCT03230318|593263858|FG000|Overall Study|Clinical progression|17|||
164244388|NCT03230318|593263859|FG001|Overall Study|Clinical progression|7|||
164244389|NCT03230318|593263858|FG000|Overall Study|Adverse Event|5|||
164244390|NCT03230318|593263859|FG001|Overall Study|Adverse Event|3|||
164244391|NCT03230318|593263858|FG000|Overall Study|Physician Decision|2|||
164244392|NCT03230318|593263859|FG001|Overall Study|Physician Decision|3|||
164244393|NCT03230318|593263858|FG000|Overall Study|Death|3|||
164244394|NCT03230318|593263859|FG001|Overall Study|Death|2|||
164244395|NCT03230318|593263858|FG000|Overall Study|Lost to Follow-up|1|||
164244396|NCT03230318|593263859|FG001|Overall Study|Lost to Follow-up|0|||
164244397|NCT03230318|593263858|FG000|Overall Study|Withdrawal by Subject|1|||
164244398|NCT03230318|593263859|FG001|Overall Study|Withdrawal by Subject|3|||
164574399|NCT02537678|594465631|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
164244399|NCT03230318|593263858|FG000|Overall Study|Other|3|||
164244400|NCT03230318|593263859|FG001|Overall Study|Other|7|||
164244401|NCT00075764|593263863|FG000|Overall Study|Adverse Event|5|||
164244402|NCT00075764|593263864|FG001|Overall Study|Adverse Event|12|||
164244403|NCT00075764|593263863|FG000|Overall Study|Death|4|||
164244404|NCT00075764|593263864|FG001|Overall Study|Death|8|||
164244405|NCT00075764|593263863|FG000|Overall Study|Withdrawal by Subject|28|||
164244406|NCT00075764|593263864|FG001|Overall Study|Withdrawal by Subject|18|||
164244407|NCT00075764|593263863|FG000|Overall Study|Progression|269|||
164244408|NCT00075764|593263864|FG001|Overall Study|Progression|274|||
164244409|NCT00075764|593263863|FG000|Overall Study|Still on treatment|8|||
164244410|NCT00075764|593263864|FG001|Overall Study|Still on treatment|15|||
164244411|NCT00075764|593263863|FG000|Overall Study|Delinquent|4|||
164244412|NCT00075764|593263864|FG001|Overall Study|Delinquent|2|||
164244413|NCT00075764|593263863|FG000|Overall Study|Not protocol specified|27|||
164244414|NCT00075764|593263864|FG001|Overall Study|Not protocol specified|19|||
164244415|NCT00075764|593263863|FG000|Overall Study|Under review|0|||
164244416|NCT00075764|593263864|FG001|Overall Study|Under review|1|||
164244417|NCT01057693|593263866|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
164244418|NCT01057693|593263867|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
164244419|NCT01057693|593263868|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
164244420|NCT01057693|593263866|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
164244421|NCT01057693|593263867|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
164244422|NCT01057693|593263868|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
164244423|NCT01057693|593263866|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
164336993|NCT03841448|593609849|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
164336994|NCT03841448|593609850|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
164336995|NCT03841448|593609851|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
164336996|NCT03841448|593609852|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
164336997|NCT03841448|593609849|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
164336998|NCT03841448|593609850|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
164336999|NCT03841448|593609851|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
164337000|NCT03841448|593609852|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
164337001|NCT03896165|593609853|FG000|Overall Study|Withdrawal by Subject|2|||
164337002|NCT01163266|593609854|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
164337003|NCT01163266|593609855|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
164337004|NCT01163266|593609856|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
164337005|NCT01163266|593609854|FG000|Overall Study|Lack of Efficacy|1|||
164337006|NCT01163266|593609855|FG001|Overall Study|Lack of Efficacy|3|||
164337007|NCT01163266|593609856|FG002|Overall Study|Lack of Efficacy|1|||
164337008|NCT01163266|593609854|FG000|Overall Study|Noncompliance with Study Drug|0|||
164337009|NCT01163266|593609855|FG001|Overall Study|Noncompliance with Study Drug|2|||
164337010|NCT01163266|593609856|FG002|Overall Study|Noncompliance with Study Drug|0|||
164337011|NCT01163266|593609854|FG000|Overall Study|Protocol Deviations|2|||
164337012|NCT01163266|593609855|FG001|Overall Study|Protocol Deviations|2|||
164337013|NCT01163266|593609856|FG002|Overall Study|Protocol Deviations|5|||
164337014|NCT01163266|593609854|FG000|Overall Study|Withdrawal of Consent|5|||
164337015|NCT01163266|593609855|FG001|Overall Study|Withdrawal of Consent|7|||
164337016|NCT01163266|593609856|FG002|Overall Study|Withdrawal of Consent|3|||
164337017|NCT01163266|593609854|FG000|Overall Study|Lost to Follow-up|7|||
164337018|NCT01163266|593609855|FG001|Overall Study|Lost to Follow-up|7|||
164337019|NCT01163266|593609856|FG002|Overall Study|Lost to Follow-up|10|||
164337020|NCT01163266|593609854|FG000|Overall Study|Other|1|||
164337021|NCT01163266|593609855|FG001|Overall Study|Other|1|||
164337022|NCT01163266|593609856|FG002|Overall Study|Other|2|||
164337023|NCT02919696|593609857|FG000|Overall Study|Adverse Event|1|||
164337024|NCT02919696|593609858|FG001|Overall Study|Adverse Event|2|||
164337025|NCT02919696|593609857|FG000|Overall Study|Withdrawal by Subject|2|||
164337026|NCT02919696|593609858|FG001|Overall Study|Withdrawal by Subject|1|||
164337027|NCT02919696|593609857|FG000|Overall Study|Sponsor Decision|1|||
164337028|NCT02919696|593609858|FG001|Overall Study|Sponsor Decision|1|||
164337029|NCT02919696|593609857|FG000|Overall Study|Never Treated|0|||
164337030|NCT02919696|593609858|FG001|Overall Study|Never Treated|1|||
164337031|NCT03181893|593609859|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
164337032|NCT03181893|593609860|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
164337033|NCT03181893|593609861|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
164337034|NCT03181893|593609862|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
164337035|NCT03181893|593609863|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
164337036|NCT03181893|593609864|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
164337037|NCT03181893|593609865|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
164337038|NCT03181893|593609866|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
164337039|NCT03181893|593609867|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
164337040|NCT03181893|593609868|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
164337041|NCT03181893|593609869|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
164337042|NCT03181893|593609859|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
164337043|NCT03181893|593609860|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
164337044|NCT03181893|593609861|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
164337045|NCT03181893|593609862|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
164337046|NCT03181893|593609863|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
164244424|NCT01057693|593263867|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
164244425|NCT01057693|593263868|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
164244426|NCT01057693|593263866|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
164244427|NCT01057693|593263867|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
164244428|NCT01057693|593263868|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
164337047|NCT03181893|593609864|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
164337048|NCT03181893|593609865|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
164337049|NCT03181893|593609866|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
164337050|NCT03181893|593609867|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
164337051|NCT03181893|593609868|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
164337052|NCT03181893|593609869|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
164337053|NCT03181893|593609859|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
164337054|NCT03181893|593609860|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
164337055|NCT03181893|593609861|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
164337056|NCT03181893|593609862|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
164337057|NCT03181893|593609863|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
164337058|NCT03181893|593609864|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
164337059|NCT03181893|593609865|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
164337060|NCT03181893|593609866|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
164337061|NCT03181893|593609867|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
164337062|NCT03181893|593609868|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
164337063|NCT03181893|593609869|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
164337064|NCT03181893|593609859|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
164337065|NCT03181893|593609860|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
164337066|NCT03181893|593609861|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
164337067|NCT03181893|593609862|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
164337068|NCT03181893|593609863|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
164337069|NCT03181893|593609864|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
164337070|NCT03181893|593609865|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
164337071|NCT03181893|593609866|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
164337072|NCT03181893|593609867|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
164337073|NCT03181893|593609868|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
164337074|NCT03181893|593609869|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
164337075|NCT03181893|593609859|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
164337076|NCT03181893|593609860|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
164337077|NCT03181893|593609861|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
164337078|NCT03181893|593609862|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
164337079|NCT03181893|593609863|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
164337080|NCT03181893|593609864|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
164337081|NCT03181893|593609865|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
164337082|NCT03181893|593609866|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
164337083|NCT03181893|593609867|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
164337084|NCT03181893|593609868|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
164337085|NCT03181893|593609869|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
164337086|NCT04128371|593609870|FG000|Overall Study|Lack of Efficacy|1|||
164337087|NCT04815031|593609872|FG000|Overall Study|No adverse event information (missing information)|33|||
164337088|NCT01361568|593609875|FG000|Overall Study|Adverse Event|0|||
164337089|NCT01361568|593609876|FG001|Overall Study|Adverse Event|0|||
164337090|NCT01361568|593609877|FG002|Overall Study|Adverse Event|0|||
164337091|NCT01361568|593609878|FG003|Overall Study|Adverse Event|0|||
164337092|NCT01361568|593609879|FG004|Overall Study|Adverse Event|1|||
164337093|NCT01361568|593609880|FG005|Overall Study|Adverse Event|0|||
164337094|NCT01361568|593609875|FG000|Overall Study|Physician Decision|0|||
164337095|NCT01361568|593609876|FG001|Overall Study|Physician Decision|0|||
164337096|NCT01361568|593609877|FG002|Overall Study|Physician Decision|0|||
164337097|NCT01361568|593609878|FG003|Overall Study|Physician Decision|0|||
164337098|NCT01361568|593609879|FG004|Overall Study|Physician Decision|0|||
164337099|NCT01361568|593609880|FG005|Overall Study|Physician Decision|1|||
164337100|NCT01361568|593609875|FG000|Overall Study|Withdrawal by Subject|2|||
164337101|NCT01361568|593609876|FG001|Overall Study|Withdrawal by Subject|1|||
164337102|NCT01361568|593609877|FG002|Overall Study|Withdrawal by Subject|0|||
164337103|NCT01361568|593609878|FG003|Overall Study|Withdrawal by Subject|0|||
164337104|NCT01361568|593609879|FG004|Overall Study|Withdrawal by Subject|0|||
164337105|NCT01361568|593609880|FG005|Overall Study|Withdrawal by Subject|1|||
164337106|NCT00484094|593609881|FG000|Overall Study|Discontinued|39|||
164337107|NCT00484094|593609881|FG000|Overall Study|Other|3|||
164574400|NCT02537678|594465632|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
164337108|NCT03594994|593609882|FG000|Overall Study|Adverse Event|1|||
164337109|NCT03594994|593609883|FG001|Overall Study|Adverse Event|0|||
164337110|NCT03594994|593609882|FG000|Overall Study|Withdrawal by Subject|0|||
164574401|NCT02537678|594465631|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
164574402|NCT02537678|594465632|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
164574403|NCT04348851|594465633|FG000|Post-Test 1|Withdrawal by Subject|0|||
164337111|NCT03594994|593609883|FG001|Overall Study|Withdrawal by Subject|1|||
164574404|NCT04348851|594465634|FG001|Post-Test 1|Withdrawal by Subject|1|||
164574405|NCT04348851|594465635|FG002|Post-Test 1|Withdrawal by Subject|0|||
164425853|NCT01670500|593930809|FG000|Overall Study|Withdrawal by Subject|1|||
164425854|NCT01670500|593930810|FG001|Overall Study|Withdrawal by Subject|0|||
164425855|NCT04955626|593930811|FG000|Blinded Period|Lost to Follow-up|28|||
164425856|NCT04955626|593930812|FG001|Blinded Period|Lost to Follow-up|28|||
164425857|NCT04955626|593930813|FG002|Blinded Period|Lost to Follow-up|7|||
164425858|NCT04955626|593930814|FG003|Blinded Period|Lost to Follow-up|14|||
164425859|NCT04955626|593930815|FG004|Blinded Period|Lost to Follow-up|3|||
164425860|NCT04955626|593930816|FG005|Blinded Period|Lost to Follow-up|2|||
164425861|NCT04955626|593930817|FG006|Blinded Period|Lost to Follow-up|6|||
164425862|NCT04955626|593930818|FG007|Blinded Period|Lost to Follow-up|4|||
164425863|NCT04955626|593930819|FG008|Blinded Period|Lost to Follow-up|5|||
164425864|NCT04955626|593930820|FG009|Blinded Period|Lost to Follow-up|8|||
164425865|NCT04955626|593930821|FG010|Blinded Period|Lost to Follow-up|10|||
164425866|NCT04955626|593930822|FG011|Blinded Period|Lost to Follow-up|32|||
164425867|NCT04955626|593930823|FG012|Blinded Period|Lost to Follow-up|0|||
164425868|NCT04955626|593930824|FG013|Blinded Period|Lost to Follow-up|0|||
164425869|NCT04955626|593930825|FG014|Blinded Period|Lost to Follow-up|0|||
164425870|NCT04955626|593930826|FG015|Blinded Period|Lost to Follow-up|12|||
164425871|NCT04955626|593930827|FG016|Blinded Period|Lost to Follow-up|2|||
164425872|NCT04955626|593930828|FG017|Blinded Period|Lost to Follow-up|5|||
164425873|NCT04955626|593930829|FG018|Blinded Period|Lost to Follow-up|0|||
164425874|NCT04955626|593930830|FG019|Blinded Period|Lost to Follow-up|0|||
164425875|NCT04955626|593930831|FG020|Blinded Period|Lost to Follow-up|0|||
164425876|NCT04955626|593930832|FG021|Blinded Period|Lost to Follow-up|0|||
164425877|NCT04955626|593930833|FG022|Blinded Period|Lost to Follow-up|0|||
164425878|NCT04955626|593930834|FG023|Blinded Period|Lost to Follow-up|0|||
164425879|NCT04955626|593930835|FG024|Blinded Period|Lost to Follow-up|3|||
164425880|NCT04955626|593930836|FG025|Blinded Period|Lost to Follow-up|1|||
164425881|NCT04955626|593930837|FG026|Blinded Period|Lost to Follow-up|2|||
164425882|NCT04955626|593930838|FG027|Blinded Period|Lost to Follow-up|2|||
164425883|NCT04955626|593930839|FG028|Blinded Period|Lost to Follow-up|2|||
164425884|NCT04955626|593930840|FG029|Blinded Period|Lost to Follow-up|0|||
164425885|NCT04955626|593930841|FG030|Blinded Period|Lost to Follow-up|0|||
164425886|NCT04955626|593930842|FG031|Blinded Period|Lost to Follow-up|0|||
164425887|NCT04955626|593930843|FG032|Blinded Period|Lost to Follow-up|0|||
164425888|NCT04955626|593930844|FG033|Blinded Period|Lost to Follow-up|0|||
164425889|NCT04955626|593930845|FG034|Blinded Period|Lost to Follow-up|0|||
164425890|NCT04955626|593930846|FG035|Blinded Period|Lost to Follow-up|0|||
164425891|NCT04955626|593930811|FG000|Blinded Period|Protocol Violation|5|||
164425892|NCT04955626|593930812|FG001|Blinded Period|Protocol Violation|14|||
164425893|NCT04955626|593930813|FG002|Blinded Period|Protocol Violation|0|||
164425894|NCT04955626|593930814|FG003|Blinded Period|Protocol Violation|1|||
164425895|NCT04955626|593930815|FG004|Blinded Period|Protocol Violation|2|||
164425896|NCT04955626|593930816|FG005|Blinded Period|Protocol Violation|2|||
164425897|NCT04955626|593930817|FG006|Blinded Period|Protocol Violation|0|||
164425898|NCT04955626|593930818|FG007|Blinded Period|Protocol Violation|0|||
164425899|NCT04955626|593930819|FG008|Blinded Period|Protocol Violation|0|||
164425900|NCT04955626|593930820|FG009|Blinded Period|Protocol Violation|4|||
164425901|NCT04955626|593930821|FG010|Blinded Period|Protocol Violation|6|||
164425902|NCT04955626|593930822|FG011|Blinded Period|Protocol Violation|1|||
164425903|NCT04955626|593930823|FG012|Blinded Period|Protocol Violation|0|||
164425904|NCT04955626|593930824|FG013|Blinded Period|Protocol Violation|0|||
164425905|NCT04955626|593930825|FG014|Blinded Period|Protocol Violation|2|||
164425906|NCT04955626|593930826|FG015|Blinded Period|Protocol Violation|6|||
164425907|NCT04955626|593930827|FG016|Blinded Period|Protocol Violation|4|||
164425908|NCT04955626|593930828|FG017|Blinded Period|Protocol Violation|6|||
164425909|NCT04955626|593930829|FG018|Blinded Period|Protocol Violation|0|||
164425910|NCT04955626|593930830|FG019|Blinded Period|Protocol Violation|1|||
164425911|NCT04955626|593930831|FG020|Blinded Period|Protocol Violation|0|||
164425912|NCT04955626|593930832|FG021|Blinded Period|Protocol Violation|1|||
164425913|NCT04955626|593930833|FG022|Blinded Period|Protocol Violation|0|||
164425914|NCT04955626|593930834|FG023|Blinded Period|Protocol Violation|0|||
164425915|NCT04955626|593930835|FG024|Blinded Period|Protocol Violation|4|||
164678760|NCT00115063|594848036|FG000|Overall Study|Lost to Follow-up|98|||
164678761|NCT00115063|594848037|FG001|Overall Study|Lost to Follow-up|104|||
164425916|NCT04955626|593930836|FG025|Blinded Period|Protocol Violation|6|||
164425917|NCT04955626|593930837|FG026|Blinded Period|Protocol Violation|5|||
164425918|NCT04955626|593930838|FG027|Blinded Period|Protocol Violation|3|||
164425919|NCT04955626|593930839|FG028|Blinded Period|Protocol Violation|4|||
164425920|NCT04955626|593930840|FG029|Blinded Period|Protocol Violation|3|||
164425921|NCT04955626|593930841|FG030|Blinded Period|Protocol Violation|0|||
164425922|NCT04955626|593930842|FG031|Blinded Period|Protocol Violation|0|||
164425923|NCT04955626|593930843|FG032|Blinded Period|Protocol Violation|0|||
164425924|NCT04955626|593930844|FG033|Blinded Period|Protocol Violation|0|||
164425925|NCT04955626|593930845|FG034|Blinded Period|Protocol Violation|0|||
164425926|NCT04955626|593930846|FG035|Blinded Period|Protocol Violation|0|||
164425927|NCT04955626|593930811|FG000|Blinded Period|Death|0|||
164425928|NCT04955626|593930812|FG001|Blinded Period|Death|2|||
164678762|NCT00115063|594848036|FG000|Overall Study|Death|1|||
164425929|NCT04955626|593930813|FG002|Blinded Period|Death|0|||
164425930|NCT04955626|593930814|FG003|Blinded Period|Death|0|||
164678763|NCT00115063|594848037|FG001|Overall Study|Death|0|||
164337112|NCT03308786|593609885|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
164337113|NCT00761631|593609886|FG000|Overall Study|Parent/legal guardian request|8|||
164337114|NCT00761631|593609887|FG001|Overall Study|Parent/legal guardian request|3|||
164337115|NCT00761631|593609888|FG002|Overall Study|Parent/legal guardian request|8|||
164337116|NCT00761631|593609889|FG003|Overall Study|Parent/legal guardian request|0|||
164337117|NCT00761631|593609890|FG004|Overall Study|Parent/legal guardian request|5|||
164337118|NCT00761631|593609891|FG005|Overall Study|Parent/legal guardian request|0|||
164337119|NCT00761631|593609886|FG000|Overall Study|Lost to Follow-up|2|||
164337120|NCT00761631|593609887|FG001|Overall Study|Lost to Follow-up|4|||
164337121|NCT00761631|593609888|FG002|Overall Study|Lost to Follow-up|7|||
164337122|NCT00761631|593609889|FG003|Overall Study|Lost to Follow-up|1|||
164337123|NCT00761631|593609890|FG004|Overall Study|Lost to Follow-up|6|||
164337124|NCT00761631|593609891|FG005|Overall Study|Lost to Follow-up|1|||
164337125|NCT00761631|593609886|FG000|Overall Study|Protocol Violation|2|||
164337126|NCT00761631|593609887|FG001|Overall Study|Protocol Violation|0|||
164337127|NCT00761631|593609888|FG002|Overall Study|Protocol Violation|0|||
164337128|NCT00761631|593609889|FG003|Overall Study|Protocol Violation|1|||
164337129|NCT00761631|593609890|FG004|Overall Study|Protocol Violation|5|||
164337130|NCT00761631|593609891|FG005|Overall Study|Protocol Violation|1|||
164337131|NCT00761631|593609886|FG000|Overall Study|Randomized, not treated|1|||
164337132|NCT00761631|593609887|FG001|Overall Study|Randomized, not treated|0|||
164337133|NCT00761631|593609888|FG002|Overall Study|Randomized, not treated|0|||
164337134|NCT00761631|593609889|FG003|Overall Study|Randomized, not treated|0|||
164337135|NCT00761631|593609890|FG004|Overall Study|Randomized, not treated|0|||
164337136|NCT00761631|593609891|FG005|Overall Study|Randomized, not treated|0|||
164337137|NCT00761631|593609886|FG000|Overall Study|Failed to return|1|||
164337138|NCT00761631|593609887|FG001|Overall Study|Failed to return|0|||
164337139|NCT00761631|593609888|FG002|Overall Study|Failed to return|1|||
164337140|NCT00761631|593609889|FG003|Overall Study|Failed to return|1|||
164337141|NCT00761631|593609890|FG004|Overall Study|Failed to return|5|||
164337142|NCT00761631|593609891|FG005|Overall Study|Failed to return|2|||
164337143|NCT00761631|593609886|FG000|Overall Study|Physician Decision|1|||
164337144|NCT00761631|593609887|FG001|Overall Study|Physician Decision|0|||
164337145|NCT00761631|593609888|FG002|Overall Study|Physician Decision|0|||
164337146|NCT00761631|593609889|FG003|Overall Study|Physician Decision|0|||
164337147|NCT00761631|593609890|FG004|Overall Study|Physician Decision|0|||
164337148|NCT00761631|593609891|FG005|Overall Study|Physician Decision|0|||
164337149|NCT00761631|593609886|FG000|Overall Study|Other|0|||
164337150|NCT00761631|593609887|FG001|Overall Study|Other|0|||
164337151|NCT00761631|593609888|FG002|Overall Study|Other|0|||
164337152|NCT00761631|593609889|FG003|Overall Study|Other|0|||
164337153|NCT00761631|593609890|FG004|Overall Study|Other|1|||
164337154|NCT00761631|593609891|FG005|Overall Study|Other|1|||
164337155|NCT00309985|593609892|FG000|Overall Study|Disease progression|12|||
164337156|NCT00309985|593609893|FG001|Overall Study|Disease progression|0|||
164337157|NCT00309985|593609892|FG000|Overall Study|Adverse Event|30|||
164337158|NCT00309985|593609893|FG001|Overall Study|Adverse Event|0|||
164337159|NCT00309985|593609892|FG000|Overall Study|Death|2|||
164337160|NCT00309985|593609893|FG001|Overall Study|Death|0|||
164337161|NCT00309985|593609892|FG000|Overall Study|Withdrawal by Subject|5|||
164337162|NCT00309985|593609893|FG001|Overall Study|Withdrawal by Subject|1|||
164337163|NCT00309985|593609892|FG000|Overall Study|Physician Decision|3|||
164337164|NCT00309985|593609893|FG001|Overall Study|Physician Decision|0|||
164337165|NCT00309985|593609892|FG000|Overall Study|Never started treatment|7|||
164337166|NCT00309985|593609893|FG001|Overall Study|Never started treatment|0|||
164337167|NCT00309985|593609892|FG000|Overall Study|Complicating disease|1|||
164337168|NCT00309985|593609893|FG001|Overall Study|Complicating disease|0|||
164337169|NCT00309985|593609892|FG000|Overall Study|Non-compliance|1|||
164425931|NCT04955626|593930815|FG004|Blinded Period|Death|0|||
164425932|NCT04955626|593930816|FG005|Blinded Period|Death|0|||
164425933|NCT04955626|593930817|FG006|Blinded Period|Death|0|||
164425934|NCT04955626|593930818|FG007|Blinded Period|Death|2|||
164425935|NCT04955626|593930819|FG008|Blinded Period|Death|1|||
164425936|NCT04955626|593930820|FG009|Blinded Period|Death|1|||
164425937|NCT04955626|593930821|FG010|Blinded Period|Death|0|||
164425938|NCT04955626|593930822|FG011|Blinded Period|Death|2|||
164337170|NCT00309985|593609893|FG001|Overall Study|Non-compliance|0|||
164337171|NCT00309985|593609892|FG000|Overall Study|Chemotherapy discontinued only|1|||
164337172|NCT00309985|593609893|FG001|Overall Study|Chemotherapy discontinued only|0|||
164337173|NCT03672643|593609894|FG000|Overall Study|Adverse Event|3|||
164337174|NCT03672643|593609894|FG000|Overall Study|Death|2|||
164337175|NCT03672643|593609894|FG000|Overall Study|Withdrawal by Subject|1|||
164337176|NCT03672643|593609894|FG000|Overall Study|Progressive disease|11|||
164425939|NCT04955626|593930823|FG012|Blinded Period|Death|0|||
164425940|NCT04955626|593930824|FG013|Blinded Period|Death|0|||
164425941|NCT04955626|593930825|FG014|Blinded Period|Death|0|||
164337177|NCT03672643|593609894|FG000|Overall Study|Global deterioration of health status|1|||
164337178|NCT03672643|593609894|FG000|Overall Study|Refused further treatment|7|||
164425942|NCT04955626|593930826|FG015|Blinded Period|Death|0|||
164425943|NCT04955626|593930827|FG016|Blinded Period|Death|0|||
164678764|NCT00185458|594848042|FG000|Contraception Phase|Adverse Event|37|||
164678765|NCT00185458|594848042|FG000|Contraception Phase|Lost to Follow-up|10|||
164678766|NCT00185458|594848042|FG000|Contraception Phase|Protocol Violation|2|||
164678767|NCT00185458|594848042|FG000|Contraception Phase|Physician Decision|2|||
164678768|NCT00185458|594848042|FG000|Contraception Phase|Withdrawal by Subject|7|||
164678769|NCT00185458|594848042|FG000|HRT Phase|Adverse Event|18|||
164244429|NCT01057693|593263866|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
164244430|NCT01057693|593263867|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
164244431|NCT01057693|593263868|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
164244432|NCT01057693|593263866|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
164244433|NCT01057693|593263867|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
164244434|NCT01057693|593263868|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
164244435|NCT01057693|593263866|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
164244436|NCT01057693|593263867|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
164244437|NCT01057693|593263868|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
164244438|NCT01057693|593263866|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
164244439|NCT01057693|593263867|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
164244440|NCT01057693|593263868|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
164244441|NCT01057693|593263866|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
164244442|NCT01057693|593263867|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
164244443|NCT01057693|593263868|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
164244444|NCT01057693|593263866|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
164244445|NCT01057693|593263867|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
164244446|NCT01057693|593263868|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
164244447|NCT01057693|593263866|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
164244448|NCT01057693|593263867|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
164244449|NCT01057693|593263868|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
164337179|NCT03672643|593609894|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
164337180|NCT01950390|593609895|FG000|Overall Study|Never started treatment|3|||
164337181|NCT01950390|593609896|FG001|Overall Study|Never started treatment|2|||
164337182|NCT01950390|593609895|FG000|Overall Study|Disease progression|45|||
164337183|NCT01950390|593609896|FG001|Overall Study|Disease progression|52|||
164337184|NCT01950390|593609895|FG000|Overall Study|Adverse Event|22|||
164337185|NCT01950390|593609896|FG001|Overall Study|Adverse Event|16|||
164337186|NCT01950390|593609895|FG000|Overall Study|Death|5|||
164337187|NCT01950390|593609896|FG001|Overall Study|Death|3|||
164337188|NCT01950390|593609895|FG000|Overall Study|Withdrawal by Subject|5|||
164337189|NCT01950390|593609896|FG001|Overall Study|Withdrawal by Subject|1|||
164337190|NCT01950390|593609895|FG000|Overall Study|Alternative therapy|0|||
164337191|NCT01950390|593609896|FG001|Overall Study|Alternative therapy|3|||
164337192|NCT01950390|593609895|FG000|Overall Study|Complicating disease|1|||
164337193|NCT01950390|593609896|FG001|Overall Study|Complicating disease|0|||
164337194|NCT01950390|593609895|FG000|Overall Study|On treatment|1|||
164337195|NCT01950390|593609896|FG001|Overall Study|On treatment|0|||
164337196|NCT01950390|593609895|FG000|Overall Study|Symptomatic deterioration|2|||
164337197|NCT01950390|593609896|FG001|Overall Study|Symptomatic deterioration|1|||
164337198|NCT01950390|593609895|FG000|Overall Study|Physician Decision|0|||
164337199|NCT01950390|593609896|FG001|Overall Study|Physician Decision|4|||
164337200|NCT01950390|593609895|FG000|Overall Study|Lack of clinical benefit|0|||
164244450|NCT01057693|593263866|FG000|Between Single-Blind and Double-Blind|Other|6|||
164244451|NCT01057693|593263867|FG001|Between Single-Blind and Double-Blind|Other|0|||
164244452|NCT01057693|593263868|FG002|Between Single-Blind and Double-Blind|Other|0|||
164244453|NCT01057693|593263866|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
164244454|NCT01057693|593263867|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
164244455|NCT01057693|593263868|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
164244456|NCT01057693|593263866|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
164244457|NCT01057693|593263867|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
164244458|NCT01057693|593263868|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
164337201|NCT01950390|593609896|FG001|Overall Study|Lack of clinical benefit|1|||
164337202|NCT01950390|593609895|FG000|Overall Study|Maintained PR and moved to observation only|0|||
164337203|NCT01950390|593609896|FG001|Overall Study|Maintained PR and moved to observation only|1|||
164337204|NCT02975336|593611487|FG000|DBPC (52 Weeks)|Adverse Event|16|||
164337205|NCT02975336|593611488|FG001|DBPC (52 Weeks)|Adverse Event|17|||
164337206|NCT02975336|593611489|FG002|DBPC (52 Weeks)|Adverse Event|13|||
164337207|NCT02975336|593611490|FG003|DBPC (52 Weeks)|Adverse Event|18|||
164337208|NCT02975336|593611491|FG004|DBPC (52 Weeks)|Adverse Event|0|||
164244459|NCT01057693|593263866|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
164337209|NCT02975336|593611492|FG005|DBPC (52 Weeks)|Adverse Event|0|||
164337210|NCT02975336|593611493|FG006|DBPC (52 Weeks)|Adverse Event|0|||
164337211|NCT02975336|593611494|FG007|DBPC (52 Weeks)|Adverse Event|0|||
164337212|NCT02975336|593611487|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
164337213|NCT02975336|593611488|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
164425944|NCT04955626|593930828|FG017|Blinded Period|Death|0|||
164425945|NCT04955626|593930829|FG018|Blinded Period|Death|0|||
164244460|NCT01057693|593263867|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
164244461|NCT01057693|593263868|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
164244462|NCT01057693|593263866|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
164244463|NCT01057693|593263867|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
164244464|NCT01057693|593263868|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
164244465|NCT01057693|593263866|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
164244466|NCT01057693|593263867|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
164244467|NCT01057693|593263868|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
164244468|NCT01057693|593263866|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
164244469|NCT01057693|593263867|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
164244470|NCT01057693|593263868|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
164244471|NCT01057693|593263866|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
164244472|NCT01057693|593263867|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
164244473|NCT01057693|593263868|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
164244474|NCT02959463|593263869|FG000|Overall Study|Adverse Event|1|||
164244475|NCT02959463|593263870|FG001|Overall Study|Adverse Event|1|||
164244476|NCT02959463|593263869|FG000|Overall Study|Death|1|||
164244477|NCT02959463|593263870|FG001|Overall Study|Death|0|||
164244478|NCT02959463|593263869|FG000|Overall Study|Withdrawal by Subject|1|||
164244479|NCT02959463|593263870|FG001|Overall Study|Withdrawal by Subject|0|||
164244480|NCT02413996|593263871|FG000|Overall Study|not comfortable with the intervention|9|||
164244481|NCT02413996|593263872|FG001|Overall Study|not comfortable with the intervention|2|||
164244482|NCT00709319|593263873|FG000|Overall Study|Death|4|||
164244483|NCT00709319|593263873|FG000|Overall Study|Withdrawal by Subject|2|||
164244484|NCT00090779|593263874|FG000|Step 1|Withdrawal by Subject|4|||
164244485|NCT00090779|593263875|FG001|Step 1|Withdrawal by Subject|2|||
164244486|NCT00090779|593263874|FG000|Step 1|Lost to Follow-up|3|||
164244487|NCT00090779|593263875|FG001|Step 1|Lost to Follow-up|2|||
164244488|NCT00090779|593263874|FG000|Step 1|Death|0|||
164244489|NCT00090779|593263875|FG001|Step 1|Death|2|||
164244490|NCT00090779|593263874|FG000|Step 1|Physician Decision|1|||
164244491|NCT00090779|593263875|FG001|Step 1|Physician Decision|0|||
164244492|NCT00090779|593263874|FG000|Step 1|Pregnancy|1|||
164244493|NCT00090779|593263875|FG001|Step 1|Pregnancy|0|||
164244494|NCT00090779|593263874|FG000|Step 1|Non-compliance to study requirements|0|||
164244495|NCT00090779|593263875|FG001|Step 1|Non-compliance to study requirements|1|||
164244496|NCT00090779|593263874|FG000|Step 1|Subject relocated|2|||
164244497|NCT00090779|593263875|FG001|Step 1|Subject relocated|8|||
164244498|NCT00090779|593263874|FG000|Step 2|Off study per study closure|6|||
164244499|NCT00090779|593263875|FG001|Step 2|Off study per study closure|16|||
164244500|NCT00090779|593263874|FG000|Step 2|Subject relocated|0|||
164244501|NCT00090779|593263875|FG001|Step 2|Subject relocated|1|||
164244502|NCT00090779|593263874|FG000|Step 2|Non-compliance to study requirements|0|||
164244503|NCT00090779|593263875|FG001|Step 2|Non-compliance to study requirements|1|||
164244504|NCT00090779|593263874|FG000|Step 3|Initiation of ART and off extended study|3|||
164244505|NCT00090779|593263875|FG001|Step 3|Initiation of ART and off extended study|2|||
164244506|NCT00090779|593263874|FG000|Step 3|Off extended study due to study closure|4|||
164244507|NCT00090779|593263875|FG001|Step 3|Off extended study due to study closure|3|||
164244508|NCT01672879|593263878|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
164244509|NCT01672879|593263879|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
164244510|NCT01672879|593263880|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
164244511|NCT01672879|593263878|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
164244512|NCT01672879|593263879|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
164244513|NCT01672879|593263880|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
164244514|NCT01672879|593263878|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
164244515|NCT01672879|593263879|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
164244516|NCT01672879|593263880|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
164244517|NCT01672879|593263878|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
164244518|NCT01672879|593263879|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
164244519|NCT01672879|593263880|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
164244520|NCT01672879|593263878|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
164244521|NCT01672879|593263879|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
164425946|NCT04955626|593930830|FG019|Blinded Period|Death|0|||
164337214|NCT02975336|593611489|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
164337215|NCT02975336|593611490|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
164337216|NCT02975336|593611491|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
164337217|NCT02975336|593611492|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
164337218|NCT02975336|593611493|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
164337219|NCT02975336|593611494|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
164337220|NCT02975336|593611487|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
164337221|NCT02975336|593611488|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
164337222|NCT02975336|593611489|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
164337223|NCT02975336|593611490|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
164337224|NCT02975336|593611491|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
164337225|NCT02975336|593611492|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
164337226|NCT02975336|593611493|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
164337227|NCT02975336|593611494|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
164337228|NCT02975336|593611487|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
164337229|NCT02975336|593611488|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
164337230|NCT02975336|593611489|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
164337231|NCT02975336|593611490|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
164337232|NCT02975336|593611491|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
164337233|NCT02975336|593611492|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
164337234|NCT02975336|593611493|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
164337235|NCT02975336|593611494|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
164337236|NCT02975336|593611487|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
164337237|NCT02975336|593611488|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
164337238|NCT02975336|593611489|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
164337239|NCT02975336|593611490|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
164337240|NCT02975336|593611491|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
164337241|NCT02975336|593611492|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
164337242|NCT02975336|593611493|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
164337243|NCT02975336|593611494|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
164337244|NCT02975336|593611487|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
164337245|NCT02975336|593611488|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
164337246|NCT02975336|593611489|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
164337247|NCT02975336|593611490|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
164337248|NCT02975336|593611491|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
164337249|NCT02975336|593611492|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
164337250|NCT02975336|593611493|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
164337251|NCT02975336|593611494|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
164337252|NCT02975336|593611487|FG000|LTE (104 Weeks)|Adverse Event|0|||
164337253|NCT02975336|593611488|FG001|LTE (104 Weeks)|Adverse Event|0|||
164337254|NCT02975336|593611489|FG002|LTE (104 Weeks)|Adverse Event|0|||
164337255|NCT02975336|593611490|FG003|LTE (104 Weeks)|Adverse Event|0|||
164337256|NCT02975336|593611491|FG004|LTE (104 Weeks)|Adverse Event|7|||
164337257|NCT02975336|593611492|FG005|LTE (104 Weeks)|Adverse Event|4|||
164337258|NCT02975336|593611493|FG006|LTE (104 Weeks)|Adverse Event|2|||
164337259|NCT02975336|593611494|FG007|LTE (104 Weeks)|Adverse Event|0|||
164337260|NCT02975336|593611487|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
164337261|NCT02975336|593611488|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
164337262|NCT02975336|593611489|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
164337263|NCT02975336|593611490|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
164337264|NCT02975336|593611491|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
164337265|NCT02975336|593611492|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
164337266|NCT02975336|593611493|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
164337267|NCT02975336|593611494|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
164337268|NCT02975336|593611487|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
164337269|NCT02975336|593611488|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
164337270|NCT02975336|593611489|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
164337271|NCT02975336|593611490|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
164337272|NCT02975336|593611491|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
164337273|NCT02975336|593611492|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
164337274|NCT02975336|593611493|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
164337275|NCT02975336|593611494|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
164337276|NCT02975336|593611487|FG000|LTE (104 Weeks)|Other|0|||
164337277|NCT02975336|593611488|FG001|LTE (104 Weeks)|Other|0|||
164337278|NCT02975336|593611489|FG002|LTE (104 Weeks)|Other|0|||
164337279|NCT02975336|593611490|FG003|LTE (104 Weeks)|Other|0|||
164337280|NCT02975336|593611491|FG004|LTE (104 Weeks)|Other|55|||
164337281|NCT02975336|593611492|FG005|LTE (104 Weeks)|Other|63|||
164337282|NCT02975336|593611493|FG006|LTE (104 Weeks)|Other|76|||
164337283|NCT02975336|593611494|FG007|LTE (104 Weeks)|Other|72|||
164337284|NCT02008318|593611497|FG000|Overall Study|Adverse Event|4|||
164337285|NCT02008318|593611498|FG001|Overall Study|Adverse Event|0|||
164337286|NCT02008318|593611497|FG000|Overall Study|Physician Decision|2|||
164337287|NCT02008318|593611498|FG001|Overall Study|Physician Decision|0|||
164337288|NCT02008318|593611497|FG000|Overall Study|Progressive Disease|2|||
164337289|NCT02008318|593611498|FG001|Overall Study|Progressive Disease|0|||
164337290|NCT02008318|593611497|FG000|Overall Study|Protocol Violation|1|||
164337291|NCT02008318|593611498|FG001|Overall Study|Protocol Violation|1|||
164337292|NCT02008318|593611497|FG000|Overall Study|Withdrawal by Subject|3|||
164337293|NCT02008318|593611498|FG001|Overall Study|Withdrawal by Subject|0|||
164337294|NCT02281773|593611499|FG000|Overall Study|Adverse Event|6|||
164337295|NCT02281773|593611500|FG001|Overall Study|Adverse Event|1|||
164337296|NCT02281773|593611501|FG002|Overall Study|Adverse Event|4|||
164337297|NCT02281773|593611502|FG003|Overall Study|Adverse Event|8|||
164337298|NCT02281773|593611503|FG004|Overall Study|Adverse Event|9|||
164337299|NCT02281773|593611499|FG000|Overall Study|Protocol Violation|1|||
164337300|NCT02281773|593611500|FG001|Overall Study|Protocol Violation|0|||
164337301|NCT02281773|593611501|FG002|Overall Study|Protocol Violation|0|||
164337302|NCT02281773|593611502|FG003|Overall Study|Protocol Violation|2|||
164337303|NCT02281773|593611503|FG004|Overall Study|Protocol Violation|2|||
164337304|NCT02281773|593611499|FG000|Overall Study|Lost to Follow-up|2|||
164337305|NCT02281773|593611500|FG001|Overall Study|Lost to Follow-up|2|||
164337306|NCT02281773|593611501|FG002|Overall Study|Lost to Follow-up|6|||
164337307|NCT02281773|593611502|FG003|Overall Study|Lost to Follow-up|2|||
164337308|NCT02281773|593611503|FG004|Overall Study|Lost to Follow-up|10|||
164337309|NCT02281773|593611499|FG000|Overall Study|Withdrawal by Subject|2|||
164337310|NCT02281773|593611500|FG001|Overall Study|Withdrawal by Subject|8|||
164337311|NCT02281773|593611501|FG002|Overall Study|Withdrawal by Subject|6|||
164337312|NCT02281773|593611502|FG003|Overall Study|Withdrawal by Subject|6|||
164337313|NCT02281773|593611503|FG004|Overall Study|Withdrawal by Subject|8|||
164337314|NCT02281773|593611499|FG000|Overall Study|Other Reason|0|||
164337315|NCT02281773|593611500|FG001|Overall Study|Other Reason|4|||
164337316|NCT02281773|593611501|FG002|Overall Study|Other Reason|2|||
164337317|NCT02281773|593611502|FG003|Overall Study|Other Reason|3|||
164337318|NCT02281773|593611503|FG004|Overall Study|Other Reason|1|||
164337319|NCT00385762|593611504|FG000|Overall Study|Adverse Event|1|||
164337320|NCT00385762|593611504|FG000|Overall Study|Lost to Follow-up|1|||
164337321|NCT01147640|593611522|FG000|Overall Study|Adverse Event|2|||
164337322|NCT01147640|593611523|FG001|Overall Study|Adverse Event|0|||
164337323|NCT01147640|593611522|FG000|Overall Study|Physician Decision|1|||
164337324|NCT01147640|593611523|FG001|Overall Study|Physician Decision|0|||
164337325|NCT01147640|593611522|FG000|Overall Study|Withdrawal by Subject|1|||
164337326|NCT01147640|593611523|FG001|Overall Study|Withdrawal by Subject|0|||
164337327|NCT01147640|593611522|FG000|Overall Study|Lost to Follow-up|0|||
164337328|NCT01147640|593611523|FG001|Overall Study|Lost to Follow-up|1|||
164337329|NCT01147640|593611522|FG000|Overall Study|Didn't meet eligibility criteria|1|||
164337330|NCT01147640|593611523|FG001|Overall Study|Didn't meet eligibility criteria|0|||
164337331|NCT01856907|593611526|FG000|Overall Study|Pregnancy|0|||
164337332|NCT01856907|593611527|FG001|Overall Study|Pregnancy|1|||
164337333|NCT01856907|593611528|FG002|Overall Study|Pregnancy|0|||
164337334|NCT01856907|593611526|FG000|Overall Study|Pregnancy|0|||
164337335|NCT01856907|593611527|FG001|Overall Study|Pregnancy|1|||
164337336|NCT01856907|593611528|FG002|Overall Study|Pregnancy|0|||
164337337|NCT01856907|593611526|FG000|Overall Study|Withdrawal by Subject|0|||
164337338|NCT01856907|593611527|FG001|Overall Study|Withdrawal by Subject|1|||
164337339|NCT01856907|593611528|FG002|Overall Study|Withdrawal by Subject|0|||
164337340|NCT00091442|593611529|FG000|Overall Study|Progressive Disease|220|||
164337341|NCT00091442|593611530|FG001|Overall Study|Progressive Disease|189|||
164337342|NCT00091442|593611529|FG000|Overall Study|Physician Decision|61|||
164337343|NCT00091442|593611530|FG001|Overall Study|Physician Decision|58|||
164337344|NCT00091442|593611529|FG000|Overall Study|Withdrawal by Subject|38|||
164337345|NCT00091442|593611530|FG001|Overall Study|Withdrawal by Subject|46|||
164337346|NCT00091442|593611529|FG000|Overall Study|Adverse Event|29|||
164337347|NCT00091442|593611530|FG001|Overall Study|Adverse Event|48|||
164337348|NCT00091442|593611529|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
164337349|NCT00091442|593611530|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
164337350|NCT00091442|593611529|FG000|Overall Study|Death|9|||
164337351|NCT00091442|593611530|FG001|Overall Study|Death|7|||
164337352|NCT00091442|593611529|FG000|Overall Study|Lost to Follow-up|1|||
164337353|NCT00091442|593611530|FG001|Overall Study|Lost to Follow-up|3|||
164337354|NCT00091442|593611529|FG000|Overall Study|Other|2|||
164337355|NCT00091442|593611530|FG001|Overall Study|Other|6|||
164337356|NCT00986830|593611533|FG000|Overall Study|Death|1|||
164337357|NCT00986830|593611533|FG000|Overall Study|Lost to Follow-up|1|||
164337358|NCT00986830|593611533|FG000|Overall Study|Lack of Efficacy|1|||
164337359|NCT00986830|593611533|FG000|Overall Study|Unable to access sinus with device|5|||
164337360|NCT00845858|593611534|FG000|Overall Study|Withdrawal by Subject|5|||
164337361|NCT00845858|593611535|FG001|Overall Study|Withdrawal by Subject|1|||
164337362|NCT00845858|593611536|FG002|Overall Study|Withdrawal by Subject|1|||
164337363|NCT00845858|593611534|FG000|Overall Study|Adverse Event|3|||
164337364|NCT00845858|593611535|FG001|Overall Study|Adverse Event|8|||
164337365|NCT00845858|593611536|FG002|Overall Study|Adverse Event|4|||
164337366|NCT00845858|593611534|FG000|Overall Study|Protocol Violation|0|||
164337367|NCT00845858|593611535|FG001|Overall Study|Protocol Violation|0|||
164337368|NCT00845858|593611536|FG002|Overall Study|Protocol Violation|1|||
164337369|NCT00845858|593611534|FG000|Overall Study|not eligible|0|||
164337370|NCT00845858|593611535|FG001|Overall Study|not eligible|3|||
164337371|NCT00845858|593611536|FG002|Overall Study|not eligible|2|||
164337372|NCT01436396|593611537|FG000|Overall Study|Protocol Violation|7|||
164337373|NCT01436396|593611538|FG001|Overall Study|Protocol Violation|5|||
164337374|NCT01436396|593611537|FG000|Overall Study|Adverse Event|1|||
164337375|NCT01436396|593611538|FG001|Overall Study|Adverse Event|2|||
164337376|NCT01436396|593611537|FG000|Overall Study|Withdrawal by Subject|19|||
164337377|NCT01436396|593611538|FG001|Overall Study|Withdrawal by Subject|29|||
164337378|NCT01436396|593611537|FG000|Overall Study|Serious adverse event|2|||
164337379|NCT01436396|593611538|FG001|Overall Study|Serious adverse event|3|||
164337380|NCT01436396|593611537|FG000|Overall Study|Lost to Follow-up|3|||
164337381|NCT01436396|593611538|FG001|Overall Study|Lost to Follow-up|3|||
164337382|NCT04674644|593611540|FG000|Overall Study|with missing data|37|||
164337383|NCT03469934|593611541|FG000|Overall Study|Withdrawal by Subject|0|||
164337384|NCT03469934|593611542|FG001|Overall Study|Withdrawal by Subject|1|||
164337385|NCT01024231|593611544|FG000|Overall Study|Other Reasons|1|||
164337386|NCT01024231|593611545|FG001|Overall Study|Other Reasons|2|||
164337387|NCT01024231|593611546|FG002|Overall Study|Other Reasons|0|||
164337388|NCT01024231|593611547|FG003|Overall Study|Other Reasons|0|||
164337389|NCT01024231|593611548|FG004|Overall Study|Other Reasons|2|||
164337390|NCT01024231|593611549|FG005|Overall Study|Other Reasons|0|||
164337391|NCT01024231|593611550|FG006|Overall Study|Other Reasons|1|||
164337392|NCT01024231|593611544|FG000|Overall Study|Maximum Clinical Benefit|1|||
164337393|NCT01024231|593611545|FG001|Overall Study|Maximum Clinical Benefit|2|||
164337394|NCT01024231|593611546|FG002|Overall Study|Maximum Clinical Benefit|0|||
164337395|NCT01024231|593611547|FG003|Overall Study|Maximum Clinical Benefit|1|||
164337396|NCT01024231|593611548|FG004|Overall Study|Maximum Clinical Benefit|1|||
164337397|NCT01024231|593611549|FG005|Overall Study|Maximum Clinical Benefit|0|||
164337398|NCT01024231|593611550|FG006|Overall Study|Maximum Clinical Benefit|0|||
164337399|NCT01024231|593611544|FG000|Overall Study|Disease Progression|3|||
164337400|NCT01024231|593611545|FG001|Overall Study|Disease Progression|1|||
164337401|NCT01024231|593611546|FG002|Overall Study|Disease Progression|3|||
164337402|NCT01024231|593611547|FG003|Overall Study|Disease Progression|0|||
164337403|NCT01024231|593611548|FG004|Overall Study|Disease Progression|4|||
164337404|NCT01024231|593611549|FG005|Overall Study|Disease Progression|11|||
164337405|NCT01024231|593611550|FG006|Overall Study|Disease Progression|6|||
164337406|NCT01024231|593611544|FG000|Overall Study|AE unrelated to Study Drug|0|||
164337407|NCT01024231|593611545|FG001|Overall Study|AE unrelated to Study Drug|1|||
164337408|NCT01024231|593611546|FG002|Overall Study|AE unrelated to Study Drug|0|||
164337409|NCT01024231|593611547|FG003|Overall Study|AE unrelated to Study Drug|0|||
164337410|NCT01024231|593611548|FG004|Overall Study|AE unrelated to Study Drug|0|||
164337411|NCT01024231|593611549|FG005|Overall Study|AE unrelated to Study Drug|0|||
164337412|NCT01024231|593611550|FG006|Overall Study|AE unrelated to Study Drug|0|||
164337413|NCT01024231|593611544|FG000|Overall Study|No longer meets criteria|0|||
164337414|NCT01024231|593611545|FG001|Overall Study|No longer meets criteria|0|||
164337415|NCT01024231|593611546|FG002|Overall Study|No longer meets criteria|0|||
164337416|NCT01024231|593611547|FG003|Overall Study|No longer meets criteria|0|||
164337417|NCT01024231|593611548|FG004|Overall Study|No longer meets criteria|1|||
164337418|NCT01024231|593611549|FG005|Overall Study|No longer meets criteria|0|||
164337419|NCT01024231|593611550|FG006|Overall Study|No longer meets criteria|1|||
164337420|NCT01024231|593611544|FG000|Overall Study|Study Drug Toxicity|1|||
164337421|NCT01024231|593611545|FG001|Overall Study|Study Drug Toxicity|6|||
164337422|NCT01024231|593611546|FG002|Overall Study|Study Drug Toxicity|6|||
164337423|NCT01024231|593611547|FG003|Overall Study|Study Drug Toxicity|4|||
164337424|NCT01024231|593611548|FG004|Overall Study|Study Drug Toxicity|2|||
164425947|NCT04955626|593930831|FG020|Blinded Period|Death|0|||
164425948|NCT04955626|593930832|FG021|Blinded Period|Death|0|||
164425949|NCT04955626|593930833|FG022|Blinded Period|Death|0|||
164574406|NCT04348851|594465636|FG003|Post-Test 1|Withdrawal by Subject|0|||
164337425|NCT01024231|593611549|FG005|Overall Study|Study Drug Toxicity|0|||
164337426|NCT01024231|593611550|FG006|Overall Study|Study Drug Toxicity|7|||
164337427|NCT01024231|593611544|FG000|Overall Study|Death|6|||
164337428|NCT01024231|593611545|FG001|Overall Study|Death|2|||
164337429|NCT01024231|593611546|FG002|Overall Study|Death|1|||
164337430|NCT01024231|593611547|FG003|Overall Study|Death|0|||
164337431|NCT01024231|593611548|FG004|Overall Study|Death|4|||
164337432|NCT01024231|593611549|FG005|Overall Study|Death|3|||
164337433|NCT01024231|593611550|FG006|Overall Study|Death|5|||
164337434|NCT01024231|593611544|FG000|Overall Study|Lost to Follow-up|0|||
164337435|NCT01024231|593611545|FG001|Overall Study|Lost to Follow-up|0|||
164337436|NCT01024231|593611546|FG002|Overall Study|Lost to Follow-up|0|||
164337437|NCT01024231|593611547|FG003|Overall Study|Lost to Follow-up|0|||
164337438|NCT01024231|593611548|FG004|Overall Study|Lost to Follow-up|0|||
164337439|NCT01024231|593611549|FG005|Overall Study|Lost to Follow-up|0|||
164337440|NCT01024231|593611550|FG006|Overall Study|Lost to Follow-up|1|||
164337441|NCT01024231|593611544|FG000|Overall Study|Withdrew Consent|0|||
164337442|NCT01024231|593611545|FG001|Overall Study|Withdrew Consent|1|||
164337443|NCT01024231|593611546|FG002|Overall Study|Withdrew Consent|0|||
164337444|NCT01024231|593611547|FG003|Overall Study|Withdrew Consent|0|||
164425950|NCT04955626|593930834|FG023|Blinded Period|Death|1|||
164574407|NCT04348851|594465633|FG000|Post-Test 1|Lost to Follow-up|0|||
164574408|NCT04348851|594465634|FG001|Post-Test 1|Lost to Follow-up|1|||
164574409|NCT04348851|594465635|FG002|Post-Test 1|Lost to Follow-up|0|||
164574410|NCT04348851|594465636|FG003|Post-Test 1|Lost to Follow-up|0|||
164574411|NCT04348851|594465633|FG000|Post-Test 2|Stroke survivor death|0|||
164574412|NCT04348851|594465634|FG001|Post-Test 2|Stroke survivor death|1|||
164337445|NCT01024231|593611548|FG004|Overall Study|Withdrew Consent|0|||
164337446|NCT01024231|593611549|FG005|Overall Study|Withdrew Consent|0|||
164574413|NCT04348851|594465635|FG002|Post-Test 2|Stroke survivor death|0|||
164337447|NCT01024231|593611550|FG006|Overall Study|Withdrew Consent|0|||
164337448|NCT01024231|593611544|FG000|Overall Study|Continuing on Treatment|0|||
164337449|NCT01024231|593611545|FG001|Overall Study|Continuing on Treatment|0|||
164337450|NCT01024231|593611546|FG002|Overall Study|Continuing on Treatment|0|||
164337451|NCT01024231|593611547|FG003|Overall Study|Continuing on Treatment|0|||
164337452|NCT01024231|593611548|FG004|Overall Study|Continuing on Treatment|3|||
164337453|NCT01024231|593611549|FG005|Overall Study|Continuing on Treatment|2|||
164337454|NCT01024231|593611550|FG006|Overall Study|Continuing on Treatment|0|||
164337455|NCT02761733|593611552|FG000|Overall Study|Death|3|||
164337456|NCT02761733|593611553|FG001|Overall Study|Death|5|||
164337457|NCT02761733|593611554|FG002|Overall Study|Death|1|||
164337458|NCT02761733|593611555|FG003|Overall Study|Death|1|||
164337459|NCT02761733|593611552|FG000|Overall Study|Lost to Follow-up|6|||
164337460|NCT02761733|593611553|FG001|Overall Study|Lost to Follow-up|7|||
164337461|NCT02761733|593611554|FG002|Overall Study|Lost to Follow-up|0|||
164337462|NCT02761733|593611555|FG003|Overall Study|Lost to Follow-up|3|||
164337463|NCT02761733|593611552|FG000|Overall Study|Physician Decision|4|||
164337464|NCT02761733|593611553|FG001|Overall Study|Physician Decision|0|||
164337465|NCT02761733|593611554|FG002|Overall Study|Physician Decision|0|||
164337466|NCT02761733|593611555|FG003|Overall Study|Physician Decision|0|||
164337467|NCT02761733|593611552|FG000|Overall Study|Withdrawal by Subject|2|||
164337468|NCT02761733|593611553|FG001|Overall Study|Withdrawal by Subject|0|||
164337469|NCT02761733|593611554|FG002|Overall Study|Withdrawal by Subject|0|||
164337470|NCT02761733|593611555|FG003|Overall Study|Withdrawal by Subject|0|||
164337471|NCT02761733|593611552|FG000|Overall Study|Discharged from Study Site|10|||
164337472|NCT02761733|593611553|FG001|Overall Study|Discharged from Study Site|9|||
164337473|NCT02761733|593611554|FG002|Overall Study|Discharged from Study Site|25|||
164337474|NCT02761733|593611555|FG003|Overall Study|Discharged from Study Site|11|||
164337475|NCT02761733|593611552|FG000|Overall Study|Cognitive Impairment|5|||
164337476|NCT02761733|593611553|FG001|Overall Study|Cognitive Impairment|0|||
164337477|NCT02761733|593611554|FG002|Overall Study|Cognitive Impairment|1|||
164337478|NCT02761733|593611555|FG003|Overall Study|Cognitive Impairment|0|||
164337479|NCT00669396|593611556|FG000|Overall Study|Lost to Follow-up|10|||
164337480|NCT00669396|593611557|FG001|Overall Study|Lost to Follow-up|12|||
164337481|NCT01262573|593611558|FG000|Overall Study|Withdrawal by Subject|0|||
164337482|NCT01262573|593611559|FG001|Overall Study|Withdrawal by Subject|1|||
164337483|NCT00810693|593611562|FG000|Treatment Period|Adverse Event|8|||
164337484|NCT00810693|593611563|FG001|Treatment Period|Adverse Event|1|||
164337485|NCT00810693|593611564|FG002|Treatment Period|Adverse Event|7|||
164337486|NCT00810693|593611562|FG000|Treatment Period|Death|0|||
164337487|NCT00810693|593611563|FG001|Treatment Period|Death|1|||
164337488|NCT00810693|593611564|FG002|Treatment Period|Death|2|||
164337489|NCT00810693|593611562|FG000|Treatment Period|Lack of Efficacy|0|||
164337490|NCT00810693|593611563|FG001|Treatment Period|Lack of Efficacy|0|||
164337491|NCT00810693|593611564|FG002|Treatment Period|Lack of Efficacy|1|||
164337492|NCT00810693|593611562|FG000|Treatment Period|Lost to Follow-up|1|||
164337493|NCT00810693|593611563|FG001|Treatment Period|Lost to Follow-up|0|||
164337494|NCT00810693|593611564|FG002|Treatment Period|Lost to Follow-up|0|||
164337495|NCT00810693|593611562|FG000|Treatment Period|Non-compliance|1|||
164337496|NCT00810693|593611563|FG001|Treatment Period|Non-compliance|0|||
164337497|NCT00810693|593611564|FG002|Treatment Period|Non-compliance|0|||
164337498|NCT00810693|593611562|FG000|Treatment Period|Protocol Violation|1|||
164337499|NCT00810693|593611563|FG001|Treatment Period|Protocol Violation|2|||
164574414|NCT04348851|594465636|FG003|Post-Test 2|Stroke survivor death|1|||
164574415|NCT00552110|594465637|FG000|Overall Study|Serious or Life-Threatening AE|0|||
164337500|NCT00810693|593611564|FG002|Treatment Period|Protocol Violation|2|||
164337501|NCT00810693|593611562|FG000|Treatment Period|Withdrawal by Subject|6|||
164337502|NCT00810693|593611563|FG001|Treatment Period|Withdrawal by Subject|2|||
164337503|NCT00810693|593611564|FG002|Treatment Period|Withdrawal by Subject|3|||
164337504|NCT00810693|593611562|FG000|Treatment Period|Not treated|0|||
164337505|NCT00810693|593611563|FG001|Treatment Period|Not treated|1|||
164425951|NCT04955626|593930835|FG024|Blinded Period|Death|0|||
164574416|NCT00552110|594465638|FG001|Overall Study|Serious or Life-Threatening AE|0|||
164574417|NCT00552110|594465639|FG002|Overall Study|Serious or Life-Threatening AE|1|||
164337506|NCT00810693|593611564|FG002|Treatment Period|Not treated|1|||
164337507|NCT00810693|593611562|FG000|Follow-up Period (FUP)|Adverse Event|3|||
164337508|NCT00810693|593611563|FG001|Follow-up Period (FUP)|Adverse Event|1|||
164337509|NCT00810693|593611564|FG002|Follow-up Period (FUP)|Adverse Event|1|||
164337510|NCT00810693|593611562|FG000|Follow-up Period (FUP)|Death|2|||
164337511|NCT00810693|593611563|FG001|Follow-up Period (FUP)|Death|0|||
164574418|NCT00552110|594465640|FG003|Overall Study|Serious or Life-Threatening AE|0|||
164574419|NCT00552110|594465641|FG004|Overall Study|Serious or Life-Threatening AE|0|||
164574420|NCT00552110|594465637|FG000|Overall Study|Lack of Efficacy|1|||
164244522|NCT01672879|593263880|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
164244523|NCT01672879|593263878|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
164244524|NCT01672879|593263879|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
164244525|NCT01672879|593263880|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
164244526|NCT01672879|593263878|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
164244527|NCT01672879|593263879|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
164244528|NCT01672879|593263880|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
164244529|NCT01672879|593263878|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
164244530|NCT01672879|593263879|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
164244531|NCT01672879|593263880|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
164244532|NCT01672879|593263878|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
164244533|NCT01672879|593263879|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
164244534|NCT01672879|593263880|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
164244535|NCT01672879|593263878|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
164244536|NCT01672879|593263879|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
164244537|NCT01672879|593263880|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
164244538|NCT01672879|593263878|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
164244539|NCT01672879|593263879|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
164244540|NCT01672879|593263880|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
164244541|NCT01672879|593263878|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
164244542|NCT01672879|593263879|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
164244543|NCT01672879|593263880|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
164244544|NCT01672879|593263878|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
164244545|NCT01672879|593263879|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
164244546|NCT01672879|593263880|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
164244547|NCT03951766|593263889|FG000|Treatment Phase|Lost to Follow-up|1|||
164244548|NCT03951766|593263889|FG000|Follow-up Phase|Lost to Follow-up|10|||
164244549|NCT00041470|593263890|FG000|Overall Study|Loss of Funding|38|||
164244550|NCT04158375|593263895|FG000|Overall Study|Withdrawal by Subject|0|||
164244551|NCT04158375|593263896|FG001|Overall Study|Withdrawal by Subject|3|||
164244552|NCT04158375|593263897|FG002|Overall Study|Withdrawal by Subject|0|||
164244553|NCT04847843|593263898|FG000|Overall Study|Scheduling Conflicts|6|||
164244554|NCT04847843|593263899|FG001|Overall Study|Scheduling Conflicts|9|||
164244555|NCT04847843|593263898|FG000|Overall Study|Withdrawal by Subject|1|||
164244556|NCT04847843|593263899|FG001|Overall Study|Withdrawal by Subject|0|||
164244557|NCT04847843|593263898|FG000|Overall Study|Lost to Follow-up|1|||
164244558|NCT04847843|593263899|FG001|Overall Study|Lost to Follow-up|1|||
164244559|NCT04847843|593263898|FG000|Overall Study|Pregnancy|0|||
164244560|NCT04847843|593263899|FG001|Overall Study|Pregnancy|2|||
164244561|NCT04847843|593263898|FG000|Overall Study|Discovered not eligible - recent cancer diagnosis|0|||
164244562|NCT04847843|593263899|FG001|Overall Study|Discovered not eligible - recent cancer diagnosis|1|||
164244563|NCT02734004|593263900|FG000|Overall Study|Death|36|||
164244564|NCT02734004|593263901|FG001|Overall Study|Death|24|||
164244565|NCT02734004|593263902|FG002|Overall Study|Death|26|||
164244566|NCT02734004|593263903|FG003|Overall Study|Death|35|||
164244567|NCT02734004|593263904|FG004|Overall Study|Death|13|||
164244568|NCT02734004|593263905|FG005|Overall Study|Death|17|||
164244569|NCT02734004|593263906|FG006|Overall Study|Death|20|||
164244570|NCT02734004|593263900|FG000|Overall Study|Lost to Follow-up|1|||
164244571|NCT02734004|593263901|FG001|Overall Study|Lost to Follow-up|1|||
164244572|NCT02734004|593263902|FG002|Overall Study|Lost to Follow-up|0|||
164244573|NCT02734004|593263903|FG003|Overall Study|Lost to Follow-up|0|||
164244574|NCT02734004|593263904|FG004|Overall Study|Lost to Follow-up|1|||
164244575|NCT02734004|593263905|FG005|Overall Study|Lost to Follow-up|0|||
164244576|NCT02734004|593263906|FG006|Overall Study|Lost to Follow-up|0|||
164244577|NCT02734004|593263900|FG000|Overall Study|Withdrawal by Subject|3|||
164244578|NCT02734004|593263901|FG001|Overall Study|Withdrawal by Subject|1|||
164244579|NCT02734004|593263902|FG002|Overall Study|Withdrawal by Subject|1|||
164244580|NCT02734004|593263903|FG003|Overall Study|Withdrawal by Subject|1|||
164244581|NCT02734004|593263904|FG004|Overall Study|Withdrawal by Subject|3|||
164244582|NCT02734004|593263905|FG005|Overall Study|Withdrawal by Subject|0|||
164244583|NCT02734004|593263906|FG006|Overall Study|Withdrawal by Subject|2|||
164244584|NCT02734004|593263900|FG000|Overall Study|Other|0|||
164244585|NCT02734004|593263901|FG001|Overall Study|Other|8|||
164244586|NCT02734004|593263902|FG002|Overall Study|Other|7|||
164244587|NCT02734004|593263903|FG003|Overall Study|Other|4|||
164244588|NCT02734004|593263904|FG004|Overall Study|Other|34|||
164244589|NCT02734004|593263905|FG005|Overall Study|Other|14|||
164244590|NCT02734004|593263906|FG006|Overall Study|Other|10|||
164244591|NCT05615220|593263907|FG000|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|36|||
164244592|NCT05615220|593263908|FG001|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
164244593|NCT05615220|593263909|FG002|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
164244594|NCT05615220|593263907|FG000|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|21|||
164244595|NCT05615220|593263908|FG001|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
164244596|NCT05615220|593263909|FG002|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
164244597|NCT05615220|593263907|FG000|Open label stabilization Part (12 weeks)|Adverse Event|33|||
164244598|NCT05615220|593263908|FG001|Open label stabilization Part (12 weeks)|Adverse Event|0|||
164244599|NCT05615220|593263909|FG002|Open label stabilization Part (12 weeks)|Adverse Event|0|||
164244600|NCT05615220|593263907|FG000|Open label stabilization Part (12 weeks)|Withdrawal by Subject|6|||
164244601|NCT05615220|593263908|FG001|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
164244602|NCT05615220|593263909|FG002|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
164244603|NCT05615220|593263907|FG000|Open label stabilization Part (12 weeks)|Non-compliance with study drug|1|||
164244604|NCT05615220|593263908|FG001|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
164244605|NCT05615220|593263909|FG002|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
164244606|NCT05615220|593263907|FG000|Open label stabilization Part (12 weeks)|Physician Decision|1|||
164574421|NCT00552110|594465638|FG001|Overall Study|Lack of Efficacy|0|||
164244607|NCT05615220|593263908|FG001|Open label stabilization Part (12 weeks)|Physician Decision|0|||
164244608|NCT05615220|593263909|FG002|Open label stabilization Part (12 weeks)|Physician Decision|0|||
164244609|NCT05615220|593263907|FG000|Open label stabilization Part (12 weeks)|Lost to Follow-up|3|||
164574422|NCT00552110|594465639|FG002|Overall Study|Lack of Efficacy|0|||
164574423|NCT00552110|594465640|FG003|Overall Study|Lack of Efficacy|1|||
164574424|NCT00552110|594465641|FG004|Overall Study|Lack of Efficacy|4|||
164244610|NCT05615220|593263908|FG001|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
164244611|NCT05615220|593263909|FG002|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
164244612|NCT05615220|593263907|FG000|Open label stabilization Part (12 weeks)|Protocol Deviation|1|||
164244613|NCT05615220|593263908|FG001|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
164244614|NCT05615220|593263909|FG002|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
164244615|NCT05615220|593263907|FG000|Open label stabilization Part (12 weeks)|Other|6|||
164244616|NCT05615220|593263908|FG001|Open label stabilization Part (12 weeks)|Other|0|||
164244617|NCT05615220|593263909|FG002|Open label stabilization Part (12 weeks)|Other|0|||
164244618|NCT05615220|593263907|FG000|Open label stabilization Part (12 weeks)|Lack of Efficacy|4|||
164244619|NCT05615220|593263908|FG001|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
164244620|NCT05615220|593263909|FG002|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
164244621|NCT05615220|593263907|FG000|Double Blind R/WD Part (12-24 weeks)|Relapsed|0|||
164244622|NCT05615220|593263908|FG001|Double Blind R/WD Part (12-24 weeks)|Relapsed|21|||
164244623|NCT05615220|593263909|FG002|Double Blind R/WD Part (12-24 weeks)|Relapsed|36|||
164244624|NCT05615220|593263907|FG000|Double Blind R/WD Part (12-24 weeks)|Adverse Event|0|||
164244625|NCT05615220|593263908|FG001|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
164244626|NCT05615220|593263909|FG002|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
164244627|NCT05615220|593263907|FG000|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
164244628|NCT05615220|593263908|FG001|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|1|||
164244629|NCT05615220|593263909|FG002|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
164244630|NCT05615220|593263907|FG000|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|0|||
164244631|NCT05615220|593263908|FG001|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|6|||
164244632|NCT05615220|593263909|FG002|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|2|||
164244633|NCT05615220|593263907|FG000|Double Blind R/WD Part (12-24 weeks)|Other|0|||
164244634|NCT05615220|593263908|FG001|Double Blind R/WD Part (12-24 weeks)|Other|1|||
164244635|NCT05615220|593263909|FG002|Double Blind R/WD Part (12-24 weeks)|Other|1|||
164244636|NCT01459666|593263911|FG000|Overall Study|PI left institution|5|||
164244637|NCT01459666|593263912|FG001|Overall Study|PI left institution|4|||
164337512|NCT00810693|593611564|FG002|Follow-up Period (FUP)|Death|1|||
164337513|NCT00810693|593611562|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
164337514|NCT00810693|593611563|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
164337515|NCT00810693|593611564|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
164337516|NCT00810693|593611562|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
164337517|NCT00810693|593611563|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
164574425|NCT00552110|594465637|FG000|Overall Study|Withdrawal by Subject|0|||
164574426|NCT00552110|594465638|FG001|Overall Study|Withdrawal by Subject|2|||
164574427|NCT00552110|594465639|FG002|Overall Study|Withdrawal by Subject|0|||
164574428|NCT00552110|594465640|FG003|Overall Study|Withdrawal by Subject|3|||
164574429|NCT00552110|594465641|FG004|Overall Study|Withdrawal by Subject|2|||
164574430|NCT00552110|594465637|FG000|Overall Study|Lost to Follow-up|0|||
164574431|NCT00552110|594465638|FG001|Overall Study|Lost to Follow-up|0|||
164574432|NCT00552110|594465639|FG002|Overall Study|Lost to Follow-up|0|||
164574433|NCT00552110|594465640|FG003|Overall Study|Lost to Follow-up|1|||
164574434|NCT00552110|594465641|FG004|Overall Study|Lost to Follow-up|1|||
164574435|NCT00552110|594465637|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
164574436|NCT00552110|594465638|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
164244638|NCT01061385|593263913|FG000|Overall Study|Lost to Follow-up|1|||
164244639|NCT01061385|593263914|FG001|Overall Study|Lost to Follow-up|0|||
164244640|NCT01061385|593263913|FG000|Overall Study|subject decision not related to AE|0|||
164244641|NCT01061385|593263914|FG001|Overall Study|subject decision not related to AE|1|||
164244642|NCT00533429|593263916|FG000|Overall Study|Adverse Event|3|||
164244643|NCT00533429|593263917|FG001|Overall Study|Adverse Event|1|||
164244644|NCT00533429|593263916|FG000|Overall Study|Death|1|||
164244645|NCT00533429|593263917|FG001|Overall Study|Death|0|||
164244646|NCT00533429|593263916|FG000|Overall Study|Withdrawal by Subject|2|||
164244647|NCT00533429|593263917|FG001|Overall Study|Withdrawal by Subject|0|||
164244648|NCT00533429|593263916|FG000|Overall Study|Progressive Disease|12|||
164244649|NCT00533429|593263917|FG001|Overall Study|Progressive Disease|13|||
164244650|NCT00533429|593263916|FG000|Overall Study|Symptomatic deterioration|1|||
164244651|NCT00533429|593263917|FG001|Overall Study|Symptomatic deterioration|2|||
164244652|NCT02379052|593263929|FG000|Overall Study|Protocol Violation|0|||
164244653|NCT02379052|593263930|FG001|Overall Study|Protocol Violation|1|||
164244654|NCT02379052|593263929|FG000|Overall Study|Adverse Event|0|||
164244655|NCT02379052|593263930|FG001|Overall Study|Adverse Event|1|||
164244656|NCT02379052|593263929|FG000|Overall Study|Physician Decision|1|||
164244657|NCT02379052|593263930|FG001|Overall Study|Physician Decision|1|||
164244658|NCT02379052|593263929|FG000|Overall Study|Withdrawal by Subject|2|||
164244659|NCT02379052|593263930|FG001|Overall Study|Withdrawal by Subject|0|||
164244660|NCT02379052|593263929|FG000|Overall Study|Lost to Follow-up|2|||
164244661|NCT02379052|593263930|FG001|Overall Study|Lost to Follow-up|1|||
164244662|NCT02379052|593263929|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
164244663|NCT02379052|593263930|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
164244664|NCT02379052|593263929|FG000|Overall Study|Subject was Incarcerated|0|||
164244665|NCT02379052|593263930|FG001|Overall Study|Subject was Incarcerated|1|||
164244666|NCT00127855|593263932|FG000|Primary Vaccination Course|Adverse Event|0|||
164244667|NCT00127855|593263933|FG001|Primary Vaccination Course|Adverse Event|0|||
164244668|NCT00127855|593263934|FG002|Primary Vaccination Course|Adverse Event|1|||
164244669|NCT00127855|593263935|FG003|Primary Vaccination Course|Adverse Event|0|||
164244670|NCT00127855|593263936|FG004|Primary Vaccination Course|Adverse Event|0|||
164244671|NCT00127855|593263932|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
164244672|NCT00127855|593263933|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
164244673|NCT00127855|593263934|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
164244674|NCT00127855|593263935|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
164244675|NCT00127855|593263936|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
164244676|NCT00127855|593263932|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
164244677|NCT00127855|593263933|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
164244678|NCT00127855|593263934|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
164244679|NCT00127855|593263935|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
164244680|NCT00127855|593263936|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
164244681|NCT00127855|593263932|FG000|Primary Vaccination Course|Other|0|||
164244682|NCT00127855|593263933|FG001|Primary Vaccination Course|Other|0|||
164244683|NCT00127855|593263934|FG002|Primary Vaccination Course|Other|0|||
164244684|NCT00127855|593263935|FG003|Primary Vaccination Course|Other|0|||
164244685|NCT00127855|593263936|FG004|Primary Vaccination Course|Other|1|||
164244686|NCT02343302|593263937|FG000|Overall Study|Physician Decision|1|||
164244687|NCT02343302|593263938|FG001|Overall Study|Physician Decision|1|||
164244688|NCT01282866|593263941|FG000|Overall Study|Adverse Event|1|||
164244689|NCT04834726|593263942|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
164244690|NCT04834726|593263943|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
164244691|NCT04834726|593263944|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
164244692|NCT04834726|593263945|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
164244693|NCT04834726|593263946|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
164244694|NCT04834726|593263947|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
164244695|NCT04834726|593263948|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
164244696|NCT04834726|593263949|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
164244697|NCT04834726|593263950|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
164244698|NCT02948582|593263956|FG000|Washout Period 1|Adverse Event|0|||
164244699|NCT02948582|593263957|FG001|Washout Period 1|Adverse Event|2|||
164244700|NCT02948582|593263958|FG002|Washout Period 1|Adverse Event|0|||
164337518|NCT00810693|593611564|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
164244701|NCT02948582|593263959|FG003|Washout Period 1|Adverse Event|0|||
164244702|NCT02948582|593263960|FG004|Washout Period 1|Adverse Event|0|||
164244703|NCT02948582|593263961|FG005|Washout Period 1|Adverse Event|0|||
164337519|NCT00810693|593611562|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
164678770|NCT00185458|594848042|FG000|HRT Phase|Lost to Follow-up|4|||
164678771|NCT00185458|594848042|FG000|HRT Phase|Protocol Violation|2|||
164337520|NCT00810693|593611563|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
164337521|NCT00810693|593611564|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
164678772|NCT00185458|594848042|FG000|HRT Phase|Withdrawal by Subject|3|||
164244704|NCT02948582|593263956|FG000|Washout Period 1|Protocol Violation|0|||
164244705|NCT02948582|593263957|FG001|Washout Period 1|Protocol Violation|0|||
164244706|NCT02948582|593263958|FG002|Washout Period 1|Protocol Violation|0|||
164244707|NCT02948582|593263959|FG003|Washout Period 1|Protocol Violation|0|||
164244708|NCT02948582|593263960|FG004|Washout Period 1|Protocol Violation|0|||
164244709|NCT02948582|593263961|FG005|Washout Period 1|Protocol Violation|1|||
164244710|NCT02948582|593263956|FG000|Washout Period 2|Adverse Event|0|||
164244711|NCT02948582|593263957|FG001|Washout Period 2|Adverse Event|1|||
164244712|NCT02948582|593263958|FG002|Washout Period 2|Adverse Event|0|||
164244713|NCT02948582|593263959|FG003|Washout Period 2|Adverse Event|0|||
164244714|NCT02948582|593263960|FG004|Washout Period 2|Adverse Event|0|||
164244715|NCT02948582|593263961|FG005|Washout Period 2|Adverse Event|0|||
164244716|NCT02948582|593263956|FG000|Washout Period 2|personal reasons|0|||
164244717|NCT02948582|593263957|FG001|Washout Period 2|personal reasons|0|||
164244718|NCT02948582|593263958|FG002|Washout Period 2|personal reasons|0|||
164244719|NCT02948582|593263959|FG003|Washout Period 2|personal reasons|1|||
164244720|NCT02948582|593263960|FG004|Washout Period 2|personal reasons|0|||
164244721|NCT02948582|593263961|FG005|Washout Period 2|personal reasons|0|||
164244722|NCT02948582|593263956|FG000|Washout Period 4|Adverse Event|1|||
164244723|NCT02948582|593263957|FG001|Washout Period 4|Adverse Event|0|||
164244724|NCT02948582|593263958|FG002|Washout Period 4|Adverse Event|1|||
164244725|NCT02948582|593263959|FG003|Washout Period 4|Adverse Event|0|||
164244726|NCT02948582|593263960|FG004|Washout Period 4|Adverse Event|0|||
164244727|NCT02948582|593263961|FG005|Washout Period 4|Adverse Event|0|||
164244728|NCT03606486|593263962|FG000|Overall Study|Unable to collect sample|5|||
164244729|NCT01265992|593263970|FG000|Overall Study|Lost to Follow-up|1|||
164244730|NCT01265992|593263970|FG000|Overall Study|Withdrawal by Subject|1|||
164244731|NCT01265992|593263970|FG000|Overall Study|Adverse Event|1|||
164244732|NCT01265992|593263970|FG000|Overall Study|Administrative reasons|2|||
164244733|NCT01265992|593263970|FG000|Overall Study|Stopped treatment|3|||
164244734|NCT01265992|593263970|FG000|Overall Study|Did not receive treatment|1|||
164244735|NCT02137070|593263971|FG000|Overall Study|Adverse Event|12|||
164244736|NCT02137070|593263972|FG001|Overall Study|Adverse Event|3|||
164244737|NCT02137070|593263971|FG000|Overall Study|Death|2|||
164244738|NCT02137070|593263972|FG001|Overall Study|Death|0|||
164244739|NCT02137070|593263971|FG000|Overall Study|Lost to Follow-up|24|||
164244740|NCT02137070|593263972|FG001|Overall Study|Lost to Follow-up|9|||
164244741|NCT02137070|593263971|FG000|Overall Study|Physician Decision|0|||
164244742|NCT02137070|593263972|FG001|Overall Study|Physician Decision|1|||
164244743|NCT02137070|593263971|FG000|Overall Study|Protocol Violation|18|||
164244744|NCT02137070|593263972|FG001|Overall Study|Protocol Violation|4|||
164244745|NCT02137070|593263971|FG000|Overall Study|Withdrawal by Subject|18|||
164244746|NCT02137070|593263972|FG001|Overall Study|Withdrawal by Subject|1|||
164244747|NCT03941483|593263973|FG000|Overall Study|Miscellaneous|2|||
164244748|NCT03941483|593263974|FG001|Overall Study|Miscellaneous|3|||
164244749|NCT03941483|593263975|FG002|Overall Study|Miscellaneous|0|||
164244750|NCT03941483|593263973|FG000|Overall Study|Study Terminated by Sponsor|1|||
164244751|NCT03941483|593263974|FG001|Overall Study|Study Terminated by Sponsor|0|||
164244752|NCT03941483|593263975|FG002|Overall Study|Study Terminated by Sponsor|0|||
164244753|NCT03941483|593263973|FG000|Overall Study|Withdrawal by Subject|1|||
164244754|NCT03941483|593263974|FG001|Overall Study|Withdrawal by Subject|4|||
164244755|NCT03941483|593263975|FG002|Overall Study|Withdrawal by Subject|1|||
164244756|NCT03941483|593263973|FG000|Overall Study|Lost to Follow-up|2|||
164244757|NCT03941483|593263974|FG001|Overall Study|Lost to Follow-up|1|||
164244758|NCT03941483|593263975|FG002|Overall Study|Lost to Follow-up|8|||
164244759|NCT03941483|593263973|FG000|Overall Study|Death|3|||
164244760|NCT03941483|593263974|FG001|Overall Study|Death|2|||
164244761|NCT03941483|593263975|FG002|Overall Study|Death|6|||
164244762|NCT03154476|593263980|FG000|Overall Study|Lost to Follow-up|4|||
164244763|NCT03154476|593263981|FG001|Overall Study|Lost to Follow-up|4|||
164244764|NCT01444430|593263982|FG000|Overall Study|Withdrawal by Subject|53|||
164244765|NCT01444430|593263983|FG001|Overall Study|Withdrawal by Subject|72|||
164244766|NCT01444430|593263982|FG000|Overall Study|Death|6|||
164244767|NCT01444430|593263983|FG001|Overall Study|Death|8|||
164244768|NCT01444430|593263982|FG000|Overall Study|Lost to Follow-up|2|||
164244769|NCT01444430|593263983|FG001|Overall Study|Lost to Follow-up|0|||
164244770|NCT01444430|593263982|FG000|Overall Study|CRF termination module not completed.|0|||
164244771|NCT01444430|593263983|FG001|Overall Study|CRF termination module not completed.|1|||
164244772|NCT01142388|593265509|FG000|Overall Study|Lack of Efficacy|21|||
164244773|NCT01142388|593265510|FG001|Overall Study|Lack of Efficacy|31|||
164244774|NCT01142388|593265509|FG000|Overall Study|Adverse Event|9|||
164244775|NCT01142388|593265510|FG001|Overall Study|Adverse Event|5|||
164244776|NCT01142388|593265509|FG000|Overall Study|Death|3|||
164244777|NCT01142388|593265510|FG001|Overall Study|Death|2|||
164244778|NCT01142388|593265509|FG000|Overall Study|Withdrawal by Subject|5|||
164244779|NCT01142388|593265510|FG001|Overall Study|Withdrawal by Subject|3|||
164244780|NCT01142388|593265509|FG000|Overall Study|Alternative therapy|1|||
164244781|NCT01142388|593265510|FG001|Overall Study|Alternative therapy|0|||
164244782|NCT01142388|593265509|FG000|Overall Study|Other complications|0|||
164244783|NCT01142388|593265510|FG001|Overall Study|Other complications|2|||
164244784|NCT01142388|593265509|FG000|Overall Study|Other|1|||
164244785|NCT01142388|593265510|FG001|Overall Study|Other|1|||
164244786|NCT01142388|593265509|FG000|Overall Study|Never started therapy|7|||
164244787|NCT01142388|593265510|FG001|Overall Study|Never started therapy|3|||
164678773|NCT00830024|594848043|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
164678774|NCT00830024|594848044|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
164678775|NCT02554890|594848045|FG000|Double-blind|Adverse Event|45|||
164678776|NCT02554890|594848046|FG001|Double-blind|Adverse Event|51|||
164678777|NCT02554890|594848045|FG000|Double-blind|Death|6|||
164678778|NCT02554890|594848046|FG001|Double-blind|Death|4|||
164678779|NCT02554890|594848045|FG000|Double-blind|Protocol Violation|1|||
164678780|NCT02554890|594848046|FG001|Double-blind|Protocol Violation|1|||
164678781|NCT02554890|594848045|FG000|Double-blind|Physician Decision|4|||
164678782|NCT02554890|594848046|FG001|Double-blind|Physician Decision|3|||
164678783|NCT02554890|594848045|FG000|Double-blind|Subject/Guardian decision|21|||
164678784|NCT02554890|594848046|FG001|Double-blind|Subject/Guardian decision|16|||
164678785|NCT02554890|594848045|FG000|Double-blind|Lost to Follow-up|7|||
164678786|NCT02554890|594848046|FG001|Double-blind|Lost to Follow-up|5|||
164678787|NCT02554890|594848045|FG000|Double-blind|Technical problems|1|||
164678788|NCT02554890|594848046|FG001|Double-blind|Technical problems|0|||
164678789|NCT02554890|594848045|FG000|Double-blind|Withdrawal by Subject|5|||
164678790|NCT02554890|594848046|FG001|Double-blind|Withdrawal by Subject|6|||
164678791|NCT02554890|594848045|FG000|Double-blind|Noncompliance with study treatment|6|||
164678792|NCT02554890|594848046|FG001|Double-blind|Noncompliance with study treatment|5|||
164678793|NCT02554890|594848045|FG000|Open-label|Adverse Event|0|||
164678794|NCT02554890|594848046|FG001|Open-label|Adverse Event|30|||
164678795|NCT02554890|594848045|FG000|Open-label|Death|0|||
164678796|NCT02554890|594848046|FG001|Open-label|Death|1|||
164678797|NCT02554890|594848045|FG000|Open-label|Physician Decision|0|||
164678798|NCT02554890|594848046|FG001|Open-label|Physician Decision|1|||
164678799|NCT02554890|594848045|FG000|Open-label|Subject/Guardian decision|0|||
164678800|NCT02554890|594848046|FG001|Open-label|Subject/Guardian decision|11|||
164678801|NCT02554890|594848045|FG000|Open-label|Lost to Follow-up|0|||
164678802|NCT02554890|594848046|FG001|Open-label|Lost to Follow-up|7|||
164678803|NCT02554890|594848045|FG000|Open-label|Technical problems|0|||
164678804|NCT02554890|594848046|FG001|Open-label|Technical problems|1|||
164678805|NCT02554890|594848045|FG000|Open-label|Withdrawal by Subject|0|||
164678806|NCT02554890|594848046|FG001|Open-label|Withdrawal by Subject|1|||
164678807|NCT04544410|594848049|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
164678808|NCT04544410|594848050|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
164678809|NCT04544410|594848049|FG000|Double-blind Treatment Period|Adverse Event|1|||
164678810|NCT04544410|594848050|FG001|Double-blind Treatment Period|Adverse Event|0|||
164678811|NCT04544410|594848049|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
164678812|NCT04544410|594848050|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
164678813|NCT04544410|594848049|FG000|Double-blind Treatment Period|Protocol Violation|1|||
164678814|NCT04544410|594848050|FG001|Double-blind Treatment Period|Protocol Violation|0|||
164678815|NCT04544410|594848049|FG000|Open-Label Treatment Period|Study Terminated|15|||
164678816|NCT04544410|594848050|FG001|Open-Label Treatment Period|Study Terminated|19|||
164678817|NCT04544410|594848049|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
164678818|NCT04544410|594848050|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
164678819|NCT04544410|594848049|FG000|Open-Label Treatment Period|Adverse Event|0|||
164678820|NCT04544410|594848050|FG001|Open-Label Treatment Period|Adverse Event|1|||
164678821|NCT04544410|594848049|FG000|Open-Label Treatment Period|Physician Decision|1|||
164678822|NCT04544410|594848050|FG001|Open-Label Treatment Period|Physician Decision|0|||
164678823|NCT04544410|594848049|FG000|Open-Label Treatment Period|Other|0|||
164678824|NCT04544410|594848050|FG001|Open-Label Treatment Period|Other|1|||
164678825|NCT03599193|594849389|FG000|Overall Study|Adverse Event|0|||
164678826|NCT03599193|594849390|FG001|Overall Study|Adverse Event|2|||
164678827|NCT03599193|594849389|FG000|Overall Study|Withdrawal by Subject|1|||
164678828|NCT03599193|594849390|FG001|Overall Study|Withdrawal by Subject|0|||
164678829|NCT03599193|594849389|FG000|Overall Study|Protocol Violation|1|||
164678830|NCT03599193|594849390|FG001|Overall Study|Protocol Violation|0|||
164678831|NCT03599193|594849389|FG000|Overall Study|Lost to Follow-up|0|||
164678832|NCT03599193|594849390|FG001|Overall Study|Lost to Follow-up|1|||
164678833|NCT01750294|594849391|FG000|Overall Study|Withdrawal by Subject|1|||
164678834|NCT01750294|594849391|FG000|Overall Study|Safety Endpoint|1|||
164678835|NCT01624233|594849392|FG000|Period 2 - Induction|Adverse Event|1|||
164678836|NCT01624233|594849392|FG000|Period 3 - Maintenance|Adverse Event|2|||
164678837|NCT01624233|594849392|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
164678838|NCT01624233|594849392|FG000|Period 3 - Maintenance|Physician Decision|2|||
164678839|NCT01624233|594849392|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
164678840|NCT01624233|594849392|FG000|Period 4 - Drug Free Period|Relapsed|61|||
164678841|NCT01624233|594849392|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
164678842|NCT01624233|594849392|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
164678843|NCT01624233|594849392|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
164678844|NCT01624233|594849392|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
164244788|NCT05265728|593265516|FG000|Overall Study|Adverse Event|1|||
164244789|NCT05265728|593265516|FG000|Overall Study|Study Terminated by Sponsor|5|||
164244790|NCT05265728|593265516|FG000|Overall Study|Withdrawal by Subject|2|||
164244791|NCT03493451|593265517|FG000|Overall Study|Death|11|||
164244792|NCT03493451|593265518|FG001|Overall Study|Death|26|||
164244793|NCT03493451|593265519|FG002|Overall Study|Death|3|||
164244794|NCT03493451|593265517|FG000|Overall Study|Lost to Follow-up|1|||
164244795|NCT03493451|593265518|FG001|Overall Study|Lost to Follow-up|4|||
164244796|NCT03493451|593265519|FG002|Overall Study|Lost to Follow-up|1|||
164244797|NCT03493451|593265517|FG000|Overall Study|Withdrawal by Subject|1|||
164244798|NCT03493451|593265518|FG001|Overall Study|Withdrawal by Subject|1|||
164244799|NCT03493451|593265519|FG002|Overall Study|Withdrawal by Subject|2|||
164244800|NCT03493451|593265517|FG000|Overall Study|Progressive Disease|1|||
164244801|NCT03493451|593265518|FG001|Overall Study|Progressive Disease|0|||
164244802|NCT03493451|593265519|FG002|Overall Study|Progressive Disease|0|||
164244803|NCT03493451|593265517|FG000|Overall Study|Transferred to long term extension study|8|||
164244804|NCT03493451|593265518|FG001|Overall Study|Transferred to long term extension study|13|||
164244805|NCT03493451|593265519|FG002|Overall Study|Transferred to long term extension study|5|||
164244806|NCT01693250|593265528|FG000|Overall Study|Lost to Follow-up|2|||
164244807|NCT01693250|593265529|FG001|Overall Study|Lost to Follow-up|2|||
164244808|NCT01147965|593265530|FG000|Overall Study|Progressive Disease|3|||
164244809|NCT01147965|593265531|FG001|Overall Study|Progressive Disease|3|||
164244810|NCT01147965|593265532|FG002|Overall Study|Progressive Disease|5|||
164244811|NCT01147965|593265533|FG003|Overall Study|Progressive Disease|9|||
164244812|NCT01147965|593265534|FG004|Overall Study|Progressive Disease|5|||
164244813|NCT01147965|593265535|FG005|Overall Study|Progressive Disease|5|||
164244814|NCT01147965|593265530|FG000|Overall Study|Death|0|||
164337522|NCT01297920|593611565|FG000|Overall Study|Adverse Event|42|||
164337523|NCT01297920|593611566|FG001|Overall Study|Adverse Event|10|||
164337524|NCT01297920|593611567|FG002|Overall Study|Adverse Event|38|||
164425952|NCT04955626|593930836|FG025|Blinded Period|Death|0|||
164425953|NCT04955626|593930837|FG026|Blinded Period|Death|1|||
164425954|NCT04955626|593930838|FG027|Blinded Period|Death|1|||
164425955|NCT04955626|593930839|FG028|Blinded Period|Death|0|||
164425956|NCT04955626|593930840|FG029|Blinded Period|Death|1|||
164425957|NCT04955626|593930841|FG030|Blinded Period|Death|0|||
164425958|NCT04955626|593930842|FG031|Blinded Period|Death|0|||
164425959|NCT04955626|593930843|FG032|Blinded Period|Death|0|||
164425960|NCT04955626|593930844|FG033|Blinded Period|Death|0|||
164574437|NCT00552110|594465639|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
164337525|NCT01297920|593611565|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
164337526|NCT01297920|593611566|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
164337527|NCT01297920|593611567|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
164337528|NCT01297920|593611565|FG000|Overall Study|Noncompliance|1|||
164337529|NCT01297920|593611566|FG001|Overall Study|Noncompliance|0|||
164337530|NCT01297920|593611567|FG002|Overall Study|Noncompliance|0|||
164337531|NCT01297920|593611565|FG000|Overall Study|Protocol Violation|1|||
164337532|NCT01297920|593611566|FG001|Overall Study|Protocol Violation|3|||
164337533|NCT01297920|593611567|FG002|Overall Study|Protocol Violation|0|||
164337534|NCT01297920|593611565|FG000|Overall Study|Inadequate Control of IOP|7|||
164337535|NCT01297920|593611566|FG001|Overall Study|Inadequate Control of IOP|9|||
164337536|NCT01297920|593611567|FG002|Overall Study|Inadequate Control of IOP|17|||
164337537|NCT01297920|593611565|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
164337538|NCT01297920|593611566|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
164337539|NCT01297920|593611567|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
164337540|NCT04295772|593611570|FG000|Overall Study|Protocol Violation|1|||
164337541|NCT04295772|593611571|FG001|Overall Study|Protocol Violation|0|||
164337542|NCT04295772|593611570|FG000|Overall Study|Ongoing for safety monitoring|14|||
164337543|NCT04295772|593611571|FG001|Overall Study|Ongoing for safety monitoring|1|||
164337544|NCT04295772|593611570|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
164337545|NCT04295772|593611571|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
164337546|NCT00331422|593611572|FG000|Overall Study|Did not receive entire study regimen|5|||
164574438|NCT00552110|594465640|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
164574439|NCT00552110|594465641|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
164337547|NCT02345226|593611573|FG000|Double-Blind Phase|Adverse Event|5|||
164244815|NCT01147965|593265531|FG001|Overall Study|Death|0|||
164244816|NCT01147965|593265532|FG002|Overall Study|Death|1|||
164244817|NCT01147965|593265533|FG003|Overall Study|Death|1|||
164337548|NCT02345226|593611574|FG001|Double-Blind Phase|Adverse Event|6|||
164337549|NCT02345226|593611573|FG000|Double-Blind Phase|Death|3|||
164337550|NCT02345226|593611574|FG001|Double-Blind Phase|Death|0|||
164425961|NCT04955626|593930845|FG034|Blinded Period|Death|0|||
164425962|NCT04955626|593930846|FG035|Blinded Period|Death|0|||
164425963|NCT04955626|593930811|FG000|Blinded Period|Adverse Event|0|||
164425964|NCT04955626|593930812|FG001|Blinded Period|Adverse Event|1|||
164425965|NCT04955626|593930813|FG002|Blinded Period|Adverse Event|1|||
164574440|NCT00552110|594465637|FG000|Overall Study|Withdrawn per Sponsor|0|||
164337551|NCT02345226|593611573|FG000|Double-Blind Phase|Pregnancy|0|||
164425966|NCT04955626|593930814|FG003|Blinded Period|Adverse Event|1|||
164425967|NCT04955626|593930815|FG004|Blinded Period|Adverse Event|0|||
164425968|NCT04955626|593930816|FG005|Blinded Period|Adverse Event|0|||
164425969|NCT04955626|593930817|FG006|Blinded Period|Adverse Event|0|||
164425970|NCT04955626|593930818|FG007|Blinded Period|Adverse Event|0|||
164425971|NCT04955626|593930819|FG008|Blinded Period|Adverse Event|0|||
164425972|NCT04955626|593930820|FG009|Blinded Period|Adverse Event|1|||
164425973|NCT04955626|593930821|FG010|Blinded Period|Adverse Event|1|||
164425974|NCT04955626|593930822|FG011|Blinded Period|Adverse Event|0|||
164425975|NCT04955626|593930823|FG012|Blinded Period|Adverse Event|0|||
164425976|NCT04955626|593930824|FG013|Blinded Period|Adverse Event|0|||
164425977|NCT04955626|593930825|FG014|Blinded Period|Adverse Event|0|||
164425978|NCT04955626|593930826|FG015|Blinded Period|Adverse Event|0|||
164425979|NCT04955626|593930827|FG016|Blinded Period|Adverse Event|0|||
164425980|NCT04955626|593930828|FG017|Blinded Period|Adverse Event|0|||
164425981|NCT04955626|593930829|FG018|Blinded Period|Adverse Event|1|||
164425982|NCT04955626|593930830|FG019|Blinded Period|Adverse Event|0|||
164425983|NCT04955626|593930831|FG020|Blinded Period|Adverse Event|0|||
164425984|NCT04955626|593930832|FG021|Blinded Period|Adverse Event|0|||
164425985|NCT04955626|593930833|FG022|Blinded Period|Adverse Event|0|||
164425986|NCT04955626|593930834|FG023|Blinded Period|Adverse Event|0|||
164425987|NCT04955626|593930835|FG024|Blinded Period|Adverse Event|0|||
164425988|NCT04955626|593930836|FG025|Blinded Period|Adverse Event|0|||
164425989|NCT04955626|593930837|FG026|Blinded Period|Adverse Event|1|||
164425990|NCT04955626|593930838|FG027|Blinded Period|Adverse Event|0|||
164425991|NCT04955626|593930839|FG028|Blinded Period|Adverse Event|0|||
164425992|NCT04955626|593930840|FG029|Blinded Period|Adverse Event|0|||
164425993|NCT04955626|593930841|FG030|Blinded Period|Adverse Event|0|||
164425994|NCT04955626|593930842|FG031|Blinded Period|Adverse Event|0|||
164425995|NCT04955626|593930843|FG032|Blinded Period|Adverse Event|0|||
164425996|NCT04955626|593930844|FG033|Blinded Period|Adverse Event|0|||
164425997|NCT04955626|593930845|FG034|Blinded Period|Adverse Event|0|||
164425998|NCT04955626|593930846|FG035|Blinded Period|Adverse Event|0|||
164425999|NCT04955626|593930811|FG000|Blinded Period|No longer meets eligibility criteria|1|||
164426000|NCT04955626|593930812|FG001|Blinded Period|No longer meets eligibility criteria|2|||
164426001|NCT04955626|593930813|FG002|Blinded Period|No longer meets eligibility criteria|0|||
164426002|NCT04955626|593930814|FG003|Blinded Period|No longer meets eligibility criteria|1|||
164426003|NCT04955626|593930815|FG004|Blinded Period|No longer meets eligibility criteria|0|||
164426004|NCT04955626|593930816|FG005|Blinded Period|No longer meets eligibility criteria|0|||
164426005|NCT04955626|593930817|FG006|Blinded Period|No longer meets eligibility criteria|0|||
164678845|NCT01624233|594849392|FG000|Period 6: Follow-up|Adverse Event|3|||
164337552|NCT02345226|593611574|FG001|Double-Blind Phase|Pregnancy|1|||
164337553|NCT02345226|593611573|FG000|Double-Blind Phase|Lack of Efficacy|1|||
164337554|NCT02345226|593611574|FG001|Double-Blind Phase|Lack of Efficacy|0|||
164337555|NCT02345226|593611573|FG000|Double-Blind Phase|Investigator's Discretion|4|||
164337556|NCT02345226|593611574|FG001|Double-Blind Phase|Investigator's Discretion|3|||
164337557|NCT02345226|593611573|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
164337558|NCT02345226|593611574|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
164337559|NCT02345226|593611573|FG000|Double-Blind Phase|Withdrew Consent|41|||
164337560|NCT02345226|593611574|FG001|Double-Blind Phase|Withdrew Consent|39|||
164337561|NCT02345226|593611573|FG000|Double-Blind Phase|Lost to Follow-up|12|||
164337562|NCT02345226|593611574|FG001|Double-Blind Phase|Lost to Follow-up|16|||
164337563|NCT02345226|593611573|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
164337564|NCT02345226|593611574|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
164337565|NCT02345226|593611573|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
164337566|NCT02345226|593611574|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
164337567|NCT01710046|593611580|FG000|Overall Study|Lost to Follow-up|1|||
164337568|NCT01710046|593611581|FG001|Overall Study|Lost to Follow-up|0|||
164678846|NCT01624233|594849392|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
164678847|NCT01624233|594849392|FG000|Period 6: Follow-up|Physician Decision|1|||
164678848|NCT01624233|594849392|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
164337569|NCT03386474|593611584|FG000|Overall Study|Death|1|||
164337570|NCT03386474|593611585|FG001|Overall Study|Death|0|||
164337571|NCT03386474|593611584|FG000|Overall Study|Adverse Event|0|||
164337572|NCT03386474|593611585|FG001|Overall Study|Adverse Event|1|||
164426006|NCT04955626|593930818|FG007|Blinded Period|No longer meets eligibility criteria|0|||
164426007|NCT04955626|593930819|FG008|Blinded Period|No longer meets eligibility criteria|1|||
164426008|NCT04955626|593930820|FG009|Blinded Period|No longer meets eligibility criteria|0|||
164426009|NCT04955626|593930821|FG010|Blinded Period|No longer meets eligibility criteria|1|||
164426010|NCT04955626|593930822|FG011|Blinded Period|No longer meets eligibility criteria|1|||
164426011|NCT04955626|593930823|FG012|Blinded Period|No longer meets eligibility criteria|0|||
164426012|NCT04955626|593930824|FG013|Blinded Period|No longer meets eligibility criteria|0|||
164426013|NCT04955626|593930825|FG014|Blinded Period|No longer meets eligibility criteria|0|||
164426014|NCT04955626|593930826|FG015|Blinded Period|No longer meets eligibility criteria|3|||
164244818|NCT01147965|593265534|FG004|Overall Study|Death|0|||
164244819|NCT01147965|593265535|FG005|Overall Study|Death|2|||
164244820|NCT01147965|593265530|FG000|Overall Study|Withdrawal by Subject|0|||
164244821|NCT01147965|593265531|FG001|Overall Study|Withdrawal by Subject|0|||
164244822|NCT01147965|593265532|FG002|Overall Study|Withdrawal by Subject|1|||
164244823|NCT01147965|593265533|FG003|Overall Study|Withdrawal by Subject|1|||
164244824|NCT01147965|593265534|FG004|Overall Study|Withdrawal by Subject|0|||
164244825|NCT01147965|593265535|FG005|Overall Study|Withdrawal by Subject|0|||
164244826|NCT01147965|593265530|FG000|Overall Study|Administration Of Alternative Therapy|0|||
164244827|NCT01147965|593265531|FG001|Overall Study|Administration Of Alternative Therapy|0|||
164244828|NCT01147965|593265532|FG002|Overall Study|Administration Of Alternative Therapy|0|||
164244829|NCT01147965|593265533|FG003|Overall Study|Administration Of Alternative Therapy|0|||
164244830|NCT01147965|593265534|FG004|Overall Study|Administration Of Alternative Therapy|0|||
164244831|NCT01147965|593265535|FG005|Overall Study|Administration Of Alternative Therapy|1|||
164244832|NCT01147965|593265530|FG000|Overall Study|Other|0|||
164244833|NCT01147965|593265531|FG001|Overall Study|Other|0|||
164244834|NCT01147965|593265532|FG002|Overall Study|Other|0|||
164244835|NCT01147965|593265533|FG003|Overall Study|Other|3|||
164244836|NCT01147965|593265534|FG004|Overall Study|Other|1|||
164244837|NCT01147965|593265535|FG005|Overall Study|Other|0|||
164244838|NCT02257242|593265536|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
164244839|NCT02257242|593265537|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
164574441|NCT00552110|594465638|FG001|Overall Study|Withdrawn per Sponsor|1|||
164574442|NCT00552110|594465639|FG002|Overall Study|Withdrawn per Sponsor|0|||
164574443|NCT00552110|594465640|FG003|Overall Study|Withdrawn per Sponsor|0|||
164574444|NCT00552110|594465641|FG004|Overall Study|Withdrawn per Sponsor|1|||
164574445|NCT00552110|594465637|FG000|Overall Study|Use of Prohibited Medication|1|||
164574446|NCT00552110|594465638|FG001|Overall Study|Use of Prohibited Medication|1|||
164574447|NCT00552110|594465639|FG002|Overall Study|Use of Prohibited Medication|0|||
164574448|NCT00552110|594465640|FG003|Overall Study|Use of Prohibited Medication|0|||
164244840|NCT02257242|593265538|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
164244841|NCT02257242|593265539|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
164244842|NCT02257242|593265540|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
164244843|NCT02257242|593265541|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
164244844|NCT02257242|593265542|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
164244845|NCT02257242|593265543|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
164244846|NCT02257242|593265544|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
164244847|NCT00600106|593265545|FG000|Overall Study|Withdrawal by Subject|1|||
164244848|NCT00600106|593265546|FG001|Overall Study|Withdrawal by Subject|1|||
164244849|NCT00620373|593265547|FG000|Overall Study|Unverified cancer status|33|||
164244850|NCT02213926|593265552|FG000|Overall Study|Death|59|||
164244851|NCT02213926|593265552|FG000|Overall Study|Withdrawal by Subject|10|||
164244852|NCT02213926|593265552|FG000|Overall Study|study terminated by sponsor|51|||
164244853|NCT02213926|593265552|FG000|Overall Study|Lost to Follow-up|3|||
164244854|NCT02213926|593265552|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
164244855|NCT01465386|593265553|FG000|Overall Study|Lack of Efficacy|3|||
164244856|NCT01465386|593265553|FG000|Overall Study|Adverse Event|1|||
164244857|NCT01279044|593265556|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
164244858|NCT01279044|593265557|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
164244859|NCT01279044|593265558|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
164244860|NCT01279044|593265556|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
164244861|NCT01279044|593265557|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
164244862|NCT01279044|593265558|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
164244863|NCT01279044|593265556|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
164244864|NCT01279044|593265557|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
164244865|NCT01279044|593265558|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
164244866|NCT01408277|593265561|FG000|Overall Study|Adverse Event|3|||
164574449|NCT00552110|594465641|FG004|Overall Study|Use of Prohibited Medication|0|||
164574450|NCT00552110|594465637|FG000|Overall Study|Delay of Study due to Relabeling|0|||
164574451|NCT00552110|594465638|FG001|Overall Study|Delay of Study due to Relabeling|0|||
164678849|NCT03121586|594849395|FG000|Overall Study|Study terminated by sponsor|0|||
164244867|NCT01408277|593265562|FG001|Overall Study|Adverse Event|4|||
164244868|NCT01408277|593265561|FG000|Overall Study|Lost to Follow-up|1|||
164244869|NCT01408277|593265562|FG001|Overall Study|Lost to Follow-up|0|||
164244870|NCT01408277|593265561|FG000|Overall Study|Withdrawal by Subject|2|||
164244871|NCT01408277|593265562|FG001|Overall Study|Withdrawal by Subject|0|||
164244872|NCT01408277|593265561|FG000|Overall Study|Protocol Violation|2|||
164244873|NCT01408277|593265562|FG001|Overall Study|Protocol Violation|0|||
164244874|NCT03783962|593265563|FG000|Overall Study|Lost to Follow-up|3|||
164244875|NCT03783962|593265564|FG001|Overall Study|Lost to Follow-up|6|||
164244876|NCT03783962|593265563|FG000|Overall Study|Protocol Violation|0|||
164244877|NCT03783962|593265564|FG001|Overall Study|Protocol Violation|1|||
164244878|NCT02370368|593265565|FG000|Overall Study|Adverse Event|1|||
164244879|NCT02370368|593265566|FG001|Overall Study|Adverse Event|2|||
164244880|NCT02370368|593265565|FG000|Overall Study|Withdrawal by Subject|5|||
164244881|NCT02370368|593265566|FG001|Overall Study|Withdrawal by Subject|4|||
164244882|NCT01169337|593265567|FG000|Overall Study|Lack of Efficacy|5|||
164244883|NCT01169337|593265568|FG001|Overall Study|Lack of Efficacy|7|||
164244884|NCT01169337|593265569|FG002|Overall Study|Lack of Efficacy|0|||
164244885|NCT01169337|593265567|FG000|Overall Study|Adverse Event|12|||
164244886|NCT01169337|593265568|FG001|Overall Study|Adverse Event|18|||
164244887|NCT01169337|593265569|FG002|Overall Study|Adverse Event|0|||
164244888|NCT01169337|593265567|FG000|Overall Study|Death|2|||
164244889|NCT01169337|593265568|FG001|Overall Study|Death|0|||
164244890|NCT01169337|593265569|FG002|Overall Study|Death|0|||
164244891|NCT01169337|593265567|FG000|Overall Study|Withdrawal by Subject|11|||
164244892|NCT01169337|593265568|FG001|Overall Study|Withdrawal by Subject|11|||
164244893|NCT01169337|593265569|FG002|Overall Study|Withdrawal by Subject|6|||
164244894|NCT01169337|593265567|FG000|Overall Study|Noncompliance|2|||
164244895|NCT01169337|593265568|FG001|Overall Study|Noncompliance|0|||
164244896|NCT01169337|593265569|FG002|Overall Study|Noncompliance|0|||
164244897|NCT01169337|593265567|FG000|Overall Study|Other complicating disease|1|||
164244898|NCT01169337|593265568|FG001|Overall Study|Other complicating disease|1|||
164244899|NCT01169337|593265569|FG002|Overall Study|Other complicating disease|0|||
164244900|NCT01169337|593265567|FG000|Overall Study|Physician Decision|1|||
164244901|NCT01169337|593265568|FG001|Overall Study|Physician Decision|5|||
164244902|NCT01169337|593265569|FG002|Overall Study|Physician Decision|0|||
164244903|NCT01169337|593265567|FG000|Overall Study|Alternative therapy|0|||
164244904|NCT01169337|593265568|FG001|Overall Study|Alternative therapy|2|||
164244905|NCT01169337|593265569|FG002|Overall Study|Alternative therapy|0|||
164244906|NCT01169337|593265567|FG000|Overall Study|Changed hospital|0|||
164244907|NCT01169337|593265568|FG001|Overall Study|Changed hospital|1|||
164244908|NCT01169337|593265569|FG002|Overall Study|Changed hospital|0|||
164244909|NCT01169337|593265567|FG000|Overall Study|Never started treatment|0|||
164244910|NCT01169337|593265568|FG001|Overall Study|Never started treatment|2|||
164337573|NCT00066729|593611587|FG000|Overall Study|Lost to Follow-up|1|||
164337574|NCT00066729|593611587|FG000|Overall Study|Disease progression|1|||
164337575|NCT02215096|593611590|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
164337576|NCT02215096|593611591|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
164337577|NCT02215096|593611592|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
164337578|NCT02215096|593611593|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
164337579|NCT02215096|593611594|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
164337580|NCT02215096|593611590|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
164337581|NCT02215096|593611591|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
164337582|NCT02215096|593611592|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
164337583|NCT02215096|593611593|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
164337584|NCT02215096|593611594|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
164337585|NCT02215096|593611590|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
164337586|NCT02215096|593611591|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
164337587|NCT02215096|593611592|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
164337588|NCT02215096|593611593|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
164337589|NCT02215096|593611594|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
164337590|NCT02215096|593611590|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
164337591|NCT02215096|593611591|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
164337592|NCT02215096|593611592|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
164337593|NCT02215096|593611593|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
164337594|NCT02215096|593611594|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
164337595|NCT03021304|593611595|FG000|Overall Study|Lack of Efficacy|1|||
164337596|NCT00370071|593611596|FG000|Overall Study|Withdrawal by Subject|2|||
164337597|NCT03350620|593611600|FG000|Stage 2|Adverse Event|0|||
164337598|NCT03350620|593611601|FG001|Stage 2|Adverse Event|1|||
164337599|NCT03350620|593611602|FG002|Stage 2|Adverse Event|1|||
164337600|NCT03350620|593611600|FG000|Stage 2|Lack of Efficacy|0|||
164337601|NCT03350620|593611601|FG001|Stage 2|Lack of Efficacy|2|||
164337602|NCT03350620|593611602|FG002|Stage 2|Lack of Efficacy|0|||
164574452|NCT00552110|594465639|FG002|Overall Study|Delay of Study due to Relabeling|0|||
164574453|NCT00552110|594465640|FG003|Overall Study|Delay of Study due to Relabeling|1|||
164244911|NCT01169337|593265569|FG002|Overall Study|Never started treatment|0|||
164244912|NCT01169337|593265567|FG000|Overall Study|Reason not reported|1|||
164244913|NCT01169337|593265568|FG001|Overall Study|Reason not reported|0|||
164244914|NCT01169337|593265569|FG002|Overall Study|Reason not reported|0|||
164244915|NCT01169337|593265567|FG000|Overall Study|Continuing lenalidomide|9|||
164244916|NCT01169337|593265568|FG001|Overall Study|Continuing lenalidomide|43|||
164678850|NCT03121586|594849396|FG001|Overall Study|Study terminated by sponsor|0|||
164244917|NCT01169337|593265569|FG002|Overall Study|Continuing lenalidomide|0|||
164244918|NCT01643408|593265571|FG000|Overall Study|Adverse Event|12|||
164244919|NCT01643408|593265571|FG000|Overall Study|Other|2|||
164244920|NCT03726658|593265572|FG000|Overall Study|Lost to Follow-up|0|||
164244921|NCT03726658|593265573|FG001|Overall Study|Lost to Follow-up|0|||
164244922|NCT03726658|593265574|FG002|Overall Study|Lost to Follow-up|2|||
164244923|NCT03726658|593265575|FG003|Overall Study|Lost to Follow-up|0|||
164244924|NCT03726658|593265576|FG004|Overall Study|Lost to Follow-up|0|||
164244925|NCT03726658|593265577|FG005|Overall Study|Lost to Follow-up|1|||
164244926|NCT03726658|593265578|FG006|Overall Study|Lost to Follow-up|1|||
164244927|NCT03726658|593265572|FG000|Overall Study|Withdrawal by Subject|1|||
164244928|NCT03726658|593265573|FG001|Overall Study|Withdrawal by Subject|0|||
164244929|NCT03726658|593265574|FG002|Overall Study|Withdrawal by Subject|0|||
164244930|NCT03726658|593265575|FG003|Overall Study|Withdrawal by Subject|0|||
164244931|NCT03726658|593265576|FG004|Overall Study|Withdrawal by Subject|6|||
164244932|NCT03726658|593265577|FG005|Overall Study|Withdrawal by Subject|4|||
164244933|NCT03726658|593265578|FG006|Overall Study|Withdrawal by Subject|2|||
164244934|NCT03726658|593265572|FG000|Overall Study|Pregnancy|0|||
164244935|NCT03726658|593265573|FG001|Overall Study|Pregnancy|0|||
164244936|NCT03726658|593265574|FG002|Overall Study|Pregnancy|0|||
164244937|NCT03726658|593265575|FG003|Overall Study|Pregnancy|0|||
164244938|NCT03726658|593265576|FG004|Overall Study|Pregnancy|0|||
164244939|NCT03726658|593265577|FG005|Overall Study|Pregnancy|0|||
164244940|NCT03726658|593265578|FG006|Overall Study|Pregnancy|1|||
164244941|NCT03726658|593265572|FG000|Overall Study|Not Reported|0|||
164244942|NCT03726658|593265573|FG001|Overall Study|Not Reported|0|||
164244943|NCT03726658|593265574|FG002|Overall Study|Not Reported|0|||
164244944|NCT03726658|593265575|FG003|Overall Study|Not Reported|0|||
164244945|NCT03726658|593265576|FG004|Overall Study|Not Reported|0|||
164244946|NCT03726658|593265577|FG005|Overall Study|Not Reported|0|||
164244947|NCT03726658|593265578|FG006|Overall Study|Not Reported|1|||
164244948|NCT05710640|593265579|FG000|Overall Study|Physician Decision|0|||
164244949|NCT05710640|593265580|FG001|Overall Study|Physician Decision|1|||
164244950|NCT05710640|593265579|FG000|Overall Study|Withdrawal by Subject|1|||
164244951|NCT05710640|593265580|FG001|Overall Study|Withdrawal by Subject|0|||
164244952|NCT05710640|593265579|FG000|Overall Study|Withdrew prior to first device stimulation|1|||
164244953|NCT05710640|593265580|FG001|Overall Study|Withdrew prior to first device stimulation|0|||
164244954|NCT04188509|593265581|FG000|Overall Study|Adverse Event|2|||
164244955|NCT04188509|593265581|FG000|Overall Study|Lost to Follow-up|1|||
164244956|NCT04188509|593265581|FG000|Overall Study|Withdrawal of Consent|1|||
164244957|NCT04188509|593265581|FG000|Overall Study|Discretion of Investigator|1|||
164244958|NCT04188509|593265581|FG000|Overall Study|Noncompliance|3|||
164244959|NCT04188509|593265581|FG000|Overall Study|Sponsor Decision|127|||
164244960|NCT04188509|593265581|FG000|Overall Study|Other|2|||
164244961|NCT03810014|593265589|FG000|Overall Study|Pregnancy|2|||
164244962|NCT03810014|593265590|FG001|Overall Study|Pregnancy|2|||
164244963|NCT03810014|593265591|FG002|Overall Study|Pregnancy|0|||
164244964|NCT03810014|593265592|FG003|Overall Study|Pregnancy|2|||
164244965|NCT00049322|593265597|FG000|Overall Study|disease burden|0|||
164244966|NCT00049322|593265598|FG001|Overall Study|disease burden|3|||
164244967|NCT00049322|593265597|FG000|Overall Study|Adverse Event|1|||
164244968|NCT00049322|593265598|FG001|Overall Study|Adverse Event|0|||
164244969|NCT00049322|593265597|FG000|Overall Study|refused angio|0|||
164244970|NCT00049322|593265598|FG001|Overall Study|refused angio|3|||
164678851|NCT03121586|594849397|FG002|Overall Study|Study terminated by sponsor|99|||
164678852|NCT03121586|594849395|FG000|Overall Study|Withdrawal by Subject|37|||
164678853|NCT03121586|594849396|FG001|Overall Study|Withdrawal by Subject|14|||
164678854|NCT03121586|594849397|FG002|Overall Study|Withdrawal by Subject|9|||
164678855|NCT03121586|594849395|FG000|Overall Study|Not further specified|6|||
164678856|NCT03121586|594849396|FG001|Overall Study|Not further specified|11|||
164678857|NCT03121586|594849397|FG002|Overall Study|Not further specified|10|||
164678858|NCT03121586|594849395|FG000|Overall Study|Adverse Event|16|||
164678859|NCT03121586|594849396|FG001|Overall Study|Adverse Event|5|||
164678860|NCT03121586|594849397|FG002|Overall Study|Adverse Event|6|||
164244971|NCT00703963|593265599|FG000|Overall Study|Withdrawal by Subject|7|||
164244972|NCT00703963|593265600|FG001|Overall Study|Withdrawal by Subject|13|||
164244973|NCT00703963|593265599|FG000|Overall Study|Physician Decision|0|||
164244974|NCT00703963|593265600|FG001|Overall Study|Physician Decision|1|||
164244975|NCT03994211|593265607|FG000|Core Phase|Adverse Event|0|||
164244976|NCT03994211|593265608|FG001|Core Phase|Adverse Event|1|||
164244977|NCT03994211|593265609|FG002|Core Phase|Adverse Event|0|||
164244978|NCT03994211|593265607|FG000|Extension Phase|Adverse Event|0|||
164244979|NCT03994211|593265608|FG001|Extension Phase|Adverse Event|0|||
164244980|NCT03994211|593265609|FG002|Extension Phase|Adverse Event|1|||
164244981|NCT03994211|593265607|FG000|Extension Phase|Physician Decision|0|||
164244982|NCT03994211|593265608|FG001|Extension Phase|Physician Decision|0|||
164244983|NCT03994211|593265609|FG002|Extension Phase|Physician Decision|1|||
164244984|NCT03994211|593265607|FG000|Extension Phase|Progressive Disease|0|||
164244985|NCT03994211|593265608|FG001|Extension Phase|Progressive Disease|0|||
164574454|NCT00552110|594465641|FG004|Overall Study|Delay of Study due to Relabeling|0|||
164574455|NCT00552110|594465637|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
164244986|NCT03994211|593265609|FG002|Extension Phase|Progressive Disease|20|||
164244987|NCT03994211|593265607|FG000|Extension Phase|Withdrawal by Subject|0|||
164244988|NCT03994211|593265608|FG001|Extension Phase|Withdrawal by Subject|0|||
164244989|NCT03994211|593265609|FG002|Extension Phase|Withdrawal by Subject|2|||
164244990|NCT00955474|593265613|FG000|Overall Study|Physician Decision|7|||
164244991|NCT00955474|593265614|FG001|Overall Study|Physician Decision|5|||
164244992|NCT02148263|593265616|FG000|Overall Study|Withdrawal by Subject|3|||
164244993|NCT02148263|593265617|FG001|Overall Study|Withdrawal by Subject|2|||
164244994|NCT03900728|593265618|FG000|Overall Study|No text responses|0|||
164244995|NCT03900728|593265619|FG001|Overall Study|No text responses|0|||
164244996|NCT03900728|593265620|FG002|Overall Study|No text responses|4|||
164244997|NCT01272037|593265629|FG000|Overall Study|Death|25|||
164244998|NCT01272037|593265630|FG001|Overall Study|Death|28|||
164244999|NCT01272037|593265629|FG000|Overall Study|Adverse Event|12|||
164245000|NCT01272037|593265630|FG001|Overall Study|Adverse Event|7|||
164245001|NCT01272037|593265629|FG000|Overall Study|Withdrawal by Subject|175|||
164245002|NCT01272037|593265630|FG001|Overall Study|Withdrawal by Subject|93|||
164245003|NCT01272037|593265629|FG000|Overall Study|Disease progression|70|||
164245004|NCT01272037|593265630|FG001|Overall Study|Disease progression|111|||
164245005|NCT01272037|593265629|FG000|Overall Study|Other reason|42|||
164245006|NCT01272037|593265630|FG001|Overall Study|Other reason|41|||
164245007|NCT01272037|593265629|FG000|Overall Study|Delinquent data|24|||
164245008|NCT01272037|593265630|FG001|Overall Study|Delinquent data|19|||
164245009|NCT01272037|593265629|FG000|Overall Study|Reason under review|33|||
164245010|NCT01272037|593265630|FG001|Overall Study|Reason under review|29|||
164245011|NCT01272037|593265629|FG000|Overall Study|On treatment|626|||
164245012|NCT01272037|593265630|FG001|Overall Study|On treatment|632|||
164245013|NCT01393899|593265631|FG000|Overall Study|Study terminated by sponsor|1|||
164245014|NCT01393899|593265632|FG001|Overall Study|Study terminated by sponsor|0|||
164245015|NCT01393899|593265633|FG002|Overall Study|Study terminated by sponsor|1|||
164245016|NCT01393899|593265631|FG000|Overall Study|Other|1|||
164245017|NCT01393899|593265632|FG001|Overall Study|Other|0|||
164245018|NCT01393899|593265633|FG002|Overall Study|Other|0|||
164245019|NCT01393899|593265631|FG000|Overall Study|Withdrawal by Subject|2|||
164245020|NCT01393899|593265632|FG001|Overall Study|Withdrawal by Subject|2|||
164245021|NCT01393899|593265633|FG002|Overall Study|Withdrawal by Subject|1|||
164245022|NCT01393899|593265631|FG000|Overall Study|Lost to Follow-up|0|||
164245023|NCT01393899|593265632|FG001|Overall Study|Lost to Follow-up|0|||
164245024|NCT01393899|593265633|FG002|Overall Study|Lost to Follow-up|1|||
164245025|NCT01393899|593265631|FG000|Overall Study|Does not meet entrance criteria|1|||
164245026|NCT01393899|593265632|FG001|Overall Study|Does not meet entrance criteria|0|||
164245027|NCT01393899|593265633|FG002|Overall Study|Does not meet entrance criteria|1|||
164245028|NCT01393899|593265631|FG000|Overall Study|Lack of Efficacy|26|||
164245029|NCT01393899|593265632|FG001|Overall Study|Lack of Efficacy|21|||
164245030|NCT01393899|593265633|FG002|Overall Study|Lack of Efficacy|16|||
164245031|NCT01393899|593265631|FG000|Overall Study|Adverse Event|1|||
164245032|NCT01393899|593265632|FG001|Overall Study|Adverse Event|5|||
164245033|NCT01393899|593265633|FG002|Overall Study|Adverse Event|3|||
164245034|NCT02503085|593265634|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
164245035|NCT02503085|593265635|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
164245036|NCT02503085|593265636|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
164245037|NCT02503085|593265637|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
164245038|NCT01162473|593265641|FG000|Overall Study|Adverse Event|2|||
164245039|NCT01162473|593265642|FG001|Overall Study|Adverse Event|1|||
164245040|NCT01162473|593265641|FG000|Overall Study|Withdrawal by Subject|0|||
164245041|NCT01162473|593265642|FG001|Overall Study|Withdrawal by Subject|4|||
164245042|NCT01144416|593265643|FG000|Intervention Period|Adverse Event|5|||
164574456|NCT00552110|594465638|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
164574457|NCT00552110|594465639|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
164574458|NCT00552110|594465640|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
164574459|NCT00552110|594465641|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
164574460|NCT00552110|594465637|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
164574461|NCT00552110|594465638|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
164574462|NCT00552110|594465639|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
164245043|NCT01144416|593265644|FG001|Intervention Period|Adverse Event|6|||
164245044|NCT01144416|593265643|FG000|Intervention Period|Insufficient ovarian response|11|||
164245045|NCT01144416|593265644|FG001|Intervention Period|Insufficient ovarian response|17|||
164678861|NCT03121586|594849395|FG000|Overall Study|Protocol Violation|0|||
164245046|NCT01144416|593265643|FG000|Intervention Period|Risk of OHSS|0|||
164245047|NCT01144416|593265644|FG001|Intervention Period|Risk of OHSS|1|||
164245048|NCT01144416|593265643|FG000|Intervention Period|Too high ovarian response|4|||
164245049|NCT01144416|593265644|FG001|Intervention Period|Too high ovarian response|2|||
164245050|NCT01144416|593265643|FG000|Intervention Period|No/too few/bad oocytes|7|||
164245051|NCT01144416|593265644|FG001|Intervention Period|No/too few/bad oocytes|5|||
164245052|NCT01144416|593265643|FG000|Intervention Period|No or abnormal fertilization|25|||
164574463|NCT00552110|594465640|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
164574464|NCT00552110|594465641|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
164574465|NCT02330419|594465646|FG000|Overall Study|Lost to Follow-up|3|||
164574466|NCT02330419|594465647|FG001|Overall Study|Lost to Follow-up|7|||
164574467|NCT01587989|594465651|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
164574468|NCT01587989|594465652|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
164574469|NCT01587989|594465653|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
164678862|NCT03121586|594849396|FG001|Overall Study|Protocol Violation|5|||
164678863|NCT03121586|594849397|FG002|Overall Study|Protocol Violation|0|||
164678864|NCT03121586|594849395|FG000|Overall Study|Lack of Efficacy|3|||
164678865|NCT03121586|594849396|FG001|Overall Study|Lack of Efficacy|3|||
164678866|NCT03121586|594849397|FG002|Overall Study|Lack of Efficacy|1|||
164678867|NCT03121586|594849395|FG000|Overall Study|Physician Decision|2|||
164678868|NCT03121586|594849396|FG001|Overall Study|Physician Decision|2|||
164678869|NCT03121586|594849397|FG002|Overall Study|Physician Decision|0|||
164678870|NCT03121586|594849395|FG000|Overall Study|Noncompliance with study drug|5|||
164574470|NCT01587989|594465651|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
164678871|NCT03121586|594849396|FG001|Overall Study|Noncompliance with study drug|3|||
164678872|NCT03121586|594849397|FG002|Overall Study|Noncompliance with study drug|5|||
164678873|NCT03121586|594849395|FG000|Overall Study|Lost to Follow-up|4|||
164678874|NCT03121586|594849396|FG001|Overall Study|Lost to Follow-up|2|||
164678875|NCT03121586|594849397|FG002|Overall Study|Lost to Follow-up|0|||
164678876|NCT03121586|594849395|FG000|Overall Study|Death|2|||
164678877|NCT03121586|594849396|FG001|Overall Study|Death|0|||
164678878|NCT03121586|594849397|FG002|Overall Study|Death|0|||
164678879|NCT06381102|594849398|FG000|Washout 5 Days|Withdrawal by Subject|0|||
164678880|NCT06381102|594849399|FG001|Washout 5 Days|Withdrawal by Subject|2|||
164678881|NCT02832063|594849401|FG000|Overall Study|Adverse Event|2|||
164678882|NCT02832063|594849402|FG001|Overall Study|Adverse Event|1|||
164678883|NCT02832063|594849401|FG000|Overall Study|Physician Decision|5|||
164678884|NCT02832063|594849402|FG001|Overall Study|Physician Decision|7|||
164678885|NCT02832063|594849401|FG000|Overall Study|Lost to Follow-up|15|||
164678886|NCT02832063|594849402|FG001|Overall Study|Lost to Follow-up|8|||
164678887|NCT02832063|594849401|FG000|Overall Study|Withdrawal by Subject|10|||
164678888|NCT02832063|594849402|FG001|Overall Study|Withdrawal by Subject|21|||
164678889|NCT02832063|594849401|FG000|Overall Study|Other|2|||
164678890|NCT02832063|594849402|FG001|Overall Study|Other|1|||
164678891|NCT03733730|594849403|FG000|Overall Study|Lost to Follow-up|1|||
164678892|NCT03733730|594849404|FG001|Overall Study|Lost to Follow-up|32|||
164678893|NCT03733730|594849403|FG000|Overall Study|Other|1|||
164678894|NCT03733730|594849404|FG001|Overall Study|Other|0|||
164678895|NCT03733730|594849403|FG000|Overall Study|Adverse Event|0|||
164678896|NCT03733730|594849404|FG001|Overall Study|Adverse Event|4|||
164678897|NCT03733730|594849403|FG000|Overall Study|Death|0|||
164678898|NCT03733730|594849404|FG001|Overall Study|Death|5|||
164678899|NCT03733730|594849403|FG000|Overall Study|Withdrawal by Subject|0|||
164678900|NCT03733730|594849404|FG001|Overall Study|Withdrawal by Subject|8|||
164678901|NCT00772603|594849405|FG000|Overall Study|Withdrawal by Subject|11|||
164678902|NCT00772603|594849406|FG001|Overall Study|Withdrawal by Subject|10|||
164678903|NCT00772603|594849407|FG002|Overall Study|Withdrawal by Subject|6|||
164678904|NCT00772603|594849405|FG000|Overall Study|Adverse Event|37|||
164678905|NCT00772603|594849406|FG001|Overall Study|Adverse Event|18|||
164678906|NCT00772603|594849407|FG002|Overall Study|Adverse Event|10|||
164678907|NCT00772603|594849405|FG000|Overall Study|Subject Non-compliance|1|||
164678908|NCT00772603|594849406|FG001|Overall Study|Subject Non-compliance|6|||
164678909|NCT00772603|594849407|FG002|Overall Study|Subject Non-compliance|4|||
164678910|NCT00772603|594849405|FG000|Overall Study|Protocol Violation|0|||
164678911|NCT00772603|594849406|FG001|Overall Study|Protocol Violation|1|||
164678912|NCT00772603|594849407|FG002|Overall Study|Protocol Violation|1|||
164678913|NCT00772603|594849405|FG000|Overall Study|Lost to Follow-up|1|||
164678914|NCT00772603|594849406|FG001|Overall Study|Lost to Follow-up|5|||
164678915|NCT00772603|594849407|FG002|Overall Study|Lost to Follow-up|2|||
164678916|NCT00772603|594849405|FG000|Overall Study|Physician Decision|0|||
164678917|NCT00772603|594849406|FG001|Overall Study|Physician Decision|0|||
164678918|NCT00772603|594849407|FG002|Overall Study|Physician Decision|1|||
164678919|NCT00772603|594849405|FG000|Overall Study|Other|2|||
164678920|NCT00772603|594849406|FG001|Overall Study|Other|0|||
164678921|NCT00772603|594849407|FG002|Overall Study|Other|2|||
164678922|NCT00835575|594849408|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
164678923|NCT00835575|594849409|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
164678924|NCT01564394|594849410|FG000|Overall Study|Withdrawal by Subject|6|||
164678925|NCT01564394|594849411|FG001|Overall Study|Withdrawal by Subject|10|||
164678926|NCT00859521|594849414|FG000|Washout|Withdrawal by Subject|0|||
164678927|NCT00859521|594849415|FG001|Washout|Withdrawal by Subject|1|||
164678928|NCT01609257|594849416|FG000|Overall Study|Lost to Follow-up|2|||
164678929|NCT01609257|594849417|FG001|Overall Study|Lost to Follow-up|1|||
164678930|NCT01609257|594849416|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
164678931|NCT01609257|594849417|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
164678932|NCT01609257|594849416|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
164245053|NCT01144416|593265644|FG001|Intervention Period|No or abnormal fertilization|10|||
164245054|NCT01144416|593265643|FG000|Intervention Period|No/too few/bad quality embryos|3|||
164245055|NCT01144416|593265644|FG001|Intervention Period|No/too few/bad quality embryos|3|||
164245056|NCT01144416|593265643|FG000|Intervention Period|Other|7|||
164245057|NCT01144416|593265644|FG001|Intervention Period|Other|5|||
164245058|NCT02534883|593265646|FG000|Overall Study|Early Termination|8|||
164245059|NCT02534883|593265647|FG001|Overall Study|Early Termination|3|||
164245060|NCT03328832|593265648|FG000|Overall Study|Lost to Follow-up|0|||
164245061|NCT03328832|593265649|FG001|Overall Study|Lost to Follow-up|1|||
164245062|NCT00886769|593265650|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
164245063|NCT00886769|593265651|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
164245064|NCT00049257|593265652|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
164245065|NCT00049257|593265652|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
164245066|NCT00049257|593265652|FG000|Carboplatin, Paclitaxel|Death|2|||
164245067|NCT00049257|593265652|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
164245068|NCT00132301|593265653|FG000|Overall Study|Death|7|||
164245069|NCT00132301|593265654|FG001|Overall Study|Death|6|||
164245070|NCT00132301|593265653|FG000|Overall Study|Withdrawal by Subject|5|||
164245071|NCT00132301|593265654|FG001|Overall Study|Withdrawal by Subject|2|||
164245072|NCT00132301|593265653|FG000|Overall Study|Physician Decision|1|||
164245073|NCT00132301|593265654|FG001|Overall Study|Physician Decision|1|||
164245074|NCT00132301|593265653|FG000|Overall Study|Lost to Follow-up|5|||
164245075|NCT00132301|593265654|FG001|Overall Study|Lost to Follow-up|3|||
164245076|NCT00132301|593265653|FG000|Overall Study|Other|1|||
164245077|NCT00132301|593265654|FG001|Overall Study|Other|1|||
164245078|NCT00132301|593265653|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
164245079|NCT00132301|593265654|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
164245080|NCT01890265|593265657|FG000|Overall Study|Other (Unspecified reason)|0|||
164245081|NCT01890265|593265658|FG001|Overall Study|Other (Unspecified reason)|1|||
164245082|NCT01890265|593265659|FG002|Overall Study|Other (Unspecified reason)|0|||
164245083|NCT01890265|593265660|FG003|Overall Study|Other (Unspecified reason)|0|||
164245084|NCT01890265|593265661|FG004|Overall Study|Other (Unspecified reason)|0|||
164245085|NCT01890265|593265662|FG005|Overall Study|Other (Unspecified reason)|0|||
164245086|NCT01890265|593265657|FG000|Overall Study|Progressive disease|6|||
164245087|NCT01890265|593265658|FG001|Overall Study|Progressive disease|6|||
164245088|NCT01890265|593265659|FG002|Overall Study|Progressive disease|0|||
164245089|NCT01890265|593265660|FG003|Overall Study|Progressive disease|0|||
164245090|NCT01890265|593265661|FG004|Overall Study|Progressive disease|0|||
164245091|NCT01890265|593265662|FG005|Overall Study|Progressive disease|0|||
164245092|NCT01890265|593265657|FG000|Overall Study|Adverse Event|2|||
164245093|NCT01890265|593265658|FG001|Overall Study|Adverse Event|1|||
164245094|NCT01890265|593265659|FG002|Overall Study|Adverse Event|0|||
164245095|NCT01890265|593265660|FG003|Overall Study|Adverse Event|0|||
164245096|NCT01890265|593265661|FG004|Overall Study|Adverse Event|0|||
164245097|NCT01890265|593265662|FG005|Overall Study|Adverse Event|0|||
164245098|NCT01890265|593265657|FG000|Overall Study|Death|2|||
164245099|NCT01890265|593265658|FG001|Overall Study|Death|3|||
164245100|NCT01890265|593265659|FG002|Overall Study|Death|1|||
164245101|NCT01890265|593265660|FG003|Overall Study|Death|0|||
164245102|NCT01890265|593265661|FG004|Overall Study|Death|0|||
164245103|NCT01890265|593265662|FG005|Overall Study|Death|0|||
164245104|NCT01890265|593265657|FG000|Overall Study|Withdrawal by Subject|0|||
164245105|NCT01890265|593265658|FG001|Overall Study|Withdrawal by Subject|2|||
164245106|NCT01890265|593265659|FG002|Overall Study|Withdrawal by Subject|3|||
164245107|NCT01890265|593265660|FG003|Overall Study|Withdrawal by Subject|0|||
164245108|NCT01890265|593265661|FG004|Overall Study|Withdrawal by Subject|2|||
164245109|NCT01890265|593265662|FG005|Overall Study|Withdrawal by Subject|0|||
164245110|NCT03670355|593265668|FG000|Overall Study|Adverse Event|1|||
164245111|NCT03670355|593265669|FG001|Overall Study|Adverse Event|0|||
164245112|NCT03670355|593265668|FG000|Overall Study|Unable to comply with study procedures|0|||
164426015|NCT04955626|593930827|FG016|Blinded Period|No longer meets eligibility criteria|0|||
164245113|NCT03670355|593265669|FG001|Overall Study|Unable to comply with study procedures|1|||
164245114|NCT03670355|593265668|FG000|Overall Study|Participant refused|0|||
164245115|NCT03670355|593265669|FG001|Overall Study|Participant refused|1|||
164245116|NCT03517436|593265670|FG000|Overall Study|Death|3|||
164245117|NCT03517436|593265670|FG000|Overall Study|Withdrawal by Subject|4|||
164245118|NCT03517436|593265670|FG000|Overall Study|Did not receive study valve.|1|||
164574471|NCT01587989|594465652|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
164245119|NCT04271540|593265671|FG000|Overall Study|Lost to Follow-up|1|||
164245120|NCT04271540|593265671|FG000|Overall Study|Screen Fail|5|||
164574472|NCT01587989|594465653|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
164574473|NCT01587989|594465651|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
164574474|NCT01587989|594465652|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
164574475|NCT01587989|594465653|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
164574476|NCT01587989|594465651|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
164574477|NCT01587989|594465652|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
164574478|NCT01587989|594465653|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
164337603|NCT03350620|593611600|FG000|Stage 2|Lost to Follow-up|1|||
164337604|NCT03350620|593611601|FG001|Stage 2|Lost to Follow-up|2|||
164337605|NCT03350620|593611602|FG002|Stage 2|Lost to Follow-up|2|||
164245121|NCT04587869|593265674|FG000|Overall Study|Death|1|||
164245122|NCT04587869|593265675|FG001|Overall Study|Death|0|||
164245123|NCT04587869|593265674|FG000|Overall Study|Lost to Follow-up|27|||
164245124|NCT04587869|593265675|FG001|Overall Study|Lost to Follow-up|34|||
164245125|NCT04587869|593265674|FG000|Overall Study|Grant Termination|13|||
164245126|NCT04587869|593265675|FG001|Overall Study|Grant Termination|25|||
164245127|NCT04587869|593265674|FG000|Overall Study|too busy|2|||
164245128|NCT04587869|593265675|FG001|Overall Study|too busy|0|||
164245129|NCT04587869|593265674|FG000|Overall Study|Withdrawal by Subject|2|||
164245130|NCT04587869|593265675|FG001|Overall Study|Withdrawal by Subject|2|||
164245131|NCT04587869|593265674|FG000|Overall Study|Other|1|||
164245132|NCT04587869|593265675|FG001|Overall Study|Other|0|||
164245133|NCT01102491|593265678|FG000|Overall Study|Protocol Violation|11|||
164245134|NCT01102491|593265679|FG001|Overall Study|Protocol Violation|12|||
164245135|NCT05823974|593267629|FG000|Overall Study|Lost to Follow-up|0|||
164245136|NCT05823974|593267630|FG001|Overall Study|Lost to Follow-up|3|||
164245137|NCT05823974|593267631|FG002|Overall Study|Lost to Follow-up|1|||
164245138|NCT05823974|593267632|FG003|Overall Study|Lost to Follow-up|0|||
164245139|NCT05823974|593267633|FG004|Overall Study|Lost to Follow-up|1|||
164245140|NCT05823974|593267634|FG005|Overall Study|Lost to Follow-up|0|||
164245141|NCT05823974|593267635|FG006|Overall Study|Lost to Follow-up|1|||
164245142|NCT05823974|593267636|FG007|Overall Study|Lost to Follow-up|0|||
164245143|NCT05823974|593267637|FG008|Overall Study|Lost to Follow-up|0|||
164245144|NCT05823974|593267638|FG009|Overall Study|Lost to Follow-up|1|||
164245145|NCT05823974|593267639|FG010|Overall Study|Lost to Follow-up|1|||
164245146|NCT05823974|593267640|FG011|Overall Study|Lost to Follow-up|0|||
164245147|NCT05823974|593267641|FG012|Overall Study|Lost to Follow-up|1|||
164245148|NCT05823974|593267642|FG013|Overall Study|Lost to Follow-up|2|||
164245149|NCT05823974|593267643|FG014|Overall Study|Lost to Follow-up|1|||
164245150|NCT05823974|593267644|FG015|Overall Study|Lost to Follow-up|1|||
164245151|NCT05823974|593267645|FG016|Overall Study|Lost to Follow-up|1|||
164245152|NCT05823974|593267646|FG017|Overall Study|Lost to Follow-up|0|||
164245153|NCT05823974|593267647|FG018|Overall Study|Lost to Follow-up|0|||
164245154|NCT05823974|593267648|FG019|Overall Study|Lost to Follow-up|2|||
164245155|NCT05823974|593267649|FG020|Overall Study|Lost to Follow-up|0|||
164245156|NCT05823974|593267629|FG000|Overall Study|Physician Decision|0|||
164245157|NCT05823974|593267630|FG001|Overall Study|Physician Decision|0|||
164245158|NCT05823974|593267631|FG002|Overall Study|Physician Decision|0|||
164245159|NCT05823974|593267632|FG003|Overall Study|Physician Decision|0|||
164245160|NCT05823974|593267633|FG004|Overall Study|Physician Decision|0|||
164245161|NCT05823974|593267634|FG005|Overall Study|Physician Decision|0|||
164245162|NCT05823974|593267635|FG006|Overall Study|Physician Decision|0|||
164245163|NCT05823974|593267636|FG007|Overall Study|Physician Decision|0|||
164245164|NCT05823974|593267637|FG008|Overall Study|Physician Decision|0|||
164245165|NCT05823974|593267638|FG009|Overall Study|Physician Decision|0|||
164245166|NCT05823974|593267639|FG010|Overall Study|Physician Decision|0|||
164245167|NCT05823974|593267640|FG011|Overall Study|Physician Decision|0|||
164245168|NCT05823974|593267641|FG012|Overall Study|Physician Decision|0|||
164245169|NCT05823974|593267642|FG013|Overall Study|Physician Decision|0|||
164245170|NCT05823974|593267643|FG014|Overall Study|Physician Decision|0|||
164245171|NCT05823974|593267644|FG015|Overall Study|Physician Decision|1|||
164245172|NCT05823974|593267645|FG016|Overall Study|Physician Decision|0|||
164245173|NCT05823974|593267646|FG017|Overall Study|Physician Decision|1|||
164245174|NCT05823974|593267647|FG018|Overall Study|Physician Decision|1|||
164245175|NCT05823974|593267648|FG019|Overall Study|Physician Decision|0|||
164245176|NCT05823974|593267649|FG020|Overall Study|Physician Decision|0|||
164245177|NCT05823974|593267629|FG000|Overall Study|Withdrawal by Subject|1|||
164245178|NCT05823974|593267630|FG001|Overall Study|Withdrawal by Subject|1|||
164245179|NCT05823974|593267631|FG002|Overall Study|Withdrawal by Subject|2|||
164678933|NCT01609257|594849417|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
164678934|NCT02125461|594849418|FG000|Overall Study|Withdrawal by Subject|30|||
164678935|NCT02125461|594849419|FG001|Overall Study|Withdrawal by Subject|16|||
164678936|NCT02125461|594849418|FG000|Overall Study|Lost to Follow-up|8|||
164245180|NCT05823974|593267632|FG003|Overall Study|Withdrawal by Subject|0|||
164245181|NCT05823974|593267633|FG004|Overall Study|Withdrawal by Subject|2|||
164245182|NCT05823974|593267634|FG005|Overall Study|Withdrawal by Subject|3|||
164245183|NCT05823974|593267635|FG006|Overall Study|Withdrawal by Subject|1|||
164245184|NCT05823974|593267636|FG007|Overall Study|Withdrawal by Subject|1|||
164245185|NCT05823974|593267637|FG008|Overall Study|Withdrawal by Subject|2|||
164245186|NCT05823974|593267638|FG009|Overall Study|Withdrawal by Subject|1|||
164245187|NCT05823974|593267639|FG010|Overall Study|Withdrawal by Subject|1|||
164245188|NCT05823974|593267640|FG011|Overall Study|Withdrawal by Subject|0|||
164245189|NCT05823974|593267641|FG012|Overall Study|Withdrawal by Subject|0|||
164678937|NCT02125461|594849419|FG001|Overall Study|Lost to Follow-up|3|||
164245190|NCT05823974|593267642|FG013|Overall Study|Withdrawal by Subject|1|||
164245191|NCT05823974|593267643|FG014|Overall Study|Withdrawal by Subject|1|||
164245192|NCT05823974|593267644|FG015|Overall Study|Withdrawal by Subject|3|||
164245193|NCT05823974|593267645|FG016|Overall Study|Withdrawal by Subject|0|||
164245194|NCT05823974|593267646|FG017|Overall Study|Withdrawal by Subject|2|||
164245195|NCT05823974|593267647|FG018|Overall Study|Withdrawal by Subject|2|||
164678938|NCT02125461|594849418|FG000|Overall Study|Death|260|||
164678939|NCT02125461|594849419|FG001|Overall Study|Death|149|||
164678940|NCT02125461|594849418|FG000|Overall Study|Missing Termination Reason|0|||
164678941|NCT02125461|594849419|FG001|Overall Study|Missing Termination Reason|1|||
164678942|NCT03552484|594849428|FG000|Overall Study|Death|6|||
164678943|NCT03552484|594849429|FG001|Overall Study|Death|4|||
164678944|NCT03552484|594849428|FG000|Overall Study|Lost to Follow-up|0|||
164678945|NCT03552484|594849429|FG001|Overall Study|Lost to Follow-up|16|||
164678946|NCT03499353|594849430|FG000|Treatment|Adverse Event|3|||
164678947|NCT03499353|594849430|FG000|Treatment|Progressive Disease|10|||
164678948|NCT03499353|594849430|FG000|Treatment|Other|1|||
164678949|NCT03499353|594849430|FG000|Treatment|Withdrawal by Subject|2|||
164678950|NCT03499353|594849430|FG000|Long-Term Follow-up|Death|2|||
164678951|NCT03499353|594849430|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
164678952|NCT03499353|594849430|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
164678953|NCT02241551|594849431|FG000|Overall Study|Adverse Event|1|||
164678954|NCT02241551|594849432|FG001|Overall Study|Adverse Event|0|||
164678955|NCT00469898|594849439|FG000|Overall Study|Adverse Event|7|||
164678956|NCT00469898|594849439|FG000|Overall Study|Withdrawal by Subject|4|||
164678957|NCT00469898|594849439|FG000|Overall Study|Death|4|||
164678958|NCT00469898|594849439|FG000|Overall Study|Disease progression|9|||
164678959|NCT00469898|594849439|FG000|Overall Study|Decreased performance status|1|||
164678960|NCT02663349|594849442|FG000|Overall Study|Withdrawal by Subject|6|||
164678961|NCT02751424|594849450|FG000|Part 2|Adverse Event|0|||
164678962|NCT02751424|594849451|FG001|Part 2|Adverse Event|0|||
164678963|NCT02751424|594849452|FG002|Part 2|Adverse Event|0|||
164245196|NCT05823974|593267648|FG019|Overall Study|Withdrawal by Subject|0|||
164245197|NCT05823974|593267649|FG020|Overall Study|Withdrawal by Subject|1|||
164245198|NCT05823974|593267629|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245199|NCT05823974|593267630|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245200|NCT05823974|593267631|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164426016|NCT04955626|593930828|FG017|Blinded Period|No longer meets eligibility criteria|2|||
164426017|NCT04955626|593930829|FG018|Blinded Period|No longer meets eligibility criteria|0|||
164245201|NCT05823974|593267632|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245202|NCT05823974|593267633|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245203|NCT05823974|593267634|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245204|NCT05823974|593267635|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245205|NCT05823974|593267636|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245206|NCT05823974|593267637|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245207|NCT05823974|593267638|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164337606|NCT03350620|593611600|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
164337607|NCT03350620|593611601|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
164337608|NCT03350620|593611602|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
164337609|NCT00566111|593611603|FG000|Overall Study|Adverse Event|0|||
164337610|NCT00566111|593611604|FG001|Overall Study|Adverse Event|2|||
164337611|NCT03774082|593611608|FG000|Overall Study|Death|6|||
164337612|NCT03774082|593611609|FG001|Overall Study|Death|3|||
164337613|NCT03774082|593611610|FG002|Overall Study|Death|2|||
164337614|NCT03774082|593611608|FG000|Overall Study|Subject decision|0|||
164337615|NCT03774082|593611609|FG001|Overall Study|Subject decision|3|||
164337616|NCT03774082|593611610|FG002|Overall Study|Subject decision|0|||
164337617|NCT03774082|593611608|FG000|Overall Study|Lost to Follow-up|2|||
164337618|NCT03774082|593611609|FG001|Overall Study|Lost to Follow-up|0|||
164337619|NCT03774082|593611610|FG002|Overall Study|Lost to Follow-up|0|||
164337620|NCT03774082|593611608|FG000|Overall Study|Guardian decision|0|||
164337621|NCT03774082|593611609|FG001|Overall Study|Guardian decision|0|||
164337622|NCT03774082|593611610|FG002|Overall Study|Guardian decision|1|||
164337623|NCT03774082|593611608|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
164337624|NCT03774082|593611609|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
164337625|NCT03774082|593611610|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
164337626|NCT05938920|593611611|FG000|Overall Study|Adverse Event|1|||
164337627|NCT05938920|593611612|FG001|Overall Study|Adverse Event|3|||
164337628|NCT05938920|593611613|FG002|Overall Study|Adverse Event|2|||
164337629|NCT05938920|593611614|FG003|Overall Study|Adverse Event|1|||
164337630|NCT05938920|593611611|FG000|Overall Study|Death|0|||
164678964|NCT02751424|594849453|FG003|Part 2|Adverse Event|0|||
164426018|NCT04955626|593930830|FG019|Blinded Period|No longer meets eligibility criteria|0|||
164678965|NCT02751424|594849454|FG004|Part 2|Adverse Event|0|||
164678966|NCT02751424|594849455|FG005|Part 2|Adverse Event|0|||
164678967|NCT02751424|594849456|FG006|Part 2|Adverse Event|0|||
164678968|NCT02751424|594849457|FG007|Part 2|Adverse Event|5|||
164678969|NCT02751424|594849458|FG008|Part 2|Adverse Event|0|||
164678970|NCT00716625|594849459|FG000|Overall Study|Safety was not Assessable|1|||
164678971|NCT02699463|594849464|FG000|Overall Study|Lost to Follow-up|11|||
164245208|NCT05823974|593267639|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245209|NCT05823974|593267640|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245210|NCT05823974|593267641|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245211|NCT05823974|593267642|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245212|NCT05823974|593267643|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164245213|NCT05823974|593267644|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245214|NCT05823974|593267645|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245215|NCT05823974|593267646|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245216|NCT05823974|593267647|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245217|NCT05823974|593267648|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245218|NCT05823974|593267649|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245219|NCT05823974|593267629|FG000|Overall Study|Other|0|||
164245220|NCT05823974|593267630|FG001|Overall Study|Other|1|||
164245221|NCT05823974|593267631|FG002|Overall Study|Other|1|||
164245222|NCT05823974|593267632|FG003|Overall Study|Other|1|||
164245223|NCT05823974|593267633|FG004|Overall Study|Other|0|||
164245224|NCT05823974|593267634|FG005|Overall Study|Other|1|||
164245225|NCT05823974|593267635|FG006|Overall Study|Other|1|||
164245226|NCT05823974|593267636|FG007|Overall Study|Other|1|||
164245227|NCT05823974|593267637|FG008|Overall Study|Other|1|||
164245228|NCT05823974|593267638|FG009|Overall Study|Other|0|||
164245229|NCT05823974|593267639|FG010|Overall Study|Other|0|||
164245230|NCT05823974|593267640|FG011|Overall Study|Other|0|||
164245231|NCT05823974|593267641|FG012|Overall Study|Other|2|||
164245232|NCT05823974|593267642|FG013|Overall Study|Other|1|||
164245233|NCT05823974|593267643|FG014|Overall Study|Other|0|||
164245234|NCT05823974|593267644|FG015|Overall Study|Other|1|||
164245235|NCT05823974|593267645|FG016|Overall Study|Other|0|||
164245236|NCT05823974|593267646|FG017|Overall Study|Other|0|||
164245237|NCT05823974|593267647|FG018|Overall Study|Other|0|||
164245238|NCT05823974|593267648|FG019|Overall Study|Other|0|||
164245239|NCT05823974|593267649|FG020|Overall Study|Other|0|||
164245240|NCT00316706|593267650|FG000|Overall Study|Lost to Follow-up|38|||
164245241|NCT00316706|593267651|FG001|Overall Study|Lost to Follow-up|48|||
164245242|NCT01134614|593267655|FG000|Overall Study|Still on treatment as of March 2013|21|||
164245243|NCT01134614|593267656|FG001|Overall Study|Still on treatment as of March 2013|13|||
164245244|NCT01134614|593267655|FG000|Overall Study|Progressive disease|60|||
164245245|NCT01134614|593267656|FG001|Overall Study|Progressive disease|54|||
164245246|NCT01134614|593267655|FG000|Overall Study|Adverse Event|26|||
164245247|NCT01134614|593267656|FG001|Overall Study|Adverse Event|39|||
164245248|NCT01134614|593267655|FG000|Overall Study|Death|5|||
164245249|NCT01134614|593267656|FG001|Overall Study|Death|8|||
164245250|NCT01134614|593267655|FG000|Overall Study|Withdrawal by Subject|3|||
164245251|NCT01134614|593267656|FG001|Overall Study|Withdrawal by Subject|2|||
164245252|NCT01134614|593267655|FG000|Overall Study|Alternative therapy|2|||
164245253|NCT01134614|593267656|FG001|Overall Study|Alternative therapy|0|||
164245254|NCT01134614|593267655|FG000|Overall Study|Complicating disease|2|||
164245255|NCT01134614|593267656|FG001|Overall Study|Complicating disease|1|||
164245256|NCT01134614|593267655|FG000|Overall Study|Physician's decision|0|||
164245257|NCT01134614|593267656|FG001|Overall Study|Physician's decision|1|||
164245258|NCT01134614|593267655|FG000|Overall Study|Never started treatment|4|||
164245259|NCT01134614|593267656|FG001|Overall Study|Never started treatment|1|||
164245260|NCT01134614|593267655|FG000|Overall Study|Pt received tx not allowed on study|0|||
164245261|NCT01134614|593267656|FG001|Overall Study|Pt received tx not allowed on study|1|||
164245262|NCT01134614|593267655|FG000|Overall Study|Symptomatic deterioration|0|||
164245263|NCT01134614|593267656|FG001|Overall Study|Symptomatic deterioration|1|||
164245264|NCT01134614|593267655|FG000|Overall Study|Patient in hospice care|0|||
164245265|NCT01134614|593267656|FG001|Overall Study|Patient in hospice care|1|||
164245266|NCT01485796|593267658|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
164245267|NCT01485796|593267658|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
164245268|NCT01485796|593267658|FG000|Period 2: Epoch 2|Adverse Event|3|||
164245269|NCT01485796|593267658|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
164245270|NCT01485796|593267658|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
164245271|NCT01485796|593267658|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
164245272|NCT01485796|593267658|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
164245273|NCT01485796|593267658|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
164245274|NCT01766037|593267660|FG000|Overall Study|Adverse Event|1|||
164245275|NCT01766037|593267661|FG001|Overall Study|Adverse Event|0|||
164245276|NCT01766037|593267660|FG000|Overall Study|Lack of Efficacy|1|||
164245277|NCT01766037|593267661|FG001|Overall Study|Lack of Efficacy|0|||
164245278|NCT01766037|593267660|FG000|Overall Study|Lost to Follow-up|0|||
164245279|NCT01766037|593267661|FG001|Overall Study|Lost to Follow-up|10|||
164245280|NCT01766037|593267660|FG000|Overall Study|Physician Decision|0|||
164245281|NCT01766037|593267661|FG001|Overall Study|Physician Decision|1|||
164245282|NCT01766037|593267660|FG000|Overall Study|Withdrawal by Subject|18|||
164245283|NCT01766037|593267661|FG001|Overall Study|Withdrawal by Subject|16|||
164245284|NCT01766037|593267660|FG000|Overall Study|Moved from area|5|||
164245285|NCT01766037|593267661|FG001|Overall Study|Moved from area|0|||
164245286|NCT01766037|593267660|FG000|Overall Study|medical - unrelated|1|||
164245287|NCT01766037|593267661|FG001|Overall Study|medical - unrelated|2|||
164245288|NCT01766037|593267660|FG000|Overall Study|nausea / discomfort|3|||
164245289|NCT01766037|593267661|FG001|Overall Study|nausea / discomfort|0|||
164245290|NCT00292045|593267665|FG000|Core Study (Through Week 13)|Adverse Event|1|||
164245291|NCT00292045|593267665|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
164245292|NCT02236572|593267666|FG000|Overall Study|Withdrawal by Subject|1|||
164245293|NCT02236572|593267666|FG000|Overall Study|Protocol Violation|1|||
164245294|NCT02236572|593267666|FG000|Overall Study|Lost to Follow-up|1|||
164245295|NCT00606411|593267667|FG000|Overall Study|Adverse Event|1|||
164245296|NCT00606411|593267668|FG001|Overall Study|Adverse Event|2|||
164245297|NCT00606411|593267667|FG000|Overall Study|Lack of Adherence|1|||
164245298|NCT00606411|593267668|FG001|Overall Study|Lack of Adherence|1|||
164245299|NCT00606411|593267667|FG000|Overall Study|Lack of Efficacy|1|||
164245300|NCT00606411|593267668|FG001|Overall Study|Lack of Efficacy|1|||
164245301|NCT00606411|593267667|FG000|Overall Study|Withdrawal by Subject|2|||
164245302|NCT00606411|593267668|FG001|Overall Study|Withdrawal by Subject|0|||
164245303|NCT00606411|593267667|FG000|Overall Study|Lost to Follow-up|1|||
164245304|NCT00606411|593267668|FG001|Overall Study|Lost to Follow-up|2|||
164245305|NCT00606411|593267667|FG000|Overall Study|Move out of state|0|||
164245306|NCT00606411|593267668|FG001|Overall Study|Move out of state|1|||
164245307|NCT00412958|593267669|FG000|Overall Study|Withdrawal by Subject|3|||
164245308|NCT00412958|593267670|FG001|Overall Study|Withdrawal by Subject|0|||
164245309|NCT00412958|593267671|FG002|Overall Study|Withdrawal by Subject|0|||
164245310|NCT00412958|593267672|FG003|Overall Study|Withdrawal by Subject|1|||
164245311|NCT00412958|593267669|FG000|Overall Study|Adverse Event|0|||
164245312|NCT00412958|593267670|FG001|Overall Study|Adverse Event|1|||
164245313|NCT00412958|593267671|FG002|Overall Study|Adverse Event|0|||
164245314|NCT00412958|593267672|FG003|Overall Study|Adverse Event|0|||
164245315|NCT00412958|593267669|FG000|Overall Study|Lost to Follow-up|0|||
164245316|NCT00412958|593267670|FG001|Overall Study|Lost to Follow-up|1|||
164245317|NCT00412958|593267671|FG002|Overall Study|Lost to Follow-up|0|||
164245318|NCT00412958|593267672|FG003|Overall Study|Lost to Follow-up|0|||
164245319|NCT00412958|593267669|FG000|Overall Study|Death|0|||
164245320|NCT00412958|593267670|FG001|Overall Study|Death|1|||
164245321|NCT00412958|593267671|FG002|Overall Study|Death|0|||
164245322|NCT00412958|593267672|FG003|Overall Study|Death|0|||
164245323|NCT00412958|593267669|FG000|Overall Study|Transport issue|0|||
164245324|NCT00412958|593267670|FG001|Overall Study|Transport issue|1|||
164245325|NCT00412958|593267671|FG002|Overall Study|Transport issue|0|||
164245326|NCT00412958|593267672|FG003|Overall Study|Transport issue|0|||
164245327|NCT01318135|593267673|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
164426019|NCT04955626|593930831|FG020|Blinded Period|No longer meets eligibility criteria|0|||
164426020|NCT04955626|593930832|FG021|Blinded Period|No longer meets eligibility criteria|0|||
164426021|NCT04955626|593930833|FG022|Blinded Period|No longer meets eligibility criteria|0|||
164426022|NCT04955626|593930834|FG023|Blinded Period|No longer meets eligibility criteria|0|||
164426023|NCT04955626|593930835|FG024|Blinded Period|No longer meets eligibility criteria|1|||
164426024|NCT04955626|593930836|FG025|Blinded Period|No longer meets eligibility criteria|0|||
164426025|NCT04955626|593930837|FG026|Blinded Period|No longer meets eligibility criteria|0|||
164426026|NCT04955626|593930838|FG027|Blinded Period|No longer meets eligibility criteria|1|||
164426027|NCT04955626|593930839|FG028|Blinded Period|No longer meets eligibility criteria|0|||
164426028|NCT04955626|593930840|FG029|Blinded Period|No longer meets eligibility criteria|0|||
164426029|NCT04955626|593930841|FG030|Blinded Period|No longer meets eligibility criteria|0|||
164426030|NCT04955626|593930842|FG031|Blinded Period|No longer meets eligibility criteria|0|||
164426031|NCT04955626|593930843|FG032|Blinded Period|No longer meets eligibility criteria|0|||
164426032|NCT04955626|593930844|FG033|Blinded Period|No longer meets eligibility criteria|0|||
164426033|NCT04955626|593930845|FG034|Blinded Period|No longer meets eligibility criteria|0|||
164426034|NCT04955626|593930846|FG035|Blinded Period|No longer meets eligibility criteria|0|||
164426035|NCT04955626|593930811|FG000|Blinded Period|Other|54|||
164426036|NCT04955626|593930812|FG001|Blinded Period|Other|3|||
164426037|NCT04955626|593930813|FG002|Blinded Period|Other|4|||
164426038|NCT04955626|593930814|FG003|Blinded Period|Other|2|||
164426039|NCT04955626|593930815|FG004|Blinded Period|Other|0|||
164426040|NCT04955626|593930816|FG005|Blinded Period|Other|0|||
164426041|NCT04955626|593930817|FG006|Blinded Period|Other|2|||
164426042|NCT04955626|593930818|FG007|Blinded Period|Other|2|||
164426043|NCT04955626|593930819|FG008|Blinded Period|Other|1|||
164426044|NCT04955626|593930820|FG009|Blinded Period|Other|0|||
164426045|NCT04955626|593930821|FG010|Blinded Period|Other|1|||
164426046|NCT04955626|593930822|FG011|Blinded Period|Other|1|||
164426047|NCT04955626|593930823|FG012|Blinded Period|Other|0|||
164426048|NCT04955626|593930824|FG013|Blinded Period|Other|0|||
164426049|NCT04955626|593930825|FG014|Blinded Period|Other|0|||
164426050|NCT04955626|593930826|FG015|Blinded Period|Other|0|||
164426051|NCT04955626|593930827|FG016|Blinded Period|Other|0|||
164426052|NCT04955626|593930828|FG017|Blinded Period|Other|1|||
164426053|NCT04955626|593930829|FG018|Blinded Period|Other|0|||
164426054|NCT04955626|593930830|FG019|Blinded Period|Other|0|||
164426055|NCT04955626|593930831|FG020|Blinded Period|Other|0|||
164426056|NCT04955626|593930832|FG021|Blinded Period|Other|0|||
164426057|NCT04955626|593930833|FG022|Blinded Period|Other|0|||
164426058|NCT04955626|593930834|FG023|Blinded Period|Other|0|||
164426059|NCT04955626|593930835|FG024|Blinded Period|Other|0|||
164426060|NCT04955626|593930836|FG025|Blinded Period|Other|0|||
164426061|NCT04955626|593930837|FG026|Blinded Period|Other|2|||
164426062|NCT04955626|593930838|FG027|Blinded Period|Other|0|||
164245328|NCT01318135|593267674|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
164245329|NCT01318135|593267675|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
164245330|NCT01318135|593267676|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
164245331|NCT01318135|593267677|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
164426063|NCT04955626|593930839|FG028|Blinded Period|Other|0|||
164426064|NCT04955626|593930840|FG029|Blinded Period|Other|0|||
164426065|NCT04955626|593930841|FG030|Blinded Period|Other|0|||
164426066|NCT04955626|593930842|FG031|Blinded Period|Other|0|||
164426067|NCT04955626|593930843|FG032|Blinded Period|Other|0|||
164426068|NCT04955626|593930844|FG033|Blinded Period|Other|0|||
164426069|NCT04955626|593930845|FG034|Blinded Period|Other|0|||
164426070|NCT04955626|593930846|FG035|Blinded Period|Other|0|||
164574479|NCT01587989|594465651|FG000|Randomized Study Treatment|Screening failure|0|||
164426071|NCT04955626|593930811|FG000|Blinded Period|Physician Decision|1|||
164426072|NCT04955626|593930812|FG001|Blinded Period|Physician Decision|1|||
164574480|NCT01587989|594465652|FG001|Randomized Study Treatment|Screening failure|1|||
164574481|NCT01587989|594465653|FG002|Randomized Study Treatment|Screening failure|0|||
164574482|NCT01587989|594465651|FG000|Randomized Study Treatment|Physician Decision|0|||
164574483|NCT01587989|594465652|FG001|Randomized Study Treatment|Physician Decision|0|||
164574484|NCT01587989|594465653|FG002|Randomized Study Treatment|Physician Decision|1|||
164574485|NCT00963807|594465654|FG000|Overall Study|Physician Decision|2|||
164426073|NCT04955626|593930813|FG002|Blinded Period|Physician Decision|0|||
164426074|NCT04955626|593930814|FG003|Blinded Period|Physician Decision|3|||
164426075|NCT04955626|593930815|FG004|Blinded Period|Physician Decision|0|||
164426076|NCT04955626|593930816|FG005|Blinded Period|Physician Decision|0|||
164426077|NCT04955626|593930817|FG006|Blinded Period|Physician Decision|1|||
164426078|NCT04955626|593930818|FG007|Blinded Period|Physician Decision|1|||
164426079|NCT04955626|593930819|FG008|Blinded Period|Physician Decision|0|||
164426080|NCT04955626|593930820|FG009|Blinded Period|Physician Decision|0|||
164426081|NCT04955626|593930821|FG010|Blinded Period|Physician Decision|0|||
164426082|NCT04955626|593930822|FG011|Blinded Period|Physician Decision|5|||
164426083|NCT04955626|593930823|FG012|Blinded Period|Physician Decision|0|||
164426084|NCT04955626|593930824|FG013|Blinded Period|Physician Decision|0|||
164426085|NCT04955626|593930825|FG014|Blinded Period|Physician Decision|0|||
164245332|NCT01318135|593267678|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
164245333|NCT01318135|593267679|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
164245334|NCT01318135|593267680|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
164245335|NCT01318135|593267673|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
164245336|NCT01318135|593267674|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
164245337|NCT01318135|593267675|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
164245338|NCT01318135|593267676|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
164245339|NCT01318135|593267677|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
164245340|NCT01318135|593267678|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
164245341|NCT01318135|593267679|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
164245342|NCT01318135|593267680|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
164245343|NCT01318135|593267673|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
164245344|NCT01318135|593267674|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
164245345|NCT01318135|593267675|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
164245346|NCT01318135|593267676|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
164245347|NCT01318135|593267677|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
164245348|NCT01318135|593267678|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
164245349|NCT01318135|593267679|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
164245350|NCT01318135|593267680|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
164245351|NCT01318135|593267673|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
164245352|NCT01318135|593267674|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
164245353|NCT01318135|593267675|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
164245354|NCT01318135|593267676|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
164245355|NCT01318135|593267677|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
164245356|NCT01318135|593267678|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
164245357|NCT01318135|593267679|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
164245358|NCT01318135|593267680|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
164245359|NCT01318135|593267673|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
164245360|NCT01318135|593267674|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
164245361|NCT01318135|593267675|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
164245362|NCT01318135|593267676|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
164245363|NCT01318135|593267677|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
164245364|NCT01318135|593267678|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
164245365|NCT01318135|593267679|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
164245366|NCT01318135|593267680|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
164245367|NCT01318135|593267673|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
164245368|NCT01318135|593267674|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
164245369|NCT01318135|593267675|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
164245370|NCT01318135|593267676|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
164245371|NCT01318135|593267677|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
164245372|NCT01318135|593267678|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
164245373|NCT01318135|593267679|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
164245374|NCT01318135|593267680|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
164245375|NCT01318135|593267673|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
164245376|NCT01318135|593267674|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
164245377|NCT01318135|593267675|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
164245378|NCT01318135|593267676|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
164245379|NCT01318135|593267677|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
164245380|NCT01318135|593267678|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
164245381|NCT01318135|593267679|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
164245382|NCT01318135|593267680|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
164245383|NCT03465722|593267685|FG000|Overall Study|Withdrawal by Subject|21|||
164245384|NCT03465722|593267686|FG001|Overall Study|Withdrawal by Subject|14|||
164245385|NCT03465722|593267685|FG000|Overall Study|Death|89|||
164245386|NCT03465722|593267686|FG001|Overall Study|Death|87|||
164245387|NCT03465722|593267685|FG000|Overall Study|Lost to Follow-up|5|||
164245388|NCT03465722|593267686|FG001|Overall Study|Lost to Follow-up|3|||
164245389|NCT03465722|593267685|FG000|Overall Study|Administrative/Other|33|||
164245390|NCT03465722|593267686|FG001|Overall Study|Administrative/Other|32|||
164245391|NCT03465722|593267685|FG000|Overall Study|Not treated|1|||
164245392|NCT03465722|593267686|FG001|Overall Study|Not treated|2|||
164245393|NCT03465722|593267685|FG000|Overall Study|Sponsor decision|91|||
164245394|NCT03465722|593267686|FG001|Overall Study|Sponsor decision|98|||
164245395|NCT01541865|593267687|FG000|Overall Study|Lost to Follow-up|11|||
164245396|NCT01541865|593267687|FG000|Overall Study|Withdrawal by Subject|9|||
164245397|NCT01541865|593267687|FG000|Overall Study|Adverse Event|1|||
164245398|NCT01541865|593267687|FG000|Overall Study|Protocol Violation|1|||
164245399|NCT01140867|593267690|FG000|Overall Study|Adverse Event|22|||
164245400|NCT01140867|593267690|FG000|Overall Study|Lack of Efficacy|3|||
164245401|NCT01140867|593267690|FG000|Overall Study|Lost to Follow-up|2|||
164245402|NCT01140867|593267690|FG000|Overall Study|Withdrawal by Subject|1|||
164245403|NCT01140867|593267690|FG000|Overall Study|Protocol Violation|1|||
164245404|NCT01140867|593267690|FG000|Overall Study|Uncooperative patient|2|||
164245405|NCT01140867|593267690|FG000|Overall Study|Medication Noncompliance|2|||
164245406|NCT00503425|593267701|FG000|Overall Study|Participant files lost|6|||
164245407|NCT00503425|593267701|FG000|Overall Study|Adverse Event|5|||
164245408|NCT00503425|593267701|FG000|Overall Study|Lack of Efficacy|25|||
164245409|NCT00503425|593267701|FG000|Overall Study|Withdrawal by Subject|8|||
164245410|NCT00503425|593267701|FG000|Overall Study|Lost to Follow-up|3|||
164245411|NCT00503425|593267701|FG000|Overall Study|Death|3|||
164245412|NCT00503425|593267701|FG000|Overall Study|Missing Data/Unknown|4|||
164245413|NCT00881530|593267702|FG000|Overall Study|Adverse Event|5|||
164245414|NCT00881530|593267703|FG001|Overall Study|Adverse Event|1|||
164245415|NCT00881530|593267704|FG002|Overall Study|Adverse Event|1|||
164245416|NCT00881530|593267705|FG003|Overall Study|Adverse Event|4|||
164245417|NCT00881530|593267706|FG004|Overall Study|Adverse Event|10|||
164245418|NCT00881530|593267707|FG005|Overall Study|Adverse Event|2|||
164245419|NCT00881530|593267702|FG000|Overall Study|Lack of Efficacy|1|||
164245420|NCT00881530|593267703|FG001|Overall Study|Lack of Efficacy|0|||
164245421|NCT00881530|593267704|FG002|Overall Study|Lack of Efficacy|0|||
164245422|NCT00881530|593267705|FG003|Overall Study|Lack of Efficacy|0|||
164245423|NCT00881530|593267706|FG004|Overall Study|Lack of Efficacy|1|||
164245424|NCT00881530|593267707|FG005|Overall Study|Lack of Efficacy|1|||
164245425|NCT00881530|593267702|FG000|Overall Study|Not compliant with the protocol|0|||
164245426|NCT00881530|593267703|FG001|Overall Study|Not compliant with the protocol|0|||
164426086|NCT04955626|593930826|FG015|Blinded Period|Physician Decision|0|||
164426087|NCT04955626|593930827|FG016|Blinded Period|Physician Decision|0|||
164426088|NCT04955626|593930828|FG017|Blinded Period|Physician Decision|0|||
164426089|NCT04955626|593930829|FG018|Blinded Period|Physician Decision|0|||
164426090|NCT04955626|593930830|FG019|Blinded Period|Physician Decision|0|||
164426091|NCT04955626|593930831|FG020|Blinded Period|Physician Decision|0|||
164426092|NCT04955626|593930832|FG021|Blinded Period|Physician Decision|0|||
164426093|NCT04955626|593930833|FG022|Blinded Period|Physician Decision|0|||
164426094|NCT04955626|593930834|FG023|Blinded Period|Physician Decision|0|||
164426095|NCT04955626|593930835|FG024|Blinded Period|Physician Decision|0|||
164426096|NCT04955626|593930836|FG025|Blinded Period|Physician Decision|0|||
164426097|NCT04955626|593930837|FG026|Blinded Period|Physician Decision|0|||
164426098|NCT04955626|593930838|FG027|Blinded Period|Physician Decision|0|||
164426099|NCT04955626|593930839|FG028|Blinded Period|Physician Decision|0|||
164426100|NCT04955626|593930840|FG029|Blinded Period|Physician Decision|0|||
164426101|NCT04955626|593930841|FG030|Blinded Period|Physician Decision|0|||
164426102|NCT04955626|593930842|FG031|Blinded Period|Physician Decision|0|||
164426103|NCT04955626|593930843|FG032|Blinded Period|Physician Decision|0|||
164426104|NCT04955626|593930844|FG033|Blinded Period|Physician Decision|0|||
164426105|NCT04955626|593930845|FG034|Blinded Period|Physician Decision|0|||
164426106|NCT04955626|593930846|FG035|Blinded Period|Physician Decision|0|||
164426107|NCT04955626|593930811|FG000|Blinded Period|Withdrawal by Subject|26|||
164426108|NCT04955626|593930812|FG001|Blinded Period|Withdrawal by Subject|62|||
164426109|NCT04955626|593930813|FG002|Blinded Period|Withdrawal by Subject|14|||
164426110|NCT04955626|593930814|FG003|Blinded Period|Withdrawal by Subject|16|||
164426111|NCT04955626|593930815|FG004|Blinded Period|Withdrawal by Subject|1|||
164245427|NCT00881530|593267704|FG002|Overall Study|Not compliant with the protocol|0|||
164678972|NCT02699463|594849465|FG001|Overall Study|Lost to Follow-up|8|||
164678973|NCT02699463|594849464|FG000|Overall Study|Withdrawal by Subject|4|||
164678974|NCT02699463|594849465|FG001|Overall Study|Withdrawal by Subject|1|||
164678975|NCT02488239|594849466|FG000|Overall Study|Death|3|||
164678976|NCT02488239|594849466|FG000|Overall Study|Withdrawal by Subject|3|||
164678977|NCT02488239|594849466|FG000|Overall Study|Physician Decision|2|||
164245428|NCT00881530|593267705|FG003|Overall Study|Not compliant with the protocol|0|||
164245429|NCT00881530|593267706|FG004|Overall Study|Not compliant with the protocol|2|||
164245430|NCT00881530|593267707|FG005|Overall Study|Not compliant with the protocol|0|||
164245431|NCT00881530|593267702|FG000|Overall Study|Lost to Follow-up|0|||
164245432|NCT00881530|593267703|FG001|Overall Study|Lost to Follow-up|1|||
164245433|NCT00881530|593267704|FG002|Overall Study|Lost to Follow-up|1|||
164426112|NCT04955626|593930816|FG005|Blinded Period|Withdrawal by Subject|2|||
164426113|NCT04955626|593930817|FG006|Blinded Period|Withdrawal by Subject|9|||
164245434|NCT00881530|593267705|FG003|Overall Study|Lost to Follow-up|3|||
164245435|NCT00881530|593267706|FG004|Overall Study|Lost to Follow-up|1|||
164426114|NCT04955626|593930818|FG007|Blinded Period|Withdrawal by Subject|5|||
164426115|NCT04955626|593930819|FG008|Blinded Period|Withdrawal by Subject|3|||
164426116|NCT04955626|593930820|FG009|Blinded Period|Withdrawal by Subject|15|||
164678978|NCT02488239|594849466|FG000|Overall Study|Consent ineligible|1|||
164426117|NCT04955626|593930821|FG010|Blinded Period|Withdrawal by Subject|11|||
164426118|NCT04955626|593930822|FG011|Blinded Period|Withdrawal by Subject|7|||
164426119|NCT04955626|593930823|FG012|Blinded Period|Withdrawal by Subject|2|||
164678979|NCT02488239|594849466|FG000|Overall Study|Did not undergo implant procedure|1|||
164574486|NCT00963807|594465654|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
164574487|NCT00963807|594465654|FG000|Overall Study|Disease progression|15|||
164574488|NCT03313050|594465655|FG000|Stage 2: 12 Months|Adverse Event|0|||
164574489|NCT03313050|594465656|FG001|Stage 2: 12 Months|Adverse Event|0|||
164574490|NCT03313050|594465657|FG002|Stage 2: 12 Months|Adverse Event|0|||
164574491|NCT03313050|594465658|FG003|Stage 2: 12 Months|Adverse Event|1|||
164574492|NCT03313050|594465655|FG000|Stage 2: 12 Months|Death|0|||
164574493|NCT03313050|594465656|FG001|Stage 2: 12 Months|Death|0|||
164574494|NCT03313050|594465657|FG002|Stage 2: 12 Months|Death|3|||
164574495|NCT03313050|594465658|FG003|Stage 2: 12 Months|Death|0|||
164574496|NCT03313050|594465655|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
164574497|NCT03313050|594465656|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
164574498|NCT03313050|594465657|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
164574499|NCT03313050|594465658|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
164574500|NCT03313050|594465655|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
164574501|NCT03313050|594465656|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
164574502|NCT03313050|594465657|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
164574503|NCT03313050|594465658|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
164574504|NCT03313050|594465655|FG000|Stage 2: 12 Months|Protocol deviation|0|||
164574505|NCT03313050|594465656|FG001|Stage 2: 12 Months|Protocol deviation|0|||
164574506|NCT03313050|594465657|FG002|Stage 2: 12 Months|Protocol deviation|7|||
164574507|NCT03313050|594465658|FG003|Stage 2: 12 Months|Protocol deviation|7|||
164574508|NCT03313050|594465655|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
164574509|NCT03313050|594465656|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
164574510|NCT03313050|594465657|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
164574511|NCT03313050|594465658|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
164574512|NCT03313050|594465655|FG000|Stage 2: 12 Months|Other|0|||
164574513|NCT03313050|594465656|FG001|Stage 2: 12 Months|Other|0|||
164574514|NCT03313050|594465657|FG002|Stage 2: 12 Months|Other|0|||
164678980|NCT01370733|594849470|FG000|Overall Study|Withdrawal by Subject|8|||
164678981|NCT01370733|594849471|FG001|Overall Study|Withdrawal by Subject|8|||
164678982|NCT01370733|594849470|FG000|Overall Study|Lost to Follow-up|3|||
164678983|NCT01370733|594849471|FG001|Overall Study|Lost to Follow-up|0|||
164678984|NCT01370733|594849470|FG000|Overall Study|Adverse Event|2|||
164678985|NCT01370733|594849471|FG001|Overall Study|Adverse Event|4|||
164678986|NCT01370733|594849470|FG000|Overall Study|Lack of Efficacy|3|||
164678987|NCT01370733|594849471|FG001|Overall Study|Lack of Efficacy|5|||
164678988|NCT01370733|594849470|FG000|Overall Study|Physician Decision|0|||
164678989|NCT01370733|594849471|FG001|Overall Study|Physician Decision|2|||
164678990|NCT01370733|594849470|FG000|Overall Study|Protocol Violation|1|||
164678991|NCT01370733|594849471|FG001|Overall Study|Protocol Violation|3|||
164678992|NCT01188681|594849474|FG000|Overall Study|bladder cancer|0|||
164678993|NCT01188681|594849475|FG001|Overall Study|bladder cancer|0|||
164678994|NCT01188681|594849476|FG002|Overall Study|bladder cancer|1|||
164678995|NCT01188681|594849477|FG003|Overall Study|bladder cancer|0|||
164678996|NCT01188681|594849474|FG000|Overall Study|Withdrawal by Subject|0|||
164678997|NCT01188681|594849475|FG001|Overall Study|Withdrawal by Subject|0|||
164678998|NCT01188681|594849476|FG002|Overall Study|Withdrawal by Subject|0|||
164678999|NCT01188681|594849477|FG003|Overall Study|Withdrawal by Subject|1|||
164679000|NCT01848938|594849487|FG000|Overall Study|Lost to Follow-up|1|||
164679001|NCT01848938|594849488|FG001|Overall Study|Lost to Follow-up|1|||
164679002|NCT00909753|594849491|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
164679003|NCT00909753|594849492|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
164679004|NCT00909753|594849491|FG000|Period: Second Intervention|Protocol Violation|1|||
164679005|NCT00909753|594849492|FG001|Period: Second Intervention|Protocol Violation|0|||
164679006|NCT00835536|594849497|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
164679007|NCT00835536|594849498|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
164679008|NCT03804983|594849506|FG000|Overall Study|Adverse Event|0|||
164679009|NCT03804983|594849507|FG001|Overall Study|Adverse Event|1|||
164679010|NCT03804983|594849506|FG000|Overall Study|Family Obligation|1|||
164679011|NCT03804983|594849507|FG001|Overall Study|Family Obligation|0|||
164679012|NCT03600376|594849508|FG000|Overall Study|Adverse Event|1|||
164679013|NCT03600376|594849509|FG001|Overall Study|Adverse Event|1|||
164679014|NCT03600376|594849508|FG000|Overall Study|Transferred to other facility|1|||
164679015|NCT03600376|594849509|FG001|Overall Study|Transferred to other facility|0|||
164679016|NCT03600376|594849508|FG000|Overall Study|Investigator Decision|0|||
164679017|NCT03600376|594849509|FG001|Overall Study|Investigator Decision|4|||
164679018|NCT03600376|594849508|FG000|Overall Study|Determined to be ineligible for study|0|||
164679019|NCT03600376|594849509|FG001|Overall Study|Determined to be ineligible for study|1|||
164679020|NCT03649477|594849515|FG000|Overall Study|Adverse Event|2|||
164679021|NCT03649477|594849516|FG001|Overall Study|Adverse Event|0|||
164679022|NCT03649477|594849517|FG002|Overall Study|Adverse Event|0|||
164679023|NCT01154231|594849518|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
164679024|NCT01154231|594849518|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
164679025|NCT03578809|594851064|FG000|Overall Study|Death|0|||
164679026|NCT03578809|594851065|FG001|Overall Study|Death|2|||
164679027|NCT03578809|594851066|FG002|Overall Study|Death|0|||
164245436|NCT00881530|593267707|FG005|Overall Study|Lost to Follow-up|0|||
164245437|NCT00881530|593267702|FG000|Overall Study|Refused to continue medication|7|||
164245438|NCT00881530|593267703|FG001|Overall Study|Refused to continue medication|2|||
164245439|NCT00881530|593267704|FG002|Overall Study|Refused to continue medication|1|||
164245440|NCT00881530|593267705|FG003|Overall Study|Refused to continue medication|2|||
164245441|NCT00881530|593267706|FG004|Overall Study|Refused to continue medication|0|||
164245442|NCT00881530|593267707|FG005|Overall Study|Refused to continue medication|0|||
164245443|NCT00881530|593267702|FG000|Overall Study|Other reason not defined above|1|||
164245444|NCT00881530|593267703|FG001|Overall Study|Other reason not defined above|1|||
164245445|NCT00881530|593267704|FG002|Overall Study|Other reason not defined above|2|||
164245446|NCT00881530|593267705|FG003|Overall Study|Other reason not defined above|0|||
164245447|NCT00881530|593267706|FG004|Overall Study|Other reason not defined above|0|||
164245448|NCT00881530|593267707|FG005|Overall Study|Other reason not defined above|2|||
164245449|NCT00003869|593267709|FG000|Overall Study|Adverse Event|14|||
164245450|NCT00003869|593267710|FG001|Overall Study|Adverse Event|3|||
164245451|NCT00003869|593267709|FG000|Overall Study|Withdrawal by Subject|21|||
164245452|NCT00003869|593267710|FG001|Overall Study|Withdrawal by Subject|3|||
164245453|NCT00003869|593267709|FG000|Overall Study|Death|1|||
164245454|NCT00003869|593267710|FG001|Overall Study|Death|2|||
164245455|NCT00003869|593267709|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
164245456|NCT00003869|593267710|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
164245457|NCT00763256|593267711|FG000|Overall Study|Didn't return for appointments|7|||
164245458|NCT00763256|593267712|FG001|Overall Study|Didn't return for appointments|10|||
164245459|NCT03364231|593267713|FG000|Overall Study|Adverse Event|1|||
164245460|NCT03364231|593267714|FG001|Overall Study|Adverse Event|4|||
164245461|NCT03364231|593267713|FG000|Overall Study|Death|1|||
164245462|NCT03364231|593267714|FG001|Overall Study|Death|0|||
164245463|NCT03364231|593267713|FG000|Overall Study|Investigator Decision|2|||
164245464|NCT03364231|593267714|FG001|Overall Study|Investigator Decision|2|||
164245465|NCT03364231|593267713|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
164245466|NCT03364231|593267714|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
164245467|NCT03364231|593267713|FG000|Overall Study|Withdrawal of Subject Consent|1|||
164245468|NCT03364231|593267714|FG001|Overall Study|Withdrawal of Subject Consent|0|||
164245469|NCT03364231|593267713|FG000|Overall Study|Reason Not Specified|1|||
164245470|NCT03364231|593267714|FG001|Overall Study|Reason Not Specified|0|||
164245471|NCT03364231|593267713|FG000|Overall Study|Disease Progression|0|||
164245472|NCT03364231|593267714|FG001|Overall Study|Disease Progression|6|||
164245473|NCT00124072|593267717|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
164245474|NCT00124072|593267718|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
164245475|NCT00124072|593267719|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
164245476|NCT00124072|593267720|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
164245477|NCT00124072|593267717|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
164245478|NCT00124072|593267718|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
164245479|NCT00124072|593267719|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
164679028|NCT03578809|594851067|FG003|Overall Study|Death|1|||
164679029|NCT03578809|594851064|FG000|Overall Study|Lost to Follow-up|0|||
164679030|NCT03578809|594851065|FG001|Overall Study|Lost to Follow-up|1|||
164679031|NCT03578809|594851066|FG002|Overall Study|Lost to Follow-up|0|||
164679032|NCT03578809|594851067|FG003|Overall Study|Lost to Follow-up|0|||
164679033|NCT03578809|594851064|FG000|Overall Study|Withdrawal by Subject|3|||
164679034|NCT03578809|594851065|FG001|Overall Study|Withdrawal by Subject|5|||
164679035|NCT03578809|594851066|FG002|Overall Study|Withdrawal by Subject|2|||
164679036|NCT03578809|594851067|FG003|Overall Study|Withdrawal by Subject|0|||
164679037|NCT03578809|594851064|FG000|Overall Study|Other|3|||
164679038|NCT03578809|594851065|FG001|Overall Study|Other|6|||
164679039|NCT03578809|594851066|FG002|Overall Study|Other|2|||
164679040|NCT03578809|594851067|FG003|Overall Study|Other|8|||
164679041|NCT00835705|594851068|FG000|First Intervention|Difficulty with vein|1|||
164679042|NCT00835705|594851069|FG001|First Intervention|Difficulty with vein|0|||
164245480|NCT00124072|593267720|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
164245481|NCT00124072|593267717|FG000|Overall Study|Death|499|||
164245482|NCT00124072|593267718|FG001|Overall Study|Death|484|||
164245483|NCT00124072|593267719|FG002|Overall Study|Death|471|||
164245484|NCT00124072|593267720|FG003|Overall Study|Death|480|||
164679043|NCT00835705|594851068|FG000|Second Intervention|Difficulty with vein|1|||
164245485|NCT00943761|593267726|FG000|Overall Study|Lost to Follow-up|2|||
164245486|NCT00943761|593267727|FG001|Overall Study|Lost to Follow-up|0|||
164245487|NCT00943761|593267726|FG000|Overall Study|Withdrawal by Subject|2|||
164245488|NCT00943761|593267727|FG001|Overall Study|Withdrawal by Subject|1|||
164245489|NCT02268383|593267728|FG000|Overall Study|Death|12|||
164679044|NCT00835705|594851069|FG001|Second Intervention|Difficulty with vein|0|||
164679045|NCT01116739|594851070|FG000|Overall Study|Child had 2 years of HS|110|||
164679046|NCT01116739|594851071|FG001|Overall Study|Child had 2 years of HS|128|||
164679047|NCT01116739|594851070|FG000|Overall Study|Withdrawal by Subject|6|||
164679048|NCT01116739|594851071|FG001|Overall Study|Withdrawal by Subject|0|||
164679049|NCT01116739|594851070|FG000|Overall Study|child too young|2|||
164337631|NCT05938920|593611612|FG001|Overall Study|Death|1|||
164337632|NCT05938920|593611613|FG002|Overall Study|Death|0|||
164337633|NCT05938920|593611614|FG003|Overall Study|Death|0|||
164337634|NCT05938920|593611611|FG000|Overall Study|Lost to Follow-up|0|||
164337635|NCT05938920|593611612|FG001|Overall Study|Lost to Follow-up|0|||
164337636|NCT05938920|593611613|FG002|Overall Study|Lost to Follow-up|1|||
164337637|NCT05938920|593611614|FG003|Overall Study|Lost to Follow-up|0|||
164337638|NCT05938920|593611611|FG000|Overall Study|Participant Asked to Withdraw from the Trial|1|||
164574515|NCT03313050|594465658|FG003|Stage 2: 12 Months|Other|1|||
164574516|NCT04211337|594465659|FG000|Overall Study|On Treatment|175|||
164337639|NCT05938920|593611612|FG001|Overall Study|Participant Asked to Withdraw from the Trial|0|||
164337640|NCT05938920|593611613|FG002|Overall Study|Participant Asked to Withdraw from the Trial|0|||
164245490|NCT02268383|593267728|FG000|Overall Study|Lost to Follow-up|2|||
164245491|NCT02268383|593267728|FG000|Overall Study|Withdrawal by Subject|9|||
164245492|NCT02268383|593267728|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
164245493|NCT02268383|593267728|FG000|Overall Study|Protocol deviation|3|||
164245494|NCT02268383|593267728|FG000|Overall Study|Sponsor decision|22|||
164245495|NCT02268383|593267728|FG000|Overall Study|Not reported|12|||
164245496|NCT02708680|593267731|FG000|Overall Study|Withdrawal by Subject|4|||
164245497|NCT02708680|593267732|FG001|Overall Study|Withdrawal by Subject|12|||
164245498|NCT02708680|593267733|FG002|Overall Study|Withdrawal by Subject|12|||
164245499|NCT02708680|593267731|FG000|Overall Study|Death|4|||
164245500|NCT02708680|593267732|FG001|Overall Study|Death|19|||
164245501|NCT02708680|593267733|FG002|Overall Study|Death|21|||
164245502|NCT02708680|593267731|FG000|Overall Study|Lost to Follow-up|0|||
164245503|NCT02708680|593267732|FG001|Overall Study|Lost to Follow-up|3|||
164245504|NCT02708680|593267733|FG002|Overall Study|Lost to Follow-up|3|||
164245505|NCT02708680|593267731|FG000|Overall Study|Study Terminated By Sponsor|0|||
164245506|NCT02708680|593267732|FG001|Overall Study|Study Terminated By Sponsor|5|||
164245507|NCT02708680|593267733|FG002|Overall Study|Study Terminated By Sponsor|4|||
164245508|NCT02708680|593267731|FG000|Overall Study|Other than Specified|0|||
164245509|NCT02708680|593267732|FG001|Overall Study|Other than Specified|0|||
164245510|NCT02708680|593267733|FG002|Overall Study|Other than Specified|1|||
164245511|NCT02708680|593267731|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
164245512|NCT02708680|593267732|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
164245513|NCT02708680|593267733|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
164245514|NCT01342926|593267734|FG000|Overall Study|Adverse Event|5|||
164574517|NCT04211337|594465660|FG001|Overall Study|On Treatment|40|||
164426120|NCT04955626|593930824|FG013|Blinded Period|Withdrawal by Subject|0|||
164426121|NCT04955626|593930825|FG014|Blinded Period|Withdrawal by Subject|1|||
164426122|NCT04955626|593930826|FG015|Blinded Period|Withdrawal by Subject|11|||
164574518|NCT04211337|594465659|FG000|Overall Study|Withdrawal by Subject|0|||
164574519|NCT04211337|594465660|FG001|Overall Study|Withdrawal by Subject|2|||
164574520|NCT05630846|594467999|FG000|Overall Study|Death|1|||
164574521|NCT05630846|594468000|FG001|Overall Study|Death|0|||
164245515|NCT01342926|593267735|FG001|Overall Study|Adverse Event|8|||
164245516|NCT01342926|593267736|FG002|Overall Study|Adverse Event|10|||
164245517|NCT01342926|593267737|FG003|Overall Study|Adverse Event|7|||
164574522|NCT05630846|594468001|FG002|Overall Study|Death|0|||
164574523|NCT05630846|594468002|FG003|Overall Study|Death|0|||
164574524|NCT05630846|594467999|FG000|Overall Study|Withdrawal by Subject|3|||
164574525|NCT05630846|594468000|FG001|Overall Study|Withdrawal by Subject|3|||
164574526|NCT05630846|594468001|FG002|Overall Study|Withdrawal by Subject|4|||
164574527|NCT05630846|594468002|FG003|Overall Study|Withdrawal by Subject|1|||
164574528|NCT05630846|594467999|FG000|Overall Study|Lost to Follow-up|6|||
164574529|NCT05630846|594468000|FG001|Overall Study|Lost to Follow-up|5|||
164245518|NCT01342926|593267734|FG000|Overall Study|Lost to Follow-up|0|||
164245519|NCT01342926|593267735|FG001|Overall Study|Lost to Follow-up|1|||
164245520|NCT01342926|593267736|FG002|Overall Study|Lost to Follow-up|1|||
164245521|NCT01342926|593267737|FG003|Overall Study|Lost to Follow-up|0|||
164245522|NCT01342926|593267734|FG000|Overall Study|Investigator Discretion|2|||
164245523|NCT01342926|593267735|FG001|Overall Study|Investigator Discretion|2|||
164245524|NCT01342926|593267736|FG002|Overall Study|Investigator Discretion|0|||
164245525|NCT01342926|593267737|FG003|Overall Study|Investigator Discretion|0|||
164245526|NCT01342926|593267734|FG000|Overall Study|Withdrawal by Subject|2|||
164245527|NCT01342926|593267735|FG001|Overall Study|Withdrawal by Subject|4|||
164245528|NCT01342926|593267736|FG002|Overall Study|Withdrawal by Subject|3|||
164245529|NCT01342926|593267737|FG003|Overall Study|Withdrawal by Subject|5|||
164245530|NCT04162470|593267738|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
164245531|NCT03382912|593267739|FG000|Overall Study|Physician Decision|0|||
164245532|NCT03382912|593267740|FG001|Overall Study|Physician Decision|1|||
164245533|NCT03382912|593267739|FG000|Overall Study|Sponsor Decision|6|||
164245534|NCT03382912|593267740|FG001|Overall Study|Sponsor Decision|6|||
164245535|NCT03382912|593267739|FG000|Overall Study|Withdrawal by Subject|0|||
164245536|NCT03382912|593267740|FG001|Overall Study|Withdrawal by Subject|5|||
164245537|NCT01402869|593267745|FG000|Overall Study|Required Tooth Extraction|0|||
164245538|NCT01402869|593267746|FG001|Overall Study|Required Tooth Extraction|0|||
164245539|NCT01402869|593267747|FG002|Overall Study|Required Tooth Extraction|1|||
164245540|NCT01544348|593267748|FG000|Overall Study|Lost to Follow-up|1|||
164245541|NCT01544348|593267749|FG001|Overall Study|Lost to Follow-up|0|||
164245542|NCT01544348|593267750|FG002|Overall Study|Lost to Follow-up|0|||
164245543|NCT01544348|593267751|FG003|Overall Study|Lost to Follow-up|0|||
164245544|NCT01544348|593267752|FG004|Overall Study|Lost to Follow-up|0|||
164245545|NCT01544348|593267753|FG005|Overall Study|Lost to Follow-up|0|||
164245546|NCT01544348|593267754|FG006|Overall Study|Lost to Follow-up|1|||
164245547|NCT01544348|593267755|FG007|Overall Study|Lost to Follow-up|0|||
164426123|NCT04955626|593930827|FG016|Blinded Period|Withdrawal by Subject|2|||
164245548|NCT01544348|593267748|FG000|Overall Study|Withdrawal by Subject|1|||
164574530|NCT05630846|594468001|FG002|Overall Study|Lost to Follow-up|2|||
164574531|NCT05630846|594468002|FG003|Overall Study|Lost to Follow-up|5|||
164426124|NCT04955626|593930828|FG017|Blinded Period|Withdrawal by Subject|5|||
164426125|NCT04955626|593930829|FG018|Blinded Period|Withdrawal by Subject|0|||
164426126|NCT04955626|593930830|FG019|Blinded Period|Withdrawal by Subject|0|||
164426127|NCT04955626|593930831|FG020|Blinded Period|Withdrawal by Subject|1|||
164426128|NCT04955626|593930832|FG021|Blinded Period|Withdrawal by Subject|0|||
164426129|NCT04955626|593930833|FG022|Blinded Period|Withdrawal by Subject|0|||
164574532|NCT05630846|594467999|FG000|Overall Study|Other|1|||
164574533|NCT05630846|594468000|FG001|Overall Study|Other|0|||
164574534|NCT05630846|594468001|FG002|Overall Study|Other|0|||
164574535|NCT05630846|594468002|FG003|Overall Study|Other|0|||
164574536|NCT01431287|594468004|FG000|Overall Study|not treated|0|||
164574537|NCT01431287|594468005|FG001|Overall Study|not treated|0|||
164574538|NCT01431287|594468006|FG002|Overall Study|not treated|1|||
164574539|NCT01431287|594468007|FG003|Overall Study|not treated|0|||
164574540|NCT01431287|594468008|FG004|Overall Study|not treated|0|||
164574541|NCT01431287|594468004|FG000|Overall Study|Adverse Event|59|||
164574542|NCT01431287|594468005|FG001|Overall Study|Adverse Event|57|||
164574543|NCT01431287|594468006|FG002|Overall Study|Adverse Event|53|||
164574544|NCT01431287|594468007|FG003|Overall Study|Adverse Event|33|||
164574545|NCT01431287|594468008|FG004|Overall Study|Adverse Event|41|||
164679050|NCT01116739|594851071|FG001|Overall Study|child too young|6|||
164679051|NCT01116739|594851070|FG000|Overall Study|child not enrolled in head start|10|||
164679052|NCT01116739|594851071|FG001|Overall Study|child not enrolled in head start|2|||
164679053|NCT01116739|594851070|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
164679054|NCT01116739|594851071|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
164679055|NCT05090839|594851072|FG000|Overall Study|Lost to Follow-up|2|||
164679056|NCT05090839|594851073|FG001|Overall Study|Lost to Follow-up|3|||
164679057|NCT05090839|594851074|FG002|Overall Study|Lost to Follow-up|1|||
164574546|NCT01431287|594468004|FG000|Overall Study|Non compliant with protocol|6|||
164574547|NCT01431287|594468005|FG001|Overall Study|Non compliant with protocol|6|||
164574548|NCT01431287|594468006|FG002|Overall Study|Non compliant with protocol|5|||
164679058|NCT05090839|594851075|FG003|Overall Study|Lost to Follow-up|1|||
164679059|NCT01987765|594851078|FG000|Overall Study|Protocol Violation|65|||
164679060|NCT01987765|594851078|FG000|Overall Study|Lost to Follow-up|37|||
164679061|NCT00443651|594851081|FG000|Overall Study|Death|1|||
164679062|NCT00443651|594851082|FG001|Overall Study|Death|5|||
164679063|NCT00443651|594851081|FG000|Overall Study|Adverse Event|5|||
164679064|NCT00443651|594851082|FG001|Overall Study|Adverse Event|6|||
164679065|NCT00443651|594851081|FG000|Overall Study|Lost to Follow-up|18|||
164679066|NCT00443651|594851082|FG001|Overall Study|Lost to Follow-up|12|||
164679067|NCT00443651|594851081|FG000|Overall Study|Patient's/Guardian's Decision|58|||
164679068|NCT00443651|594851082|FG001|Overall Study|Patient's/Guardian's Decision|30|||
164679069|NCT00443651|594851081|FG000|Overall Study|Physician Decision|13|||
164679070|NCT00443651|594851082|FG001|Overall Study|Physician Decision|4|||
164679071|NCT00443651|594851081|FG000|Overall Study|Pregnancy|0|||
164679072|NCT00443651|594851082|FG001|Overall Study|Pregnancy|1|||
164679073|NCT03606174|594851085|FG000|Overall Study|Death|37|||
164679074|NCT03606174|594851086|FG001|Overall Study|Death|15|||
164679075|NCT03606174|594851087|FG002|Overall Study|Death|15|||
164679076|NCT03606174|594851088|FG003|Overall Study|Death|7|||
164679077|NCT03606174|594851089|FG004|Overall Study|Death|35|||
164679078|NCT03606174|594851090|FG005|Overall Study|Death|12|||
164679079|NCT03606174|594851091|FG006|Overall Study|Death|35|||
164679080|NCT03606174|594851092|FG007|Overall Study|Death|8|||
164679081|NCT03606174|594851093|FG008|Overall Study|Death|5|||
164679082|NCT03606174|594851094|FG009|Overall Study|Death|3|||
164679083|NCT03606174|594851095|FG010|Overall Study|Death|0|||
164679084|NCT03606174|594851085|FG000|Overall Study|Lost to Follow-up|0|||
164679085|NCT03606174|594851086|FG001|Overall Study|Lost to Follow-up|0|||
164679086|NCT03606174|594851087|FG002|Overall Study|Lost to Follow-up|0|||
164679087|NCT03606174|594851088|FG003|Overall Study|Lost to Follow-up|0|||
164679088|NCT03606174|594851089|FG004|Overall Study|Lost to Follow-up|1|||
164679089|NCT03606174|594851090|FG005|Overall Study|Lost to Follow-up|1|||
164679090|NCT03606174|594851091|FG006|Overall Study|Lost to Follow-up|0|||
164679091|NCT03606174|594851092|FG007|Overall Study|Lost to Follow-up|0|||
164679092|NCT03606174|594851093|FG008|Overall Study|Lost to Follow-up|0|||
164679093|NCT03606174|594851094|FG009|Overall Study|Lost to Follow-up|0|||
164679094|NCT03606174|594851095|FG010|Overall Study|Lost to Follow-up|0|||
164679095|NCT03606174|594851085|FG000|Overall Study|Withdrawal by Subject|6|||
164679096|NCT03606174|594851086|FG001|Overall Study|Withdrawal by Subject|0|||
164679097|NCT03606174|594851087|FG002|Overall Study|Withdrawal by Subject|0|||
164679098|NCT03606174|594851088|FG003|Overall Study|Withdrawal by Subject|1|||
164679099|NCT03606174|594851089|FG004|Overall Study|Withdrawal by Subject|2|||
164679100|NCT03606174|594851090|FG005|Overall Study|Withdrawal by Subject|1|||
164679101|NCT03606174|594851091|FG006|Overall Study|Withdrawal by Subject|4|||
164679102|NCT03606174|594851092|FG007|Overall Study|Withdrawal by Subject|0|||
164426130|NCT04955626|593930834|FG023|Blinded Period|Withdrawal by Subject|0|||
164426131|NCT04955626|593930835|FG024|Blinded Period|Withdrawal by Subject|5|||
164574549|NCT01431287|594468007|FG003|Overall Study|Non compliant with protocol|6|||
164679103|NCT03606174|594851093|FG008|Overall Study|Withdrawal by Subject|0|||
164426132|NCT04955626|593930836|FG025|Blinded Period|Withdrawal by Subject|1|||
164426133|NCT04955626|593930837|FG026|Blinded Period|Withdrawal by Subject|5|||
164426134|NCT04955626|593930838|FG027|Blinded Period|Withdrawal by Subject|1|||
164426135|NCT04955626|593930839|FG028|Blinded Period|Withdrawal by Subject|4|||
164426136|NCT04955626|593930840|FG029|Blinded Period|Withdrawal by Subject|2|||
164574550|NCT01431287|594468008|FG004|Overall Study|Non compliant with protocol|5|||
164426137|NCT04955626|593930841|FG030|Blinded Period|Withdrawal by Subject|0|||
164426138|NCT04955626|593930842|FG031|Blinded Period|Withdrawal by Subject|0|||
164245549|NCT01544348|593267749|FG001|Overall Study|Withdrawal by Subject|0|||
164245550|NCT01544348|593267750|FG002|Overall Study|Withdrawal by Subject|0|||
164245551|NCT01544348|593267751|FG003|Overall Study|Withdrawal by Subject|0|||
164245552|NCT01544348|593267752|FG004|Overall Study|Withdrawal by Subject|1|||
164245553|NCT01544348|593267753|FG005|Overall Study|Withdrawal by Subject|2|||
164245554|NCT01544348|593267754|FG006|Overall Study|Withdrawal by Subject|1|||
164245555|NCT01544348|593267755|FG007|Overall Study|Withdrawal by Subject|0|||
164245556|NCT01544348|593267748|FG000|Overall Study|Physician Decision|0|||
164245557|NCT01544348|593267749|FG001|Overall Study|Physician Decision|0|||
164245558|NCT01544348|593267750|FG002|Overall Study|Physician Decision|0|||
164245559|NCT01544348|593267751|FG003|Overall Study|Physician Decision|0|||
164245560|NCT01544348|593267752|FG004|Overall Study|Physician Decision|0|||
164245561|NCT01544348|593267753|FG005|Overall Study|Physician Decision|1|||
164245562|NCT01544348|593267754|FG006|Overall Study|Physician Decision|0|||
164245563|NCT01544348|593267755|FG007|Overall Study|Physician Decision|0|||
164245564|NCT00642707|593267756|FG000|Overall Study|Adverse Event|0|||
164245565|NCT00642707|593267757|FG001|Overall Study|Adverse Event|0|||
164245566|NCT00642707|593267758|FG002|Overall Study|Adverse Event|0|||
164245567|NCT00642707|593267759|FG003|Overall Study|Adverse Event|2|||
164245568|NCT00642707|593267756|FG000|Overall Study|Withdrawal by Subject|1|||
164245569|NCT00642707|593267757|FG001|Overall Study|Withdrawal by Subject|0|||
164245570|NCT00642707|593267758|FG002|Overall Study|Withdrawal by Subject|0|||
164245571|NCT00642707|593267759|FG003|Overall Study|Withdrawal by Subject|0|||
164245572|NCT02573948|593267765|FG000|Longitudinal Cohort|Death|9|||
164245573|NCT02573948|593267765|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
164245574|NCT02573948|593267765|FG000|Longitudinal Cohort|Incarcerated|25|||
164245575|NCT00707993|593267766|FG000|Overall Study|Adverse Event|16|||
164245576|NCT00707993|593267767|FG001|Overall Study|Adverse Event|20|||
164245577|NCT00707993|593267766|FG000|Overall Study|Protocol Violation|4|||
164245578|NCT00707993|593267767|FG001|Overall Study|Protocol Violation|7|||
164245579|NCT00707993|593267766|FG000|Overall Study|Lost to Follow-up|0|||
164245580|NCT00707993|593267767|FG001|Overall Study|Lost to Follow-up|4|||
164245581|NCT00707993|593267766|FG000|Overall Study|Withdrawal by Subject|12|||
164245582|NCT00707993|593267767|FG001|Overall Study|Withdrawal by Subject|16|||
164245583|NCT00707993|593267766|FG000|Overall Study|Hyperglycemic Rescue|55|||
164245584|NCT00707993|593267767|FG001|Overall Study|Hyperglycemic Rescue|47|||
164245585|NCT00707993|593267766|FG000|Overall Study|Other|2|||
164245586|NCT00707993|593267767|FG001|Overall Study|Other|0|||
164245587|NCT00436436|593267770|FG000|Overall Study|Progression|4|||
164245588|NCT00436436|593267770|FG000|Overall Study|Adverse Event|2|||
164245589|NCT00436436|593267770|FG000|Overall Study|Death|6|||
164245590|NCT01837680|593267774|FG000|Overall Study|Lost to Follow-up|2|||
164245591|NCT01837680|593267775|FG001|Overall Study|Lost to Follow-up|2|||
164245592|NCT01837680|593267774|FG000|Overall Study|lack of insurance|0|||
164245593|NCT01837680|593267775|FG001|Overall Study|lack of insurance|2|||
164245594|NCT01837680|593267774|FG000|Overall Study|allergic reaction|6|||
164245595|NCT01837680|593267775|FG001|Overall Study|allergic reaction|0|||
164245596|NCT01837680|593267774|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
164245597|NCT01837680|593267775|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
164245598|NCT03008070|593267776|FG000|Overall Study|Adverse Event|3|||
164245599|NCT03008070|593267777|FG001|Overall Study|Adverse Event|3|||
164245600|NCT03008070|593267778|FG002|Overall Study|Adverse Event|3|||
164245601|NCT03008070|593267776|FG000|Overall Study|Lost to Follow-up|1|||
164245602|NCT03008070|593267777|FG001|Overall Study|Lost to Follow-up|1|||
164245603|NCT03008070|593267778|FG002|Overall Study|Lost to Follow-up|0|||
164245604|NCT03008070|593267776|FG000|Overall Study|Non compliance|0|||
164245605|NCT03008070|593267777|FG001|Overall Study|Non compliance|1|||
164245606|NCT03008070|593267778|FG002|Overall Study|Non compliance|1|||
164245607|NCT03008070|593267776|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
164245608|NCT03008070|593267777|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
164245609|NCT03008070|593267778|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
164245610|NCT03008070|593267776|FG000|Overall Study|Withdrawal by Subject|2|||
164574551|NCT01431287|594468004|FG000|Overall Study|Lost to Follow-up|0|||
164574552|NCT01431287|594468005|FG001|Overall Study|Lost to Follow-up|3|||
164574553|NCT01431287|594468006|FG002|Overall Study|Lost to Follow-up|2|||
164574554|NCT01431287|594468007|FG003|Overall Study|Lost to Follow-up|3|||
164245611|NCT03008070|593267777|FG001|Overall Study|Withdrawal by Subject|0|||
164574555|NCT01431287|594468008|FG004|Overall Study|Lost to Follow-up|1|||
164574556|NCT01431287|594468004|FG000|Overall Study|Consent withdrawn not due to AE|29|||
164245612|NCT03008070|593267778|FG002|Overall Study|Withdrawal by Subject|1|||
164245613|NCT03008070|593267776|FG000|Overall Study|Use of prohibited drug|0|||
164245614|NCT03008070|593267777|FG001|Overall Study|Use of prohibited drug|0|||
164337641|NCT05938920|593611614|FG003|Overall Study|Participant Asked to Withdraw from the Trial|0|||
164245615|NCT03008070|593267778|FG002|Overall Study|Use of prohibited drug|2|||
164245616|NCT05005273|593267779|FG000|Overall Study|Study Terminated|1|||
164245617|NCT05005273|593267780|FG001|Overall Study|Study Terminated|0|||
164245618|NCT04409834|593267781|FG000|Overall Study|Death|55|||
164245619|NCT04409834|593267782|FG001|Overall Study|Death|62|||
164245620|NCT03960684|593267784|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
164245621|NCT05223673|593267785|FG000|Overall Study|Protocol Violation|1|||
164245622|NCT05223673|593267785|FG000|Overall Study|Study termination|6|||
164245623|NCT04266912|593267786|FG000|Overall Study|Withdrawal by Subject|1|||
164245624|NCT04266912|593267787|FG001|Overall Study|Withdrawal by Subject|0|||
164245625|NCT04266912|593267788|FG002|Overall Study|Withdrawal by Subject|0|||
164245626|NCT04266912|593267789|FG003|Overall Study|Withdrawal by Subject|0|||
164245627|NCT04266912|593267786|FG000|Overall Study|Progression|6|||
164245628|NCT04266912|593267787|FG001|Overall Study|Progression|6|||
164245629|NCT04266912|593267788|FG002|Overall Study|Progression|0|||
164245630|NCT04266912|593267789|FG003|Overall Study|Progression|10|||
164245631|NCT02685826|593267790|FG000|Overall Study|Adverse Event|2|||
164245632|NCT02685826|593267791|FG001|Overall Study|Adverse Event|0|||
164245633|NCT02685826|593267792|FG002|Overall Study|Adverse Event|1|||
164245634|NCT02685826|593267790|FG000|Overall Study|Progressive Disease|2|||
164245635|NCT02685826|593267791|FG001|Overall Study|Progressive Disease|1|||
164245636|NCT02685826|593267792|FG002|Overall Study|Progressive Disease|0|||
164245637|NCT02685826|593267790|FG000|Overall Study|Withdrawal by Subject|2|||
164245638|NCT02685826|593267791|FG001|Overall Study|Withdrawal by Subject|0|||
164245639|NCT02685826|593267792|FG002|Overall Study|Withdrawal by Subject|0|||
164245640|NCT02685826|593267790|FG000|Overall Study|Full Clinical Hold by FDA|19|||
164245641|NCT02685826|593267791|FG001|Overall Study|Full Clinical Hold by FDA|9|||
164245642|NCT02685826|593267792|FG002|Overall Study|Full Clinical Hold by FDA|20|||
164245643|NCT01133756|593269226|FG000|Overall Study|Adverse Event|1|||
164245644|NCT01133756|593269227|FG001|Overall Study|Adverse Event|2|||
164245645|NCT01133756|593269228|FG002|Overall Study|Adverse Event|1|||
164245646|NCT01133756|593269226|FG000|Overall Study|Investigator Decision|1|||
164245647|NCT01133756|593269227|FG001|Overall Study|Investigator Decision|0|||
164245648|NCT01133756|593269228|FG002|Overall Study|Investigator Decision|0|||
164245649|NCT01133756|593269226|FG000|Overall Study|Withdrawal by Subject|0|||
164245650|NCT01133756|593269227|FG001|Overall Study|Withdrawal by Subject|1|||
164245651|NCT01133756|593269228|FG002|Overall Study|Withdrawal by Subject|0|||
164245652|NCT01133756|593269226|FG000|Overall Study|Progression of Disease|0|||
164245653|NCT01133756|593269227|FG001|Overall Study|Progression of Disease|0|||
164245654|NCT01133756|593269228|FG002|Overall Study|Progression of Disease|1|||
164245655|NCT03941873|593269231|FG000|Overall Study|Death|0|||
164245656|NCT03941873|593269232|FG001|Overall Study|Death|12|||
164245657|NCT03941873|593269233|FG002|Overall Study|Death|2|||
164245658|NCT03941873|593269234|FG003|Overall Study|Death|53|||
164245659|NCT03941873|593269231|FG000|Overall Study|Withdrawal by Subject|1|||
164245660|NCT03941873|593269232|FG001|Overall Study|Withdrawal by Subject|1|||
164245661|NCT03941873|593269233|FG002|Overall Study|Withdrawal by Subject|0|||
164245662|NCT03941873|593269234|FG003|Overall Study|Withdrawal by Subject|5|||
164337642|NCT05938920|593611611|FG000|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
164337643|NCT05938920|593611612|FG001|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
164337644|NCT05938920|593611613|FG002|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|1|||
164337645|NCT05938920|593611614|FG003|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
164337646|NCT05938920|593611611|FG000|Overall Study|Participant Refused to Come In|0|||
164337647|NCT05938920|593611612|FG001|Overall Study|Participant Refused to Come In|0|||
164337648|NCT05938920|593611613|FG002|Overall Study|Participant Refused to Come In|1|||
164337649|NCT05938920|593611614|FG003|Overall Study|Participant Refused to Come In|0|||
164337650|NCT01251861|593611615|FG000|Overall Study|Disease progression|6|||
164337651|NCT01251861|593611616|FG001|Overall Study|Disease progression|6|||
164337652|NCT01251861|593611615|FG000|Overall Study|Adverse Event|2|||
164337653|NCT01251861|593611616|FG001|Overall Study|Adverse Event|17|||
164337654|NCT01251861|593611615|FG000|Overall Study|Withdrawal by Subject|2|||
164337655|NCT01251861|593611616|FG001|Overall Study|Withdrawal by Subject|2|||
164337656|NCT01251861|593611615|FG000|Overall Study|Alternative therapy|1|||
164337657|NCT01251861|593611616|FG001|Overall Study|Alternative therapy|0|||
164337658|NCT01251861|593611615|FG000|Overall Study|Other complicating disease|0|||
164337659|NCT01251861|593611616|FG001|Overall Study|Other complicating disease|1|||
164337660|NCT01251861|593611615|FG000|Overall Study|Physician Decision|1|||
164337661|NCT01251861|593611616|FG001|Overall Study|Physician Decision|0|||
164337662|NCT01251861|593611615|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
164337663|NCT01251861|593611616|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
164337664|NCT01251861|593611615|FG000|Overall Study|Other|1|||
164337665|NCT01251861|593611616|FG001|Overall Study|Other|0|||
164337666|NCT01251861|593611615|FG000|Overall Study|Never started therapy|4|||
164337667|NCT01251861|593611616|FG001|Overall Study|Never started therapy|1|||
164245663|NCT03941873|593269231|FG000|Overall Study|Lost to Follow-up|1|||
164245664|NCT03941873|593269232|FG001|Overall Study|Lost to Follow-up|2|||
164245665|NCT03941873|593269233|FG002|Overall Study|Lost to Follow-up|0|||
164245666|NCT03941873|593269234|FG003|Overall Study|Lost to Follow-up|0|||
164245667|NCT03941873|593269231|FG000|Overall Study|Sponsor Decision|0|||
164245668|NCT03941873|593269232|FG001|Overall Study|Sponsor Decision|6|||
164245669|NCT03941873|593269233|FG002|Overall Study|Sponsor Decision|0|||
164574557|NCT01431287|594468005|FG001|Overall Study|Consent withdrawn not due to AE|30|||
164574558|NCT01431287|594468006|FG002|Overall Study|Consent withdrawn not due to AE|34|||
164574559|NCT01431287|594468007|FG003|Overall Study|Consent withdrawn not due to AE|19|||
164574560|NCT01431287|594468008|FG004|Overall Study|Consent withdrawn not due to AE|29|||
164245670|NCT03941873|593269234|FG003|Overall Study|Sponsor Decision|15|||
164574561|NCT01431287|594468004|FG000|Overall Study|not stated above|4|||
164245671|NCT03276728|593269235|FG000|Overall Study|Lost to Follow-up|0|||
164245672|NCT03276728|593269236|FG001|Overall Study|Lost to Follow-up|0|||
164245673|NCT03276728|593269237|FG002|Overall Study|Lost to Follow-up|2|||
164245674|NCT03276728|593269238|FG003|Overall Study|Lost to Follow-up|2|||
164245675|NCT03276728|593269239|FG004|Overall Study|Lost to Follow-up|0|||
164245676|NCT03276728|593269240|FG005|Overall Study|Lost to Follow-up|0|||
164245677|NCT03276728|593269241|FG006|Overall Study|Lost to Follow-up|0|||
164245678|NCT03276728|593269242|FG007|Overall Study|Lost to Follow-up|0|||
164245679|NCT03276728|593269235|FG000|Overall Study|Withdrawal by Subject|0|||
164245680|NCT03276728|593269236|FG001|Overall Study|Withdrawal by Subject|0|||
164574562|NCT01431287|594468005|FG001|Overall Study|not stated above|2|||
164574563|NCT01431287|594468006|FG002|Overall Study|not stated above|2|||
164574564|NCT01431287|594468007|FG003|Overall Study|not stated above|2|||
164574565|NCT01431287|594468008|FG004|Overall Study|not stated above|1|||
164574566|NCT03019549|594468009|FG000|Washout|DId not meet genotype criteria|11|||
164574567|NCT03019549|594468009|FG000|Period 2|Adverse Event|2|||
164574568|NCT03019549|594468009|FG000|Period 2|Physician Decision|2|||
164574569|NCT03019549|594468009|FG000|Period 2|Withdrawal by Subject|1|||
164574570|NCT01412879|594468012|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
164574571|NCT01412879|594468013|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
164574572|NCT01412879|594468014|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
164574573|NCT01412879|594468012|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
164574574|NCT01412879|594468013|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
164574575|NCT01412879|594468014|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
164574576|NCT01412879|594468012|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
164574577|NCT01412879|594468013|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
164574578|NCT01412879|594468014|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
164574579|NCT01412879|594468012|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
164679104|NCT03606174|594851094|FG009|Overall Study|Withdrawal by Subject|0|||
164679105|NCT03606174|594851095|FG010|Overall Study|Withdrawal by Subject|1|||
164679106|NCT03606174|594851085|FG000|Overall Study|Study Terminated by Sponsor|5|||
164679107|NCT03606174|594851086|FG001|Overall Study|Study Terminated by Sponsor|7|||
164679108|NCT03606174|594851087|FG002|Overall Study|Study Terminated by Sponsor|3|||
164245681|NCT03276728|593269237|FG002|Overall Study|Withdrawal by Subject|0|||
164245682|NCT03276728|593269238|FG003|Overall Study|Withdrawal by Subject|3|||
164245683|NCT03276728|593269239|FG004|Overall Study|Withdrawal by Subject|0|||
164245684|NCT03276728|593269240|FG005|Overall Study|Withdrawal by Subject|0|||
164245685|NCT03276728|593269241|FG006|Overall Study|Withdrawal by Subject|0|||
164245686|NCT03276728|593269242|FG007|Overall Study|Withdrawal by Subject|0|||
164574580|NCT01412879|594468013|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
164574581|NCT01412879|594468014|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
164574582|NCT01412879|594468012|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
164574583|NCT01412879|594468013|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
164574584|NCT01412879|594468014|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
164574585|NCT04030195|594468015|FG000|Overall Study|Withdrawal by Subject|2|||
164574586|NCT04030195|594468016|FG001|Overall Study|Withdrawal by Subject|0|||
164574587|NCT04030195|594468017|FG002|Overall Study|Withdrawal by Subject|0|||
164574588|NCT02109029|594468018|FG000|Part B|Adverse Event|0|||
164574589|NCT02109029|594468019|FG001|Part B|Adverse Event|0|||
164574590|NCT02109029|594468020|FG002|Part B|Adverse Event|0|||
164574591|NCT02109029|594468021|FG003|Part B|Adverse Event|0|||
164574592|NCT02109029|594468022|FG004|Part B|Adverse Event|1|||
164679109|NCT03606174|594851088|FG003|Overall Study|Study Terminated by Sponsor|0|||
164679110|NCT03606174|594851089|FG004|Overall Study|Study Terminated by Sponsor|11|||
164679111|NCT03606174|594851090|FG005|Overall Study|Study Terminated by Sponsor|6|||
164679112|NCT03606174|594851091|FG006|Overall Study|Study Terminated by Sponsor|12|||
164679113|NCT03606174|594851092|FG007|Overall Study|Study Terminated by Sponsor|1|||
164679114|NCT03606174|594851093|FG008|Overall Study|Study Terminated by Sponsor|3|||
164679115|NCT03606174|594851094|FG009|Overall Study|Study Terminated by Sponsor|1|||
164679116|NCT03606174|594851095|FG010|Overall Study|Study Terminated by Sponsor|2|||
164679117|NCT03606174|594851085|FG000|Overall Study|Miscellaneous|1|||
164679118|NCT03606174|594851086|FG001|Overall Study|Miscellaneous|1|||
164574593|NCT02109029|594468023|FG005|Part B|Adverse Event|1|||
164574594|NCT00496366|594468028|FG000|Overall Study|Death|1|||
164679119|NCT03606174|594851087|FG002|Overall Study|Miscellaneous|0|||
164679120|NCT03606174|594851088|FG003|Overall Study|Miscellaneous|1|||
164245687|NCT03276728|593269235|FG000|Overall Study|Decision by sponsor|0|||
164245688|NCT03276728|593269236|FG001|Overall Study|Decision by sponsor|0|||
164245689|NCT03276728|593269237|FG002|Overall Study|Decision by sponsor|0|||
164245690|NCT03276728|593269238|FG003|Overall Study|Decision by sponsor|0|||
164245691|NCT03276728|593269239|FG004|Overall Study|Decision by sponsor|1|||
164245692|NCT03276728|593269240|FG005|Overall Study|Decision by sponsor|0|||
164245693|NCT03276728|593269241|FG006|Overall Study|Decision by sponsor|2|||
164245694|NCT03276728|593269242|FG007|Overall Study|Decision by sponsor|1|||
164245695|NCT00617084|593269245|FG000|Overall Study|Withdrawal by Subject|5|||
164245696|NCT00617084|593269246|FG001|Overall Study|Withdrawal by Subject|7|||
164245697|NCT00617084|593269245|FG000|Overall Study|Missed 12 Months visit|16|||
164245698|NCT00617084|593269246|FG001|Overall Study|Missed 12 Months visit|19|||
164245699|NCT02574078|593269250|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164245700|NCT02574078|593269251|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164245701|NCT02574078|593269252|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164245702|NCT02574078|593269253|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164245703|NCT02574078|593269254|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164245704|NCT02574078|593269255|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
164245705|NCT02574078|593269256|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
164245706|NCT02574078|593269257|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164245707|NCT02574078|593269258|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
164245708|NCT02574078|593269259|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164245709|NCT02574078|593269260|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164245710|NCT02574078|593269261|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164245711|NCT02574078|593269262|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164245712|NCT02574078|593269250|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
164245713|NCT02574078|593269251|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
164245714|NCT02574078|593269252|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
164245715|NCT02574078|593269253|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
164245716|NCT02574078|593269254|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
164245717|NCT02574078|593269255|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
164245718|NCT02574078|593269256|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
164245719|NCT02574078|593269257|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
164245720|NCT02574078|593269258|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
164245721|NCT02574078|593269259|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
164245722|NCT02574078|593269260|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
164245723|NCT02574078|593269261|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
164245724|NCT02574078|593269262|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
164245725|NCT02574078|593269250|FG000|Pre-Treatment Period|Other reasons|0|||
164245726|NCT02574078|593269251|FG001|Pre-Treatment Period|Other reasons|0|||
164245727|NCT02574078|593269252|FG002|Pre-Treatment Period|Other reasons|0|||
164245728|NCT02574078|593269253|FG003|Pre-Treatment Period|Other reasons|0|||
164245729|NCT02574078|593269254|FG004|Pre-Treatment Period|Other reasons|0|||
164245730|NCT02574078|593269255|FG005|Pre-Treatment Period|Other reasons|0|||
164245731|NCT02574078|593269256|FG006|Pre-Treatment Period|Other reasons|2|||
164245732|NCT02574078|593269257|FG007|Pre-Treatment Period|Other reasons|0|||
164245733|NCT02574078|593269258|FG008|Pre-Treatment Period|Other reasons|0|||
164245734|NCT02574078|593269259|FG009|Pre-Treatment Period|Other reasons|0|||
164245735|NCT02574078|593269260|FG010|Pre-Treatment Period|Other reasons|2|||
164245736|NCT02574078|593269261|FG011|Pre-Treatment Period|Other reasons|0|||
164245737|NCT02574078|593269262|FG012|Pre-Treatment Period|Other reasons|0|||
164245738|NCT02574078|593269250|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
164245739|NCT02574078|593269251|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
164245740|NCT02574078|593269252|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
164245741|NCT02574078|593269253|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
164245742|NCT02574078|593269254|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
164245743|NCT02574078|593269255|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
164245744|NCT02574078|593269256|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
164245745|NCT02574078|593269257|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
164245746|NCT02574078|593269258|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
164245747|NCT02574078|593269259|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
164679121|NCT03606174|594851089|FG004|Overall Study|Miscellaneous|4|||
164245748|NCT02574078|593269260|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
164245749|NCT02574078|593269261|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
164245750|NCT02574078|593269262|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
164245751|NCT02574078|593269250|FG000|Treatment Period|Disease progression|6|||
164245752|NCT02574078|593269251|FG001|Treatment Period|Disease progression|4|||
164245753|NCT02574078|593269252|FG002|Treatment Period|Disease progression|7|||
164245754|NCT02574078|593269253|FG003|Treatment Period|Disease progression|18|||
164245755|NCT02574078|593269254|FG004|Treatment Period|Disease progression|16|||
164245756|NCT02574078|593269255|FG005|Treatment Period|Disease progression|26|||
164245757|NCT02574078|593269256|FG006|Treatment Period|Disease progression|5|||
164245758|NCT02574078|593269257|FG007|Treatment Period|Disease progression|9|||
164245759|NCT02574078|593269258|FG008|Treatment Period|Disease progression|8|||
164245760|NCT02574078|593269259|FG009|Treatment Period|Disease progression|5|||
164245761|NCT02574078|593269260|FG010|Treatment Period|Disease progression|20|||
164245762|NCT02574078|593269261|FG011|Treatment Period|Disease progression|29|||
164245763|NCT02574078|593269262|FG012|Treatment Period|Disease progression|2|||
164245764|NCT02574078|593269250|FG000|Treatment Period|Study drug toxicity|1|||
164245765|NCT02574078|593269251|FG001|Treatment Period|Study drug toxicity|1|||
164245766|NCT02574078|593269252|FG002|Treatment Period|Study drug toxicity|0|||
164245767|NCT02574078|593269253|FG003|Treatment Period|Study drug toxicity|5|||
164245768|NCT02574078|593269254|FG004|Treatment Period|Study drug toxicity|3|||
164245769|NCT02574078|593269255|FG005|Treatment Period|Study drug toxicity|1|||
164245770|NCT02574078|593269256|FG006|Treatment Period|Study drug toxicity|2|||
164245771|NCT02574078|593269257|FG007|Treatment Period|Study drug toxicity|0|||
164245772|NCT02574078|593269258|FG008|Treatment Period|Study drug toxicity|2|||
164245773|NCT02574078|593269259|FG009|Treatment Period|Study drug toxicity|1|||
164245774|NCT02574078|593269260|FG010|Treatment Period|Study drug toxicity|16|||
164245775|NCT02574078|593269261|FG011|Treatment Period|Study drug toxicity|2|||
164245776|NCT02574078|593269262|FG012|Treatment Period|Study drug toxicity|4|||
164245777|NCT02574078|593269250|FG000|Treatment Period|Death|2|||
164245778|NCT02574078|593269251|FG001|Treatment Period|Death|0|||
164245779|NCT02574078|593269252|FG002|Treatment Period|Death|0|||
164245780|NCT02574078|593269253|FG003|Treatment Period|Death|0|||
164245781|NCT02574078|593269254|FG004|Treatment Period|Death|1|||
164245782|NCT02574078|593269255|FG005|Treatment Period|Death|1|||
164245783|NCT02574078|593269256|FG006|Treatment Period|Death|1|||
164245784|NCT02574078|593269257|FG007|Treatment Period|Death|1|||
164245785|NCT02574078|593269258|FG008|Treatment Period|Death|7|||
164245786|NCT02574078|593269259|FG009|Treatment Period|Death|1|||
164245787|NCT02574078|593269260|FG010|Treatment Period|Death|0|||
164245788|NCT02574078|593269261|FG011|Treatment Period|Death|2|||
164245789|NCT02574078|593269262|FG012|Treatment Period|Death|1|||
164245790|NCT02574078|593269250|FG000|Treatment Period|Adverse event unrelated to drug|0|||
164245791|NCT02574078|593269251|FG001|Treatment Period|Adverse event unrelated to drug|0|||
164337668|NCT01251861|593611615|FG000|Overall Study|Potential interaction of drugs|0|||
164337669|NCT01251861|593611616|FG001|Overall Study|Potential interaction of drugs|1|||
164245792|NCT02574078|593269252|FG002|Treatment Period|Adverse event unrelated to drug|1|||
164245793|NCT02574078|593269253|FG003|Treatment Period|Adverse event unrelated to drug|0|||
164245794|NCT02574078|593269254|FG004|Treatment Period|Adverse event unrelated to drug|2|||
164245795|NCT02574078|593269255|FG005|Treatment Period|Adverse event unrelated to drug|3|||
164245796|NCT02574078|593269256|FG006|Treatment Period|Adverse event unrelated to drug|0|||
164245797|NCT02574078|593269257|FG007|Treatment Period|Adverse event unrelated to drug|0|||
164245798|NCT02574078|593269258|FG008|Treatment Period|Adverse event unrelated to drug|1|||
164245799|NCT02574078|593269259|FG009|Treatment Period|Adverse event unrelated to drug|2|||
164245800|NCT02574078|593269260|FG010|Treatment Period|Adverse event unrelated to drug|4|||
164245801|NCT02574078|593269261|FG011|Treatment Period|Adverse event unrelated to drug|1|||
164245802|NCT02574078|593269262|FG012|Treatment Period|Adverse event unrelated to drug|0|||
164245803|NCT02574078|593269250|FG000|Treatment Period|Administrative reason by Sponsor|0|||
164245804|NCT02574078|593269251|FG001|Treatment Period|Administrative reason by Sponsor|1|||
164245805|NCT02574078|593269252|FG002|Treatment Period|Administrative reason by Sponsor|0|||
164245806|NCT02574078|593269253|FG003|Treatment Period|Administrative reason by Sponsor|0|||
164245807|NCT02574078|593269254|FG004|Treatment Period|Administrative reason by Sponsor|0|||
164245808|NCT02574078|593269255|FG005|Treatment Period|Administrative reason by Sponsor|0|||
164245809|NCT02574078|593269256|FG006|Treatment Period|Administrative reason by Sponsor|1|||
164245810|NCT02574078|593269257|FG007|Treatment Period|Administrative reason by Sponsor|0|||
164245811|NCT02574078|593269258|FG008|Treatment Period|Administrative reason by Sponsor|0|||
164245812|NCT02574078|593269259|FG009|Treatment Period|Administrative reason by Sponsor|0|||
164245813|NCT02574078|593269260|FG010|Treatment Period|Administrative reason by Sponsor|0|||
164245814|NCT02574078|593269261|FG011|Treatment Period|Administrative reason by Sponsor|0|||
164245815|NCT02574078|593269262|FG012|Treatment Period|Administrative reason by Sponsor|3|||
164245816|NCT02574078|593269250|FG000|Treatment Period|Other reasons|1|||
164245817|NCT02574078|593269251|FG001|Treatment Period|Other reasons|0|||
164245818|NCT02574078|593269252|FG002|Treatment Period|Other reasons|1|||
164245819|NCT02574078|593269253|FG003|Treatment Period|Other reasons|3|||
164245820|NCT02574078|593269254|FG004|Treatment Period|Other reasons|3|||
164245821|NCT02574078|593269255|FG005|Treatment Period|Other reasons|1|||
164245822|NCT02574078|593269256|FG006|Treatment Period|Other reasons|2|||
164245823|NCT02574078|593269257|FG007|Treatment Period|Other reasons|1|||
164245824|NCT02574078|593269258|FG008|Treatment Period|Other reasons|3|||
164245825|NCT02574078|593269259|FG009|Treatment Period|Other reasons|1|||
164245826|NCT02574078|593269260|FG010|Treatment Period|Other reasons|1|||
164245827|NCT02574078|593269261|FG011|Treatment Period|Other reasons|3|||
164245828|NCT02574078|593269262|FG012|Treatment Period|Other reasons|1|||
164245829|NCT02574078|593269250|FG000|Treatment Period|Participant request to stop drug|0|||
164245830|NCT02574078|593269251|FG001|Treatment Period|Participant request to stop drug|0|||
164245831|NCT02574078|593269252|FG002|Treatment Period|Participant request to stop drug|0|||
164245832|NCT02574078|593269253|FG003|Treatment Period|Participant request to stop drug|2|||
164245833|NCT02574078|593269254|FG004|Treatment Period|Participant request to stop drug|4|||
164245834|NCT02574078|593269255|FG005|Treatment Period|Participant request to stop drug|0|||
164245835|NCT02574078|593269256|FG006|Treatment Period|Participant request to stop drug|1|||
164245836|NCT02574078|593269257|FG007|Treatment Period|Participant request to stop drug|0|||
164245837|NCT02574078|593269258|FG008|Treatment Period|Participant request to stop drug|3|||
164337670|NCT00531934|593613103|FG000|Overall Study|Adverse Event|4|||
164337671|NCT00531934|593613104|FG001|Overall Study|Adverse Event|8|||
164337672|NCT00531934|593613103|FG000|Overall Study|Progression|52|||
164337673|NCT00531934|593613104|FG001|Overall Study|Progression|42|||
164574595|NCT00260208|594468030|FG000|Overall Study|Subject withdrew consent|11|||
164574596|NCT00260208|594468031|FG001|Overall Study|Subject withdrew consent|7|||
164574597|NCT00260208|594468030|FG000|Overall Study|Lost to Follow-up|6|||
164574598|NCT00260208|594468031|FG001|Overall Study|Lost to Follow-up|1|||
164574599|NCT00260208|594468030|FG000|Overall Study|Death|12|||
164574600|NCT00260208|594468031|FG001|Overall Study|Death|10|||
164574601|NCT00260208|594468030|FG000|Overall Study|Missing|18|||
164574602|NCT00260208|594468031|FG001|Overall Study|Missing|16|||
164574603|NCT02091440|594468032|FG000|Overall Study|Death|2|||
164574604|NCT00278629|594468039|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
164574605|NCT03323749|594468040|FG000|Double-blind Period|Lost to Follow-up|4|||
164574606|NCT03323749|594468041|FG001|Double-blind Period|Lost to Follow-up|5|||
164574607|NCT03323749|594468040|FG000|Double-blind Period|Adverse Event|3|||
164574608|NCT03323749|594468041|FG001|Double-blind Period|Adverse Event|1|||
164574609|NCT03323749|594468040|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
164245838|NCT02574078|593269259|FG009|Treatment Period|Participant request to stop drug|2|||
164245839|NCT02574078|593269260|FG010|Treatment Period|Participant request to stop drug|2|||
164245840|NCT02574078|593269261|FG011|Treatment Period|Participant request to stop drug|4|||
164245841|NCT02574078|593269262|FG012|Treatment Period|Participant request to stop drug|1|||
164245842|NCT02574078|593269250|FG000|Treatment Period|Participant withdrew consent|0|||
164245843|NCT02574078|593269251|FG001|Treatment Period|Participant withdrew consent|0|||
164245844|NCT02574078|593269252|FG002|Treatment Period|Participant withdrew consent|0|||
164245845|NCT02574078|593269253|FG003|Treatment Period|Participant withdrew consent|0|||
164337674|NCT00531934|593613103|FG000|Overall Study|Death|7|||
164574610|NCT03323749|594468041|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
164679122|NCT03606174|594851090|FG005|Overall Study|Miscellaneous|7|||
164245846|NCT02574078|593269254|FG004|Treatment Period|Participant withdrew consent|1|||
164337675|NCT00531934|593613104|FG001|Overall Study|Death|10|||
164245847|NCT02574078|593269255|FG005|Treatment Period|Participant withdrew consent|1|||
164574611|NCT03323749|594468040|FG000|Open-Label Period|Adverse Event|3|||
164574612|NCT03323749|594468041|FG001|Open-Label Period|Adverse Event|10|||
164245848|NCT02574078|593269256|FG006|Treatment Period|Participant withdrew consent|0|||
164245849|NCT02574078|593269257|FG007|Treatment Period|Participant withdrew consent|1|||
164245850|NCT02574078|593269258|FG008|Treatment Period|Participant withdrew consent|0|||
164245851|NCT02574078|593269259|FG009|Treatment Period|Participant withdrew consent|2|||
164245852|NCT02574078|593269260|FG010|Treatment Period|Participant withdrew consent|1|||
164245853|NCT02574078|593269261|FG011|Treatment Period|Participant withdrew consent|4|||
164245854|NCT02574078|593269262|FG012|Treatment Period|Participant withdrew consent|1|||
164245855|NCT02574078|593269250|FG000|Treatment Period|Participant no longer meets criteria|0|||
164245856|NCT02574078|593269251|FG001|Treatment Period|Participant no longer meets criteria|0|||
164245857|NCT02574078|593269252|FG002|Treatment Period|Participant no longer meets criteria|0|||
164245858|NCT02574078|593269253|FG003|Treatment Period|Participant no longer meets criteria|0|||
164245859|NCT02574078|593269254|FG004|Treatment Period|Participant no longer meets criteria|1|||
164245860|NCT02574078|593269255|FG005|Treatment Period|Participant no longer meets criteria|0|||
164245861|NCT02574078|593269256|FG006|Treatment Period|Participant no longer meets criteria|0|||
164245862|NCT02574078|593269257|FG007|Treatment Period|Participant no longer meets criteria|0|||
164245863|NCT02574078|593269258|FG008|Treatment Period|Participant no longer meets criteria|0|||
164245864|NCT02574078|593269259|FG009|Treatment Period|Participant no longer meets criteria|1|||
164245865|NCT02574078|593269260|FG010|Treatment Period|Participant no longer meets criteria|1|||
164245866|NCT02574078|593269261|FG011|Treatment Period|Participant no longer meets criteria|1|||
164245867|NCT02574078|593269262|FG012|Treatment Period|Participant no longer meets criteria|0|||
164245868|NCT02574078|593269250|FG000|Treatment Period|Lost to Follow-up|0|||
164245869|NCT02574078|593269251|FG001|Treatment Period|Lost to Follow-up|0|||
164245870|NCT02574078|593269252|FG002|Treatment Period|Lost to Follow-up|0|||
164245871|NCT02574078|593269253|FG003|Treatment Period|Lost to Follow-up|0|||
164245872|NCT02574078|593269254|FG004|Treatment Period|Lost to Follow-up|0|||
164245873|NCT02574078|593269255|FG005|Treatment Period|Lost to Follow-up|0|||
164245874|NCT02574078|593269256|FG006|Treatment Period|Lost to Follow-up|0|||
164245875|NCT02574078|593269257|FG007|Treatment Period|Lost to Follow-up|0|||
164245876|NCT02574078|593269258|FG008|Treatment Period|Lost to Follow-up|0|||
164245877|NCT02574078|593269259|FG009|Treatment Period|Lost to Follow-up|1|||
164245878|NCT02574078|593269260|FG010|Treatment Period|Lost to Follow-up|0|||
164245879|NCT02574078|593269261|FG011|Treatment Period|Lost to Follow-up|1|||
164245880|NCT02574078|593269262|FG012|Treatment Period|Lost to Follow-up|0|||
164245881|NCT02574078|593269250|FG000|Treatment Period|Maximum clinical benefit|0|||
164245882|NCT02574078|593269251|FG001|Treatment Period|Maximum clinical benefit|0|||
164245883|NCT02574078|593269252|FG002|Treatment Period|Maximum clinical benefit|0|||
164245884|NCT02574078|593269253|FG003|Treatment Period|Maximum clinical benefit|0|||
164337676|NCT00531934|593613103|FG000|Overall Study|Withdrawal by Subject|1|||
164245885|NCT02574078|593269254|FG004|Treatment Period|Maximum clinical benefit|0|||
164245886|NCT02574078|593269255|FG005|Treatment Period|Maximum clinical benefit|0|||
164245887|NCT02574078|593269256|FG006|Treatment Period|Maximum clinical benefit|0|||
164245888|NCT02574078|593269257|FG007|Treatment Period|Maximum clinical benefit|0|||
164245889|NCT02574078|593269258|FG008|Treatment Period|Maximum clinical benefit|0|||
164245890|NCT02574078|593269259|FG009|Treatment Period|Maximum clinical benefit|1|||
164245891|NCT02574078|593269260|FG010|Treatment Period|Maximum clinical benefit|0|||
164245892|NCT02574078|593269261|FG011|Treatment Period|Maximum clinical benefit|0|||
164245893|NCT02574078|593269262|FG012|Treatment Period|Maximum clinical benefit|0|||
164245894|NCT02222688|593269263|FG000|Overall Study|Withdrawal by Subject|0|||
164245895|NCT02222688|593269264|FG001|Overall Study|Withdrawal by Subject|0|||
164245896|NCT02222688|593269265|FG002|Overall Study|Withdrawal by Subject|0|||
164245897|NCT02222688|593269266|FG003|Overall Study|Withdrawal by Subject|2|||
164245898|NCT02222688|593269267|FG004|Overall Study|Withdrawal by Subject|1|||
164245899|NCT02222688|593269268|FG005|Overall Study|Withdrawal by Subject|0|||
164245900|NCT02222688|593269269|FG006|Overall Study|Withdrawal by Subject|1|||
164245901|NCT02222688|593269263|FG000|Overall Study|Disease progression|1|||
164337677|NCT00531934|593613104|FG001|Overall Study|Withdrawal by Subject|1|||
164337678|NCT00531934|593613103|FG000|Overall Study|Other|2|||
164337679|NCT00531934|593613104|FG001|Overall Study|Other|2|||
164337680|NCT00150709|593613105|FG000|Overall Study|Protocol Violation|7|||
164337681|NCT00150709|593613106|FG001|Overall Study|Protocol Violation|8|||
164337682|NCT00150709|593613107|FG002|Overall Study|Protocol Violation|3|||
164337683|NCT00150709|593613108|FG003|Overall Study|Protocol Violation|1|||
164337684|NCT00150709|593613105|FG000|Overall Study|Adverse Event|8|||
164337685|NCT00150709|593613106|FG001|Overall Study|Adverse Event|2|||
164337686|NCT00150709|593613107|FG002|Overall Study|Adverse Event|2|||
164337687|NCT00150709|593613108|FG003|Overall Study|Adverse Event|3|||
164337688|NCT00150709|593613105|FG000|Overall Study|Lack of Efficacy|6|||
164337689|NCT00150709|593613106|FG001|Overall Study|Lack of Efficacy|11|||
164337690|NCT00150709|593613107|FG002|Overall Study|Lack of Efficacy|9|||
164337691|NCT00150709|593613108|FG003|Overall Study|Lack of Efficacy|0|||
164337692|NCT00150709|593613105|FG000|Overall Study|Withdrawal by Subject|7|||
164337693|NCT00150709|593613106|FG001|Overall Study|Withdrawal by Subject|10|||
164337694|NCT00150709|593613107|FG002|Overall Study|Withdrawal by Subject|5|||
164337695|NCT00150709|593613108|FG003|Overall Study|Withdrawal by Subject|0|||
164337696|NCT00150709|593613105|FG000|Overall Study|Lost to Follow-up|3|||
164337697|NCT00150709|593613106|FG001|Overall Study|Lost to Follow-up|2|||
164337698|NCT00150709|593613107|FG002|Overall Study|Lost to Follow-up|0|||
164337699|NCT00150709|593613108|FG003|Overall Study|Lost to Follow-up|0|||
164337700|NCT00150709|593613105|FG000|Overall Study|Sponsor decision|0|||
164337701|NCT00150709|593613106|FG001|Overall Study|Sponsor decision|0|||
164337702|NCT00150709|593613107|FG002|Overall Study|Sponsor decision|0|||
164337703|NCT00150709|593613108|FG003|Overall Study|Sponsor decision|1|||
164337704|NCT00150709|593613105|FG000|Overall Study|Site/Investigator discontinued the study|5|||
164337705|NCT00150709|593613106|FG001|Overall Study|Site/Investigator discontinued the study|5|||
164337706|NCT00150709|593613107|FG002|Overall Study|Site/Investigator discontinued the study|2|||
164337707|NCT00150709|593613108|FG003|Overall Study|Site/Investigator discontinued the study|0|||
164337708|NCT00150709|593613105|FG000|Overall Study|Decision of parent(s)|1|||
164337709|NCT00150709|593613106|FG001|Overall Study|Decision of parent(s)|2|||
164337710|NCT00150709|593613107|FG002|Overall Study|Decision of parent(s)|0|||
164337711|NCT00150709|593613108|FG003|Overall Study|Decision of parent(s)|0|||
164337712|NCT00150709|593613105|FG000|Overall Study|Decision of parent(s) and investigator|3|||
164337713|NCT00150709|593613106|FG001|Overall Study|Decision of parent(s) and investigator|0|||
164337714|NCT00150709|593613107|FG002|Overall Study|Decision of parent(s) and investigator|0|||
164337715|NCT00150709|593613108|FG003|Overall Study|Decision of parent(s) and investigator|0|||
164337716|NCT00150709|593613105|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
164337717|NCT00150709|593613106|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
164337718|NCT00150709|593613107|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
164337719|NCT00150709|593613108|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
164337720|NCT00150709|593613105|FG000|Overall Study|Investigator decision|1|||
164337721|NCT00150709|593613106|FG001|Overall Study|Investigator decision|0|||
164337722|NCT00150709|593613107|FG002|Overall Study|Investigator decision|0|||
164337723|NCT00150709|593613108|FG003|Overall Study|Investigator decision|1|||
164337724|NCT00150709|593613105|FG000|Overall Study|Subject relocated|2|||
164337725|NCT00150709|593613106|FG001|Overall Study|Subject relocated|2|||
164337726|NCT00150709|593613107|FG002|Overall Study|Subject relocated|1|||
164337727|NCT00150709|593613108|FG003|Overall Study|Subject relocated|0|||
164337728|NCT00150709|593613105|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
164337729|NCT00150709|593613106|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
164337730|NCT00150709|593613107|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
164337731|NCT00150709|593613108|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
164337732|NCT00150709|593613105|FG000|Overall Study|Convenience|0|||
164337733|NCT00150709|593613106|FG001|Overall Study|Convenience|1|||
164337734|NCT00150709|593613107|FG002|Overall Study|Convenience|0|||
164337735|NCT00150709|593613108|FG003|Overall Study|Convenience|0|||
164337736|NCT00150709|593613105|FG000|Overall Study|Subject entered new drug study|0|||
164679123|NCT03606174|594851091|FG006|Overall Study|Miscellaneous|5|||
164245902|NCT02222688|593269264|FG001|Overall Study|Disease progression|0|||
164245903|NCT02222688|593269265|FG002|Overall Study|Disease progression|0|||
164245904|NCT02222688|593269266|FG003|Overall Study|Disease progression|0|||
164245905|NCT02222688|593269267|FG004|Overall Study|Disease progression|0|||
164245906|NCT02222688|593269268|FG005|Overall Study|Disease progression|0|||
164245907|NCT02222688|593269269|FG006|Overall Study|Disease progression|0|||
164245908|NCT05935878|593269276|FG000|Overall Study|Death|1|||
164245909|NCT05935878|593269277|FG001|Overall Study|Death|2|||
164245910|NCT05935878|593269276|FG000|Overall Study|Withdrawal by Subject|5|||
164245911|NCT05935878|593269277|FG001|Overall Study|Withdrawal by Subject|5|||
164245912|NCT05935878|593269276|FG000|Overall Study|Revision of implant|1|||
164245913|NCT05935878|593269277|FG001|Overall Study|Revision of implant|1|||
164245914|NCT05935878|593269276|FG000|Overall Study|Mobile bearing dislocation|0|||
164245915|NCT05935878|593269277|FG001|Overall Study|Mobile bearing dislocation|1|||
164245916|NCT02297815|593269293|FG000|Overall Study|Lost to Follow-up|236|||
164245917|NCT02297815|593269294|FG001|Overall Study|Lost to Follow-up|140|||
164245918|NCT00662831|593269295|FG000|Overall Study|Death|4|||
164245919|NCT00662831|593269296|FG001|Overall Study|Death|1|||
164245920|NCT00662831|593269295|FG000|Overall Study|Lack of Efficacy|6|||
164245921|NCT00662831|593269296|FG001|Overall Study|Lack of Efficacy|6|||
164245922|NCT00662831|593269295|FG000|Overall Study|Lost to Follow-up|1|||
164245923|NCT00662831|593269296|FG001|Overall Study|Lost to Follow-up|0|||
164245924|NCT00662831|593269295|FG000|Overall Study|Withdrawal by Subject|2|||
164245925|NCT00662831|593269296|FG001|Overall Study|Withdrawal by Subject|1|||
164245926|NCT00662831|593269295|FG000|Overall Study|Other|62|||
164245927|NCT00662831|593269296|FG001|Overall Study|Other|31|||
164245928|NCT00662831|593269295|FG000|Overall Study|Protocol Violation|8|||
164245929|NCT00662831|593269296|FG001|Overall Study|Protocol Violation|4|||
164245930|NCT00662831|593269295|FG000|Overall Study|Adverse Event|23|||
164245931|NCT00662831|593269296|FG001|Overall Study|Adverse Event|16|||
164245932|NCT02397915|593269306|FG000|Period 1|Protocol Violation|0|||
164245933|NCT02397915|593269307|FG001|Period 1|Protocol Violation|1|||
164245934|NCT02397915|593269308|FG002|Period 1|Protocol Violation|0|||
164245935|NCT02397915|593269309|FG003|Period 1|Protocol Violation|0|||
164245936|NCT02397915|593269306|FG000|Period 1|Physician Decision|1|||
164245937|NCT02397915|593269307|FG001|Period 1|Physician Decision|0|||
164245938|NCT02397915|593269308|FG002|Period 1|Physician Decision|0|||
164245939|NCT02397915|593269309|FG003|Period 1|Physician Decision|0|||
164245940|NCT03292874|593269310|FG000|Overall Study|Due to pandemic|5|||
164245941|NCT00368745|593269311|FG000|Double-blind Treatment Period|Adverse Event|6|||
164245942|NCT00368745|593269312|FG001|Double-blind Treatment Period|Adverse Event|6|||
164245943|NCT00368745|593269311|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
164245944|NCT00368745|593269312|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
164245945|NCT00368745|593269311|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
164245946|NCT00368745|593269312|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
164245947|NCT00368745|593269311|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
164245948|NCT00368745|593269312|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
164245949|NCT00368745|593269311|FG000|Double-blind Treatment Period|Other|7|||
164245950|NCT00368745|593269312|FG001|Double-blind Treatment Period|Other|6|||
164245951|NCT00293813|593269316|FG000|Overall Study|Physician Decision|0|||
164245952|NCT00293813|593269317|FG001|Overall Study|Physician Decision|1|||
164245953|NCT00293813|593269318|FG002|Overall Study|Physician Decision|0|||
164245954|NCT00293813|593269316|FG000|Overall Study|Adverse Event|3|||
164245955|NCT00293813|593269317|FG001|Overall Study|Adverse Event|1|||
164574613|NCT03323749|594468040|FG000|Open-Label Period|Withdrawal by Subject|7|||
164679124|NCT03606174|594851092|FG007|Overall Study|Miscellaneous|0|||
164679125|NCT03606174|594851093|FG008|Overall Study|Miscellaneous|0|||
164679126|NCT03606174|594851094|FG009|Overall Study|Miscellaneous|0|||
164679127|NCT03606174|594851095|FG010|Overall Study|Miscellaneous|1|||
164679128|NCT01205035|594851101|FG000|Overall Study|Withdrawal by Subject|1|||
164679129|NCT01205035|594851102|FG001|Overall Study|Withdrawal by Subject|0|||
164679130|NCT01205035|594851101|FG000|Overall Study|Physician Decision|1|||
164679131|NCT01205035|594851102|FG001|Overall Study|Physician Decision|0|||
164679132|NCT01896934|594851103|FG000|Overall Study|Adverse Event|1|||
164679133|NCT01896934|594851103|FG000|Overall Study|Withdrawal by Subject|1|||
164679134|NCT00316277|594851105|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
164679135|NCT00316277|594851106|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
164679136|NCT00316277|594851105|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
164679137|NCT00316277|594851106|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
164679138|NCT00316277|594851105|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
164679139|NCT00316277|594851106|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
164679140|NCT00316277|594851105|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
164679141|NCT00316277|594851106|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
164679142|NCT00316277|594851105|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
164245956|NCT00293813|593269318|FG002|Overall Study|Adverse Event|1|||
164245957|NCT00293813|593269316|FG000|Overall Study|Withdrawal by Subject|7|||
164245958|NCT00293813|593269317|FG001|Overall Study|Withdrawal by Subject|4|||
164245959|NCT00293813|593269318|FG002|Overall Study|Withdrawal by Subject|4|||
164245960|NCT00293813|593269316|FG000|Overall Study|Lost to Follow-up|3|||
164245961|NCT00293813|593269317|FG001|Overall Study|Lost to Follow-up|2|||
164245962|NCT00293813|593269318|FG002|Overall Study|Lost to Follow-up|3|||
164245963|NCT00293813|593269316|FG000|Overall Study|Noncompliance|0|||
164245964|NCT00293813|593269317|FG001|Overall Study|Noncompliance|1|||
164245965|NCT00293813|593269318|FG002|Overall Study|Noncompliance|0|||
164245966|NCT01188551|593269319|FG000|Overall Study|Pharmacy issues|1|||
164245967|NCT01188551|593269320|FG001|Overall Study|Pharmacy issues|0|||
164245968|NCT01188551|593269321|FG002|Overall Study|Pharmacy issues|0|||
164245969|NCT01188551|593269322|FG003|Overall Study|Pharmacy issues|0|||
164245970|NCT01306643|593269327|FG000|Overall Study|Adverse Event|5|||
164245971|NCT01306643|593269327|FG000|Overall Study|Disease Progression|7|||
164245972|NCT01306643|593269327|FG000|Overall Study|Other: Change in Eligibility Status|1|||
164245973|NCT03458325|593269332|FG000|Overall Study|Withdrawal by Subject|1|||
164245974|NCT00414076|593269333|FG000|Overall Study|Progression|1|||
164245975|NCT00414076|593269334|FG001|Overall Study|Progression|2|||
164245976|NCT00414076|593269333|FG000|Overall Study|Withdrawal by Subject|1|||
164245977|NCT00414076|593269334|FG001|Overall Study|Withdrawal by Subject|3|||
164245978|NCT00414076|593269333|FG000|Overall Study|Adverse Event|1|||
164245979|NCT00414076|593269334|FG001|Overall Study|Adverse Event|0|||
164245980|NCT02720523|593269335|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
164245981|NCT02720523|593269336|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
164245982|NCT02720523|593269337|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
164245983|NCT02720523|593269338|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
164245984|NCT02720523|593269339|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
164245985|NCT02720523|593269340|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
164245986|NCT02720523|593269341|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
164245987|NCT02720523|593269335|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
164245988|NCT02720523|593269336|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
164245989|NCT02720523|593269337|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
164245990|NCT02720523|593269338|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
164245991|NCT02720523|593269339|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
164245992|NCT02720523|593269340|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
164245993|NCT02720523|593269341|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
164245994|NCT02720523|593269335|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
164245995|NCT02720523|593269336|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
164245996|NCT02720523|593269337|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
164245997|NCT02720523|593269338|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
164245998|NCT02720523|593269339|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
164245999|NCT02720523|593269340|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
164246000|NCT02720523|593269341|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
164246001|NCT02720523|593269335|FG000|Period 1: Placebo-controlled Period|Other|0|||
164246002|NCT02720523|593269336|FG001|Period 1: Placebo-controlled Period|Other|0|||
164246003|NCT02720523|593269337|FG002|Period 1: Placebo-controlled Period|Other|1|||
164246004|NCT02720523|593269338|FG003|Period 1: Placebo-controlled Period|Other|1|||
164246005|NCT02720523|593269339|FG004|Period 1: Placebo-controlled Period|Other|0|||
164246006|NCT02720523|593269340|FG005|Period 1: Placebo-controlled Period|Other|0|||
164246007|NCT02720523|593269341|FG006|Period 1: Placebo-controlled Period|Other|0|||
164246008|NCT02720523|593269335|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
164246009|NCT02720523|593269336|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
164246010|NCT02720523|593269337|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
164246011|NCT02720523|593269338|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
164246012|NCT02720523|593269339|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
164246013|NCT02720523|593269340|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
164337737|NCT00150709|593613106|FG001|Overall Study|Subject entered new drug study|1|||
164337738|NCT00150709|593613107|FG002|Overall Study|Subject entered new drug study|0|||
164337739|NCT00150709|593613108|FG003|Overall Study|Subject entered new drug study|0|||
164337740|NCT00150709|593613105|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
164246014|NCT02720523|593269341|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
164246015|NCT02720523|593269335|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
164246016|NCT02720523|593269336|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
164246017|NCT02720523|593269337|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
164246018|NCT02720523|593269338|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
164246019|NCT02720523|593269339|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
164246020|NCT02720523|593269340|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
164246021|NCT02720523|593269341|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
164246022|NCT02720523|593269335|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
164246023|NCT02720523|593269336|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
164246024|NCT02720523|593269337|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
164246025|NCT02720523|593269338|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
164246026|NCT02720523|593269339|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
164246027|NCT02720523|593269340|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
164246028|NCT02720523|593269341|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
164246029|NCT02720523|593269335|FG000|Period 2: Long-term Extension Period|Other|0|||
164246030|NCT02720523|593269336|FG001|Period 2: Long-term Extension Period|Other|0|||
164246031|NCT02720523|593269337|FG002|Period 2: Long-term Extension Period|Other|0|||
164246032|NCT02720523|593269338|FG003|Period 2: Long-term Extension Period|Other|0|||
164246033|NCT02720523|593269339|FG004|Period 2: Long-term Extension Period|Other|2|||
164246034|NCT02720523|593269340|FG005|Period 2: Long-term Extension Period|Other|0|||
164246035|NCT02720523|593269341|FG006|Period 2: Long-term Extension Period|Other|3|||
164246036|NCT03146663|593269342|FG000|Overall Study|Did not receive study treatment|1|||
164246037|NCT03146663|593269343|FG001|Overall Study|Did not receive study treatment|1|||
164246038|NCT05588440|593269350|FG000|Overall Study|Sponsor Decision|2|||
164246039|NCT05588440|593269351|FG001|Overall Study|Sponsor Decision|0|||
164246040|NCT05588440|593269352|FG002|Overall Study|Sponsor Decision|1|||
164246041|NCT05588440|593269350|FG000|Overall Study|Death|1|||
164246042|NCT05588440|593269351|FG001|Overall Study|Death|1|||
164246043|NCT05588440|593269352|FG002|Overall Study|Death|1|||
164246044|NCT05588440|593269350|FG000|Overall Study|Screen Fail|0|||
164246045|NCT05588440|593269351|FG001|Overall Study|Screen Fail|1|||
164246046|NCT05588440|593269352|FG002|Overall Study|Screen Fail|1|||
164246047|NCT05588440|593269350|FG000|Overall Study|Withdrawal by Subject|0|||
164246048|NCT05588440|593269351|FG001|Overall Study|Withdrawal by Subject|0|||
164246049|NCT05588440|593269352|FG002|Overall Study|Withdrawal by Subject|1|||
164246050|NCT05526521|593269353|FG000|Overall Study|Withdrawal by Subject|0|||
164246051|NCT05526521|593269354|FG001|Overall Study|Withdrawal by Subject|1|||
164246052|NCT05526521|593269355|FG002|Overall Study|Withdrawal by Subject|0|||
164246053|NCT05526521|593269356|FG003|Overall Study|Withdrawal by Subject|0|||
164246054|NCT03929913|593269357|FG000|Overall Study|Death|4|||
164246055|NCT03929913|593269357|FG000|Overall Study|Lost to Follow-up|1|||
164246056|NCT03929913|593269357|FG000|Overall Study|Failed Procedure|2|||
164246057|NCT03919929|593269360|FG000|Overall Study|Withdrawal by Subject|0|||
164246058|NCT03919929|593269361|FG001|Overall Study|Withdrawal by Subject|4|||
164246059|NCT03919929|593269360|FG000|Overall Study|Screen Failure|0|||
164246060|NCT03919929|593269361|FG001|Overall Study|Screen Failure|5|||
164246061|NCT03533660|593269362|FG000|Overall Study|Withdrawal by Subject|2|||
164246062|NCT03533660|593269363|FG001|Overall Study|Withdrawal by Subject|2|||
164246063|NCT03533660|593269362|FG000|Overall Study|Death|2|||
164246064|NCT03533660|593269363|FG001|Overall Study|Death|4|||
164246065|NCT03533660|593269362|FG000|Overall Study|Adverse Event|0|||
164246066|NCT03533660|593269363|FG001|Overall Study|Adverse Event|2|||
164246067|NCT01671956|593269364|FG000|Overall Study|Disease progression|0|||
164246068|NCT01671956|593269365|FG001|Overall Study|Disease progression|1|||
164246069|NCT01671956|593269364|FG000|Overall Study|Withdrawal by Subject|1|||
164246070|NCT01671956|593269365|FG001|Overall Study|Withdrawal by Subject|1|||
164246071|NCT01671956|593269364|FG000|Overall Study|Adverse Event|1|||
164246072|NCT01671956|593269365|FG001|Overall Study|Adverse Event|0|||
164246073|NCT03816176|593269373|FG000|Overall Study|Miscellaneous|5|||
164246074|NCT03816176|593269373|FG000|Overall Study|Lack of Efficacy|4|||
164246075|NCT03816176|593269373|FG000|Overall Study|Adverse Event|3|||
164246076|NCT03581292|593269374|FG000|Overall Study|Physician Decision|9|||
164246077|NCT03581292|593269375|FG001|Overall Study|Physician Decision|5|||
164246078|NCT03581292|593269374|FG000|Overall Study|Withdrawal by Subject|3|||
164246079|NCT03581292|593269375|FG001|Overall Study|Withdrawal by Subject|0|||
164246080|NCT03581292|593269374|FG000|Overall Study|Withdrawal before Therapy Start|1|||
164246081|NCT03581292|593269375|FG001|Overall Study|Withdrawal before Therapy Start|0|||
164246082|NCT05200572|593269376|FG000|Overall Study|Withdrawal by Subject|14|||
164246083|NCT02524145|593269380|FG000|Overall Study|Withdrawal by Subject|2|||
164246084|NCT02524145|593269381|FG001|Overall Study|Withdrawal by Subject|2|||
164246085|NCT02524145|593269382|FG002|Overall Study|Withdrawal by Subject|3|||
164246086|NCT07214935|593269385|FG000|Overall Study|Adverse Event|1|||
164246087|NCT07214935|593269386|FG001|Overall Study|Adverse Event|1|||
164246088|NCT07214935|593269387|FG002|Overall Study|Adverse Event|1|||
164246089|NCT07214935|593269388|FG003|Overall Study|Adverse Event|0|||
164246090|NCT07214935|593269385|FG000|Overall Study|Lost to Follow-up|0|||
164246091|NCT07214935|593269386|FG001|Overall Study|Lost to Follow-up|1|||
164246092|NCT07214935|593269387|FG002|Overall Study|Lost to Follow-up|0|||
164246093|NCT07214935|593269388|FG003|Overall Study|Lost to Follow-up|0|||
164246094|NCT07214935|593269385|FG000|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|1|||
164246095|NCT07214935|593269386|FG001|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
164246096|NCT07214935|593269387|FG002|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
164246097|NCT07214935|593269388|FG003|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
164246098|NCT07214935|593269385|FG000|Overall Study|Participant discontinued prior to first dosing|0|||
164246099|NCT07214935|593269386|FG001|Overall Study|Participant discontinued prior to first dosing|0|||
164246100|NCT07214935|593269387|FG002|Overall Study|Participant discontinued prior to first dosing|0|||
164246101|NCT07214935|593269388|FG003|Overall Study|Participant discontinued prior to first dosing|1|||
164299862|NCT02234843|593472953|FG009|Overall Study|Efficacy outcome reached|0|||
164299863|NCT02234843|593472944|FG000|Overall Study|Patient convenience|2|||
164299864|NCT02234843|593472945|FG001|Overall Study|Patient convenience|0|||
164299865|NCT02234843|593472946|FG002|Overall Study|Patient convenience|0|||
164299866|NCT02234843|593472947|FG003|Overall Study|Patient convenience|0|||
164299867|NCT02234843|593472948|FG004|Overall Study|Patient convenience|0|||
164299868|NCT02234843|593472949|FG005|Overall Study|Patient convenience|1|||
164299869|NCT02234843|593472950|FG006|Overall Study|Patient convenience|0|||
164299870|NCT02234843|593472951|FG007|Overall Study|Patient convenience|0|||
164299871|NCT02234843|593472952|FG008|Overall Study|Patient convenience|0|||
164299872|NCT02234843|593472953|FG009|Overall Study|Patient convenience|0|||
164299873|NCT02234843|593472944|FG000|Overall Study|Withdrawal by Subject|5|||
164299874|NCT02234843|593472945|FG001|Overall Study|Withdrawal by Subject|1|||
164299875|NCT02234843|593472946|FG002|Overall Study|Withdrawal by Subject|1|||
164299876|NCT02234843|593472947|FG003|Overall Study|Withdrawal by Subject|0|||
164299877|NCT02234843|593472948|FG004|Overall Study|Withdrawal by Subject|0|||
164299878|NCT02234843|593472949|FG005|Overall Study|Withdrawal by Subject|7|||
164299879|NCT02234843|593472950|FG006|Overall Study|Withdrawal by Subject|0|||
164299880|NCT02234843|593472951|FG007|Overall Study|Withdrawal by Subject|0|||
164299881|NCT02234843|593472952|FG008|Overall Study|Withdrawal by Subject|0|||
164299882|NCT02234843|593472953|FG009|Overall Study|Withdrawal by Subject|0|||
164299883|NCT02234843|593472944|FG000|Overall Study|Recovery|1|||
164299884|NCT02234843|593472945|FG001|Overall Study|Recovery|0|||
164299885|NCT02234843|593472946|FG002|Overall Study|Recovery|0|||
164299886|NCT02234843|593472947|FG003|Overall Study|Recovery|0|||
164299887|NCT02234843|593472948|FG004|Overall Study|Recovery|0|||
164299888|NCT02234843|593472949|FG005|Overall Study|Recovery|0|||
164299889|NCT02234843|593472950|FG006|Overall Study|Recovery|0|||
164299890|NCT02234843|593472951|FG007|Overall Study|Recovery|0|||
164299891|NCT02234843|593472952|FG008|Overall Study|Recovery|0|||
164299892|NCT02234843|593472953|FG009|Overall Study|Recovery|0|||
164299893|NCT02234843|593472944|FG000|Overall Study|Other|0|||
164299894|NCT02234843|593472945|FG001|Overall Study|Other|2|||
164299895|NCT02234843|593472946|FG002|Overall Study|Other|0|||
164299896|NCT02234843|593472947|FG003|Overall Study|Other|1|||
164299897|NCT02234843|593472948|FG004|Overall Study|Other|0|||
164299898|NCT02234843|593472949|FG005|Overall Study|Other|1|||
164299899|NCT02234843|593472950|FG006|Overall Study|Other|0|||
164299900|NCT02234843|593472951|FG007|Overall Study|Other|1|||
164299901|NCT02234843|593472952|FG008|Overall Study|Other|0|||
164299902|NCT02234843|593472953|FG009|Overall Study|Other|0|||
164299903|NCT02234843|593472944|FG000|Overall Study|Physician Decision|4|||
164299904|NCT02234843|593472945|FG001|Overall Study|Physician Decision|1|||
164299905|NCT02234843|593472946|FG002|Overall Study|Physician Decision|0|||
164299906|NCT02234843|593472947|FG003|Overall Study|Physician Decision|1|||
164299907|NCT02234843|593472948|FG004|Overall Study|Physician Decision|0|||
164299908|NCT02234843|593472949|FG005|Overall Study|Physician Decision|0|||
164299909|NCT02234843|593472950|FG006|Overall Study|Physician Decision|0|||
164299910|NCT02234843|593472951|FG007|Overall Study|Physician Decision|1|||
164299911|NCT02234843|593472952|FG008|Overall Study|Physician Decision|0|||
164299912|NCT02234843|593472953|FG009|Overall Study|Physician Decision|0|||
164426139|NCT04955626|593930843|FG032|Blinded Period|Withdrawal by Subject|0|||
164426140|NCT04955626|593930844|FG033|Blinded Period|Withdrawal by Subject|0|||
164426141|NCT04955626|593930845|FG034|Blinded Period|Withdrawal by Subject|0|||
164426142|NCT04955626|593930846|FG035|Blinded Period|Withdrawal by Subject|0|||
164426143|NCT04955626|593930811|FG000|Blinded Period|Refused further study procedures|0|||
164426144|NCT04955626|593930812|FG001|Blinded Period|Refused further study procedures|0|||
164426145|NCT04955626|593930813|FG002|Blinded Period|Refused further study procedures|0|||
164426146|NCT04955626|593930814|FG003|Blinded Period|Refused further study procedures|0|||
164574614|NCT03323749|594468041|FG001|Open-Label Period|Withdrawal by Subject|5|||
164574615|NCT01821963|594468042|FG000|Overall Study|Adverse Event|1|||
164299913|NCT02234843|593472944|FG000|Overall Study|Adverse Event|5|||
164299914|NCT02234843|593472945|FG001|Overall Study|Adverse Event|1|||
164299915|NCT02234843|593472946|FG002|Overall Study|Adverse Event|1|||
164299916|NCT02234843|593472947|FG003|Overall Study|Adverse Event|3|||
164426147|NCT04955626|593930815|FG004|Blinded Period|Refused further study procedures|0|||
164426148|NCT04955626|593930816|FG005|Blinded Period|Refused further study procedures|0|||
164574616|NCT03539432|594468049|FG000|Overall Study|Lost to Follow-up|0|||
164299917|NCT02234843|593472948|FG004|Overall Study|Adverse Event|2|||
164299918|NCT02234843|593472949|FG005|Overall Study|Adverse Event|1|||
164299919|NCT02234843|593472950|FG006|Overall Study|Adverse Event|0|||
164299920|NCT02234843|593472951|FG007|Overall Study|Adverse Event|0|||
164299921|NCT02234843|593472952|FG008|Overall Study|Adverse Event|1|||
164299922|NCT02234843|593472953|FG009|Overall Study|Adverse Event|0|||
164246102|NCT01945216|593271735|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
164246103|NCT01945216|593271735|FG000|Overall Study|Protocol Violation|42|||
164246104|NCT01945216|593271735|FG000|Overall Study|CRF not assured by investigators|5|||
164246105|NCT02982772|593271737|FG000|Intervention|Lost to Follow-up|19|||
164246106|NCT02982772|593271738|FG001|Intervention|Lost to Follow-up|13|||
164246107|NCT02982772|593271737|FG000|1M Follow-Up|Lost to Follow-up|21|||
164246108|NCT02982772|593271738|FG001|1M Follow-Up|Lost to Follow-up|18|||
164246109|NCT02982772|593271737|FG000|3M Follow-Up|Lost to Follow-up|17|||
164246110|NCT02982772|593271738|FG001|3M Follow-Up|Lost to Follow-up|11|||
164246111|NCT02982772|593271737|FG000|6M Follow-Up|Lost to Follow-up|11|||
164246112|NCT02982772|593271738|FG001|6M Follow-Up|Lost to Follow-up|9|||
164246113|NCT02982772|593271737|FG000|12M Follow-Up|Lost to Follow-up|11|||
164246114|NCT02982772|593271738|FG001|12M Follow-Up|Lost to Follow-up|5|||
164246115|NCT03107052|593271742|FG000|Overall Study|Adverse Event|6|||
164246116|NCT03107052|593271743|FG001|Overall Study|Adverse Event|1|||
164246117|NCT03107052|593271744|FG002|Overall Study|Adverse Event|2|||
164246118|NCT03107052|593271742|FG000|Overall Study|Withdrawal by Subject|9|||
164246119|NCT03107052|593271743|FG001|Overall Study|Withdrawal by Subject|5|||
164246120|NCT03107052|593271744|FG002|Overall Study|Withdrawal by Subject|8|||
164246121|NCT03107052|593271742|FG000|Overall Study|Protocol Violation|6|||
164246122|NCT03107052|593271743|FG001|Overall Study|Protocol Violation|0|||
164246123|NCT03107052|593271744|FG002|Overall Study|Protocol Violation|3|||
164246124|NCT03107052|593271742|FG000|Overall Study|Lost to Follow-up|4|||
164246125|NCT03107052|593271743|FG001|Overall Study|Lost to Follow-up|0|||
164246126|NCT03107052|593271744|FG002|Overall Study|Lost to Follow-up|1|||
164246127|NCT03107052|593271742|FG000|Overall Study|Lack of Efficacy|23|||
164246128|NCT03107052|593271743|FG001|Overall Study|Lack of Efficacy|7|||
164246129|NCT03107052|593271744|FG002|Overall Study|Lack of Efficacy|4|||
164246130|NCT03107052|593271742|FG000|Overall Study|Other than specified|4|||
164246131|NCT03107052|593271743|FG001|Overall Study|Other than specified|2|||
164246132|NCT03107052|593271744|FG002|Overall Study|Other than specified|0|||
164246133|NCT03107052|593271742|FG000|Overall Study|Study terminated due to futility|67|||
164246134|NCT03107052|593271743|FG001|Overall Study|Study terminated due to futility|31|||
164246135|NCT03107052|593271744|FG002|Overall Study|Study terminated due to futility|23|||
164246136|NCT03015363|593271745|FG000|Overall Study|Physician Decision|14|||
164246137|NCT03015363|593271745|FG000|Overall Study|Withdrawal by Subject|3|||
164246138|NCT00958360|593271746|FG000|Overall Study|Withdrawal by Subject|3|||
164246139|NCT00958360|593271747|FG001|Overall Study|Withdrawal by Subject|1|||
164246140|NCT00958360|593271746|FG000|Overall Study|Death|6|||
164246141|NCT00958360|593271747|FG001|Overall Study|Death|7|||
164246142|NCT00958360|593271746|FG000|Overall Study|Physician Decision|2|||
164246143|NCT00958360|593271747|FG001|Overall Study|Physician Decision|1|||
164246144|NCT00958360|593271746|FG000|Overall Study|Lost to Follow-up|0|||
164246145|NCT00958360|593271747|FG001|Overall Study|Lost to Follow-up|1|||
164246146|NCT01061723|593271748|FG000|Overall Study|Adverse Event|0|||
164246147|NCT01061723|593271749|FG001|Overall Study|Adverse Event|2|||
164246148|NCT01061723|593271750|FG002|Overall Study|Adverse Event|5|||
164246149|NCT01061723|593271751|FG003|Overall Study|Adverse Event|5|||
164246150|NCT01061723|593271752|FG004|Overall Study|Adverse Event|2|||
164246151|NCT01061723|593271753|FG005|Overall Study|Adverse Event|6|||
164246152|NCT01061723|593271748|FG000|Overall Study|Lack of Efficacy|2|||
164246153|NCT01061723|593271749|FG001|Overall Study|Lack of Efficacy|3|||
164246154|NCT01061723|593271750|FG002|Overall Study|Lack of Efficacy|4|||
164246155|NCT01061723|593271751|FG003|Overall Study|Lack of Efficacy|2|||
164246156|NCT01061723|593271752|FG004|Overall Study|Lack of Efficacy|1|||
164246157|NCT01061723|593271753|FG005|Overall Study|Lack of Efficacy|1|||
164246158|NCT01061723|593271748|FG000|Overall Study|Randomized but not treated|0|||
164246159|NCT01061723|593271749|FG001|Overall Study|Randomized but not treated|0|||
164246160|NCT01061723|593271750|FG002|Overall Study|Randomized but not treated|0|||
164246161|NCT01061723|593271751|FG003|Overall Study|Randomized but not treated|0|||
164246162|NCT01061723|593271752|FG004|Overall Study|Randomized but not treated|0|||
164246163|NCT01061723|593271753|FG005|Overall Study|Randomized but not treated|1|||
164246164|NCT01061723|593271748|FG000|Overall Study|Other than specified above|2|||
164246165|NCT01061723|593271749|FG001|Overall Study|Other than specified above|1|||
164246166|NCT01061723|593271750|FG002|Overall Study|Other than specified above|1|||
164246167|NCT01061723|593271751|FG003|Overall Study|Other than specified above|1|||
164246168|NCT01061723|593271752|FG004|Overall Study|Other than specified above|0|||
164246169|NCT01061723|593271753|FG005|Overall Study|Other than specified above|1|||
164246170|NCT00500357|593271754|FG000|Overall Study|Death|1|||
164246171|NCT02263326|593271755|FG000|Overall Study|Lost to Follow-up|1|||
164246172|NCT02263326|593271756|FG001|Overall Study|Lost to Follow-up|1|||
164246173|NCT01734785|593271757|FG000|Open-Label Period|Adverse Event|0|||
164246174|NCT01734785|593271758|FG001|Open-Label Period|Adverse Event|0|||
164246175|NCT01734785|593271759|FG002|Open-Label Period|Adverse Event|0|||
164246176|NCT01734785|593271760|FG003|Open-Label Period|Adverse Event|9|||
164246177|NCT01734785|593271757|FG000|Open-Label Period|Lack of Efficacy|0|||
164246178|NCT01734785|593271758|FG001|Open-Label Period|Lack of Efficacy|0|||
164246179|NCT01734785|593271759|FG002|Open-Label Period|Lack of Efficacy|0|||
164246180|NCT01734785|593271760|FG003|Open-Label Period|Lack of Efficacy|1|||
164246181|NCT01734785|593271757|FG000|Open-Label Period|Protocol Violation|0|||
164246182|NCT01734785|593271758|FG001|Open-Label Period|Protocol Violation|0|||
164246183|NCT01734785|593271759|FG002|Open-Label Period|Protocol Violation|0|||
164246184|NCT01734785|593271760|FG003|Open-Label Period|Protocol Violation|13|||
164246185|NCT01734785|593271757|FG000|Open-Label Period|Lost to Follow-up|0|||
164246186|NCT01734785|593271758|FG001|Open-Label Period|Lost to Follow-up|0|||
164246187|NCT01734785|593271759|FG002|Open-Label Period|Lost to Follow-up|0|||
164246188|NCT01734785|593271760|FG003|Open-Label Period|Lost to Follow-up|14|||
164246189|NCT01734785|593271757|FG000|Open-Label Period|Withdrawal by Subject|0|||
164246190|NCT01734785|593271758|FG001|Open-Label Period|Withdrawal by Subject|0|||
164246191|NCT01734785|593271759|FG002|Open-Label Period|Withdrawal by Subject|0|||
164246192|NCT01734785|593271760|FG003|Open-Label Period|Withdrawal by Subject|12|||
164246193|NCT01734785|593271757|FG000|Open-Label Period|Other Reasons|0|||
164246194|NCT01734785|593271758|FG001|Open-Label Period|Other Reasons|0|||
164574617|NCT03539432|594468050|FG001|Overall Study|Lost to Follow-up|1|||
164574618|NCT01381094|594468051|FG000|Overall Study|Adverse Event|1|||
164574619|NCT01381094|594468052|FG001|Overall Study|Adverse Event|2|||
164574620|NCT01381094|594468053|FG002|Overall Study|Adverse Event|0|||
164246195|NCT01734785|593271759|FG002|Open-Label Period|Other Reasons|0|||
164246196|NCT01734785|593271760|FG003|Open-Label Period|Other Reasons|224|||
164246197|NCT01734785|593271757|FG000|Double-Blind Period|Adverse Event|0|||
164246198|NCT01734785|593271758|FG001|Double-Blind Period|Adverse Event|3|||
164574621|NCT01381094|594468054|FG003|Overall Study|Adverse Event|1|||
164574622|NCT01381094|594468055|FG004|Overall Study|Adverse Event|0|||
164574623|NCT01381094|594468051|FG000|Overall Study|Lost to Follow-up|0|||
164574624|NCT01381094|594468052|FG001|Overall Study|Lost to Follow-up|0|||
164574625|NCT01381094|594468053|FG002|Overall Study|Lost to Follow-up|0|||
164574626|NCT01381094|594468054|FG003|Overall Study|Lost to Follow-up|0|||
164574627|NCT01381094|594468055|FG004|Overall Study|Lost to Follow-up|1|||
164574628|NCT01381094|594468051|FG000|Overall Study|Withdrawal of informed consent|0|||
164574629|NCT01381094|594468052|FG001|Overall Study|Withdrawal of informed consent|1|||
164574630|NCT01381094|594468053|FG002|Overall Study|Withdrawal of informed consent|0|||
164574631|NCT01381094|594468054|FG003|Overall Study|Withdrawal of informed consent|0|||
164574632|NCT01381094|594468055|FG004|Overall Study|Withdrawal of informed consent|0|||
164574633|NCT01381094|594468051|FG000|Overall Study|Participant given Aranesp injection|1|||
164574634|NCT01381094|594468052|FG001|Overall Study|Participant given Aranesp injection|0|||
164574635|NCT01381094|594468053|FG002|Overall Study|Participant given Aranesp injection|0|||
164574636|NCT01381094|594468054|FG003|Overall Study|Participant given Aranesp injection|0|||
164574637|NCT01381094|594468055|FG004|Overall Study|Participant given Aranesp injection|0|||
164574638|NCT02443402|594468058|FG000|Overall Study|Withdrawal by Subject|3|||
164574639|NCT02443402|594468059|FG001|Overall Study|Withdrawal by Subject|1|||
164574640|NCT02443402|594468058|FG000|Overall Study|Screen Failure|1|||
164574641|NCT02443402|594468059|FG001|Overall Study|Screen Failure|2|||
164574642|NCT01934504|594468061|FG000|Overall Study|Protocol Deviation|0|||
164574643|NCT01934504|594468062|FG001|Overall Study|Protocol Deviation|0|||
164574644|NCT01934504|594468063|FG002|Overall Study|Protocol Deviation|0|||
164574645|NCT01934504|594468064|FG003|Overall Study|Protocol Deviation|2|||
164574646|NCT01934504|594468061|FG000|Overall Study|Study Terminated by Sponsor|1|||
164574647|NCT01934504|594468062|FG001|Overall Study|Study Terminated by Sponsor|0|||
164574648|NCT01934504|594468063|FG002|Overall Study|Study Terminated by Sponsor|5|||
164574649|NCT01934504|594468064|FG003|Overall Study|Study Terminated by Sponsor|5|||
164574650|NCT02665689|594468065|FG000|Overall Study|Adverse Event|1|||
164574651|NCT02665689|594468066|FG001|Overall Study|Adverse Event|0|||
164574652|NCT02665689|594468065|FG000|Overall Study|Trial termination|1|||
164574653|NCT02665689|594468066|FG001|Overall Study|Trial termination|1|||
164574654|NCT02665689|594468065|FG000|Overall Study|Lost to Follow-up|0|||
164574655|NCT02665689|594468066|FG001|Overall Study|Lost to Follow-up|1|||
164574656|NCT00996840|594468069|FG000|Overall Study|Adverse Event|0|||
164574657|NCT00996840|594468070|FG001|Overall Study|Adverse Event|1|||
164246199|NCT01734785|593271759|FG002|Double-Blind Period|Adverse Event|2|||
164574658|NCT00996840|594468071|FG002|Overall Study|Adverse Event|0|||
164574659|NCT00996840|594468072|FG003|Overall Study|Adverse Event|0|||
164246200|NCT01734785|593271760|FG003|Double-Blind Period|Adverse Event|0|||
164246201|NCT01734785|593271757|FG000|Double-Blind Period|Lack of Efficacy|0|||
164246202|NCT01734785|593271758|FG001|Double-Blind Period|Lack of Efficacy|1|||
164246203|NCT01734785|593271759|FG002|Double-Blind Period|Lack of Efficacy|0|||
164574660|NCT00996840|594468073|FG004|Overall Study|Adverse Event|0|||
164574661|NCT00996840|594468069|FG000|Overall Study|Physician Decision|0|||
164574662|NCT00996840|594468070|FG001|Overall Study|Physician Decision|0|||
164574663|NCT00996840|594468071|FG002|Overall Study|Physician Decision|1|||
164574664|NCT00996840|594468072|FG003|Overall Study|Physician Decision|1|||
164574665|NCT00996840|594468073|FG004|Overall Study|Physician Decision|2|||
164574666|NCT00996840|594468069|FG000|Overall Study|Withdrawal by Subject|1|||
164574667|NCT00996840|594468070|FG001|Overall Study|Withdrawal by Subject|1|||
164574668|NCT00996840|594468071|FG002|Overall Study|Withdrawal by Subject|0|||
164574669|NCT00996840|594468072|FG003|Overall Study|Withdrawal by Subject|0|||
164574670|NCT00996840|594468073|FG004|Overall Study|Withdrawal by Subject|0|||
164574671|NCT00603239|594468075|FG000|Overall Study|Adverse Event|4|||
164246204|NCT01734785|593271760|FG003|Double-Blind Period|Lack of Efficacy|0|||
164246205|NCT01734785|593271757|FG000|Double-Blind Period|Protocol Violation|0|||
164246206|NCT01734785|593271758|FG001|Double-Blind Period|Protocol Violation|1|||
164246207|NCT01734785|593271759|FG002|Double-Blind Period|Protocol Violation|1|||
164246208|NCT01734785|593271760|FG003|Double-Blind Period|Protocol Violation|0|||
164246209|NCT01734785|593271757|FG000|Double-Blind Period|Lost to Follow-up|2|||
164246210|NCT01734785|593271758|FG001|Double-Blind Period|Lost to Follow-up|4|||
164246211|NCT01734785|593271759|FG002|Double-Blind Period|Lost to Follow-up|2|||
164246212|NCT01734785|593271760|FG003|Double-Blind Period|Lost to Follow-up|0|||
164246213|NCT01734785|593271757|FG000|Double-Blind Period|Withdrawal by Subject|2|||
164246214|NCT01734785|593271758|FG001|Double-Blind Period|Withdrawal by Subject|0|||
164246215|NCT01734785|593271759|FG002|Double-Blind Period|Withdrawal by Subject|0|||
164246216|NCT01734785|593271760|FG003|Double-Blind Period|Withdrawal by Subject|0|||
164246217|NCT01734785|593271757|FG000|Double-Blind Period|Not treated|1|||
164246218|NCT01734785|593271758|FG001|Double-Blind Period|Not treated|0|||
164246219|NCT01734785|593271759|FG002|Double-Blind Period|Not treated|0|||
164246220|NCT01734785|593271760|FG003|Double-Blind Period|Not treated|0|||
164246221|NCT02482298|593271761|FG000|Overall Study|Withdrawal by Subject|2|||
164246222|NCT02482298|593271762|FG001|Overall Study|Withdrawal by Subject|1|||
164246223|NCT02482298|593271763|FG002|Overall Study|Withdrawal by Subject|2|||
164246224|NCT02482298|593271761|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
164246225|NCT02482298|593271762|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
164246226|NCT02482298|593271763|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
164246227|NCT02482298|593271761|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
164246228|NCT02482298|593271762|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
164246229|NCT02482298|593271763|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
164246230|NCT02482298|593271761|FG000|Overall Study|Lost to Follow-up|0|||
164246231|NCT02482298|593271762|FG001|Overall Study|Lost to Follow-up|1|||
164246232|NCT02482298|593271763|FG002|Overall Study|Lost to Follow-up|0|||
164246233|NCT01582009|593271768|FG000|Overall Study|Withdrawal by Subject|1|||
164246234|NCT01582009|593271768|FG000|Overall Study|Physician Decision|1|||
164246235|NCT03592771|593271769|FG000|Overall Study|Adverse Event|2|||
164246236|NCT03592771|593271770|FG001|Overall Study|Adverse Event|0|||
164246237|NCT03592771|593271771|FG002|Overall Study|Adverse Event|1|||
164246238|NCT03592771|593271769|FG000|Overall Study|Death|0|||
164246239|NCT03592771|593271770|FG001|Overall Study|Death|1|||
164246240|NCT03592771|593271771|FG002|Overall Study|Death|1|||
164246241|NCT03592771|593271769|FG000|Overall Study|Lost to Follow-up|5|||
164246242|NCT03592771|593271770|FG001|Overall Study|Lost to Follow-up|11|||
164246243|NCT03592771|593271771|FG002|Overall Study|Lost to Follow-up|15|||
164246244|NCT03592771|593271769|FG000|Overall Study|Withdrawal by Subject|0|||
164246245|NCT03592771|593271770|FG001|Overall Study|Withdrawal by Subject|2|||
164246246|NCT03592771|593271771|FG002|Overall Study|Withdrawal by Subject|0|||
164246247|NCT01642901|593271772|FG000|12-month Follow-up|Withdrawal by Subject|1|||
164246248|NCT01642901|593271773|FG001|12-month Follow-up|Withdrawal by Subject|0|||
164246249|NCT05069597|593271776|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
164246250|NCT05069597|593271777|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
164246251|NCT03650413|593271778|FG000|Overall Study|Adverse Event|1|||
164246252|NCT03650413|593271778|FG000|Overall Study|Lack of Efficacy|17|||
164246253|NCT03650413|593271778|FG000|Overall Study|Other|9|||
164246254|NCT03650413|593271778|FG000|Overall Study|Physician Decision|2|||
164246255|NCT03650413|593271778|FG000|Overall Study|Study Terminated By Sponsor|16|||
164246256|NCT03650413|593271778|FG000|Overall Study|Withdrawal by Subject|16|||
164246257|NCT00310375|593271781|FG000|Primary Reporting Phase|Adverse Event|28|||
164246258|NCT00310375|593271782|FG001|Primary Reporting Phase|Adverse Event|22|||
164246259|NCT00310375|593271783|FG002|Primary Reporting Phase|Adverse Event|0|||
164246260|NCT00310375|593271781|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
164246261|NCT00310375|593271782|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
164246262|NCT00310375|593271783|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
164246263|NCT00310375|593271781|FG000|Primary Reporting Phase|Pregnancy|2|||
164246264|NCT00310375|593271782|FG001|Primary Reporting Phase|Pregnancy|2|||
164246265|NCT00310375|593271783|FG002|Primary Reporting Phase|Pregnancy|0|||
164246266|NCT00310375|593271781|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
164246267|NCT00310375|593271782|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
164246268|NCT00310375|593271783|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
164246269|NCT00310375|593271781|FG000|Primary Reporting Phase|Protocol Violation|8|||
164246270|NCT00310375|593271782|FG001|Primary Reporting Phase|Protocol Violation|5|||
164246271|NCT00310375|593271783|FG002|Primary Reporting Phase|Protocol Violation|0|||
164246272|NCT00310375|593271781|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
164574672|NCT00603239|594468076|FG001|Overall Study|Adverse Event|1|||
164574673|NCT00603239|594468075|FG000|Overall Study|Entry criteria not met|0|||
164574674|NCT00603239|594468076|FG001|Overall Study|Entry criteria not met|1|||
164574675|NCT00603239|594468075|FG000|Overall Study|Loss of glucose control|3|||
164574676|NCT00603239|594468076|FG001|Overall Study|Loss of glucose control|0|||
164574677|NCT00603239|594468075|FG000|Overall Study|Lost to Follow-up|2|||
164574678|NCT00603239|594468076|FG001|Overall Study|Lost to Follow-up|1|||
164574679|NCT00603239|594468075|FG000|Overall Study|Physician Decision|2|||
164574680|NCT00603239|594468076|FG001|Overall Study|Physician Decision|0|||
164574681|NCT00603239|594468075|FG000|Overall Study|Protocol Violation|2|||
164574682|NCT00603239|594468076|FG001|Overall Study|Protocol Violation|0|||
164574683|NCT00603239|594468075|FG000|Overall Study|Subject decision|2|||
164574684|NCT00603239|594468076|FG001|Overall Study|Subject decision|1|||
164574685|NCT02210780|594468078|FG000|Overall Study|Adverse Event|0|||
164574686|NCT02210780|594468079|FG001|Overall Study|Adverse Event|5|||
164574687|NCT02210780|594468078|FG000|Overall Study|Lost to Follow-up|2|||
164679143|NCT00316277|594851106|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
164679144|NCT00927069|594851107|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
164246273|NCT00310375|593271782|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
164246274|NCT00310375|593271783|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
164246275|NCT00310375|593271781|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
164246276|NCT00310375|593271782|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
164246277|NCT00310375|593271783|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
164246278|NCT00310375|593271781|FG000|Primary Reporting Phase|Physician Decision|5|||
164246279|NCT00310375|593271782|FG001|Primary Reporting Phase|Physician Decision|3|||
164246280|NCT00310375|593271783|FG002|Primary Reporting Phase|Physician Decision|0|||
164246281|NCT00310375|593271781|FG000|Primary Reporting Phase|Request of the sponsor|2|||
164246282|NCT00310375|593271782|FG001|Primary Reporting Phase|Request of the sponsor|2|||
164246283|NCT00310375|593271783|FG002|Primary Reporting Phase|Request of the sponsor|0|||
164246284|NCT00310375|593271781|FG000|Primary Reporting Phase|Failed to return|1|||
164246285|NCT00310375|593271782|FG001|Primary Reporting Phase|Failed to return|3|||
164246286|NCT00310375|593271783|FG002|Primary Reporting Phase|Failed to return|0|||
164246287|NCT00310375|593271781|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
164246288|NCT00310375|593271782|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
164246289|NCT00310375|593271783|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
164246290|NCT00310375|593271781|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
164246291|NCT00310375|593271782|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
164246292|NCT00310375|593271783|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
164246293|NCT00310375|593271781|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
164246294|NCT00310375|593271782|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
164246295|NCT00310375|593271783|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
164246296|NCT00310375|593271781|FG000|Primary Reporting Phase|Site closure|3|||
164246297|NCT00310375|593271782|FG001|Primary Reporting Phase|Site closure|0|||
164246298|NCT00310375|593271783|FG002|Primary Reporting Phase|Site closure|0|||
164246299|NCT00310375|593271781|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
164246300|NCT00310375|593271782|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
164246301|NCT00310375|593271783|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
164246302|NCT00310375|593271781|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
164246303|NCT00310375|593271782|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
164246304|NCT00310375|593271783|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
164246305|NCT00310375|593271781|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
164246306|NCT00310375|593271782|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
164246307|NCT00310375|593271783|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
164246308|NCT00310375|593271781|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
164246309|NCT00310375|593271782|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
164246310|NCT00310375|593271783|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
164246311|NCT03332173|593271784|FG000|Overall Study|Death|7|||
164246312|NCT03332173|593271784|FG000|Overall Study|Withdrawal by Subject|6|||
164246313|NCT03332173|593271784|FG000|Overall Study|Lost to Follow-up|2|||
164246314|NCT03332173|593271784|FG000|Overall Study|Transferred to long-term extension study|29|||
164246315|NCT04024436|593271785|FG000|Overall Study|Death|10|||
164246316|NCT04024436|593271786|FG001|Overall Study|Death|14|||
164246317|NCT04024436|593271787|FG002|Overall Study|Death|2|||
164246318|NCT04024436|593271788|FG003|Overall Study|Death|7|||
164574688|NCT02210780|594468079|FG001|Overall Study|Lost to Follow-up|1|||
164574689|NCT02210780|594468078|FG000|Overall Study|Withdrawal by Subject|1|||
164574690|NCT02210780|594468079|FG001|Overall Study|Withdrawal by Subject|1|||
164679145|NCT00927069|594851108|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
164679146|NCT00927069|594851109|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
164679147|NCT00927069|594851110|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
164679148|NCT00927069|594851107|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
164246319|NCT04024436|593271785|FG000|Overall Study|Loss to follow up|1|||
164246320|NCT04024436|593271786|FG001|Overall Study|Loss to follow up|0|||
164246321|NCT04024436|593271787|FG002|Overall Study|Loss to follow up|0|||
164246322|NCT04024436|593271788|FG003|Overall Study|Loss to follow up|1|||
164574691|NCT02210780|594468078|FG000|Overall Study|Physician Decision|1|||
164574692|NCT02210780|594468079|FG001|Overall Study|Physician Decision|0|||
164679149|NCT00927069|594851108|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
164246323|NCT04024436|593271785|FG000|Overall Study|Withdrawal of consent|2|||
164246324|NCT04024436|593271786|FG001|Overall Study|Withdrawal of consent|0|||
164246325|NCT04024436|593271787|FG002|Overall Study|Withdrawal of consent|0|||
164246326|NCT04024436|593271788|FG003|Overall Study|Withdrawal of consent|1|||
164246327|NCT04024436|593271785|FG000|Overall Study|Study termination by sponsor|4|||
164246328|NCT04024436|593271786|FG001|Overall Study|Study termination by sponsor|6|||
164246329|NCT04024436|593271787|FG002|Overall Study|Study termination by sponsor|2|||
164246330|NCT04024436|593271788|FG003|Overall Study|Study termination by sponsor|11|||
164246331|NCT04024436|593271785|FG000|Overall Study|Reason Not Specified|0|||
164246332|NCT04024436|593271786|FG001|Overall Study|Reason Not Specified|1|||
164246333|NCT04024436|593271787|FG002|Overall Study|Reason Not Specified|0|||
164246334|NCT04024436|593271788|FG003|Overall Study|Reason Not Specified|2|||
164246335|NCT00540592|593271789|FG000|Overall Study|Adverse Event|0|||
164246336|NCT00540592|593271790|FG001|Overall Study|Adverse Event|1|||
164246337|NCT00540592|593271791|FG002|Overall Study|Adverse Event|0|||
164246338|NCT00540592|593271792|FG003|Overall Study|Adverse Event|0|||
164246339|NCT00540592|593271793|FG004|Overall Study|Adverse Event|1|||
164246340|NCT00540592|593271794|FG005|Overall Study|Adverse Event|0|||
164246341|NCT00540592|593271795|FG006|Overall Study|Adverse Event|0|||
164246342|NCT00540592|593271796|FG007|Overall Study|Adverse Event|1|||
164246343|NCT00540592|593271797|FG008|Overall Study|Adverse Event|1|||
164246344|NCT00540592|593271798|FG009|Overall Study|Adverse Event|2|||
164246345|NCT00540592|593271789|FG000|Overall Study|Lost to Follow-up|2|||
164246346|NCT00540592|593271790|FG001|Overall Study|Lost to Follow-up|0|||
164246347|NCT00540592|593271791|FG002|Overall Study|Lost to Follow-up|0|||
164246348|NCT00540592|593271792|FG003|Overall Study|Lost to Follow-up|0|||
164246349|NCT00540592|593271793|FG004|Overall Study|Lost to Follow-up|0|||
164246350|NCT00540592|593271794|FG005|Overall Study|Lost to Follow-up|0|||
164246351|NCT00540592|593271795|FG006|Overall Study|Lost to Follow-up|0|||
164246352|NCT00540592|593271796|FG007|Overall Study|Lost to Follow-up|0|||
164246353|NCT00540592|593271797|FG008|Overall Study|Lost to Follow-up|0|||
164246354|NCT00540592|593271798|FG009|Overall Study|Lost to Follow-up|0|||
164679150|NCT00927069|594851109|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
164679151|NCT00927069|594851110|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
164679152|NCT00927069|594851107|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
164679153|NCT00927069|594851108|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
164679154|NCT00927069|594851109|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
164679155|NCT00927069|594851110|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
164679156|NCT00927069|594851107|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
164679157|NCT00927069|594851108|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
164679158|NCT00927069|594851109|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
164679159|NCT00927069|594851110|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
164679160|NCT00927069|594851107|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
164679161|NCT00927069|594851108|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
164246355|NCT00540592|593271789|FG000|Overall Study|Withdrawal by Subject|0|||
164246356|NCT00540592|593271790|FG001|Overall Study|Withdrawal by Subject|0|||
164246357|NCT00540592|593271791|FG002|Overall Study|Withdrawal by Subject|1|||
164246358|NCT00540592|593271792|FG003|Overall Study|Withdrawal by Subject|1|||
164246359|NCT00540592|593271793|FG004|Overall Study|Withdrawal by Subject|0|||
164246360|NCT00540592|593271794|FG005|Overall Study|Withdrawal by Subject|0|||
164246361|NCT00540592|593271795|FG006|Overall Study|Withdrawal by Subject|0|||
164246362|NCT00540592|593271796|FG007|Overall Study|Withdrawal by Subject|0|||
164246363|NCT00540592|593271797|FG008|Overall Study|Withdrawal by Subject|0|||
164246364|NCT00540592|593271798|FG009|Overall Study|Withdrawal by Subject|0|||
164574693|NCT02210780|594468078|FG000|Overall Study|Protocol Violation|1|||
164574694|NCT02210780|594468079|FG001|Overall Study|Protocol Violation|0|||
164574695|NCT02210780|594468078|FG000|Overall Study|Other than specified above|0|||
164574696|NCT02210780|594468079|FG001|Overall Study|Other than specified above|1|||
164574697|NCT00097539|594468080|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
164574698|NCT00097539|594468081|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
164574699|NCT00097539|594468082|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
164574700|NCT00097539|594468083|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
164574701|NCT00097539|594468084|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
164574702|NCT00097539|594468085|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
164574703|NCT00097539|594468086|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
164574704|NCT00097539|594468080|FG000|Overall Study|Withdrawal by Subject|925|||
164679162|NCT00927069|594851109|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
164679163|NCT00927069|594851110|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
164246365|NCT00131352|593271799|FG000|Initial Treatment Period|Adverse Event|1|||
164246366|NCT00131352|593271800|FG001|Initial Treatment Period|Adverse Event|3|||
164246367|NCT00131352|593271799|FG000|Initial Treatment Period|Non-compliant|1|||
164246368|NCT00131352|593271800|FG001|Initial Treatment Period|Non-compliant|2|||
164246369|NCT00131352|593271799|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
164246370|NCT00131352|593271800|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
164246371|NCT00131352|593271799|FG000|Initial Treatment Period|Lack of Efficacy|6|||
164246372|NCT00131352|593271800|FG001|Initial Treatment Period|Lack of Efficacy|4|||
164246373|NCT00131352|593271799|FG000|Initial Treatment Period|Other|0|||
164246374|NCT00131352|593271800|FG001|Initial Treatment Period|Other|2|||
164246375|NCT00131352|593271799|FG000|Repeat Treatment Period|Adverse Event|1|||
164246376|NCT00131352|593271800|FG001|Repeat Treatment Period|Adverse Event|0|||
164246377|NCT00131352|593271799|FG000|Repeat Treatment Period|Other|1|||
164246378|NCT00131352|593271800|FG001|Repeat Treatment Period|Other|0|||
164246379|NCT02553928|593271801|FG000|Overall Study|Adverse Event|2|||
164246380|NCT02553928|593271802|FG001|Overall Study|Adverse Event|1|||
164246381|NCT02553928|593271801|FG000|Overall Study|Lost to Follow-up|0|||
164246382|NCT02553928|593271802|FG001|Overall Study|Lost to Follow-up|1|||
164246383|NCT02553928|593271801|FG000|Overall Study|Administrative reason(s)|0|||
164246384|NCT02553928|593271802|FG001|Overall Study|Administrative reason(s)|1|||
164246385|NCT05507567|593271803|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
164246386|NCT05507567|593271804|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
164246387|NCT05507567|593271805|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
164246388|NCT05507567|593271803|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
164246389|NCT05507567|593271804|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
164246390|NCT05507567|593271805|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
164246391|NCT05507567|593271803|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
164246392|NCT05507567|593271804|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
164246393|NCT05507567|593271805|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
164679164|NCT01572662|594851111|FG000|Overall Study|Withdrawal by Subject|1|||
164679165|NCT01572662|594851112|FG001|Overall Study|Withdrawal by Subject|0|||
164679166|NCT01572662|594851111|FG000|Overall Study|Physician Decision|0|||
164679167|NCT01572662|594851112|FG001|Overall Study|Physician Decision|1|||
164679168|NCT03364192|594851113|FG000|Overall Study|Ineligible|10|||
164679169|NCT03364192|594851113|FG000|Overall Study|Withdrawal by Subject|5|||
164679170|NCT03364192|594851113|FG000|Overall Study|Lost to Follow-up|1|||
164679171|NCT04692155|594851114|FG000|Overall Study|Death|1|||
164679172|NCT04547192|594851115|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
164679173|NCT04547192|594851116|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
164679174|NCT04547192|594851117|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
164679175|NCT04547192|594851118|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
164679176|NCT04547192|594851115|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
164679177|NCT04547192|594851116|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
164679178|NCT04547192|594851117|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
164679179|NCT04547192|594851118|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
164679180|NCT04547192|594851115|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
164246394|NCT05507567|593271803|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
164246395|NCT05507567|593271804|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
164246396|NCT05507567|593271805|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
164246397|NCT00383331|593271806|FG000|Overall Study|Protocol Violation|0|||
164246398|NCT00383331|593271807|FG001|Overall Study|Protocol Violation|1|||
164337741|NCT00150709|593613106|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
164337742|NCT00150709|593613107|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
164337743|NCT00150709|593613108|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
164337744|NCT00150709|593613105|FG000|Overall Study|Lack of ease of swallowing|0|||
164337745|NCT00150709|593613106|FG001|Overall Study|Lack of ease of swallowing|1|||
164337746|NCT00150709|593613107|FG002|Overall Study|Lack of ease of swallowing|0|||
164337747|NCT00150709|593613108|FG003|Overall Study|Lack of ease of swallowing|0|||
164337748|NCT04092582|593613109|FG000|Overall Study|Death|1|||
164337749|NCT04092582|593613110|FG001|Overall Study|Death|1|||
164337750|NCT04092582|593613109|FG000|Overall Study|Withdrawal by Subject|4|||
164337751|NCT04092582|593613110|FG001|Overall Study|Withdrawal by Subject|1|||
164337752|NCT04092582|593613109|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
164337753|NCT04092582|593613110|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
164337754|NCT01816074|593613114|FG000|Phase 1|Time commitment issues|0|||
164337755|NCT01816074|593613115|FG001|Phase 1|Time commitment issues|0|||
164337756|NCT01816074|593613116|FG002|Phase 1|Time commitment issues|1|||
164337757|NCT01816074|593613117|FG003|Phase 1|Time commitment issues|0|||
164337758|NCT01816074|593613114|FG000|Phase 2|Time commitment Issues|0|||
164337759|NCT01816074|593613115|FG001|Phase 2|Time commitment Issues|2|||
164337760|NCT01816074|593613116|FG002|Phase 2|Time commitment Issues|0|||
164337761|NCT01816074|593613117|FG003|Phase 2|Time commitment Issues|0|||
164337762|NCT01816074|593613114|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
164337763|NCT01816074|593613115|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
164337764|NCT01816074|593613116|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
164337765|NCT01816074|593613117|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
164337766|NCT01816074|593613114|FG000|Phase 2|Physician Decision|0|||
164337767|NCT01816074|593613115|FG001|Phase 2|Physician Decision|0|||
164337768|NCT01816074|593613116|FG002|Phase 2|Physician Decision|0|||
164337769|NCT01816074|593613117|FG003|Phase 2|Physician Decision|1|||
164337770|NCT01816074|593613114|FG000|Phase 2|Withdrawal by Subject|1|||
164337771|NCT01816074|593613115|FG001|Phase 2|Withdrawal by Subject|0|||
164337772|NCT01816074|593613116|FG002|Phase 2|Withdrawal by Subject|0|||
164337773|NCT01816074|593613117|FG003|Phase 2|Withdrawal by Subject|0|||
164337774|NCT03355365|593613121|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
164337775|NCT03355365|593613122|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
164337776|NCT03355365|593613121|FG000|Year 1, First Intervention|Protocol Violation|1|||
164337777|NCT03355365|593613122|FG001|Year 1, First Intervention|Protocol Violation|0|||
164337778|NCT03355365|593613121|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
164337779|NCT03355365|593613122|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
164337780|NCT03355365|593613121|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
164337781|NCT03355365|593613122|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
164337782|NCT03355365|593613121|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
164337783|NCT03355365|593613122|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
164337784|NCT03355365|593613121|FG000|Year 2, Crossover Intervention|severe COVID|0|||
164337785|NCT03355365|593613122|FG001|Year 2, Crossover Intervention|severe COVID|1|||
164679181|NCT04547192|594851116|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
164679182|NCT04547192|594851117|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
164679183|NCT04547192|594851118|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
164679184|NCT04547192|594851115|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
164679185|NCT04547192|594851116|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
164679186|NCT04547192|594851117|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
164679187|NCT04547192|594851118|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
164679188|NCT04547192|594851115|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
164679189|NCT04547192|594851116|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
164679190|NCT04547192|594851117|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
164679191|NCT04547192|594851118|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
164679192|NCT01535222|594851119|FG000|Overall Study|Inclusion/exclusion|0|||
164679193|NCT01535222|594851120|FG001|Overall Study|Inclusion/exclusion|0|||
164679194|NCT01535222|594851121|FG002|Overall Study|Inclusion/exclusion|1|||
164679195|NCT01535222|594851122|FG003|Overall Study|Inclusion/exclusion|0|||
164679196|NCT01535222|594851123|FG004|Overall Study|Inclusion/exclusion|0|||
164679197|NCT01535222|594851124|FG005|Overall Study|Inclusion/exclusion|0|||
164679198|NCT00935012|594851127|FG000|Overall Study|Death|19|||
164679199|NCT00935012|594851127|FG000|Overall Study|Withdrawal by Subject|3|||
164679200|NCT00935012|594851127|FG000|Overall Study|Other|5|||
164679201|NCT00935012|594851127|FG000|Overall Study|Adverse Event|2|||
164679202|NCT01442155|594851128|FG000|Overall Study|Complete remission|35|||
164337786|NCT03355365|593613121|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
164337787|NCT03355365|593613122|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
164337788|NCT01303861|593613126|FG000|Overall Study|Lost to Follow-up|34|||
164337789|NCT01303861|593613127|FG001|Overall Study|Lost to Follow-up|14|||
164426149|NCT04955626|593930817|FG006|Blinded Period|Refused further study procedures|1|||
164426150|NCT04955626|593930818|FG007|Blinded Period|Refused further study procedures|0|||
164426151|NCT04955626|593930819|FG008|Blinded Period|Refused further study procedures|0|||
164426152|NCT04955626|593930820|FG009|Blinded Period|Refused further study procedures|0|||
164426153|NCT04955626|593930821|FG010|Blinded Period|Refused further study procedures|0|||
164426154|NCT04955626|593930822|FG011|Blinded Period|Refused further study procedures|2|||
164426155|NCT04955626|593930823|FG012|Blinded Period|Refused further study procedures|0|||
164426156|NCT04955626|593930824|FG013|Blinded Period|Refused further study procedures|0|||
164426157|NCT04955626|593930825|FG014|Blinded Period|Refused further study procedures|0|||
164337790|NCT01303861|593613128|FG002|Overall Study|Lost to Follow-up|27|||
164337791|NCT01303861|593613129|FG003|Overall Study|Lost to Follow-up|31|||
164337792|NCT01303861|593613126|FG000|Overall Study|Lack of Efficacy|3|||
164337793|NCT01303861|593613127|FG001|Overall Study|Lack of Efficacy|2|||
164337794|NCT01303861|593613128|FG002|Overall Study|Lack of Efficacy|1|||
164426158|NCT04955626|593930826|FG015|Blinded Period|Refused further study procedures|0|||
164426159|NCT04955626|593930827|FG016|Blinded Period|Refused further study procedures|0|||
164426160|NCT04955626|593930828|FG017|Blinded Period|Refused further study procedures|0|||
164426161|NCT04955626|593930829|FG018|Blinded Period|Refused further study procedures|0|||
164426162|NCT04955626|593930830|FG019|Blinded Period|Refused further study procedures|0|||
164426163|NCT04955626|593930831|FG020|Blinded Period|Refused further study procedures|0|||
164426164|NCT04955626|593930832|FG021|Blinded Period|Refused further study procedures|0|||
164337795|NCT01303861|593613129|FG003|Overall Study|Lack of Efficacy|0|||
164337796|NCT01303861|593613126|FG000|Overall Study|Withdrawal by Subject|16|||
164337797|NCT01303861|593613127|FG001|Overall Study|Withdrawal by Subject|8|||
164337798|NCT01303861|593613128|FG002|Overall Study|Withdrawal by Subject|8|||
164426165|NCT04955626|593930833|FG022|Blinded Period|Refused further study procedures|0|||
164679203|NCT01442155|594851128|FG000|Overall Study|Recurrence|26|||
164679204|NCT01442155|594851128|FG000|Overall Study|Adverse Event|2|||
164679205|NCT01442155|594851128|FG000|Overall Study|Lost to Follow-up|2|||
164679206|NCT01590563|594851133|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
164679207|NCT01484912|594851136|FG000|Overall Study|Withdrawal by Subject|1|||
164246399|NCT04830215|593271808|FG000|Overall Study|Adverse Event|6|||
164246400|NCT04830215|593271808|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
164246401|NCT04830215|593271808|FG000|Overall Study|Withdrawal by Subject|3|||
164246402|NCT04830215|593271808|FG000|Overall Study|Protocol Deviation|1|||
164246403|NCT00770562|593271813|FG000|Overall Study|Did not take treatment|1|||
164246404|NCT00770562|593271814|FG001|Overall Study|Did not take treatment|1|||
164246405|NCT05338710|593271815|FG000|Overall Study|Withdrawal by Subject|3|||
164246406|NCT01194219|593271816|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
164246407|NCT01194219|593271817|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
164246408|NCT01194219|593271818|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
164574705|NCT00097539|594468081|FG001|Overall Study|Withdrawal by Subject|323|||
164574706|NCT00097539|594468082|FG002|Overall Study|Withdrawal by Subject|346|||
164574707|NCT00097539|594468083|FG003|Overall Study|Withdrawal by Subject|217|||
164574708|NCT00097539|594468084|FG004|Overall Study|Withdrawal by Subject|68|||
164574709|NCT00097539|594468085|FG005|Overall Study|Withdrawal by Subject|229|||
164574710|NCT00097539|594468086|FG006|Overall Study|Withdrawal by Subject|3|||
164574711|NCT00097539|594468080|FG000|Overall Study|Participant Non-compliant|2140|||
164574712|NCT00097539|594468081|FG001|Overall Study|Participant Non-compliant|567|||
164574713|NCT00097539|594468082|FG002|Overall Study|Participant Non-compliant|1067|||
164574714|NCT00097539|594468083|FG003|Overall Study|Participant Non-compliant|353|||
164574715|NCT00097539|594468084|FG004|Overall Study|Participant Non-compliant|136|||
164574716|NCT00097539|594468085|FG005|Overall Study|Participant Non-compliant|543|||
164574717|NCT00097539|594468086|FG006|Overall Study|Participant Non-compliant|18|||
164574718|NCT00097539|594468080|FG000|Overall Study|Lack of Efficacy|249|||
164574719|NCT00097539|594468081|FG001|Overall Study|Lack of Efficacy|122|||
164574720|NCT00097539|594468082|FG002|Overall Study|Lack of Efficacy|202|||
164574721|NCT00097539|594468083|FG003|Overall Study|Lack of Efficacy|105|||
164574722|NCT00097539|594468084|FG004|Overall Study|Lack of Efficacy|45|||
164574723|NCT00097539|594468085|FG005|Overall Study|Lack of Efficacy|228|||
164246409|NCT01194219|593271819|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
164246410|NCT01194219|593271820|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
164246411|NCT01194219|593271821|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
164246412|NCT01194219|593271822|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
164246413|NCT01194219|593271823|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
164246414|NCT01194219|593271824|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
164246415|NCT01194219|593271825|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
164246416|NCT01194219|593271816|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
164246417|NCT01194219|593271817|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
164246418|NCT01194219|593271818|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
164246419|NCT01194219|593271819|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
164246420|NCT01194219|593271820|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
164246421|NCT01194219|593271821|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
164246422|NCT01194219|593271822|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
164246423|NCT01194219|593271823|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
164246424|NCT01194219|593271824|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
164246425|NCT01194219|593271825|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
164246426|NCT01194219|593271816|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
164246427|NCT01194219|593271817|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
164246428|NCT01194219|593271818|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
164246429|NCT01194219|593271819|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
164246430|NCT01194219|593271820|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
164246431|NCT01194219|593271821|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
164246432|NCT01194219|593271822|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
164246433|NCT01194219|593271823|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
164246434|NCT01194219|593271824|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
164246435|NCT01194219|593271825|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
164246436|NCT01194219|593271816|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
164246437|NCT01194219|593271817|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
164246438|NCT01194219|593271818|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
164246439|NCT01194219|593271819|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
164246440|NCT01194219|593271820|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
164246441|NCT01194219|593271821|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
164246442|NCT01194219|593271822|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
164246443|NCT01194219|593271823|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
164246444|NCT01194219|593271824|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
164246445|NCT01194219|593271825|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
164246446|NCT01194219|593271816|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
164574724|NCT00097539|594468086|FG006|Overall Study|Lack of Efficacy|5|||
164574725|NCT00097539|594468080|FG000|Overall Study|Adverse Event|78|||
164574726|NCT00097539|594468081|FG001|Overall Study|Adverse Event|133|||
164679208|NCT01484912|594851137|FG001|Overall Study|Withdrawal by Subject|0|||
164679209|NCT01484912|594851136|FG000|Overall Study|Physician Decision|0|||
164679210|NCT01484912|594851137|FG001|Overall Study|Physician Decision|1|||
164679211|NCT00205777|594851140|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
164679212|NCT00205777|594851141|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
164679213|NCT00205777|594851142|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
164679214|NCT00205777|594851143|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
164679215|NCT00205777|594851144|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
164679216|NCT00205777|594851145|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
164679217|NCT00205777|594851140|FG000|Core Study (Up to 3 Years)|Death|9|||
164679218|NCT00205777|594851141|FG001|Core Study (Up to 3 Years)|Death|7|||
164679219|NCT00205777|594851142|FG002|Core Study (Up to 3 Years)|Death|14|||
164679220|NCT00205777|594851143|FG003|Core Study (Up to 3 Years)|Death|7|||
164679221|NCT00205777|594851144|FG004|Core Study (Up to 3 Years)|Death|0|||
164679222|NCT00205777|594851145|FG005|Core Study (Up to 3 Years)|Death|0|||
164679223|NCT00205777|594851140|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
164679224|NCT00205777|594851141|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
164679225|NCT00205777|594851142|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
164679226|NCT00205777|594851143|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
164679227|NCT00205777|594851144|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
164679228|NCT00205777|594851145|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
164679229|NCT00205777|594851140|FG000|Core Study (Up to 3 Years)|Other Event|49|||
164679230|NCT00205777|594851141|FG001|Core Study (Up to 3 Years)|Other Event|52|||
164679231|NCT00205777|594851142|FG002|Core Study (Up to 3 Years)|Other Event|41|||
164246447|NCT01194219|593271817|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
164246448|NCT01194219|593271818|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
164246449|NCT01194219|593271819|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
164679232|NCT00205777|594851143|FG003|Core Study (Up to 3 Years)|Other Event|58|||
164679233|NCT00205777|594851144|FG004|Core Study (Up to 3 Years)|Other Event|0|||
164679234|NCT00205777|594851145|FG005|Core Study (Up to 3 Years)|Other Event|0|||
164679235|NCT00205777|594851140|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
164679236|NCT00205777|594851141|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
164679237|NCT00205777|594851142|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
164679238|NCT00205777|594851143|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
164679239|NCT00205777|594851144|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
164679240|NCT00205777|594851145|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
164679241|NCT00205777|594851140|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
164679242|NCT00205777|594851141|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
164679243|NCT00205777|594851142|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
164679244|NCT00205777|594851143|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
164679245|NCT00205777|594851144|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
164679246|NCT00205777|594851145|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
164679247|NCT00205777|594851140|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
164679248|NCT00205777|594851141|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
164679249|NCT00205777|594851142|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
164679250|NCT00205777|594851143|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
164679251|NCT00205777|594851144|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
164679252|NCT00205777|594851145|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
164679253|NCT00205777|594851140|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
164679254|NCT00205777|594851141|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
164679255|NCT00205777|594851142|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
164679256|NCT00205777|594851143|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
164679257|NCT00205777|594851144|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
164679258|NCT00205777|594851145|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
164679259|NCT00205777|594851140|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
164679260|NCT00205777|594851141|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
164679261|NCT00205777|594851142|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
164679262|NCT00205777|594851143|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
164679263|NCT00205777|594851144|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
164679264|NCT00205777|594851145|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
164679265|NCT00205777|594851140|FG000|Completed Core Study, Entered SE I|Other Event|52|||
164679266|NCT00205777|594851141|FG001|Completed Core Study, Entered SE I|Other Event|46|||
164679267|NCT00205777|594851142|FG002|Completed Core Study, Entered SE I|Other Event|47|||
164679268|NCT00205777|594851143|FG003|Completed Core Study, Entered SE I|Other Event|50|||
164679269|NCT00205777|594851144|FG004|Completed Core Study, Entered SE I|Other Event|0|||
164679270|NCT00205777|594851145|FG005|Completed Core Study, Entered SE I|Other Event|0|||
164679271|NCT00205777|594851140|FG000|Study Extension I|Adverse Event|57|||
164679272|NCT00205777|594851141|FG001|Study Extension I|Adverse Event|0|||
164679273|NCT00205777|594851142|FG002|Study Extension I|Adverse Event|0|||
164679274|NCT00205777|594851143|FG003|Study Extension I|Adverse Event|61|||
164679275|NCT00205777|594851144|FG004|Study Extension I|Adverse Event|58|||
164679276|NCT00205777|594851145|FG005|Study Extension I|Adverse Event|0|||
164246450|NCT01194219|593271820|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
164246451|NCT01194219|593271821|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
164246452|NCT01194219|593271822|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
164246453|NCT01194219|593271823|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
164246454|NCT01194219|593271824|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
164246455|NCT01194219|593271825|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
164246456|NCT01194219|593271816|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
164246457|NCT01194219|593271817|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
164246458|NCT01194219|593271818|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
164246459|NCT01194219|593271819|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
164246460|NCT01194219|593271820|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
164246461|NCT01194219|593271821|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
164246462|NCT01194219|593271822|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
164246463|NCT01194219|593271823|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
164246464|NCT01194219|593271824|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
164246465|NCT01194219|593271825|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
164246466|NCT01194219|593271816|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
164246467|NCT01194219|593271817|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
164246468|NCT01194219|593271818|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
164246469|NCT01194219|593271819|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
164246470|NCT01194219|593271820|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
164246471|NCT01194219|593271821|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
164246472|NCT01194219|593271822|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
164246473|NCT01194219|593271823|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
164246474|NCT01194219|593271824|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
164246475|NCT01194219|593271825|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
164246476|NCT01194219|593271816|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
164246477|NCT01194219|593271817|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
164246478|NCT01194219|593271818|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
164246479|NCT01194219|593271819|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
164246480|NCT01194219|593271820|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
164246481|NCT01194219|593271821|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
164246482|NCT01194219|593271822|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
164246483|NCT01194219|593271823|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
164246484|NCT01194219|593271824|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
164246485|NCT01194219|593271825|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
164246486|NCT01194219|593271816|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
164246487|NCT01194219|593271817|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
164246488|NCT01194219|593271818|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
164246489|NCT01194219|593271819|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
164246490|NCT01194219|593271820|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
164246491|NCT01194219|593271821|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
164246492|NCT01194219|593271822|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
164246493|NCT01194219|593271823|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
164246494|NCT01194219|593271824|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
164246495|NCT01194219|593271825|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
164246496|NCT01194219|593271816|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
164246497|NCT01194219|593271817|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
164246498|NCT01194219|593271818|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
164246499|NCT01194219|593271819|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
164246500|NCT01194219|593271820|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
164246501|NCT01194219|593271821|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
164246502|NCT01194219|593271822|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
164246503|NCT01194219|593271823|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
164246504|NCT01194219|593271824|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
164246505|NCT01194219|593271825|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
164246506|NCT01194219|593271816|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
164246507|NCT01194219|593271817|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
164246508|NCT01194219|593271818|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
164246509|NCT01194219|593271819|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
164246510|NCT01194219|593271820|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
164246511|NCT01194219|593271821|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
164246512|NCT01194219|593271822|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
164246513|NCT01194219|593271823|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
164246514|NCT01194219|593271824|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
164246515|NCT01194219|593271825|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
164246516|NCT01194219|593271816|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
164246517|NCT01194219|593271817|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
164246518|NCT01194219|593271818|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
164246519|NCT01194219|593271819|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
164246520|NCT01194219|593271820|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
164246521|NCT01194219|593271821|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
164246522|NCT01194219|593271822|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
164246523|NCT01194219|593271823|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
164246524|NCT01194219|593271824|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
164679277|NCT00205777|594851140|FG000|Study Extension I|Death|5|||
164679278|NCT00205777|594851141|FG001|Study Extension I|Death|0|||
164679279|NCT00205777|594851142|FG002|Study Extension I|Death|0|||
164679280|NCT00205777|594851143|FG003|Study Extension I|Death|1|||
164679281|NCT00205777|594851144|FG004|Study Extension I|Death|2|||
164679282|NCT00205777|594851145|FG005|Study Extension I|Death|0|||
164679283|NCT00205777|594851140|FG000|Study Extension I|Withdrawal by Subject|99|||
164679284|NCT00205777|594851141|FG001|Study Extension I|Withdrawal by Subject|0|||
164679285|NCT00205777|594851142|FG002|Study Extension I|Withdrawal by Subject|0|||
164679286|NCT00205777|594851143|FG003|Study Extension I|Withdrawal by Subject|106|||
164679287|NCT00205777|594851144|FG004|Study Extension I|Withdrawal by Subject|89|||
164679288|NCT00205777|594851145|FG005|Study Extension I|Withdrawal by Subject|0|||
164679289|NCT00205777|594851140|FG000|Study Extension I|Protocol Violation|4|||
164679290|NCT00205777|594851141|FG001|Study Extension I|Protocol Violation|0|||
164679291|NCT00205777|594851142|FG002|Study Extension I|Protocol Violation|0|||
164679292|NCT00205777|594851143|FG003|Study Extension I|Protocol Violation|8|||
164679293|NCT00205777|594851144|FG004|Study Extension I|Protocol Violation|8|||
164679294|NCT00205777|594851145|FG005|Study Extension I|Protocol Violation|0|||
164679295|NCT00205777|594851140|FG000|Study Extension I|Lack of Efficacy|0|||
164679296|NCT00205777|594851141|FG001|Study Extension I|Lack of Efficacy|0|||
164679297|NCT00205777|594851142|FG002|Study Extension I|Lack of Efficacy|0|||
164679298|NCT00205777|594851143|FG003|Study Extension I|Lack of Efficacy|1|||
164679299|NCT00205777|594851144|FG004|Study Extension I|Lack of Efficacy|2|||
164679300|NCT00205777|594851145|FG005|Study Extension I|Lack of Efficacy|0|||
164679301|NCT00205777|594851140|FG000|Study Extension I|Failed to return|15|||
164679302|NCT00205777|594851141|FG001|Study Extension I|Failed to return|0|||
164679303|NCT00205777|594851142|FG002|Study Extension I|Failed to return|0|||
164679304|NCT00205777|594851143|FG003|Study Extension I|Failed to return|17|||
164679305|NCT00205777|594851144|FG004|Study Extension I|Failed to return|13|||
164679306|NCT00205777|594851145|FG005|Study Extension I|Failed to return|0|||
164679307|NCT00205777|594851140|FG000|Study Extension I|Other Event|34|||
164679308|NCT00205777|594851141|FG001|Study Extension I|Other Event|0|||
164679309|NCT00205777|594851142|FG002|Study Extension I|Other Event|0|||
164679310|NCT00205777|594851143|FG003|Study Extension I|Other Event|34|||
164679311|NCT00205777|594851144|FG004|Study Extension I|Other Event|29|||
164679312|NCT00205777|594851145|FG005|Study Extension I|Other Event|0|||
164679313|NCT00205777|594851140|FG000|Study Extension I|Withdrawn as per protocol|0|||
164679314|NCT00205777|594851141|FG001|Study Extension I|Withdrawn as per protocol|0|||
164679315|NCT00205777|594851142|FG002|Study Extension I|Withdrawn as per protocol|1070|||
164679316|NCT00205777|594851143|FG003|Study Extension I|Withdrawn as per protocol|0|||
164679317|NCT00205777|594851144|FG004|Study Extension I|Withdrawn as per protocol|0|||
164679318|NCT00205777|594851145|FG005|Study Extension I|Withdrawn as per protocol|0|||
164679319|NCT00205777|594851140|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
164679320|NCT00205777|594851141|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
164679321|NCT00205777|594851142|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
164246525|NCT01194219|593271825|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
164246526|NCT01194219|593271816|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
164246527|NCT01194219|593271817|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
164246528|NCT01194219|593271818|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
164246529|NCT01194219|593271819|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
164246530|NCT01194219|593271820|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
164679322|NCT00205777|594851143|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
164679323|NCT00205777|594851144|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
164679324|NCT00205777|594851145|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
164679325|NCT00205777|594851140|FG000|Study Extension II|Adverse Event|0|||
164679326|NCT00205777|594851141|FG001|Study Extension II|Adverse Event|0|||
164679327|NCT00205777|594851142|FG002|Study Extension II|Adverse Event|0|||
164679328|NCT00205777|594851143|FG003|Study Extension II|Adverse Event|14|||
164679329|NCT00205777|594851144|FG004|Study Extension II|Adverse Event|0|||
164679330|NCT00205777|594851145|FG005|Study Extension II|Adverse Event|30|||
164679331|NCT00205777|594851140|FG000|Study Extension II|Death|0|||
164679332|NCT00205777|594851141|FG001|Study Extension II|Death|0|||
164679333|NCT00205777|594851142|FG002|Study Extension II|Death|0|||
164679334|NCT00205777|594851143|FG003|Study Extension II|Death|2|||
164679335|NCT00205777|594851144|FG004|Study Extension II|Death|0|||
164246531|NCT01194219|593271821|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
164246532|NCT01194219|593271822|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
164246533|NCT01194219|593271823|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
164246534|NCT01194219|593271824|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
164246535|NCT01194219|593271825|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
164246536|NCT01194219|593271816|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
164246537|NCT01194219|593271817|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
164246538|NCT01194219|593271818|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
164246539|NCT01194219|593271819|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
164246540|NCT01194219|593271820|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
164246541|NCT01194219|593271821|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
164246542|NCT01194219|593271822|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
164246543|NCT01194219|593271823|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
164246544|NCT01194219|593271824|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
164246545|NCT01194219|593271825|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
164246546|NCT01194219|593271816|FG000|Maintenance Phase Weeks16-32|Other|0|||
164246547|NCT01194219|593271817|FG001|Maintenance Phase Weeks16-32|Other|0|||
164246548|NCT01194219|593271818|FG002|Maintenance Phase Weeks16-32|Other|2|||
164246549|NCT01194219|593271819|FG003|Maintenance Phase Weeks16-32|Other|1|||
164246550|NCT01194219|593271820|FG004|Maintenance Phase Weeks16-32|Other|0|||
164246551|NCT01194219|593271821|FG005|Maintenance Phase Weeks16-32|Other|0|||
164246552|NCT01194219|593271822|FG006|Maintenance Phase Weeks16-32|Other|0|||
164246553|NCT01194219|593271823|FG007|Maintenance Phase Weeks16-32|Other|0|||
164246554|NCT01194219|593271824|FG008|Maintenance Phase Weeks16-32|Other|0|||
164246555|NCT01194219|593271825|FG009|Maintenance Phase Weeks16-32|Other|0|||
164246556|NCT01194219|593271816|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
164246557|NCT01194219|593271817|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
164246558|NCT01194219|593271818|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
164246559|NCT01194219|593271819|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
164246560|NCT01194219|593271820|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
164246561|NCT01194219|593271821|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
164246562|NCT01194219|593271822|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
164246563|NCT01194219|593271823|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
164246564|NCT01194219|593271824|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
164246565|NCT01194219|593271825|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
164246566|NCT01194219|593271816|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
164246567|NCT01194219|593271817|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
164246568|NCT01194219|593271818|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
164246569|NCT01194219|593271819|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
164246570|NCT01194219|593271820|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
164246571|NCT01194219|593271821|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
164246572|NCT01194219|593271822|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
164246573|NCT01194219|593271823|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
164246574|NCT01194219|593271824|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
164246575|NCT01194219|593271825|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
164246576|NCT01194219|593271816|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
164246577|NCT01194219|593271817|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
164246578|NCT01194219|593271818|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
164246579|NCT01194219|593271819|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
164246580|NCT01194219|593271820|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
164246581|NCT01194219|593271821|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
164246582|NCT01194219|593271822|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
164246583|NCT01194219|593271823|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
164246584|NCT01194219|593271824|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
164246585|NCT01194219|593271825|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
164246586|NCT01194219|593271816|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
164246587|NCT01194219|593271817|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
164246588|NCT01194219|593271818|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
164246589|NCT01194219|593271819|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
164337799|NCT01303861|593613129|FG003|Overall Study|Withdrawal by Subject|23|||
164337800|NCT01303861|593613126|FG000|Overall Study|Adverse Event|4|||
164574727|NCT00097539|594468082|FG002|Overall Study|Adverse Event|37|||
164574728|NCT00097539|594468083|FG003|Overall Study|Adverse Event|27|||
164574729|NCT00097539|594468084|FG004|Overall Study|Adverse Event|30|||
164574730|NCT00097539|594468085|FG005|Overall Study|Adverse Event|59|||
164574731|NCT00097539|594468086|FG006|Overall Study|Adverse Event|1|||
164574732|NCT00097539|594468080|FG000|Overall Study|Death|2|||
164574733|NCT00097539|594468081|FG001|Overall Study|Death|7|||
164246590|NCT01194219|593271820|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
164246591|NCT01194219|593271821|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
164246592|NCT01194219|593271822|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
164246593|NCT01194219|593271823|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
164246594|NCT01194219|593271824|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
164246595|NCT01194219|593271825|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
164246596|NCT01194219|593271816|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
164679336|NCT00205777|594851145|FG005|Study Extension II|Death|5|||
164679337|NCT00205777|594851140|FG000|Study Extension II|Withdrawal by Subject|0|||
164679338|NCT00205777|594851141|FG001|Study Extension II|Withdrawal by Subject|0|||
164679339|NCT00205777|594851142|FG002|Study Extension II|Withdrawal by Subject|0|||
164679340|NCT00205777|594851143|FG003|Study Extension II|Withdrawal by Subject|35|||
164679341|NCT00205777|594851144|FG004|Study Extension II|Withdrawal by Subject|0|||
164679342|NCT00205777|594851145|FG005|Study Extension II|Withdrawal by Subject|59|||
164679343|NCT00205777|594851140|FG000|Study Extension II|Protocol Violation|0|||
164679344|NCT00205777|594851141|FG001|Study Extension II|Protocol Violation|0|||
164679345|NCT00205777|594851142|FG002|Study Extension II|Protocol Violation|0|||
164679346|NCT00205777|594851143|FG003|Study Extension II|Protocol Violation|1|||
164679347|NCT00205777|594851144|FG004|Study Extension II|Protocol Violation|0|||
164679348|NCT00205777|594851145|FG005|Study Extension II|Protocol Violation|10|||
164679349|NCT00205777|594851140|FG000|Study Extension II|Lack of Efficacy|0|||
164679350|NCT00205777|594851141|FG001|Study Extension II|Lack of Efficacy|0|||
164246597|NCT01194219|593271817|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
164246598|NCT01194219|593271818|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
164337801|NCT01303861|593613127|FG001|Overall Study|Adverse Event|1|||
164337802|NCT01303861|593613128|FG002|Overall Study|Adverse Event|0|||
164337803|NCT01303861|593613129|FG003|Overall Study|Adverse Event|5|||
164337804|NCT01303861|593613126|FG000|Overall Study|Pregnancy|1|||
164337805|NCT01303861|593613127|FG001|Overall Study|Pregnancy|0|||
164337806|NCT01303861|593613128|FG002|Overall Study|Pregnancy|0|||
164337807|NCT01303861|593613129|FG003|Overall Study|Pregnancy|0|||
164337808|NCT03650556|593613135|FG000|Overall Study|Death|2|||
164337809|NCT03650556|593613135|FG000|Overall Study|Withdrawal by Subject|20|||
164337810|NCT03650556|593613135|FG000|Overall Study|Physician Decision|2|||
164337811|NCT03650556|593613135|FG000|Overall Study|Lost to Follow-up|8|||
164337812|NCT03650556|593613135|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
164337813|NCT03650556|593613135|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
164337814|NCT03917459|593613138|FG000|Overall Study|Adverse Event|1|||
164337815|NCT03917459|593613139|FG001|Overall Study|Adverse Event|0|||
164337816|NCT03917459|593613138|FG000|Overall Study|Withdrawal by Subject|0|||
164337817|NCT03917459|593613139|FG001|Overall Study|Withdrawal by Subject|1|||
164337818|NCT01500031|593613143|FG000|Overall Study|Death|1|||
164337819|NCT01500031|593613143|FG000|Overall Study|Withdrawal by Subject|4|||
164337820|NCT00917501|593613144|FG000|Overall Study|Lost to Follow-up|4|||
164337821|NCT00917501|593613145|FG001|Overall Study|Lost to Follow-up|1|||
164337822|NCT00917501|593613144|FG000|Overall Study|Withdrawal by Subject|3|||
164337823|NCT00917501|593613145|FG001|Overall Study|Withdrawal by Subject|1|||
164337824|NCT00917501|593613144|FG000|Overall Study|Lack of Efficacy|1|||
164337825|NCT00917501|593613145|FG001|Overall Study|Lack of Efficacy|2|||
164337826|NCT00917501|593613144|FG000|Overall Study|trouble swollowing capsules|0|||
164337827|NCT00917501|593613145|FG001|Overall Study|trouble swollowing capsules|1|||
164337828|NCT00850070|593613148|FG000|Overall Study|Lack of Efficacy|1|||
164337829|NCT00850070|593613149|FG001|Overall Study|Lack of Efficacy|1|||
164337830|NCT00850070|593613148|FG000|Overall Study|Adverse Event|2|||
164337831|NCT00850070|593613149|FG001|Overall Study|Adverse Event|0|||
164337832|NCT01522248|593613156|FG000|Overall Study|Lost to Follow-up|1|||
164337833|NCT01522248|593613157|FG001|Overall Study|Lost to Follow-up|0|||
164337834|NCT02191137|593613159|FG000|Treatment|Death|4|||
164337835|NCT02191137|593613159|FG000|Treatment|Withdrawal by Subject|3|||
164679351|NCT00205777|594851142|FG002|Study Extension II|Lack of Efficacy|0|||
164679352|NCT00205777|594851143|FG003|Study Extension II|Lack of Efficacy|0|||
164679353|NCT00205777|594851144|FG004|Study Extension II|Lack of Efficacy|0|||
164679354|NCT00205777|594851145|FG005|Study Extension II|Lack of Efficacy|1|||
164679355|NCT00205777|594851140|FG000|Study Extension II|Failed to return|0|||
164679356|NCT00205777|594851141|FG001|Study Extension II|Failed to return|0|||
164679357|NCT00205777|594851142|FG002|Study Extension II|Failed to return|0|||
164679358|NCT00205777|594851143|FG003|Study Extension II|Failed to return|14|||
164679359|NCT00205777|594851144|FG004|Study Extension II|Failed to return|0|||
164337836|NCT02191137|593613159|FG000|Treatment|Adverse Event|2|||
164337837|NCT02191137|593613159|FG000|Treatment|Other|1|||
164337838|NCT02191137|593613159|FG000|Follow-up|Lost to Follow-up|2|||
164337839|NCT02191137|593613159|FG000|Follow-up|Ongoing/unknown|2|||
164337840|NCT02191137|593613159|FG000|Follow-up|Adverse Event|1|||
164337841|NCT01332331|593613160|FG000|Overall Study|Lost to Follow-up|0|||
164337842|NCT01332331|593613161|FG001|Overall Study|Lost to Follow-up|1|||
164337843|NCT01332331|593613160|FG000|Overall Study|Adverse Event|1|||
164337844|NCT01332331|593613161|FG001|Overall Study|Adverse Event|1|||
164337845|NCT01332331|593613160|FG000|Overall Study|Physician Decision|1|||
164337846|NCT01332331|593613161|FG001|Overall Study|Physician Decision|0|||
164337847|NCT00538291|593613162|FG000|Overall Study|Adverse Event|2|||
164337848|NCT00538291|593613162|FG000|Overall Study|Withdrawal by Subject|1|||
164337849|NCT00694707|593613163|FG000|Overall Study|Did Not Receive Treatment|0|||
164337850|NCT00694707|593613164|FG001|Overall Study|Did Not Receive Treatment|0|||
164337851|NCT00694707|593613165|FG002|Overall Study|Did Not Receive Treatment|1|||
164337852|NCT00694707|593613166|FG003|Overall Study|Did Not Receive Treatment|1|||
164337853|NCT00694707|593613167|FG004|Overall Study|Did Not Receive Treatment|1|||
164337854|NCT00694707|593613163|FG000|Overall Study|Adverse Event|22|||
164337855|NCT00694707|593613164|FG001|Overall Study|Adverse Event|14|||
164337856|NCT00694707|593613165|FG002|Overall Study|Adverse Event|8|||
164337857|NCT00694707|593613166|FG003|Overall Study|Adverse Event|12|||
164337858|NCT00694707|593613167|FG004|Overall Study|Adverse Event|13|||
164337859|NCT00694707|593613163|FG000|Overall Study|Insufficient Therapeutic Response|33|||
164337860|NCT00694707|593613164|FG001|Overall Study|Insufficient Therapeutic Response|18|||
164337861|NCT00694707|593613165|FG002|Overall Study|Insufficient Therapeutic Response|17|||
164337862|NCT00694707|593613166|FG003|Overall Study|Insufficient Therapeutic Response|15|||
164337863|NCT00694707|593613167|FG004|Overall Study|Insufficient Therapeutic Response|10|||
164337864|NCT00694707|593613163|FG000|Overall Study|Protocol Violation|1|||
164337865|NCT00694707|593613164|FG001|Overall Study|Protocol Violation|2|||
164337866|NCT00694707|593613165|FG002|Overall Study|Protocol Violation|1|||
164337867|NCT00694707|593613166|FG003|Overall Study|Protocol Violation|3|||
164337868|NCT00694707|593613167|FG004|Overall Study|Protocol Violation|1|||
164337869|NCT00694707|593613163|FG000|Overall Study|Withdrawal of Consent|14|||
164337870|NCT00694707|593613164|FG001|Overall Study|Withdrawal of Consent|18|||
164337871|NCT00694707|593613165|FG002|Overall Study|Withdrawal of Consent|22|||
164337872|NCT00694707|593613166|FG003|Overall Study|Withdrawal of Consent|16|||
164337873|NCT00694707|593613167|FG004|Overall Study|Withdrawal of Consent|15|||
164337874|NCT00694707|593613163|FG000|Overall Study|Lost to Follow-up|0|||
164337875|NCT00694707|593613164|FG001|Overall Study|Lost to Follow-up|1|||
164337876|NCT00694707|593613165|FG002|Overall Study|Lost to Follow-up|2|||
164337877|NCT00694707|593613166|FG003|Overall Study|Lost to Follow-up|0|||
164337878|NCT00694707|593613167|FG004|Overall Study|Lost to Follow-up|0|||
164337879|NCT00694707|593613163|FG000|Overall Study|Jeopardizing Parole Status|1|||
164337880|NCT00694707|593613164|FG001|Overall Study|Jeopardizing Parole Status|0|||
164337881|NCT00694707|593613165|FG002|Overall Study|Jeopardizing Parole Status|0|||
164337882|NCT00694707|593613166|FG003|Overall Study|Jeopardizing Parole Status|0|||
164337883|NCT00694707|593613167|FG004|Overall Study|Jeopardizing Parole Status|0|||
164337884|NCT00694707|593613163|FG000|Overall Study|Death in the Family|1|||
164337885|NCT00694707|593613164|FG001|Overall Study|Death in the Family|0|||
164337886|NCT00694707|593613165|FG002|Overall Study|Death in the Family|0|||
164337887|NCT00694707|593613166|FG003|Overall Study|Death in the Family|0|||
164337888|NCT00694707|593613167|FG004|Overall Study|Death in the Family|0|||
164337889|NCT00694707|593613163|FG000|Overall Study|Arrest by Police|0|||
164337890|NCT00694707|593613164|FG001|Overall Study|Arrest by Police|1|||
164337891|NCT00694707|593613165|FG002|Overall Study|Arrest by Police|0|||
164337892|NCT00694707|593613166|FG003|Overall Study|Arrest by Police|0|||
164337893|NCT00694707|593613167|FG004|Overall Study|Arrest by Police|0|||
164337894|NCT00694707|593613163|FG000|Overall Study|Administrative Reasons|0|||
164337895|NCT00694707|593613164|FG001|Overall Study|Administrative Reasons|1|||
164337896|NCT00694707|593613165|FG002|Overall Study|Administrative Reasons|0|||
164337897|NCT00694707|593613166|FG003|Overall Study|Administrative Reasons|2|||
164337898|NCT00694707|593613167|FG004|Overall Study|Administrative Reasons|0|||
164337899|NCT00694707|593613163|FG000|Overall Study|Notification of Past Head Injury|0|||
164337900|NCT00694707|593613164|FG001|Overall Study|Notification of Past Head Injury|0|||
164337901|NCT00694707|593613165|FG002|Overall Study|Notification of Past Head Injury|0|||
164337902|NCT00694707|593613166|FG003|Overall Study|Notification of Past Head Injury|1|||
164337903|NCT00694707|593613167|FG004|Overall Study|Notification of Past Head Injury|0|||
164337904|NCT03096483|593613169|FG000|Overall Study|Withdrawal by site|1|||
164337905|NCT00369707|593613170|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
164337906|NCT00369707|593613170|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
164337907|NCT00369707|593613170|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
164337908|NCT00369707|593613170|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
164337909|NCT00369707|593613170|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
164337910|NCT00369707|593613170|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
164337911|NCT00369707|593613170|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
164246599|NCT01194219|593271819|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
164246600|NCT01194219|593271820|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
164246601|NCT01194219|593271821|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
164246602|NCT01194219|593271822|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
164246603|NCT01194219|593271823|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
164246604|NCT01194219|593271824|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
164246605|NCT01194219|593271825|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
164246606|NCT01194219|593271816|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
164246607|NCT01194219|593271817|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
164246608|NCT01194219|593271818|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
164246609|NCT01194219|593271819|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
164246610|NCT01194219|593271820|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
164246611|NCT01194219|593271821|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
164246612|NCT01194219|593271822|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
164246613|NCT01194219|593271823|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
164246614|NCT01194219|593271824|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
164246615|NCT01194219|593271825|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
164246616|NCT01194219|593271816|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
164246617|NCT01194219|593271817|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
164246618|NCT01194219|593271818|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
164246619|NCT01194219|593271819|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
164246620|NCT01194219|593271820|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
164246621|NCT01194219|593271821|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
164246622|NCT01194219|593271822|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
164246623|NCT01194219|593271823|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
164246624|NCT01194219|593271824|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
164246625|NCT01194219|593271825|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
164246626|NCT01194219|593271816|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
164246627|NCT01194219|593271817|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
164246628|NCT01194219|593271818|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
164246629|NCT01194219|593271819|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
164246630|NCT01194219|593271820|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
164246631|NCT01194219|593271821|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
164246632|NCT01194219|593271822|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
164246633|NCT01194219|593271823|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
164246634|NCT01194219|593271824|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
164246635|NCT01194219|593271825|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
164246636|NCT01194219|593271816|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
164246637|NCT01194219|593271817|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
164246638|NCT01194219|593271818|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
164246639|NCT01194219|593271819|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
164246640|NCT01194219|593271820|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
164246641|NCT01194219|593271821|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
164246642|NCT01194219|593271822|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
164246643|NCT01194219|593271823|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
164246644|NCT01194219|593271824|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
164246645|NCT01194219|593271825|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
164246646|NCT01194219|593271816|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
164246647|NCT01194219|593271817|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
164246648|NCT01194219|593271818|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
164246649|NCT01194219|593271819|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
164246650|NCT01194219|593271820|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
164246651|NCT01194219|593271821|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
164246652|NCT01194219|593271822|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
164246653|NCT01194219|593271823|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
164246654|NCT01194219|593271824|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
164246655|NCT01194219|593271825|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
164246656|NCT01194219|593271816|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
164246657|NCT01194219|593271817|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
164246658|NCT01194219|593271818|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
164246659|NCT01194219|593271819|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
164246660|NCT01194219|593271820|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
164246661|NCT01194219|593271821|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
164246662|NCT01194219|593271822|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
164246663|NCT01194219|593271823|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
164246664|NCT01194219|593271824|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
164426166|NCT04955626|593930834|FG023|Blinded Period|Refused further study procedures|0|||
164426167|NCT04955626|593930835|FG024|Blinded Period|Refused further study procedures|0|||
164426168|NCT04955626|593930836|FG025|Blinded Period|Refused further study procedures|0|||
164426169|NCT04955626|593930837|FG026|Blinded Period|Refused further study procedures|0|||
164426170|NCT04955626|593930838|FG027|Blinded Period|Refused further study procedures|0|||
164426171|NCT04955626|593930839|FG028|Blinded Period|Refused further study procedures|0|||
164426172|NCT04955626|593930840|FG029|Blinded Period|Refused further study procedures|0|||
164426173|NCT04955626|593930841|FG030|Blinded Period|Refused further study procedures|0|||
164426174|NCT04955626|593930842|FG031|Blinded Period|Refused further study procedures|0|||
164426175|NCT04955626|593930843|FG032|Blinded Period|Refused further study procedures|0|||
164426176|NCT04955626|593930844|FG033|Blinded Period|Refused further study procedures|0|||
164426177|NCT04955626|593930845|FG034|Blinded Period|Refused further study procedures|0|||
164426178|NCT04955626|593930846|FG035|Blinded Period|Refused further study procedures|0|||
164246665|NCT01194219|593271825|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
164246666|NCT01194219|593271816|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
164246667|NCT01194219|593271817|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
164246668|NCT01194219|593271818|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
164246669|NCT01194219|593271819|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
164246670|NCT01194219|593271820|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
164246671|NCT01194219|593271821|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
164246672|NCT01194219|593271822|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
164246673|NCT01194219|593271823|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
164246674|NCT01194219|593271824|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
164246675|NCT01194219|593271825|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
164246676|NCT01194219|593271816|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
164246677|NCT01194219|593271817|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
164246678|NCT01194219|593271818|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
164246679|NCT01194219|593271819|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
164246680|NCT01194219|593271820|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
164246681|NCT01194219|593271821|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
164246682|NCT01194219|593271822|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
164246683|NCT01194219|593271823|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
164246684|NCT01194219|593271824|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
164246685|NCT01194219|593271825|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
164246686|NCT01194219|593271816|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
164246687|NCT01194219|593271817|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
164246688|NCT01194219|593271818|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
164246689|NCT01194219|593271819|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
164246690|NCT01194219|593271820|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
164246691|NCT01194219|593271821|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
164246692|NCT01194219|593271822|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
164246693|NCT01194219|593271823|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
164246694|NCT01194219|593271824|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
164246695|NCT01194219|593271825|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
164337912|NCT00369707|593613170|FG000|Follow up for 2 Years After Treatment|Death|1|||
164337913|NCT00369707|593613170|FG000|Follow up for 2 Years After Treatment|Other|2|||
164337914|NCT05224141|593613171|FG000|Overall Study|Ongoing|75|||
164337915|NCT05224141|593613172|FG001|Overall Study|Ongoing|88|||
164337916|NCT05224141|593613171|FG000|Overall Study|Withdrawal by Subject|2|||
164337917|NCT05224141|593613172|FG001|Overall Study|Withdrawal by Subject|4|||
164337918|NCT05224141|593613171|FG000|Overall Study|Death|153|||
164337919|NCT05224141|593613172|FG001|Overall Study|Death|138|||
164337920|NCT02046733|593613173|FG000|Overall Study|never initiated 'treatment visits'|6|||
164337921|NCT02046733|593613174|FG001|Overall Study|never initiated 'treatment visits'|0|||
164337922|NCT04515394|593613185|FG000|Overall Study|Participant did not receive treatment|1|||
164337923|NCT00199875|593613186|FG000|Overall Study|Withdrawal by Subject|0|||
164337924|NCT00199875|593613187|FG001|Overall Study|Withdrawal by Subject|0|||
164426179|NCT04955626|593930811|FG000|Blinded Period|Participants entered open label period|4544|||
164426180|NCT04955626|593930812|FG001|Blinded Period|Participants entered open label period|4906|||
164426181|NCT04955626|593930813|FG002|Blinded Period|Participants entered open label period|0|||
164426182|NCT04955626|593930814|FG003|Blinded Period|Participants entered open label period|0|||
164426183|NCT04955626|593930815|FG004|Blinded Period|Participants entered open label period|0|||
164337925|NCT00199875|593613188|FG002|Overall Study|Withdrawal by Subject|0|||
164426184|NCT04955626|593930816|FG005|Blinded Period|Participants entered open label period|0|||
164246696|NCT01194219|593271816|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
164246697|NCT01194219|593271817|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
164337926|NCT00199875|593613189|FG003|Overall Study|Withdrawal by Subject|0|||
164337927|NCT00199875|593613190|FG004|Overall Study|Withdrawal by Subject|1|||
164337928|NCT01691898|593613192|FG000|Overall Study|Death|34|||
164426185|NCT04955626|593930817|FG006|Blinded Period|Participants entered open label period|0|||
164574734|NCT00097539|594468082|FG002|Overall Study|Death|0|||
164574735|NCT00097539|594468083|FG003|Overall Study|Death|0|||
164574736|NCT00097539|594468084|FG004|Overall Study|Death|1|||
164574737|NCT00097539|594468085|FG005|Overall Study|Death|3|||
164574738|NCT00097539|594468086|FG006|Overall Study|Death|0|||
164574739|NCT00097539|594468080|FG000|Overall Study|Reasons Other Than Above|3602|||
164574740|NCT00097539|594468081|FG001|Overall Study|Reasons Other Than Above|1382|||
164574741|NCT00097539|594468082|FG002|Overall Study|Reasons Other Than Above|1757|||
164574742|NCT00097539|594468083|FG003|Overall Study|Reasons Other Than Above|692|||
164574743|NCT00097539|594468084|FG004|Overall Study|Reasons Other Than Above|361|||
164574744|NCT00097539|594468085|FG005|Overall Study|Reasons Other Than Above|1244|||
164574745|NCT00097539|594468086|FG006|Overall Study|Reasons Other Than Above|34|||
164574746|NCT00097539|594468080|FG000|Overall Study|Reason not Specified|111|||
164574747|NCT00097539|594468081|FG001|Overall Study|Reason not Specified|49|||
164246698|NCT01194219|593271818|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
164246699|NCT01194219|593271819|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
164246700|NCT01194219|593271820|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
164246701|NCT01194219|593271821|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
164246702|NCT01194219|593271822|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
164246703|NCT01194219|593271823|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
164246704|NCT01194219|593271824|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
164246705|NCT01194219|593271825|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
164246706|NCT01081951|593271826|FG000|Overall Study|Death|54|||
164246707|NCT01081951|593271827|FG001|Overall Study|Death|47|||
164246708|NCT01081951|593271826|FG000|Overall Study|Withdrawal by Subject|2|||
164246709|NCT01081951|593271827|FG001|Overall Study|Withdrawal by Subject|6|||
164246710|NCT01081951|593271826|FG000|Overall Study|Allocated treatment but did not take it|0|||
164246711|NCT01081951|593271827|FG001|Overall Study|Allocated treatment but did not take it|1|||
164246712|NCT01081951|593271826|FG000|Overall Study|Lost to Follow-up|0|||
164246713|NCT01081951|593271827|FG001|Overall Study|Lost to Follow-up|1|||
164246714|NCT05226598|593271830|FG000|Overall Study|Death|186|||
164246715|NCT05226598|593271831|FG001|Overall Study|Death|191|||
164246716|NCT05226598|593271830|FG000|Overall Study|Withdrawal by Subject|6|||
164246717|NCT05226598|593271831|FG001|Overall Study|Withdrawal by Subject|6|||
164246718|NCT05226598|593271830|FG000|Overall Study|Ongoing|174|||
164246719|NCT05226598|593271831|FG001|Overall Study|Ongoing|176|||
164246720|NCT04503551|593271832|FG000|Overall Study|Withdrawal by Subject|5|||
164246721|NCT04503551|593271833|FG001|Overall Study|Withdrawal by Subject|3|||
164246722|NCT04503551|593271832|FG000|Overall Study|Physician Decision|1|||
164246723|NCT04503551|593271833|FG001|Overall Study|Physician Decision|0|||
164246724|NCT04503551|593271832|FG000|Overall Study|Death|0|||
164246725|NCT04503551|593271833|FG001|Overall Study|Death|1|||
164246726|NCT04503551|593271832|FG000|Overall Study|Lost to Follow-up|1|||
164246727|NCT04503551|593271833|FG001|Overall Study|Lost to Follow-up|2|||
164246728|NCT04503551|593271832|FG000|Overall Study|Ongoing at Week 52|99|||
164246729|NCT04503551|593271833|FG001|Overall Study|Ongoing at Week 52|62|||
164246730|NCT01871545|593271836|FG000|Overall Study|Death|2|||
164246731|NCT01871545|593271837|FG001|Overall Study|Death|0|||
164246732|NCT01871545|593271836|FG000|Overall Study|Lack of Efficacy|11|||
164246733|NCT01871545|593271837|FG001|Overall Study|Lack of Efficacy|2|||
164246734|NCT01871545|593271836|FG000|Overall Study|Physician Decision|4|||
164246735|NCT01871545|593271837|FG001|Overall Study|Physician Decision|0|||
164246736|NCT01871545|593271836|FG000|Overall Study|Withdrawal by Subject|0|||
164246737|NCT01871545|593271837|FG001|Overall Study|Withdrawal by Subject|1|||
164246738|NCT02569476|593271838|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
164246739|NCT02569476|593271838|FG000|Overall Study|Death|33|||
164246740|NCT02569476|593271838|FG000|Overall Study|Withdrawal by Subject|9|||
164246741|NCT02569476|593271838|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
164246742|NCT02569476|593271838|FG000|Overall Study|Palliative care|1|||
164246743|NCT02569476|593271838|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
164574748|NCT00097539|594468082|FG002|Overall Study|Reason not Specified|53|||
164679360|NCT00205777|594851145|FG005|Study Extension II|Failed to return|26|||
164679361|NCT00205777|594851140|FG000|Study Extension II|Other Event|0|||
164679362|NCT00205777|594851141|FG001|Study Extension II|Other Event|0|||
164246744|NCT02569476|593271838|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
164246745|NCT01071954|593271839|FG000|Overall Study|Noncompliance|4|||
164246746|NCT01071954|593271839|FG000|Overall Study|Adverse Event|1|||
164246747|NCT01071954|593271839|FG000|Overall Study|Withdrawal by Subject|11|||
164246748|NCT01071954|593271839|FG000|Overall Study|Requirement for Alternative Therapy|5|||
164246749|NCT01071954|593271839|FG000|Overall Study|Administrative Decision|5|||
164246750|NCT01071954|593271839|FG000|Overall Study|Protocol Specified Criteria|1|||
164246751|NCT01152788|593271840|FG000|Overall Study|Withdrawal by Subject|0|||
164246752|NCT01152788|593271841|FG001|Overall Study|Withdrawal by Subject|3|||
164246753|NCT01152788|593271840|FG000|Overall Study|No treatment|0|||
164246754|NCT01152788|593271841|FG001|Overall Study|No treatment|1|||
164246755|NCT00778336|593271844|FG000|Index Procedure-Discharge|Death|6|||
164574749|NCT00097539|594468083|FG003|Overall Study|Reason not Specified|21|||
164426186|NCT04955626|593930818|FG007|Blinded Period|Participants entered open label period|0|||
164426187|NCT04955626|593930819|FG008|Blinded Period|Participants entered open label period|0|||
164426188|NCT04955626|593930820|FG009|Blinded Period|Participants entered open label period|0|||
164426189|NCT04955626|593930821|FG010|Blinded Period|Participants entered open label period|0|||
164426190|NCT04955626|593930822|FG011|Blinded Period|Participants entered open label period|0|||
164426191|NCT04955626|593930823|FG012|Blinded Period|Participants entered open label period|0|||
164426192|NCT04955626|593930824|FG013|Blinded Period|Participants entered open label period|0|||
164426193|NCT04955626|593930825|FG014|Blinded Period|Participants entered open label period|0|||
164426194|NCT04955626|593930826|FG015|Blinded Period|Participants entered open label period|0|||
164246756|NCT00778336|593271845|FG001|Index Procedure-Discharge|Death|3|||
164426195|NCT04955626|593930827|FG016|Blinded Period|Participants entered open label period|0|||
164426196|NCT04955626|593930828|FG017|Blinded Period|Participants entered open label period|0|||
164426197|NCT04955626|593930829|FG018|Blinded Period|Participants entered open label period|0|||
164426198|NCT04955626|593930830|FG019|Blinded Period|Participants entered open label period|0|||
164426199|NCT04955626|593930831|FG020|Blinded Period|Participants entered open label period|0|||
164426200|NCT04955626|593930832|FG021|Blinded Period|Participants entered open label period|0|||
164426201|NCT04955626|593930833|FG022|Blinded Period|Participants entered open label period|0|||
164426202|NCT04955626|593930834|FG023|Blinded Period|Participants entered open label period|0|||
164426203|NCT04955626|593930835|FG024|Blinded Period|Participants entered open label period|0|||
164426204|NCT04955626|593930836|FG025|Blinded Period|Participants entered open label period|0|||
164426205|NCT04955626|593930837|FG026|Blinded Period|Participants entered open label period|0|||
164426206|NCT04955626|593930838|FG027|Blinded Period|Participants entered open label period|0|||
164426207|NCT04955626|593930839|FG028|Blinded Period|Participants entered open label period|0|||
164426208|NCT04955626|593930840|FG029|Blinded Period|Participants entered open label period|0|||
164426209|NCT04955626|593930841|FG030|Blinded Period|Participants entered open label period|0|||
164426210|NCT04955626|593930842|FG031|Blinded Period|Participants entered open label period|0|||
164426211|NCT04955626|593930843|FG032|Blinded Period|Participants entered open label period|0|||
164426212|NCT04955626|593930844|FG033|Blinded Period|Participants entered open label period|0|||
164426213|NCT04955626|593930845|FG034|Blinded Period|Participants entered open label period|0|||
164426214|NCT04955626|593930846|FG035|Blinded Period|Participants entered open label period|0|||
164426215|NCT04955626|593930811|FG000|Blinded Period|Withdrawal by parent/guardian|0|||
164426216|NCT04955626|593930812|FG001|Blinded Period|Withdrawal by parent/guardian|0|||
164426217|NCT04955626|593930813|FG002|Blinded Period|Withdrawal by parent/guardian|1|||
164426218|NCT04955626|593930814|FG003|Blinded Period|Withdrawal by parent/guardian|1|||
164426219|NCT04955626|593930815|FG004|Blinded Period|Withdrawal by parent/guardian|0|||
164426220|NCT04955626|593930816|FG005|Blinded Period|Withdrawal by parent/guardian|1|||
164426221|NCT04955626|593930817|FG006|Blinded Period|Withdrawal by parent/guardian|0|||
164426222|NCT04955626|593930818|FG007|Blinded Period|Withdrawal by parent/guardian|0|||
164426223|NCT04955626|593930819|FG008|Blinded Period|Withdrawal by parent/guardian|0|||
164426224|NCT04955626|593930820|FG009|Blinded Period|Withdrawal by parent/guardian|0|||
164426225|NCT04955626|593930821|FG010|Blinded Period|Withdrawal by parent/guardian|0|||
164426226|NCT04955626|593930822|FG011|Blinded Period|Withdrawal by parent/guardian|0|||
164426227|NCT04955626|593930823|FG012|Blinded Period|Withdrawal by parent/guardian|0|||
164426228|NCT04955626|593930824|FG013|Blinded Period|Withdrawal by parent/guardian|0|||
164426229|NCT04955626|593930825|FG014|Blinded Period|Withdrawal by parent/guardian|0|||
164426230|NCT04955626|593930826|FG015|Blinded Period|Withdrawal by parent/guardian|0|||
164246757|NCT00778336|593271846|FG002|Index Procedure-Discharge|Death|2|||
164246758|NCT00778336|593271847|FG003|Index Procedure-Discharge|Death|0|||
164246759|NCT00778336|593271844|FG000|3 Month Follow Up|Lost to Follow-up|15|||
164246760|NCT00778336|593271845|FG001|3 Month Follow Up|Lost to Follow-up|20|||
164246761|NCT00778336|593271846|FG002|3 Month Follow Up|Lost to Follow-up|3|||
164246762|NCT00778336|593271847|FG003|3 Month Follow Up|Lost to Follow-up|0|||
164246763|NCT00778336|593271844|FG000|3 Month Follow Up|Death|8|||
164246764|NCT00778336|593271845|FG001|3 Month Follow Up|Death|3|||
164246765|NCT00778336|593271846|FG002|3 Month Follow Up|Death|2|||
164246766|NCT00778336|593271847|FG003|3 Month Follow Up|Death|0|||
164426231|NCT04955626|593930827|FG016|Blinded Period|Withdrawal by parent/guardian|0|||
164246767|NCT04585269|593271848|FG000|Intervention|Withdrawal by Subject|9|||
164426232|NCT04955626|593930828|FG017|Blinded Period|Withdrawal by parent/guardian|0|||
164426233|NCT04955626|593930829|FG018|Blinded Period|Withdrawal by parent/guardian|0|||
164426234|NCT04955626|593930830|FG019|Blinded Period|Withdrawal by parent/guardian|0|||
164246768|NCT04585269|593271849|FG001|Intervention|Withdrawal by Subject|0|||
164246769|NCT04585269|593271848|FG000|Intervention|Unable to schedule|15|||
164246770|NCT04585269|593271849|FG001|Intervention|Unable to schedule|0|||
164246771|NCT04585269|593271848|FG000|Intervention|Started but did not finish (<4 sessions)|24|||
164246772|NCT04585269|593271849|FG001|Intervention|Started but did not finish (<4 sessions)|0|||
164426235|NCT04955626|593930831|FG020|Blinded Period|Withdrawal by parent/guardian|0|||
164426236|NCT04955626|593930832|FG021|Blinded Period|Withdrawal by parent/guardian|0|||
164426237|NCT04955626|593930833|FG022|Blinded Period|Withdrawal by parent/guardian|0|||
164426238|NCT04955626|593930834|FG023|Blinded Period|Withdrawal by parent/guardian|0|||
164426239|NCT04955626|593930835|FG024|Blinded Period|Withdrawal by parent/guardian|0|||
164426240|NCT04955626|593930836|FG025|Blinded Period|Withdrawal by parent/guardian|0|||
164426241|NCT04955626|593930837|FG026|Blinded Period|Withdrawal by parent/guardian|0|||
164426242|NCT04955626|593930838|FG027|Blinded Period|Withdrawal by parent/guardian|0|||
164426243|NCT04955626|593930839|FG028|Blinded Period|Withdrawal by parent/guardian|0|||
164426244|NCT04955626|593930840|FG029|Blinded Period|Withdrawal by parent/guardian|0|||
164426245|NCT04955626|593930841|FG030|Blinded Period|Withdrawal by parent/guardian|0|||
164426246|NCT04955626|593930842|FG031|Blinded Period|Withdrawal by parent/guardian|0|||
164426247|NCT04955626|593930843|FG032|Blinded Period|Withdrawal by parent/guardian|0|||
164426248|NCT04955626|593930844|FG033|Blinded Period|Withdrawal by parent/guardian|0|||
164426249|NCT04955626|593930845|FG034|Blinded Period|Withdrawal by parent/guardian|0|||
164426250|NCT04955626|593930846|FG035|Blinded Period|Withdrawal by parent/guardian|0|||
164426251|NCT04955626|593930811|FG000|Blinded Period|Medication error|0|||
164426252|NCT04955626|593930812|FG001|Blinded Period|Medication error|0|||
164426253|NCT04955626|593930813|FG002|Blinded Period|Medication error|0|||
164426254|NCT04955626|593930814|FG003|Blinded Period|Medication error|0|||
164426255|NCT04955626|593930815|FG004|Blinded Period|Medication error|0|||
164426256|NCT04955626|593930816|FG005|Blinded Period|Medication error|0|||
164426257|NCT04955626|593930817|FG006|Blinded Period|Medication error|0|||
164426258|NCT04955626|593930818|FG007|Blinded Period|Medication error|0|||
164426259|NCT04955626|593930819|FG008|Blinded Period|Medication error|0|||
164426260|NCT04955626|593930820|FG009|Blinded Period|Medication error|0|||
164426261|NCT04955626|593930821|FG010|Blinded Period|Medication error|2|||
164426262|NCT04955626|593930822|FG011|Blinded Period|Medication error|0|||
164426263|NCT04955626|593930823|FG012|Blinded Period|Medication error|0|||
164426264|NCT04955626|593930824|FG013|Blinded Period|Medication error|0|||
164426265|NCT04955626|593930825|FG014|Blinded Period|Medication error|0|||
164426266|NCT04955626|593930826|FG015|Blinded Period|Medication error|0|||
164426267|NCT04955626|593930827|FG016|Blinded Period|Medication error|0|||
164246773|NCT04585269|593271848|FG000|FU Time 2 (3 months)|Death|2|||
164246774|NCT04585269|593271849|FG001|FU Time 2 (3 months)|Death|2|||
164246775|NCT04585269|593271848|FG000|FU Time 2 (3 months)|Lost to Follow-up|14|||
164246776|NCT04585269|593271849|FG001|FU Time 2 (3 months)|Lost to Follow-up|17|||
164246777|NCT04585269|593271848|FG000|FU Time 2 (3 months)|Withdrawal by Subject|4|||
164246778|NCT04585269|593271849|FG001|FU Time 2 (3 months)|Withdrawal by Subject|0|||
164246779|NCT04585269|593271848|FG000|FU Time 3 (6 months) Primary outcomes|Death|4|||
164246780|NCT04585269|593271849|FG001|FU Time 3 (6 months) Primary outcomes|Death|1|||
164246781|NCT04585269|593271848|FG000|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|16|||
164246782|NCT04585269|593271849|FG001|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|24|||
164246783|NCT04585269|593271848|FG000|FU Time 3 (6 months) Primary outcomes|Physician Decision|2|||
164246784|NCT04585269|593271849|FG001|FU Time 3 (6 months) Primary outcomes|Physician Decision|0|||
164246785|NCT03307785|593271852|FG000|Main Study: Part A: Up to 28.5 Months|Disease progression|2|||
164246786|NCT03307785|593271853|FG001|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
164246787|NCT03307785|593271854|FG002|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
164246788|NCT03307785|593271855|FG003|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
164246789|NCT03307785|593271856|FG004|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
164426268|NCT04955626|593930828|FG017|Blinded Period|Medication error|0|||
164426269|NCT04955626|593930829|FG018|Blinded Period|Medication error|0|||
164426270|NCT04955626|593930830|FG019|Blinded Period|Medication error|0|||
164426271|NCT04955626|593930831|FG020|Blinded Period|Medication error|0|||
164426272|NCT04955626|593930832|FG021|Blinded Period|Medication error|0|||
164426273|NCT04955626|593930833|FG022|Blinded Period|Medication error|0|||
164426274|NCT04955626|593930834|FG023|Blinded Period|Medication error|0|||
164426275|NCT04955626|593930835|FG024|Blinded Period|Medication error|0|||
164426276|NCT04955626|593930836|FG025|Blinded Period|Medication error|0|||
164426277|NCT04955626|593930837|FG026|Blinded Period|Medication error|0|||
164426278|NCT04955626|593930838|FG027|Blinded Period|Medication error|0|||
164246790|NCT03307785|593271857|FG005|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
164246791|NCT03307785|593271858|FG006|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
164246792|NCT03307785|593271859|FG007|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
164246793|NCT03307785|593271860|FG008|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
164426279|NCT04955626|593930839|FG028|Blinded Period|Medication error|4|||
164426280|NCT04955626|593930840|FG029|Blinded Period|Medication error|0|||
164426281|NCT04955626|593930841|FG030|Blinded Period|Medication error|0|||
164426282|NCT04955626|593930842|FG031|Blinded Period|Medication error|0|||
164426283|NCT04955626|593930843|FG032|Blinded Period|Medication error|0|||
164426284|NCT04955626|593930844|FG033|Blinded Period|Medication error|0|||
164426285|NCT04955626|593930845|FG034|Blinded Period|Medication error|0|||
164246794|NCT03307785|593271861|FG009|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
164246795|NCT03307785|593271862|FG010|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
164426286|NCT04955626|593930846|FG035|Blinded Period|Medication error|0|||
164426287|NCT04955626|593930811|FG000|Open-Label Period|Lost to Follow-up|109|||
164426288|NCT04955626|593930812|FG001|Open-Label Period|Lost to Follow-up|41|||
164426289|NCT04955626|593930813|FG002|Open-Label Period|Lost to Follow-up|0|||
164426290|NCT04955626|593930814|FG003|Open-Label Period|Lost to Follow-up|0|||
164246796|NCT03307785|593271863|FG011|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
164246797|NCT03307785|593271864|FG012|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
164246798|NCT03307785|593271852|FG000|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
164246799|NCT03307785|593271853|FG001|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
164246800|NCT03307785|593271854|FG002|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
164246801|NCT03307785|593271855|FG003|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
164246802|NCT03307785|593271856|FG004|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
164246803|NCT03307785|593271857|FG005|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
164246804|NCT03307785|593271858|FG006|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
164246805|NCT03307785|593271859|FG007|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
164246806|NCT03307785|593271860|FG008|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
164246807|NCT03307785|593271861|FG009|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
164246808|NCT03307785|593271862|FG010|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
164246809|NCT03307785|593271863|FG011|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
164246810|NCT03307785|593271864|FG012|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
164246811|NCT03307785|593271852|FG000|Main Study: Part A: Up to 28.5 Months|Death|4|||
164246812|NCT03307785|593271853|FG001|Main Study: Part A: Up to 28.5 Months|Death|4|||
164246813|NCT03307785|593271854|FG002|Main Study: Part A: Up to 28.5 Months|Death|0|||
164246814|NCT03307785|593271855|FG003|Main Study: Part A: Up to 28.5 Months|Death|0|||
164246815|NCT03307785|593271856|FG004|Main Study: Part A: Up to 28.5 Months|Death|0|||
164246816|NCT03307785|593271857|FG005|Main Study: Part A: Up to 28.5 Months|Death|0|||
164246817|NCT03307785|593271858|FG006|Main Study: Part A: Up to 28.5 Months|Death|0|||
164246818|NCT03307785|593271859|FG007|Main Study: Part A: Up to 28.5 Months|Death|0|||
164246819|NCT03307785|593271860|FG008|Main Study: Part A: Up to 28.5 Months|Death|0|||
164246820|NCT03307785|593271861|FG009|Main Study: Part A: Up to 28.5 Months|Death|0|||
164246821|NCT03307785|593271862|FG010|Main Study: Part A: Up to 28.5 Months|Death|0|||
164246822|NCT03307785|593271863|FG011|Main Study: Part A: Up to 28.5 Months|Death|0|||
164246823|NCT03307785|593271864|FG012|Main Study: Part A: Up to 28.5 Months|Death|0|||
164246824|NCT03307785|593271852|FG000|Main Study: Part A: Up to 28.5 Months|Physician Decision|3|||
164246825|NCT03307785|593271853|FG001|Main Study: Part A: Up to 28.5 Months|Physician Decision|1|||
164246826|NCT03307785|593271854|FG002|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
164246827|NCT03307785|593271855|FG003|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
164246828|NCT03307785|593271856|FG004|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
164246829|NCT03307785|593271857|FG005|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
164246830|NCT03307785|593271858|FG006|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
164246831|NCT03307785|593271859|FG007|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
164246832|NCT03307785|593271860|FG008|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
164246833|NCT03307785|593271861|FG009|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
164246834|NCT03307785|593271862|FG010|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
164246835|NCT03307785|593271863|FG011|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
164246836|NCT03307785|593271864|FG012|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
164246837|NCT03307785|593271852|FG000|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
164246838|NCT03307785|593271853|FG001|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
164246839|NCT03307785|593271854|FG002|MainStudy: PartB: Up to Approx.66months|Disease progression|2|||
164246840|NCT03307785|593271855|FG003|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
164246841|NCT03307785|593271856|FG004|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
164246842|NCT03307785|593271857|FG005|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
164246843|NCT03307785|593271858|FG006|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
164246844|NCT03307785|593271859|FG007|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
164246845|NCT03307785|593271860|FG008|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
164246846|NCT03307785|593271861|FG009|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
164246847|NCT03307785|593271862|FG010|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
164246848|NCT03307785|593271863|FG011|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
164246849|NCT03307785|593271864|FG012|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
164337929|NCT01691898|593613193|FG001|Overall Study|Death|32|||
164337930|NCT01691898|593613194|FG002|Overall Study|Death|6|||
164337931|NCT01691898|593613195|FG003|Overall Study|Death|3|||
164337932|NCT01691898|593613196|FG004|Overall Study|Death|8|||
164337933|NCT01691898|593613197|FG005|Overall Study|Death|31|||
164337934|NCT01691898|593613192|FG000|Overall Study|Adverse Event|0|||
164337935|NCT01691898|593613193|FG001|Overall Study|Adverse Event|1|||
164246850|NCT03307785|593271852|FG000|MainStudy: PartB: Up to Approx.66months|Death|0|||
164246851|NCT03307785|593271853|FG001|MainStudy: PartB: Up to Approx.66months|Death|0|||
164246852|NCT03307785|593271854|FG002|MainStudy: PartB: Up to Approx.66months|Death|7|||
164337936|NCT01691898|593613194|FG002|Overall Study|Adverse Event|0|||
164337937|NCT01691898|593613195|FG003|Overall Study|Adverse Event|1|||
164337938|NCT01691898|593613196|FG004|Overall Study|Adverse Event|1|||
164246853|NCT03307785|593271855|FG003|MainStudy: PartB: Up to Approx.66months|Death|0|||
164246854|NCT03307785|593271856|FG004|MainStudy: PartB: Up to Approx.66months|Death|0|||
164246855|NCT03307785|593271857|FG005|MainStudy: PartB: Up to Approx.66months|Death|0|||
164246856|NCT03307785|593271858|FG006|MainStudy: PartB: Up to Approx.66months|Death|0|||
164426291|NCT04955626|593930815|FG004|Open-Label Period|Lost to Follow-up|0|||
164426292|NCT04955626|593930816|FG005|Open-Label Period|Lost to Follow-up|0|||
164426293|NCT04955626|593930817|FG006|Open-Label Period|Lost to Follow-up|0|||
164426294|NCT04955626|593930818|FG007|Open-Label Period|Lost to Follow-up|0|||
164426295|NCT04955626|593930819|FG008|Open-Label Period|Lost to Follow-up|0|||
164426296|NCT04955626|593930820|FG009|Open-Label Period|Lost to Follow-up|0|||
164426297|NCT04955626|593930821|FG010|Open-Label Period|Lost to Follow-up|0|||
164426298|NCT04955626|593930822|FG011|Open-Label Period|Lost to Follow-up|0|||
164246857|NCT03307785|593271859|FG007|MainStudy: PartB: Up to Approx.66months|Death|0|||
164246858|NCT03307785|593271860|FG008|MainStudy: PartB: Up to Approx.66months|Death|0|||
164246859|NCT03307785|593271861|FG009|MainStudy: PartB: Up to Approx.66months|Death|0|||
164246860|NCT03307785|593271862|FG010|MainStudy: PartB: Up to Approx.66months|Death|0|||
164246861|NCT03307785|593271863|FG011|MainStudy: PartB: Up to Approx.66months|Death|0|||
164246862|NCT03307785|593271864|FG012|MainStudy: PartB: Up to Approx.66months|Death|0|||
164246863|NCT03307785|593271852|FG000|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
164246864|NCT03307785|593271853|FG001|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
164246865|NCT03307785|593271854|FG002|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|2|||
164246866|NCT03307785|593271855|FG003|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
164246867|NCT03307785|593271856|FG004|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
164246868|NCT03307785|593271857|FG005|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
164246869|NCT03307785|593271858|FG006|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
164246870|NCT03307785|593271859|FG007|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
164246871|NCT03307785|593271860|FG008|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
164246872|NCT03307785|593271861|FG009|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
164246873|NCT03307785|593271862|FG010|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
164246874|NCT03307785|593271863|FG011|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
164246875|NCT03307785|593271864|FG012|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
164246876|NCT03307785|593271852|FG000|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
164246877|NCT03307785|593271853|FG001|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
164246878|NCT03307785|593271854|FG002|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|2|||
164246879|NCT03307785|593271855|FG003|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
164246880|NCT03307785|593271856|FG004|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
164246881|NCT03307785|593271857|FG005|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
164246882|NCT03307785|593271858|FG006|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
164246883|NCT03307785|593271859|FG007|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
164246884|NCT03307785|593271860|FG008|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
164246885|NCT03307785|593271861|FG009|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
164246886|NCT03307785|593271862|FG010|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
164246887|NCT03307785|593271863|FG011|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
164246888|NCT03307785|593271864|FG012|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
164246889|NCT03307785|593271852|FG000|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
164246890|NCT03307785|593271853|FG001|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
164337939|NCT01691898|593613197|FG005|Overall Study|Adverse Event|0|||
164337940|NCT01691898|593613192|FG000|Overall Study|Progression of Disease|1|||
164337941|NCT01691898|593613193|FG001|Overall Study|Progression of Disease|2|||
164337942|NCT01691898|593613194|FG002|Overall Study|Progression of Disease|1|||
164337943|NCT01691898|593613195|FG003|Overall Study|Progression of Disease|0|||
164337944|NCT01691898|593613196|FG004|Overall Study|Progression of Disease|0|||
164337945|NCT01691898|593613197|FG005|Overall Study|Progression of Disease|1|||
164337946|NCT01691898|593613192|FG000|Overall Study|Lost to Follow-up|3|||
164337947|NCT01691898|593613193|FG001|Overall Study|Lost to Follow-up|1|||
164426299|NCT04955626|593930823|FG012|Open-Label Period|Lost to Follow-up|0|||
164426300|NCT04955626|593930824|FG013|Open-Label Period|Lost to Follow-up|0|||
164426301|NCT04955626|593930825|FG014|Open-Label Period|Lost to Follow-up|0|||
164426302|NCT04955626|593930826|FG015|Open-Label Period|Lost to Follow-up|0|||
164426303|NCT04955626|593930827|FG016|Open-Label Period|Lost to Follow-up|0|||
164426304|NCT04955626|593930828|FG017|Open-Label Period|Lost to Follow-up|0|||
164246891|NCT03307785|593271854|FG002|MainStudy: PartB: Up to Approx.66months|Physician Decision|1|||
164337948|NCT01691898|593613194|FG002|Overall Study|Lost to Follow-up|0|||
164337949|NCT01691898|593613195|FG003|Overall Study|Lost to Follow-up|0|||
164426305|NCT04955626|593930829|FG018|Open-Label Period|Lost to Follow-up|0|||
164426306|NCT04955626|593930830|FG019|Open-Label Period|Lost to Follow-up|0|||
164574750|NCT00097539|594468084|FG004|Overall Study|Reason not Specified|11|||
164574751|NCT00097539|594468085|FG005|Overall Study|Reason not Specified|40|||
164574752|NCT00097539|594468086|FG006|Overall Study|Reason not Specified|2|||
164574753|NCT04938648|594468087|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
164574754|NCT04938648|594468088|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
164574755|NCT04938648|594468087|FG000|Overall Study|Patient too ill|0|||
164574756|NCT04938648|594468088|FG001|Overall Study|Patient too ill|1|||
164574757|NCT04938648|594468087|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
164574758|NCT04938648|594468088|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
164574759|NCT04938648|594468087|FG000|Overall Study|Patient did not have memory problems|1|||
164574760|NCT04938648|594468088|FG001|Overall Study|Patient did not have memory problems|1|||
164574761|NCT04938648|594468087|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
164574762|NCT04938648|594468088|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
164574763|NCT04938648|594468087|FG000|Overall Study|Care partner could not be reached|0|||
164574764|NCT04938648|594468088|FG001|Overall Study|Care partner could not be reached|1|||
164574765|NCT04938648|594468087|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
164574766|NCT04938648|594468088|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
164574767|NCT04938648|594468087|FG000|Overall Study|Withdrawal by Subject|2|||
164574768|NCT04938648|594468088|FG001|Overall Study|Withdrawal by Subject|1|||
164574769|NCT00364793|594468089|FG000|Overall Study|Adverse Event|2|||
164574770|NCT00364793|594468090|FG001|Overall Study|Adverse Event|0|||
164574771|NCT00364793|594468091|FG002|Overall Study|Adverse Event|0|||
164574772|NCT00364793|594468092|FG003|Overall Study|Adverse Event|0|||
164574773|NCT00364793|594468089|FG000|Overall Study|Death|1|||
164246892|NCT03307785|593271855|FG003|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
164574774|NCT00364793|594468090|FG001|Overall Study|Death|0|||
164337950|NCT01691898|593613196|FG004|Overall Study|Lost to Follow-up|1|||
164337951|NCT01691898|593613197|FG005|Overall Study|Lost to Follow-up|0|||
164337952|NCT01691898|593613192|FG000|Overall Study|Withdrawal by Subject|9|||
164337953|NCT01691898|593613193|FG001|Overall Study|Withdrawal by Subject|8|||
164337954|NCT01691898|593613194|FG002|Overall Study|Withdrawal by Subject|2|||
164337955|NCT01691898|593613195|FG003|Overall Study|Withdrawal by Subject|1|||
164337956|NCT01691898|593613196|FG004|Overall Study|Withdrawal by Subject|3|||
164337957|NCT01691898|593613197|FG005|Overall Study|Withdrawal by Subject|3|||
164337958|NCT01691898|593613192|FG000|Overall Study|Non-Compliance|0|||
164337959|NCT01691898|593613193|FG001|Overall Study|Non-Compliance|0|||
164337960|NCT01691898|593613194|FG002|Overall Study|Non-Compliance|0|||
164337961|NCT01691898|593613195|FG003|Overall Study|Non-Compliance|0|||
164337962|NCT01691898|593613196|FG004|Overall Study|Non-Compliance|1|||
164337963|NCT01691898|593613197|FG005|Overall Study|Non-Compliance|0|||
164337964|NCT01013350|593613198|FG000|Overall Study|Lost to Follow-up|15|||
164337965|NCT01013350|593613199|FG001|Overall Study|Lost to Follow-up|95|||
164337966|NCT01013350|593613198|FG000|Overall Study|Adverse Event|0|||
164337967|NCT01013350|593613199|FG001|Overall Study|Adverse Event|1|||
164337968|NCT01013350|593613198|FG000|Overall Study|Physician Decision|4|||
164337969|NCT01013350|593613199|FG001|Overall Study|Physician Decision|20|||
164337970|NCT01013350|593613198|FG000|Overall Study|Withdrawal by Subject|15|||
164337971|NCT01013350|593613199|FG001|Overall Study|Withdrawal by Subject|38|||
164337972|NCT01013350|593613198|FG000|Overall Study|Death|3|||
164337973|NCT01013350|593613199|FG001|Overall Study|Death|5|||
164337974|NCT01013350|593613198|FG000|Overall Study|Participant entered interventional study|0|||
164337975|NCT01013350|593613199|FG001|Overall Study|Participant entered interventional study|8|||
164337976|NCT01013350|593613198|FG000|Overall Study|Other|1|||
164337977|NCT01013350|593613199|FG001|Overall Study|Other|25|||
164337978|NCT02019277|593613200|FG000|Overall Study|Withdrawal by Subject|3|||
164337979|NCT02019277|593613200|FG000|Overall Study|Death|7|||
164337980|NCT02019277|593613200|FG000|Overall Study|Did no Cooperate|1|||
164337981|NCT02019277|593613200|FG000|Overall Study|Adverse Event|1|||
164337982|NCT03725852|593613201|FG000|Overall Study|Death|1|||
164337983|NCT03725852|593613202|FG001|Overall Study|Death|0|||
164337984|NCT03725852|593613201|FG000|Overall Study|Withdrawal by Subject|1|||
164337985|NCT03725852|593613202|FG001|Overall Study|Withdrawal by Subject|0|||
164337986|NCT03725852|593613201|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
164337987|NCT03725852|593613202|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
164337988|NCT01787331|593613206|FG000|Overall Study|Physician Decision|1|||
164337989|NCT01787331|593613206|FG000|Overall Study|Withdrawal by Subject|1|||
164337990|NCT01999868|593613207|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
164337991|NCT01999868|593613208|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
164337992|NCT01999868|593613209|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
164337993|NCT01999868|593613207|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
164337994|NCT01999868|593613208|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
164337995|NCT01999868|593613209|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
164337996|NCT01999868|593613207|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
164574775|NCT00364793|594468091|FG002|Overall Study|Death|1|||
164246893|NCT03307785|593271856|FG004|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
164246894|NCT03307785|593271857|FG005|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
164246895|NCT03307785|593271858|FG006|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
164246896|NCT03307785|593271859|FG007|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
164246897|NCT03307785|593271860|FG008|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
164246898|NCT03307785|593271861|FG009|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
164246899|NCT03307785|593271862|FG010|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
164246900|NCT03307785|593271863|FG011|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
164246901|NCT03307785|593271864|FG012|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
164246902|NCT03307785|593271852|FG000|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
164246903|NCT03307785|593271853|FG001|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
164246904|NCT03307785|593271854|FG002|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
164246905|NCT03307785|593271855|FG003|MainStudy: PartC:Up to Approx.60months|Physician Decision|3|||
164246906|NCT03307785|593271856|FG004|MainStudy: PartC:Up to Approx.60months|Physician Decision|1|||
164246907|NCT03307785|593271857|FG005|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
164246908|NCT03307785|593271858|FG006|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
164246909|NCT03307785|593271859|FG007|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
164246910|NCT03307785|593271860|FG008|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
164246911|NCT03307785|593271861|FG009|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
164246912|NCT03307785|593271862|FG010|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
164246913|NCT03307785|593271863|FG011|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
164246914|NCT03307785|593271864|FG012|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
164246915|NCT03307785|593271852|FG000|MainStudy: PartC:Up to Approx.60months|Death|0|||
164246916|NCT03307785|593271853|FG001|MainStudy: PartC:Up to Approx.60months|Death|0|||
164246917|NCT03307785|593271854|FG002|MainStudy: PartC:Up to Approx.60months|Death|0|||
164246918|NCT03307785|593271855|FG003|MainStudy: PartC:Up to Approx.60months|Death|2|||
164246919|NCT03307785|593271856|FG004|MainStudy: PartC:Up to Approx.60months|Death|5|||
164246920|NCT03307785|593271857|FG005|MainStudy: PartC:Up to Approx.60months|Death|0|||
164246921|NCT03307785|593271858|FG006|MainStudy: PartC:Up to Approx.60months|Death|0|||
164246922|NCT03307785|593271859|FG007|MainStudy: PartC:Up to Approx.60months|Death|0|||
164337997|NCT01999868|593613208|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
164337998|NCT01999868|593613209|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
164337999|NCT01999868|593613207|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
164338000|NCT01999868|593613208|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
164338001|NCT01999868|593613209|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
164338002|NCT01999868|593613207|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
164338003|NCT01999868|593613208|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
164338004|NCT01999868|593613209|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
164338005|NCT01999868|593613207|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
164338006|NCT01999868|593613208|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
164338007|NCT01999868|593613209|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
164338008|NCT01999868|593613207|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
164338009|NCT01999868|593613208|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
164338010|NCT01999868|593613209|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
164338011|NCT01999868|593613207|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
164338012|NCT01999868|593613208|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
164338013|NCT01999868|593613209|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
164338014|NCT01999868|593613207|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
164338015|NCT01999868|593613208|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
164338016|NCT01999868|593613209|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
164338017|NCT01999868|593613207|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
164338018|NCT01999868|593613208|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
164338019|NCT01999868|593613209|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
164338020|NCT01999868|593613207|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
164338021|NCT01999868|593613208|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
164338022|NCT01999868|593613209|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
164338023|NCT01999868|593613207|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
164338024|NCT01999868|593613208|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
164338025|NCT01999868|593613209|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
164338026|NCT01999868|593613207|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
164246923|NCT03307785|593271860|FG008|MainStudy: PartC:Up to Approx.60months|Death|0|||
164246924|NCT03307785|593271861|FG009|MainStudy: PartC:Up to Approx.60months|Death|0|||
164246925|NCT03307785|593271862|FG010|MainStudy: PartC:Up to Approx.60months|Death|0|||
164574776|NCT00364793|594468092|FG003|Overall Study|Death|0|||
164574777|NCT00364793|594468089|FG000|Overall Study|Lack of Efficacy|3|||
164574778|NCT00364793|594468090|FG001|Overall Study|Lack of Efficacy|3|||
164574779|NCT00364793|594468091|FG002|Overall Study|Lack of Efficacy|1|||
164574780|NCT00364793|594468092|FG003|Overall Study|Lack of Efficacy|1|||
164574781|NCT00364793|594468089|FG000|Overall Study|Lost to Follow-up|1|||
164574782|NCT00364793|594468090|FG001|Overall Study|Lost to Follow-up|0|||
164574783|NCT00364793|594468091|FG002|Overall Study|Lost to Follow-up|2|||
164574784|NCT00364793|594468092|FG003|Overall Study|Lost to Follow-up|0|||
164574785|NCT00364793|594468089|FG000|Overall Study|Poor or non-compliance|1|||
164574786|NCT00364793|594468090|FG001|Overall Study|Poor or non-compliance|1|||
164679363|NCT00205777|594851142|FG002|Study Extension II|Other Event|0|||
164679364|NCT00205777|594851143|FG003|Study Extension II|Other Event|12|||
164679365|NCT00205777|594851144|FG004|Study Extension II|Other Event|0|||
164679366|NCT00205777|594851145|FG005|Study Extension II|Other Event|20|||
164574787|NCT00364793|594468091|FG002|Overall Study|Poor or non-compliance|0|||
164574788|NCT00364793|594468092|FG003|Overall Study|Poor or non-compliance|1|||
164574789|NCT00364793|594468089|FG000|Overall Study|No longer meets criteria|0|||
164574790|NCT00364793|594468090|FG001|Overall Study|No longer meets criteria|0|||
164574791|NCT00364793|594468091|FG002|Overall Study|No longer meets criteria|0|||
164574792|NCT00364793|594468092|FG003|Overall Study|No longer meets criteria|1|||
164574793|NCT00364793|594468089|FG000|Overall Study|Withdrawal by Subject|0|||
164574794|NCT00364793|594468090|FG001|Overall Study|Withdrawal by Subject|1|||
164574795|NCT00364793|594468091|FG002|Overall Study|Withdrawal by Subject|0|||
164574796|NCT00364793|594468092|FG003|Overall Study|Withdrawal by Subject|0|||
164574797|NCT02966314|594468093|FG000|Overall Study|Lost to Follow-up|1|||
164574798|NCT02966314|594468094|FG001|Overall Study|Lost to Follow-up|0|||
164679367|NCT00205777|594851140|FG000|Study Extension II|Enrolled but not treated|0|||
164679368|NCT00205777|594851141|FG001|Study Extension II|Enrolled but not treated|0|||
164679369|NCT00205777|594851142|FG002|Study Extension II|Enrolled but not treated|0|||
164679370|NCT00205777|594851143|FG003|Study Extension II|Enrolled but not treated|71|||
164679371|NCT00205777|594851144|FG004|Study Extension II|Enrolled but not treated|0|||
164679372|NCT00205777|594851145|FG005|Study Extension II|Enrolled but not treated|131|||
164679373|NCT00700739|594851146|FG000|Overall Study|Lost to Follow-up|4|||
164679374|NCT00700739|594851147|FG001|Overall Study|Lost to Follow-up|4|||
164679375|NCT01983969|594851151|FG000|Overall Study|Disease Progression|0|||
164679376|NCT01983969|594851152|FG001|Overall Study|Disease Progression|1|||
164679377|NCT01983969|594851153|FG002|Overall Study|Disease Progression|0|||
164679378|NCT03719040|594851154|FG000|Overall Study|Withdrawal by Subject|177|||
164679379|NCT03719040|594851154|FG000|Overall Study|Lost to Follow-up|26|||
164679380|NCT00268203|594851155|FG000|Overall Study|Lost to Follow-up|92|||
164679381|NCT00268203|594851155|FG000|Overall Study|Withdrawal by Subject|9|||
164679382|NCT00268203|594851155|FG000|Overall Study|Received Other NHL Therapy|7|||
164679383|NCT00268203|594851155|FG000|Overall Study|Progressive Disease|359|||
164679384|NCT00268203|594851155|FG000|Overall Study|Death|84|||
164679385|NCT00268203|594851155|FG000|Overall Study|Reason Not Specified|34|||
164679386|NCT00268203|594851155|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
164679387|NCT04589650|594851158|FG000|Overall Study|Subject decision|6|||
164679388|NCT04589650|594851159|FG001|Overall Study|Subject decision|2|||
164574799|NCT05127486|594468095|FG000|Overall Study|Adverse Event|2|||
164574800|NCT05127486|594468096|FG001|Overall Study|Adverse Event|4|||
164574801|NCT05127486|594468095|FG000|Overall Study|Lack of Efficacy|1|||
164574802|NCT05127486|594468096|FG001|Overall Study|Lack of Efficacy|0|||
164574803|NCT05127486|594468095|FG000|Overall Study|Pregnancy|0|||
164574804|NCT05127486|594468096|FG001|Overall Study|Pregnancy|1|||
164574805|NCT05127486|594468095|FG000|Overall Study|Physician Decision|4|||
164679389|NCT04589650|594851160|FG002|Overall Study|Subject decision|2|||
164679390|NCT04589650|594851161|FG003|Overall Study|Subject decision|0|||
164679391|NCT04589650|594851162|FG004|Overall Study|Subject decision|0|||
164679392|NCT04589650|594851163|FG005|Overall Study|Subject decision|0|||
164679393|NCT04589650|594851158|FG000|Overall Study|Adverse Event|3|||
164679394|NCT04589650|594851159|FG001|Overall Study|Adverse Event|1|||
164679395|NCT04589650|594851160|FG002|Overall Study|Adverse Event|1|||
164679396|NCT04589650|594851161|FG003|Overall Study|Adverse Event|1|||
164679397|NCT04589650|594851162|FG004|Overall Study|Adverse Event|0|||
164679398|NCT04589650|594851163|FG005|Overall Study|Adverse Event|1|||
164679399|NCT04589650|594851158|FG000|Overall Study|Physician Decision|1|||
164679400|NCT04589650|594851159|FG001|Overall Study|Physician Decision|1|||
164679401|NCT04589650|594851160|FG002|Overall Study|Physician Decision|0|||
164679402|NCT04589650|594851161|FG003|Overall Study|Physician Decision|0|||
164679403|NCT04589650|594851162|FG004|Overall Study|Physician Decision|0|||
164679404|NCT04589650|594851163|FG005|Overall Study|Physician Decision|0|||
164679405|NCT04589650|594851158|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164679406|NCT04589650|594851159|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164679407|NCT04589650|594851160|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
164679408|NCT04589650|594851161|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
164679409|NCT04589650|594851162|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
164679410|NCT04589650|594851163|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
164426307|NCT04955626|593930831|FG020|Open-Label Period|Lost to Follow-up|0|||
164426308|NCT04955626|593930832|FG021|Open-Label Period|Lost to Follow-up|0|||
164426309|NCT04955626|593930833|FG022|Open-Label Period|Lost to Follow-up|0|||
164426310|NCT04955626|593930834|FG023|Open-Label Period|Lost to Follow-up|0|||
164426311|NCT04955626|593930835|FG024|Open-Label Period|Lost to Follow-up|0|||
164426312|NCT04955626|593930836|FG025|Open-Label Period|Lost to Follow-up|0|||
164426313|NCT04955626|593930837|FG026|Open-Label Period|Lost to Follow-up|0|||
164426314|NCT04955626|593930838|FG027|Open-Label Period|Lost to Follow-up|0|||
164426315|NCT04955626|593930839|FG028|Open-Label Period|Lost to Follow-up|0|||
164426316|NCT04955626|593930840|FG029|Open-Label Period|Lost to Follow-up|0|||
164679411|NCT04589650|594851158|FG000|Overall Study|Death|0|||
164679412|NCT04589650|594851159|FG001|Overall Study|Death|0|||
164679413|NCT04589650|594851160|FG002|Overall Study|Death|0|||
164679414|NCT04589650|594851161|FG003|Overall Study|Death|1|||
164679415|NCT04589650|594851162|FG004|Overall Study|Death|0|||
164679416|NCT04589650|594851163|FG005|Overall Study|Death|0|||
164679417|NCT04589650|594851158|FG000|Overall Study|Guardian Decision|0|||
164679418|NCT04589650|594851159|FG001|Overall Study|Guardian Decision|0|||
164679419|NCT04589650|594851160|FG002|Overall Study|Guardian Decision|0|||
164246926|NCT03307785|593271863|FG011|MainStudy: PartC:Up to Approx.60months|Death|0|||
164246927|NCT03307785|593271864|FG012|MainStudy: PartC:Up to Approx.60months|Death|0|||
164246928|NCT03307785|593271852|FG000|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
164246929|NCT03307785|593271853|FG001|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
164246930|NCT03307785|593271854|FG002|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
164246931|NCT03307785|593271855|FG003|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|1|||
164246932|NCT03307785|593271856|FG004|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
164246933|NCT03307785|593271857|FG005|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
164246934|NCT03307785|593271858|FG006|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
164246935|NCT03307785|593271859|FG007|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
164246936|NCT03307785|593271860|FG008|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
164246937|NCT03307785|593271861|FG009|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
164246938|NCT03307785|593271862|FG010|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
164246939|NCT03307785|593271863|FG011|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
164246940|NCT03307785|593271864|FG012|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
164246941|NCT03307785|593271852|FG000|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
164246942|NCT03307785|593271853|FG001|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
164246943|NCT03307785|593271854|FG002|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
164246944|NCT03307785|593271855|FG003|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
164246945|NCT03307785|593271856|FG004|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|1|||
164246946|NCT03307785|593271857|FG005|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
164338027|NCT01999868|593613208|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
164338028|NCT01999868|593613209|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
164338029|NCT01999868|593613207|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
164338030|NCT01999868|593613208|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
164338031|NCT01999868|593613209|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
164338032|NCT01999868|593613207|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
164338033|NCT01999868|593613208|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
164338034|NCT01999868|593613209|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
164338035|NCT00289016|593613212|FG000|Overall Study|Disease Progression|29|||
164338036|NCT00289016|593613212|FG000|Overall Study|Death|2|||
164338037|NCT00289016|593613212|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
164338038|NCT00289016|593613212|FG000|Overall Study|Withdrawal by Subject|2|||
164338039|NCT00289016|593613212|FG000|Overall Study|Adverse Event|1|||
164338040|NCT00289016|593613212|FG000|Overall Study|Other|1|||
164338041|NCT00667875|593613213|FG000|Overall Study|Adverse Event|0|||
164338042|NCT00667875|593613214|FG001|Overall Study|Adverse Event|2|||
164338043|NCT00667875|593613215|FG002|Overall Study|Adverse Event|6|||
164338044|NCT00667875|593613213|FG000|Overall Study|Withdrawal by Subject|10|||
164338045|NCT00667875|593613214|FG001|Overall Study|Withdrawal by Subject|9|||
164338046|NCT00667875|593613215|FG002|Overall Study|Withdrawal by Subject|7|||
164338047|NCT00450255|593613216|FG000|Overall Study|Prior RFA ablation of liver|1|||
164338048|NCT03553927|593613218|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
164338049|NCT03553927|593613219|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
164338050|NCT03553927|593613218|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
164426317|NCT04955626|593930841|FG030|Open-Label Period|Lost to Follow-up|0|||
164679420|NCT04589650|594851161|FG003|Overall Study|Guardian Decision|1|||
164679421|NCT04589650|594851162|FG004|Overall Study|Guardian Decision|0|||
164679422|NCT04589650|594851163|FG005|Overall Study|Guardian Decision|0|||
164679423|NCT02923349|594851164|FG000|Overall Study|Other|1|||
164246947|NCT03307785|593271858|FG006|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
164246948|NCT03307785|593271859|FG007|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
164246949|NCT03307785|593271860|FG008|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
164246950|NCT03307785|593271861|FG009|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
164246951|NCT03307785|593271862|FG010|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
164246952|NCT03307785|593271863|FG011|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
164338051|NCT03553927|593613219|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
164338052|NCT03019185|593615033|FG000|Overall Study|Lost to Follow-up|3|||
164338053|NCT03019185|593615034|FG001|Overall Study|Lost to Follow-up|0|||
164338054|NCT03019185|593615035|FG002|Overall Study|Lost to Follow-up|2|||
164246953|NCT03307785|593271864|FG012|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
164338055|NCT03019185|593615033|FG000|Overall Study|Withdrawal by Subject|1|||
164338056|NCT03019185|593615034|FG001|Overall Study|Withdrawal by Subject|1|||
164338057|NCT03019185|593615035|FG002|Overall Study|Withdrawal by Subject|0|||
164246954|NCT03307785|593271852|FG000|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
164246955|NCT03307785|593271853|FG001|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
164246956|NCT03307785|593271854|FG002|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
164246957|NCT03307785|593271855|FG003|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
164246958|NCT03307785|593271856|FG004|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
164246959|NCT03307785|593271857|FG005|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|2|||
164246960|NCT03307785|593271858|FG006|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
164246961|NCT03307785|593271859|FG007|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
164246962|NCT03307785|593271860|FG008|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
164246963|NCT03307785|593271861|FG009|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
164246964|NCT03307785|593271862|FG010|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
164246965|NCT03307785|593271863|FG011|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
164246966|NCT03307785|593271864|FG012|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
164246967|NCT03307785|593271852|FG000|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
164246968|NCT03307785|593271853|FG001|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
164246969|NCT03307785|593271854|FG002|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
164338058|NCT03019185|593615033|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
164426318|NCT04955626|593930842|FG031|Open-Label Period|Lost to Follow-up|0|||
164426319|NCT04955626|593930843|FG032|Open-Label Period|Lost to Follow-up|0|||
164426320|NCT04955626|593930844|FG033|Open-Label Period|Lost to Follow-up|0|||
164426321|NCT04955626|593930845|FG034|Open-Label Period|Lost to Follow-up|0|||
164426322|NCT04955626|593930846|FG035|Open-Label Period|Lost to Follow-up|0|||
164426323|NCT04955626|593930811|FG000|Open-Label Period|Protocol Violation|377|||
164426324|NCT04955626|593930812|FG001|Open-Label Period|Protocol Violation|48|||
164426325|NCT04955626|593930813|FG002|Open-Label Period|Protocol Violation|0|||
164426326|NCT04955626|593930814|FG003|Open-Label Period|Protocol Violation|0|||
164426327|NCT04955626|593930815|FG004|Open-Label Period|Protocol Violation|0|||
164426328|NCT04955626|593930816|FG005|Open-Label Period|Protocol Violation|0|||
164426329|NCT04955626|593930817|FG006|Open-Label Period|Protocol Violation|0|||
164426330|NCT04955626|593930818|FG007|Open-Label Period|Protocol Violation|0|||
164426331|NCT04955626|593930819|FG008|Open-Label Period|Protocol Violation|0|||
164426332|NCT04955626|593930820|FG009|Open-Label Period|Protocol Violation|0|||
164426333|NCT04955626|593930821|FG010|Open-Label Period|Protocol Violation|0|||
164426334|NCT04955626|593930822|FG011|Open-Label Period|Protocol Violation|0|||
164426335|NCT04955626|593930823|FG012|Open-Label Period|Protocol Violation|0|||
164426336|NCT04955626|593930824|FG013|Open-Label Period|Protocol Violation|0|||
164426337|NCT04955626|593930825|FG014|Open-Label Period|Protocol Violation|0|||
164426338|NCT04955626|593930826|FG015|Open-Label Period|Protocol Violation|0|||
164426339|NCT04955626|593930827|FG016|Open-Label Period|Protocol Violation|0|||
164426340|NCT04955626|593930828|FG017|Open-Label Period|Protocol Violation|0|||
164338059|NCT03019185|593615034|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
164338060|NCT03019185|593615035|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
164338061|NCT03019185|593615033|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
164338062|NCT03019185|593615034|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
164338063|NCT03019185|593615035|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
164338064|NCT02764333|593615041|FG000|Overall Study|Ineligible|1|||
164338065|NCT01200524|593615044|FG000|Overall Study|Withdrawal by Subject|1|||
164338066|NCT01200524|593615045|FG001|Overall Study|Withdrawal by Subject|1|||
164338067|NCT01200524|593615046|FG002|Overall Study|Withdrawal by Subject|3|||
164338068|NCT01200524|593615044|FG000|Overall Study|Adverse Event|1|||
164338069|NCT01200524|593615045|FG001|Overall Study|Adverse Event|0|||
164338070|NCT01200524|593615046|FG002|Overall Study|Adverse Event|0|||
164426341|NCT04955626|593930829|FG018|Open-Label Period|Protocol Violation|0|||
164338071|NCT01200524|593615044|FG000|Overall Study|Non availability of study nurse|0|||
164426342|NCT04955626|593930830|FG019|Open-Label Period|Protocol Violation|0|||
164246970|NCT03307785|593271855|FG003|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
164246971|NCT03307785|593271856|FG004|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
164246972|NCT03307785|593271857|FG005|MainStudy:PartD:Up to Approx. 62.5months|Death|1|||
164246973|NCT03307785|593271858|FG006|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
164246974|NCT03307785|593271859|FG007|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
164246975|NCT03307785|593271860|FG008|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
164246976|NCT03307785|593271861|FG009|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
164246977|NCT03307785|593271862|FG010|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
164246978|NCT03307785|593271863|FG011|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
164246979|NCT03307785|593271864|FG012|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
164246980|NCT03307785|593271852|FG000|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
164246981|NCT03307785|593271853|FG001|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
164246982|NCT03307785|593271854|FG002|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
164246983|NCT03307785|593271855|FG003|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
164246984|NCT03307785|593271856|FG004|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
164246985|NCT03307785|593271857|FG005|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|1|||
164246986|NCT03307785|593271858|FG006|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
164246987|NCT03307785|593271859|FG007|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
164246988|NCT03307785|593271860|FG008|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
164246989|NCT03307785|593271861|FG009|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
164246990|NCT03307785|593271862|FG010|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
164246991|NCT03307785|593271863|FG011|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
164246992|NCT03307785|593271864|FG012|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
164246993|NCT03307785|593271852|FG000|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
164246994|NCT03307785|593271853|FG001|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
164246995|NCT03307785|593271854|FG002|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
164246996|NCT03307785|593271855|FG003|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
164246997|NCT03307785|593271856|FG004|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
164246998|NCT03307785|593271857|FG005|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|1|||
164246999|NCT03307785|593271858|FG006|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
164247000|NCT03307785|593271859|FG007|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
164247001|NCT03307785|593271860|FG008|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
164247002|NCT03307785|593271861|FG009|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
164247003|NCT03307785|593271862|FG010|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
164247004|NCT03307785|593271863|FG011|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
164247005|NCT03307785|593271864|FG012|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
164247006|NCT03307785|593271852|FG000|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
164247007|NCT03307785|593271853|FG001|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
164247008|NCT03307785|593271854|FG002|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
164247009|NCT03307785|593271855|FG003|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
164247010|NCT03307785|593271856|FG004|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
164247011|NCT03307785|593271857|FG005|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|1|||
164247012|NCT03307785|593271858|FG006|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
164247013|NCT03307785|593271859|FG007|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
164247014|NCT03307785|593271860|FG008|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
164247015|NCT03307785|593271861|FG009|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
164247016|NCT03307785|593271862|FG010|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
164247017|NCT03307785|593271863|FG011|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
164247018|NCT03307785|593271864|FG012|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
164247019|NCT03307785|593271852|FG000|Main Study: Part E: Up to 4.4 Months|Death|0|||
164247020|NCT03307785|593271853|FG001|Main Study: Part E: Up to 4.4 Months|Death|0|||
164247021|NCT03307785|593271854|FG002|Main Study: Part E: Up to 4.4 Months|Death|0|||
164247022|NCT03307785|593271855|FG003|Main Study: Part E: Up to 4.4 Months|Death|0|||
164247023|NCT03307785|593271856|FG004|Main Study: Part E: Up to 4.4 Months|Death|0|||
164247024|NCT03307785|593271857|FG005|Main Study: Part E: Up to 4.4 Months|Death|0|||
164247025|NCT03307785|593271858|FG006|Main Study: Part E: Up to 4.4 Months|Death|1|||
164247026|NCT03307785|593271859|FG007|Main Study: Part E: Up to 4.4 Months|Death|0|||
164247027|NCT03307785|593271860|FG008|Main Study: Part E: Up to 4.4 Months|Death|0|||
164247028|NCT03307785|593271861|FG009|Main Study: Part E: Up to 4.4 Months|Death|0|||
164247029|NCT03307785|593271862|FG010|Main Study: Part E: Up to 4.4 Months|Death|0|||
164247030|NCT03307785|593271863|FG011|Main Study: Part E: Up to 4.4 Months|Death|0|||
164247031|NCT03307785|593271864|FG012|Main Study: Part E: Up to 4.4 Months|Death|0|||
164247032|NCT03307785|593271852|FG000|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
164247033|NCT03307785|593271853|FG001|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
164247034|NCT03307785|593271854|FG002|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
164247035|NCT03307785|593271855|FG003|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
164247036|NCT03307785|593271856|FG004|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
164247037|NCT03307785|593271857|FG005|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
164247038|NCT03307785|593271858|FG006|Main Study: Part E: Up to 4.4 Months|Physician Decision|1|||
164247039|NCT03307785|593271859|FG007|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
164574806|NCT05127486|594468096|FG001|Overall Study|Physician Decision|1|||
164574807|NCT05127486|594468095|FG000|Overall Study|Withdrawal by Subject|14|||
164247040|NCT03307785|593271860|FG008|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
164247041|NCT03307785|593271861|FG009|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
164247042|NCT03307785|593271862|FG010|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
164247043|NCT03307785|593271863|FG011|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
164247044|NCT03307785|593271864|FG012|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
164247045|NCT03307785|593271852|FG000|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
164247046|NCT03307785|593271853|FG001|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
164247047|NCT03307785|593271854|FG002|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
164247048|NCT03307785|593271855|FG003|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
164247049|NCT03307785|593271856|FG004|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
164247050|NCT03307785|593271857|FG005|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
164247051|NCT03307785|593271858|FG006|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
164247052|NCT03307785|593271859|FG007|Main Study: Part F: Up to 3.5 Months|Physician Decision|1|||
164247053|NCT03307785|593271860|FG008|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
164247054|NCT03307785|593271861|FG009|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
164247055|NCT03307785|593271862|FG010|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
164247056|NCT03307785|593271863|FG011|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
164247057|NCT03307785|593271864|FG012|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
164247058|NCT03307785|593271852|FG000|PACT Phase: Up to 19 Months|Death|0|||
164247059|NCT03307785|593271853|FG001|PACT Phase: Up to 19 Months|Death|0|||
164247060|NCT03307785|593271854|FG002|PACT Phase: Up to 19 Months|Death|0|||
164247061|NCT03307785|593271855|FG003|PACT Phase: Up to 19 Months|Death|0|||
164247062|NCT03307785|593271856|FG004|PACT Phase: Up to 19 Months|Death|0|||
164247063|NCT03307785|593271857|FG005|PACT Phase: Up to 19 Months|Death|0|||
164247064|NCT03307785|593271858|FG006|PACT Phase: Up to 19 Months|Death|0|||
164247065|NCT03307785|593271859|FG007|PACT Phase: Up to 19 Months|Death|0|||
164247066|NCT03307785|593271860|FG008|PACT Phase: Up to 19 Months|Death|0|||
164247067|NCT03307785|593271861|FG009|PACT Phase: Up to 19 Months|Death|0|||
164247068|NCT03307785|593271862|FG010|PACT Phase: Up to 19 Months|Death|0|||
164247069|NCT03307785|593271863|FG011|PACT Phase: Up to 19 Months|Death|0|||
164247070|NCT03307785|593271864|FG012|PACT Phase: Up to 19 Months|Death|1|||
164247071|NCT03666988|593271865|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
164247072|NCT03666988|593271866|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
164247073|NCT03666988|593271867|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
164247074|NCT03666988|593271868|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
164247075|NCT03666988|593271869|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
164247076|NCT03666988|593271870|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
164247077|NCT03666988|593271865|FG000|Part 1 (Up to 28 Months)|Other|0|||
164247078|NCT03666988|593271866|FG001|Part 1 (Up to 28 Months)|Other|1|||
164247079|NCT03666988|593271867|FG002|Part 1 (Up to 28 Months)|Other|1|||
164247080|NCT03666988|593271868|FG003|Part 1 (Up to 28 Months)|Other|0|||
164247081|NCT03666988|593271869|FG004|Part 1 (Up to 28 Months)|Other|0|||
164247082|NCT03666988|593271870|FG005|Part 1 (Up to 28 Months)|Other|0|||
164247083|NCT03666988|593271865|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
164247084|NCT03666988|593271866|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
164247085|NCT03666988|593271867|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
164247086|NCT03666988|593271868|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
164247087|NCT03666988|593271869|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
164247088|NCT03666988|593271870|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
164247089|NCT03666988|593271865|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
164247090|NCT03666988|593271866|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
164247091|NCT03666988|593271867|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
164247092|NCT03666988|593271868|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
164247093|NCT03666988|593271869|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
164247094|NCT03666988|593271870|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
164247095|NCT03666988|593271865|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
164247096|NCT03666988|593271866|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
164247097|NCT03666988|593271867|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
164247098|NCT03666988|593271868|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
164247099|NCT03666988|593271869|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
164247100|NCT03666988|593271870|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
164247101|NCT02517398|593271871|FG000|Overall Study|Death|2|||
164247102|NCT02517398|593271872|FG001|Overall Study|Death|3|||
164247103|NCT02517398|593271873|FG002|Overall Study|Death|4|||
164247104|NCT02517398|593271874|FG003|Overall Study|Death|2|||
164247105|NCT02517398|593271875|FG004|Overall Study|Death|3|||
164247106|NCT02517398|593271876|FG005|Overall Study|Death|8|||
164247107|NCT02517398|593271877|FG006|Overall Study|Death|3|||
164247108|NCT02517398|593271878|FG007|Overall Study|Death|2|||
164247109|NCT02517398|593271879|FG008|Overall Study|Death|6|||
164247110|NCT02517398|593271880|FG009|Overall Study|Death|24|||
164247111|NCT02517398|593271881|FG010|Overall Study|Death|53|||
164338072|NCT01200524|593615045|FG001|Overall Study|Non availability of study nurse|0|||
164338073|NCT01200524|593615046|FG002|Overall Study|Non availability of study nurse|1|||
164338074|NCT01868503|593615047|FG000|Overall Study|Withdrawal by Subject|1|||
164338075|NCT01868503|593615047|FG000|Overall Study|Protocol Violation|1|||
164338076|NCT00736944|593615048|FG000|Induction|Death|1|||
164338077|NCT00736944|593615048|FG000|Definitive Treatment|Physician Decision|1|||
164338078|NCT00491764|593615049|FG000|Overall Study|Adverse Event|1|||
164338079|NCT00491764|593615050|FG001|Overall Study|Adverse Event|2|||
164338080|NCT00491764|593615051|FG002|Overall Study|Adverse Event|4|||
164338081|NCT00491764|593615052|FG003|Overall Study|Adverse Event|4|||
164338082|NCT00491764|593615053|FG004|Overall Study|Adverse Event|0|||
164338083|NCT00491764|593615054|FG005|Overall Study|Adverse Event|1|||
164338084|NCT00491764|593615049|FG000|Overall Study|Lost to Follow-up|0|||
164338085|NCT00491764|593615050|FG001|Overall Study|Lost to Follow-up|1|||
164338086|NCT00491764|593615051|FG002|Overall Study|Lost to Follow-up|0|||
164338087|NCT00491764|593615052|FG003|Overall Study|Lost to Follow-up|1|||
164338088|NCT00491764|593615053|FG004|Overall Study|Lost to Follow-up|0|||
164338089|NCT00491764|593615054|FG005|Overall Study|Lost to Follow-up|3|||
164338090|NCT00491764|593615049|FG000|Overall Study|Withdrawal by Subject|2|||
164338091|NCT00491764|593615050|FG001|Overall Study|Withdrawal by Subject|3|||
164338092|NCT00491764|593615051|FG002|Overall Study|Withdrawal by Subject|1|||
164338093|NCT00491764|593615052|FG003|Overall Study|Withdrawal by Subject|2|||
164338094|NCT00491764|593615053|FG004|Overall Study|Withdrawal by Subject|2|||
164338095|NCT00491764|593615054|FG005|Overall Study|Withdrawal by Subject|4|||
164338096|NCT00491764|593615049|FG000|Overall Study|Non Compliance with the Protocol|1|||
164338097|NCT00491764|593615050|FG001|Overall Study|Non Compliance with the Protocol|0|||
164426343|NCT04955626|593930831|FG020|Open-Label Period|Protocol Violation|0|||
164426344|NCT04955626|593930832|FG021|Open-Label Period|Protocol Violation|0|||
164426345|NCT04955626|593930833|FG022|Open-Label Period|Protocol Violation|0|||
164426346|NCT04955626|593930834|FG023|Open-Label Period|Protocol Violation|0|||
164426347|NCT04955626|593930835|FG024|Open-Label Period|Protocol Violation|0|||
164426348|NCT04955626|593930836|FG025|Open-Label Period|Protocol Violation|0|||
164426349|NCT04955626|593930837|FG026|Open-Label Period|Protocol Violation|0|||
164426350|NCT04955626|593930838|FG027|Open-Label Period|Protocol Violation|0|||
164426351|NCT04955626|593930839|FG028|Open-Label Period|Protocol Violation|0|||
164426352|NCT04955626|593930840|FG029|Open-Label Period|Protocol Violation|0|||
164426353|NCT04955626|593930841|FG030|Open-Label Period|Protocol Violation|0|||
164426354|NCT04955626|593930842|FG031|Open-Label Period|Protocol Violation|0|||
164426355|NCT04955626|593930843|FG032|Open-Label Period|Protocol Violation|0|||
164426356|NCT04955626|593930844|FG033|Open-Label Period|Protocol Violation|0|||
164426357|NCT04955626|593930845|FG034|Open-Label Period|Protocol Violation|0|||
164426358|NCT04955626|593930846|FG035|Open-Label Period|Protocol Violation|0|||
164574808|NCT05127486|594468096|FG001|Overall Study|Withdrawal by Subject|13|||
164574809|NCT05127486|594468095|FG000|Overall Study|Lost to Follow-up|5|||
164574810|NCT05127486|594468096|FG001|Overall Study|Lost to Follow-up|8|||
164574811|NCT02582515|594468097|FG000|Overall Study|Withdrawal by Subject|0|||
164574812|NCT02582515|594468098|FG001|Overall Study|Withdrawal by Subject|1|||
164574813|NCT05817045|594468099|FG000|Overall Study|Protocol Violation|0|||
164574814|NCT05817045|594468100|FG001|Overall Study|Protocol Violation|3|||
164574815|NCT05817045|594468099|FG000|Overall Study|Withdrawal by Subject|10|||
164574816|NCT05817045|594468100|FG001|Overall Study|Withdrawal by Subject|7|||
164574817|NCT05817045|594468099|FG000|Overall Study|Physician Decision|3|||
164574818|NCT05817045|594468100|FG001|Overall Study|Physician Decision|0|||
164574819|NCT05817045|594468099|FG000|Overall Study|Lost to Follow-up|0|||
164247112|NCT02517398|593271882|FG011|Overall Study|Death|25|||
164247113|NCT02517398|593271883|FG012|Overall Study|Death|73|||
164247114|NCT02517398|593271884|FG013|Overall Study|Death|29|||
164338098|NCT00491764|593615051|FG002|Overall Study|Non Compliance with the Protocol|0|||
164338099|NCT00491764|593615052|FG003|Overall Study|Non Compliance with the Protocol|0|||
164338100|NCT00491764|593615053|FG004|Overall Study|Non Compliance with the Protocol|0|||
164338101|NCT00491764|593615054|FG005|Overall Study|Non Compliance with the Protocol|0|||
164338102|NCT00491764|593615049|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
164338103|NCT00491764|593615050|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
164338104|NCT00491764|593615051|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
164338105|NCT00491764|593615052|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
164338106|NCT00491764|593615053|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
164247115|NCT02517398|593271885|FG014|Overall Study|Death|26|||
164247116|NCT02517398|593271886|FG015|Overall Study|Death|23|||
164247117|NCT02517398|593271887|FG016|Overall Study|Death|26|||
164247118|NCT02517398|593271888|FG017|Overall Study|Death|25|||
164247119|NCT02517398|593271889|FG018|Overall Study|Death|22|||
164247120|NCT02517398|593271890|FG019|Overall Study|Death|7|||
164247121|NCT02517398|593271891|FG020|Overall Study|Death|26|||
164247122|NCT02517398|593271892|FG021|Overall Study|Death|30|||
164247123|NCT02517398|593271893|FG022|Overall Study|Death|20|||
164247124|NCT02517398|593271871|FG000|Overall Study|Other|0|||
164247125|NCT02517398|593271872|FG001|Overall Study|Other|0|||
164247126|NCT02517398|593271873|FG002|Overall Study|Other|0|||
164247127|NCT02517398|593271874|FG003|Overall Study|Other|1|||
164247128|NCT02517398|593271875|FG004|Overall Study|Other|0|||
164247129|NCT02517398|593271876|FG005|Overall Study|Other|0|||
164247130|NCT02517398|593271877|FG006|Overall Study|Other|0|||
164247131|NCT02517398|593271878|FG007|Overall Study|Other|0|||
164247132|NCT02517398|593271879|FG008|Overall Study|Other|0|||
164247133|NCT02517398|593271880|FG009|Overall Study|Other|1|||
164247134|NCT02517398|593271881|FG010|Overall Study|Other|0|||
164247135|NCT02517398|593271882|FG011|Overall Study|Other|0|||
164247136|NCT02517398|593271883|FG012|Overall Study|Other|0|||
164247137|NCT02517398|593271884|FG013|Overall Study|Other|1|||
164247138|NCT02517398|593271885|FG014|Overall Study|Other|0|||
164247139|NCT02517398|593271886|FG015|Overall Study|Other|1|||
164247140|NCT02517398|593271887|FG016|Overall Study|Other|1|||
164247141|NCT02517398|593271888|FG017|Overall Study|Other|0|||
164247142|NCT02517398|593271889|FG018|Overall Study|Other|0|||
164247143|NCT02517398|593271890|FG019|Overall Study|Other|1|||
164247144|NCT02517398|593271891|FG020|Overall Study|Other|0|||
164247145|NCT02517398|593271892|FG021|Overall Study|Other|0|||
164247146|NCT02517398|593271893|FG022|Overall Study|Other|0|||
164247147|NCT02517398|593271871|FG000|Overall Study|Lost to Follow-up|0|||
164247148|NCT02517398|593271872|FG001|Overall Study|Lost to Follow-up|0|||
164247149|NCT02517398|593271873|FG002|Overall Study|Lost to Follow-up|0|||
164247150|NCT02517398|593271874|FG003|Overall Study|Lost to Follow-up|0|||
164247151|NCT02517398|593271875|FG004|Overall Study|Lost to Follow-up|0|||
164247152|NCT02517398|593271876|FG005|Overall Study|Lost to Follow-up|0|||
164247153|NCT02517398|593271877|FG006|Overall Study|Lost to Follow-up|0|||
164247154|NCT02517398|593271878|FG007|Overall Study|Lost to Follow-up|0|||
164247155|NCT02517398|593271879|FG008|Overall Study|Lost to Follow-up|0|||
164247156|NCT02517398|593271880|FG009|Overall Study|Lost to Follow-up|1|||
164247157|NCT02517398|593271881|FG010|Overall Study|Lost to Follow-up|0|||
164247158|NCT02517398|593271882|FG011|Overall Study|Lost to Follow-up|2|||
164247159|NCT02517398|593271883|FG012|Overall Study|Lost to Follow-up|2|||
164247160|NCT02517398|593271884|FG013|Overall Study|Lost to Follow-up|0|||
164426359|NCT04955626|593930811|FG000|Open-Label Period|Death|5|||
164426360|NCT04955626|593930812|FG001|Open-Label Period|Death|5|||
164426361|NCT04955626|593930813|FG002|Open-Label Period|Death|0|||
164426362|NCT04955626|593930814|FG003|Open-Label Period|Death|0|||
164426363|NCT04955626|593930815|FG004|Open-Label Period|Death|0|||
164426364|NCT04955626|593930816|FG005|Open-Label Period|Death|0|||
164426365|NCT04955626|593930817|FG006|Open-Label Period|Death|0|||
164426366|NCT04955626|593930818|FG007|Open-Label Period|Death|0|||
164426367|NCT04955626|593930819|FG008|Open-Label Period|Death|0|||
164426368|NCT04955626|593930820|FG009|Open-Label Period|Death|0|||
164426369|NCT04955626|593930821|FG010|Open-Label Period|Death|0|||
164426370|NCT04955626|593930822|FG011|Open-Label Period|Death|0|||
164426371|NCT04955626|593930823|FG012|Open-Label Period|Death|0|||
164426372|NCT04955626|593930824|FG013|Open-Label Period|Death|0|||
164426373|NCT04955626|593930825|FG014|Open-Label Period|Death|0|||
164426374|NCT04955626|593930826|FG015|Open-Label Period|Death|0|||
164247161|NCT02517398|593271885|FG014|Overall Study|Lost to Follow-up|1|||
164247162|NCT02517398|593271886|FG015|Overall Study|Lost to Follow-up|1|||
164247163|NCT02517398|593271887|FG016|Overall Study|Lost to Follow-up|0|||
164247164|NCT02517398|593271888|FG017|Overall Study|Lost to Follow-up|3|||
164247165|NCT02517398|593271889|FG018|Overall Study|Lost to Follow-up|1|||
164426375|NCT04955626|593930827|FG016|Open-Label Period|Death|0|||
164426376|NCT04955626|593930828|FG017|Open-Label Period|Death|0|||
164426377|NCT04955626|593930829|FG018|Open-Label Period|Death|0|||
164426378|NCT04955626|593930830|FG019|Open-Label Period|Death|0|||
164426379|NCT04955626|593930831|FG020|Open-Label Period|Death|0|||
164426380|NCT04955626|593930832|FG021|Open-Label Period|Death|0|||
164247166|NCT02517398|593271890|FG019|Overall Study|Lost to Follow-up|0|||
164247167|NCT02517398|593271891|FG020|Overall Study|Lost to Follow-up|1|||
164247168|NCT02517398|593271892|FG021|Overall Study|Lost to Follow-up|0|||
164247169|NCT02517398|593271893|FG022|Overall Study|Lost to Follow-up|2|||
164247170|NCT02517398|593271871|FG000|Overall Study|Withdrew Consent|0|||
164247171|NCT02517398|593271872|FG001|Overall Study|Withdrew Consent|0|||
164247172|NCT02517398|593271873|FG002|Overall Study|Withdrew Consent|0|||
164426381|NCT04955626|593930833|FG022|Open-Label Period|Death|0|||
164426382|NCT04955626|593930834|FG023|Open-Label Period|Death|0|||
164247173|NCT02517398|593271874|FG003|Overall Study|Withdrew Consent|0|||
164247174|NCT02517398|593271875|FG004|Overall Study|Withdrew Consent|0|||
164426383|NCT04955626|593930835|FG024|Open-Label Period|Death|0|||
164426384|NCT04955626|593930836|FG025|Open-Label Period|Death|0|||
164247175|NCT02517398|593271876|FG005|Overall Study|Withdrew Consent|0|||
164247176|NCT02517398|593271877|FG006|Overall Study|Withdrew Consent|1|||
164247177|NCT02517398|593271878|FG007|Overall Study|Withdrew Consent|0|||
164247178|NCT02517398|593271879|FG008|Overall Study|Withdrew Consent|0|||
164247179|NCT02517398|593271880|FG009|Overall Study|Withdrew Consent|2|||
164247180|NCT02517398|593271881|FG010|Overall Study|Withdrew Consent|7|||
164247181|NCT02517398|593271882|FG011|Overall Study|Withdrew Consent|1|||
164247182|NCT02517398|593271883|FG012|Overall Study|Withdrew Consent|5|||
164247183|NCT02517398|593271884|FG013|Overall Study|Withdrew Consent|4|||
164247184|NCT02517398|593271885|FG014|Overall Study|Withdrew Consent|2|||
164247185|NCT02517398|593271886|FG015|Overall Study|Withdrew Consent|5|||
164247186|NCT02517398|593271887|FG016|Overall Study|Withdrew Consent|4|||
164247187|NCT02517398|593271888|FG017|Overall Study|Withdrew Consent|2|||
164247188|NCT02517398|593271889|FG018|Overall Study|Withdrew Consent|3|||
164247189|NCT02517398|593271890|FG019|Overall Study|Withdrew Consent|2|||
164247190|NCT02517398|593271891|FG020|Overall Study|Withdrew Consent|9|||
164247191|NCT02517398|593271892|FG021|Overall Study|Withdrew Consent|3|||
164247192|NCT02517398|593271893|FG022|Overall Study|Withdrew Consent|1|||
164247193|NCT01154452|593271898|FG000|Phase Ib|Not Treated|1|||
164247194|NCT01154452|593271899|FG001|Phase Ib|Not Treated|0|||
164247195|NCT01154452|593271900|FG002|Phase Ib|Not Treated|0|||
164247196|NCT01154452|593271901|FG003|Phase Ib|Not Treated|0|||
164247197|NCT01154452|593271898|FG000|Phase Ib|Adverse Event|2|||
164247198|NCT01154452|593271899|FG001|Phase Ib|Adverse Event|1|||
164247199|NCT01154452|593271900|FG002|Phase Ib|Adverse Event|0|||
164247200|NCT01154452|593271901|FG003|Phase Ib|Adverse Event|0|||
164247201|NCT01154452|593271898|FG000|Phase II|Withdrawal by Subject|0|||
164247202|NCT01154452|593271899|FG001|Phase II|Withdrawal by Subject|0|||
164247203|NCT01154452|593271900|FG002|Phase II|Withdrawal by Subject|1|||
164247204|NCT01154452|593271901|FG003|Phase II|Withdrawal by Subject|2|||
164247205|NCT01154452|593271898|FG000|Phase II|Adverse Event|0|||
164247206|NCT01154452|593271899|FG001|Phase II|Adverse Event|0|||
164247207|NCT01154452|593271900|FG002|Phase II|Adverse Event|4|||
164247208|NCT01154452|593271901|FG003|Phase II|Adverse Event|4|||
164247209|NCT01392573|593271902|FG000|Overall Study|Adverse Event|1|||
164247210|NCT01392573|593271903|FG001|Overall Study|Adverse Event|3|||
164247211|NCT01392573|593271902|FG000|Overall Study|Lack of Efficacy|1|||
164247212|NCT01392573|593271903|FG001|Overall Study|Lack of Efficacy|2|||
164247213|NCT01392573|593271902|FG000|Overall Study|Protocol Violation|0|||
164247214|NCT01392573|593271903|FG001|Overall Study|Protocol Violation|2|||
164247215|NCT01392573|593271902|FG000|Overall Study|Withdrawal Criteria|13|||
164247216|NCT01392573|593271903|FG001|Overall Study|Withdrawal Criteria|15|||
164426385|NCT04955626|593930837|FG026|Open-Label Period|Death|0|||
164426386|NCT04955626|593930838|FG027|Open-Label Period|Death|0|||
164426387|NCT04955626|593930839|FG028|Open-Label Period|Death|0|||
164426388|NCT04955626|593930840|FG029|Open-Label Period|Death|0|||
164426389|NCT04955626|593930841|FG030|Open-Label Period|Death|0|||
164426390|NCT04955626|593930842|FG031|Open-Label Period|Death|0|||
164426391|NCT04955626|593930843|FG032|Open-Label Period|Death|0|||
164426392|NCT04955626|593930844|FG033|Open-Label Period|Death|0|||
164426393|NCT04955626|593930845|FG034|Open-Label Period|Death|0|||
164426394|NCT04955626|593930846|FG035|Open-Label Period|Death|0|||
164426395|NCT04955626|593930811|FG000|Open-Label Period|No longer meets eligibility criteria|20|||
164426396|NCT04955626|593930812|FG001|Open-Label Period|No longer meets eligibility criteria|4|||
164426397|NCT04955626|593930813|FG002|Open-Label Period|No longer meets eligibility criteria|0|||
164426398|NCT04955626|593930814|FG003|Open-Label Period|No longer meets eligibility criteria|0|||
164426399|NCT04955626|593930815|FG004|Open-Label Period|No longer meets eligibility criteria|0|||
164426400|NCT04955626|593930816|FG005|Open-Label Period|No longer meets eligibility criteria|0|||
164426401|NCT04955626|593930817|FG006|Open-Label Period|No longer meets eligibility criteria|0|||
164426402|NCT04955626|593930818|FG007|Open-Label Period|No longer meets eligibility criteria|0|||
164426403|NCT04955626|593930819|FG008|Open-Label Period|No longer meets eligibility criteria|0|||
164426404|NCT04955626|593930820|FG009|Open-Label Period|No longer meets eligibility criteria|0|||
164426405|NCT04955626|593930821|FG010|Open-Label Period|No longer meets eligibility criteria|0|||
164426406|NCT04955626|593930822|FG011|Open-Label Period|No longer meets eligibility criteria|0|||
164247217|NCT01392573|593271902|FG000|Overall Study|Site closure|8|||
164247218|NCT01392573|593271903|FG001|Overall Study|Site closure|7|||
164247219|NCT01392573|593271902|FG000|Overall Study|Unclassified|9|||
164247220|NCT01392573|593271903|FG001|Overall Study|Unclassified|6|||
164247221|NCT00325130|593271938|FG000|Overall Study|Lost to Follow-up|6|||
164247222|NCT00325130|593271939|FG001|Overall Study|Lost to Follow-up|14|||
164426407|NCT04955626|593930823|FG012|Open-Label Period|No longer meets eligibility criteria|0|||
164426408|NCT04955626|593930824|FG013|Open-Label Period|No longer meets eligibility criteria|0|||
164426409|NCT04955626|593930825|FG014|Open-Label Period|No longer meets eligibility criteria|0|||
164247223|NCT00325130|593271938|FG000|Overall Study|Withdrawal by Subject|12|||
164247224|NCT00325130|593271939|FG001|Overall Study|Withdrawal by Subject|14|||
164247225|NCT00325130|593271938|FG000|Overall Study|Protocol Deviation|0|||
164247226|NCT00325130|593271939|FG001|Overall Study|Protocol Deviation|1|||
164247227|NCT00325130|593271938|FG000|Overall Study|Moved|0|||
164247228|NCT00325130|593271939|FG001|Overall Study|Moved|1|||
164247229|NCT00325130|593271938|FG000|Overall Study|Patient Discontinued for Other|1|||
164247230|NCT00325130|593271939|FG001|Overall Study|Patient Discontinued for Other|0|||
164247231|NCT03744910|593273224|FG000|Overall Study|Withdrew Consent|1|||
164247232|NCT03744910|593273225|FG001|Overall Study|Withdrew Consent|8|||
164247233|NCT03744910|593273224|FG000|Overall Study|Physician Decision|5|||
164247234|NCT03744910|593273225|FG001|Overall Study|Physician Decision|4|||
164247235|NCT03744910|593273224|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
164247236|NCT03744910|593273225|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
164247237|NCT03744910|593273224|FG000|Overall Study|Lost to Follow-up|0|||
164247238|NCT03744910|593273225|FG001|Overall Study|Lost to Follow-up|1|||
164247239|NCT03744910|593273224|FG000|Overall Study|Other-unspecified|4|||
164247240|NCT03744910|593273225|FG001|Overall Study|Other-unspecified|1|||
164247241|NCT02744612|593273226|FG000|Overall Study|Withdrawal by Subject|0|||
164247242|NCT02744612|593273227|FG001|Overall Study|Withdrawal by Subject|2|||
164247243|NCT00283803|593273228|FG000|Overall Study|Physician Decision|9|||
164247244|NCT00283803|593273228|FG000|Overall Study|Withdrawal by Subject|4|||
164247245|NCT01127607|593273229|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
164247246|NCT01127607|593273230|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
164247247|NCT01127607|593273229|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
164247248|NCT01127607|593273230|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
164247249|NCT02220855|593273231|FG000|Overall Study|Adverse Event|8|||
164247250|NCT02220855|593273231|FG000|Overall Study|Disease Progression|5|||
164247251|NCT02220855|593273231|FG000|Overall Study|Withdrawal by Subject|1|||
164247252|NCT03419897|593273232|FG000|Overall Study|Death|180|||
164247253|NCT03419897|593273232|FG000|Overall Study|Lost to Follow-up|1|||
164247254|NCT03419897|593273232|FG000|Overall Study|Withdrawal by Subject|6|||
164247255|NCT03419897|593273232|FG000|Overall Study|Sponsor Decision|61|||
164247256|NCT03419897|593273232|FG000|Overall Study|Physician Decision|1|||
164247257|NCT05730725|593273235|FG000|Overall Study|Withdrawal by Subject|3|||
164338107|NCT00491764|593615054|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
164338108|NCT00491764|593615049|FG000|Overall Study|Administrative|1|||
164338109|NCT00491764|593615050|FG001|Overall Study|Administrative|0|||
164338110|NCT00491764|593615051|FG002|Overall Study|Administrative|2|||
164338111|NCT00491764|593615052|FG003|Overall Study|Administrative|1|||
164338112|NCT00491764|593615053|FG004|Overall Study|Administrative|0|||
164338113|NCT00491764|593615054|FG005|Overall Study|Administrative|0|||
164338114|NCT00894166|593615055|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
164338115|NCT00894166|593615056|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
164338116|NCT00894166|593615057|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
164338117|NCT00894166|593615058|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
164338118|NCT00894166|593615059|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
164338119|NCT00894166|593615060|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
164338120|NCT00894166|593615061|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
164338121|NCT00894166|593615062|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
164338122|NCT00894166|593615055|FG000|Overall Study|Death|0|||
164338123|NCT00894166|593615056|FG001|Overall Study|Death|0|||
164338124|NCT00894166|593615057|FG002|Overall Study|Death|0|||
164338125|NCT00894166|593615058|FG003|Overall Study|Death|1|||
164338126|NCT00894166|593615059|FG004|Overall Study|Death|0|||
164338127|NCT00894166|593615060|FG005|Overall Study|Death|0|||
164338128|NCT00894166|593615061|FG006|Overall Study|Death|0|||
164338129|NCT00894166|593615062|FG007|Overall Study|Death|0|||
164338130|NCT01601132|593615063|FG000|Overall Study|Patient withdrew consent|1|||
164338131|NCT01601132|593615063|FG000|Overall Study|Protocol deviation|1|||
164338132|NCT02110238|593615064|FG000|12 Week Pivotal Phase|Adverse Event|3|||
164338133|NCT02110238|593615065|FG001|12 Week Pivotal Phase|Adverse Event|0|||
164338134|NCT02110238|593615064|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
164338135|NCT02110238|593615065|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
164338136|NCT02110238|593615064|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
164338137|NCT02110238|593615065|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
164338138|NCT02110238|593615064|FG000|12 Week Pivotal Phase|Physician Decision|0|||
164247258|NCT05730725|593273236|FG001|Overall Study|Withdrawal by Subject|0|||
164247259|NCT05730725|593273237|FG002|Overall Study|Withdrawal by Subject|0|||
164247260|NCT05730725|593273238|FG003|Overall Study|Withdrawal by Subject|1|||
164247261|NCT05730725|593273235|FG000|Overall Study|Not Reported|1|||
164247262|NCT05730725|593273236|FG001|Overall Study|Not Reported|1|||
164247263|NCT05730725|593273237|FG002|Overall Study|Not Reported|1|||
164247264|NCT05730725|593273238|FG003|Overall Study|Not Reported|1|||
164247265|NCT03053440|593273245|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
164338139|NCT02110238|593615065|FG001|12 Week Pivotal Phase|Physician Decision|2|||
164338140|NCT02110238|593615064|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
164338141|NCT02110238|593615065|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
164338142|NCT02110238|593615064|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
164338143|NCT02110238|593615065|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
164338144|NCT02110238|593615064|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
164338145|NCT02110238|593615065|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
164247266|NCT03053440|593273246|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
164247267|NCT03053440|593273245|FG000|Overall Study|Death|18|||
164247268|NCT03053440|593273246|FG001|Overall Study|Death|14|||
164247269|NCT03053440|593273245|FG000|Overall Study|Withdrawal by Subject|9|||
164247270|NCT03053440|593273246|FG001|Overall Study|Withdrawal by Subject|8|||
164247271|NCT03053440|593273245|FG000|Overall Study|Lost to Follow-up|1|||
164247272|NCT03053440|593273246|FG001|Overall Study|Lost to Follow-up|0|||
164247273|NCT03053440|593273245|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
164247274|NCT03053440|593273246|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
164338146|NCT02110238|593615064|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
164247275|NCT03053440|593273245|FG000|Overall Study|Physician Decision|2|||
164338147|NCT02110238|593615065|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
164338148|NCT02110238|593615064|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
164338149|NCT02110238|593615065|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
164338150|NCT02110238|593615064|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
164338151|NCT02110238|593615065|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
164338152|NCT02110238|593615064|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
164338153|NCT02110238|593615065|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
164338154|NCT03228433|593615070|FG000|Overall Study|Lost to Follow-up|1|||
164338155|NCT03228433|593615071|FG001|Overall Study|Lost to Follow-up|0|||
164338156|NCT03228433|593615072|FG002|Overall Study|Lost to Follow-up|0|||
164338157|NCT03228433|593615073|FG003|Overall Study|Lost to Follow-up|0|||
164338158|NCT03228433|593615074|FG004|Overall Study|Lost to Follow-up|0|||
164338159|NCT03228433|593615075|FG005|Overall Study|Lost to Follow-up|0|||
164338160|NCT03228433|593615070|FG000|Overall Study|Positive alcohol test|0|||
164338161|NCT03228433|593615071|FG001|Overall Study|Positive alcohol test|0|||
164338162|NCT03228433|593615072|FG002|Overall Study|Positive alcohol test|0|||
164338163|NCT03228433|593615073|FG003|Overall Study|Positive alcohol test|1|||
164338164|NCT03228433|593615074|FG004|Overall Study|Positive alcohol test|0|||
164338165|NCT03228433|593615075|FG005|Overall Study|Positive alcohol test|0|||
164338166|NCT03626168|593615078|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
164338167|NCT03626168|593615079|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
164338168|NCT03626168|593615078|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
164338169|NCT03626168|593615079|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
164338170|NCT03626168|593615078|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
164338171|NCT03626168|593615079|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
164338172|NCT00216476|593615080|FG000|Overall Study|Withdrawal by Subject|59|||
164338173|NCT00216476|593615081|FG001|Overall Study|Withdrawal by Subject|72|||
164338174|NCT00216476|593615082|FG002|Overall Study|Withdrawal by Subject|9|||
164338175|NCT00216476|593615080|FG000|Overall Study|Lost to Follow-up|10|||
164338176|NCT00216476|593615081|FG001|Overall Study|Lost to Follow-up|9|||
164338177|NCT00216476|593615082|FG002|Overall Study|Lost to Follow-up|1|||
164338178|NCT00216476|593615080|FG000|Overall Study|Adverse Event|6|||
164338179|NCT00216476|593615081|FG001|Overall Study|Adverse Event|10|||
164338180|NCT00216476|593615082|FG002|Overall Study|Adverse Event|1|||
164338181|NCT00216476|593615080|FG000|Overall Study|Lack of Efficacy|4|||
164338182|NCT00216476|593615081|FG001|Overall Study|Lack of Efficacy|3|||
164338183|NCT00216476|593615082|FG002|Overall Study|Lack of Efficacy|0|||
164338184|NCT00216476|593615080|FG000|Overall Study|Death|2|||
164338185|NCT00216476|593615081|FG001|Overall Study|Death|0|||
164338186|NCT00216476|593615082|FG002|Overall Study|Death|0|||
164338187|NCT00216476|593615080|FG000|Overall Study|Pregnancy|0|||
164338188|NCT00216476|593615081|FG001|Overall Study|Pregnancy|1|||
164338189|NCT00216476|593615082|FG002|Overall Study|Pregnancy|1|||
164338190|NCT00216476|593615080|FG000|Overall Study|Other|0|||
164338191|NCT00216476|593615081|FG001|Overall Study|Other|0|||
164338192|NCT00216476|593615082|FG002|Overall Study|Other|1|||
164338193|NCT00216476|593615080|FG000|Overall Study|Refuses Injection|11|||
164338194|NCT00216476|593615081|FG001|Overall Study|Refuses Injection|0|||
164338195|NCT00216476|593615082|FG002|Overall Study|Refuses Injection|0|||
164338196|NCT00216476|593615080|FG000|Overall Study|No Further Need for Treatment|3|||
164247276|NCT03053440|593273246|FG001|Overall Study|Physician Decision|1|||
164247277|NCT03053440|593273245|FG000|Overall Study|Participant Randomized but died before dosing|1|||
164338197|NCT00216476|593615081|FG001|Overall Study|No Further Need for Treatment|4|||
164338198|NCT00216476|593615082|FG002|Overall Study|No Further Need for Treatment|1|||
164338199|NCT00216476|593615080|FG000|Overall Study|Non-compliance|0|||
164338200|NCT00216476|593615081|FG001|Overall Study|Non-compliance|4|||
164338201|NCT00216476|593615082|FG002|Overall Study|Non-compliance|1|||
164338202|NCT00216476|593615080|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
164338203|NCT00216476|593615081|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
164338204|NCT00216476|593615082|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
164247278|NCT03053440|593273246|FG001|Overall Study|Participant Randomized but died before dosing|0|||
164338205|NCT00216476|593615080|FG000|Overall Study|Administrative Reasons|1|||
164338206|NCT00216476|593615081|FG001|Overall Study|Administrative Reasons|1|||
164338207|NCT00216476|593615082|FG002|Overall Study|Administrative Reasons|0|||
164247279|NCT00391053|593273252|FG000|Overall Study|Serious Adverse Events|1|||
164247280|NCT00391053|593273253|FG001|Overall Study|Serious Adverse Events|0|||
164247281|NCT00391053|593273254|FG002|Overall Study|Serious Adverse Events|1|||
164247282|NCT00391053|593273255|FG003|Overall Study|Serious Adverse Events|4|||
164247283|NCT00391053|593273252|FG000|Overall Study|Protocol Violation|2|||
164247284|NCT00391053|593273253|FG001|Overall Study|Protocol Violation|0|||
164247285|NCT00391053|593273254|FG002|Overall Study|Protocol Violation|0|||
164247286|NCT00391053|593273255|FG003|Overall Study|Protocol Violation|0|||
164247287|NCT00391053|593273252|FG000|Overall Study|Lost to Follow-up|1|||
164247288|NCT00391053|593273253|FG001|Overall Study|Lost to Follow-up|0|||
164247289|NCT00391053|593273254|FG002|Overall Study|Lost to Follow-up|0|||
164247290|NCT00391053|593273255|FG003|Overall Study|Lost to Follow-up|5|||
164247291|NCT00391053|593273252|FG000|Overall Study|Withdrawal by Subject|5|||
164247292|NCT00391053|593273253|FG001|Overall Study|Withdrawal by Subject|1|||
164247293|NCT00391053|593273254|FG002|Overall Study|Withdrawal by Subject|1|||
164247294|NCT00391053|593273255|FG003|Overall Study|Withdrawal by Subject|1|||
164247295|NCT00473889|593273257|FG000|Overall Study|Did not receive study medication|1|||
164247296|NCT00473889|593273258|FG001|Overall Study|Did not receive study medication|4|||
164247297|NCT00473889|593273257|FG000|Overall Study|Adverse Event|30|||
164247298|NCT00473889|593273258|FG001|Overall Study|Adverse Event|17|||
164247299|NCT00473889|593273257|FG000|Overall Study|Protocol Violation|4|||
164247300|NCT00473889|593273258|FG001|Overall Study|Protocol Violation|2|||
164247301|NCT00473889|593273257|FG000|Overall Study|Lack of Efficacy|28|||
164247302|NCT00473889|593273258|FG001|Overall Study|Lack of Efficacy|29|||
164338208|NCT00216476|593615080|FG000|Overall Study|Protocol Deviation|5|||
164574820|NCT05817045|594468100|FG001|Overall Study|Lost to Follow-up|1|||
164574821|NCT05817045|594468099|FG000|Overall Study|Device Deficiency|1|||
164574822|NCT05817045|594468100|FG001|Overall Study|Device Deficiency|0|||
164574823|NCT05817045|594468099|FG000|Overall Study|System Error|1|||
164574824|NCT05817045|594468100|FG001|Overall Study|System Error|0|||
164574825|NCT02688647|594468105|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
164574826|NCT02688647|594468106|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
164574827|NCT02688647|594468105|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
164574828|NCT02688647|594468106|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
164574829|NCT02688647|594468105|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
164574830|NCT02688647|594468106|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
164574831|NCT02688647|594468105|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
164574832|NCT02688647|594468106|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
164574833|NCT02688647|594468105|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
164574834|NCT02688647|594468106|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
164574835|NCT02688647|594468105|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
164574836|NCT02688647|594468106|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
164574837|NCT02688647|594468105|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
164574838|NCT02688647|594468106|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
164574839|NCT02542267|594468107|FG000|Overall Study|Withdrawal by Subject|10|||
164574840|NCT02542267|594468107|FG000|Overall Study|Physician Decision|6|||
164574841|NCT02542267|594468107|FG000|Overall Study|Lost to Follow-up|4|||
164574842|NCT02542267|594468107|FG000|Overall Study|Death|13|||
164574843|NCT02542267|594468107|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
164574844|NCT02542267|594468107|FG000|Overall Study|Other|9|||
164574845|NCT03093402|594468108|FG000|Overall Study|Lost to Follow-up|1|||
164574846|NCT03093402|594468109|FG001|Overall Study|Lost to Follow-up|0|||
164574847|NCT03093402|594468110|FG002|Overall Study|Lost to Follow-up|0|||
164574848|NCT03093402|594468111|FG003|Overall Study|Lost to Follow-up|0|||
164574849|NCT03093402|594468108|FG000|Overall Study|Withdrawal by Subject|3|||
164574850|NCT03093402|594468109|FG001|Overall Study|Withdrawal by Subject|3|||
164574851|NCT03093402|594468110|FG002|Overall Study|Withdrawal by Subject|0|||
164574852|NCT03093402|594468111|FG003|Overall Study|Withdrawal by Subject|1|||
164574853|NCT03093402|594468108|FG000|Overall Study|Withdrew prior to dosing|2|||
164247303|NCT00473889|593273257|FG000|Overall Study|Lost to Follow-up|2|||
164247304|NCT00473889|593273258|FG001|Overall Study|Lost to Follow-up|1|||
164247305|NCT00473889|593273257|FG000|Overall Study|Physician Decision|10|||
164247306|NCT00473889|593273258|FG001|Overall Study|Physician Decision|5|||
164247307|NCT00473889|593273257|FG000|Overall Study|Trial Terminated|3|||
164247308|NCT00473889|593273258|FG001|Overall Study|Trial Terminated|6|||
164247309|NCT00473889|593273257|FG000|Overall Study|Withdrawal by Subject|5|||
164247310|NCT00473889|593273258|FG001|Overall Study|Withdrawal by Subject|0|||
164247311|NCT02140970|593273259|FG000|Overall Study|Lost to Follow-up|1|||
164247312|NCT02140970|593273260|FG001|Overall Study|Lost to Follow-up|2|||
164247313|NCT02140970|593273259|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
164247314|NCT02140970|593273260|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
164247315|NCT02140970|593273259|FG000|Overall Study|Did not meet inclusion criteria|0|||
164574854|NCT03093402|594468109|FG001|Overall Study|Withdrew prior to dosing|1|||
164574855|NCT03093402|594468110|FG002|Overall Study|Withdrew prior to dosing|2|||
164247316|NCT02140970|593273260|FG001|Overall Study|Did not meet inclusion criteria|1|||
164247317|NCT00460655|593273264|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
164247318|NCT00460655|593273265|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
164247319|NCT00460655|593273266|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
164247320|NCT00460655|593273267|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
164247321|NCT00460655|593273264|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
164247322|NCT00460655|593273265|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
164247323|NCT00460655|593273266|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
164247324|NCT00460655|593273267|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
164247325|NCT00460655|593273264|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
164247326|NCT00460655|593273265|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
164247327|NCT00460655|593273266|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
164247328|NCT00460655|593273267|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
164247329|NCT00460655|593273264|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
164247330|NCT00460655|593273265|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
164247331|NCT00460655|593273266|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
164247332|NCT00460655|593273267|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
164247333|NCT00460655|593273264|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
164247334|NCT00460655|593273265|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
164247335|NCT00460655|593273266|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
164247336|NCT00460655|593273267|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
164247337|NCT00460655|593273264|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
164247338|NCT00460655|593273265|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
164247339|NCT00460655|593273266|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
164247340|NCT00460655|593273267|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
164247341|NCT00590122|593273268|FG000|Overall Study|swallowed oral dissolving dose|1|||
164247342|NCT00590122|593273269|FG001|Overall Study|swallowed oral dissolving dose|0|||
164247343|NCT03050450|593273270|FG000|Overall Study|Physician Decision|1|||
164247344|NCT03050450|593273271|FG001|Overall Study|Physician Decision|0|||
164247345|NCT03050450|593273272|FG002|Overall Study|Physician Decision|0|||
164247346|NCT03050450|593273273|FG003|Overall Study|Physician Decision|0|||
164247347|NCT03050450|593273274|FG004|Overall Study|Physician Decision|0|||
164247348|NCT00735553|593273278|FG000|Overall Study|Study prematurely terminated|77|||
164247349|NCT02705105|593273279|FG000|Treatment|Objective Disease Progression|1|||
164247350|NCT02705105|593273280|FG001|Treatment|Objective Disease Progression|50|||
164247351|NCT02705105|593273279|FG000|Treatment|Withdrawal by Subject|3|||
164247352|NCT02705105|593273280|FG001|Treatment|Withdrawal by Subject|5|||
164247353|NCT02705105|593273279|FG000|Treatment|Adverse Event|0|||
164247354|NCT02705105|593273280|FG001|Treatment|Adverse Event|17|||
164247355|NCT02705105|593273279|FG000|Treatment|Clinical Disease Progression|0|||
164247356|NCT02705105|593273280|FG001|Treatment|Clinical Disease Progression|32|||
164426410|NCT04955626|593930826|FG015|Open-Label Period|No longer meets eligibility criteria|0|||
164426411|NCT04955626|593930827|FG016|Open-Label Period|No longer meets eligibility criteria|0|||
164426412|NCT04955626|593930828|FG017|Open-Label Period|No longer meets eligibility criteria|0|||
164426413|NCT04955626|593930829|FG018|Open-Label Period|No longer meets eligibility criteria|0|||
164426414|NCT04955626|593930830|FG019|Open-Label Period|No longer meets eligibility criteria|0|||
164426415|NCT04955626|593930831|FG020|Open-Label Period|No longer meets eligibility criteria|0|||
164426416|NCT04955626|593930832|FG021|Open-Label Period|No longer meets eligibility criteria|0|||
164426417|NCT04955626|593930833|FG022|Open-Label Period|No longer meets eligibility criteria|0|||
164247357|NCT02705105|593273279|FG000|Treatment|Physician Decision|0|||
164247358|NCT02705105|593273280|FG001|Treatment|Physician Decision|3|||
164247359|NCT02705105|593273279|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
164247360|NCT02705105|593273280|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
164247361|NCT02705105|593273279|FG000|Follow-Up|Death|3|||
164247362|NCT02705105|593273280|FG001|Follow-Up|Death|68|||
164247363|NCT02705105|593273279|FG000|Follow-Up|Withdrawal by Subject|1|||
164247364|NCT02705105|593273280|FG001|Follow-Up|Withdrawal by Subject|14|||
164247365|NCT02705105|593273279|FG000|Follow-Up|Study Terminated|0|||
164247366|NCT02705105|593273280|FG001|Follow-Up|Study Terminated|26|||
164247367|NCT02705105|593273279|FG000|Follow-Up|Discontinued per Amendment 3|0|||
164247368|NCT02705105|593273280|FG001|Follow-Up|Discontinued per Amendment 3|2|||
164247369|NCT04908683|593273281|FG000|Overall Study|Failure to meet continuation criteria|34|||
164247370|NCT04908683|593273282|FG001|Overall Study|Failure to meet continuation criteria|22|||
164247371|NCT04908683|593273281|FG000|Overall Study|Initiated prohibited medication|3|||
164247372|NCT04908683|593273282|FG001|Overall Study|Initiated prohibited medication|0|||
164247373|NCT04908683|593273281|FG000|Overall Study|Randomized by mistake|1|||
164247374|NCT04908683|593273282|FG001|Overall Study|Randomized by mistake|0|||
164247375|NCT04908683|593273281|FG000|Overall Study|Lost to Follow-up|679|||
164247376|NCT04908683|593273282|FG001|Overall Study|Lost to Follow-up|341|||
164247377|NCT04908683|593273281|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
164426418|NCT04955626|593930834|FG023|Open-Label Period|No longer meets eligibility criteria|0|||
164574856|NCT03093402|594468111|FG003|Overall Study|Withdrew prior to dosing|3|||
164574857|NCT03093402|594468108|FG000|Overall Study|Ineligible for study|1|||
164574858|NCT03093402|594468109|FG001|Overall Study|Ineligible for study|0|||
164574859|NCT03093402|594468110|FG002|Overall Study|Ineligible for study|0|||
164574860|NCT03093402|594468111|FG003|Overall Study|Ineligible for study|0|||
164574861|NCT03093402|594468108|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
164247378|NCT04908683|593273282|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
164247379|NCT04908683|593273281|FG000|Overall Study|Physician Decision|44|||
164247380|NCT04908683|593273282|FG001|Overall Study|Physician Decision|35|||
164247381|NCT04908683|593273281|FG000|Overall Study|Technical problems|12|||
164247382|NCT04908683|593273282|FG001|Overall Study|Technical problems|9|||
164247383|NCT04908683|593273281|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
164247384|NCT04908683|593273282|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
164247385|NCT04908683|593273281|FG000|Overall Study|Protocol Violation|2|||
164247386|NCT04908683|593273282|FG001|Overall Study|Protocol Violation|0|||
164247387|NCT04908683|593273281|FG000|Overall Study|Withdrawal by Subject|1188|||
164247388|NCT04908683|593273282|FG001|Overall Study|Withdrawal by Subject|570|||
164574862|NCT03093402|594468109|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
164574863|NCT03093402|594468110|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
164247389|NCT04908683|593273281|FG000|Overall Study|Site Closure by Sponsor|6|||
164247390|NCT04908683|593273282|FG001|Overall Study|Site Closure by Sponsor|3|||
164247391|NCT04908683|593273281|FG000|Overall Study|Adverse Event|21|||
164247392|NCT04908683|593273282|FG001|Overall Study|Adverse Event|11|||
164247393|NCT04908683|593273281|FG000|Overall Study|Death|101|||
164247394|NCT04908683|593273282|FG001|Overall Study|Death|61|||
164247395|NCT04908683|593273281|FG000|Overall Study|Sponsor's decision|14398|||
164247396|NCT04908683|593273282|FG001|Overall Study|Sponsor's decision|7205|||
164247397|NCT04908683|593273281|FG000|Overall Study|Other|92|||
164247398|NCT04908683|593273282|FG001|Overall Study|Other|50|||
164247399|NCT04908683|593273281|FG000|Overall Study|Randomized not vaccinated|108|||
164247400|NCT04908683|593273282|FG001|Overall Study|Randomized not vaccinated|52|||
164247401|NCT00910910|593273283|FG000|Overall Study|Adverse Event|63|||
164247402|NCT00910910|593273284|FG001|Overall Study|Adverse Event|35|||
164247403|NCT00910910|593273283|FG000|Overall Study|PD without histologic change|27|||
164247404|NCT00910910|593273284|FG001|Overall Study|PD without histologic change|23|||
164247405|NCT00910910|593273283|FG000|Overall Study|PD with histologic change|0|||
164247406|NCT00910910|593273284|FG001|Overall Study|PD with histologic change|2|||
164247407|NCT00910910|593273283|FG000|Overall Study|Withdrawal by Subject|7|||
164247408|NCT00910910|593273284|FG001|Overall Study|Withdrawal by Subject|5|||
164247409|NCT00910910|593273283|FG000|Overall Study|Lost to Follow-up|2|||
164247410|NCT00910910|593273284|FG001|Overall Study|Lost to Follow-up|2|||
164247411|NCT00910910|593273283|FG000|Overall Study|Death|9|||
164247412|NCT00910910|593273284|FG001|Overall Study|Death|3|||
164247413|NCT00910910|593273283|FG000|Overall Study|Protocol Violation|2|||
164247414|NCT00910910|593273284|FG001|Overall Study|Protocol Violation|2|||
164247415|NCT00910910|593273283|FG000|Overall Study|Completed 13 cycles of treatment|0|||
164247416|NCT00910910|593273284|FG001|Overall Study|Completed 13 cycles of treatment|118|||
164247417|NCT00910910|593273283|FG000|Overall Study|Other|114|||
164338209|NCT00216476|593615081|FG001|Overall Study|Protocol Deviation|1|||
164338210|NCT00216476|593615082|FG002|Overall Study|Protocol Deviation|0|||
164338211|NCT00216476|593615080|FG000|Overall Study|Patient Moved|2|||
164338212|NCT00216476|593615081|FG001|Overall Study|Patient Moved|2|||
164338213|NCT00216476|593615082|FG002|Overall Study|Patient Moved|0|||
164338214|NCT04738734|593615092|FG000|Overall Study|Withdrawal by Subject|2|||
164338215|NCT04738734|593615093|FG001|Overall Study|Withdrawal by Subject|4|||
164338216|NCT04738734|593615092|FG000|Overall Study|Lost to Follow-up|5|||
164338217|NCT04738734|593615093|FG001|Overall Study|Lost to Follow-up|2|||
164338218|NCT04738734|593615092|FG000|Overall Study|Physician Decision|0|||
164338219|NCT04738734|593615093|FG001|Overall Study|Physician Decision|1|||
164574864|NCT03093402|594468111|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
164338220|NCT04738734|593615092|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
164338221|NCT04738734|593615093|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
164338222|NCT02808650|593615094|FG000|Overall Study|Death|0|||
164574865|NCT01147497|594468116|FG000|Overall Study|failed insertion|2|||
164574866|NCT01147497|594468117|FG001|Overall Study|failed insertion|0|||
164247418|NCT00910910|593273284|FG001|Overall Study|Other|32|||
164247419|NCT00910910|593273283|FG000|Overall Study|Untreated before cycle 1|1|||
164338223|NCT02808650|593615095|FG001|Overall Study|Death|0|||
164338224|NCT02808650|593615096|FG002|Overall Study|Death|0|||
164247420|NCT00910910|593273284|FG001|Overall Study|Untreated before cycle 1|2|||
164247421|NCT01973231|593273285|FG000|Overall Study|Protocol Violation|1|||
164247422|NCT01973231|593273286|FG001|Overall Study|Protocol Violation|1|||
164247423|NCT01973231|593273285|FG000|Overall Study|Lost to Follow-up|1|||
164247424|NCT01973231|593273286|FG001|Overall Study|Lost to Follow-up|1|||
164338225|NCT02808650|593615097|FG003|Overall Study|Death|0|||
164338226|NCT02808650|593615098|FG004|Overall Study|Death|1|||
164338227|NCT02808650|593615094|FG000|Overall Study|Lack of Efficacy|5|||
164574867|NCT02197377|594468118|FG000|Overall Study|Insertion Failure|0|||
164574868|NCT02197377|594468119|FG001|Overall Study|Insertion Failure|3|||
164574869|NCT01974323|594468120|FG000|Overall Study|Other Reasons|25|||
164574870|NCT01974323|594468121|FG001|Overall Study|Other Reasons|28|||
164574871|NCT01974323|594468120|FG000|Overall Study|Protocol Violation|2|||
164574872|NCT01974323|594468121|FG001|Overall Study|Protocol Violation|2|||
164574873|NCT01974323|594468120|FG000|Overall Study|Personal Reasons|15|||
164574874|NCT01974323|594468121|FG001|Overall Study|Personal Reasons|19|||
164574875|NCT01974323|594468120|FG000|Overall Study|Lost to Follow-up|45|||
164574876|NCT01974323|594468121|FG001|Overall Study|Lost to Follow-up|40|||
164574877|NCT01974323|594468120|FG000|Overall Study|Pregnancy|2|||
164574878|NCT01974323|594468121|FG001|Overall Study|Pregnancy|1|||
164247425|NCT01973231|593273285|FG000|Overall Study|unclassified|2|||
164247426|NCT01973231|593273286|FG001|Overall Study|unclassified|1|||
164247427|NCT01973231|593273285|FG000|Overall Study|Withdrawal by Subject|7|||
164247428|NCT01973231|593273286|FG001|Overall Study|Withdrawal by Subject|9|||
164247429|NCT00040742|593273290|FG000|Overall Study|Death|0|||
164247430|NCT00040742|593273291|FG001|Overall Study|Death|0|||
164247431|NCT00040742|593273292|FG002|Overall Study|Death|1|||
164247432|NCT00040742|593273293|FG003|Overall Study|Death|0|||
164247433|NCT00040742|593273290|FG000|Overall Study|Adverse Event|15|||
164247434|NCT00040742|593273291|FG001|Overall Study|Adverse Event|16|||
164247435|NCT00040742|593273292|FG002|Overall Study|Adverse Event|21|||
164247436|NCT00040742|593273293|FG003|Overall Study|Adverse Event|9|||
164247437|NCT00040742|593273290|FG000|Overall Study|Withdrawal by Subject|7|||
164247438|NCT00040742|593273291|FG001|Overall Study|Withdrawal by Subject|15|||
164247439|NCT00040742|593273292|FG002|Overall Study|Withdrawal by Subject|10|||
164247440|NCT00040742|593273293|FG003|Overall Study|Withdrawal by Subject|13|||
164247441|NCT00040742|593273290|FG000|Overall Study|Chemotoxicity|4|||
164247442|NCT00040742|593273291|FG001|Overall Study|Chemotoxicity|3|||
164247443|NCT00040742|593273292|FG002|Overall Study|Chemotoxicity|5|||
164247444|NCT00040742|593273293|FG003|Overall Study|Chemotoxicity|2|||
164247445|NCT00040742|593273290|FG000|Overall Study|Incomplete Forms|6|||
164247446|NCT00040742|593273291|FG001|Overall Study|Incomplete Forms|10|||
164247447|NCT00040742|593273292|FG002|Overall Study|Incomplete Forms|4|||
164247448|NCT00040742|593273293|FG003|Overall Study|Incomplete Forms|5|||
164247449|NCT00040742|593273290|FG000|Overall Study|Other medical|7|||
164247450|NCT00040742|593273291|FG001|Overall Study|Other medical|5|||
164247451|NCT00040742|593273292|FG002|Overall Study|Other medical|5|||
164247452|NCT00040742|593273293|FG003|Overall Study|Other medical|5|||
164247453|NCT00624468|593273294|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
164247454|NCT00624468|593273295|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
164247455|NCT00624468|593273296|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
164247456|NCT00624468|593273297|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
164247457|NCT00624468|593273294|FG000|Double-blind Period|Withdrew Prematurely|1|||
164247458|NCT00624468|593273295|FG001|Double-blind Period|Withdrew Prematurely|1|||
164247459|NCT00624468|593273296|FG002|Double-blind Period|Withdrew Prematurely|0|||
164247460|NCT00624468|593273297|FG003|Double-blind Period|Withdrew Prematurely|0|||
164247461|NCT00624468|593273294|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
164247462|NCT00624468|593273295|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
164247463|NCT00624468|593273296|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
164247464|NCT00624468|593273297|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
164247465|NCT00624468|593273294|FG000|Safety Follow-up (SFU) Period|Other|0|||
164247466|NCT00624468|593273295|FG001|Safety Follow-up (SFU) Period|Other|0|||
164247467|NCT00624468|593273296|FG002|Safety Follow-up (SFU) Period|Other|1|||
164426419|NCT04955626|593930835|FG024|Open-Label Period|No longer meets eligibility criteria|0|||
164426420|NCT04955626|593930836|FG025|Open-Label Period|No longer meets eligibility criteria|0|||
164426421|NCT04955626|593930837|FG026|Open-Label Period|No longer meets eligibility criteria|0|||
164426422|NCT04955626|593930838|FG027|Open-Label Period|No longer meets eligibility criteria|0|||
164426423|NCT04955626|593930839|FG028|Open-Label Period|No longer meets eligibility criteria|0|||
164247468|NCT00624468|593273297|FG003|Safety Follow-up (SFU) Period|Other|1|||
164247469|NCT05384834|593273298|FG000|Overall Study|Lost to Follow-up|43|||
164247470|NCT05384834|593273298|FG000|Overall Study|Withdrawal by Subject|5|||
164247471|NCT01523743|593273299|FG000|Period 1|Adverse Event|1|||
164247472|NCT01523743|593273300|FG001|Period 1|Adverse Event|0|||
164247473|NCT01523743|593273299|FG000|Period 1|Withdrawal by Subject|6|||
164247474|NCT01523743|593273300|FG001|Period 1|Withdrawal by Subject|2|||
164247475|NCT01523743|593273299|FG000|Period 1|Lost to Follow-up|1|||
164247476|NCT01523743|593273300|FG001|Period 1|Lost to Follow-up|0|||
164247477|NCT01523743|593273299|FG000|Period 1|Lack of Efficacy|1|||
164247478|NCT01523743|593273300|FG001|Period 1|Lack of Efficacy|0|||
164247479|NCT01523743|593273299|FG000|Period 1|Felt unable to empty bladder|1|||
164247480|NCT01523743|593273300|FG001|Period 1|Felt unable to empty bladder|0|||
164247481|NCT01523743|593273299|FG000|Period 2|Withdrawal by Subject|0|||
164247482|NCT01523743|593273300|FG001|Period 2|Withdrawal by Subject|2|||
164247483|NCT01523743|593273299|FG000|Period 2|Adverse Event|1|||
164247484|NCT01523743|593273300|FG001|Period 2|Adverse Event|0|||
164247485|NCT01434654|593273301|FG000|Overall Study|Withdrawal by Subject|1|||
164247486|NCT01434654|593273302|FG001|Overall Study|Withdrawal by Subject|0|||
164247487|NCT01434654|593273301|FG000|Overall Study|Lost to Follow-up|1|||
164574879|NCT01974323|594468120|FG000|Overall Study|Lack of Efficacy|1|||
164574880|NCT01974323|594468121|FG001|Overall Study|Lack of Efficacy|1|||
164574881|NCT01974323|594468120|FG000|Overall Study|Adverse Event|2|||
164574882|NCT01974323|594468121|FG001|Overall Study|Adverse Event|2|||
164574883|NCT00331760|594468122|FG000|Overall Study|Ineligible / no protocol treatment|15|||
164574884|NCT00331760|594468123|FG001|Overall Study|Ineligible / no protocol treatment|8|||
164574885|NCT00699192|594468124|FG000|Overall Study|Missing|1|||
164574886|NCT00699192|594468125|FG001|Overall Study|Missing|1|||
164574887|NCT00699192|594468126|FG002|Overall Study|Missing|1|||
164574888|NCT00699192|594468124|FG000|Overall Study|Adverse Event|9|||
164574889|NCT00699192|594468125|FG001|Overall Study|Adverse Event|4|||
164574890|NCT00699192|594468126|FG002|Overall Study|Adverse Event|3|||
164574891|NCT00699192|594468124|FG000|Overall Study|Abnormal test procedure result(s)|0|||
164247488|NCT01434654|593273302|FG001|Overall Study|Lost to Follow-up|0|||
164247489|NCT00363142|593273303|FG000|Overall Study|Adverse Event|2|||
164247490|NCT00363142|593273304|FG001|Overall Study|Adverse Event|0|||
164574892|NCT00699192|594468125|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164574893|NCT00699192|594468126|FG002|Overall Study|Abnormal test procedure result(s)|1|||
164574894|NCT00699192|594468124|FG000|Overall Study|Lack of Efficacy|0|||
164574895|NCT00699192|594468125|FG001|Overall Study|Lack of Efficacy|0|||
164574896|NCT00699192|594468126|FG002|Overall Study|Lack of Efficacy|1|||
164574897|NCT00699192|594468124|FG000|Overall Study|Withdrawal by Subject|3|||
164574898|NCT00699192|594468125|FG001|Overall Study|Withdrawal by Subject|2|||
164574899|NCT00699192|594468126|FG002|Overall Study|Withdrawal by Subject|4|||
164574900|NCT00699192|594468124|FG000|Overall Study|Administrative problems|1|||
164574901|NCT00699192|594468125|FG001|Overall Study|Administrative problems|3|||
164574902|NCT00699192|594468126|FG002|Overall Study|Administrative problems|1|||
164574903|NCT00699192|594468124|FG000|Overall Study|Protocol Violation|2|||
164574904|NCT00699192|594468125|FG001|Overall Study|Protocol Violation|2|||
164574905|NCT00699192|594468126|FG002|Overall Study|Protocol Violation|0|||
164574906|NCT01773473|594468127|FG000|Overall Study|Adverse Event|3|||
164247491|NCT00363142|593273303|FG000|Overall Study|Lack of Efficacy|0|||
164247492|NCT00363142|593273304|FG001|Overall Study|Lack of Efficacy|1|||
164574907|NCT01773473|594468128|FG001|Overall Study|Adverse Event|2|||
164574908|NCT01773473|594468127|FG000|Overall Study|Protocol Violation|0|||
164574909|NCT01773473|594468128|FG001|Overall Study|Protocol Violation|4|||
164574910|NCT01773473|594468127|FG000|Overall Study|Physician Decision|3|||
164574911|NCT01773473|594468128|FG001|Overall Study|Physician Decision|5|||
164574912|NCT01773473|594468127|FG000|Overall Study|Sponsor Decision|2|||
164574913|NCT01773473|594468128|FG001|Overall Study|Sponsor Decision|0|||
164574914|NCT01773473|594468127|FG000|Overall Study|Lack of Efficacy|0|||
164574915|NCT01773473|594468128|FG001|Overall Study|Lack of Efficacy|1|||
164574916|NCT01773473|594468127|FG000|Overall Study|Non-Compliance with study drug|1|||
164574917|NCT01773473|594468128|FG001|Overall Study|Non-Compliance with study drug|4|||
164574918|NCT01773473|594468127|FG000|Overall Study|Withdrawal by Subject|5|||
164574919|NCT01773473|594468128|FG001|Overall Study|Withdrawal by Subject|3|||
164574920|NCT01773473|594468127|FG000|Overall Study|Lost to Follow-up|2|||
164574921|NCT01773473|594468128|FG001|Overall Study|Lost to Follow-up|0|||
164574922|NCT00826514|594468129|FG000|Overall Study|Adverse Event|1|||
164574923|NCT00826514|594468130|FG001|Overall Study|Adverse Event|1|||
164574924|NCT00826514|594468129|FG000|Overall Study|Lack of Efficacy|0|||
164574925|NCT00826514|594468130|FG001|Overall Study|Lack of Efficacy|1|||
164574926|NCT00826514|594468129|FG000|Overall Study|Withdrawal by Subject|2|||
164574927|NCT00826514|594468130|FG001|Overall Study|Withdrawal by Subject|3|||
164574928|NCT03663166|594468131|FG000|Overall Study|Withdrawal by Subject|1|||
164574929|NCT00707577|594468133|FG000|Overall Study|Withdrawal by Subject|3|||
164574930|NCT00707577|594468134|FG001|Overall Study|Withdrawal by Subject|2|||
164574931|NCT00707577|594468133|FG000|Overall Study|Lost to Follow-up|34|||
164574932|NCT00707577|594468134|FG001|Overall Study|Lost to Follow-up|25|||
164574933|NCT00707577|594468133|FG000|Overall Study|Left employment|13|||
164574934|NCT00707577|594468134|FG001|Overall Study|Left employment|10|||
164574935|NCT00707577|594468133|FG000|Overall Study|Pregnancy|4|||
164574936|NCT00707577|594468134|FG001|Overall Study|Pregnancy|1|||
164574937|NCT00190775|594468135|FG000|Overall Study|Adverse Event|57|||
164574938|NCT00190775|594468136|FG001|Overall Study|Adverse Event|22|||
164574939|NCT00190775|594468135|FG000|Overall Study|Satisfactory Response|1|||
164574940|NCT00190775|594468136|FG001|Overall Study|Satisfactory Response|0|||
164574941|NCT00190775|594468135|FG000|Overall Study|Lack of Efficacy|28|||
164574942|NCT00190775|594468136|FG001|Overall Study|Lack of Efficacy|32|||
164574943|NCT00190775|594468135|FG000|Overall Study|Lost to Follow-up|31|||
164574944|NCT00190775|594468136|FG001|Overall Study|Lost to Follow-up|23|||
164574945|NCT00190775|594468135|FG000|Overall Study|Participant Moved|0|||
164679424|NCT02923349|594851165|FG001|Overall Study|Other|2|||
164574946|NCT00190775|594468136|FG001|Overall Study|Participant Moved|1|||
164574947|NCT00190775|594468135|FG000|Overall Study|Withdrawal by Subject|24|||
164574948|NCT00190775|594468136|FG001|Overall Study|Withdrawal by Subject|13|||
164679425|NCT02923349|594851166|FG002|Overall Study|Other|4|||
164574949|NCT00190775|594468135|FG000|Overall Study|Sponsor Decision|1|||
164574950|NCT00190775|594468136|FG001|Overall Study|Sponsor Decision|0|||
164574951|NCT00190775|594468135|FG000|Overall Study|Physician Decision|3|||
164574952|NCT00190775|594468136|FG001|Overall Study|Physician Decision|0|||
164574953|NCT00190775|594468135|FG000|Overall Study|Noncompliance|3|||
164574954|NCT00190775|594468136|FG001|Overall Study|Noncompliance|5|||
164679426|NCT02923349|594851167|FG003|Overall Study|Other|1|||
164247493|NCT00363142|593273303|FG000|Overall Study|Lost to Follow-up|1|||
164574955|NCT00190775|594468135|FG000|Overall Study|Protocol Violation|0|||
164574956|NCT00190775|594468136|FG001|Overall Study|Protocol Violation|1|||
164574957|NCT00190775|594468135|FG000|Overall Study|Exclusion Criteria Met|1|||
164247494|NCT00363142|593273304|FG001|Overall Study|Lost to Follow-up|0|||
164247495|NCT00363142|593273303|FG000|Overall Study|Non-compliance|1|||
164247496|NCT00363142|593273304|FG001|Overall Study|Non-compliance|1|||
164247497|NCT00363142|593273303|FG000|Overall Study|Withdrawal by Subject|3|||
164247498|NCT00363142|593273304|FG001|Overall Study|Withdrawal by Subject|1|||
164679427|NCT02923349|594851168|FG004|Overall Study|Other|3|||
164679428|NCT02923349|594851169|FG005|Overall Study|Other|0|||
164679429|NCT02923349|594851170|FG006|Overall Study|Other|1|||
164679430|NCT02923349|594851164|FG000|Overall Study|Withdrawal by Subject|2|||
164679431|NCT02923349|594851165|FG001|Overall Study|Withdrawal by Subject|2|||
164679432|NCT02923349|594851166|FG002|Overall Study|Withdrawal by Subject|8|||
164679433|NCT02923349|594851167|FG003|Overall Study|Withdrawal by Subject|10|||
164679434|NCT02923349|594851168|FG004|Overall Study|Withdrawal by Subject|12|||
164679435|NCT02923349|594851169|FG005|Overall Study|Withdrawal by Subject|3|||
164679436|NCT02923349|594851170|FG006|Overall Study|Withdrawal by Subject|0|||
164679437|NCT02923349|594851164|FG000|Overall Study|Physician Decision|0|||
164679438|NCT02923349|594851165|FG001|Overall Study|Physician Decision|0|||
164679439|NCT02923349|594851166|FG002|Overall Study|Physician Decision|0|||
164679440|NCT02923349|594851167|FG003|Overall Study|Physician Decision|1|||
164679441|NCT02923349|594851168|FG004|Overall Study|Physician Decision|1|||
164679442|NCT02923349|594851169|FG005|Overall Study|Physician Decision|0|||
164679443|NCT02923349|594851170|FG006|Overall Study|Physician Decision|2|||
164679444|NCT02923349|594851164|FG000|Overall Study|Lost to Follow-up|0|||
164679445|NCT02923349|594851165|FG001|Overall Study|Lost to Follow-up|0|||
164679446|NCT02923349|594851166|FG002|Overall Study|Lost to Follow-up|3|||
164679447|NCT02923349|594851167|FG003|Overall Study|Lost to Follow-up|0|||
164679448|NCT02923349|594851168|FG004|Overall Study|Lost to Follow-up|1|||
164679449|NCT02923349|594851169|FG005|Overall Study|Lost to Follow-up|1|||
164679450|NCT02923349|594851170|FG006|Overall Study|Lost to Follow-up|0|||
164679451|NCT02923349|594851164|FG000|Overall Study|Death|1|||
164679452|NCT02923349|594851165|FG001|Overall Study|Death|0|||
164679453|NCT02923349|594851166|FG002|Overall Study|Death|2|||
164247499|NCT01340664|593273307|FG000|Overall Study|Adverse Event|0|||
164247500|NCT01340664|593273308|FG001|Overall Study|Adverse Event|1|||
164247501|NCT01340664|593273309|FG002|Overall Study|Adverse Event|7|||
164247502|NCT01340664|593273307|FG000|Overall Study|Lost to Follow-up|2|||
164247503|NCT01340664|593273308|FG001|Overall Study|Lost to Follow-up|0|||
164247504|NCT01340664|593273309|FG002|Overall Study|Lost to Follow-up|2|||
164247505|NCT01340664|593273307|FG000|Overall Study|Withdrawal by Subject|2|||
164247506|NCT01340664|593273308|FG001|Overall Study|Withdrawal by Subject|4|||
164247507|NCT01340664|593273309|FG002|Overall Study|Withdrawal by Subject|0|||
164338228|NCT02808650|593615095|FG001|Overall Study|Lack of Efficacy|5|||
164338229|NCT02808650|593615096|FG002|Overall Study|Lack of Efficacy|6|||
164338230|NCT02808650|593615097|FG003|Overall Study|Lack of Efficacy|5|||
164338231|NCT02808650|593615098|FG004|Overall Study|Lack of Efficacy|4|||
164338232|NCT02808650|593615094|FG000|Overall Study|Physician Decision|1|||
164338233|NCT02808650|593615095|FG001|Overall Study|Physician Decision|1|||
164338234|NCT02808650|593615096|FG002|Overall Study|Physician Decision|0|||
164338235|NCT02808650|593615097|FG003|Overall Study|Physician Decision|0|||
164338236|NCT02808650|593615098|FG004|Overall Study|Physician Decision|0|||
164338237|NCT02808650|593615094|FG000|Overall Study|Withdrawal by Subject|0|||
164338238|NCT02808650|593615095|FG001|Overall Study|Withdrawal by Subject|0|||
164338239|NCT02808650|593615096|FG002|Overall Study|Withdrawal by Subject|0|||
164338240|NCT02808650|593615097|FG003|Overall Study|Withdrawal by Subject|1|||
164338241|NCT02808650|593615098|FG004|Overall Study|Withdrawal by Subject|1|||
164338242|NCT04093414|593615101|FG000|3 Month Follow up|Physician Decision|0|||
164338243|NCT04093414|593615102|FG001|3 Month Follow up|Physician Decision|1|||
164338244|NCT04093414|593615101|FG000|6month Follow up|Physician Decision|1|||
164338245|NCT04093414|593615102|FG001|6month Follow up|Physician Decision|3|||
164338246|NCT04889222|593615103|FG000|Overall Study|Did not meet eligibility criteria|8|||
164338247|NCT04889222|593615103|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
164338248|NCT04889222|593615103|FG000|Overall Study|Did not proceed due to time constraints|5|||
164338249|NCT01180647|593615104|FG000|Overall Study|Lost to Follow-up|5|||
164338250|NCT01180647|593615105|FG001|Overall Study|Lost to Follow-up|6|||
164338251|NCT00071396|593615112|FG000|Overall Study|Withdrawal by Subject|1|||
164338252|NCT00071396|593615112|FG000|Overall Study|Physician Decision|2|||
164338253|NCT04545554|593615113|FG000|Overall Study|Withdrawal by Subject|0|||
164338254|NCT04545554|593615114|FG001|Overall Study|Withdrawal by Subject|0|||
164338255|NCT04545554|593615115|FG002|Overall Study|Withdrawal by Subject|0|||
164338256|NCT04545554|593615116|FG003|Overall Study|Withdrawal by Subject|1|||
164338257|NCT04545554|593615117|FG004|Overall Study|Withdrawal by Subject|0|||
164338258|NCT04545554|593615118|FG005|Overall Study|Withdrawal by Subject|0|||
164338259|NCT02639546|593615119|FG000|Overall Study|Death|2|||
164679454|NCT02923349|594851167|FG003|Overall Study|Death|4|||
164679455|NCT02923349|594851168|FG004|Overall Study|Death|2|||
164679456|NCT02923349|594851169|FG005|Overall Study|Death|3|||
164679457|NCT02923349|594851170|FG006|Overall Study|Death|0|||
164338260|NCT02639546|593615120|FG001|Overall Study|Death|2|||
164679458|NCT00950989|594851171|FG000|Overall Study|Death|0|||
164338261|NCT02639546|593615121|FG002|Overall Study|Death|1|||
164338262|NCT02639546|593615122|FG003|Overall Study|Death|2|||
164338263|NCT02639546|593615123|FG004|Overall Study|Death|2|||
164338264|NCT02639546|593615124|FG005|Overall Study|Death|2|||
164338265|NCT02639546|593615125|FG006|Overall Study|Death|0|||
164338266|NCT02639546|593615126|FG007|Overall Study|Death|0|||
164338267|NCT02639546|593615119|FG000|Overall Study|Lost to Follow-up|0|||
164338268|NCT02639546|593615120|FG001|Overall Study|Lost to Follow-up|0|||
164338269|NCT02639546|593615121|FG002|Overall Study|Lost to Follow-up|1|||
164574958|NCT00190775|594468136|FG001|Overall Study|Exclusion Criteria Met|3|||
164574959|NCT01794780|594468137|FG000|Overall Study|Adverse Event|0|||
164574960|NCT01794780|594468138|FG001|Overall Study|Adverse Event|1|||
164574961|NCT01794780|594468139|FG002|Overall Study|Adverse Event|2|||
164338270|NCT02639546|593615122|FG003|Overall Study|Lost to Follow-up|0|||
164338271|NCT02639546|593615123|FG004|Overall Study|Lost to Follow-up|1|||
164338272|NCT02639546|593615124|FG005|Overall Study|Lost to Follow-up|1|||
164338273|NCT02639546|593615125|FG006|Overall Study|Lost to Follow-up|0|||
164338274|NCT02639546|593615126|FG007|Overall Study|Lost to Follow-up|1|||
164338275|NCT02639546|593615119|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
164338276|NCT02639546|593615120|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
164338277|NCT02639546|593615121|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
164574962|NCT01794780|594468140|FG003|Overall Study|Adverse Event|0|||
164574963|NCT01794780|594468141|FG004|Overall Study|Adverse Event|0|||
164574964|NCT01794780|594468142|FG005|Overall Study|Adverse Event|0|||
164574965|NCT01794780|594468143|FG006|Overall Study|Adverse Event|0|||
164338278|NCT02639546|593615122|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
164338279|NCT02639546|593615123|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
164338280|NCT02639546|593615124|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
164338281|NCT02639546|593615125|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
164338282|NCT02639546|593615126|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
164338283|NCT02639546|593615119|FG000|Overall Study|Study Terminated By Sponsor|0|||
164338284|NCT02639546|593615120|FG001|Overall Study|Study Terminated By Sponsor|2|||
164338285|NCT02639546|593615121|FG002|Overall Study|Study Terminated By Sponsor|3|||
164338286|NCT02639546|593615122|FG003|Overall Study|Study Terminated By Sponsor|4|||
164574966|NCT01794780|594468144|FG007|Overall Study|Adverse Event|0|||
164679459|NCT00950989|594851172|FG001|Overall Study|Death|0|||
164679460|NCT00950989|594851173|FG002|Overall Study|Death|1|||
164679461|NCT00950989|594851174|FG003|Overall Study|Death|0|||
164679462|NCT00950989|594851171|FG000|Overall Study|Administrative Decision|0|||
164679463|NCT00950989|594851172|FG001|Overall Study|Administrative Decision|1|||
164679464|NCT00950989|594851173|FG002|Overall Study|Administrative Decision|0|||
164679465|NCT00950989|594851174|FG003|Overall Study|Administrative Decision|0|||
164679466|NCT00950989|594851171|FG000|Overall Study|Disease Progression|0|||
164679467|NCT00950989|594851172|FG001|Overall Study|Disease Progression|0|||
164679468|NCT00950989|594851173|FG002|Overall Study|Disease Progression|1|||
164247508|NCT01340664|593273307|FG000|Overall Study|Glycemic withdrawal criteria|2|||
164247509|NCT01340664|593273308|FG001|Overall Study|Glycemic withdrawal criteria|0|||
164247510|NCT01340664|593273309|FG002|Overall Study|Glycemic withdrawal criteria|0|||
164247511|NCT01340664|593273307|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
164247512|NCT01340664|593273308|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
164247513|NCT01340664|593273309|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
164247514|NCT01340664|593273307|FG000|Overall Study|Other|1|||
164247515|NCT01340664|593273308|FG001|Overall Study|Other|2|||
164574967|NCT01794780|594468137|FG000|Overall Study|Death|0|||
164247516|NCT01340664|593273309|FG002|Overall Study|Other|2|||
164247517|NCT01926444|593273311|FG000|Overall Study|Colonoscopy not performed|0|||
164247518|NCT01926444|593273312|FG001|Overall Study|Colonoscopy not performed|0|||
164247519|NCT01926444|593273313|FG002|Overall Study|Colonoscopy not performed|4|||
164247520|NCT01926444|593273314|FG003|Overall Study|Colonoscopy not performed|2|||
164247521|NCT02243371|593273322|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
164426424|NCT04955626|593930840|FG029|Open-Label Period|No longer meets eligibility criteria|0|||
164426425|NCT04955626|593930841|FG030|Open-Label Period|No longer meets eligibility criteria|0|||
164426426|NCT04955626|593930842|FG031|Open-Label Period|No longer meets eligibility criteria|0|||
164426427|NCT04955626|593930843|FG032|Open-Label Period|No longer meets eligibility criteria|0|||
164426428|NCT04955626|593930844|FG033|Open-Label Period|No longer meets eligibility criteria|0|||
164426429|NCT04955626|593930845|FG034|Open-Label Period|No longer meets eligibility criteria|0|||
164426430|NCT04955626|593930846|FG035|Open-Label Period|No longer meets eligibility criteria|0|||
164426431|NCT04955626|593930811|FG000|Open-Label Period|Other|621|||
164426432|NCT04955626|593930812|FG001|Open-Label Period|Other|429|||
164426433|NCT04955626|593930813|FG002|Open-Label Period|Other|0|||
164426434|NCT04955626|593930814|FG003|Open-Label Period|Other|0|||
164426435|NCT04955626|593930815|FG004|Open-Label Period|Other|0|||
164426436|NCT04955626|593930816|FG005|Open-Label Period|Other|0|||
164426437|NCT04955626|593930817|FG006|Open-Label Period|Other|0|||
164426438|NCT04955626|593930818|FG007|Open-Label Period|Other|0|||
164426439|NCT04955626|593930819|FG008|Open-Label Period|Other|0|||
164426440|NCT04955626|593930820|FG009|Open-Label Period|Other|0|||
164426441|NCT04955626|593930821|FG010|Open-Label Period|Other|0|||
164426442|NCT04955626|593930822|FG011|Open-Label Period|Other|0|||
164426443|NCT04955626|593930823|FG012|Open-Label Period|Other|0|||
164426444|NCT04955626|593930824|FG013|Open-Label Period|Other|0|||
164426445|NCT04955626|593930825|FG014|Open-Label Period|Other|0|||
164426446|NCT04955626|593930826|FG015|Open-Label Period|Other|0|||
164426447|NCT04955626|593930827|FG016|Open-Label Period|Other|0|||
164426448|NCT04955626|593930828|FG017|Open-Label Period|Other|0|||
164426449|NCT04955626|593930829|FG018|Open-Label Period|Other|0|||
164426450|NCT04955626|593930830|FG019|Open-Label Period|Other|0|||
164426451|NCT04955626|593930831|FG020|Open-Label Period|Other|0|||
164426452|NCT04955626|593930832|FG021|Open-Label Period|Other|0|||
164574968|NCT01794780|594468138|FG001|Overall Study|Death|2|||
164574969|NCT01794780|594468139|FG002|Overall Study|Death|14|||
164574970|NCT01794780|594468140|FG003|Overall Study|Death|1|||
164574971|NCT01794780|594468141|FG004|Overall Study|Death|0|||
164574972|NCT01794780|594468142|FG005|Overall Study|Death|9|||
164574973|NCT01794780|594468143|FG006|Overall Study|Death|4|||
164574974|NCT01794780|594468144|FG007|Overall Study|Death|0|||
164574975|NCT01794780|594468137|FG000|Overall Study|Lost to Follow-up|10|||
164574976|NCT01794780|594468138|FG001|Overall Study|Lost to Follow-up|64|||
164574977|NCT01794780|594468139|FG002|Overall Study|Lost to Follow-up|165|||
164574978|NCT01794780|594468140|FG003|Overall Study|Lost to Follow-up|53|||
164574979|NCT01794780|594468141|FG004|Overall Study|Lost to Follow-up|2|||
164574980|NCT01794780|594468142|FG005|Overall Study|Lost to Follow-up|99|||
164574981|NCT01794780|594468143|FG006|Overall Study|Lost to Follow-up|30|||
164574982|NCT01794780|594468144|FG007|Overall Study|Lost to Follow-up|5|||
164574983|NCT01794780|594468137|FG000|Overall Study|Withdrew informed consent|7|||
164574984|NCT01794780|594468138|FG001|Overall Study|Withdrew informed consent|17|||
164574985|NCT01794780|594468139|FG002|Overall Study|Withdrew informed consent|36|||
164574986|NCT01794780|594468140|FG003|Overall Study|Withdrew informed consent|9|||
164574987|NCT01794780|594468141|FG004|Overall Study|Withdrew informed consent|0|||
164574988|NCT01794780|594468142|FG005|Overall Study|Withdrew informed consent|48|||
164574989|NCT01794780|594468143|FG006|Overall Study|Withdrew informed consent|4|||
164574990|NCT01794780|594468144|FG007|Overall Study|Withdrew informed consent|3|||
164574991|NCT01794780|594468137|FG000|Overall Study|Other|0|||
164574992|NCT01794780|594468138|FG001|Overall Study|Other|12|||
164574993|NCT01794780|594468139|FG002|Overall Study|Other|25|||
164574994|NCT01794780|594468140|FG003|Overall Study|Other|20|||
164574995|NCT01794780|594468141|FG004|Overall Study|Other|1|||
164574996|NCT01794780|594468142|FG005|Overall Study|Other|24|||
164574997|NCT01794780|594468143|FG006|Overall Study|Other|4|||
164574998|NCT01794780|594468144|FG007|Overall Study|Other|1|||
164574999|NCT02286102|594468145|FG000|Overall Study|Screen Failure|1|||
164247522|NCT02243371|593273323|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
164247523|NCT02243371|593273322|FG000|Overall Study|Death (unrelated)|2|||
164426453|NCT04955626|593930833|FG022|Open-Label Period|Other|0|||
164426454|NCT04955626|593930834|FG023|Open-Label Period|Other|0|||
164426455|NCT04955626|593930835|FG024|Open-Label Period|Other|0|||
164575000|NCT02286102|594468146|FG001|Overall Study|Screen Failure|1|||
164575001|NCT01967225|594468147|FG000|Overall Study|Adverse Event|3|||
164575002|NCT01967225|594468148|FG001|Overall Study|Adverse Event|1|||
164575003|NCT01967225|594468147|FG000|Overall Study|Withdrawal by Subject|2|||
164426456|NCT04955626|593930836|FG025|Open-Label Period|Other|0|||
164426457|NCT04955626|593930837|FG026|Open-Label Period|Other|0|||
164426458|NCT04955626|593930838|FG027|Open-Label Period|Other|0|||
164426459|NCT04955626|593930839|FG028|Open-Label Period|Other|0|||
164575004|NCT01967225|594468148|FG001|Overall Study|Withdrawal by Subject|1|||
164575005|NCT01967225|594468147|FG000|Overall Study|Lack of Efficacy|1|||
164247524|NCT02243371|593273323|FG001|Overall Study|Death (unrelated)|4|||
164247525|NCT02243371|593273322|FG000|Overall Study|Adverse Event (unrelated)|0|||
164247526|NCT02243371|593273323|FG001|Overall Study|Adverse Event (unrelated)|1|||
164247527|NCT02243371|593273322|FG000|Overall Study|Lack of Clinical Benefit|0|||
164247528|NCT02243371|593273323|FG001|Overall Study|Lack of Clinical Benefit|1|||
164247529|NCT02243371|593273322|FG000|Overall Study|Withdrawal by Subject|0|||
164247530|NCT02243371|593273323|FG001|Overall Study|Withdrawal by Subject|2|||
164247531|NCT02441101|593273324|FG000|Overall Study|Withdrawal by Subject|1|||
164247532|NCT02441101|593273325|FG001|Overall Study|Withdrawal by Subject|0|||
164247533|NCT02441101|593273324|FG000|Overall Study|Lost to Follow-up|1|||
164247534|NCT02441101|593273325|FG001|Overall Study|Lost to Follow-up|0|||
164426460|NCT04955626|593930840|FG029|Open-Label Period|Other|0|||
164426461|NCT04955626|593930841|FG030|Open-Label Period|Other|0|||
164426462|NCT04955626|593930842|FG031|Open-Label Period|Other|0|||
164426463|NCT04955626|593930843|FG032|Open-Label Period|Other|0|||
164426464|NCT04955626|593930844|FG033|Open-Label Period|Other|0|||
164426465|NCT04955626|593930845|FG034|Open-Label Period|Other|0|||
164426466|NCT04955626|593930846|FG035|Open-Label Period|Other|0|||
164426467|NCT04955626|593930811|FG000|Open-Label Period|Physician Decision|2|||
164426468|NCT04955626|593930812|FG001|Open-Label Period|Physician Decision|0|||
164426469|NCT04955626|593930813|FG002|Open-Label Period|Physician Decision|0|||
164426470|NCT04955626|593930814|FG003|Open-Label Period|Physician Decision|0|||
164426471|NCT04955626|593930815|FG004|Open-Label Period|Physician Decision|0|||
164426472|NCT04955626|593930816|FG005|Open-Label Period|Physician Decision|0|||
164426473|NCT04955626|593930817|FG006|Open-Label Period|Physician Decision|0|||
164426474|NCT04955626|593930818|FG007|Open-Label Period|Physician Decision|0|||
164426475|NCT04955626|593930819|FG008|Open-Label Period|Physician Decision|0|||
164426476|NCT04955626|593930820|FG009|Open-Label Period|Physician Decision|0|||
164426477|NCT04955626|593930821|FG010|Open-Label Period|Physician Decision|0|||
164575006|NCT01967225|594468148|FG001|Overall Study|Lack of Efficacy|1|||
164575007|NCT01967225|594468147|FG000|Overall Study|Switching to other therapy|2|||
164247535|NCT02441101|593273324|FG000|Overall Study|PI relocated and study terminated|1|||
164247536|NCT02441101|593273325|FG001|Overall Study|PI relocated and study terminated|0|||
164575008|NCT01967225|594468148|FG001|Overall Study|Switching to other therapy|0|||
164575009|NCT01967225|594468147|FG000|Overall Study|Protocol driven decision point|1|||
164247537|NCT02528942|593273328|FG000|Overall Study|Did not meet imaging criteria|9|||
164247538|NCT02528942|593273328|FG000|Overall Study|Lost to Follow-up|25|||
164247539|NCT00271856|593273329|FG000|Overall Study|Withdrawal by Subject|1|||
164247540|NCT00271856|593273330|FG001|Overall Study|Withdrawal by Subject|7|||
164247541|NCT00271856|593273329|FG000|Overall Study|Lost to Follow-up|10|||
164247542|NCT00271856|593273330|FG001|Overall Study|Lost to Follow-up|11|||
164247543|NCT04599803|593273331|FG000|Overall Study|Withdrawal by Subject|5|||
164247544|NCT04599803|593273331|FG000|Overall Study|Lost to Follow-up|26|||
164247545|NCT02544750|593273332|FG000|Overall Study|Physician Decision|3|||
164247546|NCT02544750|593273333|FG001|Overall Study|Physician Decision|1|||
164247547|NCT02544750|593273332|FG000|Overall Study|Other reasons|69|||
164247548|NCT02544750|593273333|FG001|Overall Study|Other reasons|39|||
164247549|NCT02544750|593273332|FG000|Overall Study|Met withdrawal criteria|2|||
164247550|NCT02544750|593273333|FG001|Overall Study|Met withdrawal criteria|2|||
164247551|NCT02544750|593273332|FG000|Overall Study|Transition To Commercial Product|1|||
164247552|NCT02544750|593273333|FG001|Overall Study|Transition To Commercial Product|0|||
164247553|NCT02544750|593273332|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
164247554|NCT02544750|593273333|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
164247555|NCT02544750|593273332|FG000|Overall Study|Adverse Event|8|||
164247556|NCT02544750|593273333|FG001|Overall Study|Adverse Event|10|||
164247557|NCT02544750|593273332|FG000|Overall Study|Withdrawal by Subject|10|||
164247558|NCT02544750|593273333|FG001|Overall Study|Withdrawal by Subject|4|||
164247559|NCT02544750|593273332|FG000|Overall Study|Lost to Follow-up|1|||
164247560|NCT02544750|593273333|FG001|Overall Study|Lost to Follow-up|0|||
164247561|NCT03035864|593273336|FG000|Treatment Period|Adverse Event|1|||
164247562|NCT03035864|593273337|FG001|Treatment Period|Adverse Event|0|||
164247563|NCT03035864|593273336|FG000|Treatment Period|Other|3|||
164247564|NCT03035864|593273337|FG001|Treatment Period|Other|1|||
164247565|NCT03035864|593273336|FG000|Follow-up Period|Adverse Event|1|||
164247566|NCT03035864|593273337|FG001|Follow-up Period|Adverse Event|0|||
164247567|NCT03035864|593273336|FG000|Follow-up Period|Lost to Follow-up|6|||
164247568|NCT03035864|593273337|FG001|Follow-up Period|Lost to Follow-up|2|||
164575010|NCT01967225|594468148|FG001|Overall Study|Protocol driven decision point|0|||
164575011|NCT01967225|594468147|FG000|Overall Study|Logistical difficulties|1|||
164247569|NCT03035864|593273336|FG000|Follow-up Period|Physician Decision|1|||
164247570|NCT03035864|593273337|FG001|Follow-up Period|Physician Decision|0|||
164426478|NCT04955626|593930822|FG011|Open-Label Period|Physician Decision|0|||
164426479|NCT04955626|593930823|FG012|Open-Label Period|Physician Decision|0|||
164247571|NCT03035864|593273336|FG000|Follow-up Period|Other|3|||
164426480|NCT04955626|593930824|FG013|Open-Label Period|Physician Decision|0|||
164426481|NCT04955626|593930825|FG014|Open-Label Period|Physician Decision|0|||
164575012|NCT01967225|594468148|FG001|Overall Study|Logistical difficulties|0|||
164575013|NCT01967225|594468147|FG000|Overall Study|Protocol Violation|2|||
164426482|NCT04955626|593930826|FG015|Open-Label Period|Physician Decision|0|||
164426483|NCT04955626|593930827|FG016|Open-Label Period|Physician Decision|0|||
164426484|NCT04955626|593930828|FG017|Open-Label Period|Physician Decision|0|||
164426485|NCT04955626|593930829|FG018|Open-Label Period|Physician Decision|0|||
164426486|NCT04955626|593930830|FG019|Open-Label Period|Physician Decision|0|||
164426487|NCT04955626|593930831|FG020|Open-Label Period|Physician Decision|0|||
164426488|NCT04955626|593930832|FG021|Open-Label Period|Physician Decision|0|||
164426489|NCT04955626|593930833|FG022|Open-Label Period|Physician Decision|0|||
164426490|NCT04955626|593930834|FG023|Open-Label Period|Physician Decision|0|||
164426491|NCT04955626|593930835|FG024|Open-Label Period|Physician Decision|0|||
164426492|NCT04955626|593930836|FG025|Open-Label Period|Physician Decision|0|||
164426493|NCT04955626|593930837|FG026|Open-Label Period|Physician Decision|0|||
164426494|NCT04955626|593930838|FG027|Open-Label Period|Physician Decision|0|||
164426495|NCT04955626|593930839|FG028|Open-Label Period|Physician Decision|0|||
164426496|NCT04955626|593930840|FG029|Open-Label Period|Physician Decision|0|||
164426497|NCT04955626|593930841|FG030|Open-Label Period|Physician Decision|0|||
164426498|NCT04955626|593930842|FG031|Open-Label Period|Physician Decision|0|||
164426499|NCT04955626|593930843|FG032|Open-Label Period|Physician Decision|0|||
164426500|NCT04955626|593930844|FG033|Open-Label Period|Physician Decision|0|||
164426501|NCT04955626|593930845|FG034|Open-Label Period|Physician Decision|0|||
164426502|NCT04955626|593930846|FG035|Open-Label Period|Physician Decision|0|||
164426503|NCT04955626|593930811|FG000|Open-Label Period|Withdrawal by Subject|135|||
164426504|NCT04955626|593930812|FG001|Open-Label Period|Withdrawal by Subject|25|||
164426505|NCT04955626|593930813|FG002|Open-Label Period|Withdrawal by Subject|0|||
164247572|NCT03035864|593273337|FG001|Follow-up Period|Other|2|||
164247573|NCT00100802|593273340|FG000|Overall Study|Adverse Event|9|||
164247574|NCT00100802|593273340|FG000|Overall Study|Death|1|||
164247575|NCT00100802|593273340|FG000|Overall Study|Lack of Efficacy|47|||
164247576|NCT00100802|593273340|FG000|Overall Study|Physician Decision|5|||
164247577|NCT00100802|593273340|FG000|Overall Study|Protocol Violation|1|||
164247578|NCT00100802|593273340|FG000|Overall Study|Withdrawal by Subject|5|||
164247579|NCT00100802|593273340|FG000|Overall Study|Ineligible|12|||
164247580|NCT02712983|593275288|FG000|Treatment Phase|Adverse Event|3|||
164247581|NCT02712983|593275289|FG001|Treatment Phase|Adverse Event|1|||
164247582|NCT02712983|593275290|FG002|Treatment Phase|Adverse Event|1|||
164247583|NCT02712983|593275291|FG003|Treatment Phase|Adverse Event|4|||
164247584|NCT02712983|593275292|FG004|Treatment Phase|Adverse Event|3|||
164247585|NCT02712983|593275293|FG005|Treatment Phase|Adverse Event|0|||
164247586|NCT02712983|593275294|FG006|Treatment Phase|Adverse Event|6|||
164247587|NCT02712983|593275295|FG007|Treatment Phase|Adverse Event|6|||
164247588|NCT02712983|593275296|FG008|Treatment Phase|Adverse Event|1|||
164247589|NCT02712983|593275288|FG000|Treatment Phase|Protocol Deviation|0|||
164247590|NCT02712983|593275289|FG001|Treatment Phase|Protocol Deviation|0|||
164247591|NCT02712983|593275290|FG002|Treatment Phase|Protocol Deviation|0|||
164247592|NCT02712983|593275291|FG003|Treatment Phase|Protocol Deviation|2|||
164247593|NCT02712983|593275292|FG004|Treatment Phase|Protocol Deviation|0|||
164338287|NCT02639546|593615123|FG004|Overall Study|Study Terminated By Sponsor|4|||
164338288|NCT02639546|593615124|FG005|Overall Study|Study Terminated By Sponsor|3|||
164338289|NCT02639546|593615125|FG006|Overall Study|Study Terminated By Sponsor|3|||
164338290|NCT02639546|593615126|FG007|Overall Study|Study Terminated By Sponsor|9|||
164338291|NCT02639546|593615119|FG000|Overall Study|Withdrawal by Subject|2|||
164338292|NCT02639546|593615120|FG001|Overall Study|Withdrawal by Subject|2|||
164426506|NCT04955626|593930814|FG003|Open-Label Period|Withdrawal by Subject|0|||
164426507|NCT04955626|593930815|FG004|Open-Label Period|Withdrawal by Subject|0|||
164679469|NCT00950989|594851174|FG003|Overall Study|Disease Progression|0|||
164247594|NCT02712983|593275293|FG005|Treatment Phase|Protocol Deviation|0|||
164338293|NCT02639546|593615121|FG002|Overall Study|Withdrawal by Subject|1|||
164338294|NCT02639546|593615122|FG003|Overall Study|Withdrawal by Subject|0|||
164338295|NCT02639546|593615123|FG004|Overall Study|Withdrawal by Subject|0|||
164338296|NCT02639546|593615124|FG005|Overall Study|Withdrawal by Subject|1|||
164338297|NCT02639546|593615125|FG006|Overall Study|Withdrawal by Subject|2|||
164247595|NCT02712983|593275294|FG006|Treatment Phase|Protocol Deviation|1|||
164247596|NCT02712983|593275295|FG007|Treatment Phase|Protocol Deviation|0|||
164247597|NCT02712983|593275296|FG008|Treatment Phase|Protocol Deviation|0|||
164426508|NCT04955626|593930816|FG005|Open-Label Period|Withdrawal by Subject|0|||
164247598|NCT02712983|593275288|FG000|Treatment Phase|Technical Problems|0|||
164426509|NCT04955626|593930817|FG006|Open-Label Period|Withdrawal by Subject|0|||
164426510|NCT04955626|593930818|FG007|Open-Label Period|Withdrawal by Subject|0|||
164426511|NCT04955626|593930819|FG008|Open-Label Period|Withdrawal by Subject|0|||
164426512|NCT04955626|593930820|FG009|Open-Label Period|Withdrawal by Subject|0|||
164426513|NCT04955626|593930821|FG010|Open-Label Period|Withdrawal by Subject|0|||
164426514|NCT04955626|593930822|FG011|Open-Label Period|Withdrawal by Subject|0|||
164426515|NCT04955626|593930823|FG012|Open-Label Period|Withdrawal by Subject|0|||
164426516|NCT04955626|593930824|FG013|Open-Label Period|Withdrawal by Subject|0|||
164426517|NCT04955626|593930825|FG014|Open-Label Period|Withdrawal by Subject|0|||
164679470|NCT00950989|594851171|FG000|Overall Study|Withdrawal by Subject|2|||
164247599|NCT02712983|593275289|FG001|Treatment Phase|Technical Problems|0|||
164426518|NCT04955626|593930826|FG015|Open-Label Period|Withdrawal by Subject|0|||
164426519|NCT04955626|593930827|FG016|Open-Label Period|Withdrawal by Subject|0|||
164426520|NCT04955626|593930828|FG017|Open-Label Period|Withdrawal by Subject|0|||
164426521|NCT04955626|593930829|FG018|Open-Label Period|Withdrawal by Subject|0|||
164426522|NCT04955626|593930830|FG019|Open-Label Period|Withdrawal by Subject|0|||
164426523|NCT04955626|593930831|FG020|Open-Label Period|Withdrawal by Subject|0|||
164426524|NCT04955626|593930832|FG021|Open-Label Period|Withdrawal by Subject|0|||
164426525|NCT04955626|593930833|FG022|Open-Label Period|Withdrawal by Subject|0|||
164426526|NCT04955626|593930834|FG023|Open-Label Period|Withdrawal by Subject|0|||
164426527|NCT04955626|593930835|FG024|Open-Label Period|Withdrawal by Subject|0|||
164426528|NCT04955626|593930836|FG025|Open-Label Period|Withdrawal by Subject|0|||
164426529|NCT04955626|593930837|FG026|Open-Label Period|Withdrawal by Subject|0|||
164426530|NCT04955626|593930838|FG027|Open-Label Period|Withdrawal by Subject|0|||
164426531|NCT04955626|593930839|FG028|Open-Label Period|Withdrawal by Subject|0|||
164426532|NCT04955626|593930840|FG029|Open-Label Period|Withdrawal by Subject|0|||
164426533|NCT04955626|593930841|FG030|Open-Label Period|Withdrawal by Subject|0|||
164426534|NCT04955626|593930842|FG031|Open-Label Period|Withdrawal by Subject|0|||
164426535|NCT04955626|593930843|FG032|Open-Label Period|Withdrawal by Subject|0|||
164426536|NCT04955626|593930844|FG033|Open-Label Period|Withdrawal by Subject|0|||
164426537|NCT04955626|593930845|FG034|Open-Label Period|Withdrawal by Subject|0|||
164426538|NCT04955626|593930846|FG035|Open-Label Period|Withdrawal by Subject|0|||
164426539|NCT04955626|593930811|FG000|Open-Label Period|Refused further study procedures|1|||
164426540|NCT04955626|593930812|FG001|Open-Label Period|Refused further study procedures|0|||
164426541|NCT04955626|593930813|FG002|Open-Label Period|Refused further study procedures|0|||
164426542|NCT04955626|593930814|FG003|Open-Label Period|Refused further study procedures|0|||
164426543|NCT04955626|593930815|FG004|Open-Label Period|Refused further study procedures|0|||
164426544|NCT04955626|593930816|FG005|Open-Label Period|Refused further study procedures|0|||
164426545|NCT04955626|593930817|FG006|Open-Label Period|Refused further study procedures|0|||
164426546|NCT04955626|593930818|FG007|Open-Label Period|Refused further study procedures|0|||
164426547|NCT04955626|593930819|FG008|Open-Label Period|Refused further study procedures|0|||
164426548|NCT04955626|593930820|FG009|Open-Label Period|Refused further study procedures|0|||
164426549|NCT04955626|593930821|FG010|Open-Label Period|Refused further study procedures|0|||
164426550|NCT04955626|593930822|FG011|Open-Label Period|Refused further study procedures|0|||
164426551|NCT04955626|593930823|FG012|Open-Label Period|Refused further study procedures|0|||
164426552|NCT04955626|593930824|FG013|Open-Label Period|Refused further study procedures|0|||
164426553|NCT04955626|593930825|FG014|Open-Label Period|Refused further study procedures|0|||
164426554|NCT04955626|593930826|FG015|Open-Label Period|Refused further study procedures|0|||
164426555|NCT04955626|593930827|FG016|Open-Label Period|Refused further study procedures|0|||
164426556|NCT04955626|593930828|FG017|Open-Label Period|Refused further study procedures|0|||
164426557|NCT04955626|593930829|FG018|Open-Label Period|Refused further study procedures|0|||
164426558|NCT04955626|593930830|FG019|Open-Label Period|Refused further study procedures|0|||
164426559|NCT04955626|593930831|FG020|Open-Label Period|Refused further study procedures|0|||
164426560|NCT04955626|593930832|FG021|Open-Label Period|Refused further study procedures|0|||
164426561|NCT04955626|593930833|FG022|Open-Label Period|Refused further study procedures|0|||
164426562|NCT04955626|593930834|FG023|Open-Label Period|Refused further study procedures|0|||
164426563|NCT04955626|593930835|FG024|Open-Label Period|Refused further study procedures|0|||
164426564|NCT04955626|593930836|FG025|Open-Label Period|Refused further study procedures|0|||
164426565|NCT04955626|593930837|FG026|Open-Label Period|Refused further study procedures|0|||
164426566|NCT04955626|593930838|FG027|Open-Label Period|Refused further study procedures|0|||
164426567|NCT04955626|593930839|FG028|Open-Label Period|Refused further study procedures|0|||
164426568|NCT04955626|593930840|FG029|Open-Label Period|Refused further study procedures|0|||
164426569|NCT04955626|593930841|FG030|Open-Label Period|Refused further study procedures|0|||
164426570|NCT04955626|593930842|FG031|Open-Label Period|Refused further study procedures|0|||
164338298|NCT02639546|593615126|FG007|Overall Study|Withdrawal by Subject|1|||
164338299|NCT02478372|593615127|FG000|Overall Study|Protocol Violation|12|||
164338300|NCT02478372|593615128|FG001|Overall Study|Protocol Violation|8|||
164338301|NCT02478372|593615127|FG000|Overall Study|Lost to Follow-up|1|||
164338302|NCT02478372|593615128|FG001|Overall Study|Lost to Follow-up|4|||
164338303|NCT02478372|593615127|FG000|Overall Study|Death|0|||
164338304|NCT02478372|593615128|FG001|Overall Study|Death|2|||
164338305|NCT00116428|593615129|FG000|Overall Study|Withdrawal by Subject|2|||
164338306|NCT00116428|593615130|FG001|Overall Study|Withdrawal by Subject|5|||
164338307|NCT00116428|593615129|FG000|Overall Study|Did not meet inclusion criteria|1|||
164338308|NCT00116428|593615130|FG001|Overall Study|Did not meet inclusion criteria|0|||
164338309|NCT01032174|593615131|FG000|Overall Study|Adverse Event|0|||
164338310|NCT01032174|593615132|FG001|Overall Study|Adverse Event|1|||
164426571|NCT04955626|593930843|FG032|Open-Label Period|Refused further study procedures|0|||
164338311|NCT00113087|593615133|FG000|Overall Study|Death or Transplant|14|||
164338312|NCT00113087|593615134|FG001|Overall Study|Death or Transplant|16|||
164338313|NCT00113087|593615133|FG000|Overall Study|Family or MD withdrew subject|10|||
164247600|NCT02712983|593275290|FG002|Treatment Phase|Technical Problems|0|||
164247601|NCT02712983|593275291|FG003|Treatment Phase|Technical Problems|0|||
164247602|NCT02712983|593275292|FG004|Treatment Phase|Technical Problems|0|||
164247603|NCT02712983|593275293|FG005|Treatment Phase|Technical Problems|0|||
164247604|NCT02712983|593275294|FG006|Treatment Phase|Technical Problems|1|||
164247605|NCT02712983|593275295|FG007|Treatment Phase|Technical Problems|0|||
164679471|NCT00950989|594851172|FG001|Overall Study|Withdrawal by Subject|1|||
164247606|NCT02712983|593275296|FG008|Treatment Phase|Technical Problems|0|||
164247607|NCT02712983|593275288|FG000|Treatment Phase|Physician Decision|0|||
164247608|NCT02712983|593275289|FG001|Treatment Phase|Physician Decision|0|||
164247609|NCT02712983|593275290|FG002|Treatment Phase|Physician Decision|0|||
164247610|NCT02712983|593275291|FG003|Treatment Phase|Physician Decision|0|||
164247611|NCT02712983|593275292|FG004|Treatment Phase|Physician Decision|0|||
164247612|NCT02712983|593275293|FG005|Treatment Phase|Physician Decision|0|||
164247613|NCT02712983|593275294|FG006|Treatment Phase|Physician Decision|0|||
164338314|NCT00113087|593615134|FG001|Overall Study|Family or MD withdrew subject|5|||
164338315|NCT03452228|593615135|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
164338316|NCT03452228|593615136|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
164338317|NCT03452228|593615137|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
164338318|NCT03452228|593615135|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
164338319|NCT03452228|593615136|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
164338320|NCT03452228|593615137|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164338321|NCT03452228|593615135|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
164338322|NCT03452228|593615136|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
164338323|NCT03452228|593615137|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
164338324|NCT03452228|593615135|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164338325|NCT03452228|593615136|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164338326|NCT03452228|593615137|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
164338327|NCT03212690|593615138|FG000|Overall Study|Protocol Violation|1|||
164338328|NCT03208127|593615140|FG000|Overall Study|Death|1|||
164338329|NCT01254331|593615145|FG000|Initial Phase|Adverse Event|3|||
164338330|NCT01254331|593615145|FG000|Initial Phase|Withdrawal by Subject|1|||
164338331|NCT01254331|593615145|FG000|Initial Phase|Pregnancy|1|||
164338332|NCT01254331|593615145|FG000|Extension Phase|Lack of Efficacy|1|||
164338333|NCT01254331|593615145|FG000|Extension Phase|Lost to Follow-up|3|||
164338334|NCT01011738|593615146|FG000|Overall Study|Death|12|||
164338335|NCT01011738|593615147|FG001|Overall Study|Death|3|||
164338336|NCT01011738|593615148|FG002|Overall Study|Death|0|||
164338337|NCT01011738|593615146|FG000|Overall Study|Unknown reasons|312|||
164338338|NCT01011738|593615147|FG001|Overall Study|Unknown reasons|291|||
164338339|NCT01011738|593615148|FG002|Overall Study|Unknown reasons|17|||
164338340|NCT00287365|593615149|FG000|Overall Study|sample not acquired|13|||
164338341|NCT00968864|593615150|FG000|Overall Study|Protocol exception/ not evaluable|1|||
164338342|NCT01967173|593615151|FG000|Overall Study|Lost to Follow-up|5|||
164338343|NCT01967173|593615152|FG001|Overall Study|Lost to Follow-up|3|||
164338344|NCT01967173|593615153|FG002|Overall Study|Lost to Follow-up|2|||
164338345|NCT01967173|593615154|FG003|Overall Study|Lost to Follow-up|4|||
164338346|NCT01967173|593615155|FG004|Overall Study|Lost to Follow-up|8|||
164338347|NCT01967173|593615156|FG005|Overall Study|Lost to Follow-up|12|||
164338348|NCT01967173|593615157|FG006|Overall Study|Lost to Follow-up|6|||
164338349|NCT01967173|593615158|FG007|Overall Study|Lost to Follow-up|8|||
164338350|NCT01967173|593615151|FG000|Overall Study|Physician Decision|2|||
164338351|NCT01967173|593615152|FG001|Overall Study|Physician Decision|0|||
164338352|NCT01967173|593615153|FG002|Overall Study|Physician Decision|2|||
164338353|NCT01967173|593615154|FG003|Overall Study|Physician Decision|1|||
164338354|NCT01967173|593615155|FG004|Overall Study|Physician Decision|1|||
164338355|NCT01967173|593615156|FG005|Overall Study|Physician Decision|1|||
164338356|NCT01967173|593615157|FG006|Overall Study|Physician Decision|1|||
164338357|NCT01967173|593615158|FG007|Overall Study|Physician Decision|0|||
164338358|NCT01967173|593615151|FG000|Overall Study|Lack of Efficacy|2|||
164338359|NCT01967173|593615152|FG001|Overall Study|Lack of Efficacy|0|||
164338360|NCT01967173|593615153|FG002|Overall Study|Lack of Efficacy|2|||
164338361|NCT01967173|593615154|FG003|Overall Study|Lack of Efficacy|2|||
164338362|NCT01967173|593615155|FG004|Overall Study|Lack of Efficacy|0|||
164338363|NCT01967173|593615156|FG005|Overall Study|Lack of Efficacy|1|||
164338364|NCT01967173|593615157|FG006|Overall Study|Lack of Efficacy|0|||
164338365|NCT01967173|593615158|FG007|Overall Study|Lack of Efficacy|2|||
164338366|NCT01967173|593615151|FG000|Overall Study|Pregnancy|0|||
164338367|NCT01967173|593615152|FG001|Overall Study|Pregnancy|0|||
164338368|NCT01967173|593615153|FG002|Overall Study|Pregnancy|0|||
164679472|NCT00950989|594851173|FG002|Overall Study|Withdrawal by Subject|0|||
164338369|NCT01967173|593615154|FG003|Overall Study|Pregnancy|0|||
164338370|NCT01967173|593615155|FG004|Overall Study|Pregnancy|0|||
164338371|NCT01967173|593615156|FG005|Overall Study|Pregnancy|0|||
164338372|NCT01967173|593615157|FG006|Overall Study|Pregnancy|1|||
164679473|NCT00950989|594851174|FG003|Overall Study|Withdrawal by Subject|0|||
164338373|NCT01967173|593615158|FG007|Overall Study|Pregnancy|1|||
164247614|NCT02712983|593275295|FG007|Treatment Phase|Physician Decision|1|||
164247615|NCT02712983|593275296|FG008|Treatment Phase|Physician Decision|1|||
164247616|NCT02712983|593275288|FG000|Treatment Phase|Subject Decision|2|||
164247617|NCT02712983|593275289|FG001|Treatment Phase|Subject Decision|0|||
164247618|NCT02712983|593275290|FG002|Treatment Phase|Subject Decision|0|||
164247619|NCT02712983|593275291|FG003|Treatment Phase|Subject Decision|2|||
164247620|NCT02712983|593275292|FG004|Treatment Phase|Subject Decision|1|||
164247621|NCT02712983|593275293|FG005|Treatment Phase|Subject Decision|0|||
164247622|NCT02712983|593275294|FG006|Treatment Phase|Subject Decision|1|||
164247623|NCT02712983|593275295|FG007|Treatment Phase|Subject Decision|2|||
164247624|NCT02712983|593275296|FG008|Treatment Phase|Subject Decision|0|||
164426572|NCT04955626|593930844|FG033|Open-Label Period|Refused further study procedures|0|||
164426573|NCT04955626|593930845|FG034|Open-Label Period|Refused further study procedures|0|||
164426574|NCT04955626|593930846|FG035|Open-Label Period|Refused further study procedures|0|||
164426575|NCT04955626|593930811|FG000|Open-Label Period|Adverse Event|1|||
164426576|NCT04955626|593930812|FG001|Open-Label Period|Adverse Event|0|||
164426577|NCT04955626|593930813|FG002|Open-Label Period|Adverse Event|0|||
164426578|NCT04955626|593930814|FG003|Open-Label Period|Adverse Event|0|||
164426579|NCT04955626|593930815|FG004|Open-Label Period|Adverse Event|0|||
164426580|NCT04955626|593930816|FG005|Open-Label Period|Adverse Event|0|||
164426581|NCT04955626|593930817|FG006|Open-Label Period|Adverse Event|0|||
164426582|NCT04955626|593930818|FG007|Open-Label Period|Adverse Event|0|||
164426583|NCT04955626|593930819|FG008|Open-Label Period|Adverse Event|0|||
164426584|NCT04955626|593930820|FG009|Open-Label Period|Adverse Event|0|||
164426585|NCT04955626|593930821|FG010|Open-Label Period|Adverse Event|0|||
164426586|NCT04955626|593930822|FG011|Open-Label Period|Adverse Event|0|||
164426587|NCT04955626|593930823|FG012|Open-Label Period|Adverse Event|0|||
164247625|NCT02712983|593275288|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
164247626|NCT02712983|593275289|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
164247627|NCT02712983|593275290|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
164247628|NCT02712983|593275291|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
164247629|NCT02712983|593275292|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
164247630|NCT02712983|593275293|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
164247631|NCT02712983|593275294|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
164247632|NCT02712983|593275295|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
164247633|NCT02712983|593275296|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
164247634|NCT02712983|593275288|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
164247635|NCT02712983|593275289|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
164247636|NCT02712983|593275290|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
164247637|NCT02712983|593275291|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
164247638|NCT02712983|593275292|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
164247639|NCT02712983|593275293|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
164247640|NCT02712983|593275294|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
164247641|NCT02712983|593275295|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
164247642|NCT02712983|593275296|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
164247643|NCT02712983|593275288|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
164247644|NCT02712983|593275289|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
164247645|NCT02712983|593275290|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
164247646|NCT02712983|593275291|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
164247647|NCT02712983|593275292|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
164247648|NCT02712983|593275293|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
164247649|NCT02712983|593275294|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
164247650|NCT02712983|593275295|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
164247651|NCT02712983|593275296|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
164247652|NCT03280303|593275297|FG000|Overall Study|Death|505|||
164247653|NCT03280303|593275297|FG000|Overall Study|Study terminated by sponsor|383|||
164247654|NCT03280303|593275297|FG000|Overall Study|Other|148|||
164247655|NCT03280303|593275297|FG000|Overall Study|No longer willing to participate in study|101|||
164247656|NCT03280303|593275297|FG000|Overall Study|Lost to follow up|39|||
164247657|NCT03280303|593275297|FG000|Overall Study|Adverse Event|20|||
164247658|NCT00064259|593275298|FG000|Overall Study|Adverse Event|1|||
164247659|NCT00064259|593275299|FG001|Overall Study|Adverse Event|0|||
164247660|NCT00064259|593275300|FG002|Overall Study|Adverse Event|0|||
164426588|NCT04955626|593930824|FG013|Open-Label Period|Adverse Event|0|||
164247661|NCT00064259|593275301|FG003|Overall Study|Adverse Event|1|||
164247662|NCT01132651|593275304|FG000|Overall Study|Lost to Follow-up|1|||
164247663|NCT01132651|593275305|FG001|Overall Study|Lost to Follow-up|1|||
164426589|NCT04955626|593930825|FG014|Open-Label Period|Adverse Event|0|||
164426590|NCT04955626|593930826|FG015|Open-Label Period|Adverse Event|0|||
164575014|NCT01967225|594468148|FG001|Overall Study|Protocol Violation|0|||
164575015|NCT00327444|594468149|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
164426591|NCT04955626|593930827|FG016|Open-Label Period|Adverse Event|0|||
164247664|NCT00948857|593275306|FG000|Overall Study|Lost to Follow-up|1|||
164247665|NCT00948857|593275307|FG001|Overall Study|Lost to Follow-up|0|||
164247666|NCT03430843|593275309|FG000|Overall Study|Death|233|||
164247667|NCT03430843|593275310|FG001|Overall Study|Death|233|||
164247668|NCT03430843|593275309|FG000|Overall Study|Sponsor Decision|17|||
164247669|NCT03430843|593275310|FG001|Overall Study|Sponsor Decision|6|||
164247670|NCT03430843|593275309|FG000|Overall Study|Withdrawal by Subject|5|||
164247671|NCT03430843|593275310|FG001|Overall Study|Withdrawal by Subject|14|||
164247672|NCT03430843|593275309|FG000|Overall Study|Lost to Follow-up|1|||
164247673|NCT03430843|593275310|FG001|Overall Study|Lost to Follow-up|3|||
164247674|NCT05360966|593275319|FG000|Overall Study|Adverse Event|5|||
164247675|NCT05360966|593275320|FG001|Overall Study|Adverse Event|5|||
164247676|NCT05360966|593275319|FG000|Overall Study|Withdrawal of Consent|5|||
164247677|NCT05360966|593275320|FG001|Overall Study|Withdrawal of Consent|3|||
164247678|NCT05360966|593275319|FG000|Overall Study|Noncompliance|2|||
164247679|NCT05360966|593275320|FG001|Overall Study|Noncompliance|1|||
164247680|NCT05360966|593275319|FG000|Overall Study|Lost to Follow-up|2|||
164247681|NCT05360966|593275320|FG001|Overall Study|Lost to Follow-up|3|||
164247682|NCT05360966|593275319|FG000|Overall Study|Protocol Deviation|2|||
164247683|NCT05360966|593275320|FG001|Overall Study|Protocol Deviation|1|||
164247684|NCT05360966|593275319|FG000|Overall Study|As specified in the Clinical Study Report|1|||
164247685|NCT05360966|593275320|FG001|Overall Study|As specified in the Clinical Study Report|3|||
164247686|NCT05396014|593275321|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
164247687|NCT05396014|593275322|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247688|NCT05396014|593275323|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247689|NCT05396014|593275324|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247690|NCT05396014|593275325|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247691|NCT05396014|593275326|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247692|NCT05396014|593275327|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247693|NCT05396014|593275328|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247694|NCT05396014|593275329|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247695|NCT05396014|593275330|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247696|NCT05396014|593275331|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247697|NCT05396014|593275332|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247698|NCT05396014|593275333|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247699|NCT05396014|593275334|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
164247700|NCT05396014|593275335|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247701|NCT05396014|593275336|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247702|NCT05396014|593275337|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247703|NCT05396014|593275338|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247704|NCT05396014|593275339|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247705|NCT05396014|593275340|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247706|NCT05396014|593275341|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247707|NCT05396014|593275342|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247708|NCT05396014|593275343|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247709|NCT05396014|593275344|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247710|NCT05396014|593275345|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247711|NCT05396014|593275346|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247712|NCT05396014|593275347|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
164247713|NCT05396014|593275348|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247714|NCT05396014|593275349|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247715|NCT05396014|593275350|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247716|NCT05396014|593275351|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247717|NCT05396014|593275352|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247718|NCT05396014|593275353|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247719|NCT05396014|593275354|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247720|NCT05396014|593275355|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247721|NCT05396014|593275356|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247722|NCT05396014|593275357|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247723|NCT05396014|593275358|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247724|NCT05396014|593275359|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247725|NCT05396014|593275360|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
164247726|NCT05396014|593275361|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247727|NCT05396014|593275362|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164575016|NCT00327444|594468150|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
164575017|NCT00327444|594468149|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
164247728|NCT05396014|593275363|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247729|NCT05396014|593275321|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
164247730|NCT05396014|593275322|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164426592|NCT04955626|593930828|FG017|Open-Label Period|Adverse Event|0|||
164426593|NCT04955626|593930829|FG018|Open-Label Period|Adverse Event|0|||
164426594|NCT04955626|593930830|FG019|Open-Label Period|Adverse Event|0|||
164426595|NCT04955626|593930831|FG020|Open-Label Period|Adverse Event|0|||
164426596|NCT04955626|593930832|FG021|Open-Label Period|Adverse Event|0|||
164426597|NCT04955626|593930833|FG022|Open-Label Period|Adverse Event|0|||
164426598|NCT04955626|593930834|FG023|Open-Label Period|Adverse Event|0|||
164426599|NCT04955626|593930835|FG024|Open-Label Period|Adverse Event|0|||
164426600|NCT04955626|593930836|FG025|Open-Label Period|Adverse Event|0|||
164426601|NCT04955626|593930837|FG026|Open-Label Period|Adverse Event|0|||
164575018|NCT00327444|594468150|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
164247731|NCT05396014|593275323|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247732|NCT05396014|593275324|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247733|NCT05396014|593275325|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247734|NCT05396014|593275326|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247735|NCT05396014|593275327|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247736|NCT05396014|593275328|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247737|NCT05396014|593275329|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247738|NCT05396014|593275330|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247739|NCT05396014|593275331|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247740|NCT05396014|593275332|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247741|NCT05396014|593275333|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247742|NCT05396014|593275334|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
164247743|NCT05396014|593275335|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247744|NCT05396014|593275336|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247745|NCT05396014|593275337|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247746|NCT05396014|593275338|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247747|NCT05396014|593275339|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247748|NCT05396014|593275340|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247749|NCT05396014|593275341|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247750|NCT05396014|593275342|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247751|NCT05396014|593275343|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247752|NCT05396014|593275344|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247753|NCT05396014|593275345|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164338374|NCT01967173|593615151|FG000|Overall Study|Adverse Event|0|||
164338375|NCT01967173|593615152|FG001|Overall Study|Adverse Event|0|||
164338376|NCT01967173|593615153|FG002|Overall Study|Adverse Event|0|||
164338377|NCT01967173|593615154|FG003|Overall Study|Adverse Event|0|||
164338378|NCT01967173|593615155|FG004|Overall Study|Adverse Event|0|||
164338379|NCT01967173|593615156|FG005|Overall Study|Adverse Event|0|||
164338380|NCT01967173|593615157|FG006|Overall Study|Adverse Event|0|||
164338381|NCT01967173|593615158|FG007|Overall Study|Adverse Event|1|||
164338382|NCT01967173|593615151|FG000|Overall Study|Withdrawal by Subject|15|||
164338383|NCT01967173|593615152|FG001|Overall Study|Withdrawal by Subject|14|||
164338384|NCT01967173|593615153|FG002|Overall Study|Withdrawal by Subject|10|||
164338385|NCT01967173|593615154|FG003|Overall Study|Withdrawal by Subject|7|||
164338386|NCT01967173|593615155|FG004|Overall Study|Withdrawal by Subject|8|||
164338387|NCT01967173|593615156|FG005|Overall Study|Withdrawal by Subject|9|||
164338388|NCT01967173|593615157|FG006|Overall Study|Withdrawal by Subject|10|||
164338389|NCT01967173|593615158|FG007|Overall Study|Withdrawal by Subject|12|||
164338390|NCT01346969|593615159|FG000|Overall Study|Withdrawal by Subject|0|||
164338391|NCT01346969|593615160|FG001|Overall Study|Withdrawal by Subject|0|||
164338392|NCT01346969|593615161|FG002|Overall Study|Withdrawal by Subject|1|||
164338393|NCT01346969|593615162|FG003|Overall Study|Withdrawal by Subject|0|||
164338394|NCT01346969|593615159|FG000|Overall Study|Lost to Follow-up|1|||
164338395|NCT01346969|593615160|FG001|Overall Study|Lost to Follow-up|0|||
164338396|NCT01346969|593615161|FG002|Overall Study|Lost to Follow-up|2|||
164338397|NCT01346969|593615162|FG003|Overall Study|Lost to Follow-up|0|||
164338398|NCT01346969|593615159|FG000|Overall Study|Physician Decision|0|||
164338399|NCT01346969|593615160|FG001|Overall Study|Physician Decision|0|||
164338400|NCT01346969|593615161|FG002|Overall Study|Physician Decision|0|||
164338401|NCT01346969|593615162|FG003|Overall Study|Physician Decision|1|||
164575019|NCT00327444|594468149|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
164338402|NCT01346969|593615159|FG000|Overall Study|Randomized but not treated|1|||
164338403|NCT01346969|593615160|FG001|Overall Study|Randomized but not treated|0|||
164426602|NCT04955626|593930838|FG027|Open-Label Period|Adverse Event|0|||
164426603|NCT04955626|593930839|FG028|Open-Label Period|Adverse Event|0|||
164426604|NCT04955626|593930840|FG029|Open-Label Period|Adverse Event|0|||
164426605|NCT04955626|593930841|FG030|Open-Label Period|Adverse Event|0|||
164426606|NCT04955626|593930842|FG031|Open-Label Period|Adverse Event|0|||
164426607|NCT04955626|593930843|FG032|Open-Label Period|Adverse Event|0|||
164426608|NCT04955626|593930844|FG033|Open-Label Period|Adverse Event|0|||
164247754|NCT05396014|593275346|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247755|NCT05396014|593275347|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
164247756|NCT05396014|593275348|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247757|NCT05396014|593275349|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247758|NCT05396014|593275350|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247759|NCT05396014|593275351|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247760|NCT05396014|593275352|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247761|NCT05396014|593275353|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247762|NCT05396014|593275354|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247763|NCT05396014|593275355|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247764|NCT05396014|593275356|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247765|NCT05396014|593275357|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247766|NCT05396014|593275358|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247767|NCT05396014|593275359|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247768|NCT05396014|593275360|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
164426609|NCT04955626|593930845|FG034|Open-Label Period|Adverse Event|0|||
164247769|NCT05396014|593275361|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247770|NCT05396014|593275362|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247771|NCT05396014|593275363|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247772|NCT05396014|593275321|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
164247773|NCT05396014|593275322|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247774|NCT05396014|593275323|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247775|NCT05396014|593275324|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247776|NCT05396014|593275325|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247777|NCT05396014|593275326|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247778|NCT05396014|593275327|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247779|NCT05396014|593275328|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247780|NCT05396014|593275329|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247781|NCT05396014|593275330|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247782|NCT05396014|593275331|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247783|NCT05396014|593275332|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247784|NCT05396014|593275333|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247785|NCT05396014|593275334|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
164247786|NCT05396014|593275335|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247787|NCT05396014|593275336|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247788|NCT05396014|593275337|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247789|NCT05396014|593275338|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247790|NCT05396014|593275339|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247791|NCT05396014|593275340|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164426610|NCT04955626|593930846|FG035|Open-Label Period|Adverse Event|0|||
164426611|NCT04955626|593930811|FG000|Open-Label Period|Withdrawal by parent/guardian|1|||
164426612|NCT04955626|593930812|FG001|Open-Label Period|Withdrawal by parent/guardian|0|||
164426613|NCT04955626|593930813|FG002|Open-Label Period|Withdrawal by parent/guardian|0|||
164426614|NCT04955626|593930814|FG003|Open-Label Period|Withdrawal by parent/guardian|0|||
164426615|NCT04955626|593930815|FG004|Open-Label Period|Withdrawal by parent/guardian|0|||
164426616|NCT04955626|593930816|FG005|Open-Label Period|Withdrawal by parent/guardian|0|||
164426617|NCT04955626|593930817|FG006|Open-Label Period|Withdrawal by parent/guardian|0|||
164426618|NCT04955626|593930818|FG007|Open-Label Period|Withdrawal by parent/guardian|0|||
164426619|NCT04955626|593930819|FG008|Open-Label Period|Withdrawal by parent/guardian|0|||
164426620|NCT04955626|593930820|FG009|Open-Label Period|Withdrawal by parent/guardian|0|||
164426621|NCT04955626|593930821|FG010|Open-Label Period|Withdrawal by parent/guardian|0|||
164426622|NCT04955626|593930822|FG011|Open-Label Period|Withdrawal by parent/guardian|0|||
164426623|NCT04955626|593930823|FG012|Open-Label Period|Withdrawal by parent/guardian|0|||
164426624|NCT04955626|593930824|FG013|Open-Label Period|Withdrawal by parent/guardian|0|||
164247792|NCT05396014|593275341|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164426625|NCT04955626|593930825|FG014|Open-Label Period|Withdrawal by parent/guardian|0|||
164426626|NCT04955626|593930826|FG015|Open-Label Period|Withdrawal by parent/guardian|0|||
164426627|NCT04955626|593930827|FG016|Open-Label Period|Withdrawal by parent/guardian|0|||
164426628|NCT04955626|593930828|FG017|Open-Label Period|Withdrawal by parent/guardian|0|||
164426629|NCT04955626|593930829|FG018|Open-Label Period|Withdrawal by parent/guardian|0|||
164247793|NCT05396014|593275342|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164426630|NCT04955626|593930830|FG019|Open-Label Period|Withdrawal by parent/guardian|0|||
164426631|NCT04955626|593930831|FG020|Open-Label Period|Withdrawal by parent/guardian|0|||
164426632|NCT04955626|593930832|FG021|Open-Label Period|Withdrawal by parent/guardian|0|||
164426633|NCT04955626|593930833|FG022|Open-Label Period|Withdrawal by parent/guardian|0|||
164247794|NCT05396014|593275343|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164679474|NCT00950989|594851171|FG000|Overall Study|Adverse Event|2|||
164426634|NCT04955626|593930834|FG023|Open-Label Period|Withdrawal by parent/guardian|0|||
164426635|NCT04955626|593930835|FG024|Open-Label Period|Withdrawal by parent/guardian|0|||
164426636|NCT04955626|593930836|FG025|Open-Label Period|Withdrawal by parent/guardian|0|||
164426637|NCT04955626|593930837|FG026|Open-Label Period|Withdrawal by parent/guardian|0|||
164426638|NCT04955626|593930838|FG027|Open-Label Period|Withdrawal by parent/guardian|0|||
164426639|NCT04955626|593930839|FG028|Open-Label Period|Withdrawal by parent/guardian|0|||
164426640|NCT04955626|593930840|FG029|Open-Label Period|Withdrawal by parent/guardian|0|||
164426641|NCT04955626|593930841|FG030|Open-Label Period|Withdrawal by parent/guardian|0|||
164426642|NCT04955626|593930842|FG031|Open-Label Period|Withdrawal by parent/guardian|0|||
164426643|NCT04955626|593930843|FG032|Open-Label Period|Withdrawal by parent/guardian|0|||
164247795|NCT05396014|593275344|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247796|NCT05396014|593275345|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247797|NCT05396014|593275346|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247798|NCT05396014|593275347|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
164247799|NCT05396014|593275348|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247800|NCT05396014|593275349|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247801|NCT05396014|593275350|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247802|NCT05396014|593275351|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247803|NCT05396014|593275352|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247804|NCT05396014|593275353|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247805|NCT05396014|593275354|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247806|NCT05396014|593275355|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247807|NCT05396014|593275356|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247808|NCT05396014|593275357|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247809|NCT05396014|593275358|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247810|NCT05396014|593275359|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247811|NCT05396014|593275360|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
164247812|NCT05396014|593275361|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247813|NCT05396014|593275362|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247814|NCT05396014|593275363|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247815|NCT05396014|593275321|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247816|NCT05396014|593275322|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247817|NCT05396014|593275323|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247818|NCT05396014|593275324|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247819|NCT05396014|593275325|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247820|NCT05396014|593275326|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247821|NCT05396014|593275327|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247822|NCT05396014|593275328|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247823|NCT05396014|593275329|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247824|NCT05396014|593275330|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247825|NCT05396014|593275331|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247826|NCT05396014|593275332|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247827|NCT05396014|593275333|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247828|NCT05396014|593275334|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247829|NCT05396014|593275335|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164426644|NCT04955626|593930844|FG033|Open-Label Period|Withdrawal by parent/guardian|0|||
164247830|NCT05396014|593275336|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247831|NCT05396014|593275337|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247832|NCT05396014|593275338|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247833|NCT05396014|593275339|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247834|NCT05396014|593275340|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247835|NCT05396014|593275341|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247836|NCT05396014|593275342|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247837|NCT05396014|593275343|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247838|NCT05396014|593275344|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247839|NCT05396014|593275345|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247840|NCT05396014|593275346|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247841|NCT05396014|593275347|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
164247842|NCT05396014|593275348|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247843|NCT05396014|593275349|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247844|NCT05396014|593275350|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247845|NCT05396014|593275351|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247846|NCT05396014|593275352|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164426645|NCT04955626|593930845|FG034|Open-Label Period|Withdrawal by parent/guardian|0|||
164426646|NCT04955626|593930846|FG035|Open-Label Period|Withdrawal by parent/guardian|0|||
164679475|NCT00950989|594851172|FG001|Overall Study|Adverse Event|1|||
164247847|NCT05396014|593275353|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247848|NCT05396014|593275354|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247849|NCT05396014|593275355|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247850|NCT05396014|593275356|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247851|NCT05396014|593275357|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247852|NCT05396014|593275358|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247853|NCT05396014|593275359|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247854|NCT05396014|593275360|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
164247855|NCT05396014|593275361|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247856|NCT05396014|593275362|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247857|NCT05396014|593275363|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247858|NCT05396014|593275321|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247859|NCT05396014|593275322|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247860|NCT05396014|593275323|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247861|NCT05396014|593275324|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247862|NCT05396014|593275325|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247863|NCT05396014|593275326|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247864|NCT05396014|593275327|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247865|NCT05396014|593275328|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247866|NCT05396014|593275329|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247867|NCT05396014|593275330|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247868|NCT05396014|593275331|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247869|NCT05396014|593275332|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247870|NCT05396014|593275333|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247871|NCT05396014|593275334|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247872|NCT05396014|593275335|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247873|NCT05396014|593275336|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247874|NCT05396014|593275337|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247875|NCT05396014|593275338|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247876|NCT05396014|593275339|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247877|NCT05396014|593275340|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247878|NCT05396014|593275341|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247879|NCT05396014|593275342|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247880|NCT05396014|593275343|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247881|NCT05396014|593275344|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247882|NCT05396014|593275345|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247883|NCT05396014|593275346|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247884|NCT05396014|593275347|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
164247885|NCT05396014|593275348|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247886|NCT05396014|593275349|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247887|NCT05396014|593275350|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247888|NCT05396014|593275351|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247889|NCT05396014|593275352|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247890|NCT05396014|593275353|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247891|NCT05396014|593275354|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247892|NCT05396014|593275355|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247893|NCT05396014|593275356|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247894|NCT05396014|593275357|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247895|NCT05396014|593275358|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247896|NCT05396014|593275359|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247897|NCT05396014|593275360|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247898|NCT05396014|593275361|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247899|NCT05396014|593275362|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247900|NCT05396014|593275363|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247901|NCT05396014|593275321|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247902|NCT05396014|593275322|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247903|NCT05396014|593275323|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247904|NCT05396014|593275324|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247905|NCT05396014|593275325|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247906|NCT05396014|593275326|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247907|NCT05396014|593275327|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247908|NCT05396014|593275328|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247909|NCT05396014|593275329|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247910|NCT05396014|593275330|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247911|NCT05396014|593275331|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247912|NCT05396014|593275332|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164426647|NCT04955626|593930811|FG000|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164575020|NCT00327444|594468150|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
164247913|NCT05396014|593275333|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247914|NCT05396014|593275334|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
164575021|NCT00327444|594468149|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
164575022|NCT00327444|594468150|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
164247915|NCT05396014|593275335|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247916|NCT05396014|593275336|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247917|NCT05396014|593275337|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247918|NCT05396014|593275338|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247919|NCT05396014|593275339|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247920|NCT05396014|593275340|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247921|NCT05396014|593275341|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247922|NCT05396014|593275342|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247923|NCT05396014|593275343|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247924|NCT05396014|593275344|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247925|NCT05396014|593275345|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247926|NCT05396014|593275346|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247927|NCT05396014|593275347|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247928|NCT05396014|593275348|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247929|NCT05396014|593275349|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247930|NCT05396014|593275350|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247931|NCT05396014|593275351|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247932|NCT05396014|593275352|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247933|NCT05396014|593275353|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247934|NCT05396014|593275354|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247935|NCT05396014|593275355|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247936|NCT05396014|593275356|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247937|NCT05396014|593275357|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247938|NCT05396014|593275358|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247939|NCT05396014|593275359|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247940|NCT05396014|593275360|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247941|NCT05396014|593275361|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247942|NCT05396014|593275362|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247943|NCT05396014|593275363|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247944|NCT05396014|593275321|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
164247945|NCT05396014|593275322|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247946|NCT05396014|593275323|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247947|NCT05396014|593275324|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247948|NCT05396014|593275325|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164338404|NCT01346969|593615161|FG002|Overall Study|Randomized but not treated|0|||
164338405|NCT01346969|593615162|FG003|Overall Study|Randomized but not treated|0|||
164338406|NCT03666624|593615164|FG000|Overall Study|participant grieving over recent death of parent|1|||
164338407|NCT03666624|593615165|FG001|Overall Study|participant grieving over recent death of parent|0|||
164338408|NCT05213481|593615167|FG000|Overall Study|Adverse Event|3|||
164338409|NCT05213481|593615167|FG000|Overall Study|Lost to Follow-up|1|||
164338410|NCT00447005|593615169|FG000|Overall Study|Adverse Event|1|||
164338411|NCT00447005|593615169|FG000|Overall Study|Lack of Efficacy|11|||
164338412|NCT00397215|593615170|FG000|Month 0 (Day 0)|Adverse Event|0|||
164338413|NCT00397215|593615171|FG001|Month 0 (Day 0)|Adverse Event|1|||
164338414|NCT00397215|593615172|FG002|Month 0 (Day 0)|Adverse Event|0|||
164338415|NCT00397215|593615173|FG003|Month 0 (Day 0)|Adverse Event|0|||
164338416|NCT00397215|593615170|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
164338417|NCT00397215|593615171|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
164338418|NCT00397215|593615172|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
164338419|NCT00397215|593615173|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
164338420|NCT00397215|593615170|FG000|Month 0 (Day 0)|Other|4|||
164338421|NCT00397215|593615171|FG001|Month 0 (Day 0)|Other|1|||
164338422|NCT00397215|593615172|FG002|Month 0 (Day 0)|Other|3|||
164338423|NCT00397215|593615173|FG003|Month 0 (Day 0)|Other|3|||
164338424|NCT00397215|593615170|FG000|Month 6 (Day 180)|Adverse Event|0|||
164338425|NCT00397215|593615171|FG001|Month 6 (Day 180)|Adverse Event|3|||
164338426|NCT00397215|593615172|FG002|Month 6 (Day 180)|Adverse Event|2|||
164338427|NCT00397215|593615173|FG003|Month 6 (Day 180)|Adverse Event|0|||
164338428|NCT00397215|593615170|FG000|Month 6 (Day 180)|Other|2|||
164338429|NCT00397215|593615171|FG001|Month 6 (Day 180)|Other|0|||
164338430|NCT00397215|593615172|FG002|Month 6 (Day 180)|Other|3|||
164338431|NCT00397215|593615173|FG003|Month 6 (Day 180)|Other|0|||
164338432|NCT00423514|593615174|FG000|Overall Study|Ineligible|1|||
164338433|NCT00423514|593615175|FG001|Overall Study|Ineligible|0|||
164247949|NCT05396014|593275326|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247950|NCT05396014|593275327|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247951|NCT05396014|593275328|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247952|NCT05396014|593275329|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247953|NCT05396014|593275330|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247954|NCT05396014|593275331|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247955|NCT05396014|593275332|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247956|NCT05396014|593275333|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247957|NCT05396014|593275334|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
164247958|NCT05396014|593275335|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247959|NCT05396014|593275336|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247960|NCT05396014|593275337|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247961|NCT05396014|593275338|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247962|NCT05396014|593275339|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247963|NCT05396014|593275340|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247964|NCT05396014|593275341|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247965|NCT05396014|593275342|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247966|NCT05396014|593275343|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247967|NCT05396014|593275344|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247968|NCT05396014|593275345|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247969|NCT05396014|593275346|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247970|NCT05396014|593275347|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247971|NCT05396014|593275348|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247972|NCT05396014|593275349|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247973|NCT05396014|593275350|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247974|NCT05396014|593275351|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247975|NCT05396014|593275352|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247976|NCT05396014|593275353|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247977|NCT05396014|593275354|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247978|NCT05396014|593275355|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247979|NCT05396014|593275356|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247980|NCT05396014|593275357|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247981|NCT05396014|593275358|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247982|NCT05396014|593275359|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247983|NCT05396014|593275360|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
164247984|NCT05396014|593275361|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247985|NCT05396014|593275362|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247986|NCT05396014|593275363|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247987|NCT05396014|593275321|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
164575023|NCT00327444|594468149|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
164575024|NCT00327444|594468150|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
164426648|NCT04955626|593930812|FG001|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|476|||
164426649|NCT04955626|593930813|FG002|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164247988|NCT05396014|593275322|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164247989|NCT05396014|593275323|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164247990|NCT05396014|593275324|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164247991|NCT05396014|593275325|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164247992|NCT05396014|593275326|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164247993|NCT05396014|593275327|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164247994|NCT05396014|593275328|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164247995|NCT05396014|593275329|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164247996|NCT05396014|593275330|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164247997|NCT05396014|593275331|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164247998|NCT05396014|593275332|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164247999|NCT05396014|593275333|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248000|NCT05396014|593275334|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248001|NCT05396014|593275335|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164426650|NCT04955626|593930814|FG003|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164575025|NCT00327444|594468149|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
164575026|NCT00327444|594468150|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
164575027|NCT00327444|594468149|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
164575028|NCT00327444|594468150|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
164575029|NCT00327444|594468149|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
164248002|NCT05396014|593275336|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248003|NCT05396014|593275337|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248004|NCT05396014|593275338|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248005|NCT05396014|593275339|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248006|NCT05396014|593275340|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248007|NCT05396014|593275341|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248008|NCT05396014|593275342|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248009|NCT05396014|593275343|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248010|NCT05396014|593275344|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248011|NCT05396014|593275345|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248012|NCT05396014|593275346|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248013|NCT05396014|593275347|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
164248014|NCT05396014|593275348|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248015|NCT05396014|593275349|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248016|NCT05396014|593275350|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248017|NCT05396014|593275351|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248018|NCT05396014|593275352|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248019|NCT05396014|593275353|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248020|NCT05396014|593275354|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248021|NCT05396014|593275355|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248022|NCT05396014|593275356|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248023|NCT05396014|593275357|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248024|NCT05396014|593275358|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248025|NCT05396014|593275359|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248026|NCT05396014|593275360|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248027|NCT05396014|593275361|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248028|NCT05396014|593275362|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248029|NCT05396014|593275363|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248030|NCT05396014|593275321|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248031|NCT05396014|593275322|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248032|NCT05396014|593275323|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248033|NCT05396014|593275324|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248034|NCT05396014|593275325|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248035|NCT05396014|593275326|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248036|NCT05396014|593275327|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248037|NCT05396014|593275328|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248038|NCT05396014|593275329|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248039|NCT05396014|593275330|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248040|NCT05396014|593275331|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248041|NCT05396014|593275332|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248042|NCT05396014|593275333|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248043|NCT05396014|593275334|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
164248044|NCT05396014|593275335|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248045|NCT05396014|593275336|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248046|NCT05396014|593275337|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248047|NCT05396014|593275338|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248048|NCT05396014|593275339|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248049|NCT05396014|593275340|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248050|NCT05396014|593275341|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248051|NCT05396014|593275342|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248052|NCT05396014|593275343|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248053|NCT05396014|593275344|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248054|NCT05396014|593275345|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248055|NCT05396014|593275346|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248056|NCT05396014|593275347|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248057|NCT05396014|593275348|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248058|NCT05396014|593275349|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248059|NCT05396014|593275350|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248060|NCT05396014|593275351|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248061|NCT05396014|593275352|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248062|NCT05396014|593275353|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248063|NCT05396014|593275354|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248064|NCT05396014|593275355|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248065|NCT05396014|593275356|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164679476|NCT00950989|594851173|FG002|Overall Study|Adverse Event|1|||
164248066|NCT05396014|593275357|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248067|NCT05396014|593275358|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248068|NCT05396014|593275359|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248069|NCT05396014|593275360|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248070|NCT05396014|593275361|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248071|NCT05396014|593275362|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248072|NCT05396014|593275363|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248073|NCT05396014|593275321|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248074|NCT05396014|593275322|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248075|NCT05396014|593275323|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248076|NCT05396014|593275324|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
164248077|NCT05396014|593275325|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248078|NCT05396014|593275326|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
164248079|NCT05396014|593275327|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
164248080|NCT05396014|593275328|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248081|NCT05396014|593275329|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
164248082|NCT05396014|593275330|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
164248083|NCT05396014|593275331|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248084|NCT05396014|593275332|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248085|NCT05396014|593275333|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248086|NCT05396014|593275334|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248087|NCT05396014|593275335|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248088|NCT05396014|593275336|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
164248089|NCT05396014|593275337|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248090|NCT05396014|593275338|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248091|NCT05396014|593275339|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248092|NCT05396014|593275340|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248093|NCT05396014|593275341|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248094|NCT05396014|593275342|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248095|NCT05396014|593275343|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
164248096|NCT05396014|593275344|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
164248097|NCT05396014|593275345|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
164248098|NCT05396014|593275346|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
164248099|NCT05396014|593275347|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248100|NCT05396014|593275348|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248101|NCT05396014|593275349|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248102|NCT05396014|593275350|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248103|NCT05396014|593275351|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
164248104|NCT05396014|593275352|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
164248105|NCT05396014|593275353|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248106|NCT05396014|593275354|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248107|NCT05396014|593275355|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
164248108|NCT05396014|593275356|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248109|NCT05396014|593275357|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248110|NCT05396014|593275358|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248111|NCT05396014|593275359|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248112|NCT05396014|593275360|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248113|NCT05396014|593275361|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
164248114|NCT05396014|593275362|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
164248115|NCT05396014|593275363|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
164248116|NCT05396014|593275321|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248117|NCT05396014|593275322|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248118|NCT05396014|593275323|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248119|NCT05396014|593275324|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248120|NCT05396014|593275325|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248121|NCT05396014|593275326|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248122|NCT05396014|593275327|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248123|NCT05396014|593275328|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248124|NCT05396014|593275329|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
164248125|NCT05396014|593275330|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164426651|NCT04955626|593930815|FG004|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164426652|NCT04955626|593930816|FG005|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164426653|NCT04955626|593930817|FG006|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164426654|NCT04955626|593930818|FG007|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164426655|NCT04955626|593930819|FG008|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164248126|NCT05396014|593275331|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164426656|NCT04955626|593930820|FG009|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164248127|NCT05396014|593275332|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164679477|NCT00950989|594851174|FG003|Overall Study|Adverse Event|0|||
164679478|NCT00796562|594851175|FG000|Overall Study|Death|49|||
164679479|NCT05655520|594851176|FG000|Overall Study|Adverse Event|2|||
164679480|NCT05655520|594851177|FG001|Overall Study|Adverse Event|3|||
164679481|NCT05655520|594851176|FG000|Overall Study|Physician Decision|2|||
164679482|NCT05655520|594851177|FG001|Overall Study|Physician Decision|0|||
164679483|NCT05655520|594851176|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164679484|NCT05655520|594851177|FG001|Overall Study|Non-Compliance with Study Drug|2|||
164679485|NCT05655520|594851176|FG000|Overall Study|Lost to Follow-up|1|||
164679486|NCT05655520|594851177|FG001|Overall Study|Lost to Follow-up|0|||
164679487|NCT05655520|594851176|FG000|Overall Study|Withdrawal by Subject|4|||
164679488|NCT05655520|594851177|FG001|Overall Study|Withdrawal by Subject|4|||
164679489|NCT05655520|594851176|FG000|Overall Study|Study Terminated by Sponsor|61|||
164679490|NCT05655520|594851177|FG001|Overall Study|Study Terminated by Sponsor|68|||
164679491|NCT00424047|594851178|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
164679492|NCT00424047|594851179|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
164679493|NCT00424047|594851178|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
164144025|NCT00086281|592888579|FG008|Phase 1|Serious Adverse Event|0|||
164575030|NCT00327444|594468150|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
164575031|NCT01658514|594468152|FG000|Overall Study|Protocol Violation|1|||
164575032|NCT01658514|594468153|FG001|Overall Study|Protocol Violation|0|||
164575033|NCT01658514|594468154|FG002|Overall Study|Protocol Violation|2|||
164575034|NCT00144170|594468156|FG000|Overall Study|Adverse Event|84|||
164575035|NCT00144170|594468157|FG001|Overall Study|Adverse Event|41|||
164575036|NCT00144170|594468156|FG000|Overall Study|Protocol Violation|23|||
164575037|NCT00144170|594468157|FG001|Overall Study|Protocol Violation|16|||
164575038|NCT00144170|594468156|FG000|Overall Study|Lost to Follow-up|5|||
164575039|NCT00144170|594468157|FG001|Overall Study|Lost to Follow-up|10|||
164575040|NCT00144170|594468156|FG000|Overall Study|Withdrawal by Subject|29|||
164575041|NCT00144170|594468157|FG001|Overall Study|Withdrawal by Subject|13|||
164575042|NCT00144170|594468156|FG000|Overall Study|Other reason not defined above|211|||
164575043|NCT00144170|594468157|FG001|Overall Study|Other reason not defined above|316|||
164575044|NCT00981526|594468158|FG000|Overall Study|Withdrawal by Subject|0|||
164575045|NCT00981526|594468159|FG001|Overall Study|Withdrawal by Subject|2|||
164575046|NCT00981526|594468158|FG000|Overall Study|Physician Decision|4|||
164575047|NCT00981526|594468159|FG001|Overall Study|Physician Decision|4|||
164575048|NCT00332202|594468160|FG000|Overall Study|Adverse Event|72|||
164575049|NCT00332202|594468161|FG001|Overall Study|Adverse Event|28|||
164575050|NCT00332202|594468160|FG000|Overall Study|Lost to Follow-up|2|||
164575051|NCT00332202|594468161|FG001|Overall Study|Lost to Follow-up|1|||
164575052|NCT00332202|594468160|FG000|Overall Study|Physician Decision|6|||
164575053|NCT00332202|594468161|FG001|Overall Study|Physician Decision|8|||
164575054|NCT00332202|594468160|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
164575055|NCT00332202|594468161|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
164575056|NCT00332202|594468160|FG000|Overall Study|Protocol Violation|7|||
164575057|NCT00332202|594468161|FG001|Overall Study|Protocol Violation|2|||
164575058|NCT00332202|594468160|FG000|Overall Study|Sponsor Decision|1|||
164575059|NCT00332202|594468161|FG001|Overall Study|Sponsor Decision|2|||
164575060|NCT00332202|594468160|FG000|Overall Study|Withdrawal by Subject|36|||
164575061|NCT00332202|594468161|FG001|Overall Study|Withdrawal by Subject|17|||
164575062|NCT00332202|594468160|FG000|Overall Study|Progressive Disease|106|||
164575063|NCT00332202|594468161|FG001|Overall Study|Progressive Disease|60|||
164575064|NCT00332202|594468160|FG000|Overall Study|Death|5|||
164575065|NCT00332202|594468161|FG001|Overall Study|Death|2|||
164575066|NCT01392183|594468162|FG000|First Drug Administration|Adverse Event|3|||
164575067|NCT01392183|594468163|FG001|First Drug Administration|Adverse Event|2|||
164575068|NCT01392183|594468162|FG000|First Drug Administration|Death|1|||
164575069|NCT01392183|594468163|FG001|First Drug Administration|Death|0|||
164575070|NCT01392183|594468162|FG000|First Drug Administration|Withdrawal by Subject|10|||
164575071|NCT01392183|594468163|FG001|First Drug Administration|Withdrawal by Subject|17|||
164575072|NCT00075881|594469751|FG000|Overall Study|Lack of Efficacy|18|||
164575073|NCT00075881|594469751|FG000|Overall Study|Adverse Event|7|||
164575074|NCT00075881|594469751|FG000|Overall Study|Death|1|||
164575075|NCT00075881|594469751|FG000|Overall Study|Withdrawal by Subject|2|||
164575076|NCT00075881|594469751|FG000|Overall Study|Protocol Violation|4|||
164575077|NCT00075881|594469751|FG000|Overall Study|other complicating disease|3|||
164575078|NCT00075881|594469751|FG000|Overall Study|other|4|||
164575079|NCT00075881|594469751|FG000|Overall Study|missing data|2|||
164575080|NCT00075881|594469751|FG000|Overall Study|Ineligible|1|||
164575081|NCT00075881|594469751|FG000|Overall Study|never start protocol therapy|1|||
164575082|NCT02224664|594469752|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
164575083|NCT02224664|594469753|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
164575084|NCT02224664|594469754|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
164338434|NCT02128932|593615176|FG000|Overall Study|Withdrawal by Subject|11|||
164338435|NCT02128932|593615177|FG001|Overall Study|Withdrawal by Subject|7|||
164338436|NCT02128932|593615178|FG002|Overall Study|Withdrawal by Subject|8|||
164338437|NCT02128932|593615176|FG000|Overall Study|Death|2|||
164338438|NCT02128932|593615177|FG001|Overall Study|Death|0|||
164338439|NCT02128932|593615178|FG002|Overall Study|Death|2|||
164338440|NCT02128932|593615176|FG000|Overall Study|Lost to Follow-up|2|||
164338441|NCT02128932|593615177|FG001|Overall Study|Lost to Follow-up|1|||
164338442|NCT02128932|593615178|FG002|Overall Study|Lost to Follow-up|1|||
164338443|NCT02128932|593615176|FG000|Overall Study|No reason for withdrawal|12|||
164575085|NCT02224664|594469755|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
164575086|NCT02224664|594469756|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
164575087|NCT02224664|594469752|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
164338444|NCT02128932|593615177|FG001|Overall Study|No reason for withdrawal|11|||
164338445|NCT02128932|593615178|FG002|Overall Study|No reason for withdrawal|7|||
164575088|NCT02224664|594469753|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
164575089|NCT02224664|594469754|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
164575090|NCT02224664|594469755|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
164575091|NCT02224664|594469756|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
164575092|NCT02224664|594469752|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
164575093|NCT02224664|594469753|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
164338446|NCT03685123|593615183|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
164338447|NCT03685123|593615184|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
164338448|NCT03685123|593615185|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
164338449|NCT03685123|593615183|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
164338450|NCT03685123|593615184|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
164338451|NCT03685123|593615185|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
164338452|NCT03685123|593615183|FG000|Weight Loss Phase|Lost to Follow-up|1|||
164338453|NCT03685123|593615184|FG001|Weight Loss Phase|Lost to Follow-up|0|||
164338454|NCT03685123|593615185|FG002|Weight Loss Phase|Lost to Follow-up|0|||
164338455|NCT03685123|593615183|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
164338456|NCT03685123|593615184|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
164338457|NCT03685123|593615185|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
164338458|NCT03685123|593615183|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
164338459|NCT03685123|593615184|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
164338460|NCT03685123|593615185|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
164338461|NCT03685123|593615183|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
164338462|NCT03685123|593615184|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
164338463|NCT03685123|593615185|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
164338464|NCT02959983|593615186|FG000|Overall Study|Protocol Violation|0|||
164338465|NCT02959983|593615187|FG001|Overall Study|Protocol Violation|1|||
164338466|NCT02959983|593615186|FG000|Overall Study|Lack of Efficacy|0|||
164338467|NCT02959983|593615187|FG001|Overall Study|Lack of Efficacy|1|||
164338468|NCT02959983|593615186|FG000|Overall Study|Lost to Follow-up|12|||
164338469|NCT02959983|593615187|FG001|Overall Study|Lost to Follow-up|9|||
164338470|NCT02959983|593615186|FG000|Overall Study|Other|1|||
164338471|NCT02959983|593615187|FG001|Overall Study|Other|1|||
164338472|NCT02959983|593615186|FG000|Overall Study|Physician Decision|1|||
164338473|NCT02959983|593615187|FG001|Overall Study|Physician Decision|0|||
164338474|NCT02959983|593615186|FG000|Overall Study|Adverse Event|5|||
164338475|NCT02959983|593615187|FG001|Overall Study|Adverse Event|1|||
164338476|NCT02959983|593615186|FG000|Overall Study|Withdrawal by Subject|7|||
164338477|NCT02959983|593615187|FG001|Overall Study|Withdrawal by Subject|12|||
164338478|NCT01254630|593615188|FG000|Overall Study|Adverse Event|36|||
164338479|NCT01254630|593615189|FG001|Overall Study|Adverse Event|15|||
164338480|NCT01254630|593615190|FG002|Overall Study|Adverse Event|40|||
164338481|NCT01254630|593615191|FG003|Overall Study|Adverse Event|8|||
164338482|NCT01254630|593615188|FG000|Overall Study|Death|461|||
164338483|NCT01254630|593615189|FG001|Overall Study|Death|151|||
164338484|NCT01254630|593615190|FG002|Overall Study|Death|478|||
164338485|NCT01254630|593615191|FG003|Overall Study|Death|139|||
164338486|NCT01254630|593615188|FG000|Overall Study|Lost to Follow-up|80|||
164338487|NCT01254630|593615189|FG001|Overall Study|Lost to Follow-up|26|||
164338488|NCT01254630|593615190|FG002|Overall Study|Lost to Follow-up|89|||
164338489|NCT01254630|593615191|FG003|Overall Study|Lost to Follow-up|32|||
164338490|NCT01254630|593615188|FG000|Overall Study|Physician Decision|24|||
164338491|NCT01254630|593615189|FG001|Overall Study|Physician Decision|8|||
164426657|NCT04955626|593930821|FG010|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164426658|NCT04955626|593930822|FG011|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164426659|NCT04955626|593930823|FG012|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164426660|NCT04955626|593930824|FG013|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164426661|NCT04955626|593930825|FG014|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164426662|NCT04955626|593930826|FG015|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164426663|NCT04955626|593930827|FG016|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164679494|NCT00424047|594851179|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
164679495|NCT00424047|594851178|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
164679496|NCT00424047|594851179|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
164679497|NCT00424047|594851178|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
164679498|NCT00424047|594851179|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
164679499|NCT00424047|594851178|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
164679500|NCT00424047|594851179|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
164679501|NCT00424047|594851178|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
164679502|NCT00424047|594851179|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
164679503|NCT00424047|594851178|FG000|On Study at Time of Unblinding|Adverse Event|22|||
164679504|NCT00424047|594851179|FG001|On Study at Time of Unblinding|Adverse Event|12|||
164679505|NCT00424047|594851178|FG000|On Study at Time of Unblinding|Progression of disease|92|||
164679506|NCT00424047|594851179|FG001|On Study at Time of Unblinding|Progression of disease|128|||
164679507|NCT00424047|594851178|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
164338492|NCT01254630|593615190|FG002|Overall Study|Physician Decision|16|||
164338493|NCT01254630|593615191|FG003|Overall Study|Physician Decision|7|||
164338494|NCT01254630|593615188|FG000|Overall Study|Withdrawal by Subject|201|||
164338495|NCT01254630|593615189|FG001|Overall Study|Withdrawal by Subject|94|||
164338496|NCT01254630|593615190|FG002|Overall Study|Withdrawal by Subject|188|||
164338497|NCT01254630|593615191|FG003|Overall Study|Withdrawal by Subject|89|||
164426664|NCT04955626|593930828|FG017|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164679508|NCT00424047|594851179|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
164679509|NCT00424047|594851178|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
164679510|NCT00424047|594851179|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
164679511|NCT00424047|594851178|FG000|On Study at Time of Unblinding|Death|11|||
164679512|NCT00424047|594851179|FG001|On Study at Time of Unblinding|Death|11|||
164679513|NCT00424047|594851178|FG000|On Study at Time of Unblinding|Other|5|||
164248128|NCT05396014|593275333|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164426665|NCT04955626|593930829|FG018|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164248129|NCT05396014|593275334|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248130|NCT05396014|593275335|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164426666|NCT04955626|593930830|FG019|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164426667|NCT04955626|593930831|FG020|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164426668|NCT04955626|593930832|FG021|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164248131|NCT05396014|593275336|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248132|NCT05396014|593275337|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248133|NCT05396014|593275338|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248134|NCT05396014|593275339|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248135|NCT05396014|593275340|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248136|NCT05396014|593275341|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248137|NCT05396014|593275342|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248138|NCT05396014|593275343|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
164248139|NCT05396014|593275344|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164575094|NCT02224664|594469754|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
164575095|NCT02224664|594469755|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
164575096|NCT02224664|594469756|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
164575097|NCT03195894|594469757|FG000|Overall Study|"An example is Started other treatment."|4|||
164575098|NCT03195894|594469758|FG001|Overall Study|"An example is Started other treatment."|5|||
164575099|NCT03195894|594469757|FG000|Overall Study|Withdrawal by Subject|15|||
164575100|NCT03195894|594469758|FG001|Overall Study|Withdrawal by Subject|4|||
164575101|NCT03195894|594469757|FG000|Overall Study|Lost to Follow-up|14|||
164575102|NCT03195894|594469758|FG001|Overall Study|Lost to Follow-up|19|||
164575103|NCT01056107|594469767|FG000|Overall Study|Withdrawal by Subject|0|||
164575104|NCT01056107|594469768|FG001|Overall Study|Withdrawal by Subject|1|||
164575105|NCT01056107|594469769|FG002|Overall Study|Withdrawal by Subject|3|||
164575106|NCT01056107|594469770|FG003|Overall Study|Withdrawal by Subject|0|||
164575107|NCT00377962|594469773|FG000|Core Study: 0-12 Months|Adverse Event|18|||
164575108|NCT00377962|594469774|FG001|Core Study: 0-12 Months|Adverse Event|2|||
164575109|NCT00377962|594469773|FG000|Core Study: 0-12 Months|Death|3|||
164575110|NCT00377962|594469774|FG001|Core Study: 0-12 Months|Death|0|||
164575111|NCT00377962|594469773|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
164575112|NCT00377962|594469774|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
164575113|NCT00377962|594469773|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
164575114|NCT00377962|594469774|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
164575115|NCT00377962|594469773|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
164575116|NCT00377962|594469774|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
164575117|NCT00377962|594469773|FG000|Extension Study: 12-24 Months|Death|1|||
164575118|NCT00377962|594469774|FG001|Extension Study: 12-24 Months|Death|1|||
164248140|NCT05396014|593275345|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248141|NCT05396014|593275346|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248142|NCT05396014|593275347|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164426669|NCT04955626|593930833|FG022|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164426670|NCT04955626|593930834|FG023|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164248143|NCT05396014|593275348|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164426671|NCT04955626|593930835|FG024|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164575119|NCT00377962|594469773|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
164575120|NCT00377962|594469774|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
164575121|NCT00377962|594469773|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
164575122|NCT00377962|594469774|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
164575123|NCT00377962|594469773|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
164575124|NCT00377962|594469774|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
164575125|NCT00768222|594469780|FG000|Overall Study|Lost to Follow-up|1|||
164575126|NCT00768222|594469781|FG001|Overall Study|Lost to Follow-up|1|||
164679514|NCT00424047|594851179|FG001|On Study at Time of Unblinding|Other|4|||
164679515|NCT00424047|594851178|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
164248144|NCT05396014|593275349|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248145|NCT05396014|593275350|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248146|NCT05396014|593275351|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248147|NCT05396014|593275352|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248148|NCT05396014|593275353|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248149|NCT05396014|593275354|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248150|NCT05396014|593275355|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248151|NCT05396014|593275356|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
164248152|NCT05396014|593275357|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248153|NCT05396014|593275358|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248154|NCT05396014|593275359|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248155|NCT05396014|593275360|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248156|NCT05396014|593275361|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248157|NCT05396014|593275362|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
164248158|NCT05396014|593275363|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248159|NCT05396014|593275321|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248160|NCT05396014|593275322|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248161|NCT05396014|593275323|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248162|NCT05396014|593275324|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248163|NCT05396014|593275325|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248164|NCT05396014|593275326|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248165|NCT05396014|593275327|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164426672|NCT04955626|593930836|FG025|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164426673|NCT04955626|593930837|FG026|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164426674|NCT04955626|593930838|FG027|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164426675|NCT04955626|593930839|FG028|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164426676|NCT04955626|593930840|FG029|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164426677|NCT04955626|593930841|FG030|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164426678|NCT04955626|593930842|FG031|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164426679|NCT04955626|593930843|FG032|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164426680|NCT04955626|593930844|FG033|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164426681|NCT04955626|593930845|FG034|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164426682|NCT04955626|593930846|FG035|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164426683|NCT03473756|593930847|FG000|Overall Study|Withdrawal by Subject|1|||
164426684|NCT03473756|593930848|FG001|Overall Study|Withdrawal by Subject|4|||
164426685|NCT03473756|593930847|FG000|Overall Study|Adverse Event|6|||
164426686|NCT03473756|593930848|FG001|Overall Study|Adverse Event|7|||
164426687|NCT03473756|593930847|FG000|Overall Study|Lack of Efficacy|3|||
164426688|NCT03473756|593930848|FG001|Overall Study|Lack of Efficacy|10|||
164426689|NCT03473756|593930847|FG000|Overall Study|Physician Decision|0|||
164426690|NCT03473756|593930848|FG001|Overall Study|Physician Decision|2|||
164426691|NCT03473756|593930847|FG000|Overall Study|End of study treatment|0|||
164426692|NCT03473756|593930848|FG001|Overall Study|End of study treatment|2|||
164426693|NCT03473756|593930847|FG000|Overall Study|Lost to Follow-up|0|||
164426694|NCT03473756|593930848|FG001|Overall Study|Lost to Follow-up|1|||
164248166|NCT05396014|593275328|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248167|NCT05396014|593275329|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248168|NCT05396014|593275330|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248169|NCT05396014|593275331|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248170|NCT05396014|593275332|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248171|NCT05396014|593275333|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248172|NCT05396014|593275334|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
164248173|NCT05396014|593275335|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248174|NCT05396014|593275336|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248175|NCT05396014|593275337|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248176|NCT05396014|593275338|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248177|NCT05396014|593275339|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248178|NCT05396014|593275340|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248179|NCT05396014|593275341|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248180|NCT05396014|593275342|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248181|NCT05396014|593275343|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248182|NCT05396014|593275344|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248183|NCT05396014|593275345|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248184|NCT05396014|593275346|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248185|NCT05396014|593275347|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
164426695|NCT03714022|593930849|FG000|Overall Study|Adverse Event|1|||
164248186|NCT05396014|593275348|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248187|NCT05396014|593275349|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164426696|NCT03714022|593930850|FG001|Overall Study|Adverse Event|0|||
164426697|NCT03714022|593930849|FG000|Overall Study|Consent withdrawal|0|||
164426698|NCT03714022|593930850|FG001|Overall Study|Consent withdrawal|1|||
164248188|NCT05396014|593275350|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248189|NCT05396014|593275351|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248190|NCT05396014|593275352|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248191|NCT05396014|593275353|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248192|NCT05396014|593275354|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248193|NCT05396014|593275355|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
164248194|NCT05396014|593275356|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248195|NCT05396014|593275357|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248196|NCT05396014|593275358|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248197|NCT05396014|593275359|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248198|NCT05396014|593275360|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248199|NCT05396014|593275361|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248200|NCT05396014|593275362|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248201|NCT05396014|593275363|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
164248202|NCT05396014|593275321|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248203|NCT05396014|593275322|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248204|NCT05396014|593275323|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248205|NCT05396014|593275324|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248206|NCT05396014|593275325|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248207|NCT05396014|593275326|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248208|NCT05396014|593275327|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248209|NCT05396014|593275328|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248210|NCT05396014|593275329|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248211|NCT05396014|593275330|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248212|NCT05396014|593275331|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248213|NCT05396014|593275332|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248214|NCT05396014|593275333|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248215|NCT05396014|593275334|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248216|NCT05396014|593275335|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248217|NCT05396014|593275336|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248218|NCT05396014|593275337|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248219|NCT05396014|593275338|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248220|NCT05396014|593275339|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248221|NCT05396014|593275340|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248222|NCT05396014|593275341|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248223|NCT05396014|593275342|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248224|NCT05396014|593275343|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248225|NCT05396014|593275344|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248226|NCT05396014|593275345|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248227|NCT05396014|593275346|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248228|NCT05396014|593275347|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
164248229|NCT05396014|593275348|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248230|NCT05396014|593275349|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248231|NCT05396014|593275350|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248232|NCT05396014|593275351|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248233|NCT05396014|593275352|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248234|NCT05396014|593275353|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248235|NCT05396014|593275354|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248236|NCT05396014|593275355|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248237|NCT05396014|593275356|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248238|NCT05396014|593275357|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248239|NCT05396014|593275358|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248240|NCT05396014|593275359|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248241|NCT05396014|593275360|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248242|NCT05396014|593275361|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248243|NCT05396014|593275362|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248244|NCT05396014|593275363|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248245|NCT05258890|593275371|FG000|Overall Study|Patient withdrawal|6|||
164248246|NCT05258890|593275372|FG001|Overall Study|Patient withdrawal|7|||
164248247|NCT05258890|593275371|FG000|Overall Study|Patient lost to follow-up|10|||
164248248|NCT05258890|593275372|FG001|Overall Study|Patient lost to follow-up|3|||
164248249|NCT05258890|593275371|FG000|Overall Study|Social network member withdrawal|1|||
164248250|NCT05258890|593275372|FG001|Overall Study|Social network member withdrawal|0|||
164248251|NCT05258890|593275371|FG000|Overall Study|Social network member lost to follow-up|5|||
164248252|NCT05258890|593275372|FG001|Overall Study|Social network member lost to follow-up|0|||
164248253|NCT02974140|593275373|FG000|Overall Study|Adverse Event|2|||
164248254|NCT02974140|593275373|FG000|Overall Study|Lost to Follow-up|1|||
164248255|NCT02974140|593275373|FG000|Overall Study|Study Terminated by Sponsor|36|||
164248256|NCT01905943|593275374|FG000|Overall Study|Withdrawal of consent|90|||
164248257|NCT01905943|593275374|FG000|Overall Study|Lost to Follow-up|16|||
164248258|NCT01905943|593275374|FG000|Overall Study|Investigator discretion|7|||
164248259|NCT01905943|593275374|FG000|Overall Study|Death|186|||
164248260|NCT01905943|593275374|FG000|Overall Study|Adverse Event|3|||
164248261|NCT01905943|593275374|FG000|Overall Study|Other|12|||
164248262|NCT01238991|593275375|FG000|Overall Study|Adverse Event|1|||
164248263|NCT01238991|593275376|FG001|Overall Study|Adverse Event|0|||
164248264|NCT01238991|593275377|FG002|Overall Study|Adverse Event|3|||
164248265|NCT01238991|593275378|FG003|Overall Study|Adverse Event|1|||
164248266|NCT01238991|593275379|FG004|Overall Study|Adverse Event|1|||
164248267|NCT01238991|593275380|FG005|Overall Study|Adverse Event|0|||
164248268|NCT01238991|593275381|FG006|Overall Study|Adverse Event|1|||
164248269|NCT01238991|593275382|FG007|Overall Study|Adverse Event|1|||
164248270|NCT01238991|593275383|FG008|Overall Study|Adverse Event|0|||
164248271|NCT01238991|593275384|FG009|Overall Study|Adverse Event|0|||
164248272|NCT01238991|593275375|FG000|Overall Study|Death|0|||
164248273|NCT01238991|593275376|FG001|Overall Study|Death|0|||
164248274|NCT01238991|593275377|FG002|Overall Study|Death|0|||
164248275|NCT01238991|593275378|FG003|Overall Study|Death|1|||
164248276|NCT01238991|593275379|FG004|Overall Study|Death|0|||
164248277|NCT01238991|593275380|FG005|Overall Study|Death|0|||
164248278|NCT01238991|593275381|FG006|Overall Study|Death|0|||
164248279|NCT01238991|593275382|FG007|Overall Study|Death|0|||
164248280|NCT01238991|593275383|FG008|Overall Study|Death|0|||
164248281|NCT01238991|593275384|FG009|Overall Study|Death|0|||
164248282|NCT01238991|593275375|FG000|Overall Study|Lack of Efficacy|0|||
164248283|NCT01238991|593275376|FG001|Overall Study|Lack of Efficacy|0|||
164248284|NCT01238991|593275377|FG002|Overall Study|Lack of Efficacy|1|||
164248285|NCT01238991|593275378|FG003|Overall Study|Lack of Efficacy|0|||
164248286|NCT01238991|593275379|FG004|Overall Study|Lack of Efficacy|0|||
164248287|NCT01238991|593275380|FG005|Overall Study|Lack of Efficacy|0|||
164248288|NCT01238991|593275381|FG006|Overall Study|Lack of Efficacy|0|||
164248289|NCT01238991|593275382|FG007|Overall Study|Lack of Efficacy|0|||
164248290|NCT01238991|593275383|FG008|Overall Study|Lack of Efficacy|1|||
164248291|NCT01238991|593275384|FG009|Overall Study|Lack of Efficacy|0|||
164248292|NCT01238991|593275375|FG000|Overall Study|Withdrawal by Subject|0|||
164248293|NCT01238991|593275376|FG001|Overall Study|Withdrawal by Subject|0|||
164248294|NCT01238991|593275377|FG002|Overall Study|Withdrawal by Subject|1|||
164248295|NCT01238991|593275378|FG003|Overall Study|Withdrawal by Subject|0|||
164248296|NCT01238991|593275379|FG004|Overall Study|Withdrawal by Subject|0|||
164248297|NCT01238991|593275380|FG005|Overall Study|Withdrawal by Subject|0|||
164248298|NCT01238991|593275381|FG006|Overall Study|Withdrawal by Subject|0|||
164248299|NCT01238991|593275382|FG007|Overall Study|Withdrawal by Subject|0|||
164248300|NCT01238991|593275383|FG008|Overall Study|Withdrawal by Subject|0|||
164248301|NCT01238991|593275384|FG009|Overall Study|Withdrawal by Subject|0|||
164248302|NCT01238991|593275375|FG000|Overall Study|Study Terminated by Sponsor|0|||
164248303|NCT01238991|593275376|FG001|Overall Study|Study Terminated by Sponsor|0|||
164338498|NCT01254630|593615188|FG000|Overall Study|Study terminated by sponsor|0|||
164338499|NCT01254630|593615189|FG001|Overall Study|Study terminated by sponsor|994|||
164338500|NCT01254630|593615190|FG002|Overall Study|Study terminated by sponsor|0|||
164338501|NCT01254630|593615191|FG003|Overall Study|Study terminated by sponsor|1010|||
164338502|NCT01254630|593615188|FG000|Overall Study|Status not recorded|0|||
164338503|NCT01254630|593615189|FG001|Overall Study|Status not recorded|0|||
164338504|NCT01254630|593615190|FG002|Overall Study|Status not recorded|1|||
164338505|NCT01254630|593615191|FG003|Overall Study|Status not recorded|0|||
164338506|NCT03439657|593615196|FG000|Overall Study|Adverse Event|2|||
164338507|NCT03439657|593615197|FG001|Overall Study|Adverse Event|3|||
164338508|NCT03439657|593615196|FG000|Overall Study|Lost to Follow-up|1|||
164338509|NCT03439657|593615197|FG001|Overall Study|Lost to Follow-up|0|||
164338510|NCT03439657|593615196|FG000|Overall Study|Protocol Violation|1|||
164248304|NCT01238991|593275377|FG002|Overall Study|Study Terminated by Sponsor|0|||
164248305|NCT01238991|593275378|FG003|Overall Study|Study Terminated by Sponsor|0|||
164248306|NCT01238991|593275379|FG004|Overall Study|Study Terminated by Sponsor|1|||
164248307|NCT01238991|593275380|FG005|Overall Study|Study Terminated by Sponsor|0|||
164248308|NCT01238991|593275381|FG006|Overall Study|Study Terminated by Sponsor|7|||
164248309|NCT01238991|593275382|FG007|Overall Study|Study Terminated by Sponsor|4|||
164248310|NCT01238991|593275383|FG008|Overall Study|Study Terminated by Sponsor|2|||
164248311|NCT01238991|593275384|FG009|Overall Study|Study Terminated by Sponsor|2|||
164248312|NCT01238991|593275375|FG000|Overall Study|Caregiver's request|0|||
164338511|NCT03439657|593615197|FG001|Overall Study|Protocol Violation|1|||
164338512|NCT03439657|593615196|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
164338513|NCT03439657|593615197|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
164248313|NCT01238991|593275376|FG001|Overall Study|Caregiver's request|0|||
164248314|NCT01238991|593275377|FG002|Overall Study|Caregiver's request|0|||
164248315|NCT01238991|593275378|FG003|Overall Study|Caregiver's request|0|||
164338514|NCT02925117|593615199|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
164338515|NCT02925117|593615200|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
164248316|NCT01238991|593275379|FG004|Overall Study|Caregiver's request|0|||
164248317|NCT01238991|593275380|FG005|Overall Study|Caregiver's request|0|||
164679516|NCT00424047|594851179|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
164679517|NCT00424047|594851178|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
164679518|NCT00424047|594851179|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
164679519|NCT00424047|594851178|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
164679520|NCT00424047|594851179|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
164248318|NCT01238991|593275381|FG006|Overall Study|Caregiver's request|0|||
164248319|NCT01238991|593275382|FG007|Overall Study|Caregiver's request|0|||
164248320|NCT01238991|593275383|FG008|Overall Study|Caregiver's request|1|||
164248321|NCT01238991|593275384|FG009|Overall Study|Caregiver's request|0|||
164248322|NCT01238991|593275375|FG000|Overall Study|Admission to a nursing home|1|||
164248323|NCT01238991|593275376|FG001|Overall Study|Admission to a nursing home|0|||
164248324|NCT01238991|593275377|FG002|Overall Study|Admission to a nursing home|1|||
164248325|NCT01238991|593275378|FG003|Overall Study|Admission to a nursing home|0|||
164248326|NCT01238991|593275379|FG004|Overall Study|Admission to a nursing home|0|||
164248327|NCT01238991|593275380|FG005|Overall Study|Admission to a nursing home|0|||
164248328|NCT01238991|593275381|FG006|Overall Study|Admission to a nursing home|0|||
164248329|NCT01238991|593275382|FG007|Overall Study|Admission to a nursing home|0|||
164248330|NCT01238991|593275383|FG008|Overall Study|Admission to a nursing home|0|||
164248331|NCT01238991|593275384|FG009|Overall Study|Admission to a nursing home|0|||
164248332|NCT05959447|593275391|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
164248333|NCT05959447|593275392|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
164248334|NCT05959447|593275391|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
164248335|NCT05959447|593275392|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
164248336|NCT05959447|593275391|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
164248337|NCT05959447|593275392|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
164248338|NCT05959447|593275391|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
164248339|NCT05959447|593275392|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
164248340|NCT02522429|593275393|FG000|Overall Study|Lost to Follow-up|8|||
164248341|NCT02522429|593275393|FG000|Overall Study|Adverse Event|2|||
164248342|NCT02522429|593275393|FG000|Overall Study|Death|1|||
164248343|NCT02522429|593275393|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
164248344|NCT00294671|593275394|FG000|Overall Study|Lack of Efficacy|11|||
164248345|NCT00294671|593275395|FG001|Overall Study|Lack of Efficacy|23|||
164248346|NCT00294671|593275394|FG000|Overall Study|Liver transplant|7|||
164248347|NCT00294671|593275395|FG001|Overall Study|Liver transplant|9|||
164248348|NCT00294671|593275394|FG000|Overall Study|Drug related adverse event (AE)|4|||
164248349|NCT00294671|593275395|FG001|Overall Study|Drug related adverse event (AE)|2|||
164248350|NCT00294671|593275394|FG000|Overall Study|Non-drug related AE|3|||
164248351|NCT00294671|593275395|FG001|Overall Study|Non-drug related AE|2|||
164248352|NCT00294671|593275394|FG000|Overall Study|Lost to Follow-up|1|||
164248353|NCT00294671|593275395|FG001|Overall Study|Lost to Follow-up|3|||
164248354|NCT00294671|593275394|FG000|Overall Study|Non-compliance|1|||
164248355|NCT00294671|593275395|FG001|Overall Study|Non-compliance|0|||
164248356|NCT00294671|593275394|FG000|Overall Study|Death|0|||
164248357|NCT00294671|593275395|FG001|Overall Study|Death|1|||
164248358|NCT01893411|593275400|FG000|Overall Study|Protocol Violation|1|||
164248359|NCT01893411|593275401|FG001|Overall Study|Protocol Violation|0|||
164248360|NCT01893411|593275402|FG002|Overall Study|Protocol Violation|0|||
164248361|NCT01893411|593275400|FG000|Overall Study|Physician Decision|1|||
164248362|NCT01893411|593275401|FG001|Overall Study|Physician Decision|1|||
164248363|NCT01893411|593275402|FG002|Overall Study|Physician Decision|2|||
164248364|NCT01893411|593275400|FG000|Overall Study|Lack of Efficacy|2|||
164248365|NCT01893411|593275401|FG001|Overall Study|Lack of Efficacy|1|||
164248366|NCT01893411|593275402|FG002|Overall Study|Lack of Efficacy|0|||
164248367|NCT01893411|593275400|FG000|Overall Study|Other|3|||
164248368|NCT01893411|593275401|FG001|Overall Study|Other|1|||
164338516|NCT02925117|593615201|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
164338517|NCT02925117|593615202|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
164338518|NCT02925117|593615203|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
164338519|NCT02925117|593615204|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
164338520|NCT02925117|593615205|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
164338521|NCT02925117|593615206|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
164679521|NCT00424047|594851178|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
164679522|NCT00424047|594851179|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
164679523|NCT00424047|594851178|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
164248369|NCT01893411|593275402|FG002|Overall Study|Other|3|||
164248370|NCT01893411|593275400|FG000|Overall Study|Adverse Event|1|||
164248371|NCT01893411|593275401|FG001|Overall Study|Adverse Event|0|||
164248372|NCT01893411|593275402|FG002|Overall Study|Adverse Event|0|||
164248373|NCT01893411|593275400|FG000|Overall Study|Withdrawal by Subject|7|||
164248374|NCT01893411|593275401|FG001|Overall Study|Withdrawal by Subject|4|||
164338522|NCT02925117|593615207|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
164338523|NCT02925117|593615208|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
164248375|NCT01893411|593275402|FG002|Overall Study|Withdrawal by Subject|3|||
164248376|NCT01893411|593275400|FG000|Overall Study|Lost to Follow-up|2|||
164248377|NCT01893411|593275401|FG001|Overall Study|Lost to Follow-up|0|||
164248378|NCT01893411|593275402|FG002|Overall Study|Lost to Follow-up|1|||
164248379|NCT00566982|593275403|FG000|Overall Study|Adverse Event|6|||
164248380|NCT00566982|593275404|FG001|Overall Study|Adverse Event|48|||
164248381|NCT00566982|593275403|FG000|Overall Study|Withdrawal by Subject|1|||
164426699|NCT03714022|593930849|FG000|Overall Study|Lost to Follow-up|3|||
164679524|NCT00424047|594851179|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
164679525|NCT01229150|594851183|FG000|Overall Study|Toxicity|2|||
164679526|NCT01229150|594851184|FG001|Overall Study|Toxicity|2|||
164679527|NCT01229150|594851185|FG002|Overall Study|Toxicity|0|||
164679528|NCT01229150|594851186|FG003|Overall Study|Toxicity|0|||
164679529|NCT05248204|594851187|FG000|Overall Study|Lost to Follow-up|13|||
164679530|NCT05248204|594851188|FG001|Overall Study|Lost to Follow-up|13|||
164679531|NCT05248204|594851187|FG000|Overall Study|Protocol Violation|1|||
164679532|NCT05248204|594851188|FG001|Overall Study|Protocol Violation|0|||
164679533|NCT03100344|594851189|FG000|Overall Study|Adverse Event|0|||
164426700|NCT03714022|593930850|FG001|Overall Study|Lost to Follow-up|2|||
164426701|NCT02487446|593930856|FG000|Period 1|Physician Decision|0|||
164426702|NCT02487446|593930857|FG001|Period 1|Physician Decision|1|||
164426703|NCT02487446|593930856|FG000|Period 1|Lack of Efficacy|1|||
164426704|NCT02487446|593930857|FG001|Period 1|Lack of Efficacy|0|||
164426705|NCT02487446|593930856|FG000|Period 1|Protocol deviation|3|||
164426706|NCT02487446|593930857|FG001|Period 1|Protocol deviation|2|||
164426707|NCT02487446|593930856|FG000|Period 1|Lost to Follow-up|2|||
164426708|NCT02487446|593930857|FG001|Period 1|Lost to Follow-up|0|||
164426709|NCT02487446|593930856|FG000|Period 1|Withdrawal by Subject|2|||
164426710|NCT02487446|593930857|FG001|Period 1|Withdrawal by Subject|0|||
164426711|NCT02487446|593930856|FG000|Period 1|Adverse Event|5|||
164426712|NCT02487446|593930857|FG001|Period 1|Adverse Event|5|||
164426713|NCT02487446|593930856|FG000|Washout|Lost to Follow-up|0|||
164426714|NCT02487446|593930857|FG001|Washout|Lost to Follow-up|2|||
164248382|NCT00566982|593275404|FG001|Overall Study|Withdrawal by Subject|14|||
164248383|NCT00566982|593275403|FG000|Overall Study|Protocol Violation|1|||
164248384|NCT00566982|593275404|FG001|Overall Study|Protocol Violation|4|||
164248385|NCT00566982|593275403|FG000|Overall Study|Lost to Follow-up|0|||
164248386|NCT00566982|593275404|FG001|Overall Study|Lost to Follow-up|1|||
164248387|NCT00566982|593275403|FG000|Overall Study|Other-family problems & doctor's request|0|||
164248388|NCT00566982|593275404|FG001|Overall Study|Other-family problems & doctor's request|2|||
164248389|NCT01961297|593275407|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
164248390|NCT01961297|593275408|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
164248391|NCT01947283|593275409|FG000|Overall Study|Death|1|||
164248392|NCT01947283|593275410|FG001|Overall Study|Death|1|||
164248393|NCT01947283|593275411|FG002|Overall Study|Death|1|||
164248394|NCT01947283|593275412|FG003|Overall Study|Death|0|||
164248395|NCT01947283|593275413|FG004|Overall Study|Death|0|||
164248396|NCT01947283|593275414|FG005|Overall Study|Death|0|||
164248397|NCT01947283|593275415|FG006|Overall Study|Death|0|||
164248398|NCT01947283|593275409|FG000|Overall Study|Lost to Follow-up|4|||
164248399|NCT01947283|593275410|FG001|Overall Study|Lost to Follow-up|6|||
164248400|NCT01947283|593275411|FG002|Overall Study|Lost to Follow-up|5|||
164248401|NCT01947283|593275412|FG003|Overall Study|Lost to Follow-up|5|||
164248402|NCT01947283|593275413|FG004|Overall Study|Lost to Follow-up|0|||
164248403|NCT01947283|593275414|FG005|Overall Study|Lost to Follow-up|2|||
164426715|NCT02487446|593930856|FG000|Washout|Withdrawal by Subject|1|||
164426716|NCT02487446|593930857|FG001|Washout|Withdrawal by Subject|4|||
164426717|NCT02487446|593930856|FG000|Washout|Adverse Event|2|||
164679534|NCT03100344|594851190|FG001|Overall Study|Adverse Event|3|||
164679535|NCT03100344|594851191|FG002|Overall Study|Adverse Event|2|||
164248404|NCT01947283|593275415|FG006|Overall Study|Lost to Follow-up|5|||
164248405|NCT01947283|593275409|FG000|Overall Study|Withdrawal by Subject|10|||
164248406|NCT01947283|593275410|FG001|Overall Study|Withdrawal by Subject|8|||
164248407|NCT01947283|593275411|FG002|Overall Study|Withdrawal by Subject|4|||
164426718|NCT02487446|593930857|FG001|Washout|Adverse Event|2|||
164679536|NCT03100344|594851192|FG003|Overall Study|Adverse Event|3|||
164248408|NCT01947283|593275412|FG003|Overall Study|Withdrawal by Subject|1|||
164426719|NCT02487446|593930856|FG000|Period 2|Protocol deviation|0|||
164426720|NCT02487446|593930857|FG001|Period 2|Protocol deviation|1|||
164679537|NCT03100344|594851189|FG000|Overall Study|Lack of Efficacy|2|||
164248409|NCT01947283|593275413|FG004|Overall Study|Withdrawal by Subject|0|||
164426721|NCT02487446|593930856|FG000|Period 2|Lost to Follow-up|1|||
164679538|NCT03100344|594851190|FG001|Overall Study|Lack of Efficacy|0|||
164679539|NCT03100344|594851191|FG002|Overall Study|Lack of Efficacy|0|||
164679540|NCT03100344|594851192|FG003|Overall Study|Lack of Efficacy|0|||
164248410|NCT01947283|593275414|FG005|Overall Study|Withdrawal by Subject|0|||
164426722|NCT02487446|593930857|FG001|Period 2|Lost to Follow-up|1|||
164679541|NCT03100344|594851189|FG000|Overall Study|Protocol Violation|1|||
164426723|NCT02487446|593930856|FG000|Period 2|Withdrawal by Subject|1|||
164426724|NCT02487446|593930857|FG001|Period 2|Withdrawal by Subject|1|||
164426725|NCT02487446|593930856|FG000|Period 2|Adverse Event|6|||
164248411|NCT01947283|593275415|FG006|Overall Study|Withdrawal by Subject|2|||
164248412|NCT01947283|593275409|FG000|Overall Study|No Clinical Recording|12|||
164575127|NCT00768222|594469780|FG000|Overall Study|Withdrawal by Subject|3|||
164575128|NCT00768222|594469781|FG001|Overall Study|Withdrawal by Subject|1|||
164575129|NCT00768222|594469780|FG000|Overall Study|Protocol Violation|0|||
164248413|NCT01947283|593275410|FG001|Overall Study|No Clinical Recording|6|||
164248414|NCT01947283|593275411|FG002|Overall Study|No Clinical Recording|8|||
164248415|NCT01947283|593275412|FG003|Overall Study|No Clinical Recording|10|||
164248416|NCT01947283|593275413|FG004|Overall Study|No Clinical Recording|0|||
164248417|NCT01947283|593275414|FG005|Overall Study|No Clinical Recording|0|||
164248418|NCT01947283|593275415|FG006|Overall Study|No Clinical Recording|0|||
164248419|NCT01947283|593275409|FG000|Overall Study|Non-coding Clinical Recording language|0|||
164248420|NCT01947283|593275410|FG001|Overall Study|Non-coding Clinical Recording language|0|||
164248421|NCT01947283|593275411|FG002|Overall Study|Non-coding Clinical Recording language|0|||
164248422|NCT01947283|593275412|FG003|Overall Study|Non-coding Clinical Recording language|1|||
164248423|NCT01947283|593275413|FG004|Overall Study|Non-coding Clinical Recording language|0|||
164248424|NCT01947283|593275414|FG005|Overall Study|Non-coding Clinical Recording language|0|||
164248425|NCT01947283|593275415|FG006|Overall Study|Non-coding Clinical Recording language|0|||
164248426|NCT01947283|593275409|FG000|Overall Study|Missing Follow-up Assessment|2|||
164248427|NCT01947283|593275410|FG001|Overall Study|Missing Follow-up Assessment|2|||
164248428|NCT01947283|593275411|FG002|Overall Study|Missing Follow-up Assessment|3|||
164248429|NCT01947283|593275412|FG003|Overall Study|Missing Follow-up Assessment|0|||
164575130|NCT00768222|594469781|FG001|Overall Study|Protocol Violation|2|||
164575131|NCT00265941|594469783|FG000|Overall Study|Protocol Violation|22|||
164575132|NCT00265941|594469784|FG001|Overall Study|Protocol Violation|25|||
164248430|NCT01947283|593275413|FG004|Overall Study|Missing Follow-up Assessment|0|||
164248431|NCT01947283|593275414|FG005|Overall Study|Missing Follow-up Assessment|2|||
164248432|NCT01947283|593275415|FG006|Overall Study|Missing Follow-up Assessment|0|||
164248433|NCT01947283|593275409|FG000|Overall Study|No patients were enrolled in study|0|||
164248434|NCT01947283|593275410|FG001|Overall Study|No patients were enrolled in study|0|||
164248435|NCT01947283|593275411|FG002|Overall Study|No patients were enrolled in study|0|||
164248436|NCT01947283|593275412|FG003|Overall Study|No patients were enrolled in study|0|||
164248437|NCT01947283|593275413|FG004|Overall Study|No patients were enrolled in study|0|||
164248438|NCT01947283|593275414|FG005|Overall Study|No patients were enrolled in study|3|||
164248439|NCT01947283|593275415|FG006|Overall Study|No patients were enrolled in study|1|||
164248440|NCT01498692|593275416|FG000|Overall Study|Death|4|||
164248441|NCT01498692|593275416|FG000|Overall Study|Withdrawal by Subject|1|||
164248442|NCT01498692|593275416|FG000|Overall Study|Missed 12-month visit|3|||
164248443|NCT04729972|593275417|FG000|Overall Study|Adverse Event|1|||
164248444|NCT05002985|593275418|FG000|Overall Study|Withdrawal by Subject|1|||
164248445|NCT03782259|593275419|FG000|Overall Study|Lost to Follow-up|1|||
164248446|NCT03782259|593275420|FG001|Overall Study|Lost to Follow-up|1|||
164248447|NCT03782259|593275419|FG000|Overall Study|Moved out of state|0|||
164248448|NCT03782259|593275420|FG001|Overall Study|Moved out of state|2|||
164248449|NCT03782259|593275419|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
164248450|NCT03782259|593275420|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
164248451|NCT03782259|593275419|FG000|Overall Study|Subject discontinued intervention|1|||
164248452|NCT03782259|593275420|FG001|Overall Study|Subject discontinued intervention|0|||
164248453|NCT00603941|593275421|FG000|Overall Study|Disease progression|6|||
164248454|NCT00603941|593275422|FG001|Overall Study|Disease progression|7|||
164248455|NCT00603941|593275423|FG002|Overall Study|Disease progression|1|||
164248456|NCT00603941|593275421|FG000|Overall Study|Adverse Event|1|||
164248457|NCT00603941|593275422|FG001|Overall Study|Adverse Event|0|||
164248458|NCT00603941|593275423|FG002|Overall Study|Adverse Event|1|||
164338524|NCT02925117|593615209|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
164575133|NCT00265941|594469783|FG000|Overall Study|Lost to Follow-up|1|||
164575134|NCT00265941|594469784|FG001|Overall Study|Lost to Follow-up|1|||
164679542|NCT03100344|594851190|FG001|Overall Study|Protocol Violation|0|||
164679543|NCT03100344|594851191|FG002|Overall Study|Protocol Violation|0|||
164679544|NCT03100344|594851192|FG003|Overall Study|Protocol Violation|0|||
164679545|NCT03100344|594851189|FG000|Overall Study|Withdrawal by Subject|10|||
164679546|NCT03100344|594851190|FG001|Overall Study|Withdrawal by Subject|7|||
164679547|NCT03100344|594851191|FG002|Overall Study|Withdrawal by Subject|4|||
164679548|NCT03100344|594851192|FG003|Overall Study|Withdrawal by Subject|8|||
164248459|NCT00603941|593275421|FG000|Overall Study|Physician Decision|0|||
164248460|NCT00603941|593275422|FG001|Overall Study|Physician Decision|1|||
164248461|NCT00603941|593275423|FG002|Overall Study|Physician Decision|0|||
164248462|NCT00603941|593275421|FG000|Overall Study|Withdrawal by Subject|0|||
164248463|NCT00603941|593275422|FG001|Overall Study|Withdrawal by Subject|2|||
164338525|NCT02925117|593615210|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
164338526|NCT02925117|593615199|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
164338527|NCT02925117|593615200|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
164426726|NCT02487446|593930857|FG001|Period 2|Adverse Event|2|||
164575135|NCT03976401|594469793|FG000|Overall Study|Adverse Event|2|||
164248464|NCT00603941|593275423|FG002|Overall Study|Withdrawal by Subject|0|||
164248465|NCT02707965|593275425|FG000|Overall Study|Withdrawal by Subject|0|||
164248466|NCT02707965|593275426|FG001|Overall Study|Withdrawal by Subject|0|||
164248467|NCT02707965|593275427|FG002|Overall Study|Withdrawal by Subject|1|||
164248468|NCT02707965|593275428|FG003|Overall Study|Withdrawal by Subject|0|||
164248469|NCT02707965|593275429|FG004|Overall Study|Withdrawal by Subject|0|||
164248470|NCT02707965|593275430|FG005|Overall Study|Withdrawal by Subject|0|||
164248471|NCT02707965|593275431|FG006|Overall Study|Withdrawal by Subject|0|||
164248472|NCT02707965|593275432|FG007|Overall Study|Withdrawal by Subject|2|||
164248473|NCT02707965|593275433|FG008|Overall Study|Withdrawal by Subject|0|||
164248474|NCT02707965|593275434|FG009|Overall Study|Withdrawal by Subject|0|||
164248475|NCT02707965|593275435|FG010|Overall Study|Withdrawal by Subject|0|||
164248476|NCT02707965|593275436|FG011|Overall Study|Withdrawal by Subject|0|||
164248477|NCT02707965|593275437|FG012|Overall Study|Withdrawal by Subject|0|||
164248478|NCT02707965|593275438|FG013|Overall Study|Withdrawal by Subject|0|||
164248479|NCT02707965|593275439|FG014|Overall Study|Withdrawal by Subject|0|||
164248480|NCT02707965|593275440|FG015|Overall Study|Withdrawal by Subject|0|||
164248481|NCT02707965|593275425|FG000|Overall Study|PI decisions|0|||
164248482|NCT02707965|593275426|FG001|Overall Study|PI decisions|0|||
164248483|NCT02707965|593275427|FG002|Overall Study|PI decisions|0|||
164248484|NCT02707965|593275428|FG003|Overall Study|PI decisions|0|||
164248485|NCT02707965|593275429|FG004|Overall Study|PI decisions|0|||
164248486|NCT02707965|593275430|FG005|Overall Study|PI decisions|0|||
164248487|NCT02707965|593275431|FG006|Overall Study|PI decisions|0|||
164248488|NCT02707965|593275432|FG007|Overall Study|PI decisions|0|||
164248489|NCT02707965|593275433|FG008|Overall Study|PI decisions|0|||
164248490|NCT02707965|593275434|FG009|Overall Study|PI decisions|0|||
164248491|NCT02707965|593275435|FG010|Overall Study|PI decisions|0|||
164248492|NCT02707965|593275436|FG011|Overall Study|PI decisions|0|||
164248493|NCT02707965|593275437|FG012|Overall Study|PI decisions|0|||
164248494|NCT02707965|593275438|FG013|Overall Study|PI decisions|0|||
164248495|NCT02707965|593275439|FG014|Overall Study|PI decisions|2|||
164248496|NCT02707965|593275440|FG015|Overall Study|PI decisions|0|||
164248497|NCT02707965|593275425|FG000|Overall Study|Protocol deviation|1|||
164248498|NCT02707965|593275426|FG001|Overall Study|Protocol deviation|1|||
164248499|NCT02707965|593275427|FG002|Overall Study|Protocol deviation|0|||
164248500|NCT02707965|593275428|FG003|Overall Study|Protocol deviation|0|||
164248501|NCT02707965|593275429|FG004|Overall Study|Protocol deviation|0|||
164248502|NCT02707965|593275430|FG005|Overall Study|Protocol deviation|0|||
164248503|NCT02707965|593275431|FG006|Overall Study|Protocol deviation|0|||
164248504|NCT02707965|593275432|FG007|Overall Study|Protocol deviation|1|||
164248505|NCT02707965|593275433|FG008|Overall Study|Protocol deviation|0|||
164248506|NCT02707965|593275434|FG009|Overall Study|Protocol deviation|0|||
164248507|NCT02707965|593275435|FG010|Overall Study|Protocol deviation|0|||
164248508|NCT02707965|593275436|FG011|Overall Study|Protocol deviation|0|||
164248509|NCT02707965|593275437|FG012|Overall Study|Protocol deviation|0|||
164248510|NCT02707965|593275438|FG013|Overall Study|Protocol deviation|0|||
164248511|NCT02707965|593275439|FG014|Overall Study|Protocol deviation|0|||
164248512|NCT02707965|593275440|FG015|Overall Study|Protocol deviation|0|||
164248513|NCT00249808|593275441|FG000|Overall Study|Other|27|||
164248514|NCT00249808|593275441|FG000|Overall Study|Protocol Violation|3|||
164248515|NCT00249808|593275441|FG000|Overall Study|Lost to Follow-up|8|||
164248516|NCT00249808|593275441|FG000|Overall Study|Adverse Event|81|||
164248517|NCT00249808|593275441|FG000|Overall Study|Lack of Efficacy|52|||
164248518|NCT00249808|593275441|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
164248519|NCT00711594|593275442|FG000|Overall Study|Progressive disease|2|||
164248520|NCT00711594|593275443|FG001|Overall Study|Progressive disease|2|||
164248521|NCT00711594|593275444|FG002|Overall Study|Progressive disease|6|||
164248522|NCT00711594|593275445|FG003|Overall Study|Progressive disease|44|||
164248523|NCT00711594|593275442|FG000|Overall Study|Other Adverse Event|1|||
164248524|NCT00711594|593275443|FG001|Overall Study|Other Adverse Event|0|||
164426727|NCT02234310|593930858|FG000|Overall Study|Physician Decision|1|||
164426728|NCT02234310|593930858|FG000|Overall Study|Adverse Event|1|||
164426729|NCT02234310|593930858|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
164248525|NCT00711594|593275444|FG002|Overall Study|Other Adverse Event|0|||
164248526|NCT00711594|593275445|FG003|Overall Study|Other Adverse Event|16|||
164248527|NCT00711594|593275442|FG000|Overall Study|Withdrawal by Subject|0|||
164248528|NCT00711594|593275443|FG001|Overall Study|Withdrawal by Subject|1|||
164248529|NCT00711594|593275444|FG002|Overall Study|Withdrawal by Subject|0|||
164248530|NCT00711594|593275445|FG003|Overall Study|Withdrawal by Subject|2|||
164248531|NCT00485758|593275450|FG000|Overall Study|Adverse Event|102|||
164248532|NCT00485758|593275451|FG001|Overall Study|Adverse Event|31|||
164248533|NCT00485758|593275450|FG000|Overall Study|Death|0|||
164248534|NCT00485758|593275451|FG001|Overall Study|Death|1|||
164248535|NCT00485758|593275450|FG000|Overall Study|Lost to Follow-up|5|||
164248536|NCT00485758|593275451|FG001|Overall Study|Lost to Follow-up|1|||
164248537|NCT00485758|593275450|FG000|Overall Study|Physician Decision|3|||
164248538|NCT00485758|593275451|FG001|Overall Study|Physician Decision|3|||
164248539|NCT00485758|593275450|FG000|Overall Study|Protocol Violation|11|||
164248540|NCT00485758|593275451|FG001|Overall Study|Protocol Violation|2|||
164248541|NCT00485758|593275450|FG000|Overall Study|Withdrawal by Subject|32|||
164248542|NCT00485758|593275451|FG001|Overall Study|Withdrawal by Subject|27|||
164248543|NCT00485758|593275450|FG000|Overall Study|Study Terminated by Sponsor|3|||
164248544|NCT00485758|593275451|FG001|Overall Study|Study Terminated by Sponsor|0|||
164248545|NCT00211172|593275454|FG000|Overall Study|Died or lost health plan eligibility|39|||
164248546|NCT00211172|593275455|FG001|Overall Study|Died or lost health plan eligibility|32|||
164248547|NCT02253433|593275459|FG000|Overall Study|Unable to Contact|9|||
164426730|NCT02234310|593930858|FG000|Overall Study|Withdrawal by Subject|2|||
164426731|NCT03289455|593930859|FG000|Overall Study|Death|1|||
164426732|NCT03289455|593930860|FG001|Overall Study|Death|0|||
164426733|NCT03289455|593930861|FG002|Overall Study|Death|0|||
164426734|NCT03289455|593930859|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
164426735|NCT03289455|593930860|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
164426736|NCT03289455|593930861|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
164426737|NCT03289455|593930859|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
164426738|NCT03289455|593930860|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
164426739|NCT03289455|593930861|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
164426740|NCT03289455|593930859|FG000|Overall Study|Progressive disease|3|||
164426741|NCT03289455|593930860|FG001|Overall Study|Progressive disease|4|||
164426742|NCT03289455|593930861|FG002|Overall Study|Progressive disease|5|||
164426743|NCT04951479|593930862|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
164426744|NCT03706690|593930863|FG000|Overall Study|Withdrawal by Subject|8|||
164426745|NCT03706690|593930864|FG001|Overall Study|Withdrawal by Subject|8|||
164426746|NCT03706690|593930863|FG000|Overall Study|Death|143|||
164426747|NCT03706690|593930864|FG001|Overall Study|Death|75|||
164426748|NCT03706690|593930863|FG000|Overall Study|Ongoing at DCO|121|||
164426749|NCT03706690|593930864|FG001|Overall Study|Ongoing at DCO|52|||
164426750|NCT05617040|593930865|FG000|Overall Study|Adverse Event|0|||
164426751|NCT05617040|593930866|FG001|Overall Study|Adverse Event|1|||
164426752|NCT05617040|593930867|FG002|Overall Study|Adverse Event|0|||
164426753|NCT05617040|593930865|FG000|Overall Study|Death|0|||
164426754|NCT05617040|593930866|FG001|Overall Study|Death|0|||
164426755|NCT05617040|593930867|FG002|Overall Study|Death|1|||
164426756|NCT02711826|593930868|FG000|Overall Study|Physician Decision|0|||
164426757|NCT02711826|593930869|FG001|Overall Study|Physician Decision|0|||
164426758|NCT02711826|593930870|FG002|Overall Study|Physician Decision|0|||
164426759|NCT02711826|593930871|FG003|Overall Study|Physician Decision|1|||
164679549|NCT03100344|594851189|FG000|Overall Study|Lost to Follow-up|1|||
164679550|NCT03100344|594851190|FG001|Overall Study|Lost to Follow-up|1|||
164679551|NCT03100344|594851191|FG002|Overall Study|Lost to Follow-up|1|||
164679552|NCT03100344|594851192|FG003|Overall Study|Lost to Follow-up|1|||
164679553|NCT01010503|594851193|FG000|Overall Study|Adverse Event|1|||
164679554|NCT01010503|594851193|FG000|Overall Study|Death|1|||
164679555|NCT00725322|594851194|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
164679556|NCT00725322|594851195|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
164679557|NCT00725322|594851194|FG000|Washout (28 Days)|Protocol Violation|0|||
164679558|NCT00725322|594851195|FG001|Washout (28 Days)|Protocol Violation|1|||
164679559|NCT04827394|594851198|FG000|Overall Study|Physician Decision|0|||
164679560|NCT04827394|594851199|FG001|Overall Study|Physician Decision|2|||
164679561|NCT05871151|594851200|FG000|Overall Study|Lost to Follow-up|1|||
164679562|NCT05871151|594851201|FG001|Overall Study|Lost to Follow-up|0|||
164679563|NCT05871151|594851200|FG000|Overall Study|Unrelated illness|0|||
164679564|NCT05871151|594851201|FG001|Overall Study|Unrelated illness|1|||
164679565|NCT06041256|594851202|FG000|Overall Study|Withdrawal by Subject|1|||
164679566|NCT06041256|594851203|FG001|Overall Study|Withdrawal by Subject|0|||
164679567|NCT06041256|594851204|FG002|Overall Study|Withdrawal by Subject|3|||
164679568|NCT06041256|594851205|FG003|Overall Study|Withdrawal by Subject|1|||
164679569|NCT06041256|594851206|FG004|Overall Study|Withdrawal by Subject|1|||
164679570|NCT06041256|594851202|FG000|Overall Study|Rescue|17|||
164248548|NCT02253433|593275460|FG001|Overall Study|Unable to Contact|16|||
164248549|NCT02253433|593275459|FG000|Overall Study|Death|1|||
164248550|NCT02253433|593275460|FG001|Overall Study|Death|1|||
164248551|NCT02253433|593275459|FG000|Overall Study|No Longer Interested|3|||
164426760|NCT02711826|593930872|FG004|Overall Study|Physician Decision|0|||
164426761|NCT02711826|593930868|FG000|Overall Study|Withdrawal by Subject|0|||
164426762|NCT02711826|593930869|FG001|Overall Study|Withdrawal by Subject|1|||
164426763|NCT02711826|593930870|FG002|Overall Study|Withdrawal by Subject|0|||
164679571|NCT06041256|594851203|FG001|Overall Study|Rescue|6|||
164679572|NCT06041256|594851204|FG002|Overall Study|Rescue|9|||
164248552|NCT02253433|593275460|FG001|Overall Study|No Longer Interested|15|||
164426764|NCT02711826|593930871|FG003|Overall Study|Withdrawal by Subject|4|||
164426765|NCT02711826|593930872|FG004|Overall Study|Withdrawal by Subject|0|||
164248553|NCT02253433|593275459|FG000|Overall Study|Out of Study Area|2|||
164248554|NCT02253433|593275460|FG001|Overall Study|Out of Study Area|7|||
164679573|NCT06041256|594851205|FG003|Overall Study|Rescue|6|||
164679574|NCT06041256|594851206|FG004|Overall Study|Rescue|2|||
164679575|NCT04406194|594852143|FG000|Period 1|Withdrawal by Subject|0|||
164679576|NCT04406194|594852144|FG001|Period 1|Withdrawal by Subject|1|||
164679577|NCT02888756|594852145|FG000|Analytical Treatment Interruption|Physician Decision|10|||
164679578|NCT02888756|594852146|FG001|Analytical Treatment Interruption|Physician Decision|6|||
164679579|NCT02888756|594852147|FG002|Analytical Treatment Interruption|Physician Decision|5|||
164679580|NCT00928057|594852148|FG000|Overall Study|Adverse Event|1|||
164248555|NCT02253433|593275459|FG000|Overall Study|Uncomfortable with home visitors|0|||
164248556|NCT02253433|593275460|FG001|Overall Study|Uncomfortable with home visitors|3|||
164248557|NCT02253433|593275459|FG000|Overall Study|Unstable Housing/Homeless|0|||
164248558|NCT02253433|593275460|FG001|Overall Study|Unstable Housing/Homeless|7|||
164248559|NCT02253433|593275459|FG000|Overall Study|Too Busy|0|||
164248560|NCT02253433|593275460|FG001|Overall Study|Too Busy|4|||
164248561|NCT02253433|593275459|FG000|Overall Study|Medical or Other Concerns|1|||
164248562|NCT02253433|593275460|FG001|Overall Study|Medical or Other Concerns|2|||
164248563|NCT04283656|593275462|FG000|Overall Study|Adverse Event|1|||
164248564|NCT04283656|593275463|FG001|Overall Study|Adverse Event|0|||
164248565|NCT04283656|593275462|FG000|Overall Study|Lost to Follow-up|0|||
164248566|NCT04283656|593275463|FG001|Overall Study|Lost to Follow-up|1|||
164248567|NCT00803361|593275464|FG000|Overall Study|Adverse Event|13|||
164248568|NCT00803361|593275465|FG001|Overall Study|Adverse Event|3|||
164248569|NCT00803361|593275464|FG000|Overall Study|Lack of Efficacy|4|||
164248570|NCT00803361|593275465|FG001|Overall Study|Lack of Efficacy|13|||
164248571|NCT00803361|593275464|FG000|Overall Study|Lost to Follow-up|1|||
164248572|NCT00803361|593275465|FG001|Overall Study|Lost to Follow-up|2|||
164248573|NCT00803361|593275464|FG000|Overall Study|Physician Decision|1|||
164248574|NCT00803361|593275465|FG001|Overall Study|Physician Decision|0|||
164248575|NCT00803361|593275464|FG000|Overall Study|Protocol Violation|2|||
164248576|NCT00803361|593275465|FG001|Overall Study|Protocol Violation|4|||
164248577|NCT00803361|593275464|FG000|Overall Study|Withdrawal by Subject|5|||
164248578|NCT00803361|593275465|FG001|Overall Study|Withdrawal by Subject|6|||
164248579|NCT04445519|593275466|FG000|Overall Study|Due to adaptive design|3|||
164248580|NCT04445519|593275467|FG001|Overall Study|Due to adaptive design|0|||
164248581|NCT04445519|593275468|FG002|Overall Study|Due to adaptive design|0|||
164248582|NCT04445519|593275466|FG000|Overall Study|Lost to Follow-up|0|||
164248583|NCT04445519|593275467|FG001|Overall Study|Lost to Follow-up|1|||
164248584|NCT04445519|593275468|FG002|Overall Study|Lost to Follow-up|4|||
164248585|NCT04445519|593275466|FG000|Overall Study|Sponsor or IRB Decision|0|||
164248586|NCT04445519|593275467|FG001|Overall Study|Sponsor or IRB Decision|1|||
164248587|NCT04445519|593275468|FG002|Overall Study|Sponsor or IRB Decision|2|||
164248588|NCT04445519|593275466|FG000|Overall Study|Withdrawal by Subject|0|||
164248589|NCT04445519|593275467|FG001|Overall Study|Withdrawal by Subject|3|||
164248590|NCT04445519|593275468|FG002|Overall Study|Withdrawal by Subject|3|||
164248591|NCT04445519|593275466|FG000|Overall Study|Adverse Event|0|||
164248592|NCT04445519|593275467|FG001|Overall Study|Adverse Event|8|||
164248593|NCT04445519|593275468|FG002|Overall Study|Adverse Event|6|||
164248594|NCT04445519|593275466|FG000|Overall Study|Other Reason|0|||
164248595|NCT04445519|593275467|FG001|Overall Study|Other Reason|1|||
164248596|NCT04445519|593275468|FG002|Overall Study|Other Reason|1|||
164679581|NCT00928057|594852149|FG001|Overall Study|Adverse Event|2|||
164679582|NCT00928057|594852148|FG000|Overall Study|Withdrawal by Subject|1|||
164679583|NCT00928057|594852149|FG001|Overall Study|Withdrawal by Subject|0|||
164679584|NCT00928057|594852148|FG000|Overall Study|Lost to Follow-up|0|||
164679585|NCT00928057|594852149|FG001|Overall Study|Lost to Follow-up|1|||
164679586|NCT00928057|594852148|FG000|Overall Study|Protocol Violation|0|||
164248597|NCT04445519|593275466|FG000|Overall Study|Protocol Violation|0|||
164248598|NCT04445519|593275467|FG001|Overall Study|Protocol Violation|0|||
164248599|NCT04445519|593275468|FG002|Overall Study|Protocol Violation|1|||
164248600|NCT03782064|593275469|FG000|Overall Study|Lack of Efficacy|2|||
164338528|NCT02925117|593615201|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
164338529|NCT02925117|593615202|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
164338530|NCT02925117|593615203|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
164338531|NCT02925117|593615204|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
164338532|NCT02925117|593615205|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
164338533|NCT02925117|593615206|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
164679587|NCT00928057|594852149|FG001|Overall Study|Protocol Violation|1|||
164248601|NCT03782064|593275469|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
164338534|NCT02925117|593615207|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
164338535|NCT02925117|593615208|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
164248602|NCT02446769|593275474|FG000|Screening Period|Screen Failure|11|||
164248603|NCT02446769|593275475|FG001|Screening Period|Screen Failure|0|||
164248604|NCT02446769|593275476|FG002|Screening Period|Screen Failure|0|||
164248605|NCT02446769|593275474|FG000|Study Period|Randomized in Error|0|||
164338536|NCT02925117|593615209|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
164679588|NCT03206749|594852150|FG000|Overall Study|Withdrawal of consent|5|||
164679589|NCT03206749|594852151|FG001|Overall Study|Withdrawal of consent|3|||
164679590|NCT03206749|594852152|FG002|Overall Study|Withdrawal of consent|6|||
164679591|NCT03206749|594852150|FG000|Overall Study|Lost to Follow-up|0|||
164679592|NCT03206749|594852151|FG001|Overall Study|Lost to Follow-up|0|||
164679593|NCT03206749|594852152|FG002|Overall Study|Lost to Follow-up|1|||
164679594|NCT03497130|594852154|FG000|Overall Study|Lost to Follow-up|1|||
164679595|NCT03497130|594852155|FG001|Overall Study|Lost to Follow-up|1|||
164679596|NCT04345653|594852158|FG000|Overall Study|Withdrawal by Subject|2|||
164679597|NCT03214588|594852159|FG000|Overall Study|Adverse Event|1|||
164679598|NCT03214588|594852160|FG001|Overall Study|Adverse Event|0|||
164679599|NCT03214588|594852161|FG002|Overall Study|Adverse Event|2|||
164679600|NCT03214588|594852159|FG000|Overall Study|Reason Not Specified|0|||
164679601|NCT03214588|594852160|FG001|Overall Study|Reason Not Specified|1|||
164679602|NCT03214588|594852161|FG002|Overall Study|Reason Not Specified|0|||
164679603|NCT00418938|594852162|FG000|Overall Study|Reimbursement|1|||
164679604|NCT00418938|594852163|FG001|Overall Study|Reimbursement|0|||
164679605|NCT00418938|594852162|FG000|Overall Study|Administrative decision|3|||
164679606|NCT00418938|594852163|FG001|Overall Study|Administrative decision|3|||
164248606|NCT02446769|593275475|FG001|Study Period|Randomized in Error|2|||
164248607|NCT02446769|593275476|FG002|Study Period|Randomized in Error|0|||
164248608|NCT04482439|593275477|FG000|Overall Study|Lost to Follow-up|1|||
164248609|NCT04482439|593275477|FG000|Overall Study|Unrelated illness|1|||
164248610|NCT03072043|593275480|FG000|Overall Study|Death|0|||
164248611|NCT03072043|593275481|FG001|Overall Study|Death|0|||
164248612|NCT03072043|593275482|FG002|Overall Study|Death|3|||
164248613|NCT03072043|593275480|FG000|Overall Study|Adverse Event|0|||
164248614|NCT03072043|593275481|FG001|Overall Study|Adverse Event|0|||
164248615|NCT03072043|593275482|FG002|Overall Study|Adverse Event|2|||
164248616|NCT03072043|593275480|FG000|Overall Study|Withdrawal by Subject|0|||
164248617|NCT03072043|593275481|FG001|Overall Study|Withdrawal by Subject|0|||
164248618|NCT03072043|593275482|FG002|Overall Study|Withdrawal by Subject|4|||
164248619|NCT00645840|593275483|FG000|Overall Study|Protocol Violation|3|||
164248620|NCT01823198|593275484|FG000|Overall Study|Physician Decision|0|||
164248621|NCT01823198|593275485|FG001|Overall Study|Physician Decision|1|||
164679607|NCT00418938|594852162|FG000|Overall Study|Withdrawal by Subject|16|||
164679608|NCT00418938|594852163|FG001|Overall Study|Withdrawal by Subject|15|||
164248622|NCT01823198|593275486|FG002|Overall Study|Physician Decision|0|||
164248623|NCT01823198|593275487|FG003|Overall Study|Physician Decision|0|||
164248624|NCT01823198|593275488|FG004|Overall Study|Physician Decision|0|||
164248625|NCT01823198|593275489|FG005|Overall Study|Physician Decision|3|||
164248626|NCT01823198|593275490|FG006|Overall Study|Physician Decision|3|||
164248627|NCT04677543|593275491|FG000|Overall Study|Withdrawal by Subject|4|||
164248628|NCT04677543|593275492|FG001|Overall Study|Withdrawal by Subject|1|||
164248629|NCT04677543|593275491|FG000|Overall Study|Physician Decision|0|||
164248630|NCT04677543|593275492|FG001|Overall Study|Physician Decision|1|||
164248631|NCT04677543|593275491|FG000|Overall Study|Adverse Event|0|||
164248632|NCT04677543|593275492|FG001|Overall Study|Adverse Event|1|||
164248633|NCT02342288|593275494|FG000|Overall Study|no protocol anesthesiologist available|3|||
164248634|NCT02342288|593275495|FG001|Overall Study|no protocol anesthesiologist available|2|||
164248635|NCT02342288|593275494|FG000|Overall Study|anesthesia leak in system|1|||
164248636|NCT02342288|593275495|FG001|Overall Study|anesthesia leak in system|0|||
164248637|NCT02342288|593275494|FG000|Overall Study|Withdrawal by Subject|1|||
164248638|NCT02342288|593275495|FG001|Overall Study|Withdrawal by Subject|0|||
164248639|NCT02342288|593275494|FG000|Overall Study|coordinator contaminated with blood|0|||
164248640|NCT02342288|593275495|FG001|Overall Study|coordinator contaminated with blood|1|||
164248641|NCT02342288|593275494|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
164248642|NCT02342288|593275495|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
164248643|NCT02342288|593275494|FG000|Overall Study|coordinator not available|0|||
164248644|NCT02342288|593275495|FG001|Overall Study|coordinator not available|2|||
164679609|NCT00418938|594852162|FG000|Overall Study|Lost to Follow-up|1|||
164679610|NCT00418938|594852163|FG001|Overall Study|Lost to Follow-up|3|||
164679611|NCT00418938|594852162|FG000|Overall Study|Adverse Event|1|||
164679612|NCT00418938|594852163|FG001|Overall Study|Adverse Event|1|||
164679613|NCT00418938|594852162|FG000|Overall Study|On-going|1|||
164248645|NCT04188834|593275497|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
164248646|NCT00553436|593275498|FG000|Overall Study|Conversion to another procedure|1|||
164248647|NCT02455336|593275499|FG000|Overall Study|Withdrawal by Subject|0|||
164248648|NCT02455336|593275500|FG001|Overall Study|Withdrawal by Subject|2|||
164248649|NCT02455336|593275499|FG000|Overall Study|Adverse Event|3|||
164248650|NCT02455336|593275500|FG001|Overall Study|Adverse Event|0|||
164248651|NCT02455336|593275499|FG000|Overall Study|Non-responder to treatment|2|||
164248652|NCT02455336|593275500|FG001|Overall Study|Non-responder to treatment|0|||
164679614|NCT00418938|594852163|FG001|Overall Study|On-going|1|||
164679615|NCT00418938|594852162|FG000|Overall Study|Ineligibility Determined|1|||
164679616|NCT00418938|594852163|FG001|Overall Study|Ineligibility Determined|0|||
164679617|NCT00003470|594852170|FG000|Overall Study|Not evaluable|6|||
164679618|NCT01794845|594852175|FG000|Overall Study|Withdrawal by Subject|1|||
164248653|NCT00391430|593275501|FG000|Overall Study|Withdrawal by Subject|3|||
164248654|NCT00391430|593275502|FG001|Overall Study|Withdrawal by Subject|0|||
164679619|NCT03498560|594852177|FG000|Overall Study|Found Ineligible|2|||
164679620|NCT03498560|594852177|FG000|Overall Study|Withdrawal by Subject|14|||
164248655|NCT00391430|593275503|FG002|Overall Study|Withdrawal by Subject|12|||
164248656|NCT00577707|593275506|FG000|Overall Study|Withdrawal by Subject|3|||
164248657|NCT03299244|593275507|FG000|Overall Study|Withdrawal by Subject|34|||
164248658|NCT03299244|593275508|FG001|Overall Study|Withdrawal by Subject|29|||
164248659|NCT03299244|593275507|FG000|Overall Study|Decision by Sponsor|4|||
164248660|NCT03299244|593275508|FG001|Overall Study|Decision by Sponsor|5|||
164248661|NCT03299244|593275507|FG000|Overall Study|Death|9|||
164248662|NCT03299244|593275508|FG001|Overall Study|Death|4|||
164248663|NCT03706430|593275519|FG000|Overall Study|No A-Line placed|5|||
164248664|NCT03706430|593275519|FG000|Overall Study|Subject had gel nail polish|1|||
164248665|NCT03706430|593275519|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
164248666|NCT03706430|593275519|FG000|Overall Study|Cancelled Case|6|||
164248667|NCT03706430|593275519|FG000|Overall Study|Physician Decision|2|||
164248668|NCT01928433|593275520|FG000|Overall Study|Adverse Event|5|||
164248669|NCT01928433|593275521|FG001|Overall Study|Adverse Event|2|||
164248670|NCT01928433|593275522|FG002|Overall Study|Adverse Event|5|||
164248671|NCT01928433|593275520|FG000|Overall Study|Protocol Violation|0|||
164248672|NCT01928433|593275521|FG001|Overall Study|Protocol Violation|0|||
164248673|NCT01928433|593275522|FG002|Overall Study|Protocol Violation|2|||
164248674|NCT01928433|593275520|FG000|Overall Study|Lack of Efficacy|5|||
164248675|NCT01928433|593275521|FG001|Overall Study|Lack of Efficacy|4|||
164248676|NCT01928433|593275522|FG002|Overall Study|Lack of Efficacy|4|||
164248677|NCT01928433|593275520|FG000|Overall Study|Withdrawal by Subject|0|||
164248678|NCT01928433|593275521|FG001|Overall Study|Withdrawal by Subject|4|||
164248679|NCT01928433|593275522|FG002|Overall Study|Withdrawal by Subject|0|||
164248680|NCT01928433|593275520|FG000|Overall Study|Negative screening urine culture|7|||
164248681|NCT01928433|593275521|FG001|Overall Study|Negative screening urine culture|6|||
164248682|NCT01928433|593275522|FG002|Overall Study|Negative screening urine culture|10|||
164248683|NCT01928433|593275520|FG000|Overall Study|Lost to Follow-up|0|||
164248684|NCT01928433|593275521|FG001|Overall Study|Lost to Follow-up|2|||
164248685|NCT01928433|593275522|FG002|Overall Study|Lost to Follow-up|3|||
164248686|NCT01928433|593275520|FG000|Overall Study|Other reasons|3|||
164248687|NCT01928433|593275521|FG001|Overall Study|Other reasons|3|||
164248688|NCT01928433|593275522|FG002|Overall Study|Other reasons|4|||
164248689|NCT00145626|593275523|FG000|Overall Study|Did not have NK infusions|2|||
164248690|NCT00145626|593275523|FG000|Overall Study|Turned 2 years old before treatment|1|||
164248691|NCT00145626|593275523|FG000|Overall Study|Death|1|||
164248692|NCT00145626|593275523|FG000|Overall Study|Withdrawal by Subject|1|||
164248693|NCT03381287|593275525|FG000|Overall Study|Withdrawal by Subject|0|||
164248694|NCT03381287|593275526|FG001|Overall Study|Withdrawal by Subject|1|||
164248695|NCT03381287|593275527|FG002|Overall Study|Withdrawal by Subject|0|||
164248696|NCT03381287|593275528|FG003|Overall Study|Withdrawal by Subject|0|||
164338537|NCT02925117|593615210|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
164338538|NCT02925117|593615199|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
164338539|NCT02925117|593615200|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
164575136|NCT03976401|594469794|FG001|Overall Study|Adverse Event|0|||
164575137|NCT03976401|594469795|FG002|Overall Study|Adverse Event|4|||
164575138|NCT03976401|594469796|FG003|Overall Study|Adverse Event|1|||
164575139|NCT03976401|594469797|FG004|Overall Study|Adverse Event|1|||
164575140|NCT03976401|594469798|FG005|Overall Study|Adverse Event|0|||
164575141|NCT03976401|594469793|FG000|Overall Study|Withdrawal by Subject|0|||
164575142|NCT03976401|594469794|FG001|Overall Study|Withdrawal by Subject|1|||
164575143|NCT03976401|594469795|FG002|Overall Study|Withdrawal by Subject|0|||
164575144|NCT03976401|594469796|FG003|Overall Study|Withdrawal by Subject|0|||
164575145|NCT03976401|594469797|FG004|Overall Study|Withdrawal by Subject|0|||
164575146|NCT03976401|594469798|FG005|Overall Study|Withdrawal by Subject|1|||
164248697|NCT03381287|593275525|FG000|Overall Study|Adverse Event|0|||
164248698|NCT03381287|593275526|FG001|Overall Study|Adverse Event|0|||
164248699|NCT03381287|593275527|FG002|Overall Study|Adverse Event|0|||
164248700|NCT03381287|593275528|FG003|Overall Study|Adverse Event|1|||
164248701|NCT03381287|593275525|FG000|Overall Study|Physician Decision|0|||
164248702|NCT03381287|593275526|FG001|Overall Study|Physician Decision|0|||
164248703|NCT03381287|593275527|FG002|Overall Study|Physician Decision|0|||
164248704|NCT03381287|593275528|FG003|Overall Study|Physician Decision|1|||
164248705|NCT02709720|593275529|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
164679621|NCT03498560|594852177|FG000|Overall Study|Lost to Follow-up|4|||
164248706|NCT02709720|593275529|FG000|Overall Study|Protocol Violation|1|||
164248707|NCT02709720|593275529|FG000|Overall Study|Not take study medication|1|||
164248708|NCT01198574|593275531|FG000|Overall Study|Resigned from schools|4|||
164248709|NCT01198574|593275532|FG001|Overall Study|Resigned from schools|1|||
164248710|NCT01198574|593275533|FG002|Overall Study|Resigned from schools|1|||
164248711|NCT01198574|593275534|FG003|Overall Study|Resigned from schools|4|||
164248712|NCT04439539|593277662|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
164248713|NCT04439539|593277663|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
164248714|NCT04439539|593277664|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
164575147|NCT03976401|594469793|FG000|Overall Study|Physician Decision|0|||
164575148|NCT03976401|594469794|FG001|Overall Study|Physician Decision|0|||
164575149|NCT03976401|594469795|FG002|Overall Study|Physician Decision|1|||
164575150|NCT03976401|594469796|FG003|Overall Study|Physician Decision|0|||
164679622|NCT03498560|594852177|FG000|Overall Study|Death|1|||
164679623|NCT00867360|594852178|FG000|Overall Study|Withdrawal by Subject|1|||
164679624|NCT00867360|594852179|FG001|Overall Study|Withdrawal by Subject|0|||
164679625|NCT00867360|594852178|FG000|Overall Study|Physician Decision|0|||
164679626|NCT00867360|594852179|FG001|Overall Study|Physician Decision|1|||
164679627|NCT01004510|594852180|FG000|Overall Study|Adverse Event|1|||
164679628|NCT02911025|594852182|FG000|Overall Study|Lost to Follow-up|3|||
164679629|NCT00436163|594852183|FG000|Overall Study|Lost to Follow-up|2|||
164679630|NCT00436163|594852183|FG000|Overall Study|Adverse Event|1|||
164679631|NCT02597049|594852184|FG000|Overall Study|Lost to Follow-up|0|||
164679632|NCT02597049|594852185|FG001|Overall Study|Lost to Follow-up|3|||
164679633|NCT02597049|594852186|FG002|Overall Study|Lost to Follow-up|2|||
164679634|NCT02597049|594852184|FG000|Overall Study|Withdrawal by Subject|2|||
164679635|NCT02597049|594852185|FG001|Overall Study|Withdrawal by Subject|2|||
164679636|NCT02597049|594852186|FG002|Overall Study|Withdrawal by Subject|1|||
164679637|NCT02597049|594852184|FG000|Overall Study|Adverse Event|2|||
164679638|NCT02597049|594852185|FG001|Overall Study|Adverse Event|0|||
164679639|NCT02597049|594852186|FG002|Overall Study|Adverse Event|0|||
164679640|NCT02597049|594852184|FG000|Overall Study|Death|2|||
164248715|NCT04439539|593277662|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
164575151|NCT03976401|594469797|FG004|Overall Study|Physician Decision|0|||
164575152|NCT03976401|594469798|FG005|Overall Study|Physician Decision|0|||
164248716|NCT04439539|593277663|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
164248717|NCT04439539|593277664|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
164575153|NCT03976401|594469793|FG000|Overall Study|Lost to Follow-up|1|||
164575154|NCT03976401|594469794|FG001|Overall Study|Lost to Follow-up|2|||
164679641|NCT02597049|594852185|FG001|Overall Study|Death|0|||
164679642|NCT02597049|594852186|FG002|Overall Study|Death|0|||
164679643|NCT02597049|594852184|FG000|Overall Study|Noncompliant with Study Visits|1|||
164575155|NCT03976401|594469795|FG002|Overall Study|Lost to Follow-up|0|||
164575156|NCT03976401|594469796|FG003|Overall Study|Lost to Follow-up|0|||
164679644|NCT02597049|594852185|FG001|Overall Study|Noncompliant with Study Visits|0|||
164679645|NCT02597049|594852186|FG002|Overall Study|Noncompliant with Study Visits|0|||
164679646|NCT06647173|594852192|FG000|Overall Study|Lost to Follow-up|24|||
164679647|NCT03250117|594852195|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
164679648|NCT03250117|594852196|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
164679649|NCT03250117|594852197|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
164679650|NCT03250117|594852198|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
164679651|NCT04063878|594852199|FG000|Overall Study|Withdrawal by Subject|2|||
164679652|NCT04063878|594852199|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
164679653|NCT02751827|594852200|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
164679654|NCT02751827|594852201|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
164679655|NCT02751827|594852202|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
164679656|NCT01248728|594852203|FG000|Overall Study|Adverse Event|1|||
164679657|NCT01248728|594852204|FG001|Overall Study|Adverse Event|1|||
164679658|NCT01248728|594852203|FG000|Overall Study|Withdrawal by Subject|2|||
164679659|NCT01248728|594852204|FG001|Overall Study|Withdrawal by Subject|1|||
164679660|NCT01248728|594852203|FG000|Overall Study|Lack of Efficacy|1|||
164679661|NCT01248728|594852204|FG001|Overall Study|Lack of Efficacy|0|||
164679662|NCT01841554|594852205|FG000|Overall Study|Death|7|||
164679663|NCT01841554|594852205|FG000|Overall Study|No Implantation|1|||
164679664|NCT01841554|594852205|FG000|Overall Study|Discontinued Follow Up|5|||
164679665|NCT01841554|594852205|FG000|Overall Study|Study exit due to secondary intervention|6|||
164679666|NCT00147498|594852206|FG000|Overall Study|Adverse Event|1|||
164679667|NCT00147498|594852207|FG001|Overall Study|Adverse Event|6|||
164679668|NCT00147498|594852208|FG002|Overall Study|Adverse Event|7|||
164679669|NCT00147498|594852209|FG003|Overall Study|Adverse Event|3|||
164679670|NCT00147498|594852206|FG000|Overall Study|Lack of Efficacy|1|||
164679671|NCT00147498|594852207|FG001|Overall Study|Lack of Efficacy|1|||
164679672|NCT00147498|594852208|FG002|Overall Study|Lack of Efficacy|1|||
164679673|NCT00147498|594852209|FG003|Overall Study|Lack of Efficacy|8|||
164679674|NCT00147498|594852206|FG000|Overall Study|Laboratory abnormality|0|||
164679675|NCT00147498|594852207|FG001|Overall Study|Laboratory abnormality|0|||
164679676|NCT00147498|594852208|FG002|Overall Study|Laboratory abnormality|2|||
164679677|NCT00147498|594852209|FG003|Overall Study|Laboratory abnormality|0|||
164679678|NCT00147498|594852206|FG000|Overall Study|Participant defaulted|0|||
164679679|NCT00147498|594852207|FG001|Overall Study|Participant defaulted|1|||
164679680|NCT00147498|594852208|FG002|Overall Study|Participant defaulted|4|||
164679681|NCT00147498|594852209|FG003|Overall Study|Participant defaulted|3|||
164679682|NCT00147498|594852206|FG000|Overall Study|Other|1|||
164679683|NCT00147498|594852207|FG001|Overall Study|Other|1|||
164679684|NCT00147498|594852208|FG002|Overall Study|Other|3|||
164679685|NCT00147498|594852209|FG003|Overall Study|Other|3|||
164679686|NCT01838681|594852210|FG000|Period A|Adverse Event|39|||
164679687|NCT01838681|594852211|FG001|Period A|Adverse Event|0|||
164679688|NCT01838681|594852212|FG002|Period A|Adverse Event|0|||
164679689|NCT01838681|594852213|FG003|Period A|Adverse Event|0|||
164679690|NCT01838681|594852210|FG000|Period A|Lack of Efficacy|21|||
164679691|NCT01838681|594852211|FG001|Period A|Lack of Efficacy|0|||
164679692|NCT01838681|594852212|FG002|Period A|Lack of Efficacy|0|||
164679693|NCT01838681|594852213|FG003|Period A|Lack of Efficacy|0|||
164679694|NCT01838681|594852210|FG000|Period A|Early response|148|||
164679695|NCT01838681|594852211|FG001|Period A|Early response|0|||
164679696|NCT01838681|594852212|FG002|Period A|Early response|0|||
164679697|NCT01838681|594852213|FG003|Period A|Early response|0|||
164679698|NCT01838681|594852210|FG000|Period A|Withdrawal by Subject|70|||
164679699|NCT01838681|594852211|FG001|Period A|Withdrawal by Subject|0|||
164679700|NCT01838681|594852212|FG002|Period A|Withdrawal by Subject|0|||
164679701|NCT01838681|594852213|FG003|Period A|Withdrawal by Subject|0|||
164679702|NCT01838681|594852210|FG000|Period A|Protocol Violation|16|||
164679703|NCT01838681|594852211|FG001|Period A|Protocol Violation|0|||
164679704|NCT01838681|594852212|FG002|Period A|Protocol Violation|0|||
164679705|NCT01838681|594852213|FG003|Period A|Protocol Violation|0|||
164679706|NCT01838681|594852210|FG000|Period A|Non-compliance with IMP|6|||
164679707|NCT01838681|594852211|FG001|Period A|Non-compliance with IMP|0|||
164679708|NCT01838681|594852212|FG002|Period A|Non-compliance with IMP|0|||
164679709|NCT01838681|594852213|FG003|Period A|Non-compliance with IMP|0|||
164679710|NCT01838681|594852210|FG000|Period A|Lost to Follow-up|4|||
164679711|NCT01838681|594852211|FG001|Period A|Lost to Follow-up|0|||
164679712|NCT01838681|594852212|FG002|Period A|Lost to Follow-up|0|||
164679713|NCT01838681|594852213|FG003|Period A|Lost to Follow-up|0|||
164679714|NCT01838681|594852210|FG000|Period A|Withdrawal before treatment|4|||
164679715|NCT01838681|594852211|FG001|Period A|Withdrawal before treatment|0|||
164679716|NCT01838681|594852212|FG002|Period A|Withdrawal before treatment|0|||
164679717|NCT01838681|594852213|FG003|Period A|Withdrawal before treatment|0|||
164679718|NCT01838681|594852210|FG000|Period A|Administrative or other reasons|17|||
164679719|NCT01838681|594852211|FG001|Period A|Administrative or other reasons|0|||
164679720|NCT01838681|594852212|FG002|Period A|Administrative or other reasons|0|||
164679721|NCT01838681|594852213|FG003|Period A|Administrative or other reasons|0|||
164679722|NCT01838681|594852210|FG000|Period B/A+|Adverse Event|0|||
164679723|NCT01838681|594852211|FG001|Period B/A+|Adverse Event|13|||
164679724|NCT01838681|594852212|FG002|Period B/A+|Adverse Event|27|||
164679725|NCT01838681|594852213|FG003|Period B/A+|Adverse Event|16|||
164679726|NCT01838681|594852210|FG000|Period B/A+|Lack of Efficacy|0|||
164679727|NCT01838681|594852211|FG001|Period B/A+|Lack of Efficacy|9|||
164679728|NCT01838681|594852212|FG002|Period B/A+|Lack of Efficacy|11|||
164679729|NCT01838681|594852213|FG003|Period B/A+|Lack of Efficacy|6|||
164679730|NCT01838681|594852210|FG000|Period B/A+|Withdrawal by Subject|0|||
164679731|NCT01838681|594852211|FG001|Period B/A+|Withdrawal by Subject|28|||
164679732|NCT01838681|594852212|FG002|Period B/A+|Withdrawal by Subject|35|||
164679733|NCT01838681|594852213|FG003|Period B/A+|Withdrawal by Subject|47|||
164679734|NCT01838681|594852210|FG000|Period B/A+|Protocol Violation|0|||
164679735|NCT01838681|594852211|FG001|Period B/A+|Protocol Violation|1|||
164679736|NCT01838681|594852212|FG002|Period B/A+|Protocol Violation|4|||
164679737|NCT01838681|594852213|FG003|Period B/A+|Protocol Violation|6|||
164679738|NCT01838681|594852210|FG000|Period B/A+|Non-compliance with IMP|0|||
164679739|NCT01838681|594852211|FG001|Period B/A+|Non-compliance with IMP|2|||
164679740|NCT01838681|594852212|FG002|Period B/A+|Non-compliance with IMP|3|||
164679741|NCT01838681|594852213|FG003|Period B/A+|Non-compliance with IMP|3|||
164679742|NCT01838681|594852210|FG000|Period B/A+|Lost to Follow-up|0|||
164679743|NCT01838681|594852211|FG001|Period B/A+|Lost to Follow-up|2|||
164679744|NCT01838681|594852212|FG002|Period B/A+|Lost to Follow-up|5|||
164679745|NCT01838681|594852213|FG003|Period B/A+|Lost to Follow-up|11|||
164679746|NCT01838681|594852210|FG000|Period B/A+|Withdrawal before treatment|0|||
164679747|NCT01838681|594852211|FG001|Period B/A+|Withdrawal before treatment|1|||
164679748|NCT01838681|594852212|FG002|Period B/A+|Withdrawal before treatment|0|||
164679749|NCT01838681|594852213|FG003|Period B/A+|Withdrawal before treatment|0|||
164679750|NCT01838681|594852210|FG000|Period B/A+|Administrative or other reasons|0|||
164679751|NCT01838681|594852211|FG001|Period B/A+|Administrative or other reasons|6|||
164679752|NCT01838681|594852212|FG002|Period B/A+|Administrative or other reasons|10|||
164679753|NCT01838681|594852213|FG003|Period B/A+|Administrative or other reasons|28|||
164679754|NCT00312897|594852216|FG000|Overall Study|Adverse Event|1|||
164679755|NCT00312897|594852217|FG001|Overall Study|Adverse Event|0|||
164679756|NCT00312897|594852216|FG000|Overall Study|Lost to Follow-up|2|||
164679757|NCT00312897|594852217|FG001|Overall Study|Lost to Follow-up|0|||
164679758|NCT00312897|594852216|FG000|Overall Study|Physician Decision|1|||
164679759|NCT00312897|594852217|FG001|Overall Study|Physician Decision|0|||
164679760|NCT00312897|594852216|FG000|Overall Study|Withdrawal by Subject|1|||
164679761|NCT00312897|594852217|FG001|Overall Study|Withdrawal by Subject|3|||
164679762|NCT00312897|594852216|FG000|Overall Study|Pregnancy|1|||
164679763|NCT00312897|594852217|FG001|Overall Study|Pregnancy|0|||
164679764|NCT00312897|594852216|FG000|Overall Study|discontinued prior to getting treatment|0|||
164679765|NCT00312897|594852217|FG001|Overall Study|discontinued prior to getting treatment|3|||
164679766|NCT00902538|594852218|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
164679767|NCT00902538|594852219|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
164679768|NCT00902538|594852220|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
164679769|NCT00902538|594852221|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
164679770|NCT00902538|594852222|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
164679771|NCT00902538|594852223|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
164679772|NCT00902538|594852218|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
164679773|NCT00902538|594852219|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
164679774|NCT00902538|594852220|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
164679775|NCT00902538|594852221|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
164679776|NCT00902538|594852222|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
164679777|NCT00902538|594852223|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
164679778|NCT00902538|594852218|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
164679779|NCT00902538|594852219|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
164338540|NCT02925117|593615201|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
164679780|NCT00902538|594852220|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
164679781|NCT00902538|594852221|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
164679782|NCT00902538|594852222|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
164679783|NCT00902538|594852223|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
164679784|NCT00902538|594852218|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
164679785|NCT00902538|594852219|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
164679786|NCT00902538|594852220|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
164338541|NCT02925117|593615202|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
164679787|NCT00902538|594852221|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
164248718|NCT04439539|593277662|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
164248719|NCT04439539|593277663|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
164248720|NCT04439539|593277664|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
164248721|NCT02013778|593277665|FG000|Overall Study|Death|4|||
164248722|NCT02013778|593277665|FG000|Overall Study|Withdrawal by Subject|1|||
164248723|NCT02013778|593277665|FG000|Overall Study|Physician Decision|1|||
164248724|NCT02013778|593277665|FG000|Overall Study|Adverse Event|1|||
164248725|NCT02719691|593277666|FG000|Overall Study|Physician Decision|0|||
164248726|NCT02719691|593277667|FG001|Overall Study|Physician Decision|0|||
164248727|NCT02719691|593277668|FG002|Overall Study|Physician Decision|1|||
164248728|NCT02719691|593277669|FG003|Overall Study|Physician Decision|0|||
164248729|NCT02719691|593277670|FG004|Overall Study|Physician Decision|0|||
164248730|NCT02719691|593277671|FG005|Overall Study|Physician Decision|0|||
164248731|NCT02719691|593277672|FG006|Overall Study|Physician Decision|0|||
164248732|NCT02719691|593277666|FG000|Overall Study|Withdrawal by Subject|0|||
164248733|NCT02719691|593277667|FG001|Overall Study|Withdrawal by Subject|0|||
164248734|NCT02719691|593277668|FG002|Overall Study|Withdrawal by Subject|0|||
164248735|NCT02719691|593277669|FG003|Overall Study|Withdrawal by Subject|0|||
164248736|NCT02719691|593277670|FG004|Overall Study|Withdrawal by Subject|0|||
164248737|NCT02719691|593277671|FG005|Overall Study|Withdrawal by Subject|1|||
164248738|NCT02719691|593277672|FG006|Overall Study|Withdrawal by Subject|0|||
164248739|NCT03308968|593277673|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
164248740|NCT03308968|593277674|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
164248741|NCT03308968|593277675|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
164248742|NCT03308968|593277673|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
164248743|NCT03308968|593277674|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
164248744|NCT03308968|593277675|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
164248745|NCT03308968|593277673|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
164248746|NCT03308968|593277674|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
164248747|NCT03308968|593277675|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
164248748|NCT03308968|593277673|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
164248749|NCT03308968|593277674|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
164248750|NCT03308968|593277675|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
164248751|NCT03308968|593277673|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
164248752|NCT03308968|593277674|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
164248753|NCT03308968|593277675|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
164248754|NCT03308968|593277673|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
164248755|NCT03308968|593277674|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
164248756|NCT03308968|593277675|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
164679788|NCT00902538|594852222|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
164679789|NCT00902538|594852223|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
164679790|NCT00902538|594852218|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
164679791|NCT00902538|594852219|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
164679792|NCT00902538|594852220|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
164679793|NCT00902538|594852221|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
164679794|NCT00902538|594852222|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
164679795|NCT00902538|594852223|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
164679796|NCT00902538|594852218|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
164679797|NCT00902538|594852219|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
164679798|NCT00902538|594852220|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
164679799|NCT00902538|594852221|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
164679800|NCT00902538|594852222|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
164679801|NCT00902538|594852223|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
164679802|NCT00902538|594852218|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
164679803|NCT00902538|594852219|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
164679804|NCT00902538|594852220|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
164679805|NCT00902538|594852221|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
164679806|NCT00902538|594852222|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
164679807|NCT00902538|594852223|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
164679808|NCT00902538|594852218|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
164248757|NCT03308968|593277673|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
164248758|NCT03308968|593277674|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
164248759|NCT03308968|593277675|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
164248760|NCT03308968|593277673|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
164248761|NCT03308968|593277674|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
164248762|NCT03308968|593277675|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
164248763|NCT03308968|593277673|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
164679809|NCT00902538|594852219|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
164679810|NCT00902538|594852220|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
164679811|NCT00902538|594852221|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
164679812|NCT00902538|594852222|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
164679813|NCT00902538|594852223|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
164679814|NCT00902538|594852218|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
164679815|NCT00902538|594852219|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
164679816|NCT00902538|594852220|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
164679817|NCT00902538|594852221|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
164679818|NCT00902538|594852222|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
164679819|NCT00902538|594852223|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
164679820|NCT00902538|594852218|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
164679821|NCT00902538|594852219|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
164679822|NCT00902538|594852220|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
164679823|NCT00902538|594852221|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
164679824|NCT00902538|594852222|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
164679825|NCT00902538|594852223|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
164679826|NCT00902538|594852218|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
164679827|NCT00902538|594852219|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
164679828|NCT00902538|594852220|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
164679829|NCT00902538|594852221|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
164679830|NCT00902538|594852222|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
164679831|NCT00902538|594852223|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
164679832|NCT00902538|594852218|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
164679833|NCT00902538|594852219|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
164679834|NCT00902538|594852220|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
164679835|NCT00902538|594852221|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
164679836|NCT00902538|594852222|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
164679837|NCT00902538|594852223|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
164679838|NCT00902538|594852218|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
164248764|NCT03308968|593277674|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
164248765|NCT03308968|593277675|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
164248766|NCT03308968|593277673|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
164248767|NCT03308968|593277674|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
164248768|NCT03308968|593277675|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
164248769|NCT03308968|593277673|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
164248770|NCT03308968|593277674|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
164248771|NCT03308968|593277675|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
164248772|NCT03308968|593277673|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
164248773|NCT03308968|593277674|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
164248774|NCT03308968|593277675|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
164248775|NCT03308968|593277673|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
164248776|NCT03308968|593277674|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
164248777|NCT03308968|593277675|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
164248778|NCT03308968|593277673|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
164248779|NCT03308968|593277674|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
164248780|NCT03308968|593277675|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
164248781|NCT01521923|593277681|FG000|Overall Study|AE, serious fatal|1|||
164679839|NCT00902538|594852219|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
164679840|NCT00902538|594852220|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
164679841|NCT00902538|594852221|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
164679842|NCT00902538|594852222|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
164679843|NCT00902538|594852223|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
164679844|NCT00902538|594852218|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
164679845|NCT00902538|594852219|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
164679846|NCT00902538|594852220|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
164679847|NCT00902538|594852221|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
164679848|NCT00902538|594852222|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
164679849|NCT00902538|594852223|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
164679850|NCT00902538|594852218|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
164679851|NCT00902538|594852219|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
164679852|NCT00902538|594852220|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
164679853|NCT00902538|594852221|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
164679854|NCT00902538|594852222|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
164679855|NCT00902538|594852223|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
164248782|NCT01521923|593277682|FG001|Overall Study|AE, serious fatal|0|||
164248783|NCT01521923|593277683|FG002|Overall Study|AE, serious fatal|0|||
164248784|NCT01521923|593277684|FG003|Overall Study|AE, serious fatal|0|||
164248785|NCT01521923|593277681|FG000|Overall Study|SAE, non-fatal|0|||
164248786|NCT01521923|593277682|FG001|Overall Study|SAE, non-fatal|2|||
164248787|NCT01521923|593277683|FG002|Overall Study|SAE, non-fatal|2|||
164248788|NCT01521923|593277684|FG003|Overall Study|SAE, non-fatal|0|||
164248789|NCT01521923|593277681|FG000|Overall Study|AE, non-serious, non-fatal|1|||
164248790|NCT01521923|593277682|FG001|Overall Study|AE, non-serious, non-fatal|3|||
164248791|NCT01521923|593277683|FG002|Overall Study|AE, non-serious, non-fatal|6|||
164248792|NCT01521923|593277684|FG003|Overall Study|AE, non-serious, non-fatal|2|||
164248793|NCT01521923|593277681|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
164248794|NCT01521923|593277682|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
164248795|NCT01521923|593277683|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
164248796|NCT01521923|593277684|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
164248797|NCT01521923|593277681|FG000|Overall Study|Lack of Efficacy|1|||
164248798|NCT01521923|593277682|FG001|Overall Study|Lack of Efficacy|1|||
164248799|NCT01521923|593277683|FG002|Overall Study|Lack of Efficacy|0|||
164248800|NCT01521923|593277684|FG003|Overall Study|Lack of Efficacy|0|||
164248801|NCT01521923|593277681|FG000|Overall Study|Protocol Violation|0|||
164248802|NCT01521923|593277682|FG001|Overall Study|Protocol Violation|0|||
164248803|NCT01521923|593277683|FG002|Overall Study|Protocol Violation|1|||
164248804|NCT01521923|593277684|FG003|Overall Study|Protocol Violation|0|||
164248805|NCT01521923|593277681|FG000|Overall Study|Lost to Follow-up|1|||
164248806|NCT01521923|593277682|FG001|Overall Study|Lost to Follow-up|0|||
164248807|NCT01521923|593277683|FG002|Overall Study|Lost to Follow-up|2|||
164248808|NCT01521923|593277684|FG003|Overall Study|Lost to Follow-up|1|||
164248809|NCT01521923|593277681|FG000|Overall Study|Withdrawal by Subject|1|||
164248810|NCT01521923|593277682|FG001|Overall Study|Withdrawal by Subject|1|||
164248811|NCT01521923|593277683|FG002|Overall Study|Withdrawal by Subject|1|||
164248812|NCT01521923|593277684|FG003|Overall Study|Withdrawal by Subject|2|||
164248813|NCT01521923|593277681|FG000|Overall Study|Other|2|||
164248814|NCT01521923|593277682|FG001|Overall Study|Other|1|||
164248815|NCT01521923|593277683|FG002|Overall Study|Other|3|||
164248816|NCT01521923|593277684|FG003|Overall Study|Other|6|||
164248817|NCT01521923|593277681|FG000|Overall Study|AE, captured in Period 1|0|||
164248818|NCT01521923|593277682|FG001|Overall Study|AE, captured in Period 1|1|||
164248819|NCT01521923|593277683|FG002|Overall Study|AE, captured in Period 1|0|||
164248820|NCT01521923|593277684|FG003|Overall Study|AE, captured in Period 1|1|||
164575157|NCT03976401|594469797|FG004|Overall Study|Lost to Follow-up|0|||
164575158|NCT03976401|594469798|FG005|Overall Study|Lost to Follow-up|0|||
164248821|NCT03037476|593277685|FG000|Overall Study|Lost to Follow-up|63|||
164248822|NCT03037476|593277686|FG001|Overall Study|Lost to Follow-up|46|||
164248823|NCT02403817|593277687|FG000|Overall Study|Withdrawal by Subject|5|||
164248824|NCT02403817|593277688|FG001|Overall Study|Withdrawal by Subject|0|||
164248825|NCT01208324|593277694|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
164248826|NCT01208324|593277695|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
164248827|NCT01208324|593277696|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
164248828|NCT01208324|593277697|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
164248829|NCT04556591|593277700|FG000|Overall Study|Lost to Follow-up|1|||
164248830|NCT04556591|593277701|FG001|Overall Study|Lost to Follow-up|0|||
164248831|NCT04556591|593277700|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
164248832|NCT04556591|593277701|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
164248833|NCT00984165|593277702|FG000|Overall Study|Death on study|2|||
164248834|NCT00984165|593277703|FG001|Overall Study|Death on study|0|||
164248835|NCT00984165|593277704|FG002|Overall Study|Death on study|0|||
164248836|NCT00984165|593277705|FG003|Overall Study|Death on study|0|||
164248837|NCT00984165|593277702|FG000|Overall Study|Disease progression on study|5|||
164248838|NCT00984165|593277703|FG001|Overall Study|Disease progression on study|1|||
164575159|NCT03976401|594469793|FG000|Overall Study|Protocol Violation|0|||
164575160|NCT03976401|594469794|FG001|Overall Study|Protocol Violation|1|||
164575161|NCT03976401|594469795|FG002|Overall Study|Protocol Violation|0|||
164575162|NCT03976401|594469796|FG003|Overall Study|Protocol Violation|0|||
164575163|NCT03976401|594469797|FG004|Overall Study|Protocol Violation|0|||
164248839|NCT00984165|593277704|FG002|Overall Study|Disease progression on study|0|||
164248840|NCT00984165|593277705|FG003|Overall Study|Disease progression on study|0|||
164248841|NCT00984165|593277702|FG000|Overall Study|Death of recipient|0|||
164248842|NCT00984165|593277703|FG001|Overall Study|Death of recipient|0|||
164248843|NCT00984165|593277704|FG002|Overall Study|Death of recipient|0|||
164248844|NCT00984165|593277705|FG003|Overall Study|Death of recipient|1|||
164248845|NCT00984165|593277702|FG000|Overall Study|New protocol|0|||
164248846|NCT00984165|593277703|FG001|Overall Study|New protocol|0|||
164248847|NCT00984165|593277704|FG002|Overall Study|New protocol|0|||
164248848|NCT00984165|593277705|FG003|Overall Study|New protocol|1|||
164248849|NCT00984165|593277702|FG000|Overall Study|P+/donor pair removed from protocol|0|||
164248850|NCT00984165|593277703|FG001|Overall Study|P+/donor pair removed from protocol|0|||
164575164|NCT03976401|594469798|FG005|Overall Study|Protocol Violation|0|||
164575165|NCT03976401|594469793|FG000|Overall Study|Withdrew Consent|0|||
164248851|NCT00984165|593277704|FG002|Overall Study|P+/donor pair removed from protocol|0|||
164248852|NCT00984165|593277705|FG003|Overall Study|P+/donor pair removed from protocol|1|||
164248853|NCT00984165|593277702|FG000|Overall Study|removed with a pair recipient|0|||
164248854|NCT00984165|593277703|FG001|Overall Study|removed with a pair recipient|0|||
164248855|NCT00984165|593277704|FG002|Overall Study|removed with a pair recipient|0|||
164248856|NCT00984165|593277705|FG003|Overall Study|removed with a pair recipient|1|||
164248857|NCT00135330|593277707|FG000|Overall Study|Adverse Event|2|||
164248858|NCT00135330|593277708|FG001|Overall Study|Adverse Event|5|||
164248859|NCT00135330|593277709|FG002|Overall Study|Adverse Event|1|||
164248860|NCT00135330|593277707|FG000|Overall Study|Lost to Follow-up|0|||
164248861|NCT00135330|593277708|FG001|Overall Study|Lost to Follow-up|2|||
164248862|NCT00135330|593277709|FG002|Overall Study|Lost to Follow-up|3|||
164248863|NCT00135330|593277707|FG000|Overall Study|Physician Decision|1|||
164248864|NCT00135330|593277708|FG001|Overall Study|Physician Decision|1|||
164248865|NCT00135330|593277709|FG002|Overall Study|Physician Decision|0|||
164248866|NCT00135330|593277707|FG000|Overall Study|Protocol Violation|4|||
164248867|NCT00135330|593277708|FG001|Overall Study|Protocol Violation|3|||
164248868|NCT00135330|593277709|FG002|Overall Study|Protocol Violation|3|||
164248869|NCT00135330|593277707|FG000|Overall Study|Patient Decision|5|||
164248870|NCT00135330|593277708|FG001|Overall Study|Patient Decision|1|||
164248871|NCT00135330|593277709|FG002|Overall Study|Patient Decision|4|||
164248872|NCT00135330|593277707|FG000|Overall Study|Sponsor Decision|0|||
164248873|NCT00135330|593277708|FG001|Overall Study|Sponsor Decision|1|||
164248874|NCT00135330|593277709|FG002|Overall Study|Sponsor Decision|0|||
164248875|NCT02229825|593277715|FG000|Overall Study|Personal Reasons|0|||
164248876|NCT02229825|593277716|FG001|Overall Study|Personal Reasons|1|||
164248877|NCT02229825|593277715|FG000|Overall Study|Refused continuing medication|7|||
164248878|NCT02229825|593277716|FG001|Overall Study|Refused continuing medication|6|||
164248879|NCT02229825|593277715|FG000|Overall Study|Lost to Follow-up|1|||
164248880|NCT02229825|593277716|FG001|Overall Study|Lost to Follow-up|2|||
164248881|NCT02229825|593277715|FG000|Overall Study|Protocol Violation|1|||
164248882|NCT02229825|593277716|FG001|Overall Study|Protocol Violation|1|||
164248883|NCT02229825|593277715|FG000|Overall Study|Lack of Efficacy|4|||
164248884|NCT02229825|593277716|FG001|Overall Study|Lack of Efficacy|10|||
164248885|NCT02229825|593277715|FG000|Overall Study|Adverse Event|11|||
164338542|NCT02925117|593615203|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
164338543|NCT02925117|593615204|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
164338544|NCT02925117|593615205|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
164338545|NCT02925117|593615206|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
164338546|NCT02925117|593615207|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
164338547|NCT02925117|593615208|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
164338548|NCT02925117|593615209|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
164338549|NCT02925117|593615210|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
164338550|NCT02925117|593615199|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
164338551|NCT02925117|593615200|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
164338552|NCT02925117|593615201|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
164338553|NCT02925117|593615202|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
164338554|NCT02925117|593615203|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
164338555|NCT02925117|593615204|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
164338556|NCT02925117|593615205|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
164338557|NCT02925117|593615206|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
164338558|NCT02925117|593615207|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
164338559|NCT02925117|593615208|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
164338560|NCT02925117|593615209|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
164338561|NCT02925117|593615210|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
164338562|NCT02925117|593615199|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
164338563|NCT02925117|593615200|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
164679856|NCT00902538|594852218|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
164679857|NCT00902538|594852219|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
164679858|NCT00902538|594852220|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
164679859|NCT00902538|594852221|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
164248886|NCT02229825|593277716|FG001|Overall Study|Adverse Event|9|||
164248887|NCT02229825|593277715|FG000|Overall Study|Not treated|0|||
164248888|NCT02229825|593277716|FG001|Overall Study|Not treated|1|||
164248889|NCT01309997|593277717|FG000|Overall Study|Adverse Event|1|||
164248890|NCT01309997|593277718|FG001|Overall Study|Adverse Event|0|||
164248891|NCT01309997|593277717|FG000|Overall Study|Death|1|||
164248892|NCT01309997|593277718|FG001|Overall Study|Death|3|||
164248893|NCT01309997|593277717|FG000|Overall Study|Lack of Efficacy|2|||
164338564|NCT02925117|593615201|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
164338565|NCT02925117|593615202|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
164338566|NCT02925117|593615203|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
164338567|NCT02925117|593615204|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
164338568|NCT02925117|593615205|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
164248894|NCT01309997|593277718|FG001|Overall Study|Lack of Efficacy|2|||
164248895|NCT01309997|593277717|FG000|Overall Study|Withdrawal by Subject|1|||
164248896|NCT01309997|593277718|FG001|Overall Study|Withdrawal by Subject|1|||
164426766|NCT02711826|593930868|FG000|Overall Study|Failure to manufacture cellular product|0|||
164426767|NCT02711826|593930869|FG001|Overall Study|Failure to manufacture cellular product|0|||
164575166|NCT03976401|594469794|FG001|Overall Study|Withdrew Consent|0|||
164575167|NCT03976401|594469795|FG002|Overall Study|Withdrew Consent|0|||
164575168|NCT03976401|594469796|FG003|Overall Study|Withdrew Consent|1|||
164575169|NCT03976401|594469797|FG004|Overall Study|Withdrew Consent|0|||
164575170|NCT03976401|594469798|FG005|Overall Study|Withdrew Consent|0|||
164575171|NCT04125680|594469799|FG000|Overall Study|Lost to Follow-up|15|||
164575172|NCT00049127|594469800|FG000|Overall Study|Withdrawal by Subject|0|||
164575173|NCT00049127|594469801|FG001|Overall Study|Withdrawal by Subject|0|||
164575174|NCT00049127|594469802|FG002|Overall Study|Withdrawal by Subject|1|||
164575175|NCT00049127|594469803|FG003|Overall Study|Withdrawal by Subject|0|||
164575176|NCT00049127|594469804|FG004|Overall Study|Withdrawal by Subject|0|||
164575177|NCT00474240|594469809|FG000|Overall Study|Withdrawal by Subject|1|||
164575178|NCT00474240|594469810|FG001|Overall Study|Withdrawal by Subject|1|||
164575179|NCT00474240|594469811|FG002|Overall Study|Withdrawal by Subject|0|||
164575180|NCT00474240|594469812|FG003|Overall Study|Withdrawal by Subject|2|||
164575181|NCT00474240|594469813|FG004|Overall Study|Withdrawal by Subject|3|||
164575182|NCT00474240|594469814|FG005|Overall Study|Withdrawal by Subject|1|||
164575183|NCT00474240|594469809|FG000|Overall Study|Adverse Event|0|||
164575184|NCT00474240|594469810|FG001|Overall Study|Adverse Event|0|||
164575185|NCT00474240|594469811|FG002|Overall Study|Adverse Event|9|||
164575186|NCT00474240|594469812|FG003|Overall Study|Adverse Event|14|||
164575187|NCT00474240|594469813|FG004|Overall Study|Adverse Event|5|||
164575188|NCT00474240|594469814|FG005|Overall Study|Adverse Event|16|||
164575189|NCT00474240|594469809|FG000|Overall Study|Removed due to lab value|0|||
164575190|NCT00474240|594469810|FG001|Overall Study|Removed due to lab value|0|||
164575191|NCT00474240|594469811|FG002|Overall Study|Removed due to lab value|0|||
164575192|NCT00474240|594469812|FG003|Overall Study|Removed due to lab value|0|||
164575193|NCT00474240|594469813|FG004|Overall Study|Removed due to lab value|0|||
164575194|NCT00474240|594469814|FG005|Overall Study|Removed due to lab value|1|||
164575195|NCT00466505|594469815|FG000|Overall Study|disease progression|13|||
164575196|NCT00466505|594469815|FG000|Overall Study|Adverse Event|4|||
164575197|NCT01241786|594469818|FG000|Overall Study|Lack of Efficacy|5|||
164575198|NCT02620020|594469831|FG000|Overall Study|Adverse Event|8|||
164575199|NCT02620020|594469832|FG001|Overall Study|Adverse Event|4|||
164575200|NCT02620020|594469833|FG002|Overall Study|Adverse Event|3|||
164575201|NCT02620020|594469834|FG003|Overall Study|Adverse Event|5|||
164575202|NCT02620020|594469831|FG000|Overall Study|Lost to Follow-up|4|||
164575203|NCT02620020|594469832|FG001|Overall Study|Lost to Follow-up|8|||
164575204|NCT02620020|594469833|FG002|Overall Study|Lost to Follow-up|1|||
164575205|NCT02620020|594469834|FG003|Overall Study|Lost to Follow-up|4|||
164575206|NCT02620020|594469831|FG000|Overall Study|Physician Decision|7|||
164575207|NCT02620020|594469832|FG001|Overall Study|Physician Decision|4|||
164575208|NCT02620020|594469833|FG002|Overall Study|Physician Decision|3|||
164575209|NCT02620020|594469834|FG003|Overall Study|Physician Decision|4|||
164575210|NCT02620020|594469831|FG000|Overall Study|Protocol Violation|5|||
164575211|NCT02620020|594469832|FG001|Overall Study|Protocol Violation|2|||
164575212|NCT02620020|594469833|FG002|Overall Study|Protocol Violation|1|||
164575213|NCT02620020|594469834|FG003|Overall Study|Protocol Violation|1|||
164575214|NCT02620020|594469831|FG000|Overall Study|Withdrawal by Subject|20|||
164575215|NCT02620020|594469832|FG001|Overall Study|Withdrawal by Subject|16|||
164575216|NCT02620020|594469833|FG002|Overall Study|Withdrawal by Subject|17|||
164575217|NCT02620020|594469834|FG003|Overall Study|Withdrawal by Subject|12|||
164575218|NCT02620020|594469831|FG000|Overall Study|Death|0|||
164575219|NCT02620020|594469832|FG001|Overall Study|Death|1|||
164575220|NCT02620020|594469833|FG002|Overall Study|Death|0|||
164575221|NCT02620020|594469834|FG003|Overall Study|Death|0|||
164575222|NCT03182738|594469846|FG000|Overall Study|Lost to Follow-up|9|||
164575223|NCT03182738|594469847|FG001|Overall Study|Lost to Follow-up|3|||
164575224|NCT03182738|594469846|FG000|Overall Study|Pregnancy|0|||
164575225|NCT03182738|594469847|FG001|Overall Study|Pregnancy|1|||
164575226|NCT03182738|594469846|FG000|Overall Study|Withdrawal by Subject|0|||
164575227|NCT03182738|594469847|FG001|Overall Study|Withdrawal by Subject|1|||
164575228|NCT00098787|594469848|FG000|Overall Study|Never started treatment|3|||
164575229|NCT00098787|594469849|FG001|Overall Study|Never started treatment|2|||
164575230|NCT00098787|594469850|FG002|Overall Study|Never started treatment|1|||
164575231|NCT00098787|594469848|FG000|Overall Study|Ineligible|9|||
164575232|NCT00098787|594469849|FG001|Overall Study|Ineligible|7|||
164575233|NCT00098787|594469850|FG002|Overall Study|Ineligible|3|||
164575234|NCT00098787|594469848|FG000|Overall Study|Disease progression|28|||
164575235|NCT00098787|594469849|FG001|Overall Study|Disease progression|17|||
164575236|NCT00098787|594469850|FG002|Overall Study|Disease progression|23|||
164575237|NCT00098787|594469848|FG000|Overall Study|Adverse Event|8|||
164575238|NCT00098787|594469849|FG001|Overall Study|Adverse Event|17|||
164575239|NCT00098787|594469850|FG002|Overall Study|Adverse Event|8|||
164575240|NCT00098787|594469848|FG000|Overall Study|Death|6|||
164575241|NCT00098787|594469849|FG001|Overall Study|Death|1|||
164575242|NCT00098787|594469850|FG002|Overall Study|Death|0|||
164575243|NCT00098787|594469848|FG000|Overall Study|Withdrawal by Subject|4|||
164248897|NCT04474197|593277719|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
164248898|NCT04474197|593277720|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
164248899|NCT04474197|593277721|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
164248900|NCT04474197|593277722|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
164248901|NCT01532921|593277723|FG000|Overall Study|Death|3|||
164248902|NCT01532921|593277723|FG000|Overall Study|Withdrawal by Subject|2|||
164248903|NCT01532921|593277723|FG000|Overall Study|Lost to Follow-up|3|||
164248904|NCT01532921|593277723|FG000|Overall Study|Physician Decision|7|||
164248905|NCT01532921|593277723|FG000|Overall Study|Device was explanted during procedure|1|||
164248906|NCT02526212|593277724|FG000|Overall Study|Incarceration|1|||
164248907|NCT02526212|593277725|FG001|Overall Study|Incarceration|0|||
164248908|NCT02526212|593277724|FG000|Overall Study|Lost to Follow-up|1|||
164248909|NCT02526212|593277725|FG001|Overall Study|Lost to Follow-up|0|||
164248910|NCT02526212|593277724|FG000|Overall Study|Death|0|||
164248911|NCT02526212|593277725|FG001|Overall Study|Death|1|||
164248912|NCT00588237|593277729|FG000|Overall Study|Evaluable for toxicity only|3|||
164248913|NCT00588237|593277729|FG000|Overall Study|Patien not treated|1|||
164248914|NCT01390298|593277730|FG000|Overall Study|Death|1|||
164248915|NCT01390298|593277730|FG000|Overall Study|long term ICU admission|1|||
164248916|NCT01390298|593277730|FG000|Overall Study|Withdrawal by Subject|14|||
164248917|NCT01390298|593277730|FG000|Overall Study|Lost to Follow-up|7|||
164248918|NCT01390298|593277730|FG000|Overall Study|Surgery cancelled|1|||
164248919|NCT02443337|593277734|FG000|Overall Study|Adverse Event|0|||
164248920|NCT02443337|593277735|FG001|Overall Study|Adverse Event|1|||
164248921|NCT02443337|593277734|FG000|Overall Study|Clinical Progressive Disease|3|||
164248922|NCT02443337|593277735|FG001|Overall Study|Clinical Progressive Disease|0|||
164248923|NCT02443337|593277734|FG000|Overall Study|Withdrawal by Subject|2|||
164248924|NCT02443337|593277735|FG001|Overall Study|Withdrawal by Subject|1|||
164248925|NCT02096952|593277742|FG000|Overall Study|Adverse Event|1|||
164575244|NCT00098787|594469849|FG001|Overall Study|Withdrawal by Subject|12|||
164575245|NCT00098787|594469850|FG002|Overall Study|Withdrawal by Subject|6|||
164575246|NCT00098787|594469848|FG000|Overall Study|Alternative therapy|8|||
164575247|NCT00098787|594469849|FG001|Overall Study|Alternative therapy|13|||
164575248|NCT00098787|594469850|FG002|Overall Study|Alternative therapy|13|||
164575249|NCT00098787|594469848|FG000|Overall Study|Other|7|||
164575250|NCT00098787|594469849|FG001|Overall Study|Other|6|||
164575251|NCT00098787|594469850|FG002|Overall Study|Other|9|||
164575252|NCT00684814|594469851|FG000|Washout Period of 7 Days|Adverse Event|1|||
164575253|NCT00684814|594469852|FG001|Washout Period of 7 Days|Adverse Event|2|||
164575254|NCT00684814|594469851|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
164575255|NCT00684814|594469852|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
164575256|NCT00684814|594469851|FG000|Second Intervention|Adverse Event|1|||
164575257|NCT00684814|594469852|FG001|Second Intervention|Adverse Event|0|||
164575258|NCT00446030|594469853|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
164575259|NCT00446030|594469854|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
164575260|NCT00446030|594469853|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
164248926|NCT03520920|593277743|FG000|Overall Study|Death|13|||
164248927|NCT03520920|593277744|FG001|Overall Study|Death|1|||
164248928|NCT03520920|593277745|FG002|Overall Study|Death|0|||
164248929|NCT03520920|593277743|FG000|Overall Study|Withdrawal by Subject|2|||
164248930|NCT03520920|593277744|FG001|Overall Study|Withdrawal by Subject|1|||
164248931|NCT03520920|593277745|FG002|Overall Study|Withdrawal by Subject|0|||
164248932|NCT03520920|593277743|FG000|Overall Study|Study Terminated by the Sponsor|5|||
164248933|NCT03520920|593277744|FG001|Overall Study|Study Terminated by the Sponsor|14|||
164248934|NCT03520920|593277745|FG002|Overall Study|Study Terminated by the Sponsor|5|||
164248935|NCT00372619|593277748|FG000|Overall Study|Ineligible|0|||
164248936|NCT00372619|593277749|FG001|Overall Study|Ineligible|0|||
164248937|NCT00372619|593277750|FG002|Overall Study|Ineligible|0|||
164248938|NCT00372619|593277751|FG003|Overall Study|Ineligible|0|||
164248939|NCT00372619|593277752|FG004|Overall Study|Ineligible|0|||
164248940|NCT00372619|593277753|FG005|Overall Study|Ineligible|2|||
164248941|NCT00372619|593277754|FG006|Overall Study|Ineligible|0|||
164248942|NCT00372619|593277748|FG000|Overall Study|Inevaluable|0|||
164248943|NCT00372619|593277749|FG001|Overall Study|Inevaluable|0|||
164248944|NCT00372619|593277750|FG002|Overall Study|Inevaluable|0|||
164248945|NCT00372619|593277751|FG003|Overall Study|Inevaluable|0|||
164248946|NCT00372619|593277752|FG004|Overall Study|Inevaluable|0|||
164248947|NCT00372619|593277753|FG005|Overall Study|Inevaluable|1|||
164248948|NCT00372619|593277754|FG006|Overall Study|Inevaluable|0|||
164248949|NCT00066222|593277755|FG000|Overall Study|No protocol treatment received|1|||
164248950|NCT00635349|593277756|FG000|Overall Study|Other|8|||
164248951|NCT00635349|593277757|FG001|Overall Study|Other|6|||
164248952|NCT00635349|593277756|FG000|Overall Study|Protocol Violation|18|||
164248953|NCT00635349|593277757|FG001|Overall Study|Protocol Violation|22|||
164248954|NCT00635349|593277756|FG000|Overall Study|Withdrawal by Subject|3|||
164248955|NCT00635349|593277757|FG001|Overall Study|Withdrawal by Subject|8|||
164248956|NCT00635349|593277756|FG000|Overall Study|Lost to Follow-up|4|||
164248957|NCT00635349|593277757|FG001|Overall Study|Lost to Follow-up|3|||
164248958|NCT00635349|593277756|FG000|Overall Study|Adverse Event|11|||
164248959|NCT00635349|593277757|FG001|Overall Study|Adverse Event|9|||
164248960|NCT01524224|593277768|FG000|Overall Study|Progressive Disease|1|||
164248961|NCT01524224|593277769|FG001|Overall Study|Progressive Disease|0|||
164248962|NCT01524224|593277770|FG002|Overall Study|Progressive Disease|2|||
164248963|NCT01524224|593277771|FG003|Overall Study|Progressive Disease|1|||
164248964|NCT01524224|593277772|FG004|Overall Study|Progressive Disease|2|||
164248965|NCT01524224|593277773|FG005|Overall Study|Progressive Disease|1|||
164248966|NCT01524224|593277774|FG006|Overall Study|Progressive Disease|1|||
164248967|NCT01524224|593277775|FG007|Overall Study|Progressive Disease|5|||
164248968|NCT01524224|593277768|FG000|Overall Study|Withdrawal by Subject|2|||
164248969|NCT01524224|593277769|FG001|Overall Study|Withdrawal by Subject|0|||
164248970|NCT01524224|593277770|FG002|Overall Study|Withdrawal by Subject|0|||
164248971|NCT01524224|593277771|FG003|Overall Study|Withdrawal by Subject|0|||
164248972|NCT01524224|593277772|FG004|Overall Study|Withdrawal by Subject|0|||
164248973|NCT01524224|593277773|FG005|Overall Study|Withdrawal by Subject|0|||
164248974|NCT01524224|593277774|FG006|Overall Study|Withdrawal by Subject|2|||
164679860|NCT00902538|594852222|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
164248975|NCT01524224|593277775|FG007|Overall Study|Withdrawal by Subject|0|||
164248976|NCT01524224|593277768|FG000|Overall Study|Adverse Event|0|||
164248977|NCT01524224|593277769|FG001|Overall Study|Adverse Event|1|||
164248978|NCT01524224|593277770|FG002|Overall Study|Adverse Event|0|||
164248979|NCT01524224|593277771|FG003|Overall Study|Adverse Event|0|||
164248980|NCT01524224|593277772|FG004|Overall Study|Adverse Event|0|||
164248981|NCT01524224|593277773|FG005|Overall Study|Adverse Event|1|||
164248982|NCT01524224|593277774|FG006|Overall Study|Adverse Event|0|||
164248983|NCT01524224|593277775|FG007|Overall Study|Adverse Event|0|||
164248984|NCT01524224|593277768|FG000|Overall Study|Physician Decision|0|||
164248985|NCT01524224|593277769|FG001|Overall Study|Physician Decision|0|||
164248986|NCT01524224|593277770|FG002|Overall Study|Physician Decision|0|||
164248987|NCT01524224|593277771|FG003|Overall Study|Physician Decision|1|||
164248988|NCT01524224|593277772|FG004|Overall Study|Physician Decision|1|||
164248989|NCT01524224|593277773|FG005|Overall Study|Physician Decision|0|||
164679861|NCT00902538|594852223|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
164248990|NCT01524224|593277774|FG006|Overall Study|Physician Decision|0|||
164248991|NCT01524224|593277775|FG007|Overall Study|Physician Decision|1|||
164248992|NCT01524224|593277768|FG000|Overall Study|Sponsor Decision|0|||
164248993|NCT01524224|593277769|FG001|Overall Study|Sponsor Decision|0|||
164248994|NCT01524224|593277770|FG002|Overall Study|Sponsor Decision|0|||
164248995|NCT01524224|593277771|FG003|Overall Study|Sponsor Decision|0|||
164248996|NCT01524224|593277772|FG004|Overall Study|Sponsor Decision|1|||
164248997|NCT01524224|593277773|FG005|Overall Study|Sponsor Decision|0|||
164248998|NCT01524224|593277774|FG006|Overall Study|Sponsor Decision|0|||
164248999|NCT01524224|593277775|FG007|Overall Study|Sponsor Decision|0|||
164249000|NCT05420961|593277783|FG000|Overall Study|Withdrawal by Subject|2|||
164249001|NCT05420961|593277784|FG001|Overall Study|Withdrawal by Subject|1|||
164249002|NCT05420961|593277785|FG002|Overall Study|Withdrawal by Subject|1|||
164249003|NCT05420961|593277786|FG003|Overall Study|Withdrawal by Subject|0|||
164338569|NCT02925117|593615206|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
164338570|NCT02925117|593615207|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
164338571|NCT02925117|593615208|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
164338572|NCT02925117|593615209|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
164338573|NCT02925117|593615210|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
164338574|NCT02925117|593615199|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
164338575|NCT02925117|593615200|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
164338576|NCT02925117|593615201|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
164338577|NCT02925117|593615202|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
164338578|NCT02925117|593615203|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
164338579|NCT02925117|593615204|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
164338580|NCT02925117|593615205|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
164338581|NCT02925117|593615206|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
164679862|NCT00902538|594852218|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
164679863|NCT00902538|594852219|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
164679864|NCT00902538|594852220|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
164679865|NCT00902538|594852221|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
164679866|NCT00902538|594852222|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
164249004|NCT05420961|593277787|FG004|Overall Study|Withdrawal by Subject|0|||
164249005|NCT05420961|593277783|FG000|Overall Study|Lost to Follow-up|0|||
164249006|NCT05420961|593277784|FG001|Overall Study|Lost to Follow-up|0|||
164249007|NCT05420961|593277785|FG002|Overall Study|Lost to Follow-up|1|||
164249008|NCT05420961|593277786|FG003|Overall Study|Lost to Follow-up|0|||
164249009|NCT05420961|593277787|FG004|Overall Study|Lost to Follow-up|0|||
164249010|NCT05420961|593277783|FG000|Overall Study|Randomized by mistake without study treatment|0|||
164249011|NCT05420961|593277784|FG001|Overall Study|Randomized by mistake without study treatment|0|||
164249012|NCT05420961|593277785|FG002|Overall Study|Randomized by mistake without study treatment|1|||
164249013|NCT05420961|593277786|FG003|Overall Study|Randomized by mistake without study treatment|0|||
164249014|NCT05420961|593277787|FG004|Overall Study|Randomized by mistake without study treatment|1|||
164249015|NCT02625220|593277788|FG000|Overall Study|Adverse Event|2|||
164249016|NCT02625220|593277788|FG000|Overall Study|Lost to Follow-up|2|||
164249017|NCT02625220|593277788|FG000|Overall Study|Protocol Violation|1|||
164249018|NCT02625220|593277788|FG000|Overall Study|Study discontinued at site|2|||
164249019|NCT01119066|593277789|FG000|Overall Study|Withdrawal by Subject|4|||
164249020|NCT01119066|593277790|FG001|Overall Study|Withdrawal by Subject|6|||
164249021|NCT01119066|593277791|FG002|Overall Study|Withdrawal by Subject|0|||
164249022|NCT01119066|593277792|FG003|Overall Study|Withdrawal by Subject|0|||
164249023|NCT01119066|593277789|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
164249024|NCT01119066|593277790|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
164249025|NCT01119066|593277791|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
164249026|NCT01119066|593277792|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
164249027|NCT01119066|593277789|FG000|Overall Study|Relapse identified before transplant|1|||
164249028|NCT01119066|593277790|FG001|Overall Study|Relapse identified before transplant|0|||
164249029|NCT01119066|593277791|FG002|Overall Study|Relapse identified before transplant|0|||
164249030|NCT01119066|593277792|FG003|Overall Study|Relapse identified before transplant|0|||
164249031|NCT01119066|593277789|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
164249032|NCT01119066|593277790|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
164249033|NCT01119066|593277791|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
164249034|NCT01119066|593277792|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
164249035|NCT01119066|593277789|FG000|Overall Study|Relapse identified before transplant|0|||
164249036|NCT01119066|593277790|FG001|Overall Study|Relapse identified before transplant|4|||
164249037|NCT01119066|593277791|FG002|Overall Study|Relapse identified before transplant|0|||
164249038|NCT01119066|593277792|FG003|Overall Study|Relapse identified before transplant|0|||
164249039|NCT00783835|593277793|FG000|Overall Study|Adverse Event|3|||
164249040|NCT00783835|593277793|FG000|Overall Study|Medical Criteria|1|||
164249041|NCT00783835|593277793|FG000|Overall Study|Withdrawal by Subject|2|||
164249042|NCT00783835|593277793|FG000|Overall Study|Lost to Follow-up|1|||
164249043|NCT00783835|593277793|FG000|Overall Study|Participant not Adherent|3|||
164249044|NCT00295646|593277794|FG000|Overall Study|Protocol Violation|18|||
164249045|NCT00295646|593277795|FG001|Overall Study|Protocol Violation|20|||
164249046|NCT00295646|593277796|FG002|Overall Study|Protocol Violation|20|||
164249047|NCT00295646|593277797|FG003|Overall Study|Protocol Violation|18|||
164249048|NCT00295646|593277794|FG000|Overall Study|Withdrawal by Subject|8|||
164249049|NCT00295646|593277795|FG001|Overall Study|Withdrawal by Subject|9|||
164249050|NCT00295646|593277796|FG002|Overall Study|Withdrawal by Subject|11|||
164249051|NCT00295646|593277797|FG003|Overall Study|Withdrawal by Subject|14|||
164249052|NCT00295646|593277794|FG000|Overall Study|Lost to Follow-up|0|||
164249053|NCT00295646|593277795|FG001|Overall Study|Lost to Follow-up|5|||
164249054|NCT00295646|593277796|FG002|Overall Study|Lost to Follow-up|1|||
164249055|NCT00295646|593277797|FG003|Overall Study|Lost to Follow-up|5|||
164249056|NCT00295646|593277794|FG000|Overall Study|Death|9|||
164249057|NCT00295646|593277795|FG001|Overall Study|Death|7|||
164249058|NCT00295646|593277796|FG002|Overall Study|Death|18|||
164249059|NCT00295646|593277797|FG003|Overall Study|Death|8|||
164249060|NCT00995436|593277798|FG000|Overall Study|Withdrawal by Subject|2|||
164249061|NCT00995436|593277799|FG001|Overall Study|Withdrawal by Subject|5|||
164249062|NCT00995436|593277800|FG002|Overall Study|Withdrawal by Subject|0|||
164249063|NCT01232127|593277802|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
164249064|NCT01232127|593277803|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
164338582|NCT02925117|593615207|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
164249065|NCT01232127|593277804|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
164249066|NCT03162796|593277808|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
164249067|NCT03162796|593277809|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
164249068|NCT03162796|593277810|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
164249069|NCT03162796|593277808|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
164249070|NCT03162796|593277809|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
164249071|NCT03162796|593277810|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
164338583|NCT02925117|593615208|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
164338584|NCT02925117|593615209|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
164338585|NCT02925117|593615210|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
164338586|NCT02925117|593615199|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
164426768|NCT02711826|593930870|FG002|Overall Study|Failure to manufacture cellular product|5|||
164426769|NCT02711826|593930871|FG003|Overall Study|Failure to manufacture cellular product|0|||
164426770|NCT02711826|593930872|FG004|Overall Study|Failure to manufacture cellular product|0|||
164426771|NCT02711826|593930868|FG000|Overall Study|Infusion canceled for active infection|0|||
164426772|NCT02711826|593930869|FG001|Overall Study|Infusion canceled for active infection|1|||
164426773|NCT02711826|593930870|FG002|Overall Study|Infusion canceled for active infection|0|||
164426774|NCT02711826|593930871|FG003|Overall Study|Infusion canceled for active infection|0|||
164426775|NCT02711826|593930872|FG004|Overall Study|Infusion canceled for active infection|0|||
164426776|NCT02711826|593930868|FG000|Overall Study|Screen failures|0|||
164338587|NCT02925117|593615200|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
164338588|NCT02925117|593615201|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
164426777|NCT02711826|593930869|FG001|Overall Study|Screen failures|0|||
164426778|NCT02711826|593930870|FG002|Overall Study|Screen failures|0|||
164426779|NCT02711826|593930871|FG003|Overall Study|Screen failures|4|||
164426780|NCT02711826|593930872|FG004|Overall Study|Screen failures|0|||
164426781|NCT00729690|593930873|FG000|Overall Study|IT Catheter Malfunction|0|||
164426782|NCT00729690|593930874|FG001|Overall Study|IT Catheter Malfunction|2|||
164426783|NCT00729690|593930875|FG002|Overall Study|IT Catheter Malfunction|2|||
164426784|NCT02169219|593930876|FG000|Overall Study|Lack of Efficacy|6|||
164426785|NCT04482855|593930877|FG000|Overall Study|Lost to Follow-up|1|||
164426786|NCT04482855|593930878|FG001|Overall Study|Lost to Follow-up|0|||
164575261|NCT00446030|594469854|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
164338589|NCT02925117|593615202|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
164338590|NCT02925117|593615203|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
164338591|NCT02925117|593615204|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
164338592|NCT02925117|593615205|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
164338593|NCT02925117|593615206|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
164338594|NCT02925117|593615207|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
164338595|NCT02925117|593615208|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
164338596|NCT02925117|593615209|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
164338597|NCT02925117|593615210|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
164338598|NCT02925117|593615199|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
164338599|NCT02925117|593615200|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
164338600|NCT02925117|593615201|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
164338601|NCT02925117|593615202|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
164338602|NCT02925117|593615203|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
164338603|NCT02925117|593615204|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
164338604|NCT02925117|593615205|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
164338605|NCT02925117|593615206|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
164338606|NCT02925117|593615207|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
164338607|NCT02925117|593615208|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
164338608|NCT02925117|593615209|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
164575262|NCT00446030|594469853|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
164575263|NCT00446030|594469854|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
164575264|NCT00446030|594469853|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
164575265|NCT00446030|594469854|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
164575266|NCT00446030|594469853|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
164575267|NCT00446030|594469854|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
164575268|NCT00446030|594469853|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
164575269|NCT00446030|594469854|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
164575270|NCT00446030|594469853|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
164338609|NCT02925117|593615210|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
164338610|NCT04032652|593615211|FG000|Overall Study|The study was terminated and the PI has|1|||
164338611|NCT04032652|593615212|FG001|Overall Study|The study was terminated and the PI has|1|||
164338612|NCT02663908|593615213|FG000|Overall Study|Withdrawal by Subject|8|||
164338613|NCT02663908|593615214|FG001|Overall Study|Withdrawal by Subject|5|||
164338614|NCT02663908|593615213|FG000|Overall Study|Lost to Follow-up|1|||
164338615|NCT02663908|593615214|FG001|Overall Study|Lost to Follow-up|5|||
164338616|NCT02663908|593615213|FG000|Overall Study|Adverse Event|13|||
164338617|NCT02663908|593615214|FG001|Overall Study|Adverse Event|11|||
164338618|NCT02663908|593615213|FG000|Overall Study|Protocol Violation|1|||
164338619|NCT02663908|593615214|FG001|Overall Study|Protocol Violation|2|||
164338620|NCT02663908|593615213|FG000|Overall Study|Lack of therapeutic response|2|||
164426787|NCT04482855|593930877|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
164437466|NCT02914522|593968188|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
164338621|NCT02663908|593615214|FG001|Overall Study|Lack of therapeutic response|0|||
164338622|NCT02663908|593615213|FG000|Overall Study|COVID-19|1|||
164426788|NCT04482855|593930878|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
164426789|NCT04482855|593930877|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
164426790|NCT04482855|593930878|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
164426791|NCT02507219|593930882|FG000|Overall Study|Physician Decision|1|||
164426792|NCT02507219|593930883|FG001|Overall Study|Physician Decision|0|||
164426793|NCT02507219|593930884|FG002|Overall Study|Physician Decision|0|||
164426794|NCT02507219|593930885|FG003|Overall Study|Physician Decision|0|||
164426795|NCT02507219|593930886|FG004|Overall Study|Physician Decision|0|||
164426796|NCT02507219|593930887|FG005|Overall Study|Physician Decision|0|||
164426797|NCT02507219|593930882|FG000|Overall Study|Withdrawal by Subject|0|||
164426798|NCT02507219|593930883|FG001|Overall Study|Withdrawal by Subject|0|||
164426799|NCT02507219|593930884|FG002|Overall Study|Withdrawal by Subject|0|||
164426800|NCT02507219|593930885|FG003|Overall Study|Withdrawal by Subject|0|||
164426801|NCT02507219|593930886|FG004|Overall Study|Withdrawal by Subject|1|||
164426802|NCT02507219|593930887|FG005|Overall Study|Withdrawal by Subject|0|||
164426803|NCT02886936|593930888|FG000|Overall Study|Lost to Follow-up|4|||
164426804|NCT02886936|593930889|FG001|Overall Study|Lost to Follow-up|3|||
164426805|NCT02886936|593930890|FG002|Overall Study|Lost to Follow-up|0|||
164426806|NCT04562779|593930891|FG000|Overall Study|Lost to Follow-up|7|||
164426807|NCT04562779|593930892|FG001|Overall Study|Lost to Follow-up|5|||
164426808|NCT04562779|593930893|FG002|Overall Study|Lost to Follow-up|10|||
164426809|NCT04562779|593930891|FG000|Overall Study|Protocol Violation|2|||
164426810|NCT04562779|593930892|FG001|Overall Study|Protocol Violation|2|||
164426811|NCT04562779|593930893|FG002|Overall Study|Protocol Violation|0|||
164426812|NCT02320721|593930894|FG000|Overall Study|Adverse Event|6|||
164426813|NCT02320721|593930895|FG001|Overall Study|Adverse Event|6|||
164426814|NCT02320721|593930894|FG000|Overall Study|Lack of Efficacy|2|||
164426815|NCT02320721|593930895|FG001|Overall Study|Lack of Efficacy|0|||
164426816|NCT02320721|593930894|FG000|Overall Study|Poor compliance to protocol|3|||
164426817|NCT02320721|593930895|FG001|Overall Study|Poor compliance to protocol|7|||
164426818|NCT02320721|593930894|FG000|Overall Study|Randomized but not treated|0|||
164426819|NCT02320721|593930895|FG001|Overall Study|Randomized but not treated|1|||
164426820|NCT02320721|593930894|FG000|Overall Study|Hypoglycemia|1|||
164426821|NCT02320721|593930895|FG001|Overall Study|Hypoglycemia|0|||
164426822|NCT02320721|593930894|FG000|Overall Study|Other than specified above|15|||
164426823|NCT02320721|593930895|FG001|Overall Study|Other than specified above|20|||
164426824|NCT03173248|593930896|FG000|Overall Study|Death|28|||
164426825|NCT03173248|593930897|FG001|Overall Study|Death|46|||
164426826|NCT03173248|593930896|FG000|Overall Study|Lost to Follow-up|0|||
164426827|NCT03173248|593930897|FG001|Overall Study|Lost to Follow-up|1|||
164426828|NCT03173248|593930896|FG000|Overall Study|Withdrawal by Subject|6|||
164426829|NCT03173248|593930897|FG001|Overall Study|Withdrawal by Subject|4|||
164426830|NCT03173248|593930896|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
164426831|NCT03173248|593930897|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
164426832|NCT01544582|593930898|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
164426833|NCT01544582|593930899|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
164426834|NCT01544582|593930900|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
164426835|NCT01544582|593930901|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
164426836|NCT01544582|593930898|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
164426837|NCT01544582|593930899|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
164426838|NCT01544582|593930900|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
164426839|NCT01544582|593930901|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
164426840|NCT01544582|593930898|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
164426841|NCT01544582|593930899|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
164426842|NCT01544582|593930900|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
164426843|NCT01544582|593930901|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
164426844|NCT01544582|593930898|FG000|Analysis Population|Physician Decision|0|||
164426845|NCT01544582|593930899|FG001|Analysis Population|Physician Decision|13|||
164426846|NCT01544582|593930900|FG002|Analysis Population|Physician Decision|10|||
164426847|NCT01544582|593930901|FG003|Analysis Population|Physician Decision|9|||
164575271|NCT00446030|594469854|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
164575272|NCT00446030|594469853|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
164575273|NCT00446030|594469854|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
164575274|NCT00446030|594469853|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
164575275|NCT00446030|594469854|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
164575276|NCT00446030|594469853|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
164426848|NCT01544582|593930898|FG000|Analysis Population|Safety Reason|0|||
164426849|NCT01544582|593930899|FG001|Analysis Population|Safety Reason|33|||
164426850|NCT01544582|593930900|FG002|Analysis Population|Safety Reason|31|||
164426851|NCT01544582|593930901|FG003|Analysis Population|Safety Reason|8|||
164426852|NCT01544582|593930898|FG000|Analysis Population|Effectiveness Reason|0|||
164575277|NCT00446030|594469854|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
164575278|NCT00446030|594469853|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
164575279|NCT00446030|594469854|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
164249072|NCT03162796|593277808|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
164249073|NCT03162796|593277809|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
164249074|NCT03162796|593277810|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
164249075|NCT03162796|593277808|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
164249076|NCT03162796|593277809|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
164249077|NCT03162796|593277810|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
164249078|NCT03162796|593277808|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
164249079|NCT03162796|593277809|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
164249080|NCT03162796|593277810|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
164249081|NCT03162796|593277808|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
164249082|NCT03162796|593277809|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
164249083|NCT03162796|593277810|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
164249084|NCT03162796|593277808|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
164249085|NCT03162796|593277809|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
164249086|NCT03162796|593277810|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
164249087|NCT03162796|593277808|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
164249088|NCT03162796|593277809|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
164249089|NCT03162796|593277810|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
164249090|NCT03162796|593277808|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
164249091|NCT03162796|593277809|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
164249092|NCT03162796|593277810|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
164249093|NCT03162796|593277808|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
164249094|NCT03162796|593277809|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
164249095|NCT03162796|593277810|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
164249096|NCT03162796|593277808|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
164249097|NCT03162796|593277809|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
164249098|NCT03162796|593277810|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
164249099|NCT02623205|593277811|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
164249100|NCT02623205|593277812|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
164249101|NCT02375373|593277816|FG000|Overall Study|Withdrawal by Subject|11|||
164249102|NCT02725476|593277817|FG000|Overall Study|Physician Decision|2|||
164249103|NCT02725476|593277818|FG001|Overall Study|Physician Decision|0|||
164249104|NCT02725476|593277817|FG000|Overall Study|Adverse Event|1|||
164249105|NCT02725476|593277818|FG001|Overall Study|Adverse Event|1|||
164249106|NCT00289289|593277820|FG000|Overall Study|Withdrawal by Subject|5|||
164249107|NCT00289289|593277821|FG001|Overall Study|Withdrawal by Subject|3|||
164249108|NCT00289289|593277822|FG002|Overall Study|Withdrawal by Subject|15|||
164249109|NCT00289289|593277820|FG000|Overall Study|Lost to Follow-up|1|||
164249110|NCT00289289|593277821|FG001|Overall Study|Lost to Follow-up|0|||
164249111|NCT00289289|593277822|FG002|Overall Study|Lost to Follow-up|1|||
164249112|NCT00289289|593277820|FG000|Overall Study|Death|4|||
164249113|NCT00289289|593277821|FG001|Overall Study|Death|2|||
164679867|NCT00902538|594852223|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
164249114|NCT00289289|593277822|FG002|Overall Study|Death|5|||
164249115|NCT00289289|593277820|FG000|Overall Study|No implant attempted|0|||
164249116|NCT00289289|593277821|FG001|Overall Study|No implant attempted|0|||
164249117|NCT00289289|593277822|FG002|Overall Study|No implant attempted|1|||
164249118|NCT00289289|593277820|FG000|Overall Study|Physician Decision|1|||
164249119|NCT00289289|593277821|FG001|Overall Study|Physician Decision|0|||
164249120|NCT00289289|593277822|FG002|Overall Study|Physician Decision|6|||
164249121|NCT00289289|593277820|FG000|Overall Study|Non-study device implanted|2|||
164249122|NCT00289289|593277821|FG001|Overall Study|Non-study device implanted|1|||
164249123|NCT00289289|593277822|FG002|Overall Study|Non-study device implanted|3|||
164249124|NCT00289289|593277820|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
164249125|NCT00289289|593277821|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
164249126|NCT00289289|593277822|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
164679868|NCT06336356|594852224|FG000|Overall Study|Withdrawal by Subject|1|||
164679869|NCT06336356|594852225|FG001|Overall Study|Withdrawal by Subject|0|||
164679870|NCT06336356|594852224|FG000|Overall Study|Lost to Follow Up|1|||
164249127|NCT00289289|593277820|FG000|Overall Study|Other Exit Reason|6|||
164249128|NCT00289289|593277821|FG001|Overall Study|Other Exit Reason|4|||
164249129|NCT00289289|593277822|FG002|Overall Study|Other Exit Reason|12|||
164249130|NCT01445613|593277823|FG000|30-day Follow-up|Withdrawal by Subject|6|||
164249131|NCT01445613|593277823|FG000|30-day Follow-up|Physician Decision|3|||
164249132|NCT01445613|593277823|FG000|30-day Follow-up|Missed visit|23|||
164249133|NCT01445613|593277823|FG000|30-day Follow-up|Death|3|||
164249134|NCT01445613|593277823|FG000|1-year Follow-up|Withdrawal by Subject|12|||
164249135|NCT01445613|593277823|FG000|1-year Follow-up|Missed visit|29|||
164249136|NCT01445613|593277823|FG000|1-year Follow-up|Lost to Follow-up|2|||
164249137|NCT01445613|593277823|FG000|1-year Follow-up|Death|30|||
164426853|NCT01544582|593930899|FG001|Analysis Population|Effectiveness Reason|48|||
164679871|NCT06336356|594852225|FG001|Overall Study|Lost to Follow Up|0|||
164249138|NCT01445613|593277823|FG000|1-year Follow-up|Physician Decision|2|||
164249139|NCT01445613|593277823|FG000|1-year Follow-up|Received a non-study stent|2|||
164249140|NCT00407602|593277824|FG000|Overall Study|Death - unrelated to device|1|||
164249141|NCT00407602|593277824|FG000|Overall Study|Device explanted|5|||
164249142|NCT00407602|593277824|FG000|Overall Study|Withdrawal by Subject|1|||
164249143|NCT01169701|593277825|FG000|Overall Study|Lost to Follow-up|1|||
164249144|NCT01169701|593277826|FG001|Overall Study|Lost to Follow-up|1|||
164249145|NCT01169701|593277825|FG000|Overall Study|Withdrawal by Subject|1|||
164249146|NCT01169701|593277826|FG001|Overall Study|Withdrawal by Subject|3|||
164249147|NCT01169701|593277825|FG000|Overall Study|Adverse Event|1|||
164249148|NCT01169701|593277826|FG001|Overall Study|Adverse Event|2|||
164249149|NCT01169701|593277825|FG000|Overall Study|Exclusion criteria|2|||
164249150|NCT01169701|593277826|FG001|Overall Study|Exclusion criteria|0|||
164249151|NCT01169701|593277825|FG000|Overall Study|Death|0|||
164249152|NCT01169701|593277826|FG001|Overall Study|Death|1|||
164249153|NCT01169701|593277825|FG000|Overall Study|Administrative problems|0|||
164249154|NCT01169701|593277826|FG001|Overall Study|Administrative problems|1|||
164249155|NCT01169701|593277825|FG000|Overall Study|Serious adverse event|0|||
164249156|NCT01169701|593277826|FG001|Overall Study|Serious adverse event|1|||
164249157|NCT01169701|593277825|FG000|Overall Study|Sponsor decision|0|||
164249158|NCT01169701|593277826|FG001|Overall Study|Sponsor decision|1|||
164249159|NCT02141633|593279069|FG000|Overall Study|Physician Decision|1|||
164249160|NCT02141633|593279070|FG001|Overall Study|Physician Decision|0|||
164249161|NCT00833469|593279071|FG000|Overall Study|Withdrawal by Subject|1|||
164249162|NCT00833469|593279071|FG000|Overall Study|Lost to Follow-up|1|||
164249163|NCT02943070|593279072|FG000|Overall Study|Physician Decision|1|||
164249164|NCT02943070|593279072|FG000|Overall Study|Adverse Event|2|||
164249165|NCT02943070|593279072|FG000|Overall Study|Death|2|||
164249166|NCT02943070|593279072|FG000|Overall Study|Withdrawal by Subject|3|||
164249167|NCT02943070|593279072|FG000|Overall Study|Lost to Follow-up|4|||
164249168|NCT02943070|593279072|FG000|Overall Study|Retreatment or TURP|13|||
164249169|NCT02943070|593279072|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
164249170|NCT01701362|593279073|FG000|Overall Study|Adverse events not related to study drug|1|||
164249171|NCT01701362|593279074|FG001|Overall Study|Adverse events not related to study drug|6|||
164249172|NCT01701362|593279073|FG000|Overall Study|Adverse events related to study drug|12|||
164249173|NCT01701362|593279074|FG001|Overall Study|Adverse events related to study drug|10|||
164249174|NCT01701362|593279073|FG000|Overall Study|Protocol Violation|5|||
164249175|NCT01701362|593279074|FG001|Overall Study|Protocol Violation|3|||
164249176|NCT01701362|593279073|FG000|Overall Study|No longer willing to participate|8|||
164249177|NCT01701362|593279074|FG001|Overall Study|No longer willing to participate|14|||
164249178|NCT01701362|593279073|FG000|Overall Study|Lost to Follow-up|6|||
164249179|NCT01701362|593279074|FG001|Overall Study|Lost to Follow-up|9|||
164249180|NCT01701362|593279073|FG000|Overall Study|Insufficient clinical response|6|||
164249181|NCT01701362|593279074|FG001|Overall Study|Insufficient clinical response|6|||
164249182|NCT01701362|593279073|FG000|Overall Study|Death|0|||
164249183|NCT01701362|593279074|FG001|Overall Study|Death|1|||
164249184|NCT01701362|593279073|FG000|Overall Study|Randomized but not treated|1|||
164249185|NCT01701362|593279074|FG001|Overall Study|Randomized but not treated|2|||
164249186|NCT01701362|593279073|FG000|Overall Study|Reasons other than those mentioned above|3|||
164249187|NCT01701362|593279074|FG001|Overall Study|Reasons other than those mentioned above|5|||
164249188|NCT00570778|593279075|FG000|Overall Study|Protocol deviation|2|||
164249189|NCT00570778|593279076|FG001|Overall Study|Protocol deviation|1|||
164249190|NCT00570778|593279077|FG002|Overall Study|Protocol deviation|2|||
164249191|NCT00570778|593279078|FG003|Overall Study|Protocol deviation|2|||
164249192|NCT00570778|593279075|FG000|Overall Study|Adverse Event|0|||
164249193|NCT00570778|593279076|FG001|Overall Study|Adverse Event|1|||
164249194|NCT00570778|593279077|FG002|Overall Study|Adverse Event|4|||
164249195|NCT00570778|593279078|FG003|Overall Study|Adverse Event|1|||
164249196|NCT00570778|593279075|FG000|Overall Study|Subject withdrew consent|0|||
164249197|NCT00570778|593279076|FG001|Overall Study|Subject withdrew consent|1|||
164249198|NCT00570778|593279077|FG002|Overall Study|Subject withdrew consent|0|||
164249199|NCT00570778|593279078|FG003|Overall Study|Subject withdrew consent|1|||
164249200|NCT00570778|593279075|FG000|Overall Study|Abnormal test procedure|1|||
164249201|NCT00570778|593279076|FG001|Overall Study|Abnormal test procedure|0|||
164249202|NCT00570778|593279077|FG002|Overall Study|Abnormal test procedure|0|||
164249203|NCT00570778|593279078|FG003|Overall Study|Abnormal test procedure|0|||
164575280|NCT00446030|594469853|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
164575281|NCT00446030|594469854|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
164575282|NCT00446030|594469853|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
164575283|NCT00446030|594469854|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
164249204|NCT00570778|593279075|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164249205|NCT00570778|593279076|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164249206|NCT00570778|593279077|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
164249207|NCT00570778|593279078|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
164249208|NCT00570778|593279075|FG000|Overall Study|Lost to Follow-up|0|||
164249209|NCT00570778|593279076|FG001|Overall Study|Lost to Follow-up|0|||
164249210|NCT00570778|593279077|FG002|Overall Study|Lost to Follow-up|1|||
164249211|NCT00570778|593279078|FG003|Overall Study|Lost to Follow-up|0|||
164249212|NCT00570778|593279075|FG000|Overall Study|Subject no longer requires study drug|0|||
164249213|NCT00570778|593279076|FG001|Overall Study|Subject no longer requires study drug|1|||
164249214|NCT00570778|593279077|FG002|Overall Study|Subject no longer requires study drug|0|||
164249215|NCT00570778|593279078|FG003|Overall Study|Subject no longer requires study drug|0|||
164249216|NCT00443872|593279081|FG000|Overall Study|Protocol Violation|7|||
164249217|NCT00443872|593279081|FG000|Overall Study|Lost to Follow-up|2|||
164249218|NCT00443872|593279081|FG000|Overall Study|Adverse Event|8|||
164249219|NCT01014767|593279082|FG000|Overall Study|PI left institution, data unavailable|12|||
164249220|NCT01014767|593279083|FG001|Overall Study|PI left institution, data unavailable|1|||
164249221|NCT01014767|593279084|FG002|Overall Study|PI left institution, data unavailable|4|||
164249222|NCT01014767|593279085|FG003|Overall Study|PI left institution, data unavailable|1|||
164249223|NCT00700622|593279086|FG000|Overall Study|Adverse Event|4|||
164249224|NCT00700622|593279087|FG001|Overall Study|Adverse Event|0|||
164249225|NCT00700622|593279086|FG000|Overall Study|Lost to Follow-up|0|||
164249226|NCT00700622|593279087|FG001|Overall Study|Lost to Follow-up|1|||
164249227|NCT00700622|593279086|FG000|Overall Study|Physician Decision|2|||
164249228|NCT00700622|593279087|FG001|Overall Study|Physician Decision|1|||
164249229|NCT00700622|593279086|FG000|Overall Study|Protocol Violation|0|||
164249230|NCT00700622|593279087|FG001|Overall Study|Protocol Violation|1|||
164249231|NCT00700622|593279086|FG000|Overall Study|Withdrawal by Subject|4|||
164249232|NCT00700622|593279087|FG001|Overall Study|Withdrawal by Subject|1|||
164249233|NCT00700622|593279086|FG000|Overall Study|Other|3|||
164249234|NCT00700622|593279087|FG001|Overall Study|Other|1|||
164249235|NCT00282087|593279088|FG000|Overall Study|Death|1|||
164249236|NCT00405392|593279089|FG000|Overall Study|Adverse Event|15|||
164249237|NCT00405392|593279090|FG001|Overall Study|Adverse Event|14|||
164249238|NCT00405392|593279089|FG000|Overall Study|Did not meet Eligibility criteria|7|||
164249239|NCT00405392|593279090|FG001|Overall Study|Did not meet Eligibility criteria|2|||
164249240|NCT00405392|593279089|FG000|Overall Study|Withdrawal by Subject|4|||
164249241|NCT00405392|593279090|FG001|Overall Study|Withdrawal by Subject|3|||
164249242|NCT00405392|593279089|FG000|Overall Study|Lost to Follow-up|1|||
164249243|NCT00405392|593279090|FG001|Overall Study|Lost to Follow-up|2|||
164249244|NCT00405392|593279089|FG000|Overall Study|Data missing|2|||
164249245|NCT00405392|593279090|FG001|Overall Study|Data missing|0|||
164249246|NCT00405392|593279089|FG000|Overall Study|Non-compliance|0|||
164249247|NCT00405392|593279090|FG001|Overall Study|Non-compliance|1|||
164249248|NCT00405392|593279089|FG000|Overall Study|Other|1|||
164249249|NCT00405392|593279090|FG001|Overall Study|Other|5|||
164249250|NCT01703091|593279093|FG000|Overall Study|Adverse Event|5|||
164249251|NCT01703091|593279094|FG001|Overall Study|Adverse Event|3|||
164249252|NCT01703091|593279093|FG000|Overall Study|Physician Decision|2|||
164249253|NCT01703091|593279094|FG001|Overall Study|Physician Decision|1|||
164249254|NCT01703091|593279093|FG000|Overall Study|Withdrawal by Subject|1|||
164249255|NCT01703091|593279094|FG001|Overall Study|Withdrawal by Subject|0|||
164249256|NCT01703091|593279093|FG000|Overall Study|Sponsor Decision|1|||
164249257|NCT01703091|593279094|FG001|Overall Study|Sponsor Decision|0|||
164249258|NCT02550288|593279095|FG000|Overall Study|Adverse Event|0|||
164249259|NCT02550288|593279096|FG001|Overall Study|Adverse Event|1|||
164249260|NCT02550288|593279097|FG002|Overall Study|Adverse Event|0|||
164249261|NCT02550288|593279098|FG003|Overall Study|Adverse Event|0|||
164249262|NCT02550288|593279099|FG004|Overall Study|Adverse Event|0|||
164249263|NCT02550288|593279095|FG000|Overall Study|Physician Decision|0|||
164249264|NCT02550288|593279096|FG001|Overall Study|Physician Decision|0|||
164249265|NCT02550288|593279097|FG002|Overall Study|Physician Decision|0|||
164249266|NCT02550288|593279098|FG003|Overall Study|Physician Decision|1|||
164249267|NCT02550288|593279099|FG004|Overall Study|Physician Decision|0|||
164249268|NCT02550288|593279095|FG000|Overall Study|Protocol Violation|2|||
164249269|NCT02550288|593279096|FG001|Overall Study|Protocol Violation|2|||
164249270|NCT02550288|593279097|FG002|Overall Study|Protocol Violation|1|||
164249271|NCT02550288|593279098|FG003|Overall Study|Protocol Violation|0|||
164249272|NCT02550288|593279099|FG004|Overall Study|Protocol Violation|3|||
164249273|NCT02550288|593279095|FG000|Overall Study|Participant moved|0|||
164249274|NCT02550288|593279096|FG001|Overall Study|Participant moved|0|||
164249275|NCT02550288|593279097|FG002|Overall Study|Participant moved|0|||
164249276|NCT02550288|593279098|FG003|Overall Study|Participant moved|1|||
164249277|NCT02550288|593279099|FG004|Overall Study|Participant moved|0|||
164249278|NCT02550288|593279095|FG000|Overall Study|Withdrawal by Subject|0|||
164249279|NCT02550288|593279096|FG001|Overall Study|Withdrawal by Subject|0|||
164249280|NCT02550288|593279097|FG002|Overall Study|Withdrawal by Subject|0|||
164249281|NCT02550288|593279098|FG003|Overall Study|Withdrawal by Subject|1|||
164249282|NCT02550288|593279099|FG004|Overall Study|Withdrawal by Subject|0|||
164249283|NCT00988052|593279100|FG000|Overall Study|Missing|1|||
164249284|NCT00988052|593279101|FG001|Overall Study|Missing|0|||
164249285|NCT00988052|593279100|FG000|Overall Study|Teva requested subject withdrawal|3|||
164249286|NCT00988052|593279101|FG001|Overall Study|Teva requested subject withdrawal|1|||
164249287|NCT00988052|593279100|FG000|Overall Study|Death|1|||
164249288|NCT00988052|593279101|FG001|Overall Study|Death|3|||
164249289|NCT00988052|593279100|FG000|Overall Study|Protocol Violation|6|||
164249290|NCT00988052|593279101|FG001|Overall Study|Protocol Violation|5|||
164249291|NCT00988052|593279100|FG000|Overall Study|Pregnancy|6|||
164249292|NCT00988052|593279101|FG001|Overall Study|Pregnancy|6|||
164249293|NCT00988052|593279100|FG000|Overall Study|Lack of Efficacy|8|||
164249294|NCT00988052|593279101|FG001|Overall Study|Lack of Efficacy|7|||
164249295|NCT00988052|593279100|FG000|Overall Study|Lost to Follow-up|6|||
164249296|NCT00988052|593279101|FG001|Overall Study|Lost to Follow-up|11|||
164249297|NCT00988052|593279100|FG000|Overall Study|Physician Decision|27|||
164249298|NCT00988052|593279101|FG001|Overall Study|Physician Decision|28|||
164249299|NCT00988052|593279100|FG000|Overall Study|Adverse Event|35|||
164249300|NCT00988052|593279101|FG001|Overall Study|Adverse Event|28|||
164249301|NCT00988052|593279100|FG000|Overall Study|Withdrawal by Subject|90|||
164249302|NCT00988052|593279101|FG001|Overall Study|Withdrawal by Subject|91|||
164249303|NCT00988052|593279100|FG000|Overall Study|Study terminated by sponsor|240|||
164249304|NCT00988052|593279101|FG001|Overall Study|Study terminated by sponsor|236|||
164249305|NCT00842153|593279102|FG000|Overall Study|Adverse Event|0|||
164249306|NCT00842153|593279103|FG001|Overall Study|Adverse Event|1|||
164249307|NCT00842153|593279102|FG000|Overall Study|Lost to Follow-up|1|||
164249308|NCT00842153|593279103|FG001|Overall Study|Lost to Follow-up|2|||
164249309|NCT05312697|593279105|FG000|Overall Study|Sponsor Terminated Trial|2|||
164249310|NCT02858440|593279106|FG000|Overall Study|Lost to Follow-up|3|||
164249311|NCT02858440|593279106|FG000|Overall Study|Protocol Violation|2|||
164249312|NCT02858440|593279106|FG000|Overall Study|Consent withdrawal|3|||
164249313|NCT02858440|593279106|FG000|Overall Study|Migrated/moved from study area|4|||
164249314|NCT00402324|593279107|FG000|Overall Study|Lost to Follow-up|11|||
164249315|NCT00402324|593279108|FG001|Overall Study|Lost to Follow-up|11|||
164249316|NCT00402324|593279107|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
164249317|NCT00402324|593279108|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
164249318|NCT00402324|593279107|FG000|Overall Study|Protocol Violation|8|||
164249319|NCT00402324|593279108|FG001|Overall Study|Protocol Violation|7|||
164249320|NCT00402324|593279107|FG000|Overall Study|Withdrawal by Subject|5|||
164249321|NCT00402324|593279108|FG001|Overall Study|Withdrawal by Subject|2|||
164249322|NCT00402324|593279107|FG000|Overall Study|Physician Decision|2|||
164249323|NCT00402324|593279108|FG001|Overall Study|Physician Decision|4|||
164249324|NCT00402324|593279107|FG000|Overall Study|Sponsor Decision|4|||
164249325|NCT00402324|593279108|FG001|Overall Study|Sponsor Decision|5|||
164249326|NCT00402324|593279107|FG000|Overall Study|Lack of Efficacy|1|||
164249327|NCT00402324|593279108|FG001|Overall Study|Lack of Efficacy|4|||
164249328|NCT00402324|593279107|FG000|Overall Study|Adverse Event|6|||
164249329|NCT00402324|593279108|FG001|Overall Study|Adverse Event|4|||
164249330|NCT00402324|593279107|FG000|Overall Study|Death|1|||
164249331|NCT00402324|593279108|FG001|Overall Study|Death|0|||
164249332|NCT01277822|593279109|FG000|Overall Study|Adverse Event|2|||
164249333|NCT01277822|593279110|FG001|Overall Study|Adverse Event|1|||
164249334|NCT01277822|593279109|FG000|Overall Study|Withdrawal by Subject|6|||
164249335|NCT01277822|593279110|FG001|Overall Study|Withdrawal by Subject|7|||
164249336|NCT01277822|593279109|FG000|Overall Study|Physician Decision|1|||
164249337|NCT01277822|593279110|FG001|Overall Study|Physician Decision|1|||
164249338|NCT01277822|593279109|FG000|Overall Study|Protocol Violation|1|||
164249339|NCT01277822|593279110|FG001|Overall Study|Protocol Violation|0|||
164249340|NCT01277822|593279109|FG000|Overall Study|Lost to Follow-up|2|||
164249341|NCT01277822|593279110|FG001|Overall Study|Lost to Follow-up|1|||
164249342|NCT01277822|593279109|FG000|Overall Study|Contraindicated medication used|2|||
164338623|NCT02663908|593615214|FG001|Overall Study|COVID-19|0|||
164338624|NCT02663908|593615213|FG000|Overall Study|Site closed|1|||
164249343|NCT01277822|593279110|FG001|Overall Study|Contraindicated medication used|1|||
164249344|NCT01277822|593279109|FG000|Overall Study|Participant moved|1|||
164249345|NCT01277822|593279110|FG001|Overall Study|Participant moved|0|||
164249346|NCT00997984|593279111|FG000|Overall Study|Adverse Event|1|||
164249347|NCT00997984|593279112|FG001|Overall Study|Adverse Event|8|||
164338625|NCT02663908|593615214|FG001|Overall Study|Site closed|0|||
164338626|NCT02663908|593615213|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
164249348|NCT00997984|593279113|FG002|Overall Study|Adverse Event|8|||
164249349|NCT00997984|593279111|FG000|Overall Study|Protocol Violation|1|||
164249350|NCT00997984|593279112|FG001|Overall Study|Protocol Violation|3|||
164249351|NCT00997984|593279113|FG002|Overall Study|Protocol Violation|0|||
164249352|NCT00997984|593279111|FG000|Overall Study|Withdrawal by Subject|6|||
164249353|NCT00997984|593279112|FG001|Overall Study|Withdrawal by Subject|9|||
164249354|NCT00997984|593279113|FG002|Overall Study|Withdrawal by Subject|5|||
164249355|NCT00997984|593279111|FG000|Overall Study|Lost to Follow-up|8|||
164249356|NCT00997984|593279112|FG001|Overall Study|Lost to Follow-up|5|||
164249357|NCT00997984|593279113|FG002|Overall Study|Lost to Follow-up|4|||
164249358|NCT00997984|593279111|FG000|Overall Study|Lack of Efficacy|20|||
164249359|NCT00997984|593279112|FG001|Overall Study|Lack of Efficacy|6|||
164249360|NCT00997984|593279113|FG002|Overall Study|Lack of Efficacy|3|||
164249361|NCT00997984|593279111|FG000|Overall Study|Met exclusion criteria|1|||
164249362|NCT00997984|593279112|FG001|Overall Study|Met exclusion criteria|0|||
164249363|NCT00997984|593279113|FG002|Overall Study|Met exclusion criteria|0|||
164249364|NCT00997984|593279111|FG000|Overall Study|non-compliance|0|||
164249365|NCT00997984|593279112|FG001|Overall Study|non-compliance|2|||
164249366|NCT00997984|593279113|FG002|Overall Study|non-compliance|3|||
164249367|NCT00997984|593279111|FG000|Overall Study|Wrong medication dispensed|0|||
164249368|NCT00997984|593279112|FG001|Overall Study|Wrong medication dispensed|1|||
164249369|NCT00997984|593279113|FG002|Overall Study|Wrong medication dispensed|0|||
164249370|NCT00997984|593279111|FG000|Overall Study|Suicidal ideation|0|||
164249371|NCT00997984|593279112|FG001|Overall Study|Suicidal ideation|0|||
164249372|NCT00997984|593279113|FG002|Overall Study|Suicidal ideation|1|||
164249373|NCT00997984|593279111|FG000|Overall Study|Work schedule|0|||
164249374|NCT00997984|593279112|FG001|Overall Study|Work schedule|0|||
164249375|NCT00997984|593279113|FG002|Overall Study|Work schedule|2|||
164249376|NCT01945996|593279115|FG000|Overall Study|Lost to Follow-up|3|||
164249377|NCT01945996|593279116|FG001|Overall Study|Lost to Follow-up|5|||
164249378|NCT04396795|593279117|FG000|Month 1|Lost to Follow-up|2|||
164249379|NCT04396795|593279118|FG001|Month 1|Lost to Follow-up|3|||
164249380|NCT04396795|593279117|FG000|Month 3|Lost to Follow-up|1|||
164249381|NCT04396795|593279118|FG001|Month 3|Lost to Follow-up|3|||
164249382|NCT04396795|593279117|FG000|Month 6|Lost to Follow-up|3|||
164249383|NCT04396795|593279118|FG001|Month 6|Lost to Follow-up|3|||
164249384|NCT01107392|593279120|FG000|Overall Study|Adverse Event|2|||
164249385|NCT01107392|593279121|FG001|Overall Study|Adverse Event|0|||
164249386|NCT01107392|593279120|FG000|Overall Study|Personal Reasons|2|||
164249387|NCT01107392|593279121|FG001|Overall Study|Personal Reasons|3|||
164249388|NCT01107392|593279120|FG000|Overall Study|Administrative decision|1|||
164249389|NCT01107392|593279121|FG001|Overall Study|Administrative decision|0|||
164249390|NCT02689206|593279124|FG000|Overall Study|Adverse Event|0|||
164249391|NCT02689206|593279125|FG001|Overall Study|Adverse Event|0|||
164249392|NCT02689206|593279126|FG002|Overall Study|Adverse Event|1|||
164249393|NCT02689206|593279127|FG003|Overall Study|Adverse Event|0|||
164249394|NCT02689206|593279128|FG004|Overall Study|Adverse Event|2|||
164249395|NCT02689206|593279124|FG000|Overall Study|Protocol Violation|1|||
164249396|NCT02689206|593279125|FG001|Overall Study|Protocol Violation|0|||
164249397|NCT02689206|593279126|FG002|Overall Study|Protocol Violation|0|||
164249398|NCT02689206|593279127|FG003|Overall Study|Protocol Violation|1|||
164249399|NCT02689206|593279128|FG004|Overall Study|Protocol Violation|2|||
164249400|NCT02689206|593279124|FG000|Overall Study|Other: Reached stopping criteria|0|||
164249401|NCT02689206|593279125|FG001|Overall Study|Other: Reached stopping criteria|1|||
164249402|NCT02689206|593279126|FG002|Overall Study|Other: Reached stopping criteria|2|||
164249403|NCT02689206|593279127|FG003|Overall Study|Other: Reached stopping criteria|3|||
164249404|NCT02689206|593279128|FG004|Overall Study|Other: Reached stopping criteria|4|||
164249405|NCT02689206|593279124|FG000|Overall Study|Physician Decision|1|||
164249406|NCT02689206|593279125|FG001|Overall Study|Physician Decision|0|||
164249407|NCT02689206|593279126|FG002|Overall Study|Physician Decision|0|||
164249408|NCT02689206|593279127|FG003|Overall Study|Physician Decision|0|||
164249409|NCT02689206|593279128|FG004|Overall Study|Physician Decision|0|||
164249410|NCT02689206|593279124|FG000|Overall Study|Withdrawal by Subject|1|||
164249411|NCT02689206|593279125|FG001|Overall Study|Withdrawal by Subject|0|||
164249412|NCT02689206|593279126|FG002|Overall Study|Withdrawal by Subject|1|||
164249413|NCT02689206|593279127|FG003|Overall Study|Withdrawal by Subject|0|||
164249414|NCT02689206|593279128|FG004|Overall Study|Withdrawal by Subject|0|||
164249415|NCT02520388|593279129|FG000|Overall Study|Physician Decision|1|||
164249416|NCT02520388|593279130|FG001|Overall Study|Physician Decision|0|||
164249417|NCT02520388|593279129|FG000|Overall Study|Subject or parent/guardian request|0|||
164249418|NCT02520388|593279130|FG001|Overall Study|Subject or parent/guardian request|6|||
164249419|NCT02520388|593279129|FG000|Overall Study|Adverse Event|1|||
164249420|NCT02520388|593279130|FG001|Overall Study|Adverse Event|4|||
164249421|NCT02520388|593279129|FG000|Overall Study|Lost to Follow-up|3|||
164249422|NCT02520388|593279130|FG001|Overall Study|Lost to Follow-up|2|||
164426854|NCT01544582|593930900|FG002|Analysis Population|Effectiveness Reason|29|||
164249423|NCT02520388|593279129|FG000|Overall Study|Other (reason not defined)|4|||
164249424|NCT02520388|593279130|FG001|Overall Study|Other (reason not defined)|4|||
164249425|NCT00431444|593279133|FG000|Overall Study|Protocol Violation|1|||
164249426|NCT00431444|593279134|FG001|Overall Study|Protocol Violation|4|||
164249427|NCT00431444|593279133|FG000|Overall Study|Adverse Event|2|||
164249428|NCT00431444|593279134|FG001|Overall Study|Adverse Event|1|||
164249429|NCT00431444|593279133|FG000|Overall Study|Withdrawal by Subject|1|||
164249430|NCT00431444|593279134|FG001|Overall Study|Withdrawal by Subject|1|||
164249431|NCT00431444|593279133|FG000|Overall Study|Lost to Follow-up|1|||
164249432|NCT00431444|593279134|FG001|Overall Study|Lost to Follow-up|0|||
164249433|NCT00431444|593279133|FG000|Overall Study|Administrative Problems|0|||
164249434|NCT00431444|593279134|FG001|Overall Study|Administrative Problems|1|||
164249435|NCT01352221|593279138|FG000|Double-blind Phase|Adverse Event|6|||
164249436|NCT01352221|593279139|FG001|Double-blind Phase|Adverse Event|4|||
164249437|NCT01352221|593279140|FG002|Double-blind Phase|Adverse Event|0|||
164249438|NCT01352221|593279141|FG003|Double-blind Phase|Adverse Event|0|||
164249439|NCT01352221|593279138|FG000|Double-blind Phase|Withdrawal by Subject|3|||
164249440|NCT01352221|593279139|FG001|Double-blind Phase|Withdrawal by Subject|5|||
164249441|NCT01352221|593279140|FG002|Double-blind Phase|Withdrawal by Subject|0|||
164249442|NCT01352221|593279141|FG003|Double-blind Phase|Withdrawal by Subject|0|||
164249443|NCT01352221|593279138|FG000|Double-blind Phase|Lost to Follow-up|0|||
164249444|NCT01352221|593279139|FG001|Double-blind Phase|Lost to Follow-up|1|||
164249445|NCT01352221|593279140|FG002|Double-blind Phase|Lost to Follow-up|0|||
164249446|NCT01352221|593279141|FG003|Double-blind Phase|Lost to Follow-up|0|||
164249447|NCT01352221|593279138|FG000|Double-blind Phase|Protocol Violation|0|||
164249448|NCT01352221|593279139|FG001|Double-blind Phase|Protocol Violation|1|||
164249449|NCT01352221|593279140|FG002|Double-blind Phase|Protocol Violation|0|||
164249450|NCT01352221|593279141|FG003|Double-blind Phase|Protocol Violation|0|||
164249451|NCT01352221|593279138|FG000|Open-label Phase|Physician Decision|0|||
164249452|NCT01352221|593279139|FG001|Open-label Phase|Physician Decision|0|||
164249453|NCT01352221|593279140|FG002|Open-label Phase|Physician Decision|2|||
164249454|NCT01352221|593279141|FG003|Open-label Phase|Physician Decision|1|||
164249455|NCT01352221|593279138|FG000|Open-label Phase|Pregnancy|0|||
164249456|NCT01352221|593279139|FG001|Open-label Phase|Pregnancy|0|||
164249457|NCT01352221|593279140|FG002|Open-label Phase|Pregnancy|1|||
164249458|NCT01352221|593279141|FG003|Open-label Phase|Pregnancy|0|||
164249459|NCT01352221|593279138|FG000|Open-label Phase|Adverse Event|0|||
164679872|NCT01963728|594852229|FG000|Overall Study|Study terminated early|0|||
164249460|NCT01352221|593279139|FG001|Open-label Phase|Adverse Event|0|||
164249461|NCT01352221|593279140|FG002|Open-label Phase|Adverse Event|8|||
164249462|NCT01352221|593279141|FG003|Open-label Phase|Adverse Event|4|||
164249463|NCT01352221|593279138|FG000|Open-label Phase|Withdrawal by Subject|0|||
164249464|NCT01352221|593279139|FG001|Open-label Phase|Withdrawal by Subject|0|||
164249465|NCT01352221|593279140|FG002|Open-label Phase|Withdrawal by Subject|1|||
164249466|NCT01352221|593279141|FG003|Open-label Phase|Withdrawal by Subject|6|||
164249467|NCT01352221|593279138|FG000|Open-label Phase|Worsening of IBD|0|||
164249468|NCT01352221|593279139|FG001|Open-label Phase|Worsening of IBD|0|||
164249469|NCT01352221|593279140|FG002|Open-label Phase|Worsening of IBD|1|||
164249470|NCT01352221|593279141|FG003|Open-label Phase|Worsening of IBD|0|||
164249471|NCT00200967|593279142|FG000|First Treatment Period|Withdrawal by Subject|5|||
164249472|NCT00200967|593279143|FG001|First Treatment Period|Withdrawal by Subject|1|||
164249473|NCT00200967|593279142|FG000|First Treatment Period|Pregnancy|1|||
164249474|NCT00200967|593279143|FG001|First Treatment Period|Pregnancy|0|||
164249475|NCT00200967|593279142|FG000|Wash-out Period|Lost to Follow-up|0|||
164249476|NCT00200967|593279143|FG001|Wash-out Period|Lost to Follow-up|1|||
164249477|NCT00200967|593279142|FG000|Second Treatment Period|Withdrawal by Subject|1|||
164249478|NCT00200967|593279143|FG001|Second Treatment Period|Withdrawal by Subject|2|||
164679873|NCT01963728|594852230|FG001|Overall Study|Study terminated early|1|||
164679874|NCT03114891|594852231|FG000|First Treatment Round|Lost to Follow-up|0|||
164679875|NCT03114891|594852232|FG001|First Treatment Round|Lost to Follow-up|1|||
164679876|NCT03114891|594852233|FG002|First Treatment Round|Lost to Follow-up|1|||
164679877|NCT03114891|594852234|FG003|First Treatment Round|Lost to Follow-up|0|||
164249479|NCT00200967|593279142|FG000|Run-out Period|Lost to Follow-up|1|||
164249480|NCT00200967|593279143|FG001|Run-out Period|Lost to Follow-up|0|||
164249481|NCT00980460|593279144|FG000|Overall Study|Death|0|||
164249482|NCT00980460|593279145|FG001|Overall Study|Death|0|||
164249483|NCT00980460|593279146|FG002|Overall Study|Death|1|||
164249484|NCT00980460|593279147|FG003|Overall Study|Death|2|||
164249485|NCT00980460|593279148|FG004|Overall Study|Death|1|||
164249486|NCT00980460|593279144|FG000|Overall Study|Lack of Efficacy|0|||
164249487|NCT00980460|593279145|FG001|Overall Study|Lack of Efficacy|0|||
164249488|NCT00980460|593279146|FG002|Overall Study|Lack of Efficacy|10|||
164249489|NCT00980460|593279147|FG003|Overall Study|Lack of Efficacy|6|||
164249490|NCT00980460|593279148|FG004|Overall Study|Lack of Efficacy|8|||
164249491|NCT00980460|593279144|FG000|Overall Study|Lost to Follow-up|0|||
164249492|NCT00980460|593279145|FG001|Overall Study|Lost to Follow-up|0|||
164249493|NCT00980460|593279146|FG002|Overall Study|Lost to Follow-up|0|||
164679878|NCT03114891|594852231|FG000|First Treatment Round|Withdrawal by Subject|0|||
164249494|NCT00980460|593279147|FG003|Overall Study|Lost to Follow-up|1|||
164249495|NCT00980460|593279148|FG004|Overall Study|Lost to Follow-up|0|||
164249496|NCT00980460|593279144|FG000|Overall Study|Physician Decision|0|||
164249497|NCT00980460|593279145|FG001|Overall Study|Physician Decision|0|||
164249498|NCT00980460|593279146|FG002|Overall Study|Physician Decision|11|||
164249499|NCT00980460|593279147|FG003|Overall Study|Physician Decision|5|||
164249500|NCT00980460|593279148|FG004|Overall Study|Physician Decision|3|||
164249501|NCT00980460|593279144|FG000|Overall Study|Withdrawal by Subject|0|||
164249502|NCT00980460|593279145|FG001|Overall Study|Withdrawal by Subject|0|||
164249503|NCT00980460|593279146|FG002|Overall Study|Withdrawal by Subject|1|||
164249504|NCT00980460|593279147|FG003|Overall Study|Withdrawal by Subject|0|||
164249505|NCT00980460|593279148|FG004|Overall Study|Withdrawal by Subject|0|||
164249506|NCT00980460|593279144|FG000|Overall Study|Ineligible|0|||
164249507|NCT00980460|593279145|FG001|Overall Study|Ineligible|2|||
164249508|NCT00980460|593279146|FG002|Overall Study|Ineligible|3|||
164249509|NCT00980460|593279147|FG003|Overall Study|Ineligible|1|||
164249510|NCT00980460|593279148|FG004|Overall Study|Ineligible|4|||
164249511|NCT00980460|593279144|FG000|Overall Study|Refusal of further therapy|0|||
164249512|NCT00980460|593279145|FG001|Overall Study|Refusal of further therapy|2|||
164249513|NCT00980460|593279146|FG002|Overall Study|Refusal of further therapy|3|||
164249514|NCT00980460|593279147|FG003|Overall Study|Refusal of further therapy|2|||
164249515|NCT00980460|593279148|FG004|Overall Study|Refusal of further therapy|0|||
164249516|NCT00980460|593279144|FG000|Overall Study|No therapy within 42 days of resection|0|||
164249517|NCT00980460|593279145|FG001|Overall Study|No therapy within 42 days of resection|0|||
164249518|NCT00980460|593279146|FG002|Overall Study|No therapy within 42 days of resection|3|||
164249519|NCT00980460|593279147|FG003|Overall Study|No therapy within 42 days of resection|1|||
164249520|NCT00980460|593279148|FG004|Overall Study|No therapy within 42 days of resection|0|||
164249521|NCT00980460|593279144|FG000|Overall Study|No transplant by protocol timepoints|0|||
164249522|NCT00980460|593279145|FG001|Overall Study|No transplant by protocol timepoints|0|||
164249523|NCT00980460|593279146|FG002|Overall Study|No transplant by protocol timepoints|3|||
164249524|NCT00980460|593279147|FG003|Overall Study|No transplant by protocol timepoints|0|||
164249525|NCT00980460|593279148|FG004|Overall Study|No transplant by protocol timepoints|0|||
164249526|NCT02842086|593279149|FG000|Overall Study|Randomized but Never Treated|6|||
164249527|NCT02842086|593279150|FG001|Overall Study|Randomized but Never Treated|6|||
164249528|NCT02842086|593279149|FG000|Overall Study|Still in Double-Blind Phase|7|||
164249529|NCT02842086|593279150|FG001|Overall Study|Still in Double-Blind Phase|3|||
164249530|NCT02842086|593279149|FG000|Overall Study|Adverse Event|18|||
164249531|NCT02842086|593279150|FG001|Overall Study|Adverse Event|20|||
164249532|NCT02842086|593279149|FG000|Overall Study|Death|3|||
164249533|NCT02842086|593279150|FG001|Overall Study|Death|3|||
164249534|NCT02842086|593279149|FG000|Overall Study|Investigator's Discretion|9|||
164249535|NCT02842086|593279150|FG001|Overall Study|Investigator's Discretion|13|||
164249536|NCT02842086|593279149|FG000|Overall Study|Non-Compliance with Study Drug|9|||
164249537|NCT02842086|593279150|FG001|Overall Study|Non-Compliance with Study Drug|8|||
164249538|NCT02842086|593279149|FG000|Overall Study|Protocol Violation|8|||
164249539|NCT02842086|593279150|FG001|Overall Study|Protocol Violation|4|||
164249540|NCT02842086|593279149|FG000|Overall Study|Withdrew Consent|205|||
164249541|NCT02842086|593279150|FG001|Overall Study|Withdrew Consent|194|||
164249542|NCT02842086|593279149|FG000|Overall Study|Lost to Follow-up|274|||
164249543|NCT02842086|593279150|FG001|Overall Study|Lost to Follow-up|236|||
164426855|NCT01544582|593930901|FG003|Analysis Population|Effectiveness Reason|12|||
164426856|NCT01544582|593930898|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
164426857|NCT01544582|593930899|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
164679879|NCT03114891|594852232|FG001|First Treatment Round|Withdrawal by Subject|2|||
164679880|NCT03114891|594852233|FG002|First Treatment Round|Withdrawal by Subject|0|||
164679881|NCT03114891|594852234|FG003|First Treatment Round|Withdrawal by Subject|1|||
164426858|NCT01544582|593930900|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
164426859|NCT01544582|593930901|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
164679882|NCT03114891|594852231|FG000|3 Week Break|Lost to Follow-up|1|||
164679883|NCT03114891|594852232|FG001|3 Week Break|Lost to Follow-up|0|||
164679884|NCT03114891|594852233|FG002|3 Week Break|Lost to Follow-up|0|||
164679885|NCT03114891|594852234|FG003|3 Week Break|Lost to Follow-up|1|||
164679886|NCT03114891|594852231|FG000|3 Week Break|Withdrawal by Subject|0|||
164249544|NCT02842086|593279149|FG000|Overall Study|HIV-1 Infection|5|||
164249545|NCT02842086|593279150|FG001|Overall Study|HIV-1 Infection|6|||
164249546|NCT00928187|593279151|FG000|Overall Study|Death|1|||
164249547|NCT00928187|593279152|FG001|Overall Study|Death|2|||
164249548|NCT00928187|593279153|FG002|Overall Study|Death|3|||
164249549|NCT00928187|593279151|FG000|Overall Study|Lost to Follow-up|1|||
164249550|NCT00928187|593279152|FG001|Overall Study|Lost to Follow-up|2|||
164249551|NCT00928187|593279153|FG002|Overall Study|Lost to Follow-up|1|||
164249552|NCT00928187|593279151|FG000|Overall Study|Withdrawal by Subject|0|||
164249553|NCT00928187|593279152|FG001|Overall Study|Withdrawal by Subject|1|||
164426860|NCT01544582|593930898|FG000|Analysis Population|Lost to Follow-up|0|||
164679887|NCT03114891|594852232|FG001|3 Week Break|Withdrawal by Subject|1|||
164679888|NCT03114891|594852233|FG002|3 Week Break|Withdrawal by Subject|0|||
164338627|NCT02663908|593615214|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
164338628|NCT02663908|593615213|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
164575284|NCT00446030|594469853|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
164575285|NCT00446030|594469854|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
164575286|NCT00446030|594469853|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
164575287|NCT00446030|594469854|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
164575288|NCT00446030|594469853|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
164575289|NCT00446030|594469854|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
164575290|NCT00446030|594469853|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
164575291|NCT00446030|594469854|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
164575292|NCT00446030|594469853|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
164575293|NCT00446030|594469854|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
164575294|NCT00446030|594469853|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
164575295|NCT00446030|594469854|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
164575296|NCT02886715|594469856|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164575297|NCT02886715|594469857|FG001|Overall Study|Non-Compliance With Study Drug|2|||
164575298|NCT02886715|594469858|FG002|Overall Study|Non-Compliance With Study Drug|0|||
164575299|NCT02886715|594469856|FG000|Overall Study|Adverse Event|4|||
164575300|NCT02886715|594469857|FG001|Overall Study|Adverse Event|2|||
164575301|NCT02886715|594469858|FG002|Overall Study|Adverse Event|0|||
164575302|NCT02886715|594469856|FG000|Overall Study|Lack of Efficacy|0|||
164575303|NCT02886715|594469857|FG001|Overall Study|Lack of Efficacy|2|||
164575304|NCT02886715|594469858|FG002|Overall Study|Lack of Efficacy|1|||
164575305|NCT02886715|594469856|FG000|Overall Study|Lost to Follow-up|29|||
164575306|NCT02886715|594469857|FG001|Overall Study|Lost to Follow-up|26|||
164575307|NCT02886715|594469858|FG002|Overall Study|Lost to Follow-up|10|||
164575308|NCT02886715|594469856|FG000|Overall Study|Pregnancy|1|||
164575309|NCT02886715|594469857|FG001|Overall Study|Pregnancy|1|||
164575310|NCT02886715|594469858|FG002|Overall Study|Pregnancy|1|||
164575311|NCT02886715|594469856|FG000|Overall Study|Protocol Violation|3|||
164575312|NCT02886715|594469857|FG001|Overall Study|Protocol Violation|2|||
164575313|NCT02886715|594469858|FG002|Overall Study|Protocol Violation|1|||
164575314|NCT02886715|594469856|FG000|Overall Study|Withdrawal by Subject|20|||
164575315|NCT02886715|594469857|FG001|Overall Study|Withdrawal by Subject|18|||
164575316|NCT02886715|594469858|FG002|Overall Study|Withdrawal by Subject|5|||
164575317|NCT02886715|594469856|FG000|Overall Study|missing|7|||
164575318|NCT02886715|594469857|FG001|Overall Study|missing|2|||
164575319|NCT02886715|594469858|FG002|Overall Study|missing|2|||
164575320|NCT00503399|594469861|FG000|Overall Study|Death|2|||
164575321|NCT00503399|594469862|FG001|Overall Study|Death|1|||
164575322|NCT00503399|594469861|FG000|Overall Study|Protocol Violation|1|||
164575323|NCT00503399|594469862|FG001|Overall Study|Protocol Violation|0|||
164575324|NCT00503399|594469861|FG000|Overall Study|Withdrawal by Subject|4|||
164575325|NCT00503399|594469862|FG001|Overall Study|Withdrawal by Subject|2|||
164575326|NCT00503399|594469861|FG000|Overall Study|Adverse Event|0|||
164575327|NCT00503399|594469862|FG001|Overall Study|Adverse Event|3|||
164575328|NCT00503399|594469861|FG000|Overall Study|Lost to Follow-up|0|||
164575329|NCT00503399|594469862|FG001|Overall Study|Lost to Follow-up|2|||
164575330|NCT01676961|594469863|FG000|Overall Study|Death|3|||
164575331|NCT01676961|594469863|FG000|Overall Study|Lost to Follow-up|1|||
164575332|NCT01676961|594469863|FG000|Overall Study|Withdrawal by Subject|1|||
164575333|NCT05292755|594469866|FG000|Overall Study|Lost to Follow-up|5|||
164575334|NCT05292755|594469867|FG001|Overall Study|Lost to Follow-up|9|||
164575335|NCT04052139|594469871|FG000|Overall Study|Lost to Follow-up|2|||
164575336|NCT04052139|594469872|FG001|Overall Study|Lost to Follow-up|0|||
164575337|NCT04052139|594469873|FG002|Overall Study|Lost to Follow-up|0|||
164575338|NCT04052139|594469871|FG000|Overall Study|Withdrawal by Subject|1|||
164575339|NCT04052139|594469872|FG001|Overall Study|Withdrawal by Subject|0|||
164575340|NCT04052139|594469873|FG002|Overall Study|Withdrawal by Subject|0|||
164575341|NCT02499952|594469874|FG000|Overall Study|Lost to Follow-up|1|||
164249554|NCT00928187|593279153|FG002|Overall Study|Withdrawal by Subject|1|||
164249555|NCT00928187|593279151|FG000|Overall Study|Protocol Violation|0|||
164679889|NCT03114891|594852234|FG003|3 Week Break|Withdrawal by Subject|0|||
164249556|NCT00928187|593279152|FG001|Overall Study|Protocol Violation|1|||
164249557|NCT00928187|593279153|FG002|Overall Study|Protocol Violation|0|||
164249558|NCT05696444|593279154|FG000|Treatment|Physician Decision|0|||
164249559|NCT05696444|593279155|FG001|Treatment|Physician Decision|1|||
164249560|NCT05696444|593279156|FG002|Treatment|Physician Decision|0|||
164249561|NCT05696444|593279154|FG000|30 Days|Death|1|||
164249562|NCT05696444|593279155|FG001|30 Days|Death|1|||
164249563|NCT05696444|593279156|FG002|30 Days|Death|0|||
164249564|NCT05696444|593279154|FG000|30 Days|Missed Visit|1|||
164249565|NCT05696444|593279155|FG001|30 Days|Missed Visit|1|||
164249566|NCT05696444|593279156|FG002|30 Days|Missed Visit|1|||
164249567|NCT00078806|593279996|FG000|Part 1A|Adverse Event|2|||
164249568|NCT00078806|593279997|FG001|Part 1A|Adverse Event|0|||
164249569|NCT00078806|593279998|FG002|Part 1A|Adverse Event|0|||
164249570|NCT00078806|593279999|FG003|Part 1A|Adverse Event|0|||
164249571|NCT00078806|593279996|FG000|Part 1A|Lack of Efficacy|7|||
164249572|NCT00078806|593279997|FG001|Part 1A|Lack of Efficacy|0|||
164249573|NCT00078806|593279998|FG002|Part 1A|Lack of Efficacy|0|||
164249574|NCT00078806|593279999|FG003|Part 1A|Lack of Efficacy|0|||
164249575|NCT00078806|593279996|FG000|Part 1A|Other|1|||
164249576|NCT00078806|593279997|FG001|Part 1A|Other|0|||
164249577|NCT00078806|593279998|FG002|Part 1A|Other|0|||
164679890|NCT03114891|594852231|FG000|Second Treatment Round|Lost to Follow-up|1|||
164679891|NCT03114891|594852232|FG001|Second Treatment Round|Lost to Follow-up|0|||
164679892|NCT03114891|594852233|FG002|Second Treatment Round|Lost to Follow-up|0|||
164249578|NCT00078806|593279999|FG003|Part 1A|Other|0|||
164249579|NCT00078806|593279996|FG000|Part 1B|Adverse Event|1|||
164249580|NCT00078806|593279997|FG001|Part 1B|Adverse Event|0|||
164249581|NCT00078806|593279998|FG002|Part 1B|Adverse Event|0|||
164249582|NCT00078806|593279999|FG003|Part 1B|Adverse Event|0|||
164249583|NCT00078806|593279996|FG000|Part 1B|Lack of Efficacy|7|||
164249584|NCT00078806|593279997|FG001|Part 1B|Lack of Efficacy|0|||
164249585|NCT00078806|593279998|FG002|Part 1B|Lack of Efficacy|0|||
164249586|NCT00078806|593279999|FG003|Part 1B|Lack of Efficacy|0|||
164249587|NCT00078806|593279996|FG000|Part 2|Adverse Event|0|||
164249588|NCT00078806|593279997|FG001|Part 2|Adverse Event|1|||
164249589|NCT00078806|593279998|FG002|Part 2|Adverse Event|0|||
164249590|NCT00078806|593279999|FG003|Part 2|Adverse Event|0|||
164249591|NCT00161616|593280000|FG000|Overall Study|Withdrawal by Subject|6|||
164249592|NCT00161616|593280001|FG001|Overall Study|Withdrawal by Subject|5|||
164249593|NCT00161616|593280000|FG000|Overall Study|Physician Decision|1|||
164249594|NCT00161616|593280001|FG001|Overall Study|Physician Decision|0|||
164679893|NCT03114891|594852234|FG003|Second Treatment Round|Lost to Follow-up|0|||
164679894|NCT03114891|594852231|FG000|Second Treatment Round|Physician Decision|1|||
164679895|NCT03114891|594852232|FG001|Second Treatment Round|Physician Decision|0|||
164679896|NCT03114891|594852233|FG002|Second Treatment Round|Physician Decision|0|||
164679897|NCT03114891|594852234|FG003|Second Treatment Round|Physician Decision|0|||
164679898|NCT03506633|594854416|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
164679899|NCT03506633|594854417|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
164679900|NCT03247686|594854422|FG000|Overall Study|Withdrawal by Subject|1|||
164679901|NCT03247686|594854423|FG001|Overall Study|Withdrawal by Subject|2|||
164679902|NCT02302716|594854424|FG000|Overall Study|Adverse Event|1|||
164679903|NCT02302716|594854425|FG001|Overall Study|Adverse Event|1|||
164679904|NCT02302716|594854424|FG000|Overall Study|Death|0|||
164679905|NCT02302716|594854425|FG001|Overall Study|Death|1|||
164249595|NCT00161616|593280000|FG000|Overall Study|Death|1|||
164249596|NCT00161616|593280001|FG001|Overall Study|Death|1|||
164679906|NCT02302716|594854424|FG000|Overall Study|Lack of Efficacy|0|||
164679907|NCT02302716|594854425|FG001|Overall Study|Lack of Efficacy|1|||
164679908|NCT02302716|594854424|FG000|Overall Study|Lost to Follow-up|2|||
164679909|NCT02302716|594854425|FG001|Overall Study|Lost to Follow-up|4|||
164679910|NCT02302716|594854424|FG000|Overall Study|Physician Decision|3|||
164249597|NCT00161616|593280000|FG000|Overall Study|Lost to Follow-up|17|||
164249598|NCT00161616|593280001|FG001|Overall Study|Lost to Follow-up|13|||
164249599|NCT00161616|593280000|FG000|Overall Study|Protocol deviation|1|||
164249600|NCT00161616|593280001|FG001|Overall Study|Protocol deviation|0|||
164249601|NCT00336284|593280002|FG000|Overall Study|Death|52|||
164679911|NCT02302716|594854425|FG001|Overall Study|Physician Decision|4|||
164679912|NCT02302716|594854424|FG000|Overall Study|Withdrawal by Subject|13|||
164249602|NCT00336284|593280003|FG001|Overall Study|Death|26|||
164249603|NCT00336284|593280002|FG000|Overall Study|Lost to Follow-up|82|||
164249604|NCT00336284|593280003|FG001|Overall Study|Lost to Follow-up|61|||
164249605|NCT00336284|593280002|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
164249606|NCT00336284|593280003|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
164249607|NCT00861757|593280006|FG000|Overall Study|Adverse Event|1|||
164249608|NCT00861757|593280007|FG001|Overall Study|Adverse Event|5|||
164679913|NCT02302716|594854425|FG001|Overall Study|Withdrawal by Subject|7|||
164679914|NCT02302716|594854424|FG000|Overall Study|Protocol Violation|0|||
164679915|NCT02302716|594854425|FG001|Overall Study|Protocol Violation|1|||
164679916|NCT00830258|594854426|FG000|First Intervention|Adverse Event|1|||
164679917|NCT00830258|594854427|FG001|First Intervention|Adverse Event|0|||
164679918|NCT00830258|594854426|FG000|Washout: 7 Days|Protocol Violation|1|||
164679919|NCT00830258|594854427|FG001|Washout: 7 Days|Protocol Violation|0|||
164679920|NCT00798603|594854428|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
164679921|NCT00798603|594854428|FG000|Overall Study|Withdrawal by Subject|10|||
164679922|NCT00798603|594854428|FG000|Overall Study|Adverse Event|22|||
164679923|NCT00798603|594854428|FG000|Overall Study|Physician Decision|1|||
164679924|NCT00798603|594854428|FG000|Overall Study|Lack of insurance coverage|1|||
164679925|NCT02997176|594854433|FG000|Overall Study|Adverse Event|0|||
164679926|NCT02997176|594854434|FG001|Overall Study|Adverse Event|0|||
164679927|NCT02997176|594854435|FG002|Overall Study|Adverse Event|0|||
164679928|NCT02997176|594854436|FG003|Overall Study|Adverse Event|8|||
164679929|NCT02997176|594854433|FG000|Overall Study|Progressive Disease|1|||
164679930|NCT02997176|594854434|FG001|Overall Study|Progressive Disease|0|||
164679931|NCT02997176|594854435|FG002|Overall Study|Progressive Disease|1|||
164679932|NCT02997176|594854436|FG003|Overall Study|Progressive Disease|1|||
164249609|NCT00861757|593280008|FG002|Overall Study|Adverse Event|7|||
164249610|NCT00861757|593280009|FG003|Overall Study|Adverse Event|2|||
164249611|NCT00861757|593280006|FG000|Overall Study|Entry Criteria Not Met|1|||
164249612|NCT00861757|593280007|FG001|Overall Study|Entry Criteria Not Met|2|||
164249613|NCT00861757|593280008|FG002|Overall Study|Entry Criteria Not Met|1|||
164249614|NCT00861757|593280009|FG003|Overall Study|Entry Criteria Not Met|1|||
164249615|NCT00861757|593280006|FG000|Overall Study|Lack of Efficacy|3|||
164249616|NCT00861757|593280007|FG001|Overall Study|Lack of Efficacy|1|||
164249617|NCT00861757|593280008|FG002|Overall Study|Lack of Efficacy|0|||
164249618|NCT00861757|593280009|FG003|Overall Study|Lack of Efficacy|1|||
164249619|NCT00861757|593280006|FG000|Overall Study|Lost to Follow-up|1|||
164249620|NCT00861757|593280007|FG001|Overall Study|Lost to Follow-up|0|||
164249621|NCT00861757|593280008|FG002|Overall Study|Lost to Follow-up|1|||
164249622|NCT00861757|593280009|FG003|Overall Study|Lost to Follow-up|1|||
164249623|NCT00861757|593280006|FG000|Overall Study|Physician Decision|0|||
164249624|NCT00861757|593280007|FG001|Overall Study|Physician Decision|0|||
164249625|NCT00861757|593280008|FG002|Overall Study|Physician Decision|0|||
164249626|NCT00861757|593280009|FG003|Overall Study|Physician Decision|1|||
164249627|NCT00861757|593280006|FG000|Overall Study|Protocol Violation|2|||
164249628|NCT00861757|593280007|FG001|Overall Study|Protocol Violation|2|||
164249629|NCT00861757|593280008|FG002|Overall Study|Protocol Violation|4|||
164249630|NCT00861757|593280009|FG003|Overall Study|Protocol Violation|1|||
164249631|NCT00861757|593280006|FG000|Overall Study|Withdrawal by Subject|1|||
164249632|NCT00861757|593280007|FG001|Overall Study|Withdrawal by Subject|5|||
164249633|NCT00861757|593280008|FG002|Overall Study|Withdrawal by Subject|5|||
164249634|NCT00861757|593280009|FG003|Overall Study|Withdrawal by Subject|2|||
164249635|NCT04908384|593280010|FG000|Overall Study|Lost to Follow-up|4|||
164249636|NCT04908384|593280011|FG001|Overall Study|Lost to Follow-up|4|||
164249637|NCT04908384|593280012|FG002|Overall Study|Lost to Follow-up|0|||
164249638|NCT04908384|593280013|FG003|Overall Study|Lost to Follow-up|0|||
164249639|NCT04123093|593280014|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
164679933|NCT02997176|594854433|FG000|Overall Study|Death|0|||
164679934|NCT02997176|594854434|FG001|Overall Study|Death|0|||
164679935|NCT02997176|594854435|FG002|Overall Study|Death|1|||
164679936|NCT02997176|594854436|FG003|Overall Study|Death|1|||
164249640|NCT04123093|593280015|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
164249641|NCT04123093|593280014|FG000|Phase 2|Physician Decision|0|||
164249642|NCT04123093|593280015|FG001|Phase 2|Physician Decision|1|||
164575342|NCT02499952|594469874|FG000|Overall Study|Death|9|||
164575343|NCT00519077|594469875|FG000|Overall Study|Death|6|||
164575344|NCT00519077|594469875|FG000|Overall Study|Other|2|||
164575345|NCT02120417|594469877|FG000|Overall Study|Death|5|||
164575346|NCT02120417|594469878|FG001|Overall Study|Death|1|||
164575347|NCT02120417|594469877|FG000|Overall Study|Adverse Event|3|||
164575348|NCT02120417|594469878|FG001|Overall Study|Adverse Event|9|||
164575349|NCT02120417|594469877|FG000|Overall Study|Participant decision|4|||
164575350|NCT02120417|594469878|FG001|Overall Study|Participant decision|4|||
164575351|NCT02120417|594469877|FG000|Overall Study|Disease progression|41|||
164249643|NCT04123093|593280014|FG000|Phase 2|Withdrawal by Subject|0|||
164249644|NCT04123093|593280015|FG001|Phase 2|Withdrawal by Subject|1|||
164249645|NCT03462641|593280019|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
164249646|NCT03462641|593280020|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
164338629|NCT02663908|593615214|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
164575352|NCT02120417|594469878|FG001|Overall Study|Disease progression|45|||
164575353|NCT02120417|594469877|FG000|Overall Study|Noncompliance with study treatment|0|||
164575354|NCT02120417|594469878|FG001|Overall Study|Noncompliance with study treatment|2|||
164575355|NCT02120417|594469877|FG000|Overall Study|Physician Decision|2|||
164679937|NCT02997176|594854433|FG000|Overall Study|Withdrawal by Subject|0|||
164249647|NCT03462641|593280019|FG000|Visit 2|Withdrawal by Subject|0|||
164249648|NCT03462641|593280020|FG001|Visit 2|Withdrawal by Subject|1|||
164249649|NCT02923531|593280025|FG000|Overall Study|Adverse Event|4|||
164249650|NCT02923531|593280025|FG000|Overall Study|Clinical Deterioration|1|||
164249651|NCT02923531|593280025|FG000|Overall Study|Disease Progression|3|||
164249652|NCT02923531|593280025|FG000|Overall Study|Study Termination|1|||
164249653|NCT02201329|593280026|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
164249654|NCT02201329|593280026|FG000|Overall Study|Withdrawal by Subject|2|||
164249655|NCT02997865|593280027|FG000|Overall Study|Death|2|||
164249656|NCT02997865|593280028|FG001|Overall Study|Death|1|||
164249657|NCT02997865|593280027|FG000|Overall Study|Lost to Follow-up|6|||
164249658|NCT02997865|593280028|FG001|Overall Study|Lost to Follow-up|3|||
164338630|NCT02663908|593615213|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
164338631|NCT02663908|593615214|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
164338632|NCT02663908|593615213|FG000|Overall Study|Death|1|||
164338633|NCT02663908|593615214|FG001|Overall Study|Death|0|||
164338634|NCT02663908|593615213|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
164338635|NCT02663908|593615214|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
164338636|NCT02663908|593615213|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
164338637|NCT02663908|593615214|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
164338638|NCT02004522|593615215|FG000|Overall Study|Adverse Event|55|||
164338639|NCT02004522|593615216|FG001|Overall Study|Adverse Event|6|||
164338640|NCT02004522|593615215|FG000|Overall Study|Withdrawal by Subject|13|||
164338641|NCT02004522|593615216|FG001|Overall Study|Withdrawal by Subject|7|||
164338642|NCT02004522|593615215|FG000|Overall Study|Death|12|||
164338643|NCT02004522|593615216|FG001|Overall Study|Death|3|||
164338644|NCT02004522|593615215|FG000|Overall Study|Physician Decision|3|||
164338645|NCT02004522|593615216|FG001|Overall Study|Physician Decision|4|||
164338646|NCT02004522|593615215|FG000|Overall Study|Protocol Violation|1|||
164338647|NCT02004522|593615216|FG001|Overall Study|Protocol Violation|0|||
164338648|NCT02004522|593615215|FG000|Overall Study|Other is reason listed by PI|4|||
164338649|NCT02004522|593615216|FG001|Overall Study|Other is reason listed by PI|1|||
164426861|NCT01544582|593930899|FG001|Analysis Population|Lost to Follow-up|6|||
164426862|NCT01544582|593930900|FG002|Analysis Population|Lost to Follow-up|6|||
164575356|NCT02120417|594469878|FG001|Overall Study|Physician Decision|3|||
164575357|NCT02120417|594469877|FG000|Overall Study|Other unspecified|5|||
164575358|NCT02120417|594469878|FG001|Overall Study|Other unspecified|4|||
164575359|NCT00927485|594469879|FG000|Overall Study|Adverse Event|4|||
164575360|NCT00927485|594469880|FG001|Overall Study|Adverse Event|2|||
164575361|NCT00927485|594469879|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
164575362|NCT00927485|594469880|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
164575363|NCT02305563|594469881|FG000|Treatment Period|Disease progression|0|||
164575364|NCT02305563|594469882|FG001|Treatment Period|Disease progression|0|||
164575365|NCT02305563|594469883|FG002|Treatment Period|Disease progression|15|||
164575366|NCT02305563|594469884|FG003|Treatment Period|Disease progression|6|||
164575367|NCT02305563|594469885|FG004|Treatment Period|Disease progression|6|||
164575368|NCT02305563|594469881|FG000|Treatment Period|Study drug toxicity|0|||
164575369|NCT02305563|594469882|FG001|Treatment Period|Study drug toxicity|0|||
164575370|NCT02305563|594469883|FG002|Treatment Period|Study drug toxicity|0|||
164575371|NCT02305563|594469884|FG003|Treatment Period|Study drug toxicity|1|||
164575372|NCT02305563|594469885|FG004|Treatment Period|Study drug toxicity|2|||
164575373|NCT02305563|594469881|FG000|Treatment Period|Death|0|||
164575374|NCT02305563|594469882|FG001|Treatment Period|Death|0|||
164575375|NCT02305563|594469883|FG002|Treatment Period|Death|1|||
164575376|NCT02305563|594469884|FG003|Treatment Period|Death|2|||
164575377|NCT02305563|594469885|FG004|Treatment Period|Death|1|||
164575378|NCT02305563|594469881|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
164575379|NCT02305563|594469882|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
164575380|NCT02305563|594469883|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
164575381|NCT02305563|594469884|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
164575382|NCT02305563|594469885|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
164679938|NCT02997176|594854434|FG001|Overall Study|Withdrawal by Subject|2|||
164679939|NCT02997176|594854435|FG002|Overall Study|Withdrawal by Subject|0|||
164249659|NCT02997865|593280027|FG000|Overall Study|Withdrawal by Subject|5|||
164249660|NCT02997865|593280028|FG001|Overall Study|Withdrawal by Subject|0|||
164249661|NCT04660552|593280030|FG000|Overall Study|Withdrawal by Subject|3|||
164249662|NCT04660552|593280031|FG001|Overall Study|Withdrawal by Subject|1|||
164249663|NCT03012828|593280032|FG000|Overall Study|Lost to Follow-up|1|||
164575383|NCT02305563|594469881|FG000|Treatment Period|Participant request to stop therapy|0|||
164575384|NCT02305563|594469882|FG001|Treatment Period|Participant request to stop therapy|2|||
164426863|NCT01544582|593930901|FG003|Analysis Population|Lost to Follow-up|5|||
164575385|NCT02305563|594469883|FG002|Treatment Period|Participant request to stop therapy|0|||
164575386|NCT02305563|594469884|FG003|Treatment Period|Participant request to stop therapy|1|||
164426864|NCT01544582|593930898|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
164249664|NCT03012828|593280033|FG001|Overall Study|Lost to Follow-up|0|||
164249665|NCT03012828|593280034|FG002|Overall Study|Lost to Follow-up|1|||
164249666|NCT03012828|593280035|FG003|Overall Study|Lost to Follow-up|0|||
164249667|NCT03012828|593280036|FG004|Overall Study|Lost to Follow-up|1|||
164249668|NCT03012828|593280037|FG005|Overall Study|Lost to Follow-up|0|||
164249669|NCT03012828|593280032|FG000|Overall Study|Withdrawal by Subject|0|||
164249670|NCT03012828|593280033|FG001|Overall Study|Withdrawal by Subject|0|||
164249671|NCT03012828|593280034|FG002|Overall Study|Withdrawal by Subject|1|||
164249672|NCT03012828|593280035|FG003|Overall Study|Withdrawal by Subject|0|||
164249673|NCT03012828|593280036|FG004|Overall Study|Withdrawal by Subject|0|||
164249674|NCT03012828|593280037|FG005|Overall Study|Withdrawal by Subject|1|||
164249675|NCT03012828|593280032|FG000|Overall Study|Non-compliance with protocol|0|||
164575387|NCT02305563|594469885|FG004|Treatment Period|Participant request to stop therapy|0|||
164575388|NCT02305563|594469881|FG000|Treatment Period|Participant withdrew consent|0|||
164575389|NCT02305563|594469882|FG001|Treatment Period|Participant withdrew consent|0|||
164575390|NCT02305563|594469883|FG002|Treatment Period|Participant withdrew consent|1|||
164575391|NCT02305563|594469884|FG003|Treatment Period|Participant withdrew consent|1|||
164575392|NCT02305563|594469885|FG004|Treatment Period|Participant withdrew consent|1|||
164575393|NCT02305563|594469881|FG000|Treatment Period|Maximum clinical benefit|0|||
164575394|NCT02305563|594469882|FG001|Treatment Period|Maximum clinical benefit|0|||
164575395|NCT02305563|594469883|FG002|Treatment Period|Maximum clinical benefit|0|||
164575396|NCT02305563|594469884|FG003|Treatment Period|Maximum clinical benefit|0|||
164249676|NCT03012828|593280033|FG001|Overall Study|Non-compliance with protocol|0|||
164249677|NCT03012828|593280034|FG002|Overall Study|Non-compliance with protocol|0|||
164249678|NCT03012828|593280035|FG003|Overall Study|Non-compliance with protocol|0|||
164249679|NCT03012828|593280036|FG004|Overall Study|Non-compliance with protocol|1|||
164249680|NCT03012828|593280037|FG005|Overall Study|Non-compliance with protocol|0|||
164249681|NCT03012828|593280032|FG000|Overall Study|Delay to last visit would delay DBL|0|||
164249682|NCT03012828|593280033|FG001|Overall Study|Delay to last visit would delay DBL|0|||
164249683|NCT03012828|593280034|FG002|Overall Study|Delay to last visit would delay DBL|0|||
164249684|NCT03012828|593280035|FG003|Overall Study|Delay to last visit would delay DBL|0|||
164249685|NCT03012828|593280036|FG004|Overall Study|Delay to last visit would delay DBL|0|||
164249686|NCT03012828|593280037|FG005|Overall Study|Delay to last visit would delay DBL|1|||
164249687|NCT01509846|593280038|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
164249688|NCT01509846|593280039|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
164249689|NCT01509846|593280040|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
164249690|NCT01509846|593280041|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
164249691|NCT01509846|593280042|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
164249692|NCT01509846|593280038|FG000|Received Vaccination 2|Illness|0|||
164249693|NCT01509846|593280039|FG001|Received Vaccination 2|Illness|0|||
164249694|NCT01509846|593280040|FG002|Received Vaccination 2|Illness|0|||
164249695|NCT01509846|593280041|FG003|Received Vaccination 2|Illness|0|||
164249696|NCT01509846|593280042|FG004|Received Vaccination 2|Illness|1|||
164249697|NCT01509846|593280038|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
164249698|NCT01509846|593280039|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
164249699|NCT01509846|593280040|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
164249700|NCT01509846|593280041|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
164249701|NCT01509846|593280042|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
164249702|NCT01509846|593280038|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
164249703|NCT01509846|593280039|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
164249704|NCT01509846|593280040|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
164249705|NCT01509846|593280041|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
164249706|NCT01509846|593280042|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
164249707|NCT01509846|593280038|FG000|Received Vaccination 3|Pregnancy|0|||
164249708|NCT01509846|593280039|FG001|Received Vaccination 3|Pregnancy|0|||
164249709|NCT01509846|593280040|FG002|Received Vaccination 3|Pregnancy|0|||
164249710|NCT01509846|593280041|FG003|Received Vaccination 3|Pregnancy|1|||
164249711|NCT01509846|593280042|FG004|Received Vaccination 3|Pregnancy|0|||
164249712|NCT01509846|593280038|FG000|Received Vaccination 3|Lost to Follow-up|0|||
164249713|NCT01509846|593280039|FG001|Received Vaccination 3|Lost to Follow-up|0|||
164249714|NCT01509846|593280040|FG002|Received Vaccination 3|Lost to Follow-up|1|||
164249715|NCT01509846|593280041|FG003|Received Vaccination 3|Lost to Follow-up|0|||
164249716|NCT01509846|593280042|FG004|Received Vaccination 3|Lost to Follow-up|0|||
164249717|NCT01637584|593280044|FG000|Overall Study|Withdrawal by Subject|1|||
164249718|NCT01637584|593280045|FG001|Overall Study|Withdrawal by Subject|3|||
164249719|NCT02366923|593280046|FG000|Overall Study|Withdrawal by Subject|1|||
164249720|NCT02366923|593280046|FG000|Overall Study|Positive Slit Lamp Findings|2|||
164249721|NCT02366923|593280046|FG000|Overall Study|High Astigmatism|3|||
164249722|NCT02484443|593280047|FG000|Overall Study|Lack of Efficacy|28|||
164249723|NCT02484443|593280047|FG000|Overall Study|Physician Decision|2|||
164249724|NCT02484443|593280047|FG000|Overall Study|Ineligible|2|||
164249725|NCT01970241|593280048|FG000|Overall Study|Withdrawal by Subject|2|||
164575397|NCT02305563|594469885|FG004|Treatment Period|Maximum clinical benefit|1|||
164575398|NCT02305563|594469881|FG000|Treatment Period|Poor/non-compliance|0|||
164249726|NCT01970241|593280049|FG001|Overall Study|Withdrawal by Subject|0|||
164249727|NCT01970241|593280048|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
164249728|NCT01970241|593280049|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
164249729|NCT00992056|593280050|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
164249730|NCT00992056|593280051|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
164249731|NCT00992056|593280050|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
164249732|NCT00992056|593280051|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
164249733|NCT02595866|593280052|FG000|Overall Study|Adverse Event|2|||
164249734|NCT02595866|593280053|FG001|Overall Study|Adverse Event|5|||
164249735|NCT02595866|593280052|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
164249736|NCT02595866|593280053|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
164249737|NCT02595866|593280052|FG000|Overall Study|Death|0|||
164249738|NCT02595866|593280053|FG001|Overall Study|Death|1|||
164249739|NCT02595866|593280052|FG000|Overall Study|Incarceration|1|||
164249740|NCT02595866|593280053|FG001|Overall Study|Incarceration|0|||
164249741|NCT02595866|593280052|FG000|Overall Study|Lack of Efficacy|17|||
164249742|NCT02595866|593280053|FG001|Overall Study|Lack of Efficacy|7|||
164249743|NCT02595866|593280052|FG000|Overall Study|Physician Decision|4|||
164249744|NCT02595866|593280053|FG001|Overall Study|Physician Decision|3|||
164249745|NCT02595866|593280052|FG000|Overall Study|Switched to Alternative Treatment|1|||
164249746|NCT02595866|593280053|FG001|Overall Study|Switched to Alternative Treatment|0|||
164249747|NCT02595866|593280052|FG000|Overall Study|Study Terminated|0|||
164249748|NCT02595866|593280053|FG001|Overall Study|Study Terminated|4|||
164249749|NCT02595866|593280052|FG000|Overall Study|Withdrawal by Subject|6|||
164249750|NCT02595866|593280053|FG001|Overall Study|Withdrawal by Subject|1|||
164249751|NCT01001767|593280056|FG000|Overall Study|no baseline study performed|1|||
164249752|NCT01001767|593280057|FG001|Overall Study|no baseline study performed|0|||
164249753|NCT01001767|593280056|FG000|Overall Study|Protocol Violation|1|||
164249754|NCT01001767|593280057|FG001|Overall Study|Protocol Violation|0|||
164249755|NCT01001767|593280056|FG000|Overall Study|Lost to Follow-up|1|||
164249756|NCT01001767|593280057|FG001|Overall Study|Lost to Follow-up|0|||
164249757|NCT01001767|593280056|FG000|Overall Study|Physician Decision|1|||
164249758|NCT01001767|593280057|FG001|Overall Study|Physician Decision|0|||
164249759|NCT00177294|593280058|FG000|Overall Study|Withdrawal by Subject|7|||
164249760|NCT00177294|593280059|FG001|Overall Study|Withdrawal by Subject|5|||
164249761|NCT02131311|593280060|FG000|Overall Study|Adverse Event|2|||
164249762|NCT02131311|593280060|FG000|Overall Study|Protocol Violation|1|||
164249763|NCT02131311|593280060|FG000|Overall Study|Lost to Follow-up|1|||
164249764|NCT01479764|593280061|FG000|Randomized|Adverse Event|1|||
164249765|NCT01479764|593280062|FG001|Randomized|Adverse Event|1|||
164249766|NCT01479764|593280061|FG000|Randomized|Withdrawal by Subject|1|||
164249767|NCT01479764|593280062|FG001|Randomized|Withdrawal by Subject|0|||
164249768|NCT01479764|593280061|FG000|Treated|Lost to Follow-up|0|||
164249769|NCT01479764|593280062|FG001|Treated|Lost to Follow-up|2|||
164249770|NCT03082677|593280063|FG000|Overall Study|Not Treated|2|||
164249771|NCT00255723|593280065|FG000|Overall Study|Adverse Event|1|||
164249772|NCT00255723|593280066|FG001|Overall Study|Adverse Event|1|||
164249773|NCT00255723|593280065|FG000|Overall Study|Death|0|||
164249774|NCT00255723|593280066|FG001|Overall Study|Death|1|||
164249775|NCT00255723|593280065|FG000|Overall Study|Response Data Not Available|1|||
164249776|NCT00255723|593280066|FG001|Overall Study|Response Data Not Available|0|||
164249777|NCT03711370|593280067|FG000|Overall Study|Lost to Follow-up|16|||
164249778|NCT03711370|593280068|FG001|Overall Study|Lost to Follow-up|10|||
164249779|NCT03711370|593280067|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
164249780|NCT03711370|593280068|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
164249781|NCT01030952|593280069|FG000|Overall Study|Protocol Violation|0|||
164249782|NCT01030952|593280070|FG001|Overall Study|Protocol Violation|1|||
164249783|NCT01030952|593280069|FG000|Overall Study|Informed consent withdrawal|1|||
164249784|NCT01030952|593280070|FG001|Overall Study|Informed consent withdrawal|0|||
164249785|NCT01030952|593280069|FG000|Overall Study|Lost to Follow-up|0|||
164249786|NCT01030952|593280070|FG001|Overall Study|Lost to Follow-up|1|||
164338650|NCT02004522|593615215|FG000|Overall Study|Never Dosed|2|||
164338651|NCT02004522|593615216|FG001|Overall Study|Never Dosed|4|||
164338652|NCT02004522|593615215|FG000|Overall Study|Disease Progression|35|||
164338653|NCT02004522|593615216|FG001|Overall Study|Disease Progression|31|||
164338654|NCT02004522|593615215|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
164249787|NCT01030952|593280069|FG000|Overall Study|Unexplained|1|||
164249788|NCT01030952|593280070|FG001|Overall Study|Unexplained|1|||
164249789|NCT03554018|593280075|FG000|Overall Study|Lost to Follow-up|3|||
164249790|NCT03554018|593280076|FG001|Overall Study|Lost to Follow-up|7|||
164249791|NCT00130039|593280077|FG000|Overall Study|Withdrawal by Subject|15|||
164249792|NCT00130039|593280078|FG001|Overall Study|Withdrawal by Subject|11|||
164249793|NCT00130039|593280077|FG000|Overall Study|Lost to Follow-up|3|||
164249794|NCT00130039|593280078|FG001|Overall Study|Lost to Follow-up|1|||
164249795|NCT00130039|593280077|FG000|Overall Study|Adverse Event|4|||
164249796|NCT00130039|593280078|FG001|Overall Study|Adverse Event|2|||
164249797|NCT00130039|593280077|FG000|Overall Study|Physician Decision|3|||
164338655|NCT02004522|593615216|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
164249798|NCT00130039|593280078|FG001|Overall Study|Physician Decision|0|||
164249799|NCT00130039|593280077|FG000|Overall Study|clinical events without follow up MRI|5|||
164249800|NCT00130039|593280078|FG001|Overall Study|clinical events without follow up MRI|4|||
164249801|NCT01740687|593280079|FG000|Overall Study|Lost to Follow-up|11|||
164249802|NCT01740687|593280079|FG000|Overall Study|Withdrawal by Subject|2|||
164249803|NCT01740687|593280079|FG000|Overall Study|other reason|22|||
164249804|NCT01740687|593280079|FG000|Overall Study|treatment not received|2|||
164249805|NCT00556439|593280084|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
164249806|NCT00556439|593280085|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
164249807|NCT00556439|593280086|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
164249808|NCT00556439|593280087|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
164249809|NCT00556439|593280084|FG000|Study Entry to Week 12|Physician Decision|1|||
164249810|NCT00556439|593280085|FG001|Study Entry to Week 12|Physician Decision|0|||
164249811|NCT00556439|593280086|FG002|Study Entry to Week 12|Physician Decision|0|||
164249812|NCT00556439|593280087|FG003|Study Entry to Week 12|Physician Decision|0|||
164249813|NCT00556439|593280084|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
164249814|NCT00556439|593280085|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
164249815|NCT00556439|593280086|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
164249816|NCT00556439|593280087|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
164249817|NCT00556439|593280084|FG000|Study Entry to Week 12|Recurrent infection|1|||
164249818|NCT00556439|593280085|FG001|Study Entry to Week 12|Recurrent infection|0|||
164249819|NCT00556439|593280086|FG002|Study Entry to Week 12|Recurrent infection|0|||
164249820|NCT00556439|593280087|FG003|Study Entry to Week 12|Recurrent infection|0|||
164249821|NCT00556439|593280084|FG000|Study Entry to Week 12|Malignancy|0|||
164249822|NCT00556439|593280085|FG001|Study Entry to Week 12|Malignancy|0|||
164249823|NCT00556439|593280086|FG002|Study Entry to Week 12|Malignancy|1|||
164249824|NCT00556439|593280087|FG003|Study Entry to Week 12|Malignancy|0|||
164249825|NCT00556439|593280084|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
164249826|NCT00556439|593280085|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
164249827|NCT00556439|593280086|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
164249828|NCT00556439|593280087|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
164249829|NCT00556439|593280084|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
164249830|NCT00556439|593280085|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
164249831|NCT00556439|593280086|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
164249832|NCT00556439|593280087|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
164249833|NCT00556439|593280084|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
164249834|NCT00556439|593280085|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
164249835|NCT00556439|593280086|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
164249836|NCT00556439|593280087|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
164249837|NCT00556439|593280084|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
164249838|NCT00556439|593280085|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
164249839|NCT00556439|593280086|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
164249840|NCT00556439|593280087|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
164249841|NCT02100423|593280088|FG000|Overall Study|Death|1|||
164249842|NCT02100423|593280088|FG000|Overall Study|Withdrawal by Subject|3|||
164249843|NCT02100423|593280088|FG000|Overall Study|Adverse Event|1|||
164249844|NCT02100423|593280088|FG000|Overall Study|Physician Decision|1|||
164249845|NCT00703846|593280089|FG000|Overall Study|Adverse Event|8|||
164249846|NCT00703846|593280089|FG000|Overall Study|Lost to Follow-up|55|||
164249847|NCT00703846|593280089|FG000|Overall Study|Lack of Efficacy|15|||
164249848|NCT00703846|593280089|FG000|Overall Study|Noncompliance with Study Treatment|2|||
164249849|NCT00703846|593280089|FG000|Overall Study|Withdrawal by Subject|40|||
164249850|NCT00703846|593280089|FG000|Overall Study|Death|1|||
164249851|NCT00703846|593280089|FG000|Overall Study|Other|14|||
164249852|NCT00703846|593280089|FG000|Overall Study|Did Not Receive Study Drug|2|||
164249853|NCT04601532|593280090|FG000|Overall Study|Lost to Follow-up|1|||
164249854|NCT04601532|593280091|FG001|Overall Study|Lost to Follow-up|2|||
164249855|NCT04601532|593280090|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
164249856|NCT04601532|593280091|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
164249857|NCT02195700|593280092|FG000|Overall Study|Protocol Violation|0|||
164249858|NCT02195700|593280093|FG001|Overall Study|Protocol Violation|2|||
164249859|NCT02195700|593280092|FG000|Overall Study|Noncompliance|1|||
164249860|NCT02195700|593280093|FG001|Overall Study|Noncompliance|0|||
164249861|NCT02195700|593280092|FG000|Overall Study|Adverse Event|1|||
164249862|NCT02195700|593280093|FG001|Overall Study|Adverse Event|2|||
164249863|NCT02195700|593280092|FG000|Overall Study|Withdrawal by Subject|3|||
164249864|NCT02195700|593280093|FG001|Overall Study|Withdrawal by Subject|2|||
164249865|NCT02195700|593280092|FG000|Overall Study|Lost to Follow-up|1|||
164249866|NCT02195700|593280093|FG001|Overall Study|Lost to Follow-up|1|||
164249867|NCT00670930|593280094|FG000|Overall Study|Adminstrative Problem|0|||
164249868|NCT00670930|593280095|FG001|Overall Study|Adminstrative Problem|1|||
164249869|NCT00670930|593280094|FG000|Overall Study|Lost to Follow-up|1|||
164249870|NCT00670930|593280095|FG001|Overall Study|Lost to Follow-up|0|||
164249871|NCT03062280|593282049|FG000|Overall Study|Adverse Event|1|||
164249872|NCT03062280|593282049|FG000|Overall Study|Death|1|||
164249873|NCT03062280|593282049|FG000|Overall Study|Fertility Treatment|2|||
164249874|NCT03062280|593282049|FG000|Overall Study|Physician Decision|2|||
164249875|NCT03062280|593282049|FG000|Overall Study|Pregnancy|5|||
164249876|NCT03062280|593282049|FG000|Overall Study|Withdrawal by Subject|11|||
164249877|NCT01340625|593282050|FG000|First Intervention|Adverse Event|1|||
164249878|NCT01340625|593282051|FG001|First Intervention|Adverse Event|0|||
164249879|NCT01340625|593282050|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
164249880|NCT01340625|593282051|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
164249881|NCT00854724|593282052|FG000|First Intervention|Withdrawal by Subject|1|||
164249882|NCT00854724|593282053|FG001|First Intervention|Withdrawal by Subject|1|||
164249883|NCT00854724|593282052|FG000|Washout|Protocol Violation|1|||
164249884|NCT00854724|593282053|FG001|Washout|Protocol Violation|0|||
164249885|NCT00854724|593282052|FG000|Washout|Withdrawal by Subject|0|||
164249886|NCT00854724|593282053|FG001|Washout|Withdrawal by Subject|1|||
164249887|NCT00854724|593282052|FG000|Second Intervention|Protocol Violation|1|||
164249888|NCT00854724|593282053|FG001|Second Intervention|Protocol Violation|0|||
164249889|NCT00854724|593282052|FG000|Second Intervention|Physician Decision|0|||
164249890|NCT00854724|593282053|FG001|Second Intervention|Physician Decision|1|||
164249891|NCT01519791|593282060|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
164249892|NCT01519791|593282061|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
164249893|NCT01519791|593282060|FG000|Overall Study|Protocol Violation|6|||
164249894|NCT01519791|593282061|FG001|Overall Study|Protocol Violation|19|||
164249895|NCT01519791|593282060|FG000|Overall Study|Other Reason|87|||
164249896|NCT01519791|593282061|FG001|Overall Study|Other Reason|222|||
164249897|NCT01519791|593282060|FG000|Overall Study|subjects randomized in error|2|||
164249898|NCT01519791|593282061|FG001|Overall Study|subjects randomized in error|0|||
164249899|NCT01519791|593282060|FG000|Overall Study|Lack of Efficacy|16|||
164249900|NCT01519791|593282061|FG001|Overall Study|Lack of Efficacy|20|||
164249901|NCT01519791|593282060|FG000|Overall Study|SAE, non-fatal|6|||
164249902|NCT01519791|593282061|FG001|Overall Study|SAE, non-fatal|22|||
164249903|NCT01519791|593282060|FG000|Overall Study|AE, serious fatal|0|||
164249904|NCT01519791|593282061|FG001|Overall Study|AE, serious fatal|1|||
164249905|NCT01519791|593282060|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
164249906|NCT01519791|593282061|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
164249907|NCT01519791|593282060|FG000|Overall Study|AE, non-serious non-fatal|12|||
164249908|NCT01519791|593282061|FG001|Overall Study|AE, non-serious non-fatal|31|||
164249909|NCT01519791|593282060|FG000|Overall Study|Withdrawal by Subject|15|||
164249910|NCT01519791|593282061|FG001|Overall Study|Withdrawal by Subject|37|||
164249911|NCT01519791|593282060|FG000|Overall Study|Lost to Follow-up|6|||
164249912|NCT01519791|593282061|FG001|Overall Study|Lost to Follow-up|14|||
164249913|NCT00459875|593282062|FG000|Overall Study|Ineligible participant|1|||
164249914|NCT00459875|593282062|FG000|Overall Study|Adverse Event|2|||
164249915|NCT00576628|593282064|FG000|Overall Study|Adverse Event|11|||
164249916|NCT00576628|593282064|FG000|Overall Study|Death|2|||
164249917|NCT00576628|593282064|FG000|Overall Study|Failure to return|1|||
164249918|NCT00576628|593282064|FG000|Overall Study|Refused Treatment|8|||
164249919|NCT00576628|593282064|FG000|Overall Study|Pregnancy|1|||
164249920|NCT00576628|593282064|FG000|Overall Study|RBC transfusion|1|||
164249921|NCT00576628|593282064|FG000|Overall Study|Progression of Kidney Disease|1|||
164249922|NCT00576628|593282064|FG000|Overall Study|Progression of Renal Failure|1|||
164249923|NCT00576628|593282064|FG000|Overall Study|The patient move into other town|1|||
164249924|NCT00576628|593282064|FG000|Overall Study|Transplantation|1|||
164249925|NCT00576628|593282064|FG000|Overall Study|Dialysis|15|||
164249926|NCT02789345|593282075|FG000|Overall Study|Adverse Event|0|||
164249927|NCT02789345|593282076|FG001|Overall Study|Adverse Event|0|||
164249928|NCT02789345|593282077|FG002|Overall Study|Adverse Event|1|||
164249929|NCT02789345|593282075|FG000|Overall Study|Death|0|||
164249930|NCT02789345|593282076|FG001|Overall Study|Death|0|||
164249931|NCT02789345|593282077|FG002|Overall Study|Death|1|||
164426865|NCT01544582|593930899|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
164575399|NCT02305563|594469882|FG001|Treatment Period|Poor/non-compliance|0|||
164575400|NCT02305563|594469883|FG002|Treatment Period|Poor/non-compliance|0|||
164249932|NCT02789345|593282075|FG000|Overall Study|Physician Decision|2|||
164249933|NCT02789345|593282076|FG001|Overall Study|Physician Decision|0|||
164249934|NCT02789345|593282077|FG002|Overall Study|Physician Decision|1|||
164249935|NCT02789345|593282075|FG000|Overall Study|Progressive Disease|1|||
164249936|NCT02789345|593282076|FG001|Overall Study|Progressive Disease|3|||
164249937|NCT02789345|593282077|FG002|Overall Study|Progressive Disease|14|||
164249938|NCT01709110|593282078|FG000|Overall Study|Adverse Event|56|||
164249939|NCT01709110|593282079|FG001|Overall Study|Adverse Event|48|||
164249940|NCT01709110|593282078|FG000|Overall Study|Death|14|||
164249941|NCT01709110|593282079|FG001|Overall Study|Death|6|||
164249942|NCT01709110|593282078|FG000|Overall Study|Lost to Follow-up|7|||
164249943|NCT01709110|593282079|FG001|Overall Study|Lost to Follow-up|5|||
164249944|NCT01709110|593282078|FG000|Overall Study|Protocol Violation|4|||
164249945|NCT01709110|593282079|FG001|Overall Study|Protocol Violation|6|||
164249946|NCT01709110|593282078|FG000|Overall Study|Withdrawal by Subject|96|||
164679940|NCT02997176|594854436|FG003|Overall Study|Withdrawal by Subject|1|||
164679941|NCT05511935|594854437|FG000|Overall Study|Lost to Follow-up|9|||
164679942|NCT05511935|594854438|FG001|Overall Study|Lost to Follow-up|27|||
164679943|NCT04523480|594854439|FG000|Overall Study|Lost to Follow-up|30|||
164679944|NCT04523480|594854440|FG001|Overall Study|Lost to Follow-up|35|||
164679945|NCT04523480|594854441|FG002|Overall Study|Lost to Follow-up|0|||
164679946|NCT04102345|594854442|FG000|Overall Study|Withdrawal by Subject|1|||
164679947|NCT04102345|594854443|FG001|Overall Study|Withdrawal by Subject|0|||
164679948|NCT01015287|594854446|FG000|Overall Study|Death|21|||
164679949|NCT01015287|594854447|FG001|Overall Study|Death|16|||
164679950|NCT01015287|594854446|FG000|Overall Study|Adverse Event|1|||
164679951|NCT01015287|594854447|FG001|Overall Study|Adverse Event|0|||
164679952|NCT01015287|594854446|FG000|Overall Study|Sponsor Decision|3|||
164679953|NCT01015287|594854447|FG001|Overall Study|Sponsor Decision|7|||
164679954|NCT01015287|594854446|FG000|Overall Study|Physician Decision|19|||
164679955|NCT01015287|594854447|FG001|Overall Study|Physician Decision|21|||
164679956|NCT01015287|594854446|FG000|Overall Study|Withdrawal by Subject|14|||
164679957|NCT01015287|594854447|FG001|Overall Study|Withdrawal by Subject|19|||
164679958|NCT01015287|594854446|FG000|Overall Study|Entry Criteria not Met|11|||
164679959|NCT01015287|594854447|FG001|Overall Study|Entry Criteria not Met|14|||
164679960|NCT01015287|594854446|FG000|Overall Study|Lost to Follow-up|2|||
164679961|NCT01015287|594854447|FG001|Overall Study|Lost to Follow-up|1|||
164679962|NCT01015287|594854446|FG000|Overall Study|Protocol Violation|1|||
164679963|NCT01015287|594854447|FG001|Overall Study|Protocol Violation|1|||
164679964|NCT01592240|594854448|FG000|Overall Study|Adverse Event|1|||
164679965|NCT01592240|594854449|FG001|Overall Study|Adverse Event|0|||
164679966|NCT01592240|594854450|FG002|Overall Study|Adverse Event|0|||
164679967|NCT01592240|594854451|FG003|Overall Study|Adverse Event|1|||
164679968|NCT01592240|594854452|FG004|Overall Study|Adverse Event|1|||
164679969|NCT01592240|594854453|FG005|Overall Study|Adverse Event|0|||
164679970|NCT01592240|594854454|FG006|Overall Study|Adverse Event|0|||
164679971|NCT01592240|594854448|FG000|Overall Study|Death|0|||
164679972|NCT01592240|594854449|FG001|Overall Study|Death|1|||
164679973|NCT01592240|594854450|FG002|Overall Study|Death|0|||
164679974|NCT01592240|594854451|FG003|Overall Study|Death|0|||
164679975|NCT01592240|594854452|FG004|Overall Study|Death|0|||
164679976|NCT01592240|594854453|FG005|Overall Study|Death|0|||
164679977|NCT01592240|594854454|FG006|Overall Study|Death|0|||
164679978|NCT01592240|594854448|FG000|Overall Study|Lost to Follow-up|1|||
164679979|NCT01592240|594854449|FG001|Overall Study|Lost to Follow-up|3|||
164679980|NCT01592240|594854450|FG002|Overall Study|Lost to Follow-up|1|||
164679981|NCT01592240|594854451|FG003|Overall Study|Lost to Follow-up|0|||
164679982|NCT01592240|594854452|FG004|Overall Study|Lost to Follow-up|3|||
164679983|NCT01592240|594854453|FG005|Overall Study|Lost to Follow-up|2|||
164679984|NCT01592240|594854454|FG006|Overall Study|Lost to Follow-up|0|||
164679985|NCT01592240|594854448|FG000|Overall Study|Protocol Violation|0|||
164679986|NCT01592240|594854449|FG001|Overall Study|Protocol Violation|0|||
164679987|NCT01592240|594854450|FG002|Overall Study|Protocol Violation|0|||
164679988|NCT01592240|594854451|FG003|Overall Study|Protocol Violation|0|||
164679989|NCT01592240|594854452|FG004|Overall Study|Protocol Violation|0|||
164679990|NCT01592240|594854453|FG005|Overall Study|Protocol Violation|1|||
164679991|NCT01592240|594854454|FG006|Overall Study|Protocol Violation|0|||
164679992|NCT01592240|594854448|FG000|Overall Study|Withdrawal by Subject|0|||
164679993|NCT01592240|594854449|FG001|Overall Study|Withdrawal by Subject|4|||
164679994|NCT01592240|594854450|FG002|Overall Study|Withdrawal by Subject|4|||
164679995|NCT01592240|594854451|FG003|Overall Study|Withdrawal by Subject|1|||
164679996|NCT01592240|594854452|FG004|Overall Study|Withdrawal by Subject|3|||
164679997|NCT01592240|594854453|FG005|Overall Study|Withdrawal by Subject|0|||
164679998|NCT01592240|594854454|FG006|Overall Study|Withdrawal by Subject|2|||
164679999|NCT01592240|594854448|FG000|Overall Study|Other|0|||
164680000|NCT01592240|594854449|FG001|Overall Study|Other|3|||
164680001|NCT01592240|594854450|FG002|Overall Study|Other|1|||
164680002|NCT01592240|594854451|FG003|Overall Study|Other|1|||
164680003|NCT01592240|594854452|FG004|Overall Study|Other|0|||
164680004|NCT01592240|594854453|FG005|Overall Study|Other|0|||
164680005|NCT01592240|594854454|FG006|Overall Study|Other|1|||
164680006|NCT01592240|594854448|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
164680007|NCT01592240|594854449|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
164680008|NCT01592240|594854450|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
164680009|NCT01592240|594854451|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
164680010|NCT01592240|594854452|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
164680011|NCT01592240|594854453|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
164680012|NCT01592240|594854454|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
164680013|NCT01117623|594854455|FG000|Overall Study|Adverse Event|0|||
164680014|NCT01117623|594854456|FG001|Overall Study|Adverse Event|2|||
164680015|NCT01117623|594854457|FG002|Overall Study|Adverse Event|4|||
164680016|NCT01117623|594854458|FG003|Overall Study|Adverse Event|0|||
164680017|NCT01117623|594854459|FG004|Overall Study|Adverse Event|2|||
164680018|NCT01117623|594854460|FG005|Overall Study|Adverse Event|0|||
164249947|NCT01709110|593282079|FG001|Overall Study|Withdrawal by Subject|89|||
164249948|NCT01709110|593282078|FG000|Overall Study|Physician Decision|4|||
164249949|NCT01709110|593282079|FG001|Overall Study|Physician Decision|10|||
164249950|NCT01709110|593282078|FG000|Overall Study|Sponsor Decision|2|||
164249951|NCT01709110|593282079|FG001|Overall Study|Sponsor Decision|2|||
164249952|NCT01709110|593282078|FG000|Overall Study|Lack of Efficacy|1|||
164249953|NCT01709110|593282079|FG001|Overall Study|Lack of Efficacy|1|||
164249954|NCT01709110|593282078|FG000|Overall Study|Caregiver Decision|1|||
164249955|NCT01709110|593282079|FG001|Overall Study|Caregiver Decision|1|||
164249956|NCT03286543|593282080|FG000|Consented|Screen failure before randomization|2|||
164249957|NCT03286543|593282081|FG001|Consented|Screen failure before randomization|0|||
164249958|NCT03286543|593282082|FG002|Consented|Screen failure before randomization|0|||
164249959|NCT03286543|593282080|FG000|Consented|Screen failure before enrollment|4|||
164249960|NCT03286543|593282081|FG001|Consented|Screen failure before enrollment|0|||
164249961|NCT03286543|593282082|FG002|Consented|Screen failure before enrollment|0|||
164249962|NCT03286543|593282080|FG000|Consented|TKA cancelled after enrollment|1|||
164249963|NCT03286543|593282081|FG001|Consented|TKA cancelled after enrollment|0|||
164249964|NCT03286543|593282082|FG002|Consented|TKA cancelled after enrollment|0|||
164249965|NCT03286543|593282080|FG000|Consented|Withdrawn from study|12|||
164249966|NCT03286543|593282081|FG001|Consented|Withdrawn from study|0|||
164575401|NCT02305563|594469884|FG003|Treatment Period|Poor/non-compliance|0|||
164575402|NCT02305563|594469885|FG004|Treatment Period|Poor/non-compliance|1|||
164575403|NCT02305563|594469881|FG000|Treatment Period|Administrative reason by Sponsor|0|||
164575404|NCT02305563|594469882|FG001|Treatment Period|Administrative reason by Sponsor|0|||
164575405|NCT02305563|594469883|FG002|Treatment Period|Administrative reason by Sponsor|0|||
164575406|NCT02305563|594469884|FG003|Treatment Period|Administrative reason by Sponsor|0|||
164575407|NCT02305563|594469885|FG004|Treatment Period|Administrative reason by Sponsor|1|||
164575408|NCT02305563|594469881|FG000|Treatment Period|other reason|2|||
164575409|NCT02305563|594469882|FG001|Treatment Period|other reason|0|||
164575410|NCT02305563|594469883|FG002|Treatment Period|other reason|2|||
164575411|NCT02305563|594469884|FG003|Treatment Period|other reason|2|||
164575412|NCT02305563|594469885|FG004|Treatment Period|other reason|1|||
164575413|NCT02305563|594469881|FG000|Treatment Period|Randomized but not treated|0|||
164575414|NCT02305563|594469882|FG001|Treatment Period|Randomized but not treated|0|||
164575415|NCT02305563|594469883|FG002|Treatment Period|Randomized but not treated|0|||
164575416|NCT02305563|594469884|FG003|Treatment Period|Randomized but not treated|0|||
164575417|NCT02305563|594469885|FG004|Treatment Period|Randomized but not treated|2|||
164575418|NCT02305563|594469881|FG000|Treatment Period|added ULO, then disease progression|0|||
164575419|NCT02305563|594469882|FG001|Treatment Period|added ULO, then disease progression|0|||
164575420|NCT02305563|594469883|FG002|Treatment Period|added ULO, then disease progression|0|||
164575421|NCT02305563|594469884|FG003|Treatment Period|added ULO, then disease progression|0|||
164575422|NCT02305563|594469885|FG004|Treatment Period|added ULO, then disease progression|4|||
164575423|NCT02305563|594469881|FG000|Treatment Period|added ULO; then other reason|0|||
164575424|NCT02305563|594469882|FG001|Treatment Period|added ULO; then other reason|0|||
164575425|NCT02305563|594469883|FG002|Treatment Period|added ULO; then other reason|0|||
164575426|NCT02305563|594469884|FG003|Treatment Period|added ULO; then other reason|0|||
164575427|NCT02305563|594469885|FG004|Treatment Period|added ULO; then other reason|1|||
164575428|NCT02305563|594469881|FG000|Treatment Period|added ULO, then request to stop|0|||
164575429|NCT02305563|594469882|FG001|Treatment Period|added ULO, then request to stop|0|||
164575430|NCT02305563|594469883|FG002|Treatment Period|added ULO, then request to stop|0|||
164575431|NCT02305563|594469884|FG003|Treatment Period|added ULO, then request to stop|0|||
164575432|NCT02305563|594469885|FG004|Treatment Period|added ULO, then request to stop|1|||
164575433|NCT02305563|594469881|FG000|Follow-up Period|Death|0|||
164575434|NCT02305563|594469882|FG001|Follow-up Period|Death|0|||
164575435|NCT02305563|594469883|FG002|Follow-up Period|Death|5|||
164575436|NCT02305563|594469884|FG003|Follow-up Period|Death|4|||
164575437|NCT02305563|594469885|FG004|Follow-up Period|Death|7|||
164575438|NCT02305563|594469881|FG000|Follow-up Period|Participant withdrew consent|0|||
164575439|NCT02305563|594469882|FG001|Follow-up Period|Participant withdrew consent|0|||
164575440|NCT02305563|594469883|FG002|Follow-up Period|Participant withdrew consent|2|||
164575441|NCT02305563|594469884|FG003|Follow-up Period|Participant withdrew consent|1|||
164575442|NCT02305563|594469885|FG004|Follow-up Period|Participant withdrew consent|0|||
164575443|NCT02305563|594469881|FG000|Follow-up Period|other reason|0|||
164249967|NCT03286543|593282082|FG002|Consented|Withdrawn from study|0|||
164249968|NCT03286543|593282080|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
164249969|NCT03286543|593282081|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
164575444|NCT02305563|594469882|FG001|Follow-up Period|other reason|0|||
164575445|NCT02305563|594469883|FG002|Follow-up Period|other reason|0|||
164575446|NCT02305563|594469884|FG003|Follow-up Period|other reason|0|||
164575447|NCT02305563|594469885|FG004|Follow-up Period|other reason|1|||
164575448|NCT02305563|594469881|FG000|Follow-up Period|Followup no longer required per protocol|3|||
164575449|NCT02305563|594469882|FG001|Follow-up Period|Followup no longer required per protocol|3|||
164575450|NCT02305563|594469883|FG002|Follow-up Period|Followup no longer required per protocol|4|||
164249970|NCT03286543|593282082|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
164249971|NCT03286543|593282080|FG000|Study Enrollment|Withdrawn from study|0|||
164249972|NCT03286543|593282081|FG001|Study Enrollment|Withdrawn from study|6|||
164249973|NCT03286543|593282082|FG002|Study Enrollment|Withdrawn from study|6|||
164249974|NCT02836717|593282084|FG000|Test Phase|Lack of Efficacy|14|||
164249975|NCT02836717|593282085|FG001|Test Phase|Lack of Efficacy|8|||
164249976|NCT02836717|593282086|FG002|Test Phase|Lack of Efficacy|0|||
164249977|NCT02836717|593282084|FG000|Study Phase|Adverse Event|2|||
164249978|NCT02836717|593282085|FG001|Study Phase|Adverse Event|0|||
164249979|NCT02836717|593282086|FG002|Study Phase|Adverse Event|0|||
164249980|NCT02836717|593282084|FG000|Study Phase|Lack of Efficacy|8|||
164249981|NCT02836717|593282085|FG001|Study Phase|Lack of Efficacy|6|||
164249982|NCT02836717|593282086|FG002|Study Phase|Lack of Efficacy|1|||
164249983|NCT02836717|593282084|FG000|Study Phase|Withdrawal by Subject|1|||
164249984|NCT02836717|593282085|FG001|Study Phase|Withdrawal by Subject|0|||
164249985|NCT02836717|593282086|FG002|Study Phase|Withdrawal by Subject|0|||
164249986|NCT02836717|593282084|FG000|Study Phase|Death|1|||
164249987|NCT02836717|593282085|FG001|Study Phase|Death|0|||
164249988|NCT02836717|593282086|FG002|Study Phase|Death|0|||
164249989|NCT02836717|593282084|FG000|Study Phase|abdominal surgeries|2|||
164249990|NCT02836717|593282085|FG001|Study Phase|abdominal surgeries|1|||
164249991|NCT02836717|593282086|FG002|Study Phase|abdominal surgeries|0|||
164249992|NCT00104416|593282087|FG000|Double-Blind Phase|Adverse Event|2|||
164249993|NCT00104416|593282088|FG001|Double-Blind Phase|Adverse Event|1|||
164249994|NCT00104416|593282089|FG002|Double-Blind Phase|Adverse Event|0|||
164249995|NCT00104416|593282090|FG003|Double-Blind Phase|Adverse Event|0|||
164249996|NCT00104416|593282091|FG004|Double-Blind Phase|Adverse Event|0|||
164249997|NCT00104416|593282087|FG000|Double-Blind Phase|Lost to Follow-up|0|||
164249998|NCT00104416|593282088|FG001|Double-Blind Phase|Lost to Follow-up|1|||
164249999|NCT00104416|593282089|FG002|Double-Blind Phase|Lost to Follow-up|0|||
164250000|NCT00104416|593282090|FG003|Double-Blind Phase|Lost to Follow-up|0|||
164250001|NCT00104416|593282091|FG004|Double-Blind Phase|Lost to Follow-up|0|||
164250002|NCT00104416|593282087|FG000|Double-Blind Phase|Protocol Violation|0|||
164250003|NCT00104416|593282088|FG001|Double-Blind Phase|Protocol Violation|1|||
164250004|NCT00104416|593282089|FG002|Double-Blind Phase|Protocol Violation|0|||
164250005|NCT00104416|593282090|FG003|Double-Blind Phase|Protocol Violation|0|||
164250006|NCT00104416|593282091|FG004|Double-Blind Phase|Protocol Violation|0|||
164250007|NCT00104416|593282087|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
164250008|NCT00104416|593282088|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
164250009|NCT00104416|593282089|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
164250010|NCT00104416|593282090|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
164250011|NCT00104416|593282091|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
164250012|NCT00104416|593282087|FG000|Double-Blind Phase|Pregnancy|1|||
164250013|NCT00104416|593282088|FG001|Double-Blind Phase|Pregnancy|0|||
164250014|NCT00104416|593282089|FG002|Double-Blind Phase|Pregnancy|0|||
164250015|NCT00104416|593282090|FG003|Double-Blind Phase|Pregnancy|0|||
164250016|NCT00104416|593282091|FG004|Double-Blind Phase|Pregnancy|0|||
164250017|NCT00104416|593282087|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
164250018|NCT00104416|593282088|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
164250019|NCT00104416|593282089|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
164250020|NCT00104416|593282090|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
164250021|NCT00104416|593282091|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
164250022|NCT00104416|593282087|FG000|Continuation Phase|Adverse Event|0|||
164250023|NCT00104416|593282088|FG001|Continuation Phase|Adverse Event|0|||
164250024|NCT00104416|593282089|FG002|Continuation Phase|Adverse Event|2|||
164250025|NCT00104416|593282090|FG003|Continuation Phase|Adverse Event|0|||
164250026|NCT00104416|593282091|FG004|Continuation Phase|Adverse Event|2|||
164250027|NCT00104416|593282087|FG000|Continuation Phase|Lost to Follow-up|0|||
164250028|NCT00104416|593282088|FG001|Continuation Phase|Lost to Follow-up|0|||
164250029|NCT00104416|593282089|FG002|Continuation Phase|Lost to Follow-up|1|||
164250030|NCT00104416|593282090|FG003|Continuation Phase|Lost to Follow-up|0|||
164250031|NCT00104416|593282091|FG004|Continuation Phase|Lost to Follow-up|1|||
164250032|NCT00104416|593282087|FG000|Continuation Phase|Withdrawal by Subject|0|||
164250033|NCT00104416|593282088|FG001|Continuation Phase|Withdrawal by Subject|0|||
164250034|NCT00104416|593282089|FG002|Continuation Phase|Withdrawal by Subject|2|||
164250035|NCT00104416|593282090|FG003|Continuation Phase|Withdrawal by Subject|1|||
164250036|NCT00104416|593282091|FG004|Continuation Phase|Withdrawal by Subject|1|||
164250037|NCT00104416|593282087|FG000|Continuation Phase|Pregnancy|0|||
164250038|NCT00104416|593282088|FG001|Continuation Phase|Pregnancy|0|||
164250039|NCT00104416|593282089|FG002|Continuation Phase|Pregnancy|1|||
164250040|NCT00104416|593282090|FG003|Continuation Phase|Pregnancy|1|||
164250041|NCT00104416|593282091|FG004|Continuation Phase|Pregnancy|0|||
164250042|NCT00104416|593282087|FG000|Continuation Phase|Non-compliance|0|||
164250043|NCT00104416|593282088|FG001|Continuation Phase|Non-compliance|0|||
164250044|NCT00104416|593282089|FG002|Continuation Phase|Non-compliance|0|||
164250045|NCT00104416|593282090|FG003|Continuation Phase|Non-compliance|0|||
164250046|NCT00104416|593282091|FG004|Continuation Phase|Non-compliance|1|||
164250047|NCT00438360|593282092|FG000|Overall Study|Adverse Event|6|||
164250048|NCT00438360|593282093|FG001|Overall Study|Adverse Event|1|||
164250049|NCT00438360|593282092|FG000|Overall Study|Lack of Efficacy|42|||
164250050|NCT00438360|593282093|FG001|Overall Study|Lack of Efficacy|27|||
164250051|NCT00438360|593282092|FG000|Overall Study|Other|24|||
164250052|NCT00438360|593282093|FG001|Overall Study|Other|15|||
164250053|NCT00070109|593282094|FG000|Overall Study|Death|1|||
164250054|NCT00070109|593282095|FG001|Overall Study|Death|1|||
164250055|NCT00070109|593282096|FG002|Overall Study|Death|0|||
164250056|NCT00070109|593282097|FG003|Overall Study|Death|0|||
164250057|NCT00070109|593282098|FG004|Overall Study|Death|1|||
164250058|NCT00070109|593282094|FG000|Overall Study|Lack of Efficacy|6|||
164250059|NCT00070109|593282095|FG001|Overall Study|Lack of Efficacy|4|||
164250060|NCT00070109|593282096|FG002|Overall Study|Lack of Efficacy|5|||
164250061|NCT00070109|593282097|FG003|Overall Study|Lack of Efficacy|15|||
164250062|NCT00070109|593282098|FG004|Overall Study|Lack of Efficacy|5|||
164250063|NCT00070109|593282094|FG000|Overall Study|Physician Decision|1|||
164250064|NCT00070109|593282095|FG001|Overall Study|Physician Decision|0|||
164250065|NCT00070109|593282096|FG002|Overall Study|Physician Decision|0|||
164250066|NCT00070109|593282097|FG003|Overall Study|Physician Decision|0|||
164250067|NCT00070109|593282098|FG004|Overall Study|Physician Decision|0|||
164250068|NCT00070109|593282094|FG000|Overall Study|Withdrawal by Subject|0|||
164250069|NCT00070109|593282095|FG001|Overall Study|Withdrawal by Subject|1|||
164250070|NCT00070109|593282096|FG002|Overall Study|Withdrawal by Subject|1|||
164250071|NCT00070109|593282097|FG003|Overall Study|Withdrawal by Subject|0|||
164250072|NCT00070109|593282098|FG004|Overall Study|Withdrawal by Subject|0|||
164250073|NCT00070109|593282094|FG000|Overall Study|Adverse Event|0|||
164250074|NCT00070109|593282095|FG001|Overall Study|Adverse Event|0|||
164250075|NCT00070109|593282096|FG002|Overall Study|Adverse Event|2|||
164250076|NCT00070109|593282097|FG003|Overall Study|Adverse Event|4|||
164250077|NCT00070109|593282098|FG004|Overall Study|Adverse Event|2|||
164250078|NCT00070109|593282094|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
164250079|NCT00070109|593282095|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
164250080|NCT00070109|593282096|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
164250081|NCT00070109|593282097|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
164250082|NCT00070109|593282098|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
164250083|NCT01164891|593282109|FG000|Overall Study|Disease Progression|5|||
164250084|NCT01164891|593282109|FG000|Overall Study|Adverse Event|1|||
164250085|NCT00441142|593282110|FG000|Overall Study|Adverse Event|2|||
164250086|NCT00441142|593282111|FG001|Overall Study|Adverse Event|3|||
164250087|NCT00441142|593282112|FG002|Overall Study|Adverse Event|3|||
164250088|NCT00441142|593282113|FG003|Overall Study|Adverse Event|22|||
164250089|NCT00441142|593282110|FG000|Overall Study|Lack of Efficacy|3|||
164250090|NCT00441142|593282111|FG001|Overall Study|Lack of Efficacy|3|||
164250091|NCT00441142|593282112|FG002|Overall Study|Lack of Efficacy|17|||
164250092|NCT00441142|593282113|FG003|Overall Study|Lack of Efficacy|32|||
164250093|NCT00441142|593282110|FG000|Overall Study|Withdrawal by Subject|0|||
164250094|NCT00441142|593282111|FG001|Overall Study|Withdrawal by Subject|0|||
164250095|NCT00441142|593282112|FG002|Overall Study|Withdrawal by Subject|2|||
164250096|NCT00441142|593282113|FG003|Overall Study|Withdrawal by Subject|10|||
164250097|NCT00441142|593282110|FG000|Overall Study|Patient still receiving active study tx|1|||
164250098|NCT00441142|593282111|FG001|Overall Study|Patient still receiving active study tx|0|||
164250099|NCT00441142|593282112|FG002|Overall Study|Patient still receiving active study tx|0|||
164250100|NCT00441142|593282113|FG003|Overall Study|Patient still receiving active study tx|2|||
164250101|NCT00441142|593282110|FG000|Overall Study|Physician Decision|0|||
164250102|NCT00441142|593282111|FG001|Overall Study|Physician Decision|1|||
164250103|NCT00441142|593282112|FG002|Overall Study|Physician Decision|0|||
164250104|NCT00441142|593282113|FG003|Overall Study|Physician Decision|1|||
164575451|NCT02305563|594469884|FG003|Follow-up Period|Followup no longer required per protocol|1|||
164575452|NCT02305563|594469885|FG004|Follow-up Period|Followup no longer required per protocol|4|||
164575453|NCT02370121|594469887|FG000|Overall Study|Lost to Follow-up|1|||
164575454|NCT02370121|594469888|FG001|Overall Study|Lost to Follow-up|1|||
164575455|NCT02654002|594469895|FG000|Overall Study|Adverse Event|0|||
164250105|NCT00441142|593282110|FG000|Overall Study|Death|0|||
164575456|NCT02654002|594469896|FG001|Overall Study|Adverse Event|0|||
164575457|NCT02654002|594469897|FG002|Overall Study|Adverse Event|0|||
164575458|NCT02654002|594469898|FG003|Overall Study|Adverse Event|0|||
164575459|NCT02654002|594469899|FG004|Overall Study|Adverse Event|0|||
164575460|NCT02654002|594469900|FG005|Overall Study|Adverse Event|0|||
164250106|NCT00441142|593282111|FG001|Overall Study|Death|0|||
164250107|NCT00441142|593282112|FG002|Overall Study|Death|0|||
164250108|NCT00441142|593282113|FG003|Overall Study|Death|1|||
164250109|NCT00338286|593282114|FG000|Overall Study|Withdrawal by Subject|50|||
164250110|NCT00338286|593282115|FG001|Overall Study|Withdrawal by Subject|54|||
164575461|NCT02654002|594469901|FG006|Overall Study|Adverse Event|1|||
164575462|NCT02654002|594469902|FG007|Overall Study|Adverse Event|0|||
164575463|NCT02654002|594469903|FG008|Overall Study|Adverse Event|0|||
164250111|NCT00338286|593282114|FG000|Overall Study|Lost to Follow-up|80|||
164250112|NCT00338286|593282115|FG001|Overall Study|Lost to Follow-up|66|||
164250113|NCT00338286|593282114|FG000|Overall Study|Other|103|||
164575464|NCT02654002|594469895|FG000|Overall Study|Withdrew Consent|0|||
164575465|NCT02654002|594469896|FG001|Overall Study|Withdrew Consent|0|||
164250114|NCT00338286|593282115|FG001|Overall Study|Other|93|||
164250115|NCT00022763|593282116|FG000|Overall Study|Adverse Event|1|||
164250116|NCT00022763|593282117|FG001|Overall Study|Adverse Event|2|||
164250117|NCT00022763|593282116|FG000|Overall Study|Injection Site Reactions|0|||
164250118|NCT00022763|593282117|FG001|Overall Study|Injection Site Reactions|2|||
164250119|NCT00022763|593282116|FG000|Overall Study|Death|0|||
164250120|NCT00022763|593282117|FG001|Overall Study|Death|1|||
164250121|NCT00022763|593282116|FG000|Overall Study|Lost to Follow-up|0|||
164250122|NCT00022763|593282117|FG001|Overall Study|Lost to Follow-up|3|||
164250123|NCT00022763|593282116|FG000|Overall Study|Withdrawal by Subject|4|||
164250124|NCT00022763|593282117|FG001|Overall Study|Withdrawal by Subject|7|||
164250125|NCT00022763|593282116|FG000|Overall Study|Insufficient Therapy|1|||
164250126|NCT00022763|593282117|FG001|Overall Study|Insufficient Therapy|0|||
164250127|NCT00022763|593282116|FG000|Overall Study|Admin|3|||
164250128|NCT00022763|593282117|FG001|Overall Study|Admin|2|||
164250129|NCT03248531|593282118|FG000|Overall Study|Adverse Event|0|||
164250130|NCT03248531|593282119|FG001|Overall Study|Adverse Event|0|||
164250131|NCT03248531|593282120|FG002|Overall Study|Adverse Event|1|||
164250132|NCT03248531|593282118|FG000|Overall Study|Lost to Follow-up|1|||
164250133|NCT03248531|593282119|FG001|Overall Study|Lost to Follow-up|0|||
164250134|NCT03248531|593282120|FG002|Overall Study|Lost to Follow-up|5|||
164250135|NCT03248531|593282118|FG000|Overall Study|Withdrawal by Subject|3|||
164250136|NCT03248531|593282119|FG001|Overall Study|Withdrawal by Subject|3|||
164250137|NCT03248531|593282120|FG002|Overall Study|Withdrawal by Subject|2|||
164250138|NCT03248531|593282118|FG000|Overall Study|Sponsor Request|0|||
164250139|NCT03248531|593282119|FG001|Overall Study|Sponsor Request|2|||
164250140|NCT03248531|593282120|FG002|Overall Study|Sponsor Request|0|||
164250141|NCT04908865|593282121|FG000|Overall Study|Adverse Event|2|||
164250142|NCT04908865|593282121|FG000|Overall Study|Lack of Efficacy|5|||
164250143|NCT04908865|593282121|FG000|Overall Study|Lost to Follow-up|1|||
164250144|NCT05286658|593282122|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
164250145|NCT05286658|593282122|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
164250146|NCT00470262|593282123|FG000|Overall Study|Withdrawal by Subject|2|||
164250147|NCT00470262|593282124|FG001|Overall Study|Withdrawal by Subject|0|||
164250148|NCT00851552|593282127|FG000|Overall Study|Death|2|||
164250149|NCT00851552|593282127|FG000|Overall Study|Adverse Event|1|||
164250150|NCT00851552|593282127|FG000|Overall Study|Disease Progression|4|||
164250151|NCT01558596|593282130|FG000|Overall Study|Withdrawal by Subject|1|||
164250152|NCT01558596|593282131|FG001|Overall Study|Withdrawal by Subject|0|||
164250153|NCT01558596|593282130|FG000|Overall Study|surgery elsewhere or cancelled|1|||
164250154|NCT01558596|593282131|FG001|Overall Study|surgery elsewhere or cancelled|1|||
164250155|NCT01558596|593282130|FG000|Overall Study|Protocol Violation|1|||
164250156|NCT01558596|593282131|FG001|Overall Study|Protocol Violation|0|||
164250157|NCT01437111|593282132|FG000|Overall Study|Adverse Event|2|||
164250158|NCT01437111|593282132|FG000|Overall Study|Withdrawal by Subject|4|||
164250159|NCT01437111|593282132|FG000|Overall Study|Not reported|5|||
164250160|NCT01437111|593282132|FG000|Overall Study|Physician Decision|1|||
164250161|NCT01437111|593282132|FG000|Overall Study|Lost to Follow-up|5|||
164250162|NCT01437111|593282132|FG000|Overall Study|Protocol Violation|1|||
164250163|NCT02473471|593282134|FG000|Overall Study|poor oral hygiene|2|||
164250164|NCT02473471|593282134|FG000|Overall Study|Lost to Follow-up|1|||
164250165|NCT01667133|593282135|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
164250166|NCT01667133|593282136|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
164250167|NCT01667133|593282137|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
164250168|NCT01667133|593282138|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
164250169|NCT01667133|593282139|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
164250170|NCT01667133|593282140|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
164250171|NCT01667133|593282141|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
164250172|NCT01667133|593282142|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
164250173|NCT01667133|593282143|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
164250174|NCT01667133|593282144|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
164250175|NCT01667133|593282145|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
164250176|NCT01667133|593282146|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
164575466|NCT02654002|594469897|FG002|Overall Study|Withdrew Consent|0|||
164575467|NCT02654002|594469898|FG003|Overall Study|Withdrew Consent|0|||
164250177|NCT01667133|593282135|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
164250178|NCT01667133|593282136|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
164575468|NCT02654002|594469899|FG004|Overall Study|Withdrew Consent|0|||
164575469|NCT02654002|594469900|FG005|Overall Study|Withdrew Consent|1|||
164250179|NCT01667133|593282137|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
164250180|NCT01667133|593282138|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
164250181|NCT01667133|593282139|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
164250182|NCT01667133|593282140|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
164250183|NCT01667133|593282141|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
164250184|NCT01667133|593282142|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
164250185|NCT01667133|593282143|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
164575470|NCT02654002|594469901|FG006|Overall Study|Withdrew Consent|0|||
164250186|NCT01667133|593282144|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
164250187|NCT01667133|593282145|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
164250188|NCT01667133|593282146|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
164250189|NCT01667133|593282135|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
164250190|NCT01667133|593282136|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
164250191|NCT01667133|593282137|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
164250192|NCT01667133|593282138|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
164250193|NCT01667133|593282139|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
164250194|NCT01667133|593282140|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
164250195|NCT01667133|593282141|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
164250196|NCT01667133|593282142|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
164250197|NCT01667133|593282143|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
164250198|NCT01667133|593282144|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
164250199|NCT01667133|593282145|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
164250200|NCT01667133|593282146|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
164250201|NCT01667133|593282135|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
164250202|NCT01667133|593282136|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
164250203|NCT01667133|593282137|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
164250204|NCT01667133|593282138|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
164250205|NCT01667133|593282139|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
164250206|NCT01667133|593282140|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
164250207|NCT01667133|593282141|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
164250208|NCT01667133|593282142|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
164250209|NCT01667133|593282143|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
164250210|NCT01667133|593282144|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
164250211|NCT01667133|593282145|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
164250212|NCT01667133|593282146|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
164250213|NCT01667133|593282135|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
164250214|NCT01667133|593282136|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
164250215|NCT01667133|593282137|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
164250216|NCT01667133|593282138|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
164250217|NCT01667133|593282139|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
164250218|NCT01667133|593282140|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
164250219|NCT01667133|593282141|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
164250220|NCT01667133|593282142|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
164575471|NCT02654002|594469902|FG007|Overall Study|Withdrew Consent|1|||
164575472|NCT02654002|594469903|FG008|Overall Study|Withdrew Consent|0|||
164575473|NCT05262764|594469907|FG000|Overall Study|Case report form not collected|9|||
164575474|NCT05262764|594469907|FG000|Overall Study|No patient visits after entry|23|||
164575475|NCT05262764|594469907|FG000|Overall Study|Registration rule not followed|2|||
164575476|NCT05262764|594469907|FG000|Overall Study|Patient of non-chronic heart failure|1|||
164575477|NCT00275561|594469908|FG000|Overall Study|Withdrawal by Subject|0|||
164575478|NCT00275561|594469909|FG001|Overall Study|Withdrawal by Subject|1|||
164575479|NCT00275561|594469908|FG000|Overall Study|Travel|1|||
164575480|NCT00275561|594469909|FG001|Overall Study|Travel|1|||
164575481|NCT00275561|594469908|FG000|Overall Study|Scheduling|1|||
164575482|NCT00275561|594469909|FG001|Overall Study|Scheduling|2|||
164575483|NCT00275561|594469908|FG000|Overall Study|Family Issues|0|||
164575484|NCT00275561|594469909|FG001|Overall Study|Family Issues|2|||
164575485|NCT01769105|594469910|FG000|First Intervention|Protocol Violation|2|||
164575486|NCT01769105|594469911|FG001|First Intervention|Protocol Violation|2|||
164575487|NCT01769105|594469910|FG000|Cross-over|Lost to Follow-up|5|||
164575488|NCT01769105|594469911|FG001|Cross-over|Lost to Follow-up|0|||
164575489|NCT00684177|594469916|FG000|Overall Study|Adverse Event|4|||
164575490|NCT00684177|594469917|FG001|Overall Study|Adverse Event|3|||
164575491|NCT00684177|594469916|FG000|Overall Study|Lack of Efficacy|10|||
164575492|NCT00684177|594469917|FG001|Overall Study|Lack of Efficacy|15|||
164575493|NCT00684177|594469916|FG000|Overall Study|Protocol Violation|1|||
164575494|NCT00684177|594469917|FG001|Overall Study|Protocol Violation|0|||
164575495|NCT00684177|594469916|FG000|Overall Study|Lost to Follow-up|2|||
164575496|NCT00684177|594469917|FG001|Overall Study|Lost to Follow-up|1|||
164575497|NCT00684177|594469916|FG000|Overall Study|Physician Decision|2|||
164575498|NCT00684177|594469917|FG001|Overall Study|Physician Decision|0|||
164575499|NCT00684177|594469916|FG000|Overall Study|Withdrawal by Subject|1|||
164250221|NCT01667133|593282143|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
164250222|NCT01667133|593282144|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
164575500|NCT00684177|594469917|FG001|Overall Study|Withdrawal by Subject|2|||
164575501|NCT00684177|594469916|FG000|Overall Study|Other|1|||
164575502|NCT00684177|594469917|FG001|Overall Study|Other|2|||
164575503|NCT03263091|594471684|FG000|OL Component|Withdrawal by Subject|1|||
164575504|NCT03263091|594471685|FG001|OL Component|Withdrawal by Subject|1|||
164575505|NCT03263091|594471686|FG002|OL Component|Withdrawal by Subject|0|||
164575506|NCT03263091|594471687|FG003|OL Component|Withdrawal by Subject|0|||
164250223|NCT01667133|593282145|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
164250224|NCT01667133|593282146|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
164250225|NCT01667133|593282135|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
164250226|NCT01667133|593282136|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
164250227|NCT01667133|593282137|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
164250228|NCT01667133|593282138|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
164250229|NCT01667133|593282139|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
164250230|NCT01667133|593282140|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
164250231|NCT01667133|593282141|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
164250232|NCT01667133|593282142|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
164250233|NCT01667133|593282143|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
164250234|NCT01667133|593282144|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
164250235|NCT01667133|593282145|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
164250236|NCT01667133|593282146|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
164250237|NCT01667133|593282135|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
164250238|NCT01667133|593282136|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
164250239|NCT01667133|593282137|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
164250240|NCT01667133|593282138|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
164250241|NCT01667133|593282139|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
164250242|NCT01667133|593282140|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
164250243|NCT01667133|593282141|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
164250244|NCT01667133|593282142|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
164250245|NCT01667133|593282143|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
164250246|NCT01667133|593282144|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
164250247|NCT01667133|593282145|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
164250248|NCT01667133|593282146|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
164250249|NCT01667133|593282135|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
164250250|NCT01667133|593282136|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
164250251|NCT01667133|593282137|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
164250252|NCT01667133|593282138|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
164250253|NCT01667133|593282139|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
164250254|NCT01667133|593282140|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
164250255|NCT01667133|593282141|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
164250256|NCT01667133|593282142|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
164250257|NCT01667133|593282143|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
164250258|NCT01667133|593282144|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
164250259|NCT01667133|593282145|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
164250260|NCT01667133|593282146|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
164250261|NCT01667133|593282135|FG000|Phase 2: Dose-expansion|Death|0|||
164250262|NCT01667133|593282136|FG001|Phase 2: Dose-expansion|Death|0|||
164250263|NCT01667133|593282137|FG002|Phase 2: Dose-expansion|Death|0|||
164575507|NCT03263091|594471688|FG004|OL Component|Withdrawal by Subject|0|||
164575508|NCT03263091|594471689|FG005|OL Component|Withdrawal by Subject|0|||
164680019|NCT01117623|594854461|FG006|Overall Study|Adverse Event|0|||
164680020|NCT01117623|594854462|FG007|Overall Study|Adverse Event|2|||
164680021|NCT01117623|594854455|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
164680022|NCT01117623|594854456|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
164250264|NCT01667133|593282138|FG003|Phase 2: Dose-expansion|Death|0|||
164250265|NCT01667133|593282139|FG004|Phase 2: Dose-expansion|Death|0|||
164575509|NCT03263091|594471684|FG000|OL Component|Physician Decision|0|||
164575510|NCT03263091|594471685|FG001|OL Component|Physician Decision|1|||
164575511|NCT03263091|594471686|FG002|OL Component|Physician Decision|2|||
164575512|NCT03263091|594471687|FG003|OL Component|Physician Decision|0|||
164575513|NCT03263091|594471688|FG004|OL Component|Physician Decision|0|||
164575514|NCT03263091|594471689|FG005|OL Component|Physician Decision|0|||
164575515|NCT03263091|594471684|FG000|OL Component|Death|1|||
164575516|NCT03263091|594471685|FG001|OL Component|Death|0|||
164575517|NCT03263091|594471686|FG002|OL Component|Death|0|||
164575518|NCT03263091|594471687|FG003|OL Component|Death|0|||
164575519|NCT03263091|594471688|FG004|OL Component|Death|0|||
164250266|NCT01667133|593282140|FG005|Phase 2: Dose-expansion|Death|0|||
164250267|NCT01667133|593282141|FG006|Phase 2: Dose-expansion|Death|0|||
164250268|NCT01667133|593282142|FG007|Phase 2: Dose-expansion|Death|0|||
164250269|NCT01667133|593282143|FG008|Phase 2: Dose-expansion|Death|0|||
164250270|NCT01667133|593282144|FG009|Phase 2: Dose-expansion|Death|1|||
164250271|NCT01667133|593282145|FG010|Phase 2: Dose-expansion|Death|0|||
164250272|NCT01667133|593282146|FG011|Phase 2: Dose-expansion|Death|0|||
164250273|NCT01667133|593282135|FG000|Phase 2: Dose-expansion|Other|0|||
164250274|NCT01667133|593282136|FG001|Phase 2: Dose-expansion|Other|0|||
164250275|NCT01667133|593282137|FG002|Phase 2: Dose-expansion|Other|0|||
164250276|NCT01667133|593282138|FG003|Phase 2: Dose-expansion|Other|0|||
164250277|NCT01667133|593282139|FG004|Phase 2: Dose-expansion|Other|0|||
164575520|NCT03263091|594471689|FG005|OL Component|Death|0|||
164575521|NCT03263091|594471684|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
164575522|NCT03263091|594471685|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
164680023|NCT01117623|594854457|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
164575523|NCT03263091|594471686|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
164575524|NCT03263091|594471687|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
164575525|NCT03263091|594471688|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
164575526|NCT03263091|594471689|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
164575527|NCT03263091|594471684|FG000|OL High-EPO Component|Physician Decision|0|||
164575528|NCT03263091|594471685|FG001|OL High-EPO Component|Physician Decision|0|||
164575529|NCT03263091|594471686|FG002|OL High-EPO Component|Physician Decision|0|||
164575530|NCT03263091|594471687|FG003|OL High-EPO Component|Physician Decision|1|||
164575531|NCT03263091|594471688|FG004|OL High-EPO Component|Physician Decision|0|||
164575532|NCT03263091|594471689|FG005|OL High-EPO Component|Physician Decision|0|||
164575533|NCT03263091|594471684|FG000|OL High-EPO Component|Death|0|||
164575534|NCT03263091|594471685|FG001|OL High-EPO Component|Death|0|||
164575535|NCT03263091|594471686|FG002|OL High-EPO Component|Death|0|||
164575536|NCT03263091|594471687|FG003|OL High-EPO Component|Death|3|||
164575537|NCT03263091|594471688|FG004|OL High-EPO Component|Death|0|||
164575538|NCT03263091|594471689|FG005|OL High-EPO Component|Death|0|||
164575539|NCT03263091|594471684|FG000|DB Component|Withdrawal by Subject|0|||
164575540|NCT03263091|594471685|FG001|DB Component|Withdrawal by Subject|0|||
164575541|NCT03263091|594471686|FG002|DB Component|Withdrawal by Subject|0|||
164575542|NCT03263091|594471687|FG003|DB Component|Withdrawal by Subject|0|||
164575543|NCT03263091|594471688|FG004|DB Component|Withdrawal by Subject|22|||
164575544|NCT03263091|594471689|FG005|DB Component|Withdrawal by Subject|8|||
164575545|NCT03263091|594471684|FG000|DB Component|Physician Decision|0|||
164575546|NCT03263091|594471685|FG001|DB Component|Physician Decision|0|||
164575547|NCT03263091|594471686|FG002|DB Component|Physician Decision|0|||
164575548|NCT03263091|594471687|FG003|DB Component|Physician Decision|0|||
164575549|NCT03263091|594471688|FG004|DB Component|Physician Decision|3|||
164575550|NCT03263091|594471689|FG005|DB Component|Physician Decision|1|||
164575551|NCT03263091|594471684|FG000|DB Component|Adverse Event|0|||
164575552|NCT03263091|594471685|FG001|DB Component|Adverse Event|0|||
164575553|NCT03263091|594471686|FG002|DB Component|Adverse Event|0|||
164250278|NCT01667133|593282140|FG005|Phase 2: Dose-expansion|Other|0|||
164250279|NCT01667133|593282141|FG006|Phase 2: Dose-expansion|Other|0|||
164250280|NCT01667133|593282142|FG007|Phase 2: Dose-expansion|Other|0|||
164250281|NCT01667133|593282143|FG008|Phase 2: Dose-expansion|Other|0|||
164250282|NCT01667133|593282144|FG009|Phase 2: Dose-expansion|Other|0|||
164250283|NCT01667133|593282145|FG010|Phase 2: Dose-expansion|Other|0|||
164250284|NCT01667133|593282146|FG011|Phase 2: Dose-expansion|Other|1|||
164250285|NCT01916824|593282151|FG000|Overall Study|Lost to Follow-up|3|||
164250286|NCT01916824|593282152|FG001|Overall Study|Lost to Follow-up|6|||
164250287|NCT01916824|593282151|FG000|Overall Study|Physician Decision|2|||
164250288|NCT01916824|593282152|FG001|Overall Study|Physician Decision|0|||
164250289|NCT01916824|593282151|FG000|Overall Study|Withdrawal by Subject|2|||
164250290|NCT01916824|593282152|FG001|Overall Study|Withdrawal by Subject|3|||
164250291|NCT03835481|593282157|FG000|Double-blind Period|Other not stated below|0|||
164250292|NCT03835481|593282158|FG001|Double-blind Period|Other not stated below|0|||
164250293|NCT03835481|593282159|FG002|Double-blind Period|Other not stated below|0|||
164250294|NCT03835481|593282160|FG003|Double-blind Period|Other not stated below|1|||
164250295|NCT03835481|593282161|FG004|Double-blind Period|Other not stated below|1|||
164250296|NCT03835481|593282157|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
164250297|NCT03835481|593282158|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
164250298|NCT03835481|593282159|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
164250299|NCT03835481|593282160|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
164250300|NCT03835481|593282161|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
164575554|NCT03263091|594471687|FG003|DB Component|Adverse Event|0|||
164575555|NCT03263091|594471688|FG004|DB Component|Adverse Event|2|||
164575556|NCT03263091|594471689|FG005|DB Component|Adverse Event|1|||
164575557|NCT03263091|594471684|FG000|DB Component|Lost to Follow-up|0|||
164575558|NCT03263091|594471685|FG001|DB Component|Lost to Follow-up|0|||
164575559|NCT03263091|594471686|FG002|DB Component|Lost to Follow-up|0|||
164575560|NCT03263091|594471687|FG003|DB Component|Lost to Follow-up|0|||
164575561|NCT03263091|594471688|FG004|DB Component|Lost to Follow-up|2|||
164575562|NCT03263091|594471689|FG005|DB Component|Lost to Follow-up|1|||
164575563|NCT03263091|594471684|FG000|DB Component|Death|0|||
164575564|NCT03263091|594471685|FG001|DB Component|Death|0|||
164575565|NCT03263091|594471686|FG002|DB Component|Death|0|||
164575566|NCT03263091|594471687|FG003|DB Component|Death|0|||
164575567|NCT03263091|594471688|FG004|DB Component|Death|7|||
164575568|NCT03263091|594471689|FG005|DB Component|Death|4|||
164575569|NCT03263091|594471684|FG000|DB Component|Other than specified|0|||
164575570|NCT03263091|594471685|FG001|DB Component|Other than specified|0|||
164575571|NCT03263091|594471686|FG002|DB Component|Other than specified|0|||
164575572|NCT03263091|594471687|FG003|DB Component|Other than specified|0|||
164575573|NCT03263091|594471688|FG004|DB Component|Other than specified|8|||
164575574|NCT03263091|594471689|FG005|DB Component|Other than specified|6|||
164575575|NCT03874234|594471690|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
164575576|NCT03874234|594471691|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
164575577|NCT03874234|594471692|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
164575578|NCT03874234|594471693|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
164575579|NCT03874234|594471694|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
164575580|NCT03874234|594471695|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
164575581|NCT03874234|594471696|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
164575582|NCT03874234|594471697|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
164575583|NCT03874234|594471698|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
164575584|NCT03874234|594471699|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
164575585|NCT03874234|594471700|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
164575586|NCT03874234|594471701|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
164575587|NCT03874234|594471702|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
164575588|NCT03874234|594471690|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
164575589|NCT03874234|594471691|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
164575590|NCT03874234|594471692|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
164575591|NCT03874234|594471693|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
164250301|NCT03835481|593282157|FG000|Double-blind Period|Withdrawal by Subject|0|||
164250302|NCT03835481|593282158|FG001|Double-blind Period|Withdrawal by Subject|0|||
164250303|NCT03835481|593282159|FG002|Double-blind Period|Withdrawal by Subject|1|||
164426866|NCT01544582|593930900|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
164575592|NCT03874234|594471694|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
164575593|NCT03874234|594471695|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
164575594|NCT03874234|594471696|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
164575595|NCT03874234|594471697|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
164575596|NCT03874234|594471698|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
164250304|NCT03835481|593282160|FG003|Double-blind Period|Withdrawal by Subject|0|||
164250305|NCT03835481|593282161|FG004|Double-blind Period|Withdrawal by Subject|5|||
164250306|NCT03835481|593282157|FG000|Double-blind Period|Lost to Follow-up|0|||
164250307|NCT03835481|593282158|FG001|Double-blind Period|Lost to Follow-up|0|||
164250308|NCT03835481|593282159|FG002|Double-blind Period|Lost to Follow-up|0|||
164250309|NCT03835481|593282160|FG003|Double-blind Period|Lost to Follow-up|1|||
164250310|NCT03835481|593282161|FG004|Double-blind Period|Lost to Follow-up|0|||
164250311|NCT03835481|593282157|FG000|Double-blind Period|Protocol Violation|0|||
164250312|NCT03835481|593282158|FG001|Double-blind Period|Protocol Violation|2|||
164250313|NCT03835481|593282159|FG002|Double-blind Period|Protocol Violation|0|||
164250314|NCT03835481|593282160|FG003|Double-blind Period|Protocol Violation|1|||
164250315|NCT03835481|593282161|FG004|Double-blind Period|Protocol Violation|0|||
164250316|NCT03835481|593282157|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
164250317|NCT03835481|593282158|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
164250318|NCT03835481|593282159|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
164250319|NCT03835481|593282160|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
164250320|NCT03835481|593282161|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
164250321|NCT03835481|593282157|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
164250322|NCT03835481|593282158|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
164250323|NCT03835481|593282159|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
164250324|NCT03835481|593282160|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
164250325|NCT03835481|593282161|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
164680024|NCT01117623|594854458|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
164680025|NCT01117623|594854459|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
164680026|NCT01117623|594854460|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
164680027|NCT01117623|594854461|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
164680028|NCT01117623|594854462|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
164680029|NCT01117623|594854455|FG000|Overall Study|Withdrawal by Subject|0|||
164680030|NCT01117623|594854456|FG001|Overall Study|Withdrawal by Subject|0|||
164680031|NCT01117623|594854457|FG002|Overall Study|Withdrawal by Subject|2|||
164680032|NCT01117623|594854458|FG003|Overall Study|Withdrawal by Subject|0|||
164680033|NCT01117623|594854459|FG004|Overall Study|Withdrawal by Subject|0|||
164680034|NCT01117623|594854460|FG005|Overall Study|Withdrawal by Subject|1|||
164680035|NCT01117623|594854461|FG006|Overall Study|Withdrawal by Subject|1|||
164680036|NCT01117623|594854462|FG007|Overall Study|Withdrawal by Subject|1|||
164680037|NCT01117623|594854455|FG000|Overall Study|Non-compliance with study medication|0|||
164680038|NCT01117623|594854456|FG001|Overall Study|Non-compliance with study medication|0|||
164680039|NCT01117623|594854457|FG002|Overall Study|Non-compliance with study medication|0|||
164680040|NCT01117623|594854458|FG003|Overall Study|Non-compliance with study medication|0|||
164680041|NCT01117623|594854459|FG004|Overall Study|Non-compliance with study medication|0|||
164680042|NCT01117623|594854460|FG005|Overall Study|Non-compliance with study medication|0|||
164680043|NCT01117623|594854461|FG006|Overall Study|Non-compliance with study medication|0|||
164680044|NCT01117623|594854462|FG007|Overall Study|Non-compliance with study medication|1|||
164680045|NCT01117623|594854455|FG000|Overall Study|Invest. text: completed all planned txs|0|||
164680046|NCT01117623|594854456|FG001|Overall Study|Invest. text: completed all planned txs|0|||
164680047|NCT01117623|594854457|FG002|Overall Study|Invest. text: completed all planned txs|0|||
164680048|NCT01117623|594854458|FG003|Overall Study|Invest. text: completed all planned txs|0|||
164680049|NCT01117623|594854459|FG004|Overall Study|Invest. text: completed all planned txs|0|||
164680050|NCT01117623|594854460|FG005|Overall Study|Invest. text: completed all planned txs|1|||
164680051|NCT01117623|594854461|FG006|Overall Study|Invest. text: completed all planned txs|0|||
164680052|NCT01117623|594854462|FG007|Overall Study|Invest. text: completed all planned txs|0|||
164680053|NCT02727192|594854469|FG000|Overall Study|Lost to Follow-up|1|||
164680054|NCT02727192|594854470|FG001|Overall Study|Lost to Follow-up|0|||
164680055|NCT02727192|594854471|FG002|Overall Study|Lost to Follow-up|0|||
164680056|NCT05497557|594854473|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
164680057|NCT05497557|594854474|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
164680058|NCT05497557|594854475|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
164680059|NCT00488774|594854477|FG000|Overall Study|Withdrawal of consent|2|||
164680060|NCT00488774|594854478|FG001|Overall Study|Withdrawal of consent|2|||
164680061|NCT00488774|594854479|FG002|Overall Study|Withdrawal of consent|2|||
164680062|NCT00488774|594854480|FG003|Overall Study|Withdrawal of consent|0|||
164680063|NCT00488774|594854477|FG000|Overall Study|Other|6|||
164680064|NCT00488774|594854478|FG001|Overall Study|Other|3|||
164680065|NCT00488774|594854479|FG002|Overall Study|Other|2|||
164250326|NCT03835481|593282157|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
164250327|NCT03835481|593282158|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
164426867|NCT01544582|593930901|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
164680066|NCT00488774|594854480|FG003|Overall Study|Other|2|||
164680067|NCT00488774|594854477|FG000|Overall Study|Lost to Follow-up|0|||
164680068|NCT00488774|594854478|FG001|Overall Study|Lost to Follow-up|0|||
164680069|NCT00488774|594854479|FG002|Overall Study|Lost to Follow-up|1|||
164680070|NCT00488774|594854480|FG003|Overall Study|Lost to Follow-up|1|||
164680071|NCT04590027|594854481|FG000|Overall Study|Lost to Follow-up|17|||
164250328|NCT03835481|593282159|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
164250329|NCT03835481|593282160|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
164250330|NCT03835481|593282161|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
164250331|NCT03835481|593282157|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
164250332|NCT03835481|593282158|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
164250333|NCT03835481|593282159|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
164250334|NCT03835481|593282160|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
164250335|NCT03835481|593282161|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
164250336|NCT03835481|593282157|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
164250337|NCT03835481|593282158|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
164250338|NCT03835481|593282159|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
164250339|NCT03835481|593282160|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
164250340|NCT03835481|593282161|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
164250341|NCT03835481|593282157|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
164250342|NCT03835481|593282158|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
164250343|NCT03835481|593282159|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
164250344|NCT03835481|593282160|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
164250345|NCT03835481|593282161|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
164250346|NCT00191945|593282162|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
164680072|NCT04590027|594854482|FG001|Overall Study|Lost to Follow-up|14|||
164250347|NCT00191945|593282163|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
164250348|NCT00191945|593282162|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
164680073|NCT04590027|594854481|FG000|Overall Study|Protocol Violation|0|||
164680074|NCT04590027|594854482|FG001|Overall Study|Protocol Violation|3|||
164680075|NCT05523895|594854483|FG000|Overall Study|Adverse Event|2|||
164680076|NCT05523895|594854484|FG001|Overall Study|Adverse Event|1|||
164680077|NCT05523895|594854485|FG002|Overall Study|Adverse Event|1|||
164680078|NCT05523895|594854483|FG000|Overall Study|Lost to Follow-up|0|||
164680079|NCT05523895|594854484|FG001|Overall Study|Lost to Follow-up|1|||
164680080|NCT05523895|594854485|FG002|Overall Study|Lost to Follow-up|2|||
164680081|NCT05523895|594854483|FG000|Overall Study|Noncompliance with study drug|1|||
164680082|NCT05523895|594854484|FG001|Overall Study|Noncompliance with study drug|1|||
164680083|NCT05523895|594854485|FG002|Overall Study|Noncompliance with study drug|1|||
164680084|NCT05523895|594854483|FG000|Overall Study|Protocol Violation|0|||
164680085|NCT05523895|594854484|FG001|Overall Study|Protocol Violation|2|||
164680086|NCT05523895|594854485|FG002|Overall Study|Protocol Violation|0|||
164680087|NCT05523895|594854483|FG000|Overall Study|Withdrawal by Subject|1|||
164680088|NCT05523895|594854484|FG001|Overall Study|Withdrawal by Subject|3|||
164680089|NCT05523895|594854485|FG002|Overall Study|Withdrawal by Subject|1|||
164680090|NCT05523895|594854483|FG000|Overall Study|Not further specified|0|||
164680091|NCT05523895|594854484|FG001|Overall Study|Not further specified|3|||
164680092|NCT05523895|594854485|FG002|Overall Study|Not further specified|1|||
164680093|NCT03674892|594854486|FG000|Overall Study|Lack of Efficacy|5|||
164680094|NCT03674892|594854486|FG000|Overall Study|Lost to Follow-up|3|||
164680095|NCT03674892|594854486|FG000|Overall Study|Migraine|2|||
164680096|NCT03674892|594854486|FG000|Overall Study|Excessive Tearing|1|||
164680097|NCT03674892|594854486|FG000|Overall Study|Increased Eye Pain|1|||
164680098|NCT03674892|594854486|FG000|Overall Study|Increased Facial Pain|1|||
164680099|NCT03674892|594854486|FG000|Overall Study|Sinus Irritation|1|||
164680100|NCT03674892|594854486|FG000|Overall Study|Sinus Infection|1|||
164680101|NCT05099380|594854487|FG000|Overall Study|Subject enrolled in error|1|||
164680102|NCT05099380|594854488|FG001|Overall Study|Subject enrolled in error|0|||
164680103|NCT05099380|594854487|FG000|Overall Study|Study Procedure|1|||
164680104|NCT05099380|594854488|FG001|Overall Study|Study Procedure|0|||
164680105|NCT05099380|594854487|FG000|Overall Study|Protocol Violation|1|||
164680106|NCT05099380|594854488|FG001|Overall Study|Protocol Violation|0|||
164680107|NCT05099380|594854487|FG000|Overall Study|Adverse Event|1|||
164680108|NCT05099380|594854488|FG001|Overall Study|Adverse Event|1|||
164680109|NCT05099380|594854487|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
164680110|NCT05099380|594854488|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
164680111|NCT01959672|594854494|FG000|Overall Study|Death|1|||
164680112|NCT02392195|594854495|FG000|Overall Study|Lost to Follow-up|4|||
164680113|NCT02392195|594854495|FG000|Overall Study|Withdrawal by Subject|4|||
164680114|NCT03605342|594854498|FG000|Overall Study|Withdrawal by Subject|9|||
164680115|NCT03605342|594854499|FG001|Overall Study|Withdrawal by Subject|7|||
164680116|NCT03605342|594854498|FG000|Overall Study|Lost to Follow-up|1|||
164680117|NCT03605342|594854499|FG001|Overall Study|Lost to Follow-up|1|||
164680118|NCT02842853|594854502|FG000|Overall Study|Non-compliance with the protocol|3|||
164680119|NCT02842853|594854503|FG001|Overall Study|Non-compliance with the protocol|7|||
164680120|NCT02842853|594854504|FG002|Overall Study|Non-compliance with the protocol|2|||
164680121|NCT02842853|594854505|FG003|Overall Study|Non-compliance with the protocol|5|||
164250349|NCT00191945|593282163|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
164250350|NCT00191945|593282162|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
164250351|NCT00191945|593282163|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
164250352|NCT00191945|593282162|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
164250353|NCT00191945|593282163|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
164250354|NCT02063984|593282168|FG000|Overall Study|Lost to Follow-up|6|||
164250355|NCT02063984|593282169|FG001|Overall Study|Lost to Follow-up|5|||
164250356|NCT04222699|593282172|FG000|Overall Study|Lost to Follow-up|2|||
164250357|NCT01536561|593282175|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
164250358|NCT01536561|593282175|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
164250359|NCT01536561|593282175|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
164250360|NCT01536561|593282175|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
164250361|NCT01536561|593282175|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
164250362|NCT01536561|593282175|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
164250363|NCT03583359|593282196|FG000|Overall Study|Withdrawal by Subject|15|||
164250364|NCT03583359|593282197|FG001|Overall Study|Withdrawal by Subject|6|||
164250365|NCT03583359|593282196|FG000|Overall Study|Lost to Follow-up|12|||
164250366|NCT03583359|593282197|FG001|Overall Study|Lost to Follow-up|3|||
164250367|NCT03583359|593282196|FG000|Overall Study|Adverse Event|0|||
164250368|NCT03583359|593282197|FG001|Overall Study|Adverse Event|1|||
164338656|NCT00319501|593615220|FG000|Double-blind Period|Withdrawal by Subject|0|||
164338657|NCT00319501|593615221|FG001|Double-blind Period|Withdrawal by Subject|3|||
164575597|NCT03874234|594471699|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
164575598|NCT03874234|594471700|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
164575599|NCT03874234|594471701|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
164575600|NCT03874234|594471702|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
164575601|NCT03874234|594471690|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
164575602|NCT03874234|594471691|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
164575603|NCT03874234|594471692|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
164575604|NCT03874234|594471693|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
164575605|NCT03874234|594471694|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
164575606|NCT03874234|594471695|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
164575607|NCT03874234|594471696|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
164575608|NCT03874234|594471697|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
164575609|NCT03874234|594471698|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
164575610|NCT03874234|594471699|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
164575611|NCT03874234|594471700|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
164575612|NCT03874234|594471701|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
164575613|NCT03874234|594471702|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
164575614|NCT03874234|594471690|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
164575615|NCT03874234|594471691|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
164575616|NCT03874234|594471692|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
164575617|NCT03874234|594471693|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
164575618|NCT03874234|594471694|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
164575619|NCT03874234|594471695|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
164575620|NCT03874234|594471696|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
164575621|NCT03874234|594471697|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
164575622|NCT03874234|594471698|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
164575623|NCT03874234|594471699|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
164575624|NCT03874234|594471700|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
164575625|NCT03874234|594471701|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
164575626|NCT03874234|594471702|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
164575627|NCT03874234|594471690|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
164575628|NCT03874234|594471691|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
164575629|NCT03874234|594471692|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
164575630|NCT03874234|594471693|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
164575631|NCT03874234|594471694|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
164575632|NCT03874234|594471695|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
164575633|NCT03874234|594471696|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
164575634|NCT03874234|594471697|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
164575635|NCT03874234|594471698|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
164575636|NCT03874234|594471699|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
164575637|NCT03874234|594471700|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
164575638|NCT03874234|594471701|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
164250369|NCT03583359|593282196|FG000|Overall Study|Protocol Violation|0|||
164250370|NCT03583359|593282197|FG001|Overall Study|Protocol Violation|1|||
164250371|NCT03583359|593282196|FG000|Overall Study|Other|2|||
164338658|NCT00319501|593615220|FG000|Double-blind Period|Sponsor Request|1|||
164575639|NCT03874234|594471702|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
164250372|NCT03583359|593282197|FG001|Overall Study|Other|1|||
164250373|NCT01831466|593282202|FG000|Overall Study|Protocol Violation|1|||
164250374|NCT01831466|593282203|FG001|Overall Study|Protocol Violation|1|||
164250375|NCT01831466|593282204|FG002|Overall Study|Protocol Violation|2|||
164250376|NCT01831466|593282205|FG003|Overall Study|Protocol Violation|0|||
164250377|NCT01831466|593282206|FG004|Overall Study|Protocol Violation|0|||
164250378|NCT01831466|593282207|FG005|Overall Study|Protocol Violation|1|||
164250379|NCT01831466|593282208|FG006|Overall Study|Protocol Violation|0|||
164680122|NCT02842853|594854502|FG000|Overall Study|Subject met exclusion criteria|0|||
164680123|NCT02842853|594854503|FG001|Overall Study|Subject met exclusion criteria|1|||
164680124|NCT02842853|594854504|FG002|Overall Study|Subject met exclusion criteria|0|||
164680125|NCT02842853|594854505|FG003|Overall Study|Subject met exclusion criteria|0|||
164680126|NCT02842853|594854502|FG000|Overall Study|Withdrawal by Subject|11|||
164680127|NCT02842853|594854503|FG001|Overall Study|Withdrawal by Subject|13|||
164680128|NCT02842853|594854504|FG002|Overall Study|Withdrawal by Subject|9|||
164680129|NCT02842853|594854505|FG003|Overall Study|Withdrawal by Subject|8|||
164680130|NCT02842853|594854502|FG000|Overall Study|Lost to Follow-up|9|||
164680131|NCT02842853|594854503|FG001|Overall Study|Lost to Follow-up|13|||
164680132|NCT02842853|594854504|FG002|Overall Study|Lost to Follow-up|10|||
164680133|NCT02842853|594854505|FG003|Overall Study|Lost to Follow-up|11|||
164680134|NCT04089553|594854506|FG000|Overall Study|Death|1|||
164680135|NCT04089553|594854507|FG001|Overall Study|Death|1|||
164680136|NCT04089553|594854506|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
164680137|NCT04089553|594854507|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
164680138|NCT04089553|594854506|FG000|Overall Study|Withdrawal by Subject|3|||
164680139|NCT04089553|594854507|FG001|Overall Study|Withdrawal by Subject|3|||
164680140|NCT04089553|594854506|FG000|Overall Study|Physician Decision|1|||
164680141|NCT04089553|594854507|FG001|Overall Study|Physician Decision|0|||
164680142|NCT04089553|594854506|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
164680143|NCT04089553|594854507|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
164680144|NCT04089553|594854506|FG000|Overall Study|Other|1|||
164680145|NCT04089553|594854507|FG001|Overall Study|Other|0|||
164250380|NCT01831466|593282209|FG007|Overall Study|Protocol Violation|0|||
164250381|NCT01831466|593282210|FG008|Overall Study|Protocol Violation|0|||
164250382|NCT01831466|593282211|FG009|Overall Study|Protocol Violation|0|||
164250383|NCT01831466|593282212|FG010|Overall Study|Protocol Violation|0|||
164250384|NCT01831466|593282213|FG011|Overall Study|Protocol Violation|0|||
164250385|NCT01831466|593282202|FG000|Overall Study|Other|2|||
164250386|NCT01831466|593282203|FG001|Overall Study|Other|3|||
164250387|NCT01831466|593282204|FG002|Overall Study|Other|2|||
164250388|NCT01831466|593282205|FG003|Overall Study|Other|2|||
164250389|NCT01831466|593282206|FG004|Overall Study|Other|2|||
164250390|NCT01831466|593282207|FG005|Overall Study|Other|1|||
164250391|NCT01831466|593282208|FG006|Overall Study|Other|0|||
164250392|NCT01831466|593282209|FG007|Overall Study|Other|0|||
164250393|NCT01831466|593282210|FG008|Overall Study|Other|0|||
164250394|NCT01831466|593282211|FG009|Overall Study|Other|0|||
164250395|NCT01831466|593282212|FG010|Overall Study|Other|0|||
164250396|NCT01831466|593282213|FG011|Overall Study|Other|0|||
164250397|NCT01831466|593282202|FG000|Overall Study|Non-compliance with study treatment|2|||
164250398|NCT01831466|593282203|FG001|Overall Study|Non-compliance with study treatment|1|||
164250399|NCT01831466|593282204|FG002|Overall Study|Non-compliance with study treatment|1|||
164250400|NCT01831466|593282205|FG003|Overall Study|Non-compliance with study treatment|0|||
164250401|NCT01831466|593282206|FG004|Overall Study|Non-compliance with study treatment|0|||
164250402|NCT01831466|593282207|FG005|Overall Study|Non-compliance with study treatment|1|||
164250403|NCT01831466|593282208|FG006|Overall Study|Non-compliance with study treatment|0|||
164250404|NCT01831466|593282209|FG007|Overall Study|Non-compliance with study treatment|0|||
164680146|NCT04089553|594854506|FG000|Overall Study|Adverse Event|1|||
164680147|NCT04089553|594854507|FG001|Overall Study|Adverse Event|1|||
164680148|NCT03366792|594854514|FG000|Overall Study|Withdrawal by Subject|7|||
164250405|NCT01831466|593282210|FG008|Overall Study|Non-compliance with study treatment|0|||
164680149|NCT03366792|594854514|FG000|Overall Study|Lost to Follow-up|2|||
164680150|NCT03366792|594854514|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
164680151|NCT03366792|594854514|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
164250406|NCT01831466|593282211|FG009|Overall Study|Non-compliance with study treatment|0|||
164250407|NCT01831466|593282212|FG010|Overall Study|Non-compliance with study treatment|0|||
164250408|NCT01831466|593282213|FG011|Overall Study|Non-compliance with study treatment|0|||
164338659|NCT00319501|593615221|FG001|Double-blind Period|Sponsor Request|0|||
164680152|NCT01316055|594854515|FG000|Overall Study|Lost to Follow-up|1|||
164680153|NCT01316055|594854516|FG001|Overall Study|Lost to Follow-up|0|||
164250409|NCT01831466|593282202|FG000|Overall Study|Death|0|||
164250410|NCT01831466|593282203|FG001|Overall Study|Death|1|||
164250411|NCT01831466|593282204|FG002|Overall Study|Death|0|||
164250412|NCT01831466|593282205|FG003|Overall Study|Death|0|||
164680154|NCT01316055|594854517|FG002|Overall Study|Lost to Follow-up|0|||
164250413|NCT01831466|593282206|FG004|Overall Study|Death|0|||
164250414|NCT01831466|593282207|FG005|Overall Study|Death|0|||
164250415|NCT01831466|593282208|FG006|Overall Study|Death|0|||
164250416|NCT01831466|593282209|FG007|Overall Study|Death|0|||
164250417|NCT01831466|593282210|FG008|Overall Study|Death|0|||
164250418|NCT01831466|593282211|FG009|Overall Study|Death|0|||
164250419|NCT01831466|593282212|FG010|Overall Study|Death|0|||
164250420|NCT01831466|593282213|FG011|Overall Study|Death|0|||
164250421|NCT01831466|593282202|FG000|Overall Study|Withdrawal by Subject|6|||
164250422|NCT01831466|593282203|FG001|Overall Study|Withdrawal by Subject|3|||
164250423|NCT01831466|593282204|FG002|Overall Study|Withdrawal by Subject|3|||
164250424|NCT01831466|593282205|FG003|Overall Study|Withdrawal by Subject|3|||
164250425|NCT01831466|593282206|FG004|Overall Study|Withdrawal by Subject|3|||
164250426|NCT01831466|593282207|FG005|Overall Study|Withdrawal by Subject|5|||
164250427|NCT01831466|593282208|FG006|Overall Study|Withdrawal by Subject|0|||
164250428|NCT01831466|593282209|FG007|Overall Study|Withdrawal by Subject|0|||
164250429|NCT01831466|593282210|FG008|Overall Study|Withdrawal by Subject|0|||
164250430|NCT01831466|593282211|FG009|Overall Study|Withdrawal by Subject|1|||
164250431|NCT01831466|593282212|FG010|Overall Study|Withdrawal by Subject|0|||
164250432|NCT01831466|593282213|FG011|Overall Study|Withdrawal by Subject|1|||
164250433|NCT01831466|593282202|FG000|Overall Study|Lost to Follow-up|0|||
164250434|NCT01831466|593282203|FG001|Overall Study|Lost to Follow-up|1|||
164250435|NCT01831466|593282204|FG002|Overall Study|Lost to Follow-up|4|||
164250436|NCT01831466|593282205|FG003|Overall Study|Lost to Follow-up|2|||
164250437|NCT01831466|593282206|FG004|Overall Study|Lost to Follow-up|0|||
164250438|NCT01831466|593282207|FG005|Overall Study|Lost to Follow-up|3|||
164250439|NCT01831466|593282208|FG006|Overall Study|Lost to Follow-up|0|||
164250440|NCT01831466|593282209|FG007|Overall Study|Lost to Follow-up|0|||
164250441|NCT01831466|593282210|FG008|Overall Study|Lost to Follow-up|0|||
164250442|NCT01831466|593282211|FG009|Overall Study|Lost to Follow-up|1|||
164250443|NCT01831466|593282212|FG010|Overall Study|Lost to Follow-up|0|||
164250444|NCT01831466|593282213|FG011|Overall Study|Lost to Follow-up|1|||
164250445|NCT01831466|593282202|FG000|Overall Study|Lack of Efficacy|5|||
164250446|NCT01831466|593282203|FG001|Overall Study|Lack of Efficacy|8|||
164250447|NCT01831466|593282204|FG002|Overall Study|Lack of Efficacy|7|||
164250448|NCT01831466|593282205|FG003|Overall Study|Lack of Efficacy|6|||
164250449|NCT01831466|593282206|FG004|Overall Study|Lack of Efficacy|9|||
164250450|NCT01831466|593282207|FG005|Overall Study|Lack of Efficacy|8|||
164250451|NCT01831466|593282208|FG006|Overall Study|Lack of Efficacy|1|||
164250452|NCT01831466|593282209|FG007|Overall Study|Lack of Efficacy|1|||
164250453|NCT01831466|593282210|FG008|Overall Study|Lack of Efficacy|2|||
164250454|NCT01831466|593282211|FG009|Overall Study|Lack of Efficacy|2|||
164250455|NCT01831466|593282212|FG010|Overall Study|Lack of Efficacy|2|||
164250456|NCT01831466|593282213|FG011|Overall Study|Lack of Efficacy|0|||
164250457|NCT01831466|593282202|FG000|Overall Study|Adverse Event|0|||
164250458|NCT01831466|593282203|FG001|Overall Study|Adverse Event|0|||
164250459|NCT01831466|593282204|FG002|Overall Study|Adverse Event|4|||
164250460|NCT01831466|593282205|FG003|Overall Study|Adverse Event|6|||
164250461|NCT01831466|593282206|FG004|Overall Study|Adverse Event|3|||
164250462|NCT01831466|593282207|FG005|Overall Study|Adverse Event|7|||
164250463|NCT01831466|593282208|FG006|Overall Study|Adverse Event|0|||
164250464|NCT01831466|593282209|FG007|Overall Study|Adverse Event|1|||
164250465|NCT01831466|593282210|FG008|Overall Study|Adverse Event|1|||
164250466|NCT01831466|593282211|FG009|Overall Study|Adverse Event|1|||
164575640|NCT03874234|594471690|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
164575641|NCT03874234|594471691|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
164575642|NCT03874234|594471692|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
164575643|NCT03874234|594471693|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
164575644|NCT03874234|594471694|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
164338660|NCT00319501|593615220|FG000|Double-blind Period|Did not receive treatment|42|||
164338661|NCT00319501|593615221|FG001|Double-blind Period|Did not receive treatment|29|||
164250467|NCT01831466|593282212|FG010|Overall Study|Adverse Event|0|||
164250468|NCT01831466|593282213|FG011|Overall Study|Adverse Event|2|||
164250469|NCT03497039|593282215|FG000|Overall Study|Withdrawal by Subject|1|||
164250470|NCT03497039|593282216|FG001|Overall Study|Withdrawal by Subject|0|||
164250471|NCT03497039|593282215|FG000|Overall Study|Protocol Violation|0|||
164250472|NCT03497039|593282216|FG001|Overall Study|Protocol Violation|1|||
164250473|NCT02567799|593282217|FG000|Concurrent Chemoradiotherapy|Death|1|||
164250474|NCT02567799|593282218|FG001|Concurrent Chemoradiotherapy|Death|0|||
164250475|NCT02567799|593282219|FG002|Concurrent Chemoradiotherapy|Death|0|||
164338662|NCT00319501|593615220|FG000|Open-label Period|Adverse Event|5|||
164250476|NCT02567799|593282217|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
164250477|NCT02567799|593282218|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
164250478|NCT02567799|593282219|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
164250479|NCT02567799|593282217|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
164338663|NCT00319501|593615221|FG001|Open-label Period|Adverse Event|0|||
164250480|NCT02567799|593282218|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
164250481|NCT02567799|593282219|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
164250482|NCT02567799|593282217|FG000|Follow-up|Death|1|||
164250483|NCT02567799|593282218|FG001|Follow-up|Death|0|||
164250484|NCT02567799|593282219|FG002|Follow-up|Death|1|||
164250485|NCT02567799|593282217|FG000|Follow-up|Progressive Disease|1|||
164250486|NCT02567799|593282218|FG001|Follow-up|Progressive Disease|1|||
164250487|NCT02567799|593282219|FG002|Follow-up|Progressive Disease|3|||
164250488|NCT02131662|593282220|FG000|Overall Study|Protocol Violation|1|||
164250489|NCT02131662|593282221|FG001|Overall Study|Protocol Violation|0|||
164250490|NCT02131662|593282222|FG002|Overall Study|Protocol Violation|0|||
164250491|NCT02131662|593282223|FG003|Overall Study|Protocol Violation|0|||
164250492|NCT02131662|593282224|FG004|Overall Study|Protocol Violation|0|||
164250493|NCT02131662|593282220|FG000|Overall Study|Other|2|||
164250494|NCT02131662|593282221|FG001|Overall Study|Other|4|||
164250495|NCT02131662|593282222|FG002|Overall Study|Other|3|||
164250496|NCT02131662|593282223|FG003|Overall Study|Other|3|||
164250497|NCT02131662|593282224|FG004|Overall Study|Other|4|||
164250498|NCT02131662|593282220|FG000|Overall Study|Adverse Event|0|||
164250499|NCT02131662|593282221|FG001|Overall Study|Adverse Event|1|||
164250500|NCT02131662|593282222|FG002|Overall Study|Adverse Event|1|||
164250501|NCT02131662|593282223|FG003|Overall Study|Adverse Event|1|||
164250502|NCT02131662|593282224|FG004|Overall Study|Adverse Event|3|||
164250503|NCT02131662|593282220|FG000|Overall Study|Pregnancy|0|||
164250504|NCT02131662|593282221|FG001|Overall Study|Pregnancy|1|||
164250505|NCT02131662|593282222|FG002|Overall Study|Pregnancy|0|||
164250506|NCT02131662|593282223|FG003|Overall Study|Pregnancy|1|||
164250507|NCT02131662|593282224|FG004|Overall Study|Pregnancy|0|||
164250508|NCT02131662|593282220|FG000|Overall Study|Wish for pregnancy|0|||
164250509|NCT02131662|593282221|FG001|Overall Study|Wish for pregnancy|0|||
164250510|NCT02131662|593282222|FG002|Overall Study|Wish for pregnancy|0|||
164250511|NCT02131662|593282223|FG003|Overall Study|Wish for pregnancy|0|||
164250512|NCT02131662|593282224|FG004|Overall Study|Wish for pregnancy|1|||
164250513|NCT02131662|593282220|FG000|Overall Study|Lack of Efficacy|1|||
164250514|NCT02131662|593282221|FG001|Overall Study|Lack of Efficacy|0|||
164250515|NCT02131662|593282222|FG002|Overall Study|Lack of Efficacy|0|||
164250516|NCT02131662|593282223|FG003|Overall Study|Lack of Efficacy|0|||
164250517|NCT02131662|593282224|FG004|Overall Study|Lack of Efficacy|1|||
164250518|NCT02131662|593282220|FG000|Overall Study|Withdrawal by Subject|1|||
164250519|NCT02131662|593282221|FG001|Overall Study|Withdrawal by Subject|5|||
164250520|NCT02131662|593282222|FG002|Overall Study|Withdrawal by Subject|1|||
164250521|NCT02131662|593282223|FG003|Overall Study|Withdrawal by Subject|5|||
164575645|NCT03874234|594471695|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
164575646|NCT03874234|594471696|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
164575647|NCT03874234|594471697|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
164575648|NCT03874234|594471698|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
164575649|NCT03874234|594471699|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
164575650|NCT03874234|594471700|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
164575651|NCT03874234|594471701|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
164575652|NCT03874234|594471702|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
164575653|NCT03874234|594471690|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
164575654|NCT03874234|594471691|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
164575655|NCT03874234|594471692|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
164575656|NCT03874234|594471693|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
164575657|NCT03874234|594471694|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
164575658|NCT03874234|594471695|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
164575659|NCT03874234|594471696|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
164575660|NCT03874234|594471697|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
164575661|NCT03874234|594471698|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
164575662|NCT03874234|594471699|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
164575663|NCT03874234|594471700|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
164575664|NCT03874234|594471701|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
164250522|NCT02131662|593282224|FG004|Overall Study|Withdrawal by Subject|6|||
164250523|NCT02131662|593282220|FG000|Overall Study|Lost to Follow-up|1|||
164250524|NCT02131662|593282221|FG001|Overall Study|Lost to Follow-up|3|||
164250525|NCT02131662|593282222|FG002|Overall Study|Lost to Follow-up|0|||
164250526|NCT02131662|593282223|FG003|Overall Study|Lost to Follow-up|9|||
164250527|NCT02131662|593282224|FG004|Overall Study|Lost to Follow-up|0|||
164250528|NCT02131662|593282220|FG000|Overall Study|Not treated|2|||
164250529|NCT02131662|593282221|FG001|Overall Study|Not treated|0|||
164250530|NCT02131662|593282222|FG002|Overall Study|Not treated|2|||
164250531|NCT02131662|593282223|FG003|Overall Study|Not treated|2|||
164250532|NCT02131662|593282224|FG004|Overall Study|Not treated|3|||
164250533|NCT01016132|593282247|FG000|Overall Study|Discomfort|1|||
164250534|NCT00790582|593282250|FG000|Overall Study|Death|14|||
164250535|NCT00790582|593282251|FG001|Overall Study|Death|32|||
164250536|NCT00790582|593282250|FG000|Overall Study|Physician Decision|7|||
164575665|NCT03874234|594471702|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
164250537|NCT00790582|593282251|FG001|Overall Study|Physician Decision|1|||
164250538|NCT00790582|593282250|FG000|Overall Study|Lost to Follow-up|3|||
164250539|NCT00790582|593282251|FG001|Overall Study|Lost to Follow-up|3|||
164250540|NCT00790582|593282250|FG000|Overall Study|Withdrawal by Subject|7|||
164250541|NCT00790582|593282251|FG001|Overall Study|Withdrawal by Subject|51|||
164250542|NCT00803595|593282252|FG000|Overall Study|Adverse Event|3|||
164250543|NCT00803595|593282253|FG001|Overall Study|Adverse Event|4|||
164250544|NCT00803595|593282254|FG002|Overall Study|Adverse Event|1|||
164250545|NCT00803595|593282252|FG000|Overall Study|Protocol Violation|7|||
164250546|NCT00803595|593282253|FG001|Overall Study|Protocol Violation|2|||
164680155|NCT02679729|594854519|FG000|Overall Study|Lost to Follow-up|0|||
164680156|NCT02679729|594854520|FG001|Overall Study|Lost to Follow-up|1|||
164680157|NCT02679729|594854521|FG002|Overall Study|Lost to Follow-up|0|||
164680158|NCT02679729|594854522|FG003|Overall Study|Lost to Follow-up|0|||
164680159|NCT02679729|594854523|FG004|Overall Study|Lost to Follow-up|1|||
164680160|NCT02679729|594854524|FG005|Overall Study|Lost to Follow-up|0|||
164680161|NCT02679729|594854525|FG006|Overall Study|Lost to Follow-up|0|||
164680162|NCT02679729|594854526|FG007|Overall Study|Lost to Follow-up|0|||
164680163|NCT02679729|594854527|FG008|Overall Study|Lost to Follow-up|0|||
164680164|NCT02679729|594854519|FG000|Overall Study|Participant decision|0|||
164680165|NCT02679729|594854520|FG001|Overall Study|Participant decision|1|||
164680166|NCT02679729|594854521|FG002|Overall Study|Participant decision|0|||
164680167|NCT02679729|594854522|FG003|Overall Study|Participant decision|0|||
164680168|NCT02679729|594854523|FG004|Overall Study|Participant decision|0|||
164680169|NCT02679729|594854524|FG005|Overall Study|Participant decision|0|||
164680170|NCT02679729|594854525|FG006|Overall Study|Participant decision|1|||
164680171|NCT02679729|594854526|FG007|Overall Study|Participant decision|0|||
164680172|NCT02679729|594854527|FG008|Overall Study|Participant decision|0|||
164680173|NCT01442376|594854532|FG000|Overall Study|Adverse Event|0|||
164680174|NCT01442376|594854533|FG001|Overall Study|Adverse Event|3|||
164680175|NCT01442376|594854534|FG002|Overall Study|Adverse Event|2|||
164680176|NCT01442376|594854532|FG000|Overall Study|Death|0|||
164680177|NCT01442376|594854533|FG001|Overall Study|Death|1|||
164680178|NCT01442376|594854534|FG002|Overall Study|Death|1|||
164680179|NCT01442376|594854532|FG000|Overall Study|Withdrawal of consent|0|||
164680180|NCT01442376|594854533|FG001|Overall Study|Withdrawal of consent|0|||
164680181|NCT01442376|594854534|FG002|Overall Study|Withdrawal of consent|1|||
164680182|NCT01442376|594854532|FG000|Overall Study|Patients not treated|2|||
164680183|NCT01442376|594854533|FG001|Overall Study|Patients not treated|3|||
164680184|NCT01442376|594854534|FG002|Overall Study|Patients not treated|1|||
164250547|NCT00803595|593282254|FG002|Overall Study|Protocol Violation|12|||
164250548|NCT00803595|593282252|FG000|Overall Study|Withdrawal by Subject|5|||
164250549|NCT00803595|593282253|FG001|Overall Study|Withdrawal by Subject|2|||
164250550|NCT00803595|593282254|FG002|Overall Study|Withdrawal by Subject|3|||
164680185|NCT01442376|594854532|FG000|Overall Study|Not eligible for subsequent cycles|1|||
164680186|NCT01442376|594854533|FG001|Overall Study|Not eligible for subsequent cycles|2|||
164250551|NCT02566785|593282255|FG000|Overall Study|Lost to Follow-up|0|||
164250552|NCT02566785|593282256|FG001|Overall Study|Lost to Follow-up|2|||
164680187|NCT01442376|594854534|FG002|Overall Study|Not eligible for subsequent cycles|0|||
164680188|NCT04404725|594854535|FG000|First Intervention|Withdrawal by Subject|0|||
164680189|NCT04404725|594854536|FG001|First Intervention|Withdrawal by Subject|2|||
164680190|NCT04404725|594854535|FG000|Second Intervention|Adverse Event|1|||
164680191|NCT04404725|594854536|FG001|Second Intervention|Adverse Event|1|||
164680192|NCT04404725|594854535|FG000|Second Intervention|Withdrawal by Subject|0|||
164680193|NCT04404725|594854536|FG001|Second Intervention|Withdrawal by Subject|1|||
164680194|NCT01075516|594854537|FG000|Overall Study|Death|5|||
164680195|NCT01075516|594854538|FG001|Overall Study|Death|9|||
164680196|NCT01075516|594854537|FG000|Overall Study|Lost to Follow-up|10|||
164680197|NCT01075516|594854538|FG001|Overall Study|Lost to Follow-up|2|||
164680198|NCT01075516|594854537|FG000|Overall Study|Withdrawal by Subject|3|||
164680199|NCT01075516|594854538|FG001|Overall Study|Withdrawal by Subject|5|||
164680200|NCT00674128|594854541|FG000|Overall Study|Withdrawal by Subject|25|||
164680201|NCT00674128|594854542|FG001|Overall Study|Withdrawal by Subject|23|||
164680202|NCT04631562|594854543|FG000|Overall Study|Withdrawal by Subject|0|||
164680203|NCT04631562|594854544|FG001|Overall Study|Withdrawal by Subject|0|||
164680204|NCT04631562|594854545|FG002|Overall Study|Withdrawal by Subject|0|||
164680205|NCT04631562|594854546|FG003|Overall Study|Withdrawal by Subject|0|||
164680206|NCT04631562|594854547|FG004|Overall Study|Withdrawal by Subject|0|||
164680207|NCT04631562|594854548|FG005|Overall Study|Withdrawal by Subject|0|||
164680208|NCT04631562|594854549|FG006|Overall Study|Withdrawal by Subject|0|||
164680209|NCT04631562|594854550|FG007|Overall Study|Withdrawal by Subject|1|||
164680210|NCT04631562|594854551|FG008|Overall Study|Withdrawal by Subject|0|||
164680211|NCT04631562|594854543|FG000|Overall Study|Other|0|||
164680212|NCT04631562|594854544|FG001|Overall Study|Other|0|||
164680213|NCT04631562|594854545|FG002|Overall Study|Other|0|||
164680214|NCT04631562|594854546|FG003|Overall Study|Other|0|||
164680215|NCT04631562|594854547|FG004|Overall Study|Other|0|||
164680216|NCT04631562|594854548|FG005|Overall Study|Other|0|||
164680217|NCT04631562|594854549|FG006|Overall Study|Other|0|||
164680218|NCT04631562|594854550|FG007|Overall Study|Other|0|||
164680219|NCT04631562|594854551|FG008|Overall Study|Other|1|||
164680220|NCT04631562|594854543|FG000|Overall Study|Lost to Follow-up|0|||
164680221|NCT04631562|594854544|FG001|Overall Study|Lost to Follow-up|0|||
164680222|NCT04631562|594854545|FG002|Overall Study|Lost to Follow-up|0|||
164680223|NCT04631562|594854546|FG003|Overall Study|Lost to Follow-up|1|||
164680224|NCT04631562|594854547|FG004|Overall Study|Lost to Follow-up|0|||
164680225|NCT04631562|594854548|FG005|Overall Study|Lost to Follow-up|0|||
164680226|NCT04631562|594854549|FG006|Overall Study|Lost to Follow-up|0|||
164680227|NCT04631562|594854550|FG007|Overall Study|Lost to Follow-up|0|||
164680228|NCT04631562|594854551|FG008|Overall Study|Lost to Follow-up|0|||
164680229|NCT04631562|594854543|FG000|Overall Study|Adverse Event|0|||
164680230|NCT04631562|594854544|FG001|Overall Study|Adverse Event|0|||
164680231|NCT04631562|594854545|FG002|Overall Study|Adverse Event|0|||
164680232|NCT04631562|594854546|FG003|Overall Study|Adverse Event|0|||
164680233|NCT04631562|594854547|FG004|Overall Study|Adverse Event|0|||
164680234|NCT04631562|594854548|FG005|Overall Study|Adverse Event|0|||
164680235|NCT04631562|594854549|FG006|Overall Study|Adverse Event|1|||
164680236|NCT04631562|594854550|FG007|Overall Study|Adverse Event|0|||
164680237|NCT04631562|594854551|FG008|Overall Study|Adverse Event|0|||
164680238|NCT03503318|594854553|FG000|Overall Study|Death|1|||
164680239|NCT03503318|594854554|FG001|Overall Study|Death|0|||
164680240|NCT03503318|594854555|FG002|Overall Study|Death|4|||
164680241|NCT03503318|594854553|FG000|Overall Study|Adverse Event|3|||
164250553|NCT02566785|593282255|FG000|Overall Study|Worsening condition|1|||
164250554|NCT02566785|593282256|FG001|Overall Study|Worsening condition|1|||
164250555|NCT01597908|593282257|FG000|Randomized Phase|Death|217|||
164250556|NCT01597908|593282258|FG001|Randomized Phase|Death|238|||
164250557|NCT01597908|593282259|FG002|Randomized Phase|Death|0|||
164250558|NCT01597908|593282257|FG000|Randomized Phase|Sponsor Decision|93|||
164250559|NCT01597908|593282258|FG001|Randomized Phase|Sponsor Decision|39|||
164250560|NCT01597908|593282259|FG002|Randomized Phase|Sponsor Decision|0|||
164250561|NCT01597908|593282257|FG000|Randomized Phase|Lost to Follow-up|9|||
164250562|NCT01597908|593282258|FG001|Randomized Phase|Lost to Follow-up|16|||
164250563|NCT01597908|593282259|FG002|Randomized Phase|Lost to Follow-up|0|||
164250564|NCT01597908|593282257|FG000|Randomized Phase|Physician Decision|6|||
164250565|NCT01597908|593282258|FG001|Randomized Phase|Physician Decision|3|||
164250566|NCT01597908|593282259|FG002|Randomized Phase|Physician Decision|0|||
164250567|NCT01597908|593282257|FG000|Randomized Phase|Withdrawal by Subject|26|||
164250568|NCT01597908|593282258|FG001|Randomized Phase|Withdrawal by Subject|22|||
164250569|NCT01597908|593282259|FG002|Randomized Phase|Withdrawal by Subject|0|||
164250570|NCT01597908|593282257|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
164250571|NCT01597908|593282258|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
164250572|NCT01597908|593282259|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
164250573|NCT01597908|593282257|FG000|Crossover Phase|Death|0|||
164250574|NCT01597908|593282258|FG001|Crossover Phase|Death|0|||
164250575|NCT01597908|593282259|FG002|Crossover Phase|Death|11|||
164250576|NCT01597908|593282257|FG000|Crossover Phase|Withdrawal by Subject|0|||
164680242|NCT03503318|594854554|FG001|Overall Study|Adverse Event|4|||
164680243|NCT03503318|594854555|FG002|Overall Study|Adverse Event|2|||
164680244|NCT03503318|594854553|FG000|Overall Study|Withdrawal by Subject|12|||
164680245|NCT03503318|594854554|FG001|Overall Study|Withdrawal by Subject|17|||
164680246|NCT03503318|594854555|FG002|Overall Study|Withdrawal by Subject|16|||
164680247|NCT03503318|594854553|FG000|Overall Study|Protocol Violation|5|||
164680248|NCT03503318|594854554|FG001|Overall Study|Protocol Violation|0|||
164680249|NCT03503318|594854555|FG002|Overall Study|Protocol Violation|3|||
164680250|NCT03503318|594854553|FG000|Overall Study|Lost to Follow-up|17|||
164680251|NCT03503318|594854554|FG001|Overall Study|Lost to Follow-up|15|||
164680252|NCT03503318|594854555|FG002|Overall Study|Lost to Follow-up|12|||
164680253|NCT03503318|594854553|FG000|Overall Study|Other than specified|1|||
164680254|NCT03503318|594854554|FG001|Overall Study|Other than specified|3|||
164250577|NCT01597908|593282258|FG001|Crossover Phase|Withdrawal by Subject|0|||
164250578|NCT01597908|593282259|FG002|Crossover Phase|Withdrawal by Subject|3|||
164250579|NCT01597908|593282257|FG000|Crossover Phase|Sponsor Decision|0|||
164250580|NCT01597908|593282258|FG001|Crossover Phase|Sponsor Decision|0|||
164250581|NCT01597908|593282259|FG002|Crossover Phase|Sponsor Decision|20|||
164250582|NCT02949024|593282262|FG000|Overall Study|Withdrawal by Subject|0|||
164680255|NCT03503318|594854555|FG002|Overall Study|Other than specified|3|||
164680256|NCT02139826|594854557|FG000|Overall Study|Adverse Event|1|||
164680257|NCT01825798|594854558|FG000|Overall Study|Adverse Event|1|||
164680258|NCT01825798|594854559|FG001|Overall Study|Adverse Event|5|||
164680259|NCT01825798|594854558|FG000|Overall Study|Lost to Follow-up|1|||
164680260|NCT01825798|594854559|FG001|Overall Study|Lost to Follow-up|0|||
164680261|NCT01559363|594854565|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
164680262|NCT01559363|594854566|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
164680263|NCT01559363|594854567|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
164680264|NCT01559363|594854568|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
164680265|NCT01559363|594854569|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
164680266|NCT01559363|594854570|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
164680267|NCT01559363|594854565|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
164680268|NCT01559363|594854566|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
164680269|NCT01559363|594854567|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
164680270|NCT01559363|594854568|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
164680271|NCT01559363|594854569|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
164680272|NCT01559363|594854570|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
164680273|NCT01559363|594854565|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
164680274|NCT01559363|594854566|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
164680275|NCT01559363|594854567|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
164680276|NCT01559363|594854568|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
164250583|NCT02949024|593282263|FG001|Overall Study|Withdrawal by Subject|1|||
164250584|NCT01027650|593282264|FG000|Overall Study|Personal Reasons|0|||
164250585|NCT01027650|593282265|FG001|Overall Study|Personal Reasons|0|||
164250586|NCT01027650|593282266|FG002|Overall Study|Personal Reasons|0|||
164250587|NCT01027650|593282267|FG003|Overall Study|Personal Reasons|0|||
164250588|NCT01027650|593282268|FG004|Overall Study|Personal Reasons|2|||
164250589|NCT01027650|593282269|FG005|Overall Study|Personal Reasons|1|||
164680277|NCT01559363|594854569|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
164250590|NCT01027650|593282270|FG006|Overall Study|Personal Reasons|0|||
164250591|NCT01027650|593282271|FG007|Overall Study|Personal Reasons|0|||
164250592|NCT01027650|593282264|FG000|Overall Study|Lost to Follow-up|0|||
164250593|NCT01027650|593282265|FG001|Overall Study|Lost to Follow-up|0|||
164250594|NCT01027650|593282266|FG002|Overall Study|Lost to Follow-up|0|||
164250595|NCT01027650|593282267|FG003|Overall Study|Lost to Follow-up|0|||
164250596|NCT01027650|593282268|FG004|Overall Study|Lost to Follow-up|0|||
164250597|NCT01027650|593282269|FG005|Overall Study|Lost to Follow-up|0|||
164250598|NCT01027650|593282270|FG006|Overall Study|Lost to Follow-up|1|||
164250599|NCT01027650|593282271|FG007|Overall Study|Lost to Follow-up|0|||
164250600|NCT01027650|593282264|FG000|Overall Study|Lack of Efficacy|0|||
164338664|NCT00319501|593615220|FG000|Open-label Period|Protocol Violation|6|||
164338665|NCT00319501|593615221|FG001|Open-label Period|Protocol Violation|0|||
164680278|NCT01559363|594854570|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
164680279|NCT01559363|594854565|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
164680280|NCT01559363|594854566|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
164680281|NCT01559363|594854567|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
164680282|NCT01559363|594854568|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
164680283|NCT01559363|594854569|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
164250601|NCT01027650|593282265|FG001|Overall Study|Lack of Efficacy|0|||
164338666|NCT00319501|593615220|FG000|Open-label Period|Withdrawal by Subject|38|||
164338667|NCT00319501|593615221|FG001|Open-label Period|Withdrawal by Subject|0|||
164338668|NCT00319501|593615220|FG000|Open-label Period|Principal Investigator decision|6|||
164338669|NCT00319501|593615221|FG001|Open-label Period|Principal Investigator decision|0|||
164338670|NCT00319501|593615220|FG000|Open-label Period|Sponsor request|12|||
164338671|NCT00319501|593615221|FG001|Open-label Period|Sponsor request|0|||
164575666|NCT03874234|594471690|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
164575667|NCT03874234|594471691|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
164575668|NCT03874234|594471692|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
164575669|NCT03874234|594471693|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
164575670|NCT03874234|594471694|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
164575671|NCT03874234|594471695|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
164575672|NCT03874234|594471696|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
164575673|NCT03874234|594471697|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
164575674|NCT03874234|594471698|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
164575675|NCT03874234|594471699|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
164575676|NCT03874234|594471700|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
164575677|NCT03874234|594471701|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
164575678|NCT03874234|594471702|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
164575679|NCT01217606|594471718|FG000|Initial Treatment Phase|Other Reasons|0|||
164575680|NCT01217606|594471719|FG001|Initial Treatment Phase|Other Reasons|2|||
164575681|NCT01217606|594471718|FG000|Initial Treatment Phase|Protocol Violation|3|||
164575682|NCT01217606|594471719|FG001|Initial Treatment Phase|Protocol Violation|2|||
164575683|NCT01217606|594471718|FG000|Initial Treatment Phase|Personal Reasons|0|||
164575684|NCT01217606|594471719|FG001|Initial Treatment Phase|Personal Reasons|2|||
164575685|NCT01217606|594471718|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
164575686|NCT01217606|594471719|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
164575687|NCT01217606|594471718|FG000|Initial Treatment Phase|Adverse Event|10|||
164575688|NCT01217606|594471719|FG001|Initial Treatment Phase|Adverse Event|6|||
164575689|NCT01217606|594471718|FG000|9-Month Masked Extension|Adverse Event|3|||
164575690|NCT01217606|594471719|FG001|9-Month Masked Extension|Adverse Event|6|||
164575691|NCT01217606|594471718|FG000|9-Month Masked Extension|Other Reasons|4|||
164575692|NCT01217606|594471719|FG001|9-Month Masked Extension|Other Reasons|4|||
164575693|NCT01217606|594471718|FG000|9-Month Masked Extension|Personal Reasons|2|||
164575694|NCT01217606|594471719|FG001|9-Month Masked Extension|Personal Reasons|1|||
164250602|NCT01027650|593282266|FG002|Overall Study|Lack of Efficacy|0|||
164250603|NCT01027650|593282267|FG003|Overall Study|Lack of Efficacy|0|||
164250604|NCT01027650|593282268|FG004|Overall Study|Lack of Efficacy|0|||
164338672|NCT00319501|593615220|FG000|Open-label Period|Lost to Follow-up|5|||
164338673|NCT00319501|593615221|FG001|Open-label Period|Lost to Follow-up|0|||
164338674|NCT00319501|593615220|FG000|Open-label Period|Did not receive treatment|33|||
164575695|NCT01217606|594471718|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
164575696|NCT01217606|594471719|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
164575697|NCT01217606|594471718|FG000|9-Month Masked Extension|Pregnancy|1|||
164680284|NCT01559363|594854570|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
164250605|NCT01027650|593282269|FG005|Overall Study|Lack of Efficacy|1|||
164250606|NCT01027650|593282270|FG006|Overall Study|Lack of Efficacy|0|||
164250607|NCT01027650|593282271|FG007|Overall Study|Lack of Efficacy|0|||
164250608|NCT05160415|593283962|FG000|Overall Study|Withdrawal by Subject|3|||
164250609|NCT00933608|593283963|FG000|Overall Study|Adverse Event|4|||
164250610|NCT00933608|593283964|FG001|Overall Study|Adverse Event|2|||
164250611|NCT00933608|593283963|FG000|Overall Study|Physician Decision|1|||
164250612|NCT00933608|593283964|FG001|Overall Study|Physician Decision|0|||
164250613|NCT00623233|593283967|FG000|Overall Study|Adverse Event|10|||
164250614|NCT00623233|593283967|FG000|Overall Study|Physician Decision|10|||
164250615|NCT00623233|593283967|FG000|Overall Study|Lost to Follow-up|1|||
164250616|NCT00623233|593283967|FG000|Overall Study|Withdrawal by Subject|3|||
164250617|NCT00559845|593283968|FG000|Overall Study|Withdrew Consent|1|||
164250618|NCT00559845|593283968|FG000|Overall Study|Disease Progression|1|||
164250619|NCT00559845|593283968|FG000|Overall Study|Adverse Event|3|||
164250620|NCT00559845|593283968|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
164250621|NCT00559845|593283968|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
164250622|NCT03206970|593283969|FG000|Overall Study|Death|21|||
164250623|NCT03206970|593283969|FG000|Overall Study|Withdrawal by Subject|13|||
164250624|NCT03206970|593283969|FG000|Overall Study|Lost to Follow-up|3|||
164250625|NCT03206970|593283969|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
164250626|NCT03654040|593283970|FG000|Overall Study|Death|1|||
164250627|NCT03654040|593283971|FG001|Overall Study|Death|0|||
164250628|NCT03654040|593283970|FG000|Overall Study|Withdrawal by Subject|1|||
164250629|NCT03654040|593283971|FG001|Overall Study|Withdrawal by Subject|0|||
164250630|NCT03654040|593283970|FG000|Overall Study|Study terminated by sponsor|8|||
164250631|NCT03654040|593283971|FG001|Overall Study|Study terminated by sponsor|2|||
164250632|NCT03654040|593283970|FG000|Overall Study|Failure to initiate study therapy|2|||
164250633|NCT03654040|593283971|FG001|Overall Study|Failure to initiate study therapy|0|||
164250634|NCT03654040|593283970|FG000|Overall Study|Transplanted at another center|2|||
164250635|NCT03654040|593283971|FG001|Overall Study|Transplanted at another center|0|||
164250636|NCT03654040|593283970|FG000|Overall Study|Failure to meet eligibility criteria|14|||
164250637|NCT03654040|593283971|FG001|Overall Study|Failure to meet eligibility criteria|2|||
164250638|NCT03654040|593283970|FG000|Overall Study|No longer transplant candidate|1|||
164250639|NCT03654040|593283971|FG001|Overall Study|No longer transplant candidate|0|||
164250640|NCT03654040|593283970|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
164250641|NCT03654040|593283971|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
164250642|NCT03654040|593283970|FG000|Overall Study|Recipient ineligible|0|||
164250643|NCT03654040|593283971|FG001|Overall Study|Recipient ineligible|2|||
164250644|NCT03654040|593283970|FG000|Overall Study|Received deceased liver|0|||
164250645|NCT03654040|593283971|FG001|Overall Study|Received deceased liver|1|||
164575698|NCT01217606|594471719|FG001|9-Month Masked Extension|Pregnancy|0|||
164575699|NCT01217606|594471718|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
164575700|NCT01217606|594471719|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
164575701|NCT02432807|594471721|FG000|Overall Study|Adverse Event|0|||
164575702|NCT02432807|594471722|FG001|Overall Study|Adverse Event|2|||
164575703|NCT02432807|594471721|FG000|Overall Study|Lost to Follow-up|1|||
164575704|NCT02432807|594471722|FG001|Overall Study|Lost to Follow-up|0|||
164575705|NCT02432807|594471721|FG000|Overall Study|Withdrawal by Subject|1|||
164575706|NCT02432807|594471722|FG001|Overall Study|Withdrawal by Subject|1|||
164575707|NCT02432807|594471721|FG000|Overall Study|Other|1|||
164575708|NCT02432807|594471722|FG001|Overall Study|Other|1|||
164575709|NCT00391976|594471726|FG000|Overall Study|Adverse Event|0|||
164575710|NCT00391976|594471727|FG001|Overall Study|Adverse Event|0|||
164575711|NCT00391976|594471728|FG002|Overall Study|Adverse Event|1|||
164575712|NCT00391976|594471726|FG000|Overall Study|Withdrawal of consent|0|||
164575713|NCT00391976|594471727|FG001|Overall Study|Withdrawal of consent|1|||
164575714|NCT00391976|594471728|FG002|Overall Study|Withdrawal of consent|1|||
164575715|NCT00391976|594471726|FG000|Overall Study|Lost to Follow-up|1|||
164575716|NCT00391976|594471727|FG001|Overall Study|Lost to Follow-up|2|||
164575717|NCT00391976|594471728|FG002|Overall Study|Lost to Follow-up|0|||
164575718|NCT00391976|594471726|FG000|Overall Study|Inappropriate enrollment|1|||
164575719|NCT00391976|594471727|FG001|Overall Study|Inappropriate enrollment|1|||
164575720|NCT00391976|594471728|FG002|Overall Study|Inappropriate enrollment|0|||
164575721|NCT00391976|594471726|FG000|Overall Study|Protocol deviation/violation|4|||
164575722|NCT00391976|594471727|FG001|Overall Study|Protocol deviation/violation|2|||
164575723|NCT00391976|594471728|FG002|Overall Study|Protocol deviation/violation|1|||
164575724|NCT00391976|594471726|FG000|Overall Study|Recurrence/no eradication of infection|21|||
164575725|NCT00391976|594471727|FG001|Overall Study|Recurrence/no eradication of infection|19|||
164575726|NCT00391976|594471728|FG002|Overall Study|Recurrence/no eradication of infection|0|||
164575727|NCT00391976|594471726|FG000|Overall Study|Unable to classify|0|||
164575728|NCT00391976|594471727|FG001|Overall Study|Unable to classify|0|||
164575729|NCT00391976|594471728|FG002|Overall Study|Unable to classify|1|||
164575730|NCT00391976|594471726|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
164575731|NCT00391976|594471727|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
164250646|NCT01951586|593283972|FG000|Overall Study|Death|61|||
164250647|NCT01951586|593283973|FG001|Overall Study|Death|120|||
164250648|NCT01951586|593283972|FG000|Overall Study|Withdrawal by Subject|8|||
164250649|NCT01951586|593283973|FG001|Overall Study|Withdrawal by Subject|17|||
164250650|NCT01951586|593283972|FG000|Overall Study|Lost to Follow-up|0|||
164250651|NCT01951586|593283973|FG001|Overall Study|Lost to Follow-up|1|||
164250652|NCT01951586|593283972|FG000|Overall Study|Sponsor Decision|9|||
164250653|NCT01951586|593283973|FG001|Overall Study|Sponsor Decision|10|||
164250654|NCT02120781|593283979|FG000|Overall Study|Physician Decision|2|||
164250655|NCT02120781|593283980|FG001|Overall Study|Physician Decision|0|||
164250656|NCT02120781|593283979|FG000|Overall Study|Completion not documented|2|||
164250657|NCT02120781|593283980|FG001|Overall Study|Completion not documented|1|||
164250658|NCT01977729|593283986|FG000|Overall Study|Study terminated|1|||
164250659|NCT05332392|593283987|FG000|Overall Study|Did not meet inclusion criteria|25|||
164250660|NCT05332392|593283987|FG000|Overall Study|Principal Investigator's decision|17|||
164250661|NCT05332392|593283987|FG000|Overall Study|Adverse Event|1|||
164250662|NCT05332392|593283987|FG000|Overall Study|Subject's decision|1|||
164250663|NCT01268046|593283988|FG000|Overall Study|Withdrawal by Subject|1|||
164250664|NCT01268046|593283989|FG001|Overall Study|Withdrawal by Subject|0|||
164250665|NCT01268046|593283990|FG002|Overall Study|Withdrawal by Subject|0|||
164250666|NCT01268046|593283991|FG003|Overall Study|Withdrawal by Subject|1|||
164250667|NCT01268046|593283988|FG000|Overall Study|Lost to Follow-up|0|||
164250668|NCT01268046|593283989|FG001|Overall Study|Lost to Follow-up|0|||
164250669|NCT01268046|593283990|FG002|Overall Study|Lost to Follow-up|1|||
164250670|NCT01268046|593283991|FG003|Overall Study|Lost to Follow-up|0|||
164250671|NCT03850093|593283992|FG000|Overall Study|Withdrawal by Subject|1|||
164250672|NCT03850093|593283993|FG001|Overall Study|Withdrawal by Subject|0|||
164250673|NCT03850093|593283994|FG002|Overall Study|Withdrawal by Subject|2|||
164250674|NCT03636893|593283997|FG000|Overall Study|Death|0|||
164250675|NCT03636893|593283998|FG001|Overall Study|Death|1|||
164250676|NCT03636893|593283997|FG000|Overall Study|Protocol Violation|0|||
164250677|NCT03636893|593283998|FG001|Overall Study|Protocol Violation|3|||
164250678|NCT03636893|593283997|FG000|Overall Study|Withdrawal by Subject|1|||
164250679|NCT03636893|593283998|FG001|Overall Study|Withdrawal by Subject|2|||
164250680|NCT03636893|593283997|FG000|Overall Study|Refusal to surgery|4|||
164250681|NCT03636893|593283998|FG001|Overall Study|Refusal to surgery|3|||
164250682|NCT03636893|593283997|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
164250683|NCT03636893|593283998|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
164250684|NCT03636893|593283997|FG000|Overall Study|Adverse Event|1|||
164250685|NCT03636893|593283998|FG001|Overall Study|Adverse Event|1|||
164250686|NCT02314156|593283999|FG000|Overall Study|Adverse Event|1|||
164250687|NCT02314156|593284000|FG001|Overall Study|Adverse Event|0|||
164250688|NCT02314156|593283999|FG000|Overall Study|Withdrawal by Subject|1|||
164250689|NCT02314156|593284000|FG001|Overall Study|Withdrawal by Subject|0|||
164250690|NCT00224120|593284001|FG000|Overall Study|Adverse Event|10|||
164250691|NCT00224120|593284002|FG001|Overall Study|Adverse Event|4|||
164250692|NCT00224120|593284001|FG000|Overall Study|Protocol Violation|1|||
164250693|NCT00224120|593284002|FG001|Overall Study|Protocol Violation|0|||
164250694|NCT00224120|593284001|FG000|Overall Study|Withdrawal by Subject|5|||
164250695|NCT00224120|593284002|FG001|Overall Study|Withdrawal by Subject|10|||
164250696|NCT00224120|593284001|FG000|Overall Study|Lack of Efficacy|0|||
164250697|NCT00224120|593284002|FG001|Overall Study|Lack of Efficacy|2|||
164250698|NCT00224120|593284001|FG000|Overall Study|Lost to Follow-up|2|||
164250699|NCT00224120|593284002|FG001|Overall Study|Lost to Follow-up|3|||
164250700|NCT00224120|593284001|FG000|Overall Study|Other|4|||
164250701|NCT00224120|593284002|FG001|Overall Study|Other|5|||
164250702|NCT00758069|593284007|FG000|Overall Study|Lack of Efficacy|0|||
164250703|NCT00758069|593284008|FG001|Overall Study|Lack of Efficacy|0|||
164250704|NCT00758069|593284009|FG002|Overall Study|Lack of Efficacy|1|||
164250705|NCT00758069|593284007|FG000|Overall Study|Incorrect Study Drug|1|||
164250706|NCT00758069|593284008|FG001|Overall Study|Incorrect Study Drug|0|||
164250707|NCT00758069|593284009|FG002|Overall Study|Incorrect Study Drug|0|||
164250708|NCT04560816|593284010|FG000|Overall Study|Withdrawal by Subject|1|||
164250709|NCT04560816|593284011|FG001|Overall Study|Withdrawal by Subject|1|||
164250710|NCT04560816|593284012|FG002|Overall Study|Withdrawal by Subject|1|||
164250711|NCT04560816|593284013|FG003|Overall Study|Withdrawal by Subject|0|||
164250712|NCT04560816|593284014|FG004|Overall Study|Withdrawal by Subject|3|||
164250713|NCT04560816|593284015|FG005|Overall Study|Withdrawal by Subject|0|||
164250714|NCT04560816|593284010|FG000|Overall Study|Lost to Follow-up|1|||
164250715|NCT04560816|593284011|FG001|Overall Study|Lost to Follow-up|0|||
164250716|NCT04560816|593284012|FG002|Overall Study|Lost to Follow-up|0|||
164250717|NCT04560816|593284013|FG003|Overall Study|Lost to Follow-up|0|||
164250718|NCT04560816|593284014|FG004|Overall Study|Lost to Follow-up|0|||
164250719|NCT04560816|593284015|FG005|Overall Study|Lost to Follow-up|0|||
164250720|NCT04560816|593284010|FG000|Overall Study|Protocol Violation|1|||
164250721|NCT04560816|593284011|FG001|Overall Study|Protocol Violation|0|||
164250722|NCT04560816|593284012|FG002|Overall Study|Protocol Violation|0|||
164250723|NCT04560816|593284013|FG003|Overall Study|Protocol Violation|0|||
164250724|NCT04560816|593284014|FG004|Overall Study|Protocol Violation|0|||
164250725|NCT04560816|593284015|FG005|Overall Study|Protocol Violation|0|||
164250726|NCT03226249|593284016|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
164250727|NCT03226249|593284016|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
164250728|NCT03226249|593284016|FG000|Survival Follow-up|Patients still in follow-up.|30|||
164250729|NCT02277691|593284017|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
164250730|NCT02277691|593284017|FG000|Overall Study|Voluntary Withdrawal|7|||
164250731|NCT02277691|593284017|FG000|Overall Study|Lack of Efficacy|5|||
164250732|NCT02277691|593284017|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
164250733|NCT02846389|593284020|FG000|Overall Study|Withdrawal by Subject|1|||
164250734|NCT02846389|593284021|FG001|Overall Study|Withdrawal by Subject|1|||
164250735|NCT01804049|593284024|FG000|Overall Study|Adverse Event|2|||
164250736|NCT01804049|593284025|FG001|Overall Study|Adverse Event|10|||
164250737|NCT01804049|593284024|FG000|Overall Study|Lost to Follow-up|2|||
164680285|NCT01559363|594854565|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
164680286|NCT01559363|594854566|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
164680287|NCT01559363|594854567|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
164680288|NCT01559363|594854568|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
164680289|NCT01559363|594854569|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
164680290|NCT01559363|594854570|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
164680291|NCT01559363|594854565|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
164680292|NCT01559363|594854566|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
164680293|NCT01559363|594854567|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
164680294|NCT01559363|594854568|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
164680295|NCT01559363|594854569|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
164680296|NCT01559363|594854570|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
164680297|NCT01559363|594854565|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
164680298|NCT01559363|594854566|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
164680299|NCT01559363|594854567|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
164680300|NCT01559363|594854568|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
164680301|NCT01559363|594854569|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
164680302|NCT01559363|594854570|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
164680303|NCT00112437|594854571|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
164680304|NCT00112437|594854572|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
164680305|NCT00112437|594854573|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
164680306|NCT00112437|594854574|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
164250738|NCT01804049|593284025|FG001|Overall Study|Lost to Follow-up|1|||
164250739|NCT01804049|593284024|FG000|Overall Study|Decreased interest/personal|4|||
164250740|NCT01804049|593284025|FG001|Overall Study|Decreased interest/personal|5|||
164250741|NCT01804049|593284024|FG000|Overall Study|Other health concerns|2|||
164250742|NCT01804049|593284025|FG001|Overall Study|Other health concerns|7|||
164250743|NCT01804049|593284024|FG000|Overall Study|Moved out of area|0|||
164250744|NCT01804049|593284025|FG001|Overall Study|Moved out of area|7|||
164250745|NCT01804049|593284024|FG000|Overall Study|other MD recommended|1|||
164250746|NCT01804049|593284025|FG001|Overall Study|other MD recommended|1|||
164250747|NCT01804049|593284024|FG000|Overall Study|Enrollment in dual studies|0|||
164250748|NCT01804049|593284025|FG001|Overall Study|Enrollment in dual studies|1|||
164250749|NCT03985943|593284034|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
164250750|NCT03985943|593284035|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
164250751|NCT03985943|593284036|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
164250752|NCT03985943|593284037|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
164250753|NCT03985943|593284038|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
164250754|NCT03985943|593284039|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
164250755|NCT03985943|593284034|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
164250756|NCT03985943|593284035|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
164250757|NCT03985943|593284036|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
164250758|NCT03985943|593284037|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
164250759|NCT03985943|593284038|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
164250760|NCT03985943|593284039|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
164250761|NCT03985943|593284034|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
164250762|NCT03985943|593284035|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
164338675|NCT00319501|593615221|FG001|Open-label Period|Did not receive treatment|0|||
164680307|NCT00112437|594854575|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
164680308|NCT00112437|594854576|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
164680309|NCT00112437|594854577|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
164250763|NCT03985943|593284036|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
164338676|NCT00319501|593615220|FG000|Open-label Period|Other|11|||
164250764|NCT03985943|593284037|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
164250765|NCT03985943|593284038|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
164250766|NCT03985943|593284039|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
164250767|NCT03985943|593284034|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
164575732|NCT00391976|594471728|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
164250768|NCT03985943|593284035|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
164250769|NCT03985943|593284036|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
164250770|NCT03985943|593284037|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
164250771|NCT03985943|593284038|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
164250772|NCT03985943|593284039|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
164250773|NCT03985943|593284034|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
164250774|NCT03985943|593284035|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
164250775|NCT03985943|593284036|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
164250776|NCT03985943|593284037|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
164250777|NCT03985943|593284038|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
164250778|NCT03985943|593284039|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
164338677|NCT00319501|593615221|FG001|Open-label Period|Other|0|||
164338678|NCT00319501|593615220|FG000|Open-label Extension Period|Adverse Event|2|||
164338679|NCT00319501|593615221|FG001|Open-label Extension Period|Adverse Event|0|||
164338680|NCT00319501|593615220|FG000|Open-label Extension Period|Did not receive treatment|18|||
164338681|NCT00319501|593615221|FG001|Open-label Extension Period|Did not receive treatment|0|||
164338682|NCT00319501|593615220|FG000|Open-label Extension Period|Other|1|||
164338683|NCT00319501|593615221|FG001|Open-label Extension Period|Other|0|||
164338684|NCT00319501|593615220|FG000|Open-label Extension Period|Principal investigator decision|2|||
164338685|NCT00319501|593615221|FG001|Open-label Extension Period|Principal investigator decision|0|||
164338686|NCT00319501|593615220|FG000|Open-label Extension Period|Sponsor request|26|||
164338687|NCT00319501|593615221|FG001|Open-label Extension Period|Sponsor request|0|||
164338688|NCT00319501|593615220|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
164338689|NCT00319501|593615221|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
164338690|NCT02764697|593615223|FG000|Overall Study|Lack of Efficacy|3|||
164338691|NCT00302107|593615226|FG000|Overall Study|Lost to Follow-up|6|||
164338692|NCT00302107|593615227|FG001|Overall Study|Lost to Follow-up|5|||
164338693|NCT00302107|593615226|FG000|Overall Study|Protocol Violation|1|||
164575733|NCT02725788|594471729|FG000|Overall Study|Lost to Follow-up|1|||
164575734|NCT02725788|594471730|FG001|Overall Study|Lost to Follow-up|1|||
164575735|NCT02725788|594471729|FG000|Overall Study|Protocol Violation|0|||
164575736|NCT02725788|594471730|FG001|Overall Study|Protocol Violation|1|||
164575737|NCT00828464|594471731|FG000|Overall Study|Withdrawal by Subject|1|||
164575738|NCT00502840|594471732|FG000|Overall Study|Adverse Event|5|||
164575739|NCT00502840|594471732|FG000|Overall Study|Additional or changed therapy|48|||
164575740|NCT00502840|594471732|FG000|Overall Study|Lack of Efficacy|11|||
164575741|NCT00502840|594471732|FG000|Overall Study|Protocol Violation|4|||
164575742|NCT00502840|594471732|FG000|Overall Study|Withdrawal by Subject|5|||
164575743|NCT00502840|594471732|FG000|Overall Study|Lost to Follow-up|6|||
164575744|NCT00502840|594471732|FG000|Overall Study|Administrative problems|1|||
164575745|NCT00502840|594471732|FG000|Overall Study|Other|20|||
164575746|NCT00809133|594471733|FG000|Overall Study|Progressive disease|2|||
164575747|NCT00809133|594471734|FG001|Overall Study|Progressive disease|5|||
164575748|NCT00809133|594471735|FG002|Overall Study|Progressive disease|5|||
164575749|NCT00809133|594471736|FG003|Overall Study|Progressive disease|3|||
164575750|NCT00809133|594471737|FG004|Overall Study|Progressive disease|4|||
164575751|NCT00809133|594471738|FG005|Overall Study|Progressive disease|1|||
164575752|NCT00809133|594471739|FG006|Overall Study|Progressive disease|3|||
164575753|NCT00809133|594471740|FG007|Overall Study|Progressive disease|3|||
164575754|NCT00809133|594471741|FG008|Overall Study|Progressive disease|3|||
164575755|NCT00809133|594471742|FG009|Overall Study|Progressive disease|9|||
164575756|NCT00809133|594471743|FG010|Overall Study|Progressive disease|5|||
164575757|NCT00809133|594471744|FG011|Overall Study|Progressive disease|7|||
164575758|NCT00809133|594471745|FG012|Overall Study|Progressive disease|5|||
164575759|NCT00809133|594471746|FG013|Overall Study|Progressive disease|4|||
164575760|NCT00809133|594471733|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164575761|NCT00809133|594471734|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164680310|NCT00112437|594854578|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
164338694|NCT00302107|593615227|FG001|Overall Study|Protocol Violation|0|||
164338695|NCT00302107|593615226|FG000|Overall Study|Relocation|0|||
164338696|NCT00302107|593615227|FG001|Overall Study|Relocation|1|||
164338697|NCT00302107|593615226|FG000|Overall Study|Withdrawal by Subject|0|||
164338698|NCT00302107|593615227|FG001|Overall Study|Withdrawal by Subject|3|||
164575762|NCT00809133|594471735|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164575763|NCT00809133|594471736|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164575764|NCT00809133|594471737|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164575765|NCT00809133|594471738|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
164575766|NCT00809133|594471739|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
164250779|NCT03985943|593284034|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
164250780|NCT03985943|593284035|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
164250781|NCT03985943|593284036|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
164250782|NCT03985943|593284037|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
164250783|NCT03985943|593284038|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
164250784|NCT03985943|593284039|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
164680311|NCT00112437|594854579|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
164680312|NCT00112437|594854580|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
164250785|NCT03985943|593284034|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
164250786|NCT03985943|593284035|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
164250787|NCT03985943|593284036|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
164250788|NCT03985943|593284037|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
164250789|NCT03985943|593284038|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
164250790|NCT03985943|593284039|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
164250791|NCT03985943|593284034|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
164250792|NCT03985943|593284035|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
164250793|NCT03985943|593284036|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
164250794|NCT03985943|593284037|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
164250795|NCT03985943|593284038|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
164250796|NCT03985943|593284039|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
164250797|NCT03985943|593284034|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
164250798|NCT03985943|593284035|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
164250799|NCT03985943|593284036|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
164575767|NCT00809133|594471740|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
164575768|NCT00809133|594471741|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164575769|NCT00809133|594471742|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164575770|NCT00809133|594471743|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164575771|NCT00809133|594471744|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164575772|NCT00809133|594471745|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164575773|NCT00809133|594471746|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
164575774|NCT00809133|594471733|FG000|Overall Study|Other adverse event|1|||
164575775|NCT00809133|594471734|FG001|Overall Study|Other adverse event|1|||
164575776|NCT00809133|594471735|FG002|Overall Study|Other adverse event|1|||
164575777|NCT00809133|594471736|FG003|Overall Study|Other adverse event|0|||
164575778|NCT00809133|594471737|FG004|Overall Study|Other adverse event|0|||
164575779|NCT00809133|594471738|FG005|Overall Study|Other adverse event|3|||
164575780|NCT00809133|594471739|FG006|Overall Study|Other adverse event|2|||
164575781|NCT00809133|594471740|FG007|Overall Study|Other adverse event|4|||
164575782|NCT00809133|594471741|FG008|Overall Study|Other adverse event|0|||
164575783|NCT00809133|594471742|FG009|Overall Study|Other adverse event|0|||
164575784|NCT00809133|594471743|FG010|Overall Study|Other adverse event|1|||
164575785|NCT00809133|594471744|FG011|Overall Study|Other adverse event|1|||
164680313|NCT00112437|594854581|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
164680314|NCT00112437|594854582|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
164680315|NCT00112437|594854583|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
164680316|NCT00112437|594854584|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
164680317|NCT00112437|594854585|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
164250800|NCT03985943|593284037|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
164250801|NCT03985943|593284038|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
164250802|NCT03985943|593284039|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
164250803|NCT03985943|593284034|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
164250804|NCT03985943|593284035|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
164250805|NCT03985943|593284036|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
164250806|NCT03985943|593284037|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
164250807|NCT03985943|593284038|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
164250808|NCT03985943|593284039|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
164250809|NCT03985943|593284034|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
164250810|NCT03985943|593284035|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
164426868|NCT01544582|593930898|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
164575786|NCT00809133|594471745|FG012|Overall Study|Other adverse event|0|||
164575787|NCT00809133|594471746|FG013|Overall Study|Other adverse event|1|||
164680318|NCT00112437|594854586|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
164575788|NCT00809133|594471733|FG000|Overall Study|Lost to Follow-up|0|||
164575789|NCT00809133|594471734|FG001|Overall Study|Lost to Follow-up|0|||
164680319|NCT00112437|594854587|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
164680320|NCT00112437|594854588|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
164680321|NCT00112437|594854589|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
164250811|NCT03985943|593284036|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
164250812|NCT03985943|593284037|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
164250813|NCT03985943|593284038|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
164250814|NCT03985943|593284039|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
164250815|NCT03985943|593284034|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
164250816|NCT03985943|593284035|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
164250817|NCT03985943|593284036|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
164250818|NCT03985943|593284037|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
164250819|NCT03985943|593284038|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
164250820|NCT03985943|593284039|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
164250821|NCT03985943|593284034|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
164250822|NCT03985943|593284035|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
164250823|NCT03985943|593284036|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
164250824|NCT03985943|593284037|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
164250825|NCT03985943|593284038|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
164250826|NCT03985943|593284039|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
164250827|NCT03985943|593284034|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
164250828|NCT03985943|593284035|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
164250829|NCT03985943|593284036|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
164250830|NCT03985943|593284037|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
164250831|NCT03985943|593284038|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
164250832|NCT03985943|593284039|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
164250833|NCT03985943|593284034|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
164250834|NCT03985943|593284035|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
164250835|NCT03985943|593284036|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
164250836|NCT03985943|593284037|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
164250837|NCT03985943|593284038|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
164250838|NCT03985943|593284039|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
164250839|NCT01265563|593284040|FG000|Overall Study|Withdrawal by Subject|0|||
164250840|NCT01265563|593284041|FG001|Overall Study|Withdrawal by Subject|1|||
164250841|NCT01265563|593284042|FG002|Overall Study|Withdrawal by Subject|1|||
164250842|NCT01265563|593284043|FG003|Overall Study|Withdrawal by Subject|0|||
164250843|NCT01265563|593284044|FG004|Overall Study|Withdrawal by Subject|2|||
164250844|NCT04075513|593284050|FG000|Overall Study|Withdrawal by Subject|2|||
164250845|NCT04075513|593284051|FG001|Overall Study|Withdrawal by Subject|2|||
164250846|NCT04075513|593284050|FG000|Overall Study|Lack of Efficacy|1|||
164250847|NCT04075513|593284051|FG001|Overall Study|Lack of Efficacy|0|||
164250848|NCT04075513|593284050|FG000|Overall Study|Lost to Follow-up|4|||
164250849|NCT04075513|593284051|FG001|Overall Study|Lost to Follow-up|2|||
164250850|NCT04075513|593284050|FG000|Overall Study|Switch to insulin pump|1|||
164250851|NCT04075513|593284051|FG001|Overall Study|Switch to insulin pump|0|||
164250852|NCT05730335|593284052|FG000|Overall Study|Lost to Follow-up|8|||
164250853|NCT05730335|593284052|FG000|Overall Study|Withdrawal by Subject|6|||
164250854|NCT01534351|593284055|FG000|Overall Study|Study Terminated Early|1|||
164250855|NCT01534351|593284056|FG001|Overall Study|Study Terminated Early|0|||
164250856|NCT01534351|593284057|FG002|Overall Study|Study Terminated Early|0|||
164250857|NCT01369199|593284060|FG000|Overall Study|Withdrawal by Subject|1|||
164250858|NCT01369199|593284060|FG000|Overall Study|Lost to Follow-up|2|||
164250859|NCT03248167|593284065|FG000|Overall Study|Withdrawal by Subject|2|||
164250860|NCT03248167|593284066|FG001|Overall Study|Withdrawal by Subject|2|||
164250861|NCT03248167|593284065|FG000|Overall Study|Physician Decision|0|||
164250862|NCT03248167|593284066|FG001|Overall Study|Physician Decision|1|||
164250863|NCT03248167|593284065|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
164250864|NCT03248167|593284066|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
164250865|NCT03248167|593284065|FG000|Overall Study|Lost to Follow-up|1|||
164250866|NCT03248167|593284066|FG001|Overall Study|Lost to Follow-up|0|||
164338699|NCT00302107|593615226|FG000|Overall Study|Adverse Event|1|||
164338700|NCT00302107|593615227|FG001|Overall Study|Adverse Event|0|||
164338701|NCT00437983|593615228|FG000|Overall Study|Adverse Event|6|||
164680322|NCT00112437|594854590|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
164680323|NCT00112437|594854591|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
164680324|NCT00112437|594854592|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
164680325|NCT00112437|594854593|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
164680326|NCT00112437|594854594|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
164680327|NCT00112437|594854595|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
164680328|NCT00112437|594854596|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
164250867|NCT02122146|593284067|FG000|Part 1: Dose Escalation|Death|0|||
164250868|NCT02122146|593284068|FG001|Part 1: Dose Escalation|Death|1|||
164338702|NCT00437983|593615229|FG001|Overall Study|Adverse Event|6|||
164250869|NCT02122146|593284069|FG002|Part 1: Dose Escalation|Death|1|||
164338703|NCT00437983|593615228|FG000|Overall Study|Protocol Violation|2|||
164250870|NCT02122146|593284070|FG003|Part 1: Dose Escalation|Death|0|||
164250871|NCT02122146|593284071|FG004|Part 1: Dose Escalation|Death|0|||
164250872|NCT02122146|593284072|FG005|Part 1: Dose Escalation|Death|0|||
164250873|NCT02122146|593284073|FG006|Part 1: Dose Escalation|Death|0|||
164250874|NCT02122146|593284074|FG007|Part 1: Dose Escalation|Death|0|||
164250875|NCT02122146|593284067|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
164250876|NCT02122146|593284068|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
164250877|NCT02122146|593284069|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
164250878|NCT02122146|593284070|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
164250879|NCT02122146|593284071|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
164250880|NCT02122146|593284072|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
164250881|NCT02122146|593284073|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
164250882|NCT02122146|593284074|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
164250883|NCT02122146|593284067|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164250884|NCT02122146|593284068|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164250885|NCT02122146|593284069|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164250886|NCT02122146|593284070|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
164250887|NCT02122146|593284071|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164250888|NCT02122146|593284072|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164250889|NCT02122146|593284073|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164250890|NCT02122146|593284074|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164250891|NCT02122146|593284067|FG000|Part 1: Dose Escalation|Other|1|||
164250892|NCT02122146|593284068|FG001|Part 1: Dose Escalation|Other|0|||
164250893|NCT02122146|593284069|FG002|Part 1: Dose Escalation|Other|0|||
164250894|NCT02122146|593284070|FG003|Part 1: Dose Escalation|Other|0|||
164250895|NCT02122146|593284071|FG004|Part 1: Dose Escalation|Other|0|||
164250896|NCT02122146|593284072|FG005|Part 1: Dose Escalation|Other|1|||
164250897|NCT02122146|593284073|FG006|Part 1: Dose Escalation|Other|1|||
164250898|NCT02122146|593284074|FG007|Part 1: Dose Escalation|Other|2|||
164250899|NCT03472495|593284075|FG000|Overall Study|Treatment no longer indicated|1|||
164250900|NCT03472495|593284076|FG001|Overall Study|Treatment no longer indicated|2|||
164250901|NCT03472495|593284075|FG000|Overall Study|Physician Decision|0|||
164250902|NCT03472495|593284076|FG001|Overall Study|Physician Decision|2|||
164338704|NCT00437983|593615229|FG001|Overall Study|Protocol Violation|1|||
164338705|NCT00437983|593615228|FG000|Overall Study|Withdrawal by Subject|5|||
164338706|NCT00437983|593615229|FG001|Overall Study|Withdrawal by Subject|6|||
164338707|NCT02612129|593615230|FG000|Single Dose Treatment Period|Screening Failure|1|||
164338708|NCT02612129|593615231|FG001|Single Dose Treatment Period|Screening Failure|0|||
164338709|NCT02612129|593615232|FG002|Single Dose Treatment Period|Screening Failure|0|||
164338710|NCT02612129|593615230|FG000|Continuous Treatment Period|Early Escape|0|||
164575790|NCT00809133|594471735|FG002|Overall Study|Lost to Follow-up|0|||
164575791|NCT00809133|594471736|FG003|Overall Study|Lost to Follow-up|0|||
164575792|NCT00809133|594471737|FG004|Overall Study|Lost to Follow-up|0|||
164575793|NCT00809133|594471738|FG005|Overall Study|Lost to Follow-up|1|||
164575794|NCT00809133|594471739|FG006|Overall Study|Lost to Follow-up|0|||
164575795|NCT00809133|594471740|FG007|Overall Study|Lost to Follow-up|0|||
164575796|NCT00809133|594471741|FG008|Overall Study|Lost to Follow-up|0|||
164575797|NCT00809133|594471742|FG009|Overall Study|Lost to Follow-up|0|||
164575798|NCT00809133|594471743|FG010|Overall Study|Lost to Follow-up|0|||
164575799|NCT00809133|594471744|FG011|Overall Study|Lost to Follow-up|0|||
164575800|NCT00809133|594471745|FG012|Overall Study|Lost to Follow-up|0|||
164575801|NCT00809133|594471746|FG013|Overall Study|Lost to Follow-up|0|||
164575802|NCT00809133|594471733|FG000|Overall Study|Consent withdrawn|0|||
164575803|NCT00809133|594471734|FG001|Overall Study|Consent withdrawn|0|||
164575804|NCT00809133|594471735|FG002|Overall Study|Consent withdrawn|0|||
164575805|NCT00809133|594471736|FG003|Overall Study|Consent withdrawn|0|||
164575806|NCT00809133|594471737|FG004|Overall Study|Consent withdrawn|1|||
164575807|NCT00809133|594471738|FG005|Overall Study|Consent withdrawn|0|||
164575808|NCT00809133|594471739|FG006|Overall Study|Consent withdrawn|0|||
164575809|NCT00809133|594471740|FG007|Overall Study|Consent withdrawn|0|||
164575810|NCT00809133|594471741|FG008|Overall Study|Consent withdrawn|0|||
164575811|NCT00809133|594471742|FG009|Overall Study|Consent withdrawn|0|||
164575812|NCT00809133|594471743|FG010|Overall Study|Consent withdrawn|0|||
164575813|NCT00809133|594471744|FG011|Overall Study|Consent withdrawn|0|||
164575814|NCT00809133|594471745|FG012|Overall Study|Consent withdrawn|0|||
164575815|NCT00809133|594471746|FG013|Overall Study|Consent withdrawn|0|||
164575816|NCT00809133|594471733|FG000|Overall Study|Other not mentioned above|0|||
164575817|NCT00809133|594471734|FG001|Overall Study|Other not mentioned above|1|||
164575818|NCT00809133|594471735|FG002|Overall Study|Other not mentioned above|0|||
164575819|NCT00809133|594471736|FG003|Overall Study|Other not mentioned above|0|||
164575820|NCT00809133|594471737|FG004|Overall Study|Other not mentioned above|0|||
164575821|NCT00809133|594471738|FG005|Overall Study|Other not mentioned above|1|||
164575822|NCT00809133|594471739|FG006|Overall Study|Other not mentioned above|0|||
164575823|NCT00809133|594471740|FG007|Overall Study|Other not mentioned above|0|||
164575824|NCT00809133|594471741|FG008|Overall Study|Other not mentioned above|0|||
164575825|NCT00809133|594471742|FG009|Overall Study|Other not mentioned above|0|||
164250903|NCT02584452|593284079|FG000|Overall Study|Physician Decision|1|||
164250904|NCT02584452|593284080|FG001|Overall Study|Physician Decision|1|||
164250905|NCT02584452|593284079|FG000|Overall Study|Lost to Follow-up|1|||
164250906|NCT02584452|593284080|FG001|Overall Study|Lost to Follow-up|1|||
164250907|NCT02998671|593284081|FG000|Period 1|Study Terminated By Sponsor|2|||
164250908|NCT02998671|593284082|FG001|Period 1|Study Terminated By Sponsor|1|||
164250909|NCT02998671|593284083|FG002|Period 1|Study Terminated By Sponsor|0|||
164250910|NCT02998671|593284084|FG003|Period 1|Study Terminated By Sponsor|0|||
164250911|NCT02998671|593284085|FG004|Period 1|Study Terminated By Sponsor|1|||
164250912|NCT02998671|593284081|FG000|Period 1|Withdrawal by Subject|1|||
164250913|NCT02998671|593284082|FG001|Period 1|Withdrawal by Subject|2|||
164250914|NCT02998671|593284083|FG002|Period 1|Withdrawal by Subject|0|||
164250915|NCT02998671|593284084|FG003|Period 1|Withdrawal by Subject|0|||
164250916|NCT02998671|593284085|FG004|Period 1|Withdrawal by Subject|2|||
164250917|NCT02998671|593284081|FG000|Period 1|Pregnancy|1|||
164250918|NCT02998671|593284082|FG001|Period 1|Pregnancy|0|||
164250919|NCT02998671|593284083|FG002|Period 1|Pregnancy|0|||
164250920|NCT02998671|593284084|FG003|Period 1|Pregnancy|0|||
164250921|NCT02998671|593284085|FG004|Period 1|Pregnancy|0|||
164250922|NCT02998671|593284081|FG000|Period 1|Adverse Event|0|||
164250923|NCT02998671|593284082|FG001|Period 1|Adverse Event|0|||
164250924|NCT02998671|593284083|FG002|Period 1|Adverse Event|0|||
164250925|NCT02998671|593284084|FG003|Period 1|Adverse Event|0|||
164250926|NCT02998671|593284085|FG004|Period 1|Adverse Event|1|||
164250927|NCT02998671|593284081|FG000|Period 2|Adverse Event|0|||
164250928|NCT02998671|593284082|FG001|Period 2|Adverse Event|1|||
164250929|NCT02998671|593284083|FG002|Period 2|Adverse Event|0|||
164250930|NCT02998671|593284084|FG003|Period 2|Adverse Event|0|||
164250931|NCT02998671|593284085|FG004|Period 2|Adverse Event|0|||
164250932|NCT02998671|593284081|FG000|Period 2|Study Terminated By Sponsor|3|||
164250933|NCT02998671|593284082|FG001|Period 2|Study Terminated By Sponsor|5|||
164250934|NCT02998671|593284083|FG002|Period 2|Study Terminated By Sponsor|1|||
164250935|NCT02998671|593284084|FG003|Period 2|Study Terminated By Sponsor|3|||
164250936|NCT02998671|593284085|FG004|Period 2|Study Terminated By Sponsor|0|||
164250937|NCT02998671|593284081|FG000|Period 2|Withdrawal by Subject|0|||
164250938|NCT02998671|593284082|FG001|Period 2|Withdrawal by Subject|1|||
164250939|NCT02998671|593284083|FG002|Period 2|Withdrawal by Subject|0|||
164250940|NCT02998671|593284084|FG003|Period 2|Withdrawal by Subject|0|||
164250941|NCT02998671|593284085|FG004|Period 2|Withdrawal by Subject|0|||
164250942|NCT02998671|593284081|FG000|Period 2|Lost to Follow-up|0|||
164250943|NCT02998671|593284082|FG001|Period 2|Lost to Follow-up|0|||
164250944|NCT02998671|593284083|FG002|Period 2|Lost to Follow-up|0|||
164250945|NCT02998671|593284084|FG003|Period 2|Lost to Follow-up|1|||
164250946|NCT02998671|593284085|FG004|Period 2|Lost to Follow-up|0|||
164250947|NCT02038946|593284086|FG000|Overall Study|Death|5|||
164250948|NCT02038946|593284086|FG000|Overall Study|Withdrawal by Subject|3|||
164250949|NCT02038946|593284086|FG000|Overall Study|Lost to Follow-up|2|||
164250950|NCT02038946|593284086|FG000|Overall Study|Other reasons|2|||
164250951|NCT00771927|593284090|FG000|Overall Study|Adverse Event|100|||
164250952|NCT00771927|593284091|FG001|Overall Study|Adverse Event|105|||
164250953|NCT00771927|593284090|FG000|Overall Study|Lack of Efficacy|70|||
164250954|NCT00771927|593284091|FG001|Overall Study|Lack of Efficacy|42|||
164250955|NCT00771927|593284090|FG000|Overall Study|Lost to Follow-up|46|||
164250956|NCT00771927|593284091|FG001|Overall Study|Lost to Follow-up|46|||
164250957|NCT00771927|593284090|FG000|Overall Study|Withdrawal by Subject|16|||
164250958|NCT00771927|593284091|FG001|Overall Study|Withdrawal by Subject|17|||
164250959|NCT00771927|593284090|FG000|Overall Study|Other reason|23|||
164250960|NCT00771927|593284091|FG001|Overall Study|Other reason|27|||
164250961|NCT02467192|593284095|FG000|Overall Study|Death|1|||
164250962|NCT02467192|593284095|FG000|Overall Study|revealed to have pneumonia before|2|||
164250963|NCT03213938|593284096|FG000|Overall Study|Lost to Follow-up|4|||
164250964|NCT03213938|593284097|FG001|Overall Study|Lost to Follow-up|3|||
164250965|NCT03213938|593284096|FG000|Overall Study|Lack of Efficacy|1|||
164250966|NCT03213938|593284097|FG001|Overall Study|Lack of Efficacy|0|||
164250967|NCT03213938|593284096|FG000|Overall Study|Decline to participate|5|||
164250968|NCT03213938|593284097|FG001|Overall Study|Decline to participate|4|||
164250969|NCT03213938|593284096|FG000|Overall Study|Without reason|4|||
164250970|NCT03213938|593284097|FG001|Overall Study|Without reason|5|||
164250971|NCT01814046|593284098|FG000|Drug Administration|Death due to complications of RSV|1|||
164250972|NCT01814046|593284099|FG001|Drug Administration|Death due to complications of RSV|0|||
164250973|NCT01814046|593284100|FG002|Drug Administration|Death due to complications of RSV|0|||
164250974|NCT00429182|593284101|FG000|Overall Study|Not evaluable, Disease Progression|2|||
164250975|NCT00429182|593284101|FG000|Overall Study|Not eligible|5|||
164250976|NCT03335150|593284104|FG000|Overall Study|Withdrawal by Subject|10|||
164250977|NCT03335150|593284105|FG001|Overall Study|Withdrawal by Subject|4|||
164250978|NCT03335150|593284104|FG000|Overall Study|Adverse Event|0|||
164250979|NCT03335150|593284105|FG001|Overall Study|Adverse Event|1|||
164250980|NCT02218697|593284110|FG000|Overall Study|Adverse Event|0|||
164250981|NCT02218697|593284111|FG001|Overall Study|Adverse Event|2|||
164250982|NCT02218697|593284110|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
164250983|NCT02218697|593284111|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
164250984|NCT02218697|593284110|FG000|Overall Study|Withdrawal by Subject|2|||
164250985|NCT02218697|593284111|FG001|Overall Study|Withdrawal by Subject|3|||
164250986|NCT02142803|593284114|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
164250987|NCT02142803|593284115|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
164250988|NCT02142803|593284116|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
164250989|NCT02142803|593284117|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
164250990|NCT05111002|593284120|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
164250991|NCT05111002|593284121|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
164250992|NCT05111002|593284120|FG000|Secondary Outcome|Lost to Follow-up|1|||
164250993|NCT05111002|593284121|FG001|Secondary Outcome|Lost to Follow-up|0|||
164250994|NCT04380753|593284122|FG000|Overall Study|Participants continuing study|4|||
164250995|NCT04380753|593284122|FG000|Overall Study|Death|2|||
164250996|NCT04776720|593284123|FG000|Overall Study|COVID Related|4|||
164250997|NCT04776720|593284124|FG001|Overall Study|COVID Related|2|||
164250998|NCT04776720|593284123|FG000|Overall Study|Adverse Event|2|||
164250999|NCT04776720|593284124|FG001|Overall Study|Adverse Event|0|||
164251000|NCT04776720|593284123|FG000|Overall Study|Serious Adverse Event|0|||
164575826|NCT00809133|594471743|FG010|Overall Study|Other not mentioned above|0|||
164575827|NCT00809133|594471744|FG011|Overall Study|Other not mentioned above|0|||
164251001|NCT04776720|593284124|FG001|Overall Study|Serious Adverse Event|1|||
164251002|NCT04776720|593284123|FG000|Overall Study|Too Busy|3|||
164251003|NCT04776720|593284124|FG001|Overall Study|Too Busy|1|||
164251004|NCT04776720|593284123|FG000|Overall Study|Lost to Follow-up|1|||
164251005|NCT04776720|593284124|FG001|Overall Study|Lost to Follow-up|2|||
164251006|NCT04776720|593284123|FG000|Overall Study|Family|2|||
164251007|NCT04776720|593284124|FG001|Overall Study|Family|2|||
164251008|NCT04776720|593284123|FG000|Overall Study|No remote technology access|0|||
164251009|NCT04776720|593284124|FG001|Overall Study|No remote technology access|1|||
164251010|NCT04776720|593284123|FG000|Overall Study|Withdrawal by Subject|1|||
164251011|NCT04776720|593284124|FG001|Overall Study|Withdrawal by Subject|0|||
164251012|NCT04776720|593284123|FG000|Overall Study|Cannot tolerate intervention|1|||
164251013|NCT04776720|593284124|FG001|Overall Study|Cannot tolerate intervention|0|||
164251014|NCT04776720|593284123|FG000|Overall Study|Incomplete outcome data|6|||
164251015|NCT04776720|593284124|FG001|Overall Study|Incomplete outcome data|1|||
164251016|NCT02311881|593284125|FG000|Overall Study|Did not meet the study criteria|2|||
164251017|NCT02311881|593284126|FG001|Overall Study|Did not meet the study criteria|2|||
164251018|NCT02311881|593284127|FG002|Overall Study|Did not meet the study criteria|0|||
164251019|NCT02311881|593284125|FG000|Overall Study|Adverse Event|7|||
164251020|NCT02311881|593284126|FG001|Overall Study|Adverse Event|15|||
164338711|NCT02612129|593615231|FG001|Continuous Treatment Period|Early Escape|2|||
164338712|NCT02612129|593615232|FG002|Continuous Treatment Period|Early Escape|0|||
164338713|NCT02612129|593615230|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
164338714|NCT02612129|593615231|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
164338715|NCT02612129|593615232|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
164338716|NCT02612129|593615230|FG000|Continuous Treatment Period|Safety Reasons|0|||
164338717|NCT02612129|593615231|FG001|Continuous Treatment Period|Safety Reasons|3|||
164338718|NCT02612129|593615232|FG002|Continuous Treatment Period|Safety Reasons|0|||
164338719|NCT02612129|593615230|FG000|Continuous Treatment Period|Death|0|||
164338720|NCT02612129|593615231|FG001|Continuous Treatment Period|Death|1|||
164338721|NCT02612129|593615232|FG002|Continuous Treatment Period|Death|0|||
164338722|NCT02612129|593615230|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
164338723|NCT02612129|593615231|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
164338724|NCT02612129|593615232|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
164338725|NCT02557295|593615233|FG000|Overall Study|Withdrawal by Subject|9|||
164338726|NCT02557295|593615234|FG001|Overall Study|Withdrawal by Subject|2|||
164338727|NCT02557295|593615235|FG002|Overall Study|Withdrawal by Subject|4|||
164426869|NCT01544582|593930899|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
164426870|NCT01544582|593930900|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
164575828|NCT00809133|594471745|FG012|Overall Study|Other not mentioned above|0|||
164575829|NCT00809133|594471746|FG013|Overall Study|Other not mentioned above|0|||
164575830|NCT03093155|594471748|FG000|Overall Study|Not Eligible|1|||
164251021|NCT02311881|593284127|FG002|Overall Study|Adverse Event|8|||
164251022|NCT02311881|593284125|FG000|Overall Study|Lost to Follow-up|3|||
164251023|NCT02311881|593284126|FG001|Overall Study|Lost to Follow-up|3|||
164251024|NCT02311881|593284127|FG002|Overall Study|Lost to Follow-up|2|||
164575831|NCT03093155|594471749|FG001|Overall Study|Not Eligible|0|||
164251025|NCT02311881|593284125|FG000|Overall Study|Protocol Violation|1|||
164251026|NCT02311881|593284126|FG001|Overall Study|Protocol Violation|2|||
164251027|NCT02311881|593284127|FG002|Overall Study|Protocol Violation|3|||
164251028|NCT02311881|593284125|FG000|Overall Study|Withdrawal of consent|14|||
164251029|NCT02311881|593284126|FG001|Overall Study|Withdrawal of consent|16|||
164251030|NCT02311881|593284127|FG002|Overall Study|Withdrawal of consent|17|||
164251031|NCT02311881|593284125|FG000|Overall Study|Other|0|||
164251032|NCT02311881|593284126|FG001|Overall Study|Other|0|||
164251033|NCT02311881|593284127|FG002|Overall Study|Other|1|||
164251034|NCT02311881|593284125|FG000|Overall Study|Lack of Efficacy|1|||
164251035|NCT02311881|593284126|FG001|Overall Study|Lack of Efficacy|2|||
164251036|NCT02311881|593284127|FG002|Overall Study|Lack of Efficacy|0|||
164251037|NCT02311881|593284125|FG000|Overall Study|Subject has border line pregnancy test|1|||
164251038|NCT02311881|593284126|FG001|Overall Study|Subject has border line pregnancy test|0|||
164251039|NCT02311881|593284127|FG002|Overall Study|Subject has border line pregnancy test|0|||
164251040|NCT02311881|593284125|FG000|Overall Study|Withdrawal by Subject|3|||
164251041|NCT02311881|593284126|FG001|Overall Study|Withdrawal by Subject|1|||
164426871|NCT01544582|593930901|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
164426872|NCT01544582|593930898|FG000|Analysis Population|Intolerance|0|||
164426873|NCT01544582|593930899|FG001|Analysis Population|Intolerance|1|||
164426874|NCT01544582|593930900|FG002|Analysis Population|Intolerance|0|||
164251042|NCT02311881|593284127|FG002|Overall Study|Withdrawal by Subject|4|||
164251043|NCT02311881|593284125|FG000|Overall Study|Sponsor Decision|1|||
164251044|NCT02311881|593284126|FG001|Overall Study|Sponsor Decision|1|||
164251045|NCT02311881|593284127|FG002|Overall Study|Sponsor Decision|1|||
164251046|NCT02311881|593284125|FG000|Overall Study|Protocol Deviation|1|||
164251047|NCT02311881|593284126|FG001|Overall Study|Protocol Deviation|0|||
164251048|NCT02311881|593284127|FG002|Overall Study|Protocol Deviation|0|||
164251049|NCT02311881|593284125|FG000|Overall Study|Non-Compliance|1|||
164251050|NCT02311881|593284126|FG001|Overall Study|Non-Compliance|0|||
164251051|NCT02311881|593284127|FG002|Overall Study|Non-Compliance|2|||
164426875|NCT01544582|593930901|FG003|Analysis Population|Intolerance|0|||
164426876|NCT01544582|593930898|FG000|Analysis Population|Liver Transplantation|0|||
164426877|NCT01544582|593930899|FG001|Analysis Population|Liver Transplantation|0|||
164426878|NCT01544582|593930900|FG002|Analysis Population|Liver Transplantation|1|||
164426879|NCT01544582|593930901|FG003|Analysis Population|Liver Transplantation|0|||
164426880|NCT01544582|593930898|FG000|Analysis Population|No Social Insurance|0|||
164251052|NCT02311881|593284125|FG000|Overall Study|Physician Decision|0|||
164251053|NCT02311881|593284126|FG001|Overall Study|Physician Decision|0|||
164426881|NCT01544582|593930899|FG001|Analysis Population|No Social Insurance|0|||
164426882|NCT01544582|593930900|FG002|Analysis Population|No Social Insurance|1|||
164426883|NCT01544582|593930901|FG003|Analysis Population|No Social Insurance|0|||
164426884|NCT01544582|593930898|FG000|Analysis Population|Poor Adherence|0|||
164426885|NCT01544582|593930899|FG001|Analysis Population|Poor Adherence|0|||
164426886|NCT01544582|593930900|FG002|Analysis Population|Poor Adherence|1|||
164426887|NCT01544582|593930901|FG003|Analysis Population|Poor Adherence|0|||
164426888|NCT01544582|593930898|FG000|Analysis Population|Poor Participant Compliance|0|||
164426889|NCT01544582|593930899|FG001|Analysis Population|Poor Participant Compliance|1|||
164426890|NCT01544582|593930900|FG002|Analysis Population|Poor Participant Compliance|0|||
164426891|NCT01544582|593930901|FG003|Analysis Population|Poor Participant Compliance|0|||
164426892|NCT01544582|593930898|FG000|Analysis Population|Programmed Surgery|0|||
164426893|NCT01544582|593930899|FG001|Analysis Population|Programmed Surgery|1|||
164426894|NCT01544582|593930900|FG002|Analysis Population|Programmed Surgery|0|||
164251054|NCT02311881|593284127|FG002|Overall Study|Physician Decision|1|||
164251055|NCT02311881|593284125|FG000|Overall Study|Medical Monitor Discretion|0|||
164251056|NCT02311881|593284126|FG001|Overall Study|Medical Monitor Discretion|0|||
164251057|NCT02311881|593284127|FG002|Overall Study|Medical Monitor Discretion|1|||
164251058|NCT02311881|593284125|FG000|Overall Study|Participant taking another medication|0|||
164251059|NCT02311881|593284126|FG001|Overall Study|Participant taking another medication|0|||
164251060|NCT02311881|593284127|FG002|Overall Study|Participant taking another medication|1|||
164251061|NCT02311881|593284125|FG000|Overall Study|Serious Adverse Event|0|||
164251062|NCT02311881|593284126|FG001|Overall Study|Serious Adverse Event|1|||
164251063|NCT02311881|593284127|FG002|Overall Study|Serious Adverse Event|0|||
164426895|NCT01544582|593930901|FG003|Analysis Population|Programmed Surgery|0|||
164426896|NCT01544582|593930898|FG000|Analysis Population|Participant in Jail|0|||
164426897|NCT01544582|593930899|FG001|Analysis Population|Participant in Jail|0|||
164426898|NCT01544582|593930900|FG002|Analysis Population|Participant in Jail|1|||
164426899|NCT01544582|593930901|FG003|Analysis Population|Participant in Jail|0|||
164426900|NCT03015740|593930904|FG000|Overall Study|Adverse Event|1|||
164426901|NCT03015740|593930905|FG001|Overall Study|Adverse Event|0|||
164426902|NCT03015740|593930906|FG002|Overall Study|Adverse Event|0|||
164426903|NCT03015740|593930904|FG000|Overall Study|Death|3|||
164426904|NCT03015740|593930905|FG001|Overall Study|Death|5|||
164426905|NCT03015740|593930906|FG002|Overall Study|Death|0|||
164426906|NCT03015740|593930904|FG000|Overall Study|Withdrawal by Subject|2|||
164426907|NCT03015740|593930905|FG001|Overall Study|Withdrawal by Subject|0|||
164426908|NCT03015740|593930906|FG002|Overall Study|Withdrawal by Subject|0|||
164426909|NCT05194735|593932726|FG000|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
164426910|NCT05194735|593932727|FG001|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|1|||
164251064|NCT03306433|593284128|FG000|Overall Study|Lost to Follow-up|3|||
164251065|NCT03306433|593284128|FG000|Overall Study|Patient did not have teeth extracted|1|||
164251066|NCT03306433|593284128|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
164251067|NCT00451958|593284129|FG000|CS21A (NCT00451958)|Adverse Event|21|||
164251068|NCT00451958|593284130|FG001|CS21A (NCT00451958)|Adverse Event|34|||
164251069|NCT00451958|593284131|FG002|CS21A (NCT00451958)|Adverse Event|14|||
164251070|NCT00451958|593284132|FG003|CS21A (NCT00451958)|Adverse Event|17|||
164251071|NCT00451958|593284133|FG004|CS21A (NCT00451958)|Adverse Event|0|||
164251072|NCT00451958|593284129|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
164251073|NCT00451958|593284130|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
164251074|NCT00451958|593284131|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
164251075|NCT00451958|593284132|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
164251076|NCT00451958|593284133|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
164251077|NCT00451958|593284129|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
164251078|NCT00451958|593284130|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
164251079|NCT00451958|593284131|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
164251080|NCT00451958|593284132|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
164251081|NCT00451958|593284133|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
164251082|NCT00451958|593284129|FG000|CS21A (NCT00451958)|Physician Decision|2|||
164251083|NCT00451958|593284130|FG001|CS21A (NCT00451958)|Physician Decision|4|||
164251084|NCT00451958|593284131|FG002|CS21A (NCT00451958)|Physician Decision|4|||
164251085|NCT00451958|593284132|FG003|CS21A (NCT00451958)|Physician Decision|4|||
164251086|NCT00451958|593284133|FG004|CS21A (NCT00451958)|Physician Decision|0|||
164251087|NCT00451958|593284129|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
164251088|NCT00451958|593284130|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
164251089|NCT00451958|593284131|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
164251090|NCT00451958|593284132|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
164251091|NCT00451958|593284133|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
164251092|NCT00451958|593284129|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
164251093|NCT00451958|593284130|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
164251094|NCT00451958|593284131|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
164251095|NCT00451958|593284132|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
164251096|NCT00451958|593284133|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
164251097|NCT01042158|593284136|FG000|Overall Study|Physician Decision|1|||
164251098|NCT01575808|593284137|FG000|Overall Study|Death|2|||
164251099|NCT01575808|593284138|FG001|Overall Study|Death|0|||
164251100|NCT01575808|593284137|FG000|Overall Study|Withdrawal by Subject|1|||
164251101|NCT01575808|593284138|FG001|Overall Study|Withdrawal by Subject|0|||
164251102|NCT00875485|593286206|FG000|Challenge Dose Epoch|Pregnancy|1|||
164251103|NCT00875485|593286207|FG001|Challenge Dose Epoch|Pregnancy|0|||
164251104|NCT01271010|593286208|FG000|Overall Study|Reason not specified|11|||
164251105|NCT01271010|593286208|FG000|Overall Study|Start of new CLL therapy|1|||
164251106|NCT01271010|593286208|FG000|Overall Study|Protocol Violation|1|||
164251107|NCT01271010|593286208|FG000|Overall Study|Death|2|||
164251108|NCT01271010|593286208|FG000|Overall Study|Progression and relapse of disease|1|||
164251109|NCT01271010|593286208|FG000|Overall Study|Withdrawal by Subject|18|||
164251110|NCT01271010|593286208|FG000|Overall Study|Disease progression|27|||
164251111|NCT01631747|593286209|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
164251112|NCT01631747|593286210|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
164251113|NCT01631747|593286209|FG000|Live Birth|Pregnancy Termination|1|||
164251114|NCT01631747|593286210|FG001|Live Birth|Pregnancy Termination|0|||
164251115|NCT01631747|593286209|FG000|Live Birth|MIscarriage|2|||
164251116|NCT01631747|593286210|FG001|Live Birth|MIscarriage|0|||
164251117|NCT01631747|593286209|FG000|Live Birth|Stillbirth|1|||
164251118|NCT01631747|593286210|FG001|Live Birth|Stillbirth|1|||
164251119|NCT01631747|593286209|FG000|One Year Infant Outcomes|Patient Refused|13|||
164251120|NCT01631747|593286210|FG001|One Year Infant Outcomes|Patient Refused|9|||
164251121|NCT02908685|593286211|FG000|Part 1 OLE|Withdrawal by Subject|0|||
164251122|NCT02908685|593286212|FG001|Part 1 OLE|Withdrawal by Subject|0|||
164251123|NCT02908685|593286213|FG002|Part 1 OLE|Withdrawal by Subject|0|||
164251124|NCT02908685|593286214|FG003|Part 1 OLE|Withdrawal by Subject|0|||
164338728|NCT02557295|593615236|FG003|Overall Study|Withdrawal by Subject|0|||
164338729|NCT02557295|593615237|FG004|Overall Study|Withdrawal by Subject|0|||
164338730|NCT02557295|593615238|FG005|Overall Study|Withdrawal by Subject|0|||
164251125|NCT02908685|593286215|FG004|Part 1 OLE|Withdrawal by Subject|0|||
164251126|NCT02908685|593286216|FG005|Part 1 OLE|Withdrawal by Subject|0|||
164251127|NCT02908685|593286217|FG006|Part 1 OLE|Withdrawal by Subject|0|||
164251128|NCT02908685|593286218|FG007|Part 1 OLE|Withdrawal by Subject|0|||
164251129|NCT02908685|593286219|FG008|Part 1 OLE|Withdrawal by Subject|0|||
164251130|NCT02908685|593286220|FG009|Part 1 OLE|Withdrawal by Subject|0|||
164251131|NCT02908685|593286221|FG010|Part 1 OLE|Withdrawal by Subject|2|||
164251132|NCT02908685|593286222|FG011|Part 1 OLE|Withdrawal by Subject|1|||
164251133|NCT02908685|593286223|FG012|Part 1 OLE|Withdrawal by Subject|0|||
164251134|NCT02908685|593286224|FG013|Part 1 OLE|Withdrawal by Subject|0|||
164251135|NCT02908685|593286211|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
164251136|NCT02908685|593286212|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
164251137|NCT02908685|593286213|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
164251138|NCT02908685|593286214|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
164251139|NCT02908685|593286215|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
164251140|NCT02908685|593286216|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
164251141|NCT02908685|593286217|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
164251142|NCT02908685|593286218|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
164251143|NCT02908685|593286219|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
164251144|NCT02908685|593286220|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
164251145|NCT02908685|593286221|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
164251146|NCT02908685|593286222|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
164251147|NCT02908685|593286223|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
164251148|NCT02908685|593286224|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
164251149|NCT02908685|593286211|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251150|NCT02908685|593286212|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251151|NCT02908685|593286213|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251152|NCT02908685|593286214|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251153|NCT02908685|593286215|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251154|NCT02908685|593286216|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251155|NCT02908685|593286217|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251156|NCT02908685|593286218|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251157|NCT02908685|593286219|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251158|NCT02908685|593286220|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251159|NCT02908685|593286221|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251160|NCT02908685|593286222|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251161|NCT02908685|593286223|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
164251162|NCT02908685|593286224|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251163|NCT02908685|593286211|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251164|NCT02908685|593286212|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251165|NCT02908685|593286213|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251166|NCT02908685|593286214|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251167|NCT02908685|593286215|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251168|NCT02908685|593286216|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251169|NCT02908685|593286217|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251170|NCT02908685|593286218|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251171|NCT02908685|593286219|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251172|NCT02908685|593286220|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251173|NCT02908685|593286221|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251174|NCT02908685|593286222|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251175|NCT02908685|593286223|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
164251176|NCT02908685|593286224|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251177|NCT02908685|593286211|FG000|Part 2 OLE: > Month 24|Death|0|||
164251178|NCT02908685|593286212|FG001|Part 2 OLE: > Month 24|Death|0|||
164251179|NCT02908685|593286213|FG002|Part 2 OLE: > Month 24|Death|0|||
164251180|NCT02908685|593286214|FG003|Part 2 OLE: > Month 24|Death|0|||
164251181|NCT02908685|593286215|FG004|Part 2 OLE: > Month 24|Death|0|||
164251182|NCT02908685|593286216|FG005|Part 2 OLE: > Month 24|Death|0|||
164251183|NCT02908685|593286217|FG006|Part 2 OLE: > Month 24|Death|0|||
164251184|NCT02908685|593286218|FG007|Part 2 OLE: > Month 24|Death|0|||
164251185|NCT02908685|593286219|FG008|Part 2 OLE: > Month 24|Death|0|||
164251186|NCT02908685|593286220|FG009|Part 2 OLE: > Month 24|Death|0|||
164251187|NCT02908685|593286221|FG010|Part 2 OLE: > Month 24|Death|0|||
164251188|NCT02908685|593286222|FG011|Part 2 OLE: > Month 24|Death|0|||
164251189|NCT02908685|593286223|FG012|Part 2 OLE: > Month 24|Death|1|||
164251190|NCT02908685|593286224|FG013|Part 2 OLE: > Month 24|Death|0|||
164251191|NCT02908685|593286211|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
164251192|NCT02908685|593286212|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
164251193|NCT02908685|593286213|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
164251194|NCT02908685|593286214|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
164251195|NCT02908685|593286215|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
164251196|NCT02908685|593286216|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
164251197|NCT02908685|593286217|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
164338731|NCT02557295|593615239|FG006|Overall Study|Withdrawal by Subject|15|||
164338732|NCT02557295|593615240|FG007|Overall Study|Withdrawal by Subject|1|||
164338733|NCT02557295|593615241|FG008|Overall Study|Withdrawal by Subject|3|||
164251198|NCT02908685|593286218|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
164251199|NCT02908685|593286219|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
164251200|NCT02908685|593286220|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
164251201|NCT02908685|593286221|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
164251202|NCT02908685|593286222|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
164251203|NCT02908685|593286223|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
164251204|NCT02908685|593286224|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
164251205|NCT02908685|593286211|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
164251206|NCT02908685|593286212|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
164251207|NCT02908685|593286213|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
164251208|NCT02908685|593286214|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
164251209|NCT02908685|593286215|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
164251210|NCT02908685|593286216|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
164251211|NCT02908685|593286217|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
164251212|NCT02908685|593286218|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
164251213|NCT02908685|593286219|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
164251214|NCT02908685|593286220|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
164251215|NCT02908685|593286221|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
164251216|NCT02908685|593286222|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
164251217|NCT02908685|593286223|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
164251218|NCT02908685|593286224|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
164251219|NCT02954406|593286225|FG000|Overall Study|Adverse Event|0|||
164251220|NCT02954406|593286226|FG001|Overall Study|Adverse Event|1|||
164251221|NCT02954406|593286227|FG002|Overall Study|Adverse Event|0|||
164251222|NCT02954406|593286228|FG003|Overall Study|Adverse Event|0|||
164251223|NCT02954406|593286229|FG004|Overall Study|Adverse Event|1|||
164251224|NCT02954406|593286230|FG005|Overall Study|Adverse Event|0|||
164251225|NCT02954406|593286231|FG006|Overall Study|Adverse Event|0|||
164251226|NCT02954406|593286232|FG007|Overall Study|Adverse Event|0|||
164251227|NCT02954406|593286233|FG008|Overall Study|Adverse Event|1|||
164251228|NCT02954406|593286234|FG009|Overall Study|Adverse Event|1|||
164251229|NCT02954406|593286235|FG010|Overall Study|Adverse Event|0|||
164251230|NCT02954406|593286225|FG000|Overall Study|Progressive Disease|3|||
164251231|NCT02954406|593286226|FG001|Overall Study|Progressive Disease|4|||
164251232|NCT02954406|593286227|FG002|Overall Study|Progressive Disease|3|||
164251233|NCT02954406|593286228|FG003|Overall Study|Progressive Disease|4|||
164251234|NCT02954406|593286229|FG004|Overall Study|Progressive Disease|3|||
164251235|NCT02954406|593286230|FG005|Overall Study|Progressive Disease|3|||
164251236|NCT02954406|593286231|FG006|Overall Study|Progressive Disease|2|||
164251237|NCT02954406|593286232|FG007|Overall Study|Progressive Disease|2|||
164251238|NCT02954406|593286233|FG008|Overall Study|Progressive Disease|1|||
164251239|NCT02954406|593286234|FG009|Overall Study|Progressive Disease|1|||
164251240|NCT02954406|593286235|FG010|Overall Study|Progressive Disease|0|||
164251241|NCT02954406|593286225|FG000|Overall Study|Symptomatic Deterioration|0|||
164251242|NCT02954406|593286226|FG001|Overall Study|Symptomatic Deterioration|1|||
164251243|NCT02954406|593286227|FG002|Overall Study|Symptomatic Deterioration|0|||
164251244|NCT02954406|593286228|FG003|Overall Study|Symptomatic Deterioration|0|||
164251245|NCT02954406|593286229|FG004|Overall Study|Symptomatic Deterioration|0|||
164251246|NCT02954406|593286230|FG005|Overall Study|Symptomatic Deterioration|0|||
164251247|NCT02954406|593286231|FG006|Overall Study|Symptomatic Deterioration|0|||
164251248|NCT02954406|593286232|FG007|Overall Study|Symptomatic Deterioration|0|||
164251249|NCT02954406|593286233|FG008|Overall Study|Symptomatic Deterioration|0|||
164251250|NCT02954406|593286234|FG009|Overall Study|Symptomatic Deterioration|0|||
164251251|NCT02954406|593286235|FG010|Overall Study|Symptomatic Deterioration|0|||
164251252|NCT02954406|593286225|FG000|Overall Study|Death|0|||
164251253|NCT02954406|593286226|FG001|Overall Study|Death|0|||
164251254|NCT02954406|593286227|FG002|Overall Study|Death|0|||
164251255|NCT02954406|593286228|FG003|Overall Study|Death|0|||
164251256|NCT02954406|593286229|FG004|Overall Study|Death|1|||
164251257|NCT02954406|593286230|FG005|Overall Study|Death|0|||
164251258|NCT02954406|593286231|FG006|Overall Study|Death|0|||
164251259|NCT02954406|593286232|FG007|Overall Study|Death|0|||
164251260|NCT02954406|593286233|FG008|Overall Study|Death|1|||
164251261|NCT02954406|593286234|FG009|Overall Study|Death|1|||
164251262|NCT02954406|593286235|FG010|Overall Study|Death|0|||
164251263|NCT02954406|593286225|FG000|Overall Study|Reason Not Specified|0|||
164251264|NCT02954406|593286226|FG001|Overall Study|Reason Not Specified|0|||
164338734|NCT02557295|593615233|FG000|Overall Study|Disease Progression|0|||
164338735|NCT02557295|593615234|FG001|Overall Study|Disease Progression|0|||
164338736|NCT02557295|593615235|FG002|Overall Study|Disease Progression|0|||
164251265|NCT02954406|593286227|FG002|Overall Study|Reason Not Specified|3|||
164251266|NCT02954406|593286228|FG003|Overall Study|Reason Not Specified|2|||
164251267|NCT02954406|593286229|FG004|Overall Study|Reason Not Specified|2|||
164251268|NCT02954406|593286230|FG005|Overall Study|Reason Not Specified|0|||
164251269|NCT02954406|593286231|FG006|Overall Study|Reason Not Specified|1|||
164251270|NCT02954406|593286232|FG007|Overall Study|Reason Not Specified|0|||
164251271|NCT02954406|593286233|FG008|Overall Study|Reason Not Specified|1|||
164251272|NCT02954406|593286234|FG009|Overall Study|Reason Not Specified|0|||
164251273|NCT02954406|593286235|FG010|Overall Study|Reason Not Specified|0|||
164251274|NCT00782171|593286236|FG000|Overall Study|Lost to Follow-up|2|||
164251275|NCT00782171|593286237|FG001|Overall Study|Lost to Follow-up|2|||
164251276|NCT00782171|593286236|FG000|Overall Study|Withdrawal by Subject|2|||
164251277|NCT00782171|593286237|FG001|Overall Study|Withdrawal by Subject|1|||
164251278|NCT00782171|593286236|FG000|Overall Study|complications|3|||
164426911|NCT05194735|593932728|FG002|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
164426912|NCT05194735|593932726|FG000|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
164426913|NCT05194735|593932727|FG001|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|1|||
164426914|NCT05194735|593932728|FG002|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
164426915|NCT05194735|593932726|FG000|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
164426916|NCT05194735|593932727|FG001|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|3|||
164426917|NCT05194735|593932728|FG002|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
164426918|NCT05194735|593932726|FG000|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
164426919|NCT05194735|593932727|FG001|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|1|||
164426920|NCT05194735|593932728|FG002|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
164426921|NCT00731042|593932729|FG000|Second Intervention|Did not meet inclusion criteria|0|||
164426922|NCT00731042|593932730|FG001|Second Intervention|Did not meet inclusion criteria|2|||
164426923|NCT02624778|593932731|FG000|Overall Study|Lost to Follow-up|0|||
164426924|NCT02624778|593932732|FG001|Overall Study|Lost to Follow-up|0|||
164426925|NCT02624778|593932733|FG002|Overall Study|Lost to Follow-up|1|||
164426926|NCT02624778|593932734|FG003|Overall Study|Lost to Follow-up|0|||
164426927|NCT02624778|593932735|FG004|Overall Study|Lost to Follow-up|0|||
164575832|NCT03093155|594471748|FG000|Overall Study|Withdrawal by Subject|0|||
164251279|NCT00782171|593286237|FG001|Overall Study|complications|1|||
164251280|NCT00782171|593286236|FG000|Overall Study|others|7|||
164251281|NCT00782171|593286237|FG001|Overall Study|others|9|||
164251282|NCT00782171|593286236|FG000|Overall Study|not eligible|8|||
164251283|NCT00782171|593286237|FG001|Overall Study|not eligible|6|||
164251284|NCT01691014|593286238|FG000|Overall Study|Premature Termination|1|||
164338737|NCT02557295|593615236|FG003|Overall Study|Disease Progression|0|||
164338738|NCT02557295|593615237|FG004|Overall Study|Disease Progression|0|||
164575833|NCT03093155|594471749|FG001|Overall Study|Withdrawal by Subject|1|||
164575834|NCT01700829|594471750|FG000|Overall Study|Withdrawal by Subject|1|||
164575835|NCT01700829|594471751|FG001|Overall Study|Withdrawal by Subject|1|||
164575836|NCT02786901|594471752|FG000|Overall Study|Adverse Event|1|||
164575837|NCT02786901|594471753|FG001|Overall Study|Adverse Event|1|||
164575838|NCT02786901|594471754|FG002|Overall Study|Adverse Event|2|||
164575839|NCT02786901|594471752|FG000|Overall Study|Physician Decision|1|||
164575840|NCT02786901|594471753|FG001|Overall Study|Physician Decision|0|||
164575841|NCT02786901|594471754|FG002|Overall Study|Physician Decision|0|||
164575842|NCT02786901|594471752|FG000|Overall Study|Rescue Therapy Use|71|||
164575843|NCT02786901|594471753|FG001|Overall Study|Rescue Therapy Use|49|||
164575844|NCT02786901|594471754|FG002|Overall Study|Rescue Therapy Use|33|||
164575845|NCT02786901|594471752|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
164575846|NCT02786901|594471753|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
164680329|NCT00112437|594854571|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164680330|NCT00112437|594854572|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
164680331|NCT00112437|594854573|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164680332|NCT00112437|594854574|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164680333|NCT00112437|594854575|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164680334|NCT00112437|594854576|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164680335|NCT00112437|594854577|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164680336|NCT00112437|594854578|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164680337|NCT00112437|594854579|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164680338|NCT00112437|594854580|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164680339|NCT00112437|594854581|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164680340|NCT00112437|594854582|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164680341|NCT00112437|594854583|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164338739|NCT02557295|593615238|FG005|Overall Study|Disease Progression|0|||
164338740|NCT02557295|593615239|FG006|Overall Study|Disease Progression|1|||
164338741|NCT02557295|593615240|FG007|Overall Study|Disease Progression|0|||
164338742|NCT02557295|593615241|FG008|Overall Study|Disease Progression|0|||
164338743|NCT02557295|593615233|FG000|Overall Study|Lack of Efficacy|24|||
164338744|NCT02557295|593615234|FG001|Overall Study|Lack of Efficacy|1|||
164338745|NCT02557295|593615235|FG002|Overall Study|Lack of Efficacy|3|||
164338746|NCT02557295|593615236|FG003|Overall Study|Lack of Efficacy|0|||
164338747|NCT02557295|593615237|FG004|Overall Study|Lack of Efficacy|0|||
164338748|NCT02557295|593615238|FG005|Overall Study|Lack of Efficacy|0|||
164338749|NCT02557295|593615239|FG006|Overall Study|Lack of Efficacy|12|||
164338750|NCT02557295|593615240|FG007|Overall Study|Lack of Efficacy|1|||
164338751|NCT02557295|593615241|FG008|Overall Study|Lack of Efficacy|0|||
164338752|NCT02557295|593615233|FG000|Overall Study|Adverse Event|16|||
164338753|NCT02557295|593615234|FG001|Overall Study|Adverse Event|2|||
164338754|NCT02557295|593615235|FG002|Overall Study|Adverse Event|3|||
164338755|NCT02557295|593615236|FG003|Overall Study|Adverse Event|0|||
164338756|NCT02557295|593615237|FG004|Overall Study|Adverse Event|0|||
164338757|NCT02557295|593615238|FG005|Overall Study|Adverse Event|0|||
164338758|NCT02557295|593615239|FG006|Overall Study|Adverse Event|2|||
164338759|NCT02557295|593615240|FG007|Overall Study|Adverse Event|1|||
164338760|NCT02557295|593615241|FG008|Overall Study|Adverse Event|1|||
164338761|NCT02557295|593615233|FG000|Overall Study|Lost to Follow-up|4|||
164338762|NCT02557295|593615234|FG001|Overall Study|Lost to Follow-up|0|||
164338763|NCT02557295|593615235|FG002|Overall Study|Lost to Follow-up|0|||
164338764|NCT02557295|593615236|FG003|Overall Study|Lost to Follow-up|0|||
164338765|NCT02557295|593615237|FG004|Overall Study|Lost to Follow-up|0|||
164338766|NCT02557295|593615238|FG005|Overall Study|Lost to Follow-up|0|||
164338767|NCT02557295|593615239|FG006|Overall Study|Lost to Follow-up|9|||
164338768|NCT02557295|593615240|FG007|Overall Study|Lost to Follow-up|0|||
164338769|NCT02557295|593615241|FG008|Overall Study|Lost to Follow-up|0|||
164338770|NCT02557295|593615233|FG000|Overall Study|Study Close|54|||
164338771|NCT02557295|593615234|FG001|Overall Study|Study Close|3|||
164338772|NCT02557295|593615235|FG002|Overall Study|Study Close|5|||
164338773|NCT02557295|593615236|FG003|Overall Study|Study Close|3|||
164338774|NCT02557295|593615237|FG004|Overall Study|Study Close|0|||
164338775|NCT02557295|593615238|FG005|Overall Study|Study Close|0|||
164338776|NCT02557295|593615239|FG006|Overall Study|Study Close|37|||
164575847|NCT02786901|594471754|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
164575848|NCT02786901|594471752|FG000|Overall Study|Disallowed medication|1|||
164251285|NCT01691014|593286239|FG001|Overall Study|Premature Termination|6|||
164251286|NCT01691014|593286240|FG002|Overall Study|Premature Termination|0|||
164575849|NCT02786901|594471753|FG001|Overall Study|Disallowed medication|1|||
164575850|NCT02786901|594471754|FG002|Overall Study|Disallowed medication|0|||
164680342|NCT00112437|594854584|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164680343|NCT00112437|594854585|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164680344|NCT00112437|594854586|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164575851|NCT02786901|594471752|FG000|Overall Study|Randomized in error|2|||
164575852|NCT02786901|594471753|FG001|Overall Study|Randomized in error|0|||
164575853|NCT02786901|594471754|FG002|Overall Study|Randomized in error|1|||
164575854|NCT01075178|594471755|FG000|Subject Matching|eligible but not matched|130|||
164575855|NCT01075178|594471756|FG001|Subject Matching|eligible but not matched|403|||
164575856|NCT01075178|594471755|FG000|Subject Chart Review|died before chart review period|0|||
164575857|NCT01075178|594471756|FG001|Subject Chart Review|died before chart review period|2|||
164575858|NCT01075178|594471755|FG000|Subject Chart Review|no data collected due to site closure|3|||
164575859|NCT01075178|594471756|FG001|Subject Chart Review|no data collected due to site closure|4|||
164575860|NCT01075178|594471755|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
164575861|NCT01075178|594471756|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
164575862|NCT02983604|594471757|FG000|Overall Study|Enrolled but not Treated|0|||
164575863|NCT02983604|594471758|FG001|Overall Study|Enrolled but not Treated|0|||
164251287|NCT01691014|593286241|FG003|Overall Study|Premature Termination|3|||
164251288|NCT01691014|593286238|FG000|Overall Study|Other|0|||
164251289|NCT01691014|593286239|FG001|Overall Study|Other|0|||
164251290|NCT01691014|593286240|FG002|Overall Study|Other|2|||
164575864|NCT02983604|594471759|FG002|Overall Study|Enrolled but not Treated|1|||
164575865|NCT02983604|594471760|FG003|Overall Study|Enrolled but not Treated|0|||
164575866|NCT00607048|594471762|FG000|Overall Study|Adverse Event|0|||
164575867|NCT00607048|594471763|FG001|Overall Study|Adverse Event|1|||
164575868|NCT00607048|594471764|FG002|Overall Study|Adverse Event|0|||
164575869|NCT00607048|594471765|FG003|Overall Study|Adverse Event|0|||
164575870|NCT00607048|594471766|FG004|Overall Study|Adverse Event|4|||
164575871|NCT00607048|594471767|FG005|Overall Study|Adverse Event|0|||
164575872|NCT00607048|594471762|FG000|Overall Study|Global deterioration of health|1|||
164575873|NCT00607048|594471763|FG001|Overall Study|Global deterioration of health|0|||
164575874|NCT00607048|594471764|FG002|Overall Study|Global deterioration of health|0|||
164575875|NCT00607048|594471765|FG003|Overall Study|Global deterioration of health|0|||
164575876|NCT00607048|594471766|FG004|Overall Study|Global deterioration of health|0|||
164575877|NCT00607048|594471767|FG005|Overall Study|Global deterioration of health|0|||
164575878|NCT00607048|594471762|FG000|Overall Study|Objective disease progression - relapse|1|||
164575879|NCT00607048|594471763|FG001|Overall Study|Objective disease progression - relapse|2|||
164575880|NCT00607048|594471764|FG002|Overall Study|Objective disease progression - relapse|4|||
164575881|NCT00607048|594471765|FG003|Overall Study|Objective disease progression - relapse|2|||
164575882|NCT00607048|594471766|FG004|Overall Study|Objective disease progression - relapse|2|||
164575883|NCT00607048|594471767|FG005|Overall Study|Objective disease progression - relapse|2|||
164575884|NCT00607048|594471762|FG000|Overall Study|Withdrawal by Subject|0|||
164575885|NCT00607048|594471763|FG001|Overall Study|Withdrawal by Subject|0|||
164575886|NCT00607048|594471764|FG002|Overall Study|Withdrawal by Subject|0|||
164575887|NCT00607048|594471765|FG003|Overall Study|Withdrawal by Subject|1|||
164575888|NCT00607048|594471766|FG004|Overall Study|Withdrawal by Subject|0|||
164575889|NCT00607048|594471767|FG005|Overall Study|Withdrawal by Subject|2|||
164575890|NCT00607048|594471762|FG000|Overall Study|Other|1|||
164575891|NCT00607048|594471763|FG001|Overall Study|Other|1|||
164575892|NCT00607048|594471764|FG002|Overall Study|Other|0|||
164251291|NCT01691014|593286241|FG003|Overall Study|Other|0|||
164251292|NCT01691014|593286238|FG000|Overall Study|Withdrawal by Subject|0|||
164251293|NCT01691014|593286239|FG001|Overall Study|Withdrawal by Subject|1|||
164251294|NCT01691014|593286240|FG002|Overall Study|Withdrawal by Subject|1|||
164251295|NCT01691014|593286241|FG003|Overall Study|Withdrawal by Subject|1|||
164251296|NCT01691014|593286238|FG000|Overall Study|Adverse Event|0|||
164251297|NCT01691014|593286239|FG001|Overall Study|Adverse Event|5|||
164251298|NCT01691014|593286240|FG002|Overall Study|Adverse Event|1|||
164251299|NCT01691014|593286241|FG003|Overall Study|Adverse Event|1|||
164251300|NCT01691014|593286238|FG000|Overall Study|Lack of Efficacy|2|||
164251301|NCT01691014|593286239|FG001|Overall Study|Lack of Efficacy|3|||
164251302|NCT01691014|593286240|FG002|Overall Study|Lack of Efficacy|7|||
164338777|NCT02557295|593615240|FG007|Overall Study|Study Close|3|||
164338778|NCT02557295|593615241|FG008|Overall Study|Study Close|19|||
164575893|NCT00607048|594471765|FG003|Overall Study|Other|0|||
164575894|NCT00607048|594471766|FG004|Overall Study|Other|0|||
164575895|NCT00607048|594471767|FG005|Overall Study|Other|1|||
164575896|NCT04336163|594471768|FG000|Overall Study|Lost to Follow-up|55|||
164575897|NCT04336163|594471769|FG001|Overall Study|Lost to Follow-up|0|||
164575898|NCT04927312|594471772|FG000|Overall Study|Adverse Event|1|||
164251303|NCT01691014|593286241|FG003|Overall Study|Lack of Efficacy|0|||
164251304|NCT05897242|593286244|FG000|Overall Study|Lost to Follow-up|6|||
164251305|NCT05897242|593286245|FG001|Overall Study|Lost to Follow-up|1|||
164251306|NCT05897242|593286244|FG000|Overall Study|Incomplete|1|||
164251307|NCT05897242|593286245|FG001|Overall Study|Incomplete|0|||
164251308|NCT05897242|593286244|FG000|Overall Study|Withdrawal by Subject|1|||
164575899|NCT04927312|594471772|FG000|Overall Study|Death|1|||
164251309|NCT05897242|593286245|FG001|Overall Study|Withdrawal by Subject|0|||
164251310|NCT03522246|593286246|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
164251311|NCT03522246|593286247|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
164251312|NCT03522246|593286248|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
164251313|NCT03522246|593286249|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
164251314|NCT03522246|593286250|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
164251315|NCT00814580|593286251|FG000|Overall Study|Adverse Event|6|||
164251316|NCT00814580|593286252|FG001|Overall Study|Adverse Event|15|||
164251317|NCT00814580|593286251|FG000|Overall Study|Lack of Efficacy|18|||
164251318|NCT00814580|593286252|FG001|Overall Study|Lack of Efficacy|25|||
164251319|NCT00814580|593286251|FG000|Overall Study|Protocol Violation|2|||
164680345|NCT00112437|594854587|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164251320|NCT00814580|593286252|FG001|Overall Study|Protocol Violation|0|||
164251321|NCT00814580|593286251|FG000|Overall Study|Withdrawal by Subject|2|||
164251322|NCT00814580|593286252|FG001|Overall Study|Withdrawal by Subject|2|||
164251323|NCT00814580|593286251|FG000|Overall Study|Other|1|||
164251324|NCT00814580|593286252|FG001|Overall Study|Other|3|||
164251325|NCT00814580|593286251|FG000|Overall Study|Did Not Take Drug|2|||
164338779|NCT02557295|593615233|FG000|Overall Study|except for study close|4|||
164338780|NCT02557295|593615234|FG001|Overall Study|except for study close|0|||
164338781|NCT02557295|593615235|FG002|Overall Study|except for study close|0|||
164338782|NCT02557295|593615236|FG003|Overall Study|except for study close|0|||
164338783|NCT02557295|593615237|FG004|Overall Study|except for study close|0|||
164338784|NCT02557295|593615238|FG005|Overall Study|except for study close|0|||
164338785|NCT02557295|593615239|FG006|Overall Study|except for study close|5|||
164338786|NCT02557295|593615240|FG007|Overall Study|except for study close|1|||
164338787|NCT02557295|593615241|FG008|Overall Study|except for study close|0|||
164338788|NCT01798004|593617042|FG000|Overall Study|Death|2|||
164251326|NCT00814580|593286252|FG001|Overall Study|Did Not Take Drug|2|||
164251327|NCT02482428|593286253|FG000|Overall Study|Lost to Follow-up|4|||
164251328|NCT02482428|593286254|FG001|Overall Study|Lost to Follow-up|9|||
164251329|NCT02482428|593286255|FG002|Overall Study|Lost to Follow-up|1|||
164251330|NCT02482428|593286256|FG003|Overall Study|Lost to Follow-up|2|||
164251331|NCT02482428|593286257|FG004|Overall Study|Lost to Follow-up|4|||
164338789|NCT01798004|593617042|FG000|Overall Study|Lack of Efficacy|8|||
164338790|NCT01798004|593617042|FG000|Overall Study|Physician Decision|25|||
164338791|NCT01798004|593617042|FG000|Overall Study|Withdrawal by Subject|4|||
164338792|NCT01798004|593617042|FG000|Overall Study|Ineligible|4|||
164338793|NCT01798004|593617042|FG000|Overall Study|Patient/parent refusal|7|||
164338794|NCT01798004|593617042|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
164338795|NCT01798004|593617042|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
164338796|NCT03320057|593617043|FG000|Overall Study|Lost to Follow-up|4|||
164338797|NCT03320057|593617044|FG001|Overall Study|Lost to Follow-up|17|||
164338798|NCT03320057|593617043|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
164338799|NCT03320057|593617044|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
164338800|NCT06956170|593617045|FG000|Overall Study|Death|2|||
164338801|NCT06956170|593617046|FG001|Overall Study|Death|1|||
164338802|NCT06956170|593617045|FG000|Overall Study|Withdrawal by Subject|1|||
164338803|NCT06956170|593617046|FG001|Overall Study|Withdrawal by Subject|0|||
164338804|NCT06956170|593617045|FG000|Overall Study|Ongoing|7|||
164338805|NCT06956170|593617046|FG001|Overall Study|Ongoing|10|||
164338806|NCT02323113|593617047|FG000|Overall Study|Adverse Event|3|||
164338807|NCT02323113|593617048|FG001|Overall Study|Adverse Event|3|||
164338808|NCT02323113|593617049|FG002|Overall Study|Adverse Event|2|||
164338809|NCT02323113|593617050|FG003|Overall Study|Adverse Event|5|||
164338810|NCT02323113|593617051|FG004|Overall Study|Adverse Event|8|||
164338811|NCT02323113|593617052|FG005|Overall Study|Adverse Event|3|||
164338812|NCT02323113|593617053|FG006|Overall Study|Adverse Event|6|||
164338813|NCT02323113|593617054|FG007|Overall Study|Adverse Event|0|||
164338814|NCT02323113|593617047|FG000|Overall Study|Progressive Disease|0|||
164338815|NCT02323113|593617048|FG001|Overall Study|Progressive Disease|1|||
164338816|NCT02323113|593617049|FG002|Overall Study|Progressive Disease|1|||
164338817|NCT02323113|593617050|FG003|Overall Study|Progressive Disease|0|||
164338818|NCT02323113|593617051|FG004|Overall Study|Progressive Disease|0|||
164338819|NCT02323113|593617052|FG005|Overall Study|Progressive Disease|3|||
164338820|NCT02323113|593617053|FG006|Overall Study|Progressive Disease|0|||
164338821|NCT02323113|593617054|FG007|Overall Study|Progressive Disease|0|||
164338822|NCT02323113|593617047|FG000|Overall Study|Symptomatic Deterioration|0|||
164338823|NCT02323113|593617048|FG001|Overall Study|Symptomatic Deterioration|0|||
164338824|NCT02323113|593617049|FG002|Overall Study|Symptomatic Deterioration|1|||
164338825|NCT02323113|593617050|FG003|Overall Study|Symptomatic Deterioration|0|||
164338826|NCT02323113|593617051|FG004|Overall Study|Symptomatic Deterioration|1|||
164338827|NCT02323113|593617052|FG005|Overall Study|Symptomatic Deterioration|0|||
164338828|NCT02323113|593617053|FG006|Overall Study|Symptomatic Deterioration|0|||
164338829|NCT02323113|593617054|FG007|Overall Study|Symptomatic Deterioration|0|||
164338830|NCT02323113|593617047|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
164251332|NCT02482428|593286253|FG000|Overall Study|Physician Decision|0|||
164251333|NCT02482428|593286254|FG001|Overall Study|Physician Decision|0|||
164251334|NCT02482428|593286255|FG002|Overall Study|Physician Decision|0|||
164251335|NCT02482428|593286256|FG003|Overall Study|Physician Decision|0|||
164251336|NCT02482428|593286257|FG004|Overall Study|Physician Decision|1|||
164251337|NCT02482428|593286253|FG000|Overall Study|protocol deviation|1|||
164251338|NCT02482428|593286254|FG001|Overall Study|protocol deviation|1|||
164251339|NCT02482428|593286255|FG002|Overall Study|protocol deviation|0|||
164251340|NCT02482428|593286256|FG003|Overall Study|protocol deviation|0|||
164251341|NCT02482428|593286257|FG004|Overall Study|protocol deviation|0|||
164251342|NCT02482428|593286253|FG000|Overall Study|subject/guardian decision|4|||
164251343|NCT02482428|593286254|FG001|Overall Study|subject/guardian decision|2|||
164251344|NCT02482428|593286255|FG002|Overall Study|subject/guardian decision|0|||
164251345|NCT02482428|593286256|FG003|Overall Study|subject/guardian decision|0|||
164251346|NCT02482428|593286257|FG004|Overall Study|subject/guardian decision|2|||
164251347|NCT00809835|593286260|FG000|Overall Study|Lost to Follow-up|7|||
164251348|NCT00809835|593286261|FG001|Overall Study|Lost to Follow-up|6|||
164251349|NCT00809835|593286262|FG002|Overall Study|Lost to Follow-up|10|||
164251350|NCT00809835|593286263|FG003|Overall Study|Lost to Follow-up|2|||
164251351|NCT00809835|593286260|FG000|Overall Study|Withdrawal by Subject|1|||
164251352|NCT00809835|593286261|FG001|Overall Study|Withdrawal by Subject|1|||
164251353|NCT00809835|593286262|FG002|Overall Study|Withdrawal by Subject|1|||
164251354|NCT00809835|593286263|FG003|Overall Study|Withdrawal by Subject|0|||
164251355|NCT02547038|593286264|FG000|Overall Study|Lost to Follow-up|3|||
164251356|NCT02547038|593286265|FG001|Overall Study|Lost to Follow-up|2|||
164251357|NCT00516893|593286266|FG000|Overall Study|Lost to Follow-up|4|||
164251358|NCT00516893|593286266|FG000|Overall Study|Adverse Event|3|||
164251359|NCT00516893|593286266|FG000|Overall Study|Withdrawal by Subject|2|||
164251360|NCT00516893|593286266|FG000|Overall Study|Noncompliance|2|||
164251361|NCT00516893|593286266|FG000|Overall Study|Death|1|||
164251362|NCT00516893|593286266|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
164251363|NCT00516893|593286266|FG000|Overall Study|Relocated|1|||
164251364|NCT00516893|593286266|FG000|Overall Study|Pregnancy|1|||
164251365|NCT00516893|593286266|FG000|Overall Study|Received Medication From Another Study|1|||
164251366|NCT05924165|593286273|FG000|Overall Study|Physician Decision|2|||
164251367|NCT05924165|593286274|FG001|Overall Study|Physician Decision|3|||
164251368|NCT01681186|593286275|FG000|Washout Period From Second Intervention|Adverse Event|0|||
164251369|NCT01681186|593286276|FG001|Washout Period From Second Intervention|Adverse Event|0|||
164251370|NCT01681186|593286277|FG002|Washout Period From Second Intervention|Adverse Event|0|||
164251371|NCT01681186|593286278|FG003|Washout Period From Second Intervention|Adverse Event|0|||
164251372|NCT01681186|593286279|FG004|Washout Period From Second Intervention|Adverse Event|0|||
164251373|NCT01681186|593286280|FG005|Washout Period From Second Intervention|Adverse Event|0|||
164251374|NCT01681186|593286281|FG006|Washout Period From Second Intervention|Adverse Event|1|||
164251375|NCT01681186|593286282|FG007|Washout Period From Second Intervention|Adverse Event|0|||
164251376|NCT01681186|593286275|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
164251377|NCT01681186|593286276|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
164251378|NCT01681186|593286277|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
164251379|NCT01681186|593286278|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
164251380|NCT01681186|593286279|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
164251381|NCT01681186|593286280|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
164251382|NCT01681186|593286281|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
164426928|NCT02624778|593932736|FG005|Overall Study|Lost to Follow-up|0|||
164426929|NCT02624778|593932737|FG006|Overall Study|Lost to Follow-up|0|||
164426930|NCT02624778|593932738|FG007|Overall Study|Lost to Follow-up|0|||
164426931|NCT02624778|593932739|FG008|Overall Study|Lost to Follow-up|0|||
164426932|NCT02624778|593932731|FG000|Overall Study|Withdrawal by Subject|0|||
164426933|NCT02624778|593932732|FG001|Overall Study|Withdrawal by Subject|1|||
164426934|NCT02624778|593932733|FG002|Overall Study|Withdrawal by Subject|0|||
164426935|NCT02624778|593932734|FG003|Overall Study|Withdrawal by Subject|0|||
164426936|NCT02624778|593932735|FG004|Overall Study|Withdrawal by Subject|0|||
164426937|NCT02624778|593932736|FG005|Overall Study|Withdrawal by Subject|1|||
164426938|NCT02624778|593932737|FG006|Overall Study|Withdrawal by Subject|1|||
164426939|NCT02624778|593932738|FG007|Overall Study|Withdrawal by Subject|1|||
164426940|NCT02624778|593932739|FG008|Overall Study|Withdrawal by Subject|1|||
164426941|NCT02624778|593932731|FG000|Overall Study|Adverse Event|0|||
164426942|NCT02624778|593932732|FG001|Overall Study|Adverse Event|0|||
164426943|NCT02624778|593932733|FG002|Overall Study|Adverse Event|0|||
164426944|NCT02624778|593932734|FG003|Overall Study|Adverse Event|0|||
164426945|NCT02624778|593932735|FG004|Overall Study|Adverse Event|0|||
164426946|NCT02624778|593932736|FG005|Overall Study|Adverse Event|0|||
164426947|NCT02624778|593932737|FG006|Overall Study|Adverse Event|0|||
164426948|NCT02624778|593932738|FG007|Overall Study|Adverse Event|0|||
164426949|NCT02624778|593932739|FG008|Overall Study|Adverse Event|2|||
164426950|NCT02624778|593932731|FG000|Overall Study|Death|0|||
164426951|NCT02624778|593932732|FG001|Overall Study|Death|0|||
164680346|NCT00112437|594854588|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164680347|NCT00112437|594854589|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164251383|NCT01681186|593286282|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
164251384|NCT01681186|593286275|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
164251385|NCT01681186|593286276|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
164251386|NCT01681186|593286277|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
164251387|NCT01681186|593286278|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
164251388|NCT01681186|593286279|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
164251389|NCT01681186|593286280|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
164251390|NCT01681186|593286281|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
164251391|NCT01681186|593286282|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
164251392|NCT01681186|593286275|FG000|Fourth Intervention|Protocol Violation|0|||
164680348|NCT00112437|594854590|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164251393|NCT01681186|593286276|FG001|Fourth Intervention|Protocol Violation|0|||
164251394|NCT01681186|593286277|FG002|Fourth Intervention|Protocol Violation|0|||
164251395|NCT01681186|593286278|FG003|Fourth Intervention|Protocol Violation|0|||
164251396|NCT01681186|593286279|FG004|Fourth Intervention|Protocol Violation|0|||
164251397|NCT01681186|593286280|FG005|Fourth Intervention|Protocol Violation|0|||
164251398|NCT01681186|593286281|FG006|Fourth Intervention|Protocol Violation|0|||
164251399|NCT01681186|593286282|FG007|Fourth Intervention|Protocol Violation|1|||
164251400|NCT04308239|593286283|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
164251401|NCT04308239|593286284|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
164251402|NCT04308239|593286283|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
164251403|NCT04308239|593286284|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
164251404|NCT04308239|593286283|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
164251405|NCT04308239|593286284|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
164251406|NCT04308239|593286283|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
164251407|NCT04308239|593286284|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
164251408|NCT05791565|593286287|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
164251409|NCT05791565|593286288|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
164426952|NCT02624778|593932733|FG002|Overall Study|Death|0|||
164426953|NCT02624778|593932734|FG003|Overall Study|Death|0|||
164426954|NCT02624778|593932735|FG004|Overall Study|Death|0|||
164426955|NCT02624778|593932736|FG005|Overall Study|Death|0|||
164426956|NCT02624778|593932737|FG006|Overall Study|Death|1|||
164426957|NCT02624778|593932738|FG007|Overall Study|Death|0|||
164426958|NCT02624778|593932739|FG008|Overall Study|Death|0|||
164426959|NCT02624778|593932731|FG000|Overall Study|Physician Decision|0|||
164426960|NCT02624778|593932732|FG001|Overall Study|Physician Decision|0|||
164426961|NCT02624778|593932733|FG002|Overall Study|Physician Decision|0|||
164426962|NCT02624778|593932734|FG003|Overall Study|Physician Decision|0|||
164426963|NCT02624778|593932735|FG004|Overall Study|Physician Decision|0|||
164426964|NCT02624778|593932736|FG005|Overall Study|Physician Decision|0|||
164426965|NCT02624778|593932737|FG006|Overall Study|Physician Decision|0|||
164426966|NCT02624778|593932738|FG007|Overall Study|Physician Decision|3|||
164426967|NCT02624778|593932739|FG008|Overall Study|Physician Decision|3|||
164426968|NCT00231179|593932744|FG000|Overall Study|Lost to Follow-up|21|||
164680349|NCT00112437|594854591|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164426969|NCT00231179|593932745|FG001|Overall Study|Lost to Follow-up|21|||
164426970|NCT00231179|593932744|FG000|Overall Study|Withdrawal by Subject|3|||
164426971|NCT00231179|593932745|FG001|Overall Study|Withdrawal by Subject|3|||
164251410|NCT00880269|593286289|FG000|Overall Study|Protocol Violation|1|||
164251411|NCT00880269|593286290|FG001|Overall Study|Protocol Violation|0|||
164251412|NCT00880269|593286289|FG000|Overall Study|Disease Progression|13|||
164251413|NCT00880269|593286290|FG001|Overall Study|Disease Progression|11|||
164251414|NCT00880269|593286289|FG000|Overall Study|New Cancer Therapy|1|||
164251415|NCT00880269|593286290|FG001|Overall Study|New Cancer Therapy|0|||
164251416|NCT00880269|593286289|FG000|Overall Study|Death|4|||
164251417|NCT00880269|593286290|FG001|Overall Study|Death|2|||
164251418|NCT00880269|593286289|FG000|Overall Study|Lost to Follow-up|0|||
164251419|NCT00880269|593286290|FG001|Overall Study|Lost to Follow-up|1|||
164251420|NCT00880269|593286289|FG000|Overall Study|Withdrawal by Subject|3|||
164251421|NCT00880269|593286290|FG001|Overall Study|Withdrawal by Subject|4|||
164251422|NCT00880269|593286289|FG000|Overall Study|Adverse Event|10|||
164251423|NCT00880269|593286290|FG001|Overall Study|Adverse Event|9|||
164251424|NCT02516982|593286292|FG000|Overall Study|Called in to antenatal appointment|32|||
164251425|NCT02516982|593286293|FG001|Overall Study|Called in to antenatal appointment|35|||
164251426|NCT02516982|593286294|FG002|Overall Study|Called in to antenatal appointment|0|||
164251427|NCT02516982|593286295|FG003|Overall Study|Called in to antenatal appointment|0|||
164251428|NCT02516982|593286292|FG000|Overall Study|Withdrawal by Subject|0|||
164251429|NCT02516982|593286293|FG001|Overall Study|Withdrawal by Subject|0|||
164251430|NCT02516982|593286294|FG002|Overall Study|Withdrawal by Subject|1|||
164251431|NCT02516982|593286295|FG003|Overall Study|Withdrawal by Subject|2|||
164251432|NCT02516982|593286292|FG000|Overall Study|Protocol Violation|0|||
164251433|NCT02516982|593286293|FG001|Overall Study|Protocol Violation|0|||
164251434|NCT02516982|593286294|FG002|Overall Study|Protocol Violation|1|||
164251435|NCT02516982|593286295|FG003|Overall Study|Protocol Violation|1|||
164251436|NCT02516982|593286292|FG000|Overall Study|Did not install the app|0|||
164251437|NCT02516982|593286293|FG001|Overall Study|Did not install the app|0|||
164251438|NCT02516982|593286294|FG002|Overall Study|Did not install the app|46|||
164251439|NCT02516982|593286295|FG003|Overall Study|Did not install the app|47|||
164251440|NCT03645421|593286300|FG000|Overall Study|Adverse Event|0|||
164251441|NCT03645421|593286301|FG001|Overall Study|Adverse Event|0|||
164251442|NCT03645421|593286302|FG002|Overall Study|Adverse Event|4|||
164251443|NCT03645421|593286303|FG003|Overall Study|Adverse Event|1|||
164251444|NCT03645421|593286300|FG000|Overall Study|Withdrawal by patient|0|||
164251445|NCT03645421|593286301|FG001|Overall Study|Withdrawal by patient|0|||
164251446|NCT03645421|593286302|FG002|Overall Study|Withdrawal by patient|0|||
164251447|NCT03645421|593286303|FG003|Overall Study|Withdrawal by patient|3|||
164251448|NCT03645421|593286300|FG000|Overall Study|Study specific withdrawal criteria|0|||
164251449|NCT03645421|593286301|FG001|Overall Study|Study specific withdrawal criteria|0|||
164426972|NCT02491411|593932746|FG000|Overall Study|Physician Decision|4|||
164575900|NCT04927312|594471772|FG000|Overall Study|Withdrawal by Subject|1|||
164251450|NCT03645421|593286302|FG002|Overall Study|Study specific withdrawal criteria|1|||
164251451|NCT03645421|593286303|FG003|Overall Study|Study specific withdrawal criteria|0|||
164251452|NCT03379259|593286304|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
164251453|NCT03379259|593286305|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
164251454|NCT03379259|593286306|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
164426973|NCT04610684|593932749|FG000|Study Treatment|Withdrawal by Subject|1|||
164575901|NCT04927312|594471772|FG000|Overall Study|Other|1|||
164575902|NCT04919564|594471778|FG000|Overall Study|Lost to Follow-up|1|||
164575903|NCT04919564|594471779|FG001|Overall Study|Lost to Follow-up|0|||
164575904|NCT04919564|594471778|FG000|Overall Study|Physician Decision|1|||
164575905|NCT04919564|594471779|FG001|Overall Study|Physician Decision|1|||
164575906|NCT03812510|594471782|FG000|Overall Study|Lost to Follow-up|39|||
164575907|NCT03812510|594471782|FG000|Overall Study|Withdrawal by Subject|42|||
164575908|NCT03812510|594471782|FG000|Overall Study|Physician Decision|2|||
164575909|NCT03812510|594471782|FG000|Overall Study|Study Terminated by Sponsor|9|||
164575910|NCT03812510|594471782|FG000|Overall Study|Did Not Start Study Medication|55|||
164575911|NCT03812510|594471782|FG000|Overall Study|Adverse Event|5|||
164575912|NCT03168867|594471783|FG000|Overall Study|Withdrawal by Subject|1|||
164575913|NCT03168867|594471784|FG001|Overall Study|Withdrawal by Subject|5|||
164575914|NCT01128387|594471785|FG000|Overall Study|Physician Decision|0|||
164575915|NCT01128387|594471786|FG001|Overall Study|Physician Decision|1|||
164575916|NCT01440101|594471788|FG000|Overall Study|Adverse Event|2|||
164575917|NCT01440101|594471789|FG001|Overall Study|Adverse Event|0|||
164575918|NCT01440101|594471790|FG002|Overall Study|Adverse Event|0|||
164251455|NCT03379259|593286307|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
164251456|NCT03379259|593286308|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
164251457|NCT03379259|593286309|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
164426974|NCT04610684|593932749|FG000|Study Treatment|Disease Progression|2|||
164426975|NCT04610684|593932749|FG000|Follow up|Death|2|||
164575919|NCT01440101|594471788|FG000|Overall Study|Withdrawal by Subject|0|||
164575920|NCT01440101|594471789|FG001|Overall Study|Withdrawal by Subject|3|||
164575921|NCT01440101|594471790|FG002|Overall Study|Withdrawal by Subject|1|||
164575922|NCT01440101|594471788|FG000|Overall Study|Other|0|||
164575923|NCT01440101|594471789|FG001|Overall Study|Other|1|||
164575924|NCT01440101|594471790|FG002|Overall Study|Other|0|||
164251458|NCT03379259|593286304|FG000|Overall Study|Death|0|||
164426976|NCT04610684|593932749|FG000|Follow up|Withdrawal by Subject|1|||
164426977|NCT00359619|593932751|FG000|Overall Study|Adverse Event|0|||
164426978|NCT00359619|593932752|FG001|Overall Study|Adverse Event|0|||
164426979|NCT00359619|593932753|FG002|Overall Study|Adverse Event|1|||
164426980|NCT00359619|593932754|FG003|Overall Study|Adverse Event|0|||
164426981|NCT00359619|593932755|FG004|Overall Study|Adverse Event|0|||
164426982|NCT00359619|593932756|FG005|Overall Study|Adverse Event|0|||
164426983|NCT00359619|593932757|FG006|Overall Study|Adverse Event|1|||
164426984|NCT00359619|593932751|FG000|Overall Study|Withdrawal by Subject|3|||
164426985|NCT00359619|593932752|FG001|Overall Study|Withdrawal by Subject|1|||
164680350|NCT00112437|594854592|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164680351|NCT00112437|594854593|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164680352|NCT00112437|594854594|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164251459|NCT03379259|593286305|FG001|Overall Study|Death|1|||
164251460|NCT03379259|593286306|FG002|Overall Study|Death|2|||
164426986|NCT00359619|593932753|FG002|Overall Study|Withdrawal by Subject|4|||
164426987|NCT00359619|593932754|FG003|Overall Study|Withdrawal by Subject|2|||
164426988|NCT00359619|593932755|FG004|Overall Study|Withdrawal by Subject|2|||
164426989|NCT00359619|593932756|FG005|Overall Study|Withdrawal by Subject|0|||
164426990|NCT00359619|593932757|FG006|Overall Study|Withdrawal by Subject|3|||
164426991|NCT00359619|593932751|FG000|Overall Study|Other|1|||
164426992|NCT00359619|593932752|FG001|Overall Study|Other|0|||
164426993|NCT00359619|593932753|FG002|Overall Study|Other|0|||
164426994|NCT00359619|593932754|FG003|Overall Study|Other|0|||
164426995|NCT00359619|593932755|FG004|Overall Study|Other|0|||
164426996|NCT00359619|593932756|FG005|Overall Study|Other|0|||
164426997|NCT00359619|593932757|FG006|Overall Study|Other|0|||
164426998|NCT00359619|593932751|FG000|Overall Study|Lost to Follow-up|4|||
164426999|NCT00359619|593932752|FG001|Overall Study|Lost to Follow-up|4|||
164427000|NCT00359619|593932753|FG002|Overall Study|Lost to Follow-up|2|||
164251461|NCT03379259|593286307|FG003|Overall Study|Death|1|||
164251462|NCT03379259|593286308|FG004|Overall Study|Death|4|||
164251463|NCT03379259|593286309|FG005|Overall Study|Death|2|||
164251464|NCT03379259|593286304|FG000|Overall Study|Withdrawal by Subject|0|||
164251465|NCT03379259|593286305|FG001|Overall Study|Withdrawal by Subject|0|||
164251466|NCT03379259|593286306|FG002|Overall Study|Withdrawal by Subject|1|||
164251467|NCT03379259|593286307|FG003|Overall Study|Withdrawal by Subject|0|||
164251468|NCT03379259|593286308|FG004|Overall Study|Withdrawal by Subject|2|||
164251469|NCT03379259|593286309|FG005|Overall Study|Withdrawal by Subject|0|||
164251470|NCT03379259|593286304|FG000|Overall Study|Study terminated by sponsor|0|||
164251471|NCT03379259|593286305|FG001|Overall Study|Study terminated by sponsor|0|||
164427001|NCT00359619|593932754|FG003|Overall Study|Lost to Follow-up|1|||
164427002|NCT00359619|593932755|FG004|Overall Study|Lost to Follow-up|1|||
164427003|NCT00359619|593932756|FG005|Overall Study|Lost to Follow-up|5|||
164575925|NCT00659438|594471791|FG000|Overall Study|Withdrawal by Subject|2|||
164575926|NCT00659438|594471792|FG001|Overall Study|Withdrawal by Subject|2|||
164575927|NCT00659438|594471791|FG000|Overall Study|Death|11|||
164575928|NCT00659438|594471792|FG001|Overall Study|Death|6|||
164575929|NCT00659438|594471791|FG000|Overall Study|Lost to Follow-up|1|||
164575930|NCT00659438|594471792|FG001|Overall Study|Lost to Follow-up|0|||
164575931|NCT00404092|594471800|FG000|Overall Study|Death|1|||
164575932|NCT00404092|594471801|FG001|Overall Study|Death|0|||
164575933|NCT00404092|594471802|FG002|Overall Study|Death|0|||
164575934|NCT00404092|594471803|FG003|Overall Study|Death|0|||
164575935|NCT00404092|594471800|FG000|Overall Study|Adverse Event|0|||
164575936|NCT00404092|594471801|FG001|Overall Study|Adverse Event|0|||
164575937|NCT00404092|594471802|FG002|Overall Study|Adverse Event|1|||
164251472|NCT03379259|593286306|FG002|Overall Study|Study terminated by sponsor|0|||
164251473|NCT03379259|593286307|FG003|Overall Study|Study terminated by sponsor|1|||
164251474|NCT03379259|593286308|FG004|Overall Study|Study terminated by sponsor|1|||
164427004|NCT00359619|593932757|FG006|Overall Study|Lost to Follow-up|0|||
164427005|NCT04672460|593932758|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
164427006|NCT04672460|593932759|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
164427007|NCT04672460|593932758|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
164427008|NCT04672460|593932759|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
164427009|NCT04672460|593932758|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
164427010|NCT04672460|593932759|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
164427011|NCT04672460|593932758|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
164427012|NCT04672460|593932759|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
164427013|NCT04672460|593932758|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
164575938|NCT00404092|594471803|FG003|Overall Study|Adverse Event|0|||
164575939|NCT01275222|594471806|FG000|Phase l by Treatment|Adverse Event|1|||
164575940|NCT01275222|594471807|FG001|Phase l by Treatment|Adverse Event|4|||
164251475|NCT03379259|593286309|FG005|Overall Study|Study terminated by sponsor|4|||
164575941|NCT01275222|594471808|FG002|Phase l by Treatment|Adverse Event|2|||
164575942|NCT01275222|594471809|FG003|Phase l by Treatment|Adverse Event|3|||
164427014|NCT04672460|593932759|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
164427015|NCT04672460|593932758|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
164427016|NCT04672460|593932759|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
164427017|NCT04672460|593932758|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
164427018|NCT04672460|593932759|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
164427019|NCT04672460|593932758|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
164427020|NCT04672460|593932759|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
164427021|NCT04672460|593932758|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
164427022|NCT04672460|593932759|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
164427023|NCT04672460|593932758|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
164427024|NCT04672460|593932759|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
164427025|NCT04672460|593932758|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
164427026|NCT04672460|593932759|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
164427027|NCT04672460|593932758|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
164427028|NCT04672460|593932759|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
164680353|NCT00112437|594854595|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164680354|NCT00112437|594854596|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164680355|NCT00112437|594854571|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164680356|NCT00112437|594854572|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
164680357|NCT00112437|594854573|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164680358|NCT00112437|594854574|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164251476|NCT03379259|593286304|FG000|Overall Study|Disease progression|0|||
164251477|NCT03379259|593286305|FG001|Overall Study|Disease progression|0|||
164251478|NCT03379259|593286306|FG002|Overall Study|Disease progression|0|||
164251479|NCT03379259|593286307|FG003|Overall Study|Disease progression|1|||
164251480|NCT03379259|593286308|FG004|Overall Study|Disease progression|0|||
164251481|NCT03379259|593286309|FG005|Overall Study|Disease progression|1|||
164251482|NCT03379259|593286304|FG000|Overall Study|Lost to Follow-up|0|||
164251483|NCT03379259|593286305|FG001|Overall Study|Lost to Follow-up|0|||
164251484|NCT03379259|593286306|FG002|Overall Study|Lost to Follow-up|0|||
164251485|NCT03379259|593286307|FG003|Overall Study|Lost to Follow-up|0|||
164251486|NCT03379259|593286308|FG004|Overall Study|Lost to Follow-up|1|||
164251487|NCT03379259|593286309|FG005|Overall Study|Lost to Follow-up|0|||
164251488|NCT03379259|593286304|FG000|Overall Study|Deteriorating condition|0|||
164251489|NCT03379259|593286305|FG001|Overall Study|Deteriorating condition|0|||
164251490|NCT03379259|593286306|FG002|Overall Study|Deteriorating condition|0|||
164251491|NCT03379259|593286307|FG003|Overall Study|Deteriorating condition|0|||
164251492|NCT03379259|593286308|FG004|Overall Study|Deteriorating condition|1|||
164251493|NCT03379259|593286309|FG005|Overall Study|Deteriorating condition|0|||
164251494|NCT03195660|593286310|FG000|Overall Study|The study was terminated|2|||
164251495|NCT00375427|593286311|FG000|Overall Study|Adverse Event|21|||
164251496|NCT00375427|593286312|FG001|Overall Study|Adverse Event|27|||
164251497|NCT00375427|593286311|FG000|Overall Study|Abnormal test procedure result(s)|0|||
164251498|NCT00375427|593286312|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164251499|NCT00375427|593286311|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164251500|NCT00375427|593286312|FG001|Overall Study|Abnormal laboratory value(s)|2|||
164251501|NCT00375427|593286311|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
164251502|NCT00375427|593286312|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
164251503|NCT00375427|593286311|FG000|Overall Study|Patient no longer requires study drug|3|||
164251504|NCT00375427|593286312|FG001|Overall Study|Patient no longer requires study drug|7|||
164251505|NCT00375427|593286311|FG000|Overall Study|Protocol Violation|10|||
164251506|NCT00375427|593286312|FG001|Overall Study|Protocol Violation|8|||
164251507|NCT00375427|593286311|FG000|Overall Study|Withdrawal by Subject|9|||
164251508|NCT00375427|593286312|FG001|Overall Study|Withdrawal by Subject|13|||
164251509|NCT00375427|593286311|FG000|Overall Study|Lost to Follow-up|1|||
164251510|NCT00375427|593286312|FG001|Overall Study|Lost to Follow-up|1|||
164251511|NCT00375427|593286311|FG000|Overall Study|Administrative reasons|0|||
164251512|NCT00375427|593286312|FG001|Overall Study|Administrative reasons|1|||
164251513|NCT00375427|593286311|FG000|Overall Study|Death|11|||
164251514|NCT00375427|593286312|FG001|Overall Study|Death|10|||
164251515|NCT03249909|593286318|FG000|Overall Study|Withdrawal by Subject|3|||
164251516|NCT03249909|593286319|FG001|Overall Study|Withdrawal by Subject|0|||
164251517|NCT03249909|593286320|FG002|Overall Study|Withdrawal by Subject|0|||
164251518|NCT03249909|593286318|FG000|Overall Study|Adverse Event|3|||
164251519|NCT03249909|593286319|FG001|Overall Study|Adverse Event|0|||
164251520|NCT03249909|593286320|FG002|Overall Study|Adverse Event|0|||
164251521|NCT03249909|593286318|FG000|Overall Study|Lost to Follow-up|0|||
164251522|NCT03249909|593286319|FG001|Overall Study|Lost to Follow-up|1|||
164427029|NCT04672460|593932758|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
164427030|NCT04672460|593932759|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
164680359|NCT00112437|594854575|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164680360|NCT00112437|594854576|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164251523|NCT03249909|593286320|FG002|Overall Study|Lost to Follow-up|0|||
164251524|NCT03517371|593286321|FG000|Overall Study|Adverse Event|8|||
164251525|NCT03517371|593286322|FG001|Overall Study|Adverse Event|9|||
164251526|NCT03517371|593286321|FG000|Overall Study|Lost to Follow-up|1|||
164251527|NCT03517371|593286322|FG001|Overall Study|Lost to Follow-up|2|||
164251528|NCT03517371|593286321|FG000|Overall Study|Withdrawal by Subject|4|||
164251529|NCT03517371|593286322|FG001|Overall Study|Withdrawal by Subject|4|||
164251530|NCT03517371|593286321|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
164251531|NCT03517371|593286322|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
164251532|NCT03517371|593286321|FG000|Overall Study|COVID restrictions|2|||
164251533|NCT03517371|593286322|FG001|Overall Study|COVID restrictions|0|||
164251534|NCT03517371|593286321|FG000|Overall Study|Receiving DBS Surgery|0|||
164251535|NCT03517371|593286322|FG001|Overall Study|Receiving DBS Surgery|1|||
164251536|NCT05411822|593286323|FG000|Overall Study|Withdrawal by Subject|2|||
164251537|NCT05411822|593286324|FG001|Overall Study|Withdrawal by Subject|1|||
164251538|NCT01345929|593286325|FG000|Overall Study|Withdrawal by Subject|9|||
164251539|NCT01345929|593286326|FG001|Overall Study|Withdrawal by Subject|8|||
164251540|NCT01345929|593286325|FG000|Overall Study|Lost to Follow-up|9|||
164251541|NCT01345929|593286326|FG001|Overall Study|Lost to Follow-up|9|||
164251542|NCT01345929|593286325|FG000|Overall Study|Adverse Event|0|||
164251543|NCT01345929|593286326|FG001|Overall Study|Adverse Event|1|||
164251544|NCT01345929|593286325|FG000|Overall Study|Didn't meet eligibility criteria|2|||
164251545|NCT01345929|593286326|FG001|Overall Study|Didn't meet eligibility criteria|0|||
164251546|NCT01345929|593286325|FG000|Overall Study|40,000 CFU/ML|1|||
164251547|NCT01345929|593286326|FG001|Overall Study|40,000 CFU/ML|0|||
164251548|NCT01345929|593286325|FG000|Overall Study|Patient withdrawal|0|||
164251549|NCT01345929|593286326|FG001|Overall Study|Patient withdrawal|1|||
164251550|NCT02819297|593286327|FG000|Overall Study|Withdrawal by Subject|25|||
164251551|NCT02819297|593286328|FG001|Overall Study|Withdrawal by Subject|13|||
164251552|NCT02819297|593286327|FG000|Overall Study|Lost to Follow-up|12|||
164251553|NCT02819297|593286328|FG001|Overall Study|Lost to Follow-up|14|||
164251554|NCT02819297|593286327|FG000|Overall Study|Adverse Event|12|||
164251555|NCT02819297|593286328|FG001|Overall Study|Adverse Event|10|||
164251556|NCT02819297|593286327|FG000|Overall Study|Physician Decision|5|||
164251557|NCT02819297|593286328|FG001|Overall Study|Physician Decision|5|||
164251558|NCT02819297|593286327|FG000|Overall Study|Lack of Efficacy|5|||
164251559|NCT02819297|593286328|FG001|Overall Study|Lack of Efficacy|8|||
164251560|NCT02819297|593286327|FG000|Overall Study|Protocol Violation|1|||
164251561|NCT02819297|593286328|FG001|Overall Study|Protocol Violation|2|||
164251562|NCT01670279|593286329|FG000|Overall Study|Adverse Event|0|||
164251563|NCT01670279|593286330|FG001|Overall Study|Adverse Event|1|||
164251564|NCT01670279|593286331|FG002|Overall Study|Adverse Event|0|||
164251565|NCT01670279|593286332|FG003|Overall Study|Adverse Event|0|||
164251566|NCT01670279|593286329|FG000|Overall Study|Physician Decision|0|||
164251567|NCT01670279|593286330|FG001|Overall Study|Physician Decision|1|||
164251568|NCT01670279|593286331|FG002|Overall Study|Physician Decision|0|||
164251569|NCT01670279|593286332|FG003|Overall Study|Physician Decision|0|||
164251570|NCT01670279|593286329|FG000|Overall Study|Participant met withdrawal criteria|0|||
164251571|NCT01670279|593286330|FG001|Overall Study|Participant met withdrawal criteria|0|||
164251572|NCT01670279|593286331|FG002|Overall Study|Participant met withdrawal criteria|0|||
164251573|NCT01670279|593286332|FG003|Overall Study|Participant met withdrawal criteria|1|||
164251574|NCT02318368|593286333|FG000|Overall Study|Withdrawal by Subject|2|||
164251575|NCT02318368|593286334|FG001|Overall Study|Withdrawal by Subject|0|||
164251576|NCT02318368|593286333|FG000|Overall Study|Study terminated by the sponsor|5|||
164251577|NCT02318368|593286334|FG001|Overall Study|Study terminated by the sponsor|2|||
164251578|NCT02318368|593286333|FG000|Overall Study|Death|0|||
164251579|NCT02318368|593286334|FG001|Overall Study|Death|1|||
164338831|NCT02323113|593617048|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
164338832|NCT02323113|593617049|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
164338833|NCT02323113|593617050|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
164338834|NCT02323113|593617051|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
164338835|NCT02323113|593617052|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
164338836|NCT02323113|593617053|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
164338837|NCT02323113|593617054|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
164338838|NCT02323113|593617047|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
164338839|NCT02323113|593617048|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
164338840|NCT02323113|593617049|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
164338841|NCT02323113|593617050|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
164251580|NCT01901614|593286335|FG000|Overall Study|Adverse Event|0|||
164251581|NCT01901614|593286336|FG001|Overall Study|Adverse Event|1|||
164251582|NCT01901614|593286335|FG000|Overall Study|Lost to Follow-up|1|||
164251583|NCT01901614|593286336|FG001|Overall Study|Lost to Follow-up|0|||
164251584|NCT01901614|593286335|FG000|Overall Study|Screen Fail|1|||
164251585|NCT01901614|593286336|FG001|Overall Study|Screen Fail|0|||
164251586|NCT03629223|593286337|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
164251587|NCT03629223|593286338|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
164251588|NCT03629223|593286339|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
164251589|NCT03629223|593286340|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
164251590|NCT03629223|593286341|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
164251591|NCT03629223|593286342|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
164575943|NCT01275222|594471810|FG004|Phase l by Treatment|Adverse Event|0|||
164575944|NCT01275222|594471811|FG005|Phase l by Treatment|Adverse Event|0|||
164575945|NCT01275222|594471806|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
164338842|NCT02323113|593617051|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
164338843|NCT02323113|593617052|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
164338844|NCT02323113|593617053|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
164338845|NCT02323113|593617054|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
164338846|NCT02280304|593617059|FG000|Overall Study|Lost to Follow-up|7|||
164338847|NCT02280304|593617060|FG001|Overall Study|Lost to Follow-up|8|||
164338848|NCT04805541|593617061|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
164338849|NCT00713323|593617072|FG000|Overall Study|Adverse Event|75|||
164338850|NCT00713323|593617072|FG000|Overall Study|Withdrawal by Subject|15|||
164338851|NCT00713323|593617072|FG000|Overall Study|Lost to Follow-up|11|||
164338852|NCT00713323|593617072|FG000|Overall Study|Lack of Efficacy|36|||
164338853|NCT00713323|593617072|FG000|Overall Study|Low creatine clearance at screening|1|||
164338854|NCT00713323|593617072|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
164338855|NCT00713323|593617072|FG000|Overall Study|Surgery cured allodynic pain|1|||
164338856|NCT00713323|593617072|FG000|Overall Study|Pain free|1|||
164338857|NCT00713323|593617072|FG000|Overall Study|Non-compliance|1|||
164338858|NCT00713323|593617072|FG000|Overall Study|Pain resolved|1|||
164338859|NCT00713323|593617072|FG000|Overall Study|Subject travelling to USA|1|||
164338860|NCT00713323|593617072|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
164338861|NCT00713323|593617072|FG000|Overall Study|Treatment that may interact with Sativex|1|||
164427031|NCT04672460|593932758|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
164427032|NCT04672460|593932759|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
164427033|NCT04672460|593932758|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
164427034|NCT04672460|593932759|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
164427035|NCT04672460|593932758|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
164427036|NCT04672460|593932759|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
164427037|NCT04672460|593932758|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
164427038|NCT04672460|593932759|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
164575946|NCT01275222|594471807|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
164575947|NCT01275222|594471808|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
164575948|NCT01275222|594471809|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
164575949|NCT01275222|594471810|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
164575950|NCT01275222|594471811|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
164575951|NCT01275222|594471806|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
164575952|NCT01275222|594471807|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
164575953|NCT01275222|594471808|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
164575954|NCT01275222|594471809|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
164575955|NCT01275222|594471810|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
164575956|NCT01275222|594471811|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
164575957|NCT01275222|594471806|FG000|Phase l by Treatment|Disease progression|12|||
164575958|NCT01275222|594471807|FG001|Phase l by Treatment|Disease progression|8|||
164575959|NCT01275222|594471808|FG002|Phase l by Treatment|Disease progression|2|||
164575960|NCT01275222|594471809|FG003|Phase l by Treatment|Disease progression|5|||
164575961|NCT01275222|594471810|FG004|Phase l by Treatment|Disease progression|0|||
164575962|NCT01275222|594471811|FG005|Phase l by Treatment|Disease progression|0|||
164575963|NCT01275222|594471806|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
164575964|NCT01275222|594471807|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
164575965|NCT01275222|594471808|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
164575966|NCT01275222|594471809|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
164575967|NCT01275222|594471810|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
164575968|NCT01275222|594471811|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
164575969|NCT01275222|594471806|FG000|Phase l by Treatment|Death|0|||
164575970|NCT01275222|594471807|FG001|Phase l by Treatment|Death|1|||
164575971|NCT01275222|594471808|FG002|Phase l by Treatment|Death|0|||
164575972|NCT01275222|594471809|FG003|Phase l by Treatment|Death|1|||
164575973|NCT01275222|594471810|FG004|Phase l by Treatment|Death|0|||
164575974|NCT01275222|594471811|FG005|Phase l by Treatment|Death|0|||
164575975|NCT01275222|594471806|FG000|Phase ll by Stratum|Adverse Event|0|||
164575976|NCT01275222|594471807|FG001|Phase ll by Stratum|Adverse Event|0|||
164575977|NCT01275222|594471808|FG002|Phase ll by Stratum|Adverse Event|0|||
164575978|NCT01275222|594471809|FG003|Phase ll by Stratum|Adverse Event|0|||
164575979|NCT01275222|594471810|FG004|Phase ll by Stratum|Adverse Event|2|||
164575980|NCT01275222|594471811|FG005|Phase ll by Stratum|Adverse Event|10|||
164575981|NCT01275222|594471806|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
164427039|NCT00049517|593932762|FG000|Induction|Disease progression|0|||
164575982|NCT01275222|594471807|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
164575983|NCT01275222|594471808|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
164575984|NCT01275222|594471809|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
164575985|NCT01275222|594471810|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
164575986|NCT01275222|594471811|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
164427040|NCT00049517|593932763|FG001|Induction|Disease progression|0|||
164427041|NCT00049517|593932764|FG002|Induction|Disease progression|0|||
164427042|NCT00049517|593932765|FG003|Induction|Disease progression|0|||
164427043|NCT00049517|593932766|FG004|Induction|Disease progression|18|||
164427044|NCT00049517|593932767|FG005|Induction|Disease progression|11|||
164427045|NCT00049517|593932762|FG000|Induction|Adverse Event|0|||
164251592|NCT03629223|593286337|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
164251593|NCT03629223|593286338|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
164251594|NCT03629223|593286339|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
164251595|NCT03629223|593286340|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
164427046|NCT00049517|593932763|FG001|Induction|Adverse Event|0|||
164427047|NCT00049517|593932764|FG002|Induction|Adverse Event|0|||
164427048|NCT00049517|593932765|FG003|Induction|Adverse Event|0|||
164427049|NCT00049517|593932766|FG004|Induction|Adverse Event|5|||
164427050|NCT00049517|593932767|FG005|Induction|Adverse Event|7|||
164427051|NCT00049517|593932762|FG000|Induction|Death|0|||
164427052|NCT00049517|593932763|FG001|Induction|Death|0|||
164427053|NCT00049517|593932764|FG002|Induction|Death|0|||
164427054|NCT00049517|593932765|FG003|Induction|Death|0|||
164427055|NCT00049517|593932766|FG004|Induction|Death|9|||
164427056|NCT00049517|593932767|FG005|Induction|Death|6|||
164427057|NCT00049517|593932762|FG000|Induction|Withdrawal by Subject|0|||
164427058|NCT00049517|593932763|FG001|Induction|Withdrawal by Subject|0|||
164427059|NCT00049517|593932764|FG002|Induction|Withdrawal by Subject|0|||
164427060|NCT00049517|593932765|FG003|Induction|Withdrawal by Subject|0|||
164427061|NCT00049517|593932766|FG004|Induction|Withdrawal by Subject|1|||
164427062|NCT00049517|593932767|FG005|Induction|Withdrawal by Subject|3|||
164427063|NCT00049517|593932762|FG000|Induction|Alternative therapy|0|||
164427064|NCT00049517|593932763|FG001|Induction|Alternative therapy|0|||
164427065|NCT00049517|593932764|FG002|Induction|Alternative therapy|0|||
164427066|NCT00049517|593932765|FG003|Induction|Alternative therapy|0|||
164427067|NCT00049517|593932766|FG004|Induction|Alternative therapy|2|||
164427068|NCT00049517|593932767|FG005|Induction|Alternative therapy|2|||
164427069|NCT00049517|593932762|FG000|Induction|Other complicating disease|0|||
164427070|NCT00049517|593932763|FG001|Induction|Other complicating disease|0|||
164427071|NCT00049517|593932764|FG002|Induction|Other complicating disease|0|||
164427072|NCT00049517|593932765|FG003|Induction|Other complicating disease|0|||
164427073|NCT00049517|593932766|FG004|Induction|Other complicating disease|3|||
164427074|NCT00049517|593932767|FG005|Induction|Other complicating disease|0|||
164427075|NCT00049517|593932762|FG000|Induction|Reasons not reported|0|||
164427076|NCT00049517|593932763|FG001|Induction|Reasons not reported|0|||
164427077|NCT00049517|593932764|FG002|Induction|Reasons not reported|0|||
164427078|NCT00049517|593932765|FG003|Induction|Reasons not reported|0|||
164427079|NCT00049517|593932766|FG004|Induction|Reasons not reported|22|||
164427080|NCT00049517|593932767|FG005|Induction|Reasons not reported|25|||
164427081|NCT00049517|593932762|FG000|Conditioning/Transplant|Disease progression|14|||
164427082|NCT00049517|593932763|FG001|Conditioning/Transplant|Disease progression|6|||
164427083|NCT00049517|593932764|FG002|Conditioning/Transplant|Disease progression|10|||
164427084|NCT00049517|593932765|FG003|Conditioning/Transplant|Disease progression|6|||
164427085|NCT00049517|593932766|FG004|Conditioning/Transplant|Disease progression|0|||
164427086|NCT00049517|593932767|FG005|Conditioning/Transplant|Disease progression|0|||
164427087|NCT00049517|593932762|FG000|Conditioning/Transplant|Adverse Event|2|||
164427088|NCT00049517|593932763|FG001|Conditioning/Transplant|Adverse Event|1|||
164427089|NCT00049517|593932764|FG002|Conditioning/Transplant|Adverse Event|4|||
164427090|NCT00049517|593932765|FG003|Conditioning/Transplant|Adverse Event|8|||
164427091|NCT00049517|593932766|FG004|Conditioning/Transplant|Adverse Event|0|||
164427092|NCT00049517|593932767|FG005|Conditioning/Transplant|Adverse Event|0|||
164427093|NCT00049517|593932762|FG000|Conditioning/Transplant|Death|1|||
164427094|NCT00049517|593932763|FG001|Conditioning/Transplant|Death|0|||
164575987|NCT01275222|594471806|FG000|Phase ll by Stratum|Disease progression|0|||
164575988|NCT01275222|594471807|FG001|Phase ll by Stratum|Disease progression|0|||
164575989|NCT01275222|594471808|FG002|Phase ll by Stratum|Disease progression|0|||
164427095|NCT00049517|593932764|FG002|Conditioning/Transplant|Death|0|||
164427096|NCT00049517|593932765|FG003|Conditioning/Transplant|Death|2|||
164575990|NCT01275222|594471809|FG003|Phase ll by Stratum|Disease progression|0|||
164575991|NCT01275222|594471810|FG004|Phase ll by Stratum|Disease progression|23|||
164575992|NCT01275222|594471811|FG005|Phase ll by Stratum|Disease progression|31|||
164575993|NCT01275222|594471806|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
164575994|NCT01275222|594471807|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
164575995|NCT01275222|594471808|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
164575996|NCT01275222|594471809|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
164575997|NCT01275222|594471810|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
164575998|NCT01275222|594471811|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
164575999|NCT01275222|594471806|FG000|Phase ll by Stratum|Death|0|||
164576000|NCT01275222|594471807|FG001|Phase ll by Stratum|Death|0|||
164576001|NCT01275222|594471808|FG002|Phase ll by Stratum|Death|0|||
164576002|NCT01275222|594471809|FG003|Phase ll by Stratum|Death|0|||
164576003|NCT01275222|594471810|FG004|Phase ll by Stratum|Death|1|||
164576004|NCT01275222|594471811|FG005|Phase ll by Stratum|Death|1|||
164251596|NCT03629223|593286341|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
164251597|NCT03629223|593286342|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
164251598|NCT03629223|593286337|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
164251599|NCT03629223|593286338|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
164251600|NCT03629223|593286339|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
164251601|NCT03629223|593286340|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
164251602|NCT03629223|593286341|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
164251603|NCT03629223|593286342|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
164251604|NCT03629223|593286337|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
164251605|NCT03629223|593286338|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
164251606|NCT03629223|593286339|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
164251607|NCT03629223|593286340|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
164251608|NCT03629223|593286341|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
164251609|NCT03629223|593286342|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
164251610|NCT03629223|593286337|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
164251611|NCT03629223|593286338|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
164251612|NCT03629223|593286339|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
164251613|NCT03629223|593286340|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
164251614|NCT03629223|593286341|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
164251615|NCT03629223|593286342|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
164251616|NCT02702609|593286343|FG000|Overall Study|Lost to Follow-up|8|||
164251617|NCT02702609|593286344|FG001|Overall Study|Lost to Follow-up|4|||
164251618|NCT02702609|593286343|FG000|Overall Study|Physician Decision|1|||
164251619|NCT02702609|593286344|FG001|Overall Study|Physician Decision|0|||
164251620|NCT02674464|593286345|FG000|Overall Study|Death|10|||
164251621|NCT02674464|593286346|FG001|Overall Study|Death|21|||
164251622|NCT02674464|593286345|FG000|Overall Study|Withdrawal by Subject|24|||
164251623|NCT02674464|593286346|FG001|Overall Study|Withdrawal by Subject|44|||
164251624|NCT02674464|593286345|FG000|Overall Study|Lost to Follow-up|97|||
164251625|NCT02674464|593286346|FG001|Overall Study|Lost to Follow-up|92|||
164251626|NCT02674464|593286345|FG000|Overall Study|Outside survey window|6|||
164251627|NCT02674464|593286346|FG001|Overall Study|Outside survey window|3|||
164251628|NCT04153981|593286347|FG000|Overall Study|Death|1|||
164251629|NCT04153981|593286347|FG000|Overall Study|Withdrawal by Subject|24|||
164251630|NCT04153981|593286347|FG000|Overall Study|Lost to Follow-up|1|||
164251631|NCT04153981|593286347|FG000|Overall Study|Physician Decision|1|||
164251632|NCT04153981|593286347|FG000|Overall Study|Due to Unavailable Glucometer|1|||
164251633|NCT04153981|593286347|FG000|Overall Study|Covid 19|52|||
164251634|NCT04153981|593286347|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
164251635|NCT04153981|593286347|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
164251636|NCT01555073|593286348|FG000|Overall Study|Lost to Follow-up|1|||
164251637|NCT01555073|593286349|FG001|Overall Study|Lost to Follow-up|2|||
164251638|NCT01555073|593286350|FG002|Overall Study|Lost to Follow-up|0|||
164251639|NCT01555073|593286351|FG003|Overall Study|Lost to Follow-up|5|||
164251640|NCT01262638|593286352|FG000|Overall Study|Adverse Event|3|||
164251641|NCT01262638|593286353|FG001|Overall Study|Adverse Event|4|||
164251642|NCT01262638|593286354|FG002|Overall Study|Adverse Event|3|||
164251643|NCT01262638|593286355|FG003|Overall Study|Adverse Event|4|||
164251644|NCT01262638|593286352|FG000|Overall Study|Protocol Violation|1|||
164251645|NCT01262638|593286353|FG001|Overall Study|Protocol Violation|0|||
164251646|NCT01262638|593286354|FG002|Overall Study|Protocol Violation|0|||
164251647|NCT01262638|593286355|FG003|Overall Study|Protocol Violation|1|||
164251648|NCT01262638|593286352|FG000|Overall Study|Withdrawal by Subject|2|||
164251649|NCT01262638|593286353|FG001|Overall Study|Withdrawal by Subject|1|||
164251650|NCT01262638|593286354|FG002|Overall Study|Withdrawal by Subject|0|||
164251651|NCT01262638|593286355|FG003|Overall Study|Withdrawal by Subject|1|||
164251652|NCT01262638|593286352|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
164251653|NCT01262638|593286353|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
164251654|NCT01262638|593286354|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
164251655|NCT01262638|593286355|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
164251656|NCT01262638|593286352|FG000|Overall Study|Lost to Follow-up|1|||
164251657|NCT01262638|593286353|FG001|Overall Study|Lost to Follow-up|1|||
164251658|NCT01262638|593286354|FG002|Overall Study|Lost to Follow-up|1|||
164251659|NCT01262638|593286355|FG003|Overall Study|Lost to Follow-up|1|||
164251660|NCT01262638|593286352|FG000|Overall Study|Participant Went Out of Town|0|||
164251661|NCT01262638|593286353|FG001|Overall Study|Participant Went Out of Town|0|||
164251662|NCT01262638|593286354|FG002|Overall Study|Participant Went Out of Town|1|||
164251663|NCT01262638|593286355|FG003|Overall Study|Participant Went Out of Town|0|||
164251664|NCT01071252|593286356|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
164251665|NCT01071252|593286357|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
164251666|NCT01071252|593286358|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
164251667|NCT01071252|593286359|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
164251668|NCT01071252|593286360|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
164251669|NCT01071252|593286356|FG000|Overall Study|Withdrawal by Subject|8|||
164251670|NCT01071252|593286357|FG001|Overall Study|Withdrawal by Subject|2|||
164251671|NCT01071252|593286358|FG002|Overall Study|Withdrawal by Subject|1|||
164251672|NCT01071252|593286359|FG003|Overall Study|Withdrawal by Subject|2|||
164251673|NCT01071252|593286360|FG004|Overall Study|Withdrawal by Subject|3|||
164251674|NCT01071252|593286356|FG000|Overall Study|administrative problems|1|||
164251675|NCT01071252|593286357|FG001|Overall Study|administrative problems|1|||
164251676|NCT01071252|593286358|FG002|Overall Study|administrative problems|0|||
164251677|NCT01071252|593286359|FG003|Overall Study|administrative problems|2|||
164427097|NCT00049517|593932766|FG004|Conditioning/Transplant|Death|0|||
164427098|NCT00049517|593932767|FG005|Conditioning/Transplant|Death|0|||
164427099|NCT00049517|593932762|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
164427100|NCT00049517|593932763|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
164427101|NCT00049517|593932764|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
164427102|NCT00049517|593932765|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
164427103|NCT00049517|593932766|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
164427104|NCT00049517|593932767|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
164427105|NCT00049517|593932762|FG000|Conditioning/Transplant|Alternative therapy|4|||
164576005|NCT04325503|594471812|FG000|Overall Study|Withdrawal by Subject|1|||
164251678|NCT01071252|593286360|FG004|Overall Study|administrative problems|1|||
164427106|NCT00049517|593932763|FG001|Conditioning/Transplant|Alternative therapy|4|||
164427107|NCT00049517|593932764|FG002|Conditioning/Transplant|Alternative therapy|2|||
164427108|NCT00049517|593932765|FG003|Conditioning/Transplant|Alternative therapy|1|||
164427109|NCT00049517|593932766|FG004|Conditioning/Transplant|Alternative therapy|1|||
164427110|NCT00049517|593932767|FG005|Conditioning/Transplant|Alternative therapy|0|||
164427111|NCT00049517|593932762|FG000|Conditioning/Transplant|Other complicating disease|2|||
164427112|NCT00049517|593932763|FG001|Conditioning/Transplant|Other complicating disease|0|||
164427113|NCT00049517|593932764|FG002|Conditioning/Transplant|Other complicating disease|0|||
164576006|NCT04325503|594471812|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
164251679|NCT01071252|593286356|FG000|Overall Study|Lost to Follow-up|1|||
164251680|NCT01071252|593286357|FG001|Overall Study|Lost to Follow-up|0|||
164576007|NCT02337387|594471813|FG000|Overall Study|Adverse Event|0|||
164680361|NCT00112437|594854577|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164680362|NCT00112437|594854578|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164680363|NCT00112437|594854579|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164680364|NCT00112437|594854580|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164680365|NCT00112437|594854581|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164680366|NCT00112437|594854582|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164680367|NCT00112437|594854583|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164680368|NCT00112437|594854584|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164680369|NCT00112437|594854585|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164680370|NCT00112437|594854586|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164680371|NCT00112437|594854587|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164251681|NCT01071252|593286358|FG002|Overall Study|Lost to Follow-up|1|||
164251682|NCT01071252|593286359|FG003|Overall Study|Lost to Follow-up|2|||
164251683|NCT01071252|593286360|FG004|Overall Study|Lost to Follow-up|0|||
164251684|NCT01071252|593286356|FG000|Overall Study|Adverse Event|1|||
164251685|NCT01071252|593286357|FG001|Overall Study|Adverse Event|1|||
164251686|NCT01071252|593286358|FG002|Overall Study|Adverse Event|0|||
164251687|NCT01071252|593286359|FG003|Overall Study|Adverse Event|1|||
164251688|NCT01071252|593286360|FG004|Overall Study|Adverse Event|0|||
164251689|NCT01071252|593286356|FG000|Overall Study|Death|0|||
164251690|NCT01071252|593286357|FG001|Overall Study|Death|0|||
164251691|NCT01071252|593286358|FG002|Overall Study|Death|0|||
164251692|NCT01071252|593286359|FG003|Overall Study|Death|0|||
164251693|NCT01071252|593286360|FG004|Overall Study|Death|1|||
164680372|NCT00112437|594854588|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164251694|NCT01066104|593286361|FG000|Overall Study|Adverse Event|1|||
164251695|NCT01066104|593286362|FG001|Overall Study|Adverse Event|1|||
164251696|NCT01066104|593286361|FG000|Overall Study|Protocol Violation|1|||
164251697|NCT01066104|593286362|FG001|Overall Study|Protocol Violation|0|||
164251698|NCT03902392|593286365|FG000|Overall Study|Lost to Follow-up|7|||
164251699|NCT03902392|593286366|FG001|Overall Study|Lost to Follow-up|7|||
164251700|NCT00260832|593286367|FG000|Overall Study|Adverse Event|26|||
164251701|NCT00260832|593286368|FG001|Overall Study|Adverse Event|19|||
164251702|NCT00260832|593286367|FG000|Overall Study|Progression|116|||
164251703|NCT00260832|593286368|FG001|Overall Study|Progression|96|||
164251704|NCT00260832|593286367|FG000|Overall Study|Withdrawal by Subject|15|||
164251705|NCT00260832|593286368|FG001|Overall Study|Withdrawal by Subject|17|||
164251706|NCT00260832|593286367|FG000|Overall Study|Physician Decision|15|||
164251707|NCT00260832|593286368|FG001|Overall Study|Physician Decision|9|||
164251708|NCT00260832|593286367|FG000|Overall Study|Death|43|||
164251709|NCT00260832|593286368|FG001|Overall Study|Death|62|||
164251710|NCT00260832|593286367|FG000|Overall Study|Other|10|||
164251711|NCT00260832|593286368|FG001|Overall Study|Other|7|||
164251712|NCT00260832|593286367|FG000|Overall Study|Protocol Violation|3|||
164251713|NCT00260832|593286368|FG001|Overall Study|Protocol Violation|1|||
164251714|NCT01104545|593286369|FG000|Overall Study|Adverse Event|0|||
164251715|NCT01104545|593286370|FG001|Overall Study|Adverse Event|1|||
164251716|NCT01104545|593286371|FG002|Overall Study|Adverse Event|2|||
164251717|NCT00564902|593286373|FG000|Overall Study|Withdrawal by Subject|0|||
164251718|NCT00564902|593286374|FG001|Overall Study|Withdrawal by Subject|3|||
164251719|NCT00564902|593286375|FG002|Overall Study|Withdrawal by Subject|4|||
164251720|NCT00564902|593286373|FG000|Overall Study|Death|1|||
164251721|NCT00564902|593286374|FG001|Overall Study|Death|1|||
164251722|NCT00564902|593286375|FG002|Overall Study|Death|0|||
164251723|NCT00958347|593286376|FG000|Overall Study|Death|43|||
164251724|NCT00958347|593286376|FG000|Overall Study|Withdrawal by Subject|23|||
164251725|NCT00958347|593286376|FG000|Overall Study|Lost to Follow-up|15|||
164251726|NCT00958347|593286376|FG000|Overall Study|revision/removal|10|||
164251727|NCT00958347|593286376|FG000|Overall Study|study termination|135|||
164338862|NCT04015336|593617073|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
164338863|NCT00246753|593617074|FG000|Overall Study|Withdrawal by Subject|2|||
164338864|NCT00246753|593617074|FG000|Overall Study|Physician Decision|2|||
164680373|NCT00112437|594854589|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164680374|NCT00112437|594854590|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164251728|NCT04552288|593286379|FG000|Overall Study|Death|3|||
164680375|NCT00112437|594854591|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164251729|NCT04552288|593286379|FG000|Overall Study|Lost to Follow-up|6|||
164251730|NCT04552288|593286379|FG000|Overall Study|Physician Decision|3|||
164680376|NCT00112437|594854592|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164251731|NCT04552288|593286379|FG000|Overall Study|Protocol Violation|9|||
164251732|NCT04552288|593286379|FG000|Overall Study|Withdrawal by Subject|6|||
164251733|NCT04552288|593286379|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
164251734|NCT04532294|593286380|FG000|Overall Study|Withdrawal by Subject|0|||
164251735|NCT04532294|593286381|FG001|Overall Study|Withdrawal by Subject|0|||
164251736|NCT04532294|593286382|FG002|Overall Study|Withdrawal by Subject|1|||
164251737|NCT04532294|593286380|FG000|Overall Study|Participants Not Dosed|0|||
164251738|NCT04532294|593286381|FG001|Overall Study|Participants Not Dosed|0|||
164251739|NCT04532294|593286382|FG002|Overall Study|Participants Not Dosed|2|||
164251740|NCT03089047|593286383|FG000|Overall Study|Lost to Follow-up|1|||
164251741|NCT03089047|593286384|FG001|Overall Study|Lost to Follow-up|0|||
164251742|NCT00375505|593286385|FG000|Overall Study|Adverse Event|1|||
164251743|NCT00375505|593286386|FG001|Overall Study|Adverse Event|2|||
164251744|NCT02146131|593286387|FG000|Overall Study|Physician Decision|61|||
164251745|NCT02146131|593286388|FG001|Overall Study|Physician Decision|56|||
164251746|NCT02097719|593286389|FG000|Overall Study|Subject Withdrew Consent|1|||
164251747|NCT02097719|593286390|FG001|Overall Study|Subject Withdrew Consent|0|||
164251748|NCT02097719|593286389|FG000|Overall Study|Lost to Follow-up|0|||
164251749|NCT02097719|593286390|FG001|Overall Study|Lost to Follow-up|1|||
164251750|NCT02097719|593286389|FG000|Overall Study|Adverse Event|2|||
164251751|NCT02097719|593286390|FG001|Overall Study|Adverse Event|0|||
164251752|NCT00809926|593286392|FG000|Overall Study|Adverse Event|18|||
164251753|NCT00809926|593286393|FG001|Overall Study|Adverse Event|10|||
164251754|NCT00809926|593286392|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
164251755|NCT00809926|593286393|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
164251756|NCT00809926|593286392|FG000|Overall Study|Patient withdrew consent|8|||
164251757|NCT00809926|593286393|FG001|Overall Study|Patient withdrew consent|6|||
164251758|NCT00809926|593286392|FG000|Overall Study|Lost to Follow-up|2|||
164251759|NCT00809926|593286393|FG001|Overall Study|Lost to Follow-up|1|||
164251760|NCT00809926|593286392|FG000|Overall Study|Administrative Problems|0|||
164251761|NCT00809926|593286393|FG001|Overall Study|Administrative Problems|1|||
164251762|NCT00809926|593286392|FG000|Overall Study|Protocol deviation|0|||
164251763|NCT00809926|593286393|FG001|Overall Study|Protocol deviation|2|||
164251764|NCT01108731|593286400|FG000|Overall Study|Withdrawal by Subject|1|||
164251765|NCT01108731|593286401|FG001|Overall Study|Withdrawal by Subject|1|||
164251766|NCT01108731|593286400|FG000|Overall Study|Adverse Event|3|||
164251767|NCT01108731|593286401|FG001|Overall Study|Adverse Event|3|||
164251768|NCT01451749|593286407|FG000|Overall Study|Protocol Violation|14|||
164251769|NCT01451749|593286408|FG001|Overall Study|Protocol Violation|7|||
164251770|NCT01451749|593286407|FG000|Overall Study|Lost to Follow-up|15|||
164251771|NCT01451749|593286408|FG001|Overall Study|Lost to Follow-up|5|||
164251772|NCT01451749|593286407|FG000|Overall Study|Meet the exclusion criteria,and|1|||
164251773|NCT01451749|593286408|FG001|Overall Study|Meet the exclusion criteria,and|1|||
164251774|NCT01451749|593286407|FG000|Overall Study|Adverse Event|2|||
164251775|NCT01451749|593286408|FG001|Overall Study|Adverse Event|0|||
164251776|NCT01451749|593286407|FG000|Overall Study|Withdrawal by Subject|0|||
164251777|NCT01451749|593286408|FG001|Overall Study|Withdrawal by Subject|1|||
164251778|NCT01063062|593286409|FG000|Overall Study|Patient withdrew consent|0|||
164251779|NCT01063062|593286410|FG001|Overall Study|Patient withdrew consent|1|||
164251780|NCT01063062|593286409|FG000|Overall Study|Adverse Event|2|||
164251781|NCT01063062|593286410|FG001|Overall Study|Adverse Event|4|||
164251782|NCT01063062|593286409|FG000|Overall Study|Protocol Violation|5|||
164251783|NCT01063062|593286410|FG001|Overall Study|Protocol Violation|4|||
164338865|NCT00246753|593617074|FG000|Overall Study|Adverse Event|2|||
164338866|NCT00246753|593617074|FG000|Overall Study|Unacceptable toxicity|2|||
164680377|NCT00112437|594854593|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164680378|NCT00112437|594854594|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164680379|NCT00112437|594854595|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164680380|NCT00112437|594854596|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164680381|NCT00112437|594854571|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
164680382|NCT00112437|594854572|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164251784|NCT01063062|593286409|FG000|Overall Study|Investigator's request|1|||
164251785|NCT01063062|593286410|FG001|Overall Study|Investigator's request|0|||
164251786|NCT01063062|593286409|FG000|Overall Study|Lost to Follow-up|0|||
164251787|NCT01063062|593286410|FG001|Overall Study|Lost to Follow-up|2|||
164338867|NCT05154578|593617075|FG000|Overall Study|Withdrawal by Subject|2|||
164338868|NCT05154578|593617076|FG001|Overall Study|Withdrawal by Subject|3|||
164338869|NCT05154578|593617077|FG002|Overall Study|Withdrawal by Subject|2|||
164338870|NCT05154578|593617078|FG003|Overall Study|Withdrawal by Subject|4|||
164338871|NCT05154578|593617079|FG004|Overall Study|Withdrawal by Subject|0|||
164338872|NCT05154578|593617075|FG000|Overall Study|Lost to Follow-up|0|||
164680383|NCT00112437|594854573|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
164251788|NCT01063062|593286409|FG000|Overall Study|Miscellaneous reason|0|||
164251789|NCT01063062|593286410|FG001|Overall Study|Miscellaneous reason|1|||
164251790|NCT02175277|593286411|FG000|Overall Study|Protocol-specified Criteria|1|||
164251791|NCT03818607|593288207|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
164251792|NCT03818607|593288208|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
164251793|NCT03818607|593288207|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
164251794|NCT03818607|593288208|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
164251795|NCT03818607|593288207|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
164251796|NCT03818607|593288208|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
164251797|NCT01147250|593288212|FG000|Overall Study|Lost to Follow-up|14|||
164251798|NCT01147250|593288213|FG001|Overall Study|Lost to Follow-up|11|||
164338873|NCT05154578|593617076|FG001|Overall Study|Lost to Follow-up|1|||
164338874|NCT05154578|593617077|FG002|Overall Study|Lost to Follow-up|0|||
164338875|NCT05154578|593617078|FG003|Overall Study|Lost to Follow-up|3|||
164338876|NCT05154578|593617079|FG004|Overall Study|Lost to Follow-up|0|||
164338877|NCT05154578|593617075|FG000|Overall Study|Adverse Event|0|||
164338878|NCT05154578|593617076|FG001|Overall Study|Adverse Event|0|||
164338879|NCT05154578|593617077|FG002|Overall Study|Adverse Event|0|||
164338880|NCT05154578|593617078|FG003|Overall Study|Adverse Event|1|||
164338881|NCT05154578|593617079|FG004|Overall Study|Adverse Event|0|||
164338882|NCT05154578|593617075|FG000|Overall Study|Relocated to another province|0|||
164338883|NCT05154578|593617076|FG001|Overall Study|Relocated to another province|0|||
164338884|NCT05154578|593617077|FG002|Overall Study|Relocated to another province|1|||
164338885|NCT05154578|593617078|FG003|Overall Study|Relocated to another province|0|||
164338886|NCT05154578|593617079|FG004|Overall Study|Relocated to another province|1|||
164338887|NCT05154578|593617075|FG000|Overall Study|Baby loss|0|||
164338888|NCT05154578|593617076|FG001|Overall Study|Baby loss|1|||
164338889|NCT05154578|593617077|FG002|Overall Study|Baby loss|0|||
164338890|NCT05154578|593617078|FG003|Overall Study|Baby loss|0|||
164338891|NCT05154578|593617079|FG004|Overall Study|Baby loss|0|||
164338892|NCT01419626|593617080|FG000|Overall Study|Protocol Violation|3|||
164338893|NCT01419626|593617081|FG001|Overall Study|Protocol Violation|2|||
164338894|NCT01419626|593617082|FG002|Overall Study|Protocol Violation|2|||
164338895|NCT01419626|593617080|FG000|Overall Study|Withdrawal by Subject|1|||
164338896|NCT01419626|593617081|FG001|Overall Study|Withdrawal by Subject|0|||
164338897|NCT01419626|593617082|FG002|Overall Study|Withdrawal by Subject|0|||
164338898|NCT01419626|593617080|FG000|Overall Study|Lost to Follow-up|0|||
164338899|NCT01419626|593617081|FG001|Overall Study|Lost to Follow-up|1|||
164338900|NCT01419626|593617082|FG002|Overall Study|Lost to Follow-up|1|||
164338901|NCT01146912|593617083|FG000|Overall Study|Already received influenza vaccination|817|||
164338902|NCT01146912|593617084|FG001|Overall Study|Already received influenza vaccination|822|||
164338903|NCT01146912|593617085|FG002|Overall Study|Already received influenza vaccination|13|||
164338904|NCT01146912|593617086|FG003|Overall Study|Already received influenza vaccination|15|||
164338905|NCT01146912|593617087|FG004|Overall Study|Already received influenza vaccination|41|||
164338906|NCT01146912|593617088|FG005|Overall Study|Already received influenza vaccination|61|||
164338907|NCT01146912|593617089|FG006|Overall Study|Already received influenza vaccination|56|||
164338908|NCT01146912|593617090|FG007|Overall Study|Already received influenza vaccination|0|||
164338909|NCT01146912|593617083|FG000|Overall Study|< 14 weeks gestational age|0|||
164338910|NCT01146912|593617084|FG001|Overall Study|< 14 weeks gestational age|0|||
164338911|NCT01146912|593617085|FG002|Overall Study|< 14 weeks gestational age|3|||
164338912|NCT01146912|593617086|FG003|Overall Study|< 14 weeks gestational age|2|||
164338913|NCT01146912|593617087|FG004|Overall Study|< 14 weeks gestational age|0|||
164338914|NCT01146912|593617088|FG005|Overall Study|< 14 weeks gestational age|0|||
164338915|NCT01146912|593617089|FG006|Overall Study|< 14 weeks gestational age|0|||
164338916|NCT01146912|593617090|FG007|Overall Study|< 14 weeks gestational age|0|||
164338917|NCT01146912|593617083|FG000|Overall Study|Duplicate patient|0|||
164338918|NCT01146912|593617084|FG001|Overall Study|Duplicate patient|0|||
164338919|NCT01146912|593617085|FG002|Overall Study|Duplicate patient|1|||
164338920|NCT01146912|593617086|FG003|Overall Study|Duplicate patient|0|||
164338921|NCT01146912|593617087|FG004|Overall Study|Duplicate patient|0|||
164338922|NCT01146912|593617088|FG005|Overall Study|Duplicate patient|0|||
164338923|NCT01146912|593617089|FG006|Overall Study|Duplicate patient|0|||
164251799|NCT01147250|593288212|FG000|Overall Study|Withdrawal by Subject|83|||
164251800|NCT01147250|593288213|FG001|Overall Study|Withdrawal by Subject|88|||
164251801|NCT01147250|593288212|FG000|Overall Study|Site termination by sponsor|13|||
164251802|NCT01147250|593288213|FG001|Overall Study|Site termination by sponsor|5|||
164251803|NCT01147250|593288212|FG000|Overall Study|Other than specified|0|||
164251804|NCT01147250|593288213|FG001|Overall Study|Other than specified|1|||
164251805|NCT02249091|593288215|FG000|Overall Study|Lack of Efficacy|8|||
164251806|NCT02249091|593288216|FG001|Overall Study|Lack of Efficacy|3|||
164251807|NCT02249091|593288215|FG000|Overall Study|Physician Decision|4|||
164251808|NCT02249091|593288216|FG001|Overall Study|Physician Decision|1|||
164251809|NCT02249091|593288215|FG000|Overall Study|Withdrawal by Subject|2|||
164251810|NCT02249091|593288216|FG001|Overall Study|Withdrawal by Subject|2|||
164251811|NCT02249091|593288215|FG000|Overall Study|Death|3|||
164251812|NCT02249091|593288216|FG001|Overall Study|Death|4|||
164251813|NCT02249091|593288215|FG000|Overall Study|Adverse Event|1|||
164251814|NCT02249091|593288216|FG001|Overall Study|Adverse Event|0|||
164251815|NCT02249091|593288215|FG000|Overall Study|Stable disease with following SCT|0|||
164251816|NCT02249091|593288216|FG001|Overall Study|Stable disease with following SCT|1|||
164251817|NCT02249091|593288215|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
164251818|NCT02249091|593288216|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
164251819|NCT02249091|593288215|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
164251820|NCT02249091|593288216|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
164251821|NCT02249091|593288215|FG000|Overall Study|Refractory AML|1|||
164251822|NCT02249091|593288216|FG001|Overall Study|Refractory AML|1|||
164251823|NCT00716482|593288220|FG000|Overall Study|Lost to Follow-up|6|||
164251824|NCT00716482|593288220|FG000|Overall Study|Inadequate acquisition or analysis|50|||
164251825|NCT00716482|593288220|FG000|Overall Study|no pathology obtained|10|||
164251826|NCT00716482|593288220|FG000|Overall Study|technical/machine error|28|||
164251827|NCT00716482|593288220|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
164251828|NCT00765037|593288221|FG000|Overall Study|Lost to Follow-up|5|||
164251829|NCT00765037|593288221|FG000|Overall Study|Adverse Event|1|||
164251830|NCT02125838|593288224|FG000|Overall Study|Lost to Follow-up|4|||
164251831|NCT02125838|593288225|FG001|Overall Study|Lost to Follow-up|4|||
164251832|NCT00244725|593288233|FG000|Overall Study|Lost to Follow-up|3|||
164427114|NCT00049517|593932765|FG003|Conditioning/Transplant|Other complicating disease|4|||
164427115|NCT00049517|593932766|FG004|Conditioning/Transplant|Other complicating disease|0|||
164427116|NCT00049517|593932767|FG005|Conditioning/Transplant|Other complicating disease|1|||
164680384|NCT00112437|594854574|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
164680385|NCT00112437|594854575|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
164251833|NCT00244725|593288234|FG001|Overall Study|Lost to Follow-up|4|||
164251834|NCT00244725|593288235|FG002|Overall Study|Lost to Follow-up|9|||
164251835|NCT00244725|593288236|FG003|Overall Study|Lost to Follow-up|2|||
164251836|NCT00244725|593288233|FG000|Overall Study|Withdrawal by Subject|9|||
164251837|NCT00244725|593288234|FG001|Overall Study|Withdrawal by Subject|7|||
164251838|NCT00244725|593288235|FG002|Overall Study|Withdrawal by Subject|7|||
164251839|NCT00244725|593288236|FG003|Overall Study|Withdrawal by Subject|8|||
164251840|NCT00244725|593288233|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
164251841|NCT00244725|593288234|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
164251842|NCT00244725|593288235|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
164251843|NCT00244725|593288236|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
164251844|NCT00244725|593288233|FG000|Overall Study|Physician Decision|3|||
164251845|NCT00244725|593288234|FG001|Overall Study|Physician Decision|0|||
164251846|NCT00244725|593288235|FG002|Overall Study|Physician Decision|1|||
164251847|NCT00244725|593288236|FG003|Overall Study|Physician Decision|2|||
164338924|NCT01146912|593617090|FG007|Overall Study|Duplicate patient|0|||
164338925|NCT02980783|593617091|FG000|Overall Study|Lost to Follow-up|1|||
164338926|NCT00880542|593617092|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
164338927|NCT00880542|593617092|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
164338928|NCT00880542|593617092|FG000|REP: Surgical Resection|progressive disease|1|||
164338929|NCT05047770|593617093|FG000|Overall Study|Withdrawal by Subject|15|||
164338930|NCT05047770|593617094|FG001|Overall Study|Withdrawal by Subject|10|||
164338931|NCT05047770|593617095|FG002|Overall Study|Withdrawal by Subject|6|||
164338932|NCT05047770|593617096|FG003|Overall Study|Withdrawal by Subject|12|||
164338933|NCT05047770|593617093|FG000|Overall Study|Lost to Follow-up|7|||
164338934|NCT05047770|593617094|FG001|Overall Study|Lost to Follow-up|5|||
164680386|NCT00112437|594854576|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164251848|NCT00244725|593288233|FG000|Overall Study|Adverse Events|3|||
164251849|NCT00244725|593288234|FG001|Overall Study|Adverse Events|1|||
164251850|NCT00244725|593288235|FG002|Overall Study|Adverse Events|4|||
164251851|NCT00244725|593288236|FG003|Overall Study|Adverse Events|4|||
164251852|NCT00244725|593288233|FG000|Overall Study|Withdrwal by participant|1|||
164251853|NCT00244725|593288234|FG001|Overall Study|Withdrwal by participant|0|||
164251854|NCT00244725|593288235|FG002|Overall Study|Withdrwal by participant|0|||
164338935|NCT05047770|593617095|FG002|Overall Study|Lost to Follow-up|12|||
164338936|NCT05047770|593617096|FG003|Overall Study|Lost to Follow-up|13|||
164338937|NCT05047770|593617093|FG000|Overall Study|Other|1|||
164338938|NCT05047770|593617094|FG001|Overall Study|Other|0|||
164338939|NCT05047770|593617095|FG002|Overall Study|Other|1|||
164338940|NCT05047770|593617096|FG003|Overall Study|Other|0|||
164338941|NCT01772160|593617097|FG000|Overall Study|Death|3|||
164251855|NCT00244725|593288236|FG003|Overall Study|Withdrwal by participant|1|||
164251856|NCT00244725|593288233|FG000|Overall Study|Liver function test abnormality|2|||
164251857|NCT00244725|593288234|FG001|Overall Study|Liver function test abnormality|0|||
164251858|NCT00244725|593288235|FG002|Overall Study|Liver function test abnormality|0|||
164251859|NCT00244725|593288236|FG003|Overall Study|Liver function test abnormality|1|||
164251860|NCT00244725|593288233|FG000|Overall Study|Sponsor withdrew the participant|1|||
164251861|NCT00244725|593288234|FG001|Overall Study|Sponsor withdrew the participant|0|||
164251862|NCT00244725|593288235|FG002|Overall Study|Sponsor withdrew the participant|0|||
164251863|NCT00244725|593288236|FG003|Overall Study|Sponsor withdrew the participant|1|||
164251864|NCT00244725|593288233|FG000|Overall Study|Mediciation Error|0|||
164251865|NCT00244725|593288234|FG001|Overall Study|Mediciation Error|1|||
164251866|NCT00244725|593288235|FG002|Overall Study|Mediciation Error|0|||
164251867|NCT00244725|593288236|FG003|Overall Study|Mediciation Error|0|||
164251868|NCT00244725|593288233|FG000|Overall Study|Rehab Refused to allow participantion|0|||
164251869|NCT00244725|593288234|FG001|Overall Study|Rehab Refused to allow participantion|1|||
164251870|NCT00244725|593288235|FG002|Overall Study|Rehab Refused to allow participantion|0|||
164251871|NCT00244725|593288236|FG003|Overall Study|Rehab Refused to allow participantion|0|||
164251872|NCT00244725|593288233|FG000|Overall Study|Headache|0|||
164251873|NCT00244725|593288234|FG001|Overall Study|Headache|1|||
164251874|NCT00244725|593288235|FG002|Overall Study|Headache|0|||
164251875|NCT00244725|593288236|FG003|Overall Study|Headache|0|||
164251876|NCT00244725|593288233|FG000|Overall Study|Received prohibited medication|0|||
164251877|NCT00244725|593288234|FG001|Overall Study|Received prohibited medication|1|||
164251878|NCT00244725|593288235|FG002|Overall Study|Received prohibited medication|0|||
164251879|NCT00244725|593288236|FG003|Overall Study|Received prohibited medication|1|||
164251880|NCT00244725|593288233|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
164251881|NCT00244725|593288234|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
164251882|NCT00244725|593288235|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
164251883|NCT00244725|593288236|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
164251884|NCT00244725|593288233|FG000|Overall Study|Administrative reason|0|||
164251885|NCT00244725|593288234|FG001|Overall Study|Administrative reason|0|||
164251886|NCT00244725|593288235|FG002|Overall Study|Administrative reason|1|||
164251887|NCT00244725|593288236|FG003|Overall Study|Administrative reason|0|||
164251888|NCT00244725|593288233|FG000|Overall Study|Vomit|0|||
164251889|NCT00244725|593288234|FG001|Overall Study|Vomit|0|||
164251890|NCT00244725|593288235|FG002|Overall Study|Vomit|1|||
164251891|NCT00244725|593288236|FG003|Overall Study|Vomit|0|||
164251892|NCT00244725|593288233|FG000|Overall Study|Failed to follow-up|0|||
164251893|NCT00244725|593288234|FG001|Overall Study|Failed to follow-up|0|||
164251894|NCT00244725|593288235|FG002|Overall Study|Failed to follow-up|1|||
164251895|NCT00244725|593288236|FG003|Overall Study|Failed to follow-up|1|||
164251896|NCT04004221|593288241|FG000|Overall Study|Death|89|||
164251897|NCT04004221|593288241|FG000|Overall Study|Withdrawal by Subject|5|||
164251898|NCT04004221|593288241|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
164251899|NCT04004221|593288241|FG000|Overall Study|Sponsor Decision|9|||
164251900|NCT04004221|593288241|FG000|Overall Study|Participant refused to enter LTE|1|||
164251901|NCT03423238|593288242|FG000|Overall Study|Lost to Follow-up|1|||
164251902|NCT03423238|593288243|FG001|Overall Study|Lost to Follow-up|0|||
164251903|NCT03423238|593288242|FG000|Overall Study|Withdrawal by Subject|1|||
164251904|NCT03423238|593288243|FG001|Overall Study|Withdrawal by Subject|0|||
164251905|NCT00506454|593288245|FG000|Overall Study|Withdrawal by Subject|1|||
164251906|NCT00506454|593288246|FG001|Overall Study|Withdrawal by Subject|1|||
164251907|NCT03745638|593288247|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
164251908|NCT03745638|593288248|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
164251909|NCT03745638|593288249|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
164251910|NCT03745638|593288250|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
164576008|NCT02337387|594471814|FG001|Overall Study|Adverse Event|1|||
164576009|NCT02337387|594471815|FG002|Overall Study|Adverse Event|0|||
164576010|NCT02337387|594471816|FG003|Overall Study|Adverse Event|0|||
164576011|NCT02337387|594471813|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
164576012|NCT02337387|594471814|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
164576013|NCT02337387|594471815|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
164576014|NCT02337387|594471816|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
164251911|NCT03745638|593288251|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
164251912|NCT03745638|593288252|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
164251913|NCT03745638|593288253|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
164251914|NCT03745638|593288247|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
164251915|NCT03745638|593288248|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164251916|NCT03745638|593288249|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164251917|NCT03745638|593288250|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164251918|NCT03745638|593288251|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164576015|NCT01642212|594471817|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
164576016|NCT01642212|594471818|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
164251919|NCT03745638|593288252|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164251920|NCT03745638|593288253|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164251921|NCT03745638|593288247|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
164251922|NCT03745638|593288248|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
164251923|NCT03745638|593288249|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
164251924|NCT03745638|593288250|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164251925|NCT03745638|593288251|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164251926|NCT03745638|593288252|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164251927|NCT03745638|593288253|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164251928|NCT03745638|593288247|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
164251929|NCT03745638|593288248|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
164251930|NCT03745638|593288249|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
164251931|NCT03745638|593288250|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
164251932|NCT03745638|593288251|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
164251933|NCT03745638|593288252|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
164251934|NCT03745638|593288253|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
164251935|NCT03745638|593288247|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
164251936|NCT03745638|593288248|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
164251937|NCT03745638|593288249|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
164251938|NCT03745638|593288250|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
164251939|NCT03745638|593288251|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
164251940|NCT03745638|593288252|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
164251941|NCT03745638|593288253|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
164251942|NCT03745638|593288247|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
164251943|NCT03745638|593288248|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
164251944|NCT03745638|593288249|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
164251945|NCT03745638|593288250|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
164251946|NCT03745638|593288251|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
164251947|NCT03745638|593288252|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
164251948|NCT03745638|593288253|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
164251949|NCT03745638|593288247|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
164251950|NCT03745638|593288248|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
164251951|NCT03745638|593288249|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
164251952|NCT03745638|593288250|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164251953|NCT03745638|593288251|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164251954|NCT03745638|593288252|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164251955|NCT03745638|593288253|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164251956|NCT03745638|593288247|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
164251957|NCT03745638|593288248|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
164251958|NCT03745638|593288249|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
164251959|NCT03745638|593288250|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
164251960|NCT03745638|593288251|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
164251961|NCT03745638|593288252|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
164251962|NCT03745638|593288253|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
164251963|NCT03745638|593288247|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
164251964|NCT03745638|593288248|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
164251965|NCT03745638|593288249|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
164251966|NCT03745638|593288250|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
164338942|NCT01772160|593617097|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
164338943|NCT01772160|593617097|FG000|Overall Study|Consent withdrawal|3|||
164338944|NCT01772160|593617097|FG000|Overall Study|Migrated / moved from the study area|4|||
164338945|NCT01772160|593617097|FG000|Overall Study|Lost to Follow-up|30|||
164338946|NCT01772160|593617097|FG000|Overall Study|Other|5|||
164338947|NCT02202980|593617098|FG000|Overall Study|Lack of Efficacy|1|||
164338948|NCT02202980|593617099|FG001|Overall Study|Lack of Efficacy|0|||
164338949|NCT02202980|593617100|FG002|Overall Study|Lack of Efficacy|7|||
164338950|NCT02202980|593617101|FG003|Overall Study|Lack of Efficacy|0|||
164338951|NCT02202980|593617102|FG004|Overall Study|Lack of Efficacy|3|||
164576017|NCT01642212|594471819|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
164576018|NCT01642212|594471820|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
164576019|NCT01642212|594471821|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
164576020|NCT01642212|594471817|FG000|Double-blind Treatment|Other|0|||
164576021|NCT01642212|594471818|FG001|Double-blind Treatment|Other|2|||
164576022|NCT01642212|594471819|FG002|Double-blind Treatment|Other|1|||
164576023|NCT01642212|594471820|FG003|Double-blind Treatment|Other|0|||
164576024|NCT01642212|594471821|FG004|Double-blind Treatment|Other|0|||
164576025|NCT01642212|594471817|FG000|Double-blind Treatment|Non-compliance|0|||
164576026|NCT01642212|594471818|FG001|Double-blind Treatment|Non-compliance|1|||
164251967|NCT03745638|593288251|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
164576027|NCT01642212|594471819|FG002|Double-blind Treatment|Non-compliance|0|||
164576028|NCT01642212|594471820|FG003|Double-blind Treatment|Non-compliance|0|||
164576029|NCT01642212|594471821|FG004|Double-blind Treatment|Non-compliance|0|||
164576030|NCT01642212|594471817|FG000|Double-blind Treatment|Adverse Event|0|||
164576031|NCT01642212|594471818|FG001|Double-blind Treatment|Adverse Event|0|||
164576032|NCT01642212|594471819|FG002|Double-blind Treatment|Adverse Event|1|||
164576033|NCT01642212|594471820|FG003|Double-blind Treatment|Adverse Event|0|||
164576034|NCT01642212|594471821|FG004|Double-blind Treatment|Adverse Event|0|||
164576035|NCT01642212|594471817|FG000|Open-label Extension|Adverse Event|0|||
164576036|NCT01642212|594471818|FG001|Open-label Extension|Adverse Event|0|||
164576037|NCT01642212|594471819|FG002|Open-label Extension|Adverse Event|0|||
164576038|NCT01642212|594471820|FG003|Open-label Extension|Adverse Event|3|||
164576039|NCT01642212|594471821|FG004|Open-label Extension|Adverse Event|0|||
164251968|NCT03745638|593288252|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
164576040|NCT01642212|594471817|FG000|Open-label Extension|Sponsor Decision|0|||
164576041|NCT01642212|594471818|FG001|Open-label Extension|Sponsor Decision|0|||
164251969|NCT03745638|593288253|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
164251970|NCT03745638|593288247|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
164251971|NCT03745638|593288248|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
164251972|NCT03745638|593288249|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
164251973|NCT03745638|593288250|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
164251974|NCT03745638|593288251|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
164251975|NCT03745638|593288252|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
164251976|NCT03745638|593288253|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
164251977|NCT03745638|593288247|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
164251978|NCT03745638|593288248|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
164251979|NCT03745638|593288249|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
164251980|NCT03745638|593288250|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
164251981|NCT03745638|593288251|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
164251982|NCT03745638|593288252|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
164251983|NCT03745638|593288253|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
164251984|NCT03745638|593288247|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
164251985|NCT03745638|593288248|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
164251986|NCT03745638|593288249|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
164251987|NCT03745638|593288250|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
164251988|NCT03745638|593288251|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
164251989|NCT03745638|593288252|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
164251990|NCT03745638|593288253|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
164251991|NCT03745638|593288247|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
164251992|NCT03745638|593288248|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
164251993|NCT03745638|593288249|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
164251994|NCT03745638|593288250|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
164251995|NCT03745638|593288251|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
164251996|NCT03745638|593288252|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
164251997|NCT03745638|593288253|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
164251998|NCT03745638|593288247|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
164251999|NCT03745638|593288248|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
164252000|NCT03745638|593288249|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
164252001|NCT03745638|593288250|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
164252002|NCT03745638|593288251|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
164252003|NCT03745638|593288252|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
164252004|NCT03745638|593288253|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
164252005|NCT03745638|593288247|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
164252006|NCT03745638|593288248|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
164252007|NCT03745638|593288249|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
164252008|NCT03745638|593288250|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
164252009|NCT03745638|593288251|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
164252010|NCT03745638|593288252|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
164252011|NCT03745638|593288253|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
164252012|NCT00976716|593288254|FG000|Overall Study|Adverse Event|1|||
164252013|NCT02993822|593288262|FG000|Overall Study|Lack of Efficacy|1|||
164252014|NCT02993822|593288263|FG001|Overall Study|Lack of Efficacy|1|||
164252015|NCT02993822|593288264|FG002|Overall Study|Lack of Efficacy|0|||
164252016|NCT02993822|593288265|FG003|Overall Study|Lack of Efficacy|0|||
164252017|NCT02993822|593288262|FG000|Overall Study|Protocol Violation|1|||
164252018|NCT02993822|593288263|FG001|Overall Study|Protocol Violation|0|||
164252019|NCT02993822|593288264|FG002|Overall Study|Protocol Violation|0|||
164252020|NCT02993822|593288265|FG003|Overall Study|Protocol Violation|0|||
164252021|NCT02993822|593288262|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
164252022|NCT02993822|593288263|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
164252023|NCT02993822|593288264|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
164427117|NCT00049517|593932762|FG000|Conditioning/Transplant|Reasons not reported|25|||
164427118|NCT00049517|593932763|FG001|Conditioning/Transplant|Reasons not reported|31|||
164427119|NCT00049517|593932764|FG002|Conditioning/Transplant|Reasons not reported|18|||
164427120|NCT00049517|593932765|FG003|Conditioning/Transplant|Reasons not reported|15|||
164252024|NCT02993822|593288265|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
164252025|NCT02993822|593288262|FG000|Overall Study|Adverse Event|3|||
164427121|NCT00049517|593932766|FG004|Conditioning/Transplant|Reasons not reported|5|||
164427122|NCT00049517|593932767|FG005|Conditioning/Transplant|Reasons not reported|5|||
164252026|NCT02993822|593288263|FG001|Overall Study|Adverse Event|1|||
164252027|NCT02993822|593288264|FG002|Overall Study|Adverse Event|7|||
164427123|NCT00569946|593932768|FG000|Overall Study|Adverse Event|16|||
164252028|NCT02993822|593288265|FG003|Overall Study|Adverse Event|0|||
164252029|NCT02993822|593288262|FG000|Overall Study|Withdrawal by Subject|4|||
164252030|NCT02993822|593288263|FG001|Overall Study|Withdrawal by Subject|2|||
164252031|NCT02993822|593288264|FG002|Overall Study|Withdrawal by Subject|2|||
164252032|NCT02993822|593288265|FG003|Overall Study|Withdrawal by Subject|3|||
164252033|NCT02993822|593288262|FG000|Overall Study|Lost to Follow-up|1|||
164252034|NCT02993822|593288263|FG001|Overall Study|Lost to Follow-up|0|||
164252035|NCT02993822|593288264|FG002|Overall Study|Lost to Follow-up|1|||
164252036|NCT02993822|593288265|FG003|Overall Study|Lost to Follow-up|0|||
164252037|NCT01221753|593288269|FG000|Overall Study|Adverse Event|1|||
164252038|NCT01939977|593288273|FG000|Overall Study|Adverse Event|4|||
164252039|NCT01939977|593288274|FG001|Overall Study|Adverse Event|3|||
164252040|NCT01939977|593288273|FG000|Overall Study|Lack of Efficacy|3|||
164252041|NCT01939977|593288274|FG001|Overall Study|Lack of Efficacy|0|||
164252042|NCT01939977|593288273|FG000|Overall Study|Physician Decision|1|||
164252043|NCT01939977|593288274|FG001|Overall Study|Physician Decision|1|||
164252044|NCT01939977|593288273|FG000|Overall Study|Withdrawal by Subject|0|||
164252045|NCT01939977|593288274|FG001|Overall Study|Withdrawal by Subject|2|||
164252046|NCT01939977|593288273|FG000|Overall Study|Did not meet inclusion criteria|1|||
164252047|NCT01939977|593288274|FG001|Overall Study|Did not meet inclusion criteria|0|||
164252048|NCT01939977|593288273|FG000|Overall Study|Did not receive study medication|0|||
164252049|NCT01939977|593288274|FG001|Overall Study|Did not receive study medication|1|||
164252050|NCT01603043|593288278|FG000|Overall Study|Study Futility|7|||
164252051|NCT01603043|593288279|FG001|Overall Study|Study Futility|3|||
164252052|NCT01917929|593288280|FG000|Overall Study|Death|8|||
164252053|NCT01917929|593288280|FG000|Overall Study|Lost to Follow-up|19|||
164252054|NCT01917929|593288280|FG000|Overall Study|Withdrawal by Subject|33|||
164252055|NCT01917929|593288280|FG000|Overall Study|Adverse Event|6|||
164252056|NCT01917929|593288280|FG000|Overall Study|Investigative Site Terminated|35|||
164252057|NCT01917929|593288280|FG000|Overall Study|Censored because study device not implanted|6|||
164252058|NCT01917929|593288280|FG000|Overall Study|Censored because surgery not performed|3|||
164252059|NCT01917929|593288280|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
164252060|NCT01917929|593288280|FG000|Overall Study|Sponsor terminated study|175|||
164252061|NCT01696981|593288281|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
164252062|NCT01696981|593288282|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
164252063|NCT01696981|593288281|FG000|Overall Study|Died Before Randomization|3|||
164252064|NCT01696981|593288282|FG001|Overall Study|Died Before Randomization|8|||
164252065|NCT01696981|593288281|FG000|Overall Study|Died Before ASU (Control)|278|||
164252066|NCT01696981|593288282|FG001|Overall Study|Died Before ASU (Control)|0|||
164252067|NCT01696981|593288281|FG000|Overall Study|Refused ASU (Control)|920|||
164252068|NCT01696981|593288282|FG001|Overall Study|Refused ASU (Control)|0|||
164252069|NCT01696981|593288281|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
164252070|NCT01696981|593288282|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
164252071|NCT03599518|593288283|FG000|Overall Study|Clinical progression|0|||
164427124|NCT00569946|593932768|FG000|Overall Study|Objective Progression or Relapse|42|||
164427125|NCT00569946|593932768|FG000|Overall Study|Global Deterioration of Health Status|1|||
164427126|NCT02949271|593932771|FG000|Overall Study|Lack of Efficacy|5|||
164427127|NCT02949271|593932772|FG001|Overall Study|Lack of Efficacy|4|||
164427128|NCT02949271|593932771|FG000|Overall Study|Lost to Follow-up|3|||
164427129|NCT02949271|593932772|FG001|Overall Study|Lost to Follow-up|6|||
164252072|NCT03599518|593288284|FG001|Overall Study|Clinical progression|0|||
164252073|NCT03599518|593288285|FG002|Overall Study|Clinical progression|0|||
164252074|NCT03599518|593288286|FG003|Overall Study|Clinical progression|0|||
164252075|NCT03599518|593288287|FG004|Overall Study|Clinical progression|1|||
164252076|NCT03599518|593288283|FG000|Overall Study|Adverse Event|0|||
164252077|NCT03599518|593288284|FG001|Overall Study|Adverse Event|0|||
164252078|NCT03599518|593288285|FG002|Overall Study|Adverse Event|0|||
164252079|NCT03599518|593288286|FG003|Overall Study|Adverse Event|0|||
164252080|NCT03599518|593288287|FG004|Overall Study|Adverse Event|1|||
164427130|NCT02949271|593932771|FG000|Overall Study|Physician Decision|5|||
164427131|NCT02949271|593932772|FG001|Overall Study|Physician Decision|5|||
164427132|NCT02949271|593932771|FG000|Overall Study|Protocol Violation|6|||
164252081|NCT03599518|593288283|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
164252082|NCT03599518|593288284|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
164252083|NCT03599518|593288285|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
164427133|NCT02949271|593932772|FG001|Overall Study|Protocol Violation|3|||
164427134|NCT02949271|593932771|FG000|Overall Study|Withdrawal by Subject|1|||
164427135|NCT02949271|593932772|FG001|Overall Study|Withdrawal by Subject|0|||
164427136|NCT02949271|593932771|FG000|Overall Study|Delivered prior to intervention|7|||
164252084|NCT03599518|593288286|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
164252085|NCT03599518|593288287|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
164252086|NCT03599518|593288283|FG000|Overall Study|Participant withdrawal from study treatment|0|||
164252087|NCT03599518|593288284|FG001|Overall Study|Participant withdrawal from study treatment|0|||
164252088|NCT03599518|593288285|FG002|Overall Study|Participant withdrawal from study treatment|1|||
164252089|NCT03599518|593288286|FG003|Overall Study|Participant withdrawal from study treatment|0|||
164252090|NCT03599518|593288287|FG004|Overall Study|Participant withdrawal from study treatment|0|||
164252091|NCT02798315|593288290|FG000|Overall Study|Failure to return|1|||
164252092|NCT00005947|593288291|FG000|Overall Study|Death|54|||
164252093|NCT00005947|593288292|FG001|Overall Study|Death|40|||
164252094|NCT00005947|593288291|FG000|Overall Study|Patient Refused to Continue|2|||
164252095|NCT00005947|593288292|FG001|Overall Study|Patient Refused to Continue|1|||
164252096|NCT00005947|593288291|FG000|Overall Study|Site Closure|1|||
164252097|NCT00005947|593288292|FG001|Overall Study|Site Closure|0|||
164252098|NCT00465972|593288293|FG000|Overall Study|Withdrawal by Subject|2|||
164252099|NCT00465972|593288294|FG001|Overall Study|Withdrawal by Subject|1|||
164252100|NCT05356910|593288299|FG000|Overall Study|Lost to Follow-up|10|||
164252101|NCT05356910|593288300|FG001|Overall Study|Lost to Follow-up|19|||
164252102|NCT05356910|593288301|FG002|Overall Study|Lost to Follow-up|0|||
164252103|NCT05356910|593288302|FG003|Overall Study|Lost to Follow-up|0|||
164252104|NCT05356910|593288299|FG000|Overall Study|Withdrawal by Subject|4|||
164252105|NCT05356910|593288300|FG001|Overall Study|Withdrawal by Subject|2|||
164252106|NCT05356910|593288301|FG002|Overall Study|Withdrawal by Subject|0|||
164252107|NCT05356910|593288302|FG003|Overall Study|Withdrawal by Subject|0|||
164252108|NCT02712996|593288303|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
164252109|NCT02712996|593288304|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
164252110|NCT00972517|593288305|FG000|Overall Study|Adverse Event|0|||
164252111|NCT00972517|593288306|FG001|Overall Study|Adverse Event|0|||
164252112|NCT00972517|593288307|FG002|Overall Study|Adverse Event|0|||
164252113|NCT00972517|593288308|FG003|Overall Study|Adverse Event|1|||
164252114|NCT00972517|593288309|FG004|Overall Study|Adverse Event|0|||
164252115|NCT00972517|593288310|FG005|Overall Study|Adverse Event|0|||
164252116|NCT00972517|593288305|FG000|Overall Study|Withdrawal by Subject|0|||
164252117|NCT00972517|593288306|FG001|Overall Study|Withdrawal by Subject|1|||
164252118|NCT00972517|593288307|FG002|Overall Study|Withdrawal by Subject|0|||
164252119|NCT00972517|593288308|FG003|Overall Study|Withdrawal by Subject|2|||
164252120|NCT00972517|593288309|FG004|Overall Study|Withdrawal by Subject|1|||
164252121|NCT00972517|593288310|FG005|Overall Study|Withdrawal by Subject|0|||
164252122|NCT00819156|593288311|FG000|Overall Study|Adverse Event|1|||
164252123|NCT00819156|593288312|FG001|Overall Study|Adverse Event|4|||
164252124|NCT00819156|593288313|FG002|Overall Study|Adverse Event|2|||
164252125|NCT00819156|593288314|FG003|Overall Study|Adverse Event|1|||
164252126|NCT00819156|593288315|FG004|Overall Study|Adverse Event|2|||
164252127|NCT00819156|593288316|FG005|Overall Study|Adverse Event|3|||
164252128|NCT00819156|593288311|FG000|Overall Study|Withdrawal by Subject|0|||
164252129|NCT00819156|593288312|FG001|Overall Study|Withdrawal by Subject|3|||
164252130|NCT00819156|593288313|FG002|Overall Study|Withdrawal by Subject|2|||
164252131|NCT00819156|593288314|FG003|Overall Study|Withdrawal by Subject|0|||
164252132|NCT00819156|593288315|FG004|Overall Study|Withdrawal by Subject|1|||
164252133|NCT00819156|593288316|FG005|Overall Study|Withdrawal by Subject|0|||
164252134|NCT00819156|593288311|FG000|Overall Study|Protocol Violation|1|||
164252135|NCT00819156|593288312|FG001|Overall Study|Protocol Violation|0|||
164252136|NCT00819156|593288313|FG002|Overall Study|Protocol Violation|1|||
164252137|NCT00819156|593288314|FG003|Overall Study|Protocol Violation|0|||
164252138|NCT00819156|593288315|FG004|Overall Study|Protocol Violation|0|||
164252139|NCT00819156|593288316|FG005|Overall Study|Protocol Violation|1|||
164252140|NCT00819156|593288311|FG000|Overall Study|Lost to Follow-up|0|||
164252141|NCT00819156|593288312|FG001|Overall Study|Lost to Follow-up|1|||
164252142|NCT00819156|593288313|FG002|Overall Study|Lost to Follow-up|0|||
164252143|NCT00819156|593288314|FG003|Overall Study|Lost to Follow-up|0|||
164252144|NCT00819156|593288315|FG004|Overall Study|Lost to Follow-up|0|||
164338952|NCT02202980|593617103|FG005|Overall Study|Lack of Efficacy|1|||
164338953|NCT02202980|593617104|FG006|Overall Study|Lack of Efficacy|11|||
164338954|NCT02202980|593617105|FG007|Overall Study|Lack of Efficacy|2|||
164338955|NCT02202980|593617106|FG008|Overall Study|Lack of Efficacy|2|||
164576042|NCT01642212|594471819|FG002|Open-label Extension|Sponsor Decision|0|||
164252145|NCT00819156|593288316|FG005|Overall Study|Lost to Follow-up|2|||
164252146|NCT00819156|593288311|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
164252147|NCT00819156|593288312|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
164252148|NCT00819156|593288313|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
164252149|NCT00819156|593288314|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
164338956|NCT02202980|593617107|FG009|Overall Study|Lack of Efficacy|0|||
164252150|NCT00819156|593288315|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
164338957|NCT02202980|593617108|FG010|Overall Study|Lack of Efficacy|0|||
164252151|NCT00819156|593288316|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
164252152|NCT00819156|593288311|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
164252153|NCT00819156|593288312|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
164252154|NCT00819156|593288313|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
164252155|NCT00819156|593288314|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
164252156|NCT00819156|593288315|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
164338958|NCT02202980|593617109|FG011|Overall Study|Lack of Efficacy|3|||
164427137|NCT02949271|593932772|FG001|Overall Study|Delivered prior to intervention|9|||
164427138|NCT02949271|593932771|FG000|Overall Study|Outside the window for cervical dilation|2|||
164427139|NCT02949271|593932772|FG001|Overall Study|Outside the window for cervical dilation|3|||
164427140|NCT01764386|593932779|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
164427141|NCT01764386|593932780|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
164680387|NCT00112437|594854577|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164680388|NCT00112437|594854578|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164680389|NCT00112437|594854579|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164680390|NCT00112437|594854580|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164680391|NCT00112437|594854581|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164680392|NCT00112437|594854582|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164680393|NCT00112437|594854583|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164680394|NCT00112437|594854584|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164427142|NCT01764386|593932779|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
164427143|NCT01764386|593932780|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
164427144|NCT01764386|593932779|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
164427145|NCT01764386|593932780|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
164427146|NCT01764386|593932779|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
164427147|NCT01764386|593932780|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
164427148|NCT01764386|593932779|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
164427149|NCT01764386|593932780|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
164427150|NCT01764386|593932779|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
164427151|NCT01764386|593932780|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
164427152|NCT01764386|593932779|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
164427153|NCT01764386|593932780|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
164427154|NCT01764386|593932779|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
164427155|NCT01764386|593932780|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
164427156|NCT03738241|593932781|FG000|Overall Study|Withdrawal by Subject|0|||
164427157|NCT03738241|593932782|FG001|Overall Study|Withdrawal by Subject|0|||
164427158|NCT03738241|593932783|FG002|Overall Study|Withdrawal by Subject|0|||
164427159|NCT03738241|593932784|FG003|Overall Study|Withdrawal by Subject|0|||
164427160|NCT03738241|593932785|FG004|Overall Study|Withdrawal by Subject|0|||
164427161|NCT03738241|593932786|FG005|Overall Study|Withdrawal by Subject|0|||
164427162|NCT03738241|593932787|FG006|Overall Study|Withdrawal by Subject|0|||
164427163|NCT03738241|593932788|FG007|Overall Study|Withdrawal by Subject|0|||
164427164|NCT03738241|593932789|FG008|Overall Study|Withdrawal by Subject|0|||
164427165|NCT03738241|593932790|FG009|Overall Study|Withdrawal by Subject|1|||
164427166|NCT03738241|593932781|FG000|Overall Study|Physician Decision|0|||
164427167|NCT03738241|593932782|FG001|Overall Study|Physician Decision|0|||
164427168|NCT03738241|593932783|FG002|Overall Study|Physician Decision|0|||
164427169|NCT03738241|593932784|FG003|Overall Study|Physician Decision|0|||
164427170|NCT03738241|593932785|FG004|Overall Study|Physician Decision|0|||
164427171|NCT03738241|593932786|FG005|Overall Study|Physician Decision|0|||
164427172|NCT03738241|593932787|FG006|Overall Study|Physician Decision|0|||
164427173|NCT03738241|593932788|FG007|Overall Study|Physician Decision|0|||
164427174|NCT03738241|593932789|FG008|Overall Study|Physician Decision|1|||
164427175|NCT03738241|593932790|FG009|Overall Study|Physician Decision|0|||
164427176|NCT03738241|593932781|FG000|Overall Study|Adverse Event|1|||
164427177|NCT03738241|593932782|FG001|Overall Study|Adverse Event|0|||
164427178|NCT03738241|593932783|FG002|Overall Study|Adverse Event|0|||
164427179|NCT03738241|593932784|FG003|Overall Study|Adverse Event|0|||
164427180|NCT03738241|593932785|FG004|Overall Study|Adverse Event|0|||
164427181|NCT03738241|593932786|FG005|Overall Study|Adverse Event|0|||
164427182|NCT03738241|593932787|FG006|Overall Study|Adverse Event|0|||
164427183|NCT03738241|593932788|FG007|Overall Study|Adverse Event|0|||
164427184|NCT03738241|593932789|FG008|Overall Study|Adverse Event|0|||
164427185|NCT03738241|593932790|FG009|Overall Study|Adverse Event|0|||
164427186|NCT03169361|593932791|FG000|Overall Study|Protocol Violation|32|||
164427187|NCT02788656|593932792|FG000|Overall Study|Withdrawal by Subject|1|||
164427188|NCT02788656|593932793|FG001|Overall Study|Withdrawal by Subject|0|||
164427189|NCT02263885|593932794|FG000|Overall Study|Withdrawal by Subject|7|||
164252157|NCT00819156|593288316|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
164252158|NCT00819156|593288311|FG000|Overall Study|Prostate-specific antigen progression|0|||
164252159|NCT00819156|593288312|FG001|Overall Study|Prostate-specific antigen progression|0|||
164252160|NCT00819156|593288313|FG002|Overall Study|Prostate-specific antigen progression|0|||
164427190|NCT02263885|593932794|FG000|Overall Study|Alternative Treatment|3|||
164427191|NCT01175707|593932803|FG000|Overall Study|Adverse Event|4|||
164427192|NCT01175707|593932804|FG001|Overall Study|Adverse Event|6|||
164427193|NCT01575860|593932805|FG000|Overall Study|Withdrawal by Subject|1|||
164427194|NCT01575860|593932805|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
164427195|NCT00984282|593932806|FG000|Double Blind Treatment|Adverse Event|40|||
164427196|NCT00984282|593932807|FG001|Double Blind Treatment|Adverse Event|6|||
164427197|NCT00984282|593932806|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
164427198|NCT00984282|593932807|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
164427199|NCT00984282|593932806|FG000|Double Blind Treatment|Physician Decision|1|||
164427200|NCT00984282|593932807|FG001|Double Blind Treatment|Physician Decision|2|||
164427201|NCT00984282|593932806|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
164427202|NCT00984282|593932807|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
164427203|NCT00984282|593932806|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
164427204|NCT00984282|593932807|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
164427205|NCT00984282|593932806|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
164427206|NCT00984282|593932807|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
164427207|NCT00984282|593932806|FG000|Double Blind Treatment|Lost to Follow-up|3|||
164427208|NCT00984282|593932807|FG001|Double Blind Treatment|Lost to Follow-up|0|||
164427209|NCT00984282|593932806|FG000|Double Blind Treatment|Death|8|||
164427210|NCT00984282|593932807|FG001|Double Blind Treatment|Death|4|||
164427211|NCT00984282|593932806|FG000|Double Blind Treatment|Not treated|0|||
164427212|NCT00984282|593932807|FG001|Double Blind Treatment|Not treated|1|||
164427213|NCT00984282|593932806|FG000|Double Blind Treatment|Switched to commercial drug|6|||
164427214|NCT00984282|593932807|FG001|Double Blind Treatment|Switched to commercial drug|1|||
164427215|NCT00984282|593932806|FG000|Double Blind Treatment|protocol driven decision point|1|||
164427216|NCT00984282|593932807|FG001|Double Blind Treatment|protocol driven decision point|1|||
164427217|NCT00984282|593932806|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
164427218|NCT00984282|593932807|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
164427219|NCT00984282|593932806|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
164427220|NCT00984282|593932807|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
164427221|NCT00984282|593932806|FG000|Open-label Treatment|Adverse Event|20|||
164427222|NCT00984282|593932807|FG001|Open-label Treatment|Adverse Event|30|||
164427223|NCT00984282|593932806|FG000|Open-label Treatment|Withdrawal by Subject|6|||
164427224|NCT00984282|593932807|FG001|Open-label Treatment|Withdrawal by Subject|21|||
164427225|NCT00984282|593932806|FG000|Open-label Treatment|Death|7|||
164680395|NCT00112437|594854585|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164680396|NCT00112437|594854586|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164680397|NCT00112437|594854587|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164680398|NCT00112437|594854588|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164680399|NCT00112437|594854589|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164680400|NCT00112437|594854590|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164680401|NCT00112437|594854591|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164427226|NCT00984282|593932807|FG001|Open-label Treatment|Death|15|||
164427227|NCT00984282|593932806|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
164427228|NCT00984282|593932807|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
164427229|NCT00984282|593932806|FG000|Open-label Treatment|Lost to Follow-up|1|||
164427230|NCT00984282|593932807|FG001|Open-label Treatment|Lost to Follow-up|1|||
164427231|NCT00984282|593932806|FG000|Open-label Treatment|Patient convenience|1|||
164427232|NCT00984282|593932807|FG001|Open-label Treatment|Patient convenience|0|||
164427233|NCT00984282|593932806|FG000|Open-label Treatment|Non-compliant with study medication|1|||
164427234|NCT00984282|593932807|FG001|Open-label Treatment|Non-compliant with study medication|0|||
164427235|NCT00984282|593932806|FG000|Open-label Treatment|Target lesion removed|0|||
164680402|NCT00112437|594854592|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164680403|NCT00112437|594854593|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164680404|NCT00112437|594854594|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164680405|NCT00112437|594854595|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164680406|NCT00112437|594854596|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164680407|NCT00112437|594854571|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
164680408|NCT00112437|594854572|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
164680409|NCT00112437|594854573|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
164680410|NCT00112437|594854574|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
164680411|NCT00112437|594854575|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
164680412|NCT00112437|594854576|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164680413|NCT00112437|594854577|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164680414|NCT00112437|594854578|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164680415|NCT00112437|594854579|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164680416|NCT00112437|594854580|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164680417|NCT00112437|594854581|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164680418|NCT00112437|594854582|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164680419|NCT00112437|594854583|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164680420|NCT00112437|594854584|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164680421|NCT00112437|594854585|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164680422|NCT00112437|594854586|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164680423|NCT00112437|594854587|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164680424|NCT00112437|594854588|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164680425|NCT00112437|594854589|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164680426|NCT00112437|594854590|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164427236|NCT00984282|593932807|FG001|Open-label Treatment|Target lesion removed|1|||
164427237|NCT00984282|593932806|FG000|Open-label Treatment|Protocol driven decision point|1|||
164427238|NCT00984282|593932807|FG001|Open-label Treatment|Protocol driven decision point|1|||
164427239|NCT00984282|593932806|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
164427240|NCT00984282|593932807|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
164427241|NCT00984282|593932806|FG000|Open-label Treatment|Switched to commercial drug|6|||
164427242|NCT00984282|593932807|FG001|Open-label Treatment|Switched to commercial drug|7|||
164427243|NCT00984282|593932806|FG000|Open-label Treatment|Physician Decision|1|||
164427244|NCT00984282|593932807|FG001|Open-label Treatment|Physician Decision|0|||
164427245|NCT00984282|593932806|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
164427246|NCT00984282|593932807|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
164252161|NCT00819156|593288314|FG003|Overall Study|Prostate-specific antigen progression|0|||
164252162|NCT00819156|593288315|FG004|Overall Study|Prostate-specific antigen progression|1|||
164252163|NCT00819156|593288316|FG005|Overall Study|Prostate-specific antigen progression|0|||
164252164|NCT00984594|593288317|FG000|Overall Study|Lost to Follow-up|1|||
164252165|NCT00984594|593288318|FG001|Overall Study|Lost to Follow-up|0|||
164252166|NCT00984594|593288317|FG000|Overall Study|Withdrawal by Subject|0|||
164252167|NCT00984594|593288318|FG001|Overall Study|Withdrawal by Subject|1|||
164252168|NCT00851890|593288319|FG000|Overall Study|Lost to Follow-up|0|||
164252169|NCT00851890|593288320|FG001|Overall Study|Lost to Follow-up|1|||
164252170|NCT00851890|593288321|FG002|Overall Study|Lost to Follow-up|0|||
164252171|NCT00851890|593288322|FG003|Overall Study|Lost to Follow-up|1|||
164252172|NCT03135431|593288323|FG000|Overall Study|Study Surgeon not available|2|||
164252173|NCT03135431|593288324|FG001|Overall Study|Study Surgeon not available|0|||
164252174|NCT00281099|593288327|FG000|Overall Study|Death|46|||
164252175|NCT00281099|593288328|FG001|Overall Study|Death|57|||
164252176|NCT00281099|593288327|FG000|Overall Study|Lost to Follow-up|10|||
164252177|NCT00281099|593288328|FG001|Overall Study|Lost to Follow-up|19|||
164252178|NCT00281099|593288327|FG000|Overall Study|Withdrawal by Subject|65|||
164252179|NCT00281099|593288328|FG001|Overall Study|Withdrawal by Subject|70|||
164252180|NCT00281099|593288327|FG000|Overall Study|Physician Decision|79|||
164252181|NCT00281099|593288328|FG001|Overall Study|Physician Decision|72|||
164252182|NCT00281099|593288327|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
164252183|NCT00281099|593288328|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
164252184|NCT00104728|593288329|FG000|Overall Study|screen failures|19|||
164252185|NCT03206918|593288330|FG000|Overall Study|Death|11|||
164252186|NCT03206918|593288330|FG000|Overall Study|Withdrawal by Subject|5|||
164252187|NCT03206918|593288330|FG000|Overall Study|Study terminated by sponsor|12|||
164252188|NCT03206918|593288330|FG000|Overall Study|Lost to Follow-up|3|||
164252189|NCT03206918|593288330|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
164252190|NCT02701764|593288331|FG000|Overall Study|Lost to Follow-up|0|||
164252191|NCT02701764|593288332|FG001|Overall Study|Lost to Follow-up|1|||
164252192|NCT06899737|593288338|FG000|Overall Study|Lost to Follow-up|19|||
164252193|NCT06899737|593288339|FG001|Overall Study|Lost to Follow-up|7|||
164252194|NCT01082081|593288340|FG000|Overall Study|Lost to Follow-up|0|||
164252195|NCT01082081|593288341|FG001|Overall Study|Lost to Follow-up|0|||
164252196|NCT01082081|593288342|FG002|Overall Study|Lost to Follow-up|1|||
164252197|NCT01082081|593288340|FG000|Overall Study|Withdrawal by Subject|0|||
164252198|NCT01082081|593288341|FG001|Overall Study|Withdrawal by Subject|0|||
164252199|NCT01082081|593288342|FG002|Overall Study|Withdrawal by Subject|1|||
164252200|NCT01082081|593288340|FG000|Overall Study|Other Reason|0|||
164252201|NCT01082081|593288341|FG001|Overall Study|Other Reason|1|||
164252202|NCT01082081|593288342|FG002|Overall Study|Other Reason|0|||
164252203|NCT01170273|593288343|FG000|Overall Study|Lost to Follow-up|6|||
164252204|NCT01170273|593288344|FG001|Overall Study|Lost to Follow-up|8|||
164252205|NCT01170273|593288343|FG000|Overall Study|Protocol Violation|1|||
164252206|NCT01170273|593288344|FG001|Overall Study|Protocol Violation|0|||
164680427|NCT00112437|594854591|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164680428|NCT00112437|594854592|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164680429|NCT00112437|594854593|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164680430|NCT00112437|594854594|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164680431|NCT00112437|594854595|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164427247|NCT00984282|593932806|FG000|Long Term Follow-up|Death|27|||
164680432|NCT00112437|594854596|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164680433|NCT00112437|594854571|FG000|Year 1 (12-Month Base Study)|moved|0|||
164680434|NCT00112437|594854572|FG001|Year 1 (12-Month Base Study)|moved|1|||
164680435|NCT00112437|594854573|FG002|Year 1 (12-Month Base Study)|moved|1|||
164680436|NCT00112437|594854574|FG003|Year 1 (12-Month Base Study)|moved|0|||
164680437|NCT00112437|594854575|FG004|Year 1 (12-Month Base Study)|moved|0|||
164680438|NCT00112437|594854576|FG005|Year 1 (12-Month Base Study)|moved|0|||
164680439|NCT00112437|594854577|FG006|Year 1 (12-Month Base Study)|moved|0|||
164252207|NCT01170273|593288343|FG000|Overall Study|Death|1|||
164252208|NCT01170273|593288344|FG001|Overall Study|Death|0|||
164252209|NCT01170273|593288343|FG000|Overall Study|Adverse Event|0|||
164252210|NCT01170273|593288344|FG001|Overall Study|Adverse Event|1|||
164252211|NCT03159468|593288345|FG000|Overall Study|Withdrawal by Subject|0|||
164252212|NCT03159468|593288346|FG001|Overall Study|Withdrawal by Subject|0|||
164252213|NCT03159468|593288347|FG002|Overall Study|Withdrawal by Subject|3|||
164252214|NCT03159468|593288348|FG003|Overall Study|Withdrawal by Subject|0|||
164252215|NCT03159468|593288349|FG004|Overall Study|Withdrawal by Subject|0|||
164252216|NCT03159468|593288350|FG005|Overall Study|Withdrawal by Subject|0|||
164252217|NCT00375674|593288351|FG000|Overall Study|Other|26|||
164252218|NCT00375674|593288352|FG001|Overall Study|Other|18|||
164252219|NCT00375674|593288351|FG000|Overall Study|Death|67|||
164252220|NCT00375674|593288352|FG001|Overall Study|Death|76|||
164252221|NCT00375674|593288351|FG000|Overall Study|Participants refused further follow-up|31|||
164252222|NCT00375674|593288352|FG001|Overall Study|Participants refused further follow-up|30|||
164427248|NCT00984282|593932807|FG001|Long Term Follow-up|Death|68|||
164252223|NCT00375674|593288351|FG000|Overall Study|Lost to Follow-up|17|||
164252224|NCT00375674|593288352|FG001|Overall Study|Lost to Follow-up|15|||
164252225|NCT00375674|593288351|FG000|Overall Study|Enrolled but not treated|3|||
164252226|NCT00375674|593288352|FG001|Overall Study|Enrolled but not treated|2|||
164252227|NCT00912782|593288353|FG000|Overall Study|Death|2|||
164252228|NCT00912782|593288354|FG001|Overall Study|Death|1|||
164252229|NCT00912782|593288353|FG000|Overall Study|Lost to Follow-up|0|||
164252230|NCT00912782|593288354|FG001|Overall Study|Lost to Follow-up|1|||
164252231|NCT00912782|593288353|FG000|Overall Study|Did not receive vascular access type|1|||
164252232|NCT00912782|593288354|FG001|Overall Study|Did not receive vascular access type|2|||
164252233|NCT00912782|593288353|FG000|Overall Study|Relocated before study completion|0|||
164252234|NCT00912782|593288354|FG001|Overall Study|Relocated before study completion|1|||
164252235|NCT00301262|593289992|FG000|Double Blind Phase (DB)|Adverse Event|1|||
164252236|NCT00301262|593289993|FG001|Double Blind Phase (DB)|Adverse Event|0|||
164252237|NCT00301262|593289992|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
164252238|NCT00301262|593289993|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
164252239|NCT00301262|593289992|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
164252240|NCT00301262|593289993|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
164252241|NCT00301262|593289992|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
164252242|NCT00301262|593289993|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
164252243|NCT00301262|593289992|FG000|Double Blind Phase (DB)|Other|1|||
164252244|NCT00301262|593289993|FG001|Double Blind Phase (DB)|Other|4|||
164252245|NCT00301262|593289992|FG000|Open Label Phase (OL)|Adverse Event|1|||
164252246|NCT00301262|593289993|FG001|Open Label Phase (OL)|Adverse Event|0|||
164252247|NCT00301262|593289992|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
164252248|NCT00301262|593289993|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
164252249|NCT00301262|593289992|FG000|Open Label Phase (OL)|Other|2|||
164252250|NCT00301262|593289993|FG001|Open Label Phase (OL)|Other|0|||
164252251|NCT03530995|593289994|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
164252252|NCT03530995|593289995|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
164252253|NCT03530995|593289994|FG000|Part 1 Period 3|Protocol Violation|1|||
164252254|NCT03530995|593289995|FG001|Part 1 Period 3|Protocol Violation|0|||
164252255|NCT03530995|593289994|FG000|Part 1 Period 4|Physician Decision|1|||
164252256|NCT03530995|593289995|FG001|Part 1 Period 4|Physician Decision|0|||
164252257|NCT03530995|593289994|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
164252258|NCT03530995|593289995|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
164252259|NCT01443364|593290003|FG000|Overall Study|Lack of Efficacy|14|||
164252260|NCT01443364|593290003|FG000|Overall Study|Lost to Follow-up|3|||
164252261|NCT01443364|593290003|FG000|Overall Study|Withdrawal by Subject|5|||
164252262|NCT01443364|593290003|FG000|Overall Study|Other Reason|4|||
164252263|NCT01443364|593290003|FG000|Overall Study|SAE, non-fatal|6|||
164252264|NCT01443364|593290003|FG000|Overall Study|AE, non-serious non-fatal|8|||
164252265|NCT01443364|593290003|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
164252266|NCT02650804|593290004|FG000|Overall Study|Adverse Event|3|||
164252267|NCT02650804|593290005|FG001|Overall Study|Adverse Event|2|||
164252268|NCT02650804|593290004|FG000|Overall Study|Death|1|||
164252269|NCT02650804|593290005|FG001|Overall Study|Death|2|||
164252270|NCT02650804|593290004|FG000|Overall Study|Progressive Disease|7|||
164252271|NCT02650804|593290005|FG001|Overall Study|Progressive Disease|10|||
164252272|NCT02650804|593290004|FG000|Overall Study|Physician Decision|0|||
164252273|NCT02650804|593290005|FG001|Overall Study|Physician Decision|2|||
164252274|NCT02650804|593290004|FG000|Overall Study|Withdrawal by Subject|1|||
164252275|NCT02650804|593290005|FG001|Overall Study|Withdrawal by Subject|4|||
164252276|NCT02650804|593290004|FG000|Overall Study|Symptomatic deterioration|5|||
164252277|NCT02650804|593290005|FG001|Overall Study|Symptomatic deterioration|7|||
164252278|NCT02650804|593290004|FG000|Overall Study|Protocol Violation|0|||
164252279|NCT02650804|593290005|FG001|Overall Study|Protocol Violation|1|||
164252280|NCT01986231|593290010|FG000|Overall Study|Adverse Event|1|||
164252281|NCT02150057|593290011|FG000|Overall Study|Lost to Follow-up|6|||
164576043|NCT01642212|594471820|FG003|Open-label Extension|Sponsor Decision|7|||
164576044|NCT01642212|594471821|FG004|Open-label Extension|Sponsor Decision|4|||
164252282|NCT02150057|593290012|FG001|Overall Study|Lost to Follow-up|4|||
164252283|NCT02388165|593290013|FG000|Overall Study|Study terminated by sponsor|5|||
164252284|NCT02388165|593290014|FG001|Overall Study|Study terminated by sponsor|5|||
164252285|NCT02388165|593290013|FG000|Overall Study|Other|11|||
164252286|NCT02388165|593290014|FG001|Overall Study|Other|13|||
164252287|NCT02388165|593290013|FG000|Overall Study|No longer meet eligibility criteria|40|||
164252288|NCT02388165|593290014|FG001|Overall Study|No longer meet eligibility criteria|43|||
164252289|NCT02388165|593290013|FG000|Overall Study|Withdrawal of consent|31|||
164252290|NCT02388165|593290014|FG001|Overall Study|Withdrawal of consent|32|||
164252291|NCT02388165|593290013|FG000|Overall Study|Lost to Follow-up|19|||
164252292|NCT02388165|593290014|FG001|Overall Study|Lost to Follow-up|20|||
164252293|NCT02388165|593290013|FG000|Overall Study|Death|13|||
164252294|NCT02388165|593290014|FG001|Overall Study|Death|10|||
164252295|NCT02388165|593290013|FG000|Overall Study|Adverse Event|3|||
164252296|NCT02388165|593290014|FG001|Overall Study|Adverse Event|5|||
164252297|NCT02388165|593290013|FG000|Overall Study|Did not meet entrance criteria|5|||
164252298|NCT02388165|593290014|FG001|Overall Study|Did not meet entrance criteria|2|||
164252299|NCT04551963|593290018|FG000|Overall Study|Physician Decision|1|||
164252300|NCT04551963|593290019|FG001|Overall Study|Physician Decision|1|||
164252301|NCT04551963|593290018|FG000|Overall Study|Death|1|||
164252302|NCT04551963|593290019|FG001|Overall Study|Death|0|||
164252303|NCT02974855|593290020|FG000|Overall Study|Adverse Event|0|||
164252304|NCT02974855|593290021|FG001|Overall Study|Adverse Event|1|||
164252305|NCT02974855|593290022|FG002|Overall Study|Adverse Event|0|||
164252306|NCT02974855|593290023|FG003|Overall Study|Adverse Event|1|||
164252307|NCT01474772|593290024|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
164252308|NCT01474772|593290025|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
164252309|NCT01474772|593290024|FG000|Period 1|AE not Related to Study Drug|1|||
164252310|NCT01474772|593290025|FG001|Period 1|AE not Related to Study Drug|0|||
164252311|NCT01474772|593290024|FG000|Period 1|Withdrawal by Subject|3|||
164252312|NCT01474772|593290025|FG001|Period 1|Withdrawal by Subject|1|||
164252313|NCT01474772|593290024|FG000|Period 1|Lost to Follow-up|1|||
164252314|NCT01474772|593290025|FG001|Period 1|Lost to Follow-up|0|||
164252315|NCT01474772|593290024|FG000|Period 1|Reason not Specified|1|||
164252316|NCT01474772|593290025|FG001|Period 1|Reason not Specified|1|||
164252317|NCT01474772|593290024|FG000|Washout|AE not Related to Study Drug|2|||
164252318|NCT01474772|593290025|FG001|Washout|AE not Related to Study Drug|0|||
164252319|NCT01474772|593290024|FG000|Washout|Withdrawal by Subject|1|||
164252320|NCT01474772|593290025|FG001|Washout|Withdrawal by Subject|0|||
164252321|NCT01474772|593290024|FG000|Washout|Lost to Follow-up|0|||
164252322|NCT01474772|593290025|FG001|Washout|Lost to Follow-up|1|||
164252323|NCT01474772|593290024|FG000|Washout|Reason not Specified|0|||
164252324|NCT01474772|593290025|FG001|Washout|Reason not Specified|1|||
164252325|NCT01474772|593290024|FG000|Period 2|Death|0|||
164252326|NCT01474772|593290025|FG001|Period 2|Death|1|||
164252327|NCT01474772|593290024|FG000|Period 2|AE Related to Study Drug|0|||
164252328|NCT01474772|593290025|FG001|Period 2|AE Related to Study Drug|1|||
164252329|NCT01474772|593290024|FG000|Period 2|AE not Related to Study Drug|4|||
164252330|NCT01474772|593290025|FG001|Period 2|AE not Related to Study Drug|1|||
164252331|NCT01474772|593290024|FG000|Period 2|Lack of Efficacy|1|||
164252332|NCT01474772|593290025|FG001|Period 2|Lack of Efficacy|0|||
164252333|NCT01474772|593290024|FG000|Period 2|Withdrawal by Subject|3|||
164252334|NCT01474772|593290025|FG001|Period 2|Withdrawal by Subject|4|||
164252335|NCT01474772|593290024|FG000|Period 2|Lost to Follow-up|1|||
164252336|NCT01474772|593290025|FG001|Period 2|Lost to Follow-up|1|||
164252337|NCT01474772|593290024|FG000|Period 2|Reason not Specified|0|||
164252338|NCT01474772|593290025|FG001|Period 2|Reason not Specified|2|||
164252339|NCT01474772|593290024|FG000|Follow-up|AE not Related to Study Drug|0|||
164252340|NCT01474772|593290025|FG001|Follow-up|AE not Related to Study Drug|1|||
164252341|NCT00633074|593290026|FG000|Overall Study|Adverse Event|1|||
164252342|NCT00633074|593290027|FG001|Overall Study|Adverse Event|0|||
164252343|NCT00365105|593290028|FG000|Overall Study|Protocol Violation|5|||
164252344|NCT00365105|593290029|FG001|Overall Study|Protocol Violation|8|||
164252345|NCT00748618|593290030|FG000|Overall Study|Adverse Event|1|||
164252346|NCT00748618|593290031|FG001|Overall Study|Adverse Event|0|||
164252347|NCT06004895|593290032|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
164252348|NCT06004895|593290032|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
164252349|NCT00466947|593290033|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
164252350|NCT00466947|593290034|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
164252351|NCT00466947|593290033|FG000|Study End Analysis Period|Adverse Event|35|||
164252352|NCT00466947|593290034|FG001|Study End Analysis Period|Adverse Event|43|||
164252353|NCT00466947|593290033|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
164252354|NCT00466947|593290034|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
164252355|NCT00466947|593290033|FG000|Study End Analysis Period|Physician Decision|29|||
164252356|NCT00466947|593290034|FG001|Study End Analysis Period|Physician Decision|29|||
164252357|NCT00466947|593290033|FG000|Study End Analysis Period|Protocol Violation|9|||
164576045|NCT01642212|594471817|FG000|Open-label Extension|Consent Withdrawn|0|||
164252358|NCT00466947|593290034|FG001|Study End Analysis Period|Protocol Violation|17|||
164252359|NCT00466947|593290033|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
164252360|NCT00466947|593290034|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
164252361|NCT00466947|593290033|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
164252362|NCT00466947|593290034|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
164252363|NCT00466947|593290033|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
164252364|NCT00466947|593290034|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
164252365|NCT00466947|593290033|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
164252366|NCT00466947|593290034|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
164252367|NCT00878254|593290035|FG000|Overall Study|Physician Decision|1|||
164252368|NCT00878254|593290035|FG000|Overall Study|Death|1|||
164252369|NCT00878254|593290035|FG000|Overall Study|Withdrawal by Subject|1|||
164252370|NCT01995526|593290036|FG000|Overall Study|Physician Decision|1|||
164252371|NCT03367403|593290041|FG000|Overall Study|Adverse Event|20|||
164252372|NCT03367403|593290042|FG001|Overall Study|Adverse Event|6|||
164252373|NCT03367403|593290043|FG002|Overall Study|Adverse Event|2|||
164252374|NCT03367403|593290041|FG000|Overall Study|Withdrawal by Subject|12|||
164252375|NCT03367403|593290042|FG001|Overall Study|Withdrawal by Subject|13|||
164252376|NCT03367403|593290043|FG002|Overall Study|Withdrawal by Subject|1|||
164252377|NCT03367403|593290041|FG000|Overall Study|Death|1|||
164252378|NCT03367403|593290042|FG001|Overall Study|Death|2|||
164252379|NCT03367403|593290043|FG002|Overall Study|Death|0|||
164252380|NCT03367403|593290041|FG000|Overall Study|Physician Decision|0|||
164252381|NCT03367403|593290042|FG001|Overall Study|Physician Decision|1|||
164252382|NCT03367403|593290043|FG002|Overall Study|Physician Decision|0|||
164576046|NCT01642212|594471818|FG001|Open-label Extension|Consent Withdrawn|0|||
164576047|NCT01642212|594471819|FG002|Open-label Extension|Consent Withdrawn|0|||
164576048|NCT01642212|594471820|FG003|Open-label Extension|Consent Withdrawn|0|||
164576049|NCT01642212|594471821|FG004|Open-label Extension|Consent Withdrawn|2|||
164576050|NCT01642212|594471817|FG000|Open-label Extension|Lost to Follow-up|0|||
164576051|NCT01642212|594471818|FG001|Open-label Extension|Lost to Follow-up|0|||
164576052|NCT01642212|594471819|FG002|Open-label Extension|Lost to Follow-up|0|||
164576053|NCT01642212|594471820|FG003|Open-label Extension|Lost to Follow-up|0|||
164576054|NCT01642212|594471821|FG004|Open-label Extension|Lost to Follow-up|1|||
164576055|NCT01642212|594471817|FG000|Open-label Extension|Other|0|||
164576056|NCT01642212|594471818|FG001|Open-label Extension|Other|0|||
164576057|NCT01642212|594471819|FG002|Open-label Extension|Other|0|||
164576058|NCT01642212|594471820|FG003|Open-label Extension|Other|0|||
164576059|NCT01642212|594471821|FG004|Open-label Extension|Other|1|||
164576060|NCT00957853|594471823|FG000|Overall Study|Withdrawal by Subject|1|||
164576061|NCT00957853|594471824|FG001|Overall Study|Withdrawal by Subject|0|||
164576062|NCT00957853|594471825|FG002|Overall Study|Withdrawal by Subject|0|||
164576063|NCT03871491|594471828|FG000|Overall Study|Withdrawal by Subject|14|||
164252383|NCT03367403|593290041|FG000|Overall Study|Protocol Violation|1|||
164252384|NCT03367403|593290042|FG001|Overall Study|Protocol Violation|1|||
164252385|NCT03367403|593290043|FG002|Overall Study|Protocol Violation|0|||
164252386|NCT03367403|593290041|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
164252387|NCT03367403|593290042|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
164252388|NCT03367403|593290043|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
164252389|NCT03367403|593290041|FG000|Overall Study|COVID-19|3|||
164252390|NCT03367403|593290042|FG001|Overall Study|COVID-19|6|||
164252391|NCT03367403|593290043|FG002|Overall Study|COVID-19|0|||
164252392|NCT03367403|593290041|FG000|Overall Study|Abuse of Alcohol Intake|0|||
164252393|NCT03367403|593290042|FG001|Overall Study|Abuse of Alcohol Intake|1|||
164252394|NCT03367403|593290043|FG002|Overall Study|Abuse of Alcohol Intake|0|||
164252395|NCT03367403|593290041|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
164252396|NCT03367403|593290042|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
164252397|NCT03367403|593290043|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
164252398|NCT02321319|593290048|FG000|Overall Study|Product discontinued|5|||
164252399|NCT03497975|593290051|FG000|Overall Study|Withdrew Consent|34|||
164252400|NCT03497975|593290052|FG001|Overall Study|Withdrew Consent|35|||
164252401|NCT03497975|593290051|FG000|Overall Study|Lost to Follow-up|7|||
164252402|NCT03497975|593290052|FG001|Overall Study|Lost to Follow-up|7|||
164252403|NCT03497975|593290051|FG000|Overall Study|Physician Decision|4|||
164576064|NCT03871491|594471829|FG001|Overall Study|Withdrawal by Subject|14|||
164427249|NCT00984282|593932806|FG000|Long Term Follow-up|Lost to Follow-up|3|||
164427250|NCT00984282|593932807|FG001|Long Term Follow-up|Lost to Follow-up|6|||
164427251|NCT00984282|593932806|FG000|Long Term Follow-up|Protocol driven decision point|25|||
164427252|NCT00984282|593932807|FG001|Long Term Follow-up|Protocol driven decision point|26|||
164427253|NCT00984282|593932806|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
164427254|NCT00984282|593932807|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
164427255|NCT00984282|593932806|FG000|Long Term Follow-up|Switched to commercial drug|4|||
164427256|NCT00984282|593932807|FG001|Long Term Follow-up|Switched to commercial drug|2|||
164427257|NCT00984282|593932806|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
164427258|NCT00984282|593932807|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
164427259|NCT02223793|593932808|FG000|Overall Study|Lost to Follow-up|10|||
164252404|NCT03497975|593290052|FG001|Overall Study|Physician Decision|5|||
164252405|NCT03497975|593290051|FG000|Overall Study|Discontinued|42|||
164252406|NCT03497975|593290052|FG001|Overall Study|Discontinued|39|||
164252407|NCT03497975|593290051|FG000|Overall Study|Reason Not Specified|15|||
164252408|NCT03497975|593290052|FG001|Overall Study|Reason Not Specified|14|||
164252409|NCT02141399|593290053|FG000|Overall Study|Adverse Event|158|||
164252410|NCT02141399|593290053|FG000|Overall Study|Lack of Efficacy|62|||
164252411|NCT02141399|593290053|FG000|Overall Study|Lost to Follow-up|151|||
164252412|NCT02141399|593290053|FG000|Overall Study|Non-compliance with study drug|18|||
164252413|NCT02141399|593290053|FG000|Overall Study|Other|45|||
164252414|NCT02141399|593290053|FG000|Overall Study|Physician Decision|17|||
164252415|NCT02141399|593290053|FG000|Overall Study|Pregnancy|3|||
164252416|NCT02141399|593290053|FG000|Overall Study|Protocol Violation|38|||
164252417|NCT02141399|593290053|FG000|Overall Study|Withdrawal by Subject|238|||
164252418|NCT02141399|593290053|FG000|Overall Study|Failure to meet eligibility criteria|14|||
164252419|NCT00606034|593290056|FG000|Overall Study|incarceration|1|||
164252420|NCT01734395|593290057|FG000|Overall Study|Other|65|||
164252421|NCT01734395|593290057|FG000|Overall Study|Lost to Follow-up|287|||
164252422|NCT01734395|593290057|FG000|Overall Study|Lack of Efficacy|5|||
164252423|NCT01734395|593290057|FG000|Overall Study|Adverse Event|40|||
164252424|NCT01734395|593290057|FG000|Overall Study|Withdrawal by Subject|10|||
164252425|NCT01734395|593290057|FG000|Overall Study|Missing the reasons for not completed|3|||
164252426|NCT00935493|593290063|FG000|Overall Study|Lost to Follow-up|1|||
164252427|NCT00935493|593290064|FG001|Overall Study|Lost to Follow-up|1|||
164252428|NCT00935493|593290065|FG002|Overall Study|Lost to Follow-up|1|||
164252429|NCT00935493|593290063|FG000|Overall Study|Treatment Discontinued|0|||
164252430|NCT00935493|593290064|FG001|Overall Study|Treatment Discontinued|1|||
164252431|NCT00935493|593290065|FG002|Overall Study|Treatment Discontinued|0|||
164252432|NCT01355679|593290067|FG000|Overall Study|benign tumor types found at biopsy|2|||
164252433|NCT02027311|593290068|FG000|Overall Study|Protocol Violation|3|||
164252434|NCT02027311|593290069|FG001|Overall Study|Protocol Violation|2|||
164252435|NCT00964002|593290071|FG000|Overall Study|Protocol Violation|8|||
164252436|NCT03768089|593290074|FG000|Part A|Lost to Follow-up|0|||
164252437|NCT03768089|593290075|FG001|Part A|Lost to Follow-up|0|||
164252438|NCT03768089|593290076|FG002|Part A|Lost to Follow-up|0|||
164252439|NCT03768089|593290077|FG003|Part A|Lost to Follow-up|0|||
164252440|NCT03768089|593290078|FG004|Part A|Lost to Follow-up|1|||
164252441|NCT03768089|593290079|FG005|Part A|Lost to Follow-up|0|||
164252442|NCT03768089|593290080|FG006|Part A|Lost to Follow-up|0|||
164252443|NCT03768089|593290081|FG007|Part A|Lost to Follow-up|0|||
164252444|NCT03768089|593290082|FG008|Part A|Lost to Follow-up|0|||
164252445|NCT03768089|593290083|FG009|Part A|Lost to Follow-up|0|||
164252446|NCT03768089|593290084|FG010|Part A|Lost to Follow-up|0|||
164252447|NCT03768089|593290085|FG011|Part A|Lost to Follow-up|0|||
164252448|NCT03768089|593290086|FG012|Part A|Lost to Follow-up|0|||
164252449|NCT03768089|593290087|FG013|Part A|Lost to Follow-up|0|||
164252450|NCT03768089|593290088|FG014|Part A|Lost to Follow-up|0|||
164427260|NCT02223793|593932809|FG001|Overall Study|Lost to Follow-up|1|||
164427261|NCT02223793|593932810|FG002|Overall Study|Lost to Follow-up|2|||
164576065|NCT03871491|594471830|FG002|Overall Study|Withdrawal by Subject|14|||
164252451|NCT03768089|593290089|FG015|Part A|Lost to Follow-up|0|||
164252452|NCT03768089|593290090|FG016|Part A|Lost to Follow-up|0|||
164252453|NCT03768089|593290091|FG017|Part A|Lost to Follow-up|0|||
164252454|NCT03768089|593290074|FG000|Part C|Randomized, Never Dosed|0|||
164252455|NCT03768089|593290075|FG001|Part C|Randomized, Never Dosed|0|||
164252456|NCT03768089|593290076|FG002|Part C|Randomized, Never Dosed|0|||
164252457|NCT03768089|593290077|FG003|Part C|Randomized, Never Dosed|0|||
164252458|NCT03768089|593290078|FG004|Part C|Randomized, Never Dosed|0|||
164252459|NCT03768089|593290079|FG005|Part C|Randomized, Never Dosed|0|||
164252460|NCT03768089|593290080|FG006|Part C|Randomized, Never Dosed|0|||
164252461|NCT03768089|593290081|FG007|Part C|Randomized, Never Dosed|0|||
164252462|NCT03768089|593290082|FG008|Part C|Randomized, Never Dosed|0|||
164252463|NCT03768089|593290083|FG009|Part C|Randomized, Never Dosed|0|||
164252464|NCT03768089|593290084|FG010|Part C|Randomized, Never Dosed|0|||
164252465|NCT03768089|593290085|FG011|Part C|Randomized, Never Dosed|0|||
164252466|NCT03768089|593290086|FG012|Part C|Randomized, Never Dosed|0|||
164252467|NCT03768089|593290087|FG013|Part C|Randomized, Never Dosed|0|||
164427262|NCT02223793|593932808|FG000|Overall Study|Withdrawal by Subject|3|||
164252468|NCT03768089|593290088|FG014|Part C|Randomized, Never Dosed|1|||
164252469|NCT03768089|593290089|FG015|Part C|Randomized, Never Dosed|0|||
164252470|NCT03768089|593290090|FG016|Part C|Randomized, Never Dosed|0|||
164252471|NCT03768089|593290091|FG017|Part C|Randomized, Never Dosed|0|||
164252472|NCT02091362|593290094|FG000|Period 1|Protocol Violation|1|||
164252473|NCT02091362|593290095|FG001|Period 1|Protocol Violation|0|||
164252474|NCT02091362|593290094|FG000|Period 1|Withdrawal by Subject|2|||
164252475|NCT02091362|593290095|FG001|Period 1|Withdrawal by Subject|3|||
164252476|NCT02091362|593290094|FG000|Period 1|Lost to Follow-up|0|||
164252477|NCT02091362|593290095|FG001|Period 1|Lost to Follow-up|1|||
164252478|NCT02091362|593290094|FG000|Period 1|Adverse Event|2|||
164252479|NCT02091362|593290095|FG001|Period 1|Adverse Event|0|||
164252480|NCT02091362|593290094|FG000|Wash-out|Lost to Follow-up|1|||
164252481|NCT02091362|593290095|FG001|Wash-out|Lost to Follow-up|1|||
164252482|NCT02091362|593290094|FG000|Wash-out|Withdrawal by Subject|0|||
164252483|NCT02091362|593290095|FG001|Wash-out|Withdrawal by Subject|2|||
164252484|NCT02091362|593290094|FG000|Period 2|Adverse Event|1|||
164252485|NCT02091362|593290095|FG001|Period 2|Adverse Event|0|||
164252486|NCT02091362|593290094|FG000|Period 2|Lost to Follow-up|0|||
164252487|NCT02091362|593290095|FG001|Period 2|Lost to Follow-up|1|||
164252488|NCT02091362|593290094|FG000|Period 2|Withdrawal by Subject|1|||
164252489|NCT02091362|593290095|FG001|Period 2|Withdrawal by Subject|1|||
164252490|NCT02565147|593290096|FG000|Overall Study|Withdrawal by Subject|5|||
164252491|NCT02565147|593290097|FG001|Overall Study|Withdrawal by Subject|1|||
164252492|NCT02565147|593290096|FG000|Overall Study|Lost to Follow-up|0|||
164252493|NCT02565147|593290097|FG001|Overall Study|Lost to Follow-up|1|||
164252494|NCT02565147|593290096|FG000|Overall Study|Death|1|||
164252495|NCT02565147|593290097|FG001|Overall Study|Death|1|||
164252496|NCT00787839|593290098|FG000|Overall Study|Failure to have the OGTT was most common|404|||
164252497|NCT03799952|593290101|FG000|Overall Study|Program was too easy, discontinued|1|||
164252498|NCT03799952|593290102|FG001|Overall Study|Program was too easy, discontinued|0|||
164252499|NCT03799952|593290101|FG000|Overall Study|Lost to Follow-up|0|||
164252500|NCT03799952|593290102|FG001|Overall Study|Lost to Follow-up|2|||
164252501|NCT00902850|593290103|FG000|Overall Study|Physician Decision|2|||
164252502|NCT00902850|593290104|FG001|Overall Study|Physician Decision|2|||
164252503|NCT03292640|593290107|FG000|Overall Study|Withdrawal by Subject|17|||
164252504|NCT03292640|593290108|FG001|Overall Study|Withdrawal by Subject|16|||
164252505|NCT03292640|593290107|FG000|Overall Study|Adverse Event|20|||
164252506|NCT03292640|593290108|FG001|Overall Study|Adverse Event|2|||
164252507|NCT03292640|593290107|FG000|Overall Study|Lost to Follow-up|24|||
164252508|NCT03292640|593290108|FG001|Overall Study|Lost to Follow-up|24|||
164252509|NCT02015481|593290109|FG000|Overall Study|Death|1|||
164252510|NCT03122145|593290111|FG000|Overall Study|Concurrent respiratory disease|3|||
164252511|NCT03122145|593290112|FG001|Overall Study|Concurrent respiratory disease|0|||
164252512|NCT00079391|593290113|FG000|Overall Study|Withdrawal by Subject|1|||
164252513|NCT00837161|593290114|FG000|Overall Study|refused hysterectomy|2|||
164252514|NCT01456195|593292141|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
164252515|NCT01456195|593292142|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
164252516|NCT01456195|593292143|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
164252517|NCT01456195|593292141|FG000|Overall Study|Lost to Follow-up|3|||
164252518|NCT01456195|593292142|FG001|Overall Study|Lost to Follow-up|1|||
164576066|NCT03871491|594471831|FG003|Overall Study|Withdrawal by Subject|14|||
164576067|NCT03871491|594471828|FG000|Overall Study|Physician Decision|0|||
164576068|NCT03871491|594471829|FG001|Overall Study|Physician Decision|0|||
164576069|NCT03871491|594471830|FG002|Overall Study|Physician Decision|1|||
164576070|NCT03871491|594471831|FG003|Overall Study|Physician Decision|1|||
164576071|NCT03871491|594471828|FG000|Overall Study|Lost to Follow-up|50|||
164576072|NCT03871491|594471829|FG001|Overall Study|Lost to Follow-up|15|||
164252519|NCT01456195|593292143|FG002|Overall Study|Lost to Follow-up|3|||
164576073|NCT03871491|594471830|FG002|Overall Study|Lost to Follow-up|36|||
164252520|NCT01456195|593292141|FG000|Overall Study|Voluntary Withdrawal|5|||
164252521|NCT01456195|593292142|FG001|Overall Study|Voluntary Withdrawal|3|||
164252522|NCT01456195|593292143|FG002|Overall Study|Voluntary Withdrawal|7|||
164252523|NCT01456195|593292141|FG000|Overall Study|Lack of Efficacy|0|||
164338959|NCT02202980|593617110|FG012|Overall Study|Lack of Efficacy|10|||
164338960|NCT02202980|593617111|FG013|Overall Study|Lack of Efficacy|0|||
164338961|NCT02202980|593617098|FG000|Overall Study|Protocol Violation|0|||
164252524|NCT01456195|593292142|FG001|Overall Study|Lack of Efficacy|1|||
164252525|NCT01456195|593292143|FG002|Overall Study|Lack of Efficacy|0|||
164338962|NCT02202980|593617099|FG001|Overall Study|Protocol Violation|0|||
164252526|NCT01456195|593292141|FG000|Overall Study|Other Reasons|2|||
164252527|NCT01456195|593292142|FG001|Overall Study|Other Reasons|1|||
164252528|NCT01456195|593292143|FG002|Overall Study|Other Reasons|3|||
164252529|NCT02109432|593292144|FG000|Overall Study|Withdrawal by Subject|1|||
164252530|NCT03372551|593292151|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
164252531|NCT03372551|593292152|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
164252532|NCT04683029|593292162|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
164252533|NCT04683029|593292163|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
164252534|NCT04683029|593292164|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
164252535|NCT04683029|593292165|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
164252536|NCT04683029|593292162|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
164252537|NCT04683029|593292163|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
164252538|NCT04683029|593292164|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
164252539|NCT04683029|593292165|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
164252540|NCT04683029|593292162|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
164252541|NCT04683029|593292163|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
164252542|NCT04683029|593292164|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
164252543|NCT04683029|593292165|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
164252544|NCT04299308|593292169|FG000|Overall Study|Withdrawal by Subject|1|||
164252545|NCT04299308|593292170|FG001|Overall Study|Withdrawal by Subject|0|||
164252546|NCT04299308|593292169|FG000|Overall Study|issue with PET image (1)|1|||
164252547|NCT04299308|593292170|FG001|Overall Study|issue with PET image (1)|0|||
164252548|NCT02920528|593292173|FG000|Overall Study|Incomplete Data|1|||
164252549|NCT02920528|593292174|FG001|Overall Study|Incomplete Data|1|||
164252550|NCT02920528|593292175|FG002|Overall Study|Incomplete Data|1|||
164252551|NCT02920528|593292173|FG000|Overall Study|Adverse Event|0|||
164252552|NCT02920528|593292174|FG001|Overall Study|Adverse Event|0|||
164252553|NCT02920528|593292175|FG002|Overall Study|Adverse Event|3|||
164252554|NCT02920528|593292173|FG000|Overall Study|Did not meet inclusion criteria|2|||
164680440|NCT00112437|594854578|FG007|Year 1 (12-Month Base Study)|moved|0|||
164680441|NCT00112437|594854579|FG008|Year 1 (12-Month Base Study)|moved|0|||
164680442|NCT00112437|594854580|FG009|Year 1 (12-Month Base Study)|moved|0|||
164680443|NCT00112437|594854581|FG010|Year 1 (12-Month Base Study)|moved|0|||
164680444|NCT00112437|594854582|FG011|Year 1 (12-Month Base Study)|moved|0|||
164680445|NCT00112437|594854583|FG012|Year 1 (12-Month Base Study)|moved|0|||
164680446|NCT00112437|594854584|FG013|Year 1 (12-Month Base Study)|moved|0|||
164680447|NCT00112437|594854585|FG014|Year 1 (12-Month Base Study)|moved|0|||
164680448|NCT00112437|594854586|FG015|Year 1 (12-Month Base Study)|moved|0|||
164680449|NCT00112437|594854587|FG016|Year 1 (12-Month Base Study)|moved|0|||
164680450|NCT00112437|594854588|FG017|Year 1 (12-Month Base Study)|moved|0|||
164680451|NCT00112437|594854589|FG018|Year 1 (12-Month Base Study)|moved|0|||
164680452|NCT00112437|594854590|FG019|Year 1 (12-Month Base Study)|moved|0|||
164680453|NCT00112437|594854591|FG020|Year 1 (12-Month Base Study)|moved|0|||
164680454|NCT00112437|594854592|FG021|Year 1 (12-Month Base Study)|moved|0|||
164680455|NCT00112437|594854593|FG022|Year 1 (12-Month Base Study)|moved|0|||
164680456|NCT00112437|594854594|FG023|Year 1 (12-Month Base Study)|moved|0|||
164680457|NCT00112437|594854595|FG024|Year 1 (12-Month Base Study)|moved|0|||
164680458|NCT00112437|594854596|FG025|Year 1 (12-Month Base Study)|moved|0|||
164252555|NCT02920528|593292174|FG001|Overall Study|Did not meet inclusion criteria|0|||
164252556|NCT02920528|593292175|FG002|Overall Study|Did not meet inclusion criteria|1|||
164252557|NCT03596047|593292177|FG000|Overall Study|Withdrawal by Subject|7|||
164252558|NCT03596047|593292178|FG001|Overall Study|Withdrawal by Subject|4|||
164252559|NCT03596047|593292177|FG000|Overall Study|Lost to Follow-up|0|||
164252560|NCT03596047|593292178|FG001|Overall Study|Lost to Follow-up|2|||
164252561|NCT00066703|593292179|FG000|Overall Study|Adverse Event|80|||
164252562|NCT00066703|593292180|FG001|Overall Study|Adverse Event|111|||
164338963|NCT02202980|593617100|FG002|Overall Study|Protocol Violation|0|||
164338964|NCT02202980|593617101|FG003|Overall Study|Protocol Violation|3|||
164338965|NCT02202980|593617102|FG004|Overall Study|Protocol Violation|3|||
164338966|NCT02202980|593617103|FG005|Overall Study|Protocol Violation|0|||
164338967|NCT02202980|593617104|FG006|Overall Study|Protocol Violation|0|||
164338968|NCT02202980|593617105|FG007|Overall Study|Protocol Violation|0|||
164338969|NCT02202980|593617106|FG008|Overall Study|Protocol Violation|0|||
164338970|NCT02202980|593617107|FG009|Overall Study|Protocol Violation|0|||
164338971|NCT02202980|593617108|FG010|Overall Study|Protocol Violation|0|||
164338972|NCT02202980|593617109|FG011|Overall Study|Protocol Violation|0|||
164338973|NCT02202980|593617110|FG012|Overall Study|Protocol Violation|0|||
164338974|NCT02202980|593617111|FG013|Overall Study|Protocol Violation|0|||
164338975|NCT02202980|593617098|FG000|Overall Study|Lost to Follow-up|0|||
164338976|NCT02202980|593617099|FG001|Overall Study|Lost to Follow-up|1|||
164338977|NCT02202980|593617100|FG002|Overall Study|Lost to Follow-up|1|||
164338978|NCT02202980|593617101|FG003|Overall Study|Lost to Follow-up|1|||
164252563|NCT00066703|593292179|FG000|Overall Study|Death|3|||
164338979|NCT02202980|593617102|FG004|Overall Study|Lost to Follow-up|0|||
164338980|NCT02202980|593617103|FG005|Overall Study|Lost to Follow-up|0|||
164338981|NCT02202980|593617104|FG006|Overall Study|Lost to Follow-up|0|||
164338982|NCT02202980|593617105|FG007|Overall Study|Lost to Follow-up|1|||
164338983|NCT02202980|593617106|FG008|Overall Study|Lost to Follow-up|1|||
164338984|NCT02202980|593617107|FG009|Overall Study|Lost to Follow-up|0|||
164252564|NCT00066703|593292180|FG001|Overall Study|Death|0|||
164252565|NCT00066703|593292179|FG000|Overall Study|Lack of Efficacy|114|||
164252566|NCT00066703|593292180|FG001|Overall Study|Lack of Efficacy|69|||
164252567|NCT00066703|593292179|FG000|Overall Study|Lost to Follow-up|31|||
164427263|NCT02223793|593932809|FG001|Overall Study|Withdrawal by Subject|2|||
164427264|NCT02223793|593932810|FG002|Overall Study|Withdrawal by Subject|3|||
164427265|NCT02223793|593932808|FG000|Overall Study|Moved/studycenter unable to participate|4|||
164427266|NCT02223793|593932809|FG001|Overall Study|Moved/studycenter unable to participate|6|||
164427267|NCT02223793|593932810|FG002|Overall Study|Moved/studycenter unable to participate|8|||
164427268|NCT00278564|593932812|FG000|Overall Study|Lack of Efficacy|4|||
164427269|NCT03606460|593932814|FG000|Overall Study|Lost to Follow-up|1|||
164427270|NCT03606460|593932815|FG001|Overall Study|Lost to Follow-up|8|||
164427271|NCT00003377|593932816|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
164427272|NCT00003377|593932817|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
164427273|NCT00003377|593932818|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
164252568|NCT00066703|593292180|FG001|Overall Study|Lost to Follow-up|28|||
164252569|NCT00066703|593292179|FG000|Overall Study|Withdrawal by Subject|38|||
164252570|NCT00066703|593292180|FG001|Overall Study|Withdrawal by Subject|63|||
164252571|NCT00066703|593292179|FG000|Overall Study|Treatment ongoing|346|||
164252572|NCT00066703|593292180|FG001|Overall Study|Treatment ongoing|311|||
164252573|NCT01696968|593292181|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
164252574|NCT01696968|593292182|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
164252575|NCT01696968|593292181|FG000|Overall Study|Died Before Randomization|3|||
164252576|NCT01696968|593292182|FG001|Overall Study|Died Before Randomization|8|||
164252577|NCT01696968|593292181|FG000|Overall Study|Died Before ASU (Control)|278|||
164252578|NCT01696968|593292182|FG001|Overall Study|Died Before ASU (Control)|0|||
164252579|NCT01696968|593292181|FG000|Overall Study|Refused ASU (Control)|920|||
164252580|NCT01696968|593292182|FG001|Overall Study|Refused ASU (Control)|0|||
164252581|NCT01696968|593292181|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
164252582|NCT01696968|593292182|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
164252583|NCT00734604|593292183|FG000|Overall Study|Adverse Event|0|||
164252584|NCT00734604|593292184|FG001|Overall Study|Adverse Event|2|||
164252585|NCT00734604|593292185|FG002|Overall Study|Adverse Event|0|||
164252586|NCT00734604|593292186|FG003|Overall Study|Adverse Event|2|||
164252587|NCT00734604|593292187|FG004|Overall Study|Adverse Event|1|||
164252588|NCT00734604|593292188|FG005|Overall Study|Adverse Event|1|||
164252589|NCT00734604|593292183|FG000|Overall Study|Serious Adverse Event|1|||
164252590|NCT00734604|593292184|FG001|Overall Study|Serious Adverse Event|0|||
164252591|NCT00734604|593292185|FG002|Overall Study|Serious Adverse Event|1|||
164252592|NCT00734604|593292186|FG003|Overall Study|Serious Adverse Event|2|||
164252593|NCT00734604|593292187|FG004|Overall Study|Serious Adverse Event|0|||
164427274|NCT00003377|593932819|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
164252594|NCT00734604|593292188|FG005|Overall Study|Serious Adverse Event|1|||
164252595|NCT00734604|593292183|FG000|Overall Study|Lost to Follow-up|1|||
164252596|NCT00734604|593292184|FG001|Overall Study|Lost to Follow-up|2|||
164252597|NCT00734604|593292185|FG002|Overall Study|Lost to Follow-up|2|||
164252598|NCT00734604|593292186|FG003|Overall Study|Lost to Follow-up|4|||
164252599|NCT00734604|593292187|FG004|Overall Study|Lost to Follow-up|2|||
164252600|NCT00734604|593292188|FG005|Overall Study|Lost to Follow-up|3|||
164252601|NCT00734604|593292183|FG000|Overall Study|Physician Decision|0|||
164252602|NCT00734604|593292184|FG001|Overall Study|Physician Decision|1|||
164252603|NCT00734604|593292185|FG002|Overall Study|Physician Decision|1|||
164252604|NCT00734604|593292186|FG003|Overall Study|Physician Decision|0|||
164252605|NCT00734604|593292187|FG004|Overall Study|Physician Decision|0|||
164252606|NCT00734604|593292188|FG005|Overall Study|Physician Decision|0|||
164252607|NCT00734604|593292183|FG000|Overall Study|Protocol Violation|0|||
164252608|NCT00734604|593292184|FG001|Overall Study|Protocol Violation|2|||
164252609|NCT00734604|593292185|FG002|Overall Study|Protocol Violation|0|||
164252610|NCT00734604|593292186|FG003|Overall Study|Protocol Violation|0|||
164252611|NCT00734604|593292187|FG004|Overall Study|Protocol Violation|1|||
164252612|NCT00734604|593292188|FG005|Overall Study|Protocol Violation|0|||
164252613|NCT00734604|593292183|FG000|Overall Study|Sponsor Decision|1|||
164252614|NCT00734604|593292184|FG001|Overall Study|Sponsor Decision|2|||
164252615|NCT00734604|593292185|FG002|Overall Study|Sponsor Decision|1|||
164252616|NCT00734604|593292186|FG003|Overall Study|Sponsor Decision|0|||
164252617|NCT00734604|593292187|FG004|Overall Study|Sponsor Decision|2|||
164252618|NCT00734604|593292188|FG005|Overall Study|Sponsor Decision|0|||
164252619|NCT00734604|593292183|FG000|Overall Study|Withdrawal by Subject|0|||
164252620|NCT00734604|593292184|FG001|Overall Study|Withdrawal by Subject|2|||
164252621|NCT00734604|593292185|FG002|Overall Study|Withdrawal by Subject|0|||
164252622|NCT00734604|593292186|FG003|Overall Study|Withdrawal by Subject|1|||
164252623|NCT00734604|593292187|FG004|Overall Study|Withdrawal by Subject|2|||
164252624|NCT00734604|593292188|FG005|Overall Study|Withdrawal by Subject|1|||
164252625|NCT00734604|593292183|FG000|Overall Study|Lack of Efficacy|0|||
164252626|NCT00734604|593292184|FG001|Overall Study|Lack of Efficacy|1|||
164252627|NCT00734604|593292185|FG002|Overall Study|Lack of Efficacy|1|||
164252628|NCT00734604|593292186|FG003|Overall Study|Lack of Efficacy|0|||
164252629|NCT00734604|593292187|FG004|Overall Study|Lack of Efficacy|0|||
164252630|NCT00734604|593292188|FG005|Overall Study|Lack of Efficacy|0|||
164252631|NCT02199314|593292189|FG000|Overall Study|Withdrawal by Subject|6|||
164252632|NCT02199314|593292189|FG000|Overall Study|Physician Decision|10|||
164252633|NCT04848220|593292190|FG000|Overall Study|Unable to proceed to study procedure|0|||
164252634|NCT04848220|593292191|FG001|Overall Study|Unable to proceed to study procedure|1|||
164252635|NCT04848220|593292192|FG002|Overall Study|Unable to proceed to study procedure|0|||
164252636|NCT04848220|593292190|FG000|Overall Study|Fractional flow not significant|0|||
164252637|NCT04848220|593292191|FG001|Overall Study|Fractional flow not significant|1|||
164252638|NCT04848220|593292192|FG002|Overall Study|Fractional flow not significant|0|||
164252639|NCT02557100|593292197|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
164252640|NCT02557100|593292198|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
164252641|NCT02557100|593292199|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
164252642|NCT02557100|593292197|FG000|Single Blind Treatment Period|Death|0|||
164252643|NCT02557100|593292198|FG001|Single Blind Treatment Period|Death|1|||
164252644|NCT02557100|593292199|FG002|Single Blind Treatment Period|Death|0|||
164252645|NCT02557100|593292197|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
164252646|NCT02557100|593292198|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
164252647|NCT02557100|593292199|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
164252648|NCT02557100|593292197|FG000|Single Blind Treatment Period|Adverse Event|0|||
164252649|NCT02557100|593292198|FG001|Single Blind Treatment Period|Adverse Event|1|||
164252650|NCT02557100|593292199|FG002|Single Blind Treatment Period|Adverse Event|0|||
164252651|NCT02557100|593292197|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
164252652|NCT02557100|593292198|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
164252653|NCT02557100|593292199|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
164252654|NCT02557100|593292197|FG000|Cumulative Abatacept Period|Other Reasons|0|||
164252655|NCT02557100|593292198|FG001|Cumulative Abatacept Period|Other Reasons|0|||
164252656|NCT02557100|593292199|FG002|Cumulative Abatacept Period|Other Reasons|1|||
164252657|NCT02557100|593292197|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
164252658|NCT02557100|593292198|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
164252659|NCT02557100|593292199|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
164338985|NCT02202980|593617108|FG010|Overall Study|Lost to Follow-up|0|||
164338986|NCT02202980|593617109|FG011|Overall Study|Lost to Follow-up|0|||
164252660|NCT02557100|593292197|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
164252661|NCT02557100|593292198|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
164338987|NCT02202980|593617110|FG012|Overall Study|Lost to Follow-up|1|||
164252662|NCT02557100|593292199|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
164338988|NCT02202980|593617111|FG013|Overall Study|Lost to Follow-up|0|||
164252663|NCT02513485|593292203|FG000|Overall Study|Adverse Event|1|||
164252664|NCT02513485|593292204|FG001|Overall Study|Adverse Event|0|||
164252665|NCT01436656|593292220|FG000|Dose Escalation|Death|1|||
164252666|NCT01436656|593292221|FG001|Dose Escalation|Death|3|||
164427275|NCT00003377|593932820|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
164427276|NCT00003377|593932816|FG000|Period II|Ureteral stent complications|0|||
164427277|NCT00003377|593932817|FG001|Period II|Ureteral stent complications|0|||
164427278|NCT00003377|593932818|FG002|Period II|Ureteral stent complications|0|||
164427279|NCT00003377|593932819|FG003|Period II|Ureteral stent complications|0|||
164427280|NCT00003377|593932820|FG004|Period II|Ureteral stent complications|1|||
164427281|NCT03085017|593932829|FG000|Overall Study|Death|0|||
164427282|NCT03085017|593932830|FG001|Overall Study|Death|3|||
164427283|NCT00582790|593932831|FG000|Overall Study|Rapid progression of disease|1|||
164427284|NCT02680756|593932836|FG000|Overall Study|Adverse Event|10|||
164427285|NCT02680756|593932837|FG001|Overall Study|Adverse Event|2|||
164427286|NCT02680756|593932836|FG000|Overall Study|Lost to Follow-up|7|||
164427287|NCT02680756|593932837|FG001|Overall Study|Lost to Follow-up|6|||
164427288|NCT02680756|593932836|FG000|Overall Study|Withdrawal by Subject|5|||
164427289|NCT02680756|593932837|FG001|Overall Study|Withdrawal by Subject|5|||
164427290|NCT02680756|593932836|FG000|Overall Study|Physician Decision|4|||
164427291|NCT02680756|593932837|FG001|Overall Study|Physician Decision|1|||
164427292|NCT02680756|593932836|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
164680459|NCT00112437|594854571|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164680460|NCT00112437|594854572|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164680461|NCT00112437|594854573|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164680462|NCT00112437|594854574|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
164680463|NCT00112437|594854575|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164680464|NCT00112437|594854576|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164680465|NCT00112437|594854577|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164427293|NCT02680756|593932837|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
164427294|NCT02680756|593932836|FG000|Overall Study|Blood transfusion for any reason|0|||
164427295|NCT02680756|593932837|FG001|Overall Study|Blood transfusion for any reason|1|||
164427296|NCT02680756|593932836|FG000|Overall Study|Death|1|||
164427297|NCT02680756|593932837|FG001|Overall Study|Death|0|||
164427298|NCT02680756|593932836|FG000|Overall Study|Protocol Violation|1|||
164252667|NCT01436656|593292222|FG002|Dose Escalation|Death|1|||
164252668|NCT01436656|593292223|FG003|Dose Escalation|Death|0|||
164427299|NCT02680756|593932837|FG001|Overall Study|Protocol Violation|0|||
164427300|NCT02680756|593932836|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
164680466|NCT00112437|594854578|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164680467|NCT00112437|594854579|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164680468|NCT00112437|594854580|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164680469|NCT00112437|594854581|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164680470|NCT00112437|594854582|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164680471|NCT00112437|594854583|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164680472|NCT00112437|594854584|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164680473|NCT00112437|594854585|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164680474|NCT00112437|594854586|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164680475|NCT00112437|594854587|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164680476|NCT00112437|594854588|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164680477|NCT00112437|594854589|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164680478|NCT00112437|594854590|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164680479|NCT00112437|594854591|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164680480|NCT00112437|594854592|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164680481|NCT00112437|594854593|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164680482|NCT00112437|594854594|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164680483|NCT00112437|594854595|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164680484|NCT00112437|594854596|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164680485|NCT00112437|594854571|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164427301|NCT02680756|593932837|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
164427302|NCT02680756|593932836|FG000|Overall Study|None of above or not recorded|3|||
164427303|NCT02680756|593932837|FG001|Overall Study|None of above or not recorded|2|||
164252669|NCT01436656|593292224|FG004|Dose Escalation|Death|2|||
164252670|NCT01436656|593292225|FG005|Dose Escalation|Death|1|||
164252671|NCT01436656|593292226|FG006|Dose Escalation|Death|1|||
164252672|NCT01436656|593292227|FG007|Dose Escalation|Death|1|||
164252673|NCT01436656|593292228|FG008|Dose Escalation|Death|1|||
164252674|NCT01436656|593292229|FG009|Dose Escalation|Death|0|||
164252675|NCT01436656|593292230|FG010|Dose Escalation|Death|0|||
164252676|NCT01436656|593292231|FG011|Dose Escalation|Death|0|||
164252677|NCT01436656|593292232|FG012|Dose Escalation|Death|0|||
164252678|NCT01436656|593292233|FG013|Dose Escalation|Death|0|||
164252679|NCT01436656|593292234|FG014|Dose Escalation|Death|0|||
164252680|NCT01436656|593292235|FG015|Dose Escalation|Death|0|||
164252681|NCT01436656|593292236|FG016|Dose Escalation|Death|0|||
164252682|NCT01436656|593292237|FG017|Dose Escalation|Death|0|||
164252683|NCT01436656|593292220|FG000|Dose Escalation|Protocol Violation|0|||
164252684|NCT01436656|593292221|FG001|Dose Escalation|Protocol Violation|0|||
164252685|NCT01436656|593292222|FG002|Dose Escalation|Protocol Violation|0|||
164252686|NCT01436656|593292223|FG003|Dose Escalation|Protocol Violation|0|||
164252687|NCT01436656|593292224|FG004|Dose Escalation|Protocol Violation|0|||
164252688|NCT01436656|593292225|FG005|Dose Escalation|Protocol Violation|1|||
164252689|NCT01436656|593292226|FG006|Dose Escalation|Protocol Violation|0|||
164252690|NCT01436656|593292227|FG007|Dose Escalation|Protocol Violation|0|||
164252691|NCT01436656|593292228|FG008|Dose Escalation|Protocol Violation|0|||
164252692|NCT01436656|593292229|FG009|Dose Escalation|Protocol Violation|0|||
164252693|NCT01436656|593292230|FG010|Dose Escalation|Protocol Violation|0|||
164252694|NCT01436656|593292231|FG011|Dose Escalation|Protocol Violation|0|||
164252695|NCT01436656|593292232|FG012|Dose Escalation|Protocol Violation|0|||
164252696|NCT01436656|593292233|FG013|Dose Escalation|Protocol Violation|0|||
164252697|NCT01436656|593292234|FG014|Dose Escalation|Protocol Violation|0|||
164252698|NCT01436656|593292235|FG015|Dose Escalation|Protocol Violation|0|||
164252699|NCT01436656|593292236|FG016|Dose Escalation|Protocol Violation|0|||
164252700|NCT01436656|593292237|FG017|Dose Escalation|Protocol Violation|0|||
164252701|NCT01436656|593292220|FG000|Dose Escalation|Withdrawal by Subject|0|||
164252702|NCT01436656|593292221|FG001|Dose Escalation|Withdrawal by Subject|0|||
164252703|NCT01436656|593292222|FG002|Dose Escalation|Withdrawal by Subject|0|||
164252704|NCT01436656|593292223|FG003|Dose Escalation|Withdrawal by Subject|0|||
164252705|NCT01436656|593292224|FG004|Dose Escalation|Withdrawal by Subject|1|||
164252706|NCT01436656|593292225|FG005|Dose Escalation|Withdrawal by Subject|0|||
164252707|NCT01436656|593292226|FG006|Dose Escalation|Withdrawal by Subject|0|||
164252708|NCT01436656|593292227|FG007|Dose Escalation|Withdrawal by Subject|2|||
164252709|NCT01436656|593292228|FG008|Dose Escalation|Withdrawal by Subject|0|||
164252710|NCT01436656|593292229|FG009|Dose Escalation|Withdrawal by Subject|1|||
164252711|NCT01436656|593292230|FG010|Dose Escalation|Withdrawal by Subject|1|||
164252712|NCT01436656|593292231|FG011|Dose Escalation|Withdrawal by Subject|0|||
164252713|NCT01436656|593292232|FG012|Dose Escalation|Withdrawal by Subject|0|||
164252714|NCT01436656|593292233|FG013|Dose Escalation|Withdrawal by Subject|0|||
164252715|NCT01436656|593292234|FG014|Dose Escalation|Withdrawal by Subject|0|||
164252716|NCT01436656|593292235|FG015|Dose Escalation|Withdrawal by Subject|0|||
164252717|NCT01436656|593292236|FG016|Dose Escalation|Withdrawal by Subject|0|||
164252718|NCT01436656|593292237|FG017|Dose Escalation|Withdrawal by Subject|0|||
164252719|NCT01436656|593292220|FG000|Dose Escalation|Administrative problems|0|||
164252720|NCT01436656|593292221|FG001|Dose Escalation|Administrative problems|1|||
164252721|NCT01436656|593292222|FG002|Dose Escalation|Administrative problems|0|||
164252722|NCT01436656|593292223|FG003|Dose Escalation|Administrative problems|0|||
164252723|NCT01436656|593292224|FG004|Dose Escalation|Administrative problems|0|||
164252724|NCT01436656|593292225|FG005|Dose Escalation|Administrative problems|0|||
164252725|NCT01436656|593292226|FG006|Dose Escalation|Administrative problems|0|||
164252726|NCT01436656|593292227|FG007|Dose Escalation|Administrative problems|0|||
164252727|NCT01436656|593292228|FG008|Dose Escalation|Administrative problems|0|||
164252728|NCT01436656|593292229|FG009|Dose Escalation|Administrative problems|0|||
164252729|NCT01436656|593292230|FG010|Dose Escalation|Administrative problems|0|||
164252730|NCT01436656|593292231|FG011|Dose Escalation|Administrative problems|0|||
164252731|NCT01436656|593292232|FG012|Dose Escalation|Administrative problems|0|||
164252732|NCT01436656|593292233|FG013|Dose Escalation|Administrative problems|0|||
164252733|NCT01436656|593292234|FG014|Dose Escalation|Administrative problems|0|||
164252734|NCT01436656|593292235|FG015|Dose Escalation|Administrative problems|0|||
164252735|NCT01436656|593292236|FG016|Dose Escalation|Administrative problems|0|||
164252736|NCT01436656|593292237|FG017|Dose Escalation|Administrative problems|0|||
164252737|NCT01436656|593292220|FG000|Dose Escalation|Lost to Follow-up|1|||
164252738|NCT01436656|593292221|FG001|Dose Escalation|Lost to Follow-up|0|||
164252739|NCT01436656|593292222|FG002|Dose Escalation|Lost to Follow-up|0|||
164252740|NCT01436656|593292223|FG003|Dose Escalation|Lost to Follow-up|0|||
164252741|NCT01436656|593292224|FG004|Dose Escalation|Lost to Follow-up|1|||
164252742|NCT01436656|593292225|FG005|Dose Escalation|Lost to Follow-up|0|||
164252743|NCT01436656|593292226|FG006|Dose Escalation|Lost to Follow-up|0|||
164252744|NCT01436656|593292227|FG007|Dose Escalation|Lost to Follow-up|0|||
164252745|NCT01436656|593292228|FG008|Dose Escalation|Lost to Follow-up|0|||
164252746|NCT01436656|593292229|FG009|Dose Escalation|Lost to Follow-up|0|||
164252747|NCT01436656|593292230|FG010|Dose Escalation|Lost to Follow-up|0|||
164252748|NCT01436656|593292231|FG011|Dose Escalation|Lost to Follow-up|0|||
164252749|NCT01436656|593292232|FG012|Dose Escalation|Lost to Follow-up|0|||
164252750|NCT01436656|593292233|FG013|Dose Escalation|Lost to Follow-up|0|||
164252751|NCT01436656|593292234|FG014|Dose Escalation|Lost to Follow-up|0|||
164252752|NCT01436656|593292235|FG015|Dose Escalation|Lost to Follow-up|0|||
164252753|NCT01436656|593292236|FG016|Dose Escalation|Lost to Follow-up|0|||
164252754|NCT01436656|593292237|FG017|Dose Escalation|Lost to Follow-up|0|||
164252755|NCT01436656|593292220|FG000|Dose Escalation|New anti-cancer therapy|1|||
164252756|NCT01436656|593292221|FG001|Dose Escalation|New anti-cancer therapy|0|||
164252757|NCT01436656|593292222|FG002|Dose Escalation|New anti-cancer therapy|0|||
164252758|NCT01436656|593292223|FG003|Dose Escalation|New anti-cancer therapy|0|||
164252759|NCT01436656|593292224|FG004|Dose Escalation|New anti-cancer therapy|0|||
164252760|NCT01436656|593292225|FG005|Dose Escalation|New anti-cancer therapy|0|||
164252761|NCT01436656|593292226|FG006|Dose Escalation|New anti-cancer therapy|0|||
164252762|NCT01436656|593292227|FG007|Dose Escalation|New anti-cancer therapy|0|||
164252763|NCT01436656|593292228|FG008|Dose Escalation|New anti-cancer therapy|1|||
164252764|NCT01436656|593292229|FG009|Dose Escalation|New anti-cancer therapy|1|||
164252765|NCT01436656|593292230|FG010|Dose Escalation|New anti-cancer therapy|0|||
164252766|NCT01436656|593292231|FG011|Dose Escalation|New anti-cancer therapy|0|||
164252767|NCT01436656|593292232|FG012|Dose Escalation|New anti-cancer therapy|0|||
164252768|NCT01436656|593292233|FG013|Dose Escalation|New anti-cancer therapy|0|||
164252769|NCT01436656|593292234|FG014|Dose Escalation|New anti-cancer therapy|0|||
164252770|NCT01436656|593292235|FG015|Dose Escalation|New anti-cancer therapy|0|||
164252771|NCT01436656|593292236|FG016|Dose Escalation|New anti-cancer therapy|0|||
164252772|NCT01436656|593292237|FG017|Dose Escalation|New anti-cancer therapy|0|||
164252773|NCT01436656|593292220|FG000|Dose Expansion|Adverse Event|0|||
164252774|NCT01436656|593292221|FG001|Dose Expansion|Adverse Event|0|||
164252775|NCT01436656|593292222|FG002|Dose Expansion|Adverse Event|0|||
164252776|NCT01436656|593292223|FG003|Dose Expansion|Adverse Event|0|||
164252777|NCT01436656|593292224|FG004|Dose Expansion|Adverse Event|0|||
164252778|NCT01436656|593292225|FG005|Dose Expansion|Adverse Event|0|||
164252779|NCT01436656|593292226|FG006|Dose Expansion|Adverse Event|0|||
164252780|NCT01436656|593292227|FG007|Dose Expansion|Adverse Event|0|||
164252781|NCT01436656|593292228|FG008|Dose Expansion|Adverse Event|0|||
164252782|NCT01436656|593292229|FG009|Dose Expansion|Adverse Event|0|||
164252783|NCT01436656|593292230|FG010|Dose Expansion|Adverse Event|0|||
164252784|NCT01436656|593292231|FG011|Dose Expansion|Adverse Event|1|||
164252785|NCT01436656|593292232|FG012|Dose Expansion|Adverse Event|0|||
164252786|NCT01436656|593292233|FG013|Dose Expansion|Adverse Event|0|||
164252787|NCT01436656|593292234|FG014|Dose Expansion|Adverse Event|0|||
164252788|NCT01436656|593292235|FG015|Dose Expansion|Adverse Event|0|||
164252789|NCT01436656|593292236|FG016|Dose Expansion|Adverse Event|0|||
164252790|NCT01436656|593292237|FG017|Dose Expansion|Adverse Event|0|||
164252791|NCT01436656|593292220|FG000|Dose Expansion|Withdrawal by Subject|0|||
164252792|NCT01436656|593292221|FG001|Dose Expansion|Withdrawal by Subject|0|||
164252793|NCT01436656|593292222|FG002|Dose Expansion|Withdrawal by Subject|0|||
164252794|NCT01436656|593292223|FG003|Dose Expansion|Withdrawal by Subject|0|||
164252795|NCT01436656|593292224|FG004|Dose Expansion|Withdrawal by Subject|0|||
164252796|NCT01436656|593292225|FG005|Dose Expansion|Withdrawal by Subject|0|||
164252797|NCT01436656|593292226|FG006|Dose Expansion|Withdrawal by Subject|0|||
164252798|NCT01436656|593292227|FG007|Dose Expansion|Withdrawal by Subject|0|||
164252799|NCT01436656|593292228|FG008|Dose Expansion|Withdrawal by Subject|0|||
164252800|NCT01436656|593292229|FG009|Dose Expansion|Withdrawal by Subject|0|||
164252801|NCT01436656|593292230|FG010|Dose Expansion|Withdrawal by Subject|0|||
164252802|NCT01436656|593292231|FG011|Dose Expansion|Withdrawal by Subject|1|||
164252803|NCT01436656|593292232|FG012|Dose Expansion|Withdrawal by Subject|3|||
164252804|NCT01436656|593292233|FG013|Dose Expansion|Withdrawal by Subject|1|||
164252805|NCT01436656|593292234|FG014|Dose Expansion|Withdrawal by Subject|2|||
164252806|NCT01436656|593292235|FG015|Dose Expansion|Withdrawal by Subject|0|||
164252807|NCT01436656|593292236|FG016|Dose Expansion|Withdrawal by Subject|1|||
164252808|NCT01436656|593292237|FG017|Dose Expansion|Withdrawal by Subject|1|||
164252809|NCT01436656|593292220|FG000|Dose Expansion|Death|0|||
164338989|NCT02202980|593617098|FG000|Overall Study|Withdrew Consent|0|||
164252810|NCT01436656|593292221|FG001|Dose Expansion|Death|0|||
164252811|NCT01436656|593292222|FG002|Dose Expansion|Death|0|||
164338990|NCT02202980|593617099|FG001|Overall Study|Withdrew Consent|1|||
164338991|NCT02202980|593617100|FG002|Overall Study|Withdrew Consent|2|||
164338992|NCT02202980|593617101|FG003|Overall Study|Withdrew Consent|0|||
164338993|NCT02202980|593617102|FG004|Overall Study|Withdrew Consent|0|||
164338994|NCT02202980|593617103|FG005|Overall Study|Withdrew Consent|0|||
164338995|NCT02202980|593617104|FG006|Overall Study|Withdrew Consent|0|||
164338996|NCT02202980|593617105|FG007|Overall Study|Withdrew Consent|0|||
164252812|NCT01436656|593292223|FG003|Dose Expansion|Death|0|||
164252813|NCT01436656|593292224|FG004|Dose Expansion|Death|0|||
164252814|NCT01436656|593292225|FG005|Dose Expansion|Death|0|||
164252815|NCT01436656|593292226|FG006|Dose Expansion|Death|0|||
164252816|NCT01436656|593292227|FG007|Dose Expansion|Death|0|||
164252817|NCT01436656|593292228|FG008|Dose Expansion|Death|0|||
164252818|NCT01436656|593292229|FG009|Dose Expansion|Death|0|||
164252819|NCT01436656|593292230|FG010|Dose Expansion|Death|0|||
164252820|NCT01436656|593292231|FG011|Dose Expansion|Death|0|||
164252821|NCT01436656|593292232|FG012|Dose Expansion|Death|1|||
164252822|NCT01436656|593292233|FG013|Dose Expansion|Death|0|||
164252823|NCT01436656|593292234|FG014|Dose Expansion|Death|3|||
164252824|NCT01436656|593292235|FG015|Dose Expansion|Death|0|||
164252825|NCT01436656|593292236|FG016|Dose Expansion|Death|3|||
164252826|NCT01436656|593292237|FG017|Dose Expansion|Death|3|||
164252827|NCT01436656|593292220|FG000|Dose Expansion|Lost to Follow-up|0|||
164252828|NCT01436656|593292221|FG001|Dose Expansion|Lost to Follow-up|0|||
164252829|NCT01436656|593292222|FG002|Dose Expansion|Lost to Follow-up|0|||
164252830|NCT01436656|593292223|FG003|Dose Expansion|Lost to Follow-up|0|||
164252831|NCT01436656|593292224|FG004|Dose Expansion|Lost to Follow-up|0|||
164252832|NCT01436656|593292225|FG005|Dose Expansion|Lost to Follow-up|0|||
164252833|NCT01436656|593292226|FG006|Dose Expansion|Lost to Follow-up|0|||
164252834|NCT01436656|593292227|FG007|Dose Expansion|Lost to Follow-up|0|||
164252835|NCT01436656|593292228|FG008|Dose Expansion|Lost to Follow-up|0|||
164252836|NCT01436656|593292229|FG009|Dose Expansion|Lost to Follow-up|0|||
164252837|NCT01436656|593292230|FG010|Dose Expansion|Lost to Follow-up|0|||
164252838|NCT01436656|593292231|FG011|Dose Expansion|Lost to Follow-up|0|||
164252839|NCT01436656|593292232|FG012|Dose Expansion|Lost to Follow-up|0|||
164252840|NCT01436656|593292233|FG013|Dose Expansion|Lost to Follow-up|0|||
164252841|NCT01436656|593292234|FG014|Dose Expansion|Lost to Follow-up|0|||
164252842|NCT01436656|593292235|FG015|Dose Expansion|Lost to Follow-up|0|||
164252843|NCT01436656|593292236|FG016|Dose Expansion|Lost to Follow-up|0|||
164252844|NCT01436656|593292237|FG017|Dose Expansion|Lost to Follow-up|3|||
164252845|NCT01436656|593292220|FG000|Dose Expansion|Disease progression|0|||
164252846|NCT01436656|593292221|FG001|Dose Expansion|Disease progression|0|||
164252847|NCT01436656|593292222|FG002|Dose Expansion|Disease progression|0|||
164252848|NCT01436656|593292223|FG003|Dose Expansion|Disease progression|0|||
164252849|NCT01436656|593292224|FG004|Dose Expansion|Disease progression|0|||
164252850|NCT01436656|593292225|FG005|Dose Expansion|Disease progression|0|||
164252851|NCT01436656|593292226|FG006|Dose Expansion|Disease progression|0|||
164252852|NCT01436656|593292227|FG007|Dose Expansion|Disease progression|0|||
164252853|NCT01436656|593292228|FG008|Dose Expansion|Disease progression|0|||
164252854|NCT01436656|593292229|FG009|Dose Expansion|Disease progression|0|||
164252855|NCT01436656|593292230|FG010|Dose Expansion|Disease progression|0|||
164252856|NCT01436656|593292231|FG011|Dose Expansion|Disease progression|3|||
164252857|NCT01436656|593292232|FG012|Dose Expansion|Disease progression|1|||
164252858|NCT01436656|593292233|FG013|Dose Expansion|Disease progression|0|||
164252859|NCT01436656|593292234|FG014|Dose Expansion|Disease progression|1|||
164252860|NCT01436656|593292235|FG015|Dose Expansion|Disease progression|0|||
164252861|NCT01436656|593292236|FG016|Dose Expansion|Disease progression|0|||
164252862|NCT01436656|593292237|FG017|Dose Expansion|Disease progression|1|||
164252863|NCT01436656|593292220|FG000|Dose Expansion|New cancer therapy|0|||
164252864|NCT01436656|593292221|FG001|Dose Expansion|New cancer therapy|0|||
164252865|NCT01436656|593292222|FG002|Dose Expansion|New cancer therapy|0|||
164252866|NCT01436656|593292223|FG003|Dose Expansion|New cancer therapy|0|||
164252867|NCT01436656|593292224|FG004|Dose Expansion|New cancer therapy|0|||
164252868|NCT01436656|593292225|FG005|Dose Expansion|New cancer therapy|0|||
164252869|NCT01436656|593292226|FG006|Dose Expansion|New cancer therapy|0|||
164427304|NCT00480441|593932838|FG000|Screening|Not Eligible|37|||
164427305|NCT00480441|593932839|FG001|Screening|Not Eligible|0|||
164427306|NCT00480441|593932840|FG002|Screening|Not Eligible|0|||
164427307|NCT00480441|593932838|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
164427308|NCT00480441|593932839|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
164427309|NCT00480441|593932840|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
164427310|NCT00480441|593932838|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
164427311|NCT00480441|593932839|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
164252870|NCT01436656|593292227|FG007|Dose Expansion|New cancer therapy|0|||
164252871|NCT01436656|593292228|FG008|Dose Expansion|New cancer therapy|0|||
164252872|NCT01436656|593292229|FG009|Dose Expansion|New cancer therapy|0|||
164252873|NCT01436656|593292230|FG010|Dose Expansion|New cancer therapy|0|||
164427312|NCT00480441|593932840|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
164252874|NCT01436656|593292231|FG011|Dose Expansion|New cancer therapy|1|||
164252875|NCT01436656|593292232|FG012|Dose Expansion|New cancer therapy|1|||
164252876|NCT01436656|593292233|FG013|Dose Expansion|New cancer therapy|0|||
164252877|NCT01436656|593292234|FG014|Dose Expansion|New cancer therapy|2|||
164252878|NCT01436656|593292235|FG015|Dose Expansion|New cancer therapy|0|||
164252879|NCT01436656|593292236|FG016|Dose Expansion|New cancer therapy|0|||
164252880|NCT01436656|593292237|FG017|Dose Expansion|New cancer therapy|0|||
164252881|NCT01406938|593292238|FG000|Induction Period|Subject/guardian decision|6|||
164252882|NCT01406938|593292239|FG001|Induction Period|Subject/guardian decision|8|||
164252883|NCT01406938|593292240|FG002|Induction Period|Subject/guardian decision|0|||
164427313|NCT00480441|593932838|FG000|Baseline Functional MRI|physical contraindication|4|||
164427314|NCT00480441|593932839|FG001|Baseline Functional MRI|physical contraindication|0|||
164427315|NCT00480441|593932840|FG002|Baseline Functional MRI|physical contraindication|0|||
164252884|NCT01406938|593292241|FG003|Induction Period|Subject/guardian decision|0|||
164252885|NCT01406938|593292242|FG004|Induction Period|Subject/guardian decision|0|||
164252886|NCT01406938|593292243|FG005|Induction Period|Subject/guardian decision|0|||
164252887|NCT01406938|593292238|FG000|Induction Period|Protocol deviation|1|||
164252888|NCT01406938|593292239|FG001|Induction Period|Protocol deviation|0|||
164252889|NCT01406938|593292240|FG002|Induction Period|Protocol deviation|0|||
164252890|NCT01406938|593292241|FG003|Induction Period|Protocol deviation|0|||
164252891|NCT01406938|593292242|FG004|Induction Period|Protocol deviation|0|||
164252892|NCT01406938|593292243|FG005|Induction Period|Protocol deviation|0|||
164252893|NCT01406938|593292238|FG000|Induction Period|Adverse Event|8|||
164252894|NCT01406938|593292239|FG001|Induction Period|Adverse Event|9|||
164252895|NCT01406938|593292240|FG002|Induction Period|Adverse Event|0|||
164252896|NCT01406938|593292241|FG003|Induction Period|Adverse Event|0|||
164252897|NCT01406938|593292242|FG004|Induction Period|Adverse Event|0|||
164252898|NCT01406938|593292243|FG005|Induction Period|Adverse Event|0|||
164252899|NCT01406938|593292238|FG000|Induction Period|Lack of Efficacy|1|||
164252900|NCT01406938|593292239|FG001|Induction Period|Lack of Efficacy|0|||
164252901|NCT01406938|593292240|FG002|Induction Period|Lack of Efficacy|0|||
164252902|NCT01406938|593292241|FG003|Induction Period|Lack of Efficacy|0|||
164252903|NCT01406938|593292242|FG004|Induction Period|Lack of Efficacy|0|||
164252904|NCT01406938|593292243|FG005|Induction Period|Lack of Efficacy|0|||
164252905|NCT01406938|593292238|FG000|Induction Period|Lost to Follow-up|2|||
164252906|NCT01406938|593292239|FG001|Induction Period|Lost to Follow-up|3|||
164252907|NCT01406938|593292240|FG002|Induction Period|Lost to Follow-up|0|||
164252908|NCT01406938|593292241|FG003|Induction Period|Lost to Follow-up|0|||
164252909|NCT01406938|593292242|FG004|Induction Period|Lost to Follow-up|0|||
164252910|NCT01406938|593292243|FG005|Induction Period|Lost to Follow-up|0|||
164252911|NCT01406938|593292238|FG000|Maintenance Period|Adverse Event|0|||
164252912|NCT01406938|593292239|FG001|Maintenance Period|Adverse Event|0|||
164252913|NCT01406938|593292240|FG002|Maintenance Period|Adverse Event|2|||
164252914|NCT01406938|593292241|FG003|Maintenance Period|Adverse Event|8|||
164252915|NCT01406938|593292242|FG004|Maintenance Period|Adverse Event|4|||
164252916|NCT01406938|593292243|FG005|Maintenance Period|Adverse Event|2|||
164252917|NCT01406938|593292238|FG000|Maintenance Period|Death|0|||
164252918|NCT01406938|593292239|FG001|Maintenance Period|Death|0|||
164252919|NCT01406938|593292240|FG002|Maintenance Period|Death|0|||
164252920|NCT01406938|593292241|FG003|Maintenance Period|Death|0|||
164252921|NCT01406938|593292242|FG004|Maintenance Period|Death|1|||
164252922|NCT01406938|593292243|FG005|Maintenance Period|Death|0|||
164252923|NCT01406938|593292238|FG000|Maintenance Period|Subject/guardian decision|0|||
164252924|NCT01406938|593292239|FG001|Maintenance Period|Subject/guardian decision|0|||
164252925|NCT01406938|593292240|FG002|Maintenance Period|Subject/guardian decision|11|||
164252926|NCT01406938|593292241|FG003|Maintenance Period|Subject/guardian decision|7|||
164252927|NCT01406938|593292242|FG004|Maintenance Period|Subject/guardian decision|10|||
164252928|NCT01406938|593292243|FG005|Maintenance Period|Subject/guardian decision|7|||
164252929|NCT01406938|593292238|FG000|Maintenance Period|Protocol Violation|0|||
164252930|NCT01406938|593292239|FG001|Maintenance Period|Protocol Violation|0|||
164252931|NCT01406938|593292240|FG002|Maintenance Period|Protocol Violation|2|||
164252932|NCT01406938|593292241|FG003|Maintenance Period|Protocol Violation|2|||
164252933|NCT01406938|593292242|FG004|Maintenance Period|Protocol Violation|2|||
164252934|NCT01406938|593292243|FG005|Maintenance Period|Protocol Violation|2|||
164252935|NCT01406938|593292238|FG000|Maintenance Period|Pregnancy|0|||
164252936|NCT01406938|593292239|FG001|Maintenance Period|Pregnancy|0|||
164252937|NCT01406938|593292240|FG002|Maintenance Period|Pregnancy|0|||
164252938|NCT01406938|593292241|FG003|Maintenance Period|Pregnancy|0|||
164252939|NCT01406938|593292242|FG004|Maintenance Period|Pregnancy|1|||
164252940|NCT01406938|593292243|FG005|Maintenance Period|Pregnancy|0|||
164252941|NCT01406938|593292238|FG000|Maintenance Period|Lost to Follow-up|0|||
164252942|NCT01406938|593292239|FG001|Maintenance Period|Lost to Follow-up|0|||
164252943|NCT01406938|593292240|FG002|Maintenance Period|Lost to Follow-up|0|||
164252944|NCT01406938|593292241|FG003|Maintenance Period|Lost to Follow-up|0|||
164252945|NCT01406938|593292242|FG004|Maintenance Period|Lost to Follow-up|4|||
164252946|NCT01406938|593292243|FG005|Maintenance Period|Lost to Follow-up|0|||
164252947|NCT01406938|593292238|FG000|Maintenance Period|Lack of Efficacy|0|||
164252948|NCT01406938|593292239|FG001|Maintenance Period|Lack of Efficacy|0|||
164576074|NCT03871491|594471831|FG003|Overall Study|Lost to Follow-up|11|||
164576075|NCT05202808|594471832|FG000|Overall Study|Lost to Follow-up|3|||
164252949|NCT01406938|593292240|FG002|Maintenance Period|Lack of Efficacy|2|||
164252950|NCT01406938|593292241|FG003|Maintenance Period|Lack of Efficacy|1|||
164252951|NCT01406938|593292242|FG004|Maintenance Period|Lack of Efficacy|3|||
164252952|NCT01406938|593292243|FG005|Maintenance Period|Lack of Efficacy|5|||
164252953|NCT01406938|593292238|FG000|Follow up|Lack of Efficacy|3|||
164252954|NCT01406938|593292239|FG001|Follow up|Lack of Efficacy|2|||
164252955|NCT01406938|593292240|FG002|Follow up|Lack of Efficacy|1|||
164252956|NCT01406938|593292241|FG003|Follow up|Lack of Efficacy|0|||
164252957|NCT01406938|593292242|FG004|Follow up|Lack of Efficacy|0|||
164252958|NCT01406938|593292243|FG005|Follow up|Lack of Efficacy|0|||
164252959|NCT01406938|593292238|FG000|Follow up|Patient/guardian decision|4|||
164252960|NCT01406938|593292239|FG001|Follow up|Patient/guardian decision|2|||
164252961|NCT01406938|593292240|FG002|Follow up|Patient/guardian decision|4|||
164252962|NCT01406938|593292241|FG003|Follow up|Patient/guardian decision|2|||
164252963|NCT01406938|593292242|FG004|Follow up|Patient/guardian decision|4|||
164252964|NCT01406938|593292243|FG005|Follow up|Patient/guardian decision|1|||
164252965|NCT01406938|593292238|FG000|Follow up|Protocol Violation|0|||
164252966|NCT01406938|593292239|FG001|Follow up|Protocol Violation|0|||
164252967|NCT01406938|593292240|FG002|Follow up|Protocol Violation|1|||
164252968|NCT01406938|593292241|FG003|Follow up|Protocol Violation|0|||
164252969|NCT01406938|593292242|FG004|Follow up|Protocol Violation|0|||
164252970|NCT01406938|593292243|FG005|Follow up|Protocol Violation|0|||
164252971|NCT01406938|593292238|FG000|Follow up|Physician Decision|0|||
164252972|NCT01406938|593292239|FG001|Follow up|Physician Decision|0|||
164252973|NCT01406938|593292240|FG002|Follow up|Physician Decision|2|||
164252974|NCT01406938|593292241|FG003|Follow up|Physician Decision|0|||
164252975|NCT01406938|593292242|FG004|Follow up|Physician Decision|3|||
164252976|NCT01406938|593292243|FG005|Follow up|Physician Decision|1|||
164252977|NCT01406938|593292238|FG000|Follow up|Lost to Follow-up|1|||
164252978|NCT01406938|593292239|FG001|Follow up|Lost to Follow-up|1|||
164252979|NCT01406938|593292240|FG002|Follow up|Lost to Follow-up|0|||
164252980|NCT01406938|593292241|FG003|Follow up|Lost to Follow-up|1|||
164252981|NCT01406938|593292242|FG004|Follow up|Lost to Follow-up|2|||
164252982|NCT01406938|593292243|FG005|Follow up|Lost to Follow-up|1|||
164252983|NCT01576146|593292246|FG000|Extension Period 1|Adverse Event|2|||
164252984|NCT01576146|593292246|FG000|Extension Period 1|Death|2|||
164252985|NCT01576146|593292246|FG000|Extension Period 1|Physician Decision|2|||
164252986|NCT01576146|593292246|FG000|Extension Period 1|Withdrawal by Subject|1|||
164252987|NCT01576146|593292246|FG000|Extension Period 1|Lost to Follow-up|1|||
164252988|NCT01576146|593292246|FG000|Extension Period 1|Parathyroidectomy|1|||
164252989|NCT01576146|593292246|FG000|Extension Period 1|Renal Transplant|1|||
164252990|NCT01576146|593292246|FG000|Extension Period 2|Sponsor Decision|13|||
164252991|NCT01576146|593292246|FG000|Extension Period 2|Death|1|||
164252992|NCT01576146|593292246|FG000|Extension Period 2|Adverse Event|1|||
164252993|NCT01576146|593292246|FG000|Extension Period 2|Renal Transplant|1|||
164252994|NCT01576146|593292246|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
164252995|NCT03654404|593292248|FG000|Overall Study|Death|1|||
164252996|NCT03654404|593292248|FG000|Overall Study|Lost to Follow-up|2|||
164252997|NCT03654404|593292248|FG000|Overall Study|Withdrawal by Subject|5|||
164252998|NCT00654745|593292249|FG000|Overall Study|Adverse Event|12|||
164252999|NCT00654745|593292249|FG000|Overall Study|Lost to Follow-up|7|||
164253000|NCT00654745|593292249|FG000|Overall Study|Protocol Violation|11|||
164253001|NCT00654745|593292249|FG000|Overall Study|Withdrawal by Subject|10|||
164253002|NCT00654745|593292249|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
164253003|NCT00194077|593292252|FG000|Overall Study|Lack of Efficacy|22|||
164253004|NCT00194077|593292253|FG001|Overall Study|Lack of Efficacy|29|||
164253005|NCT00194077|593292252|FG000|Overall Study|Study nonadherence|1|||
164253006|NCT00194077|593292253|FG001|Overall Study|Study nonadherence|0|||
164253007|NCT00194077|593292252|FG000|Overall Study|Withdrawal by Subject|1|||
164253008|NCT00194077|593292253|FG001|Overall Study|Withdrawal by Subject|1|||
164253009|NCT03470194|593292254|FG000|Overall Study|Lost to Follow-up|11|||
164253010|NCT03470194|593292255|FG001|Overall Study|Lost to Follow-up|17|||
164253011|NCT01822899|593292256|FG000|Overall Study|Adverse Event|6|||
164253012|NCT01822899|593292257|FG001|Overall Study|Adverse Event|5|||
164253013|NCT01822899|593292256|FG000|Overall Study|Lack of Efficacy|6|||
164253014|NCT01822899|593292257|FG001|Overall Study|Lack of Efficacy|3|||
164338997|NCT02202980|593617106|FG008|Overall Study|Withdrew Consent|1|||
164338998|NCT02202980|593617107|FG009|Overall Study|Withdrew Consent|0|||
164338999|NCT02202980|593617108|FG010|Overall Study|Withdrew Consent|0|||
164339000|NCT02202980|593617109|FG011|Overall Study|Withdrew Consent|0|||
164253015|NCT01822899|593292256|FG000|Overall Study|Protocol Violation|6|||
164253016|NCT01822899|593292257|FG001|Overall Study|Protocol Violation|3|||
164253017|NCT01822899|593292256|FG000|Overall Study|Lost to Follow-up|1|||
164253018|NCT01822899|593292257|FG001|Overall Study|Lost to Follow-up|0|||
164339001|NCT02202980|593617110|FG012|Overall Study|Withdrew Consent|0|||
164339002|NCT02202980|593617111|FG013|Overall Study|Withdrew Consent|0|||
164339003|NCT01952145|593617112|FG000|Overall Study|Protocol Violation|2|||
164339004|NCT01952145|593617113|FG001|Overall Study|Protocol Violation|1|||
164339005|NCT01952145|593617112|FG000|Overall Study|Death|0|||
164339006|NCT01952145|593617113|FG001|Overall Study|Death|1|||
164339007|NCT01952145|593617112|FG000|Overall Study|Adverse Event|9|||
164253019|NCT01822899|593292256|FG000|Overall Study|Withdrawal by Subject|5|||
164253020|NCT01822899|593292257|FG001|Overall Study|Withdrawal by Subject|7|||
164253021|NCT00759876|593292259|FG000|Overall Study|Sponsor terminated study early|36|||
164253022|NCT01450696|593292260|FG000|Overall Study|Never Treated|1|||
164253023|NCT01450696|593292261|FG001|Overall Study|Never Treated|1|||
164253024|NCT01450696|593292260|FG000|Overall Study|Death|77|||
164253025|NCT01450696|593292261|FG001|Overall Study|Death|84|||
164253026|NCT01450696|593292260|FG000|Overall Study|Lost to Follow-up|3|||
164339008|NCT01952145|593617113|FG001|Overall Study|Adverse Event|0|||
164253027|NCT01450696|593292261|FG001|Overall Study|Lost to Follow-up|3|||
164339009|NCT01952145|593617112|FG000|Overall Study|Withdrawal Criteria|16|||
164427316|NCT00480441|593932838|FG000|Randomization|Lost to Follow-up|0|||
164427317|NCT00480441|593932839|FG001|Randomization|Lost to Follow-up|7|||
164427318|NCT00480441|593932840|FG002|Randomization|Lost to Follow-up|2|||
164427319|NCT02374957|593932841|FG000|Overall Study|Patient did not complete forms correctly|1|||
164427320|NCT02374957|593932842|FG001|Overall Study|Patient did not complete forms correctly|0|||
164427321|NCT03532178|593932843|FG000|First Period|Withdrawal by Subject|1|||
164427322|NCT03532178|593932844|FG001|First Period|Withdrawal by Subject|3|||
164427323|NCT03532178|593932843|FG000|First Period|technical issues in data collection Technical issues|0|||
164427324|NCT03532178|593932844|FG001|First Period|technical issues in data collection Technical issues|1|||
164427325|NCT03532178|593932843|FG000|Second Period|Withdrawal by Subject|1|||
164427326|NCT03532178|593932844|FG001|Second Period|Withdrawal by Subject|1|||
164427327|NCT03532178|593932843|FG000|Second Period|Technical issues|0|||
164427328|NCT03532178|593932844|FG001|Second Period|Technical issues|1|||
164427329|NCT01113463|593932845|FG000|Overall Study|Physician Decision|5|||
164427330|NCT01417000|593932846|FG000|Overall Study|Death|59|||
164427331|NCT01417000|593932847|FG001|Overall Study|Death|28|||
164427332|NCT01417000|593932846|FG000|Overall Study|Lost to Follow-up|1|||
164427333|NCT01417000|593932847|FG001|Overall Study|Lost to Follow-up|0|||
164427334|NCT01417000|593932846|FG000|Overall Study|Study Terminated by Sponsor|1|||
164427335|NCT01417000|593932847|FG001|Overall Study|Study Terminated by Sponsor|1|||
164427336|NCT01657682|593932848|FG000|Overall Study|Lost to Follow-up|1|||
164427337|NCT01657682|593932849|FG001|Overall Study|Lost to Follow-up|0|||
164427338|NCT01657682|593932850|FG002|Overall Study|Lost to Follow-up|0|||
164427339|NCT01657682|593932848|FG000|Overall Study|Withdrawal by Subject|0|||
164427340|NCT01657682|593932849|FG001|Overall Study|Withdrawal by Subject|1|||
164427341|NCT01657682|593932850|FG002|Overall Study|Withdrawal by Subject|1|||
164427342|NCT01657682|593932848|FG000|Overall Study|Adverse Event|0|||
164427343|NCT01657682|593932849|FG001|Overall Study|Adverse Event|1|||
164253028|NCT01450696|593292260|FG000|Overall Study|Non-Compliance|1|||
164253029|NCT01450696|593292261|FG001|Overall Study|Non-Compliance|0|||
164427344|NCT01657682|593932850|FG002|Overall Study|Adverse Event|0|||
164427345|NCT00761774|593932854|FG000|Overall Study|Adverse Event|17|||
164427346|NCT00761774|593932854|FG000|Overall Study|Lack of Efficacy|37|||
164427347|NCT00761774|593932854|FG000|Overall Study|Lost to Follow-up|2|||
164427348|NCT00761774|593932854|FG000|Overall Study|Withdrawal by Subject|9|||
164427349|NCT00761774|593932854|FG000|Overall Study|Non-compliance|4|||
164427350|NCT00761774|593932854|FG000|Overall Study|End of study|2|||
164427351|NCT00761774|593932854|FG000|Overall Study|Reclassification of seizures|1|||
164253030|NCT01450696|593292260|FG000|Overall Study|Withdrawal by Subject|13|||
164253031|NCT01450696|593292261|FG001|Overall Study|Withdrawal by Subject|2|||
164253032|NCT01450696|593292260|FG000|Overall Study|Study Terminated by Sponsor|53|||
164253033|NCT01450696|593292261|FG001|Overall Study|Study Terminated by Sponsor|58|||
164253034|NCT02570152|593292262|FG000|Overall Study|Protocol Violation|2|||
164253035|NCT02570152|593292262|FG000|Overall Study|Migrated/moved from study area|13|||
164253036|NCT02684617|593292263|FG000|Overall Study|Adverse Event|1|||
164253037|NCT02684617|593292264|FG001|Overall Study|Adverse Event|0|||
164253038|NCT02684617|593292265|FG002|Overall Study|Adverse Event|1|||
164253039|NCT02684617|593292263|FG000|Overall Study|Death|8|||
164253040|NCT02684617|593292264|FG001|Overall Study|Death|16|||
164253041|NCT02684617|593292265|FG002|Overall Study|Death|28|||
164253042|NCT02684617|593292263|FG000|Overall Study|Withdrawal by Subject|2|||
164253043|NCT02684617|593292264|FG001|Overall Study|Withdrawal by Subject|0|||
164253044|NCT02684617|593292265|FG002|Overall Study|Withdrawal by Subject|4|||
164253045|NCT02684617|593292263|FG000|Overall Study|Screen Failure|1|||
164253046|NCT02684617|593292264|FG001|Overall Study|Screen Failure|0|||
164253047|NCT02684617|593292265|FG002|Overall Study|Screen Failure|2|||
164253048|NCT02684617|593292263|FG000|Overall Study|Study Terminated by Sponsor|6|||
164253049|NCT02684617|593292264|FG001|Overall Study|Study Terminated by Sponsor|1|||
164253050|NCT02684617|593292265|FG002|Overall Study|Study Terminated by Sponsor|5|||
164253051|NCT00853242|593292266|FG000|Overall Study|Adverse Event|0|||
164253052|NCT00853242|593292267|FG001|Overall Study|Adverse Event|1|||
164253053|NCT00853242|593292268|FG002|Overall Study|Adverse Event|1|||
164253054|NCT00853242|593292269|FG003|Overall Study|Adverse Event|0|||
164253055|NCT00853242|593292270|FG004|Overall Study|Adverse Event|3|||
164253056|NCT00853242|593292271|FG005|Overall Study|Adverse Event|1|||
164253057|NCT00853242|593292272|FG006|Overall Study|Adverse Event|1|||
164253058|NCT00853242|593292266|FG000|Overall Study|Noncompliant|0|||
164253059|NCT00853242|593292267|FG001|Overall Study|Noncompliant|0|||
164253060|NCT00853242|593292268|FG002|Overall Study|Noncompliant|0|||
164253061|NCT00853242|593292269|FG003|Overall Study|Noncompliant|0|||
164253062|NCT00853242|593292270|FG004|Overall Study|Noncompliant|1|||
164253063|NCT00853242|593292271|FG005|Overall Study|Noncompliant|0|||
164253064|NCT00853242|593292272|FG006|Overall Study|Noncompliant|0|||
164253065|NCT00853242|593292266|FG000|Overall Study|Withdrawal by Subject|1|||
164253066|NCT00853242|593292267|FG001|Overall Study|Withdrawal by Subject|2|||
164253067|NCT00853242|593292268|FG002|Overall Study|Withdrawal by Subject|0|||
164253068|NCT00853242|593292269|FG003|Overall Study|Withdrawal by Subject|4|||
164253069|NCT00853242|593292270|FG004|Overall Study|Withdrawal by Subject|0|||
164253070|NCT00853242|593292271|FG005|Overall Study|Withdrawal by Subject|0|||
164253071|NCT00853242|593292272|FG006|Overall Study|Withdrawal by Subject|2|||
164253072|NCT00853242|593292266|FG000|Overall Study|Other|2|||
164253073|NCT00853242|593292267|FG001|Overall Study|Other|0|||
164427352|NCT00761774|593932854|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
164427353|NCT00761774|593932854|FG000|Overall Study|Sponsor decision|1|||
164427354|NCT00761774|593932854|FG000|Overall Study|Investigator clinical judgement|1|||
164427355|NCT00761774|593932854|FG000|Overall Study|Patient moved out of study area|1|||
164680486|NCT00112437|594854572|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164680487|NCT00112437|594854573|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164680488|NCT00112437|594854574|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164680489|NCT00112437|594854575|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
164680490|NCT00112437|594854576|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164680491|NCT00112437|594854577|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164680492|NCT00112437|594854578|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164680493|NCT00112437|594854579|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164253074|NCT00853242|593292268|FG002|Overall Study|Other|2|||
164253075|NCT00853242|593292269|FG003|Overall Study|Other|0|||
164253076|NCT00853242|593292270|FG004|Overall Study|Other|0|||
164253077|NCT00853242|593292271|FG005|Overall Study|Other|1|||
164427356|NCT00761774|593932854|FG000|Overall Study|Coordinator leaving site|1|||
164427357|NCT00761774|593932854|FG000|Overall Study|Subject IP non-compliance|1|||
164253078|NCT00853242|593292272|FG006|Overall Study|Other|2|||
164427358|NCT00761774|593932854|FG000|Overall Study|IP stopped by hospital physician|1|||
164253079|NCT02516098|593292280|FG000|Period 1|Protocol Violation|1|||
164253080|NCT02516098|593292281|FG001|Period 1|Protocol Violation|0|||
164253081|NCT02516098|593292280|FG000|Washout After Period 1|Adverse Event|0|||
164253082|NCT02516098|593292281|FG001|Washout After Period 1|Adverse Event|1|||
164253083|NCT02516098|593292280|FG000|Period 2|Withdrawal by Subject|0|||
164253084|NCT02516098|593292281|FG001|Period 2|Withdrawal by Subject|1|||
164253085|NCT01092780|593292282|FG000|Washout Period 1|Adverse Event|0|||
164253086|NCT01092780|593292283|FG001|Washout Period 1|Adverse Event|1|||
164253087|NCT01092780|593292284|FG002|Washout Period 1|Adverse Event|0|||
164253088|NCT01092780|593292285|FG003|Washout Period 1|Adverse Event|0|||
164253089|NCT01092780|593292282|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
164253090|NCT01092780|593292283|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
164253091|NCT01092780|593292284|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
164253092|NCT01092780|593292285|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
164253093|NCT01092780|593292282|FG000|Washout Period 2|Adverse Event|0|||
164253094|NCT01092780|593292283|FG001|Washout Period 2|Adverse Event|1|||
164253095|NCT01092780|593292284|FG002|Washout Period 2|Adverse Event|1|||
164253096|NCT01092780|593292285|FG003|Washout Period 2|Adverse Event|0|||
164253097|NCT01257230|593292286|FG000|Overall Study|Not Treated|0|||
164253098|NCT01257230|593292287|FG001|Overall Study|Not Treated|0|||
164253099|NCT01257230|593292288|FG002|Overall Study|Not Treated|1|||
164253100|NCT01257230|593292286|FG000|Overall Study|Adverse Event|2|||
164253101|NCT01257230|593292287|FG001|Overall Study|Adverse Event|0|||
164253102|NCT01257230|593292288|FG002|Overall Study|Adverse Event|0|||
164427359|NCT01648283|593932858|FG000|Overall Study|Withdrawal by Subject|14|||
164427360|NCT01124617|593932859|FG000|Overall Study|Adverse Event|5|||
164427361|NCT01124617|593932860|FG001|Overall Study|Adverse Event|2|||
164253103|NCT01257230|593292286|FG000|Overall Study|Lack of Efficacy|0|||
164253104|NCT01257230|593292287|FG001|Overall Study|Lack of Efficacy|1|||
164253105|NCT01257230|593292288|FG002|Overall Study|Lack of Efficacy|0|||
164253106|NCT01257230|593292286|FG000|Overall Study|Protocol Violation|3|||
164253107|NCT01257230|593292287|FG001|Overall Study|Protocol Violation|0|||
164253108|NCT01257230|593292288|FG002|Overall Study|Protocol Violation|1|||
164253109|NCT01257230|593292286|FG000|Overall Study|Withdrawal by Subject|0|||
164253110|NCT01257230|593292287|FG001|Overall Study|Withdrawal by Subject|4|||
164253111|NCT01257230|593292288|FG002|Overall Study|Withdrawal by Subject|1|||
164253112|NCT01257230|593292286|FG000|Overall Study|Other reason not defined above|1|||
164253113|NCT01257230|593292287|FG001|Overall Study|Other reason not defined above|5|||
164253114|NCT01257230|593292288|FG002|Overall Study|Other reason not defined above|3|||
164253115|NCT01205061|593292291|FG000|Overall Study|Adverse Event|4|||
164253116|NCT01205061|593292291|FG000|Overall Study|Withdrawal by Subject|11|||
164253117|NCT01205061|593292291|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
164253118|NCT01205061|593292291|FG000|Overall Study|Lost to Follow-up|9|||
164253119|NCT01205061|593292291|FG000|Overall Study|Other|1|||
164253120|NCT04026009|593292292|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164253121|NCT04026009|593292293|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164253122|NCT04026009|593292294|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
164253123|NCT04026009|593292295|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
164253124|NCT04026009|593292296|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
164253125|NCT04026009|593292292|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
164253126|NCT04026009|593292293|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
164253127|NCT04026009|593292294|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
164253128|NCT04026009|593292295|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
164253129|NCT04026009|593292296|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
164427362|NCT01124617|593932859|FG000|Overall Study|Lack of Efficacy|2|||
164253130|NCT01988662|593292297|FG000|Overall Study|Subject/guardian decision|1|||
164253131|NCT01988662|593292298|FG001|Overall Study|Subject/guardian decision|1|||
164253132|NCT01988662|593292297|FG000|Overall Study|Adverse Event|3|||
164253133|NCT01988662|593292298|FG001|Overall Study|Adverse Event|1|||
164253134|NCT00615719|593292299|FG000|Overall Study|Physician Decision|5|||
164253135|NCT02300558|593292300|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
164253136|NCT02300558|593292300|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
164427363|NCT01124617|593932860|FG001|Overall Study|Lack of Efficacy|1|||
164427364|NCT01124617|593932859|FG000|Overall Study|Protocol Violation|1|||
164427365|NCT01124617|593932860|FG001|Overall Study|Protocol Violation|1|||
164427366|NCT01124617|593932859|FG000|Overall Study|Withdrawal by Subject|9|||
164253137|NCT02300558|593292300|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
164253138|NCT02300558|593292300|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
164253139|NCT01471028|593292301|FG000|VTI-208|Adverse Event|39|||
164253140|NCT01471028|593292302|FG001|VTI-208|Adverse Event|41|||
164253141|NCT01471028|593292301|FG000|VTI-208|Withdrawal by Subject|0|||
164253142|NCT01471028|593292302|FG001|VTI-208|Withdrawal by Subject|2|||
164253143|NCT01471028|593292301|FG000|VTI-208|Lost to Follow-up|1|||
164427367|NCT01124617|593932860|FG001|Overall Study|Withdrawal by Subject|1|||
164427368|NCT01124617|593932859|FG000|Overall Study|Other|2|||
164253144|NCT01471028|593292302|FG001|VTI-208|Lost to Follow-up|1|||
164253145|NCT01471028|593292301|FG000|VTI-208E|Death|7|||
164253146|NCT01471028|593292302|FG001|VTI-208E|Death|10|||
164253147|NCT01471028|593292301|FG000|VTI-208E|Withdrawal by Subject|1|||
164253148|NCT01471028|593292302|FG001|VTI-208E|Withdrawal by Subject|0|||
164253149|NCT01471028|593292301|FG000|VTI-208E|Lost to Follow-up|0|||
164253150|NCT01471028|593292302|FG001|VTI-208E|Lost to Follow-up|2|||
164253151|NCT02957747|593292303|FG000|Overall Study|Withdrawal by Subject|0|||
164253152|NCT02957747|593292304|FG001|Overall Study|Withdrawal by Subject|3|||
164253153|NCT02957747|593292303|FG000|Overall Study|Lost to Follow-up|10|||
164253154|NCT02957747|593292304|FG001|Overall Study|Lost to Follow-up|5|||
164253155|NCT02016716|593292313|FG000|Overall Study|Withdrawal by Subject|5|||
164253156|NCT02016716|593292314|FG001|Overall Study|Withdrawal by Subject|5|||
164253157|NCT02016716|593292315|FG002|Overall Study|Withdrawal by Subject|5|||
164253158|NCT02016716|593292313|FG000|Overall Study|Protocol-specified Criteria|0|||
164253159|NCT02016716|593292314|FG001|Overall Study|Protocol-specified Criteria|1|||
164253160|NCT02016716|593292315|FG002|Overall Study|Protocol-specified Criteria|0|||
164253161|NCT02016716|593292313|FG000|Overall Study|Lost to Follow-up|1|||
164253162|NCT02016716|593292314|FG001|Overall Study|Lost to Follow-up|2|||
164253163|NCT02016716|593292315|FG002|Overall Study|Lost to Follow-up|1|||
164253164|NCT02931838|593292316|FG000|Overall Study|Reason not provided by investigator|1|||
164253165|NCT02931838|593292317|FG001|Overall Study|Reason not provided by investigator|0|||
164253166|NCT02931838|593292318|FG002|Overall Study|Reason not provided by investigator|1|||
164253167|NCT02931838|593292319|FG003|Overall Study|Reason not provided by investigator|0|||
164253168|NCT02931838|593292320|FG004|Overall Study|Reason not provided by investigator|0|||
164253169|NCT02931838|593292321|FG005|Overall Study|Reason not provided by investigator|0|||
164253170|NCT02931838|593292316|FG000|Overall Study|Poor/non-compliance|0|||
164253171|NCT02931838|593292317|FG001|Overall Study|Poor/non-compliance|0|||
164253172|NCT02931838|593292318|FG002|Overall Study|Poor/non-compliance|1|||
164253173|NCT02931838|593292319|FG003|Overall Study|Poor/non-compliance|0|||
164253174|NCT02931838|593292320|FG004|Overall Study|Poor/non-compliance|0|||
164253175|NCT02931838|593292321|FG005|Overall Study|Poor/non-compliance|0|||
164253176|NCT02931838|593292316|FG000|Overall Study|Lack of Efficacy|5|||
164253177|NCT02931838|593292317|FG001|Overall Study|Lack of Efficacy|4|||
164253178|NCT02931838|593292318|FG002|Overall Study|Lack of Efficacy|0|||
164253179|NCT02931838|593292319|FG003|Overall Study|Lack of Efficacy|0|||
164253180|NCT02931838|593292320|FG004|Overall Study|Lack of Efficacy|0|||
164253181|NCT02931838|593292321|FG005|Overall Study|Lack of Efficacy|1|||
164253182|NCT02931838|593292316|FG000|Overall Study|Lost to Follow-up|1|||
164253183|NCT02931838|593292317|FG001|Overall Study|Lost to Follow-up|0|||
164253184|NCT02931838|593292318|FG002|Overall Study|Lost to Follow-up|1|||
164253185|NCT02931838|593292319|FG003|Overall Study|Lost to Follow-up|1|||
164253186|NCT02931838|593292320|FG004|Overall Study|Lost to Follow-up|2|||
164253187|NCT02931838|593292321|FG005|Overall Study|Lost to Follow-up|0|||
164253188|NCT02931838|593292316|FG000|Overall Study|Subject request to discontinue treatment|4|||
164253189|NCT02931838|593292317|FG001|Overall Study|Subject request to discontinue treatment|3|||
164253190|NCT02931838|593292318|FG002|Overall Study|Subject request to discontinue treatment|3|||
164253191|NCT02931838|593292319|FG003|Overall Study|Subject request to discontinue treatment|0|||
164253192|NCT02931838|593292320|FG004|Overall Study|Subject request to discontinue treatment|1|||
164253193|NCT02931838|593292321|FG005|Overall Study|Subject request to discontinue treatment|0|||
164253194|NCT02931838|593292316|FG000|Overall Study|Withdrawal by Subject|1|||
164253195|NCT02931838|593292317|FG001|Overall Study|Withdrawal by Subject|2|||
164253196|NCT02931838|593292318|FG002|Overall Study|Withdrawal by Subject|0|||
164253197|NCT02931838|593292319|FG003|Overall Study|Withdrawal by Subject|1|||
164253198|NCT02931838|593292320|FG004|Overall Study|Withdrawal by Subject|0|||
164253199|NCT02931838|593292321|FG005|Overall Study|Withdrawal by Subject|0|||
164253200|NCT02931838|593292316|FG000|Overall Study|Adverse Event|2|||
164253201|NCT02931838|593292317|FG001|Overall Study|Adverse Event|1|||
164253202|NCT02931838|593292318|FG002|Overall Study|Adverse Event|2|||
164253203|NCT02931838|593292319|FG003|Overall Study|Adverse Event|1|||
164253204|NCT02931838|593292320|FG004|Overall Study|Adverse Event|3|||
164253205|NCT02931838|593292321|FG005|Overall Study|Adverse Event|1|||
164253206|NCT01963767|593292322|FG000|Overall Study|Withdrawal by Subject|4|||
164576076|NCT05202808|594471833|FG001|Overall Study|Lost to Follow-up|1|||
164576077|NCT04996797|594471834|FG000|Overall Study|Adverse Event|0|||
164576078|NCT04996797|594471835|FG001|Overall Study|Adverse Event|2|||
164576079|NCT04996797|594471836|FG002|Overall Study|Adverse Event|0|||
164576080|NCT04996797|594471837|FG003|Overall Study|Adverse Event|1|||
164576081|NCT04996797|594471834|FG000|Overall Study|Lack of Efficacy|0|||
164576082|NCT04996797|594471835|FG001|Overall Study|Lack of Efficacy|2|||
164576083|NCT04996797|594471836|FG002|Overall Study|Lack of Efficacy|0|||
164680494|NCT00112437|594854580|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164253207|NCT01963767|593292323|FG001|Overall Study|Withdrawal by Subject|2|||
164253208|NCT01963767|593292322|FG000|Overall Study|Adverse Event|2|||
164253209|NCT01963767|593292323|FG001|Overall Study|Adverse Event|0|||
164253210|NCT01659996|593292324|FG000|Overall Study|Protocol Violation|3|||
164253211|NCT01659996|593292325|FG001|Overall Study|Protocol Violation|3|||
164576084|NCT04996797|594471837|FG003|Overall Study|Lack of Efficacy|0|||
164253212|NCT01659996|593292326|FG002|Overall Study|Protocol Violation|3|||
164253213|NCT01659996|593292324|FG000|Overall Study|Lost to Follow-up|1|||
164253214|NCT01659996|593292325|FG001|Overall Study|Lost to Follow-up|3|||
164253215|NCT01659996|593292326|FG002|Overall Study|Lost to Follow-up|2|||
164253216|NCT01659996|593292324|FG000|Overall Study|Adverse Event|0|||
164253217|NCT01659996|593292325|FG001|Overall Study|Adverse Event|0|||
164253218|NCT01659996|593292326|FG002|Overall Study|Adverse Event|1|||
164253219|NCT01659996|593292324|FG000|Overall Study|Withdrawal by Subject|4|||
164253220|NCT01659996|593292325|FG001|Overall Study|Withdrawal by Subject|1|||
164253221|NCT01659996|593292326|FG002|Overall Study|Withdrawal by Subject|5|||
164253222|NCT02709577|593292327|FG000|Overall Study|non-accommodating anatomy|0|||
164253223|NCT02709577|593292328|FG001|Overall Study|non-accommodating anatomy|1|||
164253224|NCT02709577|593292329|FG002|Overall Study|non-accommodating anatomy|0|||
164253225|NCT02709577|593292330|FG003|Overall Study|non-accommodating anatomy|0|||
164253226|NCT02709577|593292327|FG000|Overall Study|procedural complication|0|||
164253227|NCT02709577|593292328|FG001|Overall Study|procedural complication|1|||
164253228|NCT02709577|593292329|FG002|Overall Study|procedural complication|0|||
164253229|NCT02709577|593292330|FG003|Overall Study|procedural complication|0|||
164253230|NCT02709577|593292327|FG000|Overall Study|Withdrawal by Subject|2|||
164253231|NCT02709577|593292328|FG001|Overall Study|Withdrawal by Subject|3|||
164253232|NCT02709577|593292329|FG002|Overall Study|Withdrawal by Subject|2|||
164253233|NCT02709577|593292330|FG003|Overall Study|Withdrawal by Subject|0|||
164253234|NCT03823287|593292331|FG000|Overall Study|Withdrawal by Subject|25|||
164253235|NCT03823287|593292332|FG001|Overall Study|Withdrawal by Subject|17|||
164253236|NCT03823287|593292331|FG000|Overall Study|Death|13|||
164253237|NCT03823287|593292332|FG001|Overall Study|Death|7|||
164253238|NCT03823287|593292331|FG000|Overall Study|Lost to Follow-up|7|||
164253239|NCT03823287|593292332|FG001|Overall Study|Lost to Follow-up|8|||
164253240|NCT03823287|593292331|FG000|Overall Study|Adverse Event|6|||
164253241|NCT03823287|593292332|FG001|Overall Study|Adverse Event|8|||
164253242|NCT03823287|593292331|FG000|Overall Study|Physician Decision|5|||
164253243|NCT03823287|593292332|FG001|Overall Study|Physician Decision|2|||
164253244|NCT03823287|593292331|FG000|Overall Study|Lack of Efficacy|2|||
164253245|NCT03823287|593292332|FG001|Overall Study|Lack of Efficacy|0|||
164253246|NCT03823287|593292331|FG000|Overall Study|Other|2|||
164253247|NCT03823287|593292332|FG001|Overall Study|Other|4|||
164253248|NCT01059864|593292335|FG000|Open-Label Run-In Phase|Adverse Event|7|||
164576085|NCT04996797|594471834|FG000|Overall Study|Prohibited Medication|0|||
164576086|NCT04996797|594471835|FG001|Overall Study|Prohibited Medication|1|||
164253249|NCT01059864|593292336|FG001|Open-Label Run-In Phase|Adverse Event|0|||
164253250|NCT01059864|593292337|FG002|Open-Label Run-In Phase|Adverse Event|0|||
164253251|NCT01059864|593292335|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
164253252|NCT01059864|593292336|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
164253253|NCT01059864|593292337|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
164576087|NCT04996797|594471836|FG002|Overall Study|Prohibited Medication|0|||
164576088|NCT04996797|594471837|FG003|Overall Study|Prohibited Medication|0|||
164576089|NCT04996797|594471834|FG000|Overall Study|Ongoing|68|||
164576090|NCT04996797|594471835|FG001|Overall Study|Ongoing|60|||
164576091|NCT04996797|594471836|FG002|Overall Study|Ongoing|22|||
164576092|NCT04996797|594471837|FG003|Overall Study|Ongoing|20|||
164576093|NCT04996797|594471834|FG000|Overall Study|Withdrawal by Subject|0|||
164576094|NCT04996797|594471835|FG001|Overall Study|Withdrawal by Subject|2|||
164576095|NCT04996797|594471836|FG002|Overall Study|Withdrawal by Subject|0|||
164576096|NCT04996797|594471837|FG003|Overall Study|Withdrawal by Subject|0|||
164576097|NCT02793544|594471838|FG000|Overall Study|Death|10|||
164576098|NCT02793544|594471839|FG001|Overall Study|Death|8|||
164576099|NCT02793544|594471838|FG000|Overall Study|Lost to Follow-up|2|||
164576100|NCT02793544|594471839|FG001|Overall Study|Lost to Follow-up|0|||
164576101|NCT02793544|594471838|FG000|Overall Study|Withdrawal by Subject|1|||
164576102|NCT02793544|594471839|FG001|Overall Study|Withdrawal by Subject|0|||
164576103|NCT05087030|594471843|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
164576104|NCT05087030|594471844|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
164576105|NCT05087030|594471845|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
164576106|NCT05087030|594471846|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
164576107|NCT05087030|594471847|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
164253254|NCT01059864|593292335|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
164576108|NCT05087030|594471843|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
164576109|NCT05087030|594471844|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
164576110|NCT05087030|594471845|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
164576111|NCT05087030|594471846|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
164576112|NCT05087030|594471847|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
164253255|NCT01059864|593292336|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
164253256|NCT01059864|593292337|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
164253257|NCT01059864|593292335|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
164253258|NCT01059864|593292336|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
164576113|NCT05087030|594471843|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
164253259|NCT01059864|593292337|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
164253260|NCT01059864|593292335|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
164253261|NCT01059864|593292336|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
164253262|NCT01059864|593292337|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
164253263|NCT01059864|593292335|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
164253264|NCT01059864|593292336|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
164253265|NCT01059864|593292337|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
164253266|NCT03108521|593292338|FG000|Overall Study|Lost to Follow-up|3|||
164253267|NCT03108521|593292339|FG001|Overall Study|Lost to Follow-up|0|||
164253268|NCT03108521|593292338|FG000|Overall Study|Lack of Efficacy|2|||
164253269|NCT03108521|593292339|FG001|Overall Study|Lack of Efficacy|0|||
164253270|NCT03108521|593292338|FG000|Overall Study|Physician Decision|4|||
164253271|NCT03108521|593292339|FG001|Overall Study|Physician Decision|0|||
164253272|NCT03108521|593292338|FG000|Overall Study|Adverse Event|3|||
164253273|NCT03108521|593292339|FG001|Overall Study|Adverse Event|0|||
164253274|NCT03281629|593292345|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
164253275|NCT03281629|593292346|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
164253276|NCT03281629|593292345|FG000|Overall Study|Death|0|||
164253277|NCT03281629|593292346|FG001|Overall Study|Death|1|||
164253278|NCT03281629|593292345|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
164253279|NCT03281629|593292346|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
164253280|NCT01380535|593294136|FG000|Overall Study|Adverse Event|3|||
164253281|NCT01380535|593294137|FG001|Overall Study|Adverse Event|3|||
164253282|NCT01380535|593294136|FG000|Overall Study|Death|3|||
164253283|NCT01380535|593294137|FG001|Overall Study|Death|0|||
164253284|NCT01380535|593294136|FG000|Overall Study|Study site closed|0|||
164253285|NCT01380535|593294137|FG001|Overall Study|Study site closed|5|||
164253286|NCT01380535|593294136|FG000|Overall Study|Withdrawal by Subject|1|||
164253287|NCT01380535|593294137|FG001|Overall Study|Withdrawal by Subject|2|||
164253288|NCT01380535|593294136|FG000|Overall Study|Protocol Violation|0|||
164253289|NCT01380535|593294137|FG001|Overall Study|Protocol Violation|2|||
164253290|NCT01380535|593294136|FG000|Overall Study|Lack of Efficacy|0|||
164253291|NCT01380535|593294137|FG001|Overall Study|Lack of Efficacy|3|||
164253292|NCT00489424|593294138|FG000|Overall Study|Adverse Event|3|||
164253293|NCT00489424|593294139|FG001|Overall Study|Adverse Event|3|||
164253294|NCT00489424|593294140|FG002|Overall Study|Adverse Event|4|||
164253295|NCT00489424|593294138|FG000|Overall Study|Lack of Efficacy|1|||
164253296|NCT00489424|593294139|FG001|Overall Study|Lack of Efficacy|0|||
164253297|NCT00489424|593294140|FG002|Overall Study|Lack of Efficacy|0|||
164253298|NCT00489424|593294138|FG000|Overall Study|Administrative problems|0|||
164253299|NCT00489424|593294139|FG001|Overall Study|Administrative problems|2|||
164253300|NCT00489424|593294140|FG002|Overall Study|Administrative problems|1|||
164253301|NCT00394251|593294141|FG000|Overall Study|Adverse Event|7|||
164253302|NCT00394251|593294142|FG001|Overall Study|Adverse Event|5|||
164253303|NCT00394251|593294141|FG000|Overall Study|Unacceptable Toxicity|20|||
164253304|NCT00394251|593294142|FG001|Overall Study|Unacceptable Toxicity|18|||
164253305|NCT00394251|593294141|FG000|Overall Study|Physician Decision|1|||
164253306|NCT00394251|593294142|FG001|Overall Study|Physician Decision|1|||
164427369|NCT01124617|593932860|FG001|Overall Study|Other|1|||
164253307|NCT00394251|593294141|FG000|Overall Study|Protocol Violation|0|||
164253308|NCT00394251|593294142|FG001|Overall Study|Protocol Violation|1|||
164253309|NCT00394251|593294141|FG000|Overall Study|Withdrawal by Subject|7|||
164253310|NCT00394251|593294142|FG001|Overall Study|Withdrawal by Subject|11|||
164253311|NCT00394251|593294141|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
164253312|NCT00394251|593294142|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
164253313|NCT00962741|593294143|FG000|Overall Study|Failed to return|3|||
164253314|NCT00962741|593294143|FG000|Overall Study|Lost to Follow-up|2|||
164427370|NCT01318811|593932863|FG000|Overall Study|Physician Decision|1|||
164427371|NCT01318811|593932864|FG001|Overall Study|Physician Decision|1|||
164427372|NCT01318811|593932863|FG000|Overall Study|CRRT stopped for head CT|0|||
164427373|NCT01318811|593932864|FG001|Overall Study|CRRT stopped for head CT|1|||
164427374|NCT01318811|593932863|FG000|Overall Study|Death|0|||
164427375|NCT01318811|593932864|FG001|Overall Study|Death|1|||
164427376|NCT01318811|593932863|FG000|Overall Study|CRRT stopped for head MRI|0|||
164427377|NCT01318811|593932864|FG001|Overall Study|CRRT stopped for head MRI|1|||
164253315|NCT00962741|593294143|FG000|Overall Study|Withdrawal by Subject|1|||
164253316|NCT00962741|593294143|FG000|Overall Study|Lack of Efficacy|1|||
164253317|NCT00962741|593294143|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
164253318|NCT01545934|593294144|FG000|Overall Study|Withdrawal by Subject|4|||
164253319|NCT01545934|593294145|FG001|Overall Study|Withdrawal by Subject|3|||
164253320|NCT01545934|593294144|FG000|Overall Study|Lost to Follow-up|1|||
164253321|NCT01545934|593294145|FG001|Overall Study|Lost to Follow-up|0|||
164253322|NCT01843673|593294150|FG000|Overall Study|Lack of Efficacy|2|||
164253323|NCT01843673|593294150|FG000|Overall Study|Withdrawal by Subject|4|||
164253324|NCT00695955|593294155|FG000|Cohort 1|Adverse Event|26|||
164253325|NCT00695955|593294155|FG000|Cohort 1|Protocol Violation|2|||
164427378|NCT00811187|593932865|FG000|Overall Study|Unable to place device / procedure abort|3|||
164253326|NCT00695955|593294155|FG000|Cohort 1|Lost to Follow-up|30|||
164253327|NCT00695955|593294155|FG000|Cohort 1|Withdrawal by Subject|25|||
164253328|NCT00695955|593294155|FG000|Cohort 1|Lack of Efficacy|3|||
164253329|NCT00695955|593294155|FG000|Cohort 1|Other|16|||
164253330|NCT00695955|593294155|FG000|Cohort 2|Adverse Event|24|||
164253331|NCT00695955|593294155|FG000|Cohort 2|Protocol Violation|5|||
164253332|NCT00695955|593294155|FG000|Cohort 2|Lost to Follow-up|38|||
164253333|NCT00695955|593294155|FG000|Cohort 2|Withdrawal by Subject|28|||
164253334|NCT00695955|593294155|FG000|Cohort 2|Lack of Efficacy|4|||
164253335|NCT00695955|593294155|FG000|Cohort 2|Other|5|||
164253336|NCT00888329|593294156|FG000|Overall Study|Physician Decision|6|||
164253337|NCT00888329|593294157|FG001|Overall Study|Physician Decision|9|||
164253338|NCT04826094|593294158|FG000|Overall Study|Lost to Follow-up|2|||
164253339|NCT04826094|593294159|FG001|Overall Study|Lost to Follow-up|1|||
164253340|NCT04826094|593294160|FG002|Overall Study|Lost to Follow-up|0|||
164253341|NCT04826094|593294161|FG003|Overall Study|Lost to Follow-up|0|||
164253342|NCT04826094|593294162|FG004|Overall Study|Lost to Follow-up|1|||
164253343|NCT04826094|593294163|FG005|Overall Study|Lost to Follow-up|3|||
164253344|NCT04826094|593294164|FG006|Overall Study|Lost to Follow-up|1|||
164253345|NCT04826094|593294165|FG007|Overall Study|Lost to Follow-up|1|||
164253346|NCT04826094|593294158|FG000|Overall Study|Participant withdrew consent|1|||
164253347|NCT04826094|593294159|FG001|Overall Study|Participant withdrew consent|0|||
164253348|NCT04826094|593294160|FG002|Overall Study|Participant withdrew consent|0|||
164253349|NCT04826094|593294161|FG003|Overall Study|Participant withdrew consent|1|||
164253350|NCT04826094|593294162|FG004|Overall Study|Participant withdrew consent|1|||
164253351|NCT04826094|593294163|FG005|Overall Study|Participant withdrew consent|1|||
164253352|NCT04826094|593294164|FG006|Overall Study|Participant withdrew consent|0|||
164253353|NCT04826094|593294165|FG007|Overall Study|Participant withdrew consent|1|||
164253354|NCT04826094|593294158|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
164253355|NCT04826094|593294159|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
164253356|NCT04826094|593294160|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
164253357|NCT04826094|593294161|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
164253358|NCT04826094|593294162|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
164253359|NCT04826094|593294163|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
164253360|NCT04826094|593294164|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
164253361|NCT04826094|593294165|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
164253362|NCT04826094|593294158|FG000|Overall Study|Withdrawn by Investigator|0|||
164253363|NCT04826094|593294159|FG001|Overall Study|Withdrawn by Investigator|0|||
164253364|NCT04826094|593294160|FG002|Overall Study|Withdrawn by Investigator|0|||
164576114|NCT05087030|594471844|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
164576115|NCT05087030|594471845|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
164576116|NCT05087030|594471846|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
164576117|NCT05087030|594471847|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
164576118|NCT05087030|594471843|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
164576119|NCT05087030|594471844|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
164576120|NCT05087030|594471845|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
164576121|NCT05087030|594471846|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
164576122|NCT05087030|594471847|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
164576123|NCT05087030|594471843|FG000|Main Period (Week 0 to Week 52)|Death|0|||
164576124|NCT05087030|594471844|FG001|Main Period (Week 0 to Week 52)|Death|1|||
164576125|NCT05087030|594471845|FG002|Main Period (Week 0 to Week 52)|Death|0|||
164576126|NCT05087030|594471846|FG003|Main Period (Week 0 to Week 52)|Death|0|||
164576127|NCT05087030|594471847|FG004|Main Period (Week 0 to Week 52)|Death|0|||
164576128|NCT05087030|594471843|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
164576129|NCT05087030|594471844|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
164576130|NCT05087030|594471845|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
164576131|NCT05087030|594471846|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
164576132|NCT05087030|594471847|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
164576133|NCT05087030|594471843|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
164576134|NCT05087030|594471844|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
164576135|NCT05087030|594471845|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
164576136|NCT05087030|594471846|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
164576137|NCT05087030|594471847|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
164576138|NCT05087030|594471843|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
164576139|NCT05087030|594471844|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
164253365|NCT04826094|593294161|FG003|Overall Study|Withdrawn by Investigator|0|||
164253366|NCT04826094|593294162|FG004|Overall Study|Withdrawn by Investigator|0|||
164253367|NCT04826094|593294163|FG005|Overall Study|Withdrawn by Investigator|1|||
164253368|NCT04826094|593294164|FG006|Overall Study|Withdrawn by Investigator|0|||
164253369|NCT04826094|593294165|FG007|Overall Study|Withdrawn by Investigator|1|||
164253370|NCT04826094|593294158|FG000|Overall Study|Other: Moved from area|1|||
164253371|NCT04826094|593294159|FG001|Overall Study|Other: Moved from area|1|||
164253372|NCT04826094|593294160|FG002|Overall Study|Other: Moved from area|1|||
164253373|NCT04826094|593294161|FG003|Overall Study|Other: Moved from area|0|||
164253374|NCT04826094|593294162|FG004|Overall Study|Other: Moved from area|0|||
164253375|NCT04826094|593294163|FG005|Overall Study|Other: Moved from area|0|||
164253376|NCT04826094|593294164|FG006|Overall Study|Other: Moved from area|0|||
164253377|NCT04826094|593294165|FG007|Overall Study|Other: Moved from area|0|||
164253378|NCT04826094|593294158|FG000|Overall Study|Other: Declined|0|||
164253379|NCT04826094|593294159|FG001|Overall Study|Other: Declined|0|||
164253380|NCT04826094|593294160|FG002|Overall Study|Other: Declined|0|||
164253381|NCT04826094|593294161|FG003|Overall Study|Other: Declined|0|||
164253382|NCT04826094|593294162|FG004|Overall Study|Other: Declined|1|||
164253383|NCT04826094|593294163|FG005|Overall Study|Other: Declined|0|||
164253384|NCT04826094|593294164|FG006|Overall Study|Other: Declined|0|||
164253385|NCT04826094|593294165|FG007|Overall Study|Other: Declined|0|||
164253386|NCT04826094|593294158|FG000|Overall Study|Other: Vaccine not administered|0|||
164253387|NCT04826094|593294159|FG001|Overall Study|Other: Vaccine not administered|0|||
164253388|NCT04826094|593294160|FG002|Overall Study|Other: Vaccine not administered|1|||
164253389|NCT04826094|593294161|FG003|Overall Study|Other: Vaccine not administered|0|||
164253390|NCT04826094|593294162|FG004|Overall Study|Other: Vaccine not administered|0|||
164253391|NCT04826094|593294163|FG005|Overall Study|Other: Vaccine not administered|1|||
164253392|NCT04826094|593294164|FG006|Overall Study|Other: Vaccine not administered|1|||
164253393|NCT04826094|593294165|FG007|Overall Study|Other: Vaccine not administered|3|||
164253394|NCT03928418|593294172|FG000|Overall Study|Lost to Follow-up|5|||
164253395|NCT03928418|593294173|FG001|Overall Study|Lost to Follow-up|3|||
164253396|NCT03928418|593294174|FG002|Overall Study|Lost to Follow-up|5|||
164253397|NCT03928418|593294172|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
164253398|NCT03928418|593294173|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
164253399|NCT03928418|593294174|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
164253400|NCT05319600|593294175|FG000|Overall Study|Withdrawal by Subject|1|||
164253401|NCT05319600|593294176|FG001|Overall Study|Withdrawal by Subject|0|||
164253402|NCT05319600|593294175|FG000|Overall Study|Lost to Follow-up|0|||
164253403|NCT05319600|593294176|FG001|Overall Study|Lost to Follow-up|4|||
164253404|NCT00904670|593294177|FG000|Open Label Phase|Withdrawal by Subject|2|||
164253405|NCT00904670|593294178|FG001|Open Label Phase|Withdrawal by Subject|0|||
164253406|NCT00904670|593294177|FG000|Open Label Phase|Adverse Event|2|||
164253407|NCT00904670|593294178|FG001|Open Label Phase|Adverse Event|0|||
164253408|NCT00904670|593294177|FG000|Open Label Phase|Lack of Efficacy|1|||
164253409|NCT00904670|593294178|FG001|Open Label Phase|Lack of Efficacy|0|||
164253410|NCT00904670|593294177|FG000|Open Label Phase|Lost to Follow-up|1|||
164253411|NCT00904670|593294178|FG001|Open Label Phase|Lost to Follow-up|0|||
164253412|NCT00690430|593294186|FG000|Core Phase|Abnormal Laboratory value|0|||
164253413|NCT00690430|593294187|FG001|Core Phase|Abnormal Laboratory value|1|||
164253414|NCT00690430|593294188|FG002|Core Phase|Abnormal Laboratory value|0|||
164253415|NCT00690430|593294186|FG000|Core Phase|Adverse Event|5|||
164253416|NCT00690430|593294187|FG001|Core Phase|Adverse Event|1|||
164253417|NCT00690430|593294188|FG002|Core Phase|Adverse Event|0|||
164253418|NCT00690430|593294186|FG000|Core Phase|Death|0|||
164253419|NCT00690430|593294187|FG001|Core Phase|Death|2|||
164253420|NCT00690430|593294188|FG002|Core Phase|Death|0|||
164253421|NCT00690430|593294186|FG000|Core Phase|Protocol Violation|1|||
164253422|NCT00690430|593294187|FG001|Core Phase|Protocol Violation|0|||
164253423|NCT00690430|593294188|FG002|Core Phase|Protocol Violation|0|||
164253424|NCT00690430|593294186|FG000|Core Phase|Withdrawal by Subject|3|||
164253425|NCT00690430|593294187|FG001|Core Phase|Withdrawal by Subject|3|||
164253426|NCT00690430|593294188|FG002|Core Phase|Withdrawal by Subject|0|||
164427379|NCT00811187|593932866|FG001|Overall Study|Unable to place device / procedure abort|3|||
164427380|NCT02825043|593932867|FG000|Overall Study|Lost to Follow-up|4|||
164253427|NCT00690430|593294186|FG000|Core Phase|Subject no longer requires study drug|1|||
164253428|NCT00690430|593294187|FG001|Core Phase|Subject no longer requires study drug|0|||
164253429|NCT00690430|593294188|FG002|Core Phase|Subject no longer requires study drug|0|||
164253430|NCT00690430|593294186|FG000|Core Phase|Lack of Efficacy|8|||
164253431|NCT00690430|593294187|FG001|Core Phase|Lack of Efficacy|10|||
164427381|NCT00131911|593932868|FG000|Overall Study|Withdrawal by Subject|1|||
164427382|NCT00131911|593932869|FG001|Overall Study|Withdrawal by Subject|0|||
164576140|NCT05087030|594471845|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
164576141|NCT05087030|594471846|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
164576142|NCT05087030|594471847|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
164253432|NCT00690430|593294188|FG002|Core Phase|Lack of Efficacy|0|||
164253433|NCT00690430|593294186|FG000|Core Phase|Administrative Problems|0|||
164253434|NCT00690430|593294187|FG001|Core Phase|Administrative Problems|1|||
164253435|NCT00690430|593294188|FG002|Core Phase|Administrative Problems|0|||
164253436|NCT00690430|593294186|FG000|Core Phase|Early Termination|0|||
164253437|NCT00690430|593294187|FG001|Core Phase|Early Termination|5|||
164253438|NCT00690430|593294188|FG002|Core Phase|Early Termination|0|||
164253439|NCT00690430|593294186|FG000|Extension Phase|Lack of Efficacy|3|||
164253440|NCT00690430|593294187|FG001|Extension Phase|Lack of Efficacy|1|||
164253441|NCT00690430|593294188|FG002|Extension Phase|Lack of Efficacy|4|||
164253442|NCT00690430|593294186|FG000|Extension Phase|Abnormal Lab Values|1|||
164253443|NCT00690430|593294187|FG001|Extension Phase|Abnormal Lab Values|0|||
164253444|NCT00690430|593294188|FG002|Extension Phase|Abnormal Lab Values|0|||
164253445|NCT00690430|593294186|FG000|Extension Phase|Abnormal test procedure results|1|||
164253446|NCT00690430|593294187|FG001|Extension Phase|Abnormal test procedure results|0|||
164576143|NCT05087030|594471843|FG000|Main Period (Week 0 to Week 52)|Other|1|||
164576144|NCT05087030|594471844|FG001|Main Period (Week 0 to Week 52)|Other|2|||
164576145|NCT05087030|594471845|FG002|Main Period (Week 0 to Week 52)|Other|0|||
164576146|NCT05087030|594471846|FG003|Main Period (Week 0 to Week 52)|Other|0|||
164576147|NCT05087030|594471847|FG004|Main Period (Week 0 to Week 52)|Other|0|||
164576148|NCT05087030|594471843|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
164576149|NCT05087030|594471844|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
164576150|NCT05087030|594471845|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
164576151|NCT05087030|594471846|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
164576152|NCT05087030|594471847|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
164576153|NCT01237951|594471848|FG000|Overall Study|Death|1|||
164576154|NCT02970929|594471851|FG000|Overall Study|Adverse Event|18|||
164253447|NCT00690430|593294188|FG002|Extension Phase|Abnormal test procedure results|0|||
164253448|NCT00690430|593294186|FG000|Extension Phase|Administrative Problems|0|||
164253449|NCT00690430|593294187|FG001|Extension Phase|Administrative Problems|1|||
164253450|NCT00690430|593294188|FG002|Extension Phase|Administrative Problems|1|||
164253451|NCT00690430|593294186|FG000|Extension Phase|Adverse Event|2|||
164253452|NCT00690430|593294187|FG001|Extension Phase|Adverse Event|1|||
164253453|NCT00690430|593294188|FG002|Extension Phase|Adverse Event|2|||
164253454|NCT00690430|593294186|FG000|Extension Phase|Death|1|||
164253455|NCT00690430|593294187|FG001|Extension Phase|Death|1|||
164253456|NCT00690430|593294188|FG002|Extension Phase|Death|1|||
164253457|NCT00690430|593294186|FG000|Extension Phase|Withdrawal by Subject|0|||
164253458|NCT00690430|593294187|FG001|Extension Phase|Withdrawal by Subject|0|||
164253459|NCT00690430|593294188|FG002|Extension Phase|Withdrawal by Subject|2|||
164253460|NCT00690430|593294186|FG000|Extension Phase|Early Termination|10|||
164253461|NCT00690430|593294187|FG001|Extension Phase|Early Termination|1|||
164253462|NCT00690430|593294188|FG002|Extension Phase|Early Termination|3|||
164253463|NCT02120300|593294189|FG000|Overall Study|Enrolled but Never Treated|2|||
164253464|NCT02120300|593294190|FG001|Overall Study|Enrolled but Never Treated|0|||
164253465|NCT02120300|593294191|FG002|Overall Study|Enrolled but Never Treated|0|||
164253466|NCT02120300|593294192|FG003|Overall Study|Enrolled but Never Treated|0|||
164253467|NCT02120300|593294189|FG000|Overall Study|Lack of Efficacy|0|||
164253468|NCT02120300|593294190|FG001|Overall Study|Lack of Efficacy|0|||
164253469|NCT02120300|593294191|FG002|Overall Study|Lack of Efficacy|0|||
164253470|NCT02120300|593294192|FG003|Overall Study|Lack of Efficacy|1|||
164253471|NCT02120300|593294189|FG000|Overall Study|Lost to Follow-up|1|||
164253472|NCT02120300|593294190|FG001|Overall Study|Lost to Follow-up|0|||
164253473|NCT02120300|593294191|FG002|Overall Study|Lost to Follow-up|0|||
164253474|NCT02120300|593294192|FG003|Overall Study|Lost to Follow-up|0|||
164253475|NCT01721486|593294195|FG000|Overall Study|Protocol Violation|1|||
164253476|NCT01721486|593294196|FG001|Overall Study|Protocol Violation|0|||
164253477|NCT01721486|593294195|FG000|Overall Study|Physician Decision|0|||
164253478|NCT01721486|593294196|FG001|Overall Study|Physician Decision|1|||
164253479|NCT00286091|593294203|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
164253480|NCT00286091|593294204|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
164253481|NCT00286091|593294203|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
164253482|NCT00286091|593294204|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
164253483|NCT00286091|593294203|FG000|Double-blind Treatment Phase|Death|58|||
164253484|NCT00286091|593294204|FG001|Double-blind Treatment Phase|Death|65|||
164427383|NCT00329303|593932872|FG000|Overall Study|Lack of Efficacy|1|||
164576155|NCT02970929|594471851|FG000|Overall Study|Lack of Efficacy|8|||
164576156|NCT02970929|594471851|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
164576157|NCT02970929|594471851|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
164576158|NCT02970929|594471851|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
164576159|NCT02970929|594471851|FG000|Overall Study|LOST TO FOLLOWUP|6|||
164576160|NCT02970929|594471851|FG000|Overall Study|MOVED OUT OF STATE|1|||
164576161|NCT02970929|594471851|FG000|Overall Study|Withdrawal by Subject|16|||
164576162|NCT00666562|594471854|FG000|Overall Study|Withdrawal by Subject|0|||
164576163|NCT00666562|594471855|FG001|Overall Study|Withdrawal by Subject|1|||
164253485|NCT00286091|593294203|FG000|Double-blind Treatment Phase|Adverse Event|28|||
164253486|NCT00286091|593294204|FG001|Double-blind Treatment Phase|Adverse Event|40|||
164253487|NCT00286091|593294203|FG000|Double-blind Treatment Phase|Disease Progression|22|||
164253488|NCT00286091|593294204|FG001|Double-blind Treatment Phase|Disease Progression|35|||
164253489|NCT00286091|593294203|FG000|Double-blind Treatment Phase|Other|25|||
164253490|NCT00286091|593294204|FG001|Double-blind Treatment Phase|Other|33|||
164576164|NCT00666562|594471856|FG002|Overall Study|Withdrawal by Subject|0|||
164253491|NCT00286091|593294203|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
164253492|NCT00286091|593294204|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
164253493|NCT00286091|593294203|FG000|Double-blind Treatment Phase|Noncompliance|8|||
164427384|NCT00329303|593932873|FG001|Overall Study|Lack of Efficacy|0|||
164253494|NCT00286091|593294204|FG001|Double-blind Treatment Phase|Noncompliance|8|||
164253495|NCT00286091|593294203|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
164253496|NCT00286091|593294204|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
164253497|NCT00286091|593294203|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
164253498|NCT00286091|593294204|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
164253499|NCT00286091|593294203|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
164253500|NCT00286091|593294204|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
164253501|NCT00286091|593294203|FG000|Open-label Treatment Phase|Physician Decision|24|||
164253502|NCT00286091|593294204|FG001|Open-label Treatment Phase|Physician Decision|21|||
164253503|NCT00286091|593294203|FG000|Open-label Treatment Phase|Adverse Event|5|||
164253504|NCT00286091|593294204|FG001|Open-label Treatment Phase|Adverse Event|16|||
164253505|NCT00286091|593294203|FG000|Open-label Treatment Phase|Other|11|||
164253506|NCT00286091|593294204|FG001|Open-label Treatment Phase|Other|11|||
164253507|NCT00286091|593294203|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
164253508|NCT00286091|593294204|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
164253509|NCT00286091|593294203|FG000|Open-label Treatment Phase|Death|10|||
164253510|NCT00286091|593294204|FG001|Open-label Treatment Phase|Death|7|||
164253511|NCT00286091|593294203|FG000|Open-label Treatment Phase|Disease Progression|9|||
164253512|NCT00286091|593294204|FG001|Open-label Treatment Phase|Disease Progression|3|||
164253513|NCT00286091|593294203|FG000|Open-label Treatment Phase|Noncompliance|3|||
164253514|NCT00286091|593294204|FG001|Open-label Treatment Phase|Noncompliance|1|||
164253515|NCT00286091|593294203|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
164253516|NCT00286091|593294204|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
164253517|NCT00286091|593294203|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
164253518|NCT00286091|593294204|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
164253519|NCT00286091|593294203|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
164253520|NCT00286091|593294204|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
164253521|NCT02936869|593294205|FG000|Overall Study|Lost to Follow-up|1|||
164253522|NCT02936869|593294206|FG001|Overall Study|Lost to Follow-up|3|||
164253523|NCT02936869|593294205|FG000|Overall Study|Death|0|||
164253524|NCT02936869|593294206|FG001|Overall Study|Death|1|||
164253525|NCT02936869|593294205|FG000|Overall Study|Legal Case|0|||
164253526|NCT02936869|593294206|FG001|Overall Study|Legal Case|1|||
164253527|NCT02936869|593294205|FG000|Overall Study|Protocol Violation|1|||
164253528|NCT02936869|593294206|FG001|Overall Study|Protocol Violation|0|||
164253529|NCT00335738|593294207|FG000|Overall Study|Physician Decision|6|||
164253530|NCT00335738|593294208|FG001|Overall Study|Physician Decision|0|||
164253531|NCT00335738|593294207|FG000|Overall Study|Withdrawal by Subject|2|||
164253532|NCT00335738|593294208|FG001|Overall Study|Withdrawal by Subject|0|||
164253533|NCT00335738|593294207|FG000|Overall Study|Ineligible|3|||
164253534|NCT00335738|593294208|FG001|Overall Study|Ineligible|4|||
164253535|NCT05141175|593294211|FG000|Overall Study|Withdrawal by Subject|1|||
164253536|NCT02036580|593294212|FG000|Overall Study|Withdrawal by Subject|0|||
164253537|NCT02036580|593294213|FG001|Overall Study|Withdrawal by Subject|1|||
164253538|NCT02036580|593294214|FG002|Overall Study|Withdrawal by Subject|0|||
164427385|NCT00329303|593932872|FG000|Overall Study|Decision of the sponsor|0|||
164427386|NCT00329303|593932873|FG001|Overall Study|Decision of the sponsor|1|||
164427387|NCT00329303|593932872|FG000|Overall Study|Patient no longer available|1|||
164427388|NCT00329303|593932873|FG001|Overall Study|Patient no longer available|0|||
164427389|NCT00329303|593932872|FG000|Overall Study|Patient relocated|0|||
164427390|NCT00329303|593932873|FG001|Overall Study|Patient relocated|1|||
164427391|NCT01163149|593932877|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
164427392|NCT01163149|593932878|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
164427393|NCT01163149|593932879|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
164427394|NCT01163149|593932877|FG000|Extension Treatment Period|Adverse Event|0|||
164427395|NCT01163149|593932878|FG001|Extension Treatment Period|Adverse Event|1|||
164253539|NCT02036580|593294212|FG000|Overall Study|Adverse Event|1|||
164253540|NCT02036580|593294213|FG001|Overall Study|Adverse Event|0|||
164253541|NCT02036580|593294214|FG002|Overall Study|Adverse Event|0|||
164253542|NCT03098433|593294221|FG000|Overall Study|Withdrawal by Subject|10|||
164253543|NCT04470050|593294222|FG000|Double-blind Treatment Phase|Adverse Event|0|||
164253544|NCT04470050|593294223|FG001|Double-blind Treatment Phase|Adverse Event|0|||
164253545|NCT04470050|593294224|FG002|Double-blind Treatment Phase|Adverse Event|0|||
164253546|NCT04470050|593294225|FG003|Double-blind Treatment Phase|Adverse Event|1|||
164253547|NCT04470050|593294226|FG004|Double-blind Treatment Phase|Adverse Event|0|||
164253548|NCT04470050|593294227|FG005|Double-blind Treatment Phase|Adverse Event|0|||
164427396|NCT01163149|593932879|FG002|Extension Treatment Period|Adverse Event|0|||
164427397|NCT01163149|593932877|FG000|Extension Treatment Period|Noncompliance|0|||
164427398|NCT01163149|593932878|FG001|Extension Treatment Period|Noncompliance|0|||
164427399|NCT01163149|593932879|FG002|Extension Treatment Period|Noncompliance|1|||
164253549|NCT04470050|593294228|FG006|Double-blind Treatment Phase|Adverse Event|0|||
164253550|NCT04470050|593294222|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
164253551|NCT04470050|593294223|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
164253552|NCT04470050|593294224|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
164253553|NCT04470050|593294225|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
164253554|NCT04470050|593294226|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
164253555|NCT04470050|593294227|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
164253556|NCT04470050|593294228|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
164576165|NCT00666562|594471854|FG000|Overall Study|Concomitant Medication|0|||
164253557|NCT04470050|593294222|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
164253558|NCT04470050|593294223|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
164253559|NCT04470050|593294224|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
164253560|NCT04470050|593294225|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
164253561|NCT04470050|593294226|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
164253562|NCT04470050|593294227|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
164253563|NCT04470050|593294228|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
164253564|NCT01813058|593294229|FG000|Overall Study|Withdrawal by Subject|5|||
164253565|NCT01813058|593294230|FG001|Overall Study|Withdrawal by Subject|4|||
164253566|NCT03585764|593294231|FG000|Overall Study|Death|3|||
164253567|NCT03585764|593294232|FG001|Overall Study|Death|2|||
164253568|NCT03585764|593294233|FG002|Overall Study|Death|3|||
164253569|NCT03585764|593294234|FG003|Overall Study|Death|0|||
164253570|NCT03585764|593294231|FG000|Overall Study|Lost to Follow-up|0|||
164253571|NCT03585764|593294232|FG001|Overall Study|Lost to Follow-up|1|||
164253572|NCT03585764|593294233|FG002|Overall Study|Lost to Follow-up|0|||
164253573|NCT03585764|593294234|FG003|Overall Study|Lost to Follow-up|0|||
164253574|NCT03585764|593294231|FG000|Overall Study|Physician Decision|0|||
164253575|NCT03585764|593294232|FG001|Overall Study|Physician Decision|0|||
164253576|NCT03585764|593294233|FG002|Overall Study|Physician Decision|2|||
164253577|NCT03585764|593294234|FG003|Overall Study|Physician Decision|0|||
164253578|NCT01581021|593294236|FG000|Overall Study|Lost to Follow-up|4|||
164253579|NCT01581021|593294237|FG001|Overall Study|Lost to Follow-up|6|||
164253580|NCT01581021|593294236|FG000|Overall Study|More than 2 hooks in thoracic|3|||
164253581|NCT01581021|593294237|FG001|Overall Study|More than 2 hooks in thoracic|0|||
164253582|NCT01581021|593294236|FG000|Overall Study|Neuromuscular|2|||
164253583|NCT01581021|593294237|FG001|Overall Study|Neuromuscular|1|||
164253584|NCT01581021|593294236|FG000|Overall Study|Not Randomized|1|||
164253585|NCT01581021|593294237|FG001|Overall Study|Not Randomized|2|||
164253586|NCT01581021|593294236|FG000|Overall Study|Lenke 6 Classification|0|||
164253587|NCT01581021|593294237|FG001|Overall Study|Lenke 6 Classification|1|||
164253588|NCT01581021|593294236|FG000|Overall Study|Lack of Efficacy|0|||
164253589|NCT01581021|593294237|FG001|Overall Study|Lack of Efficacy|1|||
164253590|NCT03604172|593294238|FG000|Overall Study|Lost to Follow-up|1|||
164253591|NCT03604172|593294239|FG001|Overall Study|Lost to Follow-up|2|||
164253592|NCT00054327|593294240|FG000|Overall Study|Engraftment failure|1|||
164253593|NCT00054327|593294241|FG001|Overall Study|Engraftment failure|0|||
164253594|NCT00054327|593294242|FG002|Overall Study|Engraftment failure|0|||
164253595|NCT00054327|593294243|FG003|Overall Study|Engraftment failure|0|||
164253596|NCT00054327|593294244|FG004|Overall Study|Engraftment failure|0|||
164253597|NCT00054327|593294245|FG005|Overall Study|Engraftment failure|0|||
164253598|NCT03028129|593294248|FG000|Overall Study|Adverse Event|13|||
164253599|NCT03028129|593294249|FG001|Overall Study|Adverse Event|2|||
164253600|NCT03028129|593294248|FG000|Overall Study|Lost to Follow-up|50|||
164253601|NCT03028129|593294249|FG001|Overall Study|Lost to Follow-up|38|||
164253602|NCT03028129|593294248|FG000|Overall Study|Physician Decision|0|||
164253603|NCT03028129|593294249|FG001|Overall Study|Physician Decision|1|||
164253604|NCT03028129|593294248|FG000|Overall Study|Protocol Violation|1|||
164253605|NCT03028129|593294249|FG001|Overall Study|Protocol Violation|1|||
164339010|NCT01952145|593617113|FG001|Overall Study|Withdrawal Criteria|11|||
164339011|NCT01952145|593617112|FG000|Overall Study|Unclassified|1|||
164576166|NCT00666562|594471855|FG001|Overall Study|Concomitant Medication|1|||
164576167|NCT00666562|594471856|FG002|Overall Study|Concomitant Medication|0|||
164339012|NCT01952145|593617113|FG001|Overall Study|Unclassified|1|||
164339013|NCT01540838|593617117|FG000|Overall Study|Open nasogastric tube|9|||
164253606|NCT03028129|593294248|FG000|Overall Study|Withdrawal by Subject|62|||
164253607|NCT03028129|593294249|FG001|Overall Study|Withdrawal by Subject|45|||
164253608|NCT00923351|593294250|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
164253609|NCT00923351|593294251|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
164253610|NCT00923351|593294252|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
164253611|NCT00182078|593294253|FG000|Overall Study|Withdrawal by Subject|1|||
164253612|NCT00182078|593294254|FG001|Overall Study|Withdrawal by Subject|0|||
164253613|NCT01076205|593294255|FG000|Overall Study|Adverse Drug Reaction|299|||
164253614|NCT01076205|593294255|FG000|Overall Study|Lack of Effectiveness|1423|||
164253615|NCT01076205|593294255|FG000|Overall Study|Other Reason|1075|||
164576168|NCT00655928|594471857|FG000|Overall Study|Withdrawal by Subject|2|||
164576169|NCT00655928|594471858|FG001|Overall Study|Withdrawal by Subject|1|||
164253616|NCT01076205|593294255|FG000|Overall Study|Unknown Reason|71|||
164253617|NCT01076205|593294255|FG000|Overall Study|Lost to Follow-up|3151|||
164253618|NCT00361231|593294256|FG000|Overall Study|Physician Decision|3|||
164253619|NCT00361231|593294256|FG000|Overall Study|Symptomatic deterioration|5|||
164253620|NCT00361231|593294256|FG000|Overall Study|Radiographic disease progression|16|||
164253621|NCT00361231|593294256|FG000|Overall Study|Withdrawal by Subject|4|||
164253622|NCT00361231|593294256|FG000|Overall Study|Adverse Event|6|||
164253623|NCT01732510|593294258|FG000|Overall Study|Adverse Event|0|||
164253624|NCT01732510|593294259|FG001|Overall Study|Adverse Event|1|||
164253625|NCT01732510|593294260|FG002|Overall Study|Adverse Event|1|||
164253626|NCT01732510|593294261|FG003|Overall Study|Adverse Event|0|||
164253627|NCT01732510|593294262|FG004|Overall Study|Adverse Event|0|||
164253628|NCT01732510|593294263|FG005|Overall Study|Adverse Event|0|||
164253629|NCT01732510|593294264|FG006|Overall Study|Adverse Event|1|||
164253630|NCT01732510|593294258|FG000|Overall Study|Protocol Violation|0|||
164253631|NCT01732510|593294259|FG001|Overall Study|Protocol Violation|0|||
164253632|NCT01732510|593294260|FG002|Overall Study|Protocol Violation|0|||
164253633|NCT01732510|593294261|FG003|Overall Study|Protocol Violation|1|||
164253634|NCT01732510|593294262|FG004|Overall Study|Protocol Violation|0|||
164253635|NCT01732510|593294263|FG005|Overall Study|Protocol Violation|0|||
164253636|NCT01732510|593294264|FG006|Overall Study|Protocol Violation|0|||
164253637|NCT01732510|593294258|FG000|Overall Study|Withdrawal by Subject|1|||
164253638|NCT01732510|593294259|FG001|Overall Study|Withdrawal by Subject|3|||
164253639|NCT01732510|593294260|FG002|Overall Study|Withdrawal by Subject|2|||
164253640|NCT01732510|593294261|FG003|Overall Study|Withdrawal by Subject|1|||
164253641|NCT01732510|593294262|FG004|Overall Study|Withdrawal by Subject|5|||
164253642|NCT01732510|593294263|FG005|Overall Study|Withdrawal by Subject|0|||
164253643|NCT01732510|593294264|FG006|Overall Study|Withdrawal by Subject|1|||
164253644|NCT01732510|593294258|FG000|Overall Study|Lost to Follow-up|0|||
164253645|NCT01732510|593294259|FG001|Overall Study|Lost to Follow-up|0|||
164253646|NCT01732510|593294260|FG002|Overall Study|Lost to Follow-up|1|||
164253647|NCT01732510|593294261|FG003|Overall Study|Lost to Follow-up|1|||
164253648|NCT01732510|593294262|FG004|Overall Study|Lost to Follow-up|0|||
164253649|NCT01732510|593294263|FG005|Overall Study|Lost to Follow-up|1|||
164253650|NCT01732510|593294264|FG006|Overall Study|Lost to Follow-up|0|||
164253651|NCT01732510|593294258|FG000|Overall Study|Physician Decision|0|||
164253652|NCT01732510|593294259|FG001|Overall Study|Physician Decision|1|||
164253653|NCT01732510|593294260|FG002|Overall Study|Physician Decision|0|||
164253654|NCT01732510|593294261|FG003|Overall Study|Physician Decision|0|||
164253655|NCT01732510|593294262|FG004|Overall Study|Physician Decision|0|||
164253656|NCT01732510|593294263|FG005|Overall Study|Physician Decision|0|||
164253657|NCT01732510|593294264|FG006|Overall Study|Physician Decision|0|||
164253658|NCT01732510|593294258|FG000|Overall Study|Pregnancy|0|||
164253659|NCT01732510|593294259|FG001|Overall Study|Pregnancy|0|||
164253660|NCT01732510|593294260|FG002|Overall Study|Pregnancy|0|||
164253661|NCT01732510|593294261|FG003|Overall Study|Pregnancy|1|||
164253662|NCT01732510|593294262|FG004|Overall Study|Pregnancy|0|||
164253663|NCT01732510|593294263|FG005|Overall Study|Pregnancy|0|||
164253664|NCT01732510|593294264|FG006|Overall Study|Pregnancy|0|||
164253665|NCT01732510|593294258|FG000|Overall Study|Study Terminated By Sponsor|0|||
164253666|NCT01732510|593294259|FG001|Overall Study|Study Terminated By Sponsor|0|||
164253667|NCT01732510|593294260|FG002|Overall Study|Study Terminated By Sponsor|0|||
164253668|NCT01732510|593294261|FG003|Overall Study|Study Terminated By Sponsor|1|||
164253669|NCT01732510|593294262|FG004|Overall Study|Study Terminated By Sponsor|0|||
164253670|NCT01732510|593294263|FG005|Overall Study|Study Terminated By Sponsor|12|||
164253671|NCT01732510|593294264|FG006|Overall Study|Study Terminated By Sponsor|6|||
164253672|NCT00313144|593294265|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
164253673|NCT00313144|593294265|FG000|Overall Study|Death|7|||
164253674|NCT00313144|593294265|FG000|Overall Study|Lost to Follow-up|5|||
164253675|NCT00313144|593294265|FG000|Overall Study|Withdrawal by Subject|4|||
164253676|NCT00313144|593294265|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
164253677|NCT00313144|593294265|FG000|Overall Study|Physician Decision|4|||
164253678|NCT00313144|593294265|FG000|Overall Study|Adverse event - transient|5|||
164253679|NCT00313144|593294265|FG000|Overall Study|Liver transplant|1|||
164253680|NCT00313144|593294265|FG000|Overall Study|Insurance (homecare provider) change|1|||
164253681|NCT00313144|593294265|FG000|Overall Study|Change to different product|1|||
164253682|NCT00313144|593294265|FG000|Overall Study|Due to termination of the study|66|||
164253683|NCT03403361|593294266|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
164253684|NCT02487654|593294268|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
164253685|NCT02487654|593294269|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
164253686|NCT02487654|593294268|FG000|Overall Study|Withdrawal by Subject|3|||
164253687|NCT02487654|593294269|FG001|Overall Study|Withdrawal by Subject|7|||
164253688|NCT02443116|593294270|FG000|Part 1|Adverse Event|2|||
164576170|NCT00655928|594471857|FG000|Overall Study|Physician Decision|1|||
164253689|NCT02443116|593294271|FG001|Part 1|Adverse Event|3|||
164253690|NCT02443116|593294272|FG002|Part 1|Adverse Event|0|||
164253691|NCT02443116|593294273|FG003|Part 1|Adverse Event|0|||
164576171|NCT00655928|594471858|FG001|Overall Study|Physician Decision|1|||
164253692|NCT02443116|593294274|FG004|Part 1|Adverse Event|0|||
164253693|NCT02443116|593294275|FG005|Part 1|Adverse Event|0|||
164253694|NCT02443116|593294276|FG006|Part 1|Adverse Event|0|||
164253695|NCT02443116|593294277|FG007|Part 1|Adverse Event|0|||
164253696|NCT02443116|593294278|FG008|Part 1|Adverse Event|0|||
164253697|NCT02443116|593294270|FG000|Part 1|Withdrew informed consent|0|||
164253698|NCT02443116|593294271|FG001|Part 1|Withdrew informed consent|1|||
164253699|NCT02443116|593294272|FG002|Part 1|Withdrew informed consent|0|||
164253700|NCT02443116|593294273|FG003|Part 1|Withdrew informed consent|0|||
164253701|NCT02443116|593294274|FG004|Part 1|Withdrew informed consent|0|||
164253702|NCT02443116|593294275|FG005|Part 1|Withdrew informed consent|0|||
164253703|NCT02443116|593294276|FG006|Part 1|Withdrew informed consent|0|||
164253704|NCT02443116|593294277|FG007|Part 1|Withdrew informed consent|0|||
164253705|NCT02443116|593294278|FG008|Part 1|Withdrew informed consent|0|||
164253706|NCT02443116|593294270|FG000|Part 1|Lost to Follow-up|0|||
164253707|NCT02443116|593294271|FG001|Part 1|Lost to Follow-up|0|||
164253708|NCT02443116|593294272|FG002|Part 1|Lost to Follow-up|2|||
164253709|NCT02443116|593294273|FG003|Part 1|Lost to Follow-up|0|||
164253710|NCT02443116|593294274|FG004|Part 1|Lost to Follow-up|0|||
164253711|NCT02443116|593294275|FG005|Part 1|Lost to Follow-up|0|||
164253712|NCT02443116|593294276|FG006|Part 1|Lost to Follow-up|0|||
164253713|NCT02443116|593294277|FG007|Part 1|Lost to Follow-up|0|||
164253714|NCT02443116|593294278|FG008|Part 1|Lost to Follow-up|0|||
164253715|NCT02443116|593294270|FG000|Part 1|Participant moved out of state|0|||
164253716|NCT02443116|593294271|FG001|Part 1|Participant moved out of state|0|||
164253717|NCT02443116|593294272|FG002|Part 1|Participant moved out of state|1|||
164253718|NCT02443116|593294273|FG003|Part 1|Participant moved out of state|0|||
164253719|NCT02443116|593294274|FG004|Part 1|Participant moved out of state|0|||
164253720|NCT02443116|593294275|FG005|Part 1|Participant moved out of state|0|||
164253721|NCT02443116|593294276|FG006|Part 1|Participant moved out of state|0|||
164253722|NCT02443116|593294277|FG007|Part 1|Participant moved out of state|0|||
164253723|NCT02443116|593294278|FG008|Part 1|Participant moved out of state|0|||
164253724|NCT02443116|593294270|FG000|Part 1|Participant enrolled in another clinical trial|0|||
164253725|NCT02443116|593294271|FG001|Part 1|Participant enrolled in another clinical trial|0|||
164253726|NCT02443116|593294272|FG002|Part 1|Participant enrolled in another clinical trial|1|||
164253727|NCT02443116|593294273|FG003|Part 1|Participant enrolled in another clinical trial|0|||
164253728|NCT02443116|593294274|FG004|Part 1|Participant enrolled in another clinical trial|0|||
164253729|NCT02443116|593294275|FG005|Part 1|Participant enrolled in another clinical trial|0|||
164253730|NCT02443116|593294276|FG006|Part 1|Participant enrolled in another clinical trial|0|||
164253731|NCT02443116|593294277|FG007|Part 1|Participant enrolled in another clinical trial|0|||
164253732|NCT02443116|593294278|FG008|Part 1|Participant enrolled in another clinical trial|0|||
164253733|NCT02443116|593294270|FG000|Part 2|Adverse Event|0|||
164253734|NCT02443116|593294271|FG001|Part 2|Adverse Event|0|||
164253735|NCT02443116|593294272|FG002|Part 2|Adverse Event|0|||
164253736|NCT02443116|593294273|FG003|Part 2|Adverse Event|0|||
164253737|NCT02443116|593294274|FG004|Part 2|Adverse Event|1|||
164253738|NCT02443116|593294275|FG005|Part 2|Adverse Event|1|||
164253739|NCT02443116|593294276|FG006|Part 2|Adverse Event|2|||
164253740|NCT02443116|593294277|FG007|Part 2|Adverse Event|0|||
164253741|NCT02443116|593294278|FG008|Part 2|Adverse Event|0|||
164253742|NCT02443116|593294270|FG000|Part 2|Withdrew informed consent|0|||
164253743|NCT02443116|593294271|FG001|Part 2|Withdrew informed consent|0|||
164253744|NCT02443116|593294272|FG002|Part 2|Withdrew informed consent|0|||
164253745|NCT02443116|593294273|FG003|Part 2|Withdrew informed consent|0|||
164253746|NCT02443116|593294274|FG004|Part 2|Withdrew informed consent|0|||
164253747|NCT02443116|593294275|FG005|Part 2|Withdrew informed consent|1|||
164253748|NCT02443116|593294276|FG006|Part 2|Withdrew informed consent|1|||
164253749|NCT02443116|593294277|FG007|Part 2|Withdrew informed consent|0|||
164253750|NCT02443116|593294278|FG008|Part 2|Withdrew informed consent|0|||
164253751|NCT02443116|593294270|FG000|Part 2|Inability to comply with protocol|0|||
164253752|NCT02443116|593294271|FG001|Part 2|Inability to comply with protocol|0|||
164253753|NCT02443116|593294272|FG002|Part 2|Inability to comply with protocol|0|||
164253754|NCT02443116|593294273|FG003|Part 2|Inability to comply with protocol|1|||
164253755|NCT02443116|593294274|FG004|Part 2|Inability to comply with protocol|0|||
164253756|NCT02443116|593294275|FG005|Part 2|Inability to comply with protocol|0|||
164253757|NCT02443116|593294276|FG006|Part 2|Inability to comply with protocol|0|||
164253758|NCT02443116|593294277|FG007|Part 2|Inability to comply with protocol|0|||
164253759|NCT02443116|593294278|FG008|Part 2|Inability to comply with protocol|0|||
164253760|NCT02443116|593294270|FG000|Part 2|Lost to Follow-up|0|||
164253761|NCT02443116|593294271|FG001|Part 2|Lost to Follow-up|0|||
164253762|NCT02443116|593294272|FG002|Part 2|Lost to Follow-up|0|||
164253763|NCT02443116|593294273|FG003|Part 2|Lost to Follow-up|1|||
164253764|NCT02443116|593294274|FG004|Part 2|Lost to Follow-up|0|||
164253765|NCT02443116|593294275|FG005|Part 2|Lost to Follow-up|0|||
164253766|NCT02443116|593294276|FG006|Part 2|Lost to Follow-up|0|||
164253767|NCT02443116|593294277|FG007|Part 2|Lost to Follow-up|0|||
164253768|NCT02443116|593294278|FG008|Part 2|Lost to Follow-up|0|||
164253769|NCT02443116|593294270|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
164253770|NCT02443116|593294271|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
164253771|NCT02443116|593294272|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
164253772|NCT02443116|593294273|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
164253773|NCT02443116|593294274|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
164253774|NCT02443116|593294275|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
164253775|NCT02443116|593294276|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
164253776|NCT02443116|593294277|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
164253777|NCT02443116|593294278|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
164253778|NCT02443116|593294270|FG000|Part 3|Adverse Event|0|||
164253779|NCT02443116|593294271|FG001|Part 3|Adverse Event|0|||
164253780|NCT02443116|593294272|FG002|Part 3|Adverse Event|0|||
164253781|NCT02443116|593294273|FG003|Part 3|Adverse Event|0|||
164253782|NCT02443116|593294274|FG004|Part 3|Adverse Event|0|||
164253783|NCT02443116|593294275|FG005|Part 3|Adverse Event|0|||
164253784|NCT02443116|593294276|FG006|Part 3|Adverse Event|0|||
164253785|NCT02443116|593294277|FG007|Part 3|Adverse Event|0|||
164253786|NCT02443116|593294278|FG008|Part 3|Adverse Event|1|||
164253787|NCT02443116|593294270|FG000|Part 3|Withdrew informed consent|0|||
164253788|NCT02443116|593294271|FG001|Part 3|Withdrew informed consent|0|||
164253789|NCT02443116|593294272|FG002|Part 3|Withdrew informed consent|0|||
164253790|NCT02443116|593294273|FG003|Part 3|Withdrew informed consent|0|||
164253791|NCT02443116|593294274|FG004|Part 3|Withdrew informed consent|0|||
164253792|NCT02443116|593294275|FG005|Part 3|Withdrew informed consent|0|||
164253793|NCT02443116|593294276|FG006|Part 3|Withdrew informed consent|0|||
164253794|NCT02443116|593294277|FG007|Part 3|Withdrew informed consent|3|||
164253795|NCT02443116|593294278|FG008|Part 3|Withdrew informed consent|2|||
164253796|NCT02443116|593294270|FG000|Part 3|Lost to Follow-up|0|||
164253797|NCT02443116|593294271|FG001|Part 3|Lost to Follow-up|0|||
164253798|NCT02443116|593294272|FG002|Part 3|Lost to Follow-up|0|||
164253799|NCT02443116|593294273|FG003|Part 3|Lost to Follow-up|0|||
164253800|NCT02443116|593294274|FG004|Part 3|Lost to Follow-up|0|||
164253801|NCT02443116|593294275|FG005|Part 3|Lost to Follow-up|0|||
164253802|NCT02443116|593294276|FG006|Part 3|Lost to Follow-up|0|||
164253803|NCT02443116|593294277|FG007|Part 3|Lost to Follow-up|1|||
164253804|NCT02443116|593294278|FG008|Part 3|Lost to Follow-up|2|||
164253805|NCT01932372|593294279|FG000|Overall Study|Not meeting eligibility criteria|33|||
164253806|NCT01932372|593294280|FG001|Overall Study|Not meeting eligibility criteria|179|||
164253807|NCT03594747|593294285|FG000|Overall Study|Death|78|||
164253808|NCT03594747|593294286|FG001|Overall Study|Death|86|||
164253809|NCT03594747|593294287|FG002|Overall Study|Death|87|||
164253810|NCT03594747|593294285|FG000|Overall Study|Withdrawal by Subject|5|||
164253811|NCT03594747|593294286|FG001|Overall Study|Withdrawal by Subject|2|||
164253812|NCT03594747|593294287|FG002|Overall Study|Withdrawal by Subject|11|||
164253813|NCT03594747|593294285|FG000|Overall Study|Lost to Follow-up|4|||
164253814|NCT03594747|593294286|FG001|Overall Study|Lost to Follow-up|1|||
164253815|NCT03594747|593294287|FG002|Overall Study|Lost to Follow-up|1|||
164253816|NCT03594747|593294285|FG000|Overall Study|Physician Decision|0|||
164253817|NCT03594747|593294286|FG001|Overall Study|Physician Decision|1|||
164253818|NCT03594747|593294287|FG002|Overall Study|Physician Decision|0|||
164253819|NCT03594747|593294285|FG000|Overall Study|Sponsor decision|23|||
164253820|NCT03594747|593294286|FG001|Overall Study|Sponsor decision|17|||
164253821|NCT03594747|593294287|FG002|Overall Study|Sponsor decision|16|||
164253822|NCT03594747|593294285|FG000|Overall Study|Did not meet inclusion criteria|0|||
164253823|NCT03594747|593294286|FG001|Overall Study|Did not meet inclusion criteria|0|||
164253824|NCT03594747|593294287|FG002|Overall Study|Did not meet inclusion criteria|1|||
164253825|NCT03594747|593294285|FG000|Overall Study|Transfer to long term extension study|10|||
164253826|NCT03594747|593294286|FG001|Overall Study|Transfer to long term extension study|12|||
164253827|NCT03594747|593294287|FG002|Overall Study|Transfer to long term extension study|5|||
164253828|NCT04382586|593294288|FG000|Overall Study|Death|3|||
164253829|NCT04382586|593294289|FG001|Overall Study|Death|4|||
164253830|NCT04382586|593294288|FG000|Overall Study|Lost to Follow-up|11|||
164253831|NCT04382586|593294289|FG001|Overall Study|Lost to Follow-up|8|||
164253832|NCT04382586|593294288|FG000|Overall Study|Withdrawal by Subject|3|||
164253833|NCT04382586|593294289|FG001|Overall Study|Withdrawal by Subject|1|||
164253834|NCT04382586|593294288|FG000|Overall Study|Physician Decision|0|||
164253835|NCT04382586|593294289|FG001|Overall Study|Physician Decision|3|||
164253836|NCT02265536|593294297|FG000|Overall Study|Adverse Event|1|||
164427400|NCT01700530|593932881|FG000|Overall Study|Withdrawal by Subject|0|||
164427401|NCT01700530|593932882|FG001|Overall Study|Withdrawal by Subject|3|||
164576172|NCT01024244|594473090|FG000|Overall Study|Adverse Event|1|||
164253837|NCT02265536|593294298|FG001|Overall Study|Adverse Event|0|||
164253838|NCT02265536|593294299|FG002|Overall Study|Adverse Event|0|||
164253839|NCT02265536|593294300|FG003|Overall Study|Adverse Event|0|||
164253840|NCT02265536|593294301|FG004|Overall Study|Adverse Event|1|||
164253841|NCT02265536|593294302|FG005|Overall Study|Adverse Event|0|||
164427402|NCT01700530|593932883|FG002|Overall Study|Withdrawal by Subject|1|||
164576173|NCT01024244|594473091|FG001|Overall Study|Adverse Event|2|||
164253842|NCT02265536|593294297|FG000|Overall Study|Physician Decision|0|||
164576174|NCT01024244|594473092|FG002|Overall Study|Adverse Event|0|||
164253843|NCT02265536|593294298|FG001|Overall Study|Physician Decision|0|||
164253844|NCT02265536|593294299|FG002|Overall Study|Physician Decision|0|||
164253845|NCT02265536|593294300|FG003|Overall Study|Physician Decision|0|||
164253846|NCT02265536|593294301|FG004|Overall Study|Physician Decision|2|||
164576175|NCT01024244|594473093|FG003|Overall Study|Adverse Event|1|||
164576176|NCT01024244|594473094|FG004|Overall Study|Adverse Event|2|||
164253847|NCT02265536|593294302|FG005|Overall Study|Physician Decision|0|||
164253848|NCT02265536|593294297|FG000|Overall Study|Withdrawal by Subject|0|||
164253849|NCT02265536|593294298|FG001|Overall Study|Withdrawal by Subject|3|||
164253850|NCT02265536|593294299|FG002|Overall Study|Withdrawal by Subject|0|||
164253851|NCT02265536|593294300|FG003|Overall Study|Withdrawal by Subject|0|||
164253852|NCT02265536|593294301|FG004|Overall Study|Withdrawal by Subject|0|||
164253853|NCT02265536|593294302|FG005|Overall Study|Withdrawal by Subject|0|||
164253854|NCT00349349|593294305|FG000|Overall Study|Adverse Event|5|||
164253855|NCT00349349|593294306|FG001|Overall Study|Adverse Event|6|||
164253856|NCT00349349|593294307|FG002|Overall Study|Adverse Event|2|||
164253857|NCT00349349|593294305|FG000|Overall Study|Withdrawal by Subject|5|||
164253858|NCT00349349|593294306|FG001|Overall Study|Withdrawal by Subject|2|||
164253859|NCT00349349|593294307|FG002|Overall Study|Withdrawal by Subject|1|||
164253860|NCT00349349|593294305|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
164253861|NCT00349349|593294306|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
164253862|NCT00349349|593294307|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
164253863|NCT00349349|593294305|FG000|Overall Study|Death|13|||
164253864|NCT00349349|593294306|FG001|Overall Study|Death|10|||
164253865|NCT00349349|593294307|FG002|Overall Study|Death|1|||
164253866|NCT00349349|593294305|FG000|Overall Study|Other Treatment Selected|2|||
164253867|NCT00349349|593294306|FG001|Overall Study|Other Treatment Selected|0|||
164253868|NCT00349349|593294307|FG002|Overall Study|Other Treatment Selected|0|||
164253869|NCT00349349|593294305|FG000|Overall Study|Participant Reduced General Condition|0|||
164253870|NCT00349349|593294306|FG001|Overall Study|Participant Reduced General Condition|1|||
164253871|NCT00349349|593294307|FG002|Overall Study|Participant Reduced General Condition|0|||
164253872|NCT00349349|593294305|FG000|Overall Study|Physician Decision|1|||
164253873|NCT00349349|593294306|FG001|Overall Study|Physician Decision|2|||
164253874|NCT00349349|593294307|FG002|Overall Study|Physician Decision|1|||
164253875|NCT00349349|593294305|FG000|Overall Study|No Response|0|||
164253876|NCT00349349|593294306|FG001|Overall Study|No Response|3|||
164253877|NCT00349349|593294307|FG002|Overall Study|No Response|0|||
164253878|NCT00349349|593294305|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
164253879|NCT00349349|593294306|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
164253880|NCT00349349|593294307|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
164253881|NCT02907216|593294308|FG000|Overall Study|No benefit to be obtained by continuing|0|||
164253882|NCT02907216|593294309|FG001|Overall Study|No benefit to be obtained by continuing|1|||
164576177|NCT01024244|594473090|FG000|Overall Study|Entry Criteria Not Met|0|||
164253883|NCT02907216|593294308|FG000|Overall Study|Withdrawal by Subject|1|||
164253884|NCT02907216|593294309|FG001|Overall Study|Withdrawal by Subject|0|||
164253885|NCT02485639|593294314|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
164253886|NCT02485639|593294314|FG000|Overall Study|Early termination|4|||
164253887|NCT02485639|593294314|FG000|Overall Study|Withdrawal by Subject|4|||
164253888|NCT02597452|593294315|FG000|Overall Study|testing incomplete|30|||
164253889|NCT01673854|593294317|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
164253890|NCT01673854|593294317|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
164253891|NCT01673854|593294317|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
164253892|NCT01673854|593294317|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
164253893|NCT01673854|593294317|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
164253894|NCT01673854|593294317|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
164253895|NCT01673854|593294317|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
164253896|NCT01673854|593294317|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
164576178|NCT01024244|594473091|FG001|Overall Study|Entry Criteria Not Met|1|||
164253897|NCT01673854|593294317|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
164253898|NCT01673854|593294317|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
164576179|NCT01024244|594473092|FG002|Overall Study|Entry Criteria Not Met|0|||
164576180|NCT01024244|594473093|FG003|Overall Study|Entry Criteria Not Met|0|||
164576181|NCT01024244|594473094|FG004|Overall Study|Entry Criteria Not Met|0|||
164576182|NCT01024244|594473090|FG000|Overall Study|Lack of Efficacy|1|||
164253899|NCT01673854|593294317|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
164253900|NCT01673854|593294317|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
164253901|NCT00334737|593294318|FG000|Hospital Phase|Death|1|||
164253902|NCT00334737|593294319|FG001|Hospital Phase|Death|2|||
164253903|NCT00334737|593294320|FG002|Hospital Phase|Death|3|||
164339014|NCT01540838|593617118|FG001|Overall Study|Open nasogastric tube|7|||
164576183|NCT01024244|594473091|FG001|Overall Study|Lack of Efficacy|0|||
164253904|NCT00334737|593294318|FG000|Hospital Phase|Withdrawal by Subject|0|||
164253905|NCT00334737|593294319|FG001|Hospital Phase|Withdrawal by Subject|0|||
164253906|NCT00334737|593294320|FG002|Hospital Phase|Withdrawal by Subject|1|||
164253907|NCT00334737|593294318|FG000|Hospital Phase|Did not receive study drug|1|||
164253908|NCT00334737|593294319|FG001|Hospital Phase|Did not receive study drug|0|||
164253909|NCT00334737|593294320|FG002|Hospital Phase|Did not receive study drug|0|||
164253910|NCT00334737|593294318|FG000|Follow up Phase|Lost to Follow-up|5|||
164253911|NCT00334737|593294319|FG001|Follow up Phase|Lost to Follow-up|3|||
164253912|NCT00334737|593294320|FG002|Follow up Phase|Lost to Follow-up|6|||
164253913|NCT02640625|593296016|FG000|Overall Study|Adverse Event|1|||
164253914|NCT01579565|593296017|FG000|Randomized|Adverse Event|1|||
164253915|NCT01579565|593296018|FG001|Randomized|Adverse Event|3|||
164253916|NCT01579565|593296017|FG000|Randomized|Withdrawal by Subject|3|||
164253917|NCT01579565|593296018|FG001|Randomized|Withdrawal by Subject|0|||
164253918|NCT01579565|593296017|FG000|Randomized|inadequate preoperative pupil dilation|0|||
164253919|NCT01579565|593296018|FG001|Randomized|inadequate preoperative pupil dilation|1|||
164253920|NCT01579565|593296017|FG000|Randomized|prohibited preoperative eating|1|||
164253921|NCT01579565|593296018|FG001|Randomized|prohibited preoperative eating|0|||
164253922|NCT01579565|593296017|FG000|Randomized|prohibited preoperative medication|0|||
164253923|NCT01579565|593296018|FG001|Randomized|prohibited preoperative medication|1|||
164253924|NCT01579565|593296017|FG000|Treated|Physician Decision|0|||
164253925|NCT01579565|593296018|FG001|Treated|Physician Decision|1|||
164253926|NCT01579565|593296017|FG000|Treated|Lost to Follow-up|2|||
164253927|NCT01579565|593296018|FG001|Treated|Lost to Follow-up|1|||
164253928|NCT01579565|593296017|FG000|Treated|declined to return for final visit|0|||
164253929|NCT01579565|593296018|FG001|Treated|declined to return for final visit|1|||
164253930|NCT02013206|593296019|FG000|Overall Study|Progressive disease (PD)|14|||
164253931|NCT02013206|593296020|FG001|Overall Study|Progressive disease (PD)|17|||
164253932|NCT02013206|593296019|FG000|Overall Study|Symptomatic deterioration|3|||
164253933|NCT02013206|593296020|FG001|Overall Study|Symptomatic deterioration|1|||
164253934|NCT02013206|593296019|FG000|Overall Study|Adverse Event|1|||
164253935|NCT02013206|593296020|FG001|Overall Study|Adverse Event|0|||
164253936|NCT02013206|593296019|FG000|Overall Study|Patient refusal|2|||
164253937|NCT02013206|593296020|FG001|Overall Study|Patient refusal|0|||
164253938|NCT02013206|593296019|FG000|Overall Study|Patient non-compliance|1|||
164253939|NCT02013206|593296020|FG001|Overall Study|Patient non-compliance|0|||
164253940|NCT02013206|593296019|FG000|Overall Study|Death|1|||
164253941|NCT02013206|593296020|FG001|Overall Study|Death|2|||
164253942|NCT02013206|593296019|FG000|Overall Study|Other reasons off treatment|5|||
164253943|NCT02013206|593296020|FG001|Overall Study|Other reasons off treatment|2|||
164253944|NCT05425732|593296023|FG000|Overall Study|Death|4|||
164253945|NCT05425732|593296024|FG001|Overall Study|Death|2|||
164253946|NCT05425732|593296025|FG002|Overall Study|Death|0|||
164253947|NCT05425732|593296026|FG003|Overall Study|Death|0|||
164253948|NCT05425732|593296023|FG000|Overall Study|Lost to Follow-up|10|||
164253949|NCT05425732|593296024|FG001|Overall Study|Lost to Follow-up|15|||
164253950|NCT05425732|593296025|FG002|Overall Study|Lost to Follow-up|5|||
164253951|NCT05425732|593296026|FG003|Overall Study|Lost to Follow-up|3|||
164253952|NCT05425732|593296023|FG000|Overall Study|Physician Decision|0|||
164253953|NCT05425732|593296024|FG001|Overall Study|Physician Decision|2|||
164253954|NCT05425732|593296025|FG002|Overall Study|Physician Decision|0|||
164253955|NCT05425732|593296026|FG003|Overall Study|Physician Decision|0|||
164253956|NCT05425732|593296023|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
164253957|NCT05425732|593296024|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
164253958|NCT05425732|593296025|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164253959|NCT05425732|593296026|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164253960|NCT05425732|593296023|FG000|Overall Study|Withdrawal by Subject|4|||
164253961|NCT05425732|593296024|FG001|Overall Study|Withdrawal by Subject|8|||
164253962|NCT05425732|593296025|FG002|Overall Study|Withdrawal by Subject|1|||
164253963|NCT05425732|593296026|FG003|Overall Study|Withdrawal by Subject|1|||
164253964|NCT05425732|593296023|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
164253965|NCT05425732|593296024|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
164253966|NCT05425732|593296025|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
164253967|NCT05425732|593296026|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
164253968|NCT02582814|593296027|FG000|Overall Study|Study-specific withdrawal criteria|1|||
164253969|NCT02582814|593296028|FG001|Overall Study|Study-specific withdrawal criteria|0|||
164253970|NCT02582814|593296027|FG000|Overall Study|Withdrawal by Subject|4|||
164253971|NCT02582814|593296028|FG001|Overall Study|Withdrawal by Subject|3|||
164253972|NCT02582814|593296027|FG000|Overall Study|Adverse Event|4|||
164253973|NCT02582814|593296028|FG001|Overall Study|Adverse Event|4|||
164253974|NCT01558115|593296032|FG000|Overall Study|Withdrawal by Subject|3|||
164253975|NCT01558115|593296032|FG000|Overall Study|Study closed due to poor enrollment|4|||
164253976|NCT01696994|593296033|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
164253977|NCT01696994|593296034|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
164253978|NCT01696994|593296033|FG000|Overall Study|Died Before Randomization|1|||
164253979|NCT01696994|593296034|FG001|Overall Study|Died Before Randomization|2|||
164253980|NCT01696994|593296033|FG000|Overall Study|Died Before ASU (Control)|73|||
164253981|NCT01696994|593296034|FG001|Overall Study|Died Before ASU (Control)|0|||
164253982|NCT01696994|593296033|FG000|Overall Study|No Ovaries at Baseline|4807|||
164253983|NCT01696994|593296034|FG001|Overall Study|No Ovaries at Baseline|4851|||
164253984|NCT01696994|593296033|FG000|Overall Study|Refused ASU (Control)|311|||
164253985|NCT01696994|593296034|FG001|Overall Study|Refused ASU (Control)|0|||
164253986|NCT01696994|593296033|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
164253987|NCT01696994|593296034|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
164253988|NCT04644276|593296035|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
164253989|NCT04644276|593296036|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
164253990|NCT04644276|593296037|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
164253991|NCT00705250|593296038|FG000|Overall Study|Withdrawal by Subject|1|||
164253992|NCT00705250|593296038|FG000|Overall Study|Patient died in car accident|1|||
164253993|NCT01667224|593296040|FG000|Overall Study|Withdrawal by Subject|3|||
164253994|NCT01667224|593296041|FG001|Overall Study|Withdrawal by Subject|1|||
164253995|NCT01667224|593296040|FG000|Overall Study|Protocol Violation|1|||
164253996|NCT01667224|593296041|FG001|Overall Study|Protocol Violation|1|||
164576184|NCT01024244|594473092|FG002|Overall Study|Lack of Efficacy|0|||
164576185|NCT01024244|594473093|FG003|Overall Study|Lack of Efficacy|0|||
164576186|NCT01024244|594473094|FG004|Overall Study|Lack of Efficacy|0|||
164576187|NCT01024244|594473090|FG000|Overall Study|Protocol Violation|1|||
164576188|NCT01024244|594473091|FG001|Overall Study|Protocol Violation|0|||
164576189|NCT01024244|594473092|FG002|Overall Study|Protocol Violation|0|||
164576190|NCT01024244|594473093|FG003|Overall Study|Protocol Violation|0|||
164576191|NCT01024244|594473094|FG004|Overall Study|Protocol Violation|2|||
164576192|NCT01024244|594473090|FG000|Overall Study|Sponsor Decision|14|||
164576193|NCT01024244|594473091|FG001|Overall Study|Sponsor Decision|7|||
164576194|NCT01024244|594473092|FG002|Overall Study|Sponsor Decision|14|||
164576195|NCT01024244|594473093|FG003|Overall Study|Sponsor Decision|12|||
164576196|NCT01024244|594473094|FG004|Overall Study|Sponsor Decision|10|||
164576197|NCT01024244|594473090|FG000|Overall Study|Withdrawal by Subject|0|||
164576198|NCT01024244|594473091|FG001|Overall Study|Withdrawal by Subject|1|||
164576199|NCT01024244|594473092|FG002|Overall Study|Withdrawal by Subject|0|||
164576200|NCT01024244|594473093|FG003|Overall Study|Withdrawal by Subject|0|||
164576201|NCT01024244|594473094|FG004|Overall Study|Withdrawal by Subject|0|||
164576202|NCT02945657|594473095|FG000|Overall Study|Adverse Event|1|||
164576203|NCT02945657|594473095|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
164576204|NCT01535235|594473097|FG000|Overall Study|Adverse Event|1|||
164576205|NCT01535235|594473098|FG001|Overall Study|Adverse Event|0|||
164576206|NCT00858832|594473099|FG000|Overall Study|became ineligible: delivered vaginally|1|||
164576207|NCT00858832|594473100|FG001|Overall Study|became ineligible: delivered vaginally|0|||
164576208|NCT00858832|594473099|FG000|Overall Study|Adverse Event|0|||
164576209|NCT00858832|594473100|FG001|Overall Study|Adverse Event|1|||
164576210|NCT03075839|594473104|FG000|Overall Study|Lost to Follow-up|4|||
164576211|NCT05421754|594473108|FG000|Overall Study|Technical issue with sensor|1|||
164576212|NCT04433117|594473109|FG000|Overall Study|Withdrawal by Subject|1|||
164576213|NCT04433117|594473110|FG001|Overall Study|Withdrawal by Subject|0|||
164576214|NCT01051739|594473111|FG000|Overall Study|Death|3|||
164576215|NCT01051739|594473112|FG001|Overall Study|Death|3|||
164576216|NCT01051739|594473111|FG000|Overall Study|Withdrawal by Subject|25|||
164576217|NCT01051739|594473112|FG001|Overall Study|Withdrawal by Subject|10|||
164576218|NCT00824421|594473113|FG000|Overall Study|Adverse Event|6|||
164680495|NCT00112437|594854581|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164576219|NCT00824421|594473114|FG001|Overall Study|Adverse Event|6|||
164576220|NCT00824421|594473115|FG002|Overall Study|Adverse Event|6|||
164576221|NCT00824421|594473113|FG000|Overall Study|Death|0|||
164576222|NCT00824421|594473114|FG001|Overall Study|Death|1|||
164576223|NCT00824421|594473115|FG002|Overall Study|Death|0|||
164576224|NCT00824421|594473113|FG000|Overall Study|Lack of Efficacy|5|||
164576225|NCT00824421|594473114|FG001|Overall Study|Lack of Efficacy|7|||
164576226|NCT00824421|594473115|FG002|Overall Study|Lack of Efficacy|4|||
164576227|NCT00824421|594473113|FG000|Overall Study|Lost to Follow-up|2|||
164576228|NCT00824421|594473114|FG001|Overall Study|Lost to Follow-up|3|||
164576229|NCT00824421|594473115|FG002|Overall Study|Lost to Follow-up|0|||
164576230|NCT00824421|594473113|FG000|Overall Study|Pregnancy|1|||
164576231|NCT00824421|594473114|FG001|Overall Study|Pregnancy|0|||
164576232|NCT00824421|594473115|FG002|Overall Study|Pregnancy|1|||
164576233|NCT00824421|594473113|FG000|Overall Study|Withdrawal by Subject|2|||
164576234|NCT00824421|594473114|FG001|Overall Study|Withdrawal by Subject|3|||
164576235|NCT00824421|594473115|FG002|Overall Study|Withdrawal by Subject|3|||
164576236|NCT00824421|594473113|FG000|Overall Study|Randomized but not Treated|1|||
164680496|NCT00112437|594854582|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164253997|NCT03350035|593296042|FG000|Overall Study|Lack of Efficacy|2|||
164253998|NCT03350035|593296043|FG001|Overall Study|Lack of Efficacy|0|||
164253999|NCT03350035|593296044|FG002|Overall Study|Lack of Efficacy|0|||
164254000|NCT03350035|593296042|FG000|Overall Study|Subject discharged to hospice|0|||
164254001|NCT03350035|593296043|FG001|Overall Study|Subject discharged to hospice|0|||
164254002|NCT03350035|593296044|FG002|Overall Study|Subject discharged to hospice|1|||
164254003|NCT00316225|593296045|FG000|Overall Study|Adverse Event|2|||
164254004|NCT00316225|593296045|FG000|Overall Study|Physician Decision|3|||
164254005|NCT00316225|593296045|FG000|Overall Study|Progressive Disease|15|||
164254006|NCT00316225|593296045|FG000|Overall Study|Withdrawal by Subject|3|||
164427403|NCT00578227|593932884|FG000|Overall Study|Lost to Follow-up|0|||
164427404|NCT00578227|593932885|FG001|Overall Study|Lost to Follow-up|1|||
164427405|NCT00578227|593932886|FG002|Overall Study|Lost to Follow-up|1|||
164427406|NCT00578227|593932884|FG000|Overall Study|Withdrawal by Subject|5|||
164427407|NCT00578227|593932885|FG001|Overall Study|Withdrawal by Subject|1|||
164427408|NCT00578227|593932886|FG002|Overall Study|Withdrawal by Subject|3|||
164427409|NCT02820051|593932891|FG000|Overall Study|Lost to Follow-up|7|||
164576237|NCT00824421|594473114|FG001|Overall Study|Randomized but not Treated|1|||
164576238|NCT00824421|594473115|FG002|Overall Study|Randomized but not Treated|0|||
164576239|NCT00824421|594473113|FG000|Overall Study|Other|0|||
164576240|NCT00824421|594473114|FG001|Overall Study|Other|1|||
164576241|NCT00824421|594473115|FG002|Overall Study|Other|0|||
164254007|NCT00316225|593296045|FG000|Overall Study|Death|2|||
164254008|NCT01811485|593296046|FG000|Overall Study|Adverse Event|1|||
164254009|NCT01811485|593296047|FG001|Overall Study|Adverse Event|3|||
164254010|NCT01811485|593296048|FG002|Overall Study|Adverse Event|2|||
164254011|NCT01811485|593296046|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164254012|NCT01811485|593296047|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164254013|NCT01811485|593296048|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
164254014|NCT01811485|593296046|FG000|Overall Study|Administrative problems|1|||
164254015|NCT01811485|593296047|FG001|Overall Study|Administrative problems|0|||
164254016|NCT01811485|593296048|FG002|Overall Study|Administrative problems|0|||
164254017|NCT01811485|593296046|FG000|Overall Study|Protocol Deviation|0|||
164254018|NCT01811485|593296047|FG001|Overall Study|Protocol Deviation|1|||
164254019|NCT01811485|593296048|FG002|Overall Study|Protocol Deviation|0|||
164254020|NCT00425698|593296049|FG000|Overall Study|Adverse Event|3|||
164254021|NCT00425698|593296050|FG001|Overall Study|Adverse Event|1|||
164254022|NCT00425698|593296049|FG000|Overall Study|Withdrawal by Subject|0|||
164254023|NCT00425698|593296050|FG001|Overall Study|Withdrawal by Subject|1|||
164254024|NCT03831191|593296056|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
164254025|NCT03831191|593296057|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
164254026|NCT03831191|593296058|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
164254027|NCT03831191|593296059|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
164254028|NCT03831191|593296060|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
164254029|NCT03831191|593296061|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
164254030|NCT03831191|593296062|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
164254031|NCT03831191|593296063|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
164254032|NCT03831191|593296064|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
164254033|NCT03831191|593296065|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
164254034|NCT03831191|593296066|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
164254035|NCT03831191|593296067|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
164254036|NCT03831191|593296068|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
164254037|NCT03831191|593296069|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
164254038|NCT03831191|593296070|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
164254039|NCT03831191|593296056|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
164254040|NCT03831191|593296057|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
164254041|NCT03831191|593296058|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164254042|NCT03831191|593296059|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164254043|NCT03831191|593296060|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164254044|NCT03831191|593296061|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164254045|NCT03831191|593296062|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164254046|NCT03831191|593296063|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164254047|NCT03831191|593296064|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164254048|NCT03831191|593296065|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164254049|NCT03831191|593296066|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164576242|NCT03527043|594473117|FG000|Overall Study|Withdrawal by Subject|1|||
164254050|NCT03831191|593296067|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164254051|NCT03831191|593296068|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164254052|NCT03831191|593296069|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164254053|NCT03831191|593296070|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164254054|NCT03831191|593296056|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
164254055|NCT03831191|593296057|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
164427410|NCT02820051|593932892|FG001|Overall Study|Lost to Follow-up|4|||
164427411|NCT00114959|593932895|FG000|Overall Study|Lack of Efficacy|6|||
164576243|NCT03527043|594473118|FG001|Overall Study|Withdrawal by Subject|0|||
164576244|NCT02500550|594473119|FG000|Overall Study|Death|7|||
164254056|NCT03831191|593296058|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
164254057|NCT03831191|593296059|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
164254058|NCT03831191|593296060|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
164254059|NCT03831191|593296061|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
164254060|NCT03831191|593296062|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
164254061|NCT03831191|593296063|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
164254062|NCT03831191|593296064|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
164254063|NCT03831191|593296065|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
164254064|NCT03831191|593296066|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
164254065|NCT03831191|593296067|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
164254066|NCT03831191|593296068|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
164254067|NCT03831191|593296069|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
164254068|NCT03831191|593296070|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
164254069|NCT03831191|593296056|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
164254070|NCT03831191|593296057|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
164254071|NCT03831191|593296058|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
164254072|NCT03831191|593296059|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
164254073|NCT03831191|593296060|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
164254074|NCT03831191|593296061|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
164254075|NCT03831191|593296062|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
164254076|NCT03831191|593296063|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
164254077|NCT03831191|593296064|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
164254078|NCT03831191|593296065|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
164254079|NCT03831191|593296066|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
164254080|NCT03831191|593296067|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
164254081|NCT03831191|593296068|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
164254082|NCT03831191|593296069|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
164254083|NCT03831191|593296070|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
164254084|NCT03831191|593296056|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
164254085|NCT03831191|593296057|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
164254086|NCT03831191|593296058|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
164254087|NCT03831191|593296059|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
164254088|NCT03831191|593296060|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164254089|NCT03831191|593296061|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164254090|NCT03831191|593296062|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164254091|NCT03831191|593296063|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164254092|NCT03831191|593296064|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164254093|NCT03831191|593296065|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164254094|NCT03831191|593296066|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164254095|NCT03831191|593296067|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164254096|NCT03831191|593296068|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164254097|NCT03831191|593296069|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164254098|NCT03831191|593296070|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164254099|NCT03831191|593296056|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
164254100|NCT03831191|593296057|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
164254101|NCT03831191|593296058|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
164254102|NCT03831191|593296059|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
164254103|NCT03831191|593296060|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
164254104|NCT03831191|593296061|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
164339015|NCT01540838|593617117|FG000|Overall Study|Treatment doses missing|8|||
164339016|NCT01540838|593617118|FG001|Overall Study|Treatment doses missing|12|||
164339017|NCT01540838|593617117|FG000|Overall Study|Additional antibiotic treatment|1|||
164339018|NCT01540838|593617118|FG001|Overall Study|Additional antibiotic treatment|2|||
164339019|NCT01540838|593617117|FG000|Overall Study|Died before treatment initiation|1|||
164339020|NCT01540838|593617118|FG001|Overall Study|Died before treatment initiation|1|||
164339021|NCT01540838|593617117|FG000|Overall Study|Not BM. Other treatment|3|||
164339022|NCT01540838|593617118|FG001|Overall Study|Not BM. Other treatment|1|||
164339023|NCT02130570|593617119|FG000|Overall Study|Death|3|||
164339024|NCT02130570|593617120|FG001|Overall Study|Death|5|||
164427412|NCT00114959|593932895|FG000|Overall Study|Physician Decision|1|||
164576245|NCT00201851|594473120|FG000|Overall Study|Lost to Follow-up|2|||
164576246|NCT00201851|594473121|FG001|Overall Study|Lost to Follow-up|1|||
164576247|NCT00201851|594473122|FG002|Overall Study|Lost to Follow-up|0|||
164254105|NCT03831191|593296062|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
164254106|NCT03831191|593296063|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
164254107|NCT03831191|593296064|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
164254108|NCT03831191|593296065|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
164339025|NCT02130570|593617119|FG000|Overall Study|Withdrawal by Subject|6|||
164339026|NCT02130570|593617120|FG001|Overall Study|Withdrawal by Subject|3|||
164576248|NCT00201851|594473120|FG000|Overall Study|Ineligible post enrollment|6|||
164254109|NCT03831191|593296066|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
164427413|NCT00114959|593932895|FG000|Overall Study|Death|1|||
164576249|NCT00201851|594473121|FG001|Overall Study|Ineligible post enrollment|1|||
164576250|NCT00201851|594473122|FG002|Overall Study|Ineligible post enrollment|1|||
164576251|NCT02469246|594473123|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
164576252|NCT02469246|594473124|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
164576253|NCT02469246|594473123|FG000|Double-Blind Phase|Adverse Event|12|||
164576254|NCT02469246|594473124|FG001|Double-Blind Phase|Adverse Event|9|||
164576255|NCT02469246|594473123|FG000|Double-Blind Phase|Death|2|||
164576256|NCT02469246|594473124|FG001|Double-Blind Phase|Death|0|||
164576257|NCT02469246|594473123|FG000|Double-Blind Phase|Lack of Efficacy|2|||
164576258|NCT02469246|594473124|FG001|Double-Blind Phase|Lack of Efficacy|1|||
164576259|NCT02469246|594473123|FG000|Double-Blind Phase|Investigator's Discretion|8|||
164576260|NCT02469246|594473124|FG001|Double-Blind Phase|Investigator's Discretion|8|||
164576261|NCT02469246|594473123|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
164576262|NCT02469246|594473124|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
164576263|NCT02469246|594473123|FG000|Double-Blind Phase|Protocol Violation|1|||
164576264|NCT02469246|594473124|FG001|Double-Blind Phase|Protocol Violation|1|||
164576265|NCT02469246|594473123|FG000|Double-Blind Phase|Withdrew Consent|25|||
164576266|NCT02469246|594473124|FG001|Double-Blind Phase|Withdrew Consent|25|||
164576267|NCT02469246|594473123|FG000|Double-Blind Phase|Lost to Follow-up|9|||
164576268|NCT02469246|594473124|FG001|Double-Blind Phase|Lost to Follow-up|5|||
164576269|NCT02201940|594473128|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
164576270|NCT02201940|594473129|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
164576271|NCT02201940|594473128|FG000|Overall Study|Lack of Efficacy|2|||
164576272|NCT02201940|594473129|FG001|Overall Study|Lack of Efficacy|113|||
164576273|NCT02201940|594473128|FG000|Overall Study|Lost to Follow-up|5|||
164576274|NCT02201940|594473129|FG001|Overall Study|Lost to Follow-up|0|||
164576275|NCT02201940|594473128|FG000|Overall Study|Withdrew Consent|2|||
164576276|NCT02201940|594473129|FG001|Overall Study|Withdrew Consent|1|||
164576277|NCT02201940|594473128|FG000|Overall Study|Investigator's Discretion|1|||
164576278|NCT02201940|594473129|FG001|Overall Study|Investigator's Discretion|1|||
164576279|NCT02201940|594473128|FG000|Overall Study|Death|1|||
164576280|NCT02201940|594473129|FG001|Overall Study|Death|0|||
164576281|NCT02201940|594473128|FG000|Overall Study|Adverse Event|0|||
164576282|NCT02201940|594473129|FG001|Overall Study|Adverse Event|1|||
164576283|NCT00636818|594473130|FG000|Overall Study|Adverse Event|1|||
164576284|NCT00636818|594473130|FG000|Overall Study|Lost to Follow-up|2|||
164576285|NCT00636818|594473130|FG000|Overall Study|Entry Criteria Exclusion|3|||
164576286|NCT00636818|594473130|FG000|Overall Study|Protocol Violation|1|||
164576287|NCT00636818|594473130|FG000|Overall Study|Withdrawal by Subject|4|||
164576288|NCT02604264|594473131|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
164576289|NCT02604264|594473132|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
164576290|NCT02700451|594473136|FG000|Overall Study|Protocol Violation|2|||
164576291|NCT02700451|594473137|FG001|Overall Study|Protocol Violation|2|||
164576292|NCT02700451|594473138|FG002|Overall Study|Protocol Violation|3|||
164576293|NCT02700451|594473136|FG000|Overall Study|Discontinued intervention|14|||
164576294|NCT02700451|594473137|FG001|Overall Study|Discontinued intervention|15|||
164576295|NCT02700451|594473138|FG002|Overall Study|Discontinued intervention|14|||
164576296|NCT02690701|594473139|FG000|Treatment Period 1|Adverse Event|2|||
164576297|NCT02690701|594473140|FG001|Treatment Period 1|Adverse Event|2|||
164576298|NCT02690701|594473139|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164576299|NCT02690701|594473140|FG001|Treatment Period 1|Withdrawal by Subject|1|||
164576300|NCT02690701|594473139|FG000|Treatment Period 2|Adverse Event|2|||
164576301|NCT02690701|594473140|FG001|Treatment Period 2|Adverse Event|0|||
164576302|NCT02690701|594473139|FG000|Treatment Period 2|Lack of Efficacy|1|||
164576303|NCT02690701|594473140|FG001|Treatment Period 2|Lack of Efficacy|0|||
164576304|NCT02690701|594473139|FG000|Treatment Period 2|Lost to Follow-up|0|||
164576305|NCT02690701|594473140|FG001|Treatment Period 2|Lost to Follow-up|2|||
164576306|NCT02690701|594473139|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164576307|NCT02690701|594473140|FG001|Treatment Period 2|Withdrawal by Subject|2|||
164576308|NCT02690701|594473139|FG000|Treatment Period 2|Protocol Violation|0|||
164576309|NCT02690701|594473140|FG001|Treatment Period 2|Protocol Violation|1|||
164576310|NCT01511445|594473142|FG000|Overall Study|Lost to Follow-up|3|||
164254110|NCT03831191|593296067|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
164254111|NCT03831191|593296068|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
164254112|NCT03831191|593296069|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
164254113|NCT03831191|593296070|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
164576311|NCT01511445|594473143|FG001|Overall Study|Lost to Follow-up|1|||
164576312|NCT01511445|594473142|FG000|Overall Study|Protocol Violation|1|||
164576313|NCT01511445|594473143|FG001|Overall Study|Protocol Violation|3|||
164576314|NCT01511445|594473142|FG000|Overall Study|Protocol Violation|1|||
164576315|NCT01511445|594473143|FG001|Overall Study|Protocol Violation|0|||
164576316|NCT02344576|594473147|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
164254114|NCT03831191|593296056|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
164576317|NCT02344576|594473148|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
164576318|NCT02344576|594473149|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
164576319|NCT02344576|594473150|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
164254115|NCT03831191|593296057|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254116|NCT03831191|593296058|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254117|NCT03831191|593296059|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
164254118|NCT03831191|593296060|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254119|NCT03831191|593296061|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254120|NCT03831191|593296062|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254121|NCT03831191|593296063|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254122|NCT03831191|593296064|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254123|NCT03831191|593296065|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254124|NCT03831191|593296066|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254125|NCT03831191|593296067|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254126|NCT03831191|593296068|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254127|NCT03831191|593296069|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254128|NCT03831191|593296070|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254129|NCT03831191|593296056|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
164254130|NCT03831191|593296057|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
164254131|NCT03831191|593296058|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
164254132|NCT03831191|593296059|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
164254133|NCT03831191|593296060|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
164254134|NCT03831191|593296061|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
164254135|NCT03831191|593296062|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
164254136|NCT03831191|593296063|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
164254137|NCT03831191|593296064|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
164254138|NCT03831191|593296065|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
164254139|NCT03831191|593296066|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
164254140|NCT03831191|593296067|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
164254141|NCT03831191|593296068|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
164254142|NCT03831191|593296069|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
164254143|NCT03831191|593296070|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
164254144|NCT03831191|593296056|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254145|NCT03831191|593296057|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254146|NCT03831191|593296058|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254147|NCT03831191|593296059|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254148|NCT03831191|593296060|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254149|NCT03831191|593296061|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254150|NCT03831191|593296062|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254151|NCT03831191|593296063|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254152|NCT03831191|593296064|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254153|NCT03831191|593296065|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254154|NCT03831191|593296066|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254155|NCT03831191|593296067|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254156|NCT03831191|593296068|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254157|NCT03831191|593296069|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254158|NCT03831191|593296070|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
164254159|NCT03831191|593296056|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254160|NCT03831191|593296057|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254161|NCT03831191|593296058|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254162|NCT03831191|593296059|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254163|NCT03831191|593296060|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254164|NCT03831191|593296061|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254165|NCT03831191|593296062|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254166|NCT03831191|593296063|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254167|NCT03831191|593296064|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254168|NCT03831191|593296065|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254169|NCT03831191|593296066|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254170|NCT03831191|593296067|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254171|NCT03831191|593296068|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254172|NCT03831191|593296069|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254173|NCT03831191|593296070|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
164254174|NCT01177553|593296071|FG000|Overall Study|babies not yet 6 months of age|1|||
164254175|NCT01177553|593296072|FG001|Overall Study|babies not yet 6 months of age|0|||
164254176|NCT01421303|593296074|FG000|Overall Study|Lost to Follow-up|13|||
164254177|NCT01421303|593296074|FG000|Overall Study|Non compliance with study procedure|1|||
164339027|NCT02130570|593617119|FG000|Overall Study|Part of practice that discontinued study|0|||
164339028|NCT02130570|593617120|FG001|Overall Study|Part of practice that discontinued study|5|||
164254178|NCT01421303|593296074|FG000|Overall Study|Other|7|||
164254179|NCT01421303|593296074|FG000|Overall Study|Withdrawal by Subject|1|||
164254180|NCT03640507|593296075|FG000|Overall Study|Withdrawal by Subject|0|||
164254181|NCT03640507|593296076|FG001|Overall Study|Withdrawal by Subject|0|||
164254182|NCT03640507|593296077|FG002|Overall Study|Withdrawal by Subject|1|||
164254183|NCT03525600|593296078|FG000|Overall Study|Adverse Event|9|||
164254184|NCT03525600|593296079|FG001|Overall Study|Adverse Event|6|||
164254185|NCT03525600|593296080|FG002|Overall Study|Adverse Event|5|||
164254186|NCT03525600|593296081|FG003|Overall Study|Adverse Event|3|||
164254187|NCT03525600|593296078|FG000|Overall Study|Lost to Follow-up|2|||
164254188|NCT03525600|593296079|FG001|Overall Study|Lost to Follow-up|4|||
164254189|NCT03525600|593296080|FG002|Overall Study|Lost to Follow-up|4|||
164254190|NCT03525600|593296081|FG003|Overall Study|Lost to Follow-up|0|||
164254191|NCT03525600|593296078|FG000|Overall Study|Physician Decision|1|||
164254192|NCT03525600|593296079|FG001|Overall Study|Physician Decision|0|||
164254193|NCT03525600|593296080|FG002|Overall Study|Physician Decision|2|||
164254194|NCT03525600|593296081|FG003|Overall Study|Physician Decision|0|||
164254195|NCT03525600|593296078|FG000|Overall Study|Consent withdrawal|36|||
164254196|NCT03525600|593296079|FG001|Overall Study|Consent withdrawal|20|||
164254197|NCT03525600|593296080|FG002|Overall Study|Consent withdrawal|6|||
164254198|NCT03525600|593296081|FG003|Overall Study|Consent withdrawal|13|||
164254199|NCT03525600|593296078|FG000|Overall Study|Death|7|||
164254200|NCT03525600|593296079|FG001|Overall Study|Death|6|||
164254201|NCT03525600|593296080|FG002|Overall Study|Death|4|||
164254202|NCT03525600|593296081|FG003|Overall Study|Death|3|||
164254203|NCT03525600|593296078|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
164254204|NCT03525600|593296079|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
164254205|NCT03525600|593296080|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
164254206|NCT03525600|593296081|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
164254207|NCT03525600|593296078|FG000|Overall Study|Other|0|||
164254208|NCT03525600|593296079|FG001|Overall Study|Other|1|||
164254209|NCT03525600|593296080|FG002|Overall Study|Other|0|||
164254210|NCT03525600|593296081|FG003|Overall Study|Other|0|||
164254211|NCT02676895|593296082|FG000|Overall Study|Administrative reason|1|||
164254212|NCT02676895|593296083|FG001|Overall Study|Administrative reason|0|||
164254213|NCT02676895|593296084|FG002|Overall Study|Administrative reason|0|||
164254214|NCT02676895|593296082|FG000|Overall Study|Protocol Violation|1|||
164254215|NCT02676895|593296083|FG001|Overall Study|Protocol Violation|0|||
164254216|NCT02676895|593296084|FG002|Overall Study|Protocol Violation|0|||
164254217|NCT02676895|593296082|FG000|Overall Study|Adverse Event|0|||
164254218|NCT02676895|593296083|FG001|Overall Study|Adverse Event|3|||
164254219|NCT02676895|593296084|FG002|Overall Study|Adverse Event|1|||
164254220|NCT02676895|593296082|FG000|Overall Study|Lost to Follow-up|0|||
164254221|NCT02676895|593296083|FG001|Overall Study|Lost to Follow-up|0|||
164254222|NCT02676895|593296084|FG002|Overall Study|Lost to Follow-up|1|||
164254223|NCT02676895|593296082|FG000|Overall Study|Withdrawal by Subject|0|||
164254224|NCT02676895|593296083|FG001|Overall Study|Withdrawal by Subject|0|||
164254225|NCT02676895|593296084|FG002|Overall Study|Withdrawal by Subject|1|||
164254226|NCT01270880|593296088|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
164427414|NCT03929302|593934741|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
164254227|NCT00613327|593296089|FG000|Overall Study|Adverse Event|38|||
164254228|NCT00613327|593296089|FG000|Overall Study|Lost to Follow-up|8|||
164254229|NCT00613327|593296089|FG000|Overall Study|Withdrawal by Subject|6|||
164254230|NCT00613327|593296089|FG000|Overall Study|Protocol Violation|2|||
164254231|NCT00613327|593296089|FG000|Overall Study|Other|47|||
164254232|NCT00344318|593296090|FG000|Overall Study|Adverse Event|0|||
164254233|NCT00344318|593296091|FG001|Overall Study|Adverse Event|3|||
164254234|NCT00344318|593296092|FG002|Overall Study|Adverse Event|0|||
164254235|NCT00344318|593296093|FG003|Overall Study|Adverse Event|1|||
164254236|NCT00344318|593296090|FG000|Overall Study|Withdrawal by Subject|2|||
164427415|NCT03929302|593934742|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
164427416|NCT03929302|593934743|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
164427417|NCT03929302|593934741|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
164427418|NCT03929302|593934742|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
164427419|NCT03929302|593934743|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
164427420|NCT03929302|593934741|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
164254237|NCT00344318|593296091|FG001|Overall Study|Withdrawal by Subject|2|||
164254238|NCT00344318|593296092|FG002|Overall Study|Withdrawal by Subject|0|||
164254239|NCT00344318|593296093|FG003|Overall Study|Withdrawal by Subject|2|||
164254240|NCT00344318|593296090|FG000|Overall Study|Lost to Follow-up|2|||
164254241|NCT00344318|593296091|FG001|Overall Study|Lost to Follow-up|0|||
164254242|NCT00344318|593296092|FG002|Overall Study|Lost to Follow-up|1|||
164254243|NCT00344318|593296093|FG003|Overall Study|Lost to Follow-up|0|||
164254244|NCT00395486|593296099|FG000|Overall Study|Adverse Event|1|||
164254245|NCT00395486|593296100|FG001|Overall Study|Adverse Event|2|||
164254246|NCT00395486|593296099|FG000|Overall Study|Withdrawal by Subject|5|||
164254247|NCT00395486|593296100|FG001|Overall Study|Withdrawal by Subject|2|||
164254248|NCT00395486|593296099|FG000|Overall Study|Lost to Follow-up|0|||
164254249|NCT00395486|593296100|FG001|Overall Study|Lost to Follow-up|1|||
164254250|NCT00290771|593296107|FG000|Overall Study|Disease progression|95|||
164254251|NCT00290771|593296108|FG001|Overall Study|Disease progression|73|||
164254252|NCT00290771|593296107|FG000|Overall Study|Death|11|||
164254253|NCT00290771|593296108|FG001|Overall Study|Death|10|||
164254254|NCT00290771|593296107|FG000|Overall Study|Adverse Event|12|||
164254255|NCT00290771|593296108|FG001|Overall Study|Adverse Event|6|||
164254256|NCT00290771|593296107|FG000|Overall Study|Withdrawal by Subject|5|||
164254257|NCT00290771|593296108|FG001|Overall Study|Withdrawal by Subject|6|||
164254258|NCT00290771|593296107|FG000|Overall Study|Administrative problems|2|||
164254259|NCT00290771|593296108|FG001|Overall Study|Administrative problems|1|||
164254260|NCT00290771|593296107|FG000|Overall Study|Protocol Violation|2|||
164254261|NCT00290771|593296108|FG001|Overall Study|Protocol Violation|0|||
164254262|NCT00290771|593296107|FG000|Overall Study|Lost to Follow-up|0|||
164254263|NCT00290771|593296108|FG001|Overall Study|Lost to Follow-up|1|||
164254264|NCT04154293|593296111|FG000|Overall Study|Withdrawal by Subject|2|||
164254265|NCT04154293|593296112|FG001|Overall Study|Withdrawal by Subject|3|||
164254266|NCT04154293|593296113|FG002|Overall Study|Withdrawal by Subject|1|||
164254267|NCT04154293|593296111|FG000|Overall Study|Physician Decision|0|||
164254268|NCT04154293|593296112|FG001|Overall Study|Physician Decision|0|||
164254269|NCT04154293|593296113|FG002|Overall Study|Physician Decision|1|||
164254270|NCT04731298|593296114|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
164254271|NCT04731298|593296115|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
164254272|NCT01208961|593296116|FG000|High-Fat Period III|Protocol Violation|1|||
164254273|NCT01208961|593296117|FG001|High-Fat Period III|Protocol Violation|0|||
164254274|NCT01262560|593296118|FG000|Overall Study|Protocol Violation|0|||
164254275|NCT01262560|593296119|FG001|Overall Study|Protocol Violation|1|||
164254276|NCT01262560|593296120|FG002|Overall Study|Protocol Violation|2|||
164254277|NCT00350870|593296125|FG000|Overall Study|Withdrawal by Subject|21|||
164254278|NCT00350870|593296126|FG001|Overall Study|Withdrawal by Subject|17|||
164254279|NCT00350870|593296127|FG002|Overall Study|Withdrawal by Subject|15|||
164254280|NCT00350870|593296128|FG003|Overall Study|Withdrawal by Subject|14|||
164254281|NCT00350870|593296125|FG000|Overall Study|Physician Decision|1|||
164254282|NCT00350870|593296126|FG001|Overall Study|Physician Decision|0|||
164254283|NCT00350870|593296127|FG002|Overall Study|Physician Decision|1|||
164254284|NCT00350870|593296128|FG003|Overall Study|Physician Decision|1|||
164254285|NCT02095873|593296133|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
164254286|NCT02095873|593296134|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
164254287|NCT02095873|593296133|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
164254288|NCT02095873|593296134|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
164254289|NCT02095873|593296133|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
164254290|NCT02095873|593296134|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
164254291|NCT00792740|593296138|FG000|Overall Study|Disease Worsening|3|||
164254292|NCT00792740|593296139|FG001|Overall Study|Disease Worsening|2|||
164254293|NCT00792740|593296138|FG000|Overall Study|Personal Reason|1|||
164254294|NCT00792740|593296139|FG001|Overall Study|Personal Reason|0|||
164254295|NCT00792740|593296138|FG000|Overall Study|Adverse Event|1|||
164254296|NCT00792740|593296139|FG001|Overall Study|Adverse Event|3|||
164254297|NCT00792740|593296138|FG000|Overall Study|Patient's withdrawal of consent|0|||
164254298|NCT00792740|593296139|FG001|Overall Study|Patient's withdrawal of consent|1|||
164254299|NCT00792740|593296138|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
164254300|NCT00792740|593296139|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
164254301|NCT00792740|593296138|FG000|Overall Study|Other reasons|0|||
164254302|NCT00792740|593296139|FG001|Overall Study|Other reasons|1|||
164254303|NCT02791516|593296140|FG000|Overall Study|Withdrawal by Subject|1|||
164254304|NCT02791516|593296141|FG001|Overall Study|Withdrawal by Subject|1|||
164254305|NCT02524275|593296142|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
164254306|NCT01439971|593296143|FG000|Overall Study|Required number in cohort dosed|0|||
164254307|NCT01439971|593296144|FG001|Overall Study|Required number in cohort dosed|1|||
164254308|NCT01439971|593296145|FG002|Overall Study|Required number in cohort dosed|2|||
164339029|NCT01065597|593617130|FG000|Overall Study|Adverse Event|1|||
164576320|NCT02344576|594473147|FG000|1-Month Follow-Up|Death|13|||
164254309|NCT01439971|593296146|FG003|Overall Study|Required number in cohort dosed|0|||
164254310|NCT01439971|593296147|FG004|Overall Study|Required number in cohort dosed|1|||
164254311|NCT02628600|593296148|FG000|Overall Study|Death|2|||
164254312|NCT02628600|593296149|FG001|Overall Study|Death|1|||
164254313|NCT02628600|593296148|FG000|Overall Study|Adverse Event|3|||
164254314|NCT02628600|593296149|FG001|Overall Study|Adverse Event|20|||
164339030|NCT00386607|593617134|FG000|Core|Adverse Event|40|||
164254315|NCT02628600|593296148|FG000|Overall Study|Protocol Violation|0|||
164254316|NCT02628600|593296149|FG001|Overall Study|Protocol Violation|1|||
164254317|NCT02628600|593296148|FG000|Overall Study|Lack of Efficacy|2|||
164254318|NCT02628600|593296149|FG001|Overall Study|Lack of Efficacy|0|||
164254319|NCT02628600|593296148|FG000|Overall Study|Withdrawal by Subject|13|||
164254320|NCT02628600|593296149|FG001|Overall Study|Withdrawal by Subject|8|||
164339031|NCT00386607|593617135|FG001|Core|Adverse Event|0|||
164576321|NCT02344576|594473148|FG001|1-Month Follow-Up|Death|8|||
164254321|NCT02628600|593296148|FG000|Overall Study|Lost to Follow-up|1|||
164576322|NCT02344576|594473149|FG002|1-Month Follow-Up|Death|0|||
164254322|NCT02628600|593296149|FG001|Overall Study|Lost to Follow-up|0|||
164254323|NCT02628600|593296148|FG000|Overall Study|Physician Decision|2|||
164254324|NCT02628600|593296149|FG001|Overall Study|Physician Decision|2|||
164254325|NCT02628600|593296148|FG000|Overall Study|Other not specified|1|||
164254326|NCT02628600|593296149|FG001|Overall Study|Other not specified|0|||
164254327|NCT03763656|593296150|FG000|Overall Study|Physician Decision|1|||
164254328|NCT03763656|593296150|FG000|Overall Study|Protocol Violation|1|||
164254329|NCT03763656|593296150|FG000|Overall Study|Withdrawal by Subject|7|||
164254330|NCT03479541|593296151|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
164254331|NCT03479541|593296152|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
164254332|NCT03479541|593296153|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
164254333|NCT03479541|593296154|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
164254334|NCT03479541|593296151|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
164254335|NCT03479541|593296152|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
164254336|NCT03479541|593296153|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
164254337|NCT03479541|593296154|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
164254338|NCT03479541|593296151|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
164254339|NCT03479541|593296152|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
164254340|NCT03479541|593296153|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
164254341|NCT03479541|593296154|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
164576323|NCT02344576|594473150|FG003|1-Month Follow-Up|Death|0|||
164576324|NCT02344576|594473147|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
164254342|NCT03479541|593296151|FG000|Home Monitoring|Lost to Follow-up|0|||
164254343|NCT03479541|593296152|FG001|Home Monitoring|Lost to Follow-up|0|||
164254344|NCT03479541|593296153|FG002|Home Monitoring|Lost to Follow-up|8|||
164254345|NCT03479541|593296154|FG003|Home Monitoring|Lost to Follow-up|12|||
164254346|NCT03479541|593296151|FG000|Home Monitoring|Withdrawal by Subject|0|||
164254347|NCT03479541|593296152|FG001|Home Monitoring|Withdrawal by Subject|0|||
164254348|NCT03479541|593296153|FG002|Home Monitoring|Withdrawal by Subject|17|||
164254349|NCT03479541|593296154|FG003|Home Monitoring|Withdrawal by Subject|30|||
164254350|NCT03479541|593296151|FG000|Home Monitoring|Early Termination - PI Decision|0|||
164254351|NCT03479541|593296152|FG001|Home Monitoring|Early Termination - PI Decision|0|||
164254352|NCT03479541|593296153|FG002|Home Monitoring|Early Termination - PI Decision|4|||
164254353|NCT03479541|593296154|FG003|Home Monitoring|Early Termination - PI Decision|6|||
164254354|NCT03110029|593296158|FG000|Overall Study|Withdrawal by Subject|1|||
164254355|NCT03110029|593296159|FG001|Overall Study|Withdrawal by Subject|1|||
164254356|NCT02316353|593296162|FG000|Overall Study|Pregnancy|1|||
164254357|NCT02316353|593296163|FG001|Overall Study|Pregnancy|3|||
164254358|NCT02316353|593296162|FG000|Overall Study|Adverse Event|1|||
164254359|NCT02316353|593296163|FG001|Overall Study|Adverse Event|3|||
164254360|NCT02316353|593296162|FG000|Overall Study|Withdrawal by Subject|6|||
164254361|NCT02316353|593296163|FG001|Overall Study|Withdrawal by Subject|2|||
164254362|NCT03724981|593298722|FG000|First Device|Protocol Violation|1|||
164254363|NCT03724981|593298723|FG001|First Device|Protocol Violation|1|||
164254364|NCT00511433|593298725|FG000|Overall Study|Adverse Event|5|||
164254365|NCT00511433|593298726|FG001|Overall Study|Adverse Event|0|||
164254366|NCT00511433|593298725|FG000|Overall Study|Other Reason|1|||
164254367|NCT00511433|593298726|FG001|Overall Study|Other Reason|1|||
164254368|NCT00197145|593298727|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
164254369|NCT00197145|593298728|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
164254370|NCT00197145|593298727|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
164254371|NCT00197145|593298728|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
164254372|NCT00197145|593298727|FG000|Period 1: Randomized Treatment Phase|Other|2|||
164254373|NCT00197145|593298728|FG001|Period 1: Randomized Treatment Phase|Other|2|||
164254374|NCT00197145|593298727|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
164254375|NCT00197145|593298728|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
164254376|NCT00197145|593298727|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
164254377|NCT00197145|593298728|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
164254378|NCT00197145|593298727|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
164254379|NCT00197145|593298728|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
164254380|NCT00197145|593298727|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
164254381|NCT00197145|593298728|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
164254382|NCT00197145|593298727|FG000|Period 2 : Open Label Phase|Other|1|||
164254383|NCT00197145|593298728|FG001|Period 2 : Open Label Phase|Other|0|||
164254384|NCT01740089|593298729|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
164254385|NCT01740089|593298730|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
164254386|NCT01740089|593298731|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
164254387|NCT01740089|593298729|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
164254388|NCT01740089|593298730|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
164254389|NCT01740089|593298731|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
164254390|NCT01740089|593298729|FG000|After 12 Weeks|Lack of Efficacy|3|||
164254391|NCT01740089|593298730|FG001|After 12 Weeks|Lack of Efficacy|1|||
164254392|NCT01740089|593298731|FG002|After 12 Weeks|Lack of Efficacy|4|||
164254393|NCT01740089|593298729|FG000|After 12 Weeks|Adverse Event|2|||
164254394|NCT01740089|593298730|FG001|After 12 Weeks|Adverse Event|0|||
164254395|NCT01740089|593298731|FG002|After 12 Weeks|Adverse Event|5|||
164254396|NCT01740089|593298729|FG000|After 12 Weeks|Protocol Violation|1|||
164254397|NCT01740089|593298730|FG001|After 12 Weeks|Protocol Violation|1|||
164254398|NCT01740089|593298731|FG002|After 12 Weeks|Protocol Violation|1|||
164254399|NCT01740089|593298729|FG000|After 12 Weeks|Withdrawal by Subject|1|||
164254400|NCT01740089|593298730|FG001|After 12 Weeks|Withdrawal by Subject|1|||
164254401|NCT01740089|593298731|FG002|After 12 Weeks|Withdrawal by Subject|1|||
164254402|NCT00790868|593298734|FG000|Overall Study|Withdrawal by Subject|4|||
164254403|NCT00790868|593298735|FG001|Overall Study|Withdrawal by Subject|5|||
164254404|NCT00790868|593298734|FG000|Overall Study|Lost to Follow-up|2|||
164254405|NCT00790868|593298735|FG001|Overall Study|Lost to Follow-up|12|||
164254406|NCT02867813|593298739|FG000|Overall Study|Withdrawal by Subject|57|||
164254407|NCT02867813|593298740|FG001|Overall Study|Withdrawal by Subject|56|||
164254408|NCT02867813|593298739|FG000|Overall Study|Decision by Sponsor|7|||
164254409|NCT02867813|593298740|FG001|Overall Study|Decision by Sponsor|7|||
164254410|NCT02867813|593298739|FG000|Overall Study|Lost to Follow-up|91|||
164254411|NCT02867813|593298740|FG001|Overall Study|Lost to Follow-up|78|||
164254412|NCT02867813|593298739|FG000|Overall Study|Missing|2|||
164254413|NCT02867813|593298740|FG001|Overall Study|Missing|1|||
164254414|NCT02867813|593298739|FG000|Overall Study|Death|294|||
164254415|NCT02867813|593298740|FG001|Overall Study|Death|268|||
164254416|NCT02791191|593298741|FG000|Overall Study|Adverse Event|2|||
164254417|NCT02791191|593298742|FG001|Overall Study|Adverse Event|4|||
164254418|NCT02791191|593298743|FG002|Overall Study|Adverse Event|5|||
164254419|NCT02791191|593298741|FG000|Overall Study|Lack of Efficacy|0|||
164254420|NCT02791191|593298742|FG001|Overall Study|Lack of Efficacy|1|||
164254421|NCT02791191|593298743|FG002|Overall Study|Lack of Efficacy|0|||
164254422|NCT02791191|593298741|FG000|Overall Study|Study Drug Non-Compliance|0|||
164254423|NCT02791191|593298742|FG001|Overall Study|Study Drug Non-Compliance|2|||
164254424|NCT02791191|593298743|FG002|Overall Study|Study Drug Non-Compliance|0|||
164254425|NCT02791191|593298741|FG000|Overall Study|Site Closed by Sponsor|1|||
164254426|NCT02791191|593298742|FG001|Overall Study|Site Closed by Sponsor|1|||
164254427|NCT02791191|593298743|FG002|Overall Study|Site Closed by Sponsor|3|||
164254428|NCT02791191|593298741|FG000|Overall Study|Progressive Disease|1|||
164254429|NCT02791191|593298742|FG001|Overall Study|Progressive Disease|0|||
164254430|NCT02791191|593298743|FG002|Overall Study|Progressive Disease|0|||
164254431|NCT02791191|593298741|FG000|Overall Study|Study Terminated by Sponsor|29|||
164254432|NCT02791191|593298742|FG001|Overall Study|Study Terminated by Sponsor|101|||
164254433|NCT02791191|593298743|FG002|Overall Study|Study Terminated by Sponsor|109|||
164254434|NCT02791191|593298741|FG000|Overall Study|Withdrawal by Subject|3|||
164254435|NCT02791191|593298742|FG001|Overall Study|Withdrawal by Subject|1|||
164254436|NCT02791191|593298743|FG002|Overall Study|Withdrawal by Subject|3|||
164254437|NCT02791191|593298741|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
164254438|NCT02791191|593298742|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
164254439|NCT02791191|593298743|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
164254440|NCT02370537|593298744|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
164254441|NCT02370537|593298745|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
164254442|NCT02370537|593298746|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
164254443|NCT02370537|593298744|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
164254444|NCT02370537|593298745|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
164254445|NCT02370537|593298746|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
164254446|NCT02370537|593298744|FG000|Part B|Not randomised to receive treatment|1|||
164254447|NCT02370537|593298745|FG001|Part B|Not randomised to receive treatment|2|||
164254448|NCT02370537|593298746|FG002|Part B|Not randomised to receive treatment|259|||
164339032|NCT00386607|593617134|FG000|Core|Abnormal laboratory value(s)|3|||
164339033|NCT00386607|593617135|FG001|Core|Abnormal laboratory value(s)|0|||
164339034|NCT00386607|593617134|FG000|Core|Unsatisfactory therapeutic effect|23|||
164339035|NCT00386607|593617135|FG001|Core|Unsatisfactory therapeutic effect|0|||
164339036|NCT00386607|593617134|FG000|Core|Condition no longer requires study drug|4|||
164339037|NCT00386607|593617135|FG001|Core|Condition no longer requires study drug|0|||
164339038|NCT00386607|593617134|FG000|Core|Patient withdrew consent|15|||
164254449|NCT02370537|593298744|FG000|Part B|Withdrawal by Subject|0|||
164254450|NCT02370537|593298745|FG001|Part B|Withdrawal by Subject|1|||
164254451|NCT02370537|593298746|FG002|Part B|Withdrawal by Subject|0|||
164254452|NCT01952665|593298747|FG000|Overall Study|Physician Decision|3|||
164254453|NCT01952665|593298748|FG001|Overall Study|Physician Decision|2|||
164254454|NCT01952665|593298747|FG000|Overall Study|Lost to Follow-up|1|||
164339039|NCT00386607|593617135|FG001|Core|Patient withdrew consent|0|||
164339040|NCT00386607|593617134|FG000|Core|Lost to Follow-up|23|||
164254455|NCT01952665|593298748|FG001|Overall Study|Lost to Follow-up|2|||
164254456|NCT01952665|593298747|FG000|Overall Study|Adverse Event|2|||
164254457|NCT01952665|593298748|FG001|Overall Study|Adverse Event|1|||
164339041|NCT00386607|593617135|FG001|Core|Lost to Follow-up|0|||
164339042|NCT00386607|593617134|FG000|Core|Administrative problems|1|||
164254458|NCT01952665|593298747|FG000|Overall Study|Protocol Violation|0|||
164254459|NCT01952665|593298748|FG001|Overall Study|Protocol Violation|1|||
164254460|NCT02578680|593298749|FG000|Overall Study|Death|329|||
164254461|NCT02578680|593298750|FG001|Overall Study|Death|181|||
164254462|NCT02578680|593298749|FG000|Overall Study|Lost to Follow-up|3|||
164254463|NCT02578680|593298750|FG001|Overall Study|Lost to Follow-up|1|||
164254464|NCT02578680|593298749|FG000|Overall Study|Physician Decision|0|||
164254465|NCT02578680|593298750|FG001|Overall Study|Physician Decision|1|||
164254466|NCT02578680|593298749|FG000|Overall Study|Protocol Violation|1|||
164254467|NCT02578680|593298750|FG001|Overall Study|Protocol Violation|1|||
164254468|NCT02578680|593298749|FG000|Overall Study|Sponsor Decision|64|||
164254469|NCT02578680|593298750|FG001|Overall Study|Sponsor Decision|13|||
164254470|NCT02578680|593298749|FG000|Overall Study|Withdrawal by Subject|13|||
164254471|NCT02578680|593298750|FG001|Overall Study|Withdrawal by Subject|9|||
164254472|NCT01559259|593298752|FG000|Overall Study|Withdrawal by Subject|0|||
164254473|NCT01559259|593298753|FG001|Overall Study|Withdrawal by Subject|0|||
164254474|NCT01559259|593298754|FG002|Overall Study|Withdrawal by Subject|0|||
164254475|NCT01559259|593298755|FG003|Overall Study|Withdrawal by Subject|1|||
164254476|NCT01559259|593298756|FG004|Overall Study|Withdrawal by Subject|0|||
164254477|NCT01559259|593298752|FG000|Overall Study|Adverse Event|0|||
164254478|NCT01559259|593298753|FG001|Overall Study|Adverse Event|1|||
164254479|NCT01559259|593298754|FG002|Overall Study|Adverse Event|1|||
164254480|NCT01559259|593298755|FG003|Overall Study|Adverse Event|0|||
164254481|NCT01559259|593298756|FG004|Overall Study|Adverse Event|0|||
164254482|NCT03727646|593298757|FG000|Overall Study|Adverse Event|1|||
164254483|NCT03727646|593298758|FG001|Overall Study|Adverse Event|0|||
164339043|NCT00386607|593617135|FG001|Core|Administrative problems|0|||
164339044|NCT00386607|593617134|FG000|Core|Protocol Deviation|6|||
164339045|NCT00386607|593617135|FG001|Core|Protocol Deviation|0|||
164339046|NCT00386607|593617134|FG000|Extension|Adverse Event|0|||
164339047|NCT00386607|593617135|FG001|Extension|Adverse Event|6|||
164339048|NCT00386607|593617134|FG000|Extension|Abnormal laboratory value(s)|0|||
164339049|NCT00386607|593617135|FG001|Extension|Abnormal laboratory value(s)|1|||
164339050|NCT00386607|593617134|FG000|Extension|Administrative problems|0|||
164339051|NCT00386607|593617135|FG001|Extension|Administrative problems|1|||
164254484|NCT00306293|593298762|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
164254485|NCT00306293|593298763|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
164339052|NCT00386607|593617134|FG000|Extension|Lost to Follow-up|0|||
164339053|NCT00386607|593617135|FG001|Extension|Lost to Follow-up|3|||
164339054|NCT00386607|593617134|FG000|Extension|Patient withdrew consent|0|||
164339055|NCT00386607|593617135|FG001|Extension|Patient withdrew consent|5|||
164339056|NCT00386607|593617134|FG000|Extension|Unsatisfactory therapeutic effect|0|||
164339057|NCT00386607|593617135|FG001|Extension|Unsatisfactory therapeutic effect|1|||
164339058|NCT02713204|593617136|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
164576325|NCT02344576|594473148|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
164576326|NCT02344576|594473149|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
164576327|NCT02344576|594473150|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
164576328|NCT02344576|594473147|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
164576329|NCT02344576|594473148|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
164576330|NCT02344576|594473149|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
164576331|NCT02344576|594473150|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
164576332|NCT02344576|594473147|FG000|6-Month Follow-Up|Death|14|||
164576333|NCT02344576|594473148|FG001|6-Month Follow-Up|Death|14|||
164576334|NCT02344576|594473149|FG002|6-Month Follow-Up|Death|0|||
164576335|NCT02344576|594473150|FG003|6-Month Follow-Up|Death|0|||
164576336|NCT02344576|594473147|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
164576337|NCT02344576|594473148|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
164576338|NCT02344576|594473149|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
164576339|NCT02344576|594473150|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
164576340|NCT02344576|594473147|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
164576341|NCT02344576|594473148|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
164576342|NCT02344576|594473149|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
164576343|NCT02344576|594473150|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
164576344|NCT01243268|594473152|FG000|Overall Study|Lost to Follow-up|4|||
164576345|NCT01243268|594473152|FG000|Overall Study|Protocol Violation|51|||
164254486|NCT00306293|593298762|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
164339059|NCT02713204|593617137|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
164576346|NCT01243268|594473152|FG000|Overall Study|Deviation with contract date|7|||
164576347|NCT01243268|594473152|FG000|Overall Study|Duplicate subject|2|||
164576348|NCT01624142|594473157|FG000|Overall Study|Withdrawal by Subject|14|||
164254487|NCT00306293|593298763|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
164254488|NCT00306293|593298762|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
164339060|NCT02713204|593617138|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
164339061|NCT02713204|593617139|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
164339062|NCT02713204|593617140|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
164576349|NCT01624142|594473158|FG001|Overall Study|Withdrawal by Subject|4|||
164576350|NCT01624142|594473157|FG000|Overall Study|Death|3|||
164576351|NCT01624142|594473158|FG001|Overall Study|Death|6|||
164254489|NCT00306293|593298763|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
164254490|NCT00306293|593298762|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
164254491|NCT00306293|593298763|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
164254492|NCT00306293|593298762|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
164254493|NCT00306293|593298763|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
164254494|NCT00306293|593298762|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
164254495|NCT00306293|593298763|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
164254496|NCT00306293|593298762|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
164254497|NCT00306293|593298763|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
164254498|NCT00306293|593298762|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
164254499|NCT00306293|593298763|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
164254500|NCT01089413|593298766|FG000|Overall Study|Lost to Follow-up|1|||
164254501|NCT01089413|593298766|FG000|Overall Study|Progressive Disease|93|||
164254502|NCT01089413|593298766|FG000|Overall Study|Participant Withdrew Consent|1|||
164254503|NCT01089413|593298766|FG000|Overall Study|Unacceptable Toxicity|12|||
164254504|NCT01089413|593298766|FG000|Overall Study|Death|10|||
164254505|NCT01089413|593298766|FG000|Overall Study|Metastasectomy|13|||
164254506|NCT01089413|593298766|FG000|Overall Study|Other|71|||
164254507|NCT01814878|593298768|FG000|Overall Study|Adverse Event|16|||
164254508|NCT01814878|593298769|FG001|Overall Study|Adverse Event|5|||
164254509|NCT01814878|593298768|FG000|Overall Study|Withdrawal by Subject|20|||
164254510|NCT01814878|593298769|FG001|Overall Study|Withdrawal by Subject|16|||
164254511|NCT01814878|593298768|FG000|Overall Study|Protocol Violation|5|||
164254512|NCT01814878|593298769|FG001|Overall Study|Protocol Violation|5|||
164254513|NCT01814878|593298768|FG000|Overall Study|Physician Decision|3|||
164254514|NCT01814878|593298769|FG001|Overall Study|Physician Decision|1|||
164254515|NCT01814878|593298768|FG000|Overall Study|Screening failure (drop-out)|0|||
164254516|NCT01814878|593298769|FG001|Overall Study|Screening failure (drop-out)|3|||
164254517|NCT01814878|593298768|FG000|Overall Study|Other|2|||
164254518|NCT01814878|593298769|FG001|Overall Study|Other|0|||
164254519|NCT04115748|593298774|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
164254520|NCT04115748|593298775|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
164254521|NCT04115748|593298776|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
164254522|NCT04115748|593298777|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
164254523|NCT04115748|593298778|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
164254524|NCT04115748|593298779|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
164254525|NCT04115748|593298780|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
164254526|NCT04115748|593298781|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
164254527|NCT04115748|593298782|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
164254528|NCT04115748|593298783|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
164254529|NCT04115748|593298774|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
164254530|NCT04115748|593298775|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
164254531|NCT04115748|593298776|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
164254532|NCT04115748|593298777|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
164254533|NCT04115748|593298778|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
164254534|NCT04115748|593298779|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
164254535|NCT04115748|593298780|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
164254536|NCT04115748|593298781|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
164254537|NCT04115748|593298782|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
164254538|NCT04115748|593298783|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
164254539|NCT04115748|593298774|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
164254540|NCT04115748|593298775|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
164254541|NCT04115748|593298776|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
164254542|NCT04115748|593298777|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
164254543|NCT04115748|593298778|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
164254544|NCT04115748|593298779|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
164254545|NCT04115748|593298780|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
164254546|NCT04115748|593298781|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
164254547|NCT04115748|593298782|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
164254548|NCT04115748|593298783|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
164254549|NCT04115748|593298774|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
164254550|NCT04115748|593298775|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
164254551|NCT04115748|593298776|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
164254552|NCT04115748|593298777|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
164254553|NCT04115748|593298778|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
164427421|NCT03929302|593934742|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
164254554|NCT04115748|593298779|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
164254555|NCT04115748|593298780|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
164254556|NCT04115748|593298781|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
164254557|NCT04115748|593298782|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
164254558|NCT04115748|593298783|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
164254559|NCT01200407|593298784|FG000|Overall Study|Lost to Follow-up|56|||
164254560|NCT01200407|593298784|FG000|Overall Study|Adverse Event|3|||
164254561|NCT01200407|593298784|FG000|Overall Study|Withdrawal by Subject|4|||
164254562|NCT01200407|593298784|FG000|Overall Study|Other|19|||
164254563|NCT00152477|593298785|FG000|Chemotherapy Period|Adverse Event|9|||
164254564|NCT00152477|593298786|FG001|Chemotherapy Period|Adverse Event|4|||
164254565|NCT00152477|593298787|FG002|Chemotherapy Period|Adverse Event|5|||
164254566|NCT00152477|593298785|FG000|Chemotherapy Period|Death|1|||
164254567|NCT00152477|593298786|FG001|Chemotherapy Period|Death|3|||
164254568|NCT00152477|593298787|FG002|Chemotherapy Period|Death|3|||
164254569|NCT00152477|593298785|FG000|Chemotherapy Period|Lack of Efficacy|4|||
164254570|NCT00152477|593298786|FG001|Chemotherapy Period|Lack of Efficacy|5|||
164254571|NCT00152477|593298787|FG002|Chemotherapy Period|Lack of Efficacy|6|||
164254572|NCT00152477|593298785|FG000|Chemotherapy Period|Lost to Follow-up|1|||
164254573|NCT00152477|593298786|FG001|Chemotherapy Period|Lost to Follow-up|0|||
164254574|NCT00152477|593298787|FG002|Chemotherapy Period|Lost to Follow-up|1|||
164254575|NCT00152477|593298785|FG000|Chemotherapy Period|Protocol Violation|1|||
164254576|NCT00152477|593298786|FG001|Chemotherapy Period|Protocol Violation|1|||
164254577|NCT00152477|593298787|FG002|Chemotherapy Period|Protocol Violation|0|||
164254578|NCT00152477|593298785|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
164254579|NCT00152477|593298786|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
164254580|NCT00152477|593298787|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
164254581|NCT00152477|593298785|FG000|Chemotherapy Period|Progression of Disease|6|||
164254582|NCT00152477|593298786|FG001|Chemotherapy Period|Progression of Disease|8|||
164254583|NCT00152477|593298787|FG002|Chemotherapy Period|Progression of Disease|4|||
164254584|NCT00152477|593298785|FG000|Chemotherapy Period|Investigator decision|0|||
164254585|NCT00152477|593298786|FG001|Chemotherapy Period|Investigator decision|0|||
164254586|NCT00152477|593298787|FG002|Chemotherapy Period|Investigator decision|1|||
164254587|NCT00152477|593298785|FG000|Chemotherapy Period|Patient condition worsened|1|||
164254588|NCT00152477|593298786|FG001|Chemotherapy Period|Patient condition worsened|0|||
164254589|NCT00152477|593298787|FG002|Chemotherapy Period|Patient condition worsened|0|||
164254590|NCT00152477|593298785|FG000|Monotherapy Period|Adverse Event|1|||
164254591|NCT00152477|593298786|FG001|Monotherapy Period|Adverse Event|0|||
164254592|NCT00152477|593298787|FG002|Monotherapy Period|Adverse Event|5|||
164254593|NCT00152477|593298785|FG000|Monotherapy Period|Death|2|||
164254594|NCT00152477|593298786|FG001|Monotherapy Period|Death|0|||
164254595|NCT00152477|593298787|FG002|Monotherapy Period|Death|1|||
164254596|NCT00152477|593298785|FG000|Monotherapy Period|Lack of Efficacy|7|||
164254597|NCT00152477|593298786|FG001|Monotherapy Period|Lack of Efficacy|16|||
164254598|NCT00152477|593298787|FG002|Monotherapy Period|Lack of Efficacy|10|||
164254599|NCT00152477|593298785|FG000|Monotherapy Period|Protocol Violation|0|||
164254600|NCT00152477|593298786|FG001|Monotherapy Period|Protocol Violation|1|||
164254601|NCT00152477|593298787|FG002|Monotherapy Period|Protocol Violation|0|||
164254602|NCT00152477|593298785|FG000|Monotherapy Period|Withdrawal by Subject|0|||
164254603|NCT00152477|593298786|FG001|Monotherapy Period|Withdrawal by Subject|0|||
164254604|NCT00152477|593298787|FG002|Monotherapy Period|Withdrawal by Subject|4|||
164254605|NCT00152477|593298785|FG000|Monotherapy Period|Progression of Disease|5|||
164254606|NCT00152477|593298786|FG001|Monotherapy Period|Progression of Disease|11|||
164254607|NCT00152477|593298787|FG002|Monotherapy Period|Progression of Disease|12|||
164254608|NCT00152477|593298785|FG000|Monotherapy Period|Patient decision|0|||
164254609|NCT00152477|593298786|FG001|Monotherapy Period|Patient decision|1|||
164254610|NCT00152477|593298787|FG002|Monotherapy Period|Patient decision|1|||
164254611|NCT00152477|593298785|FG000|Monotherapy Period|Study personel decision|0|||
164254612|NCT00152477|593298786|FG001|Monotherapy Period|Study personel decision|0|||
164254613|NCT00152477|593298787|FG002|Monotherapy Period|Study personel decision|1|||
164254614|NCT00730041|593298790|FG000|Overall Study|Lost to Follow-up|0|||
164254615|NCT00730041|593298791|FG001|Overall Study|Lost to Follow-up|2|||
164254616|NCT00433966|593298794|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
164254617|NCT00433966|593298795|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
164254618|NCT00433966|593298796|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
164254619|NCT00433966|593298797|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
164254620|NCT00433966|593298794|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
164254621|NCT00433966|593298795|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
164254622|NCT00433966|593298796|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
164254623|NCT00433966|593298797|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
164254624|NCT00433966|593298794|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
164254625|NCT00433966|593298795|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
164254626|NCT00433966|593298796|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
164254627|NCT00433966|593298797|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
164254628|NCT00433966|593298794|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
164254629|NCT00433966|593298795|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
164254630|NCT00433966|593298796|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
164339063|NCT02713204|593617141|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
164339064|NCT02713204|593617142|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
164339065|NCT02713204|593617143|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
164254631|NCT00433966|593298797|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
164254632|NCT00433966|593298794|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
164254633|NCT00433966|593298795|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
164254634|NCT00433966|593298796|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
164254635|NCT00433966|593298797|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
164254636|NCT01296711|593298798|FG000|Overall Study|Adverse Event|3|||
164254637|NCT01296711|593298799|FG001|Overall Study|Adverse Event|1|||
164254638|NCT01296711|593298800|FG002|Overall Study|Adverse Event|4|||
164254639|NCT01296711|593298801|FG003|Overall Study|Adverse Event|3|||
164254640|NCT01296711|593298802|FG004|Overall Study|Adverse Event|1|||
164254641|NCT01296711|593298803|FG005|Overall Study|Adverse Event|6|||
164254642|NCT01296711|593298804|FG006|Overall Study|Adverse Event|11|||
164254643|NCT01296711|593298805|FG007|Overall Study|Adverse Event|3|||
164254644|NCT01296711|593298798|FG000|Overall Study|Lack of Efficacy|1|||
164254645|NCT01296711|593298799|FG001|Overall Study|Lack of Efficacy|4|||
164254646|NCT01296711|593298800|FG002|Overall Study|Lack of Efficacy|1|||
164254647|NCT01296711|593298801|FG003|Overall Study|Lack of Efficacy|1|||
164254648|NCT01296711|593298802|FG004|Overall Study|Lack of Efficacy|1|||
164254649|NCT01296711|593298803|FG005|Overall Study|Lack of Efficacy|0|||
164254650|NCT01296711|593298804|FG006|Overall Study|Lack of Efficacy|2|||
164254651|NCT01296711|593298805|FG007|Overall Study|Lack of Efficacy|3|||
164254652|NCT01296711|593298798|FG000|Overall Study|Lost to Follow-up|0|||
164254653|NCT01296711|593298799|FG001|Overall Study|Lost to Follow-up|0|||
164254654|NCT01296711|593298800|FG002|Overall Study|Lost to Follow-up|1|||
164254655|NCT01296711|593298801|FG003|Overall Study|Lost to Follow-up|1|||
164254656|NCT01296711|593298802|FG004|Overall Study|Lost to Follow-up|2|||
164254657|NCT01296711|593298803|FG005|Overall Study|Lost to Follow-up|0|||
164254658|NCT01296711|593298804|FG006|Overall Study|Lost to Follow-up|4|||
164254659|NCT01296711|593298805|FG007|Overall Study|Lost to Follow-up|2|||
164254660|NCT01296711|593298798|FG000|Overall Study|Protocol Violation|0|||
164254661|NCT01296711|593298799|FG001|Overall Study|Protocol Violation|0|||
164254662|NCT01296711|593298800|FG002|Overall Study|Protocol Violation|0|||
164254663|NCT01296711|593298801|FG003|Overall Study|Protocol Violation|1|||
164254664|NCT01296711|593298802|FG004|Overall Study|Protocol Violation|1|||
164254665|NCT01296711|593298803|FG005|Overall Study|Protocol Violation|0|||
164254666|NCT01296711|593298804|FG006|Overall Study|Protocol Violation|0|||
164254667|NCT01296711|593298805|FG007|Overall Study|Protocol Violation|0|||
164254668|NCT01296711|593298798|FG000|Overall Study|Withdrawal by Subject|4|||
164339066|NCT02713204|593617136|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164339067|NCT02713204|593617137|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164576352|NCT01624142|594473157|FG000|Overall Study|Study Closure|12|||
164339068|NCT02713204|593617138|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
164339069|NCT02713204|593617139|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164254669|NCT01296711|593298799|FG001|Overall Study|Withdrawal by Subject|2|||
164254670|NCT01296711|593298800|FG002|Overall Study|Withdrawal by Subject|2|||
164254671|NCT01296711|593298801|FG003|Overall Study|Withdrawal by Subject|1|||
164254672|NCT01296711|593298802|FG004|Overall Study|Withdrawal by Subject|1|||
164254673|NCT01296711|593298803|FG005|Overall Study|Withdrawal by Subject|1|||
164254674|NCT01296711|593298804|FG006|Overall Study|Withdrawal by Subject|2|||
164254675|NCT01296711|593298805|FG007|Overall Study|Withdrawal by Subject|1|||
164254676|NCT01296711|593298798|FG000|Overall Study|Study termination|8|||
164254677|NCT01296711|593298799|FG001|Overall Study|Study termination|1|||
164254678|NCT01296711|593298800|FG002|Overall Study|Study termination|5|||
164254679|NCT01296711|593298801|FG003|Overall Study|Study termination|4|||
164254680|NCT01296711|593298802|FG004|Overall Study|Study termination|4|||
164254681|NCT01296711|593298803|FG005|Overall Study|Study termination|4|||
164254682|NCT01296711|593298804|FG006|Overall Study|Study termination|8|||
164254683|NCT01296711|593298805|FG007|Overall Study|Study termination|10|||
164254684|NCT01296711|593298798|FG000|Overall Study|Continued elevated liver enzymes|0|||
164254685|NCT01296711|593298799|FG001|Overall Study|Continued elevated liver enzymes|0|||
164254686|NCT01296711|593298800|FG002|Overall Study|Continued elevated liver enzymes|0|||
164254687|NCT01296711|593298801|FG003|Overall Study|Continued elevated liver enzymes|1|||
164254688|NCT01296711|593298802|FG004|Overall Study|Continued elevated liver enzymes|0|||
164254689|NCT01296711|593298803|FG005|Overall Study|Continued elevated liver enzymes|0|||
164254690|NCT01296711|593298804|FG006|Overall Study|Continued elevated liver enzymes|0|||
164254691|NCT01296711|593298805|FG007|Overall Study|Continued elevated liver enzymes|0|||
164254692|NCT01296711|593298798|FG000|Overall Study|Methotrexate discontinued|0|||
164254693|NCT01296711|593298799|FG001|Overall Study|Methotrexate discontinued|0|||
164254694|NCT01296711|593298800|FG002|Overall Study|Methotrexate discontinued|0|||
164254695|NCT01296711|593298801|FG003|Overall Study|Methotrexate discontinued|1|||
164254696|NCT01296711|593298802|FG004|Overall Study|Methotrexate discontinued|0|||
164254697|NCT01296711|593298803|FG005|Overall Study|Methotrexate discontinued|0|||
164254698|NCT01296711|593298804|FG006|Overall Study|Methotrexate discontinued|0|||
164680497|NCT00112437|594854583|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164680498|NCT00112437|594854584|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164680499|NCT00112437|594854585|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164680500|NCT00112437|594854586|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164680501|NCT00112437|594854587|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164680502|NCT00112437|594854588|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164680503|NCT00112437|594854589|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164680504|NCT00112437|594854590|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164680505|NCT00112437|594854591|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164254699|NCT01296711|593298805|FG007|Overall Study|Methotrexate discontinued|0|||
164254700|NCT01296711|593298798|FG000|Overall Study|Investigator discretion|0|||
164254701|NCT01296711|593298799|FG001|Overall Study|Investigator discretion|0|||
164254702|NCT01296711|593298800|FG002|Overall Study|Investigator discretion|0|||
164254703|NCT01296711|593298801|FG003|Overall Study|Investigator discretion|0|||
164254704|NCT01296711|593298802|FG004|Overall Study|Investigator discretion|0|||
164254705|NCT01296711|593298803|FG005|Overall Study|Investigator discretion|0|||
164254706|NCT01296711|593298804|FG006|Overall Study|Investigator discretion|1|||
164254707|NCT01296711|593298805|FG007|Overall Study|Investigator discretion|0|||
164254708|NCT01296711|593298798|FG000|Overall Study|Other|0|||
164339070|NCT02713204|593617140|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164339071|NCT02713204|593617141|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164339072|NCT02713204|593617142|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164339073|NCT02713204|593617143|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164339074|NCT02713204|593617136|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164339075|NCT02713204|593617137|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
164339076|NCT02713204|593617138|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164339077|NCT02713204|593617139|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164339078|NCT02713204|593617140|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164339079|NCT02713204|593617141|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164339080|NCT02713204|593617142|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164339081|NCT02713204|593617143|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164339082|NCT02713204|593617136|FG000|From Week 12 up to Week 36|Adverse Event|1|||
164339083|NCT02713204|593617137|FG001|From Week 12 up to Week 36|Adverse Event|0|||
164339084|NCT02713204|593617138|FG002|From Week 12 up to Week 36|Adverse Event|0|||
164339085|NCT02713204|593617139|FG003|From Week 12 up to Week 36|Adverse Event|1|||
164339086|NCT02713204|593617140|FG004|From Week 12 up to Week 36|Adverse Event|1|||
164339087|NCT02713204|593617141|FG005|From Week 12 up to Week 36|Adverse Event|0|||
164339088|NCT02713204|593617142|FG006|From Week 12 up to Week 36|Adverse Event|2|||
164339089|NCT02713204|593617143|FG007|From Week 12 up to Week 36|Adverse Event|1|||
164339090|NCT02713204|593617136|FG000|From Week 12 up to Week 36|Death|0|||
164339091|NCT02713204|593617137|FG001|From Week 12 up to Week 36|Death|0|||
164339092|NCT02713204|593617138|FG002|From Week 12 up to Week 36|Death|0|||
164339093|NCT02713204|593617139|FG003|From Week 12 up to Week 36|Death|1|||
164339094|NCT02713204|593617140|FG004|From Week 12 up to Week 36|Death|0|||
164339095|NCT02713204|593617141|FG005|From Week 12 up to Week 36|Death|1|||
164254709|NCT01296711|593298799|FG001|Overall Study|Other|0|||
164680506|NCT00112437|594854592|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164680507|NCT00112437|594854593|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164680508|NCT00112437|594854594|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164680509|NCT00112437|594854595|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164680510|NCT00112437|594854596|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164680511|NCT00112437|594854571|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
164680512|NCT00112437|594854572|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
164576353|NCT01624142|594473158|FG001|Overall Study|Study Closure|6|||
164576354|NCT01624142|594473157|FG000|Overall Study|Lost to Follow-up|2|||
164576355|NCT01624142|594473158|FG001|Overall Study|Lost to Follow-up|0|||
164576356|NCT01624142|594473157|FG000|Overall Study|Other|1|||
164680513|NCT00112437|594854573|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
164680514|NCT00112437|594854574|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
164576357|NCT01624142|594473158|FG001|Overall Study|Other|0|||
164576358|NCT00667277|594473159|FG000|Overall Study|Withdrawal by Subject|2|||
164576359|NCT02722044|594473160|FG000|Overall Study|Adverse Event|2|||
164576360|NCT02722044|594473160|FG000|Overall Study|Physician Decision|1|||
164576361|NCT02722044|594473160|FG000|Overall Study|Withdrawal by Subject|1|||
164576362|NCT02722044|594473160|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
164576363|NCT04826900|594473161|FG000|Overall Study|Family factor|1|||
164576364|NCT04826900|594473162|FG001|Overall Study|Family factor|1|||
164576365|NCT04640766|594473166|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
164576366|NCT02597062|594473167|FG000|Overall Study|Ineligible|1|||
164576367|NCT00609622|594473170|FG000|Overall Study|Adverse Event|14|||
164576368|NCT00609622|594473171|FG001|Overall Study|Adverse Event|10|||
164254710|NCT01296711|593298800|FG002|Overall Study|Other|0|||
164576369|NCT00609622|594473170|FG000|Overall Study|Withdrawal by Subject|4|||
164576370|NCT00609622|594473171|FG001|Overall Study|Withdrawal by Subject|20|||
164576371|NCT00609622|594473170|FG000|Overall Study|Death|1|||
164576372|NCT00609622|594473171|FG001|Overall Study|Death|4|||
164576373|NCT00609622|594473170|FG000|Overall Study|Protocol Violation|1|||
164576374|NCT00609622|594473171|FG001|Overall Study|Protocol Violation|1|||
164576375|NCT00609622|594473170|FG000|Overall Study|Objective progression or relapse|47|||
164576376|NCT00609622|594473171|FG001|Overall Study|Objective progression or relapse|41|||
164576377|NCT00609622|594473170|FG000|Overall Study|Study terminated by sponsor|16|||
164576378|NCT00609622|594473171|FG001|Overall Study|Study terminated by sponsor|3|||
164576379|NCT00609622|594473170|FG000|Overall Study|Other|7|||
164576380|NCT00609622|594473171|FG001|Overall Study|Other|14|||
164576381|NCT00609622|594473170|FG000|Overall Study|Global deterioration of health status|6|||
164576382|NCT00609622|594473171|FG001|Overall Study|Global deterioration of health status|2|||
164576383|NCT01053429|594473172|FG000|Overall Study|Adverse Event|64|||
164576384|NCT01053429|594473172|FG000|Overall Study|Other|309|||
164576385|NCT01708057|594473175|FG000|Overall Study|Withdrawal due to study termination.|1|||
164576386|NCT01708057|594473176|FG001|Overall Study|Withdrawal due to study termination.|1|||
164576387|NCT01708057|594473177|FG002|Overall Study|Withdrawal due to study termination.|1|||
164576388|NCT01697345|594473180|FG000|Overall Study|Withdrawal by Subject|1|||
164576389|NCT01976806|594473181|FG000|Overall Study|Lost to Follow-up|1|||
164576390|NCT01976806|594473182|FG001|Overall Study|Lost to Follow-up|4|||
164576391|NCT01976806|594473181|FG000|Overall Study|Adverse Event|1|||
164576392|NCT01976806|594473182|FG001|Overall Study|Adverse Event|1|||
164576393|NCT01976806|594473181|FG000|Overall Study|Withdrawal by Subject|1|||
164680515|NCT00112437|594854575|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
164680516|NCT00112437|594854576|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
164254711|NCT01296711|593298801|FG003|Overall Study|Other|0|||
164254712|NCT01296711|593298802|FG004|Overall Study|Other|0|||
164254713|NCT01296711|593298803|FG005|Overall Study|Other|0|||
164254714|NCT01296711|593298804|FG006|Overall Study|Other|1|||
164254715|NCT01296711|593298805|FG007|Overall Study|Other|0|||
164254716|NCT01296711|593298798|FG000|Overall Study|Required restricted steroid injections|0|||
164254717|NCT01296711|593298799|FG001|Overall Study|Required restricted steroid injections|0|||
164254718|NCT01296711|593298800|FG002|Overall Study|Required restricted steroid injections|0|||
164254719|NCT01296711|593298801|FG003|Overall Study|Required restricted steroid injections|0|||
164254720|NCT01296711|593298802|FG004|Overall Study|Required restricted steroid injections|0|||
164254721|NCT01296711|593298803|FG005|Overall Study|Required restricted steroid injections|0|||
164254722|NCT01296711|593298804|FG006|Overall Study|Required restricted steroid injections|1|||
164254723|NCT01296711|593298805|FG007|Overall Study|Required restricted steroid injections|0|||
164254724|NCT01296711|593298798|FG000|Overall Study|Ongoing missed appointments|0|||
164254725|NCT01296711|593298799|FG001|Overall Study|Ongoing missed appointments|0|||
164254726|NCT01296711|593298800|FG002|Overall Study|Ongoing missed appointments|0|||
164254727|NCT01296711|593298801|FG003|Overall Study|Ongoing missed appointments|0|||
164254728|NCT01296711|593298802|FG004|Overall Study|Ongoing missed appointments|0|||
164254729|NCT01296711|593298803|FG005|Overall Study|Ongoing missed appointments|0|||
164254730|NCT01296711|593298804|FG006|Overall Study|Ongoing missed appointments|1|||
164680517|NCT00112437|594854577|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
164254731|NCT01296711|593298805|FG007|Overall Study|Ongoing missed appointments|0|||
164254732|NCT01296711|593298798|FG000|Overall Study|Failure to comply with visits|0|||
164254733|NCT01296711|593298799|FG001|Overall Study|Failure to comply with visits|0|||
164254734|NCT01296711|593298800|FG002|Overall Study|Failure to comply with visits|0|||
164254735|NCT01296711|593298801|FG003|Overall Study|Failure to comply with visits|0|||
164254736|NCT01296711|593298802|FG004|Overall Study|Failure to comply with visits|0|||
164254737|NCT01296711|593298803|FG005|Overall Study|Failure to comply with visits|0|||
164254738|NCT01296711|593298804|FG006|Overall Study|Failure to comply with visits|0|||
164254739|NCT01296711|593298805|FG007|Overall Study|Failure to comply with visits|1|||
164254740|NCT01296711|593298798|FG000|Overall Study|Patient decision due to transport|0|||
164254741|NCT01296711|593298799|FG001|Overall Study|Patient decision due to transport|0|||
164254742|NCT01296711|593298800|FG002|Overall Study|Patient decision due to transport|0|||
164254743|NCT01296711|593298801|FG003|Overall Study|Patient decision due to transport|0|||
164254744|NCT01296711|593298802|FG004|Overall Study|Patient decision due to transport|0|||
164254745|NCT01296711|593298803|FG005|Overall Study|Patient decision due to transport|0|||
164254746|NCT01296711|593298804|FG006|Overall Study|Patient decision due to transport|0|||
164254747|NCT01296711|593298805|FG007|Overall Study|Patient decision due to transport|1|||
164254748|NCT01328535|593298807|FG000|Overall Study|Ineligible|1|||
164254749|NCT01035463|593298808|FG000|Overall Study|Adverse Event|0|||
164254750|NCT01035463|593298809|FG001|Overall Study|Adverse Event|0|||
164254751|NCT01035463|593298810|FG002|Overall Study|Adverse Event|4|||
164254752|NCT01035463|593298811|FG003|Overall Study|Adverse Event|1|||
164254753|NCT01035463|593298812|FG004|Overall Study|Adverse Event|5|||
164254754|NCT01035463|593298813|FG005|Overall Study|Adverse Event|7|||
164254755|NCT01035463|593298808|FG000|Overall Study|Withdrawal by Subject|0|||
164254756|NCT01035463|593298809|FG001|Overall Study|Withdrawal by Subject|2|||
164254757|NCT01035463|593298810|FG002|Overall Study|Withdrawal by Subject|1|||
164254758|NCT01035463|593298811|FG003|Overall Study|Withdrawal by Subject|0|||
164254759|NCT01035463|593298812|FG004|Overall Study|Withdrawal by Subject|1|||
164254760|NCT01035463|593298813|FG005|Overall Study|Withdrawal by Subject|4|||
164254761|NCT01035463|593298808|FG000|Overall Study|Disease progression|0|||
164254762|NCT01035463|593298809|FG001|Overall Study|Disease progression|0|||
164254763|NCT01035463|593298810|FG002|Overall Study|Disease progression|0|||
164254764|NCT01035463|593298811|FG003|Overall Study|Disease progression|0|||
164254765|NCT01035463|593298812|FG004|Overall Study|Disease progression|0|||
164254766|NCT01035463|593298813|FG005|Overall Study|Disease progression|3|||
164254767|NCT01035463|593298808|FG000|Overall Study|Other Malignancy|0|||
164254768|NCT01035463|593298809|FG001|Overall Study|Other Malignancy|0|||
164254769|NCT01035463|593298810|FG002|Overall Study|Other Malignancy|0|||
164254770|NCT01035463|593298811|FG003|Overall Study|Other Malignancy|0|||
164254771|NCT01035463|593298812|FG004|Overall Study|Other Malignancy|0|||
164254772|NCT01035463|593298813|FG005|Overall Study|Other Malignancy|2|||
164254773|NCT01035463|593298808|FG000|Overall Study|Other|0|||
164254774|NCT01035463|593298809|FG001|Overall Study|Other|0|||
164254775|NCT01035463|593298810|FG002|Overall Study|Other|0|||
164254776|NCT01035463|593298811|FG003|Overall Study|Other|1|||
164254777|NCT01035463|593298812|FG004|Overall Study|Other|0|||
164254778|NCT01035463|593298813|FG005|Overall Study|Other|2|||
164254779|NCT01126268|593298816|FG000|Overall Study|Adverse Event|1|||
164254780|NCT03425006|593298817|FG000|Overall Study|Withdrawal by Subject|1|||
164254781|NCT03425006|593298817|FG000|Overall Study|Physician Decision|1|||
164254782|NCT03425006|593298817|FG000|Overall Study|Death|1|||
164254783|NCT03748706|593298823|FG000|Overall Study|Lost to Follow-up|1|||
164254784|NCT03070171|593298826|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
164339096|NCT02713204|593617142|FG006|From Week 12 up to Week 36|Death|0|||
164339097|NCT02713204|593617143|FG007|From Week 12 up to Week 36|Death|3|||
164339098|NCT02713204|593617136|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
164339099|NCT02713204|593617137|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
164339100|NCT02713204|593617138|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
164339101|NCT02713204|593617139|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
164339102|NCT02713204|593617140|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
164339103|NCT02713204|593617141|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
164339104|NCT02713204|593617142|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
164339105|NCT02713204|593617143|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
164339106|NCT02713204|593617136|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
164339107|NCT02713204|593617137|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
164339108|NCT02713204|593617138|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
164339109|NCT02713204|593617139|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
164254785|NCT03070171|593298827|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
164254786|NCT03070171|593298826|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
164339110|NCT02713204|593617140|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
164254787|NCT03070171|593298827|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
164254788|NCT00610857|593298833|FG000|Overall Study|Not evaluable for response|2|||
164254789|NCT03655054|593298836|FG000|Overall Study|Lost to Follow-up|1|||
164254790|NCT01626118|593298837|FG000|Overall Study|Lack of Efficacy|1|||
164254791|NCT01626118|593298838|FG001|Overall Study|Lack of Efficacy|0|||
164427422|NCT03929302|593934743|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
164427423|NCT04454567|593934744|FG000|Overall Study|Study Terminated by Sponsor|1|||
164427424|NCT04454567|593934745|FG001|Overall Study|Study Terminated by Sponsor|1|||
164427425|NCT02757885|593934750|FG000|Overall Study|Screen Failures|4|||
164427426|NCT00664521|593934751|FG000|Overall Study|Adverse Event|4|||
164254792|NCT01626118|593298839|FG002|Overall Study|Lack of Efficacy|1|||
164254793|NCT01626118|593298840|FG003|Overall Study|Lack of Efficacy|3|||
164254794|NCT01626118|593298837|FG000|Overall Study|Lost to Follow-up|1|||
164254795|NCT01626118|593298838|FG001|Overall Study|Lost to Follow-up|0|||
164254796|NCT01626118|593298839|FG002|Overall Study|Lost to Follow-up|0|||
164254797|NCT01626118|593298840|FG003|Overall Study|Lost to Follow-up|0|||
164254798|NCT01626118|593298837|FG000|Overall Study|Adverse Event|0|||
164254799|NCT01626118|593298838|FG001|Overall Study|Adverse Event|1|||
164254800|NCT01626118|593298839|FG002|Overall Study|Adverse Event|1|||
164254801|NCT01626118|593298840|FG003|Overall Study|Adverse Event|0|||
164254802|NCT01626118|593298837|FG000|Overall Study|Investigator Decision|0|||
164254803|NCT01626118|593298838|FG001|Overall Study|Investigator Decision|1|||
164254804|NCT01626118|593298839|FG002|Overall Study|Investigator Decision|0|||
164254805|NCT01626118|593298840|FG003|Overall Study|Investigator Decision|0|||
164254806|NCT00002540|593298841|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
164254807|NCT00002540|593298842|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
164254808|NCT00002540|593298841|FG000|Overall Study|Died Before Randomization|2|||
164254809|NCT00002540|593298842|FG001|Overall Study|Died Before Randomization|6|||
164254810|NCT00002540|593298841|FG000|Overall Study|Died Before ASU (Control)|202|||
164254811|NCT00002540|593298842|FG001|Overall Study|Died Before ASU (Control)|0|||
164254812|NCT00002540|593298841|FG000|Overall Study|Refused ASU (Control)|597|||
164254813|NCT00002540|593298842|FG001|Overall Study|Refused ASU (Control)|0|||
164254814|NCT00002540|593298841|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
164254815|NCT00002540|593298842|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
164254816|NCT03931382|593298843|FG000|Overall Study|Equipment malfunction|2|||
164254817|NCT03931382|593298844|FG001|Overall Study|Equipment malfunction|0|||
164254818|NCT03931382|593298845|FG002|Overall Study|Equipment malfunction|2|||
164254819|NCT03931382|593298843|FG000|Overall Study|Withdrawal by Subject|0|||
164254820|NCT03931382|593298844|FG001|Overall Study|Withdrawal by Subject|1|||
164254821|NCT03931382|593298845|FG002|Overall Study|Withdrawal by Subject|0|||
164254822|NCT02151903|593298846|FG000|Overall Study|Withdrawal by Subject|1|||
164254823|NCT02151903|593298847|FG001|Overall Study|Withdrawal by Subject|0|||
164254824|NCT02151903|593298846|FG000|Overall Study|Progressive disease|2|||
164254825|NCT02151903|593298847|FG001|Overall Study|Progressive disease|1|||
164254826|NCT01864148|593298848|FG000|Overall Study|Other|2|||
164254827|NCT01864148|593298849|FG001|Overall Study|Other|1|||
164254828|NCT01864148|593298850|FG002|Overall Study|Other|1|||
164254829|NCT01864148|593298851|FG003|Overall Study|Other|3|||
164254830|NCT01864148|593298852|FG004|Overall Study|Other|1|||
164254831|NCT01864148|593298848|FG000|Overall Study|Death|0|||
164254832|NCT01864148|593298849|FG001|Overall Study|Death|0|||
164254833|NCT01864148|593298850|FG002|Overall Study|Death|0|||
164254834|NCT01864148|593298851|FG003|Overall Study|Death|1|||
164254835|NCT01864148|593298852|FG004|Overall Study|Death|0|||
164254836|NCT01864148|593298848|FG000|Overall Study|Investigator Decision|5|||
164254837|NCT01864148|593298849|FG001|Overall Study|Investigator Decision|0|||
164254838|NCT01864148|593298850|FG002|Overall Study|Investigator Decision|0|||
164254839|NCT01864148|593298851|FG003|Overall Study|Investigator Decision|4|||
164254840|NCT01864148|593298852|FG004|Overall Study|Investigator Decision|6|||
164254841|NCT01864148|593298848|FG000|Overall Study|Withdrawal by Subject|9|||
164254842|NCT01864148|593298849|FG001|Overall Study|Withdrawal by Subject|2|||
164254843|NCT01864148|593298850|FG002|Overall Study|Withdrawal by Subject|6|||
164254844|NCT01864148|593298851|FG003|Overall Study|Withdrawal by Subject|8|||
164254845|NCT01864148|593298852|FG004|Overall Study|Withdrawal by Subject|8|||
164427427|NCT00664521|593934752|FG001|Overall Study|Adverse Event|1|||
164427428|NCT00664521|593934751|FG000|Overall Study|Lost to Follow-up|1|||
164427429|NCT00664521|593934752|FG001|Overall Study|Lost to Follow-up|0|||
164427430|NCT00664521|593934751|FG000|Overall Study|Other|1|||
164427431|NCT00664521|593934752|FG001|Overall Study|Other|0|||
164427432|NCT02459964|593934753|FG000|Overall Study|Withdrawal by Subject|0|||
164254846|NCT01864148|593298848|FG000|Overall Study|Lost to Follow-up|0|||
164254847|NCT01864148|593298849|FG001|Overall Study|Lost to Follow-up|0|||
164254848|NCT01864148|593298850|FG002|Overall Study|Lost to Follow-up|0|||
164254849|NCT01864148|593298851|FG003|Overall Study|Lost to Follow-up|2|||
164254850|NCT01864148|593298852|FG004|Overall Study|Lost to Follow-up|1|||
164254851|NCT01864148|593298848|FG000|Overall Study|Adverse Event|4|||
164254852|NCT01864148|593298849|FG001|Overall Study|Adverse Event|2|||
164254853|NCT01864148|593298850|FG002|Overall Study|Adverse Event|4|||
164254854|NCT01864148|593298851|FG003|Overall Study|Adverse Event|7|||
164254855|NCT01864148|593298852|FG004|Overall Study|Adverse Event|7|||
164254856|NCT01864148|593298848|FG000|Overall Study|Not Dosed|0|||
164427433|NCT02459964|593934754|FG001|Overall Study|Withdrawal by Subject|0|||
164254857|NCT01864148|593298849|FG001|Overall Study|Not Dosed|0|||
164427434|NCT02459964|593934755|FG002|Overall Study|Withdrawal by Subject|1|||
164254858|NCT01864148|593298850|FG002|Overall Study|Not Dosed|0|||
164254859|NCT01864148|593298851|FG003|Overall Study|Not Dosed|1|||
164254860|NCT01864148|593298852|FG004|Overall Study|Not Dosed|0|||
164254861|NCT01500252|593298855|FG000|Overall Study|Death|4|||
164254862|NCT01500252|593298856|FG001|Overall Study|Death|2|||
164254863|NCT01500252|593298855|FG000|Overall Study|Lost to Follow-up|5|||
164254864|NCT01500252|593298856|FG001|Overall Study|Lost to Follow-up|4|||
164254865|NCT00778375|593298857|FG000|Overall Study|Ineligible|3|||
164254866|NCT03490292|593298858|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
164254867|NCT03490292|593298859|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
164254868|NCT03490292|593298858|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
164254869|NCT03490292|593298859|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
164254870|NCT03490292|593298858|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
164254871|NCT03490292|593298859|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
164254872|NCT03490292|593298858|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
164254873|NCT03490292|593298859|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
164254874|NCT03490292|593298858|FG000|1 Year Follow Up Post Last Dose|Death|1|||
164254875|NCT03490292|593298859|FG001|1 Year Follow Up Post Last Dose|Death|1|||
164254876|NCT06003777|593298860|FG000|Period 1|Adverse Event|0|||
164254877|NCT06003777|593298861|FG001|Period 1|Adverse Event|0|||
164254878|NCT06003777|593298862|FG002|Period 1|Adverse Event|1|||
164254879|NCT06003777|593298863|FG003|Period 1|Adverse Event|0|||
164254880|NCT06003777|593298864|FG004|Period 1|Adverse Event|0|||
164254881|NCT06003777|593298865|FG005|Period 1|Adverse Event|0|||
164254882|NCT06003777|593298866|FG006|Period 1|Adverse Event|0|||
164254883|NCT06003777|593298867|FG007|Period 1|Adverse Event|0|||
164254884|NCT06003777|593298868|FG008|Period 1|Adverse Event|0|||
164254885|NCT06003777|593298869|FG009|Period 1|Adverse Event|0|||
164254886|NCT06003777|593298870|FG010|Period 1|Adverse Event|0|||
164254887|NCT06003777|593298871|FG011|Period 1|Adverse Event|0|||
164254888|NCT06003777|593298860|FG000|Period 1|Withdrawal by Subject|0|||
164254889|NCT06003777|593298861|FG001|Period 1|Withdrawal by Subject|0|||
164254890|NCT06003777|593298862|FG002|Period 1|Withdrawal by Subject|0|||
164254891|NCT06003777|593298863|FG003|Period 1|Withdrawal by Subject|0|||
164254892|NCT06003777|593298864|FG004|Period 1|Withdrawal by Subject|1|||
164254893|NCT06003777|593298865|FG005|Period 1|Withdrawal by Subject|0|||
164254894|NCT06003777|593298866|FG006|Period 1|Withdrawal by Subject|0|||
164254895|NCT06003777|593298867|FG007|Period 1|Withdrawal by Subject|0|||
164254896|NCT06003777|593298868|FG008|Period 1|Withdrawal by Subject|0|||
164254897|NCT06003777|593298869|FG009|Period 1|Withdrawal by Subject|0|||
164254898|NCT06003777|593298870|FG010|Period 1|Withdrawal by Subject|0|||
164254899|NCT06003777|593298871|FG011|Period 1|Withdrawal by Subject|0|||
164254900|NCT06003777|593298860|FG000|Period 2|Withdrawal by Subject|0|||
164254901|NCT06003777|593298861|FG001|Period 2|Withdrawal by Subject|0|||
164254902|NCT06003777|593298862|FG002|Period 2|Withdrawal by Subject|0|||
164254903|NCT06003777|593298863|FG003|Period 2|Withdrawal by Subject|0|||
164254904|NCT06003777|593298864|FG004|Period 2|Withdrawal by Subject|0|||
164254905|NCT06003777|593298865|FG005|Period 2|Withdrawal by Subject|0|||
164254906|NCT06003777|593298866|FG006|Period 2|Withdrawal by Subject|0|||
164254907|NCT06003777|593298867|FG007|Period 2|Withdrawal by Subject|0|||
164254908|NCT06003777|593298868|FG008|Period 2|Withdrawal by Subject|1|||
164254909|NCT06003777|593298869|FG009|Period 2|Withdrawal by Subject|0|||
164254910|NCT06003777|593298870|FG010|Period 2|Withdrawal by Subject|0|||
164254911|NCT06003777|593298871|FG011|Period 2|Withdrawal by Subject|0|||
164254912|NCT06003777|593298860|FG000|Period 3|Adverse Event|0|||
164254913|NCT06003777|593298861|FG001|Period 3|Adverse Event|0|||
164254914|NCT06003777|593298862|FG002|Period 3|Adverse Event|0|||
164254915|NCT06003777|593298863|FG003|Period 3|Adverse Event|0|||
164254916|NCT06003777|593298864|FG004|Period 3|Adverse Event|0|||
164254917|NCT06003777|593298865|FG005|Period 3|Adverse Event|0|||
164254918|NCT06003777|593298866|FG006|Period 3|Adverse Event|1|||
164254919|NCT06003777|593298867|FG007|Period 3|Adverse Event|0|||
164254920|NCT06003777|593298868|FG008|Period 3|Adverse Event|0|||
164254921|NCT06003777|593298869|FG009|Period 3|Adverse Event|0|||
164254922|NCT06003777|593298870|FG010|Period 3|Adverse Event|0|||
164254923|NCT06003777|593298871|FG011|Period 3|Adverse Event|0|||
164254924|NCT06003777|593298860|FG000|Period 4|No longer met eligibility criteria|0|||
164254925|NCT06003777|593298861|FG001|Period 4|No longer met eligibility criteria|0|||
164254926|NCT06003777|593298862|FG002|Period 4|No longer met eligibility criteria|1|||
164254927|NCT06003777|593298863|FG003|Period 4|No longer met eligibility criteria|0|||
164254928|NCT06003777|593298864|FG004|Period 4|No longer met eligibility criteria|0|||
164254929|NCT06003777|593298865|FG005|Period 4|No longer met eligibility criteria|0|||
164254930|NCT06003777|593298866|FG006|Period 4|No longer met eligibility criteria|0|||
164254931|NCT06003777|593298867|FG007|Period 4|No longer met eligibility criteria|0|||
164254932|NCT06003777|593298868|FG008|Period 4|No longer met eligibility criteria|0|||
164254933|NCT06003777|593298869|FG009|Period 4|No longer met eligibility criteria|0|||
164254934|NCT06003777|593298870|FG010|Period 4|No longer met eligibility criteria|0|||
164254935|NCT06003777|593298871|FG011|Period 4|No longer met eligibility criteria|0|||
164254936|NCT06003777|593298860|FG000|Period 4|Withdrawal by Subject|0|||
164254937|NCT06003777|593298861|FG001|Period 4|Withdrawal by Subject|1|||
164254938|NCT06003777|593298862|FG002|Period 4|Withdrawal by Subject|0|||
164254939|NCT06003777|593298863|FG003|Period 4|Withdrawal by Subject|0|||
164254940|NCT06003777|593298864|FG004|Period 4|Withdrawal by Subject|0|||
164254941|NCT06003777|593298865|FG005|Period 4|Withdrawal by Subject|0|||
164254942|NCT06003777|593298866|FG006|Period 4|Withdrawal by Subject|0|||
164254943|NCT06003777|593298867|FG007|Period 4|Withdrawal by Subject|0|||
164254944|NCT06003777|593298868|FG008|Period 4|Withdrawal by Subject|0|||
164254945|NCT06003777|593298869|FG009|Period 4|Withdrawal by Subject|0|||
164254946|NCT06003777|593298870|FG010|Period 4|Withdrawal by Subject|0|||
164254947|NCT06003777|593298871|FG011|Period 4|Withdrawal by Subject|0|||
164254948|NCT00712725|593298876|FG000|Overall Study|Adverse Event|1|||
164254949|NCT00712725|593298877|FG001|Overall Study|Adverse Event|0|||
164254950|NCT00712725|593298878|FG002|Overall Study|Adverse Event|0|||
164254951|NCT00712725|593298879|FG003|Overall Study|Adverse Event|1|||
164254952|NCT00712725|593298880|FG004|Overall Study|Adverse Event|0|||
164254953|NCT00712725|593298881|FG005|Overall Study|Adverse Event|0|||
164254954|NCT00712725|593298882|FG006|Overall Study|Adverse Event|0|||
164254955|NCT00712725|593298883|FG007|Overall Study|Adverse Event|0|||
164254956|NCT00712725|593298876|FG000|Overall Study|Lost to Follow-up|3|||
164254957|NCT00712725|593298877|FG001|Overall Study|Lost to Follow-up|2|||
164254958|NCT00712725|593298878|FG002|Overall Study|Lost to Follow-up|1|||
164254959|NCT00712725|593298879|FG003|Overall Study|Lost to Follow-up|1|||
164254960|NCT00712725|593298880|FG004|Overall Study|Lost to Follow-up|2|||
164254961|NCT00712725|593298881|FG005|Overall Study|Lost to Follow-up|2|||
164254962|NCT00712725|593298882|FG006|Overall Study|Lost to Follow-up|3|||
164254963|NCT00712725|593298883|FG007|Overall Study|Lost to Follow-up|1|||
164254964|NCT00712725|593298876|FG000|Overall Study|Physician Decision|2|||
164254965|NCT00712725|593298877|FG001|Overall Study|Physician Decision|0|||
164254966|NCT00712725|593298878|FG002|Overall Study|Physician Decision|0|||
164254967|NCT00712725|593298879|FG003|Overall Study|Physician Decision|0|||
164254968|NCT00712725|593298880|FG004|Overall Study|Physician Decision|1|||
164254969|NCT00712725|593298881|FG005|Overall Study|Physician Decision|0|||
164254970|NCT00712725|593298882|FG006|Overall Study|Physician Decision|2|||
164254971|NCT00712725|593298883|FG007|Overall Study|Physician Decision|0|||
164254972|NCT00712725|593298876|FG000|Overall Study|Pregnancy|0|||
164254973|NCT00712725|593298877|FG001|Overall Study|Pregnancy|1|||
164254974|NCT00712725|593298878|FG002|Overall Study|Pregnancy|0|||
164254975|NCT00712725|593298879|FG003|Overall Study|Pregnancy|0|||
164254976|NCT00712725|593298880|FG004|Overall Study|Pregnancy|1|||
164254977|NCT00712725|593298881|FG005|Overall Study|Pregnancy|0|||
164254978|NCT00712725|593298882|FG006|Overall Study|Pregnancy|2|||
164254979|NCT00712725|593298883|FG007|Overall Study|Pregnancy|0|||
164254980|NCT00712725|593298876|FG000|Overall Study|Protocol Violation|2|||
164254981|NCT00712725|593298877|FG001|Overall Study|Protocol Violation|0|||
164254982|NCT00712725|593298878|FG002|Overall Study|Protocol Violation|1|||
164254983|NCT00712725|593298879|FG003|Overall Study|Protocol Violation|3|||
164254984|NCT00712725|593298880|FG004|Overall Study|Protocol Violation|2|||
164254985|NCT00712725|593298881|FG005|Overall Study|Protocol Violation|0|||
164254986|NCT00712725|593298882|FG006|Overall Study|Protocol Violation|1|||
164254987|NCT00712725|593298883|FG007|Overall Study|Protocol Violation|1|||
164339111|NCT02713204|593617141|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
164339112|NCT02713204|593617142|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
164339113|NCT02713204|593617143|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
164339114|NCT00474760|593617147|FG000|Overall Study|Death|0|||
164339115|NCT00474760|593617148|FG001|Overall Study|Death|0|||
164427435|NCT02459964|593934753|FG000|Overall Study|Abnormal EKG changes|0|||
164339116|NCT00474760|593617149|FG002|Overall Study|Death|0|||
164427436|NCT02459964|593934754|FG001|Overall Study|Abnormal EKG changes|0|||
164427437|NCT02459964|593934755|FG002|Overall Study|Abnormal EKG changes|1|||
164427438|NCT01456780|593934756|FG000|Overall Study|Lost to Follow-up|3|||
164427439|NCT01456780|593934757|FG001|Overall Study|Lost to Follow-up|3|||
164427440|NCT01456780|593934758|FG002|Overall Study|Lost to Follow-up|0|||
164254988|NCT00712725|593298876|FG000|Overall Study|Withdrawal by Subject|2|||
164254989|NCT00712725|593298877|FG001|Overall Study|Withdrawal by Subject|1|||
164254990|NCT00712725|593298878|FG002|Overall Study|Withdrawal by Subject|1|||
164254991|NCT00712725|593298879|FG003|Overall Study|Withdrawal by Subject|2|||
164254992|NCT00712725|593298880|FG004|Overall Study|Withdrawal by Subject|1|||
164254993|NCT00712725|593298881|FG005|Overall Study|Withdrawal by Subject|1|||
164254994|NCT00712725|593298882|FG006|Overall Study|Withdrawal by Subject|1|||
164254995|NCT00712725|593298883|FG007|Overall Study|Withdrawal by Subject|2|||
164339117|NCT00474760|593617150|FG003|Overall Study|Death|0|||
164254996|NCT00712725|593298876|FG000|Overall Study|Lack of Qualifying Event|16|||
164254997|NCT00712725|593298877|FG001|Overall Study|Lack of Qualifying Event|2|||
164254998|NCT00712725|593298878|FG002|Overall Study|Lack of Qualifying Event|6|||
164254999|NCT00712725|593298879|FG003|Overall Study|Lack of Qualifying Event|8|||
164255000|NCT00712725|593298880|FG004|Overall Study|Lack of Qualifying Event|11|||
164339118|NCT00474760|593617151|FG004|Overall Study|Death|2|||
164339119|NCT00474760|593617152|FG005|Overall Study|Death|0|||
164427441|NCT02321540|593934764|FG000|Overall Study|Death|0|||
164339120|NCT00474760|593617153|FG006|Overall Study|Death|0|||
164255001|NCT00712725|593298881|FG005|Overall Study|Lack of Qualifying Event|13|||
164255002|NCT00712725|593298882|FG006|Overall Study|Lack of Qualifying Event|11|||
164255003|NCT00712725|593298883|FG007|Overall Study|Lack of Qualifying Event|6|||
164255004|NCT00712725|593298876|FG000|Overall Study|Protocol Specified Criteria|3|||
164255005|NCT00712725|593298877|FG001|Overall Study|Protocol Specified Criteria|0|||
164255006|NCT00712725|593298878|FG002|Overall Study|Protocol Specified Criteria|1|||
164255007|NCT00712725|593298879|FG003|Overall Study|Protocol Specified Criteria|2|||
164255008|NCT00712725|593298880|FG004|Overall Study|Protocol Specified Criteria|1|||
164255009|NCT00712725|593298881|FG005|Overall Study|Protocol Specified Criteria|0|||
164255010|NCT00712725|593298882|FG006|Overall Study|Protocol Specified Criteria|2|||
164255011|NCT00712725|593298883|FG007|Overall Study|Protocol Specified Criteria|1|||
164427442|NCT02321540|593934765|FG001|Overall Study|Death|1|||
164427443|NCT02321540|593934764|FG000|Overall Study|Progression|3|||
164427444|NCT02321540|593934765|FG001|Overall Study|Progression|9|||
164427445|NCT04541186|593934767|FG000|Main Study|Adverse Event|0|||
164427446|NCT04541186|593934768|FG001|Main Study|Adverse Event|0|||
164427447|NCT04541186|593934769|FG002|Main Study|Adverse Event|4|||
164427448|NCT04541186|593934770|FG003|Main Study|Adverse Event|0|||
164427449|NCT04541186|593934771|FG004|Main Study|Adverse Event|0|||
164427450|NCT04541186|593934767|FG000|Main Study|Investigator Decision|0|||
164427451|NCT04541186|593934768|FG001|Main Study|Investigator Decision|0|||
164255012|NCT00582712|593298890|FG000|Overall Study|Adverse Event|1|||
164255013|NCT00582712|593298890|FG000|Overall Study|Lack of Efficacy|1|||
164255014|NCT00582712|593298890|FG000|Overall Study|Withdrawal by Subject|1|||
164255015|NCT00582712|593298890|FG000|Overall Study|Complicating disease requiring treatment|1|||
164255016|NCT01901289|593298891|FG000|Overall Study|Death|32|||
164255017|NCT01901289|593298891|FG000|Overall Study|Lost to Follow-up|16|||
164255018|NCT01901289|593298891|FG000|Overall Study|Withdrawal by Subject|35|||
164255019|NCT01901289|593298891|FG000|Overall Study|Other type of endpoint met|2|||
164255020|NCT00700882|593298898|FG000|Overall Study|Never received treatment|6|||
164255021|NCT00700882|593298898|FG000|Overall Study|Ineligible|2|||
164255022|NCT00700882|593298898|FG000|Overall Study|No KIT mutation|51|||
164255023|NCT01606176|593298899|FG000|Overall Study|Adverse Event|2|||
164255024|NCT01606176|593298900|FG001|Overall Study|Adverse Event|3|||
164255025|NCT01606176|593298899|FG000|Overall Study|Disease progression|1|||
164255026|NCT01606176|593298900|FG001|Overall Study|Disease progression|0|||
164255027|NCT01606176|593298899|FG000|Overall Study|Withdrawal by Subject|1|||
164255028|NCT01606176|593298900|FG001|Overall Study|Withdrawal by Subject|0|||
164255029|NCT01818258|593298902|FG000|Overall Study|Death|3|||
164255030|NCT01818258|593298903|FG001|Overall Study|Death|0|||
164255031|NCT01818258|593298902|FG000|Overall Study|Withdrawal by Subject|0|||
164255032|NCT01818258|593298903|FG001|Overall Study|Withdrawal by Subject|1|||
164255033|NCT01818258|593298902|FG000|Overall Study|Lost to Follow-up|0|||
164255034|NCT01818258|593298903|FG001|Overall Study|Lost to Follow-up|1|||
164427452|NCT04541186|593934769|FG002|Main Study|Investigator Decision|1|||
164427453|NCT04541186|593934770|FG003|Main Study|Investigator Decision|1|||
164427454|NCT04541186|593934771|FG004|Main Study|Investigator Decision|0|||
164427455|NCT04541186|593934767|FG000|Main Study|Withdrawal by Subject|1|||
164427456|NCT04541186|593934768|FG001|Main Study|Withdrawal by Subject|1|||
164427457|NCT04541186|593934769|FG002|Main Study|Withdrawal by Subject|0|||
164427458|NCT04541186|593934770|FG003|Main Study|Withdrawal by Subject|0|||
164427459|NCT04541186|593934771|FG004|Main Study|Withdrawal by Subject|0|||
164255035|NCT01818258|593298902|FG000|Overall Study|Unable to Travel to Clinic|0|||
164255036|NCT01818258|593298903|FG001|Overall Study|Unable to Travel to Clinic|1|||
164255037|NCT02839720|593298904|FG000|Overall Study|Adverse Event|2|||
164255038|NCT02839720|593298904|FG000|Overall Study|Non-compliance|2|||
164255039|NCT02839720|593298904|FG000|Overall Study|Intercurrent Illness|1|||
164255040|NCT02839720|593298904|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
164255041|NCT00107900|593298907|FG000|Overall Study|Adverse Event|3|||
164255042|NCT00107900|593298908|FG001|Overall Study|Adverse Event|2|||
164255043|NCT00107900|593298909|FG002|Overall Study|Adverse Event|10|||
164255044|NCT00107900|593298910|FG003|Overall Study|Adverse Event|3|||
164255045|NCT00107900|593298911|FG004|Overall Study|Adverse Event|5|||
164255046|NCT00107900|593298912|FG005|Overall Study|Adverse Event|3|||
164255047|NCT00107900|593298907|FG000|Overall Study|Death|0|||
164255048|NCT00107900|593298908|FG001|Overall Study|Death|0|||
164255049|NCT00107900|593298909|FG002|Overall Study|Death|0|||
164427460|NCT04541186|593934767|FG000|Main Study|COVID-19-related Dose Interruption|0|||
164427461|NCT04541186|593934768|FG001|Main Study|COVID-19-related Dose Interruption|0|||
164427462|NCT04541186|593934769|FG002|Main Study|COVID-19-related Dose Interruption|0|||
164255050|NCT00107900|593298910|FG003|Overall Study|Death|0|||
164255051|NCT00107900|593298911|FG004|Overall Study|Death|1|||
164255052|NCT00107900|593298912|FG005|Overall Study|Death|0|||
164427463|NCT04541186|593934770|FG003|Main Study|COVID-19-related Dose Interruption|0|||
164427464|NCT04541186|593934771|FG004|Main Study|COVID-19-related Dose Interruption|1|||
164427465|NCT04541186|593934767|FG000|Main Study|Randomized in Error Not Treated|0|||
164427466|NCT04541186|593934768|FG001|Main Study|Randomized in Error Not Treated|0|||
164427467|NCT04541186|593934769|FG002|Main Study|Randomized in Error Not Treated|1|||
164255053|NCT00107900|593298907|FG000|Overall Study|Lost to Follow-up|4|||
164255054|NCT00107900|593298908|FG001|Overall Study|Lost to Follow-up|1|||
164255055|NCT00107900|593298909|FG002|Overall Study|Lost to Follow-up|3|||
164255056|NCT00107900|593298910|FG003|Overall Study|Lost to Follow-up|2|||
164255057|NCT00107900|593298911|FG004|Overall Study|Lost to Follow-up|5|||
164255058|NCT00107900|593298912|FG005|Overall Study|Lost to Follow-up|5|||
164255059|NCT00107900|593298907|FG000|Overall Study|Protocol Violation|1|||
164255060|NCT00107900|593298908|FG001|Overall Study|Protocol Violation|0|||
164255061|NCT00107900|593298909|FG002|Overall Study|Protocol Violation|5|||
164255062|NCT00107900|593298910|FG003|Overall Study|Protocol Violation|5|||
164255063|NCT00107900|593298911|FG004|Overall Study|Protocol Violation|7|||
164255064|NCT00107900|593298912|FG005|Overall Study|Protocol Violation|0|||
164255065|NCT00107900|593298907|FG000|Overall Study|Withdrawal by Subject|1|||
164255066|NCT00107900|593298908|FG001|Overall Study|Withdrawal by Subject|0|||
164255067|NCT00107900|593298909|FG002|Overall Study|Withdrawal by Subject|5|||
164255068|NCT00107900|593298910|FG003|Overall Study|Withdrawal by Subject|0|||
164255069|NCT00107900|593298911|FG004|Overall Study|Withdrawal by Subject|1|||
164255070|NCT00107900|593298912|FG005|Overall Study|Withdrawal by Subject|1|||
164255071|NCT00107900|593298907|FG000|Overall Study|Administrative Reasons|1|||
164255072|NCT00107900|593298908|FG001|Overall Study|Administrative Reasons|0|||
164255073|NCT00107900|593298909|FG002|Overall Study|Administrative Reasons|2|||
164255074|NCT00107900|593298910|FG003|Overall Study|Administrative Reasons|2|||
164255075|NCT00107900|593298911|FG004|Overall Study|Administrative Reasons|2|||
164255076|NCT00107900|593298912|FG005|Overall Study|Administrative Reasons|0|||
164255077|NCT03100539|593302225|FG000|Overall Study|Lost to Follow-up|60|||
164255078|NCT03100539|593302226|FG001|Overall Study|Lost to Follow-up|54|||
164255079|NCT03100539|593302227|FG002|Overall Study|Lost to Follow-up|17|||
164255080|NCT03100539|593302225|FG000|Overall Study|Uncollected|8|||
164255081|NCT03100539|593302226|FG001|Overall Study|Uncollected|8|||
164255082|NCT03100539|593302227|FG002|Overall Study|Uncollected|0|||
164255083|NCT03100539|593302225|FG000|Overall Study|Ally Health|0|||
164255084|NCT03100539|593302226|FG001|Overall Study|Ally Health|0|||
164255085|NCT03100539|593302227|FG002|Overall Study|Ally Health|3|||
164255086|NCT03100539|593302225|FG000|Overall Study|Disinterest|0|||
164255087|NCT03100539|593302226|FG001|Overall Study|Disinterest|0|||
164255088|NCT03100539|593302227|FG002|Overall Study|Disinterest|22|||
164255089|NCT03100539|593302225|FG000|Overall Study|Veteran Health|0|||
164255090|NCT03100539|593302226|FG001|Overall Study|Veteran Health|0|||
164255091|NCT03100539|593302227|FG002|Overall Study|Veteran Health|8|||
164255092|NCT03100539|593302225|FG000|Overall Study|Moved|0|||
164255093|NCT03100539|593302226|FG001|Overall Study|Moved|0|||
164255094|NCT03100539|593302227|FG002|Overall Study|Moved|1|||
164576394|NCT01976806|594473182|FG001|Overall Study|Withdrawal by Subject|1|||
164576395|NCT03929250|594473187|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
164576396|NCT03929250|594473188|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
164576397|NCT01523873|594473190|FG000|Overall Study|Protocol Violation|422|||
164576398|NCT06119191|594473192|FG000|Overall Study|Adverse Event|0|||
164576399|NCT06119191|594473193|FG001|Overall Study|Adverse Event|1|||
164576400|NCT06119191|594473192|FG000|Overall Study|Protocol Violation|1|||
164576401|NCT06119191|594473193|FG001|Overall Study|Protocol Violation|0|||
164576402|NCT01896232|594474738|FG000|Overall Study|Death|6|||
164576403|NCT01896232|594474739|FG001|Overall Study|Death|10|||
164576404|NCT01896232|594474738|FG000|Overall Study|Withdrawal by Subject|32|||
164576405|NCT01896232|594474739|FG001|Overall Study|Withdrawal by Subject|31|||
164576406|NCT01896232|594474738|FG000|Overall Study|Sponsor Decision|2|||
164576407|NCT01896232|594474739|FG001|Overall Study|Sponsor Decision|0|||
164576408|NCT01896232|594474738|FG000|Overall Study|Lost to Follow-up|9|||
164576409|NCT01896232|594474739|FG001|Overall Study|Lost to Follow-up|12|||
164576410|NCT00686205|594474740|FG000|Overall Study|Protocol Violation|127|||
164576411|NCT00686205|594474741|FG001|Overall Study|Protocol Violation|0|||
164576412|NCT00686205|594474740|FG000|Overall Study|Withdrawal by Subject|2|||
164576413|NCT00686205|594474741|FG001|Overall Study|Withdrawal by Subject|0|||
164576414|NCT00686205|594474740|FG000|Overall Study|Specimen handling procedure altered|5878|||
164576415|NCT00686205|594474741|FG001|Overall Study|Specimen handling procedure altered|0|||
164576416|NCT00686205|594474740|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
164576417|NCT00686205|594474741|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
164576418|NCT01485614|594474742|FG000|Randomization|Not Treated|1|||
164576419|NCT01485614|594474743|FG001|Randomization|Not Treated|0|||
164576420|NCT01485614|594474744|FG002|Randomization|Not Treated|0|||
164576421|NCT01485614|594474745|FG003|Randomization|Not Treated|0|||
164576422|NCT01485614|594474742|FG000|Weeks 0-20|Lost to Follow-up|2|||
164576423|NCT01485614|594474743|FG001|Weeks 0-20|Lost to Follow-up|0|||
164255095|NCT03100539|593302225|FG000|Overall Study|Scheduling Conflicts|0|||
164255096|NCT03100539|593302226|FG001|Overall Study|Scheduling Conflicts|0|||
164255097|NCT03100539|593302227|FG002|Overall Study|Scheduling Conflicts|12|||
164255098|NCT02596958|593302237|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
164255099|NCT02596958|593302237|FG000|Overall Study|Cancer Progression|441|||
164255100|NCT02596958|593302237|FG000|Overall Study|Death From Cancer|112|||
164255101|NCT02596958|593302237|FG000|Overall Study|Death From Other Cause|33|||
164255102|NCT02596958|593302237|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
164255103|NCT02596958|593302237|FG000|Overall Study|Administrative Reasons/Other|231|||
164255104|NCT02596958|593302237|FG000|Overall Study|Lost to Follow-up|33|||
164255105|NCT02596958|593302237|FG000|Overall Study|Missing|32|||
164255106|NCT02596958|593302237|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
164255107|NCT00983515|593302238|FG000|Ritonavir Alone|liver panel out of range|6|||
164255108|NCT00983515|593302238|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
164255109|NCT01995669|593302239|FG000|Overall Study|Progression|2|||
164255110|NCT01995669|593302240|FG001|Overall Study|Progression|1|||
164255111|NCT01995669|593302241|FG002|Overall Study|Progression|1|||
164255112|NCT01995669|593302242|FG003|Overall Study|Progression|13|||
164255113|NCT01995669|593302239|FG000|Overall Study|Adverse Event|0|||
164255114|NCT01995669|593302240|FG001|Overall Study|Adverse Event|0|||
164255115|NCT01995669|593302241|FG002|Overall Study|Adverse Event|0|||
164255116|NCT01995669|593302242|FG003|Overall Study|Adverse Event|3|||
164255117|NCT01995669|593302239|FG000|Overall Study|Death|0|||
164255118|NCT01995669|593302240|FG001|Overall Study|Death|0|||
164255119|NCT01995669|593302241|FG002|Overall Study|Death|0|||
164255120|NCT01995669|593302242|FG003|Overall Study|Death|6|||
164255121|NCT01995669|593302239|FG000|Overall Study|Withdrawal by Subject|0|||
164255122|NCT01995669|593302240|FG001|Overall Study|Withdrawal by Subject|0|||
164255123|NCT01995669|593302241|FG002|Overall Study|Withdrawal by Subject|0|||
164255124|NCT01995669|593302242|FG003|Overall Study|Withdrawal by Subject|6|||
164255125|NCT01995669|593302239|FG000|Overall Study|Insurance Expired|0|||
164255126|NCT01995669|593302240|FG001|Overall Study|Insurance Expired|0|||
164255127|NCT01995669|593302241|FG002|Overall Study|Insurance Expired|0|||
164255128|NCT01995669|593302242|FG003|Overall Study|Insurance Expired|1|||
164255129|NCT04753658|593302243|FG000|Overall Study|Progressive disease|7|||
164255130|NCT04753658|593302243|FG000|Overall Study|Other|7|||
164255131|NCT04753658|593302243|FG000|Overall Study|Adverse Event|1|||
164255132|NCT05659719|593302244|FG000|Overall Study|At sponsor's request|0|||
164255133|NCT05659719|593302245|FG001|Overall Study|At sponsor's request|0|||
164255134|NCT05659719|593302246|FG002|Overall Study|At sponsor's request|0|||
164255135|NCT05659719|593302247|FG003|Overall Study|At sponsor's request|95|||
164255136|NCT05659719|593302244|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
164255137|NCT05659719|593302245|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
164255138|NCT05659719|593302246|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
164255139|NCT05659719|593302247|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
164255140|NCT05659719|593302244|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
164255141|NCT05659719|593302245|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
164255142|NCT05659719|593302246|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
164255143|NCT05659719|593302247|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
164255144|NCT05659719|593302244|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
164255145|NCT05659719|593302245|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
164255146|NCT05659719|593302246|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
164255147|NCT05659719|593302247|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
164255148|NCT05659719|593302244|FG000|Overall Study|Lost to Follow-up|0|||
164255149|NCT05659719|593302245|FG001|Overall Study|Lost to Follow-up|0|||
164255150|NCT05659719|593302246|FG002|Overall Study|Lost to Follow-up|0|||
164255151|NCT05659719|593302247|FG003|Overall Study|Lost to Follow-up|2|||
164255152|NCT05659719|593302244|FG000|Overall Study|Moved to another observational study|0|||
164255153|NCT05659719|593302245|FG001|Overall Study|Moved to another observational study|0|||
164255154|NCT05659719|593302246|FG002|Overall Study|Moved to another observational study|0|||
164255155|NCT05659719|593302247|FG003|Overall Study|Moved to another observational study|1|||
164255156|NCT05659719|593302244|FG000|Overall Study|The child was enrolled in an interventional study|0|||
164255157|NCT05659719|593302245|FG001|Overall Study|The child was enrolled in an interventional study|0|||
164255158|NCT05659719|593302246|FG002|Overall Study|The child was enrolled in an interventional study|0|||
164576424|NCT01485614|594474744|FG002|Weeks 0-20|Lost to Follow-up|0|||
164576425|NCT01485614|594474745|FG003|Weeks 0-20|Lost to Follow-up|0|||
164576426|NCT01485614|594474742|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
164576427|NCT01485614|594474743|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
164576428|NCT01485614|594474744|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
164576429|NCT01485614|594474745|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
164576430|NCT01485614|594474742|FG000|Weeks 0-20|Withdrawal by Subject|3|||
164576431|NCT01485614|594474743|FG001|Weeks 0-20|Withdrawal by Subject|2|||
164576432|NCT01485614|594474744|FG002|Weeks 0-20|Withdrawal by Subject|1|||
164576433|NCT01485614|594474745|FG003|Weeks 0-20|Withdrawal by Subject|0|||
164255159|NCT05659719|593302247|FG003|Overall Study|The child was enrolled in an interventional study|55|||
164255160|NCT05659719|593302244|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
164255161|NCT05659719|593302245|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
164255162|NCT05659719|593302246|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
164255163|NCT05659719|593302247|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
164255164|NCT05659719|593302244|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
164255165|NCT05659719|593302245|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
164255166|NCT05659719|593302246|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
164255167|NCT05659719|593302247|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
164255168|NCT02290691|593302248|FG000|Overall Study|Noncompliance|0|||
164255169|NCT02290691|593302249|FG001|Overall Study|Noncompliance|1|||
164255170|NCT02290691|593302248|FG000|Overall Study|Withdrawal by Subject|1|||
164255171|NCT02290691|593302249|FG001|Overall Study|Withdrawal by Subject|1|||
164255172|NCT02290691|593302248|FG000|Overall Study|Lost to Follow-up|7|||
164255173|NCT02290691|593302249|FG001|Overall Study|Lost to Follow-up|7|||
164255174|NCT00185380|593302251|FG000|Overall Study|Adverse Event|41|||
164255175|NCT00185380|593302252|FG001|Overall Study|Adverse Event|43|||
164255176|NCT00185380|593302253|FG002|Overall Study|Adverse Event|48|||
164255177|NCT00185380|593302251|FG000|Overall Study|Lost to Follow-up|0|||
164255178|NCT00185380|593302252|FG001|Overall Study|Lost to Follow-up|4|||
164255179|NCT00185380|593302253|FG002|Overall Study|Lost to Follow-up|3|||
164255180|NCT00185380|593302251|FG000|Overall Study|Pregnancy|1|||
164255181|NCT00185380|593302252|FG001|Overall Study|Pregnancy|4|||
164255182|NCT00185380|593302253|FG002|Overall Study|Pregnancy|0|||
164255183|NCT00185380|593302251|FG000|Overall Study|Protocol Violation|2|||
164255184|NCT00185380|593302252|FG001|Overall Study|Protocol Violation|2|||
164255185|NCT00185380|593302253|FG002|Overall Study|Protocol Violation|1|||
164255186|NCT00185380|593302251|FG000|Overall Study|Withdrawal by Subject|1|||
164255187|NCT00185380|593302252|FG001|Overall Study|Withdrawal by Subject|2|||
164255188|NCT00185380|593302253|FG002|Overall Study|Withdrawal by Subject|0|||
164255189|NCT00185380|593302251|FG000|Overall Study|Failed insertion|1|||
164255190|NCT00185380|593302252|FG001|Overall Study|Failed insertion|1|||
164255191|NCT00185380|593302253|FG002|Overall Study|Failed insertion|2|||
164255192|NCT00185380|593302251|FG000|Overall Study|Planned pregnancy|9|||
164255193|NCT00185380|593302252|FG001|Overall Study|Planned pregnancy|12|||
164255194|NCT00185380|593302253|FG002|Overall Study|Planned pregnancy|12|||
164255195|NCT00185380|593302251|FG000|Overall Study|No need for contraception|3|||
164255196|NCT00185380|593302252|FG001|Overall Study|No need for contraception|3|||
164255197|NCT00185380|593302253|FG002|Overall Study|No need for contraception|3|||
164255198|NCT00185380|593302251|FG000|Overall Study|Could not attend visits|2|||
164255199|NCT00185380|593302252|FG001|Overall Study|Could not attend visits|0|||
164255200|NCT00185380|593302253|FG002|Overall Study|Could not attend visits|4|||
164255201|NCT00185380|593302251|FG000|Overall Study|personal reason|6|||
164255202|NCT00185380|593302252|FG001|Overall Study|personal reason|1|||
164255203|NCT00185380|593302253|FG002|Overall Study|personal reason|1|||
164255204|NCT00218634|593302254|FG000|Overall Study|Lost to Follow-up|8|||
164255205|NCT00218634|593302255|FG001|Overall Study|Lost to Follow-up|15|||
164255206|NCT02589665|593302256|FG000|Induction Period|Did not receive drug|0|||
164255207|NCT02589665|593302257|FG001|Induction Period|Did not receive drug|0|||
164255208|NCT02589665|593302258|FG002|Induction Period|Did not receive drug|0|||
164255209|NCT02589665|593302259|FG003|Induction Period|Did not receive drug|1|||
164255210|NCT02589665|593302260|FG004|Induction Period|Did not receive drug|0|||
164255211|NCT02589665|593302261|FG005|Induction Period|Did not receive drug|0|||
164255212|NCT02589665|593302262|FG006|Induction Period|Did not receive drug|0|||
164255213|NCT02589665|593302263|FG007|Induction Period|Did not receive drug|0|||
164255214|NCT02589665|593302264|FG008|Induction Period|Did not receive drug|0|||
164255215|NCT02589665|593302265|FG009|Induction Period|Did not receive drug|0|||
164427468|NCT04541186|593934770|FG003|Main Study|Randomized in Error Not Treated|0|||
164427469|NCT04541186|593934771|FG004|Main Study|Randomized in Error Not Treated|0|||
164255216|NCT02589665|593302256|FG000|Induction Period|Adverse Event|3|||
164255217|NCT02589665|593302257|FG001|Induction Period|Adverse Event|0|||
164427470|NCT04541186|593934767|FG000|Fibrate Expansion Study|Other than Specified|0|||
164255218|NCT02589665|593302258|FG002|Induction Period|Adverse Event|2|||
164255219|NCT02589665|593302259|FG003|Induction Period|Adverse Event|2|||
164255220|NCT02589665|593302260|FG004|Induction Period|Adverse Event|0|||
164427471|NCT04541186|593934768|FG001|Fibrate Expansion Study|Other than Specified|0|||
164255221|NCT02589665|593302261|FG005|Induction Period|Adverse Event|0|||
164255222|NCT02589665|593302262|FG006|Induction Period|Adverse Event|0|||
164255223|NCT02589665|593302263|FG007|Induction Period|Adverse Event|0|||
164255224|NCT02589665|593302264|FG008|Induction Period|Adverse Event|0|||
164255225|NCT02589665|593302265|FG009|Induction Period|Adverse Event|0|||
164255226|NCT02589665|593302256|FG000|Induction Period|Withdrawal by Subject|0|||
164255227|NCT02589665|593302257|FG001|Induction Period|Withdrawal by Subject|1|||
164255228|NCT02589665|593302258|FG002|Induction Period|Withdrawal by Subject|0|||
164255229|NCT02589665|593302259|FG003|Induction Period|Withdrawal by Subject|1|||
164255230|NCT02589665|593302260|FG004|Induction Period|Withdrawal by Subject|0|||
164255231|NCT02589665|593302261|FG005|Induction Period|Withdrawal by Subject|0|||
164255232|NCT02589665|593302262|FG006|Induction Period|Withdrawal by Subject|0|||
164255233|NCT02589665|593302263|FG007|Induction Period|Withdrawal by Subject|0|||
164255234|NCT02589665|593302264|FG008|Induction Period|Withdrawal by Subject|0|||
164255235|NCT02589665|593302265|FG009|Induction Period|Withdrawal by Subject|0|||
164255236|NCT02589665|593302256|FG000|Induction Period|Protocol Violation|0|||
164255237|NCT02589665|593302257|FG001|Induction Period|Protocol Violation|1|||
164255238|NCT02589665|593302258|FG002|Induction Period|Protocol Violation|0|||
164255239|NCT02589665|593302259|FG003|Induction Period|Protocol Violation|0|||
164255240|NCT02589665|593302260|FG004|Induction Period|Protocol Violation|0|||
164255241|NCT02589665|593302261|FG005|Induction Period|Protocol Violation|0|||
164255242|NCT02589665|593302262|FG006|Induction Period|Protocol Violation|0|||
164255243|NCT02589665|593302263|FG007|Induction Period|Protocol Violation|0|||
164255244|NCT02589665|593302264|FG008|Induction Period|Protocol Violation|0|||
164255245|NCT02589665|593302265|FG009|Induction Period|Protocol Violation|0|||
164255246|NCT02589665|593302256|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255247|NCT02589665|593302257|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255248|NCT02589665|593302258|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255249|NCT02589665|593302259|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255250|NCT02589665|593302260|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
164255251|NCT02589665|593302261|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
164255252|NCT02589665|593302262|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
164255253|NCT02589665|593302263|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255254|NCT02589665|593302264|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255255|NCT02589665|593302265|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255256|NCT02589665|593302256|FG000|Maintenance Period|Withdrawal by Subject|0|||
164255257|NCT02589665|593302257|FG001|Maintenance Period|Withdrawal by Subject|0|||
164255258|NCT02589665|593302258|FG002|Maintenance Period|Withdrawal by Subject|0|||
164255259|NCT02589665|593302259|FG003|Maintenance Period|Withdrawal by Subject|0|||
164255260|NCT02589665|593302260|FG004|Maintenance Period|Withdrawal by Subject|4|||
164255261|NCT02589665|593302261|FG005|Maintenance Period|Withdrawal by Subject|2|||
164255262|NCT02589665|593302262|FG006|Maintenance Period|Withdrawal by Subject|4|||
164255263|NCT02589665|593302263|FG007|Maintenance Period|Withdrawal by Subject|0|||
164255264|NCT02589665|593302264|FG008|Maintenance Period|Withdrawal by Subject|0|||
164255265|NCT02589665|593302265|FG009|Maintenance Period|Withdrawal by Subject|0|||
164255266|NCT02589665|593302256|FG000|Maintenance Period|Lack of Efficacy|0|||
164255267|NCT02589665|593302257|FG001|Maintenance Period|Lack of Efficacy|0|||
164255268|NCT02589665|593302258|FG002|Maintenance Period|Lack of Efficacy|0|||
164255269|NCT02589665|593302259|FG003|Maintenance Period|Lack of Efficacy|0|||
164255270|NCT02589665|593302260|FG004|Maintenance Period|Lack of Efficacy|2|||
164255271|NCT02589665|593302261|FG005|Maintenance Period|Lack of Efficacy|1|||
164255272|NCT02589665|593302262|FG006|Maintenance Period|Lack of Efficacy|0|||
164255273|NCT02589665|593302263|FG007|Maintenance Period|Lack of Efficacy|0|||
164255274|NCT02589665|593302264|FG008|Maintenance Period|Lack of Efficacy|0|||
164255275|NCT02589665|593302265|FG009|Maintenance Period|Lack of Efficacy|0|||
164255276|NCT02589665|593302256|FG000|Maintenance Period|Adverse Event|0|||
164255277|NCT02589665|593302257|FG001|Maintenance Period|Adverse Event|0|||
164255278|NCT02589665|593302258|FG002|Maintenance Period|Adverse Event|0|||
164255279|NCT02589665|593302259|FG003|Maintenance Period|Adverse Event|0|||
164255280|NCT02589665|593302260|FG004|Maintenance Period|Adverse Event|0|||
164255281|NCT02589665|593302261|FG005|Maintenance Period|Adverse Event|0|||
164255282|NCT02589665|593302262|FG006|Maintenance Period|Adverse Event|2|||
164255283|NCT02589665|593302263|FG007|Maintenance Period|Adverse Event|0|||
164255284|NCT02589665|593302264|FG008|Maintenance Period|Adverse Event|0|||
164255285|NCT02589665|593302265|FG009|Maintenance Period|Adverse Event|0|||
164255286|NCT02589665|593302256|FG000|Maintenance Period|Lost to Follow-up|0|||
164255287|NCT02589665|593302257|FG001|Maintenance Period|Lost to Follow-up|0|||
164255288|NCT02589665|593302258|FG002|Maintenance Period|Lost to Follow-up|0|||
164255289|NCT02589665|593302259|FG003|Maintenance Period|Lost to Follow-up|0|||
164255290|NCT02589665|593302260|FG004|Maintenance Period|Lost to Follow-up|0|||
164255291|NCT02589665|593302261|FG005|Maintenance Period|Lost to Follow-up|1|||
164255292|NCT02589665|593302262|FG006|Maintenance Period|Lost to Follow-up|0|||
164255293|NCT02589665|593302263|FG007|Maintenance Period|Lost to Follow-up|0|||
164255294|NCT02589665|593302264|FG008|Maintenance Period|Lost to Follow-up|0|||
164255295|NCT02589665|593302265|FG009|Maintenance Period|Lost to Follow-up|0|||
164255296|NCT02589665|593302256|FG000|Maintenance Period|Physician Decision|0|||
164255297|NCT02589665|593302257|FG001|Maintenance Period|Physician Decision|0|||
164255298|NCT02589665|593302258|FG002|Maintenance Period|Physician Decision|0|||
164255299|NCT02589665|593302259|FG003|Maintenance Period|Physician Decision|0|||
164255300|NCT02589665|593302260|FG004|Maintenance Period|Physician Decision|0|||
164255301|NCT02589665|593302261|FG005|Maintenance Period|Physician Decision|1|||
164255302|NCT02589665|593302262|FG006|Maintenance Period|Physician Decision|0|||
164255303|NCT02589665|593302263|FG007|Maintenance Period|Physician Decision|0|||
164255304|NCT02589665|593302264|FG008|Maintenance Period|Physician Decision|0|||
164255305|NCT02589665|593302265|FG009|Maintenance Period|Physician Decision|0|||
164255306|NCT02589665|593302256|FG000|Maintenance Period|Reason Not Collected|0|||
164255307|NCT02589665|593302257|FG001|Maintenance Period|Reason Not Collected|0|||
164255308|NCT02589665|593302258|FG002|Maintenance Period|Reason Not Collected|0|||
164255309|NCT02589665|593302259|FG003|Maintenance Period|Reason Not Collected|0|||
164255310|NCT02589665|593302260|FG004|Maintenance Period|Reason Not Collected|0|||
164255311|NCT02589665|593302261|FG005|Maintenance Period|Reason Not Collected|1|||
164255312|NCT02589665|593302262|FG006|Maintenance Period|Reason Not Collected|1|||
164255313|NCT02589665|593302263|FG007|Maintenance Period|Reason Not Collected|0|||
164255314|NCT02589665|593302264|FG008|Maintenance Period|Reason Not Collected|0|||
164255315|NCT02589665|593302265|FG009|Maintenance Period|Reason Not Collected|0|||
164255316|NCT02589665|593302256|FG000|Induction Extension Period|Adverse Event|0|||
164255317|NCT02589665|593302257|FG001|Induction Extension Period|Adverse Event|0|||
164255318|NCT02589665|593302258|FG002|Induction Extension Period|Adverse Event|0|||
164255319|NCT02589665|593302259|FG003|Induction Extension Period|Adverse Event|0|||
164255320|NCT02589665|593302260|FG004|Induction Extension Period|Adverse Event|0|||
164255321|NCT02589665|593302261|FG005|Induction Extension Period|Adverse Event|0|||
164255322|NCT02589665|593302262|FG006|Induction Extension Period|Adverse Event|0|||
164255323|NCT02589665|593302263|FG007|Induction Extension Period|Adverse Event|0|||
164255324|NCT02589665|593302264|FG008|Induction Extension Period|Adverse Event|4|||
164255325|NCT02589665|593302265|FG009|Induction Extension Period|Adverse Event|0|||
164255326|NCT02589665|593302256|FG000|Induction Extension Period|Lack of Efficacy|0|||
164255327|NCT02589665|593302257|FG001|Induction Extension Period|Lack of Efficacy|0|||
164255328|NCT02589665|593302258|FG002|Induction Extension Period|Lack of Efficacy|0|||
164255329|NCT02589665|593302259|FG003|Induction Extension Period|Lack of Efficacy|0|||
164255330|NCT02589665|593302260|FG004|Induction Extension Period|Lack of Efficacy|0|||
164255331|NCT02589665|593302261|FG005|Induction Extension Period|Lack of Efficacy|0|||
164255332|NCT02589665|593302262|FG006|Induction Extension Period|Lack of Efficacy|0|||
164255333|NCT02589665|593302263|FG007|Induction Extension Period|Lack of Efficacy|0|||
164255334|NCT02589665|593302264|FG008|Induction Extension Period|Lack of Efficacy|3|||
164255335|NCT02589665|593302265|FG009|Induction Extension Period|Lack of Efficacy|0|||
164255336|NCT02589665|593302256|FG000|Induction Extension Period|Withdrawal by Subject|0|||
164255337|NCT02589665|593302257|FG001|Induction Extension Period|Withdrawal by Subject|0|||
164255338|NCT02589665|593302258|FG002|Induction Extension Period|Withdrawal by Subject|0|||
164255339|NCT02589665|593302259|FG003|Induction Extension Period|Withdrawal by Subject|0|||
164255340|NCT02589665|593302260|FG004|Induction Extension Period|Withdrawal by Subject|0|||
164255341|NCT02589665|593302261|FG005|Induction Extension Period|Withdrawal by Subject|0|||
164255342|NCT02589665|593302262|FG006|Induction Extension Period|Withdrawal by Subject|0|||
164255343|NCT02589665|593302263|FG007|Induction Extension Period|Withdrawal by Subject|2|||
164255344|NCT02589665|593302264|FG008|Induction Extension Period|Withdrawal by Subject|3|||
164255345|NCT02589665|593302265|FG009|Induction Extension Period|Withdrawal by Subject|0|||
164255346|NCT02589665|593302256|FG000|Induction Extension Period|Physician Decision|0|||
164255347|NCT02589665|593302257|FG001|Induction Extension Period|Physician Decision|0|||
164255348|NCT02589665|593302258|FG002|Induction Extension Period|Physician Decision|0|||
164255349|NCT02589665|593302259|FG003|Induction Extension Period|Physician Decision|0|||
164255350|NCT02589665|593302260|FG004|Induction Extension Period|Physician Decision|0|||
164255351|NCT02589665|593302261|FG005|Induction Extension Period|Physician Decision|0|||
164255352|NCT02589665|593302262|FG006|Induction Extension Period|Physician Decision|0|||
164255353|NCT02589665|593302263|FG007|Induction Extension Period|Physician Decision|0|||
164255354|NCT02589665|593302264|FG008|Induction Extension Period|Physician Decision|1|||
164255355|NCT02589665|593302265|FG009|Induction Extension Period|Physician Decision|0|||
164255356|NCT02589665|593302256|FG000|Induction Extension Period|Reason Not Collected|0|||
164255357|NCT02589665|593302257|FG001|Induction Extension Period|Reason Not Collected|0|||
164255358|NCT02589665|593302258|FG002|Induction Extension Period|Reason Not Collected|0|||
164255359|NCT02589665|593302259|FG003|Induction Extension Period|Reason Not Collected|0|||
164255360|NCT02589665|593302260|FG004|Induction Extension Period|Reason Not Collected|0|||
164255361|NCT02589665|593302261|FG005|Induction Extension Period|Reason Not Collected|0|||
164255362|NCT02589665|593302262|FG006|Induction Extension Period|Reason Not Collected|0|||
164255363|NCT02589665|593302263|FG007|Induction Extension Period|Reason Not Collected|0|||
164255364|NCT02589665|593302264|FG008|Induction Extension Period|Reason Not Collected|1|||
164255365|NCT02589665|593302265|FG009|Induction Extension Period|Reason Not Collected|0|||
164339121|NCT00474760|593617147|FG000|Overall Study|Adverse Event|0|||
164576434|NCT01485614|594474742|FG000|Weeks 20-54|Lost to Follow-up|4|||
164255366|NCT02589665|593302256|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255367|NCT02589665|593302257|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255368|NCT02589665|593302258|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255369|NCT02589665|593302259|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255370|NCT02589665|593302260|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255371|NCT02589665|593302261|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255372|NCT02589665|593302262|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255373|NCT02589665|593302263|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255374|NCT02589665|593302264|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255375|NCT02589665|593302265|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
164255376|NCT02589665|593302256|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
164255377|NCT02589665|593302257|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
164255378|NCT02589665|593302258|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
164255379|NCT02589665|593302259|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
164255380|NCT02589665|593302260|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
164255381|NCT02589665|593302261|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
164255382|NCT02589665|593302262|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
164255383|NCT02589665|593302263|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
164255384|NCT02589665|593302264|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
164255385|NCT02589665|593302265|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
164255386|NCT02589665|593302256|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
164255387|NCT02589665|593302257|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
164255388|NCT02589665|593302258|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
164255389|NCT02589665|593302259|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
164255390|NCT02589665|593302260|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
164255391|NCT02589665|593302261|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
164255392|NCT02589665|593302262|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
164255393|NCT02589665|593302263|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
164255394|NCT02589665|593302264|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
164255395|NCT02589665|593302265|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
164255396|NCT02589665|593302256|FG000|Maintenance Extension Period|Adverse Event|0|||
164255397|NCT02589665|593302257|FG001|Maintenance Extension Period|Adverse Event|0|||
164255398|NCT02589665|593302258|FG002|Maintenance Extension Period|Adverse Event|0|||
164255399|NCT02589665|593302259|FG003|Maintenance Extension Period|Adverse Event|0|||
164255400|NCT02589665|593302260|FG004|Maintenance Extension Period|Adverse Event|0|||
164255401|NCT02589665|593302261|FG005|Maintenance Extension Period|Adverse Event|0|||
164255402|NCT02589665|593302262|FG006|Maintenance Extension Period|Adverse Event|0|||
164255403|NCT02589665|593302263|FG007|Maintenance Extension Period|Adverse Event|0|||
164255404|NCT02589665|593302264|FG008|Maintenance Extension Period|Adverse Event|0|||
164255405|NCT02589665|593302265|FG009|Maintenance Extension Period|Adverse Event|2|||
164255406|NCT02589665|593302256|FG000|Maintenance Extension Period|Non-responder|0|||
164255407|NCT02589665|593302257|FG001|Maintenance Extension Period|Non-responder|0|||
164255408|NCT02589665|593302258|FG002|Maintenance Extension Period|Non-responder|0|||
164255409|NCT02589665|593302259|FG003|Maintenance Extension Period|Non-responder|0|||
164255410|NCT02589665|593302260|FG004|Maintenance Extension Period|Non-responder|0|||
164255411|NCT02589665|593302261|FG005|Maintenance Extension Period|Non-responder|0|||
164255412|NCT02589665|593302262|FG006|Maintenance Extension Period|Non-responder|0|||
164255413|NCT02589665|593302263|FG007|Maintenance Extension Period|Non-responder|0|||
164255414|NCT02589665|593302264|FG008|Maintenance Extension Period|Non-responder|0|||
164255415|NCT02589665|593302265|FG009|Maintenance Extension Period|Non-responder|1|||
164255416|NCT00978380|593302266|FG000|Overall Study|Protocol Violation|2|||
164255417|NCT00978380|593302266|FG000|Overall Study|Withdrawal criteria|9|||
164255418|NCT00978380|593302266|FG000|Overall Study|Unclassified|8|||
164255419|NCT00176488|593302269|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
164255420|NCT00327015|593302270|FG000|Overall Study|Lack of Efficacy|18|||
164255421|NCT00327015|593302271|FG001|Overall Study|Lack of Efficacy|18|||
164255422|NCT00327015|593302272|FG002|Overall Study|Lack of Efficacy|35|||
164339122|NCT00474760|593617148|FG001|Overall Study|Adverse Event|0|||
164339123|NCT00474760|593617149|FG002|Overall Study|Adverse Event|0|||
164339124|NCT00474760|593617150|FG003|Overall Study|Adverse Event|0|||
164576435|NCT01485614|594474743|FG001|Weeks 20-54|Lost to Follow-up|3|||
164576436|NCT01485614|594474744|FG002|Weeks 20-54|Lost to Follow-up|1|||
164576437|NCT01485614|594474745|FG003|Weeks 20-54|Lost to Follow-up|0|||
164576438|NCT01485614|594474742|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
164576439|NCT01485614|594474743|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
164576440|NCT01485614|594474744|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
164576441|NCT01485614|594474745|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
164576442|NCT01485614|594474742|FG000|Weeks 20-54|Withdrawal by Subject|5|||
164255423|NCT00327015|593302273|FG003|Overall Study|Lack of Efficacy|29|||
164255424|NCT00327015|593302270|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
164255425|NCT00327015|593302271|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
164255426|NCT00327015|593302272|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
164255427|NCT00327015|593302273|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
164255428|NCT00327015|593302270|FG000|Overall Study|Lost to Follow-up|22|||
164255429|NCT00327015|593302271|FG001|Overall Study|Lost to Follow-up|23|||
164255430|NCT00327015|593302272|FG002|Overall Study|Lost to Follow-up|29|||
164255431|NCT00327015|593302273|FG003|Overall Study|Lost to Follow-up|22|||
164255432|NCT00327015|593302270|FG000|Overall Study|Adverse Event|14|||
164255433|NCT00327015|593302271|FG001|Overall Study|Adverse Event|10|||
164255434|NCT00327015|593302272|FG002|Overall Study|Adverse Event|14|||
164255435|NCT00327015|593302273|FG003|Overall Study|Adverse Event|14|||
164255436|NCT00327015|593302270|FG000|Overall Study|Subject no longer meets study criteria|4|||
164255437|NCT00327015|593302271|FG001|Overall Study|Subject no longer meets study criteria|2|||
164255438|NCT00327015|593302272|FG002|Overall Study|Subject no longer meets study criteria|8|||
164255439|NCT00327015|593302273|FG003|Overall Study|Subject no longer meets study criteria|7|||
164255440|NCT00327015|593302270|FG000|Overall Study|Poor/Noncompliance|11|||
164255441|NCT00327015|593302271|FG001|Overall Study|Poor/Noncompliance|8|||
164255442|NCT00327015|593302272|FG002|Overall Study|Poor/Noncompliance|4|||
164255443|NCT00327015|593302273|FG003|Overall Study|Poor/Noncompliance|5|||
164255444|NCT00327015|593302270|FG000|Overall Study|Physician Decision|0|||
164255445|NCT00327015|593302271|FG001|Overall Study|Physician Decision|1|||
164255446|NCT00327015|593302272|FG002|Overall Study|Physician Decision|3|||
164255447|NCT00327015|593302273|FG003|Overall Study|Physician Decision|2|||
164255448|NCT00327015|593302270|FG000|Overall Study|Death|1|||
164255449|NCT00327015|593302271|FG001|Overall Study|Death|2|||
164255450|NCT00327015|593302272|FG002|Overall Study|Death|2|||
164255451|NCT00327015|593302273|FG003|Overall Study|Death|3|||
164255452|NCT00327015|593302270|FG000|Overall Study|Pregnancy|0|||
164255453|NCT00327015|593302271|FG001|Overall Study|Pregnancy|2|||
164255454|NCT00327015|593302272|FG002|Overall Study|Pregnancy|1|||
164255455|NCT00327015|593302273|FG003|Overall Study|Pregnancy|1|||
164255456|NCT00327015|593302270|FG000|Overall Study|Administrative Reason by Sponsor|1|||
164255457|NCT00327015|593302271|FG001|Overall Study|Administrative Reason by Sponsor|2|||
164255458|NCT00327015|593302272|FG002|Overall Study|Administrative Reason by Sponsor|2|||
164255459|NCT00327015|593302273|FG003|Overall Study|Administrative Reason by Sponsor|1|||
164255460|NCT01892436|593302274|FG000|Overall Study|Withdrawal by Subject|8|||
164255461|NCT01892436|593302275|FG001|Overall Study|Withdrawal by Subject|15|||
164255462|NCT01892436|593302276|FG002|Overall Study|Withdrawal by Subject|4|||
164255463|NCT01892436|593302277|FG003|Overall Study|Withdrawal by Subject|4|||
164255464|NCT01892436|593302274|FG000|Overall Study|Death|1|||
164255465|NCT01892436|593302275|FG001|Overall Study|Death|1|||
164255466|NCT01892436|593302276|FG002|Overall Study|Death|0|||
164255467|NCT01892436|593302277|FG003|Overall Study|Death|0|||
164255468|NCT01892436|593302274|FG000|Overall Study|Physician Decision|2|||
164255469|NCT01892436|593302275|FG001|Overall Study|Physician Decision|1|||
164255470|NCT01892436|593302276|FG002|Overall Study|Physician Decision|0|||
164255471|NCT01892436|593302277|FG003|Overall Study|Physician Decision|1|||
164255472|NCT01892436|593302274|FG000|Overall Study|Pregnancy|0|||
164255473|NCT01892436|593302275|FG001|Overall Study|Pregnancy|2|||
164255474|NCT01892436|593302276|FG002|Overall Study|Pregnancy|1|||
164255475|NCT01892436|593302277|FG003|Overall Study|Pregnancy|0|||
164255476|NCT01892436|593302274|FG000|Overall Study|Technical problems|2|||
164255477|NCT01892436|593302275|FG001|Overall Study|Technical problems|1|||
164255478|NCT01892436|593302276|FG002|Overall Study|Technical problems|1|||
164255479|NCT01892436|593302277|FG003|Overall Study|Technical problems|1|||
164255480|NCT01892436|593302274|FG000|Overall Study|Lack of Efficacy|1|||
164427472|NCT04541186|593934769|FG002|Fibrate Expansion Study|Other than Specified|0|||
164427473|NCT04541186|593934770|FG003|Fibrate Expansion Study|Other than Specified|0|||
164427474|NCT04541186|593934771|FG004|Fibrate Expansion Study|Other than Specified|1|||
164427475|NCT00303303|593934772|FG000|Overall Study|Withdrawal by Subject|0|||
164427476|NCT00303303|593934773|FG001|Overall Study|Withdrawal by Subject|0|||
164255481|NCT01892436|593302275|FG001|Overall Study|Lack of Efficacy|2|||
164255482|NCT01892436|593302276|FG002|Overall Study|Lack of Efficacy|2|||
164255483|NCT01892436|593302277|FG003|Overall Study|Lack of Efficacy|2|||
164255484|NCT01892436|593302274|FG000|Overall Study|Lost to Follow-up|1|||
164255485|NCT01892436|593302275|FG001|Overall Study|Lost to Follow-up|1|||
164255486|NCT01892436|593302276|FG002|Overall Study|Lost to Follow-up|1|||
164427477|NCT00303303|593934774|FG002|Overall Study|Withdrawal by Subject|1|||
164427478|NCT00058058|593934775|FG000|Overall Study|Withdrawal by Subject|4|||
164427479|NCT00058058|593934775|FG000|Overall Study|Ineligible|20|||
164255487|NCT01892436|593302277|FG003|Overall Study|Lost to Follow-up|3|||
164255488|NCT01892436|593302274|FG000|Overall Study|non-compliance with treatment|1|||
164255489|NCT01892436|593302275|FG001|Overall Study|non-compliance with treatment|0|||
164255490|NCT01892436|593302276|FG002|Overall Study|non-compliance with treatment|0|||
164255491|NCT01892436|593302277|FG003|Overall Study|non-compliance with treatment|0|||
164255492|NCT01892436|593302274|FG000|Overall Study|Adverse Event|7|||
164255493|NCT01892436|593302275|FG001|Overall Study|Adverse Event|6|||
164255494|NCT01892436|593302276|FG002|Overall Study|Adverse Event|2|||
164255495|NCT01892436|593302277|FG003|Overall Study|Adverse Event|3|||
164255496|NCT02923830|593302281|FG000|Overall Study|Physician Decision|13|||
164255497|NCT02923830|593302282|FG001|Overall Study|Physician Decision|15|||
164255498|NCT00837265|593302283|FG000|Pilot Phase|Withdrawal by Subject|0|||
164255499|NCT00837265|593302284|FG001|Pilot Phase|Withdrawal by Subject|2|||
164255500|NCT00837265|593302285|FG002|Pilot Phase|Withdrawal by Subject|3|||
164255501|NCT00837265|593302286|FG003|Pilot Phase|Withdrawal by Subject|2|||
164255502|NCT00837265|593302287|FG004|Pilot Phase|Withdrawal by Subject|0|||
164255503|NCT00837265|593302288|FG005|Pilot Phase|Withdrawal by Subject|0|||
164255504|NCT00837265|593302289|FG006|Pilot Phase|Withdrawal by Subject|0|||
164255505|NCT00837265|593302283|FG000|Pilot Phase|Decision of the investigator|2|||
164255506|NCT00837265|593302284|FG001|Pilot Phase|Decision of the investigator|1|||
164255507|NCT00837265|593302285|FG002|Pilot Phase|Decision of the investigator|0|||
164255508|NCT00837265|593302286|FG003|Pilot Phase|Decision of the investigator|0|||
164255509|NCT00837265|593302287|FG004|Pilot Phase|Decision of the investigator|0|||
164255510|NCT00837265|593302288|FG005|Pilot Phase|Decision of the investigator|0|||
164255511|NCT00837265|593302289|FG006|Pilot Phase|Decision of the investigator|0|||
164255512|NCT00837265|593302283|FG000|Pilot Phase|Adverse Event|1|||
164255513|NCT00837265|593302284|FG001|Pilot Phase|Adverse Event|0|||
164255514|NCT00837265|593302285|FG002|Pilot Phase|Adverse Event|0|||
164255515|NCT00837265|593302286|FG003|Pilot Phase|Adverse Event|0|||
164255516|NCT00837265|593302287|FG004|Pilot Phase|Adverse Event|0|||
164255517|NCT00837265|593302288|FG005|Pilot Phase|Adverse Event|0|||
164255518|NCT00837265|593302289|FG006|Pilot Phase|Adverse Event|0|||
164255519|NCT00837265|593302283|FG000|Pilot Phase|Disease progression|0|||
164255520|NCT00837265|593302284|FG001|Pilot Phase|Disease progression|0|||
164255521|NCT00837265|593302285|FG002|Pilot Phase|Disease progression|0|||
164255522|NCT00837265|593302286|FG003|Pilot Phase|Disease progression|1|||
164255523|NCT00837265|593302287|FG004|Pilot Phase|Disease progression|0|||
164255524|NCT00837265|593302288|FG005|Pilot Phase|Disease progression|0|||
164255525|NCT00837265|593302289|FG006|Pilot Phase|Disease progression|0|||
164255526|NCT00837265|593302283|FG000|Pilot Phase|Participant left the city|0|||
164255527|NCT00837265|593302284|FG001|Pilot Phase|Participant left the city|0|||
164255528|NCT00837265|593302285|FG002|Pilot Phase|Participant left the city|0|||
164255529|NCT00837265|593302286|FG003|Pilot Phase|Participant left the city|1|||
164255530|NCT00837265|593302287|FG004|Pilot Phase|Participant left the city|0|||
164255531|NCT00837265|593302288|FG005|Pilot Phase|Participant left the city|0|||
164255532|NCT00837265|593302289|FG006|Pilot Phase|Participant left the city|0|||
164255533|NCT00837265|593302283|FG000|Main Phase|Withdrawal by Subject|0|||
164255534|NCT00837265|593302284|FG001|Main Phase|Withdrawal by Subject|0|||
164255535|NCT00837265|593302285|FG002|Main Phase|Withdrawal by Subject|0|||
164255536|NCT00837265|593302286|FG003|Main Phase|Withdrawal by Subject|0|||
164255537|NCT00837265|593302287|FG004|Main Phase|Withdrawal by Subject|4|||
164255538|NCT00837265|593302288|FG005|Main Phase|Withdrawal by Subject|2|||
164255539|NCT00837265|593302289|FG006|Main Phase|Withdrawal by Subject|1|||
164255540|NCT00837265|593302283|FG000|Main Phase|Decision of the investigator|0|||
164255541|NCT00837265|593302284|FG001|Main Phase|Decision of the investigator|0|||
164255542|NCT00837265|593302285|FG002|Main Phase|Decision of the investigator|0|||
164255543|NCT00837265|593302286|FG003|Main Phase|Decision of the investigator|0|||
164255544|NCT00837265|593302287|FG004|Main Phase|Decision of the investigator|0|||
164255545|NCT00837265|593302288|FG005|Main Phase|Decision of the investigator|2|||
164255546|NCT00837265|593302289|FG006|Main Phase|Decision of the investigator|1|||
164255547|NCT00837265|593302283|FG000|Main Phase|Adverse Event|0|||
164255548|NCT00837265|593302284|FG001|Main Phase|Adverse Event|0|||
164255549|NCT00837265|593302285|FG002|Main Phase|Adverse Event|0|||
164255550|NCT00837265|593302286|FG003|Main Phase|Adverse Event|0|||
164255551|NCT00837265|593302287|FG004|Main Phase|Adverse Event|0|||
164427480|NCT00058058|593934775|FG000|Overall Study|Claustrophobic|5|||
164427481|NCT00058058|593934775|FG000|Overall Study|technical issues|6|||
164255552|NCT00837265|593302288|FG005|Main Phase|Adverse Event|1|||
164255553|NCT00837265|593302289|FG006|Main Phase|Adverse Event|0|||
164255554|NCT00837265|593302283|FG000|Main Phase|Death|0|||
164255555|NCT00837265|593302284|FG001|Main Phase|Death|0|||
164255556|NCT00837265|593302285|FG002|Main Phase|Death|0|||
164255557|NCT00837265|593302286|FG003|Main Phase|Death|0|||
164255558|NCT00837265|593302287|FG004|Main Phase|Death|2|||
164255559|NCT00837265|593302288|FG005|Main Phase|Death|0|||
164255560|NCT00837265|593302289|FG006|Main Phase|Death|1|||
164255561|NCT00837265|593302283|FG000|Main Phase|Lost to Follow-up|0|||
164255562|NCT00837265|593302284|FG001|Main Phase|Lost to Follow-up|0|||
164255563|NCT00837265|593302285|FG002|Main Phase|Lost to Follow-up|0|||
164255564|NCT00837265|593302286|FG003|Main Phase|Lost to Follow-up|0|||
164255565|NCT00837265|593302287|FG004|Main Phase|Lost to Follow-up|1|||
164255566|NCT00837265|593302288|FG005|Main Phase|Lost to Follow-up|0|||
164255567|NCT00837265|593302289|FG006|Main Phase|Lost to Follow-up|0|||
164255568|NCT00837265|593302283|FG000|Main Phase|Principal investigator resignation|0|||
164255569|NCT00837265|593302284|FG001|Main Phase|Principal investigator resignation|0|||
164255570|NCT00837265|593302285|FG002|Main Phase|Principal investigator resignation|0|||
164255571|NCT00837265|593302286|FG003|Main Phase|Principal investigator resignation|0|||
164255572|NCT00837265|593302287|FG004|Main Phase|Principal investigator resignation|2|||
164255573|NCT00837265|593302288|FG005|Main Phase|Principal investigator resignation|0|||
164255574|NCT00837265|593302289|FG006|Main Phase|Principal investigator resignation|0|||
164255575|NCT00837265|593302283|FG000|Main Phase|Participant's personal reason|0|||
164255576|NCT00837265|593302284|FG001|Main Phase|Participant's personal reason|0|||
164427482|NCT00058058|593934775|FG000|Overall Study|Poor positioning, illness,pain|3|||
164427483|NCT00748969|593934776|FG000|Overall Study|Withdrawal by Subject|1|||
164427484|NCT00748969|593934777|FG001|Overall Study|Withdrawal by Subject|0|||
164255577|NCT00837265|593302285|FG002|Main Phase|Participant's personal reason|0|||
164255578|NCT00837265|593302286|FG003|Main Phase|Participant's personal reason|0|||
164255579|NCT00837265|593302287|FG004|Main Phase|Participant's personal reason|1|||
164255580|NCT00837265|593302288|FG005|Main Phase|Participant's personal reason|0|||
164255581|NCT00837265|593302289|FG006|Main Phase|Participant's personal reason|0|||
164255582|NCT01751906|593302291|FG000|Overall Study|Lost to Follow-up|151|||
164255583|NCT01751906|593302292|FG001|Overall Study|Lost to Follow-up|68|||
164255584|NCT01751906|593302291|FG000|Overall Study|Withdrawal by Subject|22|||
164255585|NCT01751906|593302292|FG001|Overall Study|Withdrawal by Subject|18|||
164255586|NCT01751906|593302291|FG000|Overall Study|Physician Decision|5|||
164255587|NCT01751906|593302292|FG001|Overall Study|Physician Decision|2|||
164255588|NCT01751906|593302291|FG000|Overall Study|Death|84|||
164255589|NCT01751906|593302292|FG001|Overall Study|Death|43|||
164255590|NCT01751906|593302291|FG000|Overall Study|Denied on premises for follow-up by law|1|||
164255591|NCT01751906|593302292|FG001|Overall Study|Denied on premises for follow-up by law|0|||
164255592|NCT00733291|593302293|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
164255593|NCT00733291|593302294|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
164255594|NCT00733291|593302295|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
164255595|NCT00733291|593302296|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
164255596|NCT02242435|593302303|FG000|Overall Study|Lost to Follow-up|3|||
164255597|NCT02242435|593302304|FG001|Overall Study|Lost to Follow-up|4|||
164255598|NCT02242435|593302303|FG000|Overall Study|Adverse Event|3|||
164255599|NCT02242435|593302304|FG001|Overall Study|Adverse Event|2|||
164255600|NCT02242435|593302303|FG000|Overall Study|Withdrawal by Subject|13|||
164255601|NCT02242435|593302304|FG001|Overall Study|Withdrawal by Subject|8|||
164255602|NCT02242435|593302303|FG000|Overall Study|Death|0|||
164255603|NCT02242435|593302304|FG001|Overall Study|Death|1|||
164255604|NCT02242435|593302303|FG000|Overall Study|Protocol Violation|1|||
164255605|NCT02242435|593302304|FG001|Overall Study|Protocol Violation|0|||
164255606|NCT02242435|593302303|FG000|Overall Study|Physician Decision|0|||
164255607|NCT02242435|593302304|FG001|Overall Study|Physician Decision|1|||
164255608|NCT00510718|593302313|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
164255609|NCT00510718|593302314|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
164255610|NCT00510718|593302313|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
164255611|NCT00510718|593302314|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
164255612|NCT00510718|593302313|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
164255613|NCT00510718|593302314|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
164255614|NCT00510718|593302313|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
164255615|NCT00510718|593302314|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
164255616|NCT00510718|593302313|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
164255617|NCT00510718|593302314|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
164255618|NCT00510718|593302313|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
164255619|NCT00510718|593302314|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
164427485|NCT00748969|593934776|FG000|Overall Study|Withdrawal by Subject|0|||
164427486|NCT00748969|593934777|FG001|Overall Study|Withdrawal by Subject|1|||
164255620|NCT00420004|593302320|FG000|Overall Study|Adverse Event|4|||
164255621|NCT00420004|593302321|FG001|Overall Study|Adverse Event|1|||
164255622|NCT00420004|593302322|FG002|Overall Study|Adverse Event|1|||
164255623|NCT00420004|593302320|FG000|Overall Study|Lack of Efficacy|5|||
164255624|NCT00420004|593302321|FG001|Overall Study|Lack of Efficacy|4|||
164255625|NCT00420004|593302322|FG002|Overall Study|Lack of Efficacy|1|||
164255626|NCT00420004|593302320|FG000|Overall Study|Lost to Follow-up|31|||
164255627|NCT00420004|593302321|FG001|Overall Study|Lost to Follow-up|12|||
164255628|NCT00420004|593302322|FG002|Overall Study|Lost to Follow-up|10|||
164255629|NCT00420004|593302320|FG000|Overall Study|Entry Criteria Not Met|0|||
164255630|NCT00420004|593302321|FG001|Overall Study|Entry Criteria Not Met|1|||
164255631|NCT00420004|593302322|FG002|Overall Study|Entry Criteria Not Met|0|||
164255632|NCT00420004|593302320|FG000|Overall Study|Physician Decision|14|||
164255633|NCT00420004|593302321|FG001|Overall Study|Physician Decision|4|||
164255634|NCT00420004|593302322|FG002|Overall Study|Physician Decision|2|||
164255635|NCT00420004|593302320|FG000|Overall Study|Protocol Violation|5|||
164255636|NCT00420004|593302321|FG001|Overall Study|Protocol Violation|4|||
164255637|NCT00420004|593302322|FG002|Overall Study|Protocol Violation|3|||
164427487|NCT03635112|593934780|FG000|Overall Study|Adverse Event|5|||
164255638|NCT00420004|593302320|FG000|Overall Study|Withdrawal by Subject|67|||
164427488|NCT03635112|593934781|FG001|Overall Study|Adverse Event|9|||
164427489|NCT03635112|593934782|FG002|Overall Study|Adverse Event|14|||
164427490|NCT03635112|593934780|FG000|Overall Study|Lost to Follow-up|1|||
164255639|NCT00420004|593302321|FG001|Overall Study|Withdrawal by Subject|42|||
164255640|NCT00420004|593302322|FG002|Overall Study|Withdrawal by Subject|14|||
164255641|NCT00420004|593302320|FG000|Overall Study|Sponsor Decision|3|||
164255642|NCT00420004|593302321|FG001|Overall Study|Sponsor Decision|3|||
164255643|NCT00420004|593302322|FG002|Overall Study|Sponsor Decision|1|||
164255644|NCT00591149|593302323|FG000|Overall Study|Adverse Event|4|||
164255645|NCT00591149|593302323|FG000|Overall Study|Withdrawal by Subject|1|||
164255646|NCT01606787|593302324|FG000|Overall Study|Withdrawal by Subject|4|||
164255647|NCT01606787|593302325|FG001|Overall Study|Withdrawal by Subject|5|||
164255648|NCT01606787|593302324|FG000|Overall Study|Surgery canceled|0|||
164255649|NCT01606787|593302325|FG001|Overall Study|Surgery canceled|2|||
164255650|NCT01610557|593302327|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
164255651|NCT01610557|593302328|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
164255652|NCT01610557|593302329|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
164255653|NCT01610557|593302330|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
164255654|NCT01610557|593302331|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
164255655|NCT01610557|593302327|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
164255656|NCT01610557|593302328|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
164255657|NCT01610557|593302329|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
164255658|NCT01610557|593302330|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
164255659|NCT01610557|593302331|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
164255660|NCT02003638|593302337|FG000|Overall Study|Withdrawal by Subject|1|||
164255661|NCT02003638|593302338|FG001|Overall Study|Withdrawal by Subject|0|||
164255662|NCT00713349|593302339|FG000|Overall Study|Protocol Violation|1|||
164255663|NCT03299881|593302340|FG000|Overall Study|Study Termination|17|||
164255664|NCT03299881|593302341|FG001|Overall Study|Study Termination|13|||
164255665|NCT01289353|593302342|FG000|Overall Study|Lost to Follow-up|2|||
164255666|NCT00129701|593302345|FG000|Overall Study|Withdrawal by Subject|33|||
164255667|NCT00006164|593302346|FG000|Overall Study|Withdrew or lost to follow-up|70|||
164255668|NCT00006164|593302347|FG001|Overall Study|Withdrew or lost to follow-up|81|||
164255669|NCT02750345|593302348|FG000|Intervention 1|Adverse Event|0|||
164255670|NCT02750345|593302349|FG001|Intervention 1|Adverse Event|0|||
164255671|NCT02750345|593302350|FG002|Intervention 1|Adverse Event|0|||
164255672|NCT02750345|593302351|FG003|Intervention 1|Adverse Event|0|||
164255673|NCT02750345|593302352|FG004|Intervention 1|Adverse Event|1|||
164255674|NCT02750345|593302353|FG005|Intervention 1|Adverse Event|0|||
164255675|NCT00223808|593302354|FG000|Overall Study|<5 hrs therapy before discharge|3|||
164255676|NCT00223808|593302355|FG001|Overall Study|<5 hrs therapy before discharge|5|||
164255677|NCT00223808|593302356|FG002|Overall Study|<5 hrs therapy before discharge|5|||
164255678|NCT00191724|593302359|FG000|Overall Study|Adverse Event|0|||
164255679|NCT00191724|593302360|FG001|Overall Study|Adverse Event|0|||
164255680|NCT00191724|593302361|FG002|Overall Study|Adverse Event|1|||
164255681|NCT00191724|593302362|FG003|Overall Study|Adverse Event|0|||
164255682|NCT00191724|593302363|FG004|Overall Study|Adverse Event|0|||
164255683|NCT00191724|593302359|FG000|Overall Study|Lost to Follow-up|1|||
164255684|NCT00191724|593302360|FG001|Overall Study|Lost to Follow-up|1|||
164255685|NCT00191724|593302361|FG002|Overall Study|Lost to Follow-up|0|||
164255686|NCT00191724|593302362|FG003|Overall Study|Lost to Follow-up|2|||
164255687|NCT00191724|593302363|FG004|Overall Study|Lost to Follow-up|3|||
164255688|NCT00191724|593302359|FG000|Overall Study|Withdrawal by Subject|0|||
164255689|NCT00191724|593302360|FG001|Overall Study|Withdrawal by Subject|0|||
164255690|NCT00191724|593302361|FG002|Overall Study|Withdrawal by Subject|0|||
164255691|NCT00191724|593302362|FG003|Overall Study|Withdrawal by Subject|1|||
164255692|NCT00191724|593302363|FG004|Overall Study|Withdrawal by Subject|0|||
164255693|NCT01231321|593302366|FG000|Overall Study|Adverse Event|3|||
164255694|NCT01231321|593302366|FG000|Overall Study|Lack of Efficacy|2|||
164255695|NCT00489736|593302367|FG000|Overall Study|Lack of Efficacy|53|||
164255696|NCT00489736|593302368|FG001|Overall Study|Lack of Efficacy|14|||
164255697|NCT00489736|593302367|FG000|Overall Study|Adverse Event|32|||
164255698|NCT00489736|593302368|FG001|Overall Study|Adverse Event|45|||
164255699|NCT00489736|593302367|FG000|Overall Study|Poor compliance|6|||
164255700|NCT00489736|593302368|FG001|Overall Study|Poor compliance|2|||
164255701|NCT00489736|593302367|FG000|Overall Study|Not coded/ Not pre-specified|5|||
164255702|NCT00489736|593302368|FG001|Overall Study|Not coded/ Not pre-specified|8|||
164255703|NCT04021524|593302369|FG000|Overall Study|Change in surgical intervention|0|||
164255704|NCT04021524|593302370|FG001|Overall Study|Change in surgical intervention|1|||
164255705|NCT06422364|593302371|FG000|Overall Study|Withdrawn due to study closure|0|||
164255706|NCT06422364|593302372|FG001|Overall Study|Withdrawn due to study closure|2|||
164255707|NCT05260073|593302374|FG000|Overall Study|Physician Decision|1|||
164255708|NCT05260073|593302374|FG000|Overall Study|Withdrawal by Subject|6|||
164255709|NCT05260073|593302374|FG000|Overall Study|Lost to Follow-up|14|||
164427491|NCT03635112|593934781|FG001|Overall Study|Lost to Follow-up|0|||
164255710|NCT03458910|593302375|FG000|Overall Study|Withdrawal by Subject|7|||
164255711|NCT03458910|593302376|FG001|Overall Study|Withdrawal by Subject|8|||
164255712|NCT03458910|593302377|FG002|Overall Study|Withdrawal by Subject|6|||
164255713|NCT03458910|593302378|FG003|Overall Study|Withdrawal by Subject|4|||
164427492|NCT03635112|593934782|FG002|Overall Study|Lost to Follow-up|1|||
164255714|NCT03458910|593302375|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
164255715|NCT03458910|593302376|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
164255716|NCT03458910|593302377|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
164255717|NCT03458910|593302378|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
164255718|NCT02752633|593302379|FG000|Overall Study|Withdrawal by Subject|1|||
164255719|NCT05059301|593302385|FG000|Overall Study|Adverse Event|0|||
164255720|NCT05059301|593302386|FG001|Overall Study|Adverse Event|2|||
164255721|NCT05059301|593302387|FG002|Overall Study|Adverse Event|2|||
164255722|NCT05059301|593302385|FG000|Overall Study|Lost to Follow-up|2|||
164255723|NCT05059301|593302386|FG001|Overall Study|Lost to Follow-up|3|||
164255724|NCT05059301|593302387|FG002|Overall Study|Lost to Follow-up|3|||
164255725|NCT01106651|593302388|FG000|Overall Study|Adverse Event|17|||
164255726|NCT01106651|593302389|FG001|Overall Study|Adverse Event|9|||
164255727|NCT01106651|593302390|FG002|Overall Study|Adverse Event|23|||
164255728|NCT01106651|593302388|FG000|Overall Study|Lost to Follow-up|8|||
164255729|NCT01106651|593302389|FG001|Overall Study|Lost to Follow-up|2|||
164255730|NCT01106651|593302390|FG002|Overall Study|Lost to Follow-up|6|||
164255731|NCT01106651|593302388|FG000|Overall Study|Physician Decision|4|||
164255732|NCT01106651|593302389|FG001|Overall Study|Physician Decision|3|||
164255733|NCT01106651|593302390|FG002|Overall Study|Physician Decision|1|||
164255734|NCT01106651|593302388|FG000|Overall Study|Protocol Violation|1|||
164255735|NCT01106651|593302389|FG001|Overall Study|Protocol Violation|2|||
164255736|NCT01106651|593302390|FG002|Overall Study|Protocol Violation|1|||
164255737|NCT01106651|593302388|FG000|Overall Study|Withdrawal by Subject|14|||
164255738|NCT01106651|593302389|FG001|Overall Study|Withdrawal by Subject|7|||
164255739|NCT01106651|593302390|FG002|Overall Study|Withdrawal by Subject|4|||
164255740|NCT01106651|593302388|FG000|Overall Study|Noncompliance with study drug|1|||
164255741|NCT01106651|593302389|FG001|Overall Study|Noncompliance with study drug|0|||
164255742|NCT01106651|593302390|FG002|Overall Study|Noncompliance with study drug|2|||
164255743|NCT01106651|593302388|FG000|Overall Study|Other|34|||
164255744|NCT01106651|593302389|FG001|Overall Study|Other|31|||
164255745|NCT01106651|593302390|FG002|Overall Study|Other|21|||
164255746|NCT01106651|593302388|FG000|Overall Study|Death|0|||
164255747|NCT01106651|593302389|FG001|Overall Study|Death|3|||
164255748|NCT01106651|593302390|FG002|Overall Study|Death|0|||
164255749|NCT02466425|593302394|FG000|Overall Study|Adverse Event|3|||
164255750|NCT02466425|593302395|FG001|Overall Study|Adverse Event|11|||
164255751|NCT02466425|593302394|FG000|Overall Study|Lack of Efficacy|4|||
164255752|NCT02466425|593302395|FG001|Overall Study|Lack of Efficacy|1|||
164255753|NCT02466425|593302394|FG000|Overall Study|Lost to Follow-up|3|||
164255754|NCT02466425|593302395|FG001|Overall Study|Lost to Follow-up|0|||
164255755|NCT02466425|593302394|FG000|Overall Study|Protocol Violation|1|||
164255756|NCT02466425|593302395|FG001|Overall Study|Protocol Violation|0|||
164255757|NCT02466425|593302394|FG000|Overall Study|Withdrawal by Subject|0|||
164255758|NCT02466425|593302395|FG001|Overall Study|Withdrawal by Subject|1|||
164255759|NCT02466425|593302394|FG000|Overall Study|Other|1|||
164255760|NCT02466425|593302395|FG001|Overall Study|Other|3|||
164255761|NCT02466425|593302394|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
164255762|NCT02466425|593302395|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164255763|NCT00889603|593302396|FG000|Overall Study|Adverse Event|7|||
164255764|NCT00889603|593302396|FG000|Overall Study|Death|3|||
164255765|NCT00889603|593302396|FG000|Overall Study|Lost to Follow-up|19|||
164255766|NCT00889603|593302396|FG000|Overall Study|No longer willing to participant in stud|4|||
164255767|NCT00889603|593302396|FG000|Overall Study|Other|4|||
164255768|NCT01832493|593302398|FG000|Overall Study|Physician Decision|2|||
164255769|NCT01832493|593302398|FG000|Overall Study|Protocol Violation|4|||
164255770|NCT01832493|593302398|FG000|Overall Study|Unable to place LV lead|2|||
164255771|NCT01814397|593302401|FG000|Overall Study|Adverse Event|7|||
164255772|NCT01814397|593302401|FG000|Overall Study|Withdrawal by Subject|7|||
164255773|NCT04238481|593302413|FG000|Overall Study|Miscellaneous|0|||
164255774|NCT04238481|593302414|FG001|Overall Study|Miscellaneous|1|||
164255775|NCT04238481|593302415|FG002|Overall Study|Miscellaneous|0|||
164255776|NCT04238481|593302416|FG003|Overall Study|Miscellaneous|0|||
164255777|NCT02247011|593302417|FG000|Overall Study|Poor quality of radiological results|125|||
164255778|NCT02152371|593302418|FG000|Overall Study|Adverse Event|6|||
164255779|NCT02152371|593302419|FG001|Overall Study|Adverse Event|2|||
164255780|NCT02152371|593302418|FG000|Overall Study|Withdrawal by Subject|3|||
164255781|NCT02152371|593302419|FG001|Overall Study|Withdrawal by Subject|7|||
164427493|NCT03635112|593934780|FG000|Overall Study|Physician Decision|5|||
164255782|NCT02152371|593302418|FG000|Overall Study|Protocol Violation|2|||
164255783|NCT02152371|593302419|FG001|Overall Study|Protocol Violation|3|||
164255784|NCT02152371|593302418|FG000|Overall Study|Lost to Follow-up|1|||
164255785|NCT02152371|593302419|FG001|Overall Study|Lost to Follow-up|0|||
164255786|NCT02152371|593302418|FG000|Overall Study|Lack of Efficacy|0|||
164255787|NCT02152371|593302419|FG001|Overall Study|Lack of Efficacy|1|||
164255788|NCT02152371|593302418|FG000|Overall Study|Physician Decision|0|||
164255789|NCT02152371|593302419|FG001|Overall Study|Physician Decision|2|||
164255790|NCT02152371|593302418|FG000|Overall Study|Reason Not Given|0|||
164255791|NCT02152371|593302419|FG001|Overall Study|Reason Not Given|1|||
164255792|NCT00656058|593302421|FG000|Overall Study|Withdrawal by Subject|2|||
164255793|NCT00656058|593302421|FG000|Overall Study|Withdrawal by Subject|4|||
164255794|NCT00349921|593302423|FG000|First Spinal Injection|Physician Decision|1|||
164255795|NCT00349921|593302424|FG001|First Spinal Injection|Physician Decision|0|||
164255796|NCT00349921|593302425|FG002|First Spinal Injection|Physician Decision|0|||
164255797|NCT00349921|593302426|FG003|First Spinal Injection|Physician Decision|0|||
164255798|NCT00349921|593302423|FG000|First Spinal Injection|Adverse Event|0|||
164255799|NCT00349921|593302424|FG001|First Spinal Injection|Adverse Event|0|||
164255800|NCT00349921|593302425|FG002|First Spinal Injection|Adverse Event|1|||
164255801|NCT00349921|593302426|FG003|First Spinal Injection|Adverse Event|0|||
164255802|NCT03194568|593302427|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
164255803|NCT05285644|593302428|FG000|Overall Study|Adverse Event|3|||
164255804|NCT05285644|593302429|FG001|Overall Study|Adverse Event|3|||
164255805|NCT05285644|593302428|FG000|Overall Study|Withdrawal of Consent|2|||
164255806|NCT05285644|593302429|FG001|Overall Study|Withdrawal of Consent|5|||
164255807|NCT05285644|593302428|FG000|Overall Study|Noncompliance|0|||
164255808|NCT05285644|593302429|FG001|Overall Study|Noncompliance|4|||
164255809|NCT05285644|593302428|FG000|Overall Study|Lost to Follow-up|4|||
164255810|NCT05285644|593302429|FG001|Overall Study|Lost to Follow-up|6|||
164255811|NCT05285644|593302428|FG000|Overall Study|Disallowed Concurrent Medication|1|||
164255812|NCT05285644|593302429|FG001|Overall Study|Disallowed Concurrent Medication|1|||
164255813|NCT05285644|593302428|FG000|Overall Study|Investigator Decision|2|||
164255814|NCT05285644|593302429|FG001|Overall Study|Investigator Decision|0|||
164255815|NCT05285644|593302428|FG000|Overall Study|Protocol Deviation|1|||
164255816|NCT05285644|593302429|FG001|Overall Study|Protocol Deviation|0|||
164255817|NCT05285644|593302428|FG000|Overall Study|As specified in the Clinical Study Report|7|||
164255818|NCT05285644|593302429|FG001|Overall Study|As specified in the Clinical Study Report|3|||
164255819|NCT00920387|593302432|FG000|Stage 1|Adverse Event|1|||
164255820|NCT00920387|593302433|FG001|Stage 1|Adverse Event|0|||
164255821|NCT00920387|593302434|FG002|Stage 1|Adverse Event|0|||
164255822|NCT01448824|593303993|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
164255823|NCT01448824|593303994|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
164255824|NCT01448824|593303995|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
164255825|NCT01448824|593303996|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
164255826|NCT01448824|593303997|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
164255827|NCT01448824|593303998|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
164255828|NCT01448824|593303999|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
164255829|NCT01448824|593304000|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
164255830|NCT01448824|593303993|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
164255831|NCT01448824|593303994|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
164255832|NCT01448824|593303995|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
164255833|NCT01448824|593303996|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
164255834|NCT01448824|593303997|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
164255835|NCT01448824|593303998|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
164255836|NCT01448824|593303999|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
164255837|NCT01448824|593304000|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
164255838|NCT01448824|593303993|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
164255839|NCT01448824|593303994|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
164255840|NCT01448824|593303995|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
164255841|NCT01448824|593303996|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
164255842|NCT01448824|593303997|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
164255843|NCT01448824|593303998|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
164255844|NCT01448824|593303999|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
164255845|NCT01448824|593304000|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
164255846|NCT01448824|593303993|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
164255847|NCT01448824|593303994|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
164255848|NCT01448824|593303995|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
164255849|NCT01448824|593303996|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
164255850|NCT01448824|593303997|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
164576443|NCT01485614|594474743|FG001|Weeks 20-54|Withdrawal by Subject|3|||
164255851|NCT01448824|593303998|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
164255852|NCT01448824|593303999|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
164255853|NCT01448824|593304000|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
164255854|NCT01448824|593303993|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
164576444|NCT01485614|594474744|FG002|Weeks 20-54|Withdrawal by Subject|0|||
164255855|NCT01448824|593303994|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
164255856|NCT01448824|593303995|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
164576445|NCT01485614|594474745|FG003|Weeks 20-54|Withdrawal by Subject|0|||
164427494|NCT03635112|593934781|FG001|Overall Study|Physician Decision|7|||
164576446|NCT01503021|594474750|FG000|Overall Study|Adverse Event|7|||
164255857|NCT01448824|593303996|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
164255858|NCT01448824|593303997|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
164255859|NCT01448824|593303998|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
164255860|NCT01448824|593303999|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
164255861|NCT01448824|593304000|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
164255862|NCT01448824|593303993|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
164255863|NCT01448824|593303994|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
164255864|NCT01448824|593303995|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
164255865|NCT01448824|593303996|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
164255866|NCT01448824|593303997|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
164255867|NCT01448824|593303998|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
164255868|NCT01448824|593303999|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
164255869|NCT01448824|593304000|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
164255870|NCT01448824|593303993|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
164255871|NCT01448824|593303994|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
164255872|NCT01448824|593303995|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
164255873|NCT01448824|593303996|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
164255874|NCT01448824|593303997|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
164255875|NCT01448824|593303998|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
164255876|NCT01448824|593303999|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
164255877|NCT01448824|593304000|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
164255878|NCT01448824|593303993|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
164255879|NCT01448824|593303994|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
164255880|NCT01448824|593303995|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
164255881|NCT01448824|593303996|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
164255882|NCT01448824|593303997|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
164255883|NCT01448824|593303998|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
164255884|NCT01448824|593303999|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
164255885|NCT01448824|593304000|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
164255886|NCT01537081|593304003|FG000|Overall Study|Adverse Event|5|||
164255887|NCT01537081|593304004|FG001|Overall Study|Adverse Event|2|||
164255888|NCT01537081|593304005|FG002|Overall Study|Adverse Event|2|||
164255889|NCT01537081|593304003|FG000|Overall Study|Lack of Efficacy|2|||
164255890|NCT01537081|593304004|FG001|Overall Study|Lack of Efficacy|1|||
164255891|NCT01537081|593304005|FG002|Overall Study|Lack of Efficacy|0|||
164255892|NCT01537081|593304003|FG000|Overall Study|Lost to Follow-up|17|||
164255893|NCT01537081|593304004|FG001|Overall Study|Lost to Follow-up|15|||
164255894|NCT01537081|593304005|FG002|Overall Study|Lost to Follow-up|9|||
164255895|NCT01537081|593304003|FG000|Overall Study|Protocol Violation|3|||
164255896|NCT01537081|593304004|FG001|Overall Study|Protocol Violation|2|||
164255897|NCT01537081|593304005|FG002|Overall Study|Protocol Violation|2|||
164255898|NCT01537081|593304003|FG000|Overall Study|Withdrawal by Subject|6|||
164255899|NCT01537081|593304004|FG001|Overall Study|Withdrawal by Subject|11|||
164255900|NCT01537081|593304005|FG002|Overall Study|Withdrawal by Subject|3|||
164255901|NCT01537081|593304003|FG000|Overall Study|Physician Decision|5|||
164255902|NCT01537081|593304004|FG001|Overall Study|Physician Decision|6|||
164255903|NCT01537081|593304005|FG002|Overall Study|Physician Decision|0|||
164255904|NCT01537081|593304003|FG000|Overall Study|Sponsor decision|0|||
164255905|NCT01537081|593304004|FG001|Overall Study|Sponsor decision|1|||
164255906|NCT01537081|593304005|FG002|Overall Study|Sponsor decision|0|||
164255907|NCT01537081|593304003|FG000|Overall Study|Assigned but never dosed|1|||
164255908|NCT01537081|593304004|FG001|Overall Study|Assigned but never dosed|0|||
164255909|NCT01537081|593304005|FG002|Overall Study|Assigned but never dosed|0|||
164255910|NCT01110330|593304010|FG000|Overall Study|Adverse Event|0|||
164255911|NCT01110330|593304011|FG001|Overall Study|Adverse Event|4|||
164255912|NCT01110330|593304012|FG002|Overall Study|Adverse Event|3|||
164255913|NCT01110330|593304010|FG000|Overall Study|Lack of Efficacy|3|||
164255914|NCT01110330|593304011|FG001|Overall Study|Lack of Efficacy|1|||
164255915|NCT01110330|593304012|FG002|Overall Study|Lack of Efficacy|1|||
164255916|NCT01110330|593304010|FG000|Overall Study|Lost to Follow-up|9|||
164255917|NCT01110330|593304011|FG001|Overall Study|Lost to Follow-up|10|||
164255918|NCT01110330|593304012|FG002|Overall Study|Lost to Follow-up|15|||
164255919|NCT01110330|593304010|FG000|Overall Study|Physician Decision|0|||
164255920|NCT01110330|593304011|FG001|Overall Study|Physician Decision|1|||
164576447|NCT01503021|594474751|FG001|Overall Study|Adverse Event|6|||
164255921|NCT01110330|593304012|FG002|Overall Study|Physician Decision|0|||
164255922|NCT01110330|593304010|FG000|Overall Study|Protocol Violation|2|||
164255923|NCT01110330|593304011|FG001|Overall Study|Protocol Violation|0|||
164255924|NCT01110330|593304012|FG002|Overall Study|Protocol Violation|4|||
164255925|NCT01110330|593304010|FG000|Overall Study|Withdrawal by Subject|0|||
164255926|NCT01110330|593304011|FG001|Overall Study|Withdrawal by Subject|6|||
164255927|NCT01110330|593304012|FG002|Overall Study|Withdrawal by Subject|2|||
164255928|NCT01110330|593304010|FG000|Overall Study|Other|1|||
164427495|NCT03635112|593934782|FG002|Overall Study|Physician Decision|5|||
164427496|NCT03635112|593934780|FG000|Overall Study|Protocol Violation|0|||
164427497|NCT03635112|593934781|FG001|Overall Study|Protocol Violation|0|||
164427498|NCT03635112|593934782|FG002|Overall Study|Protocol Violation|1|||
164427499|NCT03635112|593934780|FG000|Overall Study|Study Terminated by Sponsor|11|||
164427500|NCT03635112|593934781|FG001|Overall Study|Study Terminated by Sponsor|17|||
164427501|NCT03635112|593934782|FG002|Overall Study|Study Terminated by Sponsor|21|||
164427502|NCT03635112|593934780|FG000|Overall Study|Withdrawal by Subject|4|||
164427503|NCT03635112|593934781|FG001|Overall Study|Withdrawal by Subject|9|||
164427504|NCT03635112|593934782|FG002|Overall Study|Withdrawal by Subject|7|||
164427505|NCT03635112|593934780|FG000|Overall Study|Miscellaneous|0|||
164427506|NCT03635112|593934781|FG001|Overall Study|Miscellaneous|0|||
164427507|NCT03635112|593934782|FG002|Overall Study|Miscellaneous|1|||
164427508|NCT03006341|593934785|FG000|Overall Study|Not linked in the EMR|25069|||
164427509|NCT03006341|593934786|FG001|Overall Study|Not linked in the EMR|67505|||
164427510|NCT03006341|593934787|FG002|Overall Study|Not linked in the EMR|30993|||
164427511|NCT03006341|593934788|FG003|Overall Study|Not linked in the EMR|10685|||
164427512|NCT02950545|593934790|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
164427513|NCT02950545|593934791|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
164427514|NCT02950545|593934792|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
164427515|NCT02950545|593934793|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
164427516|NCT02950545|593934794|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
164427517|NCT02950545|593934795|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
164427518|NCT02950545|593934790|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
164427519|NCT02950545|593934791|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
164427520|NCT02950545|593934792|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
164427521|NCT02950545|593934793|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
164427522|NCT02950545|593934794|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
164427523|NCT02950545|593934795|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
164427524|NCT02950545|593934790|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
164427525|NCT02950545|593934791|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
164427526|NCT02950545|593934792|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
164427527|NCT02950545|593934793|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
164680518|NCT00112437|594854578|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
164680519|NCT00112437|594854579|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
164680520|NCT00112437|594854580|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
164680521|NCT00112437|594854581|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
164680522|NCT00112437|594854582|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
164680523|NCT00112437|594854583|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
164680524|NCT00112437|594854584|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
164680525|NCT00112437|594854585|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
164680526|NCT00112437|594854586|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
164680527|NCT00112437|594854587|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
164680528|NCT00112437|594854588|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
164680529|NCT00112437|594854589|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
164680530|NCT00112437|594854590|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
164680531|NCT00112437|594854591|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
164680532|NCT00112437|594854592|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
164427528|NCT02950545|593934794|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
164427529|NCT02950545|593934795|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
164427530|NCT02950545|593934790|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
164427531|NCT02950545|593934791|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
164427532|NCT02950545|593934792|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
164427533|NCT02950545|593934793|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
164427534|NCT02950545|593934794|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
164427535|NCT02950545|593934795|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
164427536|NCT02950545|593934790|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
164427537|NCT02950545|593934791|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
164427538|NCT02950545|593934792|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
164427539|NCT02950545|593934793|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
164427540|NCT02950545|593934794|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
164427541|NCT02950545|593934795|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
164427542|NCT03283553|593934799|FG000|Patient Participant Flow|Death|5|||
164427543|NCT03283553|593934800|FG001|Patient Participant Flow|Death|10|||
164427544|NCT03283553|593934799|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
164427545|NCT03283553|593934800|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
164427546|NCT03283553|593934799|FG000|Patient Participant Flow|Lost to Follow-up|1|||
164680533|NCT00112437|594854593|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
164680534|NCT00112437|594854594|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
164680535|NCT00112437|594854595|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
164680536|NCT00112437|594854596|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
164427547|NCT03283553|593934800|FG001|Patient Participant Flow|Lost to Follow-up|1|||
164427548|NCT03283553|593934799|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
164255929|NCT01110330|593304011|FG001|Overall Study|Other|1|||
164255930|NCT01110330|593304012|FG002|Overall Study|Other|1|||
164255931|NCT02759107|593304013|FG000|Overall Study|Adverse Event|0|||
164255932|NCT02759107|593304014|FG001|Overall Study|Adverse Event|0|||
164255933|NCT02759107|593304015|FG002|Overall Study|Adverse Event|0|||
164255934|NCT02759107|593304016|FG003|Overall Study|Adverse Event|0|||
164255935|NCT02759107|593304017|FG004|Overall Study|Adverse Event|0|||
164255936|NCT02759107|593304018|FG005|Overall Study|Adverse Event|0|||
164255937|NCT02759107|593304019|FG006|Overall Study|Adverse Event|0|||
164255938|NCT02759107|593304020|FG007|Overall Study|Adverse Event|0|||
164255939|NCT02759107|593304021|FG008|Overall Study|Adverse Event|0|||
164255940|NCT02759107|593304022|FG009|Overall Study|Adverse Event|0|||
164255941|NCT02759107|593304023|FG010|Overall Study|Adverse Event|0|||
164255942|NCT02759107|593304024|FG011|Overall Study|Adverse Event|0|||
164255943|NCT02759107|593304025|FG012|Overall Study|Adverse Event|2|||
164255944|NCT02759107|593304026|FG013|Overall Study|Adverse Event|0|||
164255945|NCT02759107|593304027|FG014|Overall Study|Adverse Event|0|||
164255946|NCT02759107|593304028|FG015|Overall Study|Adverse Event|1|||
164255947|NCT02759107|593304029|FG016|Overall Study|Adverse Event|0|||
164255948|NCT02759107|593304030|FG017|Overall Study|Adverse Event|2|||
164255949|NCT02759107|593304013|FG000|Overall Study|Scheduling Conflict|0|||
164255950|NCT02759107|593304014|FG001|Overall Study|Scheduling Conflict|0|||
164255951|NCT02759107|593304015|FG002|Overall Study|Scheduling Conflict|0|||
164255952|NCT02759107|593304016|FG003|Overall Study|Scheduling Conflict|0|||
164255953|NCT02759107|593304017|FG004|Overall Study|Scheduling Conflict|0|||
164255954|NCT02759107|593304018|FG005|Overall Study|Scheduling Conflict|0|||
164255955|NCT02759107|593304019|FG006|Overall Study|Scheduling Conflict|0|||
164255956|NCT02759107|593304020|FG007|Overall Study|Scheduling Conflict|0|||
164255957|NCT02759107|593304021|FG008|Overall Study|Scheduling Conflict|0|||
164255958|NCT02759107|593304022|FG009|Overall Study|Scheduling Conflict|1|||
164255959|NCT02759107|593304023|FG010|Overall Study|Scheduling Conflict|0|||
164255960|NCT02759107|593304024|FG011|Overall Study|Scheduling Conflict|0|||
164255961|NCT02759107|593304025|FG012|Overall Study|Scheduling Conflict|0|||
164255962|NCT02759107|593304026|FG013|Overall Study|Scheduling Conflict|0|||
164255963|NCT02759107|593304027|FG014|Overall Study|Scheduling Conflict|0|||
164255964|NCT02759107|593304028|FG015|Overall Study|Scheduling Conflict|0|||
164255965|NCT02759107|593304029|FG016|Overall Study|Scheduling Conflict|0|||
164255966|NCT02759107|593304030|FG017|Overall Study|Scheduling Conflict|0|||
164255967|NCT02526524|593304036|FG000|Overall Study|Withdrawal by Subject|3|||
164255968|NCT02526524|593304037|FG001|Overall Study|Withdrawal by Subject|3|||
164255969|NCT02526524|593304038|FG002|Overall Study|Withdrawal by Subject|6|||
164255970|NCT02526524|593304039|FG003|Overall Study|Withdrawal by Subject|1|||
164255971|NCT02526524|593304040|FG004|Overall Study|Withdrawal by Subject|9|||
164255972|NCT02526524|593304041|FG005|Overall Study|Withdrawal by Subject|5|||
164255973|NCT02526524|593304036|FG000|Overall Study|Adverse Event|3|||
164255974|NCT02526524|593304037|FG001|Overall Study|Adverse Event|2|||
164255975|NCT02526524|593304038|FG002|Overall Study|Adverse Event|4|||
164255976|NCT02526524|593304039|FG003|Overall Study|Adverse Event|2|||
164255977|NCT02526524|593304040|FG004|Overall Study|Adverse Event|6|||
164255978|NCT02526524|593304041|FG005|Overall Study|Adverse Event|8|||
164255979|NCT02526524|593304036|FG000|Overall Study|Lost to Follow-up|2|||
164255980|NCT02526524|593304037|FG001|Overall Study|Lost to Follow-up|3|||
164255981|NCT02526524|593304038|FG002|Overall Study|Lost to Follow-up|8|||
164255982|NCT02526524|593304039|FG003|Overall Study|Lost to Follow-up|1|||
164255983|NCT02526524|593304040|FG004|Overall Study|Lost to Follow-up|2|||
164339125|NCT00474760|593617151|FG004|Overall Study|Adverse Event|1|||
164339126|NCT00474760|593617152|FG005|Overall Study|Adverse Event|7|||
164339127|NCT00474760|593617153|FG006|Overall Study|Adverse Event|0|||
164339128|NCT00474760|593617147|FG000|Overall Study|Laboratory abnormality|0|||
164339129|NCT00474760|593617148|FG001|Overall Study|Laboratory abnormality|0|||
164339130|NCT00474760|593617149|FG002|Overall Study|Laboratory abnormality|0|||
164339131|NCT00474760|593617150|FG003|Overall Study|Laboratory abnormality|0|||
164339132|NCT00474760|593617151|FG004|Overall Study|Laboratory abnormality|0|||
164339133|NCT00474760|593617152|FG005|Overall Study|Laboratory abnormality|1|||
164576448|NCT01503021|594474750|FG000|Overall Study|Death|0|||
164255984|NCT02526524|593304041|FG005|Overall Study|Lost to Follow-up|5|||
164255985|NCT02526524|593304036|FG000|Overall Study|Protocol Violation|3|||
164255986|NCT02526524|593304037|FG001|Overall Study|Protocol Violation|1|||
164255987|NCT02526524|593304038|FG002|Overall Study|Protocol Violation|5|||
164255988|NCT02526524|593304039|FG003|Overall Study|Protocol Violation|3|||
164576449|NCT01503021|594474751|FG001|Overall Study|Death|2|||
164255989|NCT02526524|593304040|FG004|Overall Study|Protocol Violation|4|||
164255990|NCT02526524|593304041|FG005|Overall Study|Protocol Violation|3|||
164255991|NCT02526524|593304036|FG000|Overall Study|Loss of Glucose Control|0|||
164255992|NCT02526524|593304037|FG001|Overall Study|Loss of Glucose Control|0|||
164255993|NCT02526524|593304038|FG002|Overall Study|Loss of Glucose Control|3|||
164339134|NCT00474760|593617153|FG006|Overall Study|Laboratory abnormality|0|||
164339135|NCT00474760|593617147|FG000|Overall Study|Withdrawal by Subject|0|||
164255994|NCT02526524|593304039|FG003|Overall Study|Loss of Glucose Control|0|||
164255995|NCT02526524|593304040|FG004|Overall Study|Loss of Glucose Control|2|||
164255996|NCT02526524|593304041|FG005|Overall Study|Loss of Glucose Control|0|||
164255997|NCT02526524|593304036|FG000|Overall Study|Physician Decision|0|||
164255998|NCT02526524|593304037|FG001|Overall Study|Physician Decision|0|||
164255999|NCT02526524|593304038|FG002|Overall Study|Physician Decision|0|||
164256000|NCT02526524|593304039|FG003|Overall Study|Physician Decision|0|||
164256001|NCT02526524|593304040|FG004|Overall Study|Physician Decision|1|||
164256002|NCT02526524|593304041|FG005|Overall Study|Physician Decision|0|||
164256003|NCT02526524|593304036|FG000|Overall Study|Sponsor Decision|1|||
164256004|NCT02526524|593304037|FG001|Overall Study|Sponsor Decision|0|||
164256005|NCT02526524|593304038|FG002|Overall Study|Sponsor Decision|0|||
164256006|NCT02526524|593304039|FG003|Overall Study|Sponsor Decision|0|||
164256007|NCT02526524|593304040|FG004|Overall Study|Sponsor Decision|0|||
164256008|NCT02526524|593304041|FG005|Overall Study|Sponsor Decision|0|||
164256009|NCT03002818|593304042|FG000|Overall Study|Decision of the investigator|1|||
164256010|NCT03764631|593304044|FG000|Overall Study|Personal Reasons|3|||
164256011|NCT03764631|593304045|FG001|Overall Study|Personal Reasons|2|||
164256012|NCT03764631|593304044|FG000|Overall Study|Switching Therapy|3|||
164256013|NCT03764631|593304045|FG001|Overall Study|Switching Therapy|3|||
164256014|NCT03764631|593304044|FG000|Overall Study|Adverse Event|0|||
164256015|NCT03764631|593304045|FG001|Overall Study|Adverse Event|1|||
164256016|NCT03764631|593304044|FG000|Overall Study|Lost to Follow-up|33|||
164256017|NCT03764631|593304045|FG001|Overall Study|Lost to Follow-up|41|||
164256018|NCT03764631|593304044|FG000|Overall Study|No data as study site was closed|2|||
164256019|NCT03764631|593304045|FG001|Overall Study|No data as study site was closed|6|||
164256020|NCT01549886|593304046|FG000|Overall Study|Sponsor's decision|2|||
164256021|NCT01549886|593304047|FG001|Overall Study|Sponsor's decision|3|||
164256022|NCT00473668|593304048|FG000|Overall Study|Withdrawal by Subject|0|||
164256023|NCT00473668|593304049|FG001|Overall Study|Withdrawal by Subject|2|||
164256024|NCT00473668|593304050|FG002|Overall Study|Withdrawal by Subject|0|||
164256025|NCT00473668|593304048|FG000|Overall Study|Migrated/moved from study area|3|||
164256026|NCT00473668|593304049|FG001|Overall Study|Migrated/moved from study area|2|||
164256027|NCT00473668|593304050|FG002|Overall Study|Migrated/moved from study area|0|||
164256028|NCT00473668|593304048|FG000|Overall Study|Lost to Follow-up|0|||
164256029|NCT00473668|593304049|FG001|Overall Study|Lost to Follow-up|4|||
164256030|NCT00473668|593304050|FG002|Overall Study|Lost to Follow-up|6|||
164256031|NCT00473668|593304048|FG000|Overall Study|Other|2|||
164256032|NCT00473668|593304049|FG001|Overall Study|Other|3|||
164256033|NCT00473668|593304050|FG002|Overall Study|Other|4|||
164256034|NCT02039219|593304051|FG000|Treatment|Withdrawal by Subject|1|||
164256035|NCT02039219|593304052|FG001|Treatment|Withdrawal by Subject|0|||
164256036|NCT02039219|593304051|FG000|Treatment|Adverse Event|0|||
164256037|NCT02039219|593304052|FG001|Treatment|Adverse Event|1|||
164256038|NCT02039219|593304051|FG000|Treatment|Physician Decision|1|||
164256039|NCT02039219|593304052|FG001|Treatment|Physician Decision|0|||
164256040|NCT02039219|593304051|FG000|Treatment|Lost to Follow-up|0|||
164256041|NCT02039219|593304052|FG001|Treatment|Lost to Follow-up|1|||
164256042|NCT02039219|593304051|FG000|Treatment|Protocol Violation|1|||
164256043|NCT02039219|593304052|FG001|Treatment|Protocol Violation|0|||
164256044|NCT02039219|593304051|FG000|Treatment|Death|1|||
164256045|NCT02039219|593304052|FG001|Treatment|Death|0|||
164256046|NCT02039219|593304051|FG000|Follow up|Adverse Event|0|||
164256047|NCT02039219|593304052|FG001|Follow up|Adverse Event|1|||
164256048|NCT02226562|593304058|FG000|Overall Study|Lost to Follow-up|0|||
164256049|NCT02226562|593304059|FG001|Overall Study|Lost to Follow-up|1|||
164256050|NCT04569136|593304060|FG000|Overall Study|Lost to Follow-up|2|||
164256051|NCT04569136|593304061|FG001|Overall Study|Lost to Follow-up|0|||
164256052|NCT04569136|593304062|FG002|Overall Study|Lost to Follow-up|1|||
164256053|NCT01466660|593304068|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
164256054|NCT01466660|593304069|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
164256055|NCT01466660|593304068|FG000|Overall Study|Worsening of underlying cancer disease|5|||
164256056|NCT01466660|593304069|FG001|Overall Study|Worsening of underlying cancer disease|2|||
164339136|NCT00474760|593617148|FG001|Overall Study|Withdrawal by Subject|0|||
164256057|NCT01466660|593304068|FG000|Overall Study|Other adverse event|19|||
164256058|NCT01466660|593304069|FG001|Overall Study|Other adverse event|18|||
164256059|NCT01466660|593304068|FG000|Overall Study|Protocol Violation|2|||
164256060|NCT01466660|593304069|FG001|Overall Study|Protocol Violation|1|||
164256061|NCT01466660|593304068|FG000|Overall Study|Refused continuation of trial medication|4|||
164339137|NCT00474760|593617149|FG002|Overall Study|Withdrawal by Subject|0|||
164256062|NCT01466660|593304069|FG001|Overall Study|Refused continuation of trial medication|3|||
164256063|NCT01466660|593304068|FG000|Overall Study|Other reason not defined above|10|||
164256064|NCT01466660|593304069|FG001|Overall Study|Other reason not defined above|8|||
164256065|NCT03576066|593304070|FG000|Overall Study|Noncompliance with study drug|0|||
164256066|NCT03576066|593304071|FG001|Overall Study|Noncompliance with study drug|1|||
164339138|NCT00474760|593617150|FG003|Overall Study|Withdrawal by Subject|1|||
164256067|NCT00608023|593304072|FG000|Overall Study|Withdrawal by Subject|8|||
164256068|NCT00608023|593304073|FG001|Overall Study|Withdrawal by Subject|10|||
164256069|NCT00608023|593304074|FG002|Overall Study|Withdrawal by Subject|7|||
164256070|NCT00608023|593304072|FG000|Overall Study|Adverse Event|1|||
164256071|NCT00608023|593304073|FG001|Overall Study|Adverse Event|4|||
164256072|NCT00608023|593304074|FG002|Overall Study|Adverse Event|5|||
164256073|NCT00608023|593304072|FG000|Overall Study|Lost to Follow-up|2|||
164256074|NCT00608023|593304073|FG001|Overall Study|Lost to Follow-up|2|||
164256075|NCT00608023|593304074|FG002|Overall Study|Lost to Follow-up|1|||
164256076|NCT00608023|593304072|FG000|Overall Study|Protocol Violation|1|||
164256077|NCT00608023|593304073|FG001|Overall Study|Protocol Violation|3|||
164256078|NCT00608023|593304074|FG002|Overall Study|Protocol Violation|1|||
164256079|NCT00608023|593304072|FG000|Overall Study|Unknown reason|0|||
164256080|NCT00608023|593304073|FG001|Overall Study|Unknown reason|3|||
164256081|NCT00608023|593304074|FG002|Overall Study|Unknown reason|0|||
164256082|NCT05275010|593304078|FG000|Overall Study|Reason Not Specified|4|||
164256083|NCT05275010|593304079|FG001|Overall Study|Reason Not Specified|1|||
164256084|NCT05275010|593304078|FG000|Overall Study|Withdrawal by Subject|1|||
164256085|NCT05275010|593304079|FG001|Overall Study|Withdrawal by Subject|0|||
164256086|NCT05275010|593304078|FG000|Overall Study|Lost to Follow-up|0|||
164256087|NCT05275010|593304079|FG001|Overall Study|Lost to Follow-up|1|||
164256088|NCT04484649|593304082|FG000|Overall Study|Lost to Follow-up|2|||
164256089|NCT04484649|593304083|FG001|Overall Study|Lost to Follow-up|1|||
164256090|NCT04484649|593304082|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
164256091|NCT04484649|593304083|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
164256092|NCT01681069|593304084|FG000|Overall Study|Withdrawal by Subject|4|||
164256093|NCT01681069|593304085|FG001|Overall Study|Withdrawal by Subject|5|||
164256094|NCT01681069|593304084|FG000|Overall Study|Protocol Violation|1|||
164256095|NCT01681069|593304085|FG001|Overall Study|Protocol Violation|1|||
164256096|NCT01681069|593304084|FG000|Overall Study|Adverse Event|0|||
164256097|NCT01681069|593304085|FG001|Overall Study|Adverse Event|1|||
164256098|NCT01463696|593304086|FG000|Overall Study|Adverse Event|0|||
164256099|NCT01463696|593304087|FG001|Overall Study|Adverse Event|1|||
164256100|NCT01463696|593304088|FG002|Overall Study|Adverse Event|0|||
164256101|NCT01463696|593304089|FG003|Overall Study|Adverse Event|2|||
164256102|NCT01463696|593304090|FG004|Overall Study|Adverse Event|0|||
164256103|NCT01463696|593304091|FG005|Overall Study|Adverse Event|1|||
164256104|NCT01463696|593304092|FG006|Overall Study|Adverse Event|3|||
164256105|NCT01463696|593304093|FG007|Overall Study|Adverse Event|2|||
164256106|NCT01463696|593304086|FG000|Overall Study|Lost to Follow-up|0|||
164256107|NCT01463696|593304087|FG001|Overall Study|Lost to Follow-up|0|||
164256108|NCT01463696|593304088|FG002|Overall Study|Lost to Follow-up|1|||
164256109|NCT01463696|593304089|FG003|Overall Study|Lost to Follow-up|0|||
164256110|NCT01463696|593304090|FG004|Overall Study|Lost to Follow-up|0|||
164256111|NCT01463696|593304091|FG005|Overall Study|Lost to Follow-up|0|||
164256112|NCT01463696|593304092|FG006|Overall Study|Lost to Follow-up|0|||
164256113|NCT01463696|593304093|FG007|Overall Study|Lost to Follow-up|0|||
164256114|NCT01463696|593304086|FG000|Overall Study|Progressive Disease|0|||
164256115|NCT01463696|593304087|FG001|Overall Study|Progressive Disease|1|||
164256116|NCT01463696|593304088|FG002|Overall Study|Progressive Disease|0|||
164256117|NCT01463696|593304089|FG003|Overall Study|Progressive Disease|1|||
164427549|NCT03283553|593934800|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
164427550|NCT03283553|593934799|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
164339139|NCT00474760|593617151|FG004|Overall Study|Withdrawal by Subject|0|||
164339140|NCT00474760|593617152|FG005|Overall Study|Withdrawal by Subject|1|||
164339141|NCT00474760|593617153|FG006|Overall Study|Withdrawal by Subject|1|||
164339142|NCT00474760|593617147|FG000|Overall Study|Other|0|||
164339143|NCT00474760|593617148|FG001|Overall Study|Other|1|||
164339144|NCT00474760|593617149|FG002|Overall Study|Other|0|||
164339145|NCT00474760|593617150|FG003|Overall Study|Other|0|||
164339146|NCT00474760|593617151|FG004|Overall Study|Other|1|||
164339147|NCT00474760|593617152|FG005|Overall Study|Other|0|||
164339148|NCT00474760|593617153|FG006|Overall Study|Other|0|||
164339149|NCT00474760|593617147|FG000|Overall Study|Progressive disease|3|||
164339150|NCT00474760|593617148|FG001|Overall Study|Progressive disease|2|||
164339151|NCT00474760|593617149|FG002|Overall Study|Progressive disease|3|||
164256118|NCT01463696|593304090|FG004|Overall Study|Progressive Disease|0|||
164256119|NCT01463696|593304091|FG005|Overall Study|Progressive Disease|1|||
164256120|NCT01463696|593304092|FG006|Overall Study|Progressive Disease|4|||
164256121|NCT01463696|593304093|FG007|Overall Study|Progressive Disease|2|||
164339152|NCT00474760|593617150|FG003|Overall Study|Progressive disease|2|||
164256122|NCT01463696|593304086|FG000|Overall Study|Withdrawal by Subject|0|||
164256123|NCT01463696|593304087|FG001|Overall Study|Withdrawal by Subject|0|||
164256124|NCT01463696|593304088|FG002|Overall Study|Withdrawal by Subject|0|||
164256125|NCT01463696|593304089|FG003|Overall Study|Withdrawal by Subject|1|||
164256126|NCT01463696|593304090|FG004|Overall Study|Withdrawal by Subject|1|||
164339153|NCT00474760|593617151|FG004|Overall Study|Progressive disease|8|||
164339154|NCT00474760|593617152|FG005|Overall Study|Progressive disease|20|||
164256127|NCT01463696|593304091|FG005|Overall Study|Withdrawal by Subject|1|||
164339155|NCT00474760|593617153|FG006|Overall Study|Progressive disease|7|||
164339156|NCT00474760|593617147|FG000|Overall Study|Terminated by sponsor|0|||
164576450|NCT01503021|594474750|FG000|Overall Study|Lost to Follow-up|2|||
164427551|NCT03283553|593934800|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
164427552|NCT03283553|593934799|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
164427553|NCT03283553|593934800|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
164427554|NCT03686683|593934801|FG000|Overall Study|Withdrawal by Subject|52|||
164427555|NCT03686683|593934802|FG001|Overall Study|Withdrawal by Subject|32|||
164576451|NCT01503021|594474751|FG001|Overall Study|Lost to Follow-up|0|||
164576452|NCT01503021|594474750|FG000|Overall Study|Physician Decision|3|||
164576453|NCT01503021|594474751|FG001|Overall Study|Physician Decision|0|||
164576454|NCT01503021|594474750|FG000|Overall Study|Protocol Violation|1|||
164576455|NCT01503021|594474751|FG001|Overall Study|Protocol Violation|3|||
164576456|NCT01503021|594474750|FG000|Overall Study|Withdrawal by Subject|9|||
164576457|NCT01503021|594474751|FG001|Overall Study|Withdrawal by Subject|8|||
164576458|NCT01503021|594474750|FG000|Overall Study|Moved, received transplant, etc.|5|||
164576459|NCT01503021|594474751|FG001|Overall Study|Moved, received transplant, etc.|7|||
164576460|NCT00870688|594474752|FG000|Overall Study|Lost to Follow-up|2|||
164576461|NCT00870688|594474752|FG000|Overall Study|Death, Unrelated|1|||
164576462|NCT00870688|594474752|FG000|Overall Study|Granules in the Stools|1|||
164576463|NCT02015819|594474753|FG000|Overall Study|Rickham catheter was misaligned|0|||
164576464|NCT02015819|594474754|FG001|Overall Study|Rickham catheter was misaligned|0|||
164576465|NCT02015819|594474755|FG002|Overall Study|Rickham catheter was misaligned|0|||
164576466|NCT02015819|594474756|FG003|Overall Study|Rickham catheter was misaligned|1|||
164576467|NCT01697215|594474757|FG000|Overall Study|Physician Decision|5|||
164576468|NCT01697215|594474757|FG000|Overall Study|Malfunction|9|||
164427556|NCT03686683|593934801|FG000|Overall Study|Lost to Follow-up|23|||
164427557|NCT03686683|593934802|FG001|Overall Study|Lost to Follow-up|19|||
164427558|NCT03686683|593934801|FG000|Overall Study|Adverse Event|1|||
164427559|NCT03686683|593934802|FG001|Overall Study|Adverse Event|0|||
164427560|NCT03686683|593934801|FG000|Overall Study|Death|10|||
164427561|NCT03686683|593934802|FG001|Overall Study|Death|5|||
164427562|NCT03686683|593934801|FG000|Overall Study|Progressive Disease|1|||
164427563|NCT03686683|593934802|FG001|Overall Study|Progressive Disease|1|||
164427564|NCT03686683|593934801|FG000|Overall Study|Noncompliance|1|||
164427565|NCT03686683|593934802|FG001|Overall Study|Noncompliance|0|||
164427566|NCT03686683|593934801|FG000|Overall Study|Physician Decision|1|||
164427567|NCT03686683|593934802|FG001|Overall Study|Physician Decision|1|||
164427568|NCT03686683|593934801|FG000|Overall Study|Screen fail post-randomization|1|||
164427569|NCT03686683|593934802|FG001|Overall Study|Screen fail post-randomization|0|||
164427570|NCT03686683|593934801|FG000|Overall Study|Protocol Violation|3|||
164427571|NCT03686683|593934802|FG001|Overall Study|Protocol Violation|0|||
164427572|NCT03686683|593934801|FG000|Overall Study|No data available|1|||
164427573|NCT03686683|593934802|FG001|Overall Study|No data available|0|||
164427574|NCT01770860|593934804|FG000|Overall Study|Withdrawal by Subject|4|||
164427575|NCT01770860|593934804|FG000|Overall Study|Lost to Follow-up|1|||
164427576|NCT01770860|593934804|FG000|Overall Study|Administrative decision made by the PI|1|||
164576469|NCT01697215|594474757|FG000|Overall Study|CXR not available|9|||
164576470|NCT00087438|594474766|FG000|Overall Study|Ineligible / No protocol treatment|4|||
164427577|NCT01528709|593934805|FG000|Overall Study|Death|2|||
164427578|NCT01528709|593934806|FG001|Overall Study|Death|0|||
164427579|NCT01528709|593934805|FG000|Overall Study|Withdrawal by Subject|10|||
164427580|NCT01528709|593934806|FG001|Overall Study|Withdrawal by Subject|15|||
164427581|NCT01528709|593934805|FG000|Overall Study|allergy|1|||
164427582|NCT01528709|593934806|FG001|Overall Study|allergy|0|||
164427583|NCT00372528|593934807|FG000|Overall Study|Lack of Efficacy|1|||
164427584|NCT00372528|593934807|FG000|Overall Study|Adverse Event|1|||
164576471|NCT01486264|594474767|FG000|Overall Study|Death|1|||
164576472|NCT01486264|594474768|FG001|Overall Study|Death|1|||
164576473|NCT01486264|594474767|FG000|Overall Study|Adverse Event|3|||
164576474|NCT01486264|594474768|FG001|Overall Study|Adverse Event|3|||
164427585|NCT00372528|593934807|FG000|Overall Study|Study Terminated by Sponsor|18|||
164427586|NCT00372528|593934807|FG000|Overall Study|Other|1|||
164427587|NCT05124899|593934808|FG000|Overall Study|Lost to Follow-up|3|||
164427588|NCT00562965|593934809|FG000|Overall Study|Withdrawal by Subject|0|||
164427589|NCT00562965|593934810|FG001|Overall Study|Withdrawal by Subject|1|||
164576475|NCT01486264|594474767|FG000|Overall Study|Lack of Efficacy|6|||
164427590|NCT00562965|593934809|FG000|Overall Study|Death|2|||
164427591|NCT00562965|593934810|FG001|Overall Study|Death|4|||
164427592|NCT00562965|593934809|FG000|Overall Study|Lost to Follow-up|1|||
164427593|NCT00562965|593934810|FG001|Overall Study|Lost to Follow-up|0|||
164427594|NCT00562965|593934809|FG000|Overall Study|Other|0|||
164576476|NCT01486264|594474768|FG001|Overall Study|Lack of Efficacy|10|||
164576477|NCT01486264|594474767|FG000|Overall Study|Withdrawal by Subject|7|||
164576478|NCT01486264|594474768|FG001|Overall Study|Withdrawal by Subject|18|||
164576479|NCT01486264|594474767|FG000|Overall Study|Physician Decision|1|||
164576480|NCT01486264|594474768|FG001|Overall Study|Physician Decision|1|||
164576481|NCT01486264|594474767|FG000|Overall Study|Protocol Violation|3|||
164576482|NCT01486264|594474768|FG001|Overall Study|Protocol Violation|0|||
164576483|NCT01486264|594474767|FG000|Overall Study|Lost to Follow-up|3|||
164576484|NCT01486264|594474768|FG001|Overall Study|Lost to Follow-up|2|||
164576485|NCT01486264|594474767|FG000|Overall Study|Other|5|||
164576486|NCT01486264|594474768|FG001|Overall Study|Other|11|||
164576487|NCT01486264|594474767|FG000|Overall Study|Not treated|0|||
164576488|NCT01486264|594474768|FG001|Overall Study|Not treated|1|||
164576489|NCT00283387|594474769|FG000|First Intervention|Subject non-compliant|1|||
164576490|NCT00283387|594474770|FG001|First Intervention|Subject non-compliant|1|||
164576491|NCT00283387|594474769|FG000|First Intervention|Withdrawal by Subject|0|||
164576492|NCT00283387|594474770|FG001|First Intervention|Withdrawal by Subject|1|||
164576493|NCT05340504|594474771|FG000|Overall Study|Withdrawal by Subject|1|||
164576494|NCT05340504|594474772|FG001|Overall Study|Withdrawal by Subject|0|||
164576495|NCT03068715|594474776|FG000|Overall Study|No longer met inclusion criteria|1|||
164576496|NCT03068715|594474777|FG001|Overall Study|No longer met inclusion criteria|0|||
164576497|NCT00728416|594474778|FG000|Overall Study|Adverse Event|1|||
164576498|NCT00728416|594474779|FG001|Overall Study|Adverse Event|1|||
164576499|NCT00728416|594474778|FG000|Overall Study|Treatment Failure|0|||
164256128|NCT01463696|593304092|FG006|Overall Study|Withdrawal by Subject|2|||
164256129|NCT01463696|593304093|FG007|Overall Study|Withdrawal by Subject|0|||
164256130|NCT01463696|593304086|FG000|Overall Study|Not Treated|0|||
164256131|NCT01463696|593304087|FG001|Overall Study|Not Treated|0|||
164256132|NCT01463696|593304088|FG002|Overall Study|Not Treated|0|||
164256133|NCT01463696|593304089|FG003|Overall Study|Not Treated|0|||
164256134|NCT01463696|593304090|FG004|Overall Study|Not Treated|0|||
164256135|NCT01463696|593304091|FG005|Overall Study|Not Treated|0|||
164256136|NCT01463696|593304092|FG006|Overall Study|Not Treated|1|||
164256137|NCT01463696|593304093|FG007|Overall Study|Not Treated|0|||
164256138|NCT03883165|593304095|FG000|Overall Study|Withdrawal by Subject|4|||
164256139|NCT03883165|593304096|FG001|Overall Study|Withdrawal by Subject|3|||
164256140|NCT00967694|593304097|FG000|Overall Study|Withdrawal by Subject|6|||
164256141|NCT00245050|593304098|FG000|Overall Study|Adverse Event|3|||
164256142|NCT00245050|593304099|FG001|Overall Study|Adverse Event|2|||
164256143|NCT03275246|593304102|FG000|Overall Study|Protocol Violation|5|||
164256144|NCT03275246|593304102|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
164256145|NCT02301546|593304103|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
164256146|NCT02301546|593304104|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
164256147|NCT02301546|593304103|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
164427595|NCT00562965|593934810|FG001|Overall Study|Other|1|||
164427596|NCT03432533|593934811|FG000|Overall Study|Lost to Follow-up|1|||
164427597|NCT03432533|593934812|FG001|Overall Study|Lost to Follow-up|2|||
164427598|NCT03432533|593934811|FG000|Overall Study|Withdrawal by Subject|14|||
164427599|NCT03432533|593934812|FG001|Overall Study|Withdrawal by Subject|9|||
164427600|NCT01354938|593934817|FG000|Overall Study|Lost to Follow-up|1|||
164427601|NCT01253200|593934818|FG000|Overall Study|Death|1|||
164680537|NCT00112437|594854571|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164256148|NCT02301546|593304104|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
164256149|NCT02301546|593304103|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
164256150|NCT02301546|593304104|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
164256151|NCT02301546|593304103|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
164256152|NCT02301546|593304104|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
164256153|NCT02301546|593304103|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
164256154|NCT02301546|593304104|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
164256155|NCT02301546|593304103|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
164256156|NCT02301546|593304104|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
164256157|NCT02301546|593304103|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
164256158|NCT02301546|593304104|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
164256159|NCT05526781|593304107|FG000|Overall Study|Lost to Follow-up|1|||
164256160|NCT03905265|593304108|FG000|Overall Study|Withdrawal by Subject|1|||
164256161|NCT03905265|593304109|FG001|Overall Study|Withdrawal by Subject|1|||
164256162|NCT03905265|593304110|FG002|Overall Study|Withdrawal by Subject|0|||
164256163|NCT03905265|593304111|FG003|Overall Study|Withdrawal by Subject|0|||
164256164|NCT04952597|593304114|FG000|Overall Study|Death|12|||
164256165|NCT04952597|593304115|FG001|Overall Study|Death|13|||
164256166|NCT04952597|593304116|FG002|Overall Study|Death|14|||
164256167|NCT04952597|593304114|FG000|Overall Study|Withdrawal by Subject|1|||
164256168|NCT04952597|593304115|FG001|Overall Study|Withdrawal by Subject|0|||
164256169|NCT04952597|593304116|FG002|Overall Study|Withdrawal by Subject|3|||
164256170|NCT04952597|593304114|FG000|Overall Study|Lost to Follow-up|0|||
164256171|NCT04952597|593304115|FG001|Overall Study|Lost to Follow-up|1|||
164256172|NCT04952597|593304116|FG002|Overall Study|Lost to Follow-up|1|||
164256173|NCT03632993|593304117|FG000|Overall Study|Withdrawal by Subject|1|||
164256174|NCT03632993|593304118|FG001|Overall Study|Withdrawal by Subject|0|||
164256175|NCT03632993|593304119|FG002|Overall Study|Withdrawal by Subject|0|||
164256176|NCT03632993|593304120|FG003|Overall Study|Withdrawal by Subject|0|||
164256177|NCT03632993|593304121|FG004|Overall Study|Withdrawal by Subject|0|||
164256178|NCT03632993|593304122|FG005|Overall Study|Withdrawal by Subject|0|||
164256179|NCT03632993|593304123|FG006|Overall Study|Withdrawal by Subject|0|||
164256180|NCT03632993|593304124|FG007|Overall Study|Withdrawal by Subject|0|||
164256181|NCT03632993|593304125|FG008|Overall Study|Withdrawal by Subject|0|||
164256182|NCT03632993|593304126|FG009|Overall Study|Withdrawal by Subject|1|||
164256183|NCT03632993|593304117|FG000|Overall Study|Protocol Non-compliance|0|||
164256184|NCT03632993|593304118|FG001|Overall Study|Protocol Non-compliance|1|||
164256185|NCT03632993|593304119|FG002|Overall Study|Protocol Non-compliance|0|||
164256186|NCT03632993|593304120|FG003|Overall Study|Protocol Non-compliance|0|||
164256187|NCT03632993|593304121|FG004|Overall Study|Protocol Non-compliance|0|||
164256188|NCT03632993|593304122|FG005|Overall Study|Protocol Non-compliance|0|||
164256189|NCT03632993|593304123|FG006|Overall Study|Protocol Non-compliance|0|||
164256190|NCT03632993|593304124|FG007|Overall Study|Protocol Non-compliance|0|||
164256191|NCT03632993|593304125|FG008|Overall Study|Protocol Non-compliance|0|||
164256192|NCT03632993|593304126|FG009|Overall Study|Protocol Non-compliance|0|||
164256193|NCT03632993|593304117|FG000|Overall Study|Lost to Follow-up|0|||
164256194|NCT03632993|593304118|FG001|Overall Study|Lost to Follow-up|0|||
164256195|NCT03632993|593304119|FG002|Overall Study|Lost to Follow-up|0|||
164256196|NCT03632993|593304120|FG003|Overall Study|Lost to Follow-up|0|||
164256197|NCT03632993|593304121|FG004|Overall Study|Lost to Follow-up|0|||
164256198|NCT03632993|593304122|FG005|Overall Study|Lost to Follow-up|1|||
164256199|NCT03632993|593304123|FG006|Overall Study|Lost to Follow-up|0|||
164256200|NCT03632993|593304124|FG007|Overall Study|Lost to Follow-up|1|||
164256201|NCT03632993|593304125|FG008|Overall Study|Lost to Follow-up|0|||
164680538|NCT00112437|594854572|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164256202|NCT03632993|593304126|FG009|Overall Study|Lost to Follow-up|0|||
164256203|NCT03632993|593304117|FG000|Overall Study|Adverse Event|0|||
164256204|NCT03632993|593304118|FG001|Overall Study|Adverse Event|0|||
164427602|NCT01253200|593934819|FG001|Overall Study|Death|0|||
164427603|NCT01253200|593934820|FG002|Overall Study|Death|0|||
164427604|NCT01253200|593934821|FG003|Overall Study|Death|0|||
164427605|NCT01253200|593934822|FG004|Overall Study|Death|0|||
164680539|NCT00112437|594854573|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164256205|NCT03632993|593304119|FG002|Overall Study|Adverse Event|0|||
164256206|NCT03632993|593304120|FG003|Overall Study|Adverse Event|0|||
164256207|NCT03632993|593304121|FG004|Overall Study|Adverse Event|0|||
164256208|NCT03632993|593304122|FG005|Overall Study|Adverse Event|1|||
164256209|NCT03632993|593304123|FG006|Overall Study|Adverse Event|0|||
164256210|NCT03632993|593304124|FG007|Overall Study|Adverse Event|1|||
164256211|NCT03632993|593304125|FG008|Overall Study|Adverse Event|0|||
164256212|NCT03632993|593304126|FG009|Overall Study|Adverse Event|0|||
164256213|NCT01005316|593304127|FG000|Overall Study|Adverse Event|0|||
164256214|NCT01005316|593304128|FG001|Overall Study|Adverse Event|0|||
164256215|NCT01005316|593304129|FG002|Overall Study|Adverse Event|0|||
164256216|NCT01005316|593304130|FG003|Overall Study|Adverse Event|1|||
164256217|NCT01005316|593304127|FG000|Overall Study|Death|20|||
164256218|NCT01005316|593304128|FG001|Overall Study|Death|5|||
164256219|NCT01005316|593304129|FG002|Overall Study|Death|1|||
164256220|NCT01005316|593304130|FG003|Overall Study|Death|15|||
164256221|NCT01005316|593304127|FG000|Overall Study|Study Termination|5|||
164256222|NCT01005316|593304128|FG001|Overall Study|Study Termination|63|||
164256223|NCT01005316|593304129|FG002|Overall Study|Study Termination|9|||
164256224|NCT01005316|593304130|FG003|Overall Study|Study Termination|85|||
164256225|NCT01005316|593304127|FG000|Overall Study|Lost to Follow-up|1|||
164256226|NCT01005316|593304128|FG001|Overall Study|Lost to Follow-up|3|||
164256227|NCT01005316|593304129|FG002|Overall Study|Lost to Follow-up|0|||
164256228|NCT01005316|593304130|FG003|Overall Study|Lost to Follow-up|2|||
164256229|NCT01005316|593304127|FG000|Overall Study|Physician Decision|6|||
164256230|NCT01005316|593304128|FG001|Overall Study|Physician Decision|0|||
164256231|NCT01005316|593304129|FG002|Overall Study|Physician Decision|0|||
164256232|NCT01005316|593304130|FG003|Overall Study|Physician Decision|0|||
164256233|NCT01005316|593304127|FG000|Overall Study|Sponsor Decision|6|||
164256234|NCT01005316|593304128|FG001|Overall Study|Sponsor Decision|3|||
164256235|NCT01005316|593304129|FG002|Overall Study|Sponsor Decision|0|||
164256236|NCT01005316|593304130|FG003|Overall Study|Sponsor Decision|0|||
164256237|NCT01005316|593304127|FG000|Overall Study|Withdrawal by Subject|1|||
164256238|NCT01005316|593304128|FG001|Overall Study|Withdrawal by Subject|1|||
164256239|NCT01005316|593304129|FG002|Overall Study|Withdrawal by Subject|0|||
164256240|NCT01005316|593304130|FG003|Overall Study|Withdrawal by Subject|2|||
164256241|NCT01005316|593304127|FG000|Overall Study|Consented to Another Study|2|||
164256242|NCT01005316|593304128|FG001|Overall Study|Consented to Another Study|0|||
164256243|NCT01005316|593304129|FG002|Overall Study|Consented to Another Study|0|||
164256244|NCT01005316|593304130|FG003|Overall Study|Consented to Another Study|0|||
164256245|NCT01005316|593304127|FG000|Overall Study|Delisted|8|||
164256246|NCT01005316|593304128|FG001|Overall Study|Delisted|0|||
164256247|NCT01005316|593304129|FG002|Overall Study|Delisted|0|||
164256248|NCT01005316|593304130|FG003|Overall Study|Delisted|0|||
164256249|NCT01005316|593304127|FG000|Overall Study|Transferred Care|1|||
164256250|NCT01005316|593304128|FG001|Overall Study|Transferred Care|0|||
164256251|NCT01005316|593304129|FG002|Overall Study|Transferred Care|1|||
164256252|NCT01005316|593304130|FG003|Overall Study|Transferred Care|3|||
164256253|NCT01005316|593304127|FG000|Overall Study|Retransplanted|0|||
164256254|NCT01005316|593304128|FG001|Overall Study|Retransplanted|1|||
164256255|NCT01005316|593304129|FG002|Overall Study|Retransplanted|0|||
164256256|NCT01005316|593304130|FG003|Overall Study|Retransplanted|0|||
164256257|NCT00632827|593304131|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
164256258|NCT00632827|593304131|FG000|Overall Study|Death|2|||
164256259|NCT00632827|593304131|FG000|Overall Study|Adverse Event|5|||
164256260|NCT00632827|593304131|FG000|Overall Study|Lost to Follow-up|1|||
164256261|NCT00368836|593304134|FG000|Phase II|Screen Failure|1|||
164256262|NCT00368836|593304134|FG000|Phase II|Withdrawal by Subject|1|||
164256263|NCT00368836|593304134|FG000|Phase II|unable to collect blood and/or breath|17|||
164256264|NCT00368836|593304134|FG000|Phase II|Protocol Violation|2|||
164256265|NCT03272828|593304137|FG000|Overall Study|Lost to Follow-up|7|||
164256266|NCT03272828|593304138|FG001|Overall Study|Lost to Follow-up|7|||
164256267|NCT03272828|593304137|FG000|Overall Study|Withdrawal by Subject|2|||
164256268|NCT03272828|593304138|FG001|Overall Study|Withdrawal by Subject|0|||
164256269|NCT03272828|593304137|FG000|Overall Study|Deceased|1|||
164256270|NCT03272828|593304138|FG001|Overall Study|Deceased|1|||
164256271|NCT03272828|593304137|FG000|Overall Study|Failed implant|1|||
164256272|NCT03272828|593304138|FG001|Overall Study|Failed implant|2|||
164256273|NCT03888235|593304142|FG000|Overall Study|Lost to Follow-up|1|||
164256274|NCT03888235|593304143|FG001|Overall Study|Lost to Follow-up|1|||
164256275|NCT03888235|593304144|FG002|Overall Study|Lost to Follow-up|0|||
164256276|NCT01054560|593304145|FG000|Overall Study|Death|10|||
164256277|NCT01054560|593304146|FG001|Overall Study|Death|21|||
164256278|NCT01054560|593304145|FG000|Overall Study|Lost to Follow-up|2|||
164256279|NCT01054560|593304146|FG001|Overall Study|Lost to Follow-up|5|||
164256280|NCT01054560|593304145|FG000|Overall Study|Withdrawal by Subject|0|||
164256281|NCT01054560|593304146|FG001|Overall Study|Withdrawal by Subject|2|||
164256282|NCT01054560|593304145|FG000|Overall Study|Physician Decision|1|||
164256283|NCT01054560|593304146|FG001|Overall Study|Physician Decision|0|||
164256284|NCT01923363|593304152|FG000|Overall Study|Protocol Violation|1|||
164256285|NCT00244933|593304156|FG000|Overall Study|Not response evaluable|2|||
164256286|NCT00866047|593304157|FG000|Treatment Period|Progressive disease|13|||
164256287|NCT00866047|593304157|FG000|Treatment Period|Adverse Event|16|||
164256288|NCT00866047|593304157|FG000|Treatment Period|Physician Decision|14|||
164256289|NCT00866047|593304157|FG000|Treatment Period|Withdrawal by Subject|5|||
164256290|NCT00866047|593304157|FG000|Follow-up Period|Lost to Follow-up|5|||
164256291|NCT02928029|593304158|FG000|Overall Study|Withdrawal by Subject|0|||
164256292|NCT02928029|593304159|FG001|Overall Study|Withdrawal by Subject|1|||
164256293|NCT02928029|593304158|FG000|Overall Study|Radiological progression|1|||
164256294|NCT02928029|593304159|FG001|Overall Study|Radiological progression|0|||
164256295|NCT02928029|593304158|FG000|Overall Study|Clinical progression|1|||
164256296|NCT02928029|593304159|FG001|Overall Study|Clinical progression|2|||
164256297|NCT02928029|593304158|FG000|Overall Study|AE not related to clinical progression|1|||
164256298|NCT02928029|593304159|FG001|Overall Study|AE not related to clinical progression|1|||
164256299|NCT03703817|593304160|FG000|Overall Study|Not meeting eligibility criteria|7|||
164256300|NCT03703817|593304161|FG001|Overall Study|Not meeting eligibility criteria|4|||
164256301|NCT00616018|593304163|FG000|Overall Study|Protocol Violation|3|||
164256302|NCT03315793|593304164|FG000|Overall Study|Adverse Event|4|||
164256303|NCT03315793|593304165|FG001|Overall Study|Adverse Event|2|||
164256304|NCT03315793|593304164|FG000|Overall Study|Protocol Deviation|1|||
164256305|NCT03315793|593304165|FG001|Overall Study|Protocol Deviation|0|||
164256306|NCT03315793|593304164|FG000|Overall Study|Difficult for regular visit|0|||
164256307|NCT03315793|593304165|FG001|Overall Study|Difficult for regular visit|1|||
164256308|NCT01463111|593306121|FG000|Overall Study|Withdrawal by Subject|2|||
164256309|NCT01463111|593306121|FG000|Overall Study|Lost to Follow-up|5|||
164256310|NCT01463111|593306121|FG000|Overall Study|Physician Decision|2|||
164256311|NCT00882583|593306122|FG000|Overall Study|Physician Decision|1|||
164256312|NCT00882583|593306123|FG001|Overall Study|Physician Decision|0|||
164256313|NCT00882583|593306122|FG000|Overall Study|Adverse Event|0|||
164256314|NCT00882583|593306123|FG001|Overall Study|Adverse Event|1|||
164256315|NCT03389555|593306132|FG000|Overall Study|Protocol Violation|1|||
164256316|NCT03389555|593306133|FG001|Overall Study|Protocol Violation|3|||
164256317|NCT03389555|593306132|FG000|Overall Study|Death|1|||
164256318|NCT03389555|593306133|FG001|Overall Study|Death|0|||
164256319|NCT01885208|593306134|FG000|Overall Study|Unclassified|32|||
164256320|NCT01885208|593306135|FG001|Overall Study|Unclassified|38|||
164256321|NCT00920218|593306140|FG000|Overall Study|Serious Adverse Event|2|||
164256322|NCT00920218|593306141|FG001|Overall Study|Serious Adverse Event|0|||
164256323|NCT00920218|593306142|FG002|Overall Study|Serious Adverse Event|2|||
164256324|NCT00920218|593306143|FG003|Overall Study|Serious Adverse Event|1|||
164256325|NCT00920218|593306140|FG000|Overall Study|Withdrawal by Subject|0|||
164256326|NCT00920218|593306141|FG001|Overall Study|Withdrawal by Subject|3|||
164256327|NCT00920218|593306142|FG002|Overall Study|Withdrawal by Subject|2|||
164256328|NCT00920218|593306143|FG003|Overall Study|Withdrawal by Subject|0|||
164256329|NCT00920218|593306140|FG000|Overall Study|Migrated/moved from study area|0|||
164256330|NCT00920218|593306141|FG001|Overall Study|Migrated/moved from study area|0|||
164256331|NCT00920218|593306142|FG002|Overall Study|Migrated/moved from study area|1|||
164256332|NCT00920218|593306143|FG003|Overall Study|Migrated/moved from study area|0|||
164256333|NCT00920218|593306140|FG000|Overall Study|Lost to Follow-up|0|||
164256334|NCT00920218|593306141|FG001|Overall Study|Lost to Follow-up|1|||
164256335|NCT00920218|593306142|FG002|Overall Study|Lost to Follow-up|0|||
164256336|NCT00920218|593306143|FG003|Overall Study|Lost to Follow-up|3|||
164256337|NCT00920218|593306140|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
164256338|NCT00920218|593306141|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
164576500|NCT00728416|594474779|FG001|Overall Study|Treatment Failure|1|||
164576501|NCT00728416|594474778|FG000|Overall Study|Withdrawal by Subject|1|||
164576502|NCT00728416|594474779|FG001|Overall Study|Withdrawal by Subject|0|||
164576503|NCT00117312|594474780|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
164576504|NCT00117312|594474781|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
164576505|NCT00117312|594474782|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
164576506|NCT00117312|594474783|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
164576507|NCT00117312|594474780|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
164680540|NCT00112437|594854574|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164256339|NCT00920218|593306142|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
164256340|NCT00920218|593306143|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
164256341|NCT00920218|593306140|FG000|Overall Study|Other|0|||
164256342|NCT00920218|593306141|FG001|Overall Study|Other|0|||
164256343|NCT00920218|593306142|FG002|Overall Study|Other|1|||
164256344|NCT00920218|593306143|FG003|Overall Study|Other|0|||
164256345|NCT00923975|593306144|FG000|Overall Study|Did not meet inclusion criteria|1|||
164256346|NCT04417218|593306150|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
164256347|NCT04417218|593306151|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
164256348|NCT00873041|593306152|FG000|Core Study|Adverse Event|2|||
164576508|NCT00117312|594474781|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
164576509|NCT00117312|594474782|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
164576510|NCT00117312|594474783|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
164576511|NCT00117312|594474780|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
164576512|NCT00117312|594474781|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
164576513|NCT00117312|594474782|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
164576514|NCT00117312|594474783|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
164576515|NCT00117312|594474780|FG000|Overall Study|Other|0|||
164576516|NCT00117312|594474781|FG001|Overall Study|Other|1|||
164576517|NCT00117312|594474782|FG002|Overall Study|Other|3|||
164256349|NCT00873041|593306153|FG001|Core Study|Adverse Event|3|||
164256350|NCT00873041|593306154|FG002|Core Study|Adverse Event|1|||
164256351|NCT00873041|593306152|FG000|Core Study|Withdrawal by Subject|1|||
164256352|NCT00873041|593306153|FG001|Core Study|Withdrawal by Subject|2|||
164256353|NCT00873041|593306154|FG002|Core Study|Withdrawal by Subject|2|||
164256354|NCT00873041|593306152|FG000|Core Study|Lost to Follow-up|3|||
164256355|NCT00873041|593306153|FG001|Core Study|Lost to Follow-up|1|||
164256356|NCT00873041|593306154|FG002|Core Study|Lost to Follow-up|0|||
164256357|NCT00873041|593306152|FG000|Core Study|Abnormal laboratory value|0|||
164256358|NCT00873041|593306153|FG001|Core Study|Abnormal laboratory value|0|||
164256359|NCT00873041|593306154|FG002|Core Study|Abnormal laboratory value|1|||
164339157|NCT00474760|593617148|FG001|Overall Study|Terminated by sponsor|0|||
164339158|NCT00474760|593617149|FG002|Overall Study|Terminated by sponsor|0|||
164339159|NCT00474760|593617150|FG003|Overall Study|Terminated by sponsor|0|||
164256360|NCT00873041|593306152|FG000|Core Study|Protocol deviation|1|||
164339160|NCT00474760|593617151|FG004|Overall Study|Terminated by sponsor|0|||
164339161|NCT00474760|593617152|FG005|Overall Study|Terminated by sponsor|0|||
164339162|NCT00474760|593617153|FG006|Overall Study|Terminated by sponsor|2|||
164339163|NCT01927627|593617155|FG000|Overall Study|Adverse Event|3|||
164339164|NCT01927627|593617155|FG000|Overall Study|Lack of Efficacy|1|||
164339165|NCT01927627|593617155|FG000|Overall Study|Financial Concerns|1|||
164339166|NCT02635776|593617156|FG000|Overall Study|Physician Decision|1|||
164339167|NCT02635776|593617157|FG001|Overall Study|Physician Decision|0|||
164339168|NCT02635776|593617156|FG000|Overall Study|Adverse Event|51|||
164339169|NCT02635776|593617157|FG001|Overall Study|Adverse Event|3|||
164339170|NCT02635776|593617156|FG000|Overall Study|Withdrawal by Subject|41|||
164339171|NCT02635776|593617157|FG001|Overall Study|Withdrawal by Subject|7|||
164339172|NCT02635776|593617156|FG000|Overall Study|Lost to Follow-up|4|||
164339173|NCT02635776|593617157|FG001|Overall Study|Lost to Follow-up|0|||
164339174|NCT02635776|593617156|FG000|Overall Study|Other reasons|5|||
164339175|NCT02635776|593617157|FG001|Overall Study|Other reasons|1|||
164339176|NCT00660673|593617158|FG000|Overall Study|Adverse Event|84|||
164339177|NCT00660673|593617158|FG000|Overall Study|Lack of Efficacy|7|||
164339178|NCT00660673|593617158|FG000|Overall Study|Withdrawal by Subject|22|||
164339179|NCT00660673|593617158|FG000|Overall Study|Administrative|2|||
164339180|NCT00660673|593617158|FG000|Overall Study|Protocol Violation|2|||
164339181|NCT00579098|593617159|FG000|Overall Study|Lost to Follow-up|2|||
164339182|NCT00579098|593617160|FG001|Overall Study|Lost to Follow-up|0|||
164339183|NCT00579098|593617159|FG000|Overall Study|Adverse Event|2|||
164339184|NCT00579098|593617160|FG001|Overall Study|Adverse Event|3|||
164339185|NCT00579098|593617159|FG000|Overall Study|Withdrawal by Subject|2|||
164339186|NCT00579098|593617160|FG001|Overall Study|Withdrawal by Subject|3|||
164339187|NCT00579098|593617159|FG000|Overall Study|AF returned after ablation|3|||
164339188|NCT00579098|593617160|FG001|Overall Study|AF returned after ablation|2|||
164339189|NCT00633750|593617167|FG000|Overall Study|Adverse Event|2|||
164339190|NCT00633750|593617167|FG000|Overall Study|Withdrawal by Subject|3|||
164339191|NCT01903031|593617168|FG000|Overall Study|Not Able to Attend Clinic|1|||
164339192|NCT01903031|593617169|FG001|Overall Study|Not Able to Attend Clinic|1|||
164339193|NCT01903031|593617170|FG002|Overall Study|Not Able to Attend Clinic|0|||
164339194|NCT01903031|593617168|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
164339195|NCT01903031|593617169|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
164339196|NCT01903031|593617170|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
164339197|NCT01903031|593617168|FG000|Overall Study|Adverse Event|0|||
164339198|NCT01903031|593617169|FG001|Overall Study|Adverse Event|1|||
164339199|NCT01903031|593617170|FG002|Overall Study|Adverse Event|0|||
164339200|NCT01903031|593617168|FG000|Overall Study|Withdrawal by Subject|0|||
164339201|NCT01903031|593617169|FG001|Overall Study|Withdrawal by Subject|1|||
164339202|NCT01903031|593617170|FG002|Overall Study|Withdrawal by Subject|1|||
164339203|NCT01903031|593617168|FG000|Overall Study|Protocol Violation|0|||
164339204|NCT01903031|593617169|FG001|Overall Study|Protocol Violation|0|||
164339205|NCT01903031|593617170|FG002|Overall Study|Protocol Violation|2|||
164339206|NCT01903031|593617168|FG000|Overall Study|Lost to Follow-up|0|||
164339207|NCT01903031|593617169|FG001|Overall Study|Lost to Follow-up|0|||
164339208|NCT01903031|593617170|FG002|Overall Study|Lost to Follow-up|1|||
164256361|NCT00873041|593306153|FG001|Core Study|Protocol deviation|0|||
164256362|NCT00873041|593306154|FG002|Core Study|Protocol deviation|1|||
164339209|NCT01903031|593617168|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
164339210|NCT01903031|593617169|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
164339211|NCT01903031|593617170|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
164339212|NCT01811225|593617171|FG000|Treatment Period 1|Adverse Event|2|||
164339213|NCT01811225|593617172|FG001|Treatment Period 1|Adverse Event|3|||
164339214|NCT01811225|593617171|FG000|Treatment Period 1|Lost to Follow-up|12|||
164339215|NCT01811225|593617172|FG001|Treatment Period 1|Lost to Follow-up|8|||
164339216|NCT01811225|593617171|FG000|Treatment Period 1|transporation|1|||
164339217|NCT01811225|593617172|FG001|Treatment Period 1|transporation|0|||
164256363|NCT00873041|593306152|FG000|Extension Study|Adverse Event|1|||
164256364|NCT00873041|593306153|FG001|Extension Study|Adverse Event|0|||
164256365|NCT00873041|593306154|FG002|Extension Study|Adverse Event|1|||
164256366|NCT00873041|593306152|FG000|Extension Study|Administrative reasons|0|||
164256367|NCT00873041|593306153|FG001|Extension Study|Administrative reasons|0|||
164256368|NCT00873041|593306154|FG002|Extension Study|Administrative reasons|1|||
164256369|NCT02449889|593306157|FG000|Overall Study|Adverse Event|1|||
164256370|NCT02449889|593306158|FG001|Overall Study|Adverse Event|2|||
164256371|NCT02449889|593306159|FG002|Overall Study|Adverse Event|0|||
164256372|NCT02449889|593306157|FG000|Overall Study|Protocol Violation|0|||
164256373|NCT02449889|593306158|FG001|Overall Study|Protocol Violation|4|||
164256374|NCT02449889|593306159|FG002|Overall Study|Protocol Violation|1|||
164256375|NCT00758264|593306160|FG000|Active Phase|Withdrawal by Subject|0|||
164256376|NCT00758264|593306161|FG001|Active Phase|Withdrawal by Subject|0|||
164256377|NCT00758264|593306162|FG002|Active Phase|Withdrawal by Subject|1|||
164256378|NCT00758264|593306160|FG000|Active Phase|Lost to Follow-up|1|||
164256379|NCT00758264|593306161|FG001|Active Phase|Lost to Follow-up|0|||
164256380|NCT00758264|593306162|FG002|Active Phase|Lost to Follow-up|0|||
164256381|NCT00758264|593306160|FG000|Active Phase|Other|0|||
164256382|NCT00758264|593306161|FG001|Active Phase|Other|0|||
164256383|NCT00758264|593306162|FG002|Active Phase|Other|4|||
164256384|NCT01082874|593306164|FG000|Overall Study|Lost to Follow-up|10|||
164256385|NCT01082874|593306165|FG001|Overall Study|Lost to Follow-up|10|||
164576518|NCT00117312|594474783|FG003|Overall Study|Other|1|||
164576519|NCT00117312|594474780|FG000|Overall Study|Patient choice|0|||
164576520|NCT00117312|594474781|FG001|Overall Study|Patient choice|0|||
164576521|NCT00117312|594474782|FG002|Overall Study|Patient choice|2|||
164576522|NCT00117312|594474783|FG003|Overall Study|Patient choice|1|||
164576523|NCT00117312|594474780|FG000|Overall Study|Adverse Event|0|||
164576524|NCT00117312|594474781|FG001|Overall Study|Adverse Event|2|||
164256386|NCT01082874|593306166|FG002|Overall Study|Lost to Follow-up|6|||
164256387|NCT01082874|593306167|FG003|Overall Study|Lost to Follow-up|10|||
164256388|NCT01082874|593306164|FG000|Overall Study|Withdrawal by Subject|1|||
164256389|NCT01082874|593306165|FG001|Overall Study|Withdrawal by Subject|2|||
164256390|NCT01082874|593306166|FG002|Overall Study|Withdrawal by Subject|5|||
164256391|NCT01082874|593306167|FG003|Overall Study|Withdrawal by Subject|3|||
164256392|NCT03176472|593306178|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
164256393|NCT03176472|593306179|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
164256394|NCT03176472|593306178|FG000|Double Blind Treatment Period|Adverse Event|0|||
164256395|NCT03176472|593306179|FG001|Double Blind Treatment Period|Adverse Event|5|||
164256396|NCT03176472|593306178|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
164256397|NCT03176472|593306179|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
164256398|NCT03176472|593306178|FG000|Double Blind Treatment Period|Physician Decision|0|||
164256399|NCT03176472|593306179|FG001|Double Blind Treatment Period|Physician Decision|1|||
164256400|NCT03176472|593306178|FG000|Double Blind Treatment Period|Protocol Violation|1|||
164256401|NCT03176472|593306179|FG001|Double Blind Treatment Period|Protocol Violation|0|||
164256402|NCT03176472|593306178|FG000|Double Blind Treatment Period|Not Provided|1|||
164256403|NCT03176472|593306179|FG001|Double Blind Treatment Period|Not Provided|0|||
164256404|NCT03176472|593306178|FG000|Open Label Extension|Withdrawal by Subject|3|||
164256405|NCT03176472|593306179|FG001|Open Label Extension|Withdrawal by Subject|4|||
164256406|NCT03176472|593306178|FG000|Open Label Extension|Adverse Event|2|||
164256407|NCT03176472|593306179|FG001|Open Label Extension|Adverse Event|4|||
164256408|NCT03176472|593306178|FG000|Open Label Extension|Lost to Follow-up|1|||
164256409|NCT03176472|593306179|FG001|Open Label Extension|Lost to Follow-up|2|||
164256410|NCT03176472|593306178|FG000|Open Label Extension|Protocol Violation|0|||
164256411|NCT03176472|593306179|FG001|Open Label Extension|Protocol Violation|1|||
164256412|NCT03176472|593306178|FG000|Open Label Extension|Not Provided|2|||
164256413|NCT03176472|593306179|FG001|Open Label Extension|Not Provided|1|||
164256414|NCT01846663|593306180|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
164256415|NCT01846663|593306181|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
164256416|NCT01846663|593306180|FG000|Overall Study|Withdrawal by Subject|1|||
164256417|NCT01846663|593306181|FG001|Overall Study|Withdrawal by Subject|0|||
164256418|NCT01846663|593306180|FG000|Overall Study|Adverse Event|1|||
164256419|NCT01846663|593306181|FG001|Overall Study|Adverse Event|2|||
164256420|NCT04295681|593306195|FG000|Overall Study|Eligibility error|1|||
164256421|NCT04295681|593306196|FG001|Overall Study|Eligibility error|3|||
164339218|NCT01811225|593617171|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
164576525|NCT00117312|594474782|FG002|Overall Study|Adverse Event|0|||
164256422|NCT02210689|593306203|FG000|Overall Study|Withdrawal by Subject|7|||
164256423|NCT02210689|593306204|FG001|Overall Study|Withdrawal by Subject|4|||
164256424|NCT02210689|593306205|FG002|Overall Study|Withdrawal by Subject|2|||
164339219|NCT01811225|593617172|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
164576526|NCT00117312|594474783|FG003|Overall Study|Adverse Event|0|||
164256425|NCT02210689|593306203|FG000|Overall Study|Adverse Event|0|||
164256426|NCT02210689|593306204|FG001|Overall Study|Adverse Event|1|||
164256427|NCT02210689|593306205|FG002|Overall Study|Adverse Event|0|||
164427606|NCT01253200|593934818|FG000|Overall Study|Lost to Follow-up|1|||
164576527|NCT00117312|594474780|FG000|Overall Study|Protocol Violation|0|||
164427607|NCT01253200|593934819|FG001|Overall Study|Lost to Follow-up|1|||
164427608|NCT01253200|593934820|FG002|Overall Study|Lost to Follow-up|0|||
164427609|NCT01253200|593934821|FG003|Overall Study|Lost to Follow-up|0|||
164427610|NCT01253200|593934822|FG004|Overall Study|Lost to Follow-up|0|||
164256428|NCT02210689|593306203|FG000|Overall Study|Protocol Violation|1|||
164256429|NCT02210689|593306204|FG001|Overall Study|Protocol Violation|0|||
164256430|NCT02210689|593306205|FG002|Overall Study|Protocol Violation|0|||
164256431|NCT02210689|593306203|FG000|Overall Study|Lost to Follow-up|11|||
164256432|NCT02210689|593306204|FG001|Overall Study|Lost to Follow-up|9|||
164256433|NCT02210689|593306205|FG002|Overall Study|Lost to Follow-up|5|||
164256434|NCT02210689|593306203|FG000|Overall Study|Pregnancy|0|||
164256435|NCT02210689|593306204|FG001|Overall Study|Pregnancy|1|||
164256436|NCT02210689|593306205|FG002|Overall Study|Pregnancy|0|||
164427611|NCT01253200|593934818|FG000|Overall Study|Withdrawal by Subject|2|||
164427612|NCT01253200|593934819|FG001|Overall Study|Withdrawal by Subject|0|||
164427613|NCT01253200|593934820|FG002|Overall Study|Withdrawal by Subject|0|||
164576528|NCT00117312|594474781|FG001|Overall Study|Protocol Violation|1|||
164256437|NCT02210689|593306203|FG000|Overall Study|Lack of Efficacy|0|||
164256438|NCT02210689|593306204|FG001|Overall Study|Lack of Efficacy|1|||
164256439|NCT02210689|593306205|FG002|Overall Study|Lack of Efficacy|5|||
164256440|NCT02210689|593306203|FG000|Overall Study|Prohibited medication|2|||
164256441|NCT02210689|593306204|FG001|Overall Study|Prohibited medication|8|||
164256442|NCT02210689|593306205|FG002|Overall Study|Prohibited medication|1|||
164256443|NCT02210689|593306203|FG000|Overall Study|Negative Nugent score at baseline|6|||
164256444|NCT02210689|593306204|FG001|Overall Study|Negative Nugent score at baseline|2|||
164256445|NCT02210689|593306205|FG002|Overall Study|Negative Nugent score at baseline|2|||
164256446|NCT02210689|593306203|FG000|Overall Study|Other|25|||
164256447|NCT02210689|593306204|FG001|Overall Study|Other|21|||
164256448|NCT02210689|593306205|FG002|Overall Study|Other|8|||
164256449|NCT00675441|593306206|FG000|Overall Study|Withdrawal by Subject|2|||
164256450|NCT00675441|593306206|FG000|Overall Study|Death|1|||
164256451|NCT05427539|593306208|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
164256452|NCT05427539|593306209|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
164256453|NCT05427539|593306208|FG000|Period 1|Withdrawal by Subject|1|||
164256454|NCT05427539|593306209|FG001|Period 1|Withdrawal by Subject|0|||
164256455|NCT05129449|593306212|FG000|Overall Study|Protocol Violation|1|||
164256456|NCT02901054|593306216|FG000|Overall Study|Physician Decision|1|||
164256457|NCT02901054|593306216|FG000|Overall Study|Withdrawal by Subject|3|||
164256458|NCT03718884|593306219|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
164256459|NCT03718884|593306220|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
164256460|NCT03718884|593306219|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
164256461|NCT03718884|593306220|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
164256462|NCT02099344|593306223|FG000|Overall Study|Physician Decision|1|||
164256463|NCT02099344|593306224|FG001|Overall Study|Physician Decision|0|||
164256464|NCT00404755|593306225|FG000|Phase I (Bupropion)|Adverse Event|3|||
164256465|NCT00404755|593306225|FG000|Phase I (Bupropion)|Other|1|||
164256466|NCT00404755|593306225|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
164256467|NCT05145322|593306226|FG000|Overall Study|Lost to Follow-up|4|||
164256468|NCT05145322|593306227|FG001|Overall Study|Lost to Follow-up|5|||
164256469|NCT06359028|593306228|FG000|Overall Study|Adverse Event|1|||
164256470|NCT06359028|593306229|FG001|Overall Study|Adverse Event|0|||
164256471|NCT06359028|593306228|FG000|Overall Study|Withdrawal by Subject|1|||
164256472|NCT06359028|593306229|FG001|Overall Study|Withdrawal by Subject|0|||
164256473|NCT04700540|593306230|FG000|Overall Study|Withdrawal by Subject|12|||
164256474|NCT04700540|593306231|FG001|Overall Study|Withdrawal by Subject|8|||
164256475|NCT04700540|593306230|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
164256476|NCT04700540|593306231|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
164256477|NCT05248997|593306232|FG000|Overall Study|Lost to Follow-up|1|||
164256478|NCT05248997|593306233|FG001|Overall Study|Lost to Follow-up|1|||
164256479|NCT05248997|593306232|FG000|Overall Study|Randomized but not treated|32|||
164256480|NCT05248997|593306233|FG001|Overall Study|Randomized but not treated|25|||
164256481|NCT03515551|593306234|FG000|Overall Study|Death|4|||
164256482|NCT03515551|593306235|FG001|Overall Study|Death|1|||
164256483|NCT03515551|593306236|FG002|Overall Study|Death|2|||
164256484|NCT03515551|593306237|FG003|Overall Study|Death|2|||
164256485|NCT03515551|593306238|FG004|Overall Study|Death|2|||
164256486|NCT03515551|593306239|FG005|Overall Study|Death|4|||
164256487|NCT03515551|593306240|FG006|Overall Study|Death|1|||
164256488|NCT03515551|593306234|FG000|Overall Study|Lost to Follow-up|0|||
164256489|NCT03515551|593306235|FG001|Overall Study|Lost to Follow-up|0|||
164256490|NCT03515551|593306236|FG002|Overall Study|Lost to Follow-up|1|||
164256491|NCT03515551|593306237|FG003|Overall Study|Lost to Follow-up|0|||
164256492|NCT03515551|593306238|FG004|Overall Study|Lost to Follow-up|0|||
164256493|NCT03515551|593306239|FG005|Overall Study|Lost to Follow-up|0|||
164256494|NCT03515551|593306240|FG006|Overall Study|Lost to Follow-up|0|||
164256495|NCT03515551|593306234|FG000|Overall Study|Withdrawal by Subject|0|||
164256496|NCT03515551|593306235|FG001|Overall Study|Withdrawal by Subject|1|||
164256497|NCT03515551|593306236|FG002|Overall Study|Withdrawal by Subject|0|||
164339220|NCT01811225|593617171|FG000|Treatment Period 2|Lost to Follow-up|1|||
164339221|NCT01811225|593617172|FG001|Treatment Period 2|Lost to Follow-up|2|||
164339222|NCT01811225|593617171|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
164339223|NCT01811225|593617172|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
164339224|NCT03000569|593617173|FG000|Overall Study|Withdrawal by Subject|1|||
164427614|NCT01253200|593934821|FG003|Overall Study|Withdrawal by Subject|0|||
164427615|NCT01253200|593934822|FG004|Overall Study|Withdrawal by Subject|0|||
164427616|NCT01253200|593934818|FG000|Overall Study|Protocol Violation|1|||
164427617|NCT01253200|593934819|FG001|Overall Study|Protocol Violation|4|||
164427618|NCT01253200|593934820|FG002|Overall Study|Protocol Violation|0|||
164427619|NCT01253200|593934821|FG003|Overall Study|Protocol Violation|0|||
164427620|NCT01253200|593934822|FG004|Overall Study|Protocol Violation|5|||
164427621|NCT01253200|593934818|FG000|Overall Study|intents|10|||
164427622|NCT01253200|593934819|FG001|Overall Study|intents|10|||
164427623|NCT01253200|593934820|FG002|Overall Study|intents|1|||
164427624|NCT01253200|593934821|FG003|Overall Study|intents|3|||
164427625|NCT01253200|593934822|FG004|Overall Study|intents|0|||
164256498|NCT03515551|593306237|FG003|Overall Study|Withdrawal by Subject|0|||
164256499|NCT03515551|593306238|FG004|Overall Study|Withdrawal by Subject|0|||
164256500|NCT03515551|593306239|FG005|Overall Study|Withdrawal by Subject|0|||
164256501|NCT03515551|593306240|FG006|Overall Study|Withdrawal by Subject|1|||
164256502|NCT03515551|593306234|FG000|Overall Study|Study ended by sponsor|0|||
164256503|NCT03515551|593306235|FG001|Overall Study|Study ended by sponsor|0|||
164256504|NCT03515551|593306236|FG002|Overall Study|Study ended by sponsor|2|||
164256505|NCT03515551|593306237|FG003|Overall Study|Study ended by sponsor|1|||
164256506|NCT03515551|593306238|FG004|Overall Study|Study ended by sponsor|3|||
164256507|NCT03515551|593306239|FG005|Overall Study|Study ended by sponsor|0|||
164427626|NCT01253200|593934818|FG000|Overall Study|Attempts|6|||
164427627|NCT01253200|593934819|FG001|Overall Study|Attempts|4|||
164427628|NCT01253200|593934820|FG002|Overall Study|Attempts|1|||
164427629|NCT01253200|593934821|FG003|Overall Study|Attempts|2|||
164256508|NCT03515551|593306240|FG006|Overall Study|Study ended by sponsor|3|||
164256509|NCT03515551|593306234|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
164256510|NCT03515551|593306235|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
164256511|NCT03515551|593306236|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
164256512|NCT03515551|593306237|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
164256513|NCT03515551|593306238|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
164256514|NCT03515551|593306239|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
164256515|NCT03515551|593306240|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
164256516|NCT00673231|593306241|FG000|Overall Study|Withdrawal by Subject|14|||
164256517|NCT00673231|593306242|FG001|Overall Study|Withdrawal by Subject|10|||
164256518|NCT00673231|593306243|FG002|Overall Study|Withdrawal by Subject|8|||
164256519|NCT00673231|593306244|FG003|Overall Study|Withdrawal by Subject|6|||
164256520|NCT00673231|593306241|FG000|Overall Study|Adverse Event|6|||
164256521|NCT00673231|593306242|FG001|Overall Study|Adverse Event|5|||
164256522|NCT00673231|593306243|FG002|Overall Study|Adverse Event|9|||
164256523|NCT00673231|593306244|FG003|Overall Study|Adverse Event|6|||
164256524|NCT00673231|593306241|FG000|Overall Study|Lost to Follow-up|1|||
164256525|NCT00673231|593306242|FG001|Overall Study|Lost to Follow-up|2|||
164256526|NCT00673231|593306243|FG002|Overall Study|Lost to Follow-up|1|||
164427630|NCT01253200|593934822|FG004|Overall Study|Attempts|0|||
164427631|NCT02049437|593934823|FG000|Period 1|Adverse Event|1|||
164427632|NCT02049437|593934824|FG001|Period 1|Adverse Event|1|||
164427633|NCT02049437|593934823|FG000|Period 1|Adverse Event|1|||
164427634|NCT02049437|593934824|FG001|Period 1|Adverse Event|0|||
164427635|NCT00916006|593934838|FG000|Overall Study|Adverse Event|1|||
164427636|NCT00916006|593934839|FG001|Overall Study|Adverse Event|1|||
164427637|NCT00916006|593934838|FG000|Overall Study|Withdrawal by Subject|2|||
164427638|NCT00916006|593934839|FG001|Overall Study|Withdrawal by Subject|5|||
164256527|NCT00673231|593306244|FG003|Overall Study|Lost to Follow-up|2|||
164339225|NCT03000569|593617174|FG001|Overall Study|Withdrawal by Subject|0|||
164339226|NCT02298023|593617175|FG000|Overall Study|Withdrawal by Subject|1|||
164339227|NCT02298023|593617176|FG001|Overall Study|Withdrawal by Subject|0|||
164339228|NCT02298023|593617177|FG002|Overall Study|Withdrawal by Subject|0|||
164339229|NCT00492531|593617185|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
164339230|NCT00492531|593617186|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
164339231|NCT04122534|593617192|FG000|Overall Study|Lost to Follow-up|4|||
164339232|NCT01790932|593617193|FG000|Overall Study|Disease Progression|41|||
164427639|NCT00916006|593934838|FG000|Overall Study|Protocol Violation|0|||
164256528|NCT00673231|593306241|FG000|Overall Study|Death|0|||
164256529|NCT00673231|593306242|FG001|Overall Study|Death|0|||
164256530|NCT00673231|593306243|FG002|Overall Study|Death|1|||
164256531|NCT00673231|593306244|FG003|Overall Study|Death|0|||
164256532|NCT00673231|593306241|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
164427640|NCT00916006|593934839|FG001|Overall Study|Protocol Violation|1|||
164427641|NCT01605136|593934842|FG000|Study Period|Withdrawal by Subject|2|||
164427642|NCT01605136|593934843|FG001|Study Period|Withdrawal by Subject|0|||
164427643|NCT01605136|593934842|FG000|Study Period|Physician Decision|1|||
164256533|NCT00673231|593306242|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
164256534|NCT00673231|593306243|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
164256535|NCT00673231|593306244|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
164256536|NCT02952313|593306245|FG000|Primary Endpoint|Lost to Follow-up|4|||
164256537|NCT02952313|593306245|FG000|Primary Endpoint|Withdrawal by Subject|1|||
164256538|NCT02952313|593306245|FG000|Primary Endpoint|Lack of Efficacy|1|||
164256539|NCT02952313|593306245|FG000|Primary Endpoint|Missed visit|1|||
164256540|NCT02952313|593306245|FG000|Long-term Follow-up|Lost to Follow-up|12|||
164256541|NCT02952313|593306245|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
164256542|NCT02952313|593306245|FG000|Long-term Follow-up|Lack of Efficacy|6|||
164256543|NCT02952313|593306245|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
164256544|NCT02952313|593306245|FG000|Long-term Follow-up|Physician Decision|1|||
164256545|NCT02952313|593306245|FG000|Long-term Follow-up|Death|1|||
164256546|NCT04470908|593306250|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
164256547|NCT04376684|593306251|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
164256548|NCT04376684|593306252|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
164256549|NCT04376684|593306253|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
164256550|NCT04376684|593306254|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
164256551|NCT04376684|593306251|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
164256552|NCT04376684|593306252|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
164256553|NCT04376684|593306253|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
164256554|NCT04376684|593306254|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
164256555|NCT04376684|593306251|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
164256556|NCT04376684|593306252|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
164256557|NCT04376684|593306253|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
164256558|NCT04376684|593306254|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
164256559|NCT04376684|593306251|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
164256560|NCT04376684|593306252|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
164256561|NCT04376684|593306253|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
164256562|NCT04376684|593306254|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
164256563|NCT04376684|593306251|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
164256564|NCT04376684|593306252|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
164256565|NCT04376684|593306253|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
164256566|NCT04376684|593306254|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
164256567|NCT04376684|593306251|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
164256568|NCT04376684|593306252|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
164256569|NCT04376684|593306253|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
164576529|NCT00117312|594474782|FG002|Overall Study|Protocol Violation|3|||
164576530|NCT00117312|594474783|FG003|Overall Study|Protocol Violation|0|||
164576531|NCT00117312|594474780|FG000|Overall Study|PSA decrease <=50%|0|||
164576532|NCT00117312|594474781|FG001|Overall Study|PSA decrease <=50%|2|||
164576533|NCT00117312|594474782|FG002|Overall Study|PSA decrease <=50%|2|||
164576534|NCT00117312|594474783|FG003|Overall Study|PSA decrease <=50%|4|||
164576535|NCT00117312|594474780|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
164576536|NCT00117312|594474781|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
164576537|NCT00117312|594474782|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
164576538|NCT00117312|594474783|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
164576539|NCT00117312|594474780|FG000|Overall Study|Hepatic abnormality|0|||
164576540|NCT00117312|594474781|FG001|Overall Study|Hepatic abnormality|1|||
164576541|NCT00117312|594474782|FG002|Overall Study|Hepatic abnormality|0|||
164576542|NCT00117312|594474783|FG003|Overall Study|Hepatic abnormality|1|||
164576543|NCT00117312|594474780|FG000|Overall Study|Withdrawal by Subject|0|||
164576544|NCT00117312|594474781|FG001|Overall Study|Withdrawal by Subject|2|||
164576545|NCT00117312|594474782|FG002|Overall Study|Withdrawal by Subject|0|||
164576546|NCT00117312|594474783|FG003|Overall Study|Withdrawal by Subject|0|||
164576547|NCT01120626|594474784|FG000|Overall Study|Withdrawal by Subject|1|||
164576548|NCT01120626|594474785|FG001|Overall Study|Withdrawal by Subject|0|||
164576549|NCT00509106|594474786|FG000|Overall Study|Adverse Event|3|||
164576550|NCT00509106|594474787|FG001|Overall Study|Adverse Event|2|||
164576551|NCT00509106|594474786|FG000|Overall Study|Noncompliance|0|||
164576552|NCT00509106|594474787|FG001|Overall Study|Noncompliance|1|||
164576553|NCT00509106|594474786|FG000|Overall Study|At the request of sponsor/investigator|1|||
164576554|NCT00509106|594474787|FG001|Overall Study|At the request of sponsor/investigator|2|||
164576555|NCT00509106|594474786|FG000|Overall Study|Withdrew consent|4|||
164576556|NCT00509106|594474787|FG001|Overall Study|Withdrew consent|8|||
164576557|NCT00509106|594474786|FG000|Overall Study|Lost to Follow-up|16|||
164576558|NCT00509106|594474787|FG001|Overall Study|Lost to Follow-up|10|||
164576559|NCT00509106|594474786|FG000|Overall Study|Other|1|||
164256570|NCT04376684|593306254|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
164576560|NCT00509106|594474787|FG001|Overall Study|Other|0|||
164576561|NCT00509106|594474786|FG000|Overall Study|Death|6|||
164256571|NCT04376684|593306251|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
164256572|NCT04376684|593306252|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
164576562|NCT00509106|594474787|FG001|Overall Study|Death|6|||
164576563|NCT05089708|594474791|FG000|Overall Study|Lost to Follow-up|9|||
164576564|NCT05089708|594474792|FG001|Overall Study|Lost to Follow-up|7|||
164256573|NCT04376684|593306253|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
164256574|NCT04376684|593306254|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
164256575|NCT01666119|593306255|FG000|Overall Study|Adverse Event|6|||
164256576|NCT01666119|593306255|FG000|Overall Study|Withdrawal by Subject|16|||
164256577|NCT01666119|593306255|FG000|Overall Study|Lost to Follow-up|7|||
164256578|NCT01666119|593306255|FG000|Overall Study|non compliance with study medication, pa|18|||
164256579|NCT01666119|593306255|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
164256580|NCT02470585|593306271|FG000|Overall Study|Death|224|||
164256581|NCT02470585|593306272|FG001|Overall Study|Death|227|||
164256582|NCT02470585|593306273|FG002|Overall Study|Death|199|||
164256583|NCT02470585|593306271|FG000|Overall Study|Withdrew consent|21|||
164256584|NCT02470585|593306272|FG001|Overall Study|Withdrew consent|22|||
164256585|NCT02470585|593306273|FG002|Overall Study|Withdrew consent|31|||
164256586|NCT02470585|593306271|FG000|Overall Study|Lost to Follow-up|8|||
164256587|NCT02470585|593306272|FG001|Overall Study|Lost to Follow-up|15|||
164256588|NCT02470585|593306273|FG002|Overall Study|Lost to Follow-up|13|||
164256589|NCT02470585|593306271|FG000|Overall Study|Sponsor discontinued study|117|||
164256590|NCT02470585|593306272|FG001|Overall Study|Sponsor discontinued study|110|||
164256591|NCT02470585|593306273|FG002|Overall Study|Sponsor discontinued study|122|||
164256592|NCT02470585|593306271|FG000|Overall Study|Other, not specified|5|||
164256593|NCT02470585|593306272|FG001|Overall Study|Other, not specified|7|||
164256594|NCT02470585|593306273|FG002|Overall Study|Other, not specified|14|||
164256595|NCT02470585|593306271|FG000|Overall Study|Missing due to site non-compliance|0|||
164256596|NCT02470585|593306272|FG001|Overall Study|Missing due to site non-compliance|2|||
164256597|NCT02470585|593306273|FG002|Overall Study|Missing due to site non-compliance|3|||
164256598|NCT02602275|593306274|FG000|Day 1|Physician Decision|0|||
164256599|NCT02602275|593306275|FG001|Day 1|Physician Decision|1|||
164256600|NCT03028415|593306277|FG000|Overall Study|Lost to Follow-up|6|||
164256601|NCT03028415|593306278|FG001|Overall Study|Lost to Follow-up|3|||
164256602|NCT03028415|593306277|FG000|Overall Study|Withdrawal by Subject|1|||
164256603|NCT03028415|593306278|FG001|Overall Study|Withdrawal by Subject|0|||
164339233|NCT01790932|593617193|FG000|Overall Study|Adverse Event|7|||
164339234|NCT01790932|593617193|FG000|Overall Study|Physician Decision|1|||
164339235|NCT01790932|593617193|FG000|Overall Study|Withdrawal by Subject|1|||
164339236|NCT01441180|593617199|FG000|Overall Study|Lost to Follow-up|1|||
164339237|NCT01441180|593617200|FG001|Overall Study|Lost to Follow-up|1|||
164339238|NCT01441180|593617201|FG002|Overall Study|Lost to Follow-up|1|||
164339239|NCT01441180|593617199|FG000|Overall Study|Discontinued|0|||
164339240|NCT01441180|593617200|FG001|Overall Study|Discontinued|0|||
164339241|NCT01441180|593617201|FG002|Overall Study|Discontinued|2|||
164339242|NCT01558739|593617204|FG000|Overall Study|Adverse Event|7|||
164339243|NCT01558739|593617204|FG000|Overall Study|Withdrawal by Subject|2|||
164339244|NCT01558739|593617204|FG000|Overall Study|Death|3|||
164339245|NCT01558739|593617204|FG000|Overall Study|Disease Progression|4|||
164339246|NCT01558739|593617204|FG000|Overall Study|Protocol Violation|1|||
164339247|NCT01402011|593617209|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
164339248|NCT01402011|593617210|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
164339249|NCT01402011|593617211|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
164339250|NCT01402011|593617209|FG000|Active Treatment Period|Withdrawal by Subject|1|||
164339251|NCT01402011|593617210|FG001|Active Treatment Period|Withdrawal by Subject|3|||
164339252|NCT01402011|593617211|FG002|Active Treatment Period|Withdrawal by Subject|0|||
164339253|NCT01402011|593617209|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
164339254|NCT01402011|593617210|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
164339255|NCT01402011|593617211|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
164339256|NCT01066000|593617212|FG000|Overall Study|Protocol Violation|4|||
164339257|NCT01066000|593617212|FG000|Overall Study|Death|3|||
164339258|NCT01066000|593617212|FG000|Overall Study|Withdrawal by Subject|1|||
164339259|NCT01066000|593617212|FG000|Overall Study|Adverse Event|1|||
164339260|NCT01386008|593617213|FG000|Overall Study|exited w/o incident /study discontinued|17|||
164339261|NCT01386008|593617213|FG000|Overall Study|Adverse Event|3|||
164339262|NCT01067976|593617214|FG000|Overall Study|Study drug never administered|20|||
164339263|NCT01067976|593617214|FG000|Overall Study|Study prematurely discontinued|2|||
164427644|NCT01605136|593934843|FG001|Study Period|Physician Decision|1|||
164339264|NCT04449861|593617215|FG000|Overall Study|Withdrawal by Subject|4|||
164339265|NCT04449861|593617215|FG000|Overall Study|Lost to Follow-up|5|||
164427645|NCT01605136|593934842|FG000|Study Period|Lost to Follow-up|0|||
164427646|NCT01605136|593934843|FG001|Study Period|Lost to Follow-up|2|||
164427647|NCT01605136|593934842|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
164256604|NCT03028415|593306277|FG000|Overall Study|Discontinued due to COVID-19|1|||
164256605|NCT03028415|593306278|FG001|Overall Study|Discontinued due to COVID-19|0|||
164256606|NCT02241733|593306279|FG000|Overall Study|Lost to Follow-up|9|||
164256607|NCT02241733|593306280|FG001|Overall Study|Lost to Follow-up|4|||
164256608|NCT02241733|593306279|FG000|Overall Study|Physician Decision|6|||
164256609|NCT02241733|593306280|FG001|Overall Study|Physician Decision|2|||
164339266|NCT04449861|593617215|FG000|Overall Study|Death|112|||
164339267|NCT00976677|593617216|FG000|Overall Study|Adverse Event|1|||
164339268|NCT00976677|593617217|FG001|Overall Study|Adverse Event|0|||
164256610|NCT02241733|593306279|FG000|Overall Study|Withdrawal by Subject|0|||
164256611|NCT02241733|593306280|FG001|Overall Study|Withdrawal by Subject|2|||
164256612|NCT02241733|593306279|FG000|Overall Study|Death|0|||
164256613|NCT02241733|593306280|FG001|Overall Study|Death|2|||
164256614|NCT01866111|593306285|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
164256615|NCT01866111|593306286|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
164256616|NCT01866111|593306287|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
164256617|NCT01866111|593306288|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
164256618|NCT01866111|593306285|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
164256619|NCT01866111|593306286|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
164256620|NCT01866111|593306287|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
164256621|NCT01866111|593306288|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
164256622|NCT01866111|593306285|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
164256623|NCT01866111|593306286|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
164256624|NCT01866111|593306287|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
164256625|NCT01866111|593306288|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
164256626|NCT01866111|593306285|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
164256627|NCT01866111|593306286|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
164256628|NCT01866111|593306287|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
164256629|NCT01866111|593306288|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
164256630|NCT01866111|593306285|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
164256631|NCT01866111|593306286|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
164256632|NCT01866111|593306287|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
164256633|NCT01866111|593306288|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
164256634|NCT01866111|593306285|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
164256635|NCT01866111|593306286|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
164256636|NCT01866111|593306287|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
164256637|NCT01866111|593306288|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
164256638|NCT01866111|593306285|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
164256639|NCT01866111|593306286|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
164256640|NCT01866111|593306287|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
164256641|NCT01866111|593306288|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
164256642|NCT01866111|593306285|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
164256643|NCT01866111|593306286|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
164256644|NCT01866111|593306287|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
164256645|NCT01866111|593306288|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
164256646|NCT01866111|593306285|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
164256647|NCT01866111|593306286|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
164256648|NCT01866111|593306287|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
164256649|NCT01866111|593306288|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
164256650|NCT01866111|593306285|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
164256651|NCT01866111|593306286|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
164256652|NCT01866111|593306287|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
164256653|NCT01866111|593306288|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
164256654|NCT01866111|593306285|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
164256655|NCT01866111|593306286|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
164256656|NCT01866111|593306287|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
164256657|NCT01866111|593306288|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
164256658|NCT01866111|593306285|FG000|Open-label Extension Study YKP3089C017|Death|1|||
164256659|NCT01866111|593306286|FG001|Open-label Extension Study YKP3089C017|Death|1|||
164256660|NCT01866111|593306287|FG002|Open-label Extension Study YKP3089C017|Death|3|||
164256661|NCT01866111|593306288|FG003|Open-label Extension Study YKP3089C017|Death|2|||
164256662|NCT01866111|593306285|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
164256663|NCT01866111|593306286|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
164256664|NCT01866111|593306287|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
164256665|NCT01866111|593306288|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
164256666|NCT01866111|593306285|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
164256667|NCT01866111|593306286|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
164256668|NCT01866111|593306287|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
164256669|NCT01866111|593306288|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
164256670|NCT01866111|593306285|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
164427648|NCT01605136|593934843|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
164427649|NCT01072929|593934844|FG000|Overall Study|Adverse Event|8|||
164256671|NCT01866111|593306286|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
164256672|NCT01866111|593306287|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
164256673|NCT01866111|593306288|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
164256674|NCT04113018|593306293|FG000|Overall Study|Death|2|||
164256675|NCT04113018|593306293|FG000|Overall Study|Lost to Follow-up|1|||
164256676|NCT04113018|593306293|FG000|Overall Study|Still On Study (on study treatment)|24|||
164256677|NCT04113018|593306293|FG000|Overall Study|Still On Study (in follow up)|12|||
164256678|NCT03802630|593306294|FG000|Overall Study|Study terminated by sponsor|130|||
164256679|NCT03802630|593306295|FG001|Overall Study|Study terminated by sponsor|134|||
164256680|NCT03802630|593306294|FG000|Overall Study|Subject decision|16|||
164256681|NCT03802630|593306295|FG001|Overall Study|Subject decision|9|||
164256682|NCT03802630|593306294|FG000|Overall Study|Adverse Event|3|||
164256683|NCT03802630|593306295|FG001|Overall Study|Adverse Event|1|||
164256684|NCT03802630|593306294|FG000|Overall Study|Lost to Follow-up|2|||
164256685|NCT03802630|593306295|FG001|Overall Study|Lost to Follow-up|2|||
164256686|NCT03802630|593306294|FG000|Overall Study|Physician Decision|2|||
164256687|NCT03802630|593306295|FG001|Overall Study|Physician Decision|0|||
164427650|NCT01072929|593934845|FG001|Overall Study|Adverse Event|11|||
164256688|NCT03802630|593306294|FG000|Overall Study|Death|0|||
164256689|NCT03802630|593306295|FG001|Overall Study|Death|2|||
164256690|NCT00157196|593306296|FG000|Overall Study|Ongoing at data cut-off|9|||
164256691|NCT05005013|593306297|FG000|Overall Study|Withdrawal by Subject|5|||
164256692|NCT05005013|593306298|FG001|Overall Study|Withdrawal by Subject|1|||
164427651|NCT01072929|593934846|FG002|Overall Study|Adverse Event|2|||
164427652|NCT01072929|593934844|FG000|Overall Study|Lack of Efficacy|7|||
164427653|NCT01072929|593934845|FG001|Overall Study|Lack of Efficacy|4|||
164427654|NCT01072929|593934846|FG002|Overall Study|Lack of Efficacy|0|||
164256693|NCT05005013|593306297|FG000|Overall Study|Lost to Follow-up|3|||
164256694|NCT05005013|593306298|FG001|Overall Study|Lost to Follow-up|1|||
164256695|NCT05005013|593306297|FG000|Overall Study|Ineligibility|1|||
164256696|NCT05005013|593306298|FG001|Overall Study|Ineligibility|1|||
164256697|NCT06099223|593306299|FG000|Overall Study|Preoperative surveys missed|0|||
164256698|NCT06099223|593306300|FG001|Overall Study|Preoperative surveys missed|1|||
164256699|NCT04283994|593306303|FG000|Overall Study|Death|11|||
164256700|NCT04283994|593306304|FG001|Overall Study|Death|20|||
164339269|NCT00976677|593617216|FG000|Overall Study|Withdrawal by Subject|0|||
164339270|NCT00976677|593617217|FG001|Overall Study|Withdrawal by Subject|2|||
164339271|NCT00976677|593617216|FG000|Overall Study|Disease progression|1|||
164339272|NCT00976677|593617217|FG001|Overall Study|Disease progression|1|||
164339273|NCT00976677|593617216|FG000|Overall Study|Trial unblinded|2|||
164339274|NCT00976677|593617217|FG001|Overall Study|Trial unblinded|2|||
164256701|NCT04283994|593306305|FG002|Overall Study|Death|11|||
164256702|NCT04283994|593306306|FG003|Overall Study|Death|0|||
164256703|NCT04283994|593306307|FG004|Overall Study|Death|0|||
164256704|NCT04283994|593306308|FG005|Overall Study|Death|0|||
164256705|NCT04283994|593306309|FG006|Overall Study|Death|0|||
164256706|NCT04283994|593306303|FG000|Overall Study|Withdrawal by Subject|16|||
164256707|NCT04283994|593306304|FG001|Overall Study|Withdrawal by Subject|4|||
164256708|NCT04283994|593306305|FG002|Overall Study|Withdrawal by Subject|6|||
164256709|NCT04283994|593306306|FG003|Overall Study|Withdrawal by Subject|1|||
164339275|NCT00976677|593617216|FG000|Overall Study|Unknown/Missing|1|||
164339276|NCT00976677|593617217|FG001|Overall Study|Unknown/Missing|0|||
164339277|NCT06238362|593617222|FG000|Overall Study|Insufficient total sleep time|1|||
164339278|NCT06238362|593617223|FG001|Overall Study|Insufficient total sleep time|0|||
164339279|NCT06238362|593617222|FG000|Overall Study|Inadequate signal quality|1|||
164339280|NCT06238362|593617223|FG001|Overall Study|Inadequate signal quality|0|||
164339281|NCT01313858|593618867|FG000|Overall Study|Premature Treatment Termination|251|||
164339282|NCT01313858|593618868|FG001|Overall Study|Premature Treatment Termination|219|||
164339283|NCT01313858|593618869|FG002|Overall Study|Premature Treatment Termination|191|||
164339284|NCT01313858|593618867|FG000|Overall Study|Lost to Follow-up|35|||
164339285|NCT01313858|593618868|FG001|Overall Study|Lost to Follow-up|51|||
164339286|NCT01313858|593618869|FG002|Overall Study|Lost to Follow-up|47|||
164339287|NCT03689530|593618873|FG000|Overall Study|Withdrawal by Subject|53|||
164339288|NCT03689530|593618874|FG001|Overall Study|Withdrawal by Subject|16|||
164339289|NCT01392443|593618875|FG000|Overall Study|Disease progression|30|||
164427655|NCT01072929|593934844|FG000|Overall Study|Withdrawal by Subject|7|||
164427656|NCT01072929|593934845|FG001|Overall Study|Withdrawal by Subject|15|||
164256710|NCT04283994|593306307|FG004|Overall Study|Withdrawal by Subject|0|||
164256711|NCT04283994|593306308|FG005|Overall Study|Withdrawal by Subject|1|||
164339290|NCT01392443|593618875|FG000|Overall Study|Adverse Event|24|||
164339291|NCT01392443|593618875|FG000|Overall Study|Death|7|||
164339292|NCT01392443|593618875|FG000|Overall Study|Withdrawal by Subject|5|||
164339293|NCT01392443|593618875|FG000|Overall Study|Lost to Follow-up|1|||
164256712|NCT04283994|593306309|FG006|Overall Study|Withdrawal by Subject|0|||
164256713|NCT00583752|593306310|FG000|Overall Study|Lost to Follow-up|5|||
164256714|NCT00583752|593306311|FG001|Overall Study|Lost to Follow-up|5|||
164256715|NCT00526656|593306312|FG000|Overall Study|Death|1|||
164256716|NCT00526656|593306312|FG000|Overall Study|Refused surgery|1|||
164256717|NCT04091581|593306313|FG000|Overall Study|Lost to Follow-up|0|||
164256718|NCT04091581|593306314|FG001|Overall Study|Lost to Follow-up|1|||
164256719|NCT01795495|593306315|FG000|Overall Study|Protocol Violation|1|||
164256720|NCT01795495|593306316|FG001|Overall Study|Protocol Violation|0|||
164256721|NCT01795495|593306317|FG002|Overall Study|Protocol Violation|1|||
164256722|NCT01795495|593306315|FG000|Overall Study|Physician Decision|0|||
164256723|NCT01795495|593306316|FG001|Overall Study|Physician Decision|0|||
164256724|NCT01795495|593306317|FG002|Overall Study|Physician Decision|1|||
164256725|NCT01331837|593306318|FG000|Overall Study|Death|30|||
164256726|NCT01331837|593306319|FG001|Overall Study|Death|34|||
164256727|NCT01331837|593306318|FG000|Overall Study|Lost to Follow-up|3|||
164256728|NCT01331837|593306319|FG001|Overall Study|Lost to Follow-up|1|||
164256729|NCT01331837|593306318|FG000|Overall Study|Info not recorded|10|||
164256730|NCT01331837|593306319|FG001|Overall Study|Info not recorded|16|||
164256731|NCT01331837|593306318|FG000|Overall Study|Withdrawal by Subject|13|||
164256732|NCT01331837|593306319|FG001|Overall Study|Withdrawal by Subject|16|||
164256733|NCT01263015|593307946|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
164256734|NCT01263015|593307947|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
164256735|NCT01263015|593307946|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
164256736|NCT01263015|593307947|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
164256737|NCT01263015|593307946|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
164256738|NCT01263015|593307947|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
164256739|NCT01263015|593307946|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
164256740|NCT01263015|593307947|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
164256741|NCT01263015|593307946|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
164256742|NCT01263015|593307947|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
164256743|NCT01263015|593307946|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
164256744|NCT01263015|593307947|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
164256745|NCT01263015|593307946|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
164256746|NCT01263015|593307947|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
164256747|NCT01263015|593307946|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
164256748|NCT01263015|593307947|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
164256749|NCT01263015|593307946|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
164256750|NCT01263015|593307947|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
164256751|NCT01263015|593307946|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
164256752|NCT01263015|593307947|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
164256753|NCT01263015|593307946|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
164256754|NCT01263015|593307947|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
164256755|NCT01263015|593307946|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
164256756|NCT01263015|593307947|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
164256757|NCT05599451|593307948|FG000|Overall Study|Not randomized|11|||
164256758|NCT05599451|593307949|FG001|Overall Study|Not randomized|0|||
164256759|NCT05599451|593307950|FG002|Overall Study|Not randomized|0|||
164256760|NCT05599451|593307951|FG003|Overall Study|Not randomized|0|||
164256761|NCT05599451|593307952|FG004|Overall Study|Not randomized|0|||
164256762|NCT05599451|593307948|FG000|Overall Study|Physician Decision|0|||
164256763|NCT05599451|593307949|FG001|Overall Study|Physician Decision|0|||
164256764|NCT05599451|593307950|FG002|Overall Study|Physician Decision|0|||
164256765|NCT05599451|593307951|FG003|Overall Study|Physician Decision|1|||
164256766|NCT05599451|593307952|FG004|Overall Study|Physician Decision|0|||
164256767|NCT02723006|593307953|FG000|Overall Study|Withdrawal by Subject|0|||
164256768|NCT02723006|593307954|FG001|Overall Study|Withdrawal by Subject|1|||
164256769|NCT02723006|593307955|FG002|Overall Study|Withdrawal by Subject|1|||
164256770|NCT02723006|593307953|FG000|Overall Study|Study Terminated by Sponsor|1|||
164256771|NCT02723006|593307954|FG001|Overall Study|Study Terminated by Sponsor|6|||
164256772|NCT02723006|593307955|FG002|Overall Study|Study Terminated by Sponsor|6|||
164256773|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Adverse Event|76|||
164256774|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Adverse Event|0|||
164256775|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Adverse Event|0|||
164256776|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Death|3|||
164256777|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Death|0|||
164256778|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Death|0|||
164256779|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
164256780|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
164256781|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
164256782|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Physician Decision|9|||
164256783|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Physician Decision|0|||
164256784|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Physician Decision|0|||
164256785|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
164256786|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
164256787|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
164256788|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Disease progression|45|||
164256789|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Disease progression|0|||
164256790|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Disease progression|0|||
164256791|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
164339294|NCT01392443|593618875|FG000|Overall Study|Protocol Violation|1|||
164427657|NCT01072929|593934846|FG002|Overall Study|Withdrawal by Subject|3|||
164427658|NCT01072929|593934844|FG000|Overall Study|Protocol Violation|13|||
164427659|NCT01072929|593934845|FG001|Overall Study|Protocol Violation|11|||
164427660|NCT01072929|593934846|FG002|Overall Study|Protocol Violation|2|||
164427661|NCT01072929|593934844|FG000|Overall Study|Lost to Follow-up|8|||
164427662|NCT01072929|593934845|FG001|Overall Study|Lost to Follow-up|4|||
164427663|NCT01072929|593934846|FG002|Overall Study|Lost to Follow-up|1|||
164427664|NCT01072929|593934844|FG000|Overall Study|Noncompliance with study medication|0|||
164427665|NCT01072929|593934845|FG001|Overall Study|Noncompliance with study medication|3|||
164427666|NCT01072929|593934846|FG002|Overall Study|Noncompliance with study medication|0|||
164427667|NCT01072929|593934844|FG000|Overall Study|Noncompliance with study procedures|1|||
164427668|NCT01072929|593934845|FG001|Overall Study|Noncompliance with study procedures|0|||
164427669|NCT01072929|593934846|FG002|Overall Study|Noncompliance with study procedures|1|||
164427670|NCT01072929|593934844|FG000|Overall Study|Other|0|||
164427671|NCT01072929|593934845|FG001|Overall Study|Other|3|||
164427672|NCT01072929|593934846|FG002|Overall Study|Other|0|||
164427673|NCT01008748|593934847|FG000|Overall Study|Lost to Follow-up|80|||
164427674|NCT01008748|593934847|FG000|Overall Study|Other|1|||
164427675|NCT04833855|593934848|FG000|Overall Study|Decision by sponsor|0|||
164427676|NCT04833855|593934849|FG001|Overall Study|Decision by sponsor|1|||
164427677|NCT04833855|593934850|FG002|Overall Study|Decision by sponsor|0|||
164427678|NCT04833855|593934851|FG003|Overall Study|Decision by sponsor|0|||
164427679|NCT04833855|593934848|FG000|Overall Study|Withdrawal by Subject|4|||
164427680|NCT04833855|593934849|FG001|Overall Study|Withdrawal by Subject|1|||
164427681|NCT04833855|593934850|FG002|Overall Study|Withdrawal by Subject|3|||
164427682|NCT04833855|593934851|FG003|Overall Study|Withdrawal by Subject|1|||
164427683|NCT04833855|593934848|FG000|Overall Study|Lost to Follow-up|1|||
164256792|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
164256793|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
164256794|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
164256795|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
164256796|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
164256797|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
164256798|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
164256799|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
164256800|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
164256801|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
164256802|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
164256803|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
164256804|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
164256805|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
164256806|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
164256807|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
164256808|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
164256809|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
164256810|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
164256811|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
164256812|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
164256813|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
164256814|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
164256815|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
164256816|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
164256817|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
164256818|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Promotor request|1|||
164256819|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Promotor request|0|||
164256820|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Promotor request|0|||
164256821|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
164256822|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
164256823|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
164256824|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
164256825|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
164256826|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
164256827|NCT01461928|593307956|FG000|Maintenance I (24 Months)|Death|3|||
164256828|NCT01461928|593307957|FG001|Maintenance I (24 Months)|Death|0|||
164256829|NCT01461928|593307958|FG002|Maintenance I (24 Months)|Death|0|||
164427684|NCT04833855|593934849|FG001|Overall Study|Lost to Follow-up|0|||
164427685|NCT04833855|593934850|FG002|Overall Study|Lost to Follow-up|2|||
164427686|NCT04833855|593934851|FG003|Overall Study|Lost to Follow-up|2|||
164427687|NCT04833855|593934848|FG000|Overall Study|Protocol specified criteria|0|||
164427688|NCT04833855|593934849|FG001|Overall Study|Protocol specified criteria|0|||
164256830|NCT01461928|593307956|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
164256831|NCT01461928|593307957|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
164256832|NCT01461928|593307958|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
164256833|NCT01461928|593307956|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
164256834|NCT01461928|593307957|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
164256835|NCT01461928|593307958|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
164256836|NCT01461928|593307956|FG000|Maintenance I (24 Months)|Diseases progression|91|||
164256837|NCT01461928|593307957|FG001|Maintenance I (24 Months)|Diseases progression|0|||
164256838|NCT01461928|593307958|FG002|Maintenance I (24 Months)|Diseases progression|0|||
164256839|NCT01461928|593307956|FG000|Maintenance I (24 Months)|Adverse Event|70|||
164256840|NCT01461928|593307957|FG001|Maintenance I (24 Months)|Adverse Event|0|||
164256841|NCT01461928|593307958|FG002|Maintenance I (24 Months)|Adverse Event|0|||
164256842|NCT01461928|593307956|FG000|Maintenance I (24 Months)|Physician Decision|9|||
164256843|NCT01461928|593307957|FG001|Maintenance I (24 Months)|Physician Decision|0|||
164256844|NCT01461928|593307958|FG002|Maintenance I (24 Months)|Physician Decision|0|||
164256845|NCT01461928|593307956|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
164256846|NCT01461928|593307957|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
164256847|NCT01461928|593307958|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
164256848|NCT01461928|593307956|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
164256849|NCT01461928|593307957|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
164256850|NCT01461928|593307958|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
164256851|NCT01461928|593307956|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
164256852|NCT01461928|593307957|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
164256853|NCT01461928|593307958|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
164256854|NCT01461928|593307956|FG000|Maintenance I (24 Months)|Not compliant|1|||
164256855|NCT01461928|593307957|FG001|Maintenance I (24 Months)|Not compliant|0|||
164256856|NCT01461928|593307958|FG002|Maintenance I (24 Months)|Not compliant|0|||
164256857|NCT01461928|593307956|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
164256858|NCT01461928|593307957|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
164256859|NCT01461928|593307958|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
164256860|NCT01461928|593307956|FG000|Maintenance II (15 Months)|Adverse Event|0|||
164256861|NCT01461928|593307957|FG001|Maintenance II (15 Months)|Adverse Event|2|||
164256862|NCT01461928|593307958|FG002|Maintenance II (15 Months)|Adverse Event|0|||
164256863|NCT01461928|593307956|FG000|Maintenance II (15 Months)|Death|0|||
164256864|NCT01461928|593307957|FG001|Maintenance II (15 Months)|Death|10|||
164256865|NCT01461928|593307958|FG002|Maintenance II (15 Months)|Death|8|||
164256866|NCT01461928|593307956|FG000|Maintenance II (15 Months)|Physician Decision|0|||
164256867|NCT01461928|593307957|FG001|Maintenance II (15 Months)|Physician Decision|0|||
164256868|NCT01461928|593307958|FG002|Maintenance II (15 Months)|Physician Decision|4|||
164256869|NCT01461928|593307956|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
164256870|NCT01461928|593307957|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
164576565|NCT05089708|594474791|FG000|Overall Study|Withdrawal by Subject|3|||
164576566|NCT05089708|594474792|FG001|Overall Study|Withdrawal by Subject|1|||
164576567|NCT05089708|594474791|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
164256871|NCT01461928|593307958|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
164256872|NCT01461928|593307956|FG000|Maintenance II (15 Months)|Moved to another town|0|||
164256873|NCT01461928|593307957|FG001|Maintenance II (15 Months)|Moved to another town|1|||
164256874|NCT01461928|593307958|FG002|Maintenance II (15 Months)|Moved to another town|0|||
164256875|NCT01461928|593307956|FG000|Maintenance II (15 Months)|Disease progression|0|||
164256876|NCT01461928|593307957|FG001|Maintenance II (15 Months)|Disease progression|0|||
164256877|NCT01461928|593307958|FG002|Maintenance II (15 Months)|Disease progression|3|||
164256878|NCT01461928|593307956|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
164256879|NCT01461928|593307957|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
164256880|NCT01461928|593307958|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
164256881|NCT01461928|593307956|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
164256882|NCT01461928|593307957|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
164256883|NCT01461928|593307958|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
164256884|NCT01461928|593307956|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
164256885|NCT01461928|593307957|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
164256886|NCT01461928|593307958|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
164256887|NCT01461928|593307956|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
164256888|NCT01461928|593307957|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
164256889|NCT01461928|593307958|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
164256890|NCT01461928|593307956|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
164576568|NCT05089708|594474792|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
164256891|NCT01461928|593307957|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
164256892|NCT01461928|593307958|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
164427689|NCT04833855|593934850|FG002|Overall Study|Protocol specified criteria|2|||
164256893|NCT00539513|593307966|FG000|Overall Study|Withdrawal by Subject|2|||
164256894|NCT00539513|593307967|FG001|Overall Study|Withdrawal by Subject|1|||
164256895|NCT00539513|593307966|FG000|Overall Study|Lost to Follow-up|0|||
164256896|NCT00539513|593307967|FG001|Overall Study|Lost to Follow-up|1|||
164256897|NCT00711113|593307968|FG000|Overall Study|Lost to Follow-up|9|||
164256898|NCT00711113|593307968|FG000|Overall Study|Implant lost|2|||
164256899|NCT02456636|593307969|FG000|Overall Study|Death|0|||
164256900|NCT02456636|593307970|FG001|Overall Study|Death|3|||
164256901|NCT02456636|593307971|FG002|Overall Study|Death|0|||
164256902|NCT02456636|593307969|FG000|Overall Study|Pregnancy|1|||
164256903|NCT02456636|593307970|FG001|Overall Study|Pregnancy|3|||
164256904|NCT02456636|593307971|FG002|Overall Study|Pregnancy|5|||
164256905|NCT02456636|593307969|FG000|Overall Study|Physician Decision|4|||
164256906|NCT02456636|593307970|FG001|Overall Study|Physician Decision|5|||
164256907|NCT02456636|593307971|FG002|Overall Study|Physician Decision|4|||
164256908|NCT02456636|593307969|FG000|Overall Study|Withdrawal by Subject|13|||
164256909|NCT02456636|593307970|FG001|Overall Study|Withdrawal by Subject|14|||
164256910|NCT02456636|593307971|FG002|Overall Study|Withdrawal by Subject|16|||
164256911|NCT02456636|593307969|FG000|Overall Study|Lost to Follow-up|50|||
164256912|NCT02456636|593307970|FG001|Overall Study|Lost to Follow-up|44|||
164256913|NCT02456636|593307971|FG002|Overall Study|Lost to Follow-up|50|||
164256914|NCT05312632|593307974|FG000|Overall Study|Adverse Event|12|||
164256915|NCT05312632|593307974|FG000|Overall Study|Withdrawal by Subject|10|||
164256916|NCT05312632|593307974|FG000|Overall Study|Lack of Efficacy|4|||
164256917|NCT05312632|593307974|FG000|Overall Study|Non-compliance with study procedures|9|||
164256918|NCT05312632|593307974|FG000|Overall Study|Other|4|||
164256919|NCT02379221|593307975|FG000|Overall Study|Lost to Follow-up|1|||
164256920|NCT00519376|593307976|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256921|NCT00519376|593307977|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256922|NCT00519376|593307978|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256923|NCT00519376|593307979|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256924|NCT00519376|593307980|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256925|NCT00519376|593307981|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256926|NCT00519376|593307982|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256927|NCT00519376|593307983|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256928|NCT00519376|593307984|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256929|NCT00519376|593307985|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256930|NCT00519376|593307986|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256931|NCT00519376|593307987|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256932|NCT00519376|593307988|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
164256933|NCT00519376|593307989|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256934|NCT00519376|593307990|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256935|NCT00519376|593307991|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256936|NCT00519376|593307976|FG000|Treatment Period 4|Lost to Follow-up|0|||
164256937|NCT00519376|593307977|FG001|Treatment Period 4|Lost to Follow-up|0|||
164256938|NCT00519376|593307978|FG002|Treatment Period 4|Lost to Follow-up|1|||
164256939|NCT00519376|593307979|FG003|Treatment Period 4|Lost to Follow-up|0|||
164256940|NCT00519376|593307980|FG004|Treatment Period 4|Lost to Follow-up|0|||
164256941|NCT00519376|593307981|FG005|Treatment Period 4|Lost to Follow-up|0|||
164256942|NCT00519376|593307982|FG006|Treatment Period 4|Lost to Follow-up|0|||
164256943|NCT00519376|593307983|FG007|Treatment Period 4|Lost to Follow-up|0|||
164256944|NCT00519376|593307984|FG008|Treatment Period 4|Lost to Follow-up|0|||
164256945|NCT00519376|593307985|FG009|Treatment Period 4|Lost to Follow-up|0|||
164256946|NCT00519376|593307986|FG010|Treatment Period 4|Lost to Follow-up|0|||
164256947|NCT00519376|593307987|FG011|Treatment Period 4|Lost to Follow-up|0|||
164256948|NCT00519376|593307988|FG012|Treatment Period 4|Lost to Follow-up|0|||
164256949|NCT00519376|593307989|FG013|Treatment Period 4|Lost to Follow-up|0|||
164256950|NCT00519376|593307990|FG014|Treatment Period 4|Lost to Follow-up|0|||
164256951|NCT00519376|593307991|FG015|Treatment Period 4|Lost to Follow-up|0|||
164427690|NCT04833855|593934851|FG003|Overall Study|Protocol specified criteria|1|||
164256952|NCT03812185|593307995|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
164256953|NCT01801436|593308009|FG000|Overall Study|Withdrawal by Subject|3|||
164256954|NCT01801436|593308009|FG000|Overall Study|Adverse Event|2|||
164256955|NCT01801436|593308009|FG000|Overall Study|Progressive disease|4|||
164427691|NCT02806336|593934852|FG000|Overall Study|Physician Decision|1|||
164427692|NCT02806336|593934853|FG001|Overall Study|Physician Decision|0|||
164256956|NCT04085458|593308012|FG000|Overall Study|Other|1|||
164256957|NCT04085458|593308012|FG000|Overall Study|Withdrawal by Subject|2|||
164256958|NCT04085458|593308012|FG000|Overall Study|Adverse Event|2|||
164256959|NCT02447250|593308013|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
164256960|NCT02447250|593308013|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
164256961|NCT02447250|593308013|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
164427693|NCT02806336|593934852|FG000|Overall Study|Withdrawal by Subject|2|||
164427694|NCT02806336|593934853|FG001|Overall Study|Withdrawal by Subject|4|||
164427695|NCT02806336|593934852|FG000|Overall Study|COVID-19 research shut down|3|||
164427696|NCT02806336|593934853|FG001|Overall Study|COVID-19 research shut down|4|||
164427697|NCT02806336|593934852|FG000|Overall Study|Lack of Efficacy|0|||
164427698|NCT02806336|593934853|FG001|Overall Study|Lack of Efficacy|1|||
164427699|NCT03682536|593934854|FG000|Randomization|Withdrawal by Subject|0|||
164427700|NCT03682536|593934855|FG001|Randomization|Withdrawal by Subject|2|||
164427701|NCT03682536|593934854|FG000|Treatment|Other Reasons|8|||
164427702|NCT03682536|593934855|FG001|Treatment|Other Reasons|7|||
164427703|NCT03682536|593934854|FG000|Treatment|Physician Decision|5|||
164427704|NCT03682536|593934855|FG001|Treatment|Physician Decision|5|||
164427705|NCT03682536|593934854|FG000|Treatment|Protocol Violation|1|||
164680541|NCT00112437|594854575|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164680542|NCT00112437|594854576|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
164680543|NCT00112437|594854577|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
164680544|NCT00112437|594854578|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164680545|NCT00112437|594854579|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164680546|NCT00112437|594854580|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
164680547|NCT00112437|594854581|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164680548|NCT00112437|594854582|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164680549|NCT00112437|594854583|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164680550|NCT00112437|594854584|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164256962|NCT02743949|593308014|FG000|Overall Study|Adverse Event|0|||
164256963|NCT02743949|593308015|FG001|Overall Study|Adverse Event|0|||
164256964|NCT02743949|593308016|FG002|Overall Study|Adverse Event|2|||
164256965|NCT02743949|593308014|FG000|Overall Study|Significant Protocol Deviation|2|||
164256966|NCT02743949|593308015|FG001|Overall Study|Significant Protocol Deviation|0|||
164256967|NCT02743949|593308016|FG002|Overall Study|Significant Protocol Deviation|1|||
164256968|NCT02743949|593308014|FG000|Overall Study|Voluntary Withdrawal|2|||
164256969|NCT02743949|593308015|FG001|Overall Study|Voluntary Withdrawal|1|||
164256970|NCT02743949|593308016|FG002|Overall Study|Voluntary Withdrawal|0|||
164339295|NCT01977794|593618878|FG000|Overall Study|Adverse Event|2|||
164339296|NCT01977794|593618879|FG001|Overall Study|Adverse Event|2|||
164339297|NCT01977794|593618878|FG000|Overall Study|Lost to Follow-up|2|||
164339298|NCT01977794|593618879|FG001|Overall Study|Lost to Follow-up|1|||
164339299|NCT01977794|593618878|FG000|Overall Study|Protocol Violation|1|||
164339300|NCT01977794|593618879|FG001|Overall Study|Protocol Violation|0|||
164339301|NCT01977794|593618878|FG000|Overall Study|Death|1|||
164339302|NCT01977794|593618879|FG001|Overall Study|Death|1|||
164339303|NCT01977794|593618878|FG000|Overall Study|Withdrew consent|2|||
164339304|NCT01977794|593618879|FG001|Overall Study|Withdrew consent|1|||
164339305|NCT01977794|593618878|FG000|Overall Study|Other|0|||
164339306|NCT01977794|593618879|FG001|Overall Study|Other|1|||
164339307|NCT00533897|593618880|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
164339308|NCT00533897|593618881|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
164339309|NCT00533897|593618882|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
164339310|NCT00533897|593618883|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
164339311|NCT00533897|593618884|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
164339312|NCT00533897|593618885|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
164339313|NCT00533897|593618886|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
164339314|NCT00533897|593618887|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
164339315|NCT00533897|593618880|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
164339316|NCT00533897|593618881|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
164339317|NCT00533897|593618882|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
164339318|NCT00533897|593618883|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
164339319|NCT00533897|593618884|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
164339320|NCT00533897|593618885|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
164339321|NCT00533897|593618886|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
164339322|NCT00533897|593618887|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
164339323|NCT00533897|593618880|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
164339324|NCT00533897|593618881|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
164339325|NCT00533897|593618882|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
164339326|NCT00533897|593618883|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
164339327|NCT00533897|593618884|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
164339328|NCT00533897|593618885|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
164339329|NCT00533897|593618886|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
164339330|NCT00533897|593618887|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
164427706|NCT03682536|593934855|FG001|Treatment|Protocol Violation|0|||
164680551|NCT00112437|594854585|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164339331|NCT00533897|593618880|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
164339332|NCT00533897|593618881|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
164339333|NCT00533897|593618882|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
164427707|NCT03682536|593934854|FG000|Treatment|Study Terminated by Sponsor|1|||
164427708|NCT03682536|593934855|FG001|Treatment|Study Terminated by Sponsor|2|||
164427709|NCT03682536|593934854|FG000|Treatment|Lost to Follow-up|0|||
164427710|NCT03682536|593934855|FG001|Treatment|Lost to Follow-up|1|||
164680552|NCT00112437|594854586|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164680553|NCT00112437|594854587|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164680554|NCT00112437|594854588|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164680555|NCT00112437|594854589|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164680556|NCT00112437|594854590|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164680557|NCT00112437|594854591|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164256971|NCT01921218|593308017|FG000|Overall Study|Death|2|||
164256972|NCT01921218|593308018|FG001|Overall Study|Death|1|||
164256973|NCT01921218|593308017|FG000|Overall Study|Withdrawal by Subject|0|||
164256974|NCT01921218|593308018|FG001|Overall Study|Withdrawal by Subject|2|||
164256975|NCT01921218|593308017|FG000|Overall Study|Kidney transplant|1|||
164256976|NCT01921218|593308018|FG001|Overall Study|Kidney transplant|1|||
164256977|NCT00960011|593308019|FG000|Overall Study|Death|5|||
164256978|NCT00960011|593308020|FG001|Overall Study|Death|0|||
164256979|NCT00960011|593308019|FG000|Overall Study|Lost to Follow-up|6|||
164256980|NCT00960011|593308020|FG001|Overall Study|Lost to Follow-up|2|||
164256981|NCT01498575|593308021|FG000|Overall Sample|Withdrawal by Subject|60|||
164339334|NCT00533897|593618883|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
164339335|NCT00533897|593618884|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
164339336|NCT00533897|593618885|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
164339337|NCT00533897|593618886|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
164339338|NCT00533897|593618887|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
164339339|NCT00533897|593618880|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
164339340|NCT00533897|593618881|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
164339341|NCT00533897|593618882|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
164339342|NCT00533897|593618883|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
164339343|NCT00533897|593618884|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
164339344|NCT00533897|593618885|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
164339345|NCT00533897|593618886|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
164339346|NCT00533897|593618887|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
164339347|NCT00533897|593618880|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
164339348|NCT00533897|593618881|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
164339349|NCT00533897|593618882|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
164339350|NCT00533897|593618883|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
164339351|NCT00533897|593618884|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
164339352|NCT00533897|593618885|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
164339353|NCT00533897|593618886|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
164339354|NCT00533897|593618887|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
164339355|NCT00533897|593618880|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
164339356|NCT00533897|593618881|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
164339357|NCT00533897|593618882|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
164339358|NCT00533897|593618883|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
164339359|NCT00533897|593618884|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
164339360|NCT00533897|593618885|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
164339361|NCT00533897|593618886|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
164339362|NCT00533897|593618887|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
164339363|NCT00533897|593618880|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
164339364|NCT00533897|593618881|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
164339365|NCT00533897|593618882|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
164339366|NCT00533897|593618883|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
164339367|NCT00533897|593618884|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
164339368|NCT00533897|593618885|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
164339369|NCT00533897|593618886|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
164339370|NCT00533897|593618887|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
164339371|NCT00533897|593618880|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
164339372|NCT00533897|593618881|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
164339373|NCT00533897|593618882|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
164339374|NCT00533897|593618883|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
164339375|NCT00533897|593618884|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
164339376|NCT00533897|593618885|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
164339377|NCT00533897|593618886|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
164339378|NCT00533897|593618887|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
164680558|NCT00112437|594854592|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164680559|NCT00112437|594854593|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164256982|NCT01498575|593308022|FG001|Overall Sample|Withdrawal by Subject|14|||
164680560|NCT00112437|594854594|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164680561|NCT00112437|594854595|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164256983|NCT01498575|593308021|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
164256984|NCT01498575|593308022|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
164256985|NCT01498575|593308021|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
164256986|NCT01498575|593308022|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
164256987|NCT00090142|593308026|FG000|Treatment Period I|Lost to Follow-up|1|||
164256988|NCT00090142|593308027|FG001|Treatment Period I|Lost to Follow-up|2|||
164256989|NCT00090142|593308026|FG000|Treatment Period I|Protocol Violation|2|||
164256990|NCT00090142|593308027|FG001|Treatment Period I|Protocol Violation|0|||
164256991|NCT00090142|593308026|FG000|Treatment Period I|Withdrawal by Subject|2|||
164256992|NCT00090142|593308027|FG001|Treatment Period I|Withdrawal by Subject|0|||
164256993|NCT00090142|593308026|FG000|Treatment Period I|Other|0|||
164256994|NCT00090142|593308027|FG001|Treatment Period I|Other|1|||
164256995|NCT00090142|593308026|FG000|Treatment Period II|Other|1|||
164256996|NCT00090142|593308027|FG001|Treatment Period II|Other|0|||
164256997|NCT01126437|593308028|FG000|Overall Study|Not treated|11|||
164256998|NCT01126437|593308029|FG001|Overall Study|Not treated|18|||
164256999|NCT01126437|593308030|FG002|Overall Study|Not treated|19|||
164257000|NCT01126437|593308028|FG000|Overall Study|Sites with data irregularities/fraud|6|||
164257001|NCT01126437|593308029|FG001|Overall Study|Sites with data irregularities/fraud|6|||
164257002|NCT01126437|593308030|FG002|Overall Study|Sites with data irregularities/fraud|7|||
164257003|NCT01126437|593308028|FG000|Overall Study|Adverse Event|602|||
164257004|NCT01126437|593308029|FG001|Overall Study|Adverse Event|606|||
164257005|NCT01126437|593308030|FG002|Overall Study|Adverse Event|635|||
164257006|NCT01126437|593308028|FG000|Overall Study|Lack of Efficacy|65|||
164680562|NCT00112437|594854596|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164257007|NCT01126437|593308029|FG001|Overall Study|Lack of Efficacy|60|||
164257008|NCT01126437|593308030|FG002|Overall Study|Lack of Efficacy|59|||
164257009|NCT01126437|593308028|FG000|Overall Study|Protocol Violation|64|||
164257010|NCT01126437|593308029|FG001|Overall Study|Protocol Violation|66|||
164257011|NCT01126437|593308030|FG002|Overall Study|Protocol Violation|41|||
164257012|NCT01126437|593308028|FG000|Overall Study|Lost to Follow-up|52|||
164257013|NCT01126437|593308029|FG001|Overall Study|Lost to Follow-up|63|||
164257014|NCT01126437|593308030|FG002|Overall Study|Lost to Follow-up|55|||
164257015|NCT01126437|593308028|FG000|Overall Study|Withdrawal by Subject|331|||
164257016|NCT01126437|593308029|FG001|Overall Study|Withdrawal by Subject|335|||
164257017|NCT01126437|593308030|FG002|Overall Study|Withdrawal by Subject|319|||
164257018|NCT01126437|593308028|FG000|Overall Study|Other reason not specified|210|||
164257019|NCT01126437|593308029|FG001|Overall Study|Other reason not specified|176|||
164257020|NCT01126437|593308030|FG002|Overall Study|Other reason not specified|178|||
164257021|NCT00006046|593308036|FG000|Overall Study|Adverse Event|3|||
164257022|NCT00006046|593308037|FG001|Overall Study|Adverse Event|0|||
164257023|NCT00006046|593308038|FG002|Overall Study|Adverse Event|0|||
164257024|NCT00006046|593308039|FG003|Overall Study|Adverse Event|0|||
164257025|NCT00006046|593308040|FG004|Overall Study|Adverse Event|0|||
164257026|NCT00006046|593308036|FG000|Overall Study|Disease Progression|2|||
164257027|NCT00006046|593308037|FG001|Overall Study|Disease Progression|0|||
164257028|NCT00006046|593308038|FG002|Overall Study|Disease Progression|0|||
164257029|NCT00006046|593308039|FG003|Overall Study|Disease Progression|0|||
164257030|NCT00006046|593308040|FG004|Overall Study|Disease Progression|0|||
164257031|NCT00596154|593308041|FG000|Overall Study|Not Evaluable|2|||
164257032|NCT00642369|593308047|FG000|Overall Study|Adverse Event|2|||
164257033|NCT00642369|593308048|FG001|Overall Study|Adverse Event|3|||
164257034|NCT00642369|593308047|FG000|Overall Study|Withdrawal by Subject|1|||
164257035|NCT00642369|593308048|FG001|Overall Study|Withdrawal by Subject|0|||
164257036|NCT00642369|593308047|FG000|Overall Study|misdiagnosis|0|||
164257037|NCT00642369|593308048|FG001|Overall Study|misdiagnosis|1|||
164257038|NCT00642369|593308047|FG000|Overall Study|Lack of Efficacy|2|||
164257039|NCT00642369|593308048|FG001|Overall Study|Lack of Efficacy|2|||
164257040|NCT00996281|593308055|FG000|Overall Study|Adverse Event|75|||
164257041|NCT00996281|593308056|FG001|Overall Study|Adverse Event|37|||
164257042|NCT00996281|593308055|FG000|Overall Study|Major Protocol Deviation|6|||
164680563|NCT00112437|594854571|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164257043|NCT00996281|593308056|FG001|Overall Study|Major Protocol Deviation|7|||
164257044|NCT00996281|593308055|FG000|Overall Study|Lost to Follow-up|14|||
164257045|NCT00996281|593308056|FG001|Overall Study|Lost to Follow-up|16|||
164257046|NCT00996281|593308055|FG000|Overall Study|Withdrawal by Subject|31|||
164257047|NCT00996281|593308056|FG001|Overall Study|Withdrawal by Subject|20|||
164257048|NCT00996281|593308055|FG000|Overall Study|Lack of Efficacy|0|||
164257049|NCT00996281|593308056|FG001|Overall Study|Lack of Efficacy|2|||
164339379|NCT00533897|593618880|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
164339380|NCT00533897|593618881|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
164339381|NCT00533897|593618882|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
164680564|NCT00112437|594854572|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164257050|NCT00996281|593308055|FG000|Overall Study|Other|5|||
164257051|NCT00996281|593308056|FG001|Overall Study|Other|7|||
164427711|NCT03682536|593934854|FG000|Treatment|Withdrawal by Subject|16|||
164427712|NCT03682536|593934855|FG001|Treatment|Withdrawal by Subject|18|||
164257052|NCT05593913|593308061|FG000|Overall Study|Insufficient image quality|39|||
164257053|NCT04934800|593308064|FG000|Overall Study|Other|1|||
164257054|NCT04934800|593308064|FG000|Overall Study|Withdrawal by Subject|5|||
164257055|NCT04934800|593308064|FG000|Overall Study|Lack of Efficacy|1|||
164257056|NCT04934800|593308064|FG000|Overall Study|Adverse Event|9|||
164257057|NCT04934800|593308064|FG000|Overall Study|Lost to Follow-up|5|||
164257058|NCT04934800|593308064|FG000|Overall Study|Enrolled but not treated|1|||
164257059|NCT00516906|593308065|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
164257060|NCT00516906|593308066|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
164427713|NCT03682536|593934854|FG000|Treatment|Lack of Efficacy|41|||
164427714|NCT03682536|593934855|FG001|Treatment|Lack of Efficacy|68|||
164427715|NCT03682536|593934854|FG000|Treatment|Disease Progression|9|||
164427716|NCT03682536|593934855|FG001|Treatment|Disease Progression|7|||
164427717|NCT03682536|593934854|FG000|Treatment|Adverse Event|9|||
164427718|NCT03682536|593934855|FG001|Treatment|Adverse Event|5|||
164427719|NCT03682536|593934854|FG000|Treatment|Death|14|||
164427720|NCT03682536|593934855|FG001|Treatment|Death|13|||
164427721|NCT04824131|593934856|FG000|CAB LA Oral Phase|Adverse Event|1|||
164427722|NCT04824131|593934856|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
164427723|NCT04824131|593934856|FG000|Step 3|Withdrawal by Subject|2|||
164427724|NCT03008122|593934862|FG000|Overall Study|Physician Decision|3|||
164427725|NCT03008122|593934863|FG001|Overall Study|Physician Decision|2|||
164427726|NCT03008122|593934864|FG002|Overall Study|Physician Decision|0|||
164427727|NCT03008122|593934862|FG000|Overall Study|Withdrawal by Subject|1|||
164427728|NCT03008122|593934863|FG001|Overall Study|Withdrawal by Subject|3|||
164427729|NCT03008122|593934864|FG002|Overall Study|Withdrawal by Subject|0|||
164257061|NCT01974206|593308067|FG000|Overall Study|Did Not Take Study Drug|0|||
164427730|NCT03008122|593934862|FG000|Overall Study|Lost to Follow-up|4|||
164427731|NCT03008122|593934863|FG001|Overall Study|Lost to Follow-up|8|||
164427732|NCT03008122|593934864|FG002|Overall Study|Lost to Follow-up|3|||
164427733|NCT03008122|593934862|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
164427734|NCT03008122|593934863|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
164427735|NCT03008122|593934864|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
164427736|NCT03008122|593934862|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
164427737|NCT03008122|593934863|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
164427738|NCT03008122|593934864|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
164427739|NCT03008122|593934862|FG000|Overall Study|Death|0|||
164427740|NCT03008122|593934863|FG001|Overall Study|Death|0|||
164427741|NCT03008122|593934864|FG002|Overall Study|Death|1|||
164427742|NCT02338609|593934866|FG000|Overall Study|Physician Decision|1|||
164427743|NCT02338609|593934866|FG000|Overall Study|Death|1|||
164427744|NCT02084082|593934867|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
164427745|NCT02084082|593934868|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
164427746|NCT02084082|593934869|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
164427747|NCT02084082|593934870|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
164427748|NCT02084082|593934867|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
164427749|NCT02084082|593934868|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
164427750|NCT02084082|593934869|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
164427751|NCT02084082|593934870|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
164427752|NCT04736056|593934875|FG000|Overall Study|Death|0|||
164427753|NCT04736056|593934876|FG001|Overall Study|Death|0|||
164427754|NCT04736056|593934877|FG002|Overall Study|Death|0|||
164427755|NCT04736056|593934878|FG003|Overall Study|Death|1|||
164427756|NCT04736056|593934875|FG000|Overall Study|Lost to Follow-up|1|||
164427757|NCT04736056|593934876|FG001|Overall Study|Lost to Follow-up|0|||
164427758|NCT04736056|593934877|FG002|Overall Study|Lost to Follow-up|1|||
164427759|NCT04736056|593934878|FG003|Overall Study|Lost to Follow-up|1|||
164427760|NCT04736056|593934875|FG000|Overall Study|Withdrawal by Subject|2|||
164576569|NCT05089708|594474791|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
164576570|NCT05089708|594474792|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
164576571|NCT00594399|594474794|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
164576572|NCT00594399|594474795|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
164427761|NCT04736056|593934876|FG001|Overall Study|Withdrawal by Subject|0|||
164427762|NCT04736056|593934877|FG002|Overall Study|Withdrawal by Subject|0|||
164427763|NCT04736056|593934878|FG003|Overall Study|Withdrawal by Subject|0|||
164427764|NCT04736056|593934875|FG000|Overall Study|Physician Decision|1|||
164427765|NCT04736056|593934876|FG001|Overall Study|Physician Decision|0|||
164427766|NCT04736056|593934877|FG002|Overall Study|Physician Decision|1|||
164427767|NCT04736056|593934878|FG003|Overall Study|Physician Decision|0|||
164427768|NCT02223182|593934879|FG000|Double-Blind Period|Adverse Event|0|||
164427769|NCT02223182|593934880|FG001|Double-Blind Period|Adverse Event|2|||
164427770|NCT02223182|593934881|FG002|Double-Blind Period|Adverse Event|1|||
164427771|NCT02223182|593934882|FG003|Double-Blind Period|Adverse Event|0|||
164576573|NCT00594399|594474796|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
164576574|NCT00594399|594474794|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
164339382|NCT00533897|593618883|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
164339383|NCT00533897|593618884|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
164339384|NCT00533897|593618885|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
164339385|NCT00533897|593618886|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
164339386|NCT00533897|593618887|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
164339387|NCT00533897|593618880|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
164339388|NCT00533897|593618881|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
164339389|NCT00533897|593618882|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
164339390|NCT00533897|593618883|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
164339391|NCT00533897|593618884|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
164339392|NCT00533897|593618885|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
164339393|NCT00533897|593618886|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
164339394|NCT00533897|593618887|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
164339395|NCT00533897|593618880|FG000|Long Term Extension (LTE)|Death|0|||
164339396|NCT00533897|593618881|FG001|Long Term Extension (LTE)|Death|0|||
164339397|NCT00533897|593618882|FG002|Long Term Extension (LTE)|Death|0|||
164339398|NCT00533897|593618883|FG003|Long Term Extension (LTE)|Death|0|||
164339399|NCT00533897|593618884|FG004|Long Term Extension (LTE)|Death|0|||
164339400|NCT00533897|593618885|FG005|Long Term Extension (LTE)|Death|0|||
164339401|NCT00533897|593618886|FG006|Long Term Extension (LTE)|Death|1|||
164339402|NCT00533897|593618887|FG007|Long Term Extension (LTE)|Death|3|||
164339403|NCT00533897|593618880|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
164339404|NCT00533897|593618881|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
164339405|NCT00533897|593618882|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
164339406|NCT00533897|593618883|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
164339407|NCT00533897|593618884|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
164339408|NCT00533897|593618885|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
164339409|NCT00533897|593618886|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
164339410|NCT00533897|593618887|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
164339411|NCT00533897|593618880|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
164339412|NCT00533897|593618881|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
164339413|NCT00533897|593618882|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
164339414|NCT00533897|593618883|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
164339415|NCT00533897|593618884|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
164339416|NCT00533897|593618885|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
164339417|NCT00533897|593618886|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
164339418|NCT00533897|593618887|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
164339419|NCT00533897|593618880|FG000|Long Term Extension (LTE)|Adverse Event|0|||
164339420|NCT00533897|593618881|FG001|Long Term Extension (LTE)|Adverse Event|0|||
164339421|NCT00533897|593618882|FG002|Long Term Extension (LTE)|Adverse Event|0|||
164339422|NCT00533897|593618883|FG003|Long Term Extension (LTE)|Adverse Event|0|||
164339423|NCT00533897|593618884|FG004|Long Term Extension (LTE)|Adverse Event|0|||
164339424|NCT00533897|593618885|FG005|Long Term Extension (LTE)|Adverse Event|0|||
164427772|NCT02223182|593934879|FG000|Double-Blind Period|Withdrawal by Subject|1|||
164427773|NCT02223182|593934880|FG001|Double-Blind Period|Withdrawal by Subject|1|||
164427774|NCT02223182|593934881|FG002|Double-Blind Period|Withdrawal by Subject|1|||
164427775|NCT02223182|593934882|FG003|Double-Blind Period|Withdrawal by Subject|0|||
164427776|NCT02223182|593934879|FG000|Double-Blind Period|Lost to Follow-up|0|||
164339425|NCT00533897|593618886|FG006|Long Term Extension (LTE)|Adverse Event|2|||
164339426|NCT00533897|593618887|FG007|Long Term Extension (LTE)|Adverse Event|5|||
164339427|NCT00533897|593618880|FG000|Long Term Extension (LTE)|Pregnancy|0|||
164339428|NCT00533897|593618881|FG001|Long Term Extension (LTE)|Pregnancy|0|||
164339429|NCT00533897|593618882|FG002|Long Term Extension (LTE)|Pregnancy|0|||
164339430|NCT00533897|593618883|FG003|Long Term Extension (LTE)|Pregnancy|0|||
164339431|NCT00533897|593618884|FG004|Long Term Extension (LTE)|Pregnancy|0|||
164339432|NCT00533897|593618885|FG005|Long Term Extension (LTE)|Pregnancy|0|||
164339433|NCT00533897|593618886|FG006|Long Term Extension (LTE)|Pregnancy|0|||
164339434|NCT00533897|593618887|FG007|Long Term Extension (LTE)|Pregnancy|2|||
164339435|NCT00533897|593618880|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
164339436|NCT00533897|593618881|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
164339437|NCT00533897|593618882|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
164339438|NCT00533897|593618883|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
164339439|NCT00533897|593618884|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
164339440|NCT00533897|593618885|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
164339441|NCT00533897|593618886|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
164339442|NCT00533897|593618887|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
164339443|NCT00533897|593618880|FG000|Long Term Extension (LTE)|Other|0|||
164339444|NCT00533897|593618881|FG001|Long Term Extension (LTE)|Other|0|||
164339445|NCT00533897|593618882|FG002|Long Term Extension (LTE)|Other|0|||
164339446|NCT00533897|593618883|FG003|Long Term Extension (LTE)|Other|0|||
164339447|NCT00533897|593618884|FG004|Long Term Extension (LTE)|Other|0|||
164339448|NCT00533897|593618885|FG005|Long Term Extension (LTE)|Other|0|||
164339449|NCT00533897|593618886|FG006|Long Term Extension (LTE)|Other|1|||
164339450|NCT00533897|593618887|FG007|Long Term Extension (LTE)|Other|6|||
164339451|NCT01546207|593618890|FG000|Overall Study|Death|1|||
164339452|NCT01626456|593618891|FG000|Overall Study|Withdrawal by Subject|21|||
164339453|NCT01626456|593618892|FG001|Overall Study|Withdrawal by Subject|46|||
164339454|NCT01626456|593618891|FG000|Overall Study|Adverse Event|2|||
164339455|NCT01626456|593618892|FG001|Overall Study|Adverse Event|27|||
164339456|NCT01626456|593618891|FG000|Overall Study|Lost to Follow-up|2|||
164339457|NCT01626456|593618892|FG001|Overall Study|Lost to Follow-up|27|||
164339458|NCT01626456|593618891|FG000|Overall Study|Lack of Efficacy|6|||
164339459|NCT01626456|593618892|FG001|Overall Study|Lack of Efficacy|7|||
164339460|NCT01626456|593618891|FG000|Overall Study|Physician Decision|1|||
164339461|NCT01626456|593618892|FG001|Overall Study|Physician Decision|4|||
164339462|NCT01626456|593618891|FG000|Overall Study|Protocol Violation|1|||
164339463|NCT01626456|593618892|FG001|Overall Study|Protocol Violation|1|||
164339464|NCT01626456|593618891|FG000|Overall Study|Site Closure|2|||
164339465|NCT01626456|593618892|FG001|Overall Study|Site Closure|3|||
164339466|NCT01626456|593618891|FG000|Overall Study|Incarceration|0|||
164339467|NCT01626456|593618892|FG001|Overall Study|Incarceration|2|||
164339468|NCT00506662|593618893|FG000|Overall Study|Adverse Event|0|||
164339469|NCT00506662|593618894|FG001|Overall Study|Adverse Event|2|||
164339470|NCT00506662|593618893|FG000|Overall Study|Lack of Efficacy|1|||
164339471|NCT00506662|593618894|FG001|Overall Study|Lack of Efficacy|0|||
164339472|NCT00506662|593618893|FG000|Overall Study|Protocol Violation|2|||
164339473|NCT00506662|593618894|FG001|Overall Study|Protocol Violation|4|||
164339474|NCT00506662|593618893|FG000|Overall Study|Trial terminated|10|||
164339475|NCT00506662|593618894|FG001|Overall Study|Trial terminated|16|||
164339476|NCT00506662|593618893|FG000|Overall Study|Not recorded|4|||
164339477|NCT00506662|593618894|FG001|Overall Study|Not recorded|6|||
164339478|NCT00491075|593618896|FG000|Overall Study|Withdrawal by Subject|1|||
164339479|NCT00491075|593618896|FG000|Overall Study|Physician Decision|1|||
164339480|NCT01603355|593618897|FG000|Overall Study|Lack of Efficacy|2|||
164339481|NCT03750955|593618900|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
164339482|NCT03750955|593618901|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
164339483|NCT03750955|593618900|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
164339484|NCT03750955|593618901|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
164339485|NCT00697788|593618904|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
164339486|NCT00697788|593618905|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
164339487|NCT00697788|593618906|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
164339488|NCT00697788|593618907|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
164339489|NCT00697788|593618908|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
164339490|NCT00697788|593618909|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
164339491|NCT00697788|593618910|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
164339492|NCT00697788|593618911|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
164339493|NCT00697788|593618904|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
164339494|NCT00697788|593618905|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
164339495|NCT00697788|593618906|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
164339496|NCT00697788|593618907|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
164339497|NCT00697788|593618908|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
164339498|NCT00697788|593618909|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
164339499|NCT00697788|593618910|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
164339500|NCT00697788|593618911|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
164339501|NCT00142935|593618912|FG000|Overall Study|Other reason|1|||
164339502|NCT00142935|593618913|FG001|Overall Study|Other reason|1|||
164339503|NCT00142935|593618914|FG002|Overall Study|Other reason|1|||
164427777|NCT02223182|593934880|FG001|Double-Blind Period|Lost to Follow-up|1|||
164427778|NCT02223182|593934881|FG002|Double-Blind Period|Lost to Follow-up|0|||
164427779|NCT02223182|593934882|FG003|Double-Blind Period|Lost to Follow-up|0|||
164427780|NCT02223182|593934879|FG000|Double-Blind Period|Non Compliance|0|||
164427781|NCT02223182|593934880|FG001|Double-Blind Period|Non Compliance|0|||
164427782|NCT02223182|593934881|FG002|Double-Blind Period|Non Compliance|0|||
164427783|NCT02223182|593934882|FG003|Double-Blind Period|Non Compliance|1|||
164427784|NCT02223182|593934879|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
164427785|NCT02223182|593934880|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
164427786|NCT02223182|593934881|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
164427787|NCT02223182|593934882|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
164427788|NCT02223182|593934879|FG000|Open-Label 500 Period|Adverse Event|1|||
164339504|NCT00142935|593618912|FG000|Overall Study|Lost to Follow-up|2|||
164339505|NCT00142935|593618913|FG001|Overall Study|Lost to Follow-up|5|||
164427789|NCT02223182|593934880|FG001|Open-Label 500 Period|Adverse Event|0|||
164339506|NCT00142935|593618914|FG002|Overall Study|Lost to Follow-up|5|||
164339507|NCT00142935|593618912|FG000|Overall Study|Death|0|||
164576575|NCT00594399|594474795|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
164576576|NCT00594399|594474796|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
164576577|NCT00594399|594474794|FG000|Initial 3 Month Counseling|Personal issues|2|||
164576578|NCT00594399|594474795|FG001|Initial 3 Month Counseling|Personal issues|0|||
164576579|NCT00594399|594474796|FG002|Initial 3 Month Counseling|Personal issues|0|||
164576580|NCT00594399|594474794|FG000|Initial 3 Month Counseling|Too busy|7|||
164576581|NCT00594399|594474795|FG001|Initial 3 Month Counseling|Too busy|1|||
164576582|NCT00594399|594474796|FG002|Initial 3 Month Counseling|Too busy|0|||
164576583|NCT00594399|594474794|FG000|Initial 3 Month Counseling|Pain|2|||
164576584|NCT00594399|594474795|FG001|Initial 3 Month Counseling|Pain|0|||
164576585|NCT00594399|594474796|FG002|Initial 3 Month Counseling|Pain|0|||
164576586|NCT00594399|594474794|FG000|Initial 3 Month Counseling|Moved|1|||
164576587|NCT00594399|594474795|FG001|Initial 3 Month Counseling|Moved|0|||
164576588|NCT00594399|594474796|FG002|Initial 3 Month Counseling|Moved|0|||
164576589|NCT00594399|594474794|FG000|Initial 3 Month Counseling|Family illness|1|||
164576590|NCT00594399|594474795|FG001|Initial 3 Month Counseling|Family illness|0|||
164576591|NCT00594399|594474796|FG002|Initial 3 Month Counseling|Family illness|0|||
164576592|NCT00594399|594474794|FG000|Rerandomization Arm 1 Only|Death|2|||
164576593|NCT00594399|594474795|FG001|Rerandomization Arm 1 Only|Death|1|||
164576594|NCT00594399|594474796|FG002|Rerandomization Arm 1 Only|Death|0|||
164576595|NCT00594399|594474794|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
164576596|NCT00594399|594474795|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
164576597|NCT00594399|594474796|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
164576598|NCT03293680|594474797|FG000|Overall Study|Death|1|||
164576599|NCT03293680|594474797|FG000|Overall Study|Did not meet inclusion criteria|8|||
164576600|NCT02853760|594474805|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
164576601|NCT02853760|594474806|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
164576602|NCT02853760|594474807|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
164576603|NCT02853760|594474808|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
164576604|NCT02853760|594474809|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
164576605|NCT02853760|594474810|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
164576606|NCT00702143|594474811|FG000|Overall Study|Lost to Follow-up|0|||
164576607|NCT00702143|594474812|FG001|Overall Study|Lost to Follow-up|0|||
164576608|NCT00702143|594474813|FG002|Overall Study|Lost to Follow-up|1|||
164576609|NCT00488631|594474814|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
164576610|NCT00488631|594474815|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
164576611|NCT00488631|594474816|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
164576612|NCT00488631|594474817|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
164576613|NCT00488631|594474818|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
164576614|NCT00488631|594474819|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
164576615|NCT00488631|594474820|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
164576616|NCT00488631|594474821|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
164257062|NCT01974206|593308068|FG001|Overall Study|Did Not Take Study Drug|1|||
164257063|NCT01974206|593308067|FG000|Overall Study|Physician Decision|1|||
164257064|NCT01974206|593308068|FG001|Overall Study|Physician Decision|0|||
164257065|NCT01974206|593308067|FG000|Overall Study|Withdrawal by Subject|3|||
164257066|NCT01974206|593308068|FG001|Overall Study|Withdrawal by Subject|0|||
164257067|NCT01974206|593308067|FG000|Overall Study|Lost to Follow-up|1|||
164257068|NCT01974206|593308068|FG001|Overall Study|Lost to Follow-up|0|||
164257069|NCT01974206|593308067|FG000|Overall Study|Death|1|||
164257070|NCT01974206|593308068|FG001|Overall Study|Death|0|||
164257071|NCT02059499|593308070|FG000|Upto Week 20|Lost to Follow-up|2|||
164339508|NCT00142935|593618913|FG001|Overall Study|Death|2|||
164576617|NCT00488631|594474822|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
164576618|NCT00488631|594474823|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
164576619|NCT00488631|594474814|FG000|Double Blind Period (Week 0-54)|Death|0|||
164576620|NCT00488631|594474815|FG001|Double Blind Period (Week 0-54)|Death|0|||
164576621|NCT00488631|594474816|FG002|Double Blind Period (Week 0-54)|Death|0|||
164576622|NCT00488631|594474817|FG003|Double Blind Period (Week 0-54)|Death|0|||
164576623|NCT00488631|594474818|FG004|Double Blind Period (Week 0-54)|Death|0|||
164576624|NCT00488631|594474819|FG005|Double Blind Period (Week 0-54)|Death|1|||
164576625|NCT00488631|594474820|FG006|Double Blind Period (Week 0-54)|Death|0|||
164576626|NCT00488631|594474821|FG007|Double Blind Period (Week 0-54)|Death|0|||
164576627|NCT00488631|594474822|FG008|Double Blind Period (Week 0-54)|Death|0|||
164576628|NCT00488631|594474823|FG009|Double Blind Period (Week 0-54)|Death|0|||
164576629|NCT00488631|594474814|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
164339509|NCT00142935|593618914|FG002|Overall Study|Death|1|||
164576630|NCT00488631|594474815|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
164576631|NCT00488631|594474816|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
164576632|NCT00488631|594474817|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
164576633|NCT00488631|594474818|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
164427790|NCT02223182|593934881|FG002|Open-Label 500 Period|Adverse Event|2|||
164427791|NCT02223182|593934882|FG003|Open-Label 500 Period|Adverse Event|1|||
164427792|NCT02223182|593934879|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
164427793|NCT02223182|593934880|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
164257072|NCT02059499|593308071|FG001|Upto Week 20|Lost to Follow-up|6|||
164257073|NCT02059499|593308072|FG002|Upto Week 20|Lost to Follow-up|0|||
164257074|NCT02059499|593308070|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
164257075|NCT02059499|593308071|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
164257076|NCT02059499|593308072|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
164257077|NCT02059499|593308070|FG000|Upto Week 20|Withdrawal by Subject|1|||
164257078|NCT02059499|593308071|FG001|Upto Week 20|Withdrawal by Subject|1|||
164257079|NCT02059499|593308072|FG002|Upto Week 20|Withdrawal by Subject|0|||
164257080|NCT02059499|593308070|FG000|Upto Week 20|No treatment per protocol criteria|0|||
164257081|NCT02059499|593308071|FG001|Upto Week 20|No treatment per protocol criteria|0|||
164257082|NCT02059499|593308072|FG002|Upto Week 20|No treatment per protocol criteria|5|||
164257083|NCT02059499|593308070|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
164257084|NCT02059499|593308071|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
164257085|NCT02059499|593308072|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
164257086|NCT02059499|593308070|FG000|Post-week 20|Lost to Follow-up|0|||
164257087|NCT02059499|593308071|FG001|Post-week 20|Lost to Follow-up|2|||
164257088|NCT02059499|593308072|FG002|Post-week 20|Lost to Follow-up|0|||
164257089|NCT02059499|593308070|FG000|Post-week 20|Withdrawal by Subject|0|||
164257090|NCT02059499|593308071|FG001|Post-week 20|Withdrawal by Subject|1|||
164257091|NCT02059499|593308072|FG002|Post-week 20|Withdrawal by Subject|0|||
164257092|NCT02059499|593308070|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
164257093|NCT02059499|593308071|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
164257094|NCT02059499|593308072|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
164257095|NCT03989349|593308077|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
164257096|NCT03989349|593308078|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
164257097|NCT03989349|593308079|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
164257098|NCT03989349|593308080|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
164257099|NCT03989349|593308081|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
164257100|NCT03989349|593308082|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
164257101|NCT03989349|593308077|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
164257102|NCT03989349|593308078|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
164257103|NCT03989349|593308079|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
164257104|NCT03989349|593308080|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
164257105|NCT03989349|593308081|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
164257106|NCT03989349|593308082|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
164257107|NCT03989349|593308077|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
164257108|NCT03989349|593308078|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
164257109|NCT03989349|593308079|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
164257110|NCT03989349|593308080|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
164257111|NCT03989349|593308081|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
164257112|NCT03989349|593308082|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
164257113|NCT03989349|593308077|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
164257114|NCT03989349|593308078|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
164257115|NCT03989349|593308079|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
164257116|NCT03989349|593308080|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
164257117|NCT03989349|593308081|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
164257118|NCT03989349|593308082|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
164257119|NCT03989349|593308077|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
164257120|NCT03989349|593308078|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
164257121|NCT03989349|593308079|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
164257122|NCT03989349|593308080|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
164257123|NCT03989349|593308081|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
164257124|NCT03989349|593308082|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
164257125|NCT03989349|593308077|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
164257126|NCT03989349|593308078|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
164257127|NCT03989349|593308079|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
164257128|NCT03989349|593308080|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
164257129|NCT03989349|593308081|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
164427794|NCT02223182|593934881|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
164427795|NCT02223182|593934882|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
164427796|NCT02223182|593934879|FG000|Open-Label 500 Period|Physician Decision|0|||
164427797|NCT02223182|593934880|FG001|Open-Label 500 Period|Physician Decision|0|||
164257130|NCT03989349|593308082|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
164257131|NCT03989349|593308077|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
164257132|NCT03989349|593308078|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
164257133|NCT03989349|593308079|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
164257134|NCT03989349|593308080|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
164257135|NCT03989349|593308081|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
164257136|NCT03989349|593308082|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
164257137|NCT03989349|593308077|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
164257138|NCT03989349|593308078|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
164257139|NCT03989349|593308079|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
164257140|NCT03989349|593308080|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
164257141|NCT03989349|593308081|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
164257142|NCT03989349|593308082|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
164257143|NCT03989349|593308077|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
164257144|NCT03989349|593308078|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
164257145|NCT03989349|593308079|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
164257146|NCT03989349|593308080|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
164257147|NCT03989349|593308081|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
164257148|NCT03989349|593308082|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
164257149|NCT03989349|593308077|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
164257150|NCT03989349|593308078|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
164257151|NCT03989349|593308079|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
164257152|NCT03989349|593308080|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
164257153|NCT03989349|593308081|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
164257154|NCT03989349|593308082|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
164339510|NCT01180985|593618919|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
164339511|NCT01180985|593618920|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
164339512|NCT00705289|593618921|FG000|Overall Study|Subject or treating physician's choice|131|||
164339513|NCT00619177|593618927|FG000|Overall Study|Adverse Event|18|||
164339514|NCT00619177|593618927|FG000|Overall Study|Lost to Follow-up|2|||
164339515|NCT00619177|593618927|FG000|Overall Study|Lack of Efficacy|1|||
164339516|NCT00619177|593618927|FG000|Overall Study|Missing termination information|481|||
164339517|NCT00619177|593618927|FG000|Overall Study|Not specified reasons|6|||
164339518|NCT01281137|593618932|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
164339519|NCT01281137|593618933|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
164339520|NCT01281137|593618932|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
164339521|NCT01281137|593618933|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
164339522|NCT01281137|593618932|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
164339523|NCT01281137|593618933|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
164339524|NCT01281137|593618932|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
164339525|NCT01281137|593618933|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
164339526|NCT01281137|593618932|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
164339527|NCT01281137|593618933|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
164339528|NCT00788073|593618934|FG000|STX209 Then Placebo|Adverse Event|1|||
164339529|NCT00788073|593618935|FG001|STX209 Then Placebo|Adverse Event|0|||
164339530|NCT00788073|593618934|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
164339531|NCT00788073|593618935|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
164339532|NCT00788073|593618934|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
164339533|NCT00788073|593618935|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
164339534|NCT00788073|593618934|FG000|STX209 Then Placebo|unable to return due to travel|0|||
164339535|NCT00788073|593618935|FG001|STX209 Then Placebo|unable to return due to travel|1|||
164339536|NCT00788073|593618934|FG000|Placebo Then STX209|Adverse Event|2|||
164339537|NCT00788073|593618935|FG001|Placebo Then STX209|Adverse Event|0|||
164339538|NCT00788073|593618934|FG000|Placebo Then STX209|Protocol Violation|0|||
164339539|NCT00788073|593618935|FG001|Placebo Then STX209|Protocol Violation|1|||
164339540|NCT03608254|593618936|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
164339541|NCT03608254|593618936|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
164339542|NCT00910273|593618937|FG000|Overall Study|Lack of Efficacy|6|||
164339543|NCT00910273|593618938|FG001|Overall Study|Lack of Efficacy|9|||
164339544|NCT00910273|593618937|FG000|Overall Study|Adverse Event|1|||
164576634|NCT00488631|594474819|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
164576635|NCT00488631|594474820|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
164257155|NCT03989349|593308077|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
164257156|NCT03989349|593308078|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
164257157|NCT03989349|593308079|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
164257158|NCT03989349|593308080|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
164257159|NCT03989349|593308081|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
164257160|NCT03989349|593308082|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
164257161|NCT03989349|593308077|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
164257162|NCT03989349|593308078|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
164257163|NCT03989349|593308079|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
164257164|NCT03989349|593308080|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
164257165|NCT03989349|593308081|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
164257166|NCT03989349|593308082|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
164257167|NCT03989349|593308077|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
164257168|NCT03989349|593308078|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
164257169|NCT03989349|593308079|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
164257170|NCT03989349|593308080|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
164257171|NCT03989349|593308081|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
164257172|NCT03989349|593308082|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
164257173|NCT03989349|593308077|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
164257174|NCT03989349|593308078|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
164257175|NCT03989349|593308079|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
164257176|NCT03989349|593308080|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
164257177|NCT03989349|593308081|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
164257178|NCT03989349|593308082|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
164257179|NCT02684058|593308083|FG000|Treatment Period|Progressive disease|4|||
164257180|NCT02684058|593308084|FG001|Treatment Period|Progressive disease|10|||
164257181|NCT02684058|593308085|FG002|Treatment Period|Progressive disease|19|||
164257182|NCT02684058|593308083|FG000|Treatment Period|Adverse Event|3|||
164257183|NCT02684058|593308084|FG001|Treatment Period|Adverse Event|8|||
164257184|NCT02684058|593308085|FG002|Treatment Period|Adverse Event|1|||
164257185|NCT02684058|593308083|FG000|Treatment Period|Physician Decision|5|||
164257186|NCT02684058|593308084|FG001|Treatment Period|Physician Decision|1|||
164257187|NCT02684058|593308085|FG002|Treatment Period|Physician Decision|2|||
164257188|NCT02684058|593308083|FG000|Treatment Period|New therapy for study indication|1|||
164257189|NCT02684058|593308084|FG001|Treatment Period|New therapy for study indication|0|||
164257190|NCT02684058|593308085|FG002|Treatment Period|New therapy for study indication|0|||
164257191|NCT02684058|593308083|FG000|Treatment Period|Protocol deviation|0|||
164257192|NCT02684058|593308084|FG001|Treatment Period|Protocol deviation|1|||
164427798|NCT02223182|593934881|FG002|Open-Label 500 Period|Physician Decision|0|||
164427799|NCT02223182|593934882|FG003|Open-Label 500 Period|Physician Decision|1|||
164427800|NCT02223182|593934879|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
164427801|NCT02223182|593934880|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
164427802|NCT02223182|593934881|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
164427803|NCT02223182|593934882|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
164427804|NCT02223182|593934879|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
164427805|NCT02223182|593934880|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
164427806|NCT02223182|593934881|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
164427807|NCT02223182|593934882|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
164427808|NCT02223182|593934879|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
164427809|NCT02223182|593934880|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
164427810|NCT02223182|593934881|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
164427811|NCT02223182|593934882|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
164427812|NCT02223182|593934879|FG000|Open-Label 300 Period|Non Compliance|0|||
164427813|NCT02223182|593934880|FG001|Open-Label 300 Period|Non Compliance|2|||
164427814|NCT02223182|593934881|FG002|Open-Label 300 Period|Non Compliance|1|||
164427815|NCT02223182|593934882|FG003|Open-Label 300 Period|Non Compliance|0|||
164427816|NCT04956692|593934889|FG000|Overall Study|Death|115|||
164427817|NCT04956692|593934890|FG001|Overall Study|Death|47|||
164427818|NCT04956692|593934889|FG000|Overall Study|Lost to Follow-up|0|||
164427819|NCT04956692|593934890|FG001|Overall Study|Lost to Follow-up|1|||
164427820|NCT04956692|593934889|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
164427821|NCT04956692|593934890|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164427822|NCT04956692|593934889|FG000|Overall Study|Withdrawal by Subject|5|||
164427823|NCT04956692|593934890|FG001|Overall Study|Withdrawal by Subject|2|||
164427824|NCT04956692|593934889|FG000|Overall Study|Ongoing in Study|236|||
164427825|NCT04956692|593934890|FG001|Overall Study|Ongoing in Study|123|||
164427826|NCT02099539|593934895|FG000|Overall Study|Progressive Disease|3|||
164427827|NCT02099539|593934896|FG001|Overall Study|Progressive Disease|2|||
164427828|NCT02099539|593934897|FG002|Overall Study|Progressive Disease|2|||
164427829|NCT02099539|593934898|FG003|Overall Study|Progressive Disease|1|||
164339545|NCT00910273|593618938|FG001|Overall Study|Adverse Event|1|||
164339546|NCT00910273|593618937|FG000|Overall Study|Withdrawal by Subject|1|||
164339547|NCT00910273|593618938|FG001|Overall Study|Withdrawal by Subject|0|||
164339548|NCT00910273|593618937|FG000|Overall Study|Discontinuation of study by sponsor|8|||
164339549|NCT00910273|593618938|FG001|Overall Study|Discontinuation of study by sponsor|2|||
164339550|NCT00910273|593618937|FG000|Overall Study|Protocol Violation|1|||
164339551|NCT00910273|593618938|FG001|Overall Study|Protocol Violation|0|||
164339552|NCT00910273|593618937|FG000|Overall Study|Lost to Follow-up|1|||
164339553|NCT00910273|593618938|FG001|Overall Study|Lost to Follow-up|1|||
164339554|NCT03540030|593618939|FG000|Overall Study|Withdrawal by Subject|2|||
164339555|NCT03540030|593618940|FG001|Overall Study|Withdrawal by Subject|1|||
164339556|NCT03540030|593618939|FG000|Overall Study|screen fail|7|||
164339557|NCT03540030|593618940|FG001|Overall Study|screen fail|1|||
164339558|NCT03540030|593618939|FG000|Overall Study|never had surgery after signing consent|9|||
164339559|NCT03540030|593618940|FG001|Overall Study|never had surgery after signing consent|1|||
164339560|NCT00569270|593618941|FG000|Period: First Intervention|Protocol Violation|0|||
164339561|NCT00569270|593618942|FG001|Period: First Intervention|Protocol Violation|1|||
164339562|NCT04729621|593618947|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
164339563|NCT04729621|593618948|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
164339564|NCT04729621|593618949|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
164339565|NCT04729621|593618950|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
164339566|NCT04729621|593618951|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
164339567|NCT04729621|593618947|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
164339568|NCT04729621|593618948|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
164427830|NCT02099539|593934899|FG004|Overall Study|Progressive Disease|4|||
164427831|NCT02099539|593934900|FG005|Overall Study|Progressive Disease|2|||
164427832|NCT02099539|593934901|FG006|Overall Study|Progressive Disease|0|||
164427833|NCT02099539|593934895|FG000|Overall Study|Adverse Event|0|||
164427834|NCT02099539|593934896|FG001|Overall Study|Adverse Event|0|||
164427835|NCT02099539|593934897|FG002|Overall Study|Adverse Event|1|||
164427836|NCT02099539|593934898|FG003|Overall Study|Adverse Event|1|||
164427837|NCT02099539|593934899|FG004|Overall Study|Adverse Event|0|||
164427838|NCT02099539|593934900|FG005|Overall Study|Adverse Event|0|||
164427839|NCT02099539|593934901|FG006|Overall Study|Adverse Event|0|||
164427840|NCT02099539|593934895|FG000|Overall Study|Physician Decision|0|||
164427841|NCT02099539|593934896|FG001|Overall Study|Physician Decision|0|||
164427842|NCT02099539|593934897|FG002|Overall Study|Physician Decision|0|||
164427843|NCT02099539|593934898|FG003|Overall Study|Physician Decision|0|||
164427844|NCT02099539|593934899|FG004|Overall Study|Physician Decision|0|||
164427845|NCT02099539|593934900|FG005|Overall Study|Physician Decision|1|||
164427846|NCT02099539|593934901|FG006|Overall Study|Physician Decision|0|||
164427847|NCT01449721|593934903|FG000|Overall Study|Physician Decision|0|||
164427848|NCT01449721|593934904|FG001|Overall Study|Physician Decision|1|||
164427849|NCT01449721|593934903|FG000|Overall Study|Physician Decision|0|||
164427850|NCT01449721|593934904|FG001|Overall Study|Physician Decision|1|||
164427851|NCT02148718|593934905|FG000|Overall Study|Protocol Violation|26|||
164427852|NCT02148718|593934905|FG000|Overall Study|Discontinued Study Prematurely|5|||
164427853|NCT00333788|593934912|FG000|Overall Study|Adverse Event|44|||
164427854|NCT00333788|593934912|FG000|Overall Study|Lack of Efficacy|80|||
164427855|NCT00333788|593934912|FG000|Overall Study|Lost to Follow-up|2|||
164427856|NCT00333788|593934912|FG000|Overall Study|Withdrawal by Subject|24|||
164427857|NCT00333788|593934912|FG000|Overall Study|Other: Non-compliance|2|||
164427858|NCT00333788|593934912|FG000|Overall Study|Other: Moved|2|||
164427859|NCT00333788|593934912|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
164427860|NCT00333788|593934912|FG000|Overall Study|Other: Investigator decision|1|||
164427861|NCT00333788|593934912|FG000|Overall Study|Other: Quality of life concern|1|||
164427862|NCT00333788|593934912|FG000|Overall Study|Other: Sponsor decision|1|||
164427863|NCT00333788|593934912|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
164427864|NCT00333788|593934912|FG000|Overall Study|Other: Medical monitor decision|1|||
164427865|NCT00333788|593934912|FG000|Overall Study|Other: Physician decision|1|||
164427866|NCT00333788|593934912|FG000|Overall Study|Other: Signed consent for another study|1|||
164427867|NCT04739423|593934913|FG000|Overall Study|Protocol Violation|0|||
164339569|NCT04729621|593618949|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
164427868|NCT04739423|593934914|FG001|Overall Study|Protocol Violation|1|||
164339570|NCT04729621|593618950|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
164339571|NCT04729621|593618951|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
164339572|NCT04729621|593618947|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
164427869|NCT04739423|593934915|FG002|Overall Study|Protocol Violation|0|||
164427870|NCT04739423|593934916|FG003|Overall Study|Protocol Violation|0|||
164427871|NCT04739423|593934917|FG004|Overall Study|Protocol Violation|0|||
164427872|NCT04739423|593934918|FG005|Overall Study|Protocol Violation|0|||
164427873|NCT04739423|593934913|FG000|Overall Study|Adverse Event|0|||
164427874|NCT04739423|593934914|FG001|Overall Study|Adverse Event|0|||
164427875|NCT04739423|593934915|FG002|Overall Study|Adverse Event|1|||
164427876|NCT04739423|593934916|FG003|Overall Study|Adverse Event|0|||
164427877|NCT04739423|593934917|FG004|Overall Study|Adverse Event|1|||
164427878|NCT04739423|593934918|FG005|Overall Study|Adverse Event|0|||
164427879|NCT04739423|593934913|FG000|Overall Study|Withdrawal by Subject|0|||
164427880|NCT04739423|593934914|FG001|Overall Study|Withdrawal by Subject|0|||
164427881|NCT04739423|593934915|FG002|Overall Study|Withdrawal by Subject|0|||
164576636|NCT00488631|594474821|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
164576637|NCT00488631|594474822|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
164576638|NCT00488631|594474823|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
164576639|NCT00488631|594474814|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
164576640|NCT00488631|594474815|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
164576641|NCT00488631|594474816|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
164576642|NCT00488631|594474817|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
164576643|NCT00488631|594474818|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
164576644|NCT00488631|594474819|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
164576645|NCT00488631|594474820|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
164576646|NCT00488631|594474821|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
164576647|NCT00488631|594474822|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
164576648|NCT00488631|594474823|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
164576649|NCT00488631|594474814|FG000|Double Blind Period (Week 0-54)|Other|6|||
164576650|NCT00488631|594474815|FG001|Double Blind Period (Week 0-54)|Other|12|||
164576651|NCT00488631|594474816|FG002|Double Blind Period (Week 0-54)|Other|10|||
164576652|NCT00488631|594474817|FG003|Double Blind Period (Week 0-54)|Other|11|||
164576653|NCT00488631|594474818|FG004|Double Blind Period (Week 0-54)|Other|14|||
164576654|NCT00488631|594474819|FG005|Double Blind Period (Week 0-54)|Other|34|||
164576655|NCT00488631|594474820|FG006|Double Blind Period (Week 0-54)|Other|0|||
164576656|NCT00488631|594474821|FG007|Double Blind Period (Week 0-54)|Other|0|||
164576657|NCT00488631|594474822|FG008|Double Blind Period (Week 0-54)|Other|0|||
164576658|NCT00488631|594474823|FG009|Double Blind Period (Week 0-54)|Other|0|||
164576659|NCT00488631|594474814|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
164576660|NCT00488631|594474815|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
164576661|NCT00488631|594474816|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
164576662|NCT00488631|594474817|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
164576663|NCT00488631|594474818|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
164576664|NCT00488631|594474819|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
164576665|NCT00488631|594474820|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
164576666|NCT00488631|594474821|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
164576667|NCT00488631|594474822|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
164257193|NCT02684058|593308085|FG002|Treatment Period|Protocol deviation|0|||
164257194|NCT02684058|593308083|FG000|Treatment Period|Subject/guardian decision|4|||
164257195|NCT02684058|593308084|FG001|Treatment Period|Subject/guardian decision|3|||
164257196|NCT02684058|593308085|FG002|Treatment Period|Subject/guardian decision|0|||
164427882|NCT04739423|593934916|FG003|Overall Study|Withdrawal by Subject|0|||
164427883|NCT04739423|593934917|FG004|Overall Study|Withdrawal by Subject|0|||
164427884|NCT04739423|593934918|FG005|Overall Study|Withdrawal by Subject|1|||
164427885|NCT01342887|593934922|FG000|Overall Study|Death|2|||
164427886|NCT00663962|593934923|FG000|Overall Study|somnolence|1|||
164427887|NCT00663962|593934924|FG001|Overall Study|somnolence|0|||
164427888|NCT04978363|593937203|FG000|Overall Study|Other medical issues unrelated to the study|0|||
164427889|NCT04978363|593937204|FG001|Overall Study|Other medical issues unrelated to the study|0|||
164427890|NCT04978363|593937205|FG002|Overall Study|Other medical issues unrelated to the study|0|||
164427891|NCT04978363|593937206|FG003|Overall Study|Other medical issues unrelated to the study|0|||
164427892|NCT04978363|593937207|FG004|Overall Study|Other medical issues unrelated to the study|1|||
164427893|NCT04978363|593937208|FG005|Overall Study|Other medical issues unrelated to the study|0|||
164427894|NCT04978363|593937209|FG006|Overall Study|Other medical issues unrelated to the study|0|||
164427895|NCT04978363|593937210|FG007|Overall Study|Other medical issues unrelated to the study|0|||
164427896|NCT04978363|593937211|FG008|Overall Study|Other medical issues unrelated to the study|0|||
164427897|NCT04978363|593937212|FG009|Overall Study|Other medical issues unrelated to the study|0|||
164427898|NCT04978363|593937213|FG010|Overall Study|Other medical issues unrelated to the study|0|||
164427899|NCT04978363|593937203|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
164427900|NCT04978363|593937204|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
164427901|NCT04978363|593937205|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
164576668|NCT00488631|594474823|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
164576669|NCT00488631|594474814|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
164576670|NCT00488631|594474815|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
164576671|NCT00488631|594474816|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
164576672|NCT00488631|594474817|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
164576673|NCT00488631|594474818|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
164576674|NCT00488631|594474819|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
164576675|NCT00488631|594474820|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
164257197|NCT02684058|593308083|FG000|Treatment Period|Death|0|||
164257198|NCT02684058|593308084|FG001|Treatment Period|Death|0|||
164257199|NCT02684058|593308085|FG002|Treatment Period|Death|2|||
164257200|NCT02684058|593308083|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
164427902|NCT04978363|593937206|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
164427903|NCT04978363|593937207|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
164427904|NCT04978363|593937208|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
164427905|NCT04978363|593937209|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
164427906|NCT04978363|593937210|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
164427907|NCT04978363|593937211|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
164427908|NCT04978363|593937212|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
164427909|NCT04978363|593937213|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
164427910|NCT04978363|593937203|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
164427911|NCT04978363|593937204|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
164427912|NCT04978363|593937205|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
164427913|NCT04978363|593937206|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
164427914|NCT04978363|593937207|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
164427915|NCT04978363|593937208|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
164427916|NCT04978363|593937209|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
164427917|NCT04978363|593937210|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
164427918|NCT04978363|593937211|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
164427919|NCT04978363|593937212|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
164427920|NCT04978363|593937213|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
164427921|NCT01251614|593937214|FG000|Overall Study|Adverse Event|1|||
164427922|NCT01251614|593937215|FG001|Overall Study|Adverse Event|0|||
164427923|NCT01251614|593937216|FG002|Overall Study|Adverse Event|1|||
164427924|NCT01251614|593937214|FG000|Overall Study|Lack of Efficacy|1|||
164427925|NCT01251614|593937215|FG001|Overall Study|Lack of Efficacy|9|||
164427926|NCT01251614|593937216|FG002|Overall Study|Lack of Efficacy|4|||
164427927|NCT01251614|593937214|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
164427928|NCT01251614|593937215|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
164427929|NCT01251614|593937216|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
164427930|NCT01251614|593937214|FG000|Overall Study|Pregnancy|0|||
164427931|NCT01251614|593937215|FG001|Overall Study|Pregnancy|0|||
164427932|NCT01251614|593937216|FG002|Overall Study|Pregnancy|2|||
164427933|NCT01251614|593937214|FG000|Overall Study|Loss of Disease Control|0|||
164427934|NCT01251614|593937215|FG001|Overall Study|Loss of Disease Control|1|||
164427935|NCT01251614|593937216|FG002|Overall Study|Loss of Disease Control|0|||
164427936|NCT01251614|593937214|FG000|Overall Study|Withdrawal by Subject|0|||
164427937|NCT01251614|593937215|FG001|Overall Study|Withdrawal by Subject|2|||
164427938|NCT01251614|593937216|FG002|Overall Study|Withdrawal by Subject|1|||
164427939|NCT01251614|593937214|FG000|Overall Study|Lost to Follow-up|0|||
164576676|NCT00488631|594474821|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
164576677|NCT00488631|594474822|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
164576678|NCT00488631|594474823|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
164576679|NCT00488631|594474814|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
164576680|NCT00488631|594474815|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
164576681|NCT00488631|594474816|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
164576682|NCT00488631|594474817|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
164576683|NCT00488631|594474818|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
164576684|NCT00488631|594474819|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
164576685|NCT00488631|594474820|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
164576686|NCT00488631|594474821|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
164576687|NCT00488631|594474822|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
164576688|NCT00488631|594474823|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
164576689|NCT00488631|594474814|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
164576690|NCT00488631|594474815|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
164576691|NCT00488631|594474816|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
164576692|NCT00488631|594474817|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
164576693|NCT00488631|594474818|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
164576694|NCT00488631|594474819|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
164576695|NCT00488631|594474820|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
164576696|NCT00488631|594474821|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
164576697|NCT00488631|594474822|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
164576698|NCT00488631|594474823|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
164427940|NCT01251614|593937215|FG001|Overall Study|Lost to Follow-up|1|||
164427941|NCT01251614|593937216|FG002|Overall Study|Lost to Follow-up|0|||
164427942|NCT01876043|593937217|FG000|Overall Study|Death|1|||
164427943|NCT01876043|593937217|FG000|Overall Study|Withdrawal by Subject|1|||
164427944|NCT00079937|593937219|FG000|Overall Study|Adverse Event|2|||
164427945|NCT00079937|593937220|FG001|Overall Study|Adverse Event|1|||
164427946|NCT00079937|593937219|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164427947|NCT00079937|593937220|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164427948|NCT00079937|593937219|FG000|Overall Study|Subject no longer requires study drug|3|||
164427949|NCT00079937|593937220|FG001|Overall Study|Subject no longer requires study drug|0|||
164427950|NCT00079937|593937219|FG000|Overall Study|Protocol Violation|8|||
164427951|NCT00079937|593937220|FG001|Overall Study|Protocol Violation|6|||
164427952|NCT00079937|593937219|FG000|Overall Study|Withdrawal by Subject|21|||
164427953|NCT00079937|593937220|FG001|Overall Study|Withdrawal by Subject|7|||
164427954|NCT00079937|593937219|FG000|Overall Study|Lost to Follow-up|12|||
164427955|NCT00079937|593937220|FG001|Overall Study|Lost to Follow-up|5|||
164427956|NCT00079937|593937219|FG000|Overall Study|Administrative problems|22|||
164427957|NCT00079937|593937220|FG001|Overall Study|Administrative problems|11|||
164257201|NCT02684058|593308084|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
164257202|NCT02684058|593308085|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
164257203|NCT02684058|593308083|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
164257204|NCT02684058|593308084|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
164257205|NCT02684058|593308085|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
164257206|NCT02684058|593308083|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
164257207|NCT02684058|593308084|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
164257208|NCT02684058|593308085|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
164257209|NCT02684058|593308083|FG000|Post-treatment Efficacy Follow-up|Death|0|||
164257210|NCT02684058|593308084|FG001|Post-treatment Efficacy Follow-up|Death|0|||
164257211|NCT02684058|593308085|FG002|Post-treatment Efficacy Follow-up|Death|3|||
164257212|NCT02684058|593308083|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
164257213|NCT02684058|593308084|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
164257214|NCT02684058|593308085|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
164257215|NCT02684058|593308083|FG000|Post-treatment Survival Follow-up|Death|0|||
164257216|NCT02684058|593308084|FG001|Post-treatment Survival Follow-up|Death|0|||
164257217|NCT02684058|593308085|FG002|Post-treatment Survival Follow-up|Death|7|||
164257218|NCT02684058|593308083|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
164257219|NCT02684058|593308084|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
164257220|NCT02684058|593308085|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
164257221|NCT02684058|593308083|FG000|Crossover Treatment Period|Progressive disease|0|||
164257222|NCT02684058|593308084|FG001|Crossover Treatment Period|Progressive disease|1|||
164257223|NCT02684058|593308085|FG002|Crossover Treatment Period|Progressive disease|0|||
164257224|NCT01802580|593308086|FG000|Overall Study|Physician Decision|1|||
164257225|NCT01802580|593308087|FG001|Overall Study|Physician Decision|0|||
164257226|NCT01802580|593308086|FG000|Overall Study|Protocol Violation|2|||
164257227|NCT01802580|593308087|FG001|Overall Study|Protocol Violation|0|||
164257228|NCT01802580|593308086|FG000|Overall Study|Withdrawal by Subject|5|||
164257229|NCT01802580|593308087|FG001|Overall Study|Withdrawal by Subject|6|||
164257230|NCT01802580|593308086|FG000|Overall Study|Other|1|||
164257231|NCT01802580|593308087|FG001|Overall Study|Other|3|||
164257232|NCT01802580|593308086|FG000|Overall Study|Lack of Efficacy|0|||
164257233|NCT01802580|593308087|FG001|Overall Study|Lack of Efficacy|2|||
164257234|NCT03255967|593308088|FG000|Overall Study|Adverse Event|26|||
164257235|NCT03255967|593308089|FG001|Overall Study|Adverse Event|30|||
164257236|NCT03255967|593308088|FG000|Overall Study|Withdrawal by Subject|6|||
164257237|NCT03255967|593308089|FG001|Overall Study|Withdrawal by Subject|6|||
164257238|NCT03255967|593308088|FG000|Overall Study|Schedule conflict|6|||
164257239|NCT03255967|593308089|FG001|Overall Study|Schedule conflict|4|||
164257240|NCT03255967|593308088|FG000|Overall Study|POA did not sign consent form|2|||
164257241|NCT03255967|593308089|FG001|Overall Study|POA did not sign consent form|0|||
164257242|NCT01252186|593308090|FG000|Overall Study|Adverse Event|9|||
164257243|NCT01252186|593308091|FG001|Overall Study|Adverse Event|6|||
164257244|NCT01252186|593308092|FG002|Overall Study|Adverse Event|8|||
164257245|NCT01252186|593308090|FG000|Overall Study|Withdrawal by Subject|2|||
164257246|NCT01252186|593308091|FG001|Overall Study|Withdrawal by Subject|5|||
164257247|NCT01252186|593308092|FG002|Overall Study|Withdrawal by Subject|2|||
164257248|NCT01252186|593308090|FG000|Overall Study|Physician Decision|0|||
164257249|NCT01252186|593308091|FG001|Overall Study|Physician Decision|0|||
164257250|NCT01252186|593308092|FG002|Overall Study|Physician Decision|1|||
164257251|NCT01252186|593308090|FG000|Overall Study|Non-compliance|0|||
164257252|NCT01252186|593308091|FG001|Overall Study|Non-compliance|3|||
164257253|NCT01252186|593308092|FG002|Overall Study|Non-compliance|4|||
164257254|NCT01252186|593308090|FG000|Overall Study|Protocol Violation|0|||
164427958|NCT02857283|593937221|FG000|First Exposure|Withdrawal by Subject|1|||
164427959|NCT02857283|593937222|FG001|First Exposure|Withdrawal by Subject|0|||
164257255|NCT01252186|593308091|FG001|Overall Study|Protocol Violation|0|||
164257256|NCT01252186|593308092|FG002|Overall Study|Protocol Violation|1|||
164257257|NCT01252186|593308090|FG000|Overall Study|Pregnancy|2|||
164257258|NCT01252186|593308091|FG001|Overall Study|Pregnancy|2|||
164257259|NCT01252186|593308092|FG002|Overall Study|Pregnancy|0|||
164257260|NCT01252186|593308090|FG000|Overall Study|Sponsor Request|2|||
164257261|NCT01252186|593308091|FG001|Overall Study|Sponsor Request|1|||
164257262|NCT01252186|593308092|FG002|Overall Study|Sponsor Request|0|||
164257263|NCT01252186|593308090|FG000|Overall Study|Lost to Follow-up|10|||
164257264|NCT01252186|593308091|FG001|Overall Study|Lost to Follow-up|10|||
164257265|NCT01252186|593308092|FG002|Overall Study|Lost to Follow-up|11|||
164257266|NCT01252186|593308090|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
164257267|NCT01252186|593308091|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
164257268|NCT01252186|593308092|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
164257269|NCT01327053|593308097|FG000|Overall Study|Adverse Event|23|||
164257270|NCT01327053|593308098|FG001|Overall Study|Adverse Event|57|||
164257271|NCT01327053|593308097|FG000|Overall Study|Patient/guardian decision|11|||
164257272|NCT01327053|593308098|FG001|Overall Study|Patient/guardian decision|35|||
164257273|NCT01327053|593308097|FG000|Overall Study|Physician Decision|10|||
164257274|NCT01327053|593308098|FG001|Overall Study|Physician Decision|14|||
164257275|NCT01327053|593308097|FG000|Overall Study|Death|1|||
164257276|NCT01327053|593308098|FG001|Overall Study|Death|5|||
164257277|NCT01327053|593308097|FG000|Overall Study|Lost to Follow-up|2|||
164257278|NCT01327053|593308098|FG001|Overall Study|Lost to Follow-up|4|||
164257279|NCT01327053|593308097|FG000|Overall Study|Non-compliance with study treatment|0|||
164257280|NCT01327053|593308098|FG001|Overall Study|Non-compliance with study treatment|5|||
164257281|NCT01327053|593308097|FG000|Overall Study|Study terminated by Sponsor|1|||
164257282|NCT01327053|593308098|FG001|Overall Study|Study terminated by Sponsor|3|||
164257283|NCT01327053|593308097|FG000|Overall Study|Progressive disease|31|||
164257284|NCT01327053|593308098|FG001|Overall Study|Progressive disease|26|||
164257285|NCT01327053|593308097|FG000|Overall Study|Protocol Violation|0|||
164257286|NCT01327053|593308098|FG001|Overall Study|Protocol Violation|1|||
164257287|NCT01327053|593308097|FG000|Overall Study|Untreated|0|||
164257288|NCT01327053|593308098|FG001|Overall Study|Untreated|1|||
164257289|NCT00778258|593308099|FG000|Overall Study|Adverse Event|1|||
164257290|NCT00778258|593308100|FG001|Overall Study|Adverse Event|0|||
164257291|NCT00778258|593308101|FG002|Overall Study|Adverse Event|0|||
164257292|NCT00778258|593308102|FG003|Overall Study|Adverse Event|0|||
164257293|NCT00778258|593308103|FG004|Overall Study|Adverse Event|0|||
164257294|NCT00778258|593308104|FG005|Overall Study|Adverse Event|1|||
164257295|NCT00778258|593308105|FG006|Overall Study|Adverse Event|0|||
164257296|NCT00778258|593308106|FG007|Overall Study|Adverse Event|0|||
164257297|NCT00778258|593308107|FG008|Overall Study|Adverse Event|0|||
164257298|NCT00778258|593308099|FG000|Overall Study|Lost to Follow-up|0|||
164257299|NCT00778258|593308100|FG001|Overall Study|Lost to Follow-up|0|||
164257300|NCT00778258|593308101|FG002|Overall Study|Lost to Follow-up|2|||
164257301|NCT00778258|593308102|FG003|Overall Study|Lost to Follow-up|0|||
164257302|NCT00778258|593308103|FG004|Overall Study|Lost to Follow-up|0|||
164257303|NCT00778258|593308104|FG005|Overall Study|Lost to Follow-up|3|||
164257304|NCT00778258|593308105|FG006|Overall Study|Lost to Follow-up|2|||
164257305|NCT00778258|593308106|FG007|Overall Study|Lost to Follow-up|2|||
164257306|NCT00778258|593308107|FG008|Overall Study|Lost to Follow-up|0|||
164257307|NCT00778258|593308099|FG000|Overall Study|Withdrawal by Subject|6|||
164257308|NCT00778258|593308100|FG001|Overall Study|Withdrawal by Subject|2|||
164257309|NCT00778258|593308101|FG002|Overall Study|Withdrawal by Subject|8|||
164257310|NCT00778258|593308102|FG003|Overall Study|Withdrawal by Subject|2|||
164257311|NCT00778258|593308103|FG004|Overall Study|Withdrawal by Subject|0|||
164257312|NCT00778258|593308104|FG005|Overall Study|Withdrawal by Subject|6|||
164257313|NCT00778258|593308105|FG006|Overall Study|Withdrawal by Subject|12|||
164257314|NCT00778258|593308106|FG007|Overall Study|Withdrawal by Subject|12|||
164257315|NCT00778258|593308107|FG008|Overall Study|Withdrawal by Subject|4|||
164257316|NCT00778258|593308099|FG000|Overall Study|New Contraindication|0|||
164257317|NCT00778258|593308100|FG001|Overall Study|New Contraindication|0|||
164257318|NCT00778258|593308101|FG002|Overall Study|New Contraindication|0|||
164257319|NCT00778258|593308102|FG003|Overall Study|New Contraindication|0|||
164257320|NCT00778258|593308103|FG004|Overall Study|New Contraindication|0|||
164257321|NCT00778258|593308104|FG005|Overall Study|New Contraindication|0|||
164257322|NCT00778258|593308105|FG006|Overall Study|New Contraindication|0|||
164257323|NCT00778258|593308106|FG007|Overall Study|New Contraindication|1|||
164339573|NCT04729621|593618948|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
164339574|NCT04729621|593618949|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
164257324|NCT00778258|593308107|FG008|Overall Study|New Contraindication|0|||
164257325|NCT00778258|593308099|FG000|Overall Study|Non-compliance|0|||
164257326|NCT00778258|593308100|FG001|Overall Study|Non-compliance|0|||
164257327|NCT00778258|593308101|FG002|Overall Study|Non-compliance|0|||
164257328|NCT00778258|593308102|FG003|Overall Study|Non-compliance|1|||
164257329|NCT00778258|593308103|FG004|Overall Study|Non-compliance|0|||
164257330|NCT00778258|593308104|FG005|Overall Study|Non-compliance|0|||
164257331|NCT00778258|593308105|FG006|Overall Study|Non-compliance|0|||
164427960|NCT00093795|593937223|FG000|Overall Study|No follow up data|20|||
164427961|NCT00093795|593937224|FG001|Overall Study|No follow up data|16|||
164427962|NCT00093795|593937225|FG002|Overall Study|No follow up data|17|||
164427963|NCT00613301|593937226|FG000|Overall Study|Adverse Event|49|||
164427964|NCT00613301|593937226|FG000|Overall Study|Lost to Follow-up|88|||
164427965|NCT00613301|593937226|FG000|Overall Study|Withdrawal by Subject|5|||
164427966|NCT00613301|593937226|FG000|Overall Study|Death|6|||
164427967|NCT00613301|593937226|FG000|Overall Study|Lack of Efficacy|13|||
164427968|NCT00613301|593937226|FG000|Overall Study|Physician Decision|2|||
164427969|NCT00613301|593937226|FG000|Overall Study|No data was collected|53|||
164427970|NCT00613301|593937226|FG000|Overall Study|Irregularly enrolled patients|12|||
164427971|NCT01684046|593937229|FG000|Period 1, First 30 Days|Adverse Event|0|||
164427972|NCT01684046|593937230|FG001|Period 1, First 30 Days|Adverse Event|2|||
164427973|NCT00587288|593937231|FG000|Overall Study|Adverse Event|0|||
164427974|NCT00587288|593937232|FG001|Overall Study|Adverse Event|1|||
164427975|NCT00587288|593937231|FG000|Overall Study|Lack of Efficacy|2|||
164427976|NCT00587288|593937232|FG001|Overall Study|Lack of Efficacy|8|||
164427977|NCT00587288|593937231|FG000|Overall Study|Protocol Violation|1|||
164427978|NCT00587288|593937232|FG001|Overall Study|Protocol Violation|0|||
164427979|NCT00762463|593937233|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
164427980|NCT00762463|593937234|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
164427981|NCT00762463|593937235|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
164427982|NCT00762463|593937236|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
164427983|NCT00762463|593937233|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
164427984|NCT00762463|593937234|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
164427985|NCT00762463|593937235|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
164427986|NCT00762463|593937236|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
164427987|NCT00762463|593937233|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
164427988|NCT00762463|593937234|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
164427989|NCT00762463|593937235|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
164427990|NCT00762463|593937236|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
164427991|NCT00762463|593937233|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
164427992|NCT00762463|593937234|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
164427993|NCT00762463|593937235|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
164427994|NCT00762463|593937236|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
164427995|NCT00762463|593937233|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
164427996|NCT00762463|593937234|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
164427997|NCT00762463|593937235|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
164427998|NCT00762463|593937236|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
164427999|NCT00762463|593937233|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
164428000|NCT00762463|593937234|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
164428001|NCT00762463|593937235|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
164428002|NCT00762463|593937236|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
164428003|NCT00762463|593937233|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
164428004|NCT00762463|593937234|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
164428005|NCT00762463|593937235|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
164428006|NCT00762463|593937236|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
164428007|NCT00762463|593937233|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
164428008|NCT00762463|593937234|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
164428009|NCT00762463|593937235|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
164428010|NCT00762463|593937236|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
164428011|NCT00797862|593937237|FG000|Overall Study|Adverse Event|86|||
164428012|NCT00797862|593937238|FG001|Overall Study|Adverse Event|44|||
164428013|NCT00797862|593937239|FG002|Overall Study|Adverse Event|58|||
164428014|NCT00797862|593937237|FG000|Overall Study|Abnormal Test Procedure Result|0|||
164428015|NCT00797862|593937238|FG001|Overall Study|Abnormal Test Procedure Result|1|||
164428016|NCT00797862|593937239|FG002|Overall Study|Abnormal Test Procedure Result|1|||
164428017|NCT00797862|593937237|FG000|Overall Study|Lack of Efficacy|1|||
164428018|NCT00797862|593937238|FG001|Overall Study|Lack of Efficacy|7|||
164428019|NCT00797862|593937239|FG002|Overall Study|Lack of Efficacy|6|||
164428020|NCT00797862|593937237|FG000|Overall Study|No longer required study medication|1|||
164428021|NCT00797862|593937238|FG001|Overall Study|No longer required study medication|0|||
164428022|NCT00797862|593937239|FG002|Overall Study|No longer required study medication|0|||
164428023|NCT00797862|593937237|FG000|Overall Study|Withdrawal by Subject|14|||
164428024|NCT00797862|593937238|FG001|Overall Study|Withdrawal by Subject|7|||
164428025|NCT00797862|593937239|FG002|Overall Study|Withdrawal by Subject|7|||
164428026|NCT00797862|593937237|FG000|Overall Study|Lost to Follow-up|11|||
164428027|NCT00797862|593937238|FG001|Overall Study|Lost to Follow-up|0|||
164428028|NCT00797862|593937239|FG002|Overall Study|Lost to Follow-up|5|||
164428029|NCT00797862|593937237|FG000|Overall Study|Administrative Problem|4|||
164428030|NCT00797862|593937238|FG001|Overall Study|Administrative Problem|0|||
164428031|NCT00797862|593937239|FG002|Overall Study|Administrative Problem|0|||
164428032|NCT00797862|593937237|FG000|Overall Study|Protocol Violation|4|||
164428033|NCT00797862|593937238|FG001|Overall Study|Protocol Violation|6|||
164428034|NCT00797862|593937239|FG002|Overall Study|Protocol Violation|8|||
164428035|NCT00797862|593937237|FG000|Overall Study|Mis-randomized|3|||
164428036|NCT00797862|593937238|FG001|Overall Study|Mis-randomized|3|||
164428037|NCT00797862|593937239|FG002|Overall Study|Mis-randomized|1|||
164428038|NCT00531479|593937240|FG000|Overall Study|Death|68|||
164428039|NCT00531479|593937241|FG001|Overall Study|Death|71|||
164428040|NCT00531479|593937240|FG000|Overall Study|Lost to Follow-up|0|||
164428041|NCT00531479|593937241|FG001|Overall Study|Lost to Follow-up|2|||
164428042|NCT00531479|593937240|FG000|Overall Study|Other|0|||
164428043|NCT00531479|593937241|FG001|Overall Study|Other|1|||
164428044|NCT00531479|593937240|FG000|Overall Study|Withdrawal by Subject|6|||
164428045|NCT00531479|593937241|FG001|Overall Study|Withdrawal by Subject|6|||
164428046|NCT00531479|593937240|FG000|Overall Study|Did not receive treatment|2|||
164428047|NCT00531479|593937241|FG001|Overall Study|Did not receive treatment|3|||
164428048|NCT05074498|593937246|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
164428049|NCT05074498|593937247|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
164428050|NCT05074498|593937248|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
164428051|NCT05074498|593937249|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
164428052|NCT05074498|593937250|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
164428053|NCT05074498|593937251|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
164428054|NCT05074498|593937246|FG000|Part 1 (Upto Day 104)|Other|1|||
164428055|NCT05074498|593937247|FG001|Part 1 (Upto Day 104)|Other|0|||
164428056|NCT05074498|593937248|FG002|Part 1 (Upto Day 104)|Other|0|||
164428057|NCT05074498|593937249|FG003|Part 1 (Upto Day 104)|Other|0|||
164428058|NCT05074498|593937250|FG004|Part 1 (Upto Day 104)|Other|0|||
164428059|NCT05074498|593937251|FG005|Part 1 (Upto Day 104)|Other|0|||
164428060|NCT05074498|593937246|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
164428061|NCT05074498|593937247|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
164428062|NCT05074498|593937248|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
164428063|NCT05074498|593937249|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
164428064|NCT05074498|593937250|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
164428065|NCT05074498|593937251|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
164428066|NCT05074498|593937246|FG000|Part 2 (Upto Day 104)|Death|0|||
164428067|NCT05074498|593937247|FG001|Part 2 (Upto Day 104)|Death|0|||
164257332|NCT00778258|593308106|FG007|Overall Study|Non-compliance|0|||
164257333|NCT00778258|593308107|FG008|Overall Study|Non-compliance|0|||
164257334|NCT00778258|593308099|FG000|Overall Study|Other|0|||
164257335|NCT00778258|593308100|FG001|Overall Study|Other|0|||
164257336|NCT00778258|593308101|FG002|Overall Study|Other|0|||
164257337|NCT00778258|593308102|FG003|Overall Study|Other|0|||
164257338|NCT00778258|593308103|FG004|Overall Study|Other|0|||
164257339|NCT00778258|593308104|FG005|Overall Study|Other|0|||
164257340|NCT00778258|593308105|FG006|Overall Study|Other|1|||
164257341|NCT00778258|593308106|FG007|Overall Study|Other|0|||
164257342|NCT00778258|593308107|FG008|Overall Study|Other|0|||
164257343|NCT00661726|593308108|FG000|Overall Study|Adverse Event|1|||
164257344|NCT02147197|593308109|FG000|Overall Study|Adverse Event|1|||
164257345|NCT02147197|593308110|FG001|Overall Study|Adverse Event|0|||
164576699|NCT00488631|594474814|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
164576700|NCT00488631|594474815|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
164576701|NCT00488631|594474816|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
164576702|NCT00488631|594474817|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
164576703|NCT00488631|594474818|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
164576704|NCT00488631|594474819|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
164576705|NCT00488631|594474820|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
164576706|NCT00488631|594474821|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
164576707|NCT00488631|594474822|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
164576708|NCT00488631|594474823|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
164576709|NCT04091217|594474824|FG000|Overall Study|Lost to Follow-up|2|||
164576710|NCT05300087|594474825|FG000|Overall Study|Withdrawal by Subject|0|||
164576711|NCT05300087|594474826|FG001|Overall Study|Withdrawal by Subject|1|||
164257346|NCT02147197|593308111|FG002|Overall Study|Adverse Event|0|||
164257347|NCT02147197|593308109|FG000|Overall Study|Withdrawal of Consent|4|||
164428068|NCT05074498|593937248|FG002|Part 2 (Upto Day 104)|Death|0|||
164428069|NCT05074498|593937249|FG003|Part 2 (Upto Day 104)|Death|0|||
164576712|NCT02495948|594474827|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
164257348|NCT02147197|593308110|FG001|Overall Study|Withdrawal of Consent|3|||
164257349|NCT02147197|593308111|FG002|Overall Study|Withdrawal of Consent|2|||
164257350|NCT02147197|593308109|FG000|Overall Study|Lost to Follow-up|2|||
164428070|NCT05074498|593937250|FG004|Part 2 (Upto Day 104)|Death|1|||
164428071|NCT05074498|593937251|FG005|Part 2 (Upto Day 104)|Death|0|||
164428072|NCT05074498|593937246|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
164428073|NCT05074498|593937247|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
164428074|NCT05074498|593937248|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
164428075|NCT05074498|593937249|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
164428076|NCT05074498|593937250|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
164428077|NCT05074498|593937251|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
164680565|NCT00112437|594854573|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164680566|NCT00112437|594854574|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164680567|NCT00112437|594854575|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164680568|NCT00112437|594854576|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164680569|NCT00112437|594854577|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164680570|NCT00112437|594854578|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164680571|NCT00112437|594854579|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
164680572|NCT00112437|594854580|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164680573|NCT00112437|594854581|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164680574|NCT00112437|594854582|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164680575|NCT00112437|594854583|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164680576|NCT00112437|594854584|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164680577|NCT00112437|594854585|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164680578|NCT00112437|594854586|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164680579|NCT00112437|594854587|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164680580|NCT00112437|594854588|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164680581|NCT00112437|594854589|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164680582|NCT00112437|594854590|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164680583|NCT00112437|594854591|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164680584|NCT00112437|594854592|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164680585|NCT00112437|594854593|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164680586|NCT00112437|594854594|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164680587|NCT00112437|594854595|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164680588|NCT00112437|594854596|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164680589|NCT00112437|594854571|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680590|NCT00112437|594854572|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680591|NCT00112437|594854573|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680592|NCT00112437|594854574|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680593|NCT00112437|594854575|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680594|NCT00112437|594854576|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680595|NCT00112437|594854577|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680596|NCT00112437|594854578|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680597|NCT00112437|594854579|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
164680598|NCT00112437|594854580|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680599|NCT00112437|594854581|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680600|NCT00112437|594854582|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680601|NCT00112437|594854583|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680602|NCT00112437|594854584|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680603|NCT00112437|594854585|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680604|NCT00112437|594854586|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680605|NCT00112437|594854587|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680606|NCT00112437|594854588|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680607|NCT00112437|594854589|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680608|NCT00112437|594854590|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680609|NCT00112437|594854591|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680610|NCT00112437|594854592|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680611|NCT00112437|594854593|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680612|NCT00112437|594854594|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680613|NCT00112437|594854595|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680614|NCT00112437|594854596|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
164680615|NCT00112437|594854571|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164680616|NCT00112437|594854572|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164680617|NCT00112437|594854573|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164680618|NCT00112437|594854574|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164680619|NCT00112437|594854575|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164680620|NCT00112437|594854576|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
164680621|NCT00112437|594854577|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
164428078|NCT05074498|593937246|FG000|Part 2 (Upto Day 104)|Other|0|||
164428079|NCT05074498|593937247|FG001|Part 2 (Upto Day 104)|Other|0|||
164428080|NCT05074498|593937248|FG002|Part 2 (Upto Day 104)|Other|0|||
164428081|NCT05074498|593937249|FG003|Part 2 (Upto Day 104)|Other|0|||
164428082|NCT05074498|593937250|FG004|Part 2 (Upto Day 104)|Other|1|||
164428083|NCT05074498|593937251|FG005|Part 2 (Upto Day 104)|Other|0|||
164428084|NCT01306331|593937253|FG000|Overall Study|Adverse Event|28|||
164428085|NCT01306331|593937254|FG001|Overall Study|Adverse Event|25|||
164428086|NCT01306331|593937253|FG000|Overall Study|Lost to Follow-up|321|||
164428087|NCT01306331|593937254|FG001|Overall Study|Lost to Follow-up|323|||
164428088|NCT01306331|593937253|FG000|Overall Study|Physician Decision|26|||
164428089|NCT01306331|593937254|FG001|Overall Study|Physician Decision|22|||
164428090|NCT01306331|593937253|FG000|Overall Study|Pregnancy|136|||
164428091|NCT01306331|593937254|FG001|Overall Study|Pregnancy|151|||
164428092|NCT01306331|593937253|FG000|Overall Study|Protocol Violation|154|||
164428093|NCT01306331|593937254|FG001|Overall Study|Protocol Violation|124|||
164428094|NCT01306331|593937253|FG000|Overall Study|Withdrawal by Subject|163|||
164428095|NCT01306331|593937254|FG001|Overall Study|Withdrawal by Subject|152|||
164428096|NCT01306331|593937253|FG000|Overall Study|Not sexually active|29|||
164428097|NCT01306331|593937254|FG001|Overall Study|Not sexually active|28|||
164428098|NCT01306331|593937253|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
164428099|NCT01306331|593937254|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
164428100|NCT01306331|593937253|FG000|Overall Study|Other|34|||
164428101|NCT01306331|593937254|FG001|Overall Study|Other|32|||
164428102|NCT00172185|593937261|FG000|Overall Study|Adverse Event|0|||
164428103|NCT00172185|593937262|FG001|Overall Study|Adverse Event|1|||
164428104|NCT00172185|593937263|FG002|Overall Study|Adverse Event|3|||
164428105|NCT00172185|593937264|FG003|Overall Study|Adverse Event|4|||
164428106|NCT00172185|593937261|FG000|Overall Study|Physician Decision|0|||
164428107|NCT00172185|593937262|FG001|Overall Study|Physician Decision|0|||
164428108|NCT00172185|593937263|FG002|Overall Study|Physician Decision|1|||
164428109|NCT00172185|593937264|FG003|Overall Study|Physician Decision|0|||
164428110|NCT00172185|593937261|FG000|Overall Study|SPONSOR Decision|0|||
164428111|NCT00172185|593937262|FG001|Overall Study|SPONSOR Decision|1|||
164428112|NCT00172185|593937263|FG002|Overall Study|SPONSOR Decision|0|||
164428113|NCT00172185|593937264|FG003|Overall Study|SPONSOR Decision|0|||
164428114|NCT00172185|593937261|FG000|Overall Study|Withdrawal by Subject|0|||
164428115|NCT00172185|593937262|FG001|Overall Study|Withdrawal by Subject|0|||
164428116|NCT00172185|593937263|FG002|Overall Study|Withdrawal by Subject|1|||
164428117|NCT00172185|593937264|FG003|Overall Study|Withdrawal by Subject|0|||
164428118|NCT01677936|593937265|FG000|Overall Study|Lost to Follow-up|4|||
164428119|NCT01677936|593937266|FG001|Overall Study|Lost to Follow-up|1|||
164428120|NCT01677936|593937265|FG000|Overall Study|Protocol Violation|3|||
164428121|NCT01677936|593937266|FG001|Overall Study|Protocol Violation|0|||
164428122|NCT01677936|593937265|FG000|Overall Study|Adverse Event|1|||
164428123|NCT01677936|593937266|FG001|Overall Study|Adverse Event|0|||
164428124|NCT01677936|593937265|FG000|Overall Study|Lost to Follow-up|1|||
164428125|NCT01677936|593937266|FG001|Overall Study|Lost to Follow-up|0|||
164428126|NCT01677936|593937265|FG000|Overall Study|Protocol Violation|0|||
164428127|NCT01677936|593937266|FG001|Overall Study|Protocol Violation|4|||
164428128|NCT02790606|593937269|FG000|Overall Study|Death|27|||
164428129|NCT02790606|593937269|FG000|Overall Study|Lost to Follow-up|4|||
164428130|NCT02790606|593937269|FG000|Overall Study|Physician Decision|3|||
164428131|NCT02790606|593937269|FG000|Overall Study|Withdrawal by Subject|1|||
164428132|NCT02735915|593937270|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
164428133|NCT02735915|593937270|FG000|Overall Study|Withdrawal following SAE|2|||
164428134|NCT02735915|593937270|FG000|Overall Study|Withdrawal by Subject|1|||
164428135|NCT05328973|593937271|FG000|Overall Study|Withdrawal by Subject|0|||
164428136|NCT05328973|593937272|FG001|Overall Study|Withdrawal by Subject|1|||
164428137|NCT00409708|593937278|FG000|Treatment|Abnormal test procedure result(s)|1|||
164428138|NCT00409708|593937279|FG001|Treatment|Abnormal test procedure result(s)|0|||
164576713|NCT02495948|594474828|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
164576714|NCT02495948|594474827|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
164257351|NCT02147197|593308110|FG001|Overall Study|Lost to Follow-up|3|||
164257352|NCT02147197|593308111|FG002|Overall Study|Lost to Follow-up|1|||
164257353|NCT02147197|593308109|FG000|Overall Study|Protocol Violation|1|||
164257354|NCT02147197|593308110|FG001|Overall Study|Protocol Violation|0|||
164428139|NCT00409708|593937278|FG000|Treatment|Lack of Efficacy|0|||
164428140|NCT00409708|593937279|FG001|Treatment|Lack of Efficacy|1|||
164428141|NCT00409708|593937278|FG000|Treatment|Protocol Violation|6|||
164428142|NCT00409708|593937279|FG001|Treatment|Protocol Violation|2|||
164428143|NCT00409708|593937278|FG000|Treatment|Withdrawal by Subject|3|||
164428144|NCT00409708|593937279|FG001|Treatment|Withdrawal by Subject|8|||
164428145|NCT00409708|593937278|FG000|Treatment|Lost to Follow-up|0|||
164428146|NCT00409708|593937279|FG001|Treatment|Lost to Follow-up|6|||
164428147|NCT00409708|593937278|FG000|Treatment|Administrative problems|5|||
164428148|NCT00409708|593937279|FG001|Treatment|Administrative problems|0|||
164428149|NCT00409708|593937278|FG000|Washout|Lack of Efficacy|9|||
164576715|NCT02495948|594474828|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
164428150|NCT00409708|593937279|FG001|Washout|Lack of Efficacy|1|||
164257355|NCT02147197|593308111|FG002|Overall Study|Protocol Violation|3|||
164257356|NCT02147197|593308109|FG000|Overall Study|Other Miscellaneous Reasons|1|||
164257357|NCT02147197|593308110|FG001|Overall Study|Other Miscellaneous Reasons|0|||
164257358|NCT02147197|593308111|FG002|Overall Study|Other Miscellaneous Reasons|3|||
164257359|NCT02644096|593308112|FG000|Overall Study|Withdrawal by Subject|28|||
164257360|NCT02644096|593308113|FG001|Overall Study|Withdrawal by Subject|25|||
164257361|NCT00322452|593308114|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164257362|NCT00322452|593308115|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
164257363|NCT00322452|593308114|FG000|Overall Study|Lost to Follow-up|5|||
164257364|NCT00322452|593308115|FG001|Overall Study|Lost to Follow-up|2|||
164257365|NCT00322452|593308114|FG000|Overall Study|Withdrawal by Subject|19|||
164257366|NCT00322452|593308115|FG001|Overall Study|Withdrawal by Subject|46|||
164257367|NCT00322452|593308114|FG000|Overall Study|Death|223|||
164257368|NCT00322452|593308115|FG001|Overall Study|Death|227|||
164257369|NCT02438384|593308116|FG000|Overall Study|Lost to Follow-up|8|||
164257370|NCT02438384|593308117|FG001|Overall Study|Lost to Follow-up|6|||
164257371|NCT02438384|593308118|FG002|Overall Study|Lost to Follow-up|4|||
164257372|NCT02650128|593308119|FG000|Overall Study|Death|2|||
164257373|NCT00303446|593309858|FG000|Overall Study|Withdrawal by Subject|2|||
164257374|NCT00303446|593309859|FG001|Overall Study|Withdrawal by Subject|2|||
164257375|NCT00303446|593309858|FG000|Overall Study|Death|0|||
164257376|NCT00303446|593309859|FG001|Overall Study|Death|1|||
164257377|NCT00303446|593309858|FG000|Overall Study|Physician Decision|0|||
164257378|NCT00303446|593309859|FG001|Overall Study|Physician Decision|1|||
164257379|NCT03116828|593309861|FG000|Overall Study|Adverse Event|1|||
164257380|NCT03116828|593309862|FG001|Overall Study|Adverse Event|10|||
164339575|NCT04729621|593618950|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
164339576|NCT04729621|593618951|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
164339577|NCT04729621|593618947|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
164339578|NCT04729621|593618948|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
164339579|NCT04729621|593618949|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
164339580|NCT04729621|593618950|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
164339581|NCT04729621|593618951|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
164339582|NCT04729621|593618947|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
164339583|NCT04729621|593618948|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
164339584|NCT04729621|593618949|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
164339585|NCT04729621|593618950|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
164339586|NCT04729621|593618951|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
164339587|NCT04729621|593618947|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
164339588|NCT04729621|593618948|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
164339589|NCT04729621|593618949|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
164339590|NCT04729621|593618950|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
164339591|NCT04729621|593618951|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
164339592|NCT00347360|593618953|FG000|Overall Study|Adverse Event|1|||
164339593|NCT00347360|593618954|FG001|Overall Study|Adverse Event|2|||
164339594|NCT00347360|593618955|FG002|Overall Study|Adverse Event|0|||
164339595|NCT00347360|593618956|FG003|Overall Study|Adverse Event|4|||
164339596|NCT00347360|593618957|FG004|Overall Study|Adverse Event|1|||
164339597|NCT00347360|593618958|FG005|Overall Study|Adverse Event|2|||
164339598|NCT00347360|593618959|FG006|Overall Study|Adverse Event|2|||
164339599|NCT00347360|593618960|FG007|Overall Study|Adverse Event|0|||
164339600|NCT00347360|593618961|FG008|Overall Study|Adverse Event|2|||
164339601|NCT00347360|593618962|FG009|Overall Study|Adverse Event|3|||
164339602|NCT00347360|593618963|FG010|Overall Study|Adverse Event|3|||
164339603|NCT00347360|593618964|FG011|Overall Study|Adverse Event|1|||
164339604|NCT00347360|593618965|FG012|Overall Study|Adverse Event|3|||
164339605|NCT00347360|593618966|FG013|Overall Study|Adverse Event|2|||
164339606|NCT00347360|593618967|FG014|Overall Study|Adverse Event|2|||
164428151|NCT00409708|593937278|FG000|Washout|Protocol Violation|0|||
164428152|NCT00409708|593937279|FG001|Washout|Protocol Violation|1|||
164428153|NCT00409708|593937278|FG000|Washout|Withdrawal by Subject|11|||
164428154|NCT00409708|593937279|FG001|Washout|Withdrawal by Subject|5|||
164428155|NCT00409708|593937278|FG000|Washout|Lost to Follow-up|1|||
164339607|NCT00347360|593618953|FG000|Overall Study|Lost to Follow-up|0|||
164339608|NCT00347360|593618954|FG001|Overall Study|Lost to Follow-up|0|||
164339609|NCT00347360|593618955|FG002|Overall Study|Lost to Follow-up|0|||
164339610|NCT00347360|593618956|FG003|Overall Study|Lost to Follow-up|2|||
164339611|NCT00347360|593618957|FG004|Overall Study|Lost to Follow-up|1|||
164339612|NCT00347360|593618958|FG005|Overall Study|Lost to Follow-up|1|||
164339613|NCT00347360|593618959|FG006|Overall Study|Lost to Follow-up|0|||
164428156|NCT00409708|593937279|FG001|Washout|Lost to Follow-up|3|||
164428157|NCT01211665|593937280|FG000|Overall Study|Withdrawal by Subject|1|||
164257381|NCT03116828|593309861|FG000|Overall Study|Withdrawal by Subject|4|||
164257382|NCT03116828|593309862|FG001|Overall Study|Withdrawal by Subject|8|||
164257383|NCT03116828|593309861|FG000|Overall Study|OTHER|3|||
164257384|NCT03116828|593309862|FG001|Overall Study|OTHER|3|||
164428158|NCT01211665|593937281|FG001|Overall Study|Withdrawal by Subject|0|||
164428159|NCT01211665|593937280|FG000|Overall Study|Death|1|||
164428160|NCT01211665|593937281|FG001|Overall Study|Death|0|||
164428161|NCT00498186|593937284|FG000|Overall Study|Protocol Violation|10|||
164428162|NCT00498186|593937284|FG000|Overall Study|Lack of Efficacy|31|||
164428163|NCT00498186|593937284|FG000|Overall Study|Adverse Event|89|||
164428164|NCT00498186|593937284|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
164428165|NCT00498186|593937284|FG000|Overall Study|Withdrawal by Subject|18|||
164428166|NCT00498186|593937284|FG000|Overall Study|Lost to Follow-up|3|||
164428167|NCT00498186|593937284|FG000|Overall Study|Other|10|||
164428168|NCT03302156|593937287|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
164428169|NCT03302156|593937288|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
164428170|NCT03302156|593937289|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
164428171|NCT02390557|593937290|FG000|Wave 2|Survey non-respondent|72|||
164428172|NCT02390557|593937291|FG001|Wave 2|Survey non-respondent|41|||
164428173|NCT02390557|593937292|FG002|Wave 2|Survey non-respondent|23|||
164428174|NCT00945477|593937298|FG000|Overall Study|Adverse Event|3|||
164428175|NCT00945477|593937298|FG000|Overall Study|Lack of Efficacy|2|||
164680622|NCT00112437|594854578|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
164680623|NCT00112437|594854579|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
164428176|NCT00945477|593937298|FG000|Overall Study|Withdrawal by Subject|1|||
164428177|NCT00797225|593937302|FG000|Weeks 1 to 12|Adverse Event|0|||
164428178|NCT00797225|593937303|FG001|Weeks 1 to 12|Adverse Event|0|||
164428179|NCT00797225|593937304|FG002|Weeks 1 to 12|Adverse Event|1|||
164428180|NCT00797225|593937305|FG003|Weeks 1 to 12|Adverse Event|0|||
164428181|NCT00797225|593937306|FG004|Weeks 1 to 12|Adverse Event|0|||
164428182|NCT00797225|593937307|FG005|Weeks 1 to 12|Adverse Event|0|||
164428183|NCT00797225|593937308|FG006|Weeks 1 to 12|Adverse Event|0|||
164428184|NCT00797225|593937309|FG007|Weeks 1 to 12|Adverse Event|0|||
164428185|NCT00797225|593937302|FG000|Weeks 1 to 12|Non-compliance|0|||
164428186|NCT00797225|593937303|FG001|Weeks 1 to 12|Non-compliance|1|||
164428187|NCT00797225|593937304|FG002|Weeks 1 to 12|Non-compliance|0|||
164428188|NCT00797225|593937305|FG003|Weeks 1 to 12|Non-compliance|0|||
164428189|NCT00797225|593937306|FG004|Weeks 1 to 12|Non-compliance|0|||
164428190|NCT00797225|593937307|FG005|Weeks 1 to 12|Non-compliance|0|||
164428191|NCT00797225|593937308|FG006|Weeks 1 to 12|Non-compliance|0|||
164428192|NCT00797225|593937309|FG007|Weeks 1 to 12|Non-compliance|0|||
164428193|NCT00797225|593937302|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
164428194|NCT00797225|593937303|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
164428195|NCT00797225|593937304|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
164428196|NCT00797225|593937305|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
164428197|NCT00797225|593937306|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
164428198|NCT00797225|593937307|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
164428199|NCT00797225|593937308|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
164428200|NCT00797225|593937309|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
164428201|NCT00797225|593937302|FG000|Weeks 1 to 12|Sponsor Decision|1|||
164428202|NCT00797225|593937303|FG001|Weeks 1 to 12|Sponsor Decision|0|||
164428203|NCT00797225|593937304|FG002|Weeks 1 to 12|Sponsor Decision|0|||
164428204|NCT00797225|593937305|FG003|Weeks 1 to 12|Sponsor Decision|0|||
164428205|NCT00797225|593937306|FG004|Weeks 1 to 12|Sponsor Decision|0|||
164428206|NCT00797225|593937307|FG005|Weeks 1 to 12|Sponsor Decision|0|||
164428207|NCT00797225|593937308|FG006|Weeks 1 to 12|Sponsor Decision|0|||
164428208|NCT00797225|593937309|FG007|Weeks 1 to 12|Sponsor Decision|0|||
164339614|NCT00347360|593618960|FG007|Overall Study|Lost to Follow-up|1|||
164339615|NCT00347360|593618961|FG008|Overall Study|Lost to Follow-up|1|||
164339616|NCT00347360|593618962|FG009|Overall Study|Lost to Follow-up|2|||
164339617|NCT00347360|593618963|FG010|Overall Study|Lost to Follow-up|0|||
164339618|NCT00347360|593618964|FG011|Overall Study|Lost to Follow-up|0|||
164339619|NCT00347360|593618965|FG012|Overall Study|Lost to Follow-up|1|||
164339620|NCT00347360|593618966|FG013|Overall Study|Lost to Follow-up|0|||
164339621|NCT00347360|593618967|FG014|Overall Study|Lost to Follow-up|0|||
164339622|NCT00347360|593618953|FG000|Overall Study|Protocol Violation|2|||
164428209|NCT00797225|593937302|FG000|Weeks 13 to 24|Non-compliance|0|||
164428210|NCT00797225|593937303|FG001|Weeks 13 to 24|Non-compliance|2|||
164428211|NCT00797225|593937304|FG002|Weeks 13 to 24|Non-compliance|0|||
164428212|NCT00797225|593937305|FG003|Weeks 13 to 24|Non-compliance|0|||
164428213|NCT00797225|593937306|FG004|Weeks 13 to 24|Non-compliance|0|||
164428214|NCT00797225|593937307|FG005|Weeks 13 to 24|Non-compliance|0|||
164428215|NCT00797225|593937308|FG006|Weeks 13 to 24|Non-compliance|0|||
164680624|NCT00112437|594854580|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
164680625|NCT00112437|594854581|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164680626|NCT00112437|594854582|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164339623|NCT00347360|593618954|FG001|Overall Study|Protocol Violation|3|||
164428216|NCT00797225|593937309|FG007|Weeks 13 to 24|Non-compliance|0|||
164428217|NCT00797225|593937302|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
164428218|NCT00797225|593937303|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
164428219|NCT00797225|593937304|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
164428220|NCT00797225|593937305|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
164428221|NCT00797225|593937306|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
164428222|NCT00797225|593937307|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
164428223|NCT00797225|593937308|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
164428224|NCT00797225|593937309|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
164428225|NCT00797225|593937302|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
164428226|NCT00797225|593937303|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
164428227|NCT00797225|593937304|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
164428228|NCT00797225|593937305|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
164428229|NCT00797225|593937306|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
164428230|NCT00797225|593937307|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
164428231|NCT00797225|593937308|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
164428232|NCT00797225|593937309|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
164257385|NCT05243745|593309865|FG000|Overall Study|Withdrawal by Subject|0|||
164257386|NCT05243745|593309866|FG001|Overall Study|Withdrawal by Subject|0|||
164257387|NCT05243745|593309867|FG002|Overall Study|Withdrawal by Subject|0|||
164257388|NCT05243745|593309868|FG003|Overall Study|Withdrawal by Subject|1|||
164257389|NCT05243745|593309865|FG000|Overall Study|Unable to Attend Visit 6|0|||
164257390|NCT05243745|593309866|FG001|Overall Study|Unable to Attend Visit 6|0|||
164257391|NCT05243745|593309867|FG002|Overall Study|Unable to Attend Visit 6|1|||
164257392|NCT05243745|593309868|FG003|Overall Study|Unable to Attend Visit 6|0|||
164257393|NCT04187144|593309881|FG000|Overall Study|Lost to Follow-up|12|||
164257394|NCT04187144|593309882|FG001|Overall Study|Lost to Follow-up|11|||
164257395|NCT04187144|593309881|FG000|Overall Study|Withdrawal by Subject|20|||
164257396|NCT04187144|593309882|FG001|Overall Study|Withdrawal by Subject|18|||
164257397|NCT04187144|593309881|FG000|Overall Study|Adverse Event|19|||
164257398|NCT04187144|593309882|FG001|Overall Study|Adverse Event|4|||
164257399|NCT04187144|593309881|FG000|Overall Study|Physician Decision|5|||
164257400|NCT04187144|593309882|FG001|Overall Study|Physician Decision|3|||
164257401|NCT04187144|593309881|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
164257402|NCT04187144|593309882|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
164257403|NCT04187144|593309881|FG000|Overall Study|Protocol Deviation|1|||
164257404|NCT04187144|593309882|FG001|Overall Study|Protocol Deviation|4|||
164257405|NCT03842969|593309883|FG000|Overall Study|Participant declined follow-up visit|0|||
164257406|NCT03842969|593309884|FG001|Overall Study|Participant declined follow-up visit|1|||
164257407|NCT03842969|593309885|FG002|Overall Study|Participant declined follow-up visit|0|||
164257408|NCT03842969|593309883|FG000|Overall Study|Sponsor's decision|12|||
164257409|NCT03842969|593309884|FG001|Overall Study|Sponsor's decision|99|||
164257410|NCT03842969|593309885|FG002|Overall Study|Sponsor's decision|61|||
164257411|NCT03842969|593309883|FG000|Overall Study|Pregnancy|0|||
164257412|NCT03842969|593309884|FG001|Overall Study|Pregnancy|0|||
164257413|NCT03842969|593309885|FG002|Overall Study|Pregnancy|1|||
164428233|NCT00797225|593937302|FG000|Weeks 13 to 24|Adverse Event|0|||
164428234|NCT00797225|593937303|FG001|Weeks 13 to 24|Adverse Event|1|||
164428235|NCT00797225|593937304|FG002|Weeks 13 to 24|Adverse Event|0|||
164428236|NCT00797225|593937305|FG003|Weeks 13 to 24|Adverse Event|0|||
164428237|NCT00797225|593937306|FG004|Weeks 13 to 24|Adverse Event|0|||
164428238|NCT00797225|593937307|FG005|Weeks 13 to 24|Adverse Event|0|||
164428239|NCT00797225|593937308|FG006|Weeks 13 to 24|Adverse Event|1|||
164428240|NCT00797225|593937309|FG007|Weeks 13 to 24|Adverse Event|0|||
164428241|NCT00797225|593937302|FG000|Weeks 13 to 24|Sponsor Decision|0|||
164428242|NCT00797225|593937303|FG001|Weeks 13 to 24|Sponsor Decision|0|||
164428243|NCT00797225|593937304|FG002|Weeks 13 to 24|Sponsor Decision|0|||
164428244|NCT00797225|593937305|FG003|Weeks 13 to 24|Sponsor Decision|0|||
164428245|NCT00797225|593937306|FG004|Weeks 13 to 24|Sponsor Decision|0|||
164428246|NCT00797225|593937307|FG005|Weeks 13 to 24|Sponsor Decision|0|||
164428247|NCT00797225|593937308|FG006|Weeks 13 to 24|Sponsor Decision|1|||
164428248|NCT00797225|593937309|FG007|Weeks 13 to 24|Sponsor Decision|0|||
164428249|NCT04159896|593937310|FG000|Overall Study|Lack of Efficacy|7|||
164428250|NCT04159896|593937310|FG000|Overall Study|Withdrawal by Subject|1|||
164428251|NCT04159896|593937310|FG000|Overall Study|Adverse Event|1|||
164257414|NCT03842969|593309883|FG000|Overall Study|Death|1|||
164428252|NCT04159896|593937310|FG000|Overall Study|A transient ischaemic attack|1|||
164428253|NCT01222247|593937311|FG000|Overall Study|Lost to Follow-up|2|||
164428254|NCT01222247|593937312|FG001|Overall Study|Lost to Follow-up|2|||
164428255|NCT04529538|593937313|FG000|Overall Study|Lost to Follow-up|3|||
164428256|NCT04529538|593937314|FG001|Overall Study|Lost to Follow-up|2|||
164428257|NCT04529538|593937315|FG002|Overall Study|Lost to Follow-up|1|||
164428258|NCT04529538|593937316|FG003|Overall Study|Lost to Follow-up|0|||
164428259|NCT04529538|593937317|FG004|Overall Study|Lost to Follow-up|1|||
164428260|NCT04529538|593937318|FG005|Overall Study|Lost to Follow-up|1|||
164257415|NCT03842969|593309884|FG001|Overall Study|Death|0|||
164257416|NCT03842969|593309885|FG002|Overall Study|Death|1|||
164257417|NCT03842969|593309883|FG000|Overall Study|Withdrawal by Subject|3|||
164257418|NCT03842969|593309884|FG001|Overall Study|Withdrawal by Subject|30|||
164257419|NCT03842969|593309885|FG002|Overall Study|Withdrawal by Subject|18|||
164257420|NCT03842969|593309883|FG000|Overall Study|Protocol Violation|1|||
164257421|NCT03842969|593309884|FG001|Overall Study|Protocol Violation|1|||
164257422|NCT03842969|593309885|FG002|Overall Study|Protocol Violation|0|||
164257423|NCT03842969|593309883|FG000|Overall Study|Physician Decision|0|||
164257424|NCT03842969|593309884|FG001|Overall Study|Physician Decision|3|||
164257425|NCT03842969|593309885|FG002|Overall Study|Physician Decision|0|||
164257426|NCT03842969|593309883|FG000|Overall Study|Lost to Follow-up|0|||
164257427|NCT03842969|593309884|FG001|Overall Study|Lost to Follow-up|2|||
164257428|NCT03842969|593309885|FG002|Overall Study|Lost to Follow-up|0|||
164257429|NCT03842969|593309883|FG000|Overall Study|Adverse Event|0|||
164257430|NCT03842969|593309884|FG001|Overall Study|Adverse Event|2|||
164257431|NCT03842969|593309885|FG002|Overall Study|Adverse Event|0|||
164257432|NCT01044745|593309886|FG000|Overall Study|Ineiligible|2|||
164257433|NCT01159171|593309889|FG000|Overall Study|Adverse Event|11|||
164257434|NCT01159171|593309889|FG000|Overall Study|Progression of Disease|28|||
164257435|NCT01159171|593309889|FG000|Overall Study|Protocol Violation|1|||
164257436|NCT01159171|593309889|FG000|Overall Study|Need for Surgery|5|||
164257437|NCT01159171|593309889|FG000|Overall Study|Medical Decision|4|||
164257438|NCT01159171|593309889|FG000|Overall Study|Death|1|||
164257439|NCT02264665|593309890|FG000|Overall Study|Other|0|||
164257440|NCT02264665|593309891|FG001|Overall Study|Other|0|||
164257441|NCT02264665|593309892|FG002|Overall Study|Other|3|||
164257442|NCT02264665|593309893|FG003|Overall Study|Other|0|||
164257443|NCT02264665|593309894|FG004|Overall Study|Other|0|||
164257444|NCT02264665|593309895|FG005|Overall Study|Other|0|||
164257445|NCT02264665|593309896|FG006|Overall Study|Other|0|||
164257446|NCT02264665|593309890|FG000|Overall Study|Death|9|||
164257447|NCT02264665|593309891|FG001|Overall Study|Death|8|||
164257448|NCT02264665|593309892|FG002|Overall Study|Death|13|||
164257449|NCT02264665|593309893|FG003|Overall Study|Death|5|||
164257450|NCT02264665|593309894|FG004|Overall Study|Death|0|||
164257451|NCT02264665|593309895|FG005|Overall Study|Death|0|||
164257452|NCT02264665|593309896|FG006|Overall Study|Death|1|||
164257453|NCT02264665|593309890|FG000|Overall Study|Lost to Follow-up|1|||
164257454|NCT02264665|593309891|FG001|Overall Study|Lost to Follow-up|0|||
164257455|NCT02264665|593309892|FG002|Overall Study|Lost to Follow-up|2|||
164257456|NCT02264665|593309893|FG003|Overall Study|Lost to Follow-up|1|||
164257457|NCT02264665|593309894|FG004|Overall Study|Lost to Follow-up|0|||
164257458|NCT02264665|593309895|FG005|Overall Study|Lost to Follow-up|0|||
164257459|NCT02264665|593309896|FG006|Overall Study|Lost to Follow-up|0|||
164339624|NCT00347360|593618955|FG002|Overall Study|Protocol Violation|1|||
164339625|NCT00347360|593618956|FG003|Overall Study|Protocol Violation|2|||
164339626|NCT00347360|593618957|FG004|Overall Study|Protocol Violation|1|||
164339627|NCT00347360|593618958|FG005|Overall Study|Protocol Violation|2|||
164339628|NCT00347360|593618959|FG006|Overall Study|Protocol Violation|0|||
164339629|NCT00347360|593618960|FG007|Overall Study|Protocol Violation|0|||
164339630|NCT00347360|593618961|FG008|Overall Study|Protocol Violation|1|||
164339631|NCT00347360|593618962|FG009|Overall Study|Protocol Violation|2|||
164339632|NCT00347360|593618963|FG010|Overall Study|Protocol Violation|0|||
164339633|NCT00347360|593618964|FG011|Overall Study|Protocol Violation|0|||
164339634|NCT00347360|593618965|FG012|Overall Study|Protocol Violation|0|||
164339635|NCT00347360|593618966|FG013|Overall Study|Protocol Violation|1|||
164339636|NCT00347360|593618967|FG014|Overall Study|Protocol Violation|0|||
164339637|NCT00347360|593618953|FG000|Overall Study|Withdrawal by Subject|0|||
164339638|NCT00347360|593618954|FG001|Overall Study|Withdrawal by Subject|1|||
164339639|NCT00347360|593618955|FG002|Overall Study|Withdrawal by Subject|2|||
164339640|NCT00347360|593618956|FG003|Overall Study|Withdrawal by Subject|4|||
164339641|NCT00347360|593618957|FG004|Overall Study|Withdrawal by Subject|1|||
164339642|NCT00347360|593618958|FG005|Overall Study|Withdrawal by Subject|2|||
164339643|NCT00347360|593618959|FG006|Overall Study|Withdrawal by Subject|1|||
164339644|NCT00347360|593618960|FG007|Overall Study|Withdrawal by Subject|1|||
164339645|NCT00347360|593618961|FG008|Overall Study|Withdrawal by Subject|1|||
164339646|NCT00347360|593618962|FG009|Overall Study|Withdrawal by Subject|1|||
164339647|NCT00347360|593618963|FG010|Overall Study|Withdrawal by Subject|0|||
164339648|NCT00347360|593618964|FG011|Overall Study|Withdrawal by Subject|3|||
164339649|NCT00347360|593618965|FG012|Overall Study|Withdrawal by Subject|4|||
164339650|NCT00347360|593618966|FG013|Overall Study|Withdrawal by Subject|2|||
164257460|NCT02264665|593309890|FG000|Overall Study|Participant decision|0|||
164257461|NCT02264665|593309891|FG001|Overall Study|Participant decision|0|||
164339651|NCT00347360|593618967|FG014|Overall Study|Withdrawal by Subject|1|||
164339652|NCT00347360|593618953|FG000|Overall Study|Lack of Efficacy|1|||
164257462|NCT02264665|593309892|FG002|Overall Study|Participant decision|0|||
164257463|NCT02264665|593309893|FG003|Overall Study|Participant decision|1|||
164257464|NCT02264665|593309894|FG004|Overall Study|Participant decision|0|||
164257465|NCT02264665|593309895|FG005|Overall Study|Participant decision|0|||
164257466|NCT02264665|593309896|FG006|Overall Study|Participant decision|0|||
164257467|NCT02264665|593309890|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
164257468|NCT02264665|593309891|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
164257469|NCT02264665|593309892|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
164339653|NCT00347360|593618954|FG001|Overall Study|Lack of Efficacy|1|||
164339654|NCT00347360|593618955|FG002|Overall Study|Lack of Efficacy|3|||
164339655|NCT00347360|593618956|FG003|Overall Study|Lack of Efficacy|1|||
164576716|NCT00100048|594474829|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
164576717|NCT00100048|594474830|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
164576718|NCT00100048|594474831|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
164576719|NCT00100048|594474832|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
164576720|NCT00100048|594474833|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
164576721|NCT00100048|594474834|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
164576722|NCT00100048|594474829|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
164576723|NCT00100048|594474830|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
164576724|NCT00100048|594474831|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
164576725|NCT00100048|594474832|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
164576726|NCT00100048|594474833|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
164576727|NCT00100048|594474834|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
164576728|NCT00100048|594474829|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
164576729|NCT00100048|594474830|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
164576730|NCT00100048|594474831|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
164576731|NCT00100048|594474832|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
164576732|NCT00100048|594474833|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
164576733|NCT00100048|594474834|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
164576734|NCT00100048|594474829|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
164576735|NCT00100048|594474830|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
164576736|NCT00100048|594474831|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
164576737|NCT00100048|594474832|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
164576738|NCT00100048|594474833|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
164257470|NCT02264665|593309893|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
164257471|NCT02264665|593309894|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
164257472|NCT02264665|593309895|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
164257473|NCT02264665|593309896|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
164257474|NCT02264665|593309890|FG000|Overall Study|Data Missing|0|||
164257475|NCT02264665|593309891|FG001|Overall Study|Data Missing|0|||
164257476|NCT02264665|593309892|FG002|Overall Study|Data Missing|1|||
164257477|NCT02264665|593309893|FG003|Overall Study|Data Missing|0|||
164257478|NCT02264665|593309894|FG004|Overall Study|Data Missing|0|||
164257479|NCT02264665|593309895|FG005|Overall Study|Data Missing|0|||
164257480|NCT02264665|593309896|FG006|Overall Study|Data Missing|0|||
164257481|NCT01962987|593309897|FG000|Overall Study|Adverse Event|4|||
164257482|NCT01962987|593309898|FG001|Overall Study|Adverse Event|4|||
164257483|NCT01962987|593309899|FG002|Overall Study|Adverse Event|0|||
164257484|NCT01962987|593309897|FG000|Overall Study|Lost to Follow-up|0|||
164257485|NCT01962987|593309898|FG001|Overall Study|Lost to Follow-up|0|||
164257486|NCT01962987|593309899|FG002|Overall Study|Lost to Follow-up|1|||
164257487|NCT01962987|593309897|FG000|Overall Study|Non compliance with dosing requirements|4|||
164257488|NCT01962987|593309898|FG001|Overall Study|Non compliance with dosing requirements|2|||
164257489|NCT01962987|593309899|FG002|Overall Study|Non compliance with dosing requirements|0|||
164257490|NCT01962987|593309897|FG000|Overall Study|Miscellaneous|1|||
164257491|NCT01962987|593309898|FG001|Overall Study|Miscellaneous|9|||
164257492|NCT01962987|593309899|FG002|Overall Study|Miscellaneous|2|||
164257493|NCT01962987|593309897|FG000|Overall Study|Restricted medication|5|||
164257494|NCT01962987|593309898|FG001|Overall Study|Restricted medication|1|||
164257495|NCT01962987|593309899|FG002|Overall Study|Restricted medication|1|||
164257496|NCT01962987|593309897|FG000|Overall Study|Serious Adverse Event|1|||
164257497|NCT01962987|593309898|FG001|Overall Study|Serious Adverse Event|0|||
164257498|NCT01962987|593309899|FG002|Overall Study|Serious Adverse Event|0|||
164257499|NCT01962987|593309897|FG000|Overall Study|Withdrawal by Subject|11|||
164257500|NCT01962987|593309898|FG001|Overall Study|Withdrawal by Subject|10|||
164257501|NCT01962987|593309899|FG002|Overall Study|Withdrawal by Subject|6|||
164257502|NCT01962987|593309897|FG000|Overall Study|Randomized in Error|4|||
164257503|NCT01962987|593309898|FG001|Overall Study|Randomized in Error|2|||
164257504|NCT01962987|593309899|FG002|Overall Study|Randomized in Error|2|||
164257505|NCT00789581|593309900|FG000|AC Therapy|Adverse Event|2|||
164257506|NCT00789581|593309901|FG001|AC Therapy|Adverse Event|3|||
164576739|NCT00100048|594474834|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
164576740|NCT00100048|594474829|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
164576741|NCT00100048|594474830|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
164576742|NCT00100048|594474831|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
164576743|NCT00100048|594474832|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
164576744|NCT00100048|594474833|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
164257507|NCT00789581|593309900|FG000|AC Therapy|Withdrawal by Subject|4|||
164257508|NCT00789581|593309901|FG001|AC Therapy|Withdrawal by Subject|7|||
164576745|NCT00100048|594474834|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
164257509|NCT00789581|593309900|FG000|AC Therapy|Disease recurrence|3|||
164257510|NCT00789581|593309901|FG001|AC Therapy|Disease recurrence|1|||
164339656|NCT00347360|593618957|FG004|Overall Study|Lack of Efficacy|0|||
164339657|NCT00347360|593618958|FG005|Overall Study|Lack of Efficacy|1|||
164339658|NCT00347360|593618959|FG006|Overall Study|Lack of Efficacy|0|||
164339659|NCT00347360|593618960|FG007|Overall Study|Lack of Efficacy|1|||
164339660|NCT00347360|593618961|FG008|Overall Study|Lack of Efficacy|1|||
164339661|NCT00347360|593618962|FG009|Overall Study|Lack of Efficacy|0|||
164339662|NCT00347360|593618963|FG010|Overall Study|Lack of Efficacy|0|||
164339663|NCT00347360|593618964|FG011|Overall Study|Lack of Efficacy|0|||
164339664|NCT00347360|593618965|FG012|Overall Study|Lack of Efficacy|0|||
164339665|NCT00347360|593618966|FG013|Overall Study|Lack of Efficacy|0|||
164339666|NCT00347360|593618967|FG014|Overall Study|Lack of Efficacy|0|||
164339667|NCT00347360|593618953|FG000|Overall Study|Reason not listed/blank|1|||
164339668|NCT00347360|593618954|FG001|Overall Study|Reason not listed/blank|0|||
164339669|NCT00347360|593618955|FG002|Overall Study|Reason not listed/blank|0|||
164339670|NCT00347360|593618956|FG003|Overall Study|Reason not listed/blank|0|||
164339671|NCT00347360|593618957|FG004|Overall Study|Reason not listed/blank|0|||
164339672|NCT00347360|593618958|FG005|Overall Study|Reason not listed/blank|0|||
164339673|NCT00347360|593618959|FG006|Overall Study|Reason not listed/blank|1|||
164339674|NCT00347360|593618960|FG007|Overall Study|Reason not listed/blank|0|||
164339675|NCT00347360|593618961|FG008|Overall Study|Reason not listed/blank|0|||
164339676|NCT00347360|593618962|FG009|Overall Study|Reason not listed/blank|0|||
164339677|NCT00347360|593618963|FG010|Overall Study|Reason not listed/blank|0|||
164339678|NCT00347360|593618964|FG011|Overall Study|Reason not listed/blank|0|||
164339679|NCT00347360|593618965|FG012|Overall Study|Reason not listed/blank|0|||
164339680|NCT00347360|593618966|FG013|Overall Study|Reason not listed/blank|1|||
164339681|NCT00347360|593618967|FG014|Overall Study|Reason not listed/blank|0|||
164339682|NCT00347360|593618953|FG000|Overall Study|Per sponsors instruction|0|||
164339683|NCT00347360|593618954|FG001|Overall Study|Per sponsors instruction|1|||
164339684|NCT00347360|593618955|FG002|Overall Study|Per sponsors instruction|0|||
164339685|NCT00347360|593618956|FG003|Overall Study|Per sponsors instruction|0|||
164339686|NCT00347360|593618957|FG004|Overall Study|Per sponsors instruction|0|||
164339687|NCT00347360|593618958|FG005|Overall Study|Per sponsors instruction|0|||
164339688|NCT00347360|593618959|FG006|Overall Study|Per sponsors instruction|0|||
164339689|NCT00347360|593618960|FG007|Overall Study|Per sponsors instruction|0|||
164339690|NCT00347360|593618961|FG008|Overall Study|Per sponsors instruction|0|||
164339691|NCT00347360|593618962|FG009|Overall Study|Per sponsors instruction|0|||
164339692|NCT00347360|593618963|FG010|Overall Study|Per sponsors instruction|0|||
164339693|NCT00347360|593618964|FG011|Overall Study|Per sponsors instruction|0|||
164339694|NCT00347360|593618965|FG012|Overall Study|Per sponsors instruction|0|||
164339695|NCT00347360|593618966|FG013|Overall Study|Per sponsors instruction|0|||
164339696|NCT00347360|593618967|FG014|Overall Study|Per sponsors instruction|0|||
164339697|NCT00347360|593618953|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
164339698|NCT00347360|593618954|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
164339699|NCT00347360|593618955|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
164339700|NCT00347360|593618956|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
164339701|NCT00347360|593618957|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
164339702|NCT00347360|593618958|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
164339703|NCT00347360|593618959|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
164339704|NCT00347360|593618960|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
164339705|NCT00347360|593618961|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
164339706|NCT00347360|593618962|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
164339707|NCT00347360|593618963|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
164339708|NCT00347360|593618964|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
164339709|NCT00347360|593618965|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
164339710|NCT00347360|593618966|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
164339711|NCT00347360|593618967|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
164339712|NCT00347360|593618953|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
164339713|NCT00347360|593618954|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
164339714|NCT00347360|593618955|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
164339715|NCT00347360|593618956|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
164339716|NCT00347360|593618957|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
164339717|NCT00347360|593618958|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
164339718|NCT00347360|593618959|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
164339719|NCT00347360|593618960|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
164339720|NCT00347360|593618961|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
164339721|NCT00347360|593618962|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
164339722|NCT00347360|593618963|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
164339723|NCT00347360|593618964|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
164339724|NCT00347360|593618965|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
164339725|NCT00347360|593618966|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
164428261|NCT04529538|593937319|FG006|Overall Study|Lost to Follow-up|2|||
164339726|NCT00347360|593618967|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
164680627|NCT00112437|594854583|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164680628|NCT00112437|594854584|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164680629|NCT00112437|594854585|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164257511|NCT00789581|593309900|FG000|AC Therapy|Intercurrent Illness|1|||
164257512|NCT00789581|593309901|FG001|AC Therapy|Intercurrent Illness|0|||
164257513|NCT00789581|593309900|FG000|AC Therapy|Never Treated|1|||
164257514|NCT00789581|593309901|FG001|AC Therapy|Never Treated|4|||
164257515|NCT00789581|593309900|FG000|AC Therapy|Other|0|||
164257516|NCT00789581|593309901|FG001|AC Therapy|Other|2|||
164257517|NCT00789581|593309900|FG000|Adjuvant Therapy|Never treated|2|||
164257518|NCT00789581|593309901|FG001|Adjuvant Therapy|Never treated|2|||
164257519|NCT00789581|593309900|FG000|Adjuvant Therapy|Adverse Event|20|||
164257520|NCT00789581|593309901|FG001|Adjuvant Therapy|Adverse Event|44|||
164257521|NCT00789581|593309900|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
164257522|NCT00789581|593309901|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
164257523|NCT00789581|593309900|FG000|Adjuvant Therapy|Disease recurrence|2|||
164257524|NCT00789581|593309901|FG001|Adjuvant Therapy|Disease recurrence|1|||
164257525|NCT00789581|593309900|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
164257526|NCT00789581|593309901|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
164257527|NCT00789581|593309900|FG000|Adjuvant Therapy|Protocol Violation|1|||
164257528|NCT00789581|593309901|FG001|Adjuvant Therapy|Protocol Violation|1|||
164257529|NCT00789581|593309900|FG000|Adjuvant Therapy|Other|0|||
164257530|NCT00789581|593309901|FG001|Adjuvant Therapy|Other|1|||
164257531|NCT01468207|593309902|FG000|Treatment Period 1|Adverse Event|1|||
164257532|NCT01468207|593309903|FG001|Treatment Period 1|Adverse Event|0|||
164257533|NCT01468207|593309904|FG002|Treatment Period 1|Adverse Event|0|||
164257534|NCT01468207|593309905|FG003|Treatment Period 1|Adverse Event|0|||
164257535|NCT01468207|593309906|FG004|Treatment Period 1|Adverse Event|0|||
164257536|NCT01468207|593309907|FG005|Treatment Period 1|Adverse Event|0|||
164257537|NCT01468207|593309902|FG000|Treatment Period 1|Protocol Violation|1|||
164339727|NCT00347360|593618953|FG000|Overall Study|Abnormal lab values|0|||
164339728|NCT00347360|593618954|FG001|Overall Study|Abnormal lab values|0|||
164680630|NCT00112437|594854586|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164680631|NCT00112437|594854587|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164680632|NCT00112437|594854588|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164680633|NCT00112437|594854589|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164680634|NCT00112437|594854590|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164680635|NCT00112437|594854591|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164680636|NCT00112437|594854592|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164680637|NCT00112437|594854593|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164680638|NCT00112437|594854594|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164680639|NCT00112437|594854595|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164680640|NCT00112437|594854596|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164680641|NCT00112437|594854571|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164680642|NCT00112437|594854572|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164680643|NCT00112437|594854573|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164680644|NCT00112437|594854574|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164680645|NCT00112437|594854575|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164680646|NCT00112437|594854576|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164680647|NCT00112437|594854577|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164680648|NCT00112437|594854578|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164680649|NCT00112437|594854579|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164680650|NCT00112437|594854580|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
164680651|NCT00112437|594854581|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164257538|NCT01468207|593309903|FG001|Treatment Period 1|Protocol Violation|1|||
164339729|NCT00347360|593618955|FG002|Overall Study|Abnormal lab values|0|||
164339730|NCT00347360|593618956|FG003|Overall Study|Abnormal lab values|0|||
164339731|NCT00347360|593618957|FG004|Overall Study|Abnormal lab values|0|||
164339732|NCT00347360|593618958|FG005|Overall Study|Abnormal lab values|0|||
164339733|NCT00347360|593618959|FG006|Overall Study|Abnormal lab values|1|||
164339734|NCT00347360|593618960|FG007|Overall Study|Abnormal lab values|0|||
164339735|NCT00347360|593618961|FG008|Overall Study|Abnormal lab values|0|||
164339736|NCT00347360|593618962|FG009|Overall Study|Abnormal lab values|0|||
164339737|NCT00347360|593618963|FG010|Overall Study|Abnormal lab values|0|||
164257539|NCT01468207|593309904|FG002|Treatment Period 1|Protocol Violation|0|||
164257540|NCT01468207|593309905|FG003|Treatment Period 1|Protocol Violation|0|||
164257541|NCT01468207|593309906|FG004|Treatment Period 1|Protocol Violation|0|||
164257542|NCT01468207|593309907|FG005|Treatment Period 1|Protocol Violation|0|||
164257543|NCT01468207|593309902|FG000|Treatment Period 1|Withdrawal by Subject|5|||
164339738|NCT00347360|593618964|FG011|Overall Study|Abnormal lab values|0|||
164339739|NCT00347360|593618965|FG012|Overall Study|Abnormal lab values|0|||
164257544|NCT01468207|593309903|FG001|Treatment Period 1|Withdrawal by Subject|4|||
164257545|NCT01468207|593309904|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164339740|NCT00347360|593618966|FG013|Overall Study|Abnormal lab values|0|||
164680652|NCT00112437|594854582|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164680653|NCT00112437|594854583|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164680654|NCT00112437|594854584|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164680655|NCT00112437|594854585|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164257546|NCT01468207|593309905|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164257547|NCT01468207|593309906|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164257548|NCT01468207|593309907|FG005|Treatment Period 1|Withdrawal by Subject|0|||
164257549|NCT01468207|593309902|FG000|Treatment Period 1|Lost to Follow-up|2|||
164257550|NCT01468207|593309903|FG001|Treatment Period 1|Lost to Follow-up|1|||
164257551|NCT01468207|593309904|FG002|Treatment Period 1|Lost to Follow-up|0|||
164257552|NCT01468207|593309905|FG003|Treatment Period 1|Lost to Follow-up|0|||
164257553|NCT01468207|593309906|FG004|Treatment Period 1|Lost to Follow-up|0|||
164257554|NCT01468207|593309907|FG005|Treatment Period 1|Lost to Follow-up|0|||
164257555|NCT01468207|593309902|FG000|Treatment Period 1|Other|0|||
164257556|NCT01468207|593309903|FG001|Treatment Period 1|Other|2|||
164257557|NCT01468207|593309904|FG002|Treatment Period 1|Other|0|||
164257558|NCT01468207|593309905|FG003|Treatment Period 1|Other|0|||
164257559|NCT01468207|593309906|FG004|Treatment Period 1|Other|0|||
164257560|NCT01468207|593309907|FG005|Treatment Period 1|Other|0|||
164257561|NCT01468207|593309902|FG000|Treatment Period 2|Adverse Event|0|||
164257562|NCT01468207|593309903|FG001|Treatment Period 2|Adverse Event|0|||
164257563|NCT01468207|593309904|FG002|Treatment Period 2|Adverse Event|6|||
164257564|NCT01468207|593309905|FG003|Treatment Period 2|Adverse Event|1|||
164257565|NCT01468207|593309906|FG004|Treatment Period 2|Adverse Event|2|||
164257566|NCT01468207|593309907|FG005|Treatment Period 2|Adverse Event|1|||
164257567|NCT01468207|593309902|FG000|Treatment Period 2|Lack of Efficacy|0|||
164257568|NCT01468207|593309903|FG001|Treatment Period 2|Lack of Efficacy|0|||
164257569|NCT01468207|593309904|FG002|Treatment Period 2|Lack of Efficacy|1|||
164257570|NCT01468207|593309905|FG003|Treatment Period 2|Lack of Efficacy|1|||
164257571|NCT01468207|593309906|FG004|Treatment Period 2|Lack of Efficacy|0|||
164257572|NCT01468207|593309907|FG005|Treatment Period 2|Lack of Efficacy|2|||
164257573|NCT01468207|593309902|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164257574|NCT01468207|593309903|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164257575|NCT01468207|593309904|FG002|Treatment Period 2|Withdrawal by Subject|5|||
164257576|NCT01468207|593309905|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164257577|NCT01468207|593309906|FG004|Treatment Period 2|Withdrawal by Subject|0|||
164257578|NCT01468207|593309907|FG005|Treatment Period 2|Withdrawal by Subject|2|||
164257579|NCT01468207|593309902|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
164257580|NCT01468207|593309903|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
164257581|NCT01468207|593309904|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
164257582|NCT01468207|593309905|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
164428262|NCT04529538|593937320|FG007|Overall Study|Lost to Follow-up|0|||
164428263|NCT04529538|593937313|FG000|Overall Study|Not eligible at enrollment|0|||
164428264|NCT04529538|593937314|FG001|Overall Study|Not eligible at enrollment|1|||
164428265|NCT04529538|593937315|FG002|Overall Study|Not eligible at enrollment|2|||
164428266|NCT04529538|593937316|FG003|Overall Study|Not eligible at enrollment|1|||
164428267|NCT04529538|593937317|FG004|Overall Study|Not eligible at enrollment|0|||
164428268|NCT04529538|593937318|FG005|Overall Study|Not eligible at enrollment|0|||
164428269|NCT04529538|593937319|FG006|Overall Study|Not eligible at enrollment|0|||
164257583|NCT01468207|593309906|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
164257584|NCT01468207|593309907|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
164680656|NCT00112437|594854586|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164680657|NCT00112437|594854587|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164257585|NCT01468207|593309902|FG000|Treatment Period 2|Lost to Follow-up|0|||
164257586|NCT01468207|593309903|FG001|Treatment Period 2|Lost to Follow-up|0|||
164257587|NCT01468207|593309904|FG002|Treatment Period 2|Lost to Follow-up|5|||
164257588|NCT01468207|593309905|FG003|Treatment Period 2|Lost to Follow-up|1|||
164428270|NCT04529538|593937320|FG007|Overall Study|Not eligible at enrollment|1|||
164428271|NCT04529538|593937313|FG000|Overall Study|Withdrawal by Subject|0|||
164428272|NCT04529538|593937314|FG001|Overall Study|Withdrawal by Subject|1|||
164428273|NCT04529538|593937315|FG002|Overall Study|Withdrawal by Subject|1|||
164428274|NCT04529538|593937316|FG003|Overall Study|Withdrawal by Subject|2|||
164428275|NCT04529538|593937317|FG004|Overall Study|Withdrawal by Subject|0|||
164428276|NCT04529538|593937318|FG005|Overall Study|Withdrawal by Subject|2|||
164428277|NCT04529538|593937319|FG006|Overall Study|Withdrawal by Subject|3|||
164257589|NCT01468207|593309906|FG004|Treatment Period 2|Lost to Follow-up|0|||
164257590|NCT01468207|593309907|FG005|Treatment Period 2|Lost to Follow-up|0|||
164257591|NCT01468207|593309902|FG000|Treatment Period 2|Other|0|||
164257592|NCT01468207|593309903|FG001|Treatment Period 2|Other|0|||
164257593|NCT01468207|593309904|FG002|Treatment Period 2|Other|5|||
164257594|NCT01468207|593309905|FG003|Treatment Period 2|Other|1|||
164257595|NCT01468207|593309906|FG004|Treatment Period 2|Other|1|||
164257596|NCT01468207|593309907|FG005|Treatment Period 2|Other|2|||
164257597|NCT00470093|593309908|FG000|Overall Study|Adverse Event|2|||
164257598|NCT00664560|593309909|FG000|Overall Study|Adverse Event|19|||
164257599|NCT00664560|593309910|FG001|Overall Study|Adverse Event|16|||
164257600|NCT00664560|593309911|FG002|Overall Study|Adverse Event|7|||
164257601|NCT00664560|593309909|FG000|Overall Study|Withdrawal by Subject|9|||
164257602|NCT00664560|593309910|FG001|Overall Study|Withdrawal by Subject|13|||
164257603|NCT00664560|593309911|FG002|Overall Study|Withdrawal by Subject|7|||
164257604|NCT00664560|593309909|FG000|Overall Study|Lost to Follow-up|0|||
164257605|NCT00664560|593309910|FG001|Overall Study|Lost to Follow-up|2|||
164257606|NCT00664560|593309911|FG002|Overall Study|Lost to Follow-up|0|||
164257607|NCT00664560|593309909|FG000|Overall Study|Other|11|||
164257608|NCT00664560|593309910|FG001|Overall Study|Other|4|||
164257609|NCT00664560|593309911|FG002|Overall Study|Other|5|||
164257610|NCT01328041|593309912|FG000|Overall Study|Adverse Event|7|||
164257611|NCT01328041|593309912|FG000|Overall Study|Lack of Efficacy|27|||
164257612|NCT01328041|593309912|FG000|Overall Study|Protocol Violation|7|||
164257613|NCT01328041|593309912|FG000|Overall Study|Lost to Follow-up|7|||
164257614|NCT01328041|593309912|FG000|Overall Study|Physician Decision|2|||
164257615|NCT01328041|593309912|FG000|Overall Study|Withdrawal by Subject|7|||
164257616|NCT03392883|593309915|FG000|Overall Study|Lost to Follow-up|122|||
164257617|NCT03392883|593309916|FG001|Overall Study|Lost to Follow-up|13|||
164257618|NCT03392883|593309917|FG002|Overall Study|Lost to Follow-up|9|||
164257619|NCT03392883|593309915|FG000|Overall Study|Death|4|||
164257620|NCT03392883|593309916|FG001|Overall Study|Death|0|||
164257621|NCT03392883|593309917|FG002|Overall Study|Death|0|||
164257622|NCT03392883|593309915|FG000|Overall Study|Lack of Efficacy|29|||
164257623|NCT03392883|593309916|FG001|Overall Study|Lack of Efficacy|0|||
164257624|NCT03392883|593309917|FG002|Overall Study|Lack of Efficacy|0|||
164257625|NCT03392883|593309915|FG000|Overall Study|Withdrawal by Subject|180|||
164257626|NCT03392883|593309916|FG001|Overall Study|Withdrawal by Subject|0|||
164257627|NCT03392883|593309917|FG002|Overall Study|Withdrawal by Subject|0|||
164257628|NCT03392883|593309915|FG000|Overall Study|Adverse Event|1|||
164257629|NCT03392883|593309916|FG001|Overall Study|Adverse Event|0|||
164257630|NCT03392883|593309917|FG002|Overall Study|Adverse Event|0|||
164257631|NCT02688088|593309919|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
164257632|NCT02688088|593309920|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
164257633|NCT02688088|593309921|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
164257634|NCT02688088|593309922|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
164257635|NCT02688088|593309923|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
164257636|NCT02688088|593309919|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
164257637|NCT02688088|593309920|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
164257638|NCT02688088|593309921|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
164257639|NCT02688088|593309922|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
164257640|NCT02688088|593309923|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
164257641|NCT02688088|593309919|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
164257642|NCT02688088|593309920|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
164257643|NCT02688088|593309921|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
164257644|NCT02688088|593309922|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
164257645|NCT02688088|593309923|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
164257646|NCT02688088|593309919|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
164257647|NCT02688088|593309920|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
164257648|NCT02688088|593309921|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
164257649|NCT02688088|593309922|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
164257650|NCT02688088|593309923|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
164257651|NCT02688088|593309919|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
164257652|NCT02688088|593309920|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
164257653|NCT02688088|593309921|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
164428278|NCT04529538|593937320|FG007|Overall Study|Withdrawal by Subject|0|||
164428279|NCT04529538|593937313|FG000|Overall Study|Other|0|||
164257654|NCT02688088|593309922|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
164257655|NCT02688088|593309923|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
164257656|NCT02688088|593309919|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
164257657|NCT02688088|593309920|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
164257658|NCT02688088|593309921|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
164257659|NCT02688088|593309922|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
164257660|NCT02688088|593309923|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
164257661|NCT02688088|593309919|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
164257662|NCT02688088|593309920|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
164428280|NCT04529538|593937314|FG001|Overall Study|Other|1|||
164257663|NCT02688088|593309921|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
164257664|NCT02688088|593309922|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
164257665|NCT02688088|593309923|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
164257666|NCT02688088|593309919|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
164257667|NCT02688088|593309920|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
164257668|NCT02688088|593309921|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
164257669|NCT02688088|593309922|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
164257670|NCT02688088|593309923|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
164257671|NCT02688088|593309919|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
164257672|NCT02688088|593309920|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
164257673|NCT02688088|593309921|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
164257674|NCT02688088|593309922|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
164257675|NCT02688088|593309923|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
164257676|NCT00515294|593309935|FG000|Overall Study|Lost to Follow-up|3|||
164257677|NCT00515294|593309936|FG001|Overall Study|Lost to Follow-up|2|||
164257678|NCT00515294|593309937|FG002|Overall Study|Lost to Follow-up|3|||
164257679|NCT00515294|593309938|FG003|Overall Study|Lost to Follow-up|1|||
164257680|NCT00515294|593309935|FG000|Overall Study|Driver simulator problems|1|||
164257681|NCT00515294|593309936|FG001|Overall Study|Driver simulator problems|1|||
164257682|NCT00515294|593309937|FG002|Overall Study|Driver simulator problems|1|||
164257683|NCT00515294|593309938|FG003|Overall Study|Driver simulator problems|3|||
164257684|NCT00515294|593309935|FG000|Overall Study|Caffeine amount inaccurate|5|||
164257685|NCT00515294|593309936|FG001|Overall Study|Caffeine amount inaccurate|0|||
164257686|NCT00515294|593309937|FG002|Overall Study|Caffeine amount inaccurate|7|||
164257687|NCT00515294|593309938|FG003|Overall Study|Caffeine amount inaccurate|0|||
164257688|NCT01453205|593309939|FG000|Overall Study|Lost to Follow-up|3|||
164257689|NCT01453205|593309940|FG001|Overall Study|Lost to Follow-up|0|||
164257690|NCT01453205|593309941|FG002|Overall Study|Lost to Follow-up|1|||
164257691|NCT01453205|593309939|FG000|Overall Study|Withdrawal by Subject|8|||
164257692|NCT01453205|593309940|FG001|Overall Study|Withdrawal by Subject|3|||
164257693|NCT01453205|593309941|FG002|Overall Study|Withdrawal by Subject|0|||
164257694|NCT01453205|593309939|FG000|Overall Study|Death|24|||
164257695|NCT01453205|593309940|FG001|Overall Study|Death|22|||
164257696|NCT01453205|593309941|FG002|Overall Study|Death|18|||
164257697|NCT01453205|593309939|FG000|Overall Study|Other|45|||
164257698|NCT01453205|593309940|FG001|Overall Study|Other|27|||
164257699|NCT01453205|593309941|FG002|Overall Study|Other|35|||
164257700|NCT05596734|593309942|FG000|Substudy A|Withdrawal by Subject|1|||
164257701|NCT05596734|593309943|FG001|Substudy A|Withdrawal by Subject|0|||
164257702|NCT05596734|593309944|FG002|Substudy A|Withdrawal by Subject|0|||
164257703|NCT05596734|593309945|FG003|Substudy A|Withdrawal by Subject|0|||
164257704|NCT05596734|593309946|FG004|Substudy A|Withdrawal by Subject|0|||
164257705|NCT05596734|593309947|FG005|Substudy A|Withdrawal by Subject|0|||
164257706|NCT05596734|593309948|FG006|Substudy A|Withdrawal by Subject|1|||
164257707|NCT05596734|593309949|FG007|Substudy A|Withdrawal by Subject|0|||
164257708|NCT05596734|593309950|FG008|Substudy A|Withdrawal by Subject|0|||
164257709|NCT05596734|593309951|FG009|Substudy A|Withdrawal by Subject|0|||
164257710|NCT05596734|593309952|FG010|Substudy A|Withdrawal by Subject|0|||
164257711|NCT05596734|593309953|FG011|Substudy A|Withdrawal by Subject|0|||
164257712|NCT05596734|593309954|FG012|Substudy A|Withdrawal by Subject|0|||
164257713|NCT05596734|593309955|FG013|Substudy A|Withdrawal by Subject|0|||
164257714|NCT05596734|593309956|FG014|Substudy A|Withdrawal by Subject|0|||
164257715|NCT05596734|593309957|FG015|Substudy A|Withdrawal by Subject|0|||
164257716|NCT05596734|593309958|FG016|Substudy A|Withdrawal by Subject|0|||
164257717|NCT05596734|593309959|FG017|Substudy A|Withdrawal by Subject|0|||
164257718|NCT05596734|593309960|FG018|Substudy A|Withdrawal by Subject|0|||
164257719|NCT05596734|593309961|FG019|Substudy A|Withdrawal by Subject|0|||
164257720|NCT05596734|593309962|FG020|Substudy A|Withdrawal by Subject|0|||
164257721|NCT05596734|593309963|FG021|Substudy A|Withdrawal by Subject|0|||
164257722|NCT05596734|593309964|FG022|Substudy A|Withdrawal by Subject|0|||
164257723|NCT05596734|593309965|FG023|Substudy A|Withdrawal by Subject|0|||
164257724|NCT05596734|593309942|FG000|Substudy A|Lost to Follow-up|1|||
164257725|NCT05596734|593309943|FG001|Substudy A|Lost to Follow-up|0|||
164257726|NCT05596734|593309944|FG002|Substudy A|Lost to Follow-up|1|||
164257727|NCT05596734|593309945|FG003|Substudy A|Lost to Follow-up|0|||
164257728|NCT05596734|593309946|FG004|Substudy A|Lost to Follow-up|0|||
164257729|NCT05596734|593309947|FG005|Substudy A|Lost to Follow-up|0|||
164257730|NCT05596734|593309948|FG006|Substudy A|Lost to Follow-up|0|||
164257731|NCT05596734|593309949|FG007|Substudy A|Lost to Follow-up|0|||
164257732|NCT05596734|593309950|FG008|Substudy A|Lost to Follow-up|0|||
164339741|NCT00347360|593618967|FG014|Overall Study|Abnormal lab values|0|||
164339742|NCT00347360|593618953|FG000|Overall Study|PI recommended early withdrawal|0|||
164339743|NCT00347360|593618954|FG001|Overall Study|PI recommended early withdrawal|0|||
164257733|NCT05596734|593309951|FG009|Substudy A|Lost to Follow-up|0|||
164257734|NCT05596734|593309952|FG010|Substudy A|Lost to Follow-up|0|||
164257735|NCT05596734|593309953|FG011|Substudy A|Lost to Follow-up|0|||
164257736|NCT05596734|593309954|FG012|Substudy A|Lost to Follow-up|0|||
164680658|NCT00112437|594854588|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164680659|NCT00112437|594854589|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164680660|NCT00112437|594854590|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164680661|NCT00112437|594854591|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164680662|NCT00112437|594854592|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164680663|NCT00112437|594854593|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164680664|NCT00112437|594854594|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164680665|NCT00112437|594854595|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164680666|NCT00112437|594854596|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164257737|NCT05596734|593309955|FG013|Substudy A|Lost to Follow-up|0|||
164257738|NCT05596734|593309956|FG014|Substudy A|Lost to Follow-up|0|||
164257739|NCT05596734|593309957|FG015|Substudy A|Lost to Follow-up|0|||
164257740|NCT05596734|593309958|FG016|Substudy A|Lost to Follow-up|0|||
164257741|NCT05596734|593309959|FG017|Substudy A|Lost to Follow-up|0|||
164257742|NCT05596734|593309960|FG018|Substudy A|Lost to Follow-up|0|||
164257743|NCT05596734|593309961|FG019|Substudy A|Lost to Follow-up|0|||
164257744|NCT05596734|593309962|FG020|Substudy A|Lost to Follow-up|0|||
164257745|NCT05596734|593309963|FG021|Substudy A|Lost to Follow-up|0|||
164257746|NCT05596734|593309964|FG022|Substudy A|Lost to Follow-up|0|||
164257747|NCT05596734|593309965|FG023|Substudy A|Lost to Follow-up|0|||
164257748|NCT05596734|593309942|FG000|Substudy B|Withdrawal by Subject|0|||
164257749|NCT05596734|593309943|FG001|Substudy B|Withdrawal by Subject|0|||
164257750|NCT05596734|593309944|FG002|Substudy B|Withdrawal by Subject|0|||
164257751|NCT05596734|593309945|FG003|Substudy B|Withdrawal by Subject|0|||
164257752|NCT05596734|593309946|FG004|Substudy B|Withdrawal by Subject|0|||
164257753|NCT05596734|593309947|FG005|Substudy B|Withdrawal by Subject|0|||
164257754|NCT05596734|593309948|FG006|Substudy B|Withdrawal by Subject|0|||
164257755|NCT05596734|593309949|FG007|Substudy B|Withdrawal by Subject|0|||
164257756|NCT05596734|593309950|FG008|Substudy B|Withdrawal by Subject|0|||
164257757|NCT05596734|593309951|FG009|Substudy B|Withdrawal by Subject|0|||
164257758|NCT05596734|593309952|FG010|Substudy B|Withdrawal by Subject|0|||
164257759|NCT05596734|593309953|FG011|Substudy B|Withdrawal by Subject|0|||
164339744|NCT00347360|593618955|FG002|Overall Study|PI recommended early withdrawal|0|||
164339745|NCT00347360|593618956|FG003|Overall Study|PI recommended early withdrawal|0|||
164339746|NCT00347360|593618957|FG004|Overall Study|PI recommended early withdrawal|0|||
164339747|NCT00347360|593618958|FG005|Overall Study|PI recommended early withdrawal|0|||
164339748|NCT00347360|593618959|FG006|Overall Study|PI recommended early withdrawal|0|||
164339749|NCT00347360|593618960|FG007|Overall Study|PI recommended early withdrawal|0|||
164339750|NCT00347360|593618961|FG008|Overall Study|PI recommended early withdrawal|0|||
164339751|NCT00347360|593618962|FG009|Overall Study|PI recommended early withdrawal|1|||
164339752|NCT00347360|593618963|FG010|Overall Study|PI recommended early withdrawal|0|||
164339753|NCT00347360|593618964|FG011|Overall Study|PI recommended early withdrawal|0|||
164339754|NCT00347360|593618965|FG012|Overall Study|PI recommended early withdrawal|0|||
164339755|NCT00347360|593618966|FG013|Overall Study|PI recommended early withdrawal|0|||
164339756|NCT00347360|593618967|FG014|Overall Study|PI recommended early withdrawal|0|||
164339757|NCT00347360|593618953|FG000|Overall Study|Did not meet criteria before ABPM|0|||
164339758|NCT00347360|593618954|FG001|Overall Study|Did not meet criteria before ABPM|0|||
164339759|NCT00347360|593618955|FG002|Overall Study|Did not meet criteria before ABPM|0|||
164339760|NCT00347360|593618956|FG003|Overall Study|Did not meet criteria before ABPM|0|||
164339761|NCT00347360|593618957|FG004|Overall Study|Did not meet criteria before ABPM|0|||
164339762|NCT00347360|593618958|FG005|Overall Study|Did not meet criteria before ABPM|0|||
164339763|NCT00347360|593618959|FG006|Overall Study|Did not meet criteria before ABPM|0|||
164339764|NCT00347360|593618960|FG007|Overall Study|Did not meet criteria before ABPM|0|||
164339765|NCT00347360|593618961|FG008|Overall Study|Did not meet criteria before ABPM|0|||
164339766|NCT00347360|593618962|FG009|Overall Study|Did not meet criteria before ABPM|0|||
164339767|NCT00347360|593618963|FG010|Overall Study|Did not meet criteria before ABPM|1|||
164339768|NCT00347360|593618964|FG011|Overall Study|Did not meet criteria before ABPM|0|||
164339769|NCT00347360|593618965|FG012|Overall Study|Did not meet criteria before ABPM|0|||
164339770|NCT00347360|593618966|FG013|Overall Study|Did not meet criteria before ABPM|0|||
164339771|NCT00347360|593618967|FG014|Overall Study|Did not meet criteria before ABPM|0|||
164339772|NCT00347360|593618953|FG000|Overall Study|Randomized in error|0|||
164257760|NCT05596734|593309954|FG012|Substudy B|Withdrawal by Subject|1|||
164257761|NCT05596734|593309955|FG013|Substudy B|Withdrawal by Subject|0|||
164257762|NCT05596734|593309956|FG014|Substudy B|Withdrawal by Subject|1|||
164257763|NCT05596734|593309957|FG015|Substudy B|Withdrawal by Subject|2|||
164339773|NCT00347360|593618954|FG001|Overall Study|Randomized in error|0|||
164339774|NCT00347360|593618955|FG002|Overall Study|Randomized in error|0|||
164339775|NCT00347360|593618956|FG003|Overall Study|Randomized in error|0|||
164339776|NCT00347360|593618957|FG004|Overall Study|Randomized in error|0|||
164257764|NCT05596734|593309958|FG016|Substudy B|Withdrawal by Subject|2|||
164257765|NCT05596734|593309959|FG017|Substudy B|Withdrawal by Subject|1|||
164257766|NCT05596734|593309960|FG018|Substudy B|Withdrawal by Subject|2|||
164257767|NCT05596734|593309961|FG019|Substudy B|Withdrawal by Subject|0|||
164257768|NCT05596734|593309962|FG020|Substudy B|Withdrawal by Subject|0|||
164257769|NCT05596734|593309963|FG021|Substudy B|Withdrawal by Subject|0|||
164257770|NCT05596734|593309964|FG022|Substudy B|Withdrawal by Subject|0|||
164257771|NCT05596734|593309965|FG023|Substudy B|Withdrawal by Subject|1|||
164257772|NCT05596734|593309942|FG000|Substudy B|Physician Decision|0|||
164428281|NCT04529538|593937315|FG002|Overall Study|Other|0|||
164428282|NCT04529538|593937316|FG003|Overall Study|Other|0|||
164428283|NCT04529538|593937317|FG004|Overall Study|Other|0|||
164428284|NCT04529538|593937318|FG005|Overall Study|Other|0|||
164428285|NCT04529538|593937319|FG006|Overall Study|Other|0|||
164428286|NCT04529538|593937320|FG007|Overall Study|Other|0|||
164428287|NCT04529538|593937313|FG000|Overall Study|Adverse Event|0|||
164428288|NCT04529538|593937314|FG001|Overall Study|Adverse Event|0|||
164428289|NCT04529538|593937315|FG002|Overall Study|Adverse Event|0|||
164428290|NCT04529538|593937316|FG003|Overall Study|Adverse Event|1|||
164428291|NCT04529538|593937317|FG004|Overall Study|Adverse Event|0|||
164428292|NCT04529538|593937318|FG005|Overall Study|Adverse Event|0|||
164428293|NCT04529538|593937319|FG006|Overall Study|Adverse Event|0|||
164428294|NCT04529538|593937320|FG007|Overall Study|Adverse Event|0|||
164428295|NCT04529538|593937313|FG000|Overall Study|Protocol Deviation|0|||
164428296|NCT04529538|593937314|FG001|Overall Study|Protocol Deviation|0|||
164428297|NCT04529538|593937315|FG002|Overall Study|Protocol Deviation|0|||
164428298|NCT04529538|593937316|FG003|Overall Study|Protocol Deviation|1|||
164428299|NCT04529538|593937317|FG004|Overall Study|Protocol Deviation|0|||
164428300|NCT04529538|593937318|FG005|Overall Study|Protocol Deviation|0|||
164428301|NCT04529538|593937319|FG006|Overall Study|Protocol Deviation|0|||
164428302|NCT04529538|593937320|FG007|Overall Study|Protocol Deviation|0|||
164428303|NCT04529538|593937313|FG000|Overall Study|Physician Decision|0|||
164428304|NCT04529538|593937314|FG001|Overall Study|Physician Decision|0|||
164428305|NCT04529538|593937315|FG002|Overall Study|Physician Decision|0|||
164428306|NCT04529538|593937316|FG003|Overall Study|Physician Decision|0|||
164428307|NCT04529538|593937317|FG004|Overall Study|Physician Decision|0|||
164428308|NCT04529538|593937318|FG005|Overall Study|Physician Decision|1|||
164428309|NCT04529538|593937319|FG006|Overall Study|Physician Decision|0|||
164428310|NCT04529538|593937320|FG007|Overall Study|Physician Decision|1|||
164428311|NCT01822821|593937322|FG000|Overall Study|Eligible surgery cancelled|1|||
164428312|NCT01822821|593937323|FG001|Overall Study|Eligible surgery cancelled|1|||
164428313|NCT01822821|593937322|FG000|Overall Study|Other reasons|1|||
164428314|NCT01822821|593937323|FG001|Overall Study|Other reasons|0|||
164428315|NCT03251378|593937326|FG000|Overall Study|Death|3|||
164428316|NCT03251378|593937327|FG001|Overall Study|Death|2|||
164428317|NCT03251378|593937328|FG002|Overall Study|Death|3|||
164428318|NCT03251378|593937329|FG003|Overall Study|Death|30|||
164428319|NCT03251378|593937330|FG004|Overall Study|Death|24|||
164428320|NCT03251378|593937331|FG005|Overall Study|Death|12|||
164428321|NCT03251378|593937332|FG006|Overall Study|Death|12|||
164428322|NCT03251378|593937326|FG000|Overall Study|Lost to Follow-up|0|||
164428323|NCT03251378|593937327|FG001|Overall Study|Lost to Follow-up|0|||
164428324|NCT03251378|593937328|FG002|Overall Study|Lost to Follow-up|1|||
164428325|NCT03251378|593937329|FG003|Overall Study|Lost to Follow-up|3|||
164428326|NCT03251378|593937330|FG004|Overall Study|Lost to Follow-up|0|||
164428327|NCT03251378|593937331|FG005|Overall Study|Lost to Follow-up|0|||
164428328|NCT03251378|593937332|FG006|Overall Study|Lost to Follow-up|0|||
164428329|NCT03251378|593937326|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
164428330|NCT03251378|593937327|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
164428331|NCT03251378|593937328|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
164576746|NCT00100048|594474829|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
164576747|NCT00100048|594474830|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
164576748|NCT00100048|594474831|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
164576749|NCT00100048|594474832|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
164576750|NCT00100048|594474833|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
164576751|NCT00100048|594474834|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
164576752|NCT00100048|594474829|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
164576753|NCT00100048|594474830|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
164576754|NCT00100048|594474831|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
164576755|NCT00100048|594474832|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
164428332|NCT03251378|593937329|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
164428333|NCT03251378|593937330|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
164257773|NCT05596734|593309943|FG001|Substudy B|Physician Decision|0|||
164257774|NCT05596734|593309944|FG002|Substudy B|Physician Decision|0|||
164428334|NCT03251378|593937331|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
164428335|NCT03251378|593937332|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
164428336|NCT03251378|593937326|FG000|Overall Study|Progressive disease|2|||
164428337|NCT03251378|593937327|FG001|Overall Study|Progressive disease|0|||
164428338|NCT03251378|593937328|FG002|Overall Study|Progressive disease|0|||
164428339|NCT03251378|593937329|FG003|Overall Study|Progressive disease|1|||
164428340|NCT03251378|593937330|FG004|Overall Study|Progressive disease|0|||
164428341|NCT03251378|593937331|FG005|Overall Study|Progressive disease|0|||
164428342|NCT03251378|593937332|FG006|Overall Study|Progressive disease|0|||
164428343|NCT03251378|593937326|FG000|Overall Study|Physician Decision|0|||
164428344|NCT03251378|593937327|FG001|Overall Study|Physician Decision|2|||
164428345|NCT03251378|593937328|FG002|Overall Study|Physician Decision|0|||
164428346|NCT03251378|593937329|FG003|Overall Study|Physician Decision|0|||
164428347|NCT03251378|593937330|FG004|Overall Study|Physician Decision|0|||
164428348|NCT03251378|593937331|FG005|Overall Study|Physician Decision|0|||
164428349|NCT03251378|593937332|FG006|Overall Study|Physician Decision|0|||
164428350|NCT03251378|593937326|FG000|Overall Study|Other|2|||
164428351|NCT03251378|593937327|FG001|Overall Study|Other|3|||
164428352|NCT03251378|593937328|FG002|Overall Study|Other|2|||
164428353|NCT03251378|593937329|FG003|Overall Study|Other|0|||
164428354|NCT03251378|593937330|FG004|Overall Study|Other|1|||
164428355|NCT03251378|593937331|FG005|Overall Study|Other|1|||
164428356|NCT03251378|593937332|FG006|Overall Study|Other|1|||
164428357|NCT03251378|593937326|FG000|Overall Study|Other|0|||
164428358|NCT03251378|593937327|FG001|Overall Study|Other|0|||
164428359|NCT03251378|593937328|FG002|Overall Study|Other|0|||
164428360|NCT03251378|593937329|FG003|Overall Study|Other|4|||
164428361|NCT03251378|593937330|FG004|Overall Study|Other|13|||
164428362|NCT03251378|593937331|FG005|Overall Study|Other|0|||
164428363|NCT03251378|593937332|FG006|Overall Study|Other|0|||
164428364|NCT02322775|593937337|FG000|Overall Study|Adverse Event|1|||
164428365|NCT02322775|593937338|FG001|Overall Study|Adverse Event|0|||
164428366|NCT02322775|593937337|FG000|Overall Study|Lost to Follow-up|0|||
164428367|NCT02322775|593937338|FG001|Overall Study|Lost to Follow-up|1|||
164428368|NCT02322775|593937337|FG000|Overall Study|Protocol Violation|1|||
164428369|NCT02322775|593937338|FG001|Overall Study|Protocol Violation|0|||
164428370|NCT02322775|593937337|FG000|Overall Study|Withdrawal by Subject|3|||
164428371|NCT02322775|593937338|FG001|Overall Study|Withdrawal by Subject|4|||
164680667|NCT00112437|594854571|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
164680668|NCT00112437|594854572|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
164428372|NCT02322775|593937337|FG000|Overall Study|Not willing to perform all FU visits|0|||
164428373|NCT02322775|593937338|FG001|Overall Study|Not willing to perform all FU visits|1|||
164428374|NCT05780047|593937339|FG000|Overall Study|Did not submit baseline urine test kit|226|||
164428375|NCT05780047|593937339|FG000|Overall Study|Lost to Follow-up|34|||
164680669|NCT00112437|594854573|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
164680670|NCT00112437|594854574|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
164428376|NCT05780047|593937339|FG000|Overall Study|Did not submit second urine test kit|124|||
164428377|NCT01007552|593937342|FG000|Overall Study|Withdrawal by Subject|1|||
164428378|NCT03212365|593937358|FG000|Overall Study|Discharged prior to Xa level|12|||
164428379|NCT03212365|593937359|FG001|Overall Study|Discharged prior to Xa level|8|||
164428380|NCT03212365|593937358|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
164428381|NCT03212365|593937359|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
164428382|NCT03212365|593937358|FG000|Overall Study|Refused study medication|3|||
164428383|NCT03212365|593937359|FG001|Overall Study|Refused study medication|0|||
164428384|NCT03212365|593937358|FG000|Overall Study|Initiated heparin infusion on floor|1|||
164428385|NCT03212365|593937359|FG001|Overall Study|Initiated heparin infusion on floor|1|||
164428386|NCT03212365|593937358|FG000|Overall Study|Unexpected return to OR|1|||
164428387|NCT03212365|593937359|FG001|Overall Study|Unexpected return to OR|1|||
164428388|NCT03212365|593937358|FG000|Overall Study|Medication distribution error|1|||
164428389|NCT03212365|593937359|FG001|Overall Study|Medication distribution error|0|||
164680671|NCT00112437|594854575|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
164680672|NCT00112437|594854576|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
164680673|NCT00112437|594854577|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
164680674|NCT00112437|594854578|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
164680675|NCT00112437|594854579|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
164680676|NCT00112437|594854580|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
164428390|NCT03212365|593937358|FG000|Overall Study|Required epidural placement|1|||
164428391|NCT03212365|593937359|FG001|Overall Study|Required epidural placement|0|||
164428392|NCT03212365|593937358|FG000|Overall Study|Withdrawal by Subject|0|||
164428393|NCT03212365|593937359|FG001|Overall Study|Withdrawal by Subject|1|||
164428394|NCT03212365|593937358|FG000|Overall Study|developed acute renal failure|0|||
164680677|NCT00112437|594854581|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
164680678|NCT00112437|594854582|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
164680679|NCT00112437|594854583|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
164680680|NCT00112437|594854584|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
164428395|NCT03212365|593937359|FG001|Overall Study|developed acute renal failure|1|||
164428396|NCT00333138|593937360|FG000|Core Study (6 Months)|Adverse Event|4|||
164257775|NCT05596734|593309945|FG003|Substudy B|Physician Decision|0|||
164257776|NCT05596734|593309946|FG004|Substudy B|Physician Decision|0|||
164257777|NCT05596734|593309947|FG005|Substudy B|Physician Decision|0|||
164257778|NCT05596734|593309948|FG006|Substudy B|Physician Decision|0|||
164680681|NCT00112437|594854585|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
164680682|NCT00112437|594854586|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
164680683|NCT00112437|594854587|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
164680684|NCT00112437|594854588|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
164680685|NCT00112437|594854589|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
164680686|NCT00112437|594854590|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
164680687|NCT00112437|594854591|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
164680688|NCT00112437|594854592|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
164680689|NCT00112437|594854593|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
164680690|NCT00112437|594854594|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
164680691|NCT00112437|594854595|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
164680692|NCT00112437|594854596|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
164680693|NCT00112437|594854571|FG000|Year 2 (12-Month Extension)|Moved|0|||
164680694|NCT00112437|594854572|FG001|Year 2 (12-Month Extension)|Moved|0|||
164680695|NCT00112437|594854573|FG002|Year 2 (12-Month Extension)|Moved|0|||
164680696|NCT00112437|594854574|FG003|Year 2 (12-Month Extension)|Moved|0|||
164680697|NCT00112437|594854575|FG004|Year 2 (12-Month Extension)|Moved|0|||
164680698|NCT00112437|594854576|FG005|Year 2 (12-Month Extension)|Moved|0|||
164680699|NCT00112437|594854577|FG006|Year 2 (12-Month Extension)|Moved|0|||
164680700|NCT00112437|594854578|FG007|Year 2 (12-Month Extension)|Moved|0|||
164680701|NCT00112437|594854579|FG008|Year 2 (12-Month Extension)|Moved|0|||
164680702|NCT00112437|594854580|FG009|Year 2 (12-Month Extension)|Moved|1|||
164680703|NCT00112437|594854581|FG010|Year 2 (12-Month Extension)|Moved|0|||
164680704|NCT00112437|594854582|FG011|Year 2 (12-Month Extension)|Moved|0|||
164680705|NCT00112437|594854583|FG012|Year 2 (12-Month Extension)|Moved|0|||
164680706|NCT00112437|594854584|FG013|Year 2 (12-Month Extension)|Moved|0|||
164680707|NCT00112437|594854585|FG014|Year 2 (12-Month Extension)|Moved|0|||
164680708|NCT00112437|594854586|FG015|Year 2 (12-Month Extension)|Moved|0|||
164680709|NCT00112437|594854587|FG016|Year 2 (12-Month Extension)|Moved|0|||
164680710|NCT00112437|594854588|FG017|Year 2 (12-Month Extension)|Moved|0|||
164680711|NCT00112437|594854589|FG018|Year 2 (12-Month Extension)|Moved|0|||
164680712|NCT00112437|594854590|FG019|Year 2 (12-Month Extension)|Moved|0|||
164680713|NCT00112437|594854591|FG020|Year 2 (12-Month Extension)|Moved|0|||
164680714|NCT00112437|594854592|FG021|Year 2 (12-Month Extension)|Moved|0|||
164680715|NCT00112437|594854593|FG022|Year 2 (12-Month Extension)|Moved|0|||
164680716|NCT00112437|594854594|FG023|Year 2 (12-Month Extension)|Moved|0|||
164680717|NCT00112437|594854595|FG024|Year 2 (12-Month Extension)|Moved|0|||
164680718|NCT00112437|594854596|FG025|Year 2 (12-Month Extension)|Moved|0|||
164680719|NCT00112437|594854571|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
164680720|NCT00112437|594854572|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
164680721|NCT00112437|594854573|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
164680722|NCT00112437|594854574|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
164680723|NCT00112437|594854575|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
164680724|NCT00112437|594854576|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
164680725|NCT00112437|594854577|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
164680726|NCT00112437|594854578|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
164680727|NCT00112437|594854579|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
164680728|NCT00112437|594854580|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
164680729|NCT00112437|594854581|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
164680730|NCT00112437|594854582|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
164680731|NCT00112437|594854583|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
164680732|NCT00112437|594854584|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
164680733|NCT00112437|594854585|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
164680734|NCT00112437|594854586|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
164680735|NCT00112437|594854587|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
164680736|NCT00112437|594854588|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
164680737|NCT00112437|594854589|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
164680738|NCT00112437|594854590|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
164680739|NCT00112437|594854591|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
164680740|NCT00112437|594854592|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
164680741|NCT00112437|594854593|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
164680742|NCT00112437|594854594|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
164680743|NCT00112437|594854595|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
164680744|NCT00112437|594854596|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
164680745|NCT00112437|594854571|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164257779|NCT05596734|593309949|FG007|Substudy B|Physician Decision|0|||
164680746|NCT00112437|594854572|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164680747|NCT00112437|594854573|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164680748|NCT00112437|594854574|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164257780|NCT05596734|593309950|FG008|Substudy B|Physician Decision|0|||
164257781|NCT05596734|593309951|FG009|Substudy B|Physician Decision|0|||
164428397|NCT00333138|593937361|FG001|Core Study (6 Months)|Adverse Event|5|||
164680749|NCT00112437|594854575|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164680750|NCT00112437|594854576|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164680751|NCT00112437|594854577|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164680752|NCT00112437|594854578|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164680753|NCT00112437|594854579|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164680754|NCT00112437|594854580|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164680755|NCT00112437|594854581|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164680756|NCT00112437|594854582|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
164680757|NCT00112437|594854583|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164680758|NCT00112437|594854584|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
164428398|NCT00333138|593937362|FG002|Core Study (6 Months)|Adverse Event|8|||
164428399|NCT00333138|593937360|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
164428400|NCT00333138|593937361|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
164680759|NCT00112437|594854585|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164680760|NCT00112437|594854586|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
164680761|NCT00112437|594854587|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164680762|NCT00112437|594854588|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164680763|NCT00112437|594854589|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
164680764|NCT00112437|594854590|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164680765|NCT00112437|594854591|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164680766|NCT00112437|594854592|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164680767|NCT00112437|594854593|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164680768|NCT00112437|594854594|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164680769|NCT00112437|594854595|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164428401|NCT00333138|593937362|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
164428402|NCT00333138|593937360|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
164428403|NCT00333138|593937361|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
164428404|NCT00333138|593937362|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
164428405|NCT00333138|593937360|FG000|Core Study (6 Months)|Protocol Violation|1|||
164428406|NCT00333138|593937361|FG001|Core Study (6 Months)|Protocol Violation|0|||
164428407|NCT00333138|593937362|FG002|Core Study (6 Months)|Protocol Violation|1|||
164428408|NCT00333138|593937360|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
164428409|NCT00333138|593937361|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
164428410|NCT00333138|593937362|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
164428411|NCT00333138|593937360|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
164428412|NCT00333138|593937361|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
164428413|NCT00333138|593937362|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
164428414|NCT00333138|593937360|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
164428415|NCT00333138|593937361|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
164257782|NCT05596734|593309952|FG010|Substudy B|Physician Decision|0|||
164257783|NCT05596734|593309953|FG011|Substudy B|Physician Decision|0|||
164257784|NCT05596734|593309954|FG012|Substudy B|Physician Decision|0|||
164257785|NCT05596734|593309955|FG013|Substudy B|Physician Decision|0|||
164257786|NCT05596734|593309956|FG014|Substudy B|Physician Decision|0|||
164257787|NCT05596734|593309957|FG015|Substudy B|Physician Decision|1|||
164257788|NCT05596734|593309958|FG016|Substudy B|Physician Decision|0|||
164257789|NCT05596734|593309959|FG017|Substudy B|Physician Decision|0|||
164257790|NCT05596734|593309960|FG018|Substudy B|Physician Decision|0|||
164428416|NCT00333138|593937362|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
164428417|NCT00333138|593937360|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
164428418|NCT00333138|593937361|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
164428419|NCT00333138|593937362|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
164428420|NCT00333138|593937360|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
164428421|NCT00333138|593937361|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
164428422|NCT00333138|593937362|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
164428423|NCT00333138|593937360|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
164428424|NCT00333138|593937361|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
164428425|NCT00333138|593937362|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
164428426|NCT00333138|593937360|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
164428427|NCT00333138|593937361|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
164428428|NCT00333138|593937362|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
164428429|NCT00333138|593937360|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
164428430|NCT00333138|593937361|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
164428431|NCT00333138|593937362|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
164428432|NCT00333138|593937360|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
164257791|NCT05596734|593309961|FG019|Substudy B|Physician Decision|0|||
164257792|NCT05596734|593309962|FG020|Substudy B|Physician Decision|0|||
164257793|NCT05596734|593309963|FG021|Substudy B|Physician Decision|0|||
164257794|NCT05596734|593309964|FG022|Substudy B|Physician Decision|0|||
164257795|NCT05596734|593309965|FG023|Substudy B|Physician Decision|0|||
164257796|NCT05596734|593309942|FG000|Substudy B|Lost to Follow-up|0|||
164257797|NCT05596734|593309943|FG001|Substudy B|Lost to Follow-up|0|||
164257798|NCT05596734|593309944|FG002|Substudy B|Lost to Follow-up|0|||
164428433|NCT00333138|593937361|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
164428434|NCT00333138|593937362|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
164428435|NCT00333138|593937360|FG000|Extension Study (Month6 to End of Study)|Death|0|||
164428436|NCT00333138|593937361|FG001|Extension Study (Month6 to End of Study)|Death|1|||
164428437|NCT00333138|593937362|FG002|Extension Study (Month6 to End of Study)|Death|0|||
164428438|NCT03005288|593937363|FG000|Overall Study|Withdrawal by Subject|7|||
164428439|NCT03005288|593937364|FG001|Overall Study|Withdrawal by Subject|5|||
164428440|NCT03005288|593937363|FG000|Overall Study|Lost to Follow-up|0|||
164428441|NCT03005288|593937364|FG001|Overall Study|Lost to Follow-up|1|||
164428442|NCT03005288|593937363|FG000|Overall Study|Adverse Event|5|||
164428443|NCT03005288|593937364|FG001|Overall Study|Adverse Event|0|||
164428444|NCT03005288|593937363|FG000|Overall Study|Protocol deviation|0|||
164428445|NCT03005288|593937364|FG001|Overall Study|Protocol deviation|1|||
164257799|NCT05596734|593309945|FG003|Substudy B|Lost to Follow-up|0|||
164257800|NCT05596734|593309946|FG004|Substudy B|Lost to Follow-up|0|||
164257801|NCT05596734|593309947|FG005|Substudy B|Lost to Follow-up|0|||
164257802|NCT05596734|593309948|FG006|Substudy B|Lost to Follow-up|0|||
164257803|NCT05596734|593309949|FG007|Substudy B|Lost to Follow-up|0|||
164428446|NCT03005288|593937363|FG000|Overall Study|Physician Decision|0|||
164680770|NCT00112437|594854596|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164680771|NCT00112437|594854571|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164257804|NCT05596734|593309950|FG008|Substudy B|Lost to Follow-up|0|||
164257805|NCT05596734|593309951|FG009|Substudy B|Lost to Follow-up|0|||
164257806|NCT05596734|593309952|FG010|Substudy B|Lost to Follow-up|0|||
164257807|NCT05596734|593309953|FG011|Substudy B|Lost to Follow-up|0|||
164257808|NCT05596734|593309954|FG012|Substudy B|Lost to Follow-up|1|||
164257809|NCT05596734|593309955|FG013|Substudy B|Lost to Follow-up|0|||
164257810|NCT05596734|593309956|FG014|Substudy B|Lost to Follow-up|1|||
164257811|NCT05596734|593309957|FG015|Substudy B|Lost to Follow-up|1|||
164257812|NCT05596734|593309958|FG016|Substudy B|Lost to Follow-up|0|||
164257813|NCT05596734|593309959|FG017|Substudy B|Lost to Follow-up|0|||
164257814|NCT05596734|593309960|FG018|Substudy B|Lost to Follow-up|0|||
164257815|NCT05596734|593309961|FG019|Substudy B|Lost to Follow-up|0|||
164257816|NCT05596734|593309962|FG020|Substudy B|Lost to Follow-up|0|||
164257817|NCT05596734|593309963|FG021|Substudy B|Lost to Follow-up|0|||
164257818|NCT05596734|593309964|FG022|Substudy B|Lost to Follow-up|0|||
164257819|NCT05596734|593309965|FG023|Substudy B|Lost to Follow-up|0|||
164257820|NCT02118766|593309970|FG000|Overall Study|Adverse Event|7|||
164257821|NCT02118766|593309971|FG001|Overall Study|Adverse Event|2|||
164257822|NCT02118766|593309970|FG000|Overall Study|Withdrawal by Subject|3|||
164257823|NCT02118766|593309971|FG001|Overall Study|Withdrawal by Subject|6|||
164257824|NCT02118766|593309970|FG000|Overall Study|Lost to Follow-up|5|||
164339777|NCT00347360|593618958|FG005|Overall Study|Randomized in error|0|||
164339778|NCT00347360|593618959|FG006|Overall Study|Randomized in error|0|||
164339779|NCT00347360|593618960|FG007|Overall Study|Randomized in error|0|||
164680772|NCT00112437|594854572|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164680773|NCT00112437|594854573|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164257825|NCT02118766|593309971|FG001|Overall Study|Lost to Follow-up|4|||
164257826|NCT02118766|593309970|FG000|Overall Study|Withdrawal by parent/guardian|12|||
164339780|NCT00347360|593618961|FG008|Overall Study|Randomized in error|0|||
164339781|NCT00347360|593618962|FG009|Overall Study|Randomized in error|0|||
164339782|NCT00347360|593618963|FG010|Overall Study|Randomized in error|0|||
164339783|NCT00347360|593618964|FG011|Overall Study|Randomized in error|1|||
164339784|NCT00347360|593618965|FG012|Overall Study|Randomized in error|0|||
164339785|NCT00347360|593618966|FG013|Overall Study|Randomized in error|0|||
164339786|NCT00347360|593618967|FG014|Overall Study|Randomized in error|0|||
164339787|NCT00347360|593618953|FG000|Overall Study|Failed inclusion criteria #4|0|||
164339788|NCT00347360|593618954|FG001|Overall Study|Failed inclusion criteria #4|0|||
164339789|NCT00347360|593618955|FG002|Overall Study|Failed inclusion criteria #4|0|||
164339790|NCT00347360|593618956|FG003|Overall Study|Failed inclusion criteria #4|0|||
164339791|NCT00347360|593618957|FG004|Overall Study|Failed inclusion criteria #4|0|||
164339792|NCT00347360|593618958|FG005|Overall Study|Failed inclusion criteria #4|0|||
164339793|NCT00347360|593618959|FG006|Overall Study|Failed inclusion criteria #4|0|||
164339794|NCT00347360|593618960|FG007|Overall Study|Failed inclusion criteria #4|0|||
164339795|NCT00347360|593618961|FG008|Overall Study|Failed inclusion criteria #4|0|||
164339796|NCT00347360|593618962|FG009|Overall Study|Failed inclusion criteria #4|0|||
164339797|NCT00347360|593618963|FG010|Overall Study|Failed inclusion criteria #4|0|||
164339798|NCT00347360|593618964|FG011|Overall Study|Failed inclusion criteria #4|1|||
164339799|NCT00347360|593618965|FG012|Overall Study|Failed inclusion criteria #4|0|||
164339800|NCT00347360|593618966|FG013|Overall Study|Failed inclusion criteria #4|0|||
164339801|NCT00347360|593618967|FG014|Overall Study|Failed inclusion criteria #4|0|||
164339802|NCT00347360|593618953|FG000|Overall Study|Prolonged duration between visits|0|||
164339803|NCT00347360|593618954|FG001|Overall Study|Prolonged duration between visits|0|||
164339804|NCT00347360|593618955|FG002|Overall Study|Prolonged duration between visits|0|||
164339805|NCT00347360|593618956|FG003|Overall Study|Prolonged duration between visits|0|||
164339806|NCT00347360|593618957|FG004|Overall Study|Prolonged duration between visits|0|||
164339807|NCT00347360|593618958|FG005|Overall Study|Prolonged duration between visits|0|||
164339808|NCT00347360|593618959|FG006|Overall Study|Prolonged duration between visits|0|||
164339809|NCT00347360|593618960|FG007|Overall Study|Prolonged duration between visits|0|||
164339810|NCT00347360|593618961|FG008|Overall Study|Prolonged duration between visits|0|||
164339811|NCT00347360|593618962|FG009|Overall Study|Prolonged duration between visits|0|||
164339812|NCT00347360|593618963|FG010|Overall Study|Prolonged duration between visits|0|||
164339813|NCT00347360|593618964|FG011|Overall Study|Prolonged duration between visits|0|||
164339814|NCT00347360|593618965|FG012|Overall Study|Prolonged duration between visits|1|||
164339815|NCT00347360|593618966|FG013|Overall Study|Prolonged duration between visits|0|||
164339816|NCT00347360|593618967|FG014|Overall Study|Prolonged duration between visits|0|||
164257827|NCT02118766|593309971|FG001|Overall Study|Withdrawal by parent/guardian|18|||
164257828|NCT02118766|593309970|FG000|Overall Study|Other|3|||
164339817|NCT00347360|593618953|FG000|Overall Study|Subject left town, ran out of study drug|0|||
164339818|NCT00347360|593618954|FG001|Overall Study|Subject left town, ran out of study drug|0|||
164339819|NCT00347360|593618955|FG002|Overall Study|Subject left town, ran out of study drug|0|||
164339820|NCT00347360|593618956|FG003|Overall Study|Subject left town, ran out of study drug|0|||
164339821|NCT00347360|593618957|FG004|Overall Study|Subject left town, ran out of study drug|0|||
164428447|NCT03005288|593937364|FG001|Overall Study|Physician Decision|1|||
164428448|NCT04011033|593937365|FG000|Overall Study|Physician Decision|2|||
164428449|NCT04011033|593937366|FG001|Overall Study|Physician Decision|3|||
164428450|NCT04011033|593937365|FG000|Overall Study|Withdrawal by Subject|1|||
164428451|NCT04011033|593937366|FG001|Overall Study|Withdrawal by Subject|0|||
164428452|NCT01823341|593937367|FG000|Overall Study|Failed run-in|7|||
164428453|NCT01823341|593937367|FG000|Overall Study|Withdrawal by Subject|7|||
164428454|NCT01823341|593937367|FG000|Overall Study|Adverse Event|1|||
164428455|NCT01449929|593937383|FG000|Randomization Phase 96 Week|Adverse Event|5|||
164428456|NCT01449929|593937384|FG001|Randomization Phase 96 Week|Adverse Event|13|||
164428457|NCT01449929|593937385|FG002|Randomization Phase 96 Week|Adverse Event|0|||
164428458|NCT01449929|593937383|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
164257829|NCT02118766|593309971|FG001|Overall Study|Other|1|||
164257830|NCT04210245|593309972|FG000|Overall Study|Adverse Event|0|||
164257831|NCT04210245|593309973|FG001|Overall Study|Adverse Event|3|||
164257832|NCT04210245|593309974|FG002|Overall Study|Adverse Event|6|||
164257833|NCT04210245|593309975|FG003|Overall Study|Adverse Event|0|||
164257834|NCT04210245|593309972|FG000|Overall Study|Withdrawal by Subject|0|||
164257835|NCT04210245|593309973|FG001|Overall Study|Withdrawal by Subject|1|||
164257836|NCT04210245|593309974|FG002|Overall Study|Withdrawal by Subject|4|||
164257837|NCT04210245|593309975|FG003|Overall Study|Withdrawal by Subject|4|||
164428459|NCT01449929|593937384|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
164257838|NCT04210245|593309972|FG000|Overall Study|Lost to Follow-up|0|||
164257839|NCT04210245|593309973|FG001|Overall Study|Lost to Follow-up|1|||
164257840|NCT04210245|593309974|FG002|Overall Study|Lost to Follow-up|1|||
164257841|NCT04210245|593309975|FG003|Overall Study|Lost to Follow-up|1|||
164257842|NCT04210245|593309972|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
164257843|NCT04210245|593309973|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
164257844|NCT04210245|593309974|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
164257845|NCT04210245|593309975|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
164257846|NCT02248649|593309976|FG000|Overall Study|Death|7|||
164257847|NCT02248649|593309977|FG001|Overall Study|Death|11|||
164257848|NCT02248649|593309976|FG000|Overall Study|Lost to Follow-up|14|||
164257849|NCT02248649|593309977|FG001|Overall Study|Lost to Follow-up|10|||
164257850|NCT04621240|593309983|FG000|Overall Study|Withdrawal by Subject|36|||
164257851|NCT01221623|593309984|FG000|Overall Study|Withdrawal by Subject|19|||
164576756|NCT00100048|594474833|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
164576757|NCT00100048|594474834|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
164576758|NCT00100048|594474829|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
164576759|NCT00100048|594474830|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
164576760|NCT00100048|594474831|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
164576761|NCT00100048|594474832|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
164576762|NCT00100048|594474833|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
164576763|NCT00100048|594474834|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
164576764|NCT01822561|594474836|FG000|Overall Study|Withdrawal by Subject|2|||
164576765|NCT02747004|594474837|FG000|Overall Study|Withdrawal by Subject|8|||
164576766|NCT02747004|594474838|FG001|Overall Study|Withdrawal by Subject|5|||
164576767|NCT02747004|594474839|FG002|Overall Study|Withdrawal by Subject|4|||
164576768|NCT02747004|594474837|FG000|Overall Study|Lost to Follow-up|1|||
164576769|NCT02747004|594474838|FG001|Overall Study|Lost to Follow-up|2|||
164576770|NCT02747004|594474839|FG002|Overall Study|Lost to Follow-up|2|||
164576771|NCT02747004|594474837|FG000|Overall Study|on study treatment/follow-up|48|||
164576772|NCT02747004|594474838|FG001|Overall Study|on study treatment/follow-up|42|||
164576773|NCT02747004|594474839|FG002|Overall Study|on study treatment/follow-up|41|||
164576774|NCT01444300|594474840|FG000|Overall Study|Adverse Event|4|||
164576775|NCT01444300|594474841|FG001|Overall Study|Adverse Event|0|||
164576776|NCT04885257|594474843|FG000|Overall Study|Withdrawal by Subject|1|||
164576777|NCT04885257|594474844|FG001|Overall Study|Withdrawal by Subject|0|||
164576778|NCT00818259|594474845|FG000|Part I|Withdrawal by Subject|1|||
164576779|NCT00818259|594474846|FG001|Part I|Withdrawal by Subject|0|||
164576780|NCT00818259|594474847|FG002|Part I|Withdrawal by Subject|0|||
164257852|NCT01221623|593309985|FG001|Overall Study|Withdrawal by Subject|8|||
164257853|NCT01221623|593309984|FG000|Overall Study|Lost to Follow-up|7|||
164428460|NCT01449929|593937385|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
164428461|NCT01449929|593937383|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
164576781|NCT00818259|594474848|FG003|Part I|Withdrawal by Subject|0|||
164576782|NCT00818259|594474849|FG004|Part I|Withdrawal by Subject|0|||
164576783|NCT00818259|594474850|FG005|Part I|Withdrawal by Subject|0|||
164576784|NCT00818259|594474851|FG006|Part I|Withdrawal by Subject|0|||
164257854|NCT01221623|593309985|FG001|Overall Study|Lost to Follow-up|1|||
164257855|NCT01221623|593309984|FG000|Overall Study|Adverse Event|6|||
164257856|NCT01221623|593309985|FG001|Overall Study|Adverse Event|3|||
164257857|NCT01221623|593309984|FG000|Overall Study|Death|1|||
164257858|NCT01221623|593309985|FG001|Overall Study|Death|0|||
164257859|NCT01221623|593309984|FG000|Overall Study|Other|5|||
164257860|NCT01221623|593309985|FG001|Overall Study|Other|2|||
164257861|NCT00780143|593309986|FG000|Overall Study|Progressive disease|1|||
164257862|NCT00780143|593309986|FG000|Overall Study|Toxicity|1|||
164257863|NCT00780143|593309986|FG000|Overall Study|Adverse Event|1|||
164257864|NCT00830375|593309991|FG000|Overall Study|Lost to Follow-up|1|||
164257865|NCT01700959|593309992|FG000|Overall Study|Adverse Event|0|||
164257866|NCT01700959|593309993|FG001|Overall Study|Adverse Event|1|||
164257867|NCT01700959|593309994|FG002|Overall Study|Adverse Event|1|||
164257868|NCT01700959|593309995|FG003|Overall Study|Adverse Event|2|||
164257869|NCT01700959|593309996|FG004|Overall Study|Adverse Event|0|||
164257870|NCT01700959|593309997|FG005|Overall Study|Adverse Event|2|||
164428462|NCT01449929|593937384|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
164428463|NCT01449929|593937385|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
164428464|NCT01449929|593937383|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
164428465|NCT01449929|593937384|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
164428466|NCT01449929|593937385|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
164428467|NCT01449929|593937383|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
164680774|NCT00112437|594854574|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164680775|NCT00112437|594854575|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164680776|NCT00112437|594854576|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164680777|NCT00112437|594854577|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164680778|NCT00112437|594854578|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164680779|NCT00112437|594854579|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164680780|NCT00112437|594854580|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164680781|NCT00112437|594854581|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164680782|NCT00112437|594854582|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164680783|NCT00112437|594854583|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164680784|NCT00112437|594854584|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164257871|NCT01700959|593309992|FG000|Overall Study|Withdrawal by Subject|15|||
164257872|NCT01700959|593309993|FG001|Overall Study|Withdrawal by Subject|9|||
164257873|NCT01700959|593309994|FG002|Overall Study|Withdrawal by Subject|12|||
164428468|NCT01449929|593937384|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
164428469|NCT01449929|593937385|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
164428470|NCT01449929|593937383|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
164428471|NCT01449929|593937384|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
164428472|NCT01449929|593937385|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
164428473|NCT01449929|593937383|FG000|Randomization Phase 96 Week|Physician Decision|2|||
164576785|NCT00818259|594474852|FG007|Part I|Withdrawal by Subject|0|||
164576786|NCT00818259|594474853|FG008|Part I|Withdrawal by Subject|0|||
164576787|NCT00818259|594474845|FG000|Part II|Physician Decision|0|||
164576788|NCT00818259|594474846|FG001|Part II|Physician Decision|0|||
164576789|NCT00818259|594474847|FG002|Part II|Physician Decision|1|||
164576790|NCT00818259|594474848|FG003|Part II|Physician Decision|0|||
164576791|NCT00818259|594474849|FG004|Part II|Physician Decision|0|||
164576792|NCT00818259|594474850|FG005|Part II|Physician Decision|0|||
164576793|NCT00818259|594474851|FG006|Part II|Physician Decision|0|||
164339822|NCT00347360|593618958|FG005|Overall Study|Subject left town, ran out of study drug|0|||
164576794|NCT00818259|594474852|FG007|Part II|Physician Decision|0|||
164576795|NCT00818259|594474853|FG008|Part II|Physician Decision|0|||
164576796|NCT00818259|594474845|FG000|Part II|Lack of Efficacy|0|||
164576797|NCT00818259|594474846|FG001|Part II|Lack of Efficacy|0|||
164576798|NCT00818259|594474847|FG002|Part II|Lack of Efficacy|0|||
164576799|NCT00818259|594474848|FG003|Part II|Lack of Efficacy|1|||
164576800|NCT00818259|594474849|FG004|Part II|Lack of Efficacy|0|||
164576801|NCT00818259|594474850|FG005|Part II|Lack of Efficacy|0|||
164576802|NCT00818259|594474851|FG006|Part II|Lack of Efficacy|0|||
164576803|NCT00818259|594474852|FG007|Part II|Lack of Efficacy|0|||
164576804|NCT00818259|594474853|FG008|Part II|Lack of Efficacy|0|||
164257874|NCT01700959|593309995|FG003|Overall Study|Withdrawal by Subject|11|||
164257875|NCT01700959|593309996|FG004|Overall Study|Withdrawal by Subject|8|||
164257876|NCT01700959|593309997|FG005|Overall Study|Withdrawal by Subject|12|||
164339823|NCT00347360|593618959|FG006|Overall Study|Subject left town, ran out of study drug|0|||
164339824|NCT00347360|593618960|FG007|Overall Study|Subject left town, ran out of study drug|0|||
164339825|NCT00347360|593618961|FG008|Overall Study|Subject left town, ran out of study drug|0|||
164339826|NCT00347360|593618962|FG009|Overall Study|Subject left town, ran out of study drug|0|||
164339827|NCT00347360|593618963|FG010|Overall Study|Subject left town, ran out of study drug|0|||
164339828|NCT00347360|593618964|FG011|Overall Study|Subject left town, ran out of study drug|0|||
164339829|NCT00347360|593618965|FG012|Overall Study|Subject left town, ran out of study drug|0|||
164576805|NCT00818259|594474845|FG000|Part II|Not Treated|0|||
164680785|NCT00112437|594854585|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164257877|NCT01700959|593309992|FG000|Overall Study|Ineligible|2|||
164257878|NCT01700959|593309993|FG001|Overall Study|Ineligible|1|||
164257879|NCT01700959|593309994|FG002|Overall Study|Ineligible|2|||
164257880|NCT01700959|593309995|FG003|Overall Study|Ineligible|0|||
164257881|NCT01700959|593309996|FG004|Overall Study|Ineligible|0|||
164257882|NCT01700959|593309997|FG005|Overall Study|Ineligible|1|||
164257883|NCT01700959|593309992|FG000|Overall Study|Noncompliant|9|||
164257884|NCT01700959|593309993|FG001|Overall Study|Noncompliant|9|||
164257885|NCT01700959|593309994|FG002|Overall Study|Noncompliant|17|||
164428474|NCT01449929|593937384|FG001|Randomization Phase 96 Week|Physician Decision|3|||
164428475|NCT01449929|593937385|FG002|Randomization Phase 96 Week|Physician Decision|0|||
164428476|NCT01449929|593937383|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
164428477|NCT01449929|593937384|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
164428478|NCT01449929|593937385|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
164428479|NCT01449929|593937383|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
164428480|NCT01449929|593937384|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
164428481|NCT01449929|593937385|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
164428482|NCT01449929|593937383|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
164428483|NCT01449929|593937384|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
164428484|NCT01449929|593937385|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
164428485|NCT01449929|593937383|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
164428486|NCT01449929|593937384|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
164428487|NCT01449929|593937385|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
164428488|NCT03253653|593937386|FG000|Overall Study|Withdrawal by Subject|4|||
164428489|NCT03253653|593937387|FG001|Overall Study|Withdrawal by Subject|1|||
164428490|NCT03253653|593937386|FG000|Overall Study|Protocol Violation|0|||
164428491|NCT03253653|593937387|FG001|Overall Study|Protocol Violation|5|||
164428492|NCT00946114|593939361|FG000|Overall Study|Death|5|||
164428493|NCT00946114|593939362|FG001|Overall Study|Death|2|||
164428494|NCT00946114|593939361|FG000|Overall Study|Other|1|||
164680786|NCT00112437|594854586|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
164680787|NCT00112437|594854587|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164680788|NCT00112437|594854588|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164680789|NCT00112437|594854589|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164680790|NCT00112437|594854590|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164680791|NCT00112437|594854591|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164680792|NCT00112437|594854592|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164680793|NCT00112437|594854593|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164680794|NCT00112437|594854594|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164680795|NCT00112437|594854595|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164680796|NCT00112437|594854596|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164680797|NCT00112437|594854571|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
164680798|NCT00112437|594854572|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
164680799|NCT00112437|594854573|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
164680800|NCT00112437|594854574|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
164680801|NCT00112437|594854575|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
164680802|NCT00112437|594854576|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
164680803|NCT00112437|594854577|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
164680804|NCT00112437|594854578|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
164680805|NCT00112437|594854579|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
164680806|NCT00112437|594854580|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
164680807|NCT00112437|594854581|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
164680808|NCT00112437|594854582|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
164257886|NCT01700959|593309995|FG003|Overall Study|Noncompliant|18|||
164428495|NCT00946114|593939362|FG001|Overall Study|Other|0|||
164428496|NCT00946114|593939361|FG000|Overall Study|Withdrawal by Subject|2|||
164428497|NCT00946114|593939362|FG001|Overall Study|Withdrawal by Subject|0|||
164428498|NCT00723294|593939363|FG000|Overall Study|Lobular histology|2|||
164428499|NCT00723294|593939363|FG000|Overall Study|>25% intraductal component|1|||
164428500|NCT00723294|593939363|FG000|Overall Study|No MRI tumor enhancement|1|||
164428501|NCT00723294|593939363|FG000|Overall Study|1.0-Tesla MRI|1|||
164428502|NCT00723294|593939363|FG000|Overall Study|No cryoabalation|2|||
164680809|NCT00112437|594854583|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
164680810|NCT00112437|594854584|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
164680811|NCT00112437|594854585|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
164257887|NCT01700959|593309996|FG004|Overall Study|Noncompliant|15|||
164257888|NCT01700959|593309997|FG005|Overall Study|Noncompliant|9|||
164428503|NCT00723294|593939363|FG000|Overall Study|Did not undergo surgery|1|||
164428504|NCT00723294|593939363|FG000|Overall Study|Treated prior to registration|1|||
164680812|NCT00112437|594854586|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
164257889|NCT01700959|593309992|FG000|Overall Study|Side effects|1|||
164339830|NCT00347360|593618966|FG013|Overall Study|Subject left town, ran out of study drug|1|||
164339831|NCT00347360|593618967|FG014|Overall Study|Subject left town, ran out of study drug|0|||
164339832|NCT00347360|593618953|FG000|Overall Study|Subject refuse to sign updated consent|0|||
164339833|NCT00347360|593618954|FG001|Overall Study|Subject refuse to sign updated consent|0|||
164339834|NCT00347360|593618955|FG002|Overall Study|Subject refuse to sign updated consent|0|||
164339835|NCT00347360|593618956|FG003|Overall Study|Subject refuse to sign updated consent|0|||
164339836|NCT00347360|593618957|FG004|Overall Study|Subject refuse to sign updated consent|0|||
164339837|NCT00347360|593618958|FG005|Overall Study|Subject refuse to sign updated consent|0|||
164339838|NCT00347360|593618959|FG006|Overall Study|Subject refuse to sign updated consent|0|||
164339839|NCT00347360|593618960|FG007|Overall Study|Subject refuse to sign updated consent|0|||
164339840|NCT00347360|593618961|FG008|Overall Study|Subject refuse to sign updated consent|0|||
164339841|NCT00347360|593618962|FG009|Overall Study|Subject refuse to sign updated consent|0|||
164339842|NCT00347360|593618963|FG010|Overall Study|Subject refuse to sign updated consent|0|||
164339843|NCT00347360|593618964|FG011|Overall Study|Subject refuse to sign updated consent|0|||
164339844|NCT00347360|593618965|FG012|Overall Study|Subject refuse to sign updated consent|0|||
164339845|NCT00347360|593618966|FG013|Overall Study|Subject refuse to sign updated consent|0|||
164339846|NCT00347360|593618967|FG014|Overall Study|Subject refuse to sign updated consent|1|||
164339847|NCT00347360|593618953|FG000|Overall Study|Visits conflicted with new job|0|||
164339848|NCT00347360|593618954|FG001|Overall Study|Visits conflicted with new job|0|||
164339849|NCT00347360|593618955|FG002|Overall Study|Visits conflicted with new job|0|||
164339850|NCT00347360|593618956|FG003|Overall Study|Visits conflicted with new job|0|||
164339851|NCT00347360|593618957|FG004|Overall Study|Visits conflicted with new job|0|||
164339852|NCT00347360|593618958|FG005|Overall Study|Visits conflicted with new job|0|||
164339853|NCT00347360|593618959|FG006|Overall Study|Visits conflicted with new job|1|||
164339854|NCT00347360|593618960|FG007|Overall Study|Visits conflicted with new job|0|||
164339855|NCT00347360|593618961|FG008|Overall Study|Visits conflicted with new job|0|||
164339856|NCT00347360|593618962|FG009|Overall Study|Visits conflicted with new job|0|||
164339857|NCT00347360|593618963|FG010|Overall Study|Visits conflicted with new job|0|||
164339858|NCT00347360|593618964|FG011|Overall Study|Visits conflicted with new job|0|||
164339859|NCT00347360|593618965|FG012|Overall Study|Visits conflicted with new job|0|||
164339860|NCT00347360|593618966|FG013|Overall Study|Visits conflicted with new job|0|||
164339861|NCT00347360|593618967|FG014|Overall Study|Visits conflicted with new job|0|||
164339862|NCT01387789|593618970|FG000|Overall Study|Adverse Event|5|||
164339863|NCT01387789|593618970|FG000|Overall Study|Lack of Efficacy|2|||
164339864|NCT01387789|593618970|FG000|Overall Study|Lost to Follow-up|1|||
164339865|NCT00913380|593618971|FG000|Clinical Outcomes|Lost to Follow-up|6|||
164339866|NCT00913380|593618972|FG001|Clinical Outcomes|Lost to Follow-up|6|||
164339867|NCT02187744|593618973|FG000|Study|Participant refused further follow-up|1|||
164339868|NCT02187744|593618974|FG001|Study|Participant refused further follow-up|0|||
164339869|NCT02187744|593618973|FG000|Study|Other|2|||
164339870|NCT02187744|593618974|FG001|Study|Other|1|||
164339871|NCT02187744|593618973|FG000|Study|Lost to Follow-up|0|||
164339872|NCT02187744|593618974|FG001|Study|Lost to Follow-up|2|||
164339873|NCT02187744|593618973|FG000|Study|Related adverse event, not serious|0|||
164339874|NCT02187744|593618974|FG001|Study|Related adverse event, not serious|2|||
164339875|NCT02187744|593618973|FG000|Study|Death|1|||
164339876|NCT02187744|593618974|FG001|Study|Death|0|||
164339877|NCT02187744|593618973|FG000|Study|Related adverse event, serious non-fatal|0|||
164339878|NCT02187744|593618974|FG001|Study|Related adverse event, serious non-fatal|1|||
164576806|NCT00818259|594474846|FG001|Part II|Not Treated|0|||
164576807|NCT00818259|594474847|FG002|Part II|Not Treated|0|||
164576808|NCT00818259|594474848|FG003|Part II|Not Treated|1|||
164576809|NCT00818259|594474849|FG004|Part II|Not Treated|0|||
164576810|NCT00818259|594474850|FG005|Part II|Not Treated|0|||
164576811|NCT00818259|594474851|FG006|Part II|Not Treated|0|||
164576812|NCT00818259|594474852|FG007|Part II|Not Treated|0|||
164339879|NCT02187744|593618973|FG000|Treatment|Death|1|||
164339880|NCT02187744|593618974|FG001|Treatment|Death|0|||
164339881|NCT02187744|593618973|FG000|Treatment|Related adverse event, serious non-fatal|0|||
164339882|NCT02187744|593618974|FG001|Treatment|Related adverse event, serious non-fatal|1|||
164339883|NCT02187744|593618973|FG000|Treatment|Related adverse event, not serious|0|||
164339884|NCT02187744|593618974|FG001|Treatment|Related adverse event, not serious|2|||
164339885|NCT02187744|593618973|FG000|Treatment|Lost to Follow-up|0|||
164576813|NCT00818259|594474853|FG008|Part II|Not Treated|0|||
164576814|NCT00818259|594474845|FG000|Part IV|Physician Decision|0|||
164576815|NCT00818259|594474846|FG001|Part IV|Physician Decision|0|||
164257890|NCT01700959|593309993|FG001|Overall Study|Side effects|4|||
164257891|NCT01700959|593309994|FG002|Overall Study|Side effects|8|||
164257892|NCT01700959|593309995|FG003|Overall Study|Side effects|4|||
164257893|NCT01700959|593309996|FG004|Overall Study|Side effects|4|||
164257894|NCT01700959|593309997|FG005|Overall Study|Side effects|1|||
164257895|NCT01457014|593309998|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
164576816|NCT00818259|594474847|FG002|Part IV|Physician Decision|0|||
164576817|NCT00818259|594474848|FG003|Part IV|Physician Decision|0|||
164576818|NCT00818259|594474849|FG004|Part IV|Physician Decision|0|||
164576819|NCT00818259|594474850|FG005|Part IV|Physician Decision|1|||
164576820|NCT00818259|594474851|FG006|Part IV|Physician Decision|0|||
164576821|NCT00818259|594474852|FG007|Part IV|Physician Decision|0|||
164576822|NCT00818259|594474853|FG008|Part IV|Physician Decision|0|||
164576823|NCT00818259|594474845|FG000|Part V|Adverse Event|0|||
164576824|NCT00818259|594474846|FG001|Part V|Adverse Event|0|||
164576825|NCT00818259|594474847|FG002|Part V|Adverse Event|0|||
164257896|NCT01457014|593309999|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
164257897|NCT01457014|593310000|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
164257898|NCT01457014|593310001|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
164257899|NCT01457014|593309998|FG000|First Night|Withdrawal by Subject|3|||
164257900|NCT01457014|593309999|FG001|First Night|Withdrawal by Subject|0|||
164257901|NCT01457014|593310000|FG002|First Night|Withdrawal by Subject|0|||
164257902|NCT01457014|593310001|FG003|First Night|Withdrawal by Subject|0|||
164257903|NCT02461290|593310002|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
164257904|NCT02461290|593310002|FG000|Overall Study|Lost to Follow-up|3|||
164257905|NCT03319953|593310003|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
164257906|NCT03319953|593310004|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
164257907|NCT03319953|593310005|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
164257908|NCT03319953|593310006|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
164339886|NCT02187744|593618974|FG001|Treatment|Lost to Follow-up|1|||
164339887|NCT02187744|593618973|FG000|Treatment|Other|2|||
164339888|NCT02187744|593618974|FG001|Treatment|Other|0|||
164339889|NCT02187744|593618973|FG000|Treatment|Participant refused continued treatment|1|||
164339890|NCT02187744|593618974|FG001|Treatment|Participant refused continued treatment|1|||
164339891|NCT01788228|593618975|FG000|Overall Study|Migrated/moved from study area|1|||
164339892|NCT01788228|593618976|FG001|Overall Study|Migrated/moved from study area|0|||
164339893|NCT01972568|593618981|FG000|Overall Study|Other events|3|||
164339894|NCT01972568|593618982|FG001|Overall Study|Other events|0|||
164339895|NCT01972568|593618983|FG002|Overall Study|Other events|0|||
164339896|NCT01972568|593618981|FG000|Overall Study|Lack of Efficacy|0|||
164339897|NCT01972568|593618982|FG001|Overall Study|Lack of Efficacy|1|||
164339898|NCT01972568|593618983|FG002|Overall Study|Lack of Efficacy|2|||
164339899|NCT01972568|593618981|FG000|Overall Study|Protocol Violation|1|||
164339900|NCT01972568|593618982|FG001|Overall Study|Protocol Violation|2|||
164339901|NCT01972568|593618983|FG002|Overall Study|Protocol Violation|2|||
164339902|NCT01972568|593618981|FG000|Overall Study|Withdrawal by Subject|6|||
164339903|NCT01972568|593618982|FG001|Overall Study|Withdrawal by Subject|3|||
164339904|NCT01972568|593618983|FG002|Overall Study|Withdrawal by Subject|7|||
164339905|NCT01972568|593618981|FG000|Overall Study|Lost to Follow-up|1|||
164339906|NCT01972568|593618982|FG001|Overall Study|Lost to Follow-up|0|||
164339907|NCT01972568|593618983|FG002|Overall Study|Lost to Follow-up|0|||
164339908|NCT01972568|593618981|FG000|Overall Study|Adverse Event|5|||
164339909|NCT01972568|593618982|FG001|Overall Study|Adverse Event|6|||
164339910|NCT01972568|593618983|FG002|Overall Study|Adverse Event|5|||
164339911|NCT02059408|593618987|FG000|Overall Study|Did not get tested|0|||
164339912|NCT02059408|593618988|FG001|Overall Study|Did not get tested|330|||
164339913|NCT02059408|593618989|FG002|Overall Study|Did not get tested|358|||
164339914|NCT04223973|593618995|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
164339915|NCT04223973|593618996|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
164339916|NCT04223973|593618995|FG000|Overall Study|Adverse Event|4|||
164339917|NCT04223973|593618996|FG001|Overall Study|Adverse Event|0|||
164576826|NCT00818259|594474848|FG003|Part V|Adverse Event|0|||
164576827|NCT00818259|594474849|FG004|Part V|Adverse Event|0|||
164257909|NCT03319953|593310003|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
164257910|NCT03319953|593310004|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
164257911|NCT03319953|593310005|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
164257912|NCT03319953|593310006|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
164257913|NCT04027049|593310010|FG000|Overall Study|Withdrawn by family|1|||
164339918|NCT04223973|593618995|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
164339919|NCT04223973|593618996|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
164339920|NCT04223973|593618995|FG000|Overall Study|Physician Decision|1|||
164339921|NCT04223973|593618996|FG001|Overall Study|Physician Decision|1|||
164339922|NCT04223973|593618995|FG000|Overall Study|Withdrawal by Subject|0|||
164576828|NCT00818259|594474850|FG005|Part V|Adverse Event|0|||
164576829|NCT00818259|594474851|FG006|Part V|Adverse Event|0|||
164576830|NCT00818259|594474852|FG007|Part V|Adverse Event|1|||
164576831|NCT00818259|594474853|FG008|Part V|Adverse Event|0|||
164576832|NCT03372941|594474854|FG000|Overall Study|Lost to Follow-up|2|||
164576833|NCT03372941|594474855|FG001|Overall Study|Lost to Follow-up|4|||
164576834|NCT00741819|594474856|FG000|Overall Study|Adverse Event|3|||
164576835|NCT00741819|594474856|FG000|Overall Study|Withdrawal by Subject|3|||
164576836|NCT00741819|594474856|FG000|Overall Study|Death|1|||
164576837|NCT00741819|594474856|FG000|Overall Study|Disease progression|1|||
164576838|NCT00686543|594474857|FG000|Overall Study|Adverse Event|9|||
164576839|NCT00686543|594474858|FG001|Overall Study|Adverse Event|1|||
164576840|NCT00686543|594474859|FG002|Overall Study|Adverse Event|3|||
164576841|NCT00686543|594474860|FG003|Overall Study|Adverse Event|2|||
164576842|NCT00686543|594474857|FG000|Overall Study|Withdrawal by Subject|2|||
164576843|NCT00686543|594474858|FG001|Overall Study|Withdrawal by Subject|0|||
164576844|NCT00686543|594474859|FG002|Overall Study|Withdrawal by Subject|0|||
164576845|NCT00686543|594474860|FG003|Overall Study|Withdrawal by Subject|0|||
164576846|NCT00686543|594474857|FG000|Overall Study|Protocol Violation|3|||
164576847|NCT00686543|594474858|FG001|Overall Study|Protocol Violation|0|||
164576848|NCT00686543|594474859|FG002|Overall Study|Protocol Violation|2|||
164576849|NCT00686543|594474860|FG003|Overall Study|Protocol Violation|1|||
164680813|NCT00112437|594854587|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
164680814|NCT00112437|594854588|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
164680815|NCT00112437|594854589|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
164680816|NCT00112437|594854590|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
164680817|NCT00112437|594854591|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
164680818|NCT00112437|594854592|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
164680819|NCT00112437|594854593|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
164680820|NCT00112437|594854594|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
164680821|NCT00112437|594854595|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
164680822|NCT00112437|594854596|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
164680823|NCT00112437|594854571|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164680824|NCT00112437|594854572|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164680825|NCT00112437|594854573|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164680826|NCT00112437|594854574|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164680827|NCT00112437|594854575|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164680828|NCT00112437|594854576|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164680829|NCT00112437|594854577|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164680830|NCT00112437|594854578|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164680831|NCT00112437|594854579|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164680832|NCT00112437|594854580|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164680833|NCT00112437|594854581|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164680834|NCT00112437|594854582|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
164680835|NCT00112437|594854583|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164680836|NCT00112437|594854584|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164680837|NCT00112437|594854585|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
164339923|NCT04223973|593618996|FG001|Overall Study|Withdrawal by Subject|1|||
164339924|NCT00594659|593618997|FG000|Overall Study|Lost to Follow-up|13|||
164339925|NCT00594659|593618998|FG001|Overall Study|Lost to Follow-up|9|||
164339926|NCT00594659|593618999|FG002|Overall Study|Lost to Follow-up|7|||
164339927|NCT00142298|593619001|FG000|Overall Study|Adverse Event|10|||
164339928|NCT00142298|593619002|FG001|Overall Study|Adverse Event|10|||
164339929|NCT00142298|593619003|FG002|Overall Study|Adverse Event|1|||
164339930|NCT00142298|593619004|FG003|Overall Study|Adverse Event|5|||
164339931|NCT00142298|593619005|FG004|Overall Study|Adverse Event|2|||
164339932|NCT00142298|593619006|FG005|Overall Study|Adverse Event|2|||
164339933|NCT00142298|593619007|FG006|Overall Study|Adverse Event|0|||
164339934|NCT00142298|593619008|FG007|Overall Study|Adverse Event|0|||
164339935|NCT00142298|593619009|FG008|Overall Study|Adverse Event|0|||
164339936|NCT00142298|593619010|FG009|Overall Study|Adverse Event|0|||
164339937|NCT00142298|593619001|FG000|Overall Study|Clinical disease progression|1|||
164339938|NCT00142298|593619002|FG001|Overall Study|Clinical disease progression|0|||
164339939|NCT00142298|593619003|FG002|Overall Study|Clinical disease progression|0|||
164339940|NCT00142298|593619004|FG003|Overall Study|Clinical disease progression|0|||
164339941|NCT00142298|593619005|FG004|Overall Study|Clinical disease progression|0|||
164339942|NCT00142298|593619006|FG005|Overall Study|Clinical disease progression|0|||
164339943|NCT00142298|593619007|FG006|Overall Study|Clinical disease progression|0|||
164339944|NCT00142298|593619008|FG007|Overall Study|Clinical disease progression|0|||
164339945|NCT00142298|593619009|FG008|Overall Study|Clinical disease progression|0|||
164339946|NCT00142298|593619010|FG009|Overall Study|Clinical disease progression|0|||
164339947|NCT00142298|593619001|FG000|Overall Study|Death|1|||
164339948|NCT00142298|593619002|FG001|Overall Study|Death|1|||
164339949|NCT00142298|593619003|FG002|Overall Study|Death|1|||
164339950|NCT00142298|593619004|FG003|Overall Study|Death|0|||
164339951|NCT00142298|593619005|FG004|Overall Study|Death|0|||
164339952|NCT00142298|593619006|FG005|Overall Study|Death|6|||
164339953|NCT00142298|593619007|FG006|Overall Study|Death|0|||
164576850|NCT00752986|594474861|FG000|Overall Study|Withdrawal by Subject|2|||
164680838|NCT00112437|594854586|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164680839|NCT00112437|594854587|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164680840|NCT00112437|594854588|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164680841|NCT00112437|594854589|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164680842|NCT00112437|594854590|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164680843|NCT00112437|594854591|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164680844|NCT00112437|594854592|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164680845|NCT00112437|594854593|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164680846|NCT00112437|594854594|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164680847|NCT00112437|594854595|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164680848|NCT00112437|594854596|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164257914|NCT04027049|593310011|FG001|Overall Study|Withdrawn by family|0|||
164257915|NCT04027049|593310010|FG000|Overall Study|Participant safety|1|||
164257916|NCT04027049|593310011|FG001|Overall Study|Participant safety|0|||
164257917|NCT00871923|593311634|FG000|Overall Study|Death|1|||
164257918|NCT00871923|593311634|FG000|Overall Study|Withdrawal by Subject|1|||
164257919|NCT00496483|593311640|FG000|Overall Study|Not dosed|9|||
164257920|NCT00496483|593311640|FG000|Overall Study|Adverse Event|2|||
164257921|NCT00496483|593311640|FG000|Overall Study|Lack of Efficacy|1|||
164257922|NCT04258995|593311642|FG000|Overall Study|Lost to Follow-up|1|||
164257923|NCT04258995|593311643|FG001|Overall Study|Lost to Follow-up|1|||
164257924|NCT03285958|593311645|FG000|Overall Study|Lost to Follow-up|1|||
164257925|NCT03285958|593311646|FG001|Overall Study|Lost to Follow-up|1|||
164257926|NCT03285958|593311645|FG000|Overall Study|Withdrawal by Subject|1|||
164257927|NCT03285958|593311646|FG001|Overall Study|Withdrawal by Subject|0|||
164257928|NCT03285958|593311645|FG000|Overall Study|Not able to attend required orientation|3|||
164257929|NCT03285958|593311646|FG001|Overall Study|Not able to attend required orientation|0|||
164257930|NCT02998203|593311647|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
164257931|NCT02998203|593311648|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
164257932|NCT02998203|593311647|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
164257933|NCT02998203|593311648|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
164257934|NCT01145352|593311651|FG000|Overall Study|Found to have been registered twice|6|||
164257935|NCT01145352|593311651|FG000|Overall Study|Treated before marketing approval|4|||
164257936|NCT01145352|593311651|FG000|Overall Study|Syringe formulation was used|1|||
164428505|NCT00723294|593939363|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
164428506|NCT00723294|593939363|FG000|Overall Study|Benign lesion|1|||
164428507|NCT00723294|593939363|FG000|Overall Study|Withdrawal by Subject|1|||
164428508|NCT00723294|593939363|FG000|Overall Study|No treatment due to probe failure|1|||
164428509|NCT01257503|593939364|FG000|Overall Study|Lost to Follow-up|7|||
164428510|NCT01257503|593939365|FG001|Overall Study|Lost to Follow-up|10|||
164428511|NCT01257503|593939364|FG000|Overall Study|Over 5 years old at enrollment|0|||
164428512|NCT01257503|593939365|FG001|Overall Study|Over 5 years old at enrollment|1|||
164428513|NCT01257503|593939364|FG000|Overall Study|strep culture positive at enrollment|1|||
164428514|NCT01257503|593939365|FG001|Overall Study|strep culture positive at enrollment|0|||
164428515|NCT00088465|593939366|FG000|Overall Study|Withdrawal by Subject|290|||
164428516|NCT00088465|593939366|FG000|Overall Study|Adverse Event|77|||
164428517|NCT00088465|593939366|FG000|Overall Study|Lost to Follow-up|57|||
164428518|NCT00088465|593939366|FG000|Overall Study|Physician Decision|45|||
164428519|NCT00088465|593939366|FG000|Overall Study|Sponsor Decision|37|||
164428520|NCT00088465|593939366|FG000|Overall Study|Lack of Efficacy|27|||
164428521|NCT00088465|593939366|FG000|Overall Study|Protocol Violation|17|||
164428522|NCT00088465|593939366|FG000|Overall Study|Death|11|||
164428523|NCT04565249|593939367|FG000|Overall Study|Death|0|||
164428524|NCT04565249|593939368|FG001|Overall Study|Death|0|||
164428525|NCT04565249|593939369|FG002|Overall Study|Death|0|||
164428526|NCT04565249|593939370|FG003|Overall Study|Death|1|||
164428527|NCT02333630|593939371|FG000|Overall Study|Lost to Follow-up|5|||
164428528|NCT02333630|593939372|FG001|Overall Study|Lost to Follow-up|2|||
164428529|NCT02359435|593939373|FG000|Overall Study|Lost to Follow-up|4|||
164428530|NCT02359435|593939374|FG001|Overall Study|Lost to Follow-up|4|||
164428531|NCT00315055|593939375|FG000|Overall Study|Protocol Violation|2|||
164428532|NCT00315055|593939376|FG001|Overall Study|Protocol Violation|4|||
164428533|NCT00315055|593939375|FG000|Overall Study|Lost to Follow-up|1|||
164428534|NCT00315055|593939376|FG001|Overall Study|Lost to Follow-up|1|||
164428535|NCT02347943|593939378|FG000|Overall Study|Study was cancelled|140|||
164428536|NCT02347943|593939379|FG001|Overall Study|Study was cancelled|67|||
164428537|NCT02347943|593939380|FG002|Overall Study|Study was cancelled|45|||
164428538|NCT03613129|593939385|FG000|Pre-treatment Assessment|Protocol Violation|2|||
164428539|NCT03613129|593939386|FG001|Pre-treatment Assessment|Protocol Violation|0|||
164428540|NCT03613129|593939387|FG002|Pre-treatment Assessment|Protocol Violation|0|||
164428541|NCT03613129|593939388|FG003|Pre-treatment Assessment|Protocol Violation|0|||
164428542|NCT03613129|593939389|FG004|Pre-treatment Assessment|Protocol Violation|0|||
164428543|NCT03613129|593939385|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
164428544|NCT03613129|593939386|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
164428545|NCT03613129|593939387|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
164428546|NCT03613129|593939388|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
164428547|NCT03613129|593939389|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
164428548|NCT02334306|593939390|FG000|Double-blind Period|Adverse Event|0|||
164428549|NCT02334306|593939391|FG001|Double-blind Period|Adverse Event|1|||
164428550|NCT02334306|593939390|FG000|Double-blind Period|Withdrawal by Subject|1|||
164428551|NCT02334306|593939391|FG001|Double-blind Period|Withdrawal by Subject|1|||
164428552|NCT01687270|593939392|FG000|Overall Study|Lack of Efficacy|11|||
164428553|NCT01687270|593939392|FG000|Overall Study|Lost to Follow-up|1|||
164428554|NCT00711646|593939393|FG000|Overall Study|Adverse Event|6|||
164428555|NCT00711646|593939394|FG001|Overall Study|Adverse Event|1|||
164428556|NCT00711646|593939393|FG000|Overall Study|Withdrawal by Subject|4|||
164428557|NCT00711646|593939394|FG001|Overall Study|Withdrawal by Subject|0|||
164428558|NCT00711646|593939393|FG000|Overall Study|Protocol Violation|0|||
164428559|NCT00711646|593939394|FG001|Overall Study|Protocol Violation|1|||
164680849|NCT00112437|594854571|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164680850|NCT00112437|594854572|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164680851|NCT00112437|594854573|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164680852|NCT00112437|594854574|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164680853|NCT00112437|594854575|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164680854|NCT00112437|594854576|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164257937|NCT00316693|593311654|FG000|Overall Study|Adverse Event|6|||
164257938|NCT00316693|593311655|FG001|Overall Study|Adverse Event|1|||
164257939|NCT00316693|593311654|FG000|Overall Study|Protocol Violation|1|||
164428560|NCT00711646|593939393|FG000|Overall Study|Lost to Follow-up|1|||
164428561|NCT00711646|593939394|FG001|Overall Study|Lost to Follow-up|0|||
164428562|NCT00711646|593939393|FG000|Overall Study|administrative decision|0|||
164428563|NCT00711646|593939394|FG001|Overall Study|administrative decision|1|||
164428564|NCT00711646|593939393|FG000|Overall Study|patient non-compliance|1|||
164428565|NCT00711646|593939394|FG001|Overall Study|patient non-compliance|0|||
164428566|NCT03441360|593939395|FG000|Overall Study|Radiological disease progression|5|||
164428567|NCT03441360|593939396|FG001|Overall Study|Radiological disease progression|6|||
164428568|NCT03441360|593939397|FG002|Overall Study|Radiological disease progression|4|||
164428569|NCT03441360|593939395|FG000|Overall Study|Clinical disease progression|2|||
164428570|NCT03441360|593939396|FG001|Overall Study|Clinical disease progression|2|||
164680855|NCT00112437|594854577|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164680856|NCT00112437|594854578|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164680857|NCT00112437|594854579|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164680858|NCT00112437|594854580|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164680859|NCT00112437|594854581|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
164680860|NCT00112437|594854582|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
164680861|NCT00112437|594854583|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164680862|NCT00112437|594854584|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164680863|NCT00112437|594854585|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164680864|NCT00112437|594854586|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164680865|NCT00112437|594854587|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164680866|NCT00112437|594854588|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164680867|NCT00112437|594854589|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164680868|NCT00112437|594854590|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164680869|NCT00112437|594854591|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164680870|NCT00112437|594854592|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164680871|NCT00112437|594854593|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164680872|NCT00112437|594854594|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164680873|NCT00112437|594854595|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164680874|NCT00112437|594854596|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164680875|NCT00112437|594854571|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164680876|NCT00112437|594854572|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164680877|NCT00112437|594854573|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164680878|NCT00112437|594854574|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164680879|NCT00112437|594854575|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164680880|NCT00112437|594854576|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164680881|NCT00112437|594854577|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164339954|NCT00142298|593619008|FG007|Overall Study|Death|0|||
164339955|NCT00142298|593619009|FG008|Overall Study|Death|0|||
164339956|NCT00142298|593619010|FG009|Overall Study|Death|0|||
164339957|NCT00142298|593619001|FG000|Overall Study|Lack of Efficacy|44|||
164339958|NCT00142298|593619002|FG001|Overall Study|Lack of Efficacy|62|||
164339959|NCT00142298|593619003|FG002|Overall Study|Lack of Efficacy|9|||
164339960|NCT00142298|593619004|FG003|Overall Study|Lack of Efficacy|12|||
164339961|NCT00142298|593619005|FG004|Overall Study|Lack of Efficacy|1|||
164339962|NCT00142298|593619006|FG005|Overall Study|Lack of Efficacy|0|||
164339963|NCT00142298|593619007|FG006|Overall Study|Lack of Efficacy|0|||
164339964|NCT00142298|593619008|FG007|Overall Study|Lack of Efficacy|1|||
164339965|NCT00142298|593619009|FG008|Overall Study|Lack of Efficacy|0|||
164339966|NCT00142298|593619010|FG009|Overall Study|Lack of Efficacy|0|||
164339967|NCT00142298|593619001|FG000|Overall Study|Non-compliance|15|||
164339968|NCT00142298|593619002|FG001|Overall Study|Non-compliance|13|||
164339969|NCT00142298|593619003|FG002|Overall Study|Non-compliance|0|||
164339970|NCT00142298|593619004|FG003|Overall Study|Non-compliance|6|||
164339971|NCT00142298|593619005|FG004|Overall Study|Non-compliance|1|||
164339972|NCT00142298|593619006|FG005|Overall Study|Non-compliance|0|||
164339973|NCT00142298|593619007|FG006|Overall Study|Non-compliance|0|||
164339974|NCT00142298|593619008|FG007|Overall Study|Non-compliance|3|||
164339975|NCT00142298|593619009|FG008|Overall Study|Non-compliance|3|||
164339976|NCT00142298|593619010|FG009|Overall Study|Non-compliance|0|||
164339977|NCT00142298|593619001|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
164339978|NCT00142298|593619002|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
164680882|NCT00112437|594854578|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164680883|NCT00112437|594854579|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164339979|NCT00142298|593619003|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
164680884|NCT00112437|594854580|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164339980|NCT00142298|593619004|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
164339981|NCT00142298|593619005|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
164339982|NCT00142298|593619006|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
164680885|NCT00112437|594854581|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164680886|NCT00112437|594854582|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164680887|NCT00112437|594854583|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164680888|NCT00112437|594854584|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164680889|NCT00112437|594854585|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164680890|NCT00112437|594854586|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164680891|NCT00112437|594854587|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164680892|NCT00112437|594854588|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164680893|NCT00112437|594854589|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164680894|NCT00112437|594854590|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164680895|NCT00112437|594854591|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
164680896|NCT00112437|594854592|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
164680897|NCT00112437|594854593|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164680898|NCT00112437|594854594|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164680899|NCT00112437|594854595|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164680900|NCT00112437|594854596|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164680901|NCT00112437|594854571|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680902|NCT00112437|594854572|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680903|NCT00112437|594854573|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680904|NCT00112437|594854574|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680905|NCT00112437|594854575|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680906|NCT00112437|594854576|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680907|NCT00112437|594854577|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680908|NCT00112437|594854578|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680909|NCT00112437|594854579|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680910|NCT00112437|594854580|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680911|NCT00112437|594854581|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680912|NCT00112437|594854582|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680913|NCT00112437|594854583|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680914|NCT00112437|594854584|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680915|NCT00112437|594854585|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680916|NCT00112437|594854586|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680917|NCT00112437|594854587|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680918|NCT00112437|594854588|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680919|NCT00112437|594854589|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680920|NCT00112437|594854590|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680921|NCT00112437|594854591|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
164680922|NCT00112437|594854592|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680923|NCT00112437|594854593|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680924|NCT00112437|594854594|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680925|NCT00112437|594854595|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680926|NCT00112437|594854596|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164680927|NCT00112437|594854571|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164680928|NCT00112437|594854572|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164680929|NCT00112437|594854573|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164680930|NCT00112437|594854574|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164680931|NCT00112437|594854575|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164680932|NCT00112437|594854576|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164680933|NCT00112437|594854577|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164680934|NCT00112437|594854578|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164680935|NCT00112437|594854579|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164680936|NCT00112437|594854580|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164680937|NCT00112437|594854581|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164257940|NCT00316693|593311655|FG001|Overall Study|Protocol Violation|0|||
164257941|NCT00316693|593311654|FG000|Overall Study|Withdrawal by Subject|6|||
164257942|NCT00316693|593311655|FG001|Overall Study|Withdrawal by Subject|6|||
164257943|NCT00316693|593311654|FG000|Overall Study|Lost to Follow-up|26|||
164257944|NCT00316693|593311655|FG001|Overall Study|Lost to Follow-up|34|||
164257945|NCT00316693|593311654|FG000|Overall Study|Other|38|||
164257946|NCT00316693|593311655|FG001|Overall Study|Other|44|||
164257947|NCT01967823|593311656|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
164257948|NCT00413894|593311663|FG000|Overall Study|Withdrawal by Subject|10|||
164257949|NCT00413894|593311663|FG000|Overall Study|Administrative Reasons|1|||
164257950|NCT00413894|593311663|FG000|Overall Study|Hb <10 grams/deciliter|12|||
164257951|NCT00413894|593311663|FG000|Overall Study|Adverse Event|28|||
164680938|NCT00112437|594854582|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164680939|NCT00112437|594854583|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164257952|NCT00413894|593311663|FG000|Overall Study|Protocol Violation|11|||
164257953|NCT00413894|593311663|FG000|Overall Study|Other|18|||
164257954|NCT04225676|593311664|FG000|Overall Study|Physician Decision|1|||
164257955|NCT04225676|593311664|FG000|Overall Study|Lack of Efficacy|1|||
164257956|NCT04225676|593311664|FG000|Overall Study|Study terminated by sponsor|3|||
164257957|NCT05289271|593311667|FG000|Overall Study|Mistakenly allocated, untreated|1|||
164257958|NCT05289271|593311668|FG001|Overall Study|Mistakenly allocated, untreated|0|||
164257959|NCT02019108|593311669|FG000|Overall Study|Lost to Follow-up|5|||
164257960|NCT02019108|593311670|FG001|Overall Study|Lost to Follow-up|7|||
164257961|NCT00908115|593311673|FG000|Overall Study|Other|14|||
164257962|NCT00313313|593311680|FG000|Overall Study|Lack of Efficacy|14|||
164257963|NCT00313313|593311681|FG001|Overall Study|Lack of Efficacy|9|||
164257964|NCT00313313|593311682|FG002|Overall Study|Lack of Efficacy|20|||
164257965|NCT00313313|593311680|FG000|Overall Study|Withdrawal of consent by subject|18|||
164257966|NCT00313313|593311681|FG001|Overall Study|Withdrawal of consent by subject|17|||
164257967|NCT00313313|593311682|FG002|Overall Study|Withdrawal of consent by subject|31|||
164257968|NCT00313313|593311680|FG000|Overall Study|Lost to Follow-up|10|||
164257969|NCT00313313|593311681|FG001|Overall Study|Lost to Follow-up|7|||
164257970|NCT00313313|593311682|FG002|Overall Study|Lost to Follow-up|9|||
164257971|NCT00313313|593311680|FG000|Overall Study|Adverse Event|15|||
164257972|NCT00313313|593311681|FG001|Overall Study|Adverse Event|16|||
164257973|NCT00313313|593311682|FG002|Overall Study|Adverse Event|12|||
164257974|NCT00313313|593311680|FG000|Overall Study|Physician Decision|2|||
164257975|NCT00313313|593311681|FG001|Overall Study|Physician Decision|6|||
164257976|NCT00313313|593311682|FG002|Overall Study|Physician Decision|4|||
164257977|NCT00313313|593311680|FG000|Overall Study|Poor/Noncompliance|3|||
164257978|NCT00313313|593311681|FG001|Overall Study|Poor/Noncompliance|6|||
164257979|NCT00313313|593311682|FG002|Overall Study|Poor/Noncompliance|2|||
164257980|NCT00313313|593311680|FG000|Overall Study|Pregnancy|1|||
164339983|NCT00142298|593619007|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
164339984|NCT00142298|593619008|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
164339985|NCT00142298|593619009|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
164339986|NCT00142298|593619010|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
164339987|NCT00142298|593619001|FG000|Overall Study|Pregnancy|4|||
164339988|NCT00142298|593619002|FG001|Overall Study|Pregnancy|4|||
164339989|NCT00142298|593619003|FG002|Overall Study|Pregnancy|2|||
164339990|NCT00142298|593619004|FG003|Overall Study|Pregnancy|3|||
164339991|NCT00142298|593619005|FG004|Overall Study|Pregnancy|0|||
164339992|NCT00142298|593619006|FG005|Overall Study|Pregnancy|0|||
164339993|NCT00142298|593619007|FG006|Overall Study|Pregnancy|0|||
164339994|NCT00142298|593619008|FG007|Overall Study|Pregnancy|0|||
164339995|NCT00142298|593619009|FG008|Overall Study|Pregnancy|1|||
164339996|NCT00142298|593619010|FG009|Overall Study|Pregnancy|0|||
164339997|NCT00142298|593619001|FG000|Overall Study|Virologic breakthrough|19|||
164339998|NCT00142298|593619002|FG001|Overall Study|Virologic breakthrough|23|||
164339999|NCT00142298|593619003|FG002|Overall Study|Virologic breakthrough|9|||
164340000|NCT00142298|593619004|FG003|Overall Study|Virologic breakthrough|7|||
164340001|NCT00142298|593619005|FG004|Overall Study|Virologic breakthrough|2|||
164340002|NCT00142298|593619006|FG005|Overall Study|Virologic breakthrough|3|||
164340003|NCT00142298|593619007|FG006|Overall Study|Virologic breakthrough|3|||
164576851|NCT00752986|594474862|FG001|Overall Study|Withdrawal by Subject|1|||
164576852|NCT00752986|594474863|FG002|Overall Study|Withdrawal by Subject|2|||
164576853|NCT00752986|594474861|FG000|Overall Study|Protocol Violation|3|||
164576854|NCT00752986|594474862|FG001|Overall Study|Protocol Violation|0|||
164576855|NCT00752986|594474863|FG002|Overall Study|Protocol Violation|0|||
164576856|NCT00924703|594474864|FG000|Overall Study|Withdrawal by Subject|11|||
164576857|NCT00924703|594474864|FG000|Overall Study|Physician Decision|5|||
164576858|NCT00924703|594474864|FG000|Overall Study|Lost to Follow-up|3|||
164576859|NCT00924703|594474864|FG000|Overall Study|Adverse Event|2|||
164576860|NCT00924703|594474864|FG000|Overall Study|Withdrawal by Sponsor|1|||
164576861|NCT03430310|594474869|FG000|Overall Study|Protocol Violation|2|||
164576862|NCT03430310|594474870|FG001|Overall Study|Protocol Violation|0|||
164576863|NCT03430310|594474869|FG000|Overall Study|Withdrawal by Subject|3|||
164576864|NCT03430310|594474870|FG001|Overall Study|Withdrawal by Subject|2|||
164257981|NCT00313313|593311681|FG001|Overall Study|Pregnancy|2|||
164257982|NCT00313313|593311682|FG002|Overall Study|Pregnancy|0|||
164576865|NCT03430310|594474869|FG000|Overall Study|COVID shutdown March 2020|0|||
164576866|NCT03430310|594474870|FG001|Overall Study|COVID shutdown March 2020|1|||
164576867|NCT00045032|594474875|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
164576868|NCT00045032|594474876|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
164257983|NCT00313313|593311680|FG000|Overall Study|Death|0|||
164257984|NCT00313313|593311681|FG001|Overall Study|Death|0|||
164257985|NCT00313313|593311682|FG002|Overall Study|Death|2|||
164257986|NCT00313313|593311680|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
164340004|NCT00142298|593619008|FG007|Overall Study|Virologic breakthrough|0|||
164340005|NCT00142298|593619009|FG008|Overall Study|Virologic breakthrough|0|||
164257987|NCT00313313|593311681|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
164680940|NCT00112437|594854584|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164680941|NCT00112437|594854585|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164680942|NCT00112437|594854586|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164680943|NCT00112437|594854587|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164257988|NCT00313313|593311682|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
164257989|NCT01973387|593311683|FG000|Overall Study|Adverse Event|14|||
164257990|NCT01973387|593311684|FG001|Overall Study|Adverse Event|4|||
164257991|NCT01973387|593311683|FG000|Overall Study|Withdrawal by Subject|7|||
164257992|NCT01973387|593311684|FG001|Overall Study|Withdrawal by Subject|4|||
164257993|NCT01973387|593311683|FG000|Overall Study|Study terminated by sponsor|63|||
164257994|NCT01973387|593311684|FG001|Overall Study|Study terminated by sponsor|0|||
164257995|NCT01973387|593311683|FG000|Overall Study|Progressive disease or relapse|16|||
164680944|NCT00112437|594854588|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164680945|NCT00112437|594854589|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164680946|NCT00112437|594854590|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164680947|NCT00112437|594854591|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164680948|NCT00112437|594854592|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
164680949|NCT00112437|594854593|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164680950|NCT00112437|594854594|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164680951|NCT00112437|594854595|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164680952|NCT00112437|594854596|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164680953|NCT00112437|594854571|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
164680954|NCT00112437|594854572|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
164680955|NCT00112437|594854573|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
164680956|NCT00112437|594854574|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
164680957|NCT00112437|594854575|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
164680958|NCT00112437|594854576|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
164680959|NCT00112437|594854577|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
164680960|NCT00112437|594854578|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
164680961|NCT00112437|594854579|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
164680962|NCT00112437|594854580|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
164257996|NCT01973387|593311684|FG001|Overall Study|Progressive disease or relapse|5|||
164340006|NCT00142298|593619010|FG009|Overall Study|Virologic breakthrough|0|||
164340007|NCT00142298|593619001|FG000|Overall Study|Other- not specified|0|||
164340008|NCT00142298|593619002|FG001|Overall Study|Other- not specified|3|||
164340009|NCT00142298|593619003|FG002|Overall Study|Other- not specified|0|||
164340010|NCT00142298|593619004|FG003|Overall Study|Other- not specified|1|||
164340011|NCT00142298|593619005|FG004|Overall Study|Other- not specified|0|||
164340012|NCT00142298|593619006|FG005|Overall Study|Other- not specified|0|||
164340013|NCT00142298|593619007|FG006|Overall Study|Other- not specified|0|||
164340014|NCT00142298|593619008|FG007|Overall Study|Other- not specified|0|||
164340015|NCT00142298|593619009|FG008|Overall Study|Other- not specified|0|||
164340016|NCT00142298|593619010|FG009|Overall Study|Other- not specified|0|||
164340017|NCT00142298|593619001|FG000|Overall Study|Lost to Follow-up|0|||
164340018|NCT00142298|593619002|FG001|Overall Study|Lost to Follow-up|0|||
164340019|NCT00142298|593619003|FG002|Overall Study|Lost to Follow-up|0|||
164340020|NCT00142298|593619004|FG003|Overall Study|Lost to Follow-up|0|||
164340021|NCT00142298|593619005|FG004|Overall Study|Lost to Follow-up|0|||
164340022|NCT00142298|593619006|FG005|Overall Study|Lost to Follow-up|0|||
164340023|NCT00142298|593619007|FG006|Overall Study|Lost to Follow-up|2|||
164340024|NCT00142298|593619008|FG007|Overall Study|Lost to Follow-up|0|||
164340025|NCT00142298|593619009|FG008|Overall Study|Lost to Follow-up|0|||
164340026|NCT00142298|593619010|FG009|Overall Study|Lost to Follow-up|0|||
164340027|NCT00142298|593619001|FG000|Overall Study|Treatment Failure|0|||
164340028|NCT00142298|593619002|FG001|Overall Study|Treatment Failure|0|||
164340029|NCT00142298|593619003|FG002|Overall Study|Treatment Failure|0|||
164340030|NCT00142298|593619004|FG003|Overall Study|Treatment Failure|0|||
164340031|NCT00142298|593619005|FG004|Overall Study|Treatment Failure|0|||
164340032|NCT00142298|593619006|FG005|Overall Study|Treatment Failure|2|||
164340033|NCT00142298|593619007|FG006|Overall Study|Treatment Failure|2|||
164340034|NCT00142298|593619008|FG007|Overall Study|Treatment Failure|0|||
164340035|NCT00142298|593619009|FG008|Overall Study|Treatment Failure|0|||
164340036|NCT00142298|593619010|FG009|Overall Study|Treatment Failure|0|||
164340037|NCT02423772|593619013|FG000|Overall Study|Lost to Follow-up|3|||
164680963|NCT00112437|594854581|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
164680964|NCT00112437|594854582|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
164340038|NCT02423772|593619014|FG001|Overall Study|Lost to Follow-up|3|||
164340039|NCT02423772|593619013|FG000|Overall Study|Did not begin intervention|2|||
164340040|NCT02423772|593619014|FG001|Overall Study|Did not begin intervention|5|||
164428571|NCT03441360|593939397|FG002|Overall Study|Clinical disease progression|0|||
164680965|NCT00112437|594854583|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
164680966|NCT00112437|594854584|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
164340041|NCT01193842|593619015|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
164428572|NCT03441360|593939395|FG000|Overall Study|Adverse Event|1|||
164428573|NCT03441360|593939396|FG001|Overall Study|Adverse Event|0|||
164428574|NCT03441360|593939397|FG002|Overall Study|Adverse Event|1|||
164428575|NCT01360840|593939400|FG000|Overall Study|Ongoing at data cut-off|10|||
164428576|NCT01360840|593939401|FG001|Overall Study|Ongoing at data cut-off|10|||
164428577|NCT01360840|593939402|FG002|Overall Study|Ongoing at data cut-off|9|||
164428578|NCT00920686|593939404|FG000|Overall Study|Lost to Follow-up|2|||
164428579|NCT00920686|593939405|FG001|Overall Study|Lost to Follow-up|3|||
164428580|NCT00920686|593939406|FG002|Overall Study|Lost to Follow-up|1|||
164428581|NCT00920686|593939404|FG000|Overall Study|Study drug dosing criteria not met|17|||
164428582|NCT00920686|593939405|FG001|Overall Study|Study drug dosing criteria not met|19|||
164428583|NCT00920686|593939406|FG002|Overall Study|Study drug dosing criteria not met|12|||
164428584|NCT04337489|593939407|FG000|Overall Study|Withdrawal by Subject|1|||
164428585|NCT00688688|593939408|FG000|Overall Study|Eligibility criterion not met|7|||
164428586|NCT00688688|593939409|FG001|Overall Study|Eligibility criterion not met|7|||
164428587|NCT00688688|593939410|FG002|Overall Study|Eligibility criterion not met|10|||
164428588|NCT00688688|593939408|FG000|Overall Study|Adverse Event|52|||
164428589|NCT00688688|593939409|FG001|Overall Study|Adverse Event|51|||
164428590|NCT00688688|593939410|FG002|Overall Study|Adverse Event|50|||
164428591|NCT00688688|593939408|FG000|Overall Study|Lack of Efficacy|34|||
164428592|NCT00688688|593939409|FG001|Overall Study|Lack of Efficacy|25|||
164428593|NCT00688688|593939410|FG002|Overall Study|Lack of Efficacy|45|||
164428594|NCT00688688|593939408|FG000|Overall Study|Withdrawal by Subject|66|||
164428595|NCT00688688|593939409|FG001|Overall Study|Withdrawal by Subject|75|||
164428596|NCT00688688|593939410|FG002|Overall Study|Withdrawal by Subject|65|||
164428597|NCT00688688|593939408|FG000|Overall Study|Lost to Follow-up|14|||
164428598|NCT00688688|593939409|FG001|Overall Study|Lost to Follow-up|7|||
164428599|NCT00688688|593939410|FG002|Overall Study|Lost to Follow-up|7|||
164428600|NCT00688688|593939408|FG000|Overall Study|Protocol Violation|6|||
164428601|NCT00688688|593939409|FG001|Overall Study|Protocol Violation|9|||
164428602|NCT00688688|593939410|FG002|Overall Study|Protocol Violation|11|||
164428603|NCT00688688|593939408|FG000|Overall Study|Randomized but never received study drug|1|||
164428604|NCT00688688|593939409|FG001|Overall Study|Randomized but never received study drug|0|||
164428605|NCT00688688|593939410|FG002|Overall Study|Randomized but never received study drug|0|||
164428606|NCT00688688|593939408|FG000|Overall Study|Non-compliance with study procedures|5|||
164428607|NCT00688688|593939409|FG001|Overall Study|Non-compliance with study procedures|3|||
164428608|NCT00688688|593939410|FG002|Overall Study|Non-compliance with study procedures|4|||
164428609|NCT00688688|593939408|FG000|Overall Study|Taking exclusionary medications|1|||
164428610|NCT00688688|593939409|FG001|Overall Study|Taking exclusionary medications|0|||
164428611|NCT00688688|593939410|FG002|Overall Study|Taking exclusionary medications|0|||
164428612|NCT00688688|593939408|FG000|Overall Study|Site closure|0|||
164428613|NCT00688688|593939409|FG001|Overall Study|Site closure|1|||
164428614|NCT00688688|593939410|FG002|Overall Study|Site closure|0|||
164428615|NCT00688688|593939408|FG000|Overall Study|Violation of exclusion criterion|0|||
164428616|NCT00688688|593939409|FG001|Overall Study|Violation of exclusion criterion|1|||
164428617|NCT00688688|593939410|FG002|Overall Study|Violation of exclusion criterion|0|||
164428618|NCT04296942|593939411|FG000|Overall Study|Study closure by sponsor|1|||
164428619|NCT04296942|593939412|FG001|Overall Study|Study closure by sponsor|0|||
164428620|NCT04296942|593939413|FG002|Overall Study|Study closure by sponsor|0|||
164428621|NCT03255941|593939414|FG000|Overall Study|Not eligible or refused injection|37|||
164428622|NCT03255941|593939415|FG001|Overall Study|Not eligible or refused injection|44|||
164428623|NCT03255941|593939416|FG002|Overall Study|Not eligible or refused injection|5|||
164428624|NCT03255941|593939417|FG003|Overall Study|Not eligible or refused injection|6|||
164428625|NCT03255941|593939414|FG000|Overall Study|Did not complete exit interview|1|||
164428626|NCT03255941|593939415|FG001|Overall Study|Did not complete exit interview|2|||
164428627|NCT03255941|593939416|FG002|Overall Study|Did not complete exit interview|0|||
164428628|NCT03255941|593939417|FG003|Overall Study|Did not complete exit interview|0|||
164428629|NCT00335153|593939429|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
164428630|NCT00335153|593939429|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
164428631|NCT00335153|593939429|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
164428632|NCT00335153|593939429|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
164428633|NCT00335153|593939429|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
164428634|NCT00335153|593939429|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
164576869|NCT00045032|594474877|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
164576870|NCT00045032|594474875|FG000|Overall Study|Death|22|||
164428635|NCT00335153|593939429|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
164428636|NCT00335153|593939429|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
164428637|NCT00335153|593939429|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
164428638|NCT00335153|593939429|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
164428639|NCT01237678|593939432|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
164428640|NCT01237678|593939433|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
164428641|NCT01237678|593939434|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
164428642|NCT01237678|593939432|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
164428643|NCT01237678|593939433|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
164428644|NCT01237678|593939434|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
164428645|NCT01237678|593939432|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
164428646|NCT01237678|593939433|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
164428647|NCT01237678|593939434|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
164428648|NCT01237678|593939432|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
164428649|NCT01237678|593939433|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
164428650|NCT01237678|593939434|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
164428651|NCT01237678|593939432|FG000|Phase II|Adverse Event|0|||
164428652|NCT01237678|593939433|FG001|Phase II|Adverse Event|39|||
164428653|NCT01237678|593939434|FG002|Phase II|Adverse Event|9|||
164428654|NCT01237678|593939432|FG000|Phase II|Death|0|||
164428655|NCT01237678|593939433|FG001|Phase II|Death|0|||
164428656|NCT01237678|593939434|FG002|Phase II|Death|2|||
164428657|NCT01237678|593939432|FG000|Phase II|Lack of Efficacy|0|||
164428658|NCT01237678|593939433|FG001|Phase II|Lack of Efficacy|25|||
164428659|NCT01237678|593939434|FG002|Phase II|Lack of Efficacy|3|||
164428660|NCT01237678|593939432|FG000|Phase II|Withdrawal by Subject|0|||
164428661|NCT01237678|593939433|FG001|Phase II|Withdrawal by Subject|1|||
164428662|NCT01237678|593939434|FG002|Phase II|Withdrawal by Subject|5|||
164428663|NCT01237678|593939432|FG000|Phase II|Completed Cycles 4-6|0|||
164428664|NCT01237678|593939433|FG001|Phase II|Completed Cycles 4-6|11|||
164428665|NCT01237678|593939434|FG002|Phase II|Completed Cycles 4-6|21|||
164428666|NCT01237678|593939432|FG000|Phase II|Sponsor Decision/Study Closed|0|||
164428667|NCT01237678|593939433|FG001|Phase II|Sponsor Decision/Study Closed|18|||
164428668|NCT01237678|593939434|FG002|Phase II|Sponsor Decision/Study Closed|7|||
164428669|NCT01237678|593939432|FG000|Phase II|Randomized but were not treated|0|||
164428670|NCT01237678|593939433|FG001|Phase II|Randomized but were not treated|4|||
164428671|NCT01237678|593939434|FG002|Phase II|Randomized but were not treated|3|||
164428672|NCT02954055|593939435|FG000|Overall Study|Did not initiate therapy|6|||
164428673|NCT02954055|593939436|FG001|Overall Study|Did not initiate therapy|1|||
164428674|NCT00764868|593939440|FG000|Overall Study|Adverse Event|18|||
164428675|NCT00764868|593939440|FG000|Overall Study|Withdrawal by Subject|31|||
164428676|NCT00764868|593939440|FG000|Overall Study|Non-compliance|16|||
164428677|NCT00764868|593939440|FG000|Overall Study|Lost to Follow-up|25|||
164428678|NCT00764868|593939440|FG000|Overall Study|Lack of Efficacy|5|||
164428679|NCT00764868|593939440|FG000|Overall Study|Subject moved|7|||
164428680|NCT00764868|593939440|FG000|Overall Study|Pregnancy|3|||
164428681|NCT00764868|593939440|FG000|Overall Study|Prohibited medication|1|||
164428682|NCT00764868|593939440|FG000|Overall Study|Out of town|1|||
164428683|NCT00764868|593939440|FG000|Overall Study|Misuse and compliance of study drug|1|||
164428684|NCT00764868|593939440|FG000|Overall Study|Subject sent to boarding school|1|||
164257997|NCT01973387|593311683|FG000|Overall Study|Death|4|||
164257998|NCT01973387|593311684|FG001|Overall Study|Death|3|||
164257999|NCT01973387|593311683|FG000|Overall Study|Randomized, not treated|2|||
164258000|NCT01973387|593311684|FG001|Overall Study|Randomized, not treated|2|||
164258001|NCT01345591|593311685|FG000|Overall Study|Lost to Follow-up|1|||
164258002|NCT02851797|593311686|FG000|Overall Study|Withdrawal by Subject|4|||
164258003|NCT02851797|593311687|FG001|Overall Study|Withdrawal by Subject|2|||
164428685|NCT00764868|593939440|FG000|Overall Study|Met an exclusion criteria|1|||
164258004|NCT02851797|593311686|FG000|Overall Study|Adverse Event|3|||
164258005|NCT02851797|593311687|FG001|Overall Study|Adverse Event|0|||
164258006|NCT03622112|593311689|FG000|Overall Study|Withdrawal by Subject|6|||
164258007|NCT03622112|593311690|FG001|Overall Study|Withdrawal by Subject|2|||
164258008|NCT03622112|593311691|FG002|Overall Study|Withdrawal by Subject|4|||
164258009|NCT03622112|593311692|FG003|Overall Study|Withdrawal by Subject|2|||
164258010|NCT03622112|593311693|FG004|Overall Study|Withdrawal by Subject|1|||
164258011|NCT03622112|593311694|FG005|Overall Study|Withdrawal by Subject|2|||
164258012|NCT03622112|593311695|FG006|Overall Study|Withdrawal by Subject|2|||
164258013|NCT03622112|593311689|FG000|Overall Study|Death|0|||
164258014|NCT03622112|593311690|FG001|Overall Study|Death|0|||
164258015|NCT03622112|593311691|FG002|Overall Study|Death|0|||
164258016|NCT03622112|593311692|FG003|Overall Study|Death|1|||
164258017|NCT03622112|593311693|FG004|Overall Study|Death|0|||
164258018|NCT03622112|593311694|FG005|Overall Study|Death|0|||
164258019|NCT03622112|593311695|FG006|Overall Study|Death|0|||
164258020|NCT03622112|593311689|FG000|Overall Study|Lost to Follow-up|1|||
164258021|NCT03622112|593311690|FG001|Overall Study|Lost to Follow-up|1|||
164258022|NCT03622112|593311691|FG002|Overall Study|Lost to Follow-up|0|||
164258023|NCT03622112|593311692|FG003|Overall Study|Lost to Follow-up|0|||
164340042|NCT01193842|593619016|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
164340043|NCT01193842|593619017|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
164340044|NCT01193842|593619018|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
164340045|NCT01193842|593619019|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
164340046|NCT01193842|593619015|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
164340047|NCT01193842|593619016|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
164340048|NCT01193842|593619017|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
164340049|NCT01193842|593619018|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
164340050|NCT01193842|593619019|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
164340051|NCT01193842|593619015|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
164428686|NCT00764868|593939440|FG000|Overall Study|Positive drug screen|2|||
164428687|NCT00764868|593939440|FG000|Overall Study|Sponsor requested withdrawal|1|||
164428688|NCT00783692|593939441|FG000|Induction Phase|Adverse Event|7|||
164428689|NCT00783692|593939442|FG001|Induction Phase|Adverse Event|9|||
164428690|NCT00783692|593939443|FG002|Induction Phase|Adverse Event|24|||
164680967|NCT00112437|594854585|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
164680968|NCT00112437|594854586|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
164680969|NCT00112437|594854587|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
164680970|NCT00112437|594854588|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
164680971|NCT00112437|594854589|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
164680972|NCT00112437|594854590|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
164680973|NCT00112437|594854591|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
164680974|NCT00112437|594854592|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
164680975|NCT00112437|594854593|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
164680976|NCT00112437|594854594|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
164680977|NCT00112437|594854595|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
164680978|NCT00112437|594854596|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
164680979|NCT00112437|594854571|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164680980|NCT00112437|594854572|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164680981|NCT00112437|594854573|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164680982|NCT00112437|594854574|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164680983|NCT00112437|594854575|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164680984|NCT00112437|594854576|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164680985|NCT00112437|594854577|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164680986|NCT00112437|594854578|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164680987|NCT00112437|594854579|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164680988|NCT00112437|594854580|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164680989|NCT00112437|594854581|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164680990|NCT00112437|594854582|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164680991|NCT00112437|594854583|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164680992|NCT00112437|594854584|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164680993|NCT00112437|594854585|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164680994|NCT00112437|594854586|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164680995|NCT00112437|594854587|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164680996|NCT00112437|594854588|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164680997|NCT00112437|594854589|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164680998|NCT00112437|594854590|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164258024|NCT03622112|593311693|FG004|Overall Study|Lost to Follow-up|0|||
164258025|NCT03622112|593311694|FG005|Overall Study|Lost to Follow-up|0|||
164258026|NCT03622112|593311695|FG006|Overall Study|Lost to Follow-up|0|||
164428691|NCT00783692|593939444|FG003|Induction Phase|Adverse Event|0|||
164428692|NCT00783692|593939445|FG004|Induction Phase|Adverse Event|0|||
164428693|NCT00783692|593939446|FG005|Induction Phase|Adverse Event|0|||
164428694|NCT00783692|593939447|FG006|Induction Phase|Adverse Event|0|||
164428695|NCT00783692|593939441|FG000|Induction Phase|Protocol Violation|0|||
164428696|NCT00783692|593939442|FG001|Induction Phase|Protocol Violation|0|||
164428697|NCT00783692|593939443|FG002|Induction Phase|Protocol Violation|1|||
164428698|NCT00783692|593939444|FG003|Induction Phase|Protocol Violation|0|||
164428699|NCT00783692|593939445|FG004|Induction Phase|Protocol Violation|0|||
164428700|NCT00783692|593939446|FG005|Induction Phase|Protocol Violation|0|||
164428701|NCT00783692|593939447|FG006|Induction Phase|Protocol Violation|0|||
164428702|NCT00783692|593939441|FG000|Induction Phase|Lack of Efficacy|1|||
164428703|NCT00783692|593939442|FG001|Induction Phase|Lack of Efficacy|3|||
164428704|NCT00783692|593939443|FG002|Induction Phase|Lack of Efficacy|28|||
164428705|NCT00783692|593939444|FG003|Induction Phase|Lack of Efficacy|0|||
164428706|NCT00783692|593939445|FG004|Induction Phase|Lack of Efficacy|0|||
164428707|NCT00783692|593939446|FG005|Induction Phase|Lack of Efficacy|0|||
164428708|NCT00783692|593939447|FG006|Induction Phase|Lack of Efficacy|0|||
164428709|NCT00783692|593939441|FG000|Induction Phase|Withdrawal by Subject|3|||
164428710|NCT00783692|593939442|FG001|Induction Phase|Withdrawal by Subject|9|||
164428711|NCT00783692|593939443|FG002|Induction Phase|Withdrawal by Subject|16|||
164428712|NCT00783692|593939444|FG003|Induction Phase|Withdrawal by Subject|0|||
164428713|NCT00783692|593939445|FG004|Induction Phase|Withdrawal by Subject|0|||
164428714|NCT00783692|593939446|FG005|Induction Phase|Withdrawal by Subject|0|||
164428715|NCT00783692|593939447|FG006|Induction Phase|Withdrawal by Subject|0|||
164428716|NCT00783692|593939441|FG000|Induction Phase|Lost to Follow-up|0|||
164428717|NCT00783692|593939442|FG001|Induction Phase|Lost to Follow-up|0|||
164428718|NCT00783692|593939443|FG002|Induction Phase|Lost to Follow-up|3|||
164428719|NCT00783692|593939444|FG003|Induction Phase|Lost to Follow-up|0|||
164428720|NCT00783692|593939445|FG004|Induction Phase|Lost to Follow-up|0|||
164428721|NCT00783692|593939446|FG005|Induction Phase|Lost to Follow-up|0|||
164428722|NCT00783692|593939447|FG006|Induction Phase|Lost to Follow-up|0|||
164428723|NCT00783692|593939441|FG000|Induction Phase|Other|0|||
164428724|NCT00783692|593939442|FG001|Induction Phase|Other|0|||
164428725|NCT00783692|593939443|FG002|Induction Phase|Other|2|||
164428726|NCT00783692|593939444|FG003|Induction Phase|Other|0|||
164428727|NCT00783692|593939445|FG004|Induction Phase|Other|0|||
164428728|NCT00783692|593939446|FG005|Induction Phase|Other|0|||
164428729|NCT00783692|593939447|FG006|Induction Phase|Other|0|||
164428730|NCT00783692|593939441|FG000|Maintenance Phase|Adverse Event|7|||
164428731|NCT00783692|593939442|FG001|Maintenance Phase|Adverse Event|0|||
164428732|NCT00783692|593939443|FG002|Maintenance Phase|Adverse Event|0|||
164428733|NCT00783692|593939444|FG003|Maintenance Phase|Adverse Event|15|||
164428734|NCT00783692|593939445|FG004|Maintenance Phase|Adverse Event|12|||
164428735|NCT00783692|593939446|FG005|Maintenance Phase|Adverse Event|9|||
164428736|NCT00783692|593939447|FG006|Maintenance Phase|Adverse Event|38|||
164428737|NCT00783692|593939441|FG000|Maintenance Phase|Protocol Violation|0|||
164428738|NCT00783692|593939442|FG001|Maintenance Phase|Protocol Violation|0|||
164428739|NCT00783692|593939443|FG002|Maintenance Phase|Protocol Violation|0|||
164428740|NCT00783692|593939444|FG003|Maintenance Phase|Protocol Violation|1|||
164428741|NCT00783692|593939445|FG004|Maintenance Phase|Protocol Violation|2|||
164428742|NCT00783692|593939446|FG005|Maintenance Phase|Protocol Violation|3|||
164428743|NCT00783692|593939447|FG006|Maintenance Phase|Protocol Violation|4|||
164428744|NCT00783692|593939441|FG000|Maintenance Phase|Lack of Efficacy|79|||
164428745|NCT00783692|593939442|FG001|Maintenance Phase|Lack of Efficacy|0|||
164428746|NCT00783692|593939443|FG002|Maintenance Phase|Lack of Efficacy|0|||
164428747|NCT00783692|593939444|FG003|Maintenance Phase|Lack of Efficacy|64|||
164428748|NCT00783692|593939445|FG004|Maintenance Phase|Lack of Efficacy|58|||
164428749|NCT00783692|593939446|FG005|Maintenance Phase|Lack of Efficacy|48|||
164258027|NCT03622112|593311689|FG000|Overall Study|Study-specific withdrawal criteria|10|||
164258028|NCT03622112|593311690|FG001|Overall Study|Study-specific withdrawal criteria|8|||
164258029|NCT03622112|593311691|FG002|Overall Study|Study-specific withdrawal criteria|7|||
164258030|NCT03622112|593311692|FG003|Overall Study|Study-specific withdrawal criteria|6|||
164258031|NCT03622112|593311693|FG004|Overall Study|Study-specific withdrawal criteria|4|||
164258032|NCT03622112|593311694|FG005|Overall Study|Study-specific withdrawal criteria|18|||
164258033|NCT03622112|593311695|FG006|Overall Study|Study-specific withdrawal criteria|4|||
164428750|NCT00783692|593939447|FG006|Maintenance Phase|Lack of Efficacy|177|||
164428751|NCT00783692|593939441|FG000|Maintenance Phase|Withdrawal by Subject|7|||
164428752|NCT00783692|593939442|FG001|Maintenance Phase|Withdrawal by Subject|0|||
164258034|NCT03622112|593311689|FG000|Overall Study|Protocol Violation|2|||
164258035|NCT03622112|593311690|FG001|Overall Study|Protocol Violation|0|||
164428753|NCT00783692|593939443|FG002|Maintenance Phase|Withdrawal by Subject|0|||
164428754|NCT00783692|593939444|FG003|Maintenance Phase|Withdrawal by Subject|7|||
164680999|NCT00112437|594854591|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
164258036|NCT03622112|593311691|FG002|Overall Study|Protocol Violation|1|||
164428755|NCT00783692|593939445|FG004|Maintenance Phase|Withdrawal by Subject|6|||
164428756|NCT00783692|593939446|FG005|Maintenance Phase|Withdrawal by Subject|9|||
164428757|NCT00783692|593939447|FG006|Maintenance Phase|Withdrawal by Subject|24|||
164428758|NCT00783692|593939441|FG000|Maintenance Phase|Lost to Follow-up|2|||
164428759|NCT00783692|593939442|FG001|Maintenance Phase|Lost to Follow-up|0|||
164428760|NCT00783692|593939443|FG002|Maintenance Phase|Lost to Follow-up|0|||
164428761|NCT00783692|593939444|FG003|Maintenance Phase|Lost to Follow-up|1|||
164428762|NCT00783692|593939445|FG004|Maintenance Phase|Lost to Follow-up|3|||
164428763|NCT00783692|593939446|FG005|Maintenance Phase|Lost to Follow-up|2|||
164428764|NCT00783692|593939447|FG006|Maintenance Phase|Lost to Follow-up|5|||
164428765|NCT00783692|593939441|FG000|Maintenance Phase|Other|0|||
164428766|NCT00783692|593939442|FG001|Maintenance Phase|Other|0|||
164428767|NCT00783692|593939443|FG002|Maintenance Phase|Other|0|||
164428768|NCT00783692|593939444|FG003|Maintenance Phase|Other|1|||
164428769|NCT00783692|593939445|FG004|Maintenance Phase|Other|0|||
164428770|NCT00783692|593939446|FG005|Maintenance Phase|Other|1|||
164428771|NCT00783692|593939447|FG006|Maintenance Phase|Other|1|||
164428772|NCT04438785|593939455|FG000|Overall Study|change of weight, give up intervention|2|||
164428773|NCT04438785|593939456|FG001|Overall Study|change of weight, give up intervention|10|||
164428774|NCT04831775|593939457|FG000|Overall Study|Lost to Follow-up|11|||
164428775|NCT04831775|593939458|FG001|Overall Study|Lost to Follow-up|13|||
164428776|NCT02027935|593939459|FG000|Overall Study|Death|1|||
164428777|NCT02027935|593939459|FG000|Overall Study|Lack of Efficacy|5|||
164428778|NCT02027935|593939459|FG000|Overall Study|Study Closure|1|||
164428779|NCT03115346|593939460|FG000|Overall Study|Did not have AAA surgery|28|||
164428780|NCT03115346|593939461|FG001|Overall Study|Did not have AAA surgery|15|||
164428781|NCT03115346|593939460|FG000|Overall Study|Death|3|||
164428782|NCT03115346|593939461|FG001|Overall Study|Death|1|||
164428783|NCT03115346|593939460|FG000|Overall Study|Withdrawal by Subject|0|||
164428784|NCT03115346|593939461|FG001|Overall Study|Withdrawal by Subject|3|||
164428785|NCT03115346|593939460|FG000|Overall Study|Lost to Follow-up|0|||
164428786|NCT03115346|593939461|FG001|Overall Study|Lost to Follow-up|3|||
164428787|NCT05174065|593939462|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
164428788|NCT05174065|593939463|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
164428789|NCT05174065|593939464|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
164428790|NCT05174065|593939462|FG000|Placebo-controlled Period|Other|0|||
164428791|NCT05174065|593939463|FG001|Placebo-controlled Period|Other|1|||
164428792|NCT05174065|593939464|FG002|Placebo-controlled Period|Other|0|||
164258037|NCT03622112|593311692|FG003|Overall Study|Protocol Violation|1|||
164258038|NCT03622112|593311693|FG004|Overall Study|Protocol Violation|0|||
164258039|NCT03622112|593311694|FG005|Overall Study|Protocol Violation|0|||
164258040|NCT03622112|593311695|FG006|Overall Study|Protocol Violation|0|||
164258041|NCT03622112|593311689|FG000|Overall Study|Adverse Event|6|||
164258042|NCT03622112|593311690|FG001|Overall Study|Adverse Event|8|||
164258043|NCT03622112|593311691|FG002|Overall Study|Adverse Event|4|||
164258044|NCT03622112|593311692|FG003|Overall Study|Adverse Event|11|||
164258045|NCT03622112|593311693|FG004|Overall Study|Adverse Event|4|||
164428793|NCT05174065|593939462|FG000|Placebo-controlled Period|Adverse Event|1|||
164258046|NCT03622112|593311694|FG005|Overall Study|Adverse Event|20|||
164258047|NCT03622112|593311695|FG006|Overall Study|Adverse Event|2|||
164428794|NCT05174065|593939463|FG001|Placebo-controlled Period|Adverse Event|1|||
164428795|NCT05174065|593939464|FG002|Placebo-controlled Period|Adverse Event|0|||
164428796|NCT05174065|593939462|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
164428797|NCT05174065|593939463|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
164258048|NCT03622112|593311689|FG000|Overall Study|Reason not specified|0|||
164576871|NCT00045032|594474876|FG001|Overall Study|Death|24|||
164576872|NCT00045032|594474877|FG002|Overall Study|Death|17|||
164576873|NCT00045032|594474875|FG000|Overall Study|Insufficient Therapeutic Response|542|||
164576874|NCT00045032|594474876|FG001|Overall Study|Insufficient Therapeutic Response|437|||
164576875|NCT00045032|594474877|FG002|Overall Study|Insufficient Therapeutic Response|445|||
164576876|NCT00045032|594474875|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
164576877|NCT00045032|594474876|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
164576878|NCT00045032|594474877|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
164576879|NCT00045032|594474875|FG000|Overall Study|Other Protocol Violation|2|||
164576880|NCT00045032|594474876|FG001|Overall Study|Other Protocol Violation|0|||
164576881|NCT00045032|594474877|FG002|Overall Study|Other Protocol Violation|1|||
164576882|NCT00045032|594474875|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
164576883|NCT00045032|594474876|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
164576884|NCT00045032|594474877|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
164576885|NCT00045032|594474875|FG000|Overall Study|Failure to Return|57|||
164576886|NCT00045032|594474876|FG001|Overall Study|Failure to Return|62|||
164576887|NCT00045032|594474877|FG002|Overall Study|Failure to Return|61|||
164576888|NCT00045032|594474875|FG000|Overall Study|Other|93|||
164576889|NCT00045032|594474876|FG001|Overall Study|Other|84|||
164576890|NCT00045032|594474877|FG002|Overall Study|Other|105|||
164576891|NCT02582658|594474878|FG000|Overall Study|Failure to Return|10|||
164576892|NCT02582658|594474878|FG000|Overall Study|Insufficient Virological Response|2|||
164576893|NCT02582658|594474878|FG000|Overall Study|Withdrawn Consent|1|||
164576894|NCT02582658|594474878|FG000|Overall Study|Death|1|||
164576895|NCT02582658|594474878|FG000|Overall Study|Not further specified|11|||
164576896|NCT02770807|594474879|FG000|Overall Study|Adverse Event|3|||
164258049|NCT03622112|593311690|FG001|Overall Study|Reason not specified|1|||
164258050|NCT03622112|593311691|FG002|Overall Study|Reason not specified|0|||
164258051|NCT03622112|593311692|FG003|Overall Study|Reason not specified|1|||
164258052|NCT03622112|593311693|FG004|Overall Study|Reason not specified|1|||
164258053|NCT03622112|593311694|FG005|Overall Study|Reason not specified|2|||
164258054|NCT03622112|593311695|FG006|Overall Study|Reason not specified|1|||
164258055|NCT01165320|593311698|FG000|Overall Study|Clinical adverse experience|2|||
164258056|NCT01165320|593311699|FG001|Overall Study|Clinical adverse experience|1|||
164258057|NCT01165320|593311700|FG002|Overall Study|Clinical adverse experience|0|||
164258058|NCT01165320|593311698|FG000|Overall Study|Laboratory adverse experience|1|||
164258059|NCT01165320|593311699|FG001|Overall Study|Laboratory adverse experience|0|||
164258060|NCT01165320|593311700|FG002|Overall Study|Laboratory adverse experience|0|||
164258061|NCT01165320|593311698|FG000|Overall Study|Lack of Efficacy|0|||
164258062|NCT01165320|593311699|FG001|Overall Study|Lack of Efficacy|2|||
164258063|NCT01165320|593311700|FG002|Overall Study|Lack of Efficacy|0|||
164258064|NCT01165320|593311698|FG000|Overall Study|Reason unknown|0|||
164258065|NCT01165320|593311699|FG001|Overall Study|Reason unknown|1|||
164258066|NCT01165320|593311700|FG002|Overall Study|Reason unknown|0|||
164258067|NCT03305419|593311701|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
164576897|NCT02770807|594474880|FG001|Overall Study|Adverse Event|3|||
164576898|NCT02770807|594474881|FG002|Overall Study|Adverse Event|1|||
164258068|NCT03305419|593311702|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
164258069|NCT03305419|593311703|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
164576899|NCT02770807|594474879|FG000|Overall Study|Withdrawal by Subject|7|||
164258070|NCT03305419|593311704|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
164258071|NCT03305419|593311705|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
164258072|NCT03305419|593311706|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
164258073|NCT03305419|593311707|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
164258074|NCT03305419|593311708|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
164258075|NCT03305419|593311701|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
164258076|NCT03305419|593311702|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
164258077|NCT03305419|593311703|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
164258078|NCT03305419|593311704|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
164258079|NCT03305419|593311705|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
164258080|NCT03305419|593311706|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
164258081|NCT03305419|593311707|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
164258082|NCT03305419|593311708|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
164258083|NCT03305419|593311701|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
164258084|NCT03305419|593311702|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
164258085|NCT03305419|593311703|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
164258086|NCT03305419|593311704|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
164258087|NCT03305419|593311705|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
164258088|NCT03305419|593311706|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
164576900|NCT02770807|594474880|FG001|Overall Study|Withdrawal by Subject|3|||
164576901|NCT02770807|594474881|FG002|Overall Study|Withdrawal by Subject|4|||
164576902|NCT02770807|594474879|FG000|Overall Study|Other|0|||
164576903|NCT02770807|594474880|FG001|Overall Study|Other|1|||
164576904|NCT02770807|594474881|FG002|Overall Study|Other|0|||
164576905|NCT02770807|594474879|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
164576906|NCT02770807|594474880|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
164576907|NCT02770807|594474881|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
164576908|NCT02770807|594474879|FG000|Overall Study|Physician Decision|0|||
164576909|NCT02770807|594474880|FG001|Overall Study|Physician Decision|0|||
164576910|NCT02770807|594474881|FG002|Overall Study|Physician Decision|1|||
164576911|NCT01084252|594476730|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164576912|NCT01084252|594476731|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164576913|NCT01084252|594476732|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164576914|NCT01084252|594476733|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164576915|NCT01084252|594476734|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164576916|NCT01084252|594476735|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164576917|NCT01084252|594476736|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164576918|NCT01084252|594476737|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164576919|NCT01084252|594476738|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164576920|NCT01084252|594476739|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164576921|NCT01084252|594476740|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164576922|NCT01084252|594476741|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164576923|NCT01084252|594476742|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
164576924|NCT01084252|594476743|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164576925|NCT04909463|594476744|FG000|Overall Study|Withdrawal by Subject|0|||
164576926|NCT04909463|594476745|FG001|Overall Study|Withdrawal by Subject|1|||
164576927|NCT04909463|594476746|FG002|Overall Study|Withdrawal by Subject|0|||
164258089|NCT03305419|593311707|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
164258090|NCT03305419|593311708|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
164258091|NCT03305419|593311701|FG000|Part B (14 Days)|Adverse Event|0|||
164258092|NCT03305419|593311702|FG001|Part B (14 Days)|Adverse Event|0|||
164258093|NCT03305419|593311703|FG002|Part B (14 Days)|Adverse Event|0|||
164258094|NCT03305419|593311704|FG003|Part B (14 Days)|Adverse Event|0|||
164258095|NCT03305419|593311705|FG004|Part B (14 Days)|Adverse Event|1|||
164258096|NCT03305419|593311706|FG005|Part B (14 Days)|Adverse Event|2|||
164258097|NCT03305419|593311707|FG006|Part B (14 Days)|Adverse Event|4|||
164258098|NCT03305419|593311708|FG007|Part B (14 Days)|Adverse Event|0|||
164258099|NCT03305419|593311701|FG000|Part B (14 Days)|Physician Decision|0|||
164258100|NCT03305419|593311702|FG001|Part B (14 Days)|Physician Decision|0|||
164258101|NCT03305419|593311703|FG002|Part B (14 Days)|Physician Decision|0|||
164258102|NCT03305419|593311704|FG003|Part B (14 Days)|Physician Decision|0|||
164258103|NCT03305419|593311705|FG004|Part B (14 Days)|Physician Decision|2|||
164258104|NCT03305419|593311706|FG005|Part B (14 Days)|Physician Decision|8|||
164258105|NCT03305419|593311707|FG006|Part B (14 Days)|Physician Decision|1|||
164258106|NCT03305419|593311708|FG007|Part B (14 Days)|Physician Decision|0|||
164258107|NCT01155466|593311709|FG000|Overall Study|Adverse Event|13|||
164258108|NCT01155466|593311710|FG001|Overall Study|Adverse Event|15|||
164258109|NCT01155466|593311711|FG002|Overall Study|Adverse Event|6|||
164258110|NCT01155466|593311712|FG003|Overall Study|Adverse Event|17|||
164258111|NCT01155466|593311713|FG004|Overall Study|Adverse Event|18|||
164258112|NCT01155466|593311709|FG000|Overall Study|Lost to Follow-up|0|||
164576928|NCT04909463|594476747|FG003|Overall Study|Withdrawal by Subject|0|||
164576929|NCT04909463|594476744|FG000|Overall Study|Lost to Follow-up|2|||
164576930|NCT04909463|594476745|FG001|Overall Study|Lost to Follow-up|1|||
164576931|NCT04909463|594476746|FG002|Overall Study|Lost to Follow-up|1|||
164258113|NCT01155466|593311710|FG001|Overall Study|Lost to Follow-up|0|||
164258114|NCT01155466|593311711|FG002|Overall Study|Lost to Follow-up|0|||
164258115|NCT01155466|593311712|FG003|Overall Study|Lost to Follow-up|0|||
164258116|NCT01155466|593311713|FG004|Overall Study|Lost to Follow-up|2|||
164258117|NCT01155466|593311709|FG000|Overall Study|Withdrawal by Subject|7|||
164258118|NCT01155466|593311710|FG001|Overall Study|Withdrawal by Subject|5|||
164258119|NCT01155466|593311711|FG002|Overall Study|Withdrawal by Subject|9|||
164258120|NCT01155466|593311712|FG003|Overall Study|Withdrawal by Subject|4|||
164681000|NCT00112437|594854592|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
164681001|NCT00112437|594854593|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164681002|NCT00112437|594854594|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164681003|NCT00112437|594854595|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164681004|NCT00112437|594854596|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164681005|NCT00112437|594854571|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164681006|NCT00112437|594854572|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164681007|NCT00112437|594854573|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164681008|NCT00112437|594854574|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164681009|NCT00112437|594854575|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164681010|NCT00112437|594854576|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164681011|NCT00112437|594854577|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164681012|NCT00112437|594854578|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164681013|NCT00112437|594854579|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164681014|NCT00112437|594854580|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164681015|NCT00112437|594854581|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164681016|NCT00112437|594854582|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164681017|NCT00112437|594854583|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164681018|NCT00112437|594854584|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164681019|NCT00112437|594854585|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164681020|NCT00112437|594854586|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164681021|NCT00112437|594854587|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164681022|NCT00112437|594854588|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164681023|NCT00112437|594854589|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164681024|NCT00112437|594854590|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164681025|NCT00112437|594854591|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164681026|NCT00112437|594854592|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164681027|NCT00112437|594854593|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
164681028|NCT00112437|594854594|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
164681029|NCT00112437|594854595|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164681030|NCT00112437|594854596|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
164681031|NCT00112437|594854571|FG000|Years 6-10 (60-Month Extension)|Death|0|||
164681032|NCT00112437|594854572|FG001|Years 6-10 (60-Month Extension)|Death|0|||
164681033|NCT00112437|594854573|FG002|Years 6-10 (60-Month Extension)|Death|0|||
164681034|NCT00112437|594854574|FG003|Years 6-10 (60-Month Extension)|Death|0|||
164681035|NCT00112437|594854575|FG004|Years 6-10 (60-Month Extension)|Death|0|||
164681036|NCT00112437|594854576|FG005|Years 6-10 (60-Month Extension)|Death|0|||
164681037|NCT00112437|594854577|FG006|Years 6-10 (60-Month Extension)|Death|0|||
164681038|NCT00112437|594854578|FG007|Years 6-10 (60-Month Extension)|Death|0|||
164681039|NCT00112437|594854579|FG008|Years 6-10 (60-Month Extension)|Death|0|||
164681040|NCT00112437|594854580|FG009|Years 6-10 (60-Month Extension)|Death|0|||
164681041|NCT00112437|594854581|FG010|Years 6-10 (60-Month Extension)|Death|0|||
164258121|NCT01155466|593311713|FG004|Overall Study|Withdrawal by Subject|4|||
164258122|NCT01155466|593311709|FG000|Overall Study|Protocol Violation|0|||
164340052|NCT01193842|593619016|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
164340053|NCT01193842|593619017|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
164340054|NCT01193842|593619018|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
164340055|NCT01193842|593619019|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
164340056|NCT01193842|593619015|FG000|Phase II: Randomized Groups|Death|0|||
164340057|NCT01193842|593619016|FG001|Phase II: Randomized Groups|Death|0|||
164340058|NCT01193842|593619017|FG002|Phase II: Randomized Groups|Death|0|||
164340059|NCT01193842|593619018|FG003|Phase II: Randomized Groups|Death|1|||
164340060|NCT01193842|593619019|FG004|Phase II: Randomized Groups|Death|1|||
164340061|NCT01193842|593619015|FG000|Phase II: Randomized Groups|Adverse Event|0|||
164340062|NCT01193842|593619016|FG001|Phase II: Randomized Groups|Adverse Event|0|||
164340063|NCT01193842|593619017|FG002|Phase II: Randomized Groups|Adverse Event|0|||
164340064|NCT01193842|593619018|FG003|Phase II: Randomized Groups|Adverse Event|5|||
164681042|NCT00112437|594854582|FG011|Years 6-10 (60-Month Extension)|Death|0|||
164258123|NCT01155466|593311710|FG001|Overall Study|Protocol Violation|0|||
164258124|NCT01155466|593311711|FG002|Overall Study|Protocol Violation|2|||
164340065|NCT01193842|593619019|FG004|Phase II: Randomized Groups|Adverse Event|3|||
164340066|NCT01193842|593619015|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
164428798|NCT05174065|593939464|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
164428799|NCT05174065|593939462|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
164428800|NCT05174065|593939463|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
164428801|NCT05174065|593939464|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
164428802|NCT05174065|593939462|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
164428803|NCT05174065|593939463|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
164428804|NCT05174065|593939464|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
164428805|NCT00689104|593939465|FG000|Overall Study|Eligibility criterion not met|5|||
164428806|NCT00689104|593939466|FG001|Overall Study|Eligibility criterion not met|8|||
164428807|NCT00689104|593939467|FG002|Overall Study|Eligibility criterion not met|0|||
164428808|NCT00689104|593939468|FG003|Overall Study|Eligibility criterion not met|4|||
164428809|NCT00689104|593939465|FG000|Overall Study|Adverse Event|13|||
164428810|NCT00689104|593939466|FG001|Overall Study|Adverse Event|25|||
164428811|NCT00689104|593939467|FG002|Overall Study|Adverse Event|16|||
164428812|NCT00689104|593939468|FG003|Overall Study|Adverse Event|24|||
164428813|NCT00689104|593939465|FG000|Overall Study|Lack of Efficacy|5|||
164428814|NCT00689104|593939466|FG001|Overall Study|Lack of Efficacy|6|||
164428815|NCT00689104|593939467|FG002|Overall Study|Lack of Efficacy|2|||
164428816|NCT00689104|593939468|FG003|Overall Study|Lack of Efficacy|3|||
164428817|NCT00689104|593939465|FG000|Overall Study|Withdrawal by Subject|12|||
164428818|NCT00689104|593939466|FG001|Overall Study|Withdrawal by Subject|11|||
164428819|NCT00689104|593939467|FG002|Overall Study|Withdrawal by Subject|18|||
164428820|NCT00689104|593939468|FG003|Overall Study|Withdrawal by Subject|11|||
164428821|NCT00689104|593939465|FG000|Overall Study|Lost to Follow-up|4|||
164428822|NCT00689104|593939466|FG001|Overall Study|Lost to Follow-up|3|||
164428823|NCT00689104|593939467|FG002|Overall Study|Lost to Follow-up|2|||
164428824|NCT00689104|593939468|FG003|Overall Study|Lost to Follow-up|5|||
164428825|NCT00689104|593939465|FG000|Overall Study|Protocol Violation|2|||
164428826|NCT00689104|593939466|FG001|Overall Study|Protocol Violation|3|||
164428827|NCT00689104|593939467|FG002|Overall Study|Protocol Violation|5|||
164428828|NCT00689104|593939468|FG003|Overall Study|Protocol Violation|3|||
164428829|NCT00689104|593939465|FG000|Overall Study|Randomized but never received study drug|2|||
164428830|NCT00689104|593939466|FG001|Overall Study|Randomized but never received study drug|1|||
164428831|NCT00689104|593939467|FG002|Overall Study|Randomized but never received study drug|1|||
164428832|NCT00689104|593939468|FG003|Overall Study|Randomized but never received study drug|0|||
164428833|NCT00689104|593939465|FG000|Overall Study|Physician Decision|1|||
164428834|NCT00689104|593939466|FG001|Overall Study|Physician Decision|0|||
164428835|NCT00689104|593939467|FG002|Overall Study|Physician Decision|0|||
164428836|NCT00689104|593939468|FG003|Overall Study|Physician Decision|0|||
164428837|NCT00689104|593939465|FG000|Overall Study|Non-compliance with study procedures|0|||
164428838|NCT00689104|593939466|FG001|Overall Study|Non-compliance with study procedures|0|||
164428839|NCT00689104|593939467|FG002|Overall Study|Non-compliance with study procedures|1|||
164428840|NCT00689104|593939468|FG003|Overall Study|Non-compliance with study procedures|0|||
164428841|NCT02698436|593939469|FG000|Overall Study|Adverse Event|1|||
164428842|NCT02698436|593939470|FG001|Overall Study|Adverse Event|0|||
164428843|NCT02698436|593939469|FG000|Overall Study|Withdrawal by Subject|3|||
164428844|NCT02698436|593939470|FG001|Overall Study|Withdrawal by Subject|3|||
164428845|NCT02698436|593939469|FG000|Overall Study|Lost to Follow-up|2|||
164428846|NCT02698436|593939470|FG001|Overall Study|Lost to Follow-up|4|||
164428847|NCT02698436|593939469|FG000|Overall Study|Non-compliance with study regimen|1|||
164428848|NCT02698436|593939470|FG001|Overall Study|Non-compliance with study regimen|0|||
164428849|NCT00665561|593939471|FG000|Overall Study|Death recorded on subject summary pages|75|||
164428850|NCT00665561|593939472|FG001|Overall Study|Death recorded on subject summary pages|75|||
164428851|NCT00665561|593939471|FG000|Overall Study|Does not meet entrance criteria|19|||
164428852|NCT00665561|593939472|FG001|Overall Study|Does not meet entrance criteria|21|||
164428853|NCT00665561|593939471|FG000|Overall Study|Lost to Follow-up|203|||
164428854|NCT00665561|593939472|FG001|Overall Study|Lost to Follow-up|264|||
164428855|NCT00665561|593939471|FG000|Overall Study|Withdrawal by Subject|74|||
164428856|NCT00665561|593939472|FG001|Overall Study|Withdrawal by Subject|65|||
164428857|NCT00665561|593939471|FG000|Overall Study|Other|123|||
164428858|NCT00665561|593939472|FG001|Overall Study|Other|108|||
164428859|NCT00665561|593939471|FG000|Overall Study|Site closed|8|||
164428860|NCT00665561|593939472|FG001|Overall Study|Site closed|0|||
164428861|NCT00665561|593939471|FG000|Overall Study|Withdrawn due to pregnancy|0|||
164428862|NCT00665561|593939472|FG001|Overall Study|Withdrawn due to pregnancy|1|||
164428863|NCT01734811|593939473|FG000|Overall Study|Lost to Follow-up|2|||
164428864|NCT01734811|593939474|FG001|Overall Study|Lost to Follow-up|3|||
164428865|NCT01734811|593939473|FG000|Overall Study|Withdrawal by Subject|2|||
164428866|NCT01734811|593939474|FG001|Overall Study|Withdrawal by Subject|0|||
164428867|NCT00062868|593939475|FG000|Dose Level 1|Death|2|||
164428868|NCT00062868|593939476|FG001|Dose Level 1|Death|0|||
164428869|NCT00062868|593939477|FG002|Dose Level 1|Death|0|||
164428870|NCT00062868|593939478|FG003|Dose Level 1|Death|2|||
164428871|NCT00062868|593939479|FG004|Dose Level 1|Death|0|||
164428872|NCT00062868|593939480|FG005|Dose Level 1|Death|0|||
164428873|NCT00062868|593939481|FG006|Dose Level 1|Death|3|||
164428874|NCT00062868|593939482|FG007|Dose Level 1|Death|0|||
164428875|NCT00062868|593939483|FG008|Dose Level 1|Death|0|||
164428876|NCT00062868|593939484|FG009|Dose Level 1|Death|0|||
164428877|NCT00062868|593939485|FG010|Dose Level 1|Death|0|||
164428878|NCT00062868|593939486|FG011|Dose Level 1|Death|0|||
164428879|NCT00062868|593939487|FG012|Dose Level 1|Death|0|||
164428880|NCT00062868|593939488|FG013|Dose Level 1|Death|0|||
164428881|NCT00062868|593939489|FG014|Dose Level 1|Death|0|||
164258125|NCT01155466|593311712|FG003|Overall Study|Protocol Violation|0|||
164428882|NCT00062868|593939490|FG015|Dose Level 1|Death|0|||
164428883|NCT00062868|593939491|FG016|Dose Level 1|Death|0|||
164428884|NCT00062868|593939492|FG017|Dose Level 1|Death|0|||
164428885|NCT00062868|593939493|FG018|Dose Level 1|Death|7|||
164428886|NCT00062868|593939494|FG019|Dose Level 1|Death|0|||
164428887|NCT00062868|593939495|FG020|Dose Level 1|Death|1|||
164428888|NCT00062868|593939475|FG000|Dose Level 1|Lost to Follow-up|0|||
164428889|NCT00062868|593939476|FG001|Dose Level 1|Lost to Follow-up|0|||
164428890|NCT00062868|593939477|FG002|Dose Level 1|Lost to Follow-up|0|||
164428891|NCT00062868|593939478|FG003|Dose Level 1|Lost to Follow-up|0|||
164428892|NCT00062868|593939479|FG004|Dose Level 1|Lost to Follow-up|0|||
164428893|NCT00062868|593939480|FG005|Dose Level 1|Lost to Follow-up|0|||
164428894|NCT00062868|593939481|FG006|Dose Level 1|Lost to Follow-up|0|||
164428895|NCT00062868|593939482|FG007|Dose Level 1|Lost to Follow-up|0|||
164428896|NCT00062868|593939483|FG008|Dose Level 1|Lost to Follow-up|0|||
164428897|NCT00062868|593939484|FG009|Dose Level 1|Lost to Follow-up|0|||
164428898|NCT00062868|593939485|FG010|Dose Level 1|Lost to Follow-up|0|||
164428899|NCT00062868|593939486|FG011|Dose Level 1|Lost to Follow-up|0|||
164428900|NCT00062868|593939487|FG012|Dose Level 1|Lost to Follow-up|1|||
164428901|NCT00062868|593939488|FG013|Dose Level 1|Lost to Follow-up|0|||
164428902|NCT00062868|593939489|FG014|Dose Level 1|Lost to Follow-up|0|||
164428903|NCT00062868|593939490|FG015|Dose Level 1|Lost to Follow-up|0|||
164428904|NCT00062868|593939491|FG016|Dose Level 1|Lost to Follow-up|0|||
164428905|NCT00062868|593939492|FG017|Dose Level 1|Lost to Follow-up|0|||
164428906|NCT00062868|593939493|FG018|Dose Level 1|Lost to Follow-up|2|||
164428907|NCT00062868|593939494|FG019|Dose Level 1|Lost to Follow-up|0|||
164428908|NCT00062868|593939495|FG020|Dose Level 1|Lost to Follow-up|1|||
164428909|NCT00062868|593939475|FG000|Dose Level 2|Death|0|||
164428910|NCT00062868|593939476|FG001|Dose Level 2|Death|3|||
164428911|NCT00062868|593939477|FG002|Dose Level 2|Death|0|||
164428912|NCT00062868|593939478|FG003|Dose Level 2|Death|0|||
164428913|NCT00062868|593939479|FG004|Dose Level 2|Death|2|||
164428914|NCT00062868|593939480|FG005|Dose Level 2|Death|0|||
164428915|NCT00062868|593939481|FG006|Dose Level 2|Death|0|||
164428916|NCT00062868|593939482|FG007|Dose Level 2|Death|0|||
164428917|NCT00062868|593939483|FG008|Dose Level 2|Death|0|||
164428918|NCT00062868|593939484|FG009|Dose Level 2|Death|0|||
164428919|NCT00062868|593939485|FG010|Dose Level 2|Death|1|||
164428920|NCT00062868|593939486|FG011|Dose Level 2|Death|0|||
164428921|NCT00062868|593939487|FG012|Dose Level 2|Death|0|||
164428922|NCT00062868|593939488|FG013|Dose Level 2|Death|0|||
164428923|NCT00062868|593939489|FG014|Dose Level 2|Death|0|||
164428924|NCT00062868|593939490|FG015|Dose Level 2|Death|0|||
164428925|NCT00062868|593939491|FG016|Dose Level 2|Death|2|||
164576932|NCT04909463|594476747|FG003|Overall Study|Lost to Follow-up|0|||
164576933|NCT00853632|594476748|FG000|Overall Study|Death|88|||
164576934|NCT00853632|594476748|FG000|Overall Study|Withdrawal by Subject|45|||
164576935|NCT00853632|594476748|FG000|Overall Study|Lost to Follow-up|30|||
164576936|NCT00853632|594476748|FG000|Overall Study|Reoperation/Explant|17|||
164576937|NCT00853632|594476748|FG000|Overall Study|Exit with other reason|22|||
164576938|NCT04364854|594476749|FG000|Overall Study|Withdrawal by Subject|1|||
164576939|NCT04364854|594476750|FG001|Overall Study|Withdrawal by Subject|0|||
164428926|NCT00062868|593939492|FG017|Dose Level 2|Death|0|||
164428927|NCT00062868|593939493|FG018|Dose Level 2|Death|0|||
164576940|NCT04364854|594476751|FG002|Overall Study|Withdrawal by Subject|1|||
164258126|NCT01155466|593311713|FG004|Overall Study|Protocol Violation|1|||
164428928|NCT00062868|593939494|FG019|Dose Level 2|Death|0|||
164428929|NCT00062868|593939495|FG020|Dose Level 2|Death|0|||
164428930|NCT00062868|593939475|FG000|Dose Level 2|Lost to Follow-up|0|||
164428931|NCT00062868|593939476|FG001|Dose Level 2|Lost to Follow-up|0|||
164428932|NCT00062868|593939477|FG002|Dose Level 2|Lost to Follow-up|0|||
164428933|NCT00062868|593939478|FG003|Dose Level 2|Lost to Follow-up|0|||
164428934|NCT00062868|593939479|FG004|Dose Level 2|Lost to Follow-up|0|||
164428935|NCT00062868|593939480|FG005|Dose Level 2|Lost to Follow-up|0|||
164428936|NCT00062868|593939481|FG006|Dose Level 2|Lost to Follow-up|0|||
164428937|NCT00062868|593939482|FG007|Dose Level 2|Lost to Follow-up|0|||
164428938|NCT00062868|593939483|FG008|Dose Level 2|Lost to Follow-up|0|||
164428939|NCT00062868|593939484|FG009|Dose Level 2|Lost to Follow-up|0|||
164428940|NCT00062868|593939485|FG010|Dose Level 2|Lost to Follow-up|0|||
164428941|NCT00062868|593939486|FG011|Dose Level 2|Lost to Follow-up|0|||
164428942|NCT00062868|593939487|FG012|Dose Level 2|Lost to Follow-up|0|||
164428943|NCT00062868|593939488|FG013|Dose Level 2|Lost to Follow-up|1|||
164576941|NCT04364854|594476752|FG003|Overall Study|Withdrawal by Subject|3|||
164576942|NCT04364854|594476749|FG000|Overall Study|Death|1|||
164340067|NCT01193842|593619016|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
164428944|NCT00062868|593939489|FG014|Dose Level 2|Lost to Follow-up|0|||
164428945|NCT00062868|593939490|FG015|Dose Level 2|Lost to Follow-up|0|||
164428946|NCT00062868|593939491|FG016|Dose Level 2|Lost to Follow-up|1|||
164428947|NCT00062868|593939492|FG017|Dose Level 2|Lost to Follow-up|0|||
164428948|NCT00062868|593939493|FG018|Dose Level 2|Lost to Follow-up|0|||
164428949|NCT00062868|593939494|FG019|Dose Level 2|Lost to Follow-up|0|||
164428950|NCT00062868|593939495|FG020|Dose Level 2|Lost to Follow-up|0|||
164428951|NCT00062868|593939475|FG000|Dose Level 3|Death|0|||
164428952|NCT00062868|593939476|FG001|Dose Level 3|Death|0|||
164428953|NCT00062868|593939477|FG002|Dose Level 3|Death|0|||
164428954|NCT00062868|593939478|FG003|Dose Level 3|Death|0|||
164428955|NCT00062868|593939479|FG004|Dose Level 3|Death|0|||
164428956|NCT00062868|593939480|FG005|Dose Level 3|Death|0|||
164428957|NCT00062868|593939481|FG006|Dose Level 3|Death|0|||
164428958|NCT00062868|593939482|FG007|Dose Level 3|Death|0|||
164428959|NCT00062868|593939483|FG008|Dose Level 3|Death|0|||
164428960|NCT00062868|593939484|FG009|Dose Level 3|Death|0|||
164428961|NCT00062868|593939485|FG010|Dose Level 3|Death|0|||
164428962|NCT00062868|593939486|FG011|Dose Level 3|Death|1|||
164428963|NCT00062868|593939487|FG012|Dose Level 3|Death|0|||
164428964|NCT00062868|593939488|FG013|Dose Level 3|Death|0|||
164428965|NCT00062868|593939489|FG014|Dose Level 3|Death|0|||
164428966|NCT00062868|593939490|FG015|Dose Level 3|Death|0|||
164428967|NCT00062868|593939491|FG016|Dose Level 3|Death|0|||
164340068|NCT01193842|593619017|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
164340069|NCT01193842|593619018|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
164340070|NCT01193842|593619019|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
164340071|NCT01193842|593619015|FG000|Phase II: Randomized Groups|Ineligible|0|||
164340072|NCT01193842|593619016|FG001|Phase II: Randomized Groups|Ineligible|0|||
164428968|NCT00062868|593939492|FG017|Dose Level 3|Death|1|||
164428969|NCT00062868|593939493|FG018|Dose Level 3|Death|0|||
164428970|NCT00062868|593939494|FG019|Dose Level 3|Death|0|||
164428971|NCT00062868|593939495|FG020|Dose Level 3|Death|0|||
164428972|NCT00062868|593939475|FG000|Dose Level 3|Lost to Follow-up|0|||
164428973|NCT00062868|593939476|FG001|Dose Level 3|Lost to Follow-up|0|||
164428974|NCT00062868|593939477|FG002|Dose Level 3|Lost to Follow-up|0|||
164428975|NCT00062868|593939478|FG003|Dose Level 3|Lost to Follow-up|0|||
164340073|NCT01193842|593619017|FG002|Phase II: Randomized Groups|Ineligible|0|||
164340074|NCT01193842|593619018|FG003|Phase II: Randomized Groups|Ineligible|0|||
164340075|NCT01193842|593619019|FG004|Phase II: Randomized Groups|Ineligible|1|||
164340076|NCT01193842|593619015|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
164340077|NCT01193842|593619016|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
164340078|NCT01193842|593619017|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
164340079|NCT01193842|593619018|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
164340080|NCT01193842|593619019|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
164340081|NCT03487549|593619021|FG000|Overall Study|Protocol Violation|0|||
164340082|NCT03487549|593619022|FG001|Overall Study|Protocol Violation|1|||
164340083|NCT03487549|593619021|FG000|Overall Study|Lost to Follow-up|2|||
164340084|NCT03487549|593619022|FG001|Overall Study|Lost to Follow-up|1|||
164340085|NCT03487549|593619021|FG000|Overall Study|Withdrawal by Subject|2|||
164340086|NCT03487549|593619022|FG001|Overall Study|Withdrawal by Subject|0|||
164340087|NCT01995825|593620475|FG000|Overall Study|Withdrawal by Subject|1|||
164340088|NCT01995825|593620476|FG001|Overall Study|Withdrawal by Subject|0|||
164340089|NCT00354744|593620479|FG000|Overall Study|Adverse Event|2|||
164340090|NCT00354744|593620479|FG000|Overall Study|Death|2|||
164428976|NCT00062868|593939479|FG004|Dose Level 3|Lost to Follow-up|0|||
164428977|NCT00062868|593939480|FG005|Dose Level 3|Lost to Follow-up|0|||
164428978|NCT00062868|593939481|FG006|Dose Level 3|Lost to Follow-up|0|||
164576943|NCT04364854|594476750|FG001|Overall Study|Death|0|||
164576944|NCT04364854|594476751|FG002|Overall Study|Death|0|||
164576945|NCT04364854|594476752|FG003|Overall Study|Death|0|||
164576946|NCT04364854|594476749|FG000|Overall Study|Lost to Follow-up|0|||
164576947|NCT04364854|594476750|FG001|Overall Study|Lost to Follow-up|0|||
164576948|NCT04364854|594476751|FG002|Overall Study|Lost to Follow-up|0|||
164576949|NCT04364854|594476752|FG003|Overall Study|Lost to Follow-up|1|||
164340091|NCT00354744|593620479|FG000|Overall Study|Lack of Efficacy|11|||
164428979|NCT00062868|593939482|FG007|Dose Level 3|Lost to Follow-up|0|||
164428980|NCT00062868|593939483|FG008|Dose Level 3|Lost to Follow-up|0|||
164428981|NCT00062868|593939484|FG009|Dose Level 3|Lost to Follow-up|0|||
164428982|NCT00062868|593939485|FG010|Dose Level 3|Lost to Follow-up|0|||
164428983|NCT00062868|593939486|FG011|Dose Level 3|Lost to Follow-up|0|||
164340092|NCT00354744|593620479|FG000|Overall Study|Lost to Follow-up|2|||
164340093|NCT00354744|593620479|FG000|Overall Study|Physician Decision|11|||
164340094|NCT00354744|593620479|FG000|Overall Study|Withdrawal by Subject|14|||
164428984|NCT00062868|593939487|FG012|Dose Level 3|Lost to Follow-up|0|||
164428985|NCT00062868|593939488|FG013|Dose Level 3|Lost to Follow-up|0|||
164428986|NCT00062868|593939489|FG014|Dose Level 3|Lost to Follow-up|1|||
164576950|NCT04493619|594476754|FG000|Overall Study|Death|4|||
164576951|NCT04493619|594476755|FG001|Overall Study|Death|3|||
164576952|NCT04493619|594476756|FG002|Overall Study|Death|3|||
164258127|NCT01155466|593311709|FG000|Overall Study|Administrative|0|||
164258128|NCT01155466|593311710|FG001|Overall Study|Administrative|3|||
164258129|NCT01155466|593311711|FG002|Overall Study|Administrative|0|||
164258130|NCT01155466|593311712|FG003|Overall Study|Administrative|0|||
164258131|NCT01155466|593311713|FG004|Overall Study|Administrative|0|||
164258132|NCT01155466|593311709|FG000|Overall Study|Randomized not treated|2|||
164258133|NCT01155466|593311710|FG001|Overall Study|Randomized not treated|2|||
164258134|NCT01155466|593311711|FG002|Overall Study|Randomized not treated|3|||
164258135|NCT01155466|593311712|FG003|Overall Study|Randomized not treated|0|||
164258136|NCT01155466|593311713|FG004|Overall Study|Randomized not treated|2|||
164258137|NCT02075047|593311714|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
164258138|NCT02075047|593311715|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
164258139|NCT02075047|593311714|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
164258140|NCT02075047|593311715|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
164340095|NCT00541931|593620480|FG000|Overall Study|Adverse Event|1|||
164340096|NCT00541931|593620481|FG001|Overall Study|Adverse Event|0|||
164340097|NCT00541931|593620480|FG000|Overall Study|Lost to Follow-up|3|||
164340098|NCT00541931|593620481|FG001|Overall Study|Lost to Follow-up|3|||
164340099|NCT00541931|593620480|FG000|Overall Study|Withdrawal by Subject|1|||
164340100|NCT00541931|593620481|FG001|Overall Study|Withdrawal by Subject|0|||
164340101|NCT00541931|593620480|FG000|Overall Study|Transportation Issue|0|||
164340102|NCT00541931|593620481|FG001|Overall Study|Transportation Issue|1|||
164340103|NCT03094169|593620482|FG000|Overall Study|Lack of Efficacy|0|||
164340104|NCT03094169|593620483|FG001|Overall Study|Lack of Efficacy|0|||
164340105|NCT03094169|593620484|FG002|Overall Study|Lack of Efficacy|0|||
164340106|NCT03094169|593620485|FG003|Overall Study|Lack of Efficacy|0|||
164340107|NCT03094169|593620486|FG004|Overall Study|Lack of Efficacy|0|||
164340108|NCT03094169|593620487|FG005|Overall Study|Lack of Efficacy|0|||
164340109|NCT03094169|593620488|FG006|Overall Study|Lack of Efficacy|0|||
164340110|NCT03094169|593620489|FG007|Overall Study|Lack of Efficacy|21|||
164340111|NCT03094169|593620482|FG000|Overall Study|Adverse Event|0|||
164576953|NCT04493619|594476757|FG003|Overall Study|Death|4|||
164576954|NCT04493619|594476754|FG000|Overall Study|Study discontinued early|10|||
164576955|NCT04493619|594476755|FG001|Overall Study|Study discontinued early|0|||
164576956|NCT04493619|594476756|FG002|Overall Study|Study discontinued early|4|||
164576957|NCT04493619|594476757|FG003|Overall Study|Study discontinued early|8|||
164576958|NCT04493619|594476754|FG000|Overall Study|Lost to Follow-up|0|||
164576959|NCT04493619|594476755|FG001|Overall Study|Lost to Follow-up|0|||
164576960|NCT04493619|594476756|FG002|Overall Study|Lost to Follow-up|0|||
164576961|NCT04493619|594476757|FG003|Overall Study|Lost to Follow-up|1|||
164576962|NCT03528681|594476764|FG000|Open-Label Phase|Physician Decision|2|||
164576963|NCT03528681|594476765|FG001|Open-Label Phase|Physician Decision|0|||
164576964|NCT03528681|594476766|FG002|Open-Label Phase|Physician Decision|0|||
164576965|NCT03528681|594476767|FG003|Open-Label Phase|Physician Decision|0|||
164576966|NCT03528681|594476764|FG000|Open-Label Phase|Withdrawal by Subject|8|||
164576967|NCT03528681|594476765|FG001|Open-Label Phase|Withdrawal by Subject|0|||
164576968|NCT03528681|594476766|FG002|Open-Label Phase|Withdrawal by Subject|0|||
164576969|NCT03528681|594476767|FG003|Open-Label Phase|Withdrawal by Subject|0|||
164576970|NCT03528681|594476764|FG000|Open-Label Phase|(Not collected)|4|||
164576971|NCT03528681|594476765|FG001|Open-Label Phase|(Not collected)|0|||
164576972|NCT03528681|594476766|FG002|Open-Label Phase|(Not collected)|0|||
164576973|NCT03528681|594476767|FG003|Open-Label Phase|(Not collected)|0|||
164576974|NCT03528681|594476764|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
164576975|NCT03528681|594476765|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
164576976|NCT03528681|594476766|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
164576977|NCT03528681|594476767|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
164576978|NCT03528681|594476764|FG000|Randomized Treatment Phase|Physician Decision|0|||
164576979|NCT03528681|594476765|FG001|Randomized Treatment Phase|Physician Decision|5|||
164576980|NCT03528681|594476766|FG002|Randomized Treatment Phase|Physician Decision|1|||
164576981|NCT03528681|594476767|FG003|Randomized Treatment Phase|Physician Decision|2|||
164576982|NCT03528681|594476764|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
164576983|NCT03528681|594476765|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
164576984|NCT03528681|594476766|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
164576985|NCT03528681|594476767|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
164576986|NCT03528681|594476764|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
164576987|NCT03528681|594476765|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
164576988|NCT03528681|594476766|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
164258141|NCT02075047|593311714|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
164258142|NCT02075047|593311715|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
164340112|NCT03094169|593620483|FG001|Overall Study|Adverse Event|0|||
164340113|NCT03094169|593620484|FG002|Overall Study|Adverse Event|0|||
164340114|NCT03094169|593620485|FG003|Overall Study|Adverse Event|0|||
164340115|NCT03094169|593620486|FG004|Overall Study|Adverse Event|0|||
164576989|NCT03528681|594476767|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
164681043|NCT00112437|594854583|FG012|Years 6-10 (60-Month Extension)|Death|0|||
164681044|NCT00112437|594854584|FG013|Years 6-10 (60-Month Extension)|Death|0|||
164681045|NCT00112437|594854585|FG014|Years 6-10 (60-Month Extension)|Death|0|||
164681046|NCT00112437|594854586|FG015|Years 6-10 (60-Month Extension)|Death|0|||
164681047|NCT00112437|594854587|FG016|Years 6-10 (60-Month Extension)|Death|0|||
164681048|NCT00112437|594854588|FG017|Years 6-10 (60-Month Extension)|Death|0|||
164681049|NCT00112437|594854589|FG018|Years 6-10 (60-Month Extension)|Death|0|||
164681050|NCT00112437|594854590|FG019|Years 6-10 (60-Month Extension)|Death|0|||
164681051|NCT00112437|594854591|FG020|Years 6-10 (60-Month Extension)|Death|0|||
164681052|NCT00112437|594854592|FG021|Years 6-10 (60-Month Extension)|Death|0|||
164681053|NCT00112437|594854593|FG022|Years 6-10 (60-Month Extension)|Death|0|||
164681054|NCT00112437|594854594|FG023|Years 6-10 (60-Month Extension)|Death|2|||
164258143|NCT02075047|593311714|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
164258144|NCT02075047|593311715|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
164258145|NCT02075047|593311714|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
164258146|NCT02075047|593311715|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
164258147|NCT02075047|593311714|FG000|Treatment Phase (4 Weeks)|Other|1|||
164258148|NCT02075047|593311715|FG001|Treatment Phase (4 Weeks)|Other|1|||
164258149|NCT02075047|593311714|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
164258150|NCT02075047|593311715|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
164258151|NCT02075047|593311714|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
164258152|NCT02075047|593311715|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
164258153|NCT02075047|593311714|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
164258154|NCT02075047|593311715|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
164258155|NCT02075047|593311714|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
164258156|NCT02075047|593311715|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
164258157|NCT02075047|593311714|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
164258158|NCT02075047|593311715|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
164258159|NCT02075047|593311714|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
164258160|NCT02075047|593311715|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
164258161|NCT02075047|593311714|FG000|Follow up Phase (5 Weeks)|Other|1|||
164258162|NCT02075047|593311715|FG001|Follow up Phase (5 Weeks)|Other|2|||
164258163|NCT02075047|593311714|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
164258164|NCT02075047|593311715|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
164258165|NCT00075946|593311716|FG000|Overall Study|Path ineligible: undetermined histology|0|||
164258166|NCT00075946|593311717|FG001|Overall Study|Path ineligible: undetermined histology|0|||
164258167|NCT00075946|593311718|FG002|Overall Study|Path ineligible: undetermined histology|0|||
164258168|NCT00075946|593311719|FG003|Overall Study|Path ineligible: undetermined histology|0|||
164258169|NCT00075946|593311720|FG004|Overall Study|Path ineligible: undetermined histology|6|||
164258170|NCT00075946|593311716|FG000|Overall Study|Did not achieve response after induction|0|||
164258171|NCT00075946|593311717|FG001|Overall Study|Did not achieve response after induction|0|||
164258172|NCT00075946|593311718|FG002|Overall Study|Did not achieve response after induction|0|||
164258173|NCT00075946|593311719|FG003|Overall Study|Did not achieve response after induction|0|||
164258174|NCT00075946|593311720|FG004|Overall Study|Did not achieve response after induction|182|||
164258175|NCT00075946|593311716|FG000|Overall Study|Incorrectly randomized (no response)|5|||
164258176|NCT00075946|593311717|FG001|Overall Study|Incorrectly randomized (no response)|5|||
164258177|NCT00075946|593311718|FG002|Overall Study|Incorrectly randomized (no response)|5|||
164258178|NCT00075946|593311719|FG003|Overall Study|Incorrectly randomized (no response)|1|||
164340116|NCT03094169|593620487|FG005|Overall Study|Adverse Event|0|||
164340117|NCT03094169|593620488|FG006|Overall Study|Adverse Event|0|||
164340118|NCT03094169|593620489|FG007|Overall Study|Adverse Event|2|||
164340119|NCT03094169|593620482|FG000|Overall Study|Withdrawal by Subject|0|||
164340120|NCT03094169|593620483|FG001|Overall Study|Withdrawal by Subject|0|||
164340121|NCT03094169|593620484|FG002|Overall Study|Withdrawal by Subject|0|||
164340122|NCT03094169|593620485|FG003|Overall Study|Withdrawal by Subject|0|||
164340123|NCT03094169|593620486|FG004|Overall Study|Withdrawal by Subject|0|||
164340124|NCT03094169|593620487|FG005|Overall Study|Withdrawal by Subject|0|||
164340125|NCT03094169|593620488|FG006|Overall Study|Withdrawal by Subject|1|||
164340126|NCT03094169|593620489|FG007|Overall Study|Withdrawal by Subject|1|||
164340127|NCT03094169|593620482|FG000|Overall Study|Trial Termination|0|||
164340128|NCT03094169|593620483|FG001|Overall Study|Trial Termination|0|||
164340129|NCT03094169|593620484|FG002|Overall Study|Trial Termination|0|||
164340130|NCT03094169|593620485|FG003|Overall Study|Trial Termination|0|||
164340131|NCT03094169|593620486|FG004|Overall Study|Trial Termination|0|||
164340132|NCT03094169|593620487|FG005|Overall Study|Trial Termination|0|||
164340133|NCT03094169|593620488|FG006|Overall Study|Trial Termination|0|||
164340134|NCT03094169|593620489|FG007|Overall Study|Trial Termination|1|||
164340135|NCT00617851|593620490|FG000|Overall Study|Death|0|||
164340136|NCT00617851|593620491|FG001|Overall Study|Death|0|||
164340137|NCT00617851|593620492|FG002|Overall Study|Death|0|||
164681055|NCT00112437|594854595|FG024|Years 6-10 (60-Month Extension)|Death|0|||
164576990|NCT03528681|594476764|FG000|Randomized Treatment Phase|(Not collected)|0|||
164258179|NCT00075946|593311720|FG004|Overall Study|Incorrectly randomized (no response)|0|||
164340138|NCT00617851|593620493|FG003|Overall Study|Death|1|||
164340139|NCT00617851|593620490|FG000|Overall Study|Withdrawal by Subject|14|||
164340140|NCT00617851|593620491|FG001|Overall Study|Withdrawal by Subject|7|||
164340141|NCT00617851|593620492|FG002|Overall Study|Withdrawal by Subject|12|||
164340142|NCT00617851|593620493|FG003|Overall Study|Withdrawal by Subject|4|||
164340143|NCT00617851|593620490|FG000|Overall Study|Lost to Follow-up|27|||
164258180|NCT00075946|593311716|FG000|Overall Study|Adverse Event|2|||
164258181|NCT00075946|593311717|FG001|Overall Study|Adverse Event|10|||
164258182|NCT00075946|593311718|FG002|Overall Study|Adverse Event|0|||
164258183|NCT00075946|593311719|FG003|Overall Study|Adverse Event|2|||
164258184|NCT00075946|593311720|FG004|Overall Study|Adverse Event|0|||
164258185|NCT00075946|593311716|FG000|Overall Study|Death|0|||
164258186|NCT00075946|593311717|FG001|Overall Study|Death|1|||
164258187|NCT00075946|593311718|FG002|Overall Study|Death|0|||
164258188|NCT00075946|593311719|FG003|Overall Study|Death|0|||
164258189|NCT00075946|593311720|FG004|Overall Study|Death|0|||
164258190|NCT00075946|593311716|FG000|Overall Study|Withdrawal by Subject|23|||
164258191|NCT00075946|593311717|FG001|Overall Study|Withdrawal by Subject|58|||
164258192|NCT00075946|593311718|FG002|Overall Study|Withdrawal by Subject|4|||
164258193|NCT00075946|593311719|FG003|Overall Study|Withdrawal by Subject|9|||
164258194|NCT00075946|593311720|FG004|Overall Study|Withdrawal by Subject|0|||
164258195|NCT00075946|593311716|FG000|Overall Study|Alternative therapy|16|||
164258196|NCT00075946|593311717|FG001|Overall Study|Alternative therapy|2|||
164258197|NCT00075946|593311718|FG002|Overall Study|Alternative therapy|5|||
164258198|NCT00075946|593311719|FG003|Overall Study|Alternative therapy|0|||
164258199|NCT00075946|593311720|FG004|Overall Study|Alternative therapy|0|||
164258200|NCT00075946|593311716|FG000|Overall Study|Other complicating disease|7|||
164258201|NCT00075946|593311717|FG001|Overall Study|Other complicating disease|13|||
164258202|NCT00075946|593311718|FG002|Overall Study|Other complicating disease|1|||
164258203|NCT00075946|593311719|FG003|Overall Study|Other complicating disease|4|||
164258204|NCT00075946|593311720|FG004|Overall Study|Other complicating disease|0|||
164258205|NCT00075946|593311716|FG000|Overall Study|No response to retreatment|23|||
164258206|NCT00075946|593311717|FG001|Overall Study|No response to retreatment|0|||
164258207|NCT00075946|593311718|FG002|Overall Study|No response to retreatment|2|||
164258208|NCT00075946|593311719|FG003|Overall Study|No response to retreatment|0|||
164258209|NCT00075946|593311720|FG004|Overall Study|No response to retreatment|0|||
164258210|NCT00075946|593311716|FG000|Overall Study|Time to progression less than 6 months|15|||
164258211|NCT00075946|593311717|FG001|Overall Study|Time to progression less than 6 months|30|||
164258212|NCT00075946|593311718|FG002|Overall Study|Time to progression less than 6 months|8|||
164258213|NCT00075946|593311719|FG003|Overall Study|Time to progression less than 6 months|3|||
164258214|NCT00075946|593311720|FG004|Overall Study|Time to progression less than 6 months|0|||
164258215|NCT00075946|593311716|FG000|Overall Study|Other|57|||
164258216|NCT00075946|593311717|FG001|Overall Study|Other|32|||
164258217|NCT00075946|593311718|FG002|Overall Study|Other|3|||
164258218|NCT00075946|593311719|FG003|Overall Study|Other|11|||
164258219|NCT00075946|593311720|FG004|Overall Study|Other|0|||
164258220|NCT04154605|593311725|FG000|Overall Study|Procedure Canceled|1|||
164258221|NCT04154605|593311726|FG001|Overall Study|Procedure Canceled|1|||
164258222|NCT04154605|593311725|FG000|Overall Study|Missed follow up|1|||
164258223|NCT04154605|593311726|FG001|Overall Study|Missed follow up|1|||
164258224|NCT04154605|593311725|FG000|Overall Study|Withdrawal by Subject|1|||
164258225|NCT04154605|593311726|FG001|Overall Study|Withdrawal by Subject|0|||
164258226|NCT01229254|593311729|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
164258227|NCT01229254|593311730|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
164258228|NCT01229254|593311731|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
164258229|NCT01229254|593311729|FG000|Overall Study|Adverse Event|4|||
164258230|NCT01229254|593311730|FG001|Overall Study|Adverse Event|5|||
164258231|NCT01229254|593311731|FG002|Overall Study|Adverse Event|3|||
164258232|NCT01229254|593311729|FG000|Overall Study|Lost to Follow-up|3|||
164258233|NCT01229254|593311730|FG001|Overall Study|Lost to Follow-up|0|||
164258234|NCT01229254|593311731|FG002|Overall Study|Lost to Follow-up|1|||
164258235|NCT01229254|593311729|FG000|Overall Study|Physician Decision|0|||
164258236|NCT01229254|593311730|FG001|Overall Study|Physician Decision|3|||
164258237|NCT01229254|593311731|FG002|Overall Study|Physician Decision|0|||
164340144|NCT00617851|593620491|FG001|Overall Study|Lost to Follow-up|29|||
164340145|NCT00617851|593620492|FG002|Overall Study|Lost to Follow-up|31|||
164258238|NCT01229254|593311729|FG000|Overall Study|Protocol Violation|4|||
164258239|NCT01229254|593311730|FG001|Overall Study|Protocol Violation|6|||
164258240|NCT01229254|593311731|FG002|Overall Study|Protocol Violation|5|||
164258241|NCT01229254|593311729|FG000|Overall Study|Withdrawal by Subject|1|||
164258242|NCT01229254|593311730|FG001|Overall Study|Withdrawal by Subject|0|||
164340146|NCT00617851|593620493|FG003|Overall Study|Lost to Follow-up|19|||
164340147|NCT00617851|593620490|FG000|Overall Study|Inappropriate Enrollment|5|||
164258243|NCT01229254|593311731|FG002|Overall Study|Withdrawal by Subject|1|||
164340148|NCT00617851|593620491|FG001|Overall Study|Inappropriate Enrollment|4|||
164258244|NCT01229254|593311729|FG000|Overall Study|Non-compliance with Study Drug|0|||
164258245|NCT01229254|593311730|FG001|Overall Study|Non-compliance with Study Drug|1|||
164576991|NCT03528681|594476765|FG001|Randomized Treatment Phase|(Not collected)|4|||
164576992|NCT03528681|594476766|FG002|Randomized Treatment Phase|(Not collected)|6|||
164576993|NCT03528681|594476767|FG003|Randomized Treatment Phase|(Not collected)|5|||
164576994|NCT02342171|594476777|FG000|Overall Study|Death|4|||
164258246|NCT01229254|593311731|FG002|Overall Study|Non-compliance with Study Drug|1|||
164258247|NCT02231892|593311732|FG000|Overall Study|Lost to Follow-up|1|||
164258248|NCT02231892|593311733|FG001|Overall Study|Lost to Follow-up|0|||
164576995|NCT02342171|594476778|FG001|Overall Study|Death|87|||
164576996|NCT02342171|594476777|FG000|Overall Study|Received favipiravir|10|||
164576997|NCT02342171|594476778|FG001|Overall Study|Received favipiravir|0|||
164576998|NCT02342171|594476777|FG000|Overall Study|Missing cycle treshold value|1|||
164576999|NCT02342171|594476778|FG001|Overall Study|Missing cycle treshold value|0|||
164577000|NCT02342171|594476777|FG000|Overall Study|Unknown outcome|0|||
164577001|NCT02342171|594476778|FG001|Overall Study|Unknown outcome|1|||
164577002|NCT02342171|594476777|FG000|Overall Study|Missing age data|0|||
164577003|NCT02342171|594476778|FG001|Overall Study|Missing age data|1|||
164258249|NCT02231892|593311734|FG002|Overall Study|Lost to Follow-up|3|||
164258250|NCT02231892|593311732|FG000|Overall Study|Withdrawal by Subject|4|||
164258251|NCT02231892|593311733|FG001|Overall Study|Withdrawal by Subject|3|||
164258252|NCT02231892|593311734|FG002|Overall Study|Withdrawal by Subject|15|||
164258253|NCT02231892|593311732|FG000|Overall Study|Physician Decision|0|||
164258254|NCT02231892|593311733|FG001|Overall Study|Physician Decision|2|||
164258255|NCT02231892|593311734|FG002|Overall Study|Physician Decision|4|||
164258256|NCT02231892|593311732|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
164258257|NCT02231892|593311733|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
164258258|NCT02231892|593311734|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
164258259|NCT02231892|593311732|FG000|Overall Study|Participant motor threshold was >83%|0|||
164258260|NCT02231892|593311733|FG001|Overall Study|Participant motor threshold was >83%|0|||
164258261|NCT02231892|593311734|FG002|Overall Study|Participant motor threshold was >83%|9|||
164258262|NCT02231892|593311732|FG000|Overall Study|Could not find motor threshold|2|||
164258263|NCT02231892|593311733|FG001|Overall Study|Could not find motor threshold|0|||
164258264|NCT02231892|593311734|FG002|Overall Study|Could not find motor threshold|1|||
164258265|NCT02231892|593311732|FG000|Overall Study|Could not find reliable motor hotspot|0|||
164258266|NCT02231892|593311733|FG001|Overall Study|Could not find reliable motor hotspot|0|||
164258267|NCT02231892|593311734|FG002|Overall Study|Could not find reliable motor hotspot|1|||
164258268|NCT00223977|593311744|FG000|Overall Study|Adverse Event|7|||
164258269|NCT00223977|593311745|FG001|Overall Study|Adverse Event|10|||
164258270|NCT00223977|593311746|FG002|Overall Study|Adverse Event|0|||
164258271|NCT00223977|593311744|FG000|Overall Study|Protocol Violation|0|||
164577004|NCT03518840|594476781|FG000|Overall Study|Lost to Follow-up|6|||
164577005|NCT00875420|594476784|FG000|Overall Study|Adverse Event|0|||
164577006|NCT00875420|594476785|FG001|Overall Study|Adverse Event|1|||
164577007|NCT00875420|594476786|FG002|Overall Study|Adverse Event|1|||
164577008|NCT00875420|594476787|FG003|Overall Study|Adverse Event|0|||
164258272|NCT00223977|593311745|FG001|Overall Study|Protocol Violation|0|||
164258273|NCT00223977|593311746|FG002|Overall Study|Protocol Violation|1|||
164258274|NCT00223977|593311744|FG000|Overall Study|Withdrawal by Subject|1|||
164258275|NCT00223977|593311745|FG001|Overall Study|Withdrawal by Subject|1|||
164258276|NCT00223977|593311746|FG002|Overall Study|Withdrawal by Subject|2|||
164258277|NCT00223977|593311744|FG000|Overall Study|Other|1|||
164258278|NCT00223977|593311745|FG001|Overall Study|Other|0|||
164258279|NCT00223977|593311746|FG002|Overall Study|Other|0|||
164258280|NCT01534260|593311749|FG000|Overall Study|Adverse Event|1|||
164258281|NCT01534260|593311750|FG001|Overall Study|Adverse Event|8|||
164577009|NCT00875420|594476788|FG004|Overall Study|Adverse Event|0|||
164577010|NCT00875420|594476784|FG000|Overall Study|Inability to complete study procedures|1|||
164577011|NCT00875420|594476785|FG001|Overall Study|Inability to complete study procedures|0|||
164577012|NCT00875420|594476786|FG002|Overall Study|Inability to complete study procedures|1|||
164577013|NCT00875420|594476787|FG003|Overall Study|Inability to complete study procedures|1|||
164258282|NCT01534260|593311749|FG000|Overall Study|Death|2|||
164258283|NCT01534260|593311750|FG001|Overall Study|Death|0|||
164258284|NCT01534260|593311749|FG000|Overall Study|Lack of Efficacy|1|||
164258285|NCT01534260|593311750|FG001|Overall Study|Lack of Efficacy|1|||
164258286|NCT01534260|593311749|FG000|Overall Study|Withdrawal by Subject|1|||
164258287|NCT01534260|593311750|FG001|Overall Study|Withdrawal by Subject|3|||
164258288|NCT01534260|593311749|FG000|Overall Study|Disease Progression|8|||
164258289|NCT01534260|593311750|FG001|Overall Study|Disease Progression|6|||
164258290|NCT01534260|593311749|FG000|Overall Study|Physician Decision|3|||
164258291|NCT01534260|593311750|FG001|Overall Study|Physician Decision|1|||
164258292|NCT01534260|593311749|FG000|Overall Study|No treatment, per protocol|0|||
164428987|NCT00062868|593939490|FG015|Dose Level 3|Lost to Follow-up|0|||
164428988|NCT00062868|593939491|FG016|Dose Level 3|Lost to Follow-up|0|||
164428989|NCT00062868|593939492|FG017|Dose Level 3|Lost to Follow-up|0|||
164428990|NCT00062868|593939493|FG018|Dose Level 3|Lost to Follow-up|0|||
164428991|NCT00062868|593939494|FG019|Dose Level 3|Lost to Follow-up|0|||
164428992|NCT00062868|593939495|FG020|Dose Level 3|Lost to Follow-up|0|||
164428993|NCT00062868|593939475|FG000|Dose Level 3|Withdrew|0|||
164428994|NCT00062868|593939476|FG001|Dose Level 3|Withdrew|0|||
164428995|NCT00062868|593939477|FG002|Dose Level 3|Withdrew|2|||
164428996|NCT00062868|593939478|FG003|Dose Level 3|Withdrew|0|||
164428997|NCT00062868|593939479|FG004|Dose Level 3|Withdrew|0|||
164428998|NCT00062868|593939480|FG005|Dose Level 3|Withdrew|0|||
164428999|NCT00062868|593939481|FG006|Dose Level 3|Withdrew|0|||
164429000|NCT00062868|593939482|FG007|Dose Level 3|Withdrew|0|||
164429001|NCT00062868|593939483|FG008|Dose Level 3|Withdrew|0|||
164429002|NCT00062868|593939484|FG009|Dose Level 3|Withdrew|0|||
164429003|NCT00062868|593939485|FG010|Dose Level 3|Withdrew|0|||
164429004|NCT00062868|593939486|FG011|Dose Level 3|Withdrew|0|||
164429005|NCT00062868|593939487|FG012|Dose Level 3|Withdrew|0|||
164429006|NCT00062868|593939488|FG013|Dose Level 3|Withdrew|0|||
164429007|NCT00062868|593939489|FG014|Dose Level 3|Withdrew|0|||
164429008|NCT00062868|593939490|FG015|Dose Level 3|Withdrew|0|||
164429009|NCT00062868|593939491|FG016|Dose Level 3|Withdrew|0|||
164429010|NCT00062868|593939492|FG017|Dose Level 3|Withdrew|0|||
164429011|NCT00062868|593939493|FG018|Dose Level 3|Withdrew|0|||
164429012|NCT00062868|593939494|FG019|Dose Level 3|Withdrew|0|||
164429013|NCT00062868|593939495|FG020|Dose Level 3|Withdrew|0|||
164429014|NCT03824236|593939496|FG000|Overall Study|Lost to Follow-up|0|||
164429015|NCT03824236|593939497|FG001|Overall Study|Lost to Follow-up|0|||
164429016|NCT03824236|593939498|FG002|Overall Study|Lost to Follow-up|1|||
164429017|NCT01641861|593939499|FG000|Overall Study|Lost to Follow-up|21|||
164429018|NCT01641861|593939500|FG001|Overall Study|Lost to Follow-up|16|||
164429019|NCT01641861|593939499|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
164429020|NCT01641861|593939500|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
164429021|NCT01641861|593939499|FG000|Overall Study|Died due to drowning|0|||
164429022|NCT01641861|593939500|FG001|Overall Study|Died due to drowning|1|||
164429023|NCT01101542|593939503|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
164429024|NCT01101542|593939503|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
164429025|NCT01101542|593939503|FG000|Year 4 Surveillance Period|Other|287|||
164429026|NCT01101542|593939503|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
164429027|NCT01101542|593939503|FG000|Year 5 Surveillance Period|Pregnancy|1|||
164429028|NCT01101542|593939503|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
164258293|NCT01534260|593311750|FG001|Overall Study|No treatment, per protocol|1|||
164258294|NCT02359045|593311751|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
164258295|NCT02359045|593311752|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
164258296|NCT02359045|593311751|FG000|Overall Study|Lost to Follow-up|1|||
164258297|NCT02359045|593311752|FG001|Overall Study|Lost to Follow-up|1|||
164258298|NCT02359045|593311751|FG000|Overall Study|Adverse Event|0|||
164258299|NCT02359045|593311752|FG001|Overall Study|Adverse Event|1|||
164258300|NCT01342965|593311761|FG000|Overall Study|Death|58|||
164258301|NCT01342965|593311762|FG001|Overall Study|Death|57|||
164258302|NCT01342965|593311761|FG000|Overall Study|Lost to Follow-up|5|||
164258303|NCT01342965|593311762|FG001|Overall Study|Lost to Follow-up|3|||
164258304|NCT01342965|593311761|FG000|Overall Study|Other Reasons- Unspecified|44|||
164258305|NCT01342965|593311762|FG001|Overall Study|Other Reasons- Unspecified|38|||
164258306|NCT01342965|593311761|FG000|Overall Study|Withdrawal by Subject|2|||
164258307|NCT01342965|593311762|FG001|Overall Study|Withdrawal by Subject|9|||
164258308|NCT00856206|593311763|FG000|Overall Study|Protocol Violation|6|||
164258309|NCT00856206|593311764|FG001|Overall Study|Protocol Violation|18|||
164258310|NCT00856206|593311763|FG000|Overall Study|Adverse Event|10|||
164258311|NCT00856206|593311764|FG001|Overall Study|Adverse Event|46|||
164429029|NCT01101542|593939503|FG000|Year 6 Surveillance Period|Pregnancy|1|||
164429030|NCT01101542|593939503|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
164429031|NCT00701311|593939504|FG000|Overall Study|Lack of Efficacy|3|||
164429032|NCT00701311|593939504|FG000|Overall Study|Adverse Event|3|||
164429033|NCT00701311|593939504|FG000|Overall Study|Withdrawal by Subject|2|||
164429034|NCT04580407|593939505|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
164429035|NCT04949399|593939508|FG000|Overall Study|Lost to Follow-up|11|||
164429036|NCT04949399|593939509|FG001|Overall Study|Lost to Follow-up|6|||
164258312|NCT00856206|593311763|FG000|Overall Study|Lack of Efficacy|1|||
164429037|NCT04949399|593939508|FG000|Overall Study|Withdrawal by Subject|2|||
164429038|NCT04949399|593939509|FG001|Overall Study|Withdrawal by Subject|3|||
164429039|NCT00814489|593939510|FG000|Overall Study|Other|2|||
164429040|NCT00814489|593939511|FG001|Overall Study|Other|0|||
164429041|NCT00814489|593939512|FG002|Overall Study|Other|1|||
164429042|NCT01712685|593939538|FG000|Overall Study|pt declined to participate before trmt|1|||
164429043|NCT01515319|593939539|FG000|Overall Study|Withdrawal by Subject|0|||
164429044|NCT01515319|593939540|FG001|Overall Study|Withdrawal by Subject|0|||
164429045|NCT01515319|593939541|FG002|Overall Study|Withdrawal by Subject|0|||
164429046|NCT01515319|593939542|FG003|Overall Study|Withdrawal by Subject|0|||
164429047|NCT01515319|593939543|FG004|Overall Study|Withdrawal by Subject|0|||
164429048|NCT01515319|593939544|FG005|Overall Study|Withdrawal by Subject|0|||
164429049|NCT01515319|593939545|FG006|Overall Study|Withdrawal by Subject|1|||
164429050|NCT01515319|593939546|FG007|Overall Study|Withdrawal by Subject|0|||
164429051|NCT01515319|593939547|FG008|Overall Study|Withdrawal by Subject|0|||
164429052|NCT01515319|593939548|FG009|Overall Study|Withdrawal by Subject|0|||
164429053|NCT01515319|593939539|FG000|Overall Study|Adverse Event|0|||
164429054|NCT01515319|593939540|FG001|Overall Study|Adverse Event|0|||
164429055|NCT01515319|593939541|FG002|Overall Study|Adverse Event|0|||
164429056|NCT01515319|593939542|FG003|Overall Study|Adverse Event|0|||
164429057|NCT01515319|593939543|FG004|Overall Study|Adverse Event|0|||
164429058|NCT01515319|593939544|FG005|Overall Study|Adverse Event|0|||
164429059|NCT01515319|593939545|FG006|Overall Study|Adverse Event|0|||
164429060|NCT01515319|593939546|FG007|Overall Study|Adverse Event|0|||
164429061|NCT01515319|593939547|FG008|Overall Study|Adverse Event|3|||
164429062|NCT01515319|593939548|FG009|Overall Study|Adverse Event|0|||
164429063|NCT01515319|593939539|FG000|Overall Study|Protocol Violation|0|||
164429064|NCT01515319|593939540|FG001|Overall Study|Protocol Violation|0|||
164429065|NCT01515319|593939541|FG002|Overall Study|Protocol Violation|0|||
164429066|NCT01515319|593939542|FG003|Overall Study|Protocol Violation|0|||
164429067|NCT01515319|593939543|FG004|Overall Study|Protocol Violation|0|||
164429068|NCT01515319|593939544|FG005|Overall Study|Protocol Violation|0|||
164429069|NCT01515319|593939545|FG006|Overall Study|Protocol Violation|0|||
164429070|NCT01515319|593939546|FG007|Overall Study|Protocol Violation|0|||
164429071|NCT01515319|593939547|FG008|Overall Study|Protocol Violation|2|||
164429072|NCT01515319|593939548|FG009|Overall Study|Protocol Violation|0|||
164429073|NCT01354106|593939549|FG000|Overall Study|Withdrawal by Subject|2|||
164429074|NCT00901485|593939550|FG000|Overall Study|Lack of Efficacy|0|||
164429075|NCT00901485|593939551|FG001|Overall Study|Lack of Efficacy|2|||
164429076|NCT00901485|593939550|FG000|Overall Study|Withdrawal by Subject|1|||
164429077|NCT00901485|593939551|FG001|Overall Study|Withdrawal by Subject|2|||
164429078|NCT01871285|593939552|FG000|First Intervention (1 Day)|Adverse Event|1|||
164429079|NCT01871285|593939553|FG001|First Intervention (1 Day)|Adverse Event|0|||
164429080|NCT01871285|593939554|FG002|First Intervention (1 Day)|Adverse Event|0|||
164429081|NCT01871285|593939555|FG003|First Intervention (1 Day)|Adverse Event|0|||
164429082|NCT01871285|593939552|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
164429083|NCT01871285|593939553|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
164429084|NCT01871285|593939554|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
164429085|NCT01871285|593939555|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
164429086|NCT05397470|593939556|FG000|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
164429087|NCT05397470|593939557|FG001|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|1|||
164429088|NCT05397470|593939558|FG002|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
164429089|NCT05397470|593939556|FG000|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
164429090|NCT05397470|593939557|FG001|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
164429091|NCT05397470|593939558|FG002|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|0|||
164429092|NCT05397470|593939556|FG000|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|2|||
164429093|NCT05397470|593939557|FG001|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|1|||
164258313|NCT00856206|593311764|FG001|Overall Study|Lack of Efficacy|2|||
164258314|NCT00856206|593311763|FG000|Overall Study|Withdrawal by Subject|15|||
164258315|NCT00856206|593311764|FG001|Overall Study|Withdrawal by Subject|36|||
164258316|NCT00856206|593311763|FG000|Overall Study|Lost to Follow-up|13|||
164258317|NCT00856206|593311764|FG001|Overall Study|Lost to Follow-up|39|||
164258318|NCT00856206|593311763|FG000|Overall Study|Death|2|||
164258319|NCT00856206|593311764|FG001|Overall Study|Death|2|||
164258320|NCT00856206|593311763|FG000|Overall Study|Decision by the Sponsor|4|||
164258321|NCT00856206|593311764|FG001|Overall Study|Decision by the Sponsor|8|||
164429094|NCT05397470|593939558|FG002|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|0|||
164429095|NCT05397470|593939556|FG000|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
164429096|NCT05397470|593939557|FG001|Part A: PCT Period (Up to 48 Weeks)|Other|1|||
164429097|NCT05397470|593939558|FG002|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
164429098|NCT05397470|593939556|FG000|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
164429099|NCT05397470|593939557|FG001|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
164429100|NCT05397470|593939558|FG002|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|4|||
164429101|NCT05397470|593939556|FG000|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
164429102|NCT05397470|593939557|FG001|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
164429103|NCT05397470|593939558|FG002|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|1|||
164258322|NCT00856206|593311763|FG000|Overall Study|Other than specified above|3|||
164258323|NCT00856206|593311764|FG001|Overall Study|Other than specified above|10|||
164258324|NCT02780856|593311769|FG000|Overall Study|Lost to Follow-up|1|||
164258325|NCT02226198|593313668|FG000|Lead-in Phase|Protocol Violation|1|||
164258326|NCT02226198|593313669|FG001|Lead-in Phase|Protocol Violation|0|||
164258327|NCT02226198|593313670|FG002|Lead-in Phase|Protocol Violation|0|||
164258328|NCT02226198|593313668|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
164258329|NCT02226198|593313669|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
164258330|NCT02226198|593313670|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
164258331|NCT01440517|593313673|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
164258332|NCT01288612|593313675|FG000|Overall Study|Unable to contact|11|||
164258333|NCT01288612|593313676|FG001|Overall Study|Unable to contact|16|||
164258334|NCT01288612|593313677|FG002|Overall Study|Unable to contact|20|||
164258335|NCT01288612|593313675|FG000|Overall Study|Declined|78|||
164258336|NCT01288612|593313676|FG001|Overall Study|Declined|63|||
164258337|NCT01288612|593313677|FG002|Overall Study|Declined|62|||
164258338|NCT01288612|593313675|FG000|Overall Study|Unable to intubate|0|||
164258339|NCT01288612|593313676|FG001|Overall Study|Unable to intubate|3|||
164258340|NCT01288612|593313677|FG002|Overall Study|Unable to intubate|0|||
164258341|NCT00642174|593313678|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
164258342|NCT00642174|593313679|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
164258343|NCT00896363|593313680|FG000|Overall Study|Adverse Event|3|||
164258344|NCT00896363|593313681|FG001|Overall Study|Adverse Event|4|||
164258345|NCT00896363|593313682|FG002|Overall Study|Adverse Event|2|||
164258346|NCT00896363|593313680|FG000|Overall Study|Lack of Efficacy|0|||
164258347|NCT00896363|593313681|FG001|Overall Study|Lack of Efficacy|2|||
164258348|NCT00896363|593313682|FG002|Overall Study|Lack of Efficacy|1|||
164258349|NCT00896363|593313680|FG000|Overall Study|Withdrawal by Subject|3|||
164258350|NCT00896363|593313681|FG001|Overall Study|Withdrawal by Subject|5|||
164258351|NCT00896363|593313682|FG002|Overall Study|Withdrawal by Subject|5|||
164258352|NCT01730339|593313683|FG000|Overall Study|Withdrawal by Subject|3|||
164258353|NCT01730339|593313684|FG001|Overall Study|Withdrawal by Subject|2|||
164258354|NCT01730339|593313683|FG000|Overall Study|Lost to Follow-up|1|||
164258355|NCT01730339|593313684|FG001|Overall Study|Lost to Follow-up|1|||
164258356|NCT01730339|593313683|FG000|Overall Study|Un-specified|1|||
164258357|NCT01730339|593313684|FG001|Overall Study|Un-specified|0|||
164258358|NCT01739933|593313687|FG000|Overall Study|Death|89|||
164258359|NCT01739933|593313688|FG001|Overall Study|Death|86|||
164258360|NCT01739933|593313687|FG000|Overall Study|Withdrawal by Subject|10|||
164258361|NCT01739933|593313688|FG001|Overall Study|Withdrawal by Subject|8|||
164258362|NCT01739933|593313687|FG000|Overall Study|Lost to Follow-up|3|||
164258363|NCT01739933|593313688|FG001|Overall Study|Lost to Follow-up|10|||
164258364|NCT01739933|593313687|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
164258365|NCT01739933|593313688|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
164258366|NCT03356977|593313691|FG000|Overall Study|Lost to Follow-up|3|||
164258367|NCT03356977|593313691|FG000|Overall Study|Withdrawal by parent/guardian|2|||
164258368|NCT02442310|593313697|FG000|Overall Study|Adverse Event|2|||
164258369|NCT02442310|593313697|FG000|Overall Study|Withdrawal by Subject|1|||
164258370|NCT01562314|593313698|FG000|Overall Study|Adverse Event|10|||
164258371|NCT01562314|593313699|FG001|Overall Study|Adverse Event|5|||
164258372|NCT01562314|593313698|FG000|Overall Study|Met Withdrawal Criteria|3|||
164258373|NCT01562314|593313699|FG001|Overall Study|Met Withdrawal Criteria|2|||
164258374|NCT01562314|593313698|FG000|Overall Study|Withdrawal by Subject|0|||
164258375|NCT01562314|593313699|FG001|Overall Study|Withdrawal by Subject|1|||
164258376|NCT00585546|593313700|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
164258377|NCT00585546|593313700|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
164258378|NCT03077438|593313707|FG000|Overall Study|Protocol Violation|3|||
164258379|NCT03077438|593313708|FG001|Overall Study|Protocol Violation|5|||
164258380|NCT03077438|593313707|FG000|Overall Study|Withdrawal by Subject|3|||
164258381|NCT03077438|593313708|FG001|Overall Study|Withdrawal by Subject|6|||
164258382|NCT03077438|593313707|FG000|Overall Study|Lost to Follow-up|6|||
164258383|NCT03077438|593313708|FG001|Overall Study|Lost to Follow-up|3|||
164258384|NCT00813865|593313709|FG000|Overall Study|Failure to Respond|3|||
164258385|NCT00813865|593313709|FG000|Overall Study|Lost to Follow-up|3|||
164258386|NCT00813865|593313709|FG000|Overall Study|Withdrawal by Subject|1|||
164258387|NCT00543803|593313711|FG000|Overall Study|Adverse Event|14|||
164258388|NCT00543803|593313711|FG000|Overall Study|Lack of Efficacy|22|||
164258389|NCT00543803|593313711|FG000|Overall Study|Lost to Follow-up|20|||
164258390|NCT00543803|593313711|FG000|Overall Study|Other|86|||
164258391|NCT01190475|593313712|FG000|Overall Study|Withdrawal by Subject|0|||
164258392|NCT01190475|593313713|FG001|Overall Study|Withdrawal by Subject|0|||
164258393|NCT01190475|593313714|FG002|Overall Study|Withdrawal by Subject|1|||
164258394|NCT00624585|593313715|FG000|Overall Study|Death|3|||
164258395|NCT00624585|593313715|FG000|Overall Study|Disease Progression|6|||
164258396|NCT00624585|593313715|FG000|Overall Study|Adverse Event|3|||
164429104|NCT05397470|593939556|FG000|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
164258397|NCT04154345|593313721|FG000|Overall Study|Covid-19 pandemic|4|||
164258398|NCT03505788|593313722|FG000|Overall Study|Lost to Follow-up|2|||
164258399|NCT03505788|593313723|FG001|Overall Study|Lost to Follow-up|1|||
164258400|NCT03505788|593313722|FG000|Overall Study|Withdrawal by Subject|1|||
164258401|NCT03505788|593313723|FG001|Overall Study|Withdrawal by Subject|3|||
164258402|NCT03505788|593313722|FG000|Overall Study|Physician Decision|0|||
164258403|NCT03505788|593313723|FG001|Overall Study|Physician Decision|1|||
164258404|NCT01535599|593313725|FG000|Overall Study|Adverse Event|6|||
164258405|NCT01535599|593313726|FG001|Overall Study|Adverse Event|15|||
164258406|NCT01535599|593313725|FG000|Overall Study|Lost to Follow-up|3|||
164258407|NCT01535599|593313726|FG001|Overall Study|Lost to Follow-up|4|||
164258408|NCT01535599|593313725|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
164258409|NCT01535599|593313726|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
164258410|NCT01535599|593313725|FG000|Overall Study|Treatment Failure|33|||
164258411|NCT01535599|593313726|FG001|Overall Study|Treatment Failure|66|||
164258412|NCT01535599|593313725|FG000|Overall Study|BL Culture + for Group A Strep|0|||
164258413|NCT01535599|593313726|FG001|Overall Study|BL Culture + for Group A Strep|1|||
164258414|NCT01535599|593313725|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
164258415|NCT01535599|593313726|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
164258416|NCT01535599|593313725|FG000|Overall Study|Randomized in Error|2|||
164258417|NCT01535599|593313726|FG001|Overall Study|Randomized in Error|4|||
164258418|NCT01535599|593313725|FG000|Overall Study|Did not use product|1|||
164258419|NCT01535599|593313726|FG001|Overall Study|Did not use product|0|||
164258420|NCT01535599|593313725|FG000|Overall Study|Other|1|||
164258421|NCT01535599|593313726|FG001|Overall Study|Other|0|||
164258422|NCT01535599|593313725|FG000|Overall Study|Stopped medication|0|||
164258423|NCT01535599|593313726|FG001|Overall Study|Stopped medication|1|||
164258424|NCT01535599|593313725|FG000|Overall Study|Noncompliance|0|||
164258425|NCT01535599|593313726|FG001|Overall Study|Noncompliance|1|||
164258426|NCT00676520|593313727|FG000|Overall Study|Withdrawal by Subject|163|||
164258427|NCT00676520|593313727|FG000|Overall Study|Lost to Follow-up|162|||
164258428|NCT00676520|593313727|FG000|Overall Study|Death|159|||
164258429|NCT00676520|593313727|FG000|Overall Study|Physician Decision|20|||
164258430|NCT00676520|593313727|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
164258431|NCT00676520|593313727|FG000|Overall Study|Other Reason|18|||
164258432|NCT03466099|593313738|FG000|Overall Study|Adverse Event|1|||
164258433|NCT03466099|593313739|FG001|Overall Study|Adverse Event|1|||
164258434|NCT03466099|593313740|FG002|Overall Study|Adverse Event|1|||
164340149|NCT00617851|593620492|FG002|Overall Study|Inappropriate Enrollment|1|||
164340150|NCT00617851|593620493|FG003|Overall Study|Inappropriate Enrollment|1|||
164340151|NCT00617851|593620490|FG000|Overall Study|Unable to classify|1|||
164340152|NCT00617851|593620491|FG001|Overall Study|Unable to classify|0|||
164340153|NCT00617851|593620492|FG002|Overall Study|Unable to classify|1|||
164340154|NCT00617851|593620493|FG003|Overall Study|Unable to classify|0|||
164340155|NCT05350410|593620496|FG000|Overall Study|Withdrawal by Subject|1|||
164340156|NCT01030536|593620507|FG000|Overall Study|Withdrawal by Subject|0|||
164340157|NCT01030536|593620508|FG001|Overall Study|Withdrawal by Subject|0|||
164340158|NCT01030536|593620509|FG002|Overall Study|Withdrawal by Subject|1|||
164340159|NCT01030536|593620510|FG003|Overall Study|Withdrawal by Subject|0|||
164340160|NCT01030536|593620511|FG004|Overall Study|Withdrawal by Subject|0|||
164340161|NCT01030536|593620507|FG000|Overall Study|undefined|1|||
164340162|NCT01030536|593620508|FG001|Overall Study|undefined|0|||
164340163|NCT01030536|593620509|FG002|Overall Study|undefined|1|||
164340164|NCT01030536|593620510|FG003|Overall Study|undefined|1|||
164340165|NCT01030536|593620511|FG004|Overall Study|undefined|0|||
164340166|NCT01030536|593620507|FG000|Overall Study|Adverse Event|0|||
164340167|NCT01030536|593620508|FG001|Overall Study|Adverse Event|3|||
164340168|NCT01030536|593620509|FG002|Overall Study|Adverse Event|1|||
164340169|NCT01030536|593620510|FG003|Overall Study|Adverse Event|0|||
164340170|NCT01030536|593620511|FG004|Overall Study|Adverse Event|1|||
164340171|NCT01030536|593620507|FG000|Overall Study|Progressive disease|6|||
164340172|NCT01030536|593620508|FG001|Overall Study|Progressive disease|2|||
164340173|NCT01030536|593620509|FG002|Overall Study|Progressive disease|3|||
164340174|NCT01030536|593620510|FG003|Overall Study|Progressive disease|2|||
164340175|NCT01030536|593620511|FG004|Overall Study|Progressive disease|0|||
164340176|NCT01030536|593620507|FG000|Overall Study|Death|0|||
164340177|NCT01030536|593620508|FG001|Overall Study|Death|1|||
164258435|NCT03466099|593313738|FG000|Overall Study|Withdrawal by Subject|2|||
164258436|NCT03466099|593313739|FG001|Overall Study|Withdrawal by Subject|3|||
164258437|NCT03466099|593313740|FG002|Overall Study|Withdrawal by Subject|1|||
164340178|NCT01030536|593620509|FG002|Overall Study|Death|0|||
164340179|NCT01030536|593620510|FG003|Overall Study|Death|0|||
164340180|NCT01030536|593620511|FG004|Overall Study|Death|0|||
164340181|NCT03345914|593620512|FG000|Overall Study|Transition to another study at week 16|80|||
164340182|NCT03345914|593620513|FG001|Overall Study|Transition to another study at week 16|86|||
164258438|NCT03466099|593313738|FG000|Overall Study|Use of rescue medication|8|||
164258439|NCT03466099|593313739|FG001|Overall Study|Use of rescue medication|9|||
164258440|NCT03466099|593313740|FG002|Overall Study|Use of rescue medication|13|||
164258441|NCT03466099|593313738|FG000|Overall Study|Rescued without meeting criteria|4|||
164340183|NCT03345914|593620514|FG002|Overall Study|Transition to another study at week 16|78|||
164258442|NCT03466099|593313739|FG001|Overall Study|Rescued without meeting criteria|1|||
164258443|NCT03466099|593313740|FG002|Overall Study|Rescued without meeting criteria|1|||
164258444|NCT03466099|593313738|FG000|Overall Study|Subject compliance|2|||
164258445|NCT03466099|593313739|FG001|Overall Study|Subject compliance|0|||
164258446|NCT03466099|593313740|FG002|Overall Study|Subject compliance|0|||
164258447|NCT03466099|593313738|FG000|Overall Study|Worsening disease|0|||
164258448|NCT03466099|593313739|FG001|Overall Study|Worsening disease|0|||
164258449|NCT03466099|593313740|FG002|Overall Study|Worsening disease|1|||
164258450|NCT00590824|593313745|FG000|Overall Study|Disease could not be resected|0|||
164258451|NCT00590824|593313746|FG001|Overall Study|Disease could not be resected|2|||
164258452|NCT00590824|593313747|FG002|Overall Study|Disease could not be resected|1|||
164258453|NCT00590824|593313748|FG003|Overall Study|Disease could not be resected|0|||
164258454|NCT00590824|593313745|FG000|Overall Study|Adverse Event|0|||
164258455|NCT00590824|593313746|FG001|Overall Study|Adverse Event|0|||
164258456|NCT00590824|593313747|FG002|Overall Study|Adverse Event|0|||
164258457|NCT00590824|593313748|FG003|Overall Study|Adverse Event|1|||
164258458|NCT00744978|593313751|FG000|Period 1|Lost to Follow-up|1|||
164258459|NCT00744978|593313752|FG001|Period 1|Lost to Follow-up|0|||
164258460|NCT00744978|593313751|FG000|Period 1|Withdrawal by Subject|0|||
164258461|NCT00744978|593313752|FG001|Period 1|Withdrawal by Subject|2|||
164258462|NCT00744978|593313751|FG000|Period 1|Other|0|||
164258463|NCT00744978|593313752|FG001|Period 1|Other|2|||
164258464|NCT00744978|593313751|FG000|Period 1|Adverse Event|4|||
164258465|NCT00744978|593313752|FG001|Period 1|Adverse Event|0|||
164258466|NCT00744978|593313751|FG000|Period 1|Randomized but not Treated|1|||
164258467|NCT00744978|593313752|FG001|Period 1|Randomized but not Treated|1|||
164258468|NCT00744978|593313751|FG000|Period 2|Adverse Event|0|||
164258469|NCT00744978|593313752|FG001|Period 2|Adverse Event|1|||
164258470|NCT03773133|593313753|FG000|Overall Study|Screen Failure|8|||
164258471|NCT03770728|593313754|FG000|Overall Study|Adverse Event|1|||
164258472|NCT03770728|593313755|FG001|Overall Study|Adverse Event|0|||
164258473|NCT03770728|593313756|FG002|Overall Study|Adverse Event|1|||
164258474|NCT03770728|593313757|FG003|Overall Study|Adverse Event|0|||
164258475|NCT03770728|593313754|FG000|Overall Study|Poor compliance to protocol|0|||
164258476|NCT03770728|593313755|FG001|Overall Study|Poor compliance to protocol|0|||
164258477|NCT03770728|593313756|FG002|Overall Study|Poor compliance to protocol|1|||
164258478|NCT03770728|593313757|FG003|Overall Study|Poor compliance to protocol|0|||
164258479|NCT03770728|593313754|FG000|Overall Study|Withdrawal by Subject|13|||
164258480|NCT03770728|593313755|FG001|Overall Study|Withdrawal by Subject|8|||
164258481|NCT03770728|593313756|FG002|Overall Study|Withdrawal by Subject|9|||
164258482|NCT03770728|593313757|FG003|Overall Study|Withdrawal by Subject|13|||
164258483|NCT03770728|593313754|FG000|Overall Study|Other than specified|24|||
164258484|NCT03770728|593313755|FG001|Overall Study|Other than specified|23|||
164258485|NCT03770728|593313756|FG002|Overall Study|Other than specified|21|||
164258486|NCT03770728|593313757|FG003|Overall Study|Other than specified|22|||
164258487|NCT02778555|593313758|FG000|Overall Study|Withdrawal by Subject|55|||
164258488|NCT02778555|593313759|FG001|Overall Study|Withdrawal by Subject|32|||
164258489|NCT02778555|593313760|FG002|Overall Study|Withdrawal by Subject|107|||
164258490|NCT02379988|593313761|FG000|Overall Study|Not eligible|1|||
164258491|NCT01895543|593313766|FG000|Overall Study|Withdrawal by Subject|43|||
164258492|NCT01895543|593313766|FG000|Overall Study|Lost to Follow-up|25|||
164258493|NCT01895543|593313766|FG000|Overall Study|Adverse Event|28|||
164258494|NCT01895543|593313766|FG000|Overall Study|Subject's substantial non-compliance|6|||
164258495|NCT01895543|593313766|FG000|Overall Study|Protocol Violation|1|||
164258496|NCT01895543|593313766|FG000|Overall Study|Physician Decision|2|||
164258497|NCT01895543|593313766|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
164258498|NCT00503581|593313767|FG000|Overall Study|Study closed|3|||
164258499|NCT00503581|593313768|FG001|Overall Study|Study closed|4|||
164258500|NCT00503581|593313769|FG002|Overall Study|Study closed|2|||
164258501|NCT04262882|593313770|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
164258502|NCT04262882|593313771|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
164340184|NCT03345914|593620512|FG000|Overall Study|Transition to OLE during follow-up|37|||
164340185|NCT03345914|593620513|FG001|Overall Study|Transition to OLE during follow-up|33|||
164340186|NCT03345914|593620514|FG002|Overall Study|Transition to OLE during follow-up|39|||
164681056|NCT00112437|594854596|FG025|Years 6-10 (60-Month Extension)|Death|0|||
164258503|NCT04262882|593313770|FG000|Overall Study|Lost to Follow-up|1|||
164258504|NCT04262882|593313771|FG001|Overall Study|Lost to Follow-up|0|||
164258505|NCT01301066|593313772|FG000|Overall Study|Lost to Follow-up|5|||
164258506|NCT01301066|593313773|FG001|Overall Study|Lost to Follow-up|11|||
164258507|NCT01301066|593313772|FG000|Overall Study|Protocol Violation|8|||
164258508|NCT01301066|593313773|FG001|Overall Study|Protocol Violation|7|||
164258509|NCT01301066|593313772|FG000|Overall Study|Withdrawal by Subject|4|||
164258510|NCT01301066|593313773|FG001|Overall Study|Withdrawal by Subject|9|||
164258511|NCT01301066|593313772|FG000|Overall Study|Adverse Event|6|||
164258512|NCT01301066|593313773|FG001|Overall Study|Adverse Event|6|||
164258513|NCT01301066|593313772|FG000|Overall Study|Sponsor Decision|2|||
164340187|NCT03345914|593620512|FG000|Overall Study|Physician Decision|0|||
164258514|NCT01301066|593313773|FG001|Overall Study|Sponsor Decision|1|||
164258515|NCT01301066|593313772|FG000|Overall Study|Physician Decision|0|||
164258516|NCT01301066|593313773|FG001|Overall Study|Physician Decision|1|||
164258517|NCT01301066|593313772|FG000|Overall Study|Other|2|||
164258518|NCT01301066|593313773|FG001|Overall Study|Other|0|||
164258519|NCT04003207|593313776|FG000|Overall Study|Protocol Violation|1|||
164577014|NCT00875420|594476788|FG004|Overall Study|Inability to complete study procedures|1|||
164577015|NCT00875420|594476784|FG000|Overall Study|Lost to Follow-up|1|||
164577016|NCT00875420|594476785|FG001|Overall Study|Lost to Follow-up|0|||
164577017|NCT00875420|594476786|FG002|Overall Study|Lost to Follow-up|0|||
164577018|NCT00875420|594476787|FG003|Overall Study|Lost to Follow-up|0|||
164577019|NCT00875420|594476788|FG004|Overall Study|Lost to Follow-up|0|||
164258520|NCT00468676|593313781|FG000|Overall Study|Lost to Follow-up|14|||
164258521|NCT00468676|593313782|FG001|Overall Study|Lost to Follow-up|11|||
164258522|NCT00468676|593313781|FG000|Overall Study|Death|2|||
164258523|NCT00468676|593313782|FG001|Overall Study|Death|1|||
164258524|NCT00721578|593313788|FG000|Overall Study|Death|1|||
164258525|NCT00721578|593313789|FG001|Overall Study|Death|1|||
164258526|NCT00721578|593313788|FG000|Overall Study|Withdrawal by Subject|1|||
164258527|NCT00721578|593313789|FG001|Overall Study|Withdrawal by Subject|1|||
164258528|NCT02256384|593313803|FG000|Overall Study|Withdrawal by Subject|12|||
164258529|NCT02256384|593313803|FG000|Overall Study|Equipment not capturing data|2|||
164258530|NCT05032690|593313810|FG000|Period 1|Adverse Event|0|||
164258531|NCT05032690|593313811|FG001|Period 1|Adverse Event|1|||
164258532|NCT05032690|593313812|FG002|Period 1|Adverse Event|0|||
164258533|NCT05032690|593313813|FG003|Period 1|Adverse Event|0|||
164258534|NCT05032690|593313810|FG000|Period 1|Withdrawal by Subject|1|||
164258535|NCT05032690|593313811|FG001|Period 1|Withdrawal by Subject|0|||
164258536|NCT05032690|593313812|FG002|Period 1|Withdrawal by Subject|0|||
164258537|NCT05032690|593313813|FG003|Period 1|Withdrawal by Subject|0|||
164258538|NCT05032690|593313810|FG000|Period 1|No longer meets eligibility criteria|0|||
164258539|NCT05032690|593313811|FG001|Period 1|No longer meets eligibility criteria|1|||
164258540|NCT05032690|593313812|FG002|Period 1|No longer meets eligibility criteria|0|||
164258541|NCT05032690|593313813|FG003|Period 1|No longer meets eligibility criteria|0|||
164258542|NCT05032690|593313810|FG000|Period 2|Adverse Event|1|||
164258543|NCT05032690|593313811|FG001|Period 2|Adverse Event|0|||
164258544|NCT05032690|593313812|FG002|Period 2|Adverse Event|0|||
164258545|NCT05032690|593313813|FG003|Period 2|Adverse Event|0|||
164258546|NCT05032690|593313810|FG000|Period 2|Withdrawal by Subject|0|||
164258547|NCT05032690|593313811|FG001|Period 2|Withdrawal by Subject|1|||
164258548|NCT05032690|593313812|FG002|Period 2|Withdrawal by Subject|0|||
164258549|NCT05032690|593313813|FG003|Period 2|Withdrawal by Subject|0|||
164258550|NCT05032690|593313810|FG000|Period 2|No longer meets eligibility criteria|0|||
164258551|NCT05032690|593313811|FG001|Period 2|No longer meets eligibility criteria|1|||
164258552|NCT05032690|593313812|FG002|Period 2|No longer meets eligibility criteria|0|||
164258553|NCT05032690|593313813|FG003|Period 2|No longer meets eligibility criteria|0|||
164258554|NCT05032690|593313810|FG000|Period 3|Adverse Event|0|||
164258555|NCT05032690|593313811|FG001|Period 3|Adverse Event|1|||
164258556|NCT05032690|593313812|FG002|Period 3|Adverse Event|0|||
164258557|NCT05032690|593313813|FG003|Period 3|Adverse Event|0|||
164258558|NCT00487942|593313814|FG000|Overall Study|Adverse Event|1|||
164258559|NCT00487942|593313815|FG001|Overall Study|Adverse Event|1|||
164258560|NCT00487942|593313816|FG002|Overall Study|Adverse Event|1|||
164258561|NCT00487942|593313817|FG003|Overall Study|Adverse Event|1|||
164258562|NCT00487942|593313814|FG000|Overall Study|Lost to Follow-up|1|||
164258563|NCT00487942|593313815|FG001|Overall Study|Lost to Follow-up|0|||
164258564|NCT00487942|593313816|FG002|Overall Study|Lost to Follow-up|0|||
164258565|NCT00487942|593313817|FG003|Overall Study|Lost to Follow-up|1|||
164258566|NCT00487942|593313814|FG000|Overall Study|Protocol Violation|1|||
164258567|NCT00487942|593313815|FG001|Overall Study|Protocol Violation|1|||
164258568|NCT00487942|593313816|FG002|Overall Study|Protocol Violation|0|||
164577020|NCT00875420|594476784|FG000|Overall Study|Personal reason|0|||
164577021|NCT00875420|594476785|FG001|Overall Study|Personal reason|0|||
164258569|NCT00487942|593313817|FG003|Overall Study|Protocol Violation|0|||
164258570|NCT00487942|593313814|FG000|Overall Study|Withdrawal by Subject|0|||
164258571|NCT00487942|593313815|FG001|Overall Study|Withdrawal by Subject|1|||
164258572|NCT00487942|593313816|FG002|Overall Study|Withdrawal by Subject|2|||
164258573|NCT00487942|593313817|FG003|Overall Study|Withdrawal by Subject|0|||
164258574|NCT00211757|593313818|FG000|Overall Study|Withdrawal by Subject|1|||
164258575|NCT00211757|593313819|FG001|Overall Study|Withdrawal by Subject|1|||
164258576|NCT00211757|593313818|FG000|Overall Study|Lack of Efficacy|0|||
164258577|NCT00211757|593313819|FG001|Overall Study|Lack of Efficacy|1|||
164258578|NCT05151445|593313820|FG000|Overall Study|Withdrawal by Subject|3|||
164258579|NCT02298179|593313821|FG000|Overall Study|Lost to Follow-up|0|||
164577022|NCT00875420|594476786|FG002|Overall Study|Personal reason|0|||
164577023|NCT00875420|594476787|FG003|Overall Study|Personal reason|0|||
164258580|NCT02298179|593313822|FG001|Overall Study|Lost to Follow-up|0|||
164258581|NCT02298179|593313823|FG002|Overall Study|Lost to Follow-up|1|||
164258582|NCT02298179|593313824|FG003|Overall Study|Lost to Follow-up|0|||
164258583|NCT02298179|593313825|FG004|Overall Study|Lost to Follow-up|0|||
164258584|NCT02298179|593313826|FG005|Overall Study|Lost to Follow-up|0|||
164258585|NCT02298179|593313827|FG006|Overall Study|Lost to Follow-up|0|||
164258586|NCT02298179|593313828|FG007|Overall Study|Lost to Follow-up|1|||
164258587|NCT02298179|593313829|FG008|Overall Study|Lost to Follow-up|0|||
164258588|NCT02298179|593313830|FG009|Overall Study|Lost to Follow-up|0|||
164258589|NCT02298179|593313831|FG010|Overall Study|Lost to Follow-up|0|||
164258590|NCT02298179|593313832|FG011|Overall Study|Lost to Follow-up|0|||
164258591|NCT04098367|593316008|FG000|Overall Study|Adverse Event|0|||
164258592|NCT04098367|593316009|FG001|Overall Study|Adverse Event|0|||
164258593|NCT04098367|593316010|FG002|Overall Study|Adverse Event|1|||
164258594|NCT04098367|593316008|FG000|Overall Study|Lost to Follow-up|1|||
164258595|NCT04098367|593316009|FG001|Overall Study|Lost to Follow-up|5|||
164258596|NCT04098367|593316010|FG002|Overall Study|Lost to Follow-up|2|||
164258597|NCT04098367|593316008|FG000|Overall Study|Withdrawal by Subject|0|||
164258598|NCT04098367|593316009|FG001|Overall Study|Withdrawal by Subject|0|||
164258599|NCT04098367|593316010|FG002|Overall Study|Withdrawal by Subject|1|||
164258600|NCT04098367|593316008|FG000|Overall Study|Sick . Could not attend visit|1|||
164258601|NCT04098367|593316009|FG001|Overall Study|Sick . Could not attend visit|0|||
164258602|NCT04098367|593316010|FG002|Overall Study|Sick . Could not attend visit|0|||
164258603|NCT01728077|593316011|FG000|Overall Study|Lack of Efficacy|3|||
164258604|NCT01728077|593316012|FG001|Overall Study|Lack of Efficacy|1|||
164258605|NCT01728077|593316011|FG000|Overall Study|Lost to Follow-up|1|||
164258606|NCT01728077|593316012|FG001|Overall Study|Lost to Follow-up|0|||
164340188|NCT03345914|593620513|FG001|Overall Study|Physician Decision|1|||
164340189|NCT03345914|593620514|FG002|Overall Study|Physician Decision|1|||
164340190|NCT03345914|593620512|FG000|Overall Study|Withdrawal by Subject|5|||
164340191|NCT03345914|593620513|FG001|Overall Study|Withdrawal by Subject|1|||
164340192|NCT03345914|593620514|FG002|Overall Study|Withdrawal by Subject|2|||
164340193|NCT03345914|593620512|FG000|Overall Study|Other|1|||
164340194|NCT03345914|593620513|FG001|Overall Study|Other|1|||
164340195|NCT03345914|593620514|FG002|Overall Study|Other|1|||
164340196|NCT03345914|593620512|FG000|Overall Study|Ongoing|0|||
164340197|NCT03345914|593620513|FG001|Overall Study|Ongoing|0|||
164340198|NCT03345914|593620514|FG002|Overall Study|Ongoing|1|||
164340199|NCT02601027|593620517|FG000|Registration to Surgery|Withdrawal by Subject|20|||
164340200|NCT02601027|593620518|FG001|Registration to Surgery|Withdrawal by Subject|10|||
164340201|NCT01330030|593620519|FG000|Overall Study|Lost to Follow-up|16|||
164340202|NCT01330030|593620520|FG001|Overall Study|Lost to Follow-up|17|||
164340203|NCT01365052|593620521|FG000|Overall Study|Adverse Event|4|||
164340204|NCT01365052|593620522|FG001|Overall Study|Adverse Event|4|||
164340205|NCT02248701|593620525|FG000|Overall Study|Withdrawal by Subject|2|||
164340206|NCT02248701|593620526|FG001|Overall Study|Withdrawal by Subject|1|||
164340207|NCT02248701|593620525|FG000|Overall Study|Physician Decision|0|||
164340208|NCT02248701|593620526|FG001|Overall Study|Physician Decision|1|||
164340209|NCT02248701|593620525|FG000|Overall Study|Adverse Event|1|||
164340210|NCT02248701|593620526|FG001|Overall Study|Adverse Event|0|||
164340211|NCT02248701|593620525|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
164340212|NCT02248701|593620526|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
164340213|NCT00885846|593620529|FG000|Overall Study|Withdrawal by Subject|2|||
164340214|NCT00885846|593620530|FG001|Overall Study|Withdrawal by Subject|5|||
164340215|NCT00885846|593620531|FG002|Overall Study|Withdrawal by Subject|2|||
164340216|NCT00074984|593620532|FG000|Overall Study|Death|1|||
164340217|NCT00074984|593620533|FG001|Overall Study|Death|2|||
164340218|NCT00074984|593620532|FG000|Overall Study|Withdrawal by Subject|2|||
164340219|NCT00074984|593620533|FG001|Overall Study|Withdrawal by Subject|3|||
164340220|NCT00074984|593620532|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
164429105|NCT05397470|593939557|FG001|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
164429106|NCT05397470|593939558|FG002|Part B: OLE Period (Up to Week 127)|Study closed/terminated|244|||
164340221|NCT00074984|593620533|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
164429107|NCT01919619|593939559|FG000|Overall Study|Physician Decision|1|||
164429108|NCT01919619|593939560|FG001|Overall Study|Physician Decision|1|||
164258607|NCT01728077|593316011|FG000|Overall Study|Subject choice|2|||
164340222|NCT03758443|593620534|FG000|Induction Period|Adverse Event|2|||
164340223|NCT03758443|593620535|FG001|Induction Period|Adverse Event|4|||
164340224|NCT03758443|593620536|FG002|Induction Period|Adverse Event|2|||
164340225|NCT03758443|593620537|FG003|Induction Period|Adverse Event|3|||
164340226|NCT03758443|593620534|FG000|Induction Period|Physician Decision|1|||
164340227|NCT03758443|593620535|FG001|Induction Period|Physician Decision|1|||
164340228|NCT03758443|593620536|FG002|Induction Period|Physician Decision|3|||
164258608|NCT01728077|593316012|FG001|Overall Study|Subject choice|3|||
164258609|NCT01728077|593316011|FG000|Overall Study|Death|0|||
164258610|NCT01728077|593316012|FG001|Overall Study|Death|1|||
164258611|NCT01728077|593316011|FG000|Overall Study|Patient moving|1|||
164258612|NCT01728077|593316012|FG001|Overall Study|Patient moving|0|||
164340229|NCT03758443|593620537|FG003|Induction Period|Physician Decision|0|||
164340230|NCT03758443|593620534|FG000|Induction Period|Protocol Violation|0|||
164340231|NCT03758443|593620535|FG001|Induction Period|Protocol Violation|0|||
164258613|NCT01728077|593316011|FG000|Overall Study|Non compliance|1|||
164258614|NCT01728077|593316012|FG001|Overall Study|Non compliance|0|||
164258615|NCT00378599|593316015|FG000|Overall Study|Adverse Event|38|||
164258616|NCT00378599|593316015|FG000|Overall Study|Protocol Violation|2|||
164258617|NCT00378599|593316015|FG000|Overall Study|Treatment failure|7|||
164258618|NCT00378599|593316015|FG000|Overall Study|Withdrawal by Subject|5|||
164258619|NCT03224507|593316025|FG000|Overall Study|Death|3|||
164258620|NCT03224507|593316026|FG001|Overall Study|Death|0|||
164258621|NCT03224507|593316025|FG000|Overall Study|Lack of Efficacy|6|||
164258622|NCT03224507|593316026|FG001|Overall Study|Lack of Efficacy|0|||
164258623|NCT03224507|593316025|FG000|Overall Study|Withdrawal by Subject|6|||
164258624|NCT03224507|593316026|FG001|Overall Study|Withdrawal by Subject|0|||
164258625|NCT01032291|593316027|FG000|Safety Lead-in|Adverse Event|1|||
164258626|NCT01032291|593316028|FG001|Safety Lead-in|Adverse Event|0|||
164258627|NCT01032291|593316029|FG002|Safety Lead-in|Adverse Event|0|||
164340232|NCT03758443|593620536|FG002|Induction Period|Protocol Violation|0|||
164340233|NCT03758443|593620537|FG003|Induction Period|Protocol Violation|1|||
164340234|NCT03758443|593620534|FG000|Induction Period|Withdrawal by Subject|3|||
164340235|NCT03758443|593620535|FG001|Induction Period|Withdrawal by Subject|2|||
164340236|NCT03758443|593620536|FG002|Induction Period|Withdrawal by Subject|2|||
164340237|NCT03758443|593620537|FG003|Induction Period|Withdrawal by Subject|4|||
164340238|NCT03758443|593620534|FG000|Extended Induction Period|Adverse Event|1|||
164340239|NCT03758443|593620535|FG001|Extended Induction Period|Adverse Event|1|||
164340240|NCT03758443|593620536|FG002|Extended Induction Period|Adverse Event|0|||
164340241|NCT03758443|593620537|FG003|Extended Induction Period|Adverse Event|1|||
164340242|NCT03758443|593620534|FG000|Extended Induction Period|Lost to Follow-up|1|||
164340243|NCT03758443|593620535|FG001|Extended Induction Period|Lost to Follow-up|0|||
164340244|NCT03758443|593620536|FG002|Extended Induction Period|Lost to Follow-up|0|||
164340245|NCT03758443|593620537|FG003|Extended Induction Period|Lost to Follow-up|0|||
164340246|NCT03758443|593620534|FG000|Extended Induction Period|Physician Decision|2|||
164340247|NCT03758443|593620535|FG001|Extended Induction Period|Physician Decision|1|||
164340248|NCT03758443|593620536|FG002|Extended Induction Period|Physician Decision|2|||
164340249|NCT03758443|593620537|FG003|Extended Induction Period|Physician Decision|2|||
164340250|NCT03758443|593620534|FG000|Extended Induction Period|Protocol Violation|0|||
164340251|NCT03758443|593620535|FG001|Extended Induction Period|Protocol Violation|0|||
164340252|NCT03758443|593620536|FG002|Extended Induction Period|Protocol Violation|0|||
164340253|NCT03758443|593620537|FG003|Extended Induction Period|Protocol Violation|1|||
164340254|NCT03758443|593620534|FG000|Extended Induction Period|Withdrawal by Subject|8|||
164340255|NCT03758443|593620535|FG001|Extended Induction Period|Withdrawal by Subject|1|||
164340256|NCT03758443|593620536|FG002|Extended Induction Period|Withdrawal by Subject|7|||
164340257|NCT03758443|593620537|FG003|Extended Induction Period|Withdrawal by Subject|3|||
164340258|NCT03758443|593620534|FG000|Extended Induction Period|Miscellaneous|1|||
164340259|NCT03758443|593620535|FG001|Extended Induction Period|Miscellaneous|0|||
164340260|NCT03758443|593620536|FG002|Extended Induction Period|Miscellaneous|0|||
164340261|NCT03758443|593620537|FG003|Extended Induction Period|Miscellaneous|0|||
164340262|NCT03758443|593620534|FG000|Maintenance Period|Adverse Event|1|||
164340263|NCT03758443|593620535|FG001|Maintenance Period|Adverse Event|2|||
164340264|NCT03758443|593620536|FG002|Maintenance Period|Adverse Event|0|||
164340265|NCT03758443|593620537|FG003|Maintenance Period|Adverse Event|0|||
164340266|NCT03758443|593620534|FG000|Maintenance Period|Lost to Follow-up|0|||
164340267|NCT03758443|593620535|FG001|Maintenance Period|Lost to Follow-up|0|||
164340268|NCT03758443|593620536|FG002|Maintenance Period|Lost to Follow-up|0|||
164340269|NCT03758443|593620537|FG003|Maintenance Period|Lost to Follow-up|1|||
164340270|NCT03758443|593620534|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
164340271|NCT03758443|593620535|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
164340272|NCT03758443|593620536|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
164340273|NCT03758443|593620537|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
164340274|NCT03758443|593620534|FG000|Maintenance Period|Protocol Violation|0|||
164340275|NCT03758443|593620535|FG001|Maintenance Period|Protocol Violation|1|||
164340276|NCT03758443|593620536|FG002|Maintenance Period|Protocol Violation|0|||
164340277|NCT03758443|593620537|FG003|Maintenance Period|Protocol Violation|0|||
164340278|NCT03758443|593620534|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
164340279|NCT03758443|593620535|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
164340280|NCT03758443|593620536|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
164340281|NCT03758443|593620537|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
164258628|NCT01032291|593316027|FG000|Safety Lead-in|Death|1|||
164258629|NCT01032291|593316028|FG001|Safety Lead-in|Death|0|||
164340282|NCT03758443|593620534|FG000|Maintenance Period|Withdrawal by Subject|1|||
164258630|NCT01032291|593316029|FG002|Safety Lead-in|Death|0|||
164577024|NCT00875420|594476788|FG004|Overall Study|Personal reason|1|||
164258631|NCT01032291|593316027|FG000|Proof of Concept|Adverse Event|0|||
164258632|NCT01032291|593316028|FG001|Proof of Concept|Adverse Event|5|||
164258633|NCT01032291|593316029|FG002|Proof of Concept|Adverse Event|1|||
164258634|NCT01032291|593316027|FG000|Proof of Concept|Death|0|||
164577025|NCT00875420|594476784|FG000|Overall Study|Prohibited medication|0|||
164258635|NCT01032291|593316028|FG001|Proof of Concept|Death|1|||
164258636|NCT01032291|593316029|FG002|Proof of Concept|Death|2|||
164258637|NCT01032291|593316027|FG000|Proof of Concept|Lack of Efficacy|0|||
164258638|NCT01032291|593316028|FG001|Proof of Concept|Lack of Efficacy|1|||
164258639|NCT01032291|593316029|FG002|Proof of Concept|Lack of Efficacy|0|||
164258640|NCT01032291|593316027|FG000|Proof of Concept|Never Received Study Drug|0|||
164258641|NCT01032291|593316028|FG001|Proof of Concept|Never Received Study Drug|1|||
164258642|NCT01032291|593316029|FG002|Proof of Concept|Never Received Study Drug|0|||
164258643|NCT00347438|593316030|FG000|Overall Study|Withdrawal by Subject|1|||
164258644|NCT00347438|593316030|FG000|Overall Study|Physician Decision|1|||
164258645|NCT01529515|593316033|FG000|TRANSITION PHASE|Adverse Event|16|||
164258646|NCT01529515|593316034|FG001|TRANSITION PHASE|Adverse Event|0|||
164258647|NCT01529515|593316035|FG002|TRANSITION PHASE|Adverse Event|0|||
164258648|NCT01529515|593316036|FG003|TRANSITION PHASE|Adverse Event|0|||
164258649|NCT01529515|593316033|FG000|TRANSITION PHASE|Death|1|||
164258650|NCT01529515|593316034|FG001|TRANSITION PHASE|Death|0|||
164258651|NCT01529515|593316035|FG002|TRANSITION PHASE|Death|0|||
164258652|NCT01529515|593316036|FG003|TRANSITION PHASE|Death|0|||
164258653|NCT01529515|593316033|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
164258654|NCT01529515|593316034|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
164258655|NCT01529515|593316035|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
164258656|NCT01529515|593316036|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
164258657|NCT01529515|593316033|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
164258658|NCT01529515|593316034|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
164258659|NCT01529515|593316035|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
164258660|NCT01529515|593316036|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
164258661|NCT01529515|593316033|FG000|TRANSITION PHASE|Protocol Violation|4|||
164258662|NCT01529515|593316034|FG001|TRANSITION PHASE|Protocol Violation|0|||
164258663|NCT01529515|593316035|FG002|TRANSITION PHASE|Protocol Violation|0|||
164258664|NCT01529515|593316036|FG003|TRANSITION PHASE|Protocol Violation|0|||
164258665|NCT01529515|593316033|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
164258666|NCT01529515|593316034|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
164258667|NCT01529515|593316035|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
164258668|NCT01529515|593316036|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
164258669|NCT01529515|593316033|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
164258670|NCT01529515|593316034|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
164258671|NCT01529515|593316035|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
164258672|NCT01529515|593316036|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
164258673|NCT01529515|593316033|FG000|TRANSITION PHASE|Other|9|||
164258674|NCT01529515|593316034|FG001|TRANSITION PHASE|Other|0|||
164258675|NCT01529515|593316035|FG002|TRANSITION PHASE|Other|0|||
164258676|NCT01529515|593316036|FG003|TRANSITION PHASE|Other|0|||
164258677|NCT01529515|593316033|FG000|MAINTENANCE PHASE|Adverse Event|0|||
164258678|NCT01529515|593316034|FG001|MAINTENANCE PHASE|Adverse Event|10|||
164258679|NCT01529515|593316035|FG002|MAINTENANCE PHASE|Adverse Event|0|||
164258680|NCT01529515|593316036|FG003|MAINTENANCE PHASE|Adverse Event|0|||
164258681|NCT01529515|593316033|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
164258682|NCT01529515|593316034|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
164258683|NCT01529515|593316035|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
164258684|NCT01529515|593316036|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
164258685|NCT01529515|593316033|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
164258686|NCT01529515|593316034|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
164258687|NCT01529515|593316035|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
164258688|NCT01529515|593316036|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
164258689|NCT01529515|593316033|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
164258690|NCT01529515|593316034|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
164258691|NCT01529515|593316035|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
164258692|NCT01529515|593316036|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
164577026|NCT00875420|594476785|FG001|Overall Study|Prohibited medication|0|||
164577027|NCT00875420|594476786|FG002|Overall Study|Prohibited medication|0|||
164577028|NCT00875420|594476787|FG003|Overall Study|Prohibited medication|1|||
164577029|NCT00875420|594476788|FG004|Overall Study|Prohibited medication|0|||
164577030|NCT00875420|594476784|FG000|Overall Study|Sponsor decision|0|||
164340283|NCT03758443|593620535|FG001|Maintenance Period|Withdrawal by Subject|0|||
164258693|NCT01529515|593316033|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
164258694|NCT01529515|593316034|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
164258695|NCT01529515|593316035|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
164258696|NCT01529515|593316036|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
164258697|NCT01529515|593316033|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
164258698|NCT01529515|593316034|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
164258699|NCT01529515|593316035|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
164258700|NCT01529515|593316036|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
164258701|NCT01529515|593316033|FG000|MAINTENANCE PHASE|Other|0|||
164258702|NCT01529515|593316034|FG001|MAINTENANCE PHASE|Other|10|||
164258703|NCT01529515|593316035|FG002|MAINTENANCE PHASE|Other|0|||
164258704|NCT01529515|593316036|FG003|MAINTENANCE PHASE|Other|0|||
164258705|NCT01529515|593316033|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
164258706|NCT01529515|593316034|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
164258707|NCT01529515|593316035|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
164258708|NCT01529515|593316036|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
164258709|NCT01529515|593316033|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
164258710|NCT01529515|593316034|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
164258711|NCT01529515|593316035|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
164258712|NCT01529515|593316036|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
164258713|NCT01529515|593316033|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
164258714|NCT01529515|593316034|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
164258715|NCT01529515|593316035|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
164258716|NCT01529515|593316036|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
164258717|NCT01529515|593316033|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
164429109|NCT02738840|593940886|FG000|Overall Study|MRI Scan not Performed|5|||
164429110|NCT02738840|593940886|FG000|Overall Study|Lost to Follow-up|1|||
164429111|NCT02738840|593940886|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
164577031|NCT00875420|594476785|FG001|Overall Study|Sponsor decision|1|||
164258718|NCT01529515|593316034|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
164258719|NCT01529515|593316035|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
164258720|NCT01529515|593316036|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
164258721|NCT01529515|593316033|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
164258722|NCT01529515|593316034|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
164258723|NCT01529515|593316035|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
164258724|NCT01529515|593316036|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
164258725|NCT01529515|593316033|FG000|DOUBLE BLIND PHASE|Other|0|||
164258726|NCT01529515|593316034|FG001|DOUBLE BLIND PHASE|Other|0|||
164258727|NCT01529515|593316035|FG002|DOUBLE BLIND PHASE|Other|9|||
164258728|NCT01529515|593316036|FG003|DOUBLE BLIND PHASE|Other|2|||
164258729|NCT00322023|593316038|FG000|Overall Study|various|0|||
164258730|NCT00322023|593316039|FG001|Overall Study|various|2|||
164258731|NCT00322023|593316040|FG002|Overall Study|various|6|||
164258732|NCT03327220|593316041|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
164258733|NCT03327220|593316042|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
164258734|NCT03327220|593316041|FG000|Overall Study|Investigator Decision|2|||
164258735|NCT03327220|593316042|FG001|Overall Study|Investigator Decision|0|||
164258736|NCT03327220|593316041|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
164258737|NCT03327220|593316042|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
164258738|NCT03327220|593316041|FG000|Overall Study|Fungal infection|1|||
164258739|NCT03327220|593316042|FG001|Overall Study|Fungal infection|0|||
164258740|NCT03327220|593316041|FG000|Overall Study|Discharged to Rehabilitation|0|||
164258741|NCT03327220|593316042|FG001|Overall Study|Discharged to Rehabilitation|1|||
164258742|NCT03327220|593316041|FG000|Overall Study|Missing|1|||
164258743|NCT03327220|593316042|FG001|Overall Study|Missing|0|||
164258744|NCT03920293|593316043|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
164258745|NCT03920293|593316044|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
164258746|NCT03920293|593316043|FG000|Randomized-Controlled Period|Physician Decision|1|||
164258747|NCT03920293|593316044|FG001|Randomized-Controlled Period|Physician Decision|2|||
164258748|NCT03920293|593316043|FG000|Randomized-Controlled Period|Adverse Event|0|||
164258749|NCT03920293|593316044|FG001|Randomized-Controlled Period|Adverse Event|2|||
164258750|NCT03920293|593316043|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
164258751|NCT03920293|593316044|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
164258752|NCT03920293|593316043|FG000|Randomized-Controlled Period|Death|2|||
164258753|NCT03920293|593316044|FG001|Randomized-Controlled Period|Death|0|||
164258754|NCT03920293|593316043|FG000|Randomized-Controlled Period|Protocol Violation|1|||
164258755|NCT03920293|593316044|FG001|Randomized-Controlled Period|Protocol Violation|0|||
164258756|NCT03920293|593316043|FG000|Randomized-Controlled Period|Noncompliance|1|||
164258757|NCT03920293|593316044|FG001|Randomized-Controlled Period|Noncompliance|0|||
164258758|NCT03920293|593316043|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
164258759|NCT03920293|593316044|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
164258760|NCT03920293|593316043|FG000|Open- Label Extension Period|Death|3|||
164258761|NCT03920293|593316044|FG001|Open- Label Extension Period|Death|3|||
164577032|NCT00875420|594476786|FG002|Overall Study|Sponsor decision|0|||
164258762|NCT03920293|593316043|FG000|Open- Label Extension Period|Physician Decision|5|||
164258763|NCT03920293|593316044|FG001|Open- Label Extension Period|Physician Decision|3|||
164258764|NCT03920293|593316043|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
164258765|NCT03920293|593316044|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
164258766|NCT00523705|593316045|FG000|Overall Study|No time for study.|0|||
164258767|NCT00523705|593316046|FG001|Overall Study|No time for study.|1|||
164258768|NCT00693017|593316047|FG000|Overall Study|Sponsor Decision|2|||
164258769|NCT00693017|593316048|FG001|Overall Study|Sponsor Decision|1|||
164258770|NCT00693017|593316047|FG000|Overall Study|Death|0|||
164258771|NCT00693017|593316048|FG001|Overall Study|Death|1|||
164258772|NCT01691885|593316052|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
164429112|NCT02738840|593940886|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
164577033|NCT00875420|594476787|FG003|Overall Study|Sponsor decision|0|||
164258773|NCT01691885|593316053|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
164258774|NCT01691885|593316052|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
164258775|NCT01691885|593316053|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
164258776|NCT03555981|593316054|FG000|Overall Study|Lost to Follow-up|0|||
164258777|NCT03555981|593316055|FG001|Overall Study|Lost to Follow-up|2|||
164258778|NCT00688324|593316057|FG000|Overall Study|Withdrawal by Subject|2|||
164429113|NCT02268396|593940889|FG000|Overall Study|Adverse Event|3|||
164429114|NCT02268396|593940889|FG000|Overall Study|Administrative|2|||
164429115|NCT02268396|593940889|FG000|Overall Study|Withdrawal by Subject|1|||
164429116|NCT02268396|593940889|FG000|Overall Study|Lost to Follow-up|2|||
164429117|NCT02268396|593940889|FG000|Overall Study|Protocol-Specified Criteria|2|||
164429118|NCT02268396|593940889|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
164429119|NCT01311648|593940890|FG000|Main Study|Protocol Violation|0|||
164429120|NCT01311648|593940891|FG001|Main Study|Protocol Violation|1|||
164429121|NCT01311648|593940890|FG000|Main Study|Adverse Event|0|||
164429122|NCT01311648|593940891|FG001|Main Study|Adverse Event|1|||
164429123|NCT01311648|593940890|FG000|Main Study|Inhibitor management|0|||
164258779|NCT00688324|593316057|FG000|Overall Study|Physician Decision|5|||
164258780|NCT00688324|593316057|FG000|Overall Study|Lost to Follow-up|1|||
164258781|NCT01972308|593316060|FG000|Overall Study|Withdrawal by Subject|0|||
164258782|NCT01972308|593316061|FG001|Overall Study|Withdrawal by Subject|1|||
164258783|NCT01972308|593316060|FG000|Overall Study|Lost to Follow-up|4|||
164258784|NCT01972308|593316061|FG001|Overall Study|Lost to Follow-up|6|||
164258785|NCT01972308|593316060|FG000|Overall Study|Death|4|||
164258786|NCT01972308|593316061|FG001|Overall Study|Death|1|||
164258787|NCT00847665|593316063|FG000|Overall Study|Withdrawal by Subject|1|||
164258788|NCT00847665|593316064|FG001|Overall Study|Withdrawal by Subject|0|||
164258789|NCT04035564|593316065|FG000|Overall Study|Protocol Violation|1|||
164258790|NCT04035564|593316066|FG001|Overall Study|Protocol Violation|2|||
164258791|NCT04035564|593316065|FG000|Overall Study|No laboratory available|2|||
164258792|NCT04035564|593316066|FG001|Overall Study|No laboratory available|2|||
164258793|NCT04035564|593316065|FG000|Overall Study|Guardian declined consent|1|||
164258794|NCT04035564|593316066|FG001|Overall Study|Guardian declined consent|2|||
164258795|NCT03333252|593316071|FG000|Overall Study|Adverse Event|10|||
164258796|NCT03333252|593316072|FG001|Overall Study|Adverse Event|6|||
164258797|NCT03333252|593316073|FG002|Overall Study|Adverse Event|5|||
164258798|NCT03333252|593316074|FG003|Overall Study|Adverse Event|2|||
164258799|NCT03333252|593316071|FG000|Overall Study|Death|1|||
164258800|NCT03333252|593316072|FG001|Overall Study|Death|3|||
164258801|NCT03333252|593316073|FG002|Overall Study|Death|0|||
164258802|NCT03333252|593316074|FG003|Overall Study|Death|0|||
164258803|NCT03333252|593316071|FG000|Overall Study|Lack of Efficacy|8|||
164258804|NCT03333252|593316072|FG001|Overall Study|Lack of Efficacy|4|||
164258805|NCT03333252|593316073|FG002|Overall Study|Lack of Efficacy|0|||
164258806|NCT03333252|593316074|FG003|Overall Study|Lack of Efficacy|7|||
164258807|NCT03333252|593316071|FG000|Overall Study|Lost to Follow-up|0|||
164258808|NCT03333252|593316072|FG001|Overall Study|Lost to Follow-up|5|||
164258809|NCT03333252|593316073|FG002|Overall Study|Lost to Follow-up|9|||
164258810|NCT03333252|593316074|FG003|Overall Study|Lost to Follow-up|3|||
164258811|NCT03333252|593316071|FG000|Overall Study|Withdrawal by Subject|14|||
164258812|NCT03333252|593316072|FG001|Overall Study|Withdrawal by Subject|24|||
164258813|NCT03333252|593316073|FG002|Overall Study|Withdrawal by Subject|11|||
164258814|NCT03333252|593316074|FG003|Overall Study|Withdrawal by Subject|17|||
164258815|NCT00939029|593316075|FG000|Overall Study|Withdrawal by Subject|3|||
164258816|NCT00939029|593316076|FG001|Overall Study|Withdrawal by Subject|7|||
164258817|NCT00939029|593316075|FG000|Overall Study|Lost to Follow-up|3|||
164258818|NCT00939029|593316076|FG001|Overall Study|Lost to Follow-up|4|||
164258819|NCT00939029|593316075|FG000|Overall Study|Adverse Event|0|||
164258820|NCT00939029|593316076|FG001|Overall Study|Adverse Event|1|||
164258821|NCT04686084|593316077|FG000|Overall Study|Lost to Follow-up|1|||
164258822|NCT01779856|593316079|FG000|Overall Study|Withdrawal by Subject|15|||
164258823|NCT01779856|593316079|FG000|Overall Study|Death|3|||
164258824|NCT01779856|593316079|FG000|Overall Study|Physician Decision|1|||
164258825|NCT01779856|593316079|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
164258826|NCT01779856|593316079|FG000|Overall Study|Delays in scheduling implant|1|||
164258827|NCT01779856|593316079|FG000|Overall Study|Subject ineligible for Implant|2|||
164258828|NCT01425359|593316083|FG000|Overall Study|Randomized but Not Treated|2|||
164258829|NCT01425359|593316084|FG001|Overall Study|Randomized but Not Treated|3|||
164258830|NCT01425359|593316083|FG000|Overall Study|Adverse Event|9|||
164429124|NCT01311648|593940891|FG001|Main Study|Inhibitor management|17|||
164429125|NCT01311648|593940890|FG000|Main Study|Withdrawal by Subject|0|||
164429126|NCT01311648|593940891|FG001|Main Study|Withdrawal by Subject|2|||
164429127|NCT01311648|593940890|FG000|Extension Study|Physician Decision|0|||
164258831|NCT01425359|593316084|FG001|Overall Study|Adverse Event|8|||
164258832|NCT01425359|593316083|FG000|Overall Study|Revascularization|0|||
164258833|NCT01425359|593316084|FG001|Overall Study|Revascularization|1|||
164258834|NCT01425359|593316083|FG000|Overall Study|Death|0|||
164258835|NCT01425359|593316084|FG001|Overall Study|Death|1|||
164258836|NCT01425359|593316083|FG000|Overall Study|Unsatisfactory Response|1|||
164258837|NCT01425359|593316084|FG001|Overall Study|Unsatisfactory Response|0|||
164258838|NCT01425359|593316083|FG000|Overall Study|Protocol Violation|1|||
164258839|NCT01425359|593316084|FG001|Overall Study|Protocol Violation|2|||
164258840|NCT01425359|593316083|FG000|Overall Study|Subject Withdrew Consent|1|||
164258841|NCT01425359|593316084|FG001|Overall Study|Subject Withdrew Consent|2|||
164258842|NCT01425359|593316083|FG000|Overall Study|Investigator's Discretion|2|||
164258843|NCT01425359|593316084|FG001|Overall Study|Investigator's Discretion|0|||
164258844|NCT01425359|593316083|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
164258845|NCT01425359|593316084|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
164258846|NCT03960580|593316085|FG000|Overall Study|Adverse Event|2|||
164258847|NCT03960580|593316086|FG001|Overall Study|Adverse Event|1|||
164258848|NCT03960580|593316087|FG002|Overall Study|Adverse Event|1|||
164258849|NCT03960580|593316085|FG000|Overall Study|Lost to Follow-up|1|||
164258850|NCT03960580|593316086|FG001|Overall Study|Lost to Follow-up|0|||
164258851|NCT03960580|593316087|FG002|Overall Study|Lost to Follow-up|0|||
164258852|NCT03960580|593316085|FG000|Overall Study|Lack of Efficacy|2|||
164258853|NCT03960580|593316086|FG001|Overall Study|Lack of Efficacy|1|||
164258854|NCT03960580|593316087|FG002|Overall Study|Lack of Efficacy|0|||
164258855|NCT03960580|593316085|FG000|Overall Study|Protocol Violation|0|||
164258856|NCT03960580|593316086|FG001|Overall Study|Protocol Violation|0|||
164258857|NCT03960580|593316087|FG002|Overall Study|Protocol Violation|1|||
164258858|NCT03960580|593316085|FG000|Overall Study|Withdrawal by Subject|1|||
164258859|NCT03960580|593316086|FG001|Overall Study|Withdrawal by Subject|1|||
164258860|NCT03960580|593316087|FG002|Overall Study|Withdrawal by Subject|1|||
164258861|NCT03960580|593316085|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
164258862|NCT03960580|593316086|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
164258863|NCT03960580|593316087|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
164258864|NCT02135029|593316092|FG000|Overall Study|Adverse Event|2|||
164258865|NCT02135029|593316093|FG001|Overall Study|Adverse Event|2|||
164258866|NCT02135029|593316094|FG002|Overall Study|Adverse Event|2|||
164258867|NCT02135029|593316092|FG000|Overall Study|Lost to Follow-up|0|||
164258868|NCT02135029|593316093|FG001|Overall Study|Lost to Follow-up|1|||
164258869|NCT02135029|593316094|FG002|Overall Study|Lost to Follow-up|0|||
164258870|NCT02135029|593316092|FG000|Overall Study|Withdrawal by Subject|2|||
164258871|NCT02135029|593316093|FG001|Overall Study|Withdrawal by Subject|0|||
164258872|NCT02135029|593316094|FG002|Overall Study|Withdrawal by Subject|1|||
164258873|NCT02135029|593316092|FG000|Overall Study|Other|0|||
164258874|NCT02135029|593316093|FG001|Overall Study|Other|1|||
164258875|NCT02135029|593316094|FG002|Overall Study|Other|0|||
164258876|NCT02135029|593316092|FG000|Overall Study|Death|0|||
164258877|NCT02135029|593316093|FG001|Overall Study|Death|1|||
164258878|NCT02135029|593316094|FG002|Overall Study|Death|0|||
164258879|NCT03832322|593316097|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
164258880|NCT03832322|593316098|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
164258881|NCT01778049|593316100|FG000|Open Label Treatment Period|Adverse Event|5|||
164258882|NCT01778049|593316101|FG001|Open Label Treatment Period|Adverse Event|15|||
164258883|NCT01778049|593316102|FG002|Open Label Treatment Period|Adverse Event|0|||
164258884|NCT01778049|593316103|FG003|Open Label Treatment Period|Adverse Event|0|||
164258885|NCT01778049|593316104|FG004|Open Label Treatment Period|Adverse Event|0|||
164258886|NCT01778049|593316105|FG005|Open Label Treatment Period|Adverse Event|0|||
164258887|NCT01778049|593316100|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
164258888|NCT01778049|593316101|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
164258889|NCT01778049|593316102|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
164258890|NCT01778049|593316103|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
164340284|NCT03758443|593620536|FG002|Maintenance Period|Withdrawal by Subject|1|||
164340285|NCT03758443|593620537|FG003|Maintenance Period|Withdrawal by Subject|1|||
164340286|NCT03758443|593620534|FG000|Maintenance Period|Miscellaneous|0|||
164340287|NCT03758443|593620535|FG001|Maintenance Period|Miscellaneous|0|||
164340288|NCT03758443|593620536|FG002|Maintenance Period|Miscellaneous|1|||
164340289|NCT03758443|593620537|FG003|Maintenance Period|Miscellaneous|0|||
164258891|NCT01778049|593316104|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
164258892|NCT01778049|593316105|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
164258893|NCT01778049|593316100|FG000|Open Label Treatment Period|Protocol Violation|5|||
164258894|NCT01778049|593316101|FG001|Open Label Treatment Period|Protocol Violation|5|||
164258895|NCT01778049|593316102|FG002|Open Label Treatment Period|Protocol Violation|0|||
164258896|NCT01778049|593316103|FG003|Open Label Treatment Period|Protocol Violation|0|||
164258897|NCT01778049|593316104|FG004|Open Label Treatment Period|Protocol Violation|0|||
164258898|NCT01778049|593316105|FG005|Open Label Treatment Period|Protocol Violation|0|||
164258899|NCT01778049|593316100|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
164258900|NCT01778049|593316101|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
164258901|NCT01778049|593316102|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
164258902|NCT01778049|593316103|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
164258903|NCT01778049|593316104|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
164258904|NCT01778049|593316105|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
164258905|NCT01778049|593316100|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
164258906|NCT01778049|593316101|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
164577034|NCT00875420|594476788|FG004|Overall Study|Sponsor decision|0|||
164258907|NCT01778049|593316102|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
164258908|NCT01778049|593316103|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
164258909|NCT01778049|593316104|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
164258910|NCT01778049|593316105|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
164258911|NCT01778049|593316100|FG000|Open Label Treatment Period|Not treated|2|||
164258912|NCT01778049|593316101|FG001|Open Label Treatment Period|Not treated|1|||
164258913|NCT01778049|593316102|FG002|Open Label Treatment Period|Not treated|0|||
164258914|NCT01778049|593316103|FG003|Open Label Treatment Period|Not treated|0|||
164258915|NCT01778049|593316104|FG004|Open Label Treatment Period|Not treated|0|||
164258916|NCT01778049|593316105|FG005|Open Label Treatment Period|Not treated|0|||
164258917|NCT01778049|593316100|FG000|Open Label Treatment Period|Other reason not defined above|77|||
164258918|NCT01778049|593316101|FG001|Open Label Treatment Period|Other reason not defined above|94|||
164258919|NCT01778049|593316102|FG002|Open Label Treatment Period|Other reason not defined above|0|||
164258920|NCT01778049|593316103|FG003|Open Label Treatment Period|Other reason not defined above|0|||
164258921|NCT01778049|593316104|FG004|Open Label Treatment Period|Other reason not defined above|0|||
164258922|NCT01778049|593316105|FG005|Open Label Treatment Period|Other reason not defined above|0|||
164258923|NCT01778049|593316100|FG000|Double Blind Treatment Period|Adverse Event|0|||
164258924|NCT01778049|593316101|FG001|Double Blind Treatment Period|Adverse Event|0|||
164258925|NCT01778049|593316102|FG002|Double Blind Treatment Period|Adverse Event|4|||
164258926|NCT01778049|593316103|FG003|Double Blind Treatment Period|Adverse Event|5|||
164258927|NCT01778049|593316104|FG004|Double Blind Treatment Period|Adverse Event|3|||
164258928|NCT01778049|593316105|FG005|Double Blind Treatment Period|Adverse Event|2|||
164258929|NCT01778049|593316100|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
164258930|NCT01778049|593316101|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
164258931|NCT01778049|593316102|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
164258932|NCT01778049|593316103|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
164258933|NCT01778049|593316104|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
164258934|NCT01778049|593316105|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
164258935|NCT01778049|593316100|FG000|Double Blind Treatment Period|Protocol Violation|0|||
164258936|NCT01778049|593316101|FG001|Double Blind Treatment Period|Protocol Violation|0|||
164258937|NCT01778049|593316102|FG002|Double Blind Treatment Period|Protocol Violation|2|||
164258938|NCT01778049|593316103|FG003|Double Blind Treatment Period|Protocol Violation|0|||
164258939|NCT01778049|593316104|FG004|Double Blind Treatment Period|Protocol Violation|0|||
164258940|NCT01778049|593316105|FG005|Double Blind Treatment Period|Protocol Violation|0|||
164258941|NCT01778049|593316100|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
164258942|NCT01778049|593316101|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
164258943|NCT01778049|593316102|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
164258944|NCT01778049|593316103|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
164258945|NCT01778049|593316104|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
164258946|NCT01778049|593316105|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
164258947|NCT01778049|593316100|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
164258948|NCT01778049|593316101|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
164258949|NCT01778049|593316102|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
164258950|NCT01778049|593316103|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
164258951|NCT01778049|593316104|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
164258952|NCT01778049|593316105|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
164258953|NCT01778049|593316100|FG000|Double Blind Treatment Period|Not treated|0|||
164258954|NCT01778049|593316101|FG001|Double Blind Treatment Period|Not treated|0|||
164258955|NCT01778049|593316102|FG002|Double Blind Treatment Period|Not treated|0|||
164258956|NCT01778049|593316103|FG003|Double Blind Treatment Period|Not treated|2|||
164577035|NCT00875420|594476784|FG000|Overall Study|Withdrawal by Subject|0|||
164258957|NCT01778049|593316104|FG004|Double Blind Treatment Period|Not treated|2|||
164258958|NCT01778049|593316105|FG005|Double Blind Treatment Period|Not treated|0|||
164258959|NCT01778049|593316100|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
164258960|NCT01778049|593316101|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
164258961|NCT01778049|593316102|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
164258962|NCT01778049|593316103|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
164577036|NCT00875420|594476785|FG001|Overall Study|Withdrawal by Subject|0|||
164577037|NCT00875420|594476786|FG002|Overall Study|Withdrawal by Subject|1|||
164258963|NCT01778049|593316104|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
164258964|NCT01778049|593316105|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
164258965|NCT02186652|593316106|FG000|Overall Study|Lost to Follow-up|2|||
164258966|NCT02186652|593316107|FG001|Overall Study|Lost to Follow-up|0|||
164258967|NCT00503776|593316111|FG000|Overall Study|Withdrawal by Subject|1|||
164258968|NCT00503776|593316112|FG001|Overall Study|Withdrawal by Subject|0|||
164258969|NCT00503776|593316113|FG002|Overall Study|Withdrawal by Subject|1|||
164258970|NCT00503776|593316114|FG003|Overall Study|Withdrawal by Subject|1|||
164577038|NCT00875420|594476787|FG003|Overall Study|Withdrawal by Subject|0|||
164429128|NCT01311648|593940891|FG001|Extension Study|Physician Decision|1|||
164429129|NCT01311648|593940890|FG000|Extension Study|ITI therapy with marketed product|0|||
164429130|NCT01311648|593940891|FG001|Extension Study|ITI therapy with marketed product|1|||
164429131|NCT01311648|593940890|FG000|Extension Study|Incorrect visit planning|0|||
164429132|NCT01311648|593940891|FG001|Extension Study|Incorrect visit planning|1|||
164429133|NCT01311648|593940890|FG000|Extension Study|Family's decision|0|||
164429134|NCT01311648|593940891|FG001|Extension Study|Family's decision|1|||
164429135|NCT01311648|593940890|FG000|Extension Study|Failure of ITI therapy|0|||
164429136|NCT01311648|593940891|FG001|Extension Study|Failure of ITI therapy|3|||
164429137|NCT01311648|593940890|FG000|Extension Study|Long travel|0|||
164429138|NCT01311648|593940891|FG001|Extension Study|Long travel|1|||
164429139|NCT01311648|593940890|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
164429140|NCT01311648|593940891|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
164429141|NCT01311648|593940890|FG000|Extension Study|Withdrawal by Subject|0|||
164429142|NCT01311648|593940891|FG001|Extension Study|Withdrawal by Subject|1|||
164429143|NCT01311648|593940890|FG000|Extension Study|Inhibitor management|0|||
164429144|NCT01311648|593940891|FG001|Extension Study|Inhibitor management|2|||
164429145|NCT01645111|593940892|FG000|Overall Study|Did not require Clevidipine|15|||
164429146|NCT01304706|593940898|FG000|Overall Study|Adverse Event|2|||
164429147|NCT01304706|593940898|FG000|Overall Study|Lack of Efficacy|1|||
164429148|NCT01304706|593940898|FG000|Overall Study|Death|3|||
164429149|NCT01304706|593940898|FG000|Overall Study|Withdrawal by Subject|3|||
164429150|NCT01304706|593940898|FG000|Overall Study|Lost to Follow-up|7|||
164429151|NCT01304706|593940898|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
164258971|NCT00503776|593316111|FG000|Overall Study|Physician Decision|0|||
164429152|NCT05526911|593940901|FG000|Overall Study|Adverse Event|2|||
164429153|NCT05025449|593940902|FG000|Overall Study|Withdrawal by Subject|1|||
164429154|NCT05025449|593940902|FG000|Overall Study|Patient emergently taken to operating room|1|||
164429155|NCT04358549|593940906|FG000|Overall Study|Adverse Event|0|||
164429156|NCT04358549|593940907|FG001|Overall Study|Adverse Event|1|||
164429157|NCT04358549|593940906|FG000|Overall Study|Death|1|||
164429158|NCT04358549|593940907|FG001|Overall Study|Death|0|||
164429159|NCT04358549|593940906|FG000|Overall Study|Lost to Follow-up|2|||
164429160|NCT04358549|593940907|FG001|Overall Study|Lost to Follow-up|1|||
164429161|NCT04358549|593940906|FG000|Overall Study|Withdrawal by Subject|6|||
164429162|NCT04358549|593940907|FG001|Overall Study|Withdrawal by Subject|6|||
164429163|NCT04358549|593940906|FG000|Overall Study|Start remdesivir|1|||
164429164|NCT04358549|593940907|FG001|Overall Study|Start remdesivir|0|||
164429165|NCT03712930|593940908|FG000|Overall Study|Death|7|||
164429166|NCT03712930|593940908|FG000|Overall Study|Physician Decision|1|||
164429167|NCT03712930|593940908|FG000|Overall Study|Study Terminated by Sponsor|3|||
164429168|NCT03712930|593940908|FG000|Overall Study|Progressive Disease|2|||
164429169|NCT01062126|593940915|FG000|Overall Study|Death|209|||
164429170|NCT01062126|593940915|FG000|Overall Study|All Withdrawals|324|||
164429171|NCT03837028|593940916|FG000|Overall Study|Lost to Follow-up|4|||
164258972|NCT00503776|593316112|FG001|Overall Study|Physician Decision|0|||
164258973|NCT00503776|593316113|FG002|Overall Study|Physician Decision|1|||
164258974|NCT00503776|593316114|FG003|Overall Study|Physician Decision|1|||
164258975|NCT00107315|593316115|FG000|Overall Study|Disease Progression|9|||
164258976|NCT00107315|593316115|FG000|Overall Study|Adverse Event|4|||
164258977|NCT00107315|593316115|FG000|Overall Study|Withdrawal by Subject|2|||
164258978|NCT02509039|593316120|FG000|Overall Study|Adverse Event|0|||
164258979|NCT02509039|593316121|FG001|Overall Study|Adverse Event|1|||
164429172|NCT03837028|593940917|FG001|Overall Study|Lost to Follow-up|0|||
164429173|NCT03837028|593940918|FG002|Overall Study|Lost to Follow-up|2|||
164429174|NCT03837028|593940919|FG003|Overall Study|Lost to Follow-up|0|||
164429175|NCT03837028|593940916|FG000|Overall Study|Withdrawal by Subject|12|||
164429176|NCT03837028|593940917|FG001|Overall Study|Withdrawal by Subject|11|||
164258980|NCT02509039|593316122|FG002|Overall Study|Adverse Event|1|||
164258981|NCT02509039|593316123|FG003|Overall Study|Adverse Event|1|||
164258982|NCT02509039|593316120|FG000|Overall Study|Withdrawal by Subject|0|||
164258983|NCT02509039|593316121|FG001|Overall Study|Withdrawal by Subject|0|||
164429177|NCT03837028|593940918|FG002|Overall Study|Withdrawal by Subject|11|||
164429178|NCT03837028|593940919|FG003|Overall Study|Withdrawal by Subject|7|||
164429179|NCT00646451|593940920|FG000|Overall Study|Adverse Event|3|||
164429180|NCT00646451|593940921|FG001|Overall Study|Adverse Event|0|||
164429181|NCT00646451|593940920|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
164429182|NCT00646451|593940921|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
164429183|NCT03784963|593940922|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
164429184|NCT03784963|593940923|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
164429185|NCT03784963|593940924|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
164429186|NCT03784963|593940925|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
164258984|NCT02509039|593316122|FG002|Overall Study|Withdrawal by Subject|1|||
164258985|NCT02509039|593316123|FG003|Overall Study|Withdrawal by Subject|0|||
164258986|NCT02509039|593316120|FG000|Overall Study|Progressive disease|2|||
164258987|NCT02509039|593316121|FG001|Overall Study|Progressive disease|2|||
164258988|NCT02509039|593316122|FG002|Overall Study|Progressive disease|1|||
164340290|NCT03080454|593620538|FG000|Baseline|Adverse Event|2|||
164340291|NCT03080454|593620538|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
164340292|NCT03080454|593620538|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
164340293|NCT02747875|593620539|FG000|Overall Study|Physician Decision|1|||
164340294|NCT02747875|593620540|FG001|Overall Study|Physician Decision|0|||
164340295|NCT02747875|593620539|FG000|Overall Study|Adverse Event|0|||
164340296|NCT02747875|593620540|FG001|Overall Study|Adverse Event|1|||
164340297|NCT03863197|593620541|FG000|Overall Study|Lost to Follow-up|2|||
164340298|NCT03863197|593620542|FG001|Overall Study|Lost to Follow-up|3|||
164340299|NCT03863197|593620541|FG000|Overall Study|Withdrawal by Subject|4|||
164340300|NCT03863197|593620542|FG001|Overall Study|Withdrawal by Subject|0|||
164340301|NCT03863197|593620541|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
164340302|NCT03863197|593620542|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
164340303|NCT01781975|593620543|FG000|Overall Study|Death|1|||
164340304|NCT01781975|593620544|FG001|Overall Study|Death|0|||
164340305|NCT01781975|593620543|FG000|Overall Study|Withdrawal by Subject|1|||
164429187|NCT04867902|593940926|FG000|Overall Study|Lost to Follow-up|1|||
164429188|NCT04867902|593940926|FG000|Overall Study|Withdrawal by Subject|2|||
164429189|NCT04867902|593940926|FG000|Overall Study|Protocol Violation|1|||
164429190|NCT05355116|593940927|FG000|Overall Study|Withdrawal by Subject|2|||
164429191|NCT00448864|593940930|FG000|Overall Study|Death|1|||
164429192|NCT00448864|593940931|FG001|Overall Study|Death|0|||
164429193|NCT00448864|593940932|FG002|Overall Study|Death|0|||
164429194|NCT00448864|593940930|FG000|Overall Study|Lost to Follow-up|3|||
164429195|NCT00448864|593940931|FG001|Overall Study|Lost to Follow-up|1|||
164429196|NCT00448864|593940932|FG002|Overall Study|Lost to Follow-up|0|||
164429197|NCT00448864|593940930|FG000|Overall Study|Physician Decision|1|||
164429198|NCT00448864|593940931|FG001|Overall Study|Physician Decision|0|||
164429199|NCT00448864|593940932|FG002|Overall Study|Physician Decision|1|||
164681057|NCT00112437|594854571|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164681058|NCT00112437|594854572|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164429200|NCT00448864|593940930|FG000|Overall Study|Withdrawal by Subject|0|||
164429201|NCT00448864|593940931|FG001|Overall Study|Withdrawal by Subject|2|||
164429202|NCT00448864|593940932|FG002|Overall Study|Withdrawal by Subject|0|||
164429203|NCT00448864|593940930|FG000|Overall Study|Protocol Violation|0|||
164681059|NCT00112437|594854573|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164258989|NCT02509039|593316123|FG003|Overall Study|Progressive disease|5|||
164258990|NCT02509039|593316120|FG000|Overall Study|Study terminated by Sponsor|1|||
164258991|NCT02509039|593316121|FG001|Overall Study|Study terminated by Sponsor|0|||
164258992|NCT02509039|593316122|FG002|Overall Study|Study terminated by Sponsor|0|||
164258993|NCT02509039|593316123|FG003|Overall Study|Study terminated by Sponsor|0|||
164258994|NCT03359785|593316124|FG000|Overall Study|Protocol Violation|0|||
164258995|NCT03359785|593316125|FG001|Overall Study|Protocol Violation|1|||
164258996|NCT03359785|593316126|FG002|Overall Study|Protocol Violation|0|||
164258997|NCT03359785|593316127|FG003|Overall Study|Protocol Violation|0|||
164258998|NCT03359785|593316124|FG000|Overall Study|Early study termination due to study pause|0|||
164258999|NCT03359785|593316125|FG001|Overall Study|Early study termination due to study pause|0|||
164259000|NCT03359785|593316126|FG002|Overall Study|Early study termination due to study pause|2|||
164259001|NCT03359785|593316127|FG003|Overall Study|Early study termination due to study pause|0|||
164259002|NCT03359785|593316124|FG000|Overall Study|Withdrawal by Subject|2|||
164259003|NCT03359785|593316125|FG001|Overall Study|Withdrawal by Subject|2|||
164259004|NCT03359785|593316126|FG002|Overall Study|Withdrawal by Subject|0|||
164259005|NCT03359785|593316127|FG003|Overall Study|Withdrawal by Subject|0|||
164259006|NCT03276026|593316131|FG000|Overall Study|Protocol Violation|1|||
164259007|NCT03276026|593316132|FG001|Overall Study|Protocol Violation|0|||
164259008|NCT03650803|593316133|FG000|Overall Study|Lost to Follow-up|6|||
164340306|NCT01781975|593620544|FG001|Overall Study|Withdrawal by Subject|1|||
164340307|NCT01622231|593620545|FG000|Overall Study|Physician Decision|1|||
164340308|NCT01622231|593620545|FG000|Overall Study|Withdrawal by Subject|1|||
164340309|NCT01058655|593620546|FG000|Overall Study|Withdrawal by Subject|1|||
164429204|NCT00448864|593940931|FG001|Overall Study|Protocol Violation|2|||
164429205|NCT00448864|593940932|FG002|Overall Study|Protocol Violation|0|||
164429206|NCT01390857|593940933|FG000|Overall Study|Protocol Violation|2|||
164429207|NCT01390857|593940933|FG000|Overall Study|Lost to Follow-up|1|||
164429208|NCT01390857|593940933|FG000|Overall Study|No Visit after the First Visit|7|||
164429209|NCT01474538|593940935|FG000|Treatment Period 1|Death|1|||
164681060|NCT00112437|594854574|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164259009|NCT00252694|593316137|FG000|Overall Study|Withdrawal by Subject|83|||
164259010|NCT00252694|593316138|FG001|Overall Study|Withdrawal by Subject|91|||
164259011|NCT00252694|593316137|FG000|Overall Study|Death|36|||
164259012|NCT00252694|593316138|FG001|Overall Study|Death|34|||
164259013|NCT00252694|593316137|FG000|Overall Study|Mostly Lost to Follow Up|8|||
164259014|NCT00252694|593316138|FG001|Overall Study|Mostly Lost to Follow Up|13|||
164259015|NCT00252694|593316137|FG000|Overall Study|Patient Moving|17|||
164429210|NCT01474538|593940936|FG001|Treatment Period 1|Death|0|||
164429211|NCT01474538|593940935|FG000|Treatment Period 1|Physician Decision|1|||
164681061|NCT00112437|594854575|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164681062|NCT00112437|594854576|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164681063|NCT00112437|594854577|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164681064|NCT00112437|594854578|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164681065|NCT00112437|594854579|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164681066|NCT00112437|594854580|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164259016|NCT00252694|593316138|FG001|Overall Study|Patient Moving|16|||
164259017|NCT00367744|593316140|FG000|Overall Study|Lost to Follow-up|4|||
164429212|NCT01474538|593940936|FG001|Treatment Period 1|Physician Decision|0|||
164429213|NCT01474538|593940935|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164429214|NCT01474538|593940936|FG001|Treatment Period 1|Withdrawal by Subject|3|||
164429215|NCT01474538|593940935|FG000|Treatment Period 1|Protocol Violation|0|||
164429216|NCT01474538|593940936|FG001|Treatment Period 1|Protocol Violation|1|||
164429217|NCT01474538|593940935|FG000|Treatment Period 2|Death|1|||
164429218|NCT01474538|593940936|FG001|Treatment Period 2|Death|0|||
164429219|NCT01474538|593940935|FG000|Treatment Period 2|Adverse Event|1|||
164429220|NCT01474538|593940936|FG001|Treatment Period 2|Adverse Event|1|||
164429221|NCT01474538|593940935|FG000|Treatment Period 2|Withdrawal by Subject|2|||
164429222|NCT01474538|593940936|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164429223|NCT01474538|593940935|FG000|Treatment Period 2|Sponsor decision|1|||
164429224|NCT01474538|593940936|FG001|Treatment Period 2|Sponsor decision|0|||
164429225|NCT01474538|593940935|FG000|Treatment Period 2|Physician Decision|0|||
164429226|NCT01474538|593940936|FG001|Treatment Period 2|Physician Decision|1|||
164429227|NCT01474538|593940935|FG000|Treatment Period 2|Protocol Violation|1|||
164429228|NCT01474538|593940936|FG001|Treatment Period 2|Protocol Violation|0|||
164429229|NCT00367237|593940937|FG000|Overall Study|Adverse Event|7|||
164429230|NCT00367237|593940938|FG001|Overall Study|Adverse Event|2|||
164429231|NCT00367237|593940937|FG000|Overall Study|Lost to Follow-up|1|||
164429232|NCT00367237|593940938|FG001|Overall Study|Lost to Follow-up|0|||
164429233|NCT00367237|593940937|FG000|Overall Study|Withdrawal by Subject|0|||
164429234|NCT00367237|593940938|FG001|Overall Study|Withdrawal by Subject|4|||
164429235|NCT00367237|593940937|FG000|Overall Study|Protocol Violation|2|||
164429236|NCT00367237|593940938|FG001|Overall Study|Protocol Violation|5|||
164429237|NCT00868231|593940941|FG000|Treatment Period 1|Adverse Event|0|||
164429238|NCT00868231|593940942|FG001|Treatment Period 1|Adverse Event|0|||
164429239|NCT00868231|593940943|FG002|Treatment Period 1|Adverse Event|0|||
164429240|NCT00868231|593940944|FG003|Treatment Period 1|Adverse Event|0|||
164429241|NCT00868231|593940945|FG004|Treatment Period 1|Adverse Event|1|||
164429242|NCT00868231|593940946|FG005|Treatment Period 1|Adverse Event|0|||
164429243|NCT00868231|593940941|FG000|Treatment Period 2|Adverse Event|1|||
164429244|NCT00868231|593940942|FG001|Treatment Period 2|Adverse Event|0|||
164429245|NCT00868231|593940943|FG002|Treatment Period 2|Adverse Event|0|||
164429246|NCT00868231|593940944|FG003|Treatment Period 2|Adverse Event|0|||
164429247|NCT00868231|593940945|FG004|Treatment Period 2|Adverse Event|0|||
164429248|NCT00868231|593940946|FG005|Treatment Period 2|Adverse Event|0|||
164429249|NCT00868231|593940941|FG000|Treatment Period 3|Adverse Event|0|||
164429250|NCT00868231|593940942|FG001|Treatment Period 3|Adverse Event|0|||
164429251|NCT00868231|593940943|FG002|Treatment Period 3|Adverse Event|1|||
164429252|NCT00868231|593940944|FG003|Treatment Period 3|Adverse Event|0|||
164429253|NCT00868231|593940945|FG004|Treatment Period 3|Adverse Event|0|||
164429254|NCT00868231|593940946|FG005|Treatment Period 3|Adverse Event|0|||
164429255|NCT03120676|593940947|FG000|Overall Study|Not treated|1|||
164429256|NCT00886613|593940952|FG000|Overall Study|Protocol deviation (Part B)|1|||
164429257|NCT00886613|593940953|FG001|Overall Study|Protocol deviation (Part B)|0|||
164259018|NCT00367744|593316141|FG001|Overall Study|Lost to Follow-up|5|||
164259019|NCT03664674|593316142|FG000|Overall Study|Adverse Event|1|||
164259020|NCT03664674|593316143|FG001|Overall Study|Adverse Event|1|||
164259021|NCT03664674|593316142|FG000|Overall Study|Physician Decision|0|||
164429258|NCT00886613|593940954|FG002|Overall Study|Protocol deviation (Part B)|0|||
164429259|NCT00886613|593940952|FG000|Overall Study|Lost to follow-up (Part B)|1|||
164429260|NCT00886613|593940953|FG001|Overall Study|Lost to follow-up (Part B)|0|||
164429261|NCT00886613|593940954|FG002|Overall Study|Lost to follow-up (Part B)|1|||
164429262|NCT00886613|593940952|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
164429263|NCT00886613|593940953|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
164681067|NCT00112437|594854581|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164681068|NCT00112437|594854582|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164681069|NCT00112437|594854583|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164259022|NCT03664674|593316143|FG001|Overall Study|Physician Decision|1|||
164259023|NCT03664674|593316142|FG000|Overall Study|Withdrawal by Subject|2|||
164429264|NCT00886613|593940954|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
164429265|NCT01982760|593940957|FG000|Overall Study|Physician Decision|1|||
164429266|NCT01982760|593940958|FG001|Overall Study|Physician Decision|0|||
164429267|NCT00530777|593940959|FG000|Overall Study|Lost to Follow-up|0|||
164681070|NCT00112437|594854584|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164429268|NCT00530777|593940960|FG001|Overall Study|Lost to Follow-up|1|||
164429269|NCT00530777|593940959|FG000|Overall Study|Death|1|||
164429270|NCT00530777|593940960|FG001|Overall Study|Death|2|||
164429271|NCT00530777|593940959|FG000|Overall Study|Physician Decision|1|||
164429272|NCT00530777|593940960|FG001|Overall Study|Physician Decision|0|||
164429273|NCT00530777|593940959|FG000|Overall Study|Withdrawal by Subject|0|||
164429274|NCT00530777|593940960|FG001|Overall Study|Withdrawal by Subject|1|||
164429275|NCT00530777|593940959|FG000|Overall Study|Unable to adhere to visit schedule|5|||
164429276|NCT00530777|593940960|FG001|Overall Study|Unable to adhere to visit schedule|1|||
164429277|NCT01763047|593940962|FG000|Period 1|Test Article Not Available|4|||
164429278|NCT01763047|593940963|FG001|Period 1|Test Article Not Available|1|||
164429279|NCT01763047|593940962|FG000|Period 1|Protocol Violation|4|||
164429280|NCT01763047|593940963|FG001|Period 1|Protocol Violation|4|||
164429281|NCT01763047|593940962|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
164259024|NCT03664674|593316143|FG001|Overall Study|Withdrawal by Subject|0|||
164259025|NCT04584346|593316150|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
164259026|NCT04584346|593316151|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
164259027|NCT03894969|593316160|FG000|Overall Study|Adverse Event|0|||
164259028|NCT03894969|593316161|FG001|Overall Study|Adverse Event|2|||
164259029|NCT03894969|593316162|FG002|Overall Study|Adverse Event|0|||
164259030|NCT03894969|593316163|FG003|Overall Study|Adverse Event|1|||
164259031|NCT03894969|593316164|FG004|Overall Study|Adverse Event|2|||
164429282|NCT01763047|593940963|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
164429283|NCT01763047|593940962|FG000|Period 1|Adverse Event|0|||
164429284|NCT01763047|593940963|FG001|Period 1|Adverse Event|1|||
164429285|NCT01763047|593940962|FG000|Period 1|Unsatisfactory Visual Response|0|||
164259032|NCT03894969|593316160|FG000|Overall Study|Lost to Follow-up|3|||
164259033|NCT03894969|593316161|FG001|Overall Study|Lost to Follow-up|1|||
164259034|NCT03894969|593316162|FG002|Overall Study|Lost to Follow-up|1|||
164259035|NCT03894969|593316163|FG003|Overall Study|Lost to Follow-up|0|||
164259036|NCT03894969|593316164|FG004|Overall Study|Lost to Follow-up|0|||
164429286|NCT01763047|593940963|FG001|Period 1|Unsatisfactory Visual Response|3|||
164429287|NCT01763047|593940962|FG000|Period 1|Lens Power Not Available|0|||
164429288|NCT01763047|593940963|FG001|Period 1|Lens Power Not Available|1|||
164429289|NCT01763047|593940962|FG000|Period 1|Study Site office Closed|0|||
164429290|NCT01763047|593940963|FG001|Period 1|Study Site office Closed|1|||
164577039|NCT00875420|594476788|FG004|Overall Study|Withdrawal by Subject|0|||
164577040|NCT00914628|594476791|FG000|Overall Study|Death|35|||
164577041|NCT00914628|594476792|FG001|Overall Study|Death|17|||
164259037|NCT03894969|593316160|FG000|Overall Study|Withdrawal by Subject|2|||
164259038|NCT03894969|593316161|FG001|Overall Study|Withdrawal by Subject|1|||
164577042|NCT00914628|594476791|FG000|Overall Study|Medical decision|4|||
164577043|NCT00914628|594476792|FG001|Overall Study|Medical decision|0|||
164259039|NCT03894969|593316162|FG002|Overall Study|Withdrawal by Subject|3|||
164259040|NCT03894969|593316163|FG003|Overall Study|Withdrawal by Subject|4|||
164259041|NCT03894969|593316164|FG004|Overall Study|Withdrawal by Subject|8|||
164259042|NCT03894969|593316160|FG000|Overall Study|Other|0|||
164259043|NCT03894969|593316161|FG001|Overall Study|Other|0|||
164259044|NCT03894969|593316162|FG002|Overall Study|Other|0|||
164259045|NCT03894969|593316163|FG003|Overall Study|Other|0|||
164259046|NCT03894969|593316164|FG004|Overall Study|Other|3|||
164429291|NCT01763047|593940962|FG000|Period 2|Lens Discomfort|1|||
164429292|NCT01763047|593940963|FG001|Period 2|Lens Discomfort|0|||
164429293|NCT01763047|593940962|FG000|Period 2|No longer meets Eligibility Criteria|1|||
164429294|NCT01763047|593940963|FG001|Period 2|No longer meets Eligibility Criteria|0|||
164577044|NCT00914628|594476791|FG000|Overall Study|Protocol Violation|1|||
164577045|NCT00914628|594476792|FG001|Overall Study|Protocol Violation|0|||
164577046|NCT00914628|594476791|FG000|Overall Study|Lack of Efficacy|1|||
164577047|NCT00914628|594476792|FG001|Overall Study|Lack of Efficacy|0|||
164577048|NCT00914628|594476791|FG000|Overall Study|non-randomized|1|||
164577049|NCT00914628|594476792|FG001|Overall Study|non-randomized|0|||
164577050|NCT00914628|594476791|FG000|Overall Study|Relapse|1|||
164577051|NCT00914628|594476792|FG001|Overall Study|Relapse|2|||
164577052|NCT00914628|594476791|FG000|Overall Study|Study terminated by Sponsor|14|||
164577053|NCT00914628|594476792|FG001|Overall Study|Study terminated by Sponsor|8|||
164577054|NCT00914628|594476791|FG000|Overall Study|Patients who did not receive a single dose|7|||
164577055|NCT00914628|594476792|FG001|Overall Study|Patients who did not receive a single dose|1|||
164577056|NCT00374556|594476793|FG000|Overall Study|Lost to Follow-up|1|||
164577057|NCT00374556|594476794|FG001|Overall Study|Lost to Follow-up|0|||
164577058|NCT00374556|594476793|FG000|Overall Study|Removed at baseline due to medical cond|0|||
164577059|NCT00374556|594476794|FG001|Overall Study|Removed at baseline due to medical cond|1|||
164577060|NCT00473694|594476795|FG000|Overall Study|Adverse Event|0|||
164577061|NCT00473694|594476796|FG001|Overall Study|Adverse Event|1|||
164259047|NCT03894969|593316160|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
164259048|NCT03894969|593316161|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
164259049|NCT03894969|593316162|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
164577062|NCT00473694|594476797|FG002|Overall Study|Adverse Event|0|||
164259050|NCT03894969|593316163|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
164259051|NCT03894969|593316164|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
164577063|NCT00473694|594476798|FG003|Overall Study|Adverse Event|0|||
164577064|NCT00473694|594476795|FG000|Overall Study|Participants did not receive treatment|11|||
164577065|NCT00473694|594476796|FG001|Overall Study|Participants did not receive treatment|3|||
164577066|NCT00473694|594476797|FG002|Overall Study|Participants did not receive treatment|5|||
164259052|NCT03894969|593316160|FG000|Overall Study|Solicited Adverse Event|0|||
164259053|NCT03894969|593316161|FG001|Overall Study|Solicited Adverse Event|1|||
164259054|NCT03894969|593316162|FG002|Overall Study|Solicited Adverse Event|0|||
164259055|NCT03894969|593316163|FG003|Overall Study|Solicited Adverse Event|0|||
164259056|NCT03894969|593316164|FG004|Overall Study|Solicited Adverse Event|0|||
164259057|NCT02979093|593316165|FG000|First Scan Session|Scanning data problems|1|||
164259058|NCT02979093|593316166|FG001|First Scan Session|Scanning data problems|2|||
164259059|NCT02979093|593316167|FG002|First Scan Session|Scanning data problems|2|||
164259060|NCT02979093|593316168|FG003|First Scan Session|Scanning data problems|0|||
164259061|NCT02979093|593316165|FG000|Second Scan Session|Scanning data problems|3|||
164259062|NCT02979093|593316166|FG001|Second Scan Session|Scanning data problems|0|||
164259063|NCT02979093|593316167|FG002|Second Scan Session|Scanning data problems|1|||
164259064|NCT02979093|593316168|FG003|Second Scan Session|Scanning data problems|3|||
164340310|NCT01058655|593620547|FG001|Overall Study|Withdrawal by Subject|0|||
164340311|NCT01058655|593620548|FG002|Overall Study|Withdrawal by Subject|3|||
164340312|NCT01058655|593620549|FG003|Overall Study|Withdrawal by Subject|4|||
164340313|NCT01058655|593620546|FG000|Overall Study|Prolonged Treatment Delay|0|||
164340314|NCT01058655|593620547|FG001|Overall Study|Prolonged Treatment Delay|0|||
164340315|NCT01058655|593620548|FG002|Overall Study|Prolonged Treatment Delay|0|||
164340316|NCT01058655|593620549|FG003|Overall Study|Prolonged Treatment Delay|2|||
164340317|NCT01058655|593620546|FG000|Overall Study|Symptomatic Deterioration|0|||
164340318|NCT01058655|593620547|FG001|Overall Study|Symptomatic Deterioration|0|||
164340319|NCT01058655|593620548|FG002|Overall Study|Symptomatic Deterioration|0|||
164340320|NCT01058655|593620549|FG003|Overall Study|Symptomatic Deterioration|1|||
164340321|NCT01058655|593620546|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
164340322|NCT01058655|593620547|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
164340323|NCT01058655|593620548|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
164340324|NCT01058655|593620549|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
164340325|NCT01058655|593620546|FG000|Overall Study|Death|0|||
164340326|NCT01058655|593620547|FG001|Overall Study|Death|1|||
164340327|NCT01058655|593620548|FG002|Overall Study|Death|1|||
164340328|NCT01058655|593620549|FG003|Overall Study|Death|0|||
164340329|NCT01058655|593620546|FG000|Overall Study|Disease Progression|1|||
164340330|NCT01058655|593620547|FG001|Overall Study|Disease Progression|2|||
164340331|NCT01058655|593620548|FG002|Overall Study|Disease Progression|4|||
164340332|NCT01058655|593620549|FG003|Overall Study|Disease Progression|24|||
164340333|NCT01058655|593620546|FG000|Overall Study|Other|0|||
164340334|NCT01058655|593620547|FG001|Overall Study|Other|0|||
164340335|NCT01058655|593620548|FG002|Overall Study|Other|0|||
164340336|NCT01058655|593620549|FG003|Overall Study|Other|4|||
164340337|NCT04545060|593620550|FG000|Overall Study|Adverse Event|0|||
164340338|NCT04545060|593620551|FG001|Overall Study|Adverse Event|1|||
164340339|NCT04545060|593620550|FG000|Overall Study|Death|0|||
164340340|NCT04545060|593620551|FG001|Overall Study|Death|5|||
164340341|NCT04545060|593620550|FG000|Overall Study|Lost to Follow-up|10|||
164340342|NCT04545060|593620551|FG001|Overall Study|Lost to Follow-up|13|||
164340343|NCT04545060|593620550|FG000|Overall Study|Physician Decision|3|||
164340344|NCT04545060|593620551|FG001|Overall Study|Physician Decision|0|||
164340345|NCT04545060|593620550|FG000|Overall Study|Withdrawal by Subject|17|||
164340346|NCT04545060|593620551|FG001|Overall Study|Withdrawal by Subject|22|||
164340347|NCT02939079|593620552|FG000|Overall Study|Adverse Event|2|||
164340348|NCT02939079|593620553|FG001|Overall Study|Adverse Event|1|||
164340349|NCT02939079|593620552|FG000|Overall Study|Lost to Follow-up|0|||
164340350|NCT02939079|593620553|FG001|Overall Study|Lost to Follow-up|2|||
164340351|NCT02939079|593620552|FG000|Overall Study|Protocol Violation|1|||
164340352|NCT02939079|593620553|FG001|Overall Study|Protocol Violation|0|||
164340353|NCT02939079|593620552|FG000|Overall Study|Withdrawal by Subject|0|||
164340354|NCT02939079|593620553|FG001|Overall Study|Withdrawal by Subject|1|||
164340355|NCT02939079|593620552|FG000|Overall Study|relapse during the study|1|||
164340356|NCT02939079|593620553|FG001|Overall Study|relapse during the study|1|||
164340357|NCT00973674|593620554|FG000|Overall Study|Protocol Violation|2|||
164340358|NCT00973674|593620555|FG001|Overall Study|Protocol Violation|0|||
164340359|NCT02846324|593620565|FG000|Overall Study|Other|1|||
164340360|NCT02846324|593620566|FG001|Overall Study|Other|0|||
164340361|NCT02846324|593620567|FG002|Overall Study|Other|0|||
164340362|NCT02846324|593620568|FG003|Overall Study|Other|0|||
164577067|NCT00473694|594476798|FG003|Overall Study|Participants did not receive treatment|6|||
164577068|NCT00473694|594476795|FG000|Overall Study|Lost to Follow-up|0|||
164259065|NCT02308163|593316169|FG000|Overall Study|Not fulfill eligible criteria|1|||
164259066|NCT02308163|593316170|FG001|Overall Study|Not fulfill eligible criteria|2|||
164340363|NCT02846324|593620565|FG000|Overall Study|Withdrawal by Subject|1|||
164340364|NCT02846324|593620566|FG001|Overall Study|Withdrawal by Subject|0|||
164340365|NCT02846324|593620567|FG002|Overall Study|Withdrawal by Subject|4|||
164340366|NCT02846324|593620568|FG003|Overall Study|Withdrawal by Subject|0|||
164681071|NCT00112437|594854585|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164259067|NCT02308163|593316171|FG002|Overall Study|Not fulfill eligible criteria|0|||
164259068|NCT02308163|593316172|FG003|Overall Study|Not fulfill eligible criteria|1|||
164259069|NCT02308163|593316173|FG004|Overall Study|Not fulfill eligible criteria|1|||
164259070|NCT02308163|593316169|FG000|Overall Study|Adverse Event|9|||
164259071|NCT02308163|593316170|FG001|Overall Study|Adverse Event|5|||
164259072|NCT02308163|593316171|FG002|Overall Study|Adverse Event|2|||
164259073|NCT02308163|593316172|FG003|Overall Study|Adverse Event|2|||
164259074|NCT02308163|593316173|FG004|Overall Study|Adverse Event|11|||
164259075|NCT02308163|593316169|FG000|Overall Study|Lack of Efficacy|11|||
164259076|NCT02308163|593316170|FG001|Overall Study|Lack of Efficacy|3|||
164259077|NCT02308163|593316171|FG002|Overall Study|Lack of Efficacy|8|||
164259078|NCT02308163|593316172|FG003|Overall Study|Lack of Efficacy|4|||
164259079|NCT02308163|593316173|FG004|Overall Study|Lack of Efficacy|6|||
164259080|NCT02308163|593316169|FG000|Overall Study|Withdrawal of consent|2|||
164259081|NCT02308163|593316170|FG001|Overall Study|Withdrawal of consent|3|||
164259082|NCT02308163|593316171|FG002|Overall Study|Withdrawal of consent|0|||
164259083|NCT02308163|593316172|FG003|Overall Study|Withdrawal of consent|2|||
164259084|NCT02308163|593316173|FG004|Overall Study|Withdrawal of consent|6|||
164259085|NCT02308163|593316169|FG000|Overall Study|Protocol Violation|3|||
164259086|NCT02308163|593316170|FG001|Overall Study|Protocol Violation|3|||
164259087|NCT02308163|593316171|FG002|Overall Study|Protocol Violation|3|||
164259088|NCT02308163|593316172|FG003|Overall Study|Protocol Violation|2|||
164259089|NCT02308163|593316173|FG004|Overall Study|Protocol Violation|5|||
164259090|NCT02308163|593316169|FG000|Overall Study|Lab data met discontinuation criteria|3|||
164259091|NCT02308163|593316170|FG001|Overall Study|Lab data met discontinuation criteria|0|||
164259092|NCT02308163|593316171|FG002|Overall Study|Lab data met discontinuation criteria|0|||
164259093|NCT02308163|593316172|FG003|Overall Study|Lab data met discontinuation criteria|2|||
164259094|NCT02308163|593316173|FG004|Overall Study|Lab data met discontinuation criteria|0|||
164259095|NCT02308163|593316169|FG000|Overall Study|Miscellaneous|2|||
164259096|NCT02308163|593316170|FG001|Overall Study|Miscellaneous|2|||
164259097|NCT02308163|593316171|FG002|Overall Study|Miscellaneous|1|||
164259098|NCT02308163|593316172|FG003|Overall Study|Miscellaneous|0|||
164259099|NCT02308163|593316173|FG004|Overall Study|Miscellaneous|5|||
164259100|NCT00443053|593316175|FG000|Overall Study|Adverse Event|2|||
164259101|NCT00443053|593316176|FG001|Overall Study|Adverse Event|1|||
164259102|NCT00443053|593316175|FG000|Overall Study|Withdrawal by Subject|9|||
164259103|NCT00443053|593316176|FG001|Overall Study|Withdrawal by Subject|18|||
164259104|NCT00443053|593316175|FG000|Overall Study|Lost to Follow-up|4|||
164259105|NCT00443053|593316176|FG001|Overall Study|Lost to Follow-up|5|||
164259106|NCT00443053|593316175|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
164259107|NCT00443053|593316176|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
164259108|NCT00443053|593316175|FG000|Overall Study|Noncompliance|2|||
164259109|NCT00443053|593316176|FG001|Overall Study|Noncompliance|1|||
164259110|NCT00443053|593316175|FG000|Overall Study|Other|3|||
164259111|NCT00443053|593316176|FG001|Overall Study|Other|4|||
164259112|NCT00443053|593316175|FG000|Overall Study|Physician Decision|0|||
164259113|NCT00443053|593316176|FG001|Overall Study|Physician Decision|4|||
164259114|NCT00541866|593316177|FG000|Overall Study|Adverse Event|3|||
164259115|NCT00541866|593316178|FG001|Overall Study|Adverse Event|0|||
164259116|NCT00541866|593316179|FG002|Overall Study|Adverse Event|0|||
164259117|NCT00541866|593316180|FG003|Overall Study|Adverse Event|0|||
164259118|NCT00541866|593316181|FG004|Overall Study|Adverse Event|0|||
164259119|NCT00541866|593316177|FG000|Overall Study|Death|1|||
164259120|NCT00541866|593316178|FG001|Overall Study|Death|0|||
164259121|NCT00541866|593316179|FG002|Overall Study|Death|0|||
164259122|NCT00541866|593316180|FG003|Overall Study|Death|0|||
164259123|NCT00541866|593316181|FG004|Overall Study|Death|0|||
164340367|NCT00516074|593620575|FG000|Overall Study|Adverse Event|0|||
164340368|NCT00516074|593620576|FG001|Overall Study|Adverse Event|1|||
164340369|NCT00516074|593620575|FG000|Overall Study|Subject Decision|4|||
164340370|NCT00516074|593620576|FG001|Overall Study|Subject Decision|2|||
164681072|NCT00112437|594854586|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164259124|NCT00541866|593316177|FG000|Overall Study|Lack of Efficacy|19|||
164259125|NCT00541866|593316178|FG001|Overall Study|Lack of Efficacy|15|||
164259126|NCT00541866|593316179|FG002|Overall Study|Lack of Efficacy|10|||
164259127|NCT00541866|593316180|FG003|Overall Study|Lack of Efficacy|12|||
164259128|NCT00541866|593316181|FG004|Overall Study|Lack of Efficacy|14|||
164259129|NCT00541866|593316177|FG000|Overall Study|Not Reported or Other|11|||
164259130|NCT00541866|593316178|FG001|Overall Study|Not Reported or Other|3|||
164259131|NCT00541866|593316179|FG002|Overall Study|Not Reported or Other|3|||
164340371|NCT00516074|593620575|FG000|Overall Study|Loss of Glucose Control|2|||
164340372|NCT00516074|593620576|FG001|Overall Study|Loss of Glucose Control|0|||
164259132|NCT00541866|593316180|FG003|Overall Study|Not Reported or Other|3|||
164259133|NCT00541866|593316181|FG004|Overall Study|Not Reported or Other|1|||
164259134|NCT00541866|593316177|FG000|Overall Study|Physician Decision|0|||
164259135|NCT00541866|593316178|FG001|Overall Study|Physician Decision|0|||
164259136|NCT00541866|593316179|FG002|Overall Study|Physician Decision|2|||
164429295|NCT01763047|593940962|FG000|Period 2|Study Site office Closed|1|||
164429296|NCT01763047|593940963|FG001|Period 2|Study Site office Closed|1|||
164429297|NCT01763047|593940962|FG000|Period 2|Unsatisfactory Visual Response|1|||
164429298|NCT01763047|593940963|FG001|Period 2|Unsatisfactory Visual Response|1|||
164429299|NCT01763047|593940962|FG000|Period 2|Protocol Violation|0|||
164429300|NCT01763047|593940963|FG001|Period 2|Protocol Violation|2|||
164429301|NCT01763047|593940962|FG000|Period 2|Unsatisfactory lens Fitting|0|||
164429302|NCT01763047|593940963|FG001|Period 2|Unsatisfactory lens Fitting|1|||
164429303|NCT01941316|593940969|FG000|Overall Study|Adverse Event|0|||
164429304|NCT01941316|593940970|FG001|Overall Study|Adverse Event|1|||
164429305|NCT01941316|593940971|FG002|Overall Study|Adverse Event|0|||
164429306|NCT01941316|593940972|FG003|Overall Study|Adverse Event|7|||
164429307|NCT01941316|593940969|FG000|Overall Study|Progressive Disease|3|||
164429308|NCT01941316|593940970|FG001|Overall Study|Progressive Disease|6|||
164429309|NCT01941316|593940971|FG002|Overall Study|Progressive Disease|2|||
164429310|NCT01941316|593940972|FG003|Overall Study|Progressive Disease|29|||
164429311|NCT01941316|593940969|FG000|Overall Study|Withdrawal by Subject|0|||
164429312|NCT01941316|593940970|FG001|Overall Study|Withdrawal by Subject|2|||
164429313|NCT01941316|593940971|FG002|Overall Study|Withdrawal by Subject|1|||
164429314|NCT01941316|593940972|FG003|Overall Study|Withdrawal by Subject|8|||
164429315|NCT01941316|593940969|FG000|Overall Study|Death|0|||
164429316|NCT01941316|593940970|FG001|Overall Study|Death|0|||
164429317|NCT01941316|593940971|FG002|Overall Study|Death|0|||
164429318|NCT01941316|593940972|FG003|Overall Study|Death|3|||
164429319|NCT01941316|593940969|FG000|Overall Study|Physician Decision|0|||
164429320|NCT01941316|593940970|FG001|Overall Study|Physician Decision|0|||
164429321|NCT01941316|593940971|FG002|Overall Study|Physician Decision|0|||
164429322|NCT01941316|593940972|FG003|Overall Study|Physician Decision|3|||
164429323|NCT01941316|593940969|FG000|Overall Study|Protocol Violation|0|||
164429324|NCT01941316|593940970|FG001|Overall Study|Protocol Violation|0|||
164429325|NCT01941316|593940971|FG002|Overall Study|Protocol Violation|0|||
164429326|NCT01941316|593940972|FG003|Overall Study|Protocol Violation|3|||
164429327|NCT01941316|593940969|FG000|Overall Study|Intercurrent illness|0|||
164429328|NCT01941316|593940970|FG001|Overall Study|Intercurrent illness|0|||
164429329|NCT01941316|593940971|FG002|Overall Study|Intercurrent illness|0|||
164429330|NCT01941316|593940972|FG003|Overall Study|Intercurrent illness|1|||
164429331|NCT01941316|593940969|FG000|Overall Study|Other, not specified|0|||
164429332|NCT01941316|593940970|FG001|Overall Study|Other, not specified|0|||
164429333|NCT01941316|593940971|FG002|Overall Study|Other, not specified|0|||
164429334|NCT01941316|593940972|FG003|Overall Study|Other, not specified|1|||
164429335|NCT02775435|593940973|FG000|Overall Study|Adverse Event|32|||
164429336|NCT02775435|593940974|FG001|Overall Study|Adverse Event|27|||
164259137|NCT00541866|593316180|FG003|Overall Study|Physician Decision|1|||
164259138|NCT00541866|593316181|FG004|Overall Study|Physician Decision|0|||
164259139|NCT00522418|593316182|FG000|Overall Study|Local IRB Consent Violation|5|||
164259140|NCT00522418|593316183|FG001|Overall Study|Local IRB Consent Violation|5|||
164577069|NCT00473694|594476796|FG001|Overall Study|Lost to Follow-up|0|||
164577070|NCT00473694|594476797|FG002|Overall Study|Lost to Follow-up|0|||
164577071|NCT00473694|594476798|FG003|Overall Study|Lost to Follow-up|1|||
164577072|NCT02468193|594476799|FG000|Overall Study|Adverse Event|4|||
164577073|NCT02468193|594476799|FG000|Overall Study|Subject/ Guardian decision|2|||
164259141|NCT00522418|593316182|FG000|Overall Study|Early Study Termination|46|||
164259142|NCT00522418|593316183|FG001|Overall Study|Early Study Termination|47|||
164259143|NCT00522418|593316182|FG000|Overall Study|Noncompliance|2|||
164259144|NCT00522418|593316183|FG001|Overall Study|Noncompliance|2|||
164429337|NCT02775435|593940973|FG000|Overall Study|Lost to Follow-up|2|||
164429338|NCT02775435|593940974|FG001|Overall Study|Lost to Follow-up|2|||
164429339|NCT02775435|593940973|FG000|Overall Study|Sponsor decision|44|||
164429340|NCT02775435|593940974|FG001|Overall Study|Sponsor decision|19|||
164577074|NCT00742781|594476800|FG000|Overall Study|Withdrawal by Subject|3|||
164577075|NCT01416181|594476801|FG000|Part 1|Other|10|||
164429341|NCT02775435|593940973|FG000|Overall Study|Withdrawal by Subject|4|||
164429342|NCT02775435|593940974|FG001|Overall Study|Withdrawal by Subject|9|||
164429343|NCT02775435|593940973|FG000|Overall Study|Death|196|||
164577076|NCT01416181|594476802|FG001|Part 1|Other|24|||
164259145|NCT00522418|593316182|FG000|Overall Study|Reason Not Specified|3|||
164259146|NCT00522418|593316183|FG001|Overall Study|Reason Not Specified|1|||
164259147|NCT00522418|593316182|FG000|Overall Study|Consent Withdraw|1|||
164429344|NCT02775435|593940974|FG001|Overall Study|Death|224|||
164429345|NCT00320489|593940975|FG000|Overall Study|Adverse Event|26|||
164429346|NCT00320489|593940976|FG001|Overall Study|Adverse Event|25|||
164429347|NCT00320489|593940975|FG000|Overall Study|Clinical Relapse|26|||
164429348|NCT00320489|593940976|FG001|Overall Study|Clinical Relapse|20|||
164429349|NCT00320489|593940975|FG000|Overall Study|Death|0|||
164429350|NCT00320489|593940976|FG001|Overall Study|Death|2|||
164429351|NCT00320489|593940975|FG000|Overall Study|Entry Criteria Exclusion|2|||
164577077|NCT01416181|594476801|FG000|Part 1|Death|0|||
164259148|NCT00522418|593316183|FG001|Overall Study|Consent Withdraw|2|||
164259149|NCT00522418|593316182|FG000|Overall Study|Lack of Efficacy|0|||
164259150|NCT00522418|593316183|FG001|Overall Study|Lack of Efficacy|1|||
164577078|NCT01416181|594476802|FG001|Part 1|Death|1|||
164577079|NCT01416181|594476801|FG000|Part 1|Investigator Decision|7|||
164577080|NCT01416181|594476802|FG001|Part 1|Investigator Decision|6|||
164259151|NCT02438683|593316184|FG000|Overall Study|Adverse Event|1|||
164259152|NCT02438683|593316185|FG001|Overall Study|Adverse Event|0|||
164259153|NCT02438683|593316186|FG002|Overall Study|Adverse Event|0|||
164259154|NCT02438683|593316187|FG003|Overall Study|Adverse Event|0|||
164259155|NCT02438683|593316188|FG004|Overall Study|Adverse Event|0|||
164259156|NCT02438683|593316189|FG005|Overall Study|Adverse Event|0|||
164259157|NCT00082368|593316194|FG000|Overall Study|Not treated-pt had poor IV access|1|||
164259158|NCT02825420|593316196|FG000|Overall Study|Death|30|||
164259159|NCT02825420|593316197|FG001|Overall Study|Death|12|||
164259160|NCT02825420|593316196|FG000|Overall Study|Progressive disease|6|||
164259161|NCT02825420|593316197|FG001|Overall Study|Progressive disease|1|||
164259162|NCT02825420|593316196|FG000|Overall Study|Lost to Follow-up|2|||
164259163|NCT02825420|593316197|FG001|Overall Study|Lost to Follow-up|2|||
164259164|NCT02825420|593316196|FG000|Overall Study|Withdrawal by Subject|1|||
164259165|NCT02825420|593316197|FG001|Overall Study|Withdrawal by Subject|1|||
164259166|NCT02825420|593316196|FG000|Overall Study|Protocol amendment not signed|1|||
164259167|NCT02825420|593316197|FG001|Overall Study|Protocol amendment not signed|1|||
164259168|NCT02825420|593316196|FG000|Overall Study|Physician Decision|1|||
164259169|NCT02825420|593316197|FG001|Overall Study|Physician Decision|0|||
164259170|NCT02825420|593316196|FG000|Overall Study|Did not receive PLD|2|||
164259171|NCT02825420|593316197|FG001|Overall Study|Did not receive PLD|0|||
164259172|NCT00445939|593318374|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
164259173|NCT00445939|593318375|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
164259174|NCT00445939|593318376|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
164259175|NCT00445939|593318377|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
164259176|NCT00445939|593318374|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
164259177|NCT00445939|593318375|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
164259178|NCT00445939|593318376|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
164259179|NCT00445939|593318377|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
164259180|NCT00416715|593318378|FG000|Overall Study|Not evaluable for joint aches|7|||
164259181|NCT00416715|593318378|FG000|Overall Study|Vitamin D levels not evaluable|8|||
164259182|NCT01007435|593318380|FG000|Overall Study|Adverse Event|16|||
164259183|NCT01007435|593318381|FG001|Overall Study|Adverse Event|25|||
164259184|NCT01007435|593318382|FG002|Overall Study|Adverse Event|47|||
164259185|NCT01007435|593318383|FG003|Overall Study|Adverse Event|31|||
164259186|NCT01007435|593318380|FG000|Overall Study|Death|2|||
164259187|NCT01007435|593318381|FG001|Overall Study|Death|4|||
164259188|NCT01007435|593318382|FG002|Overall Study|Death|2|||
164259189|NCT01007435|593318383|FG003|Overall Study|Death|1|||
164259190|NCT01007435|593318380|FG000|Overall Study|Insufficient Therapeutic Response|21|||
164259191|NCT01007435|593318381|FG001|Overall Study|Insufficient Therapeutic Response|7|||
164259192|NCT01007435|593318382|FG002|Overall Study|Insufficient Therapeutic Response|2|||
164259193|NCT01007435|593318383|FG003|Overall Study|Insufficient Therapeutic Response|9|||
164259194|NCT01007435|593318380|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
164259195|NCT01007435|593318381|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
164259196|NCT01007435|593318382|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
164259197|NCT01007435|593318383|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
164259198|NCT01007435|593318380|FG000|Overall Study|Other Protocol Violation|2|||
164259199|NCT01007435|593318381|FG001|Overall Study|Other Protocol Violation|0|||
164259200|NCT01007435|593318382|FG002|Overall Study|Other Protocol Violation|1|||
164259201|NCT01007435|593318383|FG003|Overall Study|Other Protocol Violation|0|||
164259202|NCT01007435|593318380|FG000|Overall Study|Refused Treatment|13|||
164259203|NCT01007435|593318381|FG001|Overall Study|Refused Treatment|13|||
164259204|NCT01007435|593318382|FG002|Overall Study|Refused Treatment|5|||
164259205|NCT01007435|593318383|FG003|Overall Study|Refused Treatment|8|||
164259206|NCT01007435|593318380|FG000|Overall Study|Failure to Return|5|||
164259207|NCT01007435|593318381|FG001|Overall Study|Failure to Return|4|||
164259208|NCT01007435|593318382|FG002|Overall Study|Failure to Return|3|||
164259209|NCT01007435|593318383|FG003|Overall Study|Failure to Return|6|||
164259210|NCT01007435|593318380|FG000|Overall Study|Reason not Specified|1|||
164259211|NCT01007435|593318381|FG001|Overall Study|Reason not Specified|1|||
164259212|NCT01007435|593318382|FG002|Overall Study|Reason not Specified|2|||
164259213|NCT01007435|593318383|FG003|Overall Study|Reason not Specified|1|||
164259214|NCT02576535|593318384|FG000|Overall Study|Withdrawal by Subject|2|||
164340373|NCT00810355|593620578|FG000|Overall Study|Lost to Follow-up|13|||
164340374|NCT00810355|593620579|FG001|Overall Study|Lost to Follow-up|17|||
164340375|NCT00810355|593620580|FG002|Overall Study|Lost to Follow-up|11|||
164340376|NCT00810355|593620578|FG000|Overall Study|Withdrawal by Subject|1|||
164340377|NCT00810355|593620579|FG001|Overall Study|Withdrawal by Subject|0|||
164259215|NCT02545517|593318385|FG000|Overall Study|Death|2|||
164259216|NCT02545517|593318386|FG001|Overall Study|Death|2|||
164259217|NCT02545517|593318387|FG002|Overall Study|Death|1|||
164259218|NCT02545517|593318385|FG000|Overall Study|Lost to Follow-up|14|||
164259219|NCT02545517|593318386|FG001|Overall Study|Lost to Follow-up|13|||
164259220|NCT02545517|593318387|FG002|Overall Study|Lost to Follow-up|17|||
164259221|NCT02545517|593318385|FG000|Overall Study|Protocol Violation|0|||
164259222|NCT02545517|593318386|FG001|Overall Study|Protocol Violation|1|||
164259223|NCT02545517|593318387|FG002|Overall Study|Protocol Violation|1|||
164259224|NCT02545517|593318385|FG000|Overall Study|Withdrawal by Subject|5|||
164259225|NCT02545517|593318386|FG001|Overall Study|Withdrawal by Subject|8|||
164259226|NCT02545517|593318387|FG002|Overall Study|Withdrawal by Subject|9|||
164259227|NCT02545517|593318385|FG000|Overall Study|Administrative reason|5|||
164259228|NCT02545517|593318386|FG001|Overall Study|Administrative reason|6|||
164259229|NCT02545517|593318387|FG002|Overall Study|Administrative reason|10|||
164259230|NCT02545517|593318385|FG000|Overall Study|Other|2|||
164259231|NCT02545517|593318386|FG001|Overall Study|Other|4|||
164259232|NCT02545517|593318387|FG002|Overall Study|Other|3|||
164259233|NCT03334851|593318388|FG000|Overall Study|Other|0|||
164259234|NCT03334851|593318389|FG001|Overall Study|Other|0|||
164259235|NCT03334851|593318390|FG002|Overall Study|Other|0|||
164259236|NCT03334851|593318391|FG003|Overall Study|Other|0|||
164259237|NCT03334851|593318392|FG004|Overall Study|Other|0|||
164259238|NCT03334851|593318393|FG005|Overall Study|Other|0|||
164259239|NCT03334851|593318394|FG006|Overall Study|Other|0|||
164259240|NCT03334851|593318395|FG007|Overall Study|Other|1|||
164259241|NCT03334851|593318396|FG008|Overall Study|Other|0|||
164259242|NCT03334851|593318397|FG009|Overall Study|Other|0|||
164259243|NCT03334851|593318398|FG010|Overall Study|Other|0|||
164259244|NCT03334851|593318399|FG011|Overall Study|Other|0|||
164259245|NCT03334851|593318400|FG012|Overall Study|Other|0|||
164259246|NCT03334851|593318388|FG000|Overall Study|Adverse Event|0|||
164259247|NCT03334851|593318389|FG001|Overall Study|Adverse Event|0|||
164259248|NCT03334851|593318390|FG002|Overall Study|Adverse Event|0|||
164259249|NCT03334851|593318391|FG003|Overall Study|Adverse Event|0|||
164259250|NCT03334851|593318392|FG004|Overall Study|Adverse Event|0|||
164259251|NCT03334851|593318393|FG005|Overall Study|Adverse Event|0|||
164259252|NCT03334851|593318394|FG006|Overall Study|Adverse Event|0|||
164259253|NCT03334851|593318395|FG007|Overall Study|Adverse Event|1|||
164259254|NCT03334851|593318396|FG008|Overall Study|Adverse Event|0|||
164259255|NCT03334851|593318397|FG009|Overall Study|Adverse Event|0|||
164259256|NCT03334851|593318398|FG010|Overall Study|Adverse Event|0|||
164259257|NCT03334851|593318399|FG011|Overall Study|Adverse Event|0|||
164259258|NCT03334851|593318400|FG012|Overall Study|Adverse Event|0|||
164259259|NCT03334851|593318388|FG000|Overall Study|Withdrawal by Subject|0|||
164259260|NCT03334851|593318389|FG001|Overall Study|Withdrawal by Subject|0|||
164259261|NCT03334851|593318390|FG002|Overall Study|Withdrawal by Subject|0|||
164259262|NCT03334851|593318391|FG003|Overall Study|Withdrawal by Subject|0|||
164259263|NCT03334851|593318392|FG004|Overall Study|Withdrawal by Subject|0|||
164259264|NCT03334851|593318393|FG005|Overall Study|Withdrawal by Subject|0|||
164259265|NCT03334851|593318394|FG006|Overall Study|Withdrawal by Subject|0|||
164259266|NCT03334851|593318395|FG007|Overall Study|Withdrawal by Subject|0|||
164259267|NCT03334851|593318396|FG008|Overall Study|Withdrawal by Subject|0|||
164259268|NCT03334851|593318397|FG009|Overall Study|Withdrawal by Subject|0|||
164259269|NCT03334851|593318398|FG010|Overall Study|Withdrawal by Subject|1|||
164259270|NCT03334851|593318399|FG011|Overall Study|Withdrawal by Subject|0|||
164259271|NCT03334851|593318400|FG012|Overall Study|Withdrawal by Subject|1|||
164259272|NCT03334851|593318388|FG000|Overall Study|Lost to Follow-up|0|||
164259273|NCT03334851|593318389|FG001|Overall Study|Lost to Follow-up|0|||
164259274|NCT03334851|593318390|FG002|Overall Study|Lost to Follow-up|0|||
164259275|NCT03334851|593318391|FG003|Overall Study|Lost to Follow-up|0|||
164259276|NCT03334851|593318392|FG004|Overall Study|Lost to Follow-up|0|||
164259277|NCT03334851|593318393|FG005|Overall Study|Lost to Follow-up|0|||
164259278|NCT03334851|593318394|FG006|Overall Study|Lost to Follow-up|0|||
164259279|NCT03334851|593318395|FG007|Overall Study|Lost to Follow-up|0|||
164259280|NCT03334851|593318396|FG008|Overall Study|Lost to Follow-up|0|||
164259281|NCT03334851|593318397|FG009|Overall Study|Lost to Follow-up|0|||
164259282|NCT03334851|593318398|FG010|Overall Study|Lost to Follow-up|2|||
164259283|NCT03334851|593318399|FG011|Overall Study|Lost to Follow-up|1|||
164259284|NCT03334851|593318400|FG012|Overall Study|Lost to Follow-up|0|||
164340378|NCT00810355|593620580|FG002|Overall Study|Withdrawal by Subject|0|||
164340379|NCT04154930|593620588|FG000|Overall Study|Withdrawal by Subject|15|||
164340380|NCT04154930|593620589|FG001|Overall Study|Withdrawal by Subject|6|||
164577081|NCT01416181|594476801|FG000|Part 1|Withdrawal by Subject|74|||
164577082|NCT01416181|594476802|FG001|Part 1|Withdrawal by Subject|48|||
164577083|NCT01416181|594476801|FG000|Part 1|Lack of Efficacy|16|||
164577084|NCT01416181|594476802|FG001|Part 1|Lack of Efficacy|8|||
164577085|NCT01416181|594476801|FG000|Part 1|Lost to Follow-up|1|||
164577086|NCT01416181|594476802|FG001|Part 1|Lost to Follow-up|1|||
164577087|NCT01416181|594476801|FG000|Part 1|Adverse Event|15|||
164577088|NCT01416181|594476802|FG001|Part 1|Adverse Event|18|||
164259285|NCT00396136|593318404|FG000|Overall Study|Death|43|||
164577089|NCT01416181|594476801|FG000|Part 1|Ongoing in Follow-Up|14|||
164259286|NCT00396136|593318404|FG000|Overall Study|Withdrawal by Subject|59|||
164259287|NCT00396136|593318404|FG000|Overall Study|Lost to Follow-up|15|||
164259288|NCT00396136|593318404|FG000|Overall Study|Study device explanted|8|||
164259289|NCT03172325|593318408|FG000|Overall Study|Adverse Event|2|||
164259290|NCT03172325|593318409|FG001|Overall Study|Adverse Event|3|||
164259291|NCT03172325|593318408|FG000|Overall Study|Positive PPD|1|||
164259292|NCT03172325|593318409|FG001|Overall Study|Positive PPD|0|||
164259293|NCT03172325|593318408|FG000|Overall Study|Poor Compliance|1|||
164259294|NCT03172325|593318409|FG001|Overall Study|Poor Compliance|1|||
164259295|NCT00385944|593318415|FG000|1st Maintenance Dose Period|Physician Decision|1|||
164259296|NCT00385944|593318416|FG001|1st Maintenance Dose Period|Physician Decision|0|||
164259297|NCT00385944|593318417|FG002|1st Maintenance Dose Period|Physician Decision|0|||
164259298|NCT00385944|593318415|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
164259299|NCT00385944|593318416|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
164259300|NCT00385944|593318417|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
164259301|NCT00385944|593318415|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
164259302|NCT00385944|593318416|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
164259303|NCT00385944|593318417|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
164259304|NCT00385944|593318415|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
164259305|NCT00385944|593318416|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
164259306|NCT00385944|593318417|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
164259307|NCT00823212|593318418|FG000|Overall Study|Death|8|||
164259308|NCT00823212|593318419|FG001|Overall Study|Death|10|||
164259309|NCT00823212|593318418|FG000|Overall Study|Withdrawal by Subject|6|||
164259310|NCT00823212|593318419|FG001|Overall Study|Withdrawal by Subject|1|||
164259311|NCT00823212|593318418|FG000|Overall Study|Incarcerated|0|||
164259312|NCT00823212|593318419|FG001|Overall Study|Incarcerated|1|||
164259313|NCT00823212|593318418|FG000|Overall Study|Missed 12-month visit|21|||
164259314|NCT00823212|593318419|FG001|Overall Study|Missed 12-month visit|21|||
164259315|NCT01694121|593318420|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
164259316|NCT01694121|593318421|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
164259317|NCT00521599|593318422|FG000|Overall Study|Adverse Event|5|||
164259318|NCT00521599|593318423|FG001|Overall Study|Adverse Event|7|||
164259319|NCT00521599|593318424|FG002|Overall Study|Adverse Event|6|||
164259320|NCT00521599|593318422|FG000|Overall Study|Treatment Failure|8|||
164259321|NCT00521599|593318423|FG001|Overall Study|Treatment Failure|9|||
164259322|NCT00521599|593318424|FG002|Overall Study|Treatment Failure|22|||
164259323|NCT00521599|593318422|FG000|Overall Study|Lost to Follow-up|2|||
164259324|NCT00521599|593318423|FG001|Overall Study|Lost to Follow-up|1|||
164259325|NCT00521599|593318424|FG002|Overall Study|Lost to Follow-up|2|||
164259326|NCT00521599|593318422|FG000|Overall Study|Withdrawal by Subject|3|||
164259327|NCT00521599|593318423|FG001|Overall Study|Withdrawal by Subject|5|||
164259328|NCT00521599|593318424|FG002|Overall Study|Withdrawal by Subject|1|||
164259329|NCT00521599|593318422|FG000|Overall Study|Withdrawal by subject treatment related|3|||
164259330|NCT00521599|593318423|FG001|Overall Study|Withdrawal by subject treatment related|1|||
164259331|NCT00521599|593318424|FG002|Overall Study|Withdrawal by subject treatment related|2|||
164259332|NCT00521599|593318422|FG000|Overall Study|Protocol Violation|2|||
164259333|NCT00521599|593318423|FG001|Overall Study|Protocol Violation|4|||
164259334|NCT00521599|593318424|FG002|Overall Study|Protocol Violation|2|||
164259335|NCT00521599|593318422|FG000|Overall Study|Did not meet protocol eligibility|2|||
164259336|NCT00521599|593318423|FG001|Overall Study|Did not meet protocol eligibility|2|||
164259337|NCT00521599|593318424|FG002|Overall Study|Did not meet protocol eligibility|1|||
164259338|NCT00496197|593318428|FG000|Overall Study|Discontinued study due to death|43|||
164259339|NCT00496197|593318428|FG000|Overall Study|Adverse Event|13|||
164259340|NCT00496197|593318428|FG000|Overall Study|Does not meet entrance criteria|5|||
164259341|NCT00496197|593318428|FG000|Overall Study|Insufficient clinical response|3|||
164259342|NCT00496197|593318428|FG000|Overall Study|Insufficient bacteriological response|10|||
164259343|NCT00496197|593318428|FG000|Overall Study|Lost to Follow-up|11|||
164259344|NCT00496197|593318428|FG000|Overall Study|Withdrawal by Subject|11|||
164259345|NCT00496197|593318428|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
164259346|NCT00496197|593318428|FG000|Overall Study|Other|14|||
164259347|NCT00496197|593318428|FG000|Overall Study|Protocol Violation|8|||
164259348|NCT00149994|593318429|FG000|Overall Study|Administrative problems:|1|||
164259349|NCT00149994|593318430|FG001|Overall Study|Administrative problems:|0|||
164259350|NCT00149994|593318429|FG000|Overall Study|Protocol Violation|0|||
164259351|NCT00149994|593318430|FG001|Overall Study|Protocol Violation|1|||
164259352|NCT01610713|593318431|FG000|Overall Study|Adverse Event|3|||
164259353|NCT01610713|593318432|FG001|Overall Study|Adverse Event|0|||
164259354|NCT01610713|593318431|FG000|Overall Study|Lack of Efficacy|1|||
164259355|NCT01610713|593318432|FG001|Overall Study|Lack of Efficacy|0|||
164259356|NCT01610713|593318431|FG000|Overall Study|low mood and poor motivation|1|||
164259357|NCT01610713|593318432|FG001|Overall Study|low mood and poor motivation|0|||
164259358|NCT01610713|593318431|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
164577090|NCT01416181|594476802|FG001|Part 1|Ongoing in Follow-Up|8|||
164259359|NCT01610713|593318432|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
164259360|NCT01610713|593318431|FG000|Overall Study|Lost to Follow-up|0|||
164259361|NCT01610713|593318432|FG001|Overall Study|Lost to Follow-up|1|||
164259362|NCT03943550|593318437|FG000|Overall Study|Adverse Event|0|||
164429352|NCT00320489|593940976|FG001|Overall Study|Entry Criteria Exclusion|4|||
164429353|NCT00320489|593940975|FG000|Overall Study|Lack of Efficacy|16|||
164259363|NCT03943550|593318438|FG001|Overall Study|Adverse Event|0|||
164259364|NCT03943550|593318439|FG002|Overall Study|Adverse Event|1|||
164429354|NCT00320489|593940976|FG001|Overall Study|Lack of Efficacy|7|||
164429355|NCT00320489|593940975|FG000|Overall Study|Lost to Follow-up|21|||
164429356|NCT00320489|593940976|FG001|Overall Study|Lost to Follow-up|22|||
164429357|NCT00320489|593940975|FG000|Overall Study|Physician Decision|8|||
164429358|NCT00320489|593940976|FG001|Overall Study|Physician Decision|8|||
164429359|NCT00320489|593940975|FG000|Overall Study|Protocol Violation|4|||
164429360|NCT00320489|593940976|FG001|Overall Study|Protocol Violation|4|||
164429361|NCT00320489|593940975|FG000|Overall Study|Sponsor Decision|3|||
164429362|NCT00320489|593940976|FG001|Overall Study|Sponsor Decision|3|||
164259365|NCT03943550|593318437|FG000|Overall Study|Lost to Follow-up|0|||
164259366|NCT03943550|593318438|FG001|Overall Study|Lost to Follow-up|0|||
164259367|NCT03943550|593318439|FG002|Overall Study|Lost to Follow-up|1|||
164259368|NCT03943550|593318437|FG000|Overall Study|Progressive Disease|0|||
164259369|NCT03943550|593318438|FG001|Overall Study|Progressive Disease|0|||
164259370|NCT03943550|593318439|FG002|Overall Study|Progressive Disease|2|||
164259371|NCT03943550|593318437|FG000|Overall Study|Participant Moved Out of the Country|0|||
164259372|NCT03943550|593318438|FG001|Overall Study|Participant Moved Out of the Country|1|||
164259373|NCT03943550|593318439|FG002|Overall Study|Participant Moved Out of the Country|0|||
164259374|NCT00543296|593318440|FG000|Overall Study|Physician Decision|7|||
164259375|NCT00934947|593318441|FG000|Overall Study|Adverse Event|0|||
164259376|NCT00934947|593318442|FG001|Overall Study|Adverse Event|2|||
164259377|NCT00096226|593318445|FG000|Overall Study|Ineligible|2|||
164259378|NCT00096226|593318445|FG000|Overall Study|Protocol treatment not started|1|||
164259379|NCT06107803|593318446|FG000|Overall Study|Adverse Event|1|||
164259380|NCT06107803|593318446|FG000|Overall Study|Withdrawal by Subject|2|||
164259381|NCT06107803|593318446|FG000|Overall Study|Protocol Violation|1|||
164259382|NCT03099174|593318448|FG000|Overall Study|Withdrawal by Subject|0|||
164259383|NCT03099174|593318449|FG001|Overall Study|Withdrawal by Subject|0|||
164259384|NCT03099174|593318450|FG002|Overall Study|Withdrawal by Subject|1|||
164259385|NCT03099174|593318451|FG003|Overall Study|Withdrawal by Subject|0|||
164259386|NCT03099174|593318452|FG004|Overall Study|Withdrawal by Subject|2|||
164259387|NCT03099174|593318453|FG005|Overall Study|Withdrawal by Subject|2|||
164259388|NCT03099174|593318454|FG006|Overall Study|Withdrawal by Subject|1|||
164259389|NCT03099174|593318455|FG007|Overall Study|Withdrawal by Subject|4|||
164259390|NCT03099174|593318448|FG000|Overall Study|Adverse Event|0|||
164259391|NCT03099174|593318449|FG001|Overall Study|Adverse Event|1|||
164259392|NCT03099174|593318450|FG002|Overall Study|Adverse Event|1|||
164259393|NCT03099174|593318451|FG003|Overall Study|Adverse Event|2|||
164259394|NCT03099174|593318452|FG004|Overall Study|Adverse Event|5|||
164429363|NCT00320489|593940975|FG000|Overall Study|Withdrawal by Subject|39|||
164429364|NCT00320489|593940976|FG001|Overall Study|Withdrawal by Subject|41|||
164429365|NCT02282527|593940977|FG000|Overall Study|Lost to Follow-up|0|||
164429366|NCT02282527|593940978|FG001|Overall Study|Lost to Follow-up|1|||
164429367|NCT02282527|593940977|FG000|Overall Study|Lack of home health aid|1|||
164429368|NCT02282527|593940978|FG001|Overall Study|Lack of home health aid|0|||
164429369|NCT00941031|593940979|FG000|Induction Period|Lack of Efficacy|2|||
164429370|NCT00941031|593940980|FG001|Induction Period|Lack of Efficacy|1|||
164429371|NCT00941031|593940981|FG002|Induction Period|Lack of Efficacy|0|||
164429372|NCT00941031|593940982|FG003|Induction Period|Lack of Efficacy|5|||
164429373|NCT00941031|593940983|FG004|Induction Period|Lack of Efficacy|0|||
164429374|NCT00941031|593940984|FG005|Induction Period|Lack of Efficacy|0|||
164429375|NCT00941031|593940985|FG006|Induction Period|Lack of Efficacy|0|||
164429376|NCT00941031|593940979|FG000|Induction Period|Withdrawal by Subject|1|||
164429377|NCT00941031|593940980|FG001|Induction Period|Withdrawal by Subject|2|||
164429378|NCT00941031|593940981|FG002|Induction Period|Withdrawal by Subject|2|||
164429379|NCT00941031|593940982|FG003|Induction Period|Withdrawal by Subject|2|||
164429380|NCT00941031|593940983|FG004|Induction Period|Withdrawal by Subject|0|||
164429381|NCT00941031|593940984|FG005|Induction Period|Withdrawal by Subject|0|||
164429382|NCT00941031|593940985|FG006|Induction Period|Withdrawal by Subject|0|||
164429383|NCT00941031|593940979|FG000|Induction Period|Adminstative Problems|1|||
164429384|NCT00941031|593940980|FG001|Induction Period|Adminstative Problems|1|||
164429385|NCT00941031|593940981|FG002|Induction Period|Adminstative Problems|1|||
164429386|NCT00941031|593940982|FG003|Induction Period|Adminstative Problems|0|||
164429387|NCT00941031|593940983|FG004|Induction Period|Adminstative Problems|0|||
164429388|NCT00941031|593940984|FG005|Induction Period|Adminstative Problems|0|||
164429389|NCT00941031|593940985|FG006|Induction Period|Adminstative Problems|0|||
164429390|NCT00941031|593940979|FG000|Induction Period|Adverse Event|1|||
164259395|NCT03099174|593318453|FG005|Overall Study|Adverse Event|3|||
164259396|NCT03099174|593318454|FG006|Overall Study|Adverse Event|6|||
164429391|NCT00941031|593940980|FG001|Induction Period|Adverse Event|0|||
164259397|NCT03099174|593318455|FG007|Overall Study|Adverse Event|4|||
164429392|NCT00941031|593940981|FG002|Induction Period|Adverse Event|3|||
164259398|NCT03099174|593318448|FG000|Overall Study|Other than listed|6|||
164429393|NCT00941031|593940982|FG003|Induction Period|Adverse Event|2|||
164577091|NCT01416181|594476801|FG000|Part 2|Adverse Event|11|||
164577092|NCT01416181|594476802|FG001|Part 2|Adverse Event|4|||
164577093|NCT01416181|594476801|FG000|Part 2|Other|234|||
164577094|NCT01416181|594476802|FG001|Part 2|Other|267|||
164577095|NCT01416181|594476801|FG000|Part 2|Investigator Decision|6|||
164577096|NCT01416181|594476802|FG001|Part 2|Investigator Decision|7|||
164577097|NCT01416181|594476801|FG000|Part 2|Withdrawal by Subject|14|||
164577098|NCT01416181|594476802|FG001|Part 2|Withdrawal by Subject|5|||
164577099|NCT01416181|594476801|FG000|Part 2|Lack of Efficacy|4|||
164577100|NCT01416181|594476802|FG001|Part 2|Lack of Efficacy|1|||
164577101|NCT01416181|594476801|FG000|Part 2|Lost to Follow-up|2|||
164577102|NCT01416181|594476802|FG001|Part 2|Lost to Follow-up|2|||
164577103|NCT01756157|594476803|FG000|First Intervention Period|Withdrawal by Subject|1|||
164577104|NCT01756157|594476804|FG001|First Intervention Period|Withdrawal by Subject|0|||
164577105|NCT01756157|594476803|FG000|First Intervention Period|Lost to Follow-up|0|||
164577106|NCT01756157|594476804|FG001|First Intervention Period|Lost to Follow-up|2|||
164577107|NCT02799381|594476807|FG000|Overall Study|Withdrew consent|3|||
164577108|NCT02799381|594476808|FG001|Overall Study|Withdrew consent|2|||
164577109|NCT02799381|594476807|FG000|Overall Study|Adverse Event|0|||
164577110|NCT02799381|594476808|FG001|Overall Study|Adverse Event|1|||
164577111|NCT02799381|594476807|FG000|Overall Study|Participant did not take any study drug|1|||
164577112|NCT02799381|594476808|FG001|Overall Study|Participant did not take any study drug|0|||
164577113|NCT02638012|594476811|FG000|Overall Study|Lost to Follow-up|1|||
164429394|NCT00941031|593940983|FG004|Induction Period|Adverse Event|0|||
164429395|NCT00941031|593940984|FG005|Induction Period|Adverse Event|0|||
164429396|NCT00941031|593940985|FG006|Induction Period|Adverse Event|0|||
164429397|NCT00941031|593940979|FG000|Maintenance Period|Withdrawal by Subject|0|||
164429398|NCT00941031|593940980|FG001|Maintenance Period|Withdrawal by Subject|0|||
164429399|NCT00941031|593940981|FG002|Maintenance Period|Withdrawal by Subject|0|||
164429400|NCT00941031|593940982|FG003|Maintenance Period|Withdrawal by Subject|0|||
164429401|NCT00941031|593940983|FG004|Maintenance Period|Withdrawal by Subject|6|||
164429402|NCT00941031|593940984|FG005|Maintenance Period|Withdrawal by Subject|2|||
164429403|NCT00941031|593940985|FG006|Maintenance Period|Withdrawal by Subject|13|||
164429404|NCT00941031|593940979|FG000|Maintenance Period|Administrative Problems|0|||
164429405|NCT00941031|593940980|FG001|Maintenance Period|Administrative Problems|0|||
164429406|NCT00941031|593940981|FG002|Maintenance Period|Administrative Problems|0|||
164429407|NCT00941031|593940982|FG003|Maintenance Period|Administrative Problems|0|||
164429408|NCT00941031|593940983|FG004|Maintenance Period|Administrative Problems|1|||
164429409|NCT00941031|593940984|FG005|Maintenance Period|Administrative Problems|0|||
164429410|NCT00941031|593940985|FG006|Maintenance Period|Administrative Problems|1|||
164429411|NCT00941031|593940979|FG000|Maintenance Period|Protocol Violation|0|||
164429412|NCT00941031|593940980|FG001|Maintenance Period|Protocol Violation|0|||
164429413|NCT00941031|593940981|FG002|Maintenance Period|Protocol Violation|0|||
164429414|NCT00941031|593940982|FG003|Maintenance Period|Protocol Violation|0|||
164429415|NCT00941031|593940983|FG004|Maintenance Period|Protocol Violation|0|||
164429416|NCT00941031|593940984|FG005|Maintenance Period|Protocol Violation|0|||
164429417|NCT00941031|593940985|FG006|Maintenance Period|Protocol Violation|1|||
164429418|NCT00941031|593940979|FG000|Maintenance Period|Adverse Event|0|||
164429419|NCT00941031|593940980|FG001|Maintenance Period|Adverse Event|0|||
164429420|NCT00941031|593940981|FG002|Maintenance Period|Adverse Event|0|||
164429421|NCT00941031|593940982|FG003|Maintenance Period|Adverse Event|0|||
164429422|NCT00941031|593940983|FG004|Maintenance Period|Adverse Event|0|||
164577114|NCT00621023|594476812|FG000|Overall Study|Death|5|||
164577115|NCT00621023|594476812|FG000|Overall Study|Follow up discontinued|1|||
164577116|NCT03816995|594476815|FG000|Overall Study|Withdrawal by Subject|3|||
164577117|NCT03816995|594476816|FG001|Overall Study|Withdrawal by Subject|1|||
164577118|NCT03816995|594476815|FG000|Overall Study|Cancelled Surgery|8|||
164577119|NCT03816995|594476816|FG001|Overall Study|Cancelled Surgery|12|||
164577120|NCT03816995|594476815|FG000|Overall Study|No wound protector used|11|||
164429423|NCT00941031|593940984|FG005|Maintenance Period|Adverse Event|2|||
164429424|NCT00941031|593940985|FG006|Maintenance Period|Adverse Event|8|||
164429425|NCT00941031|593940979|FG000|Maintenance Period|Lost to Follow-up|0|||
164429426|NCT00941031|593940980|FG001|Maintenance Period|Lost to Follow-up|0|||
164429427|NCT00941031|593940981|FG002|Maintenance Period|Lost to Follow-up|0|||
164429428|NCT00941031|593940982|FG003|Maintenance Period|Lost to Follow-up|0|||
164429429|NCT00941031|593940983|FG004|Maintenance Period|Lost to Follow-up|2|||
164429430|NCT00941031|593940984|FG005|Maintenance Period|Lost to Follow-up|2|||
164429431|NCT00941031|593940985|FG006|Maintenance Period|Lost to Follow-up|7|||
164577121|NCT03816995|594476816|FG001|Overall Study|No wound protector used|17|||
164577122|NCT03816995|594476815|FG000|Overall Study|Protocol Violation|2|||
164577123|NCT03816995|594476816|FG001|Overall Study|Protocol Violation|3|||
164577124|NCT00486902|594476817|FG000|Overall Study|Withdrawal by Subject|1|||
164577125|NCT00486902|594476818|FG001|Overall Study|Withdrawal by Subject|2|||
164577126|NCT00486902|594476817|FG000|Overall Study|decision for postpartum tubal ligation|3|||
164577127|NCT00486902|594476818|FG001|Overall Study|decision for postpartum tubal ligation|1|||
164577128|NCT00486902|594476817|FG000|Overall Study|spinal anesthetic protocal violation|1|||
164577129|NCT00486902|594476818|FG001|Overall Study|spinal anesthetic protocal violation|1|||
164577130|NCT00486902|594476817|FG000|Overall Study|Did not meet inclusion criteria|1|||
164577131|NCT00486902|594476818|FG001|Overall Study|Did not meet inclusion criteria|0|||
164259399|NCT03099174|593318449|FG001|Overall Study|Other than listed|6|||
164259400|NCT03099174|593318450|FG002|Overall Study|Other than listed|5|||
164259401|NCT03099174|593318451|FG003|Overall Study|Other than listed|6|||
164259402|NCT03099174|593318452|FG004|Overall Study|Other than listed|19|||
164577132|NCT00486902|594476817|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
164259403|NCT03099174|593318453|FG005|Overall Study|Other than listed|10|||
164259404|NCT03099174|593318454|FG006|Overall Study|Other than listed|26|||
164259405|NCT03099174|593318455|FG007|Overall Study|Other than listed|23|||
164259406|NCT02378298|593318457|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
164259407|NCT02378298|593318458|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
164259408|NCT02378298|593318459|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
164259409|NCT02378298|593318457|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
164259410|NCT02378298|593318458|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
164259411|NCT02378298|593318459|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
164259412|NCT02378298|593318457|FG000|Surveillance (19-68 Weeks)|Death|1|||
164259413|NCT02378298|593318458|FG001|Surveillance (19-68 Weeks)|Death|0|||
164259414|NCT02378298|593318459|FG002|Surveillance (19-68 Weeks)|Death|0|||
164259415|NCT04173260|593318460|FG000|Overall Study|Early termination|4|||
164259416|NCT04730635|593318461|FG000|Overall Study|Lost to Follow-up|1|||
164259417|NCT04730635|593318462|FG001|Overall Study|Lost to Follow-up|0|||
164259418|NCT04730635|593318461|FG000|Overall Study|Withdrawal by Subject|0|||
164259419|NCT04730635|593318462|FG001|Overall Study|Withdrawal by Subject|1|||
164259420|NCT03070223|593318465|FG000|Overall Study|Lost to Follow-up|34|||
164259421|NCT03070223|593318466|FG001|Overall Study|Lost to Follow-up|27|||
164259422|NCT03070223|593318465|FG000|Overall Study|Withdrawal by Subject|12|||
164259423|NCT03070223|593318466|FG001|Overall Study|Withdrawal by Subject|22|||
164259424|NCT03070223|593318465|FG000|Overall Study|Protocol Violation|0|||
164259425|NCT03070223|593318466|FG001|Overall Study|Protocol Violation|1|||
164259426|NCT03006458|593318472|FG000|First Intervention|Unsatisfied Vision|0|||
164259427|NCT03006458|593318473|FG001|First Intervention|Unsatisfied Vision|3|||
164259428|NCT03219034|593318474|FG000|Overall Study|Lost to Follow-up|9|||
164259429|NCT03219034|593318475|FG001|Overall Study|Lost to Follow-up|13|||
164259430|NCT03219034|593318474|FG000|Overall Study|Additional dental work needed|1|||
164259431|NCT03219034|593318475|FG001|Overall Study|Additional dental work needed|0|||
164259432|NCT03219034|593318474|FG000|Overall Study|UPPP Surgery|1|||
164259433|NCT03219034|593318475|FG001|Overall Study|UPPP Surgery|0|||
164259434|NCT03219034|593318474|FG000|Overall Study|Dental sensitivity|0|||
164259435|NCT03219034|593318475|FG001|Overall Study|Dental sensitivity|1|||
164259436|NCT03219034|593318474|FG000|Overall Study|Death in family|0|||
164259437|NCT03219034|593318475|FG001|Overall Study|Death in family|1|||
164259438|NCT00118846|593318476|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
164259439|NCT00118846|593318477|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
164259440|NCT00118846|593318476|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
164259441|NCT00118846|593318477|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
164259442|NCT00118846|593318476|FG000|Overall Study|Physician Decision|1|||
164259443|NCT00118846|593318477|FG001|Overall Study|Physician Decision|0|||
164259444|NCT00118846|593318476|FG000|Overall Study|Medical condition|2|||
164259445|NCT00118846|593318477|FG001|Overall Study|Medical condition|2|||
164259446|NCT00118846|593318476|FG000|Overall Study|Lost to Follow-up|0|||
164259447|NCT00118846|593318477|FG001|Overall Study|Lost to Follow-up|2|||
164340381|NCT04154930|593620588|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
164340382|NCT04154930|593620589|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
164577133|NCT00486902|594476818|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
164259448|NCT00118846|593318476|FG000|Overall Study|Personal reason|4|||
164259449|NCT00118846|593318477|FG001|Overall Study|Personal reason|5|||
164259450|NCT01468233|593318479|FG000|Treatment Period 1|Adverse Event|5|||
164577134|NCT04331899|594476819|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
164577135|NCT04331899|594476820|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
164577136|NCT01062399|594476821|FG000|Overall Study|Protocol Violation|0|||
164577137|NCT01062399|594476822|FG001|Overall Study|Protocol Violation|1|||
164577138|NCT01062399|594476823|FG002|Overall Study|Protocol Violation|0|||
164577139|NCT01062399|594476824|FG003|Overall Study|Protocol Violation|6|||
164577140|NCT01062399|594476825|FG004|Overall Study|Protocol Violation|4|||
164577141|NCT00942409|594476826|FG000|Overall Study|Lack of Efficacy|1|||
164259451|NCT01468233|593318480|FG001|Treatment Period 1|Adverse Event|3|||
164259452|NCT01468233|593318481|FG002|Treatment Period 1|Adverse Event|0|||
164259453|NCT01468233|593318482|FG003|Treatment Period 1|Adverse Event|0|||
164259454|NCT01468233|593318483|FG004|Treatment Period 1|Adverse Event|0|||
164259455|NCT01468233|593318484|FG005|Treatment Period 1|Adverse Event|0|||
164259456|NCT01468233|593318479|FG000|Treatment Period 1|Withdrawal by Subject|3|||
164577142|NCT00942409|594476826|FG000|Overall Study|study drug unavailable|2|||
164340383|NCT04154930|593620588|FG000|Overall Study|Lost to Follow-up|14|||
164259457|NCT01468233|593318480|FG001|Treatment Period 1|Withdrawal by Subject|4|||
164259458|NCT01468233|593318481|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164259459|NCT01468233|593318482|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164259460|NCT01468233|593318483|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164259461|NCT01468233|593318484|FG005|Treatment Period 1|Withdrawal by Subject|0|||
164259462|NCT01468233|593318479|FG000|Treatment Period 1|Lost to Follow-up|3|||
164259463|NCT01468233|593318480|FG001|Treatment Period 1|Lost to Follow-up|0|||
164259464|NCT01468233|593318481|FG002|Treatment Period 1|Lost to Follow-up|0|||
164259465|NCT01468233|593318482|FG003|Treatment Period 1|Lost to Follow-up|0|||
164259466|NCT01468233|593318483|FG004|Treatment Period 1|Lost to Follow-up|0|||
164259467|NCT01468233|593318484|FG005|Treatment Period 1|Lost to Follow-up|0|||
164259468|NCT01468233|593318479|FG000|Treatment Period 1|Other|1|||
164259469|NCT01468233|593318480|FG001|Treatment Period 1|Other|1|||
164259470|NCT01468233|593318481|FG002|Treatment Period 1|Other|0|||
164259471|NCT01468233|593318482|FG003|Treatment Period 1|Other|0|||
164259472|NCT01468233|593318483|FG004|Treatment Period 1|Other|0|||
164259473|NCT01468233|593318484|FG005|Treatment Period 1|Other|0|||
164259474|NCT01468233|593318479|FG000|Treatment Period 2|Adverse Event|0|||
164259475|NCT01468233|593318480|FG001|Treatment Period 2|Adverse Event|0|||
164259476|NCT01468233|593318481|FG002|Treatment Period 2|Adverse Event|3|||
164259477|NCT01468233|593318482|FG003|Treatment Period 2|Adverse Event|0|||
164259478|NCT01468233|593318483|FG004|Treatment Period 2|Adverse Event|2|||
164259479|NCT01468233|593318484|FG005|Treatment Period 2|Adverse Event|1|||
164259480|NCT01468233|593318479|FG000|Treatment Period 2|Lack of Efficacy|0|||
164259481|NCT01468233|593318480|FG001|Treatment Period 2|Lack of Efficacy|0|||
164259482|NCT01468233|593318481|FG002|Treatment Period 2|Lack of Efficacy|9|||
164259483|NCT01468233|593318482|FG003|Treatment Period 2|Lack of Efficacy|2|||
164259484|NCT01468233|593318483|FG004|Treatment Period 2|Lack of Efficacy|0|||
164259485|NCT01468233|593318484|FG005|Treatment Period 2|Lack of Efficacy|1|||
164259486|NCT01468233|593318479|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164259487|NCT01468233|593318480|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164259488|NCT01468233|593318481|FG002|Treatment Period 2|Withdrawal by Subject|9|||
164259489|NCT01468233|593318482|FG003|Treatment Period 2|Withdrawal by Subject|1|||
164259490|NCT01468233|593318483|FG004|Treatment Period 2|Withdrawal by Subject|1|||
164259491|NCT01468233|593318484|FG005|Treatment Period 2|Withdrawal by Subject|1|||
164259492|NCT01468233|593318479|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
164259493|NCT01468233|593318480|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
164259494|NCT01468233|593318481|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
164259495|NCT01468233|593318482|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
164259496|NCT01468233|593318483|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
164259497|NCT01468233|593318484|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
164259498|NCT01468233|593318479|FG000|Treatment Period 2|Lost to Follow-up|0|||
164259499|NCT01468233|593318480|FG001|Treatment Period 2|Lost to Follow-up|0|||
164259500|NCT01468233|593318481|FG002|Treatment Period 2|Lost to Follow-up|3|||
164259501|NCT01468233|593318482|FG003|Treatment Period 2|Lost to Follow-up|0|||
164259502|NCT01468233|593318483|FG004|Treatment Period 2|Lost to Follow-up|2|||
164259503|NCT01468233|593318484|FG005|Treatment Period 2|Lost to Follow-up|0|||
164259504|NCT01468233|593318479|FG000|Treatment Period 2|Other|0|||
164259505|NCT01468233|593318480|FG001|Treatment Period 2|Other|0|||
164259506|NCT01468233|593318481|FG002|Treatment Period 2|Other|3|||
164259507|NCT01468233|593318482|FG003|Treatment Period 2|Other|0|||
164259508|NCT01468233|593318483|FG004|Treatment Period 2|Other|1|||
164259509|NCT01468233|593318484|FG005|Treatment Period 2|Other|0|||
164259510|NCT01574157|593318488|FG000|Overall Study|Withdrawal by Subject|4|||
164259511|NCT01574157|593318489|FG001|Overall Study|Withdrawal by Subject|5|||
164259512|NCT01574157|593318488|FG000|Overall Study|Lost to Follow-up|0|||
164259513|NCT01574157|593318489|FG001|Overall Study|Lost to Follow-up|3|||
164259514|NCT00578877|593318490|FG000|Overall Study|Lost to Follow-up|8|||
164259515|NCT00578877|593318491|FG001|Overall Study|Lost to Follow-up|10|||
164259516|NCT00578877|593318490|FG000|Overall Study|early discontinue|61|||
164259517|NCT00578877|593318491|FG001|Overall Study|early discontinue|101|||
164259518|NCT00578877|593318490|FG000|Overall Study|did not provide follow-up data|12|||
164259519|NCT00578877|593318491|FG001|Overall Study|did not provide follow-up data|17|||
164259520|NCT01202188|593318493|FG000|Overall Study|Protocol deviation|14|||
164259521|NCT01202188|593318494|FG001|Overall Study|Protocol deviation|8|||
164259522|NCT01202188|593318495|FG002|Overall Study|Protocol deviation|12|||
164259523|NCT01202188|593318496|FG003|Overall Study|Protocol deviation|10|||
164259524|NCT01202188|593318497|FG004|Overall Study|Protocol deviation|11|||
164259525|NCT01202188|593318493|FG000|Overall Study|Subject withdrew consent|12|||
164259526|NCT01202188|593318494|FG001|Overall Study|Subject withdrew consent|13|||
164259527|NCT01202188|593318495|FG002|Overall Study|Subject withdrew consent|22|||
164429432|NCT00941031|593940979|FG000|Maintenance Period|Lack of Efficacy|0|||
164259528|NCT01202188|593318496|FG003|Overall Study|Subject withdrew consent|11|||
164259529|NCT01202188|593318497|FG004|Overall Study|Subject withdrew consent|13|||
164259530|NCT01202188|593318493|FG000|Overall Study|Adverse Event|5|||
164259531|NCT01202188|593318494|FG001|Overall Study|Adverse Event|23|||
164259532|NCT01202188|593318495|FG002|Overall Study|Adverse Event|13|||
164429433|NCT00941031|593940980|FG001|Maintenance Period|Lack of Efficacy|0|||
164429434|NCT00941031|593940981|FG002|Maintenance Period|Lack of Efficacy|0|||
164429435|NCT00941031|593940982|FG003|Maintenance Period|Lack of Efficacy|0|||
164429436|NCT00941031|593940983|FG004|Maintenance Period|Lack of Efficacy|0|||
164429437|NCT00941031|593940984|FG005|Maintenance Period|Lack of Efficacy|0|||
164429438|NCT00941031|593940985|FG006|Maintenance Period|Lack of Efficacy|13|||
164429439|NCT01872611|593940986|FG000|Overall Study|Adverse Event|3|||
164429440|NCT01872611|593940987|FG001|Overall Study|Adverse Event|1|||
164429441|NCT01872611|593940986|FG000|Overall Study|Adverse Event, prior to treatment|0|||
164429442|NCT01872611|593940987|FG001|Overall Study|Adverse Event, prior to treatment|1|||
164429443|NCT01872611|593940986|FG000|Overall Study|Death|0|||
164429444|NCT01872611|593940987|FG001|Overall Study|Death|1|||
164429445|NCT01872611|593940986|FG000|Overall Study|Death, prior to treatment|0|||
164429446|NCT01872611|593940987|FG001|Overall Study|Death, prior to treatment|1|||
164429447|NCT01872611|593940986|FG000|Overall Study|Lost to Follow-up|8|||
164429448|NCT01872611|593940987|FG001|Overall Study|Lost to Follow-up|1|||
164429449|NCT01872611|593940986|FG000|Overall Study|Physician Decision|1|||
164429450|NCT01872611|593940987|FG001|Overall Study|Physician Decision|0|||
164429451|NCT01872611|593940986|FG000|Overall Study|Withdrawal by Subject|6|||
164259533|NCT01202188|593318496|FG003|Overall Study|Adverse Event|10|||
164259534|NCT01202188|593318497|FG004|Overall Study|Adverse Event|10|||
164259535|NCT01202188|593318493|FG000|Overall Study|Administrative problems|3|||
164259536|NCT01202188|593318494|FG001|Overall Study|Administrative problems|2|||
164259537|NCT01202188|593318495|FG002|Overall Study|Administrative problems|1|||
164259538|NCT01202188|593318496|FG003|Overall Study|Administrative problems|1|||
164259539|NCT01202188|593318497|FG004|Overall Study|Administrative problems|2|||
164259540|NCT01202188|593318493|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164259541|NCT01202188|593318494|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
164259542|NCT01202188|593318495|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
164259543|NCT01202188|593318496|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
164259544|NCT01202188|593318497|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
164259545|NCT01202188|593318493|FG000|Overall Study|Lost to Follow-up|1|||
164259546|NCT01202188|593318494|FG001|Overall Study|Lost to Follow-up|1|||
164259547|NCT01202188|593318495|FG002|Overall Study|Lost to Follow-up|0|||
164259548|NCT01202188|593318496|FG003|Overall Study|Lost to Follow-up|4|||
164259549|NCT01202188|593318497|FG004|Overall Study|Lost to Follow-up|1|||
164259550|NCT01202188|593318493|FG000|Overall Study|Death|1|||
164259551|NCT01202188|593318494|FG001|Overall Study|Death|1|||
164259552|NCT01202188|593318495|FG002|Overall Study|Death|1|||
164259553|NCT01202188|593318496|FG003|Overall Study|Death|1|||
164259554|NCT01202188|593318497|FG004|Overall Study|Death|0|||
164259555|NCT01202188|593318493|FG000|Overall Study|Abnormal test procedure result (s)|0|||
164259556|NCT01202188|593318494|FG001|Overall Study|Abnormal test procedure result (s)|0|||
164259557|NCT01202188|593318495|FG002|Overall Study|Abnormal test procedure result (s)|2|||
164259558|NCT01202188|593318496|FG003|Overall Study|Abnormal test procedure result (s)|0|||
164259559|NCT01202188|593318497|FG004|Overall Study|Abnormal test procedure result (s)|0|||
164259560|NCT01632241|593318498|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
164259561|NCT01632241|593318499|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
164259562|NCT01632241|593318498|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
164259563|NCT01632241|593318499|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
164259564|NCT01632241|593318498|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
164259565|NCT01632241|593318499|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
164259566|NCT01632241|593318498|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
164259567|NCT01632241|593318499|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
164259568|NCT01632241|593318498|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
164259569|NCT01632241|593318499|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
164259570|NCT01632241|593318498|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
164429452|NCT01872611|593940987|FG001|Overall Study|Withdrawal by Subject|1|||
164429453|NCT01872611|593940986|FG000|Overall Study|Reason not provided|6|||
164429454|NCT01872611|593940987|FG001|Overall Study|Reason not provided|6|||
164429455|NCT04555044|593940988|FG000|Overall Study|Adverse Event|0|||
164429456|NCT04555044|593940989|FG001|Overall Study|Adverse Event|1|||
164429457|NCT04088188|593940991|FG000|Overall Study|Withdrawal by Subject|2|||
164259571|NCT01632241|593318499|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
164259572|NCT01632241|593318498|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
164429458|NCT04088188|593940992|FG001|Overall Study|Withdrawal by Subject|0|||
164429459|NCT04088188|593940991|FG000|Overall Study|Adverse Event|2|||
164429460|NCT04088188|593940992|FG001|Overall Study|Adverse Event|0|||
164429461|NCT03686384|593940993|FG000|Overall Study|Lack of Efficacy|4|||
164429462|NCT03686384|593940994|FG001|Overall Study|Lack of Efficacy|13|||
164259573|NCT01632241|593318499|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
164259574|NCT01632241|593318498|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
164259575|NCT01632241|593318499|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
164259576|NCT01632241|593318498|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
164259577|NCT01632241|593318499|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
164429463|NCT03686384|593940993|FG000|Overall Study|Lost to Follow-up|3|||
164429464|NCT03686384|593940994|FG001|Overall Study|Lost to Follow-up|0|||
164429465|NCT03686384|593940993|FG000|Overall Study|Physician Decision|0|||
164429466|NCT03686384|593940994|FG001|Overall Study|Physician Decision|1|||
164429467|NCT03686384|593940993|FG000|Overall Study|Took prohibited medication|0|||
164429468|NCT03686384|593940994|FG001|Overall Study|Took prohibited medication|1|||
164429469|NCT01767909|593940995|FG000|Overall Study|Withdrawal by Subject|4|||
164429470|NCT01767909|593940996|FG001|Overall Study|Withdrawal by Subject|7|||
164429471|NCT01767909|593940995|FG000|Overall Study|Adverse Event|3|||
164429472|NCT01767909|593940996|FG001|Overall Study|Adverse Event|1|||
164429473|NCT01767909|593940995|FG000|Overall Study|Withdrawal by Study Partner|3|||
164429474|NCT01767909|593940996|FG001|Overall Study|Withdrawal by Study Partner|1|||
164429475|NCT01767909|593940995|FG000|Overall Study|Non-Compliance|2|||
164429476|NCT01767909|593940996|FG001|Overall Study|Non-Compliance|0|||
164429477|NCT01767909|593940995|FG000|Overall Study|Perceived Lack of Efficacy|1|||
164429478|NCT01767909|593940996|FG001|Overall Study|Perceived Lack of Efficacy|0|||
164429479|NCT01767909|593940995|FG000|Overall Study|Investigator Recommendation|0|||
164429480|NCT01767909|593940996|FG001|Overall Study|Investigator Recommendation|1|||
164429481|NCT01767909|593940995|FG000|Overall Study|Lost to Follow-up|0|||
164259578|NCT01632241|593318498|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
164259579|NCT01632241|593318499|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
164259580|NCT01632241|593318498|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
164259581|NCT01632241|593318499|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
164259582|NCT01632241|593318498|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
164259583|NCT01632241|593318499|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
164259584|NCT01632241|593318498|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
164259585|NCT01632241|593318499|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
164259586|NCT01632241|593318498|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
164429482|NCT01767909|593940996|FG001|Overall Study|Lost to Follow-up|1|||
164429483|NCT01767909|593940995|FG000|Overall Study|LP uncessessful|0|||
164429484|NCT01767909|593940996|FG001|Overall Study|LP uncessessful|1|||
164429485|NCT01740557|593940999|FG000|Overall Study|Ineligible|1|||
164429486|NCT01740557|593940999|FG000|Overall Study|Screen failure|1|||
164429487|NCT02320253|593941000|FG000|Overall Study|Withdrawal by Subject|3|||
164429488|NCT02320253|593941001|FG001|Overall Study|Withdrawal by Subject|0|||
164429489|NCT02320253|593941002|FG002|Overall Study|Withdrawal by Subject|0|||
164429490|NCT02320253|593941000|FG000|Overall Study|Lost to Follow-up|2|||
164429491|NCT02320253|593941001|FG001|Overall Study|Lost to Follow-up|2|||
164429492|NCT02320253|593941002|FG002|Overall Study|Lost to Follow-up|1|||
164429493|NCT02320253|593941000|FG000|Overall Study|Death|1|||
164429494|NCT02320253|593941001|FG001|Overall Study|Death|0|||
164429495|NCT02320253|593941002|FG002|Overall Study|Death|1|||
164429496|NCT01737268|593941007|FG000|Overall Study|Adverse Event|6|||
164429497|NCT01737268|593941007|FG000|Overall Study|Worsening of Target Disease|2|||
164429498|NCT01737268|593941007|FG000|Overall Study|In consideration of the patient's safety|1|||
164429499|NCT04873817|593941008|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
164429500|NCT04873817|593941008|FG000|Overall Study|Lost to Follow-up|4|||
164429501|NCT04873817|593941008|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
164429502|NCT04873817|593941008|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
164429503|NCT04873817|593941008|FG000|Overall Study|Other Reasons|3|||
164259587|NCT01632241|593318499|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
164259588|NCT01846299|593318508|FG000|Overall Study|Physician Decision|4|||
164259589|NCT01846299|593318509|FG001|Overall Study|Physician Decision|2|||
164429504|NCT02696226|593941016|FG000|Overall Study|Study terminated - lack of enrollment|1|||
164259590|NCT01846299|593318508|FG000|Overall Study|Protocol deviation|1|||
164259591|NCT01846299|593318509|FG001|Overall Study|Protocol deviation|0|||
164259592|NCT01846299|593318508|FG000|Overall Study|Death|1|||
164259593|NCT01846299|593318509|FG001|Overall Study|Death|2|||
164259594|NCT01846299|593318508|FG000|Overall Study|Lost to Follow-up|3|||
164259595|NCT01846299|593318509|FG001|Overall Study|Lost to Follow-up|0|||
164259596|NCT01846299|593318508|FG000|Overall Study|Withdrawal by Subject|1|||
164429505|NCT02696226|593941017|FG001|Overall Study|Study terminated - lack of enrollment|0|||
164429506|NCT02696226|593941018|FG002|Overall Study|Study terminated - lack of enrollment|2|||
164429507|NCT02696226|593941019|FG003|Overall Study|Study terminated - lack of enrollment|0|||
164429508|NCT02909101|593941020|FG000|Overall Study|Lost to Follow-up|1|||
164429509|NCT02909101|593941021|FG001|Overall Study|Lost to Follow-up|1|||
164577143|NCT03941548|594476828|FG000|Overall Study|Adverse Event|0|||
164577144|NCT03941548|594476829|FG001|Overall Study|Adverse Event|1|||
164259597|NCT01846299|593318509|FG001|Overall Study|Withdrawal by Subject|6|||
164259598|NCT01846299|593318508|FG000|Overall Study|Adverse Event|2|||
164259599|NCT01846299|593318509|FG001|Overall Study|Adverse Event|0|||
164259600|NCT03559517|593318510|FG000|Overall Study|Withdrawal by Subject|1|||
164259601|NCT03559517|593318511|FG001|Overall Study|Withdrawal by Subject|0|||
164429510|NCT00097370|593941022|FG000|Stage 1|Adverse Event|3|||
164429511|NCT00097370|593941022|FG000|Stage 1|Withdrawal by Subject|1|||
164429512|NCT00097370|593941022|FG000|Stage 1|Lack of Efficacy|2|||
164429513|NCT00097370|593941022|FG000|Stage 2|Adverse Event|5|||
164429514|NCT00097370|593941022|FG000|Stage 2|Withdrawal by Subject|1|||
164429515|NCT00097370|593941022|FG000|Stage 2|Lack of Efficacy|3|||
164429516|NCT00097370|593941022|FG000|Stage 2|Pregnancy|1|||
164429517|NCT00097370|593941022|FG000|Stage 2|Sponsor Terminated Study|2|||
164429518|NCT00097370|593941022|FG000|Stage 2|Lost to Follow-up|1|||
164429519|NCT00097370|593941022|FG000|Stage 3|Adverse Event|2|||
164577145|NCT03941548|594476828|FG000|Overall Study|Lost to Follow-up|0|||
164577146|NCT03941548|594476829|FG001|Overall Study|Lost to Follow-up|1|||
164577147|NCT03941548|594476828|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
164259602|NCT03559517|593318512|FG002|Overall Study|Withdrawal by Subject|0|||
164259603|NCT01330628|593318513|FG000|Overall Study|Death|2|||
164259604|NCT01330628|593318514|FG001|Overall Study|Death|3|||
164259605|NCT01330628|593318513|FG000|Overall Study|Lost to Follow-up|5|||
164259606|NCT01330628|593318514|FG001|Overall Study|Lost to Follow-up|6|||
164259607|NCT01330628|593318513|FG000|Overall Study|Adverse Event|44|||
164259608|NCT01330628|593318514|FG001|Overall Study|Adverse Event|25|||
164259609|NCT01330628|593318513|FG000|Overall Study|Withdrawn|18|||
164259610|NCT01330628|593318514|FG001|Overall Study|Withdrawn|6|||
164259611|NCT01330628|593318513|FG000|Overall Study|Didn't receive study treatment|1|||
164259612|NCT01330628|593318514|FG001|Overall Study|Didn't receive study treatment|0|||
164259613|NCT03761394|593318515|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
164340384|NCT04154930|593620589|FG001|Overall Study|Lost to Follow-up|6|||
164340385|NCT04154930|593620588|FG000|Overall Study|Other|6|||
164340386|NCT04154930|593620589|FG001|Overall Study|Other|0|||
164340387|NCT00657358|593620590|FG000|Overall Study|Lack of Efficacy|6|||
164340388|NCT00400764|593620594|FG000|Phase Ib|Adverse Event|1|||
164340389|NCT00400764|593620595|FG001|Phase Ib|Adverse Event|0|||
164340390|NCT00400764|593620596|FG002|Phase Ib|Adverse Event|0|||
164340391|NCT00400764|593620597|FG003|Phase Ib|Adverse Event|0|||
164340392|NCT00400764|593620598|FG004|Phase Ib|Adverse Event|0|||
164340393|NCT00400764|593620594|FG000|Phase Ib|Death|1|||
164340394|NCT00400764|593620595|FG001|Phase Ib|Death|0|||
164340395|NCT00400764|593620596|FG002|Phase Ib|Death|0|||
164340396|NCT00400764|593620597|FG003|Phase Ib|Death|0|||
164340397|NCT00400764|593620598|FG004|Phase Ib|Death|0|||
164340398|NCT00400764|593620594|FG000|Phase Ib|Disease Progression|4|||
164340399|NCT00400764|593620595|FG001|Phase Ib|Disease Progression|4|||
164340400|NCT00400764|593620596|FG002|Phase Ib|Disease Progression|0|||
164340401|NCT00400764|593620597|FG003|Phase Ib|Disease Progression|0|||
164340402|NCT00400764|593620598|FG004|Phase Ib|Disease Progression|0|||
164340403|NCT00400764|593620594|FG000|Phase II|Death|0|||
164340404|NCT00400764|593620595|FG001|Phase II|Death|0|||
164340405|NCT00400764|593620596|FG002|Phase II|Death|1|||
164340406|NCT00400764|593620597|FG003|Phase II|Death|2|||
164340407|NCT00400764|593620598|FG004|Phase II|Death|0|||
164340408|NCT00400764|593620594|FG000|Phase II|Lost to Follow-up|0|||
164340409|NCT00400764|593620595|FG001|Phase II|Lost to Follow-up|0|||
164340410|NCT00400764|593620596|FG002|Phase II|Lost to Follow-up|1|||
164340411|NCT00400764|593620597|FG003|Phase II|Lost to Follow-up|0|||
164340412|NCT00400764|593620598|FG004|Phase II|Lost to Follow-up|0|||
164340413|NCT00400764|593620594|FG000|Phase II|Physician Decision|0|||
164340414|NCT00400764|593620595|FG001|Phase II|Physician Decision|0|||
164340415|NCT00400764|593620596|FG002|Phase II|Physician Decision|1|||
164340416|NCT00400764|593620597|FG003|Phase II|Physician Decision|1|||
164340417|NCT00400764|593620598|FG004|Phase II|Physician Decision|0|||
164340418|NCT00400764|593620594|FG000|Phase II|Sponsor's decision to terminate|0|||
164340419|NCT00400764|593620595|FG001|Phase II|Sponsor's decision to terminate|0|||
164340420|NCT00400764|593620596|FG002|Phase II|Sponsor's decision to terminate|18|||
164340421|NCT00400764|593620597|FG003|Phase II|Sponsor's decision to terminate|22|||
164340422|NCT00400764|593620598|FG004|Phase II|Sponsor's decision to terminate|11|||
164340423|NCT00400764|593620594|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
164340424|NCT00400764|593620595|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
164340425|NCT00400764|593620596|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
164340426|NCT00400764|593620597|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
164340427|NCT00400764|593620598|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
164340428|NCT00400764|593620594|FG000|Phase II|Withdrawal by Subject|0|||
164340429|NCT00400764|593620595|FG001|Phase II|Withdrawal by Subject|0|||
164340430|NCT00400764|593620596|FG002|Phase II|Withdrawal by Subject|1|||
164340431|NCT00400764|593620597|FG003|Phase II|Withdrawal by Subject|1|||
164340432|NCT00400764|593620598|FG004|Phase II|Withdrawal by Subject|0|||
164340433|NCT01449539|593620603|FG000|Overall Study|Withdrawal by Subject|3|||
164340434|NCT01449539|593620603|FG000|Overall Study|Toxicity not study related|1|||
164340435|NCT03113071|593620604|FG000|Overall Study|Withdrawal by Subject|1|||
164340436|NCT03113071|593620605|FG001|Overall Study|Withdrawal by Subject|0|||
164340437|NCT02369016|593620608|FG000|Overall Study|AE associated with clinical disease progression|2|||
164429520|NCT00097370|593941022|FG000|Stage 3|Withdrawal by Subject|3|||
164259614|NCT03761394|593318516|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
164340438|NCT02369016|593620609|FG001|Overall Study|AE associated with clinical disease progression|1|||
164429521|NCT00097370|593941022|FG000|Stage 3|Lack of Efficacy|1|||
164259615|NCT03761394|593318517|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
164259616|NCT03761394|593318518|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
164259617|NCT03761394|593318515|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
164259618|NCT03761394|593318516|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
164259619|NCT03761394|593318517|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
164259620|NCT03761394|593318518|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
164259621|NCT03761394|593318515|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
164259622|NCT03761394|593318516|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
164259623|NCT03761394|593318517|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
164259624|NCT03761394|593318518|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
164259625|NCT03761394|593318515|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
164259626|NCT03761394|593318516|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
164259627|NCT03761394|593318517|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
164259628|NCT03761394|593318518|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
164259629|NCT01080768|593318528|FG000|Overall Study|Protocol Deviation|2|||
164259630|NCT01080768|593318529|FG001|Overall Study|Protocol Deviation|1|||
164259631|NCT00580034|593318540|FG000|Overall Study|Toxicity|10|||
164259632|NCT00580034|593318541|FG001|Overall Study|Toxicity|0|||
164259633|NCT01939002|593318542|FG000|Overall Study|Adverse Event|13|||
164259634|NCT01939002|593318543|FG001|Overall Study|Adverse Event|13|||
164259635|NCT01939002|593318542|FG000|Overall Study|Withdrawal by Subject|5|||
164259636|NCT01939002|593318543|FG001|Overall Study|Withdrawal by Subject|3|||
164259637|NCT01939002|593318542|FG000|Overall Study|Other|1|||
164259638|NCT01939002|593318543|FG001|Overall Study|Other|2|||
164259639|NCT00098748|593318547|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
164259640|NCT00098748|593318548|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
164259641|NCT00098748|593318549|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
164259642|NCT00098748|593318547|FG000|Received Study Treatment|Death|2|||
164259643|NCT00098748|593318548|FG001|Received Study Treatment|Death|1|||
164259644|NCT00098748|593318549|FG002|Received Study Treatment|Death|2|||
164259645|NCT00098748|593318547|FG000|Received Study Treatment|Adverse Event|1|||
164259646|NCT00098748|593318548|FG001|Received Study Treatment|Adverse Event|2|||
164259647|NCT00098748|593318549|FG002|Received Study Treatment|Adverse Event|5|||
164259648|NCT00098748|593318547|FG000|Received Study Treatment|Lack of Efficacy|40|||
164259649|NCT00098748|593318548|FG001|Received Study Treatment|Lack of Efficacy|27|||
164259650|NCT00098748|593318549|FG002|Received Study Treatment|Lack of Efficacy|27|||
164259651|NCT00098748|593318547|FG000|Received Study Treatment|Other|2|||
164259652|NCT00098748|593318548|FG001|Received Study Treatment|Other|2|||
164259653|NCT00098748|593318549|FG002|Received Study Treatment|Other|6|||
164259654|NCT00098748|593318547|FG000|Received Study Treatment|Subject defaulted|3|||
164259655|NCT00098748|593318548|FG001|Received Study Treatment|Subject defaulted|4|||
164259656|NCT00098748|593318549|FG002|Received Study Treatment|Subject defaulted|4|||
164259657|NCT00098748|593318547|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
164259658|NCT00098748|593318548|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
164259659|NCT00098748|593318549|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
164259660|NCT00098748|593318547|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
164259661|NCT00098748|593318548|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
164259662|NCT00098748|593318549|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
164259663|NCT00098748|593318547|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
164259664|NCT00098748|593318548|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
164259665|NCT00098748|593318549|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
164259666|NCT00098748|593318547|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
164259667|NCT00098748|593318548|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
164259668|NCT00098748|593318549|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
164259669|NCT00098748|593318547|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
164259670|NCT00098748|593318548|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
164259671|NCT00098748|593318549|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
164259672|NCT03095027|593320199|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
164259673|NCT03095027|593320200|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
164259674|NCT02982018|593320201|FG000|Overall Study|Incorrect Lens Dispensed|1|||
164259675|NCT02982018|593320202|FG001|Overall Study|Incorrect Lens Dispensed|0|||
164259676|NCT02982018|593320201|FG000|Overall Study|Protocol Violation|1|||
164259677|NCT02982018|593320202|FG001|Overall Study|Protocol Violation|1|||
164259678|NCT02982018|593320201|FG000|Overall Study|Adverse Event|1|||
164259679|NCT02982018|593320202|FG001|Overall Study|Adverse Event|1|||
164340439|NCT02369016|593620608|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
164340440|NCT02369016|593620609|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
164340441|NCT02369016|593620608|FG000|Overall Study|Progressive disease - clinical progression|1|||
164340442|NCT02369016|593620609|FG001|Overall Study|Progressive disease - clinical progression|4|||
164340443|NCT02369016|593620608|FG000|Overall Study|withdrawal by patient|4|||
164577148|NCT03941548|594476829|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
164577149|NCT01242111|594476830|FG000|Overall Study|Adverse Event|1|||
164577150|NCT01242111|594476830|FG000|Overall Study|Withdrawal by Subject|1|||
164577151|NCT01242111|594476830|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
164259680|NCT02982018|593320201|FG000|Overall Study|Lens Discomfort|2|||
164259681|NCT02982018|593320202|FG001|Overall Study|Lens Discomfort|0|||
164259682|NCT02982018|593320201|FG000|Overall Study|Withdrawal by Subject|0|||
164259683|NCT02982018|593320202|FG001|Overall Study|Withdrawal by Subject|1|||
164259684|NCT03245736|593320203|FG000|Overall Study|Adverse Event|1|||
164259685|NCT03245736|593320203|FG000|Overall Study|Progressive Disease|4|||
164259686|NCT01942161|593320204|FG000|Overall Study|Adverse Event|1|||
164259687|NCT01942161|593320205|FG001|Overall Study|Adverse Event|2|||
164259688|NCT01942161|593320206|FG002|Overall Study|Adverse Event|5|||
164259689|NCT01942161|593320204|FG000|Overall Study|Physician Decision|3|||
164259690|NCT01942161|593320205|FG001|Overall Study|Physician Decision|1|||
164259691|NCT01942161|593320206|FG002|Overall Study|Physician Decision|0|||
164259692|NCT01942161|593320204|FG000|Overall Study|Protocol Violation|1|||
164259693|NCT01942161|593320205|FG001|Overall Study|Protocol Violation|0|||
164259694|NCT01942161|593320206|FG002|Overall Study|Protocol Violation|0|||
164259695|NCT01942161|593320204|FG000|Overall Study|Withdrawal by Subject|3|||
164259696|NCT01942161|593320205|FG001|Overall Study|Withdrawal by Subject|3|||
164259697|NCT01942161|593320206|FG002|Overall Study|Withdrawal by Subject|1|||
164259698|NCT01257568|593320209|FG000|Overall Study|Lost to Follow-up|2|||
164259699|NCT01257568|593320209|FG000|Overall Study|Withdrawal by Subject|6|||
164259700|NCT01257568|593320209|FG000|Overall Study|Terminated|1|||
164259701|NCT01257568|593320209|FG000|Overall Study|Component Revision|24|||
164259702|NCT00132691|593320211|FG000|Overall Study|Lost to Follow-up|5|||
164259703|NCT00132691|593320212|FG001|Overall Study|Lost to Follow-up|8|||
164259704|NCT00132691|593320211|FG000|Overall Study|Missed 2-year visit|4|||
164259705|NCT00132691|593320212|FG001|Overall Study|Missed 2-year visit|4|||
164259706|NCT00132691|593320211|FG000|Overall Study|Death|2|||
164259707|NCT00132691|593320212|FG001|Overall Study|Death|0|||
164259708|NCT02251717|593320213|FG000|Overall Study|Adverse Event|0|||
164259709|NCT02251717|593320214|FG001|Overall Study|Adverse Event|1|||
164259710|NCT02251717|593320213|FG000|Overall Study|Withdrew Consent|1|||
164259711|NCT02251717|593320214|FG001|Overall Study|Withdrew Consent|0|||
164259712|NCT00798317|593320217|FG000|Overall Study|Physician Decision|0|||
164259713|NCT00798317|593320218|FG001|Overall Study|Physician Decision|1|||
164259714|NCT00798317|593320217|FG000|Overall Study|Withdrawal by Subject|5|||
164259715|NCT00798317|593320218|FG001|Overall Study|Withdrawal by Subject|4|||
164259716|NCT00798317|593320217|FG000|Overall Study|Lost to Follow-up|2|||
164259717|NCT00798317|593320218|FG001|Overall Study|Lost to Follow-up|2|||
164259718|NCT00798317|593320217|FG000|Overall Study|Adverse Event|2|||
164259719|NCT00798317|593320218|FG001|Overall Study|Adverse Event|0|||
164259720|NCT00798317|593320217|FG000|Overall Study|Death|1|||
164577152|NCT01929083|594476833|FG000|Intervention 1|Lost to Follow-up|2|||
164577153|NCT01929083|594476834|FG001|Intervention 1|Lost to Follow-up|0|||
164577154|NCT01929083|594476833|FG000|Intervention 1|Nonadherent to study medications|1|||
164259721|NCT00798317|593320218|FG001|Overall Study|Death|0|||
164259722|NCT00919867|593320219|FG000|First Intervention|Withdrawal by Subject|0|||
164259723|NCT00919867|593320220|FG001|First Intervention|Withdrawal by Subject|0|||
164259724|NCT00919867|593320221|FG002|First Intervention|Withdrawal by Subject|1|||
164259725|NCT00919867|593320222|FG003|First Intervention|Withdrawal by Subject|0|||
164259726|NCT00919867|593320223|FG004|First Intervention|Withdrawal by Subject|0|||
164259727|NCT00919867|593320224|FG005|First Intervention|Withdrawal by Subject|0|||
164259728|NCT00919867|593320219|FG000|First Intervention|Physician Decision|0|||
164340444|NCT02369016|593620609|FG001|Overall Study|withdrawal by patient|0|||
164340445|NCT02369016|593620608|FG000|Overall Study|Progressive disease - radiological progression|6|||
164340446|NCT02369016|593620609|FG001|Overall Study|Progressive disease - radiological progression|2|||
164340447|NCT01187433|593620610|FG000|Overall Study|Protocol Violation|6|||
164340448|NCT01187433|593620611|FG001|Overall Study|Protocol Violation|2|||
164340449|NCT01187433|593620610|FG000|Overall Study|Withdrawal by Subject|5|||
164340450|NCT01187433|593620611|FG001|Overall Study|Withdrawal by Subject|2|||
164340451|NCT04203797|593620612|FG000|Overall Study|Adverse Event|1|||
164340452|NCT04203797|593620613|FG001|Overall Study|Adverse Event|0|||
164340453|NCT04203797|593620612|FG000|Overall Study|Did not complete End of Study follow-up|1|||
164340454|NCT04203797|593620613|FG001|Overall Study|Did not complete End of Study follow-up|0|||
164340455|NCT00621959|593620614|FG000|Overall Study|Adverse Event|4|||
164340456|NCT00621959|593620615|FG001|Overall Study|Adverse Event|2|||
164577155|NCT01929083|594476834|FG001|Intervention 1|Nonadherent to study medications|0|||
164259729|NCT00919867|593320220|FG001|First Intervention|Physician Decision|0|||
164259730|NCT00919867|593320221|FG002|First Intervention|Physician Decision|0|||
164259731|NCT00919867|593320222|FG003|First Intervention|Physician Decision|0|||
164259732|NCT00919867|593320223|FG004|First Intervention|Physician Decision|0|||
164259733|NCT00919867|593320224|FG005|First Intervention|Physician Decision|1|||
164259734|NCT03361189|593320234|FG000|Overall Study|Received heart transplant|1|||
164259735|NCT03361189|593320235|FG001|Overall Study|Received heart transplant|0|||
164429522|NCT00097370|593941022|FG000|Stage 3|Sponsor Terminated Study|52|||
164259736|NCT03361189|593320234|FG000|Overall Study|Pacemake replacement|0|||
164259737|NCT03361189|593320235|FG001|Overall Study|Pacemake replacement|1|||
164259738|NCT03575065|593320236|FG000|Overall Study|Death|31|||
164259739|NCT03575065|593320237|FG001|Overall Study|Death|12|||
164259740|NCT03575065|593320236|FG000|Overall Study|Sponsor's Decision|28|||
164259741|NCT03575065|593320237|FG001|Overall Study|Sponsor's Decision|13|||
164259742|NCT03575065|593320236|FG000|Overall Study|Withdrawal by Subject|2|||
164259743|NCT03575065|593320237|FG001|Overall Study|Withdrawal by Subject|1|||
164259744|NCT03575065|593320236|FG000|Overall Study|Lost to Follow-up|1|||
164259745|NCT03575065|593320237|FG001|Overall Study|Lost to Follow-up|0|||
164259746|NCT03344549|593320238|FG000|Overall Study|Withdrawal by Subject|3|||
164259747|NCT03344549|593320239|FG001|Overall Study|Withdrawal by Subject|2|||
164259748|NCT03344549|593320238|FG000|Overall Study|Dialysis|2|||
164259749|NCT03344549|593320239|FG001|Overall Study|Dialysis|0|||
164259750|NCT03344549|593320238|FG000|Overall Study|Cancer|1|||
164259751|NCT03344549|593320239|FG001|Overall Study|Cancer|0|||
164259752|NCT03344549|593320238|FG000|Overall Study|Lack of electronic device|1|||
164259753|NCT03344549|593320239|FG001|Overall Study|Lack of electronic device|0|||
164259754|NCT03344549|593320238|FG000|Overall Study|Transportation difficulty|0|||
164259755|NCT03344549|593320239|FG001|Overall Study|Transportation difficulty|13|||
164259756|NCT02323126|593320240|FG000|Overall Study|Patient / guardian decision|0|||
164259757|NCT02323126|593320241|FG001|Overall Study|Patient / guardian decision|1|||
164259758|NCT02323126|593320242|FG002|Overall Study|Patient / guardian decision|2|||
164259759|NCT02323126|593320240|FG000|Overall Study|Progressive disease|14|||
164259760|NCT02323126|593320241|FG001|Overall Study|Progressive disease|8|||
164259761|NCT02323126|593320242|FG002|Overall Study|Progressive disease|14|||
164259762|NCT02323126|593320240|FG000|Overall Study|Physician Decision|0|||
164259763|NCT02323126|593320241|FG001|Overall Study|Physician Decision|1|||
164259764|NCT02323126|593320242|FG002|Overall Study|Physician Decision|3|||
164259765|NCT02323126|593320240|FG000|Overall Study|Death|1|||
164259766|NCT02323126|593320241|FG001|Overall Study|Death|1|||
164259767|NCT02323126|593320242|FG002|Overall Study|Death|4|||
164259768|NCT02323126|593320240|FG000|Overall Study|Adverse Event|3|||
164259769|NCT02323126|593320241|FG001|Overall Study|Adverse Event|5|||
164259770|NCT02323126|593320242|FG002|Overall Study|Adverse Event|7|||
164259771|NCT01685801|593320248|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
164259772|NCT01685801|593320249|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
164259773|NCT01685801|593320250|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
164259774|NCT01685801|593320251|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
164259775|NCT01685801|593320248|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
164259776|NCT01685801|593320249|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
164259777|NCT01685801|593320250|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
164259778|NCT01685801|593320251|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
164259779|NCT00113399|593320252|FG000|Overall Study|Death|1|||
164259780|NCT00113399|593320253|FG001|Overall Study|Death|1|||
164259781|NCT00113399|593320252|FG000|Overall Study|Withdrawal by Subject|1|||
164259782|NCT00113399|593320253|FG001|Overall Study|Withdrawal by Subject|2|||
164259783|NCT00113399|593320252|FG000|Overall Study|Complete Response|0|||
164259784|NCT00113399|593320253|FG001|Overall Study|Complete Response|1|||
164259785|NCT00113399|593320252|FG000|Overall Study|Other|0|||
164259786|NCT00113399|593320253|FG001|Overall Study|Other|1|||
164259787|NCT03350256|593320254|FG000|Overall Study|Inclusion/exclusion violation|4|||
164259788|NCT03350256|593320254|FG000|Overall Study|Recommended for other therapies|2|||
164259789|NCT03350256|593320254|FG000|Overall Study|Protocol Violation|3|||
164259790|NCT03350256|593320254|FG000|Overall Study|Non compliance|2|||
164259791|NCT03350256|593320254|FG000|Overall Study|Denial by insurance|1|||
164259792|NCT03350256|593320254|FG000|Overall Study|Adverse Event|2|||
164259793|NCT03350256|593320254|FG000|Overall Study|Trial failure|12|||
164429523|NCT00097370|593941022|FG000|Stage 3|Lost to Follow-up|1|||
164429524|NCT01394991|593941023|FG000|Overall Study|Adverse Event|0|||
164429525|NCT01394991|593941024|FG001|Overall Study|Adverse Event|4|||
164429526|NCT01394991|593941023|FG000|Overall Study|Lack of Efficacy|5|||
164429527|NCT01394991|593941024|FG001|Overall Study|Lack of Efficacy|7|||
164429528|NCT01394991|593941023|FG000|Overall Study|Lost to Follow-up|6|||
164259794|NCT03350256|593320254|FG000|Overall Study|Did not proceed to permanent implant|3|||
164259795|NCT03350256|593320254|FG000|Overall Study|Withdrawal by Subject|3|||
164259796|NCT03350256|593320254|FG000|Overall Study|Subject moving out of state|1|||
164259797|NCT03350256|593320254|FG000|Overall Study|Lost to Follow-up|1|||
164259798|NCT03350256|593320254|FG000|Overall Study|Lack of Efficacy|2|||
164259799|NCT00666588|593320255|FG000|Overall Study|ineligible|2|||
164429529|NCT01394991|593941024|FG001|Overall Study|Lost to Follow-up|8|||
164577156|NCT01929083|594476833|FG000|Intervention 2|Adverse Event|0|||
164259800|NCT00666588|593320256|FG001|Overall Study|ineligible|0|||
164259801|NCT00666588|593320257|FG002|Overall Study|ineligible|0|||
164259802|NCT00666588|593320258|FG003|Overall Study|ineligible|2|||
164259803|NCT00666588|593320255|FG000|Overall Study|inevaluable|2|||
164259804|NCT00666588|593320256|FG001|Overall Study|inevaluable|0|||
164429530|NCT01394991|593941023|FG000|Overall Study|Physician Decision|1|||
164429531|NCT01394991|593941024|FG001|Overall Study|Physician Decision|3|||
164429532|NCT01394991|593941023|FG000|Overall Study|Protocol Violation|1|||
164429533|NCT01394991|593941024|FG001|Overall Study|Protocol Violation|1|||
164429534|NCT01394991|593941023|FG000|Overall Study|Withdrawal by Subject|20|||
164429535|NCT01394991|593941024|FG001|Overall Study|Withdrawal by Subject|17|||
164429536|NCT01394991|593941023|FG000|Overall Study|Chemotherapy Termination|10|||
164429537|NCT01394991|593941024|FG001|Overall Study|Chemotherapy Termination|15|||
164429538|NCT01394991|593941023|FG000|Overall Study|Disease Progression|7|||
164429539|NCT01394991|593941024|FG001|Overall Study|Disease Progression|7|||
164429540|NCT01394991|593941023|FG000|Overall Study|Prematurely Termination of Trial|9|||
164429541|NCT01394991|593941024|FG001|Overall Study|Prematurely Termination of Trial|10|||
164429542|NCT02337361|593941027|FG000|3-month Follow-up|Lost to Follow-up|19|||
164429543|NCT02337361|593941028|FG001|3-month Follow-up|Lost to Follow-up|14|||
164429544|NCT02337361|593941027|FG000|6-month Follow-up|Lost to Follow-up|2|||
164429545|NCT02337361|593941028|FG001|6-month Follow-up|Lost to Follow-up|4|||
164429546|NCT03073005|593941030|FG000|Overall Study|Death|6|||
164429547|NCT03073005|593941031|FG001|Overall Study|Death|0|||
164429548|NCT03073005|593941032|FG002|Overall Study|Death|7|||
164429549|NCT03073005|593941033|FG003|Overall Study|Death|0|||
164429550|NCT03073005|593941030|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
164429551|NCT03073005|593941031|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
164429552|NCT03073005|593941032|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
164429553|NCT03073005|593941033|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
164429554|NCT03073005|593941030|FG000|Overall Study|Lost to Follow-up|2|||
164429555|NCT03073005|593941031|FG001|Overall Study|Lost to Follow-up|2|||
164429556|NCT03073005|593941032|FG002|Overall Study|Lost to Follow-up|1|||
164429557|NCT03073005|593941033|FG003|Overall Study|Lost to Follow-up|2|||
164429558|NCT03073005|593941030|FG000|Overall Study|Withdrawal by Subject|0|||
164429559|NCT03073005|593941031|FG001|Overall Study|Withdrawal by Subject|4|||
164429560|NCT03073005|593941032|FG002|Overall Study|Withdrawal by Subject|4|||
164429561|NCT03073005|593941033|FG003|Overall Study|Withdrawal by Subject|4|||
164429562|NCT02427646|593941041|FG000|Overall Study|Lack of Efficacy|2|||
164259805|NCT00666588|593320257|FG002|Overall Study|inevaluable|0|||
164259806|NCT00666588|593320258|FG003|Overall Study|inevaluable|0|||
164259807|NCT04043234|593320259|FG000|Overall Study|Lost to Follow-up|1|||
164259808|NCT04043234|593320259|FG000|Overall Study|Withdrawal by Subject|1|||
164259809|NCT01187446|593320261|FG000|Overall Study|Patient started non-protocol therapy|0|||
164259810|NCT01187446|593320262|FG001|Overall Study|Patient started non-protocol therapy|1|||
164259811|NCT00791479|593320268|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
164259812|NCT00791479|593320269|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
164259813|NCT00791479|593320270|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
164259814|NCT00791479|593320271|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
164259815|NCT00791479|593320272|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
164259816|NCT00791479|593320273|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
164259817|NCT00791479|593320268|FG000|Overall Study|Adverse Event|0|||
164259818|NCT00791479|593320269|FG001|Overall Study|Adverse Event|1|||
164259819|NCT00791479|593320270|FG002|Overall Study|Adverse Event|0|||
164259820|NCT00791479|593320271|FG003|Overall Study|Adverse Event|2|||
164259821|NCT00791479|593320272|FG004|Overall Study|Adverse Event|0|||
164259822|NCT00791479|593320273|FG005|Overall Study|Adverse Event|1|||
164259823|NCT00791479|593320268|FG000|Overall Study|Lost to Follow-up|0|||
164259824|NCT00791479|593320269|FG001|Overall Study|Lost to Follow-up|1|||
164259825|NCT00791479|593320270|FG002|Overall Study|Lost to Follow-up|0|||
164259826|NCT00791479|593320271|FG003|Overall Study|Lost to Follow-up|0|||
164259827|NCT00791479|593320272|FG004|Overall Study|Lost to Follow-up|0|||
164259828|NCT00791479|593320273|FG005|Overall Study|Lost to Follow-up|1|||
164429563|NCT02427646|593941042|FG001|Overall Study|Lack of Efficacy|3|||
164429564|NCT02427646|593941041|FG000|Overall Study|Physician Decision|1|||
164429565|NCT02427646|593941042|FG001|Overall Study|Physician Decision|4|||
164429566|NCT02427646|593941041|FG000|Overall Study|Protocol Violation|3|||
164429567|NCT02427646|593941042|FG001|Overall Study|Protocol Violation|3|||
164259829|NCT00791479|593320268|FG000|Overall Study|Protocol Violation|2|||
164259830|NCT00791479|593320269|FG001|Overall Study|Protocol Violation|1|||
164259831|NCT00791479|593320270|FG002|Overall Study|Protocol Violation|0|||
164259832|NCT00791479|593320271|FG003|Overall Study|Protocol Violation|1|||
164259833|NCT00791479|593320272|FG004|Overall Study|Protocol Violation|0|||
164429568|NCT02427646|593941041|FG000|Overall Study|Bothersome hand weakness|2|||
164429569|NCT02427646|593941042|FG001|Overall Study|Bothersome hand weakness|4|||
164429570|NCT04880161|593941043|FG000|Overall Study|Withdrawal by Subject|1|||
164429571|NCT04880161|593941044|FG001|Overall Study|Withdrawal by Subject|0|||
164429572|NCT04880161|593941043|FG000|Overall Study|Lack of Compliance|1|||
164429573|NCT04880161|593941044|FG001|Overall Study|Lack of Compliance|1|||
164259834|NCT00791479|593320273|FG005|Overall Study|Protocol Violation|0|||
164429574|NCT04880161|593941043|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
164429575|NCT04880161|593941044|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
164259835|NCT00791479|593320268|FG000|Overall Study|Withdrawal by Subject|0|||
164259836|NCT00791479|593320269|FG001|Overall Study|Withdrawal by Subject|0|||
164259837|NCT00791479|593320270|FG002|Overall Study|Withdrawal by Subject|0|||
164259838|NCT00791479|593320271|FG003|Overall Study|Withdrawal by Subject|1|||
164259839|NCT00791479|593320272|FG004|Overall Study|Withdrawal by Subject|0|||
164259840|NCT00791479|593320273|FG005|Overall Study|Withdrawal by Subject|1|||
164259841|NCT03405935|593320276|FG000|Overall Study|Adverse Event|3|||
164259842|NCT03405935|593320276|FG000|Overall Study|Death|2|||
164259843|NCT03405935|593320276|FG000|Overall Study|Withdrawal by Subject|1|||
164259844|NCT03405935|593320276|FG000|Overall Study|Lost to Follow-up|2|||
164259845|NCT04979897|593320277|FG000|Overall Study|Death|1|||
164259846|NCT04979897|593320278|FG001|Overall Study|Death|8|||
164259847|NCT04979897|593320277|FG000|Overall Study|Lost to Follow-up|111|||
164259848|NCT04979897|593320278|FG001|Overall Study|Lost to Follow-up|56|||
164259849|NCT04979897|593320277|FG000|Overall Study|Withdrawal by Subject|7|||
164259850|NCT04979897|593320278|FG001|Overall Study|Withdrawal by Subject|2|||
164259851|NCT01774097|593320279|FG000|Overall Study|Withdrawal by Subject|1|||
164259852|NCT01774097|593320280|FG001|Overall Study|Withdrawal by Subject|1|||
164259853|NCT01774097|593320279|FG000|Overall Study|Adverse Event|1|||
164259854|NCT01774097|593320280|FG001|Overall Study|Adverse Event|1|||
164259855|NCT04659174|593320286|FG000|Overall Study|Sponsor decision to discontinue study|0|||
164259856|NCT04659174|593320287|FG001|Overall Study|Sponsor decision to discontinue study|2|||
164259857|NCT04659174|593320286|FG000|Overall Study|Lost to Follow-up|9|||
164259858|NCT04659174|593320287|FG001|Overall Study|Lost to Follow-up|11|||
164259859|NCT04659174|593320286|FG000|Overall Study|Adverse Event|8|||
164259860|NCT04659174|593320287|FG001|Overall Study|Adverse Event|5|||
164259861|NCT04659174|593320286|FG000|Overall Study|Withdrawal by Subject|17|||
164259862|NCT04659174|593320287|FG001|Overall Study|Withdrawal by Subject|33|||
164259863|NCT04659174|593320286|FG000|Overall Study|Progressive disease|0|||
164259864|NCT04659174|593320287|FG001|Overall Study|Progressive disease|2|||
164259865|NCT04659174|593320286|FG000|Overall Study|Other reasons|0|||
164259866|NCT04659174|593320287|FG001|Overall Study|Other reasons|2|||
164259867|NCT04659174|593320286|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
164259868|NCT04659174|593320287|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
164259869|NCT04659174|593320286|FG000|Overall Study|Alcohol or illegal drug use|0|||
164259870|NCT04659174|593320287|FG001|Overall Study|Alcohol or illegal drug use|3|||
164259871|NCT04659174|593320286|FG000|Overall Study|Violation of entry criteria|1|||
164259872|NCT04659174|593320287|FG001|Overall Study|Violation of entry criteria|0|||
164259873|NCT04659174|593320286|FG000|Overall Study|Death|0|||
164259874|NCT04659174|593320287|FG001|Overall Study|Death|1|||
164259875|NCT02781792|593320288|FG000|Overall Study|Adverse Event|1|||
164259876|NCT02781792|593320289|FG001|Overall Study|Adverse Event|2|||
164259877|NCT02781792|593320288|FG000|Overall Study|Withdrawal by Subject|3|||
164259878|NCT02781792|593320289|FG001|Overall Study|Withdrawal by Subject|1|||
164259879|NCT02781792|593320288|FG000|Overall Study|Lack of Efficacy|1|||
164259880|NCT02781792|593320289|FG001|Overall Study|Lack of Efficacy|1|||
164259881|NCT02781792|593320288|FG000|Overall Study|Hospice|0|||
164259882|NCT02781792|593320289|FG001|Overall Study|Hospice|1|||
164259883|NCT03447314|593320294|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
164259884|NCT03447314|593320295|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
164259885|NCT03447314|593320296|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
164259886|NCT03447314|593320297|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
164340457|NCT00621959|593620614|FG000|Overall Study|Lack of Efficacy|1|||
164340458|NCT00621959|593620615|FG001|Overall Study|Lack of Efficacy|1|||
164340459|NCT00621959|593620614|FG000|Overall Study|Lost to Follow-up|0|||
164340460|NCT00621959|593620615|FG001|Overall Study|Lost to Follow-up|2|||
164340461|NCT00621959|593620614|FG000|Overall Study|Withdrawal by Subject|1|||
164340462|NCT00621959|593620615|FG001|Overall Study|Withdrawal by Subject|1|||
164340463|NCT00621959|593620614|FG000|Overall Study|Other|1|||
164340464|NCT00621959|593620615|FG001|Overall Study|Other|3|||
164340465|NCT00242216|593620616|FG000|Overall Study|Lost to Follow-up|12|||
164340466|NCT00242216|593620617|FG001|Overall Study|Lost to Follow-up|17|||
164340467|NCT00242216|593620616|FG000|Overall Study|Death|4|||
164340468|NCT00242216|593620617|FG001|Overall Study|Death|2|||
164340469|NCT00242216|593620616|FG000|Overall Study|Lack of Efficacy|1|||
164340470|NCT00242216|593620617|FG001|Overall Study|Lack of Efficacy|2|||
164340471|NCT00242216|593620616|FG000|Overall Study|no medicaiton dispensed|1|||
164340472|NCT00242216|593620617|FG001|Overall Study|no medicaiton dispensed|1|||
164340473|NCT02484690|593620618|FG000|Overall Study|Adverse Event|1|||
164340474|NCT02484690|593620619|FG001|Overall Study|Adverse Event|3|||
164340475|NCT02484690|593620620|FG002|Overall Study|Adverse Event|0|||
164340476|NCT02484690|593620621|FG003|Overall Study|Adverse Event|0|||
164259887|NCT03447314|593320298|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
164340477|NCT02484690|593620622|FG004|Overall Study|Adverse Event|5|||
164340478|NCT02484690|593620618|FG000|Overall Study|Death|0|||
164340479|NCT02484690|593620619|FG001|Overall Study|Death|0|||
164340480|NCT02484690|593620620|FG002|Overall Study|Death|0|||
164340481|NCT02484690|593620621|FG003|Overall Study|Death|0|||
164340482|NCT02484690|593620622|FG004|Overall Study|Death|1|||
164429576|NCT04880161|593941043|FG000|Overall Study|Screen Failure|0|||
164429577|NCT04880161|593941044|FG001|Overall Study|Screen Failure|1|||
164259888|NCT03447314|593320299|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
164259889|NCT03447314|593320300|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
164259890|NCT03447314|593320301|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
164259891|NCT03447314|593320302|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
164259892|NCT03447314|593320303|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
164259893|NCT03447314|593320304|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
164259894|NCT03447314|593320305|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
164259895|NCT03447314|593320306|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
164259896|NCT03447314|593320307|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
164259897|NCT03447314|593320308|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
164429578|NCT00256308|593943342|FG000|Overall Study|Death|2|||
164429579|NCT01419717|593943343|FG000|Overall Study|Protocol-specified Criteria|62|||
164429580|NCT01419717|593943343|FG000|Overall Study|Adverse Event|19|||
164429581|NCT01419717|593943343|FG000|Overall Study|Death|17|||
164429582|NCT01419717|593943343|FG000|Overall Study|Withdrawal by Subject|10|||
164429583|NCT01419717|593943343|FG000|Overall Study|Disease Progression|9|||
164429584|NCT01419717|593943343|FG000|Overall Study|Other|4|||
164429585|NCT01419717|593943343|FG000|Overall Study|Lost to Follow-up|2|||
164429586|NCT01419717|593943343|FG000|Overall Study|Administrative Decision|1|||
164429587|NCT01419717|593943343|FG000|Overall Study|Noncompliance|1|||
164259898|NCT03447314|593320309|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
164259899|NCT03447314|593320310|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
164259900|NCT03447314|593320311|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
164259901|NCT03447314|593320294|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
164259902|NCT03447314|593320295|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259903|NCT03447314|593320296|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
164259904|NCT03447314|593320297|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259905|NCT03447314|593320298|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259906|NCT03447314|593320299|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
164259907|NCT03447314|593320300|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
164259908|NCT03447314|593320301|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259909|NCT03447314|593320302|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259910|NCT03447314|593320303|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259911|NCT03447314|593320304|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259912|NCT03447314|593320305|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259913|NCT03447314|593320306|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259914|NCT03447314|593320307|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259915|NCT03447314|593320308|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259916|NCT03447314|593320309|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259917|NCT03447314|593320310|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259918|NCT03447314|593320311|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259919|NCT03447314|593320294|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259920|NCT03447314|593320295|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164429588|NCT01240356|593943344|FG000|Overall Study|Withdrawal by Subject|2|||
164429589|NCT01240356|593943345|FG001|Overall Study|Withdrawal by Subject|0|||
164429590|NCT01240356|593943344|FG000|Overall Study|MRI contraindication|1|||
164429591|NCT01240356|593943345|FG001|Overall Study|MRI contraindication|0|||
164429592|NCT04048135|593943346|FG000|Overall Study|Withdrawal by Subject|1|||
164429593|NCT04048135|593943347|FG001|Overall Study|Withdrawal by Subject|1|||
164429594|NCT04048135|593943348|FG002|Overall Study|Withdrawal by Subject|1|||
164429595|NCT04048135|593943349|FG003|Overall Study|Withdrawal by Subject|2|||
164429596|NCT04048135|593943350|FG004|Overall Study|Withdrawal by Subject|0|||
164429597|NCT04048135|593943351|FG005|Overall Study|Withdrawal by Subject|0|||
164429598|NCT04048135|593943352|FG006|Overall Study|Withdrawal by Subject|1|||
164429599|NCT04048135|593943353|FG007|Overall Study|Withdrawal by Subject|1|||
164429600|NCT04048135|593943346|FG000|Overall Study|Adverse Event|0|||
164429601|NCT04048135|593943347|FG001|Overall Study|Adverse Event|0|||
164259921|NCT03447314|593320296|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
164259922|NCT03447314|593320297|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259923|NCT03447314|593320298|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259924|NCT03447314|593320299|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164429602|NCT04048135|593943348|FG002|Overall Study|Adverse Event|0|||
164429603|NCT04048135|593943349|FG003|Overall Study|Adverse Event|1|||
164429604|NCT04048135|593943350|FG004|Overall Study|Adverse Event|1|||
164429605|NCT04048135|593943351|FG005|Overall Study|Adverse Event|0|||
164429606|NCT04048135|593943352|FG006|Overall Study|Adverse Event|0|||
164429607|NCT04048135|593943353|FG007|Overall Study|Adverse Event|0|||
164429608|NCT04048135|593943346|FG000|Overall Study|Protocol Violation|0|||
164259925|NCT03447314|593320300|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259926|NCT03447314|593320301|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259927|NCT03447314|593320302|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259928|NCT03447314|593320303|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259929|NCT03447314|593320304|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259930|NCT03447314|593320305|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259931|NCT03447314|593320306|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259932|NCT03447314|593320307|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259933|NCT03447314|593320308|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259934|NCT03447314|593320309|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259935|NCT03447314|593320310|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259936|NCT03447314|593320311|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259937|NCT03447314|593320294|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259938|NCT03447314|593320295|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259939|NCT03447314|593320296|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
164259940|NCT03447314|593320297|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259941|NCT03447314|593320298|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259942|NCT03447314|593320299|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259943|NCT03447314|593320300|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259944|NCT03447314|593320301|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259945|NCT03447314|593320302|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259946|NCT03447314|593320303|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259947|NCT03447314|593320304|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259948|NCT03447314|593320305|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259949|NCT03447314|593320306|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259950|NCT03447314|593320307|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259951|NCT03447314|593320308|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259952|NCT03447314|593320309|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259953|NCT03447314|593320310|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259954|NCT03447314|593320311|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259955|NCT03447314|593320294|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259956|NCT03447314|593320295|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259957|NCT03447314|593320296|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259958|NCT03447314|593320297|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259959|NCT03447314|593320298|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259960|NCT03447314|593320299|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259961|NCT03447314|593320300|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259962|NCT03447314|593320301|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259963|NCT03447314|593320302|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259964|NCT03447314|593320303|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259965|NCT03447314|593320304|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
164259966|NCT03447314|593320305|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259967|NCT03447314|593320306|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259968|NCT03447314|593320307|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259969|NCT03447314|593320308|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259970|NCT03447314|593320309|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259971|NCT03447314|593320310|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259972|NCT03447314|593320311|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259973|NCT03447314|593320294|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259974|NCT03447314|593320295|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259975|NCT03447314|593320296|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164340483|NCT02484690|593620618|FG000|Overall Study|Withdrawal by Subject|1|||
164340484|NCT02484690|593620619|FG001|Overall Study|Withdrawal by Subject|3|||
164340485|NCT02484690|593620620|FG002|Overall Study|Withdrawal by Subject|1|||
164340486|NCT02484690|593620621|FG003|Overall Study|Withdrawal by Subject|2|||
164340487|NCT02484690|593620622|FG004|Overall Study|Withdrawal by Subject|0|||
164340488|NCT02484690|593620618|FG000|Overall Study|Physician Decision|2|||
164340489|NCT02484690|593620619|FG001|Overall Study|Physician Decision|0|||
164340490|NCT02484690|593620620|FG002|Overall Study|Physician Decision|1|||
164340491|NCT02484690|593620621|FG003|Overall Study|Physician Decision|0|||
164429609|NCT04048135|593943347|FG001|Overall Study|Protocol Violation|0|||
164429610|NCT04048135|593943348|FG002|Overall Study|Protocol Violation|0|||
164259976|NCT03447314|593320297|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
164259977|NCT03447314|593320298|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259978|NCT03447314|593320299|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
164259979|NCT03447314|593320300|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259980|NCT03447314|593320301|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259981|NCT03447314|593320302|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259982|NCT03447314|593320303|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164340492|NCT02484690|593620622|FG004|Overall Study|Physician Decision|0|||
164429611|NCT04048135|593943349|FG003|Overall Study|Protocol Violation|0|||
164429612|NCT04048135|593943350|FG004|Overall Study|Protocol Violation|0|||
164429613|NCT04048135|593943351|FG005|Overall Study|Protocol Violation|1|||
164429614|NCT04048135|593943352|FG006|Overall Study|Protocol Violation|0|||
164429615|NCT04048135|593943353|FG007|Overall Study|Protocol Violation|0|||
164429616|NCT02466516|593943354|FG000|Overall Study|Adverse Event|1|||
164429617|NCT02466516|593943355|FG001|Overall Study|Adverse Event|1|||
164429618|NCT02466516|593943356|FG002|Overall Study|Adverse Event|0|||
164429619|NCT02466516|593943357|FG003|Overall Study|Adverse Event|0|||
164429620|NCT02466516|593943358|FG004|Overall Study|Adverse Event|0|||
164429621|NCT02466516|593943354|FG000|Overall Study|Withdrew Consent|1|||
164429622|NCT02466516|593943355|FG001|Overall Study|Withdrew Consent|0|||
164429623|NCT02466516|593943356|FG002|Overall Study|Withdrew Consent|0|||
164429624|NCT02466516|593943357|FG003|Overall Study|Withdrew Consent|0|||
164429625|NCT02466516|593943358|FG004|Overall Study|Withdrew Consent|0|||
164429626|NCT02466516|593943354|FG000|Overall Study|Lost to Follow-up|2|||
164429627|NCT02466516|593943355|FG001|Overall Study|Lost to Follow-up|0|||
164429628|NCT02466516|593943356|FG002|Overall Study|Lost to Follow-up|1|||
164429629|NCT02466516|593943357|FG003|Overall Study|Lost to Follow-up|0|||
164429630|NCT02466516|593943358|FG004|Overall Study|Lost to Follow-up|0|||
164429631|NCT00157014|593943359|FG000|Overall Study|Death|4|||
164429632|NCT00157014|593943360|FG001|Overall Study|Death|2|||
164429633|NCT00157014|593943361|FG002|Overall Study|Death|1|||
164429634|NCT00157014|593943362|FG003|Overall Study|Death|1|||
164429635|NCT00157014|593943359|FG000|Overall Study|Physician Decision|0|||
164429636|NCT00157014|593943360|FG001|Overall Study|Physician Decision|1|||
164429637|NCT00157014|593943361|FG002|Overall Study|Physician Decision|0|||
164429638|NCT00157014|593943362|FG003|Overall Study|Physician Decision|0|||
164429639|NCT00157014|593943359|FG000|Overall Study|Medications withdrawn on family request|0|||
164429640|NCT00157014|593943360|FG001|Overall Study|Medications withdrawn on family request|1|||
164429641|NCT00157014|593943361|FG002|Overall Study|Medications withdrawn on family request|0|||
164429642|NCT00157014|593943362|FG003|Overall Study|Medications withdrawn on family request|0|||
164429643|NCT00157014|593943359|FG000|Overall Study|Patient withdrawn by investigator|1|||
164429644|NCT00157014|593943360|FG001|Overall Study|Patient withdrawn by investigator|0|||
164429645|NCT00157014|593943361|FG002|Overall Study|Patient withdrawn by investigator|0|||
164429646|NCT00157014|593943362|FG003|Overall Study|Patient withdrawn by investigator|0|||
164429647|NCT00157014|593943359|FG000|Overall Study|Patient unable to return in nursing home|1|||
164429648|NCT00157014|593943360|FG001|Overall Study|Patient unable to return in nursing home|0|||
164429649|NCT00157014|593943361|FG002|Overall Study|Patient unable to return in nursing home|0|||
164429650|NCT00157014|593943362|FG003|Overall Study|Patient unable to return in nursing home|0|||
164429651|NCT00157014|593943359|FG000|Overall Study|Patient would not receive transplant|0|||
164429652|NCT00157014|593943360|FG001|Overall Study|Patient would not receive transplant|1|||
164340493|NCT02484690|593620618|FG000|Overall Study|Lost to Follow-up|0|||
164340494|NCT02484690|593620619|FG001|Overall Study|Lost to Follow-up|0|||
164340495|NCT02484690|593620620|FG002|Overall Study|Lost to Follow-up|1|||
164340496|NCT02484690|593620621|FG003|Overall Study|Lost to Follow-up|0|||
164340497|NCT02484690|593620622|FG004|Overall Study|Lost to Follow-up|0|||
164340498|NCT03360747|593620623|FG000|Overall Study|Voluntary Withdrawal|1|||
164340499|NCT01759511|593620624|FG000|Overall Study|Adverse Event|4|||
164340500|NCT01759511|593620624|FG000|Overall Study|Death|2|||
164340501|NCT01759511|593620624|FG000|Overall Study|Lack of Efficacy|2|||
164340502|NCT01759511|593620624|FG000|Overall Study|Physician Decision|1|||
164340503|NCT01759511|593620624|FG000|Overall Study|Progressive Disease|5|||
164340504|NCT01759511|593620624|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
164340505|NCT01759511|593620624|FG000|Overall Study|Study Terminated by Sponsor|13|||
164429653|NCT00157014|593943361|FG002|Overall Study|Patient would not receive transplant|0|||
164429654|NCT00157014|593943362|FG003|Overall Study|Patient would not receive transplant|0|||
164429655|NCT00157014|593943359|FG000|Overall Study|Withdrawal by Subject|1|||
164429656|NCT00157014|593943360|FG001|Overall Study|Withdrawal by Subject|0|||
164340506|NCT01759511|593620624|FG000|Overall Study|Withdrawal by Subject|3|||
164429657|NCT00157014|593943361|FG002|Overall Study|Withdrawal by Subject|0|||
164429658|NCT00157014|593943362|FG003|Overall Study|Withdrawal by Subject|0|||
164429659|NCT01362491|593943363|FG000|Overall Study|Ineligible|1|||
164429660|NCT01362491|593943364|FG001|Overall Study|Ineligible|0|||
164429661|NCT01362491|593943365|FG002|Overall Study|Ineligible|0|||
164259983|NCT03447314|593320304|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259984|NCT03447314|593320305|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259985|NCT03447314|593320306|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259986|NCT03447314|593320307|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259987|NCT03447314|593320308|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259988|NCT03447314|593320309|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259989|NCT03447314|593320310|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259990|NCT03447314|593320311|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259991|NCT01920568|593320313|FG000|Overall Study|Adverse Event|27|||
164259992|NCT01920568|593320314|FG001|Overall Study|Adverse Event|8|||
164259993|NCT01920568|593320313|FG000|Overall Study|Protocol Violation|5|||
164259994|NCT01920568|593320314|FG001|Overall Study|Protocol Violation|3|||
164259995|NCT01920568|593320313|FG000|Overall Study|Lost to Follow-up|2|||
164259996|NCT01920568|593320314|FG001|Overall Study|Lost to Follow-up|2|||
164259997|NCT01920568|593320313|FG000|Overall Study|Physician Decision|13|||
164259998|NCT01920568|593320314|FG001|Overall Study|Physician Decision|4|||
164259999|NCT01920568|593320313|FG000|Overall Study|Withdrawal by Subject|79|||
164260000|NCT01920568|593320314|FG001|Overall Study|Withdrawal by Subject|55|||
164260001|NCT01920568|593320313|FG000|Overall Study|Death due to disease progression|25|||
164260002|NCT01920568|593320314|FG001|Overall Study|Death due to disease progression|12|||
164260003|NCT04049266|593320318|FG000|Overall Study|Adverse Event|16|||
164260004|NCT04049266|593320319|FG001|Overall Study|Adverse Event|9|||
164260005|NCT04049266|593320318|FG000|Overall Study|Non-compliance with study drug|0|||
164260006|NCT04049266|593320319|FG001|Overall Study|Non-compliance with study drug|3|||
164260007|NCT04049266|593320318|FG000|Overall Study|Withdrawal by Subject|6|||
164260008|NCT04049266|593320319|FG001|Overall Study|Withdrawal by Subject|10|||
164260009|NCT04049266|593320318|FG000|Overall Study|Lost to Follow-up|2|||
164260010|NCT04049266|593320319|FG001|Overall Study|Lost to Follow-up|2|||
164260011|NCT04049266|593320318|FG000|Overall Study|Progressive disease|11|||
164260012|NCT04049266|593320319|FG001|Overall Study|Progressive disease|2|||
164260013|NCT04049266|593320318|FG000|Overall Study|Physician Decision|1|||
164260014|NCT04049266|593320319|FG001|Overall Study|Physician Decision|0|||
164260015|NCT04049266|593320318|FG000|Overall Study|Patient moved out of state|1|||
164260016|NCT04049266|593320319|FG001|Overall Study|Patient moved out of state|0|||
164260017|NCT01703208|593320320|FG000|Overall Study|Death|61|||
164260018|NCT01703208|593320321|FG001|Overall Study|Death|48|||
164260019|NCT01703208|593320320|FG000|Overall Study|Lack of Efficacy|1|||
164260020|NCT01703208|593320321|FG001|Overall Study|Lack of Efficacy|2|||
164260021|NCT01703208|593320320|FG000|Overall Study|Lost to Follow-up|68|||
164260022|NCT01703208|593320321|FG001|Overall Study|Lost to Follow-up|62|||
164260023|NCT01703208|593320320|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164260024|NCT01703208|593320321|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164340507|NCT02569671|593620632|FG000|Overall Study|Lost to Follow-up|2|||
164340508|NCT02569671|593620633|FG001|Overall Study|Lost to Follow-up|1|||
164681073|NCT00112437|594854587|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164681074|NCT00112437|594854588|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164681075|NCT00112437|594854589|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164681076|NCT00112437|594854590|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164681077|NCT00112437|594854591|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164681078|NCT00112437|594854592|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164681079|NCT00112437|594854593|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164681080|NCT00112437|594854594|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164681081|NCT00112437|594854595|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164681082|NCT00112437|594854596|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
164681083|NCT00112437|594854571|FG000|Years 6-10 (60-Month Extension)|Other|0|||
164681084|NCT00112437|594854572|FG001|Years 6-10 (60-Month Extension)|Other|0|||
164681085|NCT00112437|594854573|FG002|Years 6-10 (60-Month Extension)|Other|0|||
164681086|NCT00112437|594854574|FG003|Years 6-10 (60-Month Extension)|Other|0|||
164681087|NCT00112437|594854575|FG004|Years 6-10 (60-Month Extension)|Other|0|||
164681088|NCT00112437|594854576|FG005|Years 6-10 (60-Month Extension)|Other|0|||
164681089|NCT00112437|594854577|FG006|Years 6-10 (60-Month Extension)|Other|0|||
164681090|NCT00112437|594854578|FG007|Years 6-10 (60-Month Extension)|Other|0|||
164681091|NCT00112437|594854579|FG008|Years 6-10 (60-Month Extension)|Other|0|||
164681092|NCT00112437|594854580|FG009|Years 6-10 (60-Month Extension)|Other|0|||
164681093|NCT00112437|594854581|FG010|Years 6-10 (60-Month Extension)|Other|0|||
164681094|NCT00112437|594854582|FG011|Years 6-10 (60-Month Extension)|Other|0|||
164260025|NCT01703208|593320320|FG000|Overall Study|Excluded Medication|1|||
164260026|NCT01703208|593320321|FG001|Overall Study|Excluded Medication|2|||
164260027|NCT01703208|593320320|FG000|Overall Study|Site Discontinued Study Participation|23|||
164260028|NCT01703208|593320321|FG001|Overall Study|Site Discontinued Study Participation|27|||
164260029|NCT01703208|593320320|FG000|Overall Study|Physician Decision|11|||
164260030|NCT01703208|593320321|FG001|Overall Study|Physician Decision|13|||
164260031|NCT01703208|593320320|FG000|Overall Study|Progressive disease|2|||
164260032|NCT01703208|593320321|FG001|Overall Study|Progressive disease|2|||
164260033|NCT01703208|593320320|FG000|Overall Study|Protocol Violation|1|||
164260034|NCT01703208|593320321|FG001|Overall Study|Protocol Violation|1|||
164260035|NCT01703208|593320320|FG000|Overall Study|Study Terminated by Sponsor|1710|||
164260036|NCT01703208|593320321|FG001|Overall Study|Study Terminated by Sponsor|1716|||
164260037|NCT01703208|593320320|FG000|Overall Study|Withdrawal by Subject|205|||
164260038|NCT01703208|593320321|FG001|Overall Study|Withdrawal by Subject|209|||
164260039|NCT01703208|593320320|FG000|Overall Study|Adverse Event|14|||
164260040|NCT01703208|593320321|FG001|Overall Study|Adverse Event|19|||
164260041|NCT01703208|593320320|FG000|Overall Study|Technical Problems|0|||
164260042|NCT01703208|593320321|FG001|Overall Study|Technical Problems|1|||
164260043|NCT01703208|593320320|FG000|Overall Study|Protocol Deviation|2|||
164260044|NCT01703208|593320321|FG001|Overall Study|Protocol Deviation|0|||
164260045|NCT04600076|593320325|FG000|Overall Study|Lost to Follow-up|3|||
164260046|NCT01639339|593320326|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
164260047|NCT01639339|593320327|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
164260048|NCT01639339|593320326|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
164260049|NCT01639339|593320327|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
164260050|NCT01639339|593320326|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
164260051|NCT01639339|593320327|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
164260052|NCT01639339|593320326|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
164260053|NCT01639339|593320327|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
164260054|NCT01639339|593320326|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
164260055|NCT01639339|593320327|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
164260056|NCT01639339|593320326|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
164260057|NCT01639339|593320327|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
164260058|NCT01639339|593320326|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
164260059|NCT01639339|593320327|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
164260060|NCT01639339|593320326|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
164260061|NCT01639339|593320327|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
164260062|NCT01639339|593320326|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
164260063|NCT01639339|593320327|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
164260064|NCT01639339|593320326|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
164260065|NCT01639339|593320327|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
164577157|NCT01929083|594476834|FG001|Intervention 2|Adverse Event|1|||
164577158|NCT02599402|594476835|FG000|Overall Study|Disease progression|153|||
164577159|NCT02599402|594476835|FG000|Overall Study|Study drug toxicity|201|||
164577160|NCT02599402|594476835|FG000|Overall Study|Death|26|||
164577161|NCT02599402|594476835|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
164577162|NCT02599402|594476835|FG000|Overall Study|Participant request to discontinue study treatment|13|||
164577163|NCT02599402|594476835|FG000|Overall Study|Participant withdrew consent|5|||
164577164|NCT02599402|594476835|FG000|Overall Study|Lost to Follow-up|1|||
164577165|NCT02599402|594476835|FG000|Overall Study|Maximum Clinical Benefit|7|||
164577166|NCT02599402|594476835|FG000|Overall Study|Poor/non-compliance|1|||
164577167|NCT02599402|594476835|FG000|Overall Study|Pregnancy|1|||
164577168|NCT02599402|594476835|FG000|Overall Study|Participant no longer met study criteria|7|||
164577169|NCT02599402|594476835|FG000|Overall Study|Other Reasons|95|||
164577170|NCT00813748|594476836|FG000|Skin Test Substudy|Physician Decision|0|||
164577171|NCT00813748|594476837|FG001|Skin Test Substudy|Physician Decision|1|||
164577172|NCT01772134|594476843|FG000|Overall Study|Adverse Event|6|||
164577173|NCT01772134|594476844|FG001|Overall Study|Adverse Event|5|||
164577174|NCT01772134|594476845|FG002|Overall Study|Adverse Event|10|||
164577175|NCT01772134|594476843|FG000|Overall Study|Withdrew Consent|3|||
164577176|NCT01772134|594476844|FG001|Overall Study|Withdrew Consent|1|||
164577177|NCT01772134|594476845|FG002|Overall Study|Withdrew Consent|5|||
164577178|NCT01772134|594476843|FG000|Overall Study|Lost to Follow-up|2|||
164577179|NCT01772134|594476844|FG001|Overall Study|Lost to Follow-up|0|||
164577180|NCT01772134|594476845|FG002|Overall Study|Lost to Follow-up|0|||
164577181|NCT01772134|594476843|FG000|Overall Study|Protocol Deviation|4|||
164577182|NCT01772134|594476844|FG001|Overall Study|Protocol Deviation|3|||
164577183|NCT01772134|594476845|FG002|Overall Study|Protocol Deviation|3|||
164577184|NCT01772134|594476843|FG000|Overall Study|Lack of Efficacy|11|||
164577185|NCT01772134|594476844|FG001|Overall Study|Lack of Efficacy|5|||
164577186|NCT01772134|594476845|FG002|Overall Study|Lack of Efficacy|3|||
164577187|NCT01772134|594476843|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
164577188|NCT01772134|594476844|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
164577189|NCT01772134|594476845|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
164577190|NCT01772134|594476843|FG000|Overall Study|Randomized Study Medication Not Received|2|||
164577191|NCT01772134|594476844|FG001|Overall Study|Randomized Study Medication Not Received|0|||
164577192|NCT01772134|594476845|FG002|Overall Study|Randomized Study Medication Not Received|1|||
164577193|NCT03830281|594476850|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
164260066|NCT02891681|593320328|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
164260067|NCT02891681|593320329|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
164260068|NCT02891681|593320330|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
164429662|NCT02501629|593943366|FG000|Overall Study|Death|0|||
164429663|NCT02501629|593943367|FG001|Overall Study|Death|1|||
164429664|NCT02501629|593943366|FG000|Overall Study|Withdrawn from study by sponsor|1|||
164260069|NCT02891681|593320328|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
164260070|NCT02891681|593320329|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
164260071|NCT02891681|593320330|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
164260072|NCT02891681|593320328|FG000|Overall Study|Taken off study after first imaging appointment|1|||
164260073|NCT02891681|593320329|FG001|Overall Study|Taken off study after first imaging appointment|0|||
164260074|NCT02891681|593320330|FG002|Overall Study|Taken off study after first imaging appointment|0|||
164260075|NCT01170598|593320331|FG000|Overall Study|Withdrawal by Subject|1|||
164260076|NCT01170598|593320331|FG000|Overall Study|Death|3|||
164260077|NCT01170598|593320331|FG000|Overall Study|Lost to Follow-up|1|||
164260078|NCT01170598|593320331|FG000|Overall Study|Refused|1|||
164260079|NCT01271712|593320332|FG000|Double Blind Treatment|Death|2|||
164260080|NCT01271712|593320333|FG001|Double Blind Treatment|Death|0|||
164260081|NCT01271712|593320332|FG000|Double Blind Treatment|Lack of Efficacy|1|||
164260082|NCT01271712|593320333|FG001|Double Blind Treatment|Lack of Efficacy|0|||
164260083|NCT01271712|593320332|FG000|Double Blind Treatment|Adverse Event|9|||
164260084|NCT01271712|593320333|FG001|Double Blind Treatment|Adverse Event|4|||
164260085|NCT01271712|593320332|FG000|Double Blind Treatment|Progressive disease|23|||
164260086|NCT01271712|593320333|FG001|Double Blind Treatment|Progressive disease|3|||
164260087|NCT01271712|593320332|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
164260088|NCT01271712|593320333|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
164260089|NCT01271712|593320332|FG000|Double Blind Treatment|Non compliance with study drug|2|||
164260090|NCT01271712|593320333|FG001|Double Blind Treatment|Non compliance with study drug|0|||
164260091|NCT01271712|593320332|FG000|Double Blind Treatment|receive no study drug|1|||
164260092|NCT01271712|593320333|FG001|Double Blind Treatment|receive no study drug|0|||
164260093|NCT01271712|593320332|FG000|Open Label Treatment|Death|6|||
164260094|NCT01271712|593320333|FG001|Open Label Treatment|Death|5|||
164260095|NCT01271712|593320332|FG000|Open Label Treatment|Withdrawal by Subject|6|||
164260096|NCT01271712|593320333|FG001|Open Label Treatment|Withdrawal by Subject|11|||
164260097|NCT01271712|593320332|FG000|Open Label Treatment|Physician Decision|2|||
164260098|NCT01271712|593320333|FG001|Open Label Treatment|Physician Decision|0|||
164260099|NCT01271712|593320332|FG000|Open Label Treatment|Adverse Event|14|||
164260100|NCT01271712|593320333|FG001|Open Label Treatment|Adverse Event|8|||
164260101|NCT01271712|593320332|FG000|Open Label Treatment|Progressive disease|59|||
164260102|NCT01271712|593320333|FG001|Open Label Treatment|Progressive disease|32|||
164260103|NCT01271712|593320332|FG000|Open Label Treatment|transferred to rollover study|1|||
164260104|NCT01271712|593320333|FG001|Open Label Treatment|transferred to rollover study|0|||
164260105|NCT01271712|593320332|FG000|Open Label Treatment|Non-compliance with study drug|1|||
164260106|NCT01271712|593320333|FG001|Open Label Treatment|Non-compliance with study drug|0|||
164260107|NCT01271712|593320332|FG000|Open Label Treatment|Protocol Violation|0|||
164429665|NCT02501629|593943367|FG001|Overall Study|Withdrawn from study by sponsor|0|||
164429666|NCT02501629|593943366|FG000|Overall Study|Early termination by sponsor|1|||
164429667|NCT02501629|593943367|FG001|Overall Study|Early termination by sponsor|0|||
164429668|NCT02501629|593943366|FG000|Overall Study|Withdrawal by Subject|3|||
164429669|NCT02501629|593943367|FG001|Overall Study|Withdrawal by Subject|5|||
164429670|NCT02501629|593943366|FG000|Overall Study|Subject did not return to site|0|||
164429671|NCT02501629|593943367|FG001|Overall Study|Subject did not return to site|1|||
164429672|NCT01168401|593943376|FG000|Overall Study|Lost to Follow-up|1|||
164429673|NCT01168401|593943377|FG001|Overall Study|Lost to Follow-up|1|||
164429674|NCT01168401|593943378|FG002|Overall Study|Lost to Follow-up|2|||
164429675|NCT01168401|593943379|FG003|Overall Study|Lost to Follow-up|1|||
164429676|NCT01168401|593943380|FG004|Overall Study|Lost to Follow-up|0|||
164429677|NCT01168401|593943381|FG005|Overall Study|Lost to Follow-up|0|||
164429678|NCT01168401|593943382|FG006|Overall Study|Lost to Follow-up|0|||
164429679|NCT01168401|593943383|FG007|Overall Study|Lost to Follow-up|0|||
164429680|NCT01168401|593943384|FG008|Overall Study|Lost to Follow-up|0|||
164429681|NCT01168401|593943385|FG009|Overall Study|Lost to Follow-up|0|||
164429682|NCT01168401|593943386|FG010|Overall Study|Lost to Follow-up|0|||
164429683|NCT01168401|593943376|FG000|Overall Study|Withdrawal by Subject|0|||
164429684|NCT01168401|593943377|FG001|Overall Study|Withdrawal by Subject|0|||
164429685|NCT01168401|593943378|FG002|Overall Study|Withdrawal by Subject|0|||
164681095|NCT00112437|594854583|FG012|Years 6-10 (60-Month Extension)|Other|0|||
164260108|NCT01271712|593320333|FG001|Open Label Treatment|Protocol Violation|1|||
164260109|NCT01271712|593320332|FG000|Open Label Treatment|Switching to other therapy|2|||
164260110|NCT01271712|593320333|FG001|Open Label Treatment|Switching to other therapy|1|||
164260111|NCT01271712|593320332|FG000|Safety Follow-up|Death|11|||
164260112|NCT01271712|593320333|FG001|Safety Follow-up|Death|7|||
164260113|NCT01271712|593320332|FG000|Safety Follow-up|Withdrawal by Subject|4|||
164429686|NCT01168401|593943379|FG003|Overall Study|Withdrawal by Subject|1|||
164429687|NCT01168401|593943380|FG004|Overall Study|Withdrawal by Subject|0|||
164429688|NCT01168401|593943381|FG005|Overall Study|Withdrawal by Subject|0|||
164681096|NCT00112437|594854584|FG013|Years 6-10 (60-Month Extension)|Other|0|||
164681097|NCT00112437|594854585|FG014|Years 6-10 (60-Month Extension)|Other|0|||
164681098|NCT00112437|594854586|FG015|Years 6-10 (60-Month Extension)|Other|0|||
164681099|NCT00112437|594854587|FG016|Years 6-10 (60-Month Extension)|Other|0|||
164681100|NCT00112437|594854588|FG017|Years 6-10 (60-Month Extension)|Other|0|||
164681101|NCT00112437|594854589|FG018|Years 6-10 (60-Month Extension)|Other|0|||
164681102|NCT00112437|594854590|FG019|Years 6-10 (60-Month Extension)|Other|0|||
164681103|NCT00112437|594854591|FG020|Years 6-10 (60-Month Extension)|Other|0|||
164260114|NCT01271712|593320333|FG001|Safety Follow-up|Withdrawal by Subject|2|||
164260115|NCT01271712|593320332|FG000|Safety Follow-up|Protocol Violation|1|||
164260116|NCT01271712|593320333|FG001|Safety Follow-up|Protocol Violation|1|||
164260117|NCT01271712|593320332|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
164260118|NCT01271712|593320333|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
164260119|NCT01271712|593320332|FG000|Safety Follow-up|No follow-up|1|||
164260120|NCT01271712|593320333|FG001|Safety Follow-up|No follow-up|1|||
164260121|NCT01271712|593320332|FG000|Safety Follow-up|Progressive disease|1|||
164260122|NCT01271712|593320333|FG001|Safety Follow-up|Progressive disease|0|||
164260123|NCT01271712|593320332|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
164260124|NCT01271712|593320333|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
164260125|NCT02685748|593320336|FG000|Overall Study|Withdrawal by Subject|3|||
164260126|NCT02685748|593320337|FG001|Overall Study|Withdrawal by Subject|2|||
164260127|NCT01944098|593320340|FG000|Overall Study|Physician Decision|1|||
164260128|NCT01944098|593320341|FG001|Overall Study|Physician Decision|0|||
164260129|NCT02136680|593320342|FG000|Overall Study|No Longer Interested|1|||
164260130|NCT02136680|593320343|FG001|Overall Study|No Longer Interested|1|||
164260131|NCT02136680|593320342|FG000|Overall Study|No longer receiving care at clinic|3|||
164260132|NCT02136680|593320343|FG001|Overall Study|No longer receiving care at clinic|5|||
164260133|NCT02136680|593320342|FG000|Overall Study|Moved away|5|||
164260134|NCT02136680|593320343|FG001|Overall Study|Moved away|4|||
164260135|NCT02136680|593320342|FG000|Overall Study|Unable to schedule|17|||
164260136|NCT02136680|593320343|FG001|Overall Study|Unable to schedule|16|||
164260137|NCT02136680|593320342|FG000|Overall Study|Study ended before interview due|6|||
164681104|NCT00112437|594854592|FG021|Years 6-10 (60-Month Extension)|Other|0|||
164681105|NCT00112437|594854593|FG022|Years 6-10 (60-Month Extension)|Other|0|||
164681106|NCT00112437|594854594|FG023|Years 6-10 (60-Month Extension)|Other|0|||
164681107|NCT00112437|594854595|FG024|Years 6-10 (60-Month Extension)|Other|1|||
164681108|NCT00112437|594854596|FG025|Years 6-10 (60-Month Extension)|Other|0|||
164681109|NCT00112437|594854571|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681110|NCT00112437|594854572|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681111|NCT00112437|594854573|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681112|NCT00112437|594854574|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681113|NCT00112437|594854575|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681114|NCT00112437|594854576|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681115|NCT00112437|594854577|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681116|NCT00112437|594854578|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681117|NCT00112437|594854579|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681118|NCT00112437|594854580|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681119|NCT00112437|594854581|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681120|NCT00112437|594854582|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681121|NCT00112437|594854583|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681122|NCT00112437|594854584|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681123|NCT00112437|594854585|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681124|NCT00112437|594854586|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681125|NCT00112437|594854587|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681126|NCT00112437|594854588|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681127|NCT00112437|594854589|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681128|NCT00112437|594854590|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681129|NCT00112437|594854591|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681130|NCT00112437|594854592|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681131|NCT00112437|594854593|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681132|NCT00112437|594854594|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
164681133|NCT00112437|594854595|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681134|NCT00112437|594854596|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164681135|NCT00112437|594854571|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164681136|NCT00112437|594854572|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164260138|NCT02136680|593320343|FG001|Overall Study|Study ended before interview due|3|||
164260139|NCT03136497|593321952|FG000|Overall Study|Screen Failure|1|||
164260140|NCT03136497|593321953|FG001|Overall Study|Screen Failure|0|||
164260141|NCT03136497|593321954|FG002|Overall Study|Screen Failure|0|||
164260142|NCT00557310|593321956|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
164260143|NCT00557310|593321956|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
164260144|NCT00557310|593321956|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
164260145|NCT00557310|593321956|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
164260146|NCT00557310|593321956|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
164260147|NCT00557310|593321956|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
164260148|NCT02351349|593321957|FG000|Overall Study|Withdrawal by Subject|2|||
164260149|NCT02351349|593321958|FG001|Overall Study|Withdrawal by Subject|3|||
164260150|NCT02649218|593321959|FG000|Overall Study|Adverse Event|8|||
164260151|NCT02649218|593321959|FG000|Overall Study|Lack of Efficacy|8|||
164260152|NCT02649218|593321959|FG000|Overall Study|Pregnancy|3|||
164260153|NCT02649218|593321959|FG000|Overall Study|Protocol Violation|3|||
164260154|NCT02649218|593321959|FG000|Overall Study|Physician Decision|1|||
164260155|NCT02649218|593321959|FG000|Overall Study|Withdrawal by Subject|2|||
164260156|NCT01224821|593321960|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
164260157|NCT01224821|593321960|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
164260158|NCT01224821|593321960|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
164260159|NCT01224821|593321960|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
164260160|NCT01224821|593321960|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
164260161|NCT01224821|593321960|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
164260162|NCT01224821|593321960|FG000|Long-Term Follow-Up|Death|2|||
164260163|NCT01224821|593321960|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
164260164|NCT02174523|593321961|FG000|Overall Study|Withdrawal by Subject|1|||
164260165|NCT02174523|593321962|FG001|Overall Study|Withdrawal by Subject|0|||
164260166|NCT00794365|593321963|FG000|Overall Study|Lost to Follow-up|38|||
164260167|NCT00794365|593321963|FG000|Overall Study|Other|17|||
164260168|NCT00794365|593321963|FG000|Overall Study|Poor Compliance|11|||
164260169|NCT00794365|593321963|FG000|Overall Study|Adverse Event|10|||
164260170|NCT00794365|593321963|FG000|Overall Study|Lack of Efficacy|3|||
164260171|NCT01451931|593321966|FG000|Overall Study|Lost to Follow-up|17|||
164260172|NCT01451931|593321967|FG001|Overall Study|Lost to Follow-up|36|||
164260173|NCT01451931|593321968|FG002|Overall Study|Lost to Follow-up|21|||
164260174|NCT01451931|593321966|FG000|Overall Study|Withdrawal by Subject|16|||
164260175|NCT01451931|593321967|FG001|Overall Study|Withdrawal by Subject|22|||
164260176|NCT01451931|593321968|FG002|Overall Study|Withdrawal by Subject|22|||
164260177|NCT04422561|593321969|FG000|Overall Study|Lost to Follow-up|25|||
164340509|NCT02569671|593620632|FG000|Overall Study|Withdrawal by Subject|1|||
164340510|NCT02569671|593620633|FG001|Overall Study|Withdrawal by Subject|3|||
164340511|NCT01757535|593620634|FG000|Overall Study|Disease Relapse|151|||
164577194|NCT03830281|594476851|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
164577195|NCT03830281|594476850|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
164577196|NCT03830281|594476851|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
164577197|NCT03830281|594476850|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
164577198|NCT03830281|594476851|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
164577199|NCT03830281|594476850|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
164577200|NCT03830281|594476851|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
164577201|NCT03830281|594476850|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
164577202|NCT03830281|594476851|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
164577203|NCT03830281|594476850|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
164577204|NCT03830281|594476851|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
164260178|NCT04422561|593321970|FG001|Overall Study|Lost to Follow-up|11|||
164260179|NCT00230282|593321976|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
164260180|NCT00230282|593321976|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
164260181|NCT00230282|593321976|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
164260182|NCT00230282|593321976|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
164260183|NCT04669262|593321986|FG000|Overall Study|Withdrawal by Subject|0|||
164260184|NCT04669262|593321987|FG001|Overall Study|Withdrawal by Subject|0|||
164340512|NCT01757535|593620635|FG001|Overall Study|Disease Relapse|181|||
164577205|NCT03830281|594476850|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
164260185|NCT04669262|593321988|FG002|Overall Study|Withdrawal by Subject|0|||
164260186|NCT04669262|593321989|FG003|Overall Study|Withdrawal by Subject|1|||
164260187|NCT04669262|593321986|FG000|Overall Study|Randomized but Not Treated|0|||
164260188|NCT04669262|593321987|FG001|Overall Study|Randomized but Not Treated|1|||
164260189|NCT04669262|593321988|FG002|Overall Study|Randomized but Not Treated|0|||
164260190|NCT04669262|593321989|FG003|Overall Study|Randomized but Not Treated|0|||
164260191|NCT01638013|593321990|FG000|Overall Study|Adverse Event|36|||
164260192|NCT01638013|593321991|FG001|Overall Study|Adverse Event|29|||
164260193|NCT01638013|593321992|FG002|Overall Study|Adverse Event|48|||
164260194|NCT01638013|593321990|FG000|Overall Study|Lack of Efficacy|39|||
164260195|NCT01638013|593321991|FG001|Overall Study|Lack of Efficacy|11|||
164260196|NCT01638013|593321992|FG002|Overall Study|Lack of Efficacy|14|||
164260197|NCT01638013|593321990|FG000|Overall Study|Protocol Violation|10|||
164260198|NCT01638013|593321991|FG001|Overall Study|Protocol Violation|7|||
164260199|NCT01638013|593321992|FG002|Overall Study|Protocol Violation|11|||
164260200|NCT01638013|593321990|FG000|Overall Study|Met discontinuation criteria|4|||
164260201|NCT01638013|593321991|FG001|Overall Study|Met discontinuation criteria|0|||
164260202|NCT01638013|593321992|FG002|Overall Study|Met discontinuation criteria|7|||
164260203|NCT01638013|593321990|FG000|Overall Study|Subject Lost to Follow up|1|||
164260204|NCT01638013|593321991|FG001|Overall Study|Subject Lost to Follow up|0|||
164260205|NCT01638013|593321992|FG002|Overall Study|Subject Lost to Follow up|1|||
164260206|NCT01638013|593321990|FG000|Overall Study|Miscellaneous|25|||
164260207|NCT01638013|593321991|FG001|Overall Study|Miscellaneous|19|||
164260208|NCT01638013|593321992|FG002|Overall Study|Miscellaneous|23|||
164260209|NCT01638013|593321990|FG000|Overall Study|Withdrawal of Consent|16|||
164260210|NCT01638013|593321991|FG001|Overall Study|Withdrawal of Consent|12|||
164260211|NCT01638013|593321992|FG002|Overall Study|Withdrawal of Consent|16|||
164260212|NCT01638013|593321990|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
164260213|NCT01638013|593321991|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
164260214|NCT01638013|593321992|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
164260215|NCT02701777|593321993|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
164260216|NCT02701777|593321994|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
164260217|NCT02701777|593321995|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
164260218|NCT02701777|593321996|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
164340513|NCT01757535|593620634|FG000|Overall Study|Other Reasons|28|||
164340514|NCT01757535|593620635|FG001|Overall Study|Other Reasons|27|||
164340515|NCT01757535|593620634|FG000|Overall Study|Adverse Event|31|||
164340516|NCT01757535|593620635|FG001|Overall Study|Adverse Event|11|||
164340517|NCT01757535|593620634|FG000|Overall Study|Withdrew Consent|19|||
164340518|NCT01757535|593620635|FG001|Overall Study|Withdrew Consent|13|||
164340519|NCT01757535|593620634|FG000|Overall Study|Physician Decision|7|||
164340520|NCT01757535|593620635|FG001|Overall Study|Physician Decision|0|||
164340521|NCT01757535|593620634|FG000|Overall Study|Death|2|||
164340522|NCT01757535|593620635|FG001|Overall Study|Death|2|||
164340523|NCT00589290|593620636|FG000|Overall Study|Withdrawal by Subject|1|||
164340524|NCT03730012|593620638|FG000|Overall Study|Adverse Event|0|||
164340525|NCT03730012|593620639|FG001|Overall Study|Adverse Event|1|||
164340526|NCT03730012|593620638|FG000|Overall Study|Lack of Efficacy|1|||
164340527|NCT03730012|593620639|FG001|Overall Study|Lack of Efficacy|5|||
164340528|NCT03730012|593620638|FG000|Overall Study|Withdrawal by Subject|0|||
164340529|NCT03730012|593620639|FG001|Overall Study|Withdrawal by Subject|1|||
164340530|NCT03730012|593620638|FG000|Overall Study|Miscellaneous|2|||
164340531|NCT03730012|593620639|FG001|Overall Study|Miscellaneous|1|||
164340532|NCT01367002|593622197|FG000|Overall Study|Withdrawal by Subject|1|||
164340533|NCT01367002|593622198|FG001|Overall Study|Withdrawal by Subject|0|||
164340534|NCT01367002|593622197|FG000|Overall Study|Physician Decision|0|||
164340535|NCT01367002|593622198|FG001|Overall Study|Physician Decision|2|||
164340536|NCT00403234|593622199|FG000|Overall Study|Withdrawal by Subject|0|||
164340537|NCT00403234|593622200|FG001|Overall Study|Withdrawal by Subject|1|||
164340538|NCT00403234|593622201|FG002|Overall Study|Withdrawal by Subject|0|||
164340539|NCT00403234|593622202|FG003|Overall Study|Withdrawal by Subject|0|||
164340540|NCT00403234|593622199|FG000|Overall Study|Adverse Event|1|||
164340541|NCT00403234|593622200|FG001|Overall Study|Adverse Event|0|||
164260219|NCT02701777|593321993|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
164260220|NCT02701777|593321994|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
164260221|NCT02701777|593321995|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
164260222|NCT02701777|593321996|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
164260223|NCT01960998|593322001|FG000|Overall Study|Lost to Follow-up|3|||
164260224|NCT01960998|593322002|FG001|Overall Study|Lost to Follow-up|7|||
164260225|NCT01960998|593322001|FG000|Overall Study|Death|0|||
164260226|NCT01960998|593322002|FG001|Overall Study|Death|1|||
164260227|NCT01960998|593322001|FG000|Overall Study|Withdrawal by Subject|8|||
164260228|NCT01960998|593322002|FG001|Overall Study|Withdrawal by Subject|2|||
164260229|NCT01960998|593322001|FG000|Overall Study|lost computer access|0|||
164260230|NCT01960998|593322002|FG001|Overall Study|lost computer access|1|||
164577206|NCT03830281|594476851|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
164260231|NCT01904149|593322005|FG000|Overall Study|Adverse Event|3|||
164260232|NCT01904149|593322006|FG001|Overall Study|Adverse Event|4|||
164260233|NCT01904149|593322007|FG002|Overall Study|Adverse Event|0|||
164260234|NCT01904149|593322008|FG003|Overall Study|Adverse Event|1|||
164260235|NCT01904149|593322009|FG004|Overall Study|Adverse Event|1|||
164260236|NCT01904149|593322010|FG005|Overall Study|Adverse Event|2|||
164260237|NCT01904149|593322005|FG000|Overall Study|Lack of Efficacy|0|||
164260238|NCT01904149|593322006|FG001|Overall Study|Lack of Efficacy|3|||
164260239|NCT01904149|593322007|FG002|Overall Study|Lack of Efficacy|1|||
164260240|NCT01904149|593322008|FG003|Overall Study|Lack of Efficacy|3|||
164260241|NCT01904149|593322009|FG004|Overall Study|Lack of Efficacy|3|||
164260242|NCT01904149|593322010|FG005|Overall Study|Lack of Efficacy|1|||
164260243|NCT01904149|593322005|FG000|Overall Study|Withdrawal by Subject|1|||
164260244|NCT01904149|593322006|FG001|Overall Study|Withdrawal by Subject|3|||
164260245|NCT01904149|593322007|FG002|Overall Study|Withdrawal by Subject|1|||
164260246|NCT01904149|593322008|FG003|Overall Study|Withdrawal by Subject|0|||
164260247|NCT01904149|593322009|FG004|Overall Study|Withdrawal by Subject|1|||
164260248|NCT01904149|593322010|FG005|Overall Study|Withdrawal by Subject|0|||
164260249|NCT01904149|593322005|FG000|Overall Study|Protocol Violation|0|||
164260250|NCT01904149|593322006|FG001|Overall Study|Protocol Violation|1|||
164260251|NCT01904149|593322007|FG002|Overall Study|Protocol Violation|0|||
164260252|NCT01904149|593322008|FG003|Overall Study|Protocol Violation|0|||
164260253|NCT01904149|593322009|FG004|Overall Study|Protocol Violation|0|||
164260254|NCT01904149|593322010|FG005|Overall Study|Protocol Violation|0|||
164260255|NCT01904149|593322005|FG000|Overall Study|non compliance with study drug|1|||
164260256|NCT01904149|593322006|FG001|Overall Study|non compliance with study drug|0|||
164260257|NCT01904149|593322007|FG002|Overall Study|non compliance with study drug|0|||
164260258|NCT01904149|593322008|FG003|Overall Study|non compliance with study drug|0|||
164260259|NCT01904149|593322009|FG004|Overall Study|non compliance with study drug|0|||
164260260|NCT01904149|593322010|FG005|Overall Study|non compliance with study drug|0|||
164260261|NCT01357161|593322011|FG000|Part 1 (Open Label Run-in)|Death|5|||
164260262|NCT01357161|593322012|FG001|Part 1 (Open Label Run-in)|Death|0|||
164260263|NCT01357161|593322013|FG002|Part 1 (Open Label Run-in)|Death|0|||
164260264|NCT01357161|593322011|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
164260265|NCT01357161|593322012|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
164260266|NCT01357161|593322013|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
164260267|NCT01357161|593322011|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
164260268|NCT01357161|593322012|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
164260269|NCT01357161|593322013|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
164260270|NCT01357161|593322011|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
164260271|NCT01357161|593322012|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
164260272|NCT01357161|593322013|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
164260273|NCT01357161|593322011|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
164260274|NCT01357161|593322012|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
164260275|NCT01357161|593322013|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
164260276|NCT01357161|593322011|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
164260277|NCT01357161|593322012|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
164260278|NCT01357161|593322013|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
164260279|NCT01357161|593322011|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
164260280|NCT01357161|593322012|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
164260281|NCT01357161|593322013|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
164260282|NCT01357161|593322011|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
164260283|NCT01357161|593322012|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
164260284|NCT01357161|593322013|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
164260285|NCT01357161|593322011|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
164260286|NCT01357161|593322012|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
164260287|NCT01357161|593322013|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
164260288|NCT01357161|593322011|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
164260289|NCT01357161|593322012|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
164340542|NCT00403234|593622201|FG002|Overall Study|Adverse Event|1|||
164260290|NCT01357161|593322013|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
164260291|NCT01357161|593322011|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
164260292|NCT01357161|593322012|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
164260293|NCT01357161|593322013|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
164260294|NCT01824823|593322014|FG000|Overall Study|Lack of Efficacy|1|||
164260295|NCT01824823|593322015|FG001|Overall Study|Lack of Efficacy|1|||
164260296|NCT01824823|593322014|FG000|Overall Study|Off-treatment reason not submitted|1|||
164260297|NCT01824823|593322015|FG001|Overall Study|Off-treatment reason not submitted|0|||
164260298|NCT03349645|593322016|FG000|Overall Study|Sponsor Terminated Study|75|||
164260299|NCT03349645|593322016|FG000|Overall Study|Withdrawal by Subject|4|||
164260300|NCT03349645|593322016|FG000|Overall Study|Protocol Violation|1|||
164260301|NCT03349645|593322016|FG000|Overall Study|Other|2|||
164260302|NCT02910401|593322017|FG000|Overall Study|Study closure Study closure|0|||
164260303|NCT02910401|593322018|FG001|Overall Study|Study closure Study closure|0|||
164260304|NCT02910401|593322019|FG002|Overall Study|Study closure Study closure|2|||
164260305|NCT02910401|593322017|FG000|Overall Study|Physician Decision|1|||
164260306|NCT02910401|593322018|FG001|Overall Study|Physician Decision|0|||
164260307|NCT02910401|593322019|FG002|Overall Study|Physician Decision|0|||
164260308|NCT00433160|593322022|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
164260309|NCT00433160|593322023|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
164260310|NCT00433160|593322022|FG000|52-Week Double-Blind (DB) Period|Death|0|||
164260311|NCT00433160|593322023|FG001|52-Week Double-Blind (DB) Period|Death|0|||
164260312|NCT00433160|593322022|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
164260313|NCT00433160|593322023|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
164260314|NCT00433160|593322022|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
164260315|NCT00433160|593322023|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
164260316|NCT00433160|593322022|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
164260317|NCT00433160|593322023|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
164260318|NCT00433160|593322022|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
164260319|NCT00433160|593322023|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
164260320|NCT00433160|593322022|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
164260321|NCT00433160|593322023|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
164260322|NCT00433160|593322022|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
164260323|NCT00433160|593322023|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
164260324|NCT00433160|593322022|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
164260325|NCT00433160|593322023|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
164260326|NCT00433160|593322022|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
164260327|NCT00433160|593322023|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
164260328|NCT00433160|593322022|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
164260329|NCT00433160|593322023|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
164260330|NCT00433160|593322022|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
164260331|NCT00433160|593322023|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
164260332|NCT00433160|593322022|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
164260333|NCT00433160|593322023|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
164260334|NCT00433160|593322022|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
164260335|NCT00433160|593322023|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
164260336|NCT00433160|593322022|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
164260337|NCT00433160|593322023|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
164260338|NCT00433160|593322022|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
164260339|NCT00433160|593322023|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
164260340|NCT01774253|593322024|FG000|Overall Study|Lack of Efficacy|4|||
164260341|NCT01774253|593322024|FG000|Overall Study|Physician Decision|2|||
164260342|NCT01774253|593322024|FG000|Overall Study|Withdrawal by Subject|2|||
164260343|NCT01774253|593322024|FG000|Overall Study|Death|1|||
164260344|NCT00772369|593322025|FG000|Overall Study|Did not return record release form|1|||
164260345|NCT02240368|593322029|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
164260346|NCT02240368|593322030|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
164260347|NCT02240368|593322031|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
164260348|NCT02240368|593322029|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
164260349|NCT02240368|593322030|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
164260350|NCT02240368|593322031|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
164260351|NCT03510468|593322032|FG000|Overall Study|Lost to Follow-up|1|||
164260352|NCT03510468|593322032|FG000|Overall Study|Adverse Event|5|||
164260353|NCT03510468|593322032|FG000|Overall Study|Physician Decision|1|||
164260354|NCT03510468|593322032|FG000|Overall Study|non-compliant with treatment|2|||
164340543|NCT00403234|593622202|FG003|Overall Study|Adverse Event|0|||
164340544|NCT00560105|593622205|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
164340545|NCT00560105|593622206|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
164260355|NCT03510468|593322032|FG000|Overall Study|Missed visit|1|||
164260356|NCT03372460|593322034|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
164681137|NCT00112437|594854573|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164681138|NCT00112437|594854574|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164681139|NCT00112437|594854575|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164681140|NCT00112437|594854576|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164681141|NCT00112437|594854577|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164681142|NCT00112437|594854578|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164681143|NCT00112437|594854579|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164681144|NCT00112437|594854580|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164681145|NCT00112437|594854581|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164681146|NCT00112437|594854582|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164681147|NCT00112437|594854583|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164681148|NCT00112437|594854584|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164681149|NCT00112437|594854585|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164681150|NCT00112437|594854586|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164681151|NCT00112437|594854587|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164260357|NCT03372460|593322035|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
164260358|NCT00916058|593322043|FG000|Phase 1|Screen Failure|0|||
164260359|NCT00916058|593322044|FG001|Phase 1|Screen Failure|0|||
164260360|NCT00916058|593322045|FG002|Phase 1|Screen Failure|0|||
164260361|NCT00916058|593322046|FG003|Phase 1|Screen Failure|0|||
164260362|NCT00916058|593322047|FG004|Phase 1|Screen Failure|0|||
164681152|NCT00112437|594854588|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164681153|NCT00112437|594854589|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164260363|NCT00916058|593322048|FG005|Phase 1|Screen Failure|1|||
164260364|NCT00916058|593322049|FG006|Phase 1|Screen Failure|0|||
164260365|NCT00916058|593322043|FG000|Phase 2|Screen Failure|0|||
164260366|NCT00916058|593322044|FG001|Phase 2|Screen Failure|0|||
164260367|NCT00916058|593322045|FG002|Phase 2|Screen Failure|0|||
164260368|NCT00916058|593322046|FG003|Phase 2|Screen Failure|0|||
164260369|NCT00916058|593322047|FG004|Phase 2|Screen Failure|0|||
164260370|NCT00916058|593322048|FG005|Phase 2|Screen Failure|0|||
164260371|NCT00916058|593322049|FG006|Phase 2|Screen Failure|3|||
164260372|NCT00871117|593322050|FG000|Overall Study|Lost to Follow-up|5|||
164260373|NCT00871117|593322051|FG001|Overall Study|Lost to Follow-up|6|||
164260374|NCT00871117|593322050|FG000|Overall Study|Other|0|||
164260375|NCT00871117|593322051|FG001|Overall Study|Other|4|||
164260376|NCT03222973|593322052|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
164260377|NCT03222973|593322053|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
164260378|NCT03222973|593322054|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
164260379|NCT03222973|593322055|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
164260380|NCT03222973|593322052|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
164260381|NCT03222973|593322053|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
164260382|NCT03222973|593322054|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
164260383|NCT03222973|593322055|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
164260384|NCT03222973|593322052|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
164260385|NCT03222973|593322053|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
164260386|NCT03222973|593322054|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
164260387|NCT03222973|593322055|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
164260388|NCT03222973|593322052|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
164260389|NCT03222973|593322053|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
164260390|NCT03222973|593322054|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
164260391|NCT03222973|593322055|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
164260392|NCT03222973|593322052|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
164260393|NCT03222973|593322053|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
164260394|NCT03222973|593322054|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
164260395|NCT03222973|593322055|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
164260396|NCT03222973|593322052|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
164260397|NCT03222973|593322053|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
164260398|NCT03222973|593322054|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
164260399|NCT03222973|593322055|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
164260400|NCT03222973|593322052|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
164260401|NCT03222973|593322053|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
164260402|NCT03222973|593322054|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
164260403|NCT03222973|593322055|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
164681154|NCT00112437|594854590|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164681155|NCT00112437|594854591|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164260404|NCT03222973|593322052|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
164260405|NCT03222973|593322053|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
164260406|NCT03222973|593322054|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
164260407|NCT03222973|593322055|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
164260408|NCT03222973|593322052|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
164260409|NCT03222973|593322053|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
164260410|NCT03222973|593322054|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
164260411|NCT03222973|593322055|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
164260412|NCT03222973|593322052|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
164260413|NCT03222973|593322053|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
164260414|NCT03222973|593322054|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
164260415|NCT03222973|593322055|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
164260416|NCT03222973|593322052|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
164260417|NCT03222973|593322053|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
164260418|NCT03222973|593322054|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
164260419|NCT03222973|593322055|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
164260420|NCT03222973|593322052|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
164260421|NCT03222973|593322053|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
164260422|NCT03222973|593322054|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
164260423|NCT03222973|593322055|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
164260424|NCT02080481|593322056|FG000|Overall Study|Never received a block.|1|||
164260425|NCT02080481|593322057|FG001|Overall Study|Never received a block.|0|||
164260426|NCT02439450|593322059|FG000|Overall Study|Adverse Event|4|||
164260427|NCT02439450|593322060|FG001|Overall Study|Adverse Event|1|||
164260428|NCT02439450|593322061|FG002|Overall Study|Adverse Event|0|||
164260429|NCT02439450|593322062|FG003|Overall Study|Adverse Event|0|||
164260430|NCT02439450|593322059|FG000|Overall Study|Withdrawal by Subject|1|||
164260431|NCT02439450|593322060|FG001|Overall Study|Withdrawal by Subject|2|||
164260432|NCT02439450|593322061|FG002|Overall Study|Withdrawal by Subject|0|||
164260433|NCT02439450|593322062|FG003|Overall Study|Withdrawal by Subject|0|||
164260434|NCT02439450|593322059|FG000|Overall Study|Death|3|||
164260435|NCT02439450|593322060|FG001|Overall Study|Death|0|||
164260436|NCT02439450|593322061|FG002|Overall Study|Death|0|||
164260437|NCT02439450|593322062|FG003|Overall Study|Death|1|||
164260438|NCT02439450|593322059|FG000|Overall Study|Progressive Disease|18|||
164260439|NCT02439450|593322060|FG001|Overall Study|Progressive Disease|41|||
164260440|NCT02439450|593322061|FG002|Overall Study|Progressive Disease|2|||
164260441|NCT02439450|593322062|FG003|Overall Study|Progressive Disease|3|||
164260442|NCT03730961|593322067|FG000|Overall Study|Adverse Event|0|||
164260443|NCT03730961|593322068|FG001|Overall Study|Adverse Event|1|||
164260444|NCT04508751|593322071|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
164260445|NCT04508751|593322072|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
164260446|NCT04508751|593322073|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
164340546|NCT01550289|593622207|FG000|Overall Study|Protocol Violation|1|||
164340547|NCT01550289|593622208|FG001|Overall Study|Protocol Violation|0|||
164340548|NCT01550289|593622207|FG000|Overall Study|Lost to Follow-up|1|||
164681156|NCT00112437|594854592|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164681157|NCT00112437|594854593|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
164681158|NCT00112437|594854594|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
164681159|NCT00112437|594854595|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164681160|NCT00112437|594854596|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
164681161|NCT01824576|594854598|FG000|Overall Study|Device deficiency|2|||
164681162|NCT03218787|594854604|FG000|Overall Study|Lost to Follow-up|12|||
164681163|NCT03218787|594854604|FG000|Overall Study|Withdrawal by Subject|72|||
164681164|NCT03218787|594854604|FG000|Overall Study|Physician Decision|11|||
164681165|NCT03218787|594854604|FG000|Overall Study|Death|111|||
164681166|NCT02896296|594854605|FG000|Overall Study|Adverse Event|1|||
164681167|NCT02896296|594854605|FG000|Overall Study|Lost to Follow-up|19|||
164681168|NCT02896296|594854605|FG000|Overall Study|Pregnancy|1|||
164681169|NCT02896296|594854605|FG000|Overall Study|Physician Decision|2|||
164260447|NCT01444027|593322084|FG000|Overall Study|Withdrawal by Subject|4|||
164260448|NCT01444027|593322085|FG001|Overall Study|Withdrawal by Subject|10|||
164260449|NCT01444027|593322086|FG002|Overall Study|Withdrawal by Subject|24|||
164260450|NCT01444027|593322084|FG000|Overall Study|Lost to Follow-up|26|||
164260451|NCT01444027|593322085|FG001|Overall Study|Lost to Follow-up|20|||
164260452|NCT01444027|593322086|FG002|Overall Study|Lost to Follow-up|14|||
164260453|NCT03551665|593322088|FG000|Overall Study|Lost to Follow-up|11|||
164260454|NCT03551665|593322089|FG001|Overall Study|Lost to Follow-up|2|||
164260455|NCT03966885|593323541|FG000|Overall Study|Death|1|||
164260456|NCT03966885|593323542|FG001|Overall Study|Death|0|||
164260457|NCT03966885|593323541|FG000|Overall Study|Lost to Follow-up|1|||
164260458|NCT03966885|593323542|FG001|Overall Study|Lost to Follow-up|2|||
164260459|NCT03966885|593323541|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
164260460|NCT03966885|593323542|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
164260461|NCT03966885|593323541|FG000|Overall Study|Moved from study area.|0|||
164260462|NCT03966885|593323542|FG001|Overall Study|Moved from study area.|2|||
164340549|NCT01550289|593622208|FG001|Overall Study|Lost to Follow-up|1|||
164340550|NCT01550289|593622207|FG000|Overall Study|Withdrawal by Subject|11|||
164260463|NCT00840060|593323543|FG000|Overall Study|Withdrawal by Subject|1|||
164260464|NCT00840060|593323544|FG001|Overall Study|Withdrawal by Subject|0|||
164260465|NCT00840060|593323543|FG000|Overall Study|Change in emotional/behavioral status|0|||
164340551|NCT01550289|593622208|FG001|Overall Study|Withdrawal by Subject|3|||
164681170|NCT02896296|594854605|FG000|Overall Study|Withdrawal by Subject|10|||
164681171|NCT02896296|594854605|FG000|Overall Study|Site closing|7|||
164681172|NCT02896296|594854605|FG000|Overall Study|Incarceration|1|||
164681173|NCT02896296|594854605|FG000|Overall Study|Relocation|1|||
164681174|NCT01120028|594854608|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
164681175|NCT01120028|594854609|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
164681176|NCT01120028|594854610|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
164681177|NCT01120028|594854611|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
164681178|NCT01120028|594854608|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
164681179|NCT01120028|594854609|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
164681180|NCT01120028|594854610|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
164681181|NCT01120028|594854611|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
164681182|NCT01473953|594854612|FG000|Overall Study|Other|1|||
164681183|NCT01473953|594854613|FG001|Overall Study|Other|0|||
164681184|NCT01473953|594854614|FG002|Overall Study|Other|0|||
164681185|NCT01473953|594854615|FG003|Overall Study|Other|0|||
164681186|NCT01473953|594854616|FG004|Overall Study|Other|0|||
164681187|NCT04633564|594854617|FG000|Period 1|Adverse Event|28|||
164681188|NCT04633564|594854618|FG001|Period 1|Adverse Event|19|||
164681189|NCT04633564|594854617|FG000|Period 1|Death|8|||
164681190|NCT04633564|594854618|FG001|Period 1|Death|7|||
164681191|NCT04633564|594854617|FG000|Period 1|Lost to Follow-up|3|||
164681192|NCT04633564|594854618|FG001|Period 1|Lost to Follow-up|5|||
164681193|NCT04633564|594854617|FG000|Period 1|Physician Decision|4|||
164681194|NCT04633564|594854618|FG001|Period 1|Physician Decision|12|||
164681195|NCT04633564|594854617|FG000|Period 1|Protocol Violation|0|||
164681196|NCT04633564|594854618|FG001|Period 1|Protocol Violation|1|||
164681197|NCT04633564|594854617|FG000|Period 1|Withdrawal by Subject|10|||
164681198|NCT04633564|594854618|FG001|Period 1|Withdrawal by Subject|8|||
164681199|NCT04633564|594854617|FG000|Period 1|Progressive disease|47|||
164681200|NCT04633564|594854618|FG001|Period 1|Progressive disease|51|||
164681201|NCT04633564|594854617|FG000|Period 1|Terminated by Sponsor|8|||
164681202|NCT04633564|594854618|FG001|Period 1|Terminated by Sponsor|6|||
164681203|NCT04633564|594854617|FG000|Period 2|Adverse Event|3|||
164681204|NCT04633564|594854618|FG001|Period 2|Adverse Event|4|||
164681205|NCT04633564|594854617|FG000|Period 2|Death|0|||
164681206|NCT04633564|594854618|FG001|Period 2|Death|2|||
164681207|NCT04633564|594854617|FG000|Period 2|Lost to Follow-up|0|||
164681208|NCT04633564|594854618|FG001|Period 2|Lost to Follow-up|1|||
164681209|NCT04633564|594854617|FG000|Period 2|Physician Decision|2|||
164681210|NCT04633564|594854618|FG001|Period 2|Physician Decision|4|||
164681211|NCT04633564|594854617|FG000|Period 2|Withdrawal by Subject|5|||
164681212|NCT04633564|594854618|FG001|Period 2|Withdrawal by Subject|1|||
164681213|NCT04633564|594854617|FG000|Period 2|Progressive Disease|74|||
164681214|NCT04633564|594854618|FG001|Period 2|Progressive Disease|82|||
164681215|NCT04633564|594854617|FG000|Period 2|Terminated by Sponsor|9|||
164681216|NCT04633564|594854618|FG001|Period 2|Terminated by Sponsor|3|||
164681217|NCT01279486|594854619|FG000|Overall Study|Lost to Follow-up|1|||
164681218|NCT04198363|594854620|FG000|Overall Study|Adverse Event|1|||
164681219|NCT04198363|594854621|FG001|Overall Study|Adverse Event|1|||
164681220|NCT04198363|594854620|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
164260466|NCT00840060|593323544|FG001|Overall Study|Change in emotional/behavioral status|1|||
164260467|NCT01514240|593323545|FG000|Overall Study|Adverse Event|4|||
164260468|NCT01514240|593323546|FG001|Overall Study|Adverse Event|4|||
164260469|NCT01514240|593323545|FG000|Overall Study|Subject Decision|2|||
164681221|NCT04198363|594854621|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
164260470|NCT01514240|593323546|FG001|Overall Study|Subject Decision|7|||
164260471|NCT00509093|593323547|FG000|Overall Study|Adverse Event|10|||
164260472|NCT00509093|593323547|FG000|Overall Study|Disease Progression|9|||
164260473|NCT00509093|593323547|FG000|Overall Study|Transformed into MDS|1|||
164260474|NCT00509093|593323547|FG000|Overall Study|Withdrawal by Subject|3|||
164340552|NCT03539081|593622209|FG000|Overall Study|Withdrawal by Subject|2|||
164681222|NCT04198363|594854620|FG000|Overall Study|Reason not Specified|1|||
164681223|NCT04198363|594854621|FG001|Overall Study|Reason not Specified|0|||
164260475|NCT00509093|593323547|FG000|Overall Study|Physician Decision|1|||
164681224|NCT03215706|594854625|FG000|Randomization|Adverse Event unrelated to study drug|1|||
164681225|NCT03215706|594854626|FG001|Randomization|Adverse Event unrelated to study drug|0|||
164681226|NCT03215706|594854625|FG000|Randomization|participant withdrew consent|1|||
164681227|NCT03215706|594854626|FG001|Randomization|participant withdrew consent|3|||
164681228|NCT03215706|594854625|FG000|Randomization|no longer meets study criteria|1|||
164681229|NCT03215706|594854626|FG001|Randomization|no longer meets study criteria|4|||
164681230|NCT03215706|594854625|FG000|Randomization|other reasons|0|||
164260476|NCT05013424|593323548|FG000|Overall Study|Lost to Follow-up|1|||
164260477|NCT05013424|593323549|FG001|Overall Study|Lost to Follow-up|1|||
164260478|NCT05013424|593323550|FG002|Overall Study|Lost to Follow-up|1|||
164681231|NCT03215706|594854626|FG001|Randomization|other reasons|2|||
164681232|NCT03215706|594854625|FG000|Treatment Period|Disease Progression|184|||
164681233|NCT03215706|594854626|FG001|Treatment Period|Disease Progression|174|||
164260479|NCT05013424|593323548|FG000|Overall Study|Withdrawal by Subject|0|||
164260480|NCT05013424|593323549|FG001|Overall Study|Withdrawal by Subject|1|||
164260481|NCT05013424|593323550|FG002|Overall Study|Withdrawal by Subject|0|||
164260482|NCT01103063|593323551|FG000|Overall Study|Adverse Event|3|||
164260483|NCT01103063|593323552|FG001|Overall Study|Adverse Event|1|||
164260484|NCT01103063|593323551|FG000|Overall Study|Lost to Follow-up|68|||
164260485|NCT01103063|593323552|FG001|Overall Study|Lost to Follow-up|51|||
164260486|NCT01103063|593323551|FG000|Overall Study|Withdrawal by Subject|60|||
164260487|NCT01103063|593323552|FG001|Overall Study|Withdrawal by Subject|15|||
164260488|NCT01103063|593323551|FG000|Overall Study|Other|16|||
164260489|NCT01103063|593323552|FG001|Overall Study|Other|11|||
164260490|NCT01103063|593323551|FG000|Overall Study|Protocol Violation|1|||
164260491|NCT01103063|593323552|FG001|Overall Study|Protocol Violation|0|||
164260492|NCT01103063|593323551|FG000|Overall Study|Study terminated by Sponsor|326|||
164260493|NCT01103063|593323552|FG001|Overall Study|Study terminated by Sponsor|342|||
164260494|NCT01103063|593323551|FG000|Overall Study|Death|3|||
164260495|NCT01103063|593323552|FG001|Overall Study|Death|1|||
164260496|NCT03899064|593323561|FG000|Overall Study|Lost to Follow-up|1|||
164260497|NCT03899064|593323561|FG000|Overall Study|Protocol Violation|2|||
164260498|NCT03899064|593323561|FG000|Overall Study|Withdrawal by Subject|2|||
164260499|NCT03899064|593323561|FG000|Overall Study|Other|2|||
164260500|NCT03283098|593323562|FG000|Overall Study|Withdrawal by Subject|0|||
164260501|NCT03283098|593323563|FG001|Overall Study|Withdrawal by Subject|1|||
164260502|NCT01069861|593323567|FG000|Overall Study|Death|1|||
164260503|NCT01069861|593323567|FG000|Overall Study|Adverse Event|1|||
164260504|NCT01069861|593323567|FG000|Overall Study|Did not meet entrance criteria|1|||
164260505|NCT00354107|593323568|FG000|Overall Study|Adverse Event|2|||
164260506|NCT00354107|593323568|FG000|Overall Study|Physician Decision|2|||
164260507|NCT00354107|593323568|FG000|Overall Study|Withdrawal by Subject|1|||
164260508|NCT03538444|593323577|FG000|Overall Study|opioid withdrawal|1|||
164260509|NCT03538444|593323578|FG001|Overall Study|opioid withdrawal|0|||
164260510|NCT00457821|593323584|FG000|Part 2|Withdrawal by Subject|0|||
164260511|NCT00457821|593323585|FG001|Part 2|Withdrawal by Subject|0|||
164260512|NCT00457821|593323586|FG002|Part 2|Withdrawal by Subject|0|||
164260513|NCT00457821|593323587|FG003|Part 2|Withdrawal by Subject|0|||
164260514|NCT00457821|593323588|FG004|Part 2|Withdrawal by Subject|0|||
164260515|NCT00457821|593323589|FG005|Part 2|Withdrawal by Subject|0|||
164260516|NCT00457821|593323590|FG006|Part 2|Withdrawal by Subject|0|||
164260517|NCT00457821|593323591|FG007|Part 2|Withdrawal by Subject|1|||
164260518|NCT00790647|593323596|FG000|Overall Study|Adverse Event|1|||
164260519|NCT02437409|593323601|FG000|Overall Study|Withdrawal by Subject|3|||
164260520|NCT02437409|593323601|FG000|Overall Study|Screening failure|12|||
164260521|NCT00027378|593323602|FG000|Overall Study|Physician Decision|0|||
164260522|NCT00027378|593323603|FG001|Overall Study|Physician Decision|3|||
164260523|NCT01369680|593323605|FG000|Overall Study|Lost to Follow-up|0|||
164260524|NCT01369680|593323606|FG001|Overall Study|Lost to Follow-up|0|||
164681234|NCT03215706|594854625|FG000|Treatment Period|Study Drug Toxicity|70|||
164681235|NCT03215706|594854626|FG001|Treatment Period|Study Drug Toxicity|24|||
164681236|NCT03215706|594854625|FG000|Treatment Period|Death|7|||
164681237|NCT03215706|594854626|FG001|Treatment Period|Death|1|||
164681238|NCT03215706|594854625|FG000|Treatment Period|Adverse event unrelated to study drug|31|||
164429689|NCT01168401|593943382|FG006|Overall Study|Withdrawal by Subject|0|||
164681239|NCT03215706|594854626|FG001|Treatment Period|Adverse event unrelated to study drug|27|||
164681240|NCT03215706|594854625|FG000|Treatment Period|Request to D/C treatment|2|||
164260525|NCT01369680|593323607|FG002|Overall Study|Lost to Follow-up|1|||
164260526|NCT01369680|593323608|FG003|Overall Study|Lost to Follow-up|2|||
164260527|NCT03549871|593323609|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
164260528|NCT03549871|593323610|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
164260529|NCT03549871|593323609|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
164260530|NCT03549871|593323610|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
164260531|NCT03549871|593323609|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
164260532|NCT03549871|593323610|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
164260533|NCT03549871|593323609|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
164260534|NCT03549871|593323610|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
164260535|NCT03549871|593323609|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
164260536|NCT03549871|593323610|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
164260537|NCT03549871|593323609|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
164681241|NCT03215706|594854626|FG001|Treatment Period|Request to D/C treatment|10|||
164260538|NCT03549871|593323610|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
164260539|NCT03549871|593323609|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
164260540|NCT03549871|593323610|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
164260541|NCT03549871|593323609|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
164260542|NCT03549871|593323610|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
164260543|NCT03549871|593323609|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
164260544|NCT03549871|593323610|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
164260545|NCT03549871|593323609|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
164260546|NCT03549871|593323610|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
164260547|NCT03549871|593323609|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
164260548|NCT03549871|593323610|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
164260549|NCT00737568|593323613|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
164260550|NCT00737568|593323614|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
164260551|NCT00737568|593323613|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
164260552|NCT00737568|593323614|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
164260553|NCT00737568|593323613|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
164260554|NCT00737568|593323614|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
164260555|NCT00737568|593323613|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
164260556|NCT00737568|593323614|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
164260557|NCT00737568|593323613|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
164260558|NCT00737568|593323614|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
164260559|NCT00737568|593323613|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
164260560|NCT00737568|593323614|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
164260561|NCT00737568|593323613|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
164260562|NCT00737568|593323614|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
164260563|NCT00737568|593323613|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
164260564|NCT00737568|593323614|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
164260565|NCT00737568|593323613|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
164260566|NCT00737568|593323614|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
164260567|NCT01133626|593323615|FG000|Overall Study|Adverse Event|0|||
164260568|NCT01133626|593323616|FG001|Overall Study|Adverse Event|1|||
164260569|NCT01133626|593323617|FG002|Overall Study|Adverse Event|0|||
164260570|NCT01133626|593323615|FG000|Overall Study|Withdrawal by Subject|1|||
164260571|NCT01133626|593323616|FG001|Overall Study|Withdrawal by Subject|2|||
164260572|NCT01133626|593323617|FG002|Overall Study|Withdrawal by Subject|2|||
164260573|NCT01133626|593323615|FG000|Overall Study|Other|0|||
164260574|NCT01133626|593323616|FG001|Overall Study|Other|2|||
164260575|NCT01133626|593323617|FG002|Overall Study|Other|0|||
164260576|NCT00951080|593323618|FG000|Overall Study|Adverse Event|3|||
164260577|NCT00951080|593323619|FG001|Overall Study|Adverse Event|3|||
164260578|NCT00951080|593323618|FG000|Overall Study|Lost to Follow-up|0|||
164260579|NCT00951080|593323619|FG001|Overall Study|Lost to Follow-up|1|||
164260580|NCT00951080|593323618|FG000|Overall Study|Physician Decision|4|||
164260581|NCT00951080|593323619|FG001|Overall Study|Physician Decision|1|||
164260582|NCT00951080|593323618|FG000|Overall Study|Other|19|||
164260583|NCT00951080|593323619|FG001|Overall Study|Other|22|||
164260584|NCT01713283|593323620|FG000|Overall Study|Lack of Efficacy|10|||
164260585|NCT01713283|593323621|FG001|Overall Study|Lack of Efficacy|2|||
164577207|NCT03830281|594476850|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
164260586|NCT01713283|593323620|FG000|Overall Study|Lost to Follow-up|1|||
164260587|NCT01713283|593323621|FG001|Overall Study|Lost to Follow-up|1|||
164260588|NCT00835640|593323622|FG000|Second Intervention|Protocol Violation|1|||
164260589|NCT00835640|593323623|FG001|Second Intervention|Protocol Violation|0|||
164260590|NCT00350272|593323624|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
164260591|NCT00350272|593323625|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
164260592|NCT00350272|593323624|FG000|Blinded 12-Week Treatment|Death|1|||
164260593|NCT00350272|593323625|FG001|Blinded 12-Week Treatment|Death|0|||
164260594|NCT00350272|593323624|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
164260595|NCT00350272|593323625|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
164577208|NCT03830281|594476851|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
164577209|NCT03830281|594476850|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
164577210|NCT03830281|594476851|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
164260596|NCT00350272|593323624|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
164260597|NCT00350272|593323625|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
164260598|NCT00350272|593323624|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
164260599|NCT00350272|593323625|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
164577211|NCT00922935|594476852|FG000|Overall Study|Protocol Violation|0|||
164260600|NCT00350272|593323624|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
164260601|NCT00350272|593323625|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
164260602|NCT00350272|593323624|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
164260603|NCT00350272|593323625|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
164260604|NCT00350272|593323624|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
164260605|NCT00350272|593323625|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
164260606|NCT00350272|593323624|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
164577212|NCT00922935|594476853|FG001|Overall Study|Protocol Violation|3|||
164577213|NCT00922935|594476854|FG002|Overall Study|Protocol Violation|0|||
164260607|NCT00350272|593323625|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
164260608|NCT00350272|593323624|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
164260609|NCT00350272|593323625|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
164260610|NCT00350272|593323624|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
164260611|NCT00350272|593323625|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
164260612|NCT00235391|593323627|FG000|Overall Study|Adverse Event|4|||
164260613|NCT00235391|593323628|FG001|Overall Study|Adverse Event|5|||
164260614|NCT00235391|593323629|FG002|Overall Study|Adverse Event|10|||
164260615|NCT00235391|593323630|FG003|Overall Study|Adverse Event|72|||
164260616|NCT00235391|593323631|FG004|Overall Study|Adverse Event|5|||
164260617|NCT00235391|593323632|FG005|Overall Study|Adverse Event|2|||
164260618|NCT00235391|593323627|FG000|Overall Study|Abnormal laboratory value(s)|3|||
164260619|NCT00235391|593323628|FG001|Overall Study|Abnormal laboratory value(s)|5|||
164260620|NCT00235391|593323629|FG002|Overall Study|Abnormal laboratory value(s)|4|||
164260621|NCT00235391|593323630|FG003|Overall Study|Abnormal laboratory value(s)|27|||
164260622|NCT00235391|593323631|FG004|Overall Study|Abnormal laboratory value(s)|1|||
164260623|NCT00235391|593323632|FG005|Overall Study|Abnormal laboratory value(s)|2|||
164260624|NCT00235391|593323627|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164260625|NCT00235391|593323628|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164260626|NCT00235391|593323629|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
164260627|NCT00235391|593323630|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
164260628|NCT00235391|593323631|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
164260629|NCT00235391|593323632|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
164260630|NCT00235391|593323627|FG000|Overall Study|Condition no longer requires treatment|3|||
164260631|NCT00235391|593323628|FG001|Overall Study|Condition no longer requires treatment|0|||
164260632|NCT00235391|593323629|FG002|Overall Study|Condition no longer requires treatment|0|||
164260633|NCT00235391|593323630|FG003|Overall Study|Condition no longer requires treatment|11|||
164260634|NCT00235391|593323631|FG004|Overall Study|Condition no longer requires treatment|1|||
164260635|NCT00235391|593323632|FG005|Overall Study|Condition no longer requires treatment|0|||
164260636|NCT00235391|593323627|FG000|Overall Study|Protocol deviation|0|||
164340553|NCT03539081|593622210|FG001|Overall Study|Withdrawal by Subject|3|||
164340554|NCT03539081|593622211|FG002|Overall Study|Withdrawal by Subject|0|||
164340555|NCT03539081|593622209|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
164340556|NCT03539081|593622210|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
164340557|NCT03539081|593622211|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
164340558|NCT02555683|593622218|FG000|Overall Study|Physician Decision|1|||
164340559|NCT02555683|593622219|FG001|Overall Study|Physician Decision|0|||
164340560|NCT02555683|593622220|FG002|Overall Study|Physician Decision|2|||
164340561|NCT02555683|593622218|FG000|Overall Study|Lost to Follow-up|2|||
164340562|NCT02555683|593622219|FG001|Overall Study|Lost to Follow-up|1|||
164340563|NCT02555683|593622220|FG002|Overall Study|Lost to Follow-up|2|||
164340564|NCT02555683|593622218|FG000|Overall Study|Technical Problems|1|||
164340565|NCT02555683|593622219|FG001|Overall Study|Technical Problems|1|||
164681242|NCT03215706|594854625|FG000|Treatment Period|Participant withdrew consent|4|||
164681243|NCT03215706|594854626|FG001|Treatment Period|Participant withdrew consent|5|||
164681244|NCT03215706|594854625|FG000|Treatment Period|Lost to Follow-up|0|||
164681245|NCT03215706|594854626|FG001|Treatment Period|Lost to Follow-up|1|||
164681246|NCT03215706|594854625|FG000|Treatment Period|Administrative reason by sponsor|0|||
164681247|NCT03215706|594854626|FG001|Treatment Period|Administrative reason by sponsor|2|||
164681248|NCT03215706|594854625|FG000|Treatment Period|other reasons|10|||
164681249|NCT03215706|594854626|FG001|Treatment Period|other reasons|5|||
164681250|NCT03215706|594854625|FG000|Treatment Period|Not reported|1|||
164681251|NCT03215706|594854626|FG001|Treatment Period|Not reported|0|||
164681252|NCT00640341|594856177|FG000|Overall Study|Adverse Event|0|||
164681253|NCT00640341|594856178|FG001|Overall Study|Adverse Event|0|||
164681254|NCT00640341|594856179|FG002|Overall Study|Adverse Event|1|||
164681255|NCT00640341|594856177|FG000|Overall Study|Positive Slit Lamp Findings|0|||
164681256|NCT00640341|594856178|FG001|Overall Study|Positive Slit Lamp Findings|0|||
164681257|NCT00640341|594856179|FG002|Overall Study|Positive Slit Lamp Findings|1|||
164681258|NCT00640341|594856177|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
164681259|NCT00640341|594856178|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
164681260|NCT00640341|594856179|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
164681261|NCT00640341|594856177|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
164681262|NCT00640341|594856178|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
164681263|NCT00640341|594856179|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
164260637|NCT00235391|593323628|FG001|Overall Study|Protocol deviation|0|||
164260638|NCT00235391|593323629|FG002|Overall Study|Protocol deviation|1|||
164260639|NCT00235391|593323630|FG003|Overall Study|Protocol deviation|11|||
164260640|NCT00235391|593323631|FG004|Overall Study|Protocol deviation|0|||
164260641|NCT00235391|593323632|FG005|Overall Study|Protocol deviation|0|||
164681264|NCT00640341|594856177|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
164681265|NCT00640341|594856178|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
164681266|NCT00640341|594856179|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
164681267|NCT00640341|594856177|FG000|Overall Study|Lost to Follow-up|2|||
164681268|NCT00640341|594856178|FG001|Overall Study|Lost to Follow-up|0|||
164681269|NCT00640341|594856179|FG002|Overall Study|Lost to Follow-up|0|||
164681270|NCT00640341|594856177|FG000|Overall Study|Withdrawal by Subject|4|||
164681271|NCT00640341|594856178|FG001|Overall Study|Withdrawal by Subject|0|||
164681272|NCT00640341|594856179|FG002|Overall Study|Withdrawal by Subject|1|||
164681273|NCT00640341|594856177|FG000|Overall Study|Unacceptable Lens Movement|1|||
164681274|NCT00640341|594856178|FG001|Overall Study|Unacceptable Lens Movement|0|||
164681275|NCT00640341|594856179|FG002|Overall Study|Unacceptable Lens Movement|0|||
164681276|NCT00640341|594856177|FG000|Overall Study|Poor fit/Uncomfortable|4|||
164681277|NCT00640341|594856178|FG001|Overall Study|Poor fit/Uncomfortable|0|||
164681278|NCT00640341|594856179|FG002|Overall Study|Poor fit/Uncomfortable|0|||
164681279|NCT00640341|594856177|FG000|Overall Study|Ineligable at Baseline|5|||
164681280|NCT00640341|594856178|FG001|Overall Study|Ineligable at Baseline|3|||
164681281|NCT00640341|594856179|FG002|Overall Study|Ineligable at Baseline|2|||
164681282|NCT00640341|594856177|FG000|Overall Study|Adverse event and positive slit lamp|1|||
164681283|NCT00640341|594856178|FG001|Overall Study|Adverse event and positive slit lamp|0|||
164681284|NCT00640341|594856179|FG002|Overall Study|Adverse event and positive slit lamp|0|||
164681285|NCT01541215|594856182|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
164681286|NCT01541215|594856183|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
164681287|NCT01541215|594856182|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
164681288|NCT01541215|594856183|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
164681289|NCT01541215|594856182|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
164681290|NCT01541215|594856183|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
164681291|NCT01541215|594856182|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
164681292|NCT01541215|594856183|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
164681293|NCT01541215|594856182|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
164681294|NCT01541215|594856183|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
164681295|NCT01541215|594856182|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
164681296|NCT01541215|594856183|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
164681297|NCT00521586|594856186|FG000|Initial Vaccination (Year 0)|Subject request|8|||
164681298|NCT00521586|594856187|FG001|Initial Vaccination (Year 0)|Subject request|11|||
164681299|NCT00521586|594856186|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
164681300|NCT00521586|594856187|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
164681301|NCT00521586|594856186|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
164681302|NCT00521586|594856187|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
164681303|NCT00521586|594856186|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
164681304|NCT00521586|594856187|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
164681305|NCT00521586|594856186|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
164681306|NCT00521586|594856187|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
164260642|NCT00235391|593323627|FG000|Overall Study|Withdrawal by Subject|2|||
164260643|NCT00235391|593323628|FG001|Overall Study|Withdrawal by Subject|3|||
164681307|NCT00521586|594856186|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
164681308|NCT00521586|594856187|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
164681309|NCT00521586|594856186|FG000|Initial Vaccination (Year 0)|Death|1|||
164681310|NCT00521586|594856187|FG001|Initial Vaccination (Year 0)|Death|0|||
164681311|NCT00521586|594856186|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
164681312|NCT00521586|594856187|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
164681313|NCT00521586|594856186|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
164681314|NCT00521586|594856187|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
164681315|NCT00521586|594856186|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
164681316|NCT00521586|594856187|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
164681317|NCT00521586|594856186|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
164681318|NCT00521586|594856187|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
164681319|NCT00521586|594856186|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
164681320|NCT00521586|594856187|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
164681321|NCT00521586|594856186|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
164681322|NCT00521586|594856187|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
164681323|NCT00521586|594856186|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
164681324|NCT00521586|594856187|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
164260644|NCT00235391|593323629|FG002|Overall Study|Withdrawal by Subject|3|||
164260645|NCT00235391|593323630|FG003|Overall Study|Withdrawal by Subject|61|||
164681325|NCT00521586|594856186|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
164681326|NCT00521586|594856187|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
164681327|NCT00521586|594856186|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
164681328|NCT00521586|594856187|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
164681329|NCT00521586|594856186|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
164681330|NCT00521586|594856187|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
164681331|NCT00521586|594856186|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
164681332|NCT00521586|594856187|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
164681333|NCT00521586|594856186|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
164681334|NCT00521586|594856187|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
164681335|NCT00529763|594856188|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
164681336|NCT00529763|594856189|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
164681337|NCT00529763|594856190|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
164681338|NCT00529763|594856188|FG000|Overall Study|Death|1|||
164681339|NCT00529763|594856189|FG001|Overall Study|Death|1|||
164681340|NCT00529763|594856190|FG002|Overall Study|Death|1|||
164681341|NCT00529763|594856188|FG000|Overall Study|Disease Progression|10|||
164681342|NCT00529763|594856189|FG001|Overall Study|Disease Progression|16|||
164681343|NCT00529763|594856190|FG002|Overall Study|Disease Progression|11|||
164681344|NCT00529763|594856188|FG000|Overall Study|Lost to Follow-up|1|||
164681345|NCT00529763|594856189|FG001|Overall Study|Lost to Follow-up|2|||
164681346|NCT00529763|594856190|FG002|Overall Study|Lost to Follow-up|3|||
164681347|NCT00529763|594856188|FG000|Overall Study|Stem Cell Transplant|0|||
164681348|NCT00529763|594856189|FG001|Overall Study|Stem Cell Transplant|3|||
164681349|NCT00529763|594856190|FG002|Overall Study|Stem Cell Transplant|1|||
164681350|NCT00529763|594856188|FG000|Overall Study|Study Drug Toxicity|3|||
164681351|NCT00529763|594856189|FG001|Overall Study|Study Drug Toxicity|6|||
164681352|NCT00529763|594856190|FG002|Overall Study|Study Drug Toxicity|4|||
164681353|NCT00529763|594856188|FG000|Overall Study|Participant Withdrew Consent|2|||
164681354|NCT00529763|594856189|FG001|Overall Study|Participant Withdrew Consent|3|||
164681355|NCT00529763|594856190|FG002|Overall Study|Participant Withdrew Consent|4|||
164681356|NCT00529763|594856188|FG000|Overall Study|Other reasons|2|||
164681357|NCT00529763|594856189|FG001|Overall Study|Other reasons|0|||
164681358|NCT00529763|594856190|FG002|Overall Study|Other reasons|2|||
164681359|NCT00529763|594856188|FG000|Overall Study|Participant request to discontinue treatment|1|||
164681360|NCT00529763|594856189|FG001|Overall Study|Participant request to discontinue treatment|1|||
164681361|NCT00529763|594856190|FG002|Overall Study|Participant request to discontinue treatment|3|||
164681362|NCT03669250|594856191|FG000|Overall Study|Adverse Event|0|||
164681363|NCT03669250|594856192|FG001|Overall Study|Adverse Event|0|||
164681364|NCT03669250|594856193|FG002|Overall Study|Adverse Event|0|||
164681365|NCT03669250|594856194|FG003|Overall Study|Adverse Event|0|||
164681366|NCT03669250|594856195|FG004|Overall Study|Adverse Event|1|||
164681367|NCT03669250|594856196|FG005|Overall Study|Adverse Event|0|||
164681368|NCT03669250|594856191|FG000|Overall Study|Withdrawal by Subject|0|||
164681369|NCT03669250|594856192|FG001|Overall Study|Withdrawal by Subject|1|||
164681370|NCT03669250|594856193|FG002|Overall Study|Withdrawal by Subject|0|||
164681371|NCT03669250|594856194|FG003|Overall Study|Withdrawal by Subject|1|||
164681372|NCT03669250|594856195|FG004|Overall Study|Withdrawal by Subject|0|||
164681373|NCT03669250|594856196|FG005|Overall Study|Withdrawal by Subject|0|||
164681374|NCT00828321|594856197|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
164681375|NCT00828321|594856198|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
164681376|NCT00828321|594856197|FG000|Second Intervention|Protocol Violation|0|||
164681377|NCT00828321|594856198|FG001|Second Intervention|Protocol Violation|1|||
164260646|NCT00235391|593323631|FG004|Overall Study|Withdrawal by Subject|5|||
164260647|NCT00235391|593323632|FG005|Overall Study|Withdrawal by Subject|0|||
164260648|NCT00235391|593323627|FG000|Overall Study|Lost to Follow-up|0|||
164260649|NCT00235391|593323628|FG001|Overall Study|Lost to Follow-up|3|||
164681378|NCT00691704|594856200|FG000|Induction Therapy|Disease Progression|1|||
164681379|NCT00691704|594856200|FG000|Induction Therapy|Active Hepatitis|1|||
164260650|NCT00235391|593323629|FG002|Overall Study|Lost to Follow-up|3|||
164681380|NCT00691704|594856200|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
164681381|NCT00691704|594856200|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
164681382|NCT00691704|594856200|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
164681383|NCT01993186|594856201|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
164681384|NCT01993186|594856202|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
164681385|NCT01993186|594856201|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
164681386|NCT01993186|594856202|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
164681387|NCT01993186|594856201|FG000|Open-Label Extension Period|Other, Not Specified|0|||
164681388|NCT01993186|594856202|FG001|Open-Label Extension Period|Other, Not Specified|1|||
164681389|NCT01993186|594856201|FG000|Open-Label Extension Period|Adverse Event|1|||
164681390|NCT01993186|594856202|FG001|Open-Label Extension Period|Adverse Event|0|||
164681391|NCT01993186|594856201|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
164681392|NCT01993186|594856202|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
164681393|NCT01993186|594856201|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
164260651|NCT00235391|593323630|FG003|Overall Study|Lost to Follow-up|16|||
164260652|NCT00235391|593323631|FG004|Overall Study|Lost to Follow-up|0|||
164260653|NCT00235391|593323632|FG005|Overall Study|Lost to Follow-up|0|||
164681394|NCT01993186|594856202|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
164260654|NCT00235391|593323627|FG000|Overall Study|Administrative problems|0|||
164260655|NCT00235391|593323628|FG001|Overall Study|Administrative problems|0|||
164260656|NCT00235391|593323629|FG002|Overall Study|Administrative problems|0|||
164260657|NCT00235391|593323630|FG003|Overall Study|Administrative problems|1|||
164260658|NCT00235391|593323631|FG004|Overall Study|Administrative problems|0|||
164260659|NCT00235391|593323632|FG005|Overall Study|Administrative problems|0|||
164260660|NCT00235391|593323627|FG000|Overall Study|Death|0|||
164260661|NCT00235391|593323628|FG001|Overall Study|Death|0|||
164260662|NCT00235391|593323629|FG002|Overall Study|Death|1|||
164260663|NCT00235391|593323630|FG003|Overall Study|Death|4|||
164260664|NCT00235391|593323631|FG004|Overall Study|Death|0|||
164260665|NCT00235391|593323632|FG005|Overall Study|Death|0|||
164260666|NCT02927925|593323635|FG000|Overall Study|Death|16|||
164260667|NCT02927925|593323635|FG000|Overall Study|Physician Decision|1|||
164260668|NCT02927925|593323635|FG000|Overall Study|Withdrawal by Subject|11|||
164260669|NCT02927925|593323635|FG000|Overall Study|Other|3|||
164260670|NCT02927925|593323635|FG000|Overall Study|Disease progression at clinical cutoff|1|||
164260671|NCT00075725|593323638|FG000|Overall Study|Adverse Event|6|||
164260672|NCT00075725|593323639|FG001|Overall Study|Adverse Event|6|||
164260673|NCT00075725|593323640|FG002|Overall Study|Adverse Event|20|||
164260674|NCT00075725|593323641|FG003|Overall Study|Adverse Event|8|||
164260675|NCT00075725|593323642|FG004|Overall Study|Adverse Event|4|||
164260676|NCT00075725|593323643|FG005|Overall Study|Adverse Event|38|||
164260677|NCT00075725|593323644|FG006|Overall Study|Adverse Event|3|||
164260678|NCT00075725|593323645|FG007|Overall Study|Adverse Event|51|||
164260679|NCT00075725|593323646|FG008|Overall Study|Adverse Event|15|||
164260680|NCT00075725|593323647|FG009|Overall Study|Adverse Event|4|||
164260681|NCT00075725|593323648|FG010|Overall Study|Adverse Event|2|||
164260682|NCT00075725|593323649|FG011|Overall Study|Adverse Event|2|||
164260683|NCT00075725|593323638|FG000|Overall Study|Death|3|||
164260684|NCT00075725|593323639|FG001|Overall Study|Death|5|||
164260685|NCT00075725|593323640|FG002|Overall Study|Death|10|||
164260686|NCT00075725|593323641|FG003|Overall Study|Death|2|||
164260687|NCT00075725|593323642|FG004|Overall Study|Death|3|||
164260688|NCT00075725|593323643|FG005|Overall Study|Death|25|||
164260689|NCT00075725|593323644|FG006|Overall Study|Death|4|||
164260690|NCT00075725|593323645|FG007|Overall Study|Death|22|||
164260691|NCT00075725|593323646|FG008|Overall Study|Death|14|||
164260692|NCT00075725|593323647|FG009|Overall Study|Death|4|||
164260693|NCT00075725|593323648|FG010|Overall Study|Death|3|||
164260694|NCT00075725|593323649|FG011|Overall Study|Death|0|||
164260695|NCT00075725|593323638|FG000|Overall Study|Lost to Follow-up|1|||
164260696|NCT00075725|593323639|FG001|Overall Study|Lost to Follow-up|1|||
164260697|NCT00075725|593323640|FG002|Overall Study|Lost to Follow-up|4|||
164260698|NCT00075725|593323641|FG003|Overall Study|Lost to Follow-up|1|||
164260699|NCT00075725|593323642|FG004|Overall Study|Lost to Follow-up|0|||
164260700|NCT00075725|593323643|FG005|Overall Study|Lost to Follow-up|13|||
164260701|NCT00075725|593323644|FG006|Overall Study|Lost to Follow-up|2|||
164260702|NCT00075725|593323645|FG007|Overall Study|Lost to Follow-up|4|||
164260703|NCT00075725|593323646|FG008|Overall Study|Lost to Follow-up|1|||
164260704|NCT00075725|593323647|FG009|Overall Study|Lost to Follow-up|0|||
164260705|NCT00075725|593323648|FG010|Overall Study|Lost to Follow-up|0|||
164577214|NCT00922935|594476852|FG000|Overall Study|Physician Decision|1|||
164577215|NCT00922935|594476853|FG001|Overall Study|Physician Decision|1|||
164260706|NCT00075725|593323649|FG011|Overall Study|Lost to Follow-up|0|||
164260707|NCT00075725|593323638|FG000|Overall Study|Physician Decision|2|||
164260708|NCT00075725|593323639|FG001|Overall Study|Physician Decision|6|||
164260709|NCT00075725|593323640|FG002|Overall Study|Physician Decision|5|||
164260710|NCT00075725|593323641|FG003|Overall Study|Physician Decision|8|||
164260711|NCT00075725|593323642|FG004|Overall Study|Physician Decision|4|||
164260712|NCT00075725|593323643|FG005|Overall Study|Physician Decision|19|||
164260713|NCT00075725|593323644|FG006|Overall Study|Physician Decision|3|||
164260714|NCT00075725|593323645|FG007|Overall Study|Physician Decision|17|||
164260715|NCT00075725|593323646|FG008|Overall Study|Physician Decision|5|||
164260716|NCT00075725|593323647|FG009|Overall Study|Physician Decision|0|||
164260717|NCT00075725|593323648|FG010|Overall Study|Physician Decision|1|||
164260718|NCT00075725|593323649|FG011|Overall Study|Physician Decision|0|||
164260719|NCT00075725|593323638|FG000|Overall Study|Pregnancy|0|||
164260720|NCT00075725|593323639|FG001|Overall Study|Pregnancy|0|||
164260721|NCT00075725|593323640|FG002|Overall Study|Pregnancy|0|||
164260722|NCT00075725|593323641|FG003|Overall Study|Pregnancy|0|||
164260723|NCT00075725|593323642|FG004|Overall Study|Pregnancy|0|||
164577216|NCT00922935|594476854|FG002|Overall Study|Physician Decision|0|||
164260724|NCT00075725|593323643|FG005|Overall Study|Pregnancy|1|||
164260725|NCT00075725|593323644|FG006|Overall Study|Pregnancy|0|||
164260726|NCT00075725|593323645|FG007|Overall Study|Pregnancy|1|||
164260727|NCT00075725|593323646|FG008|Overall Study|Pregnancy|0|||
164260728|NCT00075725|593323647|FG009|Overall Study|Pregnancy|0|||
164260729|NCT00075725|593323648|FG010|Overall Study|Pregnancy|0|||
164260730|NCT00075725|593323649|FG011|Overall Study|Pregnancy|0|||
164260731|NCT00075725|593323638|FG000|Overall Study|Protocol Violation|1|||
164260732|NCT00075725|593323639|FG001|Overall Study|Protocol Violation|1|||
164260733|NCT00075725|593323640|FG002|Overall Study|Protocol Violation|0|||
164260734|NCT00075725|593323641|FG003|Overall Study|Protocol Violation|3|||
164260735|NCT00075725|593323642|FG004|Overall Study|Protocol Violation|3|||
164260736|NCT00075725|593323643|FG005|Overall Study|Protocol Violation|2|||
164260737|NCT00075725|593323644|FG006|Overall Study|Protocol Violation|1|||
164260738|NCT00075725|593323645|FG007|Overall Study|Protocol Violation|2|||
164260739|NCT00075725|593323646|FG008|Overall Study|Protocol Violation|3|||
164260740|NCT00075725|593323647|FG009|Overall Study|Protocol Violation|0|||
164260741|NCT00075725|593323648|FG010|Overall Study|Protocol Violation|0|||
164260742|NCT00075725|593323649|FG011|Overall Study|Protocol Violation|1|||
164260743|NCT00075725|593323638|FG000|Overall Study|Withdrawal by Subject|12|||
164260744|NCT00075725|593323639|FG001|Overall Study|Withdrawal by Subject|3|||
164260745|NCT00075725|593323640|FG002|Overall Study|Withdrawal by Subject|6|||
164260746|NCT00075725|593323641|FG003|Overall Study|Withdrawal by Subject|10|||
164260747|NCT00075725|593323642|FG004|Overall Study|Withdrawal by Subject|6|||
164260748|NCT00075725|593323643|FG005|Overall Study|Withdrawal by Subject|27|||
164260749|NCT00075725|593323644|FG006|Overall Study|Withdrawal by Subject|7|||
164260750|NCT00075725|593323645|FG007|Overall Study|Withdrawal by Subject|31|||
164260751|NCT00075725|593323646|FG008|Overall Study|Withdrawal by Subject|10|||
164260752|NCT00075725|593323647|FG009|Overall Study|Withdrawal by Subject|2|||
164260753|NCT00075725|593323648|FG010|Overall Study|Withdrawal by Subject|0|||
164260754|NCT00075725|593323649|FG011|Overall Study|Withdrawal by Subject|0|||
164260755|NCT00075725|593323638|FG000|Overall Study|Disease Progression, all other reasons|17|||
164260756|NCT00075725|593323639|FG001|Overall Study|Disease Progression, all other reasons|5|||
164260757|NCT00075725|593323640|FG002|Overall Study|Disease Progression, all other reasons|33|||
164260758|NCT00075725|593323641|FG003|Overall Study|Disease Progression, all other reasons|6|||
164260759|NCT00075725|593323642|FG004|Overall Study|Disease Progression, all other reasons|21|||
164260760|NCT00075725|593323643|FG005|Overall Study|Disease Progression, all other reasons|59|||
164260761|NCT00075725|593323644|FG006|Overall Study|Disease Progression, all other reasons|20|||
164260762|NCT00075725|593323645|FG007|Overall Study|Disease Progression, all other reasons|46|||
164260763|NCT00075725|593323646|FG008|Overall Study|Disease Progression, all other reasons|21|||
164260764|NCT00075725|593323647|FG009|Overall Study|Disease Progression, all other reasons|4|||
164260765|NCT00075725|593323648|FG010|Overall Study|Disease Progression, all other reasons|0|||
164260766|NCT00075725|593323649|FG011|Overall Study|Disease Progression, all other reasons|5|||
164260767|NCT00075725|593323638|FG000|Overall Study|Patient off treatment|0|||
164260768|NCT00075725|593323639|FG001|Overall Study|Patient off treatment|0|||
164260769|NCT00075725|593323640|FG002|Overall Study|Patient off treatment|1|||
164260770|NCT00075725|593323641|FG003|Overall Study|Patient off treatment|2|||
164260771|NCT00075725|593323642|FG004|Overall Study|Patient off treatment|1|||
164260772|NCT00075725|593323643|FG005|Overall Study|Patient off treatment|0|||
164260773|NCT00075725|593323644|FG006|Overall Study|Patient off treatment|0|||
164260774|NCT00075725|593323645|FG007|Overall Study|Patient off treatment|2|||
164260775|NCT00075725|593323646|FG008|Overall Study|Patient off treatment|1|||
164260776|NCT00075725|593323647|FG009|Overall Study|Patient off treatment|0|||
164260777|NCT00075725|593323648|FG010|Overall Study|Patient off treatment|0|||
164260778|NCT00075725|593323649|FG011|Overall Study|Patient off treatment|0|||
164260779|NCT00075725|593323638|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
164260780|NCT00075725|593323639|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
164260781|NCT00075725|593323640|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
164260782|NCT00075725|593323641|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
164260783|NCT00075725|593323642|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
164260784|NCT00075725|593323643|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
164260785|NCT00075725|593323644|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
164260786|NCT00075725|593323645|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
164260787|NCT00075725|593323646|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
164260788|NCT00075725|593323647|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
164260789|NCT00075725|593323648|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
164260790|NCT00075725|593323649|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
164340566|NCT02555683|593622220|FG002|Overall Study|Technical Problems|0|||
164681395|NCT01993186|594856201|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
164340567|NCT02555683|593622218|FG000|Overall Study|Protocol deviation|0|||
164681396|NCT01993186|594856202|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
164681397|NCT02451696|594856203|FG000|Overall Study|Surgery postponed|1|||
164681398|NCT02451696|594856204|FG001|Overall Study|Surgery postponed|0|||
164681399|NCT00198133|594856205|FG000|Overall Study|Disease progression|2|||
164260791|NCT00075725|593323638|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
164260792|NCT00075725|593323639|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
164260793|NCT00075725|593323640|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
164260794|NCT00075725|593323641|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
164681400|NCT00198133|594856206|FG001|Overall Study|Disease progression|5|||
164260795|NCT00075725|593323642|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
164260796|NCT00075725|593323643|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
164260797|NCT00075725|593323644|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
164260798|NCT00075725|593323645|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
164260799|NCT00075725|593323646|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
164260800|NCT00075725|593323647|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
164260801|NCT00075725|593323648|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
164260802|NCT00075725|593323649|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
164260803|NCT00075725|593323638|FG000|Overall Study|Pt non compliant with therapy|2|||
164260804|NCT00075725|593323639|FG001|Overall Study|Pt non compliant with therapy|1|||
164260805|NCT00075725|593323640|FG002|Overall Study|Pt non compliant with therapy|1|||
164260806|NCT00075725|593323641|FG003|Overall Study|Pt non compliant with therapy|0|||
164260807|NCT00075725|593323642|FG004|Overall Study|Pt non compliant with therapy|2|||
164260808|NCT00075725|593323643|FG005|Overall Study|Pt non compliant with therapy|14|||
164260809|NCT00075725|593323644|FG006|Overall Study|Pt non compliant with therapy|2|||
164260810|NCT00075725|593323645|FG007|Overall Study|Pt non compliant with therapy|5|||
164260811|NCT00075725|593323646|FG008|Overall Study|Pt non compliant with therapy|3|||
164260812|NCT00075725|593323647|FG009|Overall Study|Pt non compliant with therapy|0|||
164260813|NCT00075725|593323648|FG010|Overall Study|Pt non compliant with therapy|0|||
164260814|NCT00075725|593323649|FG011|Overall Study|Pt non compliant with therapy|0|||
164260815|NCT00075725|593323638|FG000|Overall Study|Pt age out of range for treatment|0|||
164260816|NCT00075725|593323639|FG001|Overall Study|Pt age out of range for treatment|1|||
164260817|NCT00075725|593323640|FG002|Overall Study|Pt age out of range for treatment|0|||
164260818|NCT00075725|593323641|FG003|Overall Study|Pt age out of range for treatment|0|||
164260819|NCT00075725|593323642|FG004|Overall Study|Pt age out of range for treatment|0|||
164260820|NCT00075725|593323643|FG005|Overall Study|Pt age out of range for treatment|1|||
164260821|NCT00075725|593323644|FG006|Overall Study|Pt age out of range for treatment|0|||
164260822|NCT00075725|593323645|FG007|Overall Study|Pt age out of range for treatment|1|||
164260823|NCT00075725|593323646|FG008|Overall Study|Pt age out of range for treatment|0|||
164260824|NCT00075725|593323647|FG009|Overall Study|Pt age out of range for treatment|0|||
164260825|NCT00075725|593323648|FG010|Overall Study|Pt age out of range for treatment|0|||
164260826|NCT00075725|593323649|FG011|Overall Study|Pt age out of range for treatment|0|||
164260827|NCT00075725|593323638|FG000|Overall Study|Insurance issues|0|||
164260828|NCT00075725|593323639|FG001|Overall Study|Insurance issues|1|||
164260829|NCT00075725|593323640|FG002|Overall Study|Insurance issues|0|||
164260830|NCT00075725|593323641|FG003|Overall Study|Insurance issues|1|||
164260831|NCT00075725|593323642|FG004|Overall Study|Insurance issues|1|||
164260832|NCT00075725|593323643|FG005|Overall Study|Insurance issues|1|||
164260833|NCT00075725|593323644|FG006|Overall Study|Insurance issues|0|||
164260834|NCT00075725|593323645|FG007|Overall Study|Insurance issues|1|||
164260835|NCT00075725|593323646|FG008|Overall Study|Insurance issues|0|||
164260836|NCT00075725|593323647|FG009|Overall Study|Insurance issues|0|||
164260837|NCT00075725|593323648|FG010|Overall Study|Insurance issues|0|||
164260838|NCT00075725|593323649|FG011|Overall Study|Insurance issues|0|||
164260839|NCT00075725|593323638|FG000|Overall Study|MRD positive after extended ind|0|||
164260840|NCT00075725|593323639|FG001|Overall Study|MRD positive after extended ind|1|||
164260841|NCT00075725|593323640|FG002|Overall Study|MRD positive after extended ind|1|||
164260842|NCT00075725|593323641|FG003|Overall Study|MRD positive after extended ind|0|||
164260843|NCT00075725|593323642|FG004|Overall Study|MRD positive after extended ind|1|||
164260844|NCT00075725|593323643|FG005|Overall Study|MRD positive after extended ind|2|||
164260845|NCT00075725|593323644|FG006|Overall Study|MRD positive after extended ind|0|||
164260846|NCT00075725|593323645|FG007|Overall Study|MRD positive after extended ind|1|||
164260847|NCT00075725|593323646|FG008|Overall Study|MRD positive after extended ind|0|||
164260848|NCT00075725|593323647|FG009|Overall Study|MRD positive after extended ind|0|||
164260849|NCT00075725|593323648|FG010|Overall Study|MRD positive after extended ind|0|||
164260850|NCT00075725|593323649|FG011|Overall Study|MRD positive after extended ind|0|||
164260851|NCT00075725|593323638|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
164260852|NCT00075725|593323639|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
164260853|NCT00075725|593323640|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
164260854|NCT00075725|593323641|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
164340568|NCT02555683|593622219|FG001|Overall Study|Protocol deviation|1|||
164681401|NCT00198133|594856205|FG000|Overall Study|Adverse Event|1|||
164681402|NCT00198133|594856206|FG001|Overall Study|Adverse Event|3|||
164681403|NCT00198133|594856205|FG000|Overall Study|Withdrawal by Subject|1|||
164681404|NCT00198133|594856206|FG001|Overall Study|Withdrawal by Subject|0|||
164681405|NCT00198133|594856205|FG000|Overall Study|Physician Decision|1|||
164681406|NCT00198133|594856206|FG001|Overall Study|Physician Decision|0|||
164340569|NCT02555683|593622220|FG002|Overall Study|Protocol deviation|0|||
164340570|NCT02555683|593622218|FG000|Overall Study|Lack of Efficacy|2|||
164260855|NCT00075725|593323642|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
164260856|NCT00075725|593323643|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
164260857|NCT00075725|593323644|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
164260858|NCT00075725|593323645|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
164260859|NCT00075725|593323646|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
164260860|NCT00075725|593323647|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
164260861|NCT00075725|593323648|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
164260862|NCT00075725|593323649|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
164260863|NCT00075725|593323638|FG000|Overall Study|Inevaluable|1|||
164260864|NCT00075725|593323639|FG001|Overall Study|Inevaluable|1|||
164260865|NCT00075725|593323640|FG002|Overall Study|Inevaluable|4|||
164260866|NCT00075725|593323641|FG003|Overall Study|Inevaluable|2|||
164260867|NCT00075725|593323642|FG004|Overall Study|Inevaluable|2|||
164260868|NCT00075725|593323643|FG005|Overall Study|Inevaluable|9|||
164260869|NCT00075725|593323644|FG006|Overall Study|Inevaluable|1|||
164260870|NCT00075725|593323645|FG007|Overall Study|Inevaluable|11|||
164260871|NCT00075725|593323646|FG008|Overall Study|Inevaluable|2|||
164260872|NCT00075725|593323647|FG009|Overall Study|Inevaluable|0|||
164260873|NCT00075725|593323648|FG010|Overall Study|Inevaluable|1|||
164260874|NCT00075725|593323649|FG011|Overall Study|Inevaluable|0|||
164260875|NCT00075725|593323638|FG000|Overall Study|Other|4|||
164260876|NCT00075725|593323639|FG001|Overall Study|Other|2|||
164260877|NCT00075725|593323640|FG002|Overall Study|Other|1|||
164260878|NCT00075725|593323641|FG003|Overall Study|Other|1|||
164260879|NCT00075725|593323642|FG004|Overall Study|Other|1|||
164260880|NCT00075725|593323643|FG005|Overall Study|Other|4|||
164260881|NCT00075725|593323644|FG006|Overall Study|Other|2|||
164260882|NCT00075725|593323645|FG007|Overall Study|Other|9|||
164260883|NCT00075725|593323646|FG008|Overall Study|Other|2|||
164260884|NCT00075725|593323647|FG009|Overall Study|Other|1|||
164260885|NCT00075725|593323648|FG010|Overall Study|Other|0|||
164260886|NCT00075725|593323649|FG011|Overall Study|Other|3|||
164260887|NCT00075725|593323638|FG000|Overall Study|Pt trying to find a BM donor|0|||
164260888|NCT00075725|593323639|FG001|Overall Study|Pt trying to find a BM donor|1|||
164260889|NCT00075725|593323640|FG002|Overall Study|Pt trying to find a BM donor|0|||
164260890|NCT00075725|593323641|FG003|Overall Study|Pt trying to find a BM donor|0|||
164260891|NCT00075725|593323642|FG004|Overall Study|Pt trying to find a BM donor|0|||
164260892|NCT00075725|593323643|FG005|Overall Study|Pt trying to find a BM donor|0|||
164260893|NCT00075725|593323644|FG006|Overall Study|Pt trying to find a BM donor|0|||
164260894|NCT00075725|593323645|FG007|Overall Study|Pt trying to find a BM donor|0|||
164260895|NCT00075725|593323646|FG008|Overall Study|Pt trying to find a BM donor|0|||
164260896|NCT00075725|593323647|FG009|Overall Study|Pt trying to find a BM donor|0|||
164260897|NCT00075725|593323648|FG010|Overall Study|Pt trying to find a BM donor|0|||
164260898|NCT00075725|593323649|FG011|Overall Study|Pt trying to find a BM donor|0|||
164260899|NCT00075725|593323638|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
164260900|NCT00075725|593323639|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
164260901|NCT00075725|593323640|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
164260902|NCT00075725|593323641|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
164260903|NCT00075725|593323642|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
164260904|NCT00075725|593323643|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
164260905|NCT00075725|593323644|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
164260906|NCT00075725|593323645|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
164260907|NCT00075725|593323646|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
164260908|NCT00075725|593323647|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
164260909|NCT00075725|593323648|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
164260910|NCT00075725|593323649|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
164260911|NCT00075725|593323638|FG000|Overall Study|Unsuccessful institutional transfer|0|||
164260912|NCT00075725|593323639|FG001|Overall Study|Unsuccessful institutional transfer|0|||
164260913|NCT00075725|593323640|FG002|Overall Study|Unsuccessful institutional transfer|2|||
164260914|NCT00075725|593323641|FG003|Overall Study|Unsuccessful institutional transfer|0|||
164260915|NCT00075725|593323642|FG004|Overall Study|Unsuccessful institutional transfer|0|||
164260916|NCT00075725|593323643|FG005|Overall Study|Unsuccessful institutional transfer|0|||
164260917|NCT00075725|593323644|FG006|Overall Study|Unsuccessful institutional transfer|0|||
164260918|NCT00075725|593323645|FG007|Overall Study|Unsuccessful institutional transfer|0|||
164577217|NCT00922935|594476852|FG000|Overall Study|Lost to Follow-up|0|||
164260919|NCT00075725|593323646|FG008|Overall Study|Unsuccessful institutional transfer|0|||
164260920|NCT00075725|593323647|FG009|Overall Study|Unsuccessful institutional transfer|1|||
164260921|NCT00075725|593323648|FG010|Overall Study|Unsuccessful institutional transfer|0|||
164260922|NCT00075725|593323649|FG011|Overall Study|Unsuccessful institutional transfer|0|||
164260923|NCT00075725|593323638|FG000|Overall Study|specimen(s) not submitted|0|||
164260924|NCT00075725|593323639|FG001|Overall Study|specimen(s) not submitted|0|||
164577218|NCT00922935|594476853|FG001|Overall Study|Lost to Follow-up|1|||
164260925|NCT00075725|593323640|FG002|Overall Study|specimen(s) not submitted|2|||
164260926|NCT00075725|593323641|FG003|Overall Study|specimen(s) not submitted|0|||
164260927|NCT00075725|593323642|FG004|Overall Study|specimen(s) not submitted|0|||
164260928|NCT00075725|593323643|FG005|Overall Study|specimen(s) not submitted|0|||
164260929|NCT00075725|593323644|FG006|Overall Study|specimen(s) not submitted|0|||
164260930|NCT00075725|593323645|FG007|Overall Study|specimen(s) not submitted|0|||
164260931|NCT00075725|593323646|FG008|Overall Study|specimen(s) not submitted|0|||
164260932|NCT00075725|593323647|FG009|Overall Study|specimen(s) not submitted|0|||
164260933|NCT00075725|593323648|FG010|Overall Study|specimen(s) not submitted|0|||
164260934|NCT00075725|593323649|FG011|Overall Study|specimen(s) not submitted|0|||
164260935|NCT00075725|593323638|FG000|Overall Study|Pt went to transplant|0|||
164681407|NCT01557751|594856207|FG000|Overall Study|Physician Decision|3|||
164681408|NCT02752074|594856208|FG000|Overall Study|Lost to Follow-up|1|||
164681409|NCT02752074|594856209|FG001|Overall Study|Lost to Follow-up|4|||
164681410|NCT02752074|594856208|FG000|Overall Study|Death|146|||
164681411|NCT02752074|594856209|FG001|Overall Study|Death|129|||
164681412|NCT02752074|594856208|FG000|Overall Study|Withdrawal by Subject|9|||
164681413|NCT02752074|594856209|FG001|Overall Study|Withdrawal by Subject|10|||
164681414|NCT00840216|594856210|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
164681415|NCT00840216|594856211|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
164260936|NCT00075725|593323639|FG001|Overall Study|Pt went to transplant|0|||
164260937|NCT00075725|593323640|FG002|Overall Study|Pt went to transplant|0|||
164260938|NCT00075725|593323641|FG003|Overall Study|Pt went to transplant|1|||
164577219|NCT00922935|594476854|FG002|Overall Study|Lost to Follow-up|0|||
164577220|NCT01491945|594476855|FG000|Overall Study|Death|30|||
164577221|NCT01491945|594476855|FG000|Overall Study|Withdrwan/LTF|16|||
164577222|NCT01491945|594476855|FG000|Overall Study|Conversion|4|||
164577223|NCT01491945|594476855|FG000|Overall Study|Missed Visit|1|||
164577224|NCT00074958|594476856|FG000|Overall Study|Adverse Event|1|||
164577225|NCT03192904|594476859|FG000|Overall Study|Physician Decision|3|||
164577226|NCT03192904|594476860|FG001|Overall Study|Physician Decision|1|||
164577227|NCT03192904|594476859|FG000|Overall Study|Lost to Follow-up|0|||
164577228|NCT03192904|594476860|FG001|Overall Study|Lost to Follow-up|1|||
164577229|NCT00709202|594476861|FG000|Overall Study|Withdrawal by Subject|6|||
164577230|NCT00709202|594476862|FG001|Overall Study|Withdrawal by Subject|6|||
164577231|NCT03133767|594476863|FG000|Overall Study|Lost to Follow-up|38|||
164577232|NCT03133767|594476864|FG001|Overall Study|Lost to Follow-up|24|||
164577233|NCT03133767|594476863|FG000|Overall Study|Protocol Violation|0|||
164577234|NCT03133767|594476864|FG001|Overall Study|Protocol Violation|1|||
164577235|NCT02240706|594476865|FG000|Overall Study|Lack of Efficacy|2|||
164577236|NCT02240706|594476866|FG001|Overall Study|Lack of Efficacy|2|||
164577237|NCT02240706|594476867|FG002|Overall Study|Lack of Efficacy|2|||
164577238|NCT02240706|594476868|FG003|Overall Study|Lack of Efficacy|2|||
164577239|NCT02240706|594476869|FG004|Overall Study|Lack of Efficacy|5|||
164577240|NCT02240706|594476870|FG005|Overall Study|Lack of Efficacy|0|||
164577241|NCT02240706|594476871|FG006|Overall Study|Lack of Efficacy|0|||
164577242|NCT02240706|594476865|FG000|Overall Study|Adverse Event|1|||
164577243|NCT02240706|594476866|FG001|Overall Study|Adverse Event|0|||
164577244|NCT02240706|594476867|FG002|Overall Study|Adverse Event|1|||
164577245|NCT02240706|594476868|FG003|Overall Study|Adverse Event|0|||
164577246|NCT02240706|594476869|FG004|Overall Study|Adverse Event|2|||
164577247|NCT02240706|594476870|FG005|Overall Study|Adverse Event|0|||
164577248|NCT02240706|594476871|FG006|Overall Study|Adverse Event|0|||
164577249|NCT02240706|594476865|FG000|Overall Study|Progressive disease|0|||
164577250|NCT02240706|594476866|FG001|Overall Study|Progressive disease|0|||
164577251|NCT02240706|594476867|FG002|Overall Study|Progressive disease|0|||
164577252|NCT02240706|594476868|FG003|Overall Study|Progressive disease|0|||
164577253|NCT02240706|594476869|FG004|Overall Study|Progressive disease|1|||
164577254|NCT02240706|594476870|FG005|Overall Study|Progressive disease|0|||
164577255|NCT02240706|594476871|FG006|Overall Study|Progressive disease|0|||
164577256|NCT02240706|594476865|FG000|Overall Study|Dose limiting toxicity|0|||
164577257|NCT02240706|594476866|FG001|Overall Study|Dose limiting toxicity|0|||
164577258|NCT02240706|594476867|FG002|Overall Study|Dose limiting toxicity|0|||
164577259|NCT02240706|594476868|FG003|Overall Study|Dose limiting toxicity|0|||
164577260|NCT02240706|594476869|FG004|Overall Study|Dose limiting toxicity|1|||
164577261|NCT02240706|594476870|FG005|Overall Study|Dose limiting toxicity|0|||
164577262|NCT02240706|594476871|FG006|Overall Study|Dose limiting toxicity|0|||
164577263|NCT02240706|594476865|FG000|Overall Study|Refused to continue taking medication|0|||
164577264|NCT02240706|594476866|FG001|Overall Study|Refused to continue taking medication|1|||
164577265|NCT02240706|594476867|FG002|Overall Study|Refused to continue taking medication|3|||
164577266|NCT02240706|594476868|FG003|Overall Study|Refused to continue taking medication|1|||
164577267|NCT02240706|594476869|FG004|Overall Study|Refused to continue taking medication|2|||
164577268|NCT02240706|594476870|FG005|Overall Study|Refused to continue taking medication|0|||
164577269|NCT02240706|594476871|FG006|Overall Study|Refused to continue taking medication|0|||
164577270|NCT02240706|594476865|FG000|Overall Study|Insurance billing concerns|0|||
164577271|NCT02240706|594476866|FG001|Overall Study|Insurance billing concerns|0|||
164577272|NCT02240706|594476867|FG002|Overall Study|Insurance billing concerns|0|||
164577273|NCT02240706|594476868|FG003|Overall Study|Insurance billing concerns|1|||
164577274|NCT02240706|594476869|FG004|Overall Study|Insurance billing concerns|0|||
164577275|NCT02240706|594476870|FG005|Overall Study|Insurance billing concerns|0|||
164681416|NCT03276754|594856212|FG000|Overall Study|Withdrawal of informed consent|4|||
164577276|NCT02240706|594476871|FG006|Overall Study|Insurance billing concerns|0|||
164577277|NCT03301857|594476872|FG000|Overall Study|Death|0|||
164577278|NCT03301857|594476873|FG001|Overall Study|Death|2|||
164577279|NCT03301857|594476872|FG000|Overall Study|Lost to Follow-up|4|||
164577280|NCT03301857|594476873|FG001|Overall Study|Lost to Follow-up|2|||
164260939|NCT00075725|593323642|FG004|Overall Study|Pt went to transplant|0|||
164260940|NCT00075725|593323643|FG005|Overall Study|Pt went to transplant|1|||
164260941|NCT00075725|593323644|FG006|Overall Study|Pt went to transplant|0|||
164260942|NCT00075725|593323645|FG007|Overall Study|Pt went to transplant|0|||
164260943|NCT00075725|593323646|FG008|Overall Study|Pt went to transplant|0|||
164260944|NCT00075725|593323647|FG009|Overall Study|Pt went to transplant|0|||
164260945|NCT00075725|593323648|FG010|Overall Study|Pt went to transplant|0|||
164260946|NCT00075725|593323649|FG011|Overall Study|Pt went to transplant|0|||
164260947|NCT00075725|593323638|FG000|Overall Study|Pt received additional steroids|0|||
164260948|NCT00075725|593323639|FG001|Overall Study|Pt received additional steroids|0|||
164260949|NCT00075725|593323640|FG002|Overall Study|Pt received additional steroids|0|||
164260950|NCT00075725|593323641|FG003|Overall Study|Pt received additional steroids|1|||
164260951|NCT00075725|593323642|FG004|Overall Study|Pt received additional steroids|0|||
164260952|NCT00075725|593323643|FG005|Overall Study|Pt received additional steroids|0|||
164260953|NCT00075725|593323644|FG006|Overall Study|Pt received additional steroids|0|||
164260954|NCT00075725|593323645|FG007|Overall Study|Pt received additional steroids|0|||
164260955|NCT00075725|593323646|FG008|Overall Study|Pt received additional steroids|0|||
164260956|NCT00075725|593323647|FG009|Overall Study|Pt received additional steroids|0|||
164260957|NCT00075725|593323648|FG010|Overall Study|Pt received additional steroids|0|||
164260958|NCT00075725|593323649|FG011|Overall Study|Pt received additional steroids|0|||
164681417|NCT03276754|594856212|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
164681418|NCT03276754|594856212|FG000|Overall Study|Lost to Follow-up|27|||
164681419|NCT03276754|594856212|FG000|Overall Study|No data reported at Month 24|31|||
164681420|NCT03276754|594856212|FG000|Overall Study|Death|39|||
164681421|NCT00545792|594856213|FG000|Overall Study|Withdrawal by Subject|1|||
164681422|NCT05041361|594856215|FG000|Overall Study|Lost to Follow-up|1|||
164681423|NCT05041361|594856216|FG001|Overall Study|Lost to Follow-up|3|||
164681424|NCT01642277|594856217|FG000|Overall Study|Adverse Event|10|||
164681425|NCT01642277|594856218|FG001|Overall Study|Adverse Event|0|||
164681426|NCT01642277|594856217|FG000|Overall Study|Physician Decision|2|||
164681427|NCT01642277|594856218|FG001|Overall Study|Physician Decision|0|||
164681428|NCT01642277|594856217|FG000|Overall Study|Protocol Violation|1|||
164681429|NCT01642277|594856218|FG001|Overall Study|Protocol Violation|0|||
164681430|NCT01642277|594856217|FG000|Overall Study|Withdrawal by Subject|11|||
164681431|NCT01642277|594856218|FG001|Overall Study|Withdrawal by Subject|0|||
164260959|NCT00075725|593323638|FG000|Overall Study|Pt relocated|0|||
164260960|NCT00075725|593323639|FG001|Overall Study|Pt relocated|0|||
164260961|NCT00075725|593323640|FG002|Overall Study|Pt relocated|0|||
164260962|NCT00075725|593323641|FG003|Overall Study|Pt relocated|2|||
164260963|NCT00075725|593323642|FG004|Overall Study|Pt relocated|0|||
164260964|NCT00075725|593323643|FG005|Overall Study|Pt relocated|1|||
164260965|NCT00075725|593323644|FG006|Overall Study|Pt relocated|1|||
164260966|NCT00075725|593323645|FG007|Overall Study|Pt relocated|2|||
164260967|NCT00075725|593323646|FG008|Overall Study|Pt relocated|1|||
164260968|NCT00075725|593323647|FG009|Overall Study|Pt relocated|0|||
164260969|NCT00075725|593323648|FG010|Overall Study|Pt relocated|0|||
164260970|NCT00075725|593323649|FG011|Overall Study|Pt relocated|0|||
164260971|NCT00075725|593323638|FG000|Overall Study|Institution Terminated|0|||
164260972|NCT00075725|593323639|FG001|Overall Study|Institution Terminated|0|||
164260973|NCT00075725|593323640|FG002|Overall Study|Institution Terminated|0|||
164260974|NCT00075725|593323641|FG003|Overall Study|Institution Terminated|0|||
164260975|NCT00075725|593323642|FG004|Overall Study|Institution Terminated|1|||
164260976|NCT00075725|593323643|FG005|Overall Study|Institution Terminated|0|||
164260977|NCT00075725|593323644|FG006|Overall Study|Institution Terminated|0|||
164260978|NCT00075725|593323645|FG007|Overall Study|Institution Terminated|3|||
164260979|NCT00075725|593323646|FG008|Overall Study|Institution Terminated|0|||
164260980|NCT00075725|593323647|FG009|Overall Study|Institution Terminated|0|||
164260981|NCT00075725|593323648|FG010|Overall Study|Institution Terminated|0|||
164681432|NCT03679598|594856219|FG000|Overall Study|Adverse Event|2|||
164681433|NCT03679598|594856220|FG001|Overall Study|Adverse Event|0|||
164260982|NCT00075725|593323649|FG011|Overall Study|Institution Terminated|0|||
164260983|NCT00075725|593323638|FG000|Overall Study|Study Closure|1|||
164260984|NCT00075725|593323639|FG001|Overall Study|Study Closure|0|||
164260985|NCT00075725|593323640|FG002|Overall Study|Study Closure|0|||
164260986|NCT00075725|593323641|FG003|Overall Study|Study Closure|0|||
164260987|NCT00075725|593323642|FG004|Overall Study|Study Closure|1|||
164260988|NCT00075725|593323643|FG005|Overall Study|Study Closure|3|||
164260989|NCT00075725|593323644|FG006|Overall Study|Study Closure|0|||
164260990|NCT00075725|593323645|FG007|Overall Study|Study Closure|1|||
164260991|NCT00075725|593323646|FG008|Overall Study|Study Closure|0|||
164260992|NCT00075725|593323647|FG009|Overall Study|Study Closure|0|||
164260993|NCT00075725|593323648|FG010|Overall Study|Study Closure|0|||
164260994|NCT00075725|593323649|FG011|Overall Study|Study Closure|0|||
164260995|NCT00075725|593323638|FG000|Overall Study|Other complications|0|||
164260996|NCT00075725|593323639|FG001|Overall Study|Other complications|0|||
164260997|NCT00075725|593323640|FG002|Overall Study|Other complications|0|||
164260998|NCT00075725|593323641|FG003|Overall Study|Other complications|0|||
164260999|NCT00075725|593323642|FG004|Overall Study|Other complications|0|||
164261000|NCT00075725|593323643|FG005|Overall Study|Other complications|1|||
164261001|NCT00075725|593323644|FG006|Overall Study|Other complications|0|||
164261002|NCT00075725|593323645|FG007|Overall Study|Other complications|0|||
164261003|NCT00075725|593323646|FG008|Overall Study|Other complications|0|||
164261004|NCT00075725|593323647|FG009|Overall Study|Other complications|0|||
164261005|NCT00075725|593323648|FG010|Overall Study|Other complications|0|||
164261006|NCT00075725|593323649|FG011|Overall Study|Other complications|0|||
164261007|NCT00075725|593323638|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
164261008|NCT00075725|593323639|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
164261009|NCT00075725|593323640|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
164261010|NCT00075725|593323641|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
164261011|NCT00075725|593323642|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
164261012|NCT00075725|593323643|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
164261013|NCT00075725|593323644|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
164261014|NCT00075725|593323645|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
164261015|NCT00075725|593323646|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
164340571|NCT02555683|593622219|FG001|Overall Study|Lack of Efficacy|0|||
164340572|NCT02555683|593622220|FG002|Overall Study|Lack of Efficacy|0|||
164340573|NCT02555683|593622218|FG000|Overall Study|Death|0|||
164340574|NCT02555683|593622219|FG001|Overall Study|Death|1|||
164340575|NCT02555683|593622220|FG002|Overall Study|Death|2|||
164340576|NCT02555683|593622218|FG000|Overall Study|Adverse Event|1|||
164681434|NCT00918645|594856225|FG000|Overall Study|Withdrawal by Subject|1|||
164681435|NCT05133180|594856226|FG000|Overall Study|Withdrawal of consent|1|||
164681436|NCT05133180|594856227|FG001|Overall Study|Withdrawal of consent|1|||
164681437|NCT05133180|594856226|FG000|Overall Study|Lost to Follow-up|1|||
164681438|NCT05133180|594856227|FG001|Overall Study|Lost to Follow-up|1|||
164681439|NCT05133180|594856226|FG000|Overall Study|Documented disease progression|0|||
164681440|NCT05133180|594856227|FG001|Overall Study|Documented disease progression|1|||
164681441|NCT04723693|594856228|FG000|Overall Study|Withdrawal by Subject|2|||
164261016|NCT00075725|593323647|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
164261017|NCT00075725|593323648|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
164340577|NCT02555683|593622219|FG001|Overall Study|Adverse Event|0|||
164340578|NCT02555683|593622220|FG002|Overall Study|Adverse Event|1|||
164340579|NCT02555683|593622218|FG000|Overall Study|Subject/guardian decision|12|||
164340580|NCT02555683|593622219|FG001|Overall Study|Subject/guardian decision|12|||
164577281|NCT03301857|594476872|FG000|Overall Study|Decision by Sponsor|6|||
164577282|NCT03301857|594476873|FG001|Overall Study|Decision by Sponsor|0|||
164577283|NCT03301857|594476872|FG000|Overall Study|Withdrawal by Subject|12|||
164577284|NCT03301857|594476873|FG001|Overall Study|Withdrawal by Subject|4|||
164577285|NCT01856114|594476891|FG000|Overall Study|Withdrawal by Subject|1|||
164577286|NCT01856114|594476892|FG001|Overall Study|Withdrawal by Subject|0|||
164577287|NCT01856114|594476891|FG000|Overall Study|Adverse Event|1|||
164577288|NCT01856114|594476892|FG001|Overall Study|Adverse Event|0|||
164577289|NCT02382133|594476895|FG000|Overall Study|Death|22|||
164577290|NCT02382133|594476895|FG000|Overall Study|transfer out of ICU|4|||
164577291|NCT02382133|594476895|FG000|Overall Study|Physician Decision|2|||
164681442|NCT02157974|594856229|FG000|Overall Study|Withdrawal by Subject|0|||
164340581|NCT02555683|593622220|FG002|Overall Study|Subject/guardian decision|22|||
164340582|NCT02555683|593622218|FG000|Overall Study|Death post Treatment/safety period|0|||
164681443|NCT02157974|594856230|FG001|Overall Study|Withdrawal by Subject|1|||
164261018|NCT00075725|593323649|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
164340583|NCT02555683|593622219|FG001|Overall Study|Death post Treatment/safety period|1|||
164577292|NCT02382133|594476895|FG000|Overall Study|arterial catheter loss|4|||
164577293|NCT02382133|594476895|FG000|Overall Study|pressure injury both sites|1|||
164261019|NCT00075725|593323638|FG000|Overall Study|Pt incarcerated|0|||
164261020|NCT00075725|593323639|FG001|Overall Study|Pt incarcerated|0|||
164261021|NCT00075725|593323640|FG002|Overall Study|Pt incarcerated|0|||
164261022|NCT00075725|593323641|FG003|Overall Study|Pt incarcerated|0|||
164261023|NCT00075725|593323642|FG004|Overall Study|Pt incarcerated|0|||
164261024|NCT00075725|593323643|FG005|Overall Study|Pt incarcerated|0|||
164261025|NCT00075725|593323644|FG006|Overall Study|Pt incarcerated|0|||
164261026|NCT00075725|593323645|FG007|Overall Study|Pt incarcerated|1|||
164261027|NCT00075725|593323646|FG008|Overall Study|Pt incarcerated|0|||
164261028|NCT00075725|593323647|FG009|Overall Study|Pt incarcerated|0|||
164261029|NCT00075725|593323648|FG010|Overall Study|Pt incarcerated|0|||
164261030|NCT00075725|593323649|FG011|Overall Study|Pt incarcerated|0|||
164261031|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Death|1|||
164261032|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Death|1|||
164261033|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Death|0|||
164261034|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Death|0|||
164261035|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Death|1|||
164261036|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Death|0|||
164261037|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Death|0|||
164261038|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Death|0|||
164261039|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Death|0|||
164261040|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Death|0|||
164261041|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
164261042|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
164261043|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
164261044|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
164261045|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
164261046|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
164261047|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
164261048|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
164261049|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
164261050|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
164261051|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
164261052|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
164261053|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
164261054|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
164261055|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
164261056|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
164261057|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
164261058|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
164261059|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
164261060|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
164261061|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
164261062|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
164261063|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
164261064|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
164261065|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
164261066|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
164261067|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
164261068|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
164261069|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
164261070|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
164261071|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
164261072|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
164261073|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
164261074|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
164261075|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
164261076|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
164261077|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
164261078|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
164261079|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
164261080|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
164340584|NCT02555683|593622220|FG002|Overall Study|Death post Treatment/safety period|0|||
164340585|NCT04622306|593622224|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
164340586|NCT04622306|593622225|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
164261081|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
164261082|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
164261083|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
164261084|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
164261085|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
164261086|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
164340587|NCT04622306|593622226|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
164261087|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
164261088|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
164261089|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
164261090|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
164261091|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
164261092|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
164261093|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
164261094|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
164261095|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
164261096|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
164261097|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
164261098|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
164261099|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
164261100|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
164261101|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
164261102|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
164261103|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
164261104|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
164261105|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
164261106|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
164261107|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
164261108|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
164261109|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
164261110|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
164261111|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
164261112|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
164261113|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
164261114|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
164261115|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
164261116|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
164261117|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
164261118|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
164261119|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
164261120|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
164261121|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
164261122|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
164261123|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164261124|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
164261125|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
164261126|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164340588|NCT04622306|593622227|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
164340589|NCT04622306|593622228|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
164340590|NCT04622306|593622229|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
164340591|NCT04622306|593622224|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
164340592|NCT04622306|593622225|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
164340593|NCT04622306|593622226|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
164340594|NCT04622306|593622227|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
164340595|NCT04622306|593622228|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
164340596|NCT04622306|593622229|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
164340597|NCT01896102|593622233|FG000|Overall Study|Death|1|||
164340598|NCT01896102|593622233|FG000|Overall Study|Participant to receive allogenic transplant|2|||
164340599|NCT00696800|593622239|FG000|Overall Study|Adverse Event|16|||
164340600|NCT00696800|593622240|FG001|Overall Study|Adverse Event|3|||
164340601|NCT00696800|593622239|FG000|Overall Study|Insufficient compliance with medication|2|||
164340602|NCT00696800|593622240|FG001|Overall Study|Insufficient compliance with medication|1|||
164340603|NCT00696800|593622239|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
164429690|NCT01168401|593943383|FG007|Overall Study|Withdrawal by Subject|0|||
164261127|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164261128|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164261129|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164261130|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164261131|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261132|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261133|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
164261134|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261135|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
164261136|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261137|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261138|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261139|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261140|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261141|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
164261142|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
164261143|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
164261144|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
164261145|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
164261146|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
164261147|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
164429691|NCT01168401|593943384|FG008|Overall Study|Withdrawal by Subject|0|||
164429692|NCT01168401|593943385|FG009|Overall Study|Withdrawal by Subject|0|||
164261148|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
164261149|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
164261150|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
164261151|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261152|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261153|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261154|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
164261155|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
164261156|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261157|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261158|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261159|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261160|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261161|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
164261162|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261163|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
164261164|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
164261165|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
164261166|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261167|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261168|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261169|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261170|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261171|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
164261172|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261173|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261174|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261175|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
164261176|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261177|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261178|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261179|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261180|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261181|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261182|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261183|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261184|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261185|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
164261186|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261187|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261188|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261189|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261190|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261191|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
164261192|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
164261193|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
164261194|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
164261195|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
164429693|NCT01168401|593943386|FG010|Overall Study|Withdrawal by Subject|0|||
164429694|NCT00672256|593943388|FG000|Overall Study|PI dropped, bad data|44|||
164429695|NCT03255018|593943391|FG000|Overall Study|Death on study|0|||
164429696|NCT03255018|593943392|FG001|Overall Study|Death on study|5|||
164681444|NCT02157974|594856231|FG002|Overall Study|Withdrawal by Subject|0|||
164681445|NCT02157974|594856232|FG003|Overall Study|Withdrawal by Subject|0|||
164681446|NCT02157974|594856233|FG004|Overall Study|Withdrawal by Subject|0|||
164681447|NCT02157974|594856229|FG000|Overall Study|Screen Failure|0|||
164340604|NCT00696800|593622240|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
164681448|NCT02157974|594856230|FG001|Overall Study|Screen Failure|1|||
164681449|NCT02157974|594856231|FG002|Overall Study|Screen Failure|0|||
164681450|NCT02157974|594856232|FG003|Overall Study|Screen Failure|0|||
164681451|NCT02157974|594856233|FG004|Overall Study|Screen Failure|0|||
164681452|NCT02157974|594856229|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
164681453|NCT02157974|594856230|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
164681454|NCT02157974|594856231|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
164681455|NCT02157974|594856232|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
164681456|NCT02157974|594856233|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
164681457|NCT01808651|594856236|FG000|Study Period 1|Lost to Follow-up|1|||
164681458|NCT01808651|594856237|FG001|Study Period 1|Lost to Follow-up|3|||
164681459|NCT01808651|594856238|FG002|Study Period 1|Lost to Follow-up|0|||
164681460|NCT01808651|594856236|FG000|Study Period 1|Protocol Violation|1|||
164681461|NCT01808651|594856237|FG001|Study Period 1|Protocol Violation|0|||
164681462|NCT01808651|594856238|FG002|Study Period 1|Protocol Violation|1|||
164681463|NCT01808651|594856236|FG000|Study Period 1|Physician Decision|3|||
164681464|NCT01808651|594856237|FG001|Study Period 1|Physician Decision|2|||
164681465|NCT01808651|594856238|FG002|Study Period 1|Physician Decision|0|||
164681466|NCT01808651|594856236|FG000|Study Period 1|Lack of Efficacy|2|||
164681467|NCT01808651|594856237|FG001|Study Period 1|Lack of Efficacy|1|||
164681468|NCT01808651|594856238|FG002|Study Period 1|Lack of Efficacy|0|||
164681469|NCT01808651|594856236|FG000|Study Period 1|Adverse Event|10|||
164681470|NCT01808651|594856237|FG001|Study Period 1|Adverse Event|4|||
164681471|NCT01808651|594856238|FG002|Study Period 1|Adverse Event|1|||
164681472|NCT01808651|594856236|FG000|Study Period 1|Participant Decision|9|||
164681473|NCT01808651|594856237|FG001|Study Period 1|Participant Decision|7|||
164681474|NCT01808651|594856238|FG002|Study Period 1|Participant Decision|3|||
164681475|NCT00216736|594856240|FG000|Overall Study|Lost to Follow-up|1|||
164681476|NCT00216736|594856241|FG001|Overall Study|Lost to Follow-up|1|||
164681477|NCT02622386|594856242|FG000|First Assignment|Withdrawal by Subject|3|||
164681478|NCT02622386|594856243|FG001|First Assignment|Withdrawal by Subject|2|||
164681479|NCT02622386|594856242|FG000|Washout|Withdrawal by Subject|4|||
164681480|NCT02622386|594856243|FG001|Washout|Withdrawal by Subject|4|||
164681481|NCT02622386|594856242|FG000|Second Assignment|Withdrawal by Subject|0|||
164681482|NCT02622386|594856243|FG001|Second Assignment|Withdrawal by Subject|2|||
164681483|NCT00807495|594856245|FG000|Overall Study|Adverse Event|6|||
164681484|NCT00807495|594856246|FG001|Overall Study|Adverse Event|3|||
164681485|NCT00807495|594856247|FG002|Overall Study|Adverse Event|1|||
164681486|NCT00807495|594856248|FG003|Overall Study|Adverse Event|1|||
164681487|NCT00807495|594856249|FG004|Overall Study|Adverse Event|2|||
164681488|NCT00807495|594856245|FG000|Overall Study|Withdrawal by Patient|2|||
164681489|NCT00807495|594856246|FG001|Overall Study|Withdrawal by Patient|0|||
164681490|NCT00807495|594856247|FG002|Overall Study|Withdrawal by Patient|1|||
164681491|NCT00807495|594856248|FG003|Overall Study|Withdrawal by Patient|0|||
164681492|NCT00807495|594856249|FG004|Overall Study|Withdrawal by Patient|0|||
164681493|NCT00807495|594856245|FG000|Overall Study|Reason Not Specified|0|||
164681494|NCT00807495|594856246|FG001|Overall Study|Reason Not Specified|3|||
164681495|NCT00807495|594856247|FG002|Overall Study|Reason Not Specified|2|||
164681496|NCT00807495|594856248|FG003|Overall Study|Reason Not Specified|0|||
164681497|NCT00807495|594856249|FG004|Overall Study|Reason Not Specified|3|||
164681498|NCT05274763|594856250|FG000|Overall Study|Lost to Follow-up|1|||
164681499|NCT00841542|594856251|FG000|Period 1|Adverse Event|1|||
164681500|NCT00841542|594856252|FG001|Period 1|Adverse Event|0|||
164681501|NCT00463684|594856257|FG000|Overall Study|Withdrawal by Subject|1|||
164681502|NCT00463684|594856257|FG000|Overall Study|Lost to Follow-up|3|||
164681503|NCT01906372|594856258|FG000|Overall Study|Withdrawal by Subject|2|||
164681504|NCT03629054|594856259|FG000|Period 2 (4 Days)|Not treated|0|||
164340605|NCT00696800|593622239|FG000|Overall Study|Insufficient ovarian response|4|||
164340606|NCT00696800|593622240|FG001|Overall Study|Insufficient ovarian response|1|||
164340607|NCT00696800|593622239|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
164340608|NCT00696800|593622240|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
164340609|NCT00696800|593622239|FG000|Overall Study|Too high ovarian response|6|||
164340610|NCT00696800|593622240|FG001|Overall Study|Too high ovarian response|1|||
164681505|NCT03629054|594856260|FG001|Period 2 (4 Days)|Not treated|1|||
164681506|NCT03808376|594856261|FG000|Overall Study|Withdrawal by Subject|10|||
164340611|NCT00696800|593622239|FG000|Overall Study|No/too few/bad quality oocytes|4|||
164340612|NCT00696800|593622240|FG001|Overall Study|No/too few/bad quality oocytes|3|||
164681507|NCT02462837|594856262|FG000|Overall Study|pt developed hives|1|||
164681508|NCT02462837|594856263|FG001|Overall Study|pt developed hives|0|||
164681509|NCT02462837|594856262|FG000|Overall Study|Withdrawal by Subject|1|||
164681510|NCT02462837|594856263|FG001|Overall Study|Withdrawal by Subject|0|||
164681511|NCT00924638|594856267|FG000|Overall Study|Death|3|||
164681512|NCT00924638|594856268|FG001|Overall Study|Death|2|||
164681513|NCT00924638|594856267|FG000|Overall Study|Lost to Follow-up|1|||
164340613|NCT00696800|593622239|FG000|Overall Study|No/abnormal fertilization|11|||
164340614|NCT00696800|593622240|FG001|Overall Study|No/abnormal fertilization|13|||
164340615|NCT00696800|593622239|FG000|Overall Study|No/too few/bad quality embryos|24|||
164340616|NCT00696800|593622240|FG001|Overall Study|No/too few/bad quality embryos|18|||
164340617|NCT00696800|593622239|FG000|Overall Study|Other Reasons|5|||
164340618|NCT00696800|593622240|FG001|Overall Study|Other Reasons|3|||
164340619|NCT00696800|593622239|FG000|Overall Study|Not treated|1|||
164261196|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
164261197|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
164261198|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
164261199|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
164261200|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
164261201|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
164261202|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
164261203|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
164261204|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
164261205|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
164261206|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
164261207|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
164261208|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
164261209|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
164261210|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
164261211|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
164261212|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
164261213|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
164261214|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
164261215|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
164261216|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
164261217|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
164261218|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
164261219|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
164261220|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
164261221|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Other|5|||
164261222|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Other|1|||
164261223|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Other|0|||
164261224|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Other|3|||
164261225|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Other|0|||
164261226|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Other|0|||
164261227|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Other|0|||
164261228|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Other|0|||
164261229|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Other|0|||
164261230|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Other|0|||
164261231|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
164261232|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
164261233|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
164261234|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
164261235|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
164340620|NCT00696800|593622240|FG001|Overall Study|Not treated|2|||
164340621|NCT00762385|593622242|FG000|First Intervention|Lens Issue|1|||
164340622|NCT00762385|593622243|FG001|First Intervention|Lens Issue|1|||
164261236|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
164261237|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
164261238|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
164261239|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
164261240|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
164261241|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|Death|0|||
164261242|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|Death|0|||
164340623|NCT00762385|593622242|FG000|First Intervention|Lost to Follow-up|0|||
164340624|NCT00762385|593622243|FG001|First Intervention|Lost to Follow-up|2|||
164340625|NCT00762385|593622242|FG000|First Intervention|Ineligible|1|||
164577294|NCT04906707|594476896|FG000|Overall Study|Withdrawal by Subject|2|||
164577295|NCT04906707|594476897|FG001|Overall Study|Withdrawal by Subject|0|||
164577296|NCT04906707|594476896|FG000|Overall Study|Withdrawal due to PI decision|1|||
164577297|NCT04906707|594476897|FG001|Overall Study|Withdrawal due to PI decision|0|||
164577298|NCT04906707|594476896|FG000|Overall Study|Lost to Follow-up|0|||
164577299|NCT04906707|594476897|FG001|Overall Study|Lost to Follow-up|1|||
164577300|NCT04429022|594476899|FG000|Overall Study|Protocol Violation|18|||
164577301|NCT04429022|594476900|FG001|Overall Study|Protocol Violation|1|||
164577302|NCT04321343|594476901|FG000|Overall Study|Adverse Event|0|||
164261243|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|Death|0|||
164261244|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|Death|0|||
164261245|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|Death|0|||
164261246|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|Death|1|||
164261247|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|Death|0|||
164261248|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|Death|1|||
164681514|NCT00924638|594856268|FG001|Overall Study|Lost to Follow-up|1|||
164681515|NCT00924638|594856267|FG000|Overall Study|Withdrawal by Subject|5|||
164681516|NCT00924638|594856268|FG001|Overall Study|Withdrawal by Subject|7|||
164681517|NCT00924638|594856267|FG000|Overall Study|Physician Decision|3|||
164681518|NCT00924638|594856268|FG001|Overall Study|Physician Decision|3|||
164681519|NCT00748566|594856269|FG000|Overall Study|Adverse Event|49|||
164681520|NCT00748566|594856269|FG000|Overall Study|Death|1|||
164681521|NCT00748566|594856269|FG000|Overall Study|Lack of Efficacy|12|||
164681522|NCT00748566|594856269|FG000|Overall Study|Lost to Follow-up|1|||
164261249|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|Death|1|||
164261250|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|Death|1|||
164261251|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
164261252|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
164261253|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
164261254|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
164261255|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
164261256|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
164261257|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
164261258|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
164261259|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
164261260|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
164261261|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
164261262|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
164261263|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
164340626|NCT00762385|593622243|FG001|First Intervention|Ineligible|0|||
164681523|NCT00748566|594856269|FG000|Overall Study|Protocol Violation|13|||
164681524|NCT00748566|594856269|FG000|Overall Study|Withdrawal by Subject|22|||
164340627|NCT00762385|593622242|FG000|First Intervention|Protocol Violation|0|||
164340628|NCT00762385|593622243|FG001|First Intervention|Protocol Violation|1|||
164340629|NCT00762385|593622242|FG000|Second Intervention|Protocol Violation|3|||
164340630|NCT00762385|593622243|FG001|Second Intervention|Protocol Violation|3|||
164340631|NCT00591344|593622246|FG000|Overall Study|Transportation issues|1|||
164340632|NCT00591344|593622247|FG001|Overall Study|Transportation issues|0|||
164340633|NCT00591344|593622246|FG000|Overall Study|Moved out of state|1|||
164340634|NCT00591344|593622247|FG001|Overall Study|Moved out of state|0|||
164340635|NCT00591344|593622246|FG000|Overall Study|Medical complications|1|||
164340636|NCT00591344|593622247|FG001|Overall Study|Medical complications|3|||
164340637|NCT00591344|593622246|FG000|Overall Study|Underwent DBS|2|||
164340638|NCT00591344|593622247|FG001|Overall Study|Underwent DBS|2|||
164340639|NCT00591344|593622246|FG000|Overall Study|Death|0|||
164340640|NCT00591344|593622247|FG001|Overall Study|Death|1|||
164340641|NCT00591344|593622246|FG000|Overall Study|Lost to Follow-up|0|||
164340642|NCT00591344|593622247|FG001|Overall Study|Lost to Follow-up|1|||
164340643|NCT00591344|593622246|FG000|Overall Study|Did not want to come off medication|0|||
164340644|NCT00591344|593622247|FG001|Overall Study|Did not want to come off medication|1|||
164681525|NCT00748566|594856269|FG000|Overall Study|Study terminated by sponsor|5|||
164681526|NCT00748566|594856269|FG000|Overall Study|Other|9|||
164261264|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
164340645|NCT00493025|593622248|FG000|Overall Study|Physician Decision|19|||
164340646|NCT01609231|593622255|FG000|Overall Study|Adverse Event|1|||
164340647|NCT01609231|593622256|FG001|Overall Study|Adverse Event|3|||
164340648|NCT01609231|593622255|FG000|Overall Study|Physician Decision|1|||
164340649|NCT01609231|593622256|FG001|Overall Study|Physician Decision|0|||
164340650|NCT01609231|593622255|FG000|Overall Study|Withdrawal by Subject|1|||
164340651|NCT01609231|593622256|FG001|Overall Study|Withdrawal by Subject|0|||
164340652|NCT00494299|593622257|FG000|Overall Study|Adverse Event|93|||
164340653|NCT00494299|593622258|FG001|Overall Study|Adverse Event|13|||
164340654|NCT00494299|593622257|FG000|Overall Study|Lost to Follow-up|1|||
164340655|NCT00494299|593622258|FG001|Overall Study|Lost to Follow-up|0|||
164340656|NCT00494299|593622257|FG000|Overall Study|Physician Decision|0|||
164340657|NCT00494299|593622258|FG001|Overall Study|Physician Decision|2|||
164340658|NCT00494299|593622257|FG000|Overall Study|Protocol Violation|1|||
164340659|NCT00494299|593622258|FG001|Overall Study|Protocol Violation|2|||
164340660|NCT00494299|593622257|FG000|Overall Study|Withdrawal by Subject|8|||
164340661|NCT00494299|593622258|FG001|Overall Study|Withdrawal by Subject|3|||
164340662|NCT00494299|593622257|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
164340663|NCT00494299|593622258|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
164340664|NCT00494299|593622257|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
164681527|NCT00989950|594856270|FG000|Randomized Phase|Protocol Violation|1|||
164681528|NCT00989950|594856271|FG001|Randomized Phase|Protocol Violation|0|||
164681529|NCT00989950|594856272|FG002|Randomized Phase|Protocol Violation|0|||
164681530|NCT00989950|594856273|FG003|Randomized Phase|Protocol Violation|0|||
164681531|NCT00989950|594856270|FG000|Randomized Phase|Adverse Event|0|||
164681532|NCT00989950|594856271|FG001|Randomized Phase|Adverse Event|1|||
164681533|NCT00989950|594856272|FG002|Randomized Phase|Adverse Event|0|||
164681534|NCT00989950|594856273|FG003|Randomized Phase|Adverse Event|0|||
164261265|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
164261266|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
164261267|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
164261268|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
164261269|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
164261270|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
164261271|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
164261272|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
164261273|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
164261274|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
164261275|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
164261276|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
164261277|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
164261278|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
164261279|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
164261280|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
164261281|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
164261282|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
164261283|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
164261284|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
164261285|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
164261286|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
164261287|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
164261288|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
164261289|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
164261290|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
164261291|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164261292|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164340665|NCT00494299|593622258|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
164340666|NCT00494299|593622257|FG000|Overall Study|Site Closed by Sponsor|6|||
164681535|NCT02845336|594856277|FG000|Overall Study|Lost to Follow-up|3|||
164681536|NCT02845336|594856278|FG001|Overall Study|Lost to Follow-up|1|||
164681537|NCT02845336|594856277|FG000|Overall Study|Inability to get medication|2|||
164681538|NCT02845336|594856278|FG001|Overall Study|Inability to get medication|0|||
164681539|NCT03488108|594856279|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
164681540|NCT03488108|594856280|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
164681541|NCT03488108|594856279|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
164681542|NCT03488108|594856280|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
164681543|NCT02054715|594856282|FG000|Baseline/Follow-up 1|Refused|1|||
164681544|NCT02054715|594856283|FG001|Baseline/Follow-up 1|Refused|3|||
164681545|NCT02054715|594856282|FG000|Baseline/Follow-up 1|Medical|0|||
164681546|NCT02054715|594856283|FG001|Baseline/Follow-up 1|Medical|1|||
164681547|NCT02054715|594856282|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
164681548|NCT02054715|594856283|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
164681549|NCT02054715|594856282|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
164681550|NCT02054715|594856283|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
164681551|NCT02054715|594856282|FG000|Baseline/Follow-up 1|No Reason|0|||
164681552|NCT02054715|594856283|FG001|Baseline/Follow-up 1|No Reason|1|||
164681553|NCT02054715|594856282|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
164681554|NCT02054715|594856283|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
164681555|NCT02054715|594856282|FG000|Baseline/Follow-up 1|Ineligible|3|||
164681556|NCT02054715|594856283|FG001|Baseline/Follow-up 1|Ineligible|0|||
164681557|NCT02054715|594856282|FG000|Baseline/Follow-up 1|Hospitalization|1|||
164681558|NCT02054715|594856283|FG001|Baseline/Follow-up 1|Hospitalization|0|||
164681559|NCT02054715|594856282|FG000|Baseline/Follow-up 1|Changed Mind|1|||
164681560|NCT02054715|594856283|FG001|Baseline/Follow-up 1|Changed Mind|0|||
164681561|NCT02054715|594856282|FG000|Follow-up 2|Lost to Followup|3|||
164681562|NCT02054715|594856283|FG001|Follow-up 2|Lost to Followup|1|||
164681563|NCT02054715|594856282|FG000|Follow-up 2|Refused|3|||
164261293|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164429697|NCT03255018|593943391|FG000|Overall Study|Withdrawal by Subject|0|||
164429698|NCT03255018|593943392|FG001|Overall Study|Withdrawal by Subject|2|||
164429699|NCT01124162|593943394|FG000|First Intervention|Adverse Event|2|||
164429700|NCT01124162|593943395|FG001|First Intervention|Adverse Event|0|||
164429701|NCT01124162|593943394|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
164429702|NCT01124162|593943395|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
164429703|NCT03681691|593943396|FG000|Overall Study|COVID|1|||
164429704|NCT03681691|593943397|FG001|Overall Study|COVID|0|||
164429705|NCT03681691|593943396|FG000|Overall Study|prolonged bleeding|1|||
164429706|NCT03681691|593943397|FG001|Overall Study|prolonged bleeding|0|||
164429707|NCT03681691|593943396|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
164261294|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164261295|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164261296|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
164261297|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164261298|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
164261299|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
164261300|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164261301|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
164261302|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
164261303|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
164261304|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
164261305|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
164261306|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
164261307|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
164261308|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
164261309|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
164261310|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
164261311|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261312|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261313|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261314|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261315|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261316|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261317|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261318|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261319|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
164261320|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
164261321|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261322|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261323|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261324|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261325|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261326|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261327|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261328|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
164261329|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164429708|NCT03681691|593943397|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
164429709|NCT00465985|593943398|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
164429710|NCT00465985|593943399|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
164429711|NCT00465985|593943398|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
164429712|NCT00465985|593943399|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
164429713|NCT00465985|593943398|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
164429714|NCT00465985|593943399|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
164429715|NCT00465985|593943398|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
164577303|NCT04321343|594476902|FG001|Overall Study|Adverse Event|0|||
164577304|NCT04321343|594476903|FG002|Overall Study|Adverse Event|1|||
164577305|NCT04321343|594476904|FG003|Overall Study|Adverse Event|0|||
164577306|NCT04321343|594476901|FG000|Overall Study|Death|0|||
164681564|NCT02054715|594856283|FG001|Follow-up 2|Refused|2|||
164681565|NCT02054715|594856282|FG000|Follow-up 2|Followup Not Completed|3|||
164681566|NCT02054715|594856283|FG001|Follow-up 2|Followup Not Completed|4|||
164681567|NCT02054715|594856282|FG000|Follow-up 2|Ineligible|4|||
164681568|NCT02054715|594856283|FG001|Follow-up 2|Ineligible|5|||
164681569|NCT02054715|594856282|FG000|Follow-up 2|Death|3|||
164681570|NCT02054715|594856283|FG001|Follow-up 2|Death|3|||
164681571|NCT02054715|594856282|FG000|Follow-up 2|Hospitalization|0|||
164681572|NCT02054715|594856283|FG001|Follow-up 2|Hospitalization|2|||
164681573|NCT02054715|594856282|FG000|Follow-up 2|Changed MD/Facility|0|||
164681574|NCT02054715|594856283|FG001|Follow-up 2|Changed MD/Facility|1|||
164681575|NCT02054715|594856282|FG000|Follow-up 2|Changed Mind|0|||
164681576|NCT02054715|594856283|FG001|Follow-up 2|Changed Mind|1|||
164681577|NCT02054715|594856282|FG000|Follow-up 2|No Reason|2|||
164681578|NCT02054715|594856283|FG001|Follow-up 2|No Reason|0|||
164681579|NCT02054715|594856282|FG000|Follow-up 2|Treatment Change or Delay|1|||
164681580|NCT02054715|594856283|FG001|Follow-up 2|Treatment Change or Delay|0|||
164261330|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261331|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
164261332|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
164261333|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
164577307|NCT04321343|594476902|FG001|Overall Study|Death|0|||
164577308|NCT04321343|594476903|FG002|Overall Study|Death|0|||
164577309|NCT04321343|594476904|FG003|Overall Study|Death|1|||
164577310|NCT04321343|594476901|FG000|Overall Study|Pregnancy|1|||
164577311|NCT04321343|594476902|FG001|Overall Study|Pregnancy|0|||
164577312|NCT04321343|594476903|FG002|Overall Study|Pregnancy|0|||
164577313|NCT04321343|594476904|FG003|Overall Study|Pregnancy|0|||
164577314|NCT04321343|594476901|FG000|Overall Study|Protocol Violation|1|||
164577315|NCT04321343|594476902|FG001|Overall Study|Protocol Violation|1|||
164577316|NCT04321343|594476903|FG002|Overall Study|Protocol Violation|1|||
164577317|NCT04321343|594476904|FG003|Overall Study|Protocol Violation|1|||
164577318|NCT04321343|594476901|FG000|Overall Study|Withdrawal by Subject|0|||
164577319|NCT04321343|594476902|FG001|Overall Study|Withdrawal by Subject|6|||
164577320|NCT04321343|594476903|FG002|Overall Study|Withdrawal by Subject|0|||
164577321|NCT04321343|594476904|FG003|Overall Study|Withdrawal by Subject|2|||
164577322|NCT04321343|594476901|FG000|Overall Study|Lost to Follow-up|2|||
164577323|NCT04321343|594476902|FG001|Overall Study|Lost to Follow-up|2|||
164577324|NCT04321343|594476903|FG002|Overall Study|Lost to Follow-up|1|||
164577325|NCT04321343|594476904|FG003|Overall Study|Lost to Follow-up|3|||
164577326|NCT02581995|594476906|FG000|Overall Study|Unspecified other|3|||
164577327|NCT02581995|594476906|FG000|Overall Study|Adverse Event|6|||
164577328|NCT02581995|594476906|FG000|Overall Study|Lost to Follow-up|5|||
164577329|NCT02581995|594476906|FG000|Overall Study|Withdrawal by participant|12|||
164577330|NCT02581995|594476906|FG000|Overall Study|Physician Decision|1|||
164577331|NCT02581995|594476906|FG000|Overall Study|Death|4|||
164577332|NCT05738486|594479249|FG000|Overall Study|Continuing Study|194|||
164577333|NCT05738486|594479250|FG001|Overall Study|Continuing Study|196|||
164577334|NCT05738486|594479251|FG002|Overall Study|Continuing Study|193|||
164577335|NCT05738486|594479252|FG003|Overall Study|Continuing Study|191|||
164577336|NCT05738486|594479249|FG000|Overall Study|Withdrawal by Subject|8|||
164577337|NCT05738486|594479250|FG001|Overall Study|Withdrawal by Subject|5|||
164577338|NCT05738486|594479251|FG002|Overall Study|Withdrawal by Subject|7|||
164577339|NCT05738486|594479252|FG003|Overall Study|Withdrawal by Subject|13|||
164577340|NCT05738486|594479249|FG000|Overall Study|Adverse Event|4|||
164577341|NCT05738486|594479250|FG001|Overall Study|Adverse Event|6|||
164577342|NCT05738486|594479251|FG002|Overall Study|Adverse Event|4|||
164577343|NCT05738486|594479252|FG003|Overall Study|Adverse Event|5|||
164577344|NCT05738486|594479249|FG000|Overall Study|Physician Decision|0|||
164577345|NCT05738486|594479250|FG001|Overall Study|Physician Decision|2|||
164577346|NCT05738486|594479251|FG002|Overall Study|Physician Decision|4|||
164577347|NCT05738486|594479252|FG003|Overall Study|Physician Decision|1|||
164577348|NCT05738486|594479249|FG000|Overall Study|Lost to Follow-up|1|||
164577349|NCT05738486|594479250|FG001|Overall Study|Lost to Follow-up|1|||
164577350|NCT05738486|594479251|FG002|Overall Study|Lost to Follow-up|2|||
164577351|NCT05738486|594479252|FG003|Overall Study|Lost to Follow-up|1|||
164577352|NCT05738486|594479249|FG000|Overall Study|Participant was Non-ambulatory|0|||
164577353|NCT05738486|594479250|FG001|Overall Study|Participant was Non-ambulatory|0|||
164577354|NCT05738486|594479251|FG002|Overall Study|Participant was Non-ambulatory|1|||
164577355|NCT05738486|594479252|FG003|Overall Study|Participant was Non-ambulatory|0|||
164577356|NCT05738486|594479249|FG000|Overall Study|Participant had Poor Venous Access|0|||
164577357|NCT05738486|594479250|FG001|Overall Study|Participant had Poor Venous Access|0|||
164577358|NCT05738486|594479251|FG002|Overall Study|Participant had Poor Venous Access|0|||
164577359|NCT05738486|594479252|FG003|Overall Study|Participant had Poor Venous Access|1|||
164577360|NCT05738486|594479249|FG000|Overall Study|Assigned Treatment by Mistake|0|||
164577361|NCT05738486|594479250|FG001|Overall Study|Assigned Treatment by Mistake|0|||
164261334|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
164261335|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
164261336|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
164261337|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
164261338|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
164261339|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
164261340|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
164261341|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261342|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261343|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261344|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261345|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261346|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261347|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261348|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
164261349|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
164261350|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261351|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
164261352|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
164261353|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
164261354|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
164261355|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
164261356|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
164261357|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
164261358|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
164261359|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
164261360|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
164261361|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
164261362|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
164261363|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
164261364|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
164261365|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
164261366|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
164261367|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
164261368|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
164261369|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
164261370|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
164261371|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
164261372|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
164340667|NCT00494299|593622258|FG001|Overall Study|Site Closed by Sponsor|0|||
164340668|NCT00494299|593622257|FG000|Overall Study|Protocol Driven Decision Point|11|||
164340669|NCT00494299|593622258|FG001|Overall Study|Protocol Driven Decision Point|22|||
164340670|NCT03822182|593622264|FG000|Overall Study|Protocol Violation|0|||
164340671|NCT03822182|593622265|FG001|Overall Study|Protocol Violation|1|||
164340672|NCT03822182|593622266|FG002|Overall Study|Protocol Violation|1|||
164340673|NCT01484275|593622267|FG000|Overall Study|Study terminated by sponsor|28|||
164340674|NCT01484275|593622268|FG001|Overall Study|Study terminated by sponsor|32|||
164340675|NCT01484275|593622267|FG000|Overall Study|Other|10|||
164340676|NCT01484275|593622268|FG001|Overall Study|Other|0|||
164340677|NCT01484275|593622267|FG000|Overall Study|Death|3|||
164340678|NCT01484275|593622268|FG001|Overall Study|Death|4|||
164340679|NCT01484275|593622267|FG000|Overall Study|Withdrawal by Subject|1|||
164340680|NCT01484275|593622268|FG001|Overall Study|Withdrawal by Subject|5|||
164340681|NCT01484275|593622267|FG000|Overall Study|Lost to Follow-up|1|||
164340682|NCT01484275|593622268|FG001|Overall Study|Lost to Follow-up|1|||
164340683|NCT03113916|593622271|FG000|Overall Study|Withdrawal by Subject|9|||
164340684|NCT03113916|593622272|FG001|Overall Study|Withdrawal by Subject|7|||
164340685|NCT03113916|593622271|FG000|Overall Study|Pregnancy|1|||
164340686|NCT03113916|593622272|FG001|Overall Study|Pregnancy|3|||
164340687|NCT03113916|593622271|FG000|Overall Study|Lost to Follow-up|1|||
164340688|NCT03113916|593622272|FG001|Overall Study|Lost to Follow-up|2|||
164340689|NCT00241358|593622273|FG000|Overall Study|Determined to be not ineligible|0|||
164577362|NCT05738486|594479251|FG002|Overall Study|Assigned Treatment by Mistake|0|||
164261373|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
164261374|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
164261375|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
164261376|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
164261377|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
164261378|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
164261379|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
164261380|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
164261381|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
164261382|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
164261383|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
164261384|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
164261385|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
164261386|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
164261387|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
164261388|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
164261389|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
164261390|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
164261391|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|Other|0|||
164261392|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|Other|0|||
164261393|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|Other|0|||
164261394|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|Other|0|||
164261395|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|Other|0|||
164261396|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|Other|0|||
164261397|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|Other|0|||
164261398|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|Other|1|||
164261399|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|Other|0|||
164261400|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|Other|0|||
164261401|NCT01560637|593323660|FG000|Overall Study|Adverse Event|63|||
164261402|NCT01560637|593323660|FG000|Overall Study|Death|69|||
164261403|NCT01560637|593323660|FG000|Overall Study|Lost to Follow-up|8|||
164261404|NCT01560637|593323660|FG000|Overall Study|Protocol Violation|8|||
164261405|NCT01560637|593323660|FG000|Overall Study|Withdrawal by Subject|24|||
164261406|NCT01560637|593323660|FG000|Overall Study|Progressive Disease|20|||
164261407|NCT01560637|593323660|FG000|Overall Study|Other Reason Not Specified|6|||
164261408|NCT04962230|593323669|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
164261409|NCT04962230|593323669|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
164261410|NCT02275117|593323672|FG000|Overall Study|Adverse Event|0|||
164261411|NCT02275117|593323673|FG001|Overall Study|Adverse Event|0|||
164261412|NCT02275117|593323674|FG002|Overall Study|Adverse Event|0|||
164261413|NCT02275117|593323675|FG003|Overall Study|Adverse Event|0|||
164261414|NCT02275117|593323676|FG004|Overall Study|Adverse Event|1|||
164261415|NCT02275117|593323672|FG000|Overall Study|Lack of Efficacy|6|||
164261416|NCT02275117|593323673|FG001|Overall Study|Lack of Efficacy|7|||
164261417|NCT02275117|593323674|FG002|Overall Study|Lack of Efficacy|5|||
164261418|NCT02275117|593323675|FG003|Overall Study|Lack of Efficacy|2|||
164261419|NCT02275117|593323676|FG004|Overall Study|Lack of Efficacy|10|||
164261420|NCT02275117|593323672|FG000|Overall Study|Lost to Follow-up|11|||
164261421|NCT02275117|593323673|FG001|Overall Study|Lost to Follow-up|16|||
164261422|NCT02275117|593323674|FG002|Overall Study|Lost to Follow-up|15|||
164261423|NCT02275117|593323675|FG003|Overall Study|Lost to Follow-up|16|||
164261424|NCT02275117|593323676|FG004|Overall Study|Lost to Follow-up|8|||
164261425|NCT02275117|593323672|FG000|Overall Study|Physician Decision|0|||
164261426|NCT02275117|593323673|FG001|Overall Study|Physician Decision|1|||
164261427|NCT02275117|593323674|FG002|Overall Study|Physician Decision|1|||
164261428|NCT02275117|593323675|FG003|Overall Study|Physician Decision|0|||
164261429|NCT02275117|593323676|FG004|Overall Study|Physician Decision|1|||
164340690|NCT00241358|593622274|FG001|Overall Study|Determined to be not ineligible|1|||
164340691|NCT00241358|593622275|FG002|Overall Study|Determined to be not ineligible|1|||
164340692|NCT01893203|593622277|FG000|Overall Study|Withdrawal by Subject|1|||
164261430|NCT02275117|593323672|FG000|Overall Study|Protocol Violation|1|||
164261431|NCT02275117|593323673|FG001|Overall Study|Protocol Violation|0|||
164261432|NCT02275117|593323674|FG002|Overall Study|Protocol Violation|1|||
164261433|NCT02275117|593323675|FG003|Overall Study|Protocol Violation|1|||
164261434|NCT02275117|593323676|FG004|Overall Study|Protocol Violation|0|||
164261435|NCT02275117|593323672|FG000|Overall Study|Withdrawal by Subject|6|||
164261436|NCT02275117|593323673|FG001|Overall Study|Withdrawal by Subject|4|||
164261437|NCT02275117|593323674|FG002|Overall Study|Withdrawal by Subject|7|||
164261438|NCT02275117|593323675|FG003|Overall Study|Withdrawal by Subject|3|||
164261439|NCT02275117|593323676|FG004|Overall Study|Withdrawal by Subject|3|||
164261440|NCT02275117|593323672|FG000|Overall Study|Terminated by Sponsor|4|||
164261441|NCT02275117|593323673|FG001|Overall Study|Terminated by Sponsor|4|||
164261442|NCT02275117|593323674|FG002|Overall Study|Terminated by Sponsor|4|||
164340693|NCT01758523|593622278|FG000|Overall Study|Adverse Event|2|||
164340694|NCT01758523|593622279|FG001|Overall Study|Adverse Event|1|||
164261443|NCT02275117|593323675|FG003|Overall Study|Terminated by Sponsor|6|||
164261444|NCT02275117|593323676|FG004|Overall Study|Terminated by Sponsor|4|||
164261445|NCT02275117|593323672|FG000|Overall Study|Worsening of Study Indication|0|||
164261446|NCT02275117|593323673|FG001|Overall Study|Worsening of Study Indication|1|||
164261447|NCT02275117|593323674|FG002|Overall Study|Worsening of Study Indication|2|||
164261448|NCT02275117|593323675|FG003|Overall Study|Worsening of Study Indication|0|||
164261449|NCT02275117|593323676|FG004|Overall Study|Worsening of Study Indication|0|||
164261450|NCT02275117|593323672|FG000|Overall Study|Study Burden|5|||
164261451|NCT02275117|593323673|FG001|Overall Study|Study Burden|4|||
164261452|NCT02275117|593323674|FG002|Overall Study|Study Burden|7|||
164261453|NCT02275117|593323675|FG003|Overall Study|Study Burden|5|||
164261454|NCT02275117|593323676|FG004|Overall Study|Study Burden|7|||
164261455|NCT02275117|593323672|FG000|Overall Study|Other|1|||
164261456|NCT02275117|593323673|FG001|Overall Study|Other|0|||
164261457|NCT02275117|593323674|FG002|Overall Study|Other|0|||
164261458|NCT02275117|593323675|FG003|Overall Study|Other|0|||
164261459|NCT02275117|593323676|FG004|Overall Study|Other|2|||
164261460|NCT01081301|593323680|FG000|Overall Study|Bereaved|3|||
164261461|NCT01081301|593323680|FG000|Overall Study|Too busy|5|||
164261462|NCT01081301|593323680|FG000|Overall Study|Patient too ill|2|||
164261463|NCT01081301|593323680|FG000|Overall Study|Lost to Follow-up|4|||
164261464|NCT01646645|593323687|FG000|Overall Study|No Treated|1|||
164261465|NCT01646645|593323687|FG000|Overall Study|Inevaluable Donor|29|||
164261466|NCT00717522|593323688|FG000|Overall Study|Disease Progression|5|||
164261467|NCT00717522|593323688|FG000|Overall Study|Adverse Event|1|||
164261468|NCT00717522|593323688|FG000|Overall Study|Death|1|||
164261469|NCT01799239|593323689|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
164261470|NCT01799239|593323690|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
164261471|NCT01799239|593323689|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
164261472|NCT01799239|593323690|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
164261473|NCT01799239|593323689|FG000|Period 1 (7 Days)|Protocol Violation|0|||
164261474|NCT01799239|593323690|FG001|Period 1 (7 Days)|Protocol Violation|1|||
164261475|NCT01799239|593323689|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
164261476|NCT01799239|593323690|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
164261477|NCT01799239|593323689|FG000|Period 2 (7 Days)|Protocol Violation|1|||
164261478|NCT01799239|593323690|FG001|Period 2 (7 Days)|Protocol Violation|0|||
164261479|NCT04209114|593323691|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
164261480|NCT04209114|593323692|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
164261481|NCT04209114|593323693|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
164261482|NCT04209114|593323691|FG000|Pre-Treatment Phase|Other reasons|0|||
164261483|NCT04209114|593323692|FG001|Pre-Treatment Phase|Other reasons|0|||
164261484|NCT04209114|593323693|FG002|Pre-Treatment Phase|Other reasons|1|||
164261485|NCT04209114|593323691|FG000|Pre-Treatment Phase|Death|0|||
164261486|NCT04209114|593323692|FG001|Pre-Treatment Phase|Death|0|||
164261487|NCT04209114|593323693|FG002|Pre-Treatment Phase|Death|1|||
164261488|NCT04209114|593323691|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
164261489|NCT04209114|593323692|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
164261490|NCT04209114|593323693|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
164261491|NCT04209114|593323691|FG000|Treatment Phase|Other reasons|5|||
164261492|NCT04209114|593323692|FG001|Treatment Phase|Other reasons|3|||
164261493|NCT04209114|593323693|FG002|Treatment Phase|Other reasons|0|||
164261494|NCT04209114|593323691|FG000|Treatment Phase|Lost to Follow-up|1|||
164261495|NCT04209114|593323692|FG001|Treatment Phase|Lost to Follow-up|0|||
164261496|NCT04209114|593323693|FG002|Treatment Phase|Lost to Follow-up|0|||
164261497|NCT04209114|593323691|FG000|Treatment Phase|Participant withdrew consent|1|||
164261498|NCT04209114|593323692|FG001|Treatment Phase|Participant withdrew consent|0|||
164261499|NCT04209114|593323693|FG002|Treatment Phase|Participant withdrew consent|0|||
164261500|NCT04209114|593323691|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
164261501|NCT04209114|593323692|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
164261502|NCT04209114|593323693|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
164261503|NCT04209114|593323691|FG000|Treatment Phase|Death|4|||
164261504|NCT04209114|593323692|FG001|Treatment Phase|Death|1|||
164261505|NCT04209114|593323693|FG002|Treatment Phase|Death|0|||
164261506|NCT04209114|593323691|FG000|Treatment Phase|Study drug toxicity|4|||
164261507|NCT04209114|593323692|FG001|Treatment Phase|Study drug toxicity|6|||
164261508|NCT04209114|593323693|FG002|Treatment Phase|Study drug toxicity|0|||
164261509|NCT04209114|593323691|FG000|Treatment Phase|Disease progression|6|||
164261510|NCT04209114|593323692|FG001|Treatment Phase|Disease progression|9|||
164261511|NCT04209114|593323693|FG002|Treatment Phase|Disease progression|0|||
164261512|NCT04143217|593325489|FG000|Overall Study|Withdrawal by Subject|42|||
164261513|NCT04143217|593325489|FG000|Overall Study|Adverse Event|29|||
164261514|NCT04143217|593325489|FG000|Overall Study|Lost to Follow-up|29|||
164261515|NCT04143217|593325489|FG000|Overall Study|Lack of Efficacy|15|||
164261516|NCT04143217|593325489|FG000|Overall Study|Physician Decision|1|||
164261517|NCT04143217|593325489|FG000|Overall Study|Non-Compliance With Study Drug|6|||
164261518|NCT04143217|593325489|FG000|Overall Study|Other, Multiple Categories|11|||
164261519|NCT02210832|593325492|FG000|Overall Study|Pregnancy termination .|3|||
164261520|NCT02210832|593325493|FG001|Overall Study|Pregnancy termination .|4|||
164261521|NCT02210832|593325494|FG002|Overall Study|Pregnancy termination .|1|||
164261522|NCT02210832|593325492|FG000|Overall Study|Lost to Follow-up|26|||
164261523|NCT02210832|593325493|FG001|Overall Study|Lost to Follow-up|32|||
164261524|NCT02210832|593325494|FG002|Overall Study|Lost to Follow-up|17|||
164261525|NCT00471887|593325497|FG000|Overall Study|Adverse Event|9|||
164261526|NCT01278407|593325505|FG000|Confirmatory Phase|Adverse Event|5|||
164261527|NCT01278407|593325506|FG001|Confirmatory Phase|Adverse Event|10|||
164261528|NCT01278407|593325507|FG002|Confirmatory Phase|Adverse Event|1|||
164261529|NCT01278407|593325508|FG003|Confirmatory Phase|Adverse Event|0|||
164261530|NCT01278407|593325509|FG004|Confirmatory Phase|Adverse Event|0|||
164261531|NCT01278407|593325505|FG000|Confirmatory Phase|Participant's Choice|3|||
164261532|NCT01278407|593325506|FG001|Confirmatory Phase|Participant's Choice|5|||
164261533|NCT01278407|593325507|FG002|Confirmatory Phase|Participant's Choice|3|||
164261534|NCT01278407|593325508|FG003|Confirmatory Phase|Participant's Choice|0|||
164261535|NCT01278407|593325509|FG004|Confirmatory Phase|Participant's Choice|0|||
164261536|NCT01278407|593325505|FG000|Confirmatory Phase|Other|1|||
164261537|NCT01278407|593325506|FG001|Confirmatory Phase|Other|1|||
164261538|NCT01278407|593325507|FG002|Confirmatory Phase|Other|2|||
164261539|NCT01278407|593325508|FG003|Confirmatory Phase|Other|0|||
164261540|NCT01278407|593325509|FG004|Confirmatory Phase|Other|0|||
164261541|NCT01278407|593325505|FG000|Extension Phase|Adverse Event|0|||
164261542|NCT01278407|593325506|FG001|Extension Phase|Adverse Event|0|||
164261543|NCT01278407|593325507|FG002|Extension Phase|Adverse Event|0|||
164261544|NCT01278407|593325508|FG003|Extension Phase|Adverse Event|7|||
164261545|NCT01278407|593325509|FG004|Extension Phase|Adverse Event|16|||
164261546|NCT01278407|593325505|FG000|Extension Phase|Participant's Choice|0|||
164261547|NCT01278407|593325506|FG001|Extension Phase|Participant's Choice|0|||
164261548|NCT01278407|593325507|FG002|Extension Phase|Participant's Choice|0|||
164261549|NCT01278407|593325508|FG003|Extension Phase|Participant's Choice|4|||
164261550|NCT01278407|593325509|FG004|Extension Phase|Participant's Choice|11|||
164261551|NCT01278407|593325505|FG000|Extension Phase|Other|0|||
164261552|NCT01278407|593325506|FG001|Extension Phase|Other|0|||
164261553|NCT01278407|593325507|FG002|Extension Phase|Other|0|||
164261554|NCT01278407|593325508|FG003|Extension Phase|Other|1|||
164261555|NCT01278407|593325509|FG004|Extension Phase|Other|3|||
164261556|NCT03710876|593325510|FG000|Overall Study|Death|0|||
164261557|NCT03710876|593325511|FG001|Overall Study|Death|2|||
164261558|NCT03710876|593325510|FG000|Overall Study|Withdrawal by Subject|0|||
164261559|NCT03710876|593325511|FG001|Overall Study|Withdrawal by Subject|2|||
164261560|NCT02534935|593325512|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
164261561|NCT02534935|593325513|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
164261562|NCT02534935|593325514|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
164261563|NCT02534935|593325512|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
164261564|NCT02534935|593325513|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
164261565|NCT02534935|593325514|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
164261566|NCT02534935|593325512|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
164261567|NCT02534935|593325513|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
164261568|NCT02534935|593325514|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
164261569|NCT02534935|593325512|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
164261570|NCT02534935|593325513|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
164261571|NCT02534935|593325514|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
164261572|NCT02534935|593325512|FG000|Stage 1: 24 Months|Adverse Event|0|||
164261573|NCT02534935|593325513|FG001|Stage 1: 24 Months|Adverse Event|2|||
164261574|NCT02534935|593325514|FG002|Stage 1: 24 Months|Adverse Event|0|||
164261575|NCT02534935|593325512|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
164261576|NCT02534935|593325513|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
164261577|NCT02534935|593325514|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
164261578|NCT02534935|593325512|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
164261579|NCT02534935|593325513|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
164261580|NCT02534935|593325514|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
164261581|NCT01460719|593325515|FG000|Overall Study|Adverse Event|1|||
164261582|NCT01460719|593325515|FG000|Overall Study|Withdrawal by Subject|1|||
164261583|NCT03602885|593325521|FG000|Overall Study|Lost to Follow-up|3|||
164261584|NCT03602885|593325522|FG001|Overall Study|Lost to Follow-up|0|||
164261585|NCT02838901|593325527|FG000|Overall Study|Withdrawal by Subject|1|||
164261586|NCT02838901|593325528|FG001|Overall Study|Withdrawal by Subject|1|||
164261587|NCT02838901|593325527|FG000|Overall Study|Lost to Follow-up|1|||
164261588|NCT02838901|593325528|FG001|Overall Study|Lost to Follow-up|1|||
164261589|NCT01007123|593325529|FG000|Overall Study|Adverse Event|3|||
164261590|NCT01007123|593325530|FG001|Overall Study|Adverse Event|4|||
164261591|NCT01007123|593325531|FG002|Overall Study|Adverse Event|7|||
164261592|NCT01007123|593325532|FG003|Overall Study|Adverse Event|1|||
164261593|NCT01007123|593325529|FG000|Overall Study|Lack of Efficacy|1|||
164261594|NCT01007123|593325530|FG001|Overall Study|Lack of Efficacy|0|||
164577363|NCT05738486|594479252|FG003|Overall Study|Assigned Treatment by Mistake|1|||
164577364|NCT05738486|594479249|FG000|Overall Study|Death|0|||
164429716|NCT00465985|593943399|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
164429717|NCT02534896|593943400|FG000|Overall Study|Adverse Event|2|||
164429718|NCT02534896|593943401|FG001|Overall Study|Adverse Event|1|||
164429719|NCT02534896|593943402|FG002|Overall Study|Adverse Event|1|||
164429720|NCT02534896|593943400|FG000|Overall Study|Insufficient therapeutic response|2|||
164429721|NCT02534896|593943401|FG001|Overall Study|Insufficient therapeutic response|0|||
164429722|NCT02534896|593943402|FG002|Overall Study|Insufficient therapeutic response|0|||
164429723|NCT00269399|593943403|FG000|Overall Study|Lack of Efficacy|27|||
164429724|NCT00269399|593943404|FG001|Overall Study|Lack of Efficacy|10|||
164429725|NCT00269399|593943403|FG000|Overall Study|Adverse Event|10|||
164577365|NCT05738486|594479250|FG001|Overall Study|Death|0|||
164577366|NCT05738486|594479251|FG002|Overall Study|Death|1|||
164577367|NCT05738486|594479252|FG003|Overall Study|Death|0|||
164261595|NCT01007123|593325531|FG002|Overall Study|Lack of Efficacy|1|||
164261596|NCT01007123|593325532|FG003|Overall Study|Lack of Efficacy|4|||
164261597|NCT01007123|593325529|FG000|Overall Study|Protocol Violation|1|||
164261598|NCT01007123|593325530|FG001|Overall Study|Protocol Violation|1|||
164261599|NCT01007123|593325531|FG002|Overall Study|Protocol Violation|2|||
164261600|NCT01007123|593325532|FG003|Overall Study|Protocol Violation|1|||
164261601|NCT01007123|593325529|FG000|Overall Study|Withdrawal by Subject|1|||
164261602|NCT01007123|593325530|FG001|Overall Study|Withdrawal by Subject|0|||
164261603|NCT01007123|593325531|FG002|Overall Study|Withdrawal by Subject|1|||
164261604|NCT01007123|593325532|FG003|Overall Study|Withdrawal by Subject|0|||
164261605|NCT01007123|593325529|FG000|Overall Study|Lost to Follow-up|0|||
164261606|NCT01007123|593325530|FG001|Overall Study|Lost to Follow-up|1|||
164261607|NCT01007123|593325531|FG002|Overall Study|Lost to Follow-up|0|||
164261608|NCT01007123|593325532|FG003|Overall Study|Lost to Follow-up|0|||
164261609|NCT04431713|593325533|FG000|Overall Study|Withdrawal by Subject|2|||
164261610|NCT04431713|593325534|FG001|Overall Study|Withdrawal by Subject|0|||
164261611|NCT04431713|593325533|FG000|Overall Study|Death|2|||
164261612|NCT04431713|593325534|FG001|Overall Study|Death|2|||
164577368|NCT05738486|594479249|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|1|||
164261613|NCT02285114|593325536|FG000|Main Phase|Investigator's Discretion|0|||
164261614|NCT02285114|593325537|FG001|Main Phase|Investigator's Discretion|2|||
164261615|NCT02285114|593325538|FG002|Main Phase|Investigator's Discretion|0|||
164261616|NCT02285114|593325539|FG003|Main Phase|Investigator's Discretion|0|||
164261617|NCT02285114|593325540|FG004|Main Phase|Investigator's Discretion|0|||
164681581|NCT02252016|594856284|FG000|Overall Study|Lost to Follow-up|2|||
164681582|NCT02252016|594856285|FG001|Overall Study|Lost to Follow-up|1|||
164681583|NCT02252016|594856284|FG000|Overall Study|Physician Decision|1|||
164681584|NCT02252016|594856285|FG001|Overall Study|Physician Decision|0|||
164681585|NCT02252016|594856284|FG000|Overall Study|Withdrawal by Subject|0|||
164681586|NCT02252016|594856285|FG001|Overall Study|Withdrawal by Subject|2|||
164681587|NCT02471807|594856286|FG000|Overall Study|Death|14|||
164681588|NCT02471807|594856286|FG000|Overall Study|Withdrawal by Subject|2|||
164681589|NCT02471807|594856286|FG000|Overall Study|Explant|5|||
164681590|NCT02471807|594856286|FG000|Overall Study|Lost to Follow-up|1|||
164681591|NCT01653704|594856290|FG000|Overall Study|Technical failure during recording|1|||
164681592|NCT01653704|594856291|FG001|Overall Study|Technical failure during recording|1|||
164681593|NCT01653704|594856290|FG000|Overall Study|Performance not reflective of training|1|||
164681594|NCT01653704|594856291|FG001|Overall Study|Performance not reflective of training|0|||
164681595|NCT00985751|594856292|FG000|Overall Study|Adverse Event|0|||
164681596|NCT00985751|594856293|FG001|Overall Study|Adverse Event|0|||
164681597|NCT00985751|594856294|FG002|Overall Study|Adverse Event|0|||
164681598|NCT00985751|594856295|FG003|Overall Study|Adverse Event|0|||
164681599|NCT00985751|594856296|FG004|Overall Study|Adverse Event|1|||
164681600|NCT01899053|594856297|FG000|Overall Study|Progressive Disease|4|||
164681601|NCT01899053|594856298|FG001|Overall Study|Progressive Disease|0|||
164681602|NCT01899053|594856299|FG002|Overall Study|Progressive Disease|3|||
164681603|NCT01899053|594856300|FG003|Overall Study|Progressive Disease|0|||
164681604|NCT01899053|594856301|FG004|Overall Study|Progressive Disease|3|||
164681605|NCT01899053|594856302|FG005|Overall Study|Progressive Disease|1|||
164681606|NCT01899053|594856303|FG006|Overall Study|Progressive Disease|1|||
164681607|NCT01899053|594856304|FG007|Overall Study|Progressive Disease|1|||
164681608|NCT01899053|594856305|FG008|Overall Study|Progressive Disease|4|||
164681609|NCT01899053|594856306|FG009|Overall Study|Progressive Disease|3|||
164681610|NCT01899053|594856307|FG010|Overall Study|Progressive Disease|12|||
164681611|NCT01899053|594856308|FG011|Overall Study|Progressive Disease|5|||
164681612|NCT01899053|594856309|FG012|Overall Study|Progressive Disease|8|||
164681613|NCT01899053|594856310|FG013|Overall Study|Progressive Disease|17|||
164681614|NCT01899053|594856297|FG000|Overall Study|Adverse Event|1|||
164681615|NCT01899053|594856298|FG001|Overall Study|Adverse Event|1|||
164681616|NCT01899053|594856299|FG002|Overall Study|Adverse Event|1|||
164681617|NCT01899053|594856300|FG003|Overall Study|Adverse Event|3|||
164681618|NCT01899053|594856301|FG004|Overall Study|Adverse Event|1|||
164681619|NCT01899053|594856302|FG005|Overall Study|Adverse Event|1|||
164681620|NCT01899053|594856303|FG006|Overall Study|Adverse Event|1|||
164681621|NCT01899053|594856304|FG007|Overall Study|Adverse Event|0|||
164681622|NCT01899053|594856305|FG008|Overall Study|Adverse Event|2|||
164681623|NCT01899053|594856306|FG009|Overall Study|Adverse Event|0|||
164681624|NCT01899053|594856307|FG010|Overall Study|Adverse Event|3|||
164681625|NCT01899053|594856308|FG011|Overall Study|Adverse Event|1|||
164681626|NCT01899053|594856309|FG012|Overall Study|Adverse Event|2|||
164681627|NCT01899053|594856310|FG013|Overall Study|Adverse Event|2|||
164681628|NCT01899053|594856297|FG000|Overall Study|Reason Not Specified|0|||
164681629|NCT01899053|594856298|FG001|Overall Study|Reason Not Specified|0|||
164681630|NCT01899053|594856299|FG002|Overall Study|Reason Not Specified|0|||
164681631|NCT01899053|594856300|FG003|Overall Study|Reason Not Specified|0|||
164681632|NCT01899053|594856301|FG004|Overall Study|Reason Not Specified|0|||
164681633|NCT01899053|594856302|FG005|Overall Study|Reason Not Specified|0|||
164681634|NCT01899053|594856303|FG006|Overall Study|Reason Not Specified|1|||
164681635|NCT01899053|594856304|FG007|Overall Study|Reason Not Specified|0|||
164681636|NCT01899053|594856305|FG008|Overall Study|Reason Not Specified|0|||
164681637|NCT01899053|594856306|FG009|Overall Study|Reason Not Specified|0|||
164681638|NCT01899053|594856307|FG010|Overall Study|Reason Not Specified|0|||
164681639|NCT01899053|594856308|FG011|Overall Study|Reason Not Specified|0|||
164681640|NCT01899053|594856309|FG012|Overall Study|Reason Not Specified|1|||
164681641|NCT01899053|594856310|FG013|Overall Study|Reason Not Specified|0|||
164681642|NCT01899053|594856297|FG000|Overall Study|Withdrawal by Subject|1|||
164681643|NCT01899053|594856298|FG001|Overall Study|Withdrawal by Subject|1|||
164681644|NCT01899053|594856299|FG002|Overall Study|Withdrawal by Subject|2|||
164681645|NCT01899053|594856300|FG003|Overall Study|Withdrawal by Subject|0|||
164681646|NCT01899053|594856301|FG004|Overall Study|Withdrawal by Subject|2|||
164681647|NCT01899053|594856302|FG005|Overall Study|Withdrawal by Subject|0|||
164681648|NCT01899053|594856303|FG006|Overall Study|Withdrawal by Subject|0|||
164681649|NCT01899053|594856304|FG007|Overall Study|Withdrawal by Subject|1|||
164681650|NCT01899053|594856305|FG008|Overall Study|Withdrawal by Subject|0|||
164681651|NCT01899053|594856306|FG009|Overall Study|Withdrawal by Subject|0|||
164681652|NCT01899053|594856307|FG010|Overall Study|Withdrawal by Subject|0|||
164681653|NCT01899053|594856308|FG011|Overall Study|Withdrawal by Subject|0|||
164681654|NCT01899053|594856309|FG012|Overall Study|Withdrawal by Subject|1|||
164681655|NCT01899053|594856310|FG013|Overall Study|Withdrawal by Subject|1|||
164577369|NCT05738486|594479250|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
164577370|NCT05738486|594479251|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
164577371|NCT05738486|594479252|FG003|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
164577372|NCT02017444|594479257|FG000|Overall Study|Physician Decision|1|||
164577373|NCT02017444|594479258|FG001|Overall Study|Physician Decision|0|||
164577374|NCT02017444|594479257|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
164577375|NCT02017444|594479258|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
164577376|NCT01614457|594479262|FG000|Overall Study|Non-Compliance|1|||
164577377|NCT01614457|594479263|FG001|Overall Study|Non-Compliance|0|||
164577378|NCT01614457|594479262|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
164577379|NCT01614457|594479263|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
164577380|NCT02698410|594479264|FG000|Overall Study|Adverse Event|2|||
164577381|NCT02698410|594479264|FG000|Overall Study|Withdrawal by Subject|1|||
164577382|NCT02698410|594479264|FG000|Overall Study|Other|1|||
164577383|NCT03952130|594479265|FG000|Overall Study|Adverse Event|0|||
164577384|NCT03952130|594479266|FG001|Overall Study|Adverse Event|1|||
164577385|NCT03952130|594479265|FG000|Overall Study|Lost to Follow-up|1|||
164577386|NCT03952130|594479266|FG001|Overall Study|Lost to Follow-up|0|||
164577387|NCT03952130|594479265|FG000|Overall Study|Withdrawal by Subject|1|||
164577388|NCT03952130|594479266|FG001|Overall Study|Withdrawal by Subject|5|||
164577389|NCT01713348|594479267|FG000|Overall Study|Withdrawal by Subject|3|||
164577390|NCT01713348|594479268|FG001|Overall Study|Withdrawal by Subject|2|||
164577391|NCT01713348|594479269|FG002|Overall Study|Withdrawal by Subject|2|||
164577392|NCT01713348|594479270|FG003|Overall Study|Withdrawal by Subject|0|||
164577393|NCT01713348|594479267|FG000|Overall Study|Lost to Follow-up|1|||
164577394|NCT01713348|594479268|FG001|Overall Study|Lost to Follow-up|0|||
164577395|NCT01713348|594479269|FG002|Overall Study|Lost to Follow-up|0|||
164577396|NCT01713348|594479270|FG003|Overall Study|Lost to Follow-up|0|||
164577397|NCT03199911|594479277|FG000|Overall Study|Lost to Follow-up|5|||
164577398|NCT03199911|594479278|FG001|Overall Study|Lost to Follow-up|5|||
164577399|NCT03199911|594479277|FG000|Overall Study|Did not proceed with surgery|2|||
164577400|NCT03199911|594479278|FG001|Overall Study|Did not proceed with surgery|1|||
164577401|NCT00541307|594479279|FG000|Overall Study|Death|5|||
164577402|NCT00541307|594479279|FG000|Overall Study|Physician Decision|3|||
164577403|NCT00541307|594479279|FG000|Overall Study|Withdrawal by Subject|6|||
164577404|NCT00541307|594479279|FG000|Overall Study|Lost to Follow-up|4|||
164577405|NCT00541307|594479279|FG000|Overall Study|Subject returned early (outside window)|1|||
164577406|NCT00541307|594479279|FG000|Overall Study|Surgical Bypass|5|||
164577407|NCT02424539|594479282|FG000|Overall Study|Adverse Event|0|||
164577408|NCT02424539|594479283|FG001|Overall Study|Adverse Event|0|||
164577409|NCT02424539|594479284|FG002|Overall Study|Adverse Event|1|||
164577410|NCT02424539|594479282|FG000|Overall Study|Physician Decision|0|||
164577411|NCT02424539|594479283|FG001|Overall Study|Physician Decision|0|||
164577412|NCT02424539|594479284|FG002|Overall Study|Physician Decision|1|||
164577413|NCT02424539|594479282|FG000|Overall Study|Withdrawal by Subject|3|||
164577414|NCT02424539|594479283|FG001|Overall Study|Withdrawal by Subject|1|||
164577415|NCT02424539|594479284|FG002|Overall Study|Withdrawal by Subject|0|||
164577416|NCT02424539|594479282|FG000|Overall Study|Other: Reached stopping criteria|11|||
164577417|NCT02424539|594479283|FG001|Overall Study|Other: Reached stopping criteria|7|||
164577418|NCT02424539|594479284|FG002|Overall Study|Other: Reached stopping criteria|6|||
164261618|NCT02285114|593325541|FG005|Main Phase|Investigator's Discretion|0|||
164261619|NCT02285114|593325536|FG000|Main Phase|Enrolled but Never Treated|1|||
164261620|NCT02285114|593325537|FG001|Main Phase|Enrolled but Never Treated|0|||
164261621|NCT02285114|593325538|FG002|Main Phase|Enrolled but Never Treated|0|||
164261622|NCT02285114|593325539|FG003|Main Phase|Enrolled but Never Treated|0|||
164261623|NCT02285114|593325540|FG004|Main Phase|Enrolled but Never Treated|0|||
164261624|NCT02285114|593325541|FG005|Main Phase|Enrolled but Never Treated|0|||
164261625|NCT02285114|593325536|FG000|Main Phase|Withdrew Consent|0|||
164261626|NCT02285114|593325537|FG001|Main Phase|Withdrew Consent|0|||
164261627|NCT02285114|593325538|FG002|Main Phase|Withdrew Consent|1|||
164261628|NCT02285114|593325539|FG003|Main Phase|Withdrew Consent|0|||
164261629|NCT02285114|593325540|FG004|Main Phase|Withdrew Consent|0|||
164261630|NCT02285114|593325541|FG005|Main Phase|Withdrew Consent|0|||
164261631|NCT02285114|593325536|FG000|Extension Phase|Investigator's Discretion|0|||
164261632|NCT02285114|593325537|FG001|Extension Phase|Investigator's Discretion|0|||
164261633|NCT02285114|593325538|FG002|Extension Phase|Investigator's Discretion|0|||
164261634|NCT02285114|593325539|FG003|Extension Phase|Investigator's Discretion|14|||
164261635|NCT02285114|593325540|FG004|Extension Phase|Investigator's Discretion|1|||
164261636|NCT02285114|593325541|FG005|Extension Phase|Investigator's Discretion|0|||
164261637|NCT02285114|593325536|FG000|Extension Phase|Lost to Follow-up|0|||
164261638|NCT02285114|593325537|FG001|Extension Phase|Lost to Follow-up|0|||
164261639|NCT02285114|593325538|FG002|Extension Phase|Lost to Follow-up|0|||
164261640|NCT02285114|593325539|FG003|Extension Phase|Lost to Follow-up|1|||
164261641|NCT02285114|593325540|FG004|Extension Phase|Lost to Follow-up|1|||
164261642|NCT02285114|593325541|FG005|Extension Phase|Lost to Follow-up|0|||
164261643|NCT02285114|593325536|FG000|Extension Phase|Non-compliance with Study Drug|0|||
164261644|NCT02285114|593325537|FG001|Extension Phase|Non-compliance with Study Drug|0|||
164261645|NCT02285114|593325538|FG002|Extension Phase|Non-compliance with Study Drug|0|||
164261646|NCT02285114|593325539|FG003|Extension Phase|Non-compliance with Study Drug|2|||
164261647|NCT02285114|593325540|FG004|Extension Phase|Non-compliance with Study Drug|0|||
164261648|NCT02285114|593325541|FG005|Extension Phase|Non-compliance with Study Drug|0|||
164261649|NCT02285114|593325536|FG000|Extension Phase|Pregnancy|0|||
164261650|NCT02285114|593325537|FG001|Extension Phase|Pregnancy|0|||
164261651|NCT02285114|593325538|FG002|Extension Phase|Pregnancy|0|||
164261652|NCT02285114|593325539|FG003|Extension Phase|Pregnancy|1|||
164261653|NCT02285114|593325540|FG004|Extension Phase|Pregnancy|0|||
164261654|NCT02285114|593325541|FG005|Extension Phase|Pregnancy|0|||
164261655|NCT00320255|593325542|FG000|Overall Study|Lack of Efficacy|1|||
164261656|NCT00320255|593325543|FG001|Overall Study|Lack of Efficacy|0|||
164261657|NCT00320255|593325544|FG002|Overall Study|Lack of Efficacy|0|||
164261658|NCT00320255|593325545|FG003|Overall Study|Lack of Efficacy|0|||
164261659|NCT00320255|593325546|FG004|Overall Study|Lack of Efficacy|0|||
164261660|NCT00320255|593325547|FG005|Overall Study|Lack of Efficacy|0|||
164261661|NCT00320255|593325542|FG000|Overall Study|Adverse Event|5|||
164261662|NCT00320255|593325543|FG001|Overall Study|Adverse Event|2|||
164261663|NCT00320255|593325544|FG002|Overall Study|Adverse Event|3|||
164261664|NCT00320255|593325545|FG003|Overall Study|Adverse Event|2|||
164261665|NCT00320255|593325546|FG004|Overall Study|Adverse Event|0|||
164261666|NCT00320255|593325547|FG005|Overall Study|Adverse Event|0|||
164261667|NCT00320255|593325542|FG000|Overall Study|Withdrawal by Subject|1|||
164261668|NCT00320255|593325543|FG001|Overall Study|Withdrawal by Subject|2|||
164261669|NCT00320255|593325544|FG002|Overall Study|Withdrawal by Subject|2|||
164261670|NCT00320255|593325545|FG003|Overall Study|Withdrawal by Subject|4|||
164261671|NCT00320255|593325546|FG004|Overall Study|Withdrawal by Subject|0|||
164261672|NCT00320255|593325547|FG005|Overall Study|Withdrawal by Subject|0|||
164261673|NCT00320255|593325542|FG000|Overall Study|Poor compliance/noncompliance|1|||
164261674|NCT00320255|593325543|FG001|Overall Study|Poor compliance/noncompliance|1|||
164261675|NCT00320255|593325544|FG002|Overall Study|Poor compliance/noncompliance|0|||
164261676|NCT00320255|593325545|FG003|Overall Study|Poor compliance/noncompliance|1|||
164261677|NCT00320255|593325546|FG004|Overall Study|Poor compliance/noncompliance|0|||
164261678|NCT00320255|593325547|FG005|Overall Study|Poor compliance/noncompliance|0|||
164261679|NCT00320255|593325542|FG000|Overall Study|No longer meets study criteria|0|||
164261680|NCT00320255|593325543|FG001|Overall Study|No longer meets study criteria|0|||
164261681|NCT00320255|593325544|FG002|Overall Study|No longer meets study criteria|0|||
164261682|NCT00320255|593325545|FG003|Overall Study|No longer meets study criteria|1|||
164261683|NCT00320255|593325546|FG004|Overall Study|No longer meets study criteria|0|||
164261684|NCT00320255|593325547|FG005|Overall Study|No longer meets study criteria|0|||
164261685|NCT00320255|593325542|FG000|Overall Study|Other|3|||
164261686|NCT00320255|593325543|FG001|Overall Study|Other|2|||
164681656|NCT01899053|594856297|FG000|Overall Study|Protocol Violation|0|||
164681657|NCT01899053|594856298|FG001|Overall Study|Protocol Violation|0|||
164681658|NCT01899053|594856299|FG002|Overall Study|Protocol Violation|1|||
164681659|NCT01899053|594856300|FG003|Overall Study|Protocol Violation|0|||
164681660|NCT01899053|594856301|FG004|Overall Study|Protocol Violation|0|||
164681661|NCT01899053|594856302|FG005|Overall Study|Protocol Violation|0|||
164681662|NCT01899053|594856303|FG006|Overall Study|Protocol Violation|0|||
164681663|NCT01899053|594856304|FG007|Overall Study|Protocol Violation|0|||
164681664|NCT01899053|594856305|FG008|Overall Study|Protocol Violation|0|||
164681665|NCT01899053|594856306|FG009|Overall Study|Protocol Violation|0|||
164681666|NCT01899053|594856307|FG010|Overall Study|Protocol Violation|0|||
164681667|NCT01899053|594856308|FG011|Overall Study|Protocol Violation|0|||
164681668|NCT01899053|594856309|FG012|Overall Study|Protocol Violation|0|||
164681669|NCT01899053|594856310|FG013|Overall Study|Protocol Violation|0|||
164681670|NCT01899053|594856297|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
164681671|NCT01899053|594856298|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
164681672|NCT01899053|594856299|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
164681673|NCT01899053|594856300|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
164681674|NCT01899053|594856301|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
164681675|NCT01899053|594856302|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
164681676|NCT01899053|594856303|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
164681677|NCT01899053|594856304|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
164681678|NCT01899053|594856305|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
164340695|NCT01758523|593622278|FG000|Overall Study|Lack of Efficacy|4|||
164340696|NCT01758523|593622279|FG001|Overall Study|Lack of Efficacy|2|||
164340697|NCT01758523|593622278|FG000|Overall Study|Lost to Follow-up|3|||
164340698|NCT01758523|593622279|FG001|Overall Study|Lost to Follow-up|4|||
164340699|NCT01758523|593622278|FG000|Overall Study|Withdrawal by Subject|12|||
164340700|NCT01758523|593622279|FG001|Overall Study|Withdrawal by Subject|7|||
164340701|NCT00722800|593622280|FG000|Overall Study|Withdrawal by Subject|1|||
164340702|NCT00722800|593622281|FG001|Overall Study|Withdrawal by Subject|0|||
164340703|NCT00722800|593622280|FG000|Overall Study|Physician Decision|1|||
164340704|NCT00722800|593622281|FG001|Overall Study|Physician Decision|0|||
164340705|NCT00590135|593622282|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
164340706|NCT02130297|593622287|FG000|Overall Study|Lost to Follow-up|4|||
164340707|NCT00508755|593622296|FG000|Overall Study|Withdrawal by Subject|1|||
164340708|NCT00957580|593622297|FG000|Overall Study|Ongoing at data cut-off|0|||
164340709|NCT00957580|593622298|FG001|Overall Study|Ongoing at data cut-off|1|||
164340710|NCT00957580|593622299|FG002|Overall Study|Ongoing at data cut-off|0|||
164340711|NCT00957580|593622297|FG000|Overall Study|Enrolled but not treated|0|||
164340712|NCT00957580|593622298|FG001|Overall Study|Enrolled but not treated|1|||
164340713|NCT00957580|593622299|FG002|Overall Study|Enrolled but not treated|0|||
164340714|NCT00945893|593622300|FG000|Overall Study|Lost to Follow-up|2|||
164340715|NCT00945893|593622301|FG001|Overall Study|Lost to Follow-up|8|||
164340716|NCT00945893|593622300|FG000|Overall Study|Withdrawal of consent|1|||
164340717|NCT00945893|593622301|FG001|Overall Study|Withdrawal of consent|2|||
164340718|NCT01611155|593622302|FG000|Overall Study|Adverse Event|1|||
164340719|NCT01611155|593622303|FG001|Overall Study|Adverse Event|1|||
164340720|NCT01611155|593622302|FG000|Overall Study|Refused further treatment|6|||
164577419|NCT04178590|594479285|FG000|Overall Study|Pregnancy|1|||
164577420|NCT04178590|594479285|FG000|Overall Study|Lost to Follow-up|1|||
164577421|NCT04723537|594479286|FG000|Overall Study|Withdrawal by Subject|3|||
164577422|NCT04723537|594479287|FG001|Overall Study|Withdrawal by Subject|0|||
164577423|NCT04723537|594479288|FG002|Overall Study|Withdrawal by Subject|0|||
164577424|NCT04723537|594479286|FG000|Overall Study|Physician Decision|0|||
164577425|NCT04723537|594479287|FG001|Overall Study|Physician Decision|0|||
164577426|NCT04723537|594479288|FG002|Overall Study|Physician Decision|1|||
164577427|NCT04723537|594479286|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
164577428|NCT04723537|594479287|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
164577429|NCT04723537|594479288|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
164577430|NCT03717922|594479295|FG000|Overall Study|Lost to Follow-up|2|||
164577431|NCT03717922|594479296|FG001|Overall Study|Lost to Follow-up|2|||
164577432|NCT03126227|594479297|FG000|Overall Study|Adverse Event|43|||
164340721|NCT01611155|593622303|FG001|Overall Study|Refused further treatment|4|||
164340722|NCT01611155|593622302|FG000|Overall Study|Disease progression|1|||
164340723|NCT01611155|593622303|FG001|Overall Study|Disease progression|0|||
164340724|NCT01611155|593622302|FG000|Overall Study|Withdrawal by Subject|1|||
164340725|NCT01611155|593622303|FG001|Overall Study|Withdrawal by Subject|0|||
164340726|NCT01611155|593622302|FG000|Overall Study|Alternative treatment|0|||
164340727|NCT01611155|593622303|FG001|Overall Study|Alternative treatment|1|||
164577433|NCT03126227|594479298|FG001|Overall Study|Adverse Event|4|||
164681679|NCT01899053|594856306|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
164681680|NCT01899053|594856307|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
164681681|NCT01899053|594856308|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
164681682|NCT01899053|594856309|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
164681683|NCT01899053|594856310|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
164577434|NCT03126227|594479297|FG000|Overall Study|Death|0|||
164577435|NCT03126227|594479298|FG001|Overall Study|Death|1|||
164577436|NCT03126227|594479297|FG000|Overall Study|Lost to Follow-up|0|||
164577437|NCT03126227|594479298|FG001|Overall Study|Lost to Follow-up|1|||
164577438|NCT03126227|594479297|FG000|Overall Study|Physician Decision|2|||
164577439|NCT03126227|594479298|FG001|Overall Study|Physician Decision|0|||
164577440|NCT03126227|594479297|FG000|Overall Study|Protocol Violation|1|||
164577441|NCT03126227|594479298|FG001|Overall Study|Protocol Violation|0|||
164577442|NCT03126227|594479297|FG000|Overall Study|Withdrawal by Subject|19|||
164577443|NCT03126227|594479298|FG001|Overall Study|Withdrawal by Subject|3|||
164577444|NCT03126227|594479297|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
164577445|NCT03126227|594479298|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
164577446|NCT03126227|594479297|FG000|Overall Study|Lack of dosing compliance|2|||
164577447|NCT03126227|594479298|FG001|Overall Study|Lack of dosing compliance|0|||
164577448|NCT03126227|594479297|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
164577449|NCT03126227|594479298|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
164577450|NCT03126227|594479297|FG000|Overall Study|Scheduling conflict|1|||
164577451|NCT03126227|594479298|FG001|Overall Study|Scheduling conflict|0|||
164577452|NCT01126619|594479299|FG000|Overall Study|Not eligible for the study|2|||
164577453|NCT01126619|594479299|FG000|Overall Study|Investigator decision|4|||
164577454|NCT01126619|594479299|FG000|Overall Study|Serious adverse event|1|||
164577455|NCT01126619|594479299|FG000|Overall Study|Withdrawal by Subject|9|||
164577456|NCT01126619|594479299|FG000|Overall Study|Non-compliance|1|||
164577457|NCT04876391|594479300|FG000|Overall Study|Withdrawal by Subject|1|||
164577458|NCT04876391|594479301|FG001|Overall Study|Withdrawal by Subject|10|||
164577459|NCT04876391|594479300|FG000|Overall Study|Lost to Follow-up|2|||
164577460|NCT04876391|594479301|FG001|Overall Study|Lost to Follow-up|4|||
164577461|NCT04876391|594479300|FG000|Overall Study|Lack of Efficacy|0|||
164577462|NCT04876391|594479301|FG001|Overall Study|Lack of Efficacy|2|||
164577463|NCT04876391|594479300|FG000|Overall Study|Adverse Event|3|||
164577464|NCT04876391|594479301|FG001|Overall Study|Adverse Event|1|||
164577465|NCT04876391|594479300|FG000|Overall Study|Patient non-compliance|0|||
164577466|NCT04876391|594479301|FG001|Overall Study|Patient non-compliance|1|||
164577467|NCT04876391|594479300|FG000|Overall Study|Personal reasons|0|||
164577468|NCT04876391|594479301|FG001|Overall Study|Personal reasons|1|||
164681684|NCT01899053|594856297|FG000|Overall Study|Symptomatic Deterioration|0|||
164681685|NCT01899053|594856298|FG001|Overall Study|Symptomatic Deterioration|0|||
164577469|NCT04876391|594479300|FG000|Overall Study|Withdrawn as per protocol|2|||
164577470|NCT04876391|594479301|FG001|Overall Study|Withdrawn as per protocol|2|||
164577471|NCT01859403|594479306|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
164261687|NCT00320255|593325544|FG002|Overall Study|Other|1|||
164261688|NCT00320255|593325545|FG003|Overall Study|Other|0|||
164261689|NCT00320255|593325546|FG004|Overall Study|Other|0|||
164261690|NCT00320255|593325547|FG005|Overall Study|Other|0|||
164261691|NCT00683917|593325550|FG000|Overall Study|Study prematurely terminated|10|||
164261692|NCT03022097|593325556|FG000|Overall Study|Adverse Event|3|||
164261693|NCT03022097|593325557|FG001|Overall Study|Adverse Event|4|||
164261694|NCT03022097|593325558|FG002|Overall Study|Adverse Event|1|||
164261695|NCT03022097|593325559|FG003|Overall Study|Adverse Event|3|||
164261696|NCT03022097|593325556|FG000|Overall Study|Progressive Disease|2|||
164261697|NCT03022097|593325557|FG001|Overall Study|Progressive Disease|0|||
164261698|NCT03022097|593325558|FG002|Overall Study|Progressive Disease|5|||
164261699|NCT03022097|593325559|FG003|Overall Study|Progressive Disease|2|||
164261700|NCT03022097|593325556|FG000|Overall Study|Lack of Efficacy|0|||
164577472|NCT01859403|594479307|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
164577473|NCT01859403|594479306|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
164681686|NCT01899053|594856299|FG002|Overall Study|Symptomatic Deterioration|0|||
164681687|NCT01899053|594856300|FG003|Overall Study|Symptomatic Deterioration|0|||
164681688|NCT01899053|594856301|FG004|Overall Study|Symptomatic Deterioration|0|||
164681689|NCT01899053|594856302|FG005|Overall Study|Symptomatic Deterioration|1|||
164681690|NCT01899053|594856303|FG006|Overall Study|Symptomatic Deterioration|0|||
164577474|NCT01859403|594479307|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
164261701|NCT03022097|593325557|FG001|Overall Study|Lack of Efficacy|0|||
164261702|NCT03022097|593325558|FG002|Overall Study|Lack of Efficacy|3|||
164261703|NCT03022097|593325559|FG003|Overall Study|Lack of Efficacy|3|||
164577475|NCT01859403|594479306|FG000|Primary Endpoint Measure|Physician Decision|0|||
164261704|NCT03022097|593325556|FG000|Overall Study|Protocol Violation|1|||
164261705|NCT03022097|593325557|FG001|Overall Study|Protocol Violation|0|||
164577476|NCT01859403|594479307|FG001|Primary Endpoint Measure|Physician Decision|1|||
164577477|NCT01859403|594479306|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
164577478|NCT01859403|594479307|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
164577479|NCT01157117|594479308|FG000|Overall Study|Dosing Symptoms|0|||
164681691|NCT01899053|594856304|FG007|Overall Study|Symptomatic Deterioration|1|||
164681692|NCT01899053|594856305|FG008|Overall Study|Symptomatic Deterioration|0|||
164681693|NCT01899053|594856306|FG009|Overall Study|Symptomatic Deterioration|0|||
164261706|NCT03022097|593325558|FG002|Overall Study|Protocol Violation|1|||
164261707|NCT03022097|593325559|FG003|Overall Study|Protocol Violation|0|||
164261708|NCT03022097|593325556|FG000|Overall Study|Withdrawal by Subject|11|||
164261709|NCT03022097|593325557|FG001|Overall Study|Withdrawal by Subject|13|||
164261710|NCT03022097|593325558|FG002|Overall Study|Withdrawal by Subject|15|||
164261711|NCT03022097|593325559|FG003|Overall Study|Withdrawal by Subject|21|||
164261712|NCT03022097|593325556|FG000|Overall Study|Lost to Follow-up|0|||
164261713|NCT03022097|593325557|FG001|Overall Study|Lost to Follow-up|0|||
164261714|NCT03022097|593325558|FG002|Overall Study|Lost to Follow-up|1|||
164261715|NCT03022097|593325559|FG003|Overall Study|Lost to Follow-up|1|||
164261716|NCT03022097|593325556|FG000|Overall Study|Other|4|||
164261717|NCT03022097|593325557|FG001|Overall Study|Other|1|||
164261718|NCT03022097|593325558|FG002|Overall Study|Other|6|||
164261719|NCT03022097|593325559|FG003|Overall Study|Other|4|||
164261720|NCT03022097|593325556|FG000|Overall Study|Due to COVID-19 pandemic|0|||
164261721|NCT03022097|593325557|FG001|Overall Study|Due to COVID-19 pandemic|1|||
164261722|NCT03022097|593325558|FG002|Overall Study|Due to COVID-19 pandemic|0|||
164261723|NCT03022097|593325559|FG003|Overall Study|Due to COVID-19 pandemic|0|||
164261724|NCT03640052|593325565|FG000|Overall Study|Lost to Follow-up|0|||
164261725|NCT03640052|593325566|FG001|Overall Study|Lost to Follow-up|1|||
164261726|NCT03640052|593325567|FG002|Overall Study|Lost to Follow-up|0|||
164261727|NCT03640052|593325568|FG003|Overall Study|Lost to Follow-up|0|||
164261728|NCT03640052|593325569|FG004|Overall Study|Lost to Follow-up|0|||
164261729|NCT00623545|593325570|FG000|Overall Study|Adverse Event|6|||
164261730|NCT00623545|593325570|FG000|Overall Study|Withdrawal by Subject|4|||
164261731|NCT05479097|593325573|FG000|Overall Study|Withdrawal by Subject|2|||
164261732|NCT04126564|593325574|FG000|Overall Study|Withdrawal by Subject|0|||
164261733|NCT04126564|593325575|FG001|Overall Study|Withdrawal by Subject|2|||
164261734|NCT04126564|593325574|FG000|Overall Study|Lost to Follow-up|0|||
164261735|NCT04126564|593325575|FG001|Overall Study|Lost to Follow-up|1|||
164261736|NCT03941964|593325579|FG000|Overall Study|Adverse Event|1|||
164261737|NCT03941964|593325580|FG001|Overall Study|Adverse Event|8|||
164681694|NCT01899053|594856307|FG010|Overall Study|Symptomatic Deterioration|0|||
164681695|NCT01899053|594856308|FG011|Overall Study|Symptomatic Deterioration|1|||
164261738|NCT03941964|593325579|FG000|Overall Study|Progressive disease|7|||
164261739|NCT03941964|593325580|FG001|Overall Study|Progressive disease|3|||
164261740|NCT03941964|593325579|FG000|Overall Study|Lack of Efficacy|0|||
164261741|NCT03941964|593325580|FG001|Overall Study|Lack of Efficacy|1|||
164261742|NCT03941964|593325579|FG000|Overall Study|Death|3|||
164261743|NCT03941964|593325580|FG001|Overall Study|Death|1|||
164261744|NCT03941964|593325579|FG000|Overall Study|Withdrew consent|1|||
164261745|NCT03941964|593325580|FG001|Overall Study|Withdrew consent|3|||
164261746|NCT03941964|593325579|FG000|Overall Study|Physician Decision|9|||
164261747|NCT03941964|593325580|FG001|Overall Study|Physician Decision|2|||
164261748|NCT03941964|593325579|FG000|Overall Study|Other, not specified|2|||
164261749|NCT03941964|593325580|FG001|Overall Study|Other, not specified|1|||
164261750|NCT00445848|593325581|FG000|Overall Study|Adverse Event|14|||
164261751|NCT00445848|593325581|FG000|Overall Study|Withdrawal by Subject|4|||
164261752|NCT00445848|593325581|FG000|Overall Study|Progression|62|||
164261753|NCT00445848|593325581|FG000|Overall Study|Other-Not protocol specified|5|||
164261754|NCT05605691|593325582|FG000|Overall Study|Lost to Follow-up|1|||
164261755|NCT00855933|593325584|FG000|Overall Study|Withdrawal by Subject|0|||
164261756|NCT00855933|593325585|FG001|Overall Study|Withdrawal by Subject|1|||
164261757|NCT05463744|593325586|FG000|Treatment Period|Withdrawal by Subject|19|||
164261758|NCT05463744|593325587|FG001|Treatment Period|Withdrawal by Subject|16|||
164261759|NCT05463744|593325586|FG000|Treatment Period|Adverse Event|4|||
164261760|NCT05463744|593325587|FG001|Treatment Period|Adverse Event|4|||
164261761|NCT05463744|593325586|FG000|Treatment Period|Pregnancy|0|||
164261762|NCT05463744|593325587|FG001|Treatment Period|Pregnancy|3|||
164261763|NCT05463744|593325586|FG000|Treatment Period|Lost to Follow-up|1|||
164261764|NCT05463744|593325587|FG001|Treatment Period|Lost to Follow-up|3|||
164261765|NCT05463744|593325586|FG000|Treatment Period|Inadvertent enrollment|2|||
164261766|NCT05463744|593325587|FG001|Treatment Period|Inadvertent enrollment|1|||
164261767|NCT05463744|593325586|FG000|Treatment Period|Death|0|||
164261768|NCT05463744|593325587|FG001|Treatment Period|Death|1|||
164261769|NCT05463744|593325586|FG000|Treatment Period|Non-compliance with Study Drug|1|||
164261770|NCT05463744|593325587|FG001|Treatment Period|Non-compliance with Study Drug|0|||
164261771|NCT05463744|593325586|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
164261772|NCT05463744|593325587|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
164261773|NCT05463744|593325586|FG000|Treatment Period|Physician Decision|0|||
164261774|NCT05463744|593325587|FG001|Treatment Period|Physician Decision|1|||
164261775|NCT05463744|593325586|FG000|Follow-Up Period|Withdrawal by Subject|3|||
164261776|NCT05463744|593325587|FG001|Follow-Up Period|Withdrawal by Subject|1|||
164261777|NCT05463744|593325586|FG000|Follow-Up Period|Lost to Follow-up|1|||
164261778|NCT05463744|593325587|FG001|Follow-Up Period|Lost to Follow-up|1|||
164261779|NCT02851407|593325588|FG000|Overall Study|Withdrawal by parent/guardian|2|||
164261780|NCT02851407|593325589|FG001|Overall Study|Withdrawal by parent/guardian|7|||
164261781|NCT02851407|593325588|FG000|Overall Study|Protocol deviation|0|||
164261782|NCT02851407|593325589|FG001|Overall Study|Protocol deviation|1|||
164261783|NCT02851407|593325588|FG000|Overall Study|Transferred to another hospital to continue|1|||
164261784|NCT02851407|593325589|FG001|Overall Study|Transferred to another hospital to continue|0|||
164261785|NCT02851407|593325588|FG000|Overall Study|Other Death|30|||
164261786|NCT02851407|593325589|FG001|Overall Study|Other Death|20|||
164261787|NCT02851407|593325588|FG000|Overall Study|Adverse event, serious fatal|6|||
164681696|NCT01899053|594856309|FG012|Overall Study|Symptomatic Deterioration|2|||
164681697|NCT01899053|594856310|FG013|Overall Study|Symptomatic Deterioration|0|||
164681698|NCT03531827|594856315|FG000|Overall Study|Adverse Event|2|||
164681699|NCT03531827|594856316|FG001|Overall Study|Adverse Event|0|||
164681700|NCT03531827|594856315|FG000|Overall Study|Progressive disease|1|||
164681701|NCT03531827|594856316|FG001|Overall Study|Progressive disease|0|||
164681702|NCT03500094|594856320|FG000|Overall Study|Withdrawal by Subject|1|||
164681703|NCT03500094|594856320|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
164681704|NCT03500094|594856320|FG000|Overall Study|Lost to Follow-up|1|||
164681705|NCT01891357|594856321|FG000|Overall Study|Protocol Violation|3|||
164681706|NCT00557245|594858165|FG000|Overall Study|Lost to Follow-up|7|||
164681707|NCT00557245|594858166|FG001|Overall Study|Lost to Follow-up|8|||
164681708|NCT00557245|594858167|FG002|Overall Study|Lost to Follow-up|10|||
164681709|NCT00557245|594858165|FG000|Overall Study|Ineligible|5|||
164681710|NCT00557245|594858166|FG001|Overall Study|Ineligible|4|||
164681711|NCT00557245|594858167|FG002|Overall Study|Ineligible|2|||
164681712|NCT02658019|594858168|FG000|Overall Study|Adverse Event|1|||
164681713|NCT02316223|594858170|FG000|Overall Study|Lack of Efficacy|0|||
164681714|NCT02316223|594858171|FG001|Overall Study|Lack of Efficacy|1|||
164681715|NCT02316223|594858172|FG002|Overall Study|Lack of Efficacy|1|||
164681716|NCT02316223|594858170|FG000|Overall Study|Lost to Follow-up|27|||
164681717|NCT02316223|594858171|FG001|Overall Study|Lost to Follow-up|34|||
164681718|NCT02316223|594858172|FG002|Overall Study|Lost to Follow-up|36|||
164681719|NCT02316223|594858170|FG000|Overall Study|COPD Diagnosis|3|||
164681720|NCT02316223|594858171|FG001|Overall Study|COPD Diagnosis|2|||
164681721|NCT02316223|594858172|FG002|Overall Study|COPD Diagnosis|3|||
164681722|NCT02316223|594858170|FG000|Overall Study|Reside outside study area|1|||
164681723|NCT02316223|594858171|FG001|Overall Study|Reside outside study area|1|||
164681724|NCT02316223|594858172|FG002|Overall Study|Reside outside study area|1|||
164681725|NCT02316223|594858170|FG000|Overall Study|No asthma|2|||
164681726|NCT02316223|594858171|FG001|Overall Study|No asthma|0|||
164681727|NCT02316223|594858172|FG002|Overall Study|No asthma|0|||
164681728|NCT02316223|594858170|FG000|Overall Study|Discontinued by PI|11|||
164681729|NCT02316223|594858171|FG001|Overall Study|Discontinued by PI|19|||
164681730|NCT02316223|594858172|FG002|Overall Study|Discontinued by PI|3|||
164681731|NCT03234907|594858174|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
164681732|NCT03234907|594858175|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
164681733|NCT03234907|594858176|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
164681734|NCT03234907|594858177|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
164681735|NCT03234907|594858178|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
164681736|NCT03234907|594858179|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
164261788|NCT02851407|593325589|FG001|Overall Study|Adverse event, serious fatal|8|||
164261789|NCT02851407|593325588|FG000|Overall Study|Consent withdrawn by participant|5|||
164261790|NCT02851407|593325589|FG001|Overall Study|Consent withdrawn by participant|3|||
164340728|NCT01611155|593622302|FG000|Overall Study|Ineligible patient|0|||
164340729|NCT01611155|593622303|FG001|Overall Study|Ineligible patient|1|||
164340730|NCT01602120|593622306|FG000|Overall Study|Adverse Event|3|||
164340731|NCT01602120|593622307|FG001|Overall Study|Adverse Event|6|||
164340732|NCT01602120|593622308|FG002|Overall Study|Adverse Event|0|||
164681737|NCT03234907|594858174|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
164681738|NCT03234907|594858175|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
164681739|NCT03234907|594858176|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
164681740|NCT03234907|594858177|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
164681741|NCT03234907|594858178|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
164681742|NCT03234907|594858179|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
164681743|NCT03234907|594858174|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
164681744|NCT03234907|594858175|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
164681745|NCT03234907|594858176|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
164681746|NCT03234907|594858177|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
164261791|NCT02851407|593325588|FG000|Overall Study|Screen failure|2|||
164340733|NCT01602120|593622309|FG003|Overall Study|Adverse Event|2|||
164340734|NCT01602120|593622306|FG000|Overall Study|Death|0|||
164340735|NCT01602120|593622307|FG001|Overall Study|Death|4|||
164340736|NCT01602120|593622308|FG002|Overall Study|Death|0|||
164340737|NCT01602120|593622309|FG003|Overall Study|Death|0|||
164681747|NCT03234907|594858178|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
164681748|NCT03234907|594858179|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
164681749|NCT03234907|594858174|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
164261792|NCT02851407|593325589|FG001|Overall Study|Screen failure|1|||
164261793|NCT02851407|593325588|FG000|Overall Study|Disease relapse|9|||
164261794|NCT02851407|593325589|FG001|Overall Study|Disease relapse|6|||
164261795|NCT02851407|593325588|FG000|Overall Study|Physician Decision|7|||
164261796|NCT02851407|593325589|FG001|Overall Study|Physician Decision|6|||
164261797|NCT02851407|593325588|FG000|Overall Study|Transferred to hospital closer to home|0|||
164261798|NCT02851407|593325589|FG001|Overall Study|Transferred to hospital closer to home|1|||
164261799|NCT02851407|593325588|FG000|Overall Study|Enrolled in an investigational study|0|||
164261800|NCT02851407|593325589|FG001|Overall Study|Enrolled in an investigational study|1|||
164261801|NCT02851407|593325588|FG000|Overall Study|Early recovery|1|||
164261802|NCT02851407|593325589|FG001|Overall Study|Early recovery|0|||
164261803|NCT02851407|593325588|FG000|Overall Study|Adverse event, non-fatal|7|||
164261804|NCT02851407|593325589|FG001|Overall Study|Adverse event, non-fatal|5|||
164261805|NCT02851407|593325588|FG000|Overall Study|Lost to Follow-up|0|||
164261806|NCT02851407|593325589|FG001|Overall Study|Lost to Follow-up|2|||
164261807|NCT02585830|593325595|FG000|Overall Study|Withdrawal by Subject|3|||
164261808|NCT00812006|593325596|FG000|Overall Study|Lost to Follow-up|0|||
164261809|NCT00812006|593325597|FG001|Overall Study|Lost to Follow-up|0|||
164261810|NCT00812006|593325598|FG002|Overall Study|Lost to Follow-up|2|||
164261811|NCT00812006|593325596|FG000|Overall Study|Physician Decision|0|||
164261812|NCT00812006|593325597|FG001|Overall Study|Physician Decision|0|||
164261813|NCT00812006|593325598|FG002|Overall Study|Physician Decision|1|||
164261814|NCT00812006|593325596|FG000|Overall Study|Withdrawal by Subject|2|||
164261815|NCT00812006|593325597|FG001|Overall Study|Withdrawal by Subject|1|||
164261816|NCT00812006|593325598|FG002|Overall Study|Withdrawal by Subject|1|||
164261817|NCT00812006|593325596|FG000|Overall Study|Lack of Qualifying Event|4|||
164261818|NCT00812006|593325597|FG001|Overall Study|Lack of Qualifying Event|2|||
164261819|NCT00812006|593325598|FG002|Overall Study|Lack of Qualifying Event|2|||
164261820|NCT00068250|593325599|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
164261821|NCT00068250|593325600|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
164261822|NCT00068250|593325601|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
164261823|NCT00068250|593325602|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
164261824|NCT03242772|593325603|FG000|Overall Study|Lost to Follow-up|2|||
164261825|NCT03242772|593325604|FG001|Overall Study|Lost to Follow-up|0|||
164261826|NCT03242772|593325603|FG000|Overall Study|Physician Decision|0|||
164261827|NCT03242772|593325604|FG001|Overall Study|Physician Decision|1|||
164261828|NCT03242772|593325603|FG000|Overall Study|Withdrawal by Subject|1|||
164261829|NCT03242772|593325604|FG001|Overall Study|Withdrawal by Subject|0|||
164261830|NCT04677660|593325605|FG000|Overall Study|Lost to Follow-up|0|||
164261831|NCT04677660|593325606|FG001|Overall Study|Lost to Follow-up|2|||
164261832|NCT04677660|593325605|FG000|Overall Study|Withdrawal by Subject|0|||
164261833|NCT04677660|593325606|FG001|Overall Study|Withdrawal by Subject|1|||
164261834|NCT04677660|593325605|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
164261835|NCT04677660|593325606|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
164261836|NCT02499900|593325607|FG000|Core Study Period|Other|1|||
164261837|NCT02499900|593325608|FG001|Core Study Period|Other|4|||
164261838|NCT02499900|593325607|FG000|Core Study Period|Lost to Follow-up|1|||
164261839|NCT02499900|593325608|FG001|Core Study Period|Lost to Follow-up|2|||
164261840|NCT02499900|593325607|FG000|Core Study Period|Per sponsor request|0|||
164261841|NCT02499900|593325608|FG001|Core Study Period|Per sponsor request|1|||
164261842|NCT02499900|593325607|FG000|Core Study Period|Pregnancy|1|||
164261843|NCT02499900|593325608|FG001|Core Study Period|Pregnancy|0|||
164577480|NCT01157117|594479309|FG001|Overall Study|Dosing Symptoms|4|||
164577481|NCT01157117|594479310|FG002|Overall Study|Dosing Symptoms|0|||
164577482|NCT01157117|594479308|FG000|Overall Study|Withdrawal by Subject|4|||
164577483|NCT01157117|594479309|FG001|Overall Study|Withdrawal by Subject|1|||
164577484|NCT01157117|594479310|FG002|Overall Study|Withdrawal by Subject|1|||
164261844|NCT02499900|593325607|FG000|Core Study Period|Protocol Violation|3|||
164261845|NCT02499900|593325608|FG001|Core Study Period|Protocol Violation|0|||
164577485|NCT01157117|594479308|FG000|Overall Study|Lack of Efficacy|1|||
164577486|NCT01157117|594479309|FG001|Overall Study|Lack of Efficacy|1|||
164577487|NCT01157117|594479310|FG002|Overall Study|Lack of Efficacy|0|||
164577488|NCT01157117|594479308|FG000|Overall Study|Lost to Follow-up|0|||
164577489|NCT01157117|594479309|FG001|Overall Study|Lost to Follow-up|0|||
164577490|NCT01157117|594479310|FG002|Overall Study|Lost to Follow-up|1|||
164261846|NCT02499900|593325607|FG000|Core Study Period|Withdrawal by Subject|11|||
164261847|NCT02499900|593325608|FG001|Core Study Period|Withdrawal by Subject|10|||
164261848|NCT02499900|593325607|FG000|Core Study Period|Adverse Event|18|||
164261849|NCT02499900|593325608|FG001|Core Study Period|Adverse Event|14|||
164261850|NCT02499900|593325607|FG000|Core Study Period|Death|0|||
164577491|NCT01157117|594479308|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
164577492|NCT01157117|594479309|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
164261851|NCT02499900|593325608|FG001|Core Study Period|Death|1|||
164261852|NCT02499900|593325607|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
164261853|NCT02499900|593325608|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
164577493|NCT01157117|594479310|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
164577494|NCT00811252|594479311|FG000|Overall Study|Adverse Event|6|||
164261854|NCT02499900|593325607|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
164261855|NCT02499900|593325608|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
164261856|NCT02499900|593325607|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
164261857|NCT02499900|593325608|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
164261858|NCT02499900|593325607|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
164261859|NCT02499900|593325608|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
164261860|NCT02499900|593325607|FG000|Extension Study Period|Adverse Event|2|||
164261861|NCT02499900|593325608|FG001|Extension Study Period|Adverse Event|4|||
164261862|NCT02499900|593325607|FG000|Extension Study Period|Withdrawal by Subject|5|||
164261863|NCT02499900|593325608|FG001|Extension Study Period|Withdrawal by Subject|2|||
164261864|NCT02499900|593325607|FG000|Extension Study Period|Physician Decision|2|||
164261865|NCT02499900|593325608|FG001|Extension Study Period|Physician Decision|5|||
164261866|NCT02499900|593325607|FG000|Extension Study Period|Pregnancy|1|||
164261867|NCT02499900|593325608|FG001|Extension Study Period|Pregnancy|2|||
164261868|NCT02499900|593325607|FG000|Extension Study Period|Lost to Follow-up|2|||
164261869|NCT02499900|593325608|FG001|Extension Study Period|Lost to Follow-up|5|||
164261870|NCT02499900|593325607|FG000|Extension Study Period|Other|0|||
164261871|NCT02499900|593325608|FG001|Extension Study Period|Other|2|||
164261872|NCT03385265|593325612|FG000|Overall Study|Withdrawal by Subject|5|||
164261873|NCT03385265|593325613|FG001|Overall Study|Withdrawal by Subject|2|||
164261874|NCT03385265|593325614|FG002|Overall Study|Withdrawal by Subject|5|||
164261875|NCT03385265|593325615|FG003|Overall Study|Withdrawal by Subject|2|||
164261876|NCT01089023|593325616|FG000|Overall Study|Lost to Follow-up|3|||
164261877|NCT01089023|593325616|FG000|Overall Study|Adverse Event|1|||
164261878|NCT01089023|593325616|FG000|Overall Study|Withdrawal by Subject|1|||
164261879|NCT01089023|593325616|FG000|Overall Study|Protocol Violation|1|||
164261880|NCT01089023|593325616|FG000|Overall Study|Lack of Efficacy|1|||
164261881|NCT02434354|593325617|FG000|Overall Study|screen fail|3|||
164261882|NCT01185964|593325619|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
164261883|NCT01185964|593325620|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
164261884|NCT01185964|593325621|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
164261885|NCT01185964|593325622|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
164261886|NCT01185964|593325619|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
164261887|NCT01185964|593325620|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
164261888|NCT01185964|593325621|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
164261889|NCT01185964|593325622|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
164261890|NCT01185964|593325619|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
164261891|NCT01185964|593325620|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
164261892|NCT01185964|593325621|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
164261893|NCT01185964|593325622|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
164261894|NCT01185964|593325619|FG000|Phase 1b and Phase 2|Adverse Event|1|||
164261895|NCT01185964|593325620|FG001|Phase 1b and Phase 2|Adverse Event|0|||
164261896|NCT01185964|593325621|FG002|Phase 1b and Phase 2|Adverse Event|2|||
164577495|NCT00811252|594479312|FG001|Overall Study|Adverse Event|10|||
164577496|NCT00811252|594479313|FG002|Overall Study|Adverse Event|15|||
164577497|NCT00811252|594479311|FG000|Overall Study|Lack of Efficacy|7|||
164577498|NCT00811252|594479312|FG001|Overall Study|Lack of Efficacy|2|||
164577499|NCT00811252|594479313|FG002|Overall Study|Lack of Efficacy|0|||
164577500|NCT00811252|594479311|FG000|Overall Study|Protocol Violation|3|||
164577501|NCT00811252|594479312|FG001|Overall Study|Protocol Violation|3|||
164577502|NCT00811252|594479313|FG002|Overall Study|Protocol Violation|2|||
164577503|NCT00811252|594479311|FG000|Overall Study|Withdrawal of Consent|1|||
164577504|NCT00811252|594479312|FG001|Overall Study|Withdrawal of Consent|2|||
164577505|NCT00811252|594479313|FG002|Overall Study|Withdrawal of Consent|2|||
164577506|NCT00811252|594479311|FG000|Overall Study|Lost to Follow-up|0|||
164577507|NCT00811252|594479312|FG001|Overall Study|Lost to Follow-up|0|||
164577508|NCT00811252|594479313|FG002|Overall Study|Lost to Follow-up|2|||
164577509|NCT00811252|594479311|FG000|Overall Study|Administrative or Other Reasons|0|||
164577510|NCT00811252|594479312|FG001|Overall Study|Administrative or Other Reasons|3|||
164577511|NCT00811252|594479313|FG002|Overall Study|Administrative or Other Reasons|2|||
164261897|NCT01185964|593325622|FG003|Phase 1b and Phase 2|Adverse Event|0|||
164261898|NCT01185964|593325619|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
164261899|NCT01185964|593325620|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
164261900|NCT01185964|593325621|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
164261901|NCT01185964|593325622|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
164261902|NCT01185964|593325619|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
164340738|NCT01602120|593622306|FG000|Overall Study|Lost to Follow-up|0|||
164340739|NCT01602120|593622307|FG001|Overall Study|Lost to Follow-up|1|||
164577512|NCT01931865|594479317|FG000|Overall Study|Lost to Follow-up|2|||
164340740|NCT01602120|593622308|FG002|Overall Study|Lost to Follow-up|0|||
164577513|NCT01931865|594479317|FG000|Overall Study|Withdrawal by Subject|2|||
164577514|NCT01121406|594479318|FG000|Overall Study|Progressive disease RECIST|44|||
164261903|NCT01185964|593325620|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
164429726|NCT00269399|593943404|FG001|Overall Study|Adverse Event|4|||
164429727|NCT00269399|593943403|FG000|Overall Study|Withdrawal by Subject|2|||
164261904|NCT01185964|593325621|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
164261905|NCT01185964|593325622|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
164261906|NCT01185964|593325619|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
164261907|NCT01185964|593325620|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
164261908|NCT01185964|593325621|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
164261909|NCT01185964|593325622|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
164261910|NCT01185964|593325619|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
164261911|NCT01185964|593325620|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
164261912|NCT01185964|593325621|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
164261913|NCT01185964|593325622|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
164261914|NCT04465877|593325623|FG000|Overall Study|Noncompliant with study requirements|0|||
164261915|NCT04465877|593325624|FG001|Overall Study|Noncompliant with study requirements|0|||
164261916|NCT04465877|593325625|FG002|Overall Study|Noncompliant with study requirements|1|||
164261917|NCT04465877|593325626|FG003|Overall Study|Noncompliant with study requirements|0|||
164261918|NCT03440918|593325639|FG000|Overall Study|Protocol Violation|0|||
164261919|NCT03440918|593325640|FG001|Overall Study|Protocol Violation|16|||
164261920|NCT03576755|593325641|FG000|Overall Study|Withdrawal by Subject|1|||
164261921|NCT03576755|593325642|FG001|Overall Study|Withdrawal by Subject|0|||
164261922|NCT03576755|593325643|FG002|Overall Study|Withdrawal by Subject|0|||
164261923|NCT03576755|593325644|FG003|Overall Study|Withdrawal by Subject|0|||
164261924|NCT04346108|593325645|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
164261925|NCT04346108|593325646|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
164261926|NCT04346108|593325647|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
164261927|NCT04346108|593325645|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
164261928|NCT04346108|593325646|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
164261929|NCT04346108|593325647|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
164261930|NCT01598753|593325648|FG000|Overall Study|Adverse Event|1|||
164261931|NCT01598753|593325649|FG001|Overall Study|Adverse Event|9|||
164261932|NCT01598753|593325650|FG002|Overall Study|Adverse Event|1|||
164261933|NCT01598753|593325651|FG003|Overall Study|Adverse Event|7|||
164261934|NCT01598753|593325648|FG000|Overall Study|Lost to Follow-up|4|||
164261935|NCT01598753|593325649|FG001|Overall Study|Lost to Follow-up|3|||
164261936|NCT01598753|593325650|FG002|Overall Study|Lost to Follow-up|7|||
164261937|NCT01598753|593325651|FG003|Overall Study|Lost to Follow-up|5|||
164261938|NCT01598753|593325648|FG000|Overall Study|Physician Decision|0|||
164261939|NCT01598753|593325649|FG001|Overall Study|Physician Decision|1|||
164261940|NCT01598753|593325650|FG002|Overall Study|Physician Decision|0|||
164261941|NCT01598753|593325651|FG003|Overall Study|Physician Decision|2|||
164261942|NCT01598753|593325648|FG000|Overall Study|Withdrawal by Subject|7|||
164261943|NCT01598753|593325649|FG001|Overall Study|Withdrawal by Subject|2|||
164261944|NCT01598753|593325650|FG002|Overall Study|Withdrawal by Subject|0|||
164261945|NCT01598753|593325651|FG003|Overall Study|Withdrawal by Subject|1|||
164261946|NCT02014480|593325652|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
164261947|NCT02014480|593325653|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
164261948|NCT02014480|593325654|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
164261949|NCT02014480|593325655|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
164261950|NCT02014480|593325656|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
164261951|NCT02014480|593325657|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
164261952|NCT02014480|593325652|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164261953|NCT02014480|593325653|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
164261954|NCT02014480|593325654|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164261955|NCT02014480|593325655|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
164261956|NCT02014480|593325656|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
164261957|NCT02014480|593325657|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164261958|NCT02014480|593325652|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
164261959|NCT02014480|593325653|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
164261960|NCT02014480|593325654|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
164261961|NCT02014480|593325655|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
164261962|NCT02014480|593325656|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
164261963|NCT02014480|593325657|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
164261964|NCT02014480|593325652|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
164261965|NCT02014480|593325653|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
164261966|NCT02014480|593325654|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
164261967|NCT02014480|593325655|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
164261968|NCT02014480|593325656|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
164261969|NCT02014480|593325657|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
164340741|NCT01602120|593622309|FG003|Overall Study|Lost to Follow-up|1|||
164340742|NCT01602120|593622306|FG000|Overall Study|Protocol Violation|1|||
164340743|NCT01602120|593622307|FG001|Overall Study|Protocol Violation|1|||
164577515|NCT01121406|594479319|FG001|Overall Study|Progressive disease RECIST|28|||
164340744|NCT01602120|593622308|FG002|Overall Study|Protocol Violation|0|||
164340745|NCT01602120|593622309|FG003|Overall Study|Protocol Violation|0|||
164340746|NCT01602120|593622306|FG000|Overall Study|Non-compliance|0|||
164340747|NCT01602120|593622307|FG001|Overall Study|Non-compliance|3|||
164340748|NCT01602120|593622308|FG002|Overall Study|Non-compliance|0|||
164340749|NCT01602120|593622309|FG003|Overall Study|Non-compliance|1|||
164340750|NCT01602120|593622306|FG000|Overall Study|Withdrawal by Subject|8|||
164577516|NCT01121406|594479318|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
164577517|NCT01121406|594479319|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
164577518|NCT01121406|594479318|FG000|Overall Study|Other AE|3|||
164577519|NCT01121406|594479319|FG001|Overall Study|Other AE|10|||
164577520|NCT01121406|594479318|FG000|Overall Study|Non-compliant with protocol|0|||
164577521|NCT01121406|594479319|FG001|Overall Study|Non-compliant with protocol|2|||
164577522|NCT01121406|594479318|FG000|Overall Study|Lost to Follow-up|0|||
164577523|NCT01121406|594479319|FG001|Overall Study|Lost to Follow-up|1|||
164577524|NCT01121406|594479318|FG000|Overall Study|Refused continuation of study med.|1|||
164577525|NCT01121406|594479319|FG001|Overall Study|Refused continuation of study med.|2|||
164577526|NCT01121406|594479318|FG000|Overall Study|Reason other than specified above|2|||
164577527|NCT01121406|594479319|FG001|Overall Study|Reason other than specified above|6|||
164577528|NCT01121406|594479318|FG000|Overall Study|Not treated|1|||
164577529|NCT01121406|594479319|FG001|Overall Study|Not treated|0|||
164577530|NCT01829048|594479320|FG000|Overall Study|Withdrawal by Subject|0|||
164577531|NCT01829048|594479321|FG001|Overall Study|Withdrawal by Subject|0|||
164577532|NCT01829048|594479322|FG002|Overall Study|Withdrawal by Subject|0|||
164577533|NCT01829048|594479323|FG003|Overall Study|Withdrawal by Subject|2|||
164577534|NCT01829048|594479324|FG004|Overall Study|Withdrawal by Subject|0|||
164577535|NCT00504257|594479325|FG000|Overall Study|Withdrawal by Subject|2|||
164577536|NCT00504257|594479325|FG000|Overall Study|ineligible histology|2|||
164577537|NCT00892437|594479326|FG000|Randomized Phase|Randomized but not treated|6|||
164340751|NCT01602120|593622307|FG001|Overall Study|Withdrawal by Subject|17|||
164340752|NCT01602120|593622308|FG002|Overall Study|Withdrawal by Subject|0|||
164340753|NCT01602120|593622309|FG003|Overall Study|Withdrawal by Subject|3|||
164340754|NCT01602120|593622306|FG000|Overall Study|Study Terminated by Sponsor|12|||
164340755|NCT01602120|593622307|FG001|Overall Study|Study Terminated by Sponsor|24|||
164340756|NCT01602120|593622308|FG002|Overall Study|Study Terminated by Sponsor|17|||
164577538|NCT00892437|594479327|FG001|Randomized Phase|Randomized but not treated|0|||
164577539|NCT00892437|594479326|FG000|Randomized Phase|Adverse Event|2|||
164577540|NCT00892437|594479327|FG001|Randomized Phase|Adverse Event|2|||
164261970|NCT02014480|593325652|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
164261971|NCT02014480|593325653|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
164261972|NCT02014480|593325654|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
164261973|NCT02014480|593325655|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
164261974|NCT02014480|593325656|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
164261975|NCT02014480|593325657|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
164261976|NCT02014480|593325652|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
164261977|NCT02014480|593325653|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
164261978|NCT02014480|593325654|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
164261979|NCT02014480|593325655|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
164261980|NCT02014480|593325656|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
164261981|NCT02014480|593325657|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
164261982|NCT02014480|593325652|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164261983|NCT02014480|593325653|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164261984|NCT02014480|593325654|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164261985|NCT02014480|593325655|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164261986|NCT02014480|593325656|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164261987|NCT02014480|593325657|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
164261988|NCT00724854|593325658|FG000|Overall Study|Lack of Efficacy|187|||
164261989|NCT00724854|593325659|FG001|Overall Study|Lack of Efficacy|13|||
164261990|NCT00724854|593325658|FG000|Overall Study|Lost to Follow-up|87|||
164261991|NCT00724854|593325659|FG001|Overall Study|Lost to Follow-up|10|||
164261992|NCT00724854|593325658|FG000|Overall Study|Adverse Event|62|||
164261993|NCT00724854|593325659|FG001|Overall Study|Adverse Event|4|||
164261994|NCT00724854|593325658|FG000|Overall Study|Other|42|||
164261995|NCT00724854|593325659|FG001|Overall Study|Other|3|||
164261996|NCT00724854|593325658|FG000|Overall Study|Death|11|||
164261997|NCT00724854|593325659|FG001|Overall Study|Death|0|||
164261998|NCT00724854|593325658|FG000|Overall Study|Change of treatment|7|||
164261999|NCT00724854|593325659|FG001|Overall Study|Change of treatment|0|||
164262000|NCT00724854|593325658|FG000|Overall Study|Withdrawal by Subject|5|||
164262001|NCT00724854|593325659|FG001|Overall Study|Withdrawal by Subject|0|||
164262002|NCT00724854|593325658|FG000|Overall Study|Adverse event + lack of efficacy|2|||
164262003|NCT00724854|593325659|FG001|Overall Study|Adverse event + lack of efficacy|1|||
164262004|NCT01338610|593325660|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
164262005|NCT01338610|593325661|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
164262006|NCT01338610|593325662|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
164262007|NCT01338610|593325660|FG000|Overall Study|Protocol Violation|1|||
164262008|NCT01338610|593325661|FG001|Overall Study|Protocol Violation|0|||
164262009|NCT01338610|593325662|FG002|Overall Study|Protocol Violation|1|||
164262010|NCT01338610|593325660|FG000|Overall Study|Adverse Event|3|||
164262011|NCT01338610|593325661|FG001|Overall Study|Adverse Event|0|||
164262012|NCT01338610|593325662|FG002|Overall Study|Adverse Event|0|||
164262013|NCT01865812|593325663|FG000|Primary Treatment Phase|Adverse Event|2|||
164262014|NCT01865812|593325664|FG001|Primary Treatment Phase|Adverse Event|0|||
164262015|NCT01865812|593325663|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
164262016|NCT01865812|593325664|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
164262017|NCT01865812|593325663|FG000|Long-term Safety Extension Phase|Pruritus|0|||
164262018|NCT01865812|593325664|FG001|Long-term Safety Extension Phase|Pruritus|3|||
164262019|NCT01865812|593325663|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
164262020|NCT01865812|593325664|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
164262021|NCT01865812|593325663|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
164262022|NCT01865812|593325664|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
164262023|NCT02032407|593327952|FG000|Overall Study|Lost to Follow-up|2|||
164262024|NCT02032407|593327952|FG000|Overall Study|Pregnancy|1|||
164262025|NCT02032407|593327952|FG000|Overall Study|Other Miscellaneous Reasons|2|||
164262026|NCT02324205|593327954|FG000|Overall Study|Withdrawal by Subject|37|||
164262027|NCT00090233|593327957|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
164262028|NCT00090233|593327958|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
164262029|NCT00090233|593327957|FG000|Overall Study|Adverse Event|214|||
164262030|NCT00090233|593327958|FG001|Overall Study|Adverse Event|198|||
164262031|NCT00090233|593327957|FG000|Overall Study|Lost to Follow-up|68|||
164262032|NCT00090233|593327958|FG001|Overall Study|Lost to Follow-up|95|||
164262033|NCT00090233|593327957|FG000|Overall Study|Protocol Violation|960|||
164577541|NCT00892437|594479326|FG000|Randomized Phase|Lost to Follow-up|1|||
164577542|NCT00892437|594479327|FG001|Randomized Phase|Lost to Follow-up|3|||
164262034|NCT00090233|593327958|FG001|Overall Study|Protocol Violation|1022|||
164262035|NCT00090233|593327957|FG000|Overall Study|Withdrawal by Subject|182|||
164262036|NCT00090233|593327958|FG001|Overall Study|Withdrawal by Subject|211|||
164262037|NCT00090233|593327957|FG000|Overall Study|Moved|203|||
164262038|NCT00090233|593327958|FG001|Overall Study|Moved|189|||
164262039|NCT00090233|593327957|FG000|Overall Study|Other|1211|||
164262040|NCT00090233|593327958|FG001|Overall Study|Other|1160|||
164262041|NCT00090233|593327957|FG000|Overall Study|Data not available at data cut-off point|1552|||
164262042|NCT00090233|593327958|FG001|Overall Study|Data not available at data cut-off point|1563|||
164262043|NCT04863248|593327959|FG000|Overall Study|Sponsor Terminated|4|||
164262044|NCT04863248|593327960|FG001|Overall Study|Sponsor Terminated|1|||
164262045|NCT04863248|593327959|FG000|Overall Study|Death|0|||
164262046|NCT04863248|593327960|FG001|Overall Study|Death|1|||
164262047|NCT04863248|593327959|FG000|Overall Study|Withdrawal by Subject|0|||
164262048|NCT04863248|593327960|FG001|Overall Study|Withdrawal by Subject|1|||
164262049|NCT02536300|593327961|FG000|Overall Study|Investigator's Discretion|17|||
164262050|NCT02536300|593327962|FG001|Overall Study|Investigator's Discretion|11|||
164262051|NCT02536300|593327963|FG002|Overall Study|Investigator's Discretion|2|||
164262052|NCT02536300|593327961|FG000|Overall Study|Progressive Disease|11|||
164681750|NCT03234907|594858175|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
164681751|NCT03234907|594858176|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
164681752|NCT03234907|594858177|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
164681753|NCT03234907|594858178|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
164681754|NCT03234907|594858179|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
164681755|NCT03234907|594858174|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
164681756|NCT03234907|594858175|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
164681757|NCT03234907|594858176|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
164681758|NCT03234907|594858177|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
164681759|NCT03234907|594858178|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
164681760|NCT03234907|594858179|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
164681761|NCT03234907|594858174|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
164681762|NCT03234907|594858175|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
164681763|NCT03234907|594858176|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
164681764|NCT03234907|594858177|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
164681765|NCT03234907|594858178|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
164681766|NCT03234907|594858179|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
164681767|NCT03234907|594858174|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
164681768|NCT03234907|594858175|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
164262053|NCT02536300|593327962|FG001|Overall Study|Progressive Disease|7|||
164262054|NCT02536300|593327963|FG002|Overall Study|Progressive Disease|6|||
164262055|NCT02536300|593327961|FG000|Overall Study|Study Terminated by Sponsor|6|||
164262056|NCT02536300|593327962|FG001|Overall Study|Study Terminated by Sponsor|4|||
164262057|NCT02536300|593327963|FG002|Overall Study|Study Terminated by Sponsor|7|||
164262058|NCT02536300|593327961|FG000|Overall Study|Death|7|||
164262059|NCT02536300|593327962|FG001|Overall Study|Death|0|||
164262060|NCT02536300|593327963|FG002|Overall Study|Death|5|||
164262061|NCT02536300|593327961|FG000|Overall Study|Withdrew Consent|4|||
164262062|NCT02536300|593327962|FG001|Overall Study|Withdrew Consent|2|||
164262063|NCT02536300|593327963|FG002|Overall Study|Withdrew Consent|0|||
164262064|NCT02536300|593327961|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
164262065|NCT02536300|593327962|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
164262066|NCT02536300|593327963|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
164262067|NCT02536300|593327961|FG000|Overall Study|Enrolled but Never Treated|0|||
164262068|NCT02536300|593327962|FG001|Overall Study|Enrolled but Never Treated|0|||
164262069|NCT02536300|593327963|FG002|Overall Study|Enrolled but Never Treated|1|||
164262070|NCT02536300|593327961|FG000|Overall Study|Non-compliance With Study Drug|1|||
164262071|NCT02536300|593327962|FG001|Overall Study|Non-compliance With Study Drug|0|||
164262072|NCT02536300|593327963|FG002|Overall Study|Non-compliance With Study Drug|0|||
164262073|NCT02536300|593327961|FG000|Overall Study|Protocol Violation|0|||
164262074|NCT02536300|593327962|FG001|Overall Study|Protocol Violation|1|||
164262075|NCT02536300|593327963|FG002|Overall Study|Protocol Violation|0|||
164262076|NCT01482169|593327966|FG000|Overall Study|Physician Decision|2|||
164681769|NCT03234907|594858176|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
164681770|NCT03234907|594858177|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
164681771|NCT03234907|594858178|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
164681772|NCT03234907|594858179|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
164681773|NCT02986139|594858182|FG000|Overall Study|Sponsor Decision|1|||
164262077|NCT01777542|593327967|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
164262078|NCT01777542|593327968|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
164262079|NCT01030874|593327971|FG000|Overall Study|Withdrawal by Subject|1|||
164262080|NCT01030874|593327972|FG001|Overall Study|Withdrawal by Subject|0|||
164340757|NCT01602120|593622309|FG003|Overall Study|Study Terminated by Sponsor|44|||
164340758|NCT01602120|593622306|FG000|Overall Study|Physician Decision|2|||
164340759|NCT01602120|593622307|FG001|Overall Study|Physician Decision|3|||
164262081|NCT01030874|593327971|FG000|Overall Study|Discharged in first 2 weeks|17|||
164262082|NCT01030874|593327972|FG001|Overall Study|Discharged in first 2 weeks|16|||
164262083|NCT02279719|593327975|FG000|Overall Study|Patients randomized but never treated|0|||
164340760|NCT01602120|593622308|FG002|Overall Study|Physician Decision|0|||
164262084|NCT02279719|593327976|FG001|Overall Study|Patients randomized but never treated|0|||
164262085|NCT02279719|593327977|FG002|Overall Study|Patients randomized but never treated|0|||
164262086|NCT02279719|593327978|FG003|Overall Study|Patients randomized but never treated|0|||
164262087|NCT02279719|593327979|FG004|Overall Study|Patients randomized but never treated|3|||
164262088|NCT02279719|593327980|FG005|Overall Study|Patients randomized but never treated|0|||
164262089|NCT02279719|593327981|FG006|Overall Study|Patients randomized but never treated|3|||
164262090|NCT03541187|593327984|FG000|Overall Study|Lost to Follow-up|2|||
164262091|NCT03541187|593327985|FG001|Overall Study|Lost to Follow-up|6|||
164262092|NCT03541187|593327984|FG000|Overall Study|Pregnancy|0|||
164262093|NCT03541187|593327985|FG001|Overall Study|Pregnancy|1|||
164262094|NCT03541187|593327984|FG000|Overall Study|Withdrawal by Subject|6|||
164262095|NCT03541187|593327985|FG001|Overall Study|Withdrawal by Subject|2|||
164262096|NCT03541187|593327984|FG000|Overall Study|Moved out of town|1|||
164262097|NCT03541187|593327985|FG001|Overall Study|Moved out of town|0|||
164262098|NCT03541187|593327984|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
164262099|NCT03541187|593327985|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
164262100|NCT03541187|593327984|FG000|Overall Study|Did not meet randomization criteria|1|||
164262101|NCT03541187|593327985|FG001|Overall Study|Did not meet randomization criteria|1|||
164340761|NCT01602120|593622309|FG003|Overall Study|Physician Decision|0|||
164681774|NCT02986139|594858183|FG001|Overall Study|Sponsor Decision|2|||
164681775|NCT02986139|594858182|FG000|Overall Study|Withdrawal by Subject|0|||
164681776|NCT02986139|594858183|FG001|Overall Study|Withdrawal by Subject|1|||
164681777|NCT02986139|594858182|FG000|Overall Study|Lost to Follow-up|0|||
164681778|NCT02986139|594858183|FG001|Overall Study|Lost to Follow-up|1|||
164681779|NCT02583048|594858184|FG000|Overall Study|Withdrawal by Subject|0|||
164681780|NCT02583048|594858185|FG001|Overall Study|Withdrawal by Subject|1|||
164681781|NCT02583048|594858186|FG002|Overall Study|Withdrawal by Subject|0|||
164681782|NCT02583048|594858184|FG000|Overall Study|Failed to meet eligibility criterion|0|||
164681783|NCT02583048|594858185|FG001|Overall Study|Failed to meet eligibility criterion|0|||
164681784|NCT02583048|594858186|FG002|Overall Study|Failed to meet eligibility criterion|1|||
164681785|NCT00414726|594858190|FG000|Overall Study|Withdrawal by Subject|0|||
164681786|NCT00414726|594858191|FG001|Overall Study|Withdrawal by Subject|1|||
164681787|NCT02107196|594858192|FG000|12-week Treatment Period|Adverse Event|6|||
164681788|NCT02107196|594858193|FG001|12-week Treatment Period|Adverse Event|3|||
164340762|NCT01602120|593622306|FG000|Overall Study|Unspecified Reason|3|||
164340763|NCT01602120|593622307|FG001|Overall Study|Unspecified Reason|1|||
164340764|NCT01602120|593622308|FG002|Overall Study|Unspecified Reason|0|||
164340765|NCT01602120|593622309|FG003|Overall Study|Unspecified Reason|2|||
164340766|NCT04502433|593622310|FG000|Overall Study|Death|2|||
164340767|NCT04502433|593622311|FG001|Overall Study|Death|4|||
164340768|NCT04502433|593622310|FG000|Overall Study|Lost to Follow-up|1|||
164340769|NCT04502433|593622311|FG001|Overall Study|Lost to Follow-up|0|||
164340770|NCT04502433|593622310|FG000|Overall Study|Physician Decision|0|||
164340771|NCT04502433|593622311|FG001|Overall Study|Physician Decision|1|||
164340772|NCT01681472|593622314|FG000|Overall Study|Adverse Event|0|||
164340773|NCT01681472|593622315|FG001|Overall Study|Adverse Event|1|||
164340774|NCT01681472|593622316|FG002|Overall Study|Adverse Event|0|||
164340775|NCT01681472|593622317|FG003|Overall Study|Adverse Event|0|||
164340776|NCT01696071|593622330|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
164340777|NCT01696071|593622331|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
164340778|NCT00678080|593622335|FG000|Overall Study|Physician Decision|2|||
164340779|NCT00678080|593622336|FG001|Overall Study|Physician Decision|0|||
164681789|NCT02107196|594858192|FG000|12-week Treatment Period|Lack of Efficacy|2|||
164262102|NCT03541187|593327984|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
164262103|NCT03541187|593327985|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
164262104|NCT03541187|593327984|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
164340780|NCT00678080|593622335|FG000|Overall Study|Lost to Follow-up|1|||
164340781|NCT00678080|593622336|FG001|Overall Study|Lost to Follow-up|0|||
164340782|NCT00678080|593622335|FG000|Overall Study|Withdrawal by Subject|0|||
164340783|NCT00678080|593622336|FG001|Overall Study|Withdrawal by Subject|1|||
164340784|NCT04439201|593622339|FG000|Overall Study|Ineligible|2|||
164340785|NCT04439201|593622339|FG000|Overall Study|Never start protocol therapy|1|||
164340786|NCT04439201|593622339|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
164340787|NCT04439201|593622339|FG000|Overall Study|Mutation status not confirmed|4|||
164340788|NCT04439201|593622339|FG000|Overall Study|Adverse Event|1|||
164340789|NCT04439201|593622339|FG000|Overall Study|Death|7|||
164340790|NCT04439201|593622339|FG000|Overall Study|Withdrawal by Subject|2|||
164340791|NCT04439201|593622339|FG000|Overall Study|Disease progression|20|||
164681790|NCT02107196|594858193|FG001|12-week Treatment Period|Lack of Efficacy|1|||
164340792|NCT04439201|593622339|FG000|Overall Study|Alternative therapy|1|||
164262105|NCT03541187|593327985|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
164262106|NCT00869050|593327989|FG000|Overall Study|Screen Failure|3|||
164262107|NCT03199053|593327996|FG000|ST Period|Withdrawal by Subject|2|||
164262108|NCT03199053|593327997|FG001|ST Period|Withdrawal by Subject|4|||
164262109|NCT03199053|593327998|FG002|ST Period|Withdrawal by Subject|6|||
164262110|NCT03199053|593327996|FG000|ST Period|Withdrawal by parent/guardian|1|||
164262111|NCT03199053|593327997|FG001|ST Period|Withdrawal by parent/guardian|1|||
164262112|NCT03199053|593327998|FG002|ST Period|Withdrawal by parent/guardian|1|||
164262113|NCT03199053|593327996|FG000|ST Period|Lost to Follow-up|2|||
164262114|NCT03199053|593327997|FG001|ST Period|Lost to Follow-up|0|||
164262115|NCT03199053|593327998|FG002|ST Period|Lost to Follow-up|1|||
164262116|NCT03199053|593327996|FG000|LT Period|Withdrawal by Subject|1|||
164262117|NCT03199053|593327997|FG001|LT Period|Withdrawal by Subject|3|||
164262118|NCT03199053|593327998|FG002|LT Period|Withdrawal by Subject|3|||
164262119|NCT03199053|593327996|FG000|LT Period|Withdrawal by parent/guardian|0|||
164262120|NCT03199053|593327997|FG001|LT Period|Withdrawal by parent/guardian|0|||
164262121|NCT03199053|593327998|FG002|LT Period|Withdrawal by parent/guardian|1|||
164262122|NCT03199053|593327996|FG000|LT Period|Lost to Follow-up|0|||
164262123|NCT03199053|593327997|FG001|LT Period|Lost to Follow-up|1|||
164262124|NCT03199053|593327998|FG002|LT Period|Lost to Follow-up|1|||
164262125|NCT03199053|593327996|FG000|LT Period|Miscellaneous|0|||
164262126|NCT03199053|593327997|FG001|LT Period|Miscellaneous|0|||
164262127|NCT03199053|593327998|FG002|LT Period|Miscellaneous|2|||
164262128|NCT03199053|593327996|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
164262129|NCT03199053|593327997|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
164262130|NCT03199053|593327998|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
164262131|NCT03199053|593327996|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
164262132|NCT03199053|593327997|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
164262133|NCT03199053|593327998|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
164262134|NCT03199053|593327996|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
164262135|NCT03199053|593327997|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
164262136|NCT03199053|593327998|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
164262137|NCT03199053|593327996|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
164262138|NCT03199053|593327997|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
164262139|NCT03199053|593327998|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
164262140|NCT03298984|593328003|FG000|Overall Study|Physician Decision|1|||
164262141|NCT03298984|593328004|FG001|Overall Study|Physician Decision|0|||
164262142|NCT03298984|593328005|FG002|Overall Study|Physician Decision|0|||
164262143|NCT03298984|593328006|FG003|Overall Study|Physician Decision|6|||
164262144|NCT03298984|593328003|FG000|Overall Study|Lack of Efficacy|0|||
164262145|NCT03298984|593328004|FG001|Overall Study|Lack of Efficacy|1|||
164262146|NCT03298984|593328005|FG002|Overall Study|Lack of Efficacy|1|||
164262147|NCT03298984|593328006|FG003|Overall Study|Lack of Efficacy|4|||
164262148|NCT03298984|593328003|FG000|Overall Study|Relapsed disease (following remission)|0|||
164262149|NCT03298984|593328004|FG001|Overall Study|Relapsed disease (following remission)|0|||
164262150|NCT03298984|593328005|FG002|Overall Study|Relapsed disease (following remission)|1|||
164262151|NCT03298984|593328006|FG003|Overall Study|Relapsed disease (following remission)|1|||
164262152|NCT03298984|593328003|FG000|Overall Study|Adverse Event|0|||
164340793|NCT04439201|593622339|FG000|Overall Study|Physician Decision|1|||
164340794|NCT05136690|593622340|FG000|Period 1|Withdrawal by Subject|0|||
164340795|NCT05136690|593622341|FG001|Period 1|Withdrawal by Subject|1|||
164340796|NCT05136690|593622340|FG000|Period 2|Lost to Follow-up|0|||
164340797|NCT05136690|593622341|FG001|Period 2|Lost to Follow-up|3|||
164340798|NCT05136690|593622340|FG000|Period 2|Withdrawal by Subject|0|||
164340799|NCT05136690|593622341|FG001|Period 2|Withdrawal by Subject|1|||
164340800|NCT02020577|593622342|FG000|Overall Study|Progressive disease|3|||
164577543|NCT00892437|594479326|FG000|Randomized Phase|Investigator's Discretion|1|||
164577544|NCT00892437|594479327|FG001|Randomized Phase|Investigator's Discretion|0|||
164577545|NCT00892437|594479326|FG000|Randomized Phase|Withdrew Consent|1|||
164262153|NCT03298984|593328004|FG001|Overall Study|Adverse Event|0|||
164262154|NCT03298984|593328005|FG002|Overall Study|Adverse Event|0|||
164262155|NCT03298984|593328006|FG003|Overall Study|Adverse Event|1|||
164262156|NCT03298984|593328003|FG000|Overall Study|Death|0|||
164262157|NCT03298984|593328004|FG001|Overall Study|Death|0|||
164262158|NCT03298984|593328005|FG002|Overall Study|Death|0|||
164262159|NCT03298984|593328006|FG003|Overall Study|Death|2|||
164262160|NCT03298984|593328003|FG000|Overall Study|Insurance Company Decision|0|||
164262161|NCT03298984|593328004|FG001|Overall Study|Insurance Company Decision|0|||
164262162|NCT03298984|593328005|FG002|Overall Study|Insurance Company Decision|0|||
164340801|NCT02020577|593622343|FG001|Overall Study|Progressive disease|38|||
164340802|NCT02020577|593622342|FG000|Overall Study|Other AE or clinical progression|0|||
164340803|NCT02020577|593622343|FG001|Overall Study|Other AE or clinical progression|15|||
164340804|NCT02020577|593622342|FG000|Overall Study|Withdrawal by Subject|0|||
164340805|NCT02020577|593622343|FG001|Overall Study|Withdrawal by Subject|1|||
164577546|NCT00892437|594479327|FG001|Randomized Phase|Withdrew Consent|0|||
164340806|NCT02020577|593622342|FG000|Overall Study|Other than stated above|0|||
164262163|NCT03298984|593328006|FG003|Overall Study|Insurance Company Decision|1|||
164262164|NCT01571284|593328007|FG000|Overall Study|Participant's decision|84|||
164262165|NCT01571284|593328007|FG000|Overall Study|Lost to Follow-up|3|||
164262166|NCT01571284|593328007|FG000|Overall Study|Enrolled but not treated|2|||
164262167|NCT01571284|593328007|FG000|Overall Study|Other than specified above|80|||
164262168|NCT03883113|593328026|FG000|Overall Study|Physician Decision|4|||
164262169|NCT03883113|593328027|FG001|Overall Study|Physician Decision|2|||
164262170|NCT03883113|593328026|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
164262171|NCT03883113|593328027|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
164262172|NCT03883113|593328026|FG000|Overall Study|Pregnancy|1|||
164262173|NCT03883113|593328027|FG001|Overall Study|Pregnancy|0|||
164262174|NCT03883113|593328026|FG000|Overall Study|Adverse Event|0|||
164262175|NCT03883113|593328027|FG001|Overall Study|Adverse Event|1|||
164262176|NCT03883113|593328026|FG000|Overall Study|Withdrawal by Subject|1|||
164262177|NCT03883113|593328027|FG001|Overall Study|Withdrawal by Subject|2|||
164262178|NCT03883113|593328026|FG000|Overall Study|Lost to Follow-up|1|||
164262179|NCT03883113|593328027|FG001|Overall Study|Lost to Follow-up|0|||
164262180|NCT02323204|593328028|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
164262181|NCT02323204|593328029|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
164262182|NCT02323204|593328030|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
164262183|NCT02323204|593328031|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
164262184|NCT02323204|593328028|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
164262185|NCT02323204|593328029|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
164262186|NCT02323204|593328030|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
164262187|NCT02323204|593328031|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
164262188|NCT02323204|593328028|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
164262189|NCT02323204|593328029|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
164262190|NCT02323204|593328030|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
164262191|NCT02323204|593328031|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
164262192|NCT02323204|593328028|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
164262193|NCT02323204|593328029|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
164262194|NCT02323204|593328030|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
164262195|NCT02323204|593328031|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
164262196|NCT02323204|593328028|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
164262197|NCT02323204|593328029|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
164262198|NCT02323204|593328030|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
164262199|NCT02323204|593328031|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
164262200|NCT02323204|593328028|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
164262201|NCT02323204|593328029|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
164262202|NCT02323204|593328030|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
164262203|NCT02323204|593328031|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
164340807|NCT02020577|593622343|FG001|Overall Study|Other than stated above|1|||
164340808|NCT01453361|593622344|FG000|Overall Study|Disease Progression|6|||
164340809|NCT01453361|593622344|FG000|Overall Study|Screen-Failures|10|||
164340810|NCT01752985|593622345|FG000|Treatment Period|Subject request to discontinue treatment|1|||
164340811|NCT01752985|593622346|FG001|Treatment Period|Subject request to discontinue treatment|0|||
164340812|NCT01752985|593622347|FG002|Treatment Period|Subject request to discontinue treatment|1|||
164340813|NCT01752985|593622345|FG000|Treatment Period|Subject no longer meets study criteria|0|||
164340814|NCT01752985|593622346|FG001|Treatment Period|Subject no longer meets study criteria|1|||
164340815|NCT01752985|593622347|FG002|Treatment Period|Subject no longer meets study criteria|1|||
164340816|NCT01752985|593622345|FG000|Treatment Period|Adverse Event|2|||
164340817|NCT01752985|593622346|FG001|Treatment Period|Adverse Event|1|||
164340818|NCT01752985|593622347|FG002|Treatment Period|Adverse Event|2|||
164340819|NCT01752985|593622345|FG000|Treatment Period|Withdrawal by Subject|1|||
164340820|NCT01752985|593622346|FG001|Treatment Period|Withdrawal by Subject|1|||
164340821|NCT01752985|593622347|FG002|Treatment Period|Withdrawal by Subject|0|||
164340822|NCT01752985|593622345|FG000|Treatment Period|Lost to Follow-up|0|||
164340823|NCT01752985|593622346|FG001|Treatment Period|Lost to Follow-up|0|||
164577547|NCT00892437|594479326|FG000|Open-Label Extension Phase|Adverse Event|4|||
164577548|NCT00892437|594479327|FG001|Open-Label Extension Phase|Adverse Event|2|||
164577549|NCT00892437|594479326|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
164577550|NCT00892437|594479327|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
164577551|NCT00892437|594479326|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
164577552|NCT00892437|594479327|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
164577553|NCT00892437|594479326|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
164577554|NCT00892437|594479327|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
164577555|NCT00892437|594479326|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
164577556|NCT00892437|594479327|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
164577557|NCT03185130|594479328|FG000|Overall Study|Withdrawal by Subject|0|||
164262204|NCT02323204|593328028|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
164262205|NCT02323204|593328029|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
164262206|NCT02323204|593328030|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
164262207|NCT02323204|593328031|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
164262208|NCT02323204|593328028|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
164262209|NCT02323204|593328029|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
164262210|NCT02323204|593328030|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
164262211|NCT02323204|593328031|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
164262212|NCT02323204|593328028|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
164262213|NCT02323204|593328029|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
164262214|NCT02323204|593328030|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
164262215|NCT02323204|593328031|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
164262216|NCT02046226|593328037|FG000|Overall Study|Lost to Follow-up|7|||
164262217|NCT01095653|593328038|FG000|Overall Study|Lack of Efficacy|3|||
164262218|NCT01095653|593328039|FG001|Overall Study|Lack of Efficacy|0|||
164262219|NCT01095653|593328040|FG002|Overall Study|Lack of Efficacy|0|||
164262220|NCT01095653|593328038|FG000|Overall Study|Adverse Event|1|||
164262221|NCT01095653|593328039|FG001|Overall Study|Adverse Event|4|||
164262222|NCT01095653|593328040|FG002|Overall Study|Adverse Event|4|||
164262223|NCT01095653|593328038|FG000|Overall Study|Lost to Follow-up|1|||
164262224|NCT01095653|593328039|FG001|Overall Study|Lost to Follow-up|0|||
164262225|NCT01095653|593328040|FG002|Overall Study|Lost to Follow-up|4|||
164262226|NCT01095653|593328038|FG000|Overall Study|Withdrawal by Subject|4|||
164262227|NCT01095653|593328039|FG001|Overall Study|Withdrawal by Subject|5|||
164262228|NCT01095653|593328040|FG002|Overall Study|Withdrawal by Subject|3|||
164262229|NCT01095653|593328038|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
164262230|NCT01095653|593328039|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
164262231|NCT01095653|593328040|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
164262232|NCT00171925|593328041|FG000|Overall Study|Adverse Event|10|||
164262233|NCT00171925|593328042|FG001|Overall Study|Adverse Event|6|||
164262234|NCT00171925|593328041|FG000|Overall Study|Protocol Violation|1|||
164262235|NCT00171925|593328042|FG001|Overall Study|Protocol Violation|1|||
164262236|NCT00171925|593328041|FG000|Overall Study|Withdrawal by Subject|6|||
164262237|NCT00171925|593328042|FG001|Overall Study|Withdrawal by Subject|9|||
164262238|NCT00171925|593328041|FG000|Overall Study|Lost to Follow-up|2|||
164262239|NCT00171925|593328042|FG001|Overall Study|Lost to Follow-up|2|||
164262240|NCT00171925|593328041|FG000|Overall Study|Administrative problems|10|||
164262241|NCT00171925|593328042|FG001|Overall Study|Administrative problems|11|||
164262242|NCT00171925|593328041|FG000|Overall Study|Death|1|||
164262243|NCT00171925|593328042|FG001|Overall Study|Death|2|||
164262244|NCT02692040|593328043|FG000|Overall Study|Protocol Violation|0|||
164262245|NCT02692040|593328044|FG001|Overall Study|Protocol Violation|0|||
164262246|NCT02692040|593328045|FG002|Overall Study|Protocol Violation|0|||
164262247|NCT02692040|593328046|FG003|Overall Study|Protocol Violation|0|||
164262248|NCT02692040|593328047|FG004|Overall Study|Protocol Violation|0|||
164262249|NCT02692040|593328048|FG005|Overall Study|Protocol Violation|0|||
164262250|NCT02692040|593328049|FG006|Overall Study|Protocol Violation|0|||
164262251|NCT02692040|593328050|FG007|Overall Study|Protocol Violation|0|||
164262252|NCT02692040|593328051|FG008|Overall Study|Protocol Violation|0|||
164262253|NCT02692040|593328052|FG009|Overall Study|Protocol Violation|0|||
164262254|NCT02692040|593328053|FG010|Overall Study|Protocol Violation|0|||
164262255|NCT02692040|593328054|FG011|Overall Study|Protocol Violation|0|||
164262256|NCT02692040|593328055|FG012|Overall Study|Protocol Violation|1|||
164262257|NCT02692040|593328056|FG013|Overall Study|Protocol Violation|0|||
164262258|NCT02692040|593328057|FG014|Overall Study|Protocol Violation|0|||
164262259|NCT02692040|593328058|FG015|Overall Study|Protocol Violation|0|||
164262260|NCT02692040|593328059|FG016|Overall Study|Protocol Violation|0|||
164262261|NCT02692040|593328043|FG000|Overall Study|Adverse Event|0|||
164262262|NCT02692040|593328044|FG001|Overall Study|Adverse Event|0|||
164262263|NCT02692040|593328045|FG002|Overall Study|Adverse Event|0|||
164262264|NCT02692040|593328046|FG003|Overall Study|Adverse Event|0|||
164262265|NCT02692040|593328047|FG004|Overall Study|Adverse Event|0|||
164262266|NCT02692040|593328048|FG005|Overall Study|Adverse Event|0|||
164262267|NCT02692040|593328049|FG006|Overall Study|Adverse Event|0|||
164262268|NCT02692040|593328050|FG007|Overall Study|Adverse Event|0|||
164262269|NCT02692040|593328051|FG008|Overall Study|Adverse Event|0|||
164262270|NCT02692040|593328052|FG009|Overall Study|Adverse Event|0|||
164262271|NCT02692040|593328053|FG010|Overall Study|Adverse Event|0|||
164262272|NCT02692040|593328054|FG011|Overall Study|Adverse Event|0|||
164262273|NCT02692040|593328055|FG012|Overall Study|Adverse Event|0|||
164262274|NCT02692040|593328056|FG013|Overall Study|Adverse Event|3|||
164262275|NCT02692040|593328057|FG014|Overall Study|Adverse Event|1|||
164262276|NCT02692040|593328058|FG015|Overall Study|Adverse Event|1|||
164262277|NCT02692040|593328059|FG016|Overall Study|Adverse Event|0|||
164262278|NCT01819129|593328065|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
164262279|NCT01819129|593328066|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
164262280|NCT01819129|593328065|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
164262281|NCT01819129|593328066|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
164262282|NCT01819129|593328065|FG000|Overall Study|Other, Subject moved out of the country|0|||
164262283|NCT01819129|593328066|FG001|Overall Study|Other, Subject moved out of the country|1|||
164262284|NCT01819129|593328065|FG000|Overall Study|Withdrawal by Subject|15|||
164262285|NCT01819129|593328066|FG001|Overall Study|Withdrawal by Subject|15|||
164262286|NCT01819129|593328065|FG000|Overall Study|Lost to Follow-up|5|||
164262287|NCT01819129|593328066|FG001|Overall Study|Lost to Follow-up|2|||
164262288|NCT01819129|593328065|FG000|Overall Study|Lack of Efficacy|0|||
164262289|NCT01819129|593328066|FG001|Overall Study|Lack of Efficacy|1|||
164262290|NCT01819129|593328065|FG000|Overall Study|Adverse Event|1|||
164262291|NCT01819129|593328066|FG001|Overall Study|Adverse Event|4|||
164262292|NCT01819129|593328065|FG000|Overall Study|Death|1|||
164262293|NCT01819129|593328066|FG001|Overall Study|Death|1|||
164262294|NCT01819129|593328065|FG000|Overall Study|Withdrawal Criteria|20|||
164262295|NCT01819129|593328066|FG001|Overall Study|Withdrawal Criteria|15|||
164262296|NCT02752958|593328068|FG000|Overall Study|Adverse Event|3|||
164262297|NCT02752958|593328068|FG000|Overall Study|Lost to Follow-up|1|||
164262298|NCT02752958|593328068|FG000|Overall Study|Protocol Violation|1|||
164262299|NCT02752958|593328068|FG000|Overall Study|Withdrawal by Subject|2|||
164262300|NCT02752958|593328068|FG000|Overall Study|Other (Reason not specified)|2|||
164262301|NCT00054691|593328071|FG000|Overall Study|Unmeasurable Disease|2|||
164262302|NCT00054691|593328071|FG000|Overall Study|Noncompliant|1|||
164262303|NCT02836873|593328072|FG000|Overall Study|Protocol Violation|0|||
164262304|NCT02836873|593328073|FG001|Overall Study|Protocol Violation|1|||
164262305|NCT02836873|593328072|FG000|Overall Study|Adverse Event|1|||
164262306|NCT02836873|593328073|FG001|Overall Study|Adverse Event|4|||
164262307|NCT02836873|593328072|FG000|Overall Study|Withdrawal by Subject|2|||
164262308|NCT02836873|593328073|FG001|Overall Study|Withdrawal by Subject|2|||
164262309|NCT02836873|593328072|FG000|Overall Study|Lost to Follow-up|1|||
164262310|NCT02836873|593328073|FG001|Overall Study|Lost to Follow-up|3|||
164262311|NCT02836873|593328072|FG000|Overall Study|Physician Decision|0|||
164262312|NCT02836873|593328073|FG001|Overall Study|Physician Decision|1|||
164262313|NCT02836873|593328072|FG000|Overall Study|Other|1|||
164262314|NCT02836873|593328073|FG001|Overall Study|Other|0|||
164262315|NCT00853125|593328076|FG000|Overall Study|Study participant's donor was CMV +|1|||
164262316|NCT02914548|593328077|FG000|Overall Study|Adverse Event|15|||
164262317|NCT02914548|593328078|FG001|Overall Study|Adverse Event|7|||
164262318|NCT02914548|593328079|FG002|Overall Study|Adverse Event|15|||
164262319|NCT02914548|593328077|FG000|Overall Study|Physician Decision|2|||
164262320|NCT02914548|593328078|FG001|Overall Study|Physician Decision|2|||
164262321|NCT02914548|593328079|FG002|Overall Study|Physician Decision|0|||
164262322|NCT02914548|593328077|FG000|Overall Study|Protocol Violation|1|||
164262323|NCT02914548|593328078|FG001|Overall Study|Protocol Violation|0|||
164262324|NCT02914548|593328079|FG002|Overall Study|Protocol Violation|0|||
164262325|NCT02914548|593328077|FG000|Overall Study|Withdrawal by Subject|3|||
164262326|NCT02914548|593328078|FG001|Overall Study|Withdrawal by Subject|4|||
164262327|NCT02914548|593328079|FG002|Overall Study|Withdrawal by Subject|4|||
164262328|NCT02914548|593328077|FG000|Overall Study|>40% of body surface area|0|||
164262329|NCT02914548|593328078|FG001|Overall Study|>40% of body surface area|1|||
164262330|NCT02914548|593328079|FG002|Overall Study|>40% of body surface area|1|||
164262331|NCT03746600|593328085|FG000|Overall Study|Withdrawal by Subject|3|||
164262332|NCT03746600|593328086|FG001|Overall Study|Withdrawal by Subject|3|||
164262333|NCT03746600|593328085|FG000|Overall Study|dismissed from study|1|||
164262334|NCT03746600|593328086|FG001|Overall Study|dismissed from study|0|||
164262335|NCT03746600|593328085|FG000|Overall Study|Lost to Follow-up|1|||
164262336|NCT03746600|593328086|FG001|Overall Study|Lost to Follow-up|0|||
164262337|NCT03023826|593328087|FG000|Period 1|Withdrawal by Subject|0|||
164262338|NCT03023826|593328088|FG001|Period 1|Withdrawal by Subject|0|||
164262339|NCT03023826|593328089|FG002|Period 1|Withdrawal by Subject|0|||
164262340|NCT03023826|593328090|FG003|Period 1|Withdrawal by Subject|0|||
164429728|NCT00269399|593943404|FG001|Overall Study|Withdrawal by Subject|5|||
164429729|NCT00269399|593943403|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
164429730|NCT00269399|593943404|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
164429731|NCT00269399|593943403|FG000|Overall Study|Other|0|||
164429732|NCT00269399|593943404|FG001|Overall Study|Other|4|||
164429733|NCT00269399|593943403|FG000|Overall Study|Development of exclusion criteria|0|||
164429734|NCT00269399|593943404|FG001|Overall Study|Development of exclusion criteria|1|||
164429735|NCT03439124|593943405|FG000|Overall Study|Adverse Event|2|||
164262341|NCT03023826|593328091|FG004|Period 1|Withdrawal by Subject|1|||
164262342|NCT03023826|593328092|FG005|Period 1|Withdrawal by Subject|0|||
164262343|NCT00977938|593328098|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
164262344|NCT00977938|593328099|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
164262345|NCT00977938|593328100|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
164262346|NCT00977938|593328101|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
164429736|NCT03439124|593943406|FG001|Overall Study|Adverse Event|0|||
164262347|NCT00977938|593328098|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
164262348|NCT00977938|593328099|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
164262349|NCT00977938|593328100|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
164262350|NCT00977938|593328101|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
164262351|NCT00977938|593328098|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
164262352|NCT00977938|593328099|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
164262353|NCT00977938|593328100|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
164262354|NCT00977938|593328101|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
164262355|NCT00977938|593328098|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
164262356|NCT00977938|593328099|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
164262357|NCT00977938|593328100|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
164262358|NCT00977938|593328101|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
164262359|NCT00977938|593328098|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
164262360|NCT00977938|593328099|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
164262361|NCT00977938|593328100|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
164262362|NCT00977938|593328101|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
164262363|NCT00977938|593328098|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
164262364|NCT00977938|593328099|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
164262365|NCT00977938|593328100|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
164262366|NCT00977938|593328101|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
164262367|NCT02142283|593328105|FG000|Overall Study|Death|20|||
164262368|NCT02142283|593328106|FG001|Overall Study|Death|18|||
164262369|NCT02142283|593328105|FG000|Overall Study|Withdrawal by Subject|1|||
164262370|NCT02142283|593328106|FG001|Overall Study|Withdrawal by Subject|3|||
164262371|NCT02460783|593328107|FG000|Overall Study|Withdrawal by Subject|1|||
164262372|NCT02460783|593328108|FG001|Overall Study|Withdrawal by Subject|3|||
164262373|NCT02460783|593328107|FG000|Overall Study|Lost to Follow-up|1|||
164262374|NCT02460783|593328108|FG001|Overall Study|Lost to Follow-up|1|||
164262375|NCT01484834|593328109|FG000|Overall Study|Lost to Follow-up|5|||
164262376|NCT01484834|593328110|FG001|Overall Study|Lost to Follow-up|8|||
164262377|NCT01484834|593328111|FG002|Overall Study|Lost to Follow-up|1|||
164262378|NCT01484834|593328112|FG003|Overall Study|Lost to Follow-up|4|||
164262379|NCT00747344|593328113|FG000|Controlled Period|Adverse Event|3|||
164262380|NCT00747344|593328114|FG001|Controlled Period|Adverse Event|0|||
164262381|NCT00747344|593328115|FG002|Controlled Period|Adverse Event|0|||
164262382|NCT00747344|593328116|FG003|Controlled Period|Adverse Event|0|||
164262383|NCT00747344|593328113|FG000|Controlled Period|Lack of Efficacy|2|||
164262384|NCT00747344|593328114|FG001|Controlled Period|Lack of Efficacy|1|||
164262385|NCT00747344|593328115|FG002|Controlled Period|Lack of Efficacy|0|||
164262386|NCT00747344|593328116|FG003|Controlled Period|Lack of Efficacy|0|||
164262387|NCT00747344|593328113|FG000|Controlled Period|Other|0|||
164262388|NCT00747344|593328114|FG001|Controlled Period|Other|3|||
164262389|NCT00747344|593328115|FG002|Controlled Period|Other|0|||
164262390|NCT00747344|593328116|FG003|Controlled Period|Other|0|||
164262391|NCT00747344|593328113|FG000|After Controlled Period|Adverse Event|0|||
164262392|NCT00747344|593328114|FG001|After Controlled Period|Adverse Event|0|||
164262393|NCT00747344|593328115|FG002|After Controlled Period|Adverse Event|0|||
164262394|NCT00747344|593328116|FG003|After Controlled Period|Adverse Event|1|||
164262395|NCT01371643|593328117|FG000|Overall Study|Withdrawal by Subject|3|||
164262396|NCT01371643|593328118|FG001|Overall Study|Withdrawal by Subject|0|||
164262397|NCT02374814|593328122|FG000|Overall Study|Lost to Follow-up|1|||
164262398|NCT02374814|593328123|FG001|Overall Study|Lost to Follow-up|1|||
164262399|NCT02374814|593328124|FG002|Overall Study|Lost to Follow-up|0|||
164429737|NCT03439124|593943405|FG000|Overall Study|Lost to Follow-up|1|||
164429738|NCT03439124|593943406|FG001|Overall Study|Lost to Follow-up|0|||
164429739|NCT03439124|593943405|FG000|Overall Study|Other reasons|1|||
164429740|NCT03439124|593943406|FG001|Overall Study|Other reasons|0|||
164262400|NCT02374814|593328125|FG003|Overall Study|Lost to Follow-up|1|||
164262401|NCT02374814|593328126|FG004|Overall Study|Lost to Follow-up|0|||
164262402|NCT02374814|593328127|FG005|Overall Study|Lost to Follow-up|0|||
164262403|NCT02374814|593328122|FG000|Overall Study|Withdrawal by Subject|0|||
164262404|NCT02374814|593328123|FG001|Overall Study|Withdrawal by Subject|0|||
164262405|NCT02374814|593328124|FG002|Overall Study|Withdrawal by Subject|1|||
164429741|NCT04353037|593943407|FG000|Overall Study|Lost to Follow-up|0|||
164429742|NCT04353037|593943408|FG001|Overall Study|Lost to Follow-up|1|||
164429743|NCT04353037|593943409|FG002|Overall Study|Lost to Follow-up|2|||
164262406|NCT02374814|593328125|FG003|Overall Study|Withdrawal by Subject|1|||
164262407|NCT02374814|593328126|FG004|Overall Study|Withdrawal by Subject|0|||
164262408|NCT02374814|593328127|FG005|Overall Study|Withdrawal by Subject|0|||
164262409|NCT00884039|593328128|FG000|Overall Study|Withdrawal by Subject|0|||
164429744|NCT04353037|593943410|FG003|Overall Study|Lost to Follow-up|3|||
164262410|NCT00884039|593328129|FG001|Overall Study|Withdrawal by Subject|1|||
164262411|NCT00884039|593328128|FG000|Overall Study|Lack of Efficacy|2|||
164262412|NCT00884039|593328129|FG001|Overall Study|Lack of Efficacy|0|||
164262413|NCT02182440|593328136|FG000|Overall Study|Adverse Event|0|||
164262414|NCT02182440|593328137|FG001|Overall Study|Adverse Event|1|||
164262415|NCT02182440|593328138|FG002|Overall Study|Adverse Event|0|||
164262416|NCT02182440|593328139|FG003|Overall Study|Adverse Event|0|||
164262417|NCT02182440|593328136|FG000|Overall Study|Death|31|||
164262418|NCT02182440|593328137|FG001|Overall Study|Death|8|||
164262419|NCT02182440|593328138|FG002|Overall Study|Death|5|||
164262420|NCT02182440|593328139|FG003|Overall Study|Death|16|||
164262421|NCT02182440|593328136|FG000|Overall Study|Protocol Violation|0|||
164262422|NCT02182440|593328137|FG001|Overall Study|Protocol Violation|1|||
164262423|NCT02182440|593328138|FG002|Overall Study|Protocol Violation|0|||
164262424|NCT02182440|593328139|FG003|Overall Study|Protocol Violation|0|||
164262425|NCT02182440|593328136|FG000|Overall Study|Physician Decision|1|||
164262426|NCT02182440|593328137|FG001|Overall Study|Physician Decision|0|||
164262427|NCT02182440|593328138|FG002|Overall Study|Physician Decision|0|||
164262428|NCT02182440|593328139|FG003|Overall Study|Physician Decision|0|||
164262429|NCT02182440|593328136|FG000|Overall Study|Withdrawal by Subject|1|||
164262430|NCT02182440|593328137|FG001|Overall Study|Withdrawal by Subject|1|||
164262431|NCT02182440|593328138|FG002|Overall Study|Withdrawal by Subject|3|||
164262432|NCT02182440|593328139|FG003|Overall Study|Withdrawal by Subject|4|||
164262433|NCT02182440|593328136|FG000|Overall Study|different, e.g adm other hospital|12|||
164262434|NCT02182440|593328137|FG001|Overall Study|different, e.g adm other hospital|3|||
164262435|NCT02182440|593328138|FG002|Overall Study|different, e.g adm other hospital|3|||
164262436|NCT02182440|593328139|FG003|Overall Study|different, e.g adm other hospital|10|||
164262437|NCT03754582|593328140|FG000|Treatment Phase|Adverse Event|0|||
164262438|NCT03754582|593328141|FG001|Treatment Phase|Adverse Event|1|||
164262439|NCT03754582|593328142|FG002|Treatment Phase|Adverse Event|0|||
164262440|NCT03754582|593328140|FG000|Follow-up Phase|Other|0|||
164262441|NCT03754582|593328141|FG001|Follow-up Phase|Other|0|||
164262442|NCT03754582|593328142|FG002|Follow-up Phase|Other|1|||
164262443|NCT00072293|593328145|FG000|Overall Study|Lost to Follow-up|1|||
164262444|NCT00072293|593328146|FG001|Overall Study|Lost to Follow-up|1|||
164262445|NCT00072293|593328145|FG000|Overall Study|Withdrawal by Subject|0|||
164262446|NCT00072293|593328146|FG001|Overall Study|Withdrawal by Subject|1|||
164262447|NCT01561755|593328147|FG000|Overall Study|Lost to Follow-up|0|||
164262448|NCT01561755|593328148|FG001|Overall Study|Lost to Follow-up|1|||
164262449|NCT01166958|593328149|FG000|Overall Study|Withdrawal by Subject|1|||
164262450|NCT01166958|593328150|FG001|Overall Study|Withdrawal by Subject|0|||
164262451|NCT01605227|593328151|FG000|Overall Study|Did not receive study treatment|2|||
164262452|NCT01605227|593328152|FG001|Overall Study|Did not receive study treatment|3|||
164262453|NCT01605227|593328151|FG000|Overall Study|Adverse Event|228|||
164262454|NCT01605227|593328152|FG001|Overall Study|Adverse Event|42|||
164262455|NCT01605227|593328151|FG000|Overall Study|Progressive Disease|132|||
164262456|NCT01605227|593328152|FG001|Overall Study|Progressive Disease|128|||
164262457|NCT01605227|593328151|FG000|Overall Study|Clinical Deterioration|227|||
164262458|NCT01605227|593328152|FG001|Overall Study|Clinical Deterioration|133|||
164262459|NCT01605227|593328151|FG000|Overall Study|Lost to Follow-up|1|||
164262460|NCT01605227|593328152|FG001|Overall Study|Lost to Follow-up|0|||
164262461|NCT01605227|593328151|FG000|Overall Study|Protocol Violation|1|||
164262462|NCT01605227|593328152|FG001|Overall Study|Protocol Violation|0|||
164262463|NCT01605227|593328151|FG000|Overall Study|Physician Decision|9|||
164262464|NCT01605227|593328152|FG001|Overall Study|Physician Decision|7|||
164262465|NCT01605227|593328151|FG000|Overall Study|Withdrawal by Subject|18|||
164340824|NCT01752985|593622347|FG002|Treatment Period|Lost to Follow-up|1|||
164340825|NCT01516437|593623785|FG000|Overall Study|Reason not specified|0|||
164340826|NCT01516437|593623786|FG001|Overall Study|Reason not specified|0|||
164577558|NCT03185130|594479329|FG001|Overall Study|Withdrawal by Subject|2|||
164577559|NCT02286960|594479330|FG000|Overall Study|Lost to Follow-up|3|||
164577560|NCT02286960|594479331|FG001|Overall Study|Lost to Follow-up|3|||
164577561|NCT00500071|594479338|FG000|Screening and Washout Phase|Protocol Violation|1|||
164577562|NCT00500071|594479338|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
164577563|NCT00500071|594479338|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
164577564|NCT00500071|594479338|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
164577565|NCT00500071|594479338|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
164262466|NCT01605227|593328152|FG001|Overall Study|Withdrawal by Subject|14|||
164340827|NCT01516437|593623787|FG002|Overall Study|Reason not specified|1|||
164340828|NCT01516437|593623788|FG003|Overall Study|Reason not specified|1|||
164340829|NCT02025621|593623789|FG000|Overall Study|Withdrawal by Subject|1|||
164262467|NCT01605227|593328151|FG000|Overall Study|Sponsor Decision|2|||
164262468|NCT01605227|593328152|FG001|Overall Study|Sponsor Decision|0|||
164262469|NCT01605227|593328151|FG000|Overall Study|Started New Therapy|1|||
164262470|NCT01605227|593328152|FG001|Overall Study|Started New Therapy|0|||
164262471|NCT01605227|593328151|FG000|Overall Study|Subject Decision|0|||
164262472|NCT01605227|593328152|FG001|Overall Study|Subject Decision|1|||
164262473|NCT01605227|593328151|FG000|Overall Study|Dose Held >6 weeks|0|||
164262474|NCT01605227|593328152|FG001|Overall Study|Dose Held >6 weeks|1|||
164577566|NCT00500071|594479338|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
164262475|NCT02847858|593328153|FG000|Overall Study|Lost to Follow-up|401|||
164262476|NCT02847858|593328154|FG001|Overall Study|Lost to Follow-up|269|||
164262477|NCT00624819|593328155|FG000|Follow-up Period: Year 4|Parents decision|0|||
164262478|NCT00624819|593328156|FG001|Follow-up Period: Year 4|Parents decision|0|||
164262479|NCT00624819|593328157|FG002|Follow-up Period: Year 4|Parents decision|1|||
164262480|NCT00624819|593328158|FG003|Follow-up Period: Year 4|Parents decision|0|||
164262481|NCT00624819|593328155|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
164262482|NCT00624819|593328156|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
164262483|NCT00624819|593328157|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
164262484|NCT00624819|593328158|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
164262485|NCT02826421|593328161|FG000|Overall Study|Adverse Event|1|||
164262486|NCT02826421|593328162|FG001|Overall Study|Adverse Event|0|||
164262487|NCT02826421|593328163|FG002|Overall Study|Adverse Event|0|||
164262488|NCT02826421|593328164|FG003|Overall Study|Adverse Event|1|||
164262489|NCT02826421|593328161|FG000|Overall Study|Withdrawal by Subject|1|||
164262490|NCT02826421|593328162|FG001|Overall Study|Withdrawal by Subject|3|||
164262491|NCT02826421|593328163|FG002|Overall Study|Withdrawal by Subject|1|||
164262492|NCT02826421|593328164|FG003|Overall Study|Withdrawal by Subject|1|||
164262493|NCT02826421|593328161|FG000|Overall Study|Reason not given|1|||
164262494|NCT02826421|593328162|FG001|Overall Study|Reason not given|0|||
164262495|NCT02826421|593328163|FG002|Overall Study|Reason not given|1|||
164262496|NCT02826421|593328164|FG003|Overall Study|Reason not given|0|||
164262497|NCT02210221|593328167|FG000|Overall Study|Lack of Efficacy|7|||
164262498|NCT02210221|593328167|FG000|Overall Study|Withdrawal by Subject|43|||
164262499|NCT00405964|593328170|FG000|Overall Study|Treatment Failure|17|||
164262500|NCT00405964|593328171|FG001|Overall Study|Treatment Failure|45|||
164262501|NCT00405964|593328170|FG000|Overall Study|Adverse Event|7|||
164262502|NCT00405964|593328171|FG001|Overall Study|Adverse Event|16|||
164262503|NCT00405964|593328170|FG000|Overall Study|Lost to Follow-up|5|||
164262504|NCT00405964|593328171|FG001|Overall Study|Lost to Follow-up|5|||
164262505|NCT00405964|593328170|FG000|Overall Study|Withdrawal by Subject|19|||
164262506|NCT00405964|593328171|FG001|Overall Study|Withdrawal by Subject|23|||
164262507|NCT00405964|593328170|FG000|Overall Study|Protocol Violation|11|||
164262508|NCT00405964|593328171|FG001|Overall Study|Protocol Violation|6|||
164262509|NCT05291936|593328172|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
164262510|NCT05291936|593328173|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
164262511|NCT05291936|593328172|FG000|Period 1|Withdrew Consent during study|1|||
164262512|NCT05291936|593328173|FG001|Period 1|Withdrew Consent during study|0|||
164262513|NCT05291936|593328172|FG000|Period 2|Adverse Event|0|||
164262514|NCT05291936|593328173|FG001|Period 2|Adverse Event|1|||
164262515|NCT05291936|593328172|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
164262516|NCT05291936|593328173|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
164262517|NCT00391391|593328174|FG000|Overall Study|Adverse Event|0|||
164262518|NCT00391391|593328175|FG001|Overall Study|Adverse Event|0|||
164262519|NCT00391391|593328176|FG002|Overall Study|Adverse Event|0|||
164262520|NCT00391391|593328177|FG003|Overall Study|Adverse Event|1|||
164262521|NCT00391391|593328174|FG000|Overall Study|Lost to Follow-up|1|||
164262522|NCT00391391|593328175|FG001|Overall Study|Lost to Follow-up|3|||
164262523|NCT00391391|593328176|FG002|Overall Study|Lost to Follow-up|7|||
164262524|NCT00391391|593328177|FG003|Overall Study|Lost to Follow-up|4|||
164262525|NCT00391391|593328174|FG000|Overall Study|Protocol Violation|2|||
164262526|NCT00391391|593328175|FG001|Overall Study|Protocol Violation|3|||
164262527|NCT00391391|593328176|FG002|Overall Study|Protocol Violation|6|||
164262528|NCT00391391|593328177|FG003|Overall Study|Protocol Violation|7|||
164262529|NCT00391391|593328174|FG000|Overall Study|Withdrawal by Subject|6|||
164262530|NCT00391391|593328175|FG001|Overall Study|Withdrawal by Subject|4|||
164262531|NCT00391391|593328176|FG002|Overall Study|Withdrawal by Subject|10|||
164262532|NCT00391391|593328177|FG003|Overall Study|Withdrawal by Subject|7|||
164262533|NCT01300819|593328178|FG000|Overall Study|Adverse Event|9|||
164262534|NCT01300819|593328179|FG001|Overall Study|Adverse Event|27|||
164340830|NCT02025621|593623790|FG001|Overall Study|Withdrawal by Subject|0|||
164340831|NCT02025621|593623789|FG000|Overall Study|Death|0|||
164340832|NCT02025621|593623790|FG001|Overall Study|Death|1|||
164262535|NCT01300819|593328178|FG000|Overall Study|Lack of Efficacy|2|||
164262536|NCT01300819|593328179|FG001|Overall Study|Lack of Efficacy|1|||
164262537|NCT01300819|593328178|FG000|Overall Study|Withdrawal by Subject|10|||
164262538|NCT01300819|593328179|FG001|Overall Study|Withdrawal by Subject|12|||
164262539|NCT01300819|593328178|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
164262540|NCT01300819|593328179|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
164262541|NCT01300819|593328178|FG000|Overall Study|Refusal to down titrate study drug|0|||
164262542|NCT01300819|593328179|FG001|Overall Study|Refusal to down titrate study drug|1|||
164262543|NCT01300819|593328178|FG000|Overall Study|Administrative reason|0|||
164262544|NCT01300819|593328179|FG001|Overall Study|Administrative reason|1|||
164262545|NCT01300819|593328178|FG000|Overall Study|Safety follow up not done by mistake|0|||
164262546|NCT01300819|593328179|FG001|Overall Study|Safety follow up not done by mistake|1|||
164340833|NCT02025621|593623789|FG000|Overall Study|No longer eligible|10|||
164340834|NCT02025621|593623790|FG001|Overall Study|No longer eligible|15|||
164262547|NCT01300819|593328178|FG000|Overall Study|Follow up call was not done|1|||
164262548|NCT01300819|593328179|FG001|Overall Study|Follow up call was not done|0|||
164262549|NCT02649855|593328180|FG000|Overall Study|Refused further treatment|2|||
164262550|NCT02649855|593328181|FG001|Overall Study|Refused further treatment|1|||
164262551|NCT02649855|593328182|FG002|Overall Study|Refused further treatment|1|||
164262552|NCT02649855|593328180|FG000|Overall Study|Withdrew consent|0|||
164262553|NCT02649855|593328181|FG001|Overall Study|Withdrew consent|1|||
164262554|NCT02649855|593328182|FG002|Overall Study|Withdrew consent|0|||
164262555|NCT02649855|593328180|FG000|Overall Study|Switched to alternative treatment|0|||
164262556|NCT02649855|593328181|FG001|Overall Study|Switched to alternative treatment|1|||
164262557|NCT02649855|593328182|FG002|Overall Study|Switched to alternative treatment|1|||
164262558|NCT02649855|593328180|FG000|Overall Study|Principal investigator discretion|0|||
164262559|NCT02649855|593328181|FG001|Overall Study|Principal investigator discretion|1|||
164262560|NCT02649855|593328182|FG002|Overall Study|Principal investigator discretion|1|||
164262561|NCT02649855|593328180|FG000|Overall Study|No treatment, per protocol|1|||
164262562|NCT02649855|593328181|FG001|Overall Study|No treatment, per protocol|0|||
164262563|NCT02649855|593328182|FG002|Overall Study|No treatment, per protocol|0|||
164262564|NCT02649855|593328180|FG000|Overall Study|Initiate new treatment|1|||
164262565|NCT02649855|593328181|FG001|Overall Study|Initiate new treatment|0|||
164262566|NCT02649855|593328182|FG002|Overall Study|Initiate new treatment|0|||
164262567|NCT00428220|593330215|FG000|Overall Study|Participant died|8|||
164262568|NCT00428220|593330215|FG000|Overall Study|Global deterioration of health status|7|||
164262569|NCT00428220|593330215|FG000|Overall Study|Lost to Follow-up|4|||
164262570|NCT00428220|593330215|FG000|Overall Study|Objective progression or relapse|123|||
164262571|NCT00428220|593330215|FG000|Overall Study|Participant refused continued treatment|7|||
164262572|NCT00428220|593330215|FG000|Overall Study|Adverse Event|51|||
164262573|NCT00428220|593330215|FG000|Overall Study|Other|23|||
164262574|NCT03131596|593330218|FG000|Overall Study|Protocol Violation|3|||
164262575|NCT03131596|593330219|FG001|Overall Study|Protocol Violation|3|||
164262576|NCT03131596|593330218|FG000|Overall Study|Lost to Follow-up|3|||
164262577|NCT03131596|593330219|FG001|Overall Study|Lost to Follow-up|0|||
164262578|NCT00734071|593330220|FG000|Overall Study|Adverse Event|4|||
164262579|NCT00734071|593330221|FG001|Overall Study|Adverse Event|3|||
164262580|NCT00734071|593330220|FG000|Overall Study|Lack of Efficacy|3|||
164262581|NCT00734071|593330221|FG001|Overall Study|Lack of Efficacy|1|||
164262582|NCT00734071|593330220|FG000|Overall Study|Noncompliance|2|||
164262583|NCT00734071|593330221|FG001|Overall Study|Noncompliance|2|||
164262584|NCT00734071|593330220|FG000|Overall Study|Protocol Deviations|3|||
164262585|NCT00734071|593330221|FG001|Overall Study|Protocol Deviations|4|||
164262586|NCT00734071|593330220|FG000|Overall Study|Voluntary Withdrawal|9|||
164262587|NCT00734071|593330221|FG001|Overall Study|Voluntary Withdrawal|7|||
164262588|NCT00734071|593330220|FG000|Overall Study|Lost to Follow-up|16|||
164262589|NCT00734071|593330221|FG001|Overall Study|Lost to Follow-up|8|||
164262590|NCT00734071|593330220|FG000|Overall Study|Other|1|||
164262591|NCT00734071|593330221|FG001|Overall Study|Other|2|||
164262592|NCT03654885|593330222|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
164262593|NCT03654885|593330223|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
164262594|NCT03654885|593330222|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
164262595|NCT03654885|593330223|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
164262596|NCT03654885|593330222|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
164262597|NCT03654885|593330223|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
164262598|NCT03654885|593330222|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
164262599|NCT03654885|593330223|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
164262600|NCT03654885|593330222|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
164262601|NCT03654885|593330223|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
164262602|NCT03654885|593330222|FG000|Overall Study|Adverse Event in Study Eye|3|||
164262603|NCT03654885|593330223|FG001|Overall Study|Adverse Event in Study Eye|0|||
164262604|NCT03654885|593330222|FG000|Overall Study|Consent Withdrawn|1|||
164262605|NCT03654885|593330223|FG001|Overall Study|Consent Withdrawn|0|||
164262606|NCT03654885|593330222|FG000|Overall Study|Death|3|||
164262607|NCT03654885|593330223|FG001|Overall Study|Death|1|||
164262608|NCT03654885|593330222|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
164262609|NCT03654885|593330223|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
164262610|NCT03654885|593330222|FG000|Overall Study|Lost to Follow-up|3|||
164262611|NCT03654885|593330223|FG001|Overall Study|Lost to Follow-up|3|||
164262612|NCT05275582|593330224|FG000|Overall Study|Lost to Follow-up|1|||
164262613|NCT05275582|593330225|FG001|Overall Study|Lost to Follow-up|0|||
164262614|NCT05275582|593330224|FG000|Overall Study|Withdrawal by Subject|0|||
164262615|NCT05275582|593330225|FG001|Overall Study|Withdrawal by Subject|2|||
164262616|NCT05275582|593330224|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
164262617|NCT05275582|593330225|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
164262618|NCT05275582|593330224|FG000|Overall Study|Death|1|||
164262619|NCT05275582|593330225|FG001|Overall Study|Death|0|||
164262620|NCT05275582|593330224|FG000|Overall Study|Protocol Violation|1|||
164262621|NCT05275582|593330225|FG001|Overall Study|Protocol Violation|0|||
164262622|NCT00549900|593330227|FG000|Overall Study|Adverse Event|1|||
164262623|NCT01176565|593330235|FG000|Overall Study|Lost to Follow-up|12|||
164262624|NCT01176565|593330236|FG001|Overall Study|Lost to Follow-up|16|||
164262625|NCT01176565|593330235|FG000|Overall Study|Withdrawal by Subject|7|||
164262626|NCT01176565|593330236|FG001|Overall Study|Withdrawal by Subject|1|||
164262627|NCT01176565|593330235|FG000|Overall Study|Not Analyzed (any other reason)|1|||
164262628|NCT01176565|593330236|FG001|Overall Study|Not Analyzed (any other reason)|2|||
164262629|NCT02754141|593330237|FG000|Overall Study|Disease progression|11|||
164262630|NCT02754141|593330238|FG001|Overall Study|Disease progression|7|||
164262631|NCT02754141|593330239|FG002|Overall Study|Disease progression|8|||
164262632|NCT02754141|593330240|FG003|Overall Study|Disease progression|5|||
164262633|NCT02754141|593330241|FG004|Overall Study|Disease progression|7|||
164262634|NCT02754141|593330242|FG005|Overall Study|Disease progression|7|||
164262635|NCT02754141|593330243|FG006|Overall Study|Disease progression|7|||
164262636|NCT02754141|593330244|FG007|Overall Study|Disease progression|6|||
164262637|NCT02754141|593330245|FG008|Overall Study|Disease progression|11|||
164262638|NCT02754141|593330246|FG009|Overall Study|Disease progression|16|||
164262639|NCT02754141|593330247|FG010|Overall Study|Disease progression|18|||
164262640|NCT02754141|593330248|FG011|Overall Study|Disease progression|13|||
164262641|NCT02754141|593330249|FG012|Overall Study|Disease progression|10|||
164262642|NCT02754141|593330250|FG013|Overall Study|Disease progression|12|||
164262643|NCT02754141|593330251|FG014|Overall Study|Disease progression|12|||
164262644|NCT02754141|593330252|FG015|Overall Study|Disease progression|14|||
164262645|NCT02754141|593330253|FG016|Overall Study|Disease progression|0|||
164262646|NCT02754141|593330254|FG017|Overall Study|Disease progression|1|||
164262647|NCT02754141|593330237|FG000|Overall Study|Study drug toxicity|1|||
164262648|NCT02754141|593330238|FG001|Overall Study|Study drug toxicity|1|||
164262649|NCT02754141|593330239|FG002|Overall Study|Study drug toxicity|0|||
164262650|NCT02754141|593330240|FG003|Overall Study|Study drug toxicity|0|||
164262651|NCT02754141|593330241|FG004|Overall Study|Study drug toxicity|0|||
164262652|NCT02754141|593330242|FG005|Overall Study|Study drug toxicity|0|||
164262653|NCT02754141|593330243|FG006|Overall Study|Study drug toxicity|0|||
164262654|NCT02754141|593330244|FG007|Overall Study|Study drug toxicity|0|||
164262655|NCT02754141|593330245|FG008|Overall Study|Study drug toxicity|0|||
164262656|NCT02754141|593330246|FG009|Overall Study|Study drug toxicity|0|||
164262657|NCT02754141|593330247|FG010|Overall Study|Study drug toxicity|2|||
164262658|NCT02754141|593330248|FG011|Overall Study|Study drug toxicity|1|||
164262659|NCT02754141|593330249|FG012|Overall Study|Study drug toxicity|1|||
164262660|NCT02754141|593330250|FG013|Overall Study|Study drug toxicity|0|||
164262661|NCT02754141|593330251|FG014|Overall Study|Study drug toxicity|0|||
164262662|NCT02754141|593330252|FG015|Overall Study|Study drug toxicity|0|||
164262663|NCT02754141|593330253|FG016|Overall Study|Study drug toxicity|0|||
164262664|NCT02754141|593330254|FG017|Overall Study|Study drug toxicity|0|||
164262665|NCT02754141|593330237|FG000|Overall Study|AE unrelated to study drug|1|||
164262666|NCT02754141|593330238|FG001|Overall Study|AE unrelated to study drug|1|||
164262667|NCT02754141|593330239|FG002|Overall Study|AE unrelated to study drug|0|||
164262668|NCT02754141|593330240|FG003|Overall Study|AE unrelated to study drug|1|||
164262669|NCT02754141|593330241|FG004|Overall Study|AE unrelated to study drug|3|||
164262670|NCT02754141|593330242|FG005|Overall Study|AE unrelated to study drug|2|||
164262671|NCT02754141|593330243|FG006|Overall Study|AE unrelated to study drug|1|||
164262672|NCT02754141|593330244|FG007|Overall Study|AE unrelated to study drug|0|||
164262673|NCT02754141|593330245|FG008|Overall Study|AE unrelated to study drug|0|||
164262674|NCT02754141|593330246|FG009|Overall Study|AE unrelated to study drug|0|||
164262675|NCT02754141|593330247|FG010|Overall Study|AE unrelated to study drug|0|||
164262676|NCT02754141|593330248|FG011|Overall Study|AE unrelated to study drug|0|||
164262677|NCT02754141|593330249|FG012|Overall Study|AE unrelated to study drug|0|||
164262678|NCT02754141|593330250|FG013|Overall Study|AE unrelated to study drug|0|||
164262679|NCT02754141|593330251|FG014|Overall Study|AE unrelated to study drug|0|||
164262680|NCT02754141|593330252|FG015|Overall Study|AE unrelated to study drug|0|||
164262681|NCT02754141|593330253|FG016|Overall Study|AE unrelated to study drug|0|||
164262682|NCT02754141|593330254|FG017|Overall Study|AE unrelated to study drug|0|||
164262683|NCT02754141|593330237|FG000|Overall Study|Request to discontinue|0|||
164262684|NCT02754141|593330238|FG001|Overall Study|Request to discontinue|0|||
164262685|NCT02754141|593330239|FG002|Overall Study|Request to discontinue|0|||
164262686|NCT02754141|593330240|FG003|Overall Study|Request to discontinue|0|||
164262687|NCT02754141|593330241|FG004|Overall Study|Request to discontinue|0|||
164262688|NCT02754141|593330242|FG005|Overall Study|Request to discontinue|0|||
164262689|NCT02754141|593330243|FG006|Overall Study|Request to discontinue|0|||
164262690|NCT02754141|593330244|FG007|Overall Study|Request to discontinue|0|||
164262691|NCT02754141|593330245|FG008|Overall Study|Request to discontinue|1|||
164262692|NCT02754141|593330246|FG009|Overall Study|Request to discontinue|0|||
164262693|NCT02754141|593330247|FG010|Overall Study|Request to discontinue|0|||
164262694|NCT02754141|593330248|FG011|Overall Study|Request to discontinue|0|||
164262695|NCT02754141|593330249|FG012|Overall Study|Request to discontinue|0|||
164262696|NCT02754141|593330250|FG013|Overall Study|Request to discontinue|1|||
164262697|NCT02754141|593330251|FG014|Overall Study|Request to discontinue|1|||
164262698|NCT02754141|593330252|FG015|Overall Study|Request to discontinue|0|||
164262699|NCT02754141|593330253|FG016|Overall Study|Request to discontinue|0|||
164262700|NCT02754141|593330254|FG017|Overall Study|Request to discontinue|0|||
164262701|NCT02754141|593330237|FG000|Overall Study|Withdrew consent|0|||
164262702|NCT02754141|593330238|FG001|Overall Study|Withdrew consent|0|||
164262703|NCT02754141|593330239|FG002|Overall Study|Withdrew consent|0|||
164262704|NCT02754141|593330240|FG003|Overall Study|Withdrew consent|0|||
164262705|NCT02754141|593330241|FG004|Overall Study|Withdrew consent|0|||
164262706|NCT02754141|593330242|FG005|Overall Study|Withdrew consent|0|||
164262707|NCT02754141|593330243|FG006|Overall Study|Withdrew consent|0|||
164262708|NCT02754141|593330244|FG007|Overall Study|Withdrew consent|0|||
164262709|NCT02754141|593330245|FG008|Overall Study|Withdrew consent|0|||
164262710|NCT02754141|593330246|FG009|Overall Study|Withdrew consent|1|||
164262711|NCT02754141|593330247|FG010|Overall Study|Withdrew consent|0|||
164262712|NCT02754141|593330248|FG011|Overall Study|Withdrew consent|0|||
164262713|NCT02754141|593330249|FG012|Overall Study|Withdrew consent|0|||
164262714|NCT02754141|593330250|FG013|Overall Study|Withdrew consent|0|||
164262715|NCT02754141|593330251|FG014|Overall Study|Withdrew consent|0|||
164262716|NCT02754141|593330252|FG015|Overall Study|Withdrew consent|0|||
164262717|NCT02754141|593330253|FG016|Overall Study|Withdrew consent|0|||
164262718|NCT02754141|593330254|FG017|Overall Study|Withdrew consent|0|||
164262719|NCT02754141|593330237|FG000|Overall Study|Maximum clinical benefit|0|||
164262720|NCT02754141|593330238|FG001|Overall Study|Maximum clinical benefit|0|||
164262721|NCT02754141|593330239|FG002|Overall Study|Maximum clinical benefit|0|||
164262722|NCT02754141|593330240|FG003|Overall Study|Maximum clinical benefit|1|||
164262723|NCT02754141|593330241|FG004|Overall Study|Maximum clinical benefit|0|||
164262724|NCT02754141|593330242|FG005|Overall Study|Maximum clinical benefit|0|||
164262725|NCT02754141|593330243|FG006|Overall Study|Maximum clinical benefit|0|||
164262726|NCT02754141|593330244|FG007|Overall Study|Maximum clinical benefit|0|||
164262727|NCT02754141|593330245|FG008|Overall Study|Maximum clinical benefit|0|||
164262728|NCT02754141|593330246|FG009|Overall Study|Maximum clinical benefit|0|||
164262729|NCT02754141|593330247|FG010|Overall Study|Maximum clinical benefit|0|||
164262730|NCT02754141|593330248|FG011|Overall Study|Maximum clinical benefit|0|||
164681791|NCT02107196|594858192|FG000|12-week Treatment Period|Lost to Follow-up|3|||
164681792|NCT02107196|594858193|FG001|12-week Treatment Period|Lost to Follow-up|6|||
164681793|NCT02107196|594858192|FG000|12-week Treatment Period|Physician Decision|0|||
164681794|NCT02107196|594858193|FG001|12-week Treatment Period|Physician Decision|1|||
164681795|NCT02107196|594858192|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
164681796|NCT02107196|594858193|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
164681797|NCT02107196|594858192|FG000|12-week Treatment Period|Protocol Violation|7|||
164681798|NCT02107196|594858193|FG001|12-week Treatment Period|Protocol Violation|8|||
164681799|NCT02107196|594858192|FG000|12-week Treatment Period|Reason Missing|11|||
164681800|NCT02107196|594858193|FG001|12-week Treatment Period|Reason Missing|8|||
164681801|NCT02107196|594858192|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
164681802|NCT02107196|594858193|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
164681803|NCT02107196|594858192|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
164681804|NCT02107196|594858193|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
164681805|NCT02107196|594858192|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
164681806|NCT02107196|594858193|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
164681807|NCT02107196|594858192|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
164681808|NCT02107196|594858193|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
164681809|NCT02651987|594858196|FG000|Overall Study|Adverse Event|2|||
164681810|NCT02651987|594858197|FG001|Overall Study|Adverse Event|2|||
164681811|NCT02651987|594858196|FG000|Overall Study|Consent Withdrawn|2|||
164681812|NCT02651987|594858197|FG001|Overall Study|Consent Withdrawn|0|||
164681813|NCT02651987|594858196|FG000|Overall Study|Local PD|0|||
164681814|NCT02651987|594858197|FG001|Overall Study|Local PD|2|||
164681815|NCT02651987|594858196|FG000|Overall Study|Investigator Decision|1|||
164681816|NCT02651987|594858197|FG001|Overall Study|Investigator Decision|1|||
164681817|NCT01630616|594858198|FG000|Overall Study|Adverse Event|0|||
164262731|NCT02754141|593330249|FG012|Overall Study|Maximum clinical benefit|0|||
164262732|NCT02754141|593330250|FG013|Overall Study|Maximum clinical benefit|0|||
164262733|NCT02754141|593330251|FG014|Overall Study|Maximum clinical benefit|0|||
164262734|NCT02754141|593330252|FG015|Overall Study|Maximum clinical benefit|0|||
164262735|NCT02754141|593330253|FG016|Overall Study|Maximum clinical benefit|0|||
164262736|NCT02754141|593330254|FG017|Overall Study|Maximum clinical benefit|0|||
164262737|NCT02754141|593330237|FG000|Overall Study|No longer meets study criteria|0|||
164262738|NCT02754141|593330238|FG001|Overall Study|No longer meets study criteria|0|||
164681818|NCT01630616|594858199|FG001|Overall Study|Adverse Event|0|||
164681819|NCT01630616|594858200|FG002|Overall Study|Adverse Event|0|||
164681820|NCT01630616|594858201|FG003|Overall Study|Adverse Event|1|||
164262739|NCT02754141|593330239|FG002|Overall Study|No longer meets study criteria|0|||
164262740|NCT02754141|593330240|FG003|Overall Study|No longer meets study criteria|1|||
164429745|NCT04353037|593943407|FG000|Overall Study|Withdrawal by Subject|0|||
164429746|NCT04353037|593943408|FG001|Overall Study|Withdrawal by Subject|2|||
164429747|NCT04353037|593943409|FG002|Overall Study|Withdrawal by Subject|3|||
164429748|NCT04353037|593943410|FG003|Overall Study|Withdrawal by Subject|5|||
164429749|NCT04353037|593943407|FG000|Overall Study|Adverse Event|0|||
164429750|NCT04353037|593943408|FG001|Overall Study|Adverse Event|0|||
164429751|NCT04353037|593943409|FG002|Overall Study|Adverse Event|2|||
164429752|NCT04353037|593943410|FG003|Overall Study|Adverse Event|0|||
164429753|NCT04353037|593943407|FG000|Overall Study|Exposure Change|0|||
164429754|NCT04353037|593943408|FG001|Overall Study|Exposure Change|0|||
164429755|NCT04353037|593943409|FG002|Overall Study|Exposure Change|0|||
164429756|NCT04353037|593943410|FG003|Overall Study|Exposure Change|2|||
164429757|NCT03710564|593943411|FG000|Overall Study|Study Terminated by Sponsor|104|||
164429758|NCT03710564|593943412|FG001|Overall Study|Study Terminated by Sponsor|55|||
164429759|NCT03710564|593943411|FG000|Overall Study|Withdrawal by Subject|57|||
164429760|NCT03710564|593943412|FG001|Overall Study|Withdrawal by Subject|25|||
164429761|NCT03710564|593943411|FG000|Overall Study|Death|10|||
164429762|NCT03710564|593943412|FG001|Overall Study|Death|4|||
164429763|NCT03710564|593943411|FG000|Overall Study|Lost to Follow-up|5|||
164429764|NCT03710564|593943412|FG001|Overall Study|Lost to Follow-up|4|||
164429765|NCT03710564|593943411|FG000|Overall Study|Protocol Violation|3|||
164681821|NCT01630616|594858202|FG004|Overall Study|Adverse Event|0|||
164681822|NCT01630616|594858203|FG005|Overall Study|Adverse Event|0|||
164681823|NCT01630616|594858198|FG000|Overall Study|Withdrawal by Subject|0|||
164429766|NCT03710564|593943412|FG001|Overall Study|Protocol Violation|2|||
164429767|NCT03710564|593943411|FG000|Overall Study|Adverse Event|3|||
164429768|NCT03710564|593943412|FG001|Overall Study|Adverse Event|0|||
164429769|NCT03710564|593943411|FG000|Overall Study|Physician Decision|2|||
164429770|NCT03710564|593943412|FG001|Overall Study|Physician Decision|3|||
164429771|NCT00463151|593943414|FG000|Overall Study|Adverse Event|0|||
164429772|NCT00463151|593943415|FG001|Overall Study|Adverse Event|0|||
164429773|NCT00463151|593943416|FG002|Overall Study|Adverse Event|1|||
164429774|NCT00463151|593943417|FG003|Overall Study|Adverse Event|0|||
164429775|NCT00463151|593943414|FG000|Overall Study|Lack of Efficacy|2|||
164429776|NCT00463151|593943415|FG001|Overall Study|Lack of Efficacy|5|||
164429777|NCT00463151|593943416|FG002|Overall Study|Lack of Efficacy|2|||
164429778|NCT00463151|593943417|FG003|Overall Study|Lack of Efficacy|5|||
164429779|NCT00463151|593943414|FG000|Overall Study|Protocol Violation|0|||
164429780|NCT00463151|593943415|FG001|Overall Study|Protocol Violation|0|||
164429781|NCT00463151|593943416|FG002|Overall Study|Protocol Violation|0|||
164429782|NCT00463151|593943417|FG003|Overall Study|Protocol Violation|1|||
164429783|NCT00463151|593943414|FG000|Overall Study|Withdrawal by Subject|0|||
164429784|NCT00463151|593943415|FG001|Overall Study|Withdrawal by Subject|0|||
164429785|NCT00463151|593943416|FG002|Overall Study|Withdrawal by Subject|0|||
164429786|NCT00463151|593943417|FG003|Overall Study|Withdrawal by Subject|1|||
164429787|NCT05349084|593943418|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
164429788|NCT00293462|593943419|FG000|Overall Study|Withdrawal by Subject|4|||
164429789|NCT00293462|593943420|FG001|Overall Study|Withdrawal by Subject|3|||
164429790|NCT00293462|593943421|FG002|Overall Study|Withdrawal by Subject|8|||
164429791|NCT00293462|593943419|FG000|Overall Study|Death|1|||
164681824|NCT01630616|594858199|FG001|Overall Study|Withdrawal by Subject|0|||
164681825|NCT01630616|594858200|FG002|Overall Study|Withdrawal by Subject|0|||
164681826|NCT01630616|594858201|FG003|Overall Study|Withdrawal by Subject|2|||
164681827|NCT01630616|594858202|FG004|Overall Study|Withdrawal by Subject|0|||
164681828|NCT01630616|594858203|FG005|Overall Study|Withdrawal by Subject|0|||
164681829|NCT02725515|594858204|FG000|Overall Study|Refused infusion (no study treatment)|1|||
164681830|NCT02725515|594858205|FG001|Overall Study|Refused infusion (no study treatment)|0|||
164681831|NCT02725515|594858204|FG000|Overall Study|Loss of Improvement per Protocol|14|||
164681832|NCT02725515|594858205|FG001|Overall Study|Loss of Improvement per Protocol|25|||
164681833|NCT02725515|594858204|FG000|Overall Study|Withdrawal by Subject|2|||
164681834|NCT02725515|594858205|FG001|Overall Study|Withdrawal by Subject|1|||
164681835|NCT02725515|594858204|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164681836|NCT02725515|594858205|FG001|Overall Study|Non-Compliance With Study Drug|3|||
164429792|NCT00293462|593943420|FG001|Overall Study|Death|0|||
164429793|NCT00293462|593943421|FG002|Overall Study|Death|0|||
164429794|NCT00293462|593943419|FG000|Overall Study|Lost to Follow-up|0|||
164429795|NCT00293462|593943420|FG001|Overall Study|Lost to Follow-up|1|||
164429796|NCT00293462|593943421|FG002|Overall Study|Lost to Follow-up|0|||
164429797|NCT00293462|593943419|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
164429798|NCT00293462|593943420|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
164681837|NCT02725515|594858204|FG000|Overall Study|Lost to Follow-up|1|||
164429799|NCT00293462|593943421|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
164681838|NCT02725515|594858205|FG001|Overall Study|Lost to Follow-up|1|||
164429800|NCT00293462|593943419|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
164429801|NCT00293462|593943420|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
164429802|NCT00293462|593943421|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
164429803|NCT00293462|593943419|FG000|Overall Study|Refuse Radiation Treatment|1|||
164681839|NCT02725515|594858204|FG000|Overall Study|Adverse Event|7|||
164262741|NCT02754141|593330241|FG004|Overall Study|No longer meets study criteria|0|||
164262742|NCT02754141|593330242|FG005|Overall Study|No longer meets study criteria|0|||
164262743|NCT02754141|593330243|FG006|Overall Study|No longer meets study criteria|0|||
164262744|NCT02754141|593330244|FG007|Overall Study|No longer meets study criteria|0|||
164262745|NCT02754141|593330245|FG008|Overall Study|No longer meets study criteria|0|||
164262746|NCT02754141|593330246|FG009|Overall Study|No longer meets study criteria|0|||
164262747|NCT02754141|593330247|FG010|Overall Study|No longer meets study criteria|0|||
164262748|NCT02754141|593330248|FG011|Overall Study|No longer meets study criteria|0|||
164262749|NCT02754141|593330249|FG012|Overall Study|No longer meets study criteria|0|||
164262750|NCT02754141|593330250|FG013|Overall Study|No longer meets study criteria|0|||
164262751|NCT02754141|593330251|FG014|Overall Study|No longer meets study criteria|0|||
164262752|NCT02754141|593330252|FG015|Overall Study|No longer meets study criteria|0|||
164262753|NCT02754141|593330253|FG016|Overall Study|No longer meets study criteria|0|||
164262754|NCT02754141|593330254|FG017|Overall Study|No longer meets study criteria|0|||
164262755|NCT02754141|593330237|FG000|Overall Study|Other reasons|0|||
164262756|NCT02754141|593330238|FG001|Overall Study|Other reasons|0|||
164262757|NCT02754141|593330239|FG002|Overall Study|Other reasons|0|||
164262758|NCT02754141|593330240|FG003|Overall Study|Other reasons|0|||
164681840|NCT02725515|594858205|FG001|Overall Study|Adverse Event|2|||
164681841|NCT02725515|594858204|FG000|Overall Study|No Documented Disease Improvement|0|||
164681842|NCT02725515|594858205|FG001|Overall Study|No Documented Disease Improvement|1|||
164681843|NCT02725515|594858204|FG000|Overall Study|Completed Study Under Original Protocol|0|||
164681844|NCT02725515|594858205|FG001|Overall Study|Completed Study Under Original Protocol|1|||
164681845|NCT02725515|594858204|FG000|Overall Study|Lack of Response|0|||
164681846|NCT02725515|594858205|FG001|Overall Study|Lack of Response|1|||
164681847|NCT00640393|594858211|FG000|Part 1|Lost to Follow-up|2|||
164681848|NCT00640393|594858212|FG001|Part 1|Lost to Follow-up|0|||
164681849|NCT00640393|594858213|FG002|Part 1|Lost to Follow-up|0|||
164681850|NCT00640393|594858211|FG000|Part 1|Withdrawal by Subject|3|||
164681851|NCT00640393|594858212|FG001|Part 1|Withdrawal by Subject|0|||
164681852|NCT00640393|594858213|FG002|Part 1|Withdrawal by Subject|0|||
164681853|NCT00640393|594858211|FG000|Randomization|Withdrawn per protocol|17|||
164681854|NCT00640393|594858212|FG001|Randomization|Withdrawn per protocol|0|||
164681855|NCT00640393|594858213|FG002|Randomization|Withdrawn per protocol|0|||
164681856|NCT00640393|594858211|FG000|Randomization|Never randomized by site|2|||
164681857|NCT00640393|594858212|FG001|Randomization|Never randomized by site|0|||
164681858|NCT00640393|594858213|FG002|Randomization|Never randomized by site|0|||
164681859|NCT00640393|594858211|FG000|Part 2|Lost to Follow-up|0|||
164681860|NCT00640393|594858212|FG001|Part 2|Lost to Follow-up|2|||
164681861|NCT00640393|594858213|FG002|Part 2|Lost to Follow-up|2|||
164681862|NCT00640393|594858211|FG000|Part 2|Withdrawal by Subject|0|||
164681863|NCT00640393|594858212|FG001|Part 2|Withdrawal by Subject|6|||
164262759|NCT02754141|593330241|FG004|Overall Study|Other reasons|0|||
164681864|NCT00640393|594858213|FG002|Part 2|Withdrawal by Subject|1|||
164681865|NCT00640393|594858211|FG000|Part 2|Non-adherence|0|||
164681866|NCT00640393|594858212|FG001|Part 2|Non-adherence|1|||
164681867|NCT00640393|594858213|FG002|Part 2|Non-adherence|0|||
164681868|NCT00640393|594858211|FG000|Part 2|Adverse Event|0|||
164681869|NCT00640393|594858212|FG001|Part 2|Adverse Event|1|||
164262760|NCT02754141|593330242|FG005|Overall Study|Other reasons|0|||
164262761|NCT02754141|593330243|FG006|Overall Study|Other reasons|0|||
164262762|NCT02754141|593330244|FG007|Overall Study|Other reasons|1|||
164262763|NCT02754141|593330245|FG008|Overall Study|Other reasons|0|||
164262764|NCT02754141|593330246|FG009|Overall Study|Other reasons|0|||
164262765|NCT02754141|593330247|FG010|Overall Study|Other reasons|0|||
164262766|NCT02754141|593330248|FG011|Overall Study|Other reasons|0|||
164262767|NCT02754141|593330249|FG012|Overall Study|Other reasons|2|||
164262768|NCT02754141|593330250|FG013|Overall Study|Other reasons|0|||
164262769|NCT02754141|593330251|FG014|Overall Study|Other reasons|0|||
164262770|NCT02754141|593330252|FG015|Overall Study|Other reasons|0|||
164262771|NCT02754141|593330253|FG016|Overall Study|Other reasons|0|||
164262772|NCT02754141|593330254|FG017|Overall Study|Other reasons|0|||
164262773|NCT02754141|593330237|FG000|Overall Study|Completed treatment as per protocol|0|||
164262774|NCT02754141|593330238|FG001|Overall Study|Completed treatment as per protocol|1|||
164262775|NCT02754141|593330239|FG002|Overall Study|Completed treatment as per protocol|0|||
164262776|NCT02754141|593330240|FG003|Overall Study|Completed treatment as per protocol|0|||
164262777|NCT02754141|593330241|FG004|Overall Study|Completed treatment as per protocol|0|||
164262778|NCT02754141|593330242|FG005|Overall Study|Completed treatment as per protocol|0|||
164262779|NCT02754141|593330243|FG006|Overall Study|Completed treatment as per protocol|0|||
164262780|NCT02754141|593330244|FG007|Overall Study|Completed treatment as per protocol|0|||
164262781|NCT02754141|593330245|FG008|Overall Study|Completed treatment as per protocol|0|||
164262782|NCT02754141|593330246|FG009|Overall Study|Completed treatment as per protocol|0|||
164262783|NCT02754141|593330247|FG010|Overall Study|Completed treatment as per protocol|0|||
164262784|NCT02754141|593330248|FG011|Overall Study|Completed treatment as per protocol|0|||
164262785|NCT02754141|593330249|FG012|Overall Study|Completed treatment as per protocol|1|||
164262786|NCT02754141|593330250|FG013|Overall Study|Completed treatment as per protocol|0|||
164262787|NCT02754141|593330251|FG014|Overall Study|Completed treatment as per protocol|0|||
164262788|NCT02754141|593330252|FG015|Overall Study|Completed treatment as per protocol|0|||
164262789|NCT02754141|593330253|FG016|Overall Study|Completed treatment as per protocol|0|||
164262790|NCT02754141|593330254|FG017|Overall Study|Completed treatment as per protocol|0|||
164262791|NCT02754141|593330237|FG000|Overall Study|Not completing monotherapy|0|||
164262792|NCT02754141|593330238|FG001|Overall Study|Not completing monotherapy|0|||
164262793|NCT02754141|593330239|FG002|Overall Study|Not completing monotherapy|0|||
164262794|NCT02754141|593330240|FG003|Overall Study|Not completing monotherapy|0|||
164262795|NCT02754141|593330241|FG004|Overall Study|Not completing monotherapy|0|||
164262796|NCT02754141|593330242|FG005|Overall Study|Not completing monotherapy|0|||
164262797|NCT02754141|593330243|FG006|Overall Study|Not completing monotherapy|0|||
164262798|NCT02754141|593330244|FG007|Overall Study|Not completing monotherapy|0|||
164262799|NCT02754141|593330245|FG008|Overall Study|Not completing monotherapy|0|||
164262800|NCT02754141|593330246|FG009|Overall Study|Not completing monotherapy|0|||
164262801|NCT02754141|593330247|FG010|Overall Study|Not completing monotherapy|0|||
164262802|NCT02754141|593330248|FG011|Overall Study|Not completing monotherapy|0|||
164262803|NCT02754141|593330249|FG012|Overall Study|Not completing monotherapy|0|||
164262804|NCT02754141|593330250|FG013|Overall Study|Not completing monotherapy|1|||
164262805|NCT02754141|593330251|FG014|Overall Study|Not completing monotherapy|0|||
164262806|NCT02754141|593330252|FG015|Overall Study|Not completing monotherapy|0|||
164262807|NCT02754141|593330253|FG016|Overall Study|Not completing monotherapy|0|||
164262808|NCT02754141|593330254|FG017|Overall Study|Not completing monotherapy|0|||
164262809|NCT02680041|593330255|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
164262810|NCT02680041|593330255|FG000|Overall Study|Lost to Follow-up|2|||
164262811|NCT04239222|593330256|FG000|Baseline|Withdrawal by Subject|0|||
164262812|NCT04239222|593330257|FG001|Baseline|Withdrawal by Subject|0|||
164262813|NCT04239222|593330258|FG002|Baseline|Withdrawal by Subject|1|||
164262814|NCT04239222|593330259|FG003|Baseline|Withdrawal by Subject|1|||
164262815|NCT04239222|593330256|FG000|First Foot Assignment|Withdrawal by Subject|0|||
164262816|NCT04239222|593330257|FG001|First Foot Assignment|Withdrawal by Subject|0|||
164262817|NCT04239222|593330258|FG002|First Foot Assignment|Withdrawal by Subject|1|||
164262818|NCT04239222|593330259|FG003|First Foot Assignment|Withdrawal by Subject|0|||
164262819|NCT04239222|593330256|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
164262820|NCT04239222|593330257|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
164262821|NCT04239222|593330258|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
164262822|NCT04239222|593330259|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
164262823|NCT00937404|593330260|FG000|Overall Study|Protocol Violation|1|||
164262824|NCT00937404|593330260|FG000|Overall Study|Withdrawal by Subject|1|||
164262825|NCT01779869|593330261|FG000|Overall Study|Physician Decision|2|||
164262826|NCT01691105|593330267|FG000|1 Month Follow-up|Lost to Follow-up|41|||
164262827|NCT01691105|593330268|FG001|1 Month Follow-up|Lost to Follow-up|38|||
164262828|NCT01691105|593330267|FG000|1 Month Follow-up|Death|2|||
164262829|NCT01691105|593330268|FG001|1 Month Follow-up|Death|3|||
164262830|NCT01691105|593330267|FG000|6 Month Follow-up|Lost to Follow-up|39|||
164262831|NCT01691105|593330268|FG001|6 Month Follow-up|Lost to Follow-up|58|||
164262832|NCT01691105|593330267|FG000|6 Month Follow-up|Death|13|||
164262833|NCT01691105|593330268|FG001|6 Month Follow-up|Death|13|||
164262834|NCT01691105|593330267|FG000|12 Month Follow-up|Lost to Follow-up|50|||
164262835|NCT01691105|593330268|FG001|12 Month Follow-up|Lost to Follow-up|71|||
164262836|NCT01691105|593330267|FG000|12 Month Follow-up|Death|22|||
164262837|NCT01691105|593330268|FG001|12 Month Follow-up|Death|30|||
164262838|NCT01691105|593330267|FG000|12 Month Biochemical Verification|Death|22|||
164262839|NCT01691105|593330268|FG001|12 Month Biochemical Verification|Death|30|||
164262840|NCT01691105|593330267|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
164262841|NCT01691105|593330268|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
164262842|NCT01691105|593330267|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
164262843|NCT01691105|593330268|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
164262844|NCT00957944|593330269|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
164262845|NCT00957944|593330270|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
164262846|NCT01323270|593330274|FG000|Overall Study|Withdrawal by Subject|19|||
164262847|NCT01323270|593330275|FG001|Overall Study|Withdrawal by Subject|10|||
164262848|NCT01323270|593330274|FG000|Overall Study|Protocol Violation|9|||
164262849|NCT01323270|593330275|FG001|Overall Study|Protocol Violation|7|||
164262850|NCT01323270|593330274|FG000|Overall Study|Lost to Follow-up|4|||
164262851|NCT01323270|593330275|FG001|Overall Study|Lost to Follow-up|6|||
164262852|NCT01323270|593330274|FG000|Overall Study|Adverse Event|8|||
164262853|NCT01323270|593330275|FG001|Overall Study|Adverse Event|0|||
164262854|NCT01323270|593330274|FG000|Overall Study|Other|0|||
164262855|NCT01323270|593330275|FG001|Overall Study|Other|3|||
164340835|NCT02025621|593623789|FG000|Overall Study|Surgery initiated before infusion|3|||
164340836|NCT02025621|593623790|FG001|Overall Study|Surgery initiated before infusion|3|||
164340837|NCT00739674|593623791|FG000|Overall Study|Screening failures|19|||
164340838|NCT00739674|593623792|FG001|Overall Study|Screening failures|17|||
164340839|NCT00739674|593623791|FG000|Overall Study|Site 212 removal|19|||
164340840|NCT00739674|593623792|FG001|Overall Study|Site 212 removal|13|||
164340841|NCT00739674|593623791|FG000|Overall Study|No follow-up data|33|||
164262856|NCT01323270|593330274|FG000|Overall Study|Physician Decision|0|||
164262857|NCT01323270|593330275|FG001|Overall Study|Physician Decision|2|||
164262858|NCT01323270|593330274|FG000|Overall Study|Not eligible|1|||
164340842|NCT00739674|593623792|FG001|Overall Study|No follow-up data|18|||
164262859|NCT01323270|593330275|FG001|Overall Study|Not eligible|1|||
164262860|NCT01323270|593330274|FG000|Overall Study|Death|1|||
164262861|NCT01323270|593330275|FG001|Overall Study|Death|0|||
164262862|NCT01323270|593330274|FG000|Overall Study|Randomized, but not vaccinated|1|||
164340843|NCT00739674|593623791|FG000|Overall Study|Dietician consultation >30 days|1|||
164340844|NCT00739674|593623792|FG001|Overall Study|Dietician consultation >30 days|9|||
164262863|NCT01323270|593330275|FG001|Overall Study|Randomized, but not vaccinated|0|||
164262864|NCT02229214|593330278|FG000|Overall Study|Adverse Event|2|||
164262865|NCT02229214|593330279|FG001|Overall Study|Adverse Event|0|||
164262866|NCT02229214|593330278|FG000|Overall Study|Withdrawal by Subject|4|||
164262867|NCT02229214|593330279|FG001|Overall Study|Withdrawal by Subject|0|||
164262868|NCT00246025|593330286|FG000|Overall Study|Adverse Event|7|||
164262869|NCT00246025|593330287|FG001|Overall Study|Adverse Event|9|||
164262870|NCT00246025|593330288|FG002|Overall Study|Adverse Event|9|||
164262871|NCT00246025|593330289|FG003|Overall Study|Adverse Event|10|||
164262872|NCT00246025|593330286|FG000|Overall Study|Withdrawal by Subject|3|||
164262873|NCT00246025|593330287|FG001|Overall Study|Withdrawal by Subject|0|||
164262874|NCT00246025|593330288|FG002|Overall Study|Withdrawal by Subject|1|||
164262875|NCT00246025|593330289|FG003|Overall Study|Withdrawal by Subject|2|||
164262876|NCT00246025|593330286|FG000|Overall Study|unsuitable medical history was found|0|||
164262877|NCT00246025|593330287|FG001|Overall Study|unsuitable medical history was found|0|||
164262878|NCT00246025|593330288|FG002|Overall Study|unsuitable medical history was found|0|||
164262879|NCT00246025|593330289|FG003|Overall Study|unsuitable medical history was found|1|||
164262880|NCT03305081|593330292|FG000|Overall Study|Lost to Follow-up|10|||
164262881|NCT03305081|593330293|FG001|Overall Study|Lost to Follow-up|15|||
164262882|NCT01218100|593330294|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
164262883|NCT01218100|593330295|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
164262884|NCT01218100|593330296|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
164262885|NCT01218100|593330297|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
164262886|NCT01218100|593330294|FG000|Overall Study|Adverse Event|4|||
164262887|NCT01218100|593330295|FG001|Overall Study|Adverse Event|6|||
164262888|NCT01218100|593330296|FG002|Overall Study|Adverse Event|6|||
164262889|NCT01218100|593330297|FG003|Overall Study|Adverse Event|7|||
164262890|NCT01218100|593330294|FG000|Overall Study|Lack of Efficacy|9|||
164262891|NCT01218100|593330295|FG001|Overall Study|Lack of Efficacy|6|||
164262892|NCT01218100|593330296|FG002|Overall Study|Lack of Efficacy|5|||
164262893|NCT01218100|593330297|FG003|Overall Study|Lack of Efficacy|12|||
164262894|NCT01218100|593330294|FG000|Overall Study|Protocol Violation|0|||
164262895|NCT01218100|593330295|FG001|Overall Study|Protocol Violation|0|||
164262896|NCT01218100|593330296|FG002|Overall Study|Protocol Violation|1|||
164262897|NCT01218100|593330297|FG003|Overall Study|Protocol Violation|1|||
164262898|NCT01218100|593330294|FG000|Overall Study|Withdrawal by Subject|5|||
164262899|NCT01218100|593330295|FG001|Overall Study|Withdrawal by Subject|2|||
164262900|NCT01218100|593330296|FG002|Overall Study|Withdrawal by Subject|6|||
164262901|NCT01218100|593330297|FG003|Overall Study|Withdrawal by Subject|7|||
164262902|NCT01218100|593330294|FG000|Overall Study|Lost to Follow-up|3|||
164262903|NCT01218100|593330295|FG001|Overall Study|Lost to Follow-up|8|||
164262904|NCT01218100|593330296|FG002|Overall Study|Lost to Follow-up|2|||
164340845|NCT00739674|593623791|FG000|Overall Study|Adverse Event|22|||
164340846|NCT00739674|593623792|FG001|Overall Study|Adverse Event|13|||
164340847|NCT00739674|593623791|FG000|Overall Study|Death|1|||
164340848|NCT00739674|593623792|FG001|Overall Study|Death|0|||
164340849|NCT00739674|593623791|FG000|Overall Study|Lack of Efficacy|1|||
164340850|NCT00739674|593623792|FG001|Overall Study|Lack of Efficacy|0|||
164340851|NCT00739674|593623791|FG000|Overall Study|Lost to Follow-up|52|||
164340852|NCT00739674|593623792|FG001|Overall Study|Lost to Follow-up|30|||
164340853|NCT00739674|593623791|FG000|Overall Study|Protocol Violation|5|||
164340854|NCT00739674|593623792|FG001|Overall Study|Protocol Violation|5|||
164262905|NCT01218100|593330297|FG003|Overall Study|Lost to Follow-up|1|||
164577567|NCT00500071|594479338|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
164577568|NCT03584009|594479339|FG000|Overall Study|Death|25|||
164577569|NCT03584009|594479340|FG001|Overall Study|Death|18|||
164262906|NCT01218100|593330294|FG000|Overall Study|Other Reason|2|||
164262907|NCT01218100|593330295|FG001|Overall Study|Other Reason|2|||
164262908|NCT01218100|593330296|FG002|Overall Study|Other Reason|6|||
164262909|NCT01218100|593330297|FG003|Overall Study|Other Reason|4|||
164262910|NCT02437305|593330298|FG000|Overall Study|Lost to Follow-up|18|||
164262911|NCT02437305|593330299|FG001|Overall Study|Lost to Follow-up|12|||
164262912|NCT01118520|593330300|FG000|Overall Study|AAA repair|9|||
164262913|NCT01118520|593330301|FG001|Overall Study|AAA repair|7|||
164340855|NCT00739674|593623791|FG000|Overall Study|Withdrawal by Subject|9|||
164340856|NCT00739674|593623792|FG001|Overall Study|Withdrawal by Subject|9|||
164340857|NCT00739674|593623791|FG000|Overall Study|Reason missing|2|||
164340858|NCT00739674|593623792|FG001|Overall Study|Reason missing|0|||
164577570|NCT03584009|594479339|FG000|Overall Study|Lost to Follow-up|0|||
164262914|NCT01118520|593330302|FG002|Overall Study|AAA repair|9|||
164262915|NCT01118520|593330300|FG000|Overall Study|Adverse Event|3|||
164340859|NCT00739674|593623791|FG000|Overall Study|Clinic closed|6|||
164262916|NCT01118520|593330301|FG001|Overall Study|Adverse Event|3|||
164262917|NCT01118520|593330302|FG002|Overall Study|Adverse Event|3|||
164262918|NCT01118520|593330300|FG000|Overall Study|Withdrawal by Subject|8|||
164262919|NCT01118520|593330301|FG001|Overall Study|Withdrawal by Subject|13|||
164340860|NCT00739674|593623792|FG001|Overall Study|Clinic closed|4|||
164577571|NCT03584009|594479340|FG001|Overall Study|Lost to Follow-up|1|||
164262920|NCT01118520|593330302|FG002|Overall Study|Withdrawal by Subject|8|||
164262921|NCT01170065|593330303|FG000|Overall Study|Adverse Event|17|||
164262922|NCT01170065|593330304|FG001|Overall Study|Adverse Event|50|||
164262923|NCT01170065|593330305|FG002|Overall Study|Adverse Event|10|||
164262924|NCT01170065|593330303|FG000|Overall Study|Lost to Follow-up|1|||
164262925|NCT01170065|593330304|FG001|Overall Study|Lost to Follow-up|4|||
164262926|NCT01170065|593330305|FG002|Overall Study|Lost to Follow-up|1|||
164262927|NCT01170065|593330303|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
164262928|NCT01170065|593330304|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
164262929|NCT01170065|593330305|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
164262930|NCT01170065|593330303|FG000|Overall Study|Reason other than specified|3|||
164262931|NCT01170065|593330304|FG001|Overall Study|Reason other than specified|8|||
164262932|NCT01170065|593330305|FG002|Overall Study|Reason other than specified|3|||
164262933|NCT01170065|593330303|FG000|Overall Study|Ongoing after planned observation time|5|||
164262934|NCT01170065|593330304|FG001|Overall Study|Ongoing after planned observation time|26|||
164262935|NCT01170065|593330305|FG002|Overall Study|Ongoing after planned observation time|10|||
164262936|NCT03220581|593330306|FG000|Overall Study|Withdrawal by Subject|0|||
164262937|NCT03220581|593330307|FG001|Overall Study|Withdrawal by Subject|1|||
164262938|NCT03220581|593330306|FG000|Overall Study|Lost to Follow-up|3|||
164262939|NCT03220581|593330307|FG001|Overall Study|Lost to Follow-up|6|||
164262940|NCT01071200|593330308|FG000|Overall Study|Lack of ovarian response|1|||
164262941|NCT01071200|593330309|FG001|Overall Study|Lack of ovarian response|1|||
164262942|NCT01071200|593330308|FG000|Overall Study|No fertilization|4|||
164262943|NCT01071200|593330309|FG001|Overall Study|No fertilization|0|||
164262944|NCT01071200|593330308|FG000|Overall Study|No oocytes retrieved|1|||
164262945|NCT01071200|593330309|FG001|Overall Study|No oocytes retrieved|1|||
164262946|NCT01071200|593330308|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
164262947|NCT01071200|593330309|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
164262948|NCT01071200|593330308|FG000|Overall Study|No viable embryos|0|||
164262949|NCT01071200|593330309|FG001|Overall Study|No viable embryos|1|||
164262950|NCT01920893|593330312|FG000|Overall Study|Adverse Event|5|||
164262951|NCT01920893|593330313|FG001|Overall Study|Adverse Event|2|||
164262952|NCT01920893|593330312|FG000|Overall Study|Lack of Efficacy|2|||
164262953|NCT01920893|593330313|FG001|Overall Study|Lack of Efficacy|0|||
164262954|NCT01396265|593330314|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
164262955|NCT01767493|593330315|FG000|Overall Study|screen failures|3|||
164262956|NCT02446418|593330316|FG000|Overall Study|Adverse Event|4|||
164262957|NCT02446418|593330317|FG001|Overall Study|Adverse Event|8|||
164262958|NCT02446418|593330316|FG000|Overall Study|Physician Decision|5|||
164262959|NCT02446418|593330317|FG001|Overall Study|Physician Decision|1|||
164262960|NCT02446418|593330316|FG000|Overall Study|Withdrawal by Subject|3|||
164262961|NCT02446418|593330317|FG001|Overall Study|Withdrawal by Subject|3|||
164262962|NCT02446418|593330316|FG000|Overall Study|Lost to Follow-up|2|||
164262963|NCT02446418|593330317|FG001|Overall Study|Lost to Follow-up|2|||
164262964|NCT02446418|593330316|FG000|Overall Study|Protocol Violation|1|||
164262965|NCT02446418|593330317|FG001|Overall Study|Protocol Violation|2|||
164262966|NCT02446418|593330316|FG000|Overall Study|Lack of Efficacy|2|||
164262967|NCT02446418|593330317|FG001|Overall Study|Lack of Efficacy|0|||
164262968|NCT02446418|593330316|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
164262969|NCT02446418|593330317|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
164262970|NCT01286987|593330318|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
164262971|NCT01286987|593330319|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
164262972|NCT01286987|593330320|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
164262973|NCT01286987|593330321|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
164681870|NCT00640393|594858213|FG002|Part 2|Adverse Event|0|||
164262974|NCT01286987|593330322|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
164262975|NCT01286987|593330323|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
164262976|NCT01286987|593330324|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
164262977|NCT01286987|593330325|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
164262978|NCT01286987|593330326|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
164262979|NCT01286987|593330327|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
164262980|NCT01286987|593330328|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
164262981|NCT01286987|593330329|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
164262982|NCT01286987|593330330|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
164262983|NCT01286987|593330331|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
164681871|NCT01403194|594858214|FG000|Overall Study|Screen Failure|2|||
164262984|NCT01286987|593330332|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
164262985|NCT01286987|593330318|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
164262986|NCT01286987|593330319|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
164262987|NCT01286987|593330320|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
164262988|NCT01286987|593330321|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
164262989|NCT01286987|593330322|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
164340861|NCT00739674|593623791|FG000|Overall Study|Patient moved|3|||
164681872|NCT01403194|594858214|FG000|Overall Study|Lost to Follow-up|8|||
164681873|NCT03428750|594858215|FG000|Overall Study|Withdrawal by Subject|11|||
164262990|NCT01286987|593330323|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
164262991|NCT01286987|593330324|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
164262992|NCT01286987|593330325|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
164262993|NCT01286987|593330326|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
164262994|NCT01286987|593330327|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
164262995|NCT01286987|593330328|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
164262996|NCT01286987|593330329|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
164262997|NCT01286987|593330330|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
164262998|NCT01286987|593330331|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
164262999|NCT01286987|593330332|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
164263000|NCT01286987|593330318|FG000|Part 1: Dose Escalation|Physician Decision|0|||
164263001|NCT01286987|593330319|FG001|Part 1: Dose Escalation|Physician Decision|0|||
164263002|NCT01286987|593330320|FG002|Part 1: Dose Escalation|Physician Decision|0|||
164263003|NCT01286987|593330321|FG003|Part 1: Dose Escalation|Physician Decision|0|||
164263004|NCT01286987|593330322|FG004|Part 1: Dose Escalation|Physician Decision|1|||
164263005|NCT01286987|593330323|FG005|Part 1: Dose Escalation|Physician Decision|0|||
164263006|NCT01286987|593330324|FG006|Part 1: Dose Escalation|Physician Decision|0|||
164263007|NCT01286987|593330325|FG007|Part 1: Dose Escalation|Physician Decision|0|||
164263008|NCT01286987|593330326|FG008|Part 1: Dose Escalation|Physician Decision|0|||
164263009|NCT01286987|593330327|FG009|Part 1: Dose Escalation|Physician Decision|0|||
164263010|NCT01286987|593330328|FG010|Part 1: Dose Escalation|Physician Decision|0|||
164263011|NCT01286987|593330329|FG011|Part 1: Dose Escalation|Physician Decision|0|||
164263012|NCT01286987|593330330|FG012|Part 1: Dose Escalation|Physician Decision|0|||
164263013|NCT01286987|593330331|FG013|Part 1: Dose Escalation|Physician Decision|0|||
164263014|NCT01286987|593330332|FG014|Part 1: Dose Escalation|Physician Decision|0|||
164263015|NCT01286987|593330318|FG000|Part 2: Dose Expansion|Death|0|||
164263016|NCT01286987|593330319|FG001|Part 2: Dose Expansion|Death|0|||
164263017|NCT01286987|593330320|FG002|Part 2: Dose Expansion|Death|0|||
164263018|NCT01286987|593330321|FG003|Part 2: Dose Expansion|Death|0|||
164263019|NCT01286987|593330322|FG004|Part 2: Dose Expansion|Death|0|||
164263020|NCT01286987|593330323|FG005|Part 2: Dose Expansion|Death|0|||
164263021|NCT01286987|593330324|FG006|Part 2: Dose Expansion|Death|0|||
164263022|NCT01286987|593330325|FG007|Part 2: Dose Expansion|Death|0|||
164263023|NCT01286987|593330326|FG008|Part 2: Dose Expansion|Death|0|||
164263024|NCT01286987|593330327|FG009|Part 2: Dose Expansion|Death|0|||
164263025|NCT01286987|593330328|FG010|Part 2: Dose Expansion|Death|0|||
164263026|NCT01286987|593330329|FG011|Part 2: Dose Expansion|Death|0|||
164263027|NCT01286987|593330330|FG012|Part 2: Dose Expansion|Death|1|||
164263028|NCT01286987|593330331|FG013|Part 2: Dose Expansion|Death|1|||
164263029|NCT01286987|593330332|FG014|Part 2: Dose Expansion|Death|0|||
164263030|NCT01286987|593330318|FG000|Part 2: Dose Expansion|Physician Decision|0|||
164263031|NCT01286987|593330319|FG001|Part 2: Dose Expansion|Physician Decision|0|||
164263032|NCT01286987|593330320|FG002|Part 2: Dose Expansion|Physician Decision|0|||
164263033|NCT01286987|593330321|FG003|Part 2: Dose Expansion|Physician Decision|0|||
164263034|NCT01286987|593330322|FG004|Part 2: Dose Expansion|Physician Decision|0|||
164263035|NCT01286987|593330323|FG005|Part 2: Dose Expansion|Physician Decision|0|||
164263036|NCT01286987|593330324|FG006|Part 2: Dose Expansion|Physician Decision|0|||
164263037|NCT01286987|593330325|FG007|Part 2: Dose Expansion|Physician Decision|0|||
164263038|NCT01286987|593330326|FG008|Part 2: Dose Expansion|Physician Decision|0|||
164263039|NCT01286987|593330327|FG009|Part 2: Dose Expansion|Physician Decision|0|||
164263040|NCT01286987|593330328|FG010|Part 2: Dose Expansion|Physician Decision|1|||
164263041|NCT01286987|593330329|FG011|Part 2: Dose Expansion|Physician Decision|1|||
164263042|NCT01286987|593330330|FG012|Part 2: Dose Expansion|Physician Decision|0|||
164263043|NCT01286987|593330331|FG013|Part 2: Dose Expansion|Physician Decision|1|||
164263044|NCT01286987|593330332|FG014|Part 2: Dose Expansion|Physician Decision|0|||
164263045|NCT01286987|593330318|FG000|Part 2: Dose Expansion|Other|0|||
164263046|NCT01286987|593330319|FG001|Part 2: Dose Expansion|Other|0|||
164263047|NCT01286987|593330320|FG002|Part 2: Dose Expansion|Other|0|||
164263048|NCT01286987|593330321|FG003|Part 2: Dose Expansion|Other|0|||
164263049|NCT01286987|593330322|FG004|Part 2: Dose Expansion|Other|0|||
164263050|NCT01286987|593330323|FG005|Part 2: Dose Expansion|Other|0|||
164263051|NCT01286987|593330324|FG006|Part 2: Dose Expansion|Other|0|||
164263052|NCT01286987|593330325|FG007|Part 2: Dose Expansion|Other|0|||
164263053|NCT01286987|593330326|FG008|Part 2: Dose Expansion|Other|0|||
164263054|NCT01286987|593330327|FG009|Part 2: Dose Expansion|Other|0|||
164263055|NCT01286987|593330328|FG010|Part 2: Dose Expansion|Other|0|||
164263056|NCT01286987|593330329|FG011|Part 2: Dose Expansion|Other|0|||
164263057|NCT01286987|593330330|FG012|Part 2: Dose Expansion|Other|0|||
164263058|NCT01286987|593330331|FG013|Part 2: Dose Expansion|Other|1|||
164263059|NCT01286987|593330332|FG014|Part 2: Dose Expansion|Other|0|||
164263060|NCT01286987|593330318|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
164263061|NCT01286987|593330319|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
164263062|NCT01286987|593330320|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
164263063|NCT01286987|593330321|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
164263064|NCT01286987|593330322|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
164263065|NCT01286987|593330323|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
164263066|NCT01286987|593330324|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
164263067|NCT01286987|593330325|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
164263068|NCT01286987|593330326|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
164263069|NCT01286987|593330327|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
164263070|NCT01286987|593330328|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
164263071|NCT01286987|593330329|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
164263072|NCT01286987|593330330|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
164263073|NCT01286987|593330331|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
164263074|NCT01286987|593330332|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
164263075|NCT01286987|593330318|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
164263076|NCT01286987|593330319|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
164263077|NCT01286987|593330320|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
164263078|NCT01286987|593330321|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
164263079|NCT01286987|593330322|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
164263080|NCT01286987|593330323|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
164263081|NCT01286987|593330324|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
164263082|NCT01286987|593330325|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
164263083|NCT01286987|593330326|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
164263084|NCT01286987|593330327|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
164263085|NCT01286987|593330328|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
164263086|NCT01286987|593330329|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
164263087|NCT01286987|593330330|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
164263088|NCT01286987|593330331|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
164263089|NCT01286987|593330332|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
164263090|NCT01286987|593330318|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263091|NCT01286987|593330319|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263092|NCT01286987|593330320|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263093|NCT01286987|593330321|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263094|NCT01286987|593330322|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263095|NCT01286987|593330323|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263096|NCT01286987|593330324|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263097|NCT01286987|593330325|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263098|NCT01286987|593330326|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263099|NCT01286987|593330327|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263100|NCT01286987|593330328|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
164263101|NCT01286987|593330329|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263102|NCT01286987|593330330|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263103|NCT01286987|593330331|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263104|NCT01286987|593330332|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263105|NCT03093974|593330337|FG000|Overall Study|Withdrawal by Subject|32|||
164263106|NCT03093974|593330338|FG001|Overall Study|Withdrawal by Subject|27|||
164263107|NCT03093974|593330337|FG000|Overall Study|Adverse Event|17|||
164263108|NCT03093974|593330338|FG001|Overall Study|Adverse Event|24|||
164263109|NCT03093974|593330337|FG000|Overall Study|Death|0|||
164263110|NCT03093974|593330338|FG001|Overall Study|Death|1|||
164263111|NCT03093974|593330337|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164263112|NCT03093974|593330338|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164263113|NCT03093974|593330337|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
164263114|NCT03093974|593330338|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
164263115|NCT03093974|593330337|FG000|Overall Study|Lost to Follow-up|0|||
164263116|NCT03093974|593330338|FG001|Overall Study|Lost to Follow-up|1|||
164263117|NCT03093974|593330337|FG000|Overall Study|Other|1|||
164263118|NCT03093974|593330338|FG001|Overall Study|Other|2|||
164263119|NCT01009346|593330343|FG000|Overall Study|Adverse Event|4|||
164263120|NCT00033540|593330344|FG000|Overall Study|Adverse Event|14|||
164263121|NCT00033540|593330344|FG000|Overall Study|Death|1|||
164263122|NCT00033540|593330344|FG000|Overall Study|Progression|26|||
164263123|NCT00033540|593330344|FG000|Overall Study|Withdrawal by Subject|6|||
164577572|NCT03584009|594479339|FG000|Overall Study|Physician Decision|1|||
164577573|NCT03584009|594479340|FG001|Overall Study|Physician Decision|1|||
164577574|NCT03584009|594479339|FG000|Overall Study|Study Terminated by Sponsor|22|||
164577575|NCT03584009|594479340|FG001|Overall Study|Study Terminated by Sponsor|30|||
164577576|NCT03584009|594479339|FG000|Overall Study|Withdrawal by Subject|3|||
164263124|NCT00033540|593330344|FG000|Overall Study|Other|5|||
164263125|NCT00033540|593330344|FG000|Overall Study|Ineligible|3|||
164263126|NCT00033540|593330344|FG000|Overall Study|Never received treatment|2|||
164263127|NCT01253265|593330347|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
164263128|NCT01253265|593330348|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
164263129|NCT01253265|593330349|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
164263130|NCT01253265|593330350|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
164577577|NCT03584009|594479340|FG001|Overall Study|Withdrawal by Subject|2|||
164263131|NCT01253265|593330351|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
164263132|NCT01253265|593330347|FG000|Overall Study|Withdrawal by Subject|0|||
164263133|NCT01253265|593330348|FG001|Overall Study|Withdrawal by Subject|0|||
164263134|NCT01253265|593330349|FG002|Overall Study|Withdrawal by Subject|0|||
164263135|NCT01253265|593330350|FG003|Overall Study|Withdrawal by Subject|0|||
164263136|NCT01253265|593330351|FG004|Overall Study|Withdrawal by Subject|1|||
164263137|NCT00066469|593330354|FG000|Overall Study|Death|3|||
164263138|NCT00066469|593330354|FG000|Overall Study|Lack of Efficacy|9|||
164263139|NCT00066469|593330354|FG000|Overall Study|Lost to Follow-up|1|||
164263140|NCT00066469|593330354|FG000|Overall Study|Physician Decision|1|||
164263141|NCT00066469|593330354|FG000|Overall Study|Withdrawal by Subject|1|||
164263142|NCT00066469|593330354|FG000|Overall Study|ineligible|1|||
164263143|NCT03271047|593330355|FG000|Phase 1b: Dose Finding Period|Death|8|||
164263144|NCT03271047|593330356|FG001|Phase 1b: Dose Finding Period|Death|8|||
164263145|NCT03271047|593330357|FG002|Phase 1b: Dose Finding Period|Death|0|||
164263146|NCT03271047|593330358|FG003|Phase 1b: Dose Finding Period|Death|0|||
164263147|NCT03271047|593330355|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
164263148|NCT03271047|593330356|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
164263149|NCT03271047|593330357|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
164263150|NCT03271047|593330358|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
164263151|NCT03271047|593330355|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
164263152|NCT03271047|593330356|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
164263153|NCT03271047|593330357|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
164263154|NCT03271047|593330358|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
164263155|NCT03271047|593330355|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
164263156|NCT03271047|593330356|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
164263157|NCT03271047|593330357|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
164263158|NCT03271047|593330358|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
164263159|NCT03271047|593330355|FG000|Randomized Phase 2 Period|Other|0|||
164263160|NCT03271047|593330356|FG001|Randomized Phase 2 Period|Other|0|||
164263161|NCT03271047|593330357|FG002|Randomized Phase 2 Period|Other|0|||
164263162|NCT03271047|593330358|FG003|Randomized Phase 2 Period|Other|1|||
164263163|NCT03271047|593330355|FG000|Randomized Phase 2 Period|Death|0|||
164263164|NCT03271047|593330356|FG001|Randomized Phase 2 Period|Death|0|||
164263165|NCT03271047|593330357|FG002|Randomized Phase 2 Period|Death|20|||
164263166|NCT03271047|593330358|FG003|Randomized Phase 2 Period|Death|21|||
164263167|NCT03271047|593330355|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
164263168|NCT03271047|593330356|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
164263169|NCT03271047|593330357|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
164263170|NCT03271047|593330358|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
164263171|NCT03271047|593330355|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
164263172|NCT03271047|593330356|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
164263173|NCT03271047|593330357|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
164263174|NCT03271047|593330358|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
164263175|NCT03271047|593330355|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
164263176|NCT03271047|593330356|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
164263177|NCT03271047|593330357|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
164263178|NCT03271047|593330358|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
164263179|NCT00711802|593330359|FG000|Overall Study|Not treated (no further detail)|2|||
164263180|NCT00711802|593330360|FG001|Overall Study|Not treated (no further detail)|1|||
164263181|NCT00711802|593330361|FG002|Overall Study|Not treated (no further detail)|2|||
164263182|NCT00711802|593330362|FG003|Overall Study|Not treated (no further detail)|0|||
164263183|NCT00711802|593330363|FG004|Overall Study|Not treated (no further detail)|2|||
164263184|NCT00711802|593330364|FG005|Overall Study|Not treated (no further detail)|0|||
164681874|NCT03428750|594858216|FG001|Overall Study|Withdrawal by Subject|10|||
164681875|NCT03428750|594858215|FG000|Overall Study|Lost to Follow-up|3|||
164681876|NCT03428750|594858216|FG001|Overall Study|Lost to Follow-up|9|||
164681877|NCT03428750|594858215|FG000|Overall Study|Adverse Event|9|||
164681878|NCT03428750|594858216|FG001|Overall Study|Adverse Event|1|||
164263185|NCT00711802|593330365|FG006|Overall Study|Not treated (no further detail)|0|||
164263186|NCT00711802|593330366|FG007|Overall Study|Not treated (no further detail)|0|||
164263187|NCT00711802|593330359|FG000|Overall Study|Adverse Event|0|||
164263188|NCT00711802|593330360|FG001|Overall Study|Adverse Event|0|||
164263189|NCT00711802|593330361|FG002|Overall Study|Adverse Event|0|||
164263190|NCT00711802|593330362|FG003|Overall Study|Adverse Event|0|||
164263191|NCT00711802|593330363|FG004|Overall Study|Adverse Event|1|||
164263192|NCT00711802|593330364|FG005|Overall Study|Adverse Event|1|||
164263193|NCT00711802|593330365|FG006|Overall Study|Adverse Event|0|||
164263194|NCT00711802|593330366|FG007|Overall Study|Adverse Event|0|||
164263195|NCT00711802|593330359|FG000|Overall Study|Microbiological failure|0|||
164263196|NCT00711802|593330360|FG001|Overall Study|Microbiological failure|1|||
164263197|NCT00711802|593330361|FG002|Overall Study|Microbiological failure|0|||
164681879|NCT03428750|594858215|FG000|Overall Study|Protocol Violation|1|||
164263198|NCT00711802|593330362|FG003|Overall Study|Microbiological failure|0|||
164263199|NCT00711802|593330363|FG004|Overall Study|Microbiological failure|0|||
164263200|NCT00711802|593330364|FG005|Overall Study|Microbiological failure|1|||
164263201|NCT00711802|593330365|FG006|Overall Study|Microbiological failure|0|||
164263202|NCT00711802|593330366|FG007|Overall Study|Microbiological failure|0|||
164263203|NCT00711802|593330359|FG000|Overall Study|Protocol Violation|0|||
164263204|NCT00711802|593330360|FG001|Overall Study|Protocol Violation|0|||
164263205|NCT00711802|593330361|FG002|Overall Study|Protocol Violation|0|||
164263206|NCT00711802|593330362|FG003|Overall Study|Protocol Violation|1|||
164263207|NCT00711802|593330363|FG004|Overall Study|Protocol Violation|0|||
164263208|NCT00711802|593330364|FG005|Overall Study|Protocol Violation|0|||
164263209|NCT00711802|593330365|FG006|Overall Study|Protocol Violation|0|||
164263210|NCT00711802|593330366|FG007|Overall Study|Protocol Violation|0|||
164263211|NCT00711802|593330359|FG000|Overall Study|Physician Decision|0|||
164263212|NCT00711802|593330360|FG001|Overall Study|Physician Decision|2|||
164263213|NCT00711802|593330361|FG002|Overall Study|Physician Decision|0|||
164263214|NCT00711802|593330362|FG003|Overall Study|Physician Decision|0|||
164263215|NCT00711802|593330363|FG004|Overall Study|Physician Decision|0|||
164263216|NCT00711802|593330364|FG005|Overall Study|Physician Decision|0|||
164263217|NCT00711802|593330365|FG006|Overall Study|Physician Decision|0|||
164263218|NCT00711802|593330366|FG007|Overall Study|Physician Decision|0|||
164263219|NCT00711802|593330359|FG000|Overall Study|Withdrawal by Subject|0|||
164263220|NCT00711802|593330360|FG001|Overall Study|Withdrawal by Subject|1|||
164263221|NCT00711802|593330361|FG002|Overall Study|Withdrawal by Subject|0|||
164263222|NCT00711802|593330362|FG003|Overall Study|Withdrawal by Subject|1|||
164263223|NCT00711802|593330363|FG004|Overall Study|Withdrawal by Subject|0|||
164263224|NCT00711802|593330364|FG005|Overall Study|Withdrawal by Subject|0|||
164263225|NCT00711802|593330365|FG006|Overall Study|Withdrawal by Subject|0|||
164263226|NCT00711802|593330366|FG007|Overall Study|Withdrawal by Subject|0|||
164263227|NCT00711802|593330359|FG000|Overall Study|Lost to Follow-up|0|||
164263228|NCT00711802|593330360|FG001|Overall Study|Lost to Follow-up|0|||
164263229|NCT00711802|593330361|FG002|Overall Study|Lost to Follow-up|3|||
164263230|NCT00711802|593330362|FG003|Overall Study|Lost to Follow-up|1|||
164263231|NCT00711802|593330363|FG004|Overall Study|Lost to Follow-up|10|||
164263232|NCT00711802|593330364|FG005|Overall Study|Lost to Follow-up|6|||
164263233|NCT00711802|593330365|FG006|Overall Study|Lost to Follow-up|4|||
164263234|NCT00711802|593330366|FG007|Overall Study|Lost to Follow-up|2|||
164263235|NCT00711802|593330359|FG000|Overall Study|Reason not reported|0|||
164263236|NCT00711802|593330360|FG001|Overall Study|Reason not reported|1|||
164263237|NCT00711802|593330361|FG002|Overall Study|Reason not reported|1|||
164263238|NCT00711802|593330362|FG003|Overall Study|Reason not reported|0|||
164263239|NCT00711802|593330363|FG004|Overall Study|Reason not reported|1|||
164263240|NCT00711802|593330364|FG005|Overall Study|Reason not reported|0|||
164263241|NCT00711802|593330365|FG006|Overall Study|Reason not reported|1|||
164263242|NCT00711802|593330366|FG007|Overall Study|Reason not reported|0|||
164263243|NCT00882908|593330368|FG000|Overall Study|Adverse Event|0|||
164263244|NCT00882908|593330369|FG001|Overall Study|Adverse Event|0|||
164263245|NCT00882908|593330370|FG002|Overall Study|Adverse Event|1|||
164263246|NCT00882908|593330371|FG003|Overall Study|Adverse Event|0|||
164263247|NCT00882908|593330372|FG004|Overall Study|Adverse Event|1|||
164263248|NCT00882908|593330368|FG000|Overall Study|Lost to Follow-up|3|||
164263249|NCT00882908|593330369|FG001|Overall Study|Lost to Follow-up|5|||
164263250|NCT00882908|593330370|FG002|Overall Study|Lost to Follow-up|3|||
164263251|NCT00882908|593330371|FG003|Overall Study|Lost to Follow-up|1|||
164263252|NCT00882908|593330372|FG004|Overall Study|Lost to Follow-up|2|||
164263253|NCT00882908|593330368|FG000|Overall Study|Protocol Violation|0|||
164263254|NCT00882908|593330369|FG001|Overall Study|Protocol Violation|1|||
164263255|NCT00882908|593330370|FG002|Overall Study|Protocol Violation|0|||
164263256|NCT00882908|593330371|FG003|Overall Study|Protocol Violation|0|||
164263257|NCT00882908|593330372|FG004|Overall Study|Protocol Violation|0|||
164263258|NCT00882908|593330368|FG000|Overall Study|Withdrawal by Subject|0|||
164263259|NCT00882908|593330369|FG001|Overall Study|Withdrawal by Subject|0|||
164263260|NCT00882908|593330370|FG002|Overall Study|Withdrawal by Subject|3|||
164263261|NCT00882908|593330371|FG003|Overall Study|Withdrawal by Subject|5|||
164263262|NCT00882908|593330372|FG004|Overall Study|Withdrawal by Subject|2|||
164263263|NCT00882908|593330368|FG000|Overall Study|Subject reached a virologic endpoint|0|||
164263264|NCT00882908|593330369|FG001|Overall Study|Subject reached a virologic endpoint|0|||
164263265|NCT00882908|593330370|FG002|Overall Study|Subject reached a virologic endpoint|0|||
164263266|NCT00882908|593330371|FG003|Overall Study|Subject reached a virologic endpoint|0|||
164263267|NCT00882908|593330372|FG004|Overall Study|Subject reached a virologic endpoint|1|||
164340862|NCT00739674|593623792|FG001|Overall Study|Patient moved|2|||
164263268|NCT00882908|593330368|FG000|Overall Study|Study terminated in error|0|||
164263269|NCT00882908|593330369|FG001|Overall Study|Study terminated in error|0|||
164263270|NCT00882908|593330370|FG002|Overall Study|Study terminated in error|0|||
164263271|NCT00882908|593330371|FG003|Overall Study|Study terminated in error|1|||
164263272|NCT00882908|593330372|FG004|Overall Study|Study terminated in error|0|||
164263273|NCT03283150|593330373|FG000|Overall Study|Withdrawal by Subject|6|||
164263274|NCT03283150|593330374|FG001|Overall Study|Withdrawal by Subject|0|||
164263275|NCT03283150|593330375|FG002|Overall Study|Withdrawal by Subject|0|||
164263276|NCT00581828|593330376|FG000|Overall Study|Protocol Violation|1|||
164263277|NCT02981407|593330377|FG000|Overall Study|Withdrawal by Subject|2|||
164263278|NCT02981407|593330378|FG001|Overall Study|Withdrawal by Subject|0|||
164263279|NCT02410824|593330381|FG000|First Intervention (One Week)|Headache|0|||
164263280|NCT02410824|593330382|FG001|First Intervention (One Week)|Headache|1|||
164263281|NCT02436408|593330383|FG000|Overall Study|Death|1|||
164263282|NCT00392808|593330384|FG000|Overall Study|Lost to Follow-up|3|||
164263283|NCT00392808|593330385|FG001|Overall Study|Lost to Follow-up|2|||
164263284|NCT00392808|593330386|FG002|Overall Study|Lost to Follow-up|1|||
164263285|NCT00392808|593330387|FG003|Overall Study|Lost to Follow-up|2|||
164263286|NCT00392808|593330384|FG000|Overall Study|Unable to withdraw blood|3|||
164263287|NCT00392808|593330385|FG001|Overall Study|Unable to withdraw blood|1|||
164263288|NCT00392808|593330386|FG002|Overall Study|Unable to withdraw blood|1|||
164263289|NCT00392808|593330387|FG003|Overall Study|Unable to withdraw blood|2|||
164263290|NCT02084238|593330388|FG000|Overall Study|Lost to Follow-up|2|||
164263291|NCT02818036|593330389|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
164263292|NCT02818036|593330390|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
164263293|NCT02818036|593330389|FG000|Overall Study|Withdrawal by Subject|1|||
164263294|NCT02818036|593330390|FG001|Overall Study|Withdrawal by Subject|0|||
164263295|NCT01038713|593330391|FG000|Overall Study|Patient to hospice|1|||
164263296|NCT01038713|593330392|FG001|Overall Study|Patient to hospice|1|||
164263297|NCT01038713|593330393|FG002|Overall Study|Patient to hospice|1|||
164263298|NCT01038713|593330391|FG000|Overall Study|Lost to Follow-up|3|||
164263299|NCT01038713|593330392|FG001|Overall Study|Lost to Follow-up|0|||
164263300|NCT01038713|593330393|FG002|Overall Study|Lost to Follow-up|0|||
164263301|NCT01038713|593330391|FG000|Overall Study|Neuroendocrine Tumor|0|||
164263302|NCT01038713|593330392|FG001|Overall Study|Neuroendocrine Tumor|1|||
164263303|NCT01038713|593330393|FG002|Overall Study|Neuroendocrine Tumor|0|||
164263304|NCT01038713|593330391|FG000|Overall Study|died from PEP|0|||
164263305|NCT01038713|593330392|FG001|Overall Study|died from PEP|1|||
164263306|NCT01038713|593330393|FG002|Overall Study|died from PEP|0|||
164263307|NCT01038713|593330391|FG000|Overall Study|Autoimmune Pancreatitis|1|||
164263308|NCT01038713|593330392|FG001|Overall Study|Autoimmune Pancreatitis|0|||
164263309|NCT01038713|593330393|FG002|Overall Study|Autoimmune Pancreatitis|0|||
164263310|NCT03777917|593330394|FG000|Overall Study|Withdrawal by Subject|1|||
164263311|NCT03777917|593330395|FG001|Overall Study|Withdrawal by Subject|0|||
164263312|NCT03777917|593330394|FG000|Overall Study|Physician Decision|1|||
164263313|NCT03777917|593330395|FG001|Overall Study|Physician Decision|0|||
164263314|NCT03777917|593330394|FG000|Overall Study|Lost to Follow-up|6|||
164263315|NCT03777917|593330395|FG001|Overall Study|Lost to Follow-up|2|||
164263316|NCT03777917|593330394|FG000|Overall Study|Other|1|||
164263317|NCT03777917|593330395|FG001|Overall Study|Other|0|||
164263318|NCT01154283|593330396|FG000|0-6 Weeks|Withdrawal by Subject|7|||
164263319|NCT01154283|593330397|FG001|0-6 Weeks|Withdrawal by Subject|2|||
164263320|NCT01154283|593330396|FG000|0-6 Weeks|Death|0|||
164263321|NCT01154283|593330397|FG001|0-6 Weeks|Death|1|||
164263322|NCT01154283|593330396|FG000|7-12 Weeks|Death|1|||
164263323|NCT01154283|593330397|FG001|7-12 Weeks|Death|0|||
164263324|NCT01154283|593330396|FG000|7-12 Weeks|Withdrawal by Subject|0|||
164263325|NCT01154283|593330397|FG001|7-12 Weeks|Withdrawal by Subject|1|||
164263326|NCT04063787|593330398|FG000|Overall Study|Inadequate Doppler data|4|||
164263327|NCT04063787|593330398|FG000|Overall Study|Lost to Follow-up|2|||
164263328|NCT04063787|593330398|FG000|Overall Study|Death|3|||
164263329|NCT00320372|593330399|FG000|Overall Study|Physician Decision|4|||
164263330|NCT00320372|593330400|FG001|Overall Study|Physician Decision|7|||
164263331|NCT00320372|593330399|FG000|Overall Study|Death|7|||
164263332|NCT00320372|593330400|FG001|Overall Study|Death|8|||
164263333|NCT00320372|593330399|FG000|Overall Study|Withdrawal by Subject|55|||
164263334|NCT00320372|593330400|FG001|Overall Study|Withdrawal by Subject|37|||
164340863|NCT00739674|593623791|FG000|Overall Study|Non compliant|4|||
164340864|NCT00739674|593623792|FG001|Overall Study|Non compliant|0|||
164340865|NCT00739674|593623791|FG000|Overall Study|Unable to attend visit|3|||
164340866|NCT00739674|593623792|FG001|Overall Study|Unable to attend visit|1|||
164340867|NCT00739674|593623791|FG000|Overall Study|Home monitoring off meds|1|||
164340868|NCT00739674|593623792|FG001|Overall Study|Home monitoring off meds|0|||
164340869|NCT00739674|593623791|FG000|Overall Study|Erectile dysfunction|0|||
164263335|NCT00320372|593330399|FG000|Overall Study|Non-Compliance|40|||
164263336|NCT00320372|593330400|FG001|Overall Study|Non-Compliance|39|||
164263337|NCT00320372|593330399|FG000|Overall Study|Did not Meet (I/E)|3|||
164263338|NCT00320372|593330400|FG001|Overall Study|Did not Meet (I/E)|1|||
164340870|NCT00739674|593623792|FG001|Overall Study|Erectile dysfunction|1|||
164263339|NCT00320372|593330399|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
164263340|NCT00320372|593330400|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
164263341|NCT01416441|593330401|FG000|Overall Study|Lost to Follow-up|5|||
164263342|NCT01416441|593330401|FG000|Overall Study|Adverse Event|6|||
164263343|NCT01416441|593330401|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
164340871|NCT01897454|593623794|FG000|Overall Study|Withdrawal by Subject|1|||
164263344|NCT01416441|593330401|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
164263345|NCT01416441|593330401|FG000|Overall Study|Investigator Withdrew Subject|2|||
164263346|NCT01416441|593330401|FG000|Overall Study|Subject Withdrew Consent|12|||
164263347|NCT01416441|593330401|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
164263348|NCT03959982|593331776|FG000|Overall Study|Withdrawal by Subject|1|||
164263349|NCT03959982|593331777|FG001|Overall Study|Withdrawal by Subject|0|||
164263350|NCT03959982|593331776|FG000|Overall Study|Physician Decision|2|||
164263351|NCT03959982|593331777|FG001|Overall Study|Physician Decision|0|||
164263352|NCT03959982|593331776|FG000|Overall Study|Lost to Follow-up|1|||
164263353|NCT03959982|593331777|FG001|Overall Study|Lost to Follow-up|0|||
164263354|NCT04030247|593331778|FG000|Overall Study|Withdrawal by Subject|4|||
164263355|NCT04030247|593331778|FG000|Overall Study|Lost to Follow-up|13|||
164263356|NCT02191605|593331779|FG000|Overall Study|Lost to Follow-up|9|||
164263357|NCT02191605|593331780|FG001|Overall Study|Lost to Follow-up|4|||
164263358|NCT02191605|593331781|FG002|Overall Study|Lost to Follow-up|7|||
164263359|NCT02191605|593331782|FG003|Overall Study|Lost to Follow-up|3|||
164263360|NCT02191605|593331783|FG004|Overall Study|Lost to Follow-up|4|||
164263361|NCT01309269|593331786|FG000|Overall Study|Adverse Event|56|||
164263362|NCT01309269|593331786|FG000|Overall Study|Withdrawal by Subject|25|||
164263363|NCT01309269|593331786|FG000|Overall Study|Lack of Acceptance|15|||
164263364|NCT01309269|593331786|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
164263365|NCT01309269|593331786|FG000|Overall Study|Kidney Transplant|25|||
164263366|NCT01309269|593331786|FG000|Overall Study|Administrative Problems|141|||
164263367|NCT01309269|593331786|FG000|Overall Study|Other|256|||
164263368|NCT01309269|593331786|FG000|Overall Study|Other|1|||
164263369|NCT01309269|593331786|FG000|Overall Study|Study Completion Data Not Recorded|95|||
164263370|NCT01309269|593331786|FG000|Overall Study|Enrolled but not Treated|107|||
164263371|NCT03647267|593331803|FG000|Overall Study|Lost to Follow-up|1|||
164263372|NCT03647267|593331804|FG001|Overall Study|Lost to Follow-up|0|||
164263373|NCT05079477|593331805|FG000|Overall Study|Lost to Follow-up|2|||
164263374|NCT05079477|593331806|FG001|Overall Study|Lost to Follow-up|0|||
164263375|NCT05079477|593331805|FG000|Overall Study|Withdrawal by Subject|1|||
164263376|NCT05079477|593331806|FG001|Overall Study|Withdrawal by Subject|0|||
164263377|NCT05079477|593331805|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
164263378|NCT05079477|593331806|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
164263379|NCT05079477|593331805|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
164263380|NCT05079477|593331806|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
164263381|NCT05320393|593331809|FG000|Overall Study|Withdrawal by Subject|1|||
164263382|NCT05320393|593331810|FG001|Overall Study|Withdrawal by Subject|0|||
164263383|NCT05320393|593331811|FG002|Overall Study|Withdrawal by Subject|2|||
164263384|NCT05320393|593331809|FG000|Overall Study|Lost to Follow-up|1|||
164263385|NCT05320393|593331810|FG001|Overall Study|Lost to Follow-up|2|||
164263386|NCT05320393|593331811|FG002|Overall Study|Lost to Follow-up|1|||
164263387|NCT05320393|593331809|FG000|Overall Study|Moved; too much driving|0|||
164263388|NCT05320393|593331810|FG001|Overall Study|Moved; too much driving|0|||
164263389|NCT05320393|593331811|FG002|Overall Study|Moved; too much driving|2|||
164263390|NCT05320393|593331809|FG000|Overall Study|Did not receive treatment|0|||
164263391|NCT05320393|593331810|FG001|Overall Study|Did not receive treatment|0|||
164263392|NCT05320393|593331811|FG002|Overall Study|Did not receive treatment|1|||
164263393|NCT04411420|593331813|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
164263394|NCT04411420|593331814|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
164263395|NCT04411420|593331813|FG000|Survey Subset|Lost to Follow-up|134|||
164263396|NCT04411420|593331814|FG001|Survey Subset|Lost to Follow-up|120|||
164263397|NCT03187834|593331815|FG000|Overall Study|Lost to Follow-up|0|||
164263398|NCT03187834|593331816|FG001|Overall Study|Lost to Follow-up|1|||
164263399|NCT03187834|593331817|FG002|Overall Study|Lost to Follow-up|2|||
164263400|NCT03187834|593331818|FG003|Overall Study|Lost to Follow-up|2|||
164263401|NCT03187834|593331815|FG000|Overall Study|Had invalid anthropometric measurements|5|||
164263402|NCT03187834|593331816|FG001|Overall Study|Had invalid anthropometric measurements|3|||
164263403|NCT03187834|593331817|FG002|Overall Study|Had invalid anthropometric measurements|4|||
164263404|NCT03187834|593331818|FG003|Overall Study|Had invalid anthropometric measurements|2|||
164263405|NCT00240110|593331819|FG000|Overall Study|Lost to Follow-up|6|||
164263406|NCT00240110|593331820|FG001|Overall Study|Lost to Follow-up|7|||
164263407|NCT01344538|593331822|FG000|Overall Study|Adverse Event|1|||
164263408|NCT01344538|593331823|FG001|Overall Study|Adverse Event|1|||
164263409|NCT01344538|593331822|FG000|Overall Study|Lost to Follow-up|1|||
164263410|NCT01344538|593331823|FG001|Overall Study|Lost to Follow-up|0|||
164263411|NCT01655381|593331824|FG000|Overall Study|Investigator Decision|1|||
164577578|NCT04112914|594479341|FG000|Overall Study|Lost to Follow-up|13|||
164577579|NCT04112914|594479342|FG001|Overall Study|Lost to Follow-up|9|||
164263412|NCT01655381|593331824|FG000|Overall Study|Moved to Another City|1|||
164340872|NCT02195583|593623796|FG000|Overall Study|Lost to Follow-up|1|||
164263413|NCT01655381|593331824|FG000|Overall Study|Insufficient Treatment Response|1|||
164263414|NCT04195438|593331825|FG000|Overall Study|Withdrawal by Subject|1|||
164263415|NCT00613925|593331826|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
164263416|NCT00613925|593331827|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
164263417|NCT01156389|593331830|FG000|Overall Study|Elevated liver enzymes|4|||
164263418|NCT01156389|593331831|FG001|Overall Study|Elevated liver enzymes|0|||
164263419|NCT01156389|593331830|FG000|Overall Study|Vomiting|0|||
164263420|NCT01156389|593331831|FG001|Overall Study|Vomiting|1|||
164263421|NCT01703117|593331832|FG000|Overall Study|Adverse Event|4|||
164263422|NCT01703117|593331833|FG001|Overall Study|Adverse Event|3|||
164263423|NCT01703117|593331832|FG000|Overall Study|Withdrawal by Subject|0|||
164263424|NCT01703117|593331833|FG001|Overall Study|Withdrawal by Subject|1|||
164263425|NCT00350623|593331834|FG000|Overall Study|Lost to Follow-up|8|||
164263426|NCT00350623|593331835|FG001|Overall Study|Lost to Follow-up|3|||
164263427|NCT00350623|593331836|FG002|Overall Study|Lost to Follow-up|4|||
164263428|NCT00350623|593331834|FG000|Overall Study|Withdrawal by Subject|0|||
164263429|NCT00350623|593331835|FG001|Overall Study|Withdrawal by Subject|1|||
164263430|NCT00350623|593331836|FG002|Overall Study|Withdrawal by Subject|1|||
164263431|NCT00350623|593331834|FG000|Overall Study|patient traveling outside the country|0|||
164263432|NCT00350623|593331835|FG001|Overall Study|patient traveling outside the country|0|||
164263433|NCT00350623|593331836|FG002|Overall Study|patient traveling outside the country|1|||
164340873|NCT02195583|593623796|FG000|Overall Study|Withdrawal by Subject|4|||
164340874|NCT02195583|593623796|FG000|Overall Study|Adverse Event|2|||
164340875|NCT02195583|593623796|FG000|Overall Study|Other Reason|2|||
164340876|NCT01560403|593623797|FG000|Overall Study|Lost to Follow-up|0|||
164340877|NCT01560403|593623798|FG001|Overall Study|Lost to Follow-up|1|||
164340878|NCT00983437|593623800|FG000|Overall Study|Adverse Event|9|||
164340879|NCT00983437|593623800|FG000|Overall Study|Lack of Efficacy|1|||
164340880|NCT00983437|593623800|FG000|Overall Study|Withdrawal by Subject|8|||
164340881|NCT00983437|593623800|FG000|Overall Study|Noncompliance to Study Procedures|1|||
164340882|NCT00983437|593623800|FG000|Overall Study|Lost to Follow-up|2|||
164340883|NCT00983437|593623800|FG000|Overall Study|Other Reason|26|||
164340884|NCT04019288|593623801|FG000|Overall Study|Death|1|||
164340885|NCT04019288|593623802|FG001|Overall Study|Death|0|||
164577580|NCT04112914|594479341|FG000|Overall Study|Withdrawal by Subject|1|||
164577581|NCT04112914|594479342|FG001|Overall Study|Withdrawal by Subject|0|||
164577582|NCT00768560|594479343|FG000|Intervention Set 1|Adverse Event|0|||
164577583|NCT00768560|594479344|FG001|Intervention Set 1|Adverse Event|1|||
164577584|NCT00768560|594479345|FG002|Intervention Set 1|Adverse Event|0|||
164577585|NCT00768560|594479346|FG003|Intervention Set 1|Adverse Event|0|||
164577586|NCT00768560|594479347|FG004|Intervention Set 1|Adverse Event|0|||
164577587|NCT00768560|594479348|FG005|Intervention Set 1|Adverse Event|0|||
164577588|NCT02635204|594479349|FG000|Overall Study|Adverse Event|1|||
164577589|NCT02635204|594479350|FG001|Overall Study|Adverse Event|0|||
164577590|NCT02635204|594479349|FG000|Overall Study|Lost to Follow-up|1|||
164577591|NCT02635204|594479350|FG001|Overall Study|Lost to Follow-up|1|||
164577592|NCT00389207|594479351|FG000|Overall Study|Adverse Event|26|||
164577593|NCT00389207|594479352|FG001|Overall Study|Adverse Event|32|||
164577594|NCT00389207|594479353|FG002|Overall Study|Adverse Event|10|||
164577595|NCT00389207|594479351|FG000|Overall Study|Protocol Violation|3|||
164577596|NCT00389207|594479352|FG001|Overall Study|Protocol Violation|1|||
164577597|NCT00389207|594479353|FG002|Overall Study|Protocol Violation|4|||
164577598|NCT00389207|594479351|FG000|Overall Study|Lost to Follow-up|12|||
164577599|NCT00389207|594479352|FG001|Overall Study|Lost to Follow-up|9|||
164577600|NCT00389207|594479353|FG002|Overall Study|Lost to Follow-up|7|||
164577601|NCT00389207|594479351|FG000|Overall Study|Withdrawal by Subject|5|||
164577602|NCT00389207|594479352|FG001|Overall Study|Withdrawal by Subject|7|||
164577603|NCT00389207|594479353|FG002|Overall Study|Withdrawal by Subject|11|||
164577604|NCT00389207|594479351|FG000|Overall Study|Other|17|||
164577605|NCT00389207|594479352|FG001|Overall Study|Other|23|||
164577606|NCT00389207|594479353|FG002|Overall Study|Other|9|||
164577607|NCT04283461|594479356|FG000|Overall Study|Enrolled in separate trial|0|||
164577608|NCT04283461|594479357|FG001|Overall Study|Enrolled in separate trial|0|||
164577609|NCT04283461|594479358|FG002|Overall Study|Enrolled in separate trial|8|||
164577610|NCT04283461|594479359|FG003|Overall Study|Enrolled in separate trial|13|||
164577611|NCT04283461|594479360|FG004|Overall Study|Enrolled in separate trial|12|||
164577612|NCT04283461|594479361|FG005|Overall Study|Enrolled in separate trial|0|||
164681880|NCT03428750|594858216|FG001|Overall Study|Protocol Violation|0|||
164681881|NCT03428750|594858215|FG000|Overall Study|Administrative|0|||
164681882|NCT03428750|594858216|FG001|Overall Study|Administrative|1|||
164681883|NCT00274651|594858219|FG000|Overall Study|Adverse Event|6|||
164577613|NCT04283461|594479362|FG006|Overall Study|Enrolled in separate trial|0|||
164263434|NCT00330928|593331853|FG000|Overall Study|Lost to Follow-up|6|||
164263435|NCT00330928|593331853|FG000|Overall Study|Physician Decision|9|||
164263436|NCT00330928|593331853|FG000|Overall Study|Death|1|||
164340886|NCT04019288|593623803|FG002|Overall Study|Death|0|||
164577614|NCT04283461|594479363|FG007|Overall Study|Enrolled in separate trial|8|||
164577615|NCT04283461|594479364|FG008|Overall Study|Enrolled in separate trial|0|||
164577616|NCT04283461|594479365|FG009|Overall Study|Enrolled in separate trial|0|||
164577617|NCT04283461|594479366|FG010|Overall Study|Enrolled in separate trial|0|||
164577618|NCT04283461|594479367|FG011|Overall Study|Enrolled in separate trial|7|||
164681884|NCT00274651|594858220|FG001|Overall Study|Adverse Event|3|||
164263437|NCT00330928|593331853|FG000|Overall Study|IVUS could not be performed.|1|||
164263438|NCT03028480|593331854|FG000|Overall Study|No revisit after the first prescription date|2|||
164263439|NCT03028480|593331854|FG000|Overall Study|Did not use the drug|1|||
164577619|NCT04283461|594479368|FG012|Overall Study|Enrolled in separate trial|0|||
164577620|NCT05490771|594479369|FG000|Overall Study|Disease progression|18|||
164577621|NCT05490771|594479369|FG000|Overall Study|Adverse Event|3|||
164577622|NCT05490771|594479369|FG000|Overall Study|Other complicating disease|1|||
164577623|NCT05490771|594479369|FG000|Overall Study|Withdrawal by Subject|3|||
164577624|NCT05490771|594479369|FG000|Overall Study|Physician Decision|1|||
164577625|NCT05490771|594479369|FG000|Overall Study|Still on treatment|2|||
164577626|NCT05490771|594479369|FG000|Overall Study|Never start protocol therapy|5|||
164577627|NCT05490771|594479369|FG000|Overall Study|Ineligible|2|||
164577628|NCT00424398|594479375|FG000|Overall Study|Withdrawal by Subject|2|||
164577629|NCT00424398|594479376|FG001|Overall Study|Withdrawal by Subject|1|||
164577630|NCT00424398|594479377|FG002|Overall Study|Withdrawal by Subject|0|||
164577631|NCT00424398|594479375|FG000|Overall Study|Subject met exclusion criteria|1|||
164577632|NCT00424398|594479376|FG001|Overall Study|Subject met exclusion criteria|0|||
164577633|NCT00424398|594479377|FG002|Overall Study|Subject met exclusion criteria|0|||
164577634|NCT01023789|594479378|FG000|3 - Year Visit|Death|29|||
164577635|NCT01023789|594479378|FG000|3 - Year Visit|Withdrawal of consent|1|||
164577636|NCT01023789|594479378|FG000|3 - Year Visit|Lost to Follow-up|13|||
164577637|NCT02115308|594479389|FG000|Overall Study|Safety Screening|2|||
164577638|NCT02115308|594479390|FG001|Overall Study|Safety Screening|2|||
164577639|NCT01309737|594479391|FG000|Week 0 to 16|Death|1|||
164577640|NCT01309737|594479392|FG001|Week 0 to 16|Death|0|||
164577641|NCT01309737|594479393|FG002|Week 0 to 16|Death|1|||
164577642|NCT01309737|594479394|FG003|Week 0 to 16|Death|0|||
164577643|NCT01309737|594479395|FG004|Week 0 to 16|Death|0|||
164577644|NCT01309737|594479391|FG000|Week 0 to 16|Adverse Event|11|||
164577645|NCT01309737|594479392|FG001|Week 0 to 16|Adverse Event|10|||
164577646|NCT01309737|594479393|FG002|Week 0 to 16|Adverse Event|5|||
164577647|NCT01309737|594479394|FG003|Week 0 to 16|Adverse Event|0|||
164577648|NCT01309737|594479395|FG004|Week 0 to 16|Adverse Event|0|||
164577649|NCT01309737|594479391|FG000|Week 0 to 16|Lack of Efficacy|15|||
164577650|NCT01309737|594479392|FG001|Week 0 to 16|Lack of Efficacy|2|||
164577651|NCT01309737|594479393|FG002|Week 0 to 16|Lack of Efficacy|24|||
164577652|NCT01309737|594479394|FG003|Week 0 to 16|Lack of Efficacy|0|||
164577653|NCT01309737|594479395|FG004|Week 0 to 16|Lack of Efficacy|0|||
164577654|NCT01309737|594479391|FG000|Week 0 to 16|Lost to Follow-up|7|||
164577655|NCT01309737|594479392|FG001|Week 0 to 16|Lost to Follow-up|8|||
164577656|NCT01309737|594479393|FG002|Week 0 to 16|Lost to Follow-up|3|||
164577657|NCT01309737|594479394|FG003|Week 0 to 16|Lost to Follow-up|0|||
164577658|NCT01309737|594479395|FG004|Week 0 to 16|Lost to Follow-up|0|||
164577659|NCT01309737|594479391|FG000|Week 0 to 16|Withdrawal by Subject|7|||
164577660|NCT01309737|594479392|FG001|Week 0 to 16|Withdrawal by Subject|6|||
164577661|NCT01309737|594479393|FG002|Week 0 to 16|Withdrawal by Subject|7|||
164577662|NCT01309737|594479394|FG003|Week 0 to 16|Withdrawal by Subject|0|||
164577663|NCT01309737|594479395|FG004|Week 0 to 16|Withdrawal by Subject|0|||
164577664|NCT01309737|594479391|FG000|Week 0 to 16|Other|10|||
164577665|NCT01309737|594479392|FG001|Week 0 to 16|Other|14|||
164577666|NCT01309737|594479393|FG002|Week 0 to 16|Other|4|||
164577667|NCT01309737|594479394|FG003|Week 0 to 16|Other|0|||
164577668|NCT01309737|594479395|FG004|Week 0 to 16|Other|0|||
164577669|NCT01309737|594479391|FG000|Week 0 to 16|Randomized, but not treated|1|||
164577670|NCT01309737|594479392|FG001|Week 0 to 16|Randomized, but not treated|0|||
164577671|NCT01309737|594479393|FG002|Week 0 to 16|Randomized, but not treated|0|||
164577672|NCT01309737|594479394|FG003|Week 0 to 16|Randomized, but not treated|0|||
164577673|NCT01309737|594479395|FG004|Week 0 to 16|Randomized, but not treated|0|||
164577674|NCT01309737|594479391|FG000|Week 16 to 52|Death|0|||
164577675|NCT01309737|594479392|FG001|Week 16 to 52|Death|0|||
164577676|NCT01309737|594479393|FG002|Week 16 to 52|Death|0|||
164577677|NCT01309737|594479394|FG003|Week 16 to 52|Death|0|||
164577678|NCT01309737|594479395|FG004|Week 16 to 52|Death|1|||
164577679|NCT01309737|594479391|FG000|Week 16 to 52|Adverse Event|7|||
164577680|NCT01309737|594479392|FG001|Week 16 to 52|Adverse Event|7|||
164577681|NCT01309737|594479393|FG002|Week 16 to 52|Adverse Event|0|||
164577682|NCT01309737|594479394|FG003|Week 16 to 52|Adverse Event|6|||
164577683|NCT01309737|594479395|FG004|Week 16 to 52|Adverse Event|5|||
164577684|NCT01309737|594479391|FG000|Week 16 to 52|Lack of Efficacy|107|||
164577685|NCT01309737|594479392|FG001|Week 16 to 52|Lack of Efficacy|76|||
164577686|NCT01309737|594479393|FG002|Week 16 to 52|Lack of Efficacy|0|||
164577687|NCT01309737|594479394|FG003|Week 16 to 52|Lack of Efficacy|25|||
164577688|NCT01309737|594479395|FG004|Week 16 to 52|Lack of Efficacy|21|||
164577689|NCT01309737|594479391|FG000|Week 16 to 52|Lost to Follow-up|4|||
164577690|NCT01309737|594479392|FG001|Week 16 to 52|Lost to Follow-up|2|||
164577691|NCT01309737|594479393|FG002|Week 16 to 52|Lost to Follow-up|0|||
164577692|NCT01309737|594479394|FG003|Week 16 to 52|Lost to Follow-up|1|||
164577693|NCT01309737|594479395|FG004|Week 16 to 52|Lost to Follow-up|4|||
164577694|NCT01309737|594479391|FG000|Week 16 to 52|Withdrawal by Subject|5|||
164577695|NCT01309737|594479392|FG001|Week 16 to 52|Withdrawal by Subject|6|||
164681885|NCT00274651|594858219|FG000|Overall Study|Lack of Efficacy|13|||
164681886|NCT00274651|594858220|FG001|Overall Study|Lack of Efficacy|6|||
164681887|NCT00274651|594858219|FG000|Overall Study|Death|1|||
164681888|NCT00274651|594858220|FG001|Overall Study|Death|3|||
164681889|NCT00274651|594858219|FG000|Overall Study|Withdrawal by Subject|0|||
164681890|NCT00274651|594858220|FG001|Overall Study|Withdrawal by Subject|1|||
164681891|NCT00274651|594858219|FG000|Overall Study|Physician Decision|8|||
164681892|NCT00274651|594858220|FG001|Overall Study|Physician Decision|7|||
164681893|NCT04474405|594858221|FG000|Overall Study|Withdrawal by Subject|0|||
164681894|NCT04474405|594858222|FG001|Overall Study|Withdrawal by Subject|0|||
164681895|NCT04474405|594858223|FG002|Overall Study|Withdrawal by Subject|1|||
164681896|NCT04474405|594858224|FG003|Overall Study|Withdrawal by Subject|0|||
164681897|NCT04474405|594858225|FG004|Overall Study|Withdrawal by Subject|1|||
164681898|NCT04474405|594858226|FG005|Overall Study|Withdrawal by Subject|0|||
164681899|NCT04474405|594858221|FG000|Overall Study|Other|0|||
164681900|NCT04474405|594858222|FG001|Overall Study|Other|0|||
164681901|NCT04474405|594858223|FG002|Overall Study|Other|0|||
164681902|NCT04474405|594858224|FG003|Overall Study|Other|0|||
164681903|NCT04474405|594858225|FG004|Overall Study|Other|3|||
164681904|NCT04474405|594858226|FG005|Overall Study|Other|0|||
164681905|NCT03446768|594858227|FG000|Overall Study|Withdrawal by Subject|0|||
164681906|NCT03446768|594858228|FG001|Overall Study|Withdrawal by Subject|1|||
164681907|NCT01604941|594858232|FG000|Overall Study|Adverse Event|1|||
164681908|NCT01604941|594858233|FG001|Overall Study|Adverse Event|2|||
164681909|NCT01604941|594858234|FG002|Overall Study|Adverse Event|0|||
164681910|NCT01604941|594858235|FG003|Overall Study|Adverse Event|0|||
164681911|NCT01604941|594858236|FG004|Overall Study|Adverse Event|1|||
164681912|NCT01604941|594858237|FG005|Overall Study|Adverse Event|5|||
164681913|NCT01604941|594858232|FG000|Overall Study|Non-compliance|1|||
164681914|NCT01604941|594858233|FG001|Overall Study|Non-compliance|0|||
164681915|NCT01604941|594858234|FG002|Overall Study|Non-compliance|0|||
164681916|NCT01604941|594858235|FG003|Overall Study|Non-compliance|0|||
164681917|NCT01604941|594858236|FG004|Overall Study|Non-compliance|0|||
164681918|NCT01604941|594858237|FG005|Overall Study|Non-compliance|0|||
164681919|NCT01604941|594858232|FG000|Overall Study|Participant Decision|0|||
164681920|NCT01604941|594858233|FG001|Overall Study|Participant Decision|0|||
164681921|NCT01604941|594858234|FG002|Overall Study|Participant Decision|0|||
164681922|NCT01604941|594858235|FG003|Overall Study|Participant Decision|0|||
164681923|NCT01604941|594858236|FG004|Overall Study|Participant Decision|0|||
164681924|NCT01604941|594858237|FG005|Overall Study|Participant Decision|2|||
164681925|NCT01604941|594858232|FG000|Overall Study|Early Study Termination|9|||
164681926|NCT01604941|594858233|FG001|Overall Study|Early Study Termination|2|||
164681927|NCT01604941|594858234|FG002|Overall Study|Early Study Termination|3|||
164681928|NCT01604941|594858235|FG003|Overall Study|Early Study Termination|3|||
164681929|NCT01604941|594858236|FG004|Overall Study|Early Study Termination|0|||
164681930|NCT01604941|594858237|FG005|Overall Study|Early Study Termination|0|||
164681931|NCT01410227|594858238|FG000|Overall Study|Adverse Event|1|||
164681932|NCT01410227|594858239|FG001|Overall Study|Adverse Event|0|||
164681933|NCT01410227|594858240|FG002|Overall Study|Adverse Event|0|||
164681934|NCT01410227|594858241|FG003|Overall Study|Adverse Event|0|||
164681935|NCT01410227|594858238|FG000|Overall Study|Withdrawal by Subject|3|||
164681936|NCT01410227|594858239|FG001|Overall Study|Withdrawal by Subject|0|||
164681937|NCT01410227|594858240|FG002|Overall Study|Withdrawal by Subject|1|||
164681938|NCT01410227|594858241|FG003|Overall Study|Withdrawal by Subject|0|||
164263440|NCT03028480|593331854|FG000|Overall Study|Violation of the enrollment deadline|10|||
164263441|NCT03028480|593331854|FG000|Overall Study|Case report forms were not collected|21|||
164263442|NCT04706273|593331857|FG000|Overall Study|Withdrawal by Subject|27|||
164263443|NCT04706273|593331857|FG000|Overall Study|Physician Decision|1|||
164263444|NCT04706273|593331857|FG000|Overall Study|Lost to Follow-up|42|||
164263445|NCT04706273|593331857|FG000|Overall Study|Death|85|||
164263446|NCT04706273|593331857|FG000|Overall Study|Amputation that removes study device|2|||
164681939|NCT01410227|594858238|FG000|Overall Study|Pregnancy|0|||
164681940|NCT01410227|594858239|FG001|Overall Study|Pregnancy|0|||
164681941|NCT01410227|594858240|FG002|Overall Study|Pregnancy|0|||
164681942|NCT01410227|594858241|FG003|Overall Study|Pregnancy|1|||
164681943|NCT01410227|594858238|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
164263447|NCT04706273|593331857|FG000|Overall Study|Surgical bypass|3|||
164263448|NCT04706273|593331857|FG000|Overall Study|Changing hospital|23|||
164681944|NCT01410227|594858239|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
164681945|NCT01410227|594858240|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
164681946|NCT01410227|594858241|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
164681947|NCT00606281|594858242|FG000|Overall Study|Adverse Event|11|||
164681948|NCT00606281|594858243|FG001|Overall Study|Adverse Event|12|||
164681949|NCT00606281|594858242|FG000|Overall Study|Death|1|||
164681950|NCT00606281|594858243|FG001|Overall Study|Death|0|||
164681951|NCT00606281|594858242|FG000|Overall Study|Lack of Efficacy|28|||
164681952|NCT00606281|594858243|FG001|Overall Study|Lack of Efficacy|35|||
164681953|NCT00606281|594858242|FG000|Overall Study|Physician Decision|0|||
164681954|NCT00606281|594858243|FG001|Overall Study|Physician Decision|1|||
164681955|NCT00606281|594858242|FG000|Overall Study|Protocol Violation|3|||
164681956|NCT00606281|594858243|FG001|Overall Study|Protocol Violation|3|||
164681957|NCT00606281|594858242|FG000|Overall Study|Withdrawal by Subject|11|||
164681958|NCT00606281|594858243|FG001|Overall Study|Withdrawal by Subject|13|||
164681959|NCT00606281|594858242|FG000|Overall Study|Progression to depressive phase|1|||
164681960|NCT00606281|594858243|FG001|Overall Study|Progression to depressive phase|1|||
164681961|NCT00606281|594858242|FG000|Overall Study|Change of residence or other commitments|1|||
164681962|NCT00606281|594858243|FG001|Overall Study|Change of residence or other commitments|1|||
164681963|NCT00540423|594858245|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164681964|NCT00540423|594858246|FG001|Double-Blind Treatment Period|Adverse Event|1|||
164681965|NCT00540423|594858247|FG002|Double-Blind Treatment Period|Adverse Event|0|||
164681966|NCT00540423|594858245|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
164681967|NCT00540423|594858246|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
164681968|NCT00540423|594858247|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
164681969|NCT03131895|594858248|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
164681970|NCT03131895|594858249|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
164681971|NCT03131895|594858250|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
164681972|NCT03131895|594858251|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
164681973|NCT03131895|594858248|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
164681974|NCT03131895|594858249|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
164681975|NCT03131895|594858250|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
164681976|NCT03131895|594858251|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
164681977|NCT03131895|594858248|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
164681978|NCT03131895|594858249|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
164681979|NCT03131895|594858250|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
164681980|NCT03131895|594858251|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
164681981|NCT03131895|594858248|FG000|Washout Period (at Least 5 Days)|Other|0|||
164681982|NCT03131895|594858249|FG001|Washout Period (at Least 5 Days)|Other|0|||
164681983|NCT03131895|594858250|FG002|Washout Period (at Least 5 Days)|Other|2|||
164681984|NCT03131895|594858251|FG003|Washout Period (at Least 5 Days)|Other|0|||
164681985|NCT03131895|594858248|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
164681986|NCT03131895|594858249|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
164681987|NCT03131895|594858250|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
164681988|NCT03131895|594858251|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
164681989|NCT03131895|594858248|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
164681990|NCT03131895|594858249|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
164681991|NCT03131895|594858250|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
164681992|NCT03131895|594858251|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
164577696|NCT01309737|594479393|FG002|Week 16 to 52|Withdrawal by Subject|0|||
164577697|NCT01309737|594479394|FG003|Week 16 to 52|Withdrawal by Subject|0|||
164577698|NCT01309737|594479395|FG004|Week 16 to 52|Withdrawal by Subject|2|||
164577699|NCT01309737|594479391|FG000|Week 16 to 52|Other|10|||
164577700|NCT01309737|594479392|FG001|Week 16 to 52|Other|12|||
164577701|NCT01309737|594479393|FG002|Week 16 to 52|Other|0|||
164577702|NCT01309737|594479394|FG003|Week 16 to 52|Other|2|||
164577703|NCT01309737|594479395|FG004|Week 16 to 52|Other|0|||
164577704|NCT02333227|594479405|FG000|Overall Study|Lost to Follow-up|137|||
164577705|NCT02333227|594479406|FG001|Overall Study|Lost to Follow-up|106|||
164577706|NCT02333227|594479405|FG000|Overall Study|Pregnancy Interrupted|42|||
164577707|NCT02333227|594479406|FG001|Overall Study|Pregnancy Interrupted|89|||
164681993|NCT00731939|594858256|FG000|Overall Study|Adverse Event|6|||
164681994|NCT00731939|594858256|FG000|Overall Study|Lost to Follow-up|15|||
164681995|NCT00731939|594858256|FG000|Overall Study|Not implanted with study device|9|||
164263449|NCT04706273|593331857|FG000|Overall Study|Unable to attend hospital|2|||
164263450|NCT00759356|593331860|FG000|Overall Study|Adverse Event|0|||
164263451|NCT00759356|593331861|FG001|Overall Study|Adverse Event|1|||
164263452|NCT00759356|593331860|FG000|Overall Study|Withdrawal by Subject|0|||
164263453|NCT00759356|593331861|FG001|Overall Study|Withdrawal by Subject|2|||
164263454|NCT00759356|593331860|FG000|Overall Study|Subject was unable to return|1|||
164263455|NCT00759356|593331861|FG001|Overall Study|Subject was unable to return|0|||
164263456|NCT02403635|593331866|FG000|Overall Study|Not eligible|9|||
164263457|NCT00585221|593331870|FG000|Overall Study|Protocol Violation|8|||
164263458|NCT02509052|593331871|FG000|Overall Study|Non compliance|0|||
164577708|NCT02333227|594479405|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
164577709|NCT02333227|594479406|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
164577710|NCT03459040|594479407|FG000|Overall Study|Death|8|||
164577711|NCT03459040|594479407|FG000|Overall Study|Withdrawal by Subject|1|||
164681996|NCT00731939|594858256|FG000|Overall Study|Withdrawal by Subject|2|||
164681997|NCT00731939|594858256|FG000|Overall Study|Did not meet enrollment criteria|2|||
164681998|NCT02213263|594858257|FG000|Overall Study|Insufficient clinical response|4|||
164681999|NCT02213263|594858258|FG001|Overall Study|Insufficient clinical response|3|||
164682000|NCT02213263|594858257|FG000|Overall Study|Lost to Follow-up|0|||
164263459|NCT02509052|593331872|FG001|Overall Study|Non compliance|0|||
164263460|NCT02509052|593331873|FG002|Overall Study|Non compliance|1|||
164263461|NCT03554772|593331877|FG000|Overall Study|Lost to Follow-up|0|||
164263462|NCT03554772|593331878|FG001|Overall Study|Lost to Follow-up|0|||
164263463|NCT03554772|593331879|FG002|Overall Study|Lost to Follow-up|0|||
164263464|NCT03554772|593331880|FG003|Overall Study|Lost to Follow-up|2|||
164263465|NCT03263923|593331881|FG000|Overall Study|Withdrawal by Subject|10|||
164263466|NCT03263923|593331882|FG001|Overall Study|Withdrawal by Subject|8|||
164263467|NCT03263923|593331881|FG000|Overall Study|Lost to Follow-up|15|||
164263468|NCT03263923|593331882|FG001|Overall Study|Lost to Follow-up|13|||
164263469|NCT00241631|593331889|FG000|Run in (2 Weeks)|Physician Decision|3|||
164263470|NCT00241631|593331890|FG001|Run in (2 Weeks)|Physician Decision|3|||
164263471|NCT00241631|593331889|FG000|Phase 1 (4 Weeks)|sore throat|1|||
164263472|NCT00241631|593331890|FG001|Phase 1 (4 Weeks)|sore throat|0|||
164263473|NCT00241631|593331889|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
164263474|NCT00241631|593331890|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
164263475|NCT00241631|593331889|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
164263476|NCT00241631|593331890|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
164263477|NCT00241631|593331889|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
164263478|NCT00241631|593331890|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
164263479|NCT00435162|593331893|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
164263480|NCT00435162|593331894|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
164340887|NCT00094172|593623804|FG000|Overall Study|Adverse Event|0|||
164340888|NCT00094172|593623805|FG001|Overall Study|Adverse Event|1|||
164340889|NCT00094172|593623804|FG000|Overall Study|Lost to Follow-up|2|||
164340890|NCT00094172|593623805|FG001|Overall Study|Lost to Follow-up|0|||
164340891|NCT00094172|593623804|FG000|Overall Study|Protocol Violation|0|||
164340892|NCT00094172|593623805|FG001|Overall Study|Protocol Violation|1|||
164340893|NCT00094172|593623804|FG000|Overall Study|Withdrawal by Subject|10|||
164340894|NCT00094172|593623805|FG001|Overall Study|Withdrawal by Subject|5|||
164340895|NCT00094172|593623804|FG000|Overall Study|Primary endpoint met.|1|||
164340896|NCT00094172|593623805|FG001|Overall Study|Primary endpoint met.|0|||
164340897|NCT00094172|593623804|FG000|Overall Study|Started other MS therapy due to disease|1|||
164340898|NCT00094172|593623805|FG001|Overall Study|Started other MS therapy due to disease|0|||
164340899|NCT00289133|593623813|FG000|Overall Study|Non-study device implanted|12|||
164340900|NCT00289133|593623814|FG001|Overall Study|Non-study device implanted|0|||
164340901|NCT00289133|593623813|FG000|Overall Study|Protocol Violation|32|||
164340902|NCT00289133|593623814|FG001|Overall Study|Protocol Violation|38|||
164340903|NCT00289133|593623813|FG000|Overall Study|Withdrawal by Subject|9|||
164340904|NCT00289133|593623814|FG001|Overall Study|Withdrawal by Subject|10|||
164340905|NCT00289133|593623813|FG000|Overall Study|Death|5|||
164340906|NCT00289133|593623814|FG001|Overall Study|Death|10|||
164340907|NCT00289133|593623813|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
164340908|NCT00289133|593623814|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
164340909|NCT00289133|593623813|FG000|Overall Study|Physician Decision|41|||
164340910|NCT00289133|593623814|FG001|Overall Study|Physician Decision|45|||
164340911|NCT00289133|593623813|FG000|Overall Study|Revision|8|||
164340912|NCT00289133|593623814|FG001|Overall Study|Revision|6|||
164340913|NCT00289133|593623813|FG000|Overall Study|Lost to Follow-up|92|||
164340914|NCT00289133|593623814|FG001|Overall Study|Lost to Follow-up|115|||
164340915|NCT03372096|593623819|FG000|Overall Study|Study Closed|8|||
164340916|NCT00040365|593623820|FG000|Overall Study|Death|1|||
164340917|NCT00040365|593623820|FG000|Overall Study|Progressive disease|7|||
164340918|NCT00040365|593623820|FG000|Overall Study|Lost to Follow-up|3|||
164340919|NCT01397890|593623829|FG000|Overall Study|Withdrawal by Subject|7|||
164340920|NCT01397890|593623830|FG001|Overall Study|Withdrawal by Subject|11|||
164577712|NCT03934684|594479408|FG000|Overall Study|Participants continuing in study|11|||
164577713|NCT03934684|594479409|FG001|Overall Study|Participants continuing in study|4|||
164577714|NCT03934684|594479408|FG000|Overall Study|Discontinuation of carfilzomib|20|||
164577715|NCT03934684|594479409|FG001|Overall Study|Discontinuation of carfilzomib|30|||
164577716|NCT03934684|594479408|FG000|Overall Study|Death|2|||
164577717|NCT03934684|594479409|FG001|Overall Study|Death|2|||
164577718|NCT03934684|594479408|FG000|Overall Study|Lost to Follow-up|2|||
164577719|NCT03934684|594479409|FG001|Overall Study|Lost to Follow-up|5|||
164577720|NCT03934684|594479408|FG000|Overall Study|Withdrawal by Subject|7|||
164577721|NCT03934684|594479409|FG001|Overall Study|Withdrawal by Subject|8|||
164577722|NCT01073943|594479410|FG000|Overall Study|Withdrawal by Subject|8|||
164577723|NCT01073943|594479411|FG001|Overall Study|Withdrawal by Subject|2|||
164577724|NCT01073943|594479410|FG000|Overall Study|Protocol Violation|2|||
164577725|NCT01073943|594479411|FG001|Overall Study|Protocol Violation|1|||
164577726|NCT01073943|594479410|FG000|Overall Study|Adverse Event|1|||
164577727|NCT01073943|594479411|FG001|Overall Study|Adverse Event|1|||
164577728|NCT01073943|594479410|FG000|Overall Study|Lost to Follow-up|0|||
164577729|NCT01073943|594479411|FG001|Overall Study|Lost to Follow-up|2|||
164577730|NCT01073943|594479410|FG000|Overall Study|Power outage; colonoscopy not done|1|||
164263481|NCT00435162|593331895|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
164263482|NCT00435162|593331896|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
164340921|NCT01397890|593623829|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
164682001|NCT02213263|594858258|FG001|Overall Study|Lost to Follow-up|1|||
164682002|NCT02213263|594858257|FG000|Overall Study|No longer willing to participate|3|||
164682003|NCT02213263|594858258|FG001|Overall Study|No longer willing to participate|4|||
164682004|NCT02213263|594858257|FG000|Overall Study|Progressive disease|20|||
164682005|NCT02213263|594858258|FG001|Overall Study|Progressive disease|14|||
164682006|NCT02213263|594858257|FG000|Overall Study|Protocol Violation|0|||
164682007|NCT02213263|594858258|FG001|Overall Study|Protocol Violation|1|||
164682008|NCT02213263|594858257|FG000|Overall Study|Adverse Event|1|||
164682009|NCT02213263|594858258|FG001|Overall Study|Adverse Event|3|||
164682010|NCT05752721|594858259|FG000|Overall Study|Lost to Follow-up|22|||
164682011|NCT05752721|594858260|FG001|Overall Study|Lost to Follow-up|20|||
164682012|NCT05752721|594858259|FG000|Overall Study|Withdrawal by Subject|15|||
164682013|NCT05752721|594858260|FG001|Overall Study|Withdrawal by Subject|12|||
164682014|NCT00263588|594858261|FG000|Overall Study|Death|54|||
164682015|NCT00263588|594858262|FG001|Overall Study|Death|90|||
164682016|NCT00263588|594858261|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
164682017|NCT00263588|594858262|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
164682018|NCT00263588|594858261|FG000|Overall Study|Lost to Follow-up|7|||
164682019|NCT00263588|594858262|FG001|Overall Study|Lost to Follow-up|10|||
164682020|NCT00263588|594858261|FG000|Overall Study|Withdrawal by Subject|3|||
164682021|NCT00263588|594858262|FG001|Overall Study|Withdrawal by Subject|4|||
164682022|NCT00263588|594858261|FG000|Overall Study|Protocol Violation|0|||
164682023|NCT00263588|594858262|FG001|Overall Study|Protocol Violation|1|||
164682024|NCT00263588|594858261|FG000|Overall Study|Investigator decision|7|||
164682025|NCT00263588|594858262|FG001|Overall Study|Investigator decision|15|||
164682026|NCT00263588|594858261|FG000|Overall Study|Sponsor terminated study|0|||
164682027|NCT00263588|594858262|FG001|Overall Study|Sponsor terminated study|1|||
164682028|NCT01075282|594858270|FG000|Overall Study|Withdrawal by Subject|11|||
164682029|NCT01075282|594858271|FG001|Overall Study|Withdrawal by Subject|7|||
164682030|NCT01075282|594858272|FG002|Overall Study|Withdrawal by Subject|11|||
164682031|NCT01075282|594858270|FG000|Overall Study|Adverse Event|9|||
164682032|NCT01075282|594858271|FG001|Overall Study|Adverse Event|8|||
164682033|NCT01075282|594858272|FG002|Overall Study|Adverse Event|5|||
164682034|NCT01075282|594858270|FG000|Overall Study|Entry Criteria Not Met|3|||
164682035|NCT01075282|594858271|FG001|Overall Study|Entry Criteria Not Met|2|||
164682036|NCT01075282|594858272|FG002|Overall Study|Entry Criteria Not Met|0|||
164682037|NCT01075282|594858270|FG000|Overall Study|Lost to Follow-up|3|||
164682038|NCT01075282|594858271|FG001|Overall Study|Lost to Follow-up|3|||
164682039|NCT01075282|594858272|FG002|Overall Study|Lost to Follow-up|3|||
164682040|NCT01075282|594858270|FG000|Overall Study|Physician Decision|3|||
164682041|NCT01075282|594858271|FG001|Overall Study|Physician Decision|3|||
164682042|NCT01075282|594858272|FG002|Overall Study|Physician Decision|3|||
164682043|NCT01075282|594858270|FG000|Overall Study|Lack of Efficacy|1|||
164682044|NCT01075282|594858271|FG001|Overall Study|Lack of Efficacy|1|||
164682045|NCT01075282|594858272|FG002|Overall Study|Lack of Efficacy|0|||
164682046|NCT01075282|594858270|FG000|Overall Study|Treatment Non-compliance|1|||
164682047|NCT01075282|594858271|FG001|Overall Study|Treatment Non-compliance|2|||
164682048|NCT01075282|594858272|FG002|Overall Study|Treatment Non-compliance|2|||
164682049|NCT01075282|594858270|FG000|Overall Study|Protocol Violation|0|||
164682050|NCT01075282|594858271|FG001|Overall Study|Protocol Violation|2|||
164682051|NCT01075282|594858272|FG002|Overall Study|Protocol Violation|1|||
164682052|NCT01075282|594858270|FG000|Overall Study|Death|0|||
164682053|NCT01075282|594858271|FG001|Overall Study|Death|1|||
164682054|NCT01075282|594858272|FG002|Overall Study|Death|2|||
164682055|NCT00367133|594858273|FG000|2 Years|Death|20|||
164682056|NCT00367133|594858274|FG001|2 Years|Death|12|||
164682057|NCT00367133|594858275|FG002|2 Years|Death|12|||
164682058|NCT00367133|594858273|FG000|2 Years|Dropped|34|||
164682059|NCT00367133|594858274|FG001|2 Years|Dropped|19|||
164682060|NCT00367133|594858275|FG002|2 Years|Dropped|33|||
164682061|NCT00367133|594858273|FG000|2 Years|Missed visit|4|||
164682062|NCT00367133|594858274|FG001|2 Years|Missed visit|5|||
164682063|NCT00367133|594858275|FG002|2 Years|Missed visit|4|||
164682064|NCT00847535|594858276|FG000|Overall Study|Withdrawal by Subject|2|||
164682065|NCT00847535|594858277|FG001|Overall Study|Withdrawal by Subject|1|||
164682066|NCT00847535|594858278|FG002|Overall Study|Withdrawal by Subject|1|||
164682067|NCT00847535|594858276|FG000|Overall Study|Lost to Follow-up|0|||
164682068|NCT00847535|594858277|FG001|Overall Study|Lost to Follow-up|1|||
164682069|NCT00847535|594858278|FG002|Overall Study|Lost to Follow-up|0|||
164682070|NCT00906399|594858279|FG000|Year 1|Randomized But Not Treated|0|||
164682071|NCT00906399|594858280|FG001|Year 1|Randomized But Not Treated|1|||
164682072|NCT00906399|594858281|FG002|Year 1|Randomized But Not Treated|3|||
164682073|NCT00906399|594858282|FG003|Year 1|Randomized But Not Treated|0|||
164682074|NCT00906399|594858283|FG004|Year 1|Randomized But Not Treated|0|||
164682075|NCT00906399|594858284|FG005|Year 1|Randomized But Not Treated|0|||
164682076|NCT00906399|594858285|FG006|Year 1|Randomized But Not Treated|0|||
164682077|NCT00906399|594858279|FG000|Year 1|Adverse Event|4|||
164682078|NCT00906399|594858280|FG001|Year 1|Adverse Event|22|||
164682079|NCT00906399|594858281|FG002|Year 1|Adverse Event|24|||
164682080|NCT00906399|594858282|FG003|Year 1|Adverse Event|0|||
164682081|NCT00906399|594858283|FG004|Year 1|Adverse Event|0|||
164682082|NCT00906399|594858284|FG005|Year 1|Adverse Event|0|||
164682083|NCT00906399|594858285|FG006|Year 1|Adverse Event|0|||
164682084|NCT00906399|594858279|FG000|Year 1|Lost to Follow-up|4|||
164682085|NCT00906399|594858280|FG001|Year 1|Lost to Follow-up|4|||
164682086|NCT00906399|594858281|FG002|Year 1|Lost to Follow-up|2|||
164682087|NCT00906399|594858282|FG003|Year 1|Lost to Follow-up|0|||
164682088|NCT00906399|594858283|FG004|Year 1|Lost to Follow-up|0|||
164682089|NCT00906399|594858284|FG005|Year 1|Lost to Follow-up|0|||
164682090|NCT00906399|594858285|FG006|Year 1|Lost to Follow-up|0|||
164682091|NCT00906399|594858279|FG000|Year 1|Withdrawal by Subject|30|||
164682092|NCT00906399|594858280|FG001|Year 1|Withdrawal by Subject|32|||
164263483|NCT00435162|593331897|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
164263484|NCT00435162|593331898|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
164263485|NCT00694096|593331899|FG000|Overall Study|Withdrawal by Subject|5|||
164263486|NCT02078102|593331905|FG000|Overall Study|Adverse Event|1|||
164263487|NCT02078102|593331906|FG001|Overall Study|Adverse Event|0|||
164263488|NCT02078102|593331905|FG000|Overall Study|Withdrawal by Subject|1|||
164263489|NCT02078102|593331906|FG001|Overall Study|Withdrawal by Subject|0|||
164263490|NCT02078102|593331905|FG000|Overall Study|Physician Decision|0|||
164263491|NCT02078102|593331906|FG001|Overall Study|Physician Decision|1|||
164263492|NCT02185014|593331907|FG000|Overall Study|Adverse Event|18|||
164263493|NCT02185014|593331907|FG000|Overall Study|Withdrew Consent|8|||
164263494|NCT02185014|593331907|FG000|Overall Study|Lost to Follow-up|4|||
164263495|NCT02185014|593331907|FG000|Overall Study|Lack of Efficacy|14|||
164263496|NCT02185014|593331907|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
164263497|NCT02185014|593331907|FG000|Overall Study|Subject Noncompliance|1|||
164263498|NCT02185014|593331907|FG000|Overall Study|Other|4|||
164263499|NCT02141490|593331908|FG000|Overall Study|Screening failures|4|||
164263500|NCT02141490|593331909|FG001|Overall Study|Screening failures|0|||
164263501|NCT02141490|593331910|FG002|Overall Study|Screening failures|0|||
164263502|NCT01813721|593331911|FG000|Overall Study|Ineligibility determined|63|||
164263503|NCT01813721|593331911|FG000|Overall Study|Withdrawal by Subject|1|||
164263504|NCT02133664|593331912|FG000|Overall Study|Lost to Follow-up|2|||
164263505|NCT02133664|593331913|FG001|Overall Study|Lost to Follow-up|1|||
164263506|NCT02133664|593331912|FG000|Overall Study|Adverse Event|3|||
164263507|NCT02133664|593331913|FG001|Overall Study|Adverse Event|6|||
164263508|NCT03906656|593331914|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
164263509|NCT03906656|593331915|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
164263510|NCT03906656|593331914|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
164263511|NCT03906656|593331915|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
164263512|NCT03906656|593331914|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
164263513|NCT03906656|593331915|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
164263514|NCT03906656|593331914|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
164263515|NCT03906656|593331915|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
164682093|NCT00906399|594858281|FG002|Year 1|Withdrawal by Subject|36|||
164682094|NCT00906399|594858282|FG003|Year 1|Withdrawal by Subject|0|||
164682095|NCT00906399|594858283|FG004|Year 1|Withdrawal by Subject|0|||
164682096|NCT00906399|594858284|FG005|Year 1|Withdrawal by Subject|0|||
164682097|NCT00906399|594858285|FG006|Year 1|Withdrawal by Subject|0|||
164682098|NCT00906399|594858279|FG000|Year 1|Physician Decision|0|||
164682099|NCT00906399|594858280|FG001|Year 1|Physician Decision|1|||
164682100|NCT00906399|594858281|FG002|Year 1|Physician Decision|3|||
164682101|NCT00906399|594858282|FG003|Year 1|Physician Decision|0|||
164682102|NCT00906399|594858283|FG004|Year 1|Physician Decision|0|||
164682103|NCT00906399|594858284|FG005|Year 1|Physician Decision|0|||
164682104|NCT00906399|594858285|FG006|Year 1|Physician Decision|0|||
164682105|NCT00906399|594858279|FG000|Year 1|Death|2|||
164682106|NCT00906399|594858280|FG001|Year 1|Death|1|||
164682107|NCT00906399|594858281|FG002|Year 1|Death|1|||
164682108|NCT00906399|594858282|FG003|Year 1|Death|0|||
164682109|NCT00906399|594858283|FG004|Year 1|Death|0|||
164682110|NCT00906399|594858284|FG005|Year 1|Death|0|||
164682111|NCT00906399|594858285|FG006|Year 1|Death|0|||
164263516|NCT03906656|593331914|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
164263517|NCT03906656|593331915|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
164263518|NCT03906656|593331914|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
164263519|NCT03906656|593331915|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
164682112|NCT00906399|594858279|FG000|Year 1|Other|4|||
164682113|NCT00906399|594858280|FG001|Year 1|Other|2|||
164682114|NCT00906399|594858281|FG002|Year 1|Other|7|||
164682115|NCT00906399|594858282|FG003|Year 1|Other|0|||
164682116|NCT00906399|594858283|FG004|Year 1|Other|0|||
164682117|NCT00906399|594858284|FG005|Year 1|Other|0|||
164682118|NCT00906399|594858285|FG006|Year 1|Other|0|||
164682119|NCT00906399|594858279|FG000|Year 2|Adverse Event|0|||
164577731|NCT01073943|594479411|FG001|Overall Study|Power outage; colonoscopy not done|0|||
164577732|NCT01073943|594479410|FG000|Overall Study|Subject forgot|0|||
164577733|NCT01073943|594479411|FG001|Overall Study|Subject forgot|1|||
164577734|NCT01073943|594479410|FG000|Overall Study|Unable to return for follow-up|0|||
164577735|NCT01073943|594479411|FG001|Overall Study|Unable to return for follow-up|1|||
164577736|NCT01073943|594479410|FG000|Overall Study|Could not tolerate prep|1|||
164577737|NCT01073943|594479411|FG001|Overall Study|Could not tolerate prep|0|||
164577738|NCT05662332|594479412|FG000|Overall Study|Death|3|||
164577739|NCT05662332|594479413|FG001|Overall Study|Death|3|||
164577740|NCT05662332|594479412|FG000|Overall Study|Lost to Follow-up|3|||
164577741|NCT05662332|594479413|FG001|Overall Study|Lost to Follow-up|8|||
164577742|NCT05662332|594479412|FG000|Overall Study|Physician Decision|1|||
164577743|NCT05662332|594479413|FG001|Overall Study|Physician Decision|2|||
164577744|NCT05662332|594479412|FG000|Overall Study|Protocol Deviation|2|||
164577745|NCT05662332|594479413|FG001|Overall Study|Protocol Deviation|1|||
164577746|NCT05662332|594479412|FG000|Overall Study|Withdrawal by Subject|14|||
164577747|NCT05662332|594479413|FG001|Overall Study|Withdrawal by Subject|14|||
164577748|NCT05662332|594479412|FG000|Overall Study|Assigned Treatment by Mistake|5|||
164577749|NCT05662332|594479413|FG001|Overall Study|Assigned Treatment by Mistake|7|||
164577750|NCT05662332|594479412|FG000|Overall Study|Non-compliance with study drug|4|||
164577751|NCT05662332|594479413|FG001|Overall Study|Non-compliance with study drug|1|||
164577752|NCT05662332|594479412|FG000|Overall Study|Due to Bariatric surgery|1|||
164577753|NCT05662332|594479413|FG001|Overall Study|Due to Bariatric surgery|0|||
164577754|NCT05662332|594479412|FG000|Overall Study|Subject Moving out of State|0|||
164577755|NCT05662332|594479413|FG001|Overall Study|Subject Moving out of State|1|||
164577756|NCT05662332|594479412|FG000|Overall Study|Subject Missed the Schedule|1|||
164577757|NCT05662332|594479413|FG001|Overall Study|Subject Missed the Schedule|0|||
164577758|NCT05662332|594479412|FG000|Overall Study|The Patient Moved to Another City|1|||
164577759|NCT05662332|594479413|FG001|Overall Study|The Patient Moved to Another City|0|||
164577760|NCT03248128|594479414|FG000|Overall Study|Lost to Follow-up|1|||
164577761|NCT03248128|594479415|FG001|Overall Study|Lost to Follow-up|0|||
164577762|NCT03248128|594479414|FG000|Overall Study|Withdrawal by Subject|16|||
164577763|NCT03248128|594479415|FG001|Overall Study|Withdrawal by Subject|14|||
164577764|NCT03248128|594479414|FG000|Overall Study|Site Closed|4|||
164577765|NCT03248128|594479415|FG001|Overall Study|Site Closed|3|||
164577766|NCT03248128|594479414|FG000|Overall Study|Randomized, but did not receive treatment|1|||
164577767|NCT03248128|594479415|FG001|Overall Study|Randomized, but did not receive treatment|3|||
164577768|NCT01914679|594479416|FG000|Overall Study|Lack of Efficacy|1|||
164577769|NCT01914679|594479416|FG000|Overall Study|Sponsor terminated study|4|||
164577770|NCT00256295|594479419|FG000|Overall Study|Withdrawal by Subject|3|||
164577771|NCT00256295|594479419|FG000|Overall Study|Death|1|||
164577772|NCT01126580|594479420|FG000|Overall Study|Adverse Event|14|||
164577773|NCT01126580|594479421|FG001|Overall Study|Adverse Event|8|||
164577774|NCT01126580|594479422|FG002|Overall Study|Adverse Event|12|||
164577775|NCT01126580|594479420|FG000|Overall Study|Withdrawal by Subject|11|||
164577776|NCT01126580|594479421|FG001|Overall Study|Withdrawal by Subject|19|||
164577777|NCT01126580|594479422|FG002|Overall Study|Withdrawal by Subject|14|||
164577778|NCT01126580|594479420|FG000|Overall Study|Sponsor Decision|5|||
164577779|NCT01126580|594479421|FG001|Overall Study|Sponsor Decision|4|||
164577780|NCT01126580|594479422|FG002|Overall Study|Sponsor Decision|7|||
164577781|NCT01126580|594479420|FG000|Overall Study|Physician Decision|1|||
164577782|NCT01126580|594479421|FG001|Overall Study|Physician Decision|1|||
164577783|NCT01126580|594479422|FG002|Overall Study|Physician Decision|2|||
164682120|NCT00906399|594858280|FG001|Year 2|Adverse Event|0|||
164682121|NCT00906399|594858281|FG002|Year 2|Adverse Event|0|||
164682122|NCT00906399|594858282|FG003|Year 2|Adverse Event|9|||
164682123|NCT00906399|594858283|FG004|Year 2|Adverse Event|8|||
164682124|NCT00906399|594858284|FG005|Year 2|Adverse Event|11|||
164682125|NCT00906399|594858285|FG006|Year 2|Adverse Event|6|||
164682126|NCT00906399|594858279|FG000|Year 2|Lost to Follow-up|0|||
164682127|NCT00906399|594858280|FG001|Year 2|Lost to Follow-up|0|||
164682128|NCT00906399|594858281|FG002|Year 2|Lost to Follow-up|0|||
164682129|NCT00906399|594858282|FG003|Year 2|Lost to Follow-up|1|||
164682130|NCT00906399|594858283|FG004|Year 2|Lost to Follow-up|4|||
164682131|NCT00906399|594858284|FG005|Year 2|Lost to Follow-up|2|||
164682132|NCT00906399|594858285|FG006|Year 2|Lost to Follow-up|4|||
164682133|NCT00906399|594858279|FG000|Year 2|Withdrawal by Subject|0|||
164682134|NCT00906399|594858280|FG001|Year 2|Withdrawal by Subject|0|||
164682135|NCT00906399|594858281|FG002|Year 2|Withdrawal by Subject|0|||
164682136|NCT00906399|594858282|FG003|Year 2|Withdrawal by Subject|17|||
164682137|NCT00906399|594858283|FG004|Year 2|Withdrawal by Subject|18|||
164682138|NCT00906399|594858284|FG005|Year 2|Withdrawal by Subject|27|||
164682139|NCT00906399|594858285|FG006|Year 2|Withdrawal by Subject|13|||
164682140|NCT00906399|594858279|FG000|Year 2|Physician Decision|0|||
164682141|NCT00906399|594858280|FG001|Year 2|Physician Decision|0|||
164682142|NCT00906399|594858281|FG002|Year 2|Physician Decision|0|||
164682143|NCT00906399|594858282|FG003|Year 2|Physician Decision|0|||
164682144|NCT00906399|594858283|FG004|Year 2|Physician Decision|2|||
164682145|NCT00906399|594858284|FG005|Year 2|Physician Decision|6|||
164682146|NCT00906399|594858285|FG006|Year 2|Physician Decision|3|||
164682147|NCT00906399|594858279|FG000|Year 2|Death|0|||
164682148|NCT00906399|594858280|FG001|Year 2|Death|0|||
164682149|NCT00906399|594858281|FG002|Year 2|Death|0|||
164682150|NCT00906399|594858282|FG003|Year 2|Death|1|||
164682151|NCT00906399|594858283|FG004|Year 2|Death|0|||
164682152|NCT00906399|594858284|FG005|Year 2|Death|0|||
164682153|NCT00906399|594858285|FG006|Year 2|Death|3|||
164682154|NCT00906399|594858279|FG000|Year 2|Other|0|||
164682155|NCT00906399|594858280|FG001|Year 2|Other|0|||
164682156|NCT00906399|594858281|FG002|Year 2|Other|0|||
164682157|NCT00906399|594858282|FG003|Year 2|Other|2|||
164682158|NCT00906399|594858283|FG004|Year 2|Other|3|||
164682159|NCT00906399|594858284|FG005|Year 2|Other|1|||
164682160|NCT00906399|594858285|FG006|Year 2|Other|0|||
164682161|NCT00624286|594858286|FG000|Overall Study|Protocol Deviation|7|||
164682162|NCT00624286|594858287|FG001|Overall Study|Protocol Deviation|9|||
164682163|NCT00624286|594858286|FG000|Overall Study|Adverse Event|6|||
164682164|NCT00624286|594858287|FG001|Overall Study|Adverse Event|3|||
164682165|NCT00624286|594858286|FG000|Overall Study|Withdrawal by Subject|5|||
164682166|NCT00624286|594858287|FG001|Overall Study|Withdrawal by Subject|4|||
164682167|NCT00624286|594858286|FG000|Overall Study|Lost to Follow-up|3|||
164682168|NCT00624286|594858287|FG001|Overall Study|Lost to Follow-up|2|||
164682169|NCT00624286|594858286|FG000|Overall Study|Administrative problems|3|||
164682170|NCT00624286|594858287|FG001|Overall Study|Administrative problems|0|||
164682171|NCT00624286|594858286|FG000|Overall Study|Lack of Efficacy|1|||
164682172|NCT00624286|594858287|FG001|Overall Study|Lack of Efficacy|6|||
164682173|NCT00624286|594858286|FG000|Overall Study|Not stated|0|||
164682174|NCT00624286|594858287|FG001|Overall Study|Not stated|1|||
164682175|NCT00624286|594858286|FG000|Overall Study|Abnormal test procedure result(s)|0|||
164263520|NCT03906656|593331914|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
164263521|NCT03906656|593331915|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
164263522|NCT03906656|593331914|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
164263523|NCT03906656|593331915|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
164263524|NCT03906656|593331914|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
164263525|NCT03906656|593331915|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
164682176|NCT00624286|594858287|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164682177|NCT00624286|594858286|FG000|Overall Study|Death|0|||
164682178|NCT00624286|594858287|FG001|Overall Study|Death|1|||
164682179|NCT00834873|594858301|FG000|First Intervention|Adverse Event|0|||
164682180|NCT00834873|594858302|FG001|First Intervention|Adverse Event|1|||
164682181|NCT02055547|594858303|FG000|Overall Study|Protocol Violation|0|||
164682182|NCT02055547|594858304|FG001|Overall Study|Protocol Violation|0|||
164682183|NCT02055547|594858305|FG002|Overall Study|Protocol Violation|1|||
164682184|NCT02055547|594858306|FG003|Overall Study|Protocol Violation|0|||
164263526|NCT03906656|593331914|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
164682185|NCT02055547|594858307|FG004|Overall Study|Protocol Violation|0|||
164682186|NCT02055547|594858308|FG005|Overall Study|Protocol Violation|0|||
164682187|NCT02055547|594858309|FG006|Overall Study|Protocol Violation|1|||
164682188|NCT02055547|594858310|FG007|Overall Study|Protocol Violation|0|||
164682189|NCT02055547|594858311|FG008|Overall Study|Protocol Violation|0|||
164682190|NCT02055547|594858312|FG009|Overall Study|Protocol Violation|0|||
164682191|NCT02055547|594858313|FG010|Overall Study|Protocol Violation|0|||
164682192|NCT02055547|594858314|FG011|Overall Study|Protocol Violation|0|||
164682193|NCT02055547|594858315|FG012|Overall Study|Protocol Violation|0|||
164682194|NCT02055547|594858316|FG013|Overall Study|Protocol Violation|0|||
164682195|NCT02055547|594858317|FG014|Overall Study|Protocol Violation|0|||
164682196|NCT02055547|594858318|FG015|Overall Study|Protocol Violation|0|||
164682197|NCT02055547|594858319|FG016|Overall Study|Protocol Violation|0|||
164682198|NCT02055547|594858320|FG017|Overall Study|Protocol Violation|0|||
164682199|NCT02055547|594858321|FG018|Overall Study|Protocol Violation|0|||
164682200|NCT02055547|594858303|FG000|Overall Study|Physician Decision|0|||
164682201|NCT02055547|594858304|FG001|Overall Study|Physician Decision|1|||
164682202|NCT02055547|594858305|FG002|Overall Study|Physician Decision|1|||
164682203|NCT02055547|594858306|FG003|Overall Study|Physician Decision|0|||
164682204|NCT02055547|594858307|FG004|Overall Study|Physician Decision|1|||
164682205|NCT02055547|594858308|FG005|Overall Study|Physician Decision|0|||
164682206|NCT02055547|594858309|FG006|Overall Study|Physician Decision|0|||
164682207|NCT02055547|594858310|FG007|Overall Study|Physician Decision|0|||
164682208|NCT02055547|594858311|FG008|Overall Study|Physician Decision|0|||
164682209|NCT02055547|594858312|FG009|Overall Study|Physician Decision|1|||
164682210|NCT02055547|594858313|FG010|Overall Study|Physician Decision|1|||
164682211|NCT02055547|594858314|FG011|Overall Study|Physician Decision|0|||
164682212|NCT02055547|594858315|FG012|Overall Study|Physician Decision|0|||
164682213|NCT02055547|594858316|FG013|Overall Study|Physician Decision|0|||
164682214|NCT02055547|594858317|FG014|Overall Study|Physician Decision|0|||
164682215|NCT02055547|594858318|FG015|Overall Study|Physician Decision|0|||
164682216|NCT02055547|594858319|FG016|Overall Study|Physician Decision|0|||
164682217|NCT02055547|594858320|FG017|Overall Study|Physician Decision|0|||
164682218|NCT02055547|594858321|FG018|Overall Study|Physician Decision|0|||
164682219|NCT02055547|594858303|FG000|Overall Study|Adverse Event|0|||
164682220|NCT02055547|594858304|FG001|Overall Study|Adverse Event|0|||
164682221|NCT02055547|594858305|FG002|Overall Study|Adverse Event|0|||
164682222|NCT02055547|594858306|FG003|Overall Study|Adverse Event|0|||
164682223|NCT02055547|594858307|FG004|Overall Study|Adverse Event|0|||
164682224|NCT02055547|594858308|FG005|Overall Study|Adverse Event|0|||
164682225|NCT02055547|594858309|FG006|Overall Study|Adverse Event|1|||
164682226|NCT02055547|594858310|FG007|Overall Study|Adverse Event|0|||
164682227|NCT02055547|594858311|FG008|Overall Study|Adverse Event|1|||
164682228|NCT02055547|594858312|FG009|Overall Study|Adverse Event|0|||
164682229|NCT02055547|594858313|FG010|Overall Study|Adverse Event|0|||
164682230|NCT02055547|594858314|FG011|Overall Study|Adverse Event|0|||
164682231|NCT02055547|594858315|FG012|Overall Study|Adverse Event|0|||
164682232|NCT02055547|594858316|FG013|Overall Study|Adverse Event|0|||
164682233|NCT02055547|594858317|FG014|Overall Study|Adverse Event|0|||
164682234|NCT02055547|594858318|FG015|Overall Study|Adverse Event|0|||
164682235|NCT02055547|594858319|FG016|Overall Study|Adverse Event|0|||
164682236|NCT02055547|594858320|FG017|Overall Study|Adverse Event|0|||
164682237|NCT02055547|594858321|FG018|Overall Study|Adverse Event|0|||
164682238|NCT02055547|594858303|FG000|Overall Study|Withdrawal by Subject|0|||
164682239|NCT02055547|594858304|FG001|Overall Study|Withdrawal by Subject|0|||
164682240|NCT02055547|594858305|FG002|Overall Study|Withdrawal by Subject|0|||
164682241|NCT02055547|594858306|FG003|Overall Study|Withdrawal by Subject|0|||
164682242|NCT02055547|594858307|FG004|Overall Study|Withdrawal by Subject|0|||
164682243|NCT02055547|594858308|FG005|Overall Study|Withdrawal by Subject|1|||
164682244|NCT02055547|594858309|FG006|Overall Study|Withdrawal by Subject|0|||
164682245|NCT02055547|594858310|FG007|Overall Study|Withdrawal by Subject|0|||
164682246|NCT02055547|594858311|FG008|Overall Study|Withdrawal by Subject|1|||
164682247|NCT02055547|594858312|FG009|Overall Study|Withdrawal by Subject|0|||
164682248|NCT02055547|594858313|FG010|Overall Study|Withdrawal by Subject|0|||
164682249|NCT02055547|594858314|FG011|Overall Study|Withdrawal by Subject|0|||
164682250|NCT02055547|594858315|FG012|Overall Study|Withdrawal by Subject|0|||
164682251|NCT02055547|594858316|FG013|Overall Study|Withdrawal by Subject|1|||
164682252|NCT02055547|594858317|FG014|Overall Study|Withdrawal by Subject|0|||
164682253|NCT02055547|594858318|FG015|Overall Study|Withdrawal by Subject|1|||
164682254|NCT02055547|594858319|FG016|Overall Study|Withdrawal by Subject|0|||
164682255|NCT02055547|594858320|FG017|Overall Study|Withdrawal by Subject|0|||
164682256|NCT02055547|594858321|FG018|Overall Study|Withdrawal by Subject|0|||
164682257|NCT02055547|594858303|FG000|Overall Study|Lost to Follow-up|0|||
164682258|NCT02055547|594858304|FG001|Overall Study|Lost to Follow-up|0|||
164682259|NCT02055547|594858305|FG002|Overall Study|Lost to Follow-up|1|||
164682260|NCT02055547|594858306|FG003|Overall Study|Lost to Follow-up|0|||
164682261|NCT02055547|594858307|FG004|Overall Study|Lost to Follow-up|0|||
164682262|NCT02055547|594858308|FG005|Overall Study|Lost to Follow-up|0|||
164682263|NCT02055547|594858309|FG006|Overall Study|Lost to Follow-up|0|||
164263527|NCT03906656|593331915|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
164263528|NCT03906656|593331914|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
164682264|NCT02055547|594858310|FG007|Overall Study|Lost to Follow-up|0|||
164682265|NCT02055547|594858311|FG008|Overall Study|Lost to Follow-up|0|||
164263529|NCT03906656|593331915|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
164263530|NCT03906656|593331914|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
164263531|NCT03906656|593331915|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
164263532|NCT03906656|593331914|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
164263533|NCT03906656|593331915|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
164263534|NCT03906656|593331914|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
164682266|NCT02055547|594858312|FG009|Overall Study|Lost to Follow-up|0|||
164682267|NCT02055547|594858313|FG010|Overall Study|Lost to Follow-up|0|||
164682268|NCT02055547|594858314|FG011|Overall Study|Lost to Follow-up|0|||
164682269|NCT02055547|594858315|FG012|Overall Study|Lost to Follow-up|0|||
164682270|NCT02055547|594858316|FG013|Overall Study|Lost to Follow-up|0|||
164682271|NCT02055547|594858317|FG014|Overall Study|Lost to Follow-up|0|||
164682272|NCT02055547|594858318|FG015|Overall Study|Lost to Follow-up|0|||
164682273|NCT02055547|594858319|FG016|Overall Study|Lost to Follow-up|0|||
164682274|NCT02055547|594858320|FG017|Overall Study|Lost to Follow-up|0|||
164682275|NCT02055547|594858321|FG018|Overall Study|Lost to Follow-up|0|||
164682276|NCT01456221|594858322|FG000|Overall Study|Withdrawal by Subject|56|||
164682277|NCT01456221|594858323|FG001|Overall Study|Withdrawal by Subject|49|||
164682278|NCT01456221|594858322|FG000|Overall Study|Lost to Follow-up|1|||
164682279|NCT01456221|594858323|FG001|Overall Study|Lost to Follow-up|4|||
164682280|NCT01456221|594858322|FG000|Overall Study|Received medication|3|||
164682281|NCT01456221|594858323|FG001|Overall Study|Received medication|2|||
164682282|NCT01456221|594858322|FG000|Overall Study|Incomplete data|4|||
164682283|NCT01456221|594858323|FG001|Overall Study|Incomplete data|2|||
164682284|NCT03966911|594858325|FG000|Overall Study|Adverse Event|1|||
164682285|NCT03966911|594858326|FG001|Overall Study|Adverse Event|1|||
164682286|NCT03966911|594858325|FG000|Overall Study|Withdrawal by Subject|8|||
164682287|NCT03966911|594858326|FG001|Overall Study|Withdrawal by Subject|2|||
164682288|NCT03966911|594858325|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
164682289|NCT03966911|594858326|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
164682290|NCT01986647|594858327|FG000|Overall Study|Lost to Follow-up|4|||
164682291|NCT01986647|594858328|FG001|Overall Study|Lost to Follow-up|1|||
164682292|NCT01986647|594858329|FG002|Overall Study|Lost to Follow-up|4|||
164682293|NCT01986647|594858330|FG003|Overall Study|Lost to Follow-up|4|||
164682294|NCT01986647|594858327|FG000|Overall Study|Withdrawal by Subject|1|||
164682295|NCT01986647|594858328|FG001|Overall Study|Withdrawal by Subject|3|||
164682296|NCT01986647|594858329|FG002|Overall Study|Withdrawal by Subject|2|||
164682297|NCT01986647|594858330|FG003|Overall Study|Withdrawal by Subject|3|||
164682298|NCT01986647|594858327|FG000|Overall Study|Health|5|||
164682299|NCT01986647|594858328|FG001|Overall Study|Health|3|||
164682300|NCT01986647|594858329|FG002|Overall Study|Health|6|||
164682301|NCT01986647|594858330|FG003|Overall Study|Health|4|||
164682302|NCT01960296|594858331|FG000|Overall Study|Postponed surgery|1|||
164682303|NCT01960296|594858332|FG001|Overall Study|Postponed surgery|0|||
164682304|NCT01960296|594858331|FG000|Overall Study|Received different procedure|1|||
164682305|NCT01960296|594858332|FG001|Overall Study|Received different procedure|3|||
164682306|NCT02003391|594858333|FG000|Overall Study|Withdrawal by Subject|2|||
164682307|NCT02003391|594858334|FG001|Overall Study|Withdrawal by Subject|1|||
164682308|NCT02003391|594858333|FG000|Overall Study|Protocol Violation|0|||
164682309|NCT02003391|594858334|FG001|Overall Study|Protocol Violation|1|||
164682310|NCT02003391|594858333|FG000|Overall Study|Adverse Event|1|||
164682311|NCT02003391|594858334|FG001|Overall Study|Adverse Event|0|||
164682312|NCT02611323|594858335|FG000|Overall Study|Death|3|||
164682313|NCT02611323|594858336|FG001|Overall Study|Death|1|||
164682314|NCT02611323|594858337|FG002|Overall Study|Death|0|||
164682315|NCT02611323|594858338|FG003|Overall Study|Death|0|||
164682316|NCT02611323|594858339|FG004|Overall Study|Death|1|||
164682317|NCT02611323|594858340|FG005|Overall Study|Death|1|||
164682318|NCT02611323|594858341|FG006|Overall Study|Death|8|||
164682319|NCT02611323|594858342|FG007|Overall Study|Death|0|||
164682320|NCT02611323|594858343|FG008|Overall Study|Death|4|||
164340922|NCT01397890|593623830|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
164340923|NCT01397890|593623829|FG000|Overall Study|Death|2|||
164340924|NCT01397890|593623830|FG001|Overall Study|Death|3|||
164340925|NCT01397890|593623829|FG000|Overall Study|Lost to Follow-up|1|||
164340926|NCT01397890|593623830|FG001|Overall Study|Lost to Follow-up|4|||
164340927|NCT01397890|593623829|FG000|Overall Study|Condition under Investigation Worsened|1|||
164340928|NCT01397890|593623830|FG001|Overall Study|Condition under Investigation Worsened|3|||
164340929|NCT01397890|593623829|FG000|Overall Study|Adverse Event|1|||
164682321|NCT02611323|594858344|FG009|Overall Study|Death|6|||
164682322|NCT02611323|594858345|FG010|Overall Study|Death|26|||
164682323|NCT02611323|594858335|FG000|Overall Study|Lost to Follow-up|1|||
164682324|NCT02611323|594858336|FG001|Overall Study|Lost to Follow-up|0|||
164682325|NCT02611323|594858337|FG002|Overall Study|Lost to Follow-up|0|||
164682326|NCT02611323|594858338|FG003|Overall Study|Lost to Follow-up|0|||
164682327|NCT02611323|594858339|FG004|Overall Study|Lost to Follow-up|0|||
164682328|NCT02611323|594858340|FG005|Overall Study|Lost to Follow-up|0|||
164682329|NCT02611323|594858341|FG006|Overall Study|Lost to Follow-up|3|||
164682330|NCT02611323|594858342|FG007|Overall Study|Lost to Follow-up|0|||
164682331|NCT02611323|594858343|FG008|Overall Study|Lost to Follow-up|0|||
164682332|NCT02611323|594858344|FG009|Overall Study|Lost to Follow-up|0|||
164682333|NCT02611323|594858345|FG010|Overall Study|Lost to Follow-up|2|||
164682334|NCT02611323|594858335|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
164682335|NCT02611323|594858336|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
164682336|NCT02611323|594858337|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
164682337|NCT02611323|594858338|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
164682338|NCT02611323|594858339|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
164682339|NCT02611323|594858340|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
164682340|NCT02611323|594858341|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
164682341|NCT02611323|594858342|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
164682342|NCT02611323|594858343|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
164682343|NCT02611323|594858344|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
164682344|NCT02611323|594858345|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
164340930|NCT01397890|593623830|FG001|Overall Study|Adverse Event|2|||
164340931|NCT01397890|593623829|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
164340932|NCT01397890|593623830|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
164340933|NCT01397890|593623829|FG000|Overall Study|Others|2|||
164340934|NCT01397890|593623830|FG001|Overall Study|Others|1|||
164340935|NCT02763462|593623834|FG000|Overall Study|Protocol Violation|6|||
164340936|NCT00129272|593623835|FG000|Overall Study|Lost to Follow-up|12|||
164682345|NCT02611323|594858335|FG000|Overall Study|Progressive Disease|0|||
164682346|NCT02611323|594858336|FG001|Overall Study|Progressive Disease|0|||
164682347|NCT02611323|594858337|FG002|Overall Study|Progressive Disease|0|||
164682348|NCT02611323|594858338|FG003|Overall Study|Progressive Disease|0|||
164682349|NCT02611323|594858339|FG004|Overall Study|Progressive Disease|0|||
164682350|NCT02611323|594858340|FG005|Overall Study|Progressive Disease|0|||
164682351|NCT02611323|594858341|FG006|Overall Study|Progressive Disease|0|||
164682352|NCT02611323|594858342|FG007|Overall Study|Progressive Disease|0|||
164682353|NCT02611323|594858343|FG008|Overall Study|Progressive Disease|0|||
164682354|NCT02611323|594858344|FG009|Overall Study|Progressive Disease|0|||
164682355|NCT02611323|594858345|FG010|Overall Study|Progressive Disease|1|||
164682356|NCT02611323|594858335|FG000|Overall Study|Withdrawal by Subject|1|||
164682357|NCT02611323|594858336|FG001|Overall Study|Withdrawal by Subject|0|||
164577784|NCT01126580|594479420|FG000|Overall Study|Entry Criteria Not Met|1|||
164577785|NCT01126580|594479421|FG001|Overall Study|Entry Criteria Not Met|1|||
164577786|NCT01126580|594479422|FG002|Overall Study|Entry Criteria Not Met|2|||
164577787|NCT01126580|594479420|FG000|Overall Study|Lack of Efficacy|2|||
164682358|NCT02611323|594858337|FG002|Overall Study|Withdrawal by Subject|0|||
164682359|NCT02611323|594858338|FG003|Overall Study|Withdrawal by Subject|0|||
164682360|NCT02611323|594858339|FG004|Overall Study|Withdrawal by Subject|0|||
164682361|NCT02611323|594858340|FG005|Overall Study|Withdrawal by Subject|0|||
164682362|NCT02611323|594858341|FG006|Overall Study|Withdrawal by Subject|0|||
164682363|NCT02611323|594858342|FG007|Overall Study|Withdrawal by Subject|1|||
164340937|NCT00129272|593623836|FG001|Overall Study|Lost to Follow-up|11|||
164340938|NCT00129272|593623835|FG000|Overall Study|Withdrawal by Subject|5|||
164340939|NCT00129272|593623836|FG001|Overall Study|Withdrawal by Subject|11|||
164577788|NCT01126580|594479421|FG001|Overall Study|Lack of Efficacy|3|||
164577789|NCT01126580|594479422|FG002|Overall Study|Lack of Efficacy|4|||
164577790|NCT01126580|594479420|FG000|Overall Study|Protocol Violation|0|||
164577791|NCT01126580|594479421|FG001|Overall Study|Protocol Violation|1|||
164577792|NCT01126580|594479422|FG002|Overall Study|Protocol Violation|2|||
164577793|NCT01126580|594479420|FG000|Overall Study|Lost to Follow-up|15|||
164577794|NCT01126580|594479421|FG001|Overall Study|Lost to Follow-up|13|||
164577795|NCT01126580|594479422|FG002|Overall Study|Lost to Follow-up|9|||
164577796|NCT01126580|594479420|FG000|Overall Study|Treatment Non-compliance|0|||
164577797|NCT01126580|594479421|FG001|Overall Study|Treatment Non-compliance|2|||
164577798|NCT01126580|594479422|FG002|Overall Study|Treatment Non-compliance|3|||
164577799|NCT01731002|594479432|FG000|Overall Study|Adverse Event|0|||
164577800|NCT01731002|594479433|FG001|Overall Study|Adverse Event|2|||
164577801|NCT01731002|594479434|FG002|Overall Study|Adverse Event|2|||
164577802|NCT01731002|594479432|FG000|Overall Study|Non-Compliant|0|||
164577803|NCT01731002|594479433|FG001|Overall Study|Non-Compliant|1|||
164577804|NCT01731002|594479434|FG002|Overall Study|Non-Compliant|0|||
164577805|NCT01731002|594479432|FG000|Overall Study|Lost to Follow-up|1|||
164682364|NCT02611323|594858343|FG008|Overall Study|Withdrawal by Subject|0|||
164340940|NCT00675948|593623838|FG000|Overall Study|Adverse Event|23|||
164340941|NCT00675948|593623839|FG001|Overall Study|Adverse Event|1|||
164340942|NCT00675948|593623838|FG000|Overall Study|Lack of Efficacy|3|||
164340943|NCT00675948|593623839|FG001|Overall Study|Lack of Efficacy|0|||
164340944|NCT00675948|593623838|FG000|Overall Study|Withdrawal by Subject|7|||
164340945|NCT00675948|593623839|FG001|Overall Study|Withdrawal by Subject|0|||
164577806|NCT01731002|594479433|FG001|Overall Study|Lost to Follow-up|0|||
164577807|NCT01731002|594479434|FG002|Overall Study|Lost to Follow-up|0|||
164682365|NCT02611323|594858344|FG009|Overall Study|Withdrawal by Subject|1|||
164682366|NCT02611323|594858345|FG010|Overall Study|Withdrawal by Subject|0|||
164340946|NCT00675948|593623838|FG000|Overall Study|Lost to Follow-up|2|||
164577808|NCT01731002|594479432|FG000|Overall Study|Test Agent Discontinuation|0|||
164682367|NCT00243347|594858346|FG000|Overall Study|Lack of Efficacy|4|||
164340947|NCT00675948|593623839|FG001|Overall Study|Lost to Follow-up|0|||
164340948|NCT00675948|593623838|FG000|Overall Study|Protocol Violation|1|||
164340949|NCT00675948|593623839|FG001|Overall Study|Protocol Violation|0|||
164340950|NCT00675948|593623838|FG000|Overall Study|Pain under control|1|||
164340951|NCT00675948|593623839|FG001|Overall Study|Pain under control|0|||
164340952|NCT00675948|593623838|FG000|Overall Study|Sponsor decision|0|||
164340953|NCT00675948|593623839|FG001|Overall Study|Sponsor decision|1|||
164340954|NCT00675948|593623838|FG000|Overall Study|Patient died|1|||
164340955|NCT00675948|593623839|FG001|Overall Study|Patient died|0|||
164340956|NCT00675948|593623838|FG000|Overall Study|Patient unable to comply with diaries|1|||
164340957|NCT00675948|593623839|FG001|Overall Study|Patient unable to comply with diaries|0|||
164340958|NCT00675948|593623838|FG000|Overall Study|Patient feels unable to take medication|0|||
164340959|NCT00675948|593623839|FG001|Overall Study|Patient feels unable to take medication|1|||
164340960|NCT02100514|593623840|FG000|Treatment Period|Adverse Event|0|||
164340961|NCT02100514|593623841|FG001|Treatment Period|Adverse Event|5|||
164340962|NCT02100514|593623842|FG002|Treatment Period|Adverse Event|0|||
164340963|NCT02100514|593623843|FG003|Treatment Period|Adverse Event|0|||
164340964|NCT02100514|593623844|FG004|Treatment Period|Adverse Event|0|||
164340965|NCT02100514|593623840|FG000|Treatment Period|Death|2|||
164340966|NCT02100514|593623841|FG001|Treatment Period|Death|2|||
164340967|NCT02100514|593623842|FG002|Treatment Period|Death|0|||
164340968|NCT02100514|593623843|FG003|Treatment Period|Death|0|||
164340969|NCT02100514|593623844|FG004|Treatment Period|Death|0|||
164340970|NCT02100514|593623840|FG000|Treatment Period|Lost to Follow-up|5|||
164340971|NCT02100514|593623841|FG001|Treatment Period|Lost to Follow-up|17|||
164340972|NCT02100514|593623842|FG002|Treatment Period|Lost to Follow-up|0|||
164340973|NCT02100514|593623843|FG003|Treatment Period|Lost to Follow-up|0|||
164340974|NCT02100514|593623844|FG004|Treatment Period|Lost to Follow-up|0|||
164340975|NCT02100514|593623840|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
164340976|NCT02100514|593623841|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
164340977|NCT02100514|593623842|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
164340978|NCT02100514|593623843|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
164340979|NCT02100514|593623844|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
164340980|NCT02100514|593623840|FG000|Treatment Period|Protocol Violation|1|||
164340981|NCT02100514|593623841|FG001|Treatment Period|Protocol Violation|1|||
164340982|NCT02100514|593623842|FG002|Treatment Period|Protocol Violation|0|||
164340983|NCT02100514|593623843|FG003|Treatment Period|Protocol Violation|0|||
164340984|NCT02100514|593623844|FG004|Treatment Period|Protocol Violation|0|||
164340985|NCT02100514|593623840|FG000|Treatment Period|Withdrawal by Subject|12|||
164340986|NCT02100514|593623841|FG001|Treatment Period|Withdrawal by Subject|37|||
164340987|NCT02100514|593623842|FG002|Treatment Period|Withdrawal by Subject|0|||
164340988|NCT02100514|593623843|FG003|Treatment Period|Withdrawal by Subject|0|||
164340989|NCT02100514|593623844|FG004|Treatment Period|Withdrawal by Subject|0|||
164340990|NCT02100514|593623840|FG000|Treatment Period|Other|9|||
164340991|NCT02100514|593623841|FG001|Treatment Period|Other|11|||
164340992|NCT02100514|593623842|FG002|Treatment Period|Other|0|||
164340993|NCT02100514|593623843|FG003|Treatment Period|Other|0|||
164340994|NCT02100514|593623844|FG004|Treatment Period|Other|0|||
164340995|NCT02100514|593623840|FG000|Extension Period|Withdrew consent|0|||
164340996|NCT02100514|593623841|FG001|Extension Period|Withdrew consent|0|||
164340997|NCT02100514|593623842|FG002|Extension Period|Withdrew consent|2|||
164340998|NCT02100514|593623843|FG003|Extension Period|Withdrew consent|0|||
164340999|NCT02100514|593623844|FG004|Extension Period|Withdrew consent|0|||
164341000|NCT00319553|593623845|FG000|Overall Study|Protocol Violation|1|||
164341001|NCT00319553|593623846|FG001|Overall Study|Protocol Violation|2|||
164341002|NCT00319553|593623845|FG000|Overall Study|Lost to Follow-up|2|||
164341003|NCT00319553|593623846|FG001|Overall Study|Lost to Follow-up|1|||
164341004|NCT00319553|593623845|FG000|Overall Study|Withdrawal by Subject|1|||
164341005|NCT00319553|593623846|FG001|Overall Study|Withdrawal by Subject|1|||
164341006|NCT01145625|593623847|FG000|Overall Study|Lost to Follow-up|8|||
164341007|NCT01145625|593623848|FG001|Overall Study|Lost to Follow-up|9|||
164341008|NCT01145625|593623847|FG000|Overall Study|Adverse Event|6|||
164341009|NCT01145625|593623848|FG001|Overall Study|Adverse Event|4|||
164577809|NCT01731002|594479433|FG001|Overall Study|Test Agent Discontinuation|1|||
164577810|NCT01731002|594479434|FG002|Overall Study|Test Agent Discontinuation|0|||
164577811|NCT01731002|594479432|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
164577812|NCT01731002|594479433|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
164577813|NCT01731002|594479434|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
164577814|NCT01731002|594479432|FG000|Overall Study|Elevated IOP|1|||
164577815|NCT01731002|594479433|FG001|Overall Study|Elevated IOP|0|||
164577816|NCT01731002|594479434|FG002|Overall Study|Elevated IOP|0|||
164577817|NCT01731002|594479432|FG000|Overall Study|Inappropriate use of study medications|0|||
164577818|NCT01731002|594479433|FG001|Overall Study|Inappropriate use of study medications|0|||
164577819|NCT01731002|594479434|FG002|Overall Study|Inappropriate use of study medications|1|||
164577820|NCT00947349|594479435|FG000|Triple Treatment Combination Period|Adverse Event|0|||
164577821|NCT00947349|594479436|FG001|Triple Treatment Combination Period|Adverse Event|1|||
164577822|NCT00947349|594479437|FG002|Triple Treatment Combination Period|Adverse Event|0|||
164682368|NCT00243347|594858346|FG000|Overall Study|Adverse Event|2|||
164682369|NCT00243347|594858346|FG000|Overall Study|Death|1|||
164682370|NCT00243347|594858346|FG000|Overall Study|Withdrawal by Subject|5|||
164682371|NCT00243347|594858346|FG000|Overall Study|Condition worsened|7|||
164682372|NCT02011945|594858348|FG000|Overall Study|Participant requested to Discontinue|0|||
164682373|NCT02011945|594858349|FG001|Overall Study|Participant requested to Discontinue|1|||
164682374|NCT02011945|594858350|FG002|Overall Study|Participant requested to Discontinue|1|||
164682375|NCT02011945|594858348|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
164682376|NCT02011945|594858349|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
164682377|NCT02011945|594858350|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
164682378|NCT02011945|594858348|FG000|Overall Study|Study Drug Toxicity|0|||
164682379|NCT02011945|594858349|FG001|Overall Study|Study Drug Toxicity|0|||
164682380|NCT02011945|594858350|FG002|Overall Study|Study Drug Toxicity|1|||
164682381|NCT02011945|594858348|FG000|Overall Study|Treatment Failure|0|||
164682382|NCT02011945|594858349|FG001|Overall Study|Treatment Failure|7|||
164682383|NCT02011945|594858350|FG002|Overall Study|Treatment Failure|6|||
164682384|NCT02011945|594858348|FG000|Overall Study|No Longer Meets Study Criteria|1|||
164682385|NCT02011945|594858349|FG001|Overall Study|No Longer Meets Study Criteria|0|||
164682386|NCT02011945|594858350|FG002|Overall Study|No Longer Meets Study Criteria|0|||
164682387|NCT02011945|594858348|FG000|Overall Study|Proceeded to stem cell transplant|0|||
164682388|NCT02011945|594858349|FG001|Overall Study|Proceeded to stem cell transplant|0|||
164682389|NCT02011945|594858350|FG002|Overall Study|Proceeded to stem cell transplant|1|||
164682390|NCT02011945|594858348|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
164682391|NCT02011945|594858349|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
164682392|NCT02011945|594858350|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
164682393|NCT00258856|594859780|FG000|Overall Study|Lost to Follow-up|1|||
164682394|NCT00258856|594859781|FG001|Overall Study|Lost to Follow-up|0|||
164682395|NCT00258856|594859782|FG002|Overall Study|Lost to Follow-up|2|||
164682396|NCT00258856|594859783|FG003|Overall Study|Lost to Follow-up|0|||
164682397|NCT00258856|594859780|FG000|Overall Study|Non-compliance|2|||
164682398|NCT00258856|594859781|FG001|Overall Study|Non-compliance|0|||
164682399|NCT00258856|594859782|FG002|Overall Study|Non-compliance|0|||
164682400|NCT00258856|594859783|FG003|Overall Study|Non-compliance|1|||
164682401|NCT02488109|594859786|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
164682402|NCT02488109|594859787|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
164682403|NCT02488109|594859786|FG000|12-month Follow-Up|Lost to Follow-up|4|||
164682404|NCT02488109|594859787|FG001|12-month Follow-Up|Lost to Follow-up|7|||
164682405|NCT03969641|594859790|FG000|Overall Study|Lost to Follow-up|5|||
164682406|NCT03969641|594859791|FG001|Overall Study|Lost to Follow-up|3|||
164682407|NCT03969641|594859790|FG000|Overall Study|Withdrawal by Subject|1|||
164682408|NCT03969641|594859791|FG001|Overall Study|Withdrawal by Subject|2|||
164682409|NCT03969641|594859790|FG000|Overall Study|Found to be ineligible|1|||
164682410|NCT03969641|594859791|FG001|Overall Study|Found to be ineligible|1|||
164682411|NCT03969641|594859790|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
164682412|NCT03969641|594859791|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
164682413|NCT03969641|594859790|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
164682414|NCT03969641|594859791|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
164682415|NCT03969641|594859790|FG000|Overall Study|Elective termination|0|||
164682416|NCT03969641|594859791|FG001|Overall Study|Elective termination|1|||
164682417|NCT00754052|594859796|FG000|Overall Study|Study terminated by Sponsor|5|||
164682418|NCT00754052|594859797|FG001|Overall Study|Study terminated by Sponsor|3|||
164682419|NCT00516295|594859803|FG000|Overall Study|Lack of Efficacy|2|||
164682420|NCT00516295|594859804|FG001|Overall Study|Lack of Efficacy|0|||
164682421|NCT00516295|594859805|FG002|Overall Study|Lack of Efficacy|0|||
164682422|NCT00516295|594859803|FG000|Overall Study|Ineligible|1|||
164682423|NCT00516295|594859804|FG001|Overall Study|Ineligible|0|||
164682424|NCT00516295|594859805|FG002|Overall Study|Ineligible|0|||
164682425|NCT00660660|594859808|FG000|Overall Study|Adverse Event|1|||
164682426|NCT00660660|594859809|FG001|Overall Study|Adverse Event|0|||
164682427|NCT00660660|594859808|FG000|Overall Study|Lost to Follow-up|0|||
164682428|NCT00660660|594859809|FG001|Overall Study|Lost to Follow-up|6|||
164682429|NCT00660660|594859808|FG000|Overall Study|Lack of Efficacy|0|||
164682430|NCT00660660|594859809|FG001|Overall Study|Lack of Efficacy|2|||
164682431|NCT00660660|594859808|FG000|Overall Study|Withdrawal by Subject|3|||
164682432|NCT00660660|594859809|FG001|Overall Study|Withdrawal by Subject|0|||
164682433|NCT00660660|594859808|FG000|Overall Study|Incorrect enrollment and other|0|||
164682434|NCT00660660|594859809|FG001|Overall Study|Incorrect enrollment and other|1|||
164682435|NCT00660660|594859808|FG000|Overall Study|New medication after randomization|1|||
164682436|NCT00660660|594859809|FG001|Overall Study|New medication after randomization|0|||
164682437|NCT01380782|594859810|FG000|Overall Study|Adverse Event|0|||
164682438|NCT01380782|594859811|FG001|Overall Study|Adverse Event|1|||
164682439|NCT01380782|594859812|FG002|Overall Study|Adverse Event|0|||
164682440|NCT01380782|594859813|FG003|Overall Study|Adverse Event|0|||
164682441|NCT01380782|594859810|FG000|Overall Study|Death|1|||
164682442|NCT01380782|594859811|FG001|Overall Study|Death|0|||
164263535|NCT03906656|593331915|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
164682443|NCT01380782|594859812|FG002|Overall Study|Death|0|||
164682444|NCT01380782|594859813|FG003|Overall Study|Death|0|||
164682445|NCT01380782|594859810|FG000|Overall Study|Lack of Efficacy|10|||
164682446|NCT01380782|594859811|FG001|Overall Study|Lack of Efficacy|9|||
164682447|NCT01380782|594859812|FG002|Overall Study|Lack of Efficacy|10|||
164682448|NCT01380782|594859813|FG003|Overall Study|Lack of Efficacy|3|||
164682449|NCT01380782|594859810|FG000|Overall Study|Physician Decision|1|||
164682450|NCT01380782|594859811|FG001|Overall Study|Physician Decision|0|||
164682451|NCT01380782|594859812|FG002|Overall Study|Physician Decision|0|||
164682452|NCT01380782|594859813|FG003|Overall Study|Physician Decision|0|||
164577823|NCT00947349|594479438|FG003|Triple Treatment Combination Period|Adverse Event|0|||
164682453|NCT01380782|594859810|FG000|Overall Study|Withdrawal by Subject|0|||
164682454|NCT01380782|594859811|FG001|Overall Study|Withdrawal by Subject|0|||
164682455|NCT01380782|594859812|FG002|Overall Study|Withdrawal by Subject|1|||
164682456|NCT01380782|594859813|FG003|Overall Study|Withdrawal by Subject|1|||
164682457|NCT01701063|594859817|FG000|Overall Study|Lost to Follow-up|0|||
164577824|NCT00947349|594479435|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
164577825|NCT00947349|594479436|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
164577826|NCT00947349|594479437|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
164577827|NCT00947349|594479438|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
164577828|NCT00947349|594479435|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
164577829|NCT00947349|594479436|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
164577830|NCT00947349|594479437|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
164577831|NCT00947349|594479438|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
164577832|NCT00947349|594479435|FG000|Overall Study Standard of Care|Other|0|||
164577833|NCT00947349|594479436|FG001|Overall Study Standard of Care|Other|0|||
164577834|NCT00947349|594479437|FG002|Overall Study Standard of Care|Other|0|||
164577835|NCT00947349|594479438|FG003|Overall Study Standard of Care|Other|1|||
164577836|NCT00538681|594479439|FG000|Overall Study|Progressive Disease|7|||
164577837|NCT00538681|594479440|FG001|Overall Study|Progressive Disease|0|||
164577838|NCT00538681|594479441|FG002|Overall Study|Progressive Disease|1|||
164577839|NCT00538681|594479442|FG003|Overall Study|Progressive Disease|0|||
164577840|NCT00538681|594479439|FG000|Overall Study|Sponsor Decision|1|||
164577841|NCT00538681|594479440|FG001|Overall Study|Sponsor Decision|3|||
164577842|NCT00538681|594479441|FG002|Overall Study|Sponsor Decision|8|||
164577843|NCT00538681|594479442|FG003|Overall Study|Sponsor Decision|9|||
164577844|NCT00538681|594479439|FG000|Overall Study|Adverse Event|1|||
164577845|NCT00538681|594479440|FG001|Overall Study|Adverse Event|1|||
164577846|NCT00538681|594479441|FG002|Overall Study|Adverse Event|1|||
164577847|NCT00538681|594479442|FG003|Overall Study|Adverse Event|0|||
164577848|NCT00538681|594479439|FG000|Overall Study|Death|0|||
164577849|NCT00538681|594479440|FG001|Overall Study|Death|0|||
164577850|NCT00538681|594479441|FG002|Overall Study|Death|1|||
164577851|NCT00538681|594479442|FG003|Overall Study|Death|1|||
164577852|NCT00538681|594479439|FG000|Overall Study|Investigator Decision|0|||
164682458|NCT01701063|594859818|FG001|Overall Study|Lost to Follow-up|1|||
164682459|NCT01701063|594859819|FG002|Overall Study|Lost to Follow-up|0|||
164682460|NCT01701063|594859817|FG000|Overall Study|Withdrawal by Subject|0|||
164682461|NCT01701063|594859818|FG001|Overall Study|Withdrawal by Subject|0|||
164682462|NCT01701063|594859819|FG002|Overall Study|Withdrawal by Subject|1|||
164682463|NCT01701063|594859817|FG000|Overall Study|Other|0|||
164682464|NCT01701063|594859818|FG001|Overall Study|Other|0|||
164682465|NCT01701063|594859819|FG002|Overall Study|Other|1|||
164682466|NCT01919112|594859820|FG000|Secondary Analysis-day 30|Death|1|||
164682467|NCT01919112|594859821|FG001|Secondary Analysis-day 30|Death|1|||
164682468|NCT01919112|594859822|FG002|Secondary Analysis-day 30|Death|1|||
164682469|NCT01919112|594859820|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
164682470|NCT01919112|594859821|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
164682471|NCT01919112|594859822|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
164682472|NCT00835666|594859823|FG000|Washout|Protocol Violation|1|||
164682473|NCT00835666|594859824|FG001|Washout|Protocol Violation|0|||
164682474|NCT00835666|594859823|FG000|Washout|Withdrawal by Subject|1|||
164682475|NCT00835666|594859824|FG001|Washout|Withdrawal by Subject|0|||
164682476|NCT00635648|594859825|FG000|Overall Study|Adverse Event|12|||
164682477|NCT00635648|594859825|FG000|Overall Study|Withdrawal by Subject|9|||
164577853|NCT00538681|594479440|FG001|Overall Study|Investigator Decision|0|||
164577854|NCT00538681|594479441|FG002|Overall Study|Investigator Decision|0|||
164577855|NCT00538681|594479442|FG003|Overall Study|Investigator Decision|1|||
164577856|NCT05369806|594479443|FG000|Overall Study|Lost to Follow-up|1|||
164682478|NCT00635648|594859825|FG000|Overall Study|Physician Decision|4|||
164682479|NCT00635648|594859825|FG000|Overall Study|Rapid progression of baseline disease|4|||
164682480|NCT00635648|594859825|FG000|Overall Study|Use of other antifungal agent needed|1|||
164682481|NCT00635648|594859825|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
164682482|NCT00635648|594859825|FG000|Overall Study|Noncompliance with protocol|1|||
164682483|NCT00635648|594859825|FG000|Overall Study|Other reason|2|||
164577857|NCT00628355|594479444|FG000|Overall Study|Withdrawal by Subject|1|||
164577858|NCT00628355|594479445|FG001|Overall Study|Withdrawal by Subject|1|||
164682484|NCT04194801|594859826|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
164682485|NCT04194801|594859827|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
164682486|NCT04194801|594859828|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
164682487|NCT04194801|594859826|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
164682488|NCT04194801|594859827|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
164682489|NCT04194801|594859828|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
164682490|NCT04194801|594859826|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
164682491|NCT04194801|594859827|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
164682492|NCT04194801|594859828|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
164682493|NCT04194801|594859826|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
164682494|NCT04194801|594859827|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
164682495|NCT04194801|594859828|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
164577859|NCT01446809|594479447|FG000|Overall Study|Adverse Event|0|||
164577860|NCT01446809|594479448|FG001|Overall Study|Adverse Event|0|||
164577861|NCT01446809|594479449|FG002|Overall Study|Adverse Event|1|||
164577862|NCT01446809|594479447|FG000|Overall Study|Failure to complete study procedures|0|||
164577863|NCT01446809|594479448|FG001|Overall Study|Failure to complete study procedures|0|||
164577864|NCT01446809|594479449|FG002|Overall Study|Failure to complete study procedures|1|||
164577865|NCT01331161|594479450|FG000|Overall Study|Physician Decision|1|||
164577866|NCT01331161|594479451|FG001|Overall Study|Physician Decision|0|||
164577867|NCT01331161|594479450|FG000|Overall Study|Lost to Follow-up|0|||
164577868|NCT01331161|594479451|FG001|Overall Study|Lost to Follow-up|1|||
164577869|NCT01331161|594479450|FG000|Overall Study|Pregnancy|0|||
164577870|NCT01331161|594479451|FG001|Overall Study|Pregnancy|1|||
164577871|NCT03277196|594479452|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
164577872|NCT03277196|594479452|FG000|Overall Study|Lost to Follow-up|3|||
164577873|NCT03277196|594479452|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
164577874|NCT03277196|594479452|FG000|Overall Study|Other|2|||
164577875|NCT00469079|594481836|FG000|Overall Study|Lack of Efficacy|3|||
164577876|NCT00469079|594481837|FG001|Overall Study|Lack of Efficacy|8|||
164577877|NCT00469079|594481838|FG002|Overall Study|Lack of Efficacy|5|||
164577878|NCT00469079|594481836|FG000|Overall Study|Adverse Event|1|||
164577879|NCT00469079|594481837|FG001|Overall Study|Adverse Event|3|||
164577880|NCT00469079|594481838|FG002|Overall Study|Adverse Event|2|||
164577881|NCT00469079|594481836|FG000|Overall Study|Lost to Follow-up|4|||
164577882|NCT00469079|594481837|FG001|Overall Study|Lost to Follow-up|8|||
164577883|NCT00469079|594481838|FG002|Overall Study|Lost to Follow-up|10|||
164577884|NCT00469079|594481836|FG000|Overall Study|Withdrawal by Subject|1|||
164577885|NCT00469079|594481837|FG001|Overall Study|Withdrawal by Subject|2|||
164577886|NCT00469079|594481838|FG002|Overall Study|Withdrawal by Subject|2|||
164577887|NCT00469079|594481836|FG000|Overall Study|Ineligible|0|||
164577888|NCT00469079|594481837|FG001|Overall Study|Ineligible|1|||
164577889|NCT00469079|594481838|FG002|Overall Study|Ineligible|0|||
164577890|NCT00942162|594481839|FG000|Overall Study|Death|45|||
164577891|NCT00942162|594481840|FG001|Overall Study|Death|35|||
164577892|NCT00942162|594481841|FG002|Overall Study|Death|0|||
164577893|NCT00942162|594481839|FG000|Overall Study|Withdrawal by Subject|7|||
164577894|NCT00942162|594481840|FG001|Overall Study|Withdrawal by Subject|2|||
164577895|NCT00942162|594481841|FG002|Overall Study|Withdrawal by Subject|0|||
164577896|NCT00942162|594481839|FG000|Overall Study|Lost to Follow-up|4|||
164577897|NCT00942162|594481840|FG001|Overall Study|Lost to Follow-up|0|||
164577898|NCT00942162|594481841|FG002|Overall Study|Lost to Follow-up|0|||
164577899|NCT00942162|594481839|FG000|Overall Study|Other|14|||
164577900|NCT00942162|594481840|FG001|Overall Study|Other|13|||
164577901|NCT00942162|594481841|FG002|Overall Study|Other|2|||
164577902|NCT01006356|594481842|FG000|Overall Study|Adverse Event|6|||
164577903|NCT01006356|594481842|FG000|Overall Study|Physician Decision|1|||
164577904|NCT01006356|594481842|FG000|Overall Study|Paticipants did not cooperate|6|||
164577905|NCT01006356|594481842|FG000|Overall Study|Withdrawal by Subject|1|||
164577906|NCT01006356|594481842|FG000|Overall Study|Choice by participants|2|||
164577907|NCT01006356|594481842|FG000|Overall Study|Protocol Violation|3|||
164577908|NCT01006356|594481842|FG000|Overall Study|Other|23|||
164577909|NCT03368859|594481845|FG000|Overall Study|Withdrew Consent|5|||
164577910|NCT03368859|594481846|FG001|Overall Study|Withdrew Consent|4|||
164577911|NCT03368859|594481845|FG000|Overall Study|Death|12|||
164577912|NCT03368859|594481846|FG001|Overall Study|Death|6|||
164577913|NCT03368859|594481845|FG000|Overall Study|Study terminated by Sponsor|18|||
164577914|NCT03368859|594481846|FG001|Overall Study|Study terminated by Sponsor|23|||
164577915|NCT03368859|594481845|FG000|Overall Study|Other|1|||
164577916|NCT03368859|594481846|FG001|Overall Study|Other|1|||
164577917|NCT02559505|594481849|FG000|Overall Study|Lost to Follow-up|23|||
164577918|NCT02559505|594481850|FG001|Overall Study|Lost to Follow-up|20|||
164577919|NCT02559505|594481849|FG000|Overall Study|Withdrawal by Subject|4|||
164577920|NCT02559505|594481850|FG001|Overall Study|Withdrawal by Subject|2|||
164682496|NCT04194801|594859826|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
164682497|NCT04194801|594859827|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
164682498|NCT04194801|594859828|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
164682499|NCT04194801|594859826|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
164682500|NCT04194801|594859827|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
164682501|NCT04194801|594859828|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
164682502|NCT04194801|594859826|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
164682503|NCT04194801|594859827|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
164682504|NCT04194801|594859828|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
164682505|NCT04194801|594859826|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
164682506|NCT04194801|594859827|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
164682507|NCT04194801|594859828|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
164682508|NCT04194801|594859826|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
164682509|NCT04194801|594859827|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
164682510|NCT04194801|594859828|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
164682511|NCT04194801|594859826|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
164682512|NCT04194801|594859827|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
164682513|NCT04194801|594859828|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
164682514|NCT04194801|594859826|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
164682515|NCT04194801|594859827|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
164682516|NCT04194801|594859828|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
164682517|NCT04194801|594859826|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
164682518|NCT04194801|594859827|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
164682519|NCT04194801|594859828|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
164682520|NCT04194801|594859826|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
164682521|NCT04194801|594859827|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
164682522|NCT04194801|594859828|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
164682523|NCT04194801|594859826|FG000|Part Ib/II End of Study|Death|2|||
164682524|NCT04194801|594859827|FG001|Part Ib/II End of Study|Death|3|||
164682525|NCT04194801|594859828|FG002|Part Ib/II End of Study|Death|3|||
164682526|NCT04194801|594859826|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
164682527|NCT04194801|594859827|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
164682528|NCT04194801|594859828|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
164682529|NCT04194801|594859826|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
164682530|NCT04194801|594859827|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
164682531|NCT04194801|594859828|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
164682532|NCT04194801|594859826|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
164682533|NCT04194801|594859827|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
164682534|NCT04194801|594859828|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
164682535|NCT04194801|594859826|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
164682536|NCT04194801|594859827|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
164682537|NCT04194801|594859828|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
164682538|NCT00294047|594859829|FG000|Month 48|Adverse Event|28|||
164682539|NCT00294047|594859830|FG001|Month 48|Adverse Event|13|||
164682540|NCT00294047|594859829|FG000|Month 48|Protocol Violation|4|||
164682541|NCT00294047|594859830|FG001|Month 48|Protocol Violation|4|||
164682542|NCT00294047|594859829|FG000|Month 48|Withdrawal by Subject|111|||
164682543|NCT00294047|594859830|FG001|Month 48|Withdrawal by Subject|115|||
164682544|NCT00294047|594859829|FG000|Month 48|Lost to Follow-up|272|||
164682545|NCT00294047|594859830|FG001|Month 48|Lost to Follow-up|287|||
164682546|NCT00294047|594859829|FG000|Month 48|Other|10|||
164682547|NCT00294047|594859830|FG001|Month 48|Other|14|||
164682548|NCT00294047|594859829|FG000|Month 84|Adverse Event|4|||
164682549|NCT00294047|594859830|FG001|Month 84|Adverse Event|2|||
164682550|NCT00294047|594859829|FG000|Month 84|Protocol Violation|1|||
164682551|NCT00294047|594859830|FG001|Month 84|Protocol Violation|1|||
164682552|NCT00294047|594859829|FG000|Month 84|Withdrawal by Subject|33|||
164682553|NCT00294047|594859830|FG001|Month 84|Withdrawal by Subject|31|||
164682554|NCT00294047|594859829|FG000|Month 84|Lost to Follow-up|187|||
164682555|NCT00294047|594859830|FG001|Month 84|Lost to Follow-up|190|||
164682556|NCT00294047|594859829|FG000|Month 84|Absent Cervix|2|||
164682557|NCT00294047|594859830|FG001|Month 84|Absent Cervix|0|||
164682558|NCT00294047|594859829|FG000|Month 84|Work related reasons|4|||
164682559|NCT00294047|594859830|FG001|Month 84|Work related reasons|2|||
164682560|NCT00294047|594859829|FG000|Month 84|Center closed, subject did not transfer|1|||
164682561|NCT00294047|594859830|FG001|Month 84|Center closed, subject did not transfer|0|||
164682562|NCT00294047|594859829|FG000|Month 84|Family problems|2|||
164682563|NCT00294047|594859830|FG001|Month 84|Family problems|2|||
164682564|NCT00294047|594859829|FG000|Month 84|Lack of time|3|||
164682565|NCT00294047|594859830|FG001|Month 84|Lack of time|1|||
164682566|NCT00294047|594859829|FG000|Month 84|Personal reason|2|||
164682567|NCT00294047|594859830|FG001|Month 84|Personal reason|4|||
164682568|NCT00294047|594859829|FG000|Month 84|Subject does not want male physician|1|||
164682569|NCT00294047|594859830|FG001|Month 84|Subject does not want male physician|0|||
164682570|NCT00294047|594859829|FG000|Month 84|Transport reimbursement delayed|0|||
164682571|NCT00294047|594859830|FG001|Month 84|Transport reimbursement delayed|1|||
164682572|NCT00294047|594859829|FG000|Month 84|Unable to reach study site|1|||
164682573|NCT00294047|594859830|FG001|Month 84|Unable to reach study site|0|||
164682574|NCT00294047|594859829|FG000|Month 84|Under investigation locally|1|||
164682575|NCT00294047|594859830|FG001|Month 84|Under investigation locally|0|||
164682576|NCT00294047|594859829|FG000|Month 84|Visit missed|0|||
164682577|NCT00294047|594859830|FG001|Month 84|Visit missed|1|||
164682578|NCT00294047|594859829|FG000|Month 84|No consent for Month 84 Follow-up|731|||
164682579|NCT00294047|594859830|FG001|Month 84|No consent for Month 84 Follow-up|754|||
164682580|NCT00506831|594859831|FG000|Overall Study|Death|1|||
164682581|NCT00506831|594859831|FG000|Overall Study|Withdrawal by Subject|1|||
164682582|NCT00608322|594859837|FG000|Overall Study|Death|2|||
164682583|NCT00608322|594859838|FG001|Overall Study|Death|1|||
164682584|NCT04002648|594859839|FG000|Overall Study|Lost to Follow-up|2|||
164682585|NCT04002648|594859840|FG001|Overall Study|Lost to Follow-up|0|||
164682586|NCT02280863|594859851|FG000|Integrated Platform|Met stopping criteria|0|||
164682587|NCT02280863|594859852|FG001|Integrated Platform|Met stopping criteria|1|||
164682588|NCT03158727|594859855|FG000|Overall Study|Withdrawal by Subject|2|||
164682589|NCT03158727|594859856|FG001|Overall Study|Withdrawal by Subject|6|||
164682590|NCT03158727|594859855|FG000|Overall Study|Death|11|||
164682591|NCT03158727|594859856|FG001|Overall Study|Death|12|||
164682592|NCT03158727|594859855|FG000|Overall Study|Lost to Follow-up|1|||
164682593|NCT03158727|594859856|FG001|Overall Study|Lost to Follow-up|0|||
164682594|NCT03158727|594859855|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
164682595|NCT03158727|594859856|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
164682596|NCT03158727|594859855|FG000|Overall Study|Visit 11 not done by mistake|0|||
164682597|NCT03158727|594859856|FG001|Overall Study|Visit 11 not done by mistake|1|||
164682598|NCT03158727|594859855|FG000|Overall Study|Enrolled, not treated|1|||
164682599|NCT03158727|594859856|FG001|Overall Study|Enrolled, not treated|0|||
164682600|NCT00985439|594859857|FG000|Overall Study|Adverse Event|0|||
164682601|NCT00985439|594859858|FG001|Overall Study|Adverse Event|0|||
164682602|NCT00985439|594859859|FG002|Overall Study|Adverse Event|1|||
164682603|NCT00985439|594859860|FG003|Overall Study|Adverse Event|0|||
164577921|NCT02874794|594481851|FG000|Overall Study|Physician Decision|3|||
164577922|NCT02874794|594481852|FG001|Overall Study|Physician Decision|2|||
164577923|NCT02874794|594481851|FG000|Overall Study|Withdrawal by Subject|2|||
164577924|NCT02874794|594481852|FG001|Overall Study|Withdrawal by Subject|8|||
164577925|NCT02874794|594481851|FG000|Overall Study|Death|2|||
164577926|NCT02874794|594481852|FG001|Overall Study|Death|1|||
164577927|NCT04419506|594481855|FG000|Overall Study|Adverse Event|0|||
164577928|NCT04419506|594481856|FG001|Overall Study|Adverse Event|10|||
164577929|NCT04419506|594481857|FG002|Overall Study|Adverse Event|0|||
164682604|NCT01174186|594859861|FG000|Overall Study|Lost to Follow-up|0|||
164682605|NCT01174186|594859862|FG001|Overall Study|Lost to Follow-up|1|||
164682606|NCT01174186|594859861|FG000|Overall Study|Withdrawal by Subject|0|||
164682607|NCT01174186|594859862|FG001|Overall Study|Withdrawal by Subject|2|||
164682608|NCT00918684|594859863|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
164682609|NCT00918684|594859863|FG000|Treatment Phase|Lack of Efficacy|6|||
164682610|NCT00918684|594859863|FG000|Treatment Phase|Lost to Follow-up|2|||
164682611|NCT00918684|594859863|FG000|Treatment Phase|Physician Decision|8|||
164682612|NCT00918684|594859863|FG000|Treatment Phase|Protocol Violation|1|||
164682613|NCT00918684|594859863|FG000|Treatment Phase|Withdrawal by Subject|8|||
164682614|NCT00402103|594859864|FG000|Overall Study|Adverse Event|60|||
164682615|NCT00402103|594859865|FG001|Overall Study|Adverse Event|7|||
164577930|NCT04419506|594481858|FG003|Overall Study|Adverse Event|3|||
164682616|NCT00402103|594859864|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164682617|NCT00402103|594859865|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164682618|NCT00402103|594859864|FG000|Overall Study|Condition no longer requires study drug|2|||
164682619|NCT00402103|594859865|FG001|Overall Study|Condition no longer requires study drug|0|||
164682620|NCT00402103|594859864|FG000|Overall Study|Protocol Deviation|8|||
164682621|NCT00402103|594859865|FG001|Overall Study|Protocol Deviation|0|||
164682622|NCT00402103|594859864|FG000|Overall Study|Patient withdrew consent|12|||
164682623|NCT00402103|594859865|FG001|Overall Study|Patient withdrew consent|1|||
164682624|NCT00402103|594859864|FG000|Overall Study|Lost to Follow-up|6|||
164682625|NCT00402103|594859865|FG001|Overall Study|Lost to Follow-up|3|||
164682626|NCT00402103|594859864|FG000|Overall Study|Administrative problems|2|||
164682627|NCT00402103|594859865|FG001|Overall Study|Administrative problems|0|||
164682628|NCT00484679|594859866|FG000|Overall Study|Withdrawal by Subject|3|||
164682629|NCT00425308|594859867|FG000|Overall Study|Adverse Event|2|||
164682630|NCT00425308|594859868|FG001|Overall Study|Adverse Event|1|||
164682631|NCT00425308|594859867|FG000|Overall Study|Withdrawal by Subject|1|||
164577931|NCT04419506|594481855|FG000|Overall Study|Withdrawal by Subject|0|||
164682632|NCT00425308|594859868|FG001|Overall Study|Withdrawal by Subject|0|||
164682633|NCT00425308|594859867|FG000|Overall Study|Death|1|||
164682634|NCT00425308|594859868|FG001|Overall Study|Death|0|||
164682635|NCT01252953|594859870|FG000|Overall Study|Withdrawal by Subject|16|||
164682636|NCT01252953|594859871|FG001|Overall Study|Withdrawal by Subject|17|||
164682637|NCT01252953|594859870|FG000|Overall Study|Lost to Follow-up|22|||
164682638|NCT01252953|594859871|FG001|Overall Study|Lost to Follow-up|21|||
164682639|NCT00101439|594859874|FG000|Period 2|Withdrawal by Subject|0|||
164682640|NCT00101439|594859875|FG001|Period 2|Withdrawal by Subject|2|||
164682641|NCT00863330|594859881|FG000|Overall Study|study terminated early due to administra|6|||
164682642|NCT00487435|594859882|FG000|Overall Study|Adverse Event|146|||
164682643|NCT00487435|594859882|FG000|Overall Study|Death|2|||
164682644|NCT00487435|594859882|FG000|Overall Study|Lack of Efficacy|33|||
164682645|NCT00487435|594859882|FG000|Overall Study|Lost to Follow-up|54|||
164682646|NCT00487435|594859882|FG000|Overall Study|Pregnancy|2|||
164682647|NCT00487435|594859882|FG000|Overall Study|Withdrawal by Subject|132|||
164682648|NCT00487435|594859882|FG000|Overall Study|Resolution Of Pain|1|||
164682649|NCT00487435|594859882|FG000|Overall Study|Study Medication Non-Compliant|32|||
164682650|NCT00487435|594859882|FG000|Overall Study|Other|83|||
164682651|NCT01087502|594859889|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
164682652|NCT01087502|594859890|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
164682653|NCT01087502|594859889|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
164263536|NCT03906656|593331914|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
164682654|NCT01087502|594859890|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
164682655|NCT01087502|594859889|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
164682656|NCT01087502|594859890|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
164682657|NCT01087502|594859889|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
164682658|NCT01087502|594859890|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
164682659|NCT01087502|594859889|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
164682660|NCT01087502|594859890|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
164682661|NCT01087502|594859889|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
164682662|NCT01087502|594859890|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
164682663|NCT01087502|594859889|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
164682664|NCT01087502|594859890|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
164682665|NCT01087502|594859889|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
164682666|NCT01087502|594859890|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
164682667|NCT01087502|594859889|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
164682668|NCT01087502|594859890|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
164682669|NCT01087502|594859889|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
164682670|NCT01087502|594859890|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
164682671|NCT01087502|594859889|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
164682672|NCT01087502|594859890|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
164682673|NCT01087502|594859889|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
164682674|NCT01087502|594859890|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
164682675|NCT01151618|594859891|FG000|Overall Study|Adverse Event|2|||
164682676|NCT01151618|594859891|FG000|Overall Study|Withdrawal by Subject|7|||
164682677|NCT00868998|594859892|FG000|Overall Study|Screen Failure|1|||
164682678|NCT00868998|594859892|FG000|Overall Study|Withdrawal by Subject|1|||
164682679|NCT00868998|594859892|FG000|Overall Study|Progression of disease|2|||
164682680|NCT00868998|594859892|FG000|Overall Study|Death|1|||
164682681|NCT01483820|594859894|FG000|Overall Study|Lack of Efficacy|6|||
164682682|NCT01483820|594859894|FG000|Overall Study|Adverse Event|1|||
164682683|NCT01483820|594859894|FG000|Overall Study|Death|1|||
164682684|NCT00474188|594859898|FG000|Overall Study|Withdrawal by Subject|1|||
164682685|NCT00474188|594859898|FG000|Overall Study|Study discontinued by sponsor|5|||
164682686|NCT05412121|594859899|FG000|Overall Study|Withdrawal by Subject|4|||
164682687|NCT05412121|594859899|FG000|Overall Study|Physician Decision|1|||
164682688|NCT05412121|594859899|FG000|Overall Study|Lost to Follow-up|5|||
164682689|NCT03541252|594859900|FG000|Overall Study|Withdrawal by Subject|1|||
164682690|NCT02272803|594859901|FG000|Overall Study|Disease progression|16|||
164682691|NCT02272803|594859902|FG001|Overall Study|Disease progression|8|||
164682692|NCT02272803|594859901|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
164682693|NCT02272803|594859902|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
164682694|NCT02272803|594859901|FG000|Overall Study|Study drug toxicity|4|||
164682695|NCT02272803|594859902|FG001|Overall Study|Study drug toxicity|9|||
164682696|NCT02272803|594859901|FG000|Overall Study|Participant request to discontinue study treatment|3|||
164682697|NCT02272803|594859902|FG001|Overall Study|Participant request to discontinue study treatment|7|||
164682698|NCT02272803|594859901|FG000|Overall Study|Maximum clinical benefit|4|||
164682699|NCT02272803|594859902|FG001|Overall Study|Maximum clinical benefit|2|||
164682700|NCT02272803|594859901|FG000|Overall Study|Poor/non-compliance|2|||
164682701|NCT02272803|594859902|FG001|Overall Study|Poor/non-compliance|2|||
164682702|NCT02272803|594859901|FG000|Overall Study|Withdrawal by Subject|2|||
164682703|NCT02272803|594859902|FG001|Overall Study|Withdrawal by Subject|1|||
164682704|NCT02272803|594859901|FG000|Overall Study|Death|0|||
164682705|NCT02272803|594859902|FG001|Overall Study|Death|1|||
164682706|NCT02272803|594859901|FG000|Overall Study|Other reasons|1|||
164682707|NCT02272803|594859902|FG001|Overall Study|Other reasons|3|||
164682708|NCT02272803|594859901|FG000|Overall Study|Administrative reason by sponsor|5|||
164682709|NCT02272803|594859902|FG001|Overall Study|Administrative reason by sponsor|4|||
164682710|NCT03961204|594859903|FG000|Overall Study|Withdrawal by Subject|2|||
164682711|NCT03961204|594859903|FG000|Overall Study|Lost to Follow-up|3|||
164682712|NCT03961204|594859903|FG000|Overall Study|Other|1|||
164682713|NCT03961204|594859903|FG000|Overall Study|Missing|1|||
164682714|NCT02218216|594859904|FG000|Overall Study|Study terminated before completed|6|||
164682715|NCT02218216|594859905|FG001|Overall Study|Study terminated before completed|0|||
164682716|NCT02218216|594859906|FG002|Overall Study|Study terminated before completed|0|||
164682717|NCT02452463|594859909|FG000|Overall Study|Death|1|||
164682718|NCT02452463|594859910|FG001|Overall Study|Death|0|||
164682719|NCT02452463|594859911|FG002|Overall Study|Death|0|||
164682720|NCT02452463|594859909|FG000|Overall Study|Study Suspended|1|||
164682721|NCT02452463|594859910|FG001|Overall Study|Study Suspended|0|||
164263537|NCT03906656|593331915|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
164682722|NCT02452463|594859911|FG002|Overall Study|Study Suspended|0|||
164263538|NCT03906656|593331914|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
164263539|NCT03906656|593331915|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
164263540|NCT03906656|593331914|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
164263541|NCT03906656|593331915|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
164263542|NCT03906656|593331914|FG000|Home Use 2 (3 Months)|Death|2|||
164682723|NCT02452463|594859909|FG000|Overall Study|Recommended by DSMB|0|||
164682724|NCT02452463|594859910|FG001|Overall Study|Recommended by DSMB|1|||
164682725|NCT02452463|594859911|FG002|Overall Study|Recommended by DSMB|0|||
164682726|NCT02452463|594859909|FG000|Overall Study|Withdrawal by Subject|0|||
164682727|NCT02452463|594859910|FG001|Overall Study|Withdrawal by Subject|1|||
164682728|NCT02452463|594859911|FG002|Overall Study|Withdrawal by Subject|0|||
164682729|NCT05740098|594859912|FG000|Overall Study|Lost to Follow-up|26|||
164682730|NCT05740098|594859913|FG001|Overall Study|Lost to Follow-up|17|||
164682731|NCT05740098|594859914|FG002|Overall Study|Lost to Follow-up|21|||
164682732|NCT03067987|594859915|FG000|Overall Study|Lost to Follow-up|7|||
164682733|NCT03067987|594859916|FG001|Overall Study|Lost to Follow-up|10|||
164682734|NCT03067987|594859915|FG000|Overall Study|Protocol Violation|1|||
164682735|NCT03067987|594859916|FG001|Overall Study|Protocol Violation|2|||
164682736|NCT03067987|594859915|FG000|Overall Study|Withdrawal by Subject|2|||
164682737|NCT03067987|594859916|FG001|Overall Study|Withdrawal by Subject|1|||
164682738|NCT03733145|594859917|FG000|Overall Study|screenfail|3|||
164682739|NCT03733145|594859918|FG001|Overall Study|screenfail|3|||
164682740|NCT03733145|594859919|FG002|Overall Study|screenfail|2|||
164682741|NCT00829764|594859920|FG000|First Intervention|Adverse Event|1|||
164682742|NCT00829764|594859921|FG001|First Intervention|Adverse Event|0|||
164682743|NCT00829764|594859920|FG000|First Intervention|Withdrawal by Subject|1|||
164429804|NCT00293462|593943420|FG001|Overall Study|Refuse Radiation Treatment|0|||
164429805|NCT00293462|593943421|FG002|Overall Study|Refuse Radiation Treatment|0|||
164429806|NCT00293462|593943419|FG000|Overall Study|No Show|0|||
164429807|NCT00293462|593943420|FG001|Overall Study|No Show|0|||
164429808|NCT00293462|593943421|FG002|Overall Study|No Show|1|||
164429809|NCT00293462|593943419|FG000|Overall Study|Went back to his home country|0|||
164429810|NCT00293462|593943420|FG001|Overall Study|Went back to his home country|0|||
164429811|NCT00293462|593943421|FG002|Overall Study|Went back to his home country|1|||
164429812|NCT00293462|593943419|FG000|Overall Study|Blood clot after chemotherapy|0|||
164429813|NCT00293462|593943420|FG001|Overall Study|Blood clot after chemotherapy|0|||
164429814|NCT00293462|593943421|FG002|Overall Study|Blood clot after chemotherapy|1|||
164429815|NCT00293462|593943419|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
164429816|NCT00293462|593943420|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
164429817|NCT00293462|593943421|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
164429818|NCT00293462|593943419|FG000|Overall Study|Possible Tracheostomy leakage|0|||
164429819|NCT00293462|593943420|FG001|Overall Study|Possible Tracheostomy leakage|1|||
164429820|NCT00293462|593943421|FG002|Overall Study|Possible Tracheostomy leakage|0|||
164577932|NCT04419506|594481856|FG001|Overall Study|Withdrawal by Subject|0|||
164577933|NCT04419506|594481857|FG002|Overall Study|Withdrawal by Subject|0|||
164577934|NCT04419506|594481858|FG003|Overall Study|Withdrawal by Subject|1|||
164577935|NCT04419506|594481855|FG000|Overall Study|poor-compliance|0|||
164577936|NCT04419506|594481856|FG001|Overall Study|poor-compliance|0|||
164577937|NCT04419506|594481857|FG002|Overall Study|poor-compliance|0|||
164577938|NCT04419506|594481858|FG003|Overall Study|poor-compliance|1|||
164682744|NCT00829764|594859921|FG001|First Intervention|Withdrawal by Subject|1|||
164682745|NCT01098851|594861371|FG000|Overall Study|Equipment failure|1|||
164682746|NCT01098851|594861372|FG001|Overall Study|Equipment failure|0|||
164682747|NCT03087786|594861373|FG000|Overall Study|Withdrawal by Subject|2|||
164682748|NCT03087786|594861374|FG001|Overall Study|Withdrawal by Subject|0|||
164682749|NCT00183196|594861376|FG000|Overall Study|Withdrawal by Subject|18|||
164682750|NCT00183196|594861377|FG001|Overall Study|Withdrawal by Subject|11|||
164682751|NCT00183196|594861378|FG002|Overall Study|Withdrawal by Subject|13|||
164682752|NCT00183196|594861376|FG000|Overall Study|Adverse Event|1|||
164682753|NCT00183196|594861377|FG001|Overall Study|Adverse Event|2|||
164577939|NCT04329949|594481859|FG000|Overall Study|Death|36|||
164577940|NCT04329949|594481859|FG000|Overall Study|Withdrawal by Subject|4|||
164577941|NCT04329949|594481859|FG000|Overall Study|Termination of study by sponsor|3|||
164682754|NCT00183196|594861378|FG002|Overall Study|Adverse Event|2|||
164682755|NCT00183196|594861376|FG000|Overall Study|Legal event|1|||
164682756|NCT00183196|594861377|FG001|Overall Study|Legal event|1|||
164682757|NCT00183196|594861378|FG002|Overall Study|Legal event|1|||
164682758|NCT00183196|594861376|FG000|Overall Study|Required more intensive care|0|||
164682759|NCT00183196|594861377|FG001|Overall Study|Required more intensive care|1|||
164682760|NCT00183196|594861378|FG002|Overall Study|Required more intensive care|2|||
164682761|NCT00385736|594861379|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
164682762|NCT00385736|594861380|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
164682763|NCT00385736|594861381|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
164682764|NCT00385736|594861379|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
164682765|NCT00385736|594861380|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
164682766|NCT00385736|594861381|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
164682767|NCT00385736|594861379|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
164682768|NCT00385736|594861380|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
164682769|NCT00385736|594861381|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
164682770|NCT00385736|594861379|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
164682771|NCT00385736|594861380|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
164682772|NCT00385736|594861381|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
164682773|NCT00385736|594861379|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
164682774|NCT00385736|594861380|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
164682775|NCT00385736|594861381|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
164682776|NCT00385736|594861379|FG000|Efficacy Analysis Set - Induction|Other|0|||
164682777|NCT00385736|594861380|FG001|Efficacy Analysis Set - Induction|Other|0|||
164682778|NCT00385736|594861381|FG002|Efficacy Analysis Set - Induction|Other|1|||
164682779|NCT00385736|594861379|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
164682780|NCT00385736|594861380|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
164682781|NCT00385736|594861381|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
164682782|NCT00385736|594861379|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
164682783|NCT00385736|594861380|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
164682784|NCT00385736|594861381|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
164682785|NCT00385736|594861379|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
164682786|NCT00385736|594861380|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
164682787|NCT00385736|594861381|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
164682788|NCT00385736|594861379|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
164682789|NCT00385736|594861380|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
164682790|NCT00385736|594861381|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
164682791|NCT00385736|594861379|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
164682792|NCT00385736|594861380|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
164682793|NCT00385736|594861381|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
164682794|NCT00385736|594861379|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
164682795|NCT00385736|594861380|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
164682796|NCT00385736|594861381|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
164682797|NCT00385736|594861379|FG000|Safety Analysis Set|Adverse Event|23|||
164682798|NCT00385736|594861380|FG001|Safety Analysis Set|Adverse Event|15|||
164682799|NCT00385736|594861381|FG002|Safety Analysis Set|Adverse Event|23|||
164682800|NCT00385736|594861379|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
164682801|NCT00385736|594861380|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
164263543|NCT03906656|593331915|FG001|Home Use 2 (3 Months)|Death|0|||
164682802|NCT00385736|594861381|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
164682803|NCT00385736|594861379|FG000|Safety Analysis Set|Lost to Follow-up|0|||
164682804|NCT00385736|594861380|FG001|Safety Analysis Set|Lost to Follow-up|2|||
164263544|NCT03906656|593331914|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
164263545|NCT03906656|593331915|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
164263546|NCT03906656|593331914|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
164263547|NCT03906656|593331915|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
164263548|NCT00343915|593331917|FG000|Primary Study|Withdrawal by Subject|1|||
164263549|NCT00343915|593331918|FG001|Primary Study|Withdrawal by Subject|0|||
164263550|NCT00343915|593331917|FG000|Primary Study|Lost to Follow-up|2|||
164263551|NCT00343915|593331918|FG001|Primary Study|Lost to Follow-up|3|||
164263552|NCT00343915|593331917|FG000|Primary Study|Other|1|||
164263553|NCT00343915|593331918|FG001|Primary Study|Other|0|||
164263554|NCT00536874|593331920|FG000|Overall Study|Adverse Event|1|||
164263555|NCT00536874|593331920|FG000|Overall Study|Death|2|||
164263556|NCT00536874|593331920|FG000|Overall Study|Withdrawal by Subject|1|||
164263557|NCT01853072|593331921|FG000|Overall Study|Adverse event prior to treatment|0|||
164263558|NCT01853072|593331922|FG001|Overall Study|Adverse event prior to treatment|1|||
164263559|NCT01853072|593331921|FG000|Overall Study|Adverse Event|0|||
164263560|NCT01853072|593331922|FG001|Overall Study|Adverse Event|3|||
164263561|NCT01853072|593331921|FG000|Overall Study|Death|1|||
164263562|NCT01853072|593331922|FG001|Overall Study|Death|4|||
164263563|NCT01853072|593331921|FG000|Overall Study|Lost to Follow-up|0|||
164263564|NCT01853072|593331922|FG001|Overall Study|Lost to Follow-up|3|||
164263565|NCT01853072|593331921|FG000|Overall Study|Non-compliance with study drug|0|||
164263566|NCT01853072|593331922|FG001|Overall Study|Non-compliance with study drug|1|||
164263567|NCT01853072|593331921|FG000|Overall Study|Physician Decision|1|||
164263568|NCT01853072|593331922|FG001|Overall Study|Physician Decision|1|||
164263569|NCT01853072|593331921|FG000|Overall Study|Withdrawal by Subject|1|||
164263570|NCT01853072|593331922|FG001|Overall Study|Withdrawal by Subject|2|||
164263571|NCT01853072|593331921|FG000|Overall Study|Reason not specified|9|||
164263572|NCT01853072|593331922|FG001|Overall Study|Reason not specified|6|||
164263573|NCT00930969|593331923|FG000|Overall Study|Death|5|||
164577942|NCT01845025|594481860|FG000|Overall Study|Adverse Event|6|||
164577943|NCT01845025|594481861|FG001|Overall Study|Adverse Event|3|||
164577944|NCT01845025|594481860|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
164577945|NCT01845025|594481861|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164577946|NCT01845025|594481860|FG000|Overall Study|Withdrawal by Subject|48|||
164577947|NCT01845025|594481861|FG001|Overall Study|Withdrawal by Subject|44|||
164577948|NCT01845025|594481860|FG000|Overall Study|Lost to Follow-up|13|||
164577949|NCT01845025|594481861|FG001|Overall Study|Lost to Follow-up|13|||
164577950|NCT01845025|594481860|FG000|Overall Study|Administrative problems|8|||
164577951|NCT01845025|594481861|FG001|Overall Study|Administrative problems|8|||
164577952|NCT01845025|594481860|FG000|Overall Study|Death|2|||
164577953|NCT01845025|594481861|FG001|Overall Study|Death|0|||
164577954|NCT01845025|594481860|FG000|Overall Study|Protocol deviation|3|||
164577955|NCT01845025|594481861|FG001|Overall Study|Protocol deviation|6|||
164577956|NCT01845025|594481860|FG000|Overall Study|Missing|1|||
164577957|NCT01845025|594481861|FG001|Overall Study|Missing|1|||
164577958|NCT04645797|594481862|FG000|Overall Study|Disease Progression|3|||
164577959|NCT04645797|594481863|FG001|Overall Study|Disease Progression|3|||
164577960|NCT04645797|594481864|FG002|Overall Study|Disease Progression|1|||
164577961|NCT04645797|594481865|FG003|Overall Study|Disease Progression|0|||
164577962|NCT04645797|594481866|FG004|Overall Study|Disease Progression|0|||
164577963|NCT04645797|594481867|FG005|Overall Study|Disease Progression|0|||
164577964|NCT04645797|594481868|FG006|Overall Study|Disease Progression|0|||
164577965|NCT04645797|594481862|FG000|Overall Study|Death|3|||
164577966|NCT04645797|594481863|FG001|Overall Study|Death|1|||
164577967|NCT04645797|594481864|FG002|Overall Study|Death|0|||
164577968|NCT04645797|594481865|FG003|Overall Study|Death|0|||
164577969|NCT04645797|594481866|FG004|Overall Study|Death|0|||
164577970|NCT04645797|594481867|FG005|Overall Study|Death|0|||
164577971|NCT04645797|594481868|FG006|Overall Study|Death|0|||
164577972|NCT00345605|594481871|FG000|Arm 1|Adverse Event|0|||
164577973|NCT00345605|594481872|FG001|Arm 1|Adverse Event|1|||
164577974|NCT00345605|594481871|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
164577975|NCT00345605|594481872|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
164577976|NCT00733902|594481873|FG000|Overall Study|Death|0|||
164577977|NCT00733902|594481874|FG001|Overall Study|Death|0|||
164577978|NCT00733902|594481875|FG002|Overall Study|Death|0|||
164577979|NCT00733902|594481876|FG003|Overall Study|Death|1|||
164577980|NCT00733902|594481873|FG000|Overall Study|Adverse Event|3|||
164577981|NCT00733902|594481874|FG001|Overall Study|Adverse Event|4|||
164577982|NCT00733902|594481875|FG002|Overall Study|Adverse Event|7|||
164577983|NCT00733902|594481876|FG003|Overall Study|Adverse Event|11|||
164577984|NCT00733902|594481873|FG000|Overall Study|Lack of Efficacy|56|||
164577985|NCT00733902|594481874|FG001|Overall Study|Lack of Efficacy|21|||
164577986|NCT00733902|594481875|FG002|Overall Study|Lack of Efficacy|34|||
164577987|NCT00733902|594481876|FG003|Overall Study|Lack of Efficacy|23|||
164577988|NCT00733902|594481873|FG000|Overall Study|Protocol Violation|4|||
164577989|NCT00733902|594481874|FG001|Overall Study|Protocol Violation|6|||
164577990|NCT00733902|594481875|FG002|Overall Study|Protocol Violation|3|||
164577991|NCT00733902|594481876|FG003|Overall Study|Protocol Violation|3|||
164577992|NCT00733902|594481873|FG000|Overall Study|Withdrawal by Subject|10|||
164577993|NCT00733902|594481874|FG001|Overall Study|Withdrawal by Subject|5|||
164577994|NCT00733902|594481875|FG002|Overall Study|Withdrawal by Subject|4|||
164577995|NCT00733902|594481876|FG003|Overall Study|Withdrawal by Subject|16|||
164577996|NCT00733902|594481873|FG000|Overall Study|Entered extension study|89|||
164577997|NCT00733902|594481874|FG001|Overall Study|Entered extension study|124|||
164577998|NCT00733902|594481875|FG002|Overall Study|Entered extension study|111|||
164577999|NCT00733902|594481876|FG003|Overall Study|Entered extension study|109|||
164578000|NCT00733902|594481873|FG000|Overall Study|Randomized but not treated|2|||
164578001|NCT00733902|594481874|FG001|Overall Study|Randomized but not treated|2|||
164578002|NCT00733902|594481875|FG002|Overall Study|Randomized but not treated|2|||
164578003|NCT00733902|594481876|FG003|Overall Study|Randomized but not treated|1|||
164578004|NCT00817414|594481877|FG000|Overall Study|Adverse Event|1|||
164578005|NCT00817414|594481878|FG001|Overall Study|Adverse Event|1|||
164578006|NCT00817414|594481879|FG002|Overall Study|Adverse Event|1|||
164578007|NCT00817414|594481880|FG003|Overall Study|Adverse Event|0|||
164578008|NCT00817414|594481881|FG004|Overall Study|Adverse Event|0|||
164578009|NCT00817414|594481877|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
164578010|NCT00817414|594481878|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
164578011|NCT00817414|594481879|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
164578012|NCT00817414|594481880|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
164578013|NCT00817414|594481881|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
164578014|NCT00817414|594481877|FG000|Overall Study|Withdrawal by Subject|1|||
164578015|NCT00817414|594481878|FG001|Overall Study|Withdrawal by Subject|1|||
164578016|NCT00817414|594481879|FG002|Overall Study|Withdrawal by Subject|0|||
164263574|NCT00930969|593331923|FG000|Overall Study|Lost to Follow-up|1|||
164429821|NCT00293462|593943419|FG000|Overall Study|Low radiation dose in oral cavity|0|||
164429822|NCT00293462|593943420|FG001|Overall Study|Low radiation dose in oral cavity|1|||
164429823|NCT00293462|593943421|FG002|Overall Study|Low radiation dose in oral cavity|0|||
164429824|NCT00293462|593943419|FG000|Overall Study|Physician Decision|0|||
164429825|NCT00293462|593943420|FG001|Overall Study|Physician Decision|1|||
164429826|NCT00293462|593943421|FG002|Overall Study|Physician Decision|0|||
164429827|NCT01579578|593943422|FG000|Overall Study|Death|4|||
164429828|NCT01579578|593943423|FG001|Overall Study|Death|1|||
164429829|NCT01579578|593943422|FG000|Overall Study|Lost to Follow-up|1|||
164429830|NCT01579578|593943423|FG001|Overall Study|Lost to Follow-up|1|||
164429831|NCT01579578|593943422|FG000|Overall Study|Withdrawal by Subject|2|||
164429832|NCT01579578|593943423|FG001|Overall Study|Withdrawal by Subject|1|||
164429833|NCT01579578|593943422|FG000|Overall Study|Eligibility criteria|3|||
164429834|NCT01579578|593943423|FG001|Overall Study|Eligibility criteria|9|||
164429835|NCT01579578|593943422|FG000|Overall Study|Ongoing|3|||
164429836|NCT01579578|593943423|FG001|Overall Study|Ongoing|0|||
164429837|NCT01004263|593943426|FG000|Overall Study|Adverse Event|15|||
164429838|NCT01004263|593943426|FG000|Overall Study|Withdrawal by Subject|58|||
164429839|NCT01004263|593943426|FG000|Overall Study|Protocol Violation|10|||
164429840|NCT01004263|593943426|FG000|Overall Study|Lost to Follow-up|64|||
164429841|NCT01004263|593943426|FG000|Overall Study|Lack of Efficacy|13|||
164429842|NCT01004263|593943426|FG000|Overall Study|Pregnancy|2|||
164429843|NCT01004263|593943426|FG000|Overall Study|Physician Decision|15|||
164429844|NCT01004263|593943426|FG000|Overall Study|Lack of Qualifying Event|2|||
164429845|NCT03398356|593943430|FG000|Before Treatment|Lost to Follow-up|1|||
164429846|NCT03398356|593943431|FG001|Before Treatment|Lost to Follow-up|2|||
164429847|NCT03398356|593943432|FG002|Before Treatment|Lost to Follow-up|0|||
164429848|NCT03398356|593943430|FG000|Before Treatment|drug intolerance|2|||
164429849|NCT03398356|593943431|FG001|Before Treatment|drug intolerance|1|||
164429850|NCT03398356|593943432|FG002|Before Treatment|drug intolerance|0|||
164429851|NCT03398356|593943430|FG000|Before Treatment|Withdrawal by Subject|0|||
164429852|NCT03398356|593943431|FG001|Before Treatment|Withdrawal by Subject|5|||
164429853|NCT03398356|593943432|FG002|Before Treatment|Withdrawal by Subject|0|||
164429854|NCT03398356|593943430|FG000|Before Treatment|Physician Decision|0|||
164429855|NCT03398356|593943431|FG001|Before Treatment|Physician Decision|0|||
164429856|NCT03398356|593943432|FG002|Before Treatment|Physician Decision|11|||
164429857|NCT03398356|593943430|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
164429858|NCT03398356|593943431|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
164429859|NCT03398356|593943432|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
164429860|NCT00647348|593943435|FG000|Overall Study|Lost to Follow-up|3|||
164429861|NCT00647348|593943436|FG001|Overall Study|Lost to Follow-up|6|||
164429862|NCT00821236|593943437|FG000|Overall Study|Lost to Follow-up|3|||
164429863|NCT01582243|593943440|FG000|Overall Study|Withdrawal by Subject|1|||
164429864|NCT01582243|593943440|FG000|Overall Study|Adverse Event|1|||
164429865|NCT01582243|593943440|FG000|Overall Study|Lost to Follow-up|1|||
164429866|NCT01119703|593943447|FG000|Overall Study|Adverse Event|0|||
164429867|NCT01119703|593943448|FG001|Overall Study|Adverse Event|1|||
164429868|NCT02096003|593943449|FG000|Overall Study|Protocol Violation|0|||
164429869|NCT02096003|593943450|FG001|Overall Study|Protocol Violation|2|||
164263575|NCT00930969|593331923|FG000|Overall Study|Physician Decision|13|||
164263576|NCT00930969|593331923|FG000|Overall Study|Withdrawal by Subject|19|||
164263577|NCT01287221|593331924|FG000|Overall Study|Lack of Perceived Benefit|1|||
164263578|NCT01287221|593331925|FG001|Overall Study|Lack of Perceived Benefit|1|||
164263579|NCT01287221|593331924|FG000|Overall Study|Adverse Event|3|||
164263580|NCT01287221|593331925|FG001|Overall Study|Adverse Event|3|||
164263581|NCT01287221|593331924|FG000|Overall Study|Withdrawal by Subject|0|||
164263582|NCT01287221|593331925|FG001|Overall Study|Withdrawal by Subject|1|||
164263583|NCT03515941|593331928|FG000|Overall Study|Adverse Event|1|||
164263584|NCT03515941|593331929|FG001|Overall Study|Adverse Event|0|||
164263585|NCT03559699|593333964|FG000|Overall Study|Withdrawal by Subject|6|||
164429870|NCT02096003|593943449|FG000|Overall Study|additional surgery|2|||
164429871|NCT02096003|593943450|FG001|Overall Study|additional surgery|1|||
164429872|NCT01511250|593943451|FG000|Overall Study|Withdrawal of Consent|1|||
164429873|NCT01511250|593943452|FG001|Overall Study|Withdrawal of Consent|0|||
164429874|NCT01511250|593943453|FG002|Overall Study|Withdrawal of Consent|0|||
164429875|NCT01511250|593943454|FG003|Overall Study|Withdrawal of Consent|0|||
164429876|NCT01511250|593943455|FG004|Overall Study|Withdrawal of Consent|0|||
164429877|NCT01511250|593943456|FG005|Overall Study|Withdrawal of Consent|0|||
164578017|NCT00817414|594481880|FG003|Overall Study|Withdrawal by Subject|0|||
164263586|NCT03559699|593333964|FG000|Overall Study|Lost to Follow-up|1|||
164263587|NCT00031460|593333965|FG000|Overall Study|Lost to Follow-up|0|||
164429878|NCT01511250|593943457|FG006|Overall Study|Withdrawal of Consent|0|||
164429879|NCT01511250|593943458|FG007|Overall Study|Withdrawal of Consent|1|||
164429880|NCT01511250|593943459|FG008|Overall Study|Withdrawal of Consent|1|||
164578018|NCT00817414|594481881|FG004|Overall Study|Withdrawal by Subject|0|||
164429881|NCT01511250|593943460|FG009|Overall Study|Withdrawal of Consent|0|||
164429882|NCT01511250|593943451|FG000|Overall Study|Sponsor/Investigator Decision|1|||
164429883|NCT01511250|593943452|FG001|Overall Study|Sponsor/Investigator Decision|0|||
164429884|NCT01511250|593943453|FG002|Overall Study|Sponsor/Investigator Decision|0|||
164429885|NCT01511250|593943454|FG003|Overall Study|Sponsor/Investigator Decision|0|||
164429886|NCT01511250|593943455|FG004|Overall Study|Sponsor/Investigator Decision|0|||
164429887|NCT01511250|593943456|FG005|Overall Study|Sponsor/Investigator Decision|0|||
164429888|NCT01511250|593943457|FG006|Overall Study|Sponsor/Investigator Decision|0|||
164429889|NCT01511250|593943458|FG007|Overall Study|Sponsor/Investigator Decision|0|||
164429890|NCT01511250|593943459|FG008|Overall Study|Sponsor/Investigator Decision|0|||
164429891|NCT01511250|593943460|FG009|Overall Study|Sponsor/Investigator Decision|0|||
164429892|NCT01511250|593943451|FG000|Overall Study|Lost to Follow-up|7|||
164429893|NCT01511250|593943452|FG001|Overall Study|Lost to Follow-up|3|||
164429894|NCT01511250|593943453|FG002|Overall Study|Lost to Follow-up|3|||
164429895|NCT01511250|593943454|FG003|Overall Study|Lost to Follow-up|3|||
164429896|NCT01511250|593943455|FG004|Overall Study|Lost to Follow-up|0|||
164429897|NCT01511250|593943456|FG005|Overall Study|Lost to Follow-up|0|||
164429898|NCT01511250|593943457|FG006|Overall Study|Lost to Follow-up|2|||
164429899|NCT01511250|593943458|FG007|Overall Study|Lost to Follow-up|3|||
164429900|NCT01511250|593943459|FG008|Overall Study|Lost to Follow-up|13|||
164429901|NCT01511250|593943460|FG009|Overall Study|Lost to Follow-up|5|||
164429902|NCT01511250|593943451|FG000|Overall Study|Protocol Violation|0|||
164429903|NCT01511250|593943452|FG001|Overall Study|Protocol Violation|2|||
164429904|NCT01511250|593943453|FG002|Overall Study|Protocol Violation|1|||
164429905|NCT01511250|593943454|FG003|Overall Study|Protocol Violation|0|||
164429906|NCT01511250|593943455|FG004|Overall Study|Protocol Violation|0|||
164578019|NCT00817414|594481877|FG000|Overall Study|Lost to Follow-up|0|||
164578020|NCT00817414|594481878|FG001|Overall Study|Lost to Follow-up|0|||
164578021|NCT00817414|594481879|FG002|Overall Study|Lost to Follow-up|1|||
164578022|NCT00817414|594481880|FG003|Overall Study|Lost to Follow-up|1|||
164578023|NCT00817414|594481881|FG004|Overall Study|Lost to Follow-up|1|||
164578024|NCT00817414|594481877|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
164578025|NCT00817414|594481878|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
164578026|NCT00817414|594481879|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
164578027|NCT00817414|594481880|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
164578028|NCT00817414|594481881|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
164578029|NCT00817414|594481877|FG000|Overall Study|Protocol Violation|0|||
164578030|NCT00817414|594481878|FG001|Overall Study|Protocol Violation|0|||
164578031|NCT00817414|594481879|FG002|Overall Study|Protocol Violation|0|||
164578032|NCT00817414|594481880|FG003|Overall Study|Protocol Violation|0|||
164578033|NCT00817414|594481881|FG004|Overall Study|Protocol Violation|1|||
164578034|NCT02586805|594481885|FG000|Overall Study|Withdrawal by Subject|3|||
164578035|NCT02586805|594481886|FG001|Overall Study|Withdrawal by Subject|1|||
164578036|NCT02586805|594481887|FG002|Overall Study|Withdrawal by Subject|1|||
164578037|NCT02586805|594481888|FG003|Overall Study|Withdrawal by Subject|2|||
164578038|NCT02586805|594481885|FG000|Overall Study|Adverse Event|2|||
164578039|NCT02586805|594481886|FG001|Overall Study|Adverse Event|0|||
164578040|NCT02586805|594481887|FG002|Overall Study|Adverse Event|1|||
164578041|NCT02586805|594481888|FG003|Overall Study|Adverse Event|0|||
164578042|NCT02586805|594481885|FG000|Overall Study|Lost to Follow-up|0|||
164578043|NCT02586805|594481886|FG001|Overall Study|Lost to Follow-up|0|||
164578044|NCT02586805|594481887|FG002|Overall Study|Lost to Follow-up|1|||
164578045|NCT02586805|594481888|FG003|Overall Study|Lost to Follow-up|0|||
164578046|NCT02586805|594481885|FG000|Overall Study|Physician Decision|1|||
164578047|NCT02586805|594481886|FG001|Overall Study|Physician Decision|0|||
164578048|NCT02586805|594481887|FG002|Overall Study|Physician Decision|0|||
164578049|NCT02586805|594481888|FG003|Overall Study|Physician Decision|0|||
164578050|NCT00472303|594481902|FG000|Titration Phase|Adverse Event|22|||
164578051|NCT00472303|594481903|FG001|Titration Phase|Adverse Event|12|||
164578052|NCT00472303|594481904|FG002|Titration Phase|Adverse Event|0|||
164578053|NCT00472303|594481902|FG000|Titration Phase|Death|4|||
164578054|NCT00472303|594481903|FG001|Titration Phase|Death|2|||
164578055|NCT00472303|594481904|FG002|Titration Phase|Death|0|||
164578056|NCT00472303|594481902|FG000|Titration Phase|Lack of Efficacy|10|||
164578057|NCT00472303|594481903|FG001|Titration Phase|Lack of Efficacy|0|||
164578058|NCT00472303|594481904|FG002|Titration Phase|Lack of Efficacy|0|||
164578059|NCT00472303|594481902|FG000|Titration Phase|Withdrawal by Subject|16|||
164578060|NCT00472303|594481903|FG001|Titration Phase|Withdrawal by Subject|13|||
164578061|NCT00472303|594481904|FG002|Titration Phase|Withdrawal by Subject|0|||
164263588|NCT00031460|593333966|FG001|Overall Study|Lost to Follow-up|1|||
164429907|NCT01511250|593943456|FG005|Overall Study|Protocol Violation|0|||
164429908|NCT01511250|593943457|FG006|Overall Study|Protocol Violation|0|||
164429909|NCT01511250|593943458|FG007|Overall Study|Protocol Violation|0|||
164429910|NCT01511250|593943459|FG008|Overall Study|Protocol Violation|0|||
164578062|NCT00472303|594481902|FG000|Titration Phase|Trial Medication non-compliant|4|||
164578063|NCT00472303|594481903|FG001|Titration Phase|Trial Medication non-compliant|1|||
164429911|NCT01511250|593943460|FG009|Overall Study|Protocol Violation|0|||
164578064|NCT00472303|594481904|FG002|Titration Phase|Trial Medication non-compliant|0|||
164578065|NCT00472303|594481902|FG000|Titration Phase|Other|3|||
164578066|NCT00472303|594481903|FG001|Titration Phase|Other|1|||
164578067|NCT00472303|594481904|FG002|Titration Phase|Other|0|||
164578068|NCT00472303|594481902|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
164578069|NCT00472303|594481903|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
164578070|NCT00472303|594481904|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
164578071|NCT00472303|594481902|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
164578072|NCT00472303|594481903|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
164578073|NCT00472303|594481904|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
164578074|NCT00472303|594481902|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
164578075|NCT00472303|594481903|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
164578076|NCT00472303|594481904|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
164578077|NCT00472303|594481902|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
164578078|NCT00472303|594481903|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
164578079|NCT00472303|594481904|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
164578080|NCT00472303|594481902|FG000|Discontinuations After Titration Phase|Other|5|||
164578081|NCT00472303|594481903|FG001|Discontinuations After Titration Phase|Other|0|||
164578082|NCT00472303|594481904|FG002|Discontinuations After Titration Phase|Other|0|||
164578083|NCT00472303|594481902|FG000|Maintenance Phase|Adverse Event|5|||
164578084|NCT00472303|594481903|FG001|Maintenance Phase|Adverse Event|6|||
164578085|NCT00472303|594481904|FG002|Maintenance Phase|Adverse Event|6|||
164578086|NCT00472303|594481902|FG000|Maintenance Phase|Death|3|||
164578087|NCT00472303|594481903|FG001|Maintenance Phase|Death|0|||
164578088|NCT00472303|594481904|FG002|Maintenance Phase|Death|2|||
164578089|NCT00472303|594481902|FG000|Maintenance Phase|Lack of Efficacy|2|||
164578090|NCT00472303|594481903|FG001|Maintenance Phase|Lack of Efficacy|2|||
164578091|NCT00472303|594481904|FG002|Maintenance Phase|Lack of Efficacy|4|||
164578092|NCT00472303|594481902|FG000|Maintenance Phase|Withdrawal by Subject|6|||
164578093|NCT00472303|594481903|FG001|Maintenance Phase|Withdrawal by Subject|7|||
164578094|NCT00472303|594481904|FG002|Maintenance Phase|Withdrawal by Subject|3|||
164578095|NCT00472303|594481902|FG000|Maintenance Phase|Trial medication non-compliant|0|||
164578096|NCT00472303|594481903|FG001|Maintenance Phase|Trial medication non-compliant|0|||
164578097|NCT00472303|594481904|FG002|Maintenance Phase|Trial medication non-compliant|1|||
164578098|NCT00472303|594481902|FG000|Maintenance Phase|Resolution of pain|0|||
164578099|NCT00472303|594481903|FG001|Maintenance Phase|Resolution of pain|0|||
164578100|NCT00472303|594481904|FG002|Maintenance Phase|Resolution of pain|1|||
164578101|NCT00472303|594481902|FG000|Maintenance Phase|Other|1|||
164578102|NCT00472303|594481903|FG001|Maintenance Phase|Other|1|||
164578103|NCT00472303|594481904|FG002|Maintenance Phase|Other|0|||
164578104|NCT03596164|594481905|FG000|Overall Study|Adverse Event|0|||
164578105|NCT03596164|594481906|FG001|Overall Study|Adverse Event|1|||
164578106|NCT03596164|594481905|FG000|Overall Study|Death|1|||
164578107|NCT03596164|594481906|FG001|Overall Study|Death|0|||
164578108|NCT03427073|594481907|FG000|Overall Study|Disease Progression|1|||
164578109|NCT03427073|594481908|FG001|Overall Study|Disease Progression|1|||
164578110|NCT03427073|594481909|FG002|Overall Study|Disease Progression|1|||
164578111|NCT03427073|594481910|FG003|Overall Study|Disease Progression|3|||
164578112|NCT03427073|594481911|FG004|Overall Study|Disease Progression|3|||
164578113|NCT03427073|594481912|FG005|Overall Study|Disease Progression|4|||
164578114|NCT03427073|594481913|FG006|Overall Study|Disease Progression|2|||
164578115|NCT03427073|594481914|FG007|Overall Study|Disease Progression|3|||
164578116|NCT03427073|594481907|FG000|Overall Study|Physician Decision|0|||
164578117|NCT03427073|594481908|FG001|Overall Study|Physician Decision|0|||
164578118|NCT03427073|594481909|FG002|Overall Study|Physician Decision|0|||
164578119|NCT03427073|594481910|FG003|Overall Study|Physician Decision|0|||
164578120|NCT03427073|594481911|FG004|Overall Study|Physician Decision|0|||
164578121|NCT03427073|594481912|FG005|Overall Study|Physician Decision|0|||
164578122|NCT03427073|594481913|FG006|Overall Study|Physician Decision|1|||
164578123|NCT03427073|594481914|FG007|Overall Study|Physician Decision|1|||
164578124|NCT02835495|594481917|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
164578125|NCT02835495|594481918|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
164578126|NCT02835495|594481917|FG000|Overall Study|Declined in-person follow-up visit|4|||
164578127|NCT02835495|594481918|FG001|Overall Study|Declined in-person follow-up visit|2|||
164578128|NCT02580058|594481919|FG000|Overall Study|Adverse Event|16|||
164578129|NCT02580058|594481920|FG001|Overall Study|Adverse Event|30|||
164578130|NCT02580058|594481921|FG002|Overall Study|Adverse Event|20|||
164578131|NCT02580058|594481919|FG000|Overall Study|Death|4|||
164578132|NCT02580058|594481920|FG001|Overall Study|Death|4|||
164578133|NCT02580058|594481921|FG002|Overall Study|Death|5|||
164578134|NCT02580058|594481919|FG000|Overall Study|Physician Decision|1|||
164578135|NCT02580058|594481920|FG001|Overall Study|Physician Decision|3|||
164578136|NCT02580058|594481921|FG002|Overall Study|Physician Decision|11|||
164578137|NCT02580058|594481919|FG000|Overall Study|Other|5|||
164682805|NCT00385736|594861381|FG002|Safety Analysis Set|Lost to Follow-up|2|||
164578138|NCT02580058|594481920|FG001|Overall Study|Other|1|||
164578139|NCT02580058|594481921|FG002|Overall Study|Other|3|||
164578140|NCT02580058|594481919|FG000|Overall Study|Withdrawal by Subject|4|||
164578141|NCT02580058|594481920|FG001|Overall Study|Withdrawal by Subject|7|||
164578142|NCT02580058|594481921|FG002|Overall Study|Withdrawal by Subject|31|||
164682806|NCT00385736|594861379|FG000|Safety Analysis Set|Lack of Efficacy|38|||
164682807|NCT00385736|594861380|FG001|Safety Analysis Set|Lack of Efficacy|16|||
164682808|NCT00385736|594861381|FG002|Safety Analysis Set|Lack of Efficacy|31|||
164682809|NCT00385736|594861379|FG000|Safety Analysis Set|Protocol Violation|2|||
164682810|NCT00385736|594861380|FG001|Safety Analysis Set|Protocol Violation|1|||
164682811|NCT00385736|594861381|FG002|Safety Analysis Set|Protocol Violation|6|||
164682812|NCT00385736|594861379|FG000|Safety Analysis Set|Other|1|||
164682813|NCT00385736|594861380|FG001|Safety Analysis Set|Other|4|||
164429912|NCT04668144|593943461|FG000|Overall Study|Protocol Violation|0|||
164429913|NCT04668144|593943462|FG001|Overall Study|Protocol Violation|1|||
164429914|NCT04668144|593943463|FG002|Overall Study|Protocol Violation|2|||
164429915|NCT02095158|593943466|FG000|Overall Study|Adverse Event|14|||
164429916|NCT02095158|593943466|FG000|Overall Study|Lack of Efficacy|3|||
164429917|NCT02095158|593943466|FG000|Overall Study|Pregnancy|1|||
164429918|NCT02095158|593943466|FG000|Overall Study|Lost to Follow-up|20|||
164429919|NCT02095158|593943466|FG000|Overall Study|Personal Reasons|35|||
164429920|NCT02095158|593943466|FG000|Overall Study|Protocol Violation|1|||
164429921|NCT02095158|593943466|FG000|Overall Study|Other Miscellaneous Reasons|1|||
164429922|NCT03441984|593943467|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
164429923|NCT03441984|593943468|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
164429924|NCT03441984|593943469|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
164429925|NCT03441984|593943470|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
164578143|NCT02580058|594481919|FG000|Overall Study|Global Deterioration of Health Status|19|||
164578144|NCT02580058|594481920|FG001|Overall Study|Global Deterioration of Health Status|18|||
164578145|NCT02580058|594481921|FG002|Overall Study|Global Deterioration of Health Status|24|||
164578146|NCT02580058|594481919|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
164578147|NCT02580058|594481920|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
164578148|NCT02580058|594481921|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
164578149|NCT02580058|594481919|FG000|Overall Study|Progressive Disease|137|||
164578150|NCT02580058|594481920|FG001|Overall Study|Progressive Disease|125|||
164578151|NCT02580058|594481921|FG002|Overall Study|Progressive Disease|94|||
164578152|NCT02580058|594481919|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164578153|NCT02580058|594481920|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164578154|NCT02580058|594481921|FG002|Overall Study|Non-Compliance With Study Drug|0|||
164578155|NCT01442181|594481923|FG000|Overall Study|patient refused surgery|1|||
164578156|NCT01442181|594481924|FG001|Overall Study|patient refused surgery|0|||
164578157|NCT01442181|594481923|FG000|Overall Study|no insurance for surgery|1|||
164578158|NCT01442181|594481924|FG001|Overall Study|no insurance for surgery|0|||
164578159|NCT01442181|594481923|FG000|Overall Study|low ejection factor|0|||
164578160|NCT01442181|594481924|FG001|Overall Study|low ejection factor|1|||
164578161|NCT01442181|594481923|FG000|Overall Study|Lost to Follow-up|1|||
164578162|NCT01442181|594481924|FG001|Overall Study|Lost to Follow-up|1|||
164578163|NCT01442181|594481923|FG000|Overall Study|patient in an additional study|1|||
164578164|NCT01442181|594481924|FG001|Overall Study|patient in an additional study|0|||
164578165|NCT01442181|594481923|FG000|Overall Study|atrial fibrillation not noted|0|||
164578166|NCT01442181|594481924|FG001|Overall Study|atrial fibrillation not noted|1|||
164578167|NCT00749203|594481925|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
164578168|NCT00749203|594481926|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
164578169|NCT00749203|594481925|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
164578170|NCT00749203|594481926|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
164578171|NCT00749203|594481925|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
164578172|NCT00749203|594481926|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
164578173|NCT00749203|594481925|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
164578174|NCT00749203|594481926|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
164578175|NCT00749203|594481925|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
164578176|NCT00749203|594481926|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
164578177|NCT00749203|594481925|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
164578178|NCT00749203|594481926|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
164578179|NCT02034123|594481927|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164578180|NCT02034123|594481928|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164578181|NCT02034123|594481929|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164578182|NCT02034123|594481930|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164578183|NCT02034123|594481931|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
164578184|NCT02034123|594481932|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164578185|NCT02034123|594481933|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164578186|NCT02034123|594481934|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
164578187|NCT02034123|594481935|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
164578188|NCT02034123|594481936|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164578189|NCT02034123|594481937|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164578190|NCT02034123|594481938|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164429926|NCT03441984|593943471|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
164578191|NCT02034123|594481939|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164578192|NCT02034123|594481940|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164578193|NCT02034123|594481941|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164578194|NCT02034123|594481942|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164578195|NCT02034123|594481943|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164578196|NCT02034123|594481944|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164578197|NCT02034123|594481927|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164578198|NCT02034123|594481928|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164578199|NCT02034123|594481929|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164578200|NCT02034123|594481930|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
164578201|NCT02034123|594481931|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164578202|NCT02034123|594481932|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164578203|NCT02034123|594481933|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164578204|NCT02034123|594481934|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164578205|NCT02034123|594481935|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164578206|NCT02034123|594481936|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164578207|NCT02034123|594481937|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164578208|NCT02034123|594481938|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164578209|NCT02034123|594481939|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164578210|NCT02034123|594481940|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164578211|NCT02034123|594481941|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164578212|NCT02034123|594481942|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164578213|NCT02034123|594481943|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164578214|NCT02034123|594481944|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164578215|NCT02034123|594481927|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164578216|NCT02034123|594481928|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164578217|NCT02034123|594481929|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164578218|NCT02034123|594481930|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164578219|NCT02034123|594481931|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164578220|NCT02034123|594481932|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164578221|NCT02034123|594481933|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164578222|NCT02034123|594481934|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164578223|NCT02034123|594481935|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
164578224|NCT02034123|594481936|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164578225|NCT02034123|594481937|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164578226|NCT02034123|594481938|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164578227|NCT02034123|594481939|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164578228|NCT02034123|594481940|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164578229|NCT02034123|594481941|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164578230|NCT02034123|594481942|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164578231|NCT02034123|594481943|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164578232|NCT02034123|594481944|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164578233|NCT02034123|594481927|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164578234|NCT02034123|594481928|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164578235|NCT02034123|594481929|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164578236|NCT02034123|594481930|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
164578237|NCT02034123|594481931|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
164578238|NCT02034123|594481932|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164578239|NCT02034123|594481933|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164578240|NCT02034123|594481934|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164578241|NCT02034123|594481935|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164578242|NCT02034123|594481936|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164578243|NCT02034123|594481937|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164578244|NCT02034123|594481938|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164578245|NCT02034123|594481939|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164578246|NCT02034123|594481940|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164578247|NCT02034123|594481941|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164578248|NCT02034123|594481942|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164578249|NCT02034123|594481943|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164578250|NCT02034123|594481944|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164578251|NCT00246259|594481945|FG000|Overall Study|Other|3|||
164682814|NCT00385736|594861381|FG002|Safety Analysis Set|Other|4|||
164682815|NCT02906917|594861389|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
164682816|NCT02906917|594861390|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
164682817|NCT02906917|594861389|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
164682818|NCT02906917|594861390|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
164682819|NCT02906917|594861389|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
164682820|NCT02906917|594861390|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
164682821|NCT02906917|594861389|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
164682822|NCT02906917|594861390|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
164429927|NCT03441984|593943472|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
164429928|NCT03441984|593943473|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
164429929|NCT03441984|593943474|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
164429930|NCT03441984|593943475|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
164429931|NCT03441984|593943476|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
164429932|NCT03441984|593943477|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
164429933|NCT03441984|593943478|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
164429934|NCT00631917|593943482|FG000|Overall Study|Adverse Event|34|||
164682823|NCT02906917|594861389|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
164682824|NCT02906917|594861390|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
164682825|NCT02906917|594861389|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
164682826|NCT02906917|594861390|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
164682827|NCT02906917|594861389|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
164682828|NCT02906917|594861390|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
164682829|NCT02906917|594861389|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
164682830|NCT02906917|594861390|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
164682831|NCT00687739|594861391|FG000|Overall Study|Lost to Follow-up|2|||
164682832|NCT00687739|594861392|FG001|Overall Study|Lost to Follow-up|2|||
164682833|NCT00687739|594861393|FG002|Overall Study|Lost to Follow-up|1|||
164682834|NCT00687739|594861394|FG003|Overall Study|Lost to Follow-up|2|||
164682835|NCT00687739|594861391|FG000|Overall Study|Adverse Event|0|||
164682836|NCT00687739|594861392|FG001|Overall Study|Adverse Event|1|||
164682837|NCT00687739|594861393|FG002|Overall Study|Adverse Event|1|||
164682838|NCT00687739|594861394|FG003|Overall Study|Adverse Event|0|||
164682839|NCT02043132|594861401|FG000|Overall Study|Lost to Follow-up|1|||
164682840|NCT02043132|594861402|FG001|Overall Study|Lost to Follow-up|1|||
164682841|NCT02043132|594861401|FG000|Overall Study|screen failures|4|||
164682842|NCT02043132|594861402|FG001|Overall Study|screen failures|8|||
164682843|NCT02554877|594861403|FG000|Overall Study|Adverse Event|2|||
164682844|NCT02554877|594861404|FG001|Overall Study|Adverse Event|0|||
164682845|NCT02554877|594861405|FG002|Overall Study|Adverse Event|0|||
164682846|NCT02554877|594861406|FG003|Overall Study|Adverse Event|1|||
164682847|NCT02554877|594861403|FG000|Overall Study|Lost to Follow-up|1|||
164682848|NCT02554877|594861404|FG001|Overall Study|Lost to Follow-up|1|||
164682849|NCT02554877|594861405|FG002|Overall Study|Lost to Follow-up|1|||
164263589|NCT00031460|593333965|FG000|Overall Study|Withdrawal by Subject|1|||
164263590|NCT00031460|593333966|FG001|Overall Study|Withdrawal by Subject|1|||
164263591|NCT00031460|593333965|FG000|Overall Study|Non-Compliant|1|||
164429935|NCT00631917|593943483|FG001|Overall Study|Adverse Event|45|||
164429936|NCT00631917|593943482|FG000|Overall Study|Abnormal laboratory value(s)|2|||
164429937|NCT00631917|593943483|FG001|Overall Study|Abnormal laboratory value(s)|1|||
164429938|NCT00631917|593943482|FG000|Overall Study|Abnormal test procedure result(s)|3|||
164429939|NCT00631917|593943483|FG001|Overall Study|Abnormal test procedure result(s)|2|||
164429940|NCT00631917|593943482|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
164429941|NCT00631917|593943483|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
164429942|NCT00631917|593943482|FG000|Overall Study|No longer required study drug|0|||
164429943|NCT00631917|593943483|FG001|Overall Study|No longer required study drug|1|||
164429944|NCT00631917|593943482|FG000|Overall Study|Protocol deviation|6|||
164429945|NCT00631917|593943483|FG001|Overall Study|Protocol deviation|5|||
164429946|NCT00631917|593943482|FG000|Overall Study|Subject withdrew consent|25|||
164429947|NCT00631917|593943483|FG001|Overall Study|Subject withdrew consent|33|||
164429948|NCT00631917|593943482|FG000|Overall Study|Lost to Follow-up|7|||
164429949|NCT00631917|593943483|FG001|Overall Study|Lost to Follow-up|7|||
164429950|NCT00631917|593943482|FG000|Overall Study|Administrative problems|2|||
164429951|NCT00631917|593943483|FG001|Overall Study|Administrative problems|0|||
164429952|NCT00631917|593943482|FG000|Overall Study|Death|1|||
164429953|NCT00631917|593943483|FG001|Overall Study|Death|0|||
164429954|NCT02696785|593943489|FG000|Blinded Treatment Period|Adverse Event|0|||
164429955|NCT02696785|593943490|FG001|Blinded Treatment Period|Adverse Event|1|||
164429956|NCT02696785|593943491|FG002|Blinded Treatment Period|Adverse Event|3|||
164263592|NCT00031460|593333966|FG001|Overall Study|Non-Compliant|1|||
164682850|NCT02554877|594861406|FG003|Overall Study|Lost to Follow-up|2|||
164682851|NCT02554877|594861403|FG000|Overall Study|Did not meet entrance criteria|0|||
164682852|NCT02554877|594861404|FG001|Overall Study|Did not meet entrance criteria|0|||
164682853|NCT02554877|594861405|FG002|Overall Study|Did not meet entrance criteria|1|||
164429957|NCT02696785|593943492|FG003|Blinded Treatment Period|Adverse Event|0|||
164429958|NCT02696785|593943489|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
164429959|NCT02696785|593943490|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
164429960|NCT02696785|593943491|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
164429961|NCT02696785|593943492|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
164429962|NCT02696785|593943489|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
164429963|NCT02696785|593943490|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
164429964|NCT02696785|593943491|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
164429965|NCT02696785|593943492|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
164429966|NCT02696785|593943489|FG000|Blinded Treatment Period|Screen Failure|1|||
164429967|NCT02696785|593943490|FG001|Blinded Treatment Period|Screen Failure|0|||
164429968|NCT02696785|593943491|FG002|Blinded Treatment Period|Screen Failure|0|||
164429969|NCT02696785|593943492|FG003|Blinded Treatment Period|Screen Failure|0|||
164429970|NCT02696785|593943489|FG000|Washout Period|Withdrawal by Subject|0|||
164429971|NCT02696785|593943490|FG001|Washout Period|Withdrawal by Subject|1|||
164429972|NCT02696785|593943491|FG002|Washout Period|Withdrawal by Subject|0|||
164429973|NCT02696785|593943492|FG003|Washout Period|Withdrawal by Subject|0|||
164429974|NCT02696785|593943489|FG000|Washout Period|Lack of Efficacy|0|||
164429975|NCT02696785|593943490|FG001|Washout Period|Lack of Efficacy|1|||
164429976|NCT02696785|593943491|FG002|Washout Period|Lack of Efficacy|0|||
164429977|NCT02696785|593943492|FG003|Washout Period|Lack of Efficacy|0|||
164429978|NCT02696785|593943489|FG000|Extended Treatment Period|Adverse Event|2|||
164429979|NCT02696785|593943490|FG001|Extended Treatment Period|Adverse Event|3|||
164429980|NCT02696785|593943491|FG002|Extended Treatment Period|Adverse Event|2|||
164429981|NCT02696785|593943492|FG003|Extended Treatment Period|Adverse Event|1|||
164429982|NCT02696785|593943489|FG000|Extended Treatment Period|Lack of Efficacy|0|||
164429983|NCT02696785|593943490|FG001|Extended Treatment Period|Lack of Efficacy|1|||
164429984|NCT02696785|593943491|FG002|Extended Treatment Period|Lack of Efficacy|0|||
164429985|NCT02696785|593943492|FG003|Extended Treatment Period|Lack of Efficacy|0|||
164429986|NCT02696785|593943489|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
164429987|NCT02696785|593943490|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
164429988|NCT02696785|593943491|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
164429989|NCT02696785|593943492|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
164429990|NCT02696785|593943489|FG000|Follow-up Period|Adverse Event|0|||
164429991|NCT02696785|593943490|FG001|Follow-up Period|Adverse Event|0|||
164429992|NCT02696785|593943491|FG002|Follow-up Period|Adverse Event|8|||
164429993|NCT02696785|593943492|FG003|Follow-up Period|Adverse Event|2|||
164429994|NCT02696785|593943489|FG000|Follow-up Period|Lost to Follow-up|0|||
164429995|NCT02696785|593943490|FG001|Follow-up Period|Lost to Follow-up|0|||
164429996|NCT02696785|593943491|FG002|Follow-up Period|Lost to Follow-up|0|||
164429997|NCT02696785|593943492|FG003|Follow-up Period|Lost to Follow-up|1|||
164429998|NCT02696785|593943489|FG000|Follow-up Period|Lack of Efficacy|0|||
164429999|NCT02696785|593943490|FG001|Follow-up Period|Lack of Efficacy|0|||
164430000|NCT02696785|593943491|FG002|Follow-up Period|Lack of Efficacy|0|||
164430001|NCT02696785|593943492|FG003|Follow-up Period|Lack of Efficacy|1|||
164430002|NCT02696785|593943489|FG000|Follow-up Period|Withdrawal by Subject|1|||
164430003|NCT02696785|593943490|FG001|Follow-up Period|Withdrawal by Subject|0|||
164430004|NCT02696785|593943491|FG002|Follow-up Period|Withdrawal by Subject|5|||
164430005|NCT02696785|593943492|FG003|Follow-up Period|Withdrawal by Subject|4|||
164430006|NCT00337818|593943493|FG000|Overall Study|Lost to Follow-up|289|||
164430007|NCT00337818|593943494|FG001|Overall Study|Lost to Follow-up|91|||
164430008|NCT00337818|593943495|FG002|Overall Study|Lost to Follow-up|107|||
164430009|NCT00209274|593943499|FG000|Overall Study|Missed visit|3|||
164682854|NCT02554877|594861406|FG003|Overall Study|Did not meet entrance criteria|0|||
164682855|NCT02554877|594861403|FG000|Overall Study|No longer met eligibility criteria|1|||
164682856|NCT02554877|594861404|FG001|Overall Study|No longer met eligibility criteria|0|||
164682857|NCT02554877|594861405|FG002|Overall Study|No longer met eligibility criteria|1|||
164430010|NCT00209274|593943500|FG001|Overall Study|Missed visit|2|||
164682858|NCT02554877|594861406|FG003|Overall Study|No longer met eligibility criteria|1|||
164682859|NCT02554877|594861403|FG000|Overall Study|Protocol Violation|3|||
164682860|NCT02554877|594861404|FG001|Overall Study|Protocol Violation|1|||
164682861|NCT02554877|594861405|FG002|Overall Study|Protocol Violation|1|||
164682862|NCT02554877|594861406|FG003|Overall Study|Protocol Violation|0|||
164682863|NCT02554877|594861403|FG000|Overall Study|Other|1|||
164682864|NCT02554877|594861404|FG001|Overall Study|Other|3|||
164682865|NCT02554877|594861405|FG002|Overall Study|Other|0|||
164682866|NCT02554877|594861406|FG003|Overall Study|Other|3|||
164682867|NCT02554877|594861403|FG000|Overall Study|Insufficient clinical response|4|||
164430011|NCT00209274|593943499|FG000|Overall Study|Death|32|||
164430012|NCT00209274|593943500|FG001|Overall Study|Death|15|||
164430013|NCT00209274|593943499|FG000|Overall Study|Withdrawal by Subject|30|||
164430014|NCT00209274|593943500|FG001|Overall Study|Withdrawal by Subject|15|||
164430015|NCT00209274|593943499|FG000|Overall Study|Randomized not treated (RNT)|6|||
164682868|NCT02554877|594861404|FG001|Overall Study|Insufficient clinical response|0|||
164430016|NCT00209274|593943500|FG001|Overall Study|Randomized not treated (RNT)|15|||
164430017|NCT01190176|593943501|FG000|Overall Study|Withdrawal by Subject|1|||
164682869|NCT02554877|594861405|FG002|Overall Study|Insufficient clinical response|0|||
164682870|NCT02554877|594861406|FG003|Overall Study|Insufficient clinical response|0|||
164682871|NCT02554877|594861403|FG000|Overall Study|No longer willing to participate|0|||
164682872|NCT02554877|594861404|FG001|Overall Study|No longer willing to participate|2|||
164682873|NCT02554877|594861405|FG002|Overall Study|No longer willing to participate|2|||
164682874|NCT02554877|594861406|FG003|Overall Study|No longer willing to participate|0|||
164682875|NCT03827395|594861407|FG000|Overall Study|Lost to Follow-up|1|||
164682876|NCT03827395|594861408|FG001|Overall Study|Lost to Follow-up|0|||
164682877|NCT03827395|594861407|FG000|Overall Study|Protocol Violation|1|||
164682878|NCT03827395|594861408|FG001|Overall Study|Protocol Violation|0|||
164682879|NCT03827395|594861407|FG000|Overall Study|Became ineligible after enrollment|1|||
164682880|NCT03827395|594861408|FG001|Overall Study|Became ineligible after enrollment|2|||
164682881|NCT01537887|594861409|FG000|Period 1|Physician Decision|0|||
164682882|NCT01537887|594861410|FG001|Period 1|Physician Decision|0|||
164682883|NCT01537887|594861411|FG002|Period 1|Physician Decision|0|||
164682884|NCT01537887|594861412|FG003|Period 1|Physician Decision|0|||
164682885|NCT01537887|594861413|FG004|Period 1|Physician Decision|1|||
164682886|NCT01537887|594861414|FG005|Period 1|Physician Decision|1|||
164682887|NCT01537887|594861409|FG000|Period 1|Did not receive treatment|0|||
164682888|NCT01537887|594861410|FG001|Period 1|Did not receive treatment|0|||
164682889|NCT01537887|594861411|FG002|Period 1|Did not receive treatment|1|||
164682890|NCT01537887|594861412|FG003|Period 1|Did not receive treatment|0|||
164682891|NCT01537887|594861413|FG004|Period 1|Did not receive treatment|0|||
164682892|NCT01537887|594861414|FG005|Period 1|Did not receive treatment|0|||
164682893|NCT01537887|594861409|FG000|Period 2|Withdrawal by Subject|0|||
164682894|NCT01537887|594861410|FG001|Period 2|Withdrawal by Subject|1|||
164682895|NCT01537887|594861411|FG002|Period 2|Withdrawal by Subject|0|||
164682896|NCT01537887|594861412|FG003|Period 2|Withdrawal by Subject|0|||
164682897|NCT01537887|594861413|FG004|Period 2|Withdrawal by Subject|0|||
164682898|NCT01537887|594861414|FG005|Period 2|Withdrawal by Subject|0|||
164682899|NCT01537887|594861409|FG000|Period 3|Adverse Event|0|||
164682900|NCT01537887|594861410|FG001|Period 3|Adverse Event|0|||
164263593|NCT00031460|593333965|FG000|Overall Study|Death|0|||
164430018|NCT01190176|593943501|FG000|Overall Study|Lost to Follow-up|1|||
164430019|NCT01221181|593943502|FG000|Overall Study|Lost to Follow-up|1|||
164430020|NCT01290094|593943503|FG000|Overall Study|Withdrawal by Subject|1|||
164430021|NCT01290094|593943503|FG000|Overall Study|Lost to Follow-up|5|||
164430022|NCT01959880|593943504|FG000|Overall Study|Withdrawal by Subject|11|||
164430023|NCT01959880|593943505|FG001|Overall Study|Withdrawal by Subject|13|||
164430024|NCT01959880|593943506|FG002|Overall Study|Withdrawal by Subject|8|||
164430025|NCT01959880|593943507|FG003|Overall Study|Withdrawal by Subject|7|||
164430026|NCT01959880|593943504|FG000|Overall Study|Death|1|||
164430027|NCT01959880|593943505|FG001|Overall Study|Death|10|||
164430028|NCT01959880|593943506|FG002|Overall Study|Death|1|||
164430029|NCT01959880|593943507|FG003|Overall Study|Death|2|||
164430030|NCT01959880|593943504|FG000|Overall Study|Lost to Follow-up|95|||
164430031|NCT01959880|593943505|FG001|Overall Study|Lost to Follow-up|18|||
164430032|NCT01959880|593943506|FG002|Overall Study|Lost to Follow-up|15|||
164430033|NCT01959880|593943507|FG003|Overall Study|Lost to Follow-up|8|||
164430034|NCT01959880|593943504|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
164430035|NCT01959880|593943505|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
164430036|NCT01959880|593943506|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
164578252|NCT00246259|594481946|FG001|Overall Study|Other|3|||
164578253|NCT00246259|594481945|FG000|Overall Study|Not stable by Week 18|2|||
164578254|NCT00246259|594481946|FG001|Overall Study|Not stable by Week 18|1|||
164578255|NCT00246259|594481945|FG000|Overall Study|Participant non-compliant|4|||
164578256|NCT00246259|594481946|FG001|Overall Study|Participant non-compliant|9|||
164578257|NCT00246259|594481945|FG000|Overall Study|Lack of Efficacy|2|||
164578258|NCT00246259|594481946|FG001|Overall Study|Lack of Efficacy|2|||
164578259|NCT00246259|594481945|FG000|Overall Study|Investigator withdrew participant|2|||
164578260|NCT00246259|594481946|FG001|Overall Study|Investigator withdrew participant|0|||
164578261|NCT00246259|594481945|FG000|Overall Study|Adverse Event|5|||
164578262|NCT00246259|594481946|FG001|Overall Study|Adverse Event|0|||
164578263|NCT00246259|594481945|FG000|Overall Study|Lost to Follow-up|3|||
164578264|NCT00246259|594481946|FG001|Overall Study|Lost to Follow-up|4|||
164578265|NCT00246259|594481945|FG000|Overall Study|Withdrawal by Subject|5|||
164578266|NCT00246259|594481946|FG001|Overall Study|Withdrawal by Subject|1|||
164578267|NCT00246259|594481945|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
164578268|NCT00246259|594481946|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
164578269|NCT02698189|594481947|FG000|Overall Study|Physician Decision|3|||
164578270|NCT02698189|594481948|FG001|Overall Study|Physician Decision|0|||
164578271|NCT02698189|594481947|FG000|Overall Study|Progressive disease|0|||
164578272|NCT02698189|594481948|FG001|Overall Study|Progressive disease|5|||
164578273|NCT02698189|594481947|FG000|Overall Study|Study terminated by sponsor|0|||
164578274|NCT02698189|594481948|FG001|Overall Study|Study terminated by sponsor|1|||
164578275|NCT00855439|594481949|FG000|Overall Study|Withdrawal by Subject|2|||
164578276|NCT00855439|594481950|FG001|Overall Study|Withdrawal by Subject|0|||
164578277|NCT00855439|594481949|FG000|Overall Study|Pregnancy|1|||
164578278|NCT00855439|594481950|FG001|Overall Study|Pregnancy|0|||
164578279|NCT05502289|594481951|FG000|Period 1|Out Of Window|1|||
164578280|NCT05502289|594481952|FG001|Period 1|Out Of Window|0|||
164578281|NCT01564784|594481953|FG000|Overall Study|Other|1|||
164682901|NCT01537887|594861411|FG002|Period 3|Adverse Event|1|||
164682902|NCT01537887|594861412|FG003|Period 3|Adverse Event|0|||
164682903|NCT01537887|594861413|FG004|Period 3|Adverse Event|0|||
164682904|NCT01537887|594861414|FG005|Period 3|Adverse Event|0|||
164682905|NCT01537887|594861409|FG000|Period 3|Withdrawal by Subject|0|||
164682906|NCT01537887|594861410|FG001|Period 3|Withdrawal by Subject|1|||
164682907|NCT01537887|594861411|FG002|Period 3|Withdrawal by Subject|0|||
164682908|NCT01537887|594861412|FG003|Period 3|Withdrawal by Subject|0|||
164682909|NCT01537887|594861413|FG004|Period 3|Withdrawal by Subject|0|||
164682910|NCT01537887|594861414|FG005|Period 3|Withdrawal by Subject|0|||
164682911|NCT01370083|594861415|FG000|Overall Study|Lost to Follow-up|2|||
164682912|NCT01370083|594861416|FG001|Overall Study|Lost to Follow-up|0|||
164682913|NCT01370083|594861415|FG000|Overall Study|Adverse Event|0|||
164682914|NCT01370083|594861416|FG001|Overall Study|Adverse Event|1|||
164682915|NCT02450539|594861417|FG000|Overall Study|Withdrawal by Subject|12|||
164682916|NCT02450539|594861418|FG001|Overall Study|Withdrawal by Subject|6|||
164682917|NCT02450539|594861417|FG000|Overall Study|Lost to Follow-up|4|||
164682918|NCT02450539|594861418|FG001|Overall Study|Lost to Follow-up|1|||
164682919|NCT00418145|594861421|FG000|Overall Study|study terminated|6|||
164682920|NCT00472212|594861422|FG000|Overall Study|Lost to Follow-up|6|||
164682921|NCT00472212|594861423|FG001|Overall Study|Lost to Follow-up|4|||
164682922|NCT01438060|594861429|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
164682923|NCT01438060|594861430|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
164682924|NCT01438060|594861429|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
164682925|NCT01438060|594861430|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
164682926|NCT01438060|594861429|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
164682927|NCT01438060|594861430|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
164682928|NCT01438060|594861429|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
164682929|NCT01438060|594861430|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
164682930|NCT01438060|594861429|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
164682931|NCT01438060|594861430|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
164682932|NCT01438060|594861429|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
164341010|NCT01145625|593623847|FG000|Overall Study|Protocol Violation|3|||
164341011|NCT01145625|593623848|FG001|Overall Study|Protocol Violation|1|||
164341012|NCT01145625|593623847|FG000|Overall Study|Withdrawal by Subject|7|||
164341013|NCT01145625|593623848|FG001|Overall Study|Withdrawal by Subject|16|||
164341014|NCT01145625|593623847|FG000|Overall Study|Pregnancy|0|||
164578282|NCT01564784|594481954|FG001|Overall Study|Other|0|||
164578283|NCT01564784|594481953|FG000|Overall Study|Subject refused further follow-up|1|||
164341015|NCT01145625|593623848|FG001|Overall Study|Pregnancy|1|||
164341016|NCT01751178|593623849|FG000|Overall Study|Adverse Event|2|||
164341017|NCT01751178|593623850|FG001|Overall Study|Adverse Event|0|||
164341018|NCT01751178|593623851|FG002|Overall Study|Adverse Event|0|||
164341019|NCT01751178|593623849|FG000|Overall Study|Other Reason (unknown)|1|||
164341020|NCT01751178|593623850|FG001|Overall Study|Other Reason (unknown)|0|||
164578284|NCT01564784|594481954|FG001|Overall Study|Subject refused further follow-up|6|||
164578285|NCT01564784|594481953|FG000|Overall Study|Lost to Follow-up|1|||
164578286|NCT01564784|594481954|FG001|Overall Study|Lost to Follow-up|1|||
164578287|NCT01564784|594481953|FG000|Overall Study|Death|131|||
164682933|NCT01438060|594861430|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
164682934|NCT01438060|594861429|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
164682935|NCT01438060|594861430|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
164682936|NCT01438060|594861429|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
164682937|NCT01438060|594861430|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
164682938|NCT01438060|594861429|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
164682939|NCT01438060|594861430|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
164682940|NCT01438060|594861429|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
164682941|NCT01438060|594861430|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
164682942|NCT01438060|594861429|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
164682943|NCT01438060|594861430|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
164682944|NCT01438060|594861429|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
164682945|NCT01438060|594861430|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
164682946|NCT01438060|594861429|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
164682947|NCT01438060|594861430|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
164682948|NCT01438060|594861429|FG000|On Study Beyond Week 140|Adverse Event|0|||
164682949|NCT01438060|594861430|FG001|On Study Beyond Week 140|Adverse Event|2|||
164341021|NCT01751178|593623851|FG002|Overall Study|Other Reason (unknown)|2|||
164341022|NCT04289623|593623852|FG000|Wave 1 Emails|Email was not delivered|268|||
164341023|NCT04289623|593623853|FG001|Wave 1 Emails|Email was not delivered|257|||
164341024|NCT04289623|593623854|FG002|Wave 1 Emails|Email was not delivered|0|||
164341025|NCT04289623|593623855|FG003|Wave 1 Emails|Email was not delivered|0|||
164578288|NCT01564784|594481954|FG001|Overall Study|Death|126|||
164578289|NCT02272790|594481955|FG000|Overall Study|Physician Decision|0|||
164578290|NCT02272790|594481956|FG001|Overall Study|Physician Decision|1|||
164578291|NCT02272790|594481957|FG002|Overall Study|Physician Decision|0|||
164578292|NCT02272790|594481958|FG003|Overall Study|Physician Decision|0|||
164578293|NCT02272790|594481959|FG004|Overall Study|Physician Decision|0|||
164578294|NCT02272790|594481960|FG005|Overall Study|Physician Decision|0|||
164578295|NCT03022461|594481961|FG000|Overall Study|Death|3|||
164578296|NCT01982630|594481962|FG000|Overall Study|Adverse Event|2|||
164578297|NCT01982630|594481963|FG001|Overall Study|Adverse Event|0|||
164578298|NCT01982630|594481964|FG002|Overall Study|Adverse Event|1|||
164578299|NCT01982630|594481965|FG003|Overall Study|Adverse Event|0|||
164578300|NCT01982630|594481966|FG004|Overall Study|Adverse Event|1|||
164578301|NCT01982630|594481967|FG005|Overall Study|Adverse Event|2|||
164578302|NCT01982630|594481968|FG006|Overall Study|Adverse Event|1|||
164578303|NCT01982630|594481969|FG007|Overall Study|Adverse Event|0|||
164578304|NCT01982630|594481962|FG000|Overall Study|Physician Decision|1|||
164578305|NCT01982630|594481963|FG001|Overall Study|Physician Decision|0|||
164578306|NCT01982630|594481964|FG002|Overall Study|Physician Decision|2|||
164578307|NCT01982630|594481965|FG003|Overall Study|Physician Decision|1|||
164578308|NCT01982630|594481966|FG004|Overall Study|Physician Decision|2|||
164578309|NCT01982630|594481967|FG005|Overall Study|Physician Decision|0|||
164578310|NCT01982630|594481968|FG006|Overall Study|Physician Decision|0|||
164578311|NCT01982630|594481969|FG007|Overall Study|Physician Decision|0|||
164578312|NCT01982630|594481962|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
164578313|NCT01982630|594481963|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
164578314|NCT01982630|594481964|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
164578315|NCT01982630|594481965|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
164578316|NCT01982630|594481966|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
164578317|NCT01982630|594481967|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
164578318|NCT01982630|594481968|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
164578319|NCT01982630|594481969|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
164578320|NCT01982630|594481962|FG000|Overall Study|Withdrawal by Subject|0|||
164578321|NCT01982630|594481963|FG001|Overall Study|Withdrawal by Subject|0|||
164578322|NCT01982630|594481964|FG002|Overall Study|Withdrawal by Subject|0|||
164578323|NCT01982630|594481965|FG003|Overall Study|Withdrawal by Subject|0|||
164578324|NCT01982630|594481966|FG004|Overall Study|Withdrawal by Subject|0|||
164578325|NCT01982630|594481967|FG005|Overall Study|Withdrawal by Subject|1|||
164578326|NCT01982630|594481968|FG006|Overall Study|Withdrawal by Subject|0|||
164578327|NCT01982630|594481969|FG007|Overall Study|Withdrawal by Subject|0|||
164578328|NCT01076179|594481970|FG000|Overall Study|Withdrawal by Subject|1|||
164578329|NCT00986349|594481971|FG000|Overall Study|Unsuccessful implant procedure|3|||
164578330|NCT00986349|594481971|FG000|Overall Study|Adverse Event|2|||
164578331|NCT00986349|594481971|FG000|Overall Study|Physician Decision|1|||
164578332|NCT00986349|594481971|FG000|Overall Study|device migration|1|||
164578333|NCT02299934|594481972|FG000|Overall Study|Termination of study|13|||
164578334|NCT00561353|594481973|FG000|Overall Study|Subject reached a virologic endpoint|2|||
164578335|NCT00561353|594481974|FG001|Overall Study|Subject reached a virologic endpoint|1|||
164578336|NCT00561353|594481975|FG002|Overall Study|Subject reached a virologic endpoint|1|||
164578337|NCT00561353|594481976|FG003|Overall Study|Subject reached a virologic endpoint|4|||
164578338|NCT00561353|594481977|FG004|Overall Study|Subject reached a virologic endpoint|1|||
164578339|NCT00561353|594481978|FG005|Overall Study|Subject reached a virologic endpoint|3|||
164578340|NCT00561353|594481979|FG006|Overall Study|Subject reached a virologic endpoint|4|||
164578341|NCT00561353|594481980|FG007|Overall Study|Subject reached a virologic endpoint|4|||
164578342|NCT00561353|594481981|FG008|Overall Study|Subject reached a virologic endpoint|5|||
164578343|NCT00561353|594481982|FG009|Overall Study|Subject reached a virologic endpoint|0|||
164578344|NCT00561353|594481973|FG000|Overall Study|Subject ineligible to continue the trial|0|||
164578345|NCT00561353|594481974|FG001|Overall Study|Subject ineligible to continue the trial|0|||
164578346|NCT00561353|594481975|FG002|Overall Study|Subject ineligible to continue the trial|0|||
164578347|NCT00561353|594481976|FG003|Overall Study|Subject ineligible to continue the trial|0|||
164578348|NCT00561353|594481977|FG004|Overall Study|Subject ineligible to continue the trial|0|||
164578349|NCT00561353|594481978|FG005|Overall Study|Subject ineligible to continue the trial|1|||
164578350|NCT00561353|594481979|FG006|Overall Study|Subject ineligible to continue the trial|1|||
164578351|NCT00561353|594481980|FG007|Overall Study|Subject ineligible to continue the trial|0|||
164578352|NCT00561353|594481981|FG008|Overall Study|Subject ineligible to continue the trial|2|||
164578353|NCT00561353|594481982|FG009|Overall Study|Subject ineligible to continue the trial|1|||
164578354|NCT00561353|594481973|FG000|Overall Study|Other|1|||
164578355|NCT00561353|594481974|FG001|Overall Study|Other|0|||
164341026|NCT04289623|593623856|FG004|Wave 1 Emails|Email was not delivered|0|||
164578356|NCT00561353|594481975|FG002|Overall Study|Other|1|||
164578357|NCT00561353|594481976|FG003|Overall Study|Other|0|||
164578358|NCT00561353|594481977|FG004|Overall Study|Other|0|||
164578359|NCT00561353|594481978|FG005|Overall Study|Other|2|||
164578360|NCT00561353|594481979|FG006|Overall Study|Other|0|||
164578361|NCT00561353|594481980|FG007|Overall Study|Other|0|||
164578362|NCT00561353|594481981|FG008|Overall Study|Other|0|||
164578363|NCT00561353|594481982|FG009|Overall Study|Other|0|||
164578364|NCT00561353|594481973|FG000|Overall Study|Adverse Event|0|||
164578365|NCT00561353|594481974|FG001|Overall Study|Adverse Event|0|||
164578366|NCT00561353|594481975|FG002|Overall Study|Adverse Event|0|||
164578367|NCT00561353|594481976|FG003|Overall Study|Adverse Event|2|||
164578368|NCT00561353|594481977|FG004|Overall Study|Adverse Event|0|||
164578369|NCT00561353|594481978|FG005|Overall Study|Adverse Event|0|||
164578370|NCT00561353|594481979|FG006|Overall Study|Adverse Event|1|||
164578371|NCT00561353|594481980|FG007|Overall Study|Adverse Event|0|||
164578372|NCT00561353|594481981|FG008|Overall Study|Adverse Event|0|||
164578373|NCT00561353|594481982|FG009|Overall Study|Adverse Event|1|||
164578374|NCT00561353|594481973|FG000|Overall Study|Lost to Follow-up|2|||
164578375|NCT00561353|594481974|FG001|Overall Study|Lost to Follow-up|0|||
164578376|NCT00561353|594481975|FG002|Overall Study|Lost to Follow-up|1|||
164578377|NCT00561353|594481976|FG003|Overall Study|Lost to Follow-up|0|||
164578378|NCT00561353|594481977|FG004|Overall Study|Lost to Follow-up|0|||
164578379|NCT00561353|594481978|FG005|Overall Study|Lost to Follow-up|0|||
164578380|NCT00561353|594481979|FG006|Overall Study|Lost to Follow-up|0|||
164578381|NCT00561353|594481980|FG007|Overall Study|Lost to Follow-up|0|||
164578382|NCT00561353|594481981|FG008|Overall Study|Lost to Follow-up|0|||
164578383|NCT00561353|594481982|FG009|Overall Study|Lost to Follow-up|0|||
164578384|NCT00561353|594481973|FG000|Overall Study|Withdrawal by Subject|0|||
164578385|NCT00561353|594481974|FG001|Overall Study|Withdrawal by Subject|2|||
164578386|NCT00561353|594481975|FG002|Overall Study|Withdrawal by Subject|0|||
164578387|NCT00561353|594481976|FG003|Overall Study|Withdrawal by Subject|0|||
164578388|NCT00561353|594481977|FG004|Overall Study|Withdrawal by Subject|0|||
164578389|NCT00561353|594481978|FG005|Overall Study|Withdrawal by Subject|0|||
164578390|NCT00561353|594481979|FG006|Overall Study|Withdrawal by Subject|0|||
164682950|NCT01438060|594861429|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
164430037|NCT01959880|593943507|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
164430038|NCT01959880|593943504|FG000|Overall Study|Study completed early-FDA approved|1003|||
164430039|NCT01959880|593943505|FG001|Overall Study|Study completed early-FDA approved|311|||
164430040|NCT01959880|593943506|FG002|Overall Study|Study completed early-FDA approved|179|||
164430041|NCT01959880|593943507|FG003|Overall Study|Study completed early-FDA approved|152|||
164430042|NCT01704846|593945242|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164430043|NCT01704846|593945243|FG001|Treatment Period 2|Withdrawal by Subject|1|||
164430044|NCT01244984|593945244|FG000|Overall Study|Adverse Event|2|||
164430045|NCT01244984|593945245|FG001|Overall Study|Adverse Event|11|||
164430046|NCT01244984|593945246|FG002|Overall Study|Adverse Event|2|||
164430047|NCT01244984|593945244|FG000|Overall Study|Protocol Violation|1|||
164430048|NCT01244984|593945245|FG001|Overall Study|Protocol Violation|0|||
164430049|NCT01244984|593945246|FG002|Overall Study|Protocol Violation|0|||
164430050|NCT01244984|593945244|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
164430051|NCT01244984|593945245|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
164430052|NCT01244984|593945246|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
164430053|NCT01244984|593945244|FG000|Overall Study|Withdrawal by Subject|1|||
164430054|NCT01244984|593945245|FG001|Overall Study|Withdrawal by Subject|2|||
164430055|NCT01244984|593945246|FG002|Overall Study|Withdrawal by Subject|2|||
164682951|NCT01438060|594861430|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
164682952|NCT01438060|594861429|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
164682953|NCT01438060|594861430|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
164682954|NCT01438060|594861429|FG000|On Study Beyond Week 140|Death|0|||
164682955|NCT01438060|594861430|FG001|On Study Beyond Week 140|Death|1|||
164430056|NCT01801930|593945247|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
164578391|NCT00561353|594481980|FG007|Overall Study|Withdrawal by Subject|0|||
164578392|NCT00561353|594481981|FG008|Overall Study|Withdrawal by Subject|0|||
164578393|NCT00561353|594481982|FG009|Overall Study|Withdrawal by Subject|0|||
164578394|NCT01273818|594481983|FG000|Overall Study|Physician Decision|13|||
164430057|NCT01801930|593945248|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
164578395|NCT01273818|594481984|FG001|Overall Study|Physician Decision|2|||
164578396|NCT01273818|594481985|FG002|Overall Study|Physician Decision|9|||
164578397|NCT00761215|594481990|FG000|Overall Study|Randomized but didn't receive drug|1|||
164578398|NCT00761215|594481991|FG001|Overall Study|Randomized but didn't receive drug|1|||
164682956|NCT01438060|594861429|FG000|On Study Beyond Week 140|Other Reason|0|||
164682957|NCT01438060|594861430|FG001|On Study Beyond Week 140|Other Reason|3|||
164682958|NCT01964950|594861431|FG000|Overall Study|Protocol Violation|25|||
164682959|NCT03602339|594861432|FG000|Overall Study|Withdrawal by Subject|9|||
164578399|NCT00761215|594481992|FG002|Overall Study|Randomized but didn't receive drug|2|||
164578400|NCT00761215|594481990|FG000|Overall Study|Lost to Follow-up|6|||
164578401|NCT00761215|594481991|FG001|Overall Study|Lost to Follow-up|3|||
164682960|NCT03602339|594861432|FG000|Overall Study|Physician Decision|2|||
164682961|NCT03602339|594861432|FG000|Overall Study|Other reason|4|||
164682962|NCT01190865|594861444|FG000|Overall Study|Withdrawal by Subject|1|||
164682963|NCT01190865|594861444|FG000|Overall Study|Non-compliance|2|||
164682964|NCT00829452|594861446|FG000|First Intervention|Withdrawal by Subject|0|||
164682965|NCT00829452|594861447|FG001|First Intervention|Withdrawal by Subject|1|||
164682966|NCT00829452|594861446|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
164682967|NCT00829452|594861447|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
164682968|NCT00829452|594861446|FG000|Second Intervention|Physician Decision|0|||
164682969|NCT00829452|594861447|FG001|Second Intervention|Physician Decision|1|||
164682970|NCT02615249|594861448|FG000|Overall Study|Withdrawal by Subject|1|||
164682971|NCT05098743|594861459|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
164682972|NCT05098743|594861460|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
164682973|NCT05098743|594861459|FG000|Overall Study|Lost to Follow-up|1|||
164682974|NCT05098743|594861460|FG001|Overall Study|Lost to Follow-up|2|||
164682975|NCT04060251|594861461|FG000|Overall Study|Study terminated due to low enrollment.|7|||
164682976|NCT04060251|594861462|FG001|Overall Study|Study terminated due to low enrollment.|5|||
164682977|NCT04060251|594861463|FG002|Overall Study|Study terminated due to low enrollment.|7|||
164682978|NCT04060251|594861461|FG000|Overall Study|Adverse Event|1|||
164682979|NCT04060251|594861462|FG001|Overall Study|Adverse Event|1|||
164682980|NCT04060251|594861463|FG002|Overall Study|Adverse Event|0|||
164682981|NCT01663896|594861464|FG000|Overall Study|Various reasons|43|||
164682982|NCT00842309|594861471|FG000|Overall Study|Withdrawal by Subject|3|||
164682983|NCT00842309|594861472|FG001|Overall Study|Withdrawal by Subject|1|||
164682984|NCT02670551|594861473|FG000|Overall Study|Adverse Event|4|||
164682985|NCT02670551|594861474|FG001|Overall Study|Adverse Event|7|||
164682986|NCT02670551|594861475|FG002|Overall Study|Adverse Event|9|||
164682987|NCT02670551|594861473|FG000|Overall Study|Lack of Efficacy|2|||
164682988|NCT02670551|594861474|FG001|Overall Study|Lack of Efficacy|0|||
164682989|NCT02670551|594861475|FG002|Overall Study|Lack of Efficacy|3|||
164682990|NCT02670551|594861473|FG000|Overall Study|Withdrawal of Consent|6|||
164682991|NCT02670551|594861474|FG001|Overall Study|Withdrawal of Consent|3|||
164682992|NCT02670551|594861475|FG002|Overall Study|Withdrawal of Consent|8|||
164682993|NCT02670551|594861473|FG000|Overall Study|Lost to Follow-up|5|||
164682994|NCT02670551|594861474|FG001|Overall Study|Lost to Follow-up|7|||
164682995|NCT02670551|594861475|FG002|Overall Study|Lost to Follow-up|6|||
164682996|NCT02670551|594861473|FG000|Overall Study|Protocol Violation|1|||
164682997|NCT02670551|594861474|FG001|Overall Study|Protocol Violation|0|||
164682998|NCT02670551|594861475|FG002|Overall Study|Protocol Violation|0|||
164682999|NCT02670551|594861473|FG000|Overall Study|Noncompliance with study drug|3|||
164263594|NCT00031460|593333966|FG001|Overall Study|Death|1|||
164263595|NCT00031460|593333965|FG000|Overall Study|Reactivation of Disease|5|||
164263596|NCT00031460|593333966|FG001|Overall Study|Reactivation of Disease|9|||
164263597|NCT00031460|593333965|FG000|Overall Study|Disruption of blinded drug supply|2|||
164263598|NCT00031460|593333966|FG001|Overall Study|Disruption of blinded drug supply|0|||
164263599|NCT00031460|593333965|FG000|Overall Study|Confirmed unevaluable|0|||
164263600|NCT00031460|593333966|FG001|Overall Study|Confirmed unevaluable|1|||
164263601|NCT02080260|593333968|FG000|Overall Study|Death|18|||
164263602|NCT02080260|593333968|FG000|Overall Study|Withdrawal by Subject|1|||
164263603|NCT05438602|593333969|FG000|Treatment (15 Days)|Adverse Event|2|||
164263604|NCT05438602|593333970|FG001|Treatment (15 Days)|Adverse Event|1|||
164263605|NCT05438602|593333971|FG002|Treatment (15 Days)|Adverse Event|3|||
164263606|NCT05438602|593333969|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
164263607|NCT05438602|593333970|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
164263608|NCT05438602|593333971|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
164263609|NCT05438602|593333969|FG000|Treatment (15 Days)|Other|0|||
164263610|NCT05438602|593333970|FG001|Treatment (15 Days)|Other|0|||
164263611|NCT05438602|593333971|FG002|Treatment (15 Days)|Other|1|||
164263612|NCT05438602|593333969|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
164263613|NCT05438602|593333970|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
164263614|NCT05438602|593333971|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
164263615|NCT05438602|593333969|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
164437467|NCT02914522|593968189|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
164683000|NCT02670551|594861474|FG001|Overall Study|Noncompliance with study drug|3|||
164683001|NCT02670551|594861475|FG002|Overall Study|Noncompliance with study drug|2|||
164683002|NCT02670551|594861473|FG000|Overall Study|Other Miscellaneous Reasons|2|||
164683003|NCT02670551|594861474|FG001|Overall Study|Other Miscellaneous Reasons|3|||
164683004|NCT02670551|594861475|FG002|Overall Study|Other Miscellaneous Reasons|3|||
164683005|NCT02670551|594861473|FG000|Overall Study|Did Not Receive Treatment|5|||
164683006|NCT02670551|594861474|FG001|Overall Study|Did Not Receive Treatment|3|||
164683007|NCT02670551|594861475|FG002|Overall Study|Did Not Receive Treatment|0|||
164263616|NCT05438602|593333970|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
164263617|NCT05438602|593333971|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
164263618|NCT05438602|593333969|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
164430058|NCT01801930|593945249|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
164430059|NCT01801930|593945250|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
164430060|NCT01801930|593945247|FG000|Overall Study|DLT occurs|0|||
164430061|NCT01801930|593945248|FG001|Overall Study|DLT occurs|1|||
164430062|NCT01801930|593945249|FG002|Overall Study|DLT occurs|0|||
164430063|NCT01801930|593945250|FG003|Overall Study|DLT occurs|0|||
164430064|NCT01720043|593945251|FG000|Overall Study|Withdrawal by Subject|1|||
164430065|NCT01688973|593945252|FG000|Overall Study|Ineligible|2|||
164430066|NCT01688973|593945253|FG001|Overall Study|Ineligible|3|||
164430067|NCT03101592|593945262|FG000|Overall Study|participant files could not be located|111|||
164430068|NCT03101592|593945263|FG001|Overall Study|participant files could not be located|170|||
164430069|NCT03101592|593945264|FG002|Overall Study|participant files could not be located|118|||
164430070|NCT00372060|593945265|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
164430071|NCT00372060|593945266|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
164430072|NCT00372060|593945265|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
164430073|NCT00372060|593945266|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
164430074|NCT00372060|593945265|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
164430075|NCT00372060|593945266|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
164430076|NCT00372060|593945265|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
164430077|NCT00372060|593945266|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
164430078|NCT00372060|593945265|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
164430079|NCT00372060|593945266|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
164430080|NCT00372060|593945265|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
164430081|NCT00372060|593945266|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
164430082|NCT03382821|593945268|FG000|Overall Study|Did not receive allocated intervention.|0|||
164430083|NCT03382821|593945269|FG001|Overall Study|Did not receive allocated intervention.|3|||
164430084|NCT00282438|593945270|FG000|Overall Study|Lack of Efficacy|1|||
164430085|NCT00282438|593945271|FG001|Overall Study|Lack of Efficacy|0|||
164430086|NCT00282438|593945270|FG000|Overall Study|Death|0|||
164430087|NCT00282438|593945271|FG001|Overall Study|Death|1|||
164430088|NCT02397889|593945272|FG000|Overall Study|Physician Decision|1|||
164430089|NCT02397889|593945273|FG001|Overall Study|Physician Decision|0|||
164430090|NCT02219490|593945280|FG000|Overall Study|Adverse Event|24|||
164430091|NCT02219490|593945280|FG000|Overall Study|Withdrew consent|96|||
164430092|NCT02219490|593945280|FG000|Overall Study|Lost to Follow-up|126|||
164430093|NCT02219490|593945280|FG000|Overall Study|COVID-19 infection|2|||
164430094|NCT02219490|593945280|FG000|Overall Study|COVID-19 logistical restrictions|33|||
164430095|NCT02219490|593945280|FG000|Overall Study|Other, not specified|57|||
164430096|NCT01928940|593945284|FG000|Overall Study|Adverse Event|0|||
164430097|NCT01928940|593945285|FG001|Overall Study|Adverse Event|1|||
164430098|NCT01352507|593945288|FG000|Treatment Period 1|Adverse Event|3|||
164430099|NCT01352507|593945289|FG001|Treatment Period 1|Adverse Event|0|||
164430100|NCT01352507|593945288|FG000|Treatment Period 1|Lost to Follow-up|3|||
164430101|NCT01352507|593945289|FG001|Treatment Period 1|Lost to Follow-up|4|||
164430102|NCT01352507|593945288|FG000|Treatment Period 1|Withdrawal by Subject|7|||
164430103|NCT01352507|593945289|FG001|Treatment Period 1|Withdrawal by Subject|5|||
164430104|NCT01352507|593945288|FG000|Treatment Period 1|Physician Decision|1|||
164430105|NCT01352507|593945289|FG001|Treatment Period 1|Physician Decision|0|||
164430106|NCT01352507|593945288|FG000|Washout Period|Withdrawal by Subject|0|||
164430107|NCT01352507|593945289|FG001|Washout Period|Withdrawal by Subject|1|||
164430108|NCT01352507|593945288|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
164430109|NCT01352507|593945289|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
164430110|NCT01352507|593945288|FG000|Treatment Period 2|Withdrawal by Subject|4|||
164430111|NCT01352507|593945289|FG001|Treatment Period 2|Withdrawal by Subject|3|||
164430112|NCT01352507|593945288|FG000|Treatment Period 2|Lack of Efficacy|1|||
164430113|NCT01352507|593945289|FG001|Treatment Period 2|Lack of Efficacy|0|||
164430114|NCT04863898|593945297|FG000|Overall Study|Away from study clinic during intervention training period|2|||
164578402|NCT00761215|594481992|FG002|Overall Study|Lost to Follow-up|6|||
164578403|NCT00761215|594481990|FG000|Overall Study|Withdrawal by Subject|1|||
164578404|NCT00761215|594481991|FG001|Overall Study|Withdrawal by Subject|0|||
164578405|NCT00761215|594481992|FG002|Overall Study|Withdrawal by Subject|0|||
164578406|NCT00761215|594481990|FG000|Overall Study|Bacteremia|1|||
164578407|NCT00761215|594481991|FG001|Overall Study|Bacteremia|0|||
164430115|NCT04863898|593945297|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
164430116|NCT04863898|593945297|FG000|Overall Study|Lost to Follow-up|3|||
164430117|NCT04863898|593945297|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
164430118|NCT04863898|593945297|FG000|Overall Study|No longer employed at clinic|3|||
164430119|NCT00614744|593945298|FG000|Overall Study|Lost to Follow-up|5|||
164430120|NCT00614744|593945299|FG001|Overall Study|Lost to Follow-up|4|||
164430121|NCT00614744|593945298|FG000|Overall Study|Incomplete for Behavior Issues|0|||
164430122|NCT00614744|593945299|FG001|Overall Study|Incomplete for Behavior Issues|2|||
164578408|NCT00761215|594481992|FG002|Overall Study|Bacteremia|0|||
164341027|NCT04289623|593623857|FG005|Wave 1 Emails|Email was not delivered|0|||
164578409|NCT01097044|594482002|FG000|Overall Study|Withdrawal by Subject|4|||
164578410|NCT01097044|594482003|FG001|Overall Study|Withdrawal by Subject|4|||
164578411|NCT01097044|594482002|FG000|Overall Study|Lost to Follow-up|1|||
164578412|NCT01097044|594482003|FG001|Overall Study|Lost to Follow-up|0|||
164578413|NCT01097044|594482002|FG000|Overall Study|Withdrawal by Sponsor|0|||
164578414|NCT01097044|594482003|FG001|Overall Study|Withdrawal by Sponsor|1|||
164578415|NCT01682044|594482004|FG000|Overall Study|Death|1|||
164578416|NCT01682044|594482004|FG000|Overall Study|Progression|3|||
164578417|NCT02452359|594482008|FG000|Overall Study|Adverse Event|1|||
164341028|NCT04138810|593623860|FG000|Overall Study|Withdrawal by Subject|0|||
164341029|NCT04138810|593623861|FG001|Overall Study|Withdrawal by Subject|1|||
164341030|NCT04138810|593623860|FG000|Overall Study|Subject cancelled surgery|1|||
164341031|NCT04138810|593623861|FG001|Overall Study|Subject cancelled surgery|0|||
164341032|NCT03641339|593623864|FG000|Overall Study|Physician Decision|1|||
164341033|NCT03641339|593623865|FG001|Overall Study|Physician Decision|0|||
164341034|NCT03641339|593623866|FG002|Overall Study|Physician Decision|0|||
164341035|NCT03641339|593623867|FG003|Overall Study|Physician Decision|0|||
164341036|NCT03641339|593623868|FG004|Overall Study|Physician Decision|0|||
164341037|NCT03641339|593623869|FG005|Overall Study|Physician Decision|0|||
164341038|NCT03641339|593623864|FG000|Overall Study|Withdrawal by Subject|0|||
164341039|NCT03641339|593623865|FG001|Overall Study|Withdrawal by Subject|2|||
164341040|NCT03641339|593623866|FG002|Overall Study|Withdrawal by Subject|0|||
164341041|NCT03641339|593623867|FG003|Overall Study|Withdrawal by Subject|2|||
164341042|NCT03641339|593623868|FG004|Overall Study|Withdrawal by Subject|0|||
164341043|NCT03641339|593623869|FG005|Overall Study|Withdrawal by Subject|1|||
164341044|NCT02329080|593623870|FG000|Overall Study|Adverse Event|1|||
164341045|NCT02329080|593623870|FG000|Overall Study|Death|4|||
164341046|NCT02329080|593623870|FG000|Overall Study|Lack of Efficacy|22|||
164341047|NCT02329080|593623870|FG000|Overall Study|Lost to Follow-up|1|||
164341048|NCT02329080|593623870|FG000|Overall Study|Physician Decision|2|||
164341049|NCT02329080|593623870|FG000|Overall Study|Partial response|4|||
164341050|NCT02329080|593623870|FG000|Overall Study|Complete response|4|||
164341051|NCT00413244|593623872|FG000|Overall Study|Withdrawal by Subject|10|||
164341052|NCT00413244|593623873|FG001|Overall Study|Withdrawal by Subject|1|||
164341053|NCT02319837|593623876|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
164341054|NCT02319837|593623877|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
164341055|NCT02319837|593623878|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
164341056|NCT02319837|593623876|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
164341057|NCT02319837|593623877|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
164341058|NCT02319837|593623878|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
164341059|NCT02319837|593623876|FG000|Study Treatment Phase|Adverse Event|73|||
164341060|NCT02319837|593623877|FG001|Study Treatment Phase|Adverse Event|36|||
164341061|NCT02319837|593623878|FG002|Study Treatment Phase|Adverse Event|63|||
164341062|NCT02319837|593623876|FG000|Study Treatment Phase|Development of castration resistance|0|||
164341063|NCT02319837|593623877|FG001|Study Treatment Phase|Development of castration resistance|2|||
164341064|NCT02319837|593623878|FG002|Study Treatment Phase|Development of castration resistance|0|||
164341065|NCT02319837|593623876|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
164341066|NCT02319837|593623877|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
164341067|NCT02319837|593623878|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
164341068|NCT02319837|593623876|FG000|Study Treatment Phase|Protocol Violation|2|||
164341069|NCT02319837|593623877|FG001|Study Treatment Phase|Protocol Violation|2|||
164341070|NCT02319837|593623878|FG002|Study Treatment Phase|Protocol Violation|1|||
164341071|NCT02319837|593623876|FG000|Study Treatment Phase|Lost to Follow-up|0|||
164341072|NCT02319837|593623877|FG001|Study Treatment Phase|Lost to Follow-up|1|||
164341073|NCT02319837|593623878|FG002|Study Treatment Phase|Lost to Follow-up|0|||
164341074|NCT02319837|593623876|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
164341075|NCT02319837|593623877|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
164341076|NCT02319837|593623878|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
164341077|NCT02319837|593623876|FG000|Study Treatment Phase|Other|0|||
164341078|NCT02319837|593623877|FG001|Study Treatment Phase|Other|1|||
164341079|NCT02319837|593623878|FG002|Study Treatment Phase|Other|0|||
164341080|NCT02319837|593623876|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
164341081|NCT02319837|593623877|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
164341082|NCT02319837|593623878|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
164341083|NCT02319837|593623876|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
164341084|NCT02319837|593623877|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
164430123|NCT00877851|593945300|FG000|Overall Study|Lost to Follow-up|5|||
164430124|NCT00877851|593945301|FG001|Overall Study|Lost to Follow-up|5|||
164578418|NCT02452359|594482008|FG000|Overall Study|Lost to Follow-up|15|||
164578419|NCT02452359|594482008|FG000|Overall Study|Pregnancy|1|||
164578420|NCT02452359|594482008|FG000|Overall Study|Withdrawal by Subject|4|||
164578421|NCT03414359|594482009|FG000|Overall Study|Lack of Efficacy|1|||
164578422|NCT03414359|594482010|FG001|Overall Study|Lack of Efficacy|1|||
164578423|NCT03414359|594482009|FG000|Overall Study|Protocol Violation|0|||
164578424|NCT03414359|594482010|FG001|Overall Study|Protocol Violation|1|||
164578425|NCT00222105|594482015|FG000|Overall Study|Removed due to wrong diagnosis|1|||
164578426|NCT00222105|594482015|FG000|Overall Study|Withdrawal by Subject|1|||
164578427|NCT00222105|594482015|FG000|Overall Study|Adverse Event|8|||
164578428|NCT00222105|594482015|FG000|Overall Study|Treatment delays|2|||
164578429|NCT00222105|594482015|FG000|Overall Study|Death|2|||
164578430|NCT03395210|594483963|FG000|Overall Study|Other|0|||
164578431|NCT03395210|594483964|FG001|Overall Study|Other|0|||
164578432|NCT03395210|594483965|FG002|Overall Study|Other|0|||
164578433|NCT03395210|594483966|FG003|Overall Study|Other|0|||
164578434|NCT03395210|594483967|FG004|Overall Study|Other|1|||
164578435|NCT03395210|594483963|FG000|Overall Study|Participant Uncooperative or Noncompliant|0|||
164578436|NCT03395210|594483964|FG001|Overall Study|Participant Uncooperative or Noncompliant|0|||
164578437|NCT03395210|594483965|FG002|Overall Study|Participant Uncooperative or Noncompliant|0|||
164578438|NCT03395210|594483966|FG003|Overall Study|Participant Uncooperative or Noncompliant|0|||
164578439|NCT03395210|594483967|FG004|Overall Study|Participant Uncooperative or Noncompliant|1|||
164578440|NCT03395210|594483963|FG000|Overall Study|Adverse Event|1|||
164578441|NCT03395210|594483964|FG001|Overall Study|Adverse Event|0|||
164578442|NCT03395210|594483965|FG002|Overall Study|Adverse Event|2|||
164578443|NCT03395210|594483966|FG003|Overall Study|Adverse Event|4|||
164578444|NCT03395210|594483967|FG004|Overall Study|Adverse Event|3|||
164578445|NCT03395210|594483963|FG000|Overall Study|Need of Rescue Medication|1|||
164578446|NCT03395210|594483964|FG001|Overall Study|Need of Rescue Medication|0|||
164578447|NCT03395210|594483965|FG002|Overall Study|Need of Rescue Medication|1|||
164578448|NCT03395210|594483966|FG003|Overall Study|Need of Rescue Medication|4|||
164578449|NCT03395210|594483967|FG004|Overall Study|Need of Rescue Medication|0|||
164578450|NCT03395210|594483963|FG000|Overall Study|Lack of Response|0|||
164578451|NCT03395210|594483964|FG001|Overall Study|Lack of Response|0|||
164578452|NCT03395210|594483965|FG002|Overall Study|Lack of Response|0|||
164578453|NCT03395210|594483966|FG003|Overall Study|Lack of Response|5|||
164578454|NCT03395210|594483967|FG004|Overall Study|Lack of Response|5|||
164578455|NCT03395210|594483963|FG000|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
164578456|NCT03395210|594483964|FG001|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
164578457|NCT03395210|594483965|FG002|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
164578458|NCT03395210|594483966|FG003|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
164578459|NCT03395210|594483967|FG004|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
164578460|NCT03395210|594483963|FG000|Overall Study|Participant Decision|1|||
164578461|NCT03395210|594483964|FG001|Overall Study|Participant Decision|1|||
164578462|NCT03395210|594483965|FG002|Overall Study|Participant Decision|0|||
164578463|NCT03395210|594483966|FG003|Overall Study|Participant Decision|4|||
164578464|NCT03395210|594483967|FG004|Overall Study|Participant Decision|0|||
164578465|NCT03395210|594483963|FG000|Overall Study|Ongoing at the Time of Primary Completion Date|1|||
164578466|NCT03395210|594483964|FG001|Overall Study|Ongoing at the Time of Primary Completion Date|0|||
164578467|NCT03395210|594483965|FG002|Overall Study|Ongoing at the Time of Primary Completion Date|2|||
164578468|NCT03395210|594483966|FG003|Overall Study|Ongoing at the Time of Primary Completion Date|13|||
164578469|NCT03395210|594483967|FG004|Overall Study|Ongoing at the Time of Primary Completion Date|11|||
164578470|NCT01672892|594483968|FG000|Overall Study|Protocol Violation|7|||
164578471|NCT01672892|594483969|FG001|Overall Study|Protocol Violation|3|||
164578472|NCT00886821|594483980|FG000|Stage 2|Adverse Event|0|||
164578473|NCT00886821|594483981|FG001|Stage 2|Adverse Event|0|||
164578474|NCT00886821|594483982|FG002|Stage 2|Adverse Event|0|||
164578475|NCT00886821|594483983|FG003|Stage 2|Adverse Event|0|||
164578476|NCT00886821|594483984|FG004|Stage 2|Adverse Event|0|||
164578477|NCT00886821|594483985|FG005|Stage 2|Adverse Event|0|||
164578478|NCT00886821|594483986|FG006|Stage 2|Adverse Event|0|||
164578479|NCT00886821|594483987|FG007|Stage 2|Adverse Event|0|||
164578480|NCT00886821|594483988|FG008|Stage 2|Adverse Event|0|||
164578481|NCT00886821|594483989|FG009|Stage 2|Adverse Event|0|||
164578482|NCT00886821|594483990|FG010|Stage 2|Adverse Event|0|||
164578483|NCT00886821|594483991|FG011|Stage 2|Adverse Event|1|||
164578484|NCT00886821|594483992|FG012|Stage 2|Adverse Event|3|||
164578485|NCT00886821|594483993|FG013|Stage 2|Adverse Event|0|||
164578486|NCT00886821|594483980|FG000|Stage 2|Lost to Follow-up|0|||
164578487|NCT00886821|594483981|FG001|Stage 2|Lost to Follow-up|0|||
164578488|NCT00886821|594483982|FG002|Stage 2|Lost to Follow-up|0|||
164578489|NCT00886821|594483983|FG003|Stage 2|Lost to Follow-up|0|||
164578490|NCT00886821|594483984|FG004|Stage 2|Lost to Follow-up|0|||
164578491|NCT00886821|594483985|FG005|Stage 2|Lost to Follow-up|0|||
164578492|NCT00886821|594483986|FG006|Stage 2|Lost to Follow-up|0|||
164263619|NCT05438602|593333970|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
164263620|NCT05438602|593333971|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
164263621|NCT05438602|593333969|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
164263622|NCT05438602|593333970|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
164263623|NCT05438602|593333971|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
164263624|NCT05438602|593333969|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
164263625|NCT05438602|593333970|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
164263626|NCT05438602|593333971|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
164263627|NCT05438602|593333969|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
164263628|NCT05438602|593333970|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
164263629|NCT05438602|593333971|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
164263630|NCT05438602|593333969|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
164578493|NCT00886821|594483987|FG007|Stage 2|Lost to Follow-up|0|||
164578494|NCT00886821|594483988|FG008|Stage 2|Lost to Follow-up|0|||
164578495|NCT00886821|594483989|FG009|Stage 2|Lost to Follow-up|0|||
164578496|NCT00886821|594483990|FG010|Stage 2|Lost to Follow-up|0|||
164578497|NCT00886821|594483991|FG011|Stage 2|Lost to Follow-up|0|||
164578498|NCT00886821|594483992|FG012|Stage 2|Lost to Follow-up|2|||
164578499|NCT00886821|594483993|FG013|Stage 2|Lost to Follow-up|1|||
164578500|NCT03716726|594483996|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
164578501|NCT03716726|594483997|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
164578502|NCT03716726|594483996|FG000|12 Months Followup|Lost to Follow-up|10|||
164578503|NCT03716726|594483997|FG001|12 Months Followup|Lost to Follow-up|17|||
164578504|NCT02579603|594483998|FG000|Overall Study|Not treated|1|||
164578505|NCT02579603|594483999|FG001|Overall Study|Not treated|0|||
164578506|NCT02579603|594483998|FG000|Overall Study|Adverse Event|2|||
164578507|NCT02579603|594483999|FG001|Overall Study|Adverse Event|2|||
164578508|NCT02579603|594483998|FG000|Overall Study|Other than stated|1|||
164578509|NCT02579603|594483999|FG001|Overall Study|Other than stated|0|||
164578510|NCT02981472|594484004|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
164578511|NCT02981472|594484005|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
164578512|NCT02981472|594484004|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
164578513|NCT02981472|594484005|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164578514|NCT02981472|594484004|FG000|Treatment Period|Adverse Event|6|||
164578515|NCT02981472|594484005|FG001|Treatment Period|Adverse Event|1|||
164578516|NCT02981472|594484004|FG000|Treatment Period|Participant withdrew consent|1|||
164578517|NCT02981472|594484005|FG001|Treatment Period|Participant withdrew consent|0|||
164578518|NCT02981472|594484004|FG000|Treatment Period|Lost to Follow-up|0|||
164578519|NCT02981472|594484005|FG001|Treatment Period|Lost to Follow-up|1|||
164578520|NCT03523585|594484009|FG000|Overall Study|Progressive Disease|174|||
164578521|NCT03523585|594484010|FG001|Overall Study|Progressive Disease|64|||
164578522|NCT03523585|594484011|FG002|Overall Study|Progressive Disease|77|||
164578523|NCT03523585|594484009|FG000|Overall Study|Adverse Event|74|||
164578524|NCT03523585|594484010|FG001|Overall Study|Adverse Event|5|||
164578525|NCT03523585|594484011|FG002|Overall Study|Adverse Event|9|||
164578526|NCT03523585|594484009|FG000|Overall Study|Withdrawal by Subject|30|||
164578527|NCT03523585|594484010|FG001|Overall Study|Withdrawal by Subject|11|||
164578528|NCT03523585|594484011|FG002|Overall Study|Withdrawal by Subject|6|||
164578529|NCT03523585|594484009|FG000|Overall Study|Clinical Progression|23|||
164578530|NCT03523585|594484010|FG001|Overall Study|Clinical Progression|5|||
164578531|NCT03523585|594484011|FG002|Overall Study|Clinical Progression|10|||
164578532|NCT03523585|594484009|FG000|Overall Study|Death|4|||
164578533|NCT03523585|594484010|FG001|Overall Study|Death|0|||
164578534|NCT03523585|594484011|FG002|Overall Study|Death|1|||
164578535|NCT03523585|594484009|FG000|Overall Study|Physician Decision|2|||
164578536|NCT03523585|594484010|FG001|Overall Study|Physician Decision|1|||
164578537|NCT03523585|594484011|FG002|Overall Study|Physician Decision|0|||
164578538|NCT03523585|594484009|FG000|Overall Study|Lost to Follow-up|1|||
164578539|NCT03523585|594484010|FG001|Overall Study|Lost to Follow-up|0|||
164578540|NCT03523585|594484011|FG002|Overall Study|Lost to Follow-up|0|||
164578541|NCT03523585|594484009|FG000|Overall Study|Miscellaneous|1|||
164578542|NCT03523585|594484010|FG001|Overall Study|Miscellaneous|0|||
164578543|NCT03523585|594484011|FG002|Overall Study|Miscellaneous|0|||
164578544|NCT03523585|594484009|FG000|Overall Study|Protocol Deviation|1|||
164578545|NCT03523585|594484010|FG001|Overall Study|Protocol Deviation|0|||
164263631|NCT05438602|593333970|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
164578546|NCT03523585|594484011|FG002|Overall Study|Protocol Deviation|1|||
164578547|NCT03523585|594484009|FG000|Overall Study|Randomized But Not Treated|2|||
164578548|NCT03523585|594484010|FG001|Overall Study|Randomized But Not Treated|4|||
164578549|NCT03523585|594484011|FG002|Overall Study|Randomized But Not Treated|3|||
164578550|NCT01473004|594484014|FG000|Overall Study|Incomplete Lobar Treatment|1|||
164578551|NCT01473004|594484015|FG001|Overall Study|Incomplete Lobar Treatment|0|||
164578552|NCT00698516|594484016|FG000|Overall Study|Study Termination|2|||
164578553|NCT00698516|594484016|FG000|Overall Study|Withdrawal by Subject|3|||
164578554|NCT01584024|594484024|FG000|Overall Study|Lost to Follow-up|10|||
164578555|NCT01584024|594484024|FG000|Overall Study|Withdrawal by Subject|3|||
164578556|NCT00613314|594484025|FG000|Overall Study|Adverse Event|5|||
164578557|NCT00613314|594484025|FG000|Overall Study|Protocol Violation|14|||
164578558|NCT00613314|594484025|FG000|Overall Study|Lost to Follow-up|46|||
164578559|NCT00613314|594484025|FG000|Overall Study|Other reason not defined above|90|||
164578560|NCT04893265|594484049|FG000|Overall Study|Withdrawal by Subject|2|||
164578561|NCT04893265|594484050|FG001|Overall Study|Withdrawal by Subject|5|||
164683008|NCT04476277|594861476|FG000|Overall Study|Withdrawal by Subject|0|||
164683009|NCT04476277|594861477|FG001|Overall Study|Withdrawal by Subject|0|||
164683010|NCT04476277|594861478|FG002|Overall Study|Withdrawal by Subject|1|||
164683011|NCT04476277|594861479|FG003|Overall Study|Withdrawal by Subject|0|||
164683012|NCT01962298|594861480|FG000|Overall Study|Protocol Violation|1|||
164683013|NCT01962298|594861481|FG001|Overall Study|Protocol Violation|0|||
164683014|NCT01962298|594861482|FG002|Overall Study|Protocol Violation|1|||
164683015|NCT01962298|594861483|FG003|Overall Study|Protocol Violation|1|||
164683016|NCT01962298|594861484|FG004|Overall Study|Protocol Violation|0|||
164683017|NCT01962298|594861480|FG000|Overall Study|Data quality insufficient|2|||
164683018|NCT01962298|594861481|FG001|Overall Study|Data quality insufficient|0|||
164683019|NCT01962298|594861482|FG002|Overall Study|Data quality insufficient|3|||
164683020|NCT01962298|594861483|FG003|Overall Study|Data quality insufficient|1|||
164683021|NCT01962298|594861484|FG004|Overall Study|Data quality insufficient|4|||
164683022|NCT01962298|594861480|FG000|Overall Study|Insufficient data|0|||
164683023|NCT01962298|594861481|FG001|Overall Study|Insufficient data|2|||
164683024|NCT01962298|594861482|FG002|Overall Study|Insufficient data|1|||
164683025|NCT01962298|594861483|FG003|Overall Study|Insufficient data|0|||
164683026|NCT01962298|594861484|FG004|Overall Study|Insufficient data|1|||
164683027|NCT01962298|594861480|FG000|Overall Study|Incorrect data recorded|0|||
164683028|NCT01962298|594861481|FG001|Overall Study|Incorrect data recorded|1|||
164683029|NCT01962298|594861482|FG002|Overall Study|Incorrect data recorded|0|||
164683030|NCT01962298|594861483|FG003|Overall Study|Incorrect data recorded|0|||
164683031|NCT01962298|594861484|FG004|Overall Study|Incorrect data recorded|0|||
164683032|NCT01962298|594861480|FG000|Overall Study|Physician Decision|0|||
164683033|NCT01962298|594861481|FG001|Overall Study|Physician Decision|1|||
164683034|NCT01962298|594861482|FG002|Overall Study|Physician Decision|0|||
164683035|NCT01962298|594861483|FG003|Overall Study|Physician Decision|0|||
164683036|NCT01962298|594861484|FG004|Overall Study|Physician Decision|1|||
164683037|NCT01576705|594861485|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
164683038|NCT01576705|594861486|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
164683039|NCT01576705|594861487|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
164683040|NCT01576705|594861488|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
164683041|NCT01576705|594861485|FG000|Overall Study|invalid ICF|0|||
164683042|NCT01576705|594861486|FG001|Overall Study|invalid ICF|1|||
164683043|NCT01576705|594861487|FG002|Overall Study|invalid ICF|0|||
164683044|NCT01576705|594861488|FG003|Overall Study|invalid ICF|0|||
164683045|NCT02264977|594861490|FG000|Overall Study|Death|3|||
164683046|NCT02264977|594861490|FG000|Overall Study|Physician Decision|1|||
164683047|NCT02264977|594861490|FG000|Overall Study|Refuse to return|1|||
164683048|NCT03573544|594861491|FG000|Overall Study|Adverse Event|0|||
164683049|NCT03573544|594861492|FG001|Overall Study|Adverse Event|0|||
164683050|NCT03573544|594861493|FG002|Overall Study|Adverse Event|0|||
164683051|NCT03573544|594861494|FG003|Overall Study|Adverse Event|3|||
164683052|NCT03573544|594861495|FG004|Overall Study|Adverse Event|1|||
164263632|NCT05438602|593333971|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
164263633|NCT01930890|593333972|FG000|Overall Study|Study Termination|14|||
164578562|NCT04893265|594484049|FG000|Overall Study|Lost to Follow-up|0|||
164683053|NCT03573544|594861496|FG005|Overall Study|Adverse Event|0|||
164683054|NCT03573544|594861497|FG006|Overall Study|Adverse Event|2|||
164683055|NCT03573544|594861498|FG007|Overall Study|Adverse Event|0|||
164683056|NCT03573544|594861491|FG000|Overall Study|Physician Decision|0|||
164683057|NCT03573544|594861492|FG001|Overall Study|Physician Decision|0|||
164683058|NCT03573544|594861493|FG002|Overall Study|Physician Decision|0|||
164683059|NCT03573544|594861494|FG003|Overall Study|Physician Decision|0|||
164683060|NCT03573544|594861495|FG004|Overall Study|Physician Decision|0|||
164683061|NCT03573544|594861496|FG005|Overall Study|Physician Decision|0|||
164263634|NCT01930890|593333973|FG001|Overall Study|Study Termination|28|||
164578563|NCT04893265|594484050|FG001|Overall Study|Lost to Follow-up|4|||
164578564|NCT02465034|594484052|FG000|Overall Study|Withdrawal by Subject|1|||
164578565|NCT02465034|594484053|FG001|Overall Study|Withdrawal by Subject|1|||
164578566|NCT02465034|594484052|FG000|Overall Study|Screen fail|2|||
164578567|NCT02465034|594484053|FG001|Overall Study|Screen fail|0|||
164578568|NCT02465034|594484052|FG000|Overall Study|Could not be scheduled for study visit|0|||
164683062|NCT03573544|594861497|FG006|Overall Study|Physician Decision|1|||
164683063|NCT03573544|594861498|FG007|Overall Study|Physician Decision|0|||
164683064|NCT03573544|594861491|FG000|Overall Study|Withdrawal by Subject|2|||
164683065|NCT03573544|594861492|FG001|Overall Study|Withdrawal by Subject|0|||
164683066|NCT03573544|594861493|FG002|Overall Study|Withdrawal by Subject|0|||
164683067|NCT03573544|594861494|FG003|Overall Study|Withdrawal by Subject|1|||
164683068|NCT03573544|594861495|FG004|Overall Study|Withdrawal by Subject|1|||
164683069|NCT03573544|594861496|FG005|Overall Study|Withdrawal by Subject|1|||
164263635|NCT01930890|593333974|FG002|Overall Study|Study Termination|13|||
164578569|NCT02465034|594484053|FG001|Overall Study|Could not be scheduled for study visit|5|||
164578570|NCT00573131|594484054|FG000|Overall Study|Withdrawal by Subject|10|||
164578571|NCT00573131|594484055|FG001|Overall Study|Withdrawal by Subject|8|||
164578572|NCT03090191|594484061|FG000|Overall Study|Adverse Event|90|||
164578573|NCT03090191|594484062|FG001|Overall Study|Adverse Event|72|||
164578574|NCT03090191|594484061|FG000|Overall Study|Death|365|||
164578575|NCT03090191|594484062|FG001|Overall Study|Death|358|||
164578576|NCT03090191|594484061|FG000|Overall Study|Lost to Follow-up|382|||
164578577|NCT03090191|594484062|FG001|Overall Study|Lost to Follow-up|394|||
164578578|NCT03090191|594484061|FG000|Overall Study|Physician Decision|77|||
164578579|NCT03090191|594484062|FG001|Overall Study|Physician Decision|66|||
164578580|NCT03090191|594484061|FG000|Overall Study|Protocol Violation|43|||
164578581|NCT03090191|594484062|FG001|Overall Study|Protocol Violation|52|||
164578582|NCT03090191|594484061|FG000|Overall Study|Withdrawal by Subject|2160|||
164578583|NCT03090191|594484062|FG001|Overall Study|Withdrawal by Subject|2133|||
164578584|NCT03090191|594484061|FG000|Overall Study|Site terminated|7|||
164263636|NCT01930890|593333975|FG003|Overall Study|Study Termination|25|||
164263637|NCT01930890|593333972|FG000|Overall Study|Death|0|||
164263638|NCT01930890|593333973|FG001|Overall Study|Death|0|||
164263639|NCT01930890|593333974|FG002|Overall Study|Death|0|||
164578585|NCT03090191|594484062|FG001|Overall Study|Site terminated|8|||
164578586|NCT03090191|594484061|FG000|Overall Study|Other|66|||
164578587|NCT03090191|594484062|FG001|Overall Study|Other|60|||
164578588|NCT03090191|594484061|FG000|Overall Study|Withdrawn before any study vaccination|43|||
164578589|NCT03090191|594484062|FG001|Overall Study|Withdrawn before any study vaccination|52|||
164578590|NCT01324830|594484063|FG000|Overall Study|Progressive Disease|3|||
164578591|NCT01324830|594484064|FG001|Overall Study|Progressive Disease|2|||
164578592|NCT01324830|594484065|FG002|Overall Study|Progressive Disease|3|||
164578593|NCT01324830|594484066|FG003|Overall Study|Progressive Disease|3|||
164578594|NCT01324830|594484067|FG004|Overall Study|Progressive Disease|6|||
164578595|NCT01324830|594484068|FG005|Overall Study|Progressive Disease|6|||
164578596|NCT01324830|594484069|FG006|Overall Study|Progressive Disease|3|||
164578597|NCT01324830|594484070|FG007|Overall Study|Progressive Disease|3|||
164578598|NCT01324830|594484071|FG008|Overall Study|Progressive Disease|3|||
164578599|NCT01324830|594484072|FG009|Overall Study|Progressive Disease|6|||
164578600|NCT01324830|594484073|FG010|Overall Study|Progressive Disease|2|||
164578601|NCT01324830|594484074|FG011|Overall Study|Progressive Disease|1|||
164578602|NCT01324830|594484075|FG012|Overall Study|Progressive Disease|1|||
164578603|NCT01324830|594484076|FG013|Overall Study|Progressive Disease|1|||
164578604|NCT01324830|594484077|FG014|Overall Study|Progressive Disease|1|||
164578605|NCT01324830|594484078|FG015|Overall Study|Progressive Disease|3|||
164578606|NCT01324830|594484079|FG016|Overall Study|Progressive Disease|2|||
164578607|NCT01324830|594484080|FG017|Overall Study|Progressive Disease|3|||
164578608|NCT01324830|594484081|FG018|Overall Study|Progressive Disease|4|||
164578609|NCT01324830|594484063|FG000|Overall Study|Dose limiting toxicity|0|||
164578610|NCT01324830|594484064|FG001|Overall Study|Dose limiting toxicity|0|||
164578611|NCT01324830|594484065|FG002|Overall Study|Dose limiting toxicity|0|||
164578612|NCT01324830|594484066|FG003|Overall Study|Dose limiting toxicity|0|||
164578613|NCT01324830|594484067|FG004|Overall Study|Dose limiting toxicity|1|||
164578614|NCT01324830|594484068|FG005|Overall Study|Dose limiting toxicity|0|||
164578615|NCT01324830|594484069|FG006|Overall Study|Dose limiting toxicity|0|||
164578616|NCT01324830|594484070|FG007|Overall Study|Dose limiting toxicity|0|||
164578617|NCT01324830|594484071|FG008|Overall Study|Dose limiting toxicity|0|||
164578618|NCT01324830|594484072|FG009|Overall Study|Dose limiting toxicity|0|||
164578619|NCT01324830|594484073|FG010|Overall Study|Dose limiting toxicity|0|||
164578620|NCT01324830|594484074|FG011|Overall Study|Dose limiting toxicity|0|||
164578621|NCT01324830|594484075|FG012|Overall Study|Dose limiting toxicity|0|||
164578622|NCT01324830|594484076|FG013|Overall Study|Dose limiting toxicity|0|||
164578623|NCT01324830|594484077|FG014|Overall Study|Dose limiting toxicity|0|||
164578624|NCT01324830|594484078|FG015|Overall Study|Dose limiting toxicity|0|||
164578625|NCT01324830|594484079|FG016|Overall Study|Dose limiting toxicity|1|||
164578626|NCT01324830|594484080|FG017|Overall Study|Dose limiting toxicity|1|||
164578627|NCT01324830|594484081|FG018|Overall Study|Dose limiting toxicity|1|||
164578628|NCT01324830|594484063|FG000|Overall Study|Reason not mentioned above|0|||
164578629|NCT01324830|594484064|FG001|Overall Study|Reason not mentioned above|0|||
164578630|NCT01324830|594484065|FG002|Overall Study|Reason not mentioned above|0|||
164578631|NCT01324830|594484066|FG003|Overall Study|Reason not mentioned above|0|||
164578632|NCT01324830|594484067|FG004|Overall Study|Reason not mentioned above|0|||
164263640|NCT01930890|593333975|FG003|Overall Study|Death|1|||
164578633|NCT01324830|594484068|FG005|Overall Study|Reason not mentioned above|0|||
164578634|NCT01324830|594484069|FG006|Overall Study|Reason not mentioned above|0|||
164578635|NCT01324830|594484070|FG007|Overall Study|Reason not mentioned above|0|||
164578636|NCT01324830|594484071|FG008|Overall Study|Reason not mentioned above|0|||
164578637|NCT01324830|594484072|FG009|Overall Study|Reason not mentioned above|0|||
164578638|NCT01324830|594484073|FG010|Overall Study|Reason not mentioned above|0|||
164578639|NCT01324830|594484074|FG011|Overall Study|Reason not mentioned above|0|||
164578640|NCT01324830|594484075|FG012|Overall Study|Reason not mentioned above|0|||
164683070|NCT03573544|594861497|FG006|Overall Study|Withdrawal by Subject|0|||
164683071|NCT03573544|594861498|FG007|Overall Study|Withdrawal by Subject|1|||
164683072|NCT03573544|594861491|FG000|Overall Study|Disease progression|3|||
164683073|NCT03573544|594861492|FG001|Overall Study|Disease progression|3|||
164683074|NCT03573544|594861493|FG002|Overall Study|Disease progression|6|||
164683075|NCT03573544|594861494|FG003|Overall Study|Disease progression|4|||
164683076|NCT03573544|594861495|FG004|Overall Study|Disease progression|5|||
164683077|NCT03573544|594861496|FG005|Overall Study|Disease progression|7|||
164683078|NCT03573544|594861497|FG006|Overall Study|Disease progression|6|||
164683079|NCT03573544|594861498|FG007|Overall Study|Disease progression|7|||
164683080|NCT03105297|594861500|FG000|Baseline Phase (Day 1)|Other|21|||
164683081|NCT03105297|594861500|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
164683082|NCT03105297|594861500|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
164683083|NCT01390948|594861501|FG000|Overall Study|End of Study|1|||
164683084|NCT01390948|594861502|FG001|Overall Study|End of Study|0|||
164683085|NCT01390948|594861503|FG002|Overall Study|End of Study|0|||
164683086|NCT01390948|594861501|FG000|Overall Study|Withdrew consent|2|||
164683087|NCT01390948|594861502|FG001|Overall Study|Withdrew consent|2|||
164683088|NCT01390948|594861503|FG002|Overall Study|Withdrew consent|0|||
164683089|NCT01390948|594861501|FG000|Overall Study|Progressive Disease|2|||
164683090|NCT01390948|594861502|FG001|Overall Study|Progressive Disease|5|||
164683091|NCT01390948|594861503|FG002|Overall Study|Progressive Disease|0|||
164683092|NCT01390948|594861501|FG000|Overall Study|Death during follow-up|10|||
164683093|NCT01390948|594861502|FG001|Overall Study|Death during follow-up|11|||
164683094|NCT01390948|594861503|FG002|Overall Study|Death during follow-up|1|||
164683095|NCT01073631|594861506|FG000|Overall Study|Death|82|||
164683096|NCT01073631|594861506|FG000|Overall Study|Adverse Event|24|||
164683097|NCT01073631|594861506|FG000|Overall Study|Other|63|||
164263641|NCT01930890|593333972|FG000|Overall Study|Investigator Decision|0|||
164263642|NCT01930890|593333973|FG001|Overall Study|Investigator Decision|1|||
164263643|NCT01930890|593333974|FG002|Overall Study|Investigator Decision|0|||
164263644|NCT01930890|593333975|FG003|Overall Study|Investigator Decision|0|||
164263645|NCT01930890|593333972|FG000|Overall Study|Consent Withdrawn|0|||
164263646|NCT01930890|593333973|FG001|Overall Study|Consent Withdrawn|3|||
164263647|NCT01930890|593333974|FG002|Overall Study|Consent Withdrawn|0|||
164263648|NCT01930890|593333975|FG003|Overall Study|Consent Withdrawn|1|||
164263649|NCT01930890|593333972|FG000|Overall Study|Adverse Event|0|||
164263650|NCT01930890|593333973|FG001|Overall Study|Adverse Event|1|||
164263651|NCT01930890|593333974|FG002|Overall Study|Adverse Event|0|||
164263652|NCT01930890|593333975|FG003|Overall Study|Adverse Event|0|||
164263653|NCT02091284|593333976|FG000|Overall Study|Withdrawal by Subject|2|||
164263654|NCT02091284|593333977|FG001|Overall Study|Withdrawal by Subject|1|||
164263655|NCT02091284|593333976|FG000|Overall Study|unreliable data|1|||
164263656|NCT02091284|593333977|FG001|Overall Study|unreliable data|0|||
164263657|NCT02853435|593333978|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
164263658|NCT02853435|593333979|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
164263659|NCT02853435|593333980|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
164341085|NCT02319837|593623878|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
164263660|NCT02853435|593333981|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
164263661|NCT02853435|593333982|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
164263662|NCT02853435|593333983|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
164341086|NCT02319837|593623876|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
164341087|NCT02319837|593623877|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
164341088|NCT02319837|593623878|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
164341089|NCT02319837|593623876|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
164683098|NCT01131260|594861511|FG000|Overall Study|Randomization error|5|||
164683099|NCT01131260|594861512|FG001|Overall Study|Randomization error|1|||
164683100|NCT01131260|594861511|FG000|Overall Study|Declined to continue participation|8|||
164683101|NCT01131260|594861512|FG001|Overall Study|Declined to continue participation|13|||
164683102|NCT01131260|594861511|FG000|Overall Study|Physician Decision|22|||
164683103|NCT01131260|594861512|FG001|Overall Study|Physician Decision|24|||
164683104|NCT01131260|594861511|FG000|Overall Study|Technical problems|7|||
164683105|NCT01131260|594861512|FG001|Overall Study|Technical problems|6|||
164355671|NCT03720470|593678629|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
164263663|NCT03747120|593333984|FG000|Overall Study|treatment related toxicity|3|||
164263664|NCT03747120|593333985|FG001|Overall Study|treatment related toxicity|0|||
164683106|NCT01131260|594861511|FG000|Overall Study|Staff error|2|||
164683107|NCT01131260|594861512|FG001|Overall Study|Staff error|1|||
164683108|NCT01131260|594861511|FG000|Overall Study|Ineligible|0|||
164683109|NCT01131260|594861512|FG001|Overall Study|Ineligible|2|||
164683110|NCT00849797|594861517|FG000|First Intervention|bad veins|1|||
164683111|NCT00849797|594861518|FG001|First Intervention|bad veins|0|||
164683112|NCT00849797|594861517|FG000|First Intervention|Adverse Event|0|||
164263665|NCT03747120|593333986|FG002|Overall Study|treatment related toxicity|0|||
164263666|NCT03747120|593333984|FG000|Overall Study|Withdrawal by Subject|0|||
164430125|NCT00877851|593945300|FG000|Overall Study|computer problem|3|||
164430126|NCT00877851|593945301|FG001|Overall Study|computer problem|0|||
164430127|NCT00877851|593945300|FG000|Overall Study|no longer interested in participating|1|||
164430128|NCT00877851|593945301|FG001|Overall Study|no longer interested in participating|0|||
164683113|NCT00849797|594861518|FG001|First Intervention|Adverse Event|1|||
164683114|NCT00849797|594861517|FG000|Washout: One Week|Withdrawal by Subject|0|||
164683115|NCT00849797|594861518|FG001|Washout: One Week|Withdrawal by Subject|2|||
164683116|NCT01494532|594861519|FG000|Overall Study|Adverse Event|4|||
164683117|NCT01494532|594861520|FG001|Overall Study|Adverse Event|1|||
164683118|NCT01494532|594861521|FG002|Overall Study|Adverse Event|8|||
164683119|NCT01494532|594861522|FG003|Overall Study|Adverse Event|6|||
164683120|NCT01494532|594861523|FG004|Overall Study|Adverse Event|5|||
164683121|NCT01494532|594861524|FG005|Overall Study|Adverse Event|0|||
164683122|NCT01494532|594861519|FG000|Overall Study|Lack of Efficacy|0|||
164683123|NCT01494532|594861520|FG001|Overall Study|Lack of Efficacy|0|||
164683124|NCT01494532|594861521|FG002|Overall Study|Lack of Efficacy|0|||
164683125|NCT01494532|594861522|FG003|Overall Study|Lack of Efficacy|0|||
164683126|NCT01494532|594861523|FG004|Overall Study|Lack of Efficacy|2|||
164683127|NCT01494532|594861524|FG005|Overall Study|Lack of Efficacy|0|||
164683128|NCT01494532|594861519|FG000|Overall Study|Protocol deviation|2|||
164683129|NCT01494532|594861520|FG001|Overall Study|Protocol deviation|1|||
164683130|NCT01494532|594861521|FG002|Overall Study|Protocol deviation|3|||
164683131|NCT01494532|594861522|FG003|Overall Study|Protocol deviation|2|||
164683132|NCT01494532|594861523|FG004|Overall Study|Protocol deviation|3|||
164683133|NCT01494532|594861524|FG005|Overall Study|Protocol deviation|0|||
164683134|NCT01494532|594861519|FG000|Overall Study|Protocol-defined stopping criteria|0|||
164683135|NCT01494532|594861520|FG001|Overall Study|Protocol-defined stopping criteria|0|||
164683136|NCT01494532|594861521|FG002|Overall Study|Protocol-defined stopping criteria|1|||
164683137|NCT01494532|594861522|FG003|Overall Study|Protocol-defined stopping criteria|0|||
164683138|NCT01494532|594861523|FG004|Overall Study|Protocol-defined stopping criteria|0|||
164683139|NCT01494532|594861524|FG005|Overall Study|Protocol-defined stopping criteria|0|||
164683140|NCT01494532|594861519|FG000|Overall Study|Lost to Follow-up|1|||
164683141|NCT01494532|594861520|FG001|Overall Study|Lost to Follow-up|0|||
164683142|NCT01494532|594861521|FG002|Overall Study|Lost to Follow-up|0|||
164683143|NCT01494532|594861522|FG003|Overall Study|Lost to Follow-up|2|||
164683144|NCT01494532|594861523|FG004|Overall Study|Lost to Follow-up|0|||
164683145|NCT01494532|594861524|FG005|Overall Study|Lost to Follow-up|0|||
164683146|NCT01494532|594861519|FG000|Overall Study|Physician Decision|0|||
164683147|NCT01494532|594861520|FG001|Overall Study|Physician Decision|1|||
164683148|NCT01494532|594861521|FG002|Overall Study|Physician Decision|1|||
164683149|NCT01494532|594861522|FG003|Overall Study|Physician Decision|2|||
164683150|NCT01494532|594861523|FG004|Overall Study|Physician Decision|0|||
164683151|NCT01494532|594861524|FG005|Overall Study|Physician Decision|0|||
164683152|NCT01494532|594861519|FG000|Overall Study|Withdrawal by Subject|3|||
164683153|NCT01494532|594861520|FG001|Overall Study|Withdrawal by Subject|1|||
164683154|NCT01494532|594861521|FG002|Overall Study|Withdrawal by Subject|4|||
164683155|NCT01494532|594861522|FG003|Overall Study|Withdrawal by Subject|3|||
164683156|NCT01494532|594861523|FG004|Overall Study|Withdrawal by Subject|2|||
164683157|NCT01494532|594861524|FG005|Overall Study|Withdrawal by Subject|0|||
164683158|NCT00679081|594861525|FG000|Overall Study|Lost to Follow-up|1|||
164683159|NCT01675596|594861529|FG000|Overall Study|Death|6|||
164683160|NCT01675596|594861529|FG000|Overall Study|Exit with other reason|1|||
164683161|NCT01675596|594861529|FG000|Overall Study|Missed Visit|1|||
164683162|NCT01139762|594861530|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
164263667|NCT03747120|593333985|FG001|Overall Study|Withdrawal by Subject|1|||
164263668|NCT03747120|593333986|FG002|Overall Study|Withdrawal by Subject|2|||
164263669|NCT03362931|593334002|FG000|Overall Study|Adverse Event|1|||
164263670|NCT03362931|593334002|FG000|Overall Study|Death|2|||
164430129|NCT03285711|593945302|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
164430130|NCT03285711|593945303|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
164683163|NCT01139762|594861531|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
164683164|NCT01139762|594861532|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
164683165|NCT01139762|594861530|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
164683166|NCT01139762|594861531|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
164683167|NCT01139762|594861532|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
164683168|NCT01139762|594861530|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
164683169|NCT01139762|594861531|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
164683170|NCT01139762|594861532|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
164683171|NCT01139762|594861530|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
164683172|NCT01139762|594861531|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
164263671|NCT01998893|593334003|FG000|Overall Study|Adverse Event|2|||
164263672|NCT01998893|593334003|FG000|Overall Study|Death|1|||
164263673|NCT01998893|593334003|FG000|Overall Study|Lost to Follow-up|8|||
164263674|NCT01998893|593334003|FG000|Overall Study|Physician Decision|2|||
164263675|NCT01998893|593334003|FG000|Overall Study|Protocol Violation|2|||
164263676|NCT01998893|593334003|FG000|Overall Study|Withdrawal by Subject|1|||
164263677|NCT01998893|593334003|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
164263678|NCT03276052|593334004|FG000|Overall Study|Withdrawal by Subject|5|||
164263679|NCT03276052|593334004|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
164263680|NCT05136898|593334009|FG000|Overall Study|Adverse Event|2|||
164263681|NCT01994863|593334010|FG000|Period 1|Adverse Event|4|||
164263682|NCT01994863|593334011|FG001|Period 1|Adverse Event|0|||
164263683|NCT01994863|593334010|FG000|Period 1|Withdrawal by Subject|1|||
164263684|NCT01994863|593334011|FG001|Period 1|Withdrawal by Subject|0|||
164263685|NCT01994863|593334010|FG000|Period 1|Trial stopped by sponsor|1|||
164263686|NCT01994863|593334011|FG001|Period 1|Trial stopped by sponsor|3|||
164263687|NCT01994863|593334010|FG000|Period 1|Lack of Efficacy|1|||
164263688|NCT01994863|593334011|FG001|Period 1|Lack of Efficacy|0|||
164263689|NCT01994863|593334010|FG000|Period 2|Adverse Event|0|||
164263690|NCT01994863|593334011|FG001|Period 2|Adverse Event|1|||
164263691|NCT01994863|593334010|FG000|Period 2|Lack of Efficacy|0|||
164263692|NCT01994863|593334011|FG001|Period 2|Lack of Efficacy|2|||
164263693|NCT01994863|593334010|FG000|Period 2|Withdrawal by Subject|1|||
164263694|NCT01994863|593334011|FG001|Period 2|Withdrawal by Subject|1|||
164263695|NCT03784846|593334014|FG000|Pre-COVID Study|Lost to Follow-up|3|||
164263696|NCT03784846|593334015|FG001|Pre-COVID Study|Lost to Follow-up|3|||
164263697|NCT03784846|593334016|FG002|Pre-COVID Study|Lost to Follow-up|2|||
164263698|NCT03784846|593334014|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
164263699|NCT03784846|593334015|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
164263700|NCT03784846|593334016|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
164263701|NCT03784846|593334014|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
164263702|NCT03784846|593334015|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
164263703|NCT03784846|593334016|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
164263704|NCT03784846|593334014|FG000|Post-COVID Study|Lost to Follow-up|3|||
164263705|NCT03784846|593334015|FG001|Post-COVID Study|Lost to Follow-up|5|||
164263706|NCT03784846|593334016|FG002|Post-COVID Study|Lost to Follow-up|1|||
164263707|NCT03784846|593334014|FG000|Post-COVID Study|Withdrawal by Subject|1|||
164263708|NCT03784846|593334015|FG001|Post-COVID Study|Withdrawal by Subject|2|||
164263709|NCT03784846|593334016|FG002|Post-COVID Study|Withdrawal by Subject|0|||
164263710|NCT00931723|593334017|FG000|Overall Study|Withdrawal by Subject|11|||
164263711|NCT00931723|593334018|FG001|Overall Study|Withdrawal by Subject|13|||
164263712|NCT00931723|593334017|FG000|Overall Study|Adverse Event|6|||
164263713|NCT00931723|593334018|FG001|Overall Study|Adverse Event|13|||
164263714|NCT00931723|593334017|FG000|Overall Study|Lithium found in blood|0|||
164263715|NCT00931723|593334018|FG001|Overall Study|Lithium found in blood|1|||
164263716|NCT00931723|593334017|FG000|Overall Study|Condition under investigation worsened|1|||
164430131|NCT03285711|593945304|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
164430132|NCT03285711|593945305|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
164578641|NCT01324830|594484076|FG013|Overall Study|Reason not mentioned above|0|||
164263717|NCT00931723|593334018|FG001|Overall Study|Condition under investigation worsened|2|||
164263718|NCT00931723|593334017|FG000|Overall Study|Lost to Follow-up|1|||
164263719|NCT00931723|593334018|FG001|Overall Study|Lost to Follow-up|2|||
164263720|NCT00931723|593334017|FG000|Overall Study|Study-specific discontinuation criteria|1|||
164263721|NCT00931723|593334018|FG001|Overall Study|Study-specific discontinuation criteria|1|||
164263722|NCT00931723|593334017|FG000|Overall Study|Severe non-compliance to protocol|2|||
164263723|NCT00931723|593334018|FG001|Overall Study|Severe non-compliance to protocol|0|||
164263724|NCT00931723|593334017|FG000|Overall Study|Safety reasons|0|||
164263725|NCT00931723|593334018|FG001|Overall Study|Safety reasons|1|||
164263726|NCT00931723|593334017|FG000|Overall Study|Took prohibited concomitant medication|0|||
164263727|NCT00931723|593334018|FG001|Overall Study|Took prohibited concomitant medication|1|||
164263728|NCT00931723|593334017|FG000|Overall Study|Lack or insufficient theraputic response|2|||
164263729|NCT00931723|593334018|FG001|Overall Study|Lack or insufficient theraputic response|5|||
164263730|NCT00931723|593334017|FG000|Overall Study|Sponsor decision|1|||
164263731|NCT00931723|593334018|FG001|Overall Study|Sponsor decision|0|||
164263732|NCT00931723|593334017|FG000|Overall Study|Late hospital discharge|1|||
164263733|NCT00931723|593334018|FG001|Overall Study|Late hospital discharge|0|||
164263734|NCT03054350|593334019|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
164263735|NCT03054350|593334020|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
164263736|NCT03054350|593334021|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
164263737|NCT03054350|593334022|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
164263738|NCT03054350|593334023|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
164263739|NCT03054350|593334024|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
164263740|NCT03054350|593334019|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
164263741|NCT03054350|593334020|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
164263742|NCT03054350|593334021|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
164263743|NCT03054350|593334022|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
164263744|NCT03054350|593334023|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
164263745|NCT03054350|593334024|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
164263746|NCT03054350|593334019|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
164263747|NCT03054350|593334020|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
164263748|NCT03054350|593334021|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
164263749|NCT03054350|593334022|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
164263750|NCT03054350|593334023|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
164263751|NCT03054350|593334024|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
164263752|NCT03054350|593334019|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
164263753|NCT03054350|593334020|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
164263754|NCT03054350|593334021|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
164263755|NCT03054350|593334022|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
164263756|NCT03054350|593334023|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
164263757|NCT03054350|593334024|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
164263758|NCT01643850|593334025|FG000|Overall Study|Withdrawal by Subject|0|||
164263759|NCT01643850|593334026|FG001|Overall Study|Withdrawal by Subject|0|||
164263760|NCT01643850|593334027|FG002|Overall Study|Withdrawal by Subject|0|||
164263761|NCT01643850|593334028|FG003|Overall Study|Withdrawal by Subject|0|||
164263762|NCT01643850|593334029|FG004|Overall Study|Withdrawal by Subject|1|||
164263763|NCT01643850|593334030|FG005|Overall Study|Withdrawal by Subject|0|||
164263764|NCT01643850|593334031|FG006|Overall Study|Withdrawal by Subject|0|||
164263765|NCT01643850|593334032|FG007|Overall Study|Withdrawal by Subject|0|||
164263766|NCT01643850|593334033|FG008|Overall Study|Withdrawal by Subject|0|||
164263767|NCT01643850|593334025|FG000|Overall Study|Lost to Follow-up|0|||
164263768|NCT01643850|593334026|FG001|Overall Study|Lost to Follow-up|0|||
164263769|NCT01643850|593334027|FG002|Overall Study|Lost to Follow-up|0|||
164263770|NCT01643850|593334028|FG003|Overall Study|Lost to Follow-up|0|||
164263771|NCT01643850|593334029|FG004|Overall Study|Lost to Follow-up|0|||
164263772|NCT01643850|593334030|FG005|Overall Study|Lost to Follow-up|0|||
164263773|NCT01643850|593334031|FG006|Overall Study|Lost to Follow-up|1|||
164263774|NCT01643850|593334032|FG007|Overall Study|Lost to Follow-up|0|||
164263775|NCT01643850|593334033|FG008|Overall Study|Lost to Follow-up|1|||
164263776|NCT01643850|593334025|FG000|Overall Study|Adverse Event|0|||
164263777|NCT01643850|593334026|FG001|Overall Study|Adverse Event|0|||
164263778|NCT01643850|593334027|FG002|Overall Study|Adverse Event|0|||
164263779|NCT01643850|593334028|FG003|Overall Study|Adverse Event|0|||
164263780|NCT01643850|593334029|FG004|Overall Study|Adverse Event|1|||
164263781|NCT01643850|593334030|FG005|Overall Study|Adverse Event|0|||
164263782|NCT01643850|593334031|FG006|Overall Study|Adverse Event|0|||
164263783|NCT01643850|593334032|FG007|Overall Study|Adverse Event|0|||
164341090|NCT02319837|593623877|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
164341091|NCT02319837|593623878|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
164341092|NCT02319837|593623876|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
164341093|NCT02319837|593623877|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
164341094|NCT02319837|593623878|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
164341095|NCT02319837|593623876|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
164341096|NCT02319837|593623877|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
164263784|NCT01643850|593334033|FG008|Overall Study|Adverse Event|0|||
164263785|NCT01643850|593334025|FG000|Overall Study|Administrative Problems|0|||
164341097|NCT02319837|593623878|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
164341098|NCT02319837|593623876|FG000|Long-Term Follow-Up Phase|Death|33|||
164578642|NCT01324830|594484077|FG014|Overall Study|Reason not mentioned above|0|||
164263786|NCT01643850|593334026|FG001|Overall Study|Administrative Problems|0|||
164263787|NCT01643850|593334027|FG002|Overall Study|Administrative Problems|1|||
164263788|NCT01643850|593334028|FG003|Overall Study|Administrative Problems|0|||
164263789|NCT01643850|593334029|FG004|Overall Study|Administrative Problems|1|||
164263790|NCT01643850|593334030|FG005|Overall Study|Administrative Problems|0|||
164263791|NCT01643850|593334031|FG006|Overall Study|Administrative Problems|0|||
164263792|NCT01643850|593334032|FG007|Overall Study|Administrative Problems|0|||
164263793|NCT01643850|593334033|FG008|Overall Study|Administrative Problems|0|||
164263794|NCT01133405|593334034|FG000|Period 1|Withdrawal by Subject|0|||
164263795|NCT01133405|593334035|FG001|Period 1|Withdrawal by Subject|1|||
164263796|NCT01133405|593334036|FG002|Period 1|Withdrawal by Subject|0|||
164263797|NCT01133405|593334037|FG003|Period 1|Withdrawal by Subject|1|||
164263798|NCT01133405|593334038|FG004|Period 1|Withdrawal by Subject|0|||
164263799|NCT01133405|593334039|FG005|Period 1|Withdrawal by Subject|1|||
164263800|NCT01133405|593334040|FG006|Period 1|Withdrawal by Subject|0|||
164263801|NCT01133405|593334041|FG007|Period 1|Withdrawal by Subject|0|||
164263802|NCT01133405|593334042|FG008|Period 1|Withdrawal by Subject|0|||
164263803|NCT01133405|593334043|FG009|Period 1|Withdrawal by Subject|0|||
164263804|NCT01133405|593334034|FG000|Period 1|Physician Decision|0|||
164263805|NCT01133405|593334035|FG001|Period 1|Physician Decision|0|||
164263806|NCT01133405|593334036|FG002|Period 1|Physician Decision|0|||
164263807|NCT01133405|593334037|FG003|Period 1|Physician Decision|1|||
164263808|NCT01133405|593334038|FG004|Period 1|Physician Decision|0|||
164263809|NCT01133405|593334039|FG005|Period 1|Physician Decision|0|||
164263810|NCT01133405|593334040|FG006|Period 1|Physician Decision|0|||
164263811|NCT01133405|593334041|FG007|Period 1|Physician Decision|0|||
164263812|NCT01133405|593334042|FG008|Period 1|Physician Decision|0|||
164263813|NCT01133405|593334043|FG009|Period 1|Physician Decision|0|||
164263814|NCT01133405|593334034|FG000|Period 1|Discontinued after randomization|1|||
164263815|NCT01133405|593334035|FG001|Period 1|Discontinued after randomization|0|||
164263816|NCT01133405|593334036|FG002|Period 1|Discontinued after randomization|0|||
164263817|NCT01133405|593334037|FG003|Period 1|Discontinued after randomization|0|||
164263818|NCT01133405|593334038|FG004|Period 1|Discontinued after randomization|0|||
164263819|NCT01133405|593334039|FG005|Period 1|Discontinued after randomization|0|||
164263820|NCT01133405|593334040|FG006|Period 1|Discontinued after randomization|1|||
164263821|NCT01133405|593334041|FG007|Period 1|Discontinued after randomization|0|||
164263822|NCT01133405|593334042|FG008|Period 1|Discontinued after randomization|0|||
164263823|NCT01133405|593334043|FG009|Period 1|Discontinued after randomization|0|||
164263824|NCT01133405|593334034|FG000|Period 1|Received drug only in period 2|0|||
164263825|NCT01133405|593334035|FG001|Period 1|Received drug only in period 2|1|||
164263826|NCT01133405|593334036|FG002|Period 1|Received drug only in period 2|0|||
164263827|NCT01133405|593334037|FG003|Period 1|Received drug only in period 2|2|||
164263828|NCT01133405|593334038|FG004|Period 1|Received drug only in period 2|0|||
164263829|NCT01133405|593334039|FG005|Period 1|Received drug only in period 2|1|||
164263830|NCT01133405|593334040|FG006|Period 1|Received drug only in period 2|0|||
164263831|NCT01133405|593334041|FG007|Period 1|Received drug only in period 2|0|||
164263832|NCT01133405|593334042|FG008|Period 1|Received drug only in period 2|0|||
164263833|NCT01133405|593334043|FG009|Period 1|Received drug only in period 2|0|||
164263834|NCT01133405|593334034|FG000|Period 1|Received drug only in period 3|0|||
164263835|NCT01133405|593334035|FG001|Period 1|Received drug only in period 3|1|||
164263836|NCT01133405|593334036|FG002|Period 1|Received drug only in period 3|1|||
164263837|NCT01133405|593334037|FG003|Period 1|Received drug only in period 3|0|||
164263838|NCT01133405|593334038|FG004|Period 1|Received drug only in period 3|0|||
164263839|NCT01133405|593334039|FG005|Period 1|Received drug only in period 3|0|||
164263840|NCT01133405|593334040|FG006|Period 1|Received drug only in period 3|0|||
164263841|NCT01133405|593334041|FG007|Period 1|Received drug only in period 3|0|||
164263842|NCT01133405|593334042|FG008|Period 1|Received drug only in period 3|0|||
164263843|NCT01133405|593334043|FG009|Period 1|Received drug only in period 3|0|||
164263844|NCT01133405|593334034|FG000|Period 2|Adverse Event|0|||
164263845|NCT01133405|593334035|FG001|Period 2|Adverse Event|0|||
164263846|NCT01133405|593334036|FG002|Period 2|Adverse Event|1|||
164263847|NCT01133405|593334037|FG003|Period 2|Adverse Event|0|||
164263848|NCT01133405|593334038|FG004|Period 2|Adverse Event|0|||
164263849|NCT01133405|593334039|FG005|Period 2|Adverse Event|0|||
164263850|NCT01133405|593334040|FG006|Period 2|Adverse Event|0|||
164263851|NCT01133405|593334041|FG007|Period 2|Adverse Event|0|||
164263852|NCT01133405|593334042|FG008|Period 2|Adverse Event|0|||
164263853|NCT01133405|593334043|FG009|Period 2|Adverse Event|0|||
164263854|NCT01133405|593334034|FG000|Period 2|Withdrawal by Subject|0|||
164263855|NCT01133405|593334035|FG001|Period 2|Withdrawal by Subject|0|||
164263856|NCT01133405|593334036|FG002|Period 2|Withdrawal by Subject|0|||
164263857|NCT01133405|593334037|FG003|Period 2|Withdrawal by Subject|1|||
164263858|NCT01133405|593334038|FG004|Period 2|Withdrawal by Subject|0|||
164263859|NCT01133405|593334039|FG005|Period 2|Withdrawal by Subject|1|||
164263860|NCT01133405|593334040|FG006|Period 2|Withdrawal by Subject|0|||
164263861|NCT01133405|593334041|FG007|Period 2|Withdrawal by Subject|0|||
164263862|NCT01133405|593334042|FG008|Period 2|Withdrawal by Subject|0|||
164263863|NCT01133405|593334043|FG009|Period 2|Withdrawal by Subject|0|||
164263864|NCT01133405|593334034|FG000|Period 2|Entry Criteria Not Met|0|||
164263865|NCT01133405|593334035|FG001|Period 2|Entry Criteria Not Met|1|||
164263866|NCT01133405|593334036|FG002|Period 2|Entry Criteria Not Met|0|||
164263867|NCT01133405|593334037|FG003|Period 2|Entry Criteria Not Met|0|||
164263868|NCT01133405|593334038|FG004|Period 2|Entry Criteria Not Met|0|||
164263869|NCT01133405|593334039|FG005|Period 2|Entry Criteria Not Met|0|||
164263870|NCT01133405|593334040|FG006|Period 2|Entry Criteria Not Met|0|||
164263871|NCT01133405|593334041|FG007|Period 2|Entry Criteria Not Met|0|||
164263872|NCT01133405|593334042|FG008|Period 2|Entry Criteria Not Met|0|||
164263873|NCT01133405|593334043|FG009|Period 2|Entry Criteria Not Met|0|||
164263874|NCT01133405|593334034|FG000|Period 2|Physician Decision|0|||
164263875|NCT01133405|593334035|FG001|Period 2|Physician Decision|0|||
164263876|NCT01133405|593334036|FG002|Period 2|Physician Decision|0|||
164263877|NCT01133405|593334037|FG003|Period 2|Physician Decision|0|||
164263878|NCT01133405|593334038|FG004|Period 2|Physician Decision|0|||
164263879|NCT01133405|593334039|FG005|Period 2|Physician Decision|1|||
164263880|NCT01133405|593334040|FG006|Period 2|Physician Decision|0|||
164263881|NCT01133405|593334041|FG007|Period 2|Physician Decision|0|||
164263882|NCT01133405|593334042|FG008|Period 2|Physician Decision|0|||
164263883|NCT01133405|593334043|FG009|Period 2|Physician Decision|0|||
164263884|NCT00867087|593334046|FG000|Overall Study|Other|1|||
164263885|NCT00867087|593334046|FG000|Overall Study|Withdrawal by Subject|4|||
164263886|NCT00867087|593334046|FG000|Overall Study|Death|37|||
164263887|NCT03300024|593334047|FG000|Overall Study|Physician Decision|4|||
164263888|NCT03300024|593334048|FG001|Overall Study|Physician Decision|6|||
164263889|NCT01238835|593334049|FG000|Overall Study|Death|124|||
164263890|NCT01238835|593334049|FG000|Overall Study|Withdrawal by Subject|9|||
164263891|NCT01238835|593334049|FG000|Overall Study|Lost to Follow-up|1|||
164263892|NCT01238835|593334049|FG000|Overall Study|Site early discontinuation|2|||
164263893|NCT02088073|593334050|FG000|Acute Phase|Withdrawal by Subject|5|||
164263894|NCT02088073|593334051|FG001|Acute Phase|Withdrawal by Subject|0|||
164263895|NCT02088073|593334052|FG002|Acute Phase|Withdrawal by Subject|0|||
164263896|NCT02088073|593334053|FG003|Acute Phase|Withdrawal by Subject|0|||
164263897|NCT02088073|593334054|FG004|Acute Phase|Withdrawal by Subject|0|||
164341099|NCT02319837|593623877|FG001|Long-Term Follow-Up Phase|Death|54|||
164341100|NCT02319837|593623878|FG002|Long-Term Follow-Up Phase|Death|42|||
164578643|NCT01324830|594484078|FG015|Overall Study|Reason not mentioned above|0|||
164341101|NCT02435147|593623879|FG000|Overall Study|non-evaluable DXA scan|11|||
164341102|NCT00839852|593623882|FG000|Overall Study|Adverse Event|10|||
164341103|NCT00839852|593623882|FG000|Overall Study|Insufficient Therapeutic Response|3|||
164263898|NCT02088073|593334050|FG000|Acute Phase|Hyperkalemia|2|||
164263899|NCT02088073|593334051|FG001|Acute Phase|Hyperkalemia|0|||
164263900|NCT02088073|593334052|FG002|Acute Phase|Hyperkalemia|0|||
164263901|NCT02088073|593334053|FG003|Acute Phase|Hyperkalemia|0|||
164263902|NCT02088073|593334054|FG004|Acute Phase|Hyperkalemia|0|||
164263903|NCT02088073|593334050|FG000|Maintanance Phase|Withdrawal by Subject|0|||
164263904|NCT02088073|593334051|FG001|Maintanance Phase|Withdrawal by Subject|2|||
164263905|NCT02088073|593334052|FG002|Maintanance Phase|Withdrawal by Subject|0|||
164263906|NCT02088073|593334053|FG003|Maintanance Phase|Withdrawal by Subject|0|||
164263907|NCT02088073|593334054|FG004|Maintanance Phase|Withdrawal by Subject|0|||
164263908|NCT02088073|593334050|FG000|Maintanance Phase|Adverse Event|0|||
164263909|NCT02088073|593334051|FG001|Maintanance Phase|Adverse Event|0|||
164263910|NCT02088073|593334052|FG002|Maintanance Phase|Adverse Event|3|||
164263911|NCT02088073|593334053|FG003|Maintanance Phase|Adverse Event|0|||
164263912|NCT02088073|593334054|FG004|Maintanance Phase|Adverse Event|1|||
164263913|NCT02088073|593334050|FG000|Maintanance Phase|Physician Decision|0|||
164263914|NCT02088073|593334051|FG001|Maintanance Phase|Physician Decision|0|||
164263915|NCT02088073|593334052|FG002|Maintanance Phase|Physician Decision|0|||
164263916|NCT02088073|593334053|FG003|Maintanance Phase|Physician Decision|0|||
164263917|NCT02088073|593334054|FG004|Maintanance Phase|Physician Decision|1|||
164263918|NCT02088073|593334050|FG000|Maintanance Phase|Sponsor's decision|0|||
164263919|NCT02088073|593334051|FG001|Maintanance Phase|Sponsor's decision|2|||
164263920|NCT02088073|593334052|FG002|Maintanance Phase|Sponsor's decision|0|||
164263921|NCT02088073|593334053|FG003|Maintanance Phase|Sponsor's decision|2|||
164263922|NCT02088073|593334054|FG004|Maintanance Phase|Sponsor's decision|1|||
164263923|NCT02088073|593334050|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
164263924|NCT02088073|593334051|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
164263925|NCT02088073|593334052|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
164263926|NCT02088073|593334053|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
164263927|NCT02088073|593334054|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
164263928|NCT02088073|593334050|FG000|Maintanance Phase|Miscellaneous|0|||
164263929|NCT02088073|593334051|FG001|Maintanance Phase|Miscellaneous|2|||
164263930|NCT02088073|593334052|FG002|Maintanance Phase|Miscellaneous|1|||
164263931|NCT02088073|593334053|FG003|Maintanance Phase|Miscellaneous|2|||
164263932|NCT02088073|593334054|FG004|Maintanance Phase|Miscellaneous|1|||
164263933|NCT02088073|593334050|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
164263934|NCT02088073|593334051|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
164263935|NCT02088073|593334052|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
164263936|NCT02088073|593334053|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
164263937|NCT02088073|593334054|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
164263938|NCT02088073|593334050|FG000|Maintanance Phase|Subject compliance|0|||
164263939|NCT02088073|593334051|FG001|Maintanance Phase|Subject compliance|1|||
164263940|NCT02088073|593334052|FG002|Maintanance Phase|Subject compliance|0|||
164341104|NCT00839852|593623882|FG000|Overall Study|Protocol Violation|9|||
164341105|NCT00839852|593623882|FG000|Overall Study|Withdrawal of Consent|16|||
164341106|NCT00839852|593623882|FG000|Overall Study|Lost to Follow-up|7|||
164341107|NCT00839852|593623882|FG000|Overall Study|Lack of Compliance While in Jail|1|||
164341108|NCT00839852|593623882|FG000|Overall Study|Pregnancy|1|||
164341109|NCT03082261|593623883|FG000|Overall Study|Death|4|||
164341110|NCT03082261|593623883|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
164341111|NCT03082261|593623883|FG000|Overall Study|Insurance denial|1|||
164341112|NCT03082261|593623883|FG000|Overall Study|Peripheral lead added|1|||
164341113|NCT03082261|593623883|FG000|Overall Study|Withdrawal by Subject|40|||
164341114|NCT03082261|593623883|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
164341115|NCT03082261|593623883|FG000|Overall Study|Subject implanted with device other than study device|1|||
164341116|NCT03082261|593623883|FG000|Overall Study|Lost to Follow-up|14|||
164341117|NCT03082261|593623883|FG000|Overall Study|Subject moved to a different state|1|||
164341118|NCT03082261|593623883|FG000|Overall Study|Subject non-compliance|2|||
164341119|NCT03082261|593623883|FG000|Overall Study|Subject participation terminated by investigator|9|||
164341120|NCT03082261|593623883|FG000|Overall Study|Subject participation terminated by sponsor|4|||
164341121|NCT03082261|593623883|FG000|Overall Study|System explant|19|||
164341122|NCT03082261|593623883|FG000|Overall Study|Unable to place lead(s)|2|||
164341123|NCT03082261|593623883|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
164341124|NCT01313312|593623887|FG000|Overall Study|Adverse Event|5|||
164430133|NCT03285711|593945302|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
164430134|NCT03285711|593945303|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
164578644|NCT01324830|594484079|FG016|Overall Study|Reason not mentioned above|0|||
164578645|NCT01324830|594484080|FG017|Overall Study|Reason not mentioned above|1|||
164263941|NCT02088073|593334053|FG003|Maintanance Phase|Subject compliance|0|||
164263942|NCT02088073|593334054|FG004|Maintanance Phase|Subject compliance|0|||
164263943|NCT04612842|593334055|FG000|Overall Study|Lost to Follow-up|20|||
164263944|NCT04612842|593334056|FG001|Overall Study|Lost to Follow-up|11|||
164263945|NCT04612842|593334055|FG000|Overall Study|Withdrawal by Subject|26|||
164263946|NCT04612842|593334056|FG001|Overall Study|Withdrawal by Subject|15|||
164341125|NCT01313312|593623887|FG000|Overall Study|Withdrawal by Subject|18|||
164430135|NCT03285711|593945304|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
164430136|NCT03285711|593945305|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
164263947|NCT04612842|593334055|FG000|Overall Study|Death|2|||
164341126|NCT01313312|593623887|FG000|Overall Study|Lack of Efficacy|3|||
164341127|NCT01313312|593623887|FG000|Overall Study|Investigator Decision|1|||
164341128|NCT01313312|593623887|FG000|Overall Study|Observational Phase|1|||
164341129|NCT01313312|593623887|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
164341130|NCT01313312|593623887|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
164341131|NCT01206166|593623895|FG000|Overall Study|No evaluable data|2|||
164341132|NCT01206166|593623896|FG001|Overall Study|No evaluable data|3|||
164341133|NCT02716805|593623897|FG000|Overall Study|Progressive disease|2|||
164341134|NCT02716805|593623898|FG001|Overall Study|Progressive disease|0|||
164341135|NCT02716805|593623899|FG002|Overall Study|Progressive disease|0|||
164341136|NCT02716805|593623900|FG003|Overall Study|Progressive disease|0|||
164341137|NCT00066365|593623901|FG000|Overall Study|Adverse Event|1|||
164341138|NCT00066365|593623902|FG001|Overall Study|Adverse Event|0|||
164341139|NCT00066365|593623901|FG000|Overall Study|Lack of Efficacy|15|||
164341140|NCT00066365|593623902|FG001|Overall Study|Lack of Efficacy|12|||
164341141|NCT00066365|593623901|FG000|Overall Study|Physician Decision|1|||
164341142|NCT00066365|593623902|FG001|Overall Study|Physician Decision|0|||
164341143|NCT00066365|593623901|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
164341144|NCT00066365|593623902|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
164341145|NCT00066365|593623901|FG000|Overall Study|Ineligible|4|||
164341146|NCT00066365|593623902|FG001|Overall Study|Ineligible|2|||
164341147|NCT00467857|593623905|FG000|Overall Study|Adverse Event|1|||
164341148|NCT00467857|593623906|FG001|Overall Study|Adverse Event|0|||
164341149|NCT00467857|593623905|FG000|Overall Study|Withdrew consent|2|||
164341150|NCT00467857|593623906|FG001|Overall Study|Withdrew consent|0|||
164341151|NCT00467857|593623905|FG000|Overall Study|Death|0|||
164341152|NCT00467857|593623906|FG001|Overall Study|Death|1|||
164341153|NCT00467857|593623905|FG000|Overall Study|Discharged from court service|0|||
164341154|NCT00467857|593623906|FG001|Overall Study|Discharged from court service|1|||
164341155|NCT00467857|593623905|FG000|Overall Study|Emergency care required|0|||
164341156|NCT00467857|593623906|FG001|Overall Study|Emergency care required|1|||
164341157|NCT00467857|593623905|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
164341158|NCT00467857|593623906|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
164341159|NCT00467857|593623905|FG000|Overall Study|Discontinuation reason missing|0|||
164341160|NCT00467857|593623906|FG001|Overall Study|Discontinuation reason missing|3|||
164341161|NCT03576495|593623908|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
164341162|NCT03576495|593623909|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
164341163|NCT05306977|593623911|FG000|Overall Study|Withdrawal by Subject|1|||
164341164|NCT02628938|593623912|FG000|Overall Study|Did not attend the follow up recall|2|||
164341165|NCT02628938|593623913|FG001|Overall Study|Did not attend the follow up recall|2|||
164578646|NCT01324830|594484081|FG018|Overall Study|Reason not mentioned above|0|||
164578647|NCT01324830|594484063|FG000|Overall Study|Adverse Event, serious fatal|0|||
164578648|NCT01324830|594484064|FG001|Overall Study|Adverse Event, serious fatal|1|||
164578649|NCT01324830|594484065|FG002|Overall Study|Adverse Event, serious fatal|0|||
164578650|NCT01324830|594484066|FG003|Overall Study|Adverse Event, serious fatal|0|||
164578651|NCT01324830|594484067|FG004|Overall Study|Adverse Event, serious fatal|0|||
164578652|NCT01324830|594484068|FG005|Overall Study|Adverse Event, serious fatal|0|||
164578653|NCT01324830|594484069|FG006|Overall Study|Adverse Event, serious fatal|0|||
164578654|NCT01324830|594484070|FG007|Overall Study|Adverse Event, serious fatal|0|||
164578655|NCT01324830|594484071|FG008|Overall Study|Adverse Event, serious fatal|0|||
164578656|NCT01324830|594484072|FG009|Overall Study|Adverse Event, serious fatal|0|||
164578657|NCT01324830|594484073|FG010|Overall Study|Adverse Event, serious fatal|0|||
164578658|NCT01324830|594484074|FG011|Overall Study|Adverse Event, serious fatal|0|||
164578659|NCT01324830|594484075|FG012|Overall Study|Adverse Event, serious fatal|0|||
164578660|NCT01324830|594484076|FG013|Overall Study|Adverse Event, serious fatal|0|||
164578661|NCT01324830|594484077|FG014|Overall Study|Adverse Event, serious fatal|0|||
164578662|NCT01324830|594484078|FG015|Overall Study|Adverse Event, serious fatal|0|||
164578663|NCT01324830|594484079|FG016|Overall Study|Adverse Event, serious fatal|0|||
164578664|NCT01324830|594484080|FG017|Overall Study|Adverse Event, serious fatal|0|||
164578665|NCT01324830|594484081|FG018|Overall Study|Adverse Event, serious fatal|0|||
164578666|NCT01324830|594484063|FG000|Overall Study|Adverse Event, non-fatal|0|||
164578667|NCT01324830|594484064|FG001|Overall Study|Adverse Event, non-fatal|0|||
164578668|NCT01324830|594484065|FG002|Overall Study|Adverse Event, non-fatal|0|||
164578669|NCT01324830|594484066|FG003|Overall Study|Adverse Event, non-fatal|0|||
164578670|NCT01324830|594484067|FG004|Overall Study|Adverse Event, non-fatal|0|||
164578671|NCT01324830|594484068|FG005|Overall Study|Adverse Event, non-fatal|0|||
164578672|NCT01324830|594484069|FG006|Overall Study|Adverse Event, non-fatal|0|||
164578673|NCT01324830|594484070|FG007|Overall Study|Adverse Event, non-fatal|0|||
164578674|NCT01324830|594484071|FG008|Overall Study|Adverse Event, non-fatal|2|||
164578675|NCT01324830|594484072|FG009|Overall Study|Adverse Event, non-fatal|0|||
164578676|NCT01324830|594484073|FG010|Overall Study|Adverse Event, non-fatal|1|||
164578677|NCT01324830|594484074|FG011|Overall Study|Adverse Event, non-fatal|0|||
164578678|NCT01324830|594484075|FG012|Overall Study|Adverse Event, non-fatal|0|||
164578679|NCT01324830|594484076|FG013|Overall Study|Adverse Event, non-fatal|0|||
164263948|NCT04612842|593334056|FG001|Overall Study|Death|2|||
164263949|NCT02419131|593334057|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
164263950|NCT02419131|593334058|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
164263951|NCT02419131|593334059|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
164263952|NCT02419131|593334057|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
164263953|NCT02419131|593334058|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
164263954|NCT02419131|593334059|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
164263955|NCT03060512|593334060|FG000|Overall Study|Adverse Event|4|||
164263956|NCT03060512|593334061|FG001|Overall Study|Adverse Event|6|||
164263957|NCT03060512|593334060|FG000|Overall Study|Lost to Follow-up|1|||
164263958|NCT03060512|593334061|FG001|Overall Study|Lost to Follow-up|1|||
164263959|NCT03060512|593334060|FG000|Overall Study|Withdrawal by Subject|1|||
164263960|NCT03060512|593334061|FG001|Overall Study|Withdrawal by Subject|0|||
164263961|NCT03060512|593334060|FG000|Overall Study|Non-compliance with study medication|1|||
164263962|NCT03060512|593334061|FG001|Overall Study|Non-compliance with study medication|2|||
164263963|NCT03444766|593334065|FG000|Overall Study|Other Reasons|2|||
164263964|NCT03444766|593334065|FG000|Overall Study|Participant Withdrew Consent|5|||
164263965|NCT03444766|593334065|FG000|Overall Study|Lost to Follow-up|2|||
164263966|NCT03444766|593334065|FG000|Overall Study|Death|2|||
164263967|NCT03444766|593334065|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
164263968|NCT03444766|593334065|FG000|Overall Study|Disease Progression|49|||
164263969|NCT02969590|593334069|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
164263970|NCT02969590|593334070|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
164263971|NCT02969590|593334071|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
164263972|NCT03421743|593334072|FG000|Overall Study|Lack of Efficacy|1|||
164263973|NCT03421743|593334073|FG001|Overall Study|Lack of Efficacy|0|||
164263974|NCT03421743|593334072|FG000|Overall Study|Adverse Event|2|||
164263975|NCT03421743|593334073|FG001|Overall Study|Adverse Event|1|||
164263976|NCT03421743|593334072|FG000|Overall Study|Withdrawal by Subject|0|||
164263977|NCT03421743|593334073|FG001|Overall Study|Withdrawal by Subject|1|||
164263978|NCT02680574|593334080|FG000|Overall Study|Death|137|||
164263979|NCT02680574|593334081|FG001|Overall Study|Death|137|||
164263980|NCT02680574|593334080|FG000|Overall Study|Withdrawal by Subject|17|||
164263981|NCT02680574|593334081|FG001|Overall Study|Withdrawal by Subject|9|||
164263982|NCT02680574|593334080|FG000|Overall Study|Lost to Follow-up|4|||
164263983|NCT02680574|593334081|FG001|Overall Study|Lost to Follow-up|6|||
164263984|NCT02387164|593334084|FG000|Overall Study|Lost to Follow-up|2|||
164263985|NCT02387164|593334085|FG001|Overall Study|Lost to Follow-up|0|||
164263986|NCT02387164|593334084|FG000|Overall Study|Diagnosed|1|||
164263987|NCT02387164|593334085|FG001|Overall Study|Diagnosed|2|||
164263988|NCT02370641|593334086|FG000|Overall Study|dropped study|4|||
164263989|NCT02370641|593334087|FG001|Overall Study|dropped study|2|||
164263990|NCT01036529|593334090|FG000|Overall Study|Adverse Event|0|||
164263991|NCT01036529|593334091|FG001|Overall Study|Adverse Event|1|||
164263992|NCT01036529|593334090|FG000|Overall Study|Lost to Follow-up|0|||
164263993|NCT01036529|593334091|FG001|Overall Study|Lost to Follow-up|1|||
164263994|NCT01036529|593334090|FG000|Overall Study|Physician Decision|1|||
164263995|NCT01036529|593334091|FG001|Overall Study|Physician Decision|0|||
164263996|NCT01036529|593334090|FG000|Overall Study|Withdrawal by Subject|1|||
164263997|NCT01036529|593334091|FG001|Overall Study|Withdrawal by Subject|1|||
164263998|NCT01036529|593334090|FG000|Overall Study|Sponsor study termination|11|||
164263999|NCT01036529|593334091|FG001|Overall Study|Sponsor study termination|12|||
164264000|NCT01719003|593334092|FG000|Overall Study|Non compliant with protocol|1|||
164264001|NCT01719003|593334093|FG001|Overall Study|Non compliant with protocol|1|||
164264002|NCT01719003|593334094|FG002|Overall Study|Non compliant with protocol|0|||
164264003|NCT01719003|593334095|FG003|Overall Study|Non compliant with protocol|1|||
164264004|NCT01719003|593334096|FG004|Overall Study|Non compliant with protocol|2|||
164264005|NCT01719003|593334097|FG005|Overall Study|Non compliant with protocol|1|||
164264006|NCT01719003|593334098|FG006|Overall Study|Non compliant with protocol|2|||
164264007|NCT01719003|593334099|FG007|Overall Study|Non compliant with protocol|3|||
164264008|NCT01719003|593334100|FG008|Overall Study|Non compliant with protocol|0|||
164532545|NCT01257425|594320600|FG001|Overall Study|Death|0|||
164264009|NCT01719003|593334092|FG000|Overall Study|Adverse Event|6|||
164264010|NCT01719003|593334093|FG001|Overall Study|Adverse Event|5|||
164264011|NCT01719003|593334094|FG002|Overall Study|Adverse Event|4|||
164264012|NCT01719003|593334095|FG003|Overall Study|Adverse Event|3|||
164264013|NCT01719003|593334096|FG004|Overall Study|Adverse Event|4|||
164264014|NCT01719003|593334097|FG005|Overall Study|Adverse Event|3|||
164264015|NCT01719003|593334098|FG006|Overall Study|Adverse Event|6|||
164264016|NCT01719003|593334099|FG007|Overall Study|Adverse Event|5|||
164264017|NCT01719003|593334100|FG008|Overall Study|Adverse Event|0|||
164532546|NCT02656823|594320608|FG000|Overall Study|Adverse Event|3|||
164532547|NCT02656823|594320608|FG000|Overall Study|Lost to Follow-up|2|||
164532548|NCT01910181|594320609|FG000|Overall Study|Death|37|||
164532549|NCT01910181|594320609|FG000|Overall Study|Lost to Follow-up|3|||
164532550|NCT01910181|594320609|FG000|Overall Study|Study Terminated by Sponsor|6|||
164264018|NCT01719003|593334092|FG000|Overall Study|Lost to Follow-up|0|||
164264019|NCT01719003|593334093|FG001|Overall Study|Lost to Follow-up|6|||
164264020|NCT01719003|593334094|FG002|Overall Study|Lost to Follow-up|7|||
164264021|NCT01719003|593334095|FG003|Overall Study|Lost to Follow-up|2|||
164264022|NCT01719003|593334096|FG004|Overall Study|Lost to Follow-up|3|||
164264023|NCT01719003|593334097|FG005|Overall Study|Lost to Follow-up|4|||
164264024|NCT01719003|593334098|FG006|Overall Study|Lost to Follow-up|3|||
164264025|NCT01719003|593334099|FG007|Overall Study|Lost to Follow-up|2|||
164264026|NCT01719003|593334100|FG008|Overall Study|Lost to Follow-up|2|||
164264027|NCT01719003|593334092|FG000|Overall Study|Refusal to continue, not due to AE|2|||
164264028|NCT01719003|593334093|FG001|Overall Study|Refusal to continue, not due to AE|5|||
164264029|NCT01719003|593334094|FG002|Overall Study|Refusal to continue, not due to AE|4|||
164264030|NCT01719003|593334095|FG003|Overall Study|Refusal to continue, not due to AE|4|||
164264031|NCT01719003|593334096|FG004|Overall Study|Refusal to continue, not due to AE|4|||
164264032|NCT01719003|593334097|FG005|Overall Study|Refusal to continue, not due to AE|3|||
164264033|NCT01719003|593334098|FG006|Overall Study|Refusal to continue, not due to AE|8|||
164264034|NCT01719003|593334099|FG007|Overall Study|Refusal to continue, not due to AE|7|||
164264035|NCT01719003|593334100|FG008|Overall Study|Refusal to continue, not due to AE|1|||
164264036|NCT01719003|593334092|FG000|Overall Study|Reason other than those specified|0|||
164264037|NCT01719003|593334093|FG001|Overall Study|Reason other than those specified|0|||
164264038|NCT01719003|593334094|FG002|Overall Study|Reason other than those specified|2|||
164264039|NCT01719003|593334095|FG003|Overall Study|Reason other than those specified|3|||
164264040|NCT01719003|593334096|FG004|Overall Study|Reason other than those specified|4|||
164264041|NCT01719003|593334097|FG005|Overall Study|Reason other than those specified|1|||
164264042|NCT01719003|593334098|FG006|Overall Study|Reason other than those specified|0|||
164264043|NCT01719003|593334099|FG007|Overall Study|Reason other than those specified|3|||
164264044|NCT01719003|593334100|FG008|Overall Study|Reason other than those specified|1|||
164264045|NCT01719003|593334092|FG000|Overall Study|Lack of Efficacy|0|||
164264046|NCT01719003|593334093|FG001|Overall Study|Lack of Efficacy|0|||
164264047|NCT01719003|593334094|FG002|Overall Study|Lack of Efficacy|0|||
164264048|NCT01719003|593334095|FG003|Overall Study|Lack of Efficacy|0|||
164264049|NCT01719003|593334096|FG004|Overall Study|Lack of Efficacy|0|||
164264050|NCT01719003|593334097|FG005|Overall Study|Lack of Efficacy|0|||
164264051|NCT01719003|593334098|FG006|Overall Study|Lack of Efficacy|1|||
164264052|NCT01719003|593334099|FG007|Overall Study|Lack of Efficacy|0|||
164264053|NCT01719003|593334100|FG008|Overall Study|Lack of Efficacy|0|||
164264054|NCT02370095|593334101|FG000|Overall Study|Withdrawal by Subject|0|||
164264055|NCT02370095|593334102|FG001|Overall Study|Withdrawal by Subject|1|||
164264056|NCT00700102|593334103|FG000|Overall Study|Died|394|||
164264057|NCT00700102|593334104|FG001|Overall Study|Died|385|||
164264058|NCT00700102|593334103|FG000|Overall Study|Lost to Follow-up|8|||
164264059|NCT00700102|593334104|FG001|Overall Study|Lost to Follow-up|10|||
164430137|NCT03285711|593945302|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
164430138|NCT03285711|593945303|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
164430139|NCT03285711|593945304|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
164430140|NCT03285711|593945305|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
164430141|NCT03285711|593945302|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
164430142|NCT03285711|593945303|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
164430143|NCT03285711|593945304|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
164430144|NCT03285711|593945305|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
164430145|NCT02431533|593945306|FG000|Overall Study|Withdrawal by Subject|1|||
164430146|NCT02431533|593945307|FG001|Overall Study|Withdrawal by Subject|3|||
164430147|NCT02431533|593945306|FG000|Overall Study|Developed Exclusionary criteria|1|||
164430148|NCT02431533|593945307|FG001|Overall Study|Developed Exclusionary criteria|0|||
164430149|NCT03424239|593945310|FG000|Overall Study|Withdrawal by Subject|2|||
164430150|NCT00770211|593945318|FG000|Overall Study|Lost to Follow-up|1|||
164430151|NCT00770211|593945319|FG001|Overall Study|Lost to Follow-up|0|||
164264060|NCT01667562|593334105|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
164264061|NCT01667562|593334106|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
164430152|NCT00770211|593945318|FG000|Overall Study|Withdrawal by Subject|0|||
164430153|NCT00770211|593945319|FG001|Overall Study|Withdrawal by Subject|2|||
164578680|NCT01324830|594484077|FG014|Overall Study|Adverse Event, non-fatal|0|||
164578681|NCT01324830|594484078|FG015|Overall Study|Adverse Event, non-fatal|0|||
164578682|NCT01324830|594484079|FG016|Overall Study|Adverse Event, non-fatal|0|||
164578683|NCT01324830|594484080|FG017|Overall Study|Adverse Event, non-fatal|1|||
164578684|NCT01324830|594484081|FG018|Overall Study|Adverse Event, non-fatal|0|||
164578685|NCT01324830|594484063|FG000|Overall Study|Withdrawal by Subject|0|||
164264062|NCT01667562|593334105|FG000|Erlotinib Phase|Lost to Follow-up|0|||
164264063|NCT01667562|593334106|FG001|Erlotinib Phase|Lost to Follow-up|1|||
164264064|NCT01667562|593334105|FG000|Erlotinib Phase|Adverse Event|0|||
164264065|NCT01667562|593334106|FG001|Erlotinib Phase|Adverse Event|1|||
164264066|NCT01667562|593334105|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
164264067|NCT01667562|593334106|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
164264068|NCT02525939|593334107|FG000|Overall Study|Lost to Follow-up|27|||
164264069|NCT02525939|593334108|FG001|Overall Study|Lost to Follow-up|24|||
164264070|NCT02525939|593334107|FG000|Overall Study|Physician Decision|0|||
164264071|NCT02525939|593334108|FG001|Overall Study|Physician Decision|1|||
164264072|NCT02525939|593334107|FG000|Overall Study|Withdrawal by Subject|24|||
164264073|NCT02525939|593334108|FG001|Overall Study|Withdrawal by Subject|39|||
164264074|NCT02525939|593334107|FG000|Overall Study|Death|180|||
164264075|NCT02525939|593334108|FG001|Overall Study|Death|179|||
164264076|NCT01028716|593334109|FG000|Overall Study|Physician Decision|1|||
164264077|NCT02130986|593334110|FG000|Overall Study|Withdrawal by Subject|4|||
164264078|NCT02130986|593334111|FG001|Overall Study|Withdrawal by Subject|4|||
164264079|NCT02130986|593334110|FG000|Overall Study|Lost to Follow-up|151|||
164264080|NCT02130986|593334111|FG001|Overall Study|Lost to Follow-up|160|||
164264081|NCT01129882|593334112|FG000|Overall Study|Adverse Event|39|||
164264082|NCT01129882|593334112|FG000|Overall Study|Death|6|||
164264083|NCT01129882|593334112|FG000|Overall Study|Lack of Efficacy|5|||
164264084|NCT01129882|593334112|FG000|Overall Study|Lost to Follow-up|13|||
164264085|NCT01129882|593334112|FG000|Overall Study|Physician Decision|27|||
164264086|NCT01129882|593334112|FG000|Overall Study|Protocol Deviation|3|||
164264087|NCT01129882|593334112|FG000|Overall Study|Withdrawal Criteria Met|19|||
164264088|NCT01129882|593334112|FG000|Overall Study|Trial Termination by Sponsor|6|||
164264089|NCT01129882|593334112|FG000|Overall Study|Withdrawal by Subject|160|||
164264090|NCT01319721|593334115|FG000|Overall Study|Lost to Follow-up|1|||
164264091|NCT01319721|593334116|FG001|Overall Study|Lost to Follow-up|6|||
164264092|NCT02653495|593334117|FG000|Overall Study|Lost to Follow-up|2|||
164264093|NCT02653495|593334118|FG001|Overall Study|Lost to Follow-up|0|||
164264094|NCT02653495|593334117|FG000|Overall Study|Screening Failure|10|||
164264095|NCT02653495|593334118|FG001|Overall Study|Screening Failure|0|||
164264096|NCT02761694|593334122|FG000|Overall Study|Lack of Efficacy|0|||
164264097|NCT02761694|593334123|FG001|Overall Study|Lack of Efficacy|0|||
164264098|NCT02761694|593334124|FG002|Overall Study|Lack of Efficacy|0|||
164264099|NCT02761694|593334125|FG003|Overall Study|Lack of Efficacy|0|||
164264100|NCT02761694|593334126|FG004|Overall Study|Lack of Efficacy|0|||
164264101|NCT02761694|593334127|FG005|Overall Study|Lack of Efficacy|0|||
164264102|NCT02761694|593334128|FG006|Overall Study|Lack of Efficacy|6|||
164264103|NCT02761694|593334129|FG007|Overall Study|Lack of Efficacy|0|||
164264104|NCT02761694|593334130|FG008|Overall Study|Lack of Efficacy|0|||
164264105|NCT02761694|593334131|FG009|Overall Study|Lack of Efficacy|1|||
164264106|NCT02761694|593334132|FG010|Overall Study|Lack of Efficacy|1|||
164264107|NCT02761694|593334133|FG011|Overall Study|Lack of Efficacy|4|||
164264108|NCT02761694|593334122|FG000|Overall Study|Death|0|||
164264109|NCT02761694|593334123|FG001|Overall Study|Death|0|||
164264110|NCT02761694|593334124|FG002|Overall Study|Death|0|||
164264111|NCT02761694|593334125|FG003|Overall Study|Death|0|||
164264112|NCT02761694|593334126|FG004|Overall Study|Death|0|||
164264113|NCT02761694|593334127|FG005|Overall Study|Death|0|||
164264114|NCT02761694|593334128|FG006|Overall Study|Death|2|||
164264115|NCT02761694|593334129|FG007|Overall Study|Death|0|||
164264116|NCT02761694|593334130|FG008|Overall Study|Death|2|||
164264117|NCT02761694|593334131|FG009|Overall Study|Death|2|||
164264118|NCT02761694|593334132|FG010|Overall Study|Death|1|||
164264119|NCT02761694|593334133|FG011|Overall Study|Death|0|||
164264120|NCT02761694|593334122|FG000|Overall Study|Physician Decision|0|||
164264121|NCT02761694|593334123|FG001|Overall Study|Physician Decision|0|||
164264122|NCT02761694|593334124|FG002|Overall Study|Physician Decision|0|||
164264123|NCT02761694|593334125|FG003|Overall Study|Physician Decision|0|||
164264124|NCT02761694|593334126|FG004|Overall Study|Physician Decision|0|||
164264125|NCT02761694|593334127|FG005|Overall Study|Physician Decision|0|||
164341166|NCT02628938|593623914|FG002|Overall Study|Did not attend the follow up recall|1|||
164341167|NCT02628938|593623912|FG000|Overall Study|Failure to comply with the instructions|3|||
164341168|NCT02628938|593623913|FG001|Overall Study|Failure to comply with the instructions|0|||
164341169|NCT02628938|593623914|FG002|Overall Study|Failure to comply with the instructions|3|||
164341170|NCT02058693|593623915|FG000|Phase 1|Withdrawal by Subject|3|||
164341171|NCT02058693|593623916|FG001|Phase 1|Withdrawal by Subject|2|||
164341172|NCT02058693|593623915|FG000|Phase 1|Adverse Event|0|||
164341173|NCT02058693|593623916|FG001|Phase 1|Adverse Event|1|||
164341174|NCT02058693|593623915|FG000|Phase 1|Lack of Efficacy|1|||
164264126|NCT02761694|593334128|FG006|Overall Study|Physician Decision|1|||
164341175|NCT02058693|593623916|FG001|Phase 1|Lack of Efficacy|0|||
164264127|NCT02761694|593334129|FG007|Overall Study|Physician Decision|0|||
164264128|NCT02761694|593334130|FG008|Overall Study|Physician Decision|0|||
164341176|NCT02058693|593623915|FG000|Phase 1|Physician Decision|1|||
164341177|NCT02058693|593623916|FG001|Phase 1|Physician Decision|1|||
164341178|NCT02058693|593623915|FG000|Phase 2|Withdrawal by Subject|0|||
164264129|NCT02761694|593334131|FG009|Overall Study|Physician Decision|0|||
164264130|NCT02761694|593334132|FG010|Overall Study|Physician Decision|0|||
164264131|NCT02761694|593334133|FG011|Overall Study|Physician Decision|0|||
164264132|NCT02761694|593334122|FG000|Overall Study|Withdrawal by Subject|0|||
164264133|NCT02761694|593334123|FG001|Overall Study|Withdrawal by Subject|0|||
164264134|NCT02761694|593334124|FG002|Overall Study|Withdrawal by Subject|0|||
164264135|NCT02761694|593334125|FG003|Overall Study|Withdrawal by Subject|1|||
164264136|NCT02761694|593334126|FG004|Overall Study|Withdrawal by Subject|0|||
164264137|NCT02761694|593334127|FG005|Overall Study|Withdrawal by Subject|0|||
164264138|NCT02761694|593334128|FG006|Overall Study|Withdrawal by Subject|4|||
164264139|NCT02761694|593334129|FG007|Overall Study|Withdrawal by Subject|0|||
164264140|NCT02761694|593334130|FG008|Overall Study|Withdrawal by Subject|2|||
164264141|NCT02761694|593334131|FG009|Overall Study|Withdrawal by Subject|1|||
164264142|NCT02761694|593334132|FG010|Overall Study|Withdrawal by Subject|0|||
164264143|NCT02761694|593334133|FG011|Overall Study|Withdrawal by Subject|0|||
164264144|NCT02761694|593334122|FG000|Overall Study|Lost to Follow-up|0|||
164264145|NCT02761694|593334123|FG001|Overall Study|Lost to Follow-up|0|||
164264146|NCT02761694|593334124|FG002|Overall Study|Lost to Follow-up|0|||
164264147|NCT02761694|593334125|FG003|Overall Study|Lost to Follow-up|0|||
164264148|NCT02761694|593334126|FG004|Overall Study|Lost to Follow-up|0|||
164264149|NCT02761694|593334127|FG005|Overall Study|Lost to Follow-up|0|||
164264150|NCT02761694|593334128|FG006|Overall Study|Lost to Follow-up|1|||
164264151|NCT02761694|593334129|FG007|Overall Study|Lost to Follow-up|0|||
164264152|NCT02761694|593334130|FG008|Overall Study|Lost to Follow-up|0|||
164264153|NCT02761694|593334131|FG009|Overall Study|Lost to Follow-up|0|||
164264154|NCT02761694|593334132|FG010|Overall Study|Lost to Follow-up|0|||
164264155|NCT02761694|593334133|FG011|Overall Study|Lost to Follow-up|1|||
164264156|NCT02761694|593334122|FG000|Overall Study|Adverse Event|0|||
164264157|NCT02761694|593334123|FG001|Overall Study|Adverse Event|0|||
164264158|NCT02761694|593334124|FG002|Overall Study|Adverse Event|0|||
164264159|NCT02761694|593334125|FG003|Overall Study|Adverse Event|0|||
164264160|NCT02761694|593334126|FG004|Overall Study|Adverse Event|0|||
164264161|NCT02761694|593334127|FG005|Overall Study|Adverse Event|0|||
164264162|NCT02761694|593334128|FG006|Overall Study|Adverse Event|1|||
164264163|NCT02761694|593334129|FG007|Overall Study|Adverse Event|0|||
164264164|NCT02761694|593334130|FG008|Overall Study|Adverse Event|1|||
164264165|NCT02761694|593334131|FG009|Overall Study|Adverse Event|0|||
164264166|NCT02761694|593334132|FG010|Overall Study|Adverse Event|0|||
164264167|NCT02761694|593334133|FG011|Overall Study|Adverse Event|1|||
164264168|NCT02761694|593334122|FG000|Overall Study|Other|4|||
164264169|NCT02761694|593334123|FG001|Overall Study|Other|4|||
164264170|NCT02761694|593334124|FG002|Overall Study|Other|1|||
164264171|NCT02761694|593334125|FG003|Overall Study|Other|2|||
164264172|NCT02761694|593334126|FG004|Overall Study|Other|3|||
164264173|NCT02761694|593334127|FG005|Overall Study|Other|3|||
164264174|NCT02761694|593334128|FG006|Overall Study|Other|18|||
164264175|NCT02761694|593334129|FG007|Overall Study|Other|8|||
164264176|NCT02761694|593334130|FG008|Overall Study|Other|0|||
164264177|NCT02761694|593334131|FG009|Overall Study|Other|1|||
164264178|NCT02761694|593334132|FG010|Overall Study|Other|1|||
164264179|NCT02761694|593334133|FG011|Overall Study|Other|0|||
164264180|NCT02395055|593334139|FG000|Overall Study|Withdrawal by Subject|7|||
164264181|NCT02395055|593334140|FG001|Overall Study|Withdrawal by Subject|3|||
164264182|NCT01896271|593334141|FG000|Overall Study|Physician Decision|10|||
164264183|NCT03002623|593334145|FG000|Overall Study|Lost to Follow-up|1|||
164264184|NCT03002623|593334146|FG001|Overall Study|Lost to Follow-up|0|||
164264185|NCT03002623|593334145|FG000|Overall Study|Physician Decision|1|||
164264186|NCT03002623|593334146|FG001|Overall Study|Physician Decision|1|||
164264187|NCT00526110|593334149|FG000|Overall Study|Adverse Event|2|||
164264188|NCT00526110|593334150|FG001|Overall Study|Adverse Event|9|||
164264189|NCT00526110|593334149|FG000|Overall Study|Disease Progression|0|||
164264190|NCT00526110|593334150|FG001|Overall Study|Disease Progression|19|||
164264191|NCT00526110|593334149|FG000|Overall Study|Maximal Response|0|||
164264192|NCT00526110|593334150|FG001|Overall Study|Maximal Response|6|||
164578686|NCT01324830|594484064|FG001|Overall Study|Withdrawal by Subject|0|||
164578687|NCT01324830|594484065|FG002|Overall Study|Withdrawal by Subject|0|||
164578688|NCT01324830|594484066|FG003|Overall Study|Withdrawal by Subject|0|||
164578689|NCT01324830|594484067|FG004|Overall Study|Withdrawal by Subject|0|||
164578690|NCT01324830|594484068|FG005|Overall Study|Withdrawal by Subject|1|||
164578691|NCT01324830|594484069|FG006|Overall Study|Withdrawal by Subject|0|||
164578692|NCT01324830|594484070|FG007|Overall Study|Withdrawal by Subject|0|||
164578693|NCT01324830|594484071|FG008|Overall Study|Withdrawal by Subject|0|||
164578694|NCT01324830|594484072|FG009|Overall Study|Withdrawal by Subject|0|||
164264193|NCT00526110|593334149|FG000|Overall Study|Withdrawal by Subject|0|||
164578695|NCT01324830|594484073|FG010|Overall Study|Withdrawal by Subject|1|||
164578696|NCT01324830|594484074|FG011|Overall Study|Withdrawal by Subject|0|||
164264194|NCT00526110|593334150|FG001|Overall Study|Withdrawal by Subject|2|||
164264195|NCT00526110|593334149|FG000|Overall Study|Poor Tolerance|0|||
164264196|NCT00526110|593334150|FG001|Overall Study|Poor Tolerance|5|||
164264197|NCT00953680|593334151|FG000|Period 1|Withdrawal by Subject|0|||
164578697|NCT01324830|594484075|FG012|Overall Study|Withdrawal by Subject|0|||
164264198|NCT00953680|593334152|FG001|Period 1|Withdrawal by Subject|1|||
164264199|NCT03762616|593334154|FG000|Overall Study|Protocol Violation|2|||
164264200|NCT00758589|593336404|FG000|Overall Study|Adverse Event|3|||
164264201|NCT00758589|593336405|FG001|Overall Study|Adverse Event|2|||
164264202|NCT00758589|593336406|FG002|Overall Study|Adverse Event|5|||
164264203|NCT00758589|593336407|FG003|Overall Study|Adverse Event|4|||
164264204|NCT00758589|593336404|FG000|Overall Study|Withdrawal by Subject|0|||
164578698|NCT01324830|594484076|FG013|Overall Study|Withdrawal by Subject|0|||
164264205|NCT00758589|593336405|FG001|Overall Study|Withdrawal by Subject|1|||
164264206|NCT00758589|593336406|FG002|Overall Study|Withdrawal by Subject|1|||
164264207|NCT00758589|593336407|FG003|Overall Study|Withdrawal by Subject|1|||
164264208|NCT00758589|593336404|FG000|Overall Study|Palm stopped to work|0|||
164264209|NCT00758589|593336405|FG001|Overall Study|Palm stopped to work|0|||
164264210|NCT00758589|593336406|FG002|Overall Study|Palm stopped to work|0|||
164264211|NCT00758589|593336407|FG003|Overall Study|Palm stopped to work|1|||
164264212|NCT00583791|593336409|FG000|Overall Study|Other|67|||
164264213|NCT00583791|593336409|FG000|Overall Study|Death|6|||
164264214|NCT00203021|593336410|FG000|Overall Study|Death|4|||
164264215|NCT00203021|593336411|FG001|Overall Study|Death|1|||
164264216|NCT00203021|593336410|FG000|Overall Study|Adverse Event|10|||
164264217|NCT00203021|593336411|FG001|Overall Study|Adverse Event|5|||
164264218|NCT00203021|593336410|FG000|Overall Study|Withdrawal by Subject|45|||
164264219|NCT00203021|593336411|FG001|Overall Study|Withdrawal by Subject|48|||
164264220|NCT00203021|593336410|FG000|Overall Study|Lost to Follow-up|9|||
164264221|NCT00203021|593336411|FG001|Overall Study|Lost to Follow-up|7|||
164264222|NCT00203021|593336410|FG000|Overall Study|Other than specified|11|||
164264223|NCT00203021|593336411|FG001|Overall Study|Other than specified|16|||
164264224|NCT03204890|593336416|FG000|Overall Study|Withdrawal by Subject|1|||
164264225|NCT04524455|593336429|FG000|Overall Study|Death|3|||
164264226|NCT04524455|593336430|FG001|Overall Study|Death|3|||
164264227|NCT04524455|593336429|FG000|Overall Study|Decision by Sponsor|0|||
164264228|NCT04524455|593336430|FG001|Overall Study|Decision by Sponsor|2|||
164264229|NCT04524455|593336429|FG000|Overall Study|Withdrawal of Consent From Study|1|||
164264230|NCT04524455|593336430|FG001|Overall Study|Withdrawal of Consent From Study|0|||
164264231|NCT04524455|593336429|FG000|Overall Study|Lost to Follow-up|0|||
164264232|NCT04524455|593336430|FG001|Overall Study|Lost to Follow-up|1|||
164264233|NCT01688739|593336431|FG000|Overall Study|Administrative Decision|1|||
164264234|NCT01688739|593336432|FG001|Overall Study|Administrative Decision|0|||
164264235|NCT01688739|593336433|FG002|Overall Study|Administrative Decision|0|||
164264236|NCT01688739|593336434|FG003|Overall Study|Administrative Decision|0|||
164264237|NCT01688739|593336435|FG004|Overall Study|Administrative Decision|0|||
164264238|NCT01688739|593336436|FG005|Overall Study|Administrative Decision|0|||
164264239|NCT01688739|593336437|FG006|Overall Study|Administrative Decision|0|||
164264240|NCT01688739|593336438|FG007|Overall Study|Administrative Decision|0|||
164264241|NCT01688739|593336439|FG008|Overall Study|Administrative Decision|0|||
164264242|NCT01688739|593336440|FG009|Overall Study|Administrative Decision|0|||
164264243|NCT00490776|593336443|FG000|Overall Study|Withdrawal by Subject|1|||
164264244|NCT00490776|593336443|FG000|Overall Study|Administrative Problems|1|||
164264245|NCT00490776|593336443|FG000|Overall Study|Death|1|||
164264246|NCT00490776|593336443|FG000|Overall Study|New Cancer Therapy|1|||
164264247|NCT00490776|593336443|FG000|Overall Study|Disease Progression|5|||
164264248|NCT03383783|593336444|FG000|Overall Study|Withdrawal by Subject|2|||
164264249|NCT01340937|593336452|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
164264250|NCT01340937|593336453|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
164264251|NCT01340937|593336454|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
164264252|NCT01340937|593336455|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
164264253|NCT01340937|593336452|FG000|Period 1: Infant Series|Adverse Event|0|||
164264254|NCT01340937|593336453|FG001|Period 1: Infant Series|Adverse Event|1|||
164264255|NCT01340937|593336454|FG002|Period 1: Infant Series|Adverse Event|4|||
164683173|NCT01139762|594861532|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
164683174|NCT01139762|594861530|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
164683175|NCT01139762|594861531|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
164683176|NCT01139762|594861532|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
164683177|NCT01139762|594861530|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
164683178|NCT01139762|594861531|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
164683179|NCT01139762|594861532|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
164683180|NCT01139762|594861530|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
164683181|NCT01139762|594861531|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
164683182|NCT01139762|594861532|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
164683183|NCT01139762|594861530|FG000|Double-Blind Randomized Active Treatment|Death|0|||
164683184|NCT01139762|594861531|FG001|Double-Blind Randomized Active Treatment|Death|1|||
164264256|NCT01340937|593336455|FG003|Period 1: Infant Series|Adverse Event|0|||
164264257|NCT01340937|593336452|FG000|Period 1: Infant Series|Death|2|||
164264258|NCT01340937|593336453|FG001|Period 1: Infant Series|Death|0|||
164264259|NCT01340937|593336454|FG002|Period 1: Infant Series|Death|2|||
164264260|NCT01340937|593336455|FG003|Period 1: Infant Series|Death|0|||
164264261|NCT01340937|593336452|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
164683185|NCT01139762|594861532|FG002|Double-Blind Randomized Active Treatment|Death|1|||
164264262|NCT01340937|593336453|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
164264263|NCT01340937|593336454|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
164264264|NCT01340937|593336455|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
164264265|NCT01340937|593336452|FG000|Period 1: Infant Series|Physician Decision|2|||
164264266|NCT01340937|593336453|FG001|Period 1: Infant Series|Physician Decision|3|||
164264267|NCT01340937|593336454|FG002|Period 1: Infant Series|Physician Decision|1|||
164264268|NCT01340937|593336455|FG003|Period 1: Infant Series|Physician Decision|0|||
164264269|NCT01340937|593336452|FG000|Period 1: Infant Series|Protocol Violation|1|||
164264270|NCT01340937|593336453|FG001|Period 1: Infant Series|Protocol Violation|4|||
164264271|NCT01340937|593336454|FG002|Period 1: Infant Series|Protocol Violation|4|||
164264272|NCT01340937|593336455|FG003|Period 1: Infant Series|Protocol Violation|3|||
164264273|NCT01340937|593336452|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
164264274|NCT01340937|593336453|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
164264275|NCT01340937|593336454|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
164264276|NCT01340937|593336455|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
164264277|NCT01340937|593336452|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
164264278|NCT01340937|593336453|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
164264279|NCT01340937|593336454|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
164264280|NCT01340937|593336455|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
164264281|NCT01340937|593336452|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
164264282|NCT01340937|593336453|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
164264283|NCT01340937|593336454|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
164264284|NCT01340937|593336455|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
164264285|NCT01340937|593336452|FG000|Period 2: Interim Period|Adverse Event|1|||
164264286|NCT01340937|593336453|FG001|Period 2: Interim Period|Adverse Event|0|||
164264287|NCT01340937|593336454|FG002|Period 2: Interim Period|Adverse Event|1|||
164264288|NCT01340937|593336455|FG003|Period 2: Interim Period|Adverse Event|0|||
164264289|NCT01340937|593336452|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
164264290|NCT01340937|593336453|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
164264291|NCT01340937|593336454|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
164264292|NCT01340937|593336455|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
164264293|NCT01340937|593336452|FG000|Period 2: Interim Period|Physician Decision|0|||
164264294|NCT01340937|593336453|FG001|Period 2: Interim Period|Physician Decision|1|||
164264295|NCT01340937|593336454|FG002|Period 2: Interim Period|Physician Decision|1|||
164264296|NCT01340937|593336455|FG003|Period 2: Interim Period|Physician Decision|0|||
164264297|NCT01340937|593336452|FG000|Period 2: Interim Period|Protocol Violation|5|||
164264298|NCT01340937|593336453|FG001|Period 2: Interim Period|Protocol Violation|3|||
164264299|NCT01340937|593336454|FG002|Period 2: Interim Period|Protocol Violation|6|||
164264300|NCT01340937|593336455|FG003|Period 2: Interim Period|Protocol Violation|3|||
164264301|NCT01340937|593336452|FG000|Period 2: Interim Period|Technical problems|4|||
164264302|NCT01340937|593336453|FG001|Period 2: Interim Period|Technical problems|4|||
164264303|NCT01340937|593336454|FG002|Period 2: Interim Period|Technical problems|6|||
164264304|NCT01340937|593336455|FG003|Period 2: Interim Period|Technical problems|3|||
164264305|NCT01340937|593336452|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
164264306|NCT01340937|593336453|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
164264307|NCT01340937|593336454|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
164264308|NCT01340937|593336455|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
164264309|NCT01340937|593336452|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
164264310|NCT01340937|593336453|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
164264311|NCT01340937|593336454|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
164264312|NCT01340937|593336455|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
164264313|NCT01340937|593336452|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
164264314|NCT01340937|593336453|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
164264315|NCT01340937|593336454|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
164264316|NCT01340937|593336455|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
164264317|NCT01340937|593336452|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
164264318|NCT01340937|593336453|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
164264319|NCT01340937|593336454|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
164264320|NCT01340937|593336455|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
164264321|NCT00046930|593336456|FG000|Overall Study|Ineligible|12|||
164341179|NCT02058693|593623916|FG001|Phase 2|Withdrawal by Subject|2|||
164341180|NCT03855228|593623918|FG000|Overall Study|Adverse Event|2|||
164341181|NCT03855228|593623919|FG001|Overall Study|Adverse Event|4|||
164341182|NCT03855228|593623920|FG002|Overall Study|Adverse Event|4|||
164341183|NCT03855228|593623921|FG003|Overall Study|Adverse Event|8|||
164341184|NCT03855228|593623918|FG000|Overall Study|Treatment Failure|1|||
164264322|NCT00046930|593336457|FG001|Overall Study|Ineligible|4|||
164430154|NCT01446003|593945320|FG000|Period 1|Protocol Violation|2|||
164264323|NCT00440310|593336458|FG000|Overall Study|Lost to Follow-up|4|||
164264324|NCT00440310|593336459|FG001|Overall Study|Lost to Follow-up|5|||
164264325|NCT00440310|593336458|FG000|Overall Study|Protocol Violation|0|||
164264326|NCT00440310|593336459|FG001|Overall Study|Protocol Violation|1|||
164264327|NCT00440310|593336458|FG000|Overall Study|Withdrawal by Subject|15|||
164341185|NCT03855228|593623919|FG001|Overall Study|Treatment Failure|2|||
164341186|NCT03855228|593623920|FG002|Overall Study|Treatment Failure|1|||
164341187|NCT03855228|593623921|FG003|Overall Study|Treatment Failure|8|||
164264328|NCT00440310|593336459|FG001|Overall Study|Withdrawal by Subject|14|||
164264329|NCT00440310|593336458|FG000|Overall Study|No Reply at EOS|7|||
164264330|NCT00440310|593336459|FG001|Overall Study|No Reply at EOS|7|||
164264331|NCT00440310|593336458|FG000|Overall Study|Other|1|||
164264332|NCT00440310|593336459|FG001|Overall Study|Other|0|||
164264333|NCT00440310|593336458|FG000|Overall Study|Status Unknown|1|||
164264334|NCT00440310|593336459|FG001|Overall Study|Status Unknown|3|||
164264335|NCT01657760|593336462|FG000|Overall Study|Withdrawal by Subject|0|||
164264336|NCT01657760|593336463|FG001|Overall Study|Withdrawal by Subject|0|||
164264337|NCT01657760|593336464|FG002|Overall Study|Withdrawal by Subject|0|||
164264338|NCT01657760|593336465|FG003|Overall Study|Withdrawal by Subject|1|||
164264339|NCT01657760|593336462|FG000|Overall Study|Physician Decision|1|||
164264340|NCT01657760|593336463|FG001|Overall Study|Physician Decision|1|||
164264341|NCT01657760|593336464|FG002|Overall Study|Physician Decision|1|||
164341188|NCT03855228|593623918|FG000|Overall Study|Lost to Follow-up|0|||
164341189|NCT03855228|593623919|FG001|Overall Study|Lost to Follow-up|0|||
164341190|NCT03855228|593623920|FG002|Overall Study|Lost to Follow-up|0|||
164341191|NCT03855228|593623921|FG003|Overall Study|Lost to Follow-up|1|||
164341192|NCT03855228|593623918|FG000|Overall Study|Protocol Violation|0|||
164341193|NCT03855228|593623919|FG001|Overall Study|Protocol Violation|1|||
164264342|NCT01657760|593336465|FG003|Overall Study|Physician Decision|2|||
164341194|NCT03855228|593623920|FG002|Overall Study|Protocol Violation|2|||
164341195|NCT03855228|593623921|FG003|Overall Study|Protocol Violation|1|||
164341196|NCT03855228|593623918|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
164264343|NCT02469415|593336466|FG000|Overall Study|Withdrawal by Subject|1|||
164264344|NCT02469415|593336466|FG000|Overall Study|Investigational agent placed on hold|2|||
164264345|NCT02119156|593336467|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
164264346|NCT02119156|593336468|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
164264347|NCT02119156|593336469|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
164264348|NCT02119156|593336467|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
164264349|NCT02119156|593336468|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
164264350|NCT02119156|593336469|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
164264351|NCT02119156|593336467|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
164264352|NCT02119156|593336468|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
164264353|NCT02119156|593336469|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
164264354|NCT02119156|593336467|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
164264355|NCT02119156|593336468|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
164264356|NCT02119156|593336469|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
164264357|NCT02119156|593336467|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
164264358|NCT02119156|593336468|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
164264359|NCT02119156|593336469|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
164264360|NCT00940485|593336477|FG000|Overall Study|HBeAb positive at Baseline|3|||
164264361|NCT00940485|593336478|FG001|Overall Study|HBeAb positive at Baseline|2|||
164264362|NCT00940485|593336477|FG000|Overall Study|Lost to Follow-up|2|||
164264363|NCT00940485|593336478|FG001|Overall Study|Lost to Follow-up|3|||
164264364|NCT00940485|593336477|FG000|Overall Study|Adverse Event|8|||
164264365|NCT00940485|593336478|FG001|Overall Study|Adverse Event|0|||
164264366|NCT00940485|593336477|FG000|Overall Study|Withdrawal by Subject|1|||
164264367|NCT00940485|593336478|FG001|Overall Study|Withdrawal by Subject|1|||
164264368|NCT00940485|593336477|FG000|Overall Study|Others|1|||
164264369|NCT00940485|593336478|FG001|Overall Study|Others|1|||
164264370|NCT01113580|593336479|FG000|Overall Study|Protocol Violation|1|||
164264371|NCT01113580|593336480|FG001|Overall Study|Protocol Violation|0|||
164264372|NCT04599166|593336492|FG000|Overall Study|Technological failure connecting to study app|80|||
164264373|NCT01974752|593336493|FG000|Overall Study|Death|33|||
164264374|NCT01974752|593336494|FG001|Overall Study|Death|11|||
164264375|NCT01974752|593336493|FG000|Overall Study|Lost to Follow-up|2|||
164264376|NCT01974752|593336494|FG001|Overall Study|Lost to Follow-up|0|||
164264377|NCT01974752|593336493|FG000|Overall Study|Withdrawal by Subject|2|||
164264378|NCT01974752|593336494|FG001|Overall Study|Withdrawal by Subject|3|||
164264379|NCT01974752|593336493|FG000|Overall Study|Other Eligibility Criteria|0|||
164264380|NCT01974752|593336494|FG001|Overall Study|Other Eligibility Criteria|1|||
164683186|NCT01139762|594861530|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
164683187|NCT01139762|594861531|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
164683188|NCT01139762|594861532|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
164683189|NCT01139762|594861530|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
164683190|NCT01139762|594861531|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
164683191|NCT01139762|594861532|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
164683192|NCT01139762|594861530|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
164683193|NCT01139762|594861531|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
164683194|NCT01139762|594861532|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
164683195|NCT01139762|594861530|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
164683196|NCT01139762|594861531|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
164683197|NCT01139762|594861532|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
164683198|NCT01139762|594861530|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
164683199|NCT01139762|594861531|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
164683200|NCT01139762|594861532|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
164683201|NCT01139762|594861530|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
164683202|NCT01139762|594861531|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
164683203|NCT01139762|594861532|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
164683204|NCT01139762|594861530|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
164683205|NCT01139762|594861531|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
164683206|NCT01139762|594861532|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
164683207|NCT01018862|594861539|FG000|Overall Study|Adverse Event|2|||
164264381|NCT02317809|593336495|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
164264382|NCT02317809|593336496|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
164264383|NCT02317809|593336495|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
164264384|NCT02317809|593336496|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
164341197|NCT03855228|593623919|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
164264385|NCT02435680|593336497|FG000|Overall Study|Physician Decision|3|||
164683208|NCT01018862|594861540|FG001|Overall Study|Adverse Event|0|||
164430155|NCT01446003|593945321|FG001|Period 1|Protocol Violation|0|||
164430156|NCT01446003|593945320|FG000|Period 2|Adverse Event|1|||
164264386|NCT02435680|593336498|FG001|Overall Study|Physician Decision|0|||
164264387|NCT02435680|593336499|FG002|Overall Study|Physician Decision|0|||
164264388|NCT02435680|593336497|FG000|Overall Study|subject / guardian decision|0|||
164264389|NCT02435680|593336498|FG001|Overall Study|subject / guardian decision|3|||
164264390|NCT02435680|593336499|FG002|Overall Study|subject / guardian decision|2|||
164264391|NCT02435680|593336497|FG000|Overall Study|Adverse Event|8|||
164264392|NCT02435680|593336498|FG001|Overall Study|Adverse Event|3|||
164264393|NCT02435680|593336499|FG002|Overall Study|Adverse Event|2|||
164264394|NCT02435680|593336497|FG000|Overall Study|progressive disease|10|||
164264395|NCT02435680|593336498|FG001|Overall Study|progressive disease|7|||
164264396|NCT02435680|593336499|FG002|Overall Study|progressive disease|11|||
164264397|NCT02435680|593336497|FG000|Overall Study|not treated|0|||
164264398|NCT02435680|593336498|FG001|Overall Study|not treated|0|||
164264399|NCT02435680|593336499|FG002|Overall Study|not treated|1|||
164264400|NCT02233738|593336500|FG000|Overall Study|Lost to Follow-up|5|||
164264401|NCT02233738|593336501|FG001|Overall Study|Lost to Follow-up|12|||
164264402|NCT02233738|593336500|FG000|Overall Study|Death|0|||
164264403|NCT02233738|593336501|FG001|Overall Study|Death|1|||
164264404|NCT02233738|593336500|FG000|Overall Study|Withdrawal by Subject|0|||
164264405|NCT02233738|593336501|FG001|Overall Study|Withdrawal by Subject|1|||
164264406|NCT02233738|593336500|FG000|Overall Study|Did not return after Baseline|3|||
164264407|NCT02233738|593336501|FG001|Overall Study|Did not return after Baseline|2|||
164264408|NCT00096174|593336502|FG000|Overall Study|Lack of Efficacy|9|||
164264409|NCT00096174|593336502|FG000|Overall Study|Adverse Event|15|||
164264410|NCT00096174|593336502|FG000|Overall Study|Death|6|||
164264411|NCT00096174|593336502|FG000|Overall Study|Withdrawal by Subject|15|||
164264412|NCT00096174|593336502|FG000|Overall Study|Not started protocol therapy|3|||
164264413|NCT00096174|593336502|FG000|Overall Study|Ineligible|6|||
164430157|NCT01446003|593945321|FG001|Period 2|Adverse Event|0|||
164430158|NCT00318656|593945322|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
164264414|NCT00096174|593336502|FG000|Overall Study|other reason|8|||
164264415|NCT00953524|593336503|FG000|Overall Study|Adverse Event|2|||
164264416|NCT00953524|593336504|FG001|Overall Study|Adverse Event|0|||
164264417|NCT00953524|593336505|FG002|Overall Study|Adverse Event|1|||
164264418|NCT00953524|593336506|FG003|Overall Study|Adverse Event|2|||
164264419|NCT00953524|593336503|FG000|Overall Study|Protocol Violation|18|||
164264420|NCT00953524|593336504|FG001|Overall Study|Protocol Violation|10|||
164264421|NCT00953524|593336505|FG002|Overall Study|Protocol Violation|11|||
164264422|NCT00953524|593336506|FG003|Overall Study|Protocol Violation|6|||
164264423|NCT00953524|593336503|FG000|Overall Study|Lost to Follow-up|0|||
164264424|NCT00953524|593336504|FG001|Overall Study|Lost to Follow-up|1|||
164264425|NCT00953524|593336505|FG002|Overall Study|Lost to Follow-up|1|||
164264426|NCT00953524|593336506|FG003|Overall Study|Lost to Follow-up|0|||
164264427|NCT00953524|593336503|FG000|Overall Study|Withdrawal by Subject|2|||
164264428|NCT00953524|593336504|FG001|Overall Study|Withdrawal by Subject|4|||
164264429|NCT00953524|593336505|FG002|Overall Study|Withdrawal by Subject|1|||
164264430|NCT00953524|593336506|FG003|Overall Study|Withdrawal by Subject|0|||
164264431|NCT00294645|593336507|FG000|Overall Study|Death|10|||
164264432|NCT00294645|593336508|FG001|Overall Study|Death|18|||
164264433|NCT00294645|593336507|FG000|Overall Study|Lost to Follow-up|1|||
164430159|NCT00318656|593945323|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
164264434|NCT00294645|593336508|FG001|Overall Study|Lost to Follow-up|10|||
164430160|NCT00318656|593945322|FG000|Overall Study|Did not receive any treatment|0|||
164430161|NCT00318656|593945323|FG001|Overall Study|Did not receive any treatment|1|||
164430162|NCT00490555|593945325|FG000|Overall Study|noncompliant with drug administration|0|||
164430163|NCT00490555|593945326|FG001|Overall Study|noncompliant with drug administration|0|||
164264435|NCT00294645|593336507|FG000|Overall Study|Withdrawal by Subject|18|||
164264436|NCT00294645|593336508|FG001|Overall Study|Withdrawal by Subject|34|||
164264437|NCT00294645|593336507|FG000|Overall Study|Physician Decision|15|||
164264438|NCT00294645|593336508|FG001|Overall Study|Physician Decision|20|||
164264439|NCT00294645|593336507|FG000|Overall Study|Other|4|||
164264440|NCT00294645|593336508|FG001|Overall Study|Other|10|||
164264441|NCT00554619|593336511|FG000|Overall Study|Adverse Event|1|||
164264442|NCT00554619|593336511|FG000|Overall Study|Physician Decision|1|||
164532551|NCT03567434|594320613|FG000|Overall Study|Lost to Follow-up|1|||
164264443|NCT00554619|593336511|FG000|Overall Study|Liver Function Test Abnormality|1|||
164264444|NCT00907803|593336513|FG000|Overall Study|Withdrawal of consent - long commute|1|||
164264445|NCT00907803|593336514|FG001|Overall Study|Withdrawal of consent - long commute|0|||
164264446|NCT00907803|593336515|FG002|Overall Study|Withdrawal of consent - long commute|0|||
164264447|NCT00907803|593336513|FG000|Overall Study|Adverse Event|2|||
164264448|NCT00907803|593336514|FG001|Overall Study|Adverse Event|0|||
164264449|NCT00907803|593336515|FG002|Overall Study|Adverse Event|0|||
164264450|NCT00907803|593336513|FG000|Overall Study|Withdrawal by Subject|0|||
164264451|NCT00907803|593336514|FG001|Overall Study|Withdrawal by Subject|1|||
164532552|NCT03567434|594320614|FG001|Overall Study|Lost to Follow-up|3|||
164430164|NCT00490555|593945327|FG002|Overall Study|noncompliant with drug administration|2|||
164430165|NCT00490555|593945328|FG003|Overall Study|noncompliant with drug administration|0|||
164430166|NCT01007149|593945329|FG000|Overall Study|Administrative problems|0|||
164430167|NCT01007149|593945330|FG001|Overall Study|Administrative problems|1|||
164430168|NCT01516892|593945332|FG000|Overall Study|Adverse Event|25|||
164430169|NCT01516892|593945332|FG000|Overall Study|Lack of Efficacy|35|||
164430170|NCT01516892|593945332|FG000|Overall Study|Pregnancy|5|||
164430171|NCT01516892|593945332|FG000|Overall Study|Lost to Follow-up|82|||
164430172|NCT01516892|593945332|FG000|Overall Study|Subject Withdrew Consent|92|||
164430173|NCT01516892|593945332|FG000|Overall Study|Protocol Violation|60|||
164430174|NCT01516892|593945332|FG000|Overall Study|Other Miscellaneous Reasons|43|||
164430175|NCT01516892|593945332|FG000|Overall Study|Missing|1|||
164430176|NCT02956967|593945333|FG000|Overall Study|Adverse Event|3|||
164430177|NCT02956967|593945333|FG000|Overall Study|Reason non-related to neutropenia|10|||
164430178|NCT02956967|593945333|FG000|Overall Study|Lost to Follow-up|5|||
164430179|NCT02956967|593945333|FG000|Overall Study|Missing|1|||
164430180|NCT02956967|593945333|FG000|Overall Study|Termination of Nivestim administration|29|||
164430181|NCT00819234|593945336|FG000|Overall Study|Withdrawal by Subject|8|||
164430182|NCT00819234|593945337|FG001|Overall Study|Withdrawal by Subject|13|||
164430183|NCT00819234|593945338|FG002|Overall Study|Withdrawal by Subject|6|||
164430184|NCT00819234|593945339|FG003|Overall Study|Withdrawal by Subject|3|||
164430185|NCT00819234|593945340|FG004|Overall Study|Withdrawal by Subject|0|||
164430186|NCT00819234|593945341|FG005|Overall Study|Withdrawal by Subject|4|||
164430187|NCT00819234|593945342|FG006|Overall Study|Withdrawal by Subject|4|||
164430188|NCT00819234|593945343|FG007|Overall Study|Withdrawal by Subject|8|||
164430189|NCT00819234|593945344|FG008|Overall Study|Withdrawal by Subject|5|||
164430190|NCT00819234|593945345|FG009|Overall Study|Withdrawal by Subject|3|||
164430191|NCT00819234|593945336|FG000|Overall Study|Adverse Event|0|||
164430192|NCT00819234|593945337|FG001|Overall Study|Adverse Event|0|||
164264452|NCT00907803|593336515|FG002|Overall Study|Withdrawal by Subject|0|||
164264453|NCT00907803|593336513|FG000|Overall Study|Lost to Follow-up|0|||
164264454|NCT00907803|593336514|FG001|Overall Study|Lost to Follow-up|1|||
164264455|NCT00907803|593336515|FG002|Overall Study|Lost to Follow-up|0|||
164264456|NCT00907803|593336513|FG000|Overall Study|Protocol Violation|0|||
164264457|NCT00907803|593336514|FG001|Overall Study|Protocol Violation|1|||
164264458|NCT00907803|593336515|FG002|Overall Study|Protocol Violation|0|||
164264459|NCT05426031|593336520|FG000|Overall Study|Circulatory Arrest|3|||
164264460|NCT05426031|593336521|FG001|Overall Study|Circulatory Arrest|2|||
164264461|NCT00089986|593336522|FG000|Overall Study|Adverse Event|6|||
164264462|NCT00089986|593336523|FG001|Overall Study|Adverse Event|9|||
164264463|NCT00089986|593336524|FG002|Overall Study|Adverse Event|6|||
164264464|NCT00089986|593336522|FG000|Overall Study|Lost to Follow-up|3|||
164264465|NCT00089986|593336523|FG001|Overall Study|Lost to Follow-up|1|||
164264466|NCT00089986|593336524|FG002|Overall Study|Lost to Follow-up|1|||
164264467|NCT00089986|593336522|FG000|Overall Study|Protocol Violation|0|||
164264468|NCT00089986|593336523|FG001|Overall Study|Protocol Violation|1|||
164264469|NCT00089986|593336524|FG002|Overall Study|Protocol Violation|0|||
164264470|NCT00089986|593336522|FG000|Overall Study|Patient transferred to another hospital|2|||
164264471|NCT00089986|593336523|FG001|Overall Study|Patient transferred to another hospital|1|||
164264472|NCT00089986|593336524|FG002|Overall Study|Patient transferred to another hospital|0|||
164264473|NCT00089986|593336522|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
164264474|NCT00089986|593336523|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
164264475|NCT00089986|593336524|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
164264476|NCT00089986|593336522|FG000|Overall Study|Hemohlobin stopping rule|0|||
164264477|NCT00089986|593336523|FG001|Overall Study|Hemohlobin stopping rule|1|||
164430193|NCT00819234|593945338|FG002|Overall Study|Adverse Event|1|||
164264478|NCT00089986|593336524|FG002|Overall Study|Hemohlobin stopping rule|0|||
164430194|NCT00819234|593945339|FG003|Overall Study|Adverse Event|0|||
164430195|NCT00819234|593945340|FG004|Overall Study|Adverse Event|0|||
164430196|NCT00819234|593945341|FG005|Overall Study|Adverse Event|2|||
164683209|NCT01018862|594861541|FG002|Overall Study|Adverse Event|6|||
164264479|NCT00089986|593336522|FG000|Overall Study|Investigator decision to withdrew|0|||
164264480|NCT00089986|593336523|FG001|Overall Study|Investigator decision to withdrew|1|||
164264481|NCT00089986|593336524|FG002|Overall Study|Investigator decision to withdrew|0|||
164264482|NCT00089986|593336522|FG000|Overall Study|Enrollment in another study|0|||
164430197|NCT00819234|593945342|FG006|Overall Study|Adverse Event|0|||
164430198|NCT00819234|593945343|FG007|Overall Study|Adverse Event|0|||
164430199|NCT00819234|593945344|FG008|Overall Study|Adverse Event|0|||
164430200|NCT00819234|593945345|FG009|Overall Study|Adverse Event|0|||
164683210|NCT01018862|594861539|FG000|Overall Study|Lack of Efficacy|1|||
164683211|NCT01018862|594861540|FG001|Overall Study|Lack of Efficacy|0|||
164683212|NCT01018862|594861541|FG002|Overall Study|Lack of Efficacy|2|||
164683213|NCT01018862|594861539|FG000|Overall Study|Lost to Follow-up|3|||
164683214|NCT01018862|594861540|FG001|Overall Study|Lost to Follow-up|1|||
164683215|NCT01018862|594861541|FG002|Overall Study|Lost to Follow-up|0|||
164683216|NCT01018862|594861539|FG000|Overall Study|Protocol Violation|1|||
164683217|NCT01018862|594861540|FG001|Overall Study|Protocol Violation|3|||
164683218|NCT01018862|594861541|FG002|Overall Study|Protocol Violation|3|||
164264483|NCT00089986|593336523|FG001|Overall Study|Enrollment in another study|1|||
164264484|NCT00089986|593336524|FG002|Overall Study|Enrollment in another study|0|||
164264485|NCT00089986|593336522|FG000|Overall Study|Family decision|0|||
164264486|NCT00089986|593336523|FG001|Overall Study|Family decision|1|||
164264487|NCT00089986|593336524|FG002|Overall Study|Family decision|0|||
164264488|NCT00089986|593336522|FG000|Overall Study|Do not resuscitate (DNR)|0|||
164264489|NCT00089986|593336523|FG001|Overall Study|Do not resuscitate (DNR)|0|||
164264490|NCT00089986|593336524|FG002|Overall Study|Do not resuscitate (DNR)|1|||
164264491|NCT00089986|593336522|FG000|Overall Study|Withdrawal by Subject|3|||
164264492|NCT00089986|593336523|FG001|Overall Study|Withdrawal by Subject|6|||
164264493|NCT00089986|593336524|FG002|Overall Study|Withdrawal by Subject|2|||
164264494|NCT04065074|593336528|FG000|Overall Study|Adverse Event|1|||
164264495|NCT04065074|593336528|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
164264496|NCT02334683|593336529|FG000|First 12 Week Period|Lost to Follow-up|1|||
164264497|NCT02334683|593336530|FG001|First 12 Week Period|Lost to Follow-up|0|||
164264498|NCT02334683|593336529|FG000|Second 12 Week Period|Adverse Event|0|||
164264499|NCT02334683|593336530|FG001|Second 12 Week Period|Adverse Event|1|||
164264500|NCT01062841|593336531|FG000|Overall Study|Indwelling Device Removed|41|||
164264501|NCT01062841|593336532|FG001|Overall Study|Indwelling Device Removed|48|||
164264502|NCT01062841|593336531|FG000|Overall Study|Death|3|||
164264503|NCT01062841|593336532|FG001|Overall Study|Death|5|||
164264504|NCT01062841|593336531|FG000|Overall Study|Withdrawal by Subject|2|||
164264505|NCT01062841|593336532|FG001|Overall Study|Withdrawal by Subject|0|||
164264506|NCT01062841|593336531|FG000|Overall Study|Withdrawal by Study|3|||
164264507|NCT01062841|593336532|FG001|Overall Study|Withdrawal by Study|0|||
164264508|NCT03958656|593336533|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
164264509|NCT03958656|593336534|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
164264510|NCT03958656|593336535|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
164264511|NCT03958656|593336536|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
164683219|NCT01018862|594861539|FG000|Overall Study|Withdrawal by Subject|1|||
164683220|NCT01018862|594861540|FG001|Overall Study|Withdrawal by Subject|2|||
164683221|NCT01018862|594861541|FG002|Overall Study|Withdrawal by Subject|1|||
164683222|NCT01018862|594861539|FG000|Overall Study|administrative problems|5|||
164683223|NCT01018862|594861540|FG001|Overall Study|administrative problems|4|||
164683224|NCT01018862|594861541|FG002|Overall Study|administrative problems|4|||
164264512|NCT03958656|593336533|FG000|Overall Study|No longer meets eligibility criteria|0|||
164264513|NCT03958656|593336534|FG001|Overall Study|No longer meets eligibility criteria|0|||
164264514|NCT03958656|593336535|FG002|Overall Study|No longer meets eligibility criteria|1|||
164264515|NCT03958656|593336536|FG003|Overall Study|No longer meets eligibility criteria|0|||
164264516|NCT03958656|593336533|FG000|Overall Study|Started anti-cancer treatment|0|||
164264517|NCT03958656|593336534|FG001|Overall Study|Started anti-cancer treatment|0|||
164264518|NCT03958656|593336535|FG002|Overall Study|Started anti-cancer treatment|1|||
164264519|NCT03958656|593336536|FG003|Overall Study|Started anti-cancer treatment|0|||
164264520|NCT03831880|593336537|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
164264521|NCT03831880|593336538|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
164264522|NCT03831880|593336537|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
164264523|NCT03831880|593336538|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
164264524|NCT03158012|593336541|FG000|Overall Study|Withdrawal by Subject|0|||
164264525|NCT03158012|593336542|FG001|Overall Study|Withdrawal by Subject|1|||
164264526|NCT02788201|593336543|FG000|Overall Study|Death|1|||
164264527|NCT02788201|593336544|FG001|Overall Study|Death|1|||
164264528|NCT02788201|593336545|FG002|Overall Study|Death|1|||
164264529|NCT02788201|593336546|FG003|Overall Study|Death|1|||
164264530|NCT02788201|593336547|FG004|Overall Study|Death|0|||
164264531|NCT02788201|593336548|FG005|Overall Study|Death|1|||
164264532|NCT02788201|593336543|FG000|Overall Study|Ineligible|0|||
164264533|NCT02788201|593336544|FG001|Overall Study|Ineligible|0|||
164264534|NCT02788201|593336545|FG002|Overall Study|Ineligible|0|||
164264535|NCT02788201|593336546|FG003|Overall Study|Ineligible|0|||
164264536|NCT02788201|593336547|FG004|Overall Study|Ineligible|0|||
164264537|NCT02788201|593336548|FG005|Overall Study|Ineligible|1|||
164341198|NCT03855228|593623920|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
164341199|NCT03855228|593623921|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
164341200|NCT02993757|593623922|FG000|Overall Study|Non compliance with the protocol|155|||
164341201|NCT02993757|593623923|FG001|Overall Study|Non compliance with the protocol|170|||
164341202|NCT02993757|593623922|FG000|Overall Study|Lost to Follow-up|1|||
164341203|NCT02993757|593623923|FG001|Overall Study|Lost to Follow-up|0|||
164341204|NCT02993757|593623922|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
164341205|NCT02993757|593623923|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
164341206|NCT00190671|593623924|FG000|Overall Study|Satisfactory Response|4|||
164341207|NCT00190671|593623925|FG001|Overall Study|Satisfactory Response|7|||
164341208|NCT00190671|593623924|FG000|Overall Study|Lack of Efficacy|19|||
164341209|NCT00190671|593623925|FG001|Overall Study|Lack of Efficacy|24|||
164341210|NCT00190671|593623924|FG000|Overall Study|Death from Study Disease|1|||
164683225|NCT01968031|594861542|FG000|Overall Study|Adverse Event|13|||
164264538|NCT02788201|593336543|FG000|Overall Study|Withdrawal by Subject|0|||
164264539|NCT02788201|593336544|FG001|Overall Study|Withdrawal by Subject|0|||
164264540|NCT02788201|593336545|FG002|Overall Study|Withdrawal by Subject|0|||
164341211|NCT00190671|593623925|FG001|Overall Study|Death from Study Disease|1|||
164341212|NCT00190671|593623924|FG000|Overall Study|Adverse Event|3|||
164341213|NCT00190671|593623925|FG001|Overall Study|Adverse Event|2|||
164341214|NCT00190671|593623924|FG000|Overall Study|Clinical Relapse|0|||
164341215|NCT00190671|593623925|FG001|Overall Study|Clinical Relapse|1|||
164341216|NCT00190671|593623924|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
164341217|NCT00190671|593623925|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
164341218|NCT00190671|593623924|FG000|Overall Study|Death from Other Causes|0|||
164341219|NCT00190671|593623925|FG001|Overall Study|Death from Other Causes|2|||
164341220|NCT00190671|593623924|FG000|Overall Study|Protocol Violation|0|||
164341221|NCT00190671|593623925|FG001|Overall Study|Protocol Violation|1|||
164341222|NCT00190671|593623924|FG000|Overall Study|Withdrawal by Subject|0|||
164264541|NCT02788201|593336546|FG003|Overall Study|Withdrawal by Subject|0|||
164264542|NCT02788201|593336547|FG004|Overall Study|Withdrawal by Subject|0|||
164264543|NCT02788201|593336548|FG005|Overall Study|Withdrawal by Subject|1|||
164264544|NCT01874275|593336549|FG000|Overall Study|Lost to Follow-up|1|||
164264545|NCT01874275|593336550|FG001|Overall Study|Lost to Follow-up|0|||
164264546|NCT04662073|593336551|FG000|Overall Study|Withdrawal by Subject|1|||
164341223|NCT00190671|593623925|FG001|Overall Study|Withdrawal by Subject|2|||
164341224|NCT00087607|593623926|FG000|Overall Study|Adverse Event|14|||
164341225|NCT00087607|593623927|FG001|Overall Study|Adverse Event|24|||
164578699|NCT01324830|594484077|FG014|Overall Study|Withdrawal by Subject|0|||
164578700|NCT01324830|594484078|FG015|Overall Study|Withdrawal by Subject|0|||
164578701|NCT01324830|594484079|FG016|Overall Study|Withdrawal by Subject|0|||
164578702|NCT01324830|594484080|FG017|Overall Study|Withdrawal by Subject|0|||
164578703|NCT01324830|594484081|FG018|Overall Study|Withdrawal by Subject|1|||
164578704|NCT01973283|594484082|FG000|Overall Study|Lost to Follow-up|4|||
164578705|NCT01122927|594484089|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
164578706|NCT01122927|594484090|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
164578707|NCT01122927|594484089|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
164578708|NCT01122927|594484090|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
164578709|NCT01122927|594484089|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
164578710|NCT01122927|594484090|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
164578711|NCT01122927|594484089|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
164578712|NCT01122927|594484090|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
164578713|NCT01122927|594484089|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
164578714|NCT01122927|594484090|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
164578715|NCT01122927|594484089|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
164578716|NCT01122927|594484090|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
164578717|NCT01122927|594484089|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
164578718|NCT01122927|594484090|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
164578719|NCT01122927|594484089|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
164578720|NCT01122927|594484090|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
164578721|NCT01122927|594484089|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
164578722|NCT01122927|594484090|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
164578723|NCT01122927|594484089|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
164578724|NCT01122927|594484090|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
164578725|NCT01122927|594484089|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
164578726|NCT01122927|594484090|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
164578727|NCT01122927|594484089|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
164578728|NCT01122927|594484090|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
164578729|NCT01244737|594484098|FG000|Overall Study|Physician Decision|2|||
164578730|NCT01244737|594484099|FG001|Overall Study|Physician Decision|18|||
164578731|NCT01244737|594484100|FG002|Overall Study|Physician Decision|5|||
164578732|NCT01244737|594484098|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
164578733|NCT01244737|594484099|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
164578734|NCT01244737|594484100|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
164578735|NCT01244737|594484098|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
164264547|NCT04662073|593336552|FG001|Overall Study|Withdrawal by Subject|0|||
164341226|NCT00087607|593623926|FG000|Overall Study|Death|0|||
164341227|NCT00087607|593623927|FG001|Overall Study|Death|1|||
164264548|NCT00681564|593336553|FG000|Overall Study|Lost to Follow-up|6|||
164264549|NCT00681564|593336554|FG001|Overall Study|Lost to Follow-up|6|||
164430201|NCT00819234|593945336|FG000|Overall Study|Physician Decision|0|||
164264550|NCT00681564|593336553|FG000|Overall Study|Withdrawal by Subject|0|||
164264551|NCT00681564|593336554|FG001|Overall Study|Withdrawal by Subject|1|||
164264552|NCT00681564|593336553|FG000|Overall Study|Death|0|||
164341228|NCT00087607|593623926|FG000|Overall Study|Insufficient Therapeutic Response|53|||
164264553|NCT00681564|593336554|FG001|Overall Study|Death|1|||
164264554|NCT00762996|593336556|FG000|Period One|Protocol Violation|0|||
164264555|NCT00762996|593336557|FG001|Period One|Protocol Violation|0|||
164264556|NCT00762996|593336558|FG002|Period One|Protocol Violation|1|||
164264557|NCT00762996|593336559|FG003|Period One|Protocol Violation|0|||
164264558|NCT00762996|593336556|FG000|Period One|ineligible|0|||
164264559|NCT00762996|593336557|FG001|Period One|ineligible|0|||
164264560|NCT00762996|593336558|FG002|Period One|ineligible|1|||
164264561|NCT00762996|593336559|FG003|Period One|ineligible|1|||
164264562|NCT00762996|593336556|FG000|Period One|Adverse Event|0|||
164264563|NCT00762996|593336557|FG001|Period One|Adverse Event|0|||
164264564|NCT00762996|593336558|FG002|Period One|Adverse Event|1|||
164264565|NCT00762996|593336559|FG003|Period One|Adverse Event|0|||
164264566|NCT00762996|593336556|FG000|Period One|Withdrawal by Subject|0|||
164264567|NCT00762996|593336557|FG001|Period One|Withdrawal by Subject|0|||
164264568|NCT00762996|593336558|FG002|Period One|Withdrawal by Subject|1|||
164341229|NCT00087607|593623927|FG001|Overall Study|Insufficient Therapeutic Response|42|||
164341230|NCT00087607|593623926|FG000|Overall Study|Failure to return|21|||
164341231|NCT00087607|593623927|FG001|Overall Study|Failure to return|17|||
164341232|NCT00087607|593623926|FG000|Overall Study|Withdrew Consent|12|||
164341233|NCT00087607|593623927|FG001|Overall Study|Withdrew Consent|16|||
164341234|NCT00087607|593623926|FG000|Overall Study|Administrative|12|||
164341235|NCT00087607|593623927|FG001|Overall Study|Administrative|12|||
164341236|NCT00087607|593623926|FG000|Overall Study|Refused Treatment|5|||
164341237|NCT00087607|593623927|FG001|Overall Study|Refused Treatment|7|||
164341238|NCT00087607|593623926|FG000|Overall Study|Other Protocol Violation|5|||
164341239|NCT00087607|593623927|FG001|Overall Study|Other Protocol Violation|2|||
164341240|NCT00087607|593623926|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
164341241|NCT00087607|593623927|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
164341242|NCT02699593|593623928|FG000|Period 1|Unsatisfactory Visual Response|0|||
164341243|NCT02699593|593623929|FG001|Period 1|Unsatisfactory Visual Response|1|||
164341244|NCT02699593|593623928|FG000|Period 1|Torn Contact Len|4|||
164341245|NCT02699593|593623929|FG001|Period 1|Torn Contact Len|3|||
164341246|NCT02699593|593623928|FG000|Period 1|Protocol Violation|0|||
164341247|NCT02699593|593623929|FG001|Period 1|Protocol Violation|1|||
164341248|NCT02699593|593623928|FG000|Period 1|Withdrawal by Subject|0|||
164341249|NCT02699593|593623929|FG001|Period 1|Withdrawal by Subject|1|||
164341250|NCT02699593|593623928|FG000|Period 1|Adverse Event|1|||
164341251|NCT02699593|593623929|FG001|Period 1|Adverse Event|1|||
164341252|NCT02699593|593623928|FG000|Period 2|Adverse Event|1|||
164683226|NCT01968031|594861543|FG001|Overall Study|Adverse Event|10|||
164683227|NCT01968031|594861544|FG002|Overall Study|Adverse Event|22|||
164683228|NCT01968031|594861542|FG000|Overall Study|Withdrawal by Subject|3|||
164683229|NCT01968031|594861543|FG001|Overall Study|Withdrawal by Subject|7|||
164683230|NCT01968031|594861544|FG002|Overall Study|Withdrawal by Subject|3|||
164683231|NCT01968031|594861542|FG000|Overall Study|Did not meet entry criteria|1|||
164683232|NCT01968031|594861543|FG001|Overall Study|Did not meet entry criteria|1|||
164683233|NCT01968031|594861544|FG002|Overall Study|Did not meet entry criteria|1|||
164683234|NCT01968031|594861542|FG000|Overall Study|Noncompliance|0|||
164264569|NCT00762996|593336559|FG003|Period One|Withdrawal by Subject|0|||
164264570|NCT00657150|593336560|FG000|Overall Study|Adverse Event|19|||
164341253|NCT02699593|593623929|FG001|Period 2|Adverse Event|1|||
164341254|NCT02699593|593623928|FG000|Period 2|Lost Contact Lens|0|||
164341255|NCT02699593|593623929|FG001|Period 2|Lost Contact Lens|1|||
164264571|NCT00657150|593336561|FG001|Overall Study|Adverse Event|10|||
164341256|NCT02699593|593623928|FG000|Period 2|Torn Contact Lens|1|||
164341257|NCT02699593|593623929|FG001|Period 2|Torn Contact Lens|0|||
164341258|NCT02015754|593623930|FG000|Overall Study|Disease progression|5|||
164341259|NCT02015754|593623930|FG000|Overall Study|Change in treatment modality|5|||
164264572|NCT00657150|593336560|FG000|Overall Study|Non-compliant with protocol|5|||
164264573|NCT00657150|593336561|FG001|Overall Study|Non-compliant with protocol|9|||
164341260|NCT02015754|593623930|FG000|Overall Study|Lost to Follow-up|1|||
164683235|NCT01968031|594861543|FG001|Overall Study|Noncompliance|0|||
164683236|NCT01968031|594861544|FG002|Overall Study|Noncompliance|2|||
164264574|NCT00657150|593336560|FG000|Overall Study|Lost to Follow-up|2|||
164264575|NCT00657150|593336561|FG001|Overall Study|Lost to Follow-up|0|||
164264576|NCT00657150|593336560|FG000|Overall Study|Withdrawal by Subject|51|||
164264577|NCT00657150|593336561|FG001|Overall Study|Withdrawal by Subject|36|||
164264578|NCT00657150|593336560|FG000|Overall Study|Other|38|||
164264579|NCT00657150|593336561|FG001|Overall Study|Other|38|||
164264580|NCT00657150|593336560|FG000|Treatment|Adverse Event|60|||
164264581|NCT00657150|593336561|FG001|Treatment|Adverse Event|53|||
164264582|NCT00657150|593336560|FG000|Treatment|Non-compliant with protocol|10|||
164264583|NCT00657150|593336561|FG001|Treatment|Non-compliant with protocol|9|||
164264584|NCT00657150|593336560|FG000|Treatment|Lost to Follow-up|1|||
164264585|NCT00657150|593336561|FG001|Treatment|Lost to Follow-up|0|||
164264586|NCT00657150|593336560|FG000|Treatment|Withdrawal by Subject|23|||
164264587|NCT00657150|593336561|FG001|Treatment|Withdrawal by Subject|20|||
164264588|NCT00657150|593336560|FG000|Treatment|Other|13|||
164264589|NCT00657150|593336561|FG001|Treatment|Other|15|||
164264590|NCT00468845|593336568|FG000|Overall Study|Adverse Event|9|||
164264591|NCT00468845|593336569|FG001|Overall Study|Adverse Event|14|||
164264592|NCT00468845|593336570|FG002|Overall Study|Adverse Event|11|||
164264593|NCT00468845|593336568|FG000|Overall Study|Lost to Follow-up|2|||
164264594|NCT00468845|593336569|FG001|Overall Study|Lost to Follow-up|1|||
164264595|NCT00468845|593336570|FG002|Overall Study|Lost to Follow-up|2|||
164264596|NCT00468845|593336568|FG000|Overall Study|Other|4|||
164264597|NCT00468845|593336569|FG001|Overall Study|Other|9|||
164264598|NCT00468845|593336570|FG002|Overall Study|Other|5|||
164264599|NCT00468845|593336568|FG000|Overall Study|No longer willing to participate|5|||
164264600|NCT00468845|593336569|FG001|Overall Study|No longer willing to participate|6|||
164264601|NCT00468845|593336570|FG002|Overall Study|No longer willing to participate|10|||
164264602|NCT00468845|593336568|FG000|Overall Study|Randomized, not treated|1|||
164264603|NCT00468845|593336569|FG001|Overall Study|Randomized, not treated|4|||
164341261|NCT02229383|593623931|FG000|Overall Study|Adverse Event|7|||
164341262|NCT02229383|593623932|FG001|Overall Study|Adverse Event|4|||
164341263|NCT02229383|593623931|FG000|Overall Study|Death|0|||
164578736|NCT01244737|594484099|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
164578737|NCT01244737|594484100|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
164578738|NCT01244737|594484098|FG000|Overall Study|MIB immunopathology results not available|3|||
164578739|NCT01244737|594484099|FG001|Overall Study|MIB immunopathology results not available|2|||
164578740|NCT01244737|594484100|FG002|Overall Study|MIB immunopathology results not available|0|||
164578741|NCT01244737|594484098|FG000|Overall Study|PET data failure|0|||
164578742|NCT01244737|594484099|FG001|Overall Study|PET data failure|1|||
164578743|NCT01244737|594484100|FG002|Overall Study|PET data failure|0|||
164578744|NCT01244737|594484098|FG000|Overall Study|Withdrawal by Subject|0|||
164578745|NCT01244737|594484099|FG001|Overall Study|Withdrawal by Subject|0|||
164578746|NCT01244737|594484100|FG002|Overall Study|Withdrawal by Subject|1|||
164578747|NCT00356915|594484105|FG000|Overall Study|Non compliance|1|||
164578748|NCT00356915|594484106|FG001|Overall Study|Non compliance|2|||
164578749|NCT00356915|594484107|FG002|Overall Study|Non compliance|1|||
164578750|NCT00356915|594484105|FG000|Overall Study|Protocol Violation|2|||
164578751|NCT00356915|594484106|FG001|Overall Study|Protocol Violation|3|||
164578752|NCT00356915|594484107|FG002|Overall Study|Protocol Violation|2|||
164578753|NCT00356915|594484105|FG000|Overall Study|Withdrawal by Subject|14|||
164578754|NCT00356915|594484106|FG001|Overall Study|Withdrawal by Subject|14|||
164578755|NCT00356915|594484107|FG002|Overall Study|Withdrawal by Subject|10|||
164578756|NCT00356915|594484105|FG000|Overall Study|Lack of Efficacy|0|||
164578757|NCT00356915|594484106|FG001|Overall Study|Lack of Efficacy|0|||
164578758|NCT00356915|594484107|FG002|Overall Study|Lack of Efficacy|3|||
164578759|NCT00356915|594484105|FG000|Overall Study|Lost to Follow-up|27|||
164578760|NCT00356915|594484106|FG001|Overall Study|Lost to Follow-up|34|||
164578761|NCT00356915|594484107|FG002|Overall Study|Lost to Follow-up|14|||
164578762|NCT00356915|594484105|FG000|Overall Study|Administrative Decision|0|||
164578763|NCT00356915|594484106|FG001|Overall Study|Administrative Decision|0|||
164578764|NCT00356915|594484107|FG002|Overall Study|Administrative Decision|1|||
164578765|NCT00356915|594484105|FG000|Overall Study|Physician Decision|0|||
164578766|NCT00356915|594484106|FG001|Overall Study|Physician Decision|2|||
164578767|NCT00356915|594484107|FG002|Overall Study|Physician Decision|0|||
164578768|NCT00356915|594484105|FG000|Overall Study|Adverse Event|21|||
164578769|NCT00356915|594484106|FG001|Overall Study|Adverse Event|31|||
164578770|NCT00356915|594484107|FG002|Overall Study|Adverse Event|8|||
164578771|NCT00356915|594484105|FG000|Overall Study|Miscellaneous reasons|11|||
164264604|NCT00468845|593336570|FG002|Overall Study|Randomized, not treated|2|||
164264605|NCT00787930|593336571|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
164264606|NCT01400243|593336572|FG000|Overall Study|Protocol Violation|8|||
164264607|NCT01400243|593336573|FG001|Overall Study|Protocol Violation|11|||
164264608|NCT04316741|593336574|FG000|Baseline Enrollment|Lost to Follow-up|1|||
164264609|NCT04316741|593336575|FG001|Baseline Enrollment|Lost to Follow-up|1|||
164578772|NCT00356915|594484106|FG001|Overall Study|Miscellaneous reasons|8|||
164264610|NCT04316741|593336574|FG000|Immediate Post-Test|Lost to Follow-up|5|||
164578773|NCT00356915|594484107|FG002|Overall Study|Miscellaneous reasons|3|||
164683237|NCT01968031|594861542|FG000|Overall Study|Failed inclusion criteria|0|||
164683238|NCT01968031|594861543|FG001|Overall Study|Failed inclusion criteria|2|||
164683239|NCT01968031|594861544|FG002|Overall Study|Failed inclusion criteria|0|||
164683240|NCT01968031|594861542|FG000|Overall Study|Death|0|||
164683241|NCT01968031|594861543|FG001|Overall Study|Death|0|||
164683242|NCT01968031|594861544|FG002|Overall Study|Death|1|||
164683243|NCT01968031|594861542|FG000|Overall Study|Prohibited concomitant medication|1|||
164683244|NCT01968031|594861543|FG001|Overall Study|Prohibited concomitant medication|0|||
164683245|NCT01968031|594861544|FG002|Overall Study|Prohibited concomitant medication|0|||
164683246|NCT04594252|594861545|FG000|Overall Study|Adverse Event|0|||
164683247|NCT04594252|594861546|FG001|Overall Study|Adverse Event|2|||
164683248|NCT04573309|594863402|FG000|Overall Study|Protocol Violation|1|||
164683249|NCT04573309|594863403|FG001|Overall Study|Protocol Violation|0|||
164683250|NCT01691430|594863406|FG000|Overall Study|Death|17|||
164683251|NCT01691430|594863407|FG001|Overall Study|Death|16|||
164683252|NCT01691430|594863406|FG000|Overall Study|Withdrawal by Subject|5|||
164683253|NCT01691430|594863407|FG001|Overall Study|Withdrawal by Subject|1|||
164683254|NCT01691430|594863406|FG000|Overall Study|Lost to Follow-up|0|||
164683255|NCT01691430|594863407|FG001|Overall Study|Lost to Follow-up|3|||
164683256|NCT01894230|594863408|FG000|Overall Study|Lost to Follow-up|2|||
164683257|NCT01894230|594863409|FG001|Overall Study|Lost to Follow-up|2|||
164683258|NCT01894230|594863408|FG000|Overall Study|Withdrawal by Subject|4|||
164683259|NCT01894230|594863409|FG001|Overall Study|Withdrawal by Subject|4|||
164683260|NCT01894230|594863408|FG000|Overall Study|Non-adherent|0|||
164683261|NCT01894230|594863409|FG001|Overall Study|Non-adherent|1|||
164264611|NCT04316741|593336575|FG001|Immediate Post-Test|Lost to Follow-up|1|||
164264612|NCT04316741|593336574|FG000|1-month Post-test|Lost to Follow-up|7|||
164341264|NCT02229383|593623932|FG001|Overall Study|Death|1|||
164578774|NCT02371629|594484116|FG000|Overall Study|Patient decision|14|||
164578775|NCT02371629|594484117|FG001|Overall Study|Patient decision|10|||
164578776|NCT02371629|594484116|FG000|Overall Study|Adverse Event|8|||
164578777|NCT02371629|594484117|FG001|Overall Study|Adverse Event|8|||
164578778|NCT02371629|594484116|FG000|Overall Study|Physician Decision|2|||
164578779|NCT02371629|594484117|FG001|Overall Study|Physician Decision|3|||
164578780|NCT02371629|594484116|FG000|Overall Study|Death|1|||
164578781|NCT02371629|594484117|FG001|Overall Study|Death|1|||
164578782|NCT02371629|594484116|FG000|Overall Study|Noncompliance with study treatment|1|||
164578783|NCT02371629|594484117|FG001|Overall Study|Noncompliance with study treatment|0|||
164578784|NCT02371629|594484116|FG000|Overall Study|Lack of Efficacy|0|||
164578785|NCT02371629|594484117|FG001|Overall Study|Lack of Efficacy|2|||
164578786|NCT02371629|594484116|FG000|Overall Study|Protocol deviation|0|||
164578787|NCT02371629|594484117|FG001|Overall Study|Protocol deviation|1|||
164578788|NCT01193335|594484118|FG000|After Infant Series|Lost to Follow-up|1|||
164578789|NCT01193335|594484119|FG001|After Infant Series|Lost to Follow-up|2|||
164578790|NCT01193335|594484118|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
164578791|NCT01193335|594484119|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
164578792|NCT01193335|594484118|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
164578793|NCT01193335|594484119|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
164578794|NCT01193335|594484118|FG000|1-Year Follow-up|Lost to Follow-up|4|||
164578795|NCT01193335|594484119|FG001|1-Year Follow-up|Lost to Follow-up|0|||
164578796|NCT01193335|594484118|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
164578797|NCT01193335|594484119|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
164578798|NCT01193335|594484118|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
164578799|NCT01193335|594484119|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
164578800|NCT03486314|594484121|FG000|Part A|Adverse Event|1|||
164578801|NCT03486314|594484122|FG001|Part A|Adverse Event|0|||
164578802|NCT03486314|594484123|FG002|Part A|Adverse Event|0|||
164578803|NCT03486314|594484121|FG000|Part A|Symptomatic Deterioration|2|||
164578804|NCT03486314|594484122|FG001|Part A|Symptomatic Deterioration|0|||
164578805|NCT03486314|594484123|FG002|Part A|Symptomatic Deterioration|0|||
164578806|NCT01985321|594484124|FG000|Overall Study|Protocol Violation|4|||
164578807|NCT01985321|594484125|FG001|Overall Study|Protocol Violation|3|||
164578808|NCT01985321|594484124|FG000|Overall Study|Withdrawal by Subject|1|||
164578809|NCT01985321|594484125|FG001|Overall Study|Withdrawal by Subject|0|||
164578810|NCT01985321|594484124|FG000|Overall Study|Lost to Follow-up|5|||
164578811|NCT01985321|594484125|FG001|Overall Study|Lost to Follow-up|2|||
164578812|NCT01985321|594484124|FG000|Overall Study|Subject treated wrong type of sore|1|||
164578813|NCT01985321|594484125|FG001|Overall Study|Subject treated wrong type of sore|0|||
164683262|NCT01894230|594863408|FG000|Overall Study|Death|1|||
164683263|NCT01894230|594863409|FG001|Overall Study|Death|0|||
164683264|NCT01109849|594863410|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
164683265|NCT01109849|594863411|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
164683266|NCT01109849|594863412|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
164683267|NCT01109849|594863413|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
164578814|NCT01364467|594484128|FG000|Overall Study|Lost to Follow-up|1|||
164578815|NCT01364467|594484129|FG001|Overall Study|Lost to Follow-up|2|||
164578816|NCT03577990|594484130|FG000|Overall Study|Lost to Follow-up|4|||
164578817|NCT03577990|594484131|FG001|Overall Study|Lost to Follow-up|6|||
164578818|NCT03577990|594484130|FG000|Overall Study|Withdrawal by Subject|4|||
164578819|NCT03577990|594484131|FG001|Overall Study|Withdrawal by Subject|7|||
164578820|NCT02827877|594484132|FG000|Overall Study|Withdrawal by Subject|1|||
164578821|NCT00519532|594484135|FG000|Overall Study|Adverse Event|11|||
164578822|NCT00519532|594484135|FG000|Overall Study|Withdrawal by Subject|5|||
164578823|NCT00519532|594484135|FG000|Overall Study|Lost to Follow-up|2|||
164578824|NCT03914300|594484136|FG000|Overall Study|Adverse Event|1|||
164264613|NCT04316741|593336575|FG001|1-month Post-test|Lost to Follow-up|2|||
164264614|NCT04316741|593336574|FG000|3-month Follow-up|Lost to Follow-up|10|||
164264615|NCT04316741|593336575|FG001|3-month Follow-up|Lost to Follow-up|2|||
164264616|NCT01442064|593336576|FG000|Overall Study|Adverse Event|2|||
164264617|NCT01442064|593336577|FG001|Overall Study|Adverse Event|2|||
164264618|NCT01442064|593336578|FG002|Overall Study|Adverse Event|2|||
164264619|NCT01442064|593336579|FG003|Overall Study|Adverse Event|1|||
164264620|NCT01442064|593336580|FG004|Overall Study|Adverse Event|2|||
164264621|NCT01442064|593336581|FG005|Overall Study|Adverse Event|0|||
164264622|NCT01442064|593336576|FG000|Overall Study|Death|0|||
164341265|NCT02229383|593623931|FG000|Overall Study|Lost to Follow-up|5|||
164341266|NCT02229383|593623932|FG001|Overall Study|Lost to Follow-up|3|||
164341267|NCT02229383|593623931|FG000|Overall Study|Withdrawal by Subject|4|||
164341268|NCT02229383|593623932|FG001|Overall Study|Withdrawal by Subject|6|||
164578825|NCT00814710|594484137|FG000|Overall Study|Adverse Event|1|||
164578826|NCT00814710|594484138|FG001|Overall Study|Adverse Event|0|||
164578827|NCT00814710|594484137|FG000|Overall Study|Lost to Follow-up|7|||
164341269|NCT02229383|593623931|FG000|Overall Study|Did not receive treatment|1|||
164578828|NCT00814710|594484138|FG001|Overall Study|Lost to Follow-up|3|||
164578829|NCT04090164|594484147|FG000|Overall Study|incomplete data on file|245|||
164578830|NCT04090164|594484148|FG001|Overall Study|incomplete data on file|0|||
164578831|NCT04865731|594484149|FG000|Overall Study|Physician Decision|2|||
164578832|NCT04865731|594484150|FG001|Overall Study|Physician Decision|1|||
164578833|NCT04865731|594484149|FG000|Overall Study|Adverse Event|1|||
164578834|NCT04865731|594484150|FG001|Overall Study|Adverse Event|0|||
164578835|NCT04865731|594484149|FG000|Overall Study|Withdrawal by Subject|0|||
164264623|NCT01442064|593336577|FG001|Overall Study|Death|1|||
164264624|NCT01442064|593336578|FG002|Overall Study|Death|3|||
164264625|NCT01442064|593336579|FG003|Overall Study|Death|3|||
164264626|NCT01442064|593336580|FG004|Overall Study|Death|1|||
164264627|NCT01442064|593336581|FG005|Overall Study|Death|3|||
164341270|NCT02229383|593623932|FG001|Overall Study|Did not receive treatment|0|||
164578836|NCT04865731|594484150|FG001|Overall Study|Withdrawal by Subject|1|||
164578837|NCT01826214|594485436|FG000|Overall Study|Adverse Event|7|||
164578838|NCT01826214|594485437|FG001|Overall Study|Adverse Event|6|||
164578839|NCT01826214|594485436|FG000|Overall Study|Death|3|||
164578840|NCT01826214|594485437|FG001|Overall Study|Death|1|||
164578841|NCT01826214|594485436|FG000|Overall Study|Lost to Follow-up|1|||
164578842|NCT01826214|594485437|FG001|Overall Study|Lost to Follow-up|0|||
164578843|NCT01826214|594485436|FG000|Overall Study|Physician Decision|0|||
164578844|NCT01826214|594485437|FG001|Overall Study|Physician Decision|2|||
164578845|NCT01826214|594485436|FG000|Overall Study|Progressive disease|22|||
164578846|NCT01826214|594485437|FG001|Overall Study|Progressive disease|21|||
164578847|NCT01826214|594485436|FG000|Overall Study|Study terminated by Sponsor|0|||
164578848|NCT01826214|594485437|FG001|Overall Study|Study terminated by Sponsor|1|||
164578849|NCT01826214|594485436|FG000|Overall Study|Subject/guardian decision|2|||
164578850|NCT01826214|594485437|FG001|Overall Study|Subject/guardian decision|3|||
164578851|NCT00955110|594485438|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
164578852|NCT00955110|594485438|FG000|Treatment Phase|Adverse Event|2|||
164578853|NCT00955110|594485438|FG000|Treatment Phase|Administrative reasons|2|||
164578854|NCT00955110|594485438|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
164578855|NCT00955110|594485438|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
164578856|NCT02128490|594485439|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
164578857|NCT02128490|594485440|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
164578858|NCT02128490|594485441|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
164578859|NCT02128490|594485442|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
164578860|NCT02128490|594485443|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
164578861|NCT02128490|594485439|FG000|Overall Study|Major Protocol Deviation|1|||
164578862|NCT02128490|594485440|FG001|Overall Study|Major Protocol Deviation|2|||
164578863|NCT02128490|594485441|FG002|Overall Study|Major Protocol Deviation|0|||
164578864|NCT02128490|594485442|FG003|Overall Study|Major Protocol Deviation|2|||
164578865|NCT02128490|594485443|FG004|Overall Study|Major Protocol Deviation|2|||
164578866|NCT02128490|594485439|FG000|Overall Study|Lost to Follow-up|0|||
164578867|NCT02128490|594485440|FG001|Overall Study|Lost to Follow-up|0|||
164578868|NCT02128490|594485441|FG002|Overall Study|Lost to Follow-up|1|||
164264628|NCT01442064|593336576|FG000|Overall Study|Lost to Follow-up|5|||
164264629|NCT01442064|593336577|FG001|Overall Study|Lost to Follow-up|5|||
164264630|NCT01442064|593336578|FG002|Overall Study|Lost to Follow-up|1|||
164264631|NCT01442064|593336579|FG003|Overall Study|Lost to Follow-up|1|||
164264632|NCT01442064|593336580|FG004|Overall Study|Lost to Follow-up|3|||
164264633|NCT01442064|593336581|FG005|Overall Study|Lost to Follow-up|3|||
164264634|NCT01442064|593336576|FG000|Overall Study|Physician Decision|1|||
164264635|NCT01442064|593336577|FG001|Overall Study|Physician Decision|1|||
164264636|NCT01442064|593336578|FG002|Overall Study|Physician Decision|2|||
164264637|NCT01442064|593336579|FG003|Overall Study|Physician Decision|3|||
164264638|NCT01442064|593336580|FG004|Overall Study|Physician Decision|3|||
164264639|NCT01442064|593336581|FG005|Overall Study|Physician Decision|1|||
164264640|NCT01442064|593336576|FG000|Overall Study|Withdrawal by Subject|6|||
164264641|NCT01442064|593336577|FG001|Overall Study|Withdrawal by Subject|3|||
164264642|NCT01442064|593336578|FG002|Overall Study|Withdrawal by Subject|2|||
164264643|NCT01442064|593336579|FG003|Overall Study|Withdrawal by Subject|2|||
164264644|NCT01442064|593336580|FG004|Overall Study|Withdrawal by Subject|2|||
164264645|NCT01442064|593336581|FG005|Overall Study|Withdrawal by Subject|1|||
164264646|NCT01442064|593336576|FG000|Overall Study|Sponsor decision|82|||
164264647|NCT01442064|593336577|FG001|Overall Study|Sponsor decision|88|||
164264648|NCT01442064|593336578|FG002|Overall Study|Sponsor decision|92|||
164264649|NCT01442064|593336579|FG003|Overall Study|Sponsor decision|88|||
164264650|NCT01442064|593336580|FG004|Overall Study|Sponsor decision|95|||
164264651|NCT01442064|593336581|FG005|Overall Study|Sponsor decision|87|||
164264652|NCT01442064|593336576|FG000|Overall Study|Subject non-compliance|0|||
164264653|NCT01442064|593336577|FG001|Overall Study|Subject non-compliance|0|||
164264654|NCT01442064|593336578|FG002|Overall Study|Subject non-compliance|0|||
164264655|NCT01442064|593336579|FG003|Overall Study|Subject non-compliance|0|||
164264656|NCT01442064|593336580|FG004|Overall Study|Subject non-compliance|0|||
164264657|NCT01442064|593336581|FG005|Overall Study|Subject non-compliance|2|||
164264658|NCT01442064|593336576|FG000|Overall Study|Condition mandated other intervention|1|||
164264659|NCT01442064|593336577|FG001|Overall Study|Condition mandated other intervention|1|||
164430202|NCT00819234|593945337|FG001|Overall Study|Physician Decision|0|||
164430203|NCT00819234|593945338|FG002|Overall Study|Physician Decision|0|||
164430204|NCT00819234|593945339|FG003|Overall Study|Physician Decision|1|||
164430205|NCT00819234|593945340|FG004|Overall Study|Physician Decision|0|||
164578869|NCT02128490|594485442|FG003|Overall Study|Lost to Follow-up|1|||
164578870|NCT02128490|594485443|FG004|Overall Study|Lost to Follow-up|1|||
164264660|NCT01442064|593336578|FG002|Overall Study|Condition mandated other intervention|2|||
164430206|NCT00819234|593945341|FG005|Overall Study|Physician Decision|0|||
164578871|NCT02128490|594485439|FG000|Overall Study|Voluntary Withdrawal|3|||
164578872|NCT02128490|594485440|FG001|Overall Study|Voluntary Withdrawal|3|||
164578873|NCT02128490|594485441|FG002|Overall Study|Voluntary Withdrawal|1|||
164578874|NCT02128490|594485442|FG003|Overall Study|Voluntary Withdrawal|1|||
164578875|NCT02128490|594485443|FG004|Overall Study|Voluntary Withdrawal|2|||
164578876|NCT02128490|594485439|FG000|Overall Study|Lack of Efficacy|0|||
164578877|NCT02128490|594485440|FG001|Overall Study|Lack of Efficacy|1|||
164578878|NCT02128490|594485441|FG002|Overall Study|Lack of Efficacy|0|||
164578879|NCT02128490|594485442|FG003|Overall Study|Lack of Efficacy|0|||
164578880|NCT02128490|594485443|FG004|Overall Study|Lack of Efficacy|0|||
164578881|NCT02128490|594485439|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
164578882|NCT02128490|594485440|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
164578883|NCT02128490|594485441|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
164578884|NCT02128490|594485442|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
164578885|NCT02128490|594485443|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
164578886|NCT02128490|594485439|FG000|Overall Study|Other Miscellaneous Reasons|0|||
164578887|NCT02128490|594485440|FG001|Overall Study|Other Miscellaneous Reasons|0|||
164578888|NCT02128490|594485441|FG002|Overall Study|Other Miscellaneous Reasons|2|||
164578889|NCT02128490|594485442|FG003|Overall Study|Other Miscellaneous Reasons|1|||
164578890|NCT02128490|594485443|FG004|Overall Study|Other Miscellaneous Reasons|1|||
164578891|NCT02243176|594485444|FG000|Overall Study|Other reason|1|||
164578892|NCT02243176|594485445|FG001|Overall Study|Other reason|2|||
164578893|NCT02243176|594485444|FG000|Overall Study|protocol specified withdrawal critera|1|||
164578894|NCT02243176|594485445|FG001|Overall Study|protocol specified withdrawal critera|3|||
164578895|NCT02243176|594485444|FG000|Overall Study|Protocol Violation|2|||
164578896|NCT02243176|594485445|FG001|Overall Study|Protocol Violation|1|||
164578897|NCT02243176|594485444|FG000|Overall Study|Withdrawal by Subject|8|||
164578898|NCT02243176|594485445|FG001|Overall Study|Withdrawal by Subject|7|||
164578899|NCT02243176|594485444|FG000|Overall Study|Adverse Event|2|||
164578900|NCT02243176|594485445|FG001|Overall Study|Adverse Event|2|||
164578901|NCT03311126|594485447|FG000|Induction|Death|1|||
164578902|NCT03311126|594485447|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
164264661|NCT01442064|593336579|FG003|Overall Study|Condition mandated other intervention|0|||
164264662|NCT01442064|593336580|FG004|Overall Study|Condition mandated other intervention|0|||
164578903|NCT03113500|594485448|FG000|Overall Study|Withdrawal by Subject|1|||
164341271|NCT02229383|593623931|FG000|Overall Study|Other|3|||
164341272|NCT02229383|593623932|FG001|Overall Study|Other|8|||
164341273|NCT00873015|593623938|FG000|Overall Study|Withdrawal by Subject|0|||
164341274|NCT00873015|593623939|FG001|Overall Study|Withdrawal by Subject|1|||
164341275|NCT00873015|593623940|FG002|Overall Study|Withdrawal by Subject|0|||
164341276|NCT00873015|593623941|FG003|Overall Study|Withdrawal by Subject|0|||
164341277|NCT02400333|593625292|FG000|Overall Study|Withdrawal by Subject|0|||
164683268|NCT01109849|594863414|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
164341278|NCT02400333|593625293|FG001|Overall Study|Withdrawal by Subject|1|||
164341279|NCT02400333|593625294|FG002|Overall Study|Withdrawal by Subject|0|||
164341280|NCT02400333|593625295|FG003|Overall Study|Withdrawal by Subject|1|||
164341281|NCT02400333|593625292|FG000|Overall Study|Protocol Violation|1|||
164341282|NCT02400333|593625293|FG001|Overall Study|Protocol Violation|0|||
164341283|NCT02400333|593625294|FG002|Overall Study|Protocol Violation|2|||
164341284|NCT02400333|593625295|FG003|Overall Study|Protocol Violation|1|||
164341285|NCT01687998|593625299|FG000|Overall Study|Withdrawal by Subject|49|||
164341286|NCT01687998|593625300|FG001|Overall Study|Withdrawal by Subject|51|||
164341287|NCT01687998|593625299|FG000|Overall Study|Known to be Alive at Study End|54|||
164341288|NCT01687998|593625300|FG001|Overall Study|Known to be Alive at Study End|62|||
164341289|NCT01687998|593625299|FG000|Overall Study|Lost to Follow-up|9|||
164341290|NCT01687998|593625300|FG001|Overall Study|Lost to Follow-up|7|||
164341291|NCT01663532|593625303|FG000|Overall Study|Lost to Follow-up|9|||
164341292|NCT01663532|593625304|FG001|Overall Study|Lost to Follow-up|10|||
164683269|NCT01109849|594863410|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
164683270|NCT01109849|594863411|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
164683271|NCT01109849|594863412|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
164683272|NCT01109849|594863413|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
164683273|NCT01109849|594863414|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
164683274|NCT01109849|594863410|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
164683275|NCT01109849|594863411|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
164683276|NCT01109849|594863412|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
164683277|NCT01109849|594863413|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
164683278|NCT01109849|594863414|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
164683279|NCT01109849|594863410|FG000|Initial Randomization: ADHD Treatment|move away|2|||
164683280|NCT01109849|594863411|FG001|Initial Randomization: ADHD Treatment|move away|7|||
164683281|NCT01109849|594863412|FG002|Initial Randomization: ADHD Treatment|move away|0|||
164683282|NCT01109849|594863413|FG003|Initial Randomization: ADHD Treatment|move away|0|||
164683283|NCT01109849|594863414|FG004|Initial Randomization: ADHD Treatment|move away|0|||
164683284|NCT01109849|594863410|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
164683285|NCT01109849|594863411|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
164683286|NCT01109849|594863412|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
164683287|NCT01109849|594863413|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
164683288|NCT01109849|594863414|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
164683289|NCT01109849|594863410|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
164683290|NCT01109849|594863411|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
164683291|NCT01109849|594863412|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
164683292|NCT01109849|594863413|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
164683293|NCT01109849|594863414|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
164683294|NCT02219009|594863417|FG000|Overall Study|Withdrawal by Subject|5|||
164683295|NCT02219009|594863418|FG001|Overall Study|Withdrawal by Subject|1|||
164683296|NCT02219009|594863417|FG000|Overall Study|Adverse Event|2|||
164683297|NCT02219009|594863418|FG001|Overall Study|Adverse Event|4|||
164683298|NCT02219009|594863417|FG000|Overall Study|Lost to Follow-up|2|||
164683299|NCT02219009|594863418|FG001|Overall Study|Lost to Follow-up|2|||
164683300|NCT02219009|594863417|FG000|Overall Study|Protocol deviation|1|||
164683301|NCT02219009|594863418|FG001|Overall Study|Protocol deviation|0|||
164683302|NCT02219009|594863417|FG000|Overall Study|Physician Decision|0|||
164683303|NCT02219009|594863418|FG001|Overall Study|Physician Decision|1|||
164683304|NCT02259348|594863419|FG000|Overall Study|Donors|6|||
164683305|NCT02259348|594863419|FG000|Overall Study|Death|4|||
164683306|NCT01622660|594863420|FG000|Overall Study|Adverse Event|1|||
164683307|NCT02485158|594863422|FG000|Overall Study|Withdrawal by Subject|3|||
164683308|NCT02485158|594863422|FG000|Overall Study|expected drug side effect|1|||
164683309|NCT02664415|594863423|FG000|Overall Study|Adverse Event|1|||
164683310|NCT02664415|594863424|FG001|Overall Study|Adverse Event|0|||
164683311|NCT00642993|594863425|FG000|Overall Study|Adverse Event|85|||
164683312|NCT00642993|594863426|FG001|Overall Study|Adverse Event|4|||
164341293|NCT01663532|593625303|FG000|Overall Study|Adverse Event|7|||
164683313|NCT00642993|594863425|FG000|Overall Study|Lost to Follow-up|8|||
164683314|NCT00642993|594863426|FG001|Overall Study|Lost to Follow-up|4|||
164683315|NCT00642993|594863425|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
164683316|NCT00642993|594863426|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
164683317|NCT00642993|594863425|FG000|Overall Study|Protocol Violation|1|||
164264663|NCT01442064|593336581|FG005|Overall Study|Condition mandated other intervention|2|||
164264664|NCT01360398|593336582|FG000|Overall Study|Withdrawal by Subject|14|||
164264665|NCT01360398|593336582|FG000|Overall Study|Other|7|||
164264666|NCT01360398|593336582|FG000|Overall Study|Migrated/moved from study area|1|||
164264667|NCT02153346|593336583|FG000|Overall Study|Lost to Follow-up|11|||
164264668|NCT01710527|593336584|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
164264669|NCT01710527|593336585|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
164264670|NCT03946124|593338669|FG000|Overall Study|Withdrawal by Subject|19|||
164264671|NCT02118597|593338678|FG000|Overall Study|Sponsor terminated the study|14|||
164264672|NCT02118597|593338678|FG000|Overall Study|Serious Adverse Event|1|||
164264673|NCT02118597|593338678|FG000|Overall Study|Investigator's decision|1|||
164264674|NCT01891344|593338679|FG000|Overall Study|Ongoing|6|||
164264675|NCT01891344|593338680|FG001|Overall Study|Ongoing|2|||
164264676|NCT01891344|593338681|FG002|Overall Study|Ongoing|0|||
164264677|NCT01891344|593338682|FG003|Overall Study|Ongoing|1|||
164264678|NCT01891344|593338683|FG004|Overall Study|Ongoing|4|||
164264679|NCT01891344|593338684|FG005|Overall Study|Ongoing|1|||
164264680|NCT01891344|593338685|FG006|Overall Study|Ongoing|0|||
164264681|NCT01891344|593338686|FG007|Overall Study|Ongoing|0|||
164264682|NCT01852825|593338687|FG000|Overall Study|Withdrawal by Subject|2|||
164264683|NCT01852825|593338688|FG001|Overall Study|Withdrawal by Subject|0|||
164264684|NCT01852825|593338689|FG002|Overall Study|Withdrawal by Subject|0|||
164264685|NCT01414205|593338690|FG000|Overall Study|Death|5|||
164264686|NCT01414205|593338691|FG001|Overall Study|Death|1|||
164264687|NCT01414205|593338690|FG000|Overall Study|Lost to Follow-up|1|||
164264688|NCT01414205|593338691|FG001|Overall Study|Lost to Follow-up|4|||
164264689|NCT01414205|593338690|FG000|Overall Study|Physician Decision|0|||
164264690|NCT01414205|593338691|FG001|Overall Study|Physician Decision|1|||
164264691|NCT01414205|593338690|FG000|Overall Study|Randomized but not Treated|1|||
164264692|NCT01414205|593338691|FG001|Overall Study|Randomized but not Treated|1|||
164264693|NCT01166373|593338692|FG000|Overall Study|Lost to Follow-up|3|||
164264694|NCT01166373|593338693|FG001|Overall Study|Lost to Follow-up|2|||
164264695|NCT01166373|593338694|FG002|Overall Study|Lost to Follow-up|2|||
164264696|NCT01166373|593338695|FG003|Overall Study|Lost to Follow-up|2|||
164264697|NCT01166373|593338692|FG000|Overall Study|Withdrawal by Subject|1|||
164264698|NCT01166373|593338693|FG001|Overall Study|Withdrawal by Subject|2|||
164264699|NCT01166373|593338694|FG002|Overall Study|Withdrawal by Subject|2|||
164264700|NCT01166373|593338695|FG003|Overall Study|Withdrawal by Subject|3|||
164264701|NCT01166373|593338692|FG000|Overall Study|Physician Decision|1|||
164264702|NCT01166373|593338693|FG001|Overall Study|Physician Decision|0|||
164341294|NCT01663532|593625304|FG001|Overall Study|Adverse Event|13|||
164341295|NCT01663532|593625303|FG000|Overall Study|Met Withdrawal Criteria|7|||
164341296|NCT01663532|593625304|FG001|Overall Study|Met Withdrawal Criteria|6|||
164341297|NCT01663532|593625303|FG000|Overall Study|Physician Decision|1|||
164341298|NCT01663532|593625304|FG001|Overall Study|Physician Decision|1|||
164341299|NCT01663532|593625303|FG000|Overall Study|Withdrawal by Subject|35|||
164341300|NCT01663532|593625304|FG001|Overall Study|Withdrawal by Subject|17|||
164341301|NCT01663532|593625303|FG000|Overall Study|Lack of Efficacy|15|||
164341302|NCT01663532|593625304|FG001|Overall Study|Lack of Efficacy|60|||
164341303|NCT01871532|593625310|FG000|Overall Study|Withdrawal by Subject|1|||
164341304|NCT01871532|593625311|FG001|Overall Study|Withdrawal by Subject|2|||
164341305|NCT00283400|593625312|FG000|Overall Study|Withdrawal by Subject|1|||
164341306|NCT00283400|593625313|FG001|Overall Study|Withdrawal by Subject|1|||
164341307|NCT00283400|593625314|FG002|Overall Study|Withdrawal by Subject|0|||
164341308|NCT00283400|593625315|FG003|Overall Study|Withdrawal by Subject|0|||
164341309|NCT00283400|593625312|FG000|Overall Study|Death|1|||
164341310|NCT00283400|593625313|FG001|Overall Study|Death|0|||
164341311|NCT00283400|593625314|FG002|Overall Study|Death|1|||
164341312|NCT00283400|593625315|FG003|Overall Study|Death|0|||
164341313|NCT00934089|593625319|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
164341314|NCT00934089|593625320|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
164430207|NCT00819234|593945342|FG006|Overall Study|Physician Decision|0|||
164430208|NCT00819234|593945343|FG007|Overall Study|Physician Decision|0|||
164264703|NCT01166373|593338694|FG002|Overall Study|Physician Decision|0|||
164264704|NCT01166373|593338695|FG003|Overall Study|Physician Decision|0|||
164264705|NCT02498067|593338696|FG000|Overall Study|Lost to Follow-up|22|||
164264706|NCT02498067|593338696|FG000|Overall Study|Did not meet inclusion criteria|11|||
164264707|NCT02214225|593338701|FG000|Overall Study|Lost to Follow-up|46|||
164341315|NCT00934089|593625319|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
164341316|NCT00934089|593625320|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
164341317|NCT01020981|593625321|FG000|Overall Study|Did not return mailed survey|74|||
164341318|NCT01020981|593625322|FG001|Overall Study|Did not return mailed survey|58|||
164264708|NCT02214225|593338702|FG001|Overall Study|Lost to Follow-up|18|||
164264709|NCT02214225|593338703|FG002|Overall Study|Lost to Follow-up|18|||
164264710|NCT02214225|593338701|FG000|Overall Study|Withdrawal by Subject|2|||
164264711|NCT02214225|593338702|FG001|Overall Study|Withdrawal by Subject|0|||
164264712|NCT02214225|593338703|FG002|Overall Study|Withdrawal by Subject|2|||
164430209|NCT00819234|593945344|FG008|Overall Study|Physician Decision|0|||
164264713|NCT02214225|593338701|FG000|Overall Study|Death|5|||
164264714|NCT02214225|593338702|FG001|Overall Study|Death|0|||
164264715|NCT02214225|593338703|FG002|Overall Study|Death|1|||
164264716|NCT02214225|593338701|FG000|Overall Study|randomized in error, not vaccinated|2|||
164264717|NCT02214225|593338702|FG001|Overall Study|randomized in error, not vaccinated|1|||
164264718|NCT02214225|593338703|FG002|Overall Study|randomized in error, not vaccinated|1|||
164264719|NCT03987932|593338704|FG000|Overall Study|Lost to Follow-up|2|||
164264720|NCT03987932|593338705|FG001|Overall Study|Lost to Follow-up|1|||
164264721|NCT03987932|593338706|FG002|Overall Study|Lost to Follow-up|1|||
164264722|NCT03987932|593338704|FG000|Overall Study|Non-study related elective surgery|0|||
164264723|NCT03987932|593338705|FG001|Overall Study|Non-study related elective surgery|0|||
164264724|NCT03987932|593338706|FG002|Overall Study|Non-study related elective surgery|1|||
164264725|NCT01669421|593338709|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
164264726|NCT01669421|593338709|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
164264727|NCT02813668|593338715|FG000|Overall Study|Death|4|||
164264728|NCT02813668|593338715|FG000|Overall Study|Lost to Follow-up|509|||
164264729|NCT02813668|593338715|FG000|Overall Study|Withdrawal by Subject|148|||
164264730|NCT02813668|593338715|FG000|Overall Study|No longer at worksite|85|||
164264731|NCT02813668|593338715|FG000|Overall Study|Medical reasons not related to the study|4|||
164264732|NCT02961790|593338716|FG000|Overall Study|Canceled|4|||
164264733|NCT02961790|593338717|FG001|Overall Study|Canceled|5|||
164683318|NCT00642993|594863426|FG001|Overall Study|Protocol Violation|4|||
164683319|NCT00642993|594863425|FG000|Overall Study|Did not meet protocol eligibility|0|||
164683320|NCT00642993|594863426|FG001|Overall Study|Did not meet protocol eligibility|1|||
164683321|NCT00642993|594863425|FG000|Overall Study|Administrative|1|||
164683322|NCT00642993|594863426|FG001|Overall Study|Administrative|0|||
164683323|NCT02034513|594863427|FG000|Overall Study|Adverse Event|11|||
164683324|NCT02034513|594863428|FG001|Overall Study|Adverse Event|10|||
164683325|NCT02034513|594863427|FG000|Overall Study|Lack of Efficacy|0|||
164683326|NCT02034513|594863428|FG001|Overall Study|Lack of Efficacy|1|||
164683327|NCT02034513|594863427|FG000|Overall Study|Lost to Follow-up|6|||
164683328|NCT02034513|594863428|FG001|Overall Study|Lost to Follow-up|7|||
164683329|NCT02034513|594863427|FG000|Overall Study|Pregnancy|0|||
164683330|NCT02034513|594863428|FG001|Overall Study|Pregnancy|3|||
164683331|NCT02034513|594863427|FG000|Overall Study|Protocol Violation|7|||
164683332|NCT02034513|594863428|FG001|Overall Study|Protocol Violation|10|||
164683333|NCT02034513|594863427|FG000|Overall Study|Withdrawal by Subject|25|||
164683334|NCT02034513|594863428|FG001|Overall Study|Withdrawal by Subject|25|||
164683335|NCT02034513|594863427|FG000|Overall Study|Unclassified|0|||
164683336|NCT02034513|594863428|FG001|Overall Study|Unclassified|1|||
164683337|NCT00960154|594863429|FG000|Overall Study|Study termination|25|||
164683338|NCT00960154|594863430|FG001|Overall Study|Study termination|25|||
164683339|NCT00757705|594863431|FG000|Overall Study|Adverse Event|19|||
164683340|NCT00757705|594863431|FG000|Overall Study|Lost to Follow-up|16|||
164683341|NCT00757705|594863431|FG000|Overall Study|Withdrawal by Subject|25|||
164683342|NCT00757705|594863431|FG000|Overall Study|Insufficient Response|26|||
164683343|NCT00757705|594863431|FG000|Overall Study|Ineligible to continue|8|||
164683344|NCT00757705|594863431|FG000|Overall Study|Non-compliant|9|||
164683345|NCT00757705|594863431|FG000|Overall Study|Other|18|||
164683346|NCT04408924|594863435|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
164683347|NCT04408924|594863435|FG000|Overall Study|Lost to Follow-up|3|||
164683348|NCT04408924|594863435|FG000|Overall Study|Withdrawal by Subject|5|||
164683349|NCT04408924|594863435|FG000|Overall Study|Sponsor Decision|2|||
164264734|NCT02961790|593338718|FG002|Overall Study|Canceled|1|||
164264735|NCT02961790|593338719|FG003|Overall Study|Canceled|4|||
164264736|NCT02961790|593338716|FG000|Overall Study|without baseline data|4|||
164264737|NCT02961790|593338717|FG001|Overall Study|without baseline data|0|||
164264738|NCT02961790|593338718|FG002|Overall Study|without baseline data|1|||
164264739|NCT02961790|593338719|FG003|Overall Study|without baseline data|0|||
164264740|NCT02961790|593338716|FG000|Overall Study|without post baseline data|7|||
164264741|NCT02961790|593338717|FG001|Overall Study|without post baseline data|6|||
164264742|NCT02961790|593338718|FG002|Overall Study|without post baseline data|4|||
164264743|NCT02961790|593338719|FG003|Overall Study|without post baseline data|1|||
164264744|NCT02594098|593338724|FG000|Overall Study|Lack of Efficacy|17|||
164264745|NCT02594098|593338725|FG001|Overall Study|Lack of Efficacy|6|||
164264746|NCT02594098|593338724|FG000|Overall Study|Withdrawal by Subject|1|||
164264747|NCT02594098|593338725|FG001|Overall Study|Withdrawal by Subject|3|||
164683350|NCT00486434|594863436|FG000|Overall Study|Withdrawal by Subject|34|||
164683351|NCT00486434|594863437|FG001|Overall Study|Withdrawal by Subject|39|||
164683352|NCT00486434|594863436|FG000|Overall Study|Adverse Event|118|||
164683353|NCT00486434|594863437|FG001|Overall Study|Adverse Event|44|||
164683354|NCT00486434|594863436|FG000|Overall Study|Protocol Violation|22|||
164683355|NCT00486434|594863437|FG001|Overall Study|Protocol Violation|21|||
164683356|NCT00486434|594863436|FG000|Overall Study|Lack of Efficacy|12|||
164683357|NCT00486434|594863437|FG001|Overall Study|Lack of Efficacy|19|||
164683358|NCT00486434|594863436|FG000|Overall Study|Lost to Follow-up|2|||
164683359|NCT00486434|594863437|FG001|Overall Study|Lost to Follow-up|3|||
164683360|NCT00486434|594863436|FG000|Overall Study|Death|1|||
164683361|NCT00486434|594863437|FG001|Overall Study|Death|2|||
164683362|NCT00486434|594863436|FG000|Overall Study|Personal reasons|5|||
164683363|NCT00486434|594863437|FG001|Overall Study|Personal reasons|6|||
164683364|NCT02218541|594863438|FG000|Overall Study|Lost to Follow-up|2|||
164683365|NCT02218541|594863439|FG001|Overall Study|Lost to Follow-up|1|||
164683366|NCT02218541|594863438|FG000|Overall Study|Implant Failure|4|||
164683367|NCT02218541|594863439|FG001|Overall Study|Implant Failure|1|||
164683368|NCT04661202|594863440|FG000|Overall Study|Withdrawal by Subject|1|||
164683369|NCT04661202|594863441|FG001|Overall Study|Withdrawal by Subject|1|||
164683370|NCT04661202|594863440|FG000|Overall Study|Lack of Efficacy|2|||
164683371|NCT04661202|594863441|FG001|Overall Study|Lack of Efficacy|0|||
164683372|NCT00856349|594863442|FG000|Overall Study|Death|418|||
164683373|NCT00856349|594863442|FG000|Overall Study|Withdrawal by Subject|116|||
164683374|NCT00856349|594863442|FG000|Overall Study|Lost to Follow-up|91|||
164683375|NCT00856349|594863442|FG000|Overall Study|Protocol Violation|38|||
164683376|NCT00856349|594863442|FG000|Overall Study|Physician Decision|13|||
164683377|NCT00856349|594863442|FG000|Overall Study|Subject relocation|104|||
164683378|NCT00856349|594863442|FG000|Overall Study|Device explant|33|||
164683379|NCT00856349|594863442|FG000|Overall Study|Site closure|78|||
164683380|NCT00856349|594863442|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
164683381|NCT02313558|594863445|FG000|Overall Study|Withdrawal by Subject|2|||
164683382|NCT02313558|594863446|FG001|Overall Study|Withdrawal by Subject|0|||
164683383|NCT02313558|594863445|FG000|Overall Study|Lost to Follow-up|4|||
164683384|NCT02313558|594863446|FG001|Overall Study|Lost to Follow-up|4|||
164683385|NCT04158687|594863448|FG000|Overall Study|Adverse Event|2|||
164683386|NCT04158687|594863449|FG001|Overall Study|Adverse Event|3|||
164683387|NCT04158687|594863450|FG002|Overall Study|Adverse Event|0|||
164683388|NCT04158687|594863451|FG003|Overall Study|Adverse Event|3|||
164683389|NCT04158687|594863448|FG000|Overall Study|Lost to Follow-up|5|||
164683390|NCT04158687|594863449|FG001|Overall Study|Lost to Follow-up|12|||
164683391|NCT04158687|594863450|FG002|Overall Study|Lost to Follow-up|4|||
164683392|NCT04158687|594863451|FG003|Overall Study|Lost to Follow-up|5|||
164683393|NCT04158687|594863448|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
164683394|NCT04158687|594863449|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
164683395|NCT04158687|594863450|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
164683396|NCT04158687|594863451|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
164683397|NCT04158687|594863448|FG000|Overall Study|Non-Compliance with Study Medication|2|||
164683398|NCT04158687|594863449|FG001|Overall Study|Non-Compliance with Study Medication|2|||
164683399|NCT04158687|594863450|FG002|Overall Study|Non-Compliance with Study Medication|3|||
164683400|NCT04158687|594863451|FG003|Overall Study|Non-Compliance with Study Medication|0|||
164683401|NCT04158687|594863448|FG000|Overall Study|Investigator Decision|0|||
164683402|NCT04158687|594863449|FG001|Overall Study|Investigator Decision|0|||
164683403|NCT04158687|594863450|FG002|Overall Study|Investigator Decision|2|||
164683404|NCT04158687|594863451|FG003|Overall Study|Investigator Decision|0|||
164683405|NCT04158687|594863448|FG000|Overall Study|Protocol Violation|0|||
164683406|NCT04158687|594863449|FG001|Overall Study|Protocol Violation|2|||
164683407|NCT04158687|594863450|FG002|Overall Study|Protocol Violation|1|||
164683408|NCT04158687|594863451|FG003|Overall Study|Protocol Violation|0|||
164683409|NCT04158687|594863448|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
164683410|NCT04158687|594863449|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
164264748|NCT02594098|593338724|FG000|Overall Study|Terminated participation|6|||
164264749|NCT02594098|593338725|FG001|Overall Study|Terminated participation|2|||
164264750|NCT02594098|593338724|FG000|Overall Study|Seek alternative treatment|2|||
164264751|NCT02594098|593338725|FG001|Overall Study|Seek alternative treatment|1|||
164264752|NCT02594098|593338724|FG000|Overall Study|Other|0|||
164264753|NCT02594098|593338725|FG001|Overall Study|Other|1|||
164264754|NCT01866423|593338727|FG000|Overall Study|Lack of Efficacy|3|||
164264755|NCT01866423|593338727|FG000|Overall Study|Sponsor Decision|1|||
164264756|NCT03366103|593338728|FG000|Overall Study|Disease Progression|3|||
164264757|NCT03366103|593338729|FG001|Overall Study|Disease Progression|1|||
164264758|NCT03366103|593338730|FG002|Overall Study|Disease Progression|0|||
164264759|NCT03366103|593338728|FG000|Overall Study|Adverse Event|0|||
164264760|NCT03366103|593338729|FG001|Overall Study|Adverse Event|1|||
164264761|NCT03366103|593338730|FG002|Overall Study|Adverse Event|0|||
164264762|NCT00541099|593338737|FG000|Overall Study|Ineligible|3|||
164341319|NCT01020981|593625321|FG000|Overall Study|Survey returned undeliverable|8|||
164683411|NCT04158687|594863450|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
164683412|NCT04158687|594863451|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
164683413|NCT04158687|594863448|FG000|Overall Study|Reason not Specified|3|||
164683414|NCT04158687|594863449|FG001|Overall Study|Reason not Specified|2|||
164683415|NCT04158687|594863450|FG002|Overall Study|Reason not Specified|4|||
164683416|NCT04158687|594863451|FG003|Overall Study|Reason not Specified|4|||
164683417|NCT02072096|594863459|FG000|Overall Study|Lack of Efficacy|18|||
164683418|NCT02072096|594863460|FG001|Overall Study|Lack of Efficacy|29|||
164683419|NCT02072096|594863459|FG000|Overall Study|Protocol Violation|7|||
164683420|NCT02072096|594863460|FG001|Overall Study|Protocol Violation|7|||
164683421|NCT02072096|594863459|FG000|Overall Study|Withdrawal by Subject|5|||
164683422|NCT02072096|594863460|FG001|Overall Study|Withdrawal by Subject|7|||
164683423|NCT02072096|594863459|FG000|Overall Study|Adverse Event|5|||
164683424|NCT02072096|594863460|FG001|Overall Study|Adverse Event|2|||
164683425|NCT02072096|594863459|FG000|Overall Study|No Reason Provided|4|||
164683426|NCT02072096|594863460|FG001|Overall Study|No Reason Provided|2|||
164683427|NCT02072096|594863459|FG000|Overall Study|Death|2|||
164683428|NCT02072096|594863460|FG001|Overall Study|Death|0|||
164683429|NCT02072096|594863459|FG000|Overall Study|Physician Decision|0|||
164683430|NCT02072096|594863460|FG001|Overall Study|Physician Decision|1|||
164683431|NCT02072096|594863459|FG000|Overall Study|Study Terminated by Sponsor|43|||
164683432|NCT02072096|594863460|FG001|Overall Study|Study Terminated by Sponsor|30|||
164683433|NCT02072096|594863459|FG000|Overall Study|Lost to Follow-up|1|||
164683434|NCT02072096|594863460|FG001|Overall Study|Lost to Follow-up|0|||
164683435|NCT03236311|594863461|FG000|Overall Study|Study terminated by sponsor|0|||
164683436|NCT03236311|594863462|FG001|Overall Study|Study terminated by sponsor|2|||
164683437|NCT03236311|594863461|FG000|Overall Study|Adverse Event|0|||
164683438|NCT03236311|594863462|FG001|Overall Study|Adverse Event|1|||
164683439|NCT00669162|594863463|FG000|Overall Study|Withdrawal by Subject|1|||
164683440|NCT02412852|594863464|FG000|Overall Study|Withdrawal by Subject|0|||
164683441|NCT02412852|594863465|FG001|Overall Study|Withdrawal by Subject|1|||
164683442|NCT02412852|594863466|FG002|Overall Study|Withdrawal by Subject|0|||
164683443|NCT02412852|594863467|FG003|Overall Study|Withdrawal by Subject|0|||
164683444|NCT02412852|594863464|FG000|Overall Study|Physician Decision|0|||
164683445|NCT02412852|594863465|FG001|Overall Study|Physician Decision|0|||
164683446|NCT02412852|594863466|FG002|Overall Study|Physician Decision|0|||
164683447|NCT02412852|594863467|FG003|Overall Study|Physician Decision|1|||
164683448|NCT01051349|594863468|FG000|Overall Study|Adverse Event|88|||
164683449|NCT01051349|594863468|FG000|Overall Study|Consent Withdrawn|54|||
164683450|NCT01051349|594863468|FG000|Overall Study|Investigator Decision|6|||
164683451|NCT01051349|594863468|FG000|Overall Study|Lost to Follow-up|6|||
164683452|NCT01051349|594863468|FG000|Overall Study|Subject non-compliance|7|||
164683453|NCT01051349|594863468|FG000|Overall Study|Reason not Specified|12|||
164683454|NCT02336074|594863471|FG000|Overall Study|Adverse Event|0|||
164683455|NCT02336074|594863472|FG001|Overall Study|Adverse Event|2|||
164683456|NCT05604014|594863475|FG000|Overall Study|Lost to Follow-up|13|||
164683457|NCT01266902|594863494|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
164683458|NCT01266902|594863495|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
164683459|NCT01266902|594863496|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
164683460|NCT01266902|594863494|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
164683461|NCT01266902|594863495|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
164683462|NCT01266902|594863496|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
164683463|NCT01266902|594863494|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
164683464|NCT01266902|594863495|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
164683465|NCT01266902|594863496|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
164683466|NCT01266902|594863494|FG000|Period 1 (Main Study)|Adverse Event|3|||
164683467|NCT01266902|594863495|FG001|Period 1 (Main Study)|Adverse Event|11|||
164683468|NCT01266902|594863496|FG002|Period 1 (Main Study)|Adverse Event|0|||
164683469|NCT01266902|594863494|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
164683470|NCT01266902|594863495|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
164683471|NCT01266902|594863496|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
164683472|NCT01266902|594863494|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
164683473|NCT01266902|594863495|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
164683474|NCT01266902|594863496|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
164683475|NCT01266902|594863494|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
164683476|NCT01266902|594863495|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
164683477|NCT01266902|594863496|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
164683478|NCT01266902|594863494|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
164683479|NCT01266902|594863495|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
164683480|NCT01266902|594863496|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
164264763|NCT05590000|593338744|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
164264764|NCT01174004|593338745|FG000|Overall Study|Adverse Event|2|||
164264765|NCT01174004|593338746|FG001|Overall Study|Adverse Event|10|||
164264766|NCT01174004|593338745|FG000|Overall Study|Withdrawal by Subject|2|||
164683481|NCT01266902|594863494|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
164683482|NCT01266902|594863495|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
164683483|NCT01266902|594863496|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
164683484|NCT01266902|594863494|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
164683485|NCT01266902|594863495|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
164683486|NCT01266902|594863496|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
164683487|NCT00840203|594863500|FG000|First Intervention|Protocol Violation|1|||
164683488|NCT00840203|594863501|FG001|First Intervention|Protocol Violation|1|||
164683489|NCT00840203|594863500|FG000|Washout|Protocol Violation|1|||
164264767|NCT01174004|593338746|FG001|Overall Study|Withdrawal by Subject|3|||
164264768|NCT01174004|593338745|FG000|Overall Study|At Discretion of Sponsor|2|||
164264769|NCT01174004|593338746|FG001|Overall Study|At Discretion of Sponsor|2|||
164264770|NCT01174004|593338745|FG000|Overall Study|Protocol Violation|0|||
164264771|NCT01174004|593338746|FG001|Overall Study|Protocol Violation|1|||
164264772|NCT01174004|593338745|FG000|Overall Study|Physician Decision|1|||
164264773|NCT01174004|593338746|FG001|Overall Study|Physician Decision|0|||
164264774|NCT00434759|593338753|FG000|Overall Study|Lack of Efficacy|5|||
164264775|NCT00434759|593338754|FG001|Overall Study|Lack of Efficacy|4|||
164264776|NCT00434759|593338753|FG000|Overall Study|Withdrawal by Subject|17|||
164264777|NCT00434759|593338754|FG001|Overall Study|Withdrawal by Subject|1|||
164264778|NCT00434759|593338753|FG000|Overall Study|family affairs|2|||
164264779|NCT00434759|593338754|FG001|Overall Study|family affairs|0|||
164264780|NCT01143896|593338756|FG000|Overall Study|Did not complete Baseline Interview|5|||
164264781|NCT01143896|593338757|FG001|Overall Study|Did not complete Baseline Interview|4|||
164264782|NCT01143896|593338756|FG000|Overall Study|Lost to Follow-up|18|||
164264783|NCT01143896|593338757|FG001|Overall Study|Lost to Follow-up|13|||
164264784|NCT01143896|593338756|FG000|Overall Study|Withdrawal by Subject|13|||
164264785|NCT01143896|593338757|FG001|Overall Study|Withdrawal by Subject|5|||
164264786|NCT01143896|593338756|FG000|Overall Study|Death|6|||
164264787|NCT01143896|593338757|FG001|Overall Study|Death|3|||
164264788|NCT01318070|593338758|FG000|Overall Study|Adverse Event|1|||
164264789|NCT01318070|593338759|FG001|Overall Study|Adverse Event|1|||
164264790|NCT01318070|593338760|FG002|Overall Study|Adverse Event|5|||
164264791|NCT01318070|593338758|FG000|Overall Study|Withdrawal by Subject|0|||
164264792|NCT01318070|593338759|FG001|Overall Study|Withdrawal by Subject|1|||
164264793|NCT01318070|593338760|FG002|Overall Study|Withdrawal by Subject|1|||
164264794|NCT01318070|593338758|FG000|Overall Study|Lack of Efficacy|0|||
164264795|NCT01318070|593338759|FG001|Overall Study|Lack of Efficacy|0|||
164264796|NCT01318070|593338760|FG002|Overall Study|Lack of Efficacy|1|||
164264797|NCT01318070|593338758|FG000|Overall Study|Principal Investigator Discretion|1|||
164264798|NCT01318070|593338759|FG001|Overall Study|Principal Investigator Discretion|0|||
164264799|NCT01318070|593338760|FG002|Overall Study|Principal Investigator Discretion|0|||
164264800|NCT00042432|593338761|FG000|Overall Study|Adverse Event|4|||
164264801|NCT00042432|593338762|FG001|Overall Study|Adverse Event|1|||
164264802|NCT00042432|593338761|FG000|Overall Study|Withdrawal by Subject|1|||
164264803|NCT00042432|593338762|FG001|Overall Study|Withdrawal by Subject|3|||
164264804|NCT00042432|593338761|FG000|Overall Study|Death|0|||
164264805|NCT00042432|593338762|FG001|Overall Study|Death|2|||
164264806|NCT00042432|593338761|FG000|Overall Study|Ineligibility determined|1|||
164264807|NCT00042432|593338762|FG001|Overall Study|Ineligibility determined|0|||
164264808|NCT00042432|593338761|FG000|Overall Study|Initiation of maintenance dialysis|1|||
164264809|NCT00042432|593338762|FG001|Overall Study|Initiation of maintenance dialysis|1|||
164264810|NCT00042432|593338761|FG000|Overall Study|Other|2|||
164264811|NCT00042432|593338762|FG001|Overall Study|Other|0|||
164264812|NCT02966795|593338764|FG000|Overall Study|Patient Left the Country|0|||
164264813|NCT02966795|593338765|FG001|Overall Study|Patient Left the Country|1|||
164264814|NCT00432744|593338766|FG000|Months 0-6|Withdrawal by Subject|4|||
164264815|NCT00432744|593338767|FG001|Months 0-6|Withdrawal by Subject|4|||
164264816|NCT00432744|593338766|FG000|Months 0-6|Too disabled to score|1|||
164264817|NCT00432744|593338767|FG001|Months 0-6|Too disabled to score|0|||
164264818|NCT00432744|593338766|FG000|Months 7 - 12|Withdrawal by Subject|1|||
164264819|NCT00432744|593338767|FG001|Months 7 - 12|Withdrawal by Subject|0|||
164264820|NCT00432744|593338766|FG000|Months 7 - 12|Too disabled to score|0|||
164264821|NCT00432744|593338767|FG001|Months 7 - 12|Too disabled to score|1|||
164683490|NCT00840203|594863501|FG001|Washout|Protocol Violation|0|||
164683491|NCT02121184|594863502|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
164683492|NCT02121184|594863503|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
164683493|NCT02121184|594863502|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
164683494|NCT02121184|594863503|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
164264822|NCT00461305|593338770|FG000|Treatment|Adverse Event|26|||
164264823|NCT00461305|593338771|FG001|Treatment|Adverse Event|3|||
164341320|NCT01020981|593625322|FG001|Overall Study|Survey returned undeliverable|32|||
164341321|NCT01020981|593625321|FG000|Overall Study|Participant declined to complete survey|2|||
164341322|NCT01020981|593625322|FG001|Overall Study|Participant declined to complete survey|0|||
164341323|NCT00680017|593625326|FG000|Overall Study|Adverse Event|13|||
164341324|NCT00680017|593625327|FG001|Overall Study|Adverse Event|7|||
164341325|NCT00680017|593625326|FG000|Overall Study|Withdrawal by Subject|2|||
164264824|NCT00461305|593338770|FG000|Treatment|Lost to Follow-up|4|||
164264825|NCT00461305|593338771|FG001|Treatment|Lost to Follow-up|2|||
164264826|NCT00461305|593338770|FG000|Treatment|Protocol Violation|13|||
164264827|NCT00461305|593338771|FG001|Treatment|Protocol Violation|2|||
164264828|NCT00461305|593338770|FG000|Treatment|Withdrawal by Subject|48|||
164264829|NCT00461305|593338771|FG001|Treatment|Withdrawal by Subject|2|||
164264830|NCT00461305|593338770|FG000|Treatment|Never dispensed|5|||
164683495|NCT02121184|594863502|FG000|Overall Study|Emergency cesarean section required|0|||
164683496|NCT02121184|594863503|FG001|Overall Study|Emergency cesarean section required|2|||
164683497|NCT02121184|594863502|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
164683498|NCT02121184|594863503|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
164683499|NCT04567329|594863506|FG000|Overall Study|Withdrawal by Subject|5|||
164683500|NCT04567329|594863507|FG001|Overall Study|Withdrawal by Subject|6|||
164683501|NCT04567329|594863506|FG000|Overall Study|Protocol Violation|2|||
164683502|NCT04567329|594863507|FG001|Overall Study|Protocol Violation|3|||
164341326|NCT00680017|593625327|FG001|Overall Study|Withdrawal by Subject|5|||
164683503|NCT04567329|594863506|FG000|Overall Study|Discontinued|2|||
164683504|NCT04567329|594863507|FG001|Overall Study|Discontinued|2|||
164683505|NCT04567329|594863506|FG000|Overall Study|Lost to Follow-up|0|||
164683506|NCT04567329|594863507|FG001|Overall Study|Lost to Follow-up|1|||
164683507|NCT04567329|594863506|FG000|Overall Study|Lack of Efficacy|0|||
164683508|NCT04567329|594863507|FG001|Overall Study|Lack of Efficacy|1|||
164683509|NCT00875524|594863510|FG000|Overall Study|Serious adverse event|0|||
164683510|NCT00875524|594863511|FG001|Overall Study|Serious adverse event|1|||
164683511|NCT00875524|594863510|FG000|Overall Study|Protocol Violation|4|||
164683512|NCT00875524|594863511|FG001|Overall Study|Protocol Violation|0|||
164683513|NCT00875524|594863510|FG000|Overall Study|Lost to Follow-up|1|||
164683514|NCT00875524|594863511|FG001|Overall Study|Lost to Follow-up|0|||
164683515|NCT00875524|594863510|FG000|Overall Study|Withdrawal by Subject|3|||
164683516|NCT00875524|594863511|FG001|Overall Study|Withdrawal by Subject|5|||
164683517|NCT00574847|594863521|FG000|Overall Study|Adverse Event|2|||
164683518|NCT00574847|594863522|FG001|Overall Study|Adverse Event|0|||
164683519|NCT00574847|594863521|FG000|Overall Study|Death|1|||
164683520|NCT00574847|594863522|FG001|Overall Study|Death|0|||
164683521|NCT00574847|594863521|FG000|Overall Study|Withdrawal by Subject|2|||
164683522|NCT00574847|594863522|FG001|Overall Study|Withdrawal by Subject|2|||
164341327|NCT00680017|593625326|FG000|Overall Study|Lost to Follow-up|2|||
164341328|NCT00680017|593625327|FG001|Overall Study|Lost to Follow-up|0|||
164341329|NCT01434667|593625328|FG000|Overall Study|Lost to Follow-up|5|||
164341330|NCT01434667|593625329|FG001|Overall Study|Lost to Follow-up|10|||
164341331|NCT02034110|593625330|FG000|Overall Study|Physician Decision|0|||
164341332|NCT02034110|593625331|FG001|Overall Study|Physician Decision|0|||
164341333|NCT02034110|593625332|FG002|Overall Study|Physician Decision|0|||
164341334|NCT02034110|593625333|FG003|Overall Study|Physician Decision|0|||
164341335|NCT02034110|593625334|FG004|Overall Study|Physician Decision|2|||
164341336|NCT02034110|593625335|FG005|Overall Study|Physician Decision|0|||
164341337|NCT02034110|593625336|FG006|Overall Study|Physician Decision|1|||
164341338|NCT02034110|593625337|FG007|Overall Study|Physician Decision|0|||
164341339|NCT02034110|593625330|FG000|Overall Study|Lost to Follow-up|1|||
164341340|NCT02034110|593625331|FG001|Overall Study|Lost to Follow-up|0|||
164341341|NCT02034110|593625332|FG002|Overall Study|Lost to Follow-up|0|||
164341342|NCT02034110|593625333|FG003|Overall Study|Lost to Follow-up|0|||
164341343|NCT02034110|593625334|FG004|Overall Study|Lost to Follow-up|1|||
164341344|NCT02034110|593625335|FG005|Overall Study|Lost to Follow-up|0|||
164341345|NCT02034110|593625336|FG006|Overall Study|Lost to Follow-up|1|||
164341346|NCT02034110|593625337|FG007|Overall Study|Lost to Follow-up|0|||
164341347|NCT02034110|593625330|FG000|Overall Study|Withdrawal by Subject|5|||
164341348|NCT02034110|593625331|FG001|Overall Study|Withdrawal by Subject|7|||
164341349|NCT02034110|593625332|FG002|Overall Study|Withdrawal by Subject|0|||
164341350|NCT02034110|593625333|FG003|Overall Study|Withdrawal by Subject|3|||
164341351|NCT02034110|593625334|FG004|Overall Study|Withdrawal by Subject|7|||
164341352|NCT02034110|593625335|FG005|Overall Study|Withdrawal by Subject|0|||
164341353|NCT02034110|593625336|FG006|Overall Study|Withdrawal by Subject|3|||
164341354|NCT02034110|593625337|FG007|Overall Study|Withdrawal by Subject|1|||
164341355|NCT02034110|593625330|FG000|Overall Study|Study closed by sponsor|6|||
164341356|NCT02034110|593625331|FG001|Overall Study|Study closed by sponsor|2|||
164341357|NCT02034110|593625332|FG002|Overall Study|Study closed by sponsor|0|||
164341358|NCT02034110|593625333|FG003|Overall Study|Study closed by sponsor|6|||
164341359|NCT02034110|593625334|FG004|Overall Study|Study closed by sponsor|7|||
164341360|NCT02034110|593625335|FG005|Overall Study|Study closed by sponsor|0|||
164683523|NCT00574847|594863521|FG000|Overall Study|Physician Decision|1|||
164683524|NCT00574847|594863522|FG001|Overall Study|Physician Decision|0|||
164341361|NCT02034110|593625336|FG006|Overall Study|Study closed by sponsor|42|||
164341362|NCT02034110|593625337|FG007|Overall Study|Study closed by sponsor|0|||
164341363|NCT00064337|593625338|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
164341364|NCT00064337|593625338|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
164683525|NCT00574847|594863521|FG000|Overall Study|Did not receive medication (declined)|2|||
164683526|NCT00574847|594863522|FG001|Overall Study|Did not receive medication (declined)|5|||
164683527|NCT00957021|594863523|FG000|Overall Study|Death|5|||
164264831|NCT00461305|593338771|FG001|Treatment|Never dispensed|0|||
164264832|NCT00461305|593338770|FG000|Treatment|Study drug not taken|1|||
164264833|NCT00461305|593338771|FG001|Treatment|Study drug not taken|0|||
164264834|NCT00461305|593338770|FG000|Treatment|Partially missing diary|2|||
164264835|NCT00461305|593338771|FG001|Treatment|Partially missing diary|0|||
164264836|NCT00461305|593338770|FG000|Treatment|Other (missing drug etc)|2|||
164264837|NCT00461305|593338771|FG001|Treatment|Other (missing drug etc)|0|||
164264838|NCT00461305|593338770|FG000|Continued Treatment|Adverse Event|26|||
164341365|NCT00064337|593625338|FG000|PBSCC or Induction/PBSCC|Progression|3|||
164341366|NCT00064337|593625338|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
164341367|NCT00064337|593625338|FG000|PBSCC or Induction/PBSCC|Death|2|||
164341368|NCT00064337|593625338|FG000|Transplant|Adverse Event|9|||
164341369|NCT00064337|593625338|FG000|Transplant|Not protocol-specified|5|||
164341370|NCT00064337|593625338|FG000|Transplant|Death|3|||
164341371|NCT00064337|593625338|FG000|Transplant|Patient Refusal|2|||
164264839|NCT00461305|593338771|FG001|Continued Treatment|Adverse Event|0|||
164341372|NCT00064337|593625338|FG000|Transplant|Progression|2|||
164683528|NCT00957021|594863523|FG000|Overall Study|Lost to Follow-up|8|||
164683529|NCT00957021|594863523|FG000|Overall Study|Withdrawal by Subject|34|||
164683530|NCT00957021|594863523|FG000|Overall Study|No 2 yr ROM data|35|||
164683531|NCT00957021|594863523|FG000|Overall Study|Revised study component by 2 yr visit|8|||
164683532|NCT00957021|594863523|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
164683533|NCT00957021|594863523|FG000|Overall Study|Surgery Cancelled|9|||
164683534|NCT00957021|594863523|FG000|Overall Study|Termination due to language issue|2|||
164683535|NCT00819169|594863527|FG000|Overall Study|Withdrawal by Subject|2|||
164683536|NCT00819169|594863528|FG001|Overall Study|Withdrawal by Subject|0|||
164683537|NCT00819169|594863529|FG002|Overall Study|Withdrawal by Subject|0|||
164683538|NCT00819169|594863530|FG003|Overall Study|Withdrawal by Subject|1|||
164683539|NCT00819169|594863531|FG004|Overall Study|Withdrawal by Subject|1|||
164683540|NCT00819169|594863532|FG005|Overall Study|Withdrawal by Subject|1|||
164683541|NCT00819169|594863533|FG006|Overall Study|Withdrawal by Subject|5|||
164683542|NCT00819169|594863534|FG007|Overall Study|Withdrawal by Subject|1|||
164683543|NCT00819169|594863535|FG008|Overall Study|Withdrawal by Subject|4|||
164683544|NCT00819169|594863527|FG000|Overall Study|Lost to Follow-up|0|||
164683545|NCT00819169|594863528|FG001|Overall Study|Lost to Follow-up|2|||
164683546|NCT00819169|594863529|FG002|Overall Study|Lost to Follow-up|0|||
164683547|NCT00819169|594863530|FG003|Overall Study|Lost to Follow-up|1|||
164683548|NCT00819169|594863531|FG004|Overall Study|Lost to Follow-up|0|||
164683549|NCT00819169|594863532|FG005|Overall Study|Lost to Follow-up|6|||
164683550|NCT00819169|594863533|FG006|Overall Study|Lost to Follow-up|2|||
164683551|NCT00819169|594863534|FG007|Overall Study|Lost to Follow-up|2|||
164430210|NCT00819234|593945345|FG009|Overall Study|Physician Decision|2|||
164430211|NCT00819234|593945336|FG000|Overall Study|Protocol Violation|0|||
164430212|NCT00819234|593945337|FG001|Overall Study|Protocol Violation|0|||
164430213|NCT00819234|593945338|FG002|Overall Study|Protocol Violation|1|||
164578904|NCT02517515|594485451|FG000|Overall Study|Adverse Event|0|||
164578905|NCT02517515|594485452|FG001|Overall Study|Adverse Event|1|||
164578906|NCT02517515|594485451|FG000|Overall Study|Withdrew Consent|0|||
164578907|NCT02517515|594485452|FG001|Overall Study|Withdrew Consent|1|||
164578908|NCT02517515|594485451|FG000|Overall Study|Lost to Follow-up|1|||
164578909|NCT02517515|594485452|FG001|Overall Study|Lost to Follow-up|0|||
164578910|NCT02517515|594485451|FG000|Overall Study|Other|1|||
164578911|NCT02517515|594485452|FG001|Overall Study|Other|0|||
164578912|NCT05882890|594485454|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
164578913|NCT00719810|594485462|FG000|Overall Study|Adverse Event|0|||
164578914|NCT00719810|594485463|FG001|Overall Study|Adverse Event|2|||
164578915|NCT00719810|594485464|FG002|Overall Study|Adverse Event|3|||
164578916|NCT00719810|594485462|FG000|Overall Study|Lost to Follow-up|2|||
164578917|NCT00719810|594485463|FG001|Overall Study|Lost to Follow-up|0|||
164578918|NCT00719810|594485464|FG002|Overall Study|Lost to Follow-up|3|||
164578919|NCT00719810|594485462|FG000|Overall Study|Physician Decision|0|||
164578920|NCT00719810|594485463|FG001|Overall Study|Physician Decision|1|||
164578921|NCT00719810|594485464|FG002|Overall Study|Physician Decision|0|||
164578922|NCT00719810|594485462|FG000|Overall Study|Withdrawal by Subject|1|||
164578923|NCT00719810|594485463|FG001|Overall Study|Withdrawal by Subject|1|||
164578924|NCT00719810|594485464|FG002|Overall Study|Withdrawal by Subject|2|||
164578925|NCT02401256|594485465|FG000|Overall Study|Adverse Event|5|||
164578926|NCT02401256|594485465|FG000|Overall Study|Withdrawal by Subject|12|||
164578927|NCT00893789|594485467|FG000|Overall Study|Withdrawal by Subject|3|||
164578928|NCT00893789|594485468|FG001|Overall Study|Withdrawal by Subject|1|||
164578929|NCT00893789|594485469|FG002|Overall Study|Withdrawal by Subject|3|||
164578930|NCT00893789|594485470|FG003|Overall Study|Withdrawal by Subject|1|||
164578931|NCT00893789|594485467|FG000|Overall Study|Noncompliance With Study Drug|1|||
164578932|NCT00893789|594485468|FG001|Overall Study|Noncompliance With Study Drug|0|||
164578933|NCT00893789|594485469|FG002|Overall Study|Noncompliance With Study Drug|1|||
164578934|NCT00893789|594485470|FG003|Overall Study|Noncompliance With Study Drug|2|||
164578935|NCT00893789|594485467|FG000|Overall Study|Noncompliance With Study Procedures|1|||
164578936|NCT00893789|594485468|FG001|Overall Study|Noncompliance With Study Procedures|0|||
164578937|NCT00893789|594485469|FG002|Overall Study|Noncompliance With Study Procedures|0|||
164578938|NCT00893789|594485470|FG003|Overall Study|Noncompliance With Study Procedures|0|||
164578939|NCT00893789|594485467|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
164578940|NCT00893789|594485468|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
164578941|NCT00893789|594485469|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
164578942|NCT00893789|594485470|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
164578943|NCT00893789|594485467|FG000|Overall Study|Adverse Event|0|||
164578944|NCT00893789|594485468|FG001|Overall Study|Adverse Event|2|||
164578945|NCT00893789|594485469|FG002|Overall Study|Adverse Event|1|||
164578946|NCT00893789|594485470|FG003|Overall Study|Adverse Event|5|||
164578947|NCT00893789|594485467|FG000|Overall Study|Protocol Violation|0|||
164683552|NCT00819169|594863535|FG008|Overall Study|Lost to Follow-up|1|||
164683553|NCT00819169|594863527|FG000|Overall Study|Death|1|||
164683554|NCT00819169|594863528|FG001|Overall Study|Death|1|||
164683555|NCT00819169|594863529|FG002|Overall Study|Death|3|||
164683556|NCT00819169|594863530|FG003|Overall Study|Death|8|||
164430214|NCT00819234|593945339|FG003|Overall Study|Protocol Violation|0|||
164430215|NCT00819234|593945340|FG004|Overall Study|Protocol Violation|0|||
164578948|NCT00893789|594485468|FG001|Overall Study|Protocol Violation|1|||
164578949|NCT00893789|594485469|FG002|Overall Study|Protocol Violation|1|||
164578950|NCT00893789|594485470|FG003|Overall Study|Protocol Violation|4|||
164578951|NCT00893789|594485467|FG000|Overall Study|Lost to Follow-up|0|||
164578952|NCT00893789|594485468|FG001|Overall Study|Lost to Follow-up|0|||
164578953|NCT00893789|594485469|FG002|Overall Study|Lost to Follow-up|0|||
164578954|NCT00893789|594485470|FG003|Overall Study|Lost to Follow-up|1|||
164578955|NCT02037919|594485471|FG000|Overall Study|Lost to Follow-up|30|||
164578956|NCT02037919|594485472|FG001|Overall Study|Lost to Follow-up|45|||
164578957|NCT00886938|594485475|FG000|Overall Study|Adverse Event|1|||
164578958|NCT00886938|594485475|FG000|Overall Study|Withdrawal by Subject|1|||
164578959|NCT00917384|594485476|FG000|Overall Study|Lost to Follow-up|4|||
164578960|NCT00917384|594485477|FG001|Overall Study|Lost to Follow-up|2|||
164578961|NCT00917384|594485476|FG000|Overall Study|Withdrawal by Subject|10|||
164578962|NCT00917384|594485477|FG001|Overall Study|Withdrawal by Subject|2|||
164578963|NCT01458340|594485482|FG000|Overall Study|Adverse Event|5|||
164578964|NCT01458340|594485483|FG001|Overall Study|Adverse Event|4|||
164578965|NCT01458340|594485484|FG002|Overall Study|Adverse Event|2|||
164578966|NCT01458340|594485482|FG000|Overall Study|Lost to Follow-up|3|||
164578967|NCT01458340|594485483|FG001|Overall Study|Lost to Follow-up|3|||
164578968|NCT01458340|594485484|FG002|Overall Study|Lost to Follow-up|10|||
164578969|NCT01458340|594485482|FG000|Overall Study|Miscellaneous|0|||
164578970|NCT01458340|594485483|FG001|Overall Study|Miscellaneous|1|||
164578971|NCT01458340|594485484|FG002|Overall Study|Miscellaneous|0|||
164578972|NCT01458340|594485482|FG000|Overall Study|Physician Decision|1|||
164578973|NCT01458340|594485483|FG001|Overall Study|Physician Decision|1|||
164578974|NCT01458340|594485484|FG002|Overall Study|Physician Decision|2|||
164578975|NCT01458340|594485482|FG000|Overall Study|Protocol Violation|6|||
164578976|NCT01458340|594485483|FG001|Overall Study|Protocol Violation|6|||
164578977|NCT01458340|594485484|FG002|Overall Study|Protocol Violation|5|||
164578978|NCT01458340|594485482|FG000|Overall Study|Withdrawal by Subject|12|||
164578979|NCT01458340|594485483|FG001|Overall Study|Withdrawal by Subject|6|||
164578980|NCT01458340|594485484|FG002|Overall Study|Withdrawal by Subject|4|||
164578981|NCT01575548|594485487|FG000|Overall Study|Adverse Event|15|||
164578982|NCT01575548|594485488|FG001|Overall Study|Adverse Event|2|||
164578983|NCT01575548|594485487|FG000|Overall Study|Disease progression|12|||
164578984|NCT01575548|594485488|FG001|Overall Study|Disease progression|25|||
164578985|NCT01575548|594485487|FG000|Overall Study|Death|1|||
164578986|NCT01575548|594485488|FG001|Overall Study|Death|0|||
164578987|NCT01575548|594485487|FG000|Overall Study|Other complicating disease|1|||
164578988|NCT01575548|594485488|FG001|Overall Study|Other complicating disease|0|||
164578989|NCT01575548|594485487|FG000|Overall Study|Withdrawal by Subject|7|||
164578990|NCT01575548|594485488|FG001|Overall Study|Withdrawal by Subject|3|||
164578991|NCT01575548|594485487|FG000|Overall Study|Noncompliance|1|||
164578992|NCT01575548|594485488|FG001|Overall Study|Noncompliance|0|||
164578993|NCT01575548|594485487|FG000|Overall Study|Anticipated surgery|0|||
164578994|NCT01575548|594485488|FG001|Overall Study|Anticipated surgery|1|||
164578995|NCT01575548|594485487|FG000|Overall Study|Never started protocol therapy|3|||
164264840|NCT00461305|593338770|FG000|Continued Treatment|Lost to Follow-up|4|||
164264841|NCT00461305|593338771|FG001|Continued Treatment|Lost to Follow-up|0|||
164264842|NCT00461305|593338770|FG000|Continued Treatment|Protocol Violation|13|||
164264843|NCT00461305|593338771|FG001|Continued Treatment|Protocol Violation|0|||
164264844|NCT00461305|593338770|FG000|Continued Treatment|Withdrawal by Subject|48|||
164264845|NCT00461305|593338771|FG001|Continued Treatment|Withdrawal by Subject|0|||
164264846|NCT00461305|593338770|FG000|Continued Treatment|Partially missing diary|2|||
164264847|NCT00461305|593338771|FG001|Continued Treatment|Partially missing diary|0|||
164264848|NCT00461305|593338770|FG000|Continued Treatment|Other (missing drug etc)|2|||
164264849|NCT00461305|593338771|FG001|Continued Treatment|Other (missing drug etc)|0|||
164264850|NCT02513823|593338772|FG000|Overall Study|Lost to Follow-up|4|||
164264851|NCT02513823|593338772|FG000|Overall Study|Physician Decision|1|||
164264852|NCT02743780|593338773|FG000|Part 3 (7 Days)|Adverse Event|0|||
164264853|NCT02743780|593338774|FG001|Part 3 (7 Days)|Adverse Event|0|||
164264854|NCT02743780|593338775|FG002|Part 3 (7 Days)|Adverse Event|1|||
164430216|NCT00819234|593945341|FG005|Overall Study|Protocol Violation|0|||
164578996|NCT01575548|594485488|FG001|Overall Study|Never started protocol therapy|2|||
164578997|NCT03872180|594485491|FG000|Overall Study|Adverse Event|4|||
164578998|NCT03872180|594485491|FG000|Overall Study|Lack of Efficacy|2|||
164578999|NCT02750410|594485493|FG000|Double-Blind Treatment Period|Adverse Event|2|||
164579000|NCT02750410|594485494|FG001|Double-Blind Treatment Period|Adverse Event|2|||
164579001|NCT02750410|594485493|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164430217|NCT00819234|593945342|FG006|Overall Study|Protocol Violation|0|||
164579002|NCT02750410|594485494|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
164579003|NCT02750410|594485493|FG000|Open-Label Extension Period|Adverse Event|5|||
164579004|NCT02750410|594485494|FG001|Open-Label Extension Period|Adverse Event|3|||
164579005|NCT02750410|594485493|FG000|Open-Label Extension Period|Protocol Violation|0|||
164430218|NCT00819234|593945343|FG007|Overall Study|Protocol Violation|0|||
164683557|NCT00819169|594863531|FG004|Overall Study|Death|5|||
164683558|NCT00819169|594863532|FG005|Overall Study|Death|7|||
164683559|NCT00819169|594863533|FG006|Overall Study|Death|9|||
164683560|NCT00819169|594863534|FG007|Overall Study|Death|4|||
164683561|NCT00819169|594863535|FG008|Overall Study|Death|7|||
164683562|NCT00819169|594863527|FG000|Overall Study|Ineligibility determined|0|||
164683563|NCT00819169|594863528|FG001|Overall Study|Ineligibility determined|0|||
164430219|NCT00819234|593945344|FG008|Overall Study|Protocol Violation|0|||
164430220|NCT00819234|593945345|FG009|Overall Study|Protocol Violation|0|||
164430221|NCT00819234|593945336|FG000|Overall Study|Lost to Follow-up|2|||
164430222|NCT00819234|593945337|FG001|Overall Study|Lost to Follow-up|2|||
164430223|NCT00819234|593945338|FG002|Overall Study|Lost to Follow-up|0|||
164430224|NCT00819234|593945339|FG003|Overall Study|Lost to Follow-up|2|||
164430225|NCT00819234|593945340|FG004|Overall Study|Lost to Follow-up|1|||
164430226|NCT00819234|593945341|FG005|Overall Study|Lost to Follow-up|1|||
164430227|NCT00819234|593945342|FG006|Overall Study|Lost to Follow-up|1|||
164430228|NCT00819234|593945343|FG007|Overall Study|Lost to Follow-up|1|||
164430229|NCT00819234|593945344|FG008|Overall Study|Lost to Follow-up|1|||
164430230|NCT00819234|593945345|FG009|Overall Study|Lost to Follow-up|2|||
164430231|NCT01096056|593945346|FG000|Overall Study|Lost to Follow-up|0|||
164430232|NCT01096056|593945347|FG001|Overall Study|Lost to Follow-up|1|||
164430233|NCT03568162|593945348|FG000|Overall Study|Adverse Event|0|||
164430234|NCT03568162|593945349|FG001|Overall Study|Adverse Event|1|||
164683564|NCT00819169|594863529|FG002|Overall Study|Ineligibility determined|0|||
164683565|NCT00819169|594863530|FG003|Overall Study|Ineligibility determined|2|||
164683566|NCT00819169|594863531|FG004|Overall Study|Ineligibility determined|0|||
164683567|NCT00819169|594863532|FG005|Overall Study|Ineligibility determined|0|||
164683568|NCT00819169|594863533|FG006|Overall Study|Ineligibility determined|0|||
164683569|NCT00819169|594863534|FG007|Overall Study|Ineligibility determined|0|||
164683570|NCT00819169|594863535|FG008|Overall Study|Ineligibility determined|1|||
164683571|NCT00819169|594863527|FG000|Overall Study|Adverse Event|0|||
164683572|NCT00819169|594863528|FG001|Overall Study|Adverse Event|0|||
164683573|NCT00819169|594863529|FG002|Overall Study|Adverse Event|0|||
164683574|NCT00819169|594863530|FG003|Overall Study|Adverse Event|0|||
164683575|NCT00819169|594863531|FG004|Overall Study|Adverse Event|1|||
164683576|NCT00819169|594863532|FG005|Overall Study|Adverse Event|0|||
164683577|NCT00819169|594863533|FG006|Overall Study|Adverse Event|0|||
164683578|NCT00819169|594863534|FG007|Overall Study|Adverse Event|0|||
164683579|NCT00819169|594863535|FG008|Overall Study|Adverse Event|0|||
164683580|NCT00819169|594863527|FG000|Overall Study|Administrative Decision|0|||
164683581|NCT00819169|594863528|FG001|Overall Study|Administrative Decision|0|||
164683582|NCT00819169|594863529|FG002|Overall Study|Administrative Decision|0|||
164683583|NCT00819169|594863530|FG003|Overall Study|Administrative Decision|0|||
164683584|NCT00819169|594863531|FG004|Overall Study|Administrative Decision|1|||
164683585|NCT00819169|594863532|FG005|Overall Study|Administrative Decision|2|||
164683586|NCT00819169|594863533|FG006|Overall Study|Administrative Decision|0|||
164683587|NCT00819169|594863534|FG007|Overall Study|Administrative Decision|2|||
164683588|NCT00819169|594863535|FG008|Overall Study|Administrative Decision|0|||
164683589|NCT02637141|594863539|FG000|Overall Study|Adverse Event|1|||
164683590|NCT02637141|594863540|FG001|Overall Study|Adverse Event|1|||
164683591|NCT02637141|594863541|FG002|Overall Study|Adverse Event|0|||
164683592|NCT02637141|594863539|FG000|Overall Study|Withdrawal by Subject|1|||
164683593|NCT02637141|594863540|FG001|Overall Study|Withdrawal by Subject|1|||
164683594|NCT02637141|594863541|FG002|Overall Study|Withdrawal by Subject|1|||
164683595|NCT01155531|594863545|FG000|Overall Study|Adverse Event|0|||
164683596|NCT01155531|594863546|FG001|Overall Study|Adverse Event|0|||
164683597|NCT01155531|594863547|FG002|Overall Study|Adverse Event|1|||
164683598|NCT01155531|594863548|FG003|Overall Study|Adverse Event|0|||
164430235|NCT03568162|593945350|FG002|Overall Study|Adverse Event|2|||
164683599|NCT01155531|594863545|FG000|Overall Study|Lost to Follow-up|0|||
164683600|NCT01155531|594863546|FG001|Overall Study|Lost to Follow-up|0|||
164683601|NCT01155531|594863547|FG002|Overall Study|Lost to Follow-up|0|||
164683602|NCT01155531|594863548|FG003|Overall Study|Lost to Follow-up|1|||
164683603|NCT01155531|594863545|FG000|Overall Study|Withdrawal by Subject|1|||
164683604|NCT01155531|594863546|FG001|Overall Study|Withdrawal by Subject|0|||
164430236|NCT03568162|593945351|FG003|Overall Study|Adverse Event|0|||
164430237|NCT03568162|593945352|FG004|Overall Study|Adverse Event|0|||
164430238|NCT03568162|593945353|FG005|Overall Study|Adverse Event|1|||
164430239|NCT03568162|593945348|FG000|Overall Study|Death|0|||
164683605|NCT01155531|594863547|FG002|Overall Study|Withdrawal by Subject|1|||
164683606|NCT01155531|594863548|FG003|Overall Study|Withdrawal by Subject|0|||
164683607|NCT02705716|594863549|FG000|Overall Study|Adverse Event|0|||
164683608|NCT02705716|594863550|FG001|Overall Study|Adverse Event|1|||
164683609|NCT02705716|594863549|FG000|Overall Study|Protocol Violation|3|||
164683610|NCT02705716|594863550|FG001|Overall Study|Protocol Violation|0|||
164683611|NCT02705716|594863549|FG000|Overall Study|Withdrawal of Consent|1|||
164683612|NCT02705716|594863550|FG001|Overall Study|Withdrawal of Consent|1|||
164683613|NCT00562718|594863551|FG000|Overall Study|Death|1|||
164683614|NCT00562718|594863551|FG000|Overall Study|Withdrawal by Subject|3|||
164683615|NCT00562718|594863551|FG000|Overall Study|Adverse Event|4|||
164683616|NCT00562718|594863551|FG000|Overall Study|Lack of Efficacy|2|||
164683617|NCT00562718|594863551|FG000|Overall Study|not stated|1|||
164683618|NCT04025021|594863552|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
164683619|NCT04025021|594863553|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
164683620|NCT03727139|594863554|FG000|Overall Study|Protocol Violation|60|||
164683621|NCT00566722|594863555|FG000|Overall Study|Adverse Event|0|||
164683622|NCT00566722|594863556|FG001|Overall Study|Adverse Event|1|||
164683623|NCT00566722|594863557|FG002|Overall Study|Adverse Event|0|||
164683624|NCT00566722|594863555|FG000|Overall Study|Withdrawal by Subject|0|||
164683625|NCT00566722|594863556|FG001|Overall Study|Withdrawal by Subject|0|||
164683626|NCT00566722|594863557|FG002|Overall Study|Withdrawal by Subject|1|||
164683627|NCT00566722|594863555|FG000|Overall Study|Lost to Follow-up|1|||
164683628|NCT00566722|594863556|FG001|Overall Study|Lost to Follow-up|1|||
164683629|NCT00566722|594863557|FG002|Overall Study|Lost to Follow-up|1|||
164683630|NCT00566722|594863555|FG000|Overall Study|Lack of Efficacy|1|||
164683631|NCT00566722|594863556|FG001|Overall Study|Lack of Efficacy|2|||
164683632|NCT00566722|594863557|FG002|Overall Study|Lack of Efficacy|4|||
164683633|NCT00566722|594863555|FG000|Overall Study|Did not meet exclusion criteria|0|||
164683634|NCT00566722|594863556|FG001|Overall Study|Did not meet exclusion criteria|0|||
164683635|NCT00566722|594863557|FG002|Overall Study|Did not meet exclusion criteria|2|||
164683636|NCT00566722|594863555|FG000|Overall Study|Serious adverse event|0|||
164683637|NCT00566722|594863556|FG001|Overall Study|Serious adverse event|1|||
164683638|NCT00566722|594863557|FG002|Overall Study|Serious adverse event|0|||
164683639|NCT00566722|594863555|FG000|Overall Study|Noncompliant with drug administration|0|||
164683640|NCT00566722|594863556|FG001|Overall Study|Noncompliant with drug administration|0|||
164683641|NCT00566722|594863557|FG002|Overall Study|Noncompliant with drug administration|1|||
164683642|NCT00858403|594863558|FG000|Overall Study|Withdrawal by Subject|1|||
164683643|NCT00858403|594863558|FG000|Overall Study|Death|3|||
164683644|NCT00858403|594863558|FG000|Overall Study|Disease Progression|1|||
164683645|NCT00714051|594863561|FG000|Overall Study|Withdrawal by Subject|1|||
164683646|NCT00714051|594863562|FG001|Overall Study|Withdrawal by Subject|0|||
164683647|NCT00714051|594863561|FG000|Overall Study|Death|0|||
164683648|NCT00714051|594863562|FG001|Overall Study|Death|1|||
164341373|NCT00064337|593625338|FG000|Maintenance|Adverse Event|3|||
164341374|NCT00064337|593625338|FG000|Maintenance|Progression|2|||
164341375|NCT00064337|593625338|FG000|Maintenance|On treatment at time of analysis|2|||
164341376|NCT00064337|593625338|FG000|Maintenance|Not protocol-specified|2|||
164341377|NCT00064337|593625338|FG000|Maintenance|Death|1|||
164341378|NCT02279420|593625339|FG000|Overall Study|Lost to Follow-up|23|||
164341379|NCT03535844|593625342|FG000|Overall Study|Withdrawal by Subject|0|||
164341380|NCT03535844|593625343|FG001|Overall Study|Withdrawal by Subject|1|||
164341381|NCT00612040|593625344|FG000|Overall Study|Adverse Event|0|||
164341382|NCT00612040|593625345|FG001|Overall Study|Adverse Event|2|||
164341383|NCT00612040|593625346|FG002|Overall Study|Adverse Event|1|||
164341384|NCT00612040|593625344|FG000|Overall Study|Protocol Violation|1|||
164341385|NCT00612040|593625345|FG001|Overall Study|Protocol Violation|2|||
164341386|NCT00612040|593625346|FG002|Overall Study|Protocol Violation|1|||
164341387|NCT00612040|593625344|FG000|Overall Study|Lack of Efficacy|2|||
164341388|NCT00612040|593625345|FG001|Overall Study|Lack of Efficacy|1|||
164341389|NCT00612040|593625346|FG002|Overall Study|Lack of Efficacy|0|||
164341390|NCT00612040|593625344|FG000|Overall Study|Unclassified|2|||
164341391|NCT00612040|593625345|FG001|Overall Study|Unclassified|2|||
164341392|NCT00612040|593625346|FG002|Overall Study|Unclassified|5|||
164341393|NCT00297830|593625347|FG000|6 Month Visit|Death|1|||
164341394|NCT00297830|593625348|FG001|6 Month Visit|Death|0|||
164341395|NCT00297830|593625349|FG002|6 Month Visit|Death|2|||
164341396|NCT00297830|593625347|FG000|6 Month Visit|Withdrawal by Subject|2|||
164341397|NCT00297830|593625348|FG001|6 Month Visit|Withdrawal by Subject|1|||
164683649|NCT00227370|594863563|FG000|Overall Study|Withdrawal by Subject|1|||
164683650|NCT00227370|594863564|FG001|Overall Study|Withdrawal by Subject|2|||
164683651|NCT00227370|594863563|FG000|Overall Study|Death|3|||
164341398|NCT00297830|593625349|FG002|6 Month Visit|Withdrawal by Subject|1|||
164341399|NCT00297830|593625347|FG000|6 Month Visit|Adverse Event|0|||
164341400|NCT00297830|593625348|FG001|6 Month Visit|Adverse Event|1|||
164341401|NCT00297830|593625349|FG002|6 Month Visit|Adverse Event|0|||
164341402|NCT00297830|593625347|FG000|12 Month Visit|Lost to Follow-up|1|||
164341403|NCT00297830|593625348|FG001|12 Month Visit|Lost to Follow-up|0|||
164341404|NCT00297830|593625349|FG002|12 Month Visit|Lost to Follow-up|0|||
164341405|NCT00297830|593625347|FG000|12 Month Visit|Adverse Event|0|||
164683652|NCT00227370|594863564|FG001|Overall Study|Death|4|||
164683653|NCT00227370|594863563|FG000|Overall Study|Adverse Event|6|||
164683654|NCT00227370|594863564|FG001|Overall Study|Adverse Event|11|||
164683655|NCT00227370|594863563|FG000|Overall Study|Physician Decision|9|||
164683656|NCT00227370|594863564|FG001|Overall Study|Physician Decision|6|||
164683657|NCT00227370|594863563|FG000|Overall Study|Other reasons|2|||
164683658|NCT00227370|594863564|FG001|Overall Study|Other reasons|1|||
164683659|NCT03846193|594863565|FG000|Overall Study|Physician Decision|0|||
164683660|NCT03846193|594863566|FG001|Overall Study|Physician Decision|0|||
164683661|NCT03846193|594863567|FG002|Overall Study|Physician Decision|1|||
164683662|NCT03846193|594863568|FG003|Overall Study|Physician Decision|0|||
164683663|NCT03846193|594863569|FG004|Overall Study|Physician Decision|0|||
164683664|NCT03846193|594863565|FG000|Overall Study|Lost to Follow-up|0|||
164683665|NCT03846193|594863566|FG001|Overall Study|Lost to Follow-up|0|||
164683666|NCT03846193|594863567|FG002|Overall Study|Lost to Follow-up|0|||
164683667|NCT03846193|594863568|FG003|Overall Study|Lost to Follow-up|0|||
164683668|NCT03846193|594863569|FG004|Overall Study|Lost to Follow-up|1|||
164683669|NCT03846193|594863565|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
164683670|NCT03846193|594863566|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
164683671|NCT03846193|594863567|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
164683672|NCT03846193|594863568|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
164683673|NCT03846193|594863569|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
164683674|NCT00840879|594863573|FG000|Second Intervention|Withdrawal by Subject|1|||
164683675|NCT00840879|594863574|FG001|Second Intervention|Withdrawal by Subject|0|||
164683676|NCT01404988|594863577|FG000|Overall Study|Death|2|||
164683677|NCT01404988|594863578|FG001|Overall Study|Death|0|||
164683678|NCT01404988|594863579|FG002|Overall Study|Death|2|||
164683679|NCT01404988|594863577|FG000|Overall Study|Adverse Event|1|||
164683680|NCT01404988|594863578|FG001|Overall Study|Adverse Event|0|||
164683681|NCT01404988|594863579|FG002|Overall Study|Adverse Event|0|||
164683682|NCT01404988|594863577|FG000|Overall Study|Withdrawal by Subject|2|||
164683683|NCT01404988|594863578|FG001|Overall Study|Withdrawal by Subject|2|||
164683684|NCT01404988|594863579|FG002|Overall Study|Withdrawal by Subject|0|||
164683685|NCT01404988|594863577|FG000|Overall Study|Lost to Follow-up|1|||
164683686|NCT01404988|594863578|FG001|Overall Study|Lost to Follow-up|2|||
164683687|NCT01404988|594863579|FG002|Overall Study|Lost to Follow-up|1|||
164683688|NCT00477594|594863580|FG000|Year 1 and Year 2|Adverse Event|4|||
164683689|NCT00477594|594863581|FG001|Year 1 and Year 2|Adverse Event|2|||
164683690|NCT00477594|594863580|FG000|Year 1 and Year 2|Physician Decision|2|||
164683691|NCT00477594|594863581|FG001|Year 1 and Year 2|Physician Decision|1|||
164683692|NCT00477594|594863580|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
164683693|NCT00477594|594863581|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
164683694|NCT00477594|594863580|FG000|Year 1 and Year 2|Other|1|||
164683695|NCT00477594|594863581|FG001|Year 1 and Year 2|Other|0|||
164683696|NCT00477594|594863580|FG000|Year 3|Adverse Event|1|||
164264855|NCT02743780|593338776|FG003|Part 3 (7 Days)|Adverse Event|0|||
164264856|NCT02743780|593338777|FG004|Part 3 (7 Days)|Adverse Event|0|||
164264857|NCT01294462|593338778|FG000|Overall Study|Lost to Follow-up|1|||
164264858|NCT01294462|593338779|FG001|Overall Study|Lost to Follow-up|0|||
164264859|NCT01294462|593338778|FG000|Overall Study|Withdrawal by Subject|65|||
164264860|NCT01294462|593338779|FG001|Overall Study|Withdrawal by Subject|63|||
164264861|NCT04342689|593338783|FG000|Overall Study|Withdrawal by Subject|32|||
164264862|NCT04342689|593338784|FG001|Overall Study|Withdrawal by Subject|33|||
164264863|NCT04342689|593338783|FG000|Overall Study|Lost to Follow-up|10|||
164264864|NCT04342689|593338784|FG001|Overall Study|Lost to Follow-up|12|||
164264865|NCT01460407|593338785|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
164264866|NCT01460407|593338786|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
164264867|NCT00844805|593338788|FG000|Treatment Phase|Adverse Event|5|||
164264868|NCT00844805|593338789|FG001|Treatment Phase|Adverse Event|1|||
164264869|NCT00844805|593338790|FG002|Treatment Phase|Adverse Event|0|||
164264870|NCT00844805|593338791|FG003|Treatment Phase|Adverse Event|0|||
164264871|NCT00844805|593338788|FG000|Treatment Phase|Withdrawal by Subject|3|||
164264872|NCT00844805|593338789|FG001|Treatment Phase|Withdrawal by Subject|4|||
164264873|NCT00844805|593338790|FG002|Treatment Phase|Withdrawal by Subject|0|||
164264874|NCT00844805|593338791|FG003|Treatment Phase|Withdrawal by Subject|0|||
164264875|NCT00844805|593338788|FG000|Treatment Phase|Noncompliance With Protocol|1|||
164264876|NCT00844805|593338789|FG001|Treatment Phase|Noncompliance With Protocol|0|||
164264877|NCT00844805|593338790|FG002|Treatment Phase|Noncompliance With Protocol|0|||
164683697|NCT00477594|594863581|FG001|Year 3|Adverse Event|0|||
164683698|NCT00477594|594863580|FG000|Year 3|Withdrawal by Subject|1|||
164264878|NCT00844805|593338791|FG003|Treatment Phase|Noncompliance With Protocol|0|||
164264879|NCT00844805|593338788|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
164264880|NCT00844805|593338789|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
164264881|NCT00844805|593338790|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
164264882|NCT00844805|593338791|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
164264883|NCT00844805|593338788|FG000|Follow-Up Phase|Adverse Event|0|||
164264884|NCT00844805|593338789|FG001|Follow-Up Phase|Adverse Event|0|||
164264885|NCT00844805|593338790|FG002|Follow-Up Phase|Adverse Event|1|||
164683699|NCT00477594|594863581|FG001|Year 3|Withdrawal by Subject|0|||
164683700|NCT00477594|594863580|FG000|Follow-up Period|Withdrawal by Subject|2|||
164264886|NCT00844805|593338791|FG003|Follow-Up Phase|Adverse Event|0|||
164264887|NCT00844805|593338788|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
164683701|NCT00477594|594863581|FG001|Follow-up Period|Withdrawal by Subject|1|||
164683702|NCT00477594|594863580|FG000|Follow-up Period|Other|1|||
164683703|NCT00477594|594863581|FG001|Follow-up Period|Other|0|||
164683704|NCT02998541|594865458|FG000|Overall Study|Adverse Event|4|||
164264888|NCT00844805|593338789|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
164579006|NCT02750410|594485494|FG001|Open-Label Extension Period|Protocol Violation|1|||
164579007|NCT02750410|594485493|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
164579008|NCT02750410|594485494|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
164579009|NCT01531725|594485495|FG000|Overall Study|Protocol Violation|5|||
164264889|NCT00844805|593338790|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
164264890|NCT00844805|593338791|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
164264891|NCT00844805|593338788|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
164264892|NCT00844805|593338789|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
164264893|NCT00844805|593338790|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
164264894|NCT00844805|593338791|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
164264895|NCT00844805|593338788|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
164264896|NCT00844805|593338789|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
164264897|NCT00844805|593338790|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
164579010|NCT02317510|594485496|FG000|Overall Study|Adverse Event|0|||
164579011|NCT02317510|594485497|FG001|Overall Study|Adverse Event|1|||
164579012|NCT03228186|594485498|FG000|Overall Study|Patient never started treatment|1|||
164579013|NCT03953118|594485499|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
164579014|NCT03953118|594485500|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
164579015|NCT02502864|594485503|FG000|Overall Study|Withdrawal by Subject|1|||
164579016|NCT00004980|594485507|FG000|Overall Study|Withdrawal by Subject|1|||
164579017|NCT00004980|594485508|FG001|Overall Study|Withdrawal by Subject|0|||
164579018|NCT00004980|594485507|FG000|Overall Study|memory difficulties|1|||
164579019|NCT00004980|594485508|FG001|Overall Study|memory difficulties|1|||
164579020|NCT00004980|594485507|FG000|Overall Study|Physician Decision|0|||
164579021|NCT00004980|594485508|FG001|Overall Study|Physician Decision|1|||
164579022|NCT01624194|594485509|FG000|Overall Study|Lost to Follow-up|1|||
164579023|NCT01624194|594485510|FG001|Overall Study|Lost to Follow-up|0|||
164579024|NCT01624194|594485509|FG000|Overall Study|Withdrawal by Subject|1|||
164579025|NCT01624194|594485510|FG001|Overall Study|Withdrawal by Subject|0|||
164579026|NCT03212261|594485511|FG000|Overall Study|Became ineligible d/t tech|2|||
164579027|NCT03212261|594485511|FG000|Overall Study|Tech Trouble- No first study visit|1|||
164579028|NCT03212261|594485511|FG000|Overall Study|Lost to Follow-up|7|||
164579029|NCT03212261|594485511|FG000|Overall Study|Family Emergency|1|||
164579030|NCT03212261|594485511|FG000|Overall Study|Too busy/ No time|5|||
164579031|NCT03815175|594485515|FG000|Overall Study|Subject Lost to Follow-up|6|||
164579032|NCT03815175|594485515|FG000|Overall Study|Subject Withdrew Consent|48|||
164579033|NCT03815175|594485515|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
164579034|NCT03815175|594485515|FG000|Overall Study|Death|86|||
164579035|NCT03815175|594485515|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
164579036|NCT03815175|594485515|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
164579037|NCT03815175|594485515|FG000|Overall Study|Other Status Change Reason|1|||
164579038|NCT03815175|594485515|FG000|Overall Study|Missed Visit|12|||
164579039|NCT02296840|594485523|FG000|Overall Study|Adverse Event|1|||
164579040|NCT02296840|594485524|FG001|Overall Study|Adverse Event|1|||
164579041|NCT02296840|594485523|FG000|Overall Study|Protocol Violation|2|||
164579042|NCT02296840|594485524|FG001|Overall Study|Protocol Violation|1|||
164579043|NCT02296840|594485523|FG000|Overall Study|Lost to Follow-up|6|||
164579044|NCT02296840|594485524|FG001|Overall Study|Lost to Follow-up|17|||
164579045|NCT00457639|594485525|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
164579046|NCT00457639|594485526|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
164579047|NCT00457639|594485525|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
164579048|NCT00457639|594485526|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
164579049|NCT00457639|594485525|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
164579050|NCT00457639|594485526|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
164579051|NCT03885284|594485527|FG000|Overall Study|Disease Progression|1|||
164579052|NCT03885284|594485528|FG001|Overall Study|Disease Progression|3|||
164579053|NCT03885284|594485527|FG000|Overall Study|Physician Decision|0|||
164579054|NCT03885284|594485528|FG001|Overall Study|Physician Decision|1|||
164683705|NCT02998541|594865459|FG001|Overall Study|Adverse Event|5|||
164264898|NCT00844805|593338791|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
164341406|NCT00297830|593625348|FG001|12 Month Visit|Adverse Event|3|||
164341407|NCT00297830|593625349|FG002|12 Month Visit|Adverse Event|0|||
164341408|NCT00297830|593625347|FG000|12 Month Visit|Withdrawal by Subject|0|||
164341409|NCT00297830|593625348|FG001|12 Month Visit|Withdrawal by Subject|3|||
164579055|NCT01450540|594485531|FG000|Overall Study|Withdrawal by Subject|19|||
164579056|NCT01450540|594485532|FG001|Overall Study|Withdrawal by Subject|13|||
164579057|NCT01450540|594485531|FG000|Overall Study|protocol deviation|3|||
164579058|NCT01450540|594485532|FG001|Overall Study|protocol deviation|23|||
164579059|NCT00140855|594485533|FG000|Overall Study|Progressive disease|2|||
164579060|NCT03542682|594485534|FG000|Overall Study|COVID-19 Protocol|0|||
164579061|NCT03542682|594485535|FG001|Overall Study|COVID-19 Protocol|1|||
164264899|NCT00844805|593338788|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
164341410|NCT00297830|593625349|FG002|12 Month Visit|Withdrawal by Subject|0|||
164683706|NCT02998541|594865460|FG002|Overall Study|Adverse Event|1|||
164683707|NCT02998541|594865458|FG000|Overall Study|Protocol Violation|1|||
164683708|NCT02998541|594865459|FG001|Overall Study|Protocol Violation|0|||
164683709|NCT02998541|594865460|FG002|Overall Study|Protocol Violation|0|||
164683710|NCT02998541|594865458|FG000|Overall Study|Withdrawal by Subject|3|||
164683711|NCT02998541|594865459|FG001|Overall Study|Withdrawal by Subject|1|||
164683712|NCT02998541|594865460|FG002|Overall Study|Withdrawal by Subject|0|||
164683713|NCT02998541|594865458|FG000|Overall Study|Lost to Follow-up|0|||
164683714|NCT02998541|594865459|FG001|Overall Study|Lost to Follow-up|3|||
164683715|NCT02998541|594865460|FG002|Overall Study|Lost to Follow-up|1|||
164683716|NCT02998541|594865458|FG000|Overall Study|Physician Decision|0|||
164683717|NCT02998541|594865459|FG001|Overall Study|Physician Decision|0|||
164683718|NCT02998541|594865460|FG002|Overall Study|Physician Decision|3|||
164683719|NCT02998541|594865458|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164683720|NCT02998541|594865459|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164683721|NCT02998541|594865460|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
164683722|NCT03540160|594865463|FG000|Overall Study|Protocol Violation|1|||
164683723|NCT03540160|594865463|FG000|Overall Study|Physician Decision|8|||
164683724|NCT03540160|594865463|FG000|Overall Study|Lack of Efficacy|60|||
164683725|NCT03540160|594865463|FG000|Overall Study|Pregnancy|1|||
164683726|NCT03540160|594865463|FG000|Overall Study|Adverse Event|20|||
164683727|NCT03540160|594865463|FG000|Overall Study|Withdrawal by Subject|68|||
164683728|NCT03540160|594865463|FG000|Overall Study|COVID-19|2|||
164264900|NCT00844805|593338789|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
164264901|NCT00844805|593338790|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
164683729|NCT03540160|594865463|FG000|Overall Study|Study Closure|10|||
164683730|NCT03540160|594865463|FG000|Overall Study|Lost to Follow-up|18|||
164683731|NCT03540160|594865463|FG000|Overall Study|Sponsor decision|191|||
164683732|NCT01944722|594865464|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
164683733|NCT01944722|594865464|FG000|Overall Study|Specimen Shipping Issues|34|||
164683734|NCT01944722|594865464|FG000|Overall Study|Improper Storage/Transport|5|||
164683735|NCT01944722|594865464|FG000|Overall Study|Insufficient Volume for Test|1|||
164683736|NCT01944722|594865464|FG000|Overall Study|Missing Specimens|3|||
164683737|NCT01944722|594865464|FG000|Overall Study|Specimens Mislabeled|2|||
164683738|NCT01944722|594865464|FG000|Overall Study|Withdrawal by Subject|8|||
164683739|NCT01944722|594865464|FG000|Overall Study|NILM Subjects <30 years old|8106|||
164683740|NCT01944722|594865464|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
164683741|NCT01944722|594865464|FG000|Overall Study|>ASCUS Cytology|1122|||
164683742|NCT01923740|594865465|FG000|Overall Study|Lost to Follow-up|4|||
164683743|NCT01923740|594865466|FG001|Overall Study|Lost to Follow-up|9|||
164683744|NCT01923740|594865465|FG000|Overall Study|Withdrawal by Subject|2|||
164683745|NCT01923740|594865466|FG001|Overall Study|Withdrawal by Subject|0|||
164683746|NCT00585286|594865468|FG000|Overall Study|Lost to Follow-up|1|||
164683747|NCT03345420|594865469|FG000|Overall Study|Withdrawal by Subject|1|||
164683748|NCT03358147|594865471|FG000|Overall Study|Withdrawal by Subject|13|||
164683749|NCT03358147|594865472|FG001|Overall Study|Withdrawal by Subject|19|||
164683750|NCT03358147|594865473|FG002|Overall Study|Withdrawal by Subject|16|||
164683751|NCT03358147|594865474|FG003|Overall Study|Withdrawal by Subject|10|||
164683752|NCT03358147|594865475|FG004|Overall Study|Withdrawal by Subject|5|||
164683753|NCT03358147|594865471|FG000|Overall Study|Adverse Event|3|||
164683754|NCT03358147|594865472|FG001|Overall Study|Adverse Event|9|||
164683755|NCT03358147|594865473|FG002|Overall Study|Adverse Event|7|||
164683756|NCT03358147|594865474|FG003|Overall Study|Adverse Event|5|||
164683757|NCT03358147|594865475|FG004|Overall Study|Adverse Event|2|||
164683758|NCT03358147|594865471|FG000|Overall Study|Lost to Follow-up|4|||
164683759|NCT03358147|594865472|FG001|Overall Study|Lost to Follow-up|3|||
164683760|NCT03358147|594865473|FG002|Overall Study|Lost to Follow-up|7|||
164264902|NCT00844805|593338791|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
164264903|NCT00259298|593338792|FG000|Overall Study|Withdrawal by Subject|1|||
164264904|NCT00259298|593338792|FG000|Overall Study|Physician Decision|2|||
164264905|NCT01011933|593338796|FG000|Overall Study|Wrong cell type|1|||
164264906|NCT01011933|593338796|FG000|Overall Study|Improper pre-protocol Rx|1|||
164264907|NCT01011933|593338796|FG000|Overall Study|Inadequate pathology|1|||
164264908|NCT01011933|593338796|FG000|Overall Study|Never treated|1|||
164264909|NCT00475865|593338798|FG000|Overall Study|Adverse Event|0|||
164264910|NCT00475865|593338799|FG001|Overall Study|Adverse Event|3|||
164264911|NCT00475865|593338800|FG002|Overall Study|Adverse Event|4|||
164264912|NCT00475865|593338798|FG000|Overall Study|Lack of Efficacy|1|||
164341411|NCT02835820|593625350|FG000|Overall Study|Baseline Screen Failure|0|||
164341412|NCT02835820|593625351|FG001|Overall Study|Baseline Screen Failure|3|||
164683761|NCT03358147|594865474|FG003|Overall Study|Lost to Follow-up|6|||
164264913|NCT00475865|593338799|FG001|Overall Study|Lack of Efficacy|0|||
164341413|NCT00827502|593625352|FG000|Overall Study|randomized but not treated|11|||
164683762|NCT03358147|594865475|FG004|Overall Study|Lost to Follow-up|4|||
164683763|NCT03358147|594865471|FG000|Overall Study|Major Protocol Deviation|11|||
164683764|NCT03358147|594865472|FG001|Overall Study|Major Protocol Deviation|3|||
164683765|NCT03358147|594865473|FG002|Overall Study|Major Protocol Deviation|2|||
164264914|NCT00475865|593338800|FG002|Overall Study|Lack of Efficacy|0|||
164264915|NCT00475865|593338798|FG000|Overall Study|Progressive disease|0|||
164264916|NCT00475865|593338799|FG001|Overall Study|Progressive disease|1|||
164264917|NCT00475865|593338800|FG002|Overall Study|Progressive disease|2|||
164264918|NCT00475865|593338798|FG000|Overall Study|Participant did not wish to continue|1|||
164264919|NCT00475865|593338799|FG001|Overall Study|Participant did not wish to continue|0|||
164264920|NCT00475865|593338800|FG002|Overall Study|Participant did not wish to continue|0|||
164264921|NCT00475865|593338798|FG000|Overall Study|Other than above|0|||
164264922|NCT00475865|593338799|FG001|Overall Study|Other than above|1|||
164264923|NCT00475865|593338800|FG002|Overall Study|Other than above|0|||
164341414|NCT00827502|593625352|FG000|Overall Study|Adverse Event|1|||
164341415|NCT00827502|593625352|FG000|Overall Study|Lost to Follow-up|4|||
164341416|NCT00827502|593625352|FG000|Overall Study|Withdrawal by Subject|5|||
164579062|NCT00840463|594485546|FG000|Overall Study|Adverse Event|1|||
164579063|NCT00840463|594485547|FG001|Overall Study|Adverse Event|0|||
164579064|NCT01887210|594485551|FG000|Overall Study|Withdrawal by Subject|1|||
164579065|NCT01887210|594485552|FG001|Overall Study|Withdrawal by Subject|3|||
164579066|NCT01887210|594485551|FG000|Overall Study|Lost to Follow-up|0|||
164579067|NCT01887210|594485552|FG001|Overall Study|Lost to Follow-up|1|||
164579068|NCT02515669|594485559|FG000|228 Week Open-Label Phase|Other|0|||
164579069|NCT02515669|594485560|FG001|228 Week Open-Label Phase|Other|0|||
164579070|NCT02515669|594485561|FG002|228 Week Open-Label Phase|Other|1|||
164579071|NCT02515669|594485562|FG003|228 Week Open-Label Phase|Other|4|||
164579072|NCT02515669|594485559|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
164579073|NCT02515669|594485560|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
164579074|NCT02515669|594485561|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
164579075|NCT02515669|594485562|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
164579076|NCT02515669|594485559|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
164579077|NCT02515669|594485560|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
164579078|NCT02515669|594485561|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
164579079|NCT02515669|594485562|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
164579080|NCT02515669|594485559|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
164579081|NCT02515669|594485560|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
164579082|NCT02515669|594485561|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
164579083|NCT02515669|594485562|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
164579084|NCT02515669|594485559|FG000|228 Week Open-Label Phase|Missing|0|||
164579085|NCT02515669|594485560|FG001|228 Week Open-Label Phase|Missing|2|||
164579086|NCT02515669|594485561|FG002|228 Week Open-Label Phase|Missing|2|||
164579087|NCT02515669|594485562|FG003|228 Week Open-Label Phase|Missing|2|||
164579088|NCT01444391|594485565|FG000|Overall Study|Death|1|||
164579089|NCT03191786|594485569|FG000|Overall Study|Death|236|||
164579090|NCT03191786|594485570|FG001|Overall Study|Death|127|||
164579091|NCT03191786|594485569|FG000|Overall Study|Lost to Follow-up|9|||
164579092|NCT03191786|594485570|FG001|Overall Study|Lost to Follow-up|3|||
164579093|NCT03191786|594485569|FG000|Overall Study|Physician Decision|1|||
164579094|NCT03191786|594485570|FG001|Overall Study|Physician Decision|0|||
164579095|NCT03191786|594485569|FG000|Overall Study|Moved to Post Trial Access Program|30|||
164579096|NCT03191786|594485570|FG001|Overall Study|Moved to Post Trial Access Program|5|||
164579097|NCT03191786|594485569|FG000|Overall Study|Withdrawal by Subject|26|||
164579098|NCT03191786|594485570|FG001|Overall Study|Withdrawal by Subject|16|||
164579099|NCT03439345|594487166|FG000|Overall Study|Lost to Follow-up|0|||
164579100|NCT03439345|594487167|FG001|Overall Study|Lost to Follow-up|1|||
164579101|NCT03439345|594487166|FG000|Overall Study|Consent withdrawn|0|||
164579102|NCT03439345|594487167|FG001|Overall Study|Consent withdrawn|1|||
164579103|NCT05781542|594487168|FG000|Overall Study|Lost to Follow-up|1|||
164579104|NCT05781542|594487169|FG001|Overall Study|Lost to Follow-up|0|||
164579105|NCT05781542|594487170|FG002|Overall Study|Lost to Follow-up|1|||
164579106|NCT05405166|594487173|FG000|Overall Study|Death|49|||
164579107|NCT05405166|594487174|FG001|Overall Study|Death|50|||
164579108|NCT05405166|594487173|FG000|Overall Study|Withdrawal by Subject|10|||
164579109|NCT05405166|594487174|FG001|Overall Study|Withdrawal by Subject|3|||
164579110|NCT05405166|594487173|FG000|Overall Study|Ongoing at the time of PCD|209|||
164579111|NCT05405166|594487174|FG001|Overall Study|Ongoing at the time of PCD|210|||
164579112|NCT01386385|594487177|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
164579113|NCT01386385|594487178|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
164579114|NCT01386385|594487179|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
164579115|NCT01386385|594487180|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
164579116|NCT01386385|594487181|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
164579117|NCT01386385|594487182|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
164579118|NCT01386385|594487183|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
164264924|NCT02726880|593338801|FG000|Overall Study|Withdrawal by Subject|2|||
164683766|NCT03358147|594865474|FG003|Overall Study|Major Protocol Deviation|3|||
164683767|NCT03358147|594865475|FG004|Overall Study|Major Protocol Deviation|1|||
164683768|NCT03358147|594865471|FG000|Overall Study|Protocol specified criteria|2|||
164683769|NCT03358147|594865472|FG001|Overall Study|Protocol specified criteria|3|||
164683770|NCT03358147|594865473|FG002|Overall Study|Protocol specified criteria|0|||
164683771|NCT03358147|594865474|FG003|Overall Study|Protocol specified criteria|3|||
164683772|NCT03358147|594865475|FG004|Overall Study|Protocol specified criteria|1|||
164683773|NCT03358147|594865471|FG000|Overall Study|Physician Decision|1|||
164683774|NCT03358147|594865472|FG001|Overall Study|Physician Decision|0|||
164683775|NCT03358147|594865473|FG002|Overall Study|Physician Decision|1|||
164683776|NCT03358147|594865474|FG003|Overall Study|Physician Decision|6|||
164264925|NCT02726880|593338802|FG001|Overall Study|Withdrawal by Subject|0|||
164264926|NCT02726880|593338801|FG000|Overall Study|Lost to Follow-up|1|||
164264927|NCT02726880|593338802|FG001|Overall Study|Lost to Follow-up|3|||
164264928|NCT00787202|593338803|FG000|Overall Study|Adverse Event|3|||
164264929|NCT00787202|593338804|FG001|Overall Study|Adverse Event|2|||
164264930|NCT00787202|593338805|FG002|Overall Study|Adverse Event|0|||
164264931|NCT00787202|593338806|FG003|Overall Study|Adverse Event|0|||
164264932|NCT00787202|593338807|FG004|Overall Study|Adverse Event|2|||
164264933|NCT00787202|593338803|FG000|Overall Study|Lack of Efficacy|5|||
164264934|NCT00787202|593338804|FG001|Overall Study|Lack of Efficacy|6|||
164264935|NCT00787202|593338805|FG002|Overall Study|Lack of Efficacy|5|||
164264936|NCT00787202|593338806|FG003|Overall Study|Lack of Efficacy|2|||
164264937|NCT00787202|593338807|FG004|Overall Study|Lack of Efficacy|1|||
164264938|NCT00787202|593338803|FG000|Overall Study|Lost to Follow-up|1|||
164264939|NCT00787202|593338804|FG001|Overall Study|Lost to Follow-up|0|||
164264940|NCT00787202|593338805|FG002|Overall Study|Lost to Follow-up|0|||
164264941|NCT00787202|593338806|FG003|Overall Study|Lost to Follow-up|0|||
164264942|NCT00787202|593338807|FG004|Overall Study|Lost to Follow-up|0|||
164264943|NCT00787202|593338803|FG000|Overall Study|Withdrawal by Subject|2|||
164264944|NCT00787202|593338804|FG001|Overall Study|Withdrawal by Subject|2|||
164264945|NCT00787202|593338805|FG002|Overall Study|Withdrawal by Subject|2|||
164264946|NCT00787202|593338806|FG003|Overall Study|Withdrawal by Subject|0|||
164264947|NCT00787202|593338807|FG004|Overall Study|Withdrawal by Subject|0|||
164264948|NCT00787202|593338803|FG000|Overall Study|Protocol Violation|2|||
164264949|NCT00787202|593338804|FG001|Overall Study|Protocol Violation|1|||
164683777|NCT03358147|594865475|FG004|Overall Study|Physician Decision|1|||
164683778|NCT03358147|594865471|FG000|Overall Study|Administrative reasons|0|||
164683779|NCT03358147|594865472|FG001|Overall Study|Administrative reasons|1|||
164683780|NCT03358147|594865473|FG002|Overall Study|Administrative reasons|0|||
164683781|NCT03358147|594865474|FG003|Overall Study|Administrative reasons|3|||
164683782|NCT03358147|594865475|FG004|Overall Study|Administrative reasons|0|||
164683783|NCT03358147|594865471|FG000|Overall Study|Lack of Efficacy|0|||
164683784|NCT03358147|594865472|FG001|Overall Study|Lack of Efficacy|1|||
164683785|NCT03358147|594865473|FG002|Overall Study|Lack of Efficacy|1|||
164683786|NCT03358147|594865474|FG003|Overall Study|Lack of Efficacy|0|||
164683787|NCT03358147|594865475|FG004|Overall Study|Lack of Efficacy|0|||
164264950|NCT00787202|593338805|FG002|Overall Study|Protocol Violation|0|||
164264951|NCT00787202|593338806|FG003|Overall Study|Protocol Violation|0|||
164264952|NCT00787202|593338807|FG004|Overall Study|Protocol Violation|1|||
164264953|NCT00787202|593338803|FG000|Overall Study|Randomized, not treated|1|||
164264954|NCT00787202|593338804|FG001|Overall Study|Randomized, not treated|0|||
164264955|NCT00787202|593338805|FG002|Overall Study|Randomized, not treated|0|||
164264956|NCT00787202|593338806|FG003|Overall Study|Randomized, not treated|0|||
164264957|NCT00787202|593338807|FG004|Overall Study|Randomized, not treated|0|||
164264958|NCT01510145|593338808|FG000|Overall Study|Adverse Event|6|||
164264959|NCT01510145|593338808|FG000|Overall Study|Lost to Follow-up|5|||
164264960|NCT01510145|593338808|FG000|Overall Study|Withdrawal by Subject|6|||
164264961|NCT01510145|593338808|FG000|Overall Study|Relative reported subject withdrew|1|||
164264962|NCT01822535|593338809|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
164264963|NCT01822535|593338810|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
164264964|NCT01822535|593338809|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
164264965|NCT01822535|593338810|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
164264966|NCT01822535|593338809|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
164264967|NCT01822535|593338810|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
164264968|NCT02278614|593338813|FG000|Overall Study|Withdrawal by Subject|3|||
164264969|NCT02278614|593338814|FG001|Overall Study|Withdrawal by Subject|5|||
164264970|NCT02278614|593338813|FG000|Overall Study|Adverse Event|1|||
164264971|NCT02278614|593338814|FG001|Overall Study|Adverse Event|0|||
164264972|NCT02278614|593338813|FG000|Overall Study|left eye was not eligible|1|||
164264973|NCT02278614|593338814|FG001|Overall Study|left eye was not eligible|0|||
164264974|NCT02279498|593338815|FG000|Overall Study|Adverse Event|3|||
164264975|NCT02279498|593338816|FG001|Overall Study|Adverse Event|0|||
164341417|NCT05096221|593625353|FG000|Part 2|Physician Decision|0|||
164341418|NCT05096221|593625354|FG001|Part 2|Physician Decision|1|||
164683788|NCT02890992|594865476|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
164264976|NCT02279498|593338815|FG000|Overall Study|Lack of Efficacy|4|||
164430240|NCT03568162|593945349|FG001|Overall Study|Death|0|||
164430241|NCT03568162|593945350|FG002|Overall Study|Death|0|||
164430242|NCT03568162|593945351|FG003|Overall Study|Death|0|||
164430243|NCT03568162|593945352|FG004|Overall Study|Death|1|||
164430244|NCT03568162|593945353|FG005|Overall Study|Death|0|||
164430245|NCT03568162|593945348|FG000|Overall Study|Lost to Follow-up|3|||
164430246|NCT03568162|593945349|FG001|Overall Study|Lost to Follow-up|2|||
164430247|NCT03568162|593945350|FG002|Overall Study|Lost to Follow-up|4|||
164430248|NCT03568162|593945351|FG003|Overall Study|Lost to Follow-up|2|||
164430249|NCT03568162|593945352|FG004|Overall Study|Lost to Follow-up|3|||
164430250|NCT03568162|593945353|FG005|Overall Study|Lost to Follow-up|2|||
164430251|NCT03568162|593945348|FG000|Overall Study|Physician Decision|0|||
164430252|NCT03568162|593945349|FG001|Overall Study|Physician Decision|1|||
164430253|NCT03568162|593945350|FG002|Overall Study|Physician Decision|1|||
164430254|NCT03568162|593945351|FG003|Overall Study|Physician Decision|0|||
164430255|NCT03568162|593945352|FG004|Overall Study|Physician Decision|1|||
164430256|NCT03568162|593945353|FG005|Overall Study|Physician Decision|0|||
164430257|NCT03568162|593945348|FG000|Overall Study|Pregnancy|0|||
164430258|NCT03568162|593945349|FG001|Overall Study|Pregnancy|0|||
164430259|NCT03568162|593945350|FG002|Overall Study|Pregnancy|0|||
164683789|NCT02890992|594865477|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
164683790|NCT02890992|594865478|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
164683791|NCT02890992|594865479|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
164683792|NCT02890992|594865480|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
164683793|NCT02890992|594865481|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
164683794|NCT02890992|594865482|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
164683795|NCT02890992|594865483|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
164683796|NCT02890992|594865476|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
164683797|NCT02890992|594865477|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
164683798|NCT02890992|594865478|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
164683799|NCT02890992|594865479|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
164683800|NCT02890992|594865480|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
164683801|NCT02890992|594865481|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
164683802|NCT02890992|594865482|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
164683803|NCT02890992|594865483|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
164683804|NCT02890992|594865476|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
164683805|NCT02890992|594865477|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
164683806|NCT02890992|594865478|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
164683807|NCT02890992|594865479|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
164683808|NCT02890992|594865480|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
164683809|NCT02890992|594865481|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
164683810|NCT02890992|594865482|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
164683811|NCT02890992|594865483|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
164683812|NCT02704091|594865484|FG000|Overall Study|Adverse Event|4|||
164683813|NCT02704091|594865485|FG001|Overall Study|Adverse Event|3|||
164683814|NCT02704091|594865484|FG000|Overall Study|Protocol Violation|5|||
164683815|NCT02704091|594865485|FG001|Overall Study|Protocol Violation|3|||
164683816|NCT02704091|594865484|FG000|Overall Study|Consent withdrawn|4|||
164683817|NCT02704091|594865485|FG001|Overall Study|Consent withdrawn|4|||
164683818|NCT02704091|594865484|FG000|Overall Study|Lost to Follow-up|13|||
164683819|NCT02704091|594865485|FG001|Overall Study|Lost to Follow-up|5|||
164683820|NCT02704091|594865484|FG000|Overall Study|Other|2|||
164683821|NCT02704091|594865485|FG001|Overall Study|Other|8|||
164683822|NCT02933060|594865496|FG000|Overall Study|Withdrawal by Subject|0|||
164683823|NCT02933060|594865497|FG001|Overall Study|Withdrawal by Subject|1|||
164683824|NCT01945580|594865498|FG000|Overall Study|Withdrawal by Subject|13|||
164683825|NCT01945580|594865499|FG001|Overall Study|Withdrawal by Subject|35|||
164683826|NCT01945580|594865498|FG000|Overall Study|Physician Decision|3|||
164683827|NCT01945580|594865499|FG001|Overall Study|Physician Decision|2|||
164683828|NCT01945580|594865498|FG000|Overall Study|Lost to Follow-up|26|||
164683829|NCT01945580|594865499|FG001|Overall Study|Lost to Follow-up|39|||
164683830|NCT01945580|594865498|FG000|Overall Study|Death|7|||
164683831|NCT01945580|594865499|FG001|Overall Study|Death|2|||
164683832|NCT01945580|594865498|FG000|Overall Study|Patient moved out of state|0|||
164683833|NCT01945580|594865499|FG001|Overall Study|Patient moved out of state|1|||
164683834|NCT01945580|594865498|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
164683835|NCT01945580|594865499|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
164683836|NCT01945580|594865498|FG000|Overall Study|Family illness - unable to return|0|||
164683837|NCT01945580|594865499|FG001|Overall Study|Family illness - unable to return|1|||
164430260|NCT03568162|593945351|FG003|Overall Study|Pregnancy|1|||
164430261|NCT03568162|593945352|FG004|Overall Study|Pregnancy|0|||
164430262|NCT03568162|593945353|FG005|Overall Study|Pregnancy|0|||
164430263|NCT03568162|593945348|FG000|Overall Study|Protocol Violation|1|||
164683838|NCT01945580|594865498|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
164683839|NCT01945580|594865499|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
164683840|NCT01945580|594865498|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
164683841|NCT01945580|594865499|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
164683842|NCT01945580|594865498|FG000|Overall Study|Noncompliance with 36 month visit|1|||
164683843|NCT01945580|594865499|FG001|Overall Study|Noncompliance with 36 month visit|0|||
164683844|NCT01945580|594865498|FG000|Overall Study|The patient moved.|1|||
164683845|NCT01945580|594865499|FG001|Overall Study|The patient moved.|0|||
164683846|NCT01945580|594865498|FG000|Overall Study|No data available|0|||
164683847|NCT01945580|594865499|FG001|Overall Study|No data available|2|||
164683848|NCT00073307|594865504|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
164683849|NCT00073307|594865505|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
164683850|NCT00073307|594865506|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
164683851|NCT00073307|594865504|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
164683852|NCT00073307|594865505|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
164683853|NCT00073307|594865506|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
164683854|NCT00073307|594865504|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
164683855|NCT00073307|594865505|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
164683856|NCT00073307|594865506|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
164683857|NCT00073307|594865504|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
164683858|NCT00073307|594865505|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
164683859|NCT00073307|594865506|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
164683860|NCT00073307|594865504|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
164683861|NCT00073307|594865505|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
164683862|NCT00073307|594865506|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
164683863|NCT00073307|594865504|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
164683864|NCT00073307|594865505|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
164683865|NCT00073307|594865506|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
164683866|NCT00073307|594865504|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
164683867|NCT00073307|594865505|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
164683868|NCT00073307|594865506|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
164683869|NCT00073307|594865504|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
164683870|NCT00073307|594865505|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
164683871|NCT00073307|594865506|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
164683872|NCT00073307|594865504|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
164683873|NCT00073307|594865505|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
164683874|NCT00073307|594865506|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
164683875|NCT00073307|594865504|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
164683876|NCT00073307|594865505|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
164683877|NCT00073307|594865506|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
164683878|NCT00073307|594865504|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
164683879|NCT00073307|594865505|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
164683880|NCT00073307|594865506|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
164683881|NCT00073307|594865504|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
164264977|NCT02279498|593338816|FG001|Overall Study|Lack of Efficacy|0|||
164683882|NCT00073307|594865505|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
164683883|NCT00073307|594865506|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
164683884|NCT00073307|594865504|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
164683885|NCT00073307|594865505|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
164683886|NCT00073307|594865506|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
164683887|NCT00073307|594865504|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
164683888|NCT00073307|594865505|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
164683889|NCT00073307|594865506|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
164683890|NCT00073307|594865504|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
164683891|NCT00073307|594865505|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
164683892|NCT00073307|594865506|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
164683893|NCT00073307|594865504|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
164683894|NCT00073307|594865505|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
164683895|NCT00073307|594865506|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
164264978|NCT02279498|593338815|FG000|Overall Study|Lost to Follow-up|0|||
164264979|NCT02279498|593338816|FG001|Overall Study|Lost to Follow-up|1|||
164264980|NCT02279498|593338815|FG000|Overall Study|Withdrawal by Subject|9|||
164264981|NCT02279498|593338816|FG001|Overall Study|Withdrawal by Subject|2|||
164264982|NCT02279498|593338815|FG000|Overall Study|Undefined|2|||
164579119|NCT01386385|594487184|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
164579120|NCT01386385|594487177|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
164579121|NCT01386385|594487178|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
164579122|NCT01386385|594487179|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
164264983|NCT02279498|593338816|FG001|Overall Study|Undefined|1|||
164264984|NCT00737711|593338817|FG000|Overall Study|Adverse Event|2|||
164264985|NCT00737711|593338817|FG000|Overall Study|Death|8|||
164264986|NCT00737711|593338817|FG000|Overall Study|Failure to return|4|||
164264987|NCT00737711|593338817|FG000|Overall Study|Protocol Violation|1|||
164264988|NCT00737711|593338817|FG000|Overall Study|Withdrawal by Subject|5|||
164264989|NCT00737711|593338817|FG000|Overall Study|Blood transfusion|6|||
164264990|NCT00737711|593338817|FG000|Overall Study|Other|5|||
164264991|NCT02739321|593338818|FG000|Overall Study|Lack of Efficacy|1|||
164264992|NCT02739321|593338819|FG001|Overall Study|Lack of Efficacy|1|||
164264993|NCT02739321|593338818|FG000|Overall Study|Lost to Follow-up|1|||
164264994|NCT02739321|593338819|FG001|Overall Study|Lost to Follow-up|1|||
164264995|NCT02739321|593338818|FG000|Overall Study|Withdrawal by Subject|1|||
164264996|NCT02739321|593338819|FG001|Overall Study|Withdrawal by Subject|2|||
164264997|NCT02558400|593338820|FG000|Overall Study|Adverse Event|47|||
164264998|NCT02558400|593338821|FG001|Overall Study|Adverse Event|53|||
164264999|NCT02558400|593338822|FG002|Overall Study|Adverse Event|4|||
164265000|NCT02558400|593338820|FG000|Overall Study|Withdrawal by Subject|13|||
164265001|NCT02558400|593338821|FG001|Overall Study|Withdrawal by Subject|9|||
164683896|NCT00073307|594865504|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
164683897|NCT00073307|594865505|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
164265002|NCT02558400|593338822|FG002|Overall Study|Withdrawal by Subject|8|||
164265003|NCT02558400|593338820|FG000|Overall Study|Non-Compliant|0|||
164265004|NCT02558400|593338821|FG001|Overall Study|Non-Compliant|1|||
164265005|NCT02558400|593338822|FG002|Overall Study|Non-Compliant|3|||
164265006|NCT02558400|593338820|FG000|Overall Study|Lost to Follow-up|5|||
164265007|NCT02558400|593338821|FG001|Overall Study|Lost to Follow-up|5|||
164265008|NCT02558400|593338822|FG002|Overall Study|Lost to Follow-up|4|||
164265009|NCT02558400|593338820|FG000|Overall Study|Lack of Efficacy|0|||
164265010|NCT02558400|593338821|FG001|Overall Study|Lack of Efficacy|13|||
164265011|NCT02558400|593338822|FG002|Overall Study|Lack of Efficacy|1|||
164265012|NCT02558400|593338820|FG000|Overall Study|Disallowed Concurrent Medication|6|||
164265013|NCT02558400|593338821|FG001|Overall Study|Disallowed Concurrent Medication|7|||
164265014|NCT02558400|593338822|FG002|Overall Study|Disallowed Concurrent Medication|5|||
164265015|NCT02558400|593338820|FG000|Overall Study|Physician Decision|2|||
164265016|NCT02558400|593338821|FG001|Overall Study|Physician Decision|2|||
164265017|NCT02558400|593338822|FG002|Overall Study|Physician Decision|0|||
164265018|NCT02558400|593338820|FG000|Overall Study|Protocol Violation|6|||
164265019|NCT02558400|593338821|FG001|Overall Study|Protocol Violation|3|||
164265020|NCT02558400|593338822|FG002|Overall Study|Protocol Violation|8|||
164265021|NCT02558400|593338820|FG000|Overall Study|Death|0|||
164579123|NCT01386385|594487180|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
164579124|NCT01386385|594487181|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
164579125|NCT01386385|594487182|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
164579126|NCT01386385|594487183|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
164579127|NCT01386385|594487184|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
164579128|NCT01386385|594487177|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
164579129|NCT01386385|594487178|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
164579130|NCT01386385|594487179|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
164579131|NCT01386385|594487180|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
164579132|NCT01386385|594487181|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
164579133|NCT01386385|594487182|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
164579134|NCT01386385|594487183|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
164579135|NCT01386385|594487184|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
164579136|NCT01386385|594487177|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
164579137|NCT01386385|594487178|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
164579138|NCT01386385|594487179|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
164579139|NCT01386385|594487180|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
164265022|NCT02558400|593338821|FG001|Overall Study|Death|1|||
164265023|NCT02558400|593338822|FG002|Overall Study|Death|0|||
164265024|NCT02558400|593338820|FG000|Overall Study|Ineligible for the study|0|||
164265025|NCT02558400|593338821|FG001|Overall Study|Ineligible for the study|2|||
164579140|NCT01386385|594487181|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
164579141|NCT01386385|594487182|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
164265026|NCT02558400|593338822|FG002|Overall Study|Ineligible for the study|0|||
164265027|NCT02230683|593338826|FG000|Overall Study|Adverse Event|1|||
164265028|NCT00624780|593338827|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
164579142|NCT01386385|594487183|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
164683898|NCT00073307|594865506|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
164683899|NCT00073307|594865504|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
164683900|NCT00073307|594865505|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
164683901|NCT00073307|594865506|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
164683902|NCT00073307|594865504|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
164683903|NCT00073307|594865505|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
164683904|NCT00073307|594865506|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
164683905|NCT00858780|594865507|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
164683906|NCT00858780|594865508|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
164683907|NCT00858780|594865509|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
164683908|NCT00858780|594865510|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
164683909|NCT00858780|594865511|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
164683910|NCT00858780|594865507|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
164683911|NCT00858780|594865508|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
164683912|NCT00858780|594865509|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
164683913|NCT00858780|594865510|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
164683914|NCT00858780|594865511|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
164683915|NCT00858780|594865507|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
164683916|NCT00858780|594865508|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
164683917|NCT00858780|594865509|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
164683918|NCT00858780|594865510|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
164265029|NCT00624780|593338828|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
164265030|NCT00624780|593338829|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
164265031|NCT00624780|593338830|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
164265032|NCT00624780|593338831|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
164265033|NCT00624780|593338832|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
164265034|NCT00624780|593338827|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
164265035|NCT00624780|593338828|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
164265036|NCT00624780|593338829|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
164265037|NCT00624780|593338830|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
164265038|NCT00624780|593338831|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
164265039|NCT00624780|593338832|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
164265040|NCT00624780|593338827|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
164265041|NCT00624780|593338828|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
164265042|NCT00624780|593338829|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
164265043|NCT00624780|593338830|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
164265044|NCT00624780|593338831|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
164265045|NCT00624780|593338832|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
164265046|NCT00624780|593338827|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
164683919|NCT00858780|594865511|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
164683920|NCT00858780|594865507|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
164683921|NCT00858780|594865508|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
164683922|NCT00858780|594865509|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
164683923|NCT00858780|594865510|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
164683924|NCT00858780|594865511|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
164683925|NCT00858780|594865507|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
164683926|NCT00858780|594865508|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
164683927|NCT00858780|594865509|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
164683928|NCT00858780|594865510|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
164683929|NCT00858780|594865511|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
164683930|NCT00858780|594865507|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
164683931|NCT00858780|594865508|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
164683932|NCT00858780|594865509|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
164683933|NCT00858780|594865510|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
164683934|NCT00858780|594865511|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
164683935|NCT01024855|594865514|FG000|Overall Study|Inclusion/exclusion criteria|1|||
164683936|NCT00577655|594865515|FG000|Overall Study|Patient Request|0|||
164683937|NCT00577655|594865516|FG001|Overall Study|Patient Request|2|||
164683938|NCT00577655|594865515|FG000|Overall Study|Protocol Violation|0|||
164683939|NCT00577655|594865516|FG001|Overall Study|Protocol Violation|1|||
164683940|NCT00577655|594865515|FG000|Overall Study|Lost to Follow-up|1|||
164265047|NCT00624780|593338828|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
164265048|NCT00624780|593338829|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
164265049|NCT00624780|593338830|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
164265050|NCT00624780|593338831|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
164265051|NCT00624780|593338832|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
164265052|NCT00624780|593338827|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
164265053|NCT00624780|593338828|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
164265054|NCT00624780|593338829|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
164265055|NCT00624780|593338830|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
164265056|NCT00624780|593338831|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
164265057|NCT00624780|593338832|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
164265058|NCT00624780|593338827|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
164265059|NCT00624780|593338828|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
164265060|NCT00624780|593338829|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
164265061|NCT00624780|593338830|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
164265062|NCT00624780|593338831|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
164265063|NCT00624780|593338832|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
164265064|NCT00624780|593338827|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
164265065|NCT00624780|593338828|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
164265066|NCT00624780|593338829|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
164579143|NCT01386385|594487184|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
164579144|NCT01386385|594487177|FG000|Phase II Concurrent CRT|Adverse Event|0|||
164579145|NCT01386385|594487178|FG001|Phase II Concurrent CRT|Adverse Event|0|||
164579146|NCT01386385|594487179|FG002|Phase II Concurrent CRT|Adverse Event|0|||
164579147|NCT01386385|594487180|FG003|Phase II Concurrent CRT|Adverse Event|0|||
164579148|NCT01386385|594487181|FG004|Phase II Concurrent CRT|Adverse Event|0|||
164579149|NCT01386385|594487182|FG005|Phase II Concurrent CRT|Adverse Event|0|||
164579150|NCT01386385|594487183|FG006|Phase II Concurrent CRT|Adverse Event|3|||
164579151|NCT01386385|594487184|FG007|Phase II Concurrent CRT|Adverse Event|3|||
164579152|NCT01386385|594487177|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
164579153|NCT01386385|594487178|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
164579154|NCT01386385|594487179|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
164579155|NCT01386385|594487180|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
164579156|NCT01386385|594487181|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
164579157|NCT01386385|594487182|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
164579158|NCT01386385|594487183|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
164579159|NCT01386385|594487184|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
164579160|NCT01386385|594487177|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
164579161|NCT01386385|594487178|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
164579162|NCT01386385|594487179|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
164579163|NCT01386385|594487180|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
164579164|NCT01386385|594487181|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
164579165|NCT01386385|594487182|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
164579166|NCT01386385|594487183|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
164579167|NCT01386385|594487184|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
164579168|NCT01386385|594487177|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
164579169|NCT01386385|594487178|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
164579170|NCT01386385|594487179|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
164579171|NCT01386385|594487180|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
164579172|NCT01386385|594487181|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
164579173|NCT01386385|594487182|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
164579174|NCT01386385|594487183|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
164579175|NCT01386385|594487184|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
164579176|NCT01386385|594487177|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
164579177|NCT01386385|594487178|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
164579178|NCT01386385|594487179|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
164579179|NCT01386385|594487180|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
164579180|NCT01386385|594487181|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
164579181|NCT01386385|594487182|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
164579182|NCT01386385|594487183|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
164579183|NCT01386385|594487184|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
164683941|NCT00577655|594865516|FG001|Overall Study|Lost to Follow-up|1|||
164683942|NCT03306277|594865520|FG000|Overall Study|Death|1|||
164341419|NCT03417219|593625358|FG000|Overall Study|Lost to Follow-up|0|||
164579184|NCT03746080|594487186|FG000|Overall Study|In follow up|2|||
164579185|NCT03746080|594487186|FG000|Overall Study|Death|15|||
164579186|NCT01843374|594487187|FG000|Overall Study|Death|155|||
164579187|NCT01843374|594487188|FG001|Overall Study|Death|313|||
164579188|NCT01843374|594487187|FG000|Overall Study|Withdrawal by Subject|14|||
164579189|NCT01843374|594487188|FG001|Overall Study|Withdrawal by Subject|20|||
164579190|NCT01843374|594487187|FG000|Overall Study|Withdrawing due to Other reason|20|||
164683943|NCT03306277|594865520|FG000|Overall Study|Adverse Event|1|||
164683944|NCT03306277|594865520|FG000|Overall Study|Withdrawal by Subject|1|||
164683945|NCT01370863|594865524|FG000|Overall Study|Adverse Event|1|||
164683946|NCT01370863|594865525|FG001|Overall Study|Adverse Event|1|||
164683947|NCT01370863|594865524|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
164683948|NCT01370863|594865525|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
164683949|NCT01370863|594865524|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
164683950|NCT01370863|594865525|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
164683951|NCT05004649|594865528|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
164683952|NCT05004649|594865528|FG000|Overall Study|Lost to Follow-up|1|||
164683953|NCT05004649|594865528|FG000|Overall Study|Withdrawal by Subject|2|||
164683954|NCT05004649|594865528|FG000|Overall Study|COVID-19|1|||
164683955|NCT01926119|594865530|FG000|Overall Study|Withdrawal by Subject|1|||
164683956|NCT00645853|594865531|FG000|Overall Study|Adverse Event|18|||
164683957|NCT00645853|594865532|FG001|Overall Study|Adverse Event|7|||
164683958|NCT00645853|594865531|FG000|Overall Study|AZ study closure in Hungary|60|||
164683959|NCT00645853|594865532|FG001|Overall Study|AZ study closure in Hungary|40|||
164683960|NCT00645853|594865531|FG000|Overall Study|Withdrawal by Subject|5|||
164683961|NCT00645853|594865532|FG001|Overall Study|Withdrawal by Subject|2|||
164683962|NCT00645853|594865531|FG000|Overall Study|Protocol Violation|0|||
164683963|NCT00645853|594865532|FG001|Overall Study|Protocol Violation|2|||
164683964|NCT00645853|594865531|FG000|Overall Study|Discontinuation criteria|2|||
164683965|NCT00645853|594865532|FG001|Overall Study|Discontinuation criteria|2|||
164683966|NCT00645853|594865531|FG000|Overall Study|recall of ICF, planned operation, death|7|||
164683967|NCT00645853|594865532|FG001|Overall Study|recall of ICF, planned operation, death|4|||
164683968|NCT00406393|594865533|FG000|Overall Study|Did not undergo transplantation|2|||
164683969|NCT00406393|594865534|FG001|Overall Study|Did not undergo transplantation|1|||
164683970|NCT03885934|594865535|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
164683971|NCT03885934|594865536|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
164683972|NCT03885934|594865537|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
164683973|NCT03885934|594865538|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
164683974|NCT03885934|594865539|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
164683975|NCT03885934|594865540|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
164683976|NCT02227238|594865541|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
164683977|NCT02227238|594865542|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
164683978|NCT02227238|594865543|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
164683979|NCT02227238|594865541|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
164683980|NCT02227238|594865542|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
164683981|NCT02227238|594865543|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
164683982|NCT02227238|594865541|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
164683983|NCT02227238|594865542|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
164683984|NCT02227238|594865543|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
164683985|NCT02227238|594865541|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
164341420|NCT03417219|593625359|FG001|Overall Study|Lost to Follow-up|3|||
164341421|NCT02264639|593625364|FG000|Overall Study|Death (after completing single-dose phase)|1|||
164341422|NCT02264639|593625365|FG001|Overall Study|Death (after completing single-dose phase)|0|||
164683986|NCT02227238|594865542|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
164683987|NCT02227238|594865543|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
164683988|NCT02227238|594865541|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
164683989|NCT02227238|594865542|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
164683990|NCT02227238|594865543|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
164683991|NCT02227238|594865541|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
164683992|NCT02227238|594865542|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
164683993|NCT02227238|594865543|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
164683994|NCT02227238|594865541|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
164683995|NCT02227238|594865542|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
164683996|NCT02227238|594865543|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
164683997|NCT02227238|594865541|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
164683998|NCT02227238|594865542|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
164683999|NCT02227238|594865543|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
164684000|NCT02227238|594865541|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
164684001|NCT02227238|594865542|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
164684002|NCT02227238|594865543|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
164684003|NCT02227238|594865541|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
164684004|NCT02227238|594865542|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
164341423|NCT02264639|593625366|FG002|Overall Study|Death (after completing single-dose phase)|0|||
164341424|NCT02264639|593625367|FG003|Overall Study|Death (after completing single-dose phase)|0|||
164684005|NCT02227238|594865543|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
164684006|NCT02227238|594865541|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
164684007|NCT02227238|594865542|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
164684008|NCT02227238|594865543|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
164684009|NCT02227238|594865541|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
164684010|NCT02227238|594865542|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
164684011|NCT02227238|594865543|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
164684012|NCT02227238|594865541|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
164684013|NCT02227238|594865542|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
164684014|NCT02227238|594865543|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
164684015|NCT02227238|594865541|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
164684016|NCT02227238|594865542|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
164684017|NCT02227238|594865543|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
164341425|NCT02264639|593625368|FG004|Overall Study|Death (after completing single-dose phase)|0|||
164684018|NCT00380588|594865544|FG000|Overall Study|Unequivocal Disease Progression|25|||
164684019|NCT00380588|594865545|FG001|Overall Study|Unequivocal Disease Progression|34|||
164684020|NCT00380588|594865544|FG000|Overall Study|Next Cycle Not Started|4|||
164684021|NCT00380588|594865545|FG001|Overall Study|Next Cycle Not Started|0|||
164684022|NCT00380588|594865544|FG000|Overall Study|Adverse Event|7|||
164684023|NCT00380588|594865545|FG001|Overall Study|Adverse Event|3|||
164684024|NCT00380588|594865544|FG000|Overall Study|Withdrawal by Subject|1|||
164684025|NCT00380588|594865545|FG001|Overall Study|Withdrawal by Subject|3|||
164684026|NCT00380588|594865544|FG000|Overall Study|Physician Decision|2|||
164684027|NCT00380588|594865545|FG001|Overall Study|Physician Decision|0|||
164684028|NCT02096705|594865546|FG000|Treatment|Adverse Event|6|||
164684029|NCT02096705|594865547|FG001|Treatment|Adverse Event|3|||
164684030|NCT02096705|594865546|FG000|Treatment|Subject request to discontinue treatment|1|||
164684031|NCT02096705|594865547|FG001|Treatment|Subject request to discontinue treatment|1|||
164684032|NCT02096705|594865546|FG000|Treatment|Withdrawal by Subject|1|||
164684033|NCT02096705|594865547|FG001|Treatment|Withdrawal by Subject|0|||
164684034|NCT02096705|594865546|FG000|Treatment|Other|1|||
164684035|NCT02096705|594865547|FG001|Treatment|Other|1|||
164684036|NCT02096705|594865546|FG000|Follow-up|Withdrawal by Subject|1|||
164684037|NCT02096705|594865547|FG001|Follow-up|Withdrawal by Subject|0|||
164684038|NCT02096705|594865546|FG000|Follow-up|Adverse Event|2|||
164684039|NCT02096705|594865547|FG001|Follow-up|Adverse Event|2|||
164684040|NCT02096705|594865546|FG000|Follow-up|Subjects not reporting status|1|||
164684041|NCT02096705|594865547|FG001|Follow-up|Subjects not reporting status|2|||
164684042|NCT02905435|594865548|FG000|Overall Study|Death|2|||
164684043|NCT02905435|594865548|FG000|Overall Study|Physician Decision|1|||
164684044|NCT02905435|594865548|FG000|Overall Study|Lost to Follow-up|4|||
164684045|NCT02377349|594865552|FG000|Overall Study|Serious Adverse Event|1|||
164684046|NCT02377349|594865553|FG001|Overall Study|Serious Adverse Event|0|||
164684047|NCT02377349|594865552|FG000|Overall Study|Protocol Violation|3|||
164684048|NCT02377349|594865553|FG001|Overall Study|Protocol Violation|2|||
164684049|NCT02377349|594865552|FG000|Overall Study|Withdrawal by Subject|5|||
164684050|NCT02377349|594865553|FG001|Overall Study|Withdrawal by Subject|3|||
164684051|NCT02377349|594865552|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
164684052|NCT02377349|594865553|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
164684053|NCT02377349|594865552|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
164684054|NCT02377349|594865553|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
164684055|NCT02377349|594865552|FG000|Overall Study|Other|0|||
164684056|NCT02377349|594865553|FG001|Overall Study|Other|1|||
164684057|NCT01507662|594865562|FG000|Overall Study|Death|26|||
164684058|NCT01507662|594865563|FG001|Overall Study|Death|18|||
164684059|NCT01507662|594865562|FG000|Overall Study|Withdrawal by Subject|290|||
164684060|NCT01507662|594865563|FG001|Overall Study|Withdrawal by Subject|287|||
164684061|NCT01507662|594865562|FG000|Overall Study|Lost to Follow-up|498|||
164684062|NCT01507662|594865563|FG001|Overall Study|Lost to Follow-up|523|||
164684063|NCT01507662|594865562|FG000|Overall Study|Proxy interview done|2|||
164684064|NCT01507662|594865563|FG001|Overall Study|Proxy interview done|3|||
164684065|NCT01395017|594865568|FG000|Overall Study|Lost to Follow-up|1|||
164341426|NCT02264639|593625364|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
164341427|NCT02264639|593625365|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
164341428|NCT02264639|593625366|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
164341429|NCT02264639|593625367|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
164341430|NCT02264639|593625368|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
164341431|NCT02264639|593625364|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
164341432|NCT02264639|593625365|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
164341433|NCT02264639|593625366|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
164341434|NCT02264639|593625367|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
164341435|NCT02264639|593625368|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
164341436|NCT02264639|593625364|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
164341437|NCT02264639|593625365|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
164341438|NCT02264639|593625366|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
164341439|NCT02264639|593625367|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
164341440|NCT02264639|593625368|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
164341441|NCT00369824|593625372|FG000|Overall Study|Adverse Event|0|||
164684066|NCT01395017|594865569|FG001|Overall Study|Lost to Follow-up|0|||
164684067|NCT01395017|594865568|FG000|Overall Study|Adverse Event|26|||
164684068|NCT01395017|594865569|FG001|Overall Study|Adverse Event|12|||
164684069|NCT01395017|594865568|FG000|Overall Study|Physician Decision|11|||
164684070|NCT01395017|594865569|FG001|Overall Study|Physician Decision|15|||
164684071|NCT01395017|594865568|FG000|Overall Study|Withdrawal by Subject|14|||
164684072|NCT01395017|594865569|FG001|Overall Study|Withdrawal by Subject|8|||
164684073|NCT01395017|594865568|FG000|Overall Study|Protocol deviation|1|||
164684074|NCT01395017|594865569|FG001|Overall Study|Protocol deviation|2|||
164684075|NCT01395017|594865568|FG000|Overall Study|Death|4|||
164684076|NCT01395017|594865569|FG001|Overall Study|Death|3|||
164684077|NCT01395017|594865568|FG000|Overall Study|Disease progression|42|||
164684078|NCT01395017|594865569|FG001|Overall Study|Disease progression|58|||
164684079|NCT01395017|594865568|FG000|Overall Study|Sponsor discontinued study|1|||
164684080|NCT01395017|594865569|FG001|Overall Study|Sponsor discontinued study|4|||
164684081|NCT03366428|594865573|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
164684082|NCT03366428|594865573|FG000|Overall Study|Adverse Event|12|||
164684083|NCT03366428|594865573|FG000|Overall Study|Clinical progression|2|||
164684084|NCT03366428|594865573|FG000|Overall Study|Withdrawal by Subject|4|||
164684085|NCT01046084|594865577|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
164684086|NCT01046084|594865578|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
164684087|NCT00999687|594865579|FG000|First Intervention|Withdrawal by Subject|1|||
164684088|NCT00999687|594865579|FG000|Second Intervention|Withdrawal by Subject|2|||
164684089|NCT00999687|594865579|FG000|Second Intervention|Lack of Efficacy|1|||
164684090|NCT03614728|594865582|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
164684091|NCT03614728|594865583|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
164684092|NCT03614728|594865584|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
164684093|NCT03614728|594865585|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
164684094|NCT03614728|594865582|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
164684095|NCT03614728|594865583|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
164684096|NCT03614728|594865584|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
164684097|NCT03614728|594865585|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
164684098|NCT01971645|594865590|FG000|Overall Study|Adverse Event|1|||
164684099|NCT01971645|594865591|FG001|Overall Study|Adverse Event|0|||
164684100|NCT01971645|594865592|FG002|Overall Study|Adverse Event|0|||
164684101|NCT01971645|594865590|FG000|Overall Study|Lost to Follow-up|1|||
164684102|NCT01971645|594865591|FG001|Overall Study|Lost to Follow-up|0|||
164684103|NCT01971645|594865592|FG002|Overall Study|Lost to Follow-up|1|||
164684104|NCT01971645|594865590|FG000|Overall Study|Protocol Violation|0|||
164684105|NCT01971645|594865591|FG001|Overall Study|Protocol Violation|0|||
164684106|NCT01971645|594865592|FG002|Overall Study|Protocol Violation|1|||
164684107|NCT02943096|594865595|FG000|Overall Study|Lack of Efficacy|0|||
164684108|NCT02943096|594865596|FG001|Overall Study|Lack of Efficacy|1|||
164684109|NCT01717040|594865600|FG000|Overall Study|Lost to Follow-up|2|||
164684110|NCT01717040|594865601|FG001|Overall Study|Lost to Follow-up|3|||
164684111|NCT01717040|594865600|FG000|Overall Study|Lack of Efficacy|1|||
164684112|NCT01717040|594865601|FG001|Overall Study|Lack of Efficacy|1|||
164684113|NCT01717040|594865600|FG000|Overall Study|Adverse Event|1|||
164684114|NCT01717040|594865601|FG001|Overall Study|Adverse Event|0|||
164684115|NCT01717040|594865600|FG000|Overall Study|Required Medication Change|0|||
164684116|NCT01717040|594865601|FG001|Overall Study|Required Medication Change|1|||
164684117|NCT01717040|594865600|FG000|Overall Study|New Substance Use Disorder|1|||
164341442|NCT00369824|593625373|FG001|Overall Study|Adverse Event|2|||
164341443|NCT00369824|593625374|FG002|Overall Study|Adverse Event|0|||
164341444|NCT00369824|593625375|FG003|Overall Study|Adverse Event|0|||
164341445|NCT00369824|593625376|FG004|Overall Study|Adverse Event|1|||
164341446|NCT00369824|593625377|FG005|Overall Study|Adverse Event|0|||
164341447|NCT00369824|593625372|FG000|Overall Study|Protocol Violation|0|||
164341448|NCT00369824|593625373|FG001|Overall Study|Protocol Violation|1|||
164341449|NCT00369824|593625374|FG002|Overall Study|Protocol Violation|0|||
164341450|NCT00369824|593625375|FG003|Overall Study|Protocol Violation|1|||
164341451|NCT00369824|593625376|FG004|Overall Study|Protocol Violation|1|||
164341452|NCT00369824|593625377|FG005|Overall Study|Protocol Violation|0|||
164341453|NCT00369824|593625372|FG000|Overall Study|Withdrawal by Subject|9|||
164341454|NCT00369824|593625373|FG001|Overall Study|Withdrawal by Subject|5|||
164341455|NCT00369824|593625374|FG002|Overall Study|Withdrawal by Subject|5|||
164341456|NCT00369824|593625375|FG003|Overall Study|Withdrawal by Subject|4|||
164341457|NCT00369824|593625376|FG004|Overall Study|Withdrawal by Subject|6|||
164341458|NCT00369824|593625377|FG005|Overall Study|Withdrawal by Subject|2|||
164341459|NCT00369824|593625372|FG000|Overall Study|Lost to Follow-up|6|||
164341460|NCT00369824|593625373|FG001|Overall Study|Lost to Follow-up|11|||
164341461|NCT00369824|593625374|FG002|Overall Study|Lost to Follow-up|7|||
164341462|NCT00369824|593625375|FG003|Overall Study|Lost to Follow-up|8|||
164341463|NCT00369824|593625376|FG004|Overall Study|Lost to Follow-up|9|||
164341464|NCT00369824|593625377|FG005|Overall Study|Lost to Follow-up|6|||
164341465|NCT00369824|593625372|FG000|Overall Study|Other|0|||
164341466|NCT00369824|593625373|FG001|Overall Study|Other|0|||
164341467|NCT00369824|593625374|FG002|Overall Study|Other|0|||
164341468|NCT00369824|593625375|FG003|Overall Study|Other|2|||
164341469|NCT00369824|593625376|FG004|Overall Study|Other|1|||
164341470|NCT00369824|593625377|FG005|Overall Study|Other|3|||
164341471|NCT01443078|593625378|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
164341472|NCT01443078|593625378|FG000|Overall Study|Withdrawal by Subject|1|||
164341473|NCT01443078|593625378|FG000|Overall Study|Patient had brain mets|1|||
164341474|NCT01390649|593625379|FG000|Overall Study|Physician Decision|1|||
164341475|NCT00415168|593625380|FG000|Overall Study|Death|26|||
164341476|NCT00415168|593625380|FG000|Overall Study|Lost to Follow-up|3|||
164684118|NCT01717040|594865601|FG001|Overall Study|New Substance Use Disorder|0|||
164430264|NCT03568162|593945349|FG001|Overall Study|Protocol Violation|0|||
164430265|NCT03568162|593945350|FG002|Overall Study|Protocol Violation|1|||
164430266|NCT03568162|593945351|FG003|Overall Study|Protocol Violation|1|||
164430267|NCT03568162|593945352|FG004|Overall Study|Protocol Violation|1|||
164430268|NCT03568162|593945353|FG005|Overall Study|Protocol Violation|1|||
164430269|NCT03568162|593945348|FG000|Overall Study|Withdrawal by Subject|15|||
164430270|NCT03568162|593945349|FG001|Overall Study|Withdrawal by Subject|15|||
164430271|NCT03568162|593945350|FG002|Overall Study|Withdrawal by Subject|26|||
164430272|NCT03568162|593945351|FG003|Overall Study|Withdrawal by Subject|22|||
164430273|NCT03568162|593945352|FG004|Overall Study|Withdrawal by Subject|6|||
164430274|NCT03568162|593945353|FG005|Overall Study|Withdrawal by Subject|9|||
164430275|NCT03568162|593945348|FG000|Overall Study|Others|3|||
164579191|NCT01843374|594487188|FG001|Overall Study|Withdrawing due to Other reason|46|||
164579192|NCT03704051|594487193|FG000|Overall Study|Withdrawal by Subject|4|||
164579193|NCT03704051|594487194|FG001|Overall Study|Withdrawal by Subject|0|||
164579194|NCT03167619|594487203|FG000|Overall Study|Death|11|||
164579195|NCT03167619|594487204|FG001|Overall Study|Death|8|||
164579196|NCT03167619|594487203|FG000|Overall Study|Withdrawal by Subject|1|||
164579197|NCT03167619|594487204|FG001|Overall Study|Withdrawal by Subject|2|||
164579198|NCT03167619|594487203|FG000|Overall Study|Physician Decision|0|||
164579199|NCT03167619|594487204|FG001|Overall Study|Physician Decision|1|||
164579200|NCT01348919|594487208|FG000|Overall Study|Adverse Event|3|||
164579201|NCT01348919|594487209|FG001|Overall Study|Adverse Event|1|||
164579202|NCT01348919|594487210|FG002|Overall Study|Adverse Event|0|||
164579203|NCT01348919|594487208|FG000|Overall Study|Withdrawal by Subject|0|||
164579204|NCT01348919|594487209|FG001|Overall Study|Withdrawal by Subject|1|||
164579205|NCT01348919|594487210|FG002|Overall Study|Withdrawal by Subject|0|||
164579206|NCT01348919|594487208|FG000|Overall Study|Disease progression|0|||
164579207|NCT01348919|594487209|FG001|Overall Study|Disease progression|1|||
164579208|NCT01348919|594487210|FG002|Overall Study|Disease progression|1|||
164579209|NCT01009463|594487211|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
164579210|NCT01009463|594487212|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
164579211|NCT01009463|594487213|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
164579212|NCT01009463|594487214|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
164579213|NCT01009463|594487215|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
164579214|NCT01009463|594487211|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
164579215|NCT01009463|594487212|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
164579216|NCT01009463|594487213|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
164579217|NCT01009463|594487214|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
164579218|NCT01009463|594487215|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
164579219|NCT01009463|594487211|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
164579220|NCT01009463|594487212|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
164579221|NCT01009463|594487213|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
164579222|NCT01009463|594487214|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
164579223|NCT01009463|594487215|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
164579224|NCT01009463|594487211|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
164579225|NCT01009463|594487212|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
164579226|NCT01009463|594487213|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
164579227|NCT01009463|594487214|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
164579228|NCT01009463|594487215|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
164579229|NCT01009463|594487211|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
164579230|NCT01009463|594487212|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
164579231|NCT01009463|594487213|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
164579232|NCT01009463|594487214|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
164579233|NCT01009463|594487215|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
164579234|NCT01009463|594487211|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
164579235|NCT01009463|594487212|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
164579236|NCT01009463|594487213|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
164579237|NCT01009463|594487214|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
164579238|NCT01009463|594487215|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
164579239|NCT01009463|594487211|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
164579240|NCT01009463|594487212|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
164579241|NCT01009463|594487213|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
164579242|NCT01009463|594487214|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
164579243|NCT01009463|594487215|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
164579244|NCT01009463|594487211|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
164579245|NCT01009463|594487212|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
164579246|NCT01009463|594487213|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
164579247|NCT01009463|594487214|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
164430276|NCT03568162|593945349|FG001|Overall Study|Others|4|||
164684119|NCT04203823|594865602|FG000|Overall Study|Withdrawal by Subject|2|||
164684120|NCT04203823|594865603|FG001|Overall Study|Withdrawal by Subject|2|||
164684121|NCT04203823|594865602|FG000|Overall Study|Adverse Event|1|||
164684122|NCT04203823|594865603|FG001|Overall Study|Adverse Event|1|||
164684123|NCT04203823|594865602|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164684124|NCT04203823|594865603|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
164684125|NCT03684928|594865604|FG000|First Intervention|Lost to Follow-up|0|||
164684126|NCT03684928|594865605|FG001|First Intervention|Lost to Follow-up|1|||
164684127|NCT03684928|594865604|FG000|First Intervention|Withdrawal by Subject|0|||
164684128|NCT03684928|594865605|FG001|First Intervention|Withdrawal by Subject|2|||
164684129|NCT03684928|594865604|FG000|Second Intervention|Soft Tissue Injury|1|||
164684130|NCT03684928|594865605|FG001|Second Intervention|Soft Tissue Injury|0|||
164684131|NCT03193021|594865606|FG000|Overall Study|Lost to Follow-up|1|||
164684132|NCT03193021|594865607|FG001|Overall Study|Lost to Follow-up|1|||
164684133|NCT02286466|594865608|FG000|Overall Study|Death|1|||
164684134|NCT02286466|594865609|FG001|Overall Study|Death|3|||
164684135|NCT02286466|594865608|FG000|Overall Study|Withdrawal by Subject|5|||
164684136|NCT02286466|594865609|FG001|Overall Study|Withdrawal by Subject|2|||
164684137|NCT02286466|594865608|FG000|Overall Study|Lost to Follow-up|1|||
164684138|NCT02286466|594865609|FG001|Overall Study|Lost to Follow-up|4|||
164684139|NCT02286466|594865608|FG000|Overall Study|Declined Clinician Assessment|0|||
164684140|NCT02286466|594865609|FG001|Overall Study|Declined Clinician Assessment|1|||
164684141|NCT00874276|594865610|FG000|Overall Study|Withdrawal by Subject|1|||
164684142|NCT00874276|594865611|FG001|Overall Study|Withdrawal by Subject|1|||
164684143|NCT02300987|594866647|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
164684144|NCT02300987|594866648|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
164684145|NCT02300987|594866647|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
164684146|NCT02300987|594866648|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
164684147|NCT02300987|594866647|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
164684148|NCT02300987|594866648|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
164684149|NCT02300987|594866647|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
164684150|NCT02300987|594866648|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
164684151|NCT02300987|594866647|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
164684152|NCT02300987|594866648|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
164684153|NCT02308241|594866649|FG000|Overall Study|Withdrawal by Subject|3|||
164684154|NCT03609944|594866650|FG000|Overall Study|Lost to Follow-up|1|||
164684155|NCT03609944|594866651|FG001|Overall Study|Lost to Follow-up|5|||
164684156|NCT03609944|594866650|FG000|Overall Study|Withdrawal by Subject|1|||
164684157|NCT03609944|594866651|FG001|Overall Study|Withdrawal by Subject|1|||
164684158|NCT02578641|594866652|FG000|Overall Study|Adverse Event|5|||
164684159|NCT02578641|594866653|FG001|Overall Study|Adverse Event|15|||
164684160|NCT02578641|594866652|FG000|Overall Study|Death|16|||
164684161|NCT02578641|594866653|FG001|Overall Study|Death|8|||
164684162|NCT02578641|594866652|FG000|Overall Study|Lost to Follow-up|0|||
164684163|NCT02578641|594866653|FG001|Overall Study|Lost to Follow-up|1|||
164684164|NCT02578641|594866652|FG000|Overall Study|Withdrawal by Subject|14|||
164684165|NCT02578641|594866653|FG001|Overall Study|Withdrawal by Subject|7|||
164684166|NCT02578641|594866652|FG000|Overall Study|Progressive Disease|69|||
164684167|NCT02578641|594866653|FG001|Overall Study|Progressive Disease|21|||
164684168|NCT02578641|594866652|FG000|Overall Study|No Study Drug|2|||
164684169|NCT02578641|594866653|FG001|Overall Study|No Study Drug|0|||
164684170|NCT02578641|594866652|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
164684171|NCT02578641|594866653|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
164684172|NCT02578641|594866652|FG000|Overall Study|Non-compliance with Study Schedule|1|||
164684173|NCT02578641|594866653|FG001|Overall Study|Non-compliance with Study Schedule|0|||
164684174|NCT02578641|594866652|FG000|Overall Study|Other|1|||
164684175|NCT02578641|594866653|FG001|Overall Study|Other|10|||
164684176|NCT02578641|594866652|FG000|Overall Study|Not treated|1|||
164684177|NCT02578641|594866653|FG001|Overall Study|Not treated|4|||
164684178|NCT05330975|594866654|FG000|Primary|Lost to Follow-up|12|||
164684179|NCT05330975|594866655|FG001|Primary|Lost to Follow-up|21|||
164684180|NCT05330975|594866656|FG002|Primary|Lost to Follow-up|38|||
164265067|NCT00624780|593338830|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
164684181|NCT05330975|594866657|FG003|Primary|Lost to Follow-up|30|||
164684182|NCT05330975|594866658|FG004|Primary|Lost to Follow-up|25|||
164684183|NCT05330975|594866659|FG005|Primary|Lost to Follow-up|28|||
164684184|NCT05330975|594866660|FG006|Primary|Lost to Follow-up|0|||
164684185|NCT05330975|594866654|FG000|Primary|Withdrawal by Subject|4|||
164684186|NCT05330975|594866655|FG001|Primary|Withdrawal by Subject|11|||
164684187|NCT05330975|594866656|FG002|Primary|Withdrawal by Subject|8|||
164684188|NCT05330975|594866657|FG003|Primary|Withdrawal by Subject|23|||
164684189|NCT05330975|594866658|FG004|Primary|Withdrawal by Subject|20|||
164684190|NCT05330975|594866659|FG005|Primary|Withdrawal by Subject|19|||
164265068|NCT00624780|593338831|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
164684191|NCT05330975|594866660|FG006|Primary|Withdrawal by Subject|0|||
164684192|NCT05330975|594866654|FG000|Primary|Protocol Violation|0|||
164684193|NCT05330975|594866655|FG001|Primary|Protocol Violation|2|||
164684194|NCT05330975|594866656|FG002|Primary|Protocol Violation|0|||
164684195|NCT05330975|594866657|FG003|Primary|Protocol Violation|4|||
164684196|NCT05330975|594866658|FG004|Primary|Protocol Violation|0|||
164684197|NCT05330975|594866659|FG005|Primary|Protocol Violation|3|||
164684198|NCT05330975|594866660|FG006|Primary|Protocol Violation|0|||
164684199|NCT05330975|594866654|FG000|Primary|Death|0|||
164684200|NCT05330975|594866655|FG001|Primary|Death|3|||
164684201|NCT05330975|594866656|FG002|Primary|Death|1|||
164684202|NCT05330975|594866657|FG003|Primary|Death|1|||
164684203|NCT05330975|594866658|FG004|Primary|Death|0|||
164684204|NCT05330975|594866659|FG005|Primary|Death|0|||
164684205|NCT05330975|594866660|FG006|Primary|Death|0|||
164684206|NCT05330975|594866654|FG000|Primary|Other Than Specified|0|||
164684207|NCT05330975|594866655|FG001|Primary|Other Than Specified|1|||
164684208|NCT05330975|594866656|FG002|Primary|Other Than Specified|2|||
164684209|NCT05330975|594866657|FG003|Primary|Other Than Specified|1|||
164684210|NCT05330975|594866658|FG004|Primary|Other Than Specified|2|||
164684211|NCT05330975|594866659|FG005|Primary|Other Than Specified|2|||
164684212|NCT05330975|594866660|FG006|Primary|Other Than Specified|0|||
164684213|NCT05330975|594866654|FG000|Primary|Adverse Event|0|||
164684214|NCT05330975|594866655|FG001|Primary|Adverse Event|0|||
164684215|NCT05330975|594866656|FG002|Primary|Adverse Event|0|||
164684216|NCT05330975|594866657|FG003|Primary|Adverse Event|1|||
164684217|NCT05330975|594866658|FG004|Primary|Adverse Event|0|||
164684218|NCT05330975|594866659|FG005|Primary|Adverse Event|0|||
164684219|NCT05330975|594866660|FG006|Primary|Adverse Event|0|||
164684220|NCT05330975|594866654|FG000|Primary|Physician Decision|0|||
164684221|NCT05330975|594866655|FG001|Primary|Physician Decision|0|||
164684222|NCT05330975|594866656|FG002|Primary|Physician Decision|0|||
164684223|NCT05330975|594866657|FG003|Primary|Physician Decision|0|||
164684224|NCT05330975|594866658|FG004|Primary|Physician Decision|1|||
164684225|NCT05330975|594866659|FG005|Primary|Physician Decision|0|||
164684226|NCT05330975|594866660|FG006|Primary|Physician Decision|0|||
164684227|NCT05330975|594866654|FG000|Revaccination|Adverse Event|0|||
164684228|NCT05330975|594866655|FG001|Revaccination|Adverse Event|0|||
164684229|NCT05330975|594866656|FG002|Revaccination|Adverse Event|0|||
164684230|NCT05330975|594866657|FG003|Revaccination|Adverse Event|0|||
164684231|NCT05330975|594866658|FG004|Revaccination|Adverse Event|0|||
164684232|NCT05330975|594866659|FG005|Revaccination|Adverse Event|0|||
164684233|NCT05330975|594866660|FG006|Revaccination|Adverse Event|3|||
164684234|NCT05330975|594866654|FG000|Revaccination|Lost to Follow-up|0|||
164684235|NCT05330975|594866655|FG001|Revaccination|Lost to Follow-up|0|||
164684236|NCT05330975|594866656|FG002|Revaccination|Lost to Follow-up|0|||
164684237|NCT05330975|594866657|FG003|Revaccination|Lost to Follow-up|0|||
164684238|NCT05330975|594866658|FG004|Revaccination|Lost to Follow-up|0|||
164684239|NCT05330975|594866659|FG005|Revaccination|Lost to Follow-up|0|||
164684240|NCT05330975|594866660|FG006|Revaccination|Lost to Follow-up|10|||
164684241|NCT05330975|594866654|FG000|Revaccination|Withdrawal by Subject|0|||
164684242|NCT05330975|594866655|FG001|Revaccination|Withdrawal by Subject|0|||
164684243|NCT05330975|594866656|FG002|Revaccination|Withdrawal by Subject|0|||
164684244|NCT05330975|594866657|FG003|Revaccination|Withdrawal by Subject|0|||
164684245|NCT05330975|594866658|FG004|Revaccination|Withdrawal by Subject|0|||
164684246|NCT05330975|594866659|FG005|Revaccination|Withdrawal by Subject|0|||
164684247|NCT05330975|594866660|FG006|Revaccination|Withdrawal by Subject|2|||
164684248|NCT05330975|594866654|FG000|Revaccination|Death|0|||
164684249|NCT05330975|594866655|FG001|Revaccination|Death|0|||
164684250|NCT05330975|594866656|FG002|Revaccination|Death|0|||
164684251|NCT05330975|594866657|FG003|Revaccination|Death|0|||
164684252|NCT05330975|594866658|FG004|Revaccination|Death|0|||
164265069|NCT00624780|593338832|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
164265070|NCT00624780|593338827|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
164265071|NCT00624780|593338828|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
164684253|NCT05330975|594866659|FG005|Revaccination|Death|0|||
164684254|NCT05330975|594866660|FG006|Revaccination|Death|3|||
164684255|NCT05267106|594866664|FG000|Overall Study|Death|50|||
164684256|NCT05267106|594866665|FG001|Overall Study|Death|2|||
164684257|NCT05267106|594866664|FG000|Overall Study|Study terminated by Sponsor|24|||
164684258|NCT05267106|594866665|FG001|Overall Study|Study terminated by Sponsor|6|||
164684259|NCT05267106|594866664|FG000|Overall Study|Withdrawal by Subject|0|||
164684260|NCT05267106|594866665|FG001|Overall Study|Withdrawal by Subject|1|||
164684261|NCT04165824|594866666|FG000|Overall Study|Adverse Event|23|||
164684262|NCT04165824|594866666|FG000|Overall Study|Physician Decision|1|||
164684263|NCT04165824|594866666|FG000|Overall Study|Withdrawal by Subject|17|||
164684264|NCT04165824|594866666|FG000|Overall Study|Other|5|||
164684265|NCT03292458|594866671|FG000|Period 1|Adverse Event|2|||
164684266|NCT03292458|594866672|FG001|Period 1|Adverse Event|0|||
164684267|NCT01513239|594866673|FG000|Period 1: Main Phase|Adverse Event|1|||
164684268|NCT01513239|594866674|FG001|Period 1: Main Phase|Adverse Event|1|||
164684269|NCT01513239|594866675|FG002|Period 1: Main Phase|Adverse Event|2|||
164684270|NCT01513239|594866676|FG003|Period 1: Main Phase|Adverse Event|0|||
164684271|NCT01513239|594866677|FG004|Period 1: Main Phase|Adverse Event|0|||
164684272|NCT01513239|594866678|FG005|Period 1: Main Phase|Adverse Event|0|||
164684273|NCT01513239|594866673|FG000|Period 1: Main Phase|Death|29|||
164684274|NCT01513239|594866674|FG001|Period 1: Main Phase|Death|22|||
164684275|NCT01513239|594866675|FG002|Period 1: Main Phase|Death|32|||
164684276|NCT01513239|594866676|FG003|Period 1: Main Phase|Death|0|||
164684277|NCT01513239|594866677|FG004|Period 1: Main Phase|Death|0|||
164684278|NCT01513239|594866678|FG005|Period 1: Main Phase|Death|0|||
164684279|NCT01513239|594866673|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
164684280|NCT01513239|594866674|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
164684281|NCT01513239|594866675|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
164684282|NCT01513239|594866676|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
164684283|NCT01513239|594866677|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
164684284|NCT01513239|594866678|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
164684285|NCT01513239|594866673|FG000|Period 1: Main Phase|Physician Decision|4|||
164684286|NCT01513239|594866674|FG001|Period 1: Main Phase|Physician Decision|4|||
164684287|NCT01513239|594866675|FG002|Period 1: Main Phase|Physician Decision|4|||
164684288|NCT01513239|594866676|FG003|Period 1: Main Phase|Physician Decision|0|||
164684289|NCT01513239|594866677|FG004|Period 1: Main Phase|Physician Decision|0|||
164684290|NCT01513239|594866678|FG005|Period 1: Main Phase|Physician Decision|0|||
164684291|NCT01513239|594866673|FG000|Period 1: Main Phase|Protocol Violation|2|||
164684292|NCT01513239|594866674|FG001|Period 1: Main Phase|Protocol Violation|2|||
164684293|NCT01513239|594866675|FG002|Period 1: Main Phase|Protocol Violation|2|||
164684294|NCT01513239|594866676|FG003|Period 1: Main Phase|Protocol Violation|0|||
164684295|NCT01513239|594866677|FG004|Period 1: Main Phase|Protocol Violation|0|||
164684296|NCT01513239|594866678|FG005|Period 1: Main Phase|Protocol Violation|0|||
164684297|NCT01513239|594866673|FG000|Period 1: Main Phase|Technical Problems|1|||
164684298|NCT01513239|594866674|FG001|Period 1: Main Phase|Technical Problems|2|||
164265072|NCT00624780|593338829|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
164265073|NCT00624780|593338830|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
164265074|NCT00624780|593338831|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
164265075|NCT00624780|593338832|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
164265076|NCT00624780|593338827|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
164265077|NCT00624780|593338828|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
164265078|NCT00624780|593338829|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
164265079|NCT00624780|593338830|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
164265080|NCT00624780|593338831|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
164265081|NCT00624780|593338832|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
164265082|NCT00624780|593338827|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
164265083|NCT00624780|593338828|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
164265084|NCT00624780|593338829|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
164265085|NCT00624780|593338830|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
164265086|NCT00624780|593338831|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
164265087|NCT00624780|593338832|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
164265088|NCT00624780|593338827|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
164265089|NCT00624780|593338828|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
164265090|NCT00624780|593338829|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
164265091|NCT00624780|593338830|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
164265092|NCT00624780|593338831|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
164265093|NCT00624780|593338832|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
164265094|NCT00624780|593338827|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
164265095|NCT00624780|593338828|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
164265096|NCT00624780|593338829|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
164265097|NCT00624780|593338830|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
164265098|NCT00624780|593338831|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
164265099|NCT00624780|593338832|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
164265100|NCT00624780|593338827|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
164265101|NCT00624780|593338828|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
164265102|NCT00624780|593338829|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
164265103|NCT00624780|593338830|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
164265104|NCT00624780|593338831|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
164265105|NCT00624780|593338832|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
164265106|NCT00624780|593338827|FG000|Follow-up (Week 26)|Death|0|||
164265107|NCT00624780|593338828|FG001|Follow-up (Week 26)|Death|0|||
164265108|NCT00624780|593338829|FG002|Follow-up (Week 26)|Death|1|||
164265109|NCT00624780|593338830|FG003|Follow-up (Week 26)|Death|0|||
164265110|NCT00624780|593338831|FG004|Follow-up (Week 26)|Death|0|||
164265111|NCT00624780|593338832|FG005|Follow-up (Week 26)|Death|0|||
164265112|NCT00624780|593338827|FG000|Follow-up (Week 26)|Adverse Event|0|||
164265113|NCT00624780|593338828|FG001|Follow-up (Week 26)|Adverse Event|0|||
164684299|NCT01513239|594866675|FG002|Period 1: Main Phase|Technical Problems|0|||
164684300|NCT01513239|594866676|FG003|Period 1: Main Phase|Technical Problems|0|||
164684301|NCT01513239|594866677|FG004|Period 1: Main Phase|Technical Problems|0|||
164684302|NCT01513239|594866678|FG005|Period 1: Main Phase|Technical Problems|0|||
164684303|NCT01513239|594866673|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
164684304|NCT01513239|594866674|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
164684305|NCT01513239|594866675|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
164684306|NCT01513239|594866676|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
164684307|NCT01513239|594866677|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
164684308|NCT01513239|594866678|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
164684309|NCT01513239|594866673|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
164684310|NCT01513239|594866674|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
164684311|NCT01513239|594866675|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
164684312|NCT01513239|594866676|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
164684313|NCT01513239|594866677|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
164684314|NCT01513239|594866678|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
164684315|NCT01513239|594866673|FG000|Period 2: 9 Month Extension Phase|Death|0|||
164684316|NCT01513239|594866674|FG001|Period 2: 9 Month Extension Phase|Death|0|||
164684317|NCT01513239|594866675|FG002|Period 2: 9 Month Extension Phase|Death|0|||
164684318|NCT01513239|594866676|FG003|Period 2: 9 Month Extension Phase|Death|2|||
164684319|NCT01513239|594866677|FG004|Period 2: 9 Month Extension Phase|Death|5|||
164684320|NCT01513239|594866678|FG005|Period 2: 9 Month Extension Phase|Death|2|||
164684321|NCT01513239|594866673|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
164684322|NCT01513239|594866674|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
164684323|NCT01513239|594866675|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
164684324|NCT01513239|594866676|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
164684325|NCT01513239|594866677|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
164684326|NCT01513239|594866678|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
164684327|NCT01513239|594866673|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
164684328|NCT01513239|594866674|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
164684329|NCT01513239|594866675|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
164684330|NCT01513239|594866676|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
164684331|NCT01513239|594866677|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
164684332|NCT01513239|594866678|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
164684333|NCT01513239|594866673|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
164684334|NCT01513239|594866674|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
164684335|NCT01513239|594866675|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
164684336|NCT01513239|594866676|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
164684337|NCT01513239|594866677|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
164684338|NCT01513239|594866678|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
164684339|NCT04569032|594866679|FG000|Overall Study|Death|10|||
164684340|NCT04569032|594866680|FG001|Overall Study|Death|13|||
164684341|NCT04569032|594866679|FG000|Overall Study|Withdrawal by Subject|2|||
164684342|NCT04569032|594866680|FG001|Overall Study|Withdrawal by Subject|0|||
164684343|NCT04569032|594866679|FG000|Overall Study|Lost to Follow-up|0|||
164684344|NCT04569032|594866680|FG001|Overall Study|Lost to Follow-up|1|||
164684345|NCT04569032|594866679|FG000|Overall Study|In long term follow up|22|||
164684346|NCT04569032|594866680|FG001|Overall Study|In long term follow up|34|||
164684347|NCT03837626|594866681|FG000|Overall Study|Adverse Event|3|||
164684348|NCT03837626|594866682|FG001|Overall Study|Adverse Event|3|||
164684349|NCT03837626|594866681|FG000|Overall Study|Withdrawal by Subject|2|||
164684350|NCT03837626|594866682|FG001|Overall Study|Withdrawal by Subject|4|||
164684351|NCT03837626|594866681|FG000|Overall Study|Physician Decision|2|||
164684352|NCT03837626|594866682|FG001|Overall Study|Physician Decision|3|||
164684353|NCT03837626|594866681|FG000|Overall Study|Lost to Follow-up|3|||
164684354|NCT03837626|594866682|FG001|Overall Study|Lost to Follow-up|1|||
164684355|NCT03599362|594866683|FG000|Overall Study|Screen Failure|3|||
164684356|NCT03707587|594866684|FG000|Overall Study|Death|0|||
164684357|NCT03707587|594866685|FG001|Overall Study|Death|1|||
164684358|NCT00834444|594866687|FG000|First Intervention|Adverse Event|1|||
164684359|NCT00834444|594866688|FG001|First Intervention|Adverse Event|0|||
164684360|NCT00834444|594866687|FG000|First Intervention|Intolerance to Venopuncture|0|||
164684361|NCT00834444|594866688|FG001|First Intervention|Intolerance to Venopuncture|1|||
164684362|NCT00834444|594866687|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
164684363|NCT00834444|594866688|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
164684364|NCT00834444|594866687|FG000|Second Intervention|Adverse Event|1|||
164684365|NCT00834444|594866688|FG001|Second Intervention|Adverse Event|0|||
164684366|NCT01496118|594866698|FG000|Overall Study|Disease progression|3|||
164684367|NCT01496118|594866699|FG001|Overall Study|Disease progression|2|||
164684368|NCT01496118|594866700|FG002|Overall Study|Disease progression|3|||
164684369|NCT01496118|594866701|FG003|Overall Study|Disease progression|1|||
164684370|NCT01496118|594866702|FG004|Overall Study|Disease progression|2|||
164684371|NCT01496118|594866703|FG005|Overall Study|Disease progression|2|||
164684372|NCT01496118|594866704|FG006|Overall Study|Disease progression|14|||
164684373|NCT01496118|594866705|FG007|Overall Study|Disease progression|10|||
164684374|NCT01496118|594866698|FG000|Overall Study|Physician Decision|0|||
164684375|NCT01496118|594866699|FG001|Overall Study|Physician Decision|0|||
164684376|NCT01496118|594866700|FG002|Overall Study|Physician Decision|0|||
164684377|NCT01496118|594866701|FG003|Overall Study|Physician Decision|0|||
164684378|NCT01496118|594866702|FG004|Overall Study|Physician Decision|1|||
164684379|NCT01496118|594866703|FG005|Overall Study|Physician Decision|0|||
164684380|NCT01496118|594866704|FG006|Overall Study|Physician Decision|3|||
164579248|NCT01009463|594487215|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
164579249|NCT01009463|594487211|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
164684381|NCT01496118|594866705|FG007|Overall Study|Physician Decision|6|||
164684382|NCT01496118|594866698|FG000|Overall Study|Adverse Event|1|||
164684383|NCT01496118|594866699|FG001|Overall Study|Adverse Event|1|||
164684384|NCT01496118|594866700|FG002|Overall Study|Adverse Event|0|||
164684385|NCT01496118|594866701|FG003|Overall Study|Adverse Event|0|||
164684386|NCT01496118|594866702|FG004|Overall Study|Adverse Event|0|||
164684387|NCT01496118|594866703|FG005|Overall Study|Adverse Event|0|||
164684388|NCT01496118|594866704|FG006|Overall Study|Adverse Event|6|||
164684389|NCT01496118|594866705|FG007|Overall Study|Adverse Event|10|||
164684390|NCT01496118|594866698|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
164684391|NCT01496118|594866699|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
164684392|NCT01496118|594866700|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
164684393|NCT01496118|594866701|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
164684394|NCT01496118|594866702|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
164684395|NCT01496118|594866703|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
164579250|NCT01009463|594487212|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
164579251|NCT01009463|594487213|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
164579252|NCT01009463|594487214|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
164579253|NCT01009463|594487215|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
164579254|NCT01009463|594487211|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
164579255|NCT01009463|594487212|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
164579256|NCT01009463|594487213|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
164579257|NCT01009463|594487214|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
164579258|NCT01009463|594487215|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
164579259|NCT01009463|594487211|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
164579260|NCT01009463|594487212|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
164579261|NCT01009463|594487213|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
164579262|NCT01009463|594487214|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
164579263|NCT01009463|594487215|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
164579264|NCT01009463|594487211|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164579265|NCT01009463|594487212|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
164579266|NCT01009463|594487213|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
164579267|NCT01009463|594487214|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
164579268|NCT01009463|594487215|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
164579269|NCT01009463|594487211|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
164579270|NCT01009463|594487212|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
164579271|NCT01009463|594487213|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
164579272|NCT01009463|594487214|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
164579273|NCT01009463|594487215|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
164579274|NCT04430348|594487216|FG000|Overall Study|Death|3|||
164579275|NCT04430348|594487217|FG001|Overall Study|Death|2|||
164579276|NCT04430348|594487218|FG002|Overall Study|Death|2|||
164579277|NCT04430348|594487219|FG003|Overall Study|Death|2|||
164579278|NCT04430348|594487220|FG004|Overall Study|Death|2|||
164579279|NCT04430348|594487221|FG005|Overall Study|Death|3|||
164579280|NCT04430348|594487216|FG000|Overall Study|Lost to Follow-up|0|||
164579281|NCT04430348|594487217|FG001|Overall Study|Lost to Follow-up|0|||
164579282|NCT04430348|594487218|FG002|Overall Study|Lost to Follow-up|0|||
164579283|NCT04430348|594487219|FG003|Overall Study|Lost to Follow-up|1|||
164579284|NCT04430348|594487220|FG004|Overall Study|Lost to Follow-up|0|||
164684396|NCT01496118|594866704|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
164684397|NCT01496118|594866705|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
164684398|NCT01496118|594866698|FG000|Overall Study|Death|0|||
164684399|NCT01496118|594866699|FG001|Overall Study|Death|0|||
164684400|NCT01496118|594866700|FG002|Overall Study|Death|0|||
164684401|NCT01496118|594866701|FG003|Overall Study|Death|0|||
164684402|NCT01496118|594866702|FG004|Overall Study|Death|0|||
164684403|NCT01496118|594866703|FG005|Overall Study|Death|0|||
164684404|NCT01496118|594866704|FG006|Overall Study|Death|1|||
164684405|NCT01496118|594866705|FG007|Overall Study|Death|1|||
164684406|NCT01496118|594866698|FG000|Overall Study|Withdrawal by Subject|0|||
164684407|NCT01496118|594866699|FG001|Overall Study|Withdrawal by Subject|0|||
164579285|NCT04430348|594487221|FG005|Overall Study|Lost to Follow-up|0|||
164430277|NCT03568162|593945350|FG002|Overall Study|Others|1|||
164430278|NCT03568162|593945351|FG003|Overall Study|Others|4|||
164430279|NCT03568162|593945352|FG004|Overall Study|Others|2|||
164430280|NCT03568162|593945353|FG005|Overall Study|Others|1|||
164430281|NCT00938340|593945354|FG000|Overall Study|Withdrawal by Subject|3|||
164430282|NCT00938340|593945354|FG000|Overall Study|Protocol Violation|1|||
164430283|NCT00938340|593945354|FG000|Overall Study|Adverse Event|1|||
164430284|NCT00924560|593945356|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
164430285|NCT00924560|593945357|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
164430286|NCT00924560|593945358|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
164430287|NCT00924560|593945356|FG000|Overall Study|Non Compliance with the Protocol|20|||
164430288|NCT00924560|593945357|FG001|Overall Study|Non Compliance with the Protocol|15|||
164684408|NCT01496118|594866700|FG002|Overall Study|Withdrawal by Subject|0|||
164684409|NCT01496118|594866701|FG003|Overall Study|Withdrawal by Subject|2|||
164684410|NCT01496118|594866702|FG004|Overall Study|Withdrawal by Subject|0|||
164684411|NCT01496118|594866703|FG005|Overall Study|Withdrawal by Subject|1|||
164684412|NCT01496118|594866704|FG006|Overall Study|Withdrawal by Subject|6|||
164684413|NCT01496118|594866705|FG007|Overall Study|Withdrawal by Subject|3|||
164684414|NCT00841659|594866706|FG000|Washout: 2 Weeks|Protocol Violation|1|||
164684415|NCT00841659|594866707|FG001|Washout: 2 Weeks|Protocol Violation|0|||
164684416|NCT03499873|594866711|FG000|Overall Study|Withdrawal by Subject|4|||
164684417|NCT03499873|594866712|FG001|Overall Study|Withdrawal by Subject|6|||
164684418|NCT03499873|594866713|FG002|Overall Study|Withdrawal by Subject|1|||
164684419|NCT03499873|594866711|FG000|Overall Study|Subjects condition worsened|0|||
164684420|NCT03499873|594866712|FG001|Overall Study|Subjects condition worsened|3|||
164684421|NCT03499873|594866713|FG002|Overall Study|Subjects condition worsened|11|||
164684422|NCT03499873|594866711|FG000|Overall Study|Adverse Event|8|||
164684423|NCT03499873|594866712|FG001|Overall Study|Adverse Event|3|||
164684424|NCT03499873|594866713|FG002|Overall Study|Adverse Event|6|||
164684425|NCT03499873|594866711|FG000|Overall Study|Physician Decision|1|||
164684426|NCT03499873|594866712|FG001|Overall Study|Physician Decision|0|||
164684427|NCT03499873|594866713|FG002|Overall Study|Physician Decision|0|||
164684428|NCT03499873|594866711|FG000|Overall Study|Administrative reasons|0|||
164684429|NCT03499873|594866712|FG001|Overall Study|Administrative reasons|1|||
164684430|NCT03499873|594866713|FG002|Overall Study|Administrative reasons|0|||
164684431|NCT03499873|594866711|FG000|Overall Study|Concomitant therapy|5|||
164684432|NCT03499873|594866712|FG001|Overall Study|Concomitant therapy|4|||
164684433|NCT03499873|594866713|FG002|Overall Study|Concomitant therapy|7|||
164684434|NCT03499873|594866711|FG000|Overall Study|Miscellaneous|1|||
164684435|NCT03499873|594866712|FG001|Overall Study|Miscellaneous|2|||
164684436|NCT03499873|594866713|FG002|Overall Study|Miscellaneous|2|||
164684437|NCT03499873|594866711|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
164684438|NCT03499873|594866712|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
164684439|NCT03499873|594866713|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
164684440|NCT04608448|594866714|FG000|Overall Study|Withdrawal by Subject|1|||
164684441|NCT04608448|594866714|FG000|Overall Study|Adverse Event|1|||
164684442|NCT01297504|594866715|FG000|Overall Study|Invalid Consent|1|||
164430289|NCT00924560|593945358|FG002|Overall Study|Non Compliance with the Protocol|4|||
164430290|NCT00924560|593945356|FG000|Overall Study|Physician Decision|2|||
164430291|NCT00924560|593945357|FG001|Overall Study|Physician Decision|3|||
164430292|NCT00924560|593945358|FG002|Overall Study|Physician Decision|4|||
164430293|NCT00924560|593945356|FG000|Overall Study|Withdrawal by Subject|50|||
164430294|NCT00924560|593945357|FG001|Overall Study|Withdrawal by Subject|44|||
164430295|NCT00924560|593945358|FG002|Overall Study|Withdrawal by Subject|18|||
164430296|NCT00924560|593945356|FG000|Overall Study|Adverse Event|39|||
164430297|NCT00924560|593945357|FG001|Overall Study|Adverse Event|33|||
164430298|NCT00924560|593945358|FG002|Overall Study|Adverse Event|0|||
164430299|NCT00924560|593945356|FG000|Overall Study|Pregnancy|5|||
164430300|NCT00924560|593945357|FG001|Overall Study|Pregnancy|7|||
164430301|NCT00924560|593945358|FG002|Overall Study|Pregnancy|1|||
164430302|NCT00924560|593945356|FG000|Overall Study|Lost to Follow-up|78|||
164430303|NCT00924560|593945357|FG001|Overall Study|Lost to Follow-up|94|||
164430304|NCT00924560|593945358|FG002|Overall Study|Lost to Follow-up|45|||
164430305|NCT00924560|593945356|FG000|Overall Study|Miscellaneous Reasons|13|||
164684443|NCT01297504|594866715|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
164684444|NCT01297504|594866715|FG000|Overall Study|No Study Visits|4|||
164684445|NCT01297504|594866715|FG000|Overall Study|Death|3|||
164684446|NCT01297504|594866715|FG000|Overall Study|Lost to Follow-up|43|||
164684447|NCT01297504|594866715|FG000|Overall Study|Withdrawal by Subject|9|||
164684448|NCT01297504|594866715|FG000|Overall Study|Site Closure|3|||
164684449|NCT01297504|594866715|FG000|Overall Study|Protocol Violation|3|||
164430306|NCT00924560|593945357|FG001|Overall Study|Miscellaneous Reasons|10|||
164430307|NCT00924560|593945358|FG002|Overall Study|Miscellaneous Reasons|10|||
164430308|NCT02753530|593945361|FG000|Overall Study|Adverse Event|7|||
164430309|NCT02753530|593945362|FG001|Overall Study|Adverse Event|1|||
164430310|NCT02753530|593945361|FG000|Overall Study|Death|0|||
164684450|NCT00654186|594866716|FG000|Overall Study|Withdrawal by Subject|5|||
164684451|NCT00881751|594866717|FG000|Overall Study|Physician Decision|0|||
164579286|NCT04430348|594487216|FG000|Overall Study|Adverse Event|0|||
164579287|NCT04430348|594487217|FG001|Overall Study|Adverse Event|0|||
164579288|NCT04430348|594487218|FG002|Overall Study|Adverse Event|0|||
164579289|NCT04430348|594487219|FG003|Overall Study|Adverse Event|0|||
164579290|NCT04430348|594487220|FG004|Overall Study|Adverse Event|0|||
164579291|NCT04430348|594487221|FG005|Overall Study|Adverse Event|1|||
164579292|NCT04430348|594487216|FG000|Overall Study|Withdrawal by Subject|0|||
164579293|NCT04430348|594487217|FG001|Overall Study|Withdrawal by Subject|1|||
164579294|NCT04430348|594487218|FG002|Overall Study|Withdrawal by Subject|0|||
164579295|NCT04430348|594487219|FG003|Overall Study|Withdrawal by Subject|0|||
164579296|NCT04430348|594487220|FG004|Overall Study|Withdrawal by Subject|0|||
164579297|NCT04430348|594487221|FG005|Overall Study|Withdrawal by Subject|1|||
164579298|NCT04430348|594487216|FG000|Overall Study|Study Terminated by Sponsor|0|||
164579299|NCT04430348|594487217|FG001|Overall Study|Study Terminated by Sponsor|0|||
164579300|NCT04430348|594487218|FG002|Overall Study|Study Terminated by Sponsor|2|||
164579301|NCT04430348|594487219|FG003|Overall Study|Study Terminated by Sponsor|0|||
164579302|NCT04430348|594487220|FG004|Overall Study|Study Terminated by Sponsor|1|||
164579303|NCT04430348|594487221|FG005|Overall Study|Study Terminated by Sponsor|1|||
164579304|NCT03839524|594487226|FG000|Overall Study|Adverse Event|1|||
164579305|NCT02024464|594487230|FG000|Overall Study|Discontinued|5|||
164579306|NCT02024464|594487231|FG001|Overall Study|Discontinued|4|||
164579307|NCT02024464|594487230|FG000|Overall Study|Missed Visits|1|||
164579308|NCT02024464|594487231|FG001|Overall Study|Missed Visits|0|||
164579309|NCT02024464|594487230|FG000|Overall Study|Lost to Follow-up|4|||
164579310|NCT02024464|594487231|FG001|Overall Study|Lost to Follow-up|7|||
164579311|NCT00384956|594487234|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
164579312|NCT01021007|594487236|FG000|Overall Study|Lost to Follow-up|1|||
164579313|NCT01021007|594487237|FG001|Overall Study|Lost to Follow-up|1|||
164579314|NCT01021007|594487236|FG000|Overall Study|Adverse Event|1|||
164579315|NCT01021007|594487237|FG001|Overall Study|Adverse Event|3|||
164579316|NCT00947154|594487240|FG000|Overall Study|Lost to Follow-up|1|||
164579317|NCT03293030|594487243|FG000|Overall Study|Withdrawal by Subject|3|||
164579318|NCT04899271|594487244|FG000|Overall Study|Lost to Follow-up|1|||
164579319|NCT04899271|594487245|FG001|Overall Study|Lost to Follow-up|0|||
164579320|NCT04899271|594487244|FG000|Overall Study|Subject request/consent withdrawal|2|||
164579321|NCT04899271|594487245|FG001|Overall Study|Subject request/consent withdrawal|0|||
164579322|NCT00900796|594487246|FG000|Phase 1|Lacked sufficient information|4|||
164579323|NCT00900796|594487246|FG000|Phase 1|Missing information at Week 16|7|||
164579324|NCT00900796|594487246|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
164579325|NCT00900796|594487246|FG000|Phase 2|Lost to Follow-up|5|||
164579326|NCT02504541|594487249|FG000|Overall Study|Adverse Event|4|||
164579327|NCT02504541|594487249|FG000|Overall Study|Withdrawal by Subject|4|||
164579328|NCT02504541|594487249|FG000|Overall Study|Lost to Follow-up|1|||
164579329|NCT02504541|594487249|FG000|Overall Study|Met Stopping Criteria|1|||
164579330|NCT02504541|594487249|FG000|Overall Study|Protocol Violation|2|||
164579331|NCT02504541|594487249|FG000|Overall Study|Termination by Sponsor|1|||
164579332|NCT02504541|594487249|FG000|Overall Study|Other|2|||
164579333|NCT02504541|594487249|FG000|Overall Study|Multiple|5|||
164579334|NCT03215277|594487250|FG000|Overall Study|Adverse Event|2|||
164579335|NCT03215277|594487251|FG001|Overall Study|Adverse Event|3|||
164579336|NCT03215277|594487250|FG000|Overall Study|Death|1|||
164579337|NCT03215277|594487251|FG001|Overall Study|Death|0|||
164579338|NCT03215277|594487250|FG000|Overall Study|Lost to Follow-up|0|||
164579339|NCT03215277|594487251|FG001|Overall Study|Lost to Follow-up|1|||
164579340|NCT03215277|594487250|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
164579341|NCT03215277|594487251|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
164579342|NCT00881205|594487252|FG000|Overall Study|Adverse Event|8|||
164579343|NCT00881205|594487253|FG001|Overall Study|Adverse Event|3|||
164579344|NCT00881205|594487252|FG000|Overall Study|Withdrawal by Subject|1|||
164579345|NCT00881205|594487253|FG001|Overall Study|Withdrawal by Subject|2|||
164579346|NCT00881205|594487252|FG000|Overall Study|Lost to Follow-up|0|||
164579347|NCT00881205|594487253|FG001|Overall Study|Lost to Follow-up|1|||
164579348|NCT00881205|594487252|FG000|Overall Study|Administrative problems|1|||
164579349|NCT00881205|594487253|FG001|Overall Study|Administrative problems|1|||
164579350|NCT00881205|594487252|FG000|Overall Study|Condition no longer requires drug|1|||
164579351|NCT00881205|594487253|FG001|Overall Study|Condition no longer requires drug|0|||
164579352|NCT02318602|594487257|FG000|Overall Study|Adverse Event|0|||
164579353|NCT02318602|594487258|FG001|Overall Study|Adverse Event|1|||
164579354|NCT02318602|594487259|FG002|Overall Study|Adverse Event|1|||
164684452|NCT00881751|594866718|FG001|Overall Study|Physician Decision|1|||
164579355|NCT02318602|594487257|FG000|Overall Study|Withdrawal by Subject|0|||
164579356|NCT02318602|594487258|FG001|Overall Study|Withdrawal by Subject|3|||
164579357|NCT02318602|594487259|FG002|Overall Study|Withdrawal by Subject|0|||
164684453|NCT00881751|594866717|FG000|Overall Study|Adverse Event|0|||
164579358|NCT02318602|594487257|FG000|Overall Study|Death|1|||
164579359|NCT02318602|594487258|FG001|Overall Study|Death|0|||
164579360|NCT02318602|594487259|FG002|Overall Study|Death|0|||
164684454|NCT00881751|594866718|FG001|Overall Study|Adverse Event|2|||
164579361|NCT02318602|594487257|FG000|Overall Study|Guardian decision to withdraw|0|||
164684455|NCT00881751|594866717|FG000|Overall Study|Withdrawal by Subject|0|||
164579362|NCT02318602|594487258|FG001|Overall Study|Guardian decision to withdraw|0|||
164684456|NCT00881751|594866718|FG001|Overall Study|Withdrawal by Subject|2|||
164684457|NCT00301964|594866719|FG000|Overall Study|Second primary|2|||
164684458|NCT00301964|594866719|FG000|Overall Study|Wrong primary|1|||
164684459|NCT00301964|594866719|FG000|Overall Study|Inadequate pathology|1|||
164684460|NCT02385708|594866720|FG000|Overall Study|Withdrawal by Subject|0|||
164684461|NCT02385708|594866721|FG001|Overall Study|Withdrawal by Subject|2|||
164684462|NCT02385708|594866720|FG000|Overall Study|Withdrawn - surgery canceled|2|||
164684463|NCT02385708|594866721|FG001|Overall Study|Withdrawn - surgery canceled|5|||
164684464|NCT02385708|594866720|FG000|Overall Study|Investigator decision|5|||
164684465|NCT02385708|594866721|FG001|Overall Study|Investigator decision|7|||
164684466|NCT02385708|594866720|FG000|Overall Study|Protocol Violation|1|||
164684467|NCT02385708|594866721|FG001|Overall Study|Protocol Violation|1|||
164684468|NCT02761915|594866722|FG000|Overall Study|Death|3|||
164684469|NCT02761915|594866723|FG001|Overall Study|Death|1|||
164684470|NCT02761915|594866724|FG002|Overall Study|Death|1|||
164684471|NCT02761915|594866725|FG003|Overall Study|Death|1|||
164684472|NCT02761915|594866726|FG004|Overall Study|Death|0|||
164684473|NCT02761915|594866727|FG005|Overall Study|Death|1|||
164684474|NCT02761915|594866722|FG000|Overall Study|Withdrawal by Subject|1|||
164684475|NCT02761915|594866723|FG001|Overall Study|Withdrawal by Subject|0|||
164684476|NCT02761915|594866724|FG002|Overall Study|Withdrawal by Subject|0|||
164684477|NCT02761915|594866725|FG003|Overall Study|Withdrawal by Subject|0|||
164684478|NCT02761915|594866726|FG004|Overall Study|Withdrawal by Subject|1|||
164684479|NCT02761915|594866727|FG005|Overall Study|Withdrawal by Subject|2|||
164684480|NCT02761915|594866722|FG000|Overall Study|Disease Progression|0|||
164684481|NCT02761915|594866723|FG001|Overall Study|Disease Progression|0|||
164684482|NCT02761915|594866724|FG002|Overall Study|Disease Progression|0|||
164684483|NCT02761915|594866725|FG003|Overall Study|Disease Progression|2|||
164684484|NCT02761915|594866726|FG004|Overall Study|Disease Progression|2|||
164684485|NCT02761915|594866727|FG005|Overall Study|Disease Progression|2|||
164684486|NCT02436200|594866728|FG000|Overall Study|Significant outlier|1|||
164684487|NCT02654145|594866735|FG000|Overall Study|Lack of Efficacy|1|||
164684488|NCT02654145|594866735|FG000|Overall Study|Protocol Violation|1|||
164684489|NCT02654145|594866735|FG000|Overall Study|Withdrawal by Subject|5|||
164684490|NCT00354835|594866736|FG000|Overall Study|Death|1|||
164684491|NCT00354835|594866737|FG001|Overall Study|Death|1|||
164684492|NCT00354835|594866736|FG000|Overall Study|Physician Decision|8|||
164684493|NCT00354835|594866737|FG001|Overall Study|Physician Decision|13|||
164684494|NCT00354835|594866736|FG000|Overall Study|Withdrawal by Subject|2|||
164684495|NCT00354835|594866737|FG001|Overall Study|Withdrawal by Subject|1|||
164684496|NCT00354835|594866736|FG000|Overall Study|Ineligible|17|||
164684497|NCT00354835|594866737|FG001|Overall Study|Ineligible|16|||
164684498|NCT00354835|594866736|FG000|Overall Study|Disease progression or relapse|15|||
164684499|NCT00354835|594866737|FG001|Overall Study|Disease progression or relapse|22|||
164684500|NCT00354835|594866736|FG000|Overall Study|Adverse Event|6|||
164684501|NCT00354835|594866737|FG001|Overall Study|Adverse Event|0|||
164684502|NCT00354835|594866736|FG000|Overall Study|Refusal of further therapy|3|||
164684503|NCT00354835|594866737|FG001|Overall Study|Refusal of further therapy|8|||
164684504|NCT01968551|594866738|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
164684505|NCT01968551|594866739|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
164579363|NCT02318602|594487259|FG002|Overall Study|Guardian decision to withdraw|1|||
164579364|NCT00693706|594487260|FG000|Overall Study|Protocol Violation|0|||
164579365|NCT00693706|594487261|FG001|Overall Study|Protocol Violation|1|||
164579366|NCT01733329|594487263|FG000|Overall Study|Protocol Violation|1|||
164579367|NCT01733329|594487264|FG001|Overall Study|Protocol Violation|1|||
164579368|NCT01733329|594487263|FG000|Overall Study|Uterine artery injury|1|||
164579369|NCT01733329|594487264|FG001|Overall Study|Uterine artery injury|0|||
164684506|NCT01968551|594866740|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
164684507|NCT01968551|594866738|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
164341477|NCT00415168|593625380|FG000|Overall Study|Physician Decision|13|||
164579370|NCT00730236|594487265|FG000|Overall Study|Adverse Event|4|||
164579371|NCT00730236|594487265|FG000|Overall Study|Withdrawal by Subject|1|||
164684508|NCT01968551|594866739|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
164684509|NCT01968551|594866740|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
164684510|NCT01968551|594866738|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
164684511|NCT01968551|594866739|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
164684512|NCT01968551|594866740|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
164684513|NCT01968551|594866738|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
164684514|NCT01968551|594866739|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
164684515|NCT01968551|594866740|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
164684516|NCT01968551|594866738|FG000|Extension Phase|Adverse Event|0|||
164684517|NCT01968551|594866739|FG001|Extension Phase|Adverse Event|0|||
164684518|NCT01968551|594866740|FG002|Extension Phase|Adverse Event|2|||
164579372|NCT00730236|594487265|FG000|Overall Study|Non-compliance|1|||
164579373|NCT00498173|594487271|FG000|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|2|||
164579374|NCT00498173|594487272|FG001|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|1|||
164579375|NCT00498173|594487273|FG002|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|0|||
164579376|NCT00095303|594487276|FG000|Main Study|Lost to Follow-up|91|||
164579377|NCT00095303|594487277|FG001|Main Study|Lost to Follow-up|87|||
164579378|NCT00095303|594487276|FG000|Follow Up Study|Lost to Follow-up|59|||
164579379|NCT00095303|594487277|FG001|Follow Up Study|Lost to Follow-up|58|||
164579380|NCT01634243|594487280|FG000|Overall Study|Adverse Event|5|||
164579381|NCT01634243|594487281|FG001|Overall Study|Adverse Event|5|||
164579382|NCT01634243|594487280|FG000|Overall Study|Lack of Efficacy|1|||
164579383|NCT01634243|594487281|FG001|Overall Study|Lack of Efficacy|0|||
164579384|NCT00258154|594487282|FG000|Overall Study|Adverse Event|1|||
164579385|NCT00258154|594487283|FG001|Overall Study|Adverse Event|0|||
164579386|NCT00258154|594487282|FG000|Overall Study|Lost to Follow-up|0|||
164579387|NCT00258154|594487283|FG001|Overall Study|Lost to Follow-up|1|||
164579388|NCT00258154|594487282|FG000|Overall Study|Protocol Violation|2|||
164579389|NCT00258154|594487283|FG001|Overall Study|Protocol Violation|1|||
164579390|NCT00258154|594487282|FG000|Overall Study|Withdrawal by Subject|3|||
164579391|NCT00258154|594487283|FG001|Overall Study|Withdrawal by Subject|4|||
164579392|NCT00258154|594487282|FG000|Overall Study|Patient Moved|3|||
164579393|NCT00258154|594487283|FG001|Overall Study|Patient Moved|1|||
164579394|NCT00613626|594487288|FG000|Overall Study|Ineligible|0|||
164579395|NCT00613626|594487289|FG001|Overall Study|Ineligible|1|||
164579396|NCT00613626|594487290|FG002|Overall Study|Ineligible|0|||
164579397|NCT04375878|594487291|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
164579398|NCT04375878|594487292|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
164579399|NCT04375878|594487293|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
164579400|NCT04375878|594487294|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
164579401|NCT04375878|594487295|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
164579402|NCT04375878|594487296|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
164579403|NCT04375878|594487291|FG000|Crossover First and Second Interventions|Adverse Event|0|||
164579404|NCT04375878|594487292|FG001|Crossover First and Second Interventions|Adverse Event|0|||
164579405|NCT04375878|594487293|FG002|Crossover First and Second Interventions|Adverse Event|1|||
164579406|NCT04375878|594487294|FG003|Crossover First and Second Interventions|Adverse Event|0|||
164579407|NCT04375878|594487295|FG004|Crossover First and Second Interventions|Adverse Event|0|||
164579408|NCT04375878|594487296|FG005|Crossover First and Second Interventions|Adverse Event|0|||
164579409|NCT04375878|594487291|FG000|Extension Phase|Withdrawal by Subject|0|||
164579410|NCT04375878|594487292|FG001|Extension Phase|Withdrawal by Subject|0|||
164579411|NCT04375878|594487293|FG002|Extension Phase|Withdrawal by Subject|0|||
164579412|NCT04375878|594487294|FG003|Extension Phase|Withdrawal by Subject|0|||
164579413|NCT04375878|594487295|FG004|Extension Phase|Withdrawal by Subject|1|||
164579414|NCT04375878|594487296|FG005|Extension Phase|Withdrawal by Subject|0|||
164579415|NCT00816036|594487297|FG000|Overall Study|Death|47|||
164579416|NCT00816036|594487298|FG001|Overall Study|Death|28|||
164579417|NCT00816036|594487297|FG000|Overall Study|Lost to Follow-up|75|||
164579418|NCT00816036|594487298|FG001|Overall Study|Lost to Follow-up|57|||
164579419|NCT00816036|594487297|FG000|Overall Study|Withdrawal by Subject|54|||
164579420|NCT00816036|594487298|FG001|Overall Study|Withdrawal by Subject|23|||
164579421|NCT00820040|594487302|FG000|Overall Study|Death|1|||
164579422|NCT00820040|594487302|FG000|Overall Study|Sponsor terminated study|1|||
164579423|NCT00820040|594487302|FG000|Overall Study|Screen failure|1|||
164579424|NCT01259466|594487303|FG000|Overall Study|Withdrawal by Subject|1|||
164579425|NCT01259466|594487304|FG001|Overall Study|Withdrawal by Subject|9|||
164579426|NCT00184054|594487308|FG000|Overall Study|Adverse Event|1|||
164579427|NCT02485717|594487314|FG000|Overall Study|Lost to Follow-up|6|||
164579428|NCT02485717|594487315|FG001|Overall Study|Lost to Follow-up|0|||
164579429|NCT02485717|594487316|FG002|Overall Study|Lost to Follow-up|0|||
164579430|NCT02485717|594487314|FG000|Overall Study|Withdrawal by Subject|0|||
164579431|NCT02485717|594487315|FG001|Overall Study|Withdrawal by Subject|0|||
164579432|NCT02485717|594487316|FG002|Overall Study|Withdrawal by Subject|1|||
164579433|NCT02485717|594487314|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
164579434|NCT02485717|594487315|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
164579435|NCT02485717|594487316|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
164579436|NCT02485717|594487314|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
164579437|NCT02485717|594487315|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
164579438|NCT02485717|594487316|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
164579439|NCT00002850|594487317|FG000|Overall Study|Death|4|||
164579440|NCT00002850|594487318|FG001|Overall Study|Death|1|||
164579441|NCT00002850|594487319|FG002|Overall Study|Death|3|||
164579442|NCT00002850|594487317|FG000|Overall Study|Protocol Violation|1|||
164579443|NCT00002850|594487318|FG001|Overall Study|Protocol Violation|0|||
164579444|NCT00002850|594487319|FG002|Overall Study|Protocol Violation|1|||
164579445|NCT00002850|594487317|FG000|Overall Study|Withdrawal by Subject|0|||
164579446|NCT00002850|594487318|FG001|Overall Study|Withdrawal by Subject|1|||
164684519|NCT01968551|594866738|FG000|Extension Phase|Death|0|||
164579447|NCT00002850|594487319|FG002|Overall Study|Withdrawal by Subject|0|||
164684520|NCT01968551|594866739|FG001|Extension Phase|Death|1|||
164684521|NCT01968551|594866740|FG002|Extension Phase|Death|0|||
164684522|NCT01968551|594866738|FG000|Extension Phase|Withdrew Consent|0|||
164684523|NCT01968551|594866739|FG001|Extension Phase|Withdrew Consent|0|||
164684524|NCT01968551|594866740|FG002|Extension Phase|Withdrew Consent|1|||
164684525|NCT01968551|594866738|FG000|Extension Phase|Lost to Follow-up|1|||
164684526|NCT01968551|594866739|FG001|Extension Phase|Lost to Follow-up|0|||
164684527|NCT01968551|594866740|FG002|Extension Phase|Lost to Follow-up|1|||
164684528|NCT06475729|594866741|FG000|Overall Study|Withdrawal by Subject|2|||
164684529|NCT06475729|594866742|FG001|Overall Study|Withdrawal by Subject|1|||
164684530|NCT06475729|594866741|FG000|Overall Study|Randomized but did not receive any dose|3|||
164684531|NCT06475729|594866742|FG001|Overall Study|Randomized but did not receive any dose|2|||
164684532|NCT06475729|594866741|FG000|Overall Study|Lost to Follow-up|1|||
164684533|NCT06475729|594866742|FG001|Overall Study|Lost to Follow-up|2|||
164684534|NCT06475729|594866741|FG000|Overall Study|Physician Decision|5|||
164579448|NCT02932267|594487321|FG000|Overall Study|Withdrawal by Subject|3|||
164579449|NCT02932267|594487321|FG000|Overall Study|Lost to Follow-up|4|||
164579450|NCT02932267|594487321|FG000|Overall Study|Pregnancy|1|||
164579451|NCT02006576|594487322|FG000|Overall Study|Withdrawal by Subject|4|||
164579452|NCT02006576|594487323|FG001|Overall Study|Withdrawal by Subject|6|||
164579453|NCT02006576|594487324|FG002|Overall Study|Withdrawal by Subject|2|||
164579454|NCT02006576|594487322|FG000|Overall Study|Death|0|||
164579455|NCT02006576|594487323|FG001|Overall Study|Death|0|||
164579456|NCT02006576|594487324|FG002|Overall Study|Death|1|||
164579457|NCT02006576|594487322|FG000|Overall Study|Lost to Follow-up|1|||
164579458|NCT02006576|594487323|FG001|Overall Study|Lost to Follow-up|0|||
164579459|NCT02006576|594487324|FG002|Overall Study|Lost to Follow-up|1|||
164579460|NCT02006576|594487322|FG000|Overall Study|Screen Failure, too sick, other|13|||
164579461|NCT02006576|594487323|FG001|Overall Study|Screen Failure, too sick, other|1|||
164579462|NCT02006576|594487324|FG002|Overall Study|Screen Failure, too sick, other|13|||
164579463|NCT00785577|594487325|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
164579464|NCT00785577|594487326|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
164579465|NCT00785577|594487327|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
164579466|NCT00785577|594487328|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
164579467|NCT00785577|594487329|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
164579468|NCT00785577|594487325|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
164579469|NCT00785577|594487326|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
164579470|NCT00785577|594487327|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
164579471|NCT00785577|594487328|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
164579472|NCT00785577|594487329|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
164579473|NCT00785577|594487325|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
164579474|NCT00785577|594487326|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
164579475|NCT00785577|594487327|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
164579476|NCT00785577|594487328|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
164579477|NCT00785577|594487329|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
164579478|NCT00785577|594487325|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
164579479|NCT00785577|594487326|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
164579480|NCT00785577|594487327|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
164579481|NCT00785577|594487328|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
164579482|NCT00785577|594487329|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
164579483|NCT00785577|594487325|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
164579484|NCT00785577|594487326|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
164579485|NCT00785577|594487327|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
164579486|NCT00785577|594487328|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
164579487|NCT00785577|594487329|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
164579488|NCT00785577|594487325|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
164684535|NCT06475729|594866742|FG001|Overall Study|Physician Decision|2|||
164684536|NCT06475729|594866741|FG000|Overall Study|Adverse Event|1|||
164684537|NCT06475729|594866742|FG001|Overall Study|Adverse Event|1|||
164684538|NCT03922750|594866749|FG000|Overall Study|Unclassified|0|||
164684539|NCT03922750|594866750|FG001|Overall Study|Unclassified|0|||
164579489|NCT00785577|594487326|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
164579490|NCT00785577|594487327|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
164579491|NCT00785577|594487328|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
164579492|NCT00785577|594487329|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
164684540|NCT03922750|594866751|FG002|Overall Study|Unclassified|1|||
164684541|NCT03922750|594866749|FG000|Overall Study|Adverse Event|0|||
164684542|NCT03922750|594866750|FG001|Overall Study|Adverse Event|1|||
164579493|NCT00785577|594487325|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
164684543|NCT03922750|594866751|FG002|Overall Study|Adverse Event|0|||
164684544|NCT02166606|594866752|FG000|Overall Study|Adverse Event|3|||
164684545|NCT02166606|594866752|FG000|Overall Study|Death|31|||
164684546|NCT02166606|594866752|FG000|Overall Study|Protocol Violation|7|||
164684547|NCT02166606|594866752|FG000|Overall Study|Lost to Follow-up|30|||
164684548|NCT02166606|594866752|FG000|Overall Study|Withdrawal by Subject|1|||
164684549|NCT02166606|594866752|FG000|Overall Study|Physician Decision|1|||
164684550|NCT02166606|594866752|FG000|Overall Study|Device upgrade|1|||
164684551|NCT02166606|594866752|FG000|Overall Study|Enrolled after End of Enrollment|4|||
164684552|NCT01958476|594866753|FG000|Overall Study|Parent requested exclusion from analysis|1|||
164684553|NCT01958476|594866754|FG001|Overall Study|Parent requested exclusion from analysis|0|||
164684554|NCT03868631|594866756|FG000|Baseline to Week 6|Adverse Event|0|||
164684555|NCT03868631|594866757|FG001|Baseline to Week 6|Adverse Event|3|||
164684556|NCT03868631|594866756|FG000|Baseline to Week 6|Protocol Violation|1|||
164684557|NCT03868631|594866757|FG001|Baseline to Week 6|Protocol Violation|1|||
164684558|NCT03868631|594866756|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
164684559|NCT03868631|594866757|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
164684560|NCT03868631|594866756|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
164684561|NCT03868631|594866757|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
164684562|NCT03868631|594866756|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
164684563|NCT03868631|594866757|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
164684564|NCT03868631|594866756|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
164684565|NCT03868631|594866757|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
164684566|NCT03867760|594866760|FG000|Overall Study|Lost to Follow-up|2|||
164684567|NCT03867760|594866761|FG001|Overall Study|Lost to Follow-up|3|||
164684568|NCT03867760|594866760|FG000|Overall Study|Withdrawal by Subject|1|||
164684569|NCT03867760|594866761|FG001|Overall Study|Withdrawal by Subject|2|||
164684570|NCT03867760|594866760|FG000|Overall Study|subject could not meet study logistics|3|||
164684571|NCT03867760|594866761|FG001|Overall Study|subject could not meet study logistics|3|||
164684572|NCT01401062|594866762|FG000|Overall Study|Death|9|||
164684573|NCT01401062|594866763|FG001|Overall Study|Death|7|||
164684574|NCT01401062|594866762|FG000|Overall Study|Physician Decision|1|||
164684575|NCT01401062|594866763|FG001|Overall Study|Physician Decision|0|||
164684576|NCT01401062|594866762|FG000|Overall Study|Withdrawal by Subject|1|||
164684577|NCT01401062|594866763|FG001|Overall Study|Withdrawal by Subject|1|||
164684578|NCT00835081|594866767|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
164684579|NCT00835081|594866768|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
164684580|NCT04236596|594866769|FG000|Overall Study|Withdrawal by Subject|1|||
164684581|NCT04236596|594866769|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
164684582|NCT04236596|594866769|FG000|Overall Study|Participants did not receive implant at all|4|||
164684583|NCT02588339|594866771|FG000|Overall Study|Withdrawal by Subject|1|||
164684584|NCT02588339|594866771|FG000|Overall Study|GVHD Progression prior to treatment|2|||
164684585|NCT02966340|594868076|FG000|Overall Study|Adverse Event|0|||
164684586|NCT02966340|594868077|FG001|Overall Study|Adverse Event|1|||
164684587|NCT02966340|594868076|FG000|Overall Study|Lost to Follow-up|0|||
164684588|NCT02966340|594868077|FG001|Overall Study|Lost to Follow-up|1|||
164684589|NCT02966340|594868076|FG000|Overall Study|Withdrawal by Subject|1|||
164684590|NCT02966340|594868077|FG001|Overall Study|Withdrawal by Subject|0|||
164684591|NCT02966340|594868076|FG000|Overall Study|data acquisition error|1|||
164684592|NCT02966340|594868077|FG001|Overall Study|data acquisition error|0|||
164684593|NCT02966340|594868076|FG000|Overall Study|startle non-responder|1|||
164684594|NCT02966340|594868077|FG001|Overall Study|startle non-responder|1|||
164684595|NCT04211766|594868078|FG000|Overall Study|Withdrawal by Subject|5|||
164684596|NCT04211766|594868079|FG001|Overall Study|Withdrawal by Subject|1|||
164684597|NCT04768296|594868080|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
164684598|NCT04768296|594868081|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
164684599|NCT00255346|594868088|FG000|Overall Study|Adverse Event|1|||
164684600|NCT00255346|594868089|FG001|Overall Study|Adverse Event|0|||
164684601|NCT00255346|594868090|FG002|Overall Study|Adverse Event|0|||
164684602|NCT00255346|594868091|FG003|Overall Study|Adverse Event|0|||
164684603|NCT00255346|594868092|FG004|Overall Study|Adverse Event|0|||
164684604|NCT04402489|594868094|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
164684605|NCT04402489|594868095|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
164684606|NCT04402489|594868096|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
164684607|NCT04402489|594868097|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
164684608|NCT04402489|594868098|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
164684609|NCT04402489|594868094|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
164684610|NCT04402489|594868095|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
164684611|NCT04402489|594868096|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
164684612|NCT04402489|594868097|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
164684613|NCT04402489|594868098|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
164684614|NCT04402489|594868094|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
164684615|NCT04402489|594868095|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
164684616|NCT04402489|594868096|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
164684617|NCT04402489|594868097|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
164684618|NCT04402489|594868098|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
164684619|NCT04402489|594868094|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
164684620|NCT04402489|594868095|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
164684621|NCT04402489|594868096|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
164684622|NCT04402489|594868097|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
164684623|NCT04402489|594868098|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
164684624|NCT04402489|594868094|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
164684625|NCT04402489|594868095|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
164684626|NCT04402489|594868096|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
164684627|NCT04402489|594868097|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
164684628|NCT04402489|594868098|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
164684629|NCT04402489|594868094|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
164684630|NCT04402489|594868095|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
164684631|NCT04402489|594868096|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
164684632|NCT04402489|594868097|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
164684633|NCT04402489|594868098|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
164684634|NCT03192891|594868099|FG000|Overall Study|Lost to Follow-up|55|||
164684635|NCT05223868|594868100|FG000|Overall Study|Lost to Follow-up|1|||
164684636|NCT05223868|594868101|FG001|Overall Study|Lost to Follow-up|3|||
164684637|NCT05223868|594868102|FG002|Overall Study|Lost to Follow-up|0|||
164684638|NCT05223868|594868103|FG003|Overall Study|Lost to Follow-up|0|||
164684639|NCT05223868|594868104|FG004|Overall Study|Lost to Follow-up|0|||
164684640|NCT05223868|594868105|FG005|Overall Study|Lost to Follow-up|1|||
164684641|NCT05223868|594868100|FG000|Overall Study|Withdrawal by Subject|6|||
164684642|NCT05223868|594868101|FG001|Overall Study|Withdrawal by Subject|2|||
164684643|NCT05223868|594868102|FG002|Overall Study|Withdrawal by Subject|3|||
164684644|NCT05223868|594868103|FG003|Overall Study|Withdrawal by Subject|1|||
164684645|NCT05223868|594868104|FG004|Overall Study|Withdrawal by Subject|1|||
164684646|NCT05223868|594868105|FG005|Overall Study|Withdrawal by Subject|2|||
164684647|NCT05223868|594868100|FG000|Overall Study|Other|0|||
164684648|NCT05223868|594868101|FG001|Overall Study|Other|2|||
164684649|NCT05223868|594868102|FG002|Overall Study|Other|0|||
164684650|NCT05223868|594868103|FG003|Overall Study|Other|0|||
164684651|NCT05223868|594868104|FG004|Overall Study|Other|1|||
164684652|NCT05223868|594868105|FG005|Overall Study|Other|1|||
164684653|NCT03395197|594868106|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
164684654|NCT03395197|594868107|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
164684655|NCT03395197|594868108|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
164684656|NCT03395197|594868109|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
164684657|NCT03395197|594868110|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
164684658|NCT03395197|594868111|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
164684659|NCT03395197|594868106|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
164684660|NCT03395197|594868107|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
164684661|NCT03395197|594868108|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
164684662|NCT03395197|594868109|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
164684663|NCT03395197|594868110|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
164430311|NCT02753530|593945362|FG001|Overall Study|Death|1|||
164684664|NCT03395197|594868111|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
164684665|NCT03395197|594868106|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
164684666|NCT03395197|594868107|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
164684667|NCT03395197|594868108|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
164684668|NCT03395197|594868109|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
164684669|NCT03395197|594868110|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
164684670|NCT03395197|594868111|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
164684671|NCT03395197|594868106|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
164684672|NCT03395197|594868107|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
164684673|NCT03395197|594868108|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
164684674|NCT03395197|594868109|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
164265114|NCT00624780|593338829|FG002|Follow-up (Week 26)|Adverse Event|0|||
164265115|NCT00624780|593338830|FG003|Follow-up (Week 26)|Adverse Event|0|||
164265116|NCT00624780|593338831|FG004|Follow-up (Week 26)|Adverse Event|1|||
164265117|NCT00624780|593338832|FG005|Follow-up (Week 26)|Adverse Event|0|||
164265118|NCT00624780|593338827|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
164430312|NCT02753530|593945361|FG000|Overall Study|Physician Decision|0|||
164265119|NCT00624780|593338828|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
164430313|NCT02753530|593945362|FG001|Overall Study|Physician Decision|1|||
164430314|NCT02753530|593945361|FG000|Overall Study|Protocol Violation|1|||
164684675|NCT03395197|594868110|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
164579494|NCT00785577|594487326|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
164579495|NCT00785577|594487327|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
164579496|NCT00785577|594487328|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
164579497|NCT00785577|594487329|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
164579498|NCT00785577|594487325|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
164579499|NCT00785577|594487326|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
164579500|NCT00785577|594487327|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
164579501|NCT00785577|594487328|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
164579502|NCT00785577|594487329|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
164579503|NCT00785577|594487325|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
164579504|NCT00785577|594487326|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
164579505|NCT00785577|594487327|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
164579506|NCT00785577|594487328|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
164579507|NCT00785577|594487329|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
164579508|NCT00785577|594487325|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
164579509|NCT00785577|594487326|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
164579510|NCT00785577|594487327|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
164579511|NCT00785577|594487328|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
164579512|NCT00785577|594487329|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
164579513|NCT01919411|594487330|FG000|Overall Study|Lost to Follow-up|2|||
164579514|NCT01919411|594487331|FG001|Overall Study|Lost to Follow-up|4|||
164579515|NCT01919411|594487330|FG000|Overall Study|Physician Decision|1|||
164579516|NCT01919411|594487331|FG001|Overall Study|Physician Decision|0|||
164579517|NCT01919411|594487330|FG000|Overall Study|Protocol Violation|2|||
164579518|NCT01919411|594487331|FG001|Overall Study|Protocol Violation|1|||
164579519|NCT00957372|594487336|FG000|PART I|Lost to Follow-up|0|||
164579520|NCT00957372|594487337|FG001|PART I|Lost to Follow-up|0|||
164579521|NCT00957372|594487338|FG002|PART I|Lost to Follow-up|1|||
164579522|NCT00957372|594487339|FG003|PART I|Lost to Follow-up|0|||
164579523|NCT00957372|594487336|FG000|PART II|Withdrawal by Subject|0|||
164579524|NCT00957372|594487337|FG001|PART II|Withdrawal by Subject|0|||
164579525|NCT00957372|594487338|FG002|PART II|Withdrawal by Subject|0|||
164579526|NCT00957372|594487339|FG003|PART II|Withdrawal by Subject|8|||
164265120|NCT00624780|593338829|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
164579527|NCT00957372|594487336|FG000|PART II|Physician Decision|0|||
164579528|NCT00957372|594487337|FG001|PART II|Physician Decision|0|||
164579529|NCT00957372|594487338|FG002|PART II|Physician Decision|0|||
164579530|NCT00957372|594487339|FG003|PART II|Physician Decision|1|||
164265121|NCT00624780|593338830|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
164265122|NCT00624780|593338831|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
164265123|NCT00624780|593338832|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
164579531|NCT00957372|594487336|FG000|PART II|Pregnancy|0|||
164579532|NCT00957372|594487337|FG001|PART II|Pregnancy|0|||
164579533|NCT00957372|594487338|FG002|PART II|Pregnancy|0|||
164579534|NCT00957372|594487339|FG003|PART II|Pregnancy|1|||
164579535|NCT00957372|594487336|FG000|PART II|Not Know|0|||
164579536|NCT00957372|594487337|FG001|PART II|Not Know|0|||
164579537|NCT00957372|594487338|FG002|PART II|Not Know|0|||
164579538|NCT00957372|594487339|FG003|PART II|Not Know|20|||
164579539|NCT00957372|594487336|FG000|PART II|Adverse Event|0|||
164579540|NCT00957372|594487337|FG001|PART II|Adverse Event|0|||
164579541|NCT00957372|594487338|FG002|PART II|Adverse Event|0|||
164579542|NCT00957372|594487339|FG003|PART II|Adverse Event|10|||
164579543|NCT00957372|594487336|FG000|PART II|Patient non-compliance|0|||
164579544|NCT00957372|594487337|FG001|PART II|Patient non-compliance|0|||
164579545|NCT00957372|594487338|FG002|PART II|Patient non-compliance|0|||
164579546|NCT00957372|594487339|FG003|PART II|Patient non-compliance|4|||
164579547|NCT03750838|594487340|FG000|Overall Study|Lost to Follow-up|10|||
164579548|NCT03750838|594487341|FG001|Overall Study|Lost to Follow-up|6|||
164579549|NCT05847881|594487344|FG000|Overall Study|Principal Investigator Decision|8|||
164579550|NCT05847881|594487344|FG000|Overall Study|Withdrawal by Subject|2|||
164579551|NCT06400238|594488599|FG000|Overall Study|Started Protocol Therapy|2|||
164579552|NCT06400238|594488599|FG000|Overall Study|Adverse Event|1|||
164579553|NCT06400238|594488599|FG000|Overall Study|Death|1|||
164579554|NCT06400238|594488599|FG000|Overall Study|Disease Progression|27|||
164579555|NCT06400238|594488599|FG000|Overall Study|Withdrawal by Subject|2|||
164579556|NCT06400238|594488599|FG000|Overall Study|Physician Decision|2|||
164579557|NCT02413398|594488602|FG000|Overall Study|Lost to Follow-up|2|||
164579558|NCT02413398|594488603|FG001|Overall Study|Lost to Follow-up|4|||
164579559|NCT02413398|594488602|FG000|Overall Study|Withdrawal by Subject|1|||
164579560|NCT02413398|594488603|FG001|Overall Study|Withdrawal by Subject|1|||
164579561|NCT02413398|594488602|FG000|Overall Study|Other Eligibility criteria|1|||
164579562|NCT02413398|594488603|FG001|Overall Study|Other Eligibility criteria|2|||
164579563|NCT05408858|594488604|FG000|Overall Study|no longer met eligibility criteria|1|||
164579564|NCT01184989|594488607|FG000|Overall Study|Adverse Event|11|||
164579565|NCT01184989|594488607|FG000|Overall Study|Withdrawal by Subject|1|||
164579566|NCT00465569|594488608|FG000|Overall Study|persistent eczema during dose escalation|1|||
164579567|NCT00465569|594488609|FG001|Overall Study|persistent eczema during dose escalation|0|||
164579568|NCT00482001|594488611|FG000|Overall Study|Protocol Violation|1|||
164579569|NCT00482001|594488612|FG001|Overall Study|Protocol Violation|1|||
164579570|NCT04786210|594488613|FG000|Overall Study|Lost to Follow-up|2|||
164579571|NCT04786210|594488613|FG000|Overall Study|Withdrawal by Subject|4|||
164579572|NCT03826914|594488614|FG000|Overall Study|Withdrawal by Subject|1|||
164579573|NCT03826914|594488615|FG001|Overall Study|Withdrawal by Subject|1|||
164579574|NCT04334148|594488616|FG000|Overall Study|positive nasal swab at baseline|0|||
164579575|NCT04334148|594488617|FG001|Overall Study|positive nasal swab at baseline|1|||
164579576|NCT05370157|594488618|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
164579577|NCT05370157|594488619|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
164579578|NCT05370157|594488618|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
164579579|NCT05370157|594488619|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
164579580|NCT01508676|594488620|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
164579581|NCT01508676|594488621|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
164579582|NCT01508676|594488620|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
164579583|NCT01508676|594488621|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
164579584|NCT01508676|594488620|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
164579585|NCT01508676|594488621|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
164579586|NCT01508676|594488620|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
164579587|NCT01508676|594488621|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
164579588|NCT01508676|594488620|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
164579589|NCT01508676|594488621|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
164579590|NCT00542828|594488622|FG000|Overall Study|Physician Decision|1|||
164684676|NCT03395197|594868111|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
164694668|NCT03250299|594905311|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
164579591|NCT00542828|594488622|FG000|Overall Study|Need for Prohibited Treatment|3|||
164579592|NCT00542828|594488622|FG000|Overall Study|Study Prematurely Discontinued|7|||
164579593|NCT00542828|594488622|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
164579594|NCT06129487|594488623|FG000|Overall Study|Data loss was due to technical issues related to eye tracking.|198|||
164579595|NCT06129487|594488624|FG001|Overall Study|Data loss was due to technical issues related to eye tracking.|206|||
164579596|NCT05139030|594488625|FG000|Overall Study|Withdrawal by Subject|1|||
164430315|NCT02753530|593945362|FG001|Overall Study|Protocol Violation|0|||
164579597|NCT05139030|594488626|FG001|Overall Study|Withdrawal by Subject|3|||
164579598|NCT05139030|594488625|FG000|Overall Study|Adverse Event|0|||
164579599|NCT05139030|594488626|FG001|Overall Study|Adverse Event|1|||
164579600|NCT05139030|594488625|FG000|Overall Study|Failure to meet continuation criteria|0|||
164579601|NCT05139030|594488626|FG001|Overall Study|Failure to meet continuation criteria|1|||
164684677|NCT03395197|594868106|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
164684678|NCT03395197|594868107|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
164684679|NCT03395197|594868108|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
164684680|NCT03395197|594868109|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
164684681|NCT03395197|594868110|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
164684682|NCT03395197|594868111|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
164684683|NCT03395197|594868106|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
164684684|NCT03395197|594868107|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
164684685|NCT03395197|594868108|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
164684686|NCT03395197|594868109|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
164684687|NCT03395197|594868110|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
164684688|NCT03395197|594868111|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
164684689|NCT03395197|594868106|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
164684690|NCT03395197|594868107|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
164684691|NCT03395197|594868108|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
164684692|NCT03395197|594868109|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
164684693|NCT03395197|594868110|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
164684694|NCT03395197|594868111|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
164684695|NCT03395197|594868106|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
164684696|NCT03395197|594868107|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
164684697|NCT03395197|594868108|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
164684698|NCT03395197|594868109|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
164684699|NCT03395197|594868110|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
164684700|NCT03395197|594868111|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
164684701|NCT03395197|594868106|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
164684702|NCT03395197|594868107|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
164341478|NCT00415168|593625380|FG000|Overall Study|Sponsor Decision|4|||
164341479|NCT00415168|593625380|FG000|Overall Study|Withdrawal by Subject|6|||
164341480|NCT01612858|593625382|FG000|Overall Study|Withdrawal by Subject|5|||
164341481|NCT01612858|593625383|FG001|Overall Study|Withdrawal by Subject|1|||
164341482|NCT00003487|593625384|FG000|Overall Study|Not evaluable|2|||
164341483|NCT00005044|593625387|FG000|Overall Study|Protocol Violation|37|||
164341484|NCT00005044|593625388|FG001|Overall Study|Protocol Violation|46|||
164341485|NCT00005044|593625387|FG000|Overall Study|Withdrawal by Subject|1|||
164341486|NCT00005044|593625388|FG001|Overall Study|Withdrawal by Subject|5|||
164341487|NCT00005044|593625387|FG000|Overall Study|No protocol treatment|0|||
164341488|NCT00005044|593625388|FG001|Overall Study|No protocol treatment|1|||
164579602|NCT03772327|594488627|FG000|Overall Study|Lost to Follow-up|3|||
164579603|NCT03772327|594488628|FG001|Overall Study|Lost to Follow-up|4|||
164579604|NCT03772327|594488627|FG000|Overall Study|Withdrawal by Subject|2|||
164579605|NCT03772327|594488628|FG001|Overall Study|Withdrawal by Subject|3|||
164579606|NCT04689828|594488629|FG000|Overall Study|Subject decision|5|||
164579607|NCT04689828|594488630|FG001|Overall Study|Subject decision|5|||
164579608|NCT04689828|594488629|FG000|Overall Study|Adverse Event|12|||
164579609|NCT04689828|594488630|FG001|Overall Study|Adverse Event|12|||
164341489|NCT00843856|593625389|FG000|Overall Study|Lost to Follow-up|1|||
164579610|NCT04689828|594488629|FG000|Overall Study|Physician Decision|24|||
164579611|NCT04689828|594488630|FG001|Overall Study|Physician Decision|32|||
164341490|NCT00843856|593625390|FG001|Overall Study|Lost to Follow-up|2|||
164579612|NCT04689828|594488629|FG000|Overall Study|Progressive disease|54|||
164579613|NCT04689828|594488630|FG001|Overall Study|Progressive disease|173|||
164579614|NCT04689828|594488629|FG000|Overall Study|Death|0|||
164579615|NCT04689828|594488630|FG001|Overall Study|Death|1|||
164579616|NCT04689828|594488629|FG000|Overall Study|Lost to Follow-up|1|||
164579617|NCT04689828|594488630|FG001|Overall Study|Lost to Follow-up|0|||
164579618|NCT04689828|594488629|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
164265124|NCT00624780|593338827|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
164265125|NCT00624780|593338828|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
164265126|NCT00624780|593338829|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
164265127|NCT00624780|593338830|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
164265128|NCT00624780|593338831|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
164265129|NCT00624780|593338832|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
164265130|NCT00624780|593338827|FG000|Follow-up (Week 26)|Other|1|||
164265131|NCT00624780|593338828|FG001|Follow-up (Week 26)|Other|1|||
164341491|NCT00345839|593625403|FG000|Overall Study|Withdrawal by Subject|91|||
164579619|NCT04689828|594488630|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
164579620|NCT04689828|594488629|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
164265132|NCT00624780|593338829|FG002|Follow-up (Week 26)|Other|0|||
164265133|NCT00624780|593338830|FG003|Follow-up (Week 26)|Other|0|||
164341492|NCT00345839|593625404|FG001|Overall Study|Withdrawal by Subject|98|||
164589026|NCT01675531|594521355|FG000|Overall Study|Withdrawal by Subject|7|||
164589027|NCT01675531|594521355|FG000|Overall Study|Lack of Efficacy|1|||
164265134|NCT00624780|593338831|FG004|Follow-up (Week 26)|Other|0|||
164589028|NCT01675531|594521355|FG000|Overall Study|Protocol Violation|8|||
164589029|NCT00623467|594521356|FG000|Overall Study|Lost to Follow-up|1|||
164589030|NCT00623467|594521356|FG000|Overall Study|Protocol Violation|4|||
164589031|NCT00623467|594521356|FG000|Overall Study|Withdrawal by Subject|2|||
164589032|NCT00273858|594521370|FG000|Overall Study|Not completed 24 month observation time|334|||
164589033|NCT00273858|594521370|FG000|Overall Study|Lost to Follow-up|101|||
164589034|NCT00273858|594521370|FG000|Overall Study|Withdrawal by Subject|21|||
164589035|NCT00273858|594521370|FG000|Overall Study|Adverse Event|81|||
164589036|NCT02232516|594521371|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
164589037|NCT02232516|594521371|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
164589038|NCT02232516|594521371|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
164589039|NCT02232516|594521371|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
164589040|NCT02232516|594521371|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
164589041|NCT02232516|594521371|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
164589042|NCT02232516|594521371|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
164589043|NCT02232516|594521371|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
164589044|NCT02232516|594521371|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
164579621|NCT04689828|594488630|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
164579622|NCT04689828|594488629|FG000|Overall Study|Participants not treated|7|||
164579623|NCT04689828|594488630|FG001|Overall Study|Participants not treated|2|||
164579624|NCT01299025|594488637|FG000|Overall Study|Withdrawal by Subject|2|||
164579625|NCT01299025|594488638|FG001|Overall Study|Withdrawal by Subject|1|||
164579626|NCT01299025|594488637|FG000|Overall Study|Lost to Follow-up|1|||
164579627|NCT01299025|594488638|FG001|Overall Study|Lost to Follow-up|0|||
164684703|NCT03395197|594868108|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
164684704|NCT03395197|594868109|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
164684705|NCT03395197|594868110|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
164684706|NCT03395197|594868111|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
164684707|NCT03395197|594868106|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
164684708|NCT03395197|594868107|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
164684709|NCT03395197|594868108|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
164684710|NCT03395197|594868109|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
164684711|NCT03395197|594868110|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
164684712|NCT03395197|594868111|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
164684713|NCT03395197|594868106|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
164684714|NCT03395197|594868107|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
164684715|NCT03395197|594868108|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
164684716|NCT03395197|594868109|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
164684717|NCT03395197|594868110|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
164684718|NCT03395197|594868111|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
164684719|NCT03395197|594868106|FG000|Analysis for DDR-Deficient Participants|Death|0|||
164684720|NCT03395197|594868107|FG001|Analysis for DDR-Deficient Participants|Death|0|||
164684721|NCT03395197|594868108|FG002|Analysis for DDR-Deficient Participants|Death|0|||
164579628|NCT05480514|594488639|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
164579629|NCT05480514|594488640|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
164579630|NCT05480514|594488639|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
164579631|NCT05480514|594488640|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
164579632|NCT05480514|594488639|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
164579633|NCT05480514|594488640|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
164579634|NCT05480514|594488639|FG000|Period 1|Covid-19 Related|1|||
164579635|NCT05480514|594488640|FG001|Period 1|Covid-19 Related|0|||
164579636|NCT05480514|594488639|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
164579637|NCT05480514|594488640|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
164579638|NCT00195351|594488641|FG000|Overall Study|Lost to Follow-up|9|||
164579639|NCT00195351|594488642|FG001|Overall Study|Lost to Follow-up|9|||
164579640|NCT00195351|594488641|FG000|Overall Study|Withdrawal by Subject|6|||
164579641|NCT00195351|594488642|FG001|Overall Study|Withdrawal by Subject|3|||
164684722|NCT03395197|594868109|FG003|Analysis for DDR-Deficient Participants|Death|0|||
164684723|NCT03395197|594868110|FG004|Analysis for DDR-Deficient Participants|Death|1|||
164684724|NCT03395197|594868111|FG005|Analysis for DDR-Deficient Participants|Death|4|||
164684725|NCT03395197|594868106|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
164684726|NCT03395197|594868107|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
164684727|NCT03395197|594868108|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
164684728|NCT03395197|594868109|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
164684729|NCT03395197|594868110|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
164684730|NCT03395197|594868111|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
164684731|NCT03395197|594868106|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
164684732|NCT03395197|594868107|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
164684733|NCT03395197|594868108|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
164684734|NCT03395197|594868109|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
164684735|NCT03395197|594868110|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
164684736|NCT03395197|594868111|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
164684737|NCT03395197|594868106|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
164684738|NCT03395197|594868107|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
164684739|NCT03395197|594868108|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
164579642|NCT00195351|594488641|FG000|Overall Study|Protocol Deviation|3|||
164579643|NCT00195351|594488642|FG001|Overall Study|Protocol Deviation|2|||
164579644|NCT00195351|594488641|FG000|Overall Study|Death|3|||
164579645|NCT00195351|594488642|FG001|Overall Study|Death|1|||
164579646|NCT00195351|594488641|FG000|Overall Study|Lack of Efficacy|0|||
164579647|NCT00195351|594488642|FG001|Overall Study|Lack of Efficacy|1|||
164579648|NCT04332419|594488645|FG000|Overall Study|Withdrawal by Subject|1|||
164579649|NCT02493751|594488646|FG000|Overall Study|Withdrawal by Subject|2|||
164579650|NCT02493751|594488647|FG001|Overall Study|Withdrawal by Subject|8|||
164579651|NCT02493751|594488646|FG000|Overall Study|Death|6|||
164579652|NCT02493751|594488647|FG001|Overall Study|Death|13|||
164579653|NCT02493751|594488646|FG000|Overall Study|Lost to Follow-up|2|||
164579654|NCT02493751|594488647|FG001|Overall Study|Lost to Follow-up|3|||
164579655|NCT02493751|594488646|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
164579656|NCT02493751|594488647|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
164265135|NCT00624780|593338832|FG005|Follow-up (Week 26)|Other|0|||
164265136|NCT04068519|593338834|FG000|Dose Verification|Death|15|||
164265137|NCT04068519|593338834|FG000|Dose Verification|Withdrawal by Subject|1|||
164579657|NCT01480180|594488648|FG000|Main Phase|Withdrawal criteria|12|||
164579658|NCT01480180|594488649|FG001|Main Phase|Withdrawal criteria|1|||
164579659|NCT01480180|594488650|FG002|Main Phase|Withdrawal criteria|0|||
164579660|NCT01480180|594488651|FG003|Main Phase|Withdrawal criteria|0|||
164579661|NCT01480180|594488652|FG004|Main Phase|Withdrawal criteria|0|||
164579662|NCT01480180|594488653|FG005|Main Phase|Withdrawal criteria|0|||
164579663|NCT01480180|594488648|FG000|Main Phase|Lack of Efficacy|1|||
164579664|NCT01480180|594488649|FG001|Main Phase|Lack of Efficacy|0|||
164579665|NCT01480180|594488650|FG002|Main Phase|Lack of Efficacy|0|||
164579666|NCT01480180|594488651|FG003|Main Phase|Lack of Efficacy|0|||
164579667|NCT01480180|594488652|FG004|Main Phase|Lack of Efficacy|0|||
164579668|NCT01480180|594488653|FG005|Main Phase|Lack of Efficacy|0|||
164579669|NCT01480180|594488648|FG000|Main Phase|Non-compliance|3|||
164579670|NCT01480180|594488649|FG001|Main Phase|Non-compliance|0|||
164579671|NCT01480180|594488650|FG002|Main Phase|Non-compliance|0|||
164579672|NCT01480180|594488651|FG003|Main Phase|Non-compliance|0|||
164579673|NCT01480180|594488652|FG004|Main Phase|Non-compliance|0|||
164579674|NCT01480180|594488653|FG005|Main Phase|Non-compliance|0|||
164579675|NCT01480180|594488648|FG000|Main Phase|Unclassified|3|||
164579676|NCT01480180|594488649|FG001|Main Phase|Unclassified|0|||
164579677|NCT01480180|594488650|FG002|Main Phase|Unclassified|0|||
164579678|NCT01480180|594488651|FG003|Main Phase|Unclassified|0|||
164579679|NCT01480180|594488652|FG004|Main Phase|Unclassified|0|||
164579680|NCT01480180|594488653|FG005|Main Phase|Unclassified|0|||
164579681|NCT01480180|594488648|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
164579682|NCT01480180|594488649|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
164579683|NCT01480180|594488650|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
164579684|NCT01480180|594488651|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
164579685|NCT01480180|594488652|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
164579686|NCT01480180|594488653|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
164579687|NCT01480180|594488648|FG000|Extension Phase, Part 1|Unclassified|0|||
164579688|NCT01480180|594488649|FG001|Extension Phase, Part 1|Unclassified|0|||
164579689|NCT01480180|594488650|FG002|Extension Phase, Part 1|Unclassified|1|||
164579690|NCT01480180|594488651|FG003|Extension Phase, Part 1|Unclassified|0|||
164579691|NCT01480180|594488652|FG004|Extension Phase, Part 1|Unclassified|0|||
164579692|NCT01480180|594488653|FG005|Extension Phase, Part 1|Unclassified|0|||
164579693|NCT01480180|594488648|FG000|Extension Phase, Part 1|Adverse Event|0|||
164579694|NCT01480180|594488649|FG001|Extension Phase, Part 1|Adverse Event|0|||
164579695|NCT01480180|594488650|FG002|Extension Phase, Part 1|Adverse Event|4|||
164579696|NCT01480180|594488651|FG003|Extension Phase, Part 1|Adverse Event|1|||
164579697|NCT01480180|594488652|FG004|Extension Phase, Part 1|Adverse Event|0|||
164579698|NCT01480180|594488653|FG005|Extension Phase, Part 1|Adverse Event|0|||
164579699|NCT01480180|594488648|FG000|Extension Phase, Part 1|Change of treatment|0|||
164579700|NCT01480180|594488649|FG001|Extension Phase, Part 1|Change of treatment|0|||
164579701|NCT01480180|594488650|FG002|Extension Phase, Part 1|Change of treatment|0|||
164579702|NCT01480180|594488651|FG003|Extension Phase, Part 1|Change of treatment|9|||
164579703|NCT01480180|594488652|FG004|Extension Phase, Part 1|Change of treatment|0|||
164579704|NCT01480180|594488653|FG005|Extension Phase, Part 1|Change of treatment|0|||
164579705|NCT01480180|594488648|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
164579706|NCT01480180|594488649|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
164579707|NCT01480180|594488650|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
164579708|NCT01480180|594488651|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
164579709|NCT01480180|594488652|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
164579710|NCT01480180|594488653|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
164579711|NCT01480180|594488648|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
164579712|NCT01480180|594488649|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
164579713|NCT01480180|594488650|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
164579714|NCT01480180|594488651|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
164579715|NCT01480180|594488652|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
164579716|NCT01480180|594488653|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
164579717|NCT01480180|594488648|FG000|Extension Phase, Part 2|Unclassified|0|||
164579718|NCT01480180|594488649|FG001|Extension Phase, Part 2|Unclassified|0|||
164579719|NCT01480180|594488650|FG002|Extension Phase, Part 2|Unclassified|3|||
164579720|NCT01480180|594488651|FG003|Extension Phase, Part 2|Unclassified|1|||
164579721|NCT01480180|594488652|FG004|Extension Phase, Part 2|Unclassified|1|||
164579722|NCT01480180|594488653|FG005|Extension Phase, Part 2|Unclassified|0|||
164579723|NCT00519623|594488654|FG000|Overall Study|Adverse Event|1|||
164684740|NCT03395197|594868109|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
164684741|NCT03395197|594868110|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
164684742|NCT03395197|594868111|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
164684743|NCT03395197|594868106|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
164684744|NCT03395197|594868107|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
164684745|NCT03395197|594868108|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
164579724|NCT01824602|594488656|FG000|Overall Study|Withdrawal by Subject|0|||
164579725|NCT01824602|594488657|FG001|Overall Study|Withdrawal by Subject|0|||
164579726|NCT01824602|594488658|FG002|Overall Study|Withdrawal by Subject|1|||
164579727|NCT01824602|594488659|FG003|Overall Study|Withdrawal by Subject|2|||
164579728|NCT01824602|594488656|FG000|Overall Study|Patient non-compliance|0|||
164579729|NCT01824602|594488657|FG001|Overall Study|Patient non-compliance|0|||
164579730|NCT01824602|594488658|FG002|Overall Study|Patient non-compliance|1|||
164579731|NCT01824602|594488659|FG003|Overall Study|Patient non-compliance|0|||
164579732|NCT01824602|594488656|FG000|Overall Study|Adverse Event|1|||
164579733|NCT01824602|594488657|FG001|Overall Study|Adverse Event|0|||
164579734|NCT01824602|594488658|FG002|Overall Study|Adverse Event|2|||
164579735|NCT01824602|594488659|FG003|Overall Study|Adverse Event|2|||
164579736|NCT01824602|594488656|FG000|Overall Study|Treatment failure|0|||
164579737|NCT01824602|594488657|FG001|Overall Study|Treatment failure|0|||
164579738|NCT01824602|594488658|FG002|Overall Study|Treatment failure|0|||
164579739|NCT01824602|594488659|FG003|Overall Study|Treatment failure|1|||
164579740|NCT03819140|594488662|FG000|Overall Study|Lost to Follow-up|1|||
164579741|NCT03819140|594488663|FG001|Overall Study|Lost to Follow-up|2|||
164579742|NCT03819140|594488662|FG000|Overall Study|Withdrawal by Subject|3|||
164579743|NCT03819140|594488663|FG001|Overall Study|Withdrawal by Subject|2|||
164579744|NCT03819140|594488662|FG000|Overall Study|Adverse Event|0|||
164579745|NCT03819140|594488663|FG001|Overall Study|Adverse Event|1|||
164579746|NCT03819140|594488662|FG000|Overall Study|Unable to attend visit(s) due to contracting COVID|2|||
164579747|NCT03819140|594488663|FG001|Overall Study|Unable to attend visit(s) due to contracting COVID|1|||
164579748|NCT03819140|594488662|FG000|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|1|||
164579749|NCT03819140|594488663|FG001|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|3|||
164579750|NCT02192359|594488666|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
164579751|NCT02192359|594488667|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
164579752|NCT02192359|594488668|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
164579753|NCT02192359|594488669|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
164579754|NCT02192359|594488666|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
164579755|NCT02192359|594488667|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
164579756|NCT02192359|594488668|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
164579757|NCT02192359|594488669|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
164579758|NCT02192359|594488666|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
164579759|NCT02192359|594488667|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
164579760|NCT02192359|594488668|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
164579761|NCT02192359|594488669|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
164579762|NCT00658333|594488672|FG000|Overall Study|Adverse Event|2|||
164579763|NCT00658333|594488673|FG001|Overall Study|Adverse Event|1|||
164579764|NCT00828451|594488674|FG000|Overall Study|Death|2|||
164265138|NCT04068519|593338834|FG000|Pharmacokinetic Sub-study|Death|35|||
164265139|NCT04068519|593338834|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
164265140|NCT04068519|593338834|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
164579765|NCT00828451|594488674|FG000|Overall Study|Lack of intravenous line|7|||
164579766|NCT00828451|594488674|FG000|Overall Study|Withdrawal by Subject|1|||
164579767|NCT00828451|594488674|FG000|Overall Study|Deterioration in clinical status|1|||
164579768|NCT03256539|594488675|FG000|Overall Study|Withdrawal by Subject|0|||
164579769|NCT03256539|594488676|FG001|Overall Study|Withdrawal by Subject|3|||
164579770|NCT03256539|594488675|FG000|Overall Study|Unexpected closure of study components|8|||
164579771|NCT03256539|594488676|FG001|Overall Study|Unexpected closure of study components|4|||
164579772|NCT05755438|594488680|FG000|12-week DBVC Period|Adverse Event|4|||
164579773|NCT05755438|594488681|FG001|12-week DBVC Period|Adverse Event|1|||
164579774|NCT05755438|594488680|FG000|12-week DBVC Period|Physician Decision|1|||
164579775|NCT05755438|594488681|FG001|12-week DBVC Period|Physician Decision|1|||
164579776|NCT05755438|594488680|FG000|12-week DBVC Period|Protocol Violation|4|||
164579777|NCT05755438|594488681|FG001|12-week DBVC Period|Protocol Violation|2|||
164579778|NCT05755438|594488680|FG000|12-week DBVC Period|Withdrawal by Subject|9|||
164579779|NCT05755438|594488681|FG001|12-week DBVC Period|Withdrawal by Subject|7|||
164265141|NCT04068519|593338834|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
164265142|NCT04068519|593338834|FG000|Indication Expansion|Death|152|||
164341493|NCT00345839|593625403|FG000|Overall Study|Lost to Follow-up|58|||
164579780|NCT05755438|594488680|FG000|12-week DBVC Period|Sponsor Decision|1|||
164579781|NCT05755438|594488681|FG001|12-week DBVC Period|Sponsor Decision|0|||
164579782|NCT05755438|594488680|FG000|40-week OLE Period|Adverse Event|0|||
164579783|NCT05755438|594488681|FG001|40-week OLE Period|Adverse Event|2|||
164579784|NCT05755438|594488680|FG000|40-week OLE Period|Lack of Efficacy|1|||
164579785|NCT05755438|594488681|FG001|40-week OLE Period|Lack of Efficacy|1|||
164579786|NCT05755438|594488680|FG000|40-week OLE Period|Lost to Follow-up|1|||
164579787|NCT05755438|594488681|FG001|40-week OLE Period|Lost to Follow-up|0|||
164579788|NCT05755438|594488680|FG000|40-week OLE Period|Physician Decision|1|||
164579789|NCT05755438|594488681|FG001|40-week OLE Period|Physician Decision|1|||
164579790|NCT05755438|594488680|FG000|40-week OLE Period|Protocol Violation|1|||
164579791|NCT05755438|594488681|FG001|40-week OLE Period|Protocol Violation|1|||
164579792|NCT05755438|594488680|FG000|40-week OLE Period|Withdrawal by Subject|6|||
164579793|NCT05755438|594488681|FG001|40-week OLE Period|Withdrawal by Subject|6|||
164579794|NCT05755438|594488680|FG000|40-week OLE Period|Sponsor Decision|3|||
164579795|NCT05755438|594488681|FG001|40-week OLE Period|Sponsor Decision|0|||
164579796|NCT05755438|594488680|FG000|40-week OLE Period|Did Not Complete Safety Follow-up Period|0|||
164579797|NCT05755438|594488681|FG001|40-week OLE Period|Did Not Complete Safety Follow-up Period|1|||
164579798|NCT05755438|594488680|FG000|40-week OLE Period|Ongoing|46|||
164579799|NCT05755438|594488681|FG001|40-week OLE Period|Ongoing|58|||
164579800|NCT01548638|594488687|FG000|Overall Study|Protocol Violation|3|||
164579801|NCT01548638|594488687|FG000|Overall Study|Withdrawal by Subject|1|||
164579802|NCT02117687|594488689|FG000|Overall Study|Lost to Follow-up|0|||
164579803|NCT02117687|594488690|FG001|Overall Study|Lost to Follow-up|1|||
164579804|NCT02117687|594488689|FG000|Overall Study|Adverse Event|0|||
164579805|NCT02117687|594488690|FG001|Overall Study|Adverse Event|2|||
164579806|NCT02117687|594488689|FG000|Overall Study|Other Reasons|1|||
164579807|NCT02117687|594488690|FG001|Overall Study|Other Reasons|1|||
164579808|NCT01687673|594488694|FG000|Overall Study|Physician Decision|1|||
164579809|NCT03476239|594488695|FG000|Overall Study|Withdrawal by Subject|10|||
164579810|NCT03476239|594488695|FG000|Overall Study|Death|80|||
164579811|NCT03476239|594488695|FG000|Overall Study|Lost to Follow-up|8|||
164579812|NCT00618956|594488696|FG000|Overall Study|Adverse Event|10|||
164579813|NCT00618956|594488697|FG001|Overall Study|Adverse Event|34|||
164341494|NCT00345839|593625404|FG001|Overall Study|Lost to Follow-up|61|||
164341495|NCT03298867|593625420|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
164341496|NCT03298867|593625421|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
164341497|NCT03298867|593625420|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
164341498|NCT03298867|593625421|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
164341499|NCT03298867|593625420|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
164341500|NCT03298867|593625421|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
164341501|NCT03298867|593625420|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
164579814|NCT00618956|594488696|FG000|Overall Study|Lack of Efficacy|2|||
164579815|NCT00618956|594488697|FG001|Overall Study|Lack of Efficacy|1|||
164579816|NCT00618956|594488696|FG000|Overall Study|Withdrawal by Subject|5|||
164579817|NCT00618956|594488697|FG001|Overall Study|Withdrawal by Subject|7|||
164579818|NCT00618956|594488696|FG000|Overall Study|Lost to Follow-up|4|||
164579819|NCT00618956|594488697|FG001|Overall Study|Lost to Follow-up|5|||
164579820|NCT00618956|594488696|FG000|Overall Study|Protocol Violation|2|||
164579821|NCT00618956|594488697|FG001|Overall Study|Protocol Violation|2|||
164579822|NCT00618956|594488696|FG000|Overall Study|did not meet criteria, non-compliance|2|||
164579823|NCT00618956|594488697|FG001|Overall Study|did not meet criteria, non-compliance|1|||
164579824|NCT03598777|594488698|FG000|Overall Study|Study Terminated by Sponsor|3|||
164579825|NCT03598777|594488699|FG001|Overall Study|Study Terminated by Sponsor|0|||
164579826|NCT03598777|594488700|FG002|Overall Study|Study Terminated by Sponsor|0|||
164579827|NCT03598777|594488701|FG003|Overall Study|Study Terminated by Sponsor|0|||
164579828|NCT03598777|594488702|FG004|Overall Study|Study Terminated by Sponsor|15|||
164579829|NCT03598777|594488698|FG000|Overall Study|Withdrawal by Subject|1|||
164579830|NCT03598777|594488699|FG001|Overall Study|Withdrawal by Subject|1|||
164579831|NCT03598777|594488700|FG002|Overall Study|Withdrawal by Subject|0|||
164579832|NCT03598777|594488701|FG003|Overall Study|Withdrawal by Subject|0|||
164341502|NCT03298867|593625421|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
164579833|NCT03598777|594488702|FG004|Overall Study|Withdrawal by Subject|0|||
164579834|NCT03598777|594488698|FG000|Overall Study|Adverse Event|1|||
164579835|NCT03598777|594488699|FG001|Overall Study|Adverse Event|0|||
164579836|NCT03598777|594488700|FG002|Overall Study|Adverse Event|0|||
164579837|NCT03598777|594488701|FG003|Overall Study|Adverse Event|0|||
164579838|NCT03598777|594488702|FG004|Overall Study|Adverse Event|0|||
164579839|NCT03598777|594488698|FG000|Overall Study|Lost to Follow-up|1|||
164579840|NCT03598777|594488699|FG001|Overall Study|Lost to Follow-up|0|||
164579841|NCT03598777|594488700|FG002|Overall Study|Lost to Follow-up|0|||
164579842|NCT03598777|594488701|FG003|Overall Study|Lost to Follow-up|0|||
164579843|NCT03598777|594488702|FG004|Overall Study|Lost to Follow-up|0|||
164579844|NCT01901328|594488703|FG000|Overall Study|Lost to Follow-up|1|||
164684746|NCT03395197|594868109|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
164684747|NCT03395197|594868110|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
164684748|NCT03395197|594868111|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
164579845|NCT01901328|594488704|FG001|Overall Study|Lost to Follow-up|0|||
164579846|NCT01901328|594488703|FG000|Overall Study|Physician Decision|0|||
164579847|NCT01901328|594488704|FG001|Overall Study|Physician Decision|1|||
164579848|NCT01901328|594488703|FG000|Overall Study|Protocol Violation|1|||
164684749|NCT03395197|594868106|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
164684750|NCT03395197|594868107|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
164684751|NCT03395197|594868108|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
164684752|NCT03395197|594868109|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
164684753|NCT03395197|594868110|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
164684754|NCT03395197|594868111|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
164684755|NCT03395197|594868106|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
164684756|NCT03395197|594868107|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
164684757|NCT03395197|594868108|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
164684758|NCT03395197|594868109|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
164684759|NCT03395197|594868110|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
164684760|NCT03395197|594868111|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
164684761|NCT03395197|594868106|FG000|Analysis for DDR-Deficient Participants|Other|0|||
164684762|NCT03395197|594868107|FG001|Analysis for DDR-Deficient Participants|Other|0|||
164684763|NCT03395197|594868108|FG002|Analysis for DDR-Deficient Participants|Other|0|||
164684764|NCT03395197|594868109|FG003|Analysis for DDR-Deficient Participants|Other|0|||
164684765|NCT03395197|594868110|FG004|Analysis for DDR-Deficient Participants|Other|3|||
164684766|NCT03395197|594868111|FG005|Analysis for DDR-Deficient Participants|Other|3|||
164684767|NCT03395197|594868106|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
164684768|NCT03395197|594868107|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
164684769|NCT03395197|594868108|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
164684770|NCT03395197|594868109|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
164684771|NCT03395197|594868110|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
164684772|NCT03395197|594868111|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
164684773|NCT00659815|594868117|FG000|Overall Study|Study related symptoms and complaints|2|||
164684774|NCT00659815|594868118|FG001|Overall Study|Study related symptoms and complaints|1|||
164684775|NCT00659815|594868117|FG000|Overall Study|Inability to maintain wearing schedule|1|||
164684776|NCT00659815|594868118|FG001|Overall Study|Inability to maintain wearing schedule|2|||
164684777|NCT00659815|594868117|FG000|Overall Study|Withdrawal by Subject|1|||
164684778|NCT00659815|594868118|FG001|Overall Study|Withdrawal by Subject|1|||
164684779|NCT02655224|594868119|FG000|Overall Study|Adverse Event|1|||
164684780|NCT02655224|594868120|FG001|Overall Study|Adverse Event|1|||
164684781|NCT03036930|594868121|FG000|Overall Study|Lost to Follow-up|7|||
164684782|NCT03036930|594868121|FG000|Overall Study|Withdrawal by Subject|3|||
164684783|NCT03036930|594868121|FG000|Overall Study|Not eligible to receive transplant within 12 months|15|||
164684784|NCT04227899|594868128|FG000|Overall Study|Withdrawal by Subject|6|||
164684785|NCT04227899|594868129|FG001|Overall Study|Withdrawal by Subject|3|||
164684786|NCT04227899|594868128|FG000|Overall Study|Death|12|||
164684787|NCT04227899|594868129|FG001|Overall Study|Death|6|||
164684788|NCT04227899|594868128|FG000|Overall Study|Lost to Follow-up|2|||
164684789|NCT04227899|594868129|FG001|Overall Study|Lost to Follow-up|1|||
164579849|NCT01901328|594488704|FG001|Overall Study|Protocol Violation|1|||
164579850|NCT01901328|594488703|FG000|Overall Study|Study Terminated by Sponsor|19|||
164579851|NCT01901328|594488704|FG001|Overall Study|Study Terminated by Sponsor|16|||
164579852|NCT01901328|594488703|FG000|Overall Study|Withdrawal by Subject|1|||
164579853|NCT01901328|594488704|FG001|Overall Study|Withdrawal by Subject|2|||
164579854|NCT01901328|594488703|FG000|Overall Study|Lack of Efficacy|0|||
164579855|NCT01901328|594488704|FG001|Overall Study|Lack of Efficacy|1|||
164579856|NCT03232073|594488705|FG000|Overall Study|Death|1|||
164579857|NCT03232073|594488706|FG001|Overall Study|Death|0|||
164579858|NCT03232073|594488705|FG000|Overall Study|Adverse Event|7|||
164579859|NCT03232073|594488706|FG001|Overall Study|Adverse Event|12|||
164579860|NCT03232073|594488705|FG000|Overall Study|Lost to Follow-up|6|||
164579861|NCT03232073|594488706|FG001|Overall Study|Lost to Follow-up|6|||
164579862|NCT03232073|594488705|FG000|Overall Study|Lack of Efficacy|10|||
164579863|NCT03232073|594488706|FG001|Overall Study|Lack of Efficacy|8|||
164579864|NCT03232073|594488705|FG000|Overall Study|Physician Decision|9|||
164579865|NCT03232073|594488706|FG001|Overall Study|Physician Decision|2|||
164684790|NCT05151471|594868130|FG000|Overall Study|Adverse Event|21|||
164579866|NCT03232073|594488705|FG000|Overall Study|Withdrawal by Subject|54|||
164579867|NCT03232073|594488706|FG001|Overall Study|Withdrawal by Subject|39|||
164579868|NCT02032875|594488707|FG000|Treatment Period|Adverse Event|1|||
164341503|NCT03298867|593625420|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
164341504|NCT03298867|593625421|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
164579869|NCT02032875|594488708|FG001|Treatment Period|Adverse Event|0|||
164579870|NCT02032875|594488707|FG000|Treatment Period|Liver transplant, No extension needed|0|||
164579871|NCT02032875|594488708|FG001|Treatment Period|Liver transplant, No extension needed|1|||
164579872|NCT02032875|594488707|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
164579873|NCT02032875|594488708|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
164579874|NCT02032875|594488707|FG000|Follow-up Period|Death|0|||
164579875|NCT02032875|594488708|FG001|Follow-up Period|Death|1|||
164579876|NCT02032875|594488707|FG000|Follow-up Period|Virologic Relapse|3|||
164579877|NCT02032875|594488708|FG001|Follow-up Period|Virologic Relapse|10|||
164579878|NCT01981187|594490036|FG000|Overall Study|Participant/guardian decision|2|||
164579879|NCT01981187|594490036|FG000|Overall Study|Physician Decision|1|||
164579880|NCT01981187|594490036|FG000|Overall Study|Disease progression|2|||
164579881|NCT01981187|594490036|FG000|Overall Study|Adverse Event|7|||
164579882|NCT00443560|594490037|FG000|Overall Study|No intrathecal dose|58|||
164579883|NCT00443560|594490038|FG001|Overall Study|No intrathecal dose|26|||
164579884|NCT00443560|594490037|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
164579885|NCT00443560|594490038|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
164579886|NCT01362322|594490043|FG000|Overall Study|Withdrawal by Subject|3|||
164579887|NCT01362322|594490044|FG001|Overall Study|Withdrawal by Subject|1|||
164579888|NCT01362322|594490043|FG000|Overall Study|Lost to Follow-up|2|||
164579889|NCT01362322|594490044|FG001|Overall Study|Lost to Follow-up|6|||
164579890|NCT03715465|594490048|FG000|Overall Study|Withdrawal by Subject|1|||
164579891|NCT03715465|594490049|FG001|Overall Study|Withdrawal by Subject|2|||
164579892|NCT00174941|594490051|FG000|Overall Study|Adverse Event|1|||
164579893|NCT00174941|594490052|FG001|Overall Study|Adverse Event|10|||
164579894|NCT00174941|594490053|FG002|Overall Study|Adverse Event|2|||
164579895|NCT00174941|594490054|FG003|Overall Study|Adverse Event|13|||
164579896|NCT00174941|594490051|FG000|Overall Study|Protocol Violation|0|||
164579897|NCT00174941|594490052|FG001|Overall Study|Protocol Violation|1|||
164579898|NCT00174941|594490053|FG002|Overall Study|Protocol Violation|0|||
164579899|NCT00174941|594490054|FG003|Overall Study|Protocol Violation|1|||
164579900|NCT00174941|594490051|FG000|Overall Study|Lost to Follow-up|0|||
164579901|NCT00174941|594490052|FG001|Overall Study|Lost to Follow-up|3|||
164579902|NCT00174941|594490053|FG002|Overall Study|Lost to Follow-up|2|||
164579903|NCT00174941|594490054|FG003|Overall Study|Lost to Follow-up|5|||
164579904|NCT00174941|594490051|FG000|Overall Study|Personal Reason(s)|0|||
164579905|NCT00174941|594490052|FG001|Overall Study|Personal Reason(s)|14|||
164579906|NCT00174941|594490053|FG002|Overall Study|Personal Reason(s)|8|||
164579907|NCT00174941|594490054|FG003|Overall Study|Personal Reason(s)|22|||
164579908|NCT00174941|594490051|FG000|Overall Study|Gout Flare|0|||
164579909|NCT00174941|594490052|FG001|Overall Study|Gout Flare|4|||
164579910|NCT00174941|594490053|FG002|Overall Study|Gout Flare|4|||
164579911|NCT00174941|594490054|FG003|Overall Study|Gout Flare|8|||
164579912|NCT00174941|594490051|FG000|Overall Study|Reason Not Specified|1|||
164579913|NCT00174941|594490052|FG001|Overall Study|Reason Not Specified|6|||
164579914|NCT00174941|594490053|FG002|Overall Study|Reason Not Specified|2|||
164579915|NCT00174941|594490054|FG003|Overall Study|Reason Not Specified|9|||
164579916|NCT00440401|594490073|FG000|Overall Study|Adverse Event|2|||
164579917|NCT00440401|594490074|FG001|Overall Study|Adverse Event|1|||
164579918|NCT00440401|594490073|FG000|Overall Study|Other|2|||
164579919|NCT00440401|594490074|FG001|Overall Study|Other|5|||
164579920|NCT01925703|594490075|FG000|Overall Study|Physician Decision|1|||
164579921|NCT01925703|594490075|FG000|Overall Study|Lost to Follow-up|2|||
164579922|NCT01925703|594490075|FG000|Overall Study|Discharge prior to full iron repletion|1|||
164579923|NCT01938625|594490076|FG000|Overall Study|Withdrawal by Subject|0|||
164579924|NCT01938625|594490077|FG001|Overall Study|Withdrawal by Subject|1|||
164579925|NCT01938625|594490076|FG000|Overall Study|Adverse Event|0|||
164579926|NCT01938625|594490077|FG001|Overall Study|Adverse Event|1|||
164579927|NCT02088034|594490078|FG000|Overall Study|Lost to Follow-up|1|||
164579928|NCT02088034|594490079|FG001|Overall Study|Lost to Follow-up|1|||
164579929|NCT02088034|594490080|FG002|Overall Study|Lost to Follow-up|0|||
164579930|NCT02088034|594490078|FG000|Overall Study|Pregnancy|2|||
164579931|NCT02088034|594490079|FG001|Overall Study|Pregnancy|1|||
164579932|NCT02088034|594490080|FG002|Overall Study|Pregnancy|2|||
164579933|NCT00308620|594490081|FG000|Overall Study|Death|1|||
164579934|NCT00308620|594490082|FG001|Overall Study|Death|1|||
164579935|NCT00308620|594490083|FG002|Overall Study|Death|0|||
164579936|NCT00308620|594490081|FG000|Overall Study|Lost to Follow-up|0|||
164579937|NCT00308620|594490082|FG001|Overall Study|Lost to Follow-up|0|||
164579938|NCT00308620|594490083|FG002|Overall Study|Lost to Follow-up|1|||
164579939|NCT00091793|594490084|FG000|Overall Study|Adverse Event|1|||
164579940|NCT00091793|594490085|FG001|Overall Study|Adverse Event|2|||
164579941|NCT00091793|594490084|FG000|Overall Study|Withdrawal by Subject|10|||
164579942|NCT00091793|594490085|FG001|Overall Study|Withdrawal by Subject|15|||
164579943|NCT00091793|594490084|FG000|Overall Study|Ineligibility determined|2|||
164579944|NCT00091793|594490085|FG001|Overall Study|Ineligibility determined|0|||
164684791|NCT05151471|594868131|FG001|Overall Study|Adverse Event|16|||
164684792|NCT05151471|594868130|FG000|Overall Study|Death|1|||
164684793|NCT05151471|594868131|FG001|Overall Study|Death|0|||
164684794|NCT05151471|594868130|FG000|Overall Study|Lost to Follow-up|0|||
164684795|NCT05151471|594868131|FG001|Overall Study|Lost to Follow-up|1|||
164684796|NCT05151471|594868130|FG000|Overall Study|Withdrawal by Subject|7|||
164579945|NCT00091793|594490084|FG000|Overall Study|Lost to Follow-up|7|||
164579946|NCT00091793|594490085|FG001|Overall Study|Lost to Follow-up|5|||
164579947|NCT00091793|594490084|FG000|Overall Study|Noncompliance|2|||
164579948|NCT00091793|594490085|FG001|Overall Study|Noncompliance|0|||
164579949|NCT00091793|594490084|FG000|Overall Study|Other|2|||
164579950|NCT00091793|594490085|FG001|Overall Study|Other|0|||
164579951|NCT02424149|594490089|FG000|Overall Study|surgery cancelled|2|||
164579952|NCT02424149|594490090|FG001|Overall Study|surgery cancelled|0|||
164579953|NCT02424149|594490089|FG000|Overall Study|Withdrawal by Subject|0|||
164579954|NCT02424149|594490090|FG001|Overall Study|Withdrawal by Subject|1|||
164579955|NCT05309083|594490091|FG000|Overall Study|Withdrawal by Subject|2|||
164579956|NCT01238120|594490092|FG000|Overall Study|Withdrawal by Subject|4|||
164579957|NCT01238120|594490093|FG001|Overall Study|Withdrawal by Subject|1|||
164579958|NCT01238120|594490094|FG002|Overall Study|Withdrawal by Subject|2|||
164579959|NCT01238120|594490095|FG003|Overall Study|Withdrawal by Subject|5|||
164684797|NCT05151471|594868131|FG001|Overall Study|Withdrawal by Subject|9|||
164684798|NCT05151471|594868130|FG000|Overall Study|Study terminated by sponsor|49|||
164684799|NCT05151471|594868131|FG001|Overall Study|Study terminated by sponsor|47|||
164579960|NCT01238120|594490092|FG000|Overall Study|Lost to Follow-up|2|||
164579961|NCT01238120|594490093|FG001|Overall Study|Lost to Follow-up|0|||
164579962|NCT01238120|594490094|FG002|Overall Study|Lost to Follow-up|1|||
164579963|NCT01238120|594490095|FG003|Overall Study|Lost to Follow-up|1|||
164579964|NCT01238120|594490092|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
164579965|NCT01238120|594490093|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
164579966|NCT01238120|594490094|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
164579967|NCT01238120|594490095|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
164579968|NCT02498652|594490099|FG000|Overall Study|Protocol Violation|0|||
164579969|NCT02498652|594490100|FG001|Overall Study|Protocol Violation|1|||
164579970|NCT02388776|594490103|FG000|Overall Study|Death|1|||
164579971|NCT02388776|594490103|FG000|Overall Study|Lost to Follow-up|1|||
164579972|NCT04222725|594490111|FG000|Overall Study|Adverse Event|0|||
164579973|NCT04222725|594490112|FG001|Overall Study|Adverse Event|1|||
164579974|NCT04222725|594490113|FG002|Overall Study|Adverse Event|0|||
164579975|NCT04222725|594490114|FG003|Overall Study|Adverse Event|0|||
164579976|NCT00104871|594490115|FG000|Overall Study|Not evaluable|1|||
164579977|NCT01476787|594490121|FG000|Treatment|Progression|64|||
164579978|NCT01476787|594490122|FG001|Treatment|Progression|71|||
164579979|NCT01476787|594490121|FG000|Treatment|Toxicity|44|||
164579980|NCT01476787|594490122|FG001|Treatment|Toxicity|16|||
164579981|NCT01476787|594490121|FG000|Treatment|Death|0|||
164579982|NCT01476787|594490122|FG001|Treatment|Death|1|||
164579983|NCT01476787|594490121|FG000|Treatment|Withdrawal by Subject|3|||
164579984|NCT01476787|594490122|FG001|Treatment|Withdrawal by Subject|14|||
164579985|NCT01476787|594490121|FG000|Treatment|Major protocol violation|1|||
164579986|NCT01476787|594490122|FG001|Treatment|Major protocol violation|6|||
164579987|NCT01476787|594490121|FG000|Treatment|Other reasons|10|||
164579988|NCT01476787|594490122|FG001|Treatment|Other reasons|22|||
164579989|NCT01476787|594490121|FG000|Treatment|Concurrent illness|12|||
164579990|NCT01476787|594490122|FG001|Treatment|Concurrent illness|9|||
164579991|NCT01476787|594490121|FG000|Treatment|Insufficient response|15|||
164579992|NCT01476787|594490122|FG001|Treatment|Insufficient response|3|||
164579993|NCT01476787|594490121|FG000|Treatment|Voluntary treatment discontinuation|8|||
164579994|NCT01476787|594490122|FG001|Treatment|Voluntary treatment discontinuation|4|||
164579995|NCT02234622|594490128|FG000|Overall Study|Withdrawal by Subject|16|||
164684800|NCT05151471|594868130|FG000|Overall Study|Other|2|||
164684801|NCT05151471|594868131|FG001|Overall Study|Other|1|||
164684802|NCT00396162|594868136|FG000|Overall Study|Withdrawal by Subject|2|||
164579996|NCT02234622|594490129|FG001|Overall Study|Withdrawal by Subject|22|||
164579997|NCT02234622|594490128|FG000|Overall Study|Lost to Follow-up|27|||
164579998|NCT02234622|594490129|FG001|Overall Study|Lost to Follow-up|14|||
164684803|NCT00396162|594868137|FG001|Overall Study|Withdrawal by Subject|3|||
164684804|NCT02694536|594868138|FG000|Overall Study|Progressive Disease|40|||
164684805|NCT02694536|594868138|FG000|Overall Study|Lost to Follow-up|1|||
164579999|NCT00144300|594490130|FG000|Overall Study|Adverse Event|18|||
164580000|NCT00144300|594490131|FG001|Overall Study|Adverse Event|16|||
164580001|NCT00144300|594490130|FG000|Overall Study|Protocol Violation|1|||
164580002|NCT00144300|594490131|FG001|Overall Study|Protocol Violation|3|||
164580003|NCT00144300|594490130|FG000|Overall Study|Lost to Follow-up|3|||
164580004|NCT00144300|594490131|FG001|Overall Study|Lost to Follow-up|0|||
164580005|NCT00144300|594490130|FG000|Overall Study|Withdrawal by Subject|6|||
164580006|NCT00144300|594490131|FG001|Overall Study|Withdrawal by Subject|6|||
164580007|NCT00144300|594490130|FG000|Overall Study|Other reason (not specified)|1|||
164684806|NCT02694536|594868138|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
164684807|NCT02694536|594868138|FG000|Overall Study|Withdrawal by Subject|8|||
164265143|NCT04068519|593338834|FG000|Indication Expansion|Withdrawal by Subject|10|||
164265144|NCT04068519|593338834|FG000|Indication Expansion|Lost to Follow-up|7|||
164265145|NCT00969761|593338835|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
164684808|NCT02694536|594868138|FG000|Overall Study|Death|8|||
164684809|NCT02694536|594868138|FG000|Overall Study|Other|22|||
164684810|NCT01741545|594868139|FG000|Treatment Period|Lack of Efficacy|0|||
164684811|NCT01741545|594868140|FG001|Treatment Period|Lack of Efficacy|1|||
164684812|NCT01741545|594868139|FG000|Treatment Period|Adverse event, non-fatal|1|||
164684813|NCT01741545|594868140|FG001|Treatment Period|Adverse event, non-fatal|3|||
164684814|NCT01741545|594868139|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
164684815|NCT01741545|594868140|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
164684816|NCT01741545|594868139|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
164684817|NCT01741545|594868140|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
164684818|NCT01911429|594868141|FG000|Overall Study|Adverse Event|5|||
164684819|NCT01911429|594868142|FG001|Overall Study|Adverse Event|3|||
164684820|NCT01911429|594868143|FG002|Overall Study|Adverse Event|9|||
164684821|NCT01911429|594868141|FG000|Overall Study|Lack of Efficacy|1|||
164684822|NCT01911429|594868142|FG001|Overall Study|Lack of Efficacy|2|||
164684823|NCT01911429|594868143|FG002|Overall Study|Lack of Efficacy|4|||
164684824|NCT01911429|594868141|FG000|Overall Study|Lost to Follow-up|0|||
164684825|NCT01911429|594868142|FG001|Overall Study|Lost to Follow-up|0|||
164684826|NCT01911429|594868143|FG002|Overall Study|Lost to Follow-up|1|||
164684827|NCT01911429|594868141|FG000|Overall Study|Protocol Violation|0|||
164684828|NCT01911429|594868142|FG001|Overall Study|Protocol Violation|0|||
164684829|NCT01911429|594868143|FG002|Overall Study|Protocol Violation|1|||
164684830|NCT01911429|594868141|FG000|Overall Study|Withdrawal by Subject|5|||
164684831|NCT01911429|594868142|FG001|Overall Study|Withdrawal by Subject|5|||
164684832|NCT01911429|594868143|FG002|Overall Study|Withdrawal by Subject|4|||
164684833|NCT01911429|594868141|FG000|Overall Study|Accidental randomization|0|||
164684834|NCT01911429|594868142|FG001|Overall Study|Accidental randomization|0|||
164684835|NCT01911429|594868143|FG002|Overall Study|Accidental randomization|1|||
164684836|NCT01911429|594868141|FG000|Overall Study|subject left study|1|||
164684837|NCT01911429|594868142|FG001|Overall Study|subject left study|0|||
164684838|NCT01911429|594868143|FG002|Overall Study|subject left study|0|||
164684839|NCT01664039|594868147|FG000|Overall Study|Adverse Event|3|||
164684840|NCT01664039|594868148|FG001|Overall Study|Adverse Event|4|||
164684841|NCT01664039|594868147|FG000|Overall Study|Lost to Follow-up|1|||
164684842|NCT01664039|594868148|FG001|Overall Study|Lost to Follow-up|1|||
164684843|NCT01664039|594868147|FG000|Overall Study|Withdrawal by Subject|1|||
164684844|NCT01664039|594868148|FG001|Overall Study|Withdrawal by Subject|3|||
164684845|NCT01664039|594868147|FG000|Overall Study|Noncompliance|1|||
164684846|NCT01664039|594868148|FG001|Overall Study|Noncompliance|1|||
164684847|NCT01853176|594868149|FG000|Overall Study|Study terminated|4|||
164684848|NCT01853176|594868150|FG001|Overall Study|Study terminated|0|||
164684849|NCT02276885|594868151|FG000|Overall Study|Withdrawal by Subject|2|||
164684850|NCT02276885|594868152|FG001|Overall Study|Withdrawal by Subject|0|||
164684851|NCT02276885|594868151|FG000|Overall Study|Lost to Follow-up|5|||
164684852|NCT02276885|594868152|FG001|Overall Study|Lost to Follow-up|2|||
164684853|NCT05029687|594868158|FG000|Overall Study|Withdrawal by Subject|4|||
164684854|NCT05029687|594868159|FG001|Overall Study|Withdrawal by Subject|0|||
164684855|NCT05029687|594868160|FG002|Overall Study|Withdrawal by Subject|2|||
164684856|NCT05029687|594868158|FG000|Overall Study|Lost to Follow-up|4|||
164684857|NCT05029687|594868159|FG001|Overall Study|Lost to Follow-up|0|||
164684858|NCT05029687|594868160|FG002|Overall Study|Lost to Follow-up|2|||
164684859|NCT00958724|594868161|FG000|Overall Study|Disease Progression|6|||
164684860|NCT04442503|594868162|FG000|Overall Study|Adverse Event|1|||
164684861|NCT04442503|594868163|FG001|Overall Study|Adverse Event|1|||
164684862|NCT04442503|594868162|FG000|Overall Study|Lost to Follow-up|8|||
164684863|NCT04442503|594868163|FG001|Overall Study|Lost to Follow-up|6|||
164684864|NCT04442503|594868162|FG000|Overall Study|Physician Decision|0|||
164684865|NCT04442503|594868163|FG001|Overall Study|Physician Decision|2|||
164684866|NCT04442503|594868162|FG000|Overall Study|Withdrawal by Subject|3|||
164684867|NCT04442503|594868163|FG001|Overall Study|Withdrawal by Subject|4|||
164684868|NCT04442503|594868162|FG000|Overall Study|Reason not Specified|0|||
164684869|NCT04442503|594868163|FG001|Overall Study|Reason not Specified|1|||
164684870|NCT04442503|594868162|FG000|Overall Study|Randomized but not Treated|3|||
164684871|NCT04442503|594868163|FG001|Overall Study|Randomized but not Treated|1|||
164684872|NCT05034874|594868170|FG000|Overall Study|Withdrawal by Subject|6|||
164684873|NCT05034874|594868171|FG001|Overall Study|Withdrawal by Subject|6|||
164684874|NCT05034874|594868170|FG000|Overall Study|Lost to Follow-up|18|||
164684875|NCT05034874|594868171|FG001|Overall Study|Lost to Follow-up|8|||
164684876|NCT05034874|594868170|FG000|Overall Study|Physician Decision|0|||
164684877|NCT05034874|594868171|FG001|Overall Study|Physician Decision|1|||
164684878|NCT05034874|594868170|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
164684879|NCT05034874|594868171|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
164684880|NCT00474058|594868172|FG000|Overall Study|Adverse Event|11|||
164684881|NCT00474058|594868173|FG001|Overall Study|Adverse Event|6|||
164684882|NCT00474058|594868172|FG000|Overall Study|Lack of Efficacy|0|||
164684883|NCT00474058|594868173|FG001|Overall Study|Lack of Efficacy|4|||
164684884|NCT00474058|594868172|FG000|Overall Study|Withdrawal by Subject|11|||
164684885|NCT00474058|594868173|FG001|Overall Study|Withdrawal by Subject|7|||
164684886|NCT00474058|594868172|FG000|Overall Study|Other|2|||
164684887|NCT00474058|594868173|FG001|Overall Study|Other|0|||
164684888|NCT03101358|594868174|FG000|Overall Study|Non-compliance with study schedule|1|||
164684889|NCT03101358|594868175|FG001|Overall Study|Non-compliance with study schedule|0|||
164684890|NCT03101358|594868176|FG002|Overall Study|Non-compliance with study schedule|0|||
164684891|NCT03101358|594868177|FG003|Overall Study|Non-compliance with study schedule|1|||
164684892|NCT03101358|594868174|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
164684893|NCT03101358|594868175|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
164265146|NCT00969761|593338836|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
164265147|NCT00969761|593338837|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
164265148|NCT00969761|593338838|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
164341505|NCT03298867|593625420|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
164341506|NCT03298867|593625421|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
164341507|NCT03298867|593625420|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
164341508|NCT03298867|593625421|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
164341509|NCT03298867|593625420|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
164341510|NCT03298867|593625421|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
164341511|NCT03298867|593625420|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
164341512|NCT03298867|593625421|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
164341513|NCT00300274|593625422|FG000|Overall Study|Withdrawal by Subject|12|||
164341514|NCT00300274|593625423|FG001|Overall Study|Withdrawal by Subject|3|||
164341515|NCT00300274|593625424|FG002|Overall Study|Withdrawal by Subject|14|||
164341516|NCT00300274|593625422|FG000|Overall Study|Lost to Follow-up|3|||
164341517|NCT00300274|593625423|FG001|Overall Study|Lost to Follow-up|4|||
164341518|NCT00300274|593625424|FG002|Overall Study|Lost to Follow-up|5|||
164341519|NCT00300274|593625422|FG000|Overall Study|Death|31|||
164341520|NCT00300274|593625423|FG001|Overall Study|Death|20|||
164341521|NCT00300274|593625424|FG002|Overall Study|Death|25|||
164341522|NCT00300274|593625422|FG000|Overall Study|Re-transplant|0|||
164341523|NCT00300274|593625423|FG001|Overall Study|Re-transplant|0|||
164341524|NCT00300274|593625424|FG002|Overall Study|Re-transplant|1|||
164341525|NCT06934993|593625439|FG000|Overall Study|Withdrawal by Subject|29|||
164341526|NCT06934993|593625439|FG000|Overall Study|elevated postoperative creatinine level|11|||
164341527|NCT06934993|593625439|FG000|Overall Study|Death|3|||
164341528|NCT01218113|593627424|FG000|Overall Study|Withdrawal by Subject|1|||
164341529|NCT01218113|593627425|FG001|Overall Study|Withdrawal by Subject|0|||
164341530|NCT01218113|593627426|FG002|Overall Study|Withdrawal by Subject|1|||
164341531|NCT01218113|593627424|FG000|Overall Study|Lost to Follow-up|4|||
164341532|NCT01218113|593627425|FG001|Overall Study|Lost to Follow-up|1|||
164341533|NCT01218113|593627426|FG002|Overall Study|Lost to Follow-up|4|||
164341534|NCT01218113|593627424|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
164341535|NCT01218113|593627425|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
164341536|NCT01218113|593627426|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
164341537|NCT01385566|593627430|FG000|Overall Study|Lost to Follow-up|1|||
164341538|NCT01385566|593627431|FG001|Overall Study|Lost to Follow-up|0|||
164341539|NCT01385566|593627432|FG002|Overall Study|Lost to Follow-up|0|||
164341540|NCT01385566|593627433|FG003|Overall Study|Lost to Follow-up|0|||
164341541|NCT01385566|593627434|FG004|Overall Study|Lost to Follow-up|0|||
164684894|NCT03101358|594868176|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
164684895|NCT03101358|594868177|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
164265149|NCT00969761|593338839|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
164265150|NCT00969761|593338840|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
164265151|NCT00969761|593338841|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
164265152|NCT00969761|593338842|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
164265153|NCT00969761|593338843|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
164265154|NCT00969761|593338844|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
164265155|NCT00969761|593338845|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
164265156|NCT00969761|593338846|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
164341542|NCT01385566|593627435|FG005|Overall Study|Lost to Follow-up|0|||
164341543|NCT01385566|593627430|FG000|Overall Study|Withdrawal by Subject|0|||
164341544|NCT01385566|593627431|FG001|Overall Study|Withdrawal by Subject|0|||
164341545|NCT01385566|593627432|FG002|Overall Study|Withdrawal by Subject|0|||
164341546|NCT01385566|593627433|FG003|Overall Study|Withdrawal by Subject|1|||
164684896|NCT03101358|594868174|FG000|Overall Study|Physician Decision|1|||
164684897|NCT03101358|594868175|FG001|Overall Study|Physician Decision|0|||
164684898|NCT03101358|594868176|FG002|Overall Study|Physician Decision|0|||
164684899|NCT03101358|594868177|FG003|Overall Study|Physician Decision|3|||
164684900|NCT03101358|594868174|FG000|Overall Study|Adverse Event|0|||
164684901|NCT03101358|594868175|FG001|Overall Study|Adverse Event|0|||
164684902|NCT03101358|594868176|FG002|Overall Study|Adverse Event|1|||
164684903|NCT03101358|594868177|FG003|Overall Study|Adverse Event|0|||
164684904|NCT03101358|594868174|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
164684905|NCT03101358|594868175|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
164684906|NCT03101358|594868176|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
164684907|NCT03101358|594868177|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
164684908|NCT03101358|594868174|FG000|Overall Study|Lost to Follow-up|1|||
164684909|NCT03101358|594868175|FG001|Overall Study|Lost to Follow-up|0|||
164684910|NCT03101358|594868176|FG002|Overall Study|Lost to Follow-up|0|||
164684911|NCT03101358|594868177|FG003|Overall Study|Lost to Follow-up|1|||
164684912|NCT02426918|594868178|FG000|Overall Study|Adverse Event|2|||
164684913|NCT02426918|594868179|FG001|Overall Study|Adverse Event|2|||
164684914|NCT02426918|594868180|FG002|Overall Study|Adverse Event|0|||
164684915|NCT02426918|594868178|FG000|Overall Study|Physician Decision|1|||
164684916|NCT02426918|594868179|FG001|Overall Study|Physician Decision|1|||
164684917|NCT02426918|594868180|FG002|Overall Study|Physician Decision|1|||
164684918|NCT02426918|594868178|FG000|Overall Study|Withdrawal by Subject|5|||
164684919|NCT02426918|594868179|FG001|Overall Study|Withdrawal by Subject|5|||
164684920|NCT02426918|594868180|FG002|Overall Study|Withdrawal by Subject|4|||
164684921|NCT02426918|594868178|FG000|Overall Study|Other|9|||
164684922|NCT02426918|594868179|FG001|Overall Study|Other|11|||
164684923|NCT02426918|594868180|FG002|Overall Study|Other|9|||
164684924|NCT02420353|594868183|FG000|Overall Study|Withdrawal by Subject|0|||
164684925|NCT02420353|594868184|FG001|Overall Study|Withdrawal by Subject|1|||
164684926|NCT00503867|594868185|FG000|Overall Study|Lost to Follow-up|1|||
164684927|NCT00503867|594868185|FG000|Overall Study|Adverse Event|1|||
164684928|NCT01149057|594868186|FG000|Overall Study|Lack of Efficacy|16|||
164684929|NCT01149057|594868186|FG000|Overall Study|Adverse Event|13|||
164684930|NCT01149057|594868186|FG000|Overall Study|Withdrawal by Subject|9|||
164580008|NCT00144300|594490131|FG001|Overall Study|Other reason (not specified)|3|||
164580009|NCT01650805|594490132|FG000|Overall Study|Withdrawal by Subject|1|||
164580010|NCT01650805|594490133|FG001|Overall Study|Withdrawal by Subject|0|||
164580011|NCT02403206|594490135|FG000|Overall Study|Lost to Follow-up|4|||
164580012|NCT02403206|594490136|FG001|Overall Study|Lost to Follow-up|3|||
164580013|NCT02403206|594490135|FG000|Overall Study|Physician Decision|2|||
164580014|NCT02403206|594490136|FG001|Overall Study|Physician Decision|0|||
164580015|NCT02403206|594490135|FG000|Overall Study|Withdrawal by Subject|3|||
164580016|NCT02403206|594490136|FG001|Overall Study|Withdrawal by Subject|3|||
164580017|NCT02403206|594490135|FG000|Overall Study|Reason not given|2|||
164580018|NCT02403206|594490136|FG001|Overall Study|Reason not given|4|||
164684931|NCT01149057|594868186|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
164684932|NCT01149057|594868186|FG000|Overall Study|B Cell Depletion|4|||
164684933|NCT01149057|594868186|FG000|Overall Study|Participant Non-Compliance|2|||
164684934|NCT01149057|594868186|FG000|Overall Study|Lost to Follow-up|1|||
164684935|NCT01149057|594868186|FG000|Overall Study|High Parathyroid Hormone Value|1|||
164684936|NCT01149057|594868186|FG000|Overall Study|Other|6|||
164684937|NCT05616728|594868187|FG000|Overall Study|Lost to Follow-up|0|||
164580019|NCT00630032|594490137|FG000|Overall Study|Death|55|||
164580020|NCT00630032|594490138|FG001|Overall Study|Death|49|||
164580021|NCT00630032|594490137|FG000|Overall Study|Withdrawal by Subject|3|||
164580022|NCT00630032|594490138|FG001|Overall Study|Withdrawal by Subject|2|||
164580023|NCT00630032|594490137|FG000|Overall Study|Lost to Follow-up|18|||
164580024|NCT00630032|594490138|FG001|Overall Study|Lost to Follow-up|31|||
164580025|NCT00630032|594490137|FG000|Overall Study|Protocol Violation|1|||
164684938|NCT05616728|594868188|FG001|Overall Study|Lost to Follow-up|0|||
164341547|NCT01385566|593627434|FG004|Overall Study|Withdrawal by Subject|0|||
164341548|NCT01385566|593627435|FG005|Overall Study|Withdrawal by Subject|0|||
164580026|NCT00630032|594490138|FG001|Overall Study|Protocol Violation|0|||
164580027|NCT00630032|594490137|FG000|Overall Study|Patient has moved|1|||
164580028|NCT00630032|594490138|FG001|Overall Study|Patient has moved|1|||
164580029|NCT00630032|594490137|FG000|Overall Study|Disease progression|1|||
164580030|NCT00630032|594490138|FG001|Overall Study|Disease progression|1|||
164341549|NCT00967668|593627436|FG000|Overall Study|Withdrawal by Subject|13|||
164684939|NCT05616728|594868189|FG002|Overall Study|Lost to Follow-up|1|||
164684940|NCT05616728|594868187|FG000|Overall Study|Withdrawal by Subject|1|||
164684941|NCT05616728|594868188|FG001|Overall Study|Withdrawal by Subject|1|||
164684942|NCT05616728|594868189|FG002|Overall Study|Withdrawal by Subject|0|||
164684943|NCT05616728|594868187|FG000|Overall Study|Physician Decision|1|||
164684944|NCT05616728|594868188|FG001|Overall Study|Physician Decision|1|||
164684945|NCT05616728|594868189|FG002|Overall Study|Physician Decision|1|||
164684946|NCT05616728|594868187|FG000|Overall Study|Other|0|||
164580031|NCT00630032|594490137|FG000|Overall Study|End of monitoring in US centers|11|||
164580032|NCT00630032|594490138|FG001|Overall Study|End of monitoring in US centers|11|||
164684947|NCT05616728|594868188|FG001|Overall Study|Other|2|||
164684948|NCT05616728|594868189|FG002|Overall Study|Other|0|||
164684949|NCT03504085|594868194|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
164684950|NCT03504085|594868195|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
164684951|NCT03504085|594868194|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
164684952|NCT03504085|594868195|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
164684953|NCT04133311|594868197|FG000|Period 1 Double Masked Treatment Period|Death|1|||
164684954|NCT04133311|594868198|FG001|Period 1 Double Masked Treatment Period|Death|0|||
164684955|NCT04133311|594868199|FG002|Period 1 Double Masked Treatment Period|Death|0|||
164684956|NCT04133311|594868200|FG003|Period 1 Double Masked Treatment Period|Death|0|||
164684957|NCT04133311|594868197|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
164684958|NCT04133311|594868198|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
164684959|NCT04133311|594868199|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
164684960|NCT04133311|594868200|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
164684961|NCT04133311|594868197|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
164684962|NCT04133311|594868198|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
164684963|NCT04133311|594868199|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
164684964|NCT04133311|594868200|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
164684965|NCT04133311|594868197|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
164684966|NCT04133311|594868198|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
164684967|NCT04133311|594868199|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
164684968|NCT04133311|594868200|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
164684969|NCT04133311|594868197|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
164684970|NCT04133311|594868198|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
164684971|NCT04133311|594868199|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
164684972|NCT04133311|594868200|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
164684973|NCT04133311|594868197|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
164684974|NCT04133311|594868198|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
164684975|NCT04133311|594868199|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
164684976|NCT04133311|594868200|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
164684977|NCT04133311|594868197|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
164684978|NCT04133311|594868198|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
164684979|NCT04133311|594868199|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
164684980|NCT04133311|594868200|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
164684981|NCT04133311|594868197|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
164684982|NCT04133311|594868198|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
164684983|NCT04133311|594868199|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
164684984|NCT04133311|594868200|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
164684985|NCT00728754|594868205|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
164684986|NCT00728754|594868206|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
164684987|NCT00728754|594868205|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
164684988|NCT00728754|594868206|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
164684989|NCT00728754|594868205|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
164684990|NCT00728754|594868206|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
164684991|NCT00295490|594868213|FG000|Overall Study|Protocol Violation|0|||
164684992|NCT00295490|594868214|FG001|Overall Study|Protocol Violation|0|||
164684993|NCT00295490|594868215|FG002|Overall Study|Protocol Violation|3|||
164684994|NCT00295490|594868216|FG003|Overall Study|Protocol Violation|3|||
164684995|NCT00295490|594868213|FG000|Overall Study|Withdrawal by Subject|0|||
164684996|NCT00295490|594868214|FG001|Overall Study|Withdrawal by Subject|2|||
164684997|NCT00295490|594868215|FG002|Overall Study|Withdrawal by Subject|0|||
164684998|NCT00295490|594868216|FG003|Overall Study|Withdrawal by Subject|1|||
164684999|NCT00295490|594868213|FG000|Overall Study|Lost to Follow-up|0|||
164685000|NCT00295490|594868214|FG001|Overall Study|Lost to Follow-up|0|||
164685001|NCT00295490|594868215|FG002|Overall Study|Lost to Follow-up|1|||
164685002|NCT00295490|594868216|FG003|Overall Study|Lost to Follow-up|0|||
164685003|NCT00295490|594868213|FG000|Overall Study|Adverse Event|1|||
164685004|NCT00295490|594868214|FG001|Overall Study|Adverse Event|0|||
164685005|NCT00295490|594868215|FG002|Overall Study|Adverse Event|0|||
164685006|NCT00295490|594868216|FG003|Overall Study|Adverse Event|0|||
164685007|NCT00295490|594868213|FG000|Overall Study|Other|0|||
164341550|NCT00967668|593627437|FG001|Overall Study|Withdrawal by Subject|8|||
164341551|NCT00967668|593627438|FG002|Overall Study|Withdrawal by Subject|8|||
164685008|NCT00295490|594868214|FG001|Overall Study|Other|2|||
164685009|NCT00295490|594868215|FG002|Overall Study|Other|0|||
164685010|NCT00295490|594868216|FG003|Overall Study|Other|1|||
164685011|NCT03255980|594868217|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
164685012|NCT03255980|594868218|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
164685013|NCT03255980|594868219|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
164685014|NCT03255980|594868220|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
164341552|NCT00967668|593627436|FG000|Overall Study|Death|0|||
164685015|NCT03255980|594868217|FG000|Overall Study|Adverse Event|1|||
164685016|NCT03255980|594868218|FG001|Overall Study|Adverse Event|1|||
164685017|NCT03255980|594868219|FG002|Overall Study|Adverse Event|0|||
164685018|NCT03255980|594868220|FG003|Overall Study|Adverse Event|1|||
164685019|NCT03255980|594868217|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
164685020|NCT03255980|594868218|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
164685021|NCT03255980|594868219|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
164685022|NCT03255980|594868220|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
164685023|NCT03255980|594868217|FG000|Overall Study|Lost to Follow-up|1|||
164685024|NCT03255980|594868218|FG001|Overall Study|Lost to Follow-up|1|||
164685025|NCT03255980|594868219|FG002|Overall Study|Lost to Follow-up|0|||
164685026|NCT03255980|594868220|FG003|Overall Study|Lost to Follow-up|3|||
164685027|NCT03255980|594868217|FG000|Overall Study|Withdrawal by Subject|0|||
164685028|NCT03255980|594868218|FG001|Overall Study|Withdrawal by Subject|1|||
164685029|NCT03255980|594868219|FG002|Overall Study|Withdrawal by Subject|0|||
164685030|NCT03255980|594868220|FG003|Overall Study|Withdrawal by Subject|3|||
164685031|NCT01597791|594868221|FG000|Overall Study|Physician Decision|2|||
164685032|NCT01597791|594868222|FG001|Overall Study|Physician Decision|1|||
164685033|NCT01597791|594868221|FG000|Overall Study|Cesarean Section|6|||
164685034|NCT01597791|594868222|FG001|Overall Study|Cesarean Section|7|||
164685035|NCT01597791|594868221|FG000|Overall Study|Subject withdrawal|0|||
164685036|NCT01597791|594868222|FG001|Overall Study|Subject withdrawal|1|||
164685037|NCT01597791|594868221|FG000|Overall Study|Protocol Violation|0|||
164685038|NCT01597791|594868222|FG001|Overall Study|Protocol Violation|1|||
164685039|NCT05468320|594868223|FG000|Overall Study|Other|1|||
164685040|NCT05468320|594868223|FG000|Overall Study|Adverse Event|1|||
164685041|NCT03921554|594868224|FG000|Overall Study|Adverse Event|2|||
164685042|NCT03921554|594868224|FG000|Overall Study|Withdrawal by Subject|1|||
164685043|NCT03921554|594868224|FG000|Overall Study|Death|3|||
164685044|NCT04440592|594868225|FG000|Overall Study|Adverse Event|8|||
164685045|NCT04440592|594868226|FG001|Overall Study|Adverse Event|0|||
164685046|NCT04440592|594868225|FG000|Overall Study|Lost to Follow-up|1|||
164685047|NCT04440592|594868226|FG001|Overall Study|Lost to Follow-up|0|||
164685048|NCT04440592|594868225|FG000|Overall Study|Withdrawal by Subject|1|||
164685049|NCT04440592|594868226|FG001|Overall Study|Withdrawal by Subject|1|||
164685050|NCT04440592|594868225|FG000|Overall Study|Other therapy needed|0|||
164685051|NCT04440592|594868226|FG001|Overall Study|Other therapy needed|1|||
164685052|NCT02957331|594868229|FG000|Overall Study|Protocol Violation|1|||
164685053|NCT02957331|594868230|FG001|Overall Study|Protocol Violation|0|||
164685054|NCT05568615|594870093|FG000|Overall Study|Death|1|||
164265157|NCT00969761|593338835|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
164265158|NCT00969761|593338836|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
164265159|NCT00969761|593338837|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
164265160|NCT00969761|593338838|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
164265161|NCT00969761|593338839|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
164265162|NCT00969761|593338840|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
164265163|NCT00969761|593338841|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
164265164|NCT00969761|593338842|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
164685055|NCT05568615|594870093|FG000|Overall Study|Physician Decision|1|||
164685056|NCT00565851|594870094|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
164685057|NCT00565851|594870095|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
164685058|NCT00565851|594870096|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
164685059|NCT00565851|594870097|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
164685060|NCT00565851|594870098|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
164685061|NCT00565851|594870099|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
164685062|NCT00565851|594870100|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
164685063|NCT00565851|594870101|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
164685064|NCT00565851|594870094|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
164685065|NCT00565851|594870095|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
164685066|NCT00565851|594870096|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
164685067|NCT00565851|594870097|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
164685068|NCT00565851|594870098|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
164685069|NCT00565851|594870099|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
164685070|NCT00565851|594870100|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
164685071|NCT00565851|594870101|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
164685072|NCT01520987|594870111|FG000|Overall Study|Withdrawal by Subject|1|||
164685073|NCT01520987|594870112|FG001|Overall Study|Withdrawal by Subject|0|||
164685074|NCT01520987|594870113|FG002|Overall Study|Withdrawal by Subject|0|||
164685075|NCT01520987|594870114|FG003|Overall Study|Withdrawal by Subject|0|||
164685076|NCT01520987|594870115|FG004|Overall Study|Withdrawal by Subject|0|||
164685077|NCT01520987|594870116|FG005|Overall Study|Withdrawal by Subject|1|||
164685078|NCT01520987|594870117|FG006|Overall Study|Withdrawal by Subject|0|||
164685079|NCT01520987|594870118|FG007|Overall Study|Withdrawal by Subject|0|||
164265165|NCT00969761|593338843|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
164265166|NCT00969761|593338844|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
164265167|NCT00969761|593338845|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
164265168|NCT00969761|593338846|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
164265169|NCT00969761|593338835|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
164265170|NCT00969761|593338836|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
164265171|NCT00969761|593338837|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
164580033|NCT02332915|594490143|FG000|Overall Study|Moved out of region|3|||
164580034|NCT02332915|594490144|FG001|Overall Study|Moved out of region|0|||
164580035|NCT02332915|594490143|FG000|Overall Study|Unrelated illness|1|||
164580036|NCT02332915|594490144|FG001|Overall Study|Unrelated illness|1|||
164580037|NCT02332915|594490143|FG000|Overall Study|Travel distance prohibitive|0|||
164580038|NCT02332915|594490144|FG001|Overall Study|Travel distance prohibitive|1|||
164580039|NCT02332915|594490143|FG000|Overall Study|did not meet inclusion criteria|2|||
164580040|NCT02332915|594490144|FG001|Overall Study|did not meet inclusion criteria|4|||
164580041|NCT04070378|594490148|FG000|Overall Study|Withdrawal by Subject|2|||
164580042|NCT04070378|594490148|FG000|Overall Study|Screen Failure|6|||
164580043|NCT04070378|594490148|FG000|Overall Study|Physician Decision|1|||
164580044|NCT04070378|594490148|FG000|Overall Study|Adverse Event|1|||
164580045|NCT02462889|594490149|FG000|Overall Study|Withdrawal by Subject|2|||
164580046|NCT02462889|594490150|FG001|Overall Study|Withdrawal by Subject|6|||
164580047|NCT02462889|594490149|FG000|Overall Study|Death|1|||
164580048|NCT02462889|594490150|FG001|Overall Study|Death|5|||
164580049|NCT04358458|594490153|FG000|Overall Study|Death|1|||
164580050|NCT04358458|594490154|FG001|Overall Study|Death|1|||
164580051|NCT04358458|594490155|FG002|Overall Study|Death|3|||
164265172|NCT00969761|593338838|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
164265173|NCT00969761|593338839|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
164265174|NCT00969761|593338840|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
164265175|NCT00969761|593338841|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
164265176|NCT00969761|593338842|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
164265177|NCT00969761|593338843|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
164265178|NCT00969761|593338844|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
164265179|NCT00969761|593338845|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
164265180|NCT00969761|593338846|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
164265181|NCT00969761|593338835|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
164265182|NCT00969761|593338836|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
164265183|NCT00969761|593338837|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
164265184|NCT00969761|593338838|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
164265185|NCT00969761|593338839|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
164265186|NCT00969761|593338840|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
164265187|NCT00969761|593338841|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
164265188|NCT00969761|593338842|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
164265189|NCT00969761|593338843|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
164265190|NCT00969761|593338844|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
164265191|NCT00969761|593338845|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
164265192|NCT00969761|593338846|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
164265193|NCT00969761|593338835|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
164265194|NCT00969761|593338836|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
164265195|NCT00969761|593338837|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
164265196|NCT00969761|593338838|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
164265197|NCT00969761|593338839|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
164265198|NCT00969761|593338840|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
164265199|NCT00969761|593338841|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
164265200|NCT00969761|593338842|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
164265201|NCT00969761|593338843|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
164265202|NCT00969761|593338844|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
164265203|NCT00969761|593338845|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
164265204|NCT00969761|593338846|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
164265205|NCT00969761|593338835|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
164265206|NCT00969761|593338836|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
164265207|NCT00969761|593338837|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
164265208|NCT00969761|593338838|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
164341553|NCT00967668|593627437|FG001|Overall Study|Death|2|||
164580052|NCT04358458|594490156|FG003|Overall Study|Death|8|||
164580053|NCT04358458|594490157|FG004|Overall Study|Death|1|||
164580054|NCT04358458|594490158|FG005|Overall Study|Death|6|||
164580055|NCT04358458|594490159|FG006|Overall Study|Death|2|||
164580056|NCT04358458|594490160|FG007|Overall Study|Death|3|||
164580057|NCT04358458|594490153|FG000|Overall Study|Lost to Follow-up|0|||
164580058|NCT04358458|594490154|FG001|Overall Study|Lost to Follow-up|0|||
164580059|NCT04358458|594490155|FG002|Overall Study|Lost to Follow-up|0|||
164580060|NCT04358458|594490156|FG003|Overall Study|Lost to Follow-up|0|||
164580061|NCT04358458|594490157|FG004|Overall Study|Lost to Follow-up|0|||
164580062|NCT04358458|594490158|FG005|Overall Study|Lost to Follow-up|0|||
164580063|NCT04358458|594490159|FG006|Overall Study|Lost to Follow-up|0|||
164580064|NCT04358458|594490160|FG007|Overall Study|Lost to Follow-up|1|||
164580065|NCT04358458|594490153|FG000|Overall Study|Site is closing study participation|0|||
164580066|NCT04358458|594490154|FG001|Overall Study|Site is closing study participation|0|||
164580067|NCT04358458|594490155|FG002|Overall Study|Site is closing study participation|0|||
164580068|NCT04358458|594490156|FG003|Overall Study|Site is closing study participation|1|||
164580069|NCT04358458|594490157|FG004|Overall Study|Site is closing study participation|0|||
164580070|NCT04358458|594490158|FG005|Overall Study|Site is closing study participation|0|||
164580071|NCT04358458|594490159|FG006|Overall Study|Site is closing study participation|0|||
164580072|NCT04358458|594490160|FG007|Overall Study|Site is closing study participation|0|||
164580073|NCT04358458|594490153|FG000|Overall Study|Sponsor request|2|||
164580074|NCT04358458|594490154|FG001|Overall Study|Sponsor request|3|||
164580075|NCT04358458|594490155|FG002|Overall Study|Sponsor request|3|||
164580076|NCT04358458|594490156|FG003|Overall Study|Sponsor request|0|||
164580077|NCT04358458|594490157|FG004|Overall Study|Sponsor request|2|||
164580078|NCT04358458|594490158|FG005|Overall Study|Sponsor request|3|||
164580079|NCT04358458|594490159|FG006|Overall Study|Sponsor request|1|||
164580080|NCT04358458|594490160|FG007|Overall Study|Sponsor request|1|||
164580081|NCT04358458|594490153|FG000|Overall Study|Withdrawal by Subject|0|||
164580082|NCT04358458|594490154|FG001|Overall Study|Withdrawal by Subject|0|||
164580083|NCT04358458|594490155|FG002|Overall Study|Withdrawal by Subject|1|||
164580084|NCT04358458|594490156|FG003|Overall Study|Withdrawal by Subject|1|||
164580085|NCT04358458|594490157|FG004|Overall Study|Withdrawal by Subject|0|||
164580086|NCT04358458|594490158|FG005|Overall Study|Withdrawal by Subject|1|||
164580087|NCT04358458|594490159|FG006|Overall Study|Withdrawal by Subject|0|||
164580088|NCT04358458|594490160|FG007|Overall Study|Withdrawal by Subject|1|||
164580089|NCT04636177|594490161|FG000|Two-arm, randomization portion|Withdrawal by Subject|1|||
164580090|NCT04636177|594490162|FG001|Two-arm, randomization portion|Withdrawal by Subject|1|||
164580091|NCT04636177|594490161|FG000|Two-arm, randomization portion|Lost to Follow-up|0|||
164580092|NCT04636177|594490162|FG001|Two-arm, randomization portion|Lost to Follow-up|1|||
164580093|NCT04636177|594490161|FG000|Single-arm portion|Withdrawal by Subject|1|||
164580094|NCT04636177|594490162|FG001|Single-arm portion|Withdrawal by Subject|0|||
164580095|NCT04636177|594490161|FG000|Single-arm portion|Adverse Event|1|||
164580096|NCT04636177|594490162|FG001|Single-arm portion|Adverse Event|0|||
164580097|NCT05165394|594492276|FG000|Overall Study|Withdrawal by Subject|5|||
164580098|NCT05165394|594492277|FG001|Overall Study|Withdrawal by Subject|1|||
164580099|NCT05165394|594492276|FG000|Overall Study|Lost to Follow-up|1|||
164580100|NCT05165394|594492277|FG001|Overall Study|Lost to Follow-up|2|||
164580101|NCT05165394|594492276|FG000|Overall Study|Other Than Specified|0|||
164580102|NCT05165394|594492277|FG001|Overall Study|Other Than Specified|1|||
164580103|NCT03705494|594492278|FG000|Overall Study|Lost to Follow-up|2|||
164580104|NCT03705494|594492279|FG001|Overall Study|Lost to Follow-up|1|||
164580105|NCT03705494|594492278|FG000|Overall Study|Withdrawal by Subject|5|||
164580106|NCT03705494|594492279|FG001|Overall Study|Withdrawal by Subject|2|||
164580107|NCT02495077|594492280|FG000|Overall Study|Adverse Event|0|||
164580108|NCT02495077|594492281|FG001|Overall Study|Adverse Event|1|||
164580109|NCT02495077|594492282|FG002|Overall Study|Adverse Event|1|||
164580110|NCT02495077|594492283|FG003|Overall Study|Adverse Event|0|||
164580111|NCT02495077|594492280|FG000|Overall Study|Death|3|||
164580112|NCT02495077|594492281|FG001|Overall Study|Death|5|||
164580113|NCT02495077|594492282|FG002|Overall Study|Death|0|||
164580114|NCT02495077|594492283|FG003|Overall Study|Death|0|||
164580115|NCT02495077|594492280|FG000|Overall Study|Lost to Follow-up|6|||
164580116|NCT02495077|594492281|FG001|Overall Study|Lost to Follow-up|4|||
164580117|NCT02495077|594492282|FG002|Overall Study|Lost to Follow-up|0|||
164580118|NCT02495077|594492283|FG003|Overall Study|Lost to Follow-up|0|||
164580119|NCT02495077|594492280|FG000|Overall Study|Physician Decision|2|||
164580120|NCT02495077|594492281|FG001|Overall Study|Physician Decision|1|||
164580121|NCT02495077|594492282|FG002|Overall Study|Physician Decision|4|||
164580122|NCT02495077|594492283|FG003|Overall Study|Physician Decision|0|||
164580123|NCT02495077|594492280|FG000|Overall Study|Protocol Violation|0|||
164685080|NCT02005562|594870119|FG000|Overall Study|Death|2|||
164580124|NCT02495077|594492281|FG001|Overall Study|Protocol Violation|1|||
164580125|NCT02495077|594492282|FG002|Overall Study|Protocol Violation|0|||
164580126|NCT02495077|594492283|FG003|Overall Study|Protocol Violation|0|||
164580127|NCT02495077|594492280|FG000|Overall Study|Screen Failure|0|||
164580128|NCT02495077|594492281|FG001|Overall Study|Screen Failure|0|||
164580129|NCT02495077|594492282|FG002|Overall Study|Screen Failure|0|||
164580130|NCT02495077|594492283|FG003|Overall Study|Screen Failure|48|||
164580131|NCT02495077|594492280|FG000|Overall Study|Withdrawal by Subject|7|||
164580132|NCT02495077|594492281|FG001|Overall Study|Withdrawal by Subject|7|||
164685081|NCT02005562|594870120|FG001|Overall Study|Death|2|||
164685082|NCT02005562|594870119|FG000|Overall Study|Graft loss|7|||
164685083|NCT02005562|594870120|FG001|Overall Study|Graft loss|6|||
164580133|NCT02495077|594492282|FG002|Overall Study|Withdrawal by Subject|7|||
164580134|NCT02495077|594492283|FG003|Overall Study|Withdrawal by Subject|0|||
164580135|NCT02495077|594492280|FG000|Overall Study|Covid-19 research restrictions|1|||
164580136|NCT02495077|594492281|FG001|Overall Study|Covid-19 research restrictions|0|||
164580137|NCT02495077|594492282|FG002|Overall Study|Covid-19 research restrictions|0|||
164580138|NCT02495077|594492283|FG003|Overall Study|Covid-19 research restrictions|0|||
164580139|NCT02495077|594492280|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
164580140|NCT02495077|594492281|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
164580141|NCT02495077|594492282|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
164580142|NCT02495077|594492283|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
164580143|NCT02495077|594492280|FG000|Overall Study|Incarcerated|0|||
164580144|NCT02495077|594492281|FG001|Overall Study|Incarcerated|1|||
164685084|NCT02005562|594870119|FG000|Overall Study|Withdrawal by Subject|2|||
164685085|NCT02005562|594870120|FG001|Overall Study|Withdrawal by Subject|2|||
164685086|NCT02005562|594870119|FG000|Overall Study|No transplant|1|||
164685087|NCT02005562|594870120|FG001|Overall Study|No transplant|4|||
164685088|NCT02005562|594870119|FG000|Overall Study|Physician Decision|0|||
164580145|NCT02495077|594492282|FG002|Overall Study|Incarcerated|0|||
164580146|NCT02495077|594492283|FG003|Overall Study|Incarcerated|0|||
164580147|NCT02495077|594492280|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
164580148|NCT02495077|594492281|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
164580149|NCT02495077|594492282|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
164580150|NCT02495077|594492283|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
164580151|NCT02495077|594492280|FG000|Overall Study|Timing of transplant and randomization|0|||
164580152|NCT02495077|594492281|FG001|Overall Study|Timing of transplant and randomization|0|||
164580153|NCT02495077|594492282|FG002|Overall Study|Timing of transplant and randomization|5|||
164580154|NCT02495077|594492283|FG003|Overall Study|Timing of transplant and randomization|0|||
164580155|NCT02742649|594492284|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
164580156|NCT02742649|594492285|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
164580157|NCT02742649|594492286|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
164580158|NCT02742649|594492287|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
164580159|NCT02742649|594492288|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
164580160|NCT02742649|594492284|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164580161|NCT02742649|594492285|FG001|Double-Blind Treatment Period|Adverse Event|1|||
164580162|NCT02742649|594492286|FG002|Double-Blind Treatment Period|Adverse Event|0|||
164580163|NCT02742649|594492287|FG003|Double-Blind Treatment Period|Adverse Event|0|||
164580164|NCT02742649|594492288|FG004|Double-Blind Treatment Period|Adverse Event|0|||
164580165|NCT02742649|594492284|FG000|Open-Label Period|Lost to Follow-up|0|||
164580166|NCT02742649|594492285|FG001|Open-Label Period|Lost to Follow-up|0|||
164580167|NCT02742649|594492286|FG002|Open-Label Period|Lost to Follow-up|0|||
164580168|NCT02742649|594492287|FG003|Open-Label Period|Lost to Follow-up|0|||
164580169|NCT02742649|594492288|FG004|Open-Label Period|Lost to Follow-up|1|||
164580170|NCT03937986|594492289|FG000|Overall Study|COVID-19 Pandemic|1|||
164580171|NCT02839746|594492290|FG000|Overall Study|Not met selection criteria|12|||
164580172|NCT02082184|594492295|FG000|Overall Study|Adverse Event|1|||
164685089|NCT02005562|594870120|FG001|Overall Study|Physician Decision|1|||
164685090|NCT00660387|594870121|FG000|Overall Study|Adverse Event|1|||
164685091|NCT00660387|594870122|FG001|Overall Study|Adverse Event|2|||
164685092|NCT00660387|594870121|FG000|Overall Study|Lack of Efficacy|0|||
164685093|NCT00660387|594870122|FG001|Overall Study|Lack of Efficacy|1|||
164685094|NCT00660387|594870121|FG000|Overall Study|Protocol Violation|1|||
164685095|NCT00660387|594870122|FG001|Overall Study|Protocol Violation|0|||
164685096|NCT03086135|594870123|FG000|Overall Study|Adverse Event|1|||
164685097|NCT03086135|594870123|FG000|Overall Study|Lost to Follow-up|2|||
164685098|NCT01023061|594870124|FG000|Overall Study|Withdrawal prior to treatment|2|||
164685099|NCT02710214|594870125|FG000|Overall Study|Lost to Follow-up|1|||
164685100|NCT02710214|594870126|FG001|Overall Study|Lost to Follow-up|0|||
164685101|NCT02710214|594870125|FG000|Overall Study|Lack of Efficacy|0|||
164580173|NCT02082184|594492296|FG001|Overall Study|Adverse Event|0|||
164580174|NCT02082184|594492295|FG000|Overall Study|Medical diagnosis|1|||
164685102|NCT02710214|594870126|FG001|Overall Study|Lack of Efficacy|1|||
164685103|NCT02710214|594870125|FG000|Overall Study|Death|0|||
164685104|NCT02710214|594870126|FG001|Overall Study|Death|1|||
164580175|NCT02082184|594492296|FG001|Overall Study|Medical diagnosis|2|||
164580176|NCT02082184|594492295|FG000|Overall Study|Device associated symptoms|5|||
164580177|NCT02082184|594492296|FG001|Overall Study|Device associated symptoms|0|||
164580178|NCT02082184|594492295|FG000|Overall Study|Withdrawal by Subject|3|||
164685105|NCT02832167|594870128|FG000|Treatment Period 1|Disease progression|90|||
164685106|NCT02832167|594870128|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
164685107|NCT02832167|594870128|FG000|Treatment Period 1|Death|2|||
164685108|NCT02832167|594870128|FG000|Treatment Period 1|Study Drug Toxicity|6|||
164685109|NCT02832167|594870128|FG000|Treatment Period 1|Participant request to discontinue|9|||
164685110|NCT02832167|594870128|FG000|Treatment Period 1|No longer meet study criteria|1|||
164685111|NCT02832167|594870128|FG000|Treatment Period 1|Participant withdrew consent|3|||
164685112|NCT02832167|594870128|FG000|Treatment Period 1|Other reasons|6|||
164685113|NCT02832167|594870128|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
164685114|NCT02832167|594870128|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
164685115|NCT02832167|594870128|FG000|Transition From Period 1 to Period 2|Death|2|||
164685116|NCT02832167|594870128|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
164685117|NCT02832167|594870128|FG000|Treatment Period 2|Disease progression|69|||
164685118|NCT02832167|594870128|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
164685119|NCT02832167|594870128|FG000|Treatment Period 2|Maximum clinical benefit|1|||
164685120|NCT02832167|594870128|FG000|Treatment Period 2|Study Drug Toxicity|5|||
164685121|NCT02832167|594870128|FG000|Treatment Period 2|Participant request to discontinue|2|||
164685122|NCT02832167|594870128|FG000|Treatment Period 2|Participant withdrew consent|3|||
164685123|NCT02832167|594870128|FG000|Treatment Period 2|Other reasons|3|||
164685124|NCT01754376|594870129|FG000|Overall Study|Adverse Event|1|||
164685125|NCT01754376|594870129|FG000|Overall Study|Lack of Efficacy|2|||
164685126|NCT04590781|594870130|FG000|Overall Study|Death|0|||
164685127|NCT04590781|594870131|FG001|Overall Study|Death|2|||
164685128|NCT04590781|594870130|FG000|Overall Study|Withdrawal by Subject|2|||
164685129|NCT04590781|594870131|FG001|Overall Study|Withdrawal by Subject|0|||
164685130|NCT00820599|594870133|FG000|Overall Study|Death|129|||
164685131|NCT00820599|594870133|FG000|Overall Study|Withdrawal by Subject|2|||
164685132|NCT03686215|594870134|FG000|Overall Study|Adverse Event|0|||
164685133|NCT03686215|594870135|FG001|Overall Study|Adverse Event|0|||
164685134|NCT03686215|594870136|FG002|Overall Study|Adverse Event|7|||
164685135|NCT03686215|594870134|FG000|Overall Study|Physician Decision|0|||
164685136|NCT03686215|594870135|FG001|Overall Study|Physician Decision|0|||
164685137|NCT03686215|594870136|FG002|Overall Study|Physician Decision|1|||
164685138|NCT03686215|594870134|FG000|Overall Study|Protocol Violation|0|||
164685139|NCT03686215|594870135|FG001|Overall Study|Protocol Violation|0|||
164685140|NCT03686215|594870136|FG002|Overall Study|Protocol Violation|4|||
164685141|NCT03686215|594870134|FG000|Overall Study|Device issue|1|||
164685142|NCT03686215|594870135|FG001|Overall Study|Device issue|0|||
164685143|NCT03686215|594870136|FG002|Overall Study|Device issue|2|||
164685144|NCT01456962|594870143|FG000|Overall Study|Lost to Follow-up|2|||
164685145|NCT01456962|594870144|FG001|Overall Study|Lost to Follow-up|1|||
164685146|NCT02483416|594870145|FG000|Overall Study|Other reason|0|||
164685147|NCT02483416|594870146|FG001|Overall Study|Other reason|1|||
164685148|NCT02483416|594870145|FG000|Overall Study|Treatment stop|3|||
164685149|NCT02483416|594870146|FG001|Overall Study|Treatment stop|0|||
164685150|NCT03387462|594870148|FG000|Overall Study|Lost to Follow-up|1|||
164685151|NCT01460628|594870149|FG000|Overall Study|Adverse Event|3|||
164685152|NCT01460628|594870149|FG000|Overall Study|Withdrawal by Subject|2|||
164685153|NCT00210639|594870154|FG000|Overall Study|Lost to Follow-up|37|||
164685154|NCT00210639|594870155|FG001|Overall Study|Lost to Follow-up|29|||
164685155|NCT00210639|594870154|FG000|Overall Study|Withdrawal by Subject|8|||
164685156|NCT00210639|594870155|FG001|Overall Study|Withdrawal by Subject|1|||
164685157|NCT00210639|594870154|FG000|Overall Study|Other|18|||
164685158|NCT00210639|594870155|FG001|Overall Study|Other|12|||
164685159|NCT05740371|594870170|FG000|Overall Study|Death|1|||
164685160|NCT00874822|594870174|FG000|Overall Study|excluded by criteria|8|||
164685161|NCT02854800|594870175|FG000|Overall Study|Protocol Violation|16|||
164685162|NCT02854800|594870176|FG001|Overall Study|Protocol Violation|11|||
164685163|NCT02854800|594870177|FG002|Overall Study|Protocol Violation|3|||
164685164|NCT02854800|594870175|FG000|Overall Study|Withdrawal by Subject|4|||
164685165|NCT02854800|594870176|FG001|Overall Study|Withdrawal by Subject|2|||
164685166|NCT02854800|594870177|FG002|Overall Study|Withdrawal by Subject|3|||
164685167|NCT01634139|594870179|FG000|Overall Study|Non compliant with protocol|1|||
164685168|NCT01634139|594870180|FG001|Overall Study|Non compliant with protocol|0|||
164685169|NCT01634139|594870181|FG002|Overall Study|Non compliant with protocol|0|||
164685170|NCT01634139|594870179|FG000|Overall Study|Consent withdrawn not due to AE|4|||
164685171|NCT01634139|594870180|FG001|Overall Study|Consent withdrawn not due to AE|3|||
164685172|NCT01634139|594870181|FG002|Overall Study|Consent withdrawn not due to AE|2|||
164685173|NCT01634139|594870179|FG000|Overall Study|Other|4|||
164685174|NCT01634139|594870180|FG001|Overall Study|Other|0|||
164685175|NCT01634139|594870181|FG002|Overall Study|Other|3|||
164685176|NCT01634139|594870179|FG000|Overall Study|Lost to Follow-up|0|||
164685177|NCT01634139|594870180|FG001|Overall Study|Lost to Follow-up|2|||
164685178|NCT01634139|594870181|FG002|Overall Study|Lost to Follow-up|0|||
164685179|NCT01634139|594870179|FG000|Overall Study|Not treated|1|||
164685180|NCT01634139|594870180|FG001|Overall Study|Not treated|1|||
164685181|NCT01634139|594870181|FG002|Overall Study|Not treated|0|||
164685182|NCT02627963|594870187|FG000|Overall Study|Randomized but not treated|2|||
164685183|NCT02627963|594870188|FG001|Overall Study|Randomized but not treated|6|||
164685184|NCT01168856|594870189|FG000|Overall Study|Lost to Follow-up|4|||
164685185|NCT01168856|594870190|FG001|Overall Study|Lost to Follow-up|34|||
164685186|NCT01168856|594870189|FG000|Overall Study|Withdrawal by Subject|6|||
164341554|NCT00967668|593627438|FG002|Overall Study|Death|4|||
164341555|NCT00967668|593627436|FG000|Overall Study|Removed due to behavior|1|||
164341556|NCT00967668|593627437|FG001|Overall Study|Removed due to behavior|1|||
164341557|NCT00967668|593627438|FG002|Overall Study|Removed due to behavior|2|||
164341558|NCT00967668|593627436|FG000|Overall Study|Refused Year 2|11|||
164341559|NCT00967668|593627437|FG001|Overall Study|Refused Year 2|6|||
164341560|NCT00967668|593627438|FG002|Overall Study|Refused Year 2|4|||
164341561|NCT00967668|593627436|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
164341562|NCT00967668|593627437|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
164341563|NCT00967668|593627438|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
164341564|NCT00967668|593627436|FG000|Overall Study|Lost to Follow-up|15|||
164341565|NCT00967668|593627437|FG001|Overall Study|Lost to Follow-up|9|||
164341566|NCT00967668|593627438|FG002|Overall Study|Lost to Follow-up|16|||
164341567|NCT00967668|593627436|FG000|Overall Study|Refused 12-mo assessment|3|||
164341568|NCT00967668|593627437|FG001|Overall Study|Refused 12-mo assessment|1|||
164341569|NCT00967668|593627438|FG002|Overall Study|Refused 12-mo assessment|9|||
164341570|NCT00967668|593627436|FG000|Overall Study|Pregnancy|1|||
164341571|NCT00967668|593627437|FG001|Overall Study|Pregnancy|0|||
164341572|NCT00967668|593627438|FG002|Overall Study|Pregnancy|0|||
164341573|NCT00825682|593627439|FG000|Overall Study|personal reasons/ inconvenience|13|||
164341574|NCT00825682|593627440|FG001|Overall Study|personal reasons/ inconvenience|5|||
164341575|NCT02468674|593627441|FG000|Overall Study|Adverse Event|0|||
164341576|NCT02468674|593627442|FG001|Overall Study|Adverse Event|0|||
164341577|NCT02468674|593627443|FG002|Overall Study|Adverse Event|0|||
164341578|NCT02468674|593627444|FG003|Overall Study|Adverse Event|1|||
164341579|NCT02468674|593627445|FG004|Overall Study|Adverse Event|0|||
164341580|NCT02468674|593627446|FG005|Overall Study|Adverse Event|1|||
164341581|NCT02468674|593627447|FG006|Overall Study|Adverse Event|0|||
164341582|NCT02468674|593627448|FG007|Overall Study|Adverse Event|0|||
164341583|NCT02468674|593627449|FG008|Overall Study|Adverse Event|0|||
164341584|NCT02468674|593627441|FG000|Overall Study|Lost to Follow-up|1|||
164341585|NCT02468674|593627442|FG001|Overall Study|Lost to Follow-up|0|||
164341586|NCT02468674|593627443|FG002|Overall Study|Lost to Follow-up|0|||
164341587|NCT02468674|593627444|FG003|Overall Study|Lost to Follow-up|0|||
164341588|NCT02468674|593627445|FG004|Overall Study|Lost to Follow-up|0|||
164341589|NCT02468674|593627446|FG005|Overall Study|Lost to Follow-up|0|||
164341590|NCT02468674|593627447|FG006|Overall Study|Lost to Follow-up|0|||
164341591|NCT02468674|593627448|FG007|Overall Study|Lost to Follow-up|1|||
164341592|NCT02468674|593627449|FG008|Overall Study|Lost to Follow-up|1|||
164341593|NCT02468674|593627441|FG000|Overall Study|Physician Decision|0|||
164341594|NCT02468674|593627442|FG001|Overall Study|Physician Decision|0|||
164341595|NCT02468674|593627443|FG002|Overall Study|Physician Decision|0|||
164341596|NCT02468674|593627444|FG003|Overall Study|Physician Decision|0|||
164341597|NCT02468674|593627445|FG004|Overall Study|Physician Decision|0|||
164341598|NCT02468674|593627446|FG005|Overall Study|Physician Decision|0|||
164341599|NCT02468674|593627447|FG006|Overall Study|Physician Decision|1|||
164341600|NCT02468674|593627448|FG007|Overall Study|Physician Decision|0|||
164341601|NCT02468674|593627449|FG008|Overall Study|Physician Decision|0|||
164580179|NCT02082184|594492296|FG001|Overall Study|Withdrawal by Subject|2|||
164580180|NCT02082184|594492295|FG000|Overall Study|Protocol Violation|0|||
164580181|NCT02082184|594492296|FG001|Overall Study|Protocol Violation|6|||
164580182|NCT02082184|594492295|FG000|Overall Study|Lost to Follow-up|0|||
164580183|NCT02082184|594492296|FG001|Overall Study|Lost to Follow-up|2|||
164580184|NCT02082184|594492295|FG000|Overall Study|Subject non-compliance|0|||
164580185|NCT02082184|594492296|FG001|Overall Study|Subject non-compliance|1|||
164580186|NCT01943539|594492299|FG000|Overall Study|Non-compliance with at-home intervention|4|||
164580187|NCT01943539|594492300|FG001|Overall Study|Non-compliance with at-home intervention|0|||
164580188|NCT02333331|594492301|FG000|Overall Study|Adverse Event|1|||
164580189|NCT02333331|594492302|FG001|Overall Study|Adverse Event|0|||
164580190|NCT02333331|594492303|FG002|Overall Study|Adverse Event|4|||
164580191|NCT02333331|594492304|FG003|Overall Study|Adverse Event|1|||
164580192|NCT02333331|594492301|FG000|Overall Study|Death|0|||
164580193|NCT02333331|594492302|FG001|Overall Study|Death|0|||
164341602|NCT02468674|593627441|FG000|Overall Study|Patient/Guardian Decision|0|||
164341603|NCT02468674|593627442|FG001|Overall Study|Patient/Guardian Decision|0|||
164341604|NCT02468674|593627443|FG002|Overall Study|Patient/Guardian Decision|0|||
164341605|NCT02468674|593627444|FG003|Overall Study|Patient/Guardian Decision|0|||
164341606|NCT02468674|593627445|FG004|Overall Study|Patient/Guardian Decision|1|||
164341607|NCT02468674|593627446|FG005|Overall Study|Patient/Guardian Decision|0|||
164341608|NCT02468674|593627447|FG006|Overall Study|Patient/Guardian Decision|0|||
164341609|NCT02468674|593627448|FG007|Overall Study|Patient/Guardian Decision|2|||
164341610|NCT02468674|593627449|FG008|Overall Study|Patient/Guardian Decision|1|||
164341611|NCT02468674|593627441|FG000|Overall Study|Protocol Deviation|0|||
164341612|NCT02468674|593627442|FG001|Overall Study|Protocol Deviation|0|||
164341613|NCT02468674|593627443|FG002|Overall Study|Protocol Deviation|0|||
164580194|NCT02333331|594492303|FG002|Overall Study|Death|2|||
164580195|NCT02333331|594492304|FG003|Overall Study|Death|0|||
164580196|NCT02333331|594492301|FG000|Overall Study|Lost to Follow-up|0|||
164341614|NCT02468674|593627444|FG003|Overall Study|Protocol Deviation|0|||
164341615|NCT02468674|593627445|FG004|Overall Study|Protocol Deviation|0|||
164685187|NCT01168856|594870190|FG001|Overall Study|Withdrawal by Subject|8|||
164685188|NCT01168856|594870189|FG000|Overall Study|Physician Decision|2|||
164685189|NCT01168856|594870190|FG001|Overall Study|Physician Decision|1|||
164685190|NCT01168856|594870189|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
164685191|NCT01168856|594870190|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
164685192|NCT01168856|594870189|FG000|Overall Study|Participant received anti-HCV treatment|1|||
164685193|NCT01168856|594870190|FG001|Overall Study|Participant received anti-HCV treatment|0|||
164685194|NCT01168856|594870189|FG000|Overall Study|Death|0|||
164685195|NCT01168856|594870190|FG001|Overall Study|Death|2|||
164685196|NCT01168856|594870189|FG000|Overall Study|Other|1|||
164685197|NCT01168856|594870190|FG001|Overall Study|Other|291|||
164685198|NCT01168856|594870189|FG000|Overall Study|Protocol Violation|4|||
164685199|NCT01168856|594870190|FG001|Overall Study|Protocol Violation|6|||
164685200|NCT05562011|594870191|FG000|Overall Study|Withdrawal by Subject|3|||
164685201|NCT05562011|594870191|FG000|Overall Study|Lost to Follow-up|1|||
164685202|NCT05562011|594870191|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
164685203|NCT05562011|594870191|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
164685204|NCT05562011|594870191|FG000|Overall Study|Device malfunction|13|||
164685205|NCT03073798|594870192|FG000|Overall Study|Adverse Event|1|||
164580197|NCT02333331|594492302|FG001|Overall Study|Lost to Follow-up|0|||
164580198|NCT02333331|594492303|FG002|Overall Study|Lost to Follow-up|1|||
164580199|NCT02333331|594492304|FG003|Overall Study|Lost to Follow-up|0|||
164580200|NCT02333331|594492301|FG000|Overall Study|Physician Decision|0|||
164685206|NCT03073798|594870192|FG000|Overall Study|Withdrawal by Subject|1|||
164685207|NCT04411680|594870197|FG000|Treatment Period|Adverse Event|3|||
164685208|NCT04411680|594870198|FG001|Treatment Period|Adverse Event|0|||
164685209|NCT04411680|594870197|FG000|Treatment Period|Discharged from hospital|18|||
164685210|NCT04411680|594870198|FG001|Treatment Period|Discharged from hospital|7|||
164685211|NCT04411680|594870197|FG000|Treatment Period|Missed 1 or more doses|8|||
164685212|NCT04411680|594870198|FG001|Treatment Period|Missed 1 or more doses|0|||
164685213|NCT04411680|594870197|FG000|Treatment Period|Transferred to another hospital|0|||
164685214|NCT04411680|594870198|FG001|Treatment Period|Transferred to another hospital|1|||
164685215|NCT04411680|594870197|FG000|Follow up Period|Withdrawal by Subject|2|||
164685216|NCT04411680|594870198|FG001|Follow up Period|Withdrawal by Subject|0|||
164685217|NCT04411680|594870197|FG000|Follow up Period|Lost to Follow-up|5|||
164685218|NCT04411680|594870198|FG001|Follow up Period|Lost to Follow-up|6|||
164685219|NCT04411680|594870197|FG000|Follow up Period|Death|11|||
164685220|NCT04411680|594870198|FG001|Follow up Period|Death|8|||
164685221|NCT05278858|594870199|FG000|Overall Study|Withdrawal by Subject|1|||
164685222|NCT00840658|594870200|FG000|Overall Study|Death|2|||
164685223|NCT00840658|594870201|FG001|Overall Study|Death|2|||
164685224|NCT00840658|594870202|FG002|Overall Study|Death|3|||
164685225|NCT00840658|594870203|FG003|Overall Study|Death|3|||
164685226|NCT00840658|594870200|FG000|Overall Study|Lost to Follow-up|3|||
164685227|NCT00840658|594870201|FG001|Overall Study|Lost to Follow-up|1|||
164685228|NCT00840658|594870202|FG002|Overall Study|Lost to Follow-up|2|||
164685229|NCT00840658|594870203|FG003|Overall Study|Lost to Follow-up|1|||
164685230|NCT01867658|594870204|FG000|Overall Study|Withdrawal by Subject|6|||
164685231|NCT01867658|594870204|FG000|Overall Study|Death|2|||
164685232|NCT01867658|594870204|FG000|Overall Study|Subject could not be contacted|1|||
164685233|NCT02640235|594870205|FG000|Overall Study|Withdrawal by Subject|7|||
164685234|NCT02640235|594870206|FG001|Overall Study|Withdrawal by Subject|6|||
164685235|NCT02640235|594870205|FG000|Overall Study|Lost to Follow-up|4|||
164685236|NCT02640235|594870206|FG001|Overall Study|Lost to Follow-up|3|||
164685237|NCT02640235|594870205|FG000|Overall Study|Death|2|||
164685238|NCT02640235|594870206|FG001|Overall Study|Death|3|||
164685239|NCT02640235|594870205|FG000|Overall Study|Other|1|||
164685240|NCT02640235|594870206|FG001|Overall Study|Other|2|||
164685241|NCT02372006|594870209|FG000|Overall Study|Progressive disease|8|||
164685242|NCT02372006|594870210|FG001|Overall Study|Progressive disease|7|||
164685243|NCT02372006|594870211|FG002|Overall Study|Progressive disease|34|||
164685244|NCT02372006|594870209|FG000|Overall Study|Dose limiting toxicity|0|||
164685245|NCT02372006|594870210|FG001|Overall Study|Dose limiting toxicity|1|||
164685246|NCT02372006|594870211|FG002|Overall Study|Dose limiting toxicity|0|||
164341616|NCT02468674|593627446|FG005|Overall Study|Protocol Deviation|0|||
164580201|NCT02333331|594492302|FG001|Overall Study|Physician Decision|1|||
164580202|NCT02333331|594492303|FG002|Overall Study|Physician Decision|0|||
164580203|NCT02333331|594492304|FG003|Overall Study|Physician Decision|0|||
164580204|NCT02333331|594492301|FG000|Overall Study|Protocol Deviation|0|||
164580205|NCT02333331|594492302|FG001|Overall Study|Protocol Deviation|3|||
164685247|NCT02372006|594870209|FG000|Overall Study|Adverse Event|0|||
164685248|NCT02372006|594870210|FG001|Overall Study|Adverse Event|0|||
164685249|NCT02372006|594870211|FG002|Overall Study|Adverse Event|3|||
164580206|NCT02333331|594492303|FG002|Overall Study|Protocol Deviation|2|||
164580207|NCT02333331|594492304|FG003|Overall Study|Protocol Deviation|1|||
164685250|NCT02372006|594870209|FG000|Overall Study|Withdrawal by Subject|0|||
164430316|NCT02753530|593945361|FG000|Overall Study|Withdrawal by Subject|4|||
164430317|NCT02753530|593945362|FG001|Overall Study|Withdrawal by Subject|3|||
164430318|NCT03590743|593945364|FG000|Overall Study|Withdrawal by Subject|0|||
164430319|NCT03590743|593945365|FG001|Overall Study|Withdrawal by Subject|1|||
164430320|NCT00604786|593945366|FG000|Overall Study|Lost to Follow-up|2|||
164430321|NCT00604786|593945367|FG001|Overall Study|Lost to Follow-up|0|||
164430322|NCT03369951|593945368|FG000|Overall Study|Withdrawal by Subject|3|||
164430323|NCT03369951|593945368|FG000|Overall Study|Death|1|||
164430324|NCT03369951|593945368|FG000|Overall Study|Lost to Follow-up|1|||
164430325|NCT03369951|593945368|FG000|Overall Study|Protocol Violation|1|||
164430326|NCT03677375|593945369|FG000|Overall Study|Incomplete procedure|8|||
164430327|NCT03677375|593945369|FG000|Overall Study|Adverse Event|3|||
164430328|NCT03677375|593945369|FG000|Overall Study|Physician Decision|1|||
164430329|NCT00725010|593945375|FG000|Overall Study|Toxicity|9|||
164430330|NCT00725010|593945375|FG000|Overall Study|Tumor Progression|7|||
164430331|NCT00725010|593945375|FG000|Overall Study|Withdrawal by Subject|2|||
164430332|NCT00725010|593945375|FG000|Overall Study|Death|1|||
164685251|NCT02372006|594870210|FG001|Overall Study|Withdrawal by Subject|1|||
164685252|NCT02372006|594870211|FG002|Overall Study|Withdrawal by Subject|1|||
164685253|NCT02372006|594870209|FG000|Overall Study|Other reason for not completing|0|||
164685254|NCT02372006|594870210|FG001|Overall Study|Other reason for not completing|0|||
164685255|NCT02372006|594870211|FG002|Overall Study|Other reason for not completing|1|||
164685256|NCT01859598|594870212|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
164430333|NCT00725010|593945375|FG000|Overall Study|Lost to Follow-up|1|||
164430334|NCT00725010|593945375|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
164430335|NCT00725010|593945375|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
164430336|NCT00725010|593945375|FG000|Overall Study|No further documentation|1|||
164430337|NCT00725010|593945375|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
164430338|NCT00819910|593945376|FG000|Overall Study|Adverse Event|0|||
164430339|NCT00819910|593945377|FG001|Overall Study|Adverse Event|0|||
164430340|NCT00819910|593945378|FG002|Overall Study|Adverse Event|2|||
164430341|NCT00819910|593945379|FG003|Overall Study|Adverse Event|1|||
164430342|NCT00819910|593945376|FG000|Overall Study|Withdrawal by Subject|1|||
164685257|NCT00009945|594870213|FG000|Overall Study|no follow up data|7|||
164685258|NCT00009945|594870214|FG001|Overall Study|no follow up data|5|||
164685259|NCT00672984|594870215|FG000|First Intervention|Adverse Event|5|||
164685260|NCT00672984|594870216|FG001|First Intervention|Adverse Event|0|||
164685261|NCT00672984|594870217|FG002|First Intervention|Adverse Event|0|||
164685262|NCT00672984|594870215|FG000|First Intervention|Withdrawal by Subject|1|||
164685263|NCT00672984|594870216|FG001|First Intervention|Withdrawal by Subject|2|||
164685264|NCT00672984|594870217|FG002|First Intervention|Withdrawal by Subject|2|||
164430343|NCT00819910|593945377|FG001|Overall Study|Withdrawal by Subject|1|||
164430344|NCT00819910|593945378|FG002|Overall Study|Withdrawal by Subject|1|||
164685265|NCT00672984|594870215|FG000|First Intervention|Sponsor decision|3|||
164685266|NCT00672984|594870216|FG001|First Intervention|Sponsor decision|0|||
164685267|NCT00672984|594870217|FG002|First Intervention|Sponsor decision|0|||
164685268|NCT00672984|594870215|FG000|Second Intervention|Non-compliance with facility policies|0|||
164685269|NCT00672984|594870216|FG001|Second Intervention|Non-compliance with facility policies|2|||
164685270|NCT00672984|594870217|FG002|Second Intervention|Non-compliance with facility policies|0|||
164685271|NCT00672984|594870215|FG000|Second Intervention|Withdrawal by Subject|0|||
164685272|NCT00672984|594870216|FG001|Second Intervention|Withdrawal by Subject|3|||
164685273|NCT00672984|594870217|FG002|Second Intervention|Withdrawal by Subject|0|||
164685274|NCT00672984|594870215|FG000|Second Intervention|Protocol Violation|0|||
164685275|NCT00672984|594870216|FG001|Second Intervention|Protocol Violation|1|||
164685276|NCT00672984|594870217|FG002|Second Intervention|Protocol Violation|1|||
164685277|NCT00672984|594870215|FG000|Third Intervention|Adverse Event|1|||
164685278|NCT00672984|594870216|FG001|Third Intervention|Adverse Event|0|||
164685279|NCT00672984|594870217|FG002|Third Intervention|Adverse Event|1|||
164685280|NCT00573313|594870218|FG000|Overall Study|Protocol Violation|5|||
164685281|NCT00573313|594870219|FG001|Overall Study|Protocol Violation|0|||
164685282|NCT00573313|594870220|FG002|Overall Study|Protocol Violation|6|||
164685283|NCT00573313|594870221|FG003|Overall Study|Protocol Violation|0|||
164265209|NCT00969761|593338839|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
164265210|NCT00969761|593338840|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
164265211|NCT00969761|593338841|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
164265212|NCT00969761|593338842|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
164265213|NCT00969761|593338843|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
164265214|NCT00969761|593338844|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
164265215|NCT00969761|593338845|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
164265216|NCT00969761|593338846|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
164299923|NCT02234843|593472944|FG000|Overall Study|Non-compliance with study drug|1|||
164430345|NCT00819910|593945379|FG003|Overall Study|Withdrawal by Subject|0|||
164430346|NCT00819910|593945376|FG000|Overall Study|Lost to Follow-up|1|||
164430347|NCT00819910|593945377|FG001|Overall Study|Lost to Follow-up|0|||
164430348|NCT00819910|593945378|FG002|Overall Study|Lost to Follow-up|0|||
164685284|NCT02611362|594870222|FG000|Overall Study|Withdrawal by Subject|7|||
164685285|NCT02611362|594870223|FG001|Overall Study|Withdrawal by Subject|2|||
164685286|NCT02611362|594870222|FG000|Overall Study|Lost to Follow-up|2|||
164685287|NCT02611362|594870223|FG001|Overall Study|Lost to Follow-up|4|||
164685288|NCT00354159|594870224|FG000|Randomized Study Period|Withdrawal by Subject|5|||
164685289|NCT00354159|594870225|FG001|Randomized Study Period|Withdrawal by Subject|3|||
164685290|NCT00354159|594870224|FG000|Randomized Study Period|Physician Decision|6|||
164685291|NCT00354159|594870225|FG001|Randomized Study Period|Physician Decision|10|||
164685292|NCT00354159|594870224|FG000|Randomized Study Period|Lost to Follow-up|4|||
164685293|NCT00354159|594870225|FG001|Randomized Study Period|Lost to Follow-up|0|||
164685294|NCT00354159|594870224|FG000|Randomized Study Period|Death|7|||
164685295|NCT00354159|594870225|FG001|Randomized Study Period|Death|9|||
164685296|NCT00354159|594870224|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
164685297|NCT00354159|594870225|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
164685298|NCT00354159|594870224|FG000|Long-term Follow-up|Physician Decision|127|||
164685299|NCT00354159|594870225|FG001|Long-term Follow-up|Physician Decision|122|||
164685300|NCT00354159|594870224|FG000|Long-term Follow-up|Lost to Follow-up|1|||
164685301|NCT00354159|594870225|FG001|Long-term Follow-up|Lost to Follow-up|0|||
164685302|NCT00354159|594870224|FG000|Long-term Follow-up|Death|14|||
164685303|NCT00354159|594870225|FG001|Long-term Follow-up|Death|11|||
164685304|NCT00354159|594870224|FG000|Long-term Follow-up|Study Closed|29|||
164685305|NCT00354159|594870225|FG001|Long-term Follow-up|Study Closed|34|||
164685306|NCT02229084|594870227|FG000|Overall Study|Adverse Event|1|||
164685307|NCT02229084|594870228|FG001|Overall Study|Adverse Event|0|||
164685308|NCT02229084|594870229|FG002|Overall Study|Adverse Event|0|||
164685309|NCT02229084|594870230|FG003|Overall Study|Adverse Event|0|||
164685310|NCT02229084|594870231|FG004|Overall Study|Adverse Event|0|||
164685311|NCT02229084|594870232|FG005|Overall Study|Adverse Event|0|||
164685312|NCT02229084|594870233|FG006|Overall Study|Adverse Event|0|||
164685313|NCT02229084|594870227|FG000|Overall Study|Lost to Follow-up|0|||
164685314|NCT02229084|594870228|FG001|Overall Study|Lost to Follow-up|0|||
164685315|NCT02229084|594870229|FG002|Overall Study|Lost to Follow-up|1|||
164685316|NCT02229084|594870230|FG003|Overall Study|Lost to Follow-up|1|||
164685317|NCT02229084|594870231|FG004|Overall Study|Lost to Follow-up|0|||
164685318|NCT02229084|594870232|FG005|Overall Study|Lost to Follow-up|0|||
164685319|NCT02229084|594870233|FG006|Overall Study|Lost to Follow-up|1|||
164685320|NCT02229084|594870227|FG000|Overall Study|Physician Decision|0|||
164685321|NCT02229084|594870228|FG001|Overall Study|Physician Decision|0|||
164685322|NCT02229084|594870229|FG002|Overall Study|Physician Decision|0|||
164685323|NCT02229084|594870230|FG003|Overall Study|Physician Decision|1|||
164685324|NCT02229084|594870231|FG004|Overall Study|Physician Decision|3|||
164685325|NCT02229084|594870232|FG005|Overall Study|Physician Decision|0|||
164685326|NCT02229084|594870233|FG006|Overall Study|Physician Decision|1|||
164685327|NCT02229084|594870227|FG000|Overall Study|Withdrawal by Subject|0|||
164685328|NCT02229084|594870228|FG001|Overall Study|Withdrawal by Subject|0|||
164685329|NCT02229084|594870229|FG002|Overall Study|Withdrawal by Subject|1|||
164685330|NCT02229084|594870230|FG003|Overall Study|Withdrawal by Subject|0|||
164685331|NCT02229084|594870231|FG004|Overall Study|Withdrawal by Subject|1|||
164685332|NCT02229084|594870232|FG005|Overall Study|Withdrawal by Subject|1|||
164685333|NCT02229084|594870233|FG006|Overall Study|Withdrawal by Subject|1|||
164685334|NCT02229084|594870227|FG000|Overall Study|Death|0|||
164685335|NCT02229084|594870228|FG001|Overall Study|Death|0|||
164685336|NCT02229084|594870229|FG002|Overall Study|Death|0|||
164685337|NCT02229084|594870230|FG003|Overall Study|Death|0|||
164685338|NCT02229084|594870231|FG004|Overall Study|Death|0|||
164685339|NCT02229084|594870232|FG005|Overall Study|Death|0|||
164685340|NCT02229084|594870233|FG006|Overall Study|Death|1|||
164685341|NCT01728116|594870236|FG000|Overall Study|Sponsor Terminated Study|106|||
164685342|NCT01728116|594870237|FG001|Overall Study|Sponsor Terminated Study|35|||
164685343|NCT01728116|594870236|FG000|Overall Study|Withdrawal by Subject|16|||
164685344|NCT01728116|594870237|FG001|Overall Study|Withdrawal by Subject|9|||
164685345|NCT01728116|594870236|FG000|Overall Study|Adverse Event|13|||
164685346|NCT01728116|594870237|FG001|Overall Study|Adverse Event|0|||
164685347|NCT01728116|594870236|FG000|Overall Study|Procedure/device failure|7|||
164685348|NCT01728116|594870237|FG001|Overall Study|Procedure/device failure|0|||
164685349|NCT01728116|594870236|FG000|Overall Study|Lost to Follow-up|9|||
164685350|NCT01728116|594870237|FG001|Overall Study|Lost to Follow-up|2|||
164685351|NCT01728116|594870236|FG000|Overall Study|Physician Decision|2|||
164685352|NCT01728116|594870237|FG001|Overall Study|Physician Decision|0|||
164685353|NCT01728116|594870236|FG000|Overall Study|Subject Non-Compliance|2|||
164685354|NCT01728116|594870237|FG001|Overall Study|Subject Non-Compliance|0|||
164685355|NCT01728116|594870236|FG000|Overall Study|Inter-current finding at procedure|1|||
164685356|NCT01728116|594870237|FG001|Overall Study|Inter-current finding at procedure|0|||
164685357|NCT01728116|594870236|FG000|Overall Study|Incorrectly enrolled in Study|0|||
164685358|NCT01728116|594870237|FG001|Overall Study|Incorrectly enrolled in Study|1|||
164685359|NCT01728116|594870236|FG000|Overall Study|various not noted previously|5|||
164685360|NCT01728116|594870237|FG001|Overall Study|various not noted previously|0|||
164685361|NCT01868243|594870243|FG000|Overall Study|Death|0|||
164341617|NCT02468674|593627447|FG006|Overall Study|Protocol Deviation|0|||
164341618|NCT02468674|593627448|FG007|Overall Study|Protocol Deviation|1|||
164341619|NCT02468674|593627449|FG008|Overall Study|Protocol Deviation|1|||
164341620|NCT03281577|593627450|FG000|Overall Study|Adverse Event|0|||
164341621|NCT03281577|593627451|FG001|Overall Study|Adverse Event|0|||
164341622|NCT03281577|593627452|FG002|Overall Study|Adverse Event|0|||
164341623|NCT03281577|593627453|FG003|Overall Study|Adverse Event|1|||
164341624|NCT03281577|593627450|FG000|Overall Study|Withdrawal by Subject|1|||
164341625|NCT03281577|593627451|FG001|Overall Study|Withdrawal by Subject|0|||
164341626|NCT03281577|593627452|FG002|Overall Study|Withdrawal by Subject|0|||
164341627|NCT03281577|593627453|FG003|Overall Study|Withdrawal by Subject|0|||
164341628|NCT01644565|593627458|FG000|Overall Study|Undisclosed Medical History|1|||
164341629|NCT01644565|593627459|FG001|Overall Study|Undisclosed Medical History|0|||
164341630|NCT01644565|593627460|FG002|Overall Study|Undisclosed Medical History|0|||
164341631|NCT01644565|593627461|FG003|Overall Study|Undisclosed Medical History|0|||
164341632|NCT01644565|593627462|FG004|Overall Study|Undisclosed Medical History|0|||
164341633|NCT01644565|593627463|FG005|Overall Study|Undisclosed Medical History|0|||
164341634|NCT01644565|593627464|FG006|Overall Study|Undisclosed Medical History|0|||
164341635|NCT01644565|593627465|FG007|Overall Study|Undisclosed Medical History|0|||
164341636|NCT01644565|593627466|FG008|Overall Study|Undisclosed Medical History|0|||
164341637|NCT01644565|593627458|FG000|Overall Study|Lost to Follow-up|0|||
164341638|NCT01644565|593627459|FG001|Overall Study|Lost to Follow-up|0|||
164341639|NCT01644565|593627460|FG002|Overall Study|Lost to Follow-up|0|||
164341640|NCT01644565|593627461|FG003|Overall Study|Lost to Follow-up|1|||
164341641|NCT01644565|593627462|FG004|Overall Study|Lost to Follow-up|0|||
164341642|NCT01644565|593627463|FG005|Overall Study|Lost to Follow-up|0|||
164341643|NCT01644565|593627464|FG006|Overall Study|Lost to Follow-up|0|||
164341644|NCT01644565|593627465|FG007|Overall Study|Lost to Follow-up|2|||
164341645|NCT01644565|593627466|FG008|Overall Study|Lost to Follow-up|0|||
164341646|NCT01644565|593627458|FG000|Overall Study|Family emergency|0|||
164341647|NCT01644565|593627459|FG001|Overall Study|Family emergency|0|||
164341648|NCT01644565|593627460|FG002|Overall Study|Family emergency|0|||
164341649|NCT01644565|593627461|FG003|Overall Study|Family emergency|0|||
164341650|NCT01644565|593627462|FG004|Overall Study|Family emergency|1|||
164341651|NCT01644565|593627463|FG005|Overall Study|Family emergency|0|||
164341652|NCT01644565|593627464|FG006|Overall Study|Family emergency|0|||
164341653|NCT01644565|593627465|FG007|Overall Study|Family emergency|0|||
164341654|NCT01644565|593627466|FG008|Overall Study|Family emergency|0|||
164341655|NCT01644565|593627458|FG000|Overall Study|Relocation|0|||
164341656|NCT01644565|593627459|FG001|Overall Study|Relocation|0|||
164341657|NCT01644565|593627460|FG002|Overall Study|Relocation|0|||
164341658|NCT01644565|593627461|FG003|Overall Study|Relocation|0|||
164341659|NCT01644565|593627462|FG004|Overall Study|Relocation|0|||
164341660|NCT01644565|593627463|FG005|Overall Study|Relocation|0|||
164341661|NCT01644565|593627464|FG006|Overall Study|Relocation|0|||
164341662|NCT01644565|593627465|FG007|Overall Study|Relocation|0|||
164341663|NCT01644565|593627466|FG008|Overall Study|Relocation|1|||
164341664|NCT00443261|593627467|FG000|Overall Study|Death|1|||
164341665|NCT00787891|593627468|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
164341666|NCT00787891|593627469|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
164580208|NCT02333331|594492301|FG000|Overall Study|Patient/Guardian Decision|1|||
164580209|NCT02333331|594492302|FG001|Overall Study|Patient/Guardian Decision|2|||
164580210|NCT02333331|594492303|FG002|Overall Study|Patient/Guardian Decision|9|||
164580211|NCT02333331|594492304|FG003|Overall Study|Patient/Guardian Decision|1|||
164580212|NCT01494038|594492305|FG000|Overall Study|Protocol Violation|1|||
164580213|NCT01494038|594492306|FG001|Overall Study|Protocol Violation|1|||
164580214|NCT01494038|594492305|FG000|Overall Study|Lost to Follow-up|18|||
164580215|NCT01494038|594492306|FG001|Overall Study|Lost to Follow-up|20|||
164580216|NCT01494038|594492305|FG000|Overall Study|Withdrawal by Subject|44|||
164580217|NCT01494038|594492306|FG001|Overall Study|Withdrawal by Subject|34|||
164580218|NCT01494038|594492305|FG000|Overall Study|Not able to get to clinic|21|||
164580219|NCT01494038|594492306|FG001|Overall Study|Not able to get to clinic|15|||
164580220|NCT01494038|594492305|FG000|Overall Study|Not willing to adhere to reqs|2|||
164580221|NCT01494038|594492306|FG001|Overall Study|Not willing to adhere to reqs|9|||
164341667|NCT00787891|593627468|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
164341668|NCT00787891|593627469|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
164341669|NCT00787891|593627468|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
164341670|NCT00787891|593627469|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
164341671|NCT00787891|593627468|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
164341672|NCT00787891|593627469|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
164341673|NCT00787891|593627468|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
164341674|NCT00787891|593627469|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
164341675|NCT00787891|593627468|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
164341676|NCT00787891|593627469|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
164341677|NCT00787891|593627468|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
164580222|NCT01494038|594492305|FG000|Overall Study|Death|2|||
164580223|NCT01494038|594492306|FG001|Overall Study|Death|4|||
164580224|NCT00537940|594492307|FG000|Overall Study|Adverse Event|20|||
164580225|NCT00537940|594492308|FG001|Overall Study|Adverse Event|19|||
164580226|NCT00537940|594492307|FG000|Overall Study|Lack of Efficacy|8|||
164580227|NCT00537940|594492308|FG001|Overall Study|Lack of Efficacy|16|||
164580228|NCT00537940|594492307|FG000|Overall Study|Lost to Follow-up|23|||
164580229|NCT00537940|594492308|FG001|Overall Study|Lost to Follow-up|29|||
164580230|NCT00537940|594492307|FG000|Overall Study|Withdrawal by Subject|113|||
164580231|NCT00537940|594492308|FG001|Overall Study|Withdrawal by Subject|95|||
164580232|NCT00537940|594492307|FG000|Overall Study|Protocol Violation|6|||
164580233|NCT00537940|594492308|FG001|Overall Study|Protocol Violation|4|||
164580234|NCT00537940|594492307|FG000|Overall Study|Pregnancy|1|||
164580235|NCT00537940|594492308|FG001|Overall Study|Pregnancy|1|||
164580236|NCT00537940|594492307|FG000|Overall Study|Study terminated by sponsor|2|||
164580237|NCT00537940|594492308|FG001|Overall Study|Study terminated by sponsor|3|||
164580238|NCT00537940|594492307|FG000|Overall Study|Other|10|||
164580239|NCT00537940|594492308|FG001|Overall Study|Other|12|||
164580240|NCT02138110|594492319|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
164580241|NCT02138110|594492319|FG000|Overall Scaffold Implantation|Death|3|||
164580242|NCT02158533|594492320|FG000|Stage 1|Adverse Event|6|||
164580243|NCT02158533|594492321|FG001|Stage 1|Adverse Event|4|||
164580244|NCT02158533|594492322|FG002|Stage 1|Adverse Event|7|||
164580245|NCT02158533|594492323|FG003|Stage 1|Adverse Event|0|||
164580246|NCT02158533|594492324|FG004|Stage 1|Adverse Event|0|||
164580247|NCT02158533|594492325|FG005|Stage 1|Adverse Event|0|||
164580248|NCT02158533|594492320|FG000|Stage 1|Withdrawal by Subject|3|||
164580249|NCT02158533|594492321|FG001|Stage 1|Withdrawal by Subject|2|||
164580250|NCT02158533|594492322|FG002|Stage 1|Withdrawal by Subject|1|||
164580251|NCT02158533|594492323|FG003|Stage 1|Withdrawal by Subject|0|||
164580252|NCT02158533|594492324|FG004|Stage 1|Withdrawal by Subject|0|||
164580253|NCT02158533|594492325|FG005|Stage 1|Withdrawal by Subject|0|||
164580254|NCT02158533|594492320|FG000|Stage 1|Lack of Efficacy|1|||
164580255|NCT02158533|594492321|FG001|Stage 1|Lack of Efficacy|0|||
164580256|NCT02158533|594492322|FG002|Stage 1|Lack of Efficacy|0|||
164580257|NCT02158533|594492323|FG003|Stage 1|Lack of Efficacy|0|||
164580258|NCT02158533|594492324|FG004|Stage 1|Lack of Efficacy|0|||
164580259|NCT02158533|594492325|FG005|Stage 1|Lack of Efficacy|0|||
164580260|NCT02158533|594492320|FG000|Stage 1|Lost to Follow-up|3|||
164580261|NCT02158533|594492321|FG001|Stage 1|Lost to Follow-up|1|||
164580262|NCT02158533|594492322|FG002|Stage 1|Lost to Follow-up|0|||
164580263|NCT02158533|594492323|FG003|Stage 1|Lost to Follow-up|0|||
164580264|NCT02158533|594492324|FG004|Stage 1|Lost to Follow-up|0|||
164580265|NCT02158533|594492325|FG005|Stage 1|Lost to Follow-up|0|||
164580266|NCT02158533|594492320|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
164580267|NCT02158533|594492321|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
164580268|NCT02158533|594492322|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
164580269|NCT02158533|594492323|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
164580270|NCT02158533|594492324|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
164580271|NCT02158533|594492325|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
164580272|NCT02158533|594492320|FG000|Stage 1|Non-compliance with study visits|1|||
164580273|NCT02158533|594492321|FG001|Stage 1|Non-compliance with study visits|0|||
164580274|NCT02158533|594492322|FG002|Stage 1|Non-compliance with study visits|0|||
164580275|NCT02158533|594492323|FG003|Stage 1|Non-compliance with study visits|0|||
164580276|NCT02158533|594492324|FG004|Stage 1|Non-compliance with study visits|0|||
164580277|NCT02158533|594492325|FG005|Stage 1|Non-compliance with study visits|0|||
164580278|NCT02158533|594492320|FG000|Stage 2|Adverse Event|0|||
164580279|NCT02158533|594492321|FG001|Stage 2|Adverse Event|0|||
164580280|NCT02158533|594492322|FG002|Stage 2|Adverse Event|0|||
164580281|NCT02158533|594492323|FG003|Stage 2|Adverse Event|0|||
164580282|NCT02158533|594492324|FG004|Stage 2|Adverse Event|0|||
164580283|NCT02158533|594492325|FG005|Stage 2|Adverse Event|1|||
164580284|NCT02158533|594492320|FG000|Stage 2|Lack of Efficacy|0|||
164580285|NCT02158533|594492321|FG001|Stage 2|Lack of Efficacy|0|||
164580286|NCT02158533|594492322|FG002|Stage 2|Lack of Efficacy|0|||
164580287|NCT02158533|594492323|FG003|Stage 2|Lack of Efficacy|0|||
164580288|NCT02158533|594492324|FG004|Stage 2|Lack of Efficacy|1|||
164580289|NCT02158533|594492325|FG005|Stage 2|Lack of Efficacy|0|||
164580290|NCT02158533|594492320|FG000|Stage 2|Lost to Follow-up|0|||
164580291|NCT02158533|594492321|FG001|Stage 2|Lost to Follow-up|0|||
164580292|NCT02158533|594492322|FG002|Stage 2|Lost to Follow-up|0|||
164580293|NCT02158533|594492323|FG003|Stage 2|Lost to Follow-up|1|||
164580294|NCT02158533|594492324|FG004|Stage 2|Lost to Follow-up|1|||
164580295|NCT02158533|594492325|FG005|Stage 2|Lost to Follow-up|2|||
164580296|NCT02158533|594492320|FG000|Stage 2|Withdrawal by Subject|0|||
164580297|NCT02158533|594492321|FG001|Stage 2|Withdrawal by Subject|0|||
164580298|NCT02158533|594492322|FG002|Stage 2|Withdrawal by Subject|0|||
164580299|NCT02158533|594492323|FG003|Stage 2|Withdrawal by Subject|0|||
164580300|NCT02158533|594492324|FG004|Stage 2|Withdrawal by Subject|1|||
164580301|NCT02158533|594492325|FG005|Stage 2|Withdrawal by Subject|2|||
164580302|NCT02158533|594492320|FG000|Stage 2|Physician Decision|0|||
164580303|NCT02158533|594492321|FG001|Stage 2|Physician Decision|0|||
164580304|NCT02158533|594492322|FG002|Stage 2|Physician Decision|0|||
164580305|NCT02158533|594492323|FG003|Stage 2|Physician Decision|0|||
164580306|NCT02158533|594492324|FG004|Stage 2|Physician Decision|1|||
164580307|NCT02158533|594492325|FG005|Stage 2|Physician Decision|0|||
164580308|NCT02158533|594492320|FG000|Stage 2|Pregnancy|0|||
164580309|NCT02158533|594492321|FG001|Stage 2|Pregnancy|0|||
164580310|NCT02158533|594492322|FG002|Stage 2|Pregnancy|0|||
164580311|NCT02158533|594492323|FG003|Stage 2|Pregnancy|1|||
164580312|NCT02158533|594492324|FG004|Stage 2|Pregnancy|0|||
164580313|NCT02158533|594492325|FG005|Stage 2|Pregnancy|0|||
164580314|NCT02158533|594492320|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
164580315|NCT02158533|594492321|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
164580316|NCT02158533|594492322|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
164580317|NCT02158533|594492323|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
164580318|NCT02158533|594492324|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
164580319|NCT02158533|594492325|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
164580320|NCT02158533|594492320|FG000|Stage 2|Non-adherence with study visits|0|||
164580321|NCT02158533|594492321|FG001|Stage 2|Non-adherence with study visits|0|||
164580322|NCT02158533|594492322|FG002|Stage 2|Non-adherence with study visits|0|||
164580323|NCT02158533|594492323|FG003|Stage 2|Non-adherence with study visits|0|||
164580324|NCT02158533|594492324|FG004|Stage 2|Non-adherence with study visits|0|||
164580325|NCT02158533|594492325|FG005|Stage 2|Non-adherence with study visits|1|||
164580326|NCT01389128|594492334|FG000|Overall Study|Fetal distress|1|||
164580327|NCT01389128|594492335|FG001|Overall Study|Fetal distress|0|||
164580328|NCT01389128|594492334|FG000|Overall Study|Cervix dilation stop|1|||
164580329|NCT01389128|594492335|FG001|Overall Study|Cervix dilation stop|2|||
164580330|NCT01389128|594492334|FG000|Overall Study|Rapid labor evolution|3|||
164580331|NCT01389128|594492335|FG001|Overall Study|Rapid labor evolution|2|||
164580332|NCT01389128|594492334|FG000|Overall Study|Intolerance to procedure|0|||
164580333|NCT01389128|594492335|FG001|Overall Study|Intolerance to procedure|2|||
164580334|NCT00756002|594492336|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
164580335|NCT00756002|594492337|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
164580336|NCT00756002|594492336|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
164580337|NCT00756002|594492337|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
164580338|NCT00756002|594492336|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
164580339|NCT00756002|594492337|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
164580340|NCT00756002|594492336|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
164580341|NCT00756002|594492337|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
164580342|NCT00756002|594492336|FG000|Double-Blind Treatment Period|Other|2|||
164580343|NCT00756002|594492337|FG001|Double-Blind Treatment Period|Other|2|||
164580344|NCT01451515|594492338|FG000|Overall Study|Death|0|||
164580345|NCT01451515|594492339|FG001|Overall Study|Death|1|||
164580346|NCT01451515|594492340|FG002|Overall Study|Death|0|||
164580347|NCT01451515|594492338|FG000|Overall Study|Withdrawal by Subject|0|||
164580348|NCT01451515|594492339|FG001|Overall Study|Withdrawal by Subject|1|||
164580349|NCT01451515|594492340|FG002|Overall Study|Withdrawal by Subject|0|||
164580350|NCT01451515|594492338|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
164580351|NCT01451515|594492339|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
164580352|NCT01451515|594492340|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
164580353|NCT01451515|594492338|FG000|Overall Study|Relapse (except CNS)|1|||
164580354|NCT01451515|594492339|FG001|Overall Study|Relapse (except CNS)|1|||
164580355|NCT01451515|594492340|FG002|Overall Study|Relapse (except CNS)|0|||
164580356|NCT04329923|594492345|FG000|Overall Study|Withdrawal by Subject|1|||
164580357|NCT04329923|594492346|FG001|Overall Study|Withdrawal by Subject|4|||
164580358|NCT04329923|594492347|FG002|Overall Study|Withdrawal by Subject|1|||
164580359|NCT04329923|594492348|FG003|Overall Study|Withdrawal by Subject|1|||
164580360|NCT04329923|594492349|FG004|Overall Study|Withdrawal by Subject|1|||
164580361|NCT04329923|594492350|FG005|Overall Study|Withdrawal by Subject|1|||
164580362|NCT04329923|594492345|FG000|Overall Study|early termination of study|0|||
164580363|NCT04329923|594492346|FG001|Overall Study|early termination of study|0|||
164580364|NCT04329923|594492347|FG002|Overall Study|early termination of study|0|||
164580365|NCT04329923|594492348|FG003|Overall Study|early termination of study|0|||
164580366|NCT04329923|594492349|FG004|Overall Study|early termination of study|1|||
164580367|NCT04329923|594492350|FG005|Overall Study|early termination of study|2|||
164580368|NCT04329923|594492345|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
164580369|NCT04329923|594492346|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
164580370|NCT04329923|594492347|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
164580371|NCT04329923|594492348|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
164580372|NCT04329923|594492349|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
164580373|NCT04329923|594492350|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
164580374|NCT01272180|594492351|FG000|Overall Study|Adverse Event|0|||
164580375|NCT01272180|594492352|FG001|Overall Study|Adverse Event|0|||
164580376|NCT01272180|594492353|FG002|Overall Study|Adverse Event|1|||
164580377|NCT01272180|594492354|FG003|Overall Study|Adverse Event|0|||
164580378|NCT01272180|594492351|FG000|Overall Study|Withdrawal by Subject|2|||
164580379|NCT01272180|594492352|FG001|Overall Study|Withdrawal by Subject|6|||
164580380|NCT01272180|594492353|FG002|Overall Study|Withdrawal by Subject|3|||
164685362|NCT01868243|594870244|FG001|Overall Study|Death|1|||
164685363|NCT01745094|594870245|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
164685364|NCT01745094|594870246|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
164685365|NCT01745094|594870247|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
164685366|NCT01745094|594870248|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
164685367|NCT01745094|594870245|FG000|Overall Study|Adverse Event|0|||
164685368|NCT01745094|594870246|FG001|Overall Study|Adverse Event|0|||
164685369|NCT01745094|594870247|FG002|Overall Study|Adverse Event|3|||
164685370|NCT01745094|594870248|FG003|Overall Study|Adverse Event|0|||
164685371|NCT01745094|594870245|FG000|Overall Study|Withdrawal by Subject|2|||
164685372|NCT01745094|594870246|FG001|Overall Study|Withdrawal by Subject|0|||
164685373|NCT01745094|594870247|FG002|Overall Study|Withdrawal by Subject|1|||
164685374|NCT01745094|594870248|FG003|Overall Study|Withdrawal by Subject|2|||
164685375|NCT01745094|594870245|FG000|Overall Study|Protocol Violation|1|||
164685376|NCT01745094|594870246|FG001|Overall Study|Protocol Violation|0|||
164685377|NCT01745094|594870247|FG002|Overall Study|Protocol Violation|3|||
164685378|NCT01745094|594870248|FG003|Overall Study|Protocol Violation|1|||
164685379|NCT01745094|594870245|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
164685380|NCT01745094|594870246|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
164685381|NCT01745094|594870247|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
164685382|NCT01745094|594870248|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
164685383|NCT01745094|594870245|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
164685384|NCT01745094|594870246|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
164685385|NCT01745094|594870247|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
164685386|NCT01745094|594870248|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
164685387|NCT01745094|594870245|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
164685388|NCT01745094|594870246|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
164685389|NCT01745094|594870247|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
164685390|NCT01745094|594870248|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
164685391|NCT04610580|594870249|FG000|Two-way Crossover Period|Adverse Event|1|||
164685392|NCT04610580|594870250|FG001|Two-way Crossover Period|Adverse Event|0|||
164685393|NCT04610580|594870251|FG002|Two-way Crossover Period|Adverse Event|0|||
164685394|NCT04610580|594870252|FG003|Two-way Crossover Period|Adverse Event|0|||
164685395|NCT04610580|594870253|FG004|Two-way Crossover Period|Adverse Event|0|||
164685396|NCT04610580|594870254|FG005|Two-way Crossover Period|Adverse Event|0|||
164685397|NCT04610580|594870249|FG000|Two-way Crossover Period|Physician Decision|1|||
164685398|NCT04610580|594870250|FG001|Two-way Crossover Period|Physician Decision|0|||
164685399|NCT04610580|594870251|FG002|Two-way Crossover Period|Physician Decision|0|||
164685400|NCT04610580|594870252|FG003|Two-way Crossover Period|Physician Decision|0|||
164685401|NCT04610580|594870253|FG004|Two-way Crossover Period|Physician Decision|0|||
164685402|NCT04610580|594870254|FG005|Two-way Crossover Period|Physician Decision|0|||
164685403|NCT04610580|594870249|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
164685404|NCT04610580|594870250|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
164685405|NCT04610580|594870251|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
164685406|NCT04610580|594870252|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
164685407|NCT04610580|594870253|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
164685408|NCT04610580|594870254|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
164685409|NCT04610580|594870249|FG000|Two-way Crossover Period|Other than specified|0|||
164685410|NCT04610580|594870250|FG001|Two-way Crossover Period|Other than specified|1|||
164685411|NCT04610580|594870251|FG002|Two-way Crossover Period|Other than specified|0|||
164685412|NCT04610580|594870252|FG003|Two-way Crossover Period|Other than specified|0|||
164685413|NCT04610580|594870253|FG004|Two-way Crossover Period|Other than specified|0|||
164685414|NCT04610580|594870254|FG005|Two-way Crossover Period|Other than specified|0|||
164685415|NCT04610580|594870249|FG000|Washout Before Extension Period|Other than specified|0|||
164685416|NCT04610580|594870250|FG001|Washout Before Extension Period|Other than specified|1|||
164685417|NCT04610580|594870251|FG002|Washout Before Extension Period|Other than specified|0|||
164685418|NCT04610580|594870252|FG003|Washout Before Extension Period|Other than specified|0|||
164685419|NCT04610580|594870253|FG004|Washout Before Extension Period|Other than specified|0|||
164685420|NCT04610580|594870254|FG005|Washout Before Extension Period|Other than specified|0|||
164685421|NCT04610580|594870249|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
164265217|NCT03081858|593340407|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
164265218|NCT03081858|593340408|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
164430349|NCT00819910|593945379|FG003|Overall Study|Lost to Follow-up|0|||
164685422|NCT04610580|594870250|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
164685423|NCT04610580|594870251|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
164685424|NCT04610580|594870252|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
164685425|NCT04610580|594870253|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
164685426|NCT04610580|594870254|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
164685427|NCT04610580|594870249|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
164685428|NCT04610580|594870250|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
164685429|NCT04610580|594870251|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
164685430|NCT04610580|594870252|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
164685431|NCT04610580|594870253|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
164685432|NCT04610580|594870254|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
164685433|NCT01451541|594870256|FG000|Overall Study|Adverse Event|4|||
164685434|NCT01451541|594870257|FG001|Overall Study|Adverse Event|3|||
164685435|NCT01451541|594870258|FG002|Overall Study|Adverse Event|6|||
164685436|NCT01451541|594870256|FG000|Overall Study|Lack of Efficacy|2|||
164685437|NCT01451541|594870257|FG001|Overall Study|Lack of Efficacy|0|||
164685438|NCT01451541|594870258|FG002|Overall Study|Lack of Efficacy|0|||
164685439|NCT01451541|594870256|FG000|Overall Study|Lost to Follow-up|4|||
164685440|NCT01451541|594870257|FG001|Overall Study|Lost to Follow-up|4|||
164685441|NCT01451541|594870258|FG002|Overall Study|Lost to Follow-up|7|||
164685442|NCT01451541|594870256|FG000|Overall Study|Withdrawal by Subject|15|||
164685443|NCT01451541|594870257|FG001|Overall Study|Withdrawal by Subject|8|||
164685444|NCT01451541|594870258|FG002|Overall Study|Withdrawal by Subject|6|||
164685445|NCT01451541|594870256|FG000|Overall Study|randomization error, noncompliance|11|||
164685446|NCT01451541|594870257|FG001|Overall Study|randomization error, noncompliance|10|||
164685447|NCT01451541|594870258|FG002|Overall Study|randomization error, noncompliance|8|||
164685448|NCT05665387|594870261|FG000|Overall Study|Withdrawal by Subject|1|||
164685449|NCT05665387|594870262|FG001|Overall Study|Withdrawal by Subject|0|||
164685450|NCT05665387|594870263|FG002|Overall Study|Withdrawal by Subject|1|||
164685451|NCT01824498|594870264|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
164685452|NCT01824498|594870265|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
164685453|NCT01824498|594870266|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
164685454|NCT01824498|594870267|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
164685455|NCT01824498|594870268|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
164685456|NCT01824498|594870269|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
164685457|NCT00006436|594870270|FG000|Overall Study|Refused further treatment|2|||
164685458|NCT00006436|594870270|FG000|Overall Study|Declined to participate (before treatment started)|1|||
164685459|NCT00939523|594870271|FG000|Overall Study|Lack of Efficacy|1|||
164685460|NCT00939523|594870271|FG000|Overall Study|Physician Decision|2|||
164685461|NCT00757172|594870276|FG000|Overall Study|Withdrawal by Subject|4|||
164685462|NCT00757172|594870276|FG000|Overall Study|Physician Decision|3|||
164685463|NCT00757172|594870276|FG000|Overall Study|Progression|4|||
164685464|NCT00685334|594870282|FG000|Overall Study|Withdrawal by Subject|5|||
164685465|NCT00685334|594870283|FG001|Overall Study|Withdrawal by Subject|6|||
164685466|NCT00685334|594870282|FG000|Overall Study|Lost to Follow-up|4|||
164685467|NCT00685334|594870283|FG001|Overall Study|Lost to Follow-up|0|||
164685468|NCT00685334|594870282|FG000|Overall Study|Chose to enter hospital|1|||
164685469|NCT00685334|594870283|FG001|Overall Study|Chose to enter hospital|1|||
164685470|NCT04577404|594870284|FG000|Overall Study|Adverse Event|31|||
164685471|NCT04577404|594870284|FG000|Overall Study|Death|1|||
164685472|NCT04577404|594870284|FG000|Overall Study|Lack of Efficacy|3|||
164685473|NCT04577404|594870284|FG000|Overall Study|Physician Decision|7|||
164685474|NCT04577404|594870284|FG000|Overall Study|Withdrawal by Subject|21|||
164685475|NCT04577404|594870284|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
164685476|NCT00202839|594871321|FG000|Overall Study|Adverse Event|1|||
164685477|NCT00202839|594871322|FG001|Overall Study|Adverse Event|5|||
164685478|NCT00202839|594871321|FG000|Overall Study|Physician Decision|12|||
164430350|NCT00871429|593945383|FG000|Overall Study|Lost to Follow-up|6|||
164430351|NCT00871429|593945383|FG000|Overall Study|Withdrawal by Subject|17|||
164430352|NCT00871429|593945383|FG000|Overall Study|Questionnaire not completed|1|||
164430353|NCT05460663|593945384|FG000|Overall Study|Withdrawal by Subject|2|||
164430354|NCT05460663|593945385|FG001|Overall Study|Withdrawal by Subject|5|||
164580381|NCT01272180|594492354|FG003|Overall Study|Withdrawal by Subject|2|||
164580382|NCT01272180|594492351|FG000|Overall Study|Lost to Follow-up|15|||
164580383|NCT01272180|594492352|FG001|Overall Study|Lost to Follow-up|14|||
164580384|NCT01272180|594492353|FG002|Overall Study|Lost to Follow-up|8|||
164580385|NCT01272180|594492354|FG003|Overall Study|Lost to Follow-up|10|||
164580386|NCT01272180|594492351|FG000|Overall Study|Inappropriate enrollment|0|||
164580387|NCT01272180|594492352|FG001|Overall Study|Inappropriate enrollment|0|||
164580388|NCT01272180|594492353|FG002|Overall Study|Inappropriate enrollment|1|||
164685479|NCT00202839|594871322|FG001|Overall Study|Physician Decision|0|||
164685480|NCT00202839|594871321|FG000|Overall Study|Withdrawal by Subject|6|||
164685481|NCT00202839|594871322|FG001|Overall Study|Withdrawal by Subject|2|||
164685482|NCT00202839|594871321|FG000|Overall Study|Protocol Violation|2|||
164685483|NCT00202839|594871322|FG001|Overall Study|Protocol Violation|1|||
164685484|NCT00202839|594871321|FG000|Overall Study|Lost to Follow-up|3|||
164685485|NCT00202839|594871322|FG001|Overall Study|Lost to Follow-up|2|||
164430355|NCT00828919|593945386|FG000|Overall Study|Death|0|||
164430356|NCT00828919|593945387|FG001|Overall Study|Death|1|||
164685486|NCT01662024|594871323|FG000|Overall Study|Pregnancy|2|||
164685487|NCT01662024|594871323|FG000|Overall Study|Withdrawal by Subject|3|||
164685488|NCT01490190|594871327|FG000|Overall Study|Withdrawal by Subject|9|||
164685489|NCT01490190|594871327|FG000|Overall Study|Adverse Event|17|||
164580389|NCT01272180|594492354|FG003|Overall Study|Inappropriate enrollment|1|||
164580390|NCT01272180|594492351|FG000|Overall Study|Protocol Violation|0|||
164580391|NCT01272180|594492352|FG001|Overall Study|Protocol Violation|1|||
164580392|NCT01272180|594492353|FG002|Overall Study|Protocol Violation|0|||
164580393|NCT01272180|594492354|FG003|Overall Study|Protocol Violation|1|||
164580394|NCT03230097|594492355|FG000|Overall Study|Adverse Event|2|||
164580395|NCT03230097|594492356|FG001|Overall Study|Adverse Event|1|||
164580396|NCT03230097|594492355|FG000|Overall Study|non-compliance|0|||
164580397|NCT03230097|594492356|FG001|Overall Study|non-compliance|1|||
164580398|NCT03230097|594492355|FG000|Overall Study|Lost to Follow-up|2|||
164580399|NCT03230097|594492356|FG001|Overall Study|Lost to Follow-up|4|||
164580400|NCT03230097|594492355|FG000|Overall Study|Withdrawal by Subject|7|||
164580401|NCT03230097|594492356|FG001|Overall Study|Withdrawal by Subject|3|||
164580402|NCT03230097|594492355|FG000|Overall Study|Trial termination|4|||
164580403|NCT03230097|594492356|FG001|Overall Study|Trial termination|5|||
164580404|NCT03230097|594492355|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
164580405|NCT03230097|594492356|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
164580406|NCT03230097|594492355|FG000|Overall Study|outcome event|0|||
164580407|NCT03230097|594492356|FG001|Overall Study|outcome event|1|||
164580408|NCT01588197|594492360|FG000|Overall Study|Lack of Efficacy|0|||
164580409|NCT01588197|594492361|FG001|Overall Study|Lack of Efficacy|1|||
164580410|NCT01588197|594492360|FG000|Overall Study|No MRI|1|||
164580411|NCT01588197|594492361|FG001|Overall Study|No MRI|0|||
164580412|NCT01844076|594492368|FG000|Overall Study|Adverse Event|1|||
164580413|NCT01844076|594492369|FG001|Overall Study|Adverse Event|0|||
164580414|NCT01844076|594492370|FG002|Overall Study|Adverse Event|0|||
164580415|NCT01844076|594492371|FG003|Overall Study|Adverse Event|0|||
164580416|NCT01844076|594492368|FG000|Overall Study|Withdrawal by Subject|1|||
164580417|NCT01844076|594492369|FG001|Overall Study|Withdrawal by Subject|0|||
164580418|NCT01844076|594492370|FG002|Overall Study|Withdrawal by Subject|0|||
164580419|NCT01844076|594492371|FG003|Overall Study|Withdrawal by Subject|0|||
164580420|NCT00635102|594492376|FG000|Overall Study|Withdrawal by Subject|7|||
164580421|NCT00635102|594492377|FG001|Overall Study|Withdrawal by Subject|8|||
164580422|NCT01937312|594492381|FG000|Overall Study|Adverse Event|10|||
164580423|NCT01937312|594492382|FG001|Overall Study|Adverse Event|1|||
164580424|NCT01937312|594492381|FG000|Overall Study|Lack of Efficacy|0|||
164580425|NCT01937312|594492382|FG001|Overall Study|Lack of Efficacy|1|||
164580426|NCT01937312|594492381|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
164580427|NCT01937312|594492382|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
164580428|NCT01486238|594492383|FG000|Overall Study|Death|0|||
164580429|NCT01486238|594492384|FG001|Overall Study|Death|2|||
164580430|NCT01486238|594492383|FG000|Overall Study|Withdrawal by Subject|2|||
164580431|NCT01486238|594492384|FG001|Overall Study|Withdrawal by Subject|1|||
164580432|NCT01486238|594492383|FG000|Overall Study|Lost to Follow-up|0|||
164580433|NCT01486238|594492384|FG001|Overall Study|Lost to Follow-up|3|||
164580434|NCT00847613|594492392|FG000|Overall Study|Ongoing at cut-off date|250|||
164580435|NCT00847613|594492393|FG001|Overall Study|Ongoing at cut-off date|265|||
164580436|NCT00847613|594492394|FG002|Overall Study|Ongoing at cut-off date|64|||
164580437|NCT00847613|594492395|FG003|Overall Study|Ongoing at cut-off date|64|||
164580438|NCT00847613|594492392|FG000|Overall Study|Death|1|||
164580439|NCT00847613|594492393|FG001|Overall Study|Death|1|||
164580440|NCT00847613|594492394|FG002|Overall Study|Death|0|||
164580441|NCT00847613|594492395|FG003|Overall Study|Death|0|||
164580442|NCT00847613|594492392|FG000|Overall Study|Adverse Event|36|||
164580443|NCT00847613|594492393|FG001|Overall Study|Adverse Event|26|||
164580444|NCT00847613|594492394|FG002|Overall Study|Adverse Event|5|||
164580445|NCT00847613|594492395|FG003|Overall Study|Adverse Event|6|||
164580446|NCT00847613|594492392|FG000|Overall Study|Lack of Efficacy|7|||
164580447|NCT00847613|594492393|FG001|Overall Study|Lack of Efficacy|3|||
164580448|NCT00847613|594492394|FG002|Overall Study|Lack of Efficacy|3|||
164580449|NCT00847613|594492395|FG003|Overall Study|Lack of Efficacy|1|||
164580450|NCT00847613|594492392|FG000|Overall Study|Study terminated by Sponsor|1|||
164580451|NCT00847613|594492393|FG001|Overall Study|Study terminated by Sponsor|0|||
164580452|NCT00847613|594492394|FG002|Overall Study|Study terminated by Sponsor|2|||
164580453|NCT00847613|594492395|FG003|Overall Study|Study terminated by Sponsor|1|||
164580454|NCT00847613|594492392|FG000|Overall Study|Lost to Follow-up|5|||
164580455|NCT00847613|594492393|FG001|Overall Study|Lost to Follow-up|0|||
164580456|NCT00847613|594492394|FG002|Overall Study|Lost to Follow-up|0|||
164580457|NCT00847613|594492395|FG003|Overall Study|Lost to Follow-up|3|||
164580458|NCT00847613|594492392|FG000|Overall Study|Protocol Violation|6|||
164580459|NCT00847613|594492393|FG001|Overall Study|Protocol Violation|6|||
164580460|NCT00847613|594492394|FG002|Overall Study|Protocol Violation|3|||
164580461|NCT00847613|594492395|FG003|Overall Study|Protocol Violation|1|||
164580462|NCT00847613|594492392|FG000|Overall Study|Pregnancy|1|||
164580463|NCT00847613|594492393|FG001|Overall Study|Pregnancy|1|||
164580464|NCT00847613|594492394|FG002|Overall Study|Pregnancy|0|||
164580465|NCT00847613|594492395|FG003|Overall Study|Pregnancy|0|||
164580466|NCT00847613|594492392|FG000|Overall Study|Site closure|1|||
164580467|NCT00847613|594492393|FG001|Overall Study|Site closure|0|||
164580468|NCT00847613|594492394|FG002|Overall Study|Site closure|0|||
164685490|NCT01490190|594871327|FG000|Overall Study|Protocol Violation|5|||
164685491|NCT01490190|594871327|FG000|Overall Study|Lost to Follow-up|13|||
164685492|NCT01490190|594871327|FG000|Overall Study|Relocation|1|||
164685493|NCT01490190|594871327|FG000|Overall Study|Inconvenience|1|||
164685494|NCT01490190|594871327|FG000|Overall Study|Ring expulsion|2|||
164685495|NCT00063258|594871342|FG000|Overall Study|Physician Decision|2|||
164685496|NCT00063258|594871343|FG001|Overall Study|Physician Decision|0|||
164685497|NCT00063258|594871342|FG000|Overall Study|Lack of Efficacy|2|||
164685498|NCT00063258|594871343|FG001|Overall Study|Lack of Efficacy|0|||
164685499|NCT03988608|594871344|FG000|Overall Study|Adverse Event|1|||
164685500|NCT03988608|594871344|FG000|Overall Study|Lost to Follow-up|1|||
164685501|NCT03988608|594871344|FG000|Overall Study|Withdrawal by Subject|3|||
164685502|NCT03988608|594871344|FG000|Overall Study|Death|1|||
164685503|NCT02786953|594871351|FG000|Overall Study|Withdrawal by Subject|3|||
164685504|NCT02786953|594871352|FG001|Overall Study|Withdrawal by Subject|0|||
164685505|NCT02786953|594871351|FG000|Overall Study|Physician Decision|0|||
164685506|NCT02786953|594871352|FG001|Overall Study|Physician Decision|1|||
164685507|NCT00387153|594871353|FG000|Overall Study|Adverse Event|1|||
164685508|NCT00387153|594871353|FG000|Overall Study|Disease Progression|3|||
164685509|NCT00387153|594871353|FG000|Overall Study|Lack of Response|4|||
164685510|NCT01186458|594871357|FG000|Overall Study|Adverse Event|1|||
164685511|NCT04281472|594871358|FG000|Stage A|Lack of Efficacy|8|||
164685512|NCT04281472|594871359|FG001|Stage A|Lack of Efficacy|0|||
164685513|NCT04281472|594871360|FG002|Stage A|Lack of Efficacy|0|||
164685514|NCT04281472|594871358|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
164685515|NCT04281472|594871359|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
164685516|NCT04281472|594871360|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
164685517|NCT04281472|594871358|FG000|Stage A|Adverse Event|20|||
164685518|NCT04281472|594871359|FG001|Stage A|Adverse Event|0|||
164685519|NCT04281472|594871360|FG002|Stage A|Adverse Event|0|||
164685520|NCT04281472|594871358|FG000|Stage A|Death|1|||
164685521|NCT04281472|594871359|FG001|Stage A|Death|0|||
164685522|NCT04281472|594871360|FG002|Stage A|Death|0|||
164685523|NCT04281472|594871358|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
164685524|NCT04281472|594871359|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
164685525|NCT04281472|594871360|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
164685526|NCT04281472|594871358|FG000|Stage A|Lost to Follow-up|2|||
164685527|NCT04281472|594871359|FG001|Stage A|Lost to Follow-up|0|||
164685528|NCT04281472|594871360|FG002|Stage A|Lost to Follow-up|0|||
164685529|NCT04281472|594871358|FG000|Stage A|Non-compliance with study drug|1|||
164685530|NCT04281472|594871359|FG001|Stage A|Non-compliance with study drug|0|||
164685531|NCT04281472|594871360|FG002|Stage A|Non-compliance with study drug|0|||
164685532|NCT04281472|594871358|FG000|Stage A|Physician Decision|1|||
164685533|NCT04281472|594871359|FG001|Stage A|Physician Decision|0|||
164685534|NCT04281472|594871360|FG002|Stage A|Physician Decision|0|||
164685535|NCT04281472|594871358|FG000|Stage A|Prohibited medications|2|||
164685536|NCT04281472|594871359|FG001|Stage A|Prohibited medications|0|||
164685537|NCT04281472|594871360|FG002|Stage A|Prohibited medications|0|||
164685538|NCT04281472|594871358|FG000|Stage A|Withdrawal by Subject|11|||
164685539|NCT04281472|594871359|FG001|Stage A|Withdrawal by Subject|0|||
164685540|NCT04281472|594871360|FG002|Stage A|Withdrawal by Subject|0|||
164685541|NCT04281472|594871358|FG000|Stage A|Other|5|||
164685542|NCT04281472|594871359|FG001|Stage A|Other|0|||
164685543|NCT04281472|594871360|FG002|Stage A|Other|0|||
164685544|NCT04281472|594871358|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
164685545|NCT04281472|594871359|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
164685546|NCT04281472|594871360|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
164685547|NCT04281472|594871358|FG000|Stage B|Adverse Event|0|||
164685548|NCT04281472|594871359|FG001|Stage B|Adverse Event|3|||
164685549|NCT04281472|594871360|FG002|Stage B|Adverse Event|0|||
164685550|NCT04281472|594871358|FG000|Stage B|Death|0|||
164685551|NCT04281472|594871359|FG001|Stage B|Death|0|||
164685552|NCT04281472|594871360|FG002|Stage B|Death|1|||
164685553|NCT04281472|594871358|FG000|Stage B|Lack of Efficacy|0|||
164685554|NCT04281472|594871359|FG001|Stage B|Lack of Efficacy|0|||
164685555|NCT04281472|594871360|FG002|Stage B|Lack of Efficacy|1|||
164685556|NCT04281472|594871358|FG000|Stage B|Lost to Follow-up|0|||
164685557|NCT04281472|594871359|FG001|Stage B|Lost to Follow-up|0|||
164685558|NCT04281472|594871360|FG002|Stage B|Lost to Follow-up|2|||
164685559|NCT04281472|594871358|FG000|Stage B|Prohibited medications|0|||
164685560|NCT04281472|594871359|FG001|Stage B|Prohibited medications|2|||
164685561|NCT04281472|594871360|FG002|Stage B|Prohibited medications|1|||
164685562|NCT04281472|594871358|FG000|Stage B|Protocol Violation|0|||
164685563|NCT04281472|594871359|FG001|Stage B|Protocol Violation|1|||
164685564|NCT04281472|594871360|FG002|Stage B|Protocol Violation|1|||
164685565|NCT04281472|594871358|FG000|Stage B|Sponsor decision|0|||
164685566|NCT04281472|594871359|FG001|Stage B|Sponsor decision|0|||
164685567|NCT04281472|594871360|FG002|Stage B|Sponsor decision|1|||
164685568|NCT04281472|594871358|FG000|Stage B|Withdrawal by Subject|0|||
164685569|NCT04281472|594871359|FG001|Stage B|Withdrawal by Subject|3|||
164685570|NCT04281472|594871360|FG002|Stage B|Withdrawal by Subject|3|||
164685571|NCT04281472|594871358|FG000|Stage B|Other|0|||
164685572|NCT04281472|594871359|FG001|Stage B|Other|3|||
164685573|NCT04281472|594871360|FG002|Stage B|Other|0|||
164685574|NCT01559116|594871368|FG000|Overall Study|Adverse Event|10|||
164685575|NCT01559116|594871368|FG000|Overall Study|Lack of Efficacy|1|||
164580469|NCT00847613|594492395|FG003|Overall Study|Site closure|1|||
164580470|NCT00847613|594492392|FG000|Overall Study|Withdrawal by Subject|8|||
164580471|NCT00847613|594492393|FG001|Overall Study|Withdrawal by Subject|11|||
164685576|NCT01559116|594871368|FG000|Overall Study|Lost to Follow-up|1|||
164685577|NCT01559116|594871368|FG000|Overall Study|Protocol Violation|1|||
164685578|NCT01559116|594871368|FG000|Overall Study|Withdrawal by Subject|4|||
164685579|NCT01559116|594871368|FG000|Overall Study|other than stated above|9|||
164685580|NCT01528735|594871374|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
164685581|NCT01528735|594871375|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
164685582|NCT01528735|594871374|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
164685583|NCT01528735|594871375|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
164685584|NCT03555695|594871376|FG000|Overall Study|Withdrawal by Subject|1|||
164685585|NCT03555695|594871376|FG000|Overall Study|Lost to Follow-up|1|||
164685586|NCT03555695|594871376|FG000|Overall Study|appendicitis (unrelated)|1|||
164685587|NCT03555695|594871376|FG000|Overall Study|pre-existing sciatica|1|||
164685588|NCT01426854|594871377|FG000|Overall Study|Adverse Event|1|||
164685589|NCT01426854|594871378|FG001|Overall Study|Adverse Event|5|||
164685590|NCT01426854|594871377|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
164685591|NCT01426854|594871378|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
164685592|NCT01426854|594871377|FG000|Overall Study|Lost to Follow-up|3|||
164685593|NCT01426854|594871378|FG001|Overall Study|Lost to Follow-up|0|||
164685594|NCT01426854|594871377|FG000|Overall Study|Noncompliance|0|||
164685595|NCT01426854|594871378|FG001|Overall Study|Noncompliance|1|||
164685596|NCT01426854|594871377|FG000|Overall Study|Treatment Failure|0|||
164685597|NCT01426854|594871378|FG001|Overall Study|Treatment Failure|16|||
164685598|NCT01426854|594871377|FG000|Overall Study|Protocol Deviation|0|||
164685599|NCT01426854|594871378|FG001|Overall Study|Protocol Deviation|1|||
164685600|NCT01426854|594871377|FG000|Overall Study|Other|3|||
164685601|NCT01426854|594871378|FG001|Overall Study|Other|2|||
164685602|NCT01942135|594871381|FG000|Overall Study|Adverse Event|21|||
164685603|NCT01942135|594871382|FG001|Overall Study|Adverse Event|7|||
164685604|NCT01942135|594871381|FG000|Overall Study|Global Deterioration of Health Status|9|||
164685605|NCT01942135|594871382|FG001|Overall Study|Global Deterioration of Health Status|6|||
164685606|NCT01942135|594871381|FG000|Overall Study|Randomized Not Treated|2|||
164685607|NCT01942135|594871382|FG001|Overall Study|Randomized Not Treated|2|||
164685608|NCT01942135|594871381|FG000|Overall Study|Death|2|||
164685609|NCT01942135|594871382|FG001|Overall Study|Death|1|||
164685610|NCT01942135|594871381|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
164265219|NCT03081858|593340409|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
164265220|NCT03081858|593340410|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
164265221|NCT02936284|593340413|FG000|Overall Study|Withdrawal by Subject|3|||
164265222|NCT02936284|593340414|FG001|Overall Study|Withdrawal by Subject|1|||
164265223|NCT02936284|593340413|FG000|Overall Study|Lost to Follow-up|7|||
164265224|NCT02936284|593340414|FG001|Overall Study|Lost to Follow-up|8|||
164265225|NCT01610596|593340415|FG000|Overall Study|Lost to Follow-up|0|||
164265226|NCT01610596|593340416|FG001|Overall Study|Lost to Follow-up|1|||
164265227|NCT00799591|593340419|FG000|Overall Study|De-escalation of doses|20|||
164265228|NCT00799591|593340419|FG000|Overall Study|Death|14|||
164265229|NCT00799591|593340419|FG000|Overall Study|Technical failure|12|||
164341678|NCT00787891|593627469|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
164580472|NCT00847613|594492394|FG002|Overall Study|Withdrawal by Subject|2|||
164580473|NCT00847613|594492395|FG003|Overall Study|Withdrawal by Subject|2|||
164580474|NCT00847613|594492392|FG000|Overall Study|Participant moved|4|||
164580475|NCT00847613|594492393|FG001|Overall Study|Participant moved|1|||
164580476|NCT00847613|594492394|FG002|Overall Study|Participant moved|0|||
164580477|NCT00847613|594492395|FG003|Overall Study|Participant moved|0|||
164580478|NCT00847613|594492392|FG000|Overall Study|Sponsor request|0|||
164685611|NCT01942135|594871382|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
164685612|NCT01942135|594871381|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
164265230|NCT00799591|593340419|FG000|Overall Study|Resistant germ|11|||
164265231|NCT00799591|593340419|FG000|Overall Study|New infection|4|||
164265232|NCT00799591|593340419|FG000|Overall Study|Resistance germ and technical failure|2|||
164580479|NCT00847613|594492393|FG001|Overall Study|Sponsor request|1|||
164580480|NCT00847613|594492394|FG002|Overall Study|Sponsor request|0|||
164580481|NCT00847613|594492395|FG003|Overall Study|Sponsor request|0|||
164580482|NCT00847613|594492392|FG000|Overall Study|Randomized, but not treated|0|||
164685613|NCT01942135|594871382|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
164685614|NCT01942135|594871381|FG000|Overall Study|Withdrawal by Subject|4|||
164685615|NCT01942135|594871382|FG001|Overall Study|Withdrawal by Subject|3|||
164580483|NCT00847613|594492393|FG001|Overall Study|Randomized, but not treated|3|||
164580484|NCT00847613|594492394|FG002|Overall Study|Randomized, but not treated|0|||
164580485|NCT00847613|594492395|FG003|Overall Study|Randomized, but not treated|0|||
164580486|NCT00847613|594492392|FG000|Overall Study|Other|1|||
164580487|NCT00847613|594492393|FG001|Overall Study|Other|1|||
164580488|NCT00847613|594492394|FG002|Overall Study|Other|2|||
164580489|NCT00847613|594492395|FG003|Overall Study|Other|0|||
164580490|NCT00754390|594492396|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
164580491|NCT00754390|594492396|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
164580492|NCT00754390|594492396|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
164580493|NCT00754390|594492396|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
164580494|NCT00845429|594492397|FG000|Overall Study|Protocol Violation|5|||
164580495|NCT00845429|594492398|FG001|Overall Study|Protocol Violation|4|||
164580496|NCT00845429|594492399|FG002|Overall Study|Protocol Violation|7|||
164580497|NCT00845429|594492397|FG000|Overall Study|Lost to Follow-up|7|||
164580498|NCT00845429|594492398|FG001|Overall Study|Lost to Follow-up|9|||
164580499|NCT00845429|594492399|FG002|Overall Study|Lost to Follow-up|10|||
164580500|NCT00845429|594492397|FG000|Overall Study|Withdrawal by Subject|2|||
164580501|NCT00845429|594492398|FG001|Overall Study|Withdrawal by Subject|2|||
164580502|NCT00845429|594492399|FG002|Overall Study|Withdrawal by Subject|2|||
164580503|NCT00845429|594492397|FG000|Overall Study|Serious adverse event|0|||
164580504|NCT00845429|594492398|FG001|Overall Study|Serious adverse event|0|||
164580505|NCT00845429|594492399|FG002|Overall Study|Serious adverse event|1|||
164580506|NCT00587223|594492402|FG000|Overall Study|Adverse Event|1|||
164580507|NCT03519178|594492403|FG000|PF-06873600 Treatment|Adverse Event|0|||
164580508|NCT03519178|594492404|FG001|PF-06873600 Treatment|Adverse Event|0|||
164580509|NCT03519178|594492405|FG002|PF-06873600 Treatment|Adverse Event|0|||
164580510|NCT03519178|594492406|FG003|PF-06873600 Treatment|Adverse Event|0|||
164580511|NCT03519178|594492407|FG004|PF-06873600 Treatment|Adverse Event|0|||
164580512|NCT03519178|594492408|FG005|PF-06873600 Treatment|Adverse Event|0|||
164580513|NCT03519178|594492409|FG006|PF-06873600 Treatment|Adverse Event|0|||
164580514|NCT03519178|594492410|FG007|PF-06873600 Treatment|Adverse Event|2|||
164580515|NCT03519178|594492411|FG008|PF-06873600 Treatment|Adverse Event|1|||
164580516|NCT03519178|594492412|FG009|PF-06873600 Treatment|Adverse Event|0|||
164580517|NCT03519178|594492413|FG010|PF-06873600 Treatment|Adverse Event|0|||
164580518|NCT03519178|594492414|FG011|PF-06873600 Treatment|Adverse Event|0|||
164580519|NCT03519178|594492415|FG012|PF-06873600 Treatment|Adverse Event|1|||
164580520|NCT03519178|594492416|FG013|PF-06873600 Treatment|Adverse Event|3|||
164580521|NCT03519178|594492417|FG014|PF-06873600 Treatment|Adverse Event|2|||
164580522|NCT03519178|594492403|FG000|PF-06873600 Treatment|Death|0|||
164580523|NCT03519178|594492404|FG001|PF-06873600 Treatment|Death|0|||
164580524|NCT03519178|594492405|FG002|PF-06873600 Treatment|Death|0|||
164580525|NCT03519178|594492406|FG003|PF-06873600 Treatment|Death|0|||
164580526|NCT03519178|594492407|FG004|PF-06873600 Treatment|Death|0|||
164580527|NCT03519178|594492408|FG005|PF-06873600 Treatment|Death|0|||
164580528|NCT03519178|594492409|FG006|PF-06873600 Treatment|Death|0|||
164580529|NCT03519178|594492410|FG007|PF-06873600 Treatment|Death|0|||
164580530|NCT03519178|594492411|FG008|PF-06873600 Treatment|Death|1|||
164580531|NCT03519178|594492412|FG009|PF-06873600 Treatment|Death|1|||
164580532|NCT03519178|594492413|FG010|PF-06873600 Treatment|Death|0|||
164580533|NCT03519178|594492414|FG011|PF-06873600 Treatment|Death|0|||
164580534|NCT03519178|594492415|FG012|PF-06873600 Treatment|Death|0|||
164580535|NCT03519178|594492416|FG013|PF-06873600 Treatment|Death|0|||
164580536|NCT03519178|594492417|FG014|PF-06873600 Treatment|Death|1|||
164580537|NCT03519178|594492403|FG000|PF-06873600 Treatment|Physician Decision|0|||
164580538|NCT03519178|594492404|FG001|PF-06873600 Treatment|Physician Decision|0|||
164580539|NCT03519178|594492405|FG002|PF-06873600 Treatment|Physician Decision|0|||
164265233|NCT00799591|593340419|FG000|Overall Study|Persistance of fever undetermined origin|1|||
164430357|NCT00828919|593945388|FG002|Overall Study|Death|2|||
164580540|NCT03519178|594492406|FG003|PF-06873600 Treatment|Physician Decision|0|||
164580541|NCT03519178|594492407|FG004|PF-06873600 Treatment|Physician Decision|0|||
164580542|NCT03519178|594492408|FG005|PF-06873600 Treatment|Physician Decision|0|||
164580543|NCT03519178|594492409|FG006|PF-06873600 Treatment|Physician Decision|0|||
164580544|NCT03519178|594492410|FG007|PF-06873600 Treatment|Physician Decision|1|||
164580545|NCT03519178|594492411|FG008|PF-06873600 Treatment|Physician Decision|0|||
164580546|NCT03519178|594492412|FG009|PF-06873600 Treatment|Physician Decision|0|||
164580547|NCT03519178|594492413|FG010|PF-06873600 Treatment|Physician Decision|1|||
164580548|NCT03519178|594492414|FG011|PF-06873600 Treatment|Physician Decision|0|||
164580549|NCT03519178|594492415|FG012|PF-06873600 Treatment|Physician Decision|0|||
164580550|NCT03519178|594492416|FG013|PF-06873600 Treatment|Physician Decision|4|||
164580551|NCT03519178|594492417|FG014|PF-06873600 Treatment|Physician Decision|1|||
164580552|NCT03519178|594492403|FG000|PF-06873600 Treatment|Progressive disease|1|||
164580553|NCT03519178|594492404|FG001|PF-06873600 Treatment|Progressive disease|1|||
164580554|NCT03519178|594492405|FG002|PF-06873600 Treatment|Progressive disease|1|||
164580555|NCT03519178|594492406|FG003|PF-06873600 Treatment|Progressive disease|1|||
164580556|NCT03519178|594492407|FG004|PF-06873600 Treatment|Progressive disease|6|||
164580557|NCT03519178|594492408|FG005|PF-06873600 Treatment|Progressive disease|7|||
164685616|NCT01942135|594871381|FG000|Overall Study|Protocol Violation|1|||
164685617|NCT01942135|594871382|FG001|Overall Study|Protocol Violation|0|||
164685618|NCT01942135|594871381|FG000|Overall Study|Other|19|||
164685619|NCT01942135|594871382|FG001|Overall Study|Other|4|||
164685620|NCT01499043|594871383|FG000|Overall Study|Progressive disease (radiographic)|2|||
164685621|NCT01499043|594871383|FG000|Overall Study|Progressive disease (clinical)|1|||
164685622|NCT01499043|594871383|FG000|Overall Study|Withdrawal by Subject|2|||
164685623|NCT01499043|594871383|FG000|Overall Study|Adverse Event|1|||
164685624|NCT01596127|594871387|FG000|Overall Study|Patient Ineligible|1|||
164685625|NCT01566435|594871388|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
164685626|NCT00438633|594871389|FG000|Overall Study|Withdrawal by Subject|1|||
164685627|NCT00438633|594871390|FG001|Overall Study|Withdrawal by Subject|0|||
164685628|NCT00438633|594871389|FG000|Overall Study|Lost to Follow-up|15|||
164685629|NCT00438633|594871390|FG001|Overall Study|Lost to Follow-up|17|||
164685630|NCT04569084|594871391|FG000|Overall Study|Adverse Event|10|||
164685631|NCT04569084|594871392|FG001|Overall Study|Adverse Event|14|||
164685632|NCT04569084|594871391|FG000|Overall Study|Death|2|||
164265234|NCT00799591|593340419|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
164265235|NCT00799591|593340419|FG000|Overall Study|Infectious origin not probable|1|||
164265236|NCT02098369|593340420|FG000|Overall Study|Withdrawal by Subject|1|||
164265237|NCT02098369|593340421|FG001|Overall Study|Withdrawal by Subject|5|||
164265238|NCT02098369|593340422|FG002|Overall Study|Withdrawal by Subject|0|||
164265239|NCT02098369|593340420|FG000|Overall Study|Lost to Follow-up|5|||
164265240|NCT02098369|593340421|FG001|Overall Study|Lost to Follow-up|1|||
164265241|NCT02098369|593340422|FG002|Overall Study|Lost to Follow-up|3|||
164265242|NCT02098369|593340420|FG000|Overall Study|Death|1|||
164265243|NCT02098369|593340421|FG001|Overall Study|Death|1|||
164265244|NCT02098369|593340422|FG002|Overall Study|Death|1|||
164265245|NCT02098369|593340420|FG000|Overall Study|Other|0|||
164341679|NCT00787891|593627468|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
164580558|NCT03519178|594492409|FG006|PF-06873600 Treatment|Progressive disease|3|||
164580559|NCT03519178|594492410|FG007|PF-06873600 Treatment|Progressive disease|7|||
164580560|NCT03519178|594492411|FG008|PF-06873600 Treatment|Progressive disease|3|||
164580561|NCT03519178|594492412|FG009|PF-06873600 Treatment|Progressive disease|5|||
164580562|NCT03519178|594492413|FG010|PF-06873600 Treatment|Progressive disease|4|||
164580563|NCT03519178|594492414|FG011|PF-06873600 Treatment|Progressive disease|3|||
164580564|NCT03519178|594492415|FG012|PF-06873600 Treatment|Progressive disease|4|||
164580565|NCT03519178|594492416|FG013|PF-06873600 Treatment|Progressive disease|28|||
164580566|NCT03519178|594492417|FG014|PF-06873600 Treatment|Progressive disease|8|||
164580567|NCT03519178|594492403|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
164580568|NCT03519178|594492404|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
164580569|NCT03519178|594492405|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
164580570|NCT03519178|594492406|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
164580571|NCT03519178|594492407|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
164580572|NCT03519178|594492408|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
164580573|NCT03519178|594492409|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
164580574|NCT03519178|594492410|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
164580575|NCT03519178|594492411|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
164580576|NCT03519178|594492412|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
164580577|NCT03519178|594492413|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
164580578|NCT03519178|594492414|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
164580579|NCT03519178|594492415|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
164580580|NCT03519178|594492416|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
164580581|NCT03519178|594492417|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
164580582|NCT03519178|594492403|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
164580583|NCT03519178|594492404|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
164580584|NCT03519178|594492405|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
164580585|NCT03519178|594492406|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
164580586|NCT03519178|594492407|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
164580587|NCT03519178|594492408|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
164580588|NCT03519178|594492409|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
164580589|NCT03519178|594492410|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
164580590|NCT03519178|594492411|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
164580591|NCT03519178|594492412|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
164580592|NCT03519178|594492413|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
164580593|NCT03519178|594492414|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
164580594|NCT03519178|594492415|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
164580595|NCT03519178|594492416|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
164685633|NCT04569084|594871392|FG001|Overall Study|Death|3|||
164685634|NCT04569084|594871391|FG000|Overall Study|Lost to Follow-up|1|||
164685635|NCT04569084|594871392|FG001|Overall Study|Lost to Follow-up|1|||
164580596|NCT03519178|594492417|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
164685636|NCT04569084|594871391|FG000|Overall Study|Physician Decision|3|||
164685637|NCT04569084|594871392|FG001|Overall Study|Physician Decision|3|||
164685638|NCT04569084|594871391|FG000|Overall Study|Protocol Violation|2|||
164685639|NCT04569084|594871392|FG001|Overall Study|Protocol Violation|1|||
164685640|NCT04569084|594871391|FG000|Overall Study|Withdrawal by Subject|20|||
164685641|NCT04569084|594871392|FG001|Overall Study|Withdrawal by Subject|21|||
164685642|NCT04569084|594871391|FG000|Overall Study|Study terminated by sponsor|26|||
164685643|NCT04569084|594871392|FG001|Overall Study|Study terminated by sponsor|23|||
164685644|NCT04569084|594871391|FG000|Overall Study|Other|3|||
164685645|NCT04569084|594871392|FG001|Overall Study|Other|5|||
164685646|NCT03196284|594871393|FG000|Main Part|Withdrawal by Subject|0|||
164685647|NCT03196284|594871394|FG001|Main Part|Withdrawal by Subject|1|||
164685648|NCT03196284|594871395|FG002|Main Part|Withdrawal by Subject|0|||
164685649|NCT03196284|594871393|FG000|Extension Part|Lack of Efficacy|0|||
164685650|NCT03196284|594871394|FG001|Extension Part|Lack of Efficacy|0|||
164685651|NCT03196284|594871395|FG002|Extension Part|Lack of Efficacy|1|||
164685652|NCT03196284|594871393|FG000|Extension Part|Withdrawal by Subject|0|||
164685653|NCT03196284|594871394|FG001|Extension Part|Withdrawal by Subject|0|||
164685654|NCT03196284|594871395|FG002|Extension Part|Withdrawal by Subject|1|||
164685655|NCT03196284|594871393|FG000|Extension Part|Physician Decision|0|||
164685656|NCT03196284|594871394|FG001|Extension Part|Physician Decision|0|||
164685657|NCT03196284|594871395|FG002|Extension Part|Physician Decision|1|||
164685658|NCT04729101|594873180|FG000|Overall Study|Adverse Event|1|||
164685659|NCT04729101|594873181|FG001|Overall Study|Adverse Event|0|||
164685660|NCT04729101|594873180|FG000|Overall Study|Physician Decision|1|||
164685661|NCT04729101|594873181|FG001|Overall Study|Physician Decision|0|||
164685662|NCT04729101|594873180|FG000|Overall Study|Withdrawal by Subject|1|||
164685663|NCT04729101|594873181|FG001|Overall Study|Withdrawal by Subject|0|||
164685664|NCT00274625|594873182|FG000|Overall Study|Lost to Follow-up|46|||
164685665|NCT00274625|594873183|FG001|Overall Study|Lost to Follow-up|54|||
164685666|NCT00274625|594873182|FG000|Overall Study|Excluded from analysis|14|||
164685667|NCT00274625|594873183|FG001|Overall Study|Excluded from analysis|8|||
164685668|NCT02940522|594873184|FG000|Overall Study|Lost to Follow-up|1|||
164685669|NCT02940522|594873185|FG001|Overall Study|Lost to Follow-up|2|||
164685670|NCT02940522|594873184|FG000|Overall Study|Withdrawal by Subject|1|||
164685671|NCT02940522|594873185|FG001|Overall Study|Withdrawal by Subject|0|||
164685672|NCT00762411|594873186|FG000|Initial Treatment|Death|7|||
164685673|NCT00762411|594873187|FG001|Initial Treatment|Death|6|||
164685674|NCT00762411|594873186|FG000|Initial Treatment|Adverse Event|132|||
164685675|NCT00762411|594873187|FG001|Initial Treatment|Adverse Event|40|||
164685676|NCT00762411|594873186|FG000|Initial Treatment|Protocol Violation|4|||
164265246|NCT02098369|593340421|FG001|Overall Study|Other|2|||
164265247|NCT02098369|593340422|FG002|Overall Study|Other|1|||
164265248|NCT00570037|593340423|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
164265249|NCT00570037|593340424|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
164265250|NCT00413920|593340426|FG000|Overall Study|Adverse Event|9|||
164265251|NCT00413920|593340427|FG001|Overall Study|Adverse Event|11|||
164265252|NCT00413920|593340426|FG000|Overall Study|Lack of Efficacy|11|||
164265253|NCT00413920|593340427|FG001|Overall Study|Lack of Efficacy|9|||
164265254|NCT00413920|593340426|FG000|Overall Study|Death|3|||
164580597|NCT03519178|594492403|FG000|PF-06873600 Treatment|Refused further treatment|0|||
164580598|NCT03519178|594492404|FG001|PF-06873600 Treatment|Refused further treatment|1|||
164580599|NCT03519178|594492405|FG002|PF-06873600 Treatment|Refused further treatment|0|||
164580600|NCT03519178|594492406|FG003|PF-06873600 Treatment|Refused further treatment|0|||
164580601|NCT03519178|594492407|FG004|PF-06873600 Treatment|Refused further treatment|1|||
164580602|NCT03519178|594492408|FG005|PF-06873600 Treatment|Refused further treatment|0|||
164580603|NCT03519178|594492409|FG006|PF-06873600 Treatment|Refused further treatment|0|||
164580604|NCT03519178|594492410|FG007|PF-06873600 Treatment|Refused further treatment|0|||
164580605|NCT03519178|594492411|FG008|PF-06873600 Treatment|Refused further treatment|0|||
164580606|NCT03519178|594492412|FG009|PF-06873600 Treatment|Refused further treatment|0|||
164580607|NCT03519178|594492413|FG010|PF-06873600 Treatment|Refused further treatment|0|||
164685677|NCT00762411|594873187|FG001|Initial Treatment|Protocol Violation|1|||
164685678|NCT00762411|594873186|FG000|Initial Treatment|Withdrawal by Subject|65|||
164685679|NCT00762411|594873187|FG001|Initial Treatment|Withdrawal by Subject|52|||
164685680|NCT00762411|594873186|FG000|Initial Treatment|Physician Decision|1|||
164685681|NCT00762411|594873187|FG001|Initial Treatment|Physician Decision|0|||
164685682|NCT00762411|594873186|FG000|Initial Treatment|Sponsor Decision|293|||
164685683|NCT00762411|594873187|FG001|Initial Treatment|Sponsor Decision|401|||
164265255|NCT00413920|593340427|FG001|Overall Study|Death|5|||
164341680|NCT00787891|593627469|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
164341681|NCT00787891|593627468|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
164430358|NCT00828919|593945389|FG003|Overall Study|Death|0|||
164580608|NCT03519178|594492414|FG011|PF-06873600 Treatment|Refused further treatment|0|||
164580609|NCT03519178|594492415|FG012|PF-06873600 Treatment|Refused further treatment|0|||
164580610|NCT03519178|594492416|FG013|PF-06873600 Treatment|Refused further treatment|0|||
164685684|NCT00762411|594873186|FG000|Initial Treatment|Lost to Follow-up|5|||
164685685|NCT00762411|594873187|FG001|Initial Treatment|Lost to Follow-up|0|||
164685686|NCT00762411|594873186|FG000|Initial Treatment|Caregiver Decision|21|||
164685687|NCT00762411|594873187|FG001|Initial Treatment|Caregiver Decision|16|||
164685688|NCT00762411|594873186|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
164685689|NCT00762411|594873187|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
164685690|NCT00762411|594873186|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
164685691|NCT00762411|594873187|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
164685692|NCT00762411|594873186|FG000|Delayed Start|Adverse Event|0|||
164685693|NCT00762411|594873187|FG001|Delayed Start|Adverse Event|4|||
164685694|NCT00762411|594873186|FG000|Delayed Start|Protocol Violation|0|||
164685695|NCT00762411|594873187|FG001|Delayed Start|Protocol Violation|1|||
164685696|NCT00762411|594873186|FG000|Delayed Start|Sponsor Decision|16|||
164685697|NCT00762411|594873187|FG001|Delayed Start|Sponsor Decision|20|||
164685698|NCT00762411|594873186|FG000|Delayed Start|Caregiver Decision|1|||
164685699|NCT00762411|594873187|FG001|Delayed Start|Caregiver Decision|1|||
164685700|NCT00762411|594873186|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
164685701|NCT00762411|594873187|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
164685702|NCT00762411|594873186|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
164685703|NCT00762411|594873187|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
164685704|NCT00762411|594873186|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
164685705|NCT00762411|594873187|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
164685706|NCT00762411|594873186|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
164685707|NCT00762411|594873187|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
164685708|NCT00762411|594873186|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
164685709|NCT00762411|594873187|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
164685710|NCT00762411|594873186|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
164685711|NCT00762411|594873187|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
164685712|NCT04556734|594873191|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
164685713|NCT04556734|594873192|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
164685714|NCT04556734|594873193|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
164685715|NCT04556734|594873194|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164685716|NCT04556734|594873195|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164685717|NCT04556734|594873196|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164685718|NCT04556734|594873197|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164685719|NCT04556734|594873198|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164685720|NCT04556734|594873191|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
164685721|NCT04556734|594873192|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
164685722|NCT04556734|594873193|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
164685723|NCT04556734|594873194|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
164265256|NCT00413920|593340426|FG000|Overall Study|Graft Loss|5|||
164265257|NCT00413920|593340427|FG001|Overall Study|Graft Loss|3|||
164265258|NCT01765426|593340428|FG000|Overall Study|Lost to Follow-up|0|||
164265259|NCT01765426|593340429|FG001|Overall Study|Lost to Follow-up|1|||
164265260|NCT01765426|593340430|FG002|Overall Study|Lost to Follow-up|0|||
164265261|NCT01765426|593340431|FG003|Overall Study|Lost to Follow-up|0|||
164265262|NCT01665430|593340432|FG000|Overall Study|Adverse Event|1|||
164265263|NCT01665430|593340432|FG000|Overall Study|Withdrawal by Subject|6|||
164265264|NCT01665430|593340432|FG000|Overall Study|Other Unspecified|2|||
164265265|NCT02310230|593340433|FG000|Overall Study|Physician Decision|1|||
164265266|NCT02310230|593340434|FG001|Overall Study|Physician Decision|3|||
164265267|NCT02310230|593340433|FG000|Overall Study|monitor baseline taken after induction|2|||
164265268|NCT02310230|593340434|FG001|Overall Study|monitor baseline taken after induction|7|||
164685724|NCT04556734|594873195|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
164685725|NCT04556734|594873196|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
164685726|NCT04556734|594873197|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
164685727|NCT04556734|594873198|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
164685728|NCT04556734|594873191|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
164685729|NCT04556734|594873192|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164685730|NCT04556734|594873193|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
164685731|NCT04556734|594873194|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164685732|NCT04556734|594873195|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164685733|NCT04556734|594873196|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164685734|NCT04556734|594873197|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164685735|NCT04556734|594873198|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164685736|NCT04556734|594873191|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
164685737|NCT04556734|594873192|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
164685738|NCT04556734|594873193|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
164265269|NCT02310230|593340433|FG000|Overall Study|Poor signal quality|5|||
164265270|NCT02310230|593340434|FG001|Overall Study|Poor signal quality|8|||
164265271|NCT02310230|593340433|FG000|Overall Study|Case cancelled|1|||
164265272|NCT02310230|593340434|FG001|Overall Study|Case cancelled|0|||
164265273|NCT00545532|593340435|FG000|Overall Study|Withdrawal by Subject|1|||
164685739|NCT04556734|594873194|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
164685740|NCT04556734|594873195|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
164685741|NCT04556734|594873196|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
164685742|NCT04556734|594873197|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
164685743|NCT04556734|594873198|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
164685744|NCT04556734|594873191|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
164685745|NCT04556734|594873192|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
164685746|NCT04556734|594873193|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
164685747|NCT04556734|594873194|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
164685748|NCT04556734|594873195|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
164685749|NCT04556734|594873196|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
164685750|NCT04556734|594873197|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
164685751|NCT04556734|594873198|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
164685752|NCT04556734|594873191|FG000|OLE Period (28 Weeks)|Not reported|0|||
164685753|NCT04556734|594873192|FG001|OLE Period (28 Weeks)|Not reported|0|||
164685754|NCT04556734|594873193|FG002|OLE Period (28 Weeks)|Not reported|0|||
164685755|NCT04556734|594873194|FG003|OLE Period (28 Weeks)|Not reported|0|||
164685756|NCT04556734|594873195|FG004|OLE Period (28 Weeks)|Not reported|0|||
164685757|NCT04556734|594873196|FG005|OLE Period (28 Weeks)|Not reported|1|||
164685758|NCT04556734|594873197|FG006|OLE Period (28 Weeks)|Not reported|0|||
164685759|NCT04556734|594873198|FG007|OLE Period (28 Weeks)|Not reported|0|||
164685760|NCT04556734|594873191|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
164685761|NCT04556734|594873192|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
164685762|NCT04556734|594873193|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
164685763|NCT04556734|594873194|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
164685764|NCT04556734|594873195|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
164685765|NCT04556734|594873196|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
164685766|NCT04556734|594873197|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
164685767|NCT04556734|594873198|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
164685768|NCT04556734|594873191|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
164685769|NCT04556734|594873192|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
164685770|NCT04556734|594873193|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
164685771|NCT04556734|594873194|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
164685772|NCT04556734|594873195|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
164685773|NCT04556734|594873196|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
164685774|NCT04556734|594873197|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
164685775|NCT04556734|594873198|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
164685776|NCT04556734|594873191|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
164685777|NCT04556734|594873192|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
164685778|NCT04556734|594873193|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
164685779|NCT04556734|594873194|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
164685780|NCT04556734|594873195|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
164685781|NCT04556734|594873196|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
164685782|NCT04556734|594873197|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
164685783|NCT04556734|594873198|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
164685784|NCT01813435|594873205|FG000|Overall Study|did not finish experimental regimen|1902|||
164685785|NCT01813435|594873206|FG001|Overall Study|did not finish experimental regimen|770|||
164685786|NCT01813435|594873205|FG000|Overall Study|Lost to Follow-up|268|||
164685787|NCT01813435|594873206|FG001|Overall Study|Lost to Follow-up|237|||
164685788|NCT01765751|594873213|FG000|Overall Study|Lost to Follow-up|0|||
164685789|NCT01765751|594873214|FG001|Overall Study|Lost to Follow-up|2|||
164685790|NCT01765751|594873215|FG002|Overall Study|Lost to Follow-up|1|||
164685791|NCT01120899|594873216|FG000|Overall Study|Withdrawal by Subject|3|||
164685792|NCT00452348|594873217|FG000|Overall Study|Adverse Event|6|||
164685793|NCT00452348|594873218|FG001|Overall Study|Adverse Event|9|||
164685794|NCT00452348|594873217|FG000|Overall Study|Lack of Efficacy|10|||
164685795|NCT00452348|594873218|FG001|Overall Study|Lack of Efficacy|9|||
164685796|NCT00452348|594873217|FG000|Overall Study|Lost to Follow-up|14|||
164685797|NCT00452348|594873218|FG001|Overall Study|Lost to Follow-up|8|||
164685798|NCT00452348|594873217|FG000|Overall Study|Protocol Violation|22|||
164685799|NCT00452348|594873218|FG001|Overall Study|Protocol Violation|28|||
164685800|NCT00452348|594873217|FG000|Overall Study|Withdrawal by Subject|18|||
164685801|NCT00452348|594873218|FG001|Overall Study|Withdrawal by Subject|21|||
164685802|NCT00452348|594873217|FG000|Overall Study|Other|9|||
164685803|NCT00452348|594873218|FG001|Overall Study|Other|9|||
164685804|NCT01243151|594873221|FG000|Overall Study|Adverse Event|0|||
164685805|NCT01243151|594873222|FG001|Overall Study|Adverse Event|1|||
164685806|NCT01243151|594873223|FG002|Overall Study|Adverse Event|0|||
164685807|NCT01243151|594873224|FG003|Overall Study|Adverse Event|0|||
164685808|NCT01243151|594873225|FG004|Overall Study|Adverse Event|0|||
164685809|NCT01243151|594873221|FG000|Overall Study|Protocol Violation|0|||
164685810|NCT01243151|594873222|FG001|Overall Study|Protocol Violation|0|||
164685811|NCT01243151|594873223|FG002|Overall Study|Protocol Violation|1|||
164685812|NCT01243151|594873224|FG003|Overall Study|Protocol Violation|0|||
164685813|NCT01243151|594873225|FG004|Overall Study|Protocol Violation|0|||
164685814|NCT01243151|594873221|FG000|Overall Study|Other|0|||
164341682|NCT00787891|593627469|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
164341683|NCT00787891|593627468|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
164341684|NCT00787891|593627469|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
164341685|NCT01594281|593627470|FG000|Interventional Core Phase|Protocol Deviation|1|||
164341686|NCT01594281|593627471|FG001|Interventional Core Phase|Protocol Deviation|0|||
164580611|NCT03519178|594492417|FG014|PF-06873600 Treatment|Refused further treatment|1|||
164580612|NCT03519178|594492403|FG000|PF-06873600 Treatment|Other|0|||
164580613|NCT03519178|594492404|FG001|PF-06873600 Treatment|Other|0|||
164580614|NCT03519178|594492405|FG002|PF-06873600 Treatment|Other|0|||
164580615|NCT03519178|594492406|FG003|PF-06873600 Treatment|Other|0|||
164580616|NCT03519178|594492407|FG004|PF-06873600 Treatment|Other|0|||
164580617|NCT03519178|594492408|FG005|PF-06873600 Treatment|Other|0|||
164580618|NCT03519178|594492409|FG006|PF-06873600 Treatment|Other|0|||
164580619|NCT03519178|594492410|FG007|PF-06873600 Treatment|Other|0|||
164580620|NCT03519178|594492411|FG008|PF-06873600 Treatment|Other|1|||
164580621|NCT03519178|594492412|FG009|PF-06873600 Treatment|Other|0|||
164580622|NCT03519178|594492413|FG010|PF-06873600 Treatment|Other|0|||
164580623|NCT03519178|594492414|FG011|PF-06873600 Treatment|Other|0|||
164580624|NCT03519178|594492415|FG012|PF-06873600 Treatment|Other|0|||
164580625|NCT03519178|594492416|FG013|PF-06873600 Treatment|Other|1|||
164580626|NCT03519178|594492417|FG014|PF-06873600 Treatment|Other|3|||
164580627|NCT03519178|594492403|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
164580628|NCT03519178|594492404|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
164580629|NCT03519178|594492405|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
164580630|NCT03519178|594492406|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
164580631|NCT03519178|594492407|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
164580632|NCT03519178|594492408|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
164580633|NCT03519178|594492409|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
164580634|NCT03519178|594492410|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
164580635|NCT03519178|594492411|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
164580636|NCT03519178|594492412|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
164580637|NCT03519178|594492413|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
164580638|NCT03519178|594492414|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
164580639|NCT03519178|594492415|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
164580640|NCT03519178|594492416|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
164580641|NCT03519178|594492417|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
164580642|NCT03519178|594492403|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
164580643|NCT03519178|594492404|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
164580644|NCT03519178|594492405|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
164580645|NCT03519178|594492406|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
164580646|NCT03519178|594492407|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
164580647|NCT03519178|594492408|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
164580648|NCT03519178|594492409|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
164580649|NCT03519178|594492410|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
164580650|NCT03519178|594492411|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
164580651|NCT03519178|594492412|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
164580652|NCT03519178|594492413|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
164580653|NCT03519178|594492414|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
164580654|NCT03519178|594492415|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
164580655|NCT03519178|594492416|FG013|PF-06873600 Treatment|Study terminated by sponsor|5|||
164580656|NCT03519178|594492417|FG014|PF-06873600 Treatment|Study terminated by sponsor|9|||
164580657|NCT03519178|594492403|FG000|Fulvestrant. Treatment|Adverse Event|0|||
164580658|NCT03519178|594492404|FG001|Fulvestrant. Treatment|Adverse Event|0|||
164580659|NCT03519178|594492405|FG002|Fulvestrant. Treatment|Adverse Event|0|||
164580660|NCT03519178|594492406|FG003|Fulvestrant. Treatment|Adverse Event|0|||
164580661|NCT03519178|594492407|FG004|Fulvestrant. Treatment|Adverse Event|0|||
164580662|NCT03519178|594492408|FG005|Fulvestrant. Treatment|Adverse Event|0|||
164580663|NCT03519178|594492409|FG006|Fulvestrant. Treatment|Adverse Event|0|||
164580664|NCT03519178|594492410|FG007|Fulvestrant. Treatment|Adverse Event|0|||
164580665|NCT03519178|594492411|FG008|Fulvestrant. Treatment|Adverse Event|0|||
164580666|NCT03519178|594492412|FG009|Fulvestrant. Treatment|Adverse Event|0|||
164580667|NCT03519178|594492413|FG010|Fulvestrant. Treatment|Adverse Event|0|||
164580668|NCT03519178|594492414|FG011|Fulvestrant. Treatment|Adverse Event|0|||
164580669|NCT03519178|594492415|FG012|Fulvestrant. Treatment|Adverse Event|0|||
164580670|NCT03519178|594492416|FG013|Fulvestrant. Treatment|Adverse Event|1|||
164580671|NCT03519178|594492417|FG014|Fulvestrant. Treatment|Adverse Event|0|||
164580672|NCT03519178|594492403|FG000|Fulvestrant. Treatment|Death|0|||
164580673|NCT03519178|594492404|FG001|Fulvestrant. Treatment|Death|0|||
164580674|NCT03519178|594492405|FG002|Fulvestrant. Treatment|Death|0|||
164580675|NCT03519178|594492406|FG003|Fulvestrant. Treatment|Death|0|||
164580676|NCT03519178|594492407|FG004|Fulvestrant. Treatment|Death|0|||
164580677|NCT03519178|594492408|FG005|Fulvestrant. Treatment|Death|0|||
164580678|NCT03519178|594492409|FG006|Fulvestrant. Treatment|Death|0|||
164580679|NCT03519178|594492410|FG007|Fulvestrant. Treatment|Death|0|||
164580680|NCT03519178|594492411|FG008|Fulvestrant. Treatment|Death|0|||
164685815|NCT01243151|594873222|FG001|Overall Study|Other|0|||
164685816|NCT01243151|594873223|FG002|Overall Study|Other|0|||
164685817|NCT01243151|594873224|FG003|Overall Study|Other|1|||
164685818|NCT01243151|594873225|FG004|Overall Study|Other|0|||
164685819|NCT01243151|594873221|FG000|Overall Study|Randomized but not treated|0|||
164685820|NCT01243151|594873222|FG001|Overall Study|Randomized but not treated|0|||
164685821|NCT01243151|594873223|FG002|Overall Study|Randomized but not treated|0|||
164685822|NCT01243151|594873224|FG003|Overall Study|Randomized but not treated|1|||
164685823|NCT01243151|594873225|FG004|Overall Study|Randomized but not treated|0|||
164430359|NCT00828919|593945390|FG004|Overall Study|Death|0|||
164430360|NCT00828919|593945386|FG000|Overall Study|Adverse Event|2|||
164430361|NCT00828919|593945387|FG001|Overall Study|Adverse Event|2|||
164430362|NCT00828919|593945388|FG002|Overall Study|Adverse Event|2|||
164430363|NCT00828919|593945389|FG003|Overall Study|Adverse Event|1|||
164430364|NCT00828919|593945390|FG004|Overall Study|Adverse Event|3|||
164430365|NCT00828919|593945386|FG000|Overall Study|Objective progression or relapse|4|||
164430366|NCT00828919|593945387|FG001|Overall Study|Objective progression or relapse|4|||
164430367|NCT00828919|593945388|FG002|Overall Study|Objective progression or relapse|11|||
164430368|NCT00828919|593945389|FG003|Overall Study|Objective progression or relapse|0|||
164430369|NCT00828919|593945390|FG004|Overall Study|Objective progression or relapse|5|||
164430370|NCT00828919|593945386|FG000|Overall Study|No longer willing to participate in study|0|||
164430371|NCT00828919|593945387|FG001|Overall Study|No longer willing to participate in study|0|||
164430372|NCT00828919|593945388|FG002|Overall Study|No longer willing to participate in study|2|||
164430373|NCT00828919|593945389|FG003|Overall Study|No longer willing to participate in study|0|||
164430374|NCT00828919|593945390|FG004|Overall Study|No longer willing to participate in study|0|||
164430375|NCT00828919|593945386|FG000|Overall Study|Insufficient Clinical Response|0|||
164430376|NCT00828919|593945387|FG001|Overall Study|Insufficient Clinical Response|1|||
164430377|NCT00828919|593945388|FG002|Overall Study|Insufficient Clinical Response|2|||
164430378|NCT00828919|593945389|FG003|Overall Study|Insufficient Clinical Response|0|||
164430379|NCT00828919|593945390|FG004|Overall Study|Insufficient Clinical Response|0|||
164430380|NCT00828919|593945386|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
164430381|NCT00828919|593945387|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
164430382|NCT00828919|593945388|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
164430383|NCT00828919|593945389|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
164430384|NCT00828919|593945390|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
164430385|NCT00828919|593945386|FG000|Overall Study|Other|1|||
164430386|NCT00828919|593945387|FG001|Overall Study|Other|0|||
164430387|NCT00828919|593945388|FG002|Overall Study|Other|1|||
164430388|NCT00828919|593945389|FG003|Overall Study|Other|1|||
164430389|NCT00828919|593945390|FG004|Overall Study|Other|0|||
164430390|NCT00828919|593945386|FG000|Overall Study|Lost to Follow-up|0|||
164430391|NCT00828919|593945387|FG001|Overall Study|Lost to Follow-up|1|||
164430392|NCT00828919|593945388|FG002|Overall Study|Lost to Follow-up|0|||
164430393|NCT00828919|593945389|FG003|Overall Study|Lost to Follow-up|0|||
164430394|NCT00828919|593945390|FG004|Overall Study|Lost to Follow-up|0|||
164430395|NCT01562743|593945391|FG000|Overall Study|Adverse Event|29|||
164430396|NCT01562743|593945391|FG000|Overall Study|Lack of Efficacy|3|||
164430397|NCT01562743|593945391|FG000|Overall Study|Withdrawal by Subject|13|||
164430398|NCT01562743|593945391|FG000|Overall Study|Protocol Violation|1|||
164685824|NCT03119662|594873226|FG000|Overall Study|Withdrawal by Subject|0|||
164685825|NCT03119662|594873227|FG001|Overall Study|Withdrawal by Subject|1|||
164685826|NCT00544167|594873229|FG000|Overall Study|Adverse Event|21|||
164265274|NCT00545532|593340436|FG001|Overall Study|Withdrawal by Subject|3|||
164265275|NCT00545532|593340435|FG000|Overall Study|Lost to Follow-up|5|||
164265276|NCT00545532|593340436|FG001|Overall Study|Lost to Follow-up|6|||
164265277|NCT00545532|593340435|FG000|Overall Study|Death|0|||
164265278|NCT00545532|593340436|FG001|Overall Study|Death|1|||
164265279|NCT03593681|593340437|FG000|Overall Study|Inadequate sample collected|12|||
164265280|NCT03593681|593340437|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
164265281|NCT03593681|593340437|FG000|Overall Study|Protocol Violation|3|||
164265282|NCT03593681|593340437|FG000|Overall Study|Withdrawal by Subject|3|||
164265283|NCT03593681|593340437|FG000|Overall Study|Procedure not attempted|3|||
164265284|NCT03593681|593340437|FG000|Overall Study|Adverse Event|2|||
164265285|NCT03593681|593340437|FG000|Overall Study|Physician Decision|1|||
164265286|NCT01149486|593340438|FG000|First Intervention|Adverse Event|0|||
164265287|NCT01149486|593340439|FG001|First Intervention|Adverse Event|1|||
164265288|NCT00598078|593340440|FG000|Period 2 (Day 2)|Adverse Event|1|||
164265289|NCT00598078|593340441|FG001|Period 2 (Day 2)|Adverse Event|0|||
164265290|NCT01479595|593340444|FG000|Overall Study|Protocol deviation|0|||
164265291|NCT01479595|593340445|FG001|Overall Study|Protocol deviation|1|||
164265292|NCT01479595|593340444|FG000|Overall Study|Adverse Event|2|||
164685827|NCT00544167|594873229|FG000|Overall Study|Physician Decision|8|||
164265293|NCT01479595|593340445|FG001|Overall Study|Adverse Event|1|||
164685828|NCT00874549|594873230|FG000|Overall Study|Adverse Event|0|||
164265294|NCT02120365|593340446|FG000|Overall Study|Withdrawal by Subject|0|||
164685829|NCT00874549|594873231|FG001|Overall Study|Adverse Event|0|||
164685830|NCT00874549|594873232|FG002|Overall Study|Adverse Event|1|||
164685831|NCT00874549|594873233|FG003|Overall Study|Adverse Event|0|||
164685832|NCT00874549|594873230|FG000|Overall Study|Protocol Violation|1|||
164685833|NCT00874549|594873231|FG001|Overall Study|Protocol Violation|0|||
164685834|NCT00874549|594873232|FG002|Overall Study|Protocol Violation|2|||
164685835|NCT00874549|594873233|FG003|Overall Study|Protocol Violation|1|||
164685836|NCT00874549|594873230|FG000|Overall Study|Lost to Follow-up|0|||
164685837|NCT00874549|594873231|FG001|Overall Study|Lost to Follow-up|0|||
164685838|NCT00874549|594873232|FG002|Overall Study|Lost to Follow-up|1|||
164685839|NCT00874549|594873233|FG003|Overall Study|Lost to Follow-up|0|||
164685840|NCT00874549|594873230|FG000|Overall Study|Withdrawal by Subject|0|||
164685841|NCT00874549|594873231|FG001|Overall Study|Withdrawal by Subject|1|||
164685842|NCT00874549|594873232|FG002|Overall Study|Withdrawal by Subject|0|||
164685843|NCT00874549|594873233|FG003|Overall Study|Withdrawal by Subject|1|||
164685844|NCT01710358|594873236|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
164685845|NCT01710358|594873237|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
164430399|NCT01562743|593945391|FG000|Overall Study|Discontinuation criteria|2|||
164430400|NCT01562743|593945391|FG000|Overall Study|Lost to Follow-up|2|||
164430401|NCT01562743|593945391|FG000|Overall Study|Physician Decision|2|||
164430402|NCT01537133|593947205|FG000|Overall Study|Withdrawal by Subject|2|||
164430403|NCT01537133|593947206|FG001|Overall Study|Withdrawal by Subject|0|||
164430404|NCT01537133|593947207|FG002|Overall Study|Withdrawal by Subject|0|||
164430405|NCT01537133|593947208|FG003|Overall Study|Withdrawal by Subject|0|||
164430406|NCT01537133|593947205|FG000|Overall Study|Lost to Follow-up|1|||
164430407|NCT01537133|593947206|FG001|Overall Study|Lost to Follow-up|0|||
164430408|NCT01537133|593947207|FG002|Overall Study|Lost to Follow-up|0|||
164430409|NCT01537133|593947208|FG003|Overall Study|Lost to Follow-up|0|||
164430410|NCT00349908|593947209|FG000|Overall Study|Withdrawal by Subject|0|||
164430411|NCT00349908|593947210|FG001|Overall Study|Withdrawal by Subject|4|||
164430412|NCT01289119|593947214|FG000|Overall Study|Adverse Event|2|||
164430413|NCT01289119|593947215|FG001|Overall Study|Adverse Event|1|||
164430414|NCT01289119|593947216|FG002|Overall Study|Adverse Event|0|||
164430415|NCT01289119|593947217|FG003|Overall Study|Adverse Event|2|||
164685846|NCT01710358|594873238|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
164685847|NCT01710358|594873236|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
164685848|NCT01710358|594873237|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
164685849|NCT01710358|594873238|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
164685850|NCT01710358|594873236|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
164685851|NCT01710358|594873237|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
164430416|NCT01289119|593947218|FG004|Overall Study|Adverse Event|1|||
164430417|NCT01289119|593947219|FG005|Overall Study|Adverse Event|0|||
164685852|NCT01710358|594873238|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
164685853|NCT01710358|594873236|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
164685854|NCT01710358|594873237|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
164685855|NCT01710358|594873238|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
164685856|NCT01710358|594873236|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
164685857|NCT01710358|594873237|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
164685858|NCT01710358|594873238|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
164685859|NCT01710358|594873236|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
164685860|NCT01710358|594873237|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
164685861|NCT01710358|594873238|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
164685862|NCT01710358|594873236|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
164685863|NCT01710358|594873237|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
164685864|NCT01710358|594873238|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
164265295|NCT02120365|593340447|FG001|Overall Study|Withdrawal by Subject|0|||
164265296|NCT02120365|593340448|FG002|Overall Study|Withdrawal by Subject|2|||
164265297|NCT02120365|593340449|FG003|Overall Study|Withdrawal by Subject|4|||
164265298|NCT02120365|593340450|FG004|Overall Study|Withdrawal by Subject|0|||
164265299|NCT02120365|593340451|FG005|Overall Study|Withdrawal by Subject|2|||
164265300|NCT01344629|593340454|FG000|Crossover Period 2|Withdrawal by Subject|0|||
164265301|NCT01344629|593340455|FG001|Crossover Period 2|Withdrawal by Subject|1|||
164265302|NCT00900146|593340456|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
164265303|NCT00900146|593340457|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
164265304|NCT00900146|593340458|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
164430418|NCT01289119|593947214|FG000|Overall Study|Major Protocol Deviation|2|||
164685865|NCT01710358|594873236|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
164685866|NCT01710358|594873237|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
164430419|NCT01289119|593947215|FG001|Overall Study|Major Protocol Deviation|1|||
164685867|NCT01710358|594873238|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
164685868|NCT01710358|594873236|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
164685869|NCT01710358|594873237|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
164265305|NCT00900146|593340459|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
164265306|NCT00900146|593340460|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
164265307|NCT00900146|593340456|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
164265308|NCT00900146|593340457|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
164265309|NCT00900146|593340458|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
164265310|NCT00900146|593340459|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
164265311|NCT00900146|593340460|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
164265312|NCT00900146|593340456|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
164265313|NCT00900146|593340457|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
164265314|NCT00900146|593340458|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
164265315|NCT00900146|593340459|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
164265316|NCT00900146|593340460|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
164265317|NCT00900146|593340456|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
164265318|NCT00900146|593340457|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
164265319|NCT00900146|593340458|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
164265320|NCT00900146|593340459|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
164265321|NCT00900146|593340460|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
164265322|NCT00900146|593340456|FG000|Intermediate: Period III|Lost to Follow-up|2|||
164265323|NCT00900146|593340457|FG001|Intermediate: Period III|Lost to Follow-up|0|||
164265324|NCT00900146|593340458|FG002|Intermediate: Period III|Lost to Follow-up|0|||
164265325|NCT00900146|593340459|FG003|Intermediate: Period III|Lost to Follow-up|0|||
164265326|NCT00900146|593340460|FG004|Intermediate: Period III|Lost to Follow-up|1|||
164580681|NCT03519178|594492412|FG009|Fulvestrant. Treatment|Death|1|||
164580682|NCT03519178|594492413|FG010|Fulvestrant. Treatment|Death|0|||
164580683|NCT03519178|594492414|FG011|Fulvestrant. Treatment|Death|0|||
164580684|NCT03519178|594492415|FG012|Fulvestrant. Treatment|Death|0|||
164580685|NCT03519178|594492416|FG013|Fulvestrant. Treatment|Death|0|||
164580686|NCT03519178|594492417|FG014|Fulvestrant. Treatment|Death|1|||
164580687|NCT03519178|594492403|FG000|Fulvestrant. Treatment|Lost to Follow-up|0|||
164580688|NCT03519178|594492404|FG001|Fulvestrant. Treatment|Lost to Follow-up|0|||
164580689|NCT03519178|594492405|FG002|Fulvestrant. Treatment|Lost to Follow-up|0|||
164580690|NCT03519178|594492406|FG003|Fulvestrant. Treatment|Lost to Follow-up|0|||
164580691|NCT03519178|594492407|FG004|Fulvestrant. Treatment|Lost to Follow-up|0|||
164580692|NCT03519178|594492408|FG005|Fulvestrant. Treatment|Lost to Follow-up|0|||
164580693|NCT03519178|594492409|FG006|Fulvestrant. Treatment|Lost to Follow-up|0|||
164580694|NCT03519178|594492410|FG007|Fulvestrant. Treatment|Lost to Follow-up|0|||
164580695|NCT03519178|594492411|FG008|Fulvestrant. Treatment|Lost to Follow-up|0|||
164580696|NCT03519178|594492412|FG009|Fulvestrant. Treatment|Lost to Follow-up|0|||
164580697|NCT03519178|594492413|FG010|Fulvestrant. Treatment|Lost to Follow-up|0|||
164580698|NCT03519178|594492414|FG011|Fulvestrant. Treatment|Lost to Follow-up|0|||
164580699|NCT03519178|594492415|FG012|Fulvestrant. Treatment|Lost to Follow-up|0|||
164580700|NCT03519178|594492416|FG013|Fulvestrant. Treatment|Lost to Follow-up|0|||
164580701|NCT03519178|594492417|FG014|Fulvestrant. Treatment|Lost to Follow-up|1|||
164580702|NCT03519178|594492403|FG000|Fulvestrant. Treatment|Physician Decision|0|||
164580703|NCT03519178|594492404|FG001|Fulvestrant. Treatment|Physician Decision|0|||
164580704|NCT03519178|594492405|FG002|Fulvestrant. Treatment|Physician Decision|0|||
164580705|NCT03519178|594492406|FG003|Fulvestrant. Treatment|Physician Decision|0|||
164580706|NCT03519178|594492407|FG004|Fulvestrant. Treatment|Physician Decision|0|||
164580707|NCT03519178|594492408|FG005|Fulvestrant. Treatment|Physician Decision|0|||
164580708|NCT03519178|594492409|FG006|Fulvestrant. Treatment|Physician Decision|0|||
164580709|NCT03519178|594492410|FG007|Fulvestrant. Treatment|Physician Decision|0|||
164580710|NCT03519178|594492411|FG008|Fulvestrant. Treatment|Physician Decision|0|||
164580711|NCT03519178|594492412|FG009|Fulvestrant. Treatment|Physician Decision|0|||
164580712|NCT03519178|594492413|FG010|Fulvestrant. Treatment|Physician Decision|0|||
164580713|NCT03519178|594492414|FG011|Fulvestrant. Treatment|Physician Decision|0|||
164580714|NCT03519178|594492415|FG012|Fulvestrant. Treatment|Physician Decision|0|||
164580715|NCT03519178|594492416|FG013|Fulvestrant. Treatment|Physician Decision|4|||
164580716|NCT03519178|594492417|FG014|Fulvestrant. Treatment|Physician Decision|2|||
164580717|NCT03519178|594492403|FG000|Fulvestrant. Treatment|Progressive disease|0|||
164580718|NCT03519178|594492404|FG001|Fulvestrant. Treatment|Progressive disease|0|||
164580719|NCT03519178|594492405|FG002|Fulvestrant. Treatment|Progressive disease|0|||
164580720|NCT03519178|594492406|FG003|Fulvestrant. Treatment|Progressive disease|0|||
164580721|NCT03519178|594492407|FG004|Fulvestrant. Treatment|Progressive disease|0|||
164580722|NCT03519178|594492408|FG005|Fulvestrant. Treatment|Progressive disease|0|||
164580723|NCT03519178|594492409|FG006|Fulvestrant. Treatment|Progressive disease|0|||
164580724|NCT03519178|594492410|FG007|Fulvestrant. Treatment|Progressive disease|0|||
164580725|NCT03519178|594492411|FG008|Fulvestrant. Treatment|Progressive disease|0|||
164580726|NCT03519178|594492412|FG009|Fulvestrant. Treatment|Progressive disease|5|||
164580727|NCT03519178|594492413|FG010|Fulvestrant. Treatment|Progressive disease|0|||
164580728|NCT03519178|594492414|FG011|Fulvestrant. Treatment|Progressive disease|0|||
164580729|NCT03519178|594492415|FG012|Fulvestrant. Treatment|Progressive disease|0|||
164580730|NCT03519178|594492416|FG013|Fulvestrant. Treatment|Progressive disease|30|||
164685870|NCT01710358|594873238|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
164685871|NCT01710358|594873236|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
164685872|NCT01710358|594873237|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
164685873|NCT01710358|594873238|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
164685874|NCT01710358|594873236|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
164685875|NCT01710358|594873237|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
164685876|NCT01710358|594873238|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
164685877|NCT01710358|594873236|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
164685878|NCT01710358|594873237|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
164685879|NCT01710358|594873238|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
164685880|NCT01710358|594873236|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
164685881|NCT01710358|594873237|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
164685882|NCT01710358|594873238|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
164685883|NCT01710358|594873236|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
164685884|NCT01710358|594873237|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
164685885|NCT01710358|594873238|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
164685886|NCT01710358|594873236|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
164685887|NCT01710358|594873237|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
164685888|NCT01710358|594873238|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
164685889|NCT01710358|594873236|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
164685890|NCT01710358|594873237|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
164685891|NCT01710358|594873238|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
164685892|NCT01710358|594873236|FG000|Rescue Period|Adverse Event|0|||
164685893|NCT01710358|594873237|FG001|Rescue Period|Adverse Event|15|||
164685894|NCT01710358|594873238|FG002|Rescue Period|Adverse Event|0|||
164685895|NCT01710358|594873236|FG000|Rescue Period|Death|0|||
164685896|NCT01710358|594873237|FG001|Rescue Period|Death|1|||
164685897|NCT01710358|594873238|FG002|Rescue Period|Death|0|||
164685898|NCT01710358|594873236|FG000|Rescue Period|Lack of Efficacy|0|||
164685899|NCT01710358|594873237|FG001|Rescue Period|Lack of Efficacy|7|||
164685900|NCT01710358|594873238|FG002|Rescue Period|Lack of Efficacy|0|||
164685901|NCT01710358|594873236|FG000|Rescue Period|Withdrawal by Subject|0|||
164685902|NCT01710358|594873237|FG001|Rescue Period|Withdrawal by Subject|8|||
164685903|NCT01710358|594873238|FG002|Rescue Period|Withdrawal by Subject|0|||
164685904|NCT00880334|594873239|FG000|Randomized Phase|Physician Decision|1|||
164685905|NCT00880334|594873240|FG001|Randomized Phase|Physician Decision|0|||
164685906|NCT00880334|594873239|FG000|Randomized Phase|Withdrawal by Subject|2|||
164685907|NCT00880334|594873240|FG001|Randomized Phase|Withdrawal by Subject|1|||
164685908|NCT00880334|594873239|FG000|Randomized Phase|Inadequate Labs|1|||
164685909|NCT00880334|594873240|FG001|Randomized Phase|Inadequate Labs|1|||
164685910|NCT00880334|594873239|FG000|Randomized Phase|Brain Metastasis|0|||
164685911|NCT00880334|594873240|FG001|Randomized Phase|Brain Metastasis|1|||
164685912|NCT00880334|594873239|FG000|Randomized Phase|Crossover Participants|0|||
164685913|NCT00880334|594873240|FG001|Randomized Phase|Crossover Participants|37|||
164685914|NCT00084864|594873245|FG000|Overall Study|Adverse Event|1|||
164685915|NCT00084864|594873246|FG001|Overall Study|Adverse Event|0|||
164685916|NCT00084864|594873247|FG002|Overall Study|Adverse Event|0|||
164685917|NCT00084864|594873248|FG003|Overall Study|Adverse Event|0|||
164685918|NCT02460835|594873253|FG000|Overall Study|Disease progression prior to treatment|3|||
164685919|NCT02460835|594873253|FG000|Overall Study|Unable to complete planning scans|2|||
164685920|NCT02460835|594873253|FG000|Overall Study|Decrease in performance status|1|||
164685921|NCT02460835|594873253|FG000|Overall Study|Withdrawal by Subject|3|||
164685922|NCT02460835|594873253|FG000|Overall Study|Underwent fractionated RT|10|||
164685923|NCT02460835|594873253|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
164685924|NCT00969124|594873265|FG000|Overall Study|Protocol Violation|2|||
164685925|NCT00969124|594873265|FG000|Overall Study|Inadequate bowel preparation|15|||
164685926|NCT00969124|594873265|FG000|Overall Study|Inability to reach cecum|9|||
164685927|NCT00969124|594873265|FG000|Overall Study|Previously unrecognized disease|3|||
164265327|NCT00900146|593340456|FG000|Intermediate: Period III|Administrative problems|85|||
164685928|NCT00969124|594873265|FG000|Overall Study|Technical error|1|||
164685929|NCT01632306|594873286|FG000|Overall Study|Protocol Violation|1|||
164685930|NCT01632306|594873287|FG001|Overall Study|Protocol Violation|0|||
164265328|NCT00900146|593340457|FG001|Intermediate: Period III|Administrative problems|92|||
164685931|NCT01632306|594873288|FG002|Overall Study|Protocol Violation|0|||
164685932|NCT03141151|594873293|FG000|Overall Study|Lost to Follow-up|3|||
164685933|NCT03141151|594873294|FG001|Overall Study|Lost to Follow-up|2|||
164685934|NCT03141151|594873293|FG000|Overall Study|Withdrawal by Subject|3|||
164685935|NCT03141151|594873294|FG001|Overall Study|Withdrawal by Subject|2|||
164685936|NCT03277248|594873301|FG000|Overall Study|Adverse Event|3|||
164685937|NCT03277248|594873302|FG001|Overall Study|Adverse Event|1|||
164685938|NCT03277248|594873301|FG000|Overall Study|Subject Withdrawal of Consent|6|||
164685939|NCT03277248|594873302|FG001|Overall Study|Subject Withdrawal of Consent|23|||
164580731|NCT03519178|594492417|FG014|Fulvestrant. Treatment|Progressive disease|8|||
164341687|NCT01594281|593627472|FG002|Interventional Core Phase|Protocol Deviation|0|||
164341688|NCT01594281|593627470|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
164341689|NCT01594281|593627471|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
164341690|NCT01594281|593627472|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
164341691|NCT01594281|593627470|FG000|Interventional Core Phase|Death|1|||
164341692|NCT01594281|593627471|FG001|Interventional Core Phase|Death|1|||
164580732|NCT03519178|594492403|FG000|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164580733|NCT03519178|594492404|FG001|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164580734|NCT03519178|594492405|FG002|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164580735|NCT03519178|594492406|FG003|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164580736|NCT03519178|594492407|FG004|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164580737|NCT03519178|594492408|FG005|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164580738|NCT03519178|594492409|FG006|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164580739|NCT03519178|594492410|FG007|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164580740|NCT03519178|594492411|FG008|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164580741|NCT03519178|594492412|FG009|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164580742|NCT03519178|594492413|FG010|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164580743|NCT03519178|594492414|FG011|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164580744|NCT03519178|594492415|FG012|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164580745|NCT03519178|594492416|FG013|Fulvestrant. Treatment|Study terminated by sponsor|5|||
164580746|NCT03519178|594492417|FG014|Fulvestrant. Treatment|Study terminated by sponsor|9|||
164580747|NCT03519178|594492403|FG000|Fulvestrant. Treatment|Withdrawal by Subject|0|||
164580748|NCT03519178|594492404|FG001|Fulvestrant. Treatment|Withdrawal by Subject|0|||
164580749|NCT03519178|594492405|FG002|Fulvestrant. Treatment|Withdrawal by Subject|0|||
164580750|NCT03519178|594492406|FG003|Fulvestrant. Treatment|Withdrawal by Subject|0|||
164580751|NCT03519178|594492407|FG004|Fulvestrant. Treatment|Withdrawal by Subject|0|||
164580752|NCT03519178|594492408|FG005|Fulvestrant. Treatment|Withdrawal by Subject|0|||
164580753|NCT03519178|594492409|FG006|Fulvestrant. Treatment|Withdrawal by Subject|0|||
164580754|NCT03519178|594492410|FG007|Fulvestrant. Treatment|Withdrawal by Subject|0|||
164580755|NCT03519178|594492411|FG008|Fulvestrant. Treatment|Withdrawal by Subject|0|||
164580756|NCT03519178|594492412|FG009|Fulvestrant. Treatment|Withdrawal by Subject|2|||
164580757|NCT03519178|594492413|FG010|Fulvestrant. Treatment|Withdrawal by Subject|0|||
164580758|NCT03519178|594492414|FG011|Fulvestrant. Treatment|Withdrawal by Subject|0|||
164580759|NCT03519178|594492415|FG012|Fulvestrant. Treatment|Withdrawal by Subject|0|||
164580760|NCT03519178|594492416|FG013|Fulvestrant. Treatment|Withdrawal by Subject|1|||
164580761|NCT03519178|594492417|FG014|Fulvestrant. Treatment|Withdrawal by Subject|2|||
164580762|NCT03519178|594492403|FG000|Fulvestrant. Treatment|Global deterioration of health status|0|||
164580763|NCT03519178|594492404|FG001|Fulvestrant. Treatment|Global deterioration of health status|0|||
164580764|NCT03519178|594492405|FG002|Fulvestrant. Treatment|Global deterioration of health status|0|||
164580765|NCT03519178|594492406|FG003|Fulvestrant. Treatment|Global deterioration of health status|0|||
164580766|NCT03519178|594492407|FG004|Fulvestrant. Treatment|Global deterioration of health status|0|||
164580767|NCT03519178|594492408|FG005|Fulvestrant. Treatment|Global deterioration of health status|0|||
164580768|NCT03519178|594492409|FG006|Fulvestrant. Treatment|Global deterioration of health status|0|||
164580769|NCT03519178|594492410|FG007|Fulvestrant. Treatment|Global deterioration of health status|0|||
164580770|NCT03519178|594492411|FG008|Fulvestrant. Treatment|Global deterioration of health status|0|||
164580771|NCT03519178|594492412|FG009|Fulvestrant. Treatment|Global deterioration of health status|1|||
164580772|NCT03519178|594492413|FG010|Fulvestrant. Treatment|Global deterioration of health status|0|||
164580773|NCT03519178|594492414|FG011|Fulvestrant. Treatment|Global deterioration of health status|0|||
164580774|NCT03519178|594492415|FG012|Fulvestrant. Treatment|Global deterioration of health status|0|||
164580775|NCT03519178|594492416|FG013|Fulvestrant. Treatment|Global deterioration of health status|3|||
164580776|NCT03519178|594492417|FG014|Fulvestrant. Treatment|Global deterioration of health status|0|||
164580777|NCT03519178|594492403|FG000|Fulvestrant. Treatment|Refused further treatment|0|||
164580778|NCT03519178|594492404|FG001|Fulvestrant. Treatment|Refused further treatment|0|||
164580779|NCT03519178|594492405|FG002|Fulvestrant. Treatment|Refused further treatment|0|||
164580780|NCT03519178|594492406|FG003|Fulvestrant. Treatment|Refused further treatment|0|||
164580781|NCT03519178|594492407|FG004|Fulvestrant. Treatment|Refused further treatment|0|||
164580782|NCT03519178|594492408|FG005|Fulvestrant. Treatment|Refused further treatment|0|||
164580783|NCT03519178|594492409|FG006|Fulvestrant. Treatment|Refused further treatment|0|||
164580784|NCT03519178|594492410|FG007|Fulvestrant. Treatment|Refused further treatment|0|||
164580785|NCT03519178|594492411|FG008|Fulvestrant. Treatment|Refused further treatment|0|||
164580786|NCT03519178|594492412|FG009|Fulvestrant. Treatment|Refused further treatment|0|||
164580787|NCT03519178|594492413|FG010|Fulvestrant. Treatment|Refused further treatment|0|||
164580788|NCT03519178|594492414|FG011|Fulvestrant. Treatment|Refused further treatment|0|||
164580789|NCT03519178|594492415|FG012|Fulvestrant. Treatment|Refused further treatment|0|||
164580790|NCT03519178|594492416|FG013|Fulvestrant. Treatment|Refused further treatment|0|||
164580791|NCT03519178|594492417|FG014|Fulvestrant. Treatment|Refused further treatment|2|||
164685940|NCT03277248|594873301|FG000|Overall Study|Investigator/Sponsor Decision|2|||
164685941|NCT03277248|594873302|FG001|Overall Study|Investigator/Sponsor Decision|2|||
164685942|NCT03277248|594873301|FG000|Overall Study|Pregnancy|4|||
164685943|NCT03277248|594873302|FG001|Overall Study|Pregnancy|1|||
164685944|NCT03277248|594873301|FG000|Overall Study|Lost to Follow-up|0|||
164685945|NCT03277248|594873302|FG001|Overall Study|Lost to Follow-up|2|||
164685946|NCT03277248|594873301|FG000|Overall Study|Lack of Efficacy|0|||
164685947|NCT03277248|594873302|FG001|Overall Study|Lack of Efficacy|2|||
164685948|NCT03277248|594873301|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
164685949|NCT03277248|594873302|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
164685950|NCT01993940|594873303|FG000|Overall Study|Adverse Event|16|||
164685951|NCT01993940|594873304|FG001|Overall Study|Adverse Event|11|||
164685952|NCT01993940|594873303|FG000|Overall Study|Withdrawal by Subject|15|||
164685953|NCT01993940|594873304|FG001|Overall Study|Withdrawal by Subject|19|||
164685954|NCT01993940|594873303|FG000|Overall Study|Lost to Follow-up|2|||
164685955|NCT01993940|594873304|FG001|Overall Study|Lost to Follow-up|5|||
164685956|NCT01993940|594873303|FG000|Overall Study|Protocol Violation|5|||
164685957|NCT01993940|594873304|FG001|Overall Study|Protocol Violation|8|||
164685958|NCT01993940|594873303|FG000|Overall Study|Death|1|||
164685959|NCT01993940|594873304|FG001|Overall Study|Death|0|||
164685960|NCT01993940|594873303|FG000|Overall Study|Other - Miscellaneous|1|||
164685961|NCT01993940|594873304|FG001|Overall Study|Other - Miscellaneous|1|||
164685962|NCT01949532|594873305|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
164685963|NCT01949532|594873306|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
164685964|NCT00379353|594873307|FG000|Overall Study|Hospitalization|3|||
164685965|NCT00379353|594873308|FG001|Overall Study|Hospitalization|3|||
164685966|NCT00379353|594873307|FG000|Overall Study|Withdrawal by Subject|5|||
164685967|NCT00379353|594873308|FG001|Overall Study|Withdrawal by Subject|2|||
164685968|NCT00379353|594873307|FG000|Overall Study|Death|1|||
164685969|NCT00379353|594873308|FG001|Overall Study|Death|0|||
164685970|NCT00379353|594873307|FG000|Overall Study|Cardiac Tamponade|1|||
164685971|NCT00379353|594873308|FG001|Overall Study|Cardiac Tamponade|0|||
164685972|NCT00379353|594873307|FG000|Overall Study|Non-compliance|1|||
164685973|NCT00379353|594873308|FG001|Overall Study|Non-compliance|0|||
164685974|NCT00379353|594873307|FG000|Overall Study|Conflicting drug treatment|0|||
164685975|NCT00379353|594873308|FG001|Overall Study|Conflicting drug treatment|1|||
164685976|NCT01211262|594873309|FG000|Overall Study|Progressive Disease|18|||
164685977|NCT01211262|594873310|FG001|Overall Study|Progressive Disease|9|||
164685978|NCT01211262|594873309|FG000|Overall Study|Adverse Event|4|||
164685979|NCT01211262|594873310|FG001|Overall Study|Adverse Event|0|||
164685980|NCT01211262|594873309|FG000|Overall Study|Withdrawal of Consent|1|||
164685981|NCT01211262|594873310|FG001|Overall Study|Withdrawal of Consent|0|||
164685982|NCT01211262|594873309|FG000|Overall Study|Other|0|||
164685983|NCT01211262|594873310|FG001|Overall Study|Other|1|||
164685984|NCT01277510|594873311|FG000|Double-blind Phase|Non-compliance|0|||
164685985|NCT01277510|594873312|FG001|Double-blind Phase|Non-compliance|1|||
164685986|NCT01277510|594873311|FG000|Double-blind Phase|Adverse Event|1|||
164685987|NCT01277510|594873312|FG001|Double-blind Phase|Adverse Event|0|||
164685988|NCT01277510|594873311|FG000|Double-blind Phase|Withdrawal by Subject|2|||
164685989|NCT01277510|594873312|FG001|Double-blind Phase|Withdrawal by Subject|0|||
164685990|NCT01277510|594873311|FG000|Double-blind Phase|Administrative decision|7|||
164685991|NCT01277510|594873312|FG001|Double-blind Phase|Administrative decision|9|||
164685992|NCT01277510|594873311|FG000|Double-blind Phase|Death|0|||
164685993|NCT01277510|594873312|FG001|Double-blind Phase|Death|1|||
164685994|NCT01277510|594873311|FG000|Double-blind Phase|Protocol-specified criteria|2|||
164685995|NCT01277510|594873312|FG001|Double-blind Phase|Protocol-specified criteria|6|||
164685996|NCT01277510|594873311|FG000|Double-blind Phase|Other|1|||
164685997|NCT01277510|594873312|FG001|Double-blind Phase|Other|1|||
164685998|NCT01277510|594873311|FG000|Open-label Phase|Administrative decision|4|||
164685999|NCT01277510|594873312|FG001|Open-label Phase|Administrative decision|3|||
164341693|NCT01594281|593627472|FG002|Interventional Core Phase|Death|2|||
164686000|NCT01277510|594873311|FG000|Open-label Phase|Protocol-specified criteria|1|||
164686001|NCT01277510|594873312|FG001|Open-label Phase|Protocol-specified criteria|0|||
164686002|NCT01277510|594873311|FG000|Open-label Phase|Never received investigational product|2|||
164686003|NCT01277510|594873312|FG001|Open-label Phase|Never received investigational product|0|||
164686004|NCT04049097|594873313|FG000|Overall Study|Adverse Event|18|||
164686005|NCT04049097|594873313|FG000|Overall Study|Death|2|||
164686006|NCT04049097|594873313|FG000|Overall Study|Lost to Follow-up|1|||
164686007|NCT04049097|594873313|FG000|Overall Study|Physician Decision|2|||
164686008|NCT04049097|594873313|FG000|Overall Study|Withdrawal by Subject|9|||
164686009|NCT04049097|594873313|FG000|Overall Study|Protocol Violation|2|||
164686010|NCT04049097|594873313|FG000|Overall Study|Other|1|||
164686011|NCT04049097|594873313|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
164686012|NCT00533507|594873314|FG000|Overall Study|Withdrawal by Subject|1|||
164341694|NCT01594281|593627470|FG000|Interventional Core Phase|Lost to Follow-up|1|||
164341695|NCT01594281|593627471|FG001|Interventional Core Phase|Lost to Follow-up|4|||
164341696|NCT01594281|593627472|FG002|Interventional Core Phase|Lost to Follow-up|1|||
164686013|NCT01874535|594873315|FG000|Overall Study|Lost to Follow-up|10|||
164686014|NCT01874535|594873316|FG001|Overall Study|Lost to Follow-up|9|||
164686015|NCT01874535|594873315|FG000|Overall Study|incomplete symptom resolution|45|||
164686016|NCT01874535|594873316|FG001|Overall Study|incomplete symptom resolution|35|||
164686017|NCT02119936|594873329|FG000|Overall Study|Lost to Follow-up|10|||
164686018|NCT00570128|594873330|FG000|Overall Study|Adverse Event|1|||
164686019|NCT00570128|594873331|FG001|Overall Study|Adverse Event|0|||
164686020|NCT00570128|594873330|FG000|Overall Study|Lost to Follow-up|1|||
164686021|NCT00570128|594873331|FG001|Overall Study|Lost to Follow-up|0|||
164686022|NCT00570128|594873330|FG000|Overall Study|Withdrawal by Subject|2|||
164686023|NCT00570128|594873331|FG001|Overall Study|Withdrawal by Subject|0|||
164580792|NCT03519178|594492403|FG000|Fulvestrant. Treatment|Other|0|||
164580793|NCT03519178|594492404|FG001|Fulvestrant. Treatment|Other|0|||
164580794|NCT03519178|594492405|FG002|Fulvestrant. Treatment|Other|0|||
164686024|NCT05315713|594873332|FG000|Overall Study|Death|5|||
164686025|NCT05315713|594873332|FG000|Overall Study|Progressive disease|1|||
164686026|NCT05315713|594873332|FG000|Overall Study|Withdrawal by Subject|1|||
164686027|NCT05315713|594873332|FG000|Overall Study|Study terminated by sponsor|1|||
164686028|NCT00421304|594873335|FG000|Overall Study|Lost to Follow-up|5|||
164686029|NCT00421304|594873336|FG001|Overall Study|Lost to Follow-up|2|||
164686030|NCT00421304|594873337|FG002|Overall Study|Lost to Follow-up|5|||
164686031|NCT00421304|594873335|FG000|Overall Study|Withdrawal by Subject|2|||
164686032|NCT00421304|594873336|FG001|Overall Study|Withdrawal by Subject|2|||
164686033|NCT00421304|594873337|FG002|Overall Study|Withdrawal by Subject|2|||
164686034|NCT00421304|594873335|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
164686035|NCT00421304|594873336|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
164686036|NCT00421304|594873337|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
164686037|NCT00421304|594873335|FG000|Overall Study|Did not attend Day 360 visit|0|||
164686038|NCT00421304|594873336|FG001|Overall Study|Did not attend Day 360 visit|0|||
164686039|NCT00421304|594873337|FG002|Overall Study|Did not attend Day 360 visit|1|||
164430420|NCT01289119|593947216|FG002|Overall Study|Major Protocol Deviation|3|||
164430421|NCT01289119|593947217|FG003|Overall Study|Major Protocol Deviation|0|||
164430422|NCT01289119|593947218|FG004|Overall Study|Major Protocol Deviation|2|||
164430423|NCT01289119|593947219|FG005|Overall Study|Major Protocol Deviation|1|||
164430424|NCT01289119|593947214|FG000|Overall Study|Lost to Follow-up|0|||
164430425|NCT01289119|593947215|FG001|Overall Study|Lost to Follow-up|3|||
164430426|NCT01289119|593947216|FG002|Overall Study|Lost to Follow-up|0|||
164430427|NCT01289119|593947217|FG003|Overall Study|Lost to Follow-up|0|||
164430428|NCT01289119|593947218|FG004|Overall Study|Lost to Follow-up|0|||
164430429|NCT01289119|593947219|FG005|Overall Study|Lost to Follow-up|1|||
164430430|NCT01289119|593947214|FG000|Overall Study|Withdrawal by Subject|4|||
164430431|NCT01289119|593947215|FG001|Overall Study|Withdrawal by Subject|2|||
164430432|NCT01289119|593947216|FG002|Overall Study|Withdrawal by Subject|4|||
164430433|NCT01289119|593947217|FG003|Overall Study|Withdrawal by Subject|3|||
164430434|NCT01289119|593947218|FG004|Overall Study|Withdrawal by Subject|1|||
164430435|NCT01289119|593947219|FG005|Overall Study|Withdrawal by Subject|1|||
164430436|NCT01289119|593947214|FG000|Overall Study|Pregnancy|0|||
164430437|NCT01289119|593947215|FG001|Overall Study|Pregnancy|1|||
164430438|NCT01289119|593947216|FG002|Overall Study|Pregnancy|0|||
164686040|NCT00919711|594873338|FG000|Overall Study|Withdrawal by Subject|15|||
164686041|NCT00919711|594873339|FG001|Overall Study|Withdrawal by Subject|7|||
164686042|NCT00919711|594873338|FG000|Overall Study|Adverse Event|13|||
164580795|NCT03519178|594492406|FG003|Fulvestrant. Treatment|Other|0|||
164580796|NCT03519178|594492407|FG004|Fulvestrant. Treatment|Other|0|||
164686043|NCT00919711|594873339|FG001|Overall Study|Adverse Event|3|||
164686044|NCT00919711|594873338|FG000|Overall Study|Other|1|||
164686045|NCT00919711|594873339|FG001|Overall Study|Other|2|||
164686046|NCT00919711|594873338|FG000|Overall Study|Administrative Decision|0|||
164686047|NCT00919711|594873339|FG001|Overall Study|Administrative Decision|1|||
164686048|NCT00919711|594873338|FG000|Overall Study|Lost to Follow-up|2|||
164686049|NCT00919711|594873339|FG001|Overall Study|Lost to Follow-up|0|||
164580797|NCT03519178|594492408|FG005|Fulvestrant. Treatment|Other|0|||
164686050|NCT00919711|594873338|FG000|Overall Study|Death|1|||
164580798|NCT03519178|594492409|FG006|Fulvestrant. Treatment|Other|0|||
164580799|NCT03519178|594492410|FG007|Fulvestrant. Treatment|Other|0|||
164580800|NCT03519178|594492411|FG008|Fulvestrant. Treatment|Other|0|||
164580801|NCT03519178|594492412|FG009|Fulvestrant. Treatment|Other|0|||
164580802|NCT03519178|594492413|FG010|Fulvestrant. Treatment|Other|0|||
164686051|NCT00919711|594873339|FG001|Overall Study|Death|0|||
164430439|NCT01289119|593947217|FG003|Overall Study|Pregnancy|0|||
164580803|NCT03519178|594492414|FG011|Fulvestrant. Treatment|Other|0|||
164686052|NCT00919711|594873338|FG000|Overall Study|Noncompliance|1|||
164686053|NCT00919711|594873339|FG001|Overall Study|Noncompliance|0|||
164686054|NCT00903877|594873340|FG000|Overall Study|Did not meet study criteria|33|||
164686055|NCT00903877|594873340|FG000|Overall Study|Withdrawal by Subject|3|||
164686056|NCT00903877|594873340|FG000|Overall Study|Adverse Event|2|||
164686057|NCT00903877|594873340|FG000|Overall Study|Lost to Follow-up|1|||
164686058|NCT00903877|594873340|FG000|Overall Study|Participation put on hold|4|||
164265329|NCT00900146|593340458|FG002|Intermediate: Period III|Administrative problems|84|||
164265330|NCT00900146|593340459|FG003|Intermediate: Period III|Administrative problems|90|||
164265331|NCT00900146|593340460|FG004|Intermediate: Period III|Administrative problems|163|||
164265332|NCT02305849|593340461|FG000|Overall Study|Adverse Event|10|||
164265333|NCT02305849|593340462|FG001|Overall Study|Adverse Event|12|||
164265334|NCT02305849|593340463|FG002|Overall Study|Adverse Event|7|||
164265335|NCT02305849|593340464|FG003|Overall Study|Adverse Event|3|||
164265336|NCT02305849|593340461|FG000|Overall Study|Lack of Efficacy|10|||
164580804|NCT03519178|594492415|FG012|Fulvestrant. Treatment|Other|0|||
164580805|NCT03519178|594492416|FG013|Fulvestrant. Treatment|Other|1|||
164580806|NCT03519178|594492417|FG014|Fulvestrant. Treatment|Other|3|||
164580807|NCT03519178|594492403|FG000|Letrozole Treatment|Physician Decision|0|||
164580808|NCT03519178|594492404|FG001|Letrozole Treatment|Physician Decision|0|||
164580809|NCT03519178|594492405|FG002|Letrozole Treatment|Physician Decision|0|||
164580810|NCT03519178|594492406|FG003|Letrozole Treatment|Physician Decision|0|||
164580811|NCT03519178|594492407|FG004|Letrozole Treatment|Physician Decision|0|||
164580812|NCT03519178|594492408|FG005|Letrozole Treatment|Physician Decision|0|||
164580813|NCT03519178|594492409|FG006|Letrozole Treatment|Physician Decision|0|||
164580814|NCT03519178|594492410|FG007|Letrozole Treatment|Physician Decision|0|||
164580815|NCT03519178|594492411|FG008|Letrozole Treatment|Physician Decision|0|||
164580816|NCT03519178|594492412|FG009|Letrozole Treatment|Physician Decision|0|||
164580817|NCT03519178|594492413|FG010|Letrozole Treatment|Physician Decision|1|||
164580818|NCT03519178|594492414|FG011|Letrozole Treatment|Physician Decision|0|||
164580819|NCT03519178|594492415|FG012|Letrozole Treatment|Physician Decision|0|||
164580820|NCT03519178|594492416|FG013|Letrozole Treatment|Physician Decision|0|||
164580821|NCT03519178|594492417|FG014|Letrozole Treatment|Physician Decision|0|||
164580822|NCT03519178|594492403|FG000|Letrozole Treatment|Progressive disease|0|||
164580823|NCT03519178|594492404|FG001|Letrozole Treatment|Progressive disease|0|||
164580824|NCT03519178|594492405|FG002|Letrozole Treatment|Progressive disease|0|||
164580825|NCT03519178|594492406|FG003|Letrozole Treatment|Progressive disease|0|||
164580826|NCT03519178|594492407|FG004|Letrozole Treatment|Progressive disease|0|||
164580827|NCT03519178|594492408|FG005|Letrozole Treatment|Progressive disease|0|||
164580828|NCT03519178|594492409|FG006|Letrozole Treatment|Progressive disease|0|||
164580829|NCT03519178|594492410|FG007|Letrozole Treatment|Progressive disease|0|||
164580830|NCT03519178|594492411|FG008|Letrozole Treatment|Progressive disease|0|||
164580831|NCT03519178|594492412|FG009|Letrozole Treatment|Progressive disease|0|||
164580832|NCT03519178|594492413|FG010|Letrozole Treatment|Progressive disease|4|||
164580833|NCT03519178|594492414|FG011|Letrozole Treatment|Progressive disease|0|||
164580834|NCT03519178|594492415|FG012|Letrozole Treatment|Progressive disease|0|||
164580835|NCT03519178|594492416|FG013|Letrozole Treatment|Progressive disease|0|||
164580836|NCT03519178|594492417|FG014|Letrozole Treatment|Progressive disease|0|||
164580837|NCT03519178|594492403|FG000|Letrozole Treatment|Global deterioration of health status|0|||
164580838|NCT03519178|594492404|FG001|Letrozole Treatment|Global deterioration of health status|0|||
164580839|NCT03519178|594492405|FG002|Letrozole Treatment|Global deterioration of health status|0|||
164580840|NCT03519178|594492406|FG003|Letrozole Treatment|Global deterioration of health status|0|||
164580841|NCT03519178|594492407|FG004|Letrozole Treatment|Global deterioration of health status|0|||
164580842|NCT03519178|594492408|FG005|Letrozole Treatment|Global deterioration of health status|0|||
164580843|NCT03519178|594492409|FG006|Letrozole Treatment|Global deterioration of health status|0|||
164580844|NCT03519178|594492410|FG007|Letrozole Treatment|Global deterioration of health status|0|||
164580845|NCT03519178|594492411|FG008|Letrozole Treatment|Global deterioration of health status|0|||
164580846|NCT03519178|594492412|FG009|Letrozole Treatment|Global deterioration of health status|0|||
164580847|NCT03519178|594492413|FG010|Letrozole Treatment|Global deterioration of health status|2|||
164580848|NCT03519178|594492414|FG011|Letrozole Treatment|Global deterioration of health status|0|||
164580849|NCT03519178|594492415|FG012|Letrozole Treatment|Global deterioration of health status|0|||
164580850|NCT03519178|594492416|FG013|Letrozole Treatment|Global deterioration of health status|0|||
164580851|NCT03519178|594492417|FG014|Letrozole Treatment|Global deterioration of health status|0|||
164580852|NCT03519178|594492403|FG000|Follow-Up|Death|0|||
164580853|NCT03519178|594492404|FG001|Follow-Up|Death|0|||
164580854|NCT03519178|594492405|FG002|Follow-Up|Death|0|||
164580855|NCT03519178|594492406|FG003|Follow-Up|Death|0|||
164580856|NCT03519178|594492407|FG004|Follow-Up|Death|0|||
164580857|NCT03519178|594492408|FG005|Follow-Up|Death|0|||
164580858|NCT03519178|594492409|FG006|Follow-Up|Death|0|||
164580859|NCT03519178|594492410|FG007|Follow-Up|Death|0|||
164580860|NCT03519178|594492411|FG008|Follow-Up|Death|3|||
164580861|NCT03519178|594492412|FG009|Follow-Up|Death|1|||
164580862|NCT03519178|594492413|FG010|Follow-Up|Death|0|||
164580863|NCT03519178|594492414|FG011|Follow-Up|Death|0|||
164580864|NCT03519178|594492415|FG012|Follow-Up|Death|2|||
164580865|NCT03519178|594492416|FG013|Follow-Up|Death|0|||
164580866|NCT03519178|594492417|FG014|Follow-Up|Death|0|||
164580867|NCT03519178|594492403|FG000|Follow-Up|Lost to Follow-up|0|||
164580868|NCT03519178|594492404|FG001|Follow-Up|Lost to Follow-up|0|||
164580869|NCT03519178|594492405|FG002|Follow-Up|Lost to Follow-up|0|||
164580870|NCT03519178|594492406|FG003|Follow-Up|Lost to Follow-up|0|||
164580871|NCT03519178|594492407|FG004|Follow-Up|Lost to Follow-up|0|||
164580872|NCT03519178|594492408|FG005|Follow-Up|Lost to Follow-up|3|||
164341697|NCT01594281|593627470|FG000|Interventional Core Phase|Adverse Event|4|||
164341698|NCT01594281|593627471|FG001|Interventional Core Phase|Adverse Event|4|||
164341699|NCT01594281|593627472|FG002|Interventional Core Phase|Adverse Event|4|||
164341700|NCT01594281|593627470|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
164341701|NCT01594281|593627471|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
164341702|NCT01594281|593627472|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
164341703|NCT01594281|593627470|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
164341704|NCT01594281|593627471|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
164341705|NCT01594281|593627472|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
164341706|NCT01594281|593627470|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
164341707|NCT01594281|593627471|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
164341708|NCT01594281|593627472|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
164341709|NCT01193530|593627476|FG000|Overall Study|Withdrawal by Subject|2|||
164341710|NCT01193530|593627477|FG001|Overall Study|Withdrawal by Subject|2|||
164341711|NCT01193530|593627476|FG000|Overall Study|Began Contraindicated Therapy|1|||
164341712|NCT01193530|593627477|FG001|Overall Study|Began Contraindicated Therapy|0|||
164341713|NCT01193530|593627476|FG000|Overall Study|Lost Light Box|0|||
164686059|NCT03694197|594873341|FG000|Overall Study|Adverse Event|9|||
164686060|NCT03694197|594873341|FG000|Overall Study|Protocol became inconvenient to participate|1|||
164686061|NCT03694197|594873341|FG000|Overall Study|Physician Decision|4|||
164686062|NCT03694197|594873341|FG000|Overall Study|Study terminated by sponsor|1350|||
164686063|NCT03694197|594873341|FG000|Overall Study|Participant moved|5|||
164686064|NCT03694197|594873341|FG000|Overall Study|Participant withdrew consent|10|||
164686065|NCT03694197|594873341|FG000|Overall Study|Related to IMP administration|1|||
164686066|NCT03694197|594873341|FG000|Overall Study|Not disclosed|5|||
164686067|NCT03820947|594873342|FG000|Overall Study|Physician Decision|0|||
164686068|NCT03820947|594873343|FG001|Overall Study|Physician Decision|1|||
164686069|NCT03820947|594873344|FG002|Overall Study|Physician Decision|1|||
164686070|NCT03820947|594873345|FG003|Overall Study|Physician Decision|0|||
164686071|NCT03820947|594873346|FG004|Overall Study|Physician Decision|3|||
164686072|NCT03820947|594873342|FG000|Overall Study|Withdrawal by Subject|6|||
164341714|NCT01193530|593627477|FG001|Overall Study|Lost Light Box|1|||
164341715|NCT01193530|593627476|FG000|Overall Study|Returned home - out of state|0|||
164341716|NCT01193530|593627477|FG001|Overall Study|Returned home - out of state|1|||
164341717|NCT01193530|593627476|FG000|Overall Study|Non-Compliance|0|||
164341718|NCT01193530|593627477|FG001|Overall Study|Non-Compliance|1|||
164341719|NCT01890473|593627478|FG000|Overall Study|Lost to Follow-up|1|||
164580873|NCT03519178|594492409|FG006|Follow-Up|Lost to Follow-up|1|||
164580874|NCT03519178|594492410|FG007|Follow-Up|Lost to Follow-up|4|||
164580875|NCT03519178|594492411|FG008|Follow-Up|Lost to Follow-up|1|||
164580876|NCT03519178|594492412|FG009|Follow-Up|Lost to Follow-up|0|||
164580877|NCT03519178|594492413|FG010|Follow-Up|Lost to Follow-up|0|||
164580878|NCT03519178|594492414|FG011|Follow-Up|Lost to Follow-up|0|||
164580879|NCT03519178|594492415|FG012|Follow-Up|Lost to Follow-up|0|||
164580880|NCT03519178|594492416|FG013|Follow-Up|Lost to Follow-up|0|||
164580881|NCT03519178|594492417|FG014|Follow-Up|Lost to Follow-up|0|||
164580882|NCT03519178|594492403|FG000|Follow-Up|Withdrawal by Subject|1|||
164580883|NCT03519178|594492404|FG001|Follow-Up|Withdrawal by Subject|2|||
164580884|NCT03519178|594492405|FG002|Follow-Up|Withdrawal by Subject|2|||
164580885|NCT03519178|594492406|FG003|Follow-Up|Withdrawal by Subject|3|||
164580886|NCT03519178|594492407|FG004|Follow-Up|Withdrawal by Subject|5|||
164580887|NCT03519178|594492408|FG005|Follow-Up|Withdrawal by Subject|1|||
164580888|NCT03519178|594492409|FG006|Follow-Up|Withdrawal by Subject|2|||
164580889|NCT03519178|594492410|FG007|Follow-Up|Withdrawal by Subject|6|||
164580890|NCT03519178|594492411|FG008|Follow-Up|Withdrawal by Subject|5|||
164580891|NCT03519178|594492412|FG009|Follow-Up|Withdrawal by Subject|2|||
164580892|NCT03519178|594492413|FG010|Follow-Up|Withdrawal by Subject|3|||
164580893|NCT03519178|594492414|FG011|Follow-Up|Withdrawal by Subject|5|||
164580894|NCT03519178|594492415|FG012|Follow-Up|Withdrawal by Subject|2|||
164580895|NCT03519178|594492416|FG013|Follow-Up|Withdrawal by Subject|0|||
164580896|NCT03519178|594492417|FG014|Follow-Up|Withdrawal by Subject|0|||
164580897|NCT03519178|594492403|FG000|Follow-Up|Other|0|||
164580898|NCT03519178|594492404|FG001|Follow-Up|Other|0|||
164580899|NCT03519178|594492405|FG002|Follow-Up|Other|0|||
164580900|NCT03519178|594492406|FG003|Follow-Up|Other|0|||
164580901|NCT03519178|594492407|FG004|Follow-Up|Other|0|||
164580902|NCT03519178|594492408|FG005|Follow-Up|Other|0|||
164580903|NCT03519178|594492409|FG006|Follow-Up|Other|0|||
164580904|NCT03519178|594492410|FG007|Follow-Up|Other|1|||
164580905|NCT03519178|594492411|FG008|Follow-Up|Other|0|||
164580906|NCT03519178|594492412|FG009|Follow-Up|Other|0|||
164580907|NCT03519178|594492413|FG010|Follow-Up|Other|0|||
164580908|NCT03519178|594492414|FG011|Follow-Up|Other|0|||
164580909|NCT03519178|594492415|FG012|Follow-Up|Other|0|||
164580910|NCT03519178|594492416|FG013|Follow-Up|Other|0|||
164686073|NCT03820947|594873343|FG001|Overall Study|Withdrawal by Subject|10|||
164686074|NCT03820947|594873344|FG002|Overall Study|Withdrawal by Subject|3|||
164686075|NCT03820947|594873345|FG003|Overall Study|Withdrawal by Subject|8|||
164686076|NCT03820947|594873346|FG004|Overall Study|Withdrawal by Subject|5|||
164265337|NCT02305849|593340462|FG001|Overall Study|Lack of Efficacy|6|||
164265338|NCT02305849|593340463|FG002|Overall Study|Lack of Efficacy|3|||
164580911|NCT03519178|594492417|FG014|Follow-Up|Other|0|||
164580912|NCT03519178|594492403|FG000|Long-term Follow-up|Death|0|||
164580913|NCT03519178|594492404|FG001|Long-term Follow-up|Death|0|||
164580914|NCT03519178|594492405|FG002|Long-term Follow-up|Death|0|||
164580915|NCT03519178|594492406|FG003|Long-term Follow-up|Death|0|||
164580916|NCT03519178|594492407|FG004|Long-term Follow-up|Death|0|||
164580917|NCT03519178|594492408|FG005|Long-term Follow-up|Death|0|||
164580918|NCT03519178|594492409|FG006|Long-term Follow-up|Death|0|||
164580919|NCT03519178|594492410|FG007|Long-term Follow-up|Death|0|||
164580920|NCT03519178|594492411|FG008|Long-term Follow-up|Death|0|||
164580921|NCT03519178|594492412|FG009|Long-term Follow-up|Death|0|||
164580922|NCT03519178|594492413|FG010|Long-term Follow-up|Death|0|||
164580923|NCT03519178|594492414|FG011|Long-term Follow-up|Death|0|||
164580924|NCT03519178|594492415|FG012|Long-term Follow-up|Death|0|||
164580925|NCT03519178|594492416|FG013|Long-term Follow-up|Death|4|||
164580926|NCT03519178|594492417|FG014|Long-term Follow-up|Death|4|||
164580927|NCT03519178|594492403|FG000|Long-term Follow-up|Lost to Follow-up|0|||
164580928|NCT03519178|594492404|FG001|Long-term Follow-up|Lost to Follow-up|0|||
164580929|NCT03519178|594492405|FG002|Long-term Follow-up|Lost to Follow-up|0|||
164580930|NCT03519178|594492406|FG003|Long-term Follow-up|Lost to Follow-up|0|||
164580931|NCT03519178|594492407|FG004|Long-term Follow-up|Lost to Follow-up|0|||
164580932|NCT03519178|594492408|FG005|Long-term Follow-up|Lost to Follow-up|0|||
164580933|NCT03519178|594492409|FG006|Long-term Follow-up|Lost to Follow-up|0|||
164580934|NCT03519178|594492410|FG007|Long-term Follow-up|Lost to Follow-up|0|||
164580935|NCT03519178|594492411|FG008|Long-term Follow-up|Lost to Follow-up|0|||
164580936|NCT03519178|594492412|FG009|Long-term Follow-up|Lost to Follow-up|0|||
164580937|NCT03519178|594492413|FG010|Long-term Follow-up|Lost to Follow-up|0|||
164580938|NCT03519178|594492414|FG011|Long-term Follow-up|Lost to Follow-up|0|||
164580939|NCT03519178|594492415|FG012|Long-term Follow-up|Lost to Follow-up|0|||
164580940|NCT03519178|594492416|FG013|Long-term Follow-up|Lost to Follow-up|1|||
164580941|NCT03519178|594492417|FG014|Long-term Follow-up|Lost to Follow-up|1|||
164580942|NCT03519178|594492403|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
164580943|NCT03519178|594492404|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
164580944|NCT03519178|594492405|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
164580945|NCT03519178|594492406|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
164580946|NCT03519178|594492407|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
164580947|NCT03519178|594492408|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
164580948|NCT03519178|594492409|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
164580949|NCT03519178|594492410|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
164580950|NCT03519178|594492411|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
164580951|NCT03519178|594492412|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
164580952|NCT03519178|594492413|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
164580953|NCT03519178|594492414|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
164580954|NCT03519178|594492415|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
164580955|NCT03519178|594492416|FG013|Long-term Follow-up|Study terminated by sponsor|32|||
164580956|NCT03519178|594492417|FG014|Long-term Follow-up|Study terminated by sponsor|19|||
164580957|NCT03519178|594492403|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
164580958|NCT03519178|594492404|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
164580959|NCT03519178|594492405|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
164580960|NCT03519178|594492406|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
164580961|NCT03519178|594492407|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
164580962|NCT03519178|594492408|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
164580963|NCT03519178|594492409|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
164580964|NCT03519178|594492410|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
164580965|NCT03519178|594492411|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
164580966|NCT03519178|594492412|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
164580967|NCT03519178|594492413|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
164580968|NCT03519178|594492414|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
164580969|NCT03519178|594492415|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
164580970|NCT03519178|594492416|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
164580971|NCT03519178|594492417|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
164580972|NCT03519178|594492403|FG000|Long-term Follow-up|Other|0|||
164580973|NCT03519178|594492404|FG001|Long-term Follow-up|Other|0|||
164580974|NCT03519178|594492405|FG002|Long-term Follow-up|Other|0|||
164580975|NCT03519178|594492406|FG003|Long-term Follow-up|Other|0|||
164580976|NCT03519178|594492407|FG004|Long-term Follow-up|Other|0|||
164580977|NCT03519178|594492408|FG005|Long-term Follow-up|Other|0|||
164580978|NCT03519178|594492409|FG006|Long-term Follow-up|Other|0|||
164580979|NCT03519178|594492410|FG007|Long-term Follow-up|Other|0|||
164580980|NCT03519178|594492411|FG008|Long-term Follow-up|Other|0|||
164580981|NCT03519178|594492412|FG009|Long-term Follow-up|Other|0|||
164580982|NCT03519178|594492413|FG010|Long-term Follow-up|Other|0|||
164580983|NCT03519178|594492414|FG011|Long-term Follow-up|Other|0|||
164580984|NCT03519178|594492415|FG012|Long-term Follow-up|Other|0|||
164580985|NCT03519178|594492416|FG013|Long-term Follow-up|Other|0|||
164580986|NCT03519178|594492417|FG014|Long-term Follow-up|Other|1|||
164686077|NCT03820947|594873342|FG000|Overall Study|Procedure Not Attempted|0|||
164686078|NCT03820947|594873343|FG001|Overall Study|Procedure Not Attempted|2|||
164686079|NCT03820947|594873344|FG002|Overall Study|Procedure Not Attempted|1|||
164686080|NCT03820947|594873345|FG003|Overall Study|Procedure Not Attempted|0|||
164686081|NCT03820947|594873346|FG004|Overall Study|Procedure Not Attempted|0|||
164686082|NCT03820947|594873342|FG000|Overall Study|Other Exit|1|||
164686083|NCT03820947|594873343|FG001|Overall Study|Other Exit|3|||
164686084|NCT03820947|594873344|FG002|Overall Study|Other Exit|3|||
164686085|NCT03820947|594873345|FG003|Overall Study|Other Exit|3|||
164686086|NCT03820947|594873346|FG004|Overall Study|Other Exit|0|||
164686087|NCT03820947|594873342|FG000|Overall Study|Follow-up Not Done|10|||
164686088|NCT03820947|594873343|FG001|Overall Study|Follow-up Not Done|13|||
164686089|NCT03820947|594873344|FG002|Overall Study|Follow-up Not Done|2|||
164686090|NCT03820947|594873345|FG003|Overall Study|Follow-up Not Done|3|||
164686091|NCT03820947|594873346|FG004|Overall Study|Follow-up Not Done|12|||
164686092|NCT03820947|594873342|FG000|Overall Study|Death|0|||
164686093|NCT03820947|594873343|FG001|Overall Study|Death|0|||
164686094|NCT03820947|594873344|FG002|Overall Study|Death|0|||
164686095|NCT03820947|594873345|FG003|Overall Study|Death|0|||
164686096|NCT03820947|594873346|FG004|Overall Study|Death|9|||
164686097|NCT03820947|594873342|FG000|Overall Study|Lost to Follow-up|4|||
164686098|NCT03820947|594873343|FG001|Overall Study|Lost to Follow-up|6|||
164686099|NCT03820947|594873344|FG002|Overall Study|Lost to Follow-up|0|||
164686100|NCT03820947|594873345|FG003|Overall Study|Lost to Follow-up|0|||
164686101|NCT03820947|594873346|FG004|Overall Study|Lost to Follow-up|9|||
164686102|NCT05135273|594874807|FG000|Overall Study|Recruited into the army|0|||
164686103|NCT05135273|594874808|FG001|Overall Study|Recruited into the army|0|||
164686104|NCT05135273|594874809|FG002|Overall Study|Recruited into the army|0|||
164686105|NCT05135273|594874810|FG003|Overall Study|Recruited into the army|0|||
164686106|NCT05135273|594874811|FG004|Overall Study|Recruited into the army|1|||
164686107|NCT05135273|594874812|FG005|Overall Study|Recruited into the army|0|||
164686108|NCT05135273|594874813|FG006|Overall Study|Recruited into the army|0|||
164686109|NCT05135273|594874814|FG007|Overall Study|Recruited into the army|0|||
164686110|NCT05135273|594874807|FG000|Overall Study|Moved away from study site|0|||
164686111|NCT05135273|594874808|FG001|Overall Study|Moved away from study site|0|||
164686112|NCT05135273|594874809|FG002|Overall Study|Moved away from study site|0|||
164686113|NCT05135273|594874810|FG003|Overall Study|Moved away from study site|0|||
164686114|NCT05135273|594874811|FG004|Overall Study|Moved away from study site|0|||
164686115|NCT05135273|594874812|FG005|Overall Study|Moved away from study site|1|||
164686116|NCT05135273|594874813|FG006|Overall Study|Moved away from study site|1|||
164686117|NCT05135273|594874814|FG007|Overall Study|Moved away from study site|0|||
164686118|NCT05135273|594874807|FG000|Overall Study|Travel|0|||
164686119|NCT05135273|594874808|FG001|Overall Study|Travel|0|||
164686120|NCT05135273|594874809|FG002|Overall Study|Travel|0|||
164686121|NCT05135273|594874810|FG003|Overall Study|Travel|0|||
164686122|NCT05135273|594874811|FG004|Overall Study|Travel|0|||
164686123|NCT05135273|594874812|FG005|Overall Study|Travel|0|||
164686124|NCT05135273|594874813|FG006|Overall Study|Travel|0|||
164686125|NCT05135273|594874814|FG007|Overall Study|Travel|1|||
164686126|NCT04264819|594874820|FG000|Overall Study|Physician Decision|19|||
164686127|NCT04264819|594874820|FG000|Overall Study|Adverse Event|12|||
164686128|NCT04264819|594874820|FG000|Overall Study|Withdrawal by Subject|11|||
164686129|NCT04264819|594874820|FG000|Overall Study|Lost to Follow-up|2|||
164686130|NCT04264819|594874820|FG000|Overall Study|Death|2|||
164686131|NCT01680016|594874822|FG000|Overall Study|Adverse Event|0|||
164686132|NCT01680016|594874823|FG001|Overall Study|Adverse Event|0|||
164686133|NCT01680016|594874824|FG002|Overall Study|Adverse Event|1|||
164686134|NCT01680016|594874825|FG003|Overall Study|Adverse Event|4|||
164686135|NCT01680016|594874822|FG000|Overall Study|The Subject went out of The Trial|1|||
164686136|NCT01680016|594874823|FG001|Overall Study|The Subject went out of The Trial|0|||
164686137|NCT01680016|594874824|FG002|Overall Study|The Subject went out of The Trial|3|||
164686138|NCT01680016|594874825|FG003|Overall Study|The Subject went out of The Trial|0|||
164686139|NCT01680016|594874822|FG000|Overall Study|Protocol Violation|0|||
164686140|NCT01680016|594874823|FG001|Overall Study|Protocol Violation|1|||
164686141|NCT01680016|594874824|FG002|Overall Study|Protocol Violation|0|||
164686142|NCT01680016|594874825|FG003|Overall Study|Protocol Violation|0|||
164686143|NCT01680016|594874822|FG000|Overall Study|Withdrawal by Subject|5|||
164686144|NCT01680016|594874823|FG001|Overall Study|Withdrawal by Subject|7|||
164686145|NCT01680016|594874824|FG002|Overall Study|Withdrawal by Subject|1|||
164686146|NCT01680016|594874825|FG003|Overall Study|Withdrawal by Subject|1|||
164686147|NCT01958060|594874829|FG000|Overall Study|Not treated|2|||
164686148|NCT01958060|594874830|FG001|Overall Study|Not treated|0|||
164686149|NCT01958060|594874831|FG002|Overall Study|Not treated|0|||
164686150|NCT01958060|594874832|FG003|Overall Study|Not treated|0|||
164686151|NCT01958060|594874833|FG004|Overall Study|Not treated|1|||
164686152|NCT01958060|594874834|FG005|Overall Study|Not treated|0|||
164686153|NCT02846883|594874838|FG000|Overall Study|Death|0|||
164686154|NCT02846883|594874839|FG001|Overall Study|Death|1|||
164686155|NCT02846883|594874840|FG002|Overall Study|Death|1|||
164686156|NCT02846883|594874838|FG000|Overall Study|Lost to Follow-up|0|||
164686157|NCT02846883|594874839|FG001|Overall Study|Lost to Follow-up|0|||
164580987|NCT03519178|594492403|FG000|Long-term Follow-up|Global deterioration of health status|0|||
164580988|NCT03519178|594492404|FG001|Long-term Follow-up|Global deterioration of health status|0|||
164580989|NCT03519178|594492405|FG002|Long-term Follow-up|Global deterioration of health status|0|||
164265339|NCT02305849|593340464|FG003|Overall Study|Lack of Efficacy|9|||
164265340|NCT02305849|593340461|FG000|Overall Study|Withdrawal by Subject|2|||
164265341|NCT02305849|593340462|FG001|Overall Study|Withdrawal by Subject|2|||
164265342|NCT02305849|593340463|FG002|Overall Study|Withdrawal by Subject|1|||
164265343|NCT02305849|593340464|FG003|Overall Study|Withdrawal by Subject|4|||
164265344|NCT02305849|593340461|FG000|Overall Study|Lost to Follow-up|0|||
164265345|NCT02305849|593340462|FG001|Overall Study|Lost to Follow-up|2|||
164265346|NCT02305849|593340463|FG002|Overall Study|Lost to Follow-up|0|||
164265347|NCT02305849|593340464|FG003|Overall Study|Lost to Follow-up|0|||
164265348|NCT02305849|593340461|FG000|Overall Study|Protocol Violation|3|||
164265349|NCT02305849|593340462|FG001|Overall Study|Protocol Violation|2|||
164265350|NCT02305849|593340463|FG002|Overall Study|Protocol Violation|1|||
164265351|NCT02305849|593340464|FG003|Overall Study|Protocol Violation|1|||
164265352|NCT02305849|593340461|FG000|Overall Study|Lab data met discontinuation criteria|0|||
164265353|NCT02305849|593340462|FG001|Overall Study|Lab data met discontinuation criteria|1|||
164265354|NCT02305849|593340463|FG002|Overall Study|Lab data met discontinuation criteria|2|||
164265355|NCT02305849|593340464|FG003|Overall Study|Lab data met discontinuation criteria|1|||
164265356|NCT02305849|593340461|FG000|Overall Study|Miscellaneous|1|||
164265357|NCT02305849|593340462|FG001|Overall Study|Miscellaneous|2|||
164265358|NCT02305849|593340463|FG002|Overall Study|Miscellaneous|4|||
164265359|NCT02305849|593340464|FG003|Overall Study|Miscellaneous|1|||
164265360|NCT02305849|593340461|FG000|Overall Study|Not fulfill eligibility criteria|1|||
164265361|NCT02305849|593340462|FG001|Overall Study|Not fulfill eligibility criteria|1|||
164265362|NCT02305849|593340463|FG002|Overall Study|Not fulfill eligibility criteria|0|||
164265363|NCT02305849|593340464|FG003|Overall Study|Not fulfill eligibility criteria|0|||
164265364|NCT00355342|593340465|FG000|Overall Study|Adverse Event|13|||
164265365|NCT00355342|593340466|FG001|Overall Study|Adverse Event|15|||
164265366|NCT00355342|593340465|FG000|Overall Study|Lost to Follow-up|4|||
164265367|NCT00355342|593340466|FG001|Overall Study|Lost to Follow-up|2|||
164265368|NCT00355342|593340465|FG000|Overall Study|Withdrawal by Subject|14|||
164265369|NCT00355342|593340466|FG001|Overall Study|Withdrawal by Subject|11|||
164265370|NCT00355342|593340465|FG000|Overall Study|Sponsor terminated study|2|||
164265371|NCT00355342|593340466|FG001|Overall Study|Sponsor terminated study|2|||
164265372|NCT00355342|593340465|FG000|Overall Study|Overcompliant-PI discretion|1|||
164265373|NCT00355342|593340466|FG001|Overall Study|Overcompliant-PI discretion|0|||
164265374|NCT00355342|593340465|FG000|Overall Study|Use of prohibited medication|1|||
164265375|NCT00355342|593340466|FG001|Overall Study|Use of prohibited medication|0|||
164265376|NCT00355342|593340465|FG000|Overall Study|COPD exacerbation|1|||
164265377|NCT00355342|593340466|FG001|Overall Study|COPD exacerbation|1|||
164265378|NCT00355342|593340465|FG000|Overall Study|Dispensed wrong study drug kit|1|||
164265379|NCT00355342|593340466|FG001|Overall Study|Dispensed wrong study drug kit|0|||
164265380|NCT00355342|593340465|FG000|Overall Study|Non-compliance with Dexa scans|1|||
164265381|NCT00355342|593340466|FG001|Overall Study|Non-compliance with Dexa scans|0|||
164265382|NCT00355342|593340465|FG000|Overall Study|Withdrawal by participant and physician|1|||
164265383|NCT00355342|593340466|FG001|Overall Study|Withdrawal by participant and physician|0|||
164265384|NCT00355342|593340465|FG000|Overall Study|Participant relocated|0|||
164265385|NCT00355342|593340466|FG001|Overall Study|Participant relocated|1|||
164265386|NCT00355342|593340465|FG000|Overall Study|Participant discontinued study drug|0|||
164265387|NCT00355342|593340466|FG001|Overall Study|Participant discontinued study drug|1|||
164265388|NCT00355342|593340465|FG000|Overall Study|Study management|0|||
164265389|NCT00355342|593340466|FG001|Overall Study|Study management|1|||
164265390|NCT00355342|593340465|FG000|Overall Study|Protocol Violation|0|||
164265391|NCT00355342|593340466|FG001|Overall Study|Protocol Violation|1|||
164265392|NCT00355342|593340465|FG000|Overall Study|Use of protocol excluded medication|0|||
164265393|NCT00355342|593340466|FG001|Overall Study|Use of protocol excluded medication|1|||
164265394|NCT02689076|593340467|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
164265395|NCT02689076|593340468|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
164265396|NCT02689076|593340469|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
164265397|NCT02689076|593340467|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
164265398|NCT02689076|593340468|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
164265399|NCT02689076|593340469|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
164265400|NCT02689076|593340467|FG000|Overall Study|Did not have an HIE match|2|||
164265401|NCT02689076|593340468|FG001|Overall Study|Did not have an HIE match|0|||
164265402|NCT02689076|593340469|FG002|Overall Study|Did not have an HIE match|0|||
164265403|NCT02689076|593340467|FG000|Overall Study|Death during non-VA encounter|2|||
164265404|NCT02689076|593340468|FG001|Overall Study|Death during non-VA encounter|5|||
164265405|NCT02689076|593340469|FG002|Overall Study|Death during non-VA encounter|0|||
164580990|NCT03519178|594492406|FG003|Long-term Follow-up|Global deterioration of health status|0|||
164265406|NCT02689076|593340467|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
164265407|NCT02689076|593340468|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
164265408|NCT02689076|593340469|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
164265409|NCT02689076|593340467|FG000|Overall Study|Participant no longer active in VA system|1|||
164265410|NCT02689076|593340468|FG001|Overall Study|Participant no longer active in VA system|0|||
164265411|NCT02689076|593340469|FG002|Overall Study|Participant no longer active in VA system|0|||
164265412|NCT02689076|593340467|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
164265413|NCT02689076|593340468|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
164265414|NCT02689076|593340469|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
164265415|NCT00933244|593340470|FG000|Overall Study|Withdrawal by Subject|5|||
164265416|NCT00933244|593340471|FG001|Overall Study|Withdrawal by Subject|1|||
164265417|NCT00933244|593340472|FG002|Overall Study|Withdrawal by Subject|3|||
164265418|NCT00495521|593340475|FG000|Overall Study|Physician Decision|0|||
164265419|NCT00495521|593340476|FG001|Overall Study|Physician Decision|1|||
164265420|NCT00693472|593340479|FG000|Part 1|Adverse Event|1|||
164265421|NCT00693472|593340480|FG001|Part 1|Adverse Event|1|||
164265422|NCT00693472|593340481|FG002|Part 1|Adverse Event|0|||
164265423|NCT00693472|593340482|FG003|Part 1|Adverse Event|0|||
164265424|NCT00693472|593340479|FG000|Part 1|Lost to Follow-up|0|||
164265425|NCT00693472|593340480|FG001|Part 1|Lost to Follow-up|1|||
164265426|NCT00693472|593340481|FG002|Part 1|Lost to Follow-up|0|||
164265427|NCT00693472|593340482|FG003|Part 1|Lost to Follow-up|0|||
164265428|NCT00693472|593340479|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
164265429|NCT00693472|593340480|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
164265430|NCT00693472|593340481|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
164265431|NCT00693472|593340482|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
164265432|NCT00693472|593340479|FG000|Part 2|Adverse Event|0|||
164265433|NCT00693472|593340480|FG001|Part 2|Adverse Event|0|||
164265434|NCT00693472|593340481|FG002|Part 2|Adverse Event|1|||
164265435|NCT00693472|593340482|FG003|Part 2|Adverse Event|0|||
164265436|NCT00693472|593340479|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
164265437|NCT00693472|593340480|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
164265438|NCT00693472|593340481|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
164265439|NCT00693472|593340482|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
164265440|NCT02782325|593340483|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
164265441|NCT02782325|593340484|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
164265442|NCT02782325|593340485|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
164265443|NCT02782325|593340483|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
164265444|NCT02782325|593340484|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
164265445|NCT02782325|593340485|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
164265446|NCT01527383|593340488|FG000|Overall Study|Adverse Event|5|||
164265447|NCT01527383|593340489|FG001|Overall Study|Adverse Event|0|||
164265448|NCT01527383|593340488|FG000|Overall Study|Lost to Follow-up|3|||
164265449|NCT01527383|593340489|FG001|Overall Study|Lost to Follow-up|0|||
164265450|NCT01527383|593340488|FG000|Overall Study|Physician Decision|2|||
164265451|NCT01527383|593340489|FG001|Overall Study|Physician Decision|0|||
164265452|NCT01527383|593340488|FG000|Overall Study|Pregnancy|1|||
164265453|NCT01527383|593340489|FG001|Overall Study|Pregnancy|0|||
164265454|NCT01527383|593340488|FG000|Overall Study|Protocol Violation|1|||
164341720|NCT01890473|593627479|FG001|Overall Study|Lost to Follow-up|0|||
164341721|NCT01890473|593627478|FG000|Overall Study|Poor/non-compliance|1|||
164341722|NCT01890473|593627479|FG001|Overall Study|Poor/non-compliance|0|||
164341723|NCT01945281|593627480|FG000|Overall Study|Adverse Event|1|||
164341724|NCT01945281|593627481|FG001|Overall Study|Adverse Event|0|||
164341725|NCT01945281|593627480|FG000|Overall Study|Death|3|||
164341726|NCT01945281|593627481|FG001|Overall Study|Death|3|||
164686158|NCT02846883|594874840|FG002|Overall Study|Lost to Follow-up|1|||
164686159|NCT02846883|594874838|FG000|Overall Study|Withdrawal by Subject|1|||
164686160|NCT02846883|594874839|FG001|Overall Study|Withdrawal by Subject|0|||
164686161|NCT02846883|594874840|FG002|Overall Study|Withdrawal by Subject|0|||
164686162|NCT02846883|594874838|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
164686163|NCT02846883|594874839|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
164265455|NCT01527383|593340489|FG001|Overall Study|Protocol Violation|0|||
164265456|NCT01527383|593340488|FG000|Overall Study|Screen failure|1|||
164265457|NCT01527383|593340489|FG001|Overall Study|Screen failure|0|||
164265458|NCT01527383|593340488|FG000|Overall Study|Participant moved|0|||
164265459|NCT01527383|593340489|FG001|Overall Study|Participant moved|1|||
164265460|NCT01527383|593340488|FG000|Overall Study|Withdrawal by Subject|2|||
164265461|NCT01527383|593340489|FG001|Overall Study|Withdrawal by Subject|3|||
164265462|NCT00849875|593340490|FG000|Overall Study|Death|28|||
164265463|NCT00849875|593340490|FG000|Overall Study|Ongoing (unknown completion status)|11|||
164341727|NCT01945281|593627480|FG000|Overall Study|Physician Decision|1|||
164341728|NCT01945281|593627481|FG001|Overall Study|Physician Decision|1|||
164265464|NCT00849875|593340490|FG000|Overall Study|Others|6|||
164341729|NCT01945281|593627480|FG000|Overall Study|Technical Problems|1|||
164265465|NCT00849875|593340490|FG000|Overall Study|Lost to Follow-up|2|||
164265466|NCT00554099|593340495|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
164265467|NCT00554099|593340496|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
164265468|NCT00554099|593340497|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
164265469|NCT00554099|593340495|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
164265470|NCT00554099|593340496|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
164265471|NCT00554099|593340497|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
164265472|NCT00554099|593340495|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
164265473|NCT00554099|593340496|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164265474|NCT00554099|593340497|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
164265475|NCT00554099|593340495|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
164265476|NCT00554099|593340496|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
164265477|NCT00554099|593340497|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
164265478|NCT00554099|593340495|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
164265479|NCT00554099|593340496|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
164265480|NCT00554099|593340497|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
164265481|NCT00554099|593340495|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
164265482|NCT00554099|593340496|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
164265483|NCT00554099|593340497|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
164265484|NCT00554099|593340495|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
164265485|NCT00554099|593340496|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
164265486|NCT00554099|593340497|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
164265487|NCT00554099|593340495|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
164265488|NCT00554099|593340496|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
164265489|NCT00554099|593340497|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
164265490|NCT00554099|593340495|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
164265491|NCT00554099|593340496|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
164265492|NCT00554099|593340497|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
164265493|NCT04957758|593340502|FG000|Overall Study|Adverse Event|1|||
164265494|NCT04957758|593340503|FG001|Overall Study|Adverse Event|0|||
164265495|NCT04957758|593340502|FG000|Overall Study|Lost to Follow-up|0|||
164265496|NCT04957758|593340503|FG001|Overall Study|Lost to Follow-up|2|||
164265497|NCT04957758|593340502|FG000|Overall Study|Withdrawal by Subject|4|||
164265498|NCT04957758|593340503|FG001|Overall Study|Withdrawal by Subject|2|||
164265499|NCT04957758|593340502|FG000|Overall Study|Protocol Violation|0|||
164265500|NCT04957758|593340503|FG001|Overall Study|Protocol Violation|1|||
164265501|NCT03353922|593340504|FG000|Overall Study|Withdrawal by Subject|1|||
164265502|NCT03353922|593340505|FG001|Overall Study|Withdrawal by Subject|0|||
164265503|NCT03353922|593340506|FG002|Overall Study|Withdrawal by Subject|1|||
164265504|NCT03353922|593340507|FG003|Overall Study|Withdrawal by Subject|1|||
164265505|NCT03353922|593340508|FG004|Overall Study|Withdrawal by Subject|0|||
164265506|NCT03353922|593340509|FG005|Overall Study|Withdrawal by Subject|0|||
164265507|NCT03353922|593340504|FG000|Overall Study|Adverse Event|0|||
164265508|NCT03353922|593340505|FG001|Overall Study|Adverse Event|1|||
164265509|NCT03353922|593340506|FG002|Overall Study|Adverse Event|0|||
164265510|NCT03353922|593340507|FG003|Overall Study|Adverse Event|0|||
164265511|NCT03353922|593340508|FG004|Overall Study|Adverse Event|0|||
164265512|NCT03353922|593340509|FG005|Overall Study|Adverse Event|0|||
164265513|NCT03688555|593340510|FG000|Treatment Period|Adverse Event|0|||
164265514|NCT03688555|593340511|FG001|Treatment Period|Adverse Event|0|||
164265515|NCT03688555|593340512|FG002|Treatment Period|Adverse Event|1|||
164265516|NCT00886119|593340513|FG000|Period 1|Did not meet inclusion criteria|1|||
164265517|NCT00886119|593340514|FG001|Period 1|Did not meet inclusion criteria|0|||
164265518|NCT03553498|593340516|FG000|Overall Study|Missing primary outcome|1|||
164265519|NCT03553498|593340517|FG001|Overall Study|Missing primary outcome|2|||
164265520|NCT01498185|593340518|FG000|Overall Study|Adverse Event|0|||
164265521|NCT01498185|593340519|FG001|Overall Study|Adverse Event|0|||
164265522|NCT01498185|593340520|FG002|Overall Study|Adverse Event|0|||
164265523|NCT01498185|593340521|FG003|Overall Study|Adverse Event|1|||
164265524|NCT01498185|593340522|FG004|Overall Study|Adverse Event|0|||
164265525|NCT01498185|593340518|FG000|Overall Study|Withdrawal by Subject|1|||
164265526|NCT01498185|593340519|FG001|Overall Study|Withdrawal by Subject|1|||
164265527|NCT01498185|593340520|FG002|Overall Study|Withdrawal by Subject|0|||
164265528|NCT01498185|593340521|FG003|Overall Study|Withdrawal by Subject|2|||
164265529|NCT01498185|593340522|FG004|Overall Study|Withdrawal by Subject|1|||
164265530|NCT01498185|593340518|FG000|Overall Study|No longer met criteria, etc|0|||
164265531|NCT01498185|593340519|FG001|Overall Study|No longer met criteria, etc|0|||
164265532|NCT01498185|593340520|FG002|Overall Study|No longer met criteria, etc|0|||
164341730|NCT01945281|593627481|FG001|Overall Study|Technical Problems|0|||
164580991|NCT03519178|594492407|FG004|Long-term Follow-up|Global deterioration of health status|0|||
164265533|NCT01498185|593340521|FG003|Overall Study|No longer met criteria, etc|0|||
164265534|NCT01498185|593340522|FG004|Overall Study|No longer met criteria, etc|2|||
164265535|NCT01453946|593340524|FG000|Overall Study|Did not receive drug for the taper phase|1|||
164265536|NCT01453946|593340524|FG000|Overall Study|Protocol Violation|2|||
164265537|NCT01453946|593340524|FG000|Overall Study|Lack of Efficacy|3|||
164265538|NCT01453946|593340524|FG000|Overall Study|Adverse Event|3|||
164265539|NCT00846040|593340525|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
164265540|NCT00846040|593340526|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
164265541|NCT00846040|593340527|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
164265542|NCT00846040|593340525|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
164265543|NCT00846040|593340526|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
164265544|NCT00846040|593340527|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
164265545|NCT02827500|593340529|FG000|Overall Study|Death|7|||
164265546|NCT02827500|593340530|FG001|Overall Study|Death|3|||
164265547|NCT02827500|593340529|FG000|Overall Study|Lost to Follow-up|1|||
164265548|NCT02827500|593340530|FG001|Overall Study|Lost to Follow-up|1|||
164265549|NCT02827500|593340529|FG000|Overall Study|Withdrawal by Subject|3|||
164265550|NCT02827500|593340530|FG001|Overall Study|Withdrawal by Subject|1|||
164265551|NCT02827500|593340529|FG000|Overall Study|Missing primary endpoint data|3|||
164265552|NCT02827500|593340530|FG001|Overall Study|Missing primary endpoint data|1|||
164265553|NCT02827500|593340529|FG000|Overall Study|Other|5|||
164265554|NCT02827500|593340530|FG001|Overall Study|Other|1|||
164265555|NCT03697993|593340533|FG000|Overall Study|Became Ineligible after Enrollment|1|||
164265556|NCT03697993|593340534|FG001|Overall Study|Became Ineligible after Enrollment|3|||
164265557|NCT03697993|593340533|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
164265558|NCT03697993|593340534|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
164265559|NCT03697993|593340533|FG000|Overall Study|Lost to Follow-up|3|||
164265560|NCT03697993|593340534|FG001|Overall Study|Lost to Follow-up|0|||
164265561|NCT03697993|593340533|FG000|Overall Study|Physician Decision|4|||
164265562|NCT03697993|593340534|FG001|Overall Study|Physician Decision|0|||
164265563|NCT03697993|593340533|FG000|Overall Study|Initial Urine Culture Negative|0|||
164265564|NCT03697993|593340534|FG001|Overall Study|Initial Urine Culture Negative|1|||
164265565|NCT04384107|593340535|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
164265566|NCT04384107|593340536|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
164265567|NCT04384107|593340535|FG000|Overall Study|Lost to Follow-up|1|||
164265568|NCT04384107|593340536|FG001|Overall Study|Lost to Follow-up|0|||
164265569|NCT01591863|593340539|FG000|Overall Study|Adverse Event|3|||
164265570|NCT01591863|593340539|FG000|Overall Study|Withdrawal by Subject|1|||
164265571|NCT01591863|593340539|FG000|Overall Study|recurrence|9|||
164265572|NCT01591863|593340539|FG000|Overall Study|Lack of Efficacy|1|||
164265573|NCT00160654|593340540|FG000|Overall Study|Adverse Event|14|||
164265574|NCT00160654|593340540|FG000|Overall Study|Lack of Efficacy|4|||
164265575|NCT00160654|593340540|FG000|Overall Study|Lost to Follow-up|2|||
164265576|NCT00160654|593340540|FG000|Overall Study|Intake of expired drug|7|||
164265577|NCT00160654|593340540|FG000|Overall Study|Psychological trauma|1|||
164580992|NCT03519178|594492408|FG005|Long-term Follow-up|Global deterioration of health status|0|||
164580993|NCT03519178|594492409|FG006|Long-term Follow-up|Global deterioration of health status|0|||
164265578|NCT00160654|593340540|FG000|Overall Study|Sponsor decision|1|||
164265579|NCT00160654|593340540|FG000|Overall Study|Patient met exclusion criteria|1|||
164580994|NCT03519178|594492410|FG007|Long-term Follow-up|Global deterioration of health status|0|||
164580995|NCT03519178|594492411|FG008|Long-term Follow-up|Global deterioration of health status|0|||
164580996|NCT03519178|594492412|FG009|Long-term Follow-up|Global deterioration of health status|0|||
164580997|NCT03519178|594492413|FG010|Long-term Follow-up|Global deterioration of health status|0|||
164580998|NCT03519178|594492414|FG011|Long-term Follow-up|Global deterioration of health status|0|||
164580999|NCT03519178|594492415|FG012|Long-term Follow-up|Global deterioration of health status|0|||
164581000|NCT03519178|594492416|FG013|Long-term Follow-up|Global deterioration of health status|1|||
164581001|NCT03519178|594492417|FG014|Long-term Follow-up|Global deterioration of health status|0|||
164581002|NCT00072189|594492428|FG000|Overall Study|Withdrawal by Subject|1|||
164581003|NCT00970294|594492433|FG000|Overall Study|Physician Decision|4|||
164581004|NCT00970294|594492433|FG000|Overall Study|Withdrawal by Subject|1|||
164581005|NCT01877655|594492434|FG000|Overall Study|Death|57|||
164581006|NCT01877655|594492435|FG001|Overall Study|Death|52|||
164581007|NCT01877655|594492434|FG000|Overall Study|Withdrawal by Subject|18|||
164581008|NCT01877655|594492435|FG001|Overall Study|Withdrawal by Subject|26|||
164581009|NCT01877655|594492434|FG000|Overall Study|Physician Decision|11|||
164581010|NCT01877655|594492435|FG001|Overall Study|Physician Decision|10|||
164581011|NCT01877655|594492434|FG000|Overall Study|Miscellaneous|4|||
164581012|NCT01877655|594492435|FG001|Overall Study|Miscellaneous|4|||
164581013|NCT01877655|594492434|FG000|Overall Study|Randomized but Never Received Drug|8|||
164581014|NCT01877655|594492435|FG001|Overall Study|Randomized but Never Received Drug|5|||
164581015|NCT02562235|594493850|FG000|Overall Study|Adverse Event|3|||
164581016|NCT02089737|594493851|FG000|Overall Study|Survey form not completed|5|||
164581017|NCT02089737|594493851|FG000|Overall Study|Not treated|1|||
164265580|NCT00160654|593340540|FG000|Overall Study|Patient decision|1|||
164265581|NCT00160654|593340540|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
164265582|NCT00160654|593340540|FG000|Overall Study|Met exclusion criteria|1|||
164265583|NCT00831701|593340541|FG000|Overall Study|Withdrawal by Subject|2|||
164265584|NCT00831701|593340542|FG001|Overall Study|Withdrawal by Subject|0|||
164265585|NCT00831701|593340541|FG000|Overall Study|Stone expulsion before first medication|2|||
164265586|NCT00831701|593340542|FG001|Overall Study|Stone expulsion before first medication|2|||
164265587|NCT00831701|593340541|FG000|Overall Study|Lost to Follow-up|1|||
164265588|NCT00831701|593340542|FG001|Overall Study|Lost to Follow-up|3|||
164265589|NCT02366767|593340543|FG000|Overall Study|left for home after 1 day at camp|1|||
164265590|NCT02366767|593340544|FG001|Overall Study|left for home after 1 day at camp|0|||
164265591|NCT02242981|593340545|FG000|Overall Study|Withdrawal by Subject|1|||
164265592|NCT03474081|593340548|FG000|Overall Study|Adverse Event|6|||
164265593|NCT03474081|593340549|FG001|Overall Study|Adverse Event|3|||
164265594|NCT03474081|593340548|FG000|Overall Study|Lost to Follow-up|2|||
164265595|NCT03474081|593340549|FG001|Overall Study|Lost to Follow-up|1|||
164265596|NCT03474081|593340548|FG000|Overall Study|Physician Decision|3|||
164265597|NCT03474081|593340549|FG001|Overall Study|Physician Decision|2|||
164265598|NCT03474081|593340548|FG000|Overall Study|Withdrawal by Subject|5|||
164265599|NCT03474081|593340549|FG001|Overall Study|Withdrawal by Subject|7|||
164265600|NCT03474081|593340548|FG000|Overall Study|Investigator site closed|1|||
164265601|NCT03474081|593340549|FG001|Overall Study|Investigator site closed|0|||
164265602|NCT00459537|593340553|FG000|Overall Study|Adverse Event|1|||
164265603|NCT00459537|593340554|FG001|Overall Study|Adverse Event|6|||
164265604|NCT00459537|593340553|FG000|Overall Study|Lack of Efficacy|10|||
164265605|NCT00459537|593340554|FG001|Overall Study|Lack of Efficacy|11|||
164265606|NCT00459537|593340553|FG000|Overall Study|Withdrawal by Subject|20|||
164265607|NCT00459537|593340554|FG001|Overall Study|Withdrawal by Subject|26|||
164265608|NCT00459537|593340553|FG000|Overall Study|Lost to Follow-up|27|||
164265609|NCT00459537|593340554|FG001|Overall Study|Lost to Follow-up|30|||
164265610|NCT00459537|593340553|FG000|Overall Study|Administrative problems|3|||
164265611|NCT00459537|593340554|FG001|Overall Study|Administrative problems|0|||
164265612|NCT00459537|593340553|FG000|Overall Study|Protocol Violation|4|||
164265613|NCT00459537|593340554|FG001|Overall Study|Protocol Violation|3|||
164265614|NCT00459537|593340553|FG000|Overall Study|Missing|1|||
164265615|NCT00459537|593340554|FG001|Overall Study|Missing|0|||
164265616|NCT00546260|593340555|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
164265617|NCT00546260|593340556|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
164265618|NCT00664326|593342604|FG000|Overall Study|Adverse Event|14|||
164265619|NCT00664326|593342604|FG000|Overall Study|Noncompliance with study medication|3|||
164265620|NCT00664326|593342604|FG000|Overall Study|Withdrawal by Subject|1|||
164265621|NCT00664326|593342604|FG000|Overall Study|Physician Decision|1|||
164265622|NCT00664326|593342604|FG000|Overall Study|Other Reasons|3|||
164265623|NCT00664326|593342604|FG000|Overall Study|Death|2|||
164265624|NCT00664326|593342604|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
164265625|NCT01161537|593342606|FG000|Part B|Withdrawal by Subject|2|||
164265626|NCT00996801|593342607|FG000|Overall Study|Adverse Event|6|||
164265627|NCT00996801|593342608|FG001|Overall Study|Adverse Event|4|||
164265628|NCT00996801|593342609|FG002|Overall Study|Adverse Event|12|||
164265629|NCT00996801|593342610|FG003|Overall Study|Adverse Event|17|||
164265630|NCT00996801|593342611|FG004|Overall Study|Adverse Event|31|||
164265631|NCT00996801|593342612|FG005|Overall Study|Adverse Event|3|||
164265632|NCT00996801|593342607|FG000|Overall Study|Lack of Efficacy|3|||
164265633|NCT00996801|593342608|FG001|Overall Study|Lack of Efficacy|0|||
164265634|NCT00996801|593342609|FG002|Overall Study|Lack of Efficacy|1|||
164265635|NCT00996801|593342610|FG003|Overall Study|Lack of Efficacy|3|||
164265636|NCT00996801|593342611|FG004|Overall Study|Lack of Efficacy|0|||
164265637|NCT00996801|593342612|FG005|Overall Study|Lack of Efficacy|1|||
164265638|NCT00996801|593342607|FG000|Overall Study|Lost to Follow-up|0|||
164265639|NCT00996801|593342608|FG001|Overall Study|Lost to Follow-up|0|||
164265640|NCT00996801|593342609|FG002|Overall Study|Lost to Follow-up|0|||
164265641|NCT00996801|593342610|FG003|Overall Study|Lost to Follow-up|3|||
164265642|NCT00996801|593342611|FG004|Overall Study|Lost to Follow-up|3|||
164265643|NCT00996801|593342612|FG005|Overall Study|Lost to Follow-up|2|||
164265644|NCT00996801|593342607|FG000|Overall Study|Physician Decision|0|||
164265645|NCT00996801|593342608|FG001|Overall Study|Physician Decision|0|||
164265646|NCT00996801|593342609|FG002|Overall Study|Physician Decision|0|||
164265647|NCT00996801|593342610|FG003|Overall Study|Physician Decision|1|||
164265648|NCT00996801|593342611|FG004|Overall Study|Physician Decision|0|||
164265649|NCT00996801|593342612|FG005|Overall Study|Physician Decision|0|||
164265650|NCT00996801|593342607|FG000|Overall Study|Progressive Disease|0|||
164265651|NCT00996801|593342608|FG001|Overall Study|Progressive Disease|1|||
164265652|NCT00996801|593342609|FG002|Overall Study|Progressive Disease|0|||
164265653|NCT00996801|593342610|FG003|Overall Study|Progressive Disease|0|||
164265654|NCT00996801|593342611|FG004|Overall Study|Progressive Disease|0|||
164265655|NCT00996801|593342612|FG005|Overall Study|Progressive Disease|0|||
164265656|NCT00996801|593342607|FG000|Overall Study|Protocol Violation|3|||
164581018|NCT05248945|594493852|FG000|Overall Study|Adverse Event|1|||
164265657|NCT00996801|593342608|FG001|Overall Study|Protocol Violation|4|||
164265658|NCT00996801|593342609|FG002|Overall Study|Protocol Violation|1|||
164265659|NCT00996801|593342610|FG003|Overall Study|Protocol Violation|2|||
164265660|NCT00996801|593342611|FG004|Overall Study|Protocol Violation|3|||
164265661|NCT00996801|593342612|FG005|Overall Study|Protocol Violation|4|||
164265662|NCT00996801|593342607|FG000|Overall Study|Study Terminated by Sponsor|0|||
164265663|NCT00996801|593342608|FG001|Overall Study|Study Terminated by Sponsor|1|||
164265664|NCT00996801|593342609|FG002|Overall Study|Study Terminated by Sponsor|0|||
164265665|NCT00996801|593342610|FG003|Overall Study|Study Terminated by Sponsor|0|||
164265666|NCT00996801|593342611|FG004|Overall Study|Study Terminated by Sponsor|46|||
164265667|NCT00996801|593342612|FG005|Overall Study|Study Terminated by Sponsor|0|||
164265668|NCT00996801|593342607|FG000|Overall Study|Withdrawal by Subject|8|||
164265669|NCT00996801|593342608|FG001|Overall Study|Withdrawal by Subject|6|||
164265670|NCT00996801|593342609|FG002|Overall Study|Withdrawal by Subject|9|||
164265671|NCT00996801|593342610|FG003|Overall Study|Withdrawal by Subject|5|||
164265672|NCT00996801|593342611|FG004|Overall Study|Withdrawal by Subject|5|||
164265673|NCT00996801|593342612|FG005|Overall Study|Withdrawal by Subject|9|||
164265674|NCT00289198|593342613|FG000|Overall Study|Adverse Event|0|||
164265675|NCT00289198|593342614|FG001|Overall Study|Adverse Event|2|||
164265676|NCT00289198|593342613|FG000|Overall Study|Protocol Violation|2|||
164265677|NCT00289198|593342614|FG001|Overall Study|Protocol Violation|1|||
164265678|NCT00289198|593342613|FG000|Overall Study|Withdrawal by Subject|4|||
164265679|NCT00289198|593342614|FG001|Overall Study|Withdrawal by Subject|1|||
164265680|NCT00289198|593342613|FG000|Overall Study|Lack of Efficacy|2|||
164265681|NCT00289198|593342614|FG001|Overall Study|Lack of Efficacy|0|||
164686164|NCT02846883|594874840|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
164686165|NCT02846883|594874838|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
164265682|NCT00289198|593342613|FG000|Overall Study|Other: Low compliance|0|||
164265683|NCT00289198|593342614|FG001|Overall Study|Other: Low compliance|1|||
164265684|NCT00289198|593342613|FG000|Overall Study|Other: Physician's decision|0|||
164265685|NCT00289198|593342614|FG001|Overall Study|Other: Physician's decision|1|||
164265686|NCT00289198|593342613|FG000|Overall Study|Other: Unable to attend on schedule|2|||
164265687|NCT00289198|593342614|FG001|Overall Study|Other: Unable to attend on schedule|1|||
164265688|NCT00289198|593342613|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
164265689|NCT00289198|593342614|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
164265690|NCT00289198|593342613|FG000|Overall Study|Other: Impossible to come on visit|0|||
164265691|NCT00289198|593342614|FG001|Overall Study|Other: Impossible to come on visit|1|||
164265692|NCT02559414|593342621|FG000|Overall Study|Lost to Follow-up|0|||
164265693|NCT02559414|593342622|FG001|Overall Study|Lost to Follow-up|1|||
164265694|NCT02559414|593342623|FG002|Overall Study|Lost to Follow-up|0|||
164265695|NCT02559414|593342621|FG000|Overall Study|Withdrawal by Subject|1|||
164265696|NCT02559414|593342622|FG001|Overall Study|Withdrawal by Subject|0|||
164265697|NCT02559414|593342623|FG002|Overall Study|Withdrawal by Subject|1|||
164265698|NCT02559414|593342621|FG000|Overall Study|Other|0|||
164265699|NCT02559414|593342622|FG001|Overall Study|Other|1|||
164265700|NCT02559414|593342623|FG002|Overall Study|Other|1|||
164265701|NCT03369431|593342624|FG000|Overall Study|Lost to Follow-up|1|||
164265702|NCT03369431|593342625|FG001|Overall Study|Lost to Follow-up|3|||
164265703|NCT03369431|593342624|FG000|Overall Study|Withdrawal by Subject|2|||
164265704|NCT03369431|593342625|FG001|Overall Study|Withdrawal by Subject|3|||
164265705|NCT03369431|593342624|FG000|Overall Study|Protocol Violation|1|||
164265706|NCT03369431|593342625|FG001|Overall Study|Protocol Violation|1|||
164265707|NCT00004445|593342626|FG000|Overall Study|Physician Decision|2|||
164265708|NCT00004445|593342626|FG000|Overall Study|Withdrawal by Subject|1|||
164265709|NCT00076336|593342627|FG000|Overall Study|Death|13|||
164265710|NCT00076336|593342628|FG001|Overall Study|Death|17|||
164265711|NCT00076336|593342627|FG000|Overall Study|Adverse Event|4|||
164265712|NCT00076336|593342628|FG001|Overall Study|Adverse Event|4|||
164265713|NCT00076336|593342627|FG000|Overall Study|Lost to Follow-up|4|||
164265714|NCT00076336|593342628|FG001|Overall Study|Lost to Follow-up|4|||
164265715|NCT00076336|593342627|FG000|Overall Study|Non-Compliance|2|||
164265716|NCT00076336|593342628|FG001|Overall Study|Non-Compliance|0|||
164265717|NCT00076336|593342627|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
164265718|NCT00076336|593342628|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
164265719|NCT00076336|593342627|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
164265720|NCT00076336|593342628|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
164265721|NCT00076336|593342627|FG000|Overall Study|Liver Transplantation|3|||
164265722|NCT00076336|593342628|FG001|Overall Study|Liver Transplantation|3|||
164265723|NCT00076336|593342627|FG000|Overall Study|Virologic Breakthrough|14|||
164341731|NCT01819831|593627484|FG000|Overall Study|Withdrawal by Subject|1|||
164341732|NCT05074667|593627487|FG000|Overall Study|Death|1|||
164341733|NCT05074667|593627487|FG000|Overall Study|Withdrawal by Subject|4|||
164341734|NCT05074667|593627487|FG000|Overall Study|Lost to Follow-up|10|||
164341735|NCT02478632|593627492|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
164341736|NCT02478632|593627493|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
164341737|NCT02478632|593627492|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
164341738|NCT02478632|593627493|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
164341739|NCT02478632|593627492|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
164341740|NCT02478632|593627493|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
164341741|NCT01867424|593627494|FG000|Overall Study|Patient noncompliance|2|||
164341742|NCT01867424|593627495|FG001|Overall Study|Patient noncompliance|1|||
164581019|NCT05248945|594493852|FG000|Overall Study|Elevated Gamma-Glutamyl Transferase (GGT)|1|||
164581020|NCT05525975|594493853|FG000|Overall Study|Surgery cancellation|4|||
164581021|NCT05525975|594493854|FG001|Overall Study|Surgery cancellation|5|||
164581022|NCT05525975|594493853|FG000|Overall Study|didn't fill prescription|1|||
164265724|NCT00076336|593342628|FG001|Overall Study|Virologic Breakthrough|16|||
164265725|NCT00076336|593342627|FG000|Overall Study|Treatment failure|4|||
164265726|NCT00076336|593342628|FG001|Overall Study|Treatment failure|5|||
164265727|NCT02753127|593342634|FG000|Overall Study|Lost to Follow-up|13|||
164265728|NCT02753127|593342635|FG001|Overall Study|Lost to Follow-up|11|||
164265729|NCT02753127|593342634|FG000|Overall Study|Withdrawal by Subject|37|||
164265730|NCT02753127|593342635|FG001|Overall Study|Withdrawal by Subject|47|||
164265731|NCT02753127|593342634|FG000|Overall Study|Other|3|||
164265732|NCT02753127|593342635|FG001|Overall Study|Other|8|||
164265733|NCT02753127|593342634|FG000|Overall Study|Hospice|0|||
164265734|NCT02753127|593342635|FG001|Overall Study|Hospice|2|||
164265735|NCT01519674|593342640|FG000|Overall Study|Adverse Event|3|||
164265736|NCT01519674|593342641|FG001|Overall Study|Adverse Event|3|||
164265737|NCT01519674|593342642|FG002|Overall Study|Adverse Event|0|||
164265738|NCT01519674|593342640|FG000|Overall Study|Lack of Efficacy|1|||
164265739|NCT01519674|593342641|FG001|Overall Study|Lack of Efficacy|1|||
164265740|NCT01519674|593342642|FG002|Overall Study|Lack of Efficacy|1|||
164265741|NCT01519674|593342640|FG000|Overall Study|Protocol Violation|0|||
164265742|NCT01519674|593342641|FG001|Overall Study|Protocol Violation|3|||
164265743|NCT01519674|593342642|FG002|Overall Study|Protocol Violation|1|||
164265744|NCT01519674|593342640|FG000|Overall Study|Withdrawal Criteria|7|||
164265745|NCT01519674|593342641|FG001|Overall Study|Withdrawal Criteria|2|||
164265746|NCT01519674|593342642|FG002|Overall Study|Withdrawal Criteria|7|||
164265747|NCT01519674|593342640|FG000|Overall Study|Unsclassified|10|||
164265748|NCT01519674|593342641|FG001|Overall Study|Unsclassified|4|||
164265749|NCT01519674|593342642|FG002|Overall Study|Unsclassified|3|||
164265750|NCT02046174|593342646|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
164265751|NCT02046174|593342647|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
164265752|NCT00186537|593342649|FG000|Overall Study|Withdrawal by Subject|4|||
164265753|NCT00186537|593342650|FG001|Overall Study|Withdrawal by Subject|0|||
164265754|NCT00186537|593342651|FG002|Overall Study|Withdrawal by Subject|3|||
164265755|NCT00186537|593342649|FG000|Overall Study|ALT > 1.5 x ULN|3|||
164265756|NCT00186537|593342650|FG001|Overall Study|ALT > 1.5 x ULN|0|||
164265757|NCT00186537|593342651|FG002|Overall Study|ALT > 1.5 x ULN|0|||
164265758|NCT01146288|593342655|FG000|First Intervention(1 Day)|Adverse Event|0|||
164265759|NCT01146288|593342656|FG001|First Intervention(1 Day)|Adverse Event|1|||
164265760|NCT03630302|593342657|FG000|Surgery|hardware issue prevented LFP recordings|1|||
164265761|NCT03630302|593342657|FG000|3 Month Visit|Adverse Event|2|||
164265762|NCT03630302|593342657|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
164265763|NCT01135914|593342658|FG000|Overall Study|Withdrawal by Subject|1|||
164265764|NCT01135914|593342659|FG001|Overall Study|Withdrawal by Subject|3|||
164265765|NCT01135914|593342660|FG002|Overall Study|Withdrawal by Subject|6|||
164265766|NCT01135914|593342658|FG000|Overall Study|Lost to Follow-up|1|||
164265767|NCT01135914|593342659|FG001|Overall Study|Lost to Follow-up|0|||
164265768|NCT01135914|593342660|FG002|Overall Study|Lost to Follow-up|1|||
164265769|NCT01135914|593342658|FG000|Overall Study|Protocol Violation|0|||
164265770|NCT01135914|593342659|FG001|Overall Study|Protocol Violation|0|||
164265771|NCT01135914|593342660|FG002|Overall Study|Protocol Violation|3|||
164265772|NCT01135914|593342658|FG000|Overall Study|Lack of Efficacy|2|||
164265773|NCT01135914|593342659|FG001|Overall Study|Lack of Efficacy|1|||
164265774|NCT01135914|593342660|FG002|Overall Study|Lack of Efficacy|10|||
164265775|NCT01135914|593342658|FG000|Overall Study|Adverse Event|0|||
164265776|NCT01135914|593342659|FG001|Overall Study|Adverse Event|1|||
164265777|NCT01135914|593342660|FG002|Overall Study|Adverse Event|2|||
164265778|NCT00931801|593342663|FG000|Overall Study|Adverse Event|0|||
164265779|NCT00931801|593342664|FG001|Overall Study|Adverse Event|0|||
164265780|NCT00931801|593342665|FG002|Overall Study|Adverse Event|1|||
164265781|NCT00931801|593342663|FG000|Overall Study|Lost to Follow-up|0|||
164265782|NCT00931801|593342664|FG001|Overall Study|Lost to Follow-up|1|||
164265783|NCT00931801|593342665|FG002|Overall Study|Lost to Follow-up|0|||
164265784|NCT00931801|593342663|FG000|Overall Study|Withdrawal by Subject|1|||
164265785|NCT00931801|593342664|FG001|Overall Study|Withdrawal by Subject|0|||
164265786|NCT00931801|593342665|FG002|Overall Study|Withdrawal by Subject|0|||
164265787|NCT00931801|593342663|FG000|Overall Study|Confirmed Virologic Failure|0|||
164265788|NCT00931801|593342664|FG001|Overall Study|Confirmed Virologic Failure|0|||
164265789|NCT00931801|593342665|FG002|Overall Study|Confirmed Virologic Failure|3|||
164265790|NCT00746733|593342666|FG000|Second Intervention|Adverse Event|1|||
164265791|NCT00746733|593342667|FG001|Second Intervention|Adverse Event|0|||
164265792|NCT00746733|593342666|FG000|Third Intervention|Withdrawal by Subject|1|||
164265793|NCT00746733|593342667|FG001|Third Intervention|Withdrawal by Subject|1|||
164265794|NCT00610441|593342668|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
164265795|NCT00610441|593342669|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
164265796|NCT00610441|593342670|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
164265797|NCT00610441|593342671|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
164265798|NCT00610441|593342668|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
164265799|NCT00610441|593342669|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
164265800|NCT00610441|593342670|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
164265801|NCT00610441|593342671|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
164265802|NCT00610441|593342668|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
164265803|NCT00610441|593342669|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
164265804|NCT00610441|593342670|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
164265805|NCT00610441|593342671|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
164265806|NCT00610441|593342668|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
164265807|NCT00610441|593342669|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
164265808|NCT00610441|593342670|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
164265809|NCT00610441|593342671|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
164265810|NCT00610441|593342668|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
164265811|NCT00610441|593342669|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
164265812|NCT00610441|593342670|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
164265813|NCT00610441|593342671|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
164265814|NCT00610441|593342668|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
164581023|NCT05525975|594493854|FG001|Overall Study|didn't fill prescription|0|||
164581024|NCT05525975|594493853|FG000|Overall Study|Withdrawal by Subject|0|||
164265815|NCT00610441|593342669|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
164265816|NCT00610441|593342670|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
164265817|NCT00610441|593342671|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
164265818|NCT00610441|593342668|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
164265819|NCT00610441|593342669|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
164265820|NCT00610441|593342670|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
164265821|NCT00610441|593342671|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
164265822|NCT00610441|593342668|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
164265823|NCT00610441|593342669|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
164265824|NCT00610441|593342670|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
164265825|NCT00610441|593342671|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
164265826|NCT00610441|593342668|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
164265827|NCT00610441|593342669|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
164265828|NCT00610441|593342670|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
164265829|NCT00610441|593342671|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
164265830|NCT00334282|593342672|FG000|Overall Study|Lost to Follow-up|11|||
164265831|NCT00334282|593342673|FG001|Overall Study|Lost to Follow-up|5|||
164265832|NCT00334282|593342672|FG000|Overall Study|Withdrawal by Subject|17|||
164265833|NCT00334282|593342673|FG001|Overall Study|Withdrawal by Subject|3|||
164265834|NCT00334282|593342672|FG000|Overall Study|Death|194|||
164265835|NCT00334282|593342673|FG001|Overall Study|Death|100|||
164265836|NCT00837876|593342678|FG000|Overall Study|Death|2|||
164265837|NCT00837876|593342678|FG000|Overall Study|Adverse Event|7|||
164265838|NCT00837876|593342678|FG000|Overall Study|Physician Decision|1|||
164265839|NCT00837876|593342678|FG000|Overall Study|Withdrawal by Subject|3|||
164265840|NCT00837876|593342678|FG000|Overall Study|disease progression|24|||
164265841|NCT00276094|593342680|FG000|Overall Study|Adverse Event|15|||
164265842|NCT00276094|593342681|FG001|Overall Study|Adverse Event|13|||
164265843|NCT00276094|593342682|FG002|Overall Study|Adverse Event|11|||
164581025|NCT05525975|594493854|FG001|Overall Study|Withdrawal by Subject|3|||
164581026|NCT01123889|594493855|FG000|Overall Study|Lost to Follow-up|3|||
164581027|NCT01123889|594493856|FG001|Overall Study|Lost to Follow-up|1|||
164581028|NCT05090423|594493857|FG000|Overall Study|Because of the covid-19|3|||
164581029|NCT05090423|594493858|FG001|Overall Study|Because of the covid-19|2|||
164581030|NCT05090423|594493857|FG000|Overall Study|repeated ankle sprain in daily of life|0|||
164581031|NCT05090423|594493858|FG001|Overall Study|repeated ankle sprain in daily of life|1|||
164581032|NCT05733286|594493859|FG000|Overall Study|Never received study drug|2|||
164581033|NCT05733286|594493860|FG001|Overall Study|Never received study drug|3|||
164581034|NCT00685178|594493861|FG000|Overall Study|Adverse Event|1|||
164581035|NCT00685178|594493862|FG001|Overall Study|Adverse Event|5|||
164581036|NCT00685178|594493863|FG002|Overall Study|Adverse Event|2|||
164581037|NCT00685178|594493864|FG003|Overall Study|Adverse Event|4|||
164581038|NCT00685178|594493861|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
164581039|NCT00685178|594493862|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
164581040|NCT00685178|594493863|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
164581041|NCT00685178|594493864|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
164581042|NCT00685178|594493861|FG000|Overall Study|voluntary study discharge|4|||
164581043|NCT00685178|594493862|FG001|Overall Study|voluntary study discharge|5|||
164265844|NCT00276094|593342680|FG000|Overall Study|Withdrawal by Subject|14|||
164265845|NCT00276094|593342681|FG001|Overall Study|Withdrawal by Subject|14|||
164265846|NCT00276094|593342682|FG002|Overall Study|Withdrawal by Subject|12|||
164265847|NCT00276094|593342680|FG000|Overall Study|Protocol Violation|16|||
164265848|NCT00276094|593342681|FG001|Overall Study|Protocol Violation|7|||
164430440|NCT01289119|593947218|FG004|Overall Study|Pregnancy|0|||
164430441|NCT01289119|593947219|FG005|Overall Study|Pregnancy|0|||
164430442|NCT01289119|593947214|FG000|Overall Study|Lack of Efficacy|0|||
164430443|NCT01289119|593947215|FG001|Overall Study|Lack of Efficacy|1|||
164430444|NCT01289119|593947216|FG002|Overall Study|Lack of Efficacy|1|||
164430445|NCT01289119|593947217|FG003|Overall Study|Lack of Efficacy|1|||
164430446|NCT01289119|593947218|FG004|Overall Study|Lack of Efficacy|1|||
164430447|NCT01289119|593947219|FG005|Overall Study|Lack of Efficacy|1|||
164430448|NCT01289119|593947214|FG000|Overall Study|Other|1|||
164265849|NCT00276094|593342682|FG002|Overall Study|Protocol Violation|10|||
164265850|NCT00276094|593342680|FG000|Overall Study|Lost to Follow-up|8|||
164265851|NCT00276094|593342681|FG001|Overall Study|Lost to Follow-up|6|||
164265852|NCT00276094|593342682|FG002|Overall Study|Lost to Follow-up|4|||
164265853|NCT00276094|593342680|FG000|Overall Study|Other-Subject moved out of country|1|||
164265854|NCT00276094|593342681|FG001|Overall Study|Other-Subject moved out of country|0|||
164265855|NCT00276094|593342682|FG002|Overall Study|Other-Subject moved out of country|0|||
164265856|NCT00276094|593342680|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
164265857|NCT00276094|593342681|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
164265858|NCT00276094|593342682|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
164265859|NCT00276094|593342680|FG000|Overall Study|Other-Lack of efficacy|1|||
164265860|NCT00276094|593342681|FG001|Overall Study|Other-Lack of efficacy|0|||
164265861|NCT00276094|593342682|FG002|Overall Study|Other-Lack of efficacy|0|||
164265862|NCT00276094|593342680|FG000|Overall Study|Other-Refused follow-up visit|1|||
164265863|NCT00276094|593342681|FG001|Overall Study|Other-Refused follow-up visit|0|||
164265864|NCT00276094|593342682|FG002|Overall Study|Other-Refused follow-up visit|0|||
164265865|NCT00276094|593342680|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
164265866|NCT00276094|593342681|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
164265867|NCT00276094|593342682|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
164265868|NCT00276094|593342680|FG000|Overall Study|Other-Relocation|0|||
164265869|NCT00276094|593342681|FG001|Overall Study|Other-Relocation|1|||
164265870|NCT00276094|593342682|FG002|Overall Study|Other-Relocation|0|||
164341743|NCT04645953|593627496|FG000|Overall Study|Lost to Follow-up|2|||
164341744|NCT04645953|593627497|FG001|Overall Study|Lost to Follow-up|1|||
164341745|NCT04645953|593627498|FG002|Overall Study|Lost to Follow-up|1|||
164341746|NCT04645953|593627496|FG000|Overall Study|Withdrawal by Subject|0|||
164341747|NCT04645953|593627497|FG001|Overall Study|Withdrawal by Subject|1|||
164341748|NCT04645953|593627498|FG002|Overall Study|Withdrawal by Subject|0|||
164341749|NCT04645953|593627496|FG000|Overall Study|Physician Decision|0|||
164341750|NCT04645953|593627497|FG001|Overall Study|Physician Decision|1|||
164341751|NCT04645953|593627498|FG002|Overall Study|Physician Decision|0|||
164341752|NCT04645953|593627496|FG000|Overall Study|Discontinued Prior to Dosing|0|||
164430449|NCT01289119|593947215|FG001|Overall Study|Other|0|||
164430450|NCT01289119|593947216|FG002|Overall Study|Other|1|||
164430451|NCT01289119|593947217|FG003|Overall Study|Other|0|||
164430452|NCT01289119|593947218|FG004|Overall Study|Other|0|||
164430453|NCT01289119|593947219|FG005|Overall Study|Other|0|||
164430454|NCT00530335|593947222|FG000|Overall Study|Adverse Event|3|||
164430455|NCT00530335|593947222|FG000|Overall Study|Protocol Violation|1|||
164430456|NCT00530335|593947222|FG000|Overall Study|Withdrawal by Subject|1|||
164430457|NCT00530335|593947222|FG000|Overall Study|Physician Decision|1|||
164430458|NCT04577183|593947224|FG000|Overall Study|Death|1|||
164430459|NCT04577183|593947224|FG000|Overall Study|Withdrawal by Subject|3|||
164686166|NCT02846883|594874839|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
164686167|NCT02846883|594874840|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
164686168|NCT00927251|594874841|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
164686169|NCT00442351|594874845|FG000|Overall Study|Administrative|6|||
164686170|NCT00442351|594874846|FG001|Overall Study|Administrative|5|||
164686171|NCT00442351|594874845|FG000|Overall Study|Did not meet protocol eligibility|1|||
164686172|NCT00442351|594874846|FG001|Overall Study|Did not meet protocol eligibility|0|||
164265871|NCT00276094|593342680|FG000|Overall Study|Other-Study medication lost|0|||
164265872|NCT00276094|593342681|FG001|Overall Study|Other-Study medication lost|0|||
164265873|NCT00276094|593342682|FG002|Overall Study|Other-Study medication lost|1|||
164265874|NCT00787137|593342683|FG000|Overall Study|Study Termination|0|||
164265875|NCT00787137|593342684|FG001|Overall Study|Study Termination|0|||
164341753|NCT04645953|593627497|FG001|Overall Study|Discontinued Prior to Dosing|0|||
164341754|NCT04645953|593627498|FG002|Overall Study|Discontinued Prior to Dosing|2|||
164265876|NCT00787137|593342685|FG002|Overall Study|Study Termination|1|||
164265877|NCT02075632|593342689|FG000|Overall Study|Adverse Event|1|||
164265878|NCT02075632|593342690|FG001|Overall Study|Adverse Event|1|||
164341755|NCT04613375|593627499|FG000|Overall Study|Death|198|||
164341756|NCT04613375|593627499|FG000|Overall Study|Withdrawal by Subject|3|||
164341757|NCT00434954|593627503|FG000|Overall Study|Adverse Event|17|||
164430460|NCT04577183|593947224|FG000|Overall Study|Early termination|2|||
164430461|NCT02072226|593947232|FG000|Overall Study|Lost to Follow-up|11|||
164430462|NCT02072226|593947233|FG001|Overall Study|Lost to Follow-up|7|||
164430463|NCT02072226|593947232|FG000|Overall Study|Patient Non-compliance|2|||
164430464|NCT02072226|593947233|FG001|Overall Study|Patient Non-compliance|3|||
164430465|NCT02072226|593947232|FG000|Overall Study|Death|1|||
164430466|NCT02072226|593947233|FG001|Overall Study|Death|0|||
164430467|NCT02072226|593947232|FG000|Overall Study|Patient Withdrawal of Consent|1|||
164430468|NCT02072226|593947233|FG001|Overall Study|Patient Withdrawal of Consent|0|||
164430469|NCT00972543|593947236|FG000|Overall Study|Adverse Event|1|||
164430470|NCT00972543|593947237|FG001|Overall Study|Adverse Event|0|||
164430471|NCT00972543|593947236|FG000|Overall Study|Early study termination by sponsor|4|||
164265879|NCT02075632|593342689|FG000|Overall Study|Lost to Follow-up|0|||
164265880|NCT02075632|593342690|FG001|Overall Study|Lost to Follow-up|3|||
164265881|NCT02075632|593342689|FG000|Overall Study|Withdrawal by Subject|0|||
164265882|NCT02075632|593342690|FG001|Overall Study|Withdrawal by Subject|1|||
164265883|NCT03464422|593342691|FG000|Overall Study|Lost to Follow-up|2|||
164265884|NCT03464422|593342691|FG000|Overall Study|Withdrawal by Subject|2|||
164265885|NCT01628367|593342695|FG000|Overall Study|Adverse Event|1|||
164265886|NCT01628367|593342696|FG001|Overall Study|Adverse Event|0|||
164265887|NCT00740714|593342697|FG000|Overall Study|Withdrawal by Subject|17|||
164265888|NCT00740714|593342698|FG001|Overall Study|Withdrawal by Subject|19|||
164265889|NCT00740714|593342699|FG002|Overall Study|Withdrawal by Subject|29|||
164265890|NCT00394901|593342703|FG000|Baseline Phase|Protocol Violation|0|||
164265891|NCT00394901|593342704|FG001|Baseline Phase|Protocol Violation|0|||
164265892|NCT00394901|593342705|FG002|Baseline Phase|Protocol Violation|1|||
164265893|NCT00394901|593342706|FG003|Baseline Phase|Protocol Violation|0|||
164265894|NCT00394901|593342703|FG000|Double-blind Phase|Adverse Event|5|||
164265895|NCT00394901|593342704|FG001|Double-blind Phase|Adverse Event|7|||
164265896|NCT00394901|593342705|FG002|Double-blind Phase|Adverse Event|16|||
164265897|NCT00394901|593342706|FG003|Double-blind Phase|Adverse Event|20|||
164265898|NCT00394901|593342703|FG000|Double-blind Phase|Lack of Efficacy|6|||
164265899|NCT00394901|593342704|FG001|Double-blind Phase|Lack of Efficacy|4|||
164265900|NCT00394901|593342705|FG002|Double-blind Phase|Lack of Efficacy|1|||
164265901|NCT00394901|593342706|FG003|Double-blind Phase|Lack of Efficacy|3|||
164265902|NCT00394901|593342703|FG000|Double-blind Phase|Withdrawal by Subject|2|||
164265903|NCT00394901|593342704|FG001|Double-blind Phase|Withdrawal by Subject|0|||
164265904|NCT00394901|593342705|FG002|Double-blind Phase|Withdrawal by Subject|0|||
164265905|NCT00394901|593342706|FG003|Double-blind Phase|Withdrawal by Subject|0|||
164265906|NCT00394901|593342703|FG000|Double-blind Phase|Lost to Follow-up|0|||
164265907|NCT00394901|593342704|FG001|Double-blind Phase|Lost to Follow-up|0|||
164265908|NCT00394901|593342705|FG002|Double-blind Phase|Lost to Follow-up|0|||
164265909|NCT00394901|593342706|FG003|Double-blind Phase|Lost to Follow-up|1|||
164265910|NCT00394901|593342703|FG000|Double-blind Phase|Protocol Violation|0|||
164265911|NCT00394901|593342704|FG001|Double-blind Phase|Protocol Violation|0|||
164265912|NCT00394901|593342705|FG002|Double-blind Phase|Protocol Violation|0|||
164265913|NCT00394901|593342706|FG003|Double-blind Phase|Protocol Violation|1|||
164265914|NCT00394901|593342703|FG000|Double-blind Phase|Death|1|||
164265915|NCT00394901|593342704|FG001|Double-blind Phase|Death|0|||
164265916|NCT00394901|593342705|FG002|Double-blind Phase|Death|0|||
164265917|NCT00394901|593342706|FG003|Double-blind Phase|Death|0|||
164265918|NCT00394901|593342703|FG000|Double-blind Phase|Subject's Personal Reason|1|||
164265919|NCT00394901|593342704|FG001|Double-blind Phase|Subject's Personal Reason|0|||
164265920|NCT00394901|593342705|FG002|Double-blind Phase|Subject's Personal Reason|0|||
164265921|NCT00394901|593342706|FG003|Double-blind Phase|Subject's Personal Reason|1|||
164265922|NCT00394901|593342703|FG000|Double-blind Phase|Lack of Compliance|0|||
164265923|NCT00394901|593342704|FG001|Double-blind Phase|Lack of Compliance|3|||
164265924|NCT00394901|593342705|FG002|Double-blind Phase|Lack of Compliance|0|||
164265925|NCT00394901|593342706|FG003|Double-blind Phase|Lack of Compliance|0|||
164265926|NCT00394901|593342703|FG000|Double-blind Phase|Entry into another study was found|0|||
164265927|NCT00394901|593342704|FG001|Double-blind Phase|Entry into another study was found|0|||
164265928|NCT00394901|593342705|FG002|Double-blind Phase|Entry into another study was found|1|||
164265929|NCT00394901|593342706|FG003|Double-blind Phase|Entry into another study was found|0|||
164265930|NCT00394901|593342703|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
164265931|NCT00394901|593342704|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
164265932|NCT00394901|593342705|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
164265933|NCT00394901|593342706|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
164430472|NCT00972543|593947237|FG001|Overall Study|Early study termination by sponsor|1|||
164430473|NCT01466881|593947238|FG000|Overall Study|Ineligible|5|||
164581044|NCT00685178|594493863|FG002|Overall Study|voluntary study discharge|1|||
164581045|NCT00685178|594493864|FG003|Overall Study|voluntary study discharge|1|||
164265934|NCT01886690|593342717|FG000|Overall Study|Protocol Violation|0|||
164265935|NCT01886690|593342718|FG001|Overall Study|Protocol Violation|1|||
164265936|NCT01886690|593342717|FG000|Overall Study|Personal Reasons|0|||
164265937|NCT01886690|593342718|FG001|Overall Study|Personal Reasons|1|||
164430474|NCT01466881|593947238|FG000|Overall Study|Adverse Event|6|||
164265938|NCT01439074|593342719|FG000|Overall Study|Lost to Follow-up|3|||
164265939|NCT01439074|593342720|FG001|Overall Study|Lost to Follow-up|4|||
164265940|NCT01439074|593342719|FG000|Overall Study|Subject shedding|1|||
164265941|NCT01439074|593342720|FG001|Overall Study|Subject shedding|0|||
164430475|NCT01466881|593947238|FG000|Overall Study|Progression/relapse|20|||
164265942|NCT01439074|593342719|FG000|Overall Study|Withdrawal by Subject|1|||
164265943|NCT01439074|593342720|FG001|Overall Study|Withdrawal by Subject|5|||
164265944|NCT01439074|593342719|FG000|Overall Study|Other|4|||
164265945|NCT01439074|593342720|FG001|Overall Study|Other|4|||
164265946|NCT02463032|593342721|FG000|Overall Study|Lack of Efficacy|61|||
164265947|NCT02463032|593342722|FG001|Overall Study|Lack of Efficacy|50|||
164265948|NCT02463032|593342721|FG000|Overall Study|Death|8|||
164265949|NCT02463032|593342722|FG001|Overall Study|Death|8|||
164265950|NCT02463032|593342721|FG000|Overall Study|Adverse Event|2|||
164265951|NCT02463032|593342722|FG001|Overall Study|Adverse Event|6|||
164265952|NCT00612508|593342723|FG000|Overall Study|Withdrawal by Subject|3|||
164265953|NCT00612508|593342724|FG001|Overall Study|Withdrawal by Subject|4|||
164265954|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
164265955|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
164265956|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
164265957|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
164265958|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
164265959|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
164265960|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
164265961|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
164265962|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
164265963|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
164265964|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
164265965|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
164265966|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
164265967|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
164265968|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
164265969|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
164265970|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
164265971|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
164265972|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
164265973|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
164265974|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
164265975|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
164265976|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
164265977|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
164265978|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
164265979|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
164265980|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
164265981|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
164265982|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
164265983|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
164265984|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
164265985|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
164265986|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
164265987|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
164265988|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
164265989|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
164265990|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
164265991|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
164265992|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
164265993|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
164265994|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
164265995|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
164265996|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
164430476|NCT01466881|593947238|FG000|Overall Study|Death|4|||
164581046|NCT00685178|594493861|FG000|Overall Study|incarcerated|1|||
164581047|NCT00685178|594493862|FG001|Overall Study|incarcerated|3|||
164581048|NCT00685178|594493863|FG002|Overall Study|incarcerated|7|||
164581049|NCT00685178|594493864|FG003|Overall Study|incarcerated|0|||
164581050|NCT00685178|594493861|FG000|Overall Study|administrative (disciplinary) discharge|0|||
164581051|NCT00685178|594493862|FG001|Overall Study|administrative (disciplinary) discharge|1|||
164581052|NCT00685178|594493863|FG002|Overall Study|administrative (disciplinary) discharge|0|||
164581053|NCT00685178|594493864|FG003|Overall Study|administrative (disciplinary) discharge|2|||
164581054|NCT00685178|594493861|FG000|Overall Study|Pregnancy|0|||
164686173|NCT00442351|594874845|FG000|Overall Study|Other|0|||
164686174|NCT00442351|594874846|FG001|Overall Study|Other|1|||
164265997|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
164265998|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
164265999|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
164266000|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
164266001|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
164266002|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
164266003|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
164266004|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
164266005|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
164266006|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
164266007|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
164266008|NCT02008357|593342725|FG000|Open-label Extension Period|Adverse Event|8|||
164266009|NCT02008357|593342726|FG001|Open-label Extension Period|Adverse Event|7|||
164266010|NCT02008357|593342725|FG000|Open-label Extension Period|Death|7|||
164266011|NCT02008357|593342726|FG001|Open-label Extension Period|Death|4|||
164266012|NCT02008357|593342725|FG000|Open-label Extension Period|Lack of Efficacy|9|||
164266013|NCT02008357|593342726|FG001|Open-label Extension Period|Lack of Efficacy|5|||
164266014|NCT02008357|593342725|FG000|Open-label Extension Period|Lost to Follow-up|2|||
164266015|NCT02008357|593342726|FG001|Open-label Extension Period|Lost to Follow-up|2|||
164266016|NCT02008357|593342725|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
164266017|NCT02008357|593342726|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
164266018|NCT02008357|593342725|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
164266019|NCT02008357|593342726|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
164266020|NCT02008357|593342725|FG000|Open-label Extension Period|Safety Risk|2|||
164266021|NCT02008357|593342726|FG001|Open-label Extension Period|Safety Risk|1|||
164266022|NCT02008357|593342725|FG000|Open-label Extension Period|Non-Compliance|0|||
164266023|NCT02008357|593342726|FG001|Open-label Extension Period|Non-Compliance|1|||
164266024|NCT02008357|593342725|FG000|Open-label Extension Period|Investigator Recommendation|0|||
164686175|NCT00500318|594874848|FG000|Overall Study|Adverse Event|3|||
164686176|NCT00500318|594874849|FG001|Overall Study|Adverse Event|8|||
164266025|NCT02008357|593342726|FG001|Open-label Extension Period|Investigator Recommendation|1|||
164266026|NCT02008357|593342725|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
164266027|NCT02008357|593342726|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
164266028|NCT02008357|593342725|FG000|Open-label Extension Period|Coordinating Center Request|2|||
164266029|NCT02008357|593342726|FG001|Open-label Extension Period|Coordinating Center Request|4|||
164266030|NCT02008357|593342725|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
164266031|NCT02008357|593342726|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
164266032|NCT02008357|593342725|FG000|Open-label Extension Period|Study Ended|20|||
164266033|NCT02008357|593342726|FG001|Open-label Extension Period|Study Ended|25|||
164266034|NCT02008357|593342725|FG000|Open-label Extension Period|Personal Reasons|0|||
164266035|NCT02008357|593342726|FG001|Open-label Extension Period|Personal Reasons|1|||
164266036|NCT02008357|593342725|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
164266037|NCT02008357|593342726|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
164266038|NCT02008357|593342725|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
164266039|NCT02008357|593342726|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
164266040|NCT02008357|593342725|FG000|Open-label Extension Period|Other|2|||
164266041|NCT02008357|593342726|FG001|Open-label Extension Period|Other|0|||
164266042|NCT02312219|593342727|FG000|Overall Study|Withdrawal by Subject|1|||
164686177|NCT00500318|594874848|FG000|Overall Study|Protocol Violation|1|||
164266043|NCT02312219|593342728|FG001|Overall Study|Withdrawal by Subject|2|||
164266044|NCT02312219|593342727|FG000|Overall Study|could not schedule imaging in time|0|||
164266045|NCT02312219|593342728|FG001|Overall Study|could not schedule imaging in time|2|||
164266046|NCT02312219|593342727|FG000|Overall Study|Other|0|||
164266047|NCT02312219|593342728|FG001|Overall Study|Other|1|||
164266048|NCT02312219|593342727|FG000|Overall Study|Not randomized. Ineligible|0|||
164266049|NCT02312219|593342728|FG001|Overall Study|Not randomized. Ineligible|1|||
164266050|NCT04941807|593342729|FG000|Overall Study|Lost to Follow-up|1|||
164341758|NCT00434954|593627504|FG001|Overall Study|Adverse Event|2|||
164686178|NCT00500318|594874849|FG001|Overall Study|Protocol Violation|3|||
164341759|NCT00434954|593627503|FG000|Overall Study|Entry criteria not met|14|||
164341760|NCT00434954|593627504|FG001|Overall Study|Entry criteria not met|16|||
164341761|NCT00434954|593627503|FG000|Overall Study|Lost to Follow-up|0|||
164341762|NCT00434954|593627504|FG001|Overall Study|Lost to Follow-up|1|||
164341763|NCT00434954|593627503|FG000|Overall Study|Physician Decision|6|||
164341764|NCT00434954|593627504|FG001|Overall Study|Physician Decision|3|||
164686179|NCT00500318|594874848|FG000|Overall Study|Withdrawal by Subject|1|||
164686180|NCT00500318|594874849|FG001|Overall Study|Withdrawal by Subject|2|||
164266051|NCT04941807|593342730|FG001|Overall Study|Lost to Follow-up|1|||
164266052|NCT01100567|593342731|FG000|Overall Study|Withdrawal by Subject|5|||
164266053|NCT01100567|593342732|FG001|Overall Study|Withdrawal by Subject|8|||
164266054|NCT01100567|593342731|FG000|Overall Study|Early Hospital Discharge|6|||
164266055|NCT01100567|593342732|FG001|Overall Study|Early Hospital Discharge|4|||
164266056|NCT01100567|593342731|FG000|Overall Study|Lost to Follow-up|1|||
164266057|NCT01100567|593342732|FG001|Overall Study|Lost to Follow-up|2|||
164266058|NCT01100567|593342731|FG000|Overall Study|Physician Decision|0|||
164266059|NCT01100567|593342732|FG001|Overall Study|Physician Decision|1|||
164266060|NCT01100567|593342731|FG000|Overall Study|Deemed ineligible after consent|0|||
164266061|NCT01100567|593342732|FG001|Overall Study|Deemed ineligible after consent|1|||
164266062|NCT02741570|593342733|FG000|Pre-Treatment Period|Other reasons|0|||
164266063|NCT02741570|593342734|FG001|Pre-Treatment Period|Other reasons|3|||
164266064|NCT02741570|593342733|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
164266065|NCT02741570|593342734|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
164266066|NCT02741570|593342733|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
164266067|NCT02741570|593342734|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
164266068|NCT02741570|593342733|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
164266069|NCT02741570|593342734|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
164266070|NCT02741570|593342733|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
164266071|NCT02741570|593342734|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
164266072|NCT02741570|593342733|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
164266073|NCT02741570|593342734|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
164266074|NCT02741570|593342733|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
164266075|NCT02741570|593342734|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
164266076|NCT02741570|593342733|FG000|Pre-Treatment Period|Death|0|||
164266077|NCT02741570|593342734|FG001|Pre-Treatment Period|Death|1|||
164266078|NCT02741570|593342733|FG000|Pre-Treatment Period|Disease progression|0|||
164266079|NCT02741570|593342734|FG001|Pre-Treatment Period|Disease progression|1|||
164266080|NCT02741570|593342733|FG000|Treatment Period|Other reasons|47|||
164266081|NCT02741570|593342734|FG001|Treatment Period|Other reasons|12|||
164266082|NCT02741570|593342733|FG000|Treatment Period|Poor/non-compliance|0|||
164266083|NCT02741570|593342734|FG001|Treatment Period|Poor/non-compliance|2|||
164266084|NCT02741570|593342733|FG000|Treatment Period|Maximum clinical benefit|4|||
164266085|NCT02741570|593342734|FG001|Treatment Period|Maximum clinical benefit|6|||
164266086|NCT02741570|593342733|FG000|Treatment Period|Lost to Follow-up|1|||
164266087|NCT02741570|593342734|FG001|Treatment Period|Lost to Follow-up|3|||
164266088|NCT02741570|593342733|FG000|Treatment Period|Participant withdrew consent|9|||
164266089|NCT02741570|593342734|FG001|Treatment Period|Participant withdrew consent|13|||
164266090|NCT02741570|593342733|FG000|Treatment Period|Participant request to discontinue treatment|8|||
164266091|NCT02741570|593342734|FG001|Treatment Period|Participant request to discontinue treatment|23|||
164266092|NCT02741570|593342733|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
164266093|NCT02741570|593342734|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
164266094|NCT02741570|593342733|FG000|Treatment Period|Death|9|||
164266095|NCT02741570|593342734|FG001|Treatment Period|Death|7|||
164266096|NCT02741570|593342733|FG000|Treatment Period|Study drug toxicity|55|||
164266097|NCT02741570|593342734|FG001|Treatment Period|Study drug toxicity|47|||
164266098|NCT02741570|593342733|FG000|Treatment Period|Disease progression|294|||
164266099|NCT02741570|593342734|FG001|Treatment Period|Disease progression|301|||
164266100|NCT02741570|593342733|FG000|Treatment Period|Administrative reason by sponsor|0|||
164266101|NCT02741570|593342734|FG001|Treatment Period|Administrative reason by sponsor|1|||
164266102|NCT00946322|593342737|FG000|Pre-treatment|participant failure to follow up|1|||
164266103|NCT00946322|593342737|FG000|Post-treatment|participant failure to follow up|2|||
164266104|NCT03352453|593342741|FG000|Overall Study|Miscellaneous Reasons|1|||
164266105|NCT03352453|593342742|FG001|Overall Study|Miscellaneous Reasons|2|||
164266106|NCT03352453|593342741|FG000|Overall Study|Lack of Efficacy|1|||
164266107|NCT03352453|593342742|FG001|Overall Study|Lack of Efficacy|0|||
164266108|NCT03352453|593342741|FG000|Overall Study|Withdrawal by Subject|8|||
164266109|NCT03352453|593342742|FG001|Overall Study|Withdrawal by Subject|14|||
164266110|NCT03352453|593342741|FG000|Overall Study|Study Terminated by Sponsor|2|||
164266111|NCT03352453|593342742|FG001|Overall Study|Study Terminated by Sponsor|1|||
164686181|NCT00500318|594874848|FG000|Overall Study|Lack of Efficacy|0|||
164686182|NCT00500318|594874849|FG001|Overall Study|Lack of Efficacy|3|||
164686183|NCT00500318|594874848|FG000|Overall Study|Other Reason|0|||
164686184|NCT00500318|594874849|FG001|Overall Study|Other Reason|1|||
164686185|NCT01350934|594874872|FG000|Base Study|Adverse Event|6|||
164686186|NCT01350934|594874873|FG001|Base Study|Adverse Event|0|||
164266112|NCT03352453|593342741|FG000|Overall Study|Protocol Deviation|1|||
164266113|NCT03352453|593342742|FG001|Overall Study|Protocol Deviation|0|||
164266114|NCT03352453|593342741|FG000|Overall Study|Lost to Follow-up|7|||
164266115|NCT03352453|593342742|FG001|Overall Study|Lost to Follow-up|6|||
164266116|NCT03352453|593342741|FG000|Overall Study|Adverse Event|2|||
164266117|NCT03352453|593342742|FG001|Overall Study|Adverse Event|9|||
164686187|NCT01350934|594874872|FG000|Base Study|Lost to Follow-up|1|||
164266118|NCT03158272|593342745|FG000|Overall Study|Disease progression|3|||
164266119|NCT03158272|593342746|FG001|Overall Study|Disease progression|3|||
164266120|NCT03158272|593342747|FG002|Overall Study|Disease progression|4|||
164266121|NCT03158272|593342748|FG003|Overall Study|Disease progression|6|||
164266122|NCT03158272|593342745|FG000|Overall Study|Death|0|||
164266123|NCT03158272|593342746|FG001|Overall Study|Death|0|||
164266124|NCT03158272|593342747|FG002|Overall Study|Death|1|||
164266125|NCT03158272|593342748|FG003|Overall Study|Death|0|||
164266126|NCT03158272|593342745|FG000|Overall Study|Other reasons|0|||
164266127|NCT03158272|593342746|FG001|Overall Study|Other reasons|0|||
164266128|NCT03158272|593342747|FG002|Overall Study|Other reasons|1|||
164266129|NCT03158272|593342748|FG003|Overall Study|Other reasons|0|||
164266130|NCT03158272|593342745|FG000|Overall Study|Adverse event unrelated to the drug|0|||
164266131|NCT03158272|593342746|FG001|Overall Study|Adverse event unrelated to the drug|1|||
164266132|NCT03158272|593342747|FG002|Overall Study|Adverse event unrelated to the drug|0|||
164266133|NCT03158272|593342748|FG003|Overall Study|Adverse event unrelated to the drug|0|||
164266134|NCT00514020|593342749|FG000|Overall Study|Adverse Event|6|||
164266135|NCT00514020|593342749|FG000|Overall Study|Withdrawal by Subject|3|||
164266136|NCT00514020|593342749|FG000|Overall Study|Physician Decision|1|||
164266137|NCT00514020|593342749|FG000|Overall Study|disease progression|9|||
164266138|NCT00514020|593342749|FG000|Overall Study|other complicating disease|2|||
164266139|NCT00514020|593342749|FG000|Overall Study|patient went to radiation treatment|1|||
164266140|NCT00514020|593342749|FG000|Overall Study|"patients moved to the no tx group"|6|||
164266141|NCT01688921|593342750|FG000|Overall Study|Lost to Follow-up|7|||
164266142|NCT01688921|593342751|FG001|Overall Study|Lost to Follow-up|13|||
164266143|NCT01688921|593342750|FG000|Overall Study|Physician Decision|6|||
164266144|NCT01688921|593342751|FG001|Overall Study|Physician Decision|1|||
164266145|NCT01688921|593342750|FG000|Overall Study|Protocol Violation|0|||
164266146|NCT01688921|593342751|FG001|Overall Study|Protocol Violation|1|||
164266147|NCT01688921|593342750|FG000|Overall Study|informed consent|3|||
164266148|NCT01688921|593342751|FG001|Overall Study|informed consent|0|||
164266149|NCT01048866|593342759|FG000|Overall Study|Adverse Event|1|||
164266150|NCT01048866|593342760|FG001|Overall Study|Adverse Event|0|||
164266151|NCT01048866|593342759|FG000|Overall Study|Protocol Violation|1|||
164266152|NCT01048866|593342760|FG001|Overall Study|Protocol Violation|0|||
164266153|NCT01048866|593342759|FG000|Overall Study|Physician Decision|1|||
164266154|NCT01048866|593342760|FG001|Overall Study|Physician Decision|0|||
164266155|NCT01048866|593342759|FG000|Overall Study|Withdrawal by Subject|0|||
164266156|NCT01048866|593342760|FG001|Overall Study|Withdrawal by Subject|2|||
164266157|NCT01048866|593342759|FG000|Overall Study|Lost to Follow-up|0|||
164266158|NCT01048866|593342760|FG001|Overall Study|Lost to Follow-up|2|||
164266159|NCT01048866|593342759|FG000|Overall Study|Other|1|||
164266160|NCT01048866|593342760|FG001|Overall Study|Other|1|||
164266161|NCT03582813|593342761|FG000|Overall Study|Lost to Follow-up|18|||
164266162|NCT03582813|593342762|FG001|Overall Study|Lost to Follow-up|21|||
164266163|NCT03582813|593342761|FG000|Overall Study|Withdrawal by Subject|1|||
164266164|NCT03582813|593342762|FG001|Overall Study|Withdrawal by Subject|0|||
164266165|NCT02525094|593342767|FG000|Overall Study|Lost to Follow-up|2|||
164266166|NCT02525094|593342768|FG001|Overall Study|Lost to Follow-up|1|||
164266167|NCT02525094|593342767|FG000|Overall Study|Withdrawal by Subject|5|||
164266168|NCT02525094|593342768|FG001|Overall Study|Withdrawal by Subject|6|||
164266169|NCT02525094|593342767|FG000|Overall Study|Not Treated|1|||
164266170|NCT02525094|593342768|FG001|Overall Study|Not Treated|1|||
164266171|NCT01751776|593342771|FG000|Overall Study|Adverse Event|0|||
164341765|NCT00434954|593627503|FG000|Overall Study|Protocol Violation|36|||
164341766|NCT00434954|593627504|FG001|Overall Study|Protocol Violation|27|||
164341767|NCT00434954|593627503|FG000|Overall Study|Sponsor decision|1|||
164341768|NCT00434954|593627504|FG001|Overall Study|Sponsor decision|0|||
164341769|NCT00434954|593627503|FG000|Overall Study|Subject decision|8|||
164341770|NCT00434954|593627504|FG001|Overall Study|Subject decision|22|||
164341771|NCT00002651|593627505|FG000|Induction|Adverse Event|44|||
164341772|NCT00002651|593627506|FG001|Induction|Adverse Event|0|||
164341773|NCT00002651|593627507|FG002|Induction|Adverse Event|0|||
164266172|NCT01751776|593342772|FG001|Overall Study|Adverse Event|0|||
164266173|NCT01751776|593342773|FG002|Overall Study|Adverse Event|0|||
164266174|NCT01751776|593342774|FG003|Overall Study|Adverse Event|0|||
164266175|NCT01751776|593342775|FG004|Overall Study|Adverse Event|0|||
164266176|NCT01751776|593342776|FG005|Overall Study|Adverse Event|0|||
164266177|NCT01751776|593342777|FG006|Overall Study|Adverse Event|4|||
164266178|NCT01751776|593342778|FG007|Overall Study|Adverse Event|2|||
164266179|NCT01751776|593342771|FG000|Overall Study|Consent withdrawn|0|||
164266180|NCT01751776|593342772|FG001|Overall Study|Consent withdrawn|0|||
164266181|NCT01751776|593342773|FG002|Overall Study|Consent withdrawn|0|||
164266182|NCT01751776|593342774|FG003|Overall Study|Consent withdrawn|0|||
164266183|NCT01751776|593342775|FG004|Overall Study|Consent withdrawn|0|||
164266184|NCT01751776|593342776|FG005|Overall Study|Consent withdrawn|0|||
164266185|NCT01751776|593342777|FG006|Overall Study|Consent withdrawn|0|||
164266186|NCT01751776|593342778|FG007|Overall Study|Consent withdrawn|1|||
164341774|NCT00002651|593627505|FG000|Induction|Refusal unrelated to adverse event|50|||
164341775|NCT00002651|593627506|FG001|Induction|Refusal unrelated to adverse event|0|||
164266187|NCT01751776|593342771|FG000|Overall Study|Other reason not specified above|0|||
164266188|NCT01751776|593342772|FG001|Overall Study|Other reason not specified above|0|||
164266189|NCT01751776|593342773|FG002|Overall Study|Other reason not specified above|0|||
164266190|NCT01751776|593342774|FG003|Overall Study|Other reason not specified above|0|||
164266191|NCT01751776|593342775|FG004|Overall Study|Other reason not specified above|0|||
164266192|NCT01751776|593342776|FG005|Overall Study|Other reason not specified above|0|||
164266193|NCT01751776|593342777|FG006|Overall Study|Other reason not specified above|0|||
164266194|NCT01751776|593342778|FG007|Overall Study|Other reason not specified above|1|||
164266195|NCT03172130|593344409|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
164266196|NCT03172130|593344410|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
164266197|NCT00262847|593344421|FG000|Overall Study|Disease Progression|309|||
164266198|NCT00262847|593344422|FG001|Overall Study|Disease Progression|274|||
164266199|NCT00262847|593344423|FG002|Overall Study|Disease Progression|195|||
164266200|NCT00262847|593344421|FG000|Overall Study|Patient Refusal|41|||
164266201|NCT00262847|593344422|FG001|Overall Study|Patient Refusal|52|||
164266202|NCT00262847|593344423|FG002|Overall Study|Patient Refusal|47|||
164266203|NCT00262847|593344421|FG000|Overall Study|Adverse Event|74|||
164266204|NCT00262847|593344422|FG001|Overall Study|Adverse Event|88|||
164266205|NCT00262847|593344423|FG002|Overall Study|Adverse Event|108|||
164266206|NCT00262847|593344421|FG000|Overall Study|Death|8|||
164266207|NCT00262847|593344422|FG001|Overall Study|Death|8|||
164266208|NCT00262847|593344423|FG002|Overall Study|Death|11|||
164266209|NCT00262847|593344421|FG000|Overall Study|Concomitant disease|3|||
164266210|NCT00262847|593344422|FG001|Overall Study|Concomitant disease|2|||
164266211|NCT00262847|593344423|FG002|Overall Study|Concomitant disease|4|||
164266212|NCT00262847|593344421|FG000|Overall Study|Other Reasons|79|||
164266213|NCT00262847|593344422|FG001|Overall Study|Other Reasons|88|||
164266214|NCT00262847|593344423|FG002|Overall Study|Other Reasons|27|||
164266215|NCT00262847|593344421|FG000|Overall Study|Did not receive study treatment|4|||
164266216|NCT00262847|593344422|FG001|Overall Study|Did not receive study treatment|1|||
164266217|NCT00262847|593344423|FG002|Overall Study|Did not receive study treatment|4|||
164266218|NCT00387647|593344424|FG000|Overall Study|Death|18|||
164266219|NCT01825941|593344425|FG000|Overall Study|Lost to Follow-up|4|||
164266220|NCT01825941|593344426|FG001|Overall Study|Lost to Follow-up|1|||
164266221|NCT00528996|593344427|FG000|Overall Study|Other reasons than listing|6|||
164266222|NCT00528996|593344428|FG001|Overall Study|Other reasons than listing|7|||
164266223|NCT00528996|593344429|FG002|Overall Study|Other reasons than listing|14|||
164266224|NCT00528996|593344430|FG003|Overall Study|Other reasons than listing|11|||
164266225|NCT00528996|593344431|FG004|Overall Study|Other reasons than listing|5|||
164266226|NCT00528996|593344427|FG000|Overall Study|Refused continue medication|16|||
164266227|NCT00528996|593344428|FG001|Overall Study|Refused continue medication|0|||
164266228|NCT00528996|593344429|FG002|Overall Study|Refused continue medication|3|||
164266229|NCT00528996|593344430|FG003|Overall Study|Refused continue medication|3|||
164266230|NCT00528996|593344431|FG004|Overall Study|Refused continue medication|6|||
164266231|NCT00528996|593344427|FG000|Overall Study|Lost to Follow-up|2|||
164266232|NCT00528996|593344428|FG001|Overall Study|Lost to Follow-up|0|||
164266233|NCT00528996|593344429|FG002|Overall Study|Lost to Follow-up|4|||
164266234|NCT00528996|593344430|FG003|Overall Study|Lost to Follow-up|1|||
164266235|NCT00528996|593344431|FG004|Overall Study|Lost to Follow-up|3|||
164266236|NCT00528996|593344427|FG000|Overall Study|Protocol Violation|1|||
164266237|NCT00528996|593344428|FG001|Overall Study|Protocol Violation|2|||
164266238|NCT00528996|593344429|FG002|Overall Study|Protocol Violation|3|||
164266239|NCT00528996|593344430|FG003|Overall Study|Protocol Violation|3|||
164266240|NCT00528996|593344431|FG004|Overall Study|Protocol Violation|2|||
164266241|NCT00528996|593344427|FG000|Overall Study|Lack of Efficacy|7|||
164266242|NCT00528996|593344428|FG001|Overall Study|Lack of Efficacy|2|||
164266243|NCT00528996|593344429|FG002|Overall Study|Lack of Efficacy|1|||
164266244|NCT00528996|593344430|FG003|Overall Study|Lack of Efficacy|3|||
164266245|NCT00528996|593344431|FG004|Overall Study|Lack of Efficacy|3|||
164266246|NCT00528996|593344427|FG000|Overall Study|Adverse Event|32|||
164266247|NCT00528996|593344428|FG001|Overall Study|Adverse Event|13|||
164266248|NCT00528996|593344429|FG002|Overall Study|Adverse Event|18|||
164266249|NCT00528996|593344430|FG003|Overall Study|Adverse Event|29|||
164266250|NCT00528996|593344431|FG004|Overall Study|Adverse Event|18|||
164266251|NCT03495102|593344432|FG000|Overall Study|Adverse Event|5|||
164266252|NCT03495102|593344433|FG001|Overall Study|Adverse Event|7|||
164266253|NCT03495102|593344434|FG002|Overall Study|Adverse Event|10|||
164266254|NCT03495102|593344432|FG000|Overall Study|Death|3|||
164266255|NCT03495102|593344433|FG001|Overall Study|Death|4|||
164266256|NCT03495102|593344434|FG002|Overall Study|Death|4|||
164266257|NCT03495102|593344432|FG000|Overall Study|Lost to Follow-up|15|||
164266258|NCT03495102|593344433|FG001|Overall Study|Lost to Follow-up|16|||
164266259|NCT03495102|593344434|FG002|Overall Study|Lost to Follow-up|17|||
164266260|NCT03495102|593344432|FG000|Overall Study|Physician Decision|2|||
164266261|NCT03495102|593344433|FG001|Overall Study|Physician Decision|0|||
164266262|NCT03495102|593344434|FG002|Overall Study|Physician Decision|2|||
164266263|NCT03495102|593344432|FG000|Overall Study|Withdrawal by Subject|25|||
164266264|NCT03495102|593344433|FG001|Overall Study|Withdrawal by Subject|36|||
164266265|NCT03495102|593344434|FG002|Overall Study|Withdrawal by Subject|18|||
164266266|NCT03495102|593344432|FG000|Overall Study|Protocol Violation|1|||
164266267|NCT03495102|593344433|FG001|Overall Study|Protocol Violation|1|||
164266268|NCT03495102|593344434|FG002|Overall Study|Protocol Violation|0|||
164266269|NCT03495102|593344432|FG000|Overall Study|Site Closure|3|||
164266270|NCT03495102|593344433|FG001|Overall Study|Site Closure|1|||
164266271|NCT03495102|593344434|FG002|Overall Study|Site Closure|2|||
164581055|NCT00685178|594493862|FG001|Overall Study|Pregnancy|0|||
164581056|NCT00685178|594493863|FG002|Overall Study|Pregnancy|0|||
164581057|NCT00685178|594493864|FG003|Overall Study|Pregnancy|1|||
164581058|NCT00430781|594493868|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
164581059|NCT00430781|594493869|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
164581060|NCT00430781|594493870|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
164581061|NCT00430781|594493868|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
164581062|NCT00430781|594493869|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
164581063|NCT00430781|594493870|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
164581064|NCT00430781|594493868|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
164581065|NCT00430781|594493869|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
164581066|NCT00430781|594493870|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
164581067|NCT00430781|594493868|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
164581068|NCT00430781|594493869|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
164581069|NCT00430781|594493870|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
164581070|NCT00430781|594493868|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
164581071|NCT00430781|594493869|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
164581072|NCT00430781|594493870|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
164581073|NCT00430781|594493868|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
164581074|NCT00430781|594493869|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
164266272|NCT03495102|593344432|FG000|Overall Study|Non-compliance|1|||
164266273|NCT03495102|593344433|FG001|Overall Study|Non-compliance|0|||
164266274|NCT03495102|593344434|FG002|Overall Study|Non-compliance|0|||
164266275|NCT03495102|593344432|FG000|Overall Study|Participant Duplicated at Another Site|0|||
164266276|NCT03495102|593344433|FG001|Overall Study|Participant Duplicated at Another Site|0|||
164266277|NCT03495102|593344434|FG002|Overall Study|Participant Duplicated at Another Site|1|||
164266278|NCT03495102|593344432|FG000|Overall Study|Primary Care Physician Recommendation|0|||
164266279|NCT03495102|593344433|FG001|Overall Study|Primary Care Physician Recommendation|1|||
164266280|NCT03495102|593344434|FG002|Overall Study|Primary Care Physician Recommendation|0|||
164266281|NCT03495102|593344432|FG000|Overall Study|Relocated to Another Country|0|||
164266282|NCT03495102|593344433|FG001|Overall Study|Relocated to Another Country|1|||
164266283|NCT03495102|593344434|FG002|Overall Study|Relocated to Another Country|0|||
164266284|NCT03495102|593344432|FG000|Overall Study|Participant was in Rehabilitation|1|||
164266285|NCT03495102|593344433|FG001|Overall Study|Participant was in Rehabilitation|0|||
164266286|NCT03495102|593344434|FG002|Overall Study|Participant was in Rehabilitation|0|||
164266287|NCT03938324|593344435|FG000|Overall Study|Lost to Follow-up|42|||
164266288|NCT03938324|593344436|FG001|Overall Study|Lost to Follow-up|21|||
164266289|NCT03938324|593344435|FG000|Overall Study|Withdrawal by Subject|6|||
164266290|NCT03938324|593344436|FG001|Overall Study|Withdrawal by Subject|1|||
164266291|NCT05160766|593344437|FG000|Overall Study|Adverse Event|0|||
164266292|NCT05160766|593344438|FG001|Overall Study|Adverse Event|1|||
164266293|NCT05160766|593344439|FG002|Overall Study|Adverse Event|0|||
164266294|NCT05160766|593344440|FG003|Overall Study|Adverse Event|0|||
164266295|NCT05160766|593344437|FG000|Overall Study|COVID-19 infection|0|||
164266296|NCT05160766|593344438|FG001|Overall Study|COVID-19 infection|1|||
164266297|NCT05160766|593344439|FG002|Overall Study|COVID-19 infection|0|||
164266298|NCT05160766|593344440|FG003|Overall Study|COVID-19 infection|0|||
164266299|NCT05160766|593344437|FG000|Overall Study|travel time|1|||
164266300|NCT05160766|593344438|FG001|Overall Study|travel time|0|||
164266301|NCT05160766|593344439|FG002|Overall Study|travel time|0|||
164266302|NCT05160766|593344440|FG003|Overall Study|travel time|1|||
164266303|NCT05160766|593344437|FG000|Overall Study|Withdrawal by Subject|3|||
164266304|NCT05160766|593344438|FG001|Overall Study|Withdrawal by Subject|5|||
164266305|NCT05160766|593344439|FG002|Overall Study|Withdrawal by Subject|4|||
164266306|NCT05160766|593344440|FG003|Overall Study|Withdrawal by Subject|2|||
164266307|NCT05160766|593344437|FG000|Overall Study|Death|0|||
164266308|NCT05160766|593344438|FG001|Overall Study|Death|0|||
164266309|NCT05160766|593344439|FG002|Overall Study|Death|2|||
164266310|NCT05160766|593344440|FG003|Overall Study|Death|5|||
164581075|NCT00430781|594493870|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
164266311|NCT05160766|593344437|FG000|Overall Study|Lost to Follow-up|0|||
164266312|NCT05160766|593344438|FG001|Overall Study|Lost to Follow-up|0|||
164266313|NCT05160766|593344439|FG002|Overall Study|Lost to Follow-up|1|||
164266314|NCT05160766|593344440|FG003|Overall Study|Lost to Follow-up|2|||
164266315|NCT05160766|593344437|FG000|Overall Study|No show|0|||
164266316|NCT05160766|593344438|FG001|Overall Study|No show|0|||
164266317|NCT05160766|593344439|FG002|Overall Study|No show|1|||
164266318|NCT05160766|593344440|FG003|Overall Study|No show|1|||
164266319|NCT05160766|593344437|FG000|Overall Study|Physician Decision|0|||
164686188|NCT01350934|594874873|FG001|Base Study|Lost to Follow-up|0|||
164686189|NCT01350934|594874872|FG000|Base Study|Protocol Violation|1|||
164686190|NCT01350934|594874873|FG001|Base Study|Protocol Violation|1|||
164686191|NCT01350934|594874872|FG000|Base Study|Withdrawal by Subject|1|||
164686192|NCT01350934|594874873|FG001|Base Study|Withdrawal by Subject|2|||
164686193|NCT01350934|594874872|FG000|Base Study|Non-Compliance With Study Drug|2|||
164686194|NCT01350934|594874873|FG001|Base Study|Non-Compliance With Study Drug|0|||
164686195|NCT01350934|594874872|FG000|Extension Study|Adverse Event|2|||
164686196|NCT01350934|594874873|FG001|Extension Study|Adverse Event|1|||
164266320|NCT05160766|593344438|FG001|Overall Study|Physician Decision|0|||
164266321|NCT05160766|593344439|FG002|Overall Study|Physician Decision|0|||
164266322|NCT05160766|593344440|FG003|Overall Study|Physician Decision|1|||
164266323|NCT05160766|593344437|FG000|Overall Study|Protocol Violation|0|||
164266324|NCT05160766|593344438|FG001|Overall Study|Protocol Violation|0|||
164266325|NCT05160766|593344439|FG002|Overall Study|Protocol Violation|1|||
164686197|NCT01350934|594874872|FG000|Extension Study|Lost to Follow-up|2|||
164266326|NCT05160766|593344440|FG003|Overall Study|Protocol Violation|0|||
164266327|NCT01282294|593344441|FG000|Overall Study|Lost to Follow-up|14|||
164266328|NCT01282294|593344441|FG000|Overall Study|Screening failure|1|||
164266329|NCT01282294|593344441|FG000|Overall Study|Adverse Event|1|||
164266330|NCT01282294|593344441|FG000|Overall Study|Patient non-compliance|2|||
164266331|NCT01282294|593344441|FG000|Overall Study|Physician Decision|1|||
164266332|NCT02408523|593344442|FG000|Overall Study|Adverse Event|4|||
164266333|NCT02408523|593344443|FG001|Overall Study|Adverse Event|10|||
164266334|NCT02408523|593344442|FG000|Overall Study|Lack of Efficacy|0|||
164266335|NCT02408523|593344443|FG001|Overall Study|Lack of Efficacy|1|||
164266336|NCT02408523|593344442|FG000|Overall Study|Protocol Violation|1|||
164266337|NCT02408523|593344443|FG001|Overall Study|Protocol Violation|2|||
164266338|NCT02408523|593344442|FG000|Overall Study|Lost to Follow-up|2|||
164266339|NCT02408523|593344443|FG001|Overall Study|Lost to Follow-up|3|||
164341776|NCT00002651|593627507|FG002|Induction|Refusal unrelated to adverse event|0|||
164686198|NCT01350934|594874873|FG001|Extension Study|Lost to Follow-up|0|||
164686199|NCT01350934|594874872|FG000|Extension Study|Protocol Violation|1|||
164686200|NCT01350934|594874873|FG001|Extension Study|Protocol Violation|1|||
164686201|NCT01350934|594874872|FG000|Extension Study|Lack of Efficacy|0|||
164686202|NCT01350934|594874873|FG001|Extension Study|Lack of Efficacy|1|||
164686203|NCT01350934|594874872|FG000|Extension Study|Withdrawal by Subject|0|||
164686204|NCT01350934|594874873|FG001|Extension Study|Withdrawal by Subject|1|||
164686205|NCT01011335|594874874|FG000|Overall Study|Lost to Follow-up|0|||
164686206|NCT01011335|594874875|FG001|Overall Study|Lost to Follow-up|0|||
164686207|NCT01011335|594874876|FG002|Overall Study|Lost to Follow-up|1|||
164686208|NCT01011335|594874877|FG003|Overall Study|Lost to Follow-up|1|||
164686209|NCT01011335|594874878|FG004|Overall Study|Lost to Follow-up|1|||
164686210|NCT01011335|594874879|FG005|Overall Study|Lost to Follow-up|1|||
164686211|NCT01011335|594874880|FG006|Overall Study|Lost to Follow-up|2|||
164686212|NCT01011335|594874881|FG007|Overall Study|Lost to Follow-up|2|||
164686213|NCT01011335|594874882|FG008|Overall Study|Lost to Follow-up|1|||
164686214|NCT01011335|594874883|FG009|Overall Study|Lost to Follow-up|0|||
164686215|NCT01011335|594874884|FG010|Overall Study|Lost to Follow-up|0|||
164686216|NCT01011335|594874885|FG011|Overall Study|Lost to Follow-up|1|||
164686217|NCT01011335|594874886|FG012|Overall Study|Lost to Follow-up|2|||
164686218|NCT01011335|594874874|FG000|Overall Study|Protocol Violation|0|||
164686219|NCT01011335|594874875|FG001|Overall Study|Protocol Violation|1|||
164686220|NCT01011335|594874876|FG002|Overall Study|Protocol Violation|0|||
164686221|NCT01011335|594874877|FG003|Overall Study|Protocol Violation|0|||
164686222|NCT01011335|594874878|FG004|Overall Study|Protocol Violation|0|||
164686223|NCT01011335|594874879|FG005|Overall Study|Protocol Violation|0|||
164686224|NCT01011335|594874880|FG006|Overall Study|Protocol Violation|0|||
164686225|NCT01011335|594874881|FG007|Overall Study|Protocol Violation|0|||
164266340|NCT02408523|593344442|FG000|Overall Study|Withdrawal by Subject|3|||
164266341|NCT02408523|593344443|FG001|Overall Study|Withdrawal by Subject|1|||
164341777|NCT00002651|593627505|FG000|Induction|Progression/relapse|274|||
164341778|NCT00002651|593627506|FG001|Induction|Progression/relapse|0|||
164341779|NCT00002651|593627507|FG002|Induction|Progression/relapse|0|||
164686226|NCT01011335|594874882|FG008|Overall Study|Protocol Violation|0|||
164686227|NCT01011335|594874883|FG009|Overall Study|Protocol Violation|0|||
164686228|NCT01011335|594874884|FG010|Overall Study|Protocol Violation|0|||
164686229|NCT01011335|594874885|FG011|Overall Study|Protocol Violation|0|||
164686230|NCT01011335|594874886|FG012|Overall Study|Protocol Violation|0|||
164686231|NCT01011335|594874874|FG000|Overall Study|Moved/deployed or no booster|1|||
164686232|NCT01011335|594874875|FG001|Overall Study|Moved/deployed or no booster|0|||
164686233|NCT01011335|594874876|FG002|Overall Study|Moved/deployed or no booster|0|||
164266342|NCT02408523|593344442|FG000|Overall Study|Sponsor request|1|||
164266343|NCT02408523|593344443|FG001|Overall Study|Sponsor request|0|||
164266344|NCT02408523|593344442|FG000|Overall Study|Did not satisfy extension conditions|0|||
164266345|NCT02408523|593344443|FG001|Overall Study|Did not satisfy extension conditions|1|||
164266346|NCT02943915|593344444|FG000|Overall Study|Withdrawal by Subject|2|||
164341780|NCT00002651|593627505|FG000|Induction|Death|62|||
164686234|NCT01011335|594874877|FG003|Overall Study|Moved/deployed or no booster|1|||
164266347|NCT02943915|593344445|FG001|Overall Study|Withdrawal by Subject|1|||
164266348|NCT02943915|593344446|FG002|Overall Study|Withdrawal by Subject|0|||
164266349|NCT02943915|593344447|FG003|Overall Study|Withdrawal by Subject|0|||
164266350|NCT02943915|593344444|FG000|Overall Study|Lost to Follow-up|3|||
164266351|NCT02943915|593344445|FG001|Overall Study|Lost to Follow-up|1|||
164266352|NCT02943915|593344446|FG002|Overall Study|Lost to Follow-up|0|||
164266353|NCT02943915|593344447|FG003|Overall Study|Lost to Follow-up|0|||
164266354|NCT02943915|593344444|FG000|Overall Study|excluded|0|||
164266355|NCT02943915|593344445|FG001|Overall Study|excluded|1|||
164266356|NCT02943915|593344446|FG002|Overall Study|excluded|0|||
164266357|NCT02943915|593344447|FG003|Overall Study|excluded|0|||
164266358|NCT03769311|593344448|FG000|Overall Study|Withdrawal by Subject|1|||
164266359|NCT01062061|593344451|FG000|Overall Study|Enrolled more than once|2|||
164266360|NCT01062061|593344451|FG000|Overall Study|Investigated before study start|13|||
164266361|NCT01062061|593344451|FG000|Overall Study|Outside chief indications|10|||
164266362|NCT01062061|593344451|FG000|Overall Study|Failed to meet inclusion criteria|2|||
164266363|NCT00524589|593344452|FG000|Overall Study|Withdrawal by Subject|2|||
164266364|NCT00524589|593344452|FG000|Overall Study|Disease Progression|16|||
164266365|NCT01266317|593344453|FG000|Overall Study|Withdrawal by Subject|2|||
164266366|NCT00098722|593344454|FG000|Double Blind Phase|Adverse Event|7|||
164266367|NCT00098722|593344455|FG001|Double Blind Phase|Adverse Event|7|||
164266368|NCT00098722|593344456|FG002|Double Blind Phase|Adverse Event|3|||
164266369|NCT00098722|593344457|FG003|Double Blind Phase|Adverse Event|0|||
164266370|NCT00098722|593344458|FG004|Double Blind Phase|Adverse Event|0|||
164266371|NCT00098722|593344459|FG005|Double Blind Phase|Adverse Event|0|||
164686235|NCT01011335|594874878|FG004|Overall Study|Moved/deployed or no booster|0|||
164686236|NCT01011335|594874879|FG005|Overall Study|Moved/deployed or no booster|0|||
164686237|NCT01011335|594874880|FG006|Overall Study|Moved/deployed or no booster|1|||
164686238|NCT01011335|594874881|FG007|Overall Study|Moved/deployed or no booster|0|||
164686239|NCT01011335|594874882|FG008|Overall Study|Moved/deployed or no booster|1|||
164686240|NCT01011335|594874883|FG009|Overall Study|Moved/deployed or no booster|0|||
164686241|NCT01011335|594874884|FG010|Overall Study|Moved/deployed or no booster|2|||
164686242|NCT01011335|594874885|FG011|Overall Study|Moved/deployed or no booster|0|||
164686243|NCT01011335|594874886|FG012|Overall Study|Moved/deployed or no booster|0|||
164686244|NCT01011335|594874874|FG000|Overall Study|Adverse Event|0|||
164686245|NCT01011335|594874875|FG001|Overall Study|Adverse Event|0|||
164686246|NCT01011335|594874876|FG002|Overall Study|Adverse Event|0|||
164686247|NCT01011335|594874877|FG003|Overall Study|Adverse Event|0|||
164686248|NCT01011335|594874878|FG004|Overall Study|Adverse Event|0|||
164686249|NCT01011335|594874879|FG005|Overall Study|Adverse Event|0|||
164686250|NCT01011335|594874880|FG006|Overall Study|Adverse Event|0|||
164686251|NCT01011335|594874881|FG007|Overall Study|Adverse Event|0|||
164686252|NCT01011335|594874882|FG008|Overall Study|Adverse Event|0|||
164686253|NCT01011335|594874883|FG009|Overall Study|Adverse Event|0|||
164686254|NCT01011335|594874884|FG010|Overall Study|Adverse Event|4|||
164686255|NCT01011335|594874885|FG011|Overall Study|Adverse Event|0|||
164686256|NCT01011335|594874886|FG012|Overall Study|Adverse Event|1|||
164686257|NCT02435433|594874887|FG000|Overall Study|Withdrawal by Subject|2|||
164686258|NCT02435433|594874888|FG001|Overall Study|Withdrawal by Subject|3|||
164686259|NCT02435433|594874889|FG002|Overall Study|Withdrawal by Subject|1|||
164686260|NCT02435433|594874890|FG003|Overall Study|Withdrawal by Subject|0|||
164686261|NCT02435433|594874891|FG004|Overall Study|Withdrawal by Subject|0|||
164686262|NCT02435433|594874887|FG000|Overall Study|Lost to Follow-up|2|||
164686263|NCT02435433|594874888|FG001|Overall Study|Lost to Follow-up|2|||
164686264|NCT02435433|594874889|FG002|Overall Study|Lost to Follow-up|4|||
164686265|NCT02435433|594874890|FG003|Overall Study|Lost to Follow-up|1|||
164686266|NCT02435433|594874891|FG004|Overall Study|Lost to Follow-up|0|||
164686267|NCT02817828|594874892|FG000|Overall Study|Lost to Follow-up|41|||
164686268|NCT02817828|594874892|FG000|Overall Study|Adverse event not related to bleeding|104|||
164266372|NCT00098722|593344460|FG006|Double Blind Phase|Adverse Event|0|||
164266373|NCT00098722|593344454|FG000|Double Blind Phase|Death|2|||
164266374|NCT00098722|593344455|FG001|Double Blind Phase|Death|5|||
164266375|NCT00098722|593344456|FG002|Double Blind Phase|Death|0|||
164266376|NCT00098722|593344457|FG003|Double Blind Phase|Death|0|||
164686269|NCT02817828|594874892|FG000|Overall Study|Adverse event related to bleeding|53|||
164266377|NCT00098722|593344458|FG004|Double Blind Phase|Death|0|||
164266378|NCT00098722|593344459|FG005|Double Blind Phase|Death|0|||
164686270|NCT02817828|594874892|FG000|Overall Study|Protocol Violation|11|||
164686271|NCT02817828|594874892|FG000|Overall Study|Pregnancy|7|||
164686272|NCT02817828|594874892|FG000|Overall Study|Pregnancy wish|15|||
164686273|NCT02817828|594874892|FG000|Overall Study|Withdrawal by Subject|78|||
164686274|NCT02817828|594874892|FG000|Overall Study|Other|26|||
164266379|NCT00098722|593344460|FG006|Double Blind Phase|Death|0|||
164266380|NCT00098722|593344454|FG000|Double Blind Phase|Lack of Efficacy|21|||
164266381|NCT00098722|593344455|FG001|Double Blind Phase|Lack of Efficacy|23|||
164266382|NCT00098722|593344456|FG002|Double Blind Phase|Lack of Efficacy|15|||
164266383|NCT00098722|593344457|FG003|Double Blind Phase|Lack of Efficacy|0|||
164266384|NCT00098722|593344458|FG004|Double Blind Phase|Lack of Efficacy|0|||
164266385|NCT00098722|593344459|FG005|Double Blind Phase|Lack of Efficacy|0|||
164266386|NCT00098722|593344460|FG006|Double Blind Phase|Lack of Efficacy|0|||
164266387|NCT00098722|593344454|FG000|Double Blind Phase|Participant defaulted|16|||
164266388|NCT00098722|593344455|FG001|Double Blind Phase|Participant defaulted|11|||
164266389|NCT00098722|593344456|FG002|Double Blind Phase|Participant defaulted|9|||
164686275|NCT00522041|594874894|FG000|Overall Study|Adverse Event|9|||
164686276|NCT00522041|594874895|FG001|Overall Study|Adverse Event|3|||
164686277|NCT00522041|594874894|FG000|Overall Study|Protocol Violation|2|||
164686278|NCT00522041|594874895|FG001|Overall Study|Protocol Violation|0|||
164686279|NCT00522041|594874894|FG000|Overall Study|Lost to Follow-up|1|||
164686280|NCT00522041|594874895|FG001|Overall Study|Lost to Follow-up|4|||
164686281|NCT00522041|594874894|FG000|Overall Study|Voluntary withdrawal|5|||
164686282|NCT00522041|594874895|FG001|Overall Study|Voluntary withdrawal|4|||
164686283|NCT00522041|594874894|FG000|Overall Study|Did not receive treatment|0|||
164686284|NCT00522041|594874895|FG001|Overall Study|Did not receive treatment|1|||
164686285|NCT01579006|594874896|FG000|Overall Study|Lack of Efficacy|10|||
164686286|NCT01579006|594874896|FG000|Overall Study|Adverse Event|13|||
164686287|NCT01579006|594874896|FG000|Overall Study|Withdrawal by Subject|5|||
164686288|NCT01579006|594874896|FG000|Overall Study|Non-compliance|3|||
164686289|NCT01579006|594874896|FG000|Overall Study|Due to participant's health fund|1|||
164686290|NCT01579006|594874896|FG000|Overall Study|Scheduled surgery|1|||
164686291|NCT00799708|594874900|FG000|Overall Study|non-compliance|1|||
164686292|NCT00799708|594874901|FG001|Overall Study|non-compliance|0|||
164686293|NCT00799708|594874902|FG002|Overall Study|non-compliance|0|||
164686294|NCT03343639|594874903|FG000|Overall Study|Withdrawal by Subject|10|||
164686295|NCT03343639|594874904|FG001|Overall Study|Withdrawal by Subject|6|||
164686296|NCT03343639|594874903|FG000|Overall Study|Lost to Follow-up|4|||
164686297|NCT03343639|594874904|FG001|Overall Study|Lost to Follow-up|5|||
164686298|NCT03343639|594874903|FG000|Overall Study|Protocol Violation|0|||
164686299|NCT03343639|594874904|FG001|Overall Study|Protocol Violation|1|||
164686300|NCT00735696|594874907|FG000|Overall Study|Withdrawal by Subject|1|||
164686301|NCT00735696|594874907|FG000|Overall Study|Enrolled but never Treated|1|||
164686302|NCT01708954|594874908|FG000|Step 1|Disease progression|26|||
164686303|NCT01708954|594874909|FG001|Step 1|Disease progression|17|||
164686304|NCT01708954|594874910|FG002|Step 1|Disease progression|14|||
164686305|NCT01708954|594874908|FG000|Step 1|Adverse Event|3|||
164686306|NCT01708954|594874909|FG001|Step 1|Adverse Event|11|||
164686307|NCT01708954|594874910|FG002|Step 1|Adverse Event|13|||
164686308|NCT01708954|594874908|FG000|Step 1|Death|3|||
164686309|NCT01708954|594874909|FG001|Step 1|Death|2|||
164686310|NCT01708954|594874910|FG002|Step 1|Death|3|||
164686311|NCT01708954|594874908|FG000|Step 1|Withdrawal by Subject|2|||
164686312|NCT01708954|594874909|FG001|Step 1|Withdrawal by Subject|5|||
164686313|NCT01708954|594874910|FG002|Step 1|Withdrawal by Subject|3|||
164686314|NCT01708954|594874908|FG000|Step 1|Other complicating disease|0|||
164686315|NCT01708954|594874909|FG001|Step 1|Other complicating disease|2|||
164686316|NCT01708954|594874910|FG002|Step 1|Other complicating disease|0|||
164686317|NCT01708954|594874908|FG000|Step 1|Crossed over to Step 2|2|||
164686318|NCT01708954|594874909|FG001|Step 1|Crossed over to Step 2|0|||
164686319|NCT01708954|594874910|FG002|Step 1|Crossed over to Step 2|0|||
164686320|NCT01708954|594874908|FG000|Step 1|Symptomatic deterioration|1|||
164686321|NCT01708954|594874909|FG001|Step 1|Symptomatic deterioration|0|||
164686322|NCT01708954|594874910|FG002|Step 1|Symptomatic deterioration|1|||
164686323|NCT01708954|594874908|FG000|Step 1|Off-treatment reason not submitted|1|||
164686324|NCT01708954|594874909|FG001|Step 1|Off-treatment reason not submitted|1|||
164686325|NCT01708954|594874910|FG002|Step 1|Off-treatment reason not submitted|1|||
164686326|NCT01708954|594874908|FG000|Step 1|Ineligible or never received treatment|4|||
164686327|NCT01708954|594874909|FG001|Step 1|Ineligible or never received treatment|2|||
164686328|NCT01708954|594874910|FG002|Step 1|Ineligible or never received treatment|8|||
164686329|NCT01708954|594874908|FG000|Step 2|Disease progression|9|||
164686330|NCT01708954|594874909|FG001|Step 2|Disease progression|4|||
164686331|NCT01708954|594874910|FG002|Step 2|Disease progression|0|||
164266390|NCT00098722|593344457|FG003|Double Blind Phase|Participant defaulted|0|||
164266391|NCT00098722|593344458|FG004|Double Blind Phase|Participant defaulted|0|||
164266392|NCT00098722|593344459|FG005|Double Blind Phase|Participant defaulted|0|||
164686332|NCT01708954|594874908|FG000|Step 2|Adverse Event|3|||
164686333|NCT01708954|594874909|FG001|Step 2|Adverse Event|2|||
164686334|NCT01708954|594874910|FG002|Step 2|Adverse Event|0|||
164686335|NCT01708954|594874908|FG000|Step 2|Withdrawal by Subject|1|||
164686336|NCT01708954|594874909|FG001|Step 2|Withdrawal by Subject|1|||
164686337|NCT01708954|594874910|FG002|Step 2|Withdrawal by Subject|0|||
164686338|NCT01192776|594874911|FG000|Overall Study|Death|8|||
164686339|NCT01192776|594874912|FG001|Overall Study|Death|15|||
164686340|NCT01192776|594874913|FG002|Overall Study|Death|18|||
164686341|NCT01192776|594874914|FG003|Overall Study|Death|15|||
164266393|NCT00098722|593344460|FG006|Double Blind Phase|Participant defaulted|0|||
164686342|NCT01192776|594874911|FG000|Overall Study|Lost to Follow-up|3|||
164686343|NCT01192776|594874912|FG001|Overall Study|Lost to Follow-up|6|||
164686344|NCT01192776|594874913|FG002|Overall Study|Lost to Follow-up|3|||
164686345|NCT01192776|594874914|FG003|Overall Study|Lost to Follow-up|5|||
164266394|NCT00098722|593344454|FG000|Double Blind Phase|Pregnancy|1|||
164266395|NCT00098722|593344455|FG001|Double Blind Phase|Pregnancy|0|||
164266396|NCT00098722|593344456|FG002|Double Blind Phase|Pregnancy|0|||
164266397|NCT00098722|593344457|FG003|Double Blind Phase|Pregnancy|0|||
164266398|NCT00098722|593344458|FG004|Double Blind Phase|Pregnancy|0|||
164266399|NCT00098722|593344459|FG005|Double Blind Phase|Pregnancy|0|||
164266400|NCT00098722|593344460|FG006|Double Blind Phase|Pregnancy|0|||
164266401|NCT00098722|593344454|FG000|Double Blind Phase|Randomized, not treated|4|||
164266402|NCT00098722|593344455|FG001|Double Blind Phase|Randomized, not treated|3|||
164266403|NCT00098722|593344456|FG002|Double Blind Phase|Randomized, not treated|3|||
164266404|NCT00098722|593344457|FG003|Double Blind Phase|Randomized, not treated|0|||
164266405|NCT00098722|593344458|FG004|Double Blind Phase|Randomized, not treated|0|||
164266406|NCT00098722|593344459|FG005|Double Blind Phase|Randomized, not treated|0|||
164266407|NCT00098722|593344460|FG006|Double Blind Phase|Randomized, not treated|0|||
164266408|NCT00098722|593344454|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
164266409|NCT00098722|593344455|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
164266410|NCT00098722|593344456|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
164266411|NCT00098722|593344457|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
164266412|NCT00098722|593344458|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
164266413|NCT00098722|593344459|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
164266414|NCT00098722|593344460|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
164266415|NCT00098722|593344454|FG000|Double Blind Phase|Other|7|||
164266416|NCT00098722|593344455|FG001|Double Blind Phase|Other|8|||
164266417|NCT00098722|593344456|FG002|Double Blind Phase|Other|7|||
164266418|NCT00098722|593344457|FG003|Double Blind Phase|Other|0|||
164266419|NCT00098722|593344458|FG004|Double Blind Phase|Other|0|||
164266420|NCT00098722|593344459|FG005|Double Blind Phase|Other|0|||
164266421|NCT00098722|593344460|FG006|Double Blind Phase|Other|0|||
164266422|NCT00098722|593344454|FG000|Open Label Phase|Adverse Event|0|||
164266423|NCT00098722|593344455|FG001|Open Label Phase|Adverse Event|0|||
164266424|NCT00098722|593344456|FG002|Open Label Phase|Adverse Event|0|||
164266425|NCT00098722|593344457|FG003|Open Label Phase|Adverse Event|5|||
164341781|NCT00002651|593627506|FG001|Induction|Death|0|||
164341782|NCT00002651|593627507|FG002|Induction|Death|0|||
164341783|NCT00002651|593627505|FG000|Induction|Other|823|||
164341784|NCT00002651|593627506|FG001|Induction|Other|0|||
164341785|NCT00002651|593627507|FG002|Induction|Other|0|||
164266426|NCT00098722|593344458|FG004|Open Label Phase|Adverse Event|0|||
164266427|NCT00098722|593344459|FG005|Open Label Phase|Adverse Event|0|||
164341786|NCT00002651|593627505|FG000|Induction|not eligible|90|||
164341787|NCT00002651|593627506|FG001|Induction|not eligible|0|||
164341788|NCT00002651|593627507|FG002|Induction|not eligible|0|||
164581076|NCT00430781|594493868|FG000|Interim Analysis; 11 February 2008|Death|0|||
164581077|NCT00430781|594493869|FG001|Interim Analysis; 11 February 2008|Death|1|||
164581078|NCT00430781|594493870|FG002|Interim Analysis; 11 February 2008|Death|0|||
164581079|NCT00430781|594493868|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
164581080|NCT00430781|594493869|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
164581081|NCT00430781|594493870|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
164581082|NCT00430781|594493868|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
164581083|NCT00430781|594493869|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
164581084|NCT00430781|594493870|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
164581085|NCT00430781|594493868|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
164581086|NCT00430781|594493869|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
164581087|NCT00430781|594493870|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
164581088|NCT00430781|594493868|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
164581089|NCT00430781|594493869|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
164581090|NCT00430781|594493870|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
164581091|NCT00430781|594493868|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
164581092|NCT00430781|594493869|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
164581093|NCT00430781|594493870|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
164581094|NCT00430781|594493868|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
164581095|NCT00430781|594493869|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
164581096|NCT00430781|594493870|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
164581097|NCT00430781|594493868|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
164581098|NCT00430781|594493869|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
164581099|NCT00430781|594493870|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
164581100|NCT00430781|594493868|FG000|Final Analysis; 31 July 2008|Other|0|||
164581101|NCT00430781|594493869|FG001|Final Analysis; 31 July 2008|Other|1|||
164581102|NCT00430781|594493870|FG002|Final Analysis; 31 July 2008|Other|0|||
164581103|NCT00430781|594493868|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
164266428|NCT00098722|593344460|FG006|Open Label Phase|Adverse Event|0|||
164266429|NCT00098722|593344454|FG000|Open Label Phase|Death|0|||
164266430|NCT00098722|593344455|FG001|Open Label Phase|Death|0|||
164341789|NCT00002651|593627505|FG000|Consolidation and Randomization|Adverse Event|0|||
164341790|NCT00002651|593627506|FG001|Consolidation and Randomization|Adverse Event|36|||
164581104|NCT00430781|594493869|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
164581105|NCT00430781|594493870|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
164581106|NCT00430781|594493868|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
164581107|NCT00430781|594493869|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
164581108|NCT00430781|594493870|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
164581109|NCT00430781|594493868|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
164581110|NCT00430781|594493869|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
164581111|NCT00430781|594493870|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
164581112|NCT00430781|594493868|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
164581113|NCT00430781|594493869|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
164581114|NCT00430781|594493870|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
164581115|NCT00430781|594493868|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
164581116|NCT00430781|594493869|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
164266431|NCT00098722|593344456|FG002|Open Label Phase|Death|0|||
164266432|NCT00098722|593344457|FG003|Open Label Phase|Death|2|||
164266433|NCT00098722|593344458|FG004|Open Label Phase|Death|0|||
164266434|NCT00098722|593344459|FG005|Open Label Phase|Death|0|||
164266435|NCT00098722|593344460|FG006|Open Label Phase|Death|0|||
164266436|NCT00098722|593344454|FG000|Open Label Phase|Lack of Efficacy|0|||
164266437|NCT00098722|593344455|FG001|Open Label Phase|Lack of Efficacy|0|||
164266438|NCT00098722|593344456|FG002|Open Label Phase|Lack of Efficacy|0|||
164266439|NCT00098722|593344457|FG003|Open Label Phase|Lack of Efficacy|8|||
164266440|NCT00098722|593344458|FG004|Open Label Phase|Lack of Efficacy|0|||
164266441|NCT00098722|593344459|FG005|Open Label Phase|Lack of Efficacy|0|||
164341791|NCT00002651|593627507|FG002|Consolidation and Randomization|Adverse Event|14|||
164341792|NCT00002651|593627505|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
164341793|NCT00002651|593627506|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
164341794|NCT00002651|593627507|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
164341795|NCT00002651|593627505|FG000|Consolidation and Randomization|Progression/relapse|0|||
164341796|NCT00002651|593627506|FG001|Consolidation and Randomization|Progression/relapse|295|||
164341797|NCT00002651|593627507|FG002|Consolidation and Randomization|Progression/relapse|298|||
164341798|NCT00002651|593627505|FG000|Consolidation and Randomization|Death|0|||
164341799|NCT00002651|593627506|FG001|Consolidation and Randomization|Death|38|||
164341800|NCT00002651|593627507|FG002|Consolidation and Randomization|Death|48|||
164341801|NCT00002651|593627505|FG000|Consolidation and Randomization|Other|0|||
164341802|NCT00002651|593627506|FG001|Consolidation and Randomization|Other|314|||
164341803|NCT00002651|593627507|FG002|Consolidation and Randomization|Other|313|||
164341804|NCT00002651|593627505|FG000|Consolidation and Randomization|not eligible|0|||
164266442|NCT00098722|593344460|FG006|Open Label Phase|Lack of Efficacy|0|||
164266443|NCT00098722|593344454|FG000|Open Label Phase|Pregnancy|0|||
164266444|NCT00098722|593344455|FG001|Open Label Phase|Pregnancy|0|||
164266445|NCT00098722|593344456|FG002|Open Label Phase|Pregnancy|0|||
164266446|NCT00098722|593344457|FG003|Open Label Phase|Pregnancy|1|||
164266447|NCT00098722|593344458|FG004|Open Label Phase|Pregnancy|0|||
164266448|NCT00098722|593344459|FG005|Open Label Phase|Pregnancy|0|||
164266449|NCT00098722|593344460|FG006|Open Label Phase|Pregnancy|0|||
164266450|NCT00098722|593344454|FG000|Open Label Phase|Participant defaulted|0|||
164266451|NCT00098722|593344455|FG001|Open Label Phase|Participant defaulted|0|||
164266452|NCT00098722|593344456|FG002|Open Label Phase|Participant defaulted|0|||
164266453|NCT00098722|593344457|FG003|Open Label Phase|Participant defaulted|18|||
164266454|NCT00098722|593344458|FG004|Open Label Phase|Participant defaulted|0|||
164266455|NCT00098722|593344459|FG005|Open Label Phase|Participant defaulted|0|||
164266456|NCT00098722|593344460|FG006|Open Label Phase|Participant defaulted|0|||
164266457|NCT00098722|593344454|FG000|Open Label Phase|Ongoing at cut-off date|0|||
164266458|NCT00098722|593344455|FG001|Open Label Phase|Ongoing at cut-off date|0|||
164266459|NCT00098722|593344456|FG002|Open Label Phase|Ongoing at cut-off date|0|||
164266460|NCT00098722|593344457|FG003|Open Label Phase|Ongoing at cut-off date|220|||
164266461|NCT00098722|593344458|FG004|Open Label Phase|Ongoing at cut-off date|50|||
164266462|NCT00098722|593344459|FG005|Open Label Phase|Ongoing at cut-off date|0|||
164266463|NCT00098722|593344460|FG006|Open Label Phase|Ongoing at cut-off date|0|||
164266464|NCT00098722|593344454|FG000|Open Label Phase|Other|0|||
164266465|NCT00098722|593344455|FG001|Open Label Phase|Other|0|||
164341805|NCT00002651|593627506|FG001|Consolidation and Randomization|not eligible|102|||
164341806|NCT00002651|593627507|FG002|Consolidation and Randomization|not eligible|112|||
164266466|NCT00098722|593344456|FG002|Open Label Phase|Other|0|||
164266467|NCT00098722|593344457|FG003|Open Label Phase|Other|18|||
164266468|NCT00098722|593344458|FG004|Open Label Phase|Other|0|||
164266469|NCT00098722|593344459|FG005|Open Label Phase|Other|0|||
164266470|NCT00098722|593344460|FG006|Open Label Phase|Other|0|||
164266471|NCT00098722|593344454|FG000|Observation Phase|Death|0|||
164266472|NCT00098722|593344455|FG001|Observation Phase|Death|0|||
164266473|NCT00098722|593344456|FG002|Observation Phase|Death|0|||
164341807|NCT01705730|593627508|FG000|Overall Study|Lack of Efficacy|1|||
164341808|NCT01705730|593627508|FG000|Overall Study|Adverse Event|3|||
164686346|NCT02587143|594874915|FG000|Overall Study|Adverse Event|1|||
164686347|NCT02587143|594874916|FG001|Overall Study|Adverse Event|0|||
164686348|NCT01119625|594874917|FG000|Overall Study|Lost to Follow-up|1|||
164686349|NCT01119625|594874918|FG001|Overall Study|Lost to Follow-up|2|||
164266474|NCT00098722|593344457|FG003|Observation Phase|Death|0|||
164266475|NCT00098722|593344458|FG004|Observation Phase|Death|0|||
164266476|NCT00098722|593344459|FG005|Observation Phase|Death|5|||
164266477|NCT00098722|593344460|FG006|Observation Phase|Death|3|||
164266478|NCT00098722|593344454|FG000|Observation Phase|Lack of Efficacy|0|||
164266479|NCT00098722|593344455|FG001|Observation Phase|Lack of Efficacy|0|||
164266480|NCT00098722|593344456|FG002|Observation Phase|Lack of Efficacy|0|||
164266481|NCT00098722|593344457|FG003|Observation Phase|Lack of Efficacy|0|||
164266482|NCT00098722|593344458|FG004|Observation Phase|Lack of Efficacy|0|||
164266483|NCT00098722|593344459|FG005|Observation Phase|Lack of Efficacy|2|||
164266484|NCT00098722|593344460|FG006|Observation Phase|Lack of Efficacy|0|||
164266485|NCT00098722|593344454|FG000|Observation Phase|Participant defaulted|0|||
164266486|NCT00098722|593344455|FG001|Observation Phase|Participant defaulted|0|||
164266487|NCT00098722|593344456|FG002|Observation Phase|Participant defaulted|0|||
164266488|NCT00098722|593344457|FG003|Observation Phase|Participant defaulted|0|||
164266489|NCT00098722|593344458|FG004|Observation Phase|Participant defaulted|0|||
164266490|NCT00098722|593344459|FG005|Observation Phase|Participant defaulted|17|||
164266491|NCT00098722|593344460|FG006|Observation Phase|Participant defaulted|4|||
164266492|NCT00098722|593344454|FG000|Observation Phase|Other|0|||
164341809|NCT01705730|593627508|FG000|Overall Study|Lost to Follow-up|1|||
164341810|NCT01705730|593627508|FG000|Overall Study|Reason not Specified|4|||
164341811|NCT01921387|593627509|FG000|Overall Study|Adverse Event|1|||
164341812|NCT01773733|593627510|FG000|Overall Study|Adverse Event|3286|||
164341813|NCT01773733|593627511|FG001|Overall Study|Adverse Event|540|||
164341814|NCT01773733|593627510|FG000|Overall Study|Pregnancy|28|||
164341815|NCT01773733|593627511|FG001|Overall Study|Pregnancy|0|||
164341816|NCT01773733|593627510|FG000|Overall Study|Other different categories of not compl|55415|||
164341817|NCT01773733|593627511|FG001|Overall Study|Other different categories of not compl|7781|||
164341818|NCT00762229|593627514|FG000|Overall Study|Lost to Follow-up|1|||
164341819|NCT00762229|593627515|FG001|Overall Study|Lost to Follow-up|1|||
164341820|NCT00762229|593627514|FG000|Overall Study|did not recveive intervention|0|||
164341821|NCT00762229|593627515|FG001|Overall Study|did not recveive intervention|1|||
164341822|NCT01081678|593627519|FG000|Overall Study|Ineligibility Determined|0|||
164341823|NCT01081678|593627520|FG001|Overall Study|Ineligibility Determined|0|||
164341824|NCT01081678|593627521|FG002|Overall Study|Ineligibility Determined|1|||
164341825|NCT01081678|593627522|FG003|Overall Study|Ineligibility Determined|1|||
164341826|NCT01081678|593627519|FG000|Overall Study|Noncompliance|3|||
164341827|NCT01081678|593627520|FG001|Overall Study|Noncompliance|4|||
164341828|NCT01081678|593627521|FG002|Overall Study|Noncompliance|5|||
164341829|NCT01081678|593627522|FG003|Overall Study|Noncompliance|2|||
164341830|NCT01081678|593627519|FG000|Overall Study|Adverse Event|2|||
164341831|NCT01081678|593627520|FG001|Overall Study|Adverse Event|1|||
164341832|NCT01081678|593627521|FG002|Overall Study|Adverse Event|2|||
164341833|NCT01081678|593627522|FG003|Overall Study|Adverse Event|2|||
164341834|NCT01081678|593627519|FG000|Overall Study|Withdrawal by Subject|15|||
164341835|NCT01081678|593627520|FG001|Overall Study|Withdrawal by Subject|7|||
164341836|NCT01081678|593627521|FG002|Overall Study|Withdrawal by Subject|17|||
164341837|NCT01081678|593627522|FG003|Overall Study|Withdrawal by Subject|14|||
164341838|NCT01081678|593627519|FG000|Overall Study|Administrative Decision|1|||
164341839|NCT01081678|593627520|FG001|Overall Study|Administrative Decision|0|||
164341840|NCT01081678|593627521|FG002|Overall Study|Administrative Decision|0|||
164341841|NCT01081678|593627522|FG003|Overall Study|Administrative Decision|1|||
164341842|NCT01081678|593627519|FG000|Overall Study|Lost to Follow-up|4|||
164341843|NCT01081678|593627520|FG001|Overall Study|Lost to Follow-up|1|||
164341844|NCT01081678|593627521|FG002|Overall Study|Lost to Follow-up|4|||
164341845|NCT01081678|593627522|FG003|Overall Study|Lost to Follow-up|3|||
164341846|NCT01081678|593627519|FG000|Overall Study|Death|2|||
164686350|NCT01119625|594874917|FG000|Overall Study|Withdrawal by Subject|2|||
164686351|NCT01119625|594874918|FG001|Overall Study|Withdrawal by Subject|1|||
164686352|NCT01119625|594874917|FG000|Overall Study|Other|0|||
164686353|NCT01119625|594874918|FG001|Overall Study|Other|1|||
164686354|NCT01721772|594874923|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
164266493|NCT00098722|593344455|FG001|Observation Phase|Other|0|||
164266494|NCT00098722|593344456|FG002|Observation Phase|Other|0|||
164266495|NCT00098722|593344457|FG003|Observation Phase|Other|0|||
164266496|NCT00098722|593344458|FG004|Observation Phase|Other|0|||
164341847|NCT01081678|593627520|FG001|Overall Study|Death|2|||
164686355|NCT01721772|594874924|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
164341848|NCT01081678|593627521|FG002|Overall Study|Death|2|||
164341849|NCT01081678|593627522|FG003|Overall Study|Death|6|||
164341850|NCT01081678|593627519|FG000|Overall Study|Other|0|||
164341851|NCT01081678|593627520|FG001|Overall Study|Other|1|||
164341852|NCT01081678|593627521|FG002|Overall Study|Other|0|||
164341853|NCT01081678|593627522|FG003|Overall Study|Other|0|||
164341854|NCT01619423|593627525|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
164686356|NCT01721772|594874923|FG000|Pre-Treatment|Poor/non-compliance|0|||
164686357|NCT01721772|594874924|FG001|Pre-Treatment|Poor/non-compliance|1|||
164686358|NCT01721772|594874923|FG000|Pre-Treatment|Participant withdrew consent|0|||
164686359|NCT01721772|594874924|FG001|Pre-Treatment|Participant withdrew consent|1|||
164266497|NCT00098722|593344459|FG005|Observation Phase|Other|21|||
164266498|NCT00098722|593344460|FG006|Observation Phase|Other|10|||
164266499|NCT02046070|593344467|FG000|Overall Study|Progressive Disease|18|||
164266500|NCT02046070|593344468|FG001|Overall Study|Progressive Disease|11|||
164266501|NCT02046070|593344469|FG002|Overall Study|Progressive Disease|40|||
164266502|NCT02046070|593344467|FG000|Overall Study|Adverse Event|8|||
164266503|NCT02046070|593344468|FG001|Overall Study|Adverse Event|10|||
164266504|NCT02046070|593344469|FG002|Overall Study|Adverse Event|17|||
164266505|NCT02046070|593344467|FG000|Overall Study|Withdrawal by Subject|1|||
164266506|NCT02046070|593344468|FG001|Overall Study|Withdrawal by Subject|2|||
164266507|NCT02046070|593344469|FG002|Overall Study|Withdrawal by Subject|6|||
164266508|NCT02046070|593344467|FG000|Overall Study|Study Terminated by Sponsor|1|||
164266509|NCT02046070|593344468|FG001|Overall Study|Study Terminated by Sponsor|1|||
164266510|NCT02046070|593344469|FG002|Overall Study|Study Terminated by Sponsor|1|||
164266511|NCT02046070|593344467|FG000|Overall Study|Reason not Specified|4|||
164266512|NCT02046070|593344468|FG001|Overall Study|Reason not Specified|4|||
164266513|NCT02046070|593344469|FG002|Overall Study|Reason not Specified|6|||
164266514|NCT05601102|593344475|FG000|Overall Study|Death|1|||
164266515|NCT05601102|593344476|FG001|Overall Study|Death|2|||
164266516|NCT05601102|593344475|FG000|Overall Study|Withdrawal by Subject|1|||
164266517|NCT05601102|593344476|FG001|Overall Study|Withdrawal by Subject|1|||
164266518|NCT05601102|593344475|FG000|Overall Study|Lost to Follow-up|0|||
164266519|NCT05601102|593344476|FG001|Overall Study|Lost to Follow-up|2|||
164266520|NCT04284813|593344481|FG000|Overall Study|Withdrawal by Subject|1|||
164266521|NCT01145053|593344487|FG000|Overall Study|Adverse Event|22|||
164266522|NCT01145053|593344487|FG000|Overall Study|Lost to Follow-up|28|||
164266523|NCT01145053|593344487|FG000|Overall Study|Withdrawal by Subject|25|||
164266524|NCT01145053|593344487|FG000|Overall Study|Other|18|||
164266525|NCT00293709|593344488|FG000|Overall Study|Other|47|||
164266526|NCT02785458|593344489|FG000|1 Month|Withdrawal by Subject|2|||
164266527|NCT02785458|593344490|FG001|1 Month|Withdrawal by Subject|1|||
164266528|NCT02785458|593344489|FG000|1 Month|Lost to Follow-up|38|||
164266529|NCT02785458|593344490|FG001|1 Month|Lost to Follow-up|31|||
164266530|NCT02785458|593344489|FG000|1 Month|Deemed Ineligible|1|||
164266531|NCT02785458|593344490|FG001|1 Month|Deemed Ineligible|0|||
164266532|NCT02785458|593344489|FG000|1 Month|Completed Evaluation by Baseline|42|||
164266533|NCT02785458|593344490|FG001|1 Month|Completed Evaluation by Baseline|39|||
164266534|NCT02785458|593344489|FG000|1 Month|Partial Interview|0|||
164266535|NCT02785458|593344490|FG001|1 Month|Partial Interview|4|||
164266536|NCT02785458|593344489|FG000|3 Months|Withdrawal by Subject|3|||
164266537|NCT02785458|593344490|FG001|3 Months|Withdrawal by Subject|1|||
164581117|NCT00430781|594493870|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
164581118|NCT00430781|594493868|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
164581119|NCT00430781|594493869|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
164581120|NCT00430781|594493870|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
164581121|NCT00430781|594493868|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
164581122|NCT00430781|594493869|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
164581123|NCT00430781|594493870|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
164686360|NCT01721772|594874923|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
164686361|NCT01721772|594874924|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
164266538|NCT02785458|593344489|FG000|3 Months|Lost to Follow-up|25|||
164266539|NCT02785458|593344490|FG001|3 Months|Lost to Follow-up|21|||
164266540|NCT02785458|593344489|FG000|3 Months|Completed Evaluation at 1 Month|100|||
164266541|NCT02785458|593344490|FG001|3 Months|Completed Evaluation at 1 Month|89|||
164266542|NCT01146652|593344491|FG000|Overall Study|Adverse Event|506|||
164266543|NCT01146652|593344492|FG001|Overall Study|Adverse Event|15|||
164266544|NCT01146652|593344491|FG000|Overall Study|Lack of Efficacy|91|||
164341855|NCT01619423|593627526|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
164686362|NCT01721772|594874923|FG000|Treatment|Disease progression|119|||
164266545|NCT01146652|593344492|FG001|Overall Study|Lack of Efficacy|7|||
164266546|NCT01146652|593344491|FG000|Overall Study|Poor compliance to protocol|38|||
164266547|NCT01146652|593344492|FG001|Overall Study|Poor compliance to protocol|1|||
164266548|NCT01146652|593344491|FG000|Overall Study|Other unspecified reasons|314|||
164266549|NCT01146652|593344492|FG001|Overall Study|Other unspecified reasons|22|||
164266550|NCT01146652|593344491|FG000|Overall Study|Enrolled but not treated|2|||
164341856|NCT01619423|593627527|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
164266551|NCT01146652|593344492|FG001|Overall Study|Enrolled but not treated|0|||
164266552|NCT02590562|593344500|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
164341857|NCT01619423|593627528|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
164266553|NCT01457950|593344501|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
164266554|NCT01457950|593344502|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
164266555|NCT01457950|593344503|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
164341858|NCT01281865|593627531|FG000|Overall Study|Adverse Event|1|||
164266556|NCT01457950|593344504|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
164266557|NCT01457950|593344501|FG000|Double-Blind Phase|Protocol Violation|2|||
164266558|NCT01457950|593344502|FG001|Double-Blind Phase|Protocol Violation|1|||
164266559|NCT01457950|593344503|FG002|Double-Blind Phase|Protocol Violation|0|||
164266560|NCT01457950|593344504|FG003|Double-Blind Phase|Protocol Violation|0|||
164266561|NCT01457950|593344501|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
164266562|NCT01457950|593344502|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
164266563|NCT01457950|593344503|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
164266564|NCT01457950|593344504|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
164266565|NCT01457950|593344501|FG000|Open-Label Phase|Adverse Event|0|||
164266566|NCT01457950|593344502|FG001|Open-Label Phase|Adverse Event|0|||
164266567|NCT01457950|593344503|FG002|Open-Label Phase|Adverse Event|0|||
164266568|NCT01457950|593344504|FG003|Open-Label Phase|Adverse Event|1|||
164266569|NCT01457950|593344501|FG000|Open-Label Phase|Protocol Violation|0|||
164266570|NCT01457950|593344502|FG001|Open-Label Phase|Protocol Violation|0|||
164266571|NCT01457950|593344503|FG002|Open-Label Phase|Protocol Violation|0|||
164266572|NCT01457950|593344504|FG003|Open-Label Phase|Protocol Violation|1|||
164266573|NCT01457950|593344501|FG000|Open-Label Phase|Withdrawal by Subject|0|||
164266574|NCT01457950|593344502|FG001|Open-Label Phase|Withdrawal by Subject|0|||
164266575|NCT01457950|593344503|FG002|Open-Label Phase|Withdrawal by Subject|2|||
164266576|NCT01457950|593344504|FG003|Open-Label Phase|Withdrawal by Subject|0|||
164266577|NCT03351114|593344507|FG000|Overall Study|Withdrawal by Subject|1|||
164266578|NCT03249935|593344511|FG000|Overall Study|Discharged from facility early|36|||
164266579|NCT03249935|593344511|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
164266580|NCT03249935|593344511|FG000|Overall Study|Protocol Violation|5|||
164266581|NCT00989235|593344512|FG000|Overall Study|Death|0|||
164266582|NCT00989235|593344513|FG001|Overall Study|Death|1|||
164581124|NCT05098015|594493874|FG000|Overall Study|Death|1|||
164581125|NCT05098015|594493875|FG001|Overall Study|Death|1|||
164581126|NCT05098015|594493876|FG002|Overall Study|Death|3|||
164581127|NCT05098015|594493877|FG003|Overall Study|Death|0|||
164581128|NCT05098015|594493874|FG000|Overall Study|Lost to Follow-up|1|||
164581129|NCT05098015|594493875|FG001|Overall Study|Lost to Follow-up|1|||
164581130|NCT05098015|594493876|FG002|Overall Study|Lost to Follow-up|3|||
164581131|NCT05098015|594493877|FG003|Overall Study|Lost to Follow-up|3|||
164581132|NCT05098015|594493874|FG000|Overall Study|Withdrawal by Subject|0|||
164581133|NCT05098015|594493875|FG001|Overall Study|Withdrawal by Subject|1|||
164581134|NCT05098015|594493876|FG002|Overall Study|Withdrawal by Subject|0|||
164266583|NCT00989235|593344512|FG000|Overall Study|Adverse Event|0|||
164266584|NCT00989235|593344513|FG001|Overall Study|Adverse Event|1|||
164266585|NCT00989235|593344512|FG000|Overall Study|Lack of Efficacy|1|||
164266586|NCT00989235|593344513|FG001|Overall Study|Lack of Efficacy|0|||
164266587|NCT00989235|593344512|FG000|Overall Study|Withdrawal of Consent|1|||
164266588|NCT00989235|593344513|FG001|Overall Study|Withdrawal of Consent|1|||
164266589|NCT00989235|593344512|FG000|Overall Study|Desire to Become Pregnant|1|||
164266590|NCT00989235|593344513|FG001|Overall Study|Desire to Become Pregnant|0|||
164266591|NCT00989235|593344512|FG000|Overall Study|Randomized by Mistake|0|||
164266592|NCT00989235|593344513|FG001|Overall Study|Randomized by Mistake|2|||
164266593|NCT00989235|593344512|FG000|Overall Study|Lost to Follow-up|0|||
164266594|NCT00989235|593344513|FG001|Overall Study|Lost to Follow-up|1|||
164266595|NCT01352741|593344519|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
164266596|NCT01352741|593344520|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
164266597|NCT01352741|593344519|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
164266598|NCT01352741|593344520|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
164266599|NCT01352741|593344519|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
164266600|NCT01352741|593344520|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
164266601|NCT01352741|593344519|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
164266602|NCT01352741|593344520|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
164266603|NCT01352741|593344519|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
164266604|NCT01352741|593344520|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
164266605|NCT01352741|593344519|FG000|Open-label Tapentadol Titration Period|Other|4|||
164266606|NCT01352741|593344520|FG001|Open-label Tapentadol Titration Period|Other|0|||
164266607|NCT01352741|593344519|FG000|Double-blind Comparative Period|Protocol Violation|2|||
164266608|NCT01352741|593344520|FG001|Double-blind Comparative Period|Protocol Violation|0|||
164266609|NCT01352741|593344519|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
164266610|NCT01352741|593344520|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
164266611|NCT01352741|593344519|FG000|Double-blind Comparative Period|Adverse Event|16|||
164266612|NCT01352741|593344520|FG001|Double-blind Comparative Period|Adverse Event|17|||
164266613|NCT01352741|593344519|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
164266614|NCT01352741|593344520|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
164266615|NCT01352741|593344519|FG000|Double-blind Comparative Period|Death|0|||
164581135|NCT05098015|594493877|FG003|Overall Study|Withdrawal by Subject|2|||
164581136|NCT05655832|594493887|FG000|Overall Study|Not mentioned|0|||
164581137|NCT05655832|594493888|FG001|Overall Study|Not mentioned|1|||
164266616|NCT01352741|593344520|FG001|Double-blind Comparative Period|Death|1|||
164266617|NCT01352741|593344519|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
164266618|NCT01352741|593344520|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
164266619|NCT01352741|593344519|FG000|Double-blind Comparative Period|Other|1|||
164266620|NCT01352741|593344520|FG001|Double-blind Comparative Period|Other|2|||
164266621|NCT01352741|593344519|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
164266622|NCT01352741|593344520|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
164266623|NCT01352741|593344519|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
164266624|NCT01352741|593344520|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
164266625|NCT01352741|593344519|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
164266626|NCT01352741|593344520|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
164266627|NCT01352741|593344519|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
164266628|NCT01352741|593344520|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
164266629|NCT04070326|593344522|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
164266630|NCT04070326|593344523|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
164266631|NCT00645528|593344524|FG000|Overall Study|Did not show up for Visit 2|7|||
164266632|NCT01367704|593344525|FG000|Overall Study|Lost to Follow-up|47|||
164266633|NCT01367704|593344526|FG001|Overall Study|Lost to Follow-up|161|||
164266634|NCT03077698|593344529|FG000|Progestin Monotherapy|Stable Disease|8|||
164266635|NCT03077698|593344530|FG001|Progestin Monotherapy|Stable Disease|0|||
164266636|NCT03077698|593344529|FG000|Progestin Monotherapy|Adverse Event|1|||
164266637|NCT03077698|593344530|FG001|Progestin Monotherapy|Adverse Event|0|||
164266638|NCT03077698|593344529|FG000|Progestin Monotherapy|Death|1|||
164686363|NCT01721772|594874924|FG001|Treatment|Disease progression|168|||
164686364|NCT01721772|594874923|FG000|Treatment|Study drug toxicity|19|||
164686365|NCT01721772|594874924|FG001|Treatment|Study drug toxicity|10|||
164686366|NCT01721772|594874923|FG000|Treatment|Adverse event unrelated to study drug|7|||
164686367|NCT01721772|594874924|FG001|Treatment|Adverse event unrelated to study drug|7|||
164686368|NCT01721772|594874923|FG000|Treatment|Maximum clinical benefit|16|||
164686369|NCT01721772|594874924|FG001|Treatment|Maximum clinical benefit|4|||
164686370|NCT01721772|594874923|FG000|Treatment|Other|19|||
164266639|NCT03077698|593344530|FG001|Progestin Monotherapy|Death|0|||
164266640|NCT03077698|593344529|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
164266641|NCT03077698|593344530|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
164266642|NCT03077698|593344529|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
164266643|NCT03077698|593344530|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
164266644|NCT03077698|593344529|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
164266645|NCT03077698|593344530|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
164266646|NCT03077698|593344529|FG000|Safety Follow Up|Withdrawal by Subject|2|||
164266647|NCT03077698|593344530|FG001|Safety Follow Up|Withdrawal by Subject|1|||
164266648|NCT03077698|593344529|FG000|Safety Follow Up|Transfer of care to hospice|1|||
164266649|NCT03077698|593344530|FG001|Safety Follow Up|Transfer of care to hospice|0|||
164266650|NCT03461406|593344532|FG000|Overall Study|Death|1|||
164266651|NCT03461406|593344533|FG001|Overall Study|Death|2|||
164266652|NCT03461406|593344532|FG000|Overall Study|Consent Withdrawn by Participant|0|||
164266653|NCT03461406|593344533|FG001|Overall Study|Consent Withdrawn by Participant|1|||
164266654|NCT03461406|593344532|FG000|Overall Study|Screen Failure|3|||
164266655|NCT03461406|593344533|FG001|Overall Study|Screen Failure|1|||
164266656|NCT03461406|593344532|FG000|Overall Study|Reason not Specified|1|||
164266657|NCT03461406|593344533|FG001|Overall Study|Reason not Specified|3|||
164266658|NCT03461406|593344532|FG000|Overall Study|Lost to Follow-up|3|||
164266659|NCT03461406|593344533|FG001|Overall Study|Lost to Follow-up|0|||
164266660|NCT01140568|593344534|FG000|Overall Study|disease progression|31|||
164266661|NCT01140568|593344534|FG000|Overall Study|Withdrawal by Subject|1|||
164266662|NCT01140568|593344534|FG000|Overall Study|Screen Fail|4|||
164266663|NCT03618628|593344535|FG000|Overall Study|Death|1|||
164266664|NCT03618628|593344535|FG000|Overall Study|Lost to Follow-up|1|||
164266665|NCT01969500|593344536|FG000|Overall Study|Death|0|||
164266666|NCT01969500|593344537|FG001|Overall Study|Death|1|||
164266667|NCT01969500|593344536|FG000|Overall Study|extended hospitalization|1|||
164266668|NCT01969500|593344537|FG001|Overall Study|extended hospitalization|1|||
164686371|NCT01721772|594874924|FG001|Treatment|Other|2|||
164686372|NCT01721772|594874923|FG000|Treatment|Participant withdrew consent|2|||
164686373|NCT01721772|594874924|FG001|Treatment|Participant withdrew consent|5|||
164686374|NCT01721772|594874923|FG000|Treatment|Participant request to discontinue study treatment|21|||
164686375|NCT01721772|594874924|FG001|Treatment|Participant request to discontinue study treatment|8|||
164266669|NCT02193087|593344538|FG000|Overall Study|Adverse Event|2|||
164266670|NCT02193087|593344539|FG001|Overall Study|Adverse Event|0|||
164266671|NCT02193087|593344540|FG002|Overall Study|Adverse Event|0|||
164266672|NCT02193087|593344541|FG003|Overall Study|Adverse Event|11|||
164266673|NCT02193087|593344538|FG000|Overall Study|Lost to Follow-up|14|||
164266674|NCT02193087|593344539|FG001|Overall Study|Lost to Follow-up|6|||
164686376|NCT01721772|594874923|FG000|Treatment|Death|1|||
164686377|NCT01721772|594874924|FG001|Treatment|Death|0|||
164266675|NCT02193087|593344540|FG002|Overall Study|Lost to Follow-up|4|||
164266676|NCT02193087|593344541|FG003|Overall Study|Lost to Follow-up|37|||
164266677|NCT02193087|593344538|FG000|Overall Study|Protocol Violation|2|||
164266678|NCT02193087|593344539|FG001|Overall Study|Protocol Violation|0|||
164266679|NCT02193087|593344540|FG002|Overall Study|Protocol Violation|1|||
164266680|NCT02193087|593344541|FG003|Overall Study|Protocol Violation|2|||
164266681|NCT02193087|593344538|FG000|Overall Study|Withdrawal by Subject|10|||
164266682|NCT02193087|593344539|FG001|Overall Study|Withdrawal by Subject|3|||
164266683|NCT02193087|593344540|FG002|Overall Study|Withdrawal by Subject|1|||
164266684|NCT02193087|593344541|FG003|Overall Study|Withdrawal by Subject|19|||
164266685|NCT02193087|593344538|FG000|Overall Study|Other Reason Not Specified|7|||
164266686|NCT02193087|593344539|FG001|Overall Study|Other Reason Not Specified|2|||
164266687|NCT02193087|593344540|FG002|Overall Study|Other Reason Not Specified|1|||
164266688|NCT02193087|593344541|FG003|Overall Study|Other Reason Not Specified|9|||
164266689|NCT02193087|593344538|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
164266690|NCT02193087|593344539|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
164266691|NCT02193087|593344540|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
164266692|NCT02193087|593344541|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
164266693|NCT04096820|593344542|FG000|Overall Study|Did not return for intervention|2|||
164266694|NCT04096820|593344542|FG000|Overall Study|Death|1|||
164266695|NCT01241760|593344543|FG000|Overall Study|Adverse Event|1|||
164266696|NCT01241760|593344544|FG001|Overall Study|Adverse Event|0|||
164266697|NCT01241760|593344543|FG000|Overall Study|Lost to Follow-up|18|||
164266698|NCT01241760|593344544|FG001|Overall Study|Lost to Follow-up|22|||
164266699|NCT01241760|593344543|FG000|Overall Study|Withdrawal by Subject|13|||
164266700|NCT01241760|593344544|FG001|Overall Study|Withdrawal by Subject|13|||
164266701|NCT01241760|593344543|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
164266702|NCT01241760|593344544|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
164266703|NCT01241760|593344543|FG000|Overall Study|Other|1|||
164266704|NCT01241760|593344544|FG001|Overall Study|Other|1|||
164266705|NCT01636713|593344546|FG000|Overall Study|Adverse Event|16|||
164266706|NCT01636713|593344547|FG001|Overall Study|Adverse Event|16|||
164266707|NCT01636713|593344548|FG002|Overall Study|Adverse Event|7|||
164266708|NCT01636713|593344546|FG000|Overall Study|Lack of Efficacy|6|||
164266709|NCT01636713|593344547|FG001|Overall Study|Lack of Efficacy|6|||
164266710|NCT01636713|593344548|FG002|Overall Study|Lack of Efficacy|2|||
164266711|NCT01636713|593344546|FG000|Overall Study|Protocol Violation|3|||
164266712|NCT01636713|593344547|FG001|Overall Study|Protocol Violation|0|||
164266713|NCT01636713|593344548|FG002|Overall Study|Protocol Violation|1|||
164266714|NCT01636713|593344546|FG000|Overall Study|Lost to Follow-up|0|||
164266715|NCT01636713|593344547|FG001|Overall Study|Lost to Follow-up|0|||
164266716|NCT01636713|593344548|FG002|Overall Study|Lost to Follow-up|1|||
164266717|NCT01636713|593344546|FG000|Overall Study|Withdrawal by Subject|5|||
164266718|NCT01636713|593344547|FG001|Overall Study|Withdrawal by Subject|4|||
164266719|NCT01636713|593344548|FG002|Overall Study|Withdrawal by Subject|8|||
164266720|NCT01636713|593344546|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
164266721|NCT01636713|593344547|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
164266722|NCT01636713|593344548|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
164266723|NCT00276614|593344551|FG000|Overall Study|Progression of disease under study|3|||
164266724|NCT02117349|593344554|FG000|Overall Study|Withdrawal by Subject|1|||
164266725|NCT02117349|593344555|FG001|Overall Study|Withdrawal by Subject|0|||
164266726|NCT02117349|593344554|FG000|Overall Study|Lost to Follow-up|1|||
164266727|NCT02117349|593344555|FG001|Overall Study|Lost to Follow-up|1|||
164266728|NCT02117349|593344554|FG000|Overall Study|Death|1|||
164266729|NCT02117349|593344555|FG001|Overall Study|Death|0|||
164266730|NCT01977690|593344558|FG000|Overall Study|Withdrawal by Subject|0|||
164266731|NCT01977690|593344559|FG001|Overall Study|Withdrawal by Subject|4|||
164266732|NCT01711866|593344562|FG000|Overall Study|Noncompliant|3|||
164266733|NCT01711866|593344562|FG000|Overall Study|Withdrawal by Subject|3|||
164266734|NCT01711866|593344562|FG000|Overall Study|Adverse Event|2|||
164266735|NCT00456599|593344563|FG000|Overall Study|Non-compliance|1|||
164266736|NCT00456599|593344563|FG000|Overall Study|Withdrawal by Subject|2|||
164266737|NCT00260065|593344564|FG000|Overall Study|Progressive Disease|22|||
164266738|NCT00260065|593344564|FG000|Overall Study|Adverse Event|17|||
164266739|NCT00260065|593344564|FG000|Overall Study|Death|13|||
164266740|NCT00260065|593344564|FG000|Overall Study|Withdrawal by Subject|13|||
164266741|NCT00260065|593344564|FG000|Overall Study|Physician Decision|19|||
164266742|NCT00260065|593344564|FG000|Overall Study|Not otherwise specified|8|||
164266743|NCT00260065|593344564|FG000|Overall Study|Medication Noncompliance|1|||
164266744|NCT03780959|593344570|FG000|Part 1|Adverse Event|1|||
164266745|NCT03780959|593344571|FG001|Part 1|Adverse Event|0|||
164266746|NCT03780959|593344572|FG002|Part 1|Adverse Event|0|||
164266747|NCT03780959|593344570|FG000|Part 1|Withdrawal by Subject|1|||
164266748|NCT03780959|593344571|FG001|Part 1|Withdrawal by Subject|0|||
164266749|NCT03780959|593344572|FG002|Part 1|Withdrawal by Subject|0|||
164266750|NCT03780959|593344570|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
164266751|NCT03780959|593344571|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
164266752|NCT03780959|593344572|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
164266753|NCT03780959|593344570|FG000|Part 1|Response Status|2|||
164266754|NCT03780959|593344571|FG001|Part 1|Response Status|0|||
164266755|NCT03780959|593344572|FG002|Part 1|Response Status|0|||
164266756|NCT03780959|593344570|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
164266757|NCT03780959|593344571|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
164266758|NCT03780959|593344572|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
164266759|NCT03780959|593344570|FG000|Part 2|Response Status|0|||
164266760|NCT03780959|593344571|FG001|Part 2|Response Status|18|||
164266761|NCT03780959|593344572|FG002|Part 2|Response Status|6|||
164266762|NCT02831933|593346075|FG000|Overall Study|Physician Decision|11|||
164266763|NCT00358436|593346082|FG000|Overall Study|Adverse Event|29|||
164266764|NCT00358436|593346083|FG001|Overall Study|Adverse Event|13|||
164266765|NCT00358436|593346082|FG000|Overall Study|Lack of Efficacy|34|||
164266766|NCT00358436|593346083|FG001|Overall Study|Lack of Efficacy|36|||
164266767|NCT00358436|593346082|FG000|Overall Study|Lost to Follow-up|11|||
164266768|NCT00358436|593346083|FG001|Overall Study|Lost to Follow-up|6|||
164266769|NCT00358436|593346082|FG000|Overall Study|Protocol Violation|8|||
164266770|NCT00358436|593346083|FG001|Overall Study|Protocol Violation|3|||
164266771|NCT00358436|593346082|FG000|Overall Study|Withdrawal by Subject|40|||
164266772|NCT00358436|593346083|FG001|Overall Study|Withdrawal by Subject|17|||
164266773|NCT00358436|593346082|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
164266774|NCT00358436|593346083|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
164266775|NCT00358436|593346082|FG000|Overall Study|COPD exacerbation|22|||
164266776|NCT00358436|593346083|FG001|Overall Study|COPD exacerbation|10|||
164266777|NCT00358436|593346082|FG000|Overall Study|Other|6|||
164266778|NCT00358436|593346083|FG001|Overall Study|Other|1|||
164266779|NCT05065190|593346085|FG000|Overall Study|Other than listed|2|||
164266780|NCT05065190|593346086|FG001|Overall Study|Other than listed|12|||
164686378|NCT01721772|594874923|FG000|Treatment|Not reported|1|||
164686379|NCT01721772|594874924|FG001|Treatment|Not reported|0|||
164686380|NCT01721772|594874923|FG000|Treatment|Poor/non-compliance|1|||
164686381|NCT01721772|594874924|FG001|Treatment|Poor/non-compliance|0|||
164686382|NCT01721772|594874923|FG000|Treatment|Lost to Follow-up|0|||
164686383|NCT01721772|594874924|FG001|Treatment|Lost to Follow-up|1|||
164686384|NCT04542694|594874925|FG000|Overall Study|The need for prohibited therapy|2|||
164686385|NCT04542694|594874926|FG001|Overall Study|The need for prohibited therapy|0|||
164686386|NCT04542694|594874925|FG000|Overall Study|Adverse Event|1|||
164686387|NCT04542694|594874926|FG001|Overall Study|Adverse Event|0|||
164686388|NCT04542694|594874925|FG000|Overall Study|Protocol Violation|1|||
164686389|NCT04542694|594874926|FG001|Overall Study|Protocol Violation|0|||
164686390|NCT04633642|594874929|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
164686391|NCT04633642|594874930|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
164686392|NCT00611884|594874931|FG000|Overall Study|Adverse Event|1|||
164686393|NCT00611884|594874932|FG001|Overall Study|Adverse Event|0|||
164686394|NCT00611884|594874933|FG002|Overall Study|Adverse Event|0|||
164686395|NCT00611884|594874934|FG003|Overall Study|Adverse Event|1|||
164686396|NCT00611884|594874931|FG000|Overall Study|Non-Compliance|1|||
164686397|NCT00611884|594874932|FG001|Overall Study|Non-Compliance|4|||
164686398|NCT00611884|594874933|FG002|Overall Study|Non-Compliance|2|||
164686399|NCT00611884|594874934|FG003|Overall Study|Non-Compliance|2|||
164686400|NCT00611884|594874931|FG000|Overall Study|Lack of Efficacy|0|||
164686401|NCT00611884|594874932|FG001|Overall Study|Lack of Efficacy|1|||
164686402|NCT00611884|594874933|FG002|Overall Study|Lack of Efficacy|0|||
164686403|NCT00611884|594874934|FG003|Overall Study|Lack of Efficacy|0|||
164686404|NCT00611884|594874931|FG000|Overall Study|Unclassified|7|||
164686405|NCT00611884|594874932|FG001|Overall Study|Unclassified|4|||
164686406|NCT00611884|594874933|FG002|Overall Study|Unclassified|2|||
164686407|NCT00611884|594874934|FG003|Overall Study|Unclassified|3|||
164686408|NCT00981799|594874935|FG000|Overall Study|Adverse Event|1|||
164686409|NCT00981799|594874936|FG001|Overall Study|Adverse Event|1|||
164686410|NCT00981799|594874937|FG002|Overall Study|Adverse Event|0|||
164686411|NCT00981799|594874938|FG003|Overall Study|Adverse Event|0|||
164686412|NCT05387408|594874939|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
164686413|NCT04697173|594874943|FG000|Overall Study|Withdrawal by Subject|34|||
164266781|NCT05065190|593346085|FG000|Overall Study|Lack of Efficacy|4|||
164266782|NCT05065190|593346086|FG001|Overall Study|Lack of Efficacy|0|||
164266783|NCT05065190|593346085|FG000|Overall Study|Adverse Event|1|||
164266784|NCT05065190|593346086|FG001|Overall Study|Adverse Event|10|||
164266785|NCT02769962|593346094|FG000|Overall Study|Physician Decision|0|||
164266786|NCT02769962|593346095|FG001|Overall Study|Physician Decision|0|||
164266787|NCT02769962|593346096|FG002|Overall Study|Physician Decision|0|||
164266788|NCT02769962|593346097|FG003|Overall Study|Physician Decision|0|||
164266789|NCT02769962|593346098|FG004|Overall Study|Physician Decision|0|||
164686414|NCT04697173|594874944|FG001|Overall Study|Withdrawal by Subject|38|||
164686415|NCT01055834|594874945|FG000|Treatment Period I|Adverse Event|1|||
164686416|NCT01055834|594874946|FG001|Treatment Period I|Adverse Event|0|||
164686417|NCT01943435|594874947|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
164266790|NCT02769962|593346099|FG005|Overall Study|Physician Decision|1|||
164686418|NCT01943435|594874948|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
164686419|NCT01943435|594874949|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
164686420|NCT01943435|594874947|FG000|Intervention Period|Withdrawal by Subject|3|||
164686421|NCT01943435|594874948|FG001|Intervention Period|Withdrawal by Subject|3|||
164686422|NCT01943435|594874949|FG002|Intervention Period|Withdrawal by Subject|4|||
164686423|NCT01943435|594874947|FG000|2 Month Follow up|Lost to Follow-up|2|||
164686424|NCT01943435|594874948|FG001|2 Month Follow up|Lost to Follow-up|3|||
164686425|NCT01943435|594874949|FG002|2 Month Follow up|Lost to Follow-up|0|||
164686426|NCT01943435|594874947|FG000|6 Month Follow up|Lost to Follow-up|12|||
164686427|NCT01943435|594874948|FG001|6 Month Follow up|Lost to Follow-up|7|||
164686428|NCT01943435|594874949|FG002|6 Month Follow up|Lost to Follow-up|15|||
164686429|NCT04535986|594874950|FG000|Overall Study|Death|4|||
164266791|NCT02769962|593346100|FG006|Overall Study|Physician Decision|0|||
164266792|NCT02769962|593346101|FG007|Overall Study|Physician Decision|1|||
164266793|NCT02769962|593346094|FG000|Overall Study|Refused further treatment|0|||
164266794|NCT02769962|593346095|FG001|Overall Study|Refused further treatment|0|||
164266795|NCT02769962|593346096|FG002|Overall Study|Refused further treatment|0|||
164266796|NCT02769962|593346097|FG003|Overall Study|Refused further treatment|0|||
164266797|NCT02769962|593346098|FG004|Overall Study|Refused further treatment|0|||
164266798|NCT02769962|593346099|FG005|Overall Study|Refused further treatment|1|||
164266799|NCT02769962|593346100|FG006|Overall Study|Refused further treatment|1|||
164266800|NCT02769962|593346101|FG007|Overall Study|Refused further treatment|0|||
164266801|NCT05565937|593346102|FG000|Overall Study|Adverse Event|0|||
164266802|NCT05565937|593346103|FG001|Overall Study|Adverse Event|1|||
164266803|NCT05565937|593346102|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
164266804|NCT05565937|593346103|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
164266805|NCT05565937|593346102|FG000|Overall Study|Lost to Follow-up|2|||
164266806|NCT05565937|593346103|FG001|Overall Study|Lost to Follow-up|0|||
164266807|NCT05565937|593346102|FG000|Overall Study|Pregnancy|0|||
164266808|NCT05565937|593346103|FG001|Overall Study|Pregnancy|2|||
164266809|NCT05565937|593346102|FG000|Overall Study|Anisometropia|0|||
164266810|NCT05565937|593346103|FG001|Overall Study|Anisometropia|1|||
164266811|NCT04544683|593346104|FG000|Overall Study|Lost to Follow-up|2|||
164266812|NCT04544683|593346104|FG000|Overall Study|Underwent cervical spine surgery|6|||
164266813|NCT00151372|593346105|FG000|Overall Study|Death|12|||
164266814|NCT00151372|593346106|FG001|Overall Study|Death|11|||
164266815|NCT00151372|593346105|FG000|Overall Study|Lost to Follow-up|5|||
164266816|NCT00151372|593346106|FG001|Overall Study|Lost to Follow-up|5|||
164266817|NCT00151372|593346105|FG000|Overall Study|Too sick medically to continue|5|||
164266818|NCT00151372|593346106|FG001|Overall Study|Too sick medically to continue|6|||
164266819|NCT00151372|593346105|FG000|Overall Study|Withdrawal by Subject|7|||
164266820|NCT00151372|593346106|FG001|Overall Study|Withdrawal by Subject|7|||
164266821|NCT04732949|593346109|FG000|Overall Study|Withdrawal by Subject|23|||
164266822|NCT04732949|593346110|FG001|Overall Study|Withdrawal by Subject|27|||
164266823|NCT04732949|593346109|FG000|Overall Study|Protocol Violation|0|||
164266824|NCT04732949|593346110|FG001|Overall Study|Protocol Violation|1|||
164266825|NCT04732949|593346109|FG000|Overall Study|Non-compliance|0|||
164266826|NCT04732949|593346110|FG001|Overall Study|Non-compliance|2|||
164266827|NCT04732949|593346109|FG000|Overall Study|Physician Decision|2|||
164266828|NCT04732949|593346110|FG001|Overall Study|Physician Decision|1|||
164266829|NCT04732949|593346109|FG000|Overall Study|Serious adverse event (Fatal)|16|||
164266830|NCT04732949|593346110|FG001|Overall Study|Serious adverse event (Fatal)|18|||
164266831|NCT04732949|593346109|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
164266832|NCT04732949|593346110|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
164266833|NCT04732949|593346109|FG000|Overall Study|Non-serious adverse event|1|||
164266834|NCT04732949|593346110|FG001|Overall Study|Non-serious adverse event|3|||
164266835|NCT04732949|593346109|FG000|Overall Study|Lost to Follow-up|26|||
164266836|NCT04732949|593346110|FG001|Overall Study|Lost to Follow-up|27|||
164266837|NCT04732949|593346109|FG000|Overall Study|Other|6|||
164266838|NCT04732949|593346110|FG001|Overall Study|Other|3|||
164266839|NCT01023672|593346111|FG000|Overall Study|Worsening disease|2|||
164266840|NCT01023672|593346111|FG000|Overall Study|Death|1|||
164266841|NCT01286077|593346112|FG000|Overall Study|Adverse Event|2|||
164266842|NCT01286077|593346113|FG001|Overall Study|Adverse Event|0|||
164266843|NCT01286077|593346112|FG000|Overall Study|Death|1|||
164266844|NCT01286077|593346113|FG001|Overall Study|Death|0|||
164266845|NCT01286077|593346112|FG000|Overall Study|Protocol Violation|1|||
164266846|NCT01286077|593346113|FG001|Overall Study|Protocol Violation|1|||
164686430|NCT04535986|594874951|FG001|Overall Study|Death|5|||
164686431|NCT04535986|594874950|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
164686432|NCT04535986|594874951|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
164266847|NCT01286077|593346112|FG000|Overall Study|Withdrawal by Subject|0|||
164266848|NCT01286077|593346113|FG001|Overall Study|Withdrawal by Subject|2|||
164686433|NCT04535986|594874950|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
164686434|NCT04535986|594874951|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
164266849|NCT01286077|593346112|FG000|Overall Study|Intercurrent illness|1|||
164266850|NCT01286077|593346113|FG001|Overall Study|Intercurrent illness|0|||
164581138|NCT05655832|594493887|FG000|Overall Study|Withdrawal by Subject|0|||
164581139|NCT05655832|594493888|FG001|Overall Study|Withdrawal by Subject|1|||
164581140|NCT05655832|594493887|FG000|Overall Study|Protocol non-compliance|0|||
164581141|NCT05655832|594493888|FG001|Overall Study|Protocol non-compliance|1|||
164581142|NCT04516967|594493891|FG000|Core Phase|Adverse Event|2|||
164581143|NCT04516967|594493892|FG001|Core Phase|Adverse Event|1|||
164581144|NCT04516967|594493893|FG002|Core Phase|Adverse Event|0|||
164581145|NCT04516967|594493891|FG000|Core Phase|Physician Decision|1|||
164581146|NCT04516967|594493892|FG001|Core Phase|Physician Decision|1|||
164581147|NCT04516967|594493893|FG002|Core Phase|Physician Decision|0|||
164581148|NCT04516967|594493891|FG000|Core Phase|Lack of Efficacy|7|||
164581149|NCT04516967|594493892|FG001|Core Phase|Lack of Efficacy|18|||
164581150|NCT04516967|594493893|FG002|Core Phase|Lack of Efficacy|0|||
164581151|NCT01702805|594493894|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
164581152|NCT01702805|594493895|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
164581153|NCT01702805|594493894|FG000|Overall Study|Incomplete Follow-up|18|||
164581154|NCT01702805|594493895|FG001|Overall Study|Incomplete Follow-up|15|||
164581155|NCT01702805|594493894|FG000|Overall Study|Vital Status Assessment Only|40|||
164581156|NCT01702805|594493895|FG001|Overall Study|Vital Status Assessment Only|39|||
164581157|NCT01702805|594493894|FG000|Overall Study|Lost to Follow-up|5|||
164581158|NCT01702805|594493895|FG001|Overall Study|Lost to Follow-up|5|||
164581159|NCT03056287|594493896|FG000|Overall Study|Withdrawal by Subject|0|||
164581160|NCT03056287|594493897|FG001|Overall Study|Withdrawal by Subject|1|||
164581161|NCT03056287|594493898|FG002|Overall Study|Withdrawal by Subject|0|||
164581162|NCT03056287|594493899|FG003|Overall Study|Withdrawal by Subject|0|||
164581163|NCT03056287|594493896|FG000|Overall Study|move out of area|0|||
164581164|NCT03056287|594493897|FG001|Overall Study|move out of area|0|||
164581165|NCT03056287|594493898|FG002|Overall Study|move out of area|1|||
164581166|NCT03056287|594493899|FG003|Overall Study|move out of area|1|||
164581167|NCT05916170|594493900|FG000|No Warning Control|Lost to Follow-up|12|||
164581168|NCT05916170|594493900|FG000|No Warning Control|Withdrawal by Subject|15|||
164581169|NCT05916170|594493900|FG000|No Warning Control|Noncompliance with protocol|1|||
164581170|NCT05916170|594493900|FG000|Health Warning Intervention|Lost to Follow-up|15|||
164581171|NCT05916170|594493900|FG000|Health Warning Intervention|Withdrawal by Subject|10|||
164581172|NCT05916170|594493900|FG000|Health Warning Intervention|Noncompliance with protocol|14|||
164581173|NCT04576949|594493901|FG000|Overall Study|Adverse Event|1|||
164581174|NCT04576949|594493902|FG001|Overall Study|Adverse Event|3|||
164581175|NCT04576949|594493903|FG002|Overall Study|Adverse Event|2|||
164581176|NCT04576949|594493901|FG000|Overall Study|Withdrawal by Subject|41|||
164581177|NCT04576949|594493902|FG001|Overall Study|Withdrawal by Subject|26|||
164581178|NCT04576949|594493903|FG002|Overall Study|Withdrawal by Subject|18|||
164581179|NCT04576949|594493901|FG000|Overall Study|Physician Decision|3|||
164581180|NCT04576949|594493902|FG001|Overall Study|Physician Decision|0|||
164581181|NCT04576949|594493903|FG002|Overall Study|Physician Decision|0|||
164581182|NCT04576949|594493901|FG000|Overall Study|Death|0|||
164581183|NCT04576949|594493902|FG001|Overall Study|Death|1|||
164581184|NCT04576949|594493903|FG002|Overall Study|Death|0|||
164581185|NCT04576949|594493901|FG000|Overall Study|Lost to Follow-up|29|||
164581186|NCT04576949|594493902|FG001|Overall Study|Lost to Follow-up|37|||
164581187|NCT04576949|594493903|FG002|Overall Study|Lost to Follow-up|24|||
164581188|NCT04576949|594493901|FG000|Overall Study|Other, Not Specified|2|||
164581189|NCT04576949|594493902|FG001|Overall Study|Other, Not Specified|3|||
164581190|NCT04576949|594493903|FG002|Overall Study|Other, Not Specified|1|||
164581191|NCT04576949|594493901|FG000|Overall Study|Other|1|||
164581192|NCT04576949|594493902|FG001|Overall Study|Other|0|||
164581193|NCT04576949|594493903|FG002|Overall Study|Other|0|||
164581194|NCT03556904|594493906|FG000|Overall Study|Disease Progression after treatment started|3|||
164581195|NCT03556904|594493907|FG001|Overall Study|Disease Progression after treatment started|3|||
164581196|NCT03556904|594493906|FG000|Overall Study|Sponsor Termination|2|||
164581197|NCT03556904|594493907|FG001|Overall Study|Sponsor Termination|2|||
164581198|NCT03556904|594493906|FG000|Overall Study|Physician Decision|2|||
164581199|NCT03556904|594493907|FG001|Overall Study|Physician Decision|0|||
164581200|NCT03556904|594493906|FG000|Overall Study|Withdrawal by Subject|1|||
164581201|NCT03556904|594493907|FG001|Overall Study|Withdrawal by Subject|0|||
164581202|NCT05243680|594493912|FG000|Overall Study|Adverse Event|1|||
164581203|NCT05243680|594493913|FG001|Overall Study|Adverse Event|1|||
164581204|NCT05243680|594493912|FG000|Overall Study|Lack of Efficacy|1|||
164581205|NCT05243680|594493913|FG001|Overall Study|Lack of Efficacy|1|||
164581206|NCT05243680|594493912|FG000|Overall Study|Lost to Follow-up|5|||
164581207|NCT05243680|594493913|FG001|Overall Study|Lost to Follow-up|4|||
164581208|NCT05243680|594493912|FG000|Overall Study|Physician Decision|1|||
164581209|NCT05243680|594493913|FG001|Overall Study|Physician Decision|0|||
164581210|NCT05243680|594493912|FG000|Overall Study|Withdrawal by Subject|3|||
164581211|NCT05243680|594493913|FG001|Overall Study|Withdrawal by Subject|10|||
164581212|NCT05243680|594493912|FG000|Overall Study|Data integrity and GCP violations|4|||
164581213|NCT05243680|594493913|FG001|Overall Study|Data integrity and GCP violations|8|||
164581214|NCT01025336|594493915|FG000|Overall Study|Protocol Violation|0|||
164581215|NCT01025336|594493916|FG001|Overall Study|Protocol Violation|0|||
164581216|NCT01025336|594493917|FG002|Overall Study|Protocol Violation|0|||
164581217|NCT01025336|594493918|FG003|Overall Study|Protocol Violation|2|||
164581218|NCT01025336|594493919|FG004|Overall Study|Protocol Violation|0|||
164581219|NCT03794986|594493920|FG000|Overall Study|0 Sessions Attended|34|||
164581220|NCT03794986|594493921|FG001|Overall Study|0 Sessions Attended|37|||
164581221|NCT03794986|594493920|FG000|Overall Study|Withdrawal by Subject|4|||
164266851|NCT01286077|593346112|FG000|Overall Study|Non-compliance|1|||
164266852|NCT01286077|593346113|FG001|Overall Study|Non-compliance|0|||
164266853|NCT01286077|593346112|FG000|Overall Study|The subject starts with alternative MMY|0|||
164266854|NCT01286077|593346113|FG001|Overall Study|The subject starts with alternative MMY|3|||
164266855|NCT01286077|593346112|FG000|Overall Study|Patient's decision to stop treatment|3|||
164266856|NCT01286077|593346113|FG001|Overall Study|Patient's decision to stop treatment|0|||
164266857|NCT01286077|593346112|FG000|Overall Study|Progression of disease|0|||
164266858|NCT01286077|593346113|FG001|Overall Study|Progression of disease|1|||
164266859|NCT01286077|593346112|FG000|Overall Study|refill medication not received in time|1|||
164266860|NCT01286077|593346113|FG001|Overall Study|refill medication not received in time|0|||
164266861|NCT02654236|593346114|FG000|Overall Study|Withdrawal by Subject|0|||
164266862|NCT02654236|593346115|FG001|Overall Study|Withdrawal by Subject|0|||
164266863|NCT02654236|593346116|FG002|Overall Study|Withdrawal by Subject|2|||
164266864|NCT01549873|593346117|FG000|Overall Study|Physician Decision|0|||
164266865|NCT01549873|593346118|FG001|Overall Study|Physician Decision|1|||
164266866|NCT02905006|593346119|FG000|Overall Study|Adverse Event|1|||
164266867|NCT02905006|593346120|FG001|Overall Study|Adverse Event|1|||
164266868|NCT02905006|593346121|FG002|Overall Study|Adverse Event|1|||
164266869|NCT02905006|593346122|FG003|Overall Study|Adverse Event|1|||
164266870|NCT02905006|593346123|FG004|Overall Study|Adverse Event|0|||
164266871|NCT02905006|593346124|FG005|Overall Study|Adverse Event|1|||
164581222|NCT03794986|594493921|FG001|Overall Study|Withdrawal by Subject|6|||
164581223|NCT03794986|594493920|FG000|Overall Study|Protocol Violation|1|||
164581224|NCT03794986|594493921|FG001|Overall Study|Protocol Violation|0|||
164581225|NCT03043365|594493932|FG000|Weeks 0 to Week 8|Adverse Event|1|||
164581226|NCT03043365|594493933|FG001|Weeks 0 to Week 8|Adverse Event|3|||
164581227|NCT03043365|594493932|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
164581228|NCT03043365|594493933|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
164581229|NCT03043365|594493932|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
164581230|NCT03043365|594493933|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
164581231|NCT02723630|594493934|FG000|Intervention Period 1|Adverse Event|1|||
164581232|NCT02723630|594493935|FG001|Intervention Period 1|Adverse Event|0|||
164581233|NCT02723630|594493936|FG002|Intervention Period 1|Adverse Event|0|||
164581234|NCT02723630|594493937|FG003|Intervention Period 1|Adverse Event|0|||
164581235|NCT02723630|594493938|FG004|Intervention Period 1|Adverse Event|0|||
164581236|NCT02723630|594493939|FG005|Intervention Period 1|Adverse Event|0|||
164581237|NCT02723630|594493934|FG000|Intervention Period 3|consumption of restricted item|0|||
164581238|NCT02723630|594493935|FG001|Intervention Period 3|consumption of restricted item|1|||
164581239|NCT02723630|594493936|FG002|Intervention Period 3|consumption of restricted item|0|||
164581240|NCT02723630|594493937|FG003|Intervention Period 3|consumption of restricted item|0|||
164581241|NCT02723630|594493938|FG004|Intervention Period 3|consumption of restricted item|0|||
164581242|NCT02723630|594493939|FG005|Intervention Period 3|consumption of restricted item|0|||
164581243|NCT00923091|594493945|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
164581244|NCT00923091|594493946|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
164581245|NCT00923091|594493947|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
164581246|NCT00923091|594493948|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
164581247|NCT00923091|594493949|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
164581248|NCT00923091|594493950|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
164266872|NCT02905006|593346119|FG000|Overall Study|Lack of Efficacy|1|||
164266873|NCT02905006|593346120|FG001|Overall Study|Lack of Efficacy|0|||
164266874|NCT02905006|593346121|FG002|Overall Study|Lack of Efficacy|0|||
164266875|NCT02905006|593346122|FG003|Overall Study|Lack of Efficacy|0|||
164266876|NCT02905006|593346123|FG004|Overall Study|Lack of Efficacy|0|||
164266877|NCT02905006|593346124|FG005|Overall Study|Lack of Efficacy|0|||
164266878|NCT02905006|593346119|FG000|Overall Study|Protocol Violation|2|||
164266879|NCT02905006|593346120|FG001|Overall Study|Protocol Violation|0|||
164581249|NCT00923091|594493951|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
164266880|NCT02905006|593346121|FG002|Overall Study|Protocol Violation|0|||
164266881|NCT02905006|593346122|FG003|Overall Study|Protocol Violation|0|||
164266882|NCT02905006|593346123|FG004|Overall Study|Protocol Violation|0|||
164266883|NCT02905006|593346124|FG005|Overall Study|Protocol Violation|0|||
164266884|NCT02905006|593346119|FG000|Overall Study|Lost to Follow-up|0|||
164581250|NCT00923091|594493952|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
164581251|NCT00923091|594493953|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
164581252|NCT00923091|594493954|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
164581253|NCT00923091|594493955|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
164266885|NCT02905006|593346120|FG001|Overall Study|Lost to Follow-up|0|||
164266886|NCT02905006|593346121|FG002|Overall Study|Lost to Follow-up|0|||
164430477|NCT01466881|593947238|FG000|Overall Study|Other reason not protocol specified|5|||
164686435|NCT04535986|594874950|FG000|Overall Study|Adverse Event|10|||
164266887|NCT02905006|593346122|FG003|Overall Study|Lost to Follow-up|1|||
164266888|NCT02905006|593346123|FG004|Overall Study|Lost to Follow-up|1|||
164266889|NCT02905006|593346124|FG005|Overall Study|Lost to Follow-up|0|||
164266890|NCT02905006|593346119|FG000|Overall Study|Withdrawal by Subject|0|||
164266891|NCT02905006|593346120|FG001|Overall Study|Withdrawal by Subject|0|||
164266892|NCT02905006|593346121|FG002|Overall Study|Withdrawal by Subject|1|||
164266893|NCT02905006|593346122|FG003|Overall Study|Withdrawal by Subject|1|||
164266894|NCT02905006|593346123|FG004|Overall Study|Withdrawal by Subject|0|||
164266895|NCT02905006|593346124|FG005|Overall Study|Withdrawal by Subject|1|||
164266896|NCT02905006|593346119|FG000|Overall Study|Screening exclusion criteria met|1|||
164266897|NCT02905006|593346120|FG001|Overall Study|Screening exclusion criteria met|0|||
164266898|NCT02905006|593346121|FG002|Overall Study|Screening exclusion criteria met|0|||
164266899|NCT02905006|593346122|FG003|Overall Study|Screening exclusion criteria met|0|||
164266900|NCT02905006|593346123|FG004|Overall Study|Screening exclusion criteria met|0|||
164266901|NCT02905006|593346124|FG005|Overall Study|Screening exclusion criteria met|0|||
164266902|NCT02905006|593346119|FG000|Overall Study|Lab withdrawal criterion met|0|||
164266903|NCT02905006|593346120|FG001|Overall Study|Lab withdrawal criterion met|1|||
164266904|NCT02905006|593346121|FG002|Overall Study|Lab withdrawal criterion met|2|||
164266905|NCT02905006|593346122|FG003|Overall Study|Lab withdrawal criterion met|2|||
164266906|NCT02905006|593346123|FG004|Overall Study|Lab withdrawal criterion met|2|||
164266907|NCT02905006|593346124|FG005|Overall Study|Lab withdrawal criterion met|1|||
164266908|NCT02905006|593346119|FG000|Overall Study|Positive for Tuberculosis|0|||
164266909|NCT02905006|593346120|FG001|Overall Study|Positive for Tuberculosis|1|||
164266910|NCT02905006|593346121|FG002|Overall Study|Positive for Tuberculosis|0|||
164266911|NCT02905006|593346122|FG003|Overall Study|Positive for Tuberculosis|0|||
164266912|NCT02905006|593346123|FG004|Overall Study|Positive for Tuberculosis|0|||
164266913|NCT02905006|593346124|FG005|Overall Study|Positive for Tuberculosis|0|||
164266914|NCT02905006|593346119|FG000|Overall Study|Subject positive for Hep B|0|||
164266915|NCT02905006|593346120|FG001|Overall Study|Subject positive for Hep B|0|||
164266916|NCT02905006|593346121|FG002|Overall Study|Subject positive for Hep B|1|||
164266917|NCT02905006|593346122|FG003|Overall Study|Subject positive for Hep B|0|||
164266918|NCT02905006|593346123|FG004|Overall Study|Subject positive for Hep B|0|||
164266919|NCT02905006|593346124|FG005|Overall Study|Subject positive for Hep B|0|||
164266920|NCT02905006|593346119|FG000|Overall Study|Patient moved abroad|0|||
164266921|NCT02905006|593346120|FG001|Overall Study|Patient moved abroad|0|||
164266922|NCT02905006|593346121|FG002|Overall Study|Patient moved abroad|0|||
164266923|NCT02905006|593346122|FG003|Overall Study|Patient moved abroad|1|||
164266924|NCT02905006|593346123|FG004|Overall Study|Patient moved abroad|0|||
164266925|NCT02905006|593346124|FG005|Overall Study|Patient moved abroad|0|||
164266926|NCT02905006|593346119|FG000|Overall Study|Patient randomized by mistake|0|||
164266927|NCT02905006|593346120|FG001|Overall Study|Patient randomized by mistake|0|||
164266928|NCT02905006|593346121|FG002|Overall Study|Patient randomized by mistake|0|||
164266929|NCT02905006|593346122|FG003|Overall Study|Patient randomized by mistake|0|||
164266930|NCT02905006|593346123|FG004|Overall Study|Patient randomized by mistake|0|||
164266931|NCT02905006|593346124|FG005|Overall Study|Patient randomized by mistake|1|||
164266932|NCT03627065|593346127|FG000|Overall Study|Study Terminated by sponsor|1|||
164266933|NCT03627065|593346127|FG000|Overall Study|Withdrawal by Subject|2|||
164266934|NCT02797184|593346128|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
164266935|NCT02797184|593346129|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
164266936|NCT06250738|593346130|FG000|Overall Study|Lost to Follow-up|1|||
164266937|NCT02677844|593346131|FG000|Period 3|Withdrawal by Subject|0|||
164266938|NCT02677844|593346132|FG001|Period 3|Withdrawal by Subject|0|||
164266939|NCT02677844|593346133|FG002|Period 3|Withdrawal by Subject|0|||
164266940|NCT02677844|593346134|FG003|Period 3|Withdrawal by Subject|1|||
164266941|NCT02677844|593346135|FG004|Period 3|Withdrawal by Subject|0|||
164266942|NCT02677844|593346136|FG005|Period 3|Withdrawal by Subject|0|||
164266943|NCT02677844|593346137|FG006|Period 3|Withdrawal by Subject|0|||
164266944|NCT01635764|593346138|FG000|Overall Study|Adverse Event|46|||
164266945|NCT01635764|593346138|FG000|Overall Study|Lack of Efficacy|76|||
164266946|NCT01635764|593346138|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
164266947|NCT01635764|593346138|FG000|Overall Study|Protocol Deviation|1|||
164266948|NCT01635764|593346138|FG000|Overall Study|Withdrew Consent|67|||
164266949|NCT01635764|593346138|FG000|Overall Study|Lost to Follow-up|53|||
164266950|NCT01635764|593346138|FG000|Overall Study|Other|28|||
164266951|NCT01816906|593346142|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
164266952|NCT01816906|593346143|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
164266953|NCT01816906|593346142|FG000|Six Months|Lost to Follow-up|14|||
164266954|NCT01816906|593346143|FG001|Six Months|Lost to Follow-up|16|||
164266955|NCT01816906|593346142|FG000|12 Months|Adverse Event|2|||
164266956|NCT01816906|593346143|FG001|12 Months|Adverse Event|2|||
164266957|NCT01816906|593346142|FG000|12 Months|Death|0|||
164266958|NCT01816906|593346143|FG001|12 Months|Death|2|||
164686436|NCT04535986|594874951|FG001|Overall Study|Adverse Event|1|||
164266959|NCT01816906|593346142|FG000|12 Months|Lost to Follow-up|2|||
164266960|NCT01816906|593346143|FG001|12 Months|Lost to Follow-up|1|||
164266961|NCT04375397|593346144|FG000|Overall Study|Death|1|||
164266962|NCT04375397|593346145|FG001|Overall Study|Death|1|||
164686437|NCT04535986|594874950|FG000|Overall Study|Lack of Efficacy|3|||
164686438|NCT04535986|594874951|FG001|Overall Study|Lack of Efficacy|2|||
164686439|NCT04535986|594874950|FG000|Overall Study|Investigator discretion|3|||
164686440|NCT04535986|594874951|FG001|Overall Study|Investigator discretion|0|||
164686441|NCT04535986|594874950|FG000|Overall Study|Withdrawal by Subject|32|||
164686442|NCT04535986|594874951|FG001|Overall Study|Withdrawal by Subject|14|||
164686443|NCT04535986|594874950|FG000|Overall Study|Lost to Follow-up|5|||
164686444|NCT04535986|594874951|FG001|Overall Study|Lost to Follow-up|3|||
164686445|NCT04535986|594874950|FG000|Overall Study|Other|7|||
164686446|NCT04535986|594874951|FG001|Overall Study|Other|3|||
164686447|NCT00467597|594874952|FG000|Overall Study|Withdrawal by Subject|2|||
164686448|NCT00467597|594874953|FG001|Overall Study|Withdrawal by Subject|0|||
164686449|NCT04561115|594874954|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
164686450|NCT04561115|594874955|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
164686451|NCT04561115|594874954|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
164686452|NCT04561115|594874955|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
164686453|NCT04561115|594874954|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
164686454|NCT04561115|594874955|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
164686455|NCT00743145|594874956|FG000|Overall Study|Withdrawal by Subject|1|||
164686456|NCT00743145|594874956|FG000|Overall Study|Adverse Event|2|||
164686457|NCT00743145|594874956|FG000|Overall Study|Pregnancy|1|||
164686458|NCT02179190|594874957|FG000|Enrollment|Exit Prior to Device Attempt|11|||
164266963|NCT04375397|593346144|FG000|Overall Study|Withdrew consent|2|||
164266964|NCT04375397|593346145|FG001|Overall Study|Withdrew consent|0|||
164686459|NCT02179190|594874957|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
164686460|NCT02179190|594874957|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
164686461|NCT02179190|594874957|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
164686462|NCT02179190|594874957|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
164686463|NCT02179190|594874957|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
164686464|NCT01670097|594874958|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
164686465|NCT01670097|594874959|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
164686466|NCT01670097|594874958|FG000|Overall Study|Study burden|1|||
164686467|NCT01670097|594874959|FG001|Overall Study|Study burden|0|||
164686468|NCT01670097|594874958|FG000|Overall Study|COPD exacerbation|0|||
164686469|NCT01670097|594874959|FG001|Overall Study|COPD exacerbation|1|||
164686470|NCT01670097|594874958|FG000|Overall Study|Neutropenia|0|||
164686471|NCT01670097|594874959|FG001|Overall Study|Neutropenia|1|||
164686472|NCT01670097|594874958|FG000|Overall Study|Clinical deterioration|0|||
164686473|NCT01670097|594874959|FG001|Overall Study|Clinical deterioration|1|||
164686474|NCT01670097|594874958|FG000|Overall Study|Disease progression|0|||
164686475|NCT01670097|594874959|FG001|Overall Study|Disease progression|1|||
164686476|NCT02311894|594874960|FG000|Overall Study|Discontinued in error|1|||
164686477|NCT02311894|594874960|FG000|Overall Study|Lost to Follow-up|1|||
164686478|NCT02311894|594874960|FG000|Overall Study|Adverse Event|1|||
164686479|NCT02311894|594874960|FG000|Overall Study|Withdrawal by Subject|1|||
164686480|NCT00884390|594874961|FG000|Overall Study|Adverse Event|0|||
164686481|NCT00884390|594874962|FG001|Overall Study|Adverse Event|1|||
164686482|NCT00884390|594874961|FG000|Overall Study|Lost to Follow-up|0|||
164686483|NCT00884390|594874962|FG001|Overall Study|Lost to Follow-up|1|||
164686484|NCT00884390|594874961|FG000|Overall Study|Physician Decision|2|||
164686485|NCT00884390|594874962|FG001|Overall Study|Physician Decision|1|||
164686486|NCT00884390|594874961|FG000|Overall Study|Protocol Violation|4|||
164266965|NCT04375397|593346144|FG000|Overall Study|Lost to Follow-up|6|||
164266966|NCT04375397|593346145|FG001|Overall Study|Lost to Follow-up|4|||
164686487|NCT00884390|594874962|FG001|Overall Study|Protocol Violation|1|||
164686488|NCT00884390|594874961|FG000|Overall Study|Withdrawal by Subject|4|||
164686489|NCT00884390|594874962|FG001|Overall Study|Withdrawal by Subject|1|||
164686490|NCT00884390|594874961|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
164686491|NCT00884390|594874962|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
164686492|NCT00884390|594874961|FG000|Overall Study|Other|11|||
164686493|NCT00884390|594874962|FG001|Overall Study|Other|1|||
164686494|NCT01691612|594874963|FG000|Overall Study|deemed ineligible after 1st visit|6|||
164686495|NCT01691612|594874963|FG000|Overall Study|Adverse Event|1|||
164686496|NCT02623218|594874966|FG000|Overall Study|Lost to Follow-up|0|||
164686497|NCT02623218|594874967|FG001|Overall Study|Lost to Follow-up|1|||
164266967|NCT04375397|593346144|FG000|Overall Study|Other, not specified|0|||
164686498|NCT02623218|594874968|FG002|Overall Study|Lost to Follow-up|0|||
164341859|NCT01281865|593627532|FG001|Overall Study|Adverse Event|1|||
164341860|NCT01281865|593627531|FG000|Overall Study|Withdrawal by Subject|1|||
164341861|NCT01281865|593627532|FG001|Overall Study|Withdrawal by Subject|0|||
164341862|NCT01281865|593627531|FG000|Overall Study|Lack of Efficacy|1|||
164341863|NCT01281865|593627532|FG001|Overall Study|Lack of Efficacy|0|||
164341864|NCT03478657|593627534|FG000|Overall Study|Withdrawal by Subject|0|||
164341865|NCT03478657|593627535|FG001|Overall Study|Withdrawal by Subject|1|||
164341866|NCT04891978|593627536|FG000|Baseline|Protocol Violation|2|||
164341867|NCT04891978|593627537|FG001|Baseline|Protocol Violation|1|||
164341868|NCT04891978|593627538|FG002|Baseline|Protocol Violation|0|||
164341869|NCT04891978|593627536|FG000|Baseline|Missing AIRQ|1|||
164341870|NCT04891978|593627537|FG001|Baseline|Missing AIRQ|0|||
164341871|NCT04891978|593627538|FG002|Baseline|Missing AIRQ|0|||
164341872|NCT04891978|593627536|FG000|Baseline|Did not attend a baseline visit|0|||
164341873|NCT04891978|593627537|FG001|Baseline|Did not attend a baseline visit|0|||
164341874|NCT04891978|593627538|FG002|Baseline|Did not attend a baseline visit|9|||
164341875|NCT01776840|593627539|FG000|Overall Study|Lost to Follow-up|12|||
164341876|NCT01776840|593627540|FG001|Overall Study|Lost to Follow-up|7|||
164341877|NCT01776840|593627539|FG000|Overall Study|Withdrawal by Subject|32|||
164341878|NCT01776840|593627540|FG001|Overall Study|Withdrawal by Subject|48|||
164341879|NCT01776840|593627539|FG000|Overall Study|Sponsor decision|89|||
164341880|NCT01776840|593627540|FG001|Overall Study|Sponsor decision|87|||
164341881|NCT05338216|593627541|FG000|Overall Study|Withdrawal by Subject|1|||
164341882|NCT05338216|593627542|FG001|Overall Study|Withdrawal by Subject|1|||
164341883|NCT02589405|593627546|FG000|Overall Study|Adverse Event|3|||
164341884|NCT02589405|593627546|FG000|Overall Study|Withdrawal by Subject|1|||
164341885|NCT02693119|593627547|FG000|Open-Label Period|Withdrawal by Subject|0|||
164341886|NCT02693119|593627548|FG001|Open-Label Period|Withdrawal by Subject|1|||
164341887|NCT01719783|593627549|FG000|Dose 2|Physician Decision|1|||
164341888|NCT01719783|593627550|FG001|Dose 2|Physician Decision|0|||
164341889|NCT01350492|593627551|FG000|Intervention|Lost to Follow-up|2|||
164341890|NCT01350492|593627552|FG001|Intervention|Lost to Follow-up|5|||
164686499|NCT02623218|594874969|FG003|Overall Study|Lost to Follow-up|0|||
164686500|NCT02623218|594874970|FG004|Overall Study|Lost to Follow-up|0|||
164686501|NCT00537095|594874977|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
164686502|NCT00537095|594874978|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
164686503|NCT00537095|594874977|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
164686504|NCT00537095|594874978|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
164341891|NCT01350492|593627551|FG000|Intervention|Withdrawal by Subject|3|||
164341892|NCT01350492|593627552|FG001|Intervention|Withdrawal by Subject|1|||
164341893|NCT01350492|593627551|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
164341894|NCT01350492|593627552|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
164341895|NCT01350492|593627551|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
164341896|NCT01350492|593627552|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
164341897|NCT00753766|593627553|FG000|Overall Study|Physician Decision|1|||
164341898|NCT00753766|593627554|FG001|Overall Study|Physician Decision|0|||
164341899|NCT03800173|593627557|FG000|Overall Study|Lost to Follow-up|0|||
164341900|NCT03800173|593627558|FG001|Overall Study|Lost to Follow-up|0|||
164341901|NCT03800173|593627559|FG002|Overall Study|Lost to Follow-up|0|||
164341902|NCT03800173|593627560|FG003|Overall Study|Lost to Follow-up|0|||
164341903|NCT03800173|593627561|FG004|Overall Study|Lost to Follow-up|1|||
164341904|NCT00932126|593627564|FG000|Overall Study|Adverse Event|0|||
164341905|NCT00932126|593627565|FG001|Overall Study|Adverse Event|0|||
164341906|NCT00932126|593627566|FG002|Overall Study|Adverse Event|0|||
164341907|NCT00932126|593627567|FG003|Overall Study|Adverse Event|0|||
164341908|NCT00932126|593627568|FG004|Overall Study|Adverse Event|0|||
164341909|NCT00932126|593627569|FG005|Overall Study|Adverse Event|0|||
164341910|NCT00932126|593627570|FG006|Overall Study|Adverse Event|1|||
164686505|NCT00537095|594874977|FG000|Randomized Treatment Period (433 Days)|Death|3|||
164686506|NCT00537095|594874978|FG001|Randomized Treatment Period (433 Days)|Death|1|||
164686507|NCT00537095|594874977|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
164686508|NCT00537095|594874978|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
164341911|NCT00932126|593627571|FG007|Overall Study|Adverse Event|2|||
164341912|NCT00932126|593627564|FG000|Overall Study|Protocol Violation|0|||
164694669|NCT01546142|594905312|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
164341913|NCT00932126|593627565|FG001|Overall Study|Protocol Violation|0|||
164341914|NCT00932126|593627566|FG002|Overall Study|Protocol Violation|0|||
164341915|NCT00932126|593627567|FG003|Overall Study|Protocol Violation|0|||
164341916|NCT00932126|593627568|FG004|Overall Study|Protocol Violation|1|||
164341917|NCT00932126|593627569|FG005|Overall Study|Protocol Violation|0|||
164341918|NCT00932126|593627570|FG006|Overall Study|Protocol Violation|0|||
164341919|NCT00932126|593627571|FG007|Overall Study|Protocol Violation|0|||
164341920|NCT00932126|593627564|FG000|Overall Study|Withdrawal by Subject|0|||
164341921|NCT00932126|593627565|FG001|Overall Study|Withdrawal by Subject|0|||
164341922|NCT00932126|593627566|FG002|Overall Study|Withdrawal by Subject|1|||
164341923|NCT00932126|593627567|FG003|Overall Study|Withdrawal by Subject|0|||
164341924|NCT00932126|593627568|FG004|Overall Study|Withdrawal by Subject|0|||
164581254|NCT00923091|594493956|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
164581255|NCT00923091|594493957|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
164581256|NCT00923091|594493945|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
164581257|NCT00923091|594493946|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
164581258|NCT00923091|594493947|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
164581259|NCT00923091|594493948|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
164581260|NCT00923091|594493949|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
164581261|NCT00923091|594493950|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
164581262|NCT00923091|594493951|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
164581263|NCT00923091|594493952|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
164581264|NCT00923091|594493953|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
164581265|NCT00923091|594493954|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
164581266|NCT00923091|594493955|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
164581267|NCT00923091|594493956|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
164581268|NCT00923091|594493957|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
164581269|NCT00923091|594493945|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
164581270|NCT00923091|594493946|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
164581271|NCT00923091|594493947|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
164581272|NCT00923091|594493948|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
164581273|NCT00923091|594493949|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
164581274|NCT00923091|594493950|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
164581275|NCT00923091|594493951|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
164581276|NCT00923091|594493952|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
164581277|NCT00923091|594493953|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
164581278|NCT00923091|594493954|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
164581279|NCT00923091|594493955|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
164266968|NCT04375397|593346145|FG001|Overall Study|Other, not specified|1|||
164266969|NCT00086502|593346146|FG000|Overall Study|Adverse Event|11|||
164266970|NCT00086502|593346147|FG001|Overall Study|Adverse Event|2|||
164266971|NCT00086502|593346146|FG000|Overall Study|Lack of Efficacy|0|||
164266972|NCT00086502|593346147|FG001|Overall Study|Lack of Efficacy|2|||
164266973|NCT00086502|593346146|FG000|Overall Study|Lost to Follow-up|3|||
164266974|NCT00086502|593346147|FG001|Overall Study|Lost to Follow-up|1|||
164266975|NCT00086502|593346146|FG000|Overall Study|Physician Decision|1|||
164266976|NCT00086502|593346147|FG001|Overall Study|Physician Decision|1|||
164266977|NCT00086502|593346146|FG000|Overall Study|Pregnancy|0|||
164266978|NCT00086502|593346147|FG001|Overall Study|Pregnancy|1|||
164266979|NCT00086502|593346146|FG000|Overall Study|Protocol Violation|3|||
164266980|NCT00086502|593346147|FG001|Overall Study|Protocol Violation|3|||
164266981|NCT00086502|593346146|FG000|Overall Study|Withdrawal by Subject|5|||
164266982|NCT00086502|593346147|FG001|Overall Study|Withdrawal by Subject|6|||
164266983|NCT00086502|593346146|FG000|Overall Study|Patient Moved|1|||
164266984|NCT00086502|593346147|FG001|Overall Study|Patient Moved|1|||
164266985|NCT00086502|593346146|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
164266986|NCT00086502|593346147|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
164266987|NCT00086502|593346146|FG000|Overall Study|Patient Accidentally Unblinded|1|||
164266988|NCT00086502|593346147|FG001|Overall Study|Patient Accidentally Unblinded|0|||
164266989|NCT01304329|593346148|FG000|Third Intervention (3 Days)|Adverse Event|0|||
164266990|NCT01304329|593346149|FG001|Third Intervention (3 Days)|Adverse Event|1|||
164266991|NCT01304329|593346150|FG002|Third Intervention (3 Days)|Adverse Event|0|||
164266992|NCT01304329|593346151|FG003|Third Intervention (3 Days)|Adverse Event|0|||
164266993|NCT01304329|593346152|FG004|Third Intervention (3 Days)|Adverse Event|0|||
164266994|NCT01304329|593346153|FG005|Third Intervention (3 Days)|Adverse Event|0|||
164266995|NCT05545644|593346158|FG000|Overall Study|Lost to Follow-up|4|||
164266996|NCT05545644|593346159|FG001|Overall Study|Lost to Follow-up|3|||
164266997|NCT01945775|593346163|FG000|Overall Study|Death|214|||
164581280|NCT00923091|594493956|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
164581281|NCT00923091|594493957|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
164581282|NCT00923091|594493945|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
164581283|NCT00923091|594493946|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
164581284|NCT00923091|594493947|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
164430478|NCT03178201|593947241|FG000|Overall Study|Off study|5|||
164581285|NCT00923091|594493948|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
164581286|NCT00923091|594493949|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
164581287|NCT00923091|594493950|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
164581288|NCT00923091|594493951|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
164581289|NCT00923091|594493952|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
164581290|NCT00923091|594493953|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
164581291|NCT00923091|594493954|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
164581292|NCT00923091|594493955|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
164581293|NCT00923091|594493956|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
164581294|NCT00923091|594493957|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
164581295|NCT00923091|594493945|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
164581296|NCT00923091|594493946|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
164581297|NCT00923091|594493947|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
164581298|NCT00923091|594493948|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
164581299|NCT00923091|594493949|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
164581300|NCT00923091|594493950|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
164581301|NCT00923091|594493951|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
164581302|NCT00923091|594493952|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
164581303|NCT00923091|594493953|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
164581304|NCT00923091|594493954|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
164581305|NCT00923091|594493955|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
164581306|NCT00923091|594493956|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
164581307|NCT00923091|594493957|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
164581308|NCT00923091|594493945|FG000|Period III (Single-Blind)|Adverse Event|5|||
164581309|NCT00923091|594493946|FG001|Period III (Single-Blind)|Adverse Event|0|||
164581310|NCT00923091|594493947|FG002|Period III (Single-Blind)|Adverse Event|0|||
164581311|NCT00923091|594493948|FG003|Period III (Single-Blind)|Adverse Event|0|||
164581312|NCT00923091|594493949|FG004|Period III (Single-Blind)|Adverse Event|0|||
164581313|NCT00923091|594493950|FG005|Period III (Single-Blind)|Adverse Event|0|||
164581314|NCT00923091|594493951|FG006|Period III (Single-Blind)|Adverse Event|0|||
164581315|NCT00923091|594493952|FG007|Period III (Single-Blind)|Adverse Event|0|||
164581316|NCT00923091|594493953|FG008|Period III (Single-Blind)|Adverse Event|0|||
164581317|NCT00923091|594493954|FG009|Period III (Single-Blind)|Adverse Event|0|||
164581318|NCT00923091|594493955|FG010|Period III (Single-Blind)|Adverse Event|0|||
164581319|NCT00923091|594493956|FG011|Period III (Single-Blind)|Adverse Event|0|||
164581320|NCT00923091|594493957|FG012|Period III (Single-Blind)|Adverse Event|0|||
164581321|NCT00923091|594493945|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
164581322|NCT00923091|594493946|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
164581323|NCT00923091|594493947|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
164266998|NCT01945775|593346164|FG001|Overall Study|Death|98|||
164266999|NCT01945775|593346163|FG000|Overall Study|Lost to Follow-up|12|||
164267000|NCT01945775|593346164|FG001|Overall Study|Lost to Follow-up|7|||
164581324|NCT00923091|594493948|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
164581325|NCT00923091|594493949|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
164581326|NCT00923091|594493950|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
164581327|NCT00923091|594493951|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
164267001|NCT01945775|593346163|FG000|Overall Study|Withdrawal by Subject|11|||
164267002|NCT01945775|593346164|FG001|Overall Study|Withdrawal by Subject|21|||
164267003|NCT01945775|593346163|FG000|Overall Study|Other|50|||
164267004|NCT01945775|593346164|FG001|Overall Study|Other|18|||
164267005|NCT02876328|593346165|FG000|Overall Study|Death|2|||
164267006|NCT02876328|593346166|FG001|Overall Study|Death|1|||
164267007|NCT02876328|593346167|FG002|Overall Study|Death|3|||
164267008|NCT02876328|593346168|FG003|Overall Study|Death|0|||
164267009|NCT02876328|593346169|FG004|Overall Study|Death|0|||
164267010|NCT02876328|593346170|FG005|Overall Study|Death|0|||
164267011|NCT02876328|593346171|FG006|Overall Study|Death|1|||
164267012|NCT02876328|593346172|FG007|Overall Study|Death|3|||
164430479|NCT05015478|593947244|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
164430480|NCT05015478|593947245|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
164430481|NCT05015478|593947246|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
164430482|NCT05015478|593947247|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
164430483|NCT04319094|593947250|FG000|Baseline|Lost to Follow-up|4|||
164686509|NCT00537095|594874977|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
164686510|NCT00537095|594874978|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
164686511|NCT00537095|594874977|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
164686512|NCT00537095|594874978|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
164686513|NCT00537095|594874977|FG000|Open-label Period (590 Days)|Adverse Event|2|||
164686514|NCT00537095|594874978|FG001|Open-label Period (590 Days)|Adverse Event|11|||
164686515|NCT00537095|594874977|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
164686516|NCT00537095|594874978|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
164686517|NCT00537095|594874977|FG000|Open-label Period (590 Days)|Death|2|||
164686518|NCT00537095|594874978|FG001|Open-label Period (590 Days)|Death|2|||
164686519|NCT00537095|594874977|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
164686520|NCT00537095|594874978|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
164686521|NCT00537095|594874977|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
164686522|NCT00537095|594874978|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
164686523|NCT02616380|594874979|FG000|Overall Study|Lost to Follow-up|1|||
164686524|NCT02616380|594874979|FG000|Overall Study|Other|2|||
164686525|NCT05065619|594874980|FG000|Up to Day 42|Lost to Follow-up|1|||
164686526|NCT05065619|594874981|FG001|Up to Day 42|Lost to Follow-up|0|||
164686527|NCT05065619|594874980|FG000|Up to Day 42|Withdrawal by Subject|1|||
164686528|NCT05065619|594874981|FG001|Up to Day 42|Withdrawal by Subject|0|||
164686529|NCT05065619|594874980|FG000|After Day 43|Lost to Follow-up|1|||
164686530|NCT05065619|594874981|FG001|After Day 43|Lost to Follow-up|0|||
164686531|NCT05065619|594874980|FG000|After Day 43|Physician Decision|3|||
164686532|NCT05065619|594874981|FG001|After Day 43|Physician Decision|0|||
164686533|NCT05065619|594874980|FG000|After Day 43|Withdrawal by Subject|1|||
164686534|NCT05065619|594874981|FG001|After Day 43|Withdrawal by Subject|2|||
164686535|NCT05065619|594874980|FG000|After Day 43|Public vaccination|6|||
164686536|NCT05065619|594874981|FG001|After Day 43|Public vaccination|8|||
164686537|NCT05065619|594874980|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
164686538|NCT05065619|594874981|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
164686539|NCT05065619|594874980|FG000|After Day 43|Study Terminated by Sponsor|88|||
164686540|NCT05065619|594874981|FG001|After Day 43|Study Terminated by Sponsor|16|||
164686541|NCT00124618|594874982|FG000|Overall Study|Ineligible|1|||
164686542|NCT02535923|594874983|FG000|Overall Study|Lost to Follow-up|5|||
164686543|NCT02535923|594874984|FG001|Overall Study|Lost to Follow-up|5|||
164686544|NCT02535923|594874983|FG000|Overall Study|Withdrawal by Subject|4|||
164686545|NCT02535923|594874984|FG001|Overall Study|Withdrawal by Subject|3|||
164430484|NCT04319094|593947251|FG001|Baseline|Lost to Follow-up|5|||
164430485|NCT04319094|593947250|FG000|Baseline|Protocol Violation|0|||
164430486|NCT04319094|593947251|FG001|Baseline|Protocol Violation|3|||
164430487|NCT04319094|593947250|FG000|Baseline|Withdrawal by Subject|2|||
164430488|NCT04319094|593947251|FG001|Baseline|Withdrawal by Subject|1|||
164430489|NCT04319094|593947250|FG000|Post-Intervention|Death|0|||
164430490|NCT04319094|593947251|FG001|Post-Intervention|Death|1|||
164430491|NCT04319094|593947250|FG000|Post-Intervention|Lost to Follow-up|4|||
164430492|NCT04319094|593947251|FG001|Post-Intervention|Lost to Follow-up|4|||
164686546|NCT02722616|594876487|FG000|Overall Study|Sponsor closed study after one month|2|||
164686547|NCT02722616|594876488|FG001|Overall Study|Sponsor closed study after one month|0|||
164686548|NCT02722616|594876489|FG002|Overall Study|Sponsor closed study after one month|0|||
164686549|NCT01188226|594876492|FG000|Overall Study|Withdrawal by Subject|4|||
164686550|NCT04980456|594876493|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
164686551|NCT04980456|594876494|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
164267013|NCT02876328|593346173|FG008|Overall Study|Death|0|||
164267014|NCT02876328|593346174|FG009|Overall Study|Death|1|||
164267015|NCT02876328|593346175|FG010|Overall Study|Death|1|||
164430493|NCT04319094|593947250|FG000|Post-Intervention|Withdrawal by Subject|8|||
164430494|NCT04319094|593947251|FG001|Post-Intervention|Withdrawal by Subject|5|||
164430495|NCT04319094|593947250|FG000|Post-Intervention|Incomplete Data Collection|1|||
164430496|NCT04319094|593947251|FG001|Post-Intervention|Incomplete Data Collection|3|||
164430497|NCT04319094|593947250|FG000|3-month|Death|1|||
164430498|NCT04319094|593947251|FG001|3-month|Death|0|||
164430499|NCT04319094|593947250|FG000|3-month|Lost to Follow-up|2|||
164430500|NCT04319094|593947251|FG001|3-month|Lost to Follow-up|2|||
164430501|NCT04319094|593947250|FG000|3-month|Withdrawal by Subject|0|||
164430502|NCT04319094|593947251|FG001|3-month|Withdrawal by Subject|3|||
164430503|NCT04319094|593947250|FG000|3-month|Incomplete data collection|9|||
164430504|NCT04319094|593947251|FG001|3-month|Incomplete data collection|7|||
164430505|NCT04319094|593947250|FG000|6-month|Lost to Follow-up|1|||
164430506|NCT04319094|593947251|FG001|6-month|Lost to Follow-up|1|||
164430507|NCT04319094|593947250|FG000|6-month|Withdrawal by Subject|0|||
164430508|NCT04319094|593947251|FG001|6-month|Withdrawal by Subject|3|||
164430509|NCT04319094|593947250|FG000|6-month|Incomplete data collection|14|||
164430510|NCT04319094|593947251|FG001|6-month|Incomplete data collection|9|||
164430511|NCT04319094|593947250|FG000|9-month|Lost to Follow-up|8|||
164430512|NCT04319094|593947251|FG001|9-month|Lost to Follow-up|4|||
164430513|NCT04319094|593947250|FG000|9-month|Withdrawal by Subject|0|||
164430514|NCT04319094|593947251|FG001|9-month|Withdrawal by Subject|1|||
164430515|NCT04319094|593947250|FG000|9-month|Incomplete data collection|8|||
164430516|NCT04319094|593947251|FG001|9-month|Incomplete data collection|5|||
164430517|NCT04319094|593947250|FG000|12-month|Lost to Follow-up|11|||
164430518|NCT04319094|593947251|FG001|12-month|Lost to Follow-up|8|||
164430519|NCT04639947|593947254|FG000|Overall Study|Screen fail|1|||
164430520|NCT01018511|593947255|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
164430521|NCT01018511|593947256|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
164430522|NCT01018511|593947257|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
164430523|NCT01018511|593947258|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
164430524|NCT01018511|593947255|FG000|Overall Study|Adverse Event|5|||
164430525|NCT01018511|593947256|FG001|Overall Study|Adverse Event|9|||
164430526|NCT01018511|593947257|FG002|Overall Study|Adverse Event|13|||
164430527|NCT01018511|593947258|FG003|Overall Study|Adverse Event|10|||
164430528|NCT01018511|593947255|FG000|Overall Study|Lack of Efficacy|4|||
164430529|NCT01018511|593947256|FG001|Overall Study|Lack of Efficacy|1|||
164430530|NCT01018511|593947257|FG002|Overall Study|Lack of Efficacy|1|||
164430531|NCT01018511|593947258|FG003|Overall Study|Lack of Efficacy|2|||
164430532|NCT01018511|593947255|FG000|Overall Study|Withdrawal by Subject|6|||
164430533|NCT01018511|593947256|FG001|Overall Study|Withdrawal by Subject|5|||
164430534|NCT01018511|593947257|FG002|Overall Study|Withdrawal by Subject|11|||
164430535|NCT01018511|593947258|FG003|Overall Study|Withdrawal by Subject|9|||
164430536|NCT01018511|593947255|FG000|Overall Study|Lost to Follow-up|0|||
164430537|NCT01018511|593947256|FG001|Overall Study|Lost to Follow-up|0|||
164430538|NCT01018511|593947257|FG002|Overall Study|Lost to Follow-up|1|||
164430539|NCT01018511|593947258|FG003|Overall Study|Lost to Follow-up|0|||
164430540|NCT01018511|593947255|FG000|Overall Study|Protocol Violation|5|||
164430541|NCT01018511|593947256|FG001|Overall Study|Protocol Violation|8|||
164430542|NCT01018511|593947257|FG002|Overall Study|Protocol Violation|7|||
164430543|NCT01018511|593947258|FG003|Overall Study|Protocol Violation|9|||
164430544|NCT01018511|593947255|FG000|Overall Study|Miscellaneous|0|||
164430545|NCT01018511|593947256|FG001|Overall Study|Miscellaneous|2|||
164430546|NCT01018511|593947257|FG002|Overall Study|Miscellaneous|0|||
164430547|NCT01018511|593947258|FG003|Overall Study|Miscellaneous|0|||
164686552|NCT04980456|594876493|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
164686553|NCT04980456|594876494|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
164686554|NCT04980456|594876493|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
164686555|NCT04980456|594876494|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
164686556|NCT04980456|594876493|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
164430548|NCT00654238|593947259|FG000|Overall Study|Screen Failures|4|||
164430549|NCT03905135|593947260|FG000|Dose Escalation|Adverse Event|1|||
164686557|NCT04980456|594876494|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
164267016|NCT02876328|593346176|FG011|Overall Study|Death|0|||
164267017|NCT02876328|593346177|FG012|Overall Study|Death|0|||
164267018|NCT02876328|593346178|FG013|Overall Study|Death|0|||
164430550|NCT03905135|593947261|FG001|Dose Escalation|Adverse Event|1|||
164430551|NCT03905135|593947260|FG000|Dose Escalation|Progressive disease|3|||
164430552|NCT03905135|593947261|FG001|Dose Escalation|Progressive disease|1|||
164430553|NCT03905135|593947260|FG000|Dose Escalation|Intercurrent illness|1|||
164430554|NCT03905135|593947261|FG001|Dose Escalation|Intercurrent illness|0|||
164430555|NCT05096884|593947262|FG000|Overall Study|Excluded based on negative tilt table test|4|||
164430556|NCT02482233|593947263|FG000|Overall Study|Lost to Follow-up|1|||
164430557|NCT02482233|593947264|FG001|Overall Study|Lost to Follow-up|1|||
164430558|NCT04888585|593947265|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
164430559|NCT04888585|593947266|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
164430560|NCT04888585|593947267|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
164430561|NCT04888585|593947268|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
164686558|NCT02415387|594876502|FG000|Overall Study|Withdrawal by Subject|6|||
164430562|NCT04888585|593947269|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
164430563|NCT04888585|593947270|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
164430564|NCT04888585|593947271|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
164430565|NCT04888585|593947272|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
164430566|NCT04888585|593947273|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
164430567|NCT04888585|593947274|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
164430568|NCT04888585|593947275|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
164430569|NCT04888585|593947265|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
164430570|NCT04888585|593947266|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
164430571|NCT04888585|593947267|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
164430572|NCT04888585|593947268|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
164430573|NCT04888585|593947269|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
164430574|NCT04888585|593947270|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
164430575|NCT04888585|593947271|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
164430576|NCT04888585|593947272|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
164430577|NCT04888585|593947273|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
164430578|NCT04888585|593947274|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
164430579|NCT04888585|593947275|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
164430580|NCT04888585|593947265|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
164430581|NCT04888585|593947266|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
164430582|NCT04888585|593947267|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
164430583|NCT04888585|593947268|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
164430584|NCT04888585|593947269|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
164430585|NCT04888585|593947270|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
164430586|NCT04888585|593947271|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
164430587|NCT04888585|593947272|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
164430588|NCT04888585|593947273|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
164430589|NCT04888585|593947274|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
164430590|NCT04888585|593947275|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
164430591|NCT04888585|593947265|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
164430592|NCT04888585|593947266|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
164430593|NCT04888585|593947267|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
164430594|NCT04888585|593947268|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
164430595|NCT04888585|593947269|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
164430596|NCT04888585|593947270|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
164430597|NCT04888585|593947271|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
164430598|NCT04888585|593947272|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
164430599|NCT04888585|593947273|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
164430600|NCT04888585|593947274|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
164430601|NCT04888585|593947275|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
164430602|NCT04888585|593947265|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
164430603|NCT04888585|593947266|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
164430604|NCT04888585|593947267|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
164430605|NCT04888585|593947268|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
164430606|NCT04888585|593947269|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
164430607|NCT04888585|593947270|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
164430608|NCT04888585|593947271|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
164430609|NCT04888585|593947272|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
164430610|NCT04888585|593947273|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
164430611|NCT04888585|593947274|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
164430612|NCT04888585|593947275|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
164430613|NCT04888585|593947265|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
164430614|NCT04888585|593947266|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
164430615|NCT04888585|593947267|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
164430616|NCT04888585|593947268|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
164430617|NCT04888585|593947269|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
164430618|NCT04888585|593947270|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
164430619|NCT04888585|593947271|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
164430620|NCT04888585|593947272|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
164430621|NCT04888585|593947273|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
164430622|NCT04888585|593947274|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
164581328|NCT00923091|594493952|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
164581329|NCT00923091|594493953|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
164267019|NCT02876328|593346179|FG014|Overall Study|Death|0|||
164686559|NCT02415387|594876503|FG001|Overall Study|Withdrawal by Subject|1|||
164686560|NCT02415387|594876502|FG000|Overall Study|blood draw problem|0|||
164686561|NCT02415387|594876503|FG001|Overall Study|blood draw problem|1|||
164686562|NCT02415387|594876502|FG000|Overall Study|Protocol Violation|1|||
164686563|NCT02415387|594876503|FG001|Overall Study|Protocol Violation|0|||
164686564|NCT03687242|594876504|FG000|Overall Study|Adverse Event|1|||
164686565|NCT01151280|594876505|FG000|Overall Study|Adverse Event|1|||
164430623|NCT04888585|593947275|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
164430624|NCT04888585|593947265|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
164430625|NCT04888585|593947266|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
164430626|NCT04888585|593947267|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
164430627|NCT04888585|593947268|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
164430628|NCT04888585|593947269|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
164430629|NCT04888585|593947270|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
164430630|NCT04888585|593947271|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
164430631|NCT04888585|593947272|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
164430632|NCT04888585|593947273|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
164430633|NCT04888585|593947274|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
164430634|NCT04888585|593947275|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
164430635|NCT04888585|593947265|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
164430636|NCT04888585|593947266|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
164430637|NCT04888585|593947267|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
164430638|NCT04888585|593947268|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
164430639|NCT04888585|593947269|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
164430640|NCT04888585|593947270|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
164430641|NCT04888585|593947271|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
164430642|NCT04888585|593947272|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
164430643|NCT04888585|593947273|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
164430644|NCT04888585|593947274|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
164430645|NCT04888585|593947275|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
164430646|NCT04927975|593947276|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
164430647|NCT04927975|593947277|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
164430648|NCT04927975|593947278|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
164430649|NCT04927975|593947279|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
164430650|NCT04927975|593947280|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
164430651|NCT04927975|593947281|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
164430652|NCT04927975|593947276|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
164430653|NCT04927975|593947277|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
164430654|NCT04927975|593947278|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
164430655|NCT04927975|593947279|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
164430656|NCT04927975|593947280|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
164430657|NCT04927975|593947281|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
164430658|NCT04927975|593947276|FG000|Period 1 (Baseline-Week 24)|Death|0|||
164430659|NCT04927975|593947277|FG001|Period 1 (Baseline-Week 24)|Death|0|||
164430660|NCT04927975|593947278|FG002|Period 1 (Baseline-Week 24)|Death|0|||
164267020|NCT02876328|593346180|FG015|Overall Study|Death|0|||
164267021|NCT02876328|593346181|FG016|Overall Study|Death|1|||
164267022|NCT02876328|593346182|FG017|Overall Study|Death|1|||
164430661|NCT04927975|593947279|FG003|Period 1 (Baseline-Week 24)|Death|0|||
164430662|NCT04927975|593947280|FG004|Period 1 (Baseline-Week 24)|Death|0|||
164430663|NCT04927975|593947281|FG005|Period 1 (Baseline-Week 24)|Death|1|||
164430664|NCT04927975|593947276|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
164430665|NCT04927975|593947277|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
164430666|NCT04927975|593947278|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
164430667|NCT04927975|593947279|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
164430668|NCT04927975|593947280|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
164430669|NCT04927975|593947281|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
164267023|NCT02876328|593346183|FG018|Overall Study|Death|0|||
164267024|NCT02876328|593346184|FG019|Overall Study|Death|0|||
164267025|NCT02876328|593346185|FG020|Overall Study|Death|0|||
164267026|NCT02876328|593346186|FG021|Overall Study|Death|1|||
164267027|NCT02876328|593346187|FG022|Overall Study|Death|0|||
164267028|NCT02876328|593346188|FG023|Overall Study|Death|0|||
164267029|NCT02876328|593346165|FG000|Overall Study|Withdrawal by Subject|0|||
164267030|NCT02876328|593346166|FG001|Overall Study|Withdrawal by Subject|2|||
164267031|NCT02876328|593346167|FG002|Overall Study|Withdrawal by Subject|3|||
164430670|NCT04927975|593947276|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
164686566|NCT01151280|594876505|FG000|Overall Study|Lack of Efficacy|3|||
164686567|NCT02733627|594876507|FG000|Overall Study|Adverse Event|0|||
164686568|NCT02733627|594876508|FG001|Overall Study|Adverse Event|1|||
164267032|NCT02876328|593346168|FG003|Overall Study|Withdrawal by Subject|3|||
164267033|NCT02876328|593346169|FG004|Overall Study|Withdrawal by Subject|0|||
164267034|NCT02876328|593346170|FG005|Overall Study|Withdrawal by Subject|1|||
164430671|NCT04927975|593947277|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
164430672|NCT04927975|593947278|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
164430673|NCT04927975|593947279|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
164430674|NCT04927975|593947280|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
164430675|NCT04927975|593947281|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
164430676|NCT03822351|593947282|FG000|Overall Study|Death|27|||
164430677|NCT03822351|593947283|FG001|Overall Study|Death|23|||
164430678|NCT03822351|593947284|FG002|Overall Study|Death|24|||
164430679|NCT03822351|593947282|FG000|Overall Study|Lost to Follow-up|6|||
164430680|NCT03822351|593947283|FG001|Overall Study|Lost to Follow-up|2|||
164430681|NCT03822351|593947284|FG002|Overall Study|Lost to Follow-up|1|||
164430682|NCT03822351|593947282|FG000|Overall Study|Withdrawal by Subject|10|||
164430683|NCT03822351|593947283|FG001|Overall Study|Withdrawal by Subject|4|||
164430684|NCT03822351|593947284|FG002|Overall Study|Withdrawal by Subject|6|||
164430685|NCT03822351|593947282|FG000|Overall Study|Progressive Disease|2|||
164430686|NCT03822351|593947283|FG001|Overall Study|Progressive Disease|1|||
164430687|NCT03822351|593947284|FG002|Overall Study|Progressive Disease|0|||
164430688|NCT03822351|593947282|FG000|Overall Study|Not Treated|1|||
164430689|NCT03822351|593947283|FG001|Overall Study|Not Treated|1|||
164430690|NCT03822351|593947284|FG002|Overall Study|Not Treated|1|||
164430691|NCT00768066|593947287|FG000|Overall Study|Did not receive study product injection.|3|||
164430692|NCT00768066|593947288|FG001|Overall Study|Did not receive study product injection.|3|||
164430693|NCT00768066|593947289|FG002|Overall Study|Did not receive study product injection.|0|||
164430694|NCT05550337|593947290|FG000|Overall Study|Lack of Efficacy|0|||
164430695|NCT05550337|593947291|FG001|Overall Study|Lack of Efficacy|0|||
164430696|NCT05550337|593947292|FG002|Overall Study|Lack of Efficacy|1|||
164430697|NCT05550337|593947290|FG000|Overall Study|Adverse Event|1|||
164430698|NCT05550337|593947291|FG001|Overall Study|Adverse Event|5|||
164430699|NCT05550337|593947292|FG002|Overall Study|Adverse Event|0|||
164430700|NCT05550337|593947290|FG000|Overall Study|Withdrawal by Subject|8|||
164430701|NCT05550337|593947291|FG001|Overall Study|Withdrawal by Subject|14|||
164430702|NCT05550337|593947292|FG002|Overall Study|Withdrawal by Subject|10|||
164430703|NCT05550337|593947290|FG000|Overall Study|Pregnancy|0|||
164430704|NCT05550337|593947291|FG001|Overall Study|Pregnancy|0|||
164430705|NCT05550337|593947292|FG002|Overall Study|Pregnancy|1|||
164430706|NCT05550337|593947290|FG000|Overall Study|Protocol Violation|1|||
164430707|NCT05550337|593947291|FG001|Overall Study|Protocol Violation|3|||
164430708|NCT05550337|593947292|FG002|Overall Study|Protocol Violation|4|||
164430709|NCT05550337|593947290|FG000|Overall Study|Physician Decision|2|||
164430710|NCT05550337|593947291|FG001|Overall Study|Physician Decision|1|||
164430711|NCT05550337|593947292|FG002|Overall Study|Physician Decision|1|||
164430712|NCT05550337|593947290|FG000|Overall Study|Lost to Follow-up|16|||
164430713|NCT05550337|593947291|FG001|Overall Study|Lost to Follow-up|11|||
164430714|NCT05550337|593947292|FG002|Overall Study|Lost to Follow-up|11|||
164430715|NCT02189863|593947293|FG000|First 2 Weeks|Motion Sickness|4|||
164430716|NCT02189863|593947294|FG001|First 2 Weeks|Motion Sickness|2|||
164430717|NCT03697460|593947295|FG000|Overall Study|Withdrawal by Subject|3|||
164430718|NCT00813488|593947301|FG000|Titration Period 1|Adverse Event|6|||
164430719|NCT00813488|593947302|FG001|Titration Period 1|Adverse Event|1|||
164430720|NCT00813488|593947301|FG000|Titration Period 1|Lack of Efficacy|9|||
164430721|NCT00813488|593947302|FG001|Titration Period 1|Lack of Efficacy|7|||
164430722|NCT00813488|593947301|FG000|Titration Period 1|Withdrawal by Subject|2|||
164430723|NCT00813488|593947302|FG001|Titration Period 1|Withdrawal by Subject|2|||
164430724|NCT00813488|593947301|FG000|Titration Period 1|Protocol Violation|4|||
164430725|NCT00813488|593947302|FG001|Titration Period 1|Protocol Violation|3|||
164430726|NCT00813488|593947301|FG000|Titration Period 1|Non-compliance to study medication|4|||
164430727|NCT00813488|593947302|FG001|Titration Period 1|Non-compliance to study medication|1|||
164430728|NCT00813488|593947301|FG000|Titration Period 1|Non-compliance to study procedures|2|||
164430729|NCT00813488|593947302|FG001|Titration Period 1|Non-compliance to study procedures|2|||
164430730|NCT00813488|593947301|FG000|Titration Period 1|Technical Difficulties|0|||
164430731|NCT00813488|593947302|FG001|Titration Period 1|Technical Difficulties|1|||
164430732|NCT00813488|593947301|FG000|Titration Period 2|Adverse Event|2|||
164430733|NCT00813488|593947302|FG001|Titration Period 2|Adverse Event|3|||
164430734|NCT00813488|593947301|FG000|Titration Period 2|Lack of Efficacy|8|||
164430735|NCT00813488|593947302|FG001|Titration Period 2|Lack of Efficacy|4|||
164430736|NCT00813488|593947301|FG000|Titration Period 2|Protocol Violation|3|||
164430737|NCT00813488|593947302|FG001|Titration Period 2|Protocol Violation|2|||
164430738|NCT00813488|593947301|FG000|Titration Period 2|Lost to Follow-up|1|||
164430739|NCT00813488|593947302|FG001|Titration Period 2|Lost to Follow-up|0|||
164686569|NCT02733627|594876509|FG002|Overall Study|Adverse Event|1|||
164686570|NCT02733627|594876510|FG003|Overall Study|Adverse Event|0|||
164430740|NCT00813488|593947301|FG000|Titration Period 2|Non-compliance with study procedures|2|||
164430741|NCT00813488|593947302|FG001|Titration Period 2|Non-compliance with study procedures|1|||
164430742|NCT00813488|593947301|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
164430743|NCT00813488|593947302|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
164686571|NCT02733627|594876507|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
164267035|NCT02876328|593346171|FG006|Overall Study|Withdrawal by Subject|0|||
164267036|NCT02876328|593346172|FG007|Overall Study|Withdrawal by Subject|1|||
164267037|NCT02876328|593346173|FG008|Overall Study|Withdrawal by Subject|1|||
164267038|NCT02876328|593346174|FG009|Overall Study|Withdrawal by Subject|2|||
164430744|NCT00813488|593947301|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
164430745|NCT00813488|593947302|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
164430746|NCT00813488|593947301|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
164430747|NCT00813488|593947302|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
164430748|NCT00813488|593947301|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
164430749|NCT00813488|593947302|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
164430750|NCT00813488|593947301|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
164430751|NCT00813488|593947302|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
164267039|NCT02876328|593346175|FG010|Overall Study|Withdrawal by Subject|0|||
164267040|NCT02876328|593346176|FG011|Overall Study|Withdrawal by Subject|0|||
164267041|NCT02876328|593346177|FG012|Overall Study|Withdrawal by Subject|0|||
164267042|NCT02876328|593346178|FG013|Overall Study|Withdrawal by Subject|0|||
164267043|NCT02876328|593346179|FG014|Overall Study|Withdrawal by Subject|0|||
164267044|NCT02876328|593346180|FG015|Overall Study|Withdrawal by Subject|0|||
164267045|NCT02876328|593346181|FG016|Overall Study|Withdrawal by Subject|1|||
164267046|NCT02876328|593346182|FG017|Overall Study|Withdrawal by Subject|3|||
164267047|NCT02876328|593346183|FG018|Overall Study|Withdrawal by Subject|0|||
164267048|NCT02876328|593346184|FG019|Overall Study|Withdrawal by Subject|0|||
164267049|NCT02876328|593346185|FG020|Overall Study|Withdrawal by Subject|1|||
164267050|NCT02876328|593346186|FG021|Overall Study|Withdrawal by Subject|0|||
164267051|NCT02876328|593346187|FG022|Overall Study|Withdrawal by Subject|0|||
164267052|NCT02876328|593346188|FG023|Overall Study|Withdrawal by Subject|0|||
164267053|NCT02876328|593346165|FG000|Overall Study|Missed 12 Month Visit|15|||
164267054|NCT02876328|593346166|FG001|Overall Study|Missed 12 Month Visit|10|||
164267055|NCT02876328|593346167|FG002|Overall Study|Missed 12 Month Visit|11|||
164267056|NCT02876328|593346168|FG003|Overall Study|Missed 12 Month Visit|6|||
164267057|NCT02876328|593346169|FG004|Overall Study|Missed 12 Month Visit|10|||
164267058|NCT02876328|593346170|FG005|Overall Study|Missed 12 Month Visit|14|||
164267059|NCT02876328|593346171|FG006|Overall Study|Missed 12 Month Visit|3|||
164267060|NCT02876328|593346172|FG007|Overall Study|Missed 12 Month Visit|8|||
164267061|NCT02876328|593346173|FG008|Overall Study|Missed 12 Month Visit|9|||
164267062|NCT02876328|593346174|FG009|Overall Study|Missed 12 Month Visit|5|||
164267063|NCT02876328|593346175|FG010|Overall Study|Missed 12 Month Visit|4|||
164267064|NCT02876328|593346176|FG011|Overall Study|Missed 12 Month Visit|1|||
164267065|NCT02876328|593346177|FG012|Overall Study|Missed 12 Month Visit|5|||
164267066|NCT02876328|593346178|FG013|Overall Study|Missed 12 Month Visit|4|||
164267067|NCT02876328|593346179|FG014|Overall Study|Missed 12 Month Visit|4|||
164267068|NCT02876328|593346180|FG015|Overall Study|Missed 12 Month Visit|4|||
164267069|NCT02876328|593346181|FG016|Overall Study|Missed 12 Month Visit|3|||
164267070|NCT02876328|593346182|FG017|Overall Study|Missed 12 Month Visit|6|||
164267071|NCT02876328|593346183|FG018|Overall Study|Missed 12 Month Visit|2|||
164267072|NCT02876328|593346184|FG019|Overall Study|Missed 12 Month Visit|2|||
164267073|NCT02876328|593346185|FG020|Overall Study|Missed 12 Month Visit|11|||
164267074|NCT02876328|593346186|FG021|Overall Study|Missed 12 Month Visit|7|||
164267075|NCT02876328|593346187|FG022|Overall Study|Missed 12 Month Visit|1|||
164267076|NCT02876328|593346188|FG023|Overall Study|Missed 12 Month Visit|0|||
164267077|NCT01995552|593346189|FG000|Overall Study|Protocol Violation|1|||
164267078|NCT01995552|593346189|FG000|Overall Study|Lack of Efficacy|15|||
164267079|NCT01995552|593346189|FG000|Overall Study|Death|1|||
164267080|NCT02068118|593346191|FG000|18-month Comparative Study Period|Death|90|||
164267081|NCT02068118|593346192|FG001|18-month Comparative Study Period|Death|97|||
164267082|NCT02068118|593346191|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
164267083|NCT02068118|593346192|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
164267084|NCT02068118|593346191|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
164430752|NCT00813488|593947301|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
164581330|NCT00923091|594493954|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
164581331|NCT00923091|594493955|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
164581332|NCT00923091|594493956|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
164581333|NCT00923091|594493957|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
164581334|NCT00923091|594493945|FG000|Period III (Single-Blind)|Protocol Violation|3|||
164581335|NCT00923091|594493946|FG001|Period III (Single-Blind)|Protocol Violation|0|||
164581336|NCT00923091|594493947|FG002|Period III (Single-Blind)|Protocol Violation|0|||
164267085|NCT02068118|593346192|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
164267086|NCT02068118|593346191|FG000|18-month Comparative Study Period|Heart transplant|9|||
164267087|NCT02068118|593346192|FG001|18-month Comparative Study Period|Heart transplant|15|||
164267088|NCT02068118|593346191|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
164267089|NCT02068118|593346192|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
164267090|NCT02068118|593346191|FG000|18-month Comparative Study Period|Hemiplegia|0|||
164267091|NCT02068118|593346192|FG001|18-month Comparative Study Period|Hemiplegia|1|||
164267092|NCT02068118|593346191|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
164267093|NCT02068118|593346192|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
164267094|NCT02068118|593346191|FG000|18-month Comparative Study Period|Move|0|||
164267095|NCT02068118|593346192|FG001|18-month Comparative Study Period|Move|1|||
164267096|NCT02068118|593346191|FG000|18-month Comparative Study Period|Hearing loss|0|||
164267097|NCT02068118|593346192|FG001|18-month Comparative Study Period|Hearing loss|1|||
164267098|NCT02068118|593346191|FG000|Extension Period|Death|0|||
164267099|NCT02068118|593346192|FG001|Extension Period|Death|2|||
164267100|NCT02068118|593346191|FG000|Extension Period|Withdrawal by Subject|1|||
164267101|NCT02068118|593346192|FG001|Extension Period|Withdrawal by Subject|0|||
164267102|NCT02068118|593346191|FG000|Extension Period|Heart transplant|1|||
164267103|NCT02068118|593346192|FG001|Extension Period|Heart transplant|0|||
164267104|NCT02068118|593346191|FG000|Extension Period|Wrong device use|0|||
164267105|NCT02068118|593346192|FG001|Extension Period|Wrong device use|1|||
164267106|NCT00353873|593346195|FG000|Overall Study|Protocol Violation|1|||
164267107|NCT00353873|593346196|FG001|Overall Study|Protocol Violation|2|||
164267108|NCT00353873|593346195|FG000|Overall Study|Exacerbation|1|||
164267109|NCT00353873|593346196|FG001|Overall Study|Exacerbation|0|||
164267110|NCT00353873|593346195|FG000|Overall Study|Adverse Event|1|||
164267111|NCT00353873|593346196|FG001|Overall Study|Adverse Event|0|||
164267112|NCT00353873|593346195|FG000|Overall Study|Physician Decision|2|||
164267113|NCT00353873|593346196|FG001|Overall Study|Physician Decision|0|||
164267114|NCT00353873|593346195|FG000|Overall Study|Withdrawal by Subject|1|||
164267115|NCT00353873|593346196|FG001|Overall Study|Withdrawal by Subject|1|||
164267116|NCT01420627|593346197|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
164267117|NCT00453973|593346198|FG000|Overall Study|Adverse Event|4|||
164267118|NCT00453973|593346199|FG001|Overall Study|Adverse Event|9|||
164267119|NCT00453973|593346198|FG000|Overall Study|Withdrawal by Subject|7|||
164267120|NCT00453973|593346199|FG001|Overall Study|Withdrawal by Subject|6|||
164267121|NCT00453973|593346198|FG000|Overall Study|PI Decision|0|||
164267122|NCT00453973|593346199|FG001|Overall Study|PI Decision|2|||
164267123|NCT00453973|593346198|FG000|Overall Study|Relocation|1|||
164267124|NCT00453973|593346199|FG001|Overall Study|Relocation|0|||
164267125|NCT00453973|593346198|FG000|Overall Study|Renal transplant|1|||
164267126|NCT00453973|593346199|FG001|Overall Study|Renal transplant|1|||
164267127|NCT00453973|593346198|FG000|Overall Study|Site closed by sponsor|3|||
164267128|NCT00453973|593346199|FG001|Overall Study|Site closed by sponsor|0|||
164267129|NCT00453973|593346198|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
164267130|NCT00453973|593346199|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
164267131|NCT03743064|593346200|FG000|Overall Study|Adverse Event|7|||
164267132|NCT03743064|593346201|FG001|Overall Study|Adverse Event|9|||
164267133|NCT03743064|593346200|FG000|Overall Study|Death|25|||
164267134|NCT03743064|593346201|FG001|Overall Study|Death|28|||
164267135|NCT03743064|593346200|FG000|Overall Study|Lost to Follow-up|3|||
164267136|NCT03743064|593346201|FG001|Overall Study|Lost to Follow-up|6|||
164267137|NCT03743064|593346200|FG000|Overall Study|Withdrawal by Subject|28|||
164267138|NCT03743064|593346201|FG001|Overall Study|Withdrawal by Subject|25|||
164267139|NCT03743064|593346200|FG000|Overall Study|Physician Decision|2|||
164267140|NCT03743064|593346201|FG001|Overall Study|Physician Decision|4|||
164267141|NCT03743064|593346200|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
164267142|NCT03743064|593346201|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
164267143|NCT02759315|593346206|FG000|Overall Study|Adverse Event|0|||
164267144|NCT02759315|593346207|FG001|Overall Study|Adverse Event|0|||
164267145|NCT02759315|593346208|FG002|Overall Study|Adverse Event|0|||
164267146|NCT02759315|593346209|FG003|Overall Study|Adverse Event|1|||
164686572|NCT02733627|594876508|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
164686573|NCT02733627|594876509|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
164686574|NCT02733627|594876510|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
164686575|NCT02246764|594876511|FG000|Overall Study|Adverse Event|15|||
164686576|NCT02246764|594876512|FG001|Overall Study|Adverse Event|29|||
164686577|NCT02246764|594876513|FG002|Overall Study|Adverse Event|1|||
164686578|NCT02246764|594876511|FG000|Overall Study|Withdrawal by Subject|0|||
164686579|NCT02246764|594876512|FG001|Overall Study|Withdrawal by Subject|0|||
164686580|NCT02246764|594876513|FG002|Overall Study|Withdrawal by Subject|1|||
164686581|NCT02246764|594876511|FG000|Overall Study|Disallowed Concomitant Medication|1|||
164686582|NCT02246764|594876512|FG001|Overall Study|Disallowed Concomitant Medication|0|||
164267147|NCT02759315|593346210|FG004|Overall Study|Adverse Event|0|||
164267148|NCT02759315|593346206|FG000|Overall Study|Death|0|||
164267149|NCT02759315|593346207|FG001|Overall Study|Death|0|||
164267150|NCT02759315|593346208|FG002|Overall Study|Death|1|||
164267151|NCT02759315|593346209|FG003|Overall Study|Death|0|||
164267152|NCT02759315|593346210|FG004|Overall Study|Death|0|||
164267153|NCT02759315|593346206|FG000|Overall Study|Lost to Follow-up|2|||
164267154|NCT02759315|593346207|FG001|Overall Study|Lost to Follow-up|0|||
164267155|NCT02759315|593346208|FG002|Overall Study|Lost to Follow-up|4|||
164686583|NCT02246764|594876513|FG002|Overall Study|Disallowed Concomitant Medication|0|||
164267156|NCT02759315|593346209|FG003|Overall Study|Lost to Follow-up|0|||
164267157|NCT02759315|593346210|FG004|Overall Study|Lost to Follow-up|0|||
164267158|NCT02759315|593346206|FG000|Overall Study|Protocol Violation|0|||
164267159|NCT02759315|593346207|FG001|Overall Study|Protocol Violation|1|||
164267160|NCT02759315|593346208|FG002|Overall Study|Protocol Violation|0|||
164267161|NCT02759315|593346209|FG003|Overall Study|Protocol Violation|0|||
164267162|NCT02759315|593346210|FG004|Overall Study|Protocol Violation|0|||
164267163|NCT02759315|593346206|FG000|Overall Study|Study terminated prior to completion|2|||
164267164|NCT02759315|593346207|FG001|Overall Study|Study terminated prior to completion|0|||
164267165|NCT02759315|593346208|FG002|Overall Study|Study terminated prior to completion|5|||
164267166|NCT02759315|593346209|FG003|Overall Study|Study terminated prior to completion|0|||
164267167|NCT02759315|593346210|FG004|Overall Study|Study terminated prior to completion|1|||
164267168|NCT00870194|593346211|FG000|Overall Study|Adverse Event|10|||
164267169|NCT00870194|593346212|FG001|Overall Study|Adverse Event|5|||
164267170|NCT00870194|593346211|FG000|Overall Study|Lack of Efficacy|0|||
164267171|NCT00870194|593346212|FG001|Overall Study|Lack of Efficacy|1|||
164267172|NCT00870194|593346211|FG000|Overall Study|Lost to Follow-up|2|||
164267173|NCT00870194|593346212|FG001|Overall Study|Lost to Follow-up|0|||
164267174|NCT00870194|593346211|FG000|Overall Study|Physician Decision|3|||
164267175|NCT00870194|593346212|FG001|Overall Study|Physician Decision|1|||
164267176|NCT00870194|593346211|FG000|Overall Study|Protocol Violation|3|||
164267177|NCT00870194|593346212|FG001|Overall Study|Protocol Violation|3|||
164267178|NCT00870194|593346211|FG000|Overall Study|Entry Criteria Not Met|1|||
164267179|NCT00870194|593346212|FG001|Overall Study|Entry Criteria Not Met|2|||
164267180|NCT00870194|593346211|FG000|Overall Study|Subject Decision|7|||
164267181|NCT00870194|593346212|FG001|Overall Study|Subject Decision|2|||
164267182|NCT01219933|593346213|FG000|Overall Study|Adverse Event|8|||
164267183|NCT01219933|593346213|FG000|Overall Study|No LDA reached|5|||
164267184|NCT01219933|593346213|FG000|Overall Study|No LDA maintained|7|||
164267185|NCT01219933|593346213|FG000|Overall Study|Lost to Follow-up|3|||
164267186|NCT01219933|593346213|FG000|Overall Study|GC free|1|||
164267187|NCT01219933|593346213|FG000|Overall Study|Withdrawal by Subject|5|||
164267188|NCT01219933|593346213|FG000|Overall Study|Protocol Violation|8|||
164267189|NCT01219933|593346213|FG000|Overall Study|Lack of Efficacy|1|||
164267190|NCT00582738|593346214|FG000|Overall Study|Administrative Problems|7|||
164267191|NCT00582738|593346215|FG001|Overall Study|Administrative Problems|8|||
164267192|NCT00582738|593346214|FG000|Overall Study|Adverse Event|0|||
164267193|NCT00582738|593346215|FG001|Overall Study|Adverse Event|5|||
164267194|NCT00582738|593346214|FG000|Overall Study|Graft Lost|0|||
164267195|NCT00582738|593346215|FG001|Overall Study|Graft Lost|1|||
164267196|NCT00582738|593346214|FG000|Overall Study|Other|1|||
164267197|NCT00582738|593346215|FG001|Overall Study|Other|0|||
164267198|NCT00582738|593346214|FG000|Overall Study|Protocol Violation|1|||
164267199|NCT00582738|593346215|FG001|Overall Study|Protocol Violation|1|||
164267200|NCT00582738|593346214|FG000|Overall Study|Withdrawal by Subject|0|||
164267201|NCT00582738|593346215|FG001|Overall Study|Withdrawal by Subject|3|||
164267202|NCT02210091|593346219|FG000|Overall Study|Physician Decision|0|||
164267203|NCT02210091|593346220|FG001|Overall Study|Physician Decision|1|||
164267204|NCT02210091|593346219|FG000|Overall Study|Withdrawal by Sponsor|0|||
164267205|NCT02210091|593346220|FG001|Overall Study|Withdrawal by Sponsor|1|||
164267206|NCT01831817|593346221|FG000|Overall Study|Lost to Follow-up|1|||
164267207|NCT01831817|593346222|FG001|Overall Study|Lost to Follow-up|0|||
164267208|NCT01831817|593346223|FG002|Overall Study|Lost to Follow-up|0|||
164267209|NCT01831817|593346224|FG003|Overall Study|Lost to Follow-up|0|||
164267210|NCT01831817|593346221|FG000|Overall Study|Withdrawl of Consent|3|||
164267211|NCT01831817|593346222|FG001|Overall Study|Withdrawl of Consent|0|||
164267212|NCT01831817|593346223|FG002|Overall Study|Withdrawl of Consent|0|||
164267213|NCT01831817|593346224|FG003|Overall Study|Withdrawl of Consent|0|||
164267214|NCT00958217|593346225|FG000|Overall Study|Death|2|||
164267215|NCT00958217|593346226|FG001|Overall Study|Death|1|||
164267216|NCT00958217|593346225|FG000|Overall Study|Withdrawal by Subject|4|||
164267217|NCT00958217|593346226|FG001|Overall Study|Withdrawal by Subject|3|||
164267218|NCT00958217|593346225|FG000|Overall Study|Lost to Follow-up|17|||
164341925|NCT00932126|593627569|FG005|Overall Study|Withdrawal by Subject|0|||
164686584|NCT02246764|594876511|FG000|Overall Study|Physician Decision|0|||
164686585|NCT02246764|594876512|FG001|Overall Study|Physician Decision|2|||
164686586|NCT02246764|594876513|FG002|Overall Study|Physician Decision|1|||
164686587|NCT02246764|594876511|FG000|Overall Study|Protocol Violation|2|||
164686588|NCT02246764|594876512|FG001|Overall Study|Protocol Violation|1|||
164686589|NCT02246764|594876513|FG002|Overall Study|Protocol Violation|1|||
164267219|NCT00958217|593346226|FG001|Overall Study|Lost to Follow-up|19|||
164267220|NCT00958217|593346225|FG000|Overall Study|Moved out of area|1|||
164267221|NCT00958217|593346226|FG001|Overall Study|Moved out of area|1|||
164267222|NCT00958217|593346225|FG000|Overall Study|Inpatient hospitalization|0|||
164267223|NCT00958217|593346226|FG001|Overall Study|Inpatient hospitalization|1|||
164267224|NCT02198235|593346228|FG000|Overall Study|Lost to Follow-up|3|||
164267225|NCT02198235|593346229|FG001|Overall Study|Lost to Follow-up|2|||
164686590|NCT05393271|594876514|FG000|Overall Study|Physician Decision|0|||
164267226|NCT02198235|593346230|FG002|Overall Study|Lost to Follow-up|2|||
164267227|NCT02440789|593346231|FG000|Overall Study|Withdrawal by Subject|3|||
164267228|NCT02440789|593346231|FG000|Overall Study|Not willing to adhere to reqs|1|||
164267229|NCT01999218|593346232|FG000|Overall Study|Hyperglycemia|18|||
164267230|NCT01999218|593346233|FG001|Overall Study|Hyperglycemia|17|||
164267231|NCT01999218|593346234|FG002|Overall Study|Hyperglycemia|17|||
164267232|NCT01999218|593346232|FG000|Overall Study|Lack of Efficacy|1|||
164267233|NCT01999218|593346233|FG001|Overall Study|Lack of Efficacy|0|||
164267234|NCT01999218|593346234|FG002|Overall Study|Lack of Efficacy|1|||
164267235|NCT01999218|593346232|FG000|Overall Study|Lost to Follow-up|22|||
164267236|NCT01999218|593346233|FG001|Overall Study|Lost to Follow-up|17|||
164267237|NCT01999218|593346234|FG002|Overall Study|Lost to Follow-up|18|||
164267238|NCT01999218|593346232|FG000|Overall Study|Non-Compliance With Study Drug|6|||
164267239|NCT01999218|593346233|FG001|Overall Study|Non-Compliance With Study Drug|4|||
164267240|NCT01999218|593346234|FG002|Overall Study|Non-Compliance With Study Drug|1|||
164267241|NCT01999218|593346232|FG000|Overall Study|Physician Decision|1|||
164267242|NCT01999218|593346233|FG001|Overall Study|Physician Decision|4|||
164267243|NCT01999218|593346234|FG002|Overall Study|Physician Decision|6|||
164267244|NCT01999218|593346232|FG000|Overall Study|Protocol Violation|4|||
164267245|NCT01999218|593346233|FG001|Overall Study|Protocol Violation|5|||
164267246|NCT01999218|593346234|FG002|Overall Study|Protocol Violation|4|||
164267247|NCT01999218|593346232|FG000|Overall Study|Screen failure|0|||
164267248|NCT01999218|593346233|FG001|Overall Study|Screen failure|1|||
164267249|NCT01999218|593346234|FG002|Overall Study|Screen failure|0|||
164267250|NCT01999218|593346232|FG000|Overall Study|Study Terminated By Sponsor|7|||
164267251|NCT01999218|593346233|FG001|Overall Study|Study Terminated By Sponsor|5|||
164267252|NCT01999218|593346234|FG002|Overall Study|Study Terminated By Sponsor|12|||
164267253|NCT01999218|593346232|FG000|Overall Study|Participant moves|2|||
164267254|NCT01999218|593346233|FG001|Overall Study|Participant moves|5|||
164267255|NCT01999218|593346234|FG002|Overall Study|Participant moves|3|||
164267256|NCT01999218|593346232|FG000|Overall Study|Withdrawal by Subject|28|||
164267257|NCT01999218|593346233|FG001|Overall Study|Withdrawal by Subject|29|||
164267258|NCT01999218|593346234|FG002|Overall Study|Withdrawal by Subject|34|||
164267259|NCT01999218|593346232|FG000|Overall Study|Creatinine/eGFR|0|||
164267260|NCT01999218|593346233|FG001|Overall Study|Creatinine/eGFR|0|||
164267261|NCT01999218|593346234|FG002|Overall Study|Creatinine/eGFR|1|||
164267262|NCT01999218|593346232|FG000|Overall Study|Death|7|||
164267263|NCT01999218|593346233|FG001|Overall Study|Death|1|||
164267264|NCT01999218|593346234|FG002|Overall Study|Death|2|||
164267265|NCT01999218|593346232|FG000|Overall Study|Excluded Medication|1|||
164267266|NCT01999218|593346233|FG001|Overall Study|Excluded Medication|1|||
164267267|NCT01999218|593346234|FG002|Overall Study|Excluded Medication|2|||
164267268|NCT01999218|593346232|FG000|Overall Study|Adverse Event|9|||
164267269|NCT01999218|593346233|FG001|Overall Study|Adverse Event|7|||
164267270|NCT01999218|593346234|FG002|Overall Study|Adverse Event|7|||
164267271|NCT01999218|593346232|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
164267272|NCT01999218|593346233|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
164267273|NCT01999218|593346234|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
164267274|NCT01073930|593348516|FG000|Overall Study|Withdrawal by Subject|3|||
164267275|NCT01073930|593348517|FG001|Overall Study|Withdrawal by Subject|2|||
164267276|NCT01073930|593348516|FG000|Overall Study|Lost to Follow-up|0|||
164267277|NCT01073930|593348517|FG001|Overall Study|Lost to Follow-up|1|||
164267278|NCT01073930|593348516|FG000|Overall Study|Adverse Event|0|||
164267279|NCT01073930|593348517|FG001|Overall Study|Adverse Event|1|||
164267280|NCT01073930|593348516|FG000|Overall Study|Noncompliance with study drug|0|||
164267281|NCT01073930|593348517|FG001|Overall Study|Noncompliance with study drug|1|||
164267282|NCT01073930|593348516|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
164267283|NCT01073930|593348517|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
164267284|NCT04030962|593348519|FG000|Stage 2|Adverse Event|0|||
164267285|NCT04030962|593348520|FG001|Stage 2|Adverse Event|0|||
164267286|NCT04030962|593348521|FG002|Stage 2|Adverse Event|0|||
164267287|NCT04030962|593348522|FG003|Stage 2|Adverse Event|0|||
164267288|NCT04030962|593348523|FG004|Stage 2|Adverse Event|0|||
164267289|NCT04030962|593348524|FG005|Stage 2|Adverse Event|0|||
164267290|NCT04030962|593348525|FG006|Stage 2|Adverse Event|0|||
164267291|NCT04030962|593348526|FG007|Stage 2|Adverse Event|0|||
164267292|NCT04030962|593348527|FG008|Stage 2|Adverse Event|1|||
164267293|NCT04030962|593348528|FG009|Stage 2|Adverse Event|0|||
164267294|NCT04030962|593348529|FG010|Stage 2|Adverse Event|1|||
164267295|NCT04030962|593348530|FG011|Stage 2|Adverse Event|1|||
164267296|NCT04030962|593348531|FG012|Stage 2|Adverse Event|1|||
164267297|NCT04030962|593348519|FG000|Stage 2|Withdrawal by Subject|0|||
164267298|NCT04030962|593348520|FG001|Stage 2|Withdrawal by Subject|0|||
164267299|NCT04030962|593348521|FG002|Stage 2|Withdrawal by Subject|0|||
164267300|NCT04030962|593348522|FG003|Stage 2|Withdrawal by Subject|0|||
164267301|NCT04030962|593348523|FG004|Stage 2|Withdrawal by Subject|0|||
164267302|NCT04030962|593348524|FG005|Stage 2|Withdrawal by Subject|0|||
164267303|NCT04030962|593348525|FG006|Stage 2|Withdrawal by Subject|0|||
164267304|NCT04030962|593348526|FG007|Stage 2|Withdrawal by Subject|0|||
164267305|NCT04030962|593348527|FG008|Stage 2|Withdrawal by Subject|1|||
164686591|NCT05393271|594876515|FG001|Overall Study|Physician Decision|0|||
164686592|NCT05393271|594876516|FG002|Overall Study|Physician Decision|0|||
164686593|NCT05393271|594876517|FG003|Overall Study|Physician Decision|0|||
164686594|NCT05393271|594876518|FG004|Overall Study|Physician Decision|0|||
164267306|NCT04030962|593348528|FG009|Stage 2|Withdrawal by Subject|0|||
164267307|NCT04030962|593348529|FG010|Stage 2|Withdrawal by Subject|0|||
164267308|NCT04030962|593348530|FG011|Stage 2|Withdrawal by Subject|2|||
164267309|NCT04030962|593348531|FG012|Stage 2|Withdrawal by Subject|1|||
164267310|NCT04030962|593348519|FG000|Stage 2|Lost to Follow-up|0|||
164267311|NCT04030962|593348520|FG001|Stage 2|Lost to Follow-up|0|||
164267312|NCT04030962|593348521|FG002|Stage 2|Lost to Follow-up|0|||
164267313|NCT04030962|593348522|FG003|Stage 2|Lost to Follow-up|0|||
164267314|NCT04030962|593348523|FG004|Stage 2|Lost to Follow-up|0|||
164267315|NCT04030962|593348524|FG005|Stage 2|Lost to Follow-up|0|||
164267316|NCT04030962|593348525|FG006|Stage 2|Lost to Follow-up|0|||
164267317|NCT04030962|593348526|FG007|Stage 2|Lost to Follow-up|0|||
164267318|NCT04030962|593348527|FG008|Stage 2|Lost to Follow-up|1|||
164267319|NCT04030962|593348528|FG009|Stage 2|Lost to Follow-up|0|||
164267320|NCT04030962|593348529|FG010|Stage 2|Lost to Follow-up|0|||
164267321|NCT04030962|593348530|FG011|Stage 2|Lost to Follow-up|0|||
164267322|NCT04030962|593348531|FG012|Stage 2|Lost to Follow-up|0|||
164267323|NCT04030962|593348519|FG000|Stage 2|Technical Problems|0|||
164267324|NCT04030962|593348520|FG001|Stage 2|Technical Problems|0|||
164267325|NCT04030962|593348521|FG002|Stage 2|Technical Problems|0|||
164267326|NCT04030962|593348522|FG003|Stage 2|Technical Problems|0|||
164267327|NCT04030962|593348523|FG004|Stage 2|Technical Problems|0|||
164267328|NCT04030962|593348524|FG005|Stage 2|Technical Problems|0|||
164267329|NCT04030962|593348525|FG006|Stage 2|Technical Problems|0|||
164267330|NCT04030962|593348526|FG007|Stage 2|Technical Problems|0|||
164267331|NCT04030962|593348527|FG008|Stage 2|Technical Problems|0|||
164267332|NCT04030962|593348528|FG009|Stage 2|Technical Problems|0|||
164267333|NCT04030962|593348529|FG010|Stage 2|Technical Problems|0|||
164267334|NCT04030962|593348530|FG011|Stage 2|Technical Problems|1|||
164267335|NCT04030962|593348531|FG012|Stage 2|Technical Problems|0|||
164267336|NCT05288166|593348534|FG000|Overall Study|Adverse Event|1|||
164267337|NCT05288166|593348535|FG001|Overall Study|Adverse Event|0|||
164267338|NCT05288166|593348534|FG000|Overall Study|Lost to Follow-up|2|||
164267339|NCT05288166|593348535|FG001|Overall Study|Lost to Follow-up|0|||
164267340|NCT05288166|593348534|FG000|Overall Study|Physician Decision|0|||
164267341|NCT05288166|593348535|FG001|Overall Study|Physician Decision|2|||
164267342|NCT05288166|593348534|FG000|Overall Study|Screen Failure|1|||
164267343|NCT05288166|593348535|FG001|Overall Study|Screen Failure|1|||
164267344|NCT05288166|593348534|FG000|Overall Study|Withdrawal by Subject|4|||
164267345|NCT05288166|593348535|FG001|Overall Study|Withdrawal by Subject|2|||
164267346|NCT05288166|593348534|FG000|Overall Study|On Study Treatment|408|||
164267347|NCT05288166|593348535|FG001|Overall Study|On Study Treatment|418|||
164267348|NCT01114360|593348536|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
164267349|NCT01114360|593348537|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
164267350|NCT03007745|593348538|FG000|Overall Study|Sleep test negative for OSA|53|||
164267351|NCT03007745|593348539|FG001|Overall Study|Sleep test negative for OSA|49|||
164267352|NCT03007745|593348538|FG000|Overall Study|Physician Decision|6|||
164267353|NCT03007745|593348539|FG001|Overall Study|Physician Decision|9|||
164267354|NCT03007745|593348538|FG000|Overall Study|Withdrawal by Subject|38|||
164267355|NCT03007745|593348539|FG001|Overall Study|Withdrawal by Subject|16|||
164267356|NCT03007745|593348538|FG000|Overall Study|Lost to Follow-up|19|||
164267357|NCT03007745|593348539|FG001|Overall Study|Lost to Follow-up|25|||
164267358|NCT03007745|593348538|FG000|Overall Study|Unable to login to website|17|||
164267359|NCT03007745|593348539|FG001|Overall Study|Unable to login to website|4|||
164267360|NCT04912895|593348542|FG000|Overall Study|Unable to provide specimen|2|||
164267361|NCT04912895|593348543|FG001|Overall Study|Unable to provide specimen|0|||
164267362|NCT04912895|593348544|FG002|Overall Study|Unable to provide specimen|0|||
164267363|NCT02981524|593348545|FG000|Overall Study|Progressive Disease|14|||
164267364|NCT02981524|593348545|FG000|Overall Study|Death (unrelated)|1|||
164267365|NCT02981524|593348545|FG000|Overall Study|Treatment Related Toxicity|1|||
164267366|NCT02981524|593348545|FG000|Overall Study|Withdrawal by Subject|1|||
164267367|NCT00520013|593348546|FG000|Overall Study|Withdrawal by Subject|0|||
164267368|NCT00520013|593348547|FG001|Overall Study|Withdrawal by Subject|0|||
164267369|NCT00520013|593348548|FG002|Overall Study|Withdrawal by Subject|1|||
164267370|NCT00520013|593348546|FG000|Overall Study|Adverse Event|2|||
164267371|NCT00520013|593348547|FG001|Overall Study|Adverse Event|10|||
164267372|NCT00520013|593348548|FG002|Overall Study|Adverse Event|7|||
164267373|NCT00520013|593348546|FG000|Overall Study|Progressive Disease|7|||
164267374|NCT00520013|593348547|FG001|Overall Study|Progressive Disease|3|||
164267375|NCT00520013|593348548|FG002|Overall Study|Progressive Disease|0|||
164267376|NCT00520013|593348546|FG000|Overall Study|Clinical Progression|3|||
164267377|NCT00520013|593348547|FG001|Overall Study|Clinical Progression|1|||
164267378|NCT00520013|593348548|FG002|Overall Study|Clinical Progression|0|||
164267379|NCT00520013|593348546|FG000|Overall Study|Death|0|||
164267380|NCT00520013|593348547|FG001|Overall Study|Death|1|||
164267381|NCT00520013|593348548|FG002|Overall Study|Death|0|||
164686595|NCT05393271|594876519|FG005|Overall Study|Physician Decision|0|||
164267382|NCT00520013|593348546|FG000|Overall Study|Physician Decision|0|||
164267383|NCT00520013|593348547|FG001|Overall Study|Physician Decision|0|||
164267384|NCT00520013|593348548|FG002|Overall Study|Physician Decision|3|||
164267385|NCT00159913|593348549|FG000|Overall Study|Adverse Event|1|||
164267386|NCT00159913|593348550|FG001|Overall Study|Adverse Event|0|||
164267387|NCT00159913|593348551|FG002|Overall Study|Adverse Event|1|||
164267388|NCT00159913|593348552|FG003|Overall Study|Adverse Event|0|||
164267389|NCT00159913|593348549|FG000|Overall Study|Withdrawal by Subject|0|||
164267390|NCT00159913|593348550|FG001|Overall Study|Withdrawal by Subject|0|||
164267391|NCT00159913|593348551|FG002|Overall Study|Withdrawal by Subject|0|||
164267392|NCT00159913|593348552|FG003|Overall Study|Withdrawal by Subject|1|||
164267393|NCT00159913|593348549|FG000|Overall Study|Lost to Follow-up|0|||
164267394|NCT00159913|593348550|FG001|Overall Study|Lost to Follow-up|0|||
164267395|NCT00159913|593348551|FG002|Overall Study|Lost to Follow-up|0|||
164267396|NCT00159913|593348552|FG003|Overall Study|Lost to Follow-up|1|||
164267397|NCT00159913|593348549|FG000|Overall Study|Protocol Violation|1|||
164267398|NCT00159913|593348550|FG001|Overall Study|Protocol Violation|0|||
164267399|NCT00159913|593348551|FG002|Overall Study|Protocol Violation|1|||
164267400|NCT00159913|593348552|FG003|Overall Study|Protocol Violation|0|||
164267401|NCT03294135|593348553|FG000|Overall Study|Serious Adverse Event|1|||
164267402|NCT03294135|593348554|FG001|Overall Study|Serious Adverse Event|0|||
164267403|NCT03294135|593348555|FG002|Overall Study|Serious Adverse Event|0|||
164267404|NCT03294135|593348553|FG000|Overall Study|Lost to Follow-up|1|||
164267405|NCT03294135|593348554|FG001|Overall Study|Lost to Follow-up|0|||
164267406|NCT03294135|593348555|FG002|Overall Study|Lost to Follow-up|1|||
164267407|NCT03294135|593348553|FG000|Overall Study|Withdrawal by Subject|0|||
164267408|NCT03294135|593348554|FG001|Overall Study|Withdrawal by Subject|0|||
164267409|NCT03294135|593348555|FG002|Overall Study|Withdrawal by Subject|1|||
164267410|NCT03294135|593348553|FG000|Overall Study|Other|2|||
164267411|NCT03294135|593348554|FG001|Overall Study|Other|0|||
164267412|NCT03294135|593348555|FG002|Overall Study|Other|0|||
164267413|NCT02763254|593348556|FG000|Overall Study|Adverse Event|1|||
164267414|NCT03684304|593348558|FG000|Overall Study|Lost to Follow-up|19|||
164267415|NCT03684304|593348559|FG001|Overall Study|Lost to Follow-up|17|||
164267416|NCT00824005|593348560|FG000|Overall Study|Death|0|||
164267417|NCT00824005|593348561|FG001|Overall Study|Death|1|||
164267418|NCT00824005|593348560|FG000|Overall Study|Lost to Follow-up|0|||
164267419|NCT00824005|593348561|FG001|Overall Study|Lost to Follow-up|1|||
164267420|NCT01510184|593348562|FG000|Overall Study|Sponsor discretion|28|||
164267421|NCT01510184|593348563|FG001|Overall Study|Sponsor discretion|28|||
164267422|NCT01510184|593348562|FG000|Overall Study|Death|1|||
164267423|NCT01510184|593348563|FG001|Overall Study|Death|2|||
164686596|NCT05393271|594876520|FG006|Overall Study|Physician Decision|1|||
164267424|NCT01510184|593348562|FG000|Overall Study|Withdrawal by Subject|1|||
164267425|NCT01510184|593348563|FG001|Overall Study|Withdrawal by Subject|4|||
164267426|NCT01510184|593348562|FG000|Overall Study|Other|0|||
164267427|NCT01510184|593348563|FG001|Overall Study|Other|1|||
164267428|NCT01143051|593348564|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
164267429|NCT01143051|593348565|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
164267430|NCT01143051|593348566|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
164267431|NCT01143051|593348567|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
164267432|NCT01143051|593348568|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
164267433|NCT01143051|593348569|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
164267434|NCT01143051|593348564|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
164267435|NCT01143051|593348565|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
164267436|NCT01143051|593348566|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
164267437|NCT01143051|593348567|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
164267438|NCT01143051|593348568|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
164267439|NCT01143051|593348569|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
164267440|NCT03458702|593348570|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
164267441|NCT03458702|593348571|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
164267442|NCT03458702|593348570|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
164267443|NCT03458702|593348571|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
164267444|NCT01390779|593348572|FG000|Overall Study|Physician Decision|1|||
164686597|NCT05393271|594876521|FG007|Overall Study|Physician Decision|0|||
164267445|NCT00765882|593348573|FG000|Overall Study|Adverse Event|10|||
164267446|NCT00765882|593348574|FG001|Overall Study|Adverse Event|21|||
164267447|NCT00765882|593348575|FG002|Overall Study|Adverse Event|20|||
164267448|NCT00765882|593348573|FG000|Overall Study|Lack of Efficacy|4|||
164267449|NCT00765882|593348574|FG001|Overall Study|Lack of Efficacy|0|||
164267450|NCT00765882|593348575|FG002|Overall Study|Lack of Efficacy|1|||
164267451|NCT00765882|593348573|FG000|Overall Study|Protocol Violation|4|||
164267452|NCT00765882|593348574|FG001|Overall Study|Protocol Violation|3|||
164267453|NCT00765882|593348575|FG002|Overall Study|Protocol Violation|1|||
164267454|NCT00765882|593348573|FG000|Overall Study|Withdrawal by Subject|2|||
164267455|NCT00765882|593348574|FG001|Overall Study|Withdrawal by Subject|6|||
164267456|NCT00765882|593348575|FG002|Overall Study|Withdrawal by Subject|6|||
164267457|NCT00765882|593348573|FG000|Overall Study|Lost to Follow-up|1|||
164267458|NCT00765882|593348574|FG001|Overall Study|Lost to Follow-up|9|||
164267459|NCT00765882|593348575|FG002|Overall Study|Lost to Follow-up|6|||
164267460|NCT00765882|593348573|FG000|Overall Study|Other Reason|3|||
164267461|NCT00765882|593348574|FG001|Overall Study|Other Reason|1|||
164267462|NCT00765882|593348575|FG002|Overall Study|Other Reason|2|||
164267463|NCT02231762|593348578|FG000|Combination Phase|Adverse Event|10|||
164267464|NCT02231762|593348579|FG001|Combination Phase|Adverse Event|0|||
164267465|NCT02231762|593348580|FG002|Combination Phase|Adverse Event|0|||
164267466|NCT02231762|593348581|FG003|Combination Phase|Adverse Event|0|||
164267467|NCT02231762|593348578|FG000|Combination Phase|Withdrawal by Subject|2|||
164267468|NCT02231762|593348579|FG001|Combination Phase|Withdrawal by Subject|0|||
164267469|NCT02231762|593348580|FG002|Combination Phase|Withdrawal by Subject|0|||
164267470|NCT02231762|593348581|FG003|Combination Phase|Withdrawal by Subject|0|||
164267471|NCT02231762|593348578|FG000|Combination Phase|Disease Progression|6|||
164267472|NCT02231762|593348579|FG001|Combination Phase|Disease Progression|0|||
164267473|NCT02231762|593348580|FG002|Combination Phase|Disease Progression|0|||
164267474|NCT02231762|593348581|FG003|Combination Phase|Disease Progression|0|||
164267475|NCT02231762|593348578|FG000|Combination Phase|Did not meet inclusion criteria|1|||
164267476|NCT02231762|593348579|FG001|Combination Phase|Did not meet inclusion criteria|0|||
164267477|NCT02231762|593348580|FG002|Combination Phase|Did not meet inclusion criteria|0|||
164267478|NCT02231762|593348581|FG003|Combination Phase|Did not meet inclusion criteria|0|||
164267479|NCT02231762|593348578|FG000|Combination Phase|Protocol Violation|1|||
164267480|NCT02231762|593348579|FG001|Combination Phase|Protocol Violation|0|||
164267481|NCT02231762|593348580|FG002|Combination Phase|Protocol Violation|0|||
164267482|NCT02231762|593348581|FG003|Combination Phase|Protocol Violation|0|||
164267483|NCT02231762|593348578|FG000|Maintenance Phase|Disease progression|0|||
164267484|NCT02231762|593348579|FG001|Maintenance Phase|Disease progression|3|||
164267485|NCT02231762|593348580|FG002|Maintenance Phase|Disease progression|4|||
164267486|NCT02231762|593348581|FG003|Maintenance Phase|Disease progression|3|||
164267487|NCT02231762|593348578|FG000|Maintenance Phase|Adverse Event|0|||
164267488|NCT02231762|593348579|FG001|Maintenance Phase|Adverse Event|0|||
164267489|NCT02231762|593348580|FG002|Maintenance Phase|Adverse Event|1|||
164267490|NCT02231762|593348581|FG003|Maintenance Phase|Adverse Event|2|||
164267491|NCT03455829|593348582|FG000|Overall Study|Death|2|||
164267492|NCT03455829|593348583|FG001|Overall Study|Death|3|||
164267493|NCT03455829|593348584|FG002|Overall Study|Death|2|||
164267494|NCT03455829|593348585|FG003|Overall Study|Death|4|||
164267495|NCT03455829|593348586|FG004|Overall Study|Death|2|||
164267496|NCT03455829|593348582|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
164267497|NCT03455829|593348583|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
164267498|NCT03455829|593348584|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
164267499|NCT03455829|593348585|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
164267500|NCT03455829|593348586|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
164267501|NCT03455829|593348582|FG000|Overall Study|Disease progression|0|||
164267502|NCT03455829|593348583|FG001|Overall Study|Disease progression|0|||
164267503|NCT03455829|593348584|FG002|Overall Study|Disease progression|0|||
164267504|NCT03455829|593348585|FG003|Overall Study|Disease progression|1|||
164267505|NCT03455829|593348586|FG004|Overall Study|Disease progression|1|||
164267506|NCT01697462|593348587|FG000|Overall Study|Disease Progression|1|||
164267507|NCT01697462|593348587|FG000|Overall Study|Adverse Event|6|||
164267508|NCT01697462|593348587|FG000|Overall Study|Lost to Follow-up|21|||
164267509|NCT01697462|593348587|FG000|Overall Study|Withdrawal by Subject|12|||
164267510|NCT01697462|593348587|FG000|Overall Study|Investigator Decision|21|||
164267511|NCT01697462|593348587|FG000|Overall Study|Death|1|||
164267512|NCT01697462|593348587|FG000|Overall Study|Other|10|||
164267513|NCT01697462|593348587|FG000|Overall Study|Missing|5|||
164267514|NCT00168103|593348588|FG000|Overall Study|Withdrawal by Subject|1|||
164267515|NCT00168103|593348589|FG001|Overall Study|Withdrawal by Subject|2|||
164267516|NCT00168103|593348590|FG002|Overall Study|Withdrawal by Subject|1|||
164267517|NCT00168103|593348591|FG003|Overall Study|Withdrawal by Subject|0|||
164267518|NCT00168103|593348588|FG000|Overall Study|Lost to Follow-up|1|||
164267519|NCT00168103|593348589|FG001|Overall Study|Lost to Follow-up|3|||
164581337|NCT00923091|594493948|FG003|Period III (Single-Blind)|Protocol Violation|0|||
164581338|NCT00923091|594493949|FG004|Period III (Single-Blind)|Protocol Violation|0|||
164581339|NCT00923091|594493950|FG005|Period III (Single-Blind)|Protocol Violation|0|||
164686598|NCT05393271|594876522|FG008|Overall Study|Physician Decision|0|||
164267520|NCT00168103|593348590|FG002|Overall Study|Lost to Follow-up|0|||
164267521|NCT00168103|593348591|FG003|Overall Study|Lost to Follow-up|0|||
164267522|NCT03532932|593348600|FG000|Overall Study|Protocol Deviation|33|||
164267523|NCT03532932|593348601|FG001|Overall Study|Protocol Deviation|31|||
164267524|NCT03532932|593348600|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
164267525|NCT03532932|593348601|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
164267526|NCT03532932|593348600|FG000|Overall Study|Withdrawal by Subject|2|||
164267527|NCT03532932|593348601|FG001|Overall Study|Withdrawal by Subject|0|||
164267528|NCT03532932|593348600|FG000|Overall Study|Lost to Follow-up|15|||
164267529|NCT03532932|593348601|FG001|Overall Study|Lost to Follow-up|9|||
164267530|NCT03532932|593348600|FG000|Overall Study|Adverse Event|4|||
164267531|NCT03532932|593348601|FG001|Overall Study|Adverse Event|3|||
164267532|NCT03532932|593348600|FG000|Overall Study|Death|0|||
164267533|NCT03532932|593348601|FG001|Overall Study|Death|2|||
164267534|NCT03532932|593348600|FG000|Overall Study|Other|11|||
164267535|NCT03532932|593348601|FG001|Overall Study|Other|16|||
164267536|NCT02255565|593348603|FG000|Overall Study|Withdrawal by Subject|0|||
164267537|NCT02255565|593348604|FG001|Overall Study|Withdrawal by Subject|1|||
164267538|NCT02255565|593348605|FG002|Overall Study|Withdrawal by Subject|0|||
164267539|NCT02699450|593348606|FG000|Overall Study|Death|2|||
164267540|NCT02699450|593348607|FG001|Overall Study|Death|1|||
164267541|NCT02699450|593348608|FG002|Overall Study|Death|2|||
164267542|NCT02699450|593348606|FG000|Overall Study|Met Criteria for Study Exit|0|||
164267543|NCT02699450|593348607|FG001|Overall Study|Met Criteria for Study Exit|0|||
164267544|NCT02699450|593348608|FG002|Overall Study|Met Criteria for Study Exit|1|||
164267545|NCT02699450|593348606|FG000|Overall Study|Protocol Violation|4|||
164267546|NCT02699450|593348607|FG001|Overall Study|Protocol Violation|3|||
164267547|NCT02699450|593348608|FG002|Overall Study|Protocol Violation|5|||
164267548|NCT02699450|593348606|FG000|Overall Study|Lost to Follow-up|3|||
164267549|NCT02699450|593348607|FG001|Overall Study|Lost to Follow-up|0|||
164267550|NCT02699450|593348608|FG002|Overall Study|Lost to Follow-up|5|||
164267551|NCT02699450|593348606|FG000|Overall Study|Physician Decision|2|||
164267552|NCT02699450|593348607|FG001|Overall Study|Physician Decision|0|||
164267553|NCT02699450|593348608|FG002|Overall Study|Physician Decision|0|||
164267554|NCT02699450|593348606|FG000|Overall Study|Withdrawal by Subject|3|||
164267555|NCT02699450|593348607|FG001|Overall Study|Withdrawal by Subject|1|||
164267556|NCT02699450|593348608|FG002|Overall Study|Withdrawal by Subject|2|||
164430753|NCT00813488|593947302|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
164430754|NCT00813488|593947301|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
164430755|NCT00813488|593947302|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
164430756|NCT00813488|593947301|FG000|Double-blind Treatment Period 2|Other|1|||
164430757|NCT00813488|593947302|FG001|Double-blind Treatment Period 2|Other|0|||
164430758|NCT00813488|593947301|FG000|Open-label Extension|Adverse Event|1|||
164430759|NCT00813488|593947302|FG001|Open-label Extension|Adverse Event|2|||
164430760|NCT00813488|593947301|FG000|Open-label Extension|Lack of Efficacy|3|||
164430761|NCT00813488|593947302|FG001|Open-label Extension|Lack of Efficacy|0|||
164430762|NCT00813488|593947301|FG000|Open-label Extension|Withdrawal by Subject|0|||
164430763|NCT00813488|593947302|FG001|Open-label Extension|Withdrawal by Subject|2|||
164430764|NCT00813488|593947301|FG000|Open-label Extension|Protocol Violation|1|||
164430765|NCT00813488|593947302|FG001|Open-label Extension|Protocol Violation|2|||
164430766|NCT00813488|593947301|FG000|Open-label Extension|Non-compliance study medication|4|||
164430767|NCT00813488|593947302|FG001|Open-label Extension|Non-compliance study medication|0|||
164430768|NCT00813488|593947301|FG000|Open-label Extension|Non-compliance study procedures|2|||
164430769|NCT00813488|593947302|FG001|Open-label Extension|Non-compliance study procedures|1|||
164430770|NCT00813488|593947301|FG000|Open-label Extension|Other|1|||
164430771|NCT00813488|593947302|FG001|Open-label Extension|Other|0|||
164430772|NCT02414828|593947305|FG000|Overall Study|Lost to Follow-up|0|||
164430773|NCT02414828|593947306|FG001|Overall Study|Lost to Follow-up|1|||
164430774|NCT02414828|593947307|FG002|Overall Study|Lost to Follow-up|1|||
164430775|NCT02414828|593947308|FG003|Overall Study|Lost to Follow-up|2|||
164430776|NCT00630864|593947310|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
164430777|NCT00630864|593947310|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
164430778|NCT00430677|593947311|FG000|Short-term Period|Death|1|||
164430779|NCT00430677|593947312|FG001|Short-term Period|Death|1|||
164267557|NCT02699450|593348606|FG000|Overall Study|Adverse Event|1|||
164267558|NCT02699450|593348607|FG001|Overall Study|Adverse Event|0|||
164267559|NCT02699450|593348608|FG002|Overall Study|Adverse Event|0|||
164267560|NCT00810901|593348609|FG000|Overall Study|Lost to Follow-up|88|||
164267561|NCT00810901|593348610|FG001|Overall Study|Lost to Follow-up|58|||
164267562|NCT03689712|593348612|FG000|Overall Study|Adverse Event|1|||
164267563|NCT03689712|593348613|FG001|Overall Study|Adverse Event|0|||
164267564|NCT03689712|593348612|FG000|Overall Study|Death|20|||
164267565|NCT03689712|593348613|FG001|Overall Study|Death|10|||
164267566|NCT03689712|593348612|FG000|Overall Study|Lost to Follow-up|6|||
164267567|NCT03689712|593348613|FG001|Overall Study|Lost to Follow-up|6|||
164267568|NCT03689712|593348612|FG000|Overall Study|Other|1|||
164267569|NCT03689712|593348613|FG001|Overall Study|Other|0|||
164267570|NCT03689712|593348612|FG000|Overall Study|Patient Non-Compliance|0|||
164267571|NCT03689712|593348613|FG001|Overall Study|Patient Non-Compliance|1|||
164267572|NCT03689712|593348612|FG000|Overall Study|Withdrawal by Subject|20|||
164267573|NCT03689712|593348613|FG001|Overall Study|Withdrawal by Subject|4|||
164267574|NCT03689712|593348612|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
164267575|NCT03689712|593348613|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
164267576|NCT03689712|593348612|FG000|Overall Study|Randomized but not Treated|13|||
164267577|NCT03689712|593348613|FG001|Overall Study|Randomized but not Treated|7|||
164267578|NCT03689712|593348612|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
164267579|NCT03689712|593348613|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
164267580|NCT01133275|593348623|FG000|Overall Study|Withdrawal by Subject|1|||
164267581|NCT01133275|593348623|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
164267582|NCT02266875|593348628|FG000|Overall Study|Withdrawal by Subject|9|||
164267583|NCT02266875|593348629|FG001|Overall Study|Withdrawal by Subject|0|||
164267584|NCT02266875|593348628|FG000|Overall Study|Lost to Follow-up|2|||
164267585|NCT02266875|593348629|FG001|Overall Study|Lost to Follow-up|0|||
164267586|NCT00413010|593348630|FG000|Overall Study|Adverse Event|8|||
164267587|NCT00413010|593348631|FG001|Overall Study|Adverse Event|4|||
164267588|NCT00413010|593348630|FG000|Overall Study|Laboratory abnormality|0|||
164267589|NCT00413010|593348631|FG001|Overall Study|Laboratory abnormality|2|||
164267590|NCT00413010|593348630|FG000|Overall Study|Lack of Efficacy|0|||
164267591|NCT00413010|593348631|FG001|Overall Study|Lack of Efficacy|3|||
164267592|NCT00413010|593348630|FG000|Overall Study|Lost to Follow-up|3|||
164267593|NCT00413010|593348631|FG001|Overall Study|Lost to Follow-up|0|||
164267594|NCT00413010|593348630|FG000|Overall Study|Withdrawal by Subject|7|||
164267595|NCT00413010|593348631|FG001|Overall Study|Withdrawal by Subject|2|||
164267596|NCT00413010|593348630|FG000|Overall Study|Due to termination of the study|54|||
164267597|NCT00413010|593348631|FG001|Overall Study|Due to termination of the study|52|||
164267598|NCT02956850|593348632|FG000|Overall Study|Withdrawal by Subject|0|||
164267599|NCT02956850|593348633|FG001|Overall Study|Withdrawal by Subject|0|||
164267600|NCT02956850|593348634|FG002|Overall Study|Withdrawal by Subject|0|||
164267601|NCT02956850|593348635|FG003|Overall Study|Withdrawal by Subject|0|||
164267602|NCT02956850|593348636|FG004|Overall Study|Withdrawal by Subject|0|||
164267603|NCT02956850|593348637|FG005|Overall Study|Withdrawal by Subject|0|||
164267604|NCT02956850|593348638|FG006|Overall Study|Withdrawal by Subject|0|||
164267605|NCT02956850|593348639|FG007|Overall Study|Withdrawal by Subject|0|||
164267606|NCT02956850|593348640|FG008|Overall Study|Withdrawal by Subject|0|||
164267607|NCT02956850|593348641|FG009|Overall Study|Withdrawal by Subject|0|||
164267608|NCT02956850|593348642|FG010|Overall Study|Withdrawal by Subject|0|||
164267609|NCT02956850|593348643|FG011|Overall Study|Withdrawal by Subject|0|||
164267610|NCT02956850|593348644|FG012|Overall Study|Withdrawal by Subject|0|||
164267611|NCT02956850|593348645|FG013|Overall Study|Withdrawal by Subject|0|||
164267612|NCT02956850|593348646|FG014|Overall Study|Withdrawal by Subject|0|||
164267613|NCT02956850|593348647|FG015|Overall Study|Withdrawal by Subject|0|||
164267614|NCT02956850|593348648|FG016|Overall Study|Withdrawal by Subject|0|||
164267615|NCT02956850|593348649|FG017|Overall Study|Withdrawal by Subject|1|||
164267616|NCT00708734|593348650|FG000|Overall Study|scheduling conflict|2|||
164267617|NCT00708734|593348650|FG000|Overall Study|moved|1|||
164267618|NCT00708734|593348650|FG000|Overall Study|leg injury|1|||
164267619|NCT00708734|593348650|FG000|Overall Study|knee replacement|1|||
164267620|NCT00708734|593348650|FG000|Overall Study|vertigo|1|||
164267621|NCT00708734|593348650|FG000|Overall Study|leg fracture|1|||
164267622|NCT03412604|593348651|FG000|Overall Study|Withdrawal by Subject|1|||
164267623|NCT02634606|593348652|FG000|Overall Study|unable to obtain the drug at start|13|||
164267624|NCT00993499|593348660|FG000|Run-in Period (8 Days)|Adverse Event|0|||
164267625|NCT00993499|593348661|FG001|Run-in Period (8 Days)|Adverse Event|1|||
164267626|NCT00993499|593348662|FG002|Run-in Period (8 Days)|Adverse Event|0|||
164267627|NCT00993499|593348663|FG003|Run-in Period (8 Days)|Adverse Event|0|||
164267628|NCT00993499|593348664|FG004|Run-in Period (8 Days)|Adverse Event|0|||
164267629|NCT00993499|593348665|FG005|Run-in Period (8 Days)|Adverse Event|0|||
164267630|NCT00993499|593348660|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
164267631|NCT00993499|593348661|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
164267632|NCT00993499|593348662|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
164267633|NCT00993499|593348663|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
164267634|NCT00993499|593348664|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
164267635|NCT00993499|593348665|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
164267636|NCT00993499|593348660|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
164267637|NCT00993499|593348661|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
164267638|NCT00993499|593348662|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
164267639|NCT00993499|593348663|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
164267640|NCT00993499|593348664|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
164267641|NCT00993499|593348665|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
164267642|NCT00993499|593348660|FG000|Run-in Period (8 Days)|Progressive disease|0|||
164267643|NCT00993499|593348661|FG001|Run-in Period (8 Days)|Progressive disease|1|||
164267644|NCT00993499|593348662|FG002|Run-in Period (8 Days)|Progressive disease|1|||
164267645|NCT00993499|593348663|FG003|Run-in Period (8 Days)|Progressive disease|0|||
164267646|NCT00993499|593348664|FG004|Run-in Period (8 Days)|Progressive disease|0|||
164267647|NCT00993499|593348665|FG005|Run-in Period (8 Days)|Progressive disease|0|||
164267648|NCT00993499|593348660|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
164267649|NCT00993499|593348661|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
164267650|NCT00993499|593348662|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
164267651|NCT00993499|593348663|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
164267652|NCT00993499|593348664|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
164267653|NCT00993499|593348665|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
164267654|NCT00993499|593348660|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
164267655|NCT00993499|593348661|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
164267656|NCT00993499|593348662|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
164267657|NCT00993499|593348663|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
164267658|NCT00993499|593348664|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
164267659|NCT00993499|593348665|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
164267660|NCT00993499|593348660|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
164267661|NCT00993499|593348661|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
164267662|NCT00993499|593348662|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
164267663|NCT00993499|593348663|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
164267664|NCT00993499|593348664|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
164267665|NCT00993499|593348665|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
164267666|NCT00993499|593348660|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
164267667|NCT00993499|593348661|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
164267668|NCT00993499|593348662|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
164267669|NCT00993499|593348663|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
164267670|NCT00993499|593348664|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
164267671|NCT00993499|593348665|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
164267672|NCT00993499|593348660|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
164267673|NCT00993499|593348661|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
164267674|NCT00993499|593348662|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
164267675|NCT00993499|593348663|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
164267676|NCT00993499|593348664|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
164267677|NCT00993499|593348665|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
164267678|NCT00993499|593348660|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
164267679|NCT00993499|593348661|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
164267680|NCT00993499|593348662|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
164267681|NCT00993499|593348663|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
164267682|NCT00993499|593348664|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
164267683|NCT00993499|593348665|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
164267684|NCT00993499|593348660|FG000|Discontinued After Starting Course 3|DLT|1|||
164267685|NCT00993499|593348661|FG001|Discontinued After Starting Course 3|DLT|0|||
164267686|NCT00993499|593348662|FG002|Discontinued After Starting Course 3|DLT|2|||
164267687|NCT00993499|593348663|FG003|Discontinued After Starting Course 3|DLT|1|||
164267688|NCT00993499|593348664|FG004|Discontinued After Starting Course 3|DLT|0|||
164267689|NCT00993499|593348665|FG005|Discontinued After Starting Course 3|DLT|0|||
164267690|NCT00993499|593348660|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
164267691|NCT00993499|593348661|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
164267692|NCT00993499|593348662|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
164267693|NCT00993499|593348663|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
164267694|NCT00993499|593348664|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
164267695|NCT00993499|593348665|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
164267696|NCT05432167|593348668|FG000|Overall Study|Adverse Event|0|||
164267697|NCT05432167|593348669|FG001|Overall Study|Adverse Event|2|||
164267698|NCT05432167|593348670|FG002|Overall Study|Adverse Event|1|||
164267699|NCT05432167|593348668|FG000|Overall Study|Lost to Follow-up|3|||
164267700|NCT05432167|593348669|FG001|Overall Study|Lost to Follow-up|3|||
164267701|NCT05432167|593348670|FG002|Overall Study|Lost to Follow-up|2|||
164267702|NCT05432167|593348668|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
164267703|NCT05432167|593348669|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
164267704|NCT05432167|593348670|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
164267705|NCT05432167|593348668|FG000|Overall Study|Physician Decision|1|||
164267706|NCT05432167|593348669|FG001|Overall Study|Physician Decision|0|||
164267707|NCT05432167|593348670|FG002|Overall Study|Physician Decision|0|||
164267708|NCT05432167|593348668|FG000|Overall Study|Withdrawal by Subject|7|||
164341926|NCT00932126|593627570|FG006|Overall Study|Withdrawal by Subject|0|||
164267709|NCT05432167|593348669|FG001|Overall Study|Withdrawal by Subject|4|||
164267710|NCT05432167|593348670|FG002|Overall Study|Withdrawal by Subject|11|||
164267711|NCT05432167|593348668|FG000|Overall Study|Other|0|||
164267712|NCT05432167|593348669|FG001|Overall Study|Other|0|||
164267713|NCT05432167|593348670|FG002|Overall Study|Other|1|||
164267714|NCT01287195|593348671|FG000|Overall Study|Withdrawal by Subject|2|||
164267715|NCT00283868|593348678|FG000|Overall Study|Lost to Follow-up|7|||
164267716|NCT00283868|593348679|FG001|Overall Study|Lost to Follow-up|8|||
164267717|NCT01515475|593348680|FG000|Overall Study|Lost to Follow-up|20|||
164267718|NCT01515475|593348681|FG001|Overall Study|Lost to Follow-up|15|||
164267719|NCT01515475|593348682|FG002|Overall Study|Lost to Follow-up|12|||
164267720|NCT01515475|593348683|FG003|Overall Study|Lost to Follow-up|12|||
164267721|NCT01996592|593348688|FG000|Overall Study|no response to text/no diary entry|32|||
164267722|NCT01996592|593348688|FG000|Overall Study|change in surgical date|4|||
164267723|NCT01996592|593348688|FG000|Overall Study|Withdrawal by Subject|5|||
164267724|NCT01996592|593348688|FG000|Overall Study|change in mode of delivery|4|||
164267725|NCT01406015|593348689|FG000|Overall Study|Withdrawal by Subject|3|||
164267726|NCT01406015|593348690|FG001|Overall Study|Withdrawal by Subject|3|||
164267727|NCT00707746|593348692|FG000|Treatment Period|Adverse Event|2|||
164267728|NCT00707746|593348693|FG001|Treatment Period|Adverse Event|4|||
164267729|NCT00707746|593348692|FG000|Treatment Period|Ineligibility|0|||
164267730|NCT00707746|593348693|FG001|Treatment Period|Ineligibility|1|||
164267731|NCT02573246|593348698|FG000|Overall Study|Lost to Follow-up|2|||
164267732|NCT02573246|593348699|FG001|Overall Study|Lost to Follow-up|0|||
164267733|NCT02573246|593348700|FG002|Overall Study|Lost to Follow-up|0|||
164267734|NCT02573246|593348701|FG003|Overall Study|Lost to Follow-up|0|||
164267735|NCT02573246|593348702|FG004|Overall Study|Lost to Follow-up|1|||
164267736|NCT02573246|593348698|FG000|Overall Study|Withdrawal by Subject|0|||
164267737|NCT02573246|593348699|FG001|Overall Study|Withdrawal by Subject|0|||
164267738|NCT02573246|593348700|FG002|Overall Study|Withdrawal by Subject|0|||
164267739|NCT02573246|593348701|FG003|Overall Study|Withdrawal by Subject|0|||
164267740|NCT02573246|593348702|FG004|Overall Study|Withdrawal by Subject|1|||
164267741|NCT02573246|593348698|FG000|Overall Study|Physician Decision|1|||
164267742|NCT02573246|593348699|FG001|Overall Study|Physician Decision|1|||
164267743|NCT02573246|593348700|FG002|Overall Study|Physician Decision|3|||
164267744|NCT02573246|593348701|FG003|Overall Study|Physician Decision|2|||
164267745|NCT02573246|593348702|FG004|Overall Study|Physician Decision|2|||
164267746|NCT01902888|593348703|FG000|Overall Study|Study Terminated|3|||
164267747|NCT02256267|593348704|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
164267748|NCT02256267|593348704|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
164267749|NCT03149003|593348705|FG000|Overall Study|Randomized but not treated|0|||
164267750|NCT03149003|593348706|FG001|Overall Study|Randomized but not treated|1|||
164267751|NCT03149003|593348707|FG002|Overall Study|Randomized but not treated|18|||
164267752|NCT01685983|593348708|FG000|Overall Study|Adverse Event|7|||
164267753|NCT01685983|593348708|FG000|Overall Study|Death|1|||
164267754|NCT01685983|593348708|FG000|Overall Study|Withdrawal by Subject|19|||
164267755|NCT01685983|593348708|FG000|Overall Study|Protocol Violation|2|||
164267756|NCT01685983|593348708|FG000|Overall Study|Physician Decision|13|||
164267757|NCT01685983|593348708|FG000|Overall Study|Other|7|||
164267758|NCT01685983|593348708|FG000|Overall Study|Progressive Disease|32|||
164267759|NCT01685983|593348708|FG000|Overall Study|Noncompliance with Study Drug|1|||
164267760|NCT01443130|593348709|FG000|Overall Study|Lost to Follow-up|44|||
164267761|NCT01443130|593348710|FG001|Overall Study|Lost to Follow-up|42|||
164267762|NCT01443130|593348711|FG002|Overall Study|Lost to Follow-up|50|||
164267763|NCT01443130|593348712|FG003|Overall Study|Lost to Follow-up|23|||
164267764|NCT01443130|593348713|FG004|Overall Study|Lost to Follow-up|25|||
164267765|NCT01443130|593348714|FG005|Overall Study|Lost to Follow-up|21|||
164267766|NCT01443130|593348709|FG000|Overall Study|Death|0|||
164267767|NCT01443130|593348710|FG001|Overall Study|Death|1|||
164267768|NCT01443130|593348711|FG002|Overall Study|Death|0|||
164267769|NCT01443130|593348712|FG003|Overall Study|Death|7|||
164267770|NCT01443130|593348713|FG004|Overall Study|Death|10|||
164267771|NCT01443130|593348714|FG005|Overall Study|Death|8|||
164267772|NCT01443130|593348709|FG000|Overall Study|Adverse Event|2|||
164267773|NCT01443130|593348710|FG001|Overall Study|Adverse Event|1|||
164267774|NCT01443130|593348711|FG002|Overall Study|Adverse Event|1|||
164267775|NCT01443130|593348712|FG003|Overall Study|Adverse Event|0|||
164341927|NCT00932126|593627571|FG007|Overall Study|Withdrawal by Subject|1|||
164341928|NCT00932126|593627564|FG000|Overall Study|Objective progression or relapse|3|||
164341929|NCT00932126|593627565|FG001|Overall Study|Objective progression or relapse|3|||
164341930|NCT00932126|593627566|FG002|Overall Study|Objective progression or relapse|2|||
164267776|NCT01443130|593348713|FG004|Overall Study|Adverse Event|0|||
164267777|NCT01443130|593348714|FG005|Overall Study|Adverse Event|0|||
164267778|NCT01443130|593348709|FG000|Overall Study|Protocol Violation|2|||
164267779|NCT01443130|593348710|FG001|Overall Study|Protocol Violation|1|||
164267780|NCT01443130|593348711|FG002|Overall Study|Protocol Violation|3|||
164341931|NCT00932126|593627567|FG003|Overall Study|Objective progression or relapse|3|||
164341932|NCT00932126|593627568|FG004|Overall Study|Objective progression or relapse|3|||
164267781|NCT01443130|593348712|FG003|Overall Study|Protocol Violation|2|||
164267782|NCT01443130|593348713|FG004|Overall Study|Protocol Violation|2|||
164267783|NCT01443130|593348714|FG005|Overall Study|Protocol Violation|3|||
164267784|NCT01443130|593348709|FG000|Overall Study|Withdrawal by Subject|15|||
164267785|NCT01443130|593348710|FG001|Overall Study|Withdrawal by Subject|14|||
164267786|NCT01443130|593348711|FG002|Overall Study|Withdrawal by Subject|12|||
164267787|NCT01443130|593348712|FG003|Overall Study|Withdrawal by Subject|7|||
164267788|NCT01443130|593348713|FG004|Overall Study|Withdrawal by Subject|7|||
164267789|NCT01443130|593348714|FG005|Overall Study|Withdrawal by Subject|2|||
164267790|NCT01443130|593348709|FG000|Overall Study|Death of Subject's Infant|5|||
164267791|NCT01443130|593348710|FG001|Overall Study|Death of Subject's Infant|10|||
164267792|NCT01443130|593348711|FG002|Overall Study|Death of Subject's Infant|11|||
164686599|NCT05393271|594876523|FG009|Overall Study|Physician Decision|0|||
164686600|NCT05393271|594876524|FG010|Overall Study|Physician Decision|0|||
164686601|NCT01717313|594876528|FG000|Phase A (Weeks 0 to 24)|Death|0|||
164686602|NCT01717313|594876529|FG001|Phase A (Weeks 0 to 24)|Death|1|||
164686603|NCT01717313|594876528|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
164267793|NCT01443130|593348712|FG003|Overall Study|Death of Subject's Infant|0|||
164267794|NCT01443130|593348713|FG004|Overall Study|Death of Subject's Infant|0|||
164267795|NCT01443130|593348714|FG005|Overall Study|Death of Subject's Infant|0|||
164267796|NCT02758301|593348715|FG000|Overall Study|Death|12|||
164267797|NCT02758301|593348716|FG001|Overall Study|Death|0|||
164267798|NCT02758301|593348715|FG000|Overall Study|Physician Decision|10|||
164267799|NCT02758301|593348716|FG001|Overall Study|Physician Decision|1|||
164267800|NCT02758301|593348715|FG000|Overall Study|Withdrawal by Subject|5|||
164267801|NCT02758301|593348716|FG001|Overall Study|Withdrawal by Subject|6|||
164267802|NCT02758301|593348715|FG000|Overall Study|Lost to Follow-up|7|||
164267803|NCT02758301|593348716|FG001|Overall Study|Lost to Follow-up|0|||
164267804|NCT02758301|593348715|FG000|Overall Study|Protocol Violation|0|||
164267805|NCT02758301|593348716|FG001|Overall Study|Protocol Violation|1|||
164267806|NCT00364533|593348717|FG000|Overall Study|Adverse Event|8|||
164267807|NCT00364533|593348718|FG001|Overall Study|Adverse Event|7|||
164267808|NCT00364533|593348719|FG002|Overall Study|Adverse Event|15|||
164267809|NCT00364533|593348720|FG003|Overall Study|Adverse Event|5|||
164267810|NCT00364533|593348721|FG004|Overall Study|Adverse Event|2|||
164267811|NCT00364533|593348717|FG000|Overall Study|Withdrawal by Subject|4|||
164267812|NCT00364533|593348718|FG001|Overall Study|Withdrawal by Subject|8|||
164267813|NCT00364533|593348719|FG002|Overall Study|Withdrawal by Subject|6|||
164267814|NCT00364533|593348720|FG003|Overall Study|Withdrawal by Subject|6|||
164267815|NCT00364533|593348721|FG004|Overall Study|Withdrawal by Subject|6|||
164267816|NCT00364533|593348717|FG000|Overall Study|Lack of Efficacy|22|||
164267817|NCT00364533|593348718|FG001|Overall Study|Lack of Efficacy|22|||
164267818|NCT00364533|593348719|FG002|Overall Study|Lack of Efficacy|21|||
164267819|NCT00364533|593348720|FG003|Overall Study|Lack of Efficacy|17|||
164267820|NCT00364533|593348721|FG004|Overall Study|Lack of Efficacy|42|||
164267821|NCT00364533|593348717|FG000|Overall Study|Subject discharged from hospital|4|||
164267822|NCT00364533|593348718|FG001|Overall Study|Subject discharged from hospital|1|||
164267823|NCT00364533|593348719|FG002|Overall Study|Subject discharged from hospital|2|||
164267824|NCT00364533|593348720|FG003|Overall Study|Subject discharged from hospital|3|||
164267825|NCT00364533|593348721|FG004|Overall Study|Subject discharged from hospital|1|||
164267826|NCT00364533|593348717|FG000|Overall Study|Variations in drug compliance|2|||
164267827|NCT00364533|593348718|FG001|Overall Study|Variations in drug compliance|1|||
164267828|NCT00364533|593348719|FG002|Overall Study|Variations in drug compliance|1|||
164267829|NCT00364533|593348720|FG003|Overall Study|Variations in drug compliance|0|||
164267830|NCT00364533|593348721|FG004|Overall Study|Variations in drug compliance|0|||
164267831|NCT00364533|593348717|FG000|Overall Study|Non-compliance|1|||
164267832|NCT00364533|593348718|FG001|Overall Study|Non-compliance|0|||
164267833|NCT00364533|593348719|FG002|Overall Study|Non-compliance|0|||
164267834|NCT00364533|593348720|FG003|Overall Study|Non-compliance|0|||
164267835|NCT00364533|593348721|FG004|Overall Study|Non-compliance|0|||
164267836|NCT00364533|593348717|FG000|Overall Study|Protocol Violation|1|||
164267837|NCT00364533|593348718|FG001|Overall Study|Protocol Violation|1|||
164267838|NCT00364533|593348719|FG002|Overall Study|Protocol Violation|0|||
164267839|NCT00364533|593348720|FG003|Overall Study|Protocol Violation|0|||
164267840|NCT00364533|593348721|FG004|Overall Study|Protocol Violation|0|||
164267841|NCT01490294|593348723|FG000|Overall Study|Prematurely discontinuation|4|||
164267842|NCT01490294|593348724|FG001|Overall Study|Prematurely discontinuation|0|||
164267843|NCT01490294|593348725|FG002|Overall Study|Prematurely discontinuation|1|||
164267844|NCT01490294|593348726|FG003|Overall Study|Prematurely discontinuation|1|||
164267845|NCT01490294|593348723|FG000|Overall Study|Adverse Event|1|||
164267846|NCT01490294|593348724|FG001|Overall Study|Adverse Event|0|||
164267847|NCT01490294|593348725|FG002|Overall Study|Adverse Event|0|||
164267848|NCT01490294|593348726|FG003|Overall Study|Adverse Event|0|||
164686604|NCT01717313|594876529|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
164686605|NCT01717313|594876528|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
164686606|NCT01717313|594876529|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
164686607|NCT01717313|594876528|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
164267849|NCT01266590|593349975|FG000|Overall Study|Adverse Event|3|||
164267850|NCT01266590|593349975|FG000|Overall Study|Lost to Follow-up|1|||
164267851|NCT01266590|593349975|FG000|Overall Study|Withdrawal by Subject|1|||
164267852|NCT01266590|593349975|FG000|Overall Study|Physician Decision|1|||
164267853|NCT00511134|593349976|FG000|Overall Study|Withdrawal by Subject|0|||
164267854|NCT00511134|593349977|FG001|Overall Study|Withdrawal by Subject|2|||
164267855|NCT01949090|593349978|FG000|Overall Study|Serious Adverse Event|0|||
164267856|NCT01949090|593349979|FG001|Overall Study|Serious Adverse Event|1|||
164267857|NCT01949090|593349980|FG002|Overall Study|Serious Adverse Event|2|||
164267858|NCT01949090|593349981|FG003|Overall Study|Serious Adverse Event|0|||
164267859|NCT01949090|593349982|FG004|Overall Study|Serious Adverse Event|1|||
164267860|NCT01949090|593349978|FG000|Overall Study|Withdrawal by Subject|2|||
164267861|NCT01949090|593349979|FG001|Overall Study|Withdrawal by Subject|0|||
164267862|NCT01949090|593349980|FG002|Overall Study|Withdrawal by Subject|0|||
164267863|NCT01949090|593349981|FG003|Overall Study|Withdrawal by Subject|0|||
164267864|NCT01949090|593349982|FG004|Overall Study|Withdrawal by Subject|1|||
164267865|NCT01949090|593349978|FG000|Overall Study|Protocol non-compliance|0|||
164267866|NCT01949090|593349979|FG001|Overall Study|Protocol non-compliance|0|||
164267867|NCT01949090|593349980|FG002|Overall Study|Protocol non-compliance|0|||
164267868|NCT01949090|593349981|FG003|Overall Study|Protocol non-compliance|0|||
164267869|NCT01949090|593349982|FG004|Overall Study|Protocol non-compliance|1|||
164267870|NCT01949090|593349978|FG000|Overall Study|Lost to Follow-up|2|||
164267871|NCT01949090|593349979|FG001|Overall Study|Lost to Follow-up|1|||
164267872|NCT01949090|593349980|FG002|Overall Study|Lost to Follow-up|0|||
164267873|NCT01949090|593349981|FG003|Overall Study|Lost to Follow-up|1|||
164267874|NCT01949090|593349982|FG004|Overall Study|Lost to Follow-up|1|||
164267875|NCT00541346|593349983|FG000|Follow-up|Adverse Event|1|||
164267876|NCT02008773|593349984|FG000|Overall Study|Adverse Event|3|||
164267877|NCT02008773|593349985|FG001|Overall Study|Adverse Event|3|||
164267878|NCT02008773|593349986|FG002|Overall Study|Adverse Event|1|||
164267879|NCT02008773|593349987|FG003|Overall Study|Adverse Event|2|||
164267880|NCT02008773|593349984|FG000|Overall Study|Medication Non-compliance|2|||
164267881|NCT02008773|593349985|FG001|Overall Study|Medication Non-compliance|1|||
164267882|NCT02008773|593349986|FG002|Overall Study|Medication Non-compliance|3|||
164267883|NCT02008773|593349987|FG003|Overall Study|Medication Non-compliance|2|||
164267884|NCT02008773|593349984|FG000|Overall Study|Withdrawal by Subject|8|||
164267885|NCT02008773|593349985|FG001|Overall Study|Withdrawal by Subject|4|||
164267886|NCT02008773|593349986|FG002|Overall Study|Withdrawal by Subject|7|||
164267887|NCT02008773|593349987|FG003|Overall Study|Withdrawal by Subject|6|||
164267888|NCT02008773|593349984|FG000|Overall Study|Lost to Follow-up|0|||
164267889|NCT02008773|593349985|FG001|Overall Study|Lost to Follow-up|1|||
164267890|NCT02008773|593349986|FG002|Overall Study|Lost to Follow-up|3|||
164267891|NCT02008773|593349987|FG003|Overall Study|Lost to Follow-up|2|||
164267892|NCT02804750|593349993|FG000|Period 1|Adverse Event|0|||
164267893|NCT02804750|593349994|FG001|Period 1|Adverse Event|2|||
164267894|NCT02804750|593349993|FG000|Period 1|Withdrawal by Subject|0|||
164267895|NCT02804750|593349994|FG001|Period 1|Withdrawal by Subject|1|||
164267896|NCT02804750|593349993|FG000|Period 2|Adverse Event|1|||
164267897|NCT02804750|593349994|FG001|Period 2|Adverse Event|0|||
164267898|NCT02804750|593349993|FG000|Period 3|Adverse Event|0|||
164267899|NCT02804750|593349994|FG001|Period 3|Adverse Event|2|||
164267900|NCT02804750|593349993|FG000|Period 4|Adverse Event|0|||
164267901|NCT02804750|593349994|FG001|Period 4|Adverse Event|5|||
164267902|NCT04435600|593350000|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164267903|NCT04435600|593350001|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164267904|NCT04435600|593350002|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
164267905|NCT04435600|593350003|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164267906|NCT04435600|593350004|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164267907|NCT04435600|593350005|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164267908|NCT04435600|593350006|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164267909|NCT04435600|593350007|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164267910|NCT04435600|593350008|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164267911|NCT04435600|593350009|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164267912|NCT04435600|593350000|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
164267913|NCT04435600|593350001|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
164341933|NCT00932126|593627569|FG005|Overall Study|Objective progression or relapse|3|||
164341934|NCT00932126|593627570|FG006|Overall Study|Objective progression or relapse|3|||
164341935|NCT00932126|593627571|FG007|Overall Study|Objective progression or relapse|5|||
164267914|NCT04435600|593350002|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
164267915|NCT04435600|593350003|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
164267916|NCT04435600|593350004|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
164267917|NCT04435600|593350005|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
164267918|NCT04435600|593350006|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
164267919|NCT04435600|593350007|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
164267920|NCT04435600|593350008|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
164267921|NCT04435600|593350009|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
164267922|NCT04435600|593350000|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
164267923|NCT04435600|593350001|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
164267924|NCT04435600|593350002|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
164267925|NCT04435600|593350003|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
164267926|NCT04435600|593350004|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
164267927|NCT04435600|593350005|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
164267928|NCT04435600|593350006|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
164267929|NCT04435600|593350007|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
164267930|NCT04435600|593350008|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
164267931|NCT04435600|593350009|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
164267932|NCT04435600|593350000|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
164267933|NCT04435600|593350001|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
164267934|NCT04435600|593350002|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
164267935|NCT04435600|593350003|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
164267936|NCT04435600|593350004|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
164267937|NCT04435600|593350005|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
164267938|NCT04435600|593350006|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
164267939|NCT04435600|593350007|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
164267940|NCT04435600|593350008|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
164267941|NCT04435600|593350009|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
164267942|NCT05149313|593350017|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
164267943|NCT05149313|593350018|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
164267944|NCT05149313|593350019|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
164267945|NCT05149313|593350020|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
164267946|NCT05149313|593350017|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
164267947|NCT05149313|593350018|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
164267948|NCT05149313|593350019|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
164267949|NCT05149313|593350020|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
164267950|NCT05149313|593350017|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
164267951|NCT05149313|593350018|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
164267952|NCT05149313|593350019|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
164267953|NCT05149313|593350020|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
164267954|NCT05149313|593350017|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
164267955|NCT05149313|593350018|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
164267956|NCT05149313|593350019|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
164267957|NCT05149313|593350020|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
164267958|NCT05149313|593350017|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
164267959|NCT05149313|593350018|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
164267960|NCT05149313|593350019|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
164267961|NCT05149313|593350020|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
164267962|NCT05149313|593350017|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
164267963|NCT05149313|593350018|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
164267964|NCT05149313|593350019|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
164267965|NCT05149313|593350020|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
164267966|NCT05149313|593350017|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
164267967|NCT05149313|593350018|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
164267968|NCT05149313|593350019|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
164267969|NCT05149313|593350020|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
164267970|NCT05149313|593350017|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164267971|NCT05149313|593350018|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164267972|NCT05149313|593350019|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
164267973|NCT05149313|593350020|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
164267974|NCT05149313|593350017|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
164267975|NCT05149313|593350018|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
164267976|NCT05149313|593350019|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
164267977|NCT05149313|593350020|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
164267978|NCT05149313|593350017|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164267979|NCT05149313|593350018|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164267980|NCT05149313|593350019|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
164267981|NCT05149313|593350020|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164267982|NCT05149313|593350017|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
164267983|NCT05149313|593350018|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
164267984|NCT05149313|593350019|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
164267985|NCT05149313|593350020|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
164267986|NCT03826342|593350030|FG000|Overall Study|Withdrawal by Subject|8|||
164267987|NCT03826342|593350031|FG001|Overall Study|Withdrawal by Subject|1|||
164267988|NCT03826342|593350030|FG000|Overall Study|Lost to Follow-up|7|||
164267989|NCT03826342|593350031|FG001|Overall Study|Lost to Follow-up|7|||
164267990|NCT03826342|593350030|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
164267991|NCT03826342|593350031|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
164267992|NCT02212678|593350034|FG000|Overall Study|Adverse Event|1|||
164267993|NCT02337634|593350035|FG000|Overall Study|Protocol Violation|3|||
164267994|NCT02337634|593350036|FG001|Overall Study|Protocol Violation|1|||
164267995|NCT02337634|593350035|FG000|Overall Study|Lost to Follow-up|1|||
164267996|NCT02337634|593350036|FG001|Overall Study|Lost to Follow-up|0|||
164267997|NCT02428205|593350038|FG000|Overall Study|Lack of Efficacy|1|||
164267998|NCT02428205|593350039|FG001|Overall Study|Lack of Efficacy|0|||
164267999|NCT02428205|593350038|FG000|Overall Study|Lost to Follow-up|1|||
164268000|NCT02428205|593350039|FG001|Overall Study|Lost to Follow-up|1|||
164268001|NCT02428205|593350038|FG000|Overall Study|Worse behavior|0|||
164268002|NCT02428205|593350039|FG001|Overall Study|Worse behavior|1|||
164268003|NCT02888743|593350040|FG000|Overall Study|Withdrawal by Subject|1|||
164268004|NCT02888743|593350041|FG001|Overall Study|Withdrawal by Subject|2|||
164268005|NCT02888743|593350042|FG002|Overall Study|Withdrawal by Subject|2|||
164268006|NCT02888743|593350043|FG003|Overall Study|Withdrawal by Subject|0|||
164268007|NCT02888743|593350044|FG004|Overall Study|Withdrawal by Subject|1|||
164268008|NCT02888743|593350040|FG000|Overall Study|Disease progression before treatment|2|||
164268009|NCT02888743|593350041|FG001|Overall Study|Disease progression before treatment|0|||
164268010|NCT02888743|593350042|FG002|Overall Study|Disease progression before treatment|2|||
164268011|NCT02888743|593350043|FG003|Overall Study|Disease progression before treatment|0|||
164268012|NCT02888743|593350044|FG004|Overall Study|Disease progression before treatment|0|||
164268013|NCT02888743|593350040|FG000|Overall Study|Patient ineligible|1|||
164268014|NCT02888743|593350041|FG001|Overall Study|Patient ineligible|2|||
164268015|NCT02888743|593350042|FG002|Overall Study|Patient ineligible|0|||
164268016|NCT02888743|593350043|FG003|Overall Study|Patient ineligible|0|||
164268017|NCT02888743|593350044|FG004|Overall Study|Patient ineligible|0|||
164268018|NCT00527319|593350045|FG000|Overall Study|Withdrawal by Subject|5|||
164268019|NCT00527319|593350046|FG001|Overall Study|Withdrawal by Subject|0|||
164268020|NCT00527319|593350047|FG002|Overall Study|Withdrawal by Subject|1|||
164268021|NCT00527319|593350045|FG000|Overall Study|Lost to Follow-up|1|||
164268022|NCT00527319|593350046|FG001|Overall Study|Lost to Follow-up|0|||
164268023|NCT00527319|593350047|FG002|Overall Study|Lost to Follow-up|0|||
164268024|NCT00527319|593350045|FG000|Overall Study|Death|0|||
164268025|NCT00527319|593350046|FG001|Overall Study|Death|3|||
164268026|NCT00527319|593350047|FG002|Overall Study|Death|1|||
164268027|NCT00527319|593350045|FG000|Overall Study|Intercurrent Medical Illness|0|||
164268028|NCT00527319|593350046|FG001|Overall Study|Intercurrent Medical Illness|1|||
164268029|NCT00527319|593350047|FG002|Overall Study|Intercurrent Medical Illness|3|||
164268030|NCT00527319|593350045|FG000|Overall Study|Adverse Event|0|||
164268031|NCT00527319|593350046|FG001|Overall Study|Adverse Event|0|||
164268032|NCT00527319|593350047|FG002|Overall Study|Adverse Event|1|||
164268033|NCT01804582|593350050|FG000|Overall Study|Lost to Follow-up|47|||
164268034|NCT01804582|593350051|FG001|Overall Study|Lost to Follow-up|56|||
164268035|NCT01804582|593350050|FG000|Overall Study|Physician Decision|2|||
164268036|NCT01804582|593350051|FG001|Overall Study|Physician Decision|0|||
164268037|NCT00431951|593350054|FG000|Overall Study|Inability to follow study procedures|1|||
164268038|NCT00431951|593350055|FG001|Overall Study|Inability to follow study procedures|0|||
164268039|NCT00431951|593350056|FG002|Overall Study|Inability to follow study procedures|1|||
164268040|NCT00431951|593350057|FG003|Overall Study|Inability to follow study procedures|2|||
164268041|NCT00431951|593350054|FG000|Overall Study|Lost to Follow-up|0|||
164268042|NCT00431951|593350055|FG001|Overall Study|Lost to Follow-up|1|||
164268043|NCT00431951|593350056|FG002|Overall Study|Lost to Follow-up|0|||
164268044|NCT00431951|593350057|FG003|Overall Study|Lost to Follow-up|0|||
164268045|NCT00431951|593350054|FG000|Overall Study|Withdrawal by Subject|0|||
164268046|NCT00431951|593350055|FG001|Overall Study|Withdrawal by Subject|1|||
164268047|NCT00431951|593350056|FG002|Overall Study|Withdrawal by Subject|0|||
164268048|NCT00431951|593350057|FG003|Overall Study|Withdrawal by Subject|0|||
164268049|NCT00431951|593350054|FG000|Overall Study|Adverse Event|0|||
164268050|NCT00431951|593350055|FG001|Overall Study|Adverse Event|0|||
164268051|NCT00431951|593350056|FG002|Overall Study|Adverse Event|1|||
164268052|NCT00431951|593350057|FG003|Overall Study|Adverse Event|0|||
164268053|NCT00385723|593350058|FG000|Overall Study|Lost to Follow-up|1|||
164268054|NCT00385723|593350059|FG001|Overall Study|Lost to Follow-up|1|||
164268055|NCT00385723|593350060|FG002|Overall Study|Lost to Follow-up|0|||
164268056|NCT00385723|593350058|FG000|Overall Study|Withdrawal by Subject|1|||
164268057|NCT00385723|593350059|FG001|Overall Study|Withdrawal by Subject|0|||
164268058|NCT00385723|593350060|FG002|Overall Study|Withdrawal by Subject|2|||
164268059|NCT00689793|593350065|FG000|Overall Study|Lost to Follow-up|4|||
164268060|NCT00689793|593350066|FG001|Overall Study|Lost to Follow-up|5|||
164268061|NCT01920152|593350067|FG000|Overall Study|Withdrawal by Subject|1|||
164268062|NCT01920152|593350068|FG001|Overall Study|Withdrawal by Subject|2|||
164268063|NCT01167907|593350074|FG000|Overall Study|Protocol Violation|1|||
164268064|NCT01167907|593350075|FG001|Overall Study|Protocol Violation|0|||
164268065|NCT01167907|593350074|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
164341936|NCT00932126|593627564|FG000|Overall Study|Other|0|||
164268066|NCT01167907|593350075|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
164268067|NCT01814670|593350082|FG000|Overall Study|Protocol Violation|12|||
164268068|NCT00973102|593350083|FG000|Overall Study|Protocol Violation|1|||
164268069|NCT00973102|593350084|FG001|Overall Study|Protocol Violation|0|||
164268070|NCT00973102|593350083|FG000|Overall Study|Prisoner|0|||
164268071|NCT00973102|593350084|FG001|Overall Study|Prisoner|1|||
164268072|NCT01066780|593350085|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
164268073|NCT01066780|593350086|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
164268074|NCT02360293|593350087|FG000|Overall Study|Lost to Follow-up|73|||
164268075|NCT02360293|593350088|FG001|Overall Study|Lost to Follow-up|95|||
164268076|NCT02360293|593350087|FG000|Overall Study|Withdrawal by Subject|2|||
164268077|NCT02360293|593350088|FG001|Overall Study|Withdrawal by Subject|1|||
164268078|NCT02360293|593350087|FG000|Overall Study|Excluded|1|||
164268079|NCT02360293|593350088|FG001|Overall Study|Excluded|0|||
164268080|NCT02226549|593350089|FG000|Overall Study|Randomized but Never Treated|1|||
164268081|NCT02226549|593350090|FG001|Overall Study|Randomized but Never Treated|0|||
164268082|NCT02226549|593350089|FG000|Overall Study|Lost to Follow-up|0|||
164268083|NCT02226549|593350090|FG001|Overall Study|Lost to Follow-up|1|||
164268084|NCT03099148|593350091|FG000|Wash-out|scheduling conflict|0|||
164268085|NCT03099148|593350092|FG001|Wash-out|scheduling conflict|1|||
164268086|NCT03099148|593350093|FG002|Wash-out|scheduling conflict|0|||
164268087|NCT03099148|593350094|FG003|Wash-out|scheduling conflict|0|||
164268088|NCT03099148|593350091|FG000|Wash-out|Adverse Event|0|||
164268089|NCT03099148|593350092|FG001|Wash-out|Adverse Event|1|||
164268090|NCT03099148|593350093|FG002|Wash-out|Adverse Event|0|||
164268091|NCT03099148|593350094|FG003|Wash-out|Adverse Event|0|||
164268092|NCT01269385|593350095|FG000|Overall Study|Adverse Event|1|||
164268093|NCT01269385|593350096|FG001|Overall Study|Adverse Event|1|||
164268094|NCT01269385|593350097|FG002|Overall Study|Adverse Event|0|||
164268095|NCT01269385|593350098|FG003|Overall Study|Adverse Event|0|||
164268096|NCT00687609|593350103|FG000|Overall Study|Physician Decision|1|||
164268097|NCT00687609|593350103|FG000|Overall Study|Withdrawal by Subject|2|||
164268098|NCT02713529|593350104|FG000|Overall Study|Withdrawal by Subject|3|||
164268099|NCT02713529|593350105|FG001|Overall Study|Withdrawal by Subject|1|||
164268100|NCT02713529|593350106|FG002|Overall Study|Withdrawal by Subject|4|||
164268101|NCT02713529|593350107|FG003|Overall Study|Withdrawal by Subject|2|||
164268102|NCT02713529|593350108|FG004|Overall Study|Withdrawal by Subject|0|||
164268103|NCT02713529|593350109|FG005|Overall Study|Withdrawal by Subject|1|||
164268104|NCT02713529|593350110|FG006|Overall Study|Withdrawal by Subject|1|||
164268105|NCT02713529|593350104|FG000|Overall Study|Lost to Follow-up|1|||
164268106|NCT02713529|593350105|FG001|Overall Study|Lost to Follow-up|0|||
164268107|NCT02713529|593350106|FG002|Overall Study|Lost to Follow-up|1|||
164268108|NCT02713529|593350107|FG003|Overall Study|Lost to Follow-up|0|||
164268109|NCT02713529|593350108|FG004|Overall Study|Lost to Follow-up|0|||
164268110|NCT02713529|593350109|FG005|Overall Study|Lost to Follow-up|0|||
164268111|NCT02713529|593350110|FG006|Overall Study|Lost to Follow-up|0|||
164268112|NCT02713529|593350104|FG000|Overall Study|Death|3|||
164268113|NCT02713529|593350105|FG001|Overall Study|Death|3|||
164268114|NCT02713529|593350106|FG002|Overall Study|Death|26|||
164268115|NCT02713529|593350107|FG003|Overall Study|Death|27|||
164268116|NCT02713529|593350108|FG004|Overall Study|Death|3|||
164268117|NCT02713529|593350109|FG005|Overall Study|Death|13|||
164268118|NCT02713529|593350110|FG006|Overall Study|Death|3|||
164268119|NCT03667690|593351693|FG000|Overall Study|Adverse Event|0|||
164268120|NCT03667690|593351694|FG001|Overall Study|Adverse Event|3|||
164268121|NCT03667690|593351693|FG000|Overall Study|Death|22|||
164268122|NCT03667690|593351694|FG001|Overall Study|Death|21|||
164268123|NCT03667690|593351693|FG000|Overall Study|Lost to Follow-up|4|||
164268124|NCT03667690|593351694|FG001|Overall Study|Lost to Follow-up|5|||
164268125|NCT03667690|593351693|FG000|Overall Study|Withdrawal by Subject|7|||
164268126|NCT03667690|593351694|FG001|Overall Study|Withdrawal by Subject|8|||
164268127|NCT03667690|593351693|FG000|Overall Study|Subject could not return for additional investigational product|1|||
164268128|NCT03667690|593351694|FG001|Overall Study|Subject could not return for additional investigational product|0|||
164268129|NCT03667690|593351693|FG000|Overall Study|Subject discharged to hospice care|2|||
164268130|NCT03667690|593351694|FG001|Overall Study|Subject discharged to hospice care|0|||
164268131|NCT03667690|593351693|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
164268132|NCT03667690|593351694|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
164268133|NCT03667690|593351693|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
164268134|NCT03667690|593351694|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
164268135|NCT03667690|593351693|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
164268136|NCT03667690|593351694|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
164268137|NCT03667690|593351693|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
164268138|NCT03667690|593351694|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
164430780|NCT00430677|593947313|FG002|Short-term Period|Death|5|||
164430781|NCT00430677|593947311|FG000|Short-term Period|Adverse Event|15|||
164268139|NCT03667690|593351693|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
164268140|NCT03667690|593351694|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
164268141|NCT01192568|593351703|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
164268142|NCT01192568|593351704|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
164268143|NCT01192568|593351705|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
164268144|NCT01192568|593351706|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
164268145|NCT01192568|593351703|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
164268146|NCT01192568|593351704|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
164268147|NCT01192568|593351705|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
164268148|NCT01192568|593351706|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
164268149|NCT02593825|593351707|FG000|Intervention|Lost to Follow-up|10|||
164268150|NCT02593825|593351708|FG001|Intervention|Lost to Follow-up|12|||
164268151|NCT06359080|593351709|FG000|Overall Study|Withdrawal by Subject|3|||
164268152|NCT02783170|593351714|FG000|Overall Study|Randomized but not Vaccinated|1|||
164268153|NCT02783170|593351715|FG001|Overall Study|Randomized but not Vaccinated|0|||
164268154|NCT03323736|593351718|FG000|Overall Study|Screen Failure|14|||
164268155|NCT03323736|593351719|FG001|Overall Study|Screen Failure|9|||
164268156|NCT03323736|593351720|FG002|Overall Study|Screen Failure|1|||
164268157|NCT03323736|593351718|FG000|Overall Study|Withdrawal Before Treatment|3|||
164268158|NCT03323736|593351719|FG001|Overall Study|Withdrawal Before Treatment|1|||
164268159|NCT03323736|593351720|FG002|Overall Study|Withdrawal Before Treatment|1|||
164268160|NCT03323736|593351718|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
164268161|NCT03323736|593351719|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
164268162|NCT03323736|593351720|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
164268163|NCT01806064|593351721|FG000|Overall Study|Randomized Not Enrolled|0|||
164268164|NCT01806064|593351722|FG001|Overall Study|Randomized Not Enrolled|0|||
164268165|NCT01806064|593351723|FG002|Overall Study|Randomized Not Enrolled|0|||
164268166|NCT01806064|593351724|FG003|Overall Study|Randomized Not Enrolled|1|||
164268167|NCT01806064|593351725|FG004|Overall Study|Randomized Not Enrolled|2|||
164268168|NCT00701805|593351731|FG000|Overall Study|Withdrawal by Subject|3|||
164268169|NCT00701805|593351732|FG001|Overall Study|Withdrawal by Subject|1|||
164268170|NCT00701805|593351733|FG002|Overall Study|Withdrawal by Subject|4|||
164268171|NCT00701805|593351734|FG003|Overall Study|Withdrawal by Subject|3|||
164268172|NCT00701805|593351731|FG000|Overall Study|Adverse Event|0|||
164268173|NCT00701805|593351732|FG001|Overall Study|Adverse Event|1|||
164268174|NCT00701805|593351733|FG002|Overall Study|Adverse Event|1|||
164268175|NCT00701805|593351734|FG003|Overall Study|Adverse Event|0|||
164268176|NCT00701805|593351731|FG000|Overall Study|Missed 7 consecutive doses|0|||
164268177|NCT00701805|593351732|FG001|Overall Study|Missed 7 consecutive doses|1|||
164268178|NCT00701805|593351733|FG002|Overall Study|Missed 7 consecutive doses|0|||
164268179|NCT00701805|593351734|FG003|Overall Study|Missed 7 consecutive doses|0|||
164268180|NCT00701805|593351731|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
164268181|NCT00701805|593351732|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
164268182|NCT00701805|593351733|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
164268183|NCT00701805|593351734|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
164268184|NCT00701805|593351731|FG000|Overall Study|Physician decision, change of therapy|0|||
164268185|NCT00701805|593351732|FG001|Overall Study|Physician decision, change of therapy|0|||
164268186|NCT00701805|593351733|FG002|Overall Study|Physician decision, change of therapy|0|||
164268187|NCT00701805|593351734|FG003|Overall Study|Physician decision, change of therapy|1|||
164268188|NCT00701805|593351731|FG000|Overall Study|Difficult to travel to dialysis site|0|||
164268189|NCT00701805|593351732|FG001|Overall Study|Difficult to travel to dialysis site|0|||
164268190|NCT00701805|593351733|FG002|Overall Study|Difficult to travel to dialysis site|1|||
164268191|NCT00701805|593351734|FG003|Overall Study|Difficult to travel to dialysis site|0|||
164268192|NCT00701805|593351731|FG000|Overall Study|Resumption criteria were not met|0|||
164268193|NCT00701805|593351732|FG001|Overall Study|Resumption criteria were not met|1|||
164430782|NCT00430677|593947312|FG001|Short-term Period|Adverse Event|13|||
164430783|NCT00430677|593947313|FG002|Short-term Period|Adverse Event|9|||
164686608|NCT01717313|594876529|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
164686609|NCT01717313|594876528|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
164686610|NCT01717313|594876529|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
164686611|NCT01717313|594876528|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
164686612|NCT01717313|594876529|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
164268194|NCT00701805|593351733|FG002|Overall Study|Resumption criteria were not met|0|||
164268195|NCT00701805|593351734|FG003|Overall Study|Resumption criteria were not met|0|||
164268196|NCT05063539|593351735|FG000|Overall Study|Adverse Event|1|||
164268197|NCT05063539|593351736|FG001|Overall Study|Adverse Event|2|||
164268198|NCT05063539|593351737|FG002|Overall Study|Adverse Event|1|||
164268199|NCT05063539|593351735|FG000|Overall Study|Death|0|||
164268200|NCT05063539|593351736|FG001|Overall Study|Death|1|||
164268201|NCT05063539|593351737|FG002|Overall Study|Death|1|||
164268202|NCT05063539|593351735|FG000|Overall Study|Lost to Follow-up|0|||
164430784|NCT00430677|593947311|FG000|Short-term Period|Lack of Efficacy|5|||
164268203|NCT05063539|593351736|FG001|Overall Study|Lost to Follow-up|1|||
164268204|NCT05063539|593351737|FG002|Overall Study|Lost to Follow-up|0|||
164268205|NCT05063539|593351735|FG000|Overall Study|Physician Decision|4|||
164268206|NCT05063539|593351736|FG001|Overall Study|Physician Decision|3|||
164268207|NCT05063539|593351737|FG002|Overall Study|Physician Decision|1|||
164268208|NCT05063539|593351735|FG000|Overall Study|Progressive Disease|0|||
164268209|NCT05063539|593351736|FG001|Overall Study|Progressive Disease|2|||
164268210|NCT05063539|593351737|FG002|Overall Study|Progressive Disease|0|||
164268211|NCT05063539|593351735|FG000|Overall Study|Withdrawal by Subject|17|||
164268212|NCT05063539|593351736|FG001|Overall Study|Withdrawal by Subject|26|||
164268213|NCT05063539|593351737|FG002|Overall Study|Withdrawal by Subject|14|||
164268214|NCT05063539|593351735|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
164268215|NCT05063539|593351736|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
164268216|NCT05063539|593351737|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
164268217|NCT05063539|593351735|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
164268218|NCT05063539|593351736|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
164268219|NCT05063539|593351737|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
164268220|NCT05063539|593351735|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
164268221|NCT05063539|593351736|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
164268222|NCT05063539|593351737|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
164268223|NCT05063539|593351735|FG000|Overall Study|Discontinued due to Common Close Design|0|||
164268224|NCT05063539|593351736|FG001|Overall Study|Discontinued due to Common Close Design|1|||
164268225|NCT05063539|593351737|FG002|Overall Study|Discontinued due to Common Close Design|0|||
164268226|NCT05063539|593351735|FG000|Overall Study|Participant not co-operative|0|||
164268227|NCT05063539|593351736|FG001|Overall Study|Participant not co-operative|1|||
164268228|NCT05063539|593351737|FG002|Overall Study|Participant not co-operative|0|||
164268229|NCT05063539|593351735|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
164268230|NCT05063539|593351736|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
164268231|NCT05063539|593351737|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
164268232|NCT05063539|593351735|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
164268233|NCT05063539|593351736|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
164268234|NCT05063539|593351737|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
164268235|NCT04256512|593351738|FG000|Overall Study|Withdrawal by Subject|1|||
164268236|NCT03199469|593351739|FG000|Overall Study|Randomized, not treated|0|||
164268237|NCT03199469|593351740|FG001|Overall Study|Randomized, not treated|3|||
164268238|NCT03199469|593351739|FG000|Overall Study|Withdrawal by Subject|1|||
164268239|NCT03199469|593351740|FG001|Overall Study|Withdrawal by Subject|0|||
164268240|NCT03199469|593351739|FG000|Overall Study|Death|1|||
164268241|NCT03199469|593351740|FG001|Overall Study|Death|3|||
164268242|NCT03199469|593351739|FG000|Overall Study|Ongoing|5|||
164268243|NCT03199469|593351740|FG001|Overall Study|Ongoing|14|||
164268244|NCT04692077|593351743|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
164268245|NCT01751139|593351744|FG000|Overall Study|Other|135|||
164268246|NCT01751139|593351744|FG000|Overall Study|Sponsor study termination|1609|||
164268247|NCT01751139|593351744|FG000|Overall Study|Lost to Follow-up|240|||
164268248|NCT01751139|593351744|FG000|Overall Study|Withdrawal by Subject|251|||
164268249|NCT01751139|593351744|FG000|Overall Study|Adverse Event|1|||
164268250|NCT01751139|593351744|FG000|Overall Study|Death|31|||
164268251|NCT03344172|593351745|FG000|Overall Study|Received <1 dose of treatment|1|||
164268252|NCT03344172|593351746|FG001|Overall Study|Received <1 dose of treatment|0|||
164268253|NCT03106415|593351747|FG000|Phase 1|Withdrawal by Subject|1|||
164268254|NCT03106415|593351748|FG001|Phase 1|Withdrawal by Subject|0|||
164268255|NCT03106415|593351749|FG002|Phase 1|Withdrawal by Subject|0|||
164268256|NCT03106415|593351747|FG000|Phase 1|Adverse Event|1|||
164268257|NCT03106415|593351748|FG001|Phase 1|Adverse Event|1|||
164268258|NCT03106415|593351749|FG002|Phase 1|Adverse Event|0|||
164268259|NCT03106415|593351747|FG000|Phase 1|Protocol Violation|0|||
164268260|NCT03106415|593351748|FG001|Phase 1|Protocol Violation|1|||
164268261|NCT03106415|593351749|FG002|Phase 1|Protocol Violation|0|||
164268262|NCT01300351|593351751|FG000|Overall Study|Did not receive treatment|2|||
164268263|NCT01300351|593351752|FG001|Overall Study|Did not receive treatment|0|||
164268264|NCT01300351|593351751|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
164268265|NCT01300351|593351752|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
164268266|NCT01300351|593351751|FG000|Overall Study|Lost to Follow-up|0|||
164268267|NCT01300351|593351752|FG001|Overall Study|Lost to Follow-up|1|||
164268268|NCT01300351|593351751|FG000|Overall Study|Adverse Event|0|||
164268269|NCT01300351|593351752|FG001|Overall Study|Adverse Event|4|||
164341937|NCT00932126|593627565|FG001|Overall Study|Other|0|||
164341938|NCT00932126|593627566|FG002|Overall Study|Other|0|||
164341939|NCT00932126|593627567|FG003|Overall Study|Other|0|||
164341940|NCT00932126|593627568|FG004|Overall Study|Other|1|||
164686613|NCT01717313|594876528|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
164686614|NCT01717313|594876529|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
164686615|NCT01717313|594876528|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
164686616|NCT01717313|594876529|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
164686617|NCT01717313|594876528|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
164268270|NCT01300351|593351751|FG000|Overall Study|Withdrawal by Subject|7|||
164268271|NCT01300351|593351752|FG001|Overall Study|Withdrawal by Subject|10|||
164268272|NCT05824936|593351755|FG000|Overall Study|Lost to Follow-up|1|||
164268273|NCT00096018|593351756|FG000|Overall Study|Became Ineligible (not treated)|0|||
164268274|NCT00096018|593351757|FG001|Overall Study|Became Ineligible (not treated)|3|||
164268275|NCT00096018|593351756|FG000|Overall Study|Miscellaneous (not treated)|0|||
164268276|NCT00096018|593351757|FG001|Overall Study|Miscellaneous (not treated)|2|||
164268277|NCT00096018|593351756|FG000|Overall Study|Adverse Event|0|||
164268278|NCT00096018|593351757|FG001|Overall Study|Adverse Event|5|||
164268279|NCT00096018|593351756|FG000|Overall Study|Death|0|||
164268280|NCT00096018|593351757|FG001|Overall Study|Death|1|||
164268281|NCT00096018|593351756|FG000|Overall Study|Withdrawal by Subject|0|||
164268282|NCT00096018|593351757|FG001|Overall Study|Withdrawal by Subject|2|||
164268283|NCT00096018|593351756|FG000|Overall Study|Miscellaneous|2|||
164268284|NCT00096018|593351757|FG001|Overall Study|Miscellaneous|1|||
164268285|NCT00673881|593351758|FG000|Overall Study|Withdrawal by Subject|1|||
164268286|NCT00483041|593351759|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
164268287|NCT00483041|593351760|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
164268288|NCT02258529|593351761|FG000|Overall Study|Study Terminated by Sponsor|9|||
164268289|NCT02258529|593351761|FG000|Overall Study|Adverse Event|1|||
164268290|NCT00875056|593351764|FG000|Overall Study|Adverse Event|6|||
164268291|NCT00875056|593351765|FG001|Overall Study|Adverse Event|1|||
164268292|NCT00875056|593351766|FG002|Overall Study|Adverse Event|2|||
164268293|NCT00875056|593351764|FG000|Overall Study|Progressive Disease|14|||
164268294|NCT00875056|593351765|FG001|Overall Study|Progressive Disease|8|||
164268295|NCT00875056|593351766|FG002|Overall Study|Progressive Disease|3|||
164268296|NCT00875056|593351764|FG000|Overall Study|Withdrawal by Subject|3|||
164268297|NCT00875056|593351765|FG001|Overall Study|Withdrawal by Subject|0|||
164268298|NCT00875056|593351766|FG002|Overall Study|Withdrawal by Subject|1|||
164268299|NCT01842581|593351775|FG000|Overall Study|Adverse Event|6|||
164268300|NCT01842581|593351776|FG001|Overall Study|Adverse Event|4|||
164268301|NCT01842581|593351775|FG000|Overall Study|HE breakthrough|26|||
164268302|NCT01842581|593351776|FG001|Overall Study|HE breakthrough|13|||
164268303|NCT01842581|593351775|FG000|Overall Study|Liver transplant|2|||
164268304|NCT01842581|593351776|FG001|Overall Study|Liver transplant|0|||
164268305|NCT01842581|593351775|FG000|Overall Study|Lost to Follow-up|2|||
164268306|NCT01842581|593351776|FG001|Overall Study|Lost to Follow-up|5|||
164268307|NCT01842581|593351775|FG000|Overall Study|Withdrawal by Subject|5|||
164268308|NCT01842581|593351776|FG001|Overall Study|Withdrawal by Subject|7|||
164268309|NCT01842581|593351775|FG000|Overall Study|Other than specified|3|||
164268310|NCT01842581|593351776|FG001|Overall Study|Other than specified|1|||
164268311|NCT02648217|593351779|FG000|Overall Study|Adverse Event|0|||
164268312|NCT02648217|593351780|FG001|Overall Study|Adverse Event|1|||
164268313|NCT02648217|593351779|FG000|Overall Study|Lost to Follow-up|1|||
164268314|NCT02648217|593351780|FG001|Overall Study|Lost to Follow-up|1|||
164268315|NCT02648217|593351779|FG000|Overall Study|Withdrawal by Subject|4|||
164268316|NCT02648217|593351780|FG001|Overall Study|Withdrawal by Subject|3|||
164268317|NCT02648217|593351779|FG000|Overall Study|Unclassified|5|||
164268318|NCT02648217|593351780|FG001|Overall Study|Unclassified|0|||
164268319|NCT02553538|593351781|FG000|Overall Study|Could Not Reach by Telephone|133|||
164268320|NCT02553538|593351782|FG001|Overall Study|Could Not Reach by Telephone|0|||
164268321|NCT02553538|593351781|FG000|Overall Study|Died or Left Network|54|||
164268322|NCT02553538|593351782|FG001|Overall Study|Died or Left Network|56|||
164268323|NCT00815191|593351790|FG000|Overall Study|Protocol Violation|1|||
164268324|NCT00815191|593351791|FG001|Overall Study|Protocol Violation|1|||
164341941|NCT00932126|593627569|FG005|Overall Study|Other|0|||
164341942|NCT00932126|593627570|FG006|Overall Study|Other|1|||
164341943|NCT00932126|593627571|FG007|Overall Study|Other|2|||
164341944|NCT02121522|593627579|FG000|Overall Study|Adverse Event|1|||
164341945|NCT01235689|593627580|FG000|Overall Study|Adverse Event|12|||
164341946|NCT01235689|593627581|FG001|Overall Study|Adverse Event|16|||
164686618|NCT01717313|594876529|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
164268325|NCT02900170|593351792|FG000|Overall Study|Lost to Follow-up|8|||
164268326|NCT01873729|593351793|FG000|Overall Study|Withdrawal by Subject|1|||
164341947|NCT01235689|593627580|FG000|Overall Study|Lack of Efficacy|12|||
164341948|NCT01235689|593627581|FG001|Overall Study|Lack of Efficacy|5|||
164341949|NCT01235689|593627580|FG000|Overall Study|Withdrawal by Subject|3|||
164341950|NCT01235689|593627581|FG001|Overall Study|Withdrawal by Subject|4|||
164268327|NCT01741532|593351794|FG000|Overall Study|Adverse Event|4|||
164268328|NCT01741532|593351795|FG001|Overall Study|Adverse Event|0|||
164268329|NCT01741532|593351794|FG000|Overall Study|Withdrawal by Subject|1|||
164268330|NCT01741532|593351795|FG001|Overall Study|Withdrawal by Subject|1|||
164268331|NCT01741532|593351794|FG000|Overall Study|Protocol Violation|0|||
164268332|NCT01741532|593351795|FG001|Overall Study|Protocol Violation|1|||
164268333|NCT01741532|593351794|FG000|Overall Study|Worsening of the disease|3|||
164268334|NCT01741532|593351795|FG001|Overall Study|Worsening of the disease|1|||
164268335|NCT01741532|593351794|FG000|Overall Study|Sponsor decision|1|||
164268336|NCT01741532|593351795|FG001|Overall Study|Sponsor decision|0|||
164268337|NCT01741532|593351794|FG000|Overall Study|Medical event|1|||
164268338|NCT01741532|593351795|FG001|Overall Study|Medical event|0|||
164268339|NCT00613080|593351796|FG000|Overall Study|Ineligible / no protocol treatment|11|||
164268340|NCT02012686|593351798|FG000|Overall Study|muscle contraction|0|||
164268341|NCT02012686|593351799|FG001|Overall Study|muscle contraction|1|||
164268342|NCT02012686|593351798|FG000|Overall Study|electrocardiography monitoring noise|0|||
164268343|NCT02012686|593351799|FG001|Overall Study|electrocardiography monitoring noise|1|||
164268344|NCT01703065|593351800|FG000|Overall Study|Lack of Efficacy|1|||
164268345|NCT01703065|593351801|FG001|Overall Study|Lack of Efficacy|0|||
164268346|NCT02124772|593351802|FG000|Overall Study|Lack of Efficacy|2|||
164268347|NCT02124772|593351803|FG001|Overall Study|Lack of Efficacy|0|||
164268348|NCT02124772|593351804|FG002|Overall Study|Lack of Efficacy|0|||
164268349|NCT02124772|593351805|FG003|Overall Study|Lack of Efficacy|1|||
164268350|NCT02124772|593351806|FG004|Overall Study|Lack of Efficacy|2|||
164268351|NCT02124772|593351807|FG005|Overall Study|Lack of Efficacy|3|||
164268352|NCT02124772|593351808|FG006|Overall Study|Lack of Efficacy|0|||
164268353|NCT02124772|593351809|FG007|Overall Study|Lack of Efficacy|2|||
164268354|NCT02124772|593351810|FG008|Overall Study|Lack of Efficacy|0|||
164268355|NCT02124772|593351811|FG009|Overall Study|Lack of Efficacy|1|||
164268356|NCT02124772|593351812|FG010|Overall Study|Lack of Efficacy|0|||
164268357|NCT02124772|593351813|FG011|Overall Study|Lack of Efficacy|0|||
164268358|NCT02124772|593351814|FG012|Overall Study|Lack of Efficacy|1|||
164268359|NCT02124772|593351802|FG000|Overall Study|Adverse Event|1|||
164268360|NCT02124772|593351803|FG001|Overall Study|Adverse Event|4|||
164268361|NCT02124772|593351804|FG002|Overall Study|Adverse Event|1|||
164268362|NCT02124772|593351805|FG003|Overall Study|Adverse Event|5|||
164268363|NCT02124772|593351806|FG004|Overall Study|Adverse Event|2|||
164268364|NCT02124772|593351807|FG005|Overall Study|Adverse Event|1|||
164268365|NCT02124772|593351808|FG006|Overall Study|Adverse Event|1|||
164268366|NCT02124772|593351809|FG007|Overall Study|Adverse Event|5|||
164268367|NCT02124772|593351810|FG008|Overall Study|Adverse Event|0|||
164268368|NCT02124772|593351811|FG009|Overall Study|Adverse Event|3|||
164268369|NCT02124772|593351812|FG010|Overall Study|Adverse Event|1|||
164268370|NCT02124772|593351813|FG011|Overall Study|Adverse Event|3|||
164268371|NCT02124772|593351814|FG012|Overall Study|Adverse Event|1|||
164268372|NCT02124772|593351802|FG000|Overall Study|Withdrawal consent|0|||
164268373|NCT02124772|593351803|FG001|Overall Study|Withdrawal consent|1|||
164268374|NCT02124772|593351804|FG002|Overall Study|Withdrawal consent|1|||
164268375|NCT02124772|593351805|FG003|Overall Study|Withdrawal consent|1|||
164268376|NCT02124772|593351806|FG004|Overall Study|Withdrawal consent|0|||
164268377|NCT02124772|593351807|FG005|Overall Study|Withdrawal consent|1|||
164268378|NCT02124772|593351808|FG006|Overall Study|Withdrawal consent|1|||
164268379|NCT02124772|593351809|FG007|Overall Study|Withdrawal consent|0|||
164268380|NCT02124772|593351810|FG008|Overall Study|Withdrawal consent|0|||
164268381|NCT02124772|593351811|FG009|Overall Study|Withdrawal consent|1|||
164268382|NCT02124772|593351812|FG010|Overall Study|Withdrawal consent|0|||
164268383|NCT02124772|593351813|FG011|Overall Study|Withdrawal consent|1|||
164268384|NCT02124772|593351814|FG012|Overall Study|Withdrawal consent|0|||
164268385|NCT02124772|593351802|FG000|Overall Study|Investigator discretion|0|||
164268386|NCT02124772|593351803|FG001|Overall Study|Investigator discretion|2|||
164268387|NCT02124772|593351804|FG002|Overall Study|Investigator discretion|2|||
164268388|NCT02124772|593351805|FG003|Overall Study|Investigator discretion|1|||
164268389|NCT02124772|593351806|FG004|Overall Study|Investigator discretion|1|||
164268390|NCT02124772|593351807|FG005|Overall Study|Investigator discretion|0|||
164268391|NCT02124772|593351808|FG006|Overall Study|Investigator discretion|1|||
164268392|NCT02124772|593351809|FG007|Overall Study|Investigator discretion|0|||
164268393|NCT02124772|593351810|FG008|Overall Study|Investigator discretion|0|||
164268394|NCT02124772|593351811|FG009|Overall Study|Investigator discretion|1|||
164268395|NCT02124772|593351812|FG010|Overall Study|Investigator discretion|0|||
164268396|NCT02124772|593351813|FG011|Overall Study|Investigator discretion|1|||
164268397|NCT02124772|593351814|FG012|Overall Study|Investigator discretion|0|||
164268398|NCT02124772|593351802|FG000|Overall Study|Progressive disease|0|||
164268399|NCT02124772|593351803|FG001|Overall Study|Progressive disease|0|||
164268400|NCT02124772|593351804|FG002|Overall Study|Progressive disease|0|||
164268401|NCT02124772|593351805|FG003|Overall Study|Progressive disease|0|||
164268402|NCT02124772|593351806|FG004|Overall Study|Progressive disease|0|||
164268403|NCT02124772|593351807|FG005|Overall Study|Progressive disease|0|||
164268404|NCT02124772|593351808|FG006|Overall Study|Progressive disease|1|||
164268405|NCT02124772|593351809|FG007|Overall Study|Progressive disease|1|||
164341951|NCT01235689|593627580|FG000|Overall Study|Lost to Follow-up|1|||
164341952|NCT01235689|593627581|FG001|Overall Study|Lost to Follow-up|2|||
164341953|NCT01235689|593627580|FG000|Overall Study|Miscellaneous|1|||
164341954|NCT01235689|593627581|FG001|Overall Study|Miscellaneous|5|||
164268406|NCT02124772|593351810|FG008|Overall Study|Progressive disease|0|||
164268407|NCT02124772|593351811|FG009|Overall Study|Progressive disease|0|||
164268408|NCT02124772|593351812|FG010|Overall Study|Progressive disease|0|||
164268409|NCT02124772|593351813|FG011|Overall Study|Progressive disease|0|||
164268410|NCT02124772|593351814|FG012|Overall Study|Progressive disease|0|||
164268411|NCT02124772|593351802|FG000|Overall Study|Other|0|||
164268412|NCT02124772|593351803|FG001|Overall Study|Other|7|||
164268413|NCT02124772|593351804|FG002|Overall Study|Other|2|||
164268414|NCT02124772|593351805|FG003|Overall Study|Other|5|||
164268415|NCT02124772|593351806|FG004|Overall Study|Other|4|||
164268416|NCT02124772|593351807|FG005|Overall Study|Other|3|||
164268417|NCT02124772|593351808|FG006|Overall Study|Other|4|||
164268418|NCT02124772|593351809|FG007|Overall Study|Other|1|||
164268419|NCT02124772|593351810|FG008|Overall Study|Other|1|||
164268420|NCT02124772|593351811|FG009|Overall Study|Other|1|||
164268421|NCT02124772|593351812|FG010|Overall Study|Other|1|||
164268422|NCT02124772|593351813|FG011|Overall Study|Other|1|||
164268423|NCT02124772|593351814|FG012|Overall Study|Other|0|||
164268424|NCT01827332|593351815|FG000|Overall Study|Lost to Follow-up|2|||
164268425|NCT01827332|593351816|FG001|Overall Study|Lost to Follow-up|1|||
164268426|NCT01739803|593351817|FG000|Overall Study|Lost to Follow-up|9|||
164268427|NCT01739803|593351818|FG001|Overall Study|Lost to Follow-up|6|||
164268428|NCT03759041|593351822|FG000|Overall Study|Withdrawal by Subject|4|||
164268429|NCT03759041|593351823|FG001|Overall Study|Withdrawal by Subject|10|||
164268430|NCT03759041|593351824|FG002|Overall Study|Withdrawal by Subject|10|||
164268431|NCT03759041|593351822|FG000|Overall Study|Adverse Event|1|||
164268432|NCT03759041|593351823|FG001|Overall Study|Adverse Event|3|||
164268433|NCT03759041|593351824|FG002|Overall Study|Adverse Event|4|||
164268434|NCT03759041|593351822|FG000|Overall Study|Lack of Efficacy|0|||
164268435|NCT03759041|593351823|FG001|Overall Study|Lack of Efficacy|0|||
164268436|NCT03759041|593351824|FG002|Overall Study|Lack of Efficacy|1|||
164268437|NCT03759041|593351822|FG000|Overall Study|Study Terminated by Sponsor|15|||
164268438|NCT03759041|593351823|FG001|Overall Study|Study Terminated by Sponsor|16|||
164268439|NCT03759041|593351824|FG002|Overall Study|Study Terminated by Sponsor|10|||
164268440|NCT03759041|593351822|FG000|Overall Study|Other reason for discontinuation|0|||
164268441|NCT03759041|593351823|FG001|Overall Study|Other reason for discontinuation|2|||
164268442|NCT03759041|593351824|FG002|Overall Study|Other reason for discontinuation|1|||
164268443|NCT03759041|593351822|FG000|Overall Study|Lost to Follow-up|7|||
164268444|NCT03759041|593351823|FG001|Overall Study|Lost to Follow-up|2|||
164268445|NCT03759041|593351824|FG002|Overall Study|Lost to Follow-up|2|||
164268446|NCT03759041|593351822|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
164268447|NCT03759041|593351823|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
164268448|NCT03759041|593351824|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
164268449|NCT02449018|593351825|FG000|Overall Study|Abnormal laboratory value|0|||
164268450|NCT02449018|593351826|FG001|Overall Study|Abnormal laboratory value|1|||
164268451|NCT02449018|593351825|FG000|Overall Study|Administrative problems|1|||
164268452|NCT02449018|593351826|FG001|Overall Study|Administrative problems|0|||
164268453|NCT02449018|593351825|FG000|Overall Study|Adverse Event|5|||
164268454|NCT02449018|593351826|FG001|Overall Study|Adverse Event|1|||
164268455|NCT02449018|593351825|FG000|Overall Study|Protocol deviation|4|||
164268456|NCT02449018|593351826|FG001|Overall Study|Protocol deviation|0|||
164268457|NCT02449018|593351825|FG000|Overall Study|Patient decision|2|||
164268458|NCT02449018|593351826|FG001|Overall Study|Patient decision|0|||
164268459|NCT00525824|593351832|FG000|Overall Study|Adverse Event|7|||
164268460|NCT00525824|593351833|FG001|Overall Study|Adverse Event|11|||
164268461|NCT00525824|593351834|FG002|Overall Study|Adverse Event|6|||
164268462|NCT00525824|593351835|FG003|Overall Study|Adverse Event|7|||
164268463|NCT00525824|593351832|FG000|Overall Study|Withdrawal by Subject|5|||
164268464|NCT00525824|593351833|FG001|Overall Study|Withdrawal by Subject|9|||
164268465|NCT00525824|593351834|FG002|Overall Study|Withdrawal by Subject|3|||
164268466|NCT00525824|593351835|FG003|Overall Study|Withdrawal by Subject|4|||
164341955|NCT00806351|593627582|FG000|Overall Study|Death|5|||
164341956|NCT00806351|593627583|FG001|Overall Study|Death|4|||
164268467|NCT00525824|593351832|FG000|Overall Study|Lost to Follow-up|4|||
164268468|NCT00525824|593351833|FG001|Overall Study|Lost to Follow-up|2|||
164268469|NCT00525824|593351834|FG002|Overall Study|Lost to Follow-up|4|||
164268470|NCT00525824|593351835|FG003|Overall Study|Lost to Follow-up|0|||
164268471|NCT00525824|593351832|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
164268472|NCT00525824|593351833|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
164268473|NCT00525824|593351834|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
164268474|NCT00525824|593351835|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
164268475|NCT00525824|593351832|FG000|Overall Study|Severe non-compliance|0|||
164268476|NCT00525824|593351833|FG001|Overall Study|Severe non-compliance|1|||
164268477|NCT00525824|593351834|FG002|Overall Study|Severe non-compliance|1|||
164268478|NCT00525824|593351835|FG003|Overall Study|Severe non-compliance|1|||
164268479|NCT00525824|593351832|FG000|Overall Study|Safety reasons|1|||
164268480|NCT00525824|593351833|FG001|Overall Study|Safety reasons|0|||
164268481|NCT00525824|593351834|FG002|Overall Study|Safety reasons|1|||
164268482|NCT00525824|593351835|FG003|Overall Study|Safety reasons|0|||
164268483|NCT00525824|593351832|FG000|Overall Study|Other|1|||
164268484|NCT00525824|593351833|FG001|Overall Study|Other|3|||
164268485|NCT00525824|593351834|FG002|Overall Study|Other|3|||
164268486|NCT00525824|593351835|FG003|Overall Study|Other|1|||
164268487|NCT01522404|593351839|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
164268488|NCT01522404|593351840|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
164268489|NCT01522404|593351839|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
164268490|NCT01522404|593351840|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
164268491|NCT01522404|593351839|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
164268492|NCT01522404|593351840|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
164268493|NCT02698371|593351841|FG000|All Participants Flow|Lost to Follow-up|3|||
164268494|NCT02698371|593351841|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
164268495|NCT02698371|593351841|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
164268496|NCT02698371|593351841|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
164268497|NCT02698371|593351841|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
164268498|NCT02698371|593351841|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
164268499|NCT02698371|593351841|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
164268500|NCT01440881|593351844|FG000|Overall Study|Death|0|||
164268501|NCT01440881|593351845|FG001|Overall Study|Death|1|||
164268502|NCT02644356|593351847|FG000|Overall Study|Withdrawal by Subject|2|||
164268503|NCT02290938|593351848|FG000|Overall Study|Lost to Follow-up|14|||
164268504|NCT02290938|593351849|FG001|Overall Study|Lost to Follow-up|43|||
164268505|NCT00897390|593351850|FG000|Overall Study|Adverse Event|2|||
164268506|NCT00897390|593351850|FG000|Overall Study|No Longer Met Study Criteria|1|||
164268507|NCT00897390|593351850|FG000|Overall Study|Personal Reasons|1|||
164268508|NCT00897390|593351850|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
164268509|NCT04500769|593352807|FG000|Overall Study|Withdrawal by Subject|5|||
164268510|NCT05011513|593352808|FG000|Overall Study|Death|0|||
164268511|NCT05011513|593352809|FG001|Overall Study|Death|1|||
164268512|NCT05011513|593352808|FG000|Overall Study|Lost to Follow-up|4|||
164268513|NCT05011513|593352809|FG001|Overall Study|Lost to Follow-up|0|||
164268514|NCT05011513|593352808|FG000|Overall Study|Withdrawal by Subject|18|||
164268515|NCT05011513|593352809|FG001|Overall Study|Withdrawal by Subject|17|||
164268516|NCT05011513|593352808|FG000|Overall Study|Other|4|||
164268517|NCT05011513|593352809|FG001|Overall Study|Other|2|||
164268518|NCT01511562|593352810|FG000|Induction|Adverse Event|2|||
164268519|NCT01511562|593352811|FG001|Induction|Adverse Event|0|||
164268520|NCT01511562|593352810|FG000|Induction|Disease Progression|3|||
164268521|NCT01511562|593352811|FG001|Induction|Disease Progression|7|||
164268522|NCT01511562|593352810|FG000|Induction|Death|1|||
164268523|NCT01511562|593352811|FG001|Induction|Death|3|||
164268524|NCT01511562|593352810|FG000|Induction|Withdrawal by Subject|0|||
164268525|NCT01511562|593352811|FG001|Induction|Withdrawal by Subject|4|||
164268526|NCT01511562|593352810|FG000|Induction|Other|3|||
164268527|NCT01511562|593352811|FG001|Induction|Other|0|||
164268528|NCT01511562|593352810|FG000|Consolidation|Withdrawal by Subject|1|||
164268529|NCT01511562|593352811|FG001|Consolidation|Withdrawal by Subject|0|||
164268530|NCT01511562|593352810|FG000|Consolidation|Other|1|||
164268531|NCT01511562|593352811|FG001|Consolidation|Other|0|||
164581340|NCT00923091|594493951|FG006|Period III (Single-Blind)|Protocol Violation|0|||
164581341|NCT00923091|594493952|FG007|Period III (Single-Blind)|Protocol Violation|0|||
164581342|NCT00923091|594493953|FG008|Period III (Single-Blind)|Protocol Violation|0|||
164581343|NCT00923091|594493954|FG009|Period III (Single-Blind)|Protocol Violation|0|||
164268532|NCT04736199|593352812|FG000|Overall Study|Adverse Event|28|||
164268533|NCT04736199|593352813|FG001|Overall Study|Adverse Event|22|||
164268534|NCT04736199|593352812|FG000|Overall Study|Death|9|||
164268535|NCT04736199|593352813|FG001|Overall Study|Death|3|||
164268536|NCT04736199|593352812|FG000|Overall Study|Lost to Follow-up|4|||
164268537|NCT04736199|593352813|FG001|Overall Study|Lost to Follow-up|1|||
164268538|NCT04736199|593352812|FG000|Overall Study|Physician Decision|5|||
164268539|NCT04736199|593352813|FG001|Overall Study|Physician Decision|9|||
164268540|NCT04736199|593352812|FG000|Overall Study|Withdrawal by Subject|21|||
164268541|NCT04736199|593352813|FG001|Overall Study|Withdrawal by Subject|9|||
164268542|NCT04736199|593352812|FG000|Overall Study|Progressive disease|120|||
164268543|NCT04736199|593352813|FG001|Overall Study|Progressive disease|101|||
164268544|NCT04736199|593352812|FG000|Overall Study|Subject decision|13|||
164268545|NCT04736199|593352813|FG001|Overall Study|Subject decision|13|||
164268546|NCT04736199|593352812|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
164268547|NCT04736199|593352813|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
164268548|NCT04736199|593352812|FG000|Overall Study|Additional primary malignancy|1|||
164268549|NCT04736199|593352813|FG001|Overall Study|Additional primary malignancy|0|||
164268550|NCT04736199|593352812|FG000|Overall Study|Non-compliance with study drug|0|||
164268551|NCT04736199|593352813|FG001|Overall Study|Non-compliance with study drug|1|||
164268552|NCT04736199|593352812|FG000|Overall Study|Other reason|0|||
164268553|NCT04736199|593352813|FG001|Overall Study|Other reason|1|||
164268554|NCT04736199|593352812|FG000|Overall Study|Ongoing with study drug|240|||
164268555|NCT04736199|593352813|FG001|Overall Study|Ongoing with study drug|63|||
164268556|NCT04736199|593352812|FG000|Overall Study|Study drug never administered|3|||
164268557|NCT04736199|593352813|FG001|Overall Study|Study drug never administered|0|||
164268558|NCT04744831|593352814|FG000|Overall Study|Adverse Event|6|||
164268559|NCT04744831|593352815|FG001|Overall Study|Adverse Event|4|||
164268560|NCT04744831|593352814|FG000|Overall Study|Clinical Progression|5|||
164268561|NCT04744831|593352815|FG001|Overall Study|Clinical Progression|5|||
164268562|NCT04744831|593352814|FG000|Overall Study|Death|2|||
164268563|NCT04744831|593352815|FG001|Overall Study|Death|1|||
164268564|NCT04744831|593352814|FG000|Overall Study|Other|5|||
164268565|NCT04744831|593352815|FG001|Overall Study|Other|1|||
164268566|NCT04744831|593352814|FG000|Overall Study|Progressive Disease|63|||
164268567|NCT04744831|593352815|FG001|Overall Study|Progressive Disease|29|||
164268568|NCT04744831|593352814|FG000|Overall Study|Withdrawal by Subject|1|||
164268569|NCT04744831|593352815|FG001|Overall Study|Withdrawal by Subject|0|||
164268570|NCT06024096|593352818|FG000|Overall Study|Lost to Follow-up|2|||
164268571|NCT06024096|593352819|FG001|Overall Study|Lost to Follow-up|5|||
164268572|NCT06024096|593352818|FG000|Overall Study|Physician Decision|0|||
164268573|NCT06024096|593352819|FG001|Overall Study|Physician Decision|1|||
164268574|NCT06024096|593352818|FG000|Overall Study|Withdrawal by Subject|2|||
164268575|NCT06024096|593352819|FG001|Overall Study|Withdrawal by Subject|3|||
164268576|NCT05818137|593352820|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
164268577|NCT05818137|593352820|FG000|Extension Treatment Period|Ongoing participants|44|||
164268578|NCT04938037|593352821|FG000|Overall Study|Lost to Follow-up|4|||
164268579|NCT04938037|593352822|FG001|Overall Study|Lost to Follow-up|3|||
164268580|NCT05925374|593352823|FG000|Overall Study|Lost to Follow-up|13|||
164268581|NCT03320330|593352826|FG000|Overall Study|Lack of Efficacy|5|||
164268582|NCT03320330|593352827|FG001|Overall Study|Lack of Efficacy|5|||
164268583|NCT03320330|593352828|FG002|Overall Study|Lack of Efficacy|14|||
164268584|NCT03320330|593352826|FG000|Overall Study|Physician Decision|1|||
164268585|NCT03320330|593352827|FG001|Overall Study|Physician Decision|0|||
164268586|NCT03320330|593352828|FG002|Overall Study|Physician Decision|0|||
164268587|NCT05206370|593352829|FG000|Overall Study|Adverse Event|3|||
164268588|NCT05206370|593352830|FG001|Overall Study|Adverse Event|4|||
164268589|NCT05206370|593352831|FG002|Overall Study|Adverse Event|5|||
164268590|NCT05206370|593352829|FG000|Overall Study|Withdrawal by Subject|27|||
164268591|NCT05206370|593352830|FG001|Overall Study|Withdrawal by Subject|30|||
164268592|NCT05206370|593352831|FG002|Overall Study|Withdrawal by Subject|24|||
164268593|NCT05206370|593352829|FG000|Overall Study|Physician Decision|1|||
164268594|NCT05206370|593352830|FG001|Overall Study|Physician Decision|3|||
164268595|NCT05206370|593352831|FG002|Overall Study|Physician Decision|2|||
164268596|NCT05206370|593352829|FG000|Overall Study|Death|0|||
164268597|NCT05206370|593352830|FG001|Overall Study|Death|1|||
164268598|NCT05206370|593352831|FG002|Overall Study|Death|3|||
164268599|NCT05206370|593352829|FG000|Overall Study|Lost to Follow-up|23|||
164268600|NCT05206370|593352830|FG001|Overall Study|Lost to Follow-up|16|||
164268601|NCT05206370|593352831|FG002|Overall Study|Lost to Follow-up|14|||
164268602|NCT05206370|593352829|FG000|Overall Study|Other, Nor Specified|2|||
164268603|NCT05206370|593352830|FG001|Overall Study|Other, Nor Specified|2|||
164268604|NCT05206370|593352831|FG002|Overall Study|Other, Nor Specified|4|||
164268605|NCT04998851|593352832|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
164268606|NCT04998851|593352833|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
164268607|NCT04998851|593352832|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
164268608|NCT04998851|593352833|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
164268609|NCT06038123|593352838|FG000|Overall Study|Withdrawal by Subject|1|||
164268610|NCT06038123|593352838|FG000|Overall Study|not return due to femur fracture|1|||
164268611|NCT05218499|593352839|FG000|Overall Study|Not treated|1|||
164268612|NCT05218499|593352840|FG001|Overall Study|Not treated|1|||
164268613|NCT05218499|593352841|FG002|Overall Study|Not treated|8|||
164268614|NCT05218499|593352839|FG000|Overall Study|Death|2|||
164268615|NCT05218499|593352840|FG001|Overall Study|Death|0|||
164268616|NCT05218499|593352841|FG002|Overall Study|Death|0|||
164268617|NCT05218499|593352839|FG000|Overall Study|Other than listed|3|||
164268618|NCT05218499|593352840|FG001|Overall Study|Other than listed|7|||
164268619|NCT05218499|593352841|FG002|Overall Study|Other than listed|10|||
164268620|NCT05218499|593352839|FG000|Overall Study|Protocol deviation|5|||
164268621|NCT05218499|593352840|FG001|Overall Study|Protocol deviation|6|||
164268622|NCT05218499|593352841|FG002|Overall Study|Protocol deviation|4|||
164268623|NCT05218499|593352839|FG000|Overall Study|Technical problems|0|||
164268624|NCT05218499|593352840|FG001|Overall Study|Technical problems|1|||
164268625|NCT05218499|593352841|FG002|Overall Study|Technical problems|0|||
164268626|NCT05218499|593352839|FG000|Overall Study|Burden of trial procedures|0|||
164268627|NCT05218499|593352840|FG001|Overall Study|Burden of trial procedures|1|||
164268628|NCT05218499|593352841|FG002|Overall Study|Burden of trial procedures|2|||
164268629|NCT05218499|593352839|FG000|Overall Study|Clinical disease progression|6|||
164268630|NCT05218499|593352840|FG001|Overall Study|Clinical disease progression|6|||
164268631|NCT05218499|593352841|FG002|Overall Study|Clinical disease progression|11|||
164268632|NCT05218499|593352839|FG000|Overall Study|Objective disease progression|44|||
164268633|NCT05218499|593352840|FG001|Overall Study|Objective disease progression|61|||
164268634|NCT05218499|593352841|FG002|Overall Study|Objective disease progression|42|||
164268635|NCT05218499|593352839|FG000|Overall Study|Adverse Event|11|||
164268636|NCT05218499|593352840|FG001|Overall Study|Adverse Event|36|||
164268637|NCT05218499|593352841|FG002|Overall Study|Adverse Event|9|||
164268638|NCT05218499|593352839|FG000|Overall Study|On treatment at time of snapshot|18|||
164268639|NCT05218499|593352840|FG001|Overall Study|On treatment at time of snapshot|29|||
164268640|NCT05218499|593352841|FG002|Overall Study|On treatment at time of snapshot|0|||
164268641|NCT05431387|593352850|FG000|Overall Study|Adverse Event|1|||
164268642|NCT05431387|593352851|FG001|Overall Study|Adverse Event|0|||
164268643|NCT05431387|593352850|FG000|Overall Study|Withdrawal by Subject|4|||
164268644|NCT05431387|593352851|FG001|Overall Study|Withdrawal by Subject|4|||
164268645|NCT05431387|593352850|FG000|Overall Study|Physician Decision|0|||
164268646|NCT05431387|593352851|FG001|Overall Study|Physician Decision|1|||
164268647|NCT05431387|593352850|FG000|Overall Study|Lost to Follow-up|5|||
164268648|NCT05431387|593352851|FG001|Overall Study|Lost to Follow-up|9|||
164268649|NCT05431387|593352850|FG000|Overall Study|Other, Not Specified|1|||
164268650|NCT05431387|593352851|FG001|Overall Study|Other, Not Specified|4|||
164268651|NCT03199391|593352852|FG000|Overall Study|Death|1|||
164268652|NCT03199391|593352852|FG000|Overall Study|Lost to Follow-up|3|||
164268653|NCT03199391|593352852|FG000|Overall Study|Adverse Event|2|||
164268654|NCT03199391|593352852|FG000|Overall Study|Withdrawal by Subject|10|||
164268655|NCT01867086|593352853|FG000|Overall Study|Disease Progression|1|||
164268656|NCT04257929|593352854|FG000|Overall Study|Adverse Event|1|||
164268657|NCT04257929|593352855|FG001|Overall Study|Adverse Event|0|||
164268658|NCT04257929|593352856|FG002|Overall Study|Adverse Event|1|||
164268659|NCT04257929|593352854|FG000|Overall Study|Withdrawal by Subject|1|||
164268660|NCT04257929|593352855|FG001|Overall Study|Withdrawal by Subject|0|||
164268661|NCT04257929|593352856|FG002|Overall Study|Withdrawal by Subject|0|||
164268662|NCT04257929|593352854|FG000|Overall Study|COVID-19|0|||
164268663|NCT04257929|593352855|FG001|Overall Study|COVID-19|1|||
164268664|NCT04257929|593352856|FG002|Overall Study|COVID-19|1|||
164268665|NCT04257929|593352854|FG000|Overall Study|Lost to Follow-up|0|||
164268666|NCT04257929|593352855|FG001|Overall Study|Lost to Follow-up|0|||
164268667|NCT04257929|593352856|FG002|Overall Study|Lost to Follow-up|1|||
164268668|NCT06036914|593352857|FG000|Overall Study|Withdrawal by Subject|1|||
164268669|NCT06036914|593352858|FG001|Overall Study|Withdrawal by Subject|0|||
164268670|NCT04697381|593352859|FG000|Extension Period|Adverse Event|0|||
164268671|NCT04697381|593352860|FG001|Extension Period|Adverse Event|0|||
164268672|NCT04697381|593352861|FG002|Extension Period|Adverse Event|3|||
164268673|NCT04697381|593352859|FG000|Extension Period|Physician Decision|0|||
164268674|NCT04697381|593352860|FG001|Extension Period|Physician Decision|0|||
164268675|NCT04697381|593352861|FG002|Extension Period|Physician Decision|2|||
164268676|NCT04697381|593352859|FG000|Extension Period|Other|0|||
164268677|NCT04697381|593352860|FG001|Extension Period|Other|0|||
164268678|NCT04697381|593352861|FG002|Extension Period|Other|1|||
164268679|NCT02486718|593352866|FG000|Enrollment Phase|Death|19|||
164268680|NCT02486718|593352867|FG001|Enrollment Phase|Death|0|||
164268681|NCT02486718|593352868|FG002|Enrollment Phase|Death|0|||
164268682|NCT02486718|593352866|FG000|Enrollment Phase|Symptomatic deterioration|1|||
164268683|NCT02486718|593352867|FG001|Enrollment Phase|Symptomatic deterioration|0|||
164268684|NCT02486718|593352868|FG002|Enrollment Phase|Symptomatic deterioration|0|||
164268685|NCT02486718|593352866|FG000|Enrollment Phase|Withdrawal by Subject|86|||
164268686|NCT02486718|593352867|FG001|Enrollment Phase|Withdrawal by Subject|0|||
164268687|NCT02486718|593352868|FG002|Enrollment Phase|Withdrawal by Subject|0|||
164341957|NCT00672646|593627587|FG000|Overall Study|Lost to Follow-up|0|||
164341958|NCT00672646|593627588|FG001|Overall Study|Lost to Follow-up|1|||
164341959|NCT00672646|593627589|FG002|Overall Study|Lost to Follow-up|2|||
164341960|NCT00672646|593627587|FG000|Overall Study|Withdrawal by Subject|0|||
164268688|NCT02486718|593352866|FG000|Enrollment Phase|Protocol Violation|18|||
164268689|NCT02486718|593352867|FG001|Enrollment Phase|Protocol Violation|0|||
164268690|NCT02486718|593352868|FG002|Enrollment Phase|Protocol Violation|0|||
164268691|NCT02486718|593352866|FG000|Enrollment Phase|Physician Decision|18|||
164268692|NCT02486718|593352867|FG001|Enrollment Phase|Physician Decision|0|||
164268693|NCT02486718|593352868|FG002|Enrollment Phase|Physician Decision|0|||
164268694|NCT02486718|593352866|FG000|Enrollment Phase|Reason not provided|41|||
164268695|NCT02486718|593352867|FG001|Enrollment Phase|Reason not provided|0|||
164268696|NCT02486718|593352868|FG002|Enrollment Phase|Reason not provided|0|||
164268697|NCT02486718|593352866|FG000|Enrollment Phase|Disease relapse|54|||
164268698|NCT02486718|593352867|FG001|Enrollment Phase|Disease relapse|0|||
164268699|NCT02486718|593352868|FG002|Enrollment Phase|Disease relapse|0|||
164341961|NCT00672646|593627588|FG001|Overall Study|Withdrawal by Subject|0|||
164268700|NCT02486718|593352866|FG000|Enrollment Phase|Lost to Follow-up|4|||
164268701|NCT02486718|593352867|FG001|Enrollment Phase|Lost to Follow-up|0|||
164268702|NCT02486718|593352868|FG002|Enrollment Phase|Lost to Follow-up|0|||
164268703|NCT02486718|593352866|FG000|Enrollment Phase|Adverse Event|34|||
164268704|NCT02486718|593352867|FG001|Enrollment Phase|Adverse Event|0|||
164268705|NCT02486718|593352868|FG002|Enrollment Phase|Adverse Event|0|||
164268706|NCT02486718|593352866|FG000|Randomized Phase|Withdrawal by Subject|0|||
164268707|NCT02486718|593352867|FG001|Randomized Phase|Withdrawal by Subject|44|||
164268708|NCT02486718|593352868|FG002|Randomized Phase|Withdrawal by Subject|47|||
164268709|NCT02486718|593352866|FG000|Randomized Phase|Protocol Violation|0|||
164268710|NCT02486718|593352867|FG001|Randomized Phase|Protocol Violation|2|||
164268711|NCT02486718|593352868|FG002|Randomized Phase|Protocol Violation|0|||
164268712|NCT02486718|593352866|FG000|Randomized Phase|Physician Decision|0|||
164268713|NCT02486718|593352867|FG001|Randomized Phase|Physician Decision|0|||
164268714|NCT02486718|593352868|FG002|Randomized Phase|Physician Decision|3|||
164268715|NCT02486718|593352866|FG000|Randomized Phase|Lost to Follow-up|0|||
164268716|NCT02486718|593352867|FG001|Randomized Phase|Lost to Follow-up|5|||
164268717|NCT02486718|593352868|FG002|Randomized Phase|Lost to Follow-up|11|||
164268718|NCT02486718|593352866|FG000|Randomized Phase|Disease Relapse|0|||
164268719|NCT02486718|593352867|FG001|Randomized Phase|Disease Relapse|1|||
164268720|NCT02486718|593352868|FG002|Randomized Phase|Disease Relapse|0|||
164268721|NCT02486718|593352866|FG000|Randomized Phase|Death|0|||
164268722|NCT02486718|593352867|FG001|Randomized Phase|Death|154|||
164268723|NCT02486718|593352868|FG002|Randomized Phase|Death|155|||
164268724|NCT02486718|593352866|FG000|Randomized Phase|Ongoing|0|||
164268725|NCT02486718|593352867|FG001|Randomized Phase|Ongoing|301|||
164268726|NCT02486718|593352868|FG002|Randomized Phase|Ongoing|282|||
164268727|NCT04271475|593352869|FG000|DB Period: Day 1 up to EODBT|Death|1|||
164268728|NCT04271475|593352870|FG001|DB Period: Day 1 up to EODBT|Death|0|||
164268729|NCT04271475|593352871|FG002|DB Period: Day 1 up to EODBT|Death|0|||
164268730|NCT04271475|593352872|FG003|DB Period: Day 1 up to EODBT|Death|0|||
164268731|NCT04271475|593352869|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
164268732|NCT04271475|593352870|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
164268733|NCT04271475|593352871|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
164268734|NCT04271475|593352872|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
164268735|NCT04271475|593352869|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
164268736|NCT04271475|593352870|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
164268737|NCT04271475|593352871|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
164268738|NCT04271475|593352872|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
164268739|NCT04271475|593352869|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
164268740|NCT04271475|593352870|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
164268741|NCT04271475|593352871|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
164268742|NCT04271475|593352872|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
164268743|NCT04271475|593352869|FG000|DB Period: Day 1 up to EODBT|Other|8|||
164268744|NCT04271475|593352870|FG001|DB Period: Day 1 up to EODBT|Other|5|||
164268745|NCT04271475|593352871|FG002|DB Period: Day 1 up to EODBT|Other|0|||
164268746|NCT04271475|593352872|FG003|DB Period: Day 1 up to EODBT|Other|0|||
164268747|NCT04271475|593352869|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
164268748|NCT04271475|593352870|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
164268749|NCT04271475|593352871|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
164268750|NCT04271475|593352872|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
164268751|NCT04271475|593352869|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
164268752|NCT04271475|593352870|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
164268753|NCT04271475|593352871|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
164268754|NCT04271475|593352872|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
164268755|NCT04088331|593352877|FG000|Overall Study|Lost to Follow-up|3|||
164268756|NCT04088331|593352877|FG000|Overall Study|Withdrawal by Subject|7|||
164268757|NCT04088331|593352877|FG000|Overall Study|Adverse Event|4|||
164268758|NCT01818284|593352878|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
164268759|NCT01818284|593352879|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
164268760|NCT01818284|593352878|FG000|Overall Study|Death|0|||
164268761|NCT01818284|593352879|FG001|Overall Study|Death|2|||
164268762|NCT03298451|593352880|FG000|Overall Study|Death|275|||
164268763|NCT03298451|593352881|FG001|Overall Study|Death|260|||
164268764|NCT03298451|593352882|FG002|Overall Study|Death|122|||
164341962|NCT00672646|593627589|FG002|Overall Study|Withdrawal by Subject|1|||
164268765|NCT03298451|593352883|FG003|Overall Study|Death|280|||
164341963|NCT00289783|593627590|FG000|Primary Phase|Adverse Event|10|||
164268766|NCT03298451|593352880|FG000|Overall Study|Lost to Follow-up|1|||
164268767|NCT03298451|593352881|FG001|Overall Study|Lost to Follow-up|1|||
164341964|NCT00289783|593627591|FG001|Primary Phase|Adverse Event|1|||
164341965|NCT00289783|593627590|FG000|Primary Phase|Protocol Violation|27|||
164341966|NCT00289783|593627591|FG001|Primary Phase|Protocol Violation|6|||
164268768|NCT03298451|593352882|FG002|Overall Study|Lost to Follow-up|0|||
164268769|NCT03298451|593352883|FG003|Overall Study|Lost to Follow-up|7|||
164268770|NCT03298451|593352880|FG000|Overall Study|Withdrawal by Subject|9|||
164268771|NCT03298451|593352881|FG001|Overall Study|Withdrawal by Subject|7|||
164268772|NCT03298451|593352882|FG002|Overall Study|Withdrawal by Subject|1|||
164341967|NCT00289783|593627590|FG000|Primary Phase|Withdrawal by Subject|93|||
164268773|NCT03298451|593352883|FG003|Overall Study|Withdrawal by Subject|20|||
164268774|NCT01299571|593352887|FG000|Overall Study|Protocol Violation|107|||
164268775|NCT00286221|593352889|FG000|Overall Study|Protocol Violation|2|||
164268776|NCT00286221|593352890|FG001|Overall Study|Protocol Violation|1|||
164268777|NCT00286221|593352891|FG002|Overall Study|Protocol Violation|6|||
164268778|NCT00286221|593352892|FG003|Overall Study|Protocol Violation|4|||
164268779|NCT00286221|593352889|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
164268780|NCT00286221|593352890|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
164268781|NCT00286221|593352891|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
164268782|NCT00286221|593352892|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
164268783|NCT00286221|593352889|FG000|Overall Study|Inability to trigger PCA|2|||
164268784|NCT00286221|593352890|FG001|Overall Study|Inability to trigger PCA|0|||
164268785|NCT00286221|593352891|FG002|Overall Study|Inability to trigger PCA|0|||
164268786|NCT00286221|593352892|FG003|Overall Study|Inability to trigger PCA|0|||
164268787|NCT00286221|593352889|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
164268788|NCT00286221|593352890|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
164268789|NCT00286221|593352891|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
164268790|NCT00286221|593352892|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
164268791|NCT00357656|593352893|FG000|Overall Study|Other, No surgery performed|0|||
164268792|NCT00357656|593352894|FG001|Overall Study|Other, No surgery performed|3|||
164268793|NCT02805725|593353667|FG000|Phase I (Dose escalation part)|Clinical progression|0|||
164268794|NCT02805725|593353668|FG001|Phase I (Dose escalation part)|Clinical progression|0|||
164268795|NCT02805725|593353669|FG002|Phase I (Dose escalation part)|Clinical progression|1|||
164268796|NCT02805725|593353670|FG003|Phase I (Dose escalation part)|Clinical progression|0|||
164268797|NCT02805725|593353671|FG004|Phase I (Dose escalation part)|Clinical progression|0|||
164268798|NCT02805725|593353667|FG000|Phase I (Dose escalation part)|Adverse Event|0|||
164268799|NCT02805725|593353668|FG001|Phase I (Dose escalation part)|Adverse Event|0|||
164268800|NCT02805725|593353669|FG002|Phase I (Dose escalation part)|Adverse Event|1|||
164268801|NCT02805725|593353670|FG003|Phase I (Dose escalation part)|Adverse Event|2|||
164268802|NCT02805725|593353671|FG004|Phase I (Dose escalation part)|Adverse Event|0|||
164268803|NCT02805725|593353667|FG000|Phase II|Protocol Violation|0|||
164268804|NCT02805725|593353668|FG001|Phase II|Protocol Violation|0|||
164268805|NCT02805725|593353669|FG002|Phase II|Protocol Violation|0|||
164268806|NCT02805725|593353670|FG003|Phase II|Protocol Violation|0|||
164268807|NCT02805725|593353671|FG004|Phase II|Protocol Violation|6|||
164268808|NCT05702918|593353675|FG000|Overall Study|Withdrawal by Subject|0|||
164268809|NCT05702918|593353676|FG001|Overall Study|Withdrawal by Subject|2|||
164268810|NCT05702918|593353675|FG000|Overall Study|Lost to Follow-up|0|||
164268811|NCT05702918|593353676|FG001|Overall Study|Lost to Follow-up|2|||
164268812|NCT05702918|593353675|FG000|Overall Study|Unrelated injury|2|||
164268813|NCT05702918|593353676|FG001|Overall Study|Unrelated injury|0|||
164268814|NCT03500172|593353682|FG000|Period 1: Baseline Randomization|Death|0|||
164268815|NCT03500172|593353683|FG001|Period 1: Baseline Randomization|Death|0|||
164268816|NCT03500172|593353684|FG002|Period 1: Baseline Randomization|Death|0|||
164268817|NCT03500172|593353685|FG003|Period 1: Baseline Randomization|Death|0|||
164268818|NCT03500172|593353686|FG004|Period 1: Baseline Randomization|Death|0|||
164268819|NCT03500172|593353687|FG005|Period 1: Baseline Randomization|Death|0|||
164268820|NCT03500172|593353688|FG006|Period 1: Baseline Randomization|Death|0|||
164268821|NCT03500172|593353689|FG007|Period 1: Baseline Randomization|Death|0|||
164268822|NCT03500172|593353690|FG008|Period 1: Baseline Randomization|Death|0|||
164268823|NCT03500172|593353691|FG009|Period 1: Baseline Randomization|Death|2|||
164268824|NCT03500172|593353692|FG010|Period 1: Baseline Randomization|Death|0|||
164268825|NCT03500172|593353682|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
164268826|NCT03500172|593353683|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
164268827|NCT03500172|593353684|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
164268828|NCT03500172|593353685|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
164268829|NCT03500172|593353686|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
164268830|NCT03500172|593353687|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
164268831|NCT03500172|593353688|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
164268832|NCT03500172|593353689|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
164268833|NCT03500172|593353690|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
164268834|NCT03500172|593353691|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
164268835|NCT03500172|593353692|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
164268836|NCT03500172|593353682|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
164268837|NCT03500172|593353683|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
164268838|NCT03500172|593353684|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
164268839|NCT03500172|593353685|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
164268840|NCT03500172|593353686|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
164268841|NCT03500172|593353687|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
164268842|NCT03500172|593353688|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
164268843|NCT03500172|593353689|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
164268844|NCT03500172|593353690|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
164268845|NCT03500172|593353691|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
164268846|NCT03500172|593353692|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
164268847|NCT03500172|593353682|FG000|Period 2: Re-Randomization|Death|0|||
164268848|NCT03500172|593353683|FG001|Period 2: Re-Randomization|Death|0|||
164268849|NCT03500172|593353684|FG002|Period 2: Re-Randomization|Death|0|||
164268850|NCT03500172|593353685|FG003|Period 2: Re-Randomization|Death|4|||
164268851|NCT03500172|593353686|FG004|Period 2: Re-Randomization|Death|2|||
164268852|NCT03500172|593353687|FG005|Period 2: Re-Randomization|Death|0|||
164268853|NCT03500172|593353688|FG006|Period 2: Re-Randomization|Death|5|||
164268854|NCT03500172|593353689|FG007|Period 2: Re-Randomization|Death|2|||
164268855|NCT03500172|593353690|FG008|Period 2: Re-Randomization|Death|0|||
164268856|NCT03500172|593353691|FG009|Period 2: Re-Randomization|Death|0|||
164268857|NCT03500172|593353692|FG010|Period 2: Re-Randomization|Death|0|||
164268858|NCT03171545|593353695|FG000|Baseline|Withdrawal by Subject|0|||
164268859|NCT03171545|593353696|FG001|Baseline|Withdrawal by Subject|0|||
164268860|NCT03171545|593353697|FG002|Baseline|Withdrawal by Subject|1|||
164268861|NCT03171545|593353698|FG003|Baseline|Withdrawal by Subject|2|||
164268862|NCT03171545|593353695|FG000|Baseline|Transferred out of clinic|4|||
164268863|NCT03171545|593353696|FG001|Baseline|Transferred out of clinic|0|||
164268864|NCT03171545|593353697|FG002|Baseline|Transferred out of clinic|2|||
164268865|NCT03171545|593353698|FG003|Baseline|Transferred out of clinic|0|||
164268866|NCT03171545|593353695|FG000|Baseline|Death|1|||
164268867|NCT03171545|593353696|FG001|Baseline|Death|2|||
164268868|NCT03171545|593353697|FG002|Baseline|Death|1|||
164268869|NCT03171545|593353698|FG003|Baseline|Death|5|||
164268870|NCT03171545|593353695|FG000|Baseline|Recovered renal function|0|||
164268871|NCT03171545|593353696|FG001|Baseline|Recovered renal function|0|||
164268872|NCT03171545|593353697|FG002|Baseline|Recovered renal function|1|||
164268873|NCT03171545|593353698|FG003|Baseline|Recovered renal function|0|||
164268874|NCT03171545|593353695|FG000|Baseline|Received transplant|0|||
164268875|NCT03171545|593353696|FG001|Baseline|Received transplant|0|||
164268876|NCT03171545|593353697|FG002|Baseline|Received transplant|1|||
164268877|NCT03171545|593353698|FG003|Baseline|Received transplant|0|||
164268878|NCT03171545|593353695|FG000|Baseline|No longer receiving in-center hemodialysis|0|||
164268879|NCT03171545|593353696|FG001|Baseline|No longer receiving in-center hemodialysis|2|||
164268880|NCT03171545|593353697|FG002|Baseline|No longer receiving in-center hemodialysis|3|||
164268881|NCT03171545|593353698|FG003|Baseline|No longer receiving in-center hemodialysis|0|||
164268882|NCT03171545|593353695|FG000|Intervention|Withdrawal by Subject|2|||
164268883|NCT03171545|593353696|FG001|Intervention|Withdrawal by Subject|0|||
164268884|NCT03171545|593353697|FG002|Intervention|Withdrawal by Subject|0|||
164268885|NCT03171545|593353698|FG003|Intervention|Withdrawal by Subject|4|||
164268886|NCT03171545|593353695|FG000|Intervention|Transferred out of clinic|12|||
164268887|NCT03171545|593353696|FG001|Intervention|Transferred out of clinic|9|||
164268888|NCT03171545|593353697|FG002|Intervention|Transferred out of clinic|17|||
164268889|NCT03171545|593353698|FG003|Intervention|Transferred out of clinic|9|||
164268890|NCT03171545|593353695|FG000|Intervention|Death|26|||
164268891|NCT03171545|593353696|FG001|Intervention|Death|16|||
164268892|NCT03171545|593353697|FG002|Intervention|Death|29|||
164268893|NCT03171545|593353698|FG003|Intervention|Death|14|||
164268894|NCT03171545|593353695|FG000|Intervention|Received transplant|7|||
164268895|NCT03171545|593353696|FG001|Intervention|Received transplant|5|||
164268896|NCT03171545|593353697|FG002|Intervention|Received transplant|3|||
164268897|NCT03171545|593353698|FG003|Intervention|Received transplant|6|||
164268898|NCT03171545|593353695|FG000|Intervention|No longer receiving in-center hemodialysis|7|||
164268899|NCT03171545|593353696|FG001|Intervention|No longer receiving in-center hemodialysis|4|||
164268900|NCT03171545|593353697|FG002|Intervention|No longer receiving in-center hemodialysis|4|||
164341968|NCT00289783|593627591|FG001|Primary Phase|Withdrawal by Subject|40|||
164341969|NCT00289783|593627590|FG000|Primary Phase|Lost to Follow-up|60|||
164341970|NCT00289783|593627591|FG001|Primary Phase|Lost to Follow-up|14|||
164341971|NCT00289783|593627590|FG000|Primary Phase|Migration from the study area|26|||
164341972|NCT00289783|593627591|FG001|Primary Phase|Migration from the study area|10|||
164341973|NCT00289783|593627590|FG000|Primary Phase|Other|32|||
164341974|NCT00289783|593627591|FG001|Primary Phase|Other|12|||
164341975|NCT00289783|593627590|FG000|Fourth Dose Phase|Adverse Event|1|||
164341976|NCT00289783|593627591|FG001|Fourth Dose Phase|Adverse Event|0|||
164341977|NCT00289783|593627590|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
164341978|NCT00289783|593627591|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
164341979|NCT00289783|593627590|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
164268901|NCT03171545|593353698|FG003|Intervention|No longer receiving in-center hemodialysis|6|||
164268902|NCT03171545|593353695|FG000|Intervention|Lost to Follow-up|0|||
164268903|NCT03171545|593353696|FG001|Intervention|Lost to Follow-up|1|||
164268904|NCT03171545|593353697|FG002|Intervention|Lost to Follow-up|0|||
164268905|NCT03171545|593353698|FG003|Intervention|Lost to Follow-up|0|||
164268906|NCT03171545|593353695|FG000|Follow up|Withdrawal by Subject|1|||
164268907|NCT03171545|593353696|FG001|Follow up|Withdrawal by Subject|1|||
164268908|NCT03171545|593353697|FG002|Follow up|Withdrawal by Subject|0|||
164268909|NCT03171545|593353698|FG003|Follow up|Withdrawal by Subject|0|||
164268910|NCT03171545|593353695|FG000|Follow up|Transferred out of clinic|4|||
164268911|NCT03171545|593353696|FG001|Follow up|Transferred out of clinic|4|||
164268912|NCT03171545|593353697|FG002|Follow up|Transferred out of clinic|12|||
164268913|NCT03171545|593353698|FG003|Follow up|Transferred out of clinic|7|||
164268914|NCT03171545|593353695|FG000|Follow up|Death|18|||
164268915|NCT03171545|593353696|FG001|Follow up|Death|12|||
164268916|NCT03171545|593353697|FG002|Follow up|Death|5|||
164268917|NCT03171545|593353698|FG003|Follow up|Death|8|||
164268918|NCT03171545|593353695|FG000|Follow up|Received transplant|4|||
164268919|NCT03171545|593353696|FG001|Follow up|Received transplant|1|||
164268920|NCT03171545|593353697|FG002|Follow up|Received transplant|0|||
164268921|NCT03171545|593353698|FG003|Follow up|Received transplant|1|||
164268922|NCT03171545|593353695|FG000|Follow up|No longer receiving in-center hemodialysis|4|||
164268923|NCT03171545|593353696|FG001|Follow up|No longer receiving in-center hemodialysis|2|||
164268924|NCT03171545|593353697|FG002|Follow up|No longer receiving in-center hemodialysis|1|||
164268925|NCT03171545|593353698|FG003|Follow up|No longer receiving in-center hemodialysis|0|||
164268926|NCT03171545|593353695|FG000|Follow up|Lost to Follow-up|1|||
164268927|NCT03171545|593353696|FG001|Follow up|Lost to Follow-up|2|||
164268928|NCT03171545|593353697|FG002|Follow up|Lost to Follow-up|3|||
164268929|NCT03171545|593353698|FG003|Follow up|Lost to Follow-up|1|||
164268930|NCT04409457|593353709|FG000|Screening Prior to Randomization|Screening fail prior to randomization|16|||
164268931|NCT04409457|593353710|FG001|Screening Prior to Randomization|Screening fail prior to randomization|13|||
164268932|NCT04409457|593353711|FG002|Screening Prior to Randomization|Screening fail prior to randomization|0|||
164268933|NCT04409457|593353712|FG003|Screening Prior to Randomization|Screening fail prior to randomization|0|||
164268934|NCT04409457|593353713|FG004|Screening Prior to Randomization|Screening fail prior to randomization|0|||
164268935|NCT04409457|593353714|FG005|Screening Prior to Randomization|Screening fail prior to randomization|0|||
164268936|NCT04409457|593353709|FG000|Screening Prior to Randomization|Withdrawal by Subject|2|||
164268937|NCT04409457|593353710|FG001|Screening Prior to Randomization|Withdrawal by Subject|1|||
164268938|NCT04409457|593353711|FG002|Screening Prior to Randomization|Withdrawal by Subject|0|||
164268939|NCT04409457|593353712|FG003|Screening Prior to Randomization|Withdrawal by Subject|0|||
164268940|NCT04409457|593353713|FG004|Screening Prior to Randomization|Withdrawal by Subject|0|||
164268941|NCT04409457|593353714|FG005|Screening Prior to Randomization|Withdrawal by Subject|0|||
164268942|NCT04409457|593353709|FG000|Randomization|Withdrawal by Subject|0|||
164268943|NCT04409457|593353710|FG001|Randomization|Withdrawal by Subject|0|||
164268944|NCT04409457|593353711|FG002|Randomization|Withdrawal by Subject|0|||
164268945|NCT04409457|593353712|FG003|Randomization|Withdrawal by Subject|0|||
164268946|NCT04409457|593353713|FG004|Randomization|Withdrawal by Subject|1|||
164268947|NCT04409457|593353714|FG005|Randomization|Withdrawal by Subject|0|||
164268948|NCT04409457|593353709|FG000|Randomization|Incidental MRI finding at scan 1|0|||
164268949|NCT04409457|593353710|FG001|Randomization|Incidental MRI finding at scan 1|0|||
164268950|NCT04409457|593353711|FG002|Randomization|Incidental MRI finding at scan 1|0|||
164268951|NCT04409457|593353712|FG003|Randomization|Incidental MRI finding at scan 1|1|||
164268952|NCT04409457|593353713|FG004|Randomization|Incidental MRI finding at scan 1|0|||
164268953|NCT04409457|593353714|FG005|Randomization|Incidental MRI finding at scan 1|1|||
164268954|NCT04409457|593353709|FG000|Randomization|Technical/equipment error at scan 1|0|||
164268955|NCT04409457|593353710|FG001|Randomization|Technical/equipment error at scan 1|0|||
164268956|NCT04409457|593353711|FG002|Randomization|Technical/equipment error at scan 1|0|||
164268957|NCT04409457|593353712|FG003|Randomization|Technical/equipment error at scan 1|0|||
164268958|NCT04409457|593353713|FG004|Randomization|Technical/equipment error at scan 1|0|||
164268959|NCT04409457|593353714|FG005|Randomization|Technical/equipment error at scan 1|1|||
164268960|NCT04865770|593353715|FG000|Overall Study|Withdrawal by Subject|3|||
164268961|NCT04865770|593353716|FG001|Overall Study|Withdrawal by Subject|0|||
164341980|NCT00289783|593627591|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
164341981|NCT00289783|593627590|FG000|Fourth Dose Phase|Migration from the study area|1|||
164341982|NCT00289783|593627591|FG001|Fourth Dose Phase|Migration from the study area|1|||
164341983|NCT00289783|593627590|FG000|Fourth Dose Phase|Other|22|||
164341984|NCT00289783|593627591|FG001|Fourth Dose Phase|Other|10|||
164341985|NCT05248867|593627592|FG000|Double-blind Period|Lost to Follow-up|0|||
164341986|NCT05248867|593627593|FG001|Double-blind Period|Lost to Follow-up|3|||
164686619|NCT01617096|594876534|FG000|Overall Study|Withdrawal by Subject|96|||
164686620|NCT01617096|594876535|FG001|Overall Study|Withdrawal by Subject|81|||
164268962|NCT04865770|593353715|FG000|Overall Study|Physician Decision|9|||
164268963|NCT04865770|593353716|FG001|Overall Study|Physician Decision|0|||
164268964|NCT04865770|593353715|FG000|Overall Study|Death|1|||
164268965|NCT04865770|593353716|FG001|Overall Study|Death|1|||
164268966|NCT04522973|593353722|FG000|Overall Study|Lost to Follow-up|4|||
164268967|NCT04522973|593353722|FG000|Overall Study|Could not adhere to study schedule|1|||
164268968|NCT04007796|593353723|FG000|Overall Study|Exclusion criterion met during the trial|1|||
164268969|NCT04007796|593353724|FG001|Overall Study|Exclusion criterion met during the trial|1|||
164268970|NCT04007796|593353723|FG000|Overall Study|Withdrawal by Subject|1|||
164268971|NCT04007796|593353724|FG001|Overall Study|Withdrawal by Subject|0|||
164268972|NCT03573401|593353725|FG000|Overall Study|Withdrawal by Subject|2|||
164268973|NCT03573401|593353726|FG001|Overall Study|Withdrawal by Subject|0|||
164268974|NCT03573401|593353725|FG000|Overall Study|Subject non-compliance with study schedule|1|||
164686621|NCT01617096|594876534|FG000|Overall Study|Lost to Follow-up|37|||
164268975|NCT03573401|593353726|FG001|Overall Study|Subject non-compliance with study schedule|0|||
164268976|NCT03573401|593353725|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
164268977|NCT03573401|593353726|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
164268978|NCT03573401|593353725|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
164268979|NCT03573401|593353726|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
164268980|NCT05579249|593353727|FG000|Overall Study|Withdrawal by Subject|1|||
164268981|NCT05579249|593353728|FG001|Overall Study|Withdrawal by Subject|3|||
164268982|NCT05579249|593353727|FG000|Overall Study|Lost to Follow-up|33|||
164268983|NCT05579249|593353728|FG001|Overall Study|Lost to Follow-up|52|||
164268984|NCT05579249|593353727|FG000|Overall Study|Physician Decision|2|||
164268985|NCT05579249|593353728|FG001|Overall Study|Physician Decision|2|||
164268986|NCT05579249|593353727|FG000|Overall Study|Death|0|||
164268987|NCT05579249|593353728|FG001|Overall Study|Death|2|||
164268988|NCT05028517|593353729|FG000|Overall Study|Lost to Follow-up|13|||
164268989|NCT05028517|593353730|FG001|Overall Study|Lost to Follow-up|20|||
164268990|NCT05028517|593353731|FG002|Overall Study|Lost to Follow-up|12|||
164268991|NCT05028517|593353729|FG000|Overall Study|Withdrawal by Subject|0|||
164268992|NCT05028517|593353730|FG001|Overall Study|Withdrawal by Subject|0|||
164268993|NCT05028517|593353731|FG002|Overall Study|Withdrawal by Subject|1|||
164268994|NCT00267150|593353732|FG000|Overall Study|Adverse Event|1|||
164268995|NCT00969436|593353736|FG000|Overall Study|Protocol Violation|1|||
164268996|NCT00969436|593353737|FG001|Overall Study|Protocol Violation|3|||
164268997|NCT00969436|593353738|FG002|Overall Study|Protocol Violation|0|||
164268998|NCT00969436|593353736|FG000|Overall Study|Migrated/moved from study area|12|||
164268999|NCT00969436|593353737|FG001|Overall Study|Migrated/moved from study area|10|||
164269000|NCT00969436|593353738|FG002|Overall Study|Migrated/moved from study area|2|||
164269001|NCT00969436|593353736|FG000|Overall Study|Father - serious health problem|0|||
164269002|NCT00969436|593353737|FG001|Overall Study|Father - serious health problem|0|||
164269003|NCT00969436|593353738|FG002|Overall Study|Father - serious health problem|1|||
164269004|NCT00969436|593353736|FG000|Overall Study|Parents personal problem|0|||
164269005|NCT00969436|593353737|FG001|Overall Study|Parents personal problem|0|||
164269006|NCT00969436|593353738|FG002|Overall Study|Parents personal problem|1|||
164269007|NCT00969436|593353736|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
164269008|NCT00969436|593353737|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
164269009|NCT00969436|593353738|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
164269010|NCT00969436|593353736|FG000|Overall Study|Withdrawal by Subject|3|||
164269011|NCT00969436|593353737|FG001|Overall Study|Withdrawal by Subject|0|||
164341987|NCT05248867|593627594|FG002|Double-blind Period|Lost to Follow-up|0|||
164341988|NCT05248867|593627595|FG003|Double-blind Period|Lost to Follow-up|0|||
164341989|NCT05248867|593627596|FG004|Double-blind Period|Lost to Follow-up|0|||
164341990|NCT05248867|593627597|FG005|Double-blind Period|Lost to Follow-up|0|||
164341991|NCT05248867|593627592|FG000|Double-blind Period|Withdrawal by Subject|5|||
164341992|NCT05248867|593627593|FG001|Double-blind Period|Withdrawal by Subject|14|||
164341993|NCT05248867|593627594|FG002|Double-blind Period|Withdrawal by Subject|0|||
164341994|NCT05248867|593627595|FG003|Double-blind Period|Withdrawal by Subject|0|||
164341995|NCT05248867|593627596|FG004|Double-blind Period|Withdrawal by Subject|0|||
164341996|NCT05248867|593627597|FG005|Double-blind Period|Withdrawal by Subject|0|||
164341997|NCT05248867|593627592|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
164341998|NCT05248867|593627593|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
164341999|NCT05248867|593627594|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
164342000|NCT05248867|593627595|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
164342001|NCT05248867|593627596|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
164342002|NCT05248867|593627597|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
164342003|NCT05248867|593627592|FG000|Double-blind Period|Other, not specified|3|||
164342004|NCT05248867|593627593|FG001|Double-blind Period|Other, not specified|8|||
164342005|NCT05248867|593627594|FG002|Double-blind Period|Other, not specified|0|||
164430785|NCT00430677|593947312|FG001|Short-term Period|Lack of Efficacy|6|||
164686622|NCT01617096|594876535|FG001|Overall Study|Lost to Follow-up|32|||
164686623|NCT01617096|594876534|FG000|Overall Study|Physician Decision|10|||
164686624|NCT01617096|594876535|FG001|Overall Study|Physician Decision|18|||
164686625|NCT01617096|594876534|FG000|Overall Study|Death|4|||
164686626|NCT01617096|594876535|FG001|Overall Study|Death|3|||
164686627|NCT01617096|594876534|FG000|Overall Study|Other|1|||
164686628|NCT01617096|594876535|FG001|Overall Study|Other|3|||
164686629|NCT01196390|594876538|FG000|Overall Study|Protocol Violation|4|||
164686630|NCT01196390|594876539|FG001|Overall Study|Protocol Violation|5|||
164686631|NCT01532908|594876540|FG000|Overall Study|Not Transplanted|1|||
164686632|NCT01532908|594876541|FG001|Overall Study|Not Transplanted|0|||
164686633|NCT00252564|594876542|FG000|Overall Study|Adverse Event|17|||
164686634|NCT00252564|594876543|FG001|Overall Study|Adverse Event|13|||
164686635|NCT00252564|594876542|FG000|Overall Study|Unrelated Complication|2|||
164686636|NCT00252564|594876543|FG001|Overall Study|Unrelated Complication|1|||
164269012|NCT00969436|593353738|FG002|Overall Study|Withdrawal by Subject|2|||
164269013|NCT00969436|593353736|FG000|Overall Study|Lost to Follow-up|8|||
164269014|NCT00969436|593353737|FG001|Overall Study|Lost to Follow-up|8|||
164269015|NCT00969436|593353738|FG002|Overall Study|Lost to Follow-up|5|||
164269016|NCT00351273|593353739|FG000|Overall Study|Lost to Follow-up|1|||
164269017|NCT00351273|593353740|FG001|Overall Study|Lost to Follow-up|2|||
164269018|NCT00351273|593353741|FG002|Overall Study|Lost to Follow-up|5|||
164269019|NCT01672866|593353742|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
164269020|NCT01672866|593353743|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
164269021|NCT01672866|593353744|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
164269022|NCT01672866|593353742|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
164269023|NCT01672866|593353743|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
164269024|NCT01672866|593353744|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
164269025|NCT01672866|593353742|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
164269026|NCT01672866|593353743|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
164269027|NCT01672866|593353744|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
164269028|NCT01672866|593353742|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
164269029|NCT01672866|593353743|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
164269030|NCT01672866|593353744|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
164269031|NCT01672866|593353742|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
164269032|NCT01672866|593353743|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
164269033|NCT01672866|593353744|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
164269034|NCT01672866|593353742|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
164269035|NCT01672866|593353743|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
164269036|NCT01672866|593353744|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
164269037|NCT01672866|593353742|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
164269038|NCT01672866|593353743|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
164269039|NCT01672866|593353744|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
164269040|NCT01672866|593353742|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
164269041|NCT01672866|593353743|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
164269042|NCT01672866|593353744|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
164269043|NCT01672866|593353742|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
164269044|NCT01672866|593353743|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
164269045|NCT01672866|593353744|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
164269046|NCT01672866|593353742|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
164269047|NCT01672866|593353743|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
164269048|NCT01672866|593353744|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
164269049|NCT01672866|593353742|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
164269050|NCT01672866|593353743|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
164269051|NCT01672866|593353744|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
164269052|NCT01672866|593353742|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
164269053|NCT01672866|593353743|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
164269054|NCT01672866|593353744|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
164269055|NCT01672866|593353742|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
164269056|NCT01672866|593353743|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
164269057|NCT01672866|593353744|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
164269058|NCT02544373|593353747|FG000|Overall Study|Lost to Follow-up|5|||
164269059|NCT02544373|593353748|FG001|Overall Study|Lost to Follow-up|3|||
164686637|NCT00252564|594876542|FG000|Overall Study|Disease Progression|14|||
164686638|NCT00252564|594876543|FG001|Overall Study|Disease Progression|20|||
164686639|NCT00252564|594876542|FG000|Overall Study|Death|0|||
164686640|NCT00252564|594876543|FG001|Overall Study|Death|3|||
164686641|NCT00252564|594876542|FG000|Overall Study|Physician Decision|1|||
164686642|NCT00252564|594876543|FG001|Overall Study|Physician Decision|0|||
164686643|NCT00252564|594876542|FG000|Overall Study|Lost to Follow-up|1|||
164686644|NCT00252564|594876543|FG001|Overall Study|Lost to Follow-up|0|||
164686645|NCT00252564|594876542|FG000|Overall Study|Patient Request|4|||
164686646|NCT00252564|594876543|FG001|Overall Study|Patient Request|5|||
164686647|NCT00252564|594876542|FG000|Overall Study|Withdrawal by Subject|0|||
164686648|NCT00252564|594876543|FG001|Overall Study|Withdrawal by Subject|2|||
164686649|NCT03480022|594876544|FG000|Overall Study|Pregnancy|2|||
164686650|NCT03480022|594876545|FG001|Overall Study|Pregnancy|0|||
164686651|NCT03480022|594876544|FG000|Overall Study|Adverse Event|6|||
164686652|NCT03480022|594876545|FG001|Overall Study|Adverse Event|0|||
164269060|NCT02544373|593353747|FG000|Overall Study|Withdrawal by Subject|8|||
164269061|NCT02544373|593353748|FG001|Overall Study|Withdrawal by Subject|2|||
164269062|NCT04514341|593353749|FG000|Step 2 (Months 19-21)|In a 3-month delay period|0|||
164269063|NCT04514341|593353750|FG001|Step 2 (Months 19-21)|In a 3-month delay period|15725|||
164686653|NCT03480022|594876544|FG000|Overall Study|Lack of Efficacy|0|||
164686654|NCT03480022|594876545|FG001|Overall Study|Lack of Efficacy|2|||
164686655|NCT03480022|594876544|FG000|Overall Study|Physician Decision|0|||
164686656|NCT03480022|594876545|FG001|Overall Study|Physician Decision|1|||
164686657|NCT03480022|594876544|FG000|Overall Study|Withdrawal by Subject|2|||
164686658|NCT03480022|594876545|FG001|Overall Study|Withdrawal by Subject|0|||
164686659|NCT03480022|594876544|FG000|Overall Study|Medication concerns|1|||
164686660|NCT03480022|594876545|FG001|Overall Study|Medication concerns|0|||
164269064|NCT04514341|593353749|FG000|Step 4 (Months 31-33)|In a 3-month delay period|0|||
164269065|NCT04514341|593353750|FG001|Step 4 (Months 31-33)|In a 3-month delay period|15037|||
164269066|NCT01216683|593354689|FG000|Induction|Never started treatment|0|||
164269067|NCT01216683|593354690|FG001|Induction|Never started treatment|6|||
164269068|NCT01216683|593354691|FG002|Induction|Never started treatment|3|||
164269069|NCT01216683|593354689|FG000|Induction|Lack of Efficacy|4|||
164269070|NCT01216683|593354690|FG001|Induction|Lack of Efficacy|3|||
164269071|NCT01216683|593354691|FG002|Induction|Lack of Efficacy|7|||
164269072|NCT01216683|593354689|FG000|Induction|Adverse Event|0|||
164269073|NCT01216683|593354690|FG001|Induction|Adverse Event|5|||
164269074|NCT01216683|593354691|FG002|Induction|Adverse Event|5|||
164269075|NCT01216683|593354689|FG000|Induction|Death|0|||
164269076|NCT01216683|593354690|FG001|Induction|Death|0|||
164269077|NCT01216683|593354691|FG002|Induction|Death|2|||
164269078|NCT01216683|593354689|FG000|Induction|Withdrawal by Subject|0|||
164269079|NCT01216683|593354690|FG001|Induction|Withdrawal by Subject|4|||
164269080|NCT01216683|593354691|FG002|Induction|Withdrawal by Subject|2|||
164269081|NCT01216683|593354689|FG000|Induction|Other disease|0|||
164269082|NCT01216683|593354690|FG001|Induction|Other disease|1|||
164269083|NCT01216683|593354691|FG002|Induction|Other disease|2|||
164269084|NCT01216683|593354689|FG000|Continuation|Lack of Efficacy|3|||
164269085|NCT01216683|593354690|FG001|Continuation|Lack of Efficacy|2|||
164269086|NCT01216683|593354691|FG002|Continuation|Lack of Efficacy|7|||
164269087|NCT01216683|593354689|FG000|Continuation|Adverse Event|5|||
164269088|NCT01216683|593354690|FG001|Continuation|Adverse Event|3|||
164269089|NCT01216683|593354691|FG002|Continuation|Adverse Event|16|||
164269090|NCT01216683|593354689|FG000|Continuation|Death|1|||
164269091|NCT01216683|593354690|FG001|Continuation|Death|0|||
164269092|NCT01216683|593354691|FG002|Continuation|Death|2|||
164269093|NCT01216683|593354689|FG000|Continuation|Withdrawal by Subject|4|||
164269094|NCT01216683|593354690|FG001|Continuation|Withdrawal by Subject|5|||
164269095|NCT01216683|593354691|FG002|Continuation|Withdrawal by Subject|9|||
164269096|NCT01216683|593354689|FG000|Continuation|Other diseases|0|||
164269097|NCT01216683|593354690|FG001|Continuation|Other diseases|2|||
164269098|NCT01216683|593354691|FG002|Continuation|Other diseases|1|||
164269099|NCT01216683|593354689|FG000|Continuation|Physician Decision|1|||
164269100|NCT01216683|593354690|FG001|Continuation|Physician Decision|0|||
164269101|NCT01216683|593354691|FG002|Continuation|Physician Decision|1|||
164269102|NCT01216683|593354689|FG000|Continuation|Non-compliance|1|||
164269103|NCT01216683|593354690|FG001|Continuation|Non-compliance|0|||
164269104|NCT01216683|593354691|FG002|Continuation|Non-compliance|1|||
164269105|NCT01216683|593354689|FG000|Continuation|Insurance change|0|||
164269106|NCT01216683|593354690|FG001|Continuation|Insurance change|1|||
164269107|NCT01216683|593354691|FG002|Continuation|Insurance change|0|||
164269108|NCT01216683|593354689|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
164269109|NCT01216683|593354690|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
164269110|NCT01216683|593354691|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
164269111|NCT01216683|593354689|FG000|Continuation|Not reported|0|||
164269112|NCT01216683|593354690|FG001|Continuation|Not reported|0|||
164269113|NCT01216683|593354691|FG002|Continuation|Not reported|1|||
164269114|NCT01216683|593354689|FG000|Continuation|Never started treatment|0|||
164686661|NCT03480022|594876544|FG000|Overall Study|Family member COVID exposure|0|||
164686662|NCT03480022|594876545|FG001|Overall Study|Family member COVID exposure|1|||
164686663|NCT00881569|594876546|FG000|Overall Study|Disease progression|1|||
164686664|NCT00881569|594876547|FG001|Overall Study|Disease progression|1|||
164269115|NCT01216683|593354690|FG001|Continuation|Never started treatment|1|||
164269116|NCT01216683|593354691|FG002|Continuation|Never started treatment|5|||
164269117|NCT01350115|593354692|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
164269118|NCT01350115|593354693|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
164269119|NCT01350115|593354692|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
164269120|NCT01350115|593354693|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
164269121|NCT01350115|593354692|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
164269122|NCT01350115|593354693|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
164269123|NCT04327024|593354694|FG000|Overall Study|Death|1|||
164269124|NCT04327024|593354695|FG001|Overall Study|Death|2|||
164686665|NCT04164758|594876548|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
164686666|NCT04164758|594876549|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
164269125|NCT04327024|593354696|FG002|Overall Study|Death|1|||
164269126|NCT04327024|593354694|FG000|Overall Study|Non-compliance with study drug|0|||
164269127|NCT04327024|593354695|FG001|Overall Study|Non-compliance with study drug|1|||
164269128|NCT04327024|593354696|FG002|Overall Study|Non-compliance with study drug|0|||
164269129|NCT04327024|593354694|FG000|Overall Study|Withdrawal by Subject|1|||
164269130|NCT04327024|593354695|FG001|Overall Study|Withdrawal by Subject|1|||
164269131|NCT04327024|593354696|FG002|Overall Study|Withdrawal by Subject|2|||
164269132|NCT03968159|593354698|FG000|Overall Study|Adverse Event|4|||
164269133|NCT03968159|593354699|FG001|Overall Study|Adverse Event|4|||
164269134|NCT03968159|593354698|FG000|Overall Study|Lost to Follow-up|1|||
164269135|NCT03968159|593354699|FG001|Overall Study|Lost to Follow-up|1|||
164269136|NCT03968159|593354698|FG000|Overall Study|Use of prohibited medication|0|||
164269137|NCT03968159|593354699|FG001|Overall Study|Use of prohibited medication|1|||
164269138|NCT03968159|593354698|FG000|Overall Study|Protocol Violation|2|||
164269139|NCT03968159|593354699|FG001|Overall Study|Protocol Violation|2|||
164269140|NCT03968159|593354698|FG000|Overall Study|Withdrawal by Subject|4|||
164269141|NCT03968159|593354699|FG001|Overall Study|Withdrawal by Subject|6|||
164269142|NCT03968159|593354698|FG000|Overall Study|Lack of Efficacy|0|||
164269143|NCT03968159|593354699|FG001|Overall Study|Lack of Efficacy|1|||
164269144|NCT03968159|593354698|FG000|Overall Study|Not further specified|2|||
164269145|NCT03968159|593354699|FG001|Overall Study|Not further specified|0|||
164269146|NCT00864851|593354700|FG000|Overall Study|Withdrawal by Subject|0|||
164269147|NCT00864851|593354701|FG001|Overall Study|Withdrawal by Subject|1|||
164269148|NCT00864851|593354702|FG002|Overall Study|Withdrawal by Subject|0|||
164269149|NCT00864851|593354700|FG000|Overall Study|Physician Decision|1|||
164269150|NCT00864851|593354701|FG001|Overall Study|Physician Decision|0|||
164269151|NCT00864851|593354702|FG002|Overall Study|Physician Decision|0|||
164269152|NCT00864851|593354700|FG000|Overall Study|Death|1|||
164269153|NCT00864851|593354701|FG001|Overall Study|Death|0|||
164269154|NCT00864851|593354702|FG002|Overall Study|Death|0|||
164269155|NCT00864851|593354700|FG000|Overall Study|Patient uncooperative|1|||
164269156|NCT00864851|593354701|FG001|Overall Study|Patient uncooperative|0|||
164269157|NCT00864851|593354702|FG002|Overall Study|Patient uncooperative|0|||
164269158|NCT00443781|593354703|FG000|Overall Study|Lost to Follow-up|10|||
164269159|NCT00443781|593354703|FG000|Overall Study|Physician Decision|2|||
164269160|NCT00443781|593354703|FG000|Overall Study|Protocol Violation|1|||
164269161|NCT00443781|593354703|FG000|Overall Study|Withdrawal by Subject|6|||
164269162|NCT00443781|593354703|FG000|Overall Study|Unable to comply with study follow up|2|||
164269163|NCT00443781|593354703|FG000|Overall Study|Investigator terminated participation|1|||
164269164|NCT00443781|593354703|FG000|Overall Study|Insurance not covered|2|||
164269165|NCT00443781|593354703|FG000|Overall Study|PD/FAD not done|1|||
164269166|NCT00430937|593354704|FG000|Overall Study|Adverse Event|3|||
164269167|NCT00430937|593354705|FG001|Overall Study|Adverse Event|8|||
164269168|NCT00430937|593354704|FG000|Overall Study|Death|0|||
164269169|NCT00430937|593354705|FG001|Overall Study|Death|1|||
164269170|NCT00430937|593354704|FG000|Overall Study|Lost to Follow-up|6|||
164269171|NCT00430937|593354705|FG001|Overall Study|Lost to Follow-up|6|||
164269172|NCT00430937|593354704|FG000|Overall Study|Withdrawal by Subject|5|||
164269173|NCT00430937|593354705|FG001|Overall Study|Withdrawal by Subject|2|||
164269174|NCT00430937|593354704|FG000|Overall Study|Protocol Violation|3|||
164269175|NCT00430937|593354705|FG001|Overall Study|Protocol Violation|2|||
164269176|NCT00430937|593354704|FG000|Overall Study|Lack of Efficacy|6|||
164269177|NCT00430937|593354705|FG001|Overall Study|Lack of Efficacy|5|||
164269178|NCT00430937|593354704|FG000|Overall Study|Inappropriate enrollment|2|||
164269179|NCT00430937|593354705|FG001|Overall Study|Inappropriate enrollment|1|||
164269180|NCT00430937|593354704|FG000|Overall Study|Administrative reasons|1|||
164269181|NCT00430937|593354705|FG001|Overall Study|Administrative reasons|0|||
164269182|NCT00430937|593354704|FG000|Overall Study|Protocol discontinuation criteria met|1|||
164269183|NCT00430937|593354705|FG001|Overall Study|Protocol discontinuation criteria met|2|||
164269184|NCT00430937|593354704|FG000|Overall Study|Unable to classify|0|||
164269185|NCT00430937|593354705|FG001|Overall Study|Unable to classify|1|||
164269186|NCT01533922|593354706|FG000|Overall Study|Adverse Event|5|||
164269187|NCT01533922|593354707|FG001|Overall Study|Adverse Event|8|||
164269188|NCT01533922|593354708|FG002|Overall Study|Adverse Event|6|||
164269189|NCT01533922|593354709|FG003|Overall Study|Adverse Event|3|||
164269190|NCT01533922|593354710|FG004|Overall Study|Adverse Event|4|||
164269191|NCT01533922|593354706|FG000|Overall Study|Lack of Efficacy|0|||
164269192|NCT01533922|593354707|FG001|Overall Study|Lack of Efficacy|0|||
164269193|NCT01533922|593354708|FG002|Overall Study|Lack of Efficacy|1|||
164269194|NCT01533922|593354709|FG003|Overall Study|Lack of Efficacy|0|||
164269195|NCT01533922|593354710|FG004|Overall Study|Lack of Efficacy|0|||
164269196|NCT01533922|593354706|FG000|Overall Study|Protocol Violation|0|||
164269197|NCT01533922|593354707|FG001|Overall Study|Protocol Violation|3|||
164342006|NCT05248867|593627595|FG003|Double-blind Period|Other, not specified|0|||
164269198|NCT01533922|593354708|FG002|Overall Study|Protocol Violation|0|||
164269199|NCT01533922|593354709|FG003|Overall Study|Protocol Violation|0|||
164269200|NCT01533922|593354710|FG004|Overall Study|Protocol Violation|1|||
164269201|NCT01533922|593354706|FG000|Overall Study|Withdrawal by Subject|3|||
164269202|NCT01533922|593354707|FG001|Overall Study|Withdrawal by Subject|1|||
164269203|NCT01533922|593354708|FG002|Overall Study|Withdrawal by Subject|2|||
164269204|NCT01533922|593354709|FG003|Overall Study|Withdrawal by Subject|2|||
164269205|NCT01533922|593354710|FG004|Overall Study|Withdrawal by Subject|1|||
164269206|NCT01533922|593354706|FG000|Overall Study|Other reason not defined above|2|||
164269207|NCT01533922|593354707|FG001|Overall Study|Other reason not defined above|0|||
164269208|NCT01533922|593354708|FG002|Overall Study|Other reason not defined above|1|||
164269209|NCT01533922|593354709|FG003|Overall Study|Other reason not defined above|0|||
164269210|NCT01533922|593354710|FG004|Overall Study|Other reason not defined above|0|||
164269211|NCT00895661|593354713|FG000|Overall Study|Death|1|||
164269212|NCT00895661|593354713|FG000|Overall Study|reason unknown|2|||
164269213|NCT02006069|593354714|FG000|Overall Study|MPP other programming|239|||
164269214|NCT02006069|593354715|FG001|Overall Study|MPP other programming|0|||
164269215|NCT02006069|593354714|FG000|Overall Study|RV only pacing|0|||
164269216|NCT02006069|593354715|FG001|Overall Study|RV only pacing|3|||
164269217|NCT02989805|593354718|FG000|Overall Study|invalid consent|6|||
164269218|NCT02989805|593354719|FG001|Overall Study|invalid consent|4|||
164269219|NCT02776033|593354720|FG000|Overall Study|Withdrawal by Subject|0|||
164269220|NCT02776033|593354721|FG001|Overall Study|Withdrawal by Subject|0|||
164269221|NCT02776033|593354722|FG002|Overall Study|Withdrawal by Subject|2|||
164269222|NCT02776033|593354720|FG000|Overall Study|Physician Decision|2|||
164269223|NCT02776033|593354721|FG001|Overall Study|Physician Decision|0|||
164269224|NCT02776033|593354722|FG002|Overall Study|Physician Decision|0|||
164269225|NCT02776033|593354720|FG000|Overall Study|Lost to Follow-up|1|||
164269226|NCT02776033|593354721|FG001|Overall Study|Lost to Follow-up|0|||
164269227|NCT02776033|593354722|FG002|Overall Study|Lost to Follow-up|0|||
164269228|NCT02776033|593354720|FG000|Overall Study|Adverse Event|1|||
164269229|NCT02776033|593354721|FG001|Overall Study|Adverse Event|2|||
164269230|NCT02776033|593354722|FG002|Overall Study|Adverse Event|0|||
164269231|NCT00685373|593354723|FG000|Overall Study|Adverse Event|3|||
164269232|NCT00685373|593354723|FG000|Overall Study|Withdrawal by Subject|5|||
164269233|NCT00685373|593354723|FG000|Overall Study|Lack of Efficacy|3|||
164269234|NCT00685373|593354723|FG000|Overall Study|Condition no longer requires study drug|1|||
164269235|NCT00685373|593354723|FG000|Overall Study|Lost to Follow-up|2|||
164269236|NCT00685373|593354723|FG000|Overall Study|Protocol Violation|1|||
164269237|NCT01302054|593354724|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
164269238|NCT01302054|593354725|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
164269239|NCT01302054|593354726|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
164269240|NCT01302054|593354724|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
164269241|NCT01302054|593354725|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
164269242|NCT01302054|593354726|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
164269243|NCT01302054|593354724|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
164269244|NCT01302054|593354725|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
164269245|NCT01302054|593354726|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
164269246|NCT01302054|593354724|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
164269247|NCT01302054|593354725|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
164269248|NCT01302054|593354726|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
164269249|NCT01302054|593354724|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
164269250|NCT01302054|593354725|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
164269251|NCT01302054|593354726|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
164269252|NCT01302054|593354724|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
164269253|NCT01302054|593354725|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
164269254|NCT01302054|593354726|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
164269255|NCT01302054|593354724|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
164269256|NCT01302054|593354725|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
164269257|NCT01302054|593354726|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
164269258|NCT01302054|593354724|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
164269259|NCT01302054|593354725|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
164269260|NCT01302054|593354726|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
164269261|NCT01302054|593354724|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
164269262|NCT01302054|593354725|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
164269263|NCT01302054|593354726|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
164430786|NCT00430677|593947313|FG002|Short-term Period|Lack of Efficacy|4|||
164581344|NCT00923091|594493955|FG010|Period III (Single-Blind)|Protocol Violation|0|||
164269264|NCT01302054|593354724|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164269265|NCT01302054|593354725|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
164269266|NCT01302054|593354726|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
164269267|NCT01302054|593354724|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
164269268|NCT01302054|593354725|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
164269269|NCT01302054|593354726|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
164269270|NCT01302054|593354724|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
164269271|NCT01302054|593354725|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
164269272|NCT01302054|593354726|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
164269273|NCT01302054|593354724|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
164269274|NCT01302054|593354725|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
164430787|NCT00430677|593947311|FG000|Short-term Period|Withdrawal by Subject|1|||
164269275|NCT01302054|593354726|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
164269276|NCT01302054|593354724|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
164269277|NCT01302054|593354725|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
164269278|NCT01302054|593354726|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
164269279|NCT01302054|593354724|FG000|Double-Blind Treatment Phase|Other|0|||
164269280|NCT01302054|593354725|FG001|Double-Blind Treatment Phase|Other|4|||
164269281|NCT01302054|593354726|FG002|Double-Blind Treatment Phase|Other|9|||
164269282|NCT02639338|593354727|FG000|Overall Study|Lost to Follow-up|2|||
164269283|NCT02639338|593354728|FG001|Overall Study|Lost to Follow-up|2|||
164269284|NCT02639338|593354727|FG000|Overall Study|Withdrew Consent|1|||
164269285|NCT02639338|593354728|FG001|Overall Study|Withdrew Consent|2|||
164269286|NCT02639338|593354727|FG000|Overall Study|Death|1|||
164269287|NCT02639338|593354728|FG001|Overall Study|Death|0|||
164269288|NCT02639338|593354727|FG000|Overall Study|Randomized but Not Treated|0|||
164269289|NCT02639338|593354728|FG001|Overall Study|Randomized but Not Treated|1|||
164269290|NCT00966719|593354734|FG000|Overall Study|Lost to Follow-up|6|||
164269291|NCT00966719|593354735|FG001|Overall Study|Lost to Follow-up|11|||
164269292|NCT03242018|593354737|FG000|Overall Study|Adverse Event|7|||
164269293|NCT03242018|593354738|FG001|Overall Study|Adverse Event|7|||
164269294|NCT03242018|593354739|FG002|Overall Study|Adverse Event|6|||
164269295|NCT03242018|593354737|FG000|Overall Study|Lost to Follow-up|2|||
164269296|NCT03242018|593354738|FG001|Overall Study|Lost to Follow-up|2|||
164269297|NCT03242018|593354739|FG002|Overall Study|Lost to Follow-up|2|||
164269298|NCT03242018|593354737|FG000|Overall Study|At the Participant's Own Request|5|||
164269299|NCT03242018|593354738|FG001|Overall Study|At the Participant's Own Request|1|||
164269300|NCT03242018|593354739|FG002|Overall Study|At the Participant's Own Request|4|||
164269301|NCT03242018|593354737|FG000|Overall Study|Reason Not Specified|3|||
164269302|NCT03242018|593354738|FG001|Overall Study|Reason Not Specified|4|||
164269303|NCT03242018|593354739|FG002|Overall Study|Reason Not Specified|1|||
164269304|NCT03242018|593354737|FG000|Overall Study|Study Terminated by Sponsor|1|||
164269305|NCT03242018|593354738|FG001|Overall Study|Study Terminated by Sponsor|0|||
164269306|NCT03242018|593354739|FG002|Overall Study|Study Terminated by Sponsor|1|||
164269307|NCT02365285|593354741|FG000|Overall Study|Physician Decision|0|||
164269308|NCT02365285|593354742|FG001|Overall Study|Physician Decision|1|||
164269309|NCT02365285|593354743|FG002|Overall Study|Physician Decision|1|||
164269310|NCT02365285|593354744|FG003|Overall Study|Physician Decision|0|||
164269311|NCT02365285|593354741|FG000|Overall Study|Adverse Event|0|||
164269312|NCT02365285|593354742|FG001|Overall Study|Adverse Event|0|||
164269313|NCT02365285|593354743|FG002|Overall Study|Adverse Event|0|||
164269314|NCT02365285|593354744|FG003|Overall Study|Adverse Event|2|||
164269315|NCT00160199|593354745|FG000|Overall Study|Adverse Event|5|||
164269316|NCT00160199|593354746|FG001|Overall Study|Adverse Event|14|||
164269317|NCT00160199|593354745|FG000|Overall Study|Lack of Efficacy|0|||
164269318|NCT00160199|593354746|FG001|Overall Study|Lack of Efficacy|1|||
164269319|NCT00160199|593354745|FG000|Overall Study|Lost to Follow-up|7|||
164269320|NCT00160199|593354746|FG001|Overall Study|Lost to Follow-up|7|||
164269321|NCT00160199|593354745|FG000|Overall Study|Withdrawal by Subject|4|||
164269322|NCT00160199|593354746|FG001|Overall Study|Withdrawal by Subject|6|||
164269323|NCT00160199|593354745|FG000|Overall Study|Administrative|0|||
164269324|NCT00160199|593354746|FG001|Overall Study|Administrative|1|||
164269325|NCT00160199|593354745|FG000|Overall Study|Protocol Violation|8|||
164269326|NCT00160199|593354746|FG001|Overall Study|Protocol Violation|8|||
164269327|NCT03262116|593354747|FG000|Overall Study|Physician Decision|0|||
164269328|NCT03262116|593354748|FG001|Overall Study|Physician Decision|2|||
164269329|NCT03262116|593354749|FG002|Overall Study|Physician Decision|1|||
164269330|NCT03262116|593354750|FG003|Overall Study|Physician Decision|1|||
164269331|NCT03262116|593354751|FG004|Overall Study|Physician Decision|1|||
164269332|NCT03262116|593354752|FG005|Overall Study|Physician Decision|2|||
164342007|NCT05248867|593627596|FG004|Double-blind Period|Other, not specified|0|||
164342008|NCT05248867|593627597|FG005|Double-blind Period|Other, not specified|0|||
164269333|NCT02635347|593354755|FG000|Overall Study|Failed screening|20|||
164342009|NCT05248867|593627592|FG000|Open-label Period|Withdrawal by Subject|0|||
164342010|NCT05248867|593627593|FG001|Open-label Period|Withdrawal by Subject|0|||
164269334|NCT02635347|593354756|FG001|Overall Study|Failed screening|7|||
164269335|NCT00635089|593354761|FG000|Overall Study|Adverse Event|7|||
164269336|NCT00635089|593354761|FG000|Overall Study|Lack of Efficacy|28|||
164269337|NCT00635089|593354761|FG000|Overall Study|Protocol Deviation|4|||
164269338|NCT00635089|593354761|FG000|Overall Study|Lost to Follow-up|8|||
164269339|NCT00635089|593354761|FG000|Overall Study|Other|31|||
164269340|NCT01283542|593354763|FG000|Main Phase|Acute or progressive vision loss|1|||
164269341|NCT01283542|593354763|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
164269342|NCT01283542|593354763|FG000|Main Phase|abnormal laboratory values|5|||
164269343|NCT01283542|593354763|FG000|Extension Phase|Physician Decision|1|||
164269344|NCT01283542|593354763|FG000|Extension Phase|Adverse Event|1|||
164269345|NCT01283542|593354763|FG000|Extension Phase|Administrative problems|1|||
164342011|NCT05248867|593627594|FG002|Open-label Period|Withdrawal by Subject|3|||
164269346|NCT02725593|593354764|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
164269347|NCT02725593|593354765|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
164269348|NCT02725593|593354764|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
164269349|NCT02725593|593354765|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
164269350|NCT02725593|593354764|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
164269351|NCT02725593|593354765|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
164269352|NCT02725593|593354764|FG000|Long Term Extension|Withdrawal by Subject|1|||
164269353|NCT02725593|593354765|FG001|Long Term Extension|Withdrawal by Subject|3|||
164269354|NCT03689244|593354766|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
164269355|NCT03689244|593354767|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
164269356|NCT03689244|593354768|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
164269357|NCT03689244|593354769|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
164269358|NCT03689244|593354766|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
164269359|NCT03689244|593354767|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
164269360|NCT03689244|593354768|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
164269361|NCT03689244|593354769|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
164269362|NCT03689244|593354766|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
164269363|NCT03689244|593354767|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
164269364|NCT03689244|593354768|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
164269365|NCT03689244|593354769|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
164269366|NCT03689244|593354766|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
164269367|NCT03689244|593354767|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
164269368|NCT03689244|593354768|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
164269369|NCT03689244|593354769|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
164269370|NCT03689244|593354766|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
164269371|NCT03689244|593354767|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
164269372|NCT03689244|593354768|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
164269373|NCT03689244|593354769|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
164269374|NCT03689244|593354766|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
164269375|NCT03689244|593354767|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
164269376|NCT03689244|593354768|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
164269377|NCT03689244|593354769|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
164269378|NCT03689244|593354766|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
164269379|NCT03689244|593354767|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
164269380|NCT03689244|593354768|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
164269381|NCT03689244|593354769|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
164269382|NCT03689244|593354766|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
164269383|NCT03689244|593354767|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
164269384|NCT03689244|593354768|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
164269385|NCT03689244|593354769|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
164269386|NCT00444067|593354774|FG000|Overall Study|Lost to Follow-up|0|||
164269387|NCT00444067|593354775|FG001|Overall Study|Lost to Follow-up|1|||
164269388|NCT04208087|593354784|FG000|Overall Study|Adverse Event|1|||
164269389|NCT04208087|593354785|FG001|Overall Study|Adverse Event|0|||
164269390|NCT04208087|593354786|FG002|Overall Study|Adverse Event|0|||
164269391|NCT04208087|593354787|FG003|Overall Study|Adverse Event|0|||
164269392|NCT04208087|593354788|FG004|Overall Study|Adverse Event|0|||
164269393|NCT04208087|593354784|FG000|Overall Study|Withdrawal by Subject|0|||
164269394|NCT04208087|593354785|FG001|Overall Study|Withdrawal by Subject|0|||
164269395|NCT04208087|593354786|FG002|Overall Study|Withdrawal by Subject|1|||
164269396|NCT04208087|593354787|FG003|Overall Study|Withdrawal by Subject|0|||
164269397|NCT04208087|593354788|FG004|Overall Study|Withdrawal by Subject|0|||
164269398|NCT04208087|593354784|FG000|Overall Study|Other|0|||
164269399|NCT04208087|593354785|FG001|Overall Study|Other|0|||
164269400|NCT04208087|593354786|FG002|Overall Study|Other|0|||
164269401|NCT04208087|593354787|FG003|Overall Study|Other|0|||
164581345|NCT00923091|594493956|FG011|Period III (Single-Blind)|Protocol Violation|0|||
164581346|NCT00923091|594493957|FG012|Period III (Single-Blind)|Protocol Violation|0|||
164269402|NCT04208087|593354788|FG004|Overall Study|Other|1|||
164269403|NCT01198509|593354789|FG000|Overall Study|Withdrawal by Subject|1|||
164269404|NCT01198509|593354790|FG001|Overall Study|Withdrawal by Subject|0|||
164269405|NCT01198509|593354791|FG002|Overall Study|Withdrawal by Subject|0|||
164269406|NCT01198509|593354792|FG003|Overall Study|Withdrawal by Subject|0|||
164269407|NCT01198509|593354793|FG004|Overall Study|Withdrawal by Subject|0|||
164269408|NCT01198509|593354794|FG005|Overall Study|Withdrawal by Subject|0|||
164269409|NCT00837759|593356685|FG000|Overall Study|Protocol Violation|3|||
164581347|NCT00923091|594493945|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
164269410|NCT00837759|593356685|FG000|Overall Study|Lost to Follow-up|1|||
164269411|NCT01597635|593356686|FG000|Part A|Adverse Event|3|||
164269412|NCT01597635|593356687|FG001|Part A|Adverse Event|0|||
164269413|NCT01597635|593356688|FG002|Part A|Adverse Event|0|||
164269414|NCT01597635|593356686|FG000|Part B|Adverse Event|0|||
164269415|NCT01597635|593356687|FG001|Part B|Adverse Event|0|||
164269416|NCT01597635|593356688|FG002|Part B|Adverse Event|1|||
164269417|NCT01597635|593356686|FG000|Part B|Protocol Violation|0|||
164686667|NCT04164758|594876550|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
164686668|NCT04164758|594876548|FG000|Overall Study|Adverse Event|0|||
164686669|NCT04164758|594876549|FG001|Overall Study|Adverse Event|1|||
164686670|NCT04164758|594876550|FG002|Overall Study|Adverse Event|0|||
164686671|NCT00697827|594876555|FG000|Overall Study|enrolled but not treated|2|||
164686672|NCT00697827|594876556|FG001|Overall Study|enrolled but not treated|1|||
164686673|NCT03259165|594876557|FG000|Overall Study|COVID 19 pandemic|1|||
164686674|NCT03259165|594876558|FG001|Overall Study|COVID 19 pandemic|1|||
164686675|NCT03732833|594876561|FG000|Overall Study|Adverse Event|0|||
164686676|NCT03732833|594876562|FG001|Overall Study|Adverse Event|3|||
164686677|NCT03732833|594876563|FG002|Overall Study|Adverse Event|1|||
164686678|NCT03732833|594876561|FG000|Overall Study|Withdrawal by Subject|11|||
164686679|NCT03732833|594876562|FG001|Overall Study|Withdrawal by Subject|13|||
164686680|NCT03732833|594876563|FG002|Overall Study|Withdrawal by Subject|8|||
164686681|NCT03732833|594876561|FG000|Overall Study|Lost to Follow-up|3|||
164686682|NCT03732833|594876562|FG001|Overall Study|Lost to Follow-up|5|||
164686683|NCT03732833|594876563|FG002|Overall Study|Lost to Follow-up|4|||
164686684|NCT03732833|594876561|FG000|Overall Study|Pregnancy|0|||
164686685|NCT03732833|594876562|FG001|Overall Study|Pregnancy|2|||
164686686|NCT03732833|594876563|FG002|Overall Study|Pregnancy|0|||
164686687|NCT03732833|594876561|FG000|Overall Study|Physician Decision|2|||
164686688|NCT03732833|594876562|FG001|Overall Study|Physician Decision|3|||
164686689|NCT03732833|594876563|FG002|Overall Study|Physician Decision|1|||
164686690|NCT03732833|594876561|FG000|Overall Study|Covid-19 related and other reasons|2|||
164269418|NCT01597635|593356687|FG001|Part B|Protocol Violation|1|||
164269419|NCT01597635|593356688|FG002|Part B|Protocol Violation|0|||
164269420|NCT01597635|593356686|FG000|Part B|Protocol-defined stopping criteria|0|||
164269421|NCT01597635|593356687|FG001|Part B|Protocol-defined stopping criteria|4|||
164269422|NCT01597635|593356688|FG002|Part B|Protocol-defined stopping criteria|3|||
164269423|NCT01597635|593356686|FG000|Part B|Withdrawal by Subject|0|||
164269424|NCT01597635|593356687|FG001|Part B|Withdrawal by Subject|1|||
164269425|NCT01597635|593356688|FG002|Part B|Withdrawal by Subject|0|||
164269426|NCT01267175|593356691|FG000|Overall Study|Withdrawal by Subject|1|||
164269427|NCT01267175|593356691|FG000|Overall Study|Lost to Follow-up|1|||
164269428|NCT02690649|593356693|FG000|Overall Study|Withdrawal by Subject|1|||
164269429|NCT02690649|593356694|FG001|Overall Study|Withdrawal by Subject|1|||
164269430|NCT02690649|593356693|FG000|Overall Study|Protocol Violation|0|||
164269431|NCT02690649|593356694|FG001|Overall Study|Protocol Violation|3|||
164269432|NCT02066129|593356695|FG000|Overall Study|Lost to Follow-up|13|||
164269433|NCT02066129|593356696|FG001|Overall Study|Lost to Follow-up|12|||
164269434|NCT02066129|593356695|FG000|Overall Study|Withdrawal by Subject|7|||
164269435|NCT02066129|593356696|FG001|Overall Study|Withdrawal by Subject|10|||
164269436|NCT02066129|593356695|FG000|Overall Study|Lack of Efficacy|8|||
164269437|NCT02066129|593356696|FG001|Overall Study|Lack of Efficacy|10|||
164269438|NCT02066129|593356695|FG000|Overall Study|Physician Decision|1|||
164269439|NCT02066129|593356696|FG001|Overall Study|Physician Decision|1|||
164269440|NCT00316888|593356697|FG000|Overall Study|Adverse Event|4|||
164269441|NCT00316888|593356698|FG001|Overall Study|Adverse Event|5|||
164269442|NCT00316888|593356697|FG000|Overall Study|Withdrawal by Subject|2|||
164269443|NCT00316888|593356698|FG001|Overall Study|Withdrawal by Subject|2|||
164269444|NCT00316888|593356697|FG000|Overall Study|Not start protocol therapy|0|||
164269445|NCT00316888|593356698|FG001|Overall Study|Not start protocol therapy|1|||
164269446|NCT00857948|593356702|FG000|Overall Study|Withdrawal by Subject|2|||
164269447|NCT00857948|593356703|FG001|Overall Study|Withdrawal by Subject|0|||
164686691|NCT03732833|594876562|FG001|Overall Study|Covid-19 related and other reasons|7|||
164686692|NCT03732833|594876563|FG002|Overall Study|Covid-19 related and other reasons|3|||
164686693|NCT01567527|594876564|FG000|Conversion Phase.|Protocol deviation|3|||
164686694|NCT01567527|594876565|FG001|Conversion Phase.|Protocol deviation|0|||
164686695|NCT01567527|594876566|FG002|Conversion Phase.|Protocol deviation|0|||
164686696|NCT01567527|594876567|FG003|Conversion Phase.|Protocol deviation|0|||
164686697|NCT01567527|594876568|FG004|Conversion Phase.|Protocol deviation|0|||
164269448|NCT00857948|593356704|FG002|Overall Study|Withdrawal by Subject|0|||
164269449|NCT00857948|593356705|FG003|Overall Study|Withdrawal by Subject|0|||
164269450|NCT00857948|593356702|FG000|Overall Study|Protocol Violation|1|||
164269451|NCT00857948|593356703|FG001|Overall Study|Protocol Violation|0|||
164269452|NCT00857948|593356704|FG002|Overall Study|Protocol Violation|1|||
164269453|NCT00857948|593356705|FG003|Overall Study|Protocol Violation|0|||
164269454|NCT00493636|593356708|FG000|Overall Study|Withdrawal by Subject|1|||
164269455|NCT00493636|593356709|FG001|Overall Study|Withdrawal by Subject|0|||
164686698|NCT01567527|594876564|FG000|Conversion Phase.|Met withdrawal criteria|10|||
164686699|NCT01567527|594876565|FG001|Conversion Phase.|Met withdrawal criteria|0|||
164686700|NCT01567527|594876566|FG002|Conversion Phase.|Met withdrawal criteria|0|||
164686701|NCT01567527|594876567|FG003|Conversion Phase.|Met withdrawal criteria|0|||
164269456|NCT00493636|593356708|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
164269457|NCT00493636|593356709|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
164269458|NCT00493636|593356708|FG000|Overall Study|Mis-randomization|1|||
164269459|NCT00493636|593356709|FG001|Overall Study|Mis-randomization|1|||
164269460|NCT01565941|593356710|FG000|Overall Study|Withdrawn by parent/guardian|3|||
164269461|NCT01565941|593356711|FG001|Overall Study|Withdrawn by parent/guardian|2|||
164269462|NCT01565941|593356710|FG000|Overall Study|Randomized; did not receive intevention|8|||
164269463|NCT01565941|593356711|FG001|Overall Study|Randomized; did not receive intevention|2|||
164269464|NCT03230292|593356712|FG000|Overall Study|Adverse Event|1|||
164269465|NCT03230292|593356712|FG000|Overall Study|Protocol Violation|1|||
164269466|NCT03230292|593356712|FG000|Overall Study|Lost to Follow-up|1|||
164269467|NCT03230292|593356712|FG000|Overall Study|Withdrawal by Subject|3|||
164269468|NCT02855944|593356713|FG000|Period 1: Treatment|Ongoing|14|||
164269469|NCT02855944|593356714|FG001|Period 1: Treatment|Ongoing|0|||
164269470|NCT02855944|593356713|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
164269471|NCT02855944|593356714|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
164269472|NCT02855944|593356713|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
164269473|NCT02855944|593356714|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
164269474|NCT03757130|593356715|FG000|Overall Study|Lost to Follow-up|0|||
164269475|NCT03757130|593356716|FG001|Overall Study|Lost to Follow-up|0|||
164269476|NCT03757130|593356717|FG002|Overall Study|Lost to Follow-up|0|||
164269477|NCT03757130|593356718|FG003|Overall Study|Lost to Follow-up|1|||
164269478|NCT03757130|593356719|FG004|Overall Study|Lost to Follow-up|0|||
164269479|NCT03757130|593356720|FG005|Overall Study|Lost to Follow-up|0|||
164269480|NCT03757130|593356721|FG006|Overall Study|Lost to Follow-up|0|||
164269481|NCT03757130|593356722|FG007|Overall Study|Lost to Follow-up|1|||
164269482|NCT03757130|593356715|FG000|Overall Study|Withdrawal by Subject|0|||
164269483|NCT03757130|593356716|FG001|Overall Study|Withdrawal by Subject|0|||
164269484|NCT03757130|593356717|FG002|Overall Study|Withdrawal by Subject|0|||
164269485|NCT03757130|593356718|FG003|Overall Study|Withdrawal by Subject|0|||
164269486|NCT03757130|593356719|FG004|Overall Study|Withdrawal by Subject|0|||
164269487|NCT03757130|593356720|FG005|Overall Study|Withdrawal by Subject|0|||
164269488|NCT03757130|593356721|FG006|Overall Study|Withdrawal by Subject|1|||
164269489|NCT03757130|593356722|FG007|Overall Study|Withdrawal by Subject|0|||
164269490|NCT01639755|593356723|FG000|Overall Study|Study Ongoing|15|||
164269491|NCT01639755|593356723|FG000|Overall Study|Patient had device explantation|4|||
164269492|NCT01439126|593356724|FG000|Overall Study|Adverse Event|2|||
164269493|NCT01439126|593356725|FG001|Overall Study|Adverse Event|0|||
164269494|NCT01439126|593356724|FG000|Overall Study|Withdrawal by Subject|5|||
164269495|NCT01439126|593356725|FG001|Overall Study|Withdrawal by Subject|21|||
164269496|NCT01439126|593356724|FG000|Overall Study|Protocol Violation|6|||
164269497|NCT01439126|593356725|FG001|Overall Study|Protocol Violation|4|||
164269498|NCT01439126|593356724|FG000|Overall Study|Lost to Follow-up|6|||
164269499|NCT01439126|593356725|FG001|Overall Study|Lost to Follow-up|3|||
164269500|NCT01439126|593356724|FG000|Overall Study|Other-Use of prohibited treatment|0|||
164581348|NCT00923091|594493946|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
164581349|NCT00923091|594493947|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
164581350|NCT00923091|594493948|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
164581351|NCT00923091|594493949|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
164581352|NCT00923091|594493950|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
164581353|NCT00923091|594493951|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
164581354|NCT00923091|594493952|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
164581355|NCT00923091|594493953|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
164581356|NCT00923091|594493954|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
164581357|NCT00923091|594493955|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
164581358|NCT00923091|594493956|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
164581359|NCT00923091|594493957|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
164581360|NCT00923091|594493945|FG000|Period IV (Double-Blind)|Adverse Event|2|||
164581361|NCT00923091|594493946|FG001|Period IV (Double-Blind)|Adverse Event|0|||
164581362|NCT00923091|594493947|FG002|Period IV (Double-Blind)|Adverse Event|0|||
164581363|NCT00923091|594493948|FG003|Period IV (Double-Blind)|Adverse Event|0|||
164581364|NCT00923091|594493949|FG004|Period IV (Double-Blind)|Adverse Event|0|||
164581365|NCT00923091|594493950|FG005|Period IV (Double-Blind)|Adverse Event|0|||
164581366|NCT00923091|594493951|FG006|Period IV (Double-Blind)|Adverse Event|0|||
164581367|NCT00923091|594493952|FG007|Period IV (Double-Blind)|Adverse Event|0|||
164581368|NCT00923091|594493953|FG008|Period IV (Double-Blind)|Adverse Event|0|||
164581369|NCT00923091|594493954|FG009|Period IV (Double-Blind)|Adverse Event|0|||
164269501|NCT01439126|593356725|FG001|Overall Study|Other-Use of prohibited treatment|2|||
164269502|NCT01439126|593356724|FG000|Overall Study|Other-Miscellaneous|12|||
164269503|NCT01439126|593356725|FG001|Overall Study|Other-Miscellaneous|12|||
164269504|NCT01617447|593356727|FG000|Overall Study|Adverse Event|0|||
164269505|NCT01617447|593356728|FG001|Overall Study|Adverse Event|1|||
164269506|NCT01617447|593356727|FG000|Overall Study|Physician Decision|0|||
164269507|NCT01617447|593356728|FG001|Overall Study|Physician Decision|2|||
164269508|NCT05059977|593356729|FG000|Overall Study|Withdrawal by Subject|0|||
164581370|NCT00923091|594493955|FG010|Period IV (Double-Blind)|Adverse Event|0|||
164581371|NCT00923091|594493956|FG011|Period IV (Double-Blind)|Adverse Event|0|||
164269509|NCT05059977|593356730|FG001|Overall Study|Withdrawal by Subject|0|||
164581372|NCT00923091|594493957|FG012|Period IV (Double-Blind)|Adverse Event|0|||
164581373|NCT00923091|594493945|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
164686702|NCT01567527|594876568|FG004|Conversion Phase.|Met withdrawal criteria|0|||
164686703|NCT01567527|594876564|FG000|Conversion Phase.|Withdrawal by Subject|32|||
164686704|NCT01567527|594876565|FG001|Conversion Phase.|Withdrawal by Subject|0|||
164686705|NCT01567527|594876566|FG002|Conversion Phase.|Withdrawal by Subject|0|||
164686706|NCT01567527|594876567|FG003|Conversion Phase.|Withdrawal by Subject|0|||
164686707|NCT01567527|594876568|FG004|Conversion Phase.|Withdrawal by Subject|0|||
164686708|NCT01567527|594876564|FG000|Conversion Phase.|Lost to Follow-up|16|||
164686709|NCT01567527|594876565|FG001|Conversion Phase.|Lost to Follow-up|0|||
164686710|NCT01567527|594876566|FG002|Conversion Phase.|Lost to Follow-up|0|||
164686711|NCT01567527|594876567|FG003|Conversion Phase.|Lost to Follow-up|0|||
164686712|NCT01567527|594876568|FG004|Conversion Phase.|Lost to Follow-up|0|||
164686713|NCT01567527|594876564|FG000|Conversion Phase.|Lack of Efficacy|2|||
164686714|NCT01567527|594876565|FG001|Conversion Phase.|Lack of Efficacy|0|||
164686715|NCT01567527|594876566|FG002|Conversion Phase.|Lack of Efficacy|0|||
164686716|NCT01567527|594876567|FG003|Conversion Phase.|Lack of Efficacy|0|||
164269510|NCT05059977|593356731|FG002|Overall Study|Withdrawal by Subject|1|||
164269511|NCT00576472|593356732|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269512|NCT00576472|593356733|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269513|NCT00576472|593356734|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269514|NCT00576472|593356735|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
164269515|NCT00576472|593356736|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269516|NCT00576472|593356737|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269517|NCT00576472|593356738|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269518|NCT00576472|593356739|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269519|NCT00576472|593356740|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269520|NCT00576472|593356741|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269521|NCT00576472|593356742|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269522|NCT00576472|593356743|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269523|NCT00576472|593356744|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269524|NCT00576472|593356745|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269525|NCT00576472|593356746|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269526|NCT00576472|593356732|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
164269527|NCT00576472|593356733|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
164269528|NCT00576472|593356734|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
164269529|NCT00576472|593356735|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
164269530|NCT00576472|593356736|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
164269531|NCT00576472|593356737|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
164269532|NCT00576472|593356738|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
164269533|NCT00576472|593356739|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
164269534|NCT00576472|593356740|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
164269535|NCT00576472|593356741|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
164269536|NCT00576472|593356742|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
164269537|NCT00576472|593356743|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
164269538|NCT00576472|593356744|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
164269539|NCT00576472|593356745|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
164269540|NCT00576472|593356746|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
164269541|NCT00576472|593356732|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269542|NCT00576472|593356733|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269543|NCT00576472|593356734|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269544|NCT00576472|593356735|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
164269545|NCT00576472|593356736|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269546|NCT00576472|593356737|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269547|NCT00576472|593356738|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269548|NCT00576472|593356739|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269549|NCT00576472|593356740|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269550|NCT00576472|593356741|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269551|NCT00576472|593356742|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269552|NCT00576472|593356743|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269553|NCT00576472|593356744|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269554|NCT00576472|593356745|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269555|NCT00576472|593356746|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269556|NCT00576472|593356732|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
164269557|NCT00576472|593356733|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
164686717|NCT01567527|594876568|FG004|Conversion Phase.|Lack of Efficacy|0|||
164686718|NCT01567527|594876564|FG000|Conversion Phase.|Adverse Event|33|||
164686719|NCT01567527|594876565|FG001|Conversion Phase.|Adverse Event|0|||
164686720|NCT01567527|594876566|FG002|Conversion Phase.|Adverse Event|0|||
164686721|NCT01567527|594876567|FG003|Conversion Phase.|Adverse Event|0|||
164686722|NCT01567527|594876568|FG004|Conversion Phase.|Adverse Event|0|||
164686723|NCT01567527|594876564|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
164686724|NCT01567527|594876565|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
164686725|NCT01567527|594876566|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
164686726|NCT01567527|594876567|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
164686727|NCT01567527|594876568|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
164686728|NCT01567527|594876564|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
164686729|NCT01567527|594876565|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
164686730|NCT01567527|594876566|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
164686731|NCT01567527|594876567|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
164686732|NCT01567527|594876568|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
164686733|NCT01567527|594876564|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
164686734|NCT01567527|594876565|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
164686735|NCT01567527|594876566|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
164686736|NCT01567527|594876567|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
164686737|NCT01567527|594876568|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
164686738|NCT01567527|594876564|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
164686739|NCT01567527|594876565|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
164686740|NCT01567527|594876566|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
164269558|NCT00576472|593356734|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
164269559|NCT00576472|593356735|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
164269560|NCT00576472|593356736|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
164269561|NCT00576472|593356737|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
164269562|NCT00576472|593356738|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
164269563|NCT00576472|593356739|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
164269564|NCT00576472|593356740|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
164269565|NCT00576472|593356741|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
164269566|NCT00576472|593356742|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
164269567|NCT00576472|593356743|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
164269568|NCT00576472|593356744|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
164269569|NCT00576472|593356745|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
164269570|NCT00576472|593356746|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
164269571|NCT00576472|593356732|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
164581374|NCT00923091|594493946|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
164581375|NCT00923091|594493947|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
164581376|NCT00923091|594493948|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
164581377|NCT00923091|594493949|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
164581378|NCT00923091|594493950|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
164581379|NCT00923091|594493951|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
164581380|NCT00923091|594493952|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
164581381|NCT00923091|594493953|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
164581382|NCT00923091|594493954|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
164581383|NCT00923091|594493955|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
164581384|NCT00923091|594493956|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
164581385|NCT00923091|594493957|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
164581386|NCT00923091|594493945|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
164581387|NCT00923091|594493946|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
164581388|NCT00923091|594493947|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
164581389|NCT00923091|594493948|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
164581390|NCT00923091|594493949|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
164581391|NCT00923091|594493950|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
164581392|NCT00923091|594493951|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
164581393|NCT00923091|594493952|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
164581394|NCT00923091|594493953|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
164581395|NCT00923091|594493954|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
164581396|NCT00923091|594493955|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
164581397|NCT00923091|594493956|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
164581398|NCT00923091|594493957|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
164581399|NCT00923091|594493945|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
164269572|NCT00576472|593356733|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269573|NCT00576472|593356734|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269574|NCT00576472|593356735|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
164581400|NCT00923091|594493946|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
164581401|NCT00923091|594493947|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
164581402|NCT00923091|594493948|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
164581403|NCT00923091|594493949|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
164269575|NCT00576472|593356736|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269576|NCT00576472|593356737|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269577|NCT00576472|593356738|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269578|NCT00576472|593356739|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269579|NCT00576472|593356740|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269580|NCT00576472|593356741|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269581|NCT00576472|593356742|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269582|NCT00576472|593356743|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269583|NCT00576472|593356744|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269584|NCT00576472|593356745|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269585|NCT00576472|593356746|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269586|NCT00576472|593356732|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
164269587|NCT00576472|593356733|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
164269588|NCT00576472|593356734|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
164269589|NCT00576472|593356735|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
164581404|NCT00923091|594493950|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
164581405|NCT00923091|594493951|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
164581406|NCT00923091|594493952|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
164581407|NCT00923091|594493953|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
164581408|NCT00923091|594493954|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
164581409|NCT00923091|594493955|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
164581410|NCT00923091|594493956|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
164581411|NCT00923091|594493957|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
164581412|NCT00923091|594493945|FG000|Period V (Double -Blind)|Protocol Violation|0|||
164581413|NCT00923091|594493946|FG001|Period V (Double -Blind)|Protocol Violation|0|||
164581414|NCT00923091|594493947|FG002|Period V (Double -Blind)|Protocol Violation|0|||
164581415|NCT00923091|594493948|FG003|Period V (Double -Blind)|Protocol Violation|0|||
164581416|NCT00923091|594493949|FG004|Period V (Double -Blind)|Protocol Violation|0|||
164581417|NCT00923091|594493950|FG005|Period V (Double -Blind)|Protocol Violation|0|||
164581418|NCT00923091|594493951|FG006|Period V (Double -Blind)|Protocol Violation|0|||
164581419|NCT00923091|594493952|FG007|Period V (Double -Blind)|Protocol Violation|0|||
164581420|NCT00923091|594493953|FG008|Period V (Double -Blind)|Protocol Violation|0|||
164581421|NCT00923091|594493954|FG009|Period V (Double -Blind)|Protocol Violation|0|||
164581422|NCT00923091|594493955|FG010|Period V (Double -Blind)|Protocol Violation|0|||
164581423|NCT00923091|594493956|FG011|Period V (Double -Blind)|Protocol Violation|0|||
164581424|NCT00923091|594493957|FG012|Period V (Double -Blind)|Protocol Violation|1|||
164581425|NCT00923091|594493945|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
164581426|NCT00923091|594493946|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
164581427|NCT00923091|594493947|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
164581428|NCT00923091|594493948|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
164581429|NCT00923091|594493949|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
164581430|NCT00923091|594493950|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
164581431|NCT00923091|594493951|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
164581432|NCT00923091|594493952|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
164581433|NCT00923091|594493953|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
164581434|NCT00923091|594493954|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
164581435|NCT00923091|594493955|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
164581436|NCT00923091|594493956|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
164581437|NCT00923091|594493957|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
164581438|NCT00923091|594493945|FG000|Period VI (Open-Label)|Adverse Event|17|||
164581439|NCT00923091|594493946|FG001|Period VI (Open-Label)|Adverse Event|0|||
164581440|NCT00923091|594493947|FG002|Period VI (Open-Label)|Adverse Event|4|||
164581441|NCT00923091|594493948|FG003|Period VI (Open-Label)|Adverse Event|1|||
164581442|NCT00923091|594493949|FG004|Period VI (Open-Label)|Adverse Event|1|||
164581443|NCT00923091|594493950|FG005|Period VI (Open-Label)|Adverse Event|0|||
164581444|NCT00923091|594493951|FG006|Period VI (Open-Label)|Adverse Event|0|||
164581445|NCT00923091|594493952|FG007|Period VI (Open-Label)|Adverse Event|0|||
164581446|NCT00923091|594493953|FG008|Period VI (Open-Label)|Adverse Event|0|||
164581447|NCT00923091|594493954|FG009|Period VI (Open-Label)|Adverse Event|0|||
164581448|NCT00923091|594493955|FG010|Period VI (Open-Label)|Adverse Event|0|||
164581449|NCT00923091|594493956|FG011|Period VI (Open-Label)|Adverse Event|0|||
164581450|NCT00923091|594493957|FG012|Period VI (Open-Label)|Adverse Event|0|||
164581451|NCT00923091|594493945|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
164269590|NCT00576472|593356736|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
164581452|NCT00923091|594493946|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
164581453|NCT00923091|594493947|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
164581454|NCT00923091|594493948|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
164581455|NCT00923091|594493949|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
164581456|NCT00923091|594493950|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
164581457|NCT00923091|594493951|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
164686741|NCT01567527|594876567|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
164686742|NCT01567527|594876568|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
164686743|NCT01567527|594876564|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
164686744|NCT01567527|594876565|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
164686745|NCT01567527|594876566|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
164686746|NCT01567527|594876567|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
164686747|NCT01567527|594876568|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
164269591|NCT00576472|593356737|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
164269592|NCT00576472|593356738|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
164269593|NCT00576472|593356739|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
164269594|NCT00576472|593356740|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
164269595|NCT00576472|593356741|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
164269596|NCT00576472|593356742|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
164269597|NCT00576472|593356743|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
164269598|NCT00576472|593356744|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
164269599|NCT00576472|593356745|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
164269600|NCT00576472|593356746|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
164269601|NCT00576472|593356732|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
164269602|NCT00576472|593356733|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
164269603|NCT00576472|593356734|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
164269604|NCT00576472|593356735|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
164269605|NCT00576472|593356736|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
164269606|NCT00576472|593356737|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
164269607|NCT00576472|593356738|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
164269608|NCT00576472|593356739|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
164269609|NCT00576472|593356740|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
164269610|NCT00576472|593356741|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
164269611|NCT00576472|593356742|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
164269612|NCT00576472|593356743|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
164269613|NCT00576472|593356744|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
164269614|NCT00576472|593356745|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
164269615|NCT00576472|593356746|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
164269616|NCT00576472|593356732|FG000|MPH Cross Over Phase|Physician Decision|0|||
164269617|NCT00576472|593356733|FG001|MPH Cross Over Phase|Physician Decision|0|||
164269618|NCT00576472|593356734|FG002|MPH Cross Over Phase|Physician Decision|0|||
164269619|NCT00576472|593356735|FG003|MPH Cross Over Phase|Physician Decision|0|||
164269620|NCT00576472|593356736|FG004|MPH Cross Over Phase|Physician Decision|0|||
164269621|NCT00576472|593356737|FG005|MPH Cross Over Phase|Physician Decision|0|||
164269622|NCT00576472|593356738|FG006|MPH Cross Over Phase|Physician Decision|4|||
164269623|NCT00576472|593356739|FG007|MPH Cross Over Phase|Physician Decision|0|||
164269624|NCT00576472|593356740|FG008|MPH Cross Over Phase|Physician Decision|0|||
164269625|NCT00576472|593356741|FG009|MPH Cross Over Phase|Physician Decision|0|||
164269626|NCT00576472|593356742|FG010|MPH Cross Over Phase|Physician Decision|0|||
164269627|NCT00576472|593356743|FG011|MPH Cross Over Phase|Physician Decision|0|||
164269628|NCT00576472|593356744|FG012|MPH Cross Over Phase|Physician Decision|0|||
164269629|NCT00576472|593356745|FG013|MPH Cross Over Phase|Physician Decision|0|||
164269630|NCT00576472|593356746|FG014|MPH Cross Over Phase|Physician Decision|0|||
164269631|NCT00576472|593356732|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
164269632|NCT00576472|593356733|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
164269633|NCT00576472|593356734|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
164269634|NCT00576472|593356735|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
164269635|NCT00576472|593356736|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
164269636|NCT00576472|593356737|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
164269637|NCT00576472|593356738|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
164269638|NCT00576472|593356739|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
164269639|NCT00576472|593356740|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
164269640|NCT00576472|593356741|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
164269641|NCT00576472|593356742|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
164269642|NCT00576472|593356743|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
164269643|NCT00576472|593356744|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
164269644|NCT00576472|593356745|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
164269645|NCT00576472|593356746|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
164269646|NCT00576472|593356732|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164269647|NCT00576472|593356733|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164269648|NCT00576472|593356734|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164269649|NCT00576472|593356735|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164269650|NCT00576472|593356736|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164269651|NCT00576472|593356737|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164269652|NCT00576472|593356738|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164686748|NCT01567527|594876564|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
164686749|NCT01567527|594876565|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
164686750|NCT01567527|594876566|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
164686751|NCT01567527|594876567|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
164686752|NCT01567527|594876568|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
164686753|NCT01567527|594876564|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
164686754|NCT01567527|594876565|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
164269653|NCT00576472|593356739|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164269654|NCT00576472|593356740|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164269655|NCT00576472|593356741|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164269656|NCT00576472|593356742|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164686755|NCT01567527|594876566|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
164686756|NCT01567527|594876567|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
164686757|NCT01567527|594876568|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
164686758|NCT01567527|594876564|FG000|IM Depot Stabilization.|Protocol deviation|0|||
164686759|NCT01567527|594876565|FG001|IM Depot Stabilization.|Protocol deviation|0|||
164686760|NCT01567527|594876566|FG002|IM Depot Stabilization.|Protocol deviation|5|||
164686761|NCT01567527|594876567|FG003|IM Depot Stabilization.|Protocol deviation|0|||
164686762|NCT01567527|594876568|FG004|IM Depot Stabilization.|Protocol deviation|0|||
164686763|NCT01567527|594876564|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
164686764|NCT01567527|594876565|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
164686765|NCT01567527|594876566|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
164686766|NCT01567527|594876567|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
164686767|NCT01567527|594876568|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
164686768|NCT01567527|594876564|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
164686769|NCT01567527|594876565|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
164686770|NCT01567527|594876566|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
164686771|NCT01567527|594876567|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
164686772|NCT01567527|594876568|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
164686773|NCT01567527|594876564|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
164686774|NCT01567527|594876565|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
164686775|NCT01567527|594876566|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
164686776|NCT01567527|594876567|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
164686777|NCT01567527|594876568|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
164686778|NCT01567527|594876564|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
164686779|NCT01567527|594876565|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
164686780|NCT01567527|594876566|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
164686781|NCT01567527|594876567|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
164686782|NCT01567527|594876568|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
164686783|NCT01567527|594876564|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
164686784|NCT01567527|594876565|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
164686785|NCT01567527|594876566|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
164686786|NCT01567527|594876567|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
164686787|NCT01567527|594876568|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
164686788|NCT01567527|594876564|FG000|IM Depot Stabilization.|Adverse Event|0|||
164686789|NCT01567527|594876565|FG001|IM Depot Stabilization.|Adverse Event|0|||
164686790|NCT01567527|594876566|FG002|IM Depot Stabilization.|Adverse Event|37|||
164686791|NCT01567527|594876567|FG003|IM Depot Stabilization.|Adverse Event|0|||
164686792|NCT01567527|594876568|FG004|IM Depot Stabilization.|Adverse Event|0|||
164686793|NCT01567527|594876564|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
164686794|NCT01567527|594876565|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
164686795|NCT01567527|594876566|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
164686796|NCT01567527|594876567|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
164686797|NCT01567527|594876568|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
164686798|NCT01567527|594876564|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
164686799|NCT01567527|594876565|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
164686800|NCT01567527|594876566|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
164269657|NCT00576472|593356743|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164269658|NCT00576472|593356744|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164269659|NCT00576472|593356745|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
164269660|NCT00576472|593356746|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164269661|NCT00576472|593356732|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
164269662|NCT00576472|593356733|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
164269663|NCT00576472|593356734|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
164342012|NCT05248867|593627595|FG003|Open-label Period|Withdrawal by Subject|1|||
164686801|NCT01567527|594876567|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
164686802|NCT01567527|594876568|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
164686803|NCT01567527|594876564|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
164686804|NCT01567527|594876565|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
164269664|NCT00576472|593356735|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
164269665|NCT00576472|593356736|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
164269666|NCT00576472|593356737|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
164269667|NCT00576472|593356738|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
164269668|NCT00576472|593356739|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
164686805|NCT01567527|594876566|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
164686806|NCT01567527|594876567|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
164686807|NCT01567527|594876568|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
164686808|NCT01567527|594876564|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
164686809|NCT01567527|594876565|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
164686810|NCT01567527|594876566|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
164686811|NCT01567527|594876567|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
164686812|NCT01567527|594876568|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
164686813|NCT01567527|594876564|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
164686814|NCT01567527|594876565|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
164686815|NCT01567527|594876566|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
164686816|NCT01567527|594876567|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
164686817|NCT01567527|594876568|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
164686818|NCT01567527|594876564|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
164686819|NCT01567527|594876565|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
164686820|NCT01567527|594876566|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
164686821|NCT01567527|594876567|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
164686822|NCT01567527|594876568|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
164686823|NCT01567527|594876564|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
164686824|NCT01567527|594876565|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
164686825|NCT01567527|594876566|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
164686826|NCT01567527|594876567|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
164686827|NCT01567527|594876568|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
164686828|NCT01567527|594876564|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
164686829|NCT01567527|594876565|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
164686830|NCT01567527|594876566|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
164686831|NCT01567527|594876567|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
164686832|NCT01567527|594876568|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
164686833|NCT01567527|594876564|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
164686834|NCT01567527|594876565|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
164686835|NCT01567527|594876566|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
164686836|NCT01567527|594876567|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
164686837|NCT01567527|594876568|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
164686838|NCT02004691|594876569|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
164686839|NCT02004691|594876570|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
164686840|NCT02004691|594876569|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
164686841|NCT02004691|594876570|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
164686842|NCT02004691|594876569|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
164686843|NCT02004691|594876570|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
164686844|NCT02004691|594876569|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
164686845|NCT02004691|594876570|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
164686846|NCT02004691|594876569|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
164686847|NCT02004691|594876570|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
164686848|NCT02004691|594876569|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
164686849|NCT02004691|594876570|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
164686850|NCT01970592|594876571|FG000|Overall Study|Withdrawal by Subject|4|||
164686851|NCT01970592|594876571|FG000|Overall Study|Physician Decision|1|||
164686852|NCT01970592|594876571|FG000|Overall Study|Adverse Event|1|||
164686853|NCT01320722|594876574|FG000|Overall Study|Did not Receive Intervention|3|||
164686854|NCT01320722|594876575|FG001|Overall Study|Did not Receive Intervention|2|||
164686855|NCT01320722|594876576|FG002|Overall Study|Did not Receive Intervention|1|||
164686856|NCT01320722|594876577|FG003|Overall Study|Did not Receive Intervention|1|||
164686857|NCT01320722|594876578|FG004|Overall Study|Did not Receive Intervention|2|||
164686858|NCT01320722|594876574|FG000|Overall Study|Lost to Follow-up|0|||
164686859|NCT01320722|594876575|FG001|Overall Study|Lost to Follow-up|1|||
164686860|NCT01320722|594876576|FG002|Overall Study|Lost to Follow-up|0|||
164686861|NCT01320722|594876577|FG003|Overall Study|Lost to Follow-up|1|||
164686862|NCT01320722|594876578|FG004|Overall Study|Lost to Follow-up|3|||
164686863|NCT01320722|594876574|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
164686864|NCT01320722|594876575|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
164686865|NCT01320722|594876576|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
164686866|NCT01320722|594876577|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
164686867|NCT01320722|594876578|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
164686868|NCT01320722|594876574|FG000|Overall Study|Participant Developed a Rash|0|||
164686869|NCT01320722|594876575|FG001|Overall Study|Participant Developed a Rash|0|||
164686870|NCT01320722|594876576|FG002|Overall Study|Participant Developed a Rash|2|||
164686871|NCT01320722|594876577|FG003|Overall Study|Participant Developed a Rash|1|||
164686872|NCT01320722|594876578|FG004|Overall Study|Participant Developed a Rash|1|||
164686873|NCT01320722|594876574|FG000|Overall Study|Non-compliant with Medication|0|||
164686874|NCT01320722|594876575|FG001|Overall Study|Non-compliant with Medication|0|||
164686875|NCT01320722|594876576|FG002|Overall Study|Non-compliant with Medication|1|||
164686876|NCT01320722|594876577|FG003|Overall Study|Non-compliant with Medication|0|||
164686877|NCT01320722|594876578|FG004|Overall Study|Non-compliant with Medication|0|||
164686878|NCT01320722|594876574|FG000|Overall Study|Adverse Event|0|||
164686879|NCT01320722|594876575|FG001|Overall Study|Adverse Event|0|||
164686880|NCT01320722|594876576|FG002|Overall Study|Adverse Event|3|||
164686881|NCT01320722|594876577|FG003|Overall Study|Adverse Event|6|||
164686882|NCT01320722|594876578|FG004|Overall Study|Adverse Event|0|||
164686883|NCT01320722|594876574|FG000|Overall Study|Not Compliant with Study Procedures|0|||
164686884|NCT01320722|594876575|FG001|Overall Study|Not Compliant with Study Procedures|0|||
164686885|NCT01320722|594876576|FG002|Overall Study|Not Compliant with Study Procedures|0|||
164686886|NCT01320722|594876577|FG003|Overall Study|Not Compliant with Study Procedures|4|||
164686887|NCT01320722|594876578|FG004|Overall Study|Not Compliant with Study Procedures|0|||
164686888|NCT01320722|594876574|FG000|Overall Study|Pregnancy|0|||
164686889|NCT01320722|594876575|FG001|Overall Study|Pregnancy|0|||
164686890|NCT01320722|594876576|FG002|Overall Study|Pregnancy|0|||
164686891|NCT01320722|594876577|FG003|Overall Study|Pregnancy|1|||
164686892|NCT01320722|594876578|FG004|Overall Study|Pregnancy|0|||
164686893|NCT01320722|594876574|FG000|Overall Study|Started an Exclusionary Medication|0|||
164686894|NCT01320722|594876575|FG001|Overall Study|Started an Exclusionary Medication|0|||
164686895|NCT01320722|594876576|FG002|Overall Study|Started an Exclusionary Medication|0|||
164686896|NCT01320722|594876577|FG003|Overall Study|Started an Exclusionary Medication|0|||
164686897|NCT01320722|594876578|FG004|Overall Study|Started an Exclusionary Medication|1|||
164686898|NCT01320722|594876574|FG000|Overall Study|Withdrew due to Health Condition|0|||
164686899|NCT01320722|594876575|FG001|Overall Study|Withdrew due to Health Condition|0|||
164686900|NCT01320722|594876576|FG002|Overall Study|Withdrew due to Health Condition|0|||
164686901|NCT01320722|594876577|FG003|Overall Study|Withdrew due to Health Condition|0|||
164686902|NCT01320722|594876578|FG004|Overall Study|Withdrew due to Health Condition|1|||
164686903|NCT03980522|594876579|FG000|Treatment Period|Adverse Event|1|||
164686904|NCT03980522|594876580|FG001|Treatment Period|Adverse Event|0|||
164686905|NCT03980522|594876581|FG002|Treatment Period|Adverse Event|0|||
164686906|NCT03980522|594876582|FG003|Treatment Period|Adverse Event|0|||
164686907|NCT03980522|594876583|FG004|Treatment Period|Adverse Event|0|||
164686908|NCT01091363|594876584|FG000|Overall Study|Withdrawal by Subject|11|||
164686909|NCT01091363|594876585|FG001|Overall Study|Withdrawal by Subject|15|||
164686910|NCT01091363|594876584|FG000|Overall Study|Lost to Follow-up|2|||
164686911|NCT01091363|594876585|FG001|Overall Study|Lost to Follow-up|2|||
164686912|NCT00160524|594876586|FG000|Overall Study|Adverse Event|119|||
164686913|NCT00160524|594876586|FG000|Overall Study|Adverse Event and Other|94|||
164686914|NCT00160524|594876586|FG000|Overall Study|Protocol Violation|16|||
164686915|NCT00160524|594876586|FG000|Overall Study|Protocol Violation and Other|2|||
164686916|NCT00160524|594876586|FG000|Overall Study|Withdrawal by Subject|141|||
164686917|NCT00160524|594876586|FG000|Overall Study|Withdrawal by Subject and Other|17|||
164686918|NCT00160524|594876586|FG000|Overall Study|Physician Decision|27|||
164686919|NCT00160524|594876586|FG000|Overall Study|Physician Decision and Other|6|||
164686920|NCT00160524|594876586|FG000|Overall Study|Lost to Follow-up|13|||
164686921|NCT00160524|594876586|FG000|Overall Study|Lost to Follow-up and Other|1|||
164686922|NCT00160524|594876586|FG000|Overall Study|Lack of Efficacy|21|||
164686923|NCT00160524|594876586|FG000|Overall Study|Lack of Efficacy and Other|1|||
164686924|NCT00160524|594876586|FG000|Overall Study|Other|20|||
164686925|NCT00021541|594876587|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
164686926|NCT00021541|594876588|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
164686927|NCT00021541|594876587|FG000|Period 1-First Treatment|Adverse Event|2|||
164686928|NCT00021541|594876588|FG001|Period 1-First Treatment|Adverse Event|1|||
164686929|NCT00021541|594876587|FG000|Period 1-First Treatment|non-adherence|3|||
164686930|NCT00021541|594876588|FG001|Period 1-First Treatment|non-adherence|0|||
164686931|NCT00021541|594876587|FG000|Period 1-First Treatment|Death|1|||
164686932|NCT00021541|594876588|FG001|Period 1-First Treatment|Death|0|||
164686933|NCT00021541|594876587|FG000|Period 1-First Treatment|Pts that did not progress|2|||
164686934|NCT00021541|594876588|FG001|Period 1-First Treatment|Pts that did not progress|2|||
164686935|NCT00021541|594876587|FG000|Period 1-First Treatment|Ineligible|0|||
164686936|NCT00021541|594876588|FG001|Period 1-First Treatment|Ineligible|2|||
164686937|NCT00021541|594876587|FG000|Period 2-crossover|refused phase B|2|||
164686938|NCT00021541|594876588|FG001|Period 2-crossover|refused phase B|2|||
164686939|NCT00021541|594876587|FG000|Period 2-crossover|Withdrawal by Subject|3|||
164686940|NCT00021541|594876588|FG001|Period 2-crossover|Withdrawal by Subject|4|||
164686941|NCT00021541|594876587|FG000|Period 2-crossover|Adverse Event|2|||
164686942|NCT00021541|594876588|FG001|Period 2-crossover|Adverse Event|2|||
164686943|NCT00021541|594876587|FG000|Period 2-crossover|non-adherence|1|||
164686944|NCT00021541|594876588|FG001|Period 2-crossover|non-adherence|0|||
164686945|NCT00021541|594876587|FG000|Period 2-crossover|Pts that did not progress|2|||
164686946|NCT00021541|594876588|FG001|Period 2-crossover|Pts that did not progress|3|||
164686947|NCT04892147|594876589|FG000|Overall Study|Withdrawal by Subject|2|||
164686948|NCT04892147|594876590|FG001|Overall Study|Withdrawal by Subject|0|||
164686949|NCT01215721|594876592|FG000|Overall Study|Adverse Event|2|||
164686950|NCT00045162|594876593|FG000|Overall Study|Ineligible|12|||
164686951|NCT00045162|594876594|FG001|Overall Study|Ineligible|8|||
164686952|NCT00045162|594876593|FG000|Overall Study|Not treated|7|||
164686953|NCT00045162|594876594|FG001|Overall Study|Not treated|2|||
164686954|NCT00045162|594876593|FG000|Overall Study|Adverse Event|55|||
164686955|NCT00045162|594876594|FG001|Overall Study|Adverse Event|50|||
164686956|NCT00045162|594876593|FG000|Overall Study|Lack of Efficacy|32|||
164686957|NCT00045162|594876594|FG001|Overall Study|Lack of Efficacy|29|||
164686958|NCT00045162|594876593|FG000|Overall Study|Death|10|||
164686959|NCT00045162|594876594|FG001|Overall Study|Death|10|||
164686960|NCT00045162|594876593|FG000|Overall Study|Withdrawal by Subject|5|||
164686961|NCT00045162|594876594|FG001|Overall Study|Withdrawal by Subject|3|||
164686962|NCT00045162|594876593|FG000|Overall Study|Other|21|||
164686963|NCT00045162|594876594|FG001|Overall Study|Other|16|||
164686964|NCT01044433|594876595|FG000|Overall Study|Lost to Follow-up|3|||
164686965|NCT01044433|594876595|FG000|Overall Study|Withdrawal by Subject|3|||
164686966|NCT05263505|594876596|FG000|Overall Study|Adverse Event|0|||
164686967|NCT05263505|594876597|FG001|Overall Study|Adverse Event|1|||
164686968|NCT00826241|594876598|FG000|Overall Study|Withdrawal from Follow-up|1|||
164686969|NCT00826241|594876598|FG000|Overall Study|Withdrew consent|2|||
164686970|NCT00826241|594876598|FG000|Overall Study|Death|4|||
164686971|NCT00826241|594876598|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
164686972|NCT00826241|594876598|FG000|Overall Study|Non-compliance|1|||
164686973|NCT00826241|594876598|FG000|Overall Study|Progression of disease|1|||
164686974|NCT00826241|594876598|FG000|Overall Study|Patient refused follow-up|3|||
164686975|NCT00826241|594876598|FG000|Overall Study|Lost to Follow-up|9|||
164686976|NCT00826241|594876598|FG000|Overall Study|Could not obtain records|1|||
164686977|NCT00826241|594876598|FG000|Overall Study|Screen failure|2|||
164686978|NCT00826241|594876598|FG000|Overall Study|Pt unable to proceed to registration|1|||
164686979|NCT00826241|594876598|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
164686980|NCT03407729|594876599|FG000|Overall Study|Lost to Follow-up|2|||
164686981|NCT03407729|594876600|FG001|Overall Study|Lost to Follow-up|0|||
164686982|NCT03407729|594876599|FG000|Overall Study|Unable to schedule|0|||
164686983|NCT03407729|594876600|FG001|Overall Study|Unable to schedule|3|||
164686984|NCT01849458|594876601|FG000|Overall Study|Lost to Follow-up|4|||
164686985|NCT01050764|594876604|FG000|Overall Study|Death, before HSCT|1|||
164686986|NCT01050764|594876604|FG000|Overall Study|Donor mobilization failure, death|1|||
164686987|NCT01050764|594876604|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
164686988|NCT00360490|594876609|FG000|Overall Study|Adverse Event|4|||
164686989|NCT00360490|594876610|FG001|Overall Study|Adverse Event|2|||
164686990|NCT00360490|594876609|FG000|Overall Study|Lost to Follow-up|2|||
164686991|NCT00360490|594876610|FG001|Overall Study|Lost to Follow-up|1|||
164686992|NCT00360490|594876609|FG000|Overall Study|Physician Decision|2|||
164686993|NCT00360490|594876610|FG001|Overall Study|Physician Decision|1|||
164686994|NCT00360490|594876609|FG000|Overall Study|Protocol Violation|0|||
164686995|NCT00360490|594876610|FG001|Overall Study|Protocol Violation|4|||
164686996|NCT00360490|594876609|FG000|Overall Study|Withdrawal by Subject|1|||
164686997|NCT00360490|594876610|FG001|Overall Study|Withdrawal by Subject|3|||
164686998|NCT02289820|594876611|FG000|Overall Study|Withdrawal by Subject|2|||
164686999|NCT02289820|594876612|FG001|Overall Study|Withdrawal by Subject|1|||
164687000|NCT02289820|594876613|FG002|Overall Study|Withdrawal by Subject|2|||
164687001|NCT02289820|594876614|FG003|Overall Study|Withdrawal by Subject|1|||
164687002|NCT02289820|594876615|FG004|Overall Study|Withdrawal by Subject|0|||
164687003|NCT02289820|594876616|FG005|Overall Study|Withdrawal by Subject|0|||
164687004|NCT02289820|594876617|FG006|Overall Study|Withdrawal by Subject|1|||
164687005|NCT02289820|594876611|FG000|Overall Study|Death|0|||
164687006|NCT02289820|594876612|FG001|Overall Study|Death|0|||
164687007|NCT02289820|594876613|FG002|Overall Study|Death|1|||
164687008|NCT02289820|594876614|FG003|Overall Study|Death|0|||
164687009|NCT02289820|594876615|FG004|Overall Study|Death|0|||
164687010|NCT02289820|594876616|FG005|Overall Study|Death|0|||
164687011|NCT02289820|594876617|FG006|Overall Study|Death|0|||
164687012|NCT02289820|594876611|FG000|Overall Study|Lost to Follow-up|0|||
164687013|NCT02289820|594876612|FG001|Overall Study|Lost to Follow-up|0|||
164687014|NCT02289820|594876613|FG002|Overall Study|Lost to Follow-up|3|||
164687015|NCT02289820|594876614|FG003|Overall Study|Lost to Follow-up|1|||
164687016|NCT02289820|594876615|FG004|Overall Study|Lost to Follow-up|0|||
164687017|NCT02289820|594876616|FG005|Overall Study|Lost to Follow-up|1|||
164687018|NCT02289820|594876617|FG006|Overall Study|Lost to Follow-up|1|||
164687019|NCT02289820|594876611|FG000|Overall Study|withdrawal of consent|0|||
164687020|NCT02289820|594876612|FG001|Overall Study|withdrawal of consent|1|||
164687021|NCT02289820|594876613|FG002|Overall Study|withdrawal of consent|0|||
164687022|NCT02289820|594876614|FG003|Overall Study|withdrawal of consent|0|||
164687023|NCT02289820|594876615|FG004|Overall Study|withdrawal of consent|0|||
164687024|NCT02289820|594876616|FG005|Overall Study|withdrawal of consent|0|||
164687025|NCT02289820|594876617|FG006|Overall Study|withdrawal of consent|0|||
164687026|NCT02005276|594876618|FG000|Overall Study|No longer interested|5|||
164687027|NCT02005276|594876619|FG001|Overall Study|No longer interested|2|||
164687028|NCT02005276|594876620|FG002|Overall Study|No longer interested|3|||
164687029|NCT02005276|594876621|FG003|Overall Study|No longer interested|3|||
164687030|NCT01929681|594876628|FG000|Overall Study|Withdrawal by Subject|1|||
164687031|NCT01929681|594876629|FG001|Overall Study|Withdrawal by Subject|0|||
164687032|NCT01929681|594876628|FG000|Overall Study|Physician Decision|1|||
164687033|NCT01929681|594876629|FG001|Overall Study|Physician Decision|1|||
164687034|NCT00556673|594876631|FG000|Overall Study|Protocol deviation|3|||
164687035|NCT00556673|594876632|FG001|Overall Study|Protocol deviation|2|||
164687036|NCT01971554|594876633|FG000|Overall Study|Lost to Follow-up|1|||
164687037|NCT01971554|594876634|FG001|Overall Study|Lost to Follow-up|0|||
164687038|NCT01971554|594876635|FG002|Overall Study|Lost to Follow-up|0|||
164687039|NCT01971554|594876636|FG003|Overall Study|Lost to Follow-up|0|||
164687040|NCT00950300|594876638|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
164687041|NCT00950300|594876639|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
164687042|NCT00950300|594876638|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
164687043|NCT00950300|594876639|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
164687044|NCT00950300|594876638|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
164687045|NCT00950300|594876639|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
164687046|NCT00950300|594876638|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
164687047|NCT00950300|594876639|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
164687048|NCT00950300|594876638|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
164687049|NCT00950300|594876639|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
164687050|NCT00950300|594876638|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
164687051|NCT00950300|594876639|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
164687052|NCT00950300|594876638|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
164687053|NCT00950300|594876639|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
164687054|NCT00950300|594876638|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
164687055|NCT00950300|594876639|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
164687056|NCT00950300|594876638|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
164687057|NCT00950300|594876639|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
164687058|NCT00950300|594876638|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
164687059|NCT00950300|594876639|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
164687060|NCT00950300|594876638|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
164687061|NCT00950300|594876639|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
164687062|NCT00950300|594876638|FG000|TFFU Period|Death|4|||
164687063|NCT00950300|594876639|FG001|TFFU Period|Death|1|||
164687064|NCT00950300|594876638|FG000|TFFU Period|Refused Treatment|10|||
164687065|NCT00950300|594876639|FG001|TFFU Period|Refused Treatment|11|||
164687066|NCT00950300|594876638|FG000|TFFU Period|Failure to Return|16|||
164687067|NCT00950300|594876639|FG001|TFFU Period|Failure to Return|16|||
164687068|NCT00950300|594876638|FG000|TFFU Period|Recurrence of Disease|63|||
164687069|NCT00950300|594876639|FG001|TFFU Period|Recurrence of Disease|72|||
164687070|NCT00950300|594876638|FG000|TFFU Period|Other|4|||
164687071|NCT00950300|594876639|FG001|TFFU Period|Other|3|||
164687072|NCT00950300|594876638|FG000|SFU Period|Death|44|||
164687073|NCT00950300|594876639|FG001|SFU Period|Death|42|||
164687074|NCT00950300|594876638|FG000|SFU Period|Lost to Follow-up|30|||
164687075|NCT00950300|594876639|FG001|SFU Period|Lost to Follow-up|28|||
164687076|NCT00950300|594876638|FG000|SFU Period|Withdrawal by Subject|4|||
164687077|NCT00950300|594876639|FG001|SFU Period|Withdrawal by Subject|8|||
164687078|NCT04194151|594876640|FG000|Overall Study|Physician Decision|1|||
164687079|NCT04194151|594876641|FG001|Overall Study|Physician Decision|1|||
164687080|NCT04194151|594876642|FG002|Overall Study|Physician Decision|1|||
164687081|NCT04194151|594876643|FG003|Overall Study|Physician Decision|1|||
164687082|NCT04194151|594876644|FG004|Overall Study|Physician Decision|0|||
164687083|NCT04194151|594876645|FG005|Overall Study|Physician Decision|1|||
164687084|NCT04194151|594876640|FG000|Overall Study|Monitorization problem|0|||
164687085|NCT04194151|594876641|FG001|Overall Study|Monitorization problem|1|||
164687086|NCT04194151|594876642|FG002|Overall Study|Monitorization problem|0|||
164687087|NCT04194151|594876643|FG003|Overall Study|Monitorization problem|0|||
164687088|NCT04194151|594876644|FG004|Overall Study|Monitorization problem|0|||
164687089|NCT04194151|594876645|FG005|Overall Study|Monitorization problem|0|||
164687090|NCT00087529|594876647|FG000|Overall Study|Death|1|||
164687091|NCT00087529|594876648|FG001|Overall Study|Death|0|||
164687092|NCT00087529|594876647|FG000|Overall Study|Adverse Event|0|||
164687093|NCT00087529|594876648|FG001|Overall Study|Adverse Event|8|||
164687094|NCT00087529|594876647|FG000|Overall Study|Pregnancy|0|||
164687095|NCT00087529|594876648|FG001|Overall Study|Pregnancy|1|||
164687096|NCT00087529|594876647|FG000|Overall Study|Lost to Follow-up|2|||
164687097|NCT00087529|594876648|FG001|Overall Study|Lost to Follow-up|3|||
164687098|NCT00087529|594876647|FG000|Overall Study|Participant Decision|14|||
164687099|NCT00087529|594876648|FG001|Overall Study|Participant Decision|37|||
164687100|NCT00087529|594876647|FG000|Overall Study|Physician Decision|4|||
164687101|NCT00087529|594876648|FG001|Overall Study|Physician Decision|8|||
164687102|NCT00087529|594876647|FG000|Overall Study|Initiation of Excluded Therapy|0|||
164687103|NCT00087529|594876648|FG001|Overall Study|Initiation of Excluded Therapy|1|||
164687104|NCT00087529|594876647|FG000|Overall Study|Participant Noncompliance|0|||
164687105|NCT00087529|594876648|FG001|Overall Study|Participant Noncompliance|1|||
164687106|NCT00087529|594876647|FG000|Overall Study|Disease Progression|5|||
164687107|NCT00087529|594876648|FG001|Overall Study|Disease Progression|4|||
164687108|NCT00087529|594876647|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
164687109|NCT00087529|594876648|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
164687110|NCT04388787|594876649|FG000|Blinded Period|Patient could not follow instructions|1|||
164687111|NCT04388787|594876649|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
164687112|NCT02129062|594878171|FG000|Overall Study|Death|1|||
164269669|NCT00576472|593356740|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
164269670|NCT00576472|593356741|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
164342013|NCT05248867|593627596|FG004|Open-label Period|Withdrawal by Subject|7|||
164342014|NCT05248867|593627597|FG005|Open-label Period|Withdrawal by Subject|9|||
164342015|NCT05248867|593627592|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
164342016|NCT05248867|593627593|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
164342017|NCT05248867|593627594|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
164342018|NCT05248867|593627595|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
164342019|NCT05248867|593627596|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
164342020|NCT05248867|593627597|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
164342021|NCT05248867|593627592|FG000|Open-label Period|Lost to Follow-up|0|||
164342022|NCT05248867|593627593|FG001|Open-label Period|Lost to Follow-up|0|||
164342023|NCT05248867|593627594|FG002|Open-label Period|Lost to Follow-up|0|||
164581458|NCT00923091|594493952|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
164581459|NCT00923091|594493953|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
164581460|NCT00923091|594493954|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
164581461|NCT00923091|594493955|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
164581462|NCT00923091|594493956|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
164581463|NCT00923091|594493957|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
164581464|NCT00923091|594493945|FG000|Period VI (Open-Label)|Protocol Violation|6|||
164581465|NCT00923091|594493946|FG001|Period VI (Open-Label)|Protocol Violation|1|||
164581466|NCT00923091|594493947|FG002|Period VI (Open-Label)|Protocol Violation|3|||
164581467|NCT00923091|594493948|FG003|Period VI (Open-Label)|Protocol Violation|1|||
164581468|NCT00923091|594493949|FG004|Period VI (Open-Label)|Protocol Violation|4|||
164581469|NCT00923091|594493950|FG005|Period VI (Open-Label)|Protocol Violation|0|||
164581470|NCT00923091|594493951|FG006|Period VI (Open-Label)|Protocol Violation|0|||
164581471|NCT00923091|594493952|FG007|Period VI (Open-Label)|Protocol Violation|0|||
164581472|NCT00923091|594493953|FG008|Period VI (Open-Label)|Protocol Violation|0|||
164581473|NCT00923091|594493954|FG009|Period VI (Open-Label)|Protocol Violation|0|||
164581474|NCT00923091|594493955|FG010|Period VI (Open-Label)|Protocol Violation|0|||
164687113|NCT02129062|594878171|FG000|Overall Study|Disease Progression|2|||
164687114|NCT04662710|594878172|FG000|Overall Study|Death|14|||
164687115|NCT04662710|594878173|FG001|Overall Study|Death|331|||
164687116|NCT04662710|594878174|FG002|Overall Study|Death|367|||
164687117|NCT04662710|594878172|FG000|Overall Study|Ongoing|1|||
164269671|NCT00576472|593356742|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
164269672|NCT00576472|593356743|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
164269673|NCT00576472|593356744|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
164269674|NCT00576472|593356745|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
164269675|NCT00576472|593356746|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
164269676|NCT00576472|593356732|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
164269677|NCT00576472|593356733|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
164269678|NCT00576472|593356734|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
164269679|NCT00576472|593356735|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
164269680|NCT00576472|593356736|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
164269681|NCT00576472|593356737|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
164581475|NCT00923091|594493956|FG011|Period VI (Open-Label)|Protocol Violation|0|||
164687118|NCT04662710|594878173|FG001|Overall Study|Ongoing|109|||
164687119|NCT04662710|594878174|FG002|Overall Study|Ongoing|56|||
164581476|NCT00923091|594493957|FG012|Period VI (Open-Label)|Protocol Violation|0|||
164581477|NCT00923091|594493945|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
164430788|NCT00430677|593947312|FG001|Short-term Period|Withdrawal by Subject|1|||
164430789|NCT00430677|593947313|FG002|Short-term Period|Withdrawal by Subject|2|||
164430790|NCT00430677|593947311|FG000|Short-term Period|Participant no longer met study criteria|1|||
164430791|NCT00430677|593947312|FG001|Short-term Period|Participant no longer met study criteria|1|||
164430792|NCT00430677|593947313|FG002|Short-term Period|Participant no longer met study criteria|2|||
164430793|NCT00430677|593947311|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
164430794|NCT00430677|593947312|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
164430795|NCT00430677|593947313|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
164430796|NCT00430677|593947311|FG000|Short-term Period|Pregnancy|0|||
164430797|NCT00430677|593947312|FG001|Short-term Period|Pregnancy|2|||
164430798|NCT00430677|593947313|FG002|Short-term Period|Pregnancy|0|||
164430799|NCT00430677|593947311|FG000|Long-term Extension Period|Death|1|||
164430800|NCT00430677|593947312|FG001|Long-term Extension Period|Death|0|||
164430801|NCT00430677|593947313|FG002|Long-term Extension Period|Death|0|||
164430802|NCT00430677|593947311|FG000|Long-term Extension Period|Adverse Event|3|||
164430803|NCT00430677|593947312|FG001|Long-term Extension Period|Adverse Event|2|||
164430804|NCT00430677|593947313|FG002|Long-term Extension Period|Adverse Event|5|||
164430805|NCT00430677|593947311|FG000|Long-term Extension Period|Lack of Efficacy|5|||
164430806|NCT00430677|593947312|FG001|Long-term Extension Period|Lack of Efficacy|3|||
164687120|NCT04662710|594878172|FG000|Overall Study|Withdrawal by Subject|0|||
164687121|NCT04662710|594878173|FG001|Overall Study|Withdrawal by Subject|3|||
164687122|NCT04662710|594878174|FG002|Overall Study|Withdrawal by Subject|14|||
164687123|NCT00224484|594878176|FG000|Overall Study|Serious Adverse Event|1|||
164687124|NCT00224484|594878177|FG001|Overall Study|Serious Adverse Event|1|||
164687125|NCT00224484|594878178|FG002|Overall Study|Serious Adverse Event|0|||
164687126|NCT00224484|594878176|FG000|Overall Study|Non-Serious Adverse Event|5|||
164687127|NCT00224484|594878177|FG001|Overall Study|Non-Serious Adverse Event|7|||
164687128|NCT00224484|594878178|FG002|Overall Study|Non-Serious Adverse Event|3|||
164269682|NCT00576472|593356738|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
164269683|NCT00576472|593356739|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
164269684|NCT00576472|593356740|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
164269685|NCT00576472|593356741|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
164269686|NCT00576472|593356742|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
164269687|NCT00576472|593356743|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
164269688|NCT00576472|593356744|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
164269689|NCT00576472|593356745|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
164269690|NCT00576472|593356746|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
164269691|NCT00576472|593356732|FG000|MPH Home Maintenance Phase|Side effects|0|||
164269692|NCT00576472|593356733|FG001|MPH Home Maintenance Phase|Side effects|0|||
164269693|NCT00576472|593356734|FG002|MPH Home Maintenance Phase|Side effects|0|||
164269694|NCT00576472|593356735|FG003|MPH Home Maintenance Phase|Side effects|0|||
164269695|NCT00576472|593356736|FG004|MPH Home Maintenance Phase|Side effects|0|||
164269696|NCT00576472|593356737|FG005|MPH Home Maintenance Phase|Side effects|0|||
164269697|NCT00576472|593356738|FG006|MPH Home Maintenance Phase|Side effects|0|||
164269698|NCT00576472|593356739|FG007|MPH Home Maintenance Phase|Side effects|0|||
164269699|NCT00576472|593356740|FG008|MPH Home Maintenance Phase|Side effects|0|||
164269700|NCT00576472|593356741|FG009|MPH Home Maintenance Phase|Side effects|0|||
164269701|NCT00576472|593356742|FG010|MPH Home Maintenance Phase|Side effects|0|||
164269702|NCT00576472|593356743|FG011|MPH Home Maintenance Phase|Side effects|0|||
164269703|NCT00576472|593356744|FG012|MPH Home Maintenance Phase|Side effects|0|||
164269704|NCT00576472|593356745|FG013|MPH Home Maintenance Phase|Side effects|0|||
164269705|NCT00576472|593356746|FG014|MPH Home Maintenance Phase|Side effects|8|||
164269706|NCT00576472|593356732|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269707|NCT00576472|593356733|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269708|NCT00576472|593356734|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269709|NCT00576472|593356735|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269710|NCT00576472|593356736|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269711|NCT00576472|593356737|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269712|NCT00576472|593356738|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269713|NCT00576472|593356739|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269714|NCT00576472|593356740|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269715|NCT00576472|593356741|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269716|NCT00576472|593356742|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269717|NCT00576472|593356743|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269718|NCT00576472|593356744|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269719|NCT00576472|593356745|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269720|NCT00576472|593356746|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
164269721|NCT00576472|593356732|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
164269722|NCT00576472|593356733|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
164269723|NCT00576472|593356734|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
164269724|NCT00576472|593356735|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
164269725|NCT00576472|593356736|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
164687129|NCT00224484|594878176|FG000|Overall Study|Protocol Violation|2|||
164687130|NCT00224484|594878177|FG001|Overall Study|Protocol Violation|2|||
164687131|NCT00224484|594878178|FG002|Overall Study|Protocol Violation|0|||
164687132|NCT00224484|594878176|FG000|Overall Study|Withdrawal by Subject|49|||
164687133|NCT00224484|594878177|FG001|Overall Study|Withdrawal by Subject|18|||
164687134|NCT00224484|594878178|FG002|Overall Study|Withdrawal by Subject|16|||
164687135|NCT00224484|594878176|FG000|Overall Study|Migrated/moved from study area|18|||
164687136|NCT00224484|594878177|FG001|Overall Study|Migrated/moved from study area|5|||
164687137|NCT00224484|594878178|FG002|Overall Study|Migrated/moved from study area|5|||
164687138|NCT00224484|594878176|FG000|Overall Study|Lost to Follow-up|66|||
164687139|NCT00224484|594878177|FG001|Overall Study|Lost to Follow-up|28|||
164687140|NCT00224484|594878178|FG002|Overall Study|Lost to Follow-up|36|||
164687141|NCT00224484|594878176|FG000|Overall Study|Reason not specified|5|||
164687142|NCT00224484|594878177|FG001|Overall Study|Reason not specified|4|||
164687143|NCT00224484|594878178|FG002|Overall Study|Reason not specified|2|||
164687144|NCT00108628|594878181|FG000|Overall Study|Withdrawal by Subject|17|||
164687145|NCT00108628|594878182|FG001|Overall Study|Withdrawal by Subject|9|||
164687146|NCT00108628|594878181|FG000|Overall Study|Lack of Efficacy|2|||
164687147|NCT00108628|594878182|FG001|Overall Study|Lack of Efficacy|1|||
164687148|NCT00108628|594878181|FG000|Overall Study|Death|1|||
164687149|NCT00108628|594878182|FG001|Overall Study|Death|0|||
164687150|NCT01453153|594878183|FG000|Overall Study|Physician Decision|0|||
164687151|NCT01453153|594878184|FG001|Overall Study|Physician Decision|0|||
164687152|NCT01453153|594878185|FG002|Overall Study|Physician Decision|1|||
164687153|NCT01453153|594878183|FG000|Overall Study|Progressive Disease|3|||
164581478|NCT00923091|594493946|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
164581479|NCT00923091|594493947|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
164581480|NCT00923091|594493948|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
164581481|NCT00923091|594493949|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
164581482|NCT00923091|594493950|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
164581483|NCT00923091|594493951|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
164581484|NCT00923091|594493952|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
164581485|NCT00923091|594493953|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
164581486|NCT00923091|594493954|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
164581487|NCT00923091|594493955|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
164581488|NCT00923091|594493956|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
164581489|NCT00923091|594493957|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
164581490|NCT00923091|594493945|FG000|Period VI (Open-Label)|Other Reason|0|||
164581491|NCT00923091|594493946|FG001|Period VI (Open-Label)|Other Reason|0|||
164581492|NCT00923091|594493947|FG002|Period VI (Open-Label)|Other Reason|0|||
164581493|NCT00923091|594493948|FG003|Period VI (Open-Label)|Other Reason|1|||
164581494|NCT00923091|594493949|FG004|Period VI (Open-Label)|Other Reason|1|||
164581495|NCT00923091|594493950|FG005|Period VI (Open-Label)|Other Reason|0|||
164581496|NCT00923091|594493951|FG006|Period VI (Open-Label)|Other Reason|0|||
164581497|NCT00923091|594493952|FG007|Period VI (Open-Label)|Other Reason|0|||
164581498|NCT00923091|594493953|FG008|Period VI (Open-Label)|Other Reason|0|||
164581499|NCT00923091|594493954|FG009|Period VI (Open-Label)|Other Reason|0|||
164581500|NCT00923091|594493955|FG010|Period VI (Open-Label)|Other Reason|0|||
164581501|NCT00923091|594493956|FG011|Period VI (Open-Label)|Other Reason|0|||
164581502|NCT00923091|594493957|FG012|Period VI (Open-Label)|Other Reason|0|||
164581503|NCT04246047|594493961|FG000|Overall Study|Death|50|||
164581504|NCT04246047|594493962|FG001|Overall Study|Death|77|||
164581505|NCT04246047|594493961|FG000|Overall Study|Lost to Follow-up|1|||
164581506|NCT04246047|594493962|FG001|Overall Study|Lost to Follow-up|3|||
164581507|NCT04246047|594493961|FG000|Overall Study|Physician Decision|4|||
164581508|NCT04246047|594493962|FG001|Overall Study|Physician Decision|10|||
164581509|NCT04246047|594493961|FG000|Overall Study|Withdrawal by Subject|19|||
164581510|NCT04246047|594493962|FG001|Overall Study|Withdrawal by Subject|26|||
164581511|NCT04246047|594493961|FG000|Overall Study|Ongoing|169|||
164581512|NCT04246047|594493962|FG001|Overall Study|Ongoing|135|||
164581513|NCT02111369|594493965|FG000|Overall Study|Lost to Follow-up|2|||
164581514|NCT02111369|594493965|FG000|Overall Study|Withdrawal by Subject|1|||
164581515|NCT05270265|594493966|FG000|Overall Study|Lost to Follow-up|0|||
164581516|NCT05270265|594493967|FG001|Overall Study|Lost to Follow-up|1|||
164687154|NCT01453153|594878184|FG001|Overall Study|Progressive Disease|2|||
164687155|NCT01453153|594878185|FG002|Overall Study|Progressive Disease|16|||
164581517|NCT05270265|594493968|FG002|Overall Study|Lost to Follow-up|0|||
164581518|NCT00624338|594493971|FG000|Overall Study|Adverse Event|14|||
164581519|NCT00624338|594493972|FG001|Overall Study|Adverse Event|14|||
164581520|NCT00624338|594493973|FG002|Overall Study|Adverse Event|18|||
164581521|NCT00624338|594493971|FG000|Overall Study|Lost to Follow-up|1|||
164581522|NCT00624338|594493972|FG001|Overall Study|Lost to Follow-up|0|||
164581523|NCT00624338|594493973|FG002|Overall Study|Lost to Follow-up|0|||
164581524|NCT00624338|594493971|FG000|Overall Study|Lack of Efficacy|11|||
164581525|NCT00624338|594493972|FG001|Overall Study|Lack of Efficacy|3|||
164581526|NCT00624338|594493973|FG002|Overall Study|Lack of Efficacy|14|||
164581527|NCT00624338|594493971|FG000|Overall Study|Protocol Violation|3|||
164687156|NCT01453153|594878183|FG000|Overall Study|Withdrawal by Subject|0|||
164269726|NCT00576472|593356737|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
164269727|NCT00576472|593356738|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
164269728|NCT00576472|593356739|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
164269729|NCT00576472|593356740|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
164269730|NCT00576472|593356741|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
164269731|NCT00576472|593356742|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
164269732|NCT00576472|593356743|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
164269733|NCT00576472|593356744|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
164269734|NCT00576472|593356745|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
164269735|NCT00576472|593356746|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
164269736|NCT00576472|593356732|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164269737|NCT00576472|593356733|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164581528|NCT00624338|594493972|FG001|Overall Study|Protocol Violation|3|||
164581529|NCT00624338|594493973|FG002|Overall Study|Protocol Violation|2|||
164581530|NCT00624338|594493971|FG000|Overall Study|Death|0|||
164581531|NCT00624338|594493972|FG001|Overall Study|Death|2|||
164581532|NCT00624338|594493973|FG002|Overall Study|Death|0|||
164581533|NCT00624338|594493971|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
164581534|NCT00624338|594493972|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
164581535|NCT00624338|594493973|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
164581536|NCT00624338|594493971|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
164581537|NCT00624338|594493972|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
164581538|NCT00624338|594493973|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
164581539|NCT00624338|594493971|FG000|Overall Study|Other|15|||
164581540|NCT00624338|594493972|FG001|Overall Study|Other|5|||
164581541|NCT00624338|594493973|FG002|Overall Study|Other|9|||
164581542|NCT00624338|594493971|FG000|Overall Study|Randomized but not treated|2|||
164581543|NCT00624338|594493972|FG001|Overall Study|Randomized but not treated|1|||
164581544|NCT00624338|594493973|FG002|Overall Study|Randomized but not treated|3|||
164581545|NCT01933672|594493978|FG000|Metformin Run-in Period|Adverse Event|1|||
164581546|NCT01933672|594493979|FG001|Metformin Run-in Period|Adverse Event|0|||
164581547|NCT01933672|594493980|FG002|Metformin Run-in Period|Adverse Event|0|||
164581548|NCT01933672|594493981|FG003|Metformin Run-in Period|Adverse Event|0|||
164581549|NCT01933672|594493982|FG004|Metformin Run-in Period|Adverse Event|0|||
164581550|NCT01933672|594493983|FG005|Metformin Run-in Period|Adverse Event|0|||
164581551|NCT01933672|594493984|FG006|Metformin Run-in Period|Adverse Event|0|||
164581552|NCT01933672|594493978|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
164581553|NCT01933672|594493979|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
164581554|NCT01933672|594493980|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
164581555|NCT01933672|594493981|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
164581556|NCT01933672|594493982|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
164581557|NCT01933672|594493983|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
164581558|NCT01933672|594493984|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
164581559|NCT01933672|594493978|FG000|Metformin Run-in Period|Other|5|||
164581560|NCT01933672|594493979|FG001|Metformin Run-in Period|Other|0|||
164581561|NCT01933672|594493980|FG002|Metformin Run-in Period|Other|0|||
164581562|NCT01933672|594493981|FG003|Metformin Run-in Period|Other|0|||
164581563|NCT01933672|594493982|FG004|Metformin Run-in Period|Other|0|||
164581564|NCT01933672|594493983|FG005|Metformin Run-in Period|Other|0|||
164581565|NCT01933672|594493984|FG006|Metformin Run-in Period|Other|0|||
164581566|NCT01933672|594493978|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
164581567|NCT01933672|594493979|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
164581568|NCT01933672|594493980|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
164581569|NCT01933672|594493981|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
164581570|NCT01933672|594493982|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
164581571|NCT01933672|594493983|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
164581572|NCT01933672|594493984|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
164581573|NCT01933672|594493978|FG000|First Intervention Period (12-16 Days)|Other|0|||
164581574|NCT01933672|594493979|FG001|First Intervention Period (12-16 Days)|Other|0|||
164581575|NCT01933672|594493980|FG002|First Intervention Period (12-16 Days)|Other|1|||
164581576|NCT01933672|594493981|FG003|First Intervention Period (12-16 Days)|Other|0|||
164269738|NCT00576472|593356734|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164269739|NCT00576472|593356735|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164269740|NCT00576472|593356736|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164269741|NCT00576472|593356737|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164269742|NCT00576472|593356738|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164581577|NCT01933672|594493982|FG004|First Intervention Period (12-16 Days)|Other|0|||
164581578|NCT01933672|594493983|FG005|First Intervention Period (12-16 Days)|Other|1|||
164581579|NCT01933672|594493984|FG006|First Intervention Period (12-16 Days)|Other|0|||
164581580|NCT01933672|594493978|FG000|Second Intervention Period (12-16 Days)|Other|0|||
164581581|NCT01933672|594493979|FG001|Second Intervention Period (12-16 Days)|Other|1|||
164269743|NCT00576472|593356739|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164269744|NCT00576472|593356740|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164269745|NCT00576472|593356741|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164269746|NCT00576472|593356742|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164269747|NCT00576472|593356743|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164269748|NCT00576472|593356744|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164269749|NCT00576472|593356745|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164269750|NCT00576472|593356746|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
164269751|NCT03443427|593356747|FG000|Overall Study|Adverse Event|2|||
164269752|NCT03443427|593356748|FG001|Overall Study|Adverse Event|3|||
164269753|NCT03443427|593356747|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
164269754|NCT03443427|593356748|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
164269755|NCT03443427|593356747|FG000|Overall Study|Other|4|||
164269756|NCT03443427|593356748|FG001|Overall Study|Other|6|||
164269757|NCT04405245|593356750|FG000|Overall Study|Adverse Event|0|||
164269758|NCT04405245|593356751|FG001|Overall Study|Adverse Event|1|||
164269759|NCT04405245|593356752|FG002|Overall Study|Adverse Event|0|||
164269760|NCT02576860|593356755|FG000|Overall Study|Adverse Event|6|||
164269761|NCT02576860|593356756|FG001|Overall Study|Adverse Event|6|||
164269762|NCT02576860|593356755|FG000|Overall Study|Lost to Follow-up|5|||
164269763|NCT02576860|593356756|FG001|Overall Study|Lost to Follow-up|7|||
164269764|NCT02576860|593356755|FG000|Overall Study|Physician Decision|0|||
164269765|NCT02576860|593356756|FG001|Overall Study|Physician Decision|1|||
164269766|NCT02576860|593356755|FG000|Overall Study|Protocol Violation|0|||
164269767|NCT02576860|593356756|FG001|Overall Study|Protocol Violation|2|||
164430807|NCT00430677|593947313|FG002|Long-term Extension Period|Lack of Efficacy|8|||
164581582|NCT01933672|594493980|FG002|Second Intervention Period (12-16 Days)|Other|1|||
164581583|NCT01933672|594493981|FG003|Second Intervention Period (12-16 Days)|Other|0|||
164581584|NCT01933672|594493982|FG004|Second Intervention Period (12-16 Days)|Other|0|||
164581585|NCT01933672|594493983|FG005|Second Intervention Period (12-16 Days)|Other|0|||
164581586|NCT01933672|594493984|FG006|Second Intervention Period (12-16 Days)|Other|0|||
164581587|NCT01933672|594493978|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
164581588|NCT01933672|594493979|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
164581589|NCT01933672|594493980|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
164581590|NCT01933672|594493981|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
164581591|NCT01933672|594493982|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
164581592|NCT01933672|594493983|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
164581593|NCT01933672|594493984|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
164581594|NCT01933672|594493978|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
164581595|NCT01933672|594493979|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
164581596|NCT01933672|594493980|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
164581597|NCT01933672|594493981|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
164581598|NCT01933672|594493982|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
164581599|NCT01933672|594493983|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
164581600|NCT01933672|594493984|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
164581601|NCT00524303|594493985|FG000|Overall Study|Lost to Follow-up|6|||
164581602|NCT00524303|594493986|FG001|Overall Study|Lost to Follow-up|0|||
164581603|NCT00524303|594493987|FG002|Overall Study|Lost to Follow-up|3|||
164581604|NCT00524303|594493985|FG000|Overall Study|Protocol Violation|0|||
164581605|NCT00524303|594493986|FG001|Overall Study|Protocol Violation|1|||
164581606|NCT00524303|594493987|FG002|Overall Study|Protocol Violation|1|||
164581607|NCT00524303|594493985|FG000|Overall Study|Withdrawal by Subject|3|||
164581608|NCT00524303|594493986|FG001|Overall Study|Withdrawal by Subject|0|||
164581609|NCT00524303|594493987|FG002|Overall Study|Withdrawal by Subject|4|||
164581610|NCT00524303|594493985|FG000|Overall Study|Death|0|||
164581611|NCT00524303|594493986|FG001|Overall Study|Death|2|||
164581612|NCT00524303|594493987|FG002|Overall Study|Death|3|||
164581613|NCT00524303|594493985|FG000|Overall Study|Adverse Event|1|||
164581614|NCT00524303|594493986|FG001|Overall Study|Adverse Event|2|||
164581615|NCT00524303|594493987|FG002|Overall Study|Adverse Event|3|||
164581616|NCT00524303|594493985|FG000|Overall Study|Did not Complete Study Dosing|1|||
164581617|NCT00524303|594493986|FG001|Overall Study|Did not Complete Study Dosing|0|||
164581618|NCT00524303|594493987|FG002|Overall Study|Did not Complete Study Dosing|0|||
164581619|NCT00524303|594493985|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
164581620|NCT00524303|594493986|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
164581621|NCT00524303|594493987|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
164581622|NCT00524303|594493985|FG000|Overall Study|Disease Progression|0|||
164581623|NCT00524303|594493986|FG001|Overall Study|Disease Progression|4|||
164269768|NCT02576860|593356755|FG000|Overall Study|Withdrawal by Subject|13|||
164269769|NCT02576860|593356756|FG001|Overall Study|Withdrawal by Subject|8|||
164269770|NCT02576860|593356755|FG000|Overall Study|Disallowed medication|1|||
164269771|NCT02576860|593356756|FG001|Overall Study|Disallowed medication|0|||
164269772|NCT00780273|593356757|FG000|Overall Study|Death|1|||
164269773|NCT00780273|593356757|FG000|Overall Study|Lost to Follow-up|1|||
164269774|NCT02391961|593356758|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
164269775|NCT02391961|593356759|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
164269776|NCT02391961|593356758|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
164269777|NCT02391961|593356759|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
164269778|NCT02391961|593356758|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
164269779|NCT02391961|593356759|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
164269780|NCT00477269|593356760|FG000|Core Study|Adverse Event|6|||
164581624|NCT00524303|594493987|FG002|Overall Study|Disease Progression|1|||
164581625|NCT00524303|594493985|FG000|Overall Study|Disease Recurrence|0|||
164581626|NCT00524303|594493986|FG001|Overall Study|Disease Recurrence|1|||
164581627|NCT00524303|594493987|FG002|Overall Study|Disease Recurrence|0|||
164581628|NCT00524303|594493985|FG000|Overall Study|Sponsor Request|0|||
164581629|NCT00524303|594493986|FG001|Overall Study|Sponsor Request|0|||
164581630|NCT00524303|594493987|FG002|Overall Study|Sponsor Request|1|||
164581631|NCT00524303|594493985|FG000|Overall Study|Physician Decision|0|||
164581632|NCT00524303|594493986|FG001|Overall Study|Physician Decision|0|||
164581633|NCT00524303|594493987|FG002|Overall Study|Physician Decision|1|||
164581634|NCT00524303|594493985|FG000|Overall Study|Completed 5 years|0|||
164581635|NCT00524303|594493986|FG001|Overall Study|Completed 5 years|0|||
164581636|NCT00524303|594493987|FG002|Overall Study|Completed 5 years|1|||
164581637|NCT03497689|594493993|FG000|Overall Study|Adverse Event|2|||
164581638|NCT03497689|594493993|FG000|Overall Study|Death|1|||
164581639|NCT03497689|594493993|FG000|Overall Study|Physician Decision|1|||
164581640|NCT03497689|594493993|FG000|Overall Study|Withdrawal by Subject|1|||
164581641|NCT03497689|594493993|FG000|Overall Study|Protocol Violation|2|||
164581642|NCT03567187|594493994|FG000|Overall Study|Lost to Follow-up|18|||
164581643|NCT05369208|594494529|FG000|Core Phase|Prohibited Medication Required|2|||
164581644|NCT05369208|594494529|FG000|Core Phase|Adverse Event|1|||
164581645|NCT05369208|594494529|FG000|Core Phase|Lack of Efficacy|1|||
164581646|NCT05441670|594494530|FG000|Overall Study|Two participants completed intervention but not post-test due to ICU admit and family challenges.|0|||
164581647|NCT05441670|594494531|FG001|Overall Study|Two participants completed intervention but not post-test due to ICU admit and family challenges.|2|||
164581648|NCT00744055|594494534|FG000|Overall Study|Withdrawal by Subject|6|||
164581649|NCT00744055|594494535|FG001|Overall Study|Withdrawal by Subject|9|||
164581650|NCT00744055|594494534|FG000|Overall Study|Lack of Efficacy|0|||
164581651|NCT00744055|594494535|FG001|Overall Study|Lack of Efficacy|1|||
164581652|NCT00744055|594494534|FG000|Overall Study|Physician Decision|0|||
164581653|NCT00744055|594494535|FG001|Overall Study|Physician Decision|2|||
164581654|NCT00744055|594494534|FG000|Overall Study|Protocol Violation|1|||
164581655|NCT00744055|594494535|FG001|Overall Study|Protocol Violation|1|||
164581656|NCT00744055|594494534|FG000|Overall Study|Lost to Follow-up|0|||
164581657|NCT00744055|594494535|FG001|Overall Study|Lost to Follow-up|1|||
164581658|NCT01059812|594494542|FG000|Overall Study|Adverse Event|9|||
164581659|NCT01059812|594494543|FG001|Overall Study|Adverse Event|5|||
164581660|NCT01059812|594494542|FG000|Overall Study|Lack of Efficacy|2|||
164581661|NCT01059812|594494543|FG001|Overall Study|Lack of Efficacy|2|||
164581662|NCT01059812|594494542|FG000|Overall Study|Protocol Violation|3|||
164581663|NCT01059812|594494543|FG001|Overall Study|Protocol Violation|1|||
164581664|NCT01059812|594494542|FG000|Overall Study|Withdrawal Criteria|9|||
164581665|NCT01059812|594494543|FG001|Overall Study|Withdrawal Criteria|4|||
164581666|NCT01059812|594494542|FG000|Overall Study|Unclassified|14|||
164581667|NCT01059812|594494543|FG001|Overall Study|Unclassified|4|||
164581668|NCT05299892|594494544|FG000|Overall Study|Withdrawal by Subject|2|||
164581669|NCT00149214|594494545|FG000|Overall Study|Adverse Event|12|||
164581670|NCT00149214|594494546|FG001|Overall Study|Adverse Event|9|||
164581671|NCT00149214|594494545|FG000|Overall Study|Withdrawal by Subject|4|||
164581672|NCT00149214|594494546|FG001|Overall Study|Withdrawal by Subject|1|||
164581673|NCT00149214|594494545|FG000|Overall Study|Physician Decision|3|||
164581674|NCT00149214|594494546|FG001|Overall Study|Physician Decision|3|||
164581675|NCT00149214|594494545|FG000|Overall Study|Sponsor Decision|0|||
164581676|NCT00149214|594494546|FG001|Overall Study|Sponsor Decision|1|||
164581677|NCT00149214|594494545|FG000|Overall Study|Progressive Disease|7|||
164581678|NCT00149214|594494546|FG001|Overall Study|Progressive Disease|3|||
164581679|NCT03334214|594494547|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
164581680|NCT03334214|594494548|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
164581681|NCT03334214|594494547|FG000|Overall Study|Withdrawal by Subject|0|||
164581682|NCT03334214|594494548|FG001|Overall Study|Withdrawal by Subject|1|||
164269781|NCT00477269|593356761|FG001|Core Study|Adverse Event|4|||
164581683|NCT03334214|594494547|FG000|Overall Study|Other|1|||
164581684|NCT03334214|594494548|FG001|Overall Study|Other|0|||
164581685|NCT05642442|594494551|FG000|Overall Study|Adverse Event|0|||
164581686|NCT05642442|594494552|FG001|Overall Study|Adverse Event|1|||
164581687|NCT05642442|594494551|FG000|Overall Study|Lack of Efficacy|0|||
164581688|NCT05642442|594494552|FG001|Overall Study|Lack of Efficacy|1|||
164581689|NCT05642442|594494551|FG000|Overall Study|Withdrawal by Subject|13|||
164269782|NCT00477269|593356762|FG002|Core Study|Adverse Event|0|||
164269783|NCT00477269|593356760|FG000|Core Study|Death|3|||
164269784|NCT00477269|593356761|FG001|Core Study|Death|3|||
164269785|NCT00477269|593356762|FG002|Core Study|Death|0|||
164269786|NCT00477269|593356760|FG000|Core Study|Withdrawn Consent|0|||
164269787|NCT00477269|593356761|FG001|Core Study|Withdrawn Consent|1|||
164269788|NCT00477269|593356762|FG002|Core Study|Withdrawn Consent|0|||
164269789|NCT00477269|593356760|FG000|Open Label Extension|Adverse Event|0|||
164581690|NCT05642442|594494552|FG001|Overall Study|Withdrawal by Subject|9|||
164269790|NCT00477269|593356761|FG001|Open Label Extension|Adverse Event|0|||
164269791|NCT00477269|593356762|FG002|Open Label Extension|Adverse Event|4|||
164269792|NCT00477269|593356760|FG000|Open Label Extension|Abnormal laboratory values|0|||
164269793|NCT00477269|593356761|FG001|Open Label Extension|Abnormal laboratory values|0|||
164269794|NCT00477269|593356762|FG002|Open Label Extension|Abnormal laboratory values|1|||
164269795|NCT00477269|593356760|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
164269796|NCT00477269|593356761|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
164269797|NCT00477269|593356762|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
164269798|NCT00477269|593356760|FG000|Open Label Extension|Adminiatrative problems|0|||
164269799|NCT00477269|593356761|FG001|Open Label Extension|Adminiatrative problems|0|||
164269800|NCT00477269|593356762|FG002|Open Label Extension|Adminiatrative problems|2|||
164269801|NCT00477269|593356760|FG000|Open Label Extension|Death|0|||
164342024|NCT05248867|593627595|FG003|Open-label Period|Lost to Follow-up|0|||
164342025|NCT05248867|593627596|FG004|Open-label Period|Lost to Follow-up|5|||
164342026|NCT05248867|593627597|FG005|Open-label Period|Lost to Follow-up|2|||
164342027|NCT05248867|593627592|FG000|Open-label Period|COVID-19 Infection|0|||
164269802|NCT00477269|593356761|FG001|Open Label Extension|Death|0|||
164269803|NCT00477269|593356762|FG002|Open Label Extension|Death|4|||
164269804|NCT01541917|593356765|FG000|Overall Study|Lost to Follow-up|2|||
164269805|NCT01541917|593356766|FG001|Overall Study|Lost to Follow-up|2|||
164581691|NCT05642442|594494551|FG000|Overall Study|Other|5|||
164581692|NCT05642442|594494552|FG001|Overall Study|Other|2|||
164581693|NCT05642442|594494551|FG000|Overall Study|Lost to Follow-up|0|||
164581694|NCT05642442|594494552|FG001|Overall Study|Lost to Follow-up|1|||
164581695|NCT00550238|594494553|FG000|Overall Study|Adverse Event|88|||
164581696|NCT00550238|594494553|FG000|Overall Study|Death|34|||
164581697|NCT00550238|594494553|FG000|Overall Study|Disease progression|46|||
164581698|NCT00550238|594494553|FG000|Overall Study|Withdrawal by Subject|167|||
164581699|NCT00550238|594494553|FG000|Overall Study|Physician Decision|31|||
164581700|NCT00550238|594494553|FG000|Overall Study|Patient noncompliance|25|||
164581701|NCT00550238|594494553|FG000|Overall Study|Lost to Follow-up|13|||
164581702|NCT00550238|594494553|FG000|Overall Study|Sponsor decision|55|||
164581703|NCT02296684|594494558|FG000|Overall Study|Withdrawal by Subject|0|||
164581704|NCT02296684|594494559|FG001|Overall Study|Withdrawal by Subject|1|||
164581705|NCT02296684|594494560|FG002|Overall Study|Withdrawal by Subject|1|||
164581706|NCT02296684|594494558|FG000|Overall Study|Death|2|||
164581707|NCT02296684|594494559|FG001|Overall Study|Death|0|||
164581708|NCT02296684|594494560|FG002|Overall Study|Death|0|||
164581709|NCT00095121|594494561|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
164581710|NCT00095121|594494562|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
164581711|NCT00095121|594494561|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
164269806|NCT01541917|593356765|FG000|Overall Study|Withdrawal by Subject|13|||
164269807|NCT01541917|593356766|FG001|Overall Study|Withdrawal by Subject|7|||
164342028|NCT05248867|593627593|FG001|Open-label Period|COVID-19 Infection|0|||
164342029|NCT05248867|593627594|FG002|Open-label Period|COVID-19 Infection|0|||
164342030|NCT05248867|593627595|FG003|Open-label Period|COVID-19 Infection|0|||
164342031|NCT05248867|593627596|FG004|Open-label Period|COVID-19 Infection|1|||
164342032|NCT05248867|593627597|FG005|Open-label Period|COVID-19 Infection|0|||
164342033|NCT05248867|593627592|FG000|Open-label Period|Other, not specified|0|||
164342034|NCT05248867|593627593|FG001|Open-label Period|Other, not specified|0|||
164342035|NCT05248867|593627594|FG002|Open-label Period|Other, not specified|0|||
164342036|NCT05248867|593627595|FG003|Open-label Period|Other, not specified|0|||
164342037|NCT05248867|593627596|FG004|Open-label Period|Other, not specified|4|||
164342038|NCT05248867|593627597|FG005|Open-label Period|Other, not specified|0|||
164342039|NCT03128411|593627599|FG000|Treatment Phase|Adverse Event|21|||
164342040|NCT03128411|593627599|FG000|Treatment Phase|Physician Decision|1|||
164581712|NCT00095121|594494562|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
164581713|NCT05561673|594494567|FG000|Overall Study|Lost to Follow-up|0|||
164581714|NCT05561673|594494568|FG001|Overall Study|Lost to Follow-up|1|||
164269808|NCT00121641|593356769|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
164342041|NCT03128411|593627599|FG000|Treatment Phase|Other|2|||
164342042|NCT03128411|593627599|FG000|Long Term Follow-up Phase|Death|2|||
164342043|NCT03749447|593629349|FG000|Overall Study|Adverse Event|11|||
164342044|NCT03749447|593629350|FG001|Overall Study|Adverse Event|3|||
164342045|NCT03749447|593629349|FG000|Overall Study|Death|1|||
164342046|NCT03749447|593629350|FG001|Overall Study|Death|1|||
164342047|NCT03749447|593629349|FG000|Overall Study|Lost to Follow-up|2|||
164342048|NCT03749447|593629350|FG001|Overall Study|Lost to Follow-up|2|||
164687157|NCT01453153|594878184|FG001|Overall Study|Withdrawal by Subject|1|||
164687158|NCT01453153|594878185|FG002|Overall Study|Withdrawal by Subject|2|||
164269809|NCT00121641|593356770|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
164269810|NCT00121641|593356771|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
164269811|NCT00121641|593356772|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
164269812|NCT00121641|593356773|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
164269813|NCT00121641|593356769|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
164269814|NCT00121641|593356770|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
164269815|NCT00121641|593356771|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
164269816|NCT00121641|593356772|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
164269817|NCT00121641|593356773|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
164269818|NCT00121641|593356769|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
164269819|NCT00121641|593356770|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
164269820|NCT00121641|593356771|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
164269821|NCT00121641|593356772|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
164269822|NCT00121641|593356773|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
164269823|NCT00121641|593356769|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
164269824|NCT00121641|593356770|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
164269825|NCT00121641|593356771|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
164269826|NCT00121641|593356772|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
164269827|NCT00121641|593356773|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
164269828|NCT00121641|593356769|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
164269829|NCT00121641|593356770|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
164269830|NCT00121641|593356771|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
164269831|NCT00121641|593356772|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
164269832|NCT00121641|593356773|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
164269833|NCT00121641|593356769|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
164269834|NCT00121641|593356770|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
164269835|NCT00121641|593356771|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
164269836|NCT00121641|593356772|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
164269837|NCT00121641|593356773|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
164269838|NCT00121641|593356769|FG000|24-week Short-term Treatment Period|Other Reason|1|||
164269839|NCT00121641|593356770|FG001|24-week Short-term Treatment Period|Other Reason|0|||
164269840|NCT00121641|593356771|FG002|24-week Short-term Treatment Period|Other Reason|0|||
164269841|NCT00121641|593356772|FG003|24-week Short-term Treatment Period|Other Reason|0|||
164269842|NCT00121641|593356773|FG004|24-week Short-term Treatment Period|Other Reason|0|||
164269843|NCT00121641|593356769|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
164269844|NCT00121641|593356770|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
164269845|NCT00121641|593356771|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
164269846|NCT00121641|593356772|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
164269847|NCT00121641|593356773|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
164269848|NCT00121641|593356769|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
164269849|NCT00121641|593356770|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
164269850|NCT00121641|593356771|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
164269851|NCT00121641|593356772|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
164269852|NCT00121641|593356773|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
164269853|NCT00121641|593356769|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
164269854|NCT00121641|593356770|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
164269855|NCT00121641|593356771|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
164687159|NCT01453153|594878183|FG000|Overall Study|Adverse Event|1|||
164687160|NCT01453153|594878184|FG001|Overall Study|Adverse Event|1|||
164687161|NCT01453153|594878185|FG002|Overall Study|Adverse Event|1|||
164687162|NCT03547635|594878188|FG000|Overall Study|Adverse Event|5|||
164687163|NCT03547635|594878189|FG001|Overall Study|Adverse Event|2|||
164687164|NCT03547635|594878190|FG002|Overall Study|Adverse Event|3|||
164687165|NCT03547635|594878188|FG000|Overall Study|Lost to Follow-up|1|||
164687166|NCT03547635|594878189|FG001|Overall Study|Lost to Follow-up|3|||
164687167|NCT03547635|594878190|FG002|Overall Study|Lost to Follow-up|4|||
164687168|NCT03547635|594878188|FG000|Overall Study|Withdrawal by Subject|1|||
164687169|NCT03547635|594878189|FG001|Overall Study|Withdrawal by Subject|0|||
164342049|NCT03749447|593629349|FG000|Overall Study|Reason Not Specified|0|||
164687170|NCT03547635|594878190|FG002|Overall Study|Withdrawal by Subject|0|||
164687171|NCT03547635|594878188|FG000|Overall Study|Withdrawal By PI|0|||
164687172|NCT03547635|594878189|FG001|Overall Study|Withdrawal By PI|1|||
164687173|NCT03547635|594878190|FG002|Overall Study|Withdrawal By PI|0|||
164687174|NCT03547635|594878188|FG000|Overall Study|Withdrawal by Sponsor|0|||
164687175|NCT03547635|594878189|FG001|Overall Study|Withdrawal by Sponsor|0|||
164342050|NCT03749447|593629350|FG001|Overall Study|Reason Not Specified|3|||
164342051|NCT03749447|593629349|FG000|Overall Study|Physician Decision|4|||
164342052|NCT03749447|593629350|FG001|Overall Study|Physician Decision|3|||
164342053|NCT03749447|593629349|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
164342054|NCT03749447|593629350|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
164342055|NCT03749447|593629349|FG000|Overall Study|Study Terminated By Sponsor|112|||
164342056|NCT03749447|593629350|FG001|Overall Study|Study Terminated By Sponsor|105|||
164342057|NCT03749447|593629349|FG000|Overall Study|Withdrawal by Subject|12|||
164342058|NCT03749447|593629350|FG001|Overall Study|Withdrawal by Subject|6|||
164342059|NCT03749447|593629349|FG000|Overall Study|Non-compliance With Study Drug|0|||
164342060|NCT03749447|593629350|FG001|Overall Study|Non-compliance With Study Drug|1|||
164342061|NCT01673867|593629352|FG000|Randomization|Adverse event unrelated to study drug|1|||
164342062|NCT01673867|593629353|FG001|Randomization|Adverse event unrelated to study drug|0|||
164342063|NCT01673867|593629352|FG000|Randomization|Participant request to discontinue study treatment|0|||
164342064|NCT01673867|593629353|FG001|Randomization|Participant request to discontinue study treatment|4|||
164342065|NCT01673867|593629352|FG000|Randomization|Withdrawal by participant|0|||
164342066|NCT01673867|593629353|FG001|Randomization|Withdrawal by participant|12|||
164342067|NCT01673867|593629352|FG000|Randomization|Lost to Follow-up|0|||
164342068|NCT01673867|593629353|FG001|Randomization|Lost to Follow-up|1|||
164342069|NCT01673867|593629352|FG000|Randomization|Participant no longer meets study criteria|4|||
164342070|NCT01673867|593629353|FG001|Randomization|Participant no longer meets study criteria|5|||
164342071|NCT01673867|593629352|FG000|Treatment|Disease Progression|208|||
164342072|NCT01673867|593629353|FG001|Treatment|Disease Progression|178|||
164342073|NCT01673867|593629352|FG000|Treatment|Study Drug Toxicity|23|||
164342074|NCT01673867|593629353|FG001|Treatment|Study Drug Toxicity|43|||
164342075|NCT01673867|593629352|FG000|Treatment|Death|2|||
164342076|NCT01673867|593629353|FG001|Treatment|Death|3|||
164342077|NCT01673867|593629352|FG000|Treatment|Adverse event unrelated to study drug|23|||
164342078|NCT01673867|593629353|FG001|Treatment|Adverse event unrelated to study drug|10|||
164342079|NCT01673867|593629352|FG000|Treatment|Participant request to discontinue study treatment|7|||
164342080|NCT01673867|593629353|FG001|Treatment|Participant request to discontinue study treatment|17|||
164342081|NCT01673867|593629352|FG000|Treatment|Withdrawal by participant|5|||
164342082|NCT01673867|593629353|FG001|Treatment|Withdrawal by participant|5|||
164342083|NCT01673867|593629352|FG000|Treatment|Maximum clinical benefit|1|||
164342084|NCT01673867|593629353|FG001|Treatment|Maximum clinical benefit|10|||
164342085|NCT01673867|593629352|FG000|Treatment|Participant no longer meets study criteria|2|||
164342086|NCT01673867|593629353|FG001|Treatment|Participant no longer meets study criteria|0|||
164342087|NCT01673867|593629352|FG000|Treatment|Administrative reason by sponsor|3|||
164342088|NCT01673867|593629353|FG001|Treatment|Administrative reason by sponsor|0|||
164342089|NCT01673867|593629352|FG000|Treatment|Other reason|11|||
164342090|NCT01673867|593629353|FG001|Treatment|Other reason|2|||
164342091|NCT02550106|593629354|FG000|Overall Study|Adverse Event|1|||
164342092|NCT02550106|593629354|FG000|Overall Study|Lack of Efficacy|3|||
164342093|NCT02550106|593629354|FG000|Overall Study|Protocol Violation|6|||
164342094|NCT02550106|593629354|FG000|Overall Study|Withdrawal by Subject|2|||
164342095|NCT01543958|593629355|FG000|Overall Study|Loss to follow-up|3|||
164342096|NCT01543958|593629355|FG000|Overall Study|ART initiation|1|||
164342097|NCT00926328|593629356|FG000|Overall Study|Lost to Follow-up|12|||
164342098|NCT00926328|593629357|FG001|Overall Study|Lost to Follow-up|14|||
164342099|NCT00726986|593629358|FG000|Induction Phase|Adverse Event|4|||
164342100|NCT00726986|593629358|FG000|Induction Phase|Withdrawal by Subject|2|||
164342101|NCT00726986|593629358|FG000|Induction Phase|Death|2|||
164342102|NCT00726986|593629358|FG000|Induction Phase|Lack of Efficacy|5|||
164581715|NCT05561673|594494569|FG002|Overall Study|Lost to Follow-up|0|||
164581716|NCT05561673|594494570|FG003|Overall Study|Lost to Follow-up|1|||
164581717|NCT05561673|594494571|FG004|Overall Study|Lost to Follow-up|0|||
164581718|NCT05561673|594494567|FG000|Overall Study|Consent withdrawal, not due to (S)AE|0|||
164581719|NCT05561673|594494568|FG001|Overall Study|Consent withdrawal, not due to (S)AE|1|||
164342103|NCT00726986|593629358|FG000|Induction Phase|Secondary Disease|2|||
164342104|NCT00726986|593629358|FG000|Maintenance Phase|Adverse Event|1|||
164342105|NCT00726986|593629358|FG000|Maintenance Phase|Lack of Efficacy|2|||
164342106|NCT01513343|593629361|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
164342107|NCT01513343|593629362|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
164342108|NCT01513343|593629361|FG000|Post Data Collection|Dropped/withdrew from study|7|||
164342109|NCT01513343|593629362|FG001|Post Data Collection|Dropped/withdrew from study|1|||
164342110|NCT01513343|593629361|FG000|Post Data Collection|Lost to Follow-up|10|||
164342111|NCT01513343|593629362|FG001|Post Data Collection|Lost to Follow-up|23|||
164342112|NCT01513343|593629361|FG000|6-month Follow-up|Lost to Follow-up|28|||
164342113|NCT01513343|593629362|FG001|6-month Follow-up|Lost to Follow-up|17|||
164342114|NCT01513343|593629361|FG000|12-month Follow-up|Lost to Follow-up|10|||
164342115|NCT01513343|593629362|FG001|12-month Follow-up|Lost to Follow-up|3|||
164342116|NCT00599924|593629363|FG000|Overall Study|Lack of Efficacy|3|||
164342117|NCT00599924|593629364|FG001|Overall Study|Lack of Efficacy|5|||
164687176|NCT03547635|594878190|FG002|Overall Study|Withdrawal by Sponsor|1|||
164687177|NCT03547635|594878188|FG000|Overall Study|Errant Randomization before Treatment|0|||
164687178|NCT03547635|594878189|FG001|Overall Study|Errant Randomization before Treatment|1|||
164687179|NCT03547635|594878190|FG002|Overall Study|Errant Randomization before Treatment|0|||
164687180|NCT03547635|594878188|FG000|Overall Study|Withdrawal by Subject|1|||
164687181|NCT03547635|594878189|FG001|Overall Study|Withdrawal by Subject|0|||
164687182|NCT03547635|594878190|FG002|Overall Study|Withdrawal by Subject|0|||
164687183|NCT03243396|594878191|FG000|Overall Study|Lost to Follow-up|2|||
164687184|NCT03243396|594878192|FG001|Overall Study|Lost to Follow-up|3|||
164687185|NCT03243396|594878193|FG002|Overall Study|Lost to Follow-up|15|||
164687186|NCT03243396|594878194|FG003|Overall Study|Lost to Follow-up|8|||
164687187|NCT03243396|594878195|FG004|Overall Study|Lost to Follow-up|1|||
164687188|NCT03243396|594878196|FG005|Overall Study|Lost to Follow-up|4|||
164687189|NCT03243396|594878197|FG006|Overall Study|Lost to Follow-up|9|||
164687190|NCT02473393|594878198|FG000|Overall Study|Adverse Event|0|||
164687191|NCT02473393|594878199|FG001|Overall Study|Adverse Event|0|||
164687192|NCT02473393|594878200|FG002|Overall Study|Adverse Event|1|||
164687193|NCT02473393|594878201|FG003|Overall Study|Adverse Event|0|||
164687194|NCT02473393|594878198|FG000|Overall Study|Withdrawal by Subject|0|||
164687195|NCT02473393|594878199|FG001|Overall Study|Withdrawal by Subject|0|||
164687196|NCT02473393|594878200|FG002|Overall Study|Withdrawal by Subject|1|||
164687197|NCT02473393|594878201|FG003|Overall Study|Withdrawal by Subject|1|||
164687198|NCT02274558|594878205|FG000|Overall Study|Adverse Event|2|||
164687199|NCT02274558|594878206|FG001|Overall Study|Adverse Event|4|||
164687200|NCT02274558|594878207|FG002|Overall Study|Adverse Event|2|||
164687201|NCT02274558|594878205|FG000|Overall Study|Non-compliance|2|||
164687202|NCT02274558|594878206|FG001|Overall Study|Non-compliance|1|||
164687203|NCT02274558|594878207|FG002|Overall Study|Non-compliance|0|||
164687204|NCT02274558|594878205|FG000|Overall Study|Withdrawal by Subject|1|||
164687205|NCT02274558|594878206|FG001|Overall Study|Withdrawal by Subject|5|||
164687206|NCT02274558|594878207|FG002|Overall Study|Withdrawal by Subject|4|||
164687207|NCT02274558|594878205|FG000|Overall Study|Death|0|||
164687208|NCT02274558|594878206|FG001|Overall Study|Death|0|||
164687209|NCT02274558|594878207|FG002|Overall Study|Death|1|||
164687210|NCT02274558|594878205|FG000|Overall Study|Lost to Follow-up|2|||
164687211|NCT02274558|594878206|FG001|Overall Study|Lost to Follow-up|1|||
164687212|NCT02274558|594878207|FG002|Overall Study|Lost to Follow-up|1|||
164269856|NCT00121641|593356772|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
164269857|NCT00121641|593356773|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
164269858|NCT00121641|593356769|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
164269859|NCT00121641|593356770|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
164269860|NCT00121641|593356771|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
164269861|NCT00121641|593356772|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
164269862|NCT00121641|593356773|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
164269863|NCT00121641|593356769|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
164269864|NCT00121641|593356770|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
164269865|NCT00121641|593356771|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
164269866|NCT00121641|593356772|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
164269867|NCT00121641|593356773|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
164269868|NCT00121641|593356769|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
164269869|NCT00121641|593356770|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
164269870|NCT00121641|593356771|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
164269871|NCT00121641|593356772|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
164269872|NCT00121641|593356773|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
164269873|NCT00121641|593356769|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
164269874|NCT00121641|593356770|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
164269875|NCT00121641|593356771|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
164269876|NCT00121641|593356772|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
164269877|NCT00121641|593356773|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
164687213|NCT02274558|594878205|FG000|Overall Study|Physician Decision|0|||
164687214|NCT02274558|594878206|FG001|Overall Study|Physician Decision|2|||
164687215|NCT02274558|594878207|FG002|Overall Study|Physician Decision|1|||
164687216|NCT02048813|594878212|FG000|Overall Study|Still on treatment|279|||
164687217|NCT02048813|594878213|FG001|Overall Study|Still on treatment|0|||
164342118|NCT00599924|593629365|FG002|Overall Study|Lack of Efficacy|1|||
164687218|NCT02048813|594878212|FG000|Overall Study|Adverse Event|40|||
164687219|NCT02048813|594878213|FG001|Overall Study|Adverse Event|38|||
164687220|NCT02048813|594878212|FG000|Overall Study|Disease progression|13|||
164687221|NCT02048813|594878213|FG001|Overall Study|Disease progression|3|||
164687222|NCT02048813|594878212|FG000|Overall Study|Withdrawal by Subject|7|||
164687223|NCT02048813|594878213|FG001|Overall Study|Withdrawal by Subject|8|||
164269878|NCT00121641|593356769|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
164269879|NCT00121641|593356770|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
164269880|NCT00121641|593356771|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
164269881|NCT00121641|593356772|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
164269882|NCT00121641|593356773|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
164269883|NCT00121641|593356769|FG000|48-month Short Term + Long Term Period|Death|0|||
164269884|NCT00121641|593356770|FG001|48-month Short Term + Long Term Period|Death|0|||
164269885|NCT00121641|593356771|FG002|48-month Short Term + Long Term Period|Death|0|||
164269886|NCT00121641|593356772|FG003|48-month Short Term + Long Term Period|Death|1|||
164269887|NCT00121641|593356773|FG004|48-month Short Term + Long Term Period|Death|0|||
164269888|NCT00121641|593356769|FG000|48-month Short Term + Long Term Period|Missing|0|||
164269889|NCT00121641|593356770|FG001|48-month Short Term + Long Term Period|Missing|0|||
164269890|NCT00121641|593356771|FG002|48-month Short Term + Long Term Period|Missing|1|||
164269891|NCT00121641|593356772|FG003|48-month Short Term + Long Term Period|Missing|0|||
164269892|NCT00121641|593356773|FG004|48-month Short Term + Long Term Period|Missing|0|||
164269893|NCT00121641|593356769|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
164269894|NCT00121641|593356770|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
164269895|NCT00121641|593356771|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
164269896|NCT00121641|593356772|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
164269897|NCT00121641|593356773|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
164269898|NCT01792518|593356774|FG000|Overall Study|Adverse Event|3|||
164269899|NCT01792518|593356775|FG001|Overall Study|Adverse Event|4|||
164269900|NCT01792518|593356774|FG000|Overall Study|Protocol Violation|0|||
164269901|NCT01792518|593356775|FG001|Overall Study|Protocol Violation|1|||
164269902|NCT01792518|593356774|FG000|Overall Study|Lost to Follow-up|3|||
164269903|NCT01792518|593356775|FG001|Overall Study|Lost to Follow-up|1|||
164269904|NCT01792518|593356774|FG000|Overall Study|Withdrawal by Subject|2|||
164581720|NCT05561673|594494569|FG002|Overall Study|Consent withdrawal, not due to (S)AE|0|||
164581721|NCT05561673|594494570|FG003|Overall Study|Consent withdrawal, not due to (S)AE|0|||
164581722|NCT05561673|594494571|FG004|Overall Study|Consent withdrawal, not due to (S)AE|0|||
164581723|NCT05561673|594494567|FG000|Overall Study|Other|1|||
164269905|NCT01792518|593356775|FG001|Overall Study|Withdrawal by Subject|0|||
164269906|NCT01792518|593356774|FG000|Overall Study|Other Reason|0|||
164581724|NCT05561673|594494568|FG001|Overall Study|Other|0|||
164581725|NCT05561673|594494569|FG002|Overall Study|Other|1|||
164581726|NCT05561673|594494570|FG003|Overall Study|Other|0|||
164581727|NCT05561673|594494571|FG004|Overall Study|Other|0|||
164581728|NCT05176847|594495792|FG000|Overall Study|Lost to Follow-up|23|||
164581729|NCT05176847|594495793|FG001|Overall Study|Lost to Follow-up|36|||
164581730|NCT05176847|594495792|FG000|Overall Study|Withdrawal by Subject|7|||
164581731|NCT05176847|594495793|FG001|Overall Study|Withdrawal by Subject|12|||
164581732|NCT05176847|594495792|FG000|Overall Study|Removed from analysis|1|||
164581733|NCT05176847|594495793|FG001|Overall Study|Removed from analysis|0|||
164581734|NCT02786537|594495794|FG000|As Randomized|Adverse Event|0|||
164581735|NCT02786537|594495795|FG001|As Randomized|Adverse Event|11|||
164581736|NCT02786537|594495796|FG002|As Randomized|Adverse Event|0|||
164581737|NCT02786537|594495797|FG003|As Randomized|Adverse Event|4|||
164581738|NCT02786537|594495798|FG004|As Randomized|Adverse Event|6|||
164581739|NCT02786537|594495799|FG005|As Randomized|Adverse Event|2|||
164581740|NCT02786537|594495794|FG000|As Randomized|Lack of Efficacy|0|||
164581741|NCT02786537|594495795|FG001|As Randomized|Lack of Efficacy|0|||
164581742|NCT02786537|594495796|FG002|As Randomized|Lack of Efficacy|0|||
164581743|NCT02786537|594495797|FG003|As Randomized|Lack of Efficacy|1|||
164581744|NCT02786537|594495798|FG004|As Randomized|Lack of Efficacy|0|||
164581745|NCT02786537|594495799|FG005|As Randomized|Lack of Efficacy|0|||
164581746|NCT02786537|594495794|FG000|As Randomized|Withdrawal by Subject|1|||
164581747|NCT02786537|594495795|FG001|As Randomized|Withdrawal by Subject|2|||
164581748|NCT02786537|594495796|FG002|As Randomized|Withdrawal by Subject|0|||
164581749|NCT02786537|594495797|FG003|As Randomized|Withdrawal by Subject|1|||
164581750|NCT02786537|594495798|FG004|As Randomized|Withdrawal by Subject|1|||
164581751|NCT02786537|594495799|FG005|As Randomized|Withdrawal by Subject|0|||
164581752|NCT02786537|594495794|FG000|As Randomized|Death|0|||
164581753|NCT02786537|594495795|FG001|As Randomized|Death|2|||
164581754|NCT02786537|594495796|FG002|As Randomized|Death|0|||
164581755|NCT02786537|594495797|FG003|As Randomized|Death|3|||
164269907|NCT01792518|593356775|FG001|Overall Study|Other Reason|1|||
164269908|NCT01565564|593356786|FG000|Overall Study|Lost to Follow-up|5|||
164269909|NCT01565564|593356787|FG001|Overall Study|Lost to Follow-up|1|||
164269910|NCT00249613|593356788|FG000|12 Month Follow-up|Death|1|||
164581756|NCT02786537|594495798|FG004|As Randomized|Death|1|||
164581757|NCT02786537|594495799|FG005|As Randomized|Death|0|||
164581758|NCT02786537|594495794|FG000|As Randomized|Non-compliance with study drug|1|||
164581759|NCT02786537|594495795|FG001|As Randomized|Non-compliance with study drug|11|||
164581760|NCT02786537|594495796|FG002|As Randomized|Non-compliance with study drug|0|||
164581761|NCT02786537|594495797|FG003|As Randomized|Non-compliance with study drug|1|||
164687224|NCT02048813|594878212|FG000|Overall Study|Death|2|||
164687225|NCT02048813|594878213|FG001|Overall Study|Death|1|||
164269911|NCT00249613|593356789|FG001|12 Month Follow-up|Death|1|||
164269912|NCT00249613|593356788|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
164269913|NCT00249613|593356789|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
164269914|NCT00249613|593356788|FG000|12 Month Follow-up|Lost to Follow-up|10|||
164269915|NCT00249613|593356789|FG001|12 Month Follow-up|Lost to Follow-up|8|||
164269916|NCT00806442|593356812|FG000|Overall Study|Lost to Follow-up|3|||
164269917|NCT00806442|593356813|FG001|Overall Study|Lost to Follow-up|2|||
164269918|NCT00806442|593356812|FG000|Overall Study|Withdrawal by Subject|1|||
164269919|NCT00806442|593356813|FG001|Overall Study|Withdrawal by Subject|5|||
164269920|NCT00654004|593356817|FG000|Overall Study|Lost to Follow-up|1|||
164269921|NCT00654004|593356818|FG001|Overall Study|Lost to Follow-up|0|||
164269922|NCT02528357|593356827|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269923|NCT02528357|593356828|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
164269924|NCT02528357|593356829|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269925|NCT02528357|593356830|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269926|NCT02528357|593356831|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269927|NCT02528357|593356832|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269928|NCT02528357|593356833|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269929|NCT02528357|593356834|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269930|NCT02528357|593356835|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269931|NCT02528357|593356836|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269932|NCT02528357|593356837|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269933|NCT02528357|593356838|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269934|NCT02528357|593356839|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269935|NCT02528357|593356840|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269936|NCT02528357|593356841|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269937|NCT02528357|593356842|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269938|NCT02528357|593356843|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269939|NCT02528357|593356844|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269940|NCT02528357|593356845|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269941|NCT02528357|593356827|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269942|NCT02528357|593356828|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269943|NCT02528357|593356829|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269944|NCT02528357|593356830|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
164269945|NCT02528357|593356831|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269946|NCT02528357|593356832|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
164269947|NCT02528357|593356833|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269948|NCT02528357|593356834|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
164269949|NCT02528357|593356835|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269950|NCT02528357|593356836|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269951|NCT02528357|593356837|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269952|NCT02528357|593356838|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269953|NCT02528357|593356839|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269954|NCT02528357|593356840|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269955|NCT02528357|593356841|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269956|NCT02528357|593356842|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269957|NCT02528357|593356843|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269958|NCT02528357|593356844|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269959|NCT02528357|593356845|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269960|NCT02528357|593356827|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269961|NCT02528357|593356828|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269962|NCT02528357|593356829|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
164269963|NCT02528357|593356830|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269964|NCT02528357|593356831|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
164269965|NCT02528357|593356832|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269966|NCT02528357|593356833|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
164269967|NCT02528357|593356834|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
164269968|NCT02528357|593356835|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269969|NCT02528357|593356836|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269970|NCT02528357|593356837|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269971|NCT02528357|593356838|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269972|NCT02528357|593356839|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164687226|NCT02048813|594878212|FG000|Overall Study|Complication|2|||
164269973|NCT02528357|593356840|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269974|NCT02528357|593356841|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269975|NCT02528357|593356842|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269976|NCT02528357|593356843|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269977|NCT02528357|593356844|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269978|NCT02528357|593356845|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269979|NCT02528357|593356827|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269980|NCT02528357|593356828|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269981|NCT02528357|593356829|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269982|NCT02528357|593356830|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164342119|NCT00599924|593629366|FG003|Overall Study|Lack of Efficacy|2|||
164342120|NCT00599924|593629367|FG004|Overall Study|Lack of Efficacy|3|||
164687227|NCT02048813|594878213|FG001|Overall Study|Complication|2|||
164687228|NCT02048813|594878212|FG000|Overall Study|Non-protocol therapy|0|||
164687229|NCT02048813|594878213|FG001|Overall Study|Non-protocol therapy|1|||
164687230|NCT02048813|594878212|FG000|Overall Study|Second primary cancer|2|||
164687231|NCT02048813|594878213|FG001|Overall Study|Second primary cancer|0|||
164687232|NCT02048813|594878212|FG000|Overall Study|Insurance|2|||
164687233|NCT02048813|594878213|FG001|Overall Study|Insurance|0|||
164687234|NCT02048813|594878212|FG000|Overall Study|Wound infection/healing|2|||
164687235|NCT02048813|594878213|FG001|Overall Study|Wound infection/healing|0|||
164687236|NCT02048813|594878212|FG000|Overall Study|Missed appointment|3|||
164687237|NCT02048813|594878213|FG001|Overall Study|Missed appointment|0|||
164687238|NCT02048813|594878212|FG000|Overall Study|Never started treatment|2|||
164687239|NCT02048813|594878213|FG001|Overall Study|Never started treatment|17|||
164687240|NCT05996198|594878214|FG000|Overall Study|Withdrawal by Subject|1|||
164687241|NCT05996198|594878215|FG001|Overall Study|Withdrawal by Subject|0|||
164687242|NCT00059332|594878219|FG000|Overall Study|Withdrawal by Subject|2|||
164687243|NCT00059332|594878220|FG001|Overall Study|Withdrawal by Subject|1|||
164687244|NCT00059332|594878219|FG000|Overall Study|Lost to Follow-up|1|||
164687245|NCT00059332|594878220|FG001|Overall Study|Lost to Follow-up|1|||
164687246|NCT03314857|594878221|FG000|Overall Study|Death|4|||
164687247|NCT03314857|594878221|FG000|Overall Study|Physician Decision|1|||
164687248|NCT02754492|594878222|FG000|Overall Study|Protocol Violation|2|||
164687249|NCT02754492|594878223|FG001|Overall Study|Protocol Violation|2|||
164687250|NCT02754492|594878224|FG002|Overall Study|Protocol Violation|0|||
164687251|NCT02754492|594878225|FG003|Overall Study|Protocol Violation|1|||
164687252|NCT02754492|594878222|FG000|Overall Study|Withdrawal by Subject|2|||
164687253|NCT02754492|594878223|FG001|Overall Study|Withdrawal by Subject|0|||
164687254|NCT02754492|594878224|FG002|Overall Study|Withdrawal by Subject|0|||
164687255|NCT02754492|594878225|FG003|Overall Study|Withdrawal by Subject|0|||
164687256|NCT02754492|594878222|FG000|Overall Study|Equipment malfuntion|0|||
164687257|NCT02754492|594878223|FG001|Overall Study|Equipment malfuntion|0|||
164687258|NCT02754492|594878224|FG002|Overall Study|Equipment malfuntion|2|||
164687259|NCT02754492|594878225|FG003|Overall Study|Equipment malfuntion|5|||
164687260|NCT02754492|594878222|FG000|Overall Study|Adverse Event|0|||
164687261|NCT02754492|594878223|FG001|Overall Study|Adverse Event|0|||
164687262|NCT02754492|594878224|FG002|Overall Study|Adverse Event|0|||
164687263|NCT02754492|594878225|FG003|Overall Study|Adverse Event|13|||
164687264|NCT02754492|594878222|FG000|Overall Study|Venous access issues not resulting in AE|0|||
164687265|NCT02754492|594878223|FG001|Overall Study|Venous access issues not resulting in AE|0|||
164687266|NCT02754492|594878224|FG002|Overall Study|Venous access issues not resulting in AE|0|||
164687267|NCT02754492|594878225|FG003|Overall Study|Venous access issues not resulting in AE|4|||
164687268|NCT01408888|594878226|FG000|First Intervention|Adverse Event|0|||
164687269|NCT01408888|594878227|FG001|First Intervention|Adverse Event|1|||
164687270|NCT01408888|594878226|FG000|First Intervention|Withdrawal by Subject|0|||
164687271|NCT01408888|594878227|FG001|First Intervention|Withdrawal by Subject|2|||
164687272|NCT01408888|594878226|FG000|Second Intervention|Withdrawal by Subject|1|||
164687273|NCT01408888|594878227|FG001|Second Intervention|Withdrawal by Subject|0|||
164687274|NCT01408888|594878226|FG000|Second Intervention|Adverse Event|1|||
164687275|NCT01408888|594878227|FG001|Second Intervention|Adverse Event|0|||
164687276|NCT00397254|594878228|FG000|Overall Study|Lost to Follow-up|2|||
164687277|NCT00397254|594878229|FG001|Overall Study|Lost to Follow-up|2|||
164342121|NCT00599924|593629368|FG005|Overall Study|Lack of Efficacy|2|||
164342122|NCT00599924|593629369|FG006|Overall Study|Lack of Efficacy|0|||
164687278|NCT00152451|594878230|FG000|Overall Study|Adverse Event|4|||
164687279|NCT00323258|594878233|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
164687280|NCT00323258|594878234|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
164687281|NCT00323258|594878233|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
164687282|NCT00323258|594878234|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
164687283|NCT00323258|594878233|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
164687284|NCT00323258|594878234|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
164687285|NCT00323258|594878233|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
164687286|NCT00323258|594878234|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
164687287|NCT00323258|594878233|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
164687288|NCT00323258|594878234|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
164687289|NCT00323258|594878233|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
164687290|NCT00323258|594878234|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
164687291|NCT00323258|594878233|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
164687292|NCT00323258|594878234|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
164687293|NCT04473326|594878239|FG000|Overall Study|Death|0|||
164687294|NCT04473326|594878240|FG001|Overall Study|Death|1|||
164687295|NCT04473326|594878239|FG000|Overall Study|Withdrawal by Subject|1|||
164687296|NCT04473326|594878240|FG001|Overall Study|Withdrawal by Subject|2|||
164687297|NCT02046122|594878241|FG000|Overall Study|Physician Decision|8|||
164269983|NCT02528357|593356831|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
164269984|NCT02528357|593356832|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164687298|NCT02046122|594878241|FG000|Overall Study|Withdrawal by Subject|1|||
164687299|NCT01097694|594878246|FG000|Overall Study|Adverse Event|5|||
164687300|NCT01097694|594878247|FG001|Overall Study|Adverse Event|0|||
164687301|NCT01097694|594878246|FG000|Overall Study|Lost to Follow-up|0|||
164687302|NCT01097694|594878247|FG001|Overall Study|Lost to Follow-up|3|||
164687303|NCT01097694|594878246|FG000|Overall Study|Withdrawal by Subject|3|||
164687304|NCT01097694|594878247|FG001|Overall Study|Withdrawal by Subject|1|||
164687305|NCT00668395|594878249|FG000|Overall Study|Withdrawal by Subject|4|||
164687306|NCT00668395|594878250|FG001|Overall Study|Withdrawal by Subject|4|||
164687307|NCT00668395|594878251|FG002|Overall Study|Withdrawal by Subject|1|||
164687308|NCT00668395|594878249|FG000|Overall Study|Adverse Event|1|||
164687309|NCT00668395|594878250|FG001|Overall Study|Adverse Event|1|||
164687310|NCT00668395|594878251|FG002|Overall Study|Adverse Event|0|||
164687311|NCT00668395|594878249|FG000|Overall Study|Physician Decision|1|||
164687312|NCT00668395|594878250|FG001|Overall Study|Physician Decision|1|||
164687313|NCT00668395|594878251|FG002|Overall Study|Physician Decision|0|||
164269985|NCT02528357|593356833|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269986|NCT02528357|593356834|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269987|NCT02528357|593356835|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269988|NCT02528357|593356836|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269989|NCT02528357|593356837|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269990|NCT02528357|593356838|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269991|NCT02528357|593356839|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269992|NCT02528357|593356840|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269993|NCT02528357|593356841|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269994|NCT02528357|593356842|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269995|NCT02528357|593356843|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269996|NCT02528357|593356844|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269997|NCT02528357|593356845|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269998|NCT02528357|593356827|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164269999|NCT02528357|593356828|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270000|NCT02528357|593356829|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270001|NCT02528357|593356830|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270002|NCT02528357|593356831|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164687314|NCT01726803|594878252|FG000|Overall Study|Lost to Follow-up|6|||
164687315|NCT01726803|594878253|FG001|Overall Study|Lost to Follow-up|1|||
164270003|NCT02528357|593356832|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270004|NCT02528357|593356833|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164342123|NCT00599924|593629363|FG000|Overall Study|Adverse Event|0|||
164342124|NCT00599924|593629364|FG001|Overall Study|Adverse Event|0|||
164342125|NCT00599924|593629365|FG002|Overall Study|Adverse Event|0|||
164342126|NCT00599924|593629366|FG003|Overall Study|Adverse Event|2|||
164342127|NCT00599924|593629367|FG004|Overall Study|Adverse Event|0|||
164342128|NCT00599924|593629368|FG005|Overall Study|Adverse Event|0|||
164687316|NCT01726803|594878252|FG000|Overall Study|Withdrawal by Subject|1|||
164687317|NCT01726803|594878253|FG001|Overall Study|Withdrawal by Subject|0|||
164687318|NCT00766493|594878255|FG000|30 Days Post-Procedure|Discontinued|7|||
164687319|NCT00766493|594878255|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
164687320|NCT00766493|594878255|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
164687321|NCT00024258|594878256|FG000|Overall Study|Withdrawal by Subject|1|||
164687322|NCT00024258|594878256|FG000|Overall Study|Disease Progression|8|||
164270005|NCT02528357|593356834|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270006|NCT02528357|593356835|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270007|NCT02528357|593356836|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270008|NCT02528357|593356837|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270009|NCT02528357|593356838|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270010|NCT02528357|593356839|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270011|NCT02528357|593356840|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
164270012|NCT02528357|593356841|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
164270013|NCT02528357|593356842|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270014|NCT02528357|593356843|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270015|NCT02528357|593356844|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270016|NCT02528357|593356845|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270017|NCT02528357|593356827|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270018|NCT02528357|593356828|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270019|NCT02528357|593356829|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270020|NCT02528357|593356830|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270021|NCT02528357|593356831|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270022|NCT02528357|593356832|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270023|NCT02528357|593356833|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270024|NCT02528357|593356834|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270025|NCT02528357|593356835|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270026|NCT02528357|593356836|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270027|NCT02528357|593356837|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270028|NCT02528357|593356838|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270029|NCT02528357|593356839|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270030|NCT02528357|593356840|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
164270031|NCT02528357|593356841|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270032|NCT02528357|593356842|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270033|NCT02528357|593356843|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270034|NCT02528357|593356844|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164342129|NCT00599924|593629369|FG006|Overall Study|Adverse Event|2|||
164342130|NCT00599924|593629363|FG000|Overall Study|Death|0|||
164342131|NCT00599924|593629364|FG001|Overall Study|Death|0|||
164342132|NCT00599924|593629365|FG002|Overall Study|Death|0|||
164581762|NCT02786537|594495798|FG004|As Randomized|Non-compliance with study drug|0|||
164581763|NCT02786537|594495799|FG005|As Randomized|Non-compliance with study drug|1|||
164581764|NCT02786537|594495794|FG000|As Randomized|Lost to treatment follow-up|4|||
164581765|NCT02786537|594495795|FG001|As Randomized|Lost to treatment follow-up|32|||
164581766|NCT02786537|594495796|FG002|As Randomized|Lost to treatment follow-up|0|||
164581767|NCT02786537|594495797|FG003|As Randomized|Lost to treatment follow-up|24|||
164581768|NCT02786537|594495798|FG004|As Randomized|Lost to treatment follow-up|4|||
164581769|NCT02786537|594495799|FG005|As Randomized|Lost to treatment follow-up|4|||
164581770|NCT02786537|594495794|FG000|As Randomized|Incarceration|0|||
164581771|NCT02786537|594495795|FG001|As Randomized|Incarceration|1|||
164581772|NCT02786537|594495796|FG002|As Randomized|Incarceration|0|||
164581773|NCT02786537|594495797|FG003|As Randomized|Incarceration|0|||
164581774|NCT02786537|594495798|FG004|As Randomized|Incarceration|0|||
164581775|NCT02786537|594495799|FG005|As Randomized|Incarceration|0|||
164581776|NCT02786537|594495794|FG000|As Randomized|Opiate Dependency Relapse|0|||
164581777|NCT02786537|594495795|FG001|As Randomized|Opiate Dependency Relapse|1|||
164581778|NCT02786537|594495796|FG002|As Randomized|Opiate Dependency Relapse|0|||
164581779|NCT02786537|594495797|FG003|As Randomized|Opiate Dependency Relapse|0|||
164581780|NCT02786537|594495798|FG004|As Randomized|Opiate Dependency Relapse|0|||
164581781|NCT02786537|594495799|FG005|As Randomized|Opiate Dependency Relapse|0|||
164581782|NCT02786537|594495794|FG000|As Randomized|HCV drugs stolen from pt|0|||
164581783|NCT02786537|594495795|FG001|As Randomized|HCV drugs stolen from pt|1|||
164581784|NCT02786537|594495796|FG002|As Randomized|HCV drugs stolen from pt|0|||
164581785|NCT02786537|594495797|FG003|As Randomized|HCV drugs stolen from pt|0|||
164270035|NCT02528357|593356845|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270036|NCT02528357|593356827|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270037|NCT02528357|593356828|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270038|NCT02528357|593356829|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164342133|NCT00599924|593629366|FG003|Overall Study|Death|2|||
164581786|NCT02786537|594495798|FG004|As Randomized|HCV drugs stolen from pt|0|||
164581787|NCT02786537|594495799|FG005|As Randomized|HCV drugs stolen from pt|0|||
164581788|NCT02786537|594495794|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
164581789|NCT02786537|594495795|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
164581790|NCT02786537|594495796|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
164581791|NCT02786537|594495797|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
164581792|NCT02786537|594495798|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
164581793|NCT02786537|594495799|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
164581794|NCT02786537|594495794|FG000|As Randomized|Subject lost insurance|0|||
164581795|NCT02786537|594495795|FG001|As Randomized|Subject lost insurance|0|||
164581796|NCT02786537|594495796|FG002|As Randomized|Subject lost insurance|0|||
164581797|NCT02786537|594495797|FG003|As Randomized|Subject lost insurance|1|||
164581798|NCT02786537|594495798|FG004|As Randomized|Subject lost insurance|0|||
164581799|NCT02786537|594495799|FG005|As Randomized|Subject lost insurance|0|||
164581800|NCT02786537|594495794|FG000|As Treated|Adverse Event|0|||
164581801|NCT02786537|594495795|FG001|As Treated|Adverse Event|11|||
164581802|NCT02786537|594495796|FG002|As Treated|Adverse Event|0|||
164581803|NCT02786537|594495797|FG003|As Treated|Adverse Event|4|||
164581804|NCT02786537|594495798|FG004|As Treated|Adverse Event|6|||
164581805|NCT02786537|594495799|FG005|As Treated|Adverse Event|2|||
164581806|NCT02786537|594495794|FG000|As Treated|Death|0|||
164581807|NCT02786537|594495795|FG001|As Treated|Death|2|||
164581808|NCT02786537|594495796|FG002|As Treated|Death|0|||
164581809|NCT02786537|594495797|FG003|As Treated|Death|3|||
164581810|NCT02786537|594495798|FG004|As Treated|Death|1|||
164581811|NCT02786537|594495799|FG005|As Treated|Death|0|||
164581812|NCT02786537|594495794|FG000|As Treated|Lack of Efficacy|0|||
164581813|NCT02786537|594495795|FG001|As Treated|Lack of Efficacy|0|||
164581814|NCT02786537|594495796|FG002|As Treated|Lack of Efficacy|0|||
164581815|NCT02786537|594495797|FG003|As Treated|Lack of Efficacy|1|||
164581816|NCT02786537|594495798|FG004|As Treated|Lack of Efficacy|0|||
164581817|NCT02786537|594495799|FG005|As Treated|Lack of Efficacy|0|||
164581818|NCT02786537|594495794|FG000|As Treated|Lost to Follow-up|4|||
164581819|NCT02786537|594495795|FG001|As Treated|Lost to Follow-up|32|||
164581820|NCT02786537|594495796|FG002|As Treated|Lost to Follow-up|0|||
164581821|NCT02786537|594495797|FG003|As Treated|Lost to Follow-up|25|||
164581822|NCT02786537|594495798|FG004|As Treated|Lost to Follow-up|4|||
164581823|NCT02786537|594495799|FG005|As Treated|Lost to Follow-up|4|||
164581824|NCT02786537|594495794|FG000|As Treated|Non-compliance with study drug|1|||
164581825|NCT02786537|594495795|FG001|As Treated|Non-compliance with study drug|11|||
164581826|NCT02786537|594495796|FG002|As Treated|Non-compliance with study drug|0|||
164581827|NCT02786537|594495797|FG003|As Treated|Non-compliance with study drug|1|||
164581828|NCT02786537|594495798|FG004|As Treated|Non-compliance with study drug|0|||
164581829|NCT02786537|594495799|FG005|As Treated|Non-compliance with study drug|1|||
164581830|NCT02786537|594495794|FG000|As Treated|Lost insurance|0|||
164581831|NCT02786537|594495795|FG001|As Treated|Lost insurance|0|||
164581832|NCT02786537|594495796|FG002|As Treated|Lost insurance|0|||
164581833|NCT02786537|594495797|FG003|As Treated|Lost insurance|1|||
164581834|NCT02786537|594495798|FG004|As Treated|Lost insurance|0|||
164581835|NCT02786537|594495799|FG005|As Treated|Lost insurance|0|||
164581836|NCT02786537|594495794|FG000|As Treated|Withdrawal by Subject|1|||
164581837|NCT02786537|594495795|FG001|As Treated|Withdrawal by Subject|2|||
164581838|NCT02786537|594495796|FG002|As Treated|Withdrawal by Subject|0|||
164581839|NCT02786537|594495797|FG003|As Treated|Withdrawal by Subject|0|||
164581840|NCT02786537|594495798|FG004|As Treated|Withdrawal by Subject|1|||
164581841|NCT02786537|594495799|FG005|As Treated|Withdrawal by Subject|0|||
164581842|NCT02786537|594495794|FG000|As Treated|Incarceration|0|||
164581843|NCT02786537|594495795|FG001|As Treated|Incarceration|1|||
164581844|NCT02786537|594495796|FG002|As Treated|Incarceration|0|||
164581845|NCT02786537|594495797|FG003|As Treated|Incarceration|0|||
164581846|NCT02786537|594495798|FG004|As Treated|Incarceration|0|||
164342134|NCT00599924|593629367|FG004|Overall Study|Death|0|||
164342135|NCT00599924|593629368|FG005|Overall Study|Death|2|||
164342136|NCT00599924|593629369|FG006|Overall Study|Death|1|||
164342137|NCT00599924|593629363|FG000|Overall Study|Protocol Violation|0|||
164342138|NCT00599924|593629364|FG001|Overall Study|Protocol Violation|0|||
164342139|NCT00599924|593629365|FG002|Overall Study|Protocol Violation|0|||
164342140|NCT00599924|593629366|FG003|Overall Study|Protocol Violation|1|||
164581847|NCT02786537|594495799|FG005|As Treated|Incarceration|0|||
164342141|NCT00599924|593629367|FG004|Overall Study|Protocol Violation|0|||
164342142|NCT00599924|593629368|FG005|Overall Study|Protocol Violation|0|||
164342143|NCT00599924|593629369|FG006|Overall Study|Protocol Violation|0|||
164581848|NCT02786537|594495794|FG000|As Treated|Opiate dependency relapse|0|||
164581849|NCT02786537|594495795|FG001|As Treated|Opiate dependency relapse|1|||
164581850|NCT02786537|594495796|FG002|As Treated|Opiate dependency relapse|0|||
164581851|NCT02786537|594495797|FG003|As Treated|Opiate dependency relapse|0|||
164581852|NCT02786537|594495798|FG004|As Treated|Opiate dependency relapse|0|||
164342144|NCT00599924|593629363|FG000|Overall Study|Withdrawal by Subject|0|||
164342145|NCT00599924|593629364|FG001|Overall Study|Withdrawal by Subject|0|||
164581853|NCT02786537|594495799|FG005|As Treated|Opiate dependency relapse|0|||
164581854|NCT02786537|594495794|FG000|As Treated|Drugs stolen from patient|0|||
164581855|NCT02786537|594495795|FG001|As Treated|Drugs stolen from patient|1|||
164581856|NCT02786537|594495796|FG002|As Treated|Drugs stolen from patient|0|||
164581857|NCT02786537|594495797|FG003|As Treated|Drugs stolen from patient|0|||
164581858|NCT02786537|594495798|FG004|As Treated|Drugs stolen from patient|0|||
164581859|NCT02786537|594495799|FG005|As Treated|Drugs stolen from patient|0|||
164581860|NCT02786537|594495794|FG000|As Treated|Advised to stop tx after loss of meds|0|||
164581861|NCT02786537|594495795|FG001|As Treated|Advised to stop tx after loss of meds|1|||
164581862|NCT02786537|594495796|FG002|As Treated|Advised to stop tx after loss of meds|0|||
164581863|NCT02786537|594495797|FG003|As Treated|Advised to stop tx after loss of meds|0|||
164581864|NCT02786537|594495798|FG004|As Treated|Advised to stop tx after loss of meds|0|||
164581865|NCT02786537|594495799|FG005|As Treated|Advised to stop tx after loss of meds|0|||
164581866|NCT00077623|594495800|FG000|Overall Study|Adverse Event|1|||
164581867|NCT00077623|594495801|FG001|Overall Study|Adverse Event|0|||
164581868|NCT00077623|594495802|FG002|Overall Study|Adverse Event|1|||
164581869|NCT00077623|594495800|FG000|Overall Study|Withdrawal by Subject|2|||
164581870|NCT00077623|594495801|FG001|Overall Study|Withdrawal by Subject|10|||
164581871|NCT00077623|594495802|FG002|Overall Study|Withdrawal by Subject|1|||
164581872|NCT00077623|594495800|FG000|Overall Study|Other-Non safety reason|18|||
164581873|NCT00077623|594495801|FG001|Overall Study|Other-Non safety reason|15|||
164581874|NCT00077623|594495802|FG002|Overall Study|Other-Non safety reason|19|||
164581875|NCT00077623|594495800|FG000|Overall Study|Insufficient therapeutic response|2|||
164581876|NCT00077623|594495801|FG001|Overall Study|Insufficient therapeutic response|0|||
164581877|NCT00077623|594495802|FG002|Overall Study|Insufficient therapeutic response|0|||
164581878|NCT00077623|594495800|FG000|Overall Study|Death|12|||
164581879|NCT00077623|594495801|FG001|Overall Study|Death|18|||
164581880|NCT00077623|594495802|FG002|Overall Study|Death|11|||
164581881|NCT00077623|594495800|FG000|Overall Study|Failure to return|1|||
164581882|NCT00077623|594495801|FG001|Overall Study|Failure to return|0|||
164581883|NCT00077623|594495802|FG002|Overall Study|Failure to return|0|||
164581884|NCT00401973|594495803|FG000|Overall Study|Adverse Event|2|||
164581885|NCT00401973|594495804|FG001|Overall Study|Adverse Event|8|||
164581886|NCT00401973|594495805|FG002|Overall Study|Adverse Event|4|||
164581887|NCT00401973|594495803|FG000|Overall Study|Clinical Relapse|0|||
164581888|NCT00401973|594495804|FG001|Overall Study|Clinical Relapse|1|||
164581889|NCT00401973|594495805|FG002|Overall Study|Clinical Relapse|1|||
164581890|NCT00401973|594495803|FG000|Overall Study|Lack of Efficacy|0|||
164581891|NCT00401973|594495804|FG001|Overall Study|Lack of Efficacy|0|||
164581892|NCT00401973|594495805|FG002|Overall Study|Lack of Efficacy|3|||
164581893|NCT00401973|594495803|FG000|Overall Study|Lost to Follow-up|2|||
164581894|NCT00401973|594495804|FG001|Overall Study|Lost to Follow-up|2|||
164581895|NCT00401973|594495805|FG002|Overall Study|Lost to Follow-up|2|||
164581896|NCT00401973|594495803|FG000|Overall Study|Physician Decision|2|||
164581897|NCT00401973|594495804|FG001|Overall Study|Physician Decision|0|||
164581898|NCT00401973|594495805|FG002|Overall Study|Physician Decision|1|||
164581899|NCT00401973|594495803|FG000|Overall Study|Protocol Violation|1|||
164581900|NCT00401973|594495804|FG001|Overall Study|Protocol Violation|2|||
164581901|NCT00401973|594495805|FG002|Overall Study|Protocol Violation|3|||
164581902|NCT00401973|594495803|FG000|Overall Study|Sponsor Decision|0|||
164581903|NCT00401973|594495804|FG001|Overall Study|Sponsor Decision|1|||
164581904|NCT00401973|594495805|FG002|Overall Study|Sponsor Decision|0|||
164581905|NCT00401973|594495803|FG000|Overall Study|Withdrawal by Subject|4|||
164581906|NCT00401973|594495804|FG001|Overall Study|Withdrawal by Subject|12|||
164581907|NCT00401973|594495805|FG002|Overall Study|Withdrawal by Subject|9|||
164581908|NCT02584634|594495806|FG000|Overall Study|Adverse Event|3|||
164581909|NCT02584634|594495807|FG001|Overall Study|Adverse Event|5|||
164581910|NCT02584634|594495806|FG000|Overall Study|Death|0|||
164581911|NCT02584634|594495807|FG001|Overall Study|Death|1|||
164581912|NCT02584634|594495806|FG000|Overall Study|Lost to Follow-up|0|||
164581913|NCT02584634|594495807|FG001|Overall Study|Lost to Follow-up|1|||
164581914|NCT02584634|594495806|FG000|Overall Study|Physician Decision|1|||
164342146|NCT00599924|593629365|FG002|Overall Study|Withdrawal by Subject|1|||
164342147|NCT00599924|593629366|FG003|Overall Study|Withdrawal by Subject|0|||
164342148|NCT00599924|593629367|FG004|Overall Study|Withdrawal by Subject|1|||
164342149|NCT00599924|593629368|FG005|Overall Study|Withdrawal by Subject|0|||
164342150|NCT00599924|593629369|FG006|Overall Study|Withdrawal by Subject|0|||
164581915|NCT02584634|594495807|FG001|Overall Study|Physician Decision|2|||
164581916|NCT02584634|594495806|FG000|Overall Study|Progressive disease|7|||
164581917|NCT02584634|594495807|FG001|Overall Study|Progressive disease|15|||
164581918|NCT02584634|594495806|FG000|Overall Study|Withdrawal by Subject|1|||
164581919|NCT02584634|594495807|FG001|Overall Study|Withdrawal by Subject|1|||
164581920|NCT02584634|594495806|FG000|Overall Study|Other|0|||
164581921|NCT02584634|594495807|FG001|Overall Study|Other|6|||
164581922|NCT04075604|594495809|FG000|Overall Study|Adverse Event|0|||
164581923|NCT04075604|594495810|FG001|Overall Study|Adverse Event|0|||
164342151|NCT00599924|593629363|FG000|Overall Study|Other|0|||
164342152|NCT00599924|593629364|FG001|Overall Study|Other|0|||
164581924|NCT04075604|594495811|FG002|Overall Study|Adverse Event|3|||
164581925|NCT04075604|594495809|FG000|Overall Study|Participant request to discontinue study treatment|0|||
164581926|NCT04075604|594495810|FG001|Overall Study|Participant request to discontinue study treatment|0|||
164270039|NCT02528357|593356830|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270040|NCT02528357|593356831|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270041|NCT02528357|593356832|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270042|NCT02528357|593356833|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270043|NCT02528357|593356834|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270044|NCT02528357|593356835|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270045|NCT02528357|593356836|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270046|NCT02528357|593356837|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
164270047|NCT02528357|593356838|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270048|NCT02528357|593356839|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
164270049|NCT02528357|593356840|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
164270050|NCT02528357|593356841|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
164270051|NCT02528357|593356842|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270052|NCT02528357|593356843|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270053|NCT02528357|593356844|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270054|NCT02528357|593356845|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270055|NCT02528357|593356827|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270056|NCT02528357|593356828|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270057|NCT02528357|593356829|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270058|NCT02528357|593356830|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270059|NCT02528357|593356831|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270060|NCT02528357|593356832|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270061|NCT02528357|593356833|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270062|NCT02528357|593356834|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270063|NCT02528357|593356835|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
164270064|NCT02528357|593356836|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
164270065|NCT02528357|593356837|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270066|NCT02528357|593356838|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
164270067|NCT02528357|593356839|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
164270068|NCT02528357|593356840|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
164270069|NCT02528357|593356841|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
164270070|NCT02528357|593356842|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270071|NCT02528357|593356843|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270072|NCT02528357|593356844|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270073|NCT02528357|593356845|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270074|NCT02528357|593356827|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270075|NCT02528357|593356828|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164342153|NCT00599924|593629365|FG002|Overall Study|Other|0|||
164342154|NCT00599924|593629366|FG003|Overall Study|Other|1|||
164342155|NCT00599924|593629367|FG004|Overall Study|Other|2|||
164342156|NCT00599924|593629368|FG005|Overall Study|Other|0|||
164342157|NCT00599924|593629369|FG006|Overall Study|Other|2|||
164342158|NCT02587234|593629370|FG000|Overall Study|Withdrawal by Subject|1|||
164342159|NCT02587234|593629371|FG001|Overall Study|Withdrawal by Subject|1|||
164342160|NCT02587234|593629370|FG000|Overall Study|Lost to Follow-up|0|||
164342161|NCT02587234|593629371|FG001|Overall Study|Lost to Follow-up|2|||
164342162|NCT02165215|593629372|FG000|Induction Phase|Adverse Event|1|||
164342163|NCT02165215|593629373|FG001|Induction Phase|Adverse Event|0|||
164342164|NCT02165215|593629374|FG002|Induction Phase|Adverse Event|0|||
164342165|NCT02165215|593629372|FG000|Induction Phase|Withdrawal by Subject|10|||
164342166|NCT02165215|593629373|FG001|Induction Phase|Withdrawal by Subject|0|||
164342167|NCT02165215|593629374|FG002|Induction Phase|Withdrawal by Subject|0|||
164342168|NCT02165215|593629372|FG000|Induction Phase|Protocol Violation|1|||
164342169|NCT02165215|593629373|FG001|Induction Phase|Protocol Violation|0|||
164342170|NCT02165215|593629374|FG002|Induction Phase|Protocol Violation|0|||
164342171|NCT02165215|593629372|FG000|Induction Phase|Physician Decision|1|||
164342172|NCT02165215|593629373|FG001|Induction Phase|Physician Decision|0|||
164342173|NCT02165215|593629374|FG002|Induction Phase|Physician Decision|0|||
164342174|NCT02165215|593629372|FG000|Induction Phase|Lack of Efficacy|2|||
164342175|NCT02165215|593629373|FG001|Induction Phase|Lack of Efficacy|0|||
164270076|NCT02528357|593356829|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270077|NCT02528357|593356830|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270078|NCT02528357|593356831|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270079|NCT02528357|593356832|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270080|NCT02528357|593356833|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270081|NCT02528357|593356834|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270082|NCT02528357|593356835|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270083|NCT02528357|593356836|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270084|NCT02528357|593356837|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270085|NCT02528357|593356838|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270086|NCT02528357|593356839|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270087|NCT02528357|593356840|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270088|NCT02528357|593356841|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270089|NCT02528357|593356842|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270090|NCT02528357|593356843|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
164270091|NCT02528357|593356844|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270092|NCT02528357|593356845|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270093|NCT02528357|593356827|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270094|NCT02528357|593356828|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270095|NCT02528357|593356829|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270096|NCT02528357|593356830|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270097|NCT02528357|593356831|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270098|NCT02528357|593356832|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270099|NCT02528357|593356833|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270100|NCT02528357|593356834|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270101|NCT02528357|593356835|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270102|NCT02528357|593356836|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270103|NCT02528357|593356837|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164342176|NCT02165215|593629374|FG002|Induction Phase|Lack of Efficacy|0|||
164342177|NCT02165215|593629372|FG000|Induction Phase|Non-Compliance|2|||
164342178|NCT02165215|593629373|FG001|Induction Phase|Non-Compliance|0|||
164581927|NCT04075604|594495811|FG002|Overall Study|Participant request to discontinue study treatment|1|||
164581928|NCT04075604|594495809|FG000|Overall Study|Participant withdrew consent|0|||
164581929|NCT04075604|594495810|FG001|Overall Study|Participant withdrew consent|0|||
164581930|NCT04075604|594495811|FG002|Overall Study|Participant withdrew consent|1|||
164581931|NCT04075604|594495809|FG000|Overall Study|Other reasons|1|||
164581932|NCT04075604|594495810|FG001|Overall Study|Other reasons|0|||
164581933|NCT04075604|594495811|FG002|Overall Study|Other reasons|0|||
164581934|NCT04075604|594495809|FG000|Overall Study|Disease progression|0|||
164581935|NCT04075604|594495810|FG001|Overall Study|Disease progression|1|||
164581936|NCT04075604|594495811|FG002|Overall Study|Disease progression|0|||
164581937|NCT04075604|594495809|FG000|Overall Study|Study drug toxicity|0|||
164581938|NCT04075604|594495810|FG001|Overall Study|Study drug toxicity|5|||
164581939|NCT04075604|594495811|FG002|Overall Study|Study drug toxicity|1|||
164581940|NCT01050062|594495815|FG000|Overall Study|Adverse Event|75|||
164581941|NCT01050062|594495816|FG001|Overall Study|Adverse Event|22|||
164581942|NCT01050062|594495815|FG000|Overall Study|Lost to Follow-up|83|||
164581943|NCT01050062|594495816|FG001|Overall Study|Lost to Follow-up|35|||
164581944|NCT01050062|594495815|FG000|Overall Study|Lack of Efficacy|22|||
164581945|NCT01050062|594495816|FG001|Overall Study|Lack of Efficacy|35|||
164581946|NCT01050062|594495815|FG000|Overall Study|Physician Decision|74|||
164581947|NCT01050062|594495816|FG001|Overall Study|Physician Decision|9|||
164581948|NCT01050062|594495815|FG000|Overall Study|Others|17|||
164581949|NCT01050062|594495816|FG001|Overall Study|Others|11|||
164581950|NCT03894540|594495817|FG000|Overall Study|Adverse Event|0|||
164581951|NCT03894540|594495818|FG001|Overall Study|Adverse Event|0|||
164581952|NCT03894540|594495819|FG002|Overall Study|Adverse Event|0|||
164581953|NCT03894540|594495820|FG003|Overall Study|Adverse Event|0|||
164581954|NCT03894540|594495821|FG004|Overall Study|Adverse Event|1|||
164581955|NCT03894540|594495822|FG005|Overall Study|Adverse Event|0|||
164581956|NCT03894540|594495817|FG000|Overall Study|Withdrawal by Subject|0|||
164581957|NCT03894540|594495818|FG001|Overall Study|Withdrawal by Subject|0|||
164342179|NCT02165215|593629374|FG002|Induction Phase|Non-Compliance|0|||
164581958|NCT03894540|594495819|FG002|Overall Study|Withdrawal by Subject|0|||
164581959|NCT03894540|594495820|FG003|Overall Study|Withdrawal by Subject|0|||
164581960|NCT03894540|594495821|FG004|Overall Study|Withdrawal by Subject|1|||
164581961|NCT03894540|594495822|FG005|Overall Study|Withdrawal by Subject|0|||
164687323|NCT01863433|594878257|FG000|Overall Study|Protocol Violation|1|||
164687324|NCT03950674|594878258|FG000|Overall Study|Death|16|||
164687325|NCT03950674|594878259|FG001|Overall Study|Death|15|||
164687326|NCT03950674|594878258|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
164687327|NCT03950674|594878259|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
164687328|NCT00830167|594878262|FG000|Overall Study|Lack of Efficacy|26|||
164687329|NCT00830167|594878263|FG001|Overall Study|Lack of Efficacy|10|||
164687330|NCT00830167|594878262|FG000|Overall Study|Adverse Event|8|||
164687331|NCT00830167|594878263|FG001|Overall Study|Adverse Event|24|||
164687332|NCT00830167|594878262|FG000|Overall Study|Not meeting entrance criteria|2|||
164687333|NCT00830167|594878263|FG001|Overall Study|Not meeting entrance criteria|5|||
164687334|NCT00830167|594878262|FG000|Overall Study|Withdrawal by Subject|2|||
164687335|NCT00830167|594878263|FG001|Overall Study|Withdrawal by Subject|0|||
164687336|NCT00830167|594878262|FG000|Overall Study|Lost to Follow-up|0|||
164687337|NCT00830167|594878263|FG001|Overall Study|Lost to Follow-up|1|||
164687338|NCT00830167|594878262|FG000|Overall Study|Protocol Violation|0|||
164687339|NCT00830167|594878263|FG001|Overall Study|Protocol Violation|1|||
164687340|NCT00830167|594878262|FG000|Overall Study|Other|2|||
164687341|NCT00830167|594878263|FG001|Overall Study|Other|2|||
164687342|NCT03428945|594878264|FG000|Overall Study|Lost to Follow-up|5|||
164687343|NCT03428945|594878265|FG001|Overall Study|Lost to Follow-up|3|||
164687344|NCT03428945|594878264|FG000|Overall Study|Withdrawal by Subject|10|||
164687345|NCT03428945|594878265|FG001|Overall Study|Withdrawal by Subject|10|||
164687346|NCT00982228|594878266|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
164687347|NCT00982228|594878267|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
164687348|NCT00982228|594878266|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
164687349|NCT00982228|594878267|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
164270104|NCT02528357|593356838|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270105|NCT02528357|593356839|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270106|NCT02528357|593356840|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270107|NCT02528357|593356841|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270108|NCT02528357|593356842|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270109|NCT02528357|593356843|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
164270110|NCT02528357|593356844|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
164270111|NCT02528357|593356845|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
164270112|NCT01455220|593356847|FG000|Overall Study|screen fail|30|||
164270113|NCT02621073|593356848|FG000|Overall Study|Lost to Follow-up|0|||
164270114|NCT02621073|593356849|FG001|Overall Study|Lost to Follow-up|1|||
164270115|NCT02621073|593356848|FG000|Overall Study|Physician Decision|3|||
164270116|NCT02621073|593356849|FG001|Overall Study|Physician Decision|2|||
164270117|NCT01595581|593356850|FG000|Overall Study|Withdrawal by Subject|1|||
164270118|NCT01595581|593356851|FG001|Overall Study|Withdrawal by Subject|0|||
164270119|NCT01969721|593356853|FG000|Overall Study|Adverse Event|3|||
164270120|NCT01969721|593356854|FG001|Overall Study|Adverse Event|8|||
164270121|NCT01969721|593356855|FG002|Overall Study|Adverse Event|3|||
164270122|NCT01969721|593356856|FG003|Overall Study|Adverse Event|2|||
164270123|NCT01969721|593356853|FG000|Overall Study|Lack of Efficacy|0|||
164270124|NCT01969721|593356854|FG001|Overall Study|Lack of Efficacy|0|||
164270125|NCT01969721|593356855|FG002|Overall Study|Lack of Efficacy|1|||
164270126|NCT01969721|593356856|FG003|Overall Study|Lack of Efficacy|0|||
164270127|NCT01969721|593356853|FG000|Overall Study|Non compliant with protocol|1|||
164270128|NCT01969721|593356854|FG001|Overall Study|Non compliant with protocol|1|||
164270129|NCT01969721|593356855|FG002|Overall Study|Non compliant with protocol|0|||
164270130|NCT01969721|593356856|FG003|Overall Study|Non compliant with protocol|2|||
164270131|NCT01969721|593356853|FG000|Overall Study|Other not defined above|0|||
164342180|NCT02165215|593629372|FG000|Induction Phase|Lost to Follow-up|6|||
164342181|NCT02165215|593629373|FG001|Induction Phase|Lost to Follow-up|0|||
164342182|NCT02165215|593629374|FG002|Induction Phase|Lost to Follow-up|0|||
164342183|NCT02165215|593629372|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164342184|NCT02165215|593629373|FG001|Maintenance Phase|Withdrawal by Subject|7|||
164342185|NCT02165215|593629374|FG002|Maintenance Phase|Withdrawal by Subject|3|||
164342186|NCT02165215|593629372|FG000|Maintenance Phase|Multiple reasons|0|||
164342187|NCT02165215|593629373|FG001|Maintenance Phase|Multiple reasons|2|||
164342188|NCT02165215|593629374|FG002|Maintenance Phase|Multiple reasons|1|||
164687350|NCT00982228|594878266|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
164342189|NCT02165215|593629372|FG000|Maintenance Phase|Lost to Follow-up|0|||
164687351|NCT00982228|594878267|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
164687352|NCT00982228|594878266|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
164687353|NCT00982228|594878267|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
164687354|NCT00982228|594878266|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
164687355|NCT00982228|594878267|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
164687356|NCT00982228|594878266|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
164687357|NCT00982228|594878267|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
164581962|NCT03894540|594495817|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
164581963|NCT03894540|594495818|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
164581964|NCT03894540|594495819|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
164581965|NCT03894540|594495820|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
164581966|NCT03894540|594495821|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
164581967|NCT03894540|594495822|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
164581968|NCT03894540|594495817|FG000|Overall Study|Progressive Disease Clinical|1|||
164581969|NCT03894540|594495818|FG001|Overall Study|Progressive Disease Clinical|1|||
164581970|NCT03894540|594495819|FG002|Overall Study|Progressive Disease Clinical|0|||
164581971|NCT03894540|594495820|FG003|Overall Study|Progressive Disease Clinical|1|||
164581972|NCT03894540|594495821|FG004|Overall Study|Progressive Disease Clinical|5|||
164581973|NCT03894540|594495822|FG005|Overall Study|Progressive Disease Clinical|1|||
164581974|NCT03894540|594495817|FG000|Overall Study|Study termination by sponsor|0|||
164581975|NCT03894540|594495818|FG001|Overall Study|Study termination by sponsor|0|||
164581976|NCT03894540|594495819|FG002|Overall Study|Study termination by sponsor|0|||
164581977|NCT03894540|594495820|FG003|Overall Study|Study termination by sponsor|0|||
164581978|NCT03894540|594495821|FG004|Overall Study|Study termination by sponsor|2|||
164581979|NCT03894540|594495822|FG005|Overall Study|Study termination by sponsor|0|||
164581980|NCT00852930|594495823|FG000|Overall Study|Withdrawal by Subject|1|||
164581981|NCT00852930|594495824|FG001|Overall Study|Withdrawal by Subject|1|||
164581982|NCT00852930|594495825|FG002|Overall Study|Withdrawal by Subject|1|||
164581983|NCT00852930|594495823|FG000|Overall Study|Physician Decision|0|||
164581984|NCT00852930|594495824|FG001|Overall Study|Physician Decision|0|||
164581985|NCT00852930|594495825|FG002|Overall Study|Physician Decision|1|||
164581986|NCT00537745|594495826|FG000|Overall Study|Did not meet eligibility criteria|2|||
164581987|NCT00537745|594495826|FG000|Overall Study|Withdrawal by Subject|2|||
164581988|NCT00537745|594495826|FG000|Overall Study|Subject unable to provide Interlock info|1|||
164581989|NCT03700892|594495828|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
164581990|NCT03700892|594495829|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
164581991|NCT03700892|594495830|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
164581992|NCT02532543|594495831|FG000|Overall Study|Lost to Follow-up|0|||
164581993|NCT02532543|594495832|FG001|Overall Study|Lost to Follow-up|0|||
164581994|NCT02532543|594495833|FG002|Overall Study|Lost to Follow-up|1|||
164581995|NCT02532543|594495834|FG003|Overall Study|Lost to Follow-up|0|||
164581996|NCT00650585|594495835|FG000|Overall Study|Lost to Follow-up|505|||
164581997|NCT00650585|594495836|FG001|Overall Study|Lost to Follow-up|482|||
164581998|NCT00650585|594495835|FG000|Overall Study|No parental consent|935|||
164581999|NCT00650585|594495836|FG001|Overall Study|No parental consent|866|||
164582000|NCT00650585|594495835|FG000|Overall Study|Excluded/ruled ineligible|357|||
164582001|NCT00650585|594495836|FG001|Overall Study|Excluded/ruled ineligible|129|||
164582002|NCT02640612|594495837|FG000|Overall Study|Adverse Event|6|||
164582003|NCT02640612|594495838|FG001|Overall Study|Adverse Event|7|||
164582004|NCT02640612|594495839|FG002|Overall Study|Adverse Event|2|||
164582005|NCT02640612|594495837|FG000|Overall Study|Death|1|||
164582006|NCT02640612|594495838|FG001|Overall Study|Death|0|||
164582007|NCT02640612|594495839|FG002|Overall Study|Death|0|||
164582008|NCT02640612|594495837|FG000|Overall Study|Withdrawal by Subject|10|||
164582009|NCT02640612|594495838|FG001|Overall Study|Withdrawal by Subject|3|||
164582010|NCT02640612|594495839|FG002|Overall Study|Withdrawal by Subject|3|||
164582011|NCT02640612|594495837|FG000|Overall Study|Lost to Follow-up|4|||
164582012|NCT02640612|594495838|FG001|Overall Study|Lost to Follow-up|1|||
164582013|NCT02640612|594495839|FG002|Overall Study|Lost to Follow-up|1|||
164582014|NCT02640612|594495837|FG000|Overall Study|Protocol Violation|0|||
164582015|NCT02640612|594495838|FG001|Overall Study|Protocol Violation|2|||
164582016|NCT02640612|594495839|FG002|Overall Study|Protocol Violation|0|||
164582017|NCT02640612|594495837|FG000|Overall Study|Lack of Efficacy|1|||
164582018|NCT02640612|594495838|FG001|Overall Study|Lack of Efficacy|1|||
164582019|NCT02640612|594495839|FG002|Overall Study|Lack of Efficacy|0|||
164582020|NCT00849212|594495840|FG000|Overall Study|Lack of Efficacy|1|||
164582021|NCT00849212|594495840|FG000|Overall Study|Withdrawal by Subject|3|||
164582022|NCT00849212|594495840|FG000|Overall Study|Adverse Event|2|||
164582023|NCT00849212|594495840|FG000|Overall Study|Miscellaneous|1|||
164582024|NCT03472534|594495849|FG000|Overall Study|Withdrawal by Subject|9|||
164582025|NCT03472534|594495849|FG000|Overall Study|Adverse Event|2|||
164582026|NCT02614794|594495850|FG000|Overall Study|Death|258|||
164582027|NCT02614794|594495851|FG001|Overall Study|Death|151|||
164582028|NCT02614794|594495850|FG000|Overall Study|Study closure by Sponsor|119|||
164582029|NCT02614794|594495851|FG001|Overall Study|Study closure by Sponsor|45|||
164582030|NCT02614794|594495850|FG000|Overall Study|Withdrawal by Subject|24|||
164582031|NCT02614794|594495851|FG001|Overall Study|Withdrawal by Subject|5|||
164687358|NCT00982228|594878266|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
164687359|NCT00982228|594878267|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
164687360|NCT00982228|594878266|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
164687361|NCT00982228|594878267|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
164687362|NCT00982228|594878266|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
164687363|NCT00982228|594878267|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
164687364|NCT00982228|594878266|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
164687365|NCT00982228|594878267|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
164687366|NCT01801917|594878271|FG000|Period 1 - Randomized|Adverse Event|1|||
164687367|NCT01801917|594878272|FG001|Period 1 - Randomized|Adverse Event|0|||
164582032|NCT02614794|594495850|FG000|Overall Study|Lost to Follow-up|7|||
164582033|NCT02614794|594495851|FG001|Overall Study|Lost to Follow-up|0|||
164582034|NCT02614794|594495850|FG000|Overall Study|Physician Decision|1|||
164582035|NCT02614794|594495851|FG001|Overall Study|Physician Decision|1|||
164582036|NCT02614794|594495850|FG000|Overall Study|Hospital closure|1|||
164582037|NCT02614794|594495851|FG001|Overall Study|Hospital closure|0|||
164582038|NCT02117050|594495854|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
164582039|NCT01591330|594495858|FG000|Period 1|Adverse Event|1|||
164582040|NCT01591330|594495859|FG001|Period 1|Adverse Event|0|||
164582041|NCT01591330|594495860|FG002|Period 1|Adverse Event|0|||
164582042|NCT01591330|594495861|FG003|Period 1|Adverse Event|0|||
164582043|NCT01591330|594495858|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
164582044|NCT01591330|594495859|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
164582045|NCT01591330|594495860|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
164582046|NCT01591330|594495861|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
164582047|NCT01591330|594495858|FG000|Period 2|Adverse Event|1|||
164582048|NCT01591330|594495859|FG001|Period 2|Adverse Event|0|||
164582049|NCT01591330|594495860|FG002|Period 2|Adverse Event|0|||
164582050|NCT01591330|594495861|FG003|Period 2|Adverse Event|0|||
164582051|NCT01662999|594495862|FG000|Period 3|Withdrawal by Subject|0|||
164582052|NCT01662999|594495863|FG001|Period 3|Withdrawal by Subject|1|||
164582053|NCT01662999|594495864|FG002|Period 3|Withdrawal by Subject|0|||
164582054|NCT01662999|594495865|FG003|Period 3|Withdrawal by Subject|0|||
164582055|NCT01662999|594495866|FG004|Period 3|Withdrawal by Subject|0|||
164582056|NCT01662999|594495867|FG005|Period 3|Withdrawal by Subject|0|||
164582057|NCT00196937|594495868|FG000|Overall Study|Serious Adverse Event|1|||
164582058|NCT00196937|594495869|FG001|Overall Study|Serious Adverse Event|0|||
164582059|NCT00196937|594495870|FG002|Overall Study|Serious Adverse Event|0|||
164582060|NCT00196937|594495868|FG000|Overall Study|Non-serious adverse event|1|||
164582061|NCT00196937|594495869|FG001|Overall Study|Non-serious adverse event|1|||
164582062|NCT00196937|594495870|FG002|Overall Study|Non-serious adverse event|1|||
164582063|NCT00196937|594495868|FG000|Overall Study|Withdrawal by Subject|0|||
164582064|NCT00196937|594495869|FG001|Overall Study|Withdrawal by Subject|0|||
164582065|NCT00196937|594495870|FG002|Overall Study|Withdrawal by Subject|2|||
164582066|NCT00196937|594495868|FG000|Overall Study|Lost to Follow-up|4|||
164582067|NCT00196937|594495869|FG001|Overall Study|Lost to Follow-up|3|||
164582068|NCT00196937|594495870|FG002|Overall Study|Lost to Follow-up|3|||
164582069|NCT00196937|594495868|FG000|Overall Study|Other|3|||
164582070|NCT00196937|594495869|FG001|Overall Study|Other|1|||
164582071|NCT00196937|594495870|FG002|Overall Study|Other|1|||
164582072|NCT03368404|594495873|FG000|Overall Study|Adverse Event|2|||
164582073|NCT03368404|594495874|FG001|Overall Study|Adverse Event|1|||
164582074|NCT03368404|594495873|FG000|Overall Study|Withdrawal by Subject|1|||
164582075|NCT03368404|594495874|FG001|Overall Study|Withdrawal by Subject|1|||
164582076|NCT04725682|594495875|FG000|Overall Study|Withdrawal by Subject|7|||
164582077|NCT04725682|594495876|FG001|Overall Study|Withdrawal by Subject|5|||
164582078|NCT04725682|594495875|FG000|Overall Study|Failed to comply with the requirements|2|||
164582079|NCT04725682|594495876|FG001|Overall Study|Failed to comply with the requirements|1|||
164582080|NCT04725682|594495875|FG000|Overall Study|Adverse Event|1|||
164582081|NCT04725682|594495876|FG001|Overall Study|Adverse Event|1|||
164582082|NCT04725682|594495875|FG000|Overall Study|Death|0|||
164582083|NCT04725682|594495876|FG001|Overall Study|Death|1|||
164582084|NCT00964795|594495877|FG000|Overall Study|Withdrawal by Subject|79|||
164582085|NCT00964795|594495877|FG000|Overall Study|Adverse Event|12|||
164582086|NCT00964795|594495877|FG000|Overall Study|Death|14|||
164582087|NCT00964795|594495877|FG000|Overall Study|Lost to Follow-up|7|||
164582088|NCT00964795|594495877|FG000|Overall Study|Termination of Study by Sponsor|169|||
164582089|NCT00964795|594495877|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
164582090|NCT00964795|594495877|FG000|Overall Study|Other|23|||
164582091|NCT02973815|594495878|FG000|Post Intervention|Death|1|||
164582092|NCT02973815|594495879|FG001|Post Intervention|Death|0|||
164582093|NCT02973815|594495878|FG000|Post Intervention|Lost to Follow-up|7|||
164582094|NCT02973815|594495879|FG001|Post Intervention|Lost to Follow-up|24|||
164582095|NCT02973815|594495878|FG000|Follow-up|Lost to Follow-up|2|||
164582096|NCT02973815|594495879|FG001|Follow-up|Lost to Follow-up|0|||
164582097|NCT03734666|594495880|FG000|Overall Study|Other|7|||
164270132|NCT01969721|593356854|FG001|Overall Study|Other not defined above|2|||
164270133|NCT01969721|593356855|FG002|Overall Study|Other not defined above|0|||
164270134|NCT01969721|593356856|FG003|Overall Study|Other not defined above|0|||
164270135|NCT01969721|593356853|FG000|Overall Study|Discontinued during washout periods.|0|||
164270136|NCT01969721|593356854|FG001|Overall Study|Discontinued during washout periods.|1|||
164270137|NCT01969721|593356855|FG002|Overall Study|Discontinued during washout periods.|1|||
164270138|NCT01969721|593356856|FG003|Overall Study|Discontinued during washout periods.|2|||
164270139|NCT00495755|593356857|FG000|Overall Study|Adverse Event|3|||
164270140|NCT02920957|593356858|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
164270141|NCT02920957|593356859|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
164270142|NCT02920957|593356858|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
164270143|NCT02920957|593356859|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
164582098|NCT03734666|594495881|FG001|Overall Study|Other|4|||
164582099|NCT03734666|594495880|FG000|Overall Study|Lost to Follow-up|12|||
164582100|NCT03734666|594495881|FG001|Overall Study|Lost to Follow-up|12|||
164582101|NCT05866185|594495882|FG000|Overall Study|Lost to Follow-up|2|||
164582102|NCT05866185|594495883|FG001|Overall Study|Lost to Follow-up|4|||
164582103|NCT05866185|594495884|FG002|Overall Study|Lost to Follow-up|4|||
164582104|NCT05866185|594495885|FG003|Overall Study|Lost to Follow-up|6|||
164582105|NCT01607892|594495888|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
164582106|NCT01607892|594495889|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
164582107|NCT01607892|594495890|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
164582108|NCT01607892|594495891|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
164582109|NCT01607892|594495892|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
164582110|NCT01607892|594495888|FG000|Overall Study|Death|4|||
164582111|NCT01607892|594495889|FG001|Overall Study|Death|2|||
164582112|NCT01607892|594495890|FG002|Overall Study|Death|8|||
164582113|NCT01607892|594495891|FG003|Overall Study|Death|10|||
164582114|NCT01607892|594495892|FG004|Overall Study|Death|3|||
164582115|NCT01607892|594495888|FG000|Overall Study|Investigator discretion|2|||
164582116|NCT01607892|594495889|FG001|Overall Study|Investigator discretion|4|||
164582117|NCT01607892|594495890|FG002|Overall Study|Investigator discretion|4|||
164582118|NCT01607892|594495891|FG003|Overall Study|Investigator discretion|8|||
164582119|NCT01607892|594495892|FG004|Overall Study|Investigator discretion|0|||
164582120|NCT01607892|594495888|FG000|Overall Study|Other treatments became available|1|||
164582121|NCT01607892|594495889|FG001|Overall Study|Other treatments became available|1|||
164582122|NCT01607892|594495890|FG002|Overall Study|Other treatments became available|0|||
164582123|NCT01607892|594495891|FG003|Overall Study|Other treatments became available|0|||
164582124|NCT01607892|594495892|FG004|Overall Study|Other treatments became available|2|||
164582125|NCT01607892|594495888|FG000|Overall Study|Intercurrent illness|1|||
164582126|NCT01607892|594495889|FG001|Overall Study|Intercurrent illness|0|||
164582127|NCT01607892|594495890|FG002|Overall Study|Intercurrent illness|0|||
164582128|NCT01607892|594495891|FG003|Overall Study|Intercurrent illness|3|||
164582129|NCT01607892|594495892|FG004|Overall Study|Intercurrent illness|0|||
164582130|NCT01607892|594495888|FG000|Overall Study|Non-Compliance with study procedures|0|||
164582131|NCT01607892|594495889|FG001|Overall Study|Non-Compliance with study procedures|0|||
164582132|NCT01607892|594495890|FG002|Overall Study|Non-Compliance with study procedures|1|||
164582133|NCT01607892|594495891|FG003|Overall Study|Non-Compliance with study procedures|0|||
164582134|NCT01607892|594495892|FG004|Overall Study|Non-Compliance with study procedures|0|||
164582135|NCT01607892|594495888|FG000|Overall Study|Consent withdrawn by participant|9|||
164582136|NCT01607892|594495889|FG001|Overall Study|Consent withdrawn by participant|4|||
164582137|NCT01607892|594495890|FG002|Overall Study|Consent withdrawn by participant|24|||
164582138|NCT01607892|594495891|FG003|Overall Study|Consent withdrawn by participant|14|||
164582139|NCT01607892|594495892|FG004|Overall Study|Consent withdrawn by participant|4|||
164582140|NCT01607892|594495888|FG000|Overall Study|Disease progression|38|||
164582141|NCT01607892|594495889|FG001|Overall Study|Disease progression|13|||
164582142|NCT01607892|594495890|FG002|Overall Study|Disease progression|37|||
164582143|NCT01607892|594495891|FG003|Overall Study|Disease progression|57|||
164582144|NCT01607892|594495892|FG004|Overall Study|Disease progression|9|||
164582145|NCT01607892|594495888|FG000|Overall Study|Incidence or severity of Adverse events|3|||
164582146|NCT01607892|594495889|FG001|Overall Study|Incidence or severity of Adverse events|3|||
164582147|NCT01607892|594495890|FG002|Overall Study|Incidence or severity of Adverse events|7|||
164582148|NCT01607892|594495891|FG003|Overall Study|Incidence or severity of Adverse events|2|||
164582149|NCT01607892|594495892|FG004|Overall Study|Incidence or severity of Adverse events|6|||
164582150|NCT03022422|594495893|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
164582151|NCT03022422|594495894|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
164582152|NCT03022422|594495895|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
164582153|NCT03022422|594495896|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
164582154|NCT03022422|594495897|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
164582155|NCT03022422|594495898|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
164582156|NCT05278104|594495902|FG000|Overall Study|Not treated|1|||
164582157|NCT05278104|594495903|FG001|Overall Study|Not treated|0|||
164687368|NCT01801917|594878273|FG002|Period 1 - Randomized|Adverse Event|1|||
164687369|NCT01801917|594878274|FG003|Period 1 - Randomized|Adverse Event|0|||
164687370|NCT01924364|594878275|FG000|Overall Study|Physician Decision|3|||
164687371|NCT00265785|594878276|FG000|Overall Study|Adverse Event|4|||
164687372|NCT00265785|594878276|FG000|Overall Study|Withdrawal by Subject|3|||
164687373|NCT00265785|594878276|FG000|Overall Study|Progression/Relapse|15|||
164687374|NCT00265785|594878276|FG000|Overall Study|Not protocol specified|2|||
164687375|NCT00265785|594878276|FG000|Overall Study|Ineligible|1|||
164687376|NCT00265785|594878276|FG000|Overall Study|Did not receive protocol treatment|2|||
164687377|NCT03919695|594878277|FG000|3-month Follow-up|Death|1|||
164687378|NCT03919695|594878278|FG001|3-month Follow-up|Death|1|||
164687379|NCT03919695|594878277|FG000|3-month Follow-up|unable to contact|0|||
164687380|NCT03919695|594878278|FG001|3-month Follow-up|unable to contact|3|||
164687381|NCT03919695|594878277|FG000|3-month Follow-up|in prison|0|||
164687382|NCT03919695|594878278|FG001|3-month Follow-up|in prison|1|||
164687383|NCT03919695|594878277|FG000|6-month Follow-up|Death|0|||
164687384|NCT03919695|594878278|FG001|6-month Follow-up|Death|1|||
164687385|NCT03919695|594878277|FG000|6-month Follow-up|Lost to Follow-up|1|||
164687386|NCT03919695|594878278|FG001|6-month Follow-up|Lost to Follow-up|2|||
164687387|NCT03919695|594878277|FG000|6-month Follow-up|in prison|0|||
164687388|NCT03919695|594878278|FG001|6-month Follow-up|in prison|2|||
164687389|NCT03919695|594878277|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
164687390|NCT03919695|594878278|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
164687391|NCT03919695|594878277|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
164687392|NCT03919695|594878278|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
164687393|NCT01688882|594878279|FG000|Overall Study|Adverse Event|1|||
164687394|NCT01688882|594878280|FG001|Overall Study|Adverse Event|0|||
164687395|NCT01688882|594878279|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164687396|NCT01688882|594878280|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
164687397|NCT01688882|594878279|FG000|Overall Study|Administrative problems|1|||
164687398|NCT01688882|594878280|FG001|Overall Study|Administrative problems|0|||
164687399|NCT04750239|594878281|FG000|Overall Study|Withdrawal by Subject|2|||
164687400|NCT04750239|594878281|FG000|Overall Study|Trial terminated by sponsor|1|||
164687401|NCT03382041|594878282|FG000|Overall Study|Consent Form Lost|2|||
164687402|NCT03382041|594878283|FG001|Overall Study|Consent Form Lost|1|||
164687403|NCT03382041|594878282|FG000|Overall Study|Withdrawal by Subject|1|||
164687404|NCT03382041|594878283|FG001|Overall Study|Withdrawal by Subject|4|||
164687405|NCT03382041|594878282|FG000|Overall Study|Lost to Follow-up|1|||
164687406|NCT03382041|594878283|FG001|Overall Study|Lost to Follow-up|4|||
164687407|NCT04640194|594878284|FG000|Overall Study|Adverse Event|3|||
164687408|NCT04640194|594878285|FG001|Overall Study|Adverse Event|7|||
164687409|NCT04640194|594878286|FG002|Overall Study|Adverse Event|0|||
164687410|NCT04640194|594878287|FG003|Overall Study|Adverse Event|5|||
164687411|NCT04640194|594878288|FG004|Overall Study|Adverse Event|0|||
164687412|NCT04640194|594878289|FG005|Overall Study|Adverse Event|4|||
164687413|NCT04640194|594878290|FG006|Overall Study|Adverse Event|0|||
164687414|NCT04640194|594878284|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
164687415|NCT04640194|594878285|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
164687416|NCT04640194|594878286|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
164687417|NCT04640194|594878287|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
164687418|NCT04640194|594878288|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
164687419|NCT04640194|594878289|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
164687420|NCT04640194|594878290|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
164687421|NCT04640194|594878284|FG000|Overall Study|fibrinogen level too low|0|||
164687422|NCT04640194|594878285|FG001|Overall Study|fibrinogen level too low|0|||
164687423|NCT04640194|594878286|FG002|Overall Study|fibrinogen level too low|0|||
164687424|NCT04640194|594878287|FG003|Overall Study|fibrinogen level too low|1|||
164687425|NCT04640194|594878288|FG004|Overall Study|fibrinogen level too low|0|||
164430808|NCT00430677|593947311|FG000|Long-term Extension Period|Lost to Follow-up|1|||
164430809|NCT00430677|593947312|FG001|Long-term Extension Period|Lost to Follow-up|1|||
164430810|NCT00430677|593947313|FG002|Long-term Extension Period|Lost to Follow-up|1|||
164430811|NCT00430677|593947311|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
164430812|NCT00430677|593947312|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
164687426|NCT04640194|594878289|FG005|Overall Study|fibrinogen level too low|0|||
164687427|NCT04640194|594878290|FG006|Overall Study|fibrinogen level too low|0|||
164430813|NCT00430677|593947313|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
164687428|NCT04640194|594878284|FG000|Overall Study|mild bleeding|0|||
164687429|NCT04640194|594878285|FG001|Overall Study|mild bleeding|0|||
164687430|NCT04640194|594878286|FG002|Overall Study|mild bleeding|0|||
164687431|NCT04640194|594878287|FG003|Overall Study|mild bleeding|1|||
164687432|NCT04640194|594878288|FG004|Overall Study|mild bleeding|0|||
164687433|NCT04640194|594878289|FG005|Overall Study|mild bleeding|0|||
164687434|NCT04640194|594878290|FG006|Overall Study|mild bleeding|0|||
164687435|NCT04640194|594878284|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
164687436|NCT04640194|594878285|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
164687437|NCT04640194|594878286|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
164582158|NCT05278104|594495902|FG000|Overall Study|Adverse Event|2|||
164582159|NCT05278104|594495903|FG001|Overall Study|Adverse Event|1|||
164582160|NCT05278104|594495902|FG000|Overall Study|Exclusion criteria not met|1|||
164687438|NCT04640194|594878287|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
164687439|NCT04640194|594878288|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
164270144|NCT02920957|593356858|FG000|First Intervention : 1 Month|Adverse Event|1|||
164270145|NCT02920957|593356859|FG001|First Intervention : 1 Month|Adverse Event|0|||
164270146|NCT02920957|593356858|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
164270147|NCT02920957|593356859|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
164270148|NCT01789606|593356862|FG000|Overall Study|Participant not Purchased the Product|0|||
164270149|NCT01789606|593356863|FG001|Overall Study|Participant not Purchased the Product|20|||
164270150|NCT01789606|593356862|FG000|Overall Study|Withdrawal by Subject|0|||
164270151|NCT01789606|593356863|FG001|Overall Study|Withdrawal by Subject|1|||
164270152|NCT01789606|593356862|FG000|Overall Study|Ineligible|6|||
164270153|NCT01789606|593356863|FG001|Overall Study|Ineligible|2|||
164270154|NCT01789606|593356862|FG000|Overall Study|Administrative Reasons|17|||
164270155|NCT01789606|593356863|FG001|Overall Study|Administrative Reasons|6|||
164270156|NCT01789606|593356862|FG000|Overall Study|No Study Medication Taken|0|||
164270157|NCT01789606|593356863|FG001|Overall Study|No Study Medication Taken|1|||
164270158|NCT01789606|593356862|FG000|Overall Study|Protocol Violation|0|||
164270159|NCT01789606|593356863|FG001|Overall Study|Protocol Violation|55|||
164270160|NCT01789606|593356862|FG000|Overall Study|Adverse Event|0|||
164270161|NCT01789606|593356863|FG001|Overall Study|Adverse Event|3|||
164270162|NCT01789606|593356862|FG000|Overall Study|Lost to Follow-up|0|||
164270163|NCT01789606|593356863|FG001|Overall Study|Lost to Follow-up|14|||
164270164|NCT01789606|593356862|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
164270165|NCT01789606|593356863|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
164270166|NCT03180307|593356866|FG000|Overall Study|Lost to Follow-up|2|||
164270167|NCT03180307|593356867|FG001|Overall Study|Lost to Follow-up|0|||
164270168|NCT03180307|593356866|FG000|Overall Study|Death|1|||
164270169|NCT03180307|593356867|FG001|Overall Study|Death|0|||
164270170|NCT03180307|593356866|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
164270171|NCT03180307|593356867|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
164270172|NCT03159104|593356868|FG000|Overall Study|Violation of inclusion criteria|1|||
164270173|NCT03159104|593356869|FG001|Overall Study|Violation of inclusion criteria|2|||
164270174|NCT01563172|593356873|FG000|Overall Study|Adverse Event|5|||
164582161|NCT05278104|594495903|FG001|Overall Study|Exclusion criteria not met|0|||
164582162|NCT00001259|594497848|FG000|Study 2|Adverse Event|0|||
164582163|NCT00001259|594497849|FG001|Study 2|Adverse Event|0|||
164582164|NCT00001259|594497850|FG002|Study 2|Adverse Event|0|||
164582165|NCT00001259|594497851|FG003|Study 2|Adverse Event|0|||
164582166|NCT00001259|594497852|FG004|Study 2|Adverse Event|2|||
164582167|NCT00001259|594497853|FG005|Study 2|Adverse Event|0|||
164582168|NCT00001259|594497854|FG006|Study 2|Adverse Event|0|||
164582169|NCT01582282|594497855|FG000|Overall Study|Adverse Event|1|||
164582170|NCT01582282|594497856|FG001|Overall Study|Adverse Event|1|||
164582171|NCT01582282|594497857|FG002|Overall Study|Adverse Event|0|||
164582172|NCT01582282|594497855|FG000|Overall Study|Lost to Follow-up|1|||
164582173|NCT01582282|594497856|FG001|Overall Study|Lost to Follow-up|0|||
164582174|NCT01582282|594497857|FG002|Overall Study|Lost to Follow-up|0|||
164582175|NCT01582282|594497855|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
164582176|NCT01582282|594497856|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
164582177|NCT01582282|594497857|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
164582178|NCT02629393|594497859|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
164582179|NCT02629393|594497859|FG000|Overall Study|Physician Decision|1|||
164582180|NCT01269125|594497860|FG000|Overall Study|Adverse Event|3|||
164582181|NCT01269125|594497861|FG001|Overall Study|Adverse Event|5|||
164582182|NCT01269125|594497862|FG002|Overall Study|Adverse Event|0|||
164582183|NCT01269125|594497860|FG000|Overall Study|Lost to Follow-up|4|||
164582184|NCT01269125|594497861|FG001|Overall Study|Lost to Follow-up|0|||
164582185|NCT01269125|594497862|FG002|Overall Study|Lost to Follow-up|0|||
164582186|NCT00151411|594497863|FG000|Overall Study|Lost to Follow-up|15|||
164582187|NCT00151411|594497864|FG001|Overall Study|Lost to Follow-up|19|||
164582188|NCT00151411|594497863|FG000|Overall Study|Withdrawal by Subject|12|||
164270175|NCT01563172|593356873|FG000|Overall Study|Lost to Follow-up|2|||
164270176|NCT01563172|593356873|FG000|Overall Study|Other (Protocol deviation)|5|||
164270177|NCT01563172|593356873|FG000|Overall Study|Other (Not specified)|1|||
164582189|NCT00151411|594497864|FG001|Overall Study|Withdrawal by Subject|20|||
164270178|NCT00720343|593358447|FG000|Overall Study|Lost to Follow-up|1|||
164270179|NCT00720343|593358448|FG001|Overall Study|Lost to Follow-up|0|||
164270180|NCT00720343|593358447|FG000|Overall Study|Protocol Violation|0|||
164270181|NCT00720343|593358448|FG001|Overall Study|Protocol Violation|2|||
164582190|NCT00151411|594497863|FG000|Overall Study|Adverse Event|6|||
164582191|NCT00151411|594497864|FG001|Overall Study|Adverse Event|0|||
164582192|NCT00151411|594497863|FG000|Overall Study|Pregnancy|0|||
164582193|NCT00151411|594497864|FG001|Overall Study|Pregnancy|4|||
164687440|NCT04640194|594878289|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
164687441|NCT04640194|594878290|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
164687442|NCT03201003|594878291|FG000|Overall Study|Adverse Event|14|||
164687443|NCT03201003|594878292|FG001|Overall Study|Adverse Event|1|||
164687444|NCT03201003|594878291|FG000|Overall Study|Other reasons|5|||
164687445|NCT03201003|594878292|FG001|Overall Study|Other reasons|1|||
164687446|NCT03201003|594878291|FG000|Overall Study|Withdrawal by Subject|4|||
164687447|NCT03201003|594878292|FG001|Overall Study|Withdrawal by Subject|1|||
164687448|NCT03201003|594878291|FG000|Overall Study|Lost to Follow-up|2|||
164687449|NCT03201003|594878292|FG001|Overall Study|Lost to Follow-up|0|||
164687450|NCT03201003|594878291|FG000|Overall Study|Protocol Violation|1|||
164687451|NCT03201003|594878292|FG001|Overall Study|Protocol Violation|0|||
164687452|NCT00834613|594878293|FG000|First Intervention|Protocol Violation|1|||
164687453|NCT00834613|594878294|FG001|First Intervention|Protocol Violation|0|||
164687454|NCT00663234|594878295|FG000|Overall Study|Not willing to adhere to requirements|1|||
164687455|NCT01253564|594878301|FG000|Overall Study|Disease Progression|22|||
164687456|NCT01253564|594878301|FG000|Overall Study|Withdrawal by Subject|1|||
164687457|NCT01253564|594878301|FG000|Overall Study|Serious Adverse Event|1|||
164687458|NCT04584983|594878303|FG000|Overall Study|Parental request for withdraw|2|||
164687459|NCT04584983|594878304|FG001|Overall Study|Parental request for withdraw|0|||
164687460|NCT05377489|594878305|FG000|Overall Study|Withdrawal by Subject|122|||
164687461|NCT05377489|594878305|FG000|Overall Study|Lost to Follow-up|21|||
164687462|NCT05377489|594878305|FG000|Overall Study|Lack of Efficacy|10|||
164687463|NCT05377489|594878305|FG000|Overall Study|Adverse Event|5|||
164270182|NCT03459365|593358451|FG000|Overall Study|Withdrawal by Subject|6|||
164582194|NCT00417612|594497865|FG000|Overall Study|Errant diagnosis|0|||
164582195|NCT00417612|594497866|FG001|Overall Study|Errant diagnosis|1|||
164582196|NCT00417612|594497865|FG000|Overall Study|Adverse Event|2|||
164270183|NCT03459365|593358451|FG000|Overall Study|Protocol Violation|8|||
164687464|NCT05377489|594878305|FG000|Overall Study|Death|4|||
164687465|NCT05377489|594878305|FG000|Overall Study|Physician Decision|3|||
164687466|NCT05377489|594878305|FG000|Overall Study|Protocol Violation|1|||
164582197|NCT00417612|594497866|FG001|Overall Study|Adverse Event|0|||
164582198|NCT00417612|594497865|FG000|Overall Study|Protocol Violation|0|||
164582199|NCT00417612|594497866|FG001|Overall Study|Protocol Violation|2|||
164582200|NCT00417612|594497865|FG000|Overall Study|Lost to Follow-up|1|||
164270184|NCT00344500|593358453|FG000|Overall Study|Adverse Event|6|||
164270185|NCT00344500|593358454|FG001|Overall Study|Adverse Event|2|||
164687467|NCT05377489|594878305|FG000|Overall Study|Other|9|||
164687468|NCT00697619|594878315|FG000|Overall Study|Lack of Efficacy|2|||
164687469|NCT00697619|594878316|FG001|Overall Study|Lack of Efficacy|2|||
164687470|NCT00697619|594878315|FG000|Overall Study|Adverse Event|4|||
164687471|NCT00697619|594878316|FG001|Overall Study|Adverse Event|6|||
164687472|NCT00559637|594879765|FG000|Overall Study|Adverse Event|22|||
164687473|NCT00559637|594879765|FG000|Overall Study|Withdrawal by Subject|4|||
164687474|NCT00559637|594879765|FG000|Overall Study|Protocol Violation|6|||
164687475|NCT00559637|594879765|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
164687476|NCT00559637|594879765|FG000|Overall Study|Failure to return|6|||
164687477|NCT00559637|594879765|FG000|Overall Study|Insufficient response|3|||
164687478|NCT00559637|594879765|FG000|Overall Study|Started requiring dialysis after month 7|2|||
164687479|NCT00559637|594879765|FG000|Overall Study|Suspected lung cancer|1|||
164687480|NCT00559637|594879765|FG000|Overall Study|Participation in another study|1|||
164687481|NCT00559637|594879765|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
164687482|NCT00559637|594879765|FG000|Overall Study|Change of center|1|||
164687483|NCT00559637|594879765|FG000|Overall Study|Change of home|1|||
164270186|NCT00344500|593358455|FG002|Overall Study|Adverse Event|0|||
164270187|NCT00344500|593358453|FG000|Overall Study|Lost to Follow-up|5|||
164270188|NCT00344500|593358454|FG001|Overall Study|Lost to Follow-up|13|||
164270189|NCT00344500|593358455|FG002|Overall Study|Lost to Follow-up|1|||
164270190|NCT00344500|593358453|FG000|Overall Study|Withdrawal by Subject|7|||
164687484|NCT00559637|594879765|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
164687485|NCT01705717|594879767|FG000|Overall Study|Adverse Event|2|||
164687486|NCT01705717|594879768|FG001|Overall Study|Adverse Event|2|||
164687487|NCT01705717|594879767|FG000|Overall Study|Lack of Efficacy|0|||
164270191|NCT00344500|593358454|FG001|Overall Study|Withdrawal by Subject|10|||
164342190|NCT02165215|593629373|FG001|Maintenance Phase|Lost to Follow-up|2|||
164342191|NCT02165215|593629374|FG002|Maintenance Phase|Lost to Follow-up|0|||
164342192|NCT02165215|593629372|FG000|Maintenance Phase|Adverse Event|0|||
164342193|NCT02165215|593629373|FG001|Maintenance Phase|Adverse Event|1|||
164582201|NCT00417612|594497866|FG001|Overall Study|Lost to Follow-up|0|||
164687488|NCT01705717|594879768|FG001|Overall Study|Lack of Efficacy|1|||
164687489|NCT01705717|594879767|FG000|Overall Study|Other|0|||
164687490|NCT01705717|594879768|FG001|Overall Study|Other|2|||
164687491|NCT02031237|594879769|FG000|Overall Study|Death|1|||
164687492|NCT02031237|594879770|FG001|Overall Study|Death|5|||
164687493|NCT02031237|594879771|FG002|Overall Study|Death|0|||
164687494|NCT02031237|594879769|FG000|Overall Study|Physician Decision|0|||
164687495|NCT02031237|594879770|FG001|Overall Study|Physician Decision|1|||
164582202|NCT01283581|594497867|FG000|Overall Study|Lost to Follow-up|8|||
164270192|NCT00344500|593358455|FG002|Overall Study|Withdrawal by Subject|0|||
164270193|NCT00344500|593358453|FG000|Overall Study|Protocol Violation|4|||
164270194|NCT00344500|593358454|FG001|Overall Study|Protocol Violation|7|||
164270195|NCT00344500|593358455|FG002|Overall Study|Protocol Violation|1|||
164270196|NCT00344500|593358453|FG000|Overall Study|Not Noted|1|||
164270197|NCT00344500|593358454|FG001|Overall Study|Not Noted|3|||
164270198|NCT00344500|593358455|FG002|Overall Study|Not Noted|0|||
164270199|NCT00599755|593358456|FG000|Overall Study|Adverse Event|11|||
164270200|NCT00599755|593358456|FG000|Overall Study|Withdrawal by Subject|2|||
164270201|NCT00599755|593358456|FG000|Overall Study|Progression of Disease|3|||
164270202|NCT00599755|593358456|FG000|Overall Study|Other Reason|2|||
164270203|NCT00599755|593358456|FG000|Overall Study|No data available|1|||
164270204|NCT04037254|593358457|FG000|Overall Study|Protocol Violation|1|||
164270205|NCT04037254|593358458|FG001|Overall Study|Protocol Violation|0|||
164270206|NCT04037254|593358459|FG002|Overall Study|Protocol Violation|0|||
164270207|NCT04037254|593358460|FG003|Overall Study|Protocol Violation|0|||
164270208|NCT04037254|593358461|FG004|Overall Study|Protocol Violation|0|||
164270209|NCT04037254|593358457|FG000|Overall Study|Withdrawal by Subject|0|||
164270210|NCT04037254|593358458|FG001|Overall Study|Withdrawal by Subject|0|||
164270211|NCT04037254|593358459|FG002|Overall Study|Withdrawal by Subject|1|||
164270212|NCT04037254|593358460|FG003|Overall Study|Withdrawal by Subject|0|||
164270213|NCT04037254|593358461|FG004|Overall Study|Withdrawal by Subject|0|||
164270214|NCT04037254|593358457|FG000|Overall Study|Delayed or incomplete treatment|0|||
164270215|NCT04037254|593358458|FG001|Overall Study|Delayed or incomplete treatment|2|||
164270216|NCT04037254|593358459|FG002|Overall Study|Delayed or incomplete treatment|1|||
164270217|NCT04037254|593358460|FG003|Overall Study|Delayed or incomplete treatment|0|||
164270218|NCT04037254|593358461|FG004|Overall Study|Delayed or incomplete treatment|0|||
164270219|NCT02198794|593358462|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
164270220|NCT02198794|593358463|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
164270221|NCT02198794|593358464|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
164270222|NCT02198794|593358465|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
164270223|NCT02198794|593358462|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
164270224|NCT02198794|593358463|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
164270225|NCT02198794|593358464|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
164270226|NCT02198794|593358465|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
164270227|NCT02198794|593358462|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
164270228|NCT02198794|593358463|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
164270229|NCT02198794|593358464|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
164270230|NCT02198794|593358465|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
164270231|NCT02198794|593358462|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
164270232|NCT02198794|593358463|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
164270233|NCT02198794|593358464|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
164270234|NCT02198794|593358465|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
164270235|NCT02198794|593358462|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
164270236|NCT02198794|593358463|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
164270237|NCT02198794|593358464|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
164270238|NCT02198794|593358465|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
164270239|NCT02198794|593358462|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
164270240|NCT02198794|593358463|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
164270241|NCT02198794|593358464|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
164270242|NCT02198794|593358465|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
164270243|NCT02198794|593358462|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
164270244|NCT02198794|593358463|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
164270245|NCT02198794|593358464|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
164270246|NCT02198794|593358465|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
164270247|NCT02198794|593358462|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
164270248|NCT02198794|593358463|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
164270249|NCT02198794|593358464|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
164270250|NCT02198794|593358465|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
164582203|NCT01283581|594497868|FG001|Overall Study|Lost to Follow-up|6|||
164582204|NCT01283581|594497869|FG002|Overall Study|Lost to Follow-up|8|||
164582205|NCT01283581|594497867|FG000|Overall Study|Withdrawal by Subject|2|||
164582206|NCT01283581|594497868|FG001|Overall Study|Withdrawal by Subject|5|||
164582207|NCT01283581|594497869|FG002|Overall Study|Withdrawal by Subject|2|||
164270251|NCT02198794|593358462|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
164270252|NCT02198794|593358463|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
164270253|NCT02198794|593358464|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
164270254|NCT02198794|593358465|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
164270255|NCT02198794|593358462|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
164342194|NCT02165215|593629374|FG002|Maintenance Phase|Adverse Event|1|||
164582208|NCT01283581|594497867|FG000|Overall Study|Adverse Event|1|||
164270256|NCT02198794|593358463|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
164270257|NCT02198794|593358464|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
164270258|NCT02198794|593358465|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
164270259|NCT02198794|593358462|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
164270260|NCT02198794|593358463|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
164270261|NCT02198794|593358464|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
164270262|NCT02198794|593358465|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
164270263|NCT02198794|593358462|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
164270264|NCT02198794|593358463|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
164270265|NCT02198794|593358464|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
164270266|NCT02198794|593358465|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
164270267|NCT02198794|593358462|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
164270268|NCT02198794|593358463|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
164270269|NCT02198794|593358464|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
164270270|NCT02198794|593358465|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
164270271|NCT02198794|593358462|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
164270272|NCT02198794|593358463|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
164270273|NCT02198794|593358464|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
164270274|NCT02198794|593358465|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
164270275|NCT02198794|593358462|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
164270276|NCT02198794|593358463|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
164270277|NCT02198794|593358464|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
164270278|NCT02198794|593358465|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
164270279|NCT01306656|593358466|FG000|Overall Study|Lost to Follow-up|1|||
164270280|NCT01306656|593358467|FG001|Overall Study|Lost to Follow-up|0|||
164270281|NCT01918332|593358471|FG000|Overall Study|Adverse Event|0|||
164270282|NCT01918332|593358472|FG001|Overall Study|Adverse Event|0|||
164270283|NCT01918332|593358473|FG002|Overall Study|Adverse Event|0|||
164270284|NCT01918332|593358474|FG003|Overall Study|Adverse Event|1|||
164270285|NCT01918332|593358471|FG000|Overall Study|Withdrawal by Subject|2|||
164270286|NCT01918332|593358472|FG001|Overall Study|Withdrawal by Subject|3|||
164270287|NCT01918332|593358473|FG002|Overall Study|Withdrawal by Subject|2|||
164270288|NCT01918332|593358474|FG003|Overall Study|Withdrawal by Subject|3|||
164270289|NCT01918332|593358471|FG000|Overall Study|Protocol Violation|6|||
164270290|NCT01918332|593358472|FG001|Overall Study|Protocol Violation|2|||
164270291|NCT01918332|593358473|FG002|Overall Study|Protocol Violation|6|||
164270292|NCT01918332|593358474|FG003|Overall Study|Protocol Violation|3|||
164270293|NCT01918332|593358471|FG000|Overall Study|lipid result by central lab did not meet|0|||
164270294|NCT01918332|593358472|FG001|Overall Study|lipid result by central lab did not meet|0|||
164270295|NCT01918332|593358473|FG002|Overall Study|lipid result by central lab did not meet|1|||
164270296|NCT01918332|593358474|FG003|Overall Study|lipid result by central lab did not meet|0|||
164270297|NCT02252965|593358477|FG000|Overall Study|Adverse Event|9|||
164270298|NCT02252965|593358478|FG001|Overall Study|Adverse Event|14|||
164270299|NCT02252965|593358477|FG000|Overall Study|Lost to Follow-up|16|||
164270300|NCT02252965|593358478|FG001|Overall Study|Lost to Follow-up|8|||
164270301|NCT02252965|593358477|FG000|Overall Study|Protocol Violation|4|||
164270302|NCT02252965|593358478|FG001|Overall Study|Protocol Violation|5|||
164582209|NCT01283581|594497868|FG001|Overall Study|Adverse Event|1|||
164582210|NCT01283581|594497869|FG002|Overall Study|Adverse Event|4|||
164582211|NCT01283581|594497867|FG000|Overall Study|Physician Decision|0|||
164582212|NCT01283581|594497868|FG001|Overall Study|Physician Decision|1|||
164582213|NCT01283581|594497869|FG002|Overall Study|Physician Decision|2|||
164582214|NCT01283581|594497867|FG000|Overall Study|Protocol Violation|0|||
164582215|NCT01283581|594497868|FG001|Overall Study|Protocol Violation|1|||
164582216|NCT01283581|594497869|FG002|Overall Study|Protocol Violation|2|||
164582217|NCT01283581|594497867|FG000|Overall Study|Noncompliance|1|||
164582218|NCT01283581|594497868|FG001|Overall Study|Noncompliance|0|||
164582219|NCT01283581|594497869|FG002|Overall Study|Noncompliance|0|||
164582220|NCT01283581|594497867|FG000|Overall Study|Investigator unblinded|0|||
164582221|NCT01283581|594497868|FG001|Overall Study|Investigator unblinded|0|||
164582222|NCT01283581|594497869|FG002|Overall Study|Investigator unblinded|1|||
164582223|NCT01283581|594497867|FG000|Overall Study|"Early termination"|0|||
164582224|NCT01283581|594497868|FG001|Overall Study|"Early termination"|0|||
164582225|NCT01283581|594497869|FG002|Overall Study|"Early termination"|1|||
164582226|NCT04426630|594497870|FG000|Overall Study|Death|4|||
164582227|NCT04426630|594497870|FG000|Overall Study|Lost to Follow-up|2|||
164270303|NCT02252965|593358477|FG000|Overall Study|Lack of Efficacy|0|||
164270304|NCT02252965|593358478|FG001|Overall Study|Lack of Efficacy|2|||
164270305|NCT02252965|593358477|FG000|Overall Study|Withdrawal by Subject|7|||
164270306|NCT02252965|593358478|FG001|Overall Study|Withdrawal by Subject|9|||
164270307|NCT02252965|593358477|FG000|Overall Study|Other|4|||
164582228|NCT02413255|594497873|FG000|Overall Study|Voluntary Withdrawal|0|||
164582229|NCT02413255|594497874|FG001|Overall Study|Voluntary Withdrawal|0|||
164582230|NCT02413255|594497875|FG002|Overall Study|Voluntary Withdrawal|0|||
164687496|NCT02031237|594879771|FG002|Overall Study|Physician Decision|0|||
164687497|NCT02031237|594879769|FG000|Overall Study|Withdrawal by Subject|2|||
164687498|NCT02031237|594879770|FG001|Overall Study|Withdrawal by Subject|2|||
164687499|NCT02031237|594879771|FG002|Overall Study|Withdrawal by Subject|0|||
164687500|NCT02031237|594879769|FG000|Overall Study|Protocol Violation|2|||
164687501|NCT02031237|594879770|FG001|Overall Study|Protocol Violation|6|||
164687502|NCT02031237|594879771|FG002|Overall Study|Protocol Violation|0|||
164687503|NCT02031237|594879769|FG000|Overall Study|Alternate Treatment Given|0|||
164687504|NCT02031237|594879770|FG001|Overall Study|Alternate Treatment Given|0|||
164687505|NCT02031237|594879771|FG002|Overall Study|Alternate Treatment Given|3|||
164687506|NCT02293460|594879772|FG000|Overall Study|Protocol Violation|1|||
164687507|NCT02293460|594879772|FG000|Overall Study|Lack of Efficacy|2|||
164687508|NCT02293460|594879772|FG000|Overall Study|Adverse Event|2|||
164687509|NCT02293460|594879772|FG000|Overall Study|Withdrawal by Subject|1|||
164687510|NCT01074008|594879777|FG000|Overall Study|Adverse Event|0|||
164687511|NCT01074008|594879778|FG001|Overall Study|Adverse Event|1|||
164687512|NCT01074008|594879779|FG002|Overall Study|Adverse Event|0|||
164687513|NCT01074008|594879780|FG003|Overall Study|Adverse Event|0|||
164687514|NCT01074008|594879781|FG004|Overall Study|Adverse Event|0|||
164687515|NCT01074008|594879782|FG005|Overall Study|Adverse Event|0|||
164687516|NCT01074008|594879783|FG006|Overall Study|Adverse Event|0|||
164687517|NCT01074008|594879784|FG007|Overall Study|Adverse Event|0|||
164687518|NCT01074008|594879785|FG008|Overall Study|Adverse Event|0|||
164687519|NCT01074008|594879777|FG000|Overall Study|Withdrawal by Subject|1|||
164687520|NCT01074008|594879778|FG001|Overall Study|Withdrawal by Subject|1|||
164687521|NCT01074008|594879779|FG002|Overall Study|Withdrawal by Subject|1|||
164687522|NCT01074008|594879780|FG003|Overall Study|Withdrawal by Subject|0|||
164687523|NCT01074008|594879781|FG004|Overall Study|Withdrawal by Subject|1|||
164687524|NCT01074008|594879782|FG005|Overall Study|Withdrawal by Subject|0|||
164687525|NCT01074008|594879783|FG006|Overall Study|Withdrawal by Subject|0|||
164687526|NCT01074008|594879784|FG007|Overall Study|Withdrawal by Subject|0|||
164687527|NCT01074008|594879785|FG008|Overall Study|Withdrawal by Subject|0|||
164687528|NCT01074008|594879777|FG000|Overall Study|Lost to Follow-up|0|||
164687529|NCT01074008|594879778|FG001|Overall Study|Lost to Follow-up|1|||
164687530|NCT01074008|594879779|FG002|Overall Study|Lost to Follow-up|1|||
164687531|NCT01074008|594879780|FG003|Overall Study|Lost to Follow-up|1|||
164687532|NCT01074008|594879781|FG004|Overall Study|Lost to Follow-up|1|||
164687533|NCT01074008|594879782|FG005|Overall Study|Lost to Follow-up|0|||
164687534|NCT01074008|594879783|FG006|Overall Study|Lost to Follow-up|1|||
164687535|NCT01074008|594879784|FG007|Overall Study|Lost to Follow-up|0|||
164687536|NCT01074008|594879785|FG008|Overall Study|Lost to Follow-up|4|||
164687537|NCT02805309|594879788|FG000|Overall Study|Lost to Follow-up|2|||
164687538|NCT02805309|594879789|FG001|Overall Study|Lost to Follow-up|2|||
164687539|NCT02805309|594879790|FG002|Overall Study|Lost to Follow-up|2|||
164687540|NCT02805309|594879788|FG000|Overall Study|Post-Randomization Exclusion|0|||
164687541|NCT02805309|594879789|FG001|Overall Study|Post-Randomization Exclusion|2|||
164687542|NCT02805309|594879790|FG002|Overall Study|Post-Randomization Exclusion|1|||
164687543|NCT01636934|594879791|FG000|Overall Study|Withdrawal by Subject|3|||
164687544|NCT01636934|594879792|FG001|Overall Study|Withdrawal by Subject|2|||
164687545|NCT01636934|594879791|FG000|Overall Study|Chemo cancel|1|||
164687546|NCT01636934|594879792|FG001|Overall Study|Chemo cancel|0|||
164687547|NCT01636934|594879791|FG000|Overall Study|Too ill to continue|1|||
164687548|NCT01636934|594879792|FG001|Overall Study|Too ill to continue|0|||
164687549|NCT01636934|594879791|FG000|Overall Study|Never started study medication|1|||
164687550|NCT01636934|594879792|FG001|Overall Study|Never started study medication|1|||
164687551|NCT05480800|594879808|FG000|Overall Study|Withdrawal by Subject|0|||
164687552|NCT05480800|594879809|FG001|Overall Study|Withdrawal by Subject|0|||
164270308|NCT02252965|593358478|FG001|Overall Study|Other|5|||
164270309|NCT04736628|593358483|FG000|Overall Study|Not treated|0|||
164270310|NCT04736628|593358484|FG001|Overall Study|Not treated|0|||
164270311|NCT04736628|593358485|FG002|Overall Study|Not treated|0|||
164270312|NCT04736628|593358486|FG003|Overall Study|Not treated|2|||
164270313|NCT04736628|593358483|FG000|Overall Study|Other reason than listed|1|||
164270314|NCT04736628|593358484|FG001|Overall Study|Other reason than listed|2|||
164270315|NCT04736628|593358485|FG002|Overall Study|Other reason than listed|2|||
164270316|NCT04736628|593358486|FG003|Overall Study|Other reason than listed|3|||
164687553|NCT05480800|594879810|FG002|Overall Study|Withdrawal by Subject|2|||
164687554|NCT05480800|594879811|FG003|Overall Study|Withdrawal by Subject|1|||
164687555|NCT05480800|594879812|FG004|Overall Study|Withdrawal by Subject|0|||
164687556|NCT05480800|594879813|FG005|Overall Study|Withdrawal by Subject|0|||
164687557|NCT05480800|594879814|FG006|Overall Study|Withdrawal by Subject|1|||
164687558|NCT05480800|594879815|FG007|Overall Study|Withdrawal by Subject|0|||
164687559|NCT05480800|594879808|FG000|Overall Study|Other|0|||
164270317|NCT04736628|593358483|FG000|Overall Study|Protocol deviation|0|||
164687560|NCT05480800|594879809|FG001|Overall Study|Other|0|||
164687561|NCT05480800|594879810|FG002|Overall Study|Other|0|||
164687562|NCT05480800|594879811|FG003|Overall Study|Other|0|||
164687563|NCT05480800|594879812|FG004|Overall Study|Other|0|||
164687564|NCT05480800|594879813|FG005|Overall Study|Other|0|||
164270318|NCT04736628|593358484|FG001|Overall Study|Protocol deviation|0|||
164270319|NCT04736628|593358485|FG002|Overall Study|Protocol deviation|0|||
164270320|NCT04736628|593358486|FG003|Overall Study|Protocol deviation|1|||
164270321|NCT04736628|593358483|FG000|Overall Study|Burden of study procedures|1|||
164270322|NCT04736628|593358484|FG001|Overall Study|Burden of study procedures|0|||
164270323|NCT04736628|593358485|FG002|Overall Study|Burden of study procedures|0|||
164582231|NCT02413255|594497876|FG003|Overall Study|Voluntary Withdrawal|0|||
164582232|NCT02413255|594497877|FG004|Overall Study|Voluntary Withdrawal|0|||
164582233|NCT02413255|594497878|FG005|Overall Study|Voluntary Withdrawal|0|||
164582234|NCT02413255|594497879|FG006|Overall Study|Voluntary Withdrawal|0|||
164582235|NCT02413255|594497880|FG007|Overall Study|Voluntary Withdrawal|0|||
164582236|NCT02413255|594497881|FG008|Overall Study|Voluntary Withdrawal|0|||
164582237|NCT02413255|594497882|FG009|Overall Study|Voluntary Withdrawal|0|||
164582238|NCT02413255|594497883|FG010|Overall Study|Voluntary Withdrawal|0|||
164582239|NCT02413255|594497884|FG011|Overall Study|Voluntary Withdrawal|0|||
164582240|NCT02413255|594497885|FG012|Overall Study|Voluntary Withdrawal|0|||
164582241|NCT02413255|594497886|FG013|Overall Study|Voluntary Withdrawal|0|||
164582242|NCT02413255|594497887|FG014|Overall Study|Voluntary Withdrawal|1|||
164582243|NCT02413255|594497888|FG015|Overall Study|Voluntary Withdrawal|0|||
164582244|NCT02413255|594497889|FG016|Overall Study|Voluntary Withdrawal|0|||
164582245|NCT03133481|594497892|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
164582246|NCT03133481|594497893|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
164582247|NCT01873950|594497899|FG000|Period 5|Withdrawal by Subject|0|||
164582248|NCT01873950|594497900|FG001|Period 5|Withdrawal by Subject|0|||
164582249|NCT01873950|594497901|FG002|Period 5|Withdrawal by Subject|0|||
164582250|NCT01873950|594497902|FG003|Period 5|Withdrawal by Subject|1|||
164582251|NCT01873950|594497903|FG004|Period 5|Withdrawal by Subject|0|||
164582252|NCT03000452|594497905|FG000|Treatment Period|Death|1|||
164582253|NCT03000452|594497905|FG000|Treatment Period|Progressive Disease (PD)|14|||
164582254|NCT03000452|594497905|FG000|Treatment Period|Physician Decision|1|||
164582255|NCT03000452|594497905|FG000|Treatment Period|Miscellaneous|2|||
164582256|NCT03000452|594497905|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
164582257|NCT03000452|594497905|FG000|Follow-Up Period|Death|3|||
164582258|NCT03000452|594497905|FG000|Follow-Up Period|Withdrawal by Subject|3|||
164582259|NCT00593112|594497906|FG000|Overall Study|Scan Anxiety|3|||
164582260|NCT00593112|594497907|FG001|Overall Study|Scan Anxiety|0|||
164582261|NCT00593112|594497906|FG000|Overall Study|Abnormal Scan|1|||
164582262|NCT00593112|594497907|FG001|Overall Study|Abnormal Scan|0|||
164582263|NCT00593112|594497906|FG000|Overall Study|Unreadable Scan|1|||
164582264|NCT00593112|594497907|FG001|Overall Study|Unreadable Scan|0|||
164582265|NCT00593112|594497906|FG000|Overall Study|Withdrawal by Subject|5|||
164582266|NCT00593112|594497907|FG001|Overall Study|Withdrawal by Subject|0|||
164582267|NCT05372315|594497908|FG000|Overall Study|Withdrawal by Subject|1|||
164582268|NCT05372315|594497909|FG001|Overall Study|Withdrawal by Subject|0|||
164582269|NCT01512368|594497911|FG000|Overall Study|Protocol Violation|3|||
164582270|NCT00328198|594497912|FG000|Treatment|Adverse Event|21|||
164582271|NCT00328198|594497912|FG000|Treatment|Death|1|||
164582272|NCT00328198|594497912|FG000|Treatment|Physician Decision|5|||
164582273|NCT00328198|594497912|FG000|Treatment|Withdrawal by Subject|5|||
164582274|NCT00328198|594497912|FG000|Treatment|Evidence of disease progression|2|||
164582275|NCT00328198|594497912|FG000|Treatment|Non-compliance|1|||
164582276|NCT00328198|594497912|FG000|Treatment|Confirmed complete response, MRD -|3|||
164582277|NCT00328198|594497912|FG000|Follow-up|Lost to Follow-up|4|||
164582278|NCT00328198|594497912|FG000|Follow-up|Death|31|||
164582279|NCT01570491|594497913|FG000|Overall Study|Lost to Follow-up|3|||
164582280|NCT01570491|594497914|FG001|Overall Study|Lost to Follow-up|1|||
164582281|NCT01570491|594497913|FG000|Overall Study|treatment: not given or discontinued|2|||
164582282|NCT01570491|594497914|FG001|Overall Study|treatment: not given or discontinued|0|||
164582283|NCT01720667|594497920|FG000|Overall Study|Adverse Event|1|||
164582284|NCT01720667|594497921|FG001|Overall Study|Adverse Event|1|||
164582285|NCT01720667|594497920|FG000|Overall Study|Withdrawal by Subject|3|||
164582286|NCT01720667|594497921|FG001|Overall Study|Withdrawal by Subject|0|||
164582287|NCT04407507|594497922|FG000|Overall Study|Withdrawal by Subject|0|||
164582288|NCT04407507|594497923|FG001|Overall Study|Withdrawal by Subject|1|||
164582289|NCT00234104|594497926|FG000|Overall Study|Adverse Event|4|||
164582290|NCT00234104|594497927|FG001|Overall Study|Adverse Event|0|||
164582291|NCT00234104|594497928|FG002|Overall Study|Adverse Event|3|||
164582292|NCT00234104|594497929|FG003|Overall Study|Adverse Event|5|||
164582293|NCT00234104|594497926|FG000|Overall Study|Protocol Violation|0|||
164582294|NCT00234104|594497927|FG001|Overall Study|Protocol Violation|0|||
164270324|NCT04736628|593358486|FG003|Overall Study|Burden of study procedures|1|||
164270325|NCT04736628|593358483|FG000|Overall Study|Change of residence|0|||
164270326|NCT04736628|593358484|FG001|Overall Study|Change of residence|1|||
164270327|NCT04736628|593358485|FG002|Overall Study|Change of residence|0|||
164270328|NCT04736628|593358486|FG003|Overall Study|Change of residence|0|||
164582295|NCT00234104|594497928|FG002|Overall Study|Protocol Violation|0|||
164582296|NCT00234104|594497929|FG003|Overall Study|Protocol Violation|1|||
164582297|NCT00234104|594497926|FG000|Overall Study|Physician Decision|0|||
164270329|NCT04736628|593358483|FG000|Overall Study|Perceived lack of efficacy|1|||
164270330|NCT04736628|593358484|FG001|Overall Study|Perceived lack of efficacy|0|||
164270331|NCT04736628|593358485|FG002|Overall Study|Perceived lack of efficacy|0|||
164270332|NCT04736628|593358486|FG003|Overall Study|Perceived lack of efficacy|1|||
164270333|NCT04736628|593358483|FG000|Overall Study|Adverse Event|3|||
164270334|NCT04736628|593358484|FG001|Overall Study|Adverse Event|2|||
164270335|NCT04736628|593358485|FG002|Overall Study|Adverse Event|4|||
164270336|NCT04736628|593358486|FG003|Overall Study|Adverse Event|3|||
164270337|NCT04279613|593358487|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
164270338|NCT04279613|593358488|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
164270339|NCT04279613|593358489|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
164270340|NCT04279613|593358490|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
164270341|NCT04279613|593358491|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
164270342|NCT04279613|593358487|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
164270343|NCT04279613|593358488|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
164270344|NCT04279613|593358489|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
164270345|NCT04279613|593358490|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
164270346|NCT04279613|593358491|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
164270347|NCT04279613|593358487|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
164270348|NCT04279613|593358488|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
164270349|NCT04279613|593358489|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
164270350|NCT04279613|593358490|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
164270351|NCT04279613|593358491|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
164270352|NCT04279613|593358487|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
164270353|NCT04279613|593358488|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
164270354|NCT04279613|593358489|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
164270355|NCT04279613|593358490|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
164270356|NCT04279613|593358491|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
164270357|NCT04279613|593358487|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
164270358|NCT04279613|593358488|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
164270359|NCT04279613|593358489|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
164270360|NCT04279613|593358490|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
164270361|NCT04279613|593358491|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
164270362|NCT02478164|593358492|FG000|Overall Study|Lack of Efficacy|13|||
164270363|NCT02478164|593358492|FG000|Overall Study|Adverse Event|1|||
164270364|NCT02478164|593358492|FG000|Overall Study|Withdrawal by Subject|1|||
164270365|NCT04051827|593358493|FG000|Overall Study|Death|1|||
164270366|NCT04051827|593358493|FG000|Overall Study|Withdrawal by Subject|4|||
164270367|NCT04051827|593358493|FG000|Overall Study|Progressive disease|16|||
164270368|NCT04051827|593358493|FG000|Overall Study|Physician Decision|1|||
164270369|NCT04051827|593358493|FG000|Overall Study|Other|4|||
164270370|NCT05779007|593358494|FG000|Overall Study|not meeting eligibility criteria|3517|||
164270371|NCT05779007|593358495|FG001|Overall Study|not meeting eligibility criteria|2009|||
164342195|NCT01877265|593629375|FG000|Treatment Period 1|Sponsor Decision|0|||
164687565|NCT05480800|594879814|FG006|Overall Study|Other|1|||
164687566|NCT05480800|594879815|FG007|Overall Study|Other|0|||
164687567|NCT00377156|594879820|FG000|Overall Study|Death|23|||
164687568|NCT00377156|594879821|FG001|Overall Study|Death|19|||
164687569|NCT00377156|594879820|FG000|Overall Study|Withdrawal by Subject|16|||
164687570|NCT00377156|594879821|FG001|Overall Study|Withdrawal by Subject|24|||
164687571|NCT00377156|594879820|FG000|Overall Study|Had follow-up <90 d|3|||
164687572|NCT00377156|594879821|FG001|Overall Study|Had follow-up <90 d|6|||
164270372|NCT01424566|593358496|FG000|Single-blind Treatment|Adverse Event|71|||
164270373|NCT01424566|593358497|FG001|Single-blind Treatment|Adverse Event|0|||
164270374|NCT01424566|593358498|FG002|Single-blind Treatment|Adverse Event|0|||
164270375|NCT01424566|593358496|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
164270376|NCT01424566|593358497|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
164270377|NCT01424566|593358498|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
164270378|NCT01424566|593358496|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
164270379|NCT01424566|593358497|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
164270380|NCT01424566|593358498|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
164270381|NCT01424566|593358496|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
164270382|NCT01424566|593358497|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
164270383|NCT01424566|593358498|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
164687573|NCT00377156|594879820|FG000|Overall Study|Cancellation|1|||
164270384|NCT01424566|593358496|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
164270385|NCT01424566|593358497|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
164270386|NCT01424566|593358498|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
164270387|NCT01424566|593358496|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
164270388|NCT01424566|593358497|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
164270389|NCT01424566|593358498|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
164687574|NCT00377156|594879821|FG001|Overall Study|Cancellation|0|||
164687575|NCT00377156|594879820|FG000|Overall Study|Refused testing|0|||
164687576|NCT00377156|594879821|FG001|Overall Study|Refused testing|1|||
164270390|NCT01424566|593358496|FG000|Double-blind Treatment|Adverse Event|0|||
164270391|NCT01424566|593358497|FG001|Double-blind Treatment|Adverse Event|21|||
164270392|NCT01424566|593358498|FG002|Double-blind Treatment|Adverse Event|13|||
164270393|NCT01424566|593358496|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
164270394|NCT01424566|593358497|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
164270395|NCT01424566|593358498|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
164270396|NCT01424566|593358496|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
164270397|NCT01424566|593358497|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
164270398|NCT01424566|593358498|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
164270399|NCT01424566|593358496|FG000|Double-blind Treatment|Lack of Efficacy|0|||
164270400|NCT01424566|593358497|FG001|Double-blind Treatment|Lack of Efficacy|1|||
164270401|NCT01424566|593358498|FG002|Double-blind Treatment|Lack of Efficacy|1|||
164270402|NCT00680368|593358501|FG000|Overall Study|not supervised, not eligible|15|||
164270403|NCT03779503|593358502|FG000|First Intervention|Adverse Event|0|||
164270404|NCT03779503|593358503|FG001|First Intervention|Adverse Event|1|||
164270405|NCT03779503|593358502|FG000|First Intervention|Withdrawal by Subject|1|||
164270406|NCT03779503|593358503|FG001|First Intervention|Withdrawal by Subject|0|||
164270407|NCT02771626|593358507|FG000|Overall Study|Adverse Event|1|||
164270408|NCT02771626|593358508|FG001|Overall Study|Adverse Event|5|||
164270409|NCT02771626|593358509|FG002|Overall Study|Adverse Event|3|||
164270410|NCT02771626|593358510|FG003|Overall Study|Adverse Event|0|||
164270411|NCT02771626|593358511|FG004|Overall Study|Adverse Event|1|||
164270412|NCT02771626|593358512|FG005|Overall Study|Adverse Event|1|||
164270413|NCT02771626|593358507|FG000|Overall Study|Radiologic Disease Progression|6|||
164270414|NCT02771626|593358508|FG001|Overall Study|Radiologic Disease Progression|13|||
164270415|NCT02771626|593358509|FG002|Overall Study|Radiologic Disease Progression|10|||
164270416|NCT02771626|593358510|FG003|Overall Study|Radiologic Disease Progression|7|||
164270417|NCT02771626|593358511|FG004|Overall Study|Radiologic Disease Progression|28|||
164270418|NCT02771626|593358512|FG005|Overall Study|Radiologic Disease Progression|15|||
164270419|NCT02771626|593358507|FG000|Overall Study|Symptomatic Deterioration|0|||
164270420|NCT02771626|593358508|FG001|Overall Study|Symptomatic Deterioration|4|||
164270421|NCT02771626|593358509|FG002|Overall Study|Symptomatic Deterioration|2|||
164270422|NCT02771626|593358510|FG003|Overall Study|Symptomatic Deterioration|0|||
164270423|NCT02771626|593358511|FG004|Overall Study|Symptomatic Deterioration|5|||
164270424|NCT02771626|593358512|FG005|Overall Study|Symptomatic Deterioration|2|||
164270425|NCT02771626|593358507|FG000|Overall Study|Participant Request|0|||
164270426|NCT02771626|593358508|FG001|Overall Study|Participant Request|1|||
164270427|NCT02771626|593358509|FG002|Overall Study|Participant Request|0|||
164270428|NCT02771626|593358510|FG003|Overall Study|Participant Request|2|||
164270429|NCT02771626|593358511|FG004|Overall Study|Participant Request|0|||
164270430|NCT02771626|593358512|FG005|Overall Study|Participant Request|1|||
164270431|NCT02771626|593358507|FG000|Overall Study|Investigator Decision|0|||
164270432|NCT02771626|593358508|FG001|Overall Study|Investigator Decision|1|||
164270433|NCT02771626|593358509|FG002|Overall Study|Investigator Decision|0|||
164270434|NCT02771626|593358510|FG003|Overall Study|Investigator Decision|0|||
164270435|NCT02771626|593358511|FG004|Overall Study|Investigator Decision|1|||
164270436|NCT02771626|593358512|FG005|Overall Study|Investigator Decision|0|||
164270437|NCT02771626|593358507|FG000|Overall Study|Study Termination by Sponsor|0|||
164270438|NCT02771626|593358508|FG001|Overall Study|Study Termination by Sponsor|2|||
164270439|NCT02771626|593358509|FG002|Overall Study|Study Termination by Sponsor|1|||
164270440|NCT02771626|593358510|FG003|Overall Study|Study Termination by Sponsor|0|||
164270441|NCT02771626|593358511|FG004|Overall Study|Study Termination by Sponsor|1|||
164270442|NCT02771626|593358512|FG005|Overall Study|Study Termination by Sponsor|0|||
164582298|NCT00234104|594497927|FG001|Overall Study|Physician Decision|1|||
164270443|NCT02771626|593358507|FG000|Overall Study|Informed Consent Withdrawn|0|||
164270444|NCT02771626|593358508|FG001|Overall Study|Informed Consent Withdrawn|0|||
164270445|NCT02771626|593358509|FG002|Overall Study|Informed Consent Withdrawn|1|||
164270446|NCT02771626|593358510|FG003|Overall Study|Informed Consent Withdrawn|0|||
164582299|NCT00234104|594497928|FG002|Overall Study|Physician Decision|2|||
164582300|NCT00234104|594497929|FG003|Overall Study|Physician Decision|2|||
164582301|NCT00546819|594497930|FG000|Overall Study|Adverse Event|2|||
164582302|NCT00546819|594497931|FG001|Overall Study|Adverse Event|3|||
164582303|NCT00546819|594497930|FG000|Overall Study|Lost to Follow-up|2|||
164582304|NCT00546819|594497931|FG001|Overall Study|Lost to Follow-up|1|||
164582305|NCT00546819|594497930|FG000|Overall Study|Withdrawal by Subject|4|||
164582306|NCT00546819|594497931|FG001|Overall Study|Withdrawal by Subject|2|||
164582307|NCT04045613|594497932|FG000|Overall Study|Adverse Event|2|||
164270447|NCT02771626|593358511|FG004|Overall Study|Informed Consent Withdrawn|1|||
164270448|NCT02771626|593358512|FG005|Overall Study|Informed Consent Withdrawn|1|||
164270449|NCT02771626|593358507|FG000|Overall Study|Other, Not Specified|1|||
164270450|NCT02771626|593358508|FG001|Overall Study|Other, Not Specified|0|||
164270451|NCT02771626|593358509|FG002|Overall Study|Other, Not Specified|0|||
164582308|NCT04045613|594497933|FG001|Overall Study|Adverse Event|2|||
164270452|NCT02771626|593358510|FG003|Overall Study|Other, Not Specified|0|||
164582309|NCT04045613|594497934|FG002|Overall Study|Adverse Event|1|||
164582310|NCT04045613|594497935|FG003|Overall Study|Adverse Event|1|||
164687577|NCT00377156|594879820|FG000|Overall Study|Ineligible|0|||
164687578|NCT00377156|594879821|FG001|Overall Study|Ineligible|1|||
164687579|NCT00377156|594879820|FG000|Overall Study|Disability or language problem|0|||
164687580|NCT00377156|594879821|FG001|Overall Study|Disability or language problem|1|||
164687581|NCT00377156|594879820|FG000|Overall Study|Other|5|||
164687582|NCT00377156|594879821|FG001|Overall Study|Other|2|||
164687583|NCT00288704|594879822|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
164687584|NCT00288704|594879823|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
164687585|NCT00288704|594879824|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
164687586|NCT00288704|594879822|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
164687587|NCT00288704|594879823|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
164687588|NCT00288704|594879824|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
164687589|NCT00288704|594879822|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
164687590|NCT00288704|594879823|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
164687591|NCT00288704|594879824|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
164687592|NCT00288704|594879822|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
164687593|NCT00288704|594879823|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
164270453|NCT02771626|593358511|FG004|Overall Study|Other, Not Specified|0|||
164270454|NCT02771626|593358512|FG005|Overall Study|Other, Not Specified|1|||
164270455|NCT02392403|593358513|FG000|Overall Study|Adverse Event|1|||
164270456|NCT02392403|593358513|FG000|Overall Study|Death|1|||
164270457|NCT02392403|593358513|FG000|Overall Study|Withdrawal by Subject|1|||
164270458|NCT02616393|593358516|FG000|Overall Study|Death|5|||
164270459|NCT02616393|593358517|FG001|Overall Study|Death|12|||
164270460|NCT02616393|593358518|FG002|Overall Study|Death|1|||
164270461|NCT02616393|593358516|FG000|Overall Study|Termination by Sponsor|4|||
164270462|NCT02616393|593358517|FG001|Overall Study|Termination by Sponsor|5|||
164270463|NCT02616393|593358518|FG002|Overall Study|Termination by Sponsor|2|||
164687594|NCT00288704|594879824|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
164687595|NCT00288704|594879822|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
164687596|NCT00288704|594879823|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
164687597|NCT00288704|594879824|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
164687598|NCT00288704|594879822|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
164687599|NCT00288704|594879823|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
164687600|NCT00288704|594879824|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
164687601|NCT00288704|594879822|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
164687602|NCT00288704|594879823|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
164687603|NCT00288704|594879824|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
164687604|NCT00676650|594879827|FG000|Overall Study|Death|45|||
164687605|NCT00676650|594879828|FG001|Overall Study|Death|14|||
164687606|NCT00676650|594879827|FG000|Overall Study|Adverse Event|159|||
164687607|NCT00676650|594879828|FG001|Overall Study|Adverse Event|21|||
164687608|NCT00676650|594879827|FG000|Overall Study|Global deterioration of health status|66|||
164687609|NCT00676650|594879828|FG001|Overall Study|Global deterioration of health status|31|||
164687610|NCT00676650|594879827|FG000|Overall Study|Lost to Follow-up|0|||
164687611|NCT00676650|594879828|FG001|Overall Study|Lost to Follow-up|1|||
164687612|NCT00676650|594879827|FG000|Overall Study|Objective progression or relapse|189|||
164687613|NCT00676650|594879828|FG001|Overall Study|Objective progression or relapse|140|||
164687614|NCT00676650|594879827|FG000|Overall Study|Other|14|||
164687615|NCT00676650|594879828|FG001|Overall Study|Other|10|||
164687616|NCT00676650|594879827|FG000|Overall Study|Protocol Violation|3|||
164687617|NCT00676650|594879828|FG001|Overall Study|Protocol Violation|1|||
164687618|NCT00676650|594879827|FG000|Overall Study|Study terminated by sponsor|57|||
164687619|NCT00676650|594879828|FG001|Overall Study|Study terminated by sponsor|43|||
164687620|NCT00676650|594879827|FG000|Overall Study|Withdrawal by Subject|48|||
164687621|NCT00676650|594879828|FG001|Overall Study|Withdrawal by Subject|24|||
164687622|NCT00676650|594879827|FG000|Overall Study|Randomized but not treated|3|||
164687623|NCT00676650|594879828|FG001|Overall Study|Randomized but not treated|4|||
164687624|NCT01802216|594879829|FG000|4 Month Visit|Participant did not show to visit|3|||
164270464|NCT02616393|593358516|FG000|Overall Study|Other|3|||
164270465|NCT02616393|593358517|FG001|Overall Study|Other|0|||
164270466|NCT02616393|593358518|FG002|Overall Study|Other|0|||
164270467|NCT02616393|593358516|FG000|Overall Study|Withdrawal by Subject|1|||
164687625|NCT01802216|594879830|FG001|4 Month Visit|Participant did not show to visit|4|||
164687626|NCT01802216|594879829|FG000|8 Month Visit|Participant did not show to visit|3|||
164687627|NCT01802216|594879830|FG001|8 Month Visit|Participant did not show to visit|5|||
164687628|NCT01802216|594879829|FG000|12 Month Visit|Participant did not show to visit|3|||
164687629|NCT01802216|594879830|FG001|12 Month Visit|Participant did not show to visit|4|||
164270468|NCT02616393|593358517|FG001|Overall Study|Withdrawal by Subject|1|||
164270469|NCT02616393|593358518|FG002|Overall Study|Withdrawal by Subject|0|||
164687630|NCT02297841|594879834|FG000|Overall Study|Withdrawal by Subject|1|||
164687631|NCT02297841|594879834|FG000|Overall Study|Protocol Violation|7|||
164687632|NCT05061992|594879835|FG000|Overall Study|Excess bowel movements|1|||
164270470|NCT02616393|593358516|FG000|Overall Study|Lost to Follow-up|0|||
164582311|NCT04045613|594497936|FG004|Overall Study|Adverse Event|0|||
164582312|NCT04045613|594497937|FG005|Overall Study|Adverse Event|0|||
164582313|NCT04045613|594497938|FG006|Overall Study|Adverse Event|1|||
164582314|NCT04045613|594497932|FG000|Overall Study|Withdrawal by Subject|0|||
164582315|NCT04045613|594497933|FG001|Overall Study|Withdrawal by Subject|5|||
164582316|NCT04045613|594497934|FG002|Overall Study|Withdrawal by Subject|0|||
164582317|NCT04045613|594497935|FG003|Overall Study|Withdrawal by Subject|0|||
164582318|NCT04045613|594497936|FG004|Overall Study|Withdrawal by Subject|0|||
164582319|NCT04045613|594497937|FG005|Overall Study|Withdrawal by Subject|1|||
164582320|NCT04045613|594497938|FG006|Overall Study|Withdrawal by Subject|0|||
164582321|NCT04045613|594497932|FG000|Overall Study|Physician Decision|2|||
164582322|NCT04045613|594497933|FG001|Overall Study|Physician Decision|0|||
164582323|NCT04045613|594497934|FG002|Overall Study|Physician Decision|0|||
164582324|NCT04045613|594497935|FG003|Overall Study|Physician Decision|0|||
164582325|NCT04045613|594497936|FG004|Overall Study|Physician Decision|1|||
164582326|NCT04045613|594497937|FG005|Overall Study|Physician Decision|0|||
164582327|NCT04045613|594497938|FG006|Overall Study|Physician Decision|0|||
164582328|NCT04045613|594497932|FG000|Overall Study|Death|3|||
164582329|NCT04045613|594497933|FG001|Overall Study|Death|0|||
164582330|NCT04045613|594497934|FG002|Overall Study|Death|0|||
164582331|NCT04045613|594497935|FG003|Overall Study|Death|0|||
164582332|NCT04045613|594497936|FG004|Overall Study|Death|0|||
164582333|NCT04045613|594497937|FG005|Overall Study|Death|0|||
164582334|NCT04045613|594497938|FG006|Overall Study|Death|1|||
164582335|NCT04045613|594497932|FG000|Overall Study|Other reasons|0|||
164582336|NCT04045613|594497933|FG001|Overall Study|Other reasons|1|||
164582337|NCT04045613|594497934|FG002|Overall Study|Other reasons|0|||
164582338|NCT04045613|594497935|FG003|Overall Study|Other reasons|0|||
164582339|NCT04045613|594497936|FG004|Overall Study|Other reasons|0|||
164582340|NCT04045613|594497937|FG005|Overall Study|Other reasons|0|||
164582341|NCT04045613|594497938|FG006|Overall Study|Other reasons|1|||
164582342|NCT04045613|594497932|FG000|Overall Study|Progressive disease: Clinical progression|1|||
164582343|NCT04045613|594497933|FG001|Overall Study|Progressive disease: Clinical progression|0|||
164582344|NCT04045613|594497934|FG002|Overall Study|Progressive disease: Clinical progression|3|||
164582345|NCT04045613|594497935|FG003|Overall Study|Progressive disease: Clinical progression|1|||
164582346|NCT04045613|594497936|FG004|Overall Study|Progressive disease: Clinical progression|1|||
164582347|NCT04045613|594497937|FG005|Overall Study|Progressive disease: Clinical progression|3|||
164582348|NCT04045613|594497938|FG006|Overall Study|Progressive disease: Clinical progression|3|||
164582349|NCT04045613|594497932|FG000|Overall Study|Progressive disease: Radiological progression|24|||
164582350|NCT04045613|594497933|FG001|Overall Study|Progressive disease: Radiological progression|6|||
164582351|NCT04045613|594497934|FG002|Overall Study|Progressive disease: Radiological progression|8|||
164582352|NCT04045613|594497935|FG003|Overall Study|Progressive disease: Radiological progression|0|||
164582353|NCT04045613|594497936|FG004|Overall Study|Progressive disease: Radiological progression|6|||
164582354|NCT04045613|594497937|FG005|Overall Study|Progressive disease: Radiological progression|6|||
164582355|NCT04045613|594497938|FG006|Overall Study|Progressive disease: Radiological progression|11|||
164582356|NCT01254344|594497945|FG000|Overall Study|Adverse Event|2|||
164582357|NCT01254344|594497946|FG001|Overall Study|Adverse Event|5|||
164582358|NCT01254344|594497945|FG000|Overall Study|Physician Decision|7|||
164582359|NCT01254344|594497946|FG001|Overall Study|Physician Decision|4|||
164582360|NCT01254344|594497945|FG000|Overall Study|Protocol Violation|1|||
164582361|NCT01254344|594497946|FG001|Overall Study|Protocol Violation|4|||
164582362|NCT01254344|594497945|FG000|Overall Study|Withdrawal by Subject|3|||
164582363|NCT01254344|594497946|FG001|Overall Study|Withdrawal by Subject|6|||
164582364|NCT00467649|594497947|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
164582365|NCT00467649|594497948|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
164582366|NCT00467649|594497949|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
164582367|NCT00467649|594497950|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
164582368|NCT00467649|594497951|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
164582369|NCT00467649|594497952|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
164582370|NCT00467649|594497947|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
164582371|NCT00467649|594497948|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
164582372|NCT00467649|594497949|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
164582373|NCT00467649|594497950|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
164582374|NCT00467649|594497951|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
164582375|NCT00467649|594497952|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
164582376|NCT00467649|594497947|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
164582377|NCT00467649|594497948|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
164582378|NCT00467649|594497949|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
164582379|NCT00467649|594497950|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
164582380|NCT00467649|594497951|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
164582381|NCT00467649|594497952|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
164582382|NCT00467649|594497947|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
164582383|NCT00467649|594497948|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
164687633|NCT05061992|594879836|FG001|Overall Study|Excess bowel movements|0|||
164687634|NCT05061992|594879835|FG000|Overall Study|Complications of Medical Care|1|||
164687635|NCT05061992|594879836|FG001|Overall Study|Complications of Medical Care|0|||
164687636|NCT05061992|594879835|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
164687637|NCT05061992|594879836|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
164687638|NCT05061992|594879835|FG000|Overall Study|Withdrawal by Subject|0|||
164687639|NCT05061992|594879836|FG001|Overall Study|Withdrawal by Subject|1|||
164687640|NCT01257581|594879840|FG000|Overall Study|Early Termination|3|||
164687641|NCT01257581|594879841|FG001|Overall Study|Early Termination|1|||
164687642|NCT01257581|594879842|FG002|Overall Study|Early Termination|2|||
164687643|NCT01257581|594879840|FG000|Overall Study|Death|2|||
164687644|NCT01257581|594879841|FG001|Overall Study|Death|2|||
164687645|NCT01257581|594879842|FG002|Overall Study|Death|4|||
164270471|NCT02616393|593358517|FG001|Overall Study|Lost to Follow-up|2|||
164270472|NCT02616393|593358518|FG002|Overall Study|Lost to Follow-up|0|||
164270473|NCT00657371|593358519|FG000|Overall Study|Poor bowel preparation|15|||
164270474|NCT00657371|593358519|FG000|Overall Study|Unable to intubate the cecum|5|||
164270475|NCT00657371|593358519|FG000|Overall Study|Protocol Violation|2|||
164270476|NCT00657371|593358519|FG000|Overall Study|Device- related reasons|13|||
164270477|NCT00657371|593358519|FG000|Overall Study|Pre-existing medical condition|4|||
164270478|NCT02642965|593358520|FG000|Overall Study|Lack of Efficacy|4|||
164687646|NCT01157234|594879843|FG000|Overall Study|Withdrawal by Subject|1|||
164687647|NCT01157234|594879844|FG001|Overall Study|Withdrawal by Subject|0|||
164687648|NCT00487695|594879855|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
164687649|NCT00487695|594879856|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
164687650|NCT00487695|594879855|FG000|First Procedure|active wheezing (did not have procedure)|1|||
164687651|NCT00487695|594879856|FG001|First Procedure|active wheezing (did not have procedure)|0|||
164687652|NCT00487695|594879855|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
164687653|NCT00487695|594879856|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
164687654|NCT00487695|594879855|FG000|Second Procedure|active wheezing|0|||
164687655|NCT00487695|594879856|FG001|Second Procedure|active wheezing|1|||
164687656|NCT00487695|594879855|FG000|Second Procedure|Withdrawal by Subject|1|||
164687657|NCT00487695|594879856|FG001|Second Procedure|Withdrawal by Subject|2|||
164687658|NCT01358877|594879857|FG000|Overall Study|Withdrawal by Subject|475|||
164687659|NCT01358877|594879858|FG001|Overall Study|Withdrawal by Subject|466|||
164687660|NCT01358877|594879857|FG000|Overall Study|Recurrence of disease|181|||
164270479|NCT02642965|593358520|FG000|Overall Study|Physician Decision|9|||
164270480|NCT00652899|593358521|FG000|Overall Study|Death|1|||
164687661|NCT01358877|594879858|FG001|Overall Study|Recurrence of disease|269|||
164687662|NCT01358877|594879857|FG000|Overall Study|Lost to Follow-up|181|||
164687663|NCT01358877|594879858|FG001|Overall Study|Lost to Follow-up|176|||
164687664|NCT01358877|594879857|FG000|Overall Study|Death|41|||
164687665|NCT01358877|594879858|FG001|Overall Study|Death|46|||
164687666|NCT01358877|594879857|FG000|Overall Study|Adverse Event|39|||
164687667|NCT01358877|594879858|FG001|Overall Study|Adverse Event|42|||
164687668|NCT01358877|594879857|FG000|Overall Study|Physician Decision|43|||
164687669|NCT01358877|594879858|FG001|Overall Study|Physician Decision|32|||
164687670|NCT01358877|594879857|FG000|Overall Study|Contralateral breast cancer|42|||
164687671|NCT01358877|594879858|FG001|Overall Study|Contralateral breast cancer|28|||
164687672|NCT01358877|594879857|FG000|Overall Study|Reason not specified|37|||
164687673|NCT01358877|594879858|FG001|Overall Study|Reason not specified|29|||
164687674|NCT00751023|594879868|FG000|Overall Study|Lost to Follow-up|11|||
164270481|NCT00652899|593358521|FG000|Overall Study|Treating physician decision|1|||
164270482|NCT02713867|593358528|FG000|Randomization|Other Reason|2|||
164270483|NCT02713867|593358529|FG001|Randomization|Other Reason|1|||
164687675|NCT00751023|594879869|FG001|Overall Study|Lost to Follow-up|7|||
164687676|NCT01547728|594879873|FG000|Overall Study|Change in procedure and equipment|1|||
164687677|NCT01547728|594879873|FG000|Overall Study|Drug not ready for subject|1|||
164687678|NCT01547728|594879873|FG000|Overall Study|Screen failure|39|||
164270484|NCT02713867|593358528|FG000|Randomization|Participant Withdrew consent|0|||
164270485|NCT02713867|593358529|FG001|Randomization|Participant Withdrew consent|2|||
164687679|NCT03448692|594879878|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
164687680|NCT03448692|594879879|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
164687681|NCT03448692|594879878|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
164687682|NCT03448692|594879879|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
164687683|NCT03448692|594879878|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
164687684|NCT03448692|594879879|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
164687685|NCT03448692|594879878|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
164687686|NCT03448692|594879879|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
164687687|NCT03448692|594879878|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
164687688|NCT03448692|594879879|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
164270486|NCT02713867|593358528|FG000|Treatment Period|Other Reasons|22|||
164270487|NCT02713867|593358529|FG001|Treatment Period|Other Reasons|28|||
164270488|NCT02713867|593358528|FG000|Treatment Period|Administrative reason by sponsor|21|||
164270489|NCT02713867|593358529|FG001|Treatment Period|Administrative reason by sponsor|16|||
164270490|NCT02713867|593358528|FG000|Treatment Period|No longer meets study criteria|2|||
164270491|NCT02713867|593358529|FG001|Treatment Period|No longer meets study criteria|1|||
164270492|NCT02713867|593358528|FG000|Treatment Period|Poor/Non Compliance|1|||
164270493|NCT02713867|593358529|FG001|Treatment Period|Poor/Non Compliance|0|||
164270494|NCT02713867|593358528|FG000|Treatment Period|Maximum Clinical Benefit|5|||
164270495|NCT02713867|593358529|FG001|Treatment Period|Maximum Clinical Benefit|6|||
164270496|NCT02713867|593358528|FG000|Treatment Period|Withdrew consent|3|||
164270497|NCT02713867|593358529|FG001|Treatment Period|Withdrew consent|6|||
164582384|NCT00467649|594497949|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
164582385|NCT00467649|594497950|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
164582386|NCT00467649|594497951|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
164582387|NCT00467649|594497952|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
164582388|NCT00467649|594497947|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
164582389|NCT00467649|594497948|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
164582390|NCT00467649|594497949|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
164582391|NCT00467649|594497950|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
164582392|NCT00467649|594497951|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
164582393|NCT00467649|594497952|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
164582394|NCT00467649|594497947|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
164582395|NCT00467649|594497948|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
164582396|NCT00467649|594497949|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
164582397|NCT00467649|594497950|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
164582398|NCT00467649|594497951|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
164582399|NCT00467649|594497952|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
164582400|NCT00467649|594497947|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
164582401|NCT00467649|594497948|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
164582402|NCT00467649|594497949|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
164582403|NCT00467649|594497950|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
164582404|NCT00467649|594497951|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
164582405|NCT00467649|594497952|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
164582406|NCT03233048|594497955|FG000|Overall Study|Withdrawal by Subject|1|||
164582407|NCT01856673|594497956|FG000|Overall Study|Withdrawal by Subject|44|||
164582408|NCT01856673|594497957|FG001|Overall Study|Withdrawal by Subject|50|||
164582409|NCT01856673|594497958|FG002|Overall Study|Withdrawal by Subject|33|||
164582410|NCT01856673|594497956|FG000|Overall Study|Lost to Follow-up|31|||
164582411|NCT01856673|594497957|FG001|Overall Study|Lost to Follow-up|34|||
164582412|NCT01856673|594497958|FG002|Overall Study|Lost to Follow-up|0|||
164582413|NCT01856673|594497956|FG000|Overall Study|Unknown reasons|9|||
164582414|NCT01856673|594497957|FG001|Overall Study|Unknown reasons|0|||
164582415|NCT01856673|594497958|FG002|Overall Study|Unknown reasons|0|||
164582416|NCT01856673|594497956|FG000|Overall Study|Psychologist decision|1|||
164582417|NCT01856673|594497957|FG001|Overall Study|Psychologist decision|0|||
164582418|NCT01856673|594497958|FG002|Overall Study|Psychologist decision|0|||
164582419|NCT01856673|594497956|FG000|Overall Study|Paperwork errors|8|||
164582420|NCT01856673|594497957|FG001|Overall Study|Paperwork errors|0|||
164582421|NCT01856673|594497958|FG002|Overall Study|Paperwork errors|0|||
164582422|NCT01856673|594497956|FG000|Overall Study|Death|1|||
164582423|NCT01856673|594497957|FG001|Overall Study|Death|1|||
164582424|NCT01856673|594497958|FG002|Overall Study|Death|0|||
164582425|NCT01856673|594497956|FG000|Overall Study|Protocol Violation|1|||
164582426|NCT01856673|594497957|FG001|Overall Study|Protocol Violation|0|||
164582427|NCT01856673|594497958|FG002|Overall Study|Protocol Violation|1|||
164582428|NCT00491530|594497959|FG000|Overall Study|Adverse Event|6|||
164582429|NCT00491530|594497960|FG001|Overall Study|Adverse Event|1|||
164582430|NCT00491530|594497961|FG002|Overall Study|Adverse Event|2|||
164582431|NCT00491530|594497959|FG000|Overall Study|Withdrawal by Subject|3|||
164582432|NCT00491530|594497960|FG001|Overall Study|Withdrawal by Subject|0|||
164582433|NCT00491530|594497961|FG002|Overall Study|Withdrawal by Subject|0|||
164582434|NCT00491530|594497959|FG000|Overall Study|Lost to Follow-up|3|||
164582435|NCT00491530|594497960|FG001|Overall Study|Lost to Follow-up|2|||
164582436|NCT00491530|594497961|FG002|Overall Study|Lost to Follow-up|2|||
164582437|NCT00491530|594497959|FG000|Overall Study|Lack of Efficacy|0|||
164582438|NCT00491530|594497960|FG001|Overall Study|Lack of Efficacy|1|||
164582439|NCT00491530|594497961|FG002|Overall Study|Lack of Efficacy|0|||
164582440|NCT00491530|594497959|FG000|Overall Study|Investigator Discretion|0|||
164582441|NCT00491530|594497960|FG001|Overall Study|Investigator Discretion|1|||
164582442|NCT00491530|594497961|FG002|Overall Study|Investigator Discretion|0|||
164582443|NCT00491530|594497959|FG000|Overall Study|Patient Request|0|||
164582444|NCT00491530|594497960|FG001|Overall Study|Patient Request|1|||
164582445|NCT00491530|594497961|FG002|Overall Study|Patient Request|0|||
164270498|NCT02713867|593358528|FG000|Treatment Period|Requested to Discontinue|8|||
164270499|NCT02713867|593358529|FG001|Treatment Period|Requested to Discontinue|8|||
164270500|NCT02713867|593358528|FG000|Treatment Period|AE unrelated to Study Drug|11|||
164270501|NCT02713867|593358529|FG001|Treatment Period|AE unrelated to Study Drug|10|||
164270502|NCT02713867|593358528|FG000|Treatment Period|Death|7|||
164270503|NCT02713867|593358529|FG001|Treatment Period|Death|3|||
164270504|NCT02713867|593358528|FG000|Treatment Period|Study Drug Toxicity|16|||
164270505|NCT02713867|593358529|FG001|Treatment Period|Study Drug Toxicity|19|||
164270506|NCT02713867|593358528|FG000|Treatment Period|Disease Progression|82|||
164270507|NCT02713867|593358529|FG001|Treatment Period|Disease Progression|83|||
164270508|NCT04135859|593358533|FG000|Overall Study|Withdrawal by Subject|1|||
164270509|NCT04135859|593358534|FG001|Overall Study|Withdrawal by Subject|0|||
164270510|NCT04135859|593358533|FG000|Overall Study|Withdrawal due to screening failure|1|||
164270511|NCT04135859|593358534|FG001|Overall Study|Withdrawal due to screening failure|2|||
164270512|NCT04135859|593358533|FG000|Overall Study|Did not complete stress test|3|||
164270513|NCT04135859|593358534|FG001|Overall Study|Did not complete stress test|3|||
164270514|NCT04135859|593358533|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
164270515|NCT04135859|593358534|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
164270516|NCT01600053|593358537|FG000|Overall Study|Adverse Event|2|||
164270517|NCT01600053|593358537|FG000|Overall Study|trial will not meet the interim endpoint|9|||
164270518|NCT02715726|593358540|FG000|Overall Study|Adverse Event|2|||
164270519|NCT02715726|593358541|FG001|Overall Study|Adverse Event|6|||
164270520|NCT02715726|593358540|FG000|Overall Study|Protocol Violation|1|||
164270521|NCT02715726|593358541|FG001|Overall Study|Protocol Violation|0|||
164342196|NCT01877265|593629376|FG001|Treatment Period 1|Sponsor Decision|0|||
164342197|NCT01877265|593629377|FG002|Treatment Period 1|Sponsor Decision|1|||
164342198|NCT01877265|593629378|FG003|Treatment Period 1|Sponsor Decision|0|||
164342199|NCT01877265|593629379|FG004|Treatment Period 1|Sponsor Decision|0|||
164342200|NCT01877265|593629380|FG005|Treatment Period 1|Sponsor Decision|0|||
164342201|NCT01877265|593629375|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
164342202|NCT01877265|593629376|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
164342203|NCT01877265|593629377|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
164342204|NCT01877265|593629378|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
164342205|NCT01877265|593629379|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
164342206|NCT01877265|593629380|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
164342207|NCT01877265|593629375|FG000|Treatment Period 3|Lost to Follow-up|1|||
164582446|NCT00491530|594497959|FG000|Overall Study|Use of Prohibited Medication|0|||
164582447|NCT00491530|594497960|FG001|Overall Study|Use of Prohibited Medication|0|||
164582448|NCT00491530|594497961|FG002|Overall Study|Use of Prohibited Medication|1|||
164582449|NCT03114969|594497962|FG000|Overall Study|Lost to Follow-up|0|||
164582450|NCT03114969|594497963|FG001|Overall Study|Lost to Follow-up|0|||
164582451|NCT03114969|594497964|FG002|Overall Study|Lost to Follow-up|3|||
164582452|NCT03114969|594497965|FG003|Overall Study|Lost to Follow-up|2|||
164582453|NCT03114969|594497966|FG004|Overall Study|Lost to Follow-up|0|||
164582454|NCT03114969|594497967|FG005|Overall Study|Lost to Follow-up|0|||
164582455|NCT03114969|594497968|FG006|Overall Study|Lost to Follow-up|0|||
164582456|NCT03114969|594497969|FG007|Overall Study|Lost to Follow-up|0|||
164582457|NCT03114969|594497970|FG008|Overall Study|Lost to Follow-up|0|||
164582458|NCT03114969|594497962|FG000|Overall Study|Adverse Event|0|||
164582459|NCT03114969|594497963|FG001|Overall Study|Adverse Event|0|||
164582460|NCT03114969|594497964|FG002|Overall Study|Adverse Event|1|||
164582461|NCT03114969|594497965|FG003|Overall Study|Adverse Event|0|||
164582462|NCT03114969|594497966|FG004|Overall Study|Adverse Event|0|||
164582463|NCT03114969|594497967|FG005|Overall Study|Adverse Event|1|||
164582464|NCT03114969|594497968|FG006|Overall Study|Adverse Event|1|||
164582465|NCT03114969|594497969|FG007|Overall Study|Adverse Event|0|||
164582466|NCT03114969|594497970|FG008|Overall Study|Adverse Event|2|||
164582467|NCT00971321|594497971|FG000|Up to Month 7|Withdrawal by Subject|1|||
164582468|NCT00971321|594497972|FG001|Up to Month 7|Withdrawal by Subject|0|||
164582469|NCT00971321|594497971|FG000|Up to Month 7|Migrated/moved from study area|3|||
164582470|NCT00971321|594497972|FG001|Up to Month 7|Migrated/moved from study area|2|||
164582471|NCT00971321|594497971|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
164582472|NCT00971321|594497972|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
164582473|NCT00971321|594497971|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
164582474|NCT00971321|594497972|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
164582475|NCT00971321|594497971|FG000|Up to Month 11-12|Lost to Follow-up|1|||
164582476|NCT00971321|594497972|FG001|Up to Month 11-12|Lost to Follow-up|0|||
164582477|NCT02436239|594497975|FG000|Open-Lable Treatment Period|Adverse Event|12|||
164582478|NCT02436239|594497976|FG001|Open-Lable Treatment Period|Adverse Event|3|||
164582479|NCT02436239|594497977|FG002|Open-Lable Treatment Period|Adverse Event|4|||
164270522|NCT02715726|593358540|FG000|Overall Study|Death|2|||
164270523|NCT02715726|593358541|FG001|Overall Study|Death|1|||
164270524|NCT02715726|593358540|FG000|Overall Study|Participant moved|1|||
164342208|NCT01877265|593629376|FG001|Treatment Period 3|Lost to Follow-up|0|||
164342209|NCT01877265|593629377|FG002|Treatment Period 3|Lost to Follow-up|0|||
164582480|NCT02436239|594497978|FG003|Open-Lable Treatment Period|Adverse Event|2|||
164582481|NCT02436239|594497975|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
164342210|NCT01877265|593629378|FG003|Treatment Period 3|Lost to Follow-up|0|||
164342211|NCT01877265|593629379|FG004|Treatment Period 3|Lost to Follow-up|0|||
164342212|NCT01877265|593629380|FG005|Treatment Period 3|Lost to Follow-up|0|||
164342213|NCT01947582|593629381|FG000|Overall Study|Withdrawal by Subject|1|||
164342214|NCT00592384|593629382|FG000|Overall Study|Withdrawal by Subject|5|||
164342215|NCT00592384|593629383|FG001|Overall Study|Withdrawal by Subject|6|||
164342216|NCT01153347|593629387|FG000|Overall Study|Withdrawal by Subject|7|||
164342217|NCT01153347|593629388|FG001|Overall Study|Withdrawal by Subject|7|||
164342218|NCT01153347|593629389|FG002|Overall Study|Withdrawal by Subject|7|||
164342219|NCT01153347|593629390|FG003|Overall Study|Withdrawal by Subject|7|||
164342220|NCT01153347|593629387|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164342221|NCT01153347|593629388|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
164342222|NCT01153347|593629389|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
164342223|NCT01153347|593629390|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
164342224|NCT01153347|593629387|FG000|Overall Study|Adverse Event|3|||
164342225|NCT01153347|593629388|FG001|Overall Study|Adverse Event|9|||
164342226|NCT01153347|593629389|FG002|Overall Study|Adverse Event|21|||
164342227|NCT01153347|593629390|FG003|Overall Study|Adverse Event|7|||
164342228|NCT01153347|593629387|FG000|Overall Study|Severe non-compliance to protocol|6|||
164342229|NCT01153347|593629388|FG001|Overall Study|Severe non-compliance to protocol|7|||
164342230|NCT01153347|593629389|FG002|Overall Study|Severe non-compliance to protocol|4|||
164342231|NCT01153347|593629390|FG003|Overall Study|Severe non-compliance to protocol|3|||
164342232|NCT01153347|593629387|FG000|Overall Study|Condition under investigation worsened|1|||
164342233|NCT01153347|593629388|FG001|Overall Study|Condition under investigation worsened|1|||
164342234|NCT01153347|593629389|FG002|Overall Study|Condition under investigation worsened|0|||
164342235|NCT01153347|593629390|FG003|Overall Study|Condition under investigation worsened|0|||
164342236|NCT01153347|593629387|FG000|Overall Study|Lack of Efficacy|2|||
164342237|NCT01153347|593629388|FG001|Overall Study|Lack of Efficacy|2|||
164342238|NCT01153347|593629389|FG002|Overall Study|Lack of Efficacy|0|||
164342239|NCT01153347|593629390|FG003|Overall Study|Lack of Efficacy|4|||
164342240|NCT01153347|593629387|FG000|Overall Study|Study-specific withdrawal criteria|4|||
164342241|NCT01153347|593629388|FG001|Overall Study|Study-specific withdrawal criteria|3|||
164342242|NCT01153347|593629389|FG002|Overall Study|Study-specific withdrawal criteria|1|||
164342243|NCT01153347|593629390|FG003|Overall Study|Study-specific withdrawal criteria|2|||
164342244|NCT01153347|593629387|FG000|Overall Study|Lost to Follow-up|4|||
164342245|NCT01153347|593629388|FG001|Overall Study|Lost to Follow-up|9|||
164342246|NCT01153347|593629389|FG002|Overall Study|Lost to Follow-up|11|||
164342247|NCT01153347|593629390|FG003|Overall Study|Lost to Follow-up|8|||
164342248|NCT01153347|593629387|FG000|Overall Study|Other|5|||
164342249|NCT01153347|593629388|FG001|Overall Study|Other|5|||
164342250|NCT01153347|593629389|FG002|Overall Study|Other|4|||
164342251|NCT01153347|593629390|FG003|Overall Study|Other|0|||
164342252|NCT01153347|593629387|FG000|Overall Study|Death|1|||
164342253|NCT01153347|593629388|FG001|Overall Study|Death|0|||
164342254|NCT01153347|593629389|FG002|Overall Study|Death|0|||
164342255|NCT01153347|593629390|FG003|Overall Study|Death|0|||
164342256|NCT04401423|593629393|FG000|Overall Study|Withdrawal by Subject|3|||
164342257|NCT04401423|593629394|FG001|Overall Study|Withdrawal by Subject|1|||
164342258|NCT04401423|593629393|FG000|Overall Study|Physician Decision|2|||
164342259|NCT04401423|593629394|FG001|Overall Study|Physician Decision|1|||
164687689|NCT02786927|594879882|FG000|Overall Study|Adverse Event|1|||
164687690|NCT02786927|594879882|FG000|Overall Study|Protocol Violation|4|||
164687691|NCT02416934|594879884|FG000|Overall Study|given steroids|1|||
164687692|NCT02416934|594879885|FG001|Overall Study|given steroids|2|||
164687693|NCT02416934|594879884|FG000|Overall Study|Lost to Follow-up|0|||
164687694|NCT02416934|594879885|FG001|Overall Study|Lost to Follow-up|2|||
164687695|NCT02416934|594879884|FG000|Overall Study|Withdrawal by Subject|1|||
164687696|NCT02416934|594879885|FG001|Overall Study|Withdrawal by Subject|0|||
164687697|NCT02416934|594879884|FG000|Overall Study|recruited during continuing renewal proc|0|||
164687698|NCT02416934|594879885|FG001|Overall Study|recruited during continuing renewal proc|1|||
164342260|NCT00003473|593629395|FG000|Overall Study|Three patients were not evaluable.|3|||
164342261|NCT04678661|593629396|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
164342262|NCT04678661|593629397|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
164342263|NCT04678661|593629396|FG000|Overall Study|Protocol Violation|2|||
164342264|NCT04678661|593629397|FG001|Overall Study|Protocol Violation|0|||
164342265|NCT04678661|593629396|FG000|Overall Study|Withdrawal by Subject|1|||
164342266|NCT04678661|593629397|FG001|Overall Study|Withdrawal by Subject|0|||
164342267|NCT04678661|593629396|FG000|Overall Study|Lost to Follow-up|2|||
164342268|NCT04678661|593629397|FG001|Overall Study|Lost to Follow-up|0|||
164342269|NCT04678661|593629396|FG000|Overall Study|Death|2|||
164342270|NCT04678661|593629397|FG001|Overall Study|Death|0|||
164342271|NCT03039283|593629400|FG000|Overall Study|Protocol Violation|2|||
164342272|NCT01086033|593629401|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
164342273|NCT01086033|593629401|FG000|Overall Study|Lost to Follow-up|86|||
164687699|NCT02416934|594879884|FG000|Overall Study|Protocol Violation|0|||
164342274|NCT01086033|593629401|FG000|Overall Study|Adverse Event|42|||
164342275|NCT01086033|593629401|FG000|Overall Study|Withdrawal by Subject|41|||
164342276|NCT01086033|593629401|FG000|Overall Study|Other|14|||
164342277|NCT01086033|593629401|FG000|Overall Study|Other|13|||
164342278|NCT01086033|593629401|FG000|Overall Study|AE and Withdrew Consent|5|||
164342279|NCT01086033|593629401|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
164342280|NCT01086033|593629401|FG000|Overall Study|Withdrew consent and Other Reason|4|||
164342281|NCT01086033|593629401|FG000|Overall Study|AE and Lack of Efficacy|4|||
164342282|NCT01086033|593629401|FG000|Overall Study|Death|1|||
164342283|NCT01086033|593629401|FG000|Overall Study|AE and Lost to Follow-up|1|||
164342284|NCT01086033|593629401|FG000|Overall Study|AE and Other Reason|1|||
164342285|NCT01086033|593629401|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
164342286|NCT02193867|593629402|FG000|Overall Study|Death|2|||
164342287|NCT02193867|593629402|FG000|Overall Study|Sponsor Study Termination|2|||
164342288|NCT03639935|593629403|FG000|Overall Study|Death|3|||
164342289|NCT03639935|593629403|FG000|Overall Study|Adverse Event|1|||
164342290|NCT02924571|593629404|FG000|Overall Study|Lost to Follow-up|1|||
164342291|NCT02924571|593629405|FG001|Overall Study|Lost to Follow-up|1|||
164342292|NCT02924571|593629406|FG002|Overall Study|Lost to Follow-up|0|||
164342293|NCT00864721|593629407|FG000|Overall Study|Patient request|11|||
164342294|NCT00864721|593629407|FG000|Overall Study|Hospitalized|1|||
164342295|NCT00864721|593629407|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
164342296|NCT00864721|593629407|FG000|Overall Study|Adverse Event|21|||
164342297|NCT00261807|593629410|FG000|Overall Study|Lost to Follow-up|2|||
164342298|NCT00261807|593629410|FG000|Overall Study|Adverse Event|2|||
164342299|NCT00261807|593629410|FG000|Overall Study|Death|1|||
164342300|NCT00261807|593629410|FG000|Overall Study|Protocol Violation|2|||
164342301|NCT02590003|593629420|FG000|Overall Study|Death|1|||
164342302|NCT02590003|593629421|FG001|Overall Study|Death|2|||
164342303|NCT03733470|593629422|FG000|Overall Study|PI Decision|1|||
164342304|NCT03733470|593629423|FG001|Overall Study|PI Decision|1|||
164342305|NCT04457336|593629426|FG000|Period 2: Part A|Withdrawal by Subject|0|||
164342306|NCT04457336|593629427|FG001|Period 2: Part A|Withdrawal by Subject|1|||
164342307|NCT04457336|593629428|FG002|Period 2: Part A|Withdrawal by Subject|1|||
164270525|NCT02715726|593358541|FG001|Overall Study|Participant moved|3|||
164270526|NCT02715726|593358540|FG000|Overall Study|Other than specified above|11|||
164270527|NCT02715726|593358541|FG001|Overall Study|Other than specified above|15|||
164270528|NCT02715726|593358540|FG000|Overall Study|Randomized but not treated|1|||
164270529|NCT02715726|593358541|FG001|Overall Study|Randomized but not treated|2|||
164270530|NCT02445573|593358542|FG000|Overall Study|Withdrawal by Subject|1|||
164270531|NCT02445573|593358543|FG001|Overall Study|Withdrawal by Subject|1|||
164270532|NCT02445573|593358542|FG000|Overall Study|Lost to Follow-up|0|||
164270533|NCT02445573|593358543|FG001|Overall Study|Lost to Follow-up|1|||
164270534|NCT04047420|593358546|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
164270535|NCT04047420|593358546|FG000|Washout Period|Refused Participation|2|||
164270536|NCT03629912|593358554|FG000|Overall Study|Lost to Follow-up|19|||
164270537|NCT03629912|593358555|FG001|Overall Study|Lost to Follow-up|7|||
164270538|NCT03629912|593358556|FG002|Overall Study|Lost to Follow-up|5|||
164270539|NCT03629912|593358557|FG003|Overall Study|Lost to Follow-up|1|||
164270540|NCT03629912|593358554|FG000|Overall Study|Withdrawal by Subject|6|||
164270541|NCT03629912|593358555|FG001|Overall Study|Withdrawal by Subject|0|||
164270542|NCT03629912|593358556|FG002|Overall Study|Withdrawal by Subject|1|||
164270543|NCT03629912|593358557|FG003|Overall Study|Withdrawal by Subject|2|||
164270544|NCT03629912|593358554|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
164270545|NCT03629912|593358555|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
164270546|NCT03629912|593358556|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
164270547|NCT03629912|593358557|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
164270548|NCT03629912|593358554|FG000|Overall Study|Death|1|||
164270549|NCT03629912|593358555|FG001|Overall Study|Death|0|||
164342308|NCT04457336|593629429|FG003|Period 2: Part A|Withdrawal by Subject|1|||
164342309|NCT04457336|593629430|FG004|Period 2: Part A|Withdrawal by Subject|0|||
164342310|NCT04457336|593629431|FG005|Period 2: Part A|Withdrawal by Subject|0|||
164342311|NCT04457336|593629432|FG006|Period 2: Part A|Withdrawal by Subject|0|||
164342312|NCT04457336|593629433|FG007|Period 2: Part A|Withdrawal by Subject|0|||
164270550|NCT03629912|593358556|FG002|Overall Study|Death|0|||
164270551|NCT03629912|593358557|FG003|Overall Study|Death|0|||
164270552|NCT02608450|593358558|FG000|Overall Study|Lost to Follow-up|39|||
164270553|NCT02608450|593358559|FG001|Overall Study|Lost to Follow-up|32|||
164270554|NCT02608450|593358558|FG000|Overall Study|Withdrawal by Subject|21|||
164270555|NCT02608450|593358559|FG001|Overall Study|Withdrawal by Subject|15|||
164342313|NCT04457336|593629426|FG000|Period 2: Part A|Adverse Event|0|||
164342314|NCT04457336|593629427|FG001|Period 2: Part A|Adverse Event|0|||
164342315|NCT04457336|593629428|FG002|Period 2: Part A|Adverse Event|1|||
164342316|NCT04457336|593629429|FG003|Period 2: Part A|Adverse Event|1|||
164342317|NCT04457336|593629430|FG004|Period 2: Part A|Adverse Event|0|||
164342318|NCT04457336|593629431|FG005|Period 2: Part A|Adverse Event|0|||
164342319|NCT04457336|593629432|FG006|Period 2: Part A|Adverse Event|0|||
164342320|NCT04457336|593629433|FG007|Period 2: Part A|Adverse Event|0|||
164270556|NCT02608450|593358558|FG000|Overall Study|Adverse Event|3|||
164270557|NCT02608450|593358559|FG001|Overall Study|Adverse Event|6|||
164270558|NCT02608450|593358558|FG000|Overall Study|Withdrawal by parent|2|||
164270559|NCT02608450|593358559|FG001|Overall Study|Withdrawal by parent|3|||
164270560|NCT02608450|593358558|FG000|Overall Study|Lack of Efficacy|0|||
164270561|NCT02608450|593358559|FG001|Overall Study|Lack of Efficacy|3|||
164270562|NCT02608450|593358558|FG000|Overall Study|Noncompliance with study drug|0|||
164270563|NCT02608450|593358559|FG001|Overall Study|Noncompliance with study drug|2|||
164270564|NCT02608450|593358558|FG000|Overall Study|Physician Decision|0|||
164270565|NCT02608450|593358559|FG001|Overall Study|Physician Decision|1|||
164270566|NCT02608450|593358558|FG000|Overall Study|Pregnancy|0|||
164270567|NCT02608450|593358559|FG001|Overall Study|Pregnancy|1|||
164270568|NCT02608450|593358558|FG000|Overall Study|Progressive disease|1|||
164270569|NCT02608450|593358559|FG001|Overall Study|Progressive disease|0|||
164270570|NCT02608450|593358558|FG000|Overall Study|Multiple reasons|0|||
164270571|NCT02608450|593358559|FG001|Overall Study|Multiple reasons|2|||
164270572|NCT02565810|593358560|FG000|Overall Study|Withdrawal by Subject|1|||
164270573|NCT02636946|593358563|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
164270574|NCT02636946|593358564|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
164270575|NCT02636946|593358563|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
164270576|NCT02636946|593358564|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
164270577|NCT02636946|593358563|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
164270578|NCT02636946|593358564|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
164270579|NCT02636946|593358563|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
164270580|NCT02636946|593358564|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
164270581|NCT02636946|593358563|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
164270582|NCT02636946|593358564|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
164270583|NCT02636946|593358563|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
164270584|NCT02636946|593358564|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
164270585|NCT03089944|593358565|FG000|Overall Study|Lost to Follow-up|8|||
164270586|NCT03089944|593358565|FG000|Overall Study|Withdrew Consent|2|||
164270587|NCT03089944|593358565|FG000|Overall Study|Adverse Event|1|||
164270588|NCT03089944|593358565|FG000|Overall Study|Other|1|||
164270589|NCT02308488|593358566|FG000|Overall Study|Withdrawal by Subject|2|||
164270590|NCT03263780|593358569|FG000|Overall Study|Withdrawal by Subject|3|||
164687700|NCT02416934|594879885|FG001|Overall Study|Protocol Violation|1|||
164687701|NCT02416934|594879884|FG000|Overall Study|surgery started late|0|||
164687702|NCT02416934|594879885|FG001|Overall Study|surgery started late|1|||
164687703|NCT02416934|594879884|FG000|Overall Study|re-operation|1|||
164687704|NCT02416934|594879885|FG001|Overall Study|re-operation|0|||
164687705|NCT00494013|594879886|FG000|Overall Study|Adverse Event|0|||
164687706|NCT00494013|594879887|FG001|Overall Study|Adverse Event|1|||
164687707|NCT00494013|594879886|FG000|Overall Study|Entry Criteria Not Met|1|||
164687708|NCT00494013|594879887|FG001|Overall Study|Entry Criteria Not Met|4|||
164687709|NCT00494013|594879886|FG000|Overall Study|Lost to Follow-up|5|||
164687710|NCT00494013|594879887|FG001|Overall Study|Lost to Follow-up|6|||
164687711|NCT00494013|594879886|FG000|Overall Study|Physician Decision|3|||
164687712|NCT00494013|594879887|FG001|Overall Study|Physician Decision|5|||
164687713|NCT00494013|594879886|FG000|Overall Study|Protocol Violation|8|||
164687714|NCT00494013|594879887|FG001|Overall Study|Protocol Violation|5|||
164687715|NCT00494013|594879886|FG000|Overall Study|Withdrawal by Subject|13|||
164687716|NCT00494013|594879887|FG001|Overall Study|Withdrawal by Subject|14|||
164687717|NCT00494013|594879886|FG000|Overall Study|Sponsor Decision|0|||
164687718|NCT00494013|594879887|FG001|Overall Study|Sponsor Decision|1|||
164270591|NCT03263780|593358569|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
164270592|NCT01839656|593358573|FG000|Overall Study|Withdrawal by Subject|1|||
164270593|NCT01839656|593358574|FG001|Overall Study|Withdrawal by Subject|1|||
164270594|NCT01839656|593358573|FG000|Overall Study|Adverse event, serious fatal|1|||
164270595|NCT01839656|593358574|FG001|Overall Study|Adverse event, serious fatal|4|||
164270596|NCT01839656|593358573|FG000|Overall Study|Early study closure|0|||
164270597|NCT01839656|593358574|FG001|Overall Study|Early study closure|11|||
164270598|NCT01839656|593358573|FG000|Overall Study|Adverse Event|1|||
164270599|NCT01839656|593358574|FG001|Overall Study|Adverse Event|0|||
164270600|NCT00499746|593358580|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
164270601|NCT00499746|593358580|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
164270602|NCT00499746|593358580|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
164687719|NCT01912807|594879891|FG000|Overall Study|Did not meet elegibility criteria|6|||
164687720|NCT01912807|594879892|FG001|Overall Study|Did not meet elegibility criteria|4|||
164270603|NCT00499746|593358580|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
164270604|NCT01012323|593358583|FG000|Overall Study|Investigator Judgment|1|||
164270605|NCT00558272|593358586|FG000|Overall Study|Adverse Event|10|||
164687721|NCT01912807|594879891|FG000|Overall Study|Lost to Follow-up|36|||
164270606|NCT00558272|593358587|FG001|Overall Study|Adverse Event|0|||
164270607|NCT00558272|593358586|FG000|Overall Study|Death|1|||
164270608|NCT00558272|593358587|FG001|Overall Study|Death|0|||
164270609|NCT00558272|593358586|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
164270610|NCT00558272|593358587|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
164270611|NCT00558272|593358586|FG000|Overall Study|AZ study team decision|0|||
164270612|NCT00558272|593358587|FG001|Overall Study|AZ study team decision|1|||
164270613|NCT00558272|593358586|FG000|Overall Study|Incorrectly enrolled|1|||
164270614|NCT00558272|593358587|FG001|Overall Study|Incorrectly enrolled|0|||
164270615|NCT00558272|593358586|FG000|Overall Study|Withdrawal by Subject|0|||
164270616|NCT00558272|593358587|FG001|Overall Study|Withdrawal by Subject|1|||
164270617|NCT00737633|593358593|FG000|Overall Study|Study terminated by sponsor|44|||
164270618|NCT00737633|593358594|FG001|Overall Study|Study terminated by sponsor|55|||
164582482|NCT02436239|594497976|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
164270619|NCT00737633|593358593|FG000|Overall Study|Lost to Follow-up|0|||
164270620|NCT00737633|593358594|FG001|Overall Study|Lost to Follow-up|1|||
164270621|NCT00737633|593358593|FG000|Overall Study|protocol non-compliance|0|||
164270622|NCT00737633|593358594|FG001|Overall Study|protocol non-compliance|1|||
164270623|NCT01105377|593358600|FG000|Overall Study|Withdrawal by Subject|0|||
164270624|NCT01105377|593358601|FG001|Overall Study|Withdrawal by Subject|1|||
164270625|NCT02409342|593358603|FG000|Overall Study|Death|211|||
164270626|NCT02409342|593358604|FG001|Overall Study|Death|201|||
164270627|NCT02409342|593358603|FG000|Overall Study|Withdrawal by Subject|24|||
164270628|NCT02409342|593358604|FG001|Overall Study|Withdrawal by Subject|17|||
164270629|NCT02409342|593358603|FG000|Overall Study|Study Terminated By Sponsor|48|||
164270630|NCT02409342|593358604|FG001|Overall Study|Study Terminated By Sponsor|59|||
164270631|NCT02409342|593358603|FG000|Overall Study|Lost to Follow-up|3|||
164582483|NCT02436239|594497977|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
164270632|NCT02409342|593358604|FG001|Overall Study|Lost to Follow-up|5|||
164270633|NCT02409342|593358603|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
164270634|NCT02409342|593358604|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
164270635|NCT02409342|593358603|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
164342321|NCT04457336|593629426|FG000|Period 2: Part A|Study Terminated|0|||
164342322|NCT04457336|593629427|FG001|Period 2: Part A|Study Terminated|0|||
164582484|NCT02436239|594497978|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
164582485|NCT02436239|594497975|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
164582486|NCT02436239|594497976|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
164582487|NCT02436239|594497977|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
164582488|NCT02436239|594497978|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
164582489|NCT02436239|594497975|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
164582490|NCT02436239|594497976|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
164582491|NCT02436239|594497977|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
164582492|NCT02436239|594497978|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
164582493|NCT02436239|594497975|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
164582494|NCT02436239|594497976|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
164582495|NCT02436239|594497977|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
164582496|NCT02436239|594497978|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
164582497|NCT02436239|594497975|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
164582498|NCT02436239|594497976|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
164582499|NCT02436239|594497977|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
164582500|NCT02436239|594497978|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
164582501|NCT02436239|594497975|FG000|Open-Lable Treatment Period|Other Reason|1|||
164582502|NCT02436239|594497976|FG001|Open-Lable Treatment Period|Other Reason|1|||
164582503|NCT02436239|594497977|FG002|Open-Lable Treatment Period|Other Reason|0|||
164582504|NCT02436239|594497978|FG003|Open-Lable Treatment Period|Other Reason|0|||
164582505|NCT02436239|594497975|FG000|Down-Taper Period|Withdrawal by Subject|4|||
164582506|NCT02436239|594497976|FG001|Down-Taper Period|Withdrawal by Subject|4|||
164582507|NCT02436239|594497977|FG002|Down-Taper Period|Withdrawal by Subject|1|||
164582508|NCT02436239|594497978|FG003|Down-Taper Period|Withdrawal by Subject|2|||
164582509|NCT02168946|594497979|FG000|Overall Study|Adverse Event|8|||
164582510|NCT02168946|594497980|FG001|Overall Study|Adverse Event|5|||
164582511|NCT02168946|594497979|FG000|Overall Study|Lost to Follow-up|3|||
164582512|NCT02168946|594497980|FG001|Overall Study|Lost to Follow-up|0|||
164582513|NCT02168946|594497979|FG000|Overall Study|Subject unable to come back for visits|1|||
164582514|NCT02168946|594497980|FG001|Overall Study|Subject unable to come back for visits|0|||
164582515|NCT00450866|594497985|FG000|Overall Study|Adverse Event|0|||
164582516|NCT00450866|594497986|FG001|Overall Study|Adverse Event|1|||
164582517|NCT00450866|594497985|FG000|Overall Study|Withdrawal by Subject|5|||
164582518|NCT00450866|594497986|FG001|Overall Study|Withdrawal by Subject|2|||
164582519|NCT00450866|594497985|FG000|Overall Study|Death|1|||
164582520|NCT00450866|594497986|FG001|Overall Study|Death|0|||
164582521|NCT00450866|594497985|FG000|Overall Study|Physician Decision|1|||
164582522|NCT00450866|594497986|FG001|Overall Study|Physician Decision|0|||
164270636|NCT02409342|593358604|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
164270637|NCT02409342|593358603|FG000|Overall Study|Sponsor Decision|1|||
164270638|NCT02409342|593358604|FG001|Overall Study|Sponsor Decision|0|||
164270639|NCT00279812|593358605|FG000|Overall Study|Protocol Violation|1|||
164270640|NCT00279812|593358606|FG001|Overall Study|Protocol Violation|1|||
164270641|NCT00279812|593358607|FG002|Overall Study|Protocol Violation|0|||
164270642|NCT00279812|593358608|FG003|Overall Study|Protocol Violation|0|||
164270643|NCT00279812|593358609|FG004|Overall Study|Protocol Violation|1|||
164270644|NCT00279812|593358610|FG005|Overall Study|Protocol Violation|0|||
164270645|NCT00279812|593358605|FG000|Overall Study|Withdrawal by Subject|0|||
164270646|NCT00279812|593358606|FG001|Overall Study|Withdrawal by Subject|4|||
164270647|NCT00279812|593358607|FG002|Overall Study|Withdrawal by Subject|2|||
164270648|NCT00279812|593358608|FG003|Overall Study|Withdrawal by Subject|0|||
164270649|NCT00279812|593358609|FG004|Overall Study|Withdrawal by Subject|0|||
164270650|NCT00279812|593358610|FG005|Overall Study|Withdrawal by Subject|0|||
164270651|NCT00279812|593358605|FG000|Overall Study|Adverse Event|0|||
164270652|NCT00279812|593358606|FG001|Overall Study|Adverse Event|1|||
164270653|NCT00279812|593358607|FG002|Overall Study|Adverse Event|1|||
164270654|NCT00279812|593358608|FG003|Overall Study|Adverse Event|0|||
164270655|NCT00279812|593358609|FG004|Overall Study|Adverse Event|2|||
164270656|NCT00279812|593358610|FG005|Overall Study|Adverse Event|1|||
164270657|NCT03834220|593358616|FG000|Overall Study|Adverse Event|1|||
164270658|NCT03834220|593358617|FG001|Overall Study|Adverse Event|0|||
164270659|NCT03834220|593358618|FG002|Overall Study|Adverse Event|0|||
164270660|NCT03834220|593358616|FG000|Overall Study|Death|8|||
164270661|NCT03834220|593358617|FG001|Overall Study|Death|1|||
164270662|NCT03834220|593358618|FG002|Overall Study|Death|17|||
164270663|NCT03834220|593358616|FG000|Overall Study|Reason not Specified|9|||
164270664|NCT03834220|593358617|FG001|Overall Study|Reason not Specified|0|||
164270665|NCT03834220|593358618|FG002|Overall Study|Reason not Specified|6|||
164270666|NCT03834220|593358616|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
164270667|NCT03834220|593358617|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
164270668|NCT03834220|593358618|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
164270669|NCT03834220|593358616|FG000|Overall Study|Withdrawal of Consent|2|||
164270670|NCT03834220|593358617|FG001|Overall Study|Withdrawal of Consent|2|||
164270671|NCT03834220|593358618|FG002|Overall Study|Withdrawal of Consent|2|||
164270672|NCT00527332|593358619|FG000|Overall Study|Protocol Violation|4|||
164270673|NCT00527332|593358620|FG001|Overall Study|Protocol Violation|8|||
164270674|NCT00527332|593358619|FG000|Overall Study|Withdrew consent|5|||
164270675|NCT00527332|593358620|FG001|Overall Study|Withdrew consent|1|||
164270676|NCT03684694|593358623|FG000|Phase 1|Withdrawal by Subject|1|||
164270677|NCT03684694|593358624|FG001|Phase 1|Withdrawal by Subject|0|||
164270678|NCT03684694|593358625|FG002|Phase 1|Withdrawal by Subject|0|||
164270679|NCT03684694|593358626|FG003|Phase 1|Withdrawal by Subject|0|||
164687722|NCT01912807|594879892|FG001|Overall Study|Lost to Follow-up|37|||
164687723|NCT02614196|594879893|FG000|Double Blind Treatment Phase|Adverse Event|8|||
164687724|NCT02614196|594879894|FG001|Double Blind Treatment Phase|Adverse Event|5|||
164687725|NCT02614196|594879895|FG002|Double Blind Treatment Phase|Adverse Event|9|||
164687726|NCT02614196|594879896|FG003|Double Blind Treatment Phase|Adverse Event|0|||
164687727|NCT02614196|594879897|FG004|Double Blind Treatment Phase|Adverse Event|0|||
164687728|NCT02614196|594879898|FG005|Double Blind Treatment Phase|Adverse Event|0|||
164687729|NCT02614196|594879893|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
164687730|NCT02614196|594879894|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
164687731|NCT02614196|594879895|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
164687732|NCT02614196|594879896|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
164687733|NCT02614196|594879897|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
164687734|NCT02614196|594879898|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
164687735|NCT02614196|594879893|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
164687736|NCT02614196|594879894|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
164687737|NCT02614196|594879895|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
164687738|NCT02614196|594879896|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
164687739|NCT02614196|594879897|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
164687740|NCT02614196|594879898|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
164687741|NCT02614196|594879893|FG000|Double Blind Treatment Phase|Physician Decision|4|||
164270680|NCT03684694|593358627|FG004|Phase 1|Withdrawal by Subject|0|||
164270681|NCT03684694|593358628|FG005|Phase 1|Withdrawal by Subject|0|||
164270682|NCT03684694|593358623|FG000|Phase 1|Investigator/Sponsor Decision|12|||
164270683|NCT03684694|593358624|FG001|Phase 1|Investigator/Sponsor Decision|2|||
164270684|NCT03684694|593358625|FG002|Phase 1|Investigator/Sponsor Decision|1|||
164270685|NCT03684694|593358626|FG003|Phase 1|Investigator/Sponsor Decision|0|||
164270686|NCT03684694|593358627|FG004|Phase 1|Investigator/Sponsor Decision|0|||
164270687|NCT03684694|593358628|FG005|Phase 1|Investigator/Sponsor Decision|0|||
164270688|NCT03684694|593358623|FG000|Phase 1|Death|24|||
164270689|NCT03684694|593358624|FG001|Phase 1|Death|0|||
164270690|NCT03684694|593358625|FG002|Phase 1|Death|3|||
164270691|NCT03684694|593358626|FG003|Phase 1|Death|0|||
164270692|NCT03684694|593358627|FG004|Phase 1|Death|0|||
164270693|NCT03684694|593358628|FG005|Phase 1|Death|0|||
164687742|NCT02614196|594879894|FG001|Double Blind Treatment Phase|Physician Decision|0|||
164687743|NCT02614196|594879895|FG002|Double Blind Treatment Phase|Physician Decision|2|||
164687744|NCT02614196|594879896|FG003|Double Blind Treatment Phase|Physician Decision|0|||
164687745|NCT02614196|594879897|FG004|Double Blind Treatment Phase|Physician Decision|0|||
164687746|NCT02614196|594879898|FG005|Double Blind Treatment Phase|Physician Decision|0|||
164687747|NCT02614196|594879893|FG000|Double Blind Treatment Phase|Pregnancy|1|||
164687748|NCT02614196|594879894|FG001|Double Blind Treatment Phase|Pregnancy|2|||
164687749|NCT02614196|594879895|FG002|Double Blind Treatment Phase|Pregnancy|0|||
164687750|NCT02614196|594879896|FG003|Double Blind Treatment Phase|Pregnancy|0|||
164687751|NCT02614196|594879897|FG004|Double Blind Treatment Phase|Pregnancy|0|||
164687752|NCT02614196|594879898|FG005|Double Blind Treatment Phase|Pregnancy|0|||
164687753|NCT02614196|594879893|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
164687754|NCT02614196|594879894|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
164687755|NCT02614196|594879895|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
164687756|NCT02614196|594879896|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
164687757|NCT02614196|594879897|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
164687758|NCT02614196|594879898|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
164687759|NCT02614196|594879893|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
164687760|NCT02614196|594879894|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
164687761|NCT02614196|594879895|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
164687762|NCT02614196|594879896|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
164687763|NCT02614196|594879897|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
164687764|NCT02614196|594879898|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
164687765|NCT02614196|594879893|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
164687766|NCT02614196|594879894|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
164687767|NCT02614196|594879895|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
164687768|NCT02614196|594879896|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
164687769|NCT02614196|594879897|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
164687770|NCT02614196|594879898|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
164687771|NCT02614196|594879893|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
164687772|NCT02614196|594879894|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
164687773|NCT02614196|594879895|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
164687774|NCT02614196|594879896|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
164687775|NCT02614196|594879897|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
164582523|NCT02675517|594497987|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
164582524|NCT02675517|594497987|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
164582525|NCT03443024|594497990|FG000|Overall Study|Adverse Event|2|||
164582526|NCT03443024|594497991|FG001|Overall Study|Adverse Event|4|||
164582527|NCT03443024|594497992|FG002|Overall Study|Adverse Event|3|||
164582528|NCT03443024|594497993|FG003|Overall Study|Adverse Event|1|||
164582529|NCT03443024|594497990|FG000|Overall Study|Lost to Follow-up|9|||
164582530|NCT03443024|594497991|FG001|Overall Study|Lost to Follow-up|9|||
164582531|NCT03443024|594497992|FG002|Overall Study|Lost to Follow-up|7|||
164582532|NCT03443024|594497993|FG003|Overall Study|Lost to Follow-up|5|||
164582533|NCT03443024|594497990|FG000|Overall Study|Withdrawal by Subject|8|||
164582534|NCT03443024|594497991|FG001|Overall Study|Withdrawal by Subject|15|||
164582535|NCT03443024|594497992|FG002|Overall Study|Withdrawal by Subject|9|||
164582536|NCT03443024|594497993|FG003|Overall Study|Withdrawal by Subject|23|||
164582537|NCT03443024|594497990|FG000|Overall Study|Physician Decision|1|||
164582538|NCT03443024|594497991|FG001|Overall Study|Physician Decision|2|||
164582539|NCT03443024|594497992|FG002|Overall Study|Physician Decision|0|||
164582540|NCT03443024|594497993|FG003|Overall Study|Physician Decision|1|||
164582541|NCT03443024|594497990|FG000|Overall Study|Sponsor Decision|1|||
164582542|NCT03443024|594497991|FG001|Overall Study|Sponsor Decision|1|||
164582543|NCT03443024|594497992|FG002|Overall Study|Sponsor Decision|0|||
164582544|NCT03443024|594497993|FG003|Overall Study|Sponsor Decision|0|||
164582545|NCT03443024|594497990|FG000|Overall Study|Protocol Deviation|0|||
164582546|NCT03443024|594497991|FG001|Overall Study|Protocol Deviation|0|||
164582547|NCT03443024|594497992|FG002|Overall Study|Protocol Deviation|0|||
164582548|NCT03443024|594497993|FG003|Overall Study|Protocol Deviation|2|||
164582549|NCT02782715|594497994|FG000|Overall Study|Withdrawal by Subject|1|||
164582550|NCT00586690|594498016|FG000|Overall Study|Death|2|||
164582551|NCT00586690|594498017|FG001|Overall Study|Death|0|||
164582552|NCT00586690|594498016|FG000|Overall Study|Disease Progression|10|||
164582553|NCT00586690|594498017|FG001|Overall Study|Disease Progression|0|||
164582554|NCT00586690|594498016|FG000|Overall Study|Adverse Event|1|||
164582555|NCT00586690|594498017|FG001|Overall Study|Adverse Event|0|||
164430814|NCT00430677|593947311|FG000|Long-term Extension Period|Pregnancy|1|||
164582556|NCT00586690|594498016|FG000|Overall Study|Lack of Efficacy|2|||
164582557|NCT00586690|594498017|FG001|Overall Study|Lack of Efficacy|0|||
164582558|NCT00586690|594498016|FG000|Overall Study|Lab can't accommodate|1|||
164582559|NCT00586690|594498017|FG001|Overall Study|Lab can't accommodate|0|||
164582560|NCT02453841|594498018|FG000|Overall Study|Protocol Violation|1|||
164687776|NCT02614196|594879898|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
164687777|NCT02614196|594879893|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
164687778|NCT02614196|594879894|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
164687779|NCT02614196|594879895|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
164687780|NCT02614196|594879896|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
164687781|NCT02614196|594879897|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
164687782|NCT02614196|594879898|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
164687783|NCT02614196|594879893|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
164687784|NCT02614196|594879894|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
164687785|NCT02614196|594879895|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
164687786|NCT02614196|594879896|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
164687787|NCT02614196|594879897|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
164687788|NCT02614196|594879898|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
164687789|NCT02614196|594879893|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
164687790|NCT02614196|594879894|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
164687791|NCT02614196|594879895|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
164687792|NCT02614196|594879896|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
164687793|NCT02614196|594879897|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
164687794|NCT02614196|594879898|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
164687795|NCT02614196|594879893|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
164687796|NCT02614196|594879894|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
164687797|NCT02614196|594879895|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
164687798|NCT02614196|594879896|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
164687799|NCT02614196|594879897|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
164687800|NCT02614196|594879898|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
164687801|NCT01539239|594879899|FG000|Overall Study|Death|5|||
164687802|NCT01539239|594879900|FG001|Overall Study|Death|5|||
164687803|NCT01539239|594879899|FG000|Overall Study|Lost to Follow-up|7|||
164687804|NCT01539239|594879900|FG001|Overall Study|Lost to Follow-up|12|||
164687805|NCT01562613|594879901|FG000|Overall Study|Lost to Follow-up|2|||
164687806|NCT01562613|594879901|FG000|Overall Study|Withdrawal by Subject|2|||
164687807|NCT00633022|594879906|FG000|Overall Study|Adverse Event|1|||
164687808|NCT00633022|594879907|FG001|Overall Study|Adverse Event|0|||
164687809|NCT00633022|594879908|FG002|Overall Study|Adverse Event|5|||
164687810|NCT00633022|594879906|FG000|Overall Study|Physician Decision|0|||
164687811|NCT00633022|594879907|FG001|Overall Study|Physician Decision|1|||
164687812|NCT00633022|594879908|FG002|Overall Study|Physician Decision|0|||
164687813|NCT01374451|594879910|FG000|Overall Study|Administrative problems|1|||
164687814|NCT01374451|594879911|FG001|Overall Study|Administrative problems|0|||
164270694|NCT03684694|593358623|FG000|Phase 1|Lost to Follow-up|0|||
164270695|NCT03684694|593358624|FG001|Phase 1|Lost to Follow-up|0|||
164270696|NCT03684694|593358625|FG002|Phase 1|Lost to Follow-up|1|||
164270697|NCT03684694|593358626|FG003|Phase 1|Lost to Follow-up|0|||
164270698|NCT03684694|593358627|FG004|Phase 1|Lost to Follow-up|0|||
164270699|NCT03684694|593358628|FG005|Phase 1|Lost to Follow-up|0|||
164270700|NCT03684694|593358623|FG000|Phase 1|Miscellaneous|0|||
164270701|NCT03684694|593358624|FG001|Phase 1|Miscellaneous|1|||
164270702|NCT03684694|593358625|FG002|Phase 1|Miscellaneous|0|||
164270703|NCT03684694|593358626|FG003|Phase 1|Miscellaneous|0|||
164270704|NCT03684694|593358627|FG004|Phase 1|Miscellaneous|0|||
164270705|NCT03684694|593358628|FG005|Phase 1|Miscellaneous|0|||
164270706|NCT03684694|593358623|FG000|Phase 2|Withdrawal by Subject|0|||
164270707|NCT03684694|593358624|FG001|Phase 2|Withdrawal by Subject|0|||
164270708|NCT03684694|593358625|FG002|Phase 2|Withdrawal by Subject|0|||
164270709|NCT03684694|593358626|FG003|Phase 2|Withdrawal by Subject|0|||
164270710|NCT03684694|593358627|FG004|Phase 2|Withdrawal by Subject|0|||
164270711|NCT03684694|593358628|FG005|Phase 2|Withdrawal by Subject|1|||
164270712|NCT03684694|593358623|FG000|Phase 2|Investigator/Sponsor Decision|0|||
164270713|NCT03684694|593358624|FG001|Phase 2|Investigator/Sponsor Decision|0|||
164270714|NCT03684694|593358625|FG002|Phase 2|Investigator/Sponsor Decision|0|||
164270715|NCT03684694|593358626|FG003|Phase 2|Investigator/Sponsor Decision|17|||
164270716|NCT03684694|593358627|FG004|Phase 2|Investigator/Sponsor Decision|16|||
164270717|NCT03684694|593358628|FG005|Phase 2|Investigator/Sponsor Decision|6|||
164270718|NCT03684694|593358623|FG000|Phase 2|Death|0|||
164270719|NCT03684694|593358624|FG001|Phase 2|Death|0|||
164270720|NCT03684694|593358625|FG002|Phase 2|Death|0|||
164270721|NCT03684694|593358626|FG003|Phase 2|Death|28|||
164687815|NCT01337596|594879912|FG000|Overall Study|Withdrawal by Subject|0|||
164687816|NCT01337596|594879913|FG001|Overall Study|Withdrawal by Subject|0|||
164687817|NCT01337596|594879914|FG002|Overall Study|Withdrawal by Subject|0|||
164687818|NCT01337596|594879915|FG003|Overall Study|Withdrawal by Subject|0|||
164687819|NCT01337596|594879916|FG004|Overall Study|Withdrawal by Subject|2|||
164270722|NCT03684694|593358627|FG004|Phase 2|Death|14|||
164270723|NCT03684694|593358628|FG005|Phase 2|Death|3|||
164270724|NCT03684694|593358623|FG000|Phase 2|Lost to Follow-up|0|||
164270725|NCT03684694|593358624|FG001|Phase 2|Lost to Follow-up|0|||
164270726|NCT03684694|593358625|FG002|Phase 2|Lost to Follow-up|0|||
164270727|NCT03684694|593358626|FG003|Phase 2|Lost to Follow-up|1|||
164687820|NCT01337596|594879917|FG005|Overall Study|Withdrawal by Subject|0|||
164687821|NCT01337596|594879918|FG006|Overall Study|Withdrawal by Subject|0|||
164687822|NCT01337596|594879919|FG007|Overall Study|Withdrawal by Subject|0|||
164687823|NCT01337596|594879920|FG008|Overall Study|Withdrawal by Subject|0|||
164687824|NCT01751087|594879926|FG000|Overall Study|Withdrawal by Subject|1|||
164687825|NCT01751087|594879927|FG001|Overall Study|Withdrawal by Subject|0|||
164687826|NCT01751087|594879928|FG002|Overall Study|Withdrawal by Subject|0|||
164687827|NCT01751087|594879926|FG000|Overall Study|Physician Decision|0|||
164687828|NCT01751087|594879927|FG001|Overall Study|Physician Decision|0|||
164687829|NCT01751087|594879928|FG002|Overall Study|Physician Decision|1|||
164687830|NCT00724958|594879929|FG000|Overall Study|Adverse Event|28|||
164687831|NCT00724958|594879929|FG000|Overall Study|Loss of Response|40|||
164687832|NCT00724958|594879929|FG000|Overall Study|No Response|18|||
164687833|NCT00724958|594879929|FG000|Overall Study|Remission|7|||
164687834|NCT00724958|594879929|FG000|Overall Study|Other Reason|76|||
164687835|NCT00724958|594879929|FG000|Overall Study|No documentation for end of therapy|13|||
164687836|NCT03035890|594881407|FG000|Overall Study|Death|1|||
164687837|NCT02459418|594881409|FG000|Overall Study|Exclusion Criteria|4|||
164687838|NCT02459418|594881410|FG001|Overall Study|Exclusion Criteria|0|||
164687839|NCT02459418|594881409|FG000|Overall Study|Protocol Violation|0|||
164687840|NCT02459418|594881410|FG001|Overall Study|Protocol Violation|2|||
164687841|NCT02459418|594881409|FG000|Overall Study|Physician Decision|0|||
164687842|NCT02459418|594881410|FG001|Overall Study|Physician Decision|2|||
164687843|NCT02459418|594881409|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
164687844|NCT02459418|594881410|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
164687845|NCT02459418|594881409|FG000|Overall Study|Adverse Event|0|||
164687846|NCT02459418|594881410|FG001|Overall Study|Adverse Event|1|||
164687847|NCT02459418|594881409|FG000|Overall Study|Withdrawal by Subject|1|||
164687848|NCT02459418|594881410|FG001|Overall Study|Withdrawal by Subject|1|||
164687849|NCT02459418|594881409|FG000|Overall Study|Elevated Creatine Kinase|1|||
164687850|NCT02459418|594881410|FG001|Overall Study|Elevated Creatine Kinase|0|||
164687851|NCT02459418|594881409|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
164687852|NCT02459418|594881410|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
164687853|NCT00653159|594881411|FG000|Overall Study|Adverse Event|4|||
164687854|NCT00653159|594881412|FG001|Overall Study|Adverse Event|1|||
164687855|NCT00653159|594881411|FG000|Overall Study|Lost to Follow-up|1|||
164687856|NCT00653159|594881412|FG001|Overall Study|Lost to Follow-up|2|||
164687857|NCT01872715|594881413|FG000|Overall Study|Adverse Event|1|||
164687858|NCT01872715|594881413|FG000|Overall Study|Protocol Violation|1|||
164687859|NCT01872715|594881413|FG000|Overall Study|Withdrawal by Subject|2|||
164687860|NCT00683592|594881416|FG000|Overall Study|Adverse Event|12|||
164687861|NCT00683592|594881417|FG001|Overall Study|Adverse Event|4|||
164270728|NCT03684694|593358627|FG004|Phase 2|Lost to Follow-up|0|||
164270729|NCT03684694|593358628|FG005|Phase 2|Lost to Follow-up|0|||
164270730|NCT03684694|593358623|FG000|Phase 2|Miscellaneous|0|||
164270731|NCT03684694|593358624|FG001|Phase 2|Miscellaneous|0|||
164270732|NCT03684694|593358625|FG002|Phase 2|Miscellaneous|0|||
164270733|NCT03684694|593358626|FG003|Phase 2|Miscellaneous|3|||
164270734|NCT03684694|593358627|FG004|Phase 2|Miscellaneous|0|||
164270735|NCT03684694|593358628|FG005|Phase 2|Miscellaneous|0|||
164270736|NCT02100475|593360417|FG000|Overall Study|Unclassified|1|||
164270737|NCT02100475|593360418|FG001|Overall Study|Unclassified|2|||
164270738|NCT02100475|593360417|FG000|Overall Study|Withdrawal criteria|1|||
164270739|NCT02100475|593360418|FG001|Overall Study|Withdrawal criteria|0|||
164270740|NCT03268941|593360419|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
164270741|NCT03268941|593360420|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
164687862|NCT00683592|594881416|FG000|Overall Study|Withdrawal by Subject|11|||
164687863|NCT00683592|594881417|FG001|Overall Study|Withdrawal by Subject|11|||
164687864|NCT00683592|594881416|FG000|Overall Study|Lost to Follow-up|17|||
164687865|NCT00683592|594881417|FG001|Overall Study|Lost to Follow-up|17|||
164687866|NCT00683592|594881416|FG000|Overall Study|Lack of Efficacy|3|||
164687867|NCT00683592|594881417|FG001|Overall Study|Lack of Efficacy|7|||
164687868|NCT00683592|594881416|FG000|Overall Study|Physician Decision|0|||
164687869|NCT00683592|594881417|FG001|Overall Study|Physician Decision|1|||
164687870|NCT00683592|594881416|FG000|Overall Study|Non-compliance|3|||
164687871|NCT00683592|594881417|FG001|Overall Study|Non-compliance|5|||
164687872|NCT00683592|594881416|FG000|Overall Study|Other|1|||
164687873|NCT00683592|594881417|FG001|Overall Study|Other|1|||
164687874|NCT03303417|594881426|FG000|Overall Study|Withdrawal by Subject|1|||
164687875|NCT03303417|594881427|FG001|Overall Study|Withdrawal by Subject|1|||
164270742|NCT03268941|593360421|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
164270743|NCT03268941|593360422|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
164270744|NCT03268941|593360423|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
164687876|NCT02697617|594881428|FG000|Overall Study|Withdrawal by Subject|0|||
164687877|NCT02697617|594881429|FG001|Overall Study|Withdrawal by Subject|2|||
164687878|NCT02697617|594881428|FG000|Overall Study|Pregnancy|1|||
164687879|NCT02697617|594881429|FG001|Overall Study|Pregnancy|0|||
164687880|NCT01848210|594881432|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
164270745|NCT03268941|593360424|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
164687881|NCT01848210|594881433|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
164687882|NCT01848210|594881432|FG000|Overall Study|Lost to Follow-up|24|||
164687883|NCT01848210|594881433|FG001|Overall Study|Lost to Follow-up|12|||
164687884|NCT01848210|594881432|FG000|Overall Study|Protocol Violation|3|||
164687885|NCT01848210|594881433|FG001|Overall Study|Protocol Violation|5|||
164687886|NCT01848210|594881432|FG000|Overall Study|Use of Forbidden Drugs|9|||
164687887|NCT01848210|594881433|FG001|Overall Study|Use of Forbidden Drugs|10|||
164687888|NCT01848210|594881432|FG000|Overall Study|Impedition Condition|5|||
164687889|NCT01848210|594881433|FG001|Overall Study|Impedition Condition|9|||
164687890|NCT01848210|594881432|FG000|Overall Study|Adverse Event|7|||
164687891|NCT01848210|594881433|FG001|Overall Study|Adverse Event|9|||
164687892|NCT01848210|594881432|FG000|Overall Study|Discontinuation Criterion|5|||
164687893|NCT01848210|594881433|FG001|Overall Study|Discontinuation Criterion|7|||
164687894|NCT01848210|594881432|FG000|Overall Study|Hypesensitivity|1|||
164687895|NCT01848210|594881433|FG001|Overall Study|Hypesensitivity|0|||
164687896|NCT01848210|594881432|FG000|Overall Study|Hepatic Function Alteration|4|||
164687897|NCT01848210|594881433|FG001|Overall Study|Hepatic Function Alteration|0|||
164687898|NCT01848210|594881432|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
164687899|NCT01848210|594881433|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
164687900|NCT01848210|594881432|FG000|Overall Study|Administrative|1|||
164687901|NCT01848210|594881433|FG001|Overall Study|Administrative|0|||
164687902|NCT00381849|594881434|FG000|Wash Out|Withdrawal by Subject|0|||
164687903|NCT00381849|594881435|FG001|Wash Out|Withdrawal by Subject|1|||
164687904|NCT01765270|594881439|FG000|Overall Study|Physician Decision|1|||
164687905|NCT01765270|594881440|FG001|Overall Study|Physician Decision|0|||
164687906|NCT01765270|594881439|FG000|Overall Study|Withdrawal by Subject|0|||
164687907|NCT01765270|594881440|FG001|Overall Study|Withdrawal by Subject|1|||
164687908|NCT00517192|594881441|FG000|Overall Study|Adverse Event|1|||
164687909|NCT00517192|594881442|FG001|Overall Study|Adverse Event|1|||
164687910|NCT00517192|594881441|FG000|Overall Study|Lost to Follow-up|1|||
164687911|NCT00517192|594881442|FG001|Overall Study|Lost to Follow-up|1|||
164687912|NCT00517192|594881441|FG000|Overall Study|Withdrawal by Subject|1|||
164687913|NCT00517192|594881442|FG001|Overall Study|Withdrawal by Subject|0|||
164687914|NCT00517192|594881441|FG000|Overall Study|Early termination of the trial|16|||
164687915|NCT00517192|594881442|FG001|Overall Study|Early termination of the trial|18|||
164687916|NCT00329160|594881444|FG000|Overall Study|Adverse Event|27|||
164687917|NCT00329160|594881444|FG000|Overall Study|Withdrawal by Subject|13|||
164687918|NCT00329160|594881444|FG000|Overall Study|Protocol Violation|2|||
164687919|NCT00329160|594881444|FG000|Overall Study|Did not Receive Study Drug|1|||
164687920|NCT00329160|594881444|FG000|Overall Study|Incomplete IVUS|45|||
164687921|NCT04501094|594881445|FG000|Overall Study|Death (unrelated to research)|1|||
164687922|NCT04501094|594881446|FG001|Overall Study|Death (unrelated to research)|0|||
164687923|NCT05212948|594881451|FG000|Initial Vaccination Period|Withdrawal by Subject|409|||
164687924|NCT05212948|594881452|FG001|Initial Vaccination Period|Withdrawal by Subject|199|||
164687925|NCT05212948|594881451|FG000|Initial Vaccination Period|Suspected Pregnancy|1|||
164687926|NCT05212948|594881452|FG001|Initial Vaccination Period|Suspected Pregnancy|0|||
164687927|NCT05212948|594881451|FG000|Initial Vaccination Period|Pregnancy|20|||
164687928|NCT05212948|594881452|FG001|Initial Vaccination Period|Pregnancy|14|||
164687929|NCT05212948|594881451|FG000|Initial Vaccination Period|Physician Decision|686|||
164687930|NCT05212948|594881452|FG001|Initial Vaccination Period|Physician Decision|401|||
164687931|NCT05212948|594881451|FG000|Initial Vaccination Period|Lost to Follow-up|106|||
164687932|NCT05212948|594881452|FG001|Initial Vaccination Period|Lost to Follow-up|42|||
164687933|NCT05212948|594881451|FG000|Initial Vaccination Period|Death|23|||
164687934|NCT05212948|594881452|FG001|Initial Vaccination Period|Death|18|||
164430815|NCT00430677|593947312|FG001|Long-term Extension Period|Pregnancy|1|||
164430816|NCT00430677|593947313|FG002|Long-term Extension Period|Pregnancy|0|||
164430817|NCT00430677|593947311|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
164430818|NCT00430677|593947312|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
164430819|NCT00430677|593947313|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
164430820|NCT00430677|593947311|FG000|Long-term Extension Period|Other|2|||
164687935|NCT05212948|594881451|FG000|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|4|||
164687936|NCT05212948|594881452|FG001|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|3|||
164687937|NCT05212948|594881451|FG000|Initial Vaccination Period|Adverse Event|36|||
164687938|NCT05212948|594881452|FG001|Initial Vaccination Period|Adverse Event|23|||
164687939|NCT05212948|594881451|FG000|Crossover Vaccination Period|Withdrawal by Subject|95|||
164687940|NCT05212948|594881452|FG001|Crossover Vaccination Period|Withdrawal by Subject|57|||
164687941|NCT05212948|594881451|FG000|Crossover Vaccination Period|Pregnancy|6|||
164687942|NCT05212948|594881452|FG001|Crossover Vaccination Period|Pregnancy|1|||
164430821|NCT00430677|593947312|FG001|Long-term Extension Period|Other|1|||
164430822|NCT00430677|593947313|FG002|Long-term Extension Period|Other|1|||
164687943|NCT05212948|594881451|FG000|Crossover Vaccination Period|Physician Decision|49|||
164687944|NCT05212948|594881452|FG001|Crossover Vaccination Period|Physician Decision|24|||
164687945|NCT05212948|594881451|FG000|Crossover Vaccination Period|Lost to Follow-up|23|||
164687946|NCT05212948|594881452|FG001|Crossover Vaccination Period|Lost to Follow-up|8|||
164687947|NCT05212948|594881451|FG000|Crossover Vaccination Period|Death|10|||
164687948|NCT05212948|594881452|FG001|Crossover Vaccination Period|Death|5|||
164687949|NCT05212948|594881451|FG000|Crossover Vaccination Period|Adverse Event|9|||
164687950|NCT05212948|594881452|FG001|Crossover Vaccination Period|Adverse Event|4|||
164687951|NCT05347693|594881453|FG000|Inpatient Period|Participant was discharged from the hospital but did not inform the site|1|||
164687952|NCT05347693|594881454|FG001|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
164687953|NCT05347693|594881455|FG002|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
164687954|NCT05347693|594881453|FG000|Inpatient Period|Withdrawal of consent|10|||
164687955|NCT05347693|594881454|FG001|Inpatient Period|Withdrawal of consent|0|||
164687956|NCT05347693|594881455|FG002|Inpatient Period|Withdrawal of consent|0|||
164687957|NCT05347693|594881453|FG000|Inpatient Period|Failure to meet inclusion/exclusion criteria|19|||
164687958|NCT05347693|594881454|FG001|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
164687959|NCT05347693|594881455|FG002|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
164687960|NCT05347693|594881453|FG000|Inpatient Period|Screening Failure|8|||
164687961|NCT05347693|594881454|FG001|Inpatient Period|Screening Failure|0|||
164687962|NCT05347693|594881455|FG002|Inpatient Period|Screening Failure|0|||
164687963|NCT05347693|594881453|FG000|Inpatient Period|Death|2|||
164687964|NCT05347693|594881454|FG001|Inpatient Period|Death|0|||
164687965|NCT05347693|594881455|FG002|Inpatient Period|Death|0|||
164687966|NCT05347693|594881453|FG000|Inpatient Period|Physician Decision|5|||
164687967|NCT05347693|594881454|FG001|Inpatient Period|Physician Decision|0|||
164687968|NCT05347693|594881455|FG002|Inpatient Period|Physician Decision|0|||
164687969|NCT05347693|594881453|FG000|Inpatient Period|Adverse Event|3|||
164270746|NCT03268941|593360425|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
164270747|NCT03268941|593360419|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
164687970|NCT05347693|594881454|FG001|Inpatient Period|Adverse Event|0|||
164687971|NCT05347693|594881455|FG002|Inpatient Period|Adverse Event|0|||
164687972|NCT05347693|594881453|FG000|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|1|||
164687973|NCT05347693|594881454|FG001|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
164687974|NCT05347693|594881455|FG002|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
164687975|NCT05347693|594881453|FG000|Outpatient Period|Adverse Event|0|||
164687976|NCT05347693|594881454|FG001|Outpatient Period|Adverse Event|9|||
164687977|NCT05347693|594881455|FG002|Outpatient Period|Adverse Event|0|||
164687978|NCT05347693|594881453|FG000|Outpatient Period|Death|0|||
164687979|NCT05347693|594881454|FG001|Outpatient Period|Death|6|||
164270748|NCT03268941|593360420|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
164270749|NCT03268941|593360421|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
164270750|NCT03268941|593360422|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
164687980|NCT05347693|594881455|FG002|Outpatient Period|Death|2|||
164687981|NCT05347693|594881453|FG000|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
164687982|NCT05347693|594881454|FG001|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
164687983|NCT05347693|594881455|FG002|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|1|||
164687984|NCT05347693|594881453|FG000|Outpatient Period|Lost to Follow-up|0|||
164687985|NCT05347693|594881454|FG001|Outpatient Period|Lost to Follow-up|0|||
164687986|NCT05347693|594881455|FG002|Outpatient Period|Lost to Follow-up|1|||
164687987|NCT05347693|594881453|FG000|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
164687988|NCT05347693|594881454|FG001|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|1|||
164687989|NCT05347693|594881455|FG002|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
164687990|NCT05347693|594881453|FG000|Outpatient Period|Scheduled hemodialysis|0|||
164687991|NCT05347693|594881454|FG001|Outpatient Period|Scheduled hemodialysis|1|||
164687992|NCT05347693|594881455|FG002|Outpatient Period|Scheduled hemodialysis|0|||
164687993|NCT05347693|594881453|FG000|Outpatient Period|Severe HK|0|||
164687994|NCT05347693|594881454|FG001|Outpatient Period|Severe HK|0|||
164687995|NCT05347693|594881455|FG002|Outpatient Period|Severe HK|1|||
164687996|NCT05347693|594881453|FG000|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
164687997|NCT05347693|594881454|FG001|Outpatient Period|Started dialysis on 16 Feb 2023|1|||
164687998|NCT05347693|594881455|FG002|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
164687999|NCT05347693|594881453|FG000|Outpatient Period|Start of dialysis|0|||
164688000|NCT05347693|594881454|FG001|Outpatient Period|Start of dialysis|0|||
164688001|NCT05347693|594881455|FG002|Outpatient Period|Start of dialysis|1|||
164688002|NCT05347693|594881453|FG000|Outpatient Period|The participant entered hemodialysis|0|||
164270751|NCT03268941|593360423|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
164270752|NCT03268941|593360424|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
164342323|NCT04457336|593629428|FG002|Period 2: Part A|Study Terminated|1|||
164688003|NCT05347693|594881454|FG001|Outpatient Period|The participant entered hemodialysis|0|||
164688004|NCT05347693|594881455|FG002|Outpatient Period|The participant entered hemodialysis|1|||
164270753|NCT03268941|593360425|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
164342324|NCT04457336|593629429|FG003|Period 2: Part A|Study Terminated|0|||
164688005|NCT05347693|594881453|FG000|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
164688006|NCT05347693|594881454|FG001|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
164688007|NCT05347693|594881455|FG002|Outpatient Period|The participant moved to another city and could not attend the study visits|1|||
164688008|NCT05347693|594881453|FG000|Outpatient Period|Withdrawal by Subject|0|||
164688009|NCT05347693|594881454|FG001|Outpatient Period|Withdrawal by Subject|8|||
164688010|NCT05347693|594881455|FG002|Outpatient Period|Withdrawal by Subject|5|||
164688011|NCT03167606|594881456|FG000|Overall Study|Lost to Follow-up|73|||
164688012|NCT03167606|594881457|FG001|Overall Study|Lost to Follow-up|64|||
164688013|NCT03167606|594881456|FG000|Overall Study|Withdrawal by Subject|6|||
164688014|NCT03167606|594881457|FG001|Overall Study|Withdrawal by Subject|5|||
164688015|NCT03167606|594881456|FG000|Overall Study|Withdrawal by Investigator|0|||
164688016|NCT03167606|594881457|FG001|Overall Study|Withdrawal by Investigator|2|||
164688017|NCT00413049|594881458|FG000|Overall Study|Adverse Event|10|||
164688018|NCT00413049|594881459|FG001|Overall Study|Adverse Event|8|||
164688019|NCT00413049|594881458|FG000|Overall Study|Withdrawal by Subject|7|||
164688020|NCT00413049|594881459|FG001|Overall Study|Withdrawal by Subject|5|||
164688021|NCT00413049|594881458|FG000|Overall Study|Lost to Follow-up|2|||
164688022|NCT00413049|594881459|FG001|Overall Study|Lost to Follow-up|3|||
164688023|NCT00413049|594881458|FG000|Overall Study|Protocol Violation|3|||
164688024|NCT00413049|594881459|FG001|Overall Study|Protocol Violation|1|||
164688025|NCT00413049|594881458|FG000|Overall Study|Subject no longer requires study drug|0|||
164688026|NCT00413049|594881459|FG001|Overall Study|Subject no longer requires study drug|1|||
164688027|NCT00413049|594881458|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164688028|NCT00413049|594881459|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164688029|NCT00413049|594881458|FG000|Overall Study|Lack of Efficacy|1|||
164688030|NCT00413049|594881459|FG001|Overall Study|Lack of Efficacy|0|||
164688031|NCT01755975|594881466|FG000|Overall Study|Adverse Event|0|||
164688032|NCT01755975|594881467|FG001|Overall Study|Adverse Event|0|||
164688033|NCT01755975|594881468|FG002|Overall Study|Adverse Event|1|||
164688034|NCT01755975|594881469|FG003|Overall Study|Adverse Event|0|||
164688035|NCT01755975|594881470|FG004|Overall Study|Adverse Event|2|||
164688036|NCT03653026|594881471|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
164688037|NCT03653026|594881472|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
164688038|NCT03653026|594881473|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
164688039|NCT03653026|594881474|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
164688040|NCT03653026|594881471|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
164688041|NCT03653026|594881472|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
164688042|NCT03653026|594881473|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
164688043|NCT03653026|594881474|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
164688044|NCT03653026|594881471|FG000|Part 1: Placebo-controlled Period|Other|0|||
164688045|NCT03653026|594881472|FG001|Part 1: Placebo-controlled Period|Other|3|||
164688046|NCT03653026|594881473|FG002|Part 1: Placebo-controlled Period|Other|0|||
164688047|NCT03653026|594881474|FG003|Part 1: Placebo-controlled Period|Other|0|||
164688048|NCT03653026|594881471|FG000|Part 2: Open-label Extension|Adverse Event|0|||
164688049|NCT03653026|594881472|FG001|Part 2: Open-label Extension|Adverse Event|0|||
164688050|NCT03653026|594881473|FG002|Part 2: Open-label Extension|Adverse Event|1|||
164688051|NCT03653026|594881474|FG003|Part 2: Open-label Extension|Adverse Event|1|||
164688052|NCT03653026|594881471|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
164688053|NCT03653026|594881472|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
164688054|NCT03653026|594881473|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
164688055|NCT03653026|594881474|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
164688056|NCT03653026|594881471|FG000|Part 2: Open-label Extension|Other|0|||
164688057|NCT03653026|594881472|FG001|Part 2: Open-label Extension|Other|0|||
164688058|NCT03653026|594881473|FG002|Part 2: Open-label Extension|Other|1|||
164688059|NCT03653026|594881474|FG003|Part 2: Open-label Extension|Other|2|||
164688060|NCT02104817|594881477|FG000|Overall Study|Death|363|||
164688061|NCT02104817|594881478|FG001|Overall Study|Death|330|||
164688062|NCT02104817|594881477|FG000|Overall Study|Lost to Follow-up|3|||
164688063|NCT02104817|594881478|FG001|Overall Study|Lost to Follow-up|2|||
164688064|NCT02104817|594881477|FG000|Overall Study|Protocol Violation|0|||
164688065|NCT02104817|594881478|FG001|Overall Study|Protocol Violation|1|||
164688066|NCT02104817|594881477|FG000|Overall Study|Study terminated by sponsor|5854|||
164688067|NCT02104817|594881478|FG001|Overall Study|Study terminated by sponsor|5901|||
164688068|NCT02104817|594881477|FG000|Overall Study|Withdrawal by Subject|111|||
164688069|NCT02104817|594881478|FG001|Overall Study|Withdrawal by Subject|78|||
164688070|NCT02104817|594881477|FG000|Overall Study|Other reasons|128|||
164688071|NCT02104817|594881478|FG001|Overall Study|Other reasons|135|||
164688072|NCT00852917|594881479|FG000|Overall Study|Adverse Event|13|||
164688073|NCT00852917|594881480|FG001|Overall Study|Adverse Event|20|||
164688074|NCT00852917|594881481|FG002|Overall Study|Adverse Event|35|||
164688075|NCT00852917|594881482|FG003|Overall Study|Adverse Event|17|||
164688076|NCT00852917|594881479|FG000|Overall Study|Lack of Efficacy|21|||
164270754|NCT03268941|593360419|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
164270755|NCT03268941|593360420|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
164270756|NCT03268941|593360421|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
164270757|NCT03268941|593360422|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
164270758|NCT03268941|593360423|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
164270759|NCT03268941|593360424|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
164270760|NCT03268941|593360425|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
164342325|NCT04457336|593629430|FG004|Period 2: Part A|Study Terminated|0|||
164688077|NCT00852917|594881480|FG001|Overall Study|Lack of Efficacy|11|||
164688078|NCT00852917|594881481|FG002|Overall Study|Lack of Efficacy|11|||
164688079|NCT00852917|594881482|FG003|Overall Study|Lack of Efficacy|47|||
164688080|NCT00852917|594881479|FG000|Overall Study|Withdrawal by Subject|4|||
164688081|NCT00852917|594881480|FG001|Overall Study|Withdrawal by Subject|8|||
164688082|NCT00852917|594881481|FG002|Overall Study|Withdrawal by Subject|10|||
164688083|NCT00852917|594881482|FG003|Overall Study|Withdrawal by Subject|9|||
164688084|NCT00852917|594881479|FG000|Overall Study|Physician Decision|6|||
164688085|NCT00852917|594881480|FG001|Overall Study|Physician Decision|7|||
164688086|NCT00852917|594881481|FG002|Overall Study|Physician Decision|2|||
164688087|NCT00852917|594881482|FG003|Overall Study|Physician Decision|19|||
164688088|NCT00852917|594881479|FG000|Overall Study|Death|0|||
164688089|NCT00852917|594881480|FG001|Overall Study|Death|0|||
164688090|NCT00852917|594881481|FG002|Overall Study|Death|0|||
164688091|NCT00852917|594881482|FG003|Overall Study|Death|1|||
164688092|NCT01597479|594881486|FG000|Overall Study|Protocol Violation|1|||
164688093|NCT01597479|594881487|FG001|Overall Study|Protocol Violation|0|||
164688094|NCT01597479|594881486|FG000|Overall Study|Lost to Follow-up|1|||
164688095|NCT01597479|594881487|FG001|Overall Study|Lost to Follow-up|0|||
164688096|NCT02167594|594881488|FG000|Overall Study|Withdrawal by Subject|2|||
164688097|NCT02167594|594881489|FG001|Overall Study|Withdrawal by Subject|0|||
164688098|NCT02167594|594881490|FG002|Overall Study|Withdrawal by Subject|0|||
164688099|NCT02167594|594881488|FG000|Overall Study|Death|0|||
164688100|NCT02167594|594881489|FG001|Overall Study|Death|1|||
164688101|NCT02167594|594881490|FG002|Overall Study|Death|0|||
164688102|NCT02340780|594881491|FG000|Overall Study|Ineligible|1|||
164688103|NCT03433703|594881492|FG000|Overall Study|Study terminated by Sponsor|2|||
164688104|NCT03422068|594881495|FG000|Overall Study|Adverse Event|0|||
164688105|NCT03422068|594881496|FG001|Overall Study|Adverse Event|1|||
164688106|NCT03422068|594881495|FG000|Overall Study|Inconvenience to frequent study visits|0|||
164688107|NCT03422068|594881496|FG001|Overall Study|Inconvenience to frequent study visits|1|||
164688108|NCT01698554|594881498|FG000|Overall Study|Adverse Event|2|||
164688109|NCT01698554|594881499|FG001|Overall Study|Adverse Event|5|||
164688110|NCT01698554|594881500|FG002|Overall Study|Adverse Event|0|||
164688111|NCT01698554|594881501|FG003|Overall Study|Adverse Event|1|||
164688112|NCT01698554|594881498|FG000|Overall Study|Lost to Follow-up|1|||
164688113|NCT01698554|594881499|FG001|Overall Study|Lost to Follow-up|0|||
164688114|NCT01698554|594881500|FG002|Overall Study|Lost to Follow-up|0|||
164688115|NCT01698554|594881501|FG003|Overall Study|Lost to Follow-up|0|||
164688116|NCT01698554|594881498|FG000|Overall Study|Personal Reasons|0|||
164688117|NCT01698554|594881499|FG001|Overall Study|Personal Reasons|5|||
164688118|NCT01698554|594881500|FG002|Overall Study|Personal Reasons|1|||
164688119|NCT01698554|594881501|FG003|Overall Study|Personal Reasons|1|||
164688120|NCT01698554|594881498|FG000|Overall Study|Protocol Violation|2|||
164688121|NCT01698554|594881499|FG001|Overall Study|Protocol Violation|0|||
164688122|NCT01698554|594881500|FG002|Overall Study|Protocol Violation|1|||
164688123|NCT01698554|594881501|FG003|Overall Study|Protocol Violation|0|||
164270761|NCT03268941|593360419|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
164270762|NCT03268941|593360420|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
164270763|NCT03268941|593360421|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
164342326|NCT04457336|593629431|FG005|Period 2: Part A|Study Terminated|0|||
164688124|NCT01698554|594881498|FG000|Overall Study|Other Miscellaneous Reasons|1|||
164688125|NCT01698554|594881499|FG001|Overall Study|Other Miscellaneous Reasons|0|||
164688126|NCT01698554|594881500|FG002|Overall Study|Other Miscellaneous Reasons|0|||
164688127|NCT01698554|594881501|FG003|Overall Study|Other Miscellaneous Reasons|0|||
164688128|NCT01583530|594881502|FG000|Overall Study|Adverse Event|0|||
164688129|NCT01583530|594881503|FG001|Overall Study|Adverse Event|0|||
164688130|NCT01583530|594881504|FG002|Overall Study|Adverse Event|0|||
164688131|NCT01583530|594881505|FG003|Overall Study|Adverse Event|0|||
164688132|NCT01583530|594881506|FG004|Overall Study|Adverse Event|0|||
164688133|NCT01583530|594881507|FG005|Overall Study|Adverse Event|1|||
164688134|NCT01583530|594881502|FG000|Overall Study|Withdrawal by Subject|0|||
164688135|NCT01583530|594881503|FG001|Overall Study|Withdrawal by Subject|3|||
164688136|NCT01583530|594881504|FG002|Overall Study|Withdrawal by Subject|0|||
164688137|NCT01583530|594881505|FG003|Overall Study|Withdrawal by Subject|1|||
164688138|NCT01583530|594881506|FG004|Overall Study|Withdrawal by Subject|1|||
164688139|NCT01583530|594881507|FG005|Overall Study|Withdrawal by Subject|2|||
164688140|NCT01583530|594881502|FG000|Overall Study|Lost to Follow-up|0|||
164688141|NCT01583530|594881503|FG001|Overall Study|Lost to Follow-up|0|||
164688142|NCT01583530|594881504|FG002|Overall Study|Lost to Follow-up|0|||
164688143|NCT01583530|594881505|FG003|Overall Study|Lost to Follow-up|0|||
164688144|NCT01583530|594881506|FG004|Overall Study|Lost to Follow-up|3|||
164688145|NCT01583530|594881507|FG005|Overall Study|Lost to Follow-up|0|||
164688146|NCT01583530|594881502|FG000|Overall Study|Lack of compliance|0|||
164688147|NCT01583530|594881503|FG001|Overall Study|Lack of compliance|0|||
164688148|NCT01583530|594881504|FG002|Overall Study|Lack of compliance|0|||
164688149|NCT01583530|594881505|FG003|Overall Study|Lack of compliance|0|||
164688150|NCT01583530|594881506|FG004|Overall Study|Lack of compliance|1|||
164688151|NCT01583530|594881507|FG005|Overall Study|Lack of compliance|0|||
164688152|NCT02416180|594881508|FG000|Overall Study|Withdrawal by Subject|1|||
164688153|NCT00640926|594881509|FG000|Overall Study|Adverse Event|2|||
164688154|NCT00640926|594881510|FG001|Overall Study|Adverse Event|3|||
164688155|NCT00640926|594881511|FG002|Overall Study|Adverse Event|2|||
164688156|NCT00640926|594881509|FG000|Overall Study|Lack of Efficacy|0|||
164688157|NCT00640926|594881510|FG001|Overall Study|Lack of Efficacy|2|||
164688158|NCT00640926|594881511|FG002|Overall Study|Lack of Efficacy|1|||
164688159|NCT00640926|594881509|FG000|Overall Study|Protocol Violation|2|||
164688160|NCT00640926|594881510|FG001|Overall Study|Protocol Violation|0|||
164688161|NCT00640926|594881511|FG002|Overall Study|Protocol Violation|2|||
164688162|NCT00640926|594881509|FG000|Overall Study|Lost to Follow-up|3|||
164688163|NCT00640926|594881510|FG001|Overall Study|Lost to Follow-up|1|||
164688164|NCT00640926|594881511|FG002|Overall Study|Lost to Follow-up|2|||
164688165|NCT00640926|594881509|FG000|Overall Study|Withdrawal by Subject|1|||
164688166|NCT00640926|594881510|FG001|Overall Study|Withdrawal by Subject|0|||
164688167|NCT00640926|594881511|FG002|Overall Study|Withdrawal by Subject|1|||
164688168|NCT02985398|594881512|FG000|Overall Study|Adverse Event|1|||
164688169|NCT02985398|594881512|FG000|Overall Study|Lost to Follow-up|4|||
164688170|NCT02985398|594881512|FG000|Overall Study|Withdrawal by Subject|8|||
164688171|NCT02985398|594881512|FG000|Overall Study|Study Burden|9|||
164688172|NCT01841073|594881513|FG000|Overall Study|Adverse Event|1|||
164270764|NCT03268941|593360422|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
164270765|NCT03268941|593360423|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
164270766|NCT03268941|593360424|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
164270767|NCT03268941|593360425|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
164270768|NCT03268941|593360419|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
164270769|NCT03268941|593360420|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
164270770|NCT03268941|593360421|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
164270771|NCT03268941|593360422|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
164270772|NCT03268941|593360423|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
164270773|NCT03268941|593360424|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
164270774|NCT03268941|593360425|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
164270775|NCT02720692|593360430|FG000|Overall Study|Withdrawal by Subject|3|||
164270776|NCT02720692|593360431|FG001|Overall Study|Withdrawal by Subject|0|||
164270777|NCT02720692|593360430|FG000|Overall Study|Physician Decision|1|||
164270778|NCT02720692|593360431|FG001|Overall Study|Physician Decision|0|||
164270779|NCT02720692|593360430|FG000|Overall Study|Lost to Follow-up|8|||
164270780|NCT02720692|593360431|FG001|Overall Study|Lost to Follow-up|3|||
164270781|NCT02720692|593360430|FG000|Overall Study|Subject unable to return for visit|1|||
164270782|NCT02720692|593360431|FG001|Overall Study|Subject unable to return for visit|0|||
164342327|NCT04457336|593629432|FG006|Period 2: Part A|Study Terminated|0|||
164270783|NCT03878758|593360432|FG000|Overall Study|Withdrawal by Subject|1|||
164270784|NCT03878758|593360432|FG000|Overall Study|Protocol defined|2|||
164342328|NCT04457336|593629433|FG007|Period 2: Part A|Study Terminated|0|||
164688173|NCT01841073|594881514|FG001|Overall Study|Adverse Event|1|||
164688174|NCT01841073|594881513|FG000|Overall Study|Physician Decision|1|||
164688175|NCT01841073|594881514|FG001|Overall Study|Physician Decision|0|||
164688176|NCT01841073|594881513|FG000|Overall Study|Lost to Follow-up|0|||
164688177|NCT01841073|594881514|FG001|Overall Study|Lost to Follow-up|2|||
164270785|NCT03878758|593360432|FG000|Overall Study|Improper consent documentation|1|||
164270786|NCT01769196|593360433|FG000|Overall Study|Adverse Event|24|||
164270787|NCT01769196|593360434|FG001|Overall Study|Adverse Event|20|||
164688178|NCT02858037|594881517|FG000|Overall Study|Death|1|||
164688179|NCT02858037|594881517|FG000|Overall Study|Withdrawal by Subject|18|||
164688180|NCT02858037|594881517|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
164688181|NCT02858037|594881517|FG000|Overall Study|Lost to Follow-up|3|||
164688182|NCT02858037|594881517|FG000|Overall Study|Other|4|||
164688183|NCT00283842|594881524|FG000|Overall Study|Adverse Event|8|||
164688184|NCT00283842|594881525|FG001|Overall Study|Adverse Event|7|||
164688185|NCT00283842|594881526|FG002|Overall Study|Adverse Event|21|||
164688186|NCT00283842|594881527|FG003|Overall Study|Adverse Event|21|||
164688187|NCT00283842|594881528|FG004|Overall Study|Adverse Event|5|||
164688188|NCT00283842|594881524|FG000|Overall Study|Protocol Violation|1|||
164688189|NCT00283842|594881525|FG001|Overall Study|Protocol Violation|5|||
164688190|NCT00283842|594881526|FG002|Overall Study|Protocol Violation|4|||
164688191|NCT00283842|594881527|FG003|Overall Study|Protocol Violation|0|||
164688192|NCT00283842|594881528|FG004|Overall Study|Protocol Violation|0|||
164688193|NCT00283842|594881524|FG000|Overall Study|Protocol deviation|0|||
164688194|NCT00283842|594881525|FG001|Overall Study|Protocol deviation|0|||
164688195|NCT00283842|594881526|FG002|Overall Study|Protocol deviation|0|||
164688196|NCT00283842|594881527|FG003|Overall Study|Protocol deviation|0|||
164688197|NCT00283842|594881528|FG004|Overall Study|Protocol deviation|2|||
164688198|NCT00283842|594881524|FG000|Overall Study|Withdrawal by Subject|2|||
164688199|NCT00283842|594881525|FG001|Overall Study|Withdrawal by Subject|1|||
164688200|NCT00283842|594881526|FG002|Overall Study|Withdrawal by Subject|1|||
164688201|NCT00283842|594881527|FG003|Overall Study|Withdrawal by Subject|5|||
164688202|NCT00283842|594881528|FG004|Overall Study|Withdrawal by Subject|4|||
164688203|NCT00283842|594881524|FG000|Overall Study|Lack of Efficacy|1|||
164688204|NCT00283842|594881525|FG001|Overall Study|Lack of Efficacy|3|||
164688205|NCT00283842|594881526|FG002|Overall Study|Lack of Efficacy|1|||
164688206|NCT00283842|594881527|FG003|Overall Study|Lack of Efficacy|0|||
164688207|NCT00283842|594881528|FG004|Overall Study|Lack of Efficacy|3|||
164688208|NCT00283842|594881524|FG000|Overall Study|Lost to Follow-up|0|||
164688209|NCT00283842|594881525|FG001|Overall Study|Lost to Follow-up|2|||
164688210|NCT00283842|594881526|FG002|Overall Study|Lost to Follow-up|4|||
164688211|NCT00283842|594881527|FG003|Overall Study|Lost to Follow-up|1|||
164688212|NCT00283842|594881528|FG004|Overall Study|Lost to Follow-up|1|||
164688213|NCT00550147|594881529|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
164688214|NCT00550147|594881529|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
164688215|NCT00550147|594881529|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
164688216|NCT00550147|594881529|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
164688217|NCT00550147|594881529|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
164688218|NCT04320745|594881530|FG000|Overall Study|Adverse Event|26|||
164688219|NCT04320745|594881530|FG000|Overall Study|Withdrawal by Subject|4|||
164688220|NCT04320745|594881530|FG000|Overall Study|Lost to Follow-up|12|||
164688221|NCT04320745|594881530|FG000|Overall Study|Protocol Deviation|2|||
164688222|NCT04320745|594881530|FG000|Overall Study|Non-compliance With Study Drug|2|||
164688223|NCT04320745|594881530|FG000|Overall Study|Reason Not Specified|1|||
164688224|NCT00046839|594881532|FG000|Overall Study|Ineligible / No protocol treatment|0|||
164688225|NCT00046839|594881533|FG001|Overall Study|Ineligible / No protocol treatment|2|||
164688226|NCT00046839|594881532|FG000|Overall Study|Withdrawal of consent|1|||
164688227|NCT00046839|594881533|FG001|Overall Study|Withdrawal of consent|0|||
164688228|NCT00715676|594881539|FG000|Overall Study|Adverse Event|3|||
164688229|NCT00715676|594881540|FG001|Overall Study|Adverse Event|5|||
164688230|NCT00715676|594881541|FG002|Overall Study|Adverse Event|21|||
164688231|NCT00715676|594881539|FG000|Overall Study|Withdrawal by Subject|1|||
164688232|NCT00715676|594881540|FG001|Overall Study|Withdrawal by Subject|3|||
164688233|NCT00715676|594881541|FG002|Overall Study|Withdrawal by Subject|8|||
164688234|NCT00715676|594881539|FG000|Overall Study|Lost to Follow-up|1|||
164688235|NCT00715676|594881540|FG001|Overall Study|Lost to Follow-up|2|||
164688236|NCT00715676|594881541|FG002|Overall Study|Lost to Follow-up|1|||
164688237|NCT00715676|594881539|FG000|Overall Study|Terminated by Sponsor|1|||
164688238|NCT00715676|594881540|FG001|Overall Study|Terminated by Sponsor|0|||
164688239|NCT00715676|594881541|FG002|Overall Study|Terminated by Sponsor|0|||
164688240|NCT00715676|594881539|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
164688241|NCT00715676|594881540|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
164688242|NCT00715676|594881541|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
164688243|NCT00715676|594881539|FG000|Overall Study|Use of Exclusionary Medication|0|||
164688244|NCT00715676|594881540|FG001|Overall Study|Use of Exclusionary Medication|0|||
164688245|NCT00715676|594881541|FG002|Overall Study|Use of Exclusionary Medication|1|||
164688246|NCT00715676|594881539|FG000|Overall Study|Elevated Blood Glucose|0|||
164688247|NCT00715676|594881540|FG001|Overall Study|Elevated Blood Glucose|1|||
164688248|NCT00715676|594881541|FG002|Overall Study|Elevated Blood Glucose|0|||
164688249|NCT03828539|594881542|FG000|Overall Study|Adverse Event|3|||
164688250|NCT03828539|594881543|FG001|Overall Study|Adverse Event|12|||
164688251|NCT03828539|594881542|FG000|Overall Study|Patient's/guardian's decision|3|||
164688252|NCT03828539|594881543|FG001|Overall Study|Patient's/guardian's decision|5|||
164688253|NCT03828539|594881542|FG000|Overall Study|Lost to Follow-up|4|||
164688254|NCT03828539|594881543|FG001|Overall Study|Lost to Follow-up|2|||
164688255|NCT03828539|594881542|FG000|Overall Study|Protocol Violation|3|||
164688256|NCT03828539|594881543|FG001|Overall Study|Protocol Violation|2|||
164688257|NCT03828539|594881542|FG000|Overall Study|Withdrawal of informed consent|2|||
164688258|NCT03828539|594881543|FG001|Overall Study|Withdrawal of informed consent|1|||
164688259|NCT03828539|594881542|FG000|Overall Study|New therapy for study indication|1|||
164688260|NCT03828539|594881543|FG001|Overall Study|New therapy for study indication|0|||
164688261|NCT02224053|594881544|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
164688262|NCT02224053|594881544|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
164688263|NCT02224053|594881544|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
164688264|NCT02224053|594881544|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
164688265|NCT02224053|594881544|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
164688266|NCT01898598|594881548|FG000|Overall Study|Adverse Event|1|||
164688267|NCT01898598|594881549|FG001|Overall Study|Adverse Event|0|||
164688268|NCT01898598|594881548|FG000|Overall Study|Withdrawal by Subject|3|||
164688269|NCT01898598|594881549|FG001|Overall Study|Withdrawal by Subject|0|||
164688270|NCT01898598|594881548|FG000|Overall Study|Lost to Follow-up|0|||
164688271|NCT01898598|594881549|FG001|Overall Study|Lost to Follow-up|1|||
164688272|NCT01898598|594881548|FG000|Overall Study|Other|0|||
164688273|NCT01898598|594881549|FG001|Overall Study|Other|1|||
164688274|NCT03833427|594881550|FG000|Overall Study|Death|4|||
164688275|NCT03833427|594881551|FG001|Overall Study|Death|2|||
164688276|NCT03833427|594881552|FG002|Overall Study|Death|9|||
164688277|NCT03833427|594881553|FG003|Overall Study|Death|11|||
164688278|NCT03833427|594881554|FG004|Overall Study|Death|0|||
164688279|NCT03833427|594881555|FG005|Overall Study|Death|0|||
164688280|NCT03833427|594881556|FG006|Overall Study|Death|0|||
164688281|NCT03833427|594881550|FG000|Overall Study|Withdrawal by Subject|0|||
164688282|NCT03833427|594881551|FG001|Overall Study|Withdrawal by Subject|1|||
164688283|NCT03833427|594881552|FG002|Overall Study|Withdrawal by Subject|1|||
164688284|NCT03833427|594881553|FG003|Overall Study|Withdrawal by Subject|0|||
164688285|NCT03833427|594881554|FG004|Overall Study|Withdrawal by Subject|0|||
164688286|NCT03833427|594881555|FG005|Overall Study|Withdrawal by Subject|0|||
164688287|NCT03833427|594881556|FG006|Overall Study|Withdrawal by Subject|0|||
164688288|NCT03833427|594881550|FG000|Overall Study|Sponsor Decision|0|||
164688289|NCT03833427|594881551|FG001|Overall Study|Sponsor Decision|0|||
164688290|NCT03833427|594881552|FG002|Overall Study|Sponsor Decision|1|||
164688291|NCT03833427|594881553|FG003|Overall Study|Sponsor Decision|3|||
164688292|NCT03833427|594881554|FG004|Overall Study|Sponsor Decision|0|||
164688293|NCT03833427|594881555|FG005|Overall Study|Sponsor Decision|0|||
164688294|NCT03833427|594881556|FG006|Overall Study|Sponsor Decision|0|||
164688295|NCT03294317|594881562|FG000|Overall Study|Physician Decision|1|||
164688296|NCT03294317|594881562|FG000|Overall Study|Withdrawal by Subject|6|||
164688297|NCT03294317|594881562|FG000|Overall Study|Lost to Follow-up|1|||
164688298|NCT03294317|594881562|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
164688299|NCT03294317|594881562|FG000|Overall Study|Failed HB lead implant|8|||
164688300|NCT03294317|594881562|FG000|Overall Study|Received CRT instead|1|||
164688301|NCT03294317|594881562|FG000|Overall Study|Exited after lead revision|2|||
164688302|NCT03847974|594881563|FG000|Overall Study|relocated out of region|3|||
164688303|NCT03847974|594881563|FG000|Overall Study|Withdrawal by Subject|2|||
164688304|NCT03847974|594881563|FG000|Overall Study|Adverse Event|1|||
164688305|NCT00593827|594881569|FG000|Overall Study|On Active Treatment/Pending|0|||
164688306|NCT00593827|594881570|FG001|Overall Study|On Active Treatment/Pending|2|||
164688307|NCT01833169|594881574|FG000|Overall Study|Disease Progression|99|||
164688308|NCT01833169|594881574|FG000|Overall Study|Adverse Event|33|||
164688309|NCT01833169|594881574|FG000|Overall Study|Withdrawal by Subject|9|||
164688310|NCT01833169|594881574|FG000|Overall Study|Death|3|||
164688311|NCT01833169|594881574|FG000|Overall Study|Physician Decision|2|||
164688312|NCT05467540|594881575|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
164688313|NCT05467540|594881575|FG000|3-Month Follow-up|Lost to Follow-up|4|||
164688314|NCT05467540|594881575|FG000|3-Month Follow-up|Death|5|||
164688315|NCT05467540|594881575|FG000|12-Month Follow-up|Lost to Follow-up|6|||
164688316|NCT05467540|594881575|FG000|12-Month Follow-up|Death|8|||
164688317|NCT05467540|594881575|FG000|12-Month Follow-up|Withdrawal by Subject|1|||
164688318|NCT01709903|594881583|FG000|Overall Study|administrative problems|2|||
164688319|NCT01709903|594881584|FG001|Overall Study|administrative problems|6|||
164688320|NCT01709903|594881583|FG000|Overall Study|Abnormal test procedure results|1|||
164688321|NCT01709903|594881584|FG001|Overall Study|Abnormal test procedure results|0|||
164688322|NCT01709903|594881583|FG000|Overall Study|In ability to use device|1|||
164688323|NCT01709903|594881584|FG001|Overall Study|In ability to use device|1|||
164688324|NCT01709903|594881583|FG000|Overall Study|no longer needed study drug|0|||
164688325|NCT01709903|594881584|FG001|Overall Study|no longer needed study drug|1|||
164688326|NCT01709903|594881583|FG000|Overall Study|Lost to Follow-up|0|||
164688327|NCT01709903|594881584|FG001|Overall Study|Lost to Follow-up|2|||
164688328|NCT01709903|594881583|FG000|Overall Study|Death|2|||
164688329|NCT01709903|594881584|FG001|Overall Study|Death|0|||
164688330|NCT01709903|594881583|FG000|Overall Study|Protocol Violation|3|||
164688331|NCT01709903|594881584|FG001|Overall Study|Protocol Violation|2|||
164688332|NCT01709903|594881583|FG000|Overall Study|Lack of Efficacy|3|||
164688333|NCT01709903|594881584|FG001|Overall Study|Lack of Efficacy|3|||
164688334|NCT01709903|594881583|FG000|Overall Study|Withdrawal by Subject|6|||
164270788|NCT01769196|593360433|FG000|Overall Study|Death|21|||
164270789|NCT01769196|593360434|FG001|Overall Study|Death|26|||
164270790|NCT01769196|593360433|FG000|Overall Study|Investigator Discretion|7|||
164270791|NCT01769196|593360434|FG001|Overall Study|Investigator Discretion|3|||
164270792|NCT01769196|593360433|FG000|Overall Study|Lack of Efficacy|3|||
164270793|NCT01769196|593360434|FG001|Overall Study|Lack of Efficacy|2|||
164270794|NCT01769196|593360433|FG000|Overall Study|Progressive disease|11|||
164270795|NCT01769196|593360434|FG001|Overall Study|Progressive disease|6|||
164270796|NCT01769196|593360433|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
164270797|NCT01769196|593360434|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
164270798|NCT01769196|593360433|FG000|Overall Study|Protocol Violation|0|||
164270799|NCT01769196|593360434|FG001|Overall Study|Protocol Violation|3|||
164270800|NCT01769196|593360433|FG000|Overall Study|Study terminated by sponsor|160|||
164270801|NCT01769196|593360434|FG001|Overall Study|Study terminated by sponsor|161|||
164270802|NCT01769196|593360433|FG000|Overall Study|Participant never dosed with study drug|1|||
164270803|NCT01769196|593360434|FG001|Overall Study|Participant never dosed with study drug|0|||
164270804|NCT01769196|593360433|FG000|Overall Study|Withdrew consent|36|||
164270805|NCT01769196|593360434|FG001|Overall Study|Withdrew consent|40|||
164270806|NCT00765063|593360435|FG000|Overall Study|Lack of Efficacy|5|||
164270807|NCT00765063|593360435|FG000|Overall Study|Withdrawal by Subject|1|||
164270808|NCT00765063|593360435|FG000|Overall Study|Other|16|||
164270809|NCT00765063|593360435|FG000|Overall Study|Protocol Violation|6|||
164270810|NCT00765063|593360435|FG000|Overall Study|Adverse Event|4|||
164270811|NCT03614325|593360436|FG000|Overall Study|Withdrawal by Subject|0|||
164270812|NCT03614325|593360437|FG001|Overall Study|Withdrawal by Subject|2|||
164270813|NCT03614325|593360436|FG000|Overall Study|Surgery Cancelled|2|||
164270814|NCT03614325|593360437|FG001|Overall Study|Surgery Cancelled|1|||
164430823|NCT00430677|593947311|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
164430824|NCT00430677|593947312|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
164430825|NCT00430677|593947313|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
164430826|NCT01555762|593947316|FG000|Overall Study|No information on Bevacizumab intake|11|||
164430827|NCT01555762|593947316|FG000|Overall Study|Missing start date of infusion|8|||
164582561|NCT02453841|594498018|FG000|Overall Study|Unable to obtain blood samples|2|||
164582562|NCT01751646|594498019|FG000|Overall Study|Lost to Follow-up|5|||
164582563|NCT01751646|594498020|FG001|Overall Study|Lost to Follow-up|1|||
164582564|NCT01751646|594498019|FG000|Overall Study|Withdrawal by Subject|0|||
164582565|NCT01751646|594498020|FG001|Overall Study|Withdrawal by Subject|4|||
164582566|NCT01751646|594498019|FG000|Overall Study|Starting hormone therapy|1|||
164582567|NCT01751646|594498020|FG001|Overall Study|Starting hormone therapy|0|||
164582568|NCT01751646|594498019|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
164582569|NCT01751646|594498020|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
164582570|NCT01751646|594498019|FG000|Overall Study|Inadvertent enrollment|1|||
164582571|NCT01751646|594498020|FG001|Overall Study|Inadvertent enrollment|1|||
164582572|NCT01751646|594498019|FG000|Overall Study|Moved out of the area|1|||
164582573|NCT01751646|594498020|FG001|Overall Study|Moved out of the area|5|||
164582574|NCT01751646|594498019|FG000|Overall Study|Inability to attend required visits|0|||
164582575|NCT01751646|594498020|FG001|Overall Study|Inability to attend required visits|1|||
164582576|NCT01751646|594498019|FG000|Overall Study|Off study due to multiple obligations|0|||
164582577|NCT01751646|594498020|FG001|Overall Study|Off study due to multiple obligations|1|||
164582578|NCT01751646|594498019|FG000|Overall Study|Fails to comply with study requirements|0|||
164582579|NCT01751646|594498020|FG001|Overall Study|Fails to comply with study requirements|1|||
164582580|NCT01751646|594498019|FG000|Overall Study|Childcare issues|1|||
164582581|NCT01751646|594498020|FG001|Overall Study|Childcare issues|1|||
164582582|NCT02190591|594498021|FG000|Overall Study|Withdrawal by Subject|1|||
164582583|NCT02190591|594498022|FG001|Overall Study|Withdrawal by Subject|8|||
164582584|NCT02190591|594498021|FG000|Overall Study|Protocol Violation|1|||
164582585|NCT02190591|594498022|FG001|Overall Study|Protocol Violation|0|||
164582586|NCT02190591|594498021|FG000|Overall Study|did not use peanut ball as instructed|0|||
164582587|NCT02190591|594498022|FG001|Overall Study|did not use peanut ball as instructed|2|||
164582588|NCT02190591|594498021|FG000|Overall Study|face presentation so she was ineligible|0|||
164582589|NCT02190591|594498022|FG001|Overall Study|face presentation so she was ineligible|1|||
164582590|NCT01151137|594498025|FG000|Overall Study|Death|15|||
164582591|NCT01151137|594498026|FG001|Overall Study|Death|27|||
164582592|NCT01151137|594498025|FG000|Overall Study|Lost to Follow-up|1|||
164582593|NCT01151137|594498026|FG001|Overall Study|Lost to Follow-up|1|||
164688335|NCT01709903|594881584|FG001|Overall Study|Withdrawal by Subject|6|||
164688336|NCT01709903|594881583|FG000|Overall Study|Adverse Event|11|||
164270815|NCT03614325|593360436|FG000|Overall Study|Lost to Follow-up|2|||
164270816|NCT03614325|593360437|FG001|Overall Study|Lost to Follow-up|1|||
164270817|NCT03614325|593360436|FG000|Overall Study|Surgery never scheduled|1|||
164270818|NCT03614325|593360437|FG001|Overall Study|Surgery never scheduled|0|||
164270819|NCT00321464|593360438|FG000|Overall Study|Death|169|||
164270820|NCT00321464|593360439|FG001|Overall Study|Death|174|||
164430828|NCT01555762|593947316|FG000|Overall Study|75 years old or more ticked No|1|||
164582594|NCT03478683|594498029|FG000|Overall Study|Adverse Event|5|||
164270821|NCT00321464|593360438|FG000|Overall Study|Disease progression|124|||
164270822|NCT00321464|593360439|FG001|Overall Study|Disease progression|124|||
164270823|NCT00321464|593360438|FG000|Overall Study|Withdrawal by Subject|117|||
164270824|NCT00321464|593360439|FG001|Overall Study|Withdrawal by Subject|118|||
164270825|NCT00321464|593360438|FG000|Overall Study|Participant request|57|||
164270826|NCT00321464|593360439|FG001|Overall Study|Participant request|61|||
164270827|NCT00321464|593360438|FG000|Overall Study|Adverse Event|43|||
164270828|NCT00321464|593360439|FG001|Overall Study|Adverse Event|28|||
164270829|NCT00321464|593360438|FG000|Overall Study|Physician Decision|15|||
164270830|NCT00321464|593360439|FG001|Overall Study|Physician Decision|14|||
164270831|NCT00321464|593360438|FG000|Overall Study|Noncompliance|4|||
164270832|NCT00321464|593360439|FG001|Overall Study|Noncompliance|10|||
164270833|NCT00321464|593360438|FG000|Overall Study|Lost to Follow-up|7|||
164270834|NCT00321464|593360439|FG001|Overall Study|Lost to Follow-up|8|||
164270835|NCT00321464|593360438|FG000|Overall Study|Protocol deviation|0|||
164270836|NCT00321464|593360439|FG001|Overall Study|Protocol deviation|2|||
164270837|NCT00321464|593360438|FG000|Overall Study|Ineligibility determined|2|||
164270838|NCT00321464|593360439|FG001|Overall Study|Ineligibility determined|1|||
164270839|NCT00321464|593360438|FG000|Overall Study|Other|21|||
164270840|NCT00321464|593360439|FG001|Overall Study|Other|18|||
164270841|NCT01673620|593360445|FG000|Overall Study|Adverse Event|1|||
164688337|NCT01709903|594881584|FG001|Overall Study|Adverse Event|18|||
164688338|NCT04592419|594883231|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
164688339|NCT04592419|594883232|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
164688340|NCT04592419|594883231|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
164270842|NCT01673620|593360446|FG001|Overall Study|Adverse Event|0|||
164270843|NCT00652951|593360447|FG000|Booster Phase|Adverse event, non-fatal|0|||
164270844|NCT00652951|593360448|FG001|Booster Phase|Adverse event, non-fatal|1|||
164270845|NCT00652951|593360449|FG002|Booster Phase|Adverse event, non-fatal|0|||
164270846|NCT00652951|593360447|FG000|Booster Phase|Other|1|||
164270847|NCT00652951|593360448|FG001|Booster Phase|Other|0|||
164270848|NCT00652951|593360449|FG002|Booster Phase|Other|0|||
164270849|NCT01022424|593360450|FG000|Overall Study|Adverse Event|1|||
164270850|NCT01022424|593360450|FG000|Overall Study|Physician Decision|1|||
164270851|NCT01022424|593360450|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
164270852|NCT01206582|593360451|FG000|Overall Study|Withdrew prior to study|1|||
164270853|NCT01206582|593360452|FG001|Overall Study|Withdrew prior to study|0|||
164270854|NCT01206582|593360451|FG000|Overall Study|Discontinued intervention before week 8|1|||
164270855|NCT01206582|593360452|FG001|Overall Study|Discontinued intervention before week 8|2|||
164270856|NCT02100969|593360453|FG000|Overall Study|Did not pass screening phase|1|||
164270857|NCT00528801|593360454|FG000|Overall Study|Withdrawal by Subject|1|||
164270858|NCT00528801|593360455|FG001|Overall Study|Withdrawal by Subject|1|||
164270859|NCT00528801|593360454|FG000|Overall Study|Protocol Violation|11|||
164270860|NCT00528801|593360455|FG001|Overall Study|Protocol Violation|5|||
164270861|NCT00528801|593360454|FG000|Overall Study|Lost to Follow-up|15|||
164270862|NCT00528801|593360455|FG001|Overall Study|Lost to Follow-up|4|||
164270863|NCT00528801|593360454|FG000|Overall Study|Administrative Reasons|0|||
164688341|NCT04592419|594883232|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
164270864|NCT00528801|593360455|FG001|Overall Study|Administrative Reasons|1|||
164270865|NCT02207491|593360456|FG000|Overall Study|Adverse Event|20|||
164342329|NCT04457336|593629426|FG000|Period 2: Part A|Protocol Violation|0|||
164688342|NCT04592419|594883231|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
164688343|NCT04592419|594883232|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
164688344|NCT04592419|594883231|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
164688345|NCT04592419|594883232|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
164688346|NCT04592419|594883231|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
164688347|NCT04592419|594883232|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
164688348|NCT04592419|594883231|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
164688349|NCT04592419|594883232|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
164342330|NCT04457336|593629427|FG001|Period 2: Part A|Protocol Violation|1|||
164342331|NCT04457336|593629428|FG002|Period 2: Part A|Protocol Violation|0|||
164342332|NCT04457336|593629429|FG003|Period 2: Part A|Protocol Violation|0|||
164688350|NCT04592419|594883231|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
164688351|NCT04592419|594883232|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
164270866|NCT02207491|593360457|FG001|Overall Study|Adverse Event|4|||
164270867|NCT02207491|593360456|FG000|Overall Study|Withdrawal by Subject|3|||
164270868|NCT02207491|593360457|FG001|Overall Study|Withdrawal by Subject|2|||
164270869|NCT02207491|593360456|FG000|Overall Study|Non-compliant|0|||
164270870|NCT02207491|593360457|FG001|Overall Study|Non-compliant|1|||
164270871|NCT02207491|593360456|FG000|Overall Study|Lost to Follow-up|0|||
164270872|NCT02207491|593360457|FG001|Overall Study|Lost to Follow-up|1|||
164270873|NCT02207491|593360456|FG000|Overall Study|Lack of Efficacy|3|||
164270874|NCT02207491|593360457|FG001|Overall Study|Lack of Efficacy|0|||
164270875|NCT02207491|593360456|FG000|Overall Study|Physician Decision|2|||
164270876|NCT02207491|593360457|FG001|Overall Study|Physician Decision|0|||
164270877|NCT02207491|593360456|FG000|Overall Study|Protocol Violation|3|||
164270878|NCT02207491|593360457|FG001|Overall Study|Protocol Violation|5|||
164270879|NCT00477152|593360458|FG000|Overall Study|Parent withdrew consent|2|||
164270880|NCT00477152|593360458|FG000|Overall Study|Adverse Event|1|||
164270881|NCT00372697|593360459|FG000|Overall Study|Protocol Violation|1|||
164270882|NCT00372697|593360460|FG001|Overall Study|Protocol Violation|1|||
164270883|NCT00527982|593360462|FG000|Overall Study|Physician Decision|1|||
164270884|NCT00527982|593360463|FG001|Overall Study|Physician Decision|0|||
164430829|NCT01555762|593947316|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
164430830|NCT01555762|593947316|FG000|Overall Study|Death linked to progression of disease|165|||
164430831|NCT01555762|593947316|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
164430832|NCT01555762|593947316|FG000|Overall Study|Investigator's decision|10|||
164430833|NCT01555762|593947316|FG000|Overall Study|Participant not wishing to continue|5|||
164430834|NCT01555762|593947316|FG000|Overall Study|Missing data|1|||
164430835|NCT01555762|593947316|FG000|Overall Study|Death linked to an adverse event|14|||
164430836|NCT01772719|593947317|FG000|Overall Study|Withdrawal by Subject|3|||
164430837|NCT01772719|593947317|FG000|Overall Study|Adverse Event|2|||
164430838|NCT01772719|593947317|FG000|Overall Study|Protocol Violation|1|||
164430839|NCT01772719|593947317|FG000|Overall Study|Lost to Follow-up|1|||
164430840|NCT00477412|593947322|FG000|Overall Study|Death|0|||
164582595|NCT03478683|594498030|FG001|Overall Study|Adverse Event|3|||
164582596|NCT03478683|594498029|FG000|Overall Study|Lost to Follow-up|0|||
164582597|NCT03478683|594498030|FG001|Overall Study|Lost to Follow-up|5|||
164582598|NCT03478683|594498029|FG000|Overall Study|Physician Decision|1|||
164270885|NCT01939366|593360466|FG000|Overall Study|Adverse Event|8|||
164270886|NCT01939366|593360467|FG001|Overall Study|Adverse Event|17|||
164270887|NCT01939366|593360468|FG002|Overall Study|Adverse Event|30|||
164270888|NCT01939366|593360469|FG003|Overall Study|Adverse Event|8|||
164582599|NCT03478683|594498030|FG001|Overall Study|Physician Decision|3|||
164582600|NCT03478683|594498029|FG000|Overall Study|Withdrawal by Subject|7|||
164582601|NCT03478683|594498030|FG001|Overall Study|Withdrawal by Subject|7|||
164582602|NCT02273973|594498039|FG000|Overall Study|Adverse Event|4|||
164582603|NCT02273973|594498040|FG001|Overall Study|Adverse Event|0|||
164582604|NCT02273973|594498039|FG000|Overall Study|Withdrawal by Subject|2|||
164582605|NCT02273973|594498040|FG001|Overall Study|Withdrawal by Subject|3|||
164582606|NCT02273973|594498039|FG000|Overall Study|Death|1|||
164582607|NCT02273973|594498040|FG001|Overall Study|Death|0|||
164582608|NCT02273973|594498039|FG000|Overall Study|Non-compliance|1|||
164582609|NCT02273973|594498040|FG001|Overall Study|Non-compliance|0|||
164582610|NCT02273973|594498039|FG000|Overall Study|Protocol Violation|1|||
164582611|NCT02273973|594498040|FG001|Overall Study|Protocol Violation|0|||
164582612|NCT02273973|594498039|FG000|Overall Study|Progression of disease|0|||
164582613|NCT02273973|594498040|FG001|Overall Study|Progression of disease|2|||
164582614|NCT02273973|594498039|FG000|Overall Study|Lost to Follow-up|0|||
164582615|NCT02273973|594498040|FG001|Overall Study|Lost to Follow-up|1|||
164582616|NCT02273973|594498039|FG000|Overall Study|Physician Decision|0|||
164582617|NCT02273973|594498040|FG001|Overall Study|Physician Decision|1|||
164582618|NCT02273973|594498039|FG000|Overall Study|Reason not specified|0|||
164582619|NCT02273973|594498040|FG001|Overall Study|Reason not specified|1|||
164582620|NCT02104180|594498041|FG000|Overall Study|Protocol Violation|1|||
164582621|NCT02104180|594498042|FG001|Overall Study|Protocol Violation|0|||
164582622|NCT03246529|594498043|FG000|Core Study (until 100 d post-transplant)|Adverse Event|0|||
164582623|NCT03246529|594498044|FG001|Core Study (until 100 d post-transplant)|Adverse Event|2|||
164582624|NCT03246529|594498045|FG002|Core Study (until 100 d post-transplant)|Adverse Event|0|||
164582625|NCT03246529|594498043|FG000|Core Study (until 100 d post-transplant)|Lost to Follow-up|0|||
164582626|NCT03246529|594498044|FG001|Core Study (until 100 d post-transplant)|Lost to Follow-up|1|||
164582627|NCT03246529|594498045|FG002|Core Study (until 100 d post-transplant)|Lost to Follow-up|1|||
164582628|NCT03246529|594498043|FG000|Core Study (until 100 d post-transplant)|Other Reasons|0|||
164582629|NCT03246529|594498044|FG001|Core Study (until 100 d post-transplant)|Other Reasons|2|||
164582630|NCT03246529|594498045|FG002|Core Study (until 100 d post-transplant)|Other Reasons|2|||
164582631|NCT03246529|594498043|FG000|Core Study (until 100 d post-transplant)|Physician Decision|0|||
164582632|NCT03246529|594498044|FG001|Core Study (until 100 d post-transplant)|Physician Decision|0|||
164582633|NCT03246529|594498045|FG002|Core Study (until 100 d post-transplant)|Physician Decision|1|||
164582634|NCT03246529|594498043|FG000|Core Study (until 100 d post-transplant)|Withdrawal by Subject|0|||
164582635|NCT03246529|594498044|FG001|Core Study (until 100 d post-transplant)|Withdrawal by Subject|1|||
164270889|NCT01939366|593360470|FG004|Overall Study|Adverse Event|5|||
164270890|NCT01939366|593360466|FG000|Overall Study|Lack of Efficacy|2|||
164430841|NCT00477412|593947323|FG001|Overall Study|Death|0|||
164430842|NCT00477412|593947324|FG002|Overall Study|Death|0|||
164582636|NCT03246529|594498045|FG002|Core Study (until 100 d post-transplant)|Withdrawal by Subject|4|||
164582637|NCT03246529|594498043|FG000|Follow-up period at 1 year FU Completion|Disease progression|2|||
164582638|NCT03246529|594498044|FG001|Follow-up period at 1 year FU Completion|Disease progression|1|||
164582639|NCT03246529|594498045|FG002|Follow-up period at 1 year FU Completion|Disease progression|1|||
164270891|NCT01939366|593360467|FG001|Overall Study|Lack of Efficacy|1|||
164270892|NCT01939366|593360468|FG002|Overall Study|Lack of Efficacy|1|||
164270893|NCT01939366|593360469|FG003|Overall Study|Lack of Efficacy|1|||
164270894|NCT01939366|593360470|FG004|Overall Study|Lack of Efficacy|3|||
164270895|NCT01939366|593360466|FG000|Overall Study|Lost to Follow-up|1|||
164270896|NCT01939366|593360467|FG001|Overall Study|Lost to Follow-up|1|||
164270897|NCT01939366|593360468|FG002|Overall Study|Lost to Follow-up|0|||
164270898|NCT01939366|593360469|FG003|Overall Study|Lost to Follow-up|0|||
164270899|NCT01939366|593360470|FG004|Overall Study|Lost to Follow-up|0|||
164270900|NCT01939366|593360466|FG000|Overall Study|Withdrawal by Subject|1|||
164270901|NCT01939366|593360467|FG001|Overall Study|Withdrawal by Subject|0|||
164270902|NCT01939366|593360468|FG002|Overall Study|Withdrawal by Subject|2|||
164270903|NCT01939366|593360469|FG003|Overall Study|Withdrawal by Subject|2|||
164270904|NCT01939366|593360470|FG004|Overall Study|Withdrawal by Subject|3|||
164270905|NCT01939366|593360466|FG000|Overall Study|Inclusion criteria not met|0|||
164270906|NCT01939366|593360467|FG001|Overall Study|Inclusion criteria not met|1|||
164688352|NCT04592419|594883231|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
164688353|NCT04592419|594883232|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
164688354|NCT04592419|594883231|FG000|Open-Label Extension Period|Adverse Event|1|||
164688355|NCT04592419|594883232|FG001|Open-Label Extension Period|Adverse Event|2|||
164688356|NCT04592419|594883231|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
164688357|NCT04592419|594883232|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
164688358|NCT04592419|594883231|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
164688359|NCT04592419|594883232|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
164688360|NCT04592419|594883231|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
164270907|NCT01939366|593360468|FG002|Overall Study|Inclusion criteria not met|1|||
164270908|NCT01939366|593360469|FG003|Overall Study|Inclusion criteria not met|0|||
164270909|NCT01939366|593360470|FG004|Overall Study|Inclusion criteria not met|1|||
164270910|NCT01939366|593360466|FG000|Overall Study|Other|0|||
164270911|NCT01939366|593360467|FG001|Overall Study|Other|0|||
164270912|NCT01939366|593360468|FG002|Overall Study|Other|2|||
164270913|NCT01939366|593360469|FG003|Overall Study|Other|2|||
164270914|NCT01939366|593360470|FG004|Overall Study|Other|1|||
164270915|NCT01939366|593360466|FG000|Overall Study|Protocol Violation|0|||
164270916|NCT01939366|593360467|FG001|Overall Study|Protocol Violation|0|||
164270917|NCT01939366|593360468|FG002|Overall Study|Protocol Violation|0|||
164270918|NCT01939366|593360469|FG003|Overall Study|Protocol Violation|1|||
164270919|NCT01939366|593360470|FG004|Overall Study|Protocol Violation|0|||
164270920|NCT01939366|593360466|FG000|Overall Study|Sponsor decision|0|||
164270921|NCT01939366|593360467|FG001|Overall Study|Sponsor decision|0|||
164270922|NCT01939366|593360468|FG002|Overall Study|Sponsor decision|0|||
164270923|NCT01939366|593360469|FG003|Overall Study|Sponsor decision|0|||
164270924|NCT01939366|593360470|FG004|Overall Study|Sponsor decision|2|||
164270925|NCT01939366|593360466|FG000|Overall Study|GCP non-compliance at site|2|||
164270926|NCT01939366|593360467|FG001|Overall Study|GCP non-compliance at site|3|||
164270927|NCT01939366|593360468|FG002|Overall Study|GCP non-compliance at site|2|||
164688361|NCT04592419|594883232|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
164688362|NCT04592419|594883231|FG000|Open-Label Extension Period|Sponsor Request|73|||
164688363|NCT04592419|594883232|FG001|Open-Label Extension Period|Sponsor Request|84|||
164688364|NCT05693805|594883237|FG000|Overall Study|Completed is defined as being engaged at the 3-month follow up..|5|||
164688365|NCT05693805|594883238|FG001|Overall Study|Completed is defined as being engaged at the 3-month follow up..|2|||
164688366|NCT02943993|594883239|FG000|Overall Study|Withdrawal by Subject|52|||
164688367|NCT02943993|594883239|FG000|Overall Study|Transfer to another institution|6|||
164688368|NCT02943993|594883239|FG000|Overall Study|Lost to Follow-up|135|||
164688369|NCT02943993|594883239|FG000|Overall Study|Death|98|||
164688370|NCT02943993|594883239|FG000|Overall Study|Other reason for premature termination|32|||
164688371|NCT02943993|594883239|FG000|Overall Study|Missing reason for termination|7|||
164688372|NCT02152982|594883242|FG000|Overall Study|Withdrawal by Subject|17|||
164688373|NCT02152982|594883243|FG001|Overall Study|Withdrawal by Subject|16|||
164688374|NCT02152982|594883242|FG000|Overall Study|Did not start treatment|11|||
164688375|NCT02152982|594883243|FG001|Overall Study|Did not start treatment|5|||
164688376|NCT02152982|594883242|FG000|Overall Study|Disease progression|41|||
164688377|NCT02152982|594883243|FG001|Overall Study|Disease progression|52|||
164688378|NCT02152982|594883242|FG000|Overall Study|Adverse Event|7|||
164270928|NCT01939366|593360469|FG003|Overall Study|GCP non-compliance at site|3|||
164270929|NCT01939366|593360470|FG004|Overall Study|GCP non-compliance at site|3|||
164270930|NCT02708485|593360471|FG000|Overall Study|Withdrawal by Subject|3|||
164270931|NCT02708485|593360472|FG001|Overall Study|Withdrawal by Subject|2|||
164270932|NCT00231413|593360473|FG000|Overall Study|Non-serious AE|0|||
164270933|NCT00231413|593360474|FG001|Overall Study|Non-serious AE|0|||
164270934|NCT00231413|593360475|FG002|Overall Study|Non-serious AE|1|||
164688379|NCT02152982|594883243|FG001|Overall Study|Adverse Event|12|||
164270935|NCT00231413|593360476|FG003|Overall Study|Non-serious AE|0|||
164270936|NCT00231413|593360477|FG004|Overall Study|Non-serious AE|0|||
164270937|NCT00231413|593360478|FG005|Overall Study|Non-serious AE|0|||
164270938|NCT00231413|593360479|FG006|Overall Study|Non-serious AE|1|||
164270939|NCT00231413|593360473|FG000|Overall Study|Withdrawal by Subject|3|||
164270940|NCT00231413|593360474|FG001|Overall Study|Withdrawal by Subject|1|||
164270941|NCT00231413|593360475|FG002|Overall Study|Withdrawal by Subject|4|||
164270942|NCT00231413|593360476|FG003|Overall Study|Withdrawal by Subject|2|||
164270943|NCT00231413|593360477|FG004|Overall Study|Withdrawal by Subject|2|||
164270944|NCT00231413|593360478|FG005|Overall Study|Withdrawal by Subject|0|||
164270945|NCT00231413|593360479|FG006|Overall Study|Withdrawal by Subject|3|||
164270946|NCT00231413|593360473|FG000|Overall Study|Migrated/moved from study area|0|||
164270947|NCT00231413|593360474|FG001|Overall Study|Migrated/moved from study area|0|||
164270948|NCT00231413|593360475|FG002|Overall Study|Migrated/moved from study area|1|||
164270949|NCT00231413|593360476|FG003|Overall Study|Migrated/moved from study area|0|||
164270950|NCT00231413|593360477|FG004|Overall Study|Migrated/moved from study area|0|||
164270951|NCT00231413|593360478|FG005|Overall Study|Migrated/moved from study area|1|||
164270952|NCT00231413|593360479|FG006|Overall Study|Migrated/moved from study area|0|||
164688380|NCT02152982|594883242|FG000|Overall Study|Complicating disease|1|||
164688381|NCT02152982|594883243|FG001|Overall Study|Complicating disease|1|||
164688382|NCT02152982|594883242|FG000|Overall Study|Death|0|||
164688383|NCT02152982|594883243|FG001|Overall Study|Death|3|||
164688384|NCT02152982|594883242|FG000|Overall Study|Physician Decision|3|||
164688385|NCT02152982|594883243|FG001|Overall Study|Physician Decision|0|||
164270953|NCT00231413|593360473|FG000|Overall Study|Lost to Follow-up|4|||
164270954|NCT00231413|593360474|FG001|Overall Study|Lost to Follow-up|4|||
164270955|NCT00231413|593360475|FG002|Overall Study|Lost to Follow-up|1|||
164270956|NCT00231413|593360476|FG003|Overall Study|Lost to Follow-up|1|||
164270957|NCT00231413|593360477|FG004|Overall Study|Lost to Follow-up|1|||
164688386|NCT04968925|594883244|FG000|Phase I- Period 1|COVID-19 related|0|||
164688387|NCT04968925|594883245|FG001|Phase I- Period 1|COVID-19 related|1|||
164688388|NCT04968925|594883246|FG002|Phase I- Period 1|COVID-19 related|0|||
164688389|NCT04968925|594883247|FG003|Phase I- Period 1|COVID-19 related|0|||
164688390|NCT04968925|594883244|FG000|Phase I- Period 1|Subject enrolled in error|1|||
164688391|NCT04968925|594883245|FG001|Phase I- Period 1|Subject enrolled in error|1|||
164688392|NCT04968925|594883246|FG002|Phase I- Period 1|Subject enrolled in error|0|||
164688393|NCT04968925|594883247|FG003|Phase I- Period 1|Subject enrolled in error|0|||
164688394|NCT04968925|594883244|FG000|Phase II- Period 1|COVID-19 Related|0|||
164688395|NCT04968925|594883245|FG001|Phase II- Period 1|COVID-19 Related|0|||
164688396|NCT04968925|594883246|FG002|Phase II- Period 1|COVID-19 Related|6|||
164688397|NCT04968925|594883247|FG003|Phase II- Period 1|COVID-19 Related|6|||
164688398|NCT04968925|594883244|FG000|Phase II- Period 1|Subject enrolled in error|0|||
164688399|NCT04968925|594883245|FG001|Phase II- Period 1|Subject enrolled in error|0|||
164688400|NCT04968925|594883246|FG002|Phase II- Period 1|Subject enrolled in error|1|||
164688401|NCT04968925|594883247|FG003|Phase II- Period 1|Subject enrolled in error|0|||
164688402|NCT04968925|594883244|FG000|Phase II -Period 2|COVID-19 related|0|||
164688403|NCT04968925|594883245|FG001|Phase II -Period 2|COVID-19 related|0|||
164688404|NCT04968925|594883246|FG002|Phase II -Period 2|COVID-19 related|4|||
164688405|NCT04968925|594883247|FG003|Phase II -Period 2|COVID-19 related|3|||
164688406|NCT04968925|594883244|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
164688407|NCT04968925|594883245|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
164688408|NCT04968925|594883246|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
164688409|NCT04968925|594883247|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
164688410|NCT00835796|594883248|FG000|First Intervention|Withdrawal by Subject|0|||
164688411|NCT00835796|594883249|FG001|First Intervention|Withdrawal by Subject|1|||
164688412|NCT00876265|594883250|FG000|Overall Study|Miscellaneous reasons|4|||
164688413|NCT00876265|594883250|FG000|Overall Study|Lost to Follow-up|6|||
164688414|NCT00876265|594883250|FG000|Overall Study|Withdrawal by Subject|2|||
164688415|NCT00695110|594883253|FG000|Treatment Period 1|Adverse Event|1|||
164688416|NCT00695110|594883253|FG000|Treatment Period 1|Withdrawal by Subject|2|||
164688417|NCT00695110|594883253|FG000|Treatment Period 3|Withdrawal by Subject|1|||
164688418|NCT00695110|594883253|FG000|Treatment Period 4|Adverse Event|1|||
164688419|NCT02510261|594883257|FG000|Overall Study|Adverse Event|5|||
164688420|NCT02510261|594883258|FG001|Overall Study|Adverse Event|8|||
164688421|NCT02510261|594883259|FG002|Overall Study|Adverse Event|0|||
164688422|NCT02510261|594883257|FG000|Overall Study|Physician Decision|1|||
164688423|NCT02510261|594883258|FG001|Overall Study|Physician Decision|5|||
164688424|NCT02510261|594883259|FG002|Overall Study|Physician Decision|0|||
164270958|NCT00231413|593360478|FG005|Overall Study|Lost to Follow-up|4|||
164270959|NCT00231413|593360479|FG006|Overall Study|Lost to Follow-up|0|||
164270960|NCT00231413|593360473|FG000|Overall Study|Pregnancy|1|||
164270961|NCT00231413|593360474|FG001|Overall Study|Pregnancy|0|||
164688425|NCT02510261|594883257|FG000|Overall Study|Death|19|||
164688426|NCT02510261|594883258|FG001|Overall Study|Death|19|||
164688427|NCT02510261|594883259|FG002|Overall Study|Death|0|||
164688428|NCT02510261|594883257|FG000|Overall Study|Withdrawal by Subject|3|||
164688429|NCT02510261|594883258|FG001|Overall Study|Withdrawal by Subject|10|||
164270962|NCT00231413|593360475|FG002|Overall Study|Pregnancy|0|||
164270963|NCT00231413|593360476|FG003|Overall Study|Pregnancy|0|||
164688430|NCT02510261|594883259|FG002|Overall Study|Withdrawal by Subject|3|||
164270964|NCT00231413|593360477|FG004|Overall Study|Pregnancy|0|||
164270965|NCT00231413|593360478|FG005|Overall Study|Pregnancy|0|||
164270966|NCT00231413|593360479|FG006|Overall Study|Pregnancy|0|||
164270967|NCT02066415|593360480|FG000|Overall Study|Decision by Sponsor|5|||
164270968|NCT02066415|593360481|FG001|Overall Study|Decision by Sponsor|4|||
164270969|NCT02066415|593360482|FG002|Overall Study|Decision by Sponsor|2|||
164270970|NCT02066415|593360480|FG000|Overall Study|Withdrawal by Subject|9|||
164270971|NCT02066415|593360481|FG001|Overall Study|Withdrawal by Subject|1|||
164270972|NCT02066415|593360482|FG002|Overall Study|Withdrawal by Subject|4|||
164270973|NCT02066415|593360480|FG000|Overall Study|Lost to Follow-up|7|||
164270974|NCT02066415|593360481|FG001|Overall Study|Lost to Follow-up|2|||
164270975|NCT02066415|593360482|FG002|Overall Study|Lost to Follow-up|2|||
164270976|NCT01423916|593360484|FG000|Overall Study|Adverse Event|5|||
164270977|NCT01423916|593360485|FG001|Overall Study|Adverse Event|9|||
164270978|NCT01423916|593360486|FG002|Overall Study|Adverse Event|2|||
164270979|NCT01423916|593360484|FG000|Overall Study|Met Withdrawal Criteria|1|||
164270980|NCT01423916|593360485|FG001|Overall Study|Met Withdrawal Criteria|1|||
164270981|NCT01423916|593360486|FG002|Overall Study|Met Withdrawal Criteria|1|||
164270982|NCT01423916|593360484|FG000|Overall Study|Physician Decision|1|||
164270983|NCT01423916|593360485|FG001|Overall Study|Physician Decision|0|||
164270984|NCT01423916|593360486|FG002|Overall Study|Physician Decision|1|||
164270985|NCT01423916|593360484|FG000|Overall Study|Withdrawal by Subject|3|||
164270986|NCT01423916|593360485|FG001|Overall Study|Withdrawal by Subject|10|||
164270987|NCT01423916|593360486|FG002|Overall Study|Withdrawal by Subject|3|||
164270988|NCT01423916|593360484|FG000|Overall Study|Protocol Deviation|1|||
164270989|NCT01423916|593360485|FG001|Overall Study|Protocol Deviation|0|||
164270990|NCT01423916|593360486|FG002|Overall Study|Protocol Deviation|0|||
164270991|NCT02276547|593360487|FG000|Overall Study|Death|2|||
164270992|NCT02276547|593360487|FG000|Overall Study|Explant|2|||
164270993|NCT00106691|593360488|FG000|Overall Study|Adverse Event|60|||
164270994|NCT00106691|593360489|FG001|Overall Study|Adverse Event|64|||
164270995|NCT00106691|593360488|FG000|Overall Study|Lost to Follow-up|23|||
164270996|NCT00106691|593360489|FG001|Overall Study|Lost to Follow-up|18|||
164270997|NCT00106691|593360488|FG000|Overall Study|Physician Decision|18|||
164270998|NCT00106691|593360489|FG001|Overall Study|Physician Decision|21|||
164270999|NCT00106691|593360488|FG000|Overall Study|Protocol Violation|13|||
164271000|NCT00106691|593360489|FG001|Overall Study|Protocol Violation|18|||
164271001|NCT00106691|593360488|FG000|Overall Study|Withdrawal by Subject|75|||
164271002|NCT00106691|593360489|FG001|Overall Study|Withdrawal by Subject|70|||
164271003|NCT00106691|593360488|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
164271004|NCT00106691|593360489|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
164271005|NCT00106691|593360488|FG000|Overall Study|QTc>480|3|||
164271006|NCT00106691|593360489|FG001|Overall Study|QTc>480|1|||
164271007|NCT00106691|593360488|FG000|Overall Study|mililtary deployment|2|||
164271008|NCT00106691|593360489|FG001|Overall Study|mililtary deployment|0|||
164271009|NCT00106691|593360488|FG000|Overall Study|Study Site Closing/PI Moved|1|||
164271010|NCT00106691|593360489|FG001|Overall Study|Study Site Closing/PI Moved|2|||
164271011|NCT00106691|593360488|FG000|Overall Study|Cardiologist recommendation|1|||
164271012|NCT00106691|593360489|FG001|Overall Study|Cardiologist recommendation|0|||
164271013|NCT00106691|593360488|FG000|Overall Study|Pt. moved to another state|1|||
164271014|NCT00106691|593360489|FG001|Overall Study|Pt. moved to another state|0|||
164271015|NCT00106691|593360488|FG000|Overall Study|Taking exclusionary avodart|1|||
164271016|NCT00106691|593360489|FG001|Overall Study|Taking exclusionary avodart|0|||
164271017|NCT00106691|593360488|FG000|Overall Study|Not able to discontinue plavix|0|||
164430843|NCT00477412|593947325|FG003|Overall Study|Death|4|||
164688431|NCT02003222|594883262|FG000|Induction|Never started treatment|0|||
164688432|NCT02003222|594883263|FG001|Induction|Never started treatment|0|||
164688433|NCT02003222|594883264|FG002|Induction|Never started treatment|0|||
164688434|NCT02003222|594883265|FG003|Induction|Never started treatment|0|||
164688435|NCT02003222|594883266|FG004|Induction|Never started treatment|8|||
164688436|NCT02003222|594883262|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
164688437|NCT02003222|594883263|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
164688438|NCT02003222|594883264|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
164688439|NCT02003222|594883265|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
164688440|NCT02003222|594883266|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
164271018|NCT00106691|593360489|FG001|Overall Study|Not able to discontinue plavix|1|||
164271019|NCT00530920|593360490|FG000|Overall Study|Randomized but not treated|0|||
164271020|NCT00530920|593360491|FG001|Overall Study|Randomized but not treated|2|||
164271021|NCT00530920|593360492|FG002|Overall Study|Randomized but not treated|0|||
164271022|NCT00530920|593360490|FG000|Overall Study|Adverse Event|0|||
164271023|NCT00530920|593360491|FG001|Overall Study|Adverse Event|0|||
164271024|NCT00530920|593360492|FG002|Overall Study|Adverse Event|3|||
164271025|NCT00530920|593360490|FG000|Overall Study|Withdrawal by Subject|0|||
164688441|NCT02003222|594883262|FG000|Induction|Adverse Event|0|||
164271026|NCT00530920|593360491|FG001|Overall Study|Withdrawal by Subject|0|||
164271027|NCT00530920|593360492|FG002|Overall Study|Withdrawal by Subject|1|||
164271028|NCT01177969|593360497|FG000|Overall Study|Protocol Violation|2|||
164271029|NCT01177969|593360498|FG001|Overall Study|Protocol Violation|1|||
164271030|NCT01177969|593360497|FG000|Overall Study|Withdrawal by Subject|1|||
164271031|NCT01177969|593360498|FG001|Overall Study|Withdrawal by Subject|2|||
164271032|NCT01353911|593360505|FG000|Overall Study|Lost to Follow-up|2|||
164271033|NCT01353911|593360506|FG001|Overall Study|Lost to Follow-up|6|||
164271034|NCT01353911|593360507|FG002|Overall Study|Lost to Follow-up|4|||
164271035|NCT01353911|593360508|FG003|Overall Study|Lost to Follow-up|0|||
164271036|NCT01353911|593360509|FG004|Overall Study|Lost to Follow-up|4|||
164271037|NCT01353911|593360510|FG005|Overall Study|Lost to Follow-up|4|||
164271038|NCT01353911|593360511|FG006|Overall Study|Lost to Follow-up|3|||
164271039|NCT01353911|593360512|FG007|Overall Study|Lost to Follow-up|6|||
164271040|NCT01353911|593360505|FG000|Overall Study|Withdrawal by Subject|2|||
164271041|NCT01353911|593360506|FG001|Overall Study|Withdrawal by Subject|3|||
164271042|NCT01353911|593360507|FG002|Overall Study|Withdrawal by Subject|4|||
164271043|NCT01353911|593360508|FG003|Overall Study|Withdrawal by Subject|2|||
164271044|NCT01353911|593360509|FG004|Overall Study|Withdrawal by Subject|2|||
164271045|NCT01353911|593360510|FG005|Overall Study|Withdrawal by Subject|3|||
164271046|NCT01353911|593360511|FG006|Overall Study|Withdrawal by Subject|3|||
164271047|NCT01353911|593360512|FG007|Overall Study|Withdrawal by Subject|9|||
164271048|NCT01353911|593360505|FG000|Overall Study|Status Not Recorded|4|||
164271049|NCT01353911|593360506|FG001|Overall Study|Status Not Recorded|0|||
164271050|NCT01353911|593360507|FG002|Overall Study|Status Not Recorded|1|||
164271051|NCT01353911|593360508|FG003|Overall Study|Status Not Recorded|0|||
164271052|NCT01353911|593360509|FG004|Overall Study|Status Not Recorded|0|||
164271053|NCT01353911|593360510|FG005|Overall Study|Status Not Recorded|0|||
164271054|NCT01353911|593360511|FG006|Overall Study|Status Not Recorded|0|||
164271055|NCT01353911|593360512|FG007|Overall Study|Status Not Recorded|0|||
164271056|NCT01504204|593360513|FG000|Overall Study|Lost to Follow-up|1|||
164271057|NCT01504204|593360514|FG001|Overall Study|Lost to Follow-up|1|||
164271058|NCT02049138|593360519|FG000|Overall Study|Adverse Event|46|||
164271059|NCT02049138|593360520|FG001|Overall Study|Adverse Event|25|||
164271060|NCT02049138|593360521|FG002|Overall Study|Adverse Event|1|||
164271061|NCT02049138|593360519|FG000|Overall Study|Withdrawal by Subject|57|||
164271062|NCT02049138|593360520|FG001|Overall Study|Withdrawal by Subject|21|||
164271063|NCT02049138|593360521|FG002|Overall Study|Withdrawal by Subject|5|||
164271064|NCT02049138|593360519|FG000|Overall Study|Lost to Follow-up|18|||
164271065|NCT02049138|593360520|FG001|Overall Study|Lost to Follow-up|5|||
164271066|NCT02049138|593360521|FG002|Overall Study|Lost to Follow-up|1|||
164271067|NCT02049138|593360519|FG000|Overall Study|Lack of Efficacy|10|||
164271068|NCT02049138|593360520|FG001|Overall Study|Lack of Efficacy|26|||
164271069|NCT02049138|593360521|FG002|Overall Study|Lack of Efficacy|1|||
164271070|NCT02049138|593360519|FG000|Overall Study|Non-Compliance|15|||
164271071|NCT02049138|593360520|FG001|Overall Study|Non-Compliance|6|||
164271072|NCT02049138|593360521|FG002|Overall Study|Non-Compliance|0|||
164271073|NCT02049138|593360519|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
164271074|NCT02049138|593360520|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
164271075|NCT02049138|593360521|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
164271076|NCT02049138|593360519|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
164271077|NCT02049138|593360520|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
164271078|NCT02049138|593360521|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
164271079|NCT02049138|593360519|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
164271080|NCT02049138|593360520|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
164271081|NCT02049138|593360521|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
164271082|NCT02049138|593360519|FG000|Overall Study|Other|15|||
164271083|NCT02049138|593360520|FG001|Overall Study|Other|13|||
164271084|NCT02049138|593360521|FG002|Overall Study|Other|0|||
164271085|NCT02049138|593360519|FG000|Overall Study|Missing|0|||
164271086|NCT02049138|593360520|FG001|Overall Study|Missing|1|||
164271087|NCT02049138|593360521|FG002|Overall Study|Missing|0|||
164271088|NCT03995355|593360522|FG000|Overall Study|Adverse Event|1|||
164271089|NCT03995355|593360523|FG001|Overall Study|Adverse Event|0|||
164271090|NCT03995355|593360522|FG000|Overall Study|Withdrawal by Subject|1|||
164271091|NCT03995355|593360523|FG001|Overall Study|Withdrawal by Subject|0|||
164271092|NCT03995355|593360522|FG000|Overall Study|Scheduling Issues|0|||
164271093|NCT03995355|593360523|FG001|Overall Study|Scheduling Issues|1|||
164342333|NCT04457336|593629430|FG004|Period 2: Part A|Protocol Violation|0|||
164342334|NCT04457336|593629431|FG005|Period 2: Part A|Protocol Violation|0|||
164271094|NCT00094107|593360524|FG000|Overall Study|Lack of Efficacy|23|||
164271095|NCT00094107|593360524|FG000|Overall Study|Death|5|||
164271096|NCT00094107|593360524|FG000|Overall Study|Adverse Event|3|||
164271097|NCT00094107|593360524|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
164271098|NCT00587847|593360525|FG000|Overall Study|Lack of Efficacy|5|||
164271099|NCT00587847|593360525|FG000|Overall Study|Adverse Event|2|||
164271100|NCT00343382|593360527|FG000|Overall Study|Adverse Event|2|||
164271101|NCT00343382|593360528|FG001|Overall Study|Adverse Event|10|||
164271102|NCT00343382|593360529|FG002|Overall Study|Adverse Event|7|||
164271103|NCT00343382|593360527|FG000|Overall Study|Withdrawal by Subject|1|||
164271104|NCT00343382|593360528|FG001|Overall Study|Withdrawal by Subject|2|||
164342335|NCT04457336|593629432|FG006|Period 2: Part A|Protocol Violation|0|||
164688442|NCT02003222|594883263|FG001|Induction|Adverse Event|0|||
164688443|NCT02003222|594883264|FG002|Induction|Adverse Event|0|||
164271105|NCT00343382|593360529|FG002|Overall Study|Withdrawal by Subject|6|||
164271106|NCT00343382|593360527|FG000|Overall Study|Other Reason Not Specified|1|||
164271107|NCT00343382|593360528|FG001|Overall Study|Other Reason Not Specified|2|||
164271108|NCT00343382|593360529|FG002|Overall Study|Other Reason Not Specified|4|||
164271109|NCT02966015|593360538|FG000|Inclusion Visit|did not answer questionnaire|8|||
164271110|NCT02966015|593360539|FG001|Inclusion Visit|did not answer questionnaire|3|||
164271111|NCT02241187|593360540|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
164271112|NCT02356887|593360541|FG000|Overall Study|poor compliance|2|||
164271113|NCT00199888|593360542|FG000|Overall Study|Lost to Follow-up|1|||
164271114|NCT05219669|593360547|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
164271115|NCT05219669|593360548|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
164271116|NCT05219669|593360549|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
164271117|NCT05219669|593360550|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
164271118|NCT05219669|593360551|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
164271119|NCT05219669|593360552|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
164271120|NCT02177838|593360554|FG000|Overall Study|Withdrawal by Subject|1|||
164271121|NCT02177838|593360554|FG000|Overall Study|Physician Decision|1|||
164271122|NCT02177838|593360554|FG000|Overall Study|Death|1|||
164271123|NCT02404649|593360556|FG000|Overall Study|Adverse Event|1|||
164582640|NCT03246529|594498043|FG000|Follow-up period at 1 year FU Completion|Lost to Follow-up|1|||
164582641|NCT03246529|594498044|FG001|Follow-up period at 1 year FU Completion|Lost to Follow-up|3|||
164271124|NCT02404649|593360557|FG001|Overall Study|Adverse Event|2|||
164271125|NCT02299076|593360558|FG000|Overall Study|Fraudulent Entries|20|||
164271126|NCT02299076|593360559|FG001|Overall Study|Fraudulent Entries|14|||
164271127|NCT00162266|593360560|FG000|Double-Blind Period|Adverse Event|5|||
164271128|NCT00162266|593360561|FG001|Double-Blind Period|Adverse Event|9|||
164271129|NCT00162266|593360562|FG002|Double-Blind Period|Adverse Event|11|||
164271130|NCT00162266|593360563|FG003|Double-Blind Period|Adverse Event|0|||
164271131|NCT00162266|593360560|FG000|Double-Blind Period|Death|0|||
164271132|NCT00162266|593360561|FG001|Double-Blind Period|Death|1|||
164271133|NCT00162266|593360562|FG002|Double-Blind Period|Death|0|||
164271134|NCT00162266|593360563|FG003|Double-Blind Period|Death|0|||
164271135|NCT00162266|593360560|FG000|Double-Blind Period|Lost to Follow-up|1|||
164271136|NCT00162266|593360561|FG001|Double-Blind Period|Lost to Follow-up|2|||
164271137|NCT00162266|593360562|FG002|Double-Blind Period|Lost to Follow-up|0|||
164271138|NCT00162266|593360563|FG003|Double-Blind Period|Lost to Follow-up|0|||
164271139|NCT00162266|593360560|FG000|Double-Blind Period|Other Reason|1|||
164271140|NCT00162266|593360561|FG001|Double-Blind Period|Other Reason|0|||
164271141|NCT00162266|593360562|FG002|Double-Blind Period|Other Reason|1|||
164271142|NCT00162266|593360563|FG003|Double-Blind Period|Other Reason|0|||
164271143|NCT00162266|593360560|FG000|Double-Blind Period|Lack of Efficacy|13|||
164271144|NCT00162266|593360561|FG001|Double-Blind Period|Lack of Efficacy|17|||
164271145|NCT00162266|593360562|FG002|Double-Blind Period|Lack of Efficacy|30|||
164271146|NCT00162266|593360563|FG003|Double-Blind Period|Lack of Efficacy|0|||
164271147|NCT00162266|593360560|FG000|Double-Blind Period|Withdrawal by Subject|5|||
164271148|NCT00162266|593360561|FG001|Double-Blind Period|Withdrawal by Subject|2|||
164271149|NCT00162266|593360562|FG002|Double-Blind Period|Withdrawal by Subject|6|||
164271150|NCT00162266|593360563|FG003|Double-Blind Period|Withdrawal by Subject|0|||
164271151|NCT00162266|593360560|FG000|Open-Label Period|Death|0|||
164582642|NCT03246529|594498045|FG002|Follow-up period at 1 year FU Completion|Lost to Follow-up|0|||
164582643|NCT03246529|594498043|FG000|Follow-up period at 1 year FU Completion|Withdrawal by Subject|0|||
164582644|NCT03246529|594498044|FG001|Follow-up period at 1 year FU Completion|Withdrawal by Subject|3|||
164582645|NCT03246529|594498045|FG002|Follow-up period at 1 year FU Completion|Withdrawal by Subject|0|||
164582646|NCT03246529|594498043|FG000|Follow-up period at 1 year FU Completion|Death|0|||
164582647|NCT03246529|594498044|FG001|Follow-up period at 1 year FU Completion|Death|0|||
164582648|NCT03246529|594498045|FG002|Follow-up period at 1 year FU Completion|Death|1|||
164582649|NCT01676116|594498046|FG000|Overall Study|Withdrawal criteria|2|||
164582650|NCT01676116|594498047|FG001|Overall Study|Withdrawal criteria|14|||
164582651|NCT01676116|594498046|FG000|Overall Study|Adverse Event|1|||
164582652|NCT01676116|594498047|FG001|Overall Study|Adverse Event|2|||
164582653|NCT01676116|594498046|FG000|Overall Study|Unclassified|4|||
164582654|NCT01676116|594498047|FG001|Overall Study|Unclassified|10|||
164688444|NCT02003222|594883265|FG003|Induction|Adverse Event|0|||
164271152|NCT00162266|593360561|FG001|Open-Label Period|Death|0|||
164271153|NCT00162266|593360562|FG002|Open-Label Period|Death|0|||
164271154|NCT00162266|593360563|FG003|Open-Label Period|Death|7|||
164271155|NCT00162266|593360560|FG000|Open-Label Period|Adverse Event|0|||
164271156|NCT00162266|593360561|FG001|Open-Label Period|Adverse Event|0|||
164271157|NCT00162266|593360562|FG002|Open-Label Period|Adverse Event|0|||
164271158|NCT00162266|593360563|FG003|Open-Label Period|Adverse Event|46|||
164271159|NCT00162266|593360560|FG000|Open-Label Period|Lack of Efficacy|0|||
164271160|NCT00162266|593360561|FG001|Open-Label Period|Lack of Efficacy|0|||
164271161|NCT00162266|593360562|FG002|Open-Label Period|Lack of Efficacy|0|||
164582655|NCT01676116|594498046|FG000|Overall Study|Protocol Violation|9|||
164688445|NCT02003222|594883266|FG004|Induction|Adverse Event|13|||
164271162|NCT00162266|593360563|FG003|Open-Label Period|Lack of Efficacy|26|||
164271163|NCT00162266|593360560|FG000|Open-Label Period|Lost to Follow-up|0|||
164271164|NCT00162266|593360561|FG001|Open-Label Period|Lost to Follow-up|0|||
164271165|NCT00162266|593360562|FG002|Open-Label Period|Lost to Follow-up|0|||
164271166|NCT00162266|593360563|FG003|Open-Label Period|Lost to Follow-up|3|||
164688446|NCT02003222|594883262|FG000|Induction|Alternative therapy|0|||
164688447|NCT02003222|594883263|FG001|Induction|Alternative therapy|0|||
164688448|NCT02003222|594883264|FG002|Induction|Alternative therapy|0|||
164688449|NCT02003222|594883265|FG003|Induction|Alternative therapy|0|||
164271167|NCT00162266|593360560|FG000|Open-Label Period|Withdrawal by Subject|0|||
164271168|NCT00162266|593360561|FG001|Open-Label Period|Withdrawal by Subject|0|||
164271169|NCT00162266|593360562|FG002|Open-Label Period|Withdrawal by Subject|0|||
164271170|NCT00162266|593360563|FG003|Open-Label Period|Withdrawal by Subject|31|||
164271171|NCT00162266|593360560|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
164271172|NCT00162266|593360561|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
164271173|NCT00162266|593360562|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
164271174|NCT00162266|593360563|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
164271175|NCT00162266|593360560|FG000|Open-Label Period|Other Reasons|0|||
164271176|NCT00162266|593360561|FG001|Open-Label Period|Other Reasons|0|||
164271177|NCT00162266|593360562|FG002|Open-Label Period|Other Reasons|0|||
164271178|NCT00162266|593360563|FG003|Open-Label Period|Other Reasons|15|||
164271179|NCT00330668|593360564|FG000|BID Dosing Period|Adverse Event|1|||
164271180|NCT00330668|593360564|FG000|BID Dosing Period|Lost to Follow-up|7|||
164271181|NCT00330668|593360564|FG000|BID Dosing Period|Non-Compliance|5|||
164271182|NCT00330668|593360564|FG000|BID Dosing Period|Withdrawal by Subject|19|||
164271183|NCT00330668|593360564|FG000|BID Dosing Period|Sponsor's decision|1|||
164271184|NCT00330668|593360564|FG000|BID Dosing Period|Other|3|||
164271185|NCT00330668|593360564|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
164688450|NCT02003222|594883266|FG004|Induction|Alternative therapy|12|||
164688451|NCT02003222|594883262|FG000|Induction|Disease progression|0|||
164688452|NCT02003222|594883263|FG001|Induction|Disease progression|0|||
164688453|NCT02003222|594883264|FG002|Induction|Disease progression|0|||
164688454|NCT02003222|594883265|FG003|Induction|Disease progression|0|||
164688455|NCT02003222|594883266|FG004|Induction|Disease progression|22|||
164688456|NCT02003222|594883262|FG000|Induction|Death|0|||
164688457|NCT02003222|594883263|FG001|Induction|Death|0|||
164688458|NCT02003222|594883264|FG002|Induction|Death|0|||
164271186|NCT00330668|593360564|FG000|QD Dosing Period|Other|1|||
164271187|NCT00330668|593360564|FG000|QD Dosing Period|Withdrawal by Subject|1|||
164271188|NCT00330668|593360564|FG000|QD Dosing Period|Lost to Follow-up|2|||
164271189|NCT02273960|593360565|FG000|Short Term Period|Lost to Follow-up|1|||
164271190|NCT02273960|593360566|FG001|Short Term Period|Lost to Follow-up|0|||
164271191|NCT02273960|593360567|FG002|Short Term Period|Lost to Follow-up|0|||
164271192|NCT02273960|593360568|FG003|Short Term Period|Lost to Follow-up|0|||
164271193|NCT02273960|593360565|FG000|Short Term Period|Lack of Efficacy|0|||
164271194|NCT02273960|593360566|FG001|Short Term Period|Lack of Efficacy|0|||
164271195|NCT02273960|593360567|FG002|Short Term Period|Lack of Efficacy|0|||
164271196|NCT02273960|593360568|FG003|Short Term Period|Lack of Efficacy|1|||
164271197|NCT02273960|593360565|FG000|Short Term Period|ST complete, not entering LTE|4|||
164271198|NCT02273960|593360566|FG001|Short Term Period|ST complete, not entering LTE|6|||
164271199|NCT02273960|593360567|FG002|Short Term Period|ST complete, not entering LTE|4|||
164271200|NCT02273960|593360568|FG003|Short Term Period|ST complete, not entering LTE|5|||
164271201|NCT02273960|593360565|FG000|Long Term Extension|Death|0|||
164271202|NCT02273960|593360566|FG001|Long Term Extension|Death|0|||
164271203|NCT02273960|593360567|FG002|Long Term Extension|Death|0|||
164271204|NCT02273960|593360568|FG003|Long Term Extension|Death|1|||
164271205|NCT03442296|593360573|FG000|3 Month Follow-up|Death|3|||
164271206|NCT03442296|593360574|FG001|3 Month Follow-up|Death|1|||
164271207|NCT03442296|593360573|FG000|3 Month Follow-up|Lost to Follow-up|1|||
164271208|NCT03442296|593360574|FG001|3 Month Follow-up|Lost to Follow-up|1|||
164271209|NCT03442296|593360573|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
164271210|NCT03442296|593360574|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
164271211|NCT03442296|593360573|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
164271212|NCT03442296|593360574|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
164271213|NCT03442296|593360573|FG000|12 Month Follow-up|Incomplete measurement|1|||
164271214|NCT03442296|593360574|FG001|12 Month Follow-up|Incomplete measurement|1|||
164271215|NCT00447122|593360575|FG000|Overall Study|worsening medical condition -came off|0|||
164271216|NCT00447122|593360576|FG001|Overall Study|worsening medical condition -came off|1|||
164271217|NCT00447122|593360577|FG002|Overall Study|worsening medical condition -came off|0|||
164271218|NCT00447122|593360578|FG003|Overall Study|worsening medical condition -came off|0|||
164271219|NCT04046250|593360581|FG000|Overall Study|Death|0|||
164271220|NCT04046250|593360582|FG001|Overall Study|Death|1|||
164271221|NCT04046250|593360581|FG000|Overall Study|Withdrawal by Subject|3|||
164688459|NCT02003222|594883265|FG003|Induction|Death|0|||
164688460|NCT02003222|594883266|FG004|Induction|Death|3|||
164688461|NCT02003222|594883262|FG000|Induction|Withdrawal by Subject|0|||
164688462|NCT02003222|594883263|FG001|Induction|Withdrawal by Subject|0|||
164271222|NCT04046250|593360582|FG001|Overall Study|Withdrawal by Subject|3|||
164271223|NCT02806960|593362633|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
164271224|NCT02806960|593362634|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
164271225|NCT02806960|593362635|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
164271226|NCT02806960|593362636|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
164271227|NCT01629953|593362638|FG000|Overall Study|Death|3|||
164271228|NCT01629953|593362639|FG001|Overall Study|Death|1|||
164271229|NCT01629953|593362638|FG000|Overall Study|Lost to Follow-up|10|||
164271230|NCT01629953|593362639|FG001|Overall Study|Lost to Follow-up|14|||
164271231|NCT03221842|593362642|FG000|Period 1 (Open-label)|Adverse Event|4|||
164271232|NCT03221842|593362643|FG001|Period 1 (Open-label)|Adverse Event|0|||
164271233|NCT03221842|593362642|FG000|Period 1 (Open-label)|Physician Decision|2|||
164271234|NCT03221842|593362643|FG001|Period 1 (Open-label)|Physician Decision|0|||
164271235|NCT03221842|593362642|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
164271236|NCT03221842|593362643|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
164271237|NCT03221842|593362642|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
164271238|NCT03221842|593362643|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
164271239|NCT03221842|593362642|FG000|Period 1 (Open-label)|Other|2|||
164271240|NCT03221842|593362643|FG001|Period 1 (Open-label)|Other|0|||
164271241|NCT03221842|593362642|FG000|Period 2 (Randomized, Blinded)|Death|0|||
164271242|NCT03221842|593362643|FG001|Period 2 (Randomized, Blinded)|Death|1|||
164271243|NCT03221842|593362642|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
164271244|NCT03221842|593362643|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
164271245|NCT02504580|593362644|FG000|Overall Study|Other|1|||
164271246|NCT02504580|593362645|FG001|Overall Study|Other|0|||
164271247|NCT02504580|593362646|FG002|Overall Study|Other|0|||
164271248|NCT02504580|593362647|FG003|Overall Study|Other|2|||
164271249|NCT02504580|593362648|FG004|Overall Study|Other|1|||
164271250|NCT02504580|593362649|FG005|Overall Study|Other|1|||
164271251|NCT02504580|593362650|FG006|Overall Study|Other|1|||
164271252|NCT02504580|593362651|FG007|Overall Study|Other|2|||
164271253|NCT02504580|593362652|FG008|Overall Study|Other|0|||
164271254|NCT02504580|593362653|FG009|Overall Study|Other|0|||
164271255|NCT02504580|593362654|FG010|Overall Study|Other|0|||
164271256|NCT02504580|593362655|FG011|Overall Study|Other|2|||
164271257|NCT02504580|593362644|FG000|Overall Study|Subject refusal to continue|0|||
164271258|NCT02504580|593362645|FG001|Overall Study|Subject refusal to continue|1|||
164271259|NCT02504580|593362646|FG002|Overall Study|Subject refusal to continue|0|||
164271260|NCT02504580|593362647|FG003|Overall Study|Subject refusal to continue|0|||
164271261|NCT02504580|593362648|FG004|Overall Study|Subject refusal to continue|0|||
164271262|NCT02504580|593362649|FG005|Overall Study|Subject refusal to continue|0|||
164271263|NCT02504580|593362650|FG006|Overall Study|Subject refusal to continue|0|||
164271264|NCT02504580|593362651|FG007|Overall Study|Subject refusal to continue|0|||
164271265|NCT02504580|593362652|FG008|Overall Study|Subject refusal to continue|0|||
164271266|NCT02504580|593362653|FG009|Overall Study|Subject refusal to continue|0|||
164271267|NCT02504580|593362654|FG010|Overall Study|Subject refusal to continue|0|||
164271268|NCT02504580|593362655|FG011|Overall Study|Subject refusal to continue|0|||
164271269|NCT00007020|593362658|FG000|Overall Study|Death|16|||
164271270|NCT00007020|593362658|FG000|Overall Study|Lost to Follow-up|13|||
164271271|NCT00007020|593362658|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
164271272|NCT00007020|593362658|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
164271273|NCT00007020|593362658|FG000|Overall Study|Pt cared for by outside physician|4|||
164271274|NCT00007020|593362658|FG000|Overall Study|No evidence of treatment|6|||
164271275|NCT01100528|593362664|FG000|Overall Study|Death|1|||
164271276|NCT01100528|593362664|FG000|Overall Study|Withdrawal by Subject|2|||
164271277|NCT03242252|593362665|FG000|Overall Study|At the Participant's own Request|18|||
164271278|NCT03242252|593362666|FG001|Overall Study|At the Participant's own Request|10|||
164271279|NCT03242252|593362667|FG002|Overall Study|At the Participant's own Request|15|||
164688463|NCT02003222|594883264|FG002|Induction|Withdrawal by Subject|0|||
164688464|NCT02003222|594883265|FG003|Induction|Withdrawal by Subject|0|||
164688465|NCT02003222|594883266|FG004|Induction|Withdrawal by Subject|8|||
164688466|NCT02003222|594883262|FG000|Induction|Other reasons|0|||
164688467|NCT02003222|594883263|FG001|Induction|Other reasons|0|||
164688468|NCT02003222|594883264|FG002|Induction|Other reasons|0|||
164271280|NCT03242252|593362665|FG000|Overall Study|Adverse Event|8|||
164271281|NCT03242252|593362666|FG001|Overall Study|Adverse Event|6|||
164271282|NCT03242252|593362667|FG002|Overall Study|Adverse Event|9|||
164271283|NCT03242252|593362665|FG000|Overall Study|Poor Compliance to Protocol|0|||
164271284|NCT03242252|593362666|FG001|Overall Study|Poor Compliance to Protocol|2|||
164271285|NCT03242252|593362667|FG002|Overall Study|Poor Compliance to Protocol|3|||
164271286|NCT03242252|593362665|FG000|Overall Study|Study Terminated by Sponsor|1|||
164271287|NCT03242252|593362666|FG001|Overall Study|Study Terminated by Sponsor|0|||
164271288|NCT03242252|593362667|FG002|Overall Study|Study Terminated by Sponsor|0|||
164271289|NCT03242252|593362665|FG000|Overall Study|Reason not Specified|4|||
164271290|NCT03242252|593362666|FG001|Overall Study|Reason not Specified|4|||
164271291|NCT03242252|593362667|FG002|Overall Study|Reason not Specified|1|||
164688469|NCT02003222|594883265|FG003|Induction|Other reasons|0|||
164688470|NCT02003222|594883266|FG004|Induction|Other reasons|22|||
164582656|NCT01676116|594498047|FG001|Overall Study|Protocol Violation|3|||
164582657|NCT00793585|594498048|FG000|Overall Study|Adverse Event|1|||
164271292|NCT03242252|593362665|FG000|Overall Study|Lost to Follow-up|5|||
164271293|NCT03242252|593362666|FG001|Overall Study|Lost to Follow-up|1|||
164271294|NCT03242252|593362667|FG002|Overall Study|Lost to Follow-up|4|||
164271295|NCT01659255|593362668|FG000|Overall Study|Adverse Event|0|||
164271296|NCT01659255|593362669|FG001|Overall Study|Adverse Event|0|||
164271297|NCT01659255|593362670|FG002|Overall Study|Adverse Event|0|||
164271298|NCT01659255|593362671|FG003|Overall Study|Adverse Event|0|||
164271299|NCT01659255|593362672|FG004|Overall Study|Adverse Event|0|||
164271300|NCT01659255|593362673|FG005|Overall Study|Adverse Event|1|||
164271301|NCT01659255|593362674|FG006|Overall Study|Adverse Event|1|||
164271302|NCT01659255|593362675|FG007|Overall Study|Adverse Event|0|||
164271303|NCT01659255|593362676|FG008|Overall Study|Adverse Event|0|||
164271304|NCT01659255|593362677|FG009|Overall Study|Adverse Event|1|||
164271305|NCT01659255|593362678|FG010|Overall Study|Adverse Event|0|||
164271306|NCT01659255|593362679|FG011|Overall Study|Adverse Event|1|||
164271307|NCT01659255|593362680|FG012|Overall Study|Adverse Event|0|||
164271308|NCT01659255|593362681|FG013|Overall Study|Adverse Event|2|||
164271309|NCT01659255|593362682|FG014|Overall Study|Adverse Event|0|||
164271310|NCT01659255|593362683|FG015|Overall Study|Adverse Event|1|||
164271311|NCT01659255|593362684|FG016|Overall Study|Adverse Event|0|||
164271312|NCT01659255|593362668|FG000|Overall Study|Death|0|||
164271313|NCT01659255|593362669|FG001|Overall Study|Death|1|||
164271314|NCT01659255|593362670|FG002|Overall Study|Death|0|||
164271315|NCT01659255|593362671|FG003|Overall Study|Death|0|||
164271316|NCT01659255|593362672|FG004|Overall Study|Death|0|||
164271317|NCT01659255|593362673|FG005|Overall Study|Death|0|||
164271318|NCT01659255|593362674|FG006|Overall Study|Death|0|||
164271319|NCT01659255|593362675|FG007|Overall Study|Death|1|||
164271320|NCT01659255|593362676|FG008|Overall Study|Death|1|||
164271321|NCT01659255|593362677|FG009|Overall Study|Death|0|||
164271322|NCT01659255|593362678|FG010|Overall Study|Death|0|||
164271323|NCT01659255|593362679|FG011|Overall Study|Death|0|||
164271324|NCT01659255|593362680|FG012|Overall Study|Death|1|||
164271325|NCT01659255|593362681|FG013|Overall Study|Death|1|||
164271326|NCT01659255|593362682|FG014|Overall Study|Death|2|||
164271327|NCT01659255|593362683|FG015|Overall Study|Death|1|||
164271328|NCT01659255|593362684|FG016|Overall Study|Death|0|||
164271329|NCT01659255|593362668|FG000|Overall Study|Progressive Disease|2|||
164271330|NCT01659255|593362669|FG001|Overall Study|Progressive Disease|0|||
164271331|NCT01659255|593362670|FG002|Overall Study|Progressive Disease|0|||
164271332|NCT01659255|593362671|FG003|Overall Study|Progressive Disease|0|||
164271333|NCT01659255|593362672|FG004|Overall Study|Progressive Disease|0|||
164271334|NCT01659255|593362673|FG005|Overall Study|Progressive Disease|0|||
164271335|NCT01659255|593362674|FG006|Overall Study|Progressive Disease|0|||
164271336|NCT01659255|593362675|FG007|Overall Study|Progressive Disease|1|||
164271337|NCT01659255|593362676|FG008|Overall Study|Progressive Disease|0|||
164271338|NCT01659255|593362677|FG009|Overall Study|Progressive Disease|2|||
164271339|NCT01659255|593362678|FG010|Overall Study|Progressive Disease|2|||
164271340|NCT01659255|593362679|FG011|Overall Study|Progressive Disease|3|||
164271341|NCT01659255|593362680|FG012|Overall Study|Progressive Disease|5|||
164271342|NCT01659255|593362681|FG013|Overall Study|Progressive Disease|13|||
164582658|NCT00793585|594498049|FG001|Overall Study|Adverse Event|1|||
164271343|NCT01659255|593362682|FG014|Overall Study|Progressive Disease|6|||
164271344|NCT01659255|593362683|FG015|Overall Study|Progressive Disease|2|||
164582659|NCT00793585|594498048|FG000|Overall Study|Protocol Violation|1|||
164582660|NCT00793585|594498049|FG001|Overall Study|Protocol Violation|2|||
164582661|NCT01821677|594498050|FG000|Overall Study|Adverse Event|4|||
164582662|NCT01821677|594498051|FG001|Overall Study|Adverse Event|6|||
164582663|NCT01821677|594498052|FG002|Overall Study|Adverse Event|5|||
164582664|NCT01821677|594498050|FG000|Overall Study|Physician Decision|1|||
164582665|NCT01821677|594498051|FG001|Overall Study|Physician Decision|4|||
164582666|NCT01821677|594498052|FG002|Overall Study|Physician Decision|1|||
164582667|NCT01821677|594498050|FG000|Overall Study|Non-compliance|0|||
164271345|NCT01659255|593362684|FG016|Overall Study|Progressive Disease|3|||
164271346|NCT01659255|593362668|FG000|Overall Study|Withdrew Consent|0|||
164271347|NCT01659255|593362669|FG001|Overall Study|Withdrew Consent|0|||
164271348|NCT01659255|593362670|FG002|Overall Study|Withdrew Consent|0|||
164271349|NCT01659255|593362671|FG003|Overall Study|Withdrew Consent|0|||
164271350|NCT01659255|593362672|FG004|Overall Study|Withdrew Consent|0|||
164271351|NCT01659255|593362673|FG005|Overall Study|Withdrew Consent|0|||
164271352|NCT01659255|593362674|FG006|Overall Study|Withdrew Consent|0|||
164271353|NCT01659255|593362675|FG007|Overall Study|Withdrew Consent|0|||
164582668|NCT01821677|594498051|FG001|Overall Study|Non-compliance|1|||
164582669|NCT01821677|594498052|FG002|Overall Study|Non-compliance|2|||
164271354|NCT01659255|593362676|FG008|Overall Study|Withdrew Consent|0|||
164271355|NCT01659255|593362677|FG009|Overall Study|Withdrew Consent|0|||
164271356|NCT01659255|593362678|FG010|Overall Study|Withdrew Consent|1|||
164271357|NCT01659255|593362679|FG011|Overall Study|Withdrew Consent|0|||
164271358|NCT01659255|593362680|FG012|Overall Study|Withdrew Consent|0|||
164271359|NCT01659255|593362681|FG013|Overall Study|Withdrew Consent|1|||
164582670|NCT01821677|594498050|FG000|Overall Study|Lost to Follow-up|2|||
164271360|NCT01659255|593362682|FG014|Overall Study|Withdrew Consent|0|||
164271361|NCT01659255|593362683|FG015|Overall Study|Withdrew Consent|0|||
164271362|NCT01659255|593362684|FG016|Overall Study|Withdrew Consent|0|||
164271363|NCT01659255|593362668|FG000|Overall Study|Investigator Decision|0|||
164271364|NCT01659255|593362669|FG001|Overall Study|Investigator Decision|0|||
164271365|NCT01659255|593362670|FG002|Overall Study|Investigator Decision|0|||
164271366|NCT01659255|593362671|FG003|Overall Study|Investigator Decision|0|||
164271367|NCT01659255|593362672|FG004|Overall Study|Investigator Decision|0|||
164271368|NCT01659255|593362673|FG005|Overall Study|Investigator Decision|0|||
164271369|NCT01659255|593362674|FG006|Overall Study|Investigator Decision|0|||
164271370|NCT01659255|593362675|FG007|Overall Study|Investigator Decision|0|||
164271371|NCT01659255|593362676|FG008|Overall Study|Investigator Decision|0|||
164271372|NCT01659255|593362677|FG009|Overall Study|Investigator Decision|0|||
164271373|NCT01659255|593362678|FG010|Overall Study|Investigator Decision|0|||
164271374|NCT01659255|593362679|FG011|Overall Study|Investigator Decision|0|||
164271375|NCT01659255|593362680|FG012|Overall Study|Investigator Decision|1|||
164271376|NCT01659255|593362681|FG013|Overall Study|Investigator Decision|1|||
164271377|NCT01659255|593362682|FG014|Overall Study|Investigator Decision|0|||
164271378|NCT01659255|593362683|FG015|Overall Study|Investigator Decision|0|||
164271379|NCT01659255|593362684|FG016|Overall Study|Investigator Decision|0|||
164271380|NCT01659255|593362668|FG000|Overall Study|Sponsor's Decision|0|||
164271381|NCT01659255|593362669|FG001|Overall Study|Sponsor's Decision|0|||
164271382|NCT01659255|593362670|FG002|Overall Study|Sponsor's Decision|0|||
164271383|NCT01659255|593362671|FG003|Overall Study|Sponsor's Decision|0|||
164271384|NCT01659255|593362672|FG004|Overall Study|Sponsor's Decision|0|||
164271385|NCT01659255|593362673|FG005|Overall Study|Sponsor's Decision|0|||
164271386|NCT01659255|593362674|FG006|Overall Study|Sponsor's Decision|1|||
164271387|NCT01659255|593362675|FG007|Overall Study|Sponsor's Decision|0|||
164271388|NCT01659255|593362676|FG008|Overall Study|Sponsor's Decision|0|||
164271389|NCT01659255|593362677|FG009|Overall Study|Sponsor's Decision|0|||
164271390|NCT01659255|593362678|FG010|Overall Study|Sponsor's Decision|0|||
164271391|NCT01659255|593362679|FG011|Overall Study|Sponsor's Decision|0|||
164271392|NCT01659255|593362680|FG012|Overall Study|Sponsor's Decision|0|||
164271393|NCT01659255|593362681|FG013|Overall Study|Sponsor's Decision|0|||
164271394|NCT01659255|593362682|FG014|Overall Study|Sponsor's Decision|0|||
164271395|NCT01659255|593362683|FG015|Overall Study|Sponsor's Decision|0|||
164271396|NCT01659255|593362684|FG016|Overall Study|Sponsor's Decision|0|||
164271397|NCT01659255|593362668|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271398|NCT01659255|593362669|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271399|NCT01659255|593362670|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271400|NCT01659255|593362671|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271401|NCT01659255|593362672|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164430844|NCT00477412|593947322|FG000|Overall Study|Lost to Follow-up|0|||
164430845|NCT00477412|593947323|FG001|Overall Study|Lost to Follow-up|0|||
164430846|NCT00477412|593947324|FG002|Overall Study|Lost to Follow-up|0|||
164430847|NCT00477412|593947325|FG003|Overall Study|Lost to Follow-up|1|||
164430848|NCT00477412|593947322|FG000|Overall Study|Withdrawal by Subject|0|||
164430849|NCT00477412|593947323|FG001|Overall Study|Withdrawal by Subject|0|||
164430850|NCT00477412|593947324|FG002|Overall Study|Withdrawal by Subject|0|||
164582671|NCT01821677|594498051|FG001|Overall Study|Lost to Follow-up|1|||
164582672|NCT01821677|594498052|FG002|Overall Study|Lost to Follow-up|3|||
164271402|NCT01659255|593362673|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271403|NCT01659255|593362674|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271404|NCT01659255|593362675|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271405|NCT01659255|593362676|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271406|NCT01659255|593362677|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271407|NCT01659255|593362678|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271408|NCT01659255|593362679|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164582673|NCT01821677|594498050|FG000|Overall Study|Protocol Violation|0|||
164582674|NCT01821677|594498051|FG001|Overall Study|Protocol Violation|0|||
164582675|NCT01821677|594498052|FG002|Overall Study|Protocol Violation|2|||
164582676|NCT01821677|594498050|FG000|Overall Study|Withdrawal by Subject|7|||
164271409|NCT01659255|593362680|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271410|NCT01659255|593362681|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164582677|NCT01821677|594498051|FG001|Overall Study|Withdrawal by Subject|3|||
164271411|NCT01659255|593362682|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271412|NCT01659255|593362683|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
164271413|NCT01659255|593362684|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271414|NCT01659255|593362668|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
164271415|NCT01659255|593362669|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
164271416|NCT01659255|593362670|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
164430851|NCT00477412|593947325|FG003|Overall Study|Withdrawal by Subject|2|||
164582678|NCT01821677|594498052|FG002|Overall Study|Withdrawal by Subject|2|||
164271417|NCT01659255|593362671|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
164271418|NCT01659255|593362672|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
164271419|NCT01659255|593362673|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
164271420|NCT01659255|593362674|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
164271421|NCT01659255|593362675|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
164271422|NCT01659255|593362676|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
164271423|NCT01659255|593362677|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
164271424|NCT01659255|593362678|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
164271425|NCT01659255|593362679|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
164271426|NCT01659255|593362680|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
164271427|NCT01659255|593362681|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
164271428|NCT01659255|593362682|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
164271429|NCT01659255|593362683|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
164271430|NCT01659255|593362684|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
164271431|NCT01116427|593362685|FG000|Core Phase|Adverse Event|0|||
164271432|NCT01116427|593362686|FG001|Core Phase|Adverse Event|1|||
164271433|NCT01116427|593362685|FG000|Core Phase|Lost to Follow-up|1|||
164271434|NCT01116427|593362686|FG001|Core Phase|Lost to Follow-up|0|||
164271435|NCT01116427|593362685|FG000|Core Phase|Withdrawal by Subject|3|||
164271436|NCT01116427|593362686|FG001|Core Phase|Withdrawal by Subject|0|||
164271437|NCT01116427|593362685|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
164271438|NCT01116427|593362686|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
164271439|NCT01116427|593362685|FG000|Extension Phase|Adverse Event|1|||
164271440|NCT01116427|593362686|FG001|Extension Phase|Adverse Event|1|||
164271441|NCT01116427|593362685|FG000|Extension Phase|Lost to Follow-up|2|||
164271442|NCT01116427|593362686|FG001|Extension Phase|Lost to Follow-up|0|||
164271443|NCT01116427|593362685|FG000|Extension Phase|Withdrawal by Subject|5|||
164271444|NCT01116427|593362686|FG001|Extension Phase|Withdrawal by Subject|1|||
164271445|NCT01116427|593362685|FG000|Extension Phase|Not using appropriate birth control|1|||
164271446|NCT01116427|593362686|FG001|Extension Phase|Not using appropriate birth control|0|||
164271447|NCT03316950|593362689|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
164271448|NCT03316950|593362690|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
164271449|NCT03316950|593362691|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
164271450|NCT03316950|593362692|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
164271451|NCT03316950|593362689|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
164271452|NCT03316950|593362690|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
164271453|NCT03316950|593362691|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
164271454|NCT03316950|593362692|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
164271455|NCT03316950|593362689|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
164271456|NCT03316950|593362690|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
164271457|NCT03316950|593362691|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
164271458|NCT03316950|593362692|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
164271459|NCT04094584|593362693|FG000|Overall Study|No interest in study|88|||
164271460|NCT04094584|593362693|FG000|Overall Study|Unwilling to undergo screening tests|36|||
164271461|NCT04094584|593362693|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
164271462|NCT04094584|593362693|FG000|Overall Study|Opioid use|7|||
164271463|NCT04094584|593362693|FG000|Overall Study|Need for major surgery in study period|4|||
164271464|NCT04094584|593362693|FG000|Overall Study|eligible but declined enrollment|4|||
164271465|NCT04094584|593362693|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
164271466|NCT04094584|593362693|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
164271467|NCT04094584|593362693|FG000|Overall Study|Lost to Follow-up|3|||
164271468|NCT04094584|593362693|FG000|Overall Study|Withdrawal by Subject|2|||
164271469|NCT01754194|593362694|FG000|Overall Study|Lost to Follow-up|39|||
164271470|NCT01754194|593362695|FG001|Overall Study|Lost to Follow-up|14|||
164271471|NCT01754194|593362694|FG000|Overall Study|Withdrawal by Subject|4|||
164271472|NCT01754194|593362695|FG001|Overall Study|Withdrawal by Subject|5|||
164271473|NCT01754194|593362694|FG000|Overall Study|Other|9|||
164271474|NCT01754194|593362695|FG001|Overall Study|Other|8|||
164271475|NCT00907296|593362696|FG000|Overall Study|Ineligibility Determined|1|||
164582679|NCT01821677|594498050|FG000|Overall Study|Other|9|||
164582680|NCT01821677|594498051|FG001|Overall Study|Other|0|||
164582681|NCT01821677|594498052|FG002|Overall Study|Other|0|||
164582682|NCT01769404|594498053|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
164271476|NCT00907296|593362697|FG001|Overall Study|Ineligibility Determined|0|||
164271477|NCT00907296|593362698|FG002|Overall Study|Ineligibility Determined|0|||
164271478|NCT00907296|593362699|FG003|Overall Study|Ineligibility Determined|1|||
164271479|NCT00907296|593362700|FG004|Overall Study|Ineligibility Determined|0|||
164271480|NCT00907296|593362701|FG005|Overall Study|Ineligibility Determined|0|||
164430852|NCT00477412|593947322|FG000|Overall Study|Second Malignancy|0|||
164582683|NCT01769404|594498054|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
164582684|NCT01769404|594498053|FG000|Treatment Period 1|Withdrawal by Subject|3|||
164271481|NCT00907296|593362702|FG006|Overall Study|Ineligibility Determined|0|||
164271482|NCT00907296|593362703|FG007|Overall Study|Ineligibility Determined|1|||
164271483|NCT00907296|593362704|FG008|Overall Study|Ineligibility Determined|0|||
164271484|NCT00907296|593362705|FG009|Overall Study|Ineligibility Determined|0|||
164271485|NCT00907296|593362696|FG000|Overall Study|Protocol Deviation|0|||
164271486|NCT00907296|593362697|FG001|Overall Study|Protocol Deviation|1|||
164271487|NCT00907296|593362698|FG002|Overall Study|Protocol Deviation|0|||
164271488|NCT00907296|593362699|FG003|Overall Study|Protocol Deviation|0|||
164271489|NCT00907296|593362700|FG004|Overall Study|Protocol Deviation|0|||
164271490|NCT00907296|593362701|FG005|Overall Study|Protocol Deviation|0|||
164271491|NCT00907296|593362702|FG006|Overall Study|Protocol Deviation|0|||
164271492|NCT00907296|593362703|FG007|Overall Study|Protocol Deviation|0|||
164271493|NCT00907296|593362704|FG008|Overall Study|Protocol Deviation|0|||
164271494|NCT00907296|593362705|FG009|Overall Study|Protocol Deviation|0|||
164271495|NCT00907296|593362696|FG000|Overall Study|Noncompliance|1|||
164271496|NCT00907296|593362697|FG001|Overall Study|Noncompliance|1|||
164271497|NCT00907296|593362698|FG002|Overall Study|Noncompliance|1|||
164271498|NCT00907296|593362699|FG003|Overall Study|Noncompliance|0|||
164271499|NCT00907296|593362700|FG004|Overall Study|Noncompliance|0|||
164271500|NCT00907296|593362701|FG005|Overall Study|Noncompliance|1|||
164271501|NCT00907296|593362702|FG006|Overall Study|Noncompliance|0|||
164271502|NCT00907296|593362703|FG007|Overall Study|Noncompliance|2|||
164271503|NCT00907296|593362704|FG008|Overall Study|Noncompliance|0|||
164271504|NCT00907296|593362705|FG009|Overall Study|Noncompliance|0|||
164271505|NCT00907296|593362696|FG000|Overall Study|Adverse Event|2|||
164271506|NCT00907296|593362697|FG001|Overall Study|Adverse Event|0|||
164271507|NCT00907296|593362698|FG002|Overall Study|Adverse Event|0|||
164271508|NCT00907296|593362699|FG003|Overall Study|Adverse Event|0|||
164271509|NCT00907296|593362700|FG004|Overall Study|Adverse Event|0|||
164342336|NCT04457336|593629433|FG007|Period 2: Part A|Protocol Violation|0|||
164342337|NCT04457336|593629426|FG000|Period 2: Part A|Lost to Follow-up|0|||
164342338|NCT04457336|593629427|FG001|Period 2: Part A|Lost to Follow-up|1|||
164342339|NCT04457336|593629428|FG002|Period 2: Part A|Lost to Follow-up|0|||
164342340|NCT04457336|593629429|FG003|Period 2: Part A|Lost to Follow-up|0|||
164342341|NCT04457336|593629430|FG004|Period 2: Part A|Lost to Follow-up|0|||
164342342|NCT04457336|593629431|FG005|Period 2: Part A|Lost to Follow-up|0|||
164342343|NCT04457336|593629432|FG006|Period 2: Part A|Lost to Follow-up|0|||
164342344|NCT04457336|593629433|FG007|Period 2: Part A|Lost to Follow-up|0|||
164342345|NCT04457336|593629426|FG000|Period 2: Part A|Other|0|||
164342346|NCT04457336|593629427|FG001|Period 2: Part A|Other|1|||
164342347|NCT04457336|593629428|FG002|Period 2: Part A|Other|0|||
164342348|NCT04457336|593629429|FG003|Period 2: Part A|Other|0|||
164342349|NCT04457336|593629430|FG004|Period 2: Part A|Other|0|||
164342350|NCT04457336|593629431|FG005|Period 2: Part A|Other|0|||
164342351|NCT04457336|593629432|FG006|Period 2: Part A|Other|0|||
164342352|NCT04457336|593629433|FG007|Period 2: Part A|Other|0|||
164342353|NCT04457336|593629426|FG000|Period 2: Part A|Physician Decision|0|||
164342354|NCT04457336|593629427|FG001|Period 2: Part A|Physician Decision|0|||
164342355|NCT04457336|593629428|FG002|Period 2: Part A|Physician Decision|0|||
164342356|NCT04457336|593629429|FG003|Period 2: Part A|Physician Decision|1|||
164342357|NCT04457336|593629430|FG004|Period 2: Part A|Physician Decision|0|||
164342358|NCT04457336|593629431|FG005|Period 2: Part A|Physician Decision|0|||
164342359|NCT04457336|593629432|FG006|Period 2: Part A|Physician Decision|0|||
164342360|NCT04457336|593629433|FG007|Period 2: Part A|Physician Decision|0|||
164342361|NCT04457336|593629426|FG000|Period 3: Part B|Study Terminated|0|||
164342362|NCT04457336|593629427|FG001|Period 3: Part B|Study Terminated|0|||
164342363|NCT04457336|593629428|FG002|Period 3: Part B|Study Terminated|0|||
164342364|NCT04457336|593629429|FG003|Period 3: Part B|Study Terminated|0|||
164271510|NCT00907296|593362701|FG005|Overall Study|Adverse Event|0|||
164271511|NCT00907296|593362702|FG006|Overall Study|Adverse Event|1|||
164271512|NCT00907296|593362703|FG007|Overall Study|Adverse Event|0|||
164342365|NCT04457336|593629430|FG004|Period 3: Part B|Study Terminated|1|||
164342366|NCT04457336|593629431|FG005|Period 3: Part B|Study Terminated|10|||
164582685|NCT01769404|594498054|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164342367|NCT04457336|593629432|FG006|Period 3: Part B|Study Terminated|13|||
164342368|NCT04457336|593629433|FG007|Period 3: Part B|Study Terminated|0|||
164582686|NCT01769404|594498053|FG000|Treatment Period 1|Sponsor decision|1|||
164582687|NCT01769404|594498054|FG001|Treatment Period 1|Sponsor decision|0|||
164582688|NCT01769404|594498053|FG000|Treatment Period 2|Sponsor decision|7|||
164582689|NCT01769404|594498054|FG001|Treatment Period 2|Sponsor decision|0|||
164582690|NCT00538733|594498055|FG000|Overall Study|Adverse Event|8|||
164271513|NCT00907296|593362704|FG008|Overall Study|Adverse Event|0|||
164271514|NCT00907296|593362705|FG009|Overall Study|Adverse Event|1|||
164271515|NCT00907296|593362696|FG000|Overall Study|Withdrawal by Subject|7|||
164271516|NCT00907296|593362697|FG001|Overall Study|Withdrawal by Subject|2|||
164271517|NCT00907296|593362698|FG002|Overall Study|Withdrawal by Subject|1|||
164342369|NCT04457336|593629426|FG000|Period 3: Part B|Withdrawal by Subject|0|||
164342370|NCT04457336|593629427|FG001|Period 3: Part B|Withdrawal by Subject|0|||
164342371|NCT04457336|593629428|FG002|Period 3: Part B|Withdrawal by Subject|0|||
164271518|NCT00907296|593362699|FG003|Overall Study|Withdrawal by Subject|1|||
164271519|NCT00907296|593362700|FG004|Overall Study|Withdrawal by Subject|1|||
164271520|NCT00907296|593362701|FG005|Overall Study|Withdrawal by Subject|5|||
164271521|NCT00907296|593362702|FG006|Overall Study|Withdrawal by Subject|3|||
164271522|NCT00907296|593362703|FG007|Overall Study|Withdrawal by Subject|2|||
164271523|NCT00907296|593362704|FG008|Overall Study|Withdrawal by Subject|4|||
164271524|NCT00907296|593362705|FG009|Overall Study|Withdrawal by Subject|2|||
164271525|NCT00907296|593362696|FG000|Overall Study|Lost to Follow-up|9|||
164271526|NCT00907296|593362697|FG001|Overall Study|Lost to Follow-up|1|||
164271527|NCT00907296|593362698|FG002|Overall Study|Lost to Follow-up|0|||
164430853|NCT00477412|593947323|FG001|Overall Study|Second Malignancy|0|||
164430854|NCT00477412|593947324|FG002|Overall Study|Second Malignancy|0|||
164430855|NCT00477412|593947325|FG003|Overall Study|Second Malignancy|1|||
164430856|NCT00477412|593947322|FG000|Overall Study|Adverse Event|1|||
164430857|NCT00477412|593947323|FG001|Overall Study|Adverse Event|0|||
164430858|NCT00477412|593947324|FG002|Overall Study|Adverse Event|1|||
164430859|NCT00477412|593947325|FG003|Overall Study|Adverse Event|0|||
164430860|NCT00299702|593947328|FG000|Overall Study|Death|1|||
164430861|NCT00299702|593947329|FG001|Overall Study|Death|0|||
164430862|NCT00299702|593947328|FG000|Overall Study|Adverse Event|0|||
164430863|NCT00299702|593947329|FG001|Overall Study|Adverse Event|4|||
164430864|NCT00299702|593947328|FG000|Overall Study|Lost to Follow-up|18|||
164430865|NCT00299702|593947329|FG001|Overall Study|Lost to Follow-up|10|||
164430866|NCT00299702|593947328|FG000|Overall Study|Withdrawal by Subject|25|||
164430867|NCT00299702|593947329|FG001|Overall Study|Withdrawal by Subject|23|||
164430868|NCT00299702|593947328|FG000|Overall Study|Pregnancy|0|||
164430869|NCT00299702|593947329|FG001|Overall Study|Pregnancy|1|||
164430870|NCT00299702|593947328|FG000|Overall Study|Insufficient Response|4|||
164430871|NCT00299702|593947329|FG001|Overall Study|Insufficient Response|3|||
164430872|NCT00299702|593947328|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
164430873|NCT00299702|593947329|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
164430874|NCT01560949|593947330|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
164430875|NCT01560949|593947330|FG000|Surgery Phase|Physician Decision|3|||
164430876|NCT02931396|593947333|FG000|Overall Study|Lost to Follow-up|3|||
164430877|NCT02931396|593947334|FG001|Overall Study|Lost to Follow-up|0|||
164430878|NCT02931396|593947333|FG000|Overall Study|Withdrawal by Subject|2|||
164430879|NCT02931396|593947334|FG001|Overall Study|Withdrawal by Subject|0|||
164430880|NCT00670540|593947337|FG000|Overall Study|ineligible|17|||
164271528|NCT00907296|593362699|FG003|Overall Study|Lost to Follow-up|2|||
164271529|NCT00907296|593362700|FG004|Overall Study|Lost to Follow-up|0|||
164271530|NCT00907296|593362701|FG005|Overall Study|Lost to Follow-up|3|||
164271531|NCT00907296|593362702|FG006|Overall Study|Lost to Follow-up|2|||
164271532|NCT00907296|593362703|FG007|Overall Study|Lost to Follow-up|2|||
164271533|NCT00907296|593362704|FG008|Overall Study|Lost to Follow-up|0|||
164271534|NCT00907296|593362705|FG009|Overall Study|Lost to Follow-up|4|||
164271535|NCT00791557|593362706|FG000|Overall Study|Adverse Event|1|||
164430881|NCT00670540|593947337|FG000|Overall Study|not living in France|348|||
164430882|NCT00670540|593947337|FG000|Overall Study|refused to participate|189|||
164430883|NCT00670540|593947337|FG000|Overall Study|controls randomised for no follow up|2770|||
164430884|NCT00670540|593947337|FG000|Overall Study|missing information inclusion criteria|1|||
164430885|NCT00681811|593947338|FG000|Overall Study|Adverse Event|1|||
164430886|NCT00681811|593947339|FG001|Overall Study|Adverse Event|1|||
164582691|NCT00538733|594498055|FG000|Overall Study|Death|1|||
164582692|NCT00538733|594498055|FG000|Overall Study|declined to participate|2|||
164582693|NCT00538733|594498055|FG000|Overall Study|still on therapy|1|||
164582694|NCT02452970|594499577|FG000|Overall Study|Adverse Event|1|||
164582695|NCT02100657|594499578|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
164582696|NCT02100657|594499579|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
164582697|NCT02100657|594499580|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
164582698|NCT02100657|594499578|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
164582699|NCT02100657|594499579|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
164582700|NCT02100657|594499580|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
164582701|NCT02100657|594499578|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
164582702|NCT02100657|594499579|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
164582703|NCT02100657|594499580|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
164582704|NCT02100657|594499578|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
164582705|NCT02100657|594499579|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
164582706|NCT02100657|594499580|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
164271536|NCT01079936|593362707|FG000|Phase I: MTD|First Remission Status|2|||
164430887|NCT00681811|593947338|FG000|Overall Study|Withdrawal by Subject|2|||
164430888|NCT00681811|593947339|FG001|Overall Study|Withdrawal by Subject|2|||
164430889|NCT00681811|593947338|FG000|Overall Study|Non-compliance|0|||
164430890|NCT00681811|593947339|FG001|Overall Study|Non-compliance|1|||
164582707|NCT02100657|594499578|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
164582708|NCT02100657|594499579|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
164271537|NCT01079936|593362708|FG001|Phase I: MTD|First Remission Status|0|||
164271538|NCT01079936|593362709|FG002|Phase I: MTD|First Remission Status|0|||
164271539|NCT01079936|593362710|FG003|Phase I: MTD|First Remission Status|0|||
164271540|NCT01079936|593362711|FG004|Phase I: MTD|First Remission Status|0|||
164271541|NCT01079936|593362707|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
164271542|NCT01079936|593362708|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
164271543|NCT01079936|593362709|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
164271544|NCT01079936|593362710|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
164271545|NCT01079936|593362711|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
164271546|NCT01079936|593362707|FG000|Phase II|Adverse Event|0|||
164271547|NCT01079936|593362708|FG001|Phase II|Adverse Event|0|||
164271548|NCT01079936|593362709|FG002|Phase II|Adverse Event|1|||
164271549|NCT01079936|593362710|FG003|Phase II|Adverse Event|0|||
164271550|NCT01079936|593362711|FG004|Phase II|Adverse Event|0|||
164271551|NCT01079936|593362707|FG000|Phase II|Insurance Issue|0|||
164271552|NCT01079936|593362708|FG001|Phase II|Insurance Issue|0|||
164271553|NCT01079936|593362709|FG002|Phase II|Insurance Issue|0|||
164271554|NCT01079936|593362710|FG003|Phase II|Insurance Issue|0|||
164271555|NCT01079936|593362711|FG004|Phase II|Insurance Issue|1|||
164271556|NCT02322190|593362712|FG000|Overall Study|Death on study|1|||
164271557|NCT02322190|593362713|FG001|Overall Study|Death on study|0|||
164271558|NCT03344640|593362714|FG000|Overall Study|Adverse Event|1|||
164271559|NCT03344640|593362715|FG001|Overall Study|Adverse Event|0|||
164271560|NCT03344640|593362714|FG000|Overall Study|Physician Decision|1|||
164271561|NCT03344640|593362715|FG001|Overall Study|Physician Decision|1|||
164271562|NCT03344640|593362714|FG000|Overall Study|Withdrawal by Subject|1|||
164271563|NCT03344640|593362715|FG001|Overall Study|Withdrawal by Subject|2|||
164271564|NCT03344640|593362714|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
164271565|NCT03344640|593362715|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
164271566|NCT02809053|593362721|FG000|Overall Study|Death|0|||
164271567|NCT02809053|593362722|FG001|Overall Study|Death|1|||
164271568|NCT02809053|593362721|FG000|Overall Study|Lost to Follow-up|3|||
164271569|NCT02809053|593362722|FG001|Overall Study|Lost to Follow-up|1|||
164271570|NCT02809053|593362721|FG000|Overall Study|Withdrawal by Subject|2|||
164271571|NCT02809053|593362722|FG001|Overall Study|Withdrawal by Subject|3|||
164271572|NCT02809053|593362721|FG000|Overall Study|Disease Progression|2|||
164271573|NCT02809053|593362722|FG001|Overall Study|Disease Progression|1|||
164271574|NCT01147900|593362723|FG000|At Year 10|Lost to Follow-up|0|||
164271575|NCT01147900|593362724|FG001|At Year 10|Lost to Follow-up|1|||
164342372|NCT04457336|593629429|FG003|Period 3: Part B|Withdrawal by Subject|0|||
164342373|NCT04457336|593629430|FG004|Period 3: Part B|Withdrawal by Subject|0|||
164342374|NCT04457336|593629431|FG005|Period 3: Part B|Withdrawal by Subject|1|||
164342375|NCT04457336|593629432|FG006|Period 3: Part B|Withdrawal by Subject|2|||
164342376|NCT04457336|593629433|FG007|Period 3: Part B|Withdrawal by Subject|0|||
164271576|NCT01147900|593362725|FG002|At Year 10|Lost to Follow-up|0|||
164271577|NCT00025155|593362726|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
164342377|NCT04457336|593629426|FG000|Period 4: Part C|Study Terminated|0|||
164342378|NCT04457336|593629427|FG001|Period 4: Part C|Study Terminated|0|||
164342379|NCT04457336|593629428|FG002|Period 4: Part C|Study Terminated|0|||
164342380|NCT04457336|593629429|FG003|Period 4: Part C|Study Terminated|0|||
164342381|NCT04457336|593629430|FG004|Period 4: Part C|Study Terminated|0|||
164342382|NCT04457336|593629431|FG005|Period 4: Part C|Study Terminated|0|||
164342383|NCT04457336|593629432|FG006|Period 4: Part C|Study Terminated|0|||
164342384|NCT04457336|593629433|FG007|Period 4: Part C|Study Terminated|30|||
164342385|NCT04457336|593629426|FG000|Period 4: Part C|Adverse Event|0|||
164342386|NCT04457336|593629427|FG001|Period 4: Part C|Adverse Event|0|||
164342387|NCT04457336|593629428|FG002|Period 4: Part C|Adverse Event|0|||
164271578|NCT00025155|593362726|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
164271579|NCT05086510|593362727|FG000|Overall Study|Lost to Follow-up|0|||
164271580|NCT05086510|593362728|FG001|Overall Study|Lost to Follow-up|2|||
164271581|NCT05086510|593362727|FG000|Overall Study|Death|0|||
164271582|NCT05086510|593362728|FG001|Overall Study|Death|2|||
164271583|NCT03022981|593362729|FG000|Overall Study|Adverse Event|0|||
164271584|NCT03022981|593362730|FG001|Overall Study|Adverse Event|1|||
164271585|NCT03022981|593362731|FG002|Overall Study|Adverse Event|0|||
164271586|NCT03022981|593362729|FG000|Overall Study|Investigator's Discretion|0|||
164271587|NCT03022981|593362730|FG001|Overall Study|Investigator's Discretion|1|||
164342388|NCT04457336|593629429|FG003|Period 4: Part C|Adverse Event|0|||
164342389|NCT04457336|593629430|FG004|Period 4: Part C|Adverse Event|0|||
164342390|NCT04457336|593629431|FG005|Period 4: Part C|Adverse Event|0|||
164342391|NCT04457336|593629432|FG006|Period 4: Part C|Adverse Event|0|||
164342392|NCT04457336|593629433|FG007|Period 4: Part C|Adverse Event|2|||
164342393|NCT04457336|593629426|FG000|Period 4: Part C|Site Terminated|0|||
164271588|NCT03022981|593362731|FG002|Overall Study|Investigator's Discretion|2|||
164271589|NCT03022981|593362729|FG000|Overall Study|Lost to Follow-up|6|||
164271590|NCT03022981|593362730|FG001|Overall Study|Lost to Follow-up|2|||
164342394|NCT04457336|593629427|FG001|Period 4: Part C|Site Terminated|0|||
164342395|NCT04457336|593629428|FG002|Period 4: Part C|Site Terminated|0|||
164342396|NCT04457336|593629429|FG003|Period 4: Part C|Site Terminated|0|||
164430891|NCT01866917|593947340|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
164430892|NCT01866917|593947341|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
164430893|NCT01140347|593947348|FG000|Overall Study|Lost to Follow-up|5|||
164430894|NCT01140347|593947349|FG001|Overall Study|Lost to Follow-up|6|||
164430895|NCT01140347|593947348|FG000|Overall Study|Withdrawal by Subject|13|||
164430896|NCT01140347|593947349|FG001|Overall Study|Withdrawal by Subject|8|||
164430897|NCT05567159|593947354|FG000|Overall Study|Adverse Event|4|||
164271591|NCT03022981|593362731|FG002|Overall Study|Lost to Follow-up|1|||
164271592|NCT03022981|593362729|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164271593|NCT03022981|593362730|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164271594|NCT03022981|593362731|FG002|Overall Study|Non-Compliance With Study Drug|2|||
164271595|NCT03022981|593362729|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
164271596|NCT03022981|593362730|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
164271597|NCT03022981|593362731|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
164271598|NCT00884832|593362733|FG000|Overall Study|Withdrawal by Subject|0|||
164430898|NCT05567159|593947354|FG000|Overall Study|Physician Decision|3|||
164430899|NCT05567159|593947354|FG000|Overall Study|Protocol deviation|1|||
164430900|NCT00662909|593947356|FG000|Overall Study|Adverse Event|17|||
164430901|NCT00662909|593947357|FG001|Overall Study|Adverse Event|18|||
164430902|NCT00662909|593947358|FG002|Overall Study|Adverse Event|19|||
164430903|NCT00662909|593947356|FG000|Overall Study|Lack of Efficacy|9|||
164430904|NCT00662909|593947357|FG001|Overall Study|Lack of Efficacy|1|||
164430905|NCT00662909|593947358|FG002|Overall Study|Lack of Efficacy|5|||
164430906|NCT00662909|593947356|FG000|Overall Study|Withdrawal by Subject|29|||
164430907|NCT00662909|593947357|FG001|Overall Study|Withdrawal by Subject|22|||
164430908|NCT00662909|593947358|FG002|Overall Study|Withdrawal by Subject|16|||
164430909|NCT00662909|593947356|FG000|Overall Study|Lost to Follow-up|2|||
164582709|NCT02100657|594499580|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
164582710|NCT02100657|594499578|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
164582711|NCT02100657|594499579|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
164582712|NCT02100657|594499580|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
164582713|NCT02100657|594499578|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
164582714|NCT02100657|594499579|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
164582715|NCT02100657|594499580|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
164582716|NCT02100657|594499578|FG000|Cohort 3: Dose Level 3|Death|0|||
164582717|NCT02100657|594499579|FG001|Cohort 3: Dose Level 3|Death|0|||
164582718|NCT02100657|594499580|FG002|Cohort 3: Dose Level 3|Death|1|||
164582719|NCT02100657|594499578|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
164582720|NCT02100657|594499579|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
164582721|NCT02100657|594499580|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
164582722|NCT02100657|594499578|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
164582723|NCT02100657|594499579|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
164582724|NCT02100657|594499580|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
164582725|NCT02100657|594499578|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
164582726|NCT02100657|594499579|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
164582727|NCT02100657|594499580|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
164582728|NCT02100657|594499578|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
164582729|NCT02100657|594499579|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
164582730|NCT02100657|594499580|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
164582731|NCT02100657|594499578|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
164582732|NCT02100657|594499579|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
164582733|NCT02100657|594499580|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
164582734|NCT02531035|594499581|FG000|Overall Study|Death|0|||
164582735|NCT02531035|594499582|FG001|Overall Study|Death|1|||
164582736|NCT02531035|594499581|FG000|Overall Study|Protocol Violation|1|||
164582737|NCT02531035|594499582|FG001|Overall Study|Protocol Violation|1|||
164582738|NCT02531035|594499581|FG000|Overall Study|Noncompliance with study drug|8|||
164582739|NCT02531035|594499582|FG001|Overall Study|Noncompliance with study drug|3|||
164582740|NCT02531035|594499581|FG000|Overall Study|Physician Decision|1|||
164582741|NCT02531035|594499582|FG001|Overall Study|Physician Decision|0|||
164582742|NCT02531035|594499581|FG000|Overall Study|Adverse Event|16|||
164582743|NCT02531035|594499582|FG001|Overall Study|Adverse Event|45|||
164582744|NCT02531035|594499581|FG000|Overall Study|Other|3|||
164582745|NCT02531035|594499582|FG001|Overall Study|Other|2|||
164582746|NCT02531035|594499581|FG000|Overall Study|Withdrawal by Subject|42|||
164430910|NCT00662909|593947357|FG001|Overall Study|Lost to Follow-up|9|||
164430911|NCT00662909|593947358|FG002|Overall Study|Lost to Follow-up|3|||
164430912|NCT00662909|593947356|FG000|Overall Study|Protocol Violation|7|||
164430913|NCT00662909|593947357|FG001|Overall Study|Protocol Violation|4|||
164430914|NCT00662909|593947358|FG002|Overall Study|Protocol Violation|5|||
164582747|NCT02531035|594499582|FG001|Overall Study|Withdrawal by Subject|32|||
164582748|NCT02531035|594499581|FG000|Overall Study|Lost to Follow-up|8|||
164582749|NCT02531035|594499582|FG001|Overall Study|Lost to Follow-up|10|||
164582750|NCT02531035|594499581|FG000|Overall Study|Randomized, not treated|2|||
164582751|NCT02531035|594499582|FG001|Overall Study|Randomized, not treated|1|||
164271599|NCT00884832|593362734|FG001|Overall Study|Withdrawal by Subject|1|||
164271600|NCT02337725|593362735|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
164271601|NCT02337725|593362736|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
164271602|NCT02337725|593362735|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
164271603|NCT02337725|593362736|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
164271604|NCT02337725|593362735|FG000|Overall Study|Major Protocol Deviation|0|||
164271605|NCT02337725|593362736|FG001|Overall Study|Major Protocol Deviation|1|||
164271606|NCT02337725|593362735|FG000|Overall Study|Voluntary Withdrawal|14|||
164271607|NCT02337725|593362736|FG001|Overall Study|Voluntary Withdrawal|3|||
164271608|NCT02337725|593362735|FG000|Overall Study|Lack of Efficacy|4|||
164271609|NCT02337725|593362736|FG001|Overall Study|Lack of Efficacy|0|||
164271610|NCT01264770|593362738|FG000|Overall Study|Not reported|0|||
164271611|NCT01264770|593362739|FG001|Overall Study|Not reported|0|||
164271612|NCT01264770|593362740|FG002|Overall Study|Not reported|1|||
164271613|NCT01264770|593362741|FG003|Overall Study|Not reported|0|||
164271614|NCT01264770|593362742|FG004|Overall Study|Not reported|0|||
164271615|NCT01264770|593362743|FG005|Overall Study|Not reported|0|||
164271616|NCT01264770|593362738|FG000|Overall Study|e.g., change in circumstances|8|||
164271617|NCT01264770|593362739|FG001|Overall Study|e.g., change in circumstances|3|||
164271618|NCT01264770|593362740|FG002|Overall Study|e.g., change in circumstances|3|||
164271619|NCT01264770|593362741|FG003|Overall Study|e.g., change in circumstances|3|||
164271620|NCT01264770|593362742|FG004|Overall Study|e.g., change in circumstances|4|||
164271621|NCT01264770|593362743|FG005|Overall Study|e.g., change in circumstances|4|||
164271622|NCT01264770|593362738|FG000|Overall Study|Severe non-compliance to protocol|0|||
164271623|NCT01264770|593362739|FG001|Overall Study|Severe non-compliance to protocol|0|||
164271624|NCT01264770|593362740|FG002|Overall Study|Severe non-compliance to protocol|1|||
164271625|NCT01264770|593362741|FG003|Overall Study|Severe non-compliance to protocol|1|||
164271626|NCT01264770|593362742|FG004|Overall Study|Severe non-compliance to protocol|0|||
164271627|NCT01264770|593362743|FG005|Overall Study|Severe non-compliance to protocol|0|||
164271628|NCT01264770|593362738|FG000|Overall Study|Lack of therapeutic response|1|||
164271629|NCT01264770|593362739|FG001|Overall Study|Lack of therapeutic response|0|||
164271630|NCT01264770|593362740|FG002|Overall Study|Lack of therapeutic response|2|||
164271631|NCT01264770|593362741|FG003|Overall Study|Lack of therapeutic response|1|||
164271632|NCT01264770|593362742|FG004|Overall Study|Lack of therapeutic response|1|||
164271633|NCT01264770|593362743|FG005|Overall Study|Lack of therapeutic response|0|||
164271634|NCT01264770|593362738|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
164271635|NCT01264770|593362739|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
164271636|NCT01264770|593362740|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
164271637|NCT01264770|593362741|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
164271638|NCT01264770|593362742|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
164271639|NCT01264770|593362743|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
164271640|NCT01264770|593362738|FG000|Overall Study|Lost to Follow-up|0|||
164271641|NCT01264770|593362739|FG001|Overall Study|Lost to Follow-up|0|||
164271642|NCT01264770|593362740|FG002|Overall Study|Lost to Follow-up|1|||
164271643|NCT01264770|593362741|FG003|Overall Study|Lost to Follow-up|1|||
164271644|NCT01264770|593362742|FG004|Overall Study|Lost to Follow-up|0|||
164271645|NCT01264770|593362743|FG005|Overall Study|Lost to Follow-up|0|||
164271646|NCT01264770|593362738|FG000|Overall Study|Adverse Event|7|||
164271647|NCT01264770|593362739|FG001|Overall Study|Adverse Event|7|||
164271648|NCT01264770|593362740|FG002|Overall Study|Adverse Event|8|||
164271649|NCT01264770|593362741|FG003|Overall Study|Adverse Event|0|||
164271650|NCT01264770|593362742|FG004|Overall Study|Adverse Event|2|||
164271651|NCT01264770|593362743|FG005|Overall Study|Adverse Event|1|||
164271652|NCT00129961|593362744|FG000|Overall Study|Adverse Event|1|||
164271653|NCT00129961|593362745|FG001|Overall Study|Adverse Event|0|||
164271654|NCT00129961|593362744|FG000|Overall Study|Death|1|||
164271655|NCT00129961|593362745|FG001|Overall Study|Death|1|||
164271656|NCT00129961|593362744|FG000|Overall Study|Withdrawal by Sponsor|14|||
164271657|NCT00129961|593362745|FG001|Overall Study|Withdrawal by Sponsor|20|||
164271658|NCT00129961|593362744|FG000|Overall Study|Physician Decision|1|||
164271659|NCT00129961|593362745|FG001|Overall Study|Physician Decision|0|||
164271660|NCT00129961|593362744|FG000|Overall Study|Withdrawal by Subject|2|||
164271661|NCT00129961|593362745|FG001|Overall Study|Withdrawal by Subject|1|||
164271662|NCT00129961|593362744|FG000|Overall Study|Missing Record|0|||
164271663|NCT00129961|593362745|FG001|Overall Study|Missing Record|1|||
164271664|NCT00084487|593362746|FG000|Overall Study|Death|1|||
164271665|NCT04881747|593362749|FG000|Period 2 Washout|Adverse Event|1|||
164271666|NCT04881747|593362750|FG001|Period 2 Washout|Adverse Event|0|||
164271667|NCT04881747|593362751|FG002|Period 2 Washout|Adverse Event|0|||
164271668|NCT04881747|593362752|FG003|Period 2 Washout|Adverse Event|0|||
164271669|NCT04881747|593362753|FG004|Period 2 Washout|Adverse Event|1|||
164271670|NCT04881747|593362754|FG005|Period 2 Washout|Adverse Event|0|||
164271671|NCT04881747|593362749|FG000|Period 2 Washout|Withdrawal by Subject|1|||
164271672|NCT04881747|593362750|FG001|Period 2 Washout|Withdrawal by Subject|0|||
164271673|NCT04881747|593362751|FG002|Period 2 Washout|Withdrawal by Subject|0|||
164271674|NCT04881747|593362752|FG003|Period 2 Washout|Withdrawal by Subject|1|||
164271675|NCT04881747|593362753|FG004|Period 2 Washout|Withdrawal by Subject|0|||
164271676|NCT04881747|593362754|FG005|Period 2 Washout|Withdrawal by Subject|0|||
164271677|NCT02598128|593362760|FG000|Period A: Days -7 to -1|Adverse Event|1|||
164271678|NCT02598128|593362761|FG001|Period A: Days -7 to -1|Adverse Event|0|||
164271679|NCT02598128|593362762|FG002|Period A: Days -7 to -1|Adverse Event|0|||
164271680|NCT02598128|593362763|FG003|Period A: Days -7 to -1|Adverse Event|0|||
164271681|NCT01378429|593362764|FG000|Overall Study|Noncompliance with study drug|1|||
164271682|NCT01378429|593362765|FG001|Overall Study|Noncompliance with study drug|0|||
164271683|NCT01064687|593362766|FG000|Overall Study|Adverse Event|9|||
164271684|NCT01064687|593362767|FG001|Overall Study|Adverse Event|4|||
164271685|NCT01064687|593362768|FG002|Overall Study|Adverse Event|10|||
164271686|NCT01064687|593362769|FG003|Overall Study|Adverse Event|3|||
164271687|NCT01064687|593362766|FG000|Overall Study|Death|1|||
164271688|NCT01064687|593362767|FG001|Overall Study|Death|1|||
164271689|NCT01064687|593362768|FG002|Overall Study|Death|0|||
164271690|NCT01064687|593362769|FG003|Overall Study|Death|0|||
164271691|NCT01064687|593362766|FG000|Overall Study|Entry Criteria Not Met|3|||
164271692|NCT01064687|593362767|FG001|Overall Study|Entry Criteria Not Met|0|||
164271693|NCT01064687|593362768|FG002|Overall Study|Entry Criteria Not Met|0|||
164271694|NCT01064687|593362769|FG003|Overall Study|Entry Criteria Not Met|0|||
164582752|NCT01543490|594499584|FG000|Overall Study|Adverse Event|4|||
164582753|NCT01543490|594499585|FG001|Overall Study|Adverse Event|0|||
164582754|NCT01543490|594499584|FG000|Overall Study|Physician Decision|1|||
164582755|NCT01543490|594499585|FG001|Overall Study|Physician Decision|0|||
164582756|NCT01543490|594499584|FG000|Overall Study|Lack of Efficacy|3|||
164582757|NCT01543490|594499585|FG001|Overall Study|Lack of Efficacy|3|||
164582758|NCT01543490|594499584|FG000|Overall Study|Lost to Follow-up|5|||
164582759|NCT01543490|594499585|FG001|Overall Study|Lost to Follow-up|0|||
164582760|NCT01543490|594499584|FG000|Overall Study|Withdrawal by Subject|2|||
164582761|NCT01543490|594499585|FG001|Overall Study|Withdrawal by Subject|0|||
164582762|NCT01543490|594499584|FG000|Overall Study|Other-Various Administrative Reasons|1|||
164582763|NCT01543490|594499585|FG001|Overall Study|Other-Various Administrative Reasons|2|||
164582764|NCT01334125|594499589|FG000|Overall Study|Lost to Follow-up|3|||
164582765|NCT01334125|594499590|FG001|Overall Study|Lost to Follow-up|3|||
164582766|NCT00882713|594499593|FG000|Overall Study|Adverse Event|2|||
164582767|NCT00882713|594499593|FG000|Overall Study|Death|3|||
164582768|NCT00882713|594499593|FG000|Overall Study|Administrative reasons|4|||
164582769|NCT00882713|594499593|FG000|Overall Study|refused treatment/withdrew consent|4|||
164582770|NCT00882713|594499593|FG000|Overall Study|Blood transfusion|2|||
164582771|NCT00882713|594499593|FG000|Overall Study|Insufficient therapeutic response|3|||
164582772|NCT00882713|594499593|FG000|Overall Study|Failure to return|2|||
164582773|NCT00882713|594499593|FG000|Overall Study|Other - Reasons|2|||
164582774|NCT05523362|594499596|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
164582775|NCT05523362|594499596|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
164582776|NCT05523362|594499596|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
164582777|NCT05523362|594499596|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
164582778|NCT02760602|594499597|FG000|Overall Study|Withdrawal by Subject|1|||
164582779|NCT02760602|594499598|FG001|Overall Study|Withdrawal by Subject|0|||
164582780|NCT02760602|594499597|FG000|Overall Study|Terminated by sponsor|12|||
164582781|NCT02760602|594499598|FG001|Overall Study|Terminated by sponsor|13|||
164582782|NCT01335971|594499602|FG000|Overall Study|Withdrawal by Subject|1|||
164582783|NCT01335971|594499603|FG001|Overall Study|Withdrawal by Subject|0|||
164582784|NCT01335971|594499604|FG002|Overall Study|Withdrawal by Subject|0|||
164582785|NCT01335971|594499602|FG000|Overall Study|Did not complete bronchoscopy|1|||
164582786|NCT01335971|594499603|FG001|Overall Study|Did not complete bronchoscopy|1|||
164582787|NCT01335971|594499604|FG002|Overall Study|Did not complete bronchoscopy|1|||
164582788|NCT01260181|594499605|FG000|Overall Study|Decision of Investigator|1|||
164582789|NCT03351244|594499606|FG000|Overall Study|Adverse Event|7|||
164582790|NCT03351244|594499607|FG001|Overall Study|Adverse Event|11|||
164582791|NCT03351244|594499608|FG002|Overall Study|Adverse Event|12|||
164582792|NCT03351244|594499606|FG000|Overall Study|Investigator's decision|0|||
164582793|NCT03351244|594499607|FG001|Overall Study|Investigator's decision|0|||
164582794|NCT03351244|594499608|FG002|Overall Study|Investigator's decision|2|||
164582795|NCT03351244|594499606|FG000|Overall Study|System error|0|||
164582796|NCT03351244|594499607|FG001|Overall Study|System error|0|||
164582797|NCT03351244|594499608|FG002|Overall Study|System error|2|||
164271695|NCT01064687|593362766|FG000|Overall Study|Lack of Efficacy|1|||
164271696|NCT01064687|593362767|FG001|Overall Study|Lack of Efficacy|0|||
164582798|NCT03351244|594499606|FG000|Overall Study|COVID-19 restrictions|3|||
164582799|NCT03351244|594499607|FG001|Overall Study|COVID-19 restrictions|0|||
164582800|NCT03351244|594499608|FG002|Overall Study|COVID-19 restrictions|1|||
164582801|NCT03351244|594499606|FG000|Overall Study|Non-compliance|2|||
164582802|NCT03351244|594499607|FG001|Overall Study|Non-compliance|5|||
164582803|NCT03351244|594499608|FG002|Overall Study|Non-compliance|0|||
164582804|NCT03351244|594499606|FG000|Overall Study|Withdrawal by Subject|11|||
164582805|NCT03351244|594499607|FG001|Overall Study|Withdrawal by Subject|16|||
164582806|NCT03351244|594499608|FG002|Overall Study|Withdrawal by Subject|13|||
164582807|NCT03351244|594499606|FG000|Overall Study|Lost to Follow-up|2|||
164582808|NCT03351244|594499607|FG001|Overall Study|Lost to Follow-up|6|||
164271697|NCT01064687|593362768|FG002|Overall Study|Lack of Efficacy|2|||
164271698|NCT01064687|593362769|FG003|Overall Study|Lack of Efficacy|3|||
164271699|NCT01064687|593362766|FG000|Overall Study|Lost to Follow-up|7|||
164271700|NCT01064687|593362767|FG001|Overall Study|Lost to Follow-up|10|||
164271701|NCT01064687|593362768|FG002|Overall Study|Lost to Follow-up|13|||
164271702|NCT01064687|593362769|FG003|Overall Study|Lost to Follow-up|5|||
164271703|NCT01064687|593362766|FG000|Overall Study|Physician Decision|2|||
164271704|NCT01064687|593362767|FG001|Overall Study|Physician Decision|2|||
164271705|NCT01064687|593362768|FG002|Overall Study|Physician Decision|0|||
164271706|NCT01064687|593362769|FG003|Overall Study|Physician Decision|0|||
164271707|NCT01064687|593362766|FG000|Overall Study|Protocol Violation|1|||
164271708|NCT01064687|593362767|FG001|Overall Study|Protocol Violation|1|||
164271709|NCT01064687|593362768|FG002|Overall Study|Protocol Violation|0|||
164271710|NCT01064687|593362769|FG003|Overall Study|Protocol Violation|1|||
164271711|NCT01064687|593362766|FG000|Overall Study|Sponsor Decision|0|||
164271712|NCT01064687|593362767|FG001|Overall Study|Sponsor Decision|0|||
164271713|NCT01064687|593362768|FG002|Overall Study|Sponsor Decision|3|||
164271714|NCT01064687|593362769|FG003|Overall Study|Sponsor Decision|0|||
164271715|NCT01064687|593362766|FG000|Overall Study|Withdrawal by Subject|9|||
164271716|NCT01064687|593362767|FG001|Overall Study|Withdrawal by Subject|7|||
164271717|NCT01064687|593362768|FG002|Overall Study|Withdrawal by Subject|12|||
164271718|NCT01064687|593362769|FG003|Overall Study|Withdrawal by Subject|5|||
164271719|NCT01064687|593362766|FG000|Overall Study|Treatment Noncompliance|1|||
164271720|NCT01064687|593362767|FG001|Overall Study|Treatment Noncompliance|1|||
164271721|NCT01064687|593362768|FG002|Overall Study|Treatment Noncompliance|1|||
164271722|NCT01064687|593362769|FG003|Overall Study|Treatment Noncompliance|0|||
164271723|NCT00619489|593362770|FG000|Overall Study|Adverse Event|0|||
164271724|NCT00619489|593362771|FG001|Overall Study|Adverse Event|7|||
164271725|NCT00619489|593362770|FG000|Overall Study|Withdrawal by Subject|1|||
164271726|NCT00619489|593362771|FG001|Overall Study|Withdrawal by Subject|1|||
164271727|NCT00619489|593362770|FG000|Overall Study|Lack of Efficacy|0|||
164271728|NCT00619489|593362771|FG001|Overall Study|Lack of Efficacy|11|||
164271729|NCT00619489|593362770|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
164271730|NCT00619489|593362771|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
164271731|NCT03134183|593362772|FG000|Overall Study|Withdrawal by Subject|1|||
164271732|NCT03134183|593362773|FG001|Overall Study|Withdrawal by Subject|1|||
164271733|NCT02265796|593362776|FG000|Overall Study|Death|1|||
164271734|NCT02265796|593362777|FG001|Overall Study|Death|0|||
164271735|NCT02265796|593362776|FG000|Overall Study|started on excluded medication|1|||
164271736|NCT02265796|593362777|FG001|Overall Study|started on excluded medication|0|||
164271737|NCT02265796|593362776|FG000|Overall Study|Withdrawal by Subject|1|||
164271738|NCT02265796|593362777|FG001|Overall Study|Withdrawal by Subject|1|||
164271739|NCT02477553|593362778|FG000|Overall Study|Screening up-to-date|12|||
164271740|NCT02477553|593362779|FG001|Overall Study|Screening up-to-date|13|||
164271741|NCT02477553|593362778|FG000|Overall Study|No MD visit|1|||
164271742|NCT02477553|593362779|FG001|Overall Study|No MD visit|1|||
164271743|NCT02477553|593362778|FG000|Overall Study|Workup consistent w/CRC|1|||
164271744|NCT02477553|593362779|FG001|Overall Study|Workup consistent w/CRC|1|||
164271745|NCT02477553|593362778|FG000|Overall Study|Technical issues with intervention|2|||
164271746|NCT02477553|593362779|FG001|Overall Study|Technical issues with intervention|0|||
164271747|NCT02477553|593362778|FG000|Overall Study|Elevated risk for CRC|2|||
164271748|NCT02477553|593362779|FG001|Overall Study|Elevated risk for CRC|2|||
164271749|NCT02477553|593362778|FG000|Overall Study|MD advised against screening|1|||
164271750|NCT02477553|593362779|FG001|Overall Study|MD advised against screening|3|||
164271751|NCT02477553|593362778|FG000|Overall Study|patient deceased|1|||
164271752|NCT02477553|593362779|FG001|Overall Study|patient deceased|0|||
164271753|NCT04311463|593362780|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
164271754|NCT04311463|593362781|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
164271755|NCT04311463|593362780|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
164271756|NCT04311463|593362781|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
164271757|NCT04311463|593362780|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
164271758|NCT04311463|593362781|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
164271759|NCT04023682|593362782|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
164271760|NCT00454649|593362783|FG000|Overall Study|Lack of Efficacy|2|||
164271761|NCT00454649|593362784|FG001|Overall Study|Lack of Efficacy|2|||
164582809|NCT03351244|594499608|FG002|Overall Study|Lost to Follow-up|4|||
164582810|NCT03351244|594499606|FG000|Overall Study|Protocol Violation|2|||
164582811|NCT03351244|594499607|FG001|Overall Study|Protocol Violation|2|||
164582812|NCT03351244|594499608|FG002|Overall Study|Protocol Violation|0|||
164582813|NCT00474253|594499611|FG000|Overall Study|Withdrew consent|2|||
164582814|NCT00474253|594499612|FG001|Overall Study|Withdrew consent|0|||
164582815|NCT00474253|594499611|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
164582816|NCT00474253|594499612|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
164582817|NCT00474253|594499611|FG000|Overall Study|Lost to Follow-up|1|||
164582818|NCT00474253|594499612|FG001|Overall Study|Lost to Follow-up|0|||
164582819|NCT00474253|594499611|FG000|Overall Study|Discharged prior to study completion|0|||
164582820|NCT00474253|594499612|FG001|Overall Study|Discharged prior to study completion|1|||
164582821|NCT01165229|594499613|FG000|Overall Study|Serious Adverse Event|456|||
164582822|NCT01165229|594499614|FG001|Overall Study|Serious Adverse Event|487|||
164582823|NCT01165229|594499613|FG000|Overall Study|Non-Serious Adverse Event|47|||
164582824|NCT01165229|594499614|FG001|Overall Study|Non-Serious Adverse Event|15|||
164582825|NCT01165229|594499613|FG000|Overall Study|Protocol Violation|6|||
164582826|NCT01165229|594499614|FG001|Overall Study|Protocol Violation|8|||
164582827|NCT01165229|594499613|FG000|Overall Study|Withdrawal by Subject|387|||
164582828|NCT01165229|594499614|FG001|Overall Study|Withdrawal by Subject|396|||
164582829|NCT01165229|594499613|FG000|Overall Study|Migrated/moved from study area|51|||
164582830|NCT01165229|594499614|FG001|Overall Study|Migrated/moved from study area|46|||
164582831|NCT01165229|594499613|FG000|Overall Study|Lost to Follow-up|123|||
164582832|NCT01165229|594499614|FG001|Overall Study|Lost to Follow-up|133|||
164582833|NCT01165229|594499613|FG000|Overall Study|Suspected HZ Episode|2|||
164582834|NCT01165229|594499614|FG001|Overall Study|Suspected HZ Episode|2|||
164582835|NCT01165229|594499613|FG000|Overall Study|No reason from the subject|108|||
164582836|NCT01165229|594499614|FG001|Overall Study|No reason from the subject|102|||
164582837|NCT01165229|594499613|FG000|Overall Study|Unknown completion status|0|||
164582838|NCT01165229|594499614|FG001|Overall Study|Unknown completion status|1|||
164582839|NCT01357239|594499615|FG000|Stratum: All Patients|Adverse Event|0|||
164582840|NCT01357239|594499616|FG001|Stratum: All Patients|Adverse Event|0|||
164271762|NCT00454649|593362785|FG002|Overall Study|Lack of Efficacy|10|||
164271763|NCT00454649|593362786|FG003|Overall Study|Lack of Efficacy|3|||
164271764|NCT00454649|593362787|FG004|Overall Study|Lack of Efficacy|0|||
164271765|NCT00454649|593362788|FG005|Overall Study|Lack of Efficacy|4|||
164271766|NCT00454649|593362789|FG006|Overall Study|Lack of Efficacy|5|||
164271767|NCT00454649|593362790|FG007|Overall Study|Lack of Efficacy|13|||
164271768|NCT00454649|593362791|FG008|Overall Study|Lack of Efficacy|10|||
164271769|NCT00454649|593362792|FG009|Overall Study|Lack of Efficacy|2|||
164271770|NCT00454649|593362783|FG000|Overall Study|Adverse Event|0|||
164271771|NCT00454649|593362784|FG001|Overall Study|Adverse Event|1|||
164271772|NCT00454649|593362785|FG002|Overall Study|Adverse Event|3|||
164271773|NCT00454649|593362786|FG003|Overall Study|Adverse Event|0|||
164271774|NCT00454649|593362787|FG004|Overall Study|Adverse Event|1|||
164271775|NCT00454649|593362788|FG005|Overall Study|Adverse Event|2|||
164271776|NCT00454649|593362789|FG006|Overall Study|Adverse Event|3|||
164271777|NCT00454649|593362790|FG007|Overall Study|Adverse Event|4|||
164271778|NCT00454649|593362791|FG008|Overall Study|Adverse Event|6|||
164271779|NCT00454649|593362792|FG009|Overall Study|Adverse Event|2|||
164271780|NCT00454649|593362783|FG000|Overall Study|Lost to Follow-up|0|||
164271781|NCT00454649|593362784|FG001|Overall Study|Lost to Follow-up|0|||
164271782|NCT00454649|593362785|FG002|Overall Study|Lost to Follow-up|1|||
164271783|NCT00454649|593362786|FG003|Overall Study|Lost to Follow-up|0|||
164271784|NCT00454649|593362787|FG004|Overall Study|Lost to Follow-up|0|||
164271785|NCT00454649|593362788|FG005|Overall Study|Lost to Follow-up|0|||
164271786|NCT00454649|593362789|FG006|Overall Study|Lost to Follow-up|1|||
164271787|NCT00454649|593362790|FG007|Overall Study|Lost to Follow-up|0|||
164271788|NCT00454649|593362791|FG008|Overall Study|Lost to Follow-up|0|||
164271789|NCT00454649|593362792|FG009|Overall Study|Lost to Follow-up|0|||
164271790|NCT00454649|593362783|FG000|Overall Study|Other|1|||
164271791|NCT00454649|593362784|FG001|Overall Study|Other|1|||
164271792|NCT00454649|593362785|FG002|Overall Study|Other|5|||
164271793|NCT00454649|593362786|FG003|Overall Study|Other|3|||
164271794|NCT00454649|593362787|FG004|Overall Study|Other|0|||
164271795|NCT00454649|593362788|FG005|Overall Study|Other|0|||
164271796|NCT00454649|593362789|FG006|Overall Study|Other|0|||
164271797|NCT00454649|593362790|FG007|Overall Study|Other|0|||
164271798|NCT00454649|593362791|FG008|Overall Study|Other|3|||
164271799|NCT00454649|593362792|FG009|Overall Study|Other|1|||
164271800|NCT00454649|593362783|FG000|Overall Study|Withdrawal by Subject|0|||
164582841|NCT01357239|594499617|FG002|Stratum: All Patients|Adverse Event|1|||
164582842|NCT01357239|594499618|FG003|Stratum: All Patients|Adverse Event|1|||
164582843|NCT01357239|594499615|FG000|Stratum: All Patients|Subject withdrew consent|0|||
164582844|NCT01357239|594499616|FG001|Stratum: All Patients|Subject withdrew consent|0|||
164582845|NCT01357239|594499617|FG002|Stratum: All Patients|Subject withdrew consent|1|||
164582846|NCT01357239|594499618|FG003|Stratum: All Patients|Subject withdrew consent|1|||
164582847|NCT01357239|594499615|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
164582848|NCT01357239|594499616|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
164582849|NCT01357239|594499617|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
164271801|NCT00454649|593362784|FG001|Overall Study|Withdrawal by Subject|0|||
164271802|NCT00454649|593362785|FG002|Overall Study|Withdrawal by Subject|0|||
164271803|NCT00454649|593362786|FG003|Overall Study|Withdrawal by Subject|0|||
164271804|NCT00454649|593362787|FG004|Overall Study|Withdrawal by Subject|0|||
164271805|NCT00454649|593362788|FG005|Overall Study|Withdrawal by Subject|1|||
164688471|NCT02003222|594883262|FG000|Intensification|Never started treatment|0|||
164688472|NCT02003222|594883263|FG001|Intensification|Never started treatment|0|||
164688473|NCT02003222|594883264|FG002|Intensification|Never started treatment|0|||
164688474|NCT02003222|594883265|FG003|Intensification|Never started treatment|0|||
164688475|NCT02003222|594883266|FG004|Intensification|Never started treatment|2|||
164688476|NCT02003222|594883262|FG000|Intensification|Adverse Event|0|||
164271806|NCT00454649|593362789|FG006|Overall Study|Withdrawal by Subject|0|||
164271807|NCT00454649|593362790|FG007|Overall Study|Withdrawal by Subject|2|||
164271808|NCT00454649|593362791|FG008|Overall Study|Withdrawal by Subject|1|||
164271809|NCT00454649|593362792|FG009|Overall Study|Withdrawal by Subject|0|||
164271810|NCT02745535|593362794|FG000|Overall Study|Death|1|||
164271811|NCT02745535|593362794|FG000|Overall Study|Adverse Event|3|||
164271812|NCT02745535|593362794|FG000|Overall Study|Lost to Follow-up|2|||
164271813|NCT01291277|593362799|FG000|Overall Study|Death|2|||
164271814|NCT01291277|593362800|FG001|Overall Study|Death|2|||
164271815|NCT01291277|593362799|FG000|Overall Study|Lost to Follow-up|3|||
164271816|NCT01291277|593362800|FG001|Overall Study|Lost to Follow-up|1|||
164271817|NCT00377364|593362801|FG000|Overall Study|Lost to Follow-up|1|||
164271818|NCT00377364|593362802|FG001|Overall Study|Lost to Follow-up|0|||
164271819|NCT00377364|593362801|FG000|Overall Study|Withdrawal by Subject|1|||
164271820|NCT00377364|593362802|FG001|Overall Study|Withdrawal by Subject|0|||
164271821|NCT03480009|593362806|FG000|Overall Study|Lost to Follow-up|4|||
164271822|NCT03480009|593362807|FG001|Overall Study|Lost to Follow-up|5|||
164271823|NCT03480009|593362808|FG002|Overall Study|Lost to Follow-up|4|||
164271824|NCT03480009|593362809|FG003|Overall Study|Lost to Follow-up|0|||
164271825|NCT01638559|593362810|FG000|Overall Study|Lost to Follow-up|1|||
164271826|NCT01638559|593362810|FG000|Overall Study|Withdrawal by Subject|1|||
164271827|NCT01638559|593362810|FG000|Overall Study|Subject declined to travel for biopsy|1|||
164271828|NCT02014584|593362811|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
164271829|NCT02014584|593362812|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
164271830|NCT02014584|593362813|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
164271831|NCT02014584|593362814|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
164271832|NCT02014584|593362815|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
164271833|NCT02014584|593362816|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
164271834|NCT02014584|593362811|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
164688477|NCT02003222|594883263|FG001|Intensification|Adverse Event|0|||
164271835|NCT02014584|593362812|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
164271836|NCT02014584|593362813|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
164271837|NCT02014584|593362814|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
164271838|NCT02014584|593362815|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
164271839|NCT02014584|593362816|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
164271840|NCT02014584|593362811|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
164271841|NCT02014584|593362812|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
164271842|NCT02014584|593362813|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
164271843|NCT02014584|593362814|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
164271844|NCT02014584|593362815|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
164271845|NCT02014584|593362816|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
164271846|NCT02014584|593362811|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
164271847|NCT02014584|593362812|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
164271848|NCT02014584|593362813|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
164271849|NCT02014584|593362814|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
164271850|NCT02014584|593362815|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
164271851|NCT02014584|593362816|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
164271852|NCT02014584|593362811|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
164271853|NCT02014584|593362812|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
164271854|NCT02014584|593362813|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
164271855|NCT02014584|593362814|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
164271856|NCT02014584|593362815|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
164271857|NCT02014584|593362816|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
164271858|NCT00483002|593362817|FG000|Overall Study|Adverse Event|68|||
164271859|NCT00483002|593362817|FG000|Overall Study|Lack of Efficacy|555|||
164271860|NCT00483002|593362817|FG000|Overall Study|Lost to Follow-up|962|||
164271861|NCT00483002|593362817|FG000|Overall Study|Other|2|||
164271862|NCT00483002|593362817|FG000|Overall Study|Other|967|||
164271863|NCT02651220|593362821|FG000|Overall Study|Adverse Event|1|||
164271864|NCT02651220|593362822|FG001|Overall Study|Adverse Event|5|||
164688478|NCT02003222|594883264|FG002|Intensification|Adverse Event|0|||
164688479|NCT02003222|594883265|FG003|Intensification|Adverse Event|0|||
164271865|NCT02651220|593362823|FG002|Overall Study|Adverse Event|1|||
164271866|NCT02651220|593362821|FG000|Overall Study|Lost to Follow-up|8|||
164271867|NCT02651220|593362822|FG001|Overall Study|Lost to Follow-up|14|||
164271868|NCT02651220|593362823|FG002|Overall Study|Lost to Follow-up|14|||
164271869|NCT02651220|593362821|FG000|Overall Study|Non-Compliance with Study Drug|4|||
164688480|NCT02003222|594883266|FG004|Intensification|Adverse Event|6|||
164271870|NCT02651220|593362822|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164271871|NCT02651220|593362823|FG002|Overall Study|Non-Compliance with Study Drug|1|||
164271872|NCT02651220|593362821|FG000|Overall Study|Pregnancy|1|||
164271873|NCT02651220|593362822|FG001|Overall Study|Pregnancy|0|||
164271874|NCT02651220|593362823|FG002|Overall Study|Pregnancy|1|||
164271875|NCT02651220|593362821|FG000|Overall Study|Protocol Violation|0|||
164688481|NCT02003222|594883262|FG000|Intensification|Alternative therapy|0|||
164688482|NCT02003222|594883263|FG001|Intensification|Alternative therapy|0|||
164688483|NCT02003222|594883264|FG002|Intensification|Alternative therapy|0|||
164688484|NCT02003222|594883265|FG003|Intensification|Alternative therapy|0|||
164688485|NCT02003222|594883266|FG004|Intensification|Alternative therapy|8|||
164688486|NCT02003222|594883262|FG000|Intensification|Disease progression|0|||
164688487|NCT02003222|594883263|FG001|Intensification|Disease progression|0|||
164688488|NCT02003222|594883264|FG002|Intensification|Disease progression|0|||
164688489|NCT02003222|594883265|FG003|Intensification|Disease progression|0|||
164688490|NCT02003222|594883266|FG004|Intensification|Disease progression|18|||
164688491|NCT02003222|594883262|FG000|Intensification|Withdrawal by Subject|0|||
164688492|NCT02003222|594883263|FG001|Intensification|Withdrawal by Subject|0|||
164688493|NCT02003222|594883264|FG002|Intensification|Withdrawal by Subject|0|||
164688494|NCT02003222|594883265|FG003|Intensification|Withdrawal by Subject|0|||
164688495|NCT02003222|594883266|FG004|Intensification|Withdrawal by Subject|5|||
164688496|NCT02003222|594883262|FG000|Intensification|Other reasons|0|||
164688497|NCT02003222|594883263|FG001|Intensification|Other reasons|0|||
164688498|NCT02003222|594883264|FG002|Intensification|Other reasons|0|||
164688499|NCT02003222|594883265|FG003|Intensification|Other reasons|0|||
164688500|NCT02003222|594883266|FG004|Intensification|Other reasons|8|||
164271876|NCT02651220|593362822|FG001|Overall Study|Protocol Violation|0|||
164271877|NCT02651220|593362823|FG002|Overall Study|Protocol Violation|1|||
164271878|NCT02651220|593362821|FG000|Overall Study|Withdrawal by Subject|5|||
164271879|NCT02651220|593362822|FG001|Overall Study|Withdrawal by Subject|6|||
164271880|NCT02651220|593362823|FG002|Overall Study|Withdrawal by Subject|8|||
164271881|NCT02651220|593362821|FG000|Overall Study|Miscellaneous|4|||
164271882|NCT02651220|593362822|FG001|Overall Study|Miscellaneous|1|||
164271883|NCT02651220|593362823|FG002|Overall Study|Miscellaneous|2|||
164271884|NCT02651220|593362821|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164271885|NCT02651220|593362822|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
164271886|NCT02651220|593362823|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
164271887|NCT01274429|593362825|FG000|Overall Study|Study closed do to lack of funding|5|||
164271888|NCT01439373|593362826|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
164271889|NCT01439373|593362827|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
164271890|NCT01439373|593362826|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
164271891|NCT01439373|593362827|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
164271892|NCT04576897|593362830|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
164271893|NCT02593318|593362833|FG000|Overall Study|Withdrawal by Subject|1|||
164271894|NCT02593318|593362834|FG001|Overall Study|Withdrawal by Subject|1|||
164271895|NCT03109184|593364442|FG000|Overall Study|Lost to Follow-up|6|||
164271896|NCT03109184|593364443|FG001|Overall Study|Lost to Follow-up|6|||
164271897|NCT03109184|593364442|FG000|Overall Study|Withdrawal by Subject|1|||
164271898|NCT03109184|593364443|FG001|Overall Study|Withdrawal by Subject|1|||
164271899|NCT02315560|593364444|FG000|Overall Study|noncompliance by subjects|3|||
164271900|NCT04599465|593364445|FG000|Overall Study|Physician Decision|1|||
164271901|NCT04599465|593364445|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
164271902|NCT04566601|593364446|FG000|Overall Study|Other than listed|13|||
164271903|NCT04566601|593364447|FG001|Overall Study|Other than listed|4|||
164271904|NCT04566601|593364448|FG002|Overall Study|Other than listed|2|||
164271905|NCT04566601|593364449|FG003|Overall Study|Other than listed|1|||
164271906|NCT04566601|593364450|FG004|Overall Study|Other than listed|4|||
164271907|NCT04566601|593364446|FG000|Overall Study|Protocol deviation|3|||
164271908|NCT04566601|593364447|FG001|Overall Study|Protocol deviation|0|||
164271909|NCT04566601|593364448|FG002|Overall Study|Protocol deviation|1|||
164271910|NCT04566601|593364449|FG003|Overall Study|Protocol deviation|1|||
164688501|NCT04941768|594883271|FG000|Overall Study|Lost to Follow-up|10|||
164688502|NCT04941768|594883271|FG000|Overall Study|Death|24|||
164688503|NCT04941768|594883271|FG000|Overall Study|Progressive Disease|4|||
164688504|NCT04941768|594883271|FG000|Overall Study|Withdrawal by Subject|4|||
164688505|NCT04941768|594883271|FG000|Overall Study|Other|3|||
164688506|NCT04941768|594883271|FG000|Overall Study|Treatment ongoing|21|||
164688507|NCT04941768|594883271|FG000|Overall Study|Off treatment and in follow-up|21|||
164688508|NCT03302078|594883272|FG000|Washout Period|Adverse Event|0|||
164271911|NCT04566601|593364450|FG004|Overall Study|Protocol deviation|1|||
164271912|NCT04566601|593364446|FG000|Overall Study|Technical problems|0|||
164271913|NCT04566601|593364447|FG001|Overall Study|Technical problems|0|||
164271914|NCT04566601|593364448|FG002|Overall Study|Technical problems|1|||
164271915|NCT04566601|593364449|FG003|Overall Study|Technical problems|0|||
164688509|NCT03302078|594883273|FG001|Washout Period|Adverse Event|1|||
164582850|NCT01357239|594499618|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
164582851|NCT01357239|594499615|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
164582852|NCT01357239|594499616|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
164582853|NCT01357239|594499617|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
164582854|NCT01357239|594499618|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
164582855|NCT01357239|594499615|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
164582856|NCT01357239|594499616|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
164582857|NCT01357239|594499617|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
164582858|NCT01357239|594499618|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
164582859|NCT00637728|594499619|FG000|Double-blind Phase|Adverse Event|1|||
164582860|NCT00637728|594499620|FG001|Double-blind Phase|Adverse Event|0|||
164582861|NCT00637728|594499621|FG002|Double-blind Phase|Adverse Event|0|||
164582862|NCT00637728|594499619|FG000|Double-blind Phase|Non-compliance|2|||
164582863|NCT00637728|594499620|FG001|Double-blind Phase|Non-compliance|0|||
164582864|NCT00637728|594499621|FG002|Double-blind Phase|Non-compliance|0|||
164582865|NCT00637728|594499619|FG000|Double-blind Phase|Study Discontinued|1|||
164582866|NCT00637728|594499620|FG001|Double-blind Phase|Study Discontinued|1|||
164582867|NCT00637728|594499621|FG002|Double-blind Phase|Study Discontinued|0|||
164582868|NCT01499576|594499622|FG000|Overall Study|Physician Decision|12|||
164582869|NCT01499576|594499622|FG000|Overall Study|Withdrawal by Subject|9|||
164582870|NCT03396471|594499628|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
164582871|NCT03396471|594499628|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
164582872|NCT03396471|594499628|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
164582873|NCT03396471|594499628|FG000|Study Treatment - Up to 22 Months|Death|2|||
164582874|NCT03396471|594499628|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
164582875|NCT03396471|594499628|FG000|Follow up - Up to 2 Years|Death|9|||
164582876|NCT03396471|594499628|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
164271916|NCT04566601|593364450|FG004|Overall Study|Technical problems|0|||
164271917|NCT04566601|593364446|FG000|Overall Study|No reason available|3|||
164271918|NCT04566601|593364447|FG001|Overall Study|No reason available|2|||
164271919|NCT04566601|593364448|FG002|Overall Study|No reason available|7|||
164271920|NCT04566601|593364449|FG003|Overall Study|No reason available|1|||
164271921|NCT04566601|593364450|FG004|Overall Study|No reason available|5|||
164271922|NCT04566601|593364446|FG000|Overall Study|Burden of study procedures|3|||
164271923|NCT04566601|593364447|FG001|Overall Study|Burden of study procedures|0|||
164271924|NCT04566601|593364448|FG002|Overall Study|Burden of study procedures|0|||
164271925|NCT04566601|593364449|FG003|Overall Study|Burden of study procedures|3|||
164271926|NCT04566601|593364450|FG004|Overall Study|Burden of study procedures|1|||
164271927|NCT04566601|593364446|FG000|Overall Study|Change of residence|2|||
164271928|NCT04566601|593364447|FG001|Overall Study|Change of residence|2|||
164271929|NCT04566601|593364448|FG002|Overall Study|Change of residence|0|||
164271930|NCT04566601|593364449|FG003|Overall Study|Change of residence|1|||
164271931|NCT04566601|593364450|FG004|Overall Study|Change of residence|2|||
164271932|NCT04566601|593364446|FG000|Overall Study|Perceived lack of efficacy|2|||
164271933|NCT04566601|593364447|FG001|Overall Study|Perceived lack of efficacy|0|||
164271934|NCT04566601|593364448|FG002|Overall Study|Perceived lack of efficacy|1|||
164271935|NCT04566601|593364449|FG003|Overall Study|Perceived lack of efficacy|1|||
164271936|NCT04566601|593364450|FG004|Overall Study|Perceived lack of efficacy|2|||
164271937|NCT04566601|593364446|FG000|Overall Study|Adverse Event|7|||
164271938|NCT04566601|593364447|FG001|Overall Study|Adverse Event|4|||
164271939|NCT04566601|593364448|FG002|Overall Study|Adverse Event|6|||
164271940|NCT04566601|593364449|FG003|Overall Study|Adverse Event|5|||
164271941|NCT04566601|593364450|FG004|Overall Study|Adverse Event|12|||
164582877|NCT03396471|594499628|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
164582878|NCT03396471|594499628|FG000|Follow up - Up to 2 Years|study terminated|1|||
164582879|NCT03396471|594499628|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
164582880|NCT03396471|594499628|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
164582881|NCT01319929|594499631|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
164688510|NCT01886872|594883274|FG000|Overall Study|Ineligible|7|||
164688511|NCT01886872|594883275|FG001|Overall Study|Ineligible|4|||
164688512|NCT01886872|594883276|FG002|Overall Study|Ineligible|12|||
164271942|NCT02522325|593364451|FG000|Overall Study|Adverse Event|0|||
164271943|NCT02522325|593364452|FG001|Overall Study|Adverse Event|1|||
164271944|NCT01209078|593364453|FG000|Overall Study|Adverse Event|5|||
164271945|NCT01209078|593364454|FG001|Overall Study|Adverse Event|0|||
164271946|NCT01209078|593364453|FG000|Overall Study|Lost to Follow-up|4|||
164271947|NCT01209078|593364454|FG001|Overall Study|Lost to Follow-up|0|||
164582882|NCT01319929|594499632|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
164271948|NCT01209078|593364453|FG000|Overall Study|Physician Decision|5|||
164582883|NCT01319929|594499631|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
164582884|NCT01319929|594499632|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
164582885|NCT01319929|594499631|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
164688513|NCT01957150|594883277|FG000|Overall Study|Adverse Event|23|||
164271949|NCT01209078|593364454|FG001|Overall Study|Physician Decision|2|||
164688514|NCT01957150|594883278|FG001|Overall Study|Adverse Event|20|||
164688515|NCT01957150|594883277|FG000|Overall Study|Withdrawal by Subject|13|||
164688516|NCT01957150|594883278|FG001|Overall Study|Withdrawal by Subject|17|||
164688517|NCT01957150|594883277|FG000|Overall Study|Physician Decision|3|||
164688518|NCT01957150|594883278|FG001|Overall Study|Physician Decision|6|||
164688519|NCT01957150|594883277|FG000|Overall Study|Lost to Follow-up|4|||
164688520|NCT01957150|594883278|FG001|Overall Study|Lost to Follow-up|4|||
164688521|NCT01957150|594883277|FG000|Overall Study|Protocol Violation|1|||
164271950|NCT01209078|593364453|FG000|Overall Study|Withdrawal by Subject|2|||
164271951|NCT01209078|593364454|FG001|Overall Study|Withdrawal by Subject|1|||
164271952|NCT02702180|593364459|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
164271953|NCT02702180|593364460|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
164271954|NCT02702180|593364461|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
164271955|NCT02702180|593364459|FG000|Double-blind Treatment Period|Adverse Event|0|||
164271956|NCT02702180|593364460|FG001|Double-blind Treatment Period|Adverse Event|0|||
164271957|NCT02702180|593364461|FG002|Double-blind Treatment Period|Adverse Event|1|||
164271958|NCT02702180|593364459|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
164271959|NCT02702180|593364460|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
164688522|NCT01957150|594883278|FG001|Overall Study|Protocol Violation|0|||
164688523|NCT01957150|594883277|FG000|Overall Study|Lack of Efficacy|11|||
164271960|NCT02702180|593364461|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
164271961|NCT02702180|593364459|FG000|Double-blind Treatment Period|Protocol Violation|0|||
164271962|NCT02702180|593364460|FG001|Double-blind Treatment Period|Protocol Violation|0|||
164271963|NCT02702180|593364461|FG002|Double-blind Treatment Period|Protocol Violation|2|||
164271964|NCT02702180|593364459|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
164271965|NCT02702180|593364460|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
164271966|NCT02702180|593364461|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
164271967|NCT02702180|593364459|FG000|Open-label Treatment Period|Withdrawn in error|0|||
164271968|NCT02702180|593364460|FG001|Open-label Treatment Period|Withdrawn in error|0|||
164271969|NCT02702180|593364461|FG002|Open-label Treatment Period|Withdrawn in error|1|||
164271970|NCT00785980|593364462|FG000|7 Day Washout Period|Protocol Violation|3|||
164271971|NCT00448747|593364475|FG000|Overall Study|collapsed veins|1|||
164271972|NCT00448747|593364476|FG001|Overall Study|collapsed veins|0|||
164271973|NCT00387725|593364477|FG000|Overall Study|Adverse Event|0|||
164271974|NCT00387725|593364478|FG001|Overall Study|Adverse Event|0|||
164271975|NCT00387725|593364479|FG002|Overall Study|Adverse Event|0|||
164271976|NCT00387725|593364480|FG003|Overall Study|Adverse Event|1|||
164271977|NCT00387725|593364477|FG000|Overall Study|Protocol Violation|0|||
164271978|NCT00387725|593364478|FG001|Overall Study|Protocol Violation|1|||
164271979|NCT00387725|593364479|FG002|Overall Study|Protocol Violation|0|||
164271980|NCT00387725|593364480|FG003|Overall Study|Protocol Violation|0|||
164271981|NCT00387725|593364477|FG000|Overall Study|Withdrawal by Subject|1|||
164271982|NCT00387725|593364478|FG001|Overall Study|Withdrawal by Subject|0|||
164271983|NCT00387725|593364479|FG002|Overall Study|Withdrawal by Subject|1|||
164271984|NCT00387725|593364480|FG003|Overall Study|Withdrawal by Subject|0|||
164271985|NCT00387725|593364477|FG000|Overall Study|Parent/legal guardian request|0|||
164688524|NCT01957150|594883278|FG001|Overall Study|Lack of Efficacy|11|||
164688525|NCT00098475|594883279|FG000|Step 1|Progressive disease|33|||
164688526|NCT00098475|594883280|FG001|Step 1|Progressive disease|35|||
164271986|NCT00387725|593364478|FG001|Overall Study|Parent/legal guardian request|0|||
164271987|NCT00387725|593364479|FG002|Overall Study|Parent/legal guardian request|1|||
164271988|NCT00387725|593364480|FG003|Overall Study|Parent/legal guardian request|1|||
164271989|NCT00568126|593364481|FG000|Overall Study|Adverse Event|3|||
164271990|NCT00568126|593364482|FG001|Overall Study|Adverse Event|0|||
164271991|NCT00568126|593364481|FG000|Overall Study|Withdrawal by Subject|2|||
164271992|NCT00568126|593364482|FG001|Overall Study|Withdrawal by Subject|3|||
164271993|NCT00568126|593364481|FG000|Overall Study|Lost to Follow-up|4|||
164688527|NCT00098475|594883281|FG002|Step 1|Progressive disease|2|||
164271994|NCT00568126|593364482|FG001|Overall Study|Lost to Follow-up|3|||
164271995|NCT00568126|593364481|FG000|Overall Study|Lack of Efficacy|0|||
164271996|NCT00568126|593364482|FG001|Overall Study|Lack of Efficacy|1|||
164271997|NCT00568126|593364481|FG000|Overall Study|Physician Decision|2|||
164271998|NCT00568126|593364482|FG001|Overall Study|Physician Decision|2|||
164271999|NCT02241343|593364483|FG000|Overall Study|Adverse Event|1|||
164272000|NCT04680975|593364484|FG000|Overall Study|Adverse Event|3|||
164688528|NCT00098475|594883282|FG003|Step 1|Progressive disease|1|||
164688529|NCT00098475|594883279|FG000|Step 1|Adverse Event|56|||
164272001|NCT04680975|593364484|FG000|Overall Study|Death|1|||
164272002|NCT04680975|593364484|FG000|Overall Study|Progressive Disease|1|||
164272003|NCT04680975|593364484|FG000|Overall Study|Withdrawal by Subject|1|||
164272004|NCT02429791|593364486|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
164272005|NCT02429791|593364487|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
164272006|NCT02429791|593364486|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
164688530|NCT00098475|594883280|FG001|Step 1|Adverse Event|37|||
164688531|NCT00098475|594883281|FG002|Step 1|Adverse Event|0|||
164272007|NCT02429791|593364487|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
164272008|NCT02429791|593364486|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
164272009|NCT02429791|593364487|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
164272010|NCT02429791|593364486|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
164272011|NCT02429791|593364487|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
164272012|NCT02429791|593364486|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
164272013|NCT02429791|593364487|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
164272014|NCT02429791|593364486|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
164272015|NCT02429791|593364487|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
164272016|NCT02429791|593364486|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
164272017|NCT02429791|593364487|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
164272018|NCT02429791|593364486|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
164272019|NCT02429791|593364487|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
164272020|NCT02429791|593364486|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
164272021|NCT02429791|593364487|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
164272022|NCT02429791|593364486|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
164272023|NCT02429791|593364487|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
164272024|NCT02429791|593364486|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
164272025|NCT02429791|593364487|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
164272026|NCT02429791|593364486|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
164272027|NCT02429791|593364487|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
164272028|NCT02429791|593364486|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
164272029|NCT02429791|593364487|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
164272030|NCT02429791|593364486|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
164272031|NCT02429791|593364487|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
164272032|NCT02429791|593364486|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
164272033|NCT02429791|593364487|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
164272034|NCT02429791|593364486|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
164272035|NCT02429791|593364487|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
164272036|NCT02429791|593364486|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
164272037|NCT02429791|593364487|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
164272038|NCT02429791|593364486|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
164272039|NCT02429791|593364487|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
164272040|NCT02615691|593364488|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
164272041|NCT02615691|593364488|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
164272042|NCT02615691|593364488|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
164272043|NCT02615691|593364488|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
164272044|NCT04201093|593364489|FG000|Overall Study|Adverse Event|6|||
164272045|NCT04201093|593364490|FG001|Overall Study|Adverse Event|29|||
164272046|NCT04201093|593364491|FG002|Overall Study|Adverse Event|35|||
164272047|NCT04201093|593364489|FG000|Overall Study|Death|2|||
164272048|NCT04201093|593364490|FG001|Overall Study|Death|1|||
164272049|NCT04201093|593364491|FG002|Overall Study|Death|0|||
164272050|NCT04201093|593364489|FG000|Overall Study|Lack of Efficacy|5|||
164272051|NCT04201093|593364490|FG001|Overall Study|Lack of Efficacy|1|||
164272052|NCT04201093|593364491|FG002|Overall Study|Lack of Efficacy|2|||
164272053|NCT04201093|593364489|FG000|Overall Study|Lost to Follow-up|0|||
164272054|NCT04201093|593364490|FG001|Overall Study|Lost to Follow-up|0|||
164272055|NCT04201093|593364491|FG002|Overall Study|Lost to Follow-up|1|||
164272056|NCT04201093|593364489|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
164272057|NCT04201093|593364490|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
164272058|NCT04201093|593364491|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
164272059|NCT04201093|593364489|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
164272060|NCT04201093|593364490|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
164272061|NCT04201093|593364491|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
164272062|NCT04201093|593364489|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
164272063|NCT04201093|593364490|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
164272064|NCT04201093|593364491|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
164272065|NCT04201093|593364489|FG000|Overall Study|Physician Decision|1|||
164272066|NCT04201093|593364490|FG001|Overall Study|Physician Decision|0|||
164272067|NCT04201093|593364491|FG002|Overall Study|Physician Decision|0|||
164272068|NCT04201093|593364489|FG000|Overall Study|Protocol Deviation|1|||
164272069|NCT04201093|593364490|FG001|Overall Study|Protocol Deviation|0|||
164272070|NCT04201093|593364491|FG002|Overall Study|Protocol Deviation|0|||
164272071|NCT04201093|593364489|FG000|Overall Study|Site Terminated by Sponsor|5|||
164272072|NCT04201093|593364490|FG001|Overall Study|Site Terminated by Sponsor|3|||
164272073|NCT04201093|593364491|FG002|Overall Study|Site Terminated by Sponsor|1|||
164272074|NCT04201093|593364489|FG000|Overall Study|Withdrawal by Subject|7|||
164272075|NCT04201093|593364490|FG001|Overall Study|Withdrawal by Subject|8|||
164272076|NCT04201093|593364491|FG002|Overall Study|Withdrawal by Subject|15|||
164272077|NCT04201093|593364489|FG000|Overall Study|Other|0|||
164272078|NCT04201093|593364490|FG001|Overall Study|Other|1|||
164272079|NCT04201093|593364491|FG002|Overall Study|Other|2|||
164272080|NCT00881504|593364492|FG000|Overall Study|Withdrawal by Subject|1|||
164272081|NCT01276223|593364493|FG000|Overall Study|Adverse Event|7|||
164272082|NCT01276223|593364494|FG001|Overall Study|Adverse Event|4|||
164272083|NCT01276223|593364495|FG002|Overall Study|Adverse Event|1|||
164272084|NCT01276223|593364493|FG000|Overall Study|Lost to Follow-up|0|||
164272085|NCT01276223|593364494|FG001|Overall Study|Lost to Follow-up|0|||
164272086|NCT01276223|593364495|FG002|Overall Study|Lost to Follow-up|1|||
164272087|NCT01276223|593364493|FG000|Overall Study|Other|0|||
164272088|NCT01276223|593364494|FG001|Overall Study|Other|0|||
164272089|NCT01276223|593364495|FG002|Overall Study|Other|1|||
164272090|NCT01276223|593364493|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
164272091|NCT01276223|593364494|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
164272092|NCT01276223|593364495|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
164272093|NCT01276223|593364493|FG000|Overall Study|Protocol Violation|1|||
164272094|NCT01276223|593364494|FG001|Overall Study|Protocol Violation|0|||
164272095|NCT01276223|593364495|FG002|Overall Study|Protocol Violation|0|||
164272096|NCT02017522|593364496|FG000|Overall Study|Withdrawal by Subject|1|||
164272097|NCT02596230|593364497|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
164272098|NCT02596230|593364498|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
164272099|NCT02596230|593364499|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
164430915|NCT00662909|593947356|FG000|Overall Study|Randomized- never received study drug|1|||
164430916|NCT00662909|593947357|FG001|Overall Study|Randomized- never received study drug|0|||
164430917|NCT00662909|593947358|FG002|Overall Study|Randomized- never received study drug|0|||
164430918|NCT00662909|593947356|FG000|Overall Study|Non-compliance with study procedures|3|||
164430919|NCT00662909|593947357|FG001|Overall Study|Non-compliance with study procedures|3|||
164430920|NCT00662909|593947358|FG002|Overall Study|Non-compliance with study procedures|2|||
164430921|NCT00662909|593947356|FG000|Overall Study|Physician Decision|1|||
164430922|NCT00662909|593947357|FG001|Overall Study|Physician Decision|1|||
164430923|NCT00662909|593947358|FG002|Overall Study|Physician Decision|2|||
164430924|NCT00662909|593947356|FG000|Overall Study|Eligibility criterion not met|0|||
164430925|NCT00662909|593947357|FG001|Overall Study|Eligibility criterion not met|1|||
164430926|NCT00662909|593947358|FG002|Overall Study|Eligibility criterion not met|1|||
164430927|NCT03396835|593949318|FG000|Overall Study|Withdrawn prior to completion|1|||
164430928|NCT03396835|593949318|FG000|Overall Study|Did not meet criteria for data analysis|1|||
164430929|NCT03467724|593949319|FG000|Overall Study|Lost to Follow-up|5|||
164430930|NCT03467724|593949319|FG000|Overall Study|Withdrawal by Subject|1|||
164430931|NCT03467724|593949319|FG000|Overall Study|Protocol Violation|1|||
164430932|NCT03467724|593949319|FG000|Overall Study|Adverse Event|1|||
164430933|NCT01451814|593949320|FG000|Overall Study|Withdrawal by Subject|1|||
164430934|NCT01451814|593949321|FG001|Overall Study|Withdrawal by Subject|1|||
164430935|NCT01451814|593949320|FG000|Overall Study|Lost to Follow-up|5|||
164430936|NCT01451814|593949321|FG001|Overall Study|Lost to Follow-up|4|||
164430937|NCT02049866|593949322|FG000|Overall Study|Withdrawal by Subject|1|||
164430938|NCT00918957|593949325|FG000|Overall Study|Adverse Event|2|||
164430939|NCT00918957|593949326|FG001|Overall Study|Adverse Event|0|||
164430940|NCT00918957|593949325|FG000|Overall Study|Withdrawal by Subject|1|||
164430941|NCT00918957|593949326|FG001|Overall Study|Withdrawal by Subject|0|||
164430942|NCT03107611|593949327|FG000|Overall Study|Adverse Event|1|||
164430943|NCT03107611|593949328|FG001|Overall Study|Adverse Event|0|||
164430944|NCT03107611|593949329|FG002|Overall Study|Adverse Event|2|||
164430945|NCT03107611|593949327|FG000|Overall Study|Lost to Follow-up|3|||
164430946|NCT03107611|593949328|FG001|Overall Study|Lost to Follow-up|3|||
164430947|NCT03107611|593949329|FG002|Overall Study|Lost to Follow-up|3|||
164430948|NCT03107611|593949327|FG000|Overall Study|Protocol Violation|0|||
164430949|NCT03107611|593949328|FG001|Overall Study|Protocol Violation|0|||
164430950|NCT03107611|593949329|FG002|Overall Study|Protocol Violation|1|||
164430951|NCT03107611|593949327|FG000|Overall Study|Withdrawal by Subject|1|||
164272100|NCT02596230|593364500|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
164272101|NCT02596230|593364501|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
164272102|NCT02596230|593364497|FG000|Objective 2, One Year|Lost to Follow-up|0|||
164272103|NCT02596230|593364498|FG001|Objective 2, One Year|Lost to Follow-up|41|||
164272104|NCT02596230|593364499|FG002|Objective 2, One Year|Lost to Follow-up|41|||
164272105|NCT02596230|593364500|FG003|Objective 2, One Year|Lost to Follow-up|32|||
164272106|NCT02596230|593364501|FG004|Objective 2, One Year|Lost to Follow-up|46|||
164272107|NCT02596230|593364497|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
164430952|NCT03107611|593949328|FG001|Overall Study|Withdrawal by Subject|0|||
164430953|NCT03107611|593949329|FG002|Overall Study|Withdrawal by Subject|1|||
164430954|NCT03107611|593949327|FG000|Overall Study|Worsening signs/symptoms|2|||
164430955|NCT03107611|593949328|FG001|Overall Study|Worsening signs/symptoms|1|||
164582886|NCT01319929|594499632|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
164582887|NCT01319929|594499631|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
164582888|NCT01319929|594499632|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
164582889|NCT01319929|594499631|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
164582890|NCT01319929|594499632|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
164272108|NCT02596230|593364498|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
164272109|NCT02596230|593364499|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
164272110|NCT02596230|593364500|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
164272111|NCT02596230|593364501|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
164272112|NCT02596230|593364497|FG000|Objective 2, One Year|Adverse drug reaction|0|||
164272113|NCT02596230|593364498|FG001|Objective 2, One Year|Adverse drug reaction|1|||
164272114|NCT02596230|593364499|FG002|Objective 2, One Year|Adverse drug reaction|0|||
164272115|NCT02596230|593364500|FG003|Objective 2, One Year|Adverse drug reaction|0|||
164272116|NCT02596230|593364501|FG004|Objective 2, One Year|Adverse drug reaction|0|||
164272117|NCT02596230|593364497|FG000|Objective 2, One Year|Death|0|||
164272118|NCT02596230|593364498|FG001|Objective 2, One Year|Death|12|||
164272119|NCT02596230|593364499|FG002|Objective 2, One Year|Death|41|||
164272120|NCT02596230|593364500|FG003|Objective 2, One Year|Death|21|||
164272121|NCT02596230|593364501|FG004|Objective 2, One Year|Death|30|||
164272122|NCT02596230|593364497|FG000|Objective 2, One Year|Other|0|||
164272123|NCT02596230|593364498|FG001|Objective 2, One Year|Other|3|||
164272124|NCT02596230|593364499|FG002|Objective 2, One Year|Other|2|||
164272125|NCT02596230|593364500|FG003|Objective 2, One Year|Other|0|||
164272126|NCT02596230|593364501|FG004|Objective 2, One Year|Other|0|||
164272127|NCT00771615|593364502|FG000|Overall Study|Withdrawal by Subject|0|||
164272128|NCT00771615|593364503|FG001|Overall Study|Withdrawal by Subject|1|||
164272129|NCT00771615|593364504|FG002|Overall Study|Withdrawal by Subject|0|||
164272130|NCT00771615|593364505|FG003|Overall Study|Withdrawal by Subject|0|||
164272131|NCT00771615|593364506|FG004|Overall Study|Withdrawal by Subject|0|||
164272132|NCT00771615|593364507|FG005|Overall Study|Withdrawal by Subject|0|||
164272133|NCT00771615|593364508|FG006|Overall Study|Withdrawal by Subject|0|||
164272134|NCT00771615|593364509|FG007|Overall Study|Withdrawal by Subject|1|||
164272135|NCT00771615|593364510|FG008|Overall Study|Withdrawal by Subject|0|||
164272136|NCT00771615|593364502|FG000|Overall Study|Lost to Follow-up|1|||
164272137|NCT00771615|593364503|FG001|Overall Study|Lost to Follow-up|1|||
164272138|NCT00771615|593364504|FG002|Overall Study|Lost to Follow-up|1|||
164272139|NCT00771615|593364505|FG003|Overall Study|Lost to Follow-up|1|||
164272140|NCT00771615|593364506|FG004|Overall Study|Lost to Follow-up|0|||
164272141|NCT00771615|593364507|FG005|Overall Study|Lost to Follow-up|1|||
164272142|NCT00771615|593364508|FG006|Overall Study|Lost to Follow-up|1|||
164272143|NCT00771615|593364509|FG007|Overall Study|Lost to Follow-up|0|||
164272144|NCT00771615|593364510|FG008|Overall Study|Lost to Follow-up|0|||
164272145|NCT02704689|593364512|FG000|Overall Study|Physician Decision|1|||
164272146|NCT02704689|593364512|FG000|Overall Study|Study device not implanted|2|||
164272147|NCT00802893|593364513|FG000|Overall Study|study terminated|3|||
164272148|NCT00320424|593364514|FG000|Overall Study|Adverse Event|3|||
164272149|NCT00320424|593364514|FG000|Overall Study|Other|3|||
164272150|NCT02540668|593364516|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
164272151|NCT02540668|593364517|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
164272152|NCT03270891|593364518|FG000|Overall Study|Lost to Follow-up|3|||
164272153|NCT03270891|593364519|FG001|Overall Study|Lost to Follow-up|6|||
164272154|NCT03270891|593364520|FG002|Overall Study|Lost to Follow-up|0|||
164272155|NCT03270891|593364518|FG000|Overall Study|Withdrawal by Subject|1|||
164272156|NCT03270891|593364519|FG001|Overall Study|Withdrawal by Subject|0|||
164272157|NCT03270891|593364520|FG002|Overall Study|Withdrawal by Subject|0|||
164272158|NCT03270891|593364518|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
164272159|NCT03270891|593364519|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
164272160|NCT03270891|593364520|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
164342397|NCT04457336|593629430|FG004|Period 4: Part C|Site Terminated|0|||
164272161|NCT00849108|593364521|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
164342398|NCT04457336|593629431|FG005|Period 4: Part C|Site Terminated|0|||
164582891|NCT03237845|594499633|FG000|Overall Study|Adverse Event|0|||
164582892|NCT03237845|594499634|FG001|Overall Study|Adverse Event|1|||
164272162|NCT00849108|593364522|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
164272163|NCT00849108|593364521|FG000|Cohort 2 Efficacy|Adverse Event|0|||
164582893|NCT03237845|594499633|FG000|Overall Study|Lost to Follow-up|13|||
164582894|NCT03237845|594499634|FG001|Overall Study|Lost to Follow-up|10|||
164582895|NCT03237845|594499633|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
164582896|NCT03237845|594499634|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
164582897|NCT03237845|594499633|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
164272164|NCT00849108|593364522|FG001|Cohort 2 Efficacy|Adverse Event|1|||
164342399|NCT04457336|593629432|FG006|Period 4: Part C|Site Terminated|0|||
164582898|NCT03237845|594499634|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
164342400|NCT04457336|593629433|FG007|Period 4: Part C|Site Terminated|1|||
164430956|NCT03107611|593949329|FG002|Overall Study|Worsening signs/symptoms|2|||
164430957|NCT01020838|593949332|FG000|Overall Study|Death|90|||
164272165|NCT00849108|593364521|FG000|Cohort 2 Efficacy|Other|0|||
164430958|NCT01020838|593949332|FG000|Overall Study|Adverse Event|1|||
164430959|NCT01020838|593949332|FG000|Overall Study|Withdrawal by Subject|9|||
164272166|NCT00849108|593364522|FG001|Cohort 2 Efficacy|Other|9|||
164272167|NCT02211313|593364523|FG000|Overall Study|Treatment Failure|5|||
164272168|NCT02211313|593364524|FG001|Overall Study|Treatment Failure|2|||
164272169|NCT02211313|593364523|FG000|Overall Study|No Follow up Questionnaires|1|||
164272170|NCT02211313|593364524|FG001|Overall Study|No Follow up Questionnaires|1|||
164272171|NCT01943552|593364525|FG000|Overall Study|Adverse Event|3|||
164272172|NCT01943552|593364526|FG001|Overall Study|Adverse Event|2|||
164272173|NCT01943552|593364525|FG000|Overall Study|Withdrawal by Subject|6|||
164272174|NCT01943552|593364526|FG001|Overall Study|Withdrawal by Subject|6|||
164272175|NCT01943552|593364525|FG000|Overall Study|Other Reasons|16|||
164272176|NCT01943552|593364526|FG001|Overall Study|Other Reasons|17|||
164272177|NCT01475162|593364527|FG000|Overall Study|Physician Decision|1|||
164272178|NCT01475162|593364527|FG000|Overall Study|Death|10|||
164272179|NCT01475162|593364527|FG000|Overall Study|Study closed for safety|3|||
164272180|NCT00545103|593364528|FG000|Overall Study|Lack of Efficacy|48|||
164272181|NCT00545103|593364529|FG001|Overall Study|Lack of Efficacy|45|||
164272182|NCT00545103|593364530|FG002|Overall Study|Lack of Efficacy|31|||
164272183|NCT00545103|593364531|FG003|Overall Study|Lack of Efficacy|27|||
164272184|NCT00545103|593364528|FG000|Overall Study|Withdrawal by Subject|6|||
164272185|NCT00545103|593364529|FG001|Overall Study|Withdrawal by Subject|10|||
164272186|NCT00545103|593364530|FG002|Overall Study|Withdrawal by Subject|18|||
164272187|NCT00545103|593364531|FG003|Overall Study|Withdrawal by Subject|22|||
164272188|NCT00545103|593364528|FG000|Overall Study|Adverse Event|11|||
164272189|NCT00545103|593364529|FG001|Overall Study|Adverse Event|12|||
164272190|NCT00545103|593364530|FG002|Overall Study|Adverse Event|17|||
164272191|NCT00545103|593364531|FG003|Overall Study|Adverse Event|10|||
164272192|NCT00545103|593364528|FG000|Overall Study|Lost to Follow-up|4|||
164272193|NCT00545103|593364529|FG001|Overall Study|Lost to Follow-up|6|||
164272194|NCT00545103|593364530|FG002|Overall Study|Lost to Follow-up|3|||
164272195|NCT00545103|593364531|FG003|Overall Study|Lost to Follow-up|4|||
164272196|NCT00545103|593364528|FG000|Overall Study|Protocol Violation|1|||
164272197|NCT00545103|593364529|FG001|Overall Study|Protocol Violation|2|||
164272198|NCT00545103|593364530|FG002|Overall Study|Protocol Violation|3|||
164272199|NCT00545103|593364531|FG003|Overall Study|Protocol Violation|0|||
164272200|NCT00545103|593364528|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
164272201|NCT00545103|593364529|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
164272202|NCT00545103|593364530|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
164272203|NCT00545103|593364531|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
164272204|NCT00545103|593364528|FG000|Overall Study|Difficult to open package|0|||
164272205|NCT00545103|593364529|FG001|Overall Study|Difficult to open package|0|||
164272206|NCT00545103|593364530|FG002|Overall Study|Difficult to open package|0|||
164272207|NCT00545103|593364531|FG003|Overall Study|Difficult to open package|1|||
164272208|NCT00545103|593364528|FG000|Overall Study|Investigational product not taken|1|||
164272209|NCT00545103|593364529|FG001|Overall Study|Investigational product not taken|0|||
164272210|NCT00545103|593364530|FG002|Overall Study|Investigational product not taken|0|||
164272211|NCT00545103|593364531|FG003|Overall Study|Investigational product not taken|1|||
164272212|NCT00545103|593364528|FG000|Overall Study|Wish to start a family|0|||
164272213|NCT00545103|593364529|FG001|Overall Study|Wish to start a family|0|||
164272214|NCT00545103|593364530|FG002|Overall Study|Wish to start a family|0|||
164272215|NCT00545103|593364531|FG003|Overall Study|Wish to start a family|1|||
164272216|NCT00545103|593364528|FG000|Overall Study|Diverticulitis crisis|0|||
164272217|NCT00545103|593364529|FG001|Overall Study|Diverticulitis crisis|0|||
164272218|NCT00545103|593364530|FG002|Overall Study|Diverticulitis crisis|0|||
164272219|NCT00545103|593364531|FG003|Overall Study|Diverticulitis crisis|1|||
164272220|NCT00545103|593364528|FG000|Overall Study|Personal reasons|1|||
164272221|NCT00545103|593364529|FG001|Overall Study|Personal reasons|0|||
164582899|NCT03237845|594499633|FG000|Overall Study|Physician Decision|1|||
164582900|NCT03237845|594499634|FG001|Overall Study|Physician Decision|2|||
164582901|NCT03237845|594499633|FG000|Overall Study|Pregnancy|1|||
164582902|NCT03237845|594499634|FG001|Overall Study|Pregnancy|0|||
164582903|NCT03237845|594499633|FG000|Overall Study|Protocol Deviation|0|||
164582904|NCT03237845|594499634|FG001|Overall Study|Protocol Deviation|1|||
164582905|NCT03237845|594499633|FG000|Overall Study|Technical Problems|8|||
164582906|NCT03237845|594499634|FG001|Overall Study|Technical Problems|1|||
164430960|NCT01020838|593949332|FG000|Overall Study|Lost to Follow-up|6|||
164582907|NCT03237845|594499633|FG000|Overall Study|Withdrawal by Subject|3|||
164272222|NCT00545103|593364530|FG002|Overall Study|Personal reasons|0|||
164272223|NCT00545103|593364531|FG003|Overall Study|Personal reasons|0|||
164272224|NCT00545103|593364528|FG000|Overall Study|Subject's decision|1|||
164272225|NCT00545103|593364529|FG001|Overall Study|Subject's decision|0|||
164272226|NCT00545103|593364530|FG002|Overall Study|Subject's decision|0|||
164272227|NCT00545103|593364531|FG003|Overall Study|Subject's decision|0|||
164272228|NCT00545103|593364528|FG000|Overall Study|Noncompliance|0|||
164272229|NCT00545103|593364529|FG001|Overall Study|Noncompliance|1|||
164272230|NCT00545103|593364530|FG002|Overall Study|Noncompliance|0|||
164272231|NCT00545103|593364531|FG003|Overall Study|Noncompliance|0|||
164272232|NCT00545103|593364528|FG000|Overall Study|Investigator decision|0|||
164272233|NCT00545103|593364529|FG001|Overall Study|Investigator decision|0|||
164272234|NCT00545103|593364530|FG002|Overall Study|Investigator decision|1|||
164272235|NCT00545103|593364531|FG003|Overall Study|Investigator decision|0|||
164272236|NCT00545103|593364528|FG000|Overall Study|Subject moved|0|||
164272237|NCT00545103|593364529|FG001|Overall Study|Subject moved|1|||
164272238|NCT00545103|593364530|FG002|Overall Study|Subject moved|0|||
164272239|NCT00545103|593364531|FG003|Overall Study|Subject moved|0|||
164272240|NCT00545103|593364528|FG000|Overall Study|Use of prohibited medication|0|||
164342401|NCT04457336|593629426|FG000|Period 4: Part C|Other|0|||
164342402|NCT04457336|593629427|FG001|Period 4: Part C|Other|0|||
164342403|NCT04457336|593629428|FG002|Period 4: Part C|Other|0|||
164342404|NCT04457336|593629429|FG003|Period 4: Part C|Other|0|||
164342405|NCT04457336|593629430|FG004|Period 4: Part C|Other|0|||
164342406|NCT04457336|593629431|FG005|Period 4: Part C|Other|0|||
164342407|NCT04457336|593629432|FG006|Period 4: Part C|Other|0|||
164342408|NCT04457336|593629433|FG007|Period 4: Part C|Other|2|||
164342409|NCT04457336|593629426|FG000|Period 4: Part C|Withdrawal by Subject|0|||
164342410|NCT04457336|593629427|FG001|Period 4: Part C|Withdrawal by Subject|0|||
164342411|NCT04457336|593629428|FG002|Period 4: Part C|Withdrawal by Subject|0|||
164342412|NCT04457336|593629429|FG003|Period 4: Part C|Withdrawal by Subject|0|||
164342413|NCT04457336|593629430|FG004|Period 4: Part C|Withdrawal by Subject|0|||
164342414|NCT04457336|593629431|FG005|Period 4: Part C|Withdrawal by Subject|0|||
164342415|NCT04457336|593629432|FG006|Period 4: Part C|Withdrawal by Subject|0|||
164342416|NCT04457336|593629433|FG007|Period 4: Part C|Withdrawal by Subject|3|||
164342417|NCT00446251|593629442|FG000|Overall Study|On-study Transplants|2|||
164342418|NCT00446251|593629442|FG000|Overall Study|Rituximab Infusion Reaction|2|||
164342419|NCT00446251|593629442|FG000|Overall Study|Lost to Follow-up|1|||
164342420|NCT01416272|593629446|FG000|Overall Study|Unacceptable distance visual acuity|2|||
164342421|NCT01416272|593629446|FG000|Overall Study|Lost to Follow-up|1|||
164342422|NCT01416272|593629446|FG000|Overall Study|Study related complaints|1|||
164342423|NCT00702689|593629447|FG000|Overall Study|Withdrawal by Subject|4|||
164342424|NCT00702689|593629447|FG000|Overall Study|Recurrent malignancy|1|||
164342425|NCT00702689|593629447|FG000|Overall Study|Adverse Event|1|||
164342426|NCT01986907|593629450|FG000|Overall Study|Adverse Event|11|||
164342427|NCT01986907|593629450|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
164342428|NCT01986907|593629450|FG000|Overall Study|Protocol Violation|4|||
164342429|NCT01986907|593629450|FG000|Overall Study|Withdrawal by Subject|76|||
164342430|NCT01986907|593629450|FG000|Overall Study|Lost to Follow-up|38|||
164342431|NCT01986907|593629450|FG000|Overall Study|Death|9|||
164342432|NCT00239590|593629453|FG000|Randomized|Lost to Follow-up|0|||
164342433|NCT00239590|593629454|FG001|Randomized|Lost to Follow-up|1|||
164342434|NCT00239590|593629453|FG000|Randomized|Withdrawal by Subject|0|||
164342435|NCT00239590|593629454|FG001|Randomized|Withdrawal by Subject|1|||
164342436|NCT00239590|593629453|FG000|Completed Study Protocol|Adverse Event|1|||
164342437|NCT00239590|593629454|FG001|Completed Study Protocol|Adverse Event|1|||
164342438|NCT00239590|593629453|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
164342439|NCT00239590|593629454|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
164342440|NCT00892047|593629459|FG000|Overall Study|Adverse Event|2|||
164342441|NCT00892047|593629460|FG001|Overall Study|Adverse Event|2|||
164342442|NCT00892047|593629459|FG000|Overall Study|subject burden|2|||
164342443|NCT00892047|593629460|FG001|Overall Study|subject burden|3|||
164342444|NCT00892047|593629459|FG000|Overall Study|Lack of Efficacy|0|||
164342445|NCT00892047|593629460|FG001|Overall Study|Lack of Efficacy|2|||
164342446|NCT02217878|593629461|FG000|Overall Study|required morphine due to chest pain|1|||
164342447|NCT02217878|593629462|FG001|Overall Study|required morphine due to chest pain|2|||
164342448|NCT02217878|593629461|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
164272241|NCT00545103|593364529|FG001|Overall Study|Use of prohibited medication|0|||
164342449|NCT02217878|593629462|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
164272242|NCT00545103|593364530|FG002|Overall Study|Use of prohibited medication|1|||
164272243|NCT00545103|593364531|FG003|Overall Study|Use of prohibited medication|0|||
164272244|NCT00545103|593364528|FG000|Overall Study|Does not want to take study drug anymore|1|||
164272245|NCT00545103|593364529|FG001|Overall Study|Does not want to take study drug anymore|0|||
164272246|NCT00545103|593364530|FG002|Overall Study|Does not want to take study drug anymore|1|||
164272247|NCT00545103|593364531|FG003|Overall Study|Does not want to take study drug anymore|0|||
164342450|NCT00259610|593629465|FG000|Overall Study|Withdrawal by Subject|33|||
164342451|NCT00259610|593629466|FG001|Overall Study|Withdrawal by Subject|25|||
164342452|NCT00259610|593629467|FG002|Overall Study|Withdrawal by Subject|29|||
164342453|NCT00259610|593629468|FG003|Overall Study|Withdrawal by Subject|19|||
164272248|NCT00545103|593364528|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
164342454|NCT00259610|593629465|FG000|Overall Study|Lost to Follow-up|19|||
164342455|NCT00259610|593629466|FG001|Overall Study|Lost to Follow-up|8|||
164272249|NCT00545103|593364529|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
164272250|NCT00545103|593364530|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
164272251|NCT00545103|593364531|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
164272252|NCT00545103|593364528|FG000|Overall Study|Death|0|||
164272253|NCT00545103|593364529|FG001|Overall Study|Death|1|||
164272254|NCT00545103|593364530|FG002|Overall Study|Death|0|||
164272255|NCT00545103|593364531|FG003|Overall Study|Death|0|||
164272256|NCT05026853|593364532|FG000|Overall Study|Cancelled appointment|1|||
164272257|NCT05026853|593364533|FG001|Overall Study|Cancelled appointment|0|||
164272258|NCT05026853|593364532|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
164272259|NCT05026853|593364533|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
164272260|NCT05026853|593364532|FG000|Overall Study|Did not complete 12-week survey|16|||
164272261|NCT05026853|593364533|FG001|Overall Study|Did not complete 12-week survey|16|||
164272262|NCT02358044|593364534|FG000|Overall Study|Adverse Event|0|||
164272263|NCT02358044|593364535|FG001|Overall Study|Adverse Event|1|||
164272264|NCT02358044|593364534|FG000|Overall Study|Lost to Follow-up|2|||
164272265|NCT02358044|593364535|FG001|Overall Study|Lost to Follow-up|1|||
164272266|NCT02358044|593364534|FG000|Overall Study|Physician Decision|0|||
164272267|NCT02358044|593364535|FG001|Overall Study|Physician Decision|1|||
164272268|NCT02358044|593364534|FG000|Overall Study|Withdrawal by Subject|0|||
164272269|NCT02358044|593364535|FG001|Overall Study|Withdrawal by Subject|4|||
164272270|NCT01732913|593364536|FG000|Overall Study|Study Terminated by Sponsor|105|||
164272271|NCT01732913|593364537|FG001|Overall Study|Study Terminated by Sponsor|55|||
164272272|NCT01732913|593364536|FG000|Overall Study|Withdrawal by Subject|27|||
164272273|NCT01732913|593364537|FG001|Overall Study|Withdrawal by Subject|4|||
164272274|NCT01732913|593364536|FG000|Overall Study|Physician Decision|14|||
164272275|NCT01732913|593364537|FG001|Overall Study|Physician Decision|7|||
164272276|NCT01732913|593364536|FG000|Overall Study|Other|7|||
164272277|NCT01732913|593364537|FG001|Overall Study|Other|1|||
164272278|NCT01732913|593364536|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
164272279|NCT01732913|593364537|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
164272280|NCT00903331|593364538|FG000|Overall Study|Death|4|||
164272281|NCT00903331|593364539|FG001|Overall Study|Death|8|||
164272282|NCT00903331|593364538|FG000|Overall Study|Withdrawal of consent|1|||
164272283|NCT00903331|593364539|FG001|Overall Study|Withdrawal of consent|8|||
164272284|NCT00903331|593364538|FG000|Overall Study|Lung transplant|0|||
164272285|NCT00903331|593364539|FG001|Overall Study|Lung transplant|2|||
164272286|NCT02723175|593364540|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
164272287|NCT02723175|593364541|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
164272288|NCT02723175|593364540|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
164272289|NCT02723175|593364541|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
164272290|NCT03233438|593364542|FG000|Overall Study|Lost to Follow-up|4|||
164272291|NCT03233438|593364543|FG001|Overall Study|Lost to Follow-up|9|||
164582908|NCT03237845|594499634|FG001|Overall Study|Withdrawal by Subject|3|||
164688532|NCT00098475|594883282|FG003|Step 1|Adverse Event|1|||
164272292|NCT03233438|593364542|FG000|Overall Study|Withdrawal by Subject|2|||
164272293|NCT03233438|593364543|FG001|Overall Study|Withdrawal by Subject|1|||
164272294|NCT03233438|593364542|FG000|Overall Study|No recording of dalbavancin|0|||
164272295|NCT03233438|593364543|FG001|Overall Study|No recording of dalbavancin|1|||
164272296|NCT00257660|593364548|FG000|Overall Study|Lack of Efficacy|5|||
164272297|NCT00257660|593364549|FG001|Overall Study|Lack of Efficacy|23|||
164272298|NCT00257660|593364548|FG000|Overall Study|Withdrawal by Subject|2|||
164272299|NCT00257660|593364549|FG001|Overall Study|Withdrawal by Subject|0|||
164272300|NCT00257660|593364548|FG000|Overall Study|Lost to Follow-up|1|||
164272301|NCT00257660|593364549|FG001|Overall Study|Lost to Follow-up|0|||
164272302|NCT00257660|593364548|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
164272303|NCT00257660|593364549|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
164272304|NCT00257660|593364548|FG000|Overall Study|No longer wanted to do blood draws|1|||
164272305|NCT00257660|593364549|FG001|Overall Study|No longer wanted to do blood draws|0|||
164272306|NCT04109976|593364550|FG000|Overall Study|Withdrawal by Subject|1|||
164272307|NCT04109976|593364551|FG001|Overall Study|Withdrawal by Subject|0|||
164272308|NCT00491608|593364552|FG000|Overall Study|Death|2|||
164272309|NCT00491608|593364552|FG000|Overall Study|Withdrawal by Subject|1|||
164582909|NCT03237845|594499633|FG000|Overall Study|Other Reasons|4|||
164582910|NCT03237845|594499634|FG001|Overall Study|Other Reasons|0|||
164582911|NCT01221233|594499635|FG000|Overall Study|Withdrawal by Subject|3|||
164582912|NCT01221233|594499636|FG001|Overall Study|Withdrawal by Subject|1|||
164582913|NCT03865407|594499638|FG000|Overall Study|Adverse Event|1|||
164582914|NCT03865407|594499639|FG001|Overall Study|Adverse Event|0|||
164582915|NCT03865407|594499638|FG000|Overall Study|Withdrawal by Subject|1|||
164272310|NCT00413374|593364559|FG000|Overall Study|Ineligible due to screening criteria.|3|||
164272311|NCT00413374|593364560|FG001|Overall Study|Ineligible due to screening criteria.|0|||
164582916|NCT03865407|594499639|FG001|Overall Study|Withdrawal by Subject|0|||
164272312|NCT00413374|593364559|FG000|Overall Study|Adverse Event|1|||
164272313|NCT00413374|593364560|FG001|Overall Study|Adverse Event|0|||
164272314|NCT00413374|593364559|FG000|Overall Study|Lost to Follow-up|1|||
164688533|NCT00098475|594883279|FG000|Step 1|Death|8|||
164688534|NCT00098475|594883280|FG001|Step 1|Death|5|||
164688535|NCT00098475|594883281|FG002|Step 1|Death|0|||
164688536|NCT00098475|594883282|FG003|Step 1|Death|1|||
164688537|NCT00098475|594883279|FG000|Step 1|Withdrawal by Subject|14|||
164688538|NCT00098475|594883280|FG001|Step 1|Withdrawal by Subject|11|||
164688539|NCT00098475|594883281|FG002|Step 1|Withdrawal by Subject|0|||
164688540|NCT00098475|594883282|FG003|Step 1|Withdrawal by Subject|0|||
164688541|NCT00098475|594883279|FG000|Step 1|Physician Decision|5|||
164688542|NCT00098475|594883280|FG001|Step 1|Physician Decision|2|||
164688543|NCT00098475|594883281|FG002|Step 1|Physician Decision|0|||
164688544|NCT00098475|594883282|FG003|Step 1|Physician Decision|0|||
164688545|NCT00098475|594883279|FG000|Step 1|Alternative therapy|31|||
164688546|NCT00098475|594883280|FG001|Step 1|Alternative therapy|43|||
164688547|NCT00098475|594883281|FG002|Step 1|Alternative therapy|1|||
164688548|NCT00098475|594883282|FG003|Step 1|Alternative therapy|0|||
164688549|NCT00098475|594883279|FG000|Step 1|Other disease|2|||
164272315|NCT00413374|593364560|FG001|Overall Study|Lost to Follow-up|0|||
164272316|NCT00413374|593364559|FG000|Overall Study|Surgery|1|||
164272317|NCT00413374|593364560|FG001|Overall Study|Surgery|0|||
164272318|NCT00552760|593364561|FG000|Overall Study|Adverse Event|3|||
164272319|NCT00552760|593364562|FG001|Overall Study|Adverse Event|5|||
164272320|NCT00552760|593364561|FG000|Overall Study|Relapsed- Depressed Event|10|||
164272321|NCT00552760|593364562|FG001|Overall Study|Relapsed- Depressed Event|16|||
164272322|NCT00552760|593364561|FG000|Overall Study|Relapse- Manic Event|3|||
164272323|NCT00552760|593364562|FG001|Overall Study|Relapse- Manic Event|3|||
164272324|NCT00552760|593364561|FG000|Overall Study|Relapsed- Mixed Event|3|||
164272325|NCT00552760|593364562|FG001|Overall Study|Relapsed- Mixed Event|5|||
164272326|NCT00552760|593364561|FG000|Overall Study|Protocol Violation|0|||
164272327|NCT00552760|593364562|FG001|Overall Study|Protocol Violation|1|||
164272328|NCT00552760|593364561|FG000|Overall Study|Lost to Follow-up|1|||
164272329|NCT00552760|593364562|FG001|Overall Study|Lost to Follow-up|1|||
164272330|NCT00552760|593364561|FG000|Overall Study|Non-compliance|1|||
164272331|NCT00552760|593364562|FG001|Overall Study|Non-compliance|1|||
164272332|NCT00552760|593364561|FG000|Overall Study|Medical Condition|1|||
164272333|NCT00552760|593364562|FG001|Overall Study|Medical Condition|1|||
164272334|NCT00552760|593364561|FG000|Overall Study|Withdrawal by Subject|3|||
164272335|NCT00552760|593364562|FG001|Overall Study|Withdrawal by Subject|0|||
164272336|NCT00552760|593364561|FG000|Overall Study|Medication Change|1|||
164272337|NCT00552760|593364562|FG001|Overall Study|Medication Change|0|||
164272338|NCT03615066|593364564|FG000|Main Study|Withdrew Consent|0|||
164272339|NCT03615066|593364565|FG001|Main Study|Withdrew Consent|1|||
164272340|NCT03615066|593364566|FG002|Main Study|Withdrew Consent|1|||
164272341|NCT03615066|593364564|FG000|Main Study|Lost to Follow-up|0|||
164272342|NCT03615066|593364565|FG001|Main Study|Lost to Follow-up|0|||
164272343|NCT03615066|593364566|FG002|Main Study|Lost to Follow-up|1|||
164272344|NCT03615066|593364564|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
164272345|NCT03615066|593364565|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
164272346|NCT03615066|593364566|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
164272347|NCT03615066|593364564|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
164272348|NCT03615066|593364565|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
164272349|NCT03615066|593364566|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
164272350|NCT03615066|593364564|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
164272351|NCT03615066|593364565|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
164272352|NCT03615066|593364566|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
164272353|NCT00924404|593364569|FG000|Overall Study|Lost to Follow-up|6|||
164272354|NCT00924404|593364570|FG001|Overall Study|Lost to Follow-up|4|||
164272355|NCT03831945|593364571|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
164272356|NCT03831945|593364572|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
164272357|NCT03831945|593364571|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
164272358|NCT03831945|593364572|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
164272359|NCT03831945|593364571|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
164272360|NCT03831945|593364572|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
164272361|NCT03426631|593364573|FG000|Overall Study|Lost to Follow-up|0|||
164272362|NCT03426631|593364574|FG001|Overall Study|Lost to Follow-up|1|||
164272363|NCT04032080|593364575|FG000|Overall Study|Death|6|||
164272364|NCT00500760|593364576|FG000|Overall Study|Death|32|||
164272365|NCT00500760|593364577|FG001|Overall Study|Death|15|||
164688550|NCT00098475|594883280|FG001|Step 1|Other disease|1|||
164688551|NCT00098475|594883281|FG002|Step 1|Other disease|1|||
164688552|NCT00098475|594883282|FG003|Step 1|Other disease|0|||
164688553|NCT00098475|594883279|FG000|Step 1|Never started treatment|0|||
164688554|NCT00098475|594883280|FG001|Step 1|Never started treatment|2|||
164688555|NCT00098475|594883281|FG002|Step 1|Never started treatment|0|||
164688556|NCT00098475|594883282|FG003|Step 1|Never started treatment|0|||
164688557|NCT00098475|594883279|FG000|Step 1|Still on treatment as of this analysis|14|||
164688558|NCT00098475|594883280|FG001|Step 1|Still on treatment as of this analysis|27|||
164688559|NCT00098475|594883281|FG002|Step 1|Still on treatment as of this analysis|0|||
164688560|NCT00098475|594883282|FG003|Step 1|Still on treatment as of this analysis|0|||
164688561|NCT00098475|594883279|FG000|Step 1|Knee surgery|1|||
164688562|NCT00098475|594883280|FG001|Step 1|Knee surgery|0|||
164688563|NCT00098475|594883281|FG002|Step 1|Knee surgery|0|||
164688564|NCT00098475|594883282|FG003|Step 1|Knee surgery|0|||
164688565|NCT00098475|594883279|FG000|Step 1|Complications|1|||
164688566|NCT00098475|594883280|FG001|Step 1|Complications|0|||
164688567|NCT00098475|594883281|FG002|Step 1|Complications|0|||
164688568|NCT00098475|594883282|FG003|Step 1|Complications|0|||
164688569|NCT00098475|594883279|FG000|Step 1|Cannot comply due to other tx|0|||
164688570|NCT00098475|594883280|FG001|Step 1|Cannot comply due to other tx|1|||
164688571|NCT00098475|594883281|FG002|Step 1|Cannot comply due to other tx|0|||
164688572|NCT00098475|594883282|FG003|Step 1|Cannot comply due to other tx|0|||
164688573|NCT00098475|594883279|FG000|Step 1|Both patient and physician's decision|2|||
164688574|NCT00098475|594883280|FG001|Step 1|Both patient and physician's decision|1|||
164688575|NCT00098475|594883281|FG002|Step 1|Both patient and physician's decision|0|||
164688576|NCT00098475|594883282|FG003|Step 1|Both patient and physician's decision|0|||
164688577|NCT00098475|594883279|FG000|Step 1|Incorrect disease assessment|2|||
164688578|NCT00098475|594883280|FG001|Step 1|Incorrect disease assessment|0|||
164688579|NCT00098475|594883281|FG002|Step 1|Incorrect disease assessment|0|||
164688580|NCT00098475|594883282|FG003|Step 1|Incorrect disease assessment|0|||
164688581|NCT00098475|594883279|FG000|Step 1|Off treatment for > specified timeframe|1|||
164688582|NCT00098475|594883280|FG001|Step 1|Off treatment for > specified timeframe|1|||
164688583|NCT00098475|594883281|FG002|Step 1|Off treatment for > specified timeframe|0|||
164688584|NCT00098475|594883282|FG003|Step 1|Off treatment for > specified timeframe|0|||
164688585|NCT00098475|594883279|FG000|Step 1|Declining performance status|0|||
164688586|NCT00098475|594883280|FG001|Step 1|Declining performance status|1|||
164688587|NCT00098475|594883281|FG002|Step 1|Declining performance status|0|||
164688588|NCT00098475|594883282|FG003|Step 1|Declining performance status|0|||
164688589|NCT00098475|594883279|FG000|Step 1|Insurance issue|0|||
164688590|NCT00098475|594883280|FG001|Step 1|Insurance issue|1|||
164688591|NCT00098475|594883281|FG002|Step 1|Insurance issue|0|||
164688592|NCT00098475|594883282|FG003|Step 1|Insurance issue|0|||
164688593|NCT00098475|594883279|FG000|Step 1|Rising paraprotein|0|||
164688594|NCT00098475|594883280|FG001|Step 1|Rising paraprotein|1|||
164688595|NCT00098475|594883281|FG002|Step 1|Rising paraprotein|0|||
164688596|NCT00098475|594883282|FG003|Step 1|Rising paraprotein|0|||
164688597|NCT00098475|594883279|FG000|Step 1|Referred to other physicians|0|||
164688598|NCT00098475|594883280|FG001|Step 1|Referred to other physicians|1|||
164688599|NCT00098475|594883281|FG002|Step 1|Referred to other physicians|0|||
164688600|NCT00098475|594883282|FG003|Step 1|Referred to other physicians|0|||
164688601|NCT00098475|594883279|FG000|Step 1|Criteria to continue treatment not met|0|||
164688602|NCT00098475|594883280|FG001|Step 1|Criteria to continue treatment not met|1|||
164688603|NCT00098475|594883281|FG002|Step 1|Criteria to continue treatment not met|0|||
164688604|NCT00098475|594883282|FG003|Step 1|Criteria to continue treatment not met|0|||
164688605|NCT00098475|594883279|FG000|Step 1|Misinterpretation of lab data|0|||
164688606|NCT00098475|594883280|FG001|Step 1|Misinterpretation of lab data|1|||
164688607|NCT00098475|594883281|FG002|Step 1|Misinterpretation of lab data|0|||
164688608|NCT00098475|594883282|FG003|Step 1|Misinterpretation of lab data|0|||
164342456|NCT00259610|593629467|FG002|Overall Study|Lost to Follow-up|18|||
164342457|NCT00259610|593629468|FG003|Overall Study|Lost to Follow-up|15|||
164342458|NCT00259610|593629465|FG000|Overall Study|Physician Decision|6|||
164342459|NCT00259610|593629466|FG001|Overall Study|Physician Decision|4|||
164342460|NCT00259610|593629467|FG002|Overall Study|Physician Decision|7|||
164342461|NCT00259610|593629468|FG003|Overall Study|Physician Decision|2|||
164688609|NCT00098475|594883279|FG000|Step 1|Patient fell with fracture|1|||
164688610|NCT00098475|594883280|FG001|Step 1|Patient fell with fracture|0|||
164688611|NCT00098475|594883281|FG002|Step 1|Patient fell with fracture|0|||
164688612|NCT00098475|594883282|FG003|Step 1|Patient fell with fracture|0|||
164688613|NCT00098475|594883279|FG000|Step 1|Not documented|0|||
164688614|NCT00098475|594883280|FG001|Step 1|Not documented|1|||
164688615|NCT00098475|594883281|FG002|Step 1|Not documented|0|||
164688616|NCT00098475|594883282|FG003|Step 1|Not documented|0|||
164688617|NCT00098475|594883279|FG000|Step 2|Disease progression|1|||
164688618|NCT00098475|594883280|FG001|Step 2|Disease progression|4|||
164688619|NCT00098475|594883281|FG002|Step 2|Disease progression|0|||
164688620|NCT00098475|594883282|FG003|Step 2|Disease progression|0|||
164688621|NCT00098475|594883279|FG000|Step 2|Adverse Event|2|||
164688622|NCT00098475|594883280|FG001|Step 2|Adverse Event|0|||
164688623|NCT00098475|594883281|FG002|Step 2|Adverse Event|0|||
164688624|NCT00098475|594883282|FG003|Step 2|Adverse Event|0|||
164688625|NCT00098475|594883279|FG000|Step 2|Withdrawal by Subject|0|||
164688626|NCT00098475|594883280|FG001|Step 2|Withdrawal by Subject|2|||
164688627|NCT00098475|594883281|FG002|Step 2|Withdrawal by Subject|0|||
164688628|NCT00098475|594883282|FG003|Step 2|Withdrawal by Subject|0|||
164688629|NCT00098475|594883279|FG000|Step 2|Physician Decision|0|||
164688630|NCT00098475|594883280|FG001|Step 2|Physician Decision|1|||
164688631|NCT00098475|594883281|FG002|Step 2|Physician Decision|0|||
164688632|NCT00098475|594883282|FG003|Step 2|Physician Decision|0|||
164688633|NCT00098475|594883279|FG000|Step 2|Alternative therapy|1|||
164688634|NCT00098475|594883280|FG001|Step 2|Alternative therapy|2|||
164688635|NCT00098475|594883281|FG002|Step 2|Alternative therapy|0|||
164688636|NCT00098475|594883282|FG003|Step 2|Alternative therapy|0|||
164688637|NCT00098475|594883279|FG000|Step 2|Never started treatment|1|||
164688638|NCT00098475|594883280|FG001|Step 2|Never started treatment|1|||
164688639|NCT00098475|594883281|FG002|Step 2|Never started treatment|0|||
164688640|NCT00098475|594883282|FG003|Step 2|Never started treatment|0|||
164688641|NCT02472639|594883283|FG000|Overall Study|Physician Decision|4|||
164688642|NCT02472639|594883284|FG001|Overall Study|Physician Decision|3|||
164688643|NCT02050321|594883286|FG000|Overall Study|Withdrawal by Subject|1|||
164688644|NCT02050321|594883286|FG000|Overall Study|Adverse Event|1|||
164688645|NCT04768114|594883288|FG000|Overall Study|Lost to Follow-up|5|||
164688646|NCT04768114|594883289|FG001|Overall Study|Lost to Follow-up|10|||
164688647|NCT04768114|594883288|FG000|Overall Study|Withdrawal by Subject|0|||
164688648|NCT04768114|594883289|FG001|Overall Study|Withdrawal by Subject|1|||
164688649|NCT01963260|594883294|FG000|Overall Study|Withdrawal by Subject|2|||
164688650|NCT01963260|594883295|FG001|Overall Study|Withdrawal by Subject|0|||
164688651|NCT01963260|594883296|FG002|Overall Study|Withdrawal by Subject|0|||
164688652|NCT01963260|594883297|FG003|Overall Study|Withdrawal by Subject|1|||
164688653|NCT01963260|594883298|FG004|Overall Study|Withdrawal by Subject|2|||
164688654|NCT01963260|594883299|FG005|Overall Study|Withdrawal by Subject|0|||
164688655|NCT01963260|594883300|FG006|Overall Study|Withdrawal by Subject|0|||
164688656|NCT01963260|594883301|FG007|Overall Study|Withdrawal by Subject|0|||
164688657|NCT01963260|594883302|FG008|Overall Study|Withdrawal by Subject|0|||
164688658|NCT01963260|594883303|FG009|Overall Study|Withdrawal by Subject|0|||
164272366|NCT00500760|593364576|FG000|Overall Study|Withdrawal by Subject|5|||
164272367|NCT00500760|593364577|FG001|Overall Study|Withdrawal by Subject|7|||
164272368|NCT00500760|593364576|FG000|Overall Study|Administrative decision|2|||
164272369|NCT00500760|593364577|FG001|Overall Study|Administrative decision|0|||
164272370|NCT00500760|593364576|FG000|Overall Study|Lost to Follow-up|3|||
164272371|NCT00500760|593364577|FG001|Overall Study|Lost to Follow-up|0|||
164272372|NCT00500760|593364576|FG000|Overall Study|Other|1|||
164272373|NCT00500760|593364577|FG001|Overall Study|Other|2|||
164272374|NCT03691779|593364582|FG000|Part B (24 Weeks)|Adverse Event|0|||
164272375|NCT03691779|593364583|FG001|Part B (24 Weeks)|Adverse Event|1|||
164272376|NCT03691779|593364582|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
164272377|NCT03691779|593364583|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
164272378|NCT00521222|593364584|FG000|Overall Study|Lost to Follow-up|0|||
164272379|NCT00521222|593364585|FG001|Overall Study|Lost to Follow-up|0|||
164272380|NCT00521222|593364586|FG002|Overall Study|Lost to Follow-up|1|||
164272381|NCT00521222|593364587|FG003|Overall Study|Lost to Follow-up|1|||
164272382|NCT00521222|593364584|FG000|Overall Study|Withdrawal by Subject|0|||
164272383|NCT00521222|593364585|FG001|Overall Study|Withdrawal by Subject|0|||
164272384|NCT00521222|593364586|FG002|Overall Study|Withdrawal by Subject|2|||
164272385|NCT00521222|593364587|FG003|Overall Study|Withdrawal by Subject|0|||
164272386|NCT00521222|593364584|FG000|Overall Study|Physician Decision|0|||
164272387|NCT00521222|593364585|FG001|Overall Study|Physician Decision|1|||
164272388|NCT00521222|593364586|FG002|Overall Study|Physician Decision|0|||
164272389|NCT00521222|593364587|FG003|Overall Study|Physician Decision|1|||
164272390|NCT03869333|593364588|FG000|Overall Study|Lost to Follow-up|1|||
164272391|NCT03869333|593364589|FG001|Overall Study|Lost to Follow-up|0|||
164272392|NCT03869333|593364590|FG002|Overall Study|Lost to Follow-up|0|||
164272393|NCT03869333|593364591|FG003|Overall Study|Lost to Follow-up|0|||
164272394|NCT03869333|593364588|FG000|Overall Study|Pregnancy|1|||
164272395|NCT03869333|593364589|FG001|Overall Study|Pregnancy|0|||
164272396|NCT03869333|593364590|FG002|Overall Study|Pregnancy|0|||
164272397|NCT03869333|593364591|FG003|Overall Study|Pregnancy|0|||
164272398|NCT03869333|593364588|FG000|Overall Study|Physician Decision|0|||
164272399|NCT03869333|593364589|FG001|Overall Study|Physician Decision|1|||
164272400|NCT03869333|593364590|FG002|Overall Study|Physician Decision|0|||
164272401|NCT03869333|593364591|FG003|Overall Study|Physician Decision|0|||
164688659|NCT02340962|594883304|FG000|Overall Study|Lost to Follow-up|1|||
164688660|NCT02340962|594883305|FG001|Overall Study|Lost to Follow-up|0|||
164688661|NCT04994431|594883306|FG000|Overall Study|Adverse Event|1|||
164688662|NCT04994431|594883307|FG001|Overall Study|Adverse Event|0|||
164688663|NCT01341405|594883312|FG000|Overall Study|Adverse Event|0|||
164688664|NCT01341405|594883313|FG001|Overall Study|Adverse Event|1|||
164688665|NCT01341405|594883314|FG002|Overall Study|Adverse Event|1|||
164688666|NCT01341405|594883312|FG000|Overall Study|Withdrawal by Subject|3|||
164688667|NCT01341405|594883313|FG001|Overall Study|Withdrawal by Subject|2|||
164688668|NCT01341405|594883314|FG002|Overall Study|Withdrawal by Subject|1|||
164688669|NCT02760433|594883315|FG000|Overall Study|Lost to Follow-up|1|||
164688670|NCT02760433|594883316|FG001|Overall Study|Lost to Follow-up|0|||
164688671|NCT02760433|594883317|FG002|Overall Study|Lost to Follow-up|1|||
164688672|NCT02760433|594883318|FG003|Overall Study|Lost to Follow-up|0|||
164688673|NCT02760433|594883319|FG004|Overall Study|Lost to Follow-up|0|||
164688674|NCT02760433|594883315|FG000|Overall Study|Withdrawal by Subject|23|||
164688675|NCT02760433|594883316|FG001|Overall Study|Withdrawal by Subject|9|||
164688676|NCT02760433|594883317|FG002|Overall Study|Withdrawal by Subject|0|||
164688677|NCT02760433|594883318|FG003|Overall Study|Withdrawal by Subject|2|||
164688678|NCT02760433|594883319|FG004|Overall Study|Withdrawal by Subject|9|||
164688679|NCT02760433|594883315|FG000|Overall Study|Lack of Response At Week 14|0|||
164688680|NCT02760433|594883316|FG001|Overall Study|Lack of Response At Week 14|0|||
164688681|NCT02760433|594883317|FG002|Overall Study|Lack of Response At Week 14|0|||
164688682|NCT02760433|594883318|FG003|Overall Study|Lack of Response At Week 14|0|||
164688683|NCT02760433|594883319|FG004|Overall Study|Lack of Response At Week 14|1|||
164688684|NCT02760433|594883315|FG000|Overall Study|Subject refused to continue the study|1|||
164688685|NCT02760433|594883316|FG001|Overall Study|Subject refused to continue the study|0|||
164688686|NCT02760433|594883317|FG002|Overall Study|Subject refused to continue the study|0|||
164688687|NCT02760433|594883318|FG003|Overall Study|Subject refused to continue the study|0|||
164688688|NCT02760433|594883319|FG004|Overall Study|Subject refused to continue the study|0|||
164688689|NCT02760433|594883315|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
164688690|NCT02760433|594883316|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
164688691|NCT02760433|594883317|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
164688692|NCT02760433|594883318|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
164688693|NCT02760433|594883319|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
164688694|NCT02760433|594883315|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
164272402|NCT01927055|593364592|FG000|Open-label|Adverse Event|6|||
164272403|NCT01927055|593364593|FG001|Open-label|Adverse Event|0|||
164272404|NCT01927055|593364594|FG002|Open-label|Adverse Event|0|||
164272405|NCT01927055|593364592|FG000|Open-label|Withdrawal by Subject|1|||
164272406|NCT01927055|593364593|FG001|Open-label|Withdrawal by Subject|0|||
164272407|NCT01927055|593364594|FG002|Open-label|Withdrawal by Subject|0|||
164272408|NCT01927055|593364592|FG000|Open-label|Study Stopped|4|||
164272409|NCT01927055|593364593|FG001|Open-label|Study Stopped|0|||
164272410|NCT01927055|593364594|FG002|Open-label|Study Stopped|0|||
164272411|NCT01927055|593364592|FG000|Open-label|Supine Hypertension|4|||
164272412|NCT01927055|593364593|FG001|Open-label|Supine Hypertension|0|||
164272413|NCT01927055|593364594|FG002|Open-label|Supine Hypertension|0|||
164272414|NCT01927055|593364592|FG000|Open-label|Difficulty attending study visits|1|||
164272415|NCT01927055|593364593|FG001|Open-label|Difficulty attending study visits|0|||
164430961|NCT01020838|593949332|FG000|Overall Study|Most common: Study ended by sponsor|77|||
164430962|NCT04176458|593949333|FG000|Overall Study|Covid 19|4|||
164430963|NCT00891618|593949334|FG000|Overall Study|Withdrawal by Subject|1|||
164430964|NCT02145182|593949335|FG000|Overall Study|Adverse Event|4|||
164430965|NCT02145182|593949336|FG001|Overall Study|Adverse Event|1|||
164430966|NCT02145182|593949335|FG000|Overall Study|Death|7|||
164430967|NCT02145182|593949336|FG001|Overall Study|Death|7|||
164430968|NCT02145182|593949335|FG000|Overall Study|Lost to Follow-up|2|||
164430969|NCT02145182|593949336|FG001|Overall Study|Lost to Follow-up|2|||
164430970|NCT02145182|593949335|FG000|Overall Study|Pre-transplant Withdrawal|0|||
164430971|NCT02145182|593949336|FG001|Overall Study|Pre-transplant Withdrawal|2|||
164430972|NCT02145182|593949335|FG000|Overall Study|Withdrawal by Subject|5|||
164430973|NCT02145182|593949336|FG001|Overall Study|Withdrawal by Subject|4|||
164430974|NCT01670019|593949339|FG000|Overall Study|Adverse Event|3|||
164430975|NCT01670019|593949340|FG001|Overall Study|Adverse Event|0|||
164430976|NCT01670019|593949339|FG000|Overall Study|Withdrawal by Subject|6|||
164430977|NCT01670019|593949340|FG001|Overall Study|Withdrawal by Subject|0|||
164430978|NCT03586167|593949341|FG000|Overall Study|Other|1|||
164430979|NCT03586167|593949342|FG001|Overall Study|Other|0|||
164430980|NCT03537651|593949345|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
164430981|NCT03537651|593949345|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
164430982|NCT03537651|593949345|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
164272416|NCT01927055|593364594|FG002|Open-label|Difficulty attending study visits|0|||
164430983|NCT03537651|593949345|FG000|Part A (Up to 96 Weeks)|Other|1|||
164430984|NCT03537651|593949345|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
164430985|NCT03537651|593949345|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
164430986|NCT03537651|593949345|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
164430987|NCT03537651|593949345|FG000|Part B (Up to 192 Weeks)|Other|1|||
164430988|NCT05487703|593949346|FG000|Overall Study|Other|19|||
164430989|NCT05487703|593949346|FG000|Overall Study|Participant not well|5|||
164688695|NCT02760433|594883316|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
164688696|NCT02760433|594883317|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
164272417|NCT01927055|593364592|FG000|Double-Blind|Adverse Event|0|||
164272418|NCT01927055|593364593|FG001|Double-Blind|Adverse Event|1|||
164688697|NCT02760433|594883318|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
164688698|NCT02760433|594883319|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
164688699|NCT02151149|594883320|FG000|Treatment Period|Death|2|||
164688700|NCT02151149|594883321|FG001|Treatment Period|Death|3|||
164688701|NCT02151149|594883320|FG000|Treatment Period|Adverse Event|17|||
164688702|NCT02151149|594883321|FG001|Treatment Period|Adverse Event|14|||
164688703|NCT02151149|594883320|FG000|Treatment Period|Progressive Disease|25|||
164688704|NCT02151149|594883321|FG001|Treatment Period|Progressive Disease|24|||
164688705|NCT02151149|594883320|FG000|Treatment Period|Symptomatic Deterioration|2|||
164688706|NCT02151149|594883321|FG001|Treatment Period|Symptomatic Deterioration|10|||
164688707|NCT02151149|594883320|FG000|Treatment Period|Withdrawal by Subject|13|||
164688708|NCT02151149|594883321|FG001|Treatment Period|Withdrawal by Subject|11|||
164688709|NCT02151149|594883320|FG000|Treatment Period|Miscellaneous|8|||
164688710|NCT02151149|594883321|FG001|Treatment Period|Miscellaneous|7|||
164688711|NCT02151149|594883320|FG000|Treatment Period|Participants randomized but not treated|3|||
164688712|NCT02151149|594883321|FG001|Treatment Period|Participants randomized but not treated|2|||
164688713|NCT02151149|594883320|FG000|Follow-Up Period|Lost to Follow-up|2|||
164688714|NCT02151149|594883321|FG001|Follow-Up Period|Lost to Follow-up|3|||
164688715|NCT02151149|594883320|FG000|Follow-Up Period|Death|37|||
164688716|NCT02151149|594883321|FG001|Follow-Up Period|Death|34|||
164688717|NCT00057941|594883322|FG000|Overall Study|Death|1|||
164688718|NCT00057941|594883323|FG001|Overall Study|Death|2|||
164688719|NCT00057941|594883322|FG000|Overall Study|Adverse Event|7|||
164688720|NCT00057941|594883323|FG001|Overall Study|Adverse Event|9|||
164688721|NCT00057941|594883322|FG000|Overall Study|Lack of Efficacy|54|||
164688722|NCT00057941|594883323|FG001|Overall Study|Lack of Efficacy|53|||
164688723|NCT00057941|594883322|FG000|Overall Study|Withdrawal by Subject|6|||
164688724|NCT00057941|594883323|FG001|Overall Study|Withdrawal by Subject|1|||
164688725|NCT00057941|594883322|FG000|Overall Study|still on treatment|3|||
164688726|NCT00057941|594883323|FG001|Overall Study|still on treatment|1|||
164272419|NCT01927055|593364594|FG002|Double-Blind|Adverse Event|1|||
164272420|NCT01927055|593364592|FG000|Double-Blind|Protocol Violation|0|||
164272421|NCT01927055|593364593|FG001|Double-Blind|Protocol Violation|0|||
164272422|NCT01927055|593364594|FG002|Double-Blind|Protocol Violation|1|||
164272423|NCT01927055|593364592|FG000|Double-Blind|Withdrawal by Subject|0|||
164272424|NCT01927055|593364593|FG001|Double-Blind|Withdrawal by Subject|2|||
164272425|NCT01927055|593364594|FG002|Double-Blind|Withdrawal by Subject|3|||
164272426|NCT01927055|593364592|FG000|Double-Blind|Study Stopped|0|||
164272427|NCT01927055|593364593|FG001|Double-Blind|Study Stopped|7|||
164272428|NCT01927055|593364594|FG002|Double-Blind|Study Stopped|7|||
164272429|NCT01927055|593364592|FG000|Double-Blind|Supine Hypertension|0|||
164272430|NCT01927055|593364593|FG001|Double-Blind|Supine Hypertension|0|||
164272431|NCT01927055|593364594|FG002|Double-Blind|Supine Hypertension|1|||
164272432|NCT01927055|593364592|FG000|Double-Blind|Extended Vacation|0|||
164272433|NCT01927055|593364593|FG001|Double-Blind|Extended Vacation|1|||
164272434|NCT01927055|593364594|FG002|Double-Blind|Extended Vacation|0|||
164272435|NCT00649428|593366190|FG000|Overall Study|Adverse Event|2|||
164272436|NCT00649428|593366191|FG001|Overall Study|Adverse Event|2|||
164272437|NCT00649428|593366190|FG000|Overall Study|Withdrawal by Subject|6|||
164272438|NCT00649428|593366191|FG001|Overall Study|Withdrawal by Subject|6|||
164272439|NCT00649428|593366190|FG000|Overall Study|Lost to Follow-up|1|||
164272440|NCT00649428|593366191|FG001|Overall Study|Lost to Follow-up|3|||
164272441|NCT00649428|593366190|FG000|Overall Study|Insufficient manufacturing yield|5|||
164688727|NCT00057941|594883322|FG000|Overall Study|insurance, symptomatic deterioration|1|||
164688728|NCT00057941|594883323|FG001|Overall Study|insurance, symptomatic deterioration|3|||
164688729|NCT00057941|594883322|FG000|Overall Study|Ineligible|2|||
164688730|NCT00057941|594883323|FG001|Overall Study|Ineligible|5|||
164688731|NCT03419962|594883325|FG000|Overall Study|Change to other medication|1|||
164688732|NCT03419962|594883325|FG000|Overall Study|Refusal of continuing with trial drug|1|||
164688733|NCT03419962|594883325|FG000|Overall Study|Lost to Follow-up|3|||
164688734|NCT03419962|594883325|FG000|Overall Study|Difficulty in inhaling the doses|1|||
164272442|NCT00649428|593366191|FG001|Overall Study|Insufficient manufacturing yield|1|||
164272443|NCT00649428|593366190|FG000|Overall Study|Protocol Violation|6|||
164272444|NCT00649428|593366191|FG001|Overall Study|Protocol Violation|2|||
164272445|NCT00649428|593366190|FG000|Overall Study|Physician Decision|0|||
164688735|NCT03419962|594883325|FG000|Overall Study|Missing completion data|31|||
164688736|NCT03439085|594883328|FG000|Overall Study|Death|2|||
164272446|NCT00649428|593366191|FG001|Overall Study|Physician Decision|1|||
164688737|NCT03439085|594883328|FG000|Overall Study|Screen Failure|20|||
164688738|NCT01499160|594883329|FG000|Overall Study|Adverse Event|1|||
164688739|NCT01499160|594883329|FG000|Overall Study|Withdrawal by Subject|1|||
164688740|NCT01438476|594883332|FG000|Overall Study|Protocol Violation|1|||
164688741|NCT01438476|594883333|FG001|Overall Study|Protocol Violation|0|||
164688742|NCT01438476|594883332|FG000|Overall Study|Withdrawal by Subject|1|||
164688743|NCT01438476|594883333|FG001|Overall Study|Withdrawal by Subject|0|||
164272447|NCT02503501|593366193|FG000|Overall Study|Physician Decision|1|||
164272448|NCT02503501|593366194|FG001|Overall Study|Physician Decision|0|||
164342462|NCT00259610|593629465|FG000|Overall Study|Death|1|||
164342463|NCT00259610|593629466|FG001|Overall Study|Death|1|||
164342464|NCT00259610|593629467|FG002|Overall Study|Death|2|||
164342465|NCT00259610|593629468|FG003|Overall Study|Death|0|||
164342466|NCT00259610|593629465|FG000|Overall Study|non medical reason|6|||
164342467|NCT00259610|593629466|FG001|Overall Study|non medical reason|2|||
164342468|NCT00259610|593629467|FG002|Overall Study|non medical reason|10|||
164342469|NCT00259610|593629468|FG003|Overall Study|non medical reason|3|||
164342470|NCT00259610|593629465|FG000|Overall Study|Adverse Event|3|||
164342471|NCT00259610|593629466|FG001|Overall Study|Adverse Event|4|||
164342472|NCT00259610|593629467|FG002|Overall Study|Adverse Event|5|||
164342473|NCT00259610|593629468|FG003|Overall Study|Adverse Event|2|||
164342474|NCT00259610|593629465|FG000|Overall Study|Serious Adverse Event|8|||
164342475|NCT00259610|593629466|FG001|Overall Study|Serious Adverse Event|2|||
164272449|NCT02503501|593366193|FG000|Overall Study|Protocol Violation|0|||
164272450|NCT02503501|593366194|FG001|Overall Study|Protocol Violation|1|||
164272451|NCT02503501|593366193|FG000|Overall Study|Withdrawal by Subject|0|||
164272452|NCT02503501|593366194|FG001|Overall Study|Withdrawal by Subject|2|||
164272453|NCT01740401|593366195|FG000|Overall Study|Progression of disease|6|||
164272454|NCT01740401|593366195|FG000|Overall Study|Adverse Event|2|||
164272455|NCT01740401|593366195|FG000|Overall Study|Did not reach primary endpoint|2|||
164272456|NCT02008227|593366196|FG000|Overall Study|Lost to Follow-up|7|||
164272457|NCT02008227|593366197|FG001|Overall Study|Lost to Follow-up|9|||
164272458|NCT02008227|593366196|FG000|Overall Study|Death|494|||
164272459|NCT02008227|593366197|FG001|Overall Study|Death|485|||
164272460|NCT02008227|593366196|FG000|Overall Study|Withdrawal by Subject|67|||
164272461|NCT02008227|593366197|FG001|Overall Study|Withdrawal by Subject|36|||
164272462|NCT02008227|593366196|FG000|Overall Study|Study Terminated By Sponsor|44|||
164272463|NCT02008227|593366197|FG001|Overall Study|Study Terminated By Sponsor|83|||
164272464|NCT05856227|593366202|FG000|Overall Study|Adverse Event|0|||
164272465|NCT05856227|593366203|FG001|Overall Study|Adverse Event|1|||
164272466|NCT05856227|593366202|FG000|Overall Study|Due to Investigator absence|1|||
164272467|NCT05856227|593366203|FG001|Overall Study|Due to Investigator absence|0|||
164272468|NCT05856227|593366202|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
164272469|NCT05856227|593366203|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
164272470|NCT01571232|593366204|FG000|Overall Study|Lost to Follow-up|0|||
164272471|NCT01571232|593366205|FG001|Overall Study|Lost to Follow-up|1|||
164272472|NCT01571232|593366204|FG000|Overall Study|Withdrawal by Subject|1|||
164272473|NCT01571232|593366205|FG001|Overall Study|Withdrawal by Subject|0|||
164272474|NCT02294734|593366210|FG000|Overall Study|Adverse Event|5|||
164272475|NCT02294734|593366211|FG001|Overall Study|Adverse Event|5|||
164342476|NCT00259610|593629467|FG002|Overall Study|Serious Adverse Event|2|||
164342477|NCT00259610|593629468|FG003|Overall Study|Serious Adverse Event|2|||
164342478|NCT01201785|593629472|FG000|Overall Study|Lost to Follow-up|16|||
164342479|NCT02151110|593629473|FG000|Overall Study|Withdrawal by Subject|0|||
164342480|NCT02151110|593629474|FG001|Overall Study|Withdrawal by Subject|0|||
164342481|NCT02151110|593629475|FG002|Overall Study|Withdrawal by Subject|0|||
164342482|NCT02151110|593629476|FG003|Overall Study|Withdrawal by Subject|0|||
164342483|NCT02151110|593629477|FG004|Overall Study|Withdrawal by Subject|0|||
164342484|NCT02151110|593629478|FG005|Overall Study|Withdrawal by Subject|0|||
164342485|NCT02151110|593629479|FG006|Overall Study|Withdrawal by Subject|0|||
164342486|NCT02151110|593629480|FG007|Overall Study|Withdrawal by Subject|1|||
164342487|NCT02151110|593629473|FG000|Overall Study|Lost to Follow-up|0|||
164342488|NCT02151110|593629474|FG001|Overall Study|Lost to Follow-up|0|||
164342489|NCT02151110|593629475|FG002|Overall Study|Lost to Follow-up|0|||
164342490|NCT02151110|593629476|FG003|Overall Study|Lost to Follow-up|0|||
164342491|NCT02151110|593629477|FG004|Overall Study|Lost to Follow-up|0|||
164342492|NCT02151110|593629478|FG005|Overall Study|Lost to Follow-up|0|||
164430990|NCT05487703|593949346|FG000|Overall Study|Insurance Reasons|6|||
164272476|NCT02294734|593366210|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
164272477|NCT02294734|593366211|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
164430991|NCT05487703|593949346|FG000|Overall Study|Physician Decision|19|||
164272478|NCT02294734|593366210|FG000|Overall Study|Lost to Follow-up|2|||
164272479|NCT02294734|593366211|FG001|Overall Study|Lost to Follow-up|0|||
164272480|NCT02294734|593366210|FG000|Overall Study|Physician Decision|2|||
164342493|NCT02151110|593629479|FG006|Overall Study|Lost to Follow-up|0|||
164342494|NCT02151110|593629480|FG007|Overall Study|Lost to Follow-up|2|||
164342495|NCT01999179|593629481|FG000|Overall Study|Adverse Event|1|||
164430992|NCT05487703|593949346|FG000|Overall Study|Lack of Efficacy|60|||
164430993|NCT02403323|593949347|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
164430994|NCT02403323|593949348|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
164430995|NCT02403323|593949349|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
164430996|NCT02403323|593949347|FG000|Part 1: Open Label Extension Period|Death|3|||
164272481|NCT02294734|593366211|FG001|Overall Study|Physician Decision|1|||
164272482|NCT02294734|593366210|FG000|Overall Study|Withdrawal by Subject|4|||
164272483|NCT02294734|593366211|FG001|Overall Study|Withdrawal by Subject|2|||
164272484|NCT00548717|593366212|FG000|Overall Study|Death|5|||
164272485|NCT00548717|593366213|FG001|Overall Study|Death|2|||
164272486|NCT00548717|593366212|FG000|Overall Study|Relapse|3|||
164272487|NCT00548717|593366213|FG001|Overall Study|Relapse|0|||
164272488|NCT00548717|593366212|FG000|Overall Study|Alternative treatment for GVHD|1|||
164272489|NCT00548717|593366213|FG001|Overall Study|Alternative treatment for GVHD|0|||
164272490|NCT03157583|593366214|FG000|Overall Study|Other (did not meet study criteria)|1|||
164272491|NCT00908037|593366216|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
164272492|NCT00908037|593366217|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
164272493|NCT00908037|593366218|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
164272494|NCT00908037|593366219|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
164272495|NCT00908037|593366220|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
164272496|NCT00908037|593366221|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
164272497|NCT00908037|593366222|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
164272498|NCT00908037|593366223|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
164272499|NCT00908037|593366224|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
164272500|NCT00908037|593366225|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
164272501|NCT00908037|593366226|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
164272502|NCT00908037|593366227|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
164272503|NCT00908037|593366216|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
164272504|NCT00908037|593366217|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
164272505|NCT00908037|593366218|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
164272506|NCT00908037|593366219|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
164272507|NCT00908037|593366220|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
164272508|NCT00908037|593366221|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
164272509|NCT00908037|593366222|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
164272510|NCT00908037|593366223|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
164272511|NCT00908037|593366224|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
164272512|NCT00908037|593366225|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
164272513|NCT00908037|593366226|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
164272514|NCT00908037|593366227|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
164272515|NCT00908037|593366216|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
164272516|NCT00908037|593366217|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
164272517|NCT00908037|593366218|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
164272518|NCT00908037|593366219|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
164272519|NCT00908037|593366220|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
164272520|NCT00908037|593366221|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
164272521|NCT00908037|593366222|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
164272522|NCT00908037|593366223|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
164272523|NCT00908037|593366224|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
164272524|NCT00908037|593366225|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
164272525|NCT00908037|593366226|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
164272526|NCT00908037|593366227|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
164272527|NCT00908037|593366216|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
164272528|NCT00908037|593366217|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
164272529|NCT00908037|593366218|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
164272530|NCT00908037|593366219|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
164342496|NCT01999179|593629481|FG000|Overall Study|Lost to Follow-up|1|||
164342497|NCT01999179|593629481|FG000|Overall Study|Change in Therapy|3|||
164342498|NCT01999179|593629481|FG000|Overall Study|New catheter|2|||
164342499|NCT01146665|593629482|FG000|Overall Study|Withdrawal by Subject|10|||
164342500|NCT01146665|593629483|FG001|Overall Study|Withdrawal by Subject|16|||
164342501|NCT02538029|593629485|FG000|Overall Study|unable to complete cognitive assessments|1|||
164342502|NCT02538029|593629486|FG001|Overall Study|unable to complete cognitive assessments|0|||
164342503|NCT02538029|593629487|FG002|Overall Study|unable to complete cognitive assessments|1|||
164342504|NCT01064310|593629490|FG000|Period 1|Adverse Event|7|||
164342505|NCT01064310|593629491|FG001|Period 1|Adverse Event|10|||
164342506|NCT01064310|593629492|FG002|Period 1|Adverse Event|0|||
164342507|NCT01064310|593629490|FG000|Period 1|Physician Decision|1|||
164342508|NCT01064310|593629491|FG001|Period 1|Physician Decision|0|||
164342509|NCT01064310|593629492|FG002|Period 1|Physician Decision|0|||
164342510|NCT01064310|593629490|FG000|Period 1|Withdrawal by Subject|2|||
164342511|NCT01064310|593629491|FG001|Period 1|Withdrawal by Subject|2|||
164342512|NCT01064310|593629492|FG002|Period 1|Withdrawal by Subject|0|||
164342513|NCT01064310|593629490|FG000|Period 1|Lack of Efficacy|3|||
164342514|NCT01064310|593629491|FG001|Period 1|Lack of Efficacy|5|||
164342515|NCT01064310|593629492|FG002|Period 1|Lack of Efficacy|0|||
164342516|NCT01064310|593629490|FG000|Period 1|Entered Open-label Period|1|||
164342517|NCT01064310|593629491|FG001|Period 1|Entered Open-label Period|1|||
164342518|NCT01064310|593629492|FG002|Period 1|Entered Open-label Period|0|||
164342519|NCT01064310|593629490|FG000|Period 2|Adverse Event|2|||
164272531|NCT00908037|593366220|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
164272532|NCT00908037|593366221|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
164272533|NCT00908037|593366222|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
164272534|NCT00908037|593366223|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
164272535|NCT00908037|593366224|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
164272536|NCT00908037|593366225|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
164272537|NCT00908037|593366226|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
164272538|NCT00908037|593366227|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
164272539|NCT00908037|593366216|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
164272540|NCT00908037|593366217|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
164272541|NCT00908037|593366218|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
164272542|NCT00908037|593366219|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
164272543|NCT00908037|593366220|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
164272544|NCT00908037|593366221|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
164272545|NCT00908037|593366222|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
164272546|NCT00908037|593366223|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
164272547|NCT00908037|593366224|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
164272548|NCT00908037|593366225|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
164272549|NCT00908037|593366226|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
164272550|NCT00908037|593366227|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
164272551|NCT00908037|593366216|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
164272552|NCT00908037|593366217|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
164272553|NCT00908037|593366218|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
164272554|NCT00908037|593366219|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
164272555|NCT00908037|593366220|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
164272556|NCT00908037|593366221|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
164272557|NCT00908037|593366222|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
164272558|NCT00908037|593366223|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
164272559|NCT00908037|593366224|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
164272560|NCT00908037|593366225|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
164272561|NCT00908037|593366226|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
164272562|NCT00908037|593366227|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
164272563|NCT00908037|593366216|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
164272564|NCT00908037|593366217|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
164272565|NCT00908037|593366218|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
164272566|NCT00908037|593366219|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
164272567|NCT00908037|593366220|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
164272568|NCT00908037|593366221|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
164688744|NCT01438476|594883332|FG000|Overall Study|No Surgery- Disease|8|||
164688745|NCT01438476|594883333|FG001|Overall Study|No Surgery- Disease|10|||
164272569|NCT00908037|593366222|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
164272570|NCT00908037|593366223|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
164272571|NCT00908037|593366224|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
164272572|NCT00908037|593366225|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
164272573|NCT00908037|593366226|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
164272574|NCT00908037|593366227|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
164272575|NCT00908037|593366216|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
164272576|NCT00908037|593366217|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
164272577|NCT00908037|593366218|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
164272578|NCT00908037|593366219|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
164272579|NCT00908037|593366220|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
164272580|NCT00908037|593366221|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
164272581|NCT00908037|593366222|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
164272582|NCT00908037|593366223|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
164272583|NCT00908037|593366224|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
164272584|NCT00908037|593366225|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
164272585|NCT00908037|593366226|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
164688746|NCT01438476|594883332|FG000|Overall Study|Communication barrier|0|||
164688747|NCT01438476|594883333|FG001|Overall Study|Communication barrier|1|||
164688748|NCT02911935|594883334|FG000|Overall Study|Lost to Follow-up|5|||
164688749|NCT02911935|594883335|FG001|Overall Study|Lost to Follow-up|7|||
164688750|NCT00603512|594883336|FG000|Overall Study|Adverse Event|0|||
164688751|NCT00603512|594883337|FG001|Overall Study|Adverse Event|2|||
164688752|NCT00603512|594883338|FG002|Overall Study|Adverse Event|4|||
164688753|NCT00603512|594883339|FG003|Overall Study|Adverse Event|4|||
164272586|NCT00908037|593366227|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
164272587|NCT00908037|593366216|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
164272588|NCT00908037|593366217|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
164272589|NCT00908037|593366218|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
164272590|NCT00908037|593366219|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
164272591|NCT00908037|593366220|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
164272592|NCT00908037|593366221|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
164272593|NCT00908037|593366222|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
164272594|NCT00908037|593366223|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
164272595|NCT00908037|593366224|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
164272596|NCT00908037|593366225|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
164272597|NCT00908037|593366226|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
164272598|NCT00908037|593366227|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
164272599|NCT01953913|593366228|FG000|Overall Study|Disease Progression|349|||
164272600|NCT01953913|593366228|FG000|Overall Study|Worsening of underlying cancer|22|||
164272601|NCT01953913|593366228|FG000|Overall Study|Adverse Event|20|||
164272602|NCT01953913|593366228|FG000|Overall Study|Protocol Violation|6|||
164272603|NCT01953913|593366228|FG000|Overall Study|Lost to Follow-up|4|||
164272604|NCT01953913|593366228|FG000|Overall Study|Withdrawal by Subject|32|||
164272605|NCT01953913|593366228|FG000|Overall Study|Other than listed|108|||
164272606|NCT01953913|593366228|FG000|Overall Study|Not Treated|1|||
164272607|NCT02925741|593366229|FG000|Overall Study|Withdrawal by Subject|11|||
164272608|NCT02925741|593366230|FG001|Overall Study|Withdrawal by Subject|0|||
164272609|NCT00494507|593366231|FG000|Double-Blind Phase|Adverse Event|2|||
164272610|NCT00494507|593366232|FG001|Double-Blind Phase|Adverse Event|0|||
164272611|NCT00494507|593366233|FG002|Double-Blind Phase|Adverse Event|1|||
164272612|NCT00494507|593366234|FG003|Double-Blind Phase|Adverse Event|0|||
164272613|NCT00494507|593366231|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
164272614|NCT00494507|593366232|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
164272615|NCT00494507|593366233|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
164272616|NCT00494507|593366234|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
164272617|NCT00494507|593366231|FG000|Double-Blind Phase|Subject Non-compliance|0|||
164272618|NCT00494507|593366232|FG001|Double-Blind Phase|Subject Non-compliance|0|||
164272619|NCT00494507|593366233|FG002|Double-Blind Phase|Subject Non-compliance|1|||
164272620|NCT00494507|593366234|FG003|Double-Blind Phase|Subject Non-compliance|0|||
164272621|NCT00494507|593366231|FG000|Double-Blind Phase|Negative DNA test|0|||
164272622|NCT00494507|593366232|FG001|Double-Blind Phase|Negative DNA test|0|||
164272623|NCT00494507|593366233|FG002|Double-Blind Phase|Negative DNA test|0|||
164272624|NCT00494507|593366234|FG003|Double-Blind Phase|Negative DNA test|1|||
164272625|NCT00494507|593366231|FG000|Open-Label Phase|Adverse Event|0|||
164272626|NCT00494507|593366232|FG001|Open-Label Phase|Adverse Event|1|||
164272627|NCT00494507|593366233|FG002|Open-Label Phase|Adverse Event|5|||
164272628|NCT00494507|593366234|FG003|Open-Label Phase|Adverse Event|3|||
164272629|NCT00494507|593366231|FG000|Open-Label Phase|Worsening Disease|0|||
164272630|NCT00494507|593366232|FG001|Open-Label Phase|Worsening Disease|0|||
164272631|NCT00494507|593366233|FG002|Open-Label Phase|Worsening Disease|0|||
164272632|NCT00494507|593366234|FG003|Open-Label Phase|Worsening Disease|2|||
164272633|NCT02437084|593366237|FG000|Overall Study|Withdrawal by Subject|2|||
164272634|NCT02437084|593366237|FG000|Overall Study|Physician Decision|1|||
164272635|NCT00454181|593366238|FG000|Overall Study|Adverse Event|1|||
164272636|NCT00454181|593366239|FG001|Overall Study|Adverse Event|1|||
164272637|NCT00454181|593366238|FG000|Overall Study|Lost to Follow-up|11|||
164272638|NCT00454181|593366239|FG001|Overall Study|Lost to Follow-up|1|||
164272639|NCT00454181|593366238|FG000|Overall Study|Protocol Violation|1|||
164688754|NCT00603512|594883340|FG004|Overall Study|Adverse Event|2|||
164688755|NCT00603512|594883336|FG000|Overall Study|Lack of Efficacy|0|||
164688756|NCT00603512|594883337|FG001|Overall Study|Lack of Efficacy|1|||
164688757|NCT00603512|594883338|FG002|Overall Study|Lack of Efficacy|0|||
164688758|NCT00603512|594883339|FG003|Overall Study|Lack of Efficacy|0|||
164688759|NCT00603512|594883340|FG004|Overall Study|Lack of Efficacy|1|||
164688760|NCT00603512|594883336|FG000|Overall Study|Other|2|||
164688761|NCT00603512|594883337|FG001|Overall Study|Other|1|||
164688762|NCT00603512|594883338|FG002|Overall Study|Other|0|||
164688763|NCT00603512|594883339|FG003|Overall Study|Other|1|||
164272640|NCT00454181|593366239|FG001|Overall Study|Protocol Violation|1|||
164272641|NCT00454181|593366238|FG000|Overall Study|Withdrawal by Subject|2|||
164272642|NCT00454181|593366239|FG001|Overall Study|Withdrawal by Subject|0|||
164272643|NCT02613169|593366240|FG000|Overall Study|Withdrawal by Subject|4|||
164272644|NCT02613169|593366241|FG001|Overall Study|Withdrawal by Subject|1|||
164688764|NCT00603512|594883340|FG004|Overall Study|Other|1|||
164688765|NCT00603512|594883336|FG000|Overall Study|Withdrawal by Subject|0|||
164688766|NCT00603512|594883337|FG001|Overall Study|Withdrawal by Subject|0|||
164688767|NCT00603512|594883338|FG002|Overall Study|Withdrawal by Subject|0|||
164272645|NCT02613169|593366240|FG000|Overall Study|Lost to Follow-up|0|||
164272646|NCT02613169|593366241|FG001|Overall Study|Lost to Follow-up|5|||
164272647|NCT02613169|593366240|FG000|Overall Study|HIV|0|||
164272648|NCT02613169|593366241|FG001|Overall Study|HIV|2|||
164272649|NCT02613169|593366240|FG000|Overall Study|No TB infection endpoint|14|||
164272650|NCT02613169|593366241|FG001|Overall Study|No TB infection endpoint|9|||
164272651|NCT03729245|593366242|FG000|Overall Study|Lost to Follow-up|5|||
164272652|NCT03729245|593366243|FG001|Overall Study|Lost to Follow-up|6|||
164272653|NCT03729245|593366242|FG000|Overall Study|Withdrawal by Subject|16|||
164688768|NCT00603512|594883339|FG003|Overall Study|Withdrawal by Subject|0|||
164272654|NCT03729245|593366243|FG001|Overall Study|Withdrawal by Subject|19|||
164272655|NCT03729245|593366242|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
164272656|NCT03729245|593366243|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
164272657|NCT02096263|593366244|FG000|Overall Study|Adverse Event|1|||
164272658|NCT02096263|593366245|FG001|Overall Study|Adverse Event|0|||
164272659|NCT02096263|593366246|FG002|Overall Study|Adverse Event|1|||
164272660|NCT02096263|593366244|FG000|Overall Study|Lost to Follow-up|14|||
164272661|NCT02096263|593366245|FG001|Overall Study|Lost to Follow-up|18|||
164272662|NCT02096263|593366246|FG002|Overall Study|Lost to Follow-up|15|||
164272663|NCT02096263|593366244|FG000|Overall Study|Other|7|||
164272664|NCT02096263|593366245|FG001|Overall Study|Other|9|||
164342520|NCT01064310|593629491|FG001|Period 2|Adverse Event|1|||
164342521|NCT01064310|593629492|FG002|Period 2|Adverse Event|0|||
164342522|NCT01064310|593629490|FG000|Period 2|Physician Decision|0|||
164342523|NCT01064310|593629491|FG001|Period 2|Physician Decision|1|||
164342524|NCT01064310|593629492|FG002|Period 2|Physician Decision|0|||
164342525|NCT01064310|593629490|FG000|Period 2|Entered Open-label Period|1|||
164342526|NCT01064310|593629491|FG001|Period 2|Entered Open-label Period|0|||
164342527|NCT01064310|593629492|FG002|Period 2|Entered Open-label Period|0|||
164342528|NCT01064310|593629490|FG000|Period 2|Lack of Efficacy|1|||
164342529|NCT01064310|593629491|FG001|Period 2|Lack of Efficacy|4|||
164342530|NCT01064310|593629492|FG002|Period 2|Lack of Efficacy|0|||
164342531|NCT01064310|593629490|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
164342532|NCT01064310|593629491|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
164342533|NCT01064310|593629492|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
164342534|NCT01064310|593629490|FG000|Open Label Pazopinib|Adverse Event|0|||
164342535|NCT01064310|593629491|FG001|Open Label Pazopinib|Adverse Event|0|||
164342536|NCT01064310|593629492|FG002|Open Label Pazopinib|Adverse Event|12|||
164342537|NCT01064310|593629490|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
164342538|NCT01064310|593629491|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
164342539|NCT01064310|593629492|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
164342540|NCT01064310|593629490|FG000|Open Label Pazopinib|Physician Decision|0|||
164342541|NCT01064310|593629491|FG001|Open Label Pazopinib|Physician Decision|0|||
164342542|NCT01064310|593629492|FG002|Open Label Pazopinib|Physician Decision|20|||
164342543|NCT00001880|593629493|FG000|Overall Study|Death|14|||
164342544|NCT02639065|593629494|FG000|Study Treatment|Disease Progression|13|||
164342545|NCT02639065|593629494|FG000|Study Treatment|Adverse Event|9|||
164342546|NCT02639065|593629494|FG000|Study Treatment|Withdrawal by Subject|1|||
164342547|NCT02639065|593629494|FG000|Follow up|Subject refused to follow up|1|||
164342548|NCT02639065|593629494|FG000|Follow up|Symptomatic Deterioration|2|||
164342549|NCT02639065|593629494|FG000|Follow up|Death|2|||
164342550|NCT02639065|593629494|FG000|Follow up|Study Terminated|1|||
164342551|NCT02639065|593629494|FG000|Follow up|Disease Progression|3|||
164342552|NCT00660699|593629497|FG000|Overall Study|Withdrawal by Subject|2|||
164342553|NCT05147428|593629498|FG000|Overall Study|Removed prior to mailing|289|||
164342554|NCT05147428|593629499|FG001|Overall Study|Removed prior to mailing|306|||
164342555|NCT05147428|593629500|FG002|Overall Study|Removed prior to mailing|270|||
164342556|NCT05147428|593629498|FG000|Overall Study|Died or disenrolled during blackout period|239|||
164342557|NCT05147428|593629499|FG001|Overall Study|Died or disenrolled during blackout period|278|||
164342558|NCT05147428|593629500|FG002|Overall Study|Died or disenrolled during blackout period|273|||
164342559|NCT03128047|593629501|FG000|Overall Study|Withdrawal by Subject|1|||
164688769|NCT00603512|594883340|FG004|Overall Study|Withdrawal by Subject|1|||
164688770|NCT00603512|594883336|FG000|Overall Study|Randomized but not treated|0|||
164272665|NCT02096263|593366246|FG002|Overall Study|Other|6|||
164272666|NCT02096263|593366244|FG000|Overall Study|Sponsor study termination|0|||
164342560|NCT05996718|593631450|FG000|Overall Study|Lost to Follow-up|3|||
164342561|NCT01713686|593631451|FG000|Overall Study|Lost to Follow-up|9|||
164272667|NCT02096263|593366245|FG001|Overall Study|Sponsor study termination|0|||
164272668|NCT02096263|593366246|FG002|Overall Study|Sponsor study termination|1|||
164688771|NCT00603512|594883337|FG001|Overall Study|Randomized but not treated|1|||
164688772|NCT00603512|594883338|FG002|Overall Study|Randomized but not treated|1|||
164272669|NCT02096263|593366244|FG000|Overall Study|Protocol Violation|7|||
164342562|NCT01713686|593631451|FG000|Overall Study|Withdrawal by Subject|6|||
164342563|NCT02385045|593631452|FG000|Overall Study|Endoscopy could not be completed|4|||
164688773|NCT00603512|594883339|FG003|Overall Study|Randomized but not treated|2|||
164342564|NCT00115739|593631453|FG000|Overall Study|Lost to Follow-up|3|||
164342565|NCT02200211|593631457|FG000|Overall Study|Lost to Follow-up|7|||
164272670|NCT02096263|593366245|FG001|Overall Study|Protocol Violation|2|||
164272671|NCT02096263|593366246|FG002|Overall Study|Protocol Violation|8|||
164272672|NCT02096263|593366244|FG000|Overall Study|Withdrawal by Subject|5|||
164272673|NCT02096263|593366245|FG001|Overall Study|Withdrawal by Subject|7|||
164272674|NCT02096263|593366246|FG002|Overall Study|Withdrawal by Subject|8|||
164272675|NCT01571453|593366248|FG000|Overall Study|Adverse Event|14|||
164272676|NCT01571453|593366249|FG001|Overall Study|Adverse Event|32|||
164272677|NCT01571453|593366248|FG000|Overall Study|Lack of Efficacy|8|||
164272678|NCT01571453|593366249|FG001|Overall Study|Lack of Efficacy|3|||
164272679|NCT01571453|593366248|FG000|Overall Study|Non-compliance|2|||
164272680|NCT01571453|593366249|FG001|Overall Study|Non-compliance|4|||
164272681|NCT01571453|593366248|FG000|Overall Study|Protocol Violation|1|||
164272682|NCT01571453|593366249|FG001|Overall Study|Protocol Violation|5|||
164272683|NCT01571453|593366248|FG000|Overall Study|Withdrawal of consent|5|||
164272684|NCT01571453|593366249|FG001|Overall Study|Withdrawal of consent|13|||
164272685|NCT01571453|593366248|FG000|Overall Study|Lost to Follow-up|4|||
164272686|NCT01571453|593366249|FG001|Overall Study|Lost to Follow-up|2|||
164272687|NCT01571453|593366248|FG000|Overall Study|Administrative or other reason(s)|4|||
164272688|NCT01571453|593366249|FG001|Overall Study|Administrative or other reason(s)|3|||
164272689|NCT02976103|593366254|FG000|Overall Study|Withdrawal by Subject|1|||
164272690|NCT02976103|593366255|FG001|Overall Study|Withdrawal by Subject|0|||
164272691|NCT02976103|593366254|FG000|Overall Study|Lost to Follow-up|12|||
164272692|NCT02976103|593366255|FG001|Overall Study|Lost to Follow-up|8|||
164272693|NCT01985360|593366256|FG000|Overall Study|Withdrawal by Subject|4|||
164272694|NCT01985360|593366257|FG001|Overall Study|Withdrawal by Subject|0|||
164272695|NCT01985360|593366256|FG000|Overall Study|Lost to Follow-up|5|||
164272696|NCT01985360|593366257|FG001|Overall Study|Lost to Follow-up|3|||
164272697|NCT00694304|593366258|FG000|Overall Study|Adverse Event|42|||
164272698|NCT00694304|593366258|FG000|Overall Study|Lack of Efficacy|35|||
164272699|NCT00694304|593366258|FG000|Overall Study|Non-compliance With Study Product|16|||
164272700|NCT00694304|593366258|FG000|Overall Study|Protocol Violation|6|||
164272701|NCT00694304|593366258|FG000|Overall Study|Withdrawal of Consent|61|||
164272702|NCT00694304|593366258|FG000|Overall Study|Lost to Follow-up|15|||
164272703|NCT00694304|593366258|FG000|Overall Study|Administrative or Other Reasons|32|||
164272704|NCT00845065|593366262|FG000|Overall Study|Adverse Event|3|||
164272705|NCT00845065|593366263|FG001|Overall Study|Adverse Event|23|||
164272706|NCT00845065|593366262|FG000|Overall Study|Lack of Efficacy|43|||
164272707|NCT00845065|593366263|FG001|Overall Study|Lack of Efficacy|21|||
164272708|NCT00845065|593366262|FG000|Overall Study|Non-Medical Reasons|1|||
164272709|NCT00845065|593366263|FG001|Overall Study|Non-Medical Reasons|11|||
164272710|NCT02228096|593366267|FG000|Overall Study|Study terminated by Sponsor|24|||
164272711|NCT02228096|593366267|FG000|Overall Study|Lack of Efficacy|18|||
164272712|NCT02228096|593366267|FG000|Overall Study|Death|12|||
164272713|NCT02228096|593366267|FG000|Overall Study|Physician Decision|3|||
164272714|NCT02228096|593366267|FG000|Overall Study|Subject/guardian decision|2|||
164272715|NCT02228096|593366267|FG000|Overall Study|New therapy for study indication|1|||
164342566|NCT02200211|593631458|FG001|Overall Study|Lost to Follow-up|7|||
164342567|NCT02200211|593631459|FG002|Overall Study|Lost to Follow-up|1|||
164342568|NCT02200211|593631460|FG003|Overall Study|Lost to Follow-up|2|||
164342569|NCT02200211|593631457|FG000|Overall Study|Withdrawal by Subject|1|||
164342570|NCT02200211|593631458|FG001|Overall Study|Withdrawal by Subject|0|||
164342571|NCT02200211|593631459|FG002|Overall Study|Withdrawal by Subject|0|||
164342572|NCT02200211|593631460|FG003|Overall Study|Withdrawal by Subject|0|||
164342573|NCT00381485|593631461|FG000|Open-Label Run-In Period|Adverse Event|9|||
164582917|NCT03865407|594499638|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
164582918|NCT03865407|594499639|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
164582919|NCT01645280|594499640|FG000|Overall Study|Death|0|||
164582920|NCT01645280|594499641|FG001|Overall Study|Death|1|||
164582921|NCT01645280|594499642|FG002|Overall Study|Death|0|||
164582922|NCT01645280|594499643|FG003|Overall Study|Death|0|||
164582923|NCT01645280|594499644|FG004|Overall Study|Death|0|||
164582924|NCT01645280|594499640|FG000|Overall Study|Withdrawal by Subject|4|||
164582925|NCT01645280|594499641|FG001|Overall Study|Withdrawal by Subject|0|||
164272716|NCT02228096|593366267|FG000|Overall Study|Enrolled, not infused|11|||
164272717|NCT02383433|593366268|FG000|Overall Study|Disease progression|2|||
164272718|NCT00952614|593366271|FG000|Overall Study|Death|3|||
164272719|NCT00952614|593366271|FG000|Overall Study|Lost to Follow-up|3|||
164272720|NCT00952614|593366271|FG000|Overall Study|other reason|1|||
164272721|NCT02963701|593366273|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
164272722|NCT02963701|593366274|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
164272723|NCT01345682|593366275|FG000|Overall Study|Progressive disease per RECIST|226|||
164272724|NCT01345682|593366276|FG001|Overall Study|Progressive disease per RECIST|93|||
164272725|NCT01345682|593366275|FG000|Overall Study|Worsening of underlying cancer disease|23|||
164272726|NCT01345682|593366276|FG001|Overall Study|Worsening of underlying cancer disease|12|||
164272727|NCT01345682|593366275|FG000|Overall Study|Adverse Event|51|||
164342574|NCT00381485|593631462|FG001|Open-Label Run-In Period|Adverse Event|0|||
164688774|NCT00603512|594883340|FG004|Overall Study|Randomized but not treated|0|||
164688775|NCT04979858|594883341|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
164688776|NCT04979858|594883342|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
164272728|NCT01345682|593366276|FG001|Overall Study|Adverse Event|41|||
164272729|NCT01345682|593366275|FG000|Overall Study|Non-compliance with protocol|0|||
164272730|NCT01345682|593366276|FG001|Overall Study|Non-compliance with protocol|1|||
164272731|NCT01345682|593366275|FG000|Overall Study|Lost to Follow-up|0|||
164272732|NCT01345682|593366276|FG001|Overall Study|Lost to Follow-up|1|||
164272733|NCT01345682|593366275|FG000|Overall Study|Refused to continue trial medication|16|||
164272734|NCT01345682|593366276|FG001|Overall Study|Refused to continue trial medication|9|||
164272735|NCT01345682|593366275|FG000|Overall Study|Not treated|2|||
164272736|NCT01345682|593366276|FG001|Overall Study|Not treated|1|||
164272737|NCT01345682|593366275|FG000|Overall Study|Reason other than those specified above|4|||
164272738|NCT01345682|593366276|FG001|Overall Study|Reason other than those specified above|3|||
164272739|NCT00896649|593366277|FG000|Overall Study|Physician Decision|1|||
164272740|NCT00896649|593366277|FG000|Overall Study|Pregnancy|1|||
164272741|NCT00896649|593366277|FG000|Overall Study|missing documentation|1|||
164272742|NCT00896649|593366277|FG000|Overall Study|technical difficulties|2|||
164272743|NCT01075984|593366279|FG000|Treatment Phase|Adverse Event|0|||
164272744|NCT01075984|593366280|FG001|Treatment Phase|Adverse Event|1|||
164272745|NCT01075984|593366281|FG002|Treatment Phase|Adverse Event|3|||
164272746|NCT01075984|593366282|FG003|Treatment Phase|Adverse Event|7|||
164272747|NCT01075984|593366283|FG004|Treatment Phase|Adverse Event|35|||
164272748|NCT01075984|593366279|FG000|Treatment Phase|Protocol Violation|0|||
164272749|NCT01075984|593366280|FG001|Treatment Phase|Protocol Violation|0|||
164272750|NCT01075984|593366281|FG002|Treatment Phase|Protocol Violation|1|||
164272751|NCT01075984|593366282|FG003|Treatment Phase|Protocol Violation|0|||
164272752|NCT01075984|593366283|FG004|Treatment Phase|Protocol Violation|3|||
164272753|NCT01075984|593366279|FG000|Treatment Phase|Withdrawal by Subject|0|||
164272754|NCT01075984|593366280|FG001|Treatment Phase|Withdrawal by Subject|0|||
164272755|NCT01075984|593366281|FG002|Treatment Phase|Withdrawal by Subject|2|||
164272756|NCT01075984|593366282|FG003|Treatment Phase|Withdrawal by Subject|0|||
164272757|NCT01075984|593366283|FG004|Treatment Phase|Withdrawal by Subject|15|||
164272758|NCT01075984|593366279|FG000|Treatment Phase|Treatment Failure|0|||
164272759|NCT01075984|593366280|FG001|Treatment Phase|Treatment Failure|0|||
164272760|NCT01075984|593366281|FG002|Treatment Phase|Treatment Failure|1|||
164272761|NCT01075984|593366282|FG003|Treatment Phase|Treatment Failure|0|||
164272762|NCT01075984|593366283|FG004|Treatment Phase|Treatment Failure|5|||
164272763|NCT01075984|593366279|FG000|Treatment Phase|Progression of disease|0|||
164272764|NCT01075984|593366280|FG001|Treatment Phase|Progression of disease|0|||
164272765|NCT01075984|593366281|FG002|Treatment Phase|Progression of disease|0|||
164272766|NCT01075984|593366282|FG003|Treatment Phase|Progression of disease|0|||
164272767|NCT01075984|593366283|FG004|Treatment Phase|Progression of disease|2|||
164272768|NCT01075984|593366279|FG000|Follow-up Phase|Protocol Violation|0|||
164272769|NCT01075984|593366280|FG001|Follow-up Phase|Protocol Violation|0|||
164272770|NCT01075984|593366281|FG002|Follow-up Phase|Protocol Violation|1|||
164272771|NCT01075984|593366282|FG003|Follow-up Phase|Protocol Violation|0|||
164272772|NCT01075984|593366283|FG004|Follow-up Phase|Protocol Violation|3|||
164272773|NCT01075984|593366279|FG000|Follow-up Phase|Adverse Event|0|||
164272774|NCT01075984|593366280|FG001|Follow-up Phase|Adverse Event|0|||
164272775|NCT01075984|593366281|FG002|Follow-up Phase|Adverse Event|0|||
164272776|NCT01075984|593366282|FG003|Follow-up Phase|Adverse Event|2|||
164272777|NCT01075984|593366283|FG004|Follow-up Phase|Adverse Event|27|||
164272778|NCT01075984|593366279|FG000|Follow-up Phase|Administrative|0|||
164272779|NCT01075984|593366280|FG001|Follow-up Phase|Administrative|0|||
164272780|NCT01075984|593366281|FG002|Follow-up Phase|Administrative|0|||
164272781|NCT01075984|593366282|FG003|Follow-up Phase|Administrative|0|||
164272782|NCT01075984|593366283|FG004|Follow-up Phase|Administrative|1|||
164272783|NCT01075984|593366279|FG000|Follow-up Phase|Withdrawal by Subject|0|||
164272784|NCT01075984|593366280|FG001|Follow-up Phase|Withdrawal by Subject|0|||
164272785|NCT01075984|593366281|FG002|Follow-up Phase|Withdrawal by Subject|0|||
164272786|NCT01075984|593366282|FG003|Follow-up Phase|Withdrawal by Subject|0|||
164272787|NCT01075984|593366283|FG004|Follow-up Phase|Withdrawal by Subject|10|||
164272788|NCT01075984|593366279|FG000|Follow-up Phase|Progression of disease|0|||
164272789|NCT01075984|593366280|FG001|Follow-up Phase|Progression of disease|0|||
164272790|NCT01075984|593366281|FG002|Follow-up Phase|Progression of disease|0|||
164272791|NCT01075984|593366282|FG003|Follow-up Phase|Progression of disease|0|||
164272792|NCT01075984|593366283|FG004|Follow-up Phase|Progression of disease|2|||
164272793|NCT01075984|593366279|FG000|Follow-up Phase|Treatment failure|0|||
164272794|NCT01075984|593366280|FG001|Follow-up Phase|Treatment failure|0|||
164272795|NCT01075984|593366281|FG002|Follow-up Phase|Treatment failure|0|||
164272796|NCT01075984|593366282|FG003|Follow-up Phase|Treatment failure|0|||
164272797|NCT01075984|593366283|FG004|Follow-up Phase|Treatment failure|4|||
164272798|NCT03652675|593366284|FG000|Overall Study|Lost to Follow-up|4|||
164272799|NCT03652675|593366285|FG001|Overall Study|Lost to Follow-up|4|||
164272800|NCT03101085|593366286|FG000|Overall Study|Lost to Follow-up|0|||
164688777|NCT04253236|594883343|FG000|Overall Study|Adverse Event|1|||
164688778|NCT04253236|594883344|FG001|Overall Study|Adverse Event|0|||
164688779|NCT04253236|594883343|FG000|Overall Study|Safety Concerns|1|||
164688780|NCT04253236|594883344|FG001|Overall Study|Safety Concerns|0|||
164688781|NCT04253236|594883343|FG000|Overall Study|Study Terminated by Sponsor|1|||
164688782|NCT04253236|594883344|FG001|Overall Study|Study Terminated by Sponsor|0|||
164688783|NCT01896505|594883345|FG000|Overall Study|Adverse Event|1|||
164688784|NCT01896505|594883346|FG001|Overall Study|Adverse Event|0|||
164688785|NCT01896505|594883347|FG002|Overall Study|Adverse Event|2|||
164688786|NCT01896505|594883348|FG003|Overall Study|Adverse Event|1|||
164688787|NCT01896505|594883349|FG004|Overall Study|Adverse Event|1|||
164688788|NCT01896505|594883350|FG005|Overall Study|Adverse Event|0|||
164688789|NCT01896505|594883345|FG000|Overall Study|Physician Decision|1|||
164688790|NCT01896505|594883346|FG001|Overall Study|Physician Decision|3|||
164688791|NCT01896505|594883347|FG002|Overall Study|Physician Decision|2|||
164688792|NCT01896505|594883348|FG003|Overall Study|Physician Decision|0|||
164688793|NCT01896505|594883349|FG004|Overall Study|Physician Decision|0|||
164688794|NCT01896505|594883350|FG005|Overall Study|Physician Decision|1|||
164688795|NCT01896505|594883345|FG000|Overall Study|Withdrawal by Subject|1|||
164688796|NCT01896505|594883346|FG001|Overall Study|Withdrawal by Subject|0|||
164688797|NCT01896505|594883347|FG002|Overall Study|Withdrawal by Subject|3|||
164688798|NCT01896505|594883348|FG003|Overall Study|Withdrawal by Subject|1|||
164688799|NCT01896505|594883349|FG004|Overall Study|Withdrawal by Subject|0|||
164272801|NCT03101085|593366287|FG001|Overall Study|Lost to Follow-up|1|||
164272802|NCT02986854|593366289|FG000|Overall Study|Withdrawal by Subject|0|||
164272803|NCT02986854|593366290|FG001|Overall Study|Withdrawal by Subject|1|||
164272804|NCT02986854|593366291|FG002|Overall Study|Withdrawal by Subject|1|||
164272805|NCT02986854|593366289|FG000|Overall Study|Lost to Follow-up|3|||
164272806|NCT02986854|593366290|FG001|Overall Study|Lost to Follow-up|11|||
164272807|NCT02986854|593366291|FG002|Overall Study|Lost to Follow-up|2|||
164272808|NCT01895309|593366294|FG000|Overall Study|Adverse Event|13|||
164272809|NCT01895309|593366295|FG001|Overall Study|Adverse Event|17|||
164272810|NCT01895309|593366294|FG000|Overall Study|Protocol Violation|1|||
164272811|NCT01895309|593366295|FG001|Overall Study|Protocol Violation|0|||
164342575|NCT00381485|593631463|FG002|Open-Label Run-In Period|Adverse Event|0|||
164342576|NCT00381485|593631464|FG003|Open-Label Run-In Period|Adverse Event|0|||
164342577|NCT00381485|593631461|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
164430997|NCT02403323|593949348|FG001|Part 1: Open Label Extension Period|Death|0|||
164430998|NCT02403323|593949349|FG002|Part 1: Open Label Extension Period|Death|0|||
164430999|NCT02403323|593949347|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
164431000|NCT02403323|593949348|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
164431001|NCT02403323|593949349|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
164431002|NCT02403323|593949347|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
164431003|NCT02403323|593949348|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
164431004|NCT02403323|593949349|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
164431005|NCT02403323|593949347|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
164431006|NCT02403323|593949348|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
164431007|NCT02403323|593949349|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
164431008|NCT02403323|593949347|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
164431009|NCT02403323|593949348|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
164431010|NCT02403323|593949349|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
164688800|NCT01896505|594883350|FG005|Overall Study|Withdrawal by Subject|0|||
164688801|NCT01896505|594883345|FG000|Overall Study|Disease Progression|7|||
164688802|NCT01896505|594883346|FG001|Overall Study|Disease Progression|5|||
164688803|NCT01896505|594883347|FG002|Overall Study|Disease Progression|8|||
164688804|NCT01896505|594883348|FG003|Overall Study|Disease Progression|4|||
164272812|NCT01895309|593366294|FG000|Overall Study|Lack of Efficacy|1|||
164342578|NCT00381485|593631462|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
164342579|NCT00381485|593631463|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
164342580|NCT00381485|593631464|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
164342581|NCT00381485|593631461|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
164342582|NCT00381485|593631462|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
164342583|NCT00381485|593631463|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
164342584|NCT00381485|593631464|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
164342585|NCT00381485|593631461|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
164688805|NCT01896505|594883349|FG004|Overall Study|Disease Progression|4|||
164688806|NCT01896505|594883350|FG005|Overall Study|Disease Progression|4|||
164688807|NCT01896505|594883345|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
164688808|NCT01896505|594883346|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
164688809|NCT01896505|594883347|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
164688810|NCT01896505|594883348|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
164688811|NCT01896505|594883349|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
164688812|NCT01896505|594883350|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
164582926|NCT01645280|594499642|FG002|Overall Study|Withdrawal by Subject|2|||
164582927|NCT01645280|594499643|FG003|Overall Study|Withdrawal by Subject|4|||
164582928|NCT01645280|594499644|FG004|Overall Study|Withdrawal by Subject|5|||
164582929|NCT01645280|594499640|FG000|Overall Study|Lost to Follow-up|0|||
164582930|NCT01645280|594499641|FG001|Overall Study|Lost to Follow-up|0|||
164582931|NCT01645280|594499642|FG002|Overall Study|Lost to Follow-up|0|||
164582932|NCT01645280|594499643|FG003|Overall Study|Lost to Follow-up|2|||
164582933|NCT01645280|594499644|FG004|Overall Study|Lost to Follow-up|1|||
164582934|NCT01645280|594499640|FG000|Overall Study|Other|1|||
164582935|NCT01645280|594499641|FG001|Overall Study|Other|1|||
164582936|NCT01645280|594499642|FG002|Overall Study|Other|2|||
164582937|NCT01645280|594499643|FG003|Overall Study|Other|0|||
164582938|NCT01645280|594499644|FG004|Overall Study|Other|0|||
164582939|NCT01645280|594499640|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
164582940|NCT01645280|594499641|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
164582941|NCT01645280|594499642|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
164582942|NCT01645280|594499643|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
164582943|NCT01645280|594499644|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
164582944|NCT02052960|594499650|FG000|Overall Study|Adverse Event|19|||
164582945|NCT02052960|594499651|FG001|Overall Study|Adverse Event|17|||
164582946|NCT02052960|594499650|FG000|Overall Study|Protocol Violation|4|||
164582947|NCT02052960|594499651|FG001|Overall Study|Protocol Violation|3|||
164582948|NCT02052960|594499650|FG000|Overall Study|Withdrawal by Subject|6|||
164582949|NCT02052960|594499651|FG001|Overall Study|Withdrawal by Subject|11|||
164582950|NCT02052960|594499650|FG000|Overall Study|Other|25|||
164582951|NCT02052960|594499651|FG001|Overall Study|Other|15|||
164582952|NCT02460822|594499652|FG000|Overall Study|Withdrawal by Subject|1|||
164582953|NCT03849560|594499653|FG000|Overall Study|Withdrawal by Subject|1|||
164582954|NCT03849560|594499654|FG001|Overall Study|Withdrawal by Subject|0|||
164582955|NCT03849560|594499655|FG002|Overall Study|Withdrawal by Subject|0|||
164582956|NCT01633060|594499659|FG000|Randomization Phase|Protocol deviation|1|||
164582957|NCT01633060|594499660|FG001|Randomization Phase|Protocol deviation|2|||
164582958|NCT01633060|594499659|FG000|Randomization Phase|Technical problem|0|||
164582959|NCT01633060|594499660|FG001|Randomization Phase|Technical problem|1|||
164582960|NCT01633060|594499659|FG000|Treatment Phase|Adverse Event|24|||
164582961|NCT01633060|594499660|FG001|Treatment Phase|Adverse Event|3|||
164582962|NCT01633060|594499659|FG000|Treatment Phase|Lost to Follow-up|1|||
164582963|NCT01633060|594499660|FG001|Treatment Phase|Lost to Follow-up|0|||
164582964|NCT01633060|594499659|FG000|Treatment Phase|Physician Decision|16|||
164582965|NCT01633060|594499660|FG001|Treatment Phase|Physician Decision|7|||
164582966|NCT01633060|594499659|FG000|Treatment Phase|Progressive Disease|210|||
164582967|NCT01633060|594499660|FG001|Treatment Phase|Progressive Disease|120|||
164582968|NCT01633060|594499659|FG000|Treatment Phase|Protocol Deviation|1|||
164582969|NCT01633060|594499660|FG001|Treatment Phase|Protocol Deviation|0|||
164582970|NCT01633060|594499659|FG000|Treatment Phase|Study Terminated by sponsor|7|||
164582971|NCT01633060|594499660|FG001|Treatment Phase|Study Terminated by sponsor|3|||
164582972|NCT01633060|594499659|FG000|Treatment Phase|Subject/guardian decision|25|||
164582973|NCT01633060|594499660|FG001|Treatment Phase|Subject/guardian decision|4|||
164688813|NCT01896505|594883345|FG000|Overall Study|Intercurrent illness|0|||
164342586|NCT00381485|593631462|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
164342587|NCT00381485|593631463|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
164342588|NCT00381485|593631464|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
164342589|NCT00381485|593631461|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
164342590|NCT00381485|593631462|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
164342591|NCT00381485|593631463|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
164342592|NCT00381485|593631464|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
164342593|NCT00381485|593631461|FG000|Open-Label Run-In Period|Treatment failure|1|||
164342594|NCT00381485|593631462|FG001|Open-Label Run-In Period|Treatment failure|0|||
164342595|NCT00381485|593631463|FG002|Open-Label Run-In Period|Treatment failure|0|||
164431011|NCT02403323|593949347|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
164431012|NCT02403323|593949348|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
164582974|NCT01633060|594499659|FG000|Treatment Phase|Death|4|||
164582975|NCT01633060|594499660|FG001|Treatment Phase|Death|3|||
164582976|NCT01633060|594499659|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
164582977|NCT01633060|594499660|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
164582978|NCT01633060|594499659|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
164688814|NCT01896505|594883346|FG001|Overall Study|Intercurrent illness|1|||
164582979|NCT01633060|594499660|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
164582980|NCT01633060|594499659|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
164582981|NCT01633060|594499660|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
164582982|NCT01633060|594499659|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
164582983|NCT01633060|594499660|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
164688815|NCT01896505|594883347|FG002|Overall Study|Intercurrent illness|0|||
164272813|NCT01895309|593366295|FG001|Overall Study|Lack of Efficacy|3|||
164272814|NCT01895309|593366294|FG000|Overall Study|Lost to Follow-up|1|||
164272815|NCT01895309|593366295|FG001|Overall Study|Lost to Follow-up|3|||
164272816|NCT01895309|593366294|FG000|Overall Study|Physician Decision|15|||
164272817|NCT01895309|593366295|FG001|Overall Study|Physician Decision|10|||
164272818|NCT01895309|593366294|FG000|Overall Study|Withdrawal by Subject|9|||
164272819|NCT01895309|593366295|FG001|Overall Study|Withdrawal by Subject|18|||
164272820|NCT01555125|593366298|FG000|Induction Period|Lost to Follow-up|0|||
164272821|NCT01555125|593366299|FG001|Induction Period|Lost to Follow-up|2|||
164272822|NCT01555125|593366300|FG002|Induction Period|Lost to Follow-up|0|||
164272823|NCT01555125|593366301|FG003|Induction Period|Lost to Follow-up|0|||
164272824|NCT01555125|593366302|FG004|Induction Period|Lost to Follow-up|0|||
164272825|NCT01555125|593366298|FG000|Induction Period|Adverse Event|0|||
164272826|NCT01555125|593366299|FG001|Induction Period|Adverse Event|1|||
164272827|NCT01555125|593366300|FG002|Induction Period|Adverse Event|0|||
164272828|NCT01555125|593366301|FG003|Induction Period|Adverse Event|0|||
164272829|NCT01555125|593366302|FG004|Induction Period|Adverse Event|1|||
164272830|NCT01555125|593366298|FG000|Induction Period|Subject / guardian decision|0|||
164272831|NCT01555125|593366299|FG001|Induction Period|Subject / guardian decision|0|||
164272832|NCT01555125|593366300|FG002|Induction Period|Subject / guardian decision|0|||
164272833|NCT01555125|593366301|FG003|Induction Period|Subject / guardian decision|0|||
164272834|NCT01555125|593366302|FG004|Induction Period|Subject / guardian decision|2|||
164272835|NCT01555125|593366298|FG000|Induction Period|Death|1|||
164272836|NCT01555125|593366299|FG001|Induction Period|Death|0|||
164431013|NCT02403323|593949349|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
164431014|NCT02403323|593949347|FG000|Part 1: Open Label Extension Period|Other|1|||
164431015|NCT02403323|593949348|FG001|Part 1: Open Label Extension Period|Other|0|||
164431016|NCT02403323|593949349|FG002|Part 1: Open Label Extension Period|Other|0|||
164431017|NCT02403323|593949347|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
164431018|NCT02403323|593949348|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
164431019|NCT02403323|593949349|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
164431020|NCT02403323|593949347|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
164431021|NCT02403323|593949348|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
164431022|NCT02403323|593949349|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
164431023|NCT02403323|593949347|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
164431024|NCT02403323|593949348|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
164431025|NCT02403323|593949349|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
164431026|NCT02403323|593949347|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
164431027|NCT02403323|593949348|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
164431028|NCT02403323|593949349|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
164431029|NCT02403323|593949347|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
164431030|NCT02403323|593949348|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
164431031|NCT02403323|593949349|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
164431032|NCT02403323|593949347|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
164431033|NCT02403323|593949348|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
164431034|NCT02403323|593949349|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
164431035|NCT02403323|593949347|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
164431036|NCT02403323|593949348|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
164431037|NCT02403323|593949349|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
164431038|NCT02403323|593949347|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
164582984|NCT01633060|594499659|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
164582985|NCT01633060|594499660|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
164582986|NCT01633060|594499659|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
164272837|NCT01555125|593366300|FG002|Induction Period|Death|0|||
164272838|NCT01555125|593366301|FG003|Induction Period|Death|0|||
164272839|NCT01555125|593366302|FG004|Induction Period|Death|0|||
164272840|NCT01555125|593366298|FG000|Maintenance Period|Adverse Event|1|||
164272841|NCT01555125|593366299|FG001|Maintenance Period|Adverse Event|1|||
164272842|NCT01555125|593366300|FG002|Maintenance Period|Adverse Event|0|||
164272843|NCT01555125|593366301|FG003|Maintenance Period|Adverse Event|0|||
164272844|NCT01555125|593366302|FG004|Maintenance Period|Adverse Event|0|||
164272845|NCT01555125|593366298|FG000|Maintenance Period|Subject / guardian decision|1|||
164272846|NCT01555125|593366299|FG001|Maintenance Period|Subject / guardian decision|2|||
164272847|NCT01555125|593366300|FG002|Maintenance Period|Subject / guardian decision|0|||
164272848|NCT01555125|593366301|FG003|Maintenance Period|Subject / guardian decision|0|||
164272849|NCT01555125|593366302|FG004|Maintenance Period|Subject / guardian decision|0|||
164272850|NCT01555125|593366298|FG000|Maintenance Period|Lost to Follow-up|2|||
164272851|NCT01555125|593366299|FG001|Maintenance Period|Lost to Follow-up|0|||
164272852|NCT01555125|593366300|FG002|Maintenance Period|Lost to Follow-up|0|||
164272853|NCT01555125|593366301|FG003|Maintenance Period|Lost to Follow-up|1|||
164272854|NCT01555125|593366302|FG004|Maintenance Period|Lost to Follow-up|0|||
164272855|NCT01555125|593366298|FG000|Maintenance Period|Lack of Efficacy|6|||
164688816|NCT01896505|594883348|FG003|Overall Study|Intercurrent illness|0|||
164688817|NCT01896505|594883349|FG004|Overall Study|Intercurrent illness|0|||
164688818|NCT01896505|594883350|FG005|Overall Study|Intercurrent illness|0|||
164688819|NCT01896505|594883345|FG000|Overall Study|Death|0|||
164272856|NCT01555125|593366299|FG001|Maintenance Period|Lack of Efficacy|1|||
164272857|NCT01555125|593366300|FG002|Maintenance Period|Lack of Efficacy|3|||
164272858|NCT01555125|593366301|FG003|Maintenance Period|Lack of Efficacy|0|||
164272859|NCT01555125|593366302|FG004|Maintenance Period|Lack of Efficacy|0|||
164272860|NCT01555125|593366298|FG000|Maintenance Period|Physician Decision|0|||
164688820|NCT01896505|594883346|FG001|Overall Study|Death|0|||
164688821|NCT01896505|594883347|FG002|Overall Study|Death|1|||
164688822|NCT01896505|594883348|FG003|Overall Study|Death|1|||
164688823|NCT01896505|594883349|FG004|Overall Study|Death|0|||
164688824|NCT01896505|594883350|FG005|Overall Study|Death|1|||
164688825|NCT03259789|594883351|FG000|Overall Study|Adverse Event|3|||
164688826|NCT03259789|594883352|FG001|Overall Study|Adverse Event|2|||
164688827|NCT03259789|594883353|FG002|Overall Study|Adverse Event|1|||
164688828|NCT03259789|594883351|FG000|Overall Study|Withdrawal by Subject|9|||
164272861|NCT01555125|593366299|FG001|Maintenance Period|Physician Decision|0|||
164272862|NCT01555125|593366300|FG002|Maintenance Period|Physician Decision|1|||
164272863|NCT01555125|593366301|FG003|Maintenance Period|Physician Decision|0|||
164272864|NCT01555125|593366302|FG004|Maintenance Period|Physician Decision|0|||
164272865|NCT01555125|593366298|FG000|Maintenance Period|Death|0|||
164272866|NCT01555125|593366299|FG001|Maintenance Period|Death|0|||
164272867|NCT01555125|593366300|FG002|Maintenance Period|Death|0|||
164272868|NCT01555125|593366301|FG003|Maintenance Period|Death|1|||
164272869|NCT01555125|593366302|FG004|Maintenance Period|Death|0|||
164272870|NCT01555125|593366298|FG000|Extension|Adverse Event|1|||
164272871|NCT01555125|593366299|FG001|Extension|Adverse Event|2|||
164272872|NCT01555125|593366300|FG002|Extension|Adverse Event|1|||
164272873|NCT01555125|593366301|FG003|Extension|Adverse Event|1|||
164272874|NCT01555125|593366302|FG004|Extension|Adverse Event|0|||
164272875|NCT01555125|593366298|FG000|Extension|Protocol deviation|1|||
164272876|NCT01555125|593366299|FG001|Extension|Protocol deviation|0|||
164272877|NCT01555125|593366300|FG002|Extension|Protocol deviation|0|||
164272878|NCT01555125|593366301|FG003|Extension|Protocol deviation|0|||
164272879|NCT01555125|593366302|FG004|Extension|Protocol deviation|0|||
164272880|NCT01555125|593366298|FG000|Extension|Lack of Efficacy|7|||
164272881|NCT01555125|593366299|FG001|Extension|Lack of Efficacy|6|||
164272882|NCT01555125|593366300|FG002|Extension|Lack of Efficacy|3|||
164272883|NCT01555125|593366301|FG003|Extension|Lack of Efficacy|0|||
164272884|NCT01555125|593366302|FG004|Extension|Lack of Efficacy|0|||
164272885|NCT01555125|593366298|FG000|Extension|Lost to Follow-up|2|||
164272886|NCT01555125|593366299|FG001|Extension|Lost to Follow-up|1|||
164272887|NCT01555125|593366300|FG002|Extension|Lost to Follow-up|2|||
164272888|NCT01555125|593366301|FG003|Extension|Lost to Follow-up|0|||
164272889|NCT01555125|593366302|FG004|Extension|Lost to Follow-up|0|||
164272890|NCT01555125|593366298|FG000|Extension|Study terminated by sponsor|32|||
164272891|NCT01555125|593366299|FG001|Extension|Study terminated by sponsor|33|||
164272892|NCT01555125|593366300|FG002|Extension|Study terminated by sponsor|16|||
164272893|NCT01555125|593366301|FG003|Extension|Study terminated by sponsor|20|||
164272894|NCT01555125|593366302|FG004|Extension|Study terminated by sponsor|0|||
164272895|NCT01555125|593366298|FG000|Extension|Subject/guardian decision|1|||
164272896|NCT01555125|593366299|FG001|Extension|Subject/guardian decision|9|||
164272897|NCT01555125|593366300|FG002|Extension|Subject/guardian decision|1|||
164272898|NCT01555125|593366301|FG003|Extension|Subject/guardian decision|0|||
164342596|NCT00381485|593631464|FG003|Open-Label Run-In Period|Treatment failure|0|||
164342597|NCT00381485|593631461|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164342598|NCT00381485|593631462|FG001|Double-Blind Treatment Period|Adverse Event|2|||
164272899|NCT01555125|593366302|FG004|Extension|Subject/guardian decision|0|||
164272900|NCT01555125|593366298|FG000|Extension|Technical Problems|1|||
164272901|NCT01555125|593366299|FG001|Extension|Technical Problems|0|||
164272902|NCT01555125|593366300|FG002|Extension|Technical Problems|0|||
164272903|NCT01555125|593366301|FG003|Extension|Technical Problems|1|||
164272904|NCT01555125|593366302|FG004|Extension|Technical Problems|0|||
164272905|NCT01555125|593366298|FG000|Follow-Up Period|Lost to Follow-up|1|||
164272906|NCT01555125|593366299|FG001|Follow-Up Period|Lost to Follow-up|0|||
164272907|NCT01555125|593366300|FG002|Follow-Up Period|Lost to Follow-up|0|||
164342599|NCT00381485|593631463|FG002|Double-Blind Treatment Period|Adverse Event|2|||
164342600|NCT00381485|593631464|FG003|Double-Blind Treatment Period|Adverse Event|5|||
164688829|NCT03259789|594883352|FG001|Overall Study|Withdrawal by Subject|5|||
164688830|NCT03259789|594883353|FG002|Overall Study|Withdrawal by Subject|1|||
164688831|NCT03259789|594883351|FG000|Overall Study|Lost to Follow-up|5|||
164688832|NCT03259789|594883352|FG001|Overall Study|Lost to Follow-up|9|||
164688833|NCT03259789|594883353|FG002|Overall Study|Lost to Follow-up|4|||
164688834|NCT03259789|594883351|FG000|Overall Study|Physician Decision|0|||
164688835|NCT03259789|594883352|FG001|Overall Study|Physician Decision|1|||
164688836|NCT03259789|594883353|FG002|Overall Study|Physician Decision|0|||
164688837|NCT02063217|594883354|FG000|Overall Study|Withdrawal by Subject|1|||
164688838|NCT02063217|594883355|FG001|Overall Study|Withdrawal by Subject|0|||
164688839|NCT02063217|594883356|FG002|Overall Study|Withdrawal by Subject|0|||
164688840|NCT00889252|594883357|FG000|Overall Study|Adverse Event|2|||
164688841|NCT00889252|594883358|FG001|Overall Study|Adverse Event|4|||
164688842|NCT00889252|594883357|FG000|Overall Study|Withdrawal by Subject|3|||
164688843|NCT00889252|594883358|FG001|Overall Study|Withdrawal by Subject|0|||
164688844|NCT00889252|594883357|FG000|Overall Study|Protocol Violation|2|||
164688845|NCT00889252|594883358|FG001|Overall Study|Protocol Violation|0|||
164688846|NCT04291508|594883359|FG000|Overall Study|Withdrawal by Subject|1|||
164688847|NCT04291508|594883360|FG001|Overall Study|Withdrawal by Subject|0|||
164688848|NCT04291508|594883361|FG002|Overall Study|Withdrawal by Subject|1|||
164688849|NCT04291508|594883362|FG003|Overall Study|Withdrawal by Subject|0|||
164688850|NCT04291508|594883359|FG000|Overall Study|lost to follow up|4|||
164688851|NCT04291508|594883360|FG001|Overall Study|lost to follow up|0|||
164688852|NCT04291508|594883361|FG002|Overall Study|lost to follow up|1|||
164688853|NCT04291508|594883362|FG003|Overall Study|lost to follow up|0|||
164688854|NCT03566238|594883363|FG000|Overall Study|Adverse Event|0|||
164688855|NCT03566238|594883364|FG001|Overall Study|Adverse Event|0|||
164688856|NCT03566238|594883365|FG002|Overall Study|Adverse Event|1|||
164688857|NCT03566238|594883363|FG000|Overall Study|Lack of Efficacy|5|||
164688858|NCT03566238|594883364|FG001|Overall Study|Lack of Efficacy|4|||
164272908|NCT01555125|593366301|FG003|Follow-Up Period|Lost to Follow-up|0|||
164272909|NCT01555125|593366302|FG004|Follow-Up Period|Lost to Follow-up|0|||
164272910|NCT01555125|593366298|FG000|Follow-Up Period|Subject / guardian decision|3|||
164688859|NCT03566238|594883365|FG002|Overall Study|Lack of Efficacy|2|||
164688860|NCT03566238|594883363|FG000|Overall Study|Other|0|||
164688861|NCT03566238|594883364|FG001|Overall Study|Other|1|||
164688862|NCT03566238|594883365|FG002|Overall Study|Other|0|||
164688863|NCT01120691|594883387|FG000|Overall Study|Adverse Event|59|||
164688864|NCT01120691|594883388|FG001|Overall Study|Adverse Event|67|||
164688865|NCT01120691|594883389|FG002|Overall Study|Adverse Event|47|||
164688866|NCT01120691|594883387|FG000|Overall Study|Subject withdrew consent|33|||
164688867|NCT01120691|594883388|FG001|Overall Study|Subject withdrew consent|50|||
164688868|NCT01120691|594883389|FG002|Overall Study|Subject withdrew consent|44|||
164688869|NCT01120691|594883387|FG000|Overall Study|Death|21|||
164688870|NCT01120691|594883388|FG001|Overall Study|Death|22|||
164688871|NCT01120691|594883389|FG002|Overall Study|Death|24|||
164688872|NCT01120691|594883387|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
164688873|NCT01120691|594883388|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
164272911|NCT01555125|593366299|FG001|Follow-Up Period|Subject / guardian decision|1|||
164272912|NCT01555125|593366300|FG002|Follow-Up Period|Subject / guardian decision|1|||
164272913|NCT01555125|593366301|FG003|Follow-Up Period|Subject / guardian decision|1|||
164272914|NCT01555125|593366302|FG004|Follow-Up Period|Subject / guardian decision|0|||
164272915|NCT02039856|593366305|FG000|Overall Study|Death|5|||
164272916|NCT02039856|593366306|FG001|Overall Study|Death|3|||
164272917|NCT02039856|593366305|FG000|Overall Study|Partial survey completion|61|||
164272918|NCT02039856|593366306|FG001|Overall Study|Partial survey completion|26|||
164272919|NCT02039856|593366305|FG000|Overall Study|Lost to Follow-up|388|||
164272920|NCT02039856|593366306|FG001|Overall Study|Lost to Follow-up|206|||
164272921|NCT02039856|593366305|FG000|Overall Study|Withdrawal by Subject|1573|||
164272922|NCT02039856|593366306|FG001|Overall Study|Withdrawal by Subject|618|||
164272923|NCT01174173|593366318|FG000|Overall Study|drug-drug interaction|1|||
164272924|NCT00602420|593367903|FG000|Overall Study|Death|1|||
164272925|NCT00602420|593367904|FG001|Overall Study|Death|4|||
164272926|NCT00602420|593367903|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
164272927|NCT00602420|593367904|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
164272928|NCT00602420|593367903|FG000|Overall Study|Withdrawal by Subject|18|||
164272929|NCT00602420|593367904|FG001|Overall Study|Withdrawal by Subject|17|||
164272930|NCT00602420|593367903|FG000|Overall Study|Adverse Event|1|||
164688874|NCT01120691|594883389|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
164688875|NCT01120691|594883387|FG000|Overall Study|Administrative problems|15|||
164688876|NCT01120691|594883388|FG001|Overall Study|Administrative problems|8|||
164688877|NCT01120691|594883389|FG002|Overall Study|Administrative problems|9|||
164272931|NCT00602420|593367904|FG001|Overall Study|Adverse Event|0|||
164272932|NCT03775512|593367922|FG000|Overall Study|Death|1|||
164272933|NCT03775512|593367923|FG001|Overall Study|Death|1|||
164272934|NCT03775512|593367922|FG000|Overall Study|Withdrawal by Subject|7|||
164688878|NCT01120691|594883387|FG000|Overall Study|Protocol deviation|13|||
164688879|NCT01120691|594883388|FG001|Overall Study|Protocol deviation|12|||
164688880|NCT01120691|594883389|FG002|Overall Study|Protocol deviation|12|||
164688881|NCT01120691|594883387|FG000|Overall Study|Lost to Follow-up|5|||
164688882|NCT01120691|594883388|FG001|Overall Study|Lost to Follow-up|6|||
164688883|NCT01120691|594883389|FG002|Overall Study|Lost to Follow-up|4|||
164688884|NCT01120691|594883387|FG000|Overall Study|Abnormal test procedure result(s)|3|||
164272935|NCT03775512|593367923|FG001|Overall Study|Withdrawal by Subject|4|||
164272936|NCT03775512|593367922|FG000|Overall Study|Lost to Follow-up|5|||
164272937|NCT03775512|593367923|FG001|Overall Study|Lost to Follow-up|5|||
164272938|NCT03775512|593367922|FG000|Overall Study|Excluded before Catheter insertion|14|||
164272939|NCT03775512|593367923|FG001|Overall Study|Excluded before Catheter insertion|5|||
164272940|NCT03775512|593367922|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
164272941|NCT03775512|593367923|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
164272942|NCT03775512|593367922|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
164272943|NCT03775512|593367923|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
164272944|NCT00082407|593367924|FG000|Overall Study|Adverse Event|20|||
164272945|NCT00082407|593367925|FG001|Overall Study|Adverse Event|0|||
164272946|NCT00082407|593367924|FG000|Overall Study|Protocol Violation|14|||
164272947|NCT00082407|593367925|FG001|Overall Study|Protocol Violation|12|||
164272948|NCT00082407|593367924|FG000|Overall Study|Patient Decision|13|||
164272949|NCT00082407|593367925|FG001|Overall Study|Patient Decision|6|||
164272950|NCT00082407|593367924|FG000|Overall Study|Physician Decision|5|||
164272951|NCT00082407|593367925|FG001|Overall Study|Physician Decision|3|||
164272952|NCT00082407|593367924|FG000|Overall Study|Loss of Glucose Control|2|||
164272953|NCT00082407|593367925|FG001|Overall Study|Loss of Glucose Control|2|||
164272954|NCT00082407|593367924|FG000|Overall Study|Death|2|||
164272955|NCT00082407|593367925|FG001|Overall Study|Death|1|||
164272956|NCT00082407|593367924|FG000|Overall Study|Lost to Follow-up|0|||
164272957|NCT00082407|593367925|FG001|Overall Study|Lost to Follow-up|3|||
164272958|NCT03464019|593367926|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
164272959|NCT03464019|593367927|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
164272960|NCT03464019|593367928|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
164272961|NCT03464019|593367926|FG000|NODE-301 Part 1|Ablation|0|||
164342601|NCT00381485|593631461|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
164342602|NCT00381485|593631462|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
164342603|NCT00381485|593631463|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
164342604|NCT00381485|593631464|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
164342605|NCT00381485|593631461|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
164342606|NCT00381485|593631462|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
164342607|NCT00381485|593631463|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
164342608|NCT00381485|593631464|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
164342609|NCT00381485|593631461|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
164342610|NCT00381485|593631462|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
164342611|NCT00381485|593631463|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
164342612|NCT00381485|593631464|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
164342613|NCT00381485|593631461|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
164342614|NCT00381485|593631462|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
164342615|NCT00381485|593631463|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
164342616|NCT00381485|593631464|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
164342617|NCT00381485|593631461|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
164342618|NCT00381485|593631462|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
164342619|NCT00381485|593631463|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
164342620|NCT00381485|593631464|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
164342621|NCT00381485|593631461|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
164342622|NCT00381485|593631462|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
164342623|NCT00381485|593631463|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
164582987|NCT01633060|594499660|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
164582988|NCT00883753|594499661|FG000|Overall Study|Adverse Event|37|||
164582989|NCT00883753|594499661|FG000|Overall Study|Death|2|||
164582990|NCT00883753|594499661|FG000|Overall Study|Insufficient therapeutic response|16|||
164582991|NCT00883753|594499661|FG000|Overall Study|Lost to Follow-up|4|||
164582992|NCT00883753|594499661|FG000|Overall Study|Violation of selection criteria at entry|7|||
164582993|NCT00883753|594499661|FG000|Overall Study|Protocol Violation|2|||
164582994|NCT00883753|594499661|FG000|Overall Study|Refused treatment|4|||
164582995|NCT00883753|594499661|FG000|Overall Study|Withdrew consent|10|||
164582996|NCT00883753|594499661|FG000|Overall Study|Investigator's decision|17|||
164582997|NCT00883753|594499661|FG000|Overall Study|Administrative/Other|8|||
164582998|NCT02859415|594499662|FG000|Overall Study|Physician Decision|1|||
164582999|NCT02859415|594499663|FG001|Overall Study|Physician Decision|0|||
164583000|NCT02859415|594499662|FG000|Overall Study|Off treatment due to cardiac event|0|||
164272962|NCT03464019|593367927|FG001|NODE-301 Part 1|Ablation|0|||
164272963|NCT03464019|593367928|FG002|NODE-301 Part 1|Ablation|16|||
164272964|NCT03464019|593367926|FG000|NODE-301 Part 1|Test Dose Failure|0|||
164272965|NCT03464019|593367927|FG001|NODE-301 Part 1|Test Dose Failure|0|||
164272966|NCT03464019|593367928|FG002|NODE-301 Part 1|Test Dose Failure|8|||
164272967|NCT03464019|593367926|FG000|NODE-301 Part 1|Adverse Event|0|||
164272968|NCT03464019|593367927|FG001|NODE-301 Part 1|Adverse Event|0|||
164272969|NCT03464019|593367928|FG002|NODE-301 Part 1|Adverse Event|5|||
164272970|NCT03464019|593367926|FG000|NODE-301 Part 1|Physician Decision|0|||
164272971|NCT03464019|593367927|FG001|NODE-301 Part 1|Physician Decision|0|||
164272972|NCT03464019|593367928|FG002|NODE-301 Part 1|Physician Decision|4|||
164272973|NCT03464019|593367926|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
164272974|NCT03464019|593367927|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
164272975|NCT03464019|593367928|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
164272976|NCT03464019|593367926|FG000|NODE-301 Part 1|Protocol Violation|0|||
164272977|NCT03464019|593367927|FG001|NODE-301 Part 1|Protocol Violation|0|||
164272978|NCT03464019|593367928|FG002|NODE-301 Part 1|Protocol Violation|2|||
164272979|NCT03464019|593367926|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
164272980|NCT03464019|593367927|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
164272981|NCT03464019|593367928|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
164272982|NCT03464019|593367926|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
164272983|NCT03464019|593367927|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
164272984|NCT03464019|593367928|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
164272985|NCT03464019|593367926|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
164272986|NCT03464019|593367927|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
164272987|NCT03464019|593367928|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
164272988|NCT03464019|593367926|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
164272989|NCT03464019|593367927|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
164272990|NCT03464019|593367928|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
164272991|NCT03464019|593367926|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
164272992|NCT03464019|593367927|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
164272993|NCT03464019|593367928|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
164272994|NCT03464019|593367926|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
164272995|NCT03464019|593367927|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
164272996|NCT03464019|593367928|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
164272997|NCT03464019|593367926|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
164272998|NCT03464019|593367927|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
164272999|NCT03464019|593367928|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
164273000|NCT03464019|593367926|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
164273001|NCT03464019|593367927|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
164273002|NCT03464019|593367928|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
164583001|NCT02859415|594499663|FG001|Overall Study|Off treatment due to cardiac event|1|||
164583002|NCT01396525|594499666|FG000|Overall Study|Withdrawal by Subject|8|||
164273003|NCT03464019|593367926|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
164273004|NCT03464019|593367927|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
164273005|NCT03464019|593367928|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
164273006|NCT03464019|593367926|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
164273007|NCT03464019|593367927|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
164273008|NCT03464019|593367928|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
164273009|NCT03464019|593367926|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
164273010|NCT03464019|593367927|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
164273011|NCT03464019|593367928|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
164273012|NCT03464019|593367926|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
164273013|NCT03464019|593367927|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
164583003|NCT01396525|594499666|FG000|Overall Study|Death|14|||
164583004|NCT01396525|594499666|FG000|Overall Study|Lost to Follow-up|4|||
164273014|NCT03464019|593367928|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
164273015|NCT03464019|593367926|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
164273016|NCT03464019|593367927|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
164273017|NCT03464019|593367928|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
164273018|NCT03464019|593367926|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
164273019|NCT03464019|593367927|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
164273020|NCT03464019|593367928|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
164273021|NCT00767806|593367929|FG000|Overall Study|Adverse Event|30|||
164273022|NCT00767806|593367930|FG001|Overall Study|Adverse Event|11|||
164273023|NCT00767806|593367929|FG000|Overall Study|Withdrawal by Subject|8|||
164273024|NCT00767806|593367930|FG001|Overall Study|Withdrawal by Subject|13|||
164273025|NCT00767806|593367929|FG000|Overall Study|Protocol Violation|6|||
164273026|NCT00767806|593367930|FG001|Overall Study|Protocol Violation|5|||
164273027|NCT00767806|593367929|FG000|Overall Study|Lack of Efficacy|1|||
164583005|NCT00414440|594499668|FG000|Core Period|Withdrawal by Subject|70|||
164583006|NCT00414440|594499669|FG001|Core Period|Withdrawal by Subject|32|||
164273028|NCT00767806|593367930|FG001|Overall Study|Lack of Efficacy|9|||
164273029|NCT00767806|593367929|FG000|Overall Study|Physician Decision|4|||
164273030|NCT00767806|593367930|FG001|Overall Study|Physician Decision|3|||
164273031|NCT00767806|593367929|FG000|Overall Study|Lost to Follow-up|1|||
164273032|NCT00767806|593367930|FG001|Overall Study|Lost to Follow-up|4|||
164273033|NCT00767806|593367929|FG000|Overall Study|Entry Criteria Not Met|1|||
164273034|NCT00767806|593367930|FG001|Overall Study|Entry Criteria Not Met|1|||
164273035|NCT00767806|593367929|FG000|Overall Study|Sponsor Decision|0|||
164273036|NCT00767806|593367930|FG001|Overall Study|Sponsor Decision|1|||
164273037|NCT02489942|593367931|FG000|Overall Study|Request by patient|602|||
164273038|NCT02489942|593367931|FG000|Overall Study|Improvement/remission|157|||
164688885|NCT01120691|594883388|FG001|Overall Study|Abnormal test procedure result(s)|2|||
164688886|NCT01120691|594883389|FG002|Overall Study|Abnormal test procedure result(s)|1|||
164688887|NCT01120691|594883387|FG000|Overall Study|Patient's inability to use the device|3|||
164688888|NCT01120691|594883388|FG001|Overall Study|Patient's inability to use the device|1|||
164688889|NCT01120691|594883389|FG002|Overall Study|Patient's inability to use the device|0|||
164688890|NCT01120691|594883387|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164688891|NCT01120691|594883388|FG001|Overall Study|Abnormal laboratory value(s)|3|||
164688892|NCT01120691|594883389|FG002|Overall Study|Abnormal laboratory value(s)|4|||
164688893|NCT00089973|594883394|FG000|Overall Study|Adverse Event|3|||
164688894|NCT00089973|594883394|FG000|Overall Study|Withdrawal by Subject|1|||
164688895|NCT00089973|594883394|FG000|Overall Study|Disease progression|45|||
164688896|NCT00089973|594883394|FG000|Overall Study|Death|1|||
164688897|NCT01321697|594883400|FG000|Overall Study|Study Terminated|7|||
164688898|NCT01049581|594883401|FG000|Overall Study|Lost to Follow-up|2|||
164688899|NCT01049581|594883402|FG001|Overall Study|Lost to Follow-up|1|||
164688900|NCT00493792|594885410|FG000|Overall Study|Death|55|||
164688901|NCT00493792|594885411|FG001|Overall Study|Death|50|||
164688902|NCT00493792|594885410|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
164688903|NCT00493792|594885411|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
164688904|NCT00685035|594885412|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
164688905|NCT00685035|594885413|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
164688906|NCT00784979|594885419|FG000|Overall Study|incomplete data|6|||
164688907|NCT00894933|594885423|FG000|Overall Study|Lost to Follow-up|2|||
164273039|NCT02489942|593367931|FG000|Overall Study|No change/Progressive disease|263|||
164273040|NCT02489942|593367931|FG000|Overall Study|Adverse Event|522|||
164273041|NCT02489942|593367931|FG000|Overall Study|Other personal reasons|1218|||
164273042|NCT02489942|593367931|FG000|Overall Study|Lost to Follow-up|456|||
164273043|NCT02489942|593367931|FG000|Overall Study|Not continuously investigated|7|||
164273044|NCT02489942|593367931|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
164273045|NCT02489942|593367931|FG000|Overall Study|Multiple registration|1|||
164273046|NCT02489942|593367931|FG000|Overall Study|No patient visit after entry|100|||
164273047|NCT02489942|593367931|FG000|Overall Study|No treatment with Jardiance|2|||
164273048|NCT02489942|593367931|FG000|Overall Study|Patient received Jardiance before registration|1|||
164273049|NCT02489942|593367931|FG000|Overall Study|No CRF collected|86|||
164273050|NCT00858208|593367932|FG000|Overall Study|Adverse Event|3|||
164273051|NCT00858208|593367932|FG000|Overall Study|Lost to Follow-up|26|||
164273052|NCT00858208|593367932|FG000|Overall Study|Participant refused|40|||
164273053|NCT00858208|593367932|FG000|Overall Study|Other|10|||
164273054|NCT01272635|593367933|FG000|Overall Study|Lost to Follow-up|31|||
164273055|NCT01272635|593367934|FG001|Overall Study|Lost to Follow-up|20|||
164273056|NCT01272635|593367935|FG002|Overall Study|Lost to Follow-up|31|||
164273057|NCT01272635|593367936|FG003|Overall Study|Lost to Follow-up|23|||
164273058|NCT01543776|593367937|FG000|Overall Study|Withdrawal by Subject|2|||
164273059|NCT01543776|593367938|FG001|Overall Study|Withdrawal by Subject|2|||
164273060|NCT00306527|593367939|FG000|Overall Study|Lost to Follow-up|3|||
164273061|NCT00306527|593367940|FG001|Overall Study|Lost to Follow-up|4|||
164273062|NCT00306527|593367941|FG002|Overall Study|Lost to Follow-up|3|||
164273063|NCT00306527|593367942|FG003|Overall Study|Lost to Follow-up|0|||
164273064|NCT00306527|593367939|FG000|Overall Study|Withdrawal by Subject|2|||
164273065|NCT00306527|593367940|FG001|Overall Study|Withdrawal by Subject|3|||
164273066|NCT00306527|593367941|FG002|Overall Study|Withdrawal by Subject|0|||
164273067|NCT00306527|593367942|FG003|Overall Study|Withdrawal by Subject|3|||
164273068|NCT00306527|593367939|FG000|Overall Study|Adverse Event|0|||
164273069|NCT00306527|593367940|FG001|Overall Study|Adverse Event|0|||
164273070|NCT00306527|593367941|FG002|Overall Study|Adverse Event|1|||
164273071|NCT00306527|593367942|FG003|Overall Study|Adverse Event|1|||
164688908|NCT00894933|594885423|FG000|Overall Study|Cancelled Procedure|1|||
164273072|NCT00306527|593367939|FG000|Overall Study|Death|1|||
164273073|NCT00306527|593367940|FG001|Overall Study|Death|0|||
164273074|NCT00306527|593367941|FG002|Overall Study|Death|1|||
164273075|NCT00306527|593367942|FG003|Overall Study|Death|2|||
164273076|NCT00567359|593367943|FG000|Overall Study|Withdrawal by Subject|1|||
164273077|NCT00539305|593367944|FG000|Overall Study|Adverse Event|1|||
164273078|NCT00539305|593367945|FG001|Overall Study|Adverse Event|0|||
164273079|NCT00539305|593367944|FG000|Overall Study|Substance Use|0|||
164688909|NCT00894933|594885423|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
164688910|NCT04241133|594885424|FG000|Overall Study|COVID19 Precautions|14|||
164688911|NCT04241133|594885425|FG001|Overall Study|COVID19 Precautions|34|||
164688912|NCT00631007|594885428|FG000|Overall Study|Adverse Event|0|||
164431039|NCT02403323|593949348|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
164431040|NCT02403323|593949349|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
164583007|NCT00414440|594499668|FG000|Extension Period|Lost to Follow-up|44|||
164583008|NCT00414440|594499669|FG001|Extension Period|Lost to Follow-up|52|||
164583009|NCT00414440|594499668|FG000|Extension Period|Did not consent to continue follow up|61|||
164273080|NCT00539305|593367945|FG001|Overall Study|Substance Use|1|||
164273081|NCT00539305|593367944|FG000|Overall Study|Withdrawal by Subject|0|||
164273082|NCT00539305|593367945|FG001|Overall Study|Withdrawal by Subject|1|||
164431041|NCT02403323|593949347|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
164431042|NCT02403323|593949348|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
164431043|NCT02403323|593949349|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
164431044|NCT02403323|593949347|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
164431045|NCT02403323|593949348|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
164431046|NCT02403323|593949349|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
164431047|NCT00197236|593949352|FG000|Overall Study|Adverse Event|1|||
164431048|NCT00197236|593949353|FG001|Overall Study|Adverse Event|0|||
164431049|NCT00197236|593949354|FG002|Overall Study|Adverse Event|1|||
164431050|NCT00197236|593949352|FG000|Overall Study|Lost to Follow-up|5|||
164431051|NCT00197236|593949353|FG001|Overall Study|Lost to Follow-up|14|||
164431052|NCT00197236|593949354|FG002|Overall Study|Lost to Follow-up|6|||
164431053|NCT00197236|593949352|FG000|Overall Study|Protocol Violation|0|||
164431054|NCT00197236|593949353|FG001|Overall Study|Protocol Violation|0|||
164431055|NCT00197236|593949354|FG002|Overall Study|Protocol Violation|1|||
164431056|NCT00197236|593949352|FG000|Overall Study|Withdrawal by Subject|7|||
164431057|NCT00197236|593949353|FG001|Overall Study|Withdrawal by Subject|3|||
164431058|NCT00197236|593949354|FG002|Overall Study|Withdrawal by Subject|11|||
164431059|NCT00197236|593949352|FG000|Overall Study|Study drug/medication expiration|1|||
164431060|NCT00197236|593949353|FG001|Overall Study|Study drug/medication expiration|0|||
164431061|NCT00197236|593949354|FG002|Overall Study|Study drug/medication expiration|3|||
164431062|NCT00197236|593949352|FG000|Overall Study|Returned out of specified time window|0|||
164431063|NCT00197236|593949353|FG001|Overall Study|Returned out of specified time window|0|||
164431064|NCT00197236|593949354|FG002|Overall Study|Returned out of specified time window|1|||
164431065|NCT00746330|593949355|FG000|Period 1|Abnormal test procedure result|0|||
164431066|NCT00746330|593949356|FG001|Period 1|Abnormal test procedure result|0|||
164431067|NCT00746330|593949357|FG002|Period 1|Abnormal test procedure result|1|||
164431068|NCT00746330|593949358|FG003|Period 1|Abnormal test procedure result|0|||
164431069|NCT01076335|593949359|FG000|Overall Study|Withdrawal by Subject|3|||
164431070|NCT01076335|593949359|FG000|Overall Study|Withdrawal without treatment|1|||
164431071|NCT02524288|593949360|FG000|Overall Study|Adverse Event|115|||
164431072|NCT02524288|593949360|FG000|Overall Study|Lost to Follow-up|216|||
164583010|NCT00414440|594499669|FG001|Extension Period|Did not consent to continue follow up|54|||
164583011|NCT00414440|594499668|FG000|Extension Period|Other|1|||
164583012|NCT00414440|594499669|FG001|Extension Period|Other|1|||
164583013|NCT00414440|594499668|FG000|Extension Period|Administrative|16|||
164583014|NCT00414440|594499669|FG001|Extension Period|Administrative|16|||
164583015|NCT00414440|594499668|FG000|Extension Period|Death|1|||
164583016|NCT00414440|594499669|FG001|Extension Period|Death|2|||
164583017|NCT00414440|594499668|FG000|Extension Period|Withdrawal by Subject|9|||
164583018|NCT00414440|594499669|FG001|Extension Period|Withdrawal by Subject|7|||
164583019|NCT00414440|594499668|FG000|Extension Period|Not included in follow up period|18|||
164583020|NCT00414440|594499669|FG001|Extension Period|Not included in follow up period|8|||
164583021|NCT01743027|594499673|FG000|Overall Study|Adverse Event|2|||
164583022|NCT01743027|594499674|FG001|Overall Study|Adverse Event|0|||
164583023|NCT01743027|594499675|FG002|Overall Study|Adverse Event|0|||
164583024|NCT01743027|594499676|FG003|Overall Study|Adverse Event|0|||
164583025|NCT01743027|594499673|FG000|Overall Study|Lost to Follow-up|0|||
164583026|NCT01743027|594499674|FG001|Overall Study|Lost to Follow-up|0|||
164583027|NCT01743027|594499675|FG002|Overall Study|Lost to Follow-up|2|||
164583028|NCT01743027|594499676|FG003|Overall Study|Lost to Follow-up|0|||
164583029|NCT01743027|594499673|FG000|Overall Study|Progressive Disease|1|||
164583030|NCT01743027|594499674|FG001|Overall Study|Progressive Disease|4|||
164583031|NCT01743027|594499675|FG002|Overall Study|Progressive Disease|3|||
164583032|NCT01743027|594499676|FG003|Overall Study|Progressive Disease|0|||
164583033|NCT01743027|594499673|FG000|Overall Study|Protocol Violation|1|||
164583034|NCT01743027|594499674|FG001|Overall Study|Protocol Violation|1|||
164583035|NCT01743027|594499675|FG002|Overall Study|Protocol Violation|1|||
164583036|NCT01743027|594499676|FG003|Overall Study|Protocol Violation|0|||
164583037|NCT01743027|594499673|FG000|Overall Study|Withdrawal by Subject|1|||
164583038|NCT01743027|594499674|FG001|Overall Study|Withdrawal by Subject|0|||
164583039|NCT01743027|594499675|FG002|Overall Study|Withdrawal by Subject|3|||
164583040|NCT01743027|594499676|FG003|Overall Study|Withdrawal by Subject|1|||
164583041|NCT00138151|594499677|FG000|Overall Study|Withdrawal by Subject|3|||
164273083|NCT00126776|593367947|FG000|Overall Study|follow up complete on all patients|0|||
164431073|NCT02524288|593949360|FG000|Overall Study|Non-Compliance With Protocol|32|||
164583042|NCT00138151|594499677|FG000|Overall Study|Physician Decision|1|||
164688913|NCT00631007|594885429|FG001|Overall Study|Adverse Event|2|||
164688914|NCT00631007|594885430|FG002|Overall Study|Adverse Event|0|||
164273084|NCT00126776|593367948|FG001|Overall Study|follow up complete on all patients|0|||
164273085|NCT01815840|593367951|FG000|Overall Study|Missing|1|||
164273086|NCT01815840|593367952|FG001|Overall Study|Missing|0|||
164273087|NCT01815840|593367951|FG000|Overall Study|Withdrew Consent|31|||
164273088|NCT01815840|593367952|FG001|Overall Study|Withdrew Consent|30|||
164273089|NCT01815840|593367951|FG000|Overall Study|Administrative/Other|1|||
164273090|NCT01815840|593367952|FG001|Overall Study|Administrative/Other|3|||
164273091|NCT01815840|593367951|FG000|Overall Study|Adverse Event|10|||
164273092|NCT01815840|593367952|FG001|Overall Study|Adverse Event|16|||
164273093|NCT01815840|593367951|FG000|Overall Study|Death|2|||
164273094|NCT01815840|593367952|FG001|Overall Study|Death|2|||
164273095|NCT01815840|593367951|FG000|Overall Study|Disease progression|3|||
164273096|NCT01815840|593367952|FG001|Overall Study|Disease progression|2|||
164273097|NCT01815840|593367951|FG000|Overall Study|Investigators Decision|2|||
164273098|NCT01815840|593367952|FG001|Overall Study|Investigators Decision|3|||
164273099|NCT01815840|593367951|FG000|Overall Study|Lost to Follow-up|3|||
164273100|NCT01815840|593367952|FG001|Overall Study|Lost to Follow-up|6|||
164273101|NCT01815840|593367951|FG000|Overall Study|Refused Treatment|5|||
164273102|NCT01815840|593367952|FG001|Overall Study|Refused Treatment|1|||
164273103|NCT01815840|593367951|FG000|Overall Study|Sponsor Termination Treatment|1|||
164273104|NCT01815840|593367952|FG001|Overall Study|Sponsor Termination Treatment|0|||
164273105|NCT01055314|593367953|FG000|Overall Study|Adverse Event|7|||
164273106|NCT01055314|593367954|FG001|Overall Study|Adverse Event|4|||
164273107|NCT01055314|593367953|FG000|Overall Study|Death|2|||
164273108|NCT01055314|593367954|FG001|Overall Study|Death|1|||
164273109|NCT01055314|593367953|FG000|Overall Study|Lack of Efficacy|11|||
164273110|NCT01055314|593367954|FG001|Overall Study|Lack of Efficacy|19|||
164273111|NCT01055314|593367953|FG000|Overall Study|Physician Decision|10|||
164273112|NCT01055314|593367954|FG001|Overall Study|Physician Decision|5|||
164273113|NCT01055314|593367953|FG000|Overall Study|Withdrawal by Subject|1|||
164273114|NCT01055314|593367954|FG001|Overall Study|Withdrawal by Subject|0|||
164273115|NCT01055314|593367953|FG000|Overall Study|Ineligible|3|||
164273116|NCT01055314|593367954|FG001|Overall Study|Ineligible|5|||
164273117|NCT01055314|593367953|FG000|Overall Study|Refusal of further protocol therapy|10|||
164273118|NCT01055314|593367954|FG001|Overall Study|Refusal of further protocol therapy|4|||
164273119|NCT01055314|593367953|FG000|Overall Study|No treatment|1|||
164273120|NCT01055314|593367954|FG001|Overall Study|No treatment|0|||
164273121|NCT04395690|593367955|FG000|Overall Study|Lost to Follow-up|1|||
164273122|NCT04395690|593367956|FG001|Overall Study|Lost to Follow-up|1|||
164688915|NCT00631007|594885431|FG003|Overall Study|Adverse Event|2|||
164688916|NCT00631007|594885432|FG004|Overall Study|Adverse Event|3|||
164688917|NCT00631007|594885433|FG005|Overall Study|Adverse Event|2|||
164688918|NCT00631007|594885428|FG000|Overall Study|Lost to Follow-up|2|||
164273123|NCT00434642|593367957|FG000|Blinded Treatment Phase|Adverse Event|12|||
164273124|NCT00434642|593367958|FG001|Blinded Treatment Phase|Adverse Event|58|||
164273125|NCT00434642|593367957|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
164273126|NCT00434642|593367958|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
164273127|NCT00434642|593367957|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
164273128|NCT00434642|593367958|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
164273129|NCT00434642|593367957|FG000|Blinded Treatment Phase|Physician Decision|19|||
164273130|NCT00434642|593367958|FG001|Blinded Treatment Phase|Physician Decision|27|||
164273131|NCT00434642|593367957|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
164273132|NCT00434642|593367958|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
164342624|NCT00381485|593631464|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
164342625|NCT00381485|593631461|FG000|Double-Blind Treatment Period|Administrative|0|||
164342626|NCT00381485|593631462|FG001|Double-Blind Treatment Period|Administrative|1|||
164342627|NCT00381485|593631463|FG002|Double-Blind Treatment Period|Administrative|0|||
164342628|NCT00381485|593631464|FG003|Double-Blind Treatment Period|Administrative|1|||
164342629|NCT01235351|593631465|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
164342630|NCT01235351|593631466|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
164342631|NCT00745823|593631467|FG000|Overall Study|Adverse Event|5|||
164342632|NCT00745823|593631468|FG001|Overall Study|Adverse Event|3|||
164342633|NCT00745823|593631467|FG000|Overall Study|Lack of Efficacy|20|||
164273133|NCT00434642|593367957|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
164273134|NCT00434642|593367958|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
164273135|NCT00434642|593367957|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
164273136|NCT00434642|593367958|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
164273137|NCT00434642|593367957|FG000|Open-label Treatment Phase|Adverse Event|0|||
164273138|NCT00434642|593367958|FG001|Open-label Treatment Phase|Adverse Event|5|||
164273139|NCT00434642|593367957|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
164273140|NCT00434642|593367958|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
164273141|NCT00753454|593367961|FG000|Overall Study|Adverse Event|4|||
164688919|NCT00631007|594885429|FG001|Overall Study|Lost to Follow-up|1|||
164273142|NCT00753454|593367961|FG000|Overall Study|Lack of Efficacy|1|||
164273143|NCT00753454|593367961|FG000|Overall Study|Lost to Follow-up|3|||
164273144|NCT00753454|593367961|FG000|Overall Study|Withdrawal by Subject|5|||
164273145|NCT00753454|593367961|FG000|Overall Study|Investigator Decision|1|||
164273146|NCT03909152|593367962|FG000|Overall Study|Adverse Event|14|||
164273147|NCT03909152|593367963|FG001|Overall Study|Adverse Event|5|||
164273148|NCT03909152|593367964|FG002|Overall Study|Adverse Event|1|||
164273149|NCT03909152|593367965|FG003|Overall Study|Adverse Event|14|||
164273150|NCT05011058|593367966|FG000|Overall Study|Sponsor Decision|2|||
164273151|NCT05011058|593367967|FG001|Overall Study|Sponsor Decision|0|||
164273152|NCT05011058|593367968|FG002|Overall Study|Sponsor Decision|14|||
164273153|NCT05011058|593367969|FG003|Overall Study|Sponsor Decision|0|||
164273154|NCT05011058|593367970|FG004|Overall Study|Sponsor Decision|0|||
164273155|NCT05011058|593367971|FG005|Overall Study|Sponsor Decision|1|||
164273156|NCT05011058|593367972|FG006|Overall Study|Sponsor Decision|0|||
164273157|NCT05011058|593367973|FG007|Overall Study|Sponsor Decision|5|||
164273158|NCT01272869|593367974|FG000|Period 2 (14 Days)|Adverse Event|1|||
164273159|NCT01272869|593367975|FG001|Period 2 (14 Days)|Adverse Event|0|||
164273160|NCT02271945|593367976|FG000|Overall Study|Death|3|||
164273161|NCT02271945|593367977|FG001|Overall Study|Death|3|||
164273162|NCT02271945|593367976|FG000|Overall Study|Withdrawal by Subject|1|||
164273163|NCT02271945|593367977|FG001|Overall Study|Withdrawal by Subject|1|||
164273164|NCT02271945|593367976|FG000|Overall Study|Other|1|||
164273165|NCT02271945|593367977|FG001|Overall Study|Other|1|||
164273166|NCT02455076|593367978|FG000|Inpatient|Withdrawal by Subject|1|||
164273167|NCT02455076|593367979|FG001|Inpatient|Withdrawal by Subject|0|||
164273168|NCT02455076|593367980|FG002|Inpatient|Withdrawal by Subject|0|||
164342634|NCT00745823|593631468|FG001|Overall Study|Lack of Efficacy|6|||
164342635|NCT00745823|593631467|FG000|Overall Study|Lost to Follow-up|10|||
164342636|NCT00745823|593631468|FG001|Overall Study|Lost to Follow-up|11|||
164583043|NCT04925570|594499680|FG000|Overall Study|Protocol Violation|24|||
164583044|NCT04925570|594499681|FG001|Overall Study|Protocol Violation|30|||
164342637|NCT00745823|593631467|FG000|Overall Study|Physician Decision|10|||
164342638|NCT00745823|593631468|FG001|Overall Study|Physician Decision|5|||
164342639|NCT00745823|593631467|FG000|Overall Study|Pregnancy|0|||
164342640|NCT00745823|593631468|FG001|Overall Study|Pregnancy|4|||
164342641|NCT00745823|593631467|FG000|Overall Study|Withdrawal by Subject|14|||
164342642|NCT00745823|593631468|FG001|Overall Study|Withdrawal by Subject|8|||
164342643|NCT00745823|593631467|FG000|Overall Study|Study Terminated by Sponsor|326|||
164342644|NCT00745823|593631468|FG001|Overall Study|Study Terminated by Sponsor|349|||
164342645|NCT02980601|593631480|FG000|Overall Study|Lost to Follow-up|2|||
164342646|NCT02980601|593631481|FG001|Overall Study|Lost to Follow-up|2|||
164342647|NCT02980601|593631480|FG000|Overall Study|Death|0|||
164342648|NCT02980601|593631481|FG001|Overall Study|Death|1|||
164342649|NCT02980601|593631480|FG000|Overall Study|Graft loss|1|||
164342650|NCT02980601|593631481|FG001|Overall Study|Graft loss|0|||
164342651|NCT02980601|593631480|FG000|Overall Study|Failed to sign consent|2|||
164342652|NCT02980601|593631481|FG001|Overall Study|Failed to sign consent|0|||
164342653|NCT01575769|593631482|FG000|Overall Study|Adverse Event|1|||
164342654|NCT01575769|593631482|FG000|Overall Study|Study terminated by sponsor|40|||
164342655|NCT00290888|593631483|FG000|Overall Study|Physician Decision|3|||
164342656|NCT00290888|593631484|FG001|Overall Study|Physician Decision|1|||
164342657|NCT02501473|593631485|FG000|Overall Study|Study Terminated|2|||
164342658|NCT02501473|593631486|FG001|Overall Study|Study Terminated|3|||
164342659|NCT02501473|593631487|FG002|Overall Study|Study Terminated|7|||
164342660|NCT02501473|593631488|FG003|Overall Study|Study Terminated|9|||
164342661|NCT02501473|593631489|FG004|Overall Study|Study Terminated|2|||
164342662|NCT02501473|593631490|FG005|Overall Study|Study Terminated|10|||
164342663|NCT02501473|593631491|FG006|Overall Study|Study Terminated|1|||
164342664|NCT02501473|593631492|FG007|Overall Study|Study Terminated|0|||
164342665|NCT02501473|593631485|FG000|Overall Study|Withdrawal by Subject|0|||
164342666|NCT02501473|593631486|FG001|Overall Study|Withdrawal by Subject|0|||
164583045|NCT04925570|594499680|FG000|Overall Study|Withdrawal by Subject|0|||
164583046|NCT04925570|594499681|FG001|Overall Study|Withdrawal by Subject|2|||
164583047|NCT03494725|594499684|FG000|Overall Study|Withdrawal by Subject|0|||
164583048|NCT03494725|594499685|FG001|Overall Study|Withdrawal by Subject|2|||
164583049|NCT03494725|594499684|FG000|Overall Study|Antibiotic use|1|||
164583050|NCT03494725|594499685|FG001|Overall Study|Antibiotic use|0|||
164583051|NCT02619253|594499686|FG000|Overall Study|Adverse Event|0|||
164583052|NCT02619253|594499687|FG001|Overall Study|Adverse Event|0|||
164583053|NCT02619253|594499688|FG002|Overall Study|Adverse Event|1|||
164583054|NCT02619253|594499689|FG003|Overall Study|Adverse Event|1|||
164583055|NCT02619253|594499690|FG004|Overall Study|Adverse Event|3|||
164273169|NCT02455076|593367981|FG003|Inpatient|Withdrawal by Subject|0|||
164273170|NCT02455076|593367982|FG004|Inpatient|Withdrawal by Subject|0|||
164273171|NCT02455076|593367978|FG000|Inpatient|Discharged <24 h after admission|0|||
164342667|NCT02501473|593631487|FG002|Overall Study|Withdrawal by Subject|3|||
164342668|NCT02501473|593631488|FG003|Overall Study|Withdrawal by Subject|3|||
164273172|NCT02455076|593367979|FG001|Inpatient|Discharged <24 h after admission|1|||
164342669|NCT02501473|593631489|FG004|Overall Study|Withdrawal by Subject|2|||
164431074|NCT02524288|593949360|FG000|Overall Study|Non-Compliance With Study Drug|14|||
164431075|NCT02524288|593949360|FG000|Overall Study|Pregnancy Wish|6|||
164431076|NCT02524288|593949360|FG000|Overall Study|Protocol Violation|6|||
164431077|NCT02524288|593949360|FG000|Overall Study|Screen Failure|2|||
164431078|NCT02524288|593949360|FG000|Overall Study|Site Discontinued Study Participation|1|||
164431079|NCT02524288|593949360|FG000|Overall Study|Study Terminated By Sponsor|1417|||
164431080|NCT02524288|593949360|FG000|Overall Study|Subject Moved|32|||
164431081|NCT02524288|593949360|FG000|Overall Study|Withdrawal by Subject|76|||
164431082|NCT02524288|593949360|FG000|Overall Study|Pregnancy|22|||
164431083|NCT02524288|593949360|FG000|Overall Study|Physician Decision|2|||
164431084|NCT00517933|593949362|FG000|Period 1|Death|2|||
164431085|NCT00517933|593949363|FG001|Period 1|Death|1|||
164431086|NCT00517933|593949362|FG000|Period 1|Adverse Event|4|||
164431087|NCT00517933|593949363|FG001|Period 1|Adverse Event|4|||
164431088|NCT00517933|593949362|FG000|Period 1|Lost to Follow-up|2|||
164431089|NCT00517933|593949363|FG001|Period 1|Lost to Follow-up|0|||
164431090|NCT00517933|593949362|FG000|Period 1|Underwent lung transplant|0|||
164431091|NCT00517933|593949363|FG001|Period 1|Underwent lung transplant|1|||
164431092|NCT00517933|593949362|FG000|Period 2|Death|2|||
164431093|NCT00517933|593949363|FG001|Period 2|Death|4|||
164431094|NCT00517933|593949362|FG000|Period 2|Adverse Event|2|||
164273173|NCT02455076|593367980|FG002|Inpatient|Discharged <24 h after admission|0|||
164273174|NCT02455076|593367981|FG003|Inpatient|Discharged <24 h after admission|0|||
164273175|NCT02455076|593367982|FG004|Inpatient|Discharged <24 h after admission|0|||
164273176|NCT02455076|593367978|FG000|Inpatient|Adverse Event|3|||
164273177|NCT02455076|593367979|FG001|Inpatient|Adverse Event|0|||
164273178|NCT02455076|593367980|FG002|Inpatient|Adverse Event|0|||
164273179|NCT02455076|593367981|FG003|Inpatient|Adverse Event|0|||
164273180|NCT02455076|593367982|FG004|Inpatient|Adverse Event|0|||
164273181|NCT02455076|593367978|FG000|Outpatient|Adverse Event|0|||
164273182|NCT02455076|593367979|FG001|Outpatient|Adverse Event|0|||
164273183|NCT02455076|593367980|FG002|Outpatient|Adverse Event|0|||
164273184|NCT02455076|593367981|FG003|Outpatient|Adverse Event|5|||
164273185|NCT02455076|593367982|FG004|Outpatient|Adverse Event|0|||
164273186|NCT02455076|593367978|FG000|Outpatient|Lost to Follow-up|0|||
164273187|NCT02455076|593367979|FG001|Outpatient|Lost to Follow-up|0|||
164273188|NCT02455076|593367980|FG002|Outpatient|Lost to Follow-up|0|||
164273189|NCT02455076|593367981|FG003|Outpatient|Lost to Follow-up|1|||
164273190|NCT02455076|593367982|FG004|Outpatient|Lost to Follow-up|12|||
164273191|NCT00719680|593367986|FG000|Overall Study|Adverse Event|1|||
164273192|NCT00719680|593367986|FG000|Overall Study|Lost to Follow-up|1|||
164273193|NCT00719680|593367986|FG000|Overall Study|Withdrawal by Subject|3|||
164273194|NCT04676867|593367998|FG000|Overall Study|Screen failure|0|||
164273195|NCT04676867|593367999|FG001|Overall Study|Screen failure|0|||
164273196|NCT04676867|593368000|FG002|Overall Study|Screen failure|6|||
164273197|NCT04676867|593368001|FG003|Overall Study|Screen failure|2|||
164273198|NCT04676867|593367998|FG000|Overall Study|Death|0|||
164273199|NCT04676867|593367999|FG001|Overall Study|Death|0|||
164273200|NCT04676867|593368000|FG002|Overall Study|Death|1|||
164273201|NCT04676867|593368001|FG003|Overall Study|Death|0|||
164273202|NCT04676867|593367998|FG000|Overall Study|Withdrawal by Subject|2|||
164431095|NCT00517933|593949363|FG001|Period 2|Adverse Event|4|||
164431096|NCT00517933|593949362|FG000|Period 2|Physician Decision|1|||
164431097|NCT00517933|593949363|FG001|Period 2|Physician Decision|0|||
164273203|NCT04676867|593367999|FG001|Overall Study|Withdrawal by Subject|2|||
164273204|NCT04676867|593368000|FG002|Overall Study|Withdrawal by Subject|4|||
164273205|NCT04676867|593368001|FG003|Overall Study|Withdrawal by Subject|4|||
164273206|NCT04676867|593367998|FG000|Overall Study|Lost to Follow-up|1|||
164273207|NCT04676867|593367999|FG001|Overall Study|Lost to Follow-up|0|||
164273208|NCT04676867|593368000|FG002|Overall Study|Lost to Follow-up|0|||
164273209|NCT04676867|593368001|FG003|Overall Study|Lost to Follow-up|0|||
164273210|NCT01141478|593368005|FG000|Overall Study|Withdrawal by Subject|1|||
164431098|NCT00517933|593949362|FG000|Period 2|Withdrawal by Subject|1|||
164273211|NCT01141478|593368006|FG001|Overall Study|Withdrawal by Subject|1|||
164273212|NCT00551291|593368012|FG000|Overall Study|Physician Decision|1|||
164273213|NCT01581619|593368014|FG000|Overall Study|Withdrawal by Subject|1|||
164273214|NCT01581619|593368014|FG000|Overall Study|Lost to Follow-up|1|||
164431099|NCT00517933|593949363|FG001|Period 2|Withdrawal by Subject|3|||
164431100|NCT00517933|593949362|FG000|Period 2|Underwent lung transplant|0|||
164431101|NCT00517933|593949363|FG001|Period 2|Underwent lung transplant|2|||
164431102|NCT01835899|593949365|FG000|Overall Study|Adverse Event|0|||
164273215|NCT04268173|593368015|FG000|Overall Study|Lost to Follow-up|75|||
164273216|NCT04268173|593368016|FG001|Overall Study|Lost to Follow-up|108|||
164273217|NCT01375608|593368017|FG000|Overall Study|Withdrawal by Subject|2|||
164273218|NCT03836677|593368021|FG000|Period 1|Adverse Event|0|||
164273219|NCT03836677|593368022|FG001|Period 1|Adverse Event|1|||
164431103|NCT01835899|593949366|FG001|Overall Study|Adverse Event|0|||
164431104|NCT01835899|593949367|FG002|Overall Study|Adverse Event|1|||
164431105|NCT01835899|593949365|FG000|Overall Study|Other than stated above|0|||
164431106|NCT01835899|593949366|FG001|Overall Study|Other than stated above|1|||
164273220|NCT03836677|593368021|FG000|Period 2|Severe non-compliance to protocol|1|||
164273221|NCT03836677|593368022|FG001|Period 2|Severe non-compliance to protocol|0|||
164273222|NCT00710385|593368031|FG000|Overall Study|Did not qualify|1|||
164273223|NCT00710385|593368031|FG000|Overall Study|Withdrawal by Subject|1|||
164273224|NCT00710385|593368031|FG000|Overall Study|Undisclosed back pain|1|||
164273225|NCT00710385|593368031|FG000|Overall Study|Physician Decision|1|||
164273226|NCT00710385|593368031|FG000|Overall Study|Undisclosed excessive methadone use|1|||
164273227|NCT00079677|593368032|FG000|Overall Study|Adverse Event|5|||
164273228|NCT00079677|593368033|FG001|Overall Study|Adverse Event|6|||
164273229|NCT00079677|593368032|FG000|Overall Study|Lack of Efficacy|1|||
164273230|NCT00079677|593368033|FG001|Overall Study|Lack of Efficacy|0|||
164273231|NCT00079677|593368032|FG000|Overall Study|Lost to Follow-up|2|||
164273232|NCT00079677|593368033|FG001|Overall Study|Lost to Follow-up|2|||
164273233|NCT00079677|593368032|FG000|Overall Study|Physician Decision|3|||
164273234|NCT00079677|593368033|FG001|Overall Study|Physician Decision|0|||
164273235|NCT00079677|593368032|FG000|Overall Study|Protocol Violation|2|||
164273236|NCT00079677|593368033|FG001|Overall Study|Protocol Violation|3|||
164273237|NCT00079677|593368032|FG000|Overall Study|Withdrawal by Subject|5|||
164273238|NCT00079677|593368033|FG001|Overall Study|Withdrawal by Subject|3|||
164273239|NCT00079677|593368032|FG000|Overall Study|Miscellaneous|2|||
164273240|NCT00079677|593368033|FG001|Overall Study|Miscellaneous|0|||
164273241|NCT04598269|593368034|FG000|Overall Study|Adverse Event|0|||
164273242|NCT04598269|593368035|FG001|Overall Study|Adverse Event|3|||
164273243|NCT04598269|593368034|FG000|Overall Study|Withdrawal by Subject|1|||
164273244|NCT04598269|593368035|FG001|Overall Study|Withdrawal by Subject|4|||
164273245|NCT04598269|593368034|FG000|Overall Study|Lost to Follow-up|1|||
164273246|NCT04598269|593368035|FG001|Overall Study|Lost to Follow-up|0|||
164273247|NCT04598269|593368034|FG000|Overall Study|Not Treated|2|||
164273248|NCT04598269|593368035|FG001|Overall Study|Not Treated|0|||
164273249|NCT00424190|593368036|FG000|Overall Study|Withdrew consent|3|||
164273250|NCT00424190|593368037|FG001|Overall Study|Withdrew consent|4|||
164273251|NCT00424190|593368036|FG000|Overall Study|Death|3|||
164273252|NCT00424190|593368037|FG001|Overall Study|Death|0|||
164273253|NCT00424190|593368036|FG000|Overall Study|Noncompliance|1|||
164273254|NCT00424190|593368037|FG001|Overall Study|Noncompliance|2|||
164273255|NCT00424190|593368036|FG000|Overall Study|Request of sponsor or investigator|0|||
164273256|NCT00424190|593368037|FG001|Overall Study|Request of sponsor or investigator|2|||
164273257|NCT00424190|593368036|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
164273258|NCT00424190|593368037|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
164273259|NCT00424190|593368036|FG000|Overall Study|Other|15|||
164273260|NCT00424190|593368037|FG001|Overall Study|Other|21|||
164273261|NCT03040986|593368038|FG000|Overall Study|Hospice|1|||
164273262|NCT03040986|593368039|FG001|Overall Study|Hospice|0|||
164273263|NCT03040986|593368038|FG000|Overall Study|Adverse Event|2|||
164273264|NCT03040986|593368039|FG001|Overall Study|Adverse Event|1|||
164273265|NCT03040986|593368038|FG000|Overall Study|Disease progression on study|3|||
164273266|NCT03040986|593368039|FG001|Overall Study|Disease progression on study|1|||
164273267|NCT02925728|593368040|FG000|Overall Study|Death|3|||
164273268|NCT02925728|593368041|FG001|Overall Study|Death|5|||
164273269|NCT02925728|593368040|FG000|Overall Study|Physician Decision|1|||
164273270|NCT02925728|593368041|FG001|Overall Study|Physician Decision|0|||
164273271|NCT02925728|593368040|FG000|Overall Study|Withdrawal by Subject|1|||
164273272|NCT02925728|593368041|FG001|Overall Study|Withdrawal by Subject|0|||
164273273|NCT02102399|593368044|FG000|Overall Study|Withdrawal by Subject|6|||
164273274|NCT02102399|593368045|FG001|Overall Study|Withdrawal by Subject|4|||
164273275|NCT00086411|593368052|FG000|Overall Study|Lost to Follow-up|11|||
164273276|NCT00086411|593368053|FG001|Overall Study|Lost to Follow-up|11|||
164273277|NCT00086411|593368054|FG002|Overall Study|Lost to Follow-up|13|||
164273278|NCT00086411|593368055|FG003|Overall Study|Lost to Follow-up|12|||
164273279|NCT00695864|593368058|FG000|Placebo|Withdrawal by Subject|1|||
164273280|NCT00695864|593368058|FG000|Placebo|Physician Decision|4|||
164273281|NCT01624090|593368062|FG000|Overall Study|DLT, taken off therapy|0|||
164273282|NCT01624090|593368063|FG001|Overall Study|DLT, taken off therapy|1|||
164273283|NCT01624090|593368064|FG002|Overall Study|DLT, taken off therapy|0|||
164273284|NCT01624090|593368065|FG003|Overall Study|DLT, taken off therapy|0|||
164273285|NCT01624090|593368062|FG000|Overall Study|Withdrew prior to treatment|0|||
164583056|NCT02619253|594499686|FG000|Overall Study|Alternative Therapy|0|||
164583057|NCT02619253|594499687|FG001|Overall Study|Alternative Therapy|0|||
164583058|NCT02619253|594499688|FG002|Overall Study|Alternative Therapy|1|||
164583059|NCT02619253|594499689|FG003|Overall Study|Alternative Therapy|0|||
164583060|NCT02619253|594499690|FG004|Overall Study|Alternative Therapy|0|||
164583061|NCT02619253|594499686|FG000|Overall Study|Death|0|||
164583062|NCT02619253|594499687|FG001|Overall Study|Death|0|||
164583063|NCT02619253|594499688|FG002|Overall Study|Death|0|||
164583064|NCT02619253|594499689|FG003|Overall Study|Death|1|||
164583065|NCT02619253|594499690|FG004|Overall Study|Death|0|||
164583066|NCT02619253|594499686|FG000|Overall Study|Disease Progression|4|||
164583067|NCT02619253|594499687|FG001|Overall Study|Disease Progression|2|||
164583068|NCT02619253|594499688|FG002|Overall Study|Disease Progression|8|||
164273286|NCT01624090|593368063|FG001|Overall Study|Withdrew prior to treatment|1|||
164273287|NCT01624090|593368064|FG002|Overall Study|Withdrew prior to treatment|0|||
164273288|NCT01624090|593368065|FG003|Overall Study|Withdrew prior to treatment|0|||
164273289|NCT01624090|593368062|FG000|Overall Study|Died on study|0|||
164273290|NCT01624090|593368063|FG001|Overall Study|Died on study|0|||
164273291|NCT01624090|593368064|FG002|Overall Study|Died on study|2|||
164273292|NCT01624090|593368065|FG003|Overall Study|Died on study|0|||
164273293|NCT01624090|593368062|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
164273294|NCT01624090|593368063|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
164273295|NCT01624090|593368064|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
164273296|NCT01624090|593368065|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
164273297|NCT01624090|593368062|FG000|Overall Study|Dose escalated|0|||
164273298|NCT01624090|593368063|FG001|Overall Study|Dose escalated|0|||
164273299|NCT01624090|593368064|FG002|Overall Study|Dose escalated|3|||
164273300|NCT01624090|593368065|FG003|Overall Study|Dose escalated|0|||
164273301|NCT00752726|593368066|FG000|Overall Study|Lost to Follow-up|2|||
164273302|NCT00752726|593368067|FG001|Overall Study|Lost to Follow-up|1|||
164273303|NCT00752726|593368066|FG000|Overall Study|Adverse Event|3|||
164273304|NCT00752726|593368067|FG001|Overall Study|Adverse Event|0|||
164273305|NCT00752726|593368066|FG000|Overall Study|Withdrawal by Subject|5|||
164273306|NCT00752726|593368067|FG001|Overall Study|Withdrawal by Subject|10|||
164273307|NCT00752726|593368066|FG000|Overall Study|Other Reason|1|||
164273308|NCT00752726|593368067|FG001|Overall Study|Other Reason|2|||
164273309|NCT01403116|593368068|FG000|Overall Study|Adverse Event|7|||
164273310|NCT01403116|593368069|FG001|Overall Study|Adverse Event|4|||
164273311|NCT01403116|593368068|FG000|Overall Study|Lost to Follow-up|7|||
164273312|NCT01403116|593368069|FG001|Overall Study|Lost to Follow-up|5|||
164273313|NCT01403116|593368068|FG000|Overall Study|Withdrawal by Subject|12|||
164273314|NCT01403116|593368069|FG001|Overall Study|Withdrawal by Subject|15|||
164273315|NCT01403116|593368068|FG000|Overall Study|Non-compliance of study drug|3|||
164273316|NCT01403116|593368069|FG001|Overall Study|Non-compliance of study drug|0|||
164273317|NCT01403116|593368068|FG000|Overall Study|Protocol Violation|0|||
164273318|NCT01403116|593368069|FG001|Overall Study|Protocol Violation|1|||
164273319|NCT01403116|593368068|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
164273320|NCT01403116|593368069|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
164273321|NCT01403116|593368068|FG000|Overall Study|Hct >54%|2|||
164273322|NCT01403116|593368069|FG001|Overall Study|Hct >54%|0|||
164273323|NCT01403116|593368068|FG000|Overall Study|unable to keep appointments|0|||
164583069|NCT02619253|594499689|FG003|Overall Study|Disease Progression|9|||
164583070|NCT02619253|594499690|FG004|Overall Study|Disease Progression|10|||
164583071|NCT02619253|594499686|FG000|Overall Study|Needed a disqualifying therapy|0|||
164583072|NCT02619253|594499687|FG001|Overall Study|Needed a disqualifying therapy|0|||
164583073|NCT02619253|594499688|FG002|Overall Study|Needed a disqualifying therapy|1|||
164273324|NCT01403116|593368069|FG001|Overall Study|unable to keep appointments|2|||
164273325|NCT00042666|593368070|FG000|Overall Study|Adverse Event|2|||
164273326|NCT00042666|593368070|FG000|Overall Study|Death|4|||
164273327|NCT00042666|593368070|FG000|Overall Study|Protocol Violation|1|||
164273328|NCT00042666|593368070|FG000|Overall Study|Participant/Physician Perception|1|||
164273329|NCT00042666|593368070|FG000|Overall Study|Progressive Disease|41|||
164273330|NCT00042666|593368070|FG000|Overall Study|Other|1|||
164273331|NCT00042666|593368070|FG000|Overall Study|Other|4|||
164273332|NCT04232215|593368071|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
164273333|NCT04232215|593368072|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
164273334|NCT04268745|593368073|FG000|Overall Study|Lost to Follow-up|2|||
164273335|NCT04268745|593368074|FG001|Overall Study|Lost to Follow-up|3|||
164273336|NCT04268745|593368073|FG000|Overall Study|Withdrawal by Subject|4|||
164273337|NCT04268745|593368074|FG001|Overall Study|Withdrawal by Subject|2|||
164273338|NCT04268745|593368073|FG000|Overall Study|Death in the family|1|||
164273339|NCT04268745|593368074|FG001|Overall Study|Death in the family|0|||
164273340|NCT05327361|593368076|FG000|Overall Study|Lost to Follow-up|4|||
164273341|NCT00626405|593368077|FG000|Overall Study|Deemed Ineligible|1|||
164273342|NCT00626405|593368078|FG001|Overall Study|Deemed Ineligible|0|||
164583074|NCT02619253|594499689|FG003|Overall Study|Needed a disqualifying therapy|0|||
164583075|NCT02619253|594499690|FG004|Overall Study|Needed a disqualifying therapy|0|||
164583076|NCT02619253|594499686|FG000|Overall Study|Transferred to hospice|0|||
164583077|NCT02619253|594499687|FG001|Overall Study|Transferred to hospice|0|||
164583078|NCT02619253|594499688|FG002|Overall Study|Transferred to hospice|1|||
164583079|NCT02619253|594499689|FG003|Overall Study|Transferred to hospice|0|||
164583080|NCT02619253|594499690|FG004|Overall Study|Transferred to hospice|0|||
164583081|NCT02619253|594499686|FG000|Overall Study|Physician Decision|0|||
164583082|NCT02619253|594499687|FG001|Overall Study|Physician Decision|1|||
164273343|NCT00626405|593368077|FG000|Overall Study|Withdrawal by Subject|0|||
164273344|NCT00626405|593368078|FG001|Overall Study|Withdrawal by Subject|1|||
164273345|NCT03047031|593370477|FG000|Overall Study|Other than listed|1|||
164273346|NCT03047031|593370478|FG001|Overall Study|Other than listed|0|||
164273347|NCT03047031|593370479|FG002|Overall Study|Other than listed|0|||
164583083|NCT02619253|594499688|FG002|Overall Study|Physician Decision|2|||
164273348|NCT03047031|593370477|FG000|Overall Study|Lost to Follow-up|4|||
164273349|NCT03047031|593370478|FG001|Overall Study|Lost to Follow-up|0|||
164273350|NCT03047031|593370479|FG002|Overall Study|Lost to Follow-up|0|||
164273351|NCT03047031|593370477|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
164273352|NCT03047031|593370478|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
164273353|NCT03047031|593370479|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
164273354|NCT03047031|593370477|FG000|Overall Study|Adverse Event|1|||
164273355|NCT03047031|593370478|FG001|Overall Study|Adverse Event|0|||
164273356|NCT03047031|593370479|FG002|Overall Study|Adverse Event|0|||
164273357|NCT03047031|593370477|FG000|Overall Study|Withdrawal by Subject|2|||
164273358|NCT03047031|593370478|FG001|Overall Study|Withdrawal by Subject|0|||
164273359|NCT03047031|593370479|FG002|Overall Study|Withdrawal by Subject|0|||
164273360|NCT03047031|593370477|FG000|Overall Study|Change to other medication|2|||
164273361|NCT03047031|593370478|FG001|Overall Study|Change to other medication|0|||
164273362|NCT03047031|593370479|FG002|Overall Study|Change to other medication|0|||
164273363|NCT03047031|593370477|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
164273364|NCT03047031|593370478|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
164273365|NCT03047031|593370479|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
164273366|NCT01041287|593370480|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
164273367|NCT01041287|593370481|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
164273368|NCT01041287|593370480|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
164273369|NCT01041287|593370481|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
164273370|NCT01971008|593370484|FG000|Overall Study|Protocol Violation|2|||
164273371|NCT01971008|593370485|FG001|Overall Study|Protocol Violation|1|||
164273372|NCT03416127|593370486|FG000|Overall Study|Withdrawal by Subject|0|||
164273373|NCT03416127|593370487|FG001|Overall Study|Withdrawal by Subject|1|||
164273374|NCT03416127|593370488|FG002|Overall Study|Withdrawal by Subject|1|||
164273375|NCT02629822|593370489|FG000|Base Study|Lost to Follow-up|2|||
164273376|NCT02629822|593370489|FG000|Base Study|Non-Compliance With Study Drug|1|||
164273377|NCT02629822|593370489|FG000|Extension Study|Adverse Event|1|||
164273378|NCT02629822|593370489|FG000|Extension Study|Lost to Follow-up|1|||
164273379|NCT01610336|593370490|FG000|Overall Study|Progressive Disease|4|||
164273380|NCT01610336|593370491|FG001|Overall Study|Progressive Disease|6|||
164273381|NCT01610336|593370492|FG002|Overall Study|Progressive Disease|6|||
164273382|NCT01610336|593370493|FG003|Overall Study|Progressive Disease|5|||
164273383|NCT01610336|593370494|FG004|Overall Study|Progressive Disease|3|||
164273384|NCT01610336|593370495|FG005|Overall Study|Progressive Disease|10|||
164273385|NCT01610336|593370496|FG006|Overall Study|Progressive Disease|1|||
164273386|NCT01610336|593370497|FG007|Overall Study|Progressive Disease|6|||
164273387|NCT01610336|593370498|FG008|Overall Study|Progressive Disease|6|||
164273388|NCT01610336|593370499|FG009|Overall Study|Progressive Disease|40|||
164273389|NCT01610336|593370500|FG010|Overall Study|Progressive Disease|36|||
164273390|NCT01610336|593370490|FG000|Overall Study|Adverse Event|0|||
164273391|NCT01610336|593370491|FG001|Overall Study|Adverse Event|0|||
164273392|NCT01610336|593370492|FG002|Overall Study|Adverse Event|0|||
164273393|NCT01610336|593370493|FG003|Overall Study|Adverse Event|1|||
164273394|NCT01610336|593370494|FG004|Overall Study|Adverse Event|1|||
164273395|NCT01610336|593370495|FG005|Overall Study|Adverse Event|1|||
164273396|NCT01610336|593370496|FG006|Overall Study|Adverse Event|0|||
164273397|NCT01610336|593370497|FG007|Overall Study|Adverse Event|0|||
164273398|NCT01610336|593370498|FG008|Overall Study|Adverse Event|2|||
164273399|NCT01610336|593370499|FG009|Overall Study|Adverse Event|8|||
164273400|NCT01610336|593370500|FG010|Overall Study|Adverse Event|6|||
164273401|NCT01610336|593370490|FG000|Overall Study|Subject/Guardian decision|1|||
164273402|NCT01610336|593370491|FG001|Overall Study|Subject/Guardian decision|1|||
164273403|NCT01610336|593370492|FG002|Overall Study|Subject/Guardian decision|0|||
164273404|NCT01610336|593370493|FG003|Overall Study|Subject/Guardian decision|1|||
164273405|NCT01610336|593370494|FG004|Overall Study|Subject/Guardian decision|0|||
164273406|NCT01610336|593370495|FG005|Overall Study|Subject/Guardian decision|0|||
164273407|NCT01610336|593370496|FG006|Overall Study|Subject/Guardian decision|0|||
164273408|NCT01610336|593370497|FG007|Overall Study|Subject/Guardian decision|1|||
164273409|NCT01610336|593370498|FG008|Overall Study|Subject/Guardian decision|0|||
164273410|NCT01610336|593370499|FG009|Overall Study|Subject/Guardian decision|2|||
164273411|NCT01610336|593370500|FG010|Overall Study|Subject/Guardian decision|2|||
164273412|NCT01610336|593370490|FG000|Overall Study|Death|0|||
164273413|NCT01610336|593370491|FG001|Overall Study|Death|0|||
164273414|NCT01610336|593370492|FG002|Overall Study|Death|0|||
164273415|NCT01610336|593370493|FG003|Overall Study|Death|0|||
164273416|NCT01610336|593370494|FG004|Overall Study|Death|0|||
164273417|NCT01610336|593370495|FG005|Overall Study|Death|1|||
164273418|NCT01610336|593370496|FG006|Overall Study|Death|3|||
164273419|NCT01610336|593370497|FG007|Overall Study|Death|0|||
164273420|NCT01610336|593370498|FG008|Overall Study|Death|0|||
164273421|NCT01610336|593370499|FG009|Overall Study|Death|1|||
164273422|NCT01610336|593370500|FG010|Overall Study|Death|2|||
164273423|NCT01610336|593370490|FG000|Overall Study|Non-Compliance with study treatment|0|||
164273424|NCT01610336|593370491|FG001|Overall Study|Non-Compliance with study treatment|0|||
164688920|NCT00631007|594885430|FG002|Overall Study|Lost to Follow-up|2|||
164688921|NCT00631007|594885431|FG003|Overall Study|Lost to Follow-up|4|||
164688922|NCT00631007|594885432|FG004|Overall Study|Lost to Follow-up|5|||
164688923|NCT00631007|594885433|FG005|Overall Study|Lost to Follow-up|3|||
164688924|NCT00631007|594885428|FG000|Overall Study|Physician Decision|1|||
164688925|NCT00631007|594885429|FG001|Overall Study|Physician Decision|0|||
164688926|NCT00631007|594885430|FG002|Overall Study|Physician Decision|1|||
164688927|NCT00631007|594885431|FG003|Overall Study|Physician Decision|0|||
164688928|NCT00631007|594885432|FG004|Overall Study|Physician Decision|0|||
164688929|NCT00631007|594885433|FG005|Overall Study|Physician Decision|2|||
164273425|NCT01610336|593370492|FG002|Overall Study|Non-Compliance with study treatment|0|||
164273426|NCT01610336|593370493|FG003|Overall Study|Non-Compliance with study treatment|0|||
164273427|NCT01610336|593370494|FG004|Overall Study|Non-Compliance with study treatment|0|||
164273428|NCT01610336|593370495|FG005|Overall Study|Non-Compliance with study treatment|0|||
164273429|NCT01610336|593370496|FG006|Overall Study|Non-Compliance with study treatment|0|||
164273430|NCT01610336|593370497|FG007|Overall Study|Non-Compliance with study treatment|0|||
164273431|NCT01610336|593370498|FG008|Overall Study|Non-Compliance with study treatment|0|||
164273432|NCT01610336|593370499|FG009|Overall Study|Non-Compliance with study treatment|1|||
164273433|NCT01610336|593370500|FG010|Overall Study|Non-Compliance with study treatment|0|||
164273434|NCT01610336|593370490|FG000|Overall Study|Physician Decision|0|||
164273435|NCT01610336|593370491|FG001|Overall Study|Physician Decision|0|||
164273436|NCT01610336|593370492|FG002|Overall Study|Physician Decision|0|||
164273437|NCT01610336|593370493|FG003|Overall Study|Physician Decision|0|||
164273438|NCT01610336|593370494|FG004|Overall Study|Physician Decision|0|||
164273439|NCT01610336|593370495|FG005|Overall Study|Physician Decision|0|||
164273440|NCT01610336|593370496|FG006|Overall Study|Physician Decision|1|||
164273441|NCT01610336|593370497|FG007|Overall Study|Physician Decision|0|||
164273442|NCT01610336|593370498|FG008|Overall Study|Physician Decision|0|||
164273443|NCT01610336|593370499|FG009|Overall Study|Physician Decision|0|||
164273444|NCT01610336|593370500|FG010|Overall Study|Physician Decision|0|||
164273445|NCT01610336|593370490|FG000|Overall Study|Protocol Deviation|0|||
164273446|NCT01610336|593370491|FG001|Overall Study|Protocol Deviation|0|||
164273447|NCT01610336|593370492|FG002|Overall Study|Protocol Deviation|0|||
164273448|NCT01610336|593370493|FG003|Overall Study|Protocol Deviation|0|||
164273449|NCT01610336|593370494|FG004|Overall Study|Protocol Deviation|0|||
164273450|NCT01610336|593370495|FG005|Overall Study|Protocol Deviation|0|||
164273451|NCT01610336|593370496|FG006|Overall Study|Protocol Deviation|0|||
164688930|NCT00631007|594885428|FG000|Overall Study|Persistent Hyperglycemia|2|||
164688931|NCT00631007|594885429|FG001|Overall Study|Persistent Hyperglycemia|2|||
164688932|NCT00631007|594885430|FG002|Overall Study|Persistent Hyperglycemia|5|||
164688933|NCT00631007|594885431|FG003|Overall Study|Persistent Hyperglycemia|1|||
164688934|NCT00631007|594885432|FG004|Overall Study|Persistent Hyperglycemia|2|||
164688935|NCT00631007|594885433|FG005|Overall Study|Persistent Hyperglycemia|5|||
164688936|NCT00631007|594885428|FG000|Overall Study|Withdrawal by Subject|4|||
164688937|NCT00631007|594885429|FG001|Overall Study|Withdrawal by Subject|5|||
164688938|NCT00631007|594885430|FG002|Overall Study|Withdrawal by Subject|2|||
164688939|NCT00631007|594885431|FG003|Overall Study|Withdrawal by Subject|2|||
164688940|NCT00631007|594885432|FG004|Overall Study|Withdrawal by Subject|1|||
164688941|NCT00631007|594885433|FG005|Overall Study|Withdrawal by Subject|3|||
164688942|NCT00631007|594885428|FG000|Overall Study|Other|2|||
164688943|NCT00631007|594885429|FG001|Overall Study|Other|1|||
164273452|NCT01610336|593370497|FG007|Overall Study|Protocol Deviation|0|||
164273453|NCT01610336|593370498|FG008|Overall Study|Protocol Deviation|0|||
164273454|NCT01610336|593370499|FG009|Overall Study|Protocol Deviation|1|||
164273455|NCT01610336|593370500|FG010|Overall Study|Protocol Deviation|0|||
164273456|NCT01610336|593370490|FG000|Overall Study|Transfer to another trial|0|||
164273457|NCT01610336|593370491|FG001|Overall Study|Transfer to another trial|0|||
164688944|NCT00631007|594885430|FG002|Overall Study|Other|0|||
164688945|NCT00631007|594885431|FG003|Overall Study|Other|0|||
164273458|NCT01610336|593370492|FG002|Overall Study|Transfer to another trial|0|||
164273459|NCT01610336|593370493|FG003|Overall Study|Transfer to another trial|0|||
164273460|NCT01610336|593370494|FG004|Overall Study|Transfer to another trial|0|||
164431107|NCT01835899|593949367|FG002|Overall Study|Other than stated above|0|||
164431108|NCT02616263|593949368|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
164431109|NCT02616263|593949369|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
164688946|NCT00631007|594885432|FG004|Overall Study|Other|1|||
164688947|NCT00631007|594885433|FG005|Overall Study|Other|0|||
164688948|NCT00683787|594885434|FG000|Overall Study|Progression|3|||
164688949|NCT00683787|594885435|FG001|Overall Study|Progression|3|||
164688950|NCT00683787|594885436|FG002|Overall Study|Progression|0|||
164688951|NCT00683787|594885434|FG000|Overall Study|Adverse Event|0|||
164273461|NCT01610336|593370495|FG005|Overall Study|Transfer to another trial|0|||
164273462|NCT01610336|593370496|FG006|Overall Study|Transfer to another trial|0|||
164273463|NCT01610336|593370497|FG007|Overall Study|Transfer to another trial|0|||
164273464|NCT01610336|593370498|FG008|Overall Study|Transfer to another trial|0|||
164273465|NCT01610336|593370499|FG009|Overall Study|Transfer to another trial|0|||
164273466|NCT01610336|593370500|FG010|Overall Study|Transfer to another trial|1|||
164688952|NCT00683787|594885435|FG001|Overall Study|Adverse Event|0|||
164273467|NCT02397057|593370502|FG000|Overall Study|Withdrawal by Subject|6|||
164273468|NCT02397057|593370503|FG001|Overall Study|Withdrawal by Subject|7|||
164273469|NCT02397057|593370502|FG000|Overall Study|Lost to Follow-up|4|||
164273470|NCT02397057|593370503|FG001|Overall Study|Lost to Follow-up|3|||
164273471|NCT02397057|593370502|FG000|Overall Study|Death|1|||
164273472|NCT02397057|593370503|FG001|Overall Study|Death|0|||
164273473|NCT02397057|593370502|FG000|Overall Study|Adverse Event|0|||
164273474|NCT02397057|593370503|FG001|Overall Study|Adverse Event|1|||
164273475|NCT02397057|593370502|FG000|Overall Study|Physician Decision|0|||
164273476|NCT02397057|593370503|FG001|Overall Study|Physician Decision|1|||
164273477|NCT02397057|593370502|FG000|Overall Study|Subject did not receive study drug|0|||
164273478|NCT02397057|593370503|FG001|Overall Study|Subject did not receive study drug|1|||
164273479|NCT02352753|593370504|FG000|6-Month Dosing Period|Decision by sponsor|2|||
164273480|NCT02352753|593370504|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
164273481|NCT02352753|593370504|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
164273482|NCT02352753|593370504|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
164273483|NCT02352753|593370504|FG000|3-Month Dosing Period|Decision by sponsor|14|||
164273484|NCT02352753|593370504|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
164273485|NCT00679172|593370506|FG000|Overall Study|Non-compliance|1|||
164273486|NCT00679172|593370507|FG001|Overall Study|Non-compliance|1|||
164273487|NCT00679172|593370508|FG002|Overall Study|Non-compliance|0|||
164273488|NCT00679172|593370509|FG003|Overall Study|Non-compliance|1|||
164273489|NCT00679172|593370510|FG004|Overall Study|Non-compliance|0|||
164273490|NCT00679172|593370506|FG000|Overall Study|Other not specified|0|||
164273491|NCT00679172|593370507|FG001|Overall Study|Other not specified|0|||
164273492|NCT00679172|593370508|FG002|Overall Study|Other not specified|1|||
164273493|NCT00679172|593370509|FG003|Overall Study|Other not specified|0|||
164273494|NCT00679172|593370510|FG004|Overall Study|Other not specified|0|||
164273495|NCT00417963|593370511|FG000|Overall Study|Lost to Follow-up|3|||
164273496|NCT00417963|593370511|FG000|Overall Study|Withdrawal by Subject|18|||
164273497|NCT00417963|593370511|FG000|Overall Study|Death|17|||
164273498|NCT00417963|593370511|FG000|Overall Study|Study device could not be deployed|3|||
164273499|NCT00704288|593370513|FG000|Overall Treatment Period|Adverse Event|11|||
164273500|NCT00704288|593370514|FG001|Overall Treatment Period|Adverse Event|8|||
164273501|NCT00704288|593370515|FG002|Overall Treatment Period|Adverse Event|22|||
164273502|NCT00704288|593370513|FG000|Overall Treatment Period|Death|0|||
164273503|NCT00704288|593370514|FG001|Overall Treatment Period|Death|0|||
164273504|NCT00704288|593370515|FG002|Overall Treatment Period|Death|1|||
164273505|NCT00704288|593370513|FG000|Overall Treatment Period|Physician Decision|0|||
164273506|NCT00704288|593370514|FG001|Overall Treatment Period|Physician Decision|2|||
164273507|NCT00704288|593370515|FG002|Overall Treatment Period|Physician Decision|0|||
164273508|NCT00704288|593370513|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
164273509|NCT00704288|593370514|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
164273510|NCT00704288|593370515|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
164273511|NCT00704288|593370513|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
164273512|NCT00704288|593370514|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
164273513|NCT00704288|593370515|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
164273514|NCT00704288|593370513|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
164273515|NCT00704288|593370514|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
164273516|NCT00704288|593370515|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
164273517|NCT00704288|593370513|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
164273518|NCT00704288|593370514|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
164273519|NCT00704288|593370515|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
164273520|NCT00704288|593370513|FG000|Overall Treatment Period|Roll-over to another study|1|||
164273521|NCT00704288|593370514|FG001|Overall Treatment Period|Roll-over to another study|0|||
164273522|NCT00704288|593370515|FG002|Overall Treatment Period|Roll-over to another study|4|||
164273523|NCT00704288|593370513|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
164273524|NCT00704288|593370514|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
164273525|NCT00704288|593370515|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
164273526|NCT00704288|593370513|FG000|Extended Post Treatment Follow Up Period|Death|41|||
164273527|NCT00704288|593370514|FG001|Extended Post Treatment Follow Up Period|Death|50|||
164273528|NCT00704288|593370515|FG002|Extended Post Treatment Follow Up Period|Death|93|||
164273529|NCT00704288|593370513|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
164273530|NCT00704288|593370514|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
164273531|NCT00704288|593370515|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
164273532|NCT00704288|593370513|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
164273533|NCT00704288|593370514|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
164273534|NCT00704288|593370515|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
164273535|NCT00704288|593370513|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
164583084|NCT02619253|594499689|FG003|Overall Study|Physician Decision|3|||
164273536|NCT00704288|593370514|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
164273537|NCT00704288|593370515|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
164273538|NCT03927144|593370518|FG000|Core Phase|Adverse Event|9|||
164273539|NCT03927144|593370519|FG001|Core Phase|Adverse Event|5|||
164273540|NCT03927144|593370518|FG000|Core Phase|Lost to Follow-up|3|||
164342670|NCT02501473|593631490|FG005|Overall Study|Withdrawal by Subject|2|||
164342671|NCT02501473|593631491|FG006|Overall Study|Withdrawal by Subject|0|||
164342672|NCT02501473|593631492|FG007|Overall Study|Withdrawal by Subject|0|||
164342673|NCT02501473|593631485|FG000|Overall Study|Death|0|||
164342674|NCT02501473|593631486|FG001|Overall Study|Death|0|||
164342675|NCT02501473|593631487|FG002|Overall Study|Death|1|||
164342676|NCT02501473|593631488|FG003|Overall Study|Death|1|||
164342677|NCT02501473|593631489|FG004|Overall Study|Death|0|||
164342678|NCT02501473|593631490|FG005|Overall Study|Death|1|||
164342679|NCT02501473|593631491|FG006|Overall Study|Death|0|||
164342680|NCT02501473|593631492|FG007|Overall Study|Death|0|||
164342681|NCT02501473|593631485|FG000|Overall Study|Lost to Follow-up|1|||
164342682|NCT02501473|593631486|FG001|Overall Study|Lost to Follow-up|0|||
164342683|NCT02501473|593631487|FG002|Overall Study|Lost to Follow-up|1|||
164342684|NCT02501473|593631488|FG003|Overall Study|Lost to Follow-up|0|||
164342685|NCT02501473|593631489|FG004|Overall Study|Lost to Follow-up|0|||
164342686|NCT02501473|593631490|FG005|Overall Study|Lost to Follow-up|1|||
164342687|NCT02501473|593631491|FG006|Overall Study|Lost to Follow-up|0|||
164342688|NCT02501473|593631492|FG007|Overall Study|Lost to Follow-up|0|||
164342689|NCT02501473|593631485|FG000|Overall Study|Reason not specified|0|||
164342690|NCT02501473|593631486|FG001|Overall Study|Reason not specified|0|||
164342691|NCT02501473|593631487|FG002|Overall Study|Reason not specified|1|||
164342692|NCT02501473|593631488|FG003|Overall Study|Reason not specified|1|||
164342693|NCT02501473|593631489|FG004|Overall Study|Reason not specified|0|||
164342694|NCT02501473|593631490|FG005|Overall Study|Reason not specified|0|||
164342695|NCT02501473|593631491|FG006|Overall Study|Reason not specified|0|||
164342696|NCT02501473|593631492|FG007|Overall Study|Reason not specified|0|||
164342697|NCT01473836|593631493|FG000|Overall Study|Adverse Event|4|||
164342698|NCT01473836|593631493|FG000|Overall Study|Lack of Efficacy|1|||
164342699|NCT01473836|593631493|FG000|Overall Study|Does not meet entrance criteria|1|||
164342700|NCT01709513|593631494|FG000|Overall Study|Randomized but not treated|0|||
164342701|NCT01709513|593631495|FG001|Overall Study|Randomized but not treated|1|||
164342702|NCT01709513|593631496|FG002|Overall Study|Randomized but not treated|0|||
164342703|NCT01709513|593631494|FG000|Overall Study|Adverse Event|16|||
164583085|NCT02619253|594499690|FG004|Overall Study|Physician Decision|0|||
164583086|NCT02619253|594499686|FG000|Overall Study|Withdrawal by Subject|0|||
164583087|NCT02619253|594499687|FG001|Overall Study|Withdrawal by Subject|1|||
164583088|NCT02619253|594499688|FG002|Overall Study|Withdrawal by Subject|0|||
164583089|NCT02619253|594499689|FG003|Overall Study|Withdrawal by Subject|0|||
164583090|NCT02619253|594499690|FG004|Overall Study|Withdrawal by Subject|2|||
164273541|NCT03927144|593370519|FG001|Core Phase|Lost to Follow-up|2|||
164273542|NCT03927144|593370518|FG000|Core Phase|New Therapy for Study Indication|0|||
164273543|NCT03927144|593370519|FG001|Core Phase|New Therapy for Study Indication|1|||
164273544|NCT03927144|593370518|FG000|Core Phase|No Longer Clinically Benefiting|4|||
164273545|NCT03927144|593370519|FG001|Core Phase|No Longer Clinically Benefiting|4|||
164273546|NCT03927144|593370518|FG000|Core Phase|Physician Decision|2|||
164273547|NCT03927144|593370519|FG001|Core Phase|Physician Decision|8|||
164273548|NCT03927144|593370518|FG000|Core Phase|Protocol Violation|2|||
164273549|NCT03927144|593370519|FG001|Core Phase|Protocol Violation|2|||
164273550|NCT03927144|593370518|FG000|Core Phase|Withdrawal by Subject|16|||
164273551|NCT03927144|593370519|FG001|Core Phase|Withdrawal by Subject|40|||
164273552|NCT03927144|593370518|FG000|Extension Phase|Adverse Event|2|||
164273553|NCT03927144|593370519|FG001|Extension Phase|Adverse Event|1|||
164342704|NCT01709513|593631495|FG001|Overall Study|Adverse Event|31|||
164342705|NCT01709513|593631496|FG002|Overall Study|Adverse Event|23|||
164342706|NCT01709513|593631494|FG000|Overall Study|Poor compliance to protocol|2|||
164342707|NCT01709513|593631495|FG001|Overall Study|Poor compliance to protocol|0|||
164431110|NCT02616263|593949368|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
164583091|NCT02111811|594499691|FG000|Treatment Phase|Lost to Follow-up|22|||
164583092|NCT02111811|594499692|FG001|Treatment Phase|Lost to Follow-up|18|||
164583093|NCT02111811|594499691|FG000|Treatment Phase|Death|2|||
164583094|NCT02111811|594499692|FG001|Treatment Phase|Death|0|||
164583095|NCT02111811|594499691|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
164273554|NCT03927144|593370518|FG000|Extension Phase|No longer clinically benefiting|4|||
164273555|NCT03927144|593370519|FG001|Extension Phase|No longer clinically benefiting|5|||
164273556|NCT03927144|593370518|FG000|Extension Phase|Pregnancy|1|||
164273557|NCT03927144|593370519|FG001|Extension Phase|Pregnancy|0|||
164342708|NCT01709513|593631496|FG002|Overall Study|Poor compliance to protocol|0|||
164342709|NCT01709513|593631494|FG000|Overall Study|Other|3|||
164583096|NCT02111811|594499692|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
164342710|NCT01709513|593631495|FG001|Overall Study|Other|11|||
164342711|NCT01709513|593631496|FG002|Overall Study|Other|7|||
164342712|NCT02954237|593631497|FG000|Overall Study|Withdrawal by Subject|25|||
164688953|NCT00683787|594885436|FG002|Overall Study|Adverse Event|2|||
164688954|NCT02674633|594885437|FG000|Overall Study|Lost to Follow-up|3|||
164688955|NCT02674633|594885438|FG001|Overall Study|Lost to Follow-up|2|||
164688956|NCT02674633|594885437|FG000|Overall Study|Physician Decision|1|||
164688957|NCT02674633|594885438|FG001|Overall Study|Physician Decision|0|||
164688958|NCT02674633|594885437|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
164688959|NCT02674633|594885438|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
164688960|NCT01235715|594885439|FG000|Overall Study|Physician Decision|0|||
164273558|NCT03927144|593370518|FG000|Extension Phase|Protocol Violation|0|||
164273559|NCT03927144|593370519|FG001|Extension Phase|Protocol Violation|1|||
164273560|NCT03927144|593370518|FG000|Extension Phase|Withdrawal by Subject|8|||
164273561|NCT03927144|593370519|FG001|Extension Phase|Withdrawal by Subject|3|||
164273562|NCT00615030|593370522|FG000|Period I|Administrative problem|0|||
164273563|NCT00615030|593370523|FG001|Period I|Administrative problem|0|||
164273564|NCT00615030|593370524|FG002|Period I|Administrative problem|0|||
164273565|NCT00615030|593370525|FG003|Period I|Administrative problem|0|||
164273566|NCT00615030|593370526|FG004|Period I|Administrative problem|1|||
164273567|NCT00615030|593370527|FG005|Period I|Administrative problem|0|||
164273568|NCT00615030|593370528|FG006|Period I|Administrative problem|0|||
164273569|NCT00615030|593370529|FG007|Period I|Administrative problem|0|||
164273570|NCT00615030|593370530|FG008|Period I|Administrative problem|0|||
164273571|NCT00615030|593370531|FG009|Period I|Administrative problem|0|||
164273572|NCT00615030|593370532|FG010|Period I|Administrative problem|0|||
164273573|NCT00615030|593370533|FG011|Period I|Administrative problem|0|||
164273574|NCT00615030|593370522|FG000|Period I|Protocol deviation|1|||
164273575|NCT00615030|593370523|FG001|Period I|Protocol deviation|0|||
164273576|NCT00615030|593370524|FG002|Period I|Protocol deviation|0|||
164273577|NCT00615030|593370525|FG003|Period I|Protocol deviation|0|||
164273578|NCT00615030|593370526|FG004|Period I|Protocol deviation|0|||
164273579|NCT00615030|593370527|FG005|Period I|Protocol deviation|0|||
164273580|NCT00615030|593370528|FG006|Period I|Protocol deviation|0|||
164273581|NCT00615030|593370529|FG007|Period I|Protocol deviation|0|||
164273582|NCT00615030|593370530|FG008|Period I|Protocol deviation|0|||
164273583|NCT00615030|593370531|FG009|Period I|Protocol deviation|0|||
164273584|NCT00615030|593370532|FG010|Period I|Protocol deviation|0|||
164273585|NCT00615030|593370533|FG011|Period I|Protocol deviation|0|||
164273586|NCT00615030|593370522|FG000|Period I|Subject withdrew consent|0|||
164273587|NCT00615030|593370523|FG001|Period I|Subject withdrew consent|0|||
164688961|NCT01235715|594885440|FG001|Overall Study|Physician Decision|2|||
164688962|NCT00396630|594885448|FG000|Overall Study|Lost to Follow-up|1|||
164688963|NCT00396630|594885449|FG001|Overall Study|Lost to Follow-up|1|||
164273588|NCT00615030|593370524|FG002|Period I|Subject withdrew consent|0|||
164273589|NCT00615030|593370525|FG003|Period I|Subject withdrew consent|0|||
164273590|NCT00615030|593370526|FG004|Period I|Subject withdrew consent|0|||
164273591|NCT00615030|593370527|FG005|Period I|Subject withdrew consent|0|||
164273592|NCT00615030|593370528|FG006|Period I|Subject withdrew consent|0|||
164273593|NCT00615030|593370529|FG007|Period I|Subject withdrew consent|0|||
164273594|NCT00615030|593370530|FG008|Period I|Subject withdrew consent|1|||
164273595|NCT00615030|593370531|FG009|Period I|Subject withdrew consent|0|||
164273596|NCT00615030|593370532|FG010|Period I|Subject withdrew consent|1|||
164273597|NCT00615030|593370533|FG011|Period I|Subject withdrew consent|1|||
164273598|NCT00615030|593370522|FG000|Period I|Abnormal laboratory value(s)|0|||
164273599|NCT00615030|593370523|FG001|Period I|Abnormal laboratory value(s)|0|||
164273600|NCT00615030|593370524|FG002|Period I|Abnormal laboratory value(s)|0|||
164273601|NCT00615030|593370525|FG003|Period I|Abnormal laboratory value(s)|0|||
164273602|NCT00615030|593370526|FG004|Period I|Abnormal laboratory value(s)|0|||
164273603|NCT00615030|593370527|FG005|Period I|Abnormal laboratory value(s)|1|||
164273604|NCT00615030|593370528|FG006|Period I|Abnormal laboratory value(s)|0|||
164273605|NCT00615030|593370529|FG007|Period I|Abnormal laboratory value(s)|0|||
164273606|NCT00615030|593370530|FG008|Period I|Abnormal laboratory value(s)|0|||
164273607|NCT00615030|593370531|FG009|Period I|Abnormal laboratory value(s)|0|||
164273608|NCT00615030|593370532|FG010|Period I|Abnormal laboratory value(s)|0|||
164273609|NCT00615030|593370533|FG011|Period I|Abnormal laboratory value(s)|0|||
164273610|NCT00615030|593370522|FG000|Period II|Adverse Event|0|||
164273611|NCT00615030|593370523|FG001|Period II|Adverse Event|0|||
164273612|NCT00615030|593370524|FG002|Period II|Adverse Event|1|||
164273613|NCT00615030|593370525|FG003|Period II|Adverse Event|0|||
164273614|NCT00615030|593370526|FG004|Period II|Adverse Event|0|||
164273615|NCT00615030|593370527|FG005|Period II|Adverse Event|0|||
164273616|NCT00615030|593370528|FG006|Period II|Adverse Event|0|||
164273617|NCT00615030|593370529|FG007|Period II|Adverse Event|0|||
164273618|NCT00615030|593370530|FG008|Period II|Adverse Event|1|||
164273619|NCT00615030|593370531|FG009|Period II|Adverse Event|0|||
164273620|NCT00615030|593370532|FG010|Period II|Adverse Event|0|||
164273621|NCT00615030|593370533|FG011|Period II|Adverse Event|0|||
164688964|NCT00396630|594885448|FG000|Overall Study|Withdrawal by Subject|1|||
164688965|NCT00396630|594885449|FG001|Overall Study|Withdrawal by Subject|1|||
164273622|NCT00615030|593370522|FG000|Period II|Subject withdrew consent|0|||
164273623|NCT00615030|593370523|FG001|Period II|Subject withdrew consent|0|||
164273624|NCT00615030|593370524|FG002|Period II|Subject withdrew consent|0|||
164688966|NCT00396630|594885448|FG000|Overall Study|Not vaccinated at Visit 3|3|||
164688967|NCT00396630|594885449|FG001|Overall Study|Not vaccinated at Visit 3|3|||
164688968|NCT02327325|594885450|FG000|Overall Study|Withdrawal by Subject|1|||
164688969|NCT02327325|594885451|FG001|Overall Study|Withdrawal by Subject|4|||
164688970|NCT02327325|594885452|FG002|Overall Study|Withdrawal by Subject|4|||
164688971|NCT02327325|594885450|FG000|Overall Study|Excluded by Study Team|0|||
164688972|NCT02327325|594885451|FG001|Overall Study|Excluded by Study Team|0|||
164688973|NCT02327325|594885452|FG002|Overall Study|Excluded by Study Team|1|||
164688974|NCT00651183|594885455|FG000|Overall Study|Lack of Efficacy|1|||
164688975|NCT00651183|594885456|FG001|Overall Study|Lack of Efficacy|0|||
164688976|NCT00651183|594885455|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
164688977|NCT00651183|594885456|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
164688978|NCT00651183|594885455|FG000|Overall Study|Tolerability insufficient|5|||
164688979|NCT00651183|594885456|FG001|Overall Study|Tolerability insufficient|2|||
164688980|NCT00651183|594885455|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
164688981|NCT00651183|594885456|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
164688982|NCT00651183|594885455|FG000|Overall Study|Withdrawal by Subject|6|||
164688983|NCT00651183|594885456|FG001|Overall Study|Withdrawal by Subject|3|||
164688984|NCT00651183|594885455|FG000|Overall Study|Lost to Follow-up|3|||
164688985|NCT00651183|594885456|FG001|Overall Study|Lost to Follow-up|1|||
164688986|NCT00651183|594885455|FG000|Overall Study|Other reasons|4|||
164688987|NCT00651183|594885456|FG001|Overall Study|Other reasons|2|||
164688988|NCT00651183|594885455|FG000|Overall Study|missing|1|||
164688989|NCT00651183|594885456|FG001|Overall Study|missing|0|||
164688990|NCT00108082|594885460|FG000|Overall Study|Adverse Event|14|||
164688991|NCT00108082|594885461|FG001|Overall Study|Adverse Event|12|||
164688992|NCT00108082|594885462|FG002|Overall Study|Adverse Event|17|||
164688993|NCT00108082|594885460|FG000|Overall Study|Lost to Follow-up|6|||
164688994|NCT00108082|594885461|FG001|Overall Study|Lost to Follow-up|3|||
164688995|NCT00108082|594885462|FG002|Overall Study|Lost to Follow-up|7|||
164688996|NCT00108082|594885460|FG000|Overall Study|Consent Withdrawn|3|||
164688997|NCT00108082|594885461|FG001|Overall Study|Consent Withdrawn|3|||
164688998|NCT00108082|594885462|FG002|Overall Study|Consent Withdrawn|5|||
164688999|NCT00108082|594885460|FG000|Overall Study|Protocol Violation|1|||
164689000|NCT00108082|594885461|FG001|Overall Study|Protocol Violation|2|||
164689001|NCT00108082|594885462|FG002|Overall Study|Protocol Violation|0|||
164689002|NCT00108082|594885460|FG000|Overall Study|Lack of Efficacy|3|||
164689003|NCT00108082|594885461|FG001|Overall Study|Lack of Efficacy|1|||
164689004|NCT00108082|594885462|FG002|Overall Study|Lack of Efficacy|2|||
164689005|NCT00108082|594885460|FG000|Overall Study|Amendment 4: > Month 12|5|||
164689006|NCT00108082|594885461|FG001|Overall Study|Amendment 4: > Month 12|7|||
164689007|NCT00108082|594885462|FG002|Overall Study|Amendment 4: > Month 12|5|||
164689008|NCT00108082|594885460|FG000|Overall Study|Woman of Child-bearing Potential|2|||
164689009|NCT00108082|594885461|FG001|Overall Study|Woman of Child-bearing Potential|0|||
164689010|NCT00108082|594885462|FG002|Overall Study|Woman of Child-bearing Potential|2|||
164689011|NCT00108082|594885460|FG000|Overall Study|Incorrectly Randomized|0|||
164273625|NCT00615030|593370525|FG003|Period II|Subject withdrew consent|1|||
164273626|NCT00615030|593370526|FG004|Period II|Subject withdrew consent|0|||
164273627|NCT00615030|593370527|FG005|Period II|Subject withdrew consent|0|||
164273628|NCT00615030|593370528|FG006|Period II|Subject withdrew consent|1|||
164273629|NCT00615030|593370529|FG007|Period II|Subject withdrew consent|0|||
164273630|NCT00615030|593370530|FG008|Period II|Subject withdrew consent|0|||
164273631|NCT00615030|593370531|FG009|Period II|Subject withdrew consent|0|||
164273632|NCT00615030|593370532|FG010|Period II|Subject withdrew consent|0|||
164273633|NCT00615030|593370533|FG011|Period II|Subject withdrew consent|0|||
164273634|NCT00615030|593370522|FG000|Period III|Administrative problems|1|||
164273635|NCT00615030|593370523|FG001|Period III|Administrative problems|0|||
164273636|NCT00615030|593370524|FG002|Period III|Administrative problems|0|||
164689012|NCT00108082|594885461|FG001|Overall Study|Incorrectly Randomized|0|||
164689013|NCT00108082|594885462|FG002|Overall Study|Incorrectly Randomized|2|||
164689014|NCT00108082|594885460|FG000|Overall Study|Non-compliance|1|||
164689015|NCT00108082|594885461|FG001|Overall Study|Non-compliance|0|||
164273637|NCT00615030|593370525|FG003|Period III|Administrative problems|1|||
164273638|NCT00615030|593370526|FG004|Period III|Administrative problems|0|||
164273639|NCT00615030|593370527|FG005|Period III|Administrative problems|0|||
164689016|NCT00108082|594885462|FG002|Overall Study|Non-compliance|2|||
164689017|NCT00108082|594885460|FG000|Overall Study|Stopped Study Medication|0|||
164689018|NCT00108082|594885461|FG001|Overall Study|Stopped Study Medication|0|||
164689019|NCT00108082|594885462|FG002|Overall Study|Stopped Study Medication|1|||
164689020|NCT00108082|594885460|FG000|Overall Study|Site Closed Study|0|||
164689021|NCT00108082|594885461|FG001|Overall Study|Site Closed Study|2|||
164689022|NCT00108082|594885462|FG002|Overall Study|Site Closed Study|0|||
164689023|NCT00108082|594885460|FG000|Overall Study|Protocol Amendment|0|||
164689024|NCT00108082|594885461|FG001|Overall Study|Protocol Amendment|1|||
164689025|NCT00108082|594885462|FG002|Overall Study|Protocol Amendment|0|||
164689026|NCT00108082|594885460|FG000|Overall Study|Study Medication Not Tapered|0|||
164689027|NCT00108082|594885461|FG001|Overall Study|Study Medication Not Tapered|1|||
164689028|NCT00108082|594885462|FG002|Overall Study|Study Medication Not Tapered|0|||
164689029|NCT00108082|594885460|FG000|Overall Study|Subject Left Site Location|1|||
164273640|NCT00615030|593370528|FG006|Period III|Administrative problems|0|||
164689030|NCT00108082|594885461|FG001|Overall Study|Subject Left Site Location|0|||
164689031|NCT00108082|594885462|FG002|Overall Study|Subject Left Site Location|0|||
164689032|NCT00108082|594885460|FG000|Overall Study|Investigator Not at Site|1|||
164689033|NCT00108082|594885461|FG001|Overall Study|Investigator Not at Site|0|||
164689034|NCT00108082|594885462|FG002|Overall Study|Investigator Not at Site|0|||
164689035|NCT00108082|594885460|FG000|Overall Study|Blood Pressure Not Controlled|1|||
164689036|NCT00108082|594885461|FG001|Overall Study|Blood Pressure Not Controlled|0|||
164689037|NCT00108082|594885462|FG002|Overall Study|Blood Pressure Not Controlled|0|||
164689038|NCT01091103|594885466|FG000|Overall Study|Adverse Event|1|||
164689039|NCT01091103|594885466|FG000|Overall Study|Progressive Disease|3|||
164689040|NCT01270620|594885467|FG000|Overall Study|Withdrawal by Subject|1|||
164689041|NCT01270620|594885468|FG001|Overall Study|Withdrawal by Subject|3|||
164689042|NCT01045707|594885469|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
164689043|NCT01045707|594885470|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
164689044|NCT01045707|594885469|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
164689045|NCT01045707|594885470|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
164689046|NCT01045707|594885469|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
164689047|NCT01045707|594885470|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
164689048|NCT01045707|594885469|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
164689049|NCT01045707|594885470|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
164273641|NCT00615030|593370529|FG007|Period III|Administrative problems|0|||
164273642|NCT00615030|593370530|FG008|Period III|Administrative problems|0|||
164273643|NCT00615030|593370531|FG009|Period III|Administrative problems|0|||
164273644|NCT00615030|593370532|FG010|Period III|Administrative problems|0|||
164273645|NCT00615030|593370533|FG011|Period III|Administrative problems|0|||
164273646|NCT00308074|593370545|FG000|Overall Study|Withdrawal by Subject|1|||
164273647|NCT03002311|593370546|FG000|Overall Study|Lost to Follow-up|13|||
164273648|NCT03002311|593370547|FG001|Overall Study|Lost to Follow-up|26|||
164273649|NCT03002311|593370546|FG000|Overall Study|Referral provider called to schedule app|3|||
164273650|NCT03002311|593370547|FG001|Overall Study|Referral provider called to schedule app|3|||
164273651|NCT03002311|593370546|FG000|Overall Study|Physician Decision|3|||
164273652|NCT03002311|593370547|FG001|Overall Study|Physician Decision|1|||
164273653|NCT03908476|593370550|FG000|Overall Study|Death|3|||
164273654|NCT03908476|593370551|FG001|Overall Study|Death|0|||
164273655|NCT03908476|593370550|FG000|Overall Study|Lost to Follow-up|3|||
164273656|NCT03908476|593370551|FG001|Overall Study|Lost to Follow-up|1|||
164273657|NCT03908476|593370550|FG000|Overall Study|Withdrawal by Subject|7|||
164273658|NCT03908476|593370551|FG001|Overall Study|Withdrawal by Subject|1|||
164273659|NCT03908476|593370550|FG000|Overall Study|Physician Decision|2|||
164273660|NCT03908476|593370551|FG001|Overall Study|Physician Decision|0|||
164273661|NCT03908476|593370550|FG000|Overall Study|System Explanted and not Replaced|4|||
164273662|NCT03908476|593370551|FG001|Overall Study|System Explanted and not Replaced|0|||
164273663|NCT03908476|593370550|FG000|Overall Study|Intrathecal Pump|1|||
164273664|NCT03908476|593370551|FG001|Overall Study|Intrathecal Pump|0|||
164273665|NCT03908476|593370550|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
164273666|NCT03908476|593370551|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
164273667|NCT05194267|593370552|FG000|Overall Study|Withdrawal by Subject|2|||
164273668|NCT01329939|593370554|FG000|Overall Study|Lost to Follow-up|3|||
164273669|NCT01329939|593370555|FG001|Overall Study|Lost to Follow-up|0|||
164273670|NCT01329939|593370556|FG002|Overall Study|Lost to Follow-up|1|||
164273671|NCT01329939|593370557|FG003|Overall Study|Lost to Follow-up|2|||
164689050|NCT01045707|594885469|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
164689051|NCT01045707|594885470|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
164689052|NCT01045707|594885469|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
164273672|NCT01329939|593370554|FG000|Overall Study|Withdrawal by Subject|0|||
164273673|NCT01329939|593370555|FG001|Overall Study|Withdrawal by Subject|1|||
164273674|NCT01329939|593370556|FG002|Overall Study|Withdrawal by Subject|0|||
164273675|NCT01329939|593370557|FG003|Overall Study|Withdrawal by Subject|0|||
164273676|NCT01329939|593370554|FG000|Overall Study|Adverse Event|0|||
164273677|NCT01329939|593370555|FG001|Overall Study|Adverse Event|0|||
164273678|NCT01329939|593370556|FG002|Overall Study|Adverse Event|0|||
164273679|NCT01329939|593370557|FG003|Overall Study|Adverse Event|3|||
164273680|NCT03722524|593370558|FG000|Overall Study|Protocol Violation|86|||
164273681|NCT03722524|593370558|FG000|Overall Study|Adverse Event|7|||
164273682|NCT03722524|593370558|FG000|Overall Study|Lost to Follow-up|1|||
164273683|NCT03722524|593370558|FG000|Overall Study|Reason is not stated|1|||
164273684|NCT03722524|593370558|FG000|Overall Study|Physician Decision|1|||
164273685|NCT03722524|593370558|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
164273686|NCT02868229|593370559|FG000|Overall Study|Adverse Event|1|||
164273687|NCT02868229|593370560|FG001|Overall Study|Adverse Event|0|||
164689053|NCT01045707|594885470|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
164273688|NCT02868229|593370561|FG002|Overall Study|Adverse Event|0|||
164273689|NCT02868229|593370562|FG003|Overall Study|Adverse Event|1|||
164273690|NCT02868229|593370559|FG000|Overall Study|Death|0|||
164273691|NCT02868229|593370560|FG001|Overall Study|Death|0|||
164273692|NCT02868229|593370561|FG002|Overall Study|Death|1|||
164273693|NCT02868229|593370562|FG003|Overall Study|Death|1|||
164273694|NCT02868229|593370559|FG000|Overall Study|Missed dose|0|||
164273695|NCT02868229|593370560|FG001|Overall Study|Missed dose|0|||
164273696|NCT02868229|593370561|FG002|Overall Study|Missed dose|0|||
164273697|NCT02868229|593370562|FG003|Overall Study|Missed dose|3|||
164273698|NCT06151288|593370564|FG000|Overall Study|Lost to Follow-up|4|||
164273699|NCT06151288|593370565|FG001|Overall Study|Lost to Follow-up|2|||
164273700|NCT06151288|593370566|FG002|Overall Study|Lost to Follow-up|4|||
164273701|NCT06151288|593370567|FG003|Overall Study|Lost to Follow-up|3|||
164273702|NCT06151288|593370564|FG000|Overall Study|Withdrawal by Subject|4|||
164273703|NCT06151288|593370565|FG001|Overall Study|Withdrawal by Subject|5|||
164273704|NCT06151288|593370566|FG002|Overall Study|Withdrawal by Subject|1|||
164273705|NCT06151288|593370567|FG003|Overall Study|Withdrawal by Subject|1|||
164273706|NCT04369950|593370568|FG000|Overall Study|Protocol Violation|2|||
164273707|NCT04369950|593370569|FG001|Overall Study|Protocol Violation|2|||
164273708|NCT00989963|593370570|FG000|Overall Study|Adverse Event|1|||
164273709|NCT00989963|593370571|FG001|Overall Study|Adverse Event|1|||
164273710|NCT00989963|593370572|FG002|Overall Study|Adverse Event|1|||
164273711|NCT01240200|593370580|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
164273712|NCT01240200|593370581|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
164273713|NCT04071158|593370585|FG000|Overall Study|Lost to Follow-up|1|||
164273714|NCT04071158|593370586|FG001|Overall Study|Lost to Follow-up|2|||
164273715|NCT04071158|593370587|FG002|Overall Study|Lost to Follow-up|3|||
164273716|NCT04071158|593370588|FG003|Overall Study|Lost to Follow-up|3|||
164273717|NCT04071158|593370589|FG004|Overall Study|Lost to Follow-up|5|||
164273718|NCT04071158|593370585|FG000|Overall Study|Randomized but not treated|2|||
164273719|NCT04071158|593370586|FG001|Overall Study|Randomized but not treated|2|||
164273720|NCT04071158|593370587|FG002|Overall Study|Randomized but not treated|0|||
164273721|NCT04071158|593370588|FG003|Overall Study|Randomized but not treated|0|||
164273722|NCT04071158|593370589|FG004|Overall Study|Randomized but not treated|0|||
164273723|NCT01178099|593370590|FG000|Overall Study|Physician Decision|0|||
164689054|NCT01045707|594885469|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
164689055|NCT01045707|594885470|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
164689056|NCT01045707|594885469|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
164689057|NCT01045707|594885470|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
164689058|NCT01045707|594885469|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
164689059|NCT01045707|594885470|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
164689060|NCT00348816|594885471|FG000|Overall Study|Noncompliance with radiation treatment|1|||
164689061|NCT02780167|594885472|FG000|Overall Study|Adverse Event|9|||
164689062|NCT02780167|594885473|FG001|Overall Study|Adverse Event|8|||
164689063|NCT02780167|594885474|FG002|Overall Study|Adverse Event|8|||
164689064|NCT02780167|594885475|FG003|Overall Study|Adverse Event|12|||
164689065|NCT02780167|594885476|FG004|Overall Study|Adverse Event|8|||
164689066|NCT02780167|594885472|FG000|Overall Study|Lack of Efficacy|6|||
164689067|NCT02780167|594885473|FG001|Overall Study|Lack of Efficacy|5|||
164273724|NCT01178099|593370591|FG001|Overall Study|Physician Decision|1|||
164273725|NCT02473367|593370592|FG000|Wait 1|Withdrawal by Subject|1|||
164273726|NCT02473367|593370592|FG000|Period 4|Lost to Follow-up|1|||
164273727|NCT03194438|593370595|FG000|Overall Study|Withdrawal by Subject|2|||
164273728|NCT01286740|593370596|FG000|Overall Study|Enrolled but not treated|1|||
164273729|NCT01286740|593370596|FG000|Overall Study|Protocol Violation|1|||
164273730|NCT01646203|593370597|FG000|Overall Study|Adverse Event|2|||
164273731|NCT01646203|593370598|FG001|Overall Study|Adverse Event|0|||
164273732|NCT01646203|593370599|FG002|Overall Study|Adverse Event|1|||
164273733|NCT01646203|593370597|FG000|Overall Study|Withdrawal by Subject|0|||
164273734|NCT01646203|593370598|FG001|Overall Study|Withdrawal by Subject|1|||
164273735|NCT01646203|593370599|FG002|Overall Study|Withdrawal by Subject|0|||
164273736|NCT01646203|593370597|FG000|Overall Study|Physician's Decision|0|||
164273737|NCT01646203|593370598|FG001|Overall Study|Physician's Decision|1|||
164273738|NCT01646203|593370599|FG002|Overall Study|Physician's Decision|0|||
164273739|NCT02717130|593370605|FG000|Overall Study|Withdrawal by Subject|1|||
164689068|NCT02780167|594885474|FG002|Overall Study|Lack of Efficacy|6|||
164273740|NCT02717130|593370605|FG000|Overall Study|Adverse Event|1|||
164689069|NCT02780167|594885475|FG003|Overall Study|Lack of Efficacy|1|||
164689070|NCT02780167|594885476|FG004|Overall Study|Lack of Efficacy|0|||
164273741|NCT02717130|593370605|FG000|Overall Study|Physician Decision|1|||
164273742|NCT02717130|593370605|FG000|Overall Study|Study Closure|4|||
164273743|NCT00549770|593370606|FG000|Overall Study|Protocol deviation|1|||
164273744|NCT00549770|593370607|FG001|Overall Study|Protocol deviation|1|||
164273745|NCT00549770|593370608|FG002|Overall Study|Protocol deviation|1|||
164273746|NCT00549770|593370609|FG003|Overall Study|Protocol deviation|2|||
164273747|NCT00549770|593370610|FG004|Overall Study|Protocol deviation|2|||
164689071|NCT02780167|594885472|FG000|Overall Study|Lost to Follow-up|2|||
164273748|NCT00549770|593370611|FG005|Overall Study|Protocol deviation|2|||
164273749|NCT00549770|593370612|FG006|Overall Study|Protocol deviation|1|||
164273750|NCT00549770|593370613|FG007|Overall Study|Protocol deviation|2|||
164273751|NCT00549770|593370606|FG000|Overall Study|Administrative problems|0|||
164273752|NCT00549770|593370607|FG001|Overall Study|Administrative problems|1|||
164273753|NCT00549770|593370608|FG002|Overall Study|Administrative problems|0|||
164273754|NCT00549770|593370609|FG003|Overall Study|Administrative problems|0|||
164273755|NCT00549770|593370610|FG004|Overall Study|Administrative problems|0|||
164273756|NCT00549770|593370611|FG005|Overall Study|Administrative problems|0|||
164273757|NCT00549770|593370612|FG006|Overall Study|Administrative problems|0|||
164273758|NCT00549770|593370613|FG007|Overall Study|Administrative problems|1|||
164273759|NCT00549770|593370606|FG000|Overall Study|Lost to Follow-up|0|||
164273760|NCT00549770|593370607|FG001|Overall Study|Lost to Follow-up|0|||
164273761|NCT00549770|593370608|FG002|Overall Study|Lost to Follow-up|2|||
164273762|NCT00549770|593370609|FG003|Overall Study|Lost to Follow-up|2|||
164273763|NCT00549770|593370610|FG004|Overall Study|Lost to Follow-up|3|||
164273764|NCT00549770|593370611|FG005|Overall Study|Lost to Follow-up|2|||
164273765|NCT00549770|593370612|FG006|Overall Study|Lost to Follow-up|0|||
164273766|NCT00549770|593370613|FG007|Overall Study|Lost to Follow-up|0|||
164273767|NCT00549770|593370606|FG000|Overall Study|Withdrawal by Subject|4|||
164273768|NCT00549770|593370607|FG001|Overall Study|Withdrawal by Subject|6|||
164273769|NCT00549770|593370608|FG002|Overall Study|Withdrawal by Subject|4|||
164273770|NCT00549770|593370609|FG003|Overall Study|Withdrawal by Subject|5|||
164273771|NCT00549770|593370610|FG004|Overall Study|Withdrawal by Subject|6|||
164273772|NCT00549770|593370611|FG005|Overall Study|Withdrawal by Subject|6|||
164273773|NCT00549770|593370612|FG006|Overall Study|Withdrawal by Subject|4|||
164273774|NCT00549770|593370613|FG007|Overall Study|Withdrawal by Subject|9|||
164273775|NCT00549770|593370606|FG000|Overall Study|Lack of Efficacy|1|||
164273776|NCT00549770|593370607|FG001|Overall Study|Lack of Efficacy|0|||
164273777|NCT00549770|593370608|FG002|Overall Study|Lack of Efficacy|2|||
164273778|NCT00549770|593370609|FG003|Overall Study|Lack of Efficacy|3|||
164273779|NCT00549770|593370610|FG004|Overall Study|Lack of Efficacy|5|||
164689072|NCT02780167|594885473|FG001|Overall Study|Lost to Follow-up|0|||
164689073|NCT02780167|594885474|FG002|Overall Study|Lost to Follow-up|1|||
164689074|NCT02780167|594885475|FG003|Overall Study|Lost to Follow-up|0|||
164689075|NCT02780167|594885476|FG004|Overall Study|Lost to Follow-up|0|||
164273780|NCT00549770|593370611|FG005|Overall Study|Lack of Efficacy|1|||
164273781|NCT00549770|593370612|FG006|Overall Study|Lack of Efficacy|3|||
164689076|NCT02780167|594885472|FG000|Overall Study|Does not meet entrance criteria|0|||
164689077|NCT02780167|594885473|FG001|Overall Study|Does not meet entrance criteria|0|||
164273782|NCT00549770|593370613|FG007|Overall Study|Lack of Efficacy|8|||
164273783|NCT00549770|593370606|FG000|Overall Study|Abnormal test procedure results|0|||
164273784|NCT00549770|593370607|FG001|Overall Study|Abnormal test procedure results|0|||
164273785|NCT00549770|593370608|FG002|Overall Study|Abnormal test procedure results|0|||
164273786|NCT00549770|593370609|FG003|Overall Study|Abnormal test procedure results|2|||
164273787|NCT00549770|593370610|FG004|Overall Study|Abnormal test procedure results|0|||
164273788|NCT00549770|593370611|FG005|Overall Study|Abnormal test procedure results|1|||
164273789|NCT00549770|593370612|FG006|Overall Study|Abnormal test procedure results|1|||
164273790|NCT00549770|593370613|FG007|Overall Study|Abnormal test procedure results|1|||
164273791|NCT00549770|593370606|FG000|Overall Study|Abnormal laboratory values|0|||
164273792|NCT00549770|593370607|FG001|Overall Study|Abnormal laboratory values|0|||
164273793|NCT00549770|593370608|FG002|Overall Study|Abnormal laboratory values|0|||
164273794|NCT00549770|593370609|FG003|Overall Study|Abnormal laboratory values|0|||
164273795|NCT00549770|593370610|FG004|Overall Study|Abnormal laboratory values|0|||
164273796|NCT00549770|593370611|FG005|Overall Study|Abnormal laboratory values|1|||
164273797|NCT00549770|593370612|FG006|Overall Study|Abnormal laboratory values|0|||
164273798|NCT00549770|593370613|FG007|Overall Study|Abnormal laboratory values|0|||
164689078|NCT02780167|594885474|FG002|Overall Study|Does not meet entrance criteria|1|||
164689079|NCT02780167|594885475|FG003|Overall Study|Does not meet entrance criteria|0|||
164273799|NCT00549770|593370606|FG000|Overall Study|Adverse Event|1|||
164273800|NCT00549770|593370607|FG001|Overall Study|Adverse Event|3|||
164273801|NCT00549770|593370608|FG002|Overall Study|Adverse Event|1|||
164273802|NCT00549770|593370609|FG003|Overall Study|Adverse Event|2|||
164273803|NCT00549770|593370610|FG004|Overall Study|Adverse Event|1|||
164273804|NCT00549770|593370611|FG005|Overall Study|Adverse Event|0|||
164273805|NCT00549770|593370612|FG006|Overall Study|Adverse Event|5|||
164273806|NCT00549770|593370613|FG007|Overall Study|Adverse Event|4|||
164273807|NCT02335424|593370618|FG000|Overall Study|Withdrawal by Subject|19|||
164273808|NCT02335424|593370618|FG000|Overall Study|Adverse Event|25|||
164273809|NCT02335424|593370618|FG000|Overall Study|Death|273|||
164273810|NCT02335424|593370618|FG000|Overall Study|Lost to Follow-up|3|||
164273811|NCT02335424|593370618|FG000|Overall Study|Physician Decision|13|||
164273812|NCT02335424|593370618|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
164273813|NCT02335424|593370618|FG000|Overall Study|Protocol Violation|1|||
164273814|NCT02335424|593370618|FG000|Overall Study|Screen failure|1|||
164273815|NCT02712424|593370619|FG000|Overall Study|Lost to Follow-up|34|||
164689080|NCT02780167|594885476|FG004|Overall Study|Does not meet entrance criteria|0|||
164689081|NCT02780167|594885472|FG000|Overall Study|No longer meets eligibility criteria|0|||
164689082|NCT02780167|594885473|FG001|Overall Study|No longer meets eligibility criteria|0|||
164689083|NCT02780167|594885474|FG002|Overall Study|No longer meets eligibility criteria|0|||
164689084|NCT02780167|594885475|FG003|Overall Study|No longer meets eligibility criteria|1|||
164689085|NCT02780167|594885476|FG004|Overall Study|No longer meets eligibility criteria|1|||
164689086|NCT02780167|594885472|FG000|Overall Study|Protocol Violation|5|||
164431111|NCT02616263|593949369|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
164431112|NCT02616263|593949368|FG000|6 Month to 1.5 Year|Death|1|||
164431113|NCT02616263|593949369|FG001|6 Month to 1.5 Year|Death|0|||
164431114|NCT02616263|593949368|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
164431115|NCT02616263|593949369|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
164431116|NCT02616263|593949368|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
164431117|NCT02616263|593949369|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
164431118|NCT02616263|593949368|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
164431119|NCT02616263|593949369|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
164689087|NCT02780167|594885473|FG001|Overall Study|Protocol Violation|5|||
164689088|NCT02780167|594885474|FG002|Overall Study|Protocol Violation|1|||
164689089|NCT02780167|594885475|FG003|Overall Study|Protocol Violation|1|||
164689090|NCT02780167|594885476|FG004|Overall Study|Protocol Violation|2|||
164689091|NCT02780167|594885472|FG000|Overall Study|Withdrawal by Subject|6|||
164689092|NCT02780167|594885473|FG001|Overall Study|Withdrawal by Subject|4|||
164689093|NCT02780167|594885474|FG002|Overall Study|Withdrawal by Subject|4|||
164689094|NCT02780167|594885475|FG003|Overall Study|Withdrawal by Subject|3|||
164273816|NCT02712424|593370620|FG001|Overall Study|Lost to Follow-up|32|||
164273817|NCT02421601|593370623|FG000|Overall Study|Adverse Event|4|||
164273818|NCT02421601|593370623|FG000|Overall Study|Lack of Efficacy|5|||
164273819|NCT02421601|593370623|FG000|Overall Study|Physician Decision|1|||
164273820|NCT02421601|593370623|FG000|Overall Study|Withdrawal by Subject|31|||
164273821|NCT02421601|593370623|FG000|Overall Study|Others|41|||
164273822|NCT00290498|593370624|FG000|Overall Study|Death|2|||
164273823|NCT00290498|593370625|FG001|Overall Study|Death|0|||
164273824|NCT00290498|593370624|FG000|Overall Study|Physician Decision|1|||
164273825|NCT00290498|593370625|FG001|Overall Study|Physician Decision|0|||
164273826|NCT00290498|593370624|FG000|Overall Study|Withdrawal by Subject|1|||
164431120|NCT02939183|593949375|FG000|Overall Study|Death|0|||
164431121|NCT02939183|593949376|FG001|Overall Study|Death|0|||
164431122|NCT02939183|593949377|FG002|Overall Study|Death|1|||
164431123|NCT02939183|593949378|FG003|Overall Study|Death|0|||
164431124|NCT02939183|593949379|FG004|Overall Study|Death|0|||
164689095|NCT02780167|594885476|FG004|Overall Study|Withdrawal by Subject|4|||
164689096|NCT02780167|594885472|FG000|Overall Study|Other|0|||
164689097|NCT02780167|594885473|FG001|Overall Study|Other|0|||
164689098|NCT02780167|594885474|FG002|Overall Study|Other|3|||
164689099|NCT02780167|594885475|FG003|Overall Study|Other|1|||
164689100|NCT02780167|594885476|FG004|Overall Study|Other|2|||
164689101|NCT02315066|594885477|FG000|Overall Study|Lost to Follow-up|0|||
164689102|NCT02315066|594885478|FG001|Overall Study|Lost to Follow-up|1|||
164431125|NCT02939183|593949380|FG005|Overall Study|Death|2|||
164431126|NCT02939183|593949381|FG006|Overall Study|Death|1|||
164689103|NCT02315066|594885479|FG002|Overall Study|Lost to Follow-up|1|||
164689104|NCT02315066|594885480|FG003|Overall Study|Lost to Follow-up|0|||
164689105|NCT02315066|594885481|FG004|Overall Study|Lost to Follow-up|1|||
164689106|NCT02315066|594885482|FG005|Overall Study|Lost to Follow-up|0|||
164689107|NCT02315066|594885483|FG006|Overall Study|Lost to Follow-up|2|||
164689108|NCT02315066|594885484|FG007|Overall Study|Lost to Follow-up|1|||
164689109|NCT02315066|594885485|FG008|Overall Study|Lost to Follow-up|0|||
164689110|NCT02315066|594885486|FG009|Overall Study|Lost to Follow-up|0|||
164689111|NCT02315066|594885487|FG010|Overall Study|Lost to Follow-up|1|||
164689112|NCT02315066|594885488|FG011|Overall Study|Lost to Follow-up|2|||
164273827|NCT00290498|593370625|FG001|Overall Study|Withdrawal by Subject|0|||
164689113|NCT02315066|594885489|FG012|Overall Study|Lost to Follow-up|0|||
164689114|NCT02315066|594885490|FG013|Overall Study|Lost to Follow-up|4|||
164689115|NCT02315066|594885477|FG000|Overall Study|Death|2|||
164273828|NCT00290498|593370624|FG000|Overall Study|Ineligible|3|||
164273829|NCT00290498|593370625|FG001|Overall Study|Ineligible|0|||
164273830|NCT00290498|593370624|FG000|Overall Study|Non-Compliance|1|||
164273831|NCT00290498|593370625|FG001|Overall Study|Non-Compliance|0|||
164273832|NCT00599638|593370628|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
164273833|NCT00599638|593370629|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
164273834|NCT00599638|593370630|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
164431127|NCT02939183|593949382|FG007|Overall Study|Death|0|||
164431128|NCT02939183|593949383|FG008|Overall Study|Death|0|||
164431129|NCT02939183|593949375|FG000|Overall Study|Sponsor decision|0|||
164431130|NCT02939183|593949376|FG001|Overall Study|Sponsor decision|1|||
164431131|NCT02939183|593949377|FG002|Overall Study|Sponsor decision|0|||
164689116|NCT02315066|594885478|FG001|Overall Study|Death|7|||
164689117|NCT02315066|594885479|FG002|Overall Study|Death|6|||
164689118|NCT02315066|594885480|FG003|Overall Study|Death|11|||
164689119|NCT02315066|594885481|FG004|Overall Study|Death|10|||
164689120|NCT02315066|594885482|FG005|Overall Study|Death|3|||
164273835|NCT00599638|593370631|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
164273836|NCT00599638|593370628|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
164273837|NCT00599638|593370629|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
164273838|NCT00599638|593370630|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
164273839|NCT00599638|593370631|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
164273840|NCT00599638|593370628|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
164273841|NCT00599638|593370629|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
164273842|NCT00599638|593370630|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
164273843|NCT00599638|593370631|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
164273844|NCT00599638|593370628|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
164273845|NCT00599638|593370629|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
164273846|NCT00599638|593370630|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
164273847|NCT00599638|593370631|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
164273848|NCT00599638|593370628|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
164273849|NCT00599638|593370629|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
164273850|NCT00599638|593370630|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
164273851|NCT00599638|593370631|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
164273852|NCT00599638|593370628|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
164273853|NCT00599638|593370629|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
164273854|NCT00599638|593370630|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
164273855|NCT00599638|593370631|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
164273856|NCT00599638|593370628|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
164273857|NCT00599638|593370629|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
164273858|NCT00599638|593370630|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
164273859|NCT00599638|593370631|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
164273860|NCT00599638|593370628|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
164273861|NCT00599638|593370629|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
164273862|NCT00599638|593370630|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
164273863|NCT00599638|593370631|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
164273864|NCT00599638|593370628|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
164273865|NCT00599638|593370629|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
164273866|NCT00599638|593370630|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
164273867|NCT00599638|593370631|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
164273868|NCT03006887|593370632|FG000|Overall Study|Adverse Event|1|||
164273869|NCT02895945|593370633|FG000|Overall Study|Physician Decision|2|||
164273870|NCT02895945|593370634|FG001|Overall Study|Physician Decision|1|||
164273871|NCT00462748|593370635|FG000|Overall Study|Adverse Event|7|||
164273872|NCT00462748|593370636|FG001|Overall Study|Adverse Event|5|||
164273873|NCT00462748|593370637|FG002|Overall Study|Adverse Event|9|||
164273874|NCT00462748|593370635|FG000|Overall Study|Protocol Violation|0|||
164273875|NCT00462748|593370636|FG001|Overall Study|Protocol Violation|2|||
164273876|NCT00462748|593370637|FG002|Overall Study|Protocol Violation|1|||
164583097|NCT02111811|594499691|FG000|Follow up Period (Aim 2)|Death|2|||
164273877|NCT00462748|593370635|FG000|Overall Study|Withdrew consent|3|||
164273878|NCT00462748|593370636|FG001|Overall Study|Withdrew consent|3|||
164273879|NCT00462748|593370637|FG002|Overall Study|Withdrew consent|0|||
164273880|NCT00462748|593370635|FG000|Overall Study|Lost to Follow-up|1|||
164273881|NCT00462748|593370636|FG001|Overall Study|Lost to Follow-up|1|||
164273882|NCT00462748|593370637|FG002|Overall Study|Lost to Follow-up|1|||
164273883|NCT00462748|593370635|FG000|Overall Study|Discontinued after 41 days Rx|1|||
164273884|NCT00462748|593370636|FG001|Overall Study|Discontinued after 41 days Rx|0|||
164273885|NCT00462748|593370637|FG002|Overall Study|Discontinued after 41 days Rx|0|||
164273886|NCT03429543|593370638|FG000|Overall Study|Adverse Event|1|||
164273887|NCT03429543|593370639|FG001|Overall Study|Adverse Event|1|||
164273888|NCT03429543|593370640|FG002|Overall Study|Adverse Event|0|||
164273889|NCT03429543|593370641|FG003|Overall Study|Adverse Event|0|||
164273890|NCT03429543|593370642|FG004|Overall Study|Adverse Event|0|||
164273891|NCT03429543|593370643|FG005|Overall Study|Adverse Event|2|||
164273892|NCT03429543|593370644|FG006|Overall Study|Adverse Event|0|||
164273893|NCT03429543|593370638|FG000|Overall Study|Lost to Follow-up|1|||
164273894|NCT03429543|593370639|FG001|Overall Study|Lost to Follow-up|0|||
164583098|NCT02111811|594499692|FG001|Follow up Period (Aim 2)|Death|0|||
164273895|NCT03429543|593370640|FG002|Overall Study|Lost to Follow-up|0|||
164273896|NCT03429543|593370641|FG003|Overall Study|Lost to Follow-up|0|||
164273897|NCT03429543|593370642|FG004|Overall Study|Lost to Follow-up|1|||
164273898|NCT03429543|593370643|FG005|Overall Study|Lost to Follow-up|0|||
164273899|NCT03429543|593370644|FG006|Overall Study|Lost to Follow-up|0|||
164342713|NCT02954237|593631497|FG000|Overall Study|Missed visit|16|||
164583099|NCT01359982|594499693|FG000|Overall Study|Adverse Event|2|||
164583100|NCT01359982|594499694|FG001|Overall Study|Adverse Event|0|||
164583101|NCT01359982|594499695|FG002|Overall Study|Adverse Event|0|||
164273900|NCT03429543|593370638|FG000|Overall Study|Withdrawal by Subject|5|||
164583102|NCT01359982|594499696|FG003|Overall Study|Adverse Event|1|||
164583103|NCT01359982|594499697|FG004|Overall Study|Adverse Event|0|||
164689121|NCT02315066|594885483|FG006|Overall Study|Death|9|||
164689122|NCT02315066|594885484|FG007|Overall Study|Death|9|||
164689123|NCT02315066|594885485|FG008|Overall Study|Death|10|||
164689124|NCT02315066|594885486|FG009|Overall Study|Death|8|||
164689125|NCT02315066|594885487|FG010|Overall Study|Death|10|||
164273901|NCT03429543|593370639|FG001|Overall Study|Withdrawal by Subject|0|||
164273902|NCT03429543|593370640|FG002|Overall Study|Withdrawal by Subject|1|||
164273903|NCT03429543|593370641|FG003|Overall Study|Withdrawal by Subject|2|||
164273904|NCT03429543|593370642|FG004|Overall Study|Withdrawal by Subject|6|||
164273905|NCT03429543|593370643|FG005|Overall Study|Withdrawal by Subject|3|||
164273906|NCT03429543|593370644|FG006|Overall Study|Withdrawal by Subject|1|||
164273907|NCT03429543|593370638|FG000|Overall Study|Other reason than listed|0|||
164273908|NCT03429543|593370639|FG001|Overall Study|Other reason than listed|1|||
164273909|NCT03429543|593370640|FG002|Overall Study|Other reason than listed|0|||
164273910|NCT03429543|593370641|FG003|Overall Study|Other reason than listed|0|||
164273911|NCT03429543|593370642|FG004|Overall Study|Other reason than listed|4|||
164273912|NCT03429543|593370643|FG005|Overall Study|Other reason than listed|4|||
164273913|NCT03429543|593370644|FG006|Overall Study|Other reason than listed|0|||
164273914|NCT03429543|593370638|FG000|Overall Study|Not treated|0|||
164273915|NCT03429543|593370639|FG001|Overall Study|Not treated|0|||
164273916|NCT03429543|593370640|FG002|Overall Study|Not treated|0|||
164273917|NCT03429543|593370641|FG003|Overall Study|Not treated|0|||
164273918|NCT03429543|593370642|FG004|Overall Study|Not treated|1|||
164273919|NCT03429543|593370643|FG005|Overall Study|Not treated|0|||
164273920|NCT03429543|593370644|FG006|Overall Study|Not treated|0|||
164273921|NCT01600092|593370645|FG000|Overall Study|Adverse Event|2|||
164273922|NCT01600092|593370646|FG001|Overall Study|Adverse Event|0|||
164273923|NCT01600092|593370645|FG000|Overall Study|Lost to Follow-up|4|||
164273924|NCT01600092|593370646|FG001|Overall Study|Lost to Follow-up|6|||
164273925|NCT01600092|593370645|FG000|Overall Study|Withdrawal by parent/guardian|8|||
164273926|NCT01600092|593370646|FG001|Overall Study|Withdrawal by parent/guardian|6|||
164273927|NCT01600092|593370645|FG000|Overall Study|Physician Decision|1|||
164273928|NCT01600092|593370646|FG001|Overall Study|Physician Decision|1|||
164273929|NCT01600092|593370645|FG000|Overall Study|Randomized but not vaccinated|3|||
164273930|NCT01600092|593370646|FG001|Overall Study|Randomized but not vaccinated|3|||
164273931|NCT01561963|593370647|FG000|Overall Study|Adverse Event|1|||
164273932|NCT00637572|593370655|FG000|Overall Study|Adverse Event|1|||
164273933|NCT00637572|593370656|FG001|Overall Study|Adverse Event|2|||
164273934|NCT00637572|593370655|FG000|Overall Study|Death|0|||
164273935|NCT00637572|593370656|FG001|Overall Study|Death|1|||
164273936|NCT00637572|593370655|FG000|Overall Study|Lost to Follow-up|0|||
164273937|NCT00637572|593370656|FG001|Overall Study|Lost to Follow-up|1|||
164273938|NCT00637572|593370655|FG000|Overall Study|Physician Decision|1|||
164273939|NCT00637572|593370656|FG001|Overall Study|Physician Decision|1|||
164273940|NCT00637572|593370655|FG000|Overall Study|Withdrawal by Subject|0|||
164273941|NCT00637572|593370656|FG001|Overall Study|Withdrawal by Subject|2|||
164273942|NCT00637572|593370655|FG000|Overall Study|Illicit Drug Use|1|||
164273943|NCT00637572|593370656|FG001|Overall Study|Illicit Drug Use|0|||
164273944|NCT01887353|593370657|FG000|Overall Study|Study stopped early|4|||
164273945|NCT01887353|593370658|FG001|Overall Study|Study stopped early|3|||
164273946|NCT04667104|593370662|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
164689126|NCT02315066|594885488|FG011|Overall Study|Death|7|||
164689127|NCT02315066|594885489|FG012|Overall Study|Death|8|||
164689128|NCT02315066|594885490|FG013|Overall Study|Death|21|||
164689129|NCT02315066|594885477|FG000|Overall Study|Other|0|||
164689130|NCT02315066|594885478|FG001|Overall Study|Other|0|||
164689131|NCT02315066|594885479|FG002|Overall Study|Other|0|||
164689132|NCT02315066|594885480|FG003|Overall Study|Other|0|||
164273947|NCT04667104|593370663|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
164273948|NCT04667104|593370664|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
164273949|NCT01078168|593370668|FG000|Overall Study|Physician Decision|0|||
164273950|NCT01078168|593370669|FG001|Overall Study|Physician Decision|1|||
164273951|NCT05066165|593372759|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
164273952|NCT05066165|593372760|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
164273953|NCT05066165|593372759|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
164273954|NCT05066165|593372760|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
164273955|NCT03210961|593372761|FG000|Overall Study|Adverse Event|0|||
164273956|NCT03210961|593372762|FG001|Overall Study|Adverse Event|0|||
164273957|NCT03210961|593372763|FG002|Overall Study|Adverse Event|0|||
164273958|NCT03210961|593372764|FG003|Overall Study|Adverse Event|0|||
164273959|NCT03210961|593372765|FG004|Overall Study|Adverse Event|0|||
164273960|NCT03210961|593372766|FG005|Overall Study|Adverse Event|0|||
164689133|NCT02315066|594885481|FG004|Overall Study|Other|0|||
164273961|NCT03210961|593372767|FG006|Overall Study|Adverse Event|0|||
164273962|NCT03210961|593372768|FG007|Overall Study|Adverse Event|0|||
164273963|NCT03210961|593372769|FG008|Overall Study|Adverse Event|0|||
164273964|NCT03210961|593372770|FG009|Overall Study|Adverse Event|0|||
164273965|NCT03210961|593372771|FG010|Overall Study|Adverse Event|0|||
164689134|NCT02315066|594885482|FG005|Overall Study|Other|0|||
164689135|NCT02315066|594885483|FG006|Overall Study|Other|0|||
164273966|NCT03210961|593372772|FG011|Overall Study|Adverse Event|0|||
164273967|NCT03210961|593372773|FG012|Overall Study|Adverse Event|0|||
164273968|NCT03210961|593372774|FG013|Overall Study|Adverse Event|1|||
164273969|NCT03210961|593372775|FG014|Overall Study|Adverse Event|0|||
164273970|NCT03210961|593372761|FG000|Overall Study|Lost to Follow-up|0|||
164273971|NCT03210961|593372762|FG001|Overall Study|Lost to Follow-up|0|||
164273972|NCT03210961|593372763|FG002|Overall Study|Lost to Follow-up|0|||
164273973|NCT03210961|593372764|FG003|Overall Study|Lost to Follow-up|0|||
164273974|NCT03210961|593372765|FG004|Overall Study|Lost to Follow-up|0|||
164273975|NCT03210961|593372766|FG005|Overall Study|Lost to Follow-up|0|||
164273976|NCT03210961|593372767|FG006|Overall Study|Lost to Follow-up|0|||
164273977|NCT03210961|593372768|FG007|Overall Study|Lost to Follow-up|0|||
164273978|NCT03210961|593372769|FG008|Overall Study|Lost to Follow-up|0|||
164273979|NCT03210961|593372770|FG009|Overall Study|Lost to Follow-up|0|||
164273980|NCT03210961|593372771|FG010|Overall Study|Lost to Follow-up|0|||
164273981|NCT03210961|593372772|FG011|Overall Study|Lost to Follow-up|0|||
164273982|NCT03210961|593372773|FG012|Overall Study|Lost to Follow-up|0|||
164273983|NCT03210961|593372774|FG013|Overall Study|Lost to Follow-up|0|||
164273984|NCT03210961|593372775|FG014|Overall Study|Lost to Follow-up|1|||
164273985|NCT03210961|593372761|FG000|Overall Study|Withdrawal by Subject|0|||
164273986|NCT03210961|593372762|FG001|Overall Study|Withdrawal by Subject|0|||
164273987|NCT03210961|593372763|FG002|Overall Study|Withdrawal by Subject|0|||
164273988|NCT03210961|593372764|FG003|Overall Study|Withdrawal by Subject|0|||
164273989|NCT03210961|593372765|FG004|Overall Study|Withdrawal by Subject|0|||
164273990|NCT03210961|593372766|FG005|Overall Study|Withdrawal by Subject|0|||
164273991|NCT03210961|593372767|FG006|Overall Study|Withdrawal by Subject|0|||
164273992|NCT03210961|593372768|FG007|Overall Study|Withdrawal by Subject|0|||
164273993|NCT03210961|593372769|FG008|Overall Study|Withdrawal by Subject|0|||
164273994|NCT03210961|593372770|FG009|Overall Study|Withdrawal by Subject|0|||
164273995|NCT03210961|593372771|FG010|Overall Study|Withdrawal by Subject|0|||
164273996|NCT03210961|593372772|FG011|Overall Study|Withdrawal by Subject|0|||
164273997|NCT03210961|593372773|FG012|Overall Study|Withdrawal by Subject|0|||
164273998|NCT03210961|593372774|FG013|Overall Study|Withdrawal by Subject|0|||
164273999|NCT03210961|593372775|FG014|Overall Study|Withdrawal by Subject|1|||
164274000|NCT03210961|593372761|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274001|NCT03210961|593372762|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274002|NCT03210961|593372763|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274003|NCT03210961|593372764|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274004|NCT03210961|593372765|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274005|NCT03210961|593372766|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274006|NCT03210961|593372767|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274007|NCT03210961|593372768|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274008|NCT03210961|593372769|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274009|NCT03210961|593372770|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274010|NCT03210961|593372771|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274011|NCT03210961|593372772|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274012|NCT03210961|593372773|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
164583104|NCT01359982|594499698|FG005|Overall Study|Adverse Event|0|||
164274013|NCT03210961|593372774|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
164274014|NCT03210961|593372775|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274015|NCT03210961|593372761|FG000|Overall Study|Other|0|||
164274016|NCT03210961|593372762|FG001|Overall Study|Other|0|||
164274017|NCT03210961|593372763|FG002|Overall Study|Other|0|||
164274018|NCT03210961|593372764|FG003|Overall Study|Other|1|||
164274019|NCT03210961|593372765|FG004|Overall Study|Other|0|||
164274020|NCT03210961|593372766|FG005|Overall Study|Other|0|||
164274021|NCT03210961|593372767|FG006|Overall Study|Other|1|||
164274022|NCT03210961|593372768|FG007|Overall Study|Other|0|||
164274023|NCT03210961|593372769|FG008|Overall Study|Other|0|||
164274024|NCT03210961|593372770|FG009|Overall Study|Other|0|||
164274025|NCT03210961|593372771|FG010|Overall Study|Other|1|||
164274026|NCT03210961|593372772|FG011|Overall Study|Other|0|||
164274027|NCT03210961|593372773|FG012|Overall Study|Other|2|||
164274028|NCT03210961|593372774|FG013|Overall Study|Other|2|||
164274029|NCT03210961|593372775|FG014|Overall Study|Other|0|||
164274030|NCT02467582|593372776|FG000|Allocation|Withdrawal by Subject|1|||
164274031|NCT02467582|593372777|FG001|Allocation|Withdrawal by Subject|0|||
164274032|NCT02467582|593372776|FG000|Follow-up|Death|5|||
164274033|NCT02467582|593372777|FG001|Follow-up|Death|4|||
164274034|NCT02467582|593372776|FG000|Follow-up|Lost to Follow-up|6|||
164583105|NCT01359982|594499693|FG000|Overall Study|Death|1|||
164583106|NCT01359982|594499694|FG001|Overall Study|Death|0|||
164583107|NCT01359982|594499695|FG002|Overall Study|Death|0|||
164583108|NCT01359982|594499696|FG003|Overall Study|Death|0|||
164274035|NCT02467582|593372777|FG001|Follow-up|Lost to Follow-up|5|||
164274036|NCT01370265|593372778|FG000|First Intervention|Adverse Event|1|||
164274037|NCT01370265|593372779|FG001|First Intervention|Adverse Event|1|||
164583109|NCT01359982|594499697|FG004|Overall Study|Death|0|||
164274038|NCT03343626|593372780|FG000|Overall Study|Lost to Follow-up|4|||
164274039|NCT03343626|593372781|FG001|Overall Study|Lost to Follow-up|3|||
164274040|NCT03343626|593372782|FG002|Overall Study|Lost to Follow-up|2|||
164274041|NCT03343626|593372783|FG003|Overall Study|Lost to Follow-up|5|||
164274042|NCT03343626|593372784|FG004|Overall Study|Lost to Follow-up|4|||
164274043|NCT03343626|593372785|FG005|Overall Study|Lost to Follow-up|4|||
164274044|NCT03343626|593372786|FG006|Overall Study|Lost to Follow-up|4|||
164274045|NCT03343626|593372787|FG007|Overall Study|Lost to Follow-up|7|||
164274046|NCT03343626|593372780|FG000|Overall Study|Withdrawal of Consent|2|||
164274047|NCT03343626|593372781|FG001|Overall Study|Withdrawal of Consent|1|||
164274048|NCT03343626|593372782|FG002|Overall Study|Withdrawal of Consent|0|||
164274049|NCT03343626|593372783|FG003|Overall Study|Withdrawal of Consent|3|||
164274050|NCT03343626|593372784|FG004|Overall Study|Withdrawal of Consent|3|||
164274051|NCT03343626|593372785|FG005|Overall Study|Withdrawal of Consent|1|||
164274052|NCT03343626|593372786|FG006|Overall Study|Withdrawal of Consent|1|||
164274053|NCT03343626|593372787|FG007|Overall Study|Withdrawal of Consent|2|||
164274054|NCT03343626|593372780|FG000|Overall Study|Reason not Specified|0|||
164274055|NCT03343626|593372781|FG001|Overall Study|Reason not Specified|1|||
164274056|NCT03343626|593372782|FG002|Overall Study|Reason not Specified|0|||
164274057|NCT03343626|593372783|FG003|Overall Study|Reason not Specified|0|||
164274058|NCT03343626|593372784|FG004|Overall Study|Reason not Specified|0|||
164274059|NCT03343626|593372785|FG005|Overall Study|Reason not Specified|0|||
164274060|NCT03343626|593372786|FG006|Overall Study|Reason not Specified|0|||
164274061|NCT03343626|593372787|FG007|Overall Study|Reason not Specified|1|||
164274062|NCT03343626|593372780|FG000|Overall Study|Data Entry Error|0|||
164274063|NCT03343626|593372781|FG001|Overall Study|Data Entry Error|0|||
164274064|NCT03343626|593372782|FG002|Overall Study|Data Entry Error|0|||
164274065|NCT03343626|593372783|FG003|Overall Study|Data Entry Error|0|||
164689136|NCT02315066|594885484|FG007|Overall Study|Other|1|||
164274066|NCT03343626|593372784|FG004|Overall Study|Data Entry Error|0|||
164274067|NCT03343626|593372785|FG005|Overall Study|Data Entry Error|0|||
164274068|NCT03343626|593372786|FG006|Overall Study|Data Entry Error|0|||
164274069|NCT03343626|593372787|FG007|Overall Study|Data Entry Error|1|||
164274070|NCT03592368|593372793|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
164274071|NCT03592368|593372794|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
164274072|NCT03592368|593372795|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
164274073|NCT03592368|593372796|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
164274074|NCT03592368|593372793|FG000|Overall Study|Adverse Event|0|||
164274075|NCT03592368|593372794|FG001|Overall Study|Adverse Event|0|||
164274076|NCT03592368|593372795|FG002|Overall Study|Adverse Event|0|||
164274077|NCT03592368|593372796|FG003|Overall Study|Adverse Event|1|||
164274078|NCT03592368|593372793|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
164274079|NCT03592368|593372794|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
164274080|NCT03592368|593372795|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
164274081|NCT03592368|593372796|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
164274082|NCT00742417|593372798|FG000|Randomized|Withdrawal by legal representative|0|||
164274083|NCT00742417|593372799|FG001|Randomized|Withdrawal by legal representative|1|||
164274084|NCT00742417|593372798|FG000|Randomized|Withdrawal by Subject|1|||
164274085|NCT00742417|593372799|FG001|Randomized|Withdrawal by Subject|0|||
164274086|NCT00742417|593372798|FG000|Randomized|Physician Decision|1|||
164274087|NCT00742417|593372799|FG001|Randomized|Physician Decision|0|||
164274088|NCT00742417|593372798|FG000|Intensive Period|Withdrawal by Subject|1|||
164274089|NCT00742417|593372799|FG001|Intensive Period|Withdrawal by Subject|1|||
164274090|NCT00742417|593372798|FG000|Intensive Period|Adverse Event|2|||
164274091|NCT00742417|593372799|FG001|Intensive Period|Adverse Event|0|||
164274092|NCT00965575|593372804|FG000|Overall Study|subject unwillingness to swallow study c|1|||
164274093|NCT00965575|593372805|FG001|Overall Study|subject unwillingness to swallow study c|0|||
164274094|NCT02814175|593372806|FG000|Part 1|Adverse Event|2|||
164274095|NCT02814175|593372807|FG001|Part 1|Adverse Event|3|||
164274096|NCT02814175|593372808|FG002|Part 1|Adverse Event|0|||
164274097|NCT02814175|593372809|FG003|Part 1|Adverse Event|0|||
164274098|NCT02814175|593372810|FG004|Part 1|Adverse Event|0|||
164274099|NCT02814175|593372811|FG005|Part 1|Adverse Event|0|||
164274100|NCT02814175|593372806|FG000|Part 1|Withdrawal Consent|8|||
164274101|NCT02814175|593372807|FG001|Part 1|Withdrawal Consent|1|||
164274102|NCT02814175|593372808|FG002|Part 1|Withdrawal Consent|0|||
164274103|NCT02814175|593372809|FG003|Part 1|Withdrawal Consent|0|||
164274104|NCT02814175|593372810|FG004|Part 1|Withdrawal Consent|0|||
164274105|NCT02814175|593372811|FG005|Part 1|Withdrawal Consent|0|||
164274106|NCT02814175|593372806|FG000|Part 1|Lost to Follow-up|1|||
164274107|NCT02814175|593372807|FG001|Part 1|Lost to Follow-up|0|||
164274108|NCT02814175|593372808|FG002|Part 1|Lost to Follow-up|0|||
164274109|NCT02814175|593372809|FG003|Part 1|Lost to Follow-up|0|||
164274110|NCT02814175|593372810|FG004|Part 1|Lost to Follow-up|0|||
164689137|NCT02315066|594885485|FG008|Overall Study|Other|1|||
164274111|NCT02814175|593372811|FG005|Part 1|Lost to Follow-up|0|||
164274112|NCT02814175|593372806|FG000|Part 1|Lack of Efficacy|1|||
164274113|NCT02814175|593372807|FG001|Part 1|Lack of Efficacy|2|||
164274114|NCT02814175|593372808|FG002|Part 1|Lack of Efficacy|0|||
164274115|NCT02814175|593372809|FG003|Part 1|Lack of Efficacy|0|||
164274116|NCT02814175|593372810|FG004|Part 1|Lack of Efficacy|0|||
164274117|NCT02814175|593372811|FG005|Part 1|Lack of Efficacy|0|||
164274118|NCT02814175|593372806|FG000|Part 2|Adverse Event|0|||
164274119|NCT02814175|593372807|FG001|Part 2|Adverse Event|0|||
164274120|NCT02814175|593372808|FG002|Part 2|Adverse Event|0|||
164274121|NCT02814175|593372809|FG003|Part 2|Adverse Event|1|||
164274122|NCT02814175|593372810|FG004|Part 2|Adverse Event|1|||
164274123|NCT02814175|593372811|FG005|Part 2|Adverse Event|2|||
164274124|NCT02814175|593372806|FG000|Part 2|Withdrawal Consent|0|||
164274125|NCT02814175|593372807|FG001|Part 2|Withdrawal Consent|0|||
164274126|NCT02814175|593372808|FG002|Part 2|Withdrawal Consent|0|||
164274127|NCT02814175|593372809|FG003|Part 2|Withdrawal Consent|2|||
164274128|NCT02814175|593372810|FG004|Part 2|Withdrawal Consent|1|||
164274129|NCT02814175|593372811|FG005|Part 2|Withdrawal Consent|1|||
164274130|NCT02814175|593372806|FG000|Part 2|Lost to Follow-up|0|||
164274131|NCT02814175|593372807|FG001|Part 2|Lost to Follow-up|0|||
164274132|NCT02814175|593372808|FG002|Part 2|Lost to Follow-up|0|||
164274133|NCT02814175|593372809|FG003|Part 2|Lost to Follow-up|1|||
164274134|NCT02814175|593372810|FG004|Part 2|Lost to Follow-up|0|||
164274135|NCT02814175|593372811|FG005|Part 2|Lost to Follow-up|0|||
164274136|NCT02814175|593372806|FG000|Part 2|Lack of Efficacy|0|||
164274137|NCT02814175|593372807|FG001|Part 2|Lack of Efficacy|0|||
164274138|NCT02814175|593372808|FG002|Part 2|Lack of Efficacy|0|||
164274139|NCT02814175|593372809|FG003|Part 2|Lack of Efficacy|0|||
164274140|NCT02814175|593372810|FG004|Part 2|Lack of Efficacy|0|||
164274141|NCT02814175|593372811|FG005|Part 2|Lack of Efficacy|3|||
164274142|NCT04207749|593372814|FG000|Overall Study|Lost to Follow-up|0|||
164274143|NCT04207749|593372815|FG001|Overall Study|Lost to Follow-up|2|||
164274144|NCT04207749|593372814|FG000|Overall Study|Protocol Violation|0|||
164274145|NCT04207749|593372815|FG001|Overall Study|Protocol Violation|1|||
164274146|NCT04207749|593372814|FG000|Overall Study|Withdrawal by Subject|3|||
164274147|NCT04207749|593372815|FG001|Overall Study|Withdrawal by Subject|0|||
164274148|NCT04207749|593372814|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
164274149|NCT04207749|593372815|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
164274150|NCT00655629|593372816|FG000|Overall Study|Adverse Event|4|||
164274151|NCT00655629|593372817|FG001|Overall Study|Adverse Event|1|||
164274152|NCT00655629|593372816|FG000|Overall Study|Lack of Efficacy|2|||
164274153|NCT00655629|593372817|FG001|Overall Study|Lack of Efficacy|12|||
164274154|NCT00655629|593372816|FG000|Overall Study|Lost to Follow-up|4|||
164274155|NCT00655629|593372817|FG001|Overall Study|Lost to Follow-up|3|||
164274156|NCT00655629|593372816|FG000|Overall Study|Protocol Violation|5|||
164274157|NCT00655629|593372817|FG001|Overall Study|Protocol Violation|3|||
164274158|NCT00655629|593372816|FG000|Overall Study|consent withdrawn|6|||
164274159|NCT00655629|593372817|FG001|Overall Study|consent withdrawn|4|||
164274160|NCT00741013|593372818|FG000|Overall Study|Adverse Event|1|||
164274161|NCT00741013|593372819|FG001|Overall Study|Adverse Event|0|||
164274162|NCT00741013|593372820|FG002|Overall Study|Adverse Event|0|||
164274163|NCT00741013|593372818|FG000|Overall Study|Withdrawal by Subject|0|||
164274164|NCT00741013|593372819|FG001|Overall Study|Withdrawal by Subject|0|||
164274165|NCT00741013|593372820|FG002|Overall Study|Withdrawal by Subject|1|||
164274166|NCT00741013|593372818|FG000|Overall Study|Discovered failed screen after enrolled|0|||
164274167|NCT00741013|593372819|FG001|Overall Study|Discovered failed screen after enrolled|2|||
164274168|NCT00741013|593372820|FG002|Overall Study|Discovered failed screen after enrolled|0|||
164274169|NCT01754493|593372821|FG000|Overall Study|Adverse Event|1|||
164274170|NCT01754493|593372821|FG000|Overall Study|Lost to Follow-up|3|||
164274171|NCT01754493|593372821|FG000|Overall Study|Withdrawal by Subject|1|||
164274172|NCT01754493|593372821|FG000|Overall Study|Moved out of town|1|||
164274173|NCT01754493|593372821|FG000|Overall Study|Scheduling conflict|1|||
164274174|NCT01425632|593372822|FG000|Overall Study|Adverse Event|0|||
164274175|NCT01425632|593372823|FG001|Overall Study|Adverse Event|1|||
164274176|NCT01425632|593372824|FG002|Overall Study|Adverse Event|1|||
164274177|NCT01425632|593372822|FG000|Overall Study|Physician Decision|1|||
164274178|NCT01425632|593372823|FG001|Overall Study|Physician Decision|0|||
164274179|NCT01425632|593372824|FG002|Overall Study|Physician Decision|0|||
164274180|NCT01425632|593372822|FG000|Overall Study|Protocol Violation|0|||
164274181|NCT01425632|593372823|FG001|Overall Study|Protocol Violation|0|||
164274182|NCT01425632|593372824|FG002|Overall Study|Protocol Violation|2|||
164274183|NCT01425632|593372822|FG000|Overall Study|Withdrawal by Subject|0|||
164274184|NCT01425632|593372823|FG001|Overall Study|Withdrawal by Subject|0|||
164274185|NCT01425632|593372824|FG002|Overall Study|Withdrawal by Subject|1|||
164274186|NCT03461146|593372825|FG000|Overall Study|Adverse Event|2|||
164274187|NCT03461146|593372825|FG000|Overall Study|Physician Decision|1|||
164274188|NCT02140047|593372826|FG000|Overall Study|Withdrawal by parent/guardian|1|||
164274189|NCT02140047|593372827|FG001|Overall Study|Withdrawal by parent/guardian|1|||
164274190|NCT02140047|593372828|FG002|Overall Study|Withdrawal by parent/guardian|0|||
164342714|NCT02954237|593631497|FG000|Overall Study|Death|2|||
164342715|NCT01034631|593631498|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
164342716|NCT01034631|593631499|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
164342717|NCT01034631|593631500|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
164342718|NCT01034631|593631498|FG000|Phase II|Not Evaluable per protocol|0|||
164342719|NCT01034631|593631499|FG001|Phase II|Not Evaluable per protocol|0|||
164342720|NCT01034631|593631500|FG002|Phase II|Not Evaluable per protocol|2|||
164342721|NCT01034631|593631498|FG000|Phase II|Determined Ineligible per protocol|0|||
164342722|NCT01034631|593631499|FG001|Phase II|Determined Ineligible per protocol|1|||
164342723|NCT01034631|593631500|FG002|Phase II|Determined Ineligible per protocol|0|||
164342724|NCT04218695|593631501|FG000|Overall Study|Adverse Event|1|||
164342725|NCT04218695|593631502|FG001|Overall Study|Adverse Event|0|||
164342726|NCT03166735|593631503|FG000|Overall Study|Not Treated|1|||
164431132|NCT02939183|593949378|FG003|Overall Study|Sponsor decision|1|||
164431133|NCT02939183|593949379|FG004|Overall Study|Sponsor decision|2|||
164431134|NCT02939183|593949380|FG005|Overall Study|Sponsor decision|0|||
164431135|NCT02939183|593949381|FG006|Overall Study|Sponsor decision|3|||
164431136|NCT02939183|593949382|FG007|Overall Study|Sponsor decision|1|||
164431137|NCT02939183|593949383|FG008|Overall Study|Sponsor decision|4|||
164431138|NCT02939183|593949375|FG000|Overall Study|Withdrawal by Subject|0|||
164431139|NCT02939183|593949376|FG001|Overall Study|Withdrawal by Subject|2|||
164431140|NCT02939183|593949377|FG002|Overall Study|Withdrawal by Subject|0|||
164431141|NCT02939183|593949378|FG003|Overall Study|Withdrawal by Subject|1|||
164431142|NCT02939183|593949379|FG004|Overall Study|Withdrawal by Subject|0|||
164431143|NCT02939183|593949380|FG005|Overall Study|Withdrawal by Subject|0|||
164431144|NCT02939183|593949381|FG006|Overall Study|Withdrawal by Subject|2|||
164431145|NCT02939183|593949382|FG007|Overall Study|Withdrawal by Subject|2|||
164431146|NCT02939183|593949383|FG008|Overall Study|Withdrawal by Subject|2|||
164431147|NCT02939183|593949375|FG000|Overall Study|Not treated due to adverse event|0|||
164431148|NCT02939183|593949376|FG001|Overall Study|Not treated due to adverse event|0|||
164431149|NCT02939183|593949377|FG002|Overall Study|Not treated due to adverse event|0|||
164431150|NCT02939183|593949378|FG003|Overall Study|Not treated due to adverse event|1|||
164431151|NCT02939183|593949379|FG004|Overall Study|Not treated due to adverse event|0|||
164431152|NCT02939183|593949380|FG005|Overall Study|Not treated due to adverse event|0|||
164431153|NCT02939183|593949381|FG006|Overall Study|Not treated due to adverse event|1|||
164431154|NCT02939183|593949382|FG007|Overall Study|Not treated due to adverse event|0|||
164431155|NCT02939183|593949383|FG008|Overall Study|Not treated due to adverse event|0|||
164431156|NCT04939428|593949384|FG000|Overall Study|Death|0|||
164431157|NCT04939428|593949385|FG001|Overall Study|Death|1|||
164431158|NCT04939428|593949386|FG002|Overall Study|Death|0|||
164431159|NCT04939428|593949384|FG000|Overall Study|Lost to Follow-up|0|||
164431160|NCT04939428|593949385|FG001|Overall Study|Lost to Follow-up|5|||
164431161|NCT04939428|593949386|FG002|Overall Study|Lost to Follow-up|0|||
164431162|NCT04939428|593949384|FG000|Overall Study|Physician Decision|1|||
164431163|NCT04939428|593949385|FG001|Overall Study|Physician Decision|0|||
164431164|NCT04939428|593949386|FG002|Overall Study|Physician Decision|0|||
164431165|NCT04939428|593949384|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
164431166|NCT04939428|593949385|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164431167|NCT04939428|593949386|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164431168|NCT04939428|593949384|FG000|Overall Study|Withdrawal by Subject|10|||
164431169|NCT04939428|593949385|FG001|Overall Study|Withdrawal by Subject|11|||
164431170|NCT04939428|593949386|FG002|Overall Study|Withdrawal by Subject|0|||
164431171|NCT04939428|593949384|FG000|Overall Study|Unkown|6|||
164431172|NCT04939428|593949385|FG001|Overall Study|Unkown|3|||
164431173|NCT04939428|593949386|FG002|Overall Study|Unkown|0|||
164431174|NCT04939428|593949384|FG000|Overall Study|Discotinued per protocol|0|||
164431175|NCT04939428|593949385|FG001|Overall Study|Discotinued per protocol|0|||
164583110|NCT01359982|594499698|FG005|Overall Study|Death|0|||
164583111|NCT05593432|594499699|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
164342727|NCT03166735|593631504|FG001|Overall Study|Not Treated|0|||
164342728|NCT03166735|593631505|FG002|Overall Study|Not Treated|0|||
164431176|NCT04939428|593949386|FG002|Overall Study|Discotinued per protocol|902|||
164431177|NCT00235495|593949388|FG000|Overall Study|Death|52|||
164431178|NCT00235495|593949389|FG001|Overall Study|Death|42|||
164431179|NCT00235495|593949388|FG000|Overall Study|Withdrawal by Subject|5|||
164431180|NCT00235495|593949389|FG001|Overall Study|Withdrawal by Subject|3|||
164431181|NCT00235495|593949388|FG000|Overall Study|Lost to Follow-up|11|||
164431182|NCT00235495|593949389|FG001|Overall Study|Lost to Follow-up|13|||
164431183|NCT00235495|593949388|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
164431184|NCT00235495|593949389|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
164431185|NCT04523181|593949393|FG000|Overall Study|Withdrawal by Subject|4|||
164583112|NCT05593432|594499700|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
164342729|NCT03166735|593631506|FG003|Overall Study|Not Treated|0|||
164342730|NCT03166735|593631507|FG004|Overall Study|Not Treated|0|||
164431186|NCT04523181|593949394|FG001|Overall Study|Withdrawal by Subject|5|||
164342731|NCT03166735|593631503|FG000|Overall Study|follow-up not completed as planned|0|||
164274191|NCT02702414|593372829|FG000|Overall Study|Death|96|||
164274192|NCT02702414|593372830|FG001|Overall Study|Death|42|||
164274193|NCT02702414|593372829|FG000|Overall Study|Lost to Follow-up|0|||
164274194|NCT02702414|593372830|FG001|Overall Study|Lost to Follow-up|1|||
164274195|NCT02702414|593372829|FG000|Overall Study|Withdrawal by Subject|0|||
164274196|NCT02702414|593372830|FG001|Overall Study|Withdrawal by Subject|1|||
164274197|NCT02702414|593372829|FG000|Overall Study|Protocol Violation|1|||
164274198|NCT02702414|593372830|FG001|Overall Study|Protocol Violation|0|||
164274199|NCT02702414|593372829|FG000|Overall Study|Sponsor Decision|8|||
164274200|NCT02702414|593372830|FG001|Overall Study|Sponsor Decision|7|||
164274201|NCT04541628|593372831|FG000|Overall Study|Study Terminated|1|||
164274202|NCT04541628|593372832|FG001|Overall Study|Study Terminated|1|||
164274203|NCT04541628|593372833|FG002|Overall Study|Study Terminated|1|||
164274204|NCT01452919|593372837|FG000|Open-Label Treatment|Adverse Event|5|||
164274205|NCT01452919|593372838|FG001|Open-Label Treatment|Adverse Event|0|||
164274206|NCT01452919|593372839|FG002|Open-Label Treatment|Adverse Event|0|||
164274207|NCT01452919|593372837|FG000|Open-Label Treatment|Lost to Follow-up|4|||
164274208|NCT01452919|593372838|FG001|Open-Label Treatment|Lost to Follow-up|0|||
164274209|NCT01452919|593372839|FG002|Open-Label Treatment|Lost to Follow-up|0|||
164274210|NCT01452919|593372837|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
164274211|NCT01452919|593372838|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
164274212|NCT01452919|593372839|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
164274213|NCT01452919|593372837|FG000|Open-Label Treatment|Protocol Violation|4|||
164274214|NCT01452919|593372838|FG001|Open-Label Treatment|Protocol Violation|0|||
164274215|NCT01452919|593372839|FG002|Open-Label Treatment|Protocol Violation|0|||
164274216|NCT01452919|593372837|FG000|Open-Label Treatment|Sponsor Decision|1|||
164274217|NCT01452919|593372838|FG001|Open-Label Treatment|Sponsor Decision|0|||
164274218|NCT01452919|593372839|FG002|Open-Label Treatment|Sponsor Decision|0|||
164274219|NCT01452919|593372837|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
164274220|NCT01452919|593372838|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
164274221|NCT01452919|593372839|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
164274222|NCT01452919|593372837|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
164274223|NCT01452919|593372838|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
164274224|NCT01452919|593372839|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
164274225|NCT01452919|593372837|FG000|Randomization Treatment|Adverse Event|0|||
164274226|NCT01452919|593372838|FG001|Randomization Treatment|Adverse Event|0|||
164274227|NCT01452919|593372839|FG002|Randomization Treatment|Adverse Event|2|||
164274228|NCT01452919|593372837|FG000|Randomization Treatment|Sponsor Decision|0|||
164274229|NCT01452919|593372838|FG001|Randomization Treatment|Sponsor Decision|1|||
164274230|NCT01452919|593372839|FG002|Randomization Treatment|Sponsor Decision|0|||
164274231|NCT01452919|593372837|FG000|Randomization Treatment|Withdrawal by Subject|0|||
164274232|NCT01452919|593372838|FG001|Randomization Treatment|Withdrawal by Subject|1|||
164274233|NCT01452919|593372839|FG002|Randomization Treatment|Withdrawal by Subject|0|||
164274234|NCT01452919|593372837|FG000|Randomization Treatment|Subject is moving or has moved|0|||
164274235|NCT01452919|593372838|FG001|Randomization Treatment|Subject is moving or has moved|1|||
164274236|NCT01452919|593372839|FG002|Randomization Treatment|Subject is moving or has moved|0|||
164274237|NCT00859937|593372840|FG000|Overall Study|Protocol Violation|1|||
164274238|NCT00859937|593372841|FG001|Overall Study|Protocol Violation|0|||
164274239|NCT00151476|593372842|FG000|FAP Identified Subjects|Protocol Violation|0|||
164274240|NCT00151476|593372843|FG001|FAP Identified Subjects|Protocol Violation|1|||
164274241|NCT00151476|593372842|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
164274242|NCT00151476|593372843|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
164342732|NCT03166735|593631504|FG001|Overall Study|follow-up not completed as planned|1|||
164342733|NCT03166735|593631505|FG002|Overall Study|follow-up not completed as planned|1|||
164342734|NCT03166735|593631506|FG003|Overall Study|follow-up not completed as planned|0|||
164342735|NCT03166735|593631507|FG004|Overall Study|follow-up not completed as planned|1|||
164342736|NCT03166735|593631503|FG000|Overall Study|Withdrawal by Subject|0|||
164342737|NCT03166735|593631504|FG001|Overall Study|Withdrawal by Subject|0|||
164342738|NCT03166735|593631505|FG002|Overall Study|Withdrawal by Subject|1|||
164342739|NCT03166735|593631506|FG003|Overall Study|Withdrawal by Subject|1|||
164342740|NCT03166735|593631507|FG004|Overall Study|Withdrawal by Subject|2|||
164274243|NCT00151476|593372842|FG000|FAP Analyzed Subjects|Other study participation|0|||
164274244|NCT00151476|593372843|FG001|FAP Analyzed Subjects|Other study participation|1|||
164274245|NCT03446456|593372844|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
164342741|NCT03166735|593631503|FG000|Overall Study|Lost to Follow-up|0|||
164342742|NCT03166735|593631504|FG001|Overall Study|Lost to Follow-up|2|||
164342743|NCT03166735|593631505|FG002|Overall Study|Lost to Follow-up|1|||
164274246|NCT03446456|593372845|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
164274247|NCT03446456|593372844|FG000|Overall Study|Lost to Follow-up|1|||
164274248|NCT03446456|593372845|FG001|Overall Study|Lost to Follow-up|3|||
164274249|NCT03446456|593372844|FG000|Overall Study|Participant failed the toxicology test|1|||
164342744|NCT03166735|593631506|FG003|Overall Study|Lost to Follow-up|0|||
164342745|NCT03166735|593631507|FG004|Overall Study|Lost to Follow-up|1|||
164342746|NCT00799383|593631508|FG000|Overall Study|Protocol Violation|1|||
164689138|NCT02315066|594885486|FG009|Overall Study|Other|2|||
164689139|NCT02315066|594885487|FG010|Overall Study|Other|0|||
164689140|NCT02315066|594885488|FG011|Overall Study|Other|0|||
164689141|NCT02315066|594885489|FG012|Overall Study|Other|0|||
164689142|NCT02315066|594885490|FG013|Overall Study|Other|0|||
164689143|NCT02315066|594885477|FG000|Overall Study|Subject refused further follow-up|0|||
164689144|NCT02315066|594885478|FG001|Overall Study|Subject refused further follow-up|2|||
164689145|NCT02315066|594885479|FG002|Overall Study|Subject refused further follow-up|2|||
164689146|NCT02315066|594885480|FG003|Overall Study|Subject refused further follow-up|0|||
164689147|NCT02315066|594885481|FG004|Overall Study|Subject refused further follow-up|0|||
164689148|NCT02315066|594885482|FG005|Overall Study|Subject refused further follow-up|0|||
164689149|NCT02315066|594885483|FG006|Overall Study|Subject refused further follow-up|2|||
164689150|NCT02315066|594885484|FG007|Overall Study|Subject refused further follow-up|3|||
164689151|NCT02315066|594885485|FG008|Overall Study|Subject refused further follow-up|0|||
164689152|NCT02315066|594885486|FG009|Overall Study|Subject refused further follow-up|1|||
164689153|NCT02315066|594885487|FG010|Overall Study|Subject refused further follow-up|1|||
164689154|NCT02315066|594885488|FG011|Overall Study|Subject refused further follow-up|2|||
164689155|NCT02315066|594885489|FG012|Overall Study|Subject refused further follow-up|2|||
164689156|NCT02315066|594885490|FG013|Overall Study|Subject refused further follow-up|4|||
164689157|NCT02315066|594885477|FG000|Overall Study|Study ongoing at date of cut-off|0|||
164689158|NCT02315066|594885478|FG001|Overall Study|Study ongoing at date of cut-off|0|||
164689159|NCT02315066|594885479|FG002|Overall Study|Study ongoing at date of cut-off|0|||
164689160|NCT02315066|594885480|FG003|Overall Study|Study ongoing at date of cut-off|0|||
164689161|NCT02315066|594885481|FG004|Overall Study|Study ongoing at date of cut-off|0|||
164689162|NCT02315066|594885482|FG005|Overall Study|Study ongoing at date of cut-off|0|||
164689163|NCT02315066|594885483|FG006|Overall Study|Study ongoing at date of cut-off|0|||
164689164|NCT02315066|594885484|FG007|Overall Study|Study ongoing at date of cut-off|0|||
164689165|NCT02315066|594885485|FG008|Overall Study|Study ongoing at date of cut-off|0|||
164689166|NCT02315066|594885486|FG009|Overall Study|Study ongoing at date of cut-off|0|||
164689167|NCT02315066|594885487|FG010|Overall Study|Study ongoing at date of cut-off|0|||
164689168|NCT02315066|594885488|FG011|Overall Study|Study ongoing at date of cut-off|0|||
164274250|NCT03446456|593372845|FG001|Overall Study|Participant failed the toxicology test|0|||
164274251|NCT03446456|593372844|FG000|Overall Study|Break down of the experimental equipment|1|||
164274252|NCT03446456|593372845|FG001|Overall Study|Break down of the experimental equipment|0|||
164274253|NCT00658814|593372850|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
164274254|NCT00658814|593372851|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
164274255|NCT00658814|593372850|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
164274256|NCT00658814|593372851|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
164274257|NCT00658814|593372850|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
164274258|NCT00658814|593372851|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
164274259|NCT00658814|593372850|FG000|Remission Induction Chemotherapy|Death|1|||
164274260|NCT00658814|593372851|FG001|Remission Induction Chemotherapy|Death|4|||
164274261|NCT00658814|593372850|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
164274262|NCT00658814|593372851|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
164274263|NCT00658814|593372850|FG000|Remission Induction Chemotherapy|Not eligible|1|||
164274264|NCT00658814|593372851|FG001|Remission Induction Chemotherapy|Not eligible|2|||
164274265|NCT00658814|593372850|FG000|Consolidation Therapy|Not protocol specified|0|||
164274266|NCT00658814|593372851|FG001|Consolidation Therapy|Not protocol specified|1|||
164274267|NCT00658814|593372850|FG000|Consolidation Therapy|Not eligible|2|||
164274268|NCT00658814|593372851|FG001|Consolidation Therapy|Not eligible|2|||
164274269|NCT00658814|593372850|FG000|Maintenance Therapy|Adverse Event|1|||
164274270|NCT00658814|593372851|FG001|Maintenance Therapy|Adverse Event|1|||
164274271|NCT00658814|593372850|FG000|Maintenance Therapy|Not protocol specified|1|||
164274272|NCT00658814|593372851|FG001|Maintenance Therapy|Not protocol specified|0|||
164274273|NCT00658814|593372850|FG000|Maintenance Therapy|Not eligible|1|||
164274274|NCT00658814|593372851|FG001|Maintenance Therapy|Not eligible|0|||
164274275|NCT04816721|593372854|FG000|Overall Study|Withdrawal by Subject|0|||
164274276|NCT04816721|593372855|FG001|Overall Study|Withdrawal by Subject|2|||
164274277|NCT04816721|593372856|FG002|Overall Study|Withdrawal by Subject|0|||
164274278|NCT04816721|593372857|FG003|Overall Study|Withdrawal by Subject|1|||
164274279|NCT04816721|593372858|FG004|Overall Study|Withdrawal by Subject|1|||
164274280|NCT04816721|593372859|FG005|Overall Study|Withdrawal by Subject|0|||
164274281|NCT04816721|593372860|FG006|Overall Study|Withdrawal by Subject|0|||
164274282|NCT04816721|593372861|FG007|Overall Study|Withdrawal by Subject|0|||
164274283|NCT04816721|593372854|FG000|Overall Study|Miscellaneous|0|||
164274284|NCT04816721|593372855|FG001|Overall Study|Miscellaneous|0|||
164274285|NCT04816721|593372856|FG002|Overall Study|Miscellaneous|0|||
164274286|NCT04816721|593372857|FG003|Overall Study|Miscellaneous|0|||
164689169|NCT02315066|594885489|FG012|Overall Study|Study ongoing at date of cut-off|0|||
164689170|NCT02315066|594885490|FG013|Overall Study|Study ongoing at date of cut-off|1|||
164689171|NCT05148299|594885492|FG000|Treatment Period|Adverse Event|1|||
164689172|NCT05148299|594885492|FG000|Treatment Period|Physician Decision|1|||
164689173|NCT05148299|594885492|FG000|Treatment Period|Death|1|||
164274287|NCT04816721|593372858|FG004|Overall Study|Miscellaneous|0|||
164274288|NCT04816721|593372859|FG005|Overall Study|Miscellaneous|1|||
164274289|NCT04816721|593372860|FG006|Overall Study|Miscellaneous|0|||
164274290|NCT04816721|593372861|FG007|Overall Study|Miscellaneous|0|||
164274291|NCT04816721|593372854|FG000|Overall Study|Lost to Follow-up|0|||
164274292|NCT04816721|593372855|FG001|Overall Study|Lost to Follow-up|0|||
164274293|NCT04816721|593372856|FG002|Overall Study|Lost to Follow-up|0|||
164274294|NCT04816721|593372857|FG003|Overall Study|Lost to Follow-up|1|||
164274295|NCT04816721|593372858|FG004|Overall Study|Lost to Follow-up|0|||
164274296|NCT04816721|593372859|FG005|Overall Study|Lost to Follow-up|0|||
164274297|NCT04816721|593372860|FG006|Overall Study|Lost to Follow-up|0|||
164274298|NCT04816721|593372861|FG007|Overall Study|Lost to Follow-up|0|||
164274299|NCT00455143|593372862|FG000|Overall Study|Physician Decision|1|||
164274300|NCT00455143|593372862|FG000|Overall Study|Withdrawal by Subject|1|||
164274301|NCT00455143|593372862|FG000|Overall Study|Staff was not avail to follow patient|2|||
164274302|NCT00455143|593372862|FG000|Overall Study|No longer met Inclusion Criteria|1|||
164274303|NCT00455143|593372862|FG000|Overall Study|Surgical time, staff not available|1|||
164274304|NCT04856904|593372865|FG000|Overall Study|Physician Decision|1|||
164274305|NCT04856904|593372866|FG001|Overall Study|Physician Decision|1|||
164274306|NCT04856904|593372865|FG000|Overall Study|Withdrawal by Subject|13|||
164274307|NCT04856904|593372866|FG001|Overall Study|Withdrawal by Subject|13|||
164274308|NCT04856904|593372865|FG000|Overall Study|Adverse Event|1|||
164274309|NCT04856904|593372866|FG001|Overall Study|Adverse Event|1|||
164274310|NCT04856904|593372865|FG000|Overall Study|Non-compliance with study drug|1|||
164274311|NCT04856904|593372866|FG001|Overall Study|Non-compliance with study drug|1|||
164274312|NCT04856904|593372865|FG000|Overall Study|Lost to Follow-up|4|||
164274313|NCT04856904|593372866|FG001|Overall Study|Lost to Follow-up|4|||
164274314|NCT04856904|593372865|FG000|Overall Study|Withdrawal by Subject|1|||
164274315|NCT04856904|593372866|FG001|Overall Study|Withdrawal by Subject|1|||
164274316|NCT04856904|593372865|FG000|Overall Study|Protocol Violation|1|||
164274317|NCT04856904|593372866|FG001|Overall Study|Protocol Violation|1|||
164274318|NCT00847015|593372867|FG000|Overall Study|Withdrawal by Subject|1|||
164274319|NCT00847015|593372867|FG000|Overall Study|declined any surgery|1|||
164274320|NCT00847015|593372867|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
164274321|NCT01641822|593372868|FG000|Run-in Phase|Noncompliance with study drug|1|||
164274322|NCT01641822|593372869|FG001|Run-in Phase|Noncompliance with study drug|0|||
164274323|NCT01641822|593372870|FG002|Run-in Phase|Noncompliance with study drug|0|||
164274324|NCT01641822|593372868|FG000|Run-in Phase|Adverse Event|3|||
164274325|NCT01641822|593372869|FG001|Run-in Phase|Adverse Event|0|||
164274326|NCT01641822|593372870|FG002|Run-in Phase|Adverse Event|0|||
164274327|NCT01641822|593372868|FG000|Run-in Phase|Withdrew consent|1|||
164274328|NCT01641822|593372869|FG001|Run-in Phase|Withdrew consent|0|||
164274329|NCT01641822|593372870|FG002|Run-in Phase|Withdrew consent|0|||
164274330|NCT01641822|593372868|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
164274331|NCT01641822|593372869|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
164274332|NCT01641822|593372870|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
164274333|NCT01641822|593372868|FG000|Comparative Phase|Noncompliance with study drug|0|||
164274334|NCT01641822|593372869|FG001|Comparative Phase|Noncompliance with study drug|1|||
164274335|NCT01641822|593372870|FG002|Comparative Phase|Noncompliance with study drug|0|||
164274336|NCT01641822|593372868|FG000|Comparative Phase|Investigator's discretion|0|||
164274337|NCT01641822|593372869|FG001|Comparative Phase|Investigator's discretion|0|||
164274338|NCT01641822|593372870|FG002|Comparative Phase|Investigator's discretion|1|||
164274339|NCT01641822|593372868|FG000|Comparative Phase|Pregnancy|0|||
164274340|NCT01641822|593372869|FG001|Comparative Phase|Pregnancy|0|||
164274341|NCT01641822|593372870|FG002|Comparative Phase|Pregnancy|1|||
164274342|NCT01641822|593372868|FG000|Comparative Phase|Adverse event, serious fatal|0|||
164274343|NCT01641822|593372869|FG001|Comparative Phase|Adverse event, serious fatal|1|||
164274344|NCT01641822|593372870|FG002|Comparative Phase|Adverse event, serious fatal|0|||
164274345|NCT01641822|593372868|FG000|Comparative Phase|Withdrew consent|0|||
164342747|NCT00799383|593631509|FG001|Overall Study|Protocol Violation|1|||
164342748|NCT00799383|593631508|FG000|Overall Study|Adverse Event|0|||
164342749|NCT00799383|593631509|FG001|Overall Study|Adverse Event|1|||
164274346|NCT01641822|593372869|FG001|Comparative Phase|Withdrew consent|3|||
164274347|NCT01641822|593372870|FG002|Comparative Phase|Withdrew consent|7|||
164342750|NCT00799383|593631508|FG000|Overall Study|Lost to Follow-up|1|||
164342751|NCT00799383|593631509|FG001|Overall Study|Lost to Follow-up|2|||
164342752|NCT00799383|593631508|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
164274348|NCT01641822|593372868|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
164274349|NCT01641822|593372869|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
164274350|NCT01641822|593372870|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
164274351|NCT02760810|593372871|FG000|Overall Study|Protocol Violation|1|||
164274352|NCT03847909|593372874|FG000|Overall Study|Withdrawal by Subject|1|||
164274353|NCT03847909|593372875|FG001|Overall Study|Withdrawal by Subject|1|||
164274354|NCT00869401|593372876|FG000|Overall Study|Withdrawal by Subject|0|||
164342753|NCT00799383|593631509|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
164274355|NCT00869401|593372877|FG001|Overall Study|Withdrawal by Subject|0|||
164274356|NCT00869401|593372878|FG002|Overall Study|Withdrawal by Subject|0|||
164274357|NCT00869401|593372879|FG003|Overall Study|Withdrawal by Subject|5|||
164274358|NCT00869401|593372880|FG004|Overall Study|Withdrawal by Subject|3|||
164274359|NCT00581360|593372881|FG000|Overall Study|Withdrawal by Subject|1|||
164274360|NCT00082381|593372882|FG000|Overall Study|Adverse Event|27|||
164274361|NCT00082381|593372883|FG001|Overall Study|Adverse Event|2|||
164274362|NCT00082381|593372882|FG000|Overall Study|Lost to Follow-up|5|||
164274363|NCT00082381|593372883|FG001|Overall Study|Lost to Follow-up|7|||
164274364|NCT00082381|593372882|FG000|Overall Study|Patient Decision|8|||
164274365|NCT00082381|593372883|FG001|Overall Study|Patient Decision|4|||
164274366|NCT00082381|593372882|FG000|Overall Study|Physician Decision|1|||
164274367|NCT00082381|593372883|FG001|Overall Study|Physician Decision|2|||
164274368|NCT00082381|593372882|FG000|Overall Study|Protocol Violation|10|||
164274369|NCT00082381|593372883|FG001|Overall Study|Protocol Violation|11|||
164274370|NCT00082381|593372882|FG000|Overall Study|Loss of Glucose Control|4|||
164274371|NCT00082381|593372883|FG001|Overall Study|Loss of Glucose Control|0|||
164274372|NCT02345330|593372885|FG000|Overall Study|Death|1|||
164274373|NCT02345330|593372885|FG000|Overall Study|Progressive Disease|2|||
164274374|NCT00109577|593372888|FG000|Overall Study|Withdrawal by Subject|3|||
164274375|NCT00109577|593372889|FG001|Overall Study|Withdrawal by Subject|3|||
164274376|NCT03322423|593372890|FG000|Period 1|Subject no longer eligible|0|||
164274377|NCT03322423|593372891|FG001|Period 1|Subject no longer eligible|1|||
164274378|NCT03322423|593372890|FG000|Period 1|Withdrawal by Subject|0|||
164274379|NCT03322423|593372891|FG001|Period 1|Withdrawal by Subject|1|||
164274380|NCT03322423|593372890|FG000|Period 1|Incorrect Lens Dispensed|1|||
164274381|NCT03322423|593372891|FG001|Period 1|Incorrect Lens Dispensed|0|||
164274382|NCT03322423|593372890|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
164274383|NCT03322423|593372891|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
164274384|NCT03322423|593372890|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
164274385|NCT03322423|593372891|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
164274386|NCT03322423|593372890|FG000|Period 2|Protocol Violation|1|||
164274387|NCT03322423|593372891|FG001|Period 2|Protocol Violation|0|||
164274388|NCT03322423|593372890|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
164274389|NCT03322423|593372891|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
164274390|NCT04891107|593372892|FG000|Overall Study|Physician Decision|1|||
164274391|NCT04891107|593372892|FG000|Overall Study|Withdrawal by Subject|1|||
164274392|NCT04891107|593372892|FG000|Overall Study|Screen failure after consent|1|||
164431187|NCT04523181|593949393|FG000|Overall Study|Lost to Follow-up|2|||
164431188|NCT04523181|593949394|FG001|Overall Study|Lost to Follow-up|3|||
164431189|NCT04523181|593949393|FG000|Overall Study|Physician Decision|1|||
164431190|NCT04523181|593949394|FG001|Overall Study|Physician Decision|0|||
164431191|NCT04523181|593949393|FG000|Overall Study|Transferred to external facility.|1|||
164431192|NCT04523181|593949394|FG001|Overall Study|Transferred to external facility.|1|||
164431193|NCT01268566|593949401|FG000|Overall Study|Lost to Follow-up|1|||
164431194|NCT01268566|593949401|FG000|Overall Study|Withdrawal by Subject|12|||
164431195|NCT01268566|593949401|FG000|Overall Study|Death|30|||
164583113|NCT05593432|594499701|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
164583114|NCT05593432|594499702|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
164583115|NCT05593432|594499699|FG000|16-Week OLE Period|Lack of Efficacy|0|||
164583116|NCT05593432|594499700|FG001|16-Week OLE Period|Lack of Efficacy|0|||
164583117|NCT05593432|594499701|FG002|16-Week OLE Period|Lack of Efficacy|0|||
164583118|NCT05593432|594499702|FG003|16-Week OLE Period|Lack of Efficacy|1|||
164583119|NCT05593432|594499699|FG000|16-Week OLE Period|Lost to Follow-up|0|||
164689174|NCT05148299|594885492|FG000|Follow-up Period|Death|3|||
164689175|NCT02161549|594885493|FG000|Overall Study|Physician Decision|6|||
164689176|NCT02161549|594885494|FG001|Overall Study|Physician Decision|2|||
164274393|NCT02453555|593372893|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
164274394|NCT02453555|593372894|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
164274395|NCT02453555|593372895|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
164274396|NCT02453555|593372896|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
164274397|NCT02453555|593372897|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
164274398|NCT02453555|593372898|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
164274399|NCT02453555|593372893|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
164274400|NCT02453555|593372894|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
164274401|NCT02453555|593372895|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
164583120|NCT05593432|594499700|FG001|16-Week OLE Period|Lost to Follow-up|0|||
164274402|NCT02453555|593372896|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
164274403|NCT02453555|593372897|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
164274404|NCT02453555|593372898|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
164431196|NCT02042443|593949402|FG000|Overall Study|Adverse Event|2|||
164431197|NCT02042443|593949403|FG001|Overall Study|Adverse Event|1|||
164431198|NCT02042443|593949402|FG000|Overall Study|Withdrawal by Subject|0|||
164583121|NCT05593432|594499701|FG002|16-Week OLE Period|Lost to Follow-up|1|||
164274405|NCT02453555|593372893|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
164274406|NCT02453555|593372894|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
164274407|NCT02453555|593372895|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
164274408|NCT02453555|593372896|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
164274409|NCT02453555|593372897|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
164274410|NCT02453555|593372898|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
164274411|NCT02453555|593372893|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
164274412|NCT02453555|593372894|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
164274413|NCT02453555|593372895|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
164274414|NCT02453555|593372896|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
164274415|NCT02453555|593372897|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
164274416|NCT02453555|593372898|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
164274417|NCT02453555|593372893|FG000|Extension Period|Adverse Event|0|||
164274418|NCT02453555|593372894|FG001|Extension Period|Adverse Event|0|||
164274419|NCT02453555|593372895|FG002|Extension Period|Adverse Event|1|||
164274420|NCT02453555|593372896|FG003|Extension Period|Adverse Event|2|||
164274421|NCT02453555|593372897|FG004|Extension Period|Adverse Event|1|||
164274422|NCT02453555|593372898|FG005|Extension Period|Adverse Event|1|||
164274423|NCT02453555|593372893|FG000|Extension Period|Protocol Violation|0|||
164274424|NCT02453555|593372894|FG001|Extension Period|Protocol Violation|0|||
164274425|NCT02453555|593372895|FG002|Extension Period|Protocol Violation|1|||
164274426|NCT02453555|593372896|FG003|Extension Period|Protocol Violation|0|||
164274427|NCT02453555|593372897|FG004|Extension Period|Protocol Violation|0|||
164274428|NCT02453555|593372898|FG005|Extension Period|Protocol Violation|0|||
164274429|NCT02453555|593372893|FG000|Extension Period|Withdrawal by Subject|0|||
164274430|NCT02453555|593372894|FG001|Extension Period|Withdrawal by Subject|0|||
164274431|NCT02453555|593372895|FG002|Extension Period|Withdrawal by Subject|1|||
164274432|NCT02453555|593372896|FG003|Extension Period|Withdrawal by Subject|0|||
164274433|NCT02453555|593372897|FG004|Extension Period|Withdrawal by Subject|0|||
164342754|NCT00799383|593631508|FG000|Overall Study|Withdrawal by Subject|0|||
164342755|NCT00799383|593631509|FG001|Overall Study|Withdrawal by Subject|1|||
164342756|NCT03486223|593631519|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
164342757|NCT03486223|593631520|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
164342758|NCT03068130|593631531|FG000|Overall Study|Adverse Event|19|||
164342759|NCT03068130|593631531|FG000|Overall Study|Death|14|||
164342760|NCT03068130|593631531|FG000|Overall Study|Lost to Follow-up|4|||
164342761|NCT03068130|593631531|FG000|Overall Study|Withdrawal by Subject|26|||
164342762|NCT03068130|593631531|FG000|Overall Study|Administrative Reasons|3|||
164342763|NCT03068130|593631531|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
164342764|NCT03068130|593631531|FG000|Overall Study|Study terminated by sponsor|194|||
164342765|NCT00590720|593631532|FG000|Overall Study|Lost to Follow-up|1|||
164342766|NCT00590720|593631533|FG001|Overall Study|Lost to Follow-up|0|||
164342767|NCT00590720|593631532|FG000|Overall Study|Withdrawal by Subject|0|||
164342768|NCT00590720|593631533|FG001|Overall Study|Withdrawal by Subject|1|||
164342769|NCT03741062|593631538|FG000|Overall Study|Protocol Violation|1|||
164342770|NCT03741062|593631539|FG001|Overall Study|Protocol Violation|0|||
164342771|NCT02527161|593631540|FG000|Overall Study|Failed MRI|52|||
164342772|NCT02527161|593631540|FG000|Overall Study|Withdrawal by Subject|19|||
164342773|NCT02527161|593631540|FG000|Overall Study|Delay in or unfit for surgery|16|||
164342774|NCT02527161|593631540|FG000|Overall Study|MRI contraindication|6|||
164342775|NCT02527161|593631540|FG000|Overall Study|Consent violation|4|||
164342776|NCT02527161|593631540|FG000|Overall Study|Only Recruited to Part A|27|||
164342777|NCT02527161|593631540|FG000|Overall Study|Physician Decision|1|||
164274434|NCT02453555|593372898|FG005|Extension Period|Withdrawal by Subject|0|||
164274435|NCT03689855|593372903|FG000|Overall Study|Adverse Event|3|||
164274436|NCT03689855|593372903|FG000|Overall Study|Withdrawal by Subject|1|||
164274437|NCT03178669|593372904|FG000|Overall Study|Adverse Event|4|||
164274438|NCT03178669|593372905|FG001|Overall Study|Adverse Event|1|||
164274439|NCT03178669|593372906|FG002|Overall Study|Adverse Event|4|||
164274440|NCT03178669|593372907|FG003|Overall Study|Adverse Event|2|||
164342778|NCT02527161|593631540|FG000|Overall Study|Adverse Event|1|||
164342779|NCT02527161|593631540|FG000|Overall Study|Lost to Follow-up|6|||
164342780|NCT02609828|593631541|FG000|Overall Study|Adverse Event|8|||
164342781|NCT02609828|593631542|FG001|Overall Study|Adverse Event|1|||
164274441|NCT03178669|593372908|FG004|Overall Study|Adverse Event|2|||
164274442|NCT03178669|593372904|FG000|Overall Study|Lack of Efficacy|0|||
164274443|NCT03178669|593372905|FG001|Overall Study|Lack of Efficacy|0|||
164274444|NCT03178669|593372906|FG002|Overall Study|Lack of Efficacy|2|||
164274445|NCT03178669|593372907|FG003|Overall Study|Lack of Efficacy|0|||
164274446|NCT03178669|593372908|FG004|Overall Study|Lack of Efficacy|1|||
164342782|NCT02609828|593631543|FG002|Overall Study|Adverse Event|0|||
164342783|NCT02609828|593631544|FG003|Overall Study|Adverse Event|6|||
164342784|NCT02609828|593631541|FG000|Overall Study|Death|15|||
164342785|NCT02609828|593631542|FG001|Overall Study|Death|1|||
164274447|NCT03178669|593372904|FG000|Overall Study|Physician Decision|0|||
164274448|NCT03178669|593372905|FG001|Overall Study|Physician Decision|0|||
164274449|NCT03178669|593372906|FG002|Overall Study|Physician Decision|0|||
164274450|NCT03178669|593372907|FG003|Overall Study|Physician Decision|0|||
164274451|NCT03178669|593372908|FG004|Overall Study|Physician Decision|1|||
164274452|NCT03178669|593372904|FG000|Overall Study|Withdrawal by Subject|1|||
164274453|NCT03178669|593372905|FG001|Overall Study|Withdrawal by Subject|0|||
164274454|NCT03178669|593372906|FG002|Overall Study|Withdrawal by Subject|1|||
164274455|NCT03178669|593372907|FG003|Overall Study|Withdrawal by Subject|1|||
164274456|NCT03178669|593372908|FG004|Overall Study|Withdrawal by Subject|0|||
164274457|NCT03178669|593372904|FG000|Overall Study|Lost to Follow-up|0|||
164274458|NCT03178669|593372905|FG001|Overall Study|Lost to Follow-up|0|||
164274459|NCT03178669|593372906|FG002|Overall Study|Lost to Follow-up|0|||
164274460|NCT03178669|593372907|FG003|Overall Study|Lost to Follow-up|1|||
164274461|NCT03178669|593372908|FG004|Overall Study|Lost to Follow-up|0|||
164274462|NCT02914561|593372909|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
164274463|NCT02914561|593372910|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
164583122|NCT05593432|594499702|FG003|16-Week OLE Period|Lost to Follow-up|2|||
164583123|NCT05593432|594499699|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
164583124|NCT05593432|594499700|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
164583125|NCT05593432|594499701|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
164583126|NCT05593432|594499702|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
164583127|NCT00069121|594499704|FG000|Overall Study|Death|286|||
164583128|NCT00069121|594499705|FG001|Overall Study|Death|242|||
164583129|NCT00069121|594499704|FG000|Overall Study|Withdrawal by Subject|18|||
164583130|NCT00069121|594499705|FG001|Overall Study|Withdrawal by Subject|20|||
164583131|NCT00069121|594499704|FG000|Overall Study|Lost to Follow-up|63|||
164583132|NCT00069121|594499705|FG001|Overall Study|Lost to Follow-up|63|||
164583133|NCT04513158|594499706|FG000|Overall Study|Screen Failure|1|||
164274464|NCT02914561|593372911|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
164583134|NCT05635838|594500927|FG000|16-Week DBVC Period|Adverse Event|2|||
164583135|NCT05635838|594500928|FG001|16-Week DBVC Period|Adverse Event|0|||
164583136|NCT05635838|594500929|FG002|16-Week DBVC Period|Adverse Event|0|||
164583137|NCT05635838|594500930|FG003|16-Week DBVC Period|Adverse Event|0|||
164583138|NCT05635838|594500927|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
164583139|NCT05635838|594500928|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
164583140|NCT05635838|594500929|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
164583141|NCT05635838|594500930|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
164583142|NCT05635838|594500927|FG000|16-Week DBVC Period|Physician Decision|0|||
164583143|NCT05635838|594500928|FG001|16-Week DBVC Period|Physician Decision|1|||
164583144|NCT05635838|594500929|FG002|16-Week DBVC Period|Physician Decision|0|||
164583145|NCT05635838|594500930|FG003|16-Week DBVC Period|Physician Decision|0|||
164583146|NCT05635838|594500927|FG000|16-Week DBVC Period|Protocol Violation|1|||
164583147|NCT05635838|594500928|FG001|16-Week DBVC Period|Protocol Violation|0|||
164583148|NCT05635838|594500929|FG002|16-Week DBVC Period|Protocol Violation|0|||
164583149|NCT05635838|594500930|FG003|16-Week DBVC Period|Protocol Violation|0|||
164583150|NCT05635838|594500927|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
164583151|NCT05635838|594500928|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
164583152|NCT05635838|594500929|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
164583153|NCT05635838|594500930|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
164583154|NCT05635838|594500927|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
164583155|NCT05635838|594500928|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
164583156|NCT05635838|594500929|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
164583157|NCT05635838|594500930|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
164583158|NCT05635838|594500927|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
164583159|NCT05635838|594500928|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
164583160|NCT05635838|594500929|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
164583161|NCT05635838|594500930|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
164583162|NCT05635838|594500927|FG000|16-Week OLE Period|Adverse Event|0|||
164583163|NCT05635838|594500928|FG001|16-Week OLE Period|Adverse Event|0|||
164583164|NCT05635838|594500929|FG002|16-Week OLE Period|Adverse Event|0|||
164583165|NCT05635838|594500930|FG003|16-Week OLE Period|Adverse Event|2|||
164583166|NCT05635838|594500927|FG000|16-Week OLE Period|Lost to Follow-up|0|||
164583167|NCT05635838|594500928|FG001|16-Week OLE Period|Lost to Follow-up|0|||
164583168|NCT05635838|594500929|FG002|16-Week OLE Period|Lost to Follow-up|1|||
164583169|NCT05635838|594500930|FG003|16-Week OLE Period|Lost to Follow-up|3|||
164583170|NCT05635838|594500927|FG000|16-Week OLE Period|Physician Decision|0|||
164583171|NCT05635838|594500928|FG001|16-Week OLE Period|Physician Decision|0|||
164583172|NCT05635838|594500929|FG002|16-Week OLE Period|Physician Decision|0|||
164583173|NCT05635838|594500930|FG003|16-Week OLE Period|Physician Decision|1|||
164583174|NCT05635838|594500927|FG000|16-Week OLE Period|Protocol Violation|0|||
164583175|NCT05635838|594500928|FG001|16-Week OLE Period|Protocol Violation|0|||
164583176|NCT05635838|594500929|FG002|16-Week OLE Period|Protocol Violation|1|||
164583177|NCT05635838|594500930|FG003|16-Week OLE Period|Protocol Violation|1|||
164583178|NCT05635838|594500927|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
164274465|NCT02914561|593372912|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
164274466|NCT02914561|593372913|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
164274467|NCT02914561|593372914|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
164274468|NCT02914561|593372915|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
164274469|NCT02914561|593372916|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
164274470|NCT02914561|593372917|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
164274471|NCT02914561|593372918|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
164274472|NCT02914561|593372919|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
164274473|NCT02914561|593372909|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
164274474|NCT02914561|593372910|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
164274475|NCT02914561|593372911|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
164274476|NCT02914561|593372912|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
164274477|NCT02914561|593372913|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
164274478|NCT02914561|593372914|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
164274479|NCT02914561|593372915|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
164274480|NCT02914561|593372916|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
164274481|NCT02914561|593372917|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
164274482|NCT02914561|593372918|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
164274483|NCT02914561|593372919|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
164274484|NCT02914561|593372909|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
164274485|NCT02914561|593372910|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
164583179|NCT05635838|594500928|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
164583180|NCT05635838|594500929|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
164274486|NCT02914561|593372911|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
164274487|NCT02914561|593372912|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
164274488|NCT02914561|593372913|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
164274489|NCT02914561|593372914|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
164274490|NCT02914561|593372915|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
164274491|NCT02914561|593372916|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
164274492|NCT02914561|593372917|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
164274493|NCT02914561|593372918|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
164274494|NCT02914561|593372919|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
164274495|NCT02914561|593372909|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
164274496|NCT02914561|593372910|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
164274497|NCT02914561|593372911|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
164274498|NCT02914561|593372912|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
164274499|NCT02914561|593372913|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
164274500|NCT02914561|593372914|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
164274501|NCT02914561|593372915|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
164274502|NCT02914561|593372916|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
164274503|NCT02914561|593372917|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
164274504|NCT02914561|593372918|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
164274505|NCT02914561|593372919|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
164274506|NCT02914561|593372909|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
164274507|NCT02914561|593372910|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
164274508|NCT02914561|593372911|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
164274509|NCT02914561|593372912|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
164274510|NCT02914561|593372913|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
164274511|NCT02914561|593372914|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
164274512|NCT02914561|593372915|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
164274513|NCT02914561|593372916|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
164274514|NCT02914561|593372917|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
164274515|NCT02914561|593372918|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
164274516|NCT02914561|593372919|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
164274517|NCT02914561|593372909|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
164274518|NCT02914561|593372910|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
164274519|NCT02914561|593372911|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
164583181|NCT05635838|594500930|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
164583182|NCT05635838|594500927|FG000|16-Week OLE Period|Pregnancy|0|||
164583183|NCT05635838|594500928|FG001|16-Week OLE Period|Pregnancy|0|||
164583184|NCT05635838|594500929|FG002|16-Week OLE Period|Pregnancy|1|||
164583185|NCT05635838|594500930|FG003|16-Week OLE Period|Pregnancy|0|||
164583186|NCT02699515|594500937|FG000|Overall Study|Death|3|||
164583187|NCT02699515|594500938|FG001|Overall Study|Death|3|||
164583188|NCT02699515|594500939|FG002|Overall Study|Death|3|||
164583189|NCT02699515|594500940|FG003|Overall Study|Death|23|||
164583190|NCT02699515|594500941|FG004|Overall Study|Death|22|||
164583191|NCT02699515|594500942|FG005|Overall Study|Death|23|||
164274520|NCT02914561|593372912|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
164274521|NCT02914561|593372913|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
164274522|NCT02914561|593372914|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
164274523|NCT02914561|593372915|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
164274524|NCT02914561|593372916|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
164274525|NCT02914561|593372917|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
164689177|NCT01856192|594885495|FG000|Overall Study|Adverse Event|12|||
164689178|NCT01856192|594885496|FG001|Overall Study|Adverse Event|4|||
164689179|NCT01856192|594885495|FG000|Overall Study|Alternative therapy|0|||
164689180|NCT01856192|594885496|FG001|Overall Study|Alternative therapy|3|||
164689181|NCT01856192|594885495|FG000|Overall Study|Death|3|||
164689182|NCT01856192|594885496|FG001|Overall Study|Death|5|||
164274526|NCT02914561|593372918|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
164274527|NCT02914561|593372919|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
164274528|NCT02914561|593372909|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
164274529|NCT02914561|593372910|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
164274530|NCT02914561|593372911|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
164274531|NCT02914561|593372912|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
164274532|NCT02914561|593372913|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
164274533|NCT02914561|593372914|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
164274534|NCT02914561|593372915|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
164274535|NCT02914561|593372916|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
164274536|NCT02914561|593372917|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
164274537|NCT02914561|593372918|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
164274538|NCT02914561|593372919|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
164274539|NCT02914561|593372909|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
164274540|NCT02914561|593372910|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
164274541|NCT02914561|593372911|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
164274542|NCT02914561|593372912|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
164274543|NCT02914561|593372913|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
164274544|NCT02914561|593372914|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
164274545|NCT02914561|593372915|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
164274546|NCT02914561|593372916|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
164274547|NCT02914561|593372917|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
164274548|NCT02914561|593372918|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
164274549|NCT02914561|593372919|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
164274550|NCT02914561|593372909|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
164274551|NCT02914561|593372910|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
164274552|NCT02914561|593372911|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
164274553|NCT02914561|593372912|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
164274554|NCT02914561|593372913|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
164274555|NCT02914561|593372914|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
164274556|NCT02914561|593372915|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
164274557|NCT02914561|593372916|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
164274558|NCT02914561|593372917|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
164274559|NCT02914561|593372918|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
164274560|NCT02914561|593372919|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
164274561|NCT02914561|593372909|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
164274562|NCT02914561|593372910|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
164274563|NCT02914561|593372911|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
164274564|NCT02914561|593372912|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
164274565|NCT02914561|593372913|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
164274566|NCT02914561|593372914|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
164274567|NCT02914561|593372915|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
164274568|NCT02914561|593372916|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
164274569|NCT02914561|593372917|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
164274570|NCT02914561|593372918|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
164274571|NCT02914561|593372919|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
164274572|NCT02914561|593372909|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
164274573|NCT02914561|593372910|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
164274574|NCT02914561|593372911|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
164274575|NCT02914561|593372912|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
164274576|NCT02914561|593372913|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
164274577|NCT02914561|593372914|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
164342786|NCT02609828|593631543|FG002|Overall Study|Death|1|||
164689183|NCT01856192|594885495|FG000|Overall Study|Lack of Efficacy|0|||
164583192|NCT02699515|594500943|FG006|Overall Study|Death|3|||
164583193|NCT02699515|594500944|FG007|Overall Study|Death|5|||
164583194|NCT02699515|594500937|FG000|Overall Study|Withdrawal by Subject|0|||
164583195|NCT02699515|594500938|FG001|Overall Study|Withdrawal by Subject|0|||
164583196|NCT02699515|594500939|FG002|Overall Study|Withdrawal by Subject|3|||
164583197|NCT02699515|594500940|FG003|Overall Study|Withdrawal by Subject|1|||
164583198|NCT02699515|594500941|FG004|Overall Study|Withdrawal by Subject|5|||
164583199|NCT02699515|594500942|FG005|Overall Study|Withdrawal by Subject|3|||
164583200|NCT02699515|594500943|FG006|Overall Study|Withdrawal by Subject|0|||
164583201|NCT02699515|594500944|FG007|Overall Study|Withdrawal by Subject|1|||
164583202|NCT02699515|594500937|FG000|Overall Study|Other|1|||
164583203|NCT02699515|594500938|FG001|Overall Study|Other|0|||
164583204|NCT02699515|594500939|FG002|Overall Study|Other|1|||
164583205|NCT02699515|594500940|FG003|Overall Study|Other|6|||
164583206|NCT02699515|594500941|FG004|Overall Study|Other|4|||
164583207|NCT02699515|594500942|FG005|Overall Study|Other|3|||
164583208|NCT02699515|594500943|FG006|Overall Study|Other|0|||
164583209|NCT02699515|594500944|FG007|Overall Study|Other|0|||
164583210|NCT05243550|594500945|FG000|Overall Study|Ongoing in the Study|171|||
164583211|NCT05243550|594500945|FG000|Overall Study|Withdrawal by Subject|10|||
164583212|NCT05243550|594500945|FG000|Overall Study|Lost to Follow-up|7|||
164583213|NCT05243550|594500945|FG000|Overall Study|Adverse Event|3|||
164583214|NCT05243550|594500945|FG000|Overall Study|Noncompliance|1|||
164583215|NCT05243550|594500945|FG000|Overall Study|Physician Decision|1|||
164583216|NCT05243550|594500945|FG000|Overall Study|Other Reason|4|||
164583217|NCT02031146|594500948|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
164583218|NCT02031146|594500949|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
164583219|NCT02031146|594500950|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
164583220|NCT02031146|594500951|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
164583221|NCT02031146|594500952|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
164583222|NCT02031146|594500953|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
164583223|NCT02031146|594500954|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
164583224|NCT01486316|594500955|FG000|Overall Study|Device explanted with/without re-implant|3|||
164583225|NCT01486316|594500956|FG001|Overall Study|Device explanted with/without re-implant|2|||
164583226|NCT01486316|594500957|FG002|Overall Study|Device explanted with/without re-implant|0|||
164583227|NCT01486316|594500958|FG003|Overall Study|Device explanted with/without re-implant|2|||
164583228|NCT01486316|594500955|FG000|Overall Study|Not meeting eligibility criteria|0|||
164583229|NCT01486316|594500956|FG001|Overall Study|Not meeting eligibility criteria|0|||
164583230|NCT01486316|594500957|FG002|Overall Study|Not meeting eligibility criteria|1|||
164583231|NCT01486316|594500958|FG003|Overall Study|Not meeting eligibility criteria|0|||
164583232|NCT01486316|594500955|FG000|Overall Study|Withdrawal by Subject|1|||
164583233|NCT01486316|594500956|FG001|Overall Study|Withdrawal by Subject|0|||
164583234|NCT01486316|594500957|FG002|Overall Study|Withdrawal by Subject|3|||
164583235|NCT01486316|594500958|FG003|Overall Study|Withdrawal by Subject|0|||
164583236|NCT01486316|594500955|FG000|Overall Study|Physician Decision|0|||
164583237|NCT01486316|594500956|FG001|Overall Study|Physician Decision|0|||
164583238|NCT01486316|594500957|FG002|Overall Study|Physician Decision|1|||
164583239|NCT01486316|594500958|FG003|Overall Study|Physician Decision|0|||
164583240|NCT01486316|594500955|FG000|Overall Study|Death|0|||
164583241|NCT01486316|594500956|FG001|Overall Study|Death|1|||
164583242|NCT01486316|594500957|FG002|Overall Study|Death|0|||
164583243|NCT01486316|594500958|FG003|Overall Study|Death|0|||
164583244|NCT05094154|594500966|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
164583245|NCT05094154|594500967|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
164583246|NCT05094154|594500966|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
164583247|NCT05094154|594500967|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
164583248|NCT02400346|594500976|FG000|Overall Study|Adverse Event|24|||
164274578|NCT02914561|593372915|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
164274579|NCT02914561|593372916|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
164274580|NCT02914561|593372917|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
164274581|NCT02914561|593372918|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
164583249|NCT02400346|594500976|FG000|Overall Study|Lack of Efficacy|9|||
164583250|NCT02400346|594500976|FG000|Overall Study|Non-compliance with IMP|1|||
164583251|NCT02400346|594500976|FG000|Overall Study|Withdrawal by Subject|7|||
164583252|NCT02400346|594500976|FG000|Overall Study|Administrative or other reason(s)|2|||
164274582|NCT02914561|593372919|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
164583253|NCT02400346|594500976|FG000|Overall Study|Lost to Follow-up|1|||
164583254|NCT03060577|594500977|FG000|Overall Study|Withdrawal by Subject|25|||
164583255|NCT03060577|594500978|FG001|Overall Study|Withdrawal by Subject|5|||
164274583|NCT02914561|593372909|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
164583256|NCT03060577|594500977|FG000|Overall Study|Physician Decision|4|||
164583257|NCT03060577|594500978|FG001|Overall Study|Physician Decision|3|||
164583258|NCT03060577|594500977|FG000|Overall Study|Lost to Follow-up|3|||
164689184|NCT01856192|594885496|FG001|Overall Study|Lack of Efficacy|5|||
164689185|NCT01856192|594885495|FG000|Overall Study|Withdrawal by Subject|1|||
164689186|NCT01856192|594885496|FG001|Overall Study|Withdrawal by Subject|1|||
164689187|NCT01856192|594885495|FG000|Overall Study|Other diseases|1|||
164689188|NCT01856192|594885496|FG001|Overall Study|Other diseases|0|||
164689189|NCT01856192|594885495|FG000|Overall Study|Never started treatment|7|||
164689190|NCT01856192|594885496|FG001|Overall Study|Never started treatment|5|||
164689191|NCT01856192|594885495|FG000|Overall Study|Path ineligible|20|||
164689192|NCT01856192|594885496|FG001|Overall Study|Path ineligible|34|||
164689193|NCT01856192|594885495|FG000|Overall Study|Non-path ineligible|2|||
164689194|NCT01856192|594885496|FG001|Overall Study|Non-path ineligible|2|||
164689195|NCT01856192|594885495|FG000|Overall Study|Physician Decision|1|||
164689196|NCT01856192|594885496|FG001|Overall Study|Physician Decision|1|||
164689197|NCT01856192|594885495|FG000|Overall Study|Suspicion of progressive disease|1|||
164689198|NCT01856192|594885496|FG001|Overall Study|Suspicion of progressive disease|0|||
164689199|NCT01856192|594885495|FG000|Overall Study|Non-compliance|1|||
164689200|NCT01856192|594885496|FG001|Overall Study|Non-compliance|0|||
164689201|NCT04886063|594885499|FG000|Overall Study|Adverse Event|50|||
164689202|NCT04886063|594885499|FG000|Overall Study|Lack of Efficacy|31|||
164689203|NCT04886063|594885499|FG000|Overall Study|Withdrawal by Subject|45|||
164689204|NCT04886063|594885499|FG000|Overall Study|Physician Decision|3|||
164689205|NCT04886063|594885499|FG000|Overall Study|Protocol Violation|3|||
164689206|NCT04886063|594885499|FG000|Overall Study|Site closure|4|||
164689207|NCT04886063|594885499|FG000|Overall Study|Nursing home replacement|3|||
164689208|NCT04886063|594885499|FG000|Overall Study|Lost to Follow-up|5|||
164689209|NCT04886063|594885499|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
164689210|NCT04886063|594885499|FG000|Overall Study|>1 reason|20|||
164689211|NCT02451358|594885500|FG000|Overall Study|Withdrawal by Subject|1|||
164689212|NCT02451358|594885501|FG001|Overall Study|Withdrawal by Subject|1|||
164689213|NCT02451358|594885502|FG002|Overall Study|Withdrawal by Subject|0|||
164689214|NCT02451358|594885503|FG003|Overall Study|Withdrawal by Subject|0|||
164689215|NCT02451358|594885500|FG000|Overall Study|Protocol Violation|0|||
164689216|NCT02451358|594885501|FG001|Overall Study|Protocol Violation|1|||
164689217|NCT02451358|594885502|FG002|Overall Study|Protocol Violation|1|||
164689218|NCT02451358|594885503|FG003|Overall Study|Protocol Violation|0|||
164689219|NCT06128525|594885504|FG000|Overall Study|Patient withdrew consent|1|||
164689220|NCT03414034|594885509|FG000|Overall Study|Adverse Event|6|||
164689221|NCT03414034|594885510|FG001|Overall Study|Adverse Event|1|||
164689222|NCT03414034|594885511|FG002|Overall Study|Adverse Event|1|||
164689223|NCT03414034|594885509|FG000|Overall Study|Death|0|||
164689224|NCT03414034|594885510|FG001|Overall Study|Death|0|||
164689225|NCT03414034|594885511|FG002|Overall Study|Death|1|||
164689226|NCT03414034|594885509|FG000|Overall Study|Non-compliance With Study Drug|0|||
164274584|NCT02914561|593372910|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
164274585|NCT02914561|593372911|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
164274586|NCT02914561|593372912|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
164274587|NCT02914561|593372913|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
164274588|NCT02914561|593372914|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
164274589|NCT02914561|593372915|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
164274590|NCT02914561|593372916|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
164274591|NCT02914561|593372917|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
164274592|NCT02914561|593372918|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
164274593|NCT02914561|593372919|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
164274594|NCT02914561|593372909|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
164274595|NCT02914561|593372910|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
164274596|NCT02914561|593372911|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
164274597|NCT02914561|593372912|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
164274598|NCT02914561|593372913|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
164274599|NCT02914561|593372914|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
164274600|NCT02914561|593372915|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
164274601|NCT02914561|593372916|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
164274602|NCT02914561|593372917|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
164274603|NCT02914561|593372918|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
164274604|NCT02914561|593372919|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
164274605|NCT02914561|593372909|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
164689227|NCT03414034|594885510|FG001|Overall Study|Non-compliance With Study Drug|0|||
164689228|NCT03414034|594885511|FG002|Overall Study|Non-compliance With Study Drug|1|||
164689229|NCT03414034|594885509|FG000|Overall Study|Physician Decision|1|||
164689230|NCT03414034|594885510|FG001|Overall Study|Physician Decision|3|||
164689231|NCT03414034|594885511|FG002|Overall Study|Physician Decision|2|||
164689232|NCT03414034|594885509|FG000|Overall Study|Withdrawal of Informed Consent|2|||
164689233|NCT03414034|594885510|FG001|Overall Study|Withdrawal of Informed Consent|1|||
164689234|NCT03414034|594885511|FG002|Overall Study|Withdrawal of Informed Consent|4|||
164689235|NCT03414034|594885509|FG000|Overall Study|Progressive Disease|15|||
164274606|NCT02914561|593372910|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
164274607|NCT02914561|593372911|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
164274608|NCT02914561|593372912|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
164274609|NCT02914561|593372913|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
164274610|NCT02914561|593372914|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
164274611|NCT02914561|593372915|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
164274612|NCT02914561|593372916|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
164274613|NCT02914561|593372917|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
164274614|NCT02914561|593372918|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
164274615|NCT02914561|593372919|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
164274616|NCT02914561|593372909|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
164274617|NCT02914561|593372910|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
164274618|NCT02914561|593372911|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
164274619|NCT02914561|593372912|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
164274620|NCT02914561|593372913|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
164274621|NCT02914561|593372914|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
164274622|NCT02914561|593372915|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
164274623|NCT02914561|593372916|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
164342787|NCT02609828|593631544|FG003|Overall Study|Death|19|||
164342788|NCT02609828|593631541|FG000|Overall Study|Insufficient clinical response|2|||
164342789|NCT02609828|593631542|FG001|Overall Study|Insufficient clinical response|1|||
164342790|NCT02609828|593631543|FG002|Overall Study|Insufficient clinical response|0|||
164342791|NCT02609828|593631544|FG003|Overall Study|Insufficient clinical response|0|||
164342792|NCT02609828|593631541|FG000|Overall Study|Lost to Follow-up|0|||
164583259|NCT03060577|594500978|FG001|Overall Study|Lost to Follow-up|0|||
164583260|NCT03060577|594500977|FG000|Overall Study|Death|7|||
164583261|NCT03060577|594500978|FG001|Overall Study|Death|1|||
164274624|NCT02914561|593372917|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
164274625|NCT02914561|593372918|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
164274626|NCT02914561|593372919|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
164274627|NCT02914561|593372909|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
164274628|NCT02914561|593372910|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
164274629|NCT02914561|593372911|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
164274630|NCT02914561|593372912|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
164274631|NCT02914561|593372913|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
164274632|NCT02914561|593372914|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
164274633|NCT02914561|593372915|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
164274634|NCT02914561|593372916|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
164274635|NCT02914561|593372917|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
164274636|NCT02914561|593372918|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
164274637|NCT02914561|593372919|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
164274638|NCT02914561|593372909|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
164274639|NCT02914561|593372910|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
164274640|NCT02914561|593372911|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
164274641|NCT02914561|593372912|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
164274642|NCT02914561|593372913|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
164274643|NCT02914561|593372914|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
164274644|NCT02914561|593372915|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
164274645|NCT02914561|593372916|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
164274646|NCT02914561|593372917|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
164274647|NCT02914561|593372918|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
164274648|NCT02914561|593372919|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
164274649|NCT01300455|593372920|FG000|Washout|Withdrawal by Subject|1|||
164274650|NCT01300455|593372921|FG001|Washout|Withdrawal by Subject|0|||
164274651|NCT00576576|593372931|FG000|Overall Study|Lost to Follow-up|6|||
164274652|NCT00576576|593372931|FG000|Overall Study|Protocol Violation|1|||
164274653|NCT00718770|593372938|FG000|Overall Study|Adverse Event|1|||
164274654|NCT00718770|593372938|FG000|Overall Study|Lack of Efficacy|1|||
164274655|NCT00718770|593372938|FG000|Overall Study|Lack of Efficacy|1|||
164274656|NCT00718770|593372938|FG000|Overall Study|Adverse Event|1|||
164274657|NCT00718770|593372938|FG000|Overall Study|Lack of Efficacy|1|||
164274658|NCT00718770|593372938|FG000|Overall Study|Adverse Event|1|||
164274659|NCT00718770|593372938|FG000|Overall Study|Lack of Efficacy|1|||
164274660|NCT00718770|593372938|FG000|Overall Study|Adverse Event|1|||
164274661|NCT00772109|593372939|FG000|Overall Study|Serious adverse event|1|||
164274662|NCT00772109|593372940|FG001|Overall Study|Serious adverse event|0|||
164274663|NCT00772109|593372941|FG002|Overall Study|Serious adverse event|1|||
164342793|NCT02609828|593631542|FG001|Overall Study|Lost to Follow-up|0|||
164583262|NCT03060577|594500977|FG000|Overall Study|Adverse Event|9|||
164274664|NCT00772109|593372942|FG003|Overall Study|Serious adverse event|0|||
164274665|NCT00772109|593372939|FG000|Overall Study|Protocol Violation|5|||
164274666|NCT00772109|593372940|FG001|Overall Study|Protocol Violation|8|||
164274667|NCT00772109|593372941|FG002|Overall Study|Protocol Violation|7|||
164274668|NCT00772109|593372942|FG003|Overall Study|Protocol Violation|6|||
164274669|NCT00772109|593372939|FG000|Overall Study|Lost to Follow-up|7|||
164274670|NCT00772109|593372940|FG001|Overall Study|Lost to Follow-up|3|||
164274671|NCT00772109|593372941|FG002|Overall Study|Lost to Follow-up|5|||
164274672|NCT00772109|593372942|FG003|Overall Study|Lost to Follow-up|9|||
164274673|NCT00772109|593372939|FG000|Overall Study|Withdrawal by Subject|8|||
164274674|NCT00772109|593372940|FG001|Overall Study|Withdrawal by Subject|8|||
164274675|NCT00772109|593372941|FG002|Overall Study|Withdrawal by Subject|6|||
164274676|NCT00772109|593372942|FG003|Overall Study|Withdrawal by Subject|16|||
164274677|NCT00410605|593372943|FG000|Overall Study|Adverse Event|12|||
164274678|NCT00410605|593372943|FG000|Overall Study|Physician Decision|3|||
164274679|NCT00410605|593372943|FG000|Overall Study|Withdrawal by Subject|5|||
164274680|NCT00410605|593372943|FG000|Overall Study|Started Non-Protocol Therapy|3|||
164274681|NCT00410605|593372943|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
164274682|NCT00410605|593372943|FG000|Overall Study|Transferred to another Institution|1|||
164274683|NCT04583956|593372944|FG000|Overall Study|Death|9|||
164274684|NCT04583956|593372945|FG001|Overall Study|Death|11|||
164274685|NCT04583956|593372944|FG000|Overall Study|Lost to Follow-up|7|||
164274686|NCT04583956|593372945|FG001|Overall Study|Lost to Follow-up|9|||
164274687|NCT04583956|593372944|FG000|Overall Study|Protocol Violation|2|||
164274688|NCT04583956|593372945|FG001|Overall Study|Protocol Violation|0|||
164274689|NCT04583956|593372944|FG000|Overall Study|Withdrawal by Subject|0|||
164274690|NCT04583956|593372945|FG001|Overall Study|Withdrawal by Subject|2|||
164274691|NCT04583956|593372944|FG000|Overall Study|Randomized but not dosed|2|||
164274692|NCT04583956|593372945|FG001|Overall Study|Randomized but not dosed|3|||
164274693|NCT04583956|593372944|FG000|Overall Study|Withdrawal of consent before product administration|1|||
164274694|NCT04583956|593372945|FG001|Overall Study|Withdrawal of consent before product administration|0|||
164274695|NCT00703924|593374501|FG000|Overall Study|Withdrawal by Subject|1|||
164274696|NCT00703924|593374502|FG001|Overall Study|Withdrawal by Subject|1|||
164274697|NCT01900054|593374514|FG000|Overall Study|Physician Decision|1|||
164274698|NCT01900054|593374514|FG000|Overall Study|Withdrawal by Subject|1|||
164274699|NCT01959841|593374517|FG000|Overall Study|Adverse Event|1|||
164274700|NCT01959841|593374518|FG001|Overall Study|Adverse Event|3|||
164274701|NCT01959841|593374519|FG002|Overall Study|Adverse Event|2|||
164274702|NCT01959841|593374517|FG000|Overall Study|Lack of Efficacy|5|||
164274703|NCT01959841|593374518|FG001|Overall Study|Lack of Efficacy|0|||
164274704|NCT01959841|593374519|FG002|Overall Study|Lack of Efficacy|0|||
164274705|NCT01959841|593374517|FG000|Overall Study|Lost to Follow-up|1|||
164274706|NCT01959841|593374518|FG001|Overall Study|Lost to Follow-up|1|||
164274707|NCT01959841|593374519|FG002|Overall Study|Lost to Follow-up|0|||
164274708|NCT01959841|593374517|FG000|Overall Study|Physician Decision|0|||
164274709|NCT01959841|593374518|FG001|Overall Study|Physician Decision|2|||
164274710|NCT01959841|593374519|FG002|Overall Study|Physician Decision|3|||
164274711|NCT01959841|593374517|FG000|Overall Study|Protocol Violation|16|||
164274712|NCT01959841|593374518|FG001|Overall Study|Protocol Violation|23|||
164274713|NCT01959841|593374519|FG002|Overall Study|Protocol Violation|16|||
164274714|NCT01959841|593374517|FG000|Overall Study|Withdrawal by Subject|7|||
164274715|NCT01959841|593374518|FG001|Overall Study|Withdrawal by Subject|7|||
164274716|NCT01959841|593374519|FG002|Overall Study|Withdrawal by Subject|5|||
164274717|NCT01959841|593374517|FG000|Overall Study|Clinical laboratory value|2|||
164274718|NCT01959841|593374518|FG001|Overall Study|Clinical laboratory value|6|||
164274719|NCT01959841|593374519|FG002|Overall Study|Clinical laboratory value|6|||
164274720|NCT01959841|593374517|FG000|Overall Study|Platelet count below on day1 or 4|11|||
164274721|NCT01959841|593374518|FG001|Overall Study|Platelet count below on day1 or 4|15|||
164274722|NCT01959841|593374519|FG002|Overall Study|Platelet count below on day1 or 4|11|||
164274723|NCT00924508|593374535|FG000|Overall Study|Withdrawal by Subject|3|||
164274724|NCT01835223|593374538|FG000|Overall Study|Adverse Event|1|||
164274725|NCT01835223|593374539|FG001|Overall Study|Adverse Event|0|||
164274726|NCT01835223|593374538|FG000|Overall Study|Withdrawal by Subject|2|||
164274727|NCT01835223|593374539|FG001|Overall Study|Withdrawal by Subject|0|||
164274728|NCT01835223|593374538|FG000|Overall Study|Disease progression|2|||
164274729|NCT01835223|593374539|FG001|Overall Study|Disease progression|1|||
164274730|NCT01835223|593374538|FG000|Overall Study|Became Inelligible|4|||
164274731|NCT01835223|593374539|FG001|Overall Study|Became Inelligible|0|||
164274732|NCT00495625|593374543|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
164274733|NCT03679624|593374544|FG000|Overall Study|Adverse Event|1|||
164274734|NCT03679624|593374545|FG001|Overall Study|Adverse Event|0|||
164274735|NCT01912339|593374546|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
164274736|NCT01912339|593374547|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
164274737|NCT01912339|593374548|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
164274738|NCT01912339|593374546|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
164274739|NCT01912339|593374547|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
164274740|NCT01912339|593374548|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
164583263|NCT03060577|594500978|FG001|Overall Study|Adverse Event|1|||
164583264|NCT03060577|594500977|FG000|Overall Study|Inclusion/Exclusion|1|||
164583265|NCT03060577|594500978|FG001|Overall Study|Inclusion/Exclusion|0|||
164583266|NCT03060577|594500977|FG000|Overall Study|Other|8|||
164583267|NCT03060577|594500978|FG001|Overall Study|Other|2|||
164583268|NCT01306058|594500979|FG000|Overall Study|Death|1|||
164583269|NCT01306058|594500979|FG000|Overall Study|Enrolled but did not get treatment|1|||
164583270|NCT01539837|594500980|FG000|Overall Study|reduce neutrophil level|0|||
164583271|NCT01539837|594500981|FG001|Overall Study|reduce neutrophil level|1|||
164583272|NCT01539837|594500982|FG002|Overall Study|reduce neutrophil level|1|||
164583273|NCT01539837|594500980|FG000|Overall Study|bad compliance|0|||
164583274|NCT01539837|594500981|FG001|Overall Study|bad compliance|0|||
164583275|NCT01539837|594500982|FG002|Overall Study|bad compliance|1|||
164583276|NCT00849693|594500983|FG000|Acute Treatment Phase|Adverse Event|12|||
164583277|NCT00849693|594500984|FG001|Acute Treatment Phase|Adverse Event|7|||
164583278|NCT00849693|594500985|FG002|Acute Treatment Phase|Adverse Event|6|||
164583279|NCT00849693|594500986|FG003|Acute Treatment Phase|Adverse Event|4|||
164583280|NCT00849693|594500983|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
164583281|NCT00849693|594500984|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
164583282|NCT00849693|594500985|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
164583283|NCT00849693|594500986|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
164583284|NCT00849693|594500983|FG000|Acute Treatment Phase|Protocol Violation|1|||
164583285|NCT00849693|594500984|FG001|Acute Treatment Phase|Protocol Violation|5|||
164583286|NCT00849693|594500985|FG002|Acute Treatment Phase|Protocol Violation|2|||
164583287|NCT00849693|594500986|FG003|Acute Treatment Phase|Protocol Violation|6|||
164583288|NCT00849693|594500983|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
164583289|NCT00849693|594500984|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
164583290|NCT00849693|594500985|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
164583291|NCT00849693|594500986|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
164583292|NCT00849693|594500983|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
164583293|NCT00849693|594500984|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
164583294|NCT00849693|594500985|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
164583295|NCT00849693|594500986|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
164583296|NCT00849693|594500983|FG000|Acute Treatment Phase|Physician Decision|2|||
164583297|NCT00849693|594500984|FG001|Acute Treatment Phase|Physician Decision|1|||
164583298|NCT00849693|594500985|FG002|Acute Treatment Phase|Physician Decision|2|||
164583299|NCT00849693|594500986|FG003|Acute Treatment Phase|Physician Decision|1|||
164583300|NCT00849693|594500983|FG000|Acute Treatment Phase|Sponsor decision|0|||
164431199|NCT02042443|593949403|FG001|Overall Study|Withdrawal by Subject|1|||
164431200|NCT02042443|593949402|FG000|Overall Study|Progression|21|||
164431201|NCT02042443|593949403|FG001|Overall Study|Progression|17|||
164431202|NCT02042443|593949402|FG000|Overall Study|not protocol specified|1|||
164431203|NCT02042443|593949403|FG001|Overall Study|not protocol specified|1|||
164431204|NCT02042443|593949402|FG000|Overall Study|Not eligible/not analyzable|3|||
164431205|NCT02042443|593949403|FG001|Overall Study|Not eligible/not analyzable|6|||
164431206|NCT01649427|593949408|FG000|Overall Study|Adverse Event|1|||
164431207|NCT01649427|593949409|FG001|Overall Study|Adverse Event|1|||
164431208|NCT01649427|593949408|FG000|Overall Study|Withdrawal by Subject|8|||
164431209|NCT01649427|593949409|FG001|Overall Study|Withdrawal by Subject|7|||
164274741|NCT01912339|593374546|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
164274742|NCT01912339|593374547|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
164274743|NCT01912339|593374548|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
164274744|NCT01912339|593374546|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
164274745|NCT01912339|593374547|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
164274746|NCT01912339|593374548|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
164274747|NCT01912339|593374546|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
164274748|NCT01912339|593374547|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
164274749|NCT01912339|593374548|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
164274750|NCT01912339|593374546|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
164274751|NCT01912339|593374547|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
164274752|NCT01912339|593374548|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
164274753|NCT01912339|593374546|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
164274754|NCT01912339|593374547|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
164274755|NCT01912339|593374548|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
164274756|NCT01912339|593374546|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
164431210|NCT01649427|593949408|FG000|Overall Study|Lost to Follow-up|0|||
164583301|NCT00849693|594500984|FG001|Acute Treatment Phase|Sponsor decision|0|||
164583302|NCT00849693|594500985|FG002|Acute Treatment Phase|Sponsor decision|1|||
164583303|NCT00849693|594500986|FG003|Acute Treatment Phase|Sponsor decision|0|||
164583304|NCT00849693|594500983|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
164583305|NCT00849693|594500984|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
164583306|NCT00849693|594500985|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
164583307|NCT00849693|594500986|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
164431211|NCT01649427|593949409|FG001|Overall Study|Lost to Follow-up|1|||
164431212|NCT01649427|593949408|FG000|Overall Study|Graft loss|0|||
164431213|NCT01649427|593949409|FG001|Overall Study|Graft loss|1|||
164431214|NCT01649427|593949408|FG000|Overall Study|Surgical problems during nephrectomy|2|||
164431215|NCT01649427|593949409|FG001|Overall Study|Surgical problems during nephrectomy|2|||
164431216|NCT02138916|593949412|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
164431217|NCT02138916|593949413|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
164431218|NCT02138916|593949414|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
164431219|NCT02138916|593949412|FG000|Overall Study|Death|14|||
164431220|NCT02138916|593949413|FG001|Overall Study|Death|11|||
164431221|NCT02138916|593949414|FG002|Overall Study|Death|12|||
164431222|NCT02138916|593949412|FG000|Overall Study|Withdrawal by Subject|27|||
164431223|NCT02138916|593949413|FG001|Overall Study|Withdrawal by Subject|31|||
164431224|NCT02138916|593949414|FG002|Overall Study|Withdrawal by Subject|32|||
164431225|NCT02138916|593949412|FG000|Overall Study|Study specific withdrawal criteria|0|||
164431226|NCT02138916|593949413|FG001|Overall Study|Study specific withdrawal criteria|0|||
164431227|NCT02138916|593949414|FG002|Overall Study|Study specific withdrawal criteria|1|||
164431228|NCT02138916|593949412|FG000|Overall Study|incorrect enrolment|1|||
164431229|NCT02138916|593949413|FG001|Overall Study|incorrect enrolment|1|||
164431230|NCT02138916|593949414|FG002|Overall Study|incorrect enrolment|0|||
164431231|NCT02138916|593949412|FG000|Overall Study|Severe non-compliance|1|||
164431232|NCT02138916|593949413|FG001|Overall Study|Severe non-compliance|2|||
164431233|NCT02138916|593949414|FG002|Overall Study|Severe non-compliance|1|||
164431234|NCT02138916|593949412|FG000|Overall Study|Lost to Follow-up|4|||
164431235|NCT02138916|593949413|FG001|Overall Study|Lost to Follow-up|2|||
164431236|NCT02138916|593949414|FG002|Overall Study|Lost to Follow-up|3|||
164431237|NCT02138916|593949412|FG000|Overall Study|Adverse Event|4|||
164431238|NCT02138916|593949413|FG001|Overall Study|Adverse Event|4|||
164431239|NCT02138916|593949414|FG002|Overall Study|Adverse Event|3|||
164431240|NCT02784704|593949415|FG000|Overall Study|Adverse Event|4|||
164431241|NCT02784704|593949416|FG001|Overall Study|Adverse Event|2|||
164431242|NCT02784704|593949415|FG000|Overall Study|Lost to Follow-up|6|||
164431243|NCT02784704|593949416|FG001|Overall Study|Lost to Follow-up|4|||
164431244|NCT02784704|593949415|FG000|Overall Study|Withdrawal by Subject|1|||
164689236|NCT03414034|594885510|FG001|Overall Study|Progressive Disease|15|||
164689237|NCT03414034|594885511|FG002|Overall Study|Progressive Disease|17|||
164689238|NCT03414034|594885509|FG000|Overall Study|Miscellaneous|0|||
164689239|NCT03414034|594885510|FG001|Overall Study|Miscellaneous|0|||
164689240|NCT03414034|594885511|FG002|Overall Study|Miscellaneous|2|||
164689241|NCT01685008|594885512|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
164689242|NCT01685008|594885513|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
164689243|NCT01685008|594885514|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
164689244|NCT01685008|594885515|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
164689245|NCT01685008|594885512|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
164689246|NCT01685008|594885513|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
164689247|NCT01685008|594885514|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
164689248|NCT01685008|594885515|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
164689249|NCT01685008|594885512|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
164689250|NCT01685008|594885513|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
164689251|NCT01685008|594885514|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
164689252|NCT01685008|594885515|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
164689253|NCT01685008|594885512|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
164689254|NCT01685008|594885513|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
164689255|NCT01685008|594885514|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
164689256|NCT01685008|594885515|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
164689257|NCT01685008|594885512|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
164274757|NCT01912339|593374547|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
164274758|NCT01912339|593374548|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
164274759|NCT01912339|593374546|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
164274760|NCT01912339|593374547|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
164274761|NCT01912339|593374548|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
164274762|NCT01912339|593374546|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
164689258|NCT01685008|594885513|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
164274763|NCT01912339|593374547|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
164689259|NCT01685008|594885514|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
164689260|NCT01685008|594885515|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
164274764|NCT01912339|593374548|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
164431245|NCT02784704|593949416|FG001|Overall Study|Withdrawal by Subject|3|||
164431246|NCT02784704|593949415|FG000|Overall Study|Subject Non Compliance|2|||
164431247|NCT02784704|593949416|FG001|Overall Study|Subject Non Compliance|0|||
164431248|NCT01913340|593949417|FG000|Overall Study|Death|2|||
164431249|NCT01913340|593949418|FG001|Overall Study|Death|5|||
164431250|NCT01913340|593949417|FG000|Overall Study|Lost to Follow-up|1|||
164274765|NCT01912339|593374546|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
164274766|NCT01912339|593374547|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
164274767|NCT01912339|593374548|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
164274768|NCT01912339|593374546|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
164274769|NCT01912339|593374547|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
164274770|NCT01912339|593374548|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
164274771|NCT01912339|593374546|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
164274772|NCT01912339|593374547|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
164274773|NCT01912339|593374548|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
164274774|NCT04097379|593374549|FG000|Overall Study|Adverse Event|1|||
164274775|NCT04097379|593374550|FG001|Overall Study|Adverse Event|0|||
164274776|NCT04097379|593374551|FG002|Overall Study|Adverse Event|0|||
164274777|NCT04097379|593374552|FG003|Overall Study|Adverse Event|0|||
164274778|NCT04097379|593374549|FG000|Overall Study|Physician Decision|0|||
164583308|NCT00849693|594500983|FG000|Extension Phase|Adverse Event|4|||
164274779|NCT04097379|593374550|FG001|Overall Study|Physician Decision|1|||
164583309|NCT00849693|594500984|FG001|Extension Phase|Adverse Event|6|||
164274780|NCT04097379|593374551|FG002|Overall Study|Physician Decision|0|||
164274781|NCT04097379|593374552|FG003|Overall Study|Physician Decision|0|||
164274782|NCT00200356|593374557|FG000|Overall Study|Lack of Efficacy|3|||
164274783|NCT00200356|593374558|FG001|Overall Study|Lack of Efficacy|3|||
164274784|NCT00200356|593374557|FG000|Overall Study|Protocol Violation|4|||
164274785|NCT00200356|593374558|FG001|Overall Study|Protocol Violation|4|||
164274786|NCT00200356|593374557|FG000|Overall Study|Nontreatment|1|||
164274787|NCT00200356|593374558|FG001|Overall Study|Nontreatment|0|||
164274788|NCT05216224|593374564|FG000|Overall Study|Adverse Event|6|||
164274789|NCT05216224|593374565|FG001|Overall Study|Adverse Event|3|||
164274790|NCT05216224|593374564|FG000|Overall Study|Lack of Efficacy|1|||
164274791|NCT05216224|593374565|FG001|Overall Study|Lack of Efficacy|0|||
164274792|NCT05216224|593374564|FG000|Overall Study|Lost to Follow-up|8|||
164274793|NCT05216224|593374565|FG001|Overall Study|Lost to Follow-up|6|||
164274794|NCT05216224|593374564|FG000|Overall Study|Protocol Violation|1|||
164274795|NCT05216224|593374565|FG001|Overall Study|Protocol Violation|1|||
164274796|NCT05216224|593374564|FG000|Overall Study|Withdrawal by Subject|6|||
164274797|NCT05216224|593374565|FG001|Overall Study|Withdrawal by Subject|5|||
164274798|NCT05216224|593374564|FG000|Overall Study|Other than specified|1|||
164274799|NCT05216224|593374565|FG001|Overall Study|Other than specified|0|||
164274800|NCT03245008|593374566|FG000|Overall Study|Adverse Event|15|||
164274801|NCT03245008|593374567|FG001|Overall Study|Adverse Event|18|||
164274802|NCT03245008|593374568|FG002|Overall Study|Adverse Event|15|||
164274803|NCT03245008|593374569|FG003|Overall Study|Adverse Event|0|||
164274804|NCT03245008|593374570|FG004|Overall Study|Adverse Event|1|||
164274805|NCT03245008|593374566|FG000|Overall Study|Lack of Efficacy|0|||
164274806|NCT03245008|593374567|FG001|Overall Study|Lack of Efficacy|1|||
164274807|NCT03245008|593374568|FG002|Overall Study|Lack of Efficacy|0|||
164274808|NCT03245008|593374569|FG003|Overall Study|Lack of Efficacy|0|||
164274809|NCT03245008|593374570|FG004|Overall Study|Lack of Efficacy|0|||
164274810|NCT03245008|593374566|FG000|Overall Study|Lost to Follow-up|4|||
164274811|NCT03245008|593374567|FG001|Overall Study|Lost to Follow-up|1|||
164274812|NCT03245008|593374568|FG002|Overall Study|Lost to Follow-up|0|||
164274813|NCT03245008|593374569|FG003|Overall Study|Lost to Follow-up|0|||
164274814|NCT03245008|593374570|FG004|Overall Study|Lost to Follow-up|1|||
164274815|NCT03245008|593374566|FG000|Overall Study|Physician Decision|1|||
164274816|NCT03245008|593374567|FG001|Overall Study|Physician Decision|3|||
164274817|NCT03245008|593374568|FG002|Overall Study|Physician Decision|4|||
164274818|NCT03245008|593374569|FG003|Overall Study|Physician Decision|0|||
164274819|NCT03245008|593374570|FG004|Overall Study|Physician Decision|0|||
164274820|NCT03245008|593374566|FG000|Overall Study|Protocol Violation|0|||
164274821|NCT03245008|593374567|FG001|Overall Study|Protocol Violation|1|||
164274822|NCT03245008|593374568|FG002|Overall Study|Protocol Violation|0|||
164274823|NCT03245008|593374569|FG003|Overall Study|Protocol Violation|0|||
164274824|NCT03245008|593374570|FG004|Overall Study|Protocol Violation|0|||
164274825|NCT03245008|593374566|FG000|Overall Study|Withdrawal by Subject|20|||
164274826|NCT03245008|593374567|FG001|Overall Study|Withdrawal by Subject|19|||
164274827|NCT03245008|593374568|FG002|Overall Study|Withdrawal by Subject|11|||
164274828|NCT03245008|593374569|FG003|Overall Study|Withdrawal by Subject|0|||
164431251|NCT01913340|593949418|FG001|Overall Study|Lost to Follow-up|1|||
164583310|NCT00849693|594500985|FG002|Extension Phase|Adverse Event|3|||
164583311|NCT00849693|594500986|FG003|Extension Phase|Adverse Event|7|||
164583312|NCT00849693|594500983|FG000|Extension Phase|Lost to Follow-up|7|||
164583313|NCT00849693|594500984|FG001|Extension Phase|Lost to Follow-up|5|||
164274829|NCT03245008|593374570|FG004|Overall Study|Withdrawal by Subject|0|||
164274830|NCT03245008|593374566|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
164274831|NCT03245008|593374567|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
164274832|NCT03245008|593374568|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
164274833|NCT03245008|593374569|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
164274834|NCT03245008|593374570|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
164274835|NCT03245008|593374566|FG000|Overall Study|Failure to meet randomization criteria|0|||
164274836|NCT03245008|593374567|FG001|Overall Study|Failure to meet randomization criteria|1|||
164274837|NCT03245008|593374568|FG002|Overall Study|Failure to meet randomization criteria|0|||
164274838|NCT03245008|593374569|FG003|Overall Study|Failure to meet randomization criteria|1|||
164274839|NCT03245008|593374570|FG004|Overall Study|Failure to meet randomization criteria|0|||
164274840|NCT01580670|593374571|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
164274841|NCT01580670|593374571|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
164274842|NCT03266172|593374575|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
164274843|NCT03266172|593374576|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
164274844|NCT03266172|593374577|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
164274845|NCT03266172|593374575|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
164274846|NCT03266172|593374576|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
164274847|NCT03266172|593374577|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
164274848|NCT03266172|593374575|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
164274849|NCT03266172|593374576|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
164274850|NCT03266172|593374577|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
164274851|NCT03266172|593374575|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
164274852|NCT03266172|593374576|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
164274853|NCT03266172|593374577|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
164274854|NCT03266172|593374575|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
164274855|NCT03266172|593374576|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
164274856|NCT03266172|593374577|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
164274857|NCT03266172|593374575|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
164274858|NCT03266172|593374576|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
164274859|NCT03266172|593374577|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
164274860|NCT00454584|593374578|FG000|Controlled Period|Adverse Event|5|||
164274861|NCT00454584|593374579|FG001|Controlled Period|Adverse Event|2|||
164274862|NCT00454584|593374580|FG002|Controlled Period|Adverse Event|1|||
164274863|NCT00454584|593374581|FG003|Controlled Period|Adverse Event|0|||
164274864|NCT00454584|593374582|FG004|Controlled Period|Adverse Event|0|||
164274865|NCT00454584|593374583|FG005|Controlled Period|Adverse Event|0|||
164274866|NCT00454584|593374578|FG000|Controlled Period|Lost to Follow-up|1|||
164274867|NCT00454584|593374579|FG001|Controlled Period|Lost to Follow-up|2|||
164274868|NCT00454584|593374580|FG002|Controlled Period|Lost to Follow-up|2|||
164274869|NCT00454584|593374581|FG003|Controlled Period|Lost to Follow-up|0|||
164274870|NCT00454584|593374582|FG004|Controlled Period|Lost to Follow-up|0|||
164274871|NCT00454584|593374583|FG005|Controlled Period|Lost to Follow-up|0|||
164274872|NCT00454584|593374578|FG000|Controlled Period|Other|5|||
164274873|NCT00454584|593374579|FG001|Controlled Period|Other|4|||
164274874|NCT00454584|593374580|FG002|Controlled Period|Other|2|||
164274875|NCT00454584|593374581|FG003|Controlled Period|Other|0|||
164274876|NCT00454584|593374582|FG004|Controlled Period|Other|0|||
164274877|NCT00454584|593374583|FG005|Controlled Period|Other|0|||
164274878|NCT00454584|593374578|FG000|After Controlled Period|Adverse Event|0|||
164274879|NCT00454584|593374579|FG001|After Controlled Period|Adverse Event|0|||
164274880|NCT00454584|593374580|FG002|After Controlled Period|Adverse Event|0|||
164274881|NCT00454584|593374581|FG003|After Controlled Period|Adverse Event|9|||
164274882|NCT00454584|593374582|FG004|After Controlled Period|Adverse Event|3|||
164274883|NCT00454584|593374583|FG005|After Controlled Period|Adverse Event|9|||
164274884|NCT00454584|593374578|FG000|After Controlled Period|Lack of Efficacy|0|||
164274885|NCT00454584|593374579|FG001|After Controlled Period|Lack of Efficacy|0|||
164274886|NCT00454584|593374580|FG002|After Controlled Period|Lack of Efficacy|0|||
164274887|NCT00454584|593374581|FG003|After Controlled Period|Lack of Efficacy|1|||
164274888|NCT00454584|593374582|FG004|After Controlled Period|Lack of Efficacy|0|||
164274889|NCT00454584|593374583|FG005|After Controlled Period|Lack of Efficacy|0|||
164274890|NCT00454584|593374578|FG000|After Controlled Period|Lost to Follow-up|0|||
164274891|NCT00454584|593374579|FG001|After Controlled Period|Lost to Follow-up|0|||
164274892|NCT00454584|593374580|FG002|After Controlled Period|Lost to Follow-up|0|||
164274893|NCT00454584|593374581|FG003|After Controlled Period|Lost to Follow-up|2|||
164274894|NCT00454584|593374582|FG004|After Controlled Period|Lost to Follow-up|4|||
164274895|NCT00454584|593374583|FG005|After Controlled Period|Lost to Follow-up|6|||
164274896|NCT00454584|593374578|FG000|After Controlled Period|Other|0|||
164274897|NCT00454584|593374579|FG001|After Controlled Period|Other|0|||
164274898|NCT00454584|593374580|FG002|After Controlled Period|Other|0|||
164431252|NCT00603538|593949419|FG000|Overall Study|Adverse Event|0|||
164274899|NCT00454584|593374581|FG003|After Controlled Period|Other|1|||
164274900|NCT00454584|593374582|FG004|After Controlled Period|Other|0|||
164274901|NCT00454584|593374583|FG005|After Controlled Period|Other|0|||
164274902|NCT00454584|593374578|FG000|After Controlled Period|Other|0|||
164274903|NCT00454584|593374579|FG001|After Controlled Period|Other|0|||
164274904|NCT00454584|593374580|FG002|After Controlled Period|Other|0|||
164274905|NCT00454584|593374581|FG003|After Controlled Period|Other|13|||
164274906|NCT00454584|593374582|FG004|After Controlled Period|Other|5|||
164583314|NCT00849693|594500985|FG002|Extension Phase|Lost to Follow-up|6|||
164274907|NCT00454584|593374583|FG005|After Controlled Period|Other|17|||
164274908|NCT02250664|593374584|FG000|Overall Study|Lost to Follow-up|18|||
164274909|NCT02250664|593374585|FG001|Overall Study|Lost to Follow-up|28|||
164274910|NCT02250664|593374586|FG002|Overall Study|Lost to Follow-up|33|||
164274911|NCT02250664|593374584|FG000|Overall Study|Personal Reasons|7|||
164274912|NCT02250664|593374585|FG001|Overall Study|Personal Reasons|8|||
164274913|NCT02250664|593374586|FG002|Overall Study|Personal Reasons|14|||
164274914|NCT02250664|593374584|FG000|Overall Study|Adverse Event|6|||
164274915|NCT02250664|593374585|FG001|Overall Study|Adverse Event|3|||
164274916|NCT02250664|593374586|FG002|Overall Study|Adverse Event|8|||
164274917|NCT02250664|593374584|FG000|Overall Study|Incarcerated|2|||
164274918|NCT02250664|593374585|FG001|Overall Study|Incarcerated|1|||
164274919|NCT02250664|593374586|FG002|Overall Study|Incarcerated|2|||
164274920|NCT02250664|593374584|FG000|Overall Study|Withdrawal by Subject|0|||
164274921|NCT02250664|593374585|FG001|Overall Study|Withdrawal by Subject|1|||
164274922|NCT02250664|593374586|FG002|Overall Study|Withdrawal by Subject|2|||
164274923|NCT02250664|593374584|FG000|Overall Study|Death|0|||
164274924|NCT02250664|593374585|FG001|Overall Study|Death|1|||
164274925|NCT02250664|593374586|FG002|Overall Study|Death|1|||
164274926|NCT02250664|593374584|FG000|Overall Study|Physician Decision|1|||
164274927|NCT02250664|593374585|FG001|Overall Study|Physician Decision|3|||
164274928|NCT02250664|593374586|FG002|Overall Study|Physician Decision|1|||
164274929|NCT02250664|593374584|FG000|Overall Study|Protocol Violation|1|||
164274930|NCT02250664|593374585|FG001|Overall Study|Protocol Violation|0|||
164274931|NCT02250664|593374586|FG002|Overall Study|Protocol Violation|1|||
164274932|NCT02250664|593374584|FG000|Overall Study|Reason unknown|1|||
164274933|NCT02250664|593374585|FG001|Overall Study|Reason unknown|0|||
164274934|NCT02250664|593374586|FG002|Overall Study|Reason unknown|0|||
164274935|NCT01753401|593374588|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
164274936|NCT01753401|593374589|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
164274937|NCT01753401|593374590|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
164583315|NCT00849693|594500986|FG003|Extension Phase|Lost to Follow-up|6|||
164583316|NCT00849693|594500983|FG000|Extension Phase|Protocol Violation|0|||
164583317|NCT00849693|594500984|FG001|Extension Phase|Protocol Violation|3|||
164583318|NCT00849693|594500985|FG002|Extension Phase|Protocol Violation|2|||
164583319|NCT00849693|594500986|FG003|Extension Phase|Protocol Violation|3|||
164583320|NCT00849693|594500983|FG000|Extension Phase|Withdrawal by Subject|6|||
164274938|NCT01753401|593374591|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
164274939|NCT01753401|593374588|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
164274940|NCT01753401|593374589|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
164274941|NCT01753401|593374590|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
164274942|NCT01753401|593374591|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
164583321|NCT00849693|594500984|FG001|Extension Phase|Withdrawal by Subject|9|||
164583322|NCT00849693|594500985|FG002|Extension Phase|Withdrawal by Subject|10|||
164583323|NCT00849693|594500986|FG003|Extension Phase|Withdrawal by Subject|15|||
164583324|NCT00849693|594500983|FG000|Extension Phase|Parent or caregiver decision|9|||
164583325|NCT00849693|594500984|FG001|Extension Phase|Parent or caregiver decision|4|||
164689261|NCT01067521|594885516|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
164689262|NCT01067521|594885517|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
164689263|NCT01067521|594885516|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
164274943|NCT01753401|593374588|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
164274944|NCT01753401|593374589|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
164274945|NCT01753401|593374590|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
164274946|NCT01753401|593374591|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
164274947|NCT01753401|593374588|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
164689264|NCT01067521|594885517|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
164689265|NCT01067521|594885516|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
164274948|NCT01753401|593374589|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
164274949|NCT01753401|593374590|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
164274950|NCT01753401|593374591|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
164583326|NCT00849693|594500985|FG002|Extension Phase|Parent or caregiver decision|10|||
164583327|NCT00849693|594500986|FG003|Extension Phase|Parent or caregiver decision|5|||
164583328|NCT00849693|594500983|FG000|Extension Phase|Physician Decision|1|||
164583329|NCT00849693|594500984|FG001|Extension Phase|Physician Decision|1|||
164583330|NCT00849693|594500985|FG002|Extension Phase|Physician Decision|2|||
164583331|NCT00849693|594500986|FG003|Extension Phase|Physician Decision|0|||
164274951|NCT01753401|593374588|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
164274952|NCT01753401|593374589|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
164274953|NCT01753401|593374590|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
164274954|NCT01753401|593374591|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
164274955|NCT01753401|593374588|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
164342794|NCT02609828|593631543|FG002|Overall Study|Lost to Follow-up|0|||
164583332|NCT00849693|594500983|FG000|Extension Phase|Sponsor decision|1|||
164583333|NCT00849693|594500984|FG001|Extension Phase|Sponsor decision|0|||
164583334|NCT00849693|594500985|FG002|Extension Phase|Sponsor decision|0|||
164583335|NCT00849693|594500986|FG003|Extension Phase|Sponsor decision|1|||
164583336|NCT00849693|594500983|FG000|Extension Phase|Lack of Efficacy|2|||
164583337|NCT00849693|594500984|FG001|Extension Phase|Lack of Efficacy|2|||
164583338|NCT00849693|594500985|FG002|Extension Phase|Lack of Efficacy|2|||
164583339|NCT00849693|594500986|FG003|Extension Phase|Lack of Efficacy|1|||
164583340|NCT00098345|594500989|FG000|Overall Study|Adverse Event|7|||
164583341|NCT00098345|594500989|FG000|Overall Study|Withdrawal by Subject|2|||
164583342|NCT00098345|594500989|FG000|Overall Study|progression|4|||
164583343|NCT01183858|594500990|FG000|Overall Study|Death not related to Progressive Disease|5|||
164583344|NCT01183858|594500991|FG001|Overall Study|Death not related to Progressive Disease|6|||
164583345|NCT01183858|594500990|FG000|Overall Study|Adverse Event|14|||
164583346|NCT01183858|594500991|FG001|Overall Study|Adverse Event|11|||
164583347|NCT01183858|594500990|FG000|Overall Study|Investigator's Decision|0|||
164583348|NCT01183858|594500991|FG001|Overall Study|Investigator's Decision|3|||
164583349|NCT01183858|594500990|FG000|Overall Study|Insufficient Therapeutic Response|2|||
164583350|NCT01183858|594500991|FG001|Overall Study|Insufficient Therapeutic Response|0|||
164583351|NCT01183858|594500990|FG000|Overall Study|Refused Treatment|1|||
164583352|NCT01183858|594500991|FG001|Overall Study|Refused Treatment|4|||
164583353|NCT01183858|594500990|FG000|Overall Study|Withdrew Consent|4|||
164583354|NCT01183858|594500991|FG001|Overall Study|Withdrew Consent|4|||
164583355|NCT01183858|594500990|FG000|Overall Study|Discontinued Smoking|3|||
164583356|NCT01183858|594500991|FG001|Overall Study|Discontinued Smoking|1|||
164583357|NCT01183858|594500990|FG000|Overall Study|Protocol Violation|1|||
164583358|NCT01183858|594500991|FG001|Overall Study|Protocol Violation|0|||
164583359|NCT01183858|594500990|FG000|Overall Study|Administrative/Other|6|||
164583360|NCT01183858|594500991|FG001|Overall Study|Administrative/Other|6|||
164583361|NCT01183858|594500990|FG000|Overall Study|Progressive Disease|112|||
164583362|NCT01183858|594500991|FG001|Overall Study|Progressive Disease|115|||
164583363|NCT01183858|594500990|FG000|Overall Study|Death related to Progressive Disease|4|||
164583364|NCT01183858|594500991|FG001|Overall Study|Death related to Progressive Disease|5|||
164583365|NCT01183858|594500990|FG000|Overall Study|Lost to Follow-up|1|||
164583366|NCT01183858|594500991|FG001|Overall Study|Lost to Follow-up|1|||
164583367|NCT00553059|594500992|FG000|Overall Study|Deemed ineligible|1|||
164583368|NCT00553059|594500993|FG001|Overall Study|Deemed ineligible|1|||
164583369|NCT00553059|594500992|FG000|Overall Study|Drug supply not available|0|||
164583370|NCT00553059|594500993|FG001|Overall Study|Drug supply not available|1|||
164583371|NCT00984659|594500994|FG000|2-week Run-in Period|Adverse Event|8|||
164583372|NCT00984659|594500995|FG001|2-week Run-in Period|Adverse Event|0|||
164583373|NCT00984659|594500996|FG002|2-week Run-in Period|Adverse Event|0|||
164583374|NCT00984659|594500997|FG003|2-week Run-in Period|Adverse Event|0|||
164583375|NCT00984659|594500994|FG000|2-week Run-in Period|Protocol Violation|5|||
164583376|NCT00984659|594500995|FG001|2-week Run-in Period|Protocol Violation|0|||
164583377|NCT00984659|594500996|FG002|2-week Run-in Period|Protocol Violation|0|||
164583378|NCT00984659|594500997|FG003|2-week Run-in Period|Protocol Violation|0|||
164583379|NCT00984659|594500994|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
164583380|NCT00984659|594500995|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
164583381|NCT00984659|594500996|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
164583382|NCT00984659|594500997|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
164583383|NCT00984659|594500994|FG000|2-week Run-in Period|Lost to Follow-up|3|||
164583384|NCT00984659|594500995|FG001|2-week Run-in Period|Lost to Follow-up|0|||
164583385|NCT00984659|594500996|FG002|2-week Run-in Period|Lost to Follow-up|0|||
164583386|NCT00984659|594500997|FG003|2-week Run-in Period|Lost to Follow-up|0|||
164583387|NCT00984659|594500994|FG000|2-week Run-in Period|Physician Decision|10|||
164583388|NCT00984659|594500995|FG001|2-week Run-in Period|Physician Decision|0|||
164583389|NCT00984659|594500996|FG002|2-week Run-in Period|Physician Decision|0|||
164583390|NCT00984659|594500997|FG003|2-week Run-in Period|Physician Decision|0|||
164583391|NCT00984659|594500994|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
164583392|NCT00984659|594500995|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
164583393|NCT00984659|594500996|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
164583394|NCT00984659|594500997|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
164583395|NCT00984659|594500994|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
164583396|NCT00984659|594500995|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
164583397|NCT00984659|594500996|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
164583398|NCT00984659|594500997|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
164583399|NCT00984659|594500994|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
164583400|NCT00984659|594500995|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
164583401|NCT00984659|594500996|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
164583402|NCT00984659|594500997|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
164583403|NCT00984659|594500994|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
164583404|NCT00984659|594500995|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
164583405|NCT00984659|594500996|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
164583406|NCT00984659|594500997|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
164274956|NCT01753401|593374589|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
164274957|NCT01753401|593374590|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
164274958|NCT01753401|593374591|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
164274959|NCT01753401|593374588|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
164274960|NCT01753401|593374589|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
164274961|NCT01753401|593374590|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
164274962|NCT01753401|593374591|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
164274963|NCT00295932|593374594|FG000|Overall Study|Not Treated|0|||
164274964|NCT00295932|593374595|FG001|Overall Study|Not Treated|0|||
164274965|NCT00295932|593374596|FG002|Overall Study|Not Treated|0|||
164342795|NCT02609828|593631544|FG003|Overall Study|Lost to Follow-up|1|||
164342796|NCT02609828|593631541|FG000|Overall Study|Protocol Violation|2|||
164342797|NCT02609828|593631542|FG001|Overall Study|Protocol Violation|0|||
164342798|NCT02609828|593631543|FG002|Overall Study|Protocol Violation|0|||
164342799|NCT02609828|593631544|FG003|Overall Study|Protocol Violation|1|||
164342800|NCT02609828|593631541|FG000|Overall Study|Withdrawal by Subject|12|||
164342801|NCT02609828|593631542|FG001|Overall Study|Withdrawal by Subject|1|||
164342802|NCT02609828|593631543|FG002|Overall Study|Withdrawal by Subject|0|||
164342803|NCT02609828|593631544|FG003|Overall Study|Withdrawal by Subject|10|||
164342804|NCT02609828|593631541|FG000|Overall Study|Other|3|||
164342805|NCT02609828|593631542|FG001|Overall Study|Other|0|||
164342806|NCT02609828|593631543|FG002|Overall Study|Other|0|||
164342807|NCT02609828|593631544|FG003|Overall Study|Other|6|||
164342808|NCT02609828|593631541|FG000|Overall Study|Randomized but not treated|1|||
164342809|NCT02609828|593631542|FG001|Overall Study|Randomized but not treated|0|||
164342810|NCT02609828|593631543|FG002|Overall Study|Randomized but not treated|0|||
164342811|NCT02609828|593631544|FG003|Overall Study|Randomized but not treated|0|||
164342812|NCT01786668|593631547|FG000|Overall Study|Adverse Event|0|||
164342813|NCT01786668|593631548|FG001|Overall Study|Adverse Event|1|||
164342814|NCT01786668|593631549|FG002|Overall Study|Adverse Event|1|||
164342815|NCT01786668|593631550|FG003|Overall Study|Adverse Event|2|||
164342816|NCT01786668|593631547|FG000|Overall Study|Withdrawal by Subject|0|||
164342817|NCT01786668|593631548|FG001|Overall Study|Withdrawal by Subject|0|||
164342818|NCT01786668|593631549|FG002|Overall Study|Withdrawal by Subject|3|||
164342819|NCT01786668|593631550|FG003|Overall Study|Withdrawal by Subject|1|||
164342820|NCT01786668|593631547|FG000|Overall Study|Pregnancy|0|||
164342821|NCT01786668|593631548|FG001|Overall Study|Pregnancy|0|||
164342822|NCT01786668|593631549|FG002|Overall Study|Pregnancy|0|||
164342823|NCT01786668|593631550|FG003|Overall Study|Pregnancy|1|||
164342824|NCT01786668|593631547|FG000|Overall Study|Lost to Follow-up|1|||
164342825|NCT01786668|593631548|FG001|Overall Study|Lost to Follow-up|0|||
164342826|NCT01786668|593631549|FG002|Overall Study|Lost to Follow-up|1|||
164342827|NCT01786668|593631550|FG003|Overall Study|Lost to Follow-up|0|||
164342828|NCT03068455|593631555|FG000|Pre-treatment Period|Disease progression|0|||
164342829|NCT03068455|593631556|FG001|Pre-treatment Period|Disease progression|1|||
164342830|NCT03068455|593631555|FG000|Pre-treatment Period|Participant withdrew consent|1|||
164342831|NCT03068455|593631556|FG001|Pre-treatment Period|Participant withdrew consent|1|||
164342832|NCT03068455|593631555|FG000|Pre-treatment Period|Poor/non-compliance|0|||
164342833|NCT03068455|593631556|FG001|Pre-treatment Period|Poor/non-compliance|1|||
164342834|NCT03068455|593631555|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
164342835|NCT03068455|593631556|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
164342836|NCT03068455|593631555|FG000|Pre-treatment Period|Not reported|2|||
164342837|NCT03068455|593631556|FG001|Pre-treatment Period|Not reported|1|||
164342838|NCT03068455|593631555|FG000|Treatment Period|Disease progression|166|||
164342839|NCT03068455|593631556|FG001|Treatment Period|Disease progression|208|||
164342840|NCT03068455|593631555|FG000|Treatment Period|Study drug toxicity|317|||
164342841|NCT03068455|593631556|FG001|Treatment Period|Study drug toxicity|104|||
164431253|NCT00603538|593949420|FG001|Overall Study|Adverse Event|4|||
164583407|NCT00984659|594500994|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
164583408|NCT00984659|594500995|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
164274966|NCT00295932|593374597|FG003|Overall Study|Not Treated|0|||
164274967|NCT00295932|593374598|FG004|Overall Study|Not Treated|0|||
164274968|NCT00295932|593374599|FG005|Overall Study|Not Treated|0|||
164274969|NCT00295932|593374600|FG006|Overall Study|Not Treated|0|||
164274970|NCT00295932|593374601|FG007|Overall Study|Not Treated|0|||
164274971|NCT00295932|593374602|FG008|Overall Study|Not Treated|0|||
164342842|NCT03068455|593631555|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
164342843|NCT03068455|593631556|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
164342844|NCT03068455|593631555|FG000|Treatment Period|Participant request to stop therapy|33|||
164342845|NCT03068455|593631556|FG001|Treatment Period|Participant request to stop therapy|20|||
164342846|NCT03068455|593631555|FG000|Treatment Period|Participant withdrew consent|5|||
164342847|NCT03068455|593631556|FG001|Treatment Period|Participant withdrew consent|10|||
164342848|NCT03068455|593631555|FG000|Treatment Period|Poor/non-compliance|3|||
164342849|NCT03068455|593631556|FG001|Treatment Period|Poor/non-compliance|0|||
164342850|NCT03068455|593631555|FG000|Treatment Period|Participant no longer meets study criteria|1|||
164274972|NCT00295932|593374603|FG009|Overall Study|Not Treated|0|||
164274973|NCT00295932|593374604|FG010|Overall Study|Not Treated|1|||
164274974|NCT02409719|593374610|FG000|Overall Study|Lost to Follow-up|3|||
164274975|NCT02409719|593374611|FG001|Overall Study|Lost to Follow-up|3|||
164274976|NCT00565136|593374613|FG000|Overall Study|Lost to Follow-up|1|||
164274977|NCT00565136|593374613|FG000|Overall Study|Withdrawal by Subject|1|||
164274978|NCT00565136|593374613|FG000|Overall Study|Protocol Violation|1|||
164274979|NCT01026220|593374619|FG000|Induction|Death|1|||
164274980|NCT01026220|593374620|FG001|Induction|Death|0|||
164274981|NCT01026220|593374621|FG002|Induction|Death|0|||
164274982|NCT01026220|593374619|FG000|Induction|Lack of Efficacy|2|||
164274983|NCT01026220|593374620|FG001|Induction|Lack of Efficacy|0|||
164274984|NCT01026220|593374621|FG002|Induction|Lack of Efficacy|0|||
164274985|NCT01026220|593374619|FG000|Induction|Physician Decision|12|||
164274986|NCT01026220|593374620|FG001|Induction|Physician Decision|0|||
164342851|NCT03068455|593631556|FG001|Treatment Period|Participant no longer meets study criteria|3|||
164342852|NCT03068455|593631555|FG000|Treatment Period|Other reasons|12|||
164342853|NCT03068455|593631556|FG001|Treatment Period|Other reasons|4|||
164342854|NCT05379231|593631557|FG000|Home Visit|Withdrawal by Subject|2|||
164342855|NCT05379231|593631557|FG000|In-lab Visit|Withdrawal by Subject|2|||
164342856|NCT01496807|593631558|FG000|Overall Study|Progressive Disease|21|||
164342857|NCT01496807|593631558|FG000|Overall Study|Participant preference/toxicity|8|||
164342858|NCT01496807|593631558|FG000|Overall Study|Change in diagnosis|1|||
164342859|NCT03330288|593631564|FG000|Overall Study|Other reason|1|||
164342860|NCT03330288|593631565|FG001|Overall Study|Other reason|1|||
164342861|NCT03330288|593631564|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
164342862|NCT03330288|593631565|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
164342863|NCT03330288|593631564|FG000|Overall Study|Adverse Event|1|||
164342864|NCT03330288|593631565|FG001|Overall Study|Adverse Event|0|||
164342865|NCT03330288|593631564|FG000|Overall Study|Withdrawal by Subject|1|||
164342866|NCT03330288|593631565|FG001|Overall Study|Withdrawal by Subject|0|||
164342867|NCT03330288|593631564|FG000|Overall Study|Lost to Follow-up|26|||
164342868|NCT03330288|593631565|FG001|Overall Study|Lost to Follow-up|7|||
164342869|NCT02805972|593631570|FG000|Washout Period|Lost to Follow-up|3|||
164342870|NCT02805972|593631571|FG001|Washout Period|Lost to Follow-up|0|||
164342871|NCT00939640|593631573|FG000|Overall Study|Physician Decision|1|||
164342872|NCT00389597|593631580|FG000|Overall Study|Lost to Follow-up|8|||
164342873|NCT00389597|593631581|FG001|Overall Study|Lost to Follow-up|6|||
164342874|NCT00389597|593631582|FG002|Overall Study|Lost to Follow-up|4|||
164342875|NCT00389597|593631583|FG003|Overall Study|Lost to Follow-up|6|||
164342876|NCT00334958|593631584|FG000|Overall Study|Medication Noncompliance|0|||
164342877|NCT00334958|593631585|FG001|Overall Study|Medication Noncompliance|3|||
164342878|NCT00334958|593631584|FG000|Overall Study|Protocol Violation|2|||
164342879|NCT00334958|593631585|FG001|Overall Study|Protocol Violation|2|||
164342880|NCT00334958|593631584|FG000|Overall Study|Request of the investigator or sponsor|0|||
164342881|NCT00334958|593631585|FG001|Overall Study|Request of the investigator or sponsor|1|||
164342882|NCT00334958|593631584|FG000|Overall Study|Withdrawal by Subject|7|||
164342883|NCT00334958|593631585|FG001|Overall Study|Withdrawal by Subject|4|||
164342884|NCT00334958|593631584|FG000|Overall Study|Adverse Event|27|||
164342885|NCT00334958|593631585|FG001|Overall Study|Adverse Event|12|||
164342886|NCT00334958|593631584|FG000|Overall Study|Other|1|||
164583409|NCT00984659|594500996|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
164274987|NCT01026220|593374621|FG002|Induction|Physician Decision|0|||
164274988|NCT01026220|593374619|FG000|Induction|Withdrawal by Subject|9|||
164274989|NCT01026220|593374620|FG001|Induction|Withdrawal by Subject|0|||
164274990|NCT01026220|593374621|FG002|Induction|Withdrawal by Subject|0|||
164274991|NCT01026220|593374619|FG000|Induction|Ineligible|1|||
164274992|NCT01026220|593374620|FG001|Induction|Ineligible|0|||
164274993|NCT01026220|593374621|FG002|Induction|Ineligible|0|||
164274994|NCT01026220|593374619|FG000|Consolidation Maintenance|Death|0|||
164342887|NCT00334958|593631585|FG001|Overall Study|Other|2|||
164342888|NCT00306189|593631586|FG000|Overall Study|Physician Decision|0|||
164583410|NCT00984659|594500997|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
164583411|NCT00984659|594500994|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
164583412|NCT00984659|594500995|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
164583413|NCT00984659|594500996|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
164583414|NCT00984659|594500997|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
164274995|NCT01026220|593374620|FG001|Consolidation Maintenance|Death|1|||
164274996|NCT01026220|593374621|FG002|Consolidation Maintenance|Death|0|||
164342889|NCT00306189|593631587|FG001|Overall Study|Physician Decision|0|||
164342890|NCT00306189|593631588|FG002|Overall Study|Physician Decision|0|||
164342891|NCT00306189|593631589|FG003|Overall Study|Physician Decision|1|||
164342892|NCT00306189|593631586|FG000|Overall Study|Adverse Event|3|||
164342893|NCT00306189|593631587|FG001|Overall Study|Adverse Event|3|||
164342894|NCT00306189|593631588|FG002|Overall Study|Adverse Event|2|||
164342895|NCT00306189|593631589|FG003|Overall Study|Adverse Event|2|||
164342896|NCT00306189|593631586|FG000|Overall Study|Withdrawal by Subject|4|||
164274997|NCT01026220|593374619|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
164274998|NCT01026220|593374620|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
164274999|NCT01026220|593374621|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
164275000|NCT01026220|593374619|FG000|Consolidation Maintenance|Physician Decision|0|||
164275001|NCT01026220|593374620|FG001|Consolidation Maintenance|Physician Decision|2|||
164275002|NCT01026220|593374621|FG002|Consolidation Maintenance|Physician Decision|7|||
164275003|NCT01026220|593374619|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
164275004|NCT01026220|593374620|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
164275005|NCT01026220|593374621|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
164275006|NCT00778895|593374622|FG000|Active Phase|Adverse Event|3|||
164275007|NCT00778895|593374623|FG001|Active Phase|Adverse Event|1|||
164275008|NCT00778895|593374624|FG002|Active Phase|Adverse Event|0|||
164275009|NCT00778895|593374622|FG000|Active Phase|Withdrawal by Subject|1|||
164275010|NCT00778895|593374623|FG001|Active Phase|Withdrawal by Subject|4|||
164275011|NCT00778895|593374624|FG002|Active Phase|Withdrawal by Subject|0|||
164275012|NCT00778895|593374622|FG000|Active Phase|Lost to Follow-up|1|||
164275013|NCT00778895|593374623|FG001|Active Phase|Lost to Follow-up|1|||
164275014|NCT00778895|593374624|FG002|Active Phase|Lost to Follow-up|0|||
164275015|NCT00778895|593374622|FG000|Active Phase|Other|2|||
164275016|NCT00778895|593374623|FG001|Active Phase|Other|0|||
164275017|NCT00778895|593374624|FG002|Active Phase|Other|0|||
164275018|NCT00778895|593374622|FG000|ESFU Phase|Adverse Event|2|||
164275019|NCT00778895|593374623|FG001|ESFU Phase|Adverse Event|1|||
164275020|NCT00778895|593374624|FG002|ESFU Phase|Adverse Event|0|||
164275021|NCT00778895|593374622|FG000|ESFU Phase|Withdrawal by Subject|1|||
164275022|NCT00778895|593374623|FG001|ESFU Phase|Withdrawal by Subject|4|||
164275023|NCT00778895|593374624|FG002|ESFU Phase|Withdrawal by Subject|0|||
164275024|NCT00778895|593374622|FG000|ESFU Phase|Lost to Follow-up|6|||
164275025|NCT00778895|593374623|FG001|ESFU Phase|Lost to Follow-up|7|||
164275026|NCT00778895|593374624|FG002|ESFU Phase|Lost to Follow-up|2|||
164275027|NCT00778895|593374622|FG000|ESFU Phase|Other|2|||
164275028|NCT00778895|593374623|FG001|ESFU Phase|Other|0|||
164275029|NCT00778895|593374624|FG002|ESFU Phase|Other|0|||
164275030|NCT03332160|593374625|FG000|Overall Study|Withdrawal by Subject|1|||
164275031|NCT03332160|593374626|FG001|Overall Study|Withdrawal by Subject|1|||
164275032|NCT03332160|593374625|FG000|Overall Study|Adverse Event|0|||
164275033|NCT03332160|593374626|FG001|Overall Study|Adverse Event|1|||
164275034|NCT03332160|593374625|FG000|Overall Study|Developed Exclusion Criteria|0|||
164275035|NCT03332160|593374626|FG001|Overall Study|Developed Exclusion Criteria|1|||
164275036|NCT03332160|593374625|FG000|Overall Study|Non-adherence to treatment|0|||
164275037|NCT03332160|593374626|FG001|Overall Study|Non-adherence to treatment|2|||
164275038|NCT01459913|593374628|FG000|Overall Study|Adverse Event|0|||
164275039|NCT01459913|593374629|FG001|Overall Study|Adverse Event|0|||
164275040|NCT01459913|593374630|FG002|Overall Study|Adverse Event|0|||
164275041|NCT01459913|593374631|FG003|Overall Study|Adverse Event|3|||
164275042|NCT01459913|593374628|FG000|Overall Study|Withdrawal by Subject|4|||
164275043|NCT01459913|593374629|FG001|Overall Study|Withdrawal by Subject|0|||
164275044|NCT01459913|593374630|FG002|Overall Study|Withdrawal by Subject|0|||
164275045|NCT01459913|593374631|FG003|Overall Study|Withdrawal by Subject|5|||
164275046|NCT01459913|593374628|FG000|Overall Study|Lost to Follow-up|7|||
164275047|NCT01459913|593374629|FG001|Overall Study|Lost to Follow-up|4|||
164275048|NCT01459913|593374630|FG002|Overall Study|Lost to Follow-up|1|||
164275049|NCT01459913|593374631|FG003|Overall Study|Lost to Follow-up|8|||
164275050|NCT01459913|593374628|FG000|Overall Study|Death|0|||
164275051|NCT01459913|593374629|FG001|Overall Study|Death|0|||
164275052|NCT01459913|593374630|FG002|Overall Study|Death|0|||
164275053|NCT01459913|593374631|FG003|Overall Study|Death|1|||
164275054|NCT01459913|593374628|FG000|Overall Study|Non- Compliance|0|||
164275055|NCT01459913|593374629|FG001|Overall Study|Non- Compliance|0|||
164275056|NCT01459913|593374630|FG002|Overall Study|Non- Compliance|0|||
164275057|NCT01459913|593374631|FG003|Overall Study|Non- Compliance|3|||
164275058|NCT01459913|593374628|FG000|Overall Study|Physician Decision|0|||
164275059|NCT01459913|593374629|FG001|Overall Study|Physician Decision|1|||
164275060|NCT01459913|593374630|FG002|Overall Study|Physician Decision|0|||
164689266|NCT01067521|594885517|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
164689267|NCT01067521|594885516|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
164275061|NCT01459913|593374631|FG003|Overall Study|Physician Decision|0|||
164275062|NCT01459913|593374628|FG000|Overall Study|Study Terminated by Sponsor|30|||
164275063|NCT01459913|593374629|FG001|Overall Study|Study Terminated by Sponsor|15|||
164275064|NCT01459913|593374630|FG002|Overall Study|Study Terminated by Sponsor|9|||
164275065|NCT01459913|593374631|FG003|Overall Study|Study Terminated by Sponsor|11|||
164275066|NCT01459913|593374628|FG000|Overall Study|Other|0|||
164275067|NCT01459913|593374629|FG001|Overall Study|Other|0|||
164275068|NCT01459913|593374630|FG002|Overall Study|Other|3|||
164275069|NCT01459913|593374631|FG003|Overall Study|Other|1|||
164689268|NCT01067521|594885517|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
164275070|NCT01459913|593374628|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
164275071|NCT01459913|593374629|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
164275072|NCT01459913|593374630|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
164275073|NCT01459913|593374631|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
164689269|NCT01067521|594885516|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
164689270|NCT01067521|594885517|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
164275074|NCT05096312|593374634|FG000|Overall Study|Lost to Follow-up|2|||
164275075|NCT05096312|593374635|FG001|Overall Study|Lost to Follow-up|4|||
164275076|NCT05096312|593374634|FG000|Overall Study|Adverse Event|1|||
164275077|NCT05096312|593374635|FG001|Overall Study|Adverse Event|0|||
164275078|NCT03135210|593374636|FG000|Overall Study|Death|0|||
164275079|NCT03135210|593374637|FG001|Overall Study|Death|1|||
164275080|NCT03517566|593374638|FG000|Overall Study|Adverse Event|5|||
164275081|NCT03517566|593374639|FG001|Overall Study|Adverse Event|2|||
164275082|NCT03517566|593374640|FG002|Overall Study|Adverse Event|2|||
164275083|NCT03517566|593374641|FG003|Overall Study|Adverse Event|8|||
164275084|NCT03517566|593374642|FG004|Overall Study|Adverse Event|7|||
164689271|NCT01067521|594885516|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
164689272|NCT01067521|594885517|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
164275085|NCT03517566|593374638|FG000|Overall Study|Lack of Efficacy|3|||
164275086|NCT03517566|593374639|FG001|Overall Study|Lack of Efficacy|2|||
164275087|NCT03517566|593374640|FG002|Overall Study|Lack of Efficacy|1|||
164275088|NCT03517566|593374641|FG003|Overall Study|Lack of Efficacy|1|||
164689273|NCT01067521|594885516|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
164689274|NCT01067521|594885517|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
164689275|NCT01067521|594885516|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
164689276|NCT01067521|594885517|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
164689277|NCT01067521|594885516|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
164689278|NCT01067521|594885517|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
164689279|NCT01067521|594885516|FG000|Open-Label Period|Death|3|||
164689280|NCT01067521|594885517|FG001|Open-Label Period|Death|1|||
164689281|NCT01067521|594885516|FG000|Open-Label Period|Adverse Event|30|||
164689282|NCT01067521|594885517|FG001|Open-Label Period|Adverse Event|28|||
164689283|NCT01067521|594885516|FG000|Open-Label Period|Withdrawal by Subject|160|||
164689284|NCT01067521|594885517|FG001|Open-Label Period|Withdrawal by Subject|88|||
164689285|NCT01067521|594885516|FG000|Open-Label Period|Physician Decision|13|||
164689286|NCT01067521|594885517|FG001|Open-Label Period|Physician Decision|11|||
164689287|NCT01067521|594885516|FG000|Open-Label Period|Non-compliance with study drug|5|||
164689288|NCT01067521|594885517|FG001|Open-Label Period|Non-compliance with study drug|0|||
164689289|NCT01067521|594885516|FG000|Open-Label Period|Protocol Violation|3|||
164689290|NCT01067521|594885517|FG001|Open-Label Period|Protocol Violation|0|||
164275089|NCT03517566|593374642|FG004|Overall Study|Lack of Efficacy|4|||
164275090|NCT03517566|593374638|FG000|Overall Study|Lost to Follow-up|3|||
164275091|NCT03517566|593374639|FG001|Overall Study|Lost to Follow-up|1|||
164275092|NCT03517566|593374640|FG002|Overall Study|Lost to Follow-up|1|||
164275093|NCT03517566|593374641|FG003|Overall Study|Lost to Follow-up|1|||
164275094|NCT03517566|593374642|FG004|Overall Study|Lost to Follow-up|0|||
164275095|NCT03517566|593374638|FG000|Overall Study|Physician Decision|1|||
164275096|NCT03517566|593374639|FG001|Overall Study|Physician Decision|1|||
164275097|NCT03517566|593374640|FG002|Overall Study|Physician Decision|0|||
164275098|NCT03517566|593374641|FG003|Overall Study|Physician Decision|1|||
164275099|NCT03517566|593374642|FG004|Overall Study|Physician Decision|0|||
164275100|NCT03517566|593374638|FG000|Overall Study|Pregnancy|0|||
164275101|NCT03517566|593374639|FG001|Overall Study|Pregnancy|1|||
164275102|NCT03517566|593374640|FG002|Overall Study|Pregnancy|0|||
164275103|NCT03517566|593374641|FG003|Overall Study|Pregnancy|0|||
164275104|NCT03517566|593374642|FG004|Overall Study|Pregnancy|0|||
164275105|NCT03517566|593374638|FG000|Overall Study|Protocol Deviation|0|||
164275106|NCT03517566|593374639|FG001|Overall Study|Protocol Deviation|1|||
164275107|NCT03517566|593374640|FG002|Overall Study|Protocol Deviation|0|||
164275108|NCT03517566|593374641|FG003|Overall Study|Protocol Deviation|1|||
164275109|NCT03517566|593374642|FG004|Overall Study|Protocol Deviation|1|||
164275110|NCT03517566|593374638|FG000|Overall Study|Study terminated by Sponsor|11|||
164275111|NCT03517566|593374639|FG001|Overall Study|Study terminated by Sponsor|5|||
164275112|NCT03517566|593374640|FG002|Overall Study|Study terminated by Sponsor|6|||
164275113|NCT03517566|593374641|FG003|Overall Study|Study terminated by Sponsor|14|||
164275114|NCT03517566|593374642|FG004|Overall Study|Study terminated by Sponsor|12|||
164275115|NCT03517566|593374638|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
164275116|NCT03517566|593374639|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
164275117|NCT03517566|593374640|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
164275118|NCT03517566|593374641|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
164275119|NCT03517566|593374642|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
164275120|NCT00671437|593374643|FG000|Overall Study|Progressive disease before C1 week 8|8|||
164275121|NCT00671437|593374643|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
164275122|NCT00671437|593374643|FG000|Overall Study|Adverse Event|3|||
164275123|NCT00671437|593374643|FG000|Overall Study|Ineligible post-hoc|1|||
164275124|NCT04349033|593374644|FG000|Overall Study|Lost to Follow-up|3|||
164275125|NCT04349033|593374645|FG001|Overall Study|Lost to Follow-up|1|||
164689291|NCT01067521|594885516|FG000|Open-Label Period|Pregnancy|14|||
164689292|NCT01067521|594885517|FG001|Open-Label Period|Pregnancy|8|||
164275126|NCT04349033|593374646|FG002|Overall Study|Lost to Follow-up|1|||
164689293|NCT01067521|594885516|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
164275127|NCT01704456|593374650|FG000|Overall Study|Lost to Follow-up|8|||
164275128|NCT01704456|593374651|FG001|Overall Study|Lost to Follow-up|14|||
164275129|NCT00915551|593374657|FG000|Overall Study|Withdrawal by Subject|0|||
164275130|NCT00915551|593374658|FG001|Overall Study|Withdrawal by Subject|1|||
164275131|NCT04390841|593374659|FG000|Overall Study|Withdrawal by Subject|2|||
164275132|NCT02540291|593374660|FG000|Overall Study|Death|7|||
164583415|NCT00984659|594500994|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
164583416|NCT00984659|594500995|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
164583417|NCT00984659|594500996|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
164275133|NCT02540291|593374661|FG001|Overall Study|Death|7|||
164275134|NCT02540291|593374662|FG002|Overall Study|Death|5|||
164275135|NCT02540291|593374663|FG003|Overall Study|Death|7|||
164275136|NCT02540291|593374660|FG000|Overall Study|Lost to Follow-up|0|||
164275137|NCT02540291|593374661|FG001|Overall Study|Lost to Follow-up|0|||
164275138|NCT02540291|593374662|FG002|Overall Study|Lost to Follow-up|1|||
164275139|NCT02540291|593374663|FG003|Overall Study|Lost to Follow-up|0|||
164275140|NCT02540291|593374660|FG000|Overall Study|Withdrawal Of Consent|0|||
164275141|NCT02540291|593374661|FG001|Overall Study|Withdrawal Of Consent|1|||
164275142|NCT02540291|593374662|FG002|Overall Study|Withdrawal Of Consent|0|||
164275143|NCT02540291|593374663|FG003|Overall Study|Withdrawal Of Consent|0|||
164275144|NCT02540291|593374660|FG000|Overall Study|Study Terminated By Sponsor|1|||
164275145|NCT02540291|593374661|FG001|Overall Study|Study Terminated By Sponsor|0|||
164275146|NCT02540291|593374662|FG002|Overall Study|Study Terminated By Sponsor|0|||
164275147|NCT02540291|593374663|FG003|Overall Study|Study Terminated By Sponsor|0|||
164275148|NCT02540291|593374660|FG000|Overall Study|Other|0|||
164275149|NCT02540291|593374661|FG001|Overall Study|Other|0|||
164275150|NCT02540291|593374662|FG002|Overall Study|Other|1|||
164275151|NCT02540291|593374663|FG003|Overall Study|Other|0|||
164299924|NCT02234843|593472945|FG001|Overall Study|Non-compliance with study drug|0|||
164299925|NCT02234843|593472946|FG002|Overall Study|Non-compliance with study drug|0|||
164299926|NCT02234843|593472947|FG003|Overall Study|Non-compliance with study drug|0|||
164299927|NCT02234843|593472948|FG004|Overall Study|Non-compliance with study drug|0|||
164299928|NCT02234843|593472949|FG005|Overall Study|Non-compliance with study drug|1|||
164299929|NCT02234843|593472950|FG006|Overall Study|Non-compliance with study drug|1|||
164299930|NCT02234843|593472951|FG007|Overall Study|Non-compliance with study drug|0|||
164299931|NCT02234843|593472952|FG008|Overall Study|Non-compliance with study drug|0|||
164299932|NCT02234843|593472953|FG009|Overall Study|Non-compliance with study drug|0|||
164299933|NCT02234843|593472944|FG000|Overall Study|Lost to Follow-up|0|||
164299934|NCT02234843|593472945|FG001|Overall Study|Lost to Follow-up|1|||
164299935|NCT02234843|593472946|FG002|Overall Study|Lost to Follow-up|0|||
164299936|NCT02234843|593472947|FG003|Overall Study|Lost to Follow-up|0|||
164299937|NCT02234843|593472948|FG004|Overall Study|Lost to Follow-up|0|||
164299938|NCT02234843|593472949|FG005|Overall Study|Lost to Follow-up|0|||
164342897|NCT00306189|593631587|FG001|Overall Study|Withdrawal by Subject|2|||
164342898|NCT00306189|593631588|FG002|Overall Study|Withdrawal by Subject|8|||
164342899|NCT00306189|593631589|FG003|Overall Study|Withdrawal by Subject|1|||
164342900|NCT00306189|593631586|FG000|Overall Study|Ineligibility determined|1|||
164342901|NCT00306189|593631587|FG001|Overall Study|Ineligibility determined|1|||
164342902|NCT00306189|593631588|FG002|Overall Study|Ineligibility determined|1|||
164342903|NCT00306189|593631589|FG003|Overall Study|Ineligibility determined|1|||
164583418|NCT00984659|594500997|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
164583419|NCT01966731|594500998|FG000|Overall Study|Death|2|||
164583420|NCT01966731|594500998|FG000|Overall Study|Lost to Follow-up|1|||
164583421|NCT01966731|594500998|FG000|Overall Study|Physician Decision|2|||
164583422|NCT01966731|594500998|FG000|Overall Study|Follow up is not complete|600|||
164583423|NCT01966731|594500998|FG000|Overall Study|Screening Failure|29|||
164583424|NCT01966731|594500998|FG000|Overall Study|Found to be ineligible|1|||
164583425|NCT00779038|594501000|FG000|Overall Study|Study Prematurely Terminated|13|||
164583426|NCT02717546|594501004|FG000|Overall Study|Lost to Follow-up|12|||
164583427|NCT00909090|594501005|FG000|Overall Study|Lost to Follow-up|17|||
164583428|NCT00909090|594501006|FG001|Overall Study|Lost to Follow-up|17|||
164583429|NCT02926573|594501008|FG000|Overall Study|Nausea|1|||
164583430|NCT02926573|594501009|FG001|Overall Study|Nausea|0|||
164583431|NCT02926573|594501008|FG000|Overall Study|Remain intubated|2|||
164583432|NCT02926573|594501009|FG001|Overall Study|Remain intubated|2|||
164583433|NCT02926573|594501008|FG000|Overall Study|Change in surgery plan|3|||
164583434|NCT02926573|594501009|FG001|Overall Study|Change in surgery plan|1|||
164583435|NCT02926573|594501008|FG000|Overall Study|Change to outpatient status|5|||
164583436|NCT02926573|594501009|FG001|Overall Study|Change to outpatient status|1|||
164583437|NCT02926573|594501008|FG000|Overall Study|Withdrawal by Subject|0|||
164299939|NCT02234843|593472950|FG006|Overall Study|Lost to Follow-up|1|||
164299940|NCT02234843|593472951|FG007|Overall Study|Lost to Follow-up|0|||
164299941|NCT02234843|593472952|FG008|Overall Study|Lost to Follow-up|0|||
164299942|NCT02234843|593472953|FG009|Overall Study|Lost to Follow-up|0|||
164299943|NCT01652235|593472960|FG000|Overall Study|Death|9|||
164299944|NCT01652235|593472960|FG000|Overall Study|Lost to Follow-up|5|||
164689294|NCT01067521|594885517|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
164689295|NCT01067521|594885516|FG000|Open-Label Period|Lost to Follow-up|21|||
164689296|NCT01067521|594885517|FG001|Open-Label Period|Lost to Follow-up|20|||
164689297|NCT04142658|594885520|FG000|Overall Study|Death|2|||
164689298|NCT04142658|594885521|FG001|Overall Study|Death|1|||
164689299|NCT04142658|594885520|FG000|Overall Study|Lost to Follow-up|4|||
164689300|NCT04142658|594885521|FG001|Overall Study|Lost to Follow-up|13|||
164689301|NCT04142658|594885520|FG000|Overall Study|Withdrawal by Subject|9|||
164689302|NCT04142658|594885521|FG001|Overall Study|Withdrawal by Subject|16|||
164689303|NCT01781234|594885522|FG000|Overall Study|Adverse Event|2|||
164689304|NCT01781234|594885523|FG001|Overall Study|Adverse Event|0|||
164689305|NCT01781234|594885522|FG000|Overall Study|Protocol Violation|3|||
164689306|NCT01781234|594885523|FG001|Overall Study|Protocol Violation|0|||
164689307|NCT01781234|594885522|FG000|Overall Study|Withdrawal by Subject|4|||
164689308|NCT01781234|594885523|FG001|Overall Study|Withdrawal by Subject|3|||
164689309|NCT01294449|594885528|FG000|Overall Study|Death|11|||
164689310|NCT01294449|594885529|FG001|Overall Study|Death|12|||
164689311|NCT01294449|594885528|FG000|Overall Study|Withdrawal by Subject|1|||
164689312|NCT01294449|594885529|FG001|Overall Study|Withdrawal by Subject|3|||
164689313|NCT01685216|594885530|FG000|Overall Study|Did not receive study drug|1|||
164689314|NCT02466386|594885531|FG000|Overall Study|Adverse Event|5|||
164689315|NCT02466386|594885531|FG000|Overall Study|Protocol Violation|2|||
164689316|NCT02466386|594885531|FG000|Overall Study|Withdrawal by Subject|14|||
164689317|NCT02466386|594885531|FG000|Overall Study|Lost to Follow-up|5|||
164689318|NCT02466386|594885531|FG000|Overall Study|Lack of Efficacy|8|||
164689319|NCT02466386|594885531|FG000|Overall Study|Other|10|||
164689320|NCT05317195|594885532|FG000|Randomization|Withdrawal by Subject|1|||
164689321|NCT05317195|594885532|FG000|Randomization|Discontinued|6|||
164583438|NCT02926573|594501009|FG001|Overall Study|Withdrawal by Subject|2|||
164583439|NCT02926573|594501008|FG000|Overall Study|Return to operating room|0|||
164583440|NCT02926573|594501009|FG001|Overall Study|Return to operating room|2|||
164583441|NCT02926573|594501008|FG000|Overall Study|Delirium|0|||
164689322|NCT05317195|594885532|FG000|Admission|Withdrawal by Subject|2|||
164689323|NCT04718129|594885537|FG000|Overall Study|Lost to Follow-up|6|||
164583442|NCT02926573|594501009|FG001|Overall Study|Delirium|1|||
164583443|NCT03633331|594501019|FG000|Overall Study|Withdrawal by Subject|1|||
164583444|NCT01009294|594501020|FG000|Overall Study|Study discontinued by Sponsor|6|||
164583445|NCT03240081|594501021|FG000|Overall Study|Withdrawal by Subject|0|||
164583446|NCT03240081|594501022|FG001|Overall Study|Withdrawal by Subject|2|||
164583447|NCT03240081|594501021|FG000|Overall Study|Lost to Follow-up|0|||
164583448|NCT03240081|594501022|FG001|Overall Study|Lost to Follow-up|1|||
164583449|NCT00949650|594501023|FG000|Overall Study|Progressive disease|188|||
164583450|NCT00949650|594501024|FG001|Overall Study|Progressive disease|19|||
164583451|NCT00949650|594501023|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
164583452|NCT00949650|594501024|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
164583453|NCT00949650|594501023|FG000|Overall Study|Other Adverse Event (AE)|28|||
164583454|NCT00949650|594501024|FG001|Overall Study|Other Adverse Event (AE)|17|||
164583455|NCT00949650|594501023|FG000|Overall Study|Protocol Violation|1|||
164583456|NCT00949650|594501024|FG001|Overall Study|Protocol Violation|4|||
164583457|NCT00949650|594501023|FG000|Overall Study|Refusal to continue medication|7|||
164583458|NCT00949650|594501024|FG001|Overall Study|Refusal to continue medication|11|||
164583459|NCT00949650|594501023|FG000|Overall Study|Not treated|1|||
164583460|NCT00949650|594501024|FG001|Overall Study|Not treated|4|||
164583461|NCT00949650|594501023|FG000|Overall Study|Other not specified above|5|||
164583462|NCT00949650|594501024|FG001|Overall Study|Other not specified above|0|||
164583463|NCT04601272|594501027|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
164583464|NCT04601272|594501028|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
164583465|NCT04601272|594501029|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
164583466|NCT01088412|594501032|FG000|Overall Study|Adverse Event|38|||
164583467|NCT01088412|594501033|FG001|Overall Study|Adverse Event|0|||
164689324|NCT04718129|594885538|FG001|Overall Study|Lost to Follow-up|7|||
164689325|NCT02212457|594885539|FG000|Overall Study|Adverse Event|1|||
164689326|NCT02212457|594885540|FG001|Overall Study|Adverse Event|2|||
164689327|NCT02212457|594885541|FG002|Overall Study|Adverse Event|2|||
164689328|NCT02212457|594885542|FG003|Overall Study|Adverse Event|2|||
164583468|NCT01088412|594501034|FG002|Overall Study|Adverse Event|0|||
164583469|NCT01088412|594501032|FG000|Overall Study|Death|42|||
164583470|NCT01088412|594501033|FG001|Overall Study|Death|6|||
164689329|NCT02212457|594885543|FG004|Overall Study|Adverse Event|0|||
164689330|NCT02212457|594885544|FG005|Overall Study|Adverse Event|1|||
164689331|NCT02212457|594885539|FG000|Overall Study|Withdrawal by Subject|8|||
164689332|NCT02212457|594885540|FG001|Overall Study|Withdrawal by Subject|10|||
164689333|NCT02212457|594885541|FG002|Overall Study|Withdrawal by Subject|8|||
164689334|NCT02212457|594885542|FG003|Overall Study|Withdrawal by Subject|6|||
164689335|NCT02212457|594885543|FG004|Overall Study|Withdrawal by Subject|5|||
164689336|NCT02212457|594885544|FG005|Overall Study|Withdrawal by Subject|4|||
164689337|NCT02212457|594885539|FG000|Overall Study|Lost to Follow-up|6|||
164431254|NCT00603538|593949421|FG002|Overall Study|Adverse Event|2|||
164431255|NCT00603538|593949419|FG000|Overall Study|Objective progression or relapse|3|||
164431256|NCT00603538|593949420|FG001|Overall Study|Objective progression or relapse|0|||
164431257|NCT00603538|593949421|FG002|Overall Study|Objective progression or relapse|0|||
164431258|NCT05750745|593949423|FG000|Overall Study|Adverse Event|1|||
164431259|NCT05750745|593949424|FG001|Overall Study|Adverse Event|0|||
164431260|NCT05750745|593949425|FG002|Overall Study|Adverse Event|0|||
164431261|NCT05750745|593949423|FG000|Overall Study|Protocol Violation|1|||
164431262|NCT05750745|593949424|FG001|Overall Study|Protocol Violation|0|||
164431263|NCT05750745|593949425|FG002|Overall Study|Protocol Violation|0|||
164431264|NCT05750745|593949423|FG000|Overall Study|Withdrawal by Subject|0|||
164431265|NCT05750745|593949424|FG001|Overall Study|Withdrawal by Subject|1|||
164431266|NCT05750745|593949425|FG002|Overall Study|Withdrawal by Subject|0|||
164431267|NCT01836458|593949431|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
164431268|NCT01836458|593949432|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164431269|NCT01836458|593949433|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
164431270|NCT01836458|593949434|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
164431271|NCT00429793|593949435|FG000|Overall Study|Improper pre-protocol treatment|3|||
164431272|NCT00429793|593949435|FG000|Overall Study|Required test not done|1|||
164431273|NCT00429793|593949435|FG000|Overall Study|Never treated|1|||
164431274|NCT00429793|593949435|FG000|Overall Study|Non-measurable|1|||
164431275|NCT02926937|593949436|FG000|Overall Study|Adverse Event|0|||
164431276|NCT02926937|593949437|FG001|Overall Study|Adverse Event|1|||
164431277|NCT02926937|593949438|FG002|Overall Study|Adverse Event|1|||
164431278|NCT02926937|593949436|FG000|Overall Study|Poor Compliance to Protocol|1|||
164431279|NCT02926937|593949437|FG001|Overall Study|Poor Compliance to Protocol|0|||
164431280|NCT02926937|593949438|FG002|Overall Study|Poor Compliance to Protocol|0|||
164431281|NCT02926937|593949436|FG000|Overall Study|Lost to Follow-up|4|||
164431282|NCT02926937|593949437|FG001|Overall Study|Lost to Follow-up|5|||
164431283|NCT02926937|593949438|FG002|Overall Study|Lost to Follow-up|0|||
164431284|NCT02926937|593949436|FG000|Overall Study|At the Participant's own Request|11|||
164431285|NCT02926937|593949437|FG001|Overall Study|At the Participant's own Request|5|||
164431286|NCT02926937|593949438|FG002|Overall Study|At the Participant's own Request|8|||
164431287|NCT02926937|593949436|FG000|Overall Study|Reason not Specified|3|||
164431288|NCT02926937|593949437|FG001|Overall Study|Reason not Specified|4|||
164583471|NCT01088412|594501034|FG002|Overall Study|Death|0|||
164583472|NCT01088412|594501032|FG000|Overall Study|Other Reason per Case Report Form|2089|||
164583473|NCT01088412|594501033|FG001|Overall Study|Other Reason per Case Report Form|103|||
164583474|NCT01088412|594501034|FG002|Overall Study|Other Reason per Case Report Form|9|||
164583475|NCT01088412|594501032|FG000|Overall Study|Withdrawal by Subject|1761|||
164583476|NCT01088412|594501033|FG001|Overall Study|Withdrawal by Subject|25|||
164583477|NCT01088412|594501034|FG002|Overall Study|Withdrawal by Subject|1|||
164583478|NCT01088412|594501032|FG000|Overall Study|Received Another GH Product|79|||
164583479|NCT01088412|594501033|FG001|Overall Study|Received Another GH Product|0|||
164583480|NCT01088412|594501034|FG002|Overall Study|Received Another GH Product|0|||
164583481|NCT01088412|594501032|FG000|Overall Study|Participant Moved|601|||
164583482|NCT01088412|594501033|FG001|Overall Study|Participant Moved|21|||
164583483|NCT01088412|594501034|FG002|Overall Study|Participant Moved|2|||
164583484|NCT01088412|594501032|FG000|Overall Study|Physician Decision|1041|||
164583485|NCT01088412|594501033|FG001|Overall Study|Physician Decision|8|||
164583486|NCT01088412|594501034|FG002|Overall Study|Physician Decision|4|||
164583487|NCT01088412|594501032|FG000|Overall Study|Sponsor Decision|4467|||
164583488|NCT01088412|594501033|FG001|Overall Study|Sponsor Decision|79|||
164583489|NCT01088412|594501034|FG002|Overall Study|Sponsor Decision|23|||
164583490|NCT01088412|594501032|FG000|Overall Study|Third Party Required to Change Brand|487|||
164583491|NCT01088412|594501033|FG001|Overall Study|Third Party Required to Change Brand|0|||
164583492|NCT01088412|594501034|FG002|Overall Study|Third Party Required to Change Brand|0|||
164583493|NCT01088412|594501032|FG000|Overall Study|Lost to Follow-up|3052|||
164583494|NCT01088412|594501033|FG001|Overall Study|Lost to Follow-up|130|||
164583495|NCT01088412|594501034|FG002|Overall Study|Lost to Follow-up|11|||
164583496|NCT01088412|594501032|FG000|Overall Study|Study Summary Not Completed|4360|||
164583497|NCT01088412|594501033|FG001|Overall Study|Study Summary Not Completed|64|||
164583498|NCT01088412|594501034|FG002|Overall Study|Study Summary Not Completed|22|||
164583499|NCT00793104|594501035|FG000|Overall Study|Lost to Follow-up|1|||
164583500|NCT01926886|594501036|FG000|Overall Study|Administrative/other|1|||
164583501|NCT01926886|594501037|FG001|Overall Study|Administrative/other|0|||
164583502|NCT01926886|594501036|FG000|Overall Study|Adverse event/intercurrent illness|4|||
164583503|NCT01926886|594501037|FG001|Overall Study|Adverse event/intercurrent illness|0|||
164583504|NCT01926886|594501036|FG000|Overall Study|Disease progression/recurrence|4|||
164583505|NCT01926886|594501037|FG001|Overall Study|Disease progression/recurrence|0|||
164583506|NCT01926886|594501036|FG000|Overall Study|Withdrawal by Subject|15|||
164431289|NCT02926937|593949438|FG002|Overall Study|Reason not Specified|2|||
164431290|NCT01559090|593949439|FG000|Stage I|Withdrawal by Subject|2|||
164431291|NCT01559090|593949440|FG001|Stage I|Withdrawal by Subject|2|||
164431292|NCT01559090|593949441|FG002|Stage I|Withdrawal by Subject|3|||
164431293|NCT01559090|593949439|FG000|Stage II|Withdrawal by Subject|1|||
164275152|NCT01031979|593376233|FG000|Overall Study|Lost to Follow-up|5|||
164275153|NCT01031979|593376234|FG001|Overall Study|Lost to Follow-up|4|||
164275154|NCT03831100|593376235|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
164275155|NCT03831100|593376236|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
164275156|NCT02454478|593376239|FG000|Overall Study|Incomplete DLT Evaluation|1|||
164275157|NCT01732770|593376240|FG000|Overall Study|Lost to Follow-up|2|||
164275158|NCT01732770|593376241|FG001|Overall Study|Lost to Follow-up|3|||
164275159|NCT01732770|593376240|FG000|Overall Study|Withdrawal by Subject|5|||
164275160|NCT01732770|593376241|FG001|Overall Study|Withdrawal by Subject|3|||
164275161|NCT01732770|593376240|FG000|Overall Study|Decision by Sponsor|2|||
164275162|NCT01732770|593376241|FG001|Overall Study|Decision by Sponsor|2|||
164275163|NCT01732770|593376240|FG000|Overall Study|Death|1|||
164275164|NCT01732770|593376241|FG001|Overall Study|Death|0|||
164431294|NCT01559090|593949440|FG001|Stage II|Withdrawal by Subject|0|||
164583507|NCT01926886|594501037|FG001|Overall Study|Withdrawal by Subject|0|||
164583508|NCT01926886|594501036|FG000|Overall Study|Failure to return|3|||
164583509|NCT01926886|594501037|FG001|Overall Study|Failure to return|0|||
164275165|NCT01450098|593376242|FG000|Period 3|Protocol Violation|0|||
164275166|NCT01450098|593376243|FG001|Period 3|Protocol Violation|1|||
164275167|NCT01450098|593376242|FG000|Period 3|Withdrawal by Subject|0|||
164275168|NCT01450098|593376243|FG001|Period 3|Withdrawal by Subject|2|||
164275169|NCT03229109|593376246|FG000|Overall Study|Withdrawal by Subject|0|||
164275170|NCT03229109|593376247|FG001|Overall Study|Withdrawal by Subject|0|||
164275171|NCT03229109|593376248|FG002|Overall Study|Withdrawal by Subject|0|||
164275172|NCT03229109|593376249|FG003|Overall Study|Withdrawal by Subject|1|||
164275173|NCT03329196|593376252|FG000|Overall Study|Adverse Event|10|||
164275174|NCT03329196|593376253|FG001|Overall Study|Adverse Event|5|||
164275175|NCT03329196|593376252|FG000|Overall Study|Physician Decision|2|||
164275176|NCT03329196|593376253|FG001|Overall Study|Physician Decision|2|||
164275177|NCT03329196|593376252|FG000|Overall Study|Withdrawal by Subject|11|||
164275178|NCT03329196|593376253|FG001|Overall Study|Withdrawal by Subject|3|||
164275179|NCT03329196|593376252|FG000|Overall Study|Hepatic function abnormalities|0|||
164275180|NCT03329196|593376253|FG001|Overall Study|Hepatic function abnormalities|1|||
164275181|NCT03329196|593376252|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
164275182|NCT03329196|593376253|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
164275183|NCT03329196|593376252|FG000|Overall Study|Difficult to control Hb|2|||
164275184|NCT03329196|593376253|FG001|Overall Study|Difficult to control Hb|3|||
164275185|NCT03329196|593376252|FG000|Overall Study|Dialysis or renal transplant|13|||
164275186|NCT03329196|593376253|FG001|Overall Study|Dialysis or renal transplant|15|||
164275187|NCT04481750|593376257|FG000|Period 1 (Fasted)|Adverse Event|0|||
164275188|NCT04481750|593376258|FG001|Period 1 (Fasted)|Adverse Event|0|||
164275189|NCT04481750|593376259|FG002|Period 1 (Fasted)|Adverse Event|1|||
164275190|NCT04481750|593376260|FG003|Period 1 (Fasted)|Adverse Event|0|||
164275191|NCT04481750|593376261|FG004|Period 1 (Fasted)|Adverse Event|0|||
164583510|NCT01926886|594501036|FG000|Overall Study|Recurrence of disease|1|||
164583511|NCT01926886|594501037|FG001|Overall Study|Recurrence of disease|0|||
164583512|NCT01926886|594501036|FG000|Overall Study|Progression of disease|2|||
164583513|NCT01926886|594501037|FG001|Overall Study|Progression of disease|0|||
164583514|NCT01926886|594501036|FG000|Overall Study|Death|1|||
164583515|NCT01926886|594501037|FG001|Overall Study|Death|0|||
164583516|NCT01926886|594501036|FG000|Overall Study|Did not cooperate|1|||
164583517|NCT01926886|594501037|FG001|Overall Study|Did not cooperate|0|||
164583518|NCT02986373|594501038|FG000|Overall Study|Adverse Event|4|||
164583519|NCT02986373|594501038|FG000|Overall Study|Lost to Follow-up|1|||
164583520|NCT02986373|594501038|FG000|Overall Study|Withdrawal by Subject|10|||
164583521|NCT02986373|594501038|FG000|Overall Study|Other|24|||
164583522|NCT04800315|594501039|FG000|Randomization|Did not receive study treatment|1|||
164583523|NCT04800315|594501040|FG001|Randomization|Did not receive study treatment|0|||
164583524|NCT04800315|594501041|FG002|Randomization|Did not receive study treatment|0|||
164583525|NCT04800315|594501042|FG003|Randomization|Did not receive study treatment|0|||
164583526|NCT04800315|594501039|FG000|Treatment Period|Adverse Event|4|||
164583527|NCT04800315|594501040|FG001|Treatment Period|Adverse Event|2|||
164583528|NCT04800315|594501041|FG002|Treatment Period|Adverse Event|1|||
164583529|NCT04800315|594501042|FG003|Treatment Period|Adverse Event|2|||
164583530|NCT04800315|594501039|FG000|Treatment Period|Lack of Efficacy|1|||
164583531|NCT04800315|594501040|FG001|Treatment Period|Lack of Efficacy|0|||
164583532|NCT04800315|594501041|FG002|Treatment Period|Lack of Efficacy|0|||
164583533|NCT04800315|594501042|FG003|Treatment Period|Lack of Efficacy|3|||
164583534|NCT04800315|594501039|FG000|Treatment Period|Lost to Follow-up|0|||
164583535|NCT04800315|594501040|FG001|Treatment Period|Lost to Follow-up|1|||
164275192|NCT04481750|593376262|FG005|Period 1 (Fasted)|Adverse Event|0|||
164275193|NCT04481750|593376263|FG006|Period 1 (Fasted)|Adverse Event|0|||
164431295|NCT01559090|593949441|FG002|Stage II|Withdrawal by Subject|0|||
164583536|NCT04800315|594501041|FG002|Treatment Period|Lost to Follow-up|2|||
164583537|NCT04800315|594501042|FG003|Treatment Period|Lost to Follow-up|2|||
164583538|NCT04800315|594501039|FG000|Treatment Period|Withdrawal by participant|0|||
164689338|NCT02212457|594885540|FG001|Overall Study|Lost to Follow-up|7|||
164689339|NCT02212457|594885541|FG002|Overall Study|Lost to Follow-up|4|||
164689340|NCT02212457|594885542|FG003|Overall Study|Lost to Follow-up|1|||
164689341|NCT02212457|594885543|FG004|Overall Study|Lost to Follow-up|8|||
164689342|NCT02212457|594885544|FG005|Overall Study|Lost to Follow-up|4|||
164689343|NCT02212457|594885539|FG000|Overall Study|Protocol Violation|2|||
164689344|NCT02212457|594885540|FG001|Overall Study|Protocol Violation|1|||
164689345|NCT02212457|594885541|FG002|Overall Study|Protocol Violation|0|||
164689346|NCT02212457|594885542|FG003|Overall Study|Protocol Violation|1|||
164689347|NCT02212457|594885543|FG004|Overall Study|Protocol Violation|2|||
164689348|NCT02212457|594885544|FG005|Overall Study|Protocol Violation|3|||
164689349|NCT02212457|594885539|FG000|Overall Study|Other|2|||
164689350|NCT02212457|594885540|FG001|Overall Study|Other|1|||
164689351|NCT02212457|594885541|FG002|Overall Study|Other|2|||
164689352|NCT02212457|594885542|FG003|Overall Study|Other|1|||
164689353|NCT02212457|594885543|FG004|Overall Study|Other|0|||
164689354|NCT02212457|594885544|FG005|Overall Study|Other|1|||
164689355|NCT00772148|594885548|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
164689356|NCT00772148|594885549|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
164689357|NCT00772148|594885548|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
164689358|NCT00772148|594885549|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
164689359|NCT00772148|594885548|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
164689360|NCT00772148|594885549|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
164689361|NCT00772148|594885548|FG000|Maintenance Phase (Week 52)|Death|2|||
164689362|NCT00772148|594885549|FG001|Maintenance Phase (Week 52)|Death|2|||
164689363|NCT00772148|594885548|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
164689364|NCT00772148|594885549|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
164689365|NCT00772148|594885548|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
164689366|NCT00772148|594885549|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
164689367|NCT00772148|594885548|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
164275194|NCT04481750|593376264|FG007|Period 1 (Fasted)|Adverse Event|0|||
164275195|NCT04481750|593376265|FG008|Period 1 (Fasted)|Adverse Event|0|||
164275196|NCT04481750|593376266|FG009|Period 1 (Fasted)|Adverse Event|0|||
164275197|NCT04481750|593376267|FG010|Period 1 (Fasted)|Adverse Event|0|||
164275198|NCT03176771|593376268|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
164275199|NCT03176771|593376269|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
164275200|NCT03176771|593376270|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
164275201|NCT03176771|593376271|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
164275202|NCT03176771|593376272|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
164275203|NCT03176771|593376268|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
164275204|NCT03176771|593376269|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
164275205|NCT03176771|593376270|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
164275206|NCT03176771|593376271|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
164275207|NCT03176771|593376272|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
164275208|NCT03176771|593376268|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
164275209|NCT03176771|593376269|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
164275210|NCT03176771|593376270|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
164275211|NCT03176771|593376271|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
164275212|NCT03176771|593376272|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
164275213|NCT03176771|593376268|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
164275214|NCT03176771|593376269|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
164275215|NCT03176771|593376270|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
164275216|NCT03176771|593376271|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
164275217|NCT03176771|593376272|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
164275218|NCT03176771|593376268|FG000|Double-Blind Extension Period|Adverse Event|0|||
164342904|NCT00306189|593631586|FG000|Overall Study|Other|1|||
164689368|NCT00772148|594885549|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
164689369|NCT00688844|594885550|FG000|Overall Study|Lost to Follow-up|10|||
164275219|NCT03176771|593376269|FG001|Double-Blind Extension Period|Adverse Event|0|||
164275220|NCT03176771|593376270|FG002|Double-Blind Extension Period|Adverse Event|0|||
164275221|NCT03176771|593376271|FG003|Double-Blind Extension Period|Adverse Event|15|||
164275222|NCT03176771|593376272|FG004|Double-Blind Extension Period|Adverse Event|18|||
164342905|NCT00306189|593631587|FG001|Overall Study|Other|0|||
164342906|NCT00306189|593631588|FG002|Overall Study|Other|0|||
164342907|NCT00306189|593631589|FG003|Overall Study|Other|0|||
164689370|NCT00857818|594885551|FG000|Overall Study|Lack of Efficacy|1|||
164689371|NCT00857818|594885552|FG001|Overall Study|Lack of Efficacy|0|||
164689372|NCT00857818|594885551|FG000|Overall Study|Adverse Event|3|||
164689373|NCT00857818|594885552|FG001|Overall Study|Adverse Event|0|||
164689374|NCT00857818|594885551|FG000|Overall Study|Withdrawal by Subject|0|||
164689375|NCT00857818|594885552|FG001|Overall Study|Withdrawal by Subject|4|||
164689376|NCT00857818|594885551|FG000|Overall Study|Sponsor terminated study|6|||
164689377|NCT00857818|594885552|FG001|Overall Study|Sponsor terminated study|4|||
164689378|NCT00857818|594885551|FG000|Overall Study|Investigator decision|1|||
164275223|NCT03176771|593376268|FG000|Double-Blind Extension Period|Death|0|||
164275224|NCT03176771|593376269|FG001|Double-Blind Extension Period|Death|0|||
164275225|NCT03176771|593376270|FG002|Double-Blind Extension Period|Death|0|||
164275226|NCT03176771|593376271|FG003|Double-Blind Extension Period|Death|3|||
164275227|NCT03176771|593376272|FG004|Double-Blind Extension Period|Death|4|||
164275228|NCT03176771|593376268|FG000|Double-Blind Extension Period|Physician Decision|0|||
164275229|NCT03176771|593376269|FG001|Double-Blind Extension Period|Physician Decision|0|||
164275230|NCT03176771|593376270|FG002|Double-Blind Extension Period|Physician Decision|0|||
164275231|NCT03176771|593376271|FG003|Double-Blind Extension Period|Physician Decision|3|||
164275232|NCT03176771|593376272|FG004|Double-Blind Extension Period|Physician Decision|1|||
164275233|NCT03176771|593376268|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
164275234|NCT03176771|593376269|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
164275235|NCT03176771|593376270|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
164275236|NCT03176771|593376271|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
164275237|NCT03176771|593376272|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
164275238|NCT03439137|593376273|FG000|Overall Study|Adverse Event|16|||
164275239|NCT03439137|593376274|FG001|Overall Study|Adverse Event|12|||
164275240|NCT03439137|593376273|FG000|Overall Study|Physician Decision|0|||
164275241|NCT03439137|593376274|FG001|Overall Study|Physician Decision|5|||
164275242|NCT03439137|593376273|FG000|Overall Study|Withdrawal by Subject|14|||
164275243|NCT03439137|593376274|FG001|Overall Study|Withdrawal by Subject|4|||
164275244|NCT03439137|593376273|FG000|Overall Study|Conducting rescue therapy|2|||
164275245|NCT03439137|593376274|FG001|Overall Study|Conducting rescue therapy|1|||
164275246|NCT03439137|593376273|FG000|Overall Study|Difficult to control Hb|10|||
164275247|NCT03439137|593376274|FG001|Overall Study|Difficult to control Hb|2|||
164275248|NCT03439137|593376273|FG000|Overall Study|Initiation of a renal transplant|0|||
164275249|NCT03439137|593376274|FG001|Overall Study|Initiation of a renal transplant|2|||
164275250|NCT00691028|593376275|FG000|Open-label Period|Adverse Event|0|||
164275251|NCT00691028|593376276|FG001|Open-label Period|Adverse Event|0|||
164275252|NCT00691028|593376277|FG002|Open-label Period|Adverse Event|0|||
164275253|NCT00691028|593376278|FG003|Open-label Period|Adverse Event|16|||
164275254|NCT00691028|593376275|FG000|Open-label Period|Withdrawal by Subject|0|||
164275255|NCT00691028|593376276|FG001|Open-label Period|Withdrawal by Subject|0|||
164275256|NCT00691028|593376277|FG002|Open-label Period|Withdrawal by Subject|0|||
164275257|NCT00691028|593376278|FG003|Open-label Period|Withdrawal by Subject|3|||
164275258|NCT00691028|593376275|FG000|Open-label Period|not come to a hospital|0|||
164275259|NCT00691028|593376276|FG001|Open-label Period|not come to a hospital|0|||
164275260|NCT00691028|593376277|FG002|Open-label Period|not come to a hospital|0|||
164275261|NCT00691028|593376278|FG003|Open-label Period|not come to a hospital|1|||
164275262|NCT00691028|593376275|FG000|Double-blind Period|Adverse Event|8|||
164275263|NCT00691028|593376276|FG001|Double-blind Period|Adverse Event|9|||
164275264|NCT00691028|593376277|FG002|Double-blind Period|Adverse Event|6|||
164275265|NCT00691028|593376278|FG003|Double-blind Period|Adverse Event|0|||
164275266|NCT00691028|593376275|FG000|Double-blind Period|Lack of Efficacy|4|||
164275267|NCT00691028|593376276|FG001|Double-blind Period|Lack of Efficacy|3|||
164275268|NCT00691028|593376277|FG002|Double-blind Period|Lack of Efficacy|2|||
164275269|NCT00691028|593376278|FG003|Double-blind Period|Lack of Efficacy|0|||
164275270|NCT00691028|593376275|FG000|Double-blind Period|Withdrawal by Subject|1|||
164275271|NCT00691028|593376276|FG001|Double-blind Period|Withdrawal by Subject|0|||
164275272|NCT00691028|593376277|FG002|Double-blind Period|Withdrawal by Subject|1|||
164275273|NCT00691028|593376278|FG003|Double-blind Period|Withdrawal by Subject|0|||
164275274|NCT00691028|593376275|FG000|Double-blind Period|not come to a hospital.|0|||
164275275|NCT00691028|593376276|FG001|Double-blind Period|not come to a hospital.|1|||
164275276|NCT00691028|593376277|FG002|Double-blind Period|not come to a hospital.|0|||
164275277|NCT00691028|593376278|FG003|Double-blind Period|not come to a hospital.|0|||
164275278|NCT03387020|593376279|FG000|Overall Study|Adverse Event|0|||
164275279|NCT03387020|593376280|FG001|Overall Study|Adverse Event|2|||
164275280|NCT03387020|593376281|FG002|Overall Study|Adverse Event|0|||
164275281|NCT03387020|593376279|FG000|Overall Study|Withdrawal by Subject|2|||
164275282|NCT03387020|593376280|FG001|Overall Study|Withdrawal by Subject|0|||
164275283|NCT03387020|593376281|FG002|Overall Study|Withdrawal by Subject|0|||
164275284|NCT04512976|593376286|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
164275285|NCT04512976|593376287|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
164275286|NCT04512976|593376288|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
164275287|NCT04512976|593376289|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
164275288|NCT04512976|593376290|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
164275289|NCT04512976|593376291|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
164275290|NCT04617496|593376295|FG000|Overall Study|Death|2|||
164275291|NCT04617496|593376296|FG001|Overall Study|Death|1|||
164275292|NCT04617496|593376295|FG000|Overall Study|Lost to Follow-up|3|||
164275293|NCT04617496|593376296|FG001|Overall Study|Lost to Follow-up|3|||
164275294|NCT01596335|593376297|FG000|Overall Study|exacerbation of primary disease|5|||
164275295|NCT01596335|593376298|FG001|Overall Study|exacerbation of primary disease|9|||
164689379|NCT00857818|594885552|FG001|Overall Study|Investigator decision|0|||
164689380|NCT02061280|594885556|FG000|Overall Study|Protocol Violation|12|||
164689381|NCT02061280|594885557|FG001|Overall Study|Protocol Violation|8|||
164689382|NCT02061280|594885556|FG000|Overall Study|moved out of state|0|||
164689383|NCT02061280|594885557|FG001|Overall Study|moved out of state|1|||
164689384|NCT02061280|594885556|FG000|Overall Study|Withdrawal by Subject|1|||
164689385|NCT02061280|594885557|FG001|Overall Study|Withdrawal by Subject|2|||
164689386|NCT02061280|594885556|FG000|Overall Study|Lost to Follow-up|5|||
164689387|NCT02061280|594885557|FG001|Overall Study|Lost to Follow-up|1|||
164689388|NCT01977456|594885558|FG000|Overall Study|Death|5|||
164689389|NCT01841060|594887720|FG000|Overall Study|Protocol Violation|10|||
164689390|NCT05258630|594887721|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
164689391|NCT05258630|594887722|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
164689392|NCT05258630|594887721|FG000|Overall Study|Lost to Follow-up|0|||
164689393|NCT05258630|594887722|FG001|Overall Study|Lost to Follow-up|2|||
164689394|NCT02419573|594887723|FG000|Overall Study|Lost to Follow-up|3|||
164689395|NCT02419573|594887724|FG001|Overall Study|Lost to Follow-up|0|||
164689396|NCT02419573|594887723|FG000|Overall Study|Withdrawal by Subject|1|||
164689397|NCT02419573|594887724|FG001|Overall Study|Withdrawal by Subject|0|||
164689398|NCT00401245|594887725|FG000|Double Blind Titration Phase|Adverse Event|3|||
164689399|NCT00401245|594887726|FG001|Double Blind Titration Phase|Adverse Event|2|||
164689400|NCT00401245|594887727|FG002|Double Blind Titration Phase|Adverse Event|5|||
164689401|NCT00401245|594887728|FG003|Double Blind Titration Phase|Adverse Event|12|||
164689402|NCT00401245|594887729|FG004|Double Blind Titration Phase|Adverse Event|0|||
164689403|NCT00401245|594887730|FG005|Double Blind Titration Phase|Adverse Event|0|||
164689404|NCT00401245|594887731|FG006|Double Blind Titration Phase|Adverse Event|0|||
164689405|NCT00401245|594887732|FG007|Double Blind Titration Phase|Adverse Event|0|||
164689406|NCT00401245|594887725|FG000|Double Blind Titration Phase|Other|0|||
164689407|NCT00401245|594887726|FG001|Double Blind Titration Phase|Other|0|||
164689408|NCT00401245|594887727|FG002|Double Blind Titration Phase|Other|1|||
164689409|NCT00401245|594887728|FG003|Double Blind Titration Phase|Other|0|||
164689410|NCT00401245|594887729|FG004|Double Blind Titration Phase|Other|0|||
164689411|NCT00401245|594887730|FG005|Double Blind Titration Phase|Other|0|||
164689412|NCT00401245|594887731|FG006|Double Blind Titration Phase|Other|0|||
164689413|NCT00401245|594887732|FG007|Double Blind Titration Phase|Other|0|||
164689414|NCT00401245|594887725|FG000|Double Blind Titration Phase|Protocol Violation|0|||
164689415|NCT00401245|594887726|FG001|Double Blind Titration Phase|Protocol Violation|0|||
164689416|NCT00401245|594887727|FG002|Double Blind Titration Phase|Protocol Violation|0|||
164689417|NCT00401245|594887728|FG003|Double Blind Titration Phase|Protocol Violation|1|||
164689418|NCT00401245|594887729|FG004|Double Blind Titration Phase|Protocol Violation|0|||
164275296|NCT01192412|593376299|FG000|Overall Study|Lost to Follow-up|2|||
164275297|NCT01192412|593376300|FG001|Overall Study|Lost to Follow-up|1|||
164275298|NCT01192412|593376299|FG000|Overall Study|Withdrawal by Subject|2|||
164275299|NCT01192412|593376300|FG001|Overall Study|Withdrawal by Subject|1|||
164275300|NCT02421588|593376301|FG000|Overall Study|Non-treatment-related AE|8|||
164275301|NCT02421588|593376302|FG001|Overall Study|Non-treatment-related AE|8|||
164275302|NCT02421588|593376301|FG000|Overall Study|Progressive disease|152|||
164275303|NCT02421588|593376302|FG001|Overall Study|Progressive disease|135|||
164275304|NCT02421588|593376301|FG000|Overall Study|Death|11|||
164275305|NCT02421588|593376302|FG001|Overall Study|Death|3|||
164275306|NCT02421588|593376301|FG000|Overall Study|Physician Decision|8|||
164275307|NCT02421588|593376302|FG001|Overall Study|Physician Decision|17|||
164275308|NCT02421588|593376301|FG000|Overall Study|Other reason not specified|3|||
164275309|NCT02421588|593376302|FG001|Overall Study|Other reason not specified|1|||
164275310|NCT02421588|593376301|FG000|Overall Study|Symptomatic deterioration|13|||
164275311|NCT02421588|593376302|FG001|Overall Study|Symptomatic deterioration|19|||
164275312|NCT02421588|593376301|FG000|Overall Study|Treatment-related AE|10|||
164275313|NCT02421588|593376302|FG001|Overall Study|Treatment-related AE|14|||
164275314|NCT02421588|593376301|FG000|Overall Study|Withdrawal by Subject|14|||
164275315|NCT02421588|593376302|FG001|Overall Study|Withdrawal by Subject|16|||
164275316|NCT02421588|593376301|FG000|Overall Study|Not treated|2|||
164275317|NCT02421588|593376302|FG001|Overall Study|Not treated|8|||
164689419|NCT00401245|594887730|FG005|Double Blind Titration Phase|Protocol Violation|0|||
164689420|NCT00401245|594887731|FG006|Double Blind Titration Phase|Protocol Violation|0|||
164689421|NCT00401245|594887732|FG007|Double Blind Titration Phase|Protocol Violation|0|||
164689422|NCT00401245|594887725|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
164689423|NCT00401245|594887726|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
164689424|NCT00401245|594887727|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
164689425|NCT00401245|594887728|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
164689426|NCT00401245|594887729|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
164275318|NCT01004952|593376305|FG000|Overall Study|Lost to Follow-up|0|||
164275319|NCT01004952|593376306|FG001|Overall Study|Lost to Follow-up|11|||
164275320|NCT01004952|593376305|FG000|Overall Study|Withdrawal by Subject|0|||
164275321|NCT01004952|593376306|FG001|Overall Study|Withdrawal by Subject|5|||
164275322|NCT01359943|593376307|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
164689427|NCT00401245|594887730|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
164689428|NCT00401245|594887731|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
164689429|NCT00401245|594887732|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
164689430|NCT00401245|594887725|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
164689431|NCT00401245|594887726|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
164689432|NCT00401245|594887727|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
164689433|NCT00401245|594887728|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
164689434|NCT00401245|594887729|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
164689435|NCT00401245|594887730|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
164689436|NCT00401245|594887731|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
164689437|NCT00401245|594887732|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
164689438|NCT00401245|594887725|FG000|Open Label Phase|Adverse Event|5|||
164689439|NCT00401245|594887726|FG001|Open Label Phase|Adverse Event|14|||
164689440|NCT00401245|594887727|FG002|Open Label Phase|Adverse Event|6|||
164689441|NCT00401245|594887728|FG003|Open Label Phase|Adverse Event|7|||
164689442|NCT00401245|594887729|FG004|Open Label Phase|Adverse Event|0|||
164689443|NCT00401245|594887730|FG005|Open Label Phase|Adverse Event|0|||
164689444|NCT00401245|594887731|FG006|Open Label Phase|Adverse Event|0|||
164689445|NCT00401245|594887732|FG007|Open Label Phase|Adverse Event|0|||
164689446|NCT00401245|594887725|FG000|Open Label Phase|Lost to Follow-up|5|||
164689447|NCT00401245|594887726|FG001|Open Label Phase|Lost to Follow-up|7|||
164689448|NCT00401245|594887727|FG002|Open Label Phase|Lost to Follow-up|5|||
164689449|NCT00401245|594887728|FG003|Open Label Phase|Lost to Follow-up|4|||
164689450|NCT00401245|594887729|FG004|Open Label Phase|Lost to Follow-up|0|||
164689451|NCT00401245|594887730|FG005|Open Label Phase|Lost to Follow-up|0|||
164689452|NCT00401245|594887731|FG006|Open Label Phase|Lost to Follow-up|0|||
164689453|NCT00401245|594887732|FG007|Open Label Phase|Lost to Follow-up|0|||
164689454|NCT00401245|594887725|FG000|Open Label Phase|Other|4|||
164689455|NCT00401245|594887726|FG001|Open Label Phase|Other|8|||
164689456|NCT00401245|594887727|FG002|Open Label Phase|Other|7|||
164689457|NCT00401245|594887728|FG003|Open Label Phase|Other|8|||
164689458|NCT00401245|594887729|FG004|Open Label Phase|Other|0|||
164689459|NCT00401245|594887730|FG005|Open Label Phase|Other|0|||
164689460|NCT00401245|594887731|FG006|Open Label Phase|Other|0|||
164689461|NCT00401245|594887732|FG007|Open Label Phase|Other|0|||
164689462|NCT00401245|594887725|FG000|Open Label Phase|Protocol Violation|0|||
164689463|NCT00401245|594887726|FG001|Open Label Phase|Protocol Violation|1|||
164689464|NCT00401245|594887727|FG002|Open Label Phase|Protocol Violation|0|||
164689465|NCT00401245|594887728|FG003|Open Label Phase|Protocol Violation|1|||
164689466|NCT00401245|594887729|FG004|Open Label Phase|Protocol Violation|0|||
164689467|NCT00401245|594887730|FG005|Open Label Phase|Protocol Violation|0|||
164689468|NCT00401245|594887731|FG006|Open Label Phase|Protocol Violation|0|||
164689469|NCT00401245|594887732|FG007|Open Label Phase|Protocol Violation|0|||
164689470|NCT00401245|594887725|FG000|Open Label Phase|Withdrawal by Subject|3|||
164689471|NCT00401245|594887726|FG001|Open Label Phase|Withdrawal by Subject|3|||
164689472|NCT00401245|594887727|FG002|Open Label Phase|Withdrawal by Subject|2|||
164689473|NCT00401245|594887728|FG003|Open Label Phase|Withdrawal by Subject|1|||
164689474|NCT00401245|594887729|FG004|Open Label Phase|Withdrawal by Subject|0|||
164689475|NCT00401245|594887730|FG005|Open Label Phase|Withdrawal by Subject|0|||
164689476|NCT00401245|594887731|FG006|Open Label Phase|Withdrawal by Subject|0|||
164689477|NCT00401245|594887732|FG007|Open Label Phase|Withdrawal by Subject|0|||
164689478|NCT00401245|594887725|FG000|Open Label Phase|Lack of Efficacy|4|||
164689479|NCT00401245|594887726|FG001|Open Label Phase|Lack of Efficacy|2|||
164689480|NCT00401245|594887727|FG002|Open Label Phase|Lack of Efficacy|3|||
164431296|NCT03499600|593949444|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
164431297|NCT03499600|593949445|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
164431298|NCT00561574|593949446|FG000|Overall Study|Adverse Event|21|||
164431299|NCT00561574|593949447|FG001|Overall Study|Adverse Event|24|||
164275323|NCT01359943|593376308|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
164275324|NCT01359943|593376309|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
164275325|NCT01359943|593376307|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
164275326|NCT01359943|593376308|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
164275327|NCT01359943|593376309|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
164275328|NCT01359943|593376307|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
164431300|NCT00561574|593949446|FG000|Overall Study|Lack of Efficacy|11|||
164431301|NCT00561574|593949447|FG001|Overall Study|Lack of Efficacy|21|||
164431302|NCT00561574|593949446|FG000|Overall Study|Withdrawal by Subject|4|||
164431303|NCT00561574|593949447|FG001|Overall Study|Withdrawal by Subject|4|||
164431304|NCT00561574|593949446|FG000|Overall Study|Reason Unrelated to Trial|6|||
164431305|NCT00561574|593949447|FG001|Overall Study|Reason Unrelated to Trial|2|||
164431306|NCT00561574|593949446|FG000|Overall Study|Lost to Follow-up|1|||
164431307|NCT00561574|593949447|FG001|Overall Study|Lost to Follow-up|0|||
164431308|NCT00561574|593949446|FG000|Overall Study|Other|5|||
164431309|NCT00561574|593949447|FG001|Overall Study|Other|7|||
164431310|NCT01729871|593949448|FG000|Overall Study|Adverse Event|7|||
164431311|NCT01729871|593949449|FG001|Overall Study|Adverse Event|7|||
164431312|NCT01729871|593949448|FG000|Overall Study|Death|0|||
164431313|NCT01729871|593949449|FG001|Overall Study|Death|1|||
164431314|NCT01729871|593949448|FG000|Overall Study|Lack of Efficacy|0|||
164431315|NCT01729871|593949449|FG001|Overall Study|Lack of Efficacy|1|||
164431316|NCT01729871|593949448|FG000|Overall Study|Physician Decision|0|||
164431317|NCT01729871|593949449|FG001|Overall Study|Physician Decision|2|||
164431318|NCT01729871|593949448|FG000|Overall Study|Protocol Violation|1|||
164431319|NCT01729871|593949449|FG001|Overall Study|Protocol Violation|0|||
164431320|NCT01729871|593949448|FG000|Overall Study|Withdrawal by Subject|0|||
164431321|NCT01729871|593949449|FG001|Overall Study|Withdrawal by Subject|3|||
164431322|NCT01729871|593949448|FG000|Overall Study|Other|4|||
164689481|NCT00401245|594887728|FG003|Open Label Phase|Lack of Efficacy|0|||
164689482|NCT00401245|594887729|FG004|Open Label Phase|Lack of Efficacy|0|||
164689483|NCT00401245|594887730|FG005|Open Label Phase|Lack of Efficacy|0|||
164689484|NCT00401245|594887731|FG006|Open Label Phase|Lack of Efficacy|0|||
164431323|NCT01729871|593949449|FG001|Overall Study|Other|9|||
164431324|NCT03971357|593949450|FG000|Overall Study|Lack of Efficacy|0|||
164431325|NCT03971357|593949451|FG001|Overall Study|Lack of Efficacy|1|||
164431326|NCT00445692|593949452|FG000|Overall Study|Adverse Event|11|||
164431327|NCT00445692|593949452|FG000|Overall Study|Lack of Efficacy|5|||
164431328|NCT01143077|593949454|FG000|Overall Study|Lack of Efficacy|0|||
164431329|NCT01143077|593949455|FG001|Overall Study|Lack of Efficacy|2|||
164431330|NCT01143077|593949456|FG002|Overall Study|Lack of Efficacy|1|||
164431331|NCT01143077|593949454|FG000|Overall Study|Adverse Event|5|||
164431332|NCT01143077|593949455|FG001|Overall Study|Adverse Event|6|||
164431333|NCT01143077|593949456|FG002|Overall Study|Adverse Event|5|||
164431334|NCT01143077|593949454|FG000|Overall Study|Lost to Follow-up|2|||
164431335|NCT01143077|593949455|FG001|Overall Study|Lost to Follow-up|3|||
164431336|NCT01143077|593949456|FG002|Overall Study|Lost to Follow-up|4|||
164431337|NCT01143077|593949454|FG000|Overall Study|Protocol Violation|2|||
164431338|NCT01143077|593949455|FG001|Overall Study|Protocol Violation|0|||
164431339|NCT01143077|593949456|FG002|Overall Study|Protocol Violation|0|||
164431340|NCT01143077|593949454|FG000|Overall Study|Withdrawal by Subject|4|||
164431341|NCT01143077|593949455|FG001|Overall Study|Withdrawal by Subject|3|||
164431342|NCT01143077|593949456|FG002|Overall Study|Withdrawal by Subject|3|||
164431343|NCT01143077|593949454|FG000|Overall Study|Non-compliance with study drug|0|||
164431344|NCT01143077|593949455|FG001|Overall Study|Non-compliance with study drug|1|||
164689485|NCT00401245|594887732|FG007|Open Label Phase|Lack of Efficacy|0|||
164689486|NCT00401245|594887725|FG000|Double Blind Tapering Phase|Adverse Event|0|||
164689487|NCT00401245|594887726|FG001|Double Blind Tapering Phase|Adverse Event|0|||
164689488|NCT00401245|594887727|FG002|Double Blind Tapering Phase|Adverse Event|0|||
164689489|NCT00401245|594887728|FG003|Double Blind Tapering Phase|Adverse Event|0|||
164689490|NCT00401245|594887729|FG004|Double Blind Tapering Phase|Adverse Event|1|||
164689491|NCT00401245|594887730|FG005|Double Blind Tapering Phase|Adverse Event|1|||
164689492|NCT00401245|594887731|FG006|Double Blind Tapering Phase|Adverse Event|2|||
164275329|NCT01359943|593376308|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
164275330|NCT01359943|593376309|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
164275331|NCT01359943|593376307|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
164275332|NCT01359943|593376308|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
164275333|NCT01359943|593376309|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
164689493|NCT00401245|594887732|FG007|Double Blind Tapering Phase|Adverse Event|4|||
164689494|NCT00401245|594887725|FG000|Double Blind Tapering Phase|Investigator request|0|||
164275334|NCT01359943|593376307|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
164431345|NCT01143077|593949456|FG002|Overall Study|Non-compliance with study drug|1|||
164275335|NCT01359943|593376308|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
164275336|NCT01359943|593376309|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
164275337|NCT01359943|593376307|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
164431346|NCT01143077|593949454|FG000|Overall Study|Administrative|1|||
164431347|NCT01143077|593949455|FG001|Overall Study|Administrative|0|||
164431348|NCT01143077|593949456|FG002|Overall Study|Administrative|0|||
164431349|NCT01143077|593949454|FG000|Overall Study|Principal Investigator Decision|2|||
164431350|NCT01143077|593949455|FG001|Overall Study|Principal Investigator Decision|0|||
164431351|NCT01143077|593949456|FG002|Overall Study|Principal Investigator Decision|1|||
164431352|NCT01333514|593949462|FG000|Overall Study|Withdrawal by Subject|1|||
164431353|NCT01333514|593949463|FG001|Overall Study|Withdrawal by Subject|0|||
164431354|NCT00836810|593949464|FG000|Overall Study|New diagnosis|1|||
164431355|NCT00836810|593949465|FG001|Overall Study|New diagnosis|0|||
164431356|NCT02014558|593949468|FG000|Overall Study|Never Received Study Drug|0|||
164431357|NCT02014558|593949469|FG001|Overall Study|Never Received Study Drug|0|||
164431358|NCT02014558|593949470|FG002|Overall Study|Never Received Study Drug|0|||
164431359|NCT02014558|593949471|FG003|Overall Study|Never Received Study Drug|0|||
164431360|NCT02014558|593949472|FG004|Overall Study|Never Received Study Drug|1|||
164689495|NCT00401245|594887726|FG001|Double Blind Tapering Phase|Investigator request|0|||
164689496|NCT00401245|594887727|FG002|Double Blind Tapering Phase|Investigator request|0|||
164431361|NCT02014558|593949473|FG005|Overall Study|Never Received Study Drug|0|||
164431362|NCT02014558|593949474|FG006|Overall Study|Never Received Study Drug|1|||
164431363|NCT02014558|593949475|FG007|Overall Study|Never Received Study Drug|0|||
164431364|NCT02014558|593949476|FG008|Overall Study|Never Received Study Drug|2|||
164431365|NCT02014558|593949477|FG009|Overall Study|Never Received Study Drug|0|||
164431366|NCT02014558|593949478|FG010|Overall Study|Never Received Study Drug|2|||
164431367|NCT02014558|593949479|FG011|Overall Study|Never Received Study Drug|2|||
164431368|NCT02014558|593949480|FG012|Overall Study|Never Received Study Drug|0|||
164431369|NCT02014558|593949468|FG000|Overall Study|Adverse Event|0|||
164275338|NCT01359943|593376308|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
164275339|NCT01359943|593376309|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
164275340|NCT01359943|593376307|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
164275341|NCT01359943|593376308|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
164275342|NCT01359943|593376309|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
164275343|NCT01359943|593376307|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
164275344|NCT01359943|593376308|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
164275345|NCT01359943|593376309|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
164275346|NCT01359943|593376307|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
164275347|NCT01359943|593376308|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
164275348|NCT01359943|593376309|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
164275349|NCT01359943|593376307|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
164275350|NCT01359943|593376308|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
164275351|NCT01359943|593376309|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
164431370|NCT02014558|593949469|FG001|Overall Study|Adverse Event|0|||
164431371|NCT02014558|593949470|FG002|Overall Study|Adverse Event|0|||
164431372|NCT02014558|593949471|FG003|Overall Study|Adverse Event|0|||
164431373|NCT02014558|593949472|FG004|Overall Study|Adverse Event|1|||
164431374|NCT02014558|593949473|FG005|Overall Study|Adverse Event|0|||
164431375|NCT02014558|593949474|FG006|Overall Study|Adverse Event|0|||
164431376|NCT02014558|593949475|FG007|Overall Study|Adverse Event|0|||
164275352|NCT01359943|593376307|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
164275353|NCT01359943|593376308|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
164275354|NCT01359943|593376309|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
164275355|NCT01359943|593376307|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
164275356|NCT01359943|593376308|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
164275357|NCT01359943|593376309|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
164275358|NCT01359943|593376307|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
164275359|NCT01359943|593376308|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
164275360|NCT01359943|593376309|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
164275361|NCT01359943|593376307|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
164275362|NCT01359943|593376308|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
164275363|NCT01359943|593376309|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
164275364|NCT01359943|593376307|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
164275365|NCT01359943|593376308|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
164275366|NCT01359943|593376309|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
164275367|NCT01529034|593376310|FG000|Overall Study|Discontinued prior to study treatment|14|||
164275368|NCT01529034|593376310|FG000|Overall Study|Site closure|62|||
164275369|NCT01529034|593376310|FG000|Overall Study|Study termination|29|||
164275370|NCT01529034|593376310|FG000|Overall Study|Withdrawal by Subject|25|||
164275371|NCT01529034|593376310|FG000|Overall Study|No treated SCs within protocol window|13|||
164275372|NCT01529034|593376310|FG000|Overall Study|Noncompliance|8|||
164275373|NCT01529034|593376310|FG000|Overall Study|Caregiver no longer available|7|||
164275374|NCT01529034|593376310|FG000|Overall Study|Adverse Event|4|||
164275375|NCT01529034|593376310|FG000|Overall Study|Protocol Violation|4|||
164275376|NCT01529034|593376310|FG000|Overall Study|Lack of Efficacy|4|||
164275377|NCT01529034|593376310|FG000|Overall Study|Investigator no longer available|2|||
164275378|NCT01529034|593376310|FG000|Overall Study|Study drug not available|2|||
164275379|NCT03436693|593376313|FG000|Overall Study|Adverse Event|22|||
164275380|NCT03436693|593376314|FG001|Overall Study|Adverse Event|10|||
164275381|NCT03436693|593376313|FG000|Overall Study|Physician Decision|3|||
164275382|NCT03436693|593376314|FG001|Overall Study|Physician Decision|3|||
164275383|NCT03436693|593376313|FG000|Overall Study|Withdrawal by Subject|4|||
164275384|NCT03436693|593376314|FG001|Overall Study|Withdrawal by Subject|13|||
164275385|NCT03436693|593376313|FG000|Overall Study|Progressive Disease|1|||
164275386|NCT03436693|593376314|FG001|Overall Study|Progressive Disease|1|||
164275387|NCT04481789|593376315|FG000|Period 1|Withdrawal by Subject|1|||
164275388|NCT04481789|593376316|FG001|Period 1|Withdrawal by Subject|0|||
164275389|NCT04481789|593376317|FG002|Period 1|Withdrawal by Subject|0|||
164275390|NCT04481789|593376318|FG003|Period 1|Withdrawal by Subject|0|||
164275391|NCT04481789|593376319|FG004|Period 1|Withdrawal by Subject|0|||
164275392|NCT04481789|593376320|FG005|Period 1|Withdrawal by Subject|0|||
164275393|NCT04655144|593376326|FG000|Overall Study|Consumed THC|1|||
164275394|NCT04655144|593376327|FG001|Overall Study|Consumed THC|0|||
164275395|NCT04655144|593376326|FG000|Overall Study|Unilateral embolization|0|||
164275396|NCT04655144|593376327|FG001|Overall Study|Unilateral embolization|1|||
164275397|NCT04317742|593376328|FG000|Overall Study|Lost to Follow-up|57|||
164275398|NCT04317742|593376329|FG001|Overall Study|Lost to Follow-up|59|||
164275399|NCT04317742|593376328|FG000|Overall Study|Pregnancy|1|||
164275400|NCT04317742|593376329|FG001|Overall Study|Pregnancy|1|||
164275401|NCT04317742|593376328|FG000|Overall Study|Withdrawal by Subject|46|||
164275402|NCT04317742|593376329|FG001|Overall Study|Withdrawal by Subject|24|||
164275403|NCT02678923|593376330|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
164275404|NCT02678923|593376331|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
164275405|NCT02678923|593376330|FG000|Overall Study|Withdrawal by Subject|3|||
164275406|NCT02678923|593376331|FG001|Overall Study|Withdrawal by Subject|2|||
164275407|NCT02678923|593376330|FG000|Overall Study|Lost to Follow-up|1|||
164275408|NCT02678923|593376331|FG001|Overall Study|Lost to Follow-up|0|||
164275409|NCT02678923|593376330|FG000|Overall Study|Did Not Return for Study Visits|1|||
164342908|NCT01548287|593631590|FG000|Screening|No reason provided|0|||
164342909|NCT01548287|593631591|FG001|Screening|No reason provided|0|||
164342910|NCT01548287|593631592|FG002|Screening|No reason provided|0|||
164342911|NCT01548287|593631593|FG003|Screening|No reason provided|0|||
164342912|NCT01548287|593631594|FG004|Screening|No reason provided|9|||
164342913|NCT01548287|593631590|FG000|Screening|Did not meet eligibility criteria|0|||
164342914|NCT01548287|593631591|FG001|Screening|Did not meet eligibility criteria|0|||
164342915|NCT01548287|593631592|FG002|Screening|Did not meet eligibility criteria|0|||
164342916|NCT01548287|593631593|FG003|Screening|Did not meet eligibility criteria|0|||
164342917|NCT01548287|593631594|FG004|Screening|Did not meet eligibility criteria|74|||
164342918|NCT01548287|593631590|FG000|Randomized Period|Did not meet inclusion criteria|0|||
164342919|NCT01548287|593631591|FG001|Randomized Period|Did not meet inclusion criteria|0|||
164342920|NCT01548287|593631592|FG002|Randomized Period|Did not meet inclusion criteria|2|||
164342921|NCT01548287|593631593|FG003|Randomized Period|Did not meet inclusion criteria|0|||
164342922|NCT01548287|593631594|FG004|Randomized Period|Did not meet inclusion criteria|0|||
164342923|NCT01548287|593631590|FG000|Randomized Period|Adverse Event|0|||
164342924|NCT01548287|593631591|FG001|Randomized Period|Adverse Event|2|||
164342925|NCT01548287|593631592|FG002|Randomized Period|Adverse Event|5|||
164342926|NCT01548287|593631593|FG003|Randomized Period|Adverse Event|0|||
164342927|NCT01548287|593631594|FG004|Randomized Period|Adverse Event|0|||
164342928|NCT02762578|593631599|FG000|Overall Study|Adverse Event|1|||
164342929|NCT02762578|593631600|FG001|Overall Study|Adverse Event|6|||
164342930|NCT02762578|593631599|FG000|Overall Study|Protocol Violation|4|||
164342931|NCT02762578|593631600|FG001|Overall Study|Protocol Violation|2|||
164342932|NCT02762578|593631599|FG000|Overall Study|Withdrawal by Subject|4|||
164342933|NCT02762578|593631600|FG001|Overall Study|Withdrawal by Subject|2|||
164342934|NCT02762578|593631599|FG000|Overall Study|Unclassified|6|||
164342935|NCT02762578|593631600|FG001|Overall Study|Unclassified|0|||
164342936|NCT02083965|593631601|FG000|Treatment Period|Other|1|||
164342937|NCT02083965|593631602|FG001|Treatment Period|Other|0|||
164342938|NCT00282984|593631603|FG000|Overall Study|Death|2|||
164342939|NCT00282984|593631604|FG001|Overall Study|Death|5|||
164342940|NCT00282984|593631603|FG000|Overall Study|Adverse Event|8|||
164342941|NCT00282984|593631604|FG001|Overall Study|Adverse Event|5|||
164342942|NCT00282984|593631603|FG000|Overall Study|Lack of Efficacy|0|||
164342943|NCT00282984|593631604|FG001|Overall Study|Lack of Efficacy|2|||
164342944|NCT00282984|593631603|FG000|Overall Study|Lost to Follow-up|14|||
164342945|NCT00282984|593631604|FG001|Overall Study|Lost to Follow-up|10|||
164342946|NCT00282984|593631603|FG000|Overall Study|Withdrawal by Participant|22|||
164342947|NCT00282984|593631604|FG001|Overall Study|Withdrawal by Participant|34|||
164342948|NCT00282984|593631603|FG000|Overall Study|Participant stopped study medication|2|||
164342949|NCT00282984|593631604|FG001|Overall Study|Participant stopped study medication|2|||
164342950|NCT00282984|593631603|FG000|Overall Study|Participant only allowed phone follow-up|0|||
164342951|NCT00282984|593631604|FG001|Overall Study|Participant only allowed phone follow-up|1|||
164431377|NCT02014558|593949476|FG008|Overall Study|Adverse Event|2|||
164342952|NCT00282984|593631603|FG000|Overall Study|Participant used antipsychosis meds|0|||
164342953|NCT00282984|593631604|FG001|Overall Study|Participant used antipsychosis meds|1|||
164342954|NCT00282984|593631603|FG000|Overall Study|lack of motivation|1|||
164342955|NCT00282984|593631604|FG001|Overall Study|lack of motivation|0|||
164431378|NCT02014558|593949477|FG009|Overall Study|Adverse Event|2|||
164583539|NCT04800315|594501040|FG001|Treatment Period|Withdrawal by participant|0|||
164583540|NCT04800315|594501041|FG002|Treatment Period|Withdrawal by participant|0|||
164583541|NCT04800315|594501042|FG003|Treatment Period|Withdrawal by participant|4|||
164583542|NCT04800315|594501039|FG000|Treatment Period|Other Reasons|0|||
164583543|NCT04800315|594501040|FG001|Treatment Period|Other Reasons|2|||
164583544|NCT04800315|594501041|FG002|Treatment Period|Other Reasons|0|||
164583545|NCT04800315|594501042|FG003|Treatment Period|Other Reasons|1|||
164583546|NCT00753922|594501043|FG000|Overall Study|Lost to Follow-up|155|||
164583547|NCT00753922|594501044|FG001|Overall Study|Lost to Follow-up|24|||
164342956|NCT00282984|593631603|FG000|Overall Study|in prison|0|||
164431379|NCT02014558|593949478|FG010|Overall Study|Adverse Event|5|||
164583548|NCT00753922|594501045|FG002|Overall Study|Lost to Follow-up|28|||
164583549|NCT00753922|594501046|FG003|Overall Study|Lost to Follow-up|5|||
164583550|NCT00753922|594501043|FG000|Overall Study|Withdrawal by Subject|9|||
164275410|NCT02678923|593376331|FG001|Overall Study|Did Not Return for Study Visits|0|||
164275411|NCT01554514|593376334|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
164275412|NCT01554514|593376334|FG000|Overall Study|Physician Decision|1|||
164275413|NCT01966445|593376337|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
164275414|NCT01966445|593376338|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
164275415|NCT01966445|593376339|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
164275416|NCT01966445|593376340|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
164275417|NCT01966445|593376341|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
164275418|NCT01966445|593376342|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
164275419|NCT01966445|593376343|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
164275420|NCT01966445|593376337|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
164275421|NCT01966445|593376338|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
164275422|NCT01966445|593376339|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
164275423|NCT01966445|593376340|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
164275424|NCT01966445|593376341|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
164275425|NCT01966445|593376342|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
164275426|NCT01966445|593376343|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
164275427|NCT01966445|593376337|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
164275428|NCT01966445|593376338|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
164275429|NCT01966445|593376339|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
164275430|NCT01966445|593376340|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
164275431|NCT01966445|593376341|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
164275432|NCT01966445|593376342|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
164275433|NCT01966445|593376343|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
164275434|NCT01966445|593376337|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
164275435|NCT01966445|593376338|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
164275436|NCT01966445|593376339|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
164275437|NCT01966445|593376340|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
164275438|NCT01966445|593376341|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
164275439|NCT01966445|593376342|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
164275440|NCT01966445|593376343|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
164275441|NCT01966445|593376337|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
164275442|NCT01966445|593376338|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
164275443|NCT01966445|593376339|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
164275444|NCT01966445|593376340|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
164275445|NCT01966445|593376341|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
164275446|NCT01966445|593376342|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
164275447|NCT01966445|593376343|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
164275448|NCT01374178|593376344|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
164275449|NCT01374178|593376345|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
164275450|NCT01374178|593376344|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
164275451|NCT01374178|593376345|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
164275452|NCT01422824|593376346|FG000|Overall Study|Case record form not evaluated|1|||
164431380|NCT02014558|593949479|FG011|Overall Study|Adverse Event|21|||
164431381|NCT02014558|593949480|FG012|Overall Study|Adverse Event|3|||
164431382|NCT02014558|593949468|FG000|Overall Study|Death|1|||
164431383|NCT02014558|593949469|FG001|Overall Study|Death|0|||
164583551|NCT00753922|594501044|FG001|Overall Study|Withdrawal by Subject|11|||
164583552|NCT00753922|594501045|FG002|Overall Study|Withdrawal by Subject|4|||
164583553|NCT00753922|594501046|FG003|Overall Study|Withdrawal by Subject|2|||
164583554|NCT00753922|594501043|FG000|Overall Study|Patient Non-compliance|55|||
164583555|NCT00753922|594501044|FG001|Overall Study|Patient Non-compliance|22|||
164583556|NCT00753922|594501045|FG002|Overall Study|Patient Non-compliance|14|||
164583557|NCT00753922|594501046|FG003|Overall Study|Patient Non-compliance|11|||
164583558|NCT00753922|594501043|FG000|Overall Study|Patients Not Completing Visit|11|||
164583559|NCT00753922|594501044|FG001|Overall Study|Patients Not Completing Visit|0|||
164583560|NCT00753922|594501045|FG002|Overall Study|Patients Not Completing Visit|1|||
164583561|NCT00753922|594501046|FG003|Overall Study|Patients Not Completing Visit|0|||
164583562|NCT00753922|594501043|FG000|Overall Study|Death|2|||
164583563|NCT00753922|594501044|FG001|Overall Study|Death|23|||
164583564|NCT00753922|594501045|FG002|Overall Study|Death|2|||
164583565|NCT00753922|594501046|FG003|Overall Study|Death|1|||
164583566|NCT00753922|594501043|FG000|Overall Study|Discontinuation Due to Explantation|14|||
164583567|NCT00753922|594501044|FG001|Overall Study|Discontinuation Due to Explantation|14|||
164275453|NCT01422824|593376346|FG000|Overall Study|Lost to Follow-up|37|||
164275454|NCT00490022|593376347|FG000|Overall Study|Adverse Event|0|||
164275455|NCT00490022|593376348|FG001|Overall Study|Adverse Event|2|||
164275456|NCT00490022|593376347|FG000|Overall Study|Withdrawal by Subject|1|||
164275457|NCT00490022|593376348|FG001|Overall Study|Withdrawal by Subject|0|||
164275458|NCT00490022|593376347|FG000|Overall Study|Subject failed to disclose concommitant|0|||
164275459|NCT00490022|593376348|FG001|Overall Study|Subject failed to disclose concommitant|1|||
164275460|NCT00975143|593376355|FG000|Overall Study|Adverse Event|19|||
164275461|NCT00975143|593376356|FG001|Overall Study|Adverse Event|15|||
164275462|NCT00975143|593376355|FG000|Overall Study|Withdrawal by Subject|15|||
164431384|NCT02014558|593949470|FG002|Overall Study|Death|0|||
164431385|NCT02014558|593949471|FG003|Overall Study|Death|0|||
164583568|NCT00753922|594501045|FG002|Overall Study|Discontinuation Due to Explantation|14|||
164583569|NCT00753922|594501046|FG003|Overall Study|Discontinuation Due to Explantation|4|||
164583570|NCT02983292|594501048|FG000|Overall Study|Participant unwell & cannot travel|2|||
164583571|NCT02983292|594501048|FG000|Overall Study|Lost to Follow-up|3|||
164583572|NCT02983292|594501048|FG000|Overall Study|Participant withdrew consent|2|||
164583573|NCT02983292|594501048|FG000|Overall Study|Revision|7|||
164583574|NCT02983292|594501048|FG000|Overall Study|Death|1|||
164583575|NCT02983292|594501048|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
164583576|NCT02983292|594501048|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
164583577|NCT02983292|594501048|FG000|Overall Study|Participant relocation|1|||
164583578|NCT00857246|594501049|FG000|Induction Regimen|Adverse Event|1|||
164583579|NCT00857246|594501049|FG000|Induction Regimen|disease-related complications|1|||
164583580|NCT00857246|594501049|FG000|Induction Regimen|Withdrawal by Subject|1|||
164583581|NCT00857246|594501049|FG000|Surgery (Curative)|disease progression|6|||
164583582|NCT00857246|594501049|FG000|ChemoRT|Withdrawal by Subject|1|||
164583583|NCT00857246|594501049|FG000|ChemoRT|Adverse Event|2|||
164583584|NCT03851510|594501050|FG000|Overall Study|Screen Fail|1|||
164583585|NCT03851510|594501050|FG000|Overall Study|Adverse Event|1|||
164583586|NCT03851510|594501050|FG000|Overall Study|Withdrawal by Subject|1|||
164583587|NCT02426086|594501051|FG000|Overall Study|Death|33|||
164583588|NCT02426086|594501052|FG001|Overall Study|Death|36|||
164583589|NCT02426086|594501051|FG000|Overall Study|Lost to Follow-up|2|||
164583590|NCT02426086|594501052|FG001|Overall Study|Lost to Follow-up|0|||
164583591|NCT02426086|594501051|FG000|Overall Study|Study Terminated by Sponsor|5|||
164583592|NCT02426086|594501052|FG001|Overall Study|Study Terminated by Sponsor|14|||
164583593|NCT02426086|594501051|FG000|Overall Study|Withdrawal by Subject|8|||
164583594|NCT02426086|594501052|FG001|Overall Study|Withdrawal by Subject|9|||
164583595|NCT04542291|594501053|FG000|Overall Study|Adverse Event|1|||
164583596|NCT04542291|594501053|FG000|Overall Study|Physician Decision|2|||
164583597|NCT01287117|594501054|FG000|Overall Study|Adverse Event|2|||
164583598|NCT01287117|594501055|FG001|Overall Study|Adverse Event|1|||
164583599|NCT01287117|594501056|FG002|Overall Study|Adverse Event|1|||
164583600|NCT01287117|594501057|FG003|Overall Study|Adverse Event|1|||
164583601|NCT01287117|594501054|FG000|Overall Study|Lost to Follow-up|1|||
164583602|NCT01287117|594501055|FG001|Overall Study|Lost to Follow-up|1|||
164583603|NCT01287117|594501056|FG002|Overall Study|Lost to Follow-up|0|||
164583604|NCT01287117|594501057|FG003|Overall Study|Lost to Follow-up|0|||
164583605|NCT01287117|594501054|FG000|Overall Study|Physician Decision|0|||
164583606|NCT01287117|594501055|FG001|Overall Study|Physician Decision|1|||
164583607|NCT01287117|594501056|FG002|Overall Study|Physician Decision|1|||
164583608|NCT01287117|594501057|FG003|Overall Study|Physician Decision|1|||
164583609|NCT01287117|594501054|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
164583610|NCT01287117|594501055|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
164583611|NCT01287117|594501056|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
164583612|NCT01287117|594501057|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
164583613|NCT01287117|594501054|FG000|Overall Study|Disease Progression|10|||
164583614|NCT01287117|594501055|FG001|Overall Study|Disease Progression|5|||
164583615|NCT01287117|594501056|FG002|Overall Study|Disease Progression|6|||
164583616|NCT01287117|594501057|FG003|Overall Study|Disease Progression|5|||
164583617|NCT00035815|594501065|FG000|Overall Study|Withdrawal by Subject|17|||
164583618|NCT00035815|594501066|FG001|Overall Study|Withdrawal by Subject|11|||
164583619|NCT02606877|594501074|FG000|Overall Study|Adverse Event|3|||
164431386|NCT02014558|593949472|FG004|Overall Study|Death|0|||
164583620|NCT02606877|594501075|FG001|Overall Study|Adverse Event|0|||
164583621|NCT02606877|594501074|FG000|Overall Study|Non-compliance with protocol|0|||
164583622|NCT02606877|594501075|FG001|Overall Study|Non-compliance with protocol|1|||
164583623|NCT02606877|594501074|FG000|Overall Study|Other than listed above|1|||
164583624|NCT02606877|594501075|FG001|Overall Study|Other than listed above|0|||
164583625|NCT04952389|594501076|FG000|Overall Study|Withdrawal by Subject|8|||
164583626|NCT04952389|594501077|FG001|Overall Study|Withdrawal by Subject|4|||
164583627|NCT02277444|594501079|FG000|Treatment Period (Week 0-52)|Adverse Event|11|||
164583628|NCT02277444|594501079|FG000|Treatment Period (Week 0-52)|Withdrawal by Subject|3|||
164275463|NCT00975143|593376356|FG001|Overall Study|Withdrawal by Subject|15|||
164275464|NCT00975143|593376355|FG000|Overall Study|Lost to Follow-up|20|||
164275465|NCT00975143|593376356|FG001|Overall Study|Lost to Follow-up|16|||
164583629|NCT02277444|594501079|FG000|Treatment Period (Week 0-52)|Other|1|||
164583630|NCT02277444|594501079|FG000|Treatment Period (Week 0-52)|Enrolled and not Treated|3|||
164583631|NCT02277444|594501079|FG000|LTE Period (Week 52 to Week 252)|Other|43|||
164583632|NCT02277444|594501079|FG000|ETP Period (Week 252 to Week 420)|Adverse Event|1|||
164583633|NCT02277444|594501079|FG000|ETP Period (Week 252 to Week 420)|Physician Decision|3|||
164583634|NCT02277444|594501079|FG000|ETP Period (Week 252 to Week 420)|Withdrawal by Subject|2|||
164583635|NCT02277444|594501079|FG000|ETP Period (Week 252 to Week 420)|Other|8|||
164583636|NCT01266148|594502740|FG000|Overall Study|Adverse Event|2|||
164583637|NCT01266148|594502741|FG001|Overall Study|Adverse Event|0|||
164583638|NCT01266148|594502740|FG000|Overall Study|Ongoing rejection|1|||
164583639|NCT01266148|594502741|FG001|Overall Study|Ongoing rejection|0|||
164583640|NCT01266148|594502740|FG000|Overall Study|2 2R rejections|1|||
164583641|NCT01266148|594502741|FG001|Overall Study|2 2R rejections|0|||
164583642|NCT01266148|594502740|FG000|Overall Study|Death|2|||
164583643|NCT01266148|594502741|FG001|Overall Study|Death|3|||
164583644|NCT01266148|594502740|FG000|Overall Study|missing mGFR value + AE|1|||
164583645|NCT01266148|594502741|FG001|Overall Study|missing mGFR value + AE|0|||
164583646|NCT04168645|594502743|FG000|Overall Study|Lost to Follow-up|23|||
164583647|NCT04168645|594502744|FG001|Overall Study|Lost to Follow-up|28|||
164583648|NCT04168645|594502745|FG002|Overall Study|Lost to Follow-up|15|||
164583649|NCT04168645|594502746|FG003|Overall Study|Lost to Follow-up|12|||
164583650|NCT04168645|594502743|FG000|Overall Study|Death|1|||
164583651|NCT04168645|594502744|FG001|Overall Study|Death|1|||
164583652|NCT04168645|594502745|FG002|Overall Study|Death|0|||
164583653|NCT04168645|594502746|FG003|Overall Study|Death|0|||
164583654|NCT04168645|594502743|FG000|Overall Study|Withdrawal by Subject|5|||
164583655|NCT04168645|594502744|FG001|Overall Study|Withdrawal by Subject|2|||
164583656|NCT04168645|594502745|FG002|Overall Study|Withdrawal by Subject|2|||
164583657|NCT04168645|594502746|FG003|Overall Study|Withdrawal by Subject|2|||
164583658|NCT04168645|594502743|FG000|Overall Study|Administrative Withdrawal|3|||
164583659|NCT04168645|594502744|FG001|Overall Study|Administrative Withdrawal|1|||
164583660|NCT04168645|594502745|FG002|Overall Study|Administrative Withdrawal|1|||
164583661|NCT04168645|594502746|FG003|Overall Study|Administrative Withdrawal|3|||
164583662|NCT01040832|594502748|FG000|Overall Study|Adverse Event|4|||
164583663|NCT01040832|594502749|FG001|Overall Study|Adverse Event|5|||
164583664|NCT01040832|594502748|FG000|Overall Study|Death|4|||
164583665|NCT01040832|594502749|FG001|Overall Study|Death|6|||
164583666|NCT01040832|594502748|FG000|Overall Study|Withdrawal by Subject|2|||
164583667|NCT01040832|594502749|FG001|Overall Study|Withdrawal by Subject|3|||
164583668|NCT01040832|594502748|FG000|Overall Study|Progressive disease|32|||
164583669|NCT01040832|594502749|FG001|Overall Study|Progressive disease|17|||
164342957|NCT00282984|593631604|FG001|Overall Study|in prison|1|||
164583670|NCT01040832|594502748|FG000|Overall Study|Symptomatic deterioration|2|||
164342958|NCT00282984|593631603|FG000|Overall Study|Protocol Violation|2|||
164342959|NCT00282984|593631604|FG001|Overall Study|Protocol Violation|0|||
164342960|NCT00674362|593631605|FG000|Double Blind|Adverse Event|6|||
164342961|NCT00674362|593631606|FG001|Double Blind|Adverse Event|6|||
164342962|NCT00674362|593631605|FG000|Double Blind|Lack of Efficacy|2|||
164342963|NCT00674362|593631606|FG001|Double Blind|Lack of Efficacy|6|||
164342964|NCT00674362|593631605|FG000|Double Blind|Loss of efficacy|0|||
164342965|NCT00674362|593631606|FG001|Double Blind|Loss of efficacy|1|||
164342966|NCT00674362|593631605|FG000|Double Blind|Withdrawal by Subject|4|||
164342967|NCT00674362|593631606|FG001|Double Blind|Withdrawal by Subject|3|||
164342968|NCT00674362|593631605|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
164342969|NCT00674362|593631606|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
164342970|NCT00674362|593631605|FG000|Double Blind|Other: Surgery|0|||
164342971|NCT00674362|593631606|FG001|Double Blind|Other: Surgery|1|||
164583671|NCT01040832|594502749|FG001|Overall Study|Symptomatic deterioration|5|||
164583672|NCT01040832|594502748|FG000|Overall Study|Other|2|||
164583673|NCT01040832|594502749|FG001|Overall Study|Other|1|||
164583674|NCT02767570|594502752|FG000|Overall Study|Lost to Follow-up|3|||
164583675|NCT02767570|594502753|FG001|Overall Study|Lost to Follow-up|0|||
164583676|NCT02767570|594502752|FG000|Overall Study|COVID shutdown|2|||
164583677|NCT02767570|594502753|FG001|Overall Study|COVID shutdown|5|||
164583678|NCT02767570|594502752|FG000|Overall Study|Increased pain|2|||
164583679|NCT02767570|594502753|FG001|Overall Study|Increased pain|0|||
164583680|NCT02767570|594502752|FG000|Overall Study|Withdrawal by Subject|1|||
164583681|NCT02767570|594502753|FG001|Overall Study|Withdrawal by Subject|3|||
164583682|NCT02767570|594502752|FG000|Overall Study|Unrelated medical issue|1|||
164583683|NCT02767570|594502753|FG001|Overall Study|Unrelated medical issue|1|||
164583684|NCT02767570|594502752|FG000|Overall Study|Received intra-articular injection|0|||
164583685|NCT02767570|594502753|FG001|Overall Study|Received intra-articular injection|1|||
164583686|NCT01712438|594502757|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
164583687|NCT01712438|594502757|FG000|Overall Study|Ongoing ITI treatment|6|||
164342972|NCT00674362|593631605|FG000|Open Label|Adverse Event|1|||
164342973|NCT00674362|593631606|FG001|Open Label|Adverse Event|0|||
164342974|NCT00674362|593631605|FG000|Open Label|Other: Subject moved to extension study|1|||
164583688|NCT01712438|594502757|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
164275466|NCT00975143|593376355|FG000|Overall Study|Non-compliance|5|||
164275467|NCT00975143|593376356|FG001|Overall Study|Non-compliance|8|||
164275468|NCT00975143|593376355|FG000|Overall Study|Physician Decision|1|||
164275469|NCT00975143|593376356|FG001|Overall Study|Physician Decision|2|||
164275470|NCT00975143|593376355|FG000|Overall Study|Details not available|10|||
164275471|NCT00975143|593376356|FG001|Overall Study|Details not available|4|||
164275472|NCT00470418|593376357|FG000|Overall Study|Withdrawal by Subject|1|||
164275473|NCT00470418|593376358|FG001|Overall Study|Withdrawal by Subject|0|||
164275474|NCT03129360|593376359|FG000|Overall Study|Did not meet entry criteria|0|||
164275475|NCT03129360|593376360|FG001|Overall Study|Did not meet entry criteria|2|||
164275476|NCT03129360|593376361|FG002|Overall Study|Did not meet entry criteria|1|||
164275477|NCT03129360|593376359|FG000|Overall Study|Excluded due to motion in scanner|1|||
164275478|NCT03129360|593376360|FG001|Overall Study|Excluded due to motion in scanner|0|||
164275479|NCT03129360|593376361|FG002|Overall Study|Excluded due to motion in scanner|0|||
164275480|NCT01818492|593376362|FG000|Overall Study|Adverse Event|2|||
164275481|NCT01818492|593376362|FG000|Overall Study|Death|3|||
164275482|NCT01818492|593376362|FG000|Overall Study|Withdrawal by Subject|1|||
164275483|NCT01818492|593376362|FG000|Overall Study|Additional therapy when not allowed PP|4|||
164275484|NCT01729208|593376363|FG000|Baseline|Physician Decision|5|||
164275485|NCT01729208|593376364|FG001|Baseline|Physician Decision|4|||
164275486|NCT01729208|593376363|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
164275487|NCT01729208|593376364|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
164275488|NCT01729208|593376363|FG000|12 Months Follow-up|Lost to Follow-up|3|||
164275489|NCT01729208|593376364|FG001|12 Months Follow-up|Lost to Follow-up|3|||
164583689|NCT01712438|594502757|FG000|Overall Study|Prematurely Discontinued|25|||
164583690|NCT01981122|594502758|FG000|Overall Study|Withdrawal by Subject|0|||
164583691|NCT01981122|594502759|FG001|Overall Study|Withdrawal by Subject|2|||
164583692|NCT01981122|594502758|FG000|Overall Study|Protocol Violation|0|||
164583693|NCT01981122|594502759|FG001|Overall Study|Protocol Violation|1|||
164583694|NCT01981122|594502758|FG000|Overall Study|Lost to Follow-up|0|||
164583695|NCT01981122|594502759|FG001|Overall Study|Lost to Follow-up|1|||
164583696|NCT01981122|594502758|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
164583697|NCT01981122|594502759|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
164583698|NCT01981122|594502758|FG000|Overall Study|Death|14|||
164583699|NCT01981122|594502759|FG001|Overall Study|Death|15|||
164583700|NCT00089843|594502762|FG000|Overall Study|Withdrawal by Subject|1|||
164583701|NCT00089843|594502763|FG001|Overall Study|Withdrawal by Subject|4|||
164583702|NCT00089843|594502764|FG002|Overall Study|Withdrawal by Subject|5|||
164583703|NCT00089843|594502765|FG003|Overall Study|Withdrawal by Subject|6|||
164583704|NCT00089843|594502762|FG000|Overall Study|Physician Decision|1|||
164583705|NCT00089843|594502763|FG001|Overall Study|Physician Decision|0|||
164583706|NCT00089843|594502764|FG002|Overall Study|Physician Decision|0|||
164583707|NCT00089843|594502765|FG003|Overall Study|Physician Decision|1|||
164583708|NCT01330381|594502766|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
164583709|NCT01330381|594502767|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
164583710|NCT01330381|594502768|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
164583711|NCT01330381|594502766|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
164583712|NCT01330381|594502767|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
164583713|NCT01330381|594502768|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
164583714|NCT01330381|594502766|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
164583715|NCT01330381|594502767|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
164583716|NCT01330381|594502768|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
164583717|NCT01330381|594502766|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
164583718|NCT01330381|594502767|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
164583719|NCT01330381|594502768|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
164583720|NCT01330381|594502766|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
164583721|NCT01330381|594502767|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
164583722|NCT01330381|594502768|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
164583723|NCT01330381|594502766|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
164583724|NCT01330381|594502767|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
164583725|NCT01330381|594502768|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
164583726|NCT01330381|594502766|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
164583727|NCT01330381|594502767|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
164583728|NCT01330381|594502768|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
164583729|NCT01330381|594502766|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
164583730|NCT01330381|594502767|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
164583731|NCT01330381|594502768|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
164583732|NCT01330381|594502766|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
164583733|NCT01330381|594502767|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
164583734|NCT01330381|594502768|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
164583735|NCT01330381|594502766|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
164431387|NCT02014558|593949473|FG005|Overall Study|Death|0|||
164431388|NCT02014558|593949474|FG006|Overall Study|Death|1|||
164431389|NCT02014558|593949475|FG007|Overall Study|Death|1|||
164431390|NCT02014558|593949476|FG008|Overall Study|Death|2|||
164431391|NCT02014558|593949477|FG009|Overall Study|Death|5|||
164431392|NCT02014558|593949478|FG010|Overall Study|Death|5|||
164689497|NCT00401245|594887728|FG003|Double Blind Tapering Phase|Investigator request|0|||
164689498|NCT00401245|594887729|FG004|Double Blind Tapering Phase|Investigator request|0|||
164689499|NCT00401245|594887730|FG005|Double Blind Tapering Phase|Investigator request|0|||
164689500|NCT00401245|594887731|FG006|Double Blind Tapering Phase|Investigator request|0|||
164689501|NCT00401245|594887732|FG007|Double Blind Tapering Phase|Investigator request|1|||
164689502|NCT00401245|594887725|FG000|Double Blind Tapering Phase|Other|0|||
164689503|NCT00401245|594887726|FG001|Double Blind Tapering Phase|Other|0|||
164689504|NCT00401245|594887727|FG002|Double Blind Tapering Phase|Other|0|||
164689505|NCT00401245|594887728|FG003|Double Blind Tapering Phase|Other|0|||
164689506|NCT00401245|594887729|FG004|Double Blind Tapering Phase|Other|1|||
164431393|NCT02014558|593949479|FG011|Overall Study|Death|19|||
164431394|NCT02014558|593949480|FG012|Overall Study|Death|2|||
164431395|NCT02014558|593949468|FG000|Overall Study|Lack of Efficacy|1|||
164431396|NCT02014558|593949469|FG001|Overall Study|Lack of Efficacy|2|||
164431397|NCT02014558|593949470|FG002|Overall Study|Lack of Efficacy|1|||
164431398|NCT02014558|593949471|FG003|Overall Study|Lack of Efficacy|1|||
164275490|NCT01729208|593376363|FG000|24 Months Follow-up|Lost to Follow-up|3|||
164275491|NCT01729208|593376364|FG001|24 Months Follow-up|Lost to Follow-up|0|||
164275492|NCT01729208|593376363|FG000|36 Months Follow-up|Physician Decision|1|||
164431399|NCT02014558|593949472|FG004|Overall Study|Lack of Efficacy|0|||
164431400|NCT02014558|593949473|FG005|Overall Study|Lack of Efficacy|0|||
164431401|NCT02014558|593949474|FG006|Overall Study|Lack of Efficacy|1|||
164431402|NCT02014558|593949475|FG007|Overall Study|Lack of Efficacy|3|||
164431403|NCT02014558|593949476|FG008|Overall Study|Lack of Efficacy|3|||
164431404|NCT02014558|593949477|FG009|Overall Study|Lack of Efficacy|3|||
164431405|NCT02014558|593949478|FG010|Overall Study|Lack of Efficacy|16|||
164275493|NCT01729208|593376364|FG001|36 Months Follow-up|Physician Decision|0|||
164275494|NCT01729208|593376363|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
164275495|NCT01729208|593376364|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
164275496|NCT02428413|593376365|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
164275497|NCT02428413|593376366|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
164275498|NCT02428413|593376365|FG000|Overall Study|Protocol Violation|1|||
164275499|NCT02428413|593376366|FG001|Overall Study|Protocol Violation|2|||
164275500|NCT02428413|593376365|FG000|Overall Study|Case Cancelled|2|||
164275501|NCT02428413|593376366|FG001|Overall Study|Case Cancelled|0|||
164275502|NCT02428413|593376365|FG000|Overall Study|Missed Cases|1|||
164275503|NCT02428413|593376366|FG001|Overall Study|Missed Cases|2|||
164275504|NCT02428413|593376365|FG000|Overall Study|Nurse Refusal|1|||
164275505|NCT02428413|593376366|FG001|Overall Study|Nurse Refusal|0|||
164275506|NCT00885482|593376367|FG000|Overall Study|Pregnancy|1|||
164275507|NCT00885482|593376367|FG000|Overall Study|Lack of Efficacy|1|||
164275508|NCT00885482|593376367|FG000|Overall Study|Death|1|||
164275509|NCT00885482|593376367|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
164275510|NCT02772978|593376368|FG000|Overall Study|Withdrawal by Subject|1|||
164275511|NCT02772978|593376369|FG001|Overall Study|Withdrawal by Subject|1|||
164275512|NCT02438813|593376370|FG000|Overall Study|Patient Decision|59|||
164275513|NCT02438813|593376370|FG000|Overall Study|Patient Lost to Follow-Up|137|||
164275514|NCT02438813|593376370|FG000|Overall Study|Study Ended by Sponsor|80|||
164275515|NCT02438813|593376370|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
164275516|NCT00409344|593376372|FG000|Overall Study|no enrollment|0|||
164275517|NCT00409344|593376373|FG001|Overall Study|no enrollment|0|||
164275518|NCT02879578|593376376|FG000|Overall Study|Adverse Event|1|||
164275519|NCT02879578|593376377|FG001|Overall Study|Adverse Event|2|||
164275520|NCT02879578|593376378|FG002|Overall Study|Adverse Event|14|||
164275521|NCT02879578|593376376|FG000|Overall Study|Protocol Violation|0|||
164275522|NCT02879578|593376377|FG001|Overall Study|Protocol Violation|1|||
164275523|NCT02879578|593376378|FG002|Overall Study|Protocol Violation|1|||
164275524|NCT02879578|593376376|FG000|Overall Study|Withdrawal by Subject|8|||
164275525|NCT02879578|593376377|FG001|Overall Study|Withdrawal by Subject|6|||
164431406|NCT02014558|593949479|FG011|Overall Study|Lack of Efficacy|8|||
164431407|NCT02014558|593949480|FG012|Overall Study|Lack of Efficacy|5|||
164431408|NCT02014558|593949468|FG000|Overall Study|Lost to Follow-up|0|||
164275526|NCT02879578|593376378|FG002|Overall Study|Withdrawal by Subject|9|||
164275527|NCT02879578|593376376|FG000|Overall Study|Lost to Follow-up|1|||
164275528|NCT02879578|593376377|FG001|Overall Study|Lost to Follow-up|0|||
164275529|NCT02879578|593376378|FG002|Overall Study|Lost to Follow-up|4|||
164431409|NCT02014558|593949469|FG001|Overall Study|Lost to Follow-up|0|||
164431410|NCT02014558|593949470|FG002|Overall Study|Lost to Follow-up|0|||
164431411|NCT02014558|593949471|FG003|Overall Study|Lost to Follow-up|0|||
164431412|NCT02014558|593949472|FG004|Overall Study|Lost to Follow-up|0|||
164431413|NCT02014558|593949473|FG005|Overall Study|Lost to Follow-up|0|||
164689507|NCT00401245|594887730|FG005|Double Blind Tapering Phase|Other|0|||
164431414|NCT02014558|593949474|FG006|Overall Study|Lost to Follow-up|0|||
164431415|NCT02014558|593949475|FG007|Overall Study|Lost to Follow-up|0|||
164431416|NCT02014558|593949476|FG008|Overall Study|Lost to Follow-up|0|||
164431417|NCT02014558|593949477|FG009|Overall Study|Lost to Follow-up|0|||
164431418|NCT02014558|593949478|FG010|Overall Study|Lost to Follow-up|1|||
164431419|NCT02014558|593949479|FG011|Overall Study|Lost to Follow-up|0|||
164431420|NCT02014558|593949480|FG012|Overall Study|Lost to Follow-up|0|||
164431421|NCT02014558|593949468|FG000|Overall Study|Progressive Disease|1|||
164431422|NCT02014558|593949469|FG001|Overall Study|Progressive Disease|0|||
164431423|NCT02014558|593949470|FG002|Overall Study|Progressive Disease|1|||
164431424|NCT02014558|593949471|FG003|Overall Study|Progressive Disease|1|||
164431425|NCT02014558|593949472|FG004|Overall Study|Progressive Disease|1|||
164431426|NCT02014558|593949473|FG005|Overall Study|Progressive Disease|2|||
164431427|NCT02014558|593949474|FG006|Overall Study|Progressive Disease|1|||
164431428|NCT02014558|593949475|FG007|Overall Study|Progressive Disease|6|||
164431429|NCT02014558|593949476|FG008|Overall Study|Progressive Disease|5|||
164431430|NCT02014558|593949477|FG009|Overall Study|Progressive Disease|6|||
164431431|NCT02014558|593949478|FG010|Overall Study|Progressive Disease|22|||
164431432|NCT02014558|593949479|FG011|Overall Study|Progressive Disease|31|||
164431433|NCT02014558|593949480|FG012|Overall Study|Progressive Disease|6|||
164431434|NCT02014558|593949468|FG000|Overall Study|Withdrawal by Subject|0|||
164275530|NCT02879578|593376376|FG000|Overall Study|Physician Decision|0|||
164275531|NCT02879578|593376377|FG001|Overall Study|Physician Decision|0|||
164275532|NCT02879578|593376378|FG002|Overall Study|Physician Decision|4|||
164275533|NCT01879072|593376384|FG000|Overall Study|Withdrawal by Subject|121|||
164275534|NCT01879072|593376384|FG000|Overall Study|Not Transplanted|30|||
164275535|NCT02666105|593376391|FG000|Overall Study|Death|1|||
164275536|NCT00411632|593376392|FG000|Overall Study|Death|1|||
164275537|NCT01264419|593376393|FG000|Overall Study|Lost to Follow-up|3|||
164275538|NCT00659230|593376394|FG000|Overall Study|Lost to Follow-up|2|||
164275539|NCT00659230|593376395|FG001|Overall Study|Lost to Follow-up|5|||
164275540|NCT00659230|593376394|FG000|Overall Study|Lost source documentation|5|||
164275541|NCT00659230|593376395|FG001|Overall Study|Lost source documentation|4|||
164275542|NCT00659230|593376394|FG000|Overall Study|Did not return post-randomization|2|||
164275543|NCT00659230|593376395|FG001|Overall Study|Did not return post-randomization|3|||
164275544|NCT05249569|593377378|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
164275545|NCT03703856|593377379|FG000|Enrolled in study|Withdrawal by Subject|23|||
164275546|NCT03703856|593377379|FG000|Titrated to full dose|Withdrawal by Subject|5|||
164275547|NCT03703856|593377379|FG000|16 week assessment|Withdrawal by Subject|1|||
164275548|NCT03703856|593377379|FG000|24 week assessment|Withdrawal by Subject|1|||
164275549|NCT03402386|593377380|FG000|Overall Study|Adverse Event|3|||
164275550|NCT03402386|593377380|FG000|Overall Study|Physician Decision|1|||
164275551|NCT03402386|593377380|FG000|Overall Study|Difficult to control Hb|2|||
164275552|NCT05138419|593377381|FG000|Overall Study|Study terminated before participant completed.|0|||
164275553|NCT05138419|593377382|FG001|Overall Study|Study terminated before participant completed.|0|||
164275554|NCT05138419|593377383|FG002|Overall Study|Study terminated before participant completed.|1|||
164275555|NCT01048853|593377384|FG000|Overall Study|Death|1|||
164275556|NCT01048853|593377385|FG001|Overall Study|Death|0|||
164275557|NCT01048853|593377386|FG002|Overall Study|Death|0|||
164275558|NCT01048853|593377384|FG000|Overall Study|Lost to Follow-up|1|||
164275559|NCT01048853|593377385|FG001|Overall Study|Lost to Follow-up|4|||
164275560|NCT01048853|593377386|FG002|Overall Study|Lost to Follow-up|0|||
164275561|NCT01532570|593377394|FG000|Overall Study|Lack of Efficacy|1|||
164275562|NCT01532570|593377395|FG001|Overall Study|Lack of Efficacy|0|||
164275563|NCT01532570|593377396|FG002|Overall Study|Lack of Efficacy|0|||
164275564|NCT01532570|593377397|FG003|Overall Study|Lack of Efficacy|0|||
164275565|NCT01532570|593377394|FG000|Overall Study|Withdrawal by Subject|0|||
164275566|NCT01532570|593377395|FG001|Overall Study|Withdrawal by Subject|1|||
164275567|NCT01532570|593377396|FG002|Overall Study|Withdrawal by Subject|0|||
164275568|NCT01532570|593377397|FG003|Overall Study|Withdrawal by Subject|0|||
164275569|NCT01585155|593377398|FG000|Overall Study|Adverse Event|1|||
164275570|NCT01585155|593377398|FG000|Overall Study|Lack of Efficacy|2|||
164275571|NCT01585155|593377398|FG000|Overall Study|Worsening ulcerative colitis|2|||
164275572|NCT00805766|593377400|FG000|Screening Period|Adverse Event|1|||
164275573|NCT00805766|593377400|FG000|Screening Period|Lack of Efficacy|2|||
164275574|NCT00805766|593377400|FG000|Screening Period|Pregnancy|1|||
164275575|NCT00805766|593377400|FG000|Screening Period|Responder|2|||
164275576|NCT00805766|593377400|FG000|Increased Dose Period|Adverse Event|4|||
164275577|NCT00805766|593377400|FG000|Increased Dose Period|Lack of Efficacy|7|||
164275578|NCT00805766|593377400|FG000|Increased Dose Period|Pregnancy|1|||
164275579|NCT00805766|593377400|FG000|Increased Dose Period|Withdrawal by Subject|1|||
164275580|NCT04254913|593377401|FG000|Overall Study|Adverse Event|1|||
164275581|NCT02354222|593377402|FG000|Overall Study|Adverse Event|0|||
164431435|NCT02014558|593949469|FG001|Overall Study|Withdrawal by Subject|0|||
164275582|NCT02354222|593377403|FG001|Overall Study|Adverse Event|3|||
164431436|NCT02014558|593949470|FG002|Overall Study|Withdrawal by Subject|0|||
164431437|NCT02014558|593949471|FG003|Overall Study|Withdrawal by Subject|0|||
164431438|NCT02014558|593949472|FG004|Overall Study|Withdrawal by Subject|1|||
164431439|NCT02014558|593949473|FG005|Overall Study|Withdrawal by Subject|0|||
164431440|NCT02014558|593949474|FG006|Overall Study|Withdrawal by Subject|0|||
164431441|NCT02014558|593949475|FG007|Overall Study|Withdrawal by Subject|0|||
164431442|NCT02014558|593949476|FG008|Overall Study|Withdrawal by Subject|0|||
164431443|NCT02014558|593949477|FG009|Overall Study|Withdrawal by Subject|2|||
164431444|NCT02014558|593949478|FG010|Overall Study|Withdrawal by Subject|6|||
164431445|NCT02014558|593949479|FG011|Overall Study|Withdrawal by Subject|10|||
164431446|NCT02014558|593949480|FG012|Overall Study|Withdrawal by Subject|0|||
164431447|NCT02014558|593949468|FG000|Overall Study|Miscellaneous|2|||
164431448|NCT02014558|593949469|FG001|Overall Study|Miscellaneous|1|||
164431449|NCT02014558|593949470|FG002|Overall Study|Miscellaneous|1|||
164275583|NCT02354222|593377402|FG000|Overall Study|Physician Decision|1|||
164275584|NCT02354222|593377403|FG001|Overall Study|Physician Decision|1|||
164275585|NCT02354222|593377402|FG000|Overall Study|Pregnancy|1|||
164275586|NCT02354222|593377403|FG001|Overall Study|Pregnancy|0|||
164275587|NCT02354222|593377402|FG000|Overall Study|Withdrawal by Subject|2|||
164275588|NCT02354222|593377403|FG001|Overall Study|Withdrawal by Subject|3|||
164275589|NCT02354222|593377402|FG000|Overall Study|Conflict with the stopping criteria|0|||
164275590|NCT02354222|593377403|FG001|Overall Study|Conflict with the stopping criteria|4|||
164275591|NCT04300218|593377404|FG000|Overall Study|Lost to Follow-up|6|||
164275592|NCT04300218|593377405|FG001|Overall Study|Lost to Follow-up|8|||
164275593|NCT02911142|593377406|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
164275594|NCT02911142|593377406|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
164275595|NCT02911142|593377406|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
164275596|NCT02911142|593377406|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
164275597|NCT05451940|593377407|FG000|Treatment Period|Physician Decision|1|||
164275598|NCT03645863|593377408|FG000|Overall Study|Withdrawal by Subject|1|||
164275599|NCT03645863|593377409|FG001|Overall Study|Withdrawal by Subject|0|||
164275600|NCT03645863|593377410|FG002|Overall Study|Withdrawal by Subject|0|||
164275601|NCT02220907|593377411|FG000|Overall Study|Adverse Event|7|||
164275602|NCT02220907|593377411|FG000|Overall Study|Physician Decision|1|||
164275603|NCT02220907|593377411|FG000|Overall Study|Withdrawal by Subject|2|||
164275604|NCT02220907|593377411|FG000|Overall Study|Conflict with the stopping criteria|1|||
164275605|NCT00542815|593377412|FG000|Overall Study|Adverse Event|19|||
164275606|NCT00542815|593377413|FG001|Overall Study|Adverse Event|6|||
164275607|NCT00542815|593377414|FG002|Overall Study|Adverse Event|9|||
164275608|NCT00542815|593377412|FG000|Overall Study|Death|10|||
164275609|NCT00542815|593377413|FG001|Overall Study|Death|7|||
164275610|NCT00542815|593377414|FG002|Overall Study|Death|3|||
164275611|NCT00542815|593377412|FG000|Overall Study|Lack of Efficacy|9|||
164275612|NCT00542815|593377413|FG001|Overall Study|Lack of Efficacy|2|||
164275613|NCT00542815|593377414|FG002|Overall Study|Lack of Efficacy|0|||
164275614|NCT00542815|593377412|FG000|Overall Study|Physician Decision|2|||
164275615|NCT00542815|593377413|FG001|Overall Study|Physician Decision|1|||
164275616|NCT00542815|593377414|FG002|Overall Study|Physician Decision|0|||
164275617|NCT00542815|593377412|FG000|Overall Study|Protocol Violation|1|||
164275618|NCT00542815|593377413|FG001|Overall Study|Protocol Violation|1|||
164275619|NCT00542815|593377414|FG002|Overall Study|Protocol Violation|2|||
164275620|NCT00542815|593377412|FG000|Overall Study|Withdrawal by Subject|41|||
164275621|NCT00542815|593377413|FG001|Overall Study|Withdrawal by Subject|5|||
164275622|NCT00542815|593377414|FG002|Overall Study|Withdrawal by Subject|8|||
164275623|NCT00542815|593377412|FG000|Overall Study|Other reasons|24|||
164275624|NCT00542815|593377413|FG001|Overall Study|Other reasons|10|||
164275625|NCT00542815|593377414|FG002|Overall Study|Other reasons|10|||
164275626|NCT01716104|593377418|FG000|Overall Study|Do not meet inclusion criteria|6|||
164275627|NCT01716104|593377419|FG001|Overall Study|Do not meet inclusion criteria|7|||
164275628|NCT00117793|593377420|FG000|Overall Study|Withdrawal by Subject|12|||
164275629|NCT01069705|593377423|FG000|Overall Study|Adverse Event|1|||
164275630|NCT01069705|593377423|FG000|Overall Study|Withdrawal by Subject|2|||
164275631|NCT03624127|593377424|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
164275632|NCT03624127|593377425|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
164275633|NCT03624127|593377426|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
164275634|NCT03624127|593377424|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
164275635|NCT03624127|593377425|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
164275636|NCT03624127|593377426|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
164275637|NCT03624127|593377424|FG000|Treatment Week 0 - Week 16|Death|0|||
164275638|NCT03624127|593377425|FG001|Treatment Week 0 - Week 16|Death|1|||
164275639|NCT03624127|593377426|FG002|Treatment Week 0 - Week 16|Death|0|||
164431450|NCT02014558|593949471|FG003|Overall Study|Miscellaneous|1|||
164431451|NCT02014558|593949472|FG004|Overall Study|Miscellaneous|0|||
164275640|NCT03624127|593377424|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
164431452|NCT02014558|593949473|FG005|Overall Study|Miscellaneous|1|||
164431453|NCT02014558|593949474|FG006|Overall Study|Miscellaneous|0|||
164583736|NCT01330381|594502767|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
164431454|NCT02014558|593949475|FG007|Overall Study|Miscellaneous|1|||
164431455|NCT02014558|593949476|FG008|Overall Study|Miscellaneous|1|||
164431456|NCT02014558|593949477|FG009|Overall Study|Miscellaneous|3|||
164431457|NCT02014558|593949478|FG010|Overall Study|Miscellaneous|12|||
164431458|NCT02014558|593949479|FG011|Overall Study|Miscellaneous|11|||
164431459|NCT02014558|593949480|FG012|Overall Study|Miscellaneous|1|||
164431460|NCT05273801|593949481|FG000|Overall Study|Physician Decision|1|||
164431461|NCT04155424|593949484|FG000|Overall Study|Other than specified|3|||
164431462|NCT04155424|593949484|FG000|Overall Study|Withdrawal by Subject|1|||
164431463|NCT04155424|593949484|FG000|Overall Study|Adverse Event|1|||
164431464|NCT04199728|593951347|FG000|Overall Study|Adverse Event|1|||
164431465|NCT04199728|593951348|FG001|Overall Study|Adverse Event|0|||
164431466|NCT04199728|593951347|FG000|Overall Study|Withdrawal by Subject|8|||
164431467|NCT04199728|593951348|FG001|Overall Study|Withdrawal by Subject|3|||
164431468|NCT04199728|593951347|FG000|Overall Study|Screen fail after consent|0|||
164431469|NCT04199728|593951348|FG001|Overall Study|Screen fail after consent|1|||
164431470|NCT04199728|593951347|FG000|Overall Study|Early withdraw criteria met|0|||
164431471|NCT04199728|593951348|FG001|Overall Study|Early withdraw criteria met|1|||
164431472|NCT04199728|593951347|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
164275641|NCT03624127|593377425|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
164275642|NCT03624127|593377426|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
164275643|NCT03624127|593377424|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
164275644|NCT03624127|593377425|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
164275645|NCT03624127|593377426|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
164275646|NCT03624127|593377424|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
164275647|NCT03624127|593377425|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
164431473|NCT04199728|593951348|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
164431474|NCT01091454|593951355|FG000|Overall Study|Ineligible|1|||
164583737|NCT01330381|594502768|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
164583738|NCT03846947|594502769|FG000|Overall Study|technical issues with imaging sequence|2|||
164583739|NCT03216265|594502771|FG000|Overall Study|Adverse Event|2|||
164583740|NCT03216265|594502772|FG001|Overall Study|Adverse Event|0|||
164583741|NCT03216265|594502773|FG002|Overall Study|Adverse Event|2|||
164583742|NCT03216265|594502771|FG000|Overall Study|Lost to Follow-up|0|||
164583743|NCT03216265|594502772|FG001|Overall Study|Lost to Follow-up|1|||
164583744|NCT03216265|594502773|FG002|Overall Study|Lost to Follow-up|0|||
164583745|NCT03216265|594502771|FG000|Overall Study|Withdrawal by Subject|0|||
164583746|NCT03216265|594502772|FG001|Overall Study|Withdrawal by Subject|0|||
164583747|NCT03216265|594502773|FG002|Overall Study|Withdrawal by Subject|1|||
164583748|NCT01978912|594502778|FG000|Overall Study|Adverse Event|0|||
164583749|NCT01978912|594502779|FG001|Overall Study|Adverse Event|1|||
164583750|NCT01978912|594502780|FG002|Overall Study|Adverse Event|0|||
164583751|NCT01978912|594502781|FG003|Overall Study|Adverse Event|0|||
164583752|NCT01978912|594502778|FG000|Overall Study|Lost to Follow-up|1|||
164583753|NCT01978912|594502779|FG001|Overall Study|Lost to Follow-up|1|||
164583754|NCT01978912|594502780|FG002|Overall Study|Lost to Follow-up|0|||
164583755|NCT01978912|594502781|FG003|Overall Study|Lost to Follow-up|1|||
164583756|NCT01978912|594502778|FG000|Overall Study|Withdrawal by Subject|1|||
164583757|NCT01978912|594502779|FG001|Overall Study|Withdrawal by Subject|0|||
164583758|NCT01978912|594502780|FG002|Overall Study|Withdrawal by Subject|2|||
164583759|NCT01978912|594502781|FG003|Overall Study|Withdrawal by Subject|2|||
164583760|NCT01978912|594502778|FG000|Overall Study|Lumbar Surgery|1|||
164583761|NCT01978912|594502779|FG001|Overall Study|Lumbar Surgery|0|||
164583762|NCT01978912|594502780|FG002|Overall Study|Lumbar Surgery|1|||
164583763|NCT01978912|594502781|FG003|Overall Study|Lumbar Surgery|0|||
164583764|NCT01978912|594502778|FG000|Overall Study|Intradiscal Steroid Injection|0|||
164583765|NCT01978912|594502779|FG001|Overall Study|Intradiscal Steroid Injection|1|||
164583766|NCT01978912|594502780|FG002|Overall Study|Intradiscal Steroid Injection|0|||
164583767|NCT01978912|594502781|FG003|Overall Study|Intradiscal Steroid Injection|0|||
164583768|NCT00224107|594502782|FG000|Overall Study|Adverse Event|20|||
164583769|NCT00224107|594502783|FG001|Overall Study|Adverse Event|6|||
164583770|NCT00224107|594502782|FG000|Overall Study|Protocol Violation|2|||
164583771|NCT00224107|594502783|FG001|Overall Study|Protocol Violation|3|||
164583772|NCT00224107|594502782|FG000|Overall Study|Withdrawal by Subject|1|||
164689508|NCT00401245|594887731|FG006|Double Blind Tapering Phase|Other|2|||
164689509|NCT00401245|594887732|FG007|Double Blind Tapering Phase|Other|2|||
164689510|NCT00401245|594887725|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
164689511|NCT00401245|594887726|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
164689512|NCT00401245|594887727|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
164689513|NCT00401245|594887728|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
164689514|NCT00401245|594887729|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
164583773|NCT00224107|594502783|FG001|Overall Study|Withdrawal by Subject|4|||
164583774|NCT00224107|594502782|FG000|Overall Study|Lack of Efficacy|2|||
164583775|NCT00224107|594502783|FG001|Overall Study|Lack of Efficacy|0|||
164583776|NCT00224107|594502782|FG000|Overall Study|Lost to Follow-up|4|||
164583777|NCT00224107|594502783|FG001|Overall Study|Lost to Follow-up|0|||
164583778|NCT00224107|594502782|FG000|Overall Study|Physician Decision|1|||
164583779|NCT00224107|594502783|FG001|Overall Study|Physician Decision|0|||
164583780|NCT00224107|594502782|FG000|Overall Study|Other|1|||
164583781|NCT00224107|594502783|FG001|Overall Study|Other|1|||
164583782|NCT01408537|594502786|FG000|Overall Study|Withdrawal by Subject|2|||
164342975|NCT00674362|593631606|FG001|Open Label|Other: Subject moved to extension study|0|||
164342976|NCT00939770|593631609|FG000|Overall Study|Adverse Event|1|||
164342977|NCT00939770|593631610|FG001|Overall Study|Adverse Event|1|||
164342978|NCT00939770|593631611|FG002|Overall Study|Adverse Event|0|||
164342979|NCT00939770|593631612|FG003|Overall Study|Adverse Event|0|||
164583783|NCT01408537|594502786|FG000|Overall Study|Protocol Violation|3|||
164583784|NCT01408537|594502786|FG000|Overall Study|Lost to Follow-up|3|||
164583785|NCT01295905|594502793|FG000|Overall Study|Did not meet inclusion criteria|1|||
164583786|NCT01295905|594502794|FG001|Overall Study|Did not meet inclusion criteria|0|||
164583787|NCT01295905|594502793|FG000|Overall Study|Met exclusion criteria|1|||
164583788|NCT01295905|594502794|FG001|Overall Study|Met exclusion criteria|0|||
164583789|NCT03707977|594502795|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
164583790|NCT03707977|594502796|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
164583791|NCT03707977|594502797|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
164583792|NCT03707977|594502795|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
164583793|NCT03707977|594502796|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
164583794|NCT03707977|594502797|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
164583795|NCT03069690|594502798|FG000|Pregnancy Intervention|Pregnancy loss|9|||
164583796|NCT03069690|594502799|FG001|Pregnancy Intervention|Pregnancy loss|4|||
164583797|NCT03069690|594502800|FG002|Pregnancy Intervention|Pregnancy loss|0|||
164583798|NCT03069690|594502801|FG003|Pregnancy Intervention|Pregnancy loss|0|||
164583799|NCT03069690|594502802|FG004|Pregnancy Intervention|Pregnancy loss|0|||
164583800|NCT03069690|594502803|FG005|Pregnancy Intervention|Pregnancy loss|0|||
164583801|NCT03069690|594502798|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
164583802|NCT03069690|594502799|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
164583803|NCT03069690|594502800|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
164583804|NCT03069690|594502801|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
164583805|NCT03069690|594502802|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
164583806|NCT03069690|594502803|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
164583807|NCT03069690|594502798|FG000|Postpartum Intervention|Lost to Follow-up|0|||
164583808|NCT03069690|594502799|FG001|Postpartum Intervention|Lost to Follow-up|0|||
164583809|NCT03069690|594502800|FG002|Postpartum Intervention|Lost to Follow-up|5|||
164583810|NCT03069690|594502801|FG003|Postpartum Intervention|Lost to Follow-up|5|||
164583811|NCT03069690|594502802|FG004|Postpartum Intervention|Lost to Follow-up|2|||
164583812|NCT03069690|594502803|FG005|Postpartum Intervention|Lost to Follow-up|4|||
164583813|NCT02564120|594502804|FG000|Overall Study|Did not return release forms|160|||
164583814|NCT02564120|594502804|FG000|Overall Study|Death|58|||
164583815|NCT02564120|594502804|FG000|Overall Study|Withdrawal by Subject|204|||
164583816|NCT02564120|594502804|FG000|Overall Study|Other medical condition|24|||
164583817|NCT03842709|594502805|FG000|Overall Study|Withdrawal by Subject|3|||
164583818|NCT03842709|594502806|FG001|Overall Study|Withdrawal by Subject|3|||
164583819|NCT03842709|594502805|FG000|Overall Study|Lost to Follow-up|1|||
164583820|NCT03842709|594502806|FG001|Overall Study|Lost to Follow-up|0|||
164583821|NCT00641147|594502807|FG000|Completed 4 Months.|Physician Decision|1|||
164583822|NCT00641147|594502808|FG001|Completed 4 Months.|Physician Decision|0|||
164583823|NCT00641147|594502807|FG000|Completed 4 Months.|Adverse Event|1|||
164583824|NCT00641147|594502808|FG001|Completed 4 Months.|Adverse Event|0|||
164583825|NCT00641147|594502807|FG000|Completed 8 Months.|Physician Decision|2|||
164583826|NCT00641147|594502808|FG001|Completed 8 Months.|Physician Decision|1|||
164583827|NCT00641147|594502807|FG000|Completed 8 Months.|non compliance|1|||
164583828|NCT00641147|594502808|FG001|Completed 8 Months.|non compliance|0|||
164583829|NCT00641147|594502807|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
164583830|NCT00641147|594502808|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
164583831|NCT00641147|594502807|FG000|Completed 12 Months.|Physician Decision|1|||
164583832|NCT00641147|594502808|FG001|Completed 12 Months.|Physician Decision|1|||
164583833|NCT00641147|594502807|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
164583834|NCT00641147|594502808|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
164583835|NCT00641147|594502807|FG000|Completed 16 Months.|Physician Decision|1|||
164583836|NCT00641147|594502808|FG001|Completed 16 Months.|Physician Decision|0|||
164583837|NCT00641147|594502807|FG000|Completed 16 Months.|Lost to Follow-up|1|||
164583838|NCT00641147|594502808|FG001|Completed 16 Months.|Lost to Follow-up|0|||
164583839|NCT00791128|594502809|FG000|Overall Study|Adverse Event|4|||
164583840|NCT00791128|594502809|FG000|Overall Study|Device migration|2|||
164342980|NCT00939770|593631613|FG004|Overall Study|Adverse Event|6|||
164583841|NCT00791128|594502809|FG000|Overall Study|non-compliance by subject|2|||
164583842|NCT00791128|594502809|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
164583843|NCT01629667|594502810|FG000|Overall Study|Lost to Follow-up|0|||
164583844|NCT01629667|594502811|FG001|Overall Study|Lost to Follow-up|1|||
164342981|NCT00939770|593631614|FG005|Overall Study|Adverse Event|2|||
164342982|NCT00939770|593631615|FG006|Overall Study|Adverse Event|1|||
164342983|NCT00939770|593631616|FG007|Overall Study|Adverse Event|1|||
164342984|NCT00939770|593631609|FG000|Overall Study|Lack of Efficacy|4|||
164342985|NCT00939770|593631610|FG001|Overall Study|Lack of Efficacy|6|||
164342986|NCT00939770|593631611|FG002|Overall Study|Lack of Efficacy|13|||
164342987|NCT00939770|593631612|FG003|Overall Study|Lack of Efficacy|9|||
164342988|NCT00939770|593631613|FG004|Overall Study|Lack of Efficacy|16|||
164342989|NCT00939770|593631614|FG005|Overall Study|Lack of Efficacy|8|||
164342990|NCT00939770|593631615|FG006|Overall Study|Lack of Efficacy|11|||
164342991|NCT00939770|593631616|FG007|Overall Study|Lack of Efficacy|1|||
164342992|NCT00939770|593631609|FG000|Overall Study|Lost to Follow-up|0|||
164342993|NCT00939770|593631610|FG001|Overall Study|Lost to Follow-up|0|||
164342994|NCT00939770|593631611|FG002|Overall Study|Lost to Follow-up|0|||
164342995|NCT00939770|593631612|FG003|Overall Study|Lost to Follow-up|0|||
164342996|NCT00939770|593631613|FG004|Overall Study|Lost to Follow-up|1|||
164342997|NCT00939770|593631614|FG005|Overall Study|Lost to Follow-up|0|||
164342998|NCT00939770|593631615|FG006|Overall Study|Lost to Follow-up|0|||
164342999|NCT00939770|593631616|FG007|Overall Study|Lost to Follow-up|0|||
164343000|NCT00939770|593631609|FG000|Overall Study|Physician Decision|0|||
164343001|NCT00939770|593631610|FG001|Overall Study|Physician Decision|0|||
164343002|NCT00939770|593631611|FG002|Overall Study|Physician Decision|2|||
164343003|NCT00939770|593631612|FG003|Overall Study|Physician Decision|0|||
164343004|NCT00939770|593631613|FG004|Overall Study|Physician Decision|7|||
164343005|NCT00939770|593631614|FG005|Overall Study|Physician Decision|1|||
164343006|NCT00939770|593631615|FG006|Overall Study|Physician Decision|0|||
164343007|NCT00939770|593631616|FG007|Overall Study|Physician Decision|6|||
164343008|NCT00939770|593631609|FG000|Overall Study|Protocol Violation|0|||
164343009|NCT00939770|593631610|FG001|Overall Study|Protocol Violation|0|||
164343010|NCT00939770|593631611|FG002|Overall Study|Protocol Violation|0|||
164343011|NCT00939770|593631612|FG003|Overall Study|Protocol Violation|0|||
164343012|NCT00939770|593631613|FG004|Overall Study|Protocol Violation|1|||
164343013|NCT00939770|593631614|FG005|Overall Study|Protocol Violation|0|||
164343014|NCT00939770|593631615|FG006|Overall Study|Protocol Violation|0|||
164343015|NCT00939770|593631616|FG007|Overall Study|Protocol Violation|0|||
164343016|NCT00939770|593631609|FG000|Overall Study|Withdrawal by Subject|0|||
164343017|NCT00939770|593631610|FG001|Overall Study|Withdrawal by Subject|1|||
164343018|NCT00939770|593631611|FG002|Overall Study|Withdrawal by Subject|5|||
164343019|NCT00939770|593631612|FG003|Overall Study|Withdrawal by Subject|2|||
164343020|NCT00939770|593631613|FG004|Overall Study|Withdrawal by Subject|6|||
164343021|NCT00939770|593631614|FG005|Overall Study|Withdrawal by Subject|0|||
164343022|NCT00939770|593631615|FG006|Overall Study|Withdrawal by Subject|2|||
164343023|NCT00939770|593631616|FG007|Overall Study|Withdrawal by Subject|2|||
164343024|NCT04665856|593631617|FG000|Overall Study|Site Terminated by Sponsor|1|||
164343025|NCT04665856|593631618|FG001|Overall Study|Site Terminated by Sponsor|0|||
164343026|NCT04665856|593631617|FG000|Overall Study|Withdrawal by Subject|2|||
164343027|NCT04665856|593631618|FG001|Overall Study|Withdrawal by Subject|0|||
164343028|NCT04665856|593631617|FG000|Overall Study|Lost to Follow-up|3|||
164343029|NCT04665856|593631618|FG001|Overall Study|Lost to Follow-up|2|||
164343030|NCT04665856|593631617|FG000|Overall Study|Death|39|||
164343031|NCT04665856|593631618|FG001|Overall Study|Death|44|||
164343032|NCT04665856|593631617|FG000|Overall Study|Ongoing in study|17|||
164343033|NCT04665856|593631618|FG001|Overall Study|Ongoing in study|15|||
164343034|NCT03386448|593631619|FG000|Overall Study|Adverse Event|0|||
164343035|NCT03386448|593631620|FG001|Overall Study|Adverse Event|2|||
164343036|NCT02564796|593631621|FG000|Overall Study|Physician Decision|2|||
164343037|NCT02564796|593631622|FG001|Overall Study|Physician Decision|2|||
164343038|NCT00114530|593631623|FG000|Overall Study|Death|3|||
164343039|NCT00114530|593631624|FG001|Overall Study|Death|11|||
164343040|NCT00114530|593631623|FG000|Overall Study|Lost to Follow-up|1|||
164343041|NCT00114530|593631624|FG001|Overall Study|Lost to Follow-up|1|||
164343042|NCT00114530|593631623|FG000|Overall Study|Physician Decision|1|||
164343043|NCT00114530|593631624|FG001|Overall Study|Physician Decision|1|||
164343044|NCT00114530|593631623|FG000|Overall Study|Withdrawal by Subject|2|||
164343045|NCT00114530|593631624|FG001|Overall Study|Withdrawal by Subject|6|||
164343046|NCT00114530|593631623|FG000|Overall Study|Breast Cancer|1|||
164583845|NCT01629667|594502812|FG002|Overall Study|Lost to Follow-up|1|||
164583846|NCT01629667|594502810|FG000|Overall Study|Withdrawal by Subject|31|||
164343047|NCT00114530|593631624|FG001|Overall Study|Breast Cancer|0|||
164343048|NCT00114530|593631623|FG000|Overall Study|Subject decision after endpoint failure|0|||
164343049|NCT00114530|593631624|FG001|Overall Study|Subject decision after endpoint failure|1|||
164343050|NCT00114530|593631623|FG000|Overall Study|Ineligible|1|||
164343051|NCT00114530|593631624|FG001|Overall Study|Ineligible|0|||
164343052|NCT01466153|593631626|FG000|Overall Study|Disease Progression|2|||
164343053|NCT01466153|593631627|FG001|Overall Study|Disease Progression|2|||
164343054|NCT01466153|593631628|FG002|Overall Study|Disease Progression|0|||
164583847|NCT01629667|594502811|FG001|Overall Study|Withdrawal by Subject|20|||
164343055|NCT01466153|593631626|FG000|Overall Study|Adverse Event|14|||
164343056|NCT01466153|593631627|FG001|Overall Study|Adverse Event|13|||
164431475|NCT01510912|593951356|FG000|Overall Study|Adverse Event|99|||
164431476|NCT01510912|593951356|FG000|Overall Study|Lack of Efficacy|12|||
164431477|NCT01510912|593951356|FG000|Overall Study|Non-compliance with trial drug|23|||
164431478|NCT01510912|593951356|FG000|Overall Study|Withdrawal by Subject|49|||
164431479|NCT01510912|593951356|FG000|Overall Study|Physician Decision|1|||
164431480|NCT01510912|593951356|FG000|Overall Study|Protocol Violation|27|||
164431481|NCT01510912|593951356|FG000|Overall Study|Lost to Follow-up|26|||
164431482|NCT01510912|593951356|FG000|Overall Study|Other, including joint replacement|5|||
164431483|NCT02030028|593951357|FG000|Overall Study|Withdrawal by Subject|4|||
164431484|NCT02030028|593951357|FG000|Overall Study|lack of transportation|1|||
164431485|NCT00661778|593951358|FG000|Overall Study|Disease Progression|23|||
164431486|NCT00661778|593951358|FG000|Overall Study|Adverse Event|18|||
164431487|NCT00661778|593951358|FG000|Overall Study|Reason not Specified|6|||
164431488|NCT00661778|593951358|FG000|Overall Study|Protocol Violation|2|||
164431489|NCT00661778|593951358|FG000|Overall Study|Withdrawal of Consent|1|||
164431490|NCT02236559|593951360|FG000|Overall Study|Met Exclusion|3|||
164431491|NCT02236559|593951361|FG001|Overall Study|Met Exclusion|6|||
164431492|NCT02236559|593951360|FG000|Overall Study|Did not Meet Inclusion|3|||
164431493|NCT02236559|593951361|FG001|Overall Study|Did not Meet Inclusion|3|||
164431494|NCT02236559|593951360|FG000|Overall Study|Subject Did Not Consent|4|||
164431495|NCT02236559|593951361|FG001|Overall Study|Subject Did Not Consent|2|||
164431496|NCT02236559|593951360|FG000|Overall Study|Physician Decision|1|||
164431497|NCT02236559|593951361|FG001|Overall Study|Physician Decision|1|||
164431498|NCT02236559|593951360|FG000|Overall Study|Withdrawal by Subject|1|||
164431499|NCT02236559|593951361|FG001|Overall Study|Withdrawal by Subject|0|||
164431500|NCT01280591|593951362|FG000|Overall Study|Withdrawal by Subject|0|||
164431501|NCT01280591|593951363|FG001|Overall Study|Withdrawal by Subject|0|||
164431502|NCT01280591|593951364|FG002|Overall Study|Withdrawal by Subject|0|||
164431503|NCT01280591|593951365|FG003|Overall Study|Withdrawal by Subject|2|||
164431504|NCT01280591|593951362|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
164431505|NCT01280591|593951363|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
164431506|NCT01280591|593951364|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
164431507|NCT01280591|593951365|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
164431508|NCT02263508|593951366|FG000|Overall Study|Withdrawal by Subject|1|||
164689515|NCT00401245|594887730|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
164689516|NCT00401245|594887731|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
164689517|NCT00401245|594887732|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
164689518|NCT00401245|594887725|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
164275648|NCT03624127|593377426|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
164275649|NCT03624127|593377424|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
164275650|NCT03624127|593377425|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
164275651|NCT03624127|593377426|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
164275652|NCT03624127|593377424|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
164275653|NCT03624127|593377425|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
164275654|NCT03624127|593377426|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
164275655|NCT03624127|593377424|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
164275656|NCT03624127|593377425|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
164275657|NCT03624127|593377426|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
164275658|NCT03624127|593377424|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
164275659|NCT03624127|593377425|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
164275660|NCT03624127|593377426|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
164431509|NCT02263508|593951367|FG001|Overall Study|Withdrawal by Subject|23|||
164431510|NCT02263508|593951368|FG002|Overall Study|Withdrawal by Subject|17|||
164431511|NCT02263508|593951366|FG000|Overall Study|Sponsor Decision|12|||
164431512|NCT02263508|593951367|FG001|Overall Study|Sponsor Decision|165|||
164431513|NCT02263508|593951368|FG002|Overall Study|Sponsor Decision|182|||
164431514|NCT02263508|593951366|FG000|Overall Study|Lost to Follow-up|2|||
164431515|NCT02263508|593951367|FG001|Overall Study|Lost to Follow-up|7|||
164431516|NCT02263508|593951368|FG002|Overall Study|Lost to Follow-up|7|||
164431517|NCT02263508|593951366|FG000|Overall Study|Death|6|||
164431518|NCT02263508|593951367|FG001|Overall Study|Death|151|||
164689519|NCT00401245|594887726|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
164689520|NCT00401245|594887727|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
164343057|NCT01466153|593631628|FG002|Overall Study|Adverse Event|17|||
164343058|NCT01466153|593631626|FG000|Overall Study|Withdrawal of Consent|2|||
164343059|NCT01466153|593631627|FG001|Overall Study|Withdrawal of Consent|0|||
164343060|NCT01466153|593631628|FG002|Overall Study|Withdrawal of Consent|0|||
164343061|NCT01466153|593631626|FG000|Overall Study|Investigator Discretion|3|||
164343062|NCT01466153|593631627|FG001|Overall Study|Investigator Discretion|2|||
164343063|NCT01466153|593631628|FG002|Overall Study|Investigator Discretion|2|||
164343064|NCT01466153|593631626|FG000|Overall Study|Randomized-Not Treated|2|||
164689521|NCT00401245|594887728|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
164431519|NCT02263508|593951368|FG002|Overall Study|Death|140|||
164431520|NCT04148937|593951369|FG000|Overall Study|Withdrawal by Subject|0|||
164431521|NCT04148937|593951370|FG001|Overall Study|Withdrawal by Subject|0|||
164343065|NCT01466153|593631627|FG001|Overall Study|Randomized-Not Treated|3|||
164343066|NCT01466153|593631628|FG002|Overall Study|Randomized-Not Treated|4|||
164343067|NCT01466153|593631626|FG000|Overall Study|Other-Unspecified|6|||
164343068|NCT01466153|593631627|FG001|Overall Study|Other-Unspecified|4|||
164343069|NCT01466153|593631628|FG002|Overall Study|Other-Unspecified|2|||
164343070|NCT00688753|593632899|FG000|Overall Study|Disease progression|55|||
164343071|NCT00688753|593632899|FG000|Overall Study|Missing|1|||
164343072|NCT00688753|593632899|FG000|Overall Study|Death|9|||
164343073|NCT00688753|593632899|FG000|Overall Study|Withdrawal by Subject|3|||
164343074|NCT00688753|593632899|FG000|Overall Study|Adverse Event|20|||
164343075|NCT00688753|593632899|FG000|Overall Study|Protocol Violation|1|||
164343076|NCT00688753|593632899|FG000|Overall Study|Lost to Follow-up|3|||
164343077|NCT03192462|593632908|FG000|Overall Study|Death|13|||
164343078|NCT03192462|593632909|FG001|Overall Study|Death|11|||
164343079|NCT03192462|593632910|FG002|Overall Study|Death|10|||
164343080|NCT03192462|593632908|FG000|Overall Study|Lost to Follow-up|0|||
164343081|NCT03192462|593632909|FG001|Overall Study|Lost to Follow-up|1|||
164343082|NCT03192462|593632910|FG002|Overall Study|Lost to Follow-up|0|||
164343083|NCT03187197|593632912|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
164343084|NCT03187197|593632913|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
164343085|NCT03187197|593632914|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
164343086|NCT03187197|593632912|FG000|Overall Study|Withdrawal by Subject|8|||
164343087|NCT03187197|593632913|FG001|Overall Study|Withdrawal by Subject|63|||
164343088|NCT03187197|593632914|FG002|Overall Study|Withdrawal by Subject|4|||
164343089|NCT03187197|593632912|FG000|Overall Study|Lost to Follow-up|1|||
164343090|NCT03187197|593632913|FG001|Overall Study|Lost to Follow-up|60|||
164343091|NCT03187197|593632914|FG002|Overall Study|Lost to Follow-up|7|||
164343092|NCT03187197|593632912|FG000|Overall Study|Adverse Event|6|||
164343093|NCT03187197|593632913|FG001|Overall Study|Adverse Event|29|||
164343094|NCT03187197|593632914|FG002|Overall Study|Adverse Event|0|||
164343095|NCT03187197|593632912|FG000|Overall Study|Death|0|||
164343096|NCT03187197|593632913|FG001|Overall Study|Death|11|||
164343097|NCT03187197|593632914|FG002|Overall Study|Death|0|||
164343098|NCT03187197|593632912|FG000|Overall Study|Administrative problem|1|||
164343099|NCT03187197|593632913|FG001|Overall Study|Administrative problem|1|||
164343100|NCT03187197|593632914|FG002|Overall Study|Administrative problem|0|||
164343101|NCT03187197|593632912|FG000|Overall Study|Reason not listed|2|||
164343102|NCT03187197|593632913|FG001|Overall Study|Reason not listed|54|||
164343103|NCT03187197|593632914|FG002|Overall Study|Reason not listed|1|||
164343104|NCT03187197|593632912|FG000|Overall Study|Missing|1|||
164343105|NCT03187197|593632913|FG001|Overall Study|Missing|32|||
164343106|NCT03187197|593632914|FG002|Overall Study|Missing|3|||
164343107|NCT03187197|593632912|FG000|Overall Study|Status missing|2|||
164343108|NCT03187197|593632913|FG001|Overall Study|Status missing|33|||
164343109|NCT03187197|593632914|FG002|Overall Study|Status missing|3|||
164343110|NCT03187197|593632912|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
164343111|NCT03187197|593632913|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
164343112|NCT03187197|593632914|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
164343113|NCT04840615|593632915|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
164343114|NCT04840615|593632916|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
164343115|NCT04840615|593632917|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
164343116|NCT00259649|593632918|FG000|Overall Study|Lost to Follow-up|7|||
164343117|NCT00259649|593632918|FG000|Overall Study|irregular menses|3|||
164343118|NCT00982137|593632919|FG000|Overall Study|Lost to Follow-up|0|||
164343119|NCT00982137|593632920|FG001|Overall Study|Lost to Follow-up|0|||
164343120|NCT00982137|593632921|FG002|Overall Study|Lost to Follow-up|0|||
164343121|NCT00982137|593632922|FG003|Overall Study|Lost to Follow-up|1|||
164343122|NCT00982137|593632919|FG000|Overall Study|Withdrawal by Subject|0|||
164343123|NCT00982137|593632920|FG001|Overall Study|Withdrawal by Subject|1|||
164343124|NCT00982137|593632921|FG002|Overall Study|Withdrawal by Subject|0|||
164343125|NCT00982137|593632922|FG003|Overall Study|Withdrawal by Subject|0|||
164343126|NCT00126191|593632923|FG000|Overall Study|Physician Decision|0|||
164343127|NCT00126191|593632924|FG001|Overall Study|Physician Decision|1|||
164343128|NCT00126191|593632923|FG000|Overall Study|Death|0|||
164343129|NCT00126191|593632924|FG001|Overall Study|Death|1|||
164343130|NCT00674700|593632936|FG000|Year 1|Adverse Event|17|||
164343131|NCT00674700|593632937|FG001|Year 1|Adverse Event|20|||
164431522|NCT04148937|593951371|FG002|Overall Study|Withdrawal by Subject|0|||
164343132|NCT00674700|593632938|FG002|Year 1|Adverse Event|5|||
164343133|NCT00674700|593632936|FG000|Year 1|Withdrawal by Subject|7|||
164343134|NCT00674700|593632937|FG001|Year 1|Withdrawal by Subject|7|||
164343135|NCT00674700|593632938|FG002|Year 1|Withdrawal by Subject|6|||
164343136|NCT00674700|593632936|FG000|Year 1|Any other reason not above-mentioned|7|||
164343137|NCT00674700|593632937|FG001|Year 1|Any other reason not above-mentioned|7|||
164343138|NCT00674700|593632938|FG002|Year 1|Any other reason not above-mentioned|6|||
164343139|NCT00674700|593632936|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
164343140|NCT00674700|593632937|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
164343141|NCT00674700|593632938|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
164275661|NCT03624127|593377424|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
164275662|NCT03624127|593377425|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
164275663|NCT03624127|593377426|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
164275664|NCT03624127|593377424|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
164275665|NCT03624127|593377425|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
164275666|NCT03624127|593377426|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
164275667|NCT03624127|593377424|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
164275668|NCT03624127|593377425|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
164275669|NCT03624127|593377426|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
164275670|NCT03624127|593377424|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
164431523|NCT04148937|593951372|FG003|Overall Study|Withdrawal by Subject|1|||
164431524|NCT04148937|593951373|FG004|Overall Study|Withdrawal by Subject|0|||
164431525|NCT04148937|593951374|FG005|Overall Study|Withdrawal by Subject|1|||
164431526|NCT04148937|593951375|FG006|Overall Study|Withdrawal by Subject|1|||
164431527|NCT04148937|593951376|FG007|Overall Study|Withdrawal by Subject|0|||
164431528|NCT04148937|593951369|FG000|Overall Study|Lost to Follow-up|0|||
164431529|NCT04148937|593951370|FG001|Overall Study|Lost to Follow-up|0|||
164431530|NCT04148937|593951371|FG002|Overall Study|Lost to Follow-up|1|||
164431531|NCT04148937|593951372|FG003|Overall Study|Lost to Follow-up|0|||
164431532|NCT04148937|593951373|FG004|Overall Study|Lost to Follow-up|0|||
164431533|NCT04148937|593951374|FG005|Overall Study|Lost to Follow-up|2|||
164431534|NCT04148937|593951375|FG006|Overall Study|Lost to Follow-up|0|||
164431535|NCT04148937|593951376|FG007|Overall Study|Lost to Follow-up|0|||
164431536|NCT01149681|593951379|FG000|Overall Study|Withdrawal by Subject|7|||
164431537|NCT01149681|593951379|FG000|Overall Study|Progressive disease|1|||
164431538|NCT01149681|593951379|FG000|Overall Study|Physician Decision|2|||
164431539|NCT01149681|593951379|FG000|Overall Study|adverse events nonrelated study drug|2|||
164431540|NCT01259102|593951380|FG000|Overall Study|Adverse Event|1|||
164431541|NCT01259102|593951381|FG001|Overall Study|Adverse Event|0|||
164431542|NCT01259102|593951382|FG002|Overall Study|Adverse Event|1|||
164431543|NCT01259102|593951383|FG003|Overall Study|Adverse Event|1|||
164431544|NCT01259102|593951384|FG004|Overall Study|Adverse Event|0|||
164431545|NCT01259102|593951380|FG000|Overall Study|Other|0|||
164431546|NCT01259102|593951381|FG001|Overall Study|Other|0|||
164431547|NCT01259102|593951382|FG002|Overall Study|Other|1|||
164431548|NCT01259102|593951383|FG003|Overall Study|Other|1|||
164431549|NCT01259102|593951384|FG004|Overall Study|Other|1|||
164431550|NCT00817635|593951385|FG000|Overall Study|Adverse Event|1|||
164431551|NCT00817635|593951386|FG001|Overall Study|Adverse Event|0|||
164431552|NCT00817635|593951387|FG002|Overall Study|Adverse Event|0|||
164431553|NCT00817635|593951388|FG003|Overall Study|Adverse Event|1|||
164431554|NCT00817635|593951389|FG004|Overall Study|Adverse Event|1|||
164431555|NCT00817635|593951385|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
164431556|NCT00817635|593951386|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
164431557|NCT00817635|593951387|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
164431558|NCT00817635|593951388|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
164431559|NCT00817635|593951389|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
164431560|NCT00817635|593951385|FG000|Overall Study|Withdrawal by Subject|2|||
164431561|NCT00817635|593951386|FG001|Overall Study|Withdrawal by Subject|1|||
164431562|NCT00817635|593951387|FG002|Overall Study|Withdrawal by Subject|0|||
164431563|NCT00817635|593951388|FG003|Overall Study|Withdrawal by Subject|1|||
164431564|NCT00817635|593951389|FG004|Overall Study|Withdrawal by Subject|2|||
164431565|NCT00817635|593951385|FG000|Overall Study|Lost to Follow-up|0|||
164431566|NCT00817635|593951386|FG001|Overall Study|Lost to Follow-up|1|||
164431567|NCT00817635|593951387|FG002|Overall Study|Lost to Follow-up|0|||
164431568|NCT00817635|593951388|FG003|Overall Study|Lost to Follow-up|1|||
164583848|NCT01629667|594502812|FG002|Overall Study|Withdrawal by Subject|28|||
164583849|NCT01629667|594502810|FG000|Overall Study|Death|1|||
164583850|NCT01629667|594502811|FG001|Overall Study|Death|5|||
164583851|NCT01629667|594502812|FG002|Overall Study|Death|3|||
164583852|NCT01629667|594502810|FG000|Overall Study|Randomized, not treated|2|||
164275671|NCT03624127|593377425|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
164275672|NCT03624127|593377426|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
164275673|NCT03624127|593377424|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
164275674|NCT03624127|593377425|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
164275675|NCT03624127|593377426|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
164275676|NCT03624127|593377424|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
164275677|NCT03624127|593377425|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
164431569|NCT00817635|593951389|FG004|Overall Study|Lost to Follow-up|0|||
164431570|NCT00817635|593951385|FG000|Overall Study|Administrative Problems|0|||
164431571|NCT00817635|593951386|FG001|Overall Study|Administrative Problems|0|||
164583853|NCT01629667|594502811|FG001|Overall Study|Randomized, not treated|1|||
164275678|NCT03624127|593377426|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
164583854|NCT01629667|594502812|FG002|Overall Study|Randomized, not treated|0|||
164583855|NCT01629667|594502810|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
164431572|NCT00817635|593951387|FG002|Overall Study|Administrative Problems|0|||
164431573|NCT00817635|593951388|FG003|Overall Study|Administrative Problems|0|||
164275679|NCT03624127|593377424|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
164275680|NCT03624127|593377425|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
164275681|NCT03624127|593377426|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
164275682|NCT03624127|593377424|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
164275683|NCT03624127|593377425|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
164275684|NCT03624127|593377426|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
164275685|NCT03624127|593377424|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
164275686|NCT03624127|593377425|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
164275687|NCT03624127|593377426|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
164275688|NCT03624127|593377424|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
164275689|NCT03624127|593377425|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
164275690|NCT03624127|593377426|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
164275691|NCT03624127|593377424|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
164275692|NCT03624127|593377425|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
164275693|NCT03624127|593377426|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
164275694|NCT02891382|593377428|FG000|Overall Study|Lost to Follow-up|3|||
164275695|NCT02891382|593377429|FG001|Overall Study|Lost to Follow-up|4|||
164275696|NCT02891382|593377430|FG002|Overall Study|Lost to Follow-up|5|||
164275697|NCT02891382|593377431|FG003|Overall Study|Lost to Follow-up|3|||
164275698|NCT02891382|593377432|FG004|Overall Study|Lost to Follow-up|4|||
164275699|NCT02516228|593377433|FG000|Overall Study|Lost to Follow-up|1|||
164583856|NCT01629667|594502811|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
164583857|NCT01629667|594502812|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
164583858|NCT01629667|594502810|FG000|Overall Study|Requiring lung transplant|2|||
164583859|NCT01629667|594502811|FG001|Overall Study|Requiring lung transplant|1|||
164583860|NCT01629667|594502812|FG002|Overall Study|Requiring lung transplant|3|||
164583861|NCT01629667|594502810|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
164583862|NCT01629667|594502811|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
164583863|NCT01629667|594502812|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
164583864|NCT01629667|594502810|FG000|Overall Study|Started other medicine|1|||
164583865|NCT01629667|594502811|FG001|Overall Study|Started other medicine|0|||
164583866|NCT01629667|594502812|FG002|Overall Study|Started other medicine|1|||
164583867|NCT01629667|594502810|FG000|Overall Study|Site error in safety follow-up|0|||
164583868|NCT01629667|594502811|FG001|Overall Study|Site error in safety follow-up|0|||
164583869|NCT01629667|594502812|FG002|Overall Study|Site error in safety follow-up|1|||
164583870|NCT01629667|594502810|FG000|Overall Study|Enrolled in another clinical study|0|||
164583871|NCT01629667|594502811|FG001|Overall Study|Enrolled in another clinical study|1|||
164583872|NCT01629667|594502812|FG002|Overall Study|Enrolled in another clinical study|0|||
164583873|NCT01629667|594502810|FG000|Overall Study|Code break|1|||
164583874|NCT01629667|594502811|FG001|Overall Study|Code break|0|||
164583875|NCT01629667|594502812|FG002|Overall Study|Code break|0|||
164583876|NCT00592683|594502814|FG000|Overall Study|Found ineligible|0|||
164583877|NCT00592683|594502815|FG001|Overall Study|Found ineligible|1|||
164583878|NCT00592683|594502814|FG000|Overall Study|Withdrawal by Subject|1|||
164583879|NCT00592683|594502815|FG001|Overall Study|Withdrawal by Subject|0|||
164583880|NCT00592683|594502814|FG000|Overall Study|Adverse Event|0|||
164583881|NCT00592683|594502815|FG001|Overall Study|Adverse Event|2|||
164583882|NCT00592683|594502814|FG000|Overall Study|Protocol Violation|1|||
164583883|NCT00592683|594502815|FG001|Overall Study|Protocol Violation|0|||
164583884|NCT00592683|594502814|FG000|Overall Study|Study drug expired|1|||
164583885|NCT00592683|594502815|FG001|Overall Study|Study drug expired|0|||
164583886|NCT00592683|594502814|FG000|Overall Study|Other|1|||
164583887|NCT00592683|594502815|FG001|Overall Study|Other|0|||
164583888|NCT00592683|594502814|FG000|Overall Study|Lost to Follow-up|0|||
164583889|NCT00592683|594502815|FG001|Overall Study|Lost to Follow-up|1|||
164583890|NCT00201201|594502816|FG000|Overall Study|Death|0|||
164583891|NCT00201201|594502817|FG001|Overall Study|Death|2|||
164583892|NCT00201201|594502816|FG000|Overall Study|Withdrawal by Subject|5|||
164583893|NCT00201201|594502817|FG001|Overall Study|Withdrawal by Subject|5|||
164583894|NCT00891657|594502823|FG000|Overall Study|Withdrawal by Subject|1|||
164583895|NCT00891657|594502824|FG001|Overall Study|Withdrawal by Subject|1|||
164583896|NCT00537823|594502834|FG000|Overall Study|Adverse Event|2|||
164583897|NCT00537823|594502835|FG001|Overall Study|Adverse Event|0|||
164583898|NCT03455543|594502836|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
164583899|NCT03455543|594502837|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
164275700|NCT02516228|593377433|FG000|Overall Study|Withdrawal by Subject|1|||
164583900|NCT03455543|594502838|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
164583901|NCT03455543|594502836|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
164583902|NCT03455543|594502837|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
164583903|NCT03455543|594502838|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
164275701|NCT02516228|593377433|FG000|Overall Study|Physician Decision|1|||
164689522|NCT00401245|594887729|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
164689523|NCT00401245|594887730|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
164275702|NCT03916484|593377434|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
164275703|NCT03916484|593377435|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
164275704|NCT03916484|593377436|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
164275705|NCT03916484|593377437|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
164275706|NCT03916484|593377434|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
164275707|NCT03916484|593377435|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
164275708|NCT03916484|593377436|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
164275709|NCT03916484|593377437|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
164275710|NCT03281304|593377445|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
164275711|NCT03281304|593377446|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
164275712|NCT03281304|593377445|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
164275713|NCT03281304|593377446|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
164275714|NCT03281304|593377445|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
164275715|NCT03281304|593377446|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
164275716|NCT03281304|593377445|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
164275717|NCT03281304|593377446|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
164275718|NCT03281304|593377445|FG000|Treatment Phase (up to 42 Months)|Death|0|||
164275719|NCT03281304|593377446|FG001|Treatment Phase (up to 42 Months)|Death|1|||
164275720|NCT03281304|593377445|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
164275721|NCT03281304|593377446|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
164275722|NCT03281304|593377445|FG000|Treatment Phase (up to 42 Months)|Other|0|||
164275723|NCT03281304|593377446|FG001|Treatment Phase (up to 42 Months)|Other|2|||
164275724|NCT03281304|593377445|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
164275725|NCT03281304|593377446|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
164275726|NCT00858637|593377447|FG000|Active Comparison Phase|Adverse Event|14|||
164275727|NCT00858637|593377448|FG001|Active Comparison Phase|Adverse Event|0|||
164275728|NCT00858637|593377449|FG002|Active Comparison Phase|Adverse Event|0|||
164275729|NCT00858637|593377450|FG003|Active Comparison Phase|Adverse Event|9|||
164275730|NCT00858637|593377451|FG004|Active Comparison Phase|Adverse Event|0|||
164275731|NCT00858637|593377452|FG005|Active Comparison Phase|Adverse Event|0|||
164275732|NCT00858637|593377447|FG000|Active Comparison Phase|Death|1|||
164275733|NCT00858637|593377448|FG001|Active Comparison Phase|Death|0|||
164275734|NCT00858637|593377449|FG002|Active Comparison Phase|Death|0|||
164275735|NCT00858637|593377450|FG003|Active Comparison Phase|Death|1|||
164275736|NCT00858637|593377451|FG004|Active Comparison Phase|Death|0|||
164275737|NCT00858637|593377452|FG005|Active Comparison Phase|Death|0|||
164275738|NCT00858637|593377447|FG000|Active Comparison Phase|Physician Decision|1|||
164275739|NCT00858637|593377448|FG001|Active Comparison Phase|Physician Decision|0|||
164275740|NCT00858637|593377449|FG002|Active Comparison Phase|Physician Decision|0|||
164275741|NCT00858637|593377450|FG003|Active Comparison Phase|Physician Decision|1|||
164275742|NCT00858637|593377451|FG004|Active Comparison Phase|Physician Decision|0|||
164275743|NCT00858637|593377452|FG005|Active Comparison Phase|Physician Decision|0|||
164275744|NCT00858637|593377447|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
164275745|NCT00858637|593377448|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
164275746|NCT00858637|593377449|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
164275747|NCT00858637|593377450|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
164275748|NCT00858637|593377451|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
164275749|NCT00858637|593377452|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
164275750|NCT00858637|593377447|FG000|Active Comparison Phase|Other Reasons|1|||
164275751|NCT00858637|593377448|FG001|Active Comparison Phase|Other Reasons|0|||
164275752|NCT00858637|593377449|FG002|Active Comparison Phase|Other Reasons|0|||
164275753|NCT00858637|593377450|FG003|Active Comparison Phase|Other Reasons|1|||
164275754|NCT00858637|593377451|FG004|Active Comparison Phase|Other Reasons|0|||
164275755|NCT00858637|593377452|FG005|Active Comparison Phase|Other Reasons|0|||
164275756|NCT00858637|593377447|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
164343142|NCT00674700|593632936|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
164343143|NCT00674700|593632937|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
164343144|NCT00674700|593632938|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
164343145|NCT00674700|593632936|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
164343146|NCT00674700|593632937|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
164343147|NCT00674700|593632938|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
164343148|NCT00621985|593632947|FG000|Dexamethasone Admission|Adverse Event|1|||
164343149|NCT01806298|593632948|FG000|Overall Study|Adverse Event|3|||
164343150|NCT01806298|593632948|FG000|Overall Study|Protocol Non-compliance|1|||
164343151|NCT01806298|593632948|FG000|Overall Study|Withdrawal by Subject|1|||
164343152|NCT01806298|593632948|FG000|Overall Study|Other|5|||
164343153|NCT01001377|593632951|FG000|Overall Study|Ineligibility determined|2|||
164343154|NCT01001377|593632952|FG001|Overall Study|Ineligibility determined|0|||
164343155|NCT01001377|593632951|FG000|Overall Study|Withdrawal by Subject|19|||
164275757|NCT00858637|593377448|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
164275758|NCT00858637|593377449|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
164275759|NCT00858637|593377450|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
164275760|NCT00858637|593377451|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
164275761|NCT00858637|593377452|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
164275762|NCT00858637|593377447|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
164275763|NCT00858637|593377448|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
164275764|NCT00858637|593377449|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
164275765|NCT00858637|593377450|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
164275766|NCT00858637|593377451|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
164275767|NCT00858637|593377452|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
164275768|NCT02292706|593377455|FG000|Overall Study|Lost to Follow-up|20|||
164275769|NCT02292706|593377456|FG001|Overall Study|Lost to Follow-up|44|||
164275770|NCT02292706|593377457|FG002|Overall Study|Lost to Follow-up|24|||
164275771|NCT02292706|593377458|FG003|Overall Study|Lost to Follow-up|61|||
164275772|NCT02292706|593377459|FG004|Overall Study|Lost to Follow-up|21|||
164275773|NCT02292706|593377460|FG005|Overall Study|Lost to Follow-up|52|||
164275774|NCT02292706|593377461|FG006|Overall Study|Lost to Follow-up|25|||
164275775|NCT02292706|593377462|FG007|Overall Study|Lost to Follow-up|0|||
164275776|NCT02292706|593377455|FG000|Overall Study|Withdrew consent|15|||
164275777|NCT02292706|593377456|FG001|Overall Study|Withdrew consent|56|||
164275778|NCT02292706|593377457|FG002|Overall Study|Withdrew consent|43|||
164275779|NCT02292706|593377458|FG003|Overall Study|Withdrew consent|36|||
164275780|NCT02292706|593377459|FG004|Overall Study|Withdrew consent|13|||
164275781|NCT02292706|593377460|FG005|Overall Study|Withdrew consent|51|||
164275782|NCT02292706|593377461|FG006|Overall Study|Withdrew consent|20|||
164275783|NCT02292706|593377462|FG007|Overall Study|Withdrew consent|0|||
164275784|NCT02292706|593377455|FG000|Overall Study|Death|3|||
164275785|NCT02292706|593377456|FG001|Overall Study|Death|11|||
164275786|NCT02292706|593377457|FG002|Overall Study|Death|16|||
164275787|NCT02292706|593377458|FG003|Overall Study|Death|22|||
164275788|NCT02292706|593377459|FG004|Overall Study|Death|8|||
164275789|NCT02292706|593377460|FG005|Overall Study|Death|17|||
164275790|NCT02292706|593377461|FG006|Overall Study|Death|3|||
164275791|NCT02292706|593377462|FG007|Overall Study|Death|0|||
164275792|NCT02292706|593377455|FG000|Overall Study|Study terminated by sponsor|0|||
164275793|NCT02292706|593377456|FG001|Overall Study|Study terminated by sponsor|9|||
164275794|NCT02292706|593377457|FG002|Overall Study|Study terminated by sponsor|4|||
164275795|NCT02292706|593377458|FG003|Overall Study|Study terminated by sponsor|21|||
164275796|NCT02292706|593377459|FG004|Overall Study|Study terminated by sponsor|11|||
164275797|NCT02292706|593377460|FG005|Overall Study|Study terminated by sponsor|13|||
164275798|NCT02292706|593377461|FG006|Overall Study|Study terminated by sponsor|3|||
164275799|NCT02292706|593377462|FG007|Overall Study|Study terminated by sponsor|0|||
164275800|NCT02292706|593377455|FG000|Overall Study|Investigator's discretion|4|||
164275801|NCT02292706|593377456|FG001|Overall Study|Investigator's discretion|9|||
164275802|NCT02292706|593377457|FG002|Overall Study|Investigator's discretion|7|||
164275803|NCT02292706|593377458|FG003|Overall Study|Investigator's discretion|11|||
164275804|NCT02292706|593377459|FG004|Overall Study|Investigator's discretion|4|||
164275805|NCT02292706|593377460|FG005|Overall Study|Investigator's discretion|10|||
164275806|NCT02292706|593377461|FG006|Overall Study|Investigator's discretion|1|||
164275807|NCT02292706|593377462|FG007|Overall Study|Investigator's discretion|0|||
164275808|NCT02292706|593377455|FG000|Overall Study|Liver transplant|1|||
164275809|NCT02292706|593377456|FG001|Overall Study|Liver transplant|1|||
164275810|NCT02292706|593377457|FG002|Overall Study|Liver transplant|11|||
164275811|NCT02292706|593377458|FG003|Overall Study|Liver transplant|16|||
164275812|NCT02292706|593377459|FG004|Overall Study|Liver transplant|5|||
164275813|NCT02292706|593377460|FG005|Overall Study|Liver transplant|6|||
164275814|NCT02292706|593377461|FG006|Overall Study|Liver transplant|5|||
164275815|NCT02292706|593377462|FG007|Overall Study|Liver transplant|0|||
164275816|NCT02292706|593377455|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
164275817|NCT02292706|593377456|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
164275818|NCT02292706|593377457|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
164275819|NCT02292706|593377458|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
164275820|NCT02292706|593377459|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
164343156|NCT01001377|593632952|FG001|Overall Study|Withdrawal by Subject|20|||
164343157|NCT01001377|593632951|FG000|Overall Study|Lost to Follow-up|14|||
164343158|NCT01001377|593632952|FG001|Overall Study|Lost to Follow-up|17|||
164343159|NCT01001377|593632951|FG000|Overall Study|Death|391|||
164343160|NCT01001377|593632952|FG001|Overall Study|Death|384|||
164343161|NCT04343261|593632953|FG000|Overall Study|Adverse Event|1|||
164343162|NCT04343261|593632953|FG000|Overall Study|received inadequate amount of antibodies|7|||
164343163|NCT02849678|593632954|FG000|Overall Study|Protocol Violation|3|||
164583904|NCT03455543|594502836|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
164275821|NCT02292706|593377460|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
164275822|NCT02292706|593377461|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
164275823|NCT02292706|593377462|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
164343164|NCT02849678|593632955|FG001|Overall Study|Protocol Violation|6|||
164343165|NCT00289991|593632956|FG000|Overall Study|Death|35|||
164343166|NCT00289991|593632957|FG001|Overall Study|Death|38|||
164343167|NCT00289991|593632956|FG000|Overall Study|Adverse Event|15|||
164343168|NCT00289991|593632957|FG001|Overall Study|Adverse Event|13|||
164343169|NCT00289991|593632956|FG000|Overall Study|Failure of prophylaxis|1|||
164343170|NCT00289991|593632957|FG001|Overall Study|Failure of prophylaxis|1|||
164343171|NCT00289991|593632956|FG000|Overall Study|Fungal breakthrough infection|0|||
164343172|NCT00289991|593632957|FG001|Overall Study|Fungal breakthrough infection|1|||
164343173|NCT00289991|593632956|FG000|Overall Study|Lost to Follow-up|0|||
164343174|NCT00289991|593632957|FG001|Overall Study|Lost to Follow-up|1|||
164343175|NCT00289991|593632956|FG000|Overall Study|Withdrawal by Subject|2|||
164343176|NCT00289991|593632957|FG001|Overall Study|Withdrawal by Subject|12|||
164343177|NCT00289991|593632956|FG000|Overall Study|Other|5|||
164343178|NCT00289991|593632957|FG001|Overall Study|Other|14|||
164343179|NCT04447794|593632958|FG000|Overall Study|Lost to Follow-up|2|||
164343180|NCT04447794|593632959|FG001|Overall Study|Lost to Follow-up|3|||
164343181|NCT04447794|593632960|FG002|Overall Study|Lost to Follow-up|8|||
164343182|NCT04447794|593632958|FG000|Overall Study|Withdrawal by Subject|1|||
164343183|NCT04447794|593632959|FG001|Overall Study|Withdrawal by Subject|1|||
164343184|NCT04447794|593632960|FG002|Overall Study|Withdrawal by Subject|0|||
164343185|NCT00205881|593632961|FG000|Overall Study|Withdrawal by Subject|16|||
164343186|NCT01090492|593632965|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
164343187|NCT01090492|593632966|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
164343188|NCT01090492|593632967|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
164343189|NCT01090492|593632968|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
164343190|NCT01090492|593632969|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
164343191|NCT01090492|593632970|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
164343192|NCT01090492|593632971|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
164343193|NCT01090492|593632972|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
164343194|NCT01090492|593632965|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
164343195|NCT01090492|593632966|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
164343196|NCT01090492|593632967|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
164343197|NCT01090492|593632968|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
164343198|NCT01090492|593632969|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
164343199|NCT01090492|593632970|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
164275824|NCT02292706|593377455|FG000|Overall Study|Subject terminated by sponsor|1|||
164275825|NCT02292706|593377456|FG001|Overall Study|Subject terminated by sponsor|0|||
164275826|NCT02292706|593377457|FG002|Overall Study|Subject terminated by sponsor|0|||
164275827|NCT02292706|593377458|FG003|Overall Study|Subject terminated by sponsor|2|||
164275828|NCT02292706|593377459|FG004|Overall Study|Subject terminated by sponsor|1|||
164275829|NCT02292706|593377460|FG005|Overall Study|Subject terminated by sponsor|0|||
164275830|NCT02292706|593377461|FG006|Overall Study|Subject terminated by sponsor|0|||
164275831|NCT02292706|593377462|FG007|Overall Study|Subject terminated by sponsor|0|||
164275832|NCT02292706|593377455|FG000|Overall Study|Missing|0|||
164275833|NCT02292706|593377456|FG001|Overall Study|Missing|0|||
164275834|NCT02292706|593377457|FG002|Overall Study|Missing|1|||
164275835|NCT02292706|593377458|FG003|Overall Study|Missing|1|||
164275836|NCT02292706|593377459|FG004|Overall Study|Missing|0|||
164275837|NCT02292706|593377460|FG005|Overall Study|Missing|1|||
164275838|NCT02292706|593377461|FG006|Overall Study|Missing|0|||
164275839|NCT02292706|593377462|FG007|Overall Study|Missing|0|||
164275840|NCT02292706|593377455|FG000|Overall Study|Virologic relapse or reinfection|1|||
164583905|NCT03455543|594502837|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
164583906|NCT03455543|594502838|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
164583907|NCT03455543|594502836|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
164583908|NCT03455543|594502837|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
164583909|NCT03455543|594502838|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
164583910|NCT03455543|594502836|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
164583911|NCT03455543|594502837|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
164583912|NCT03455543|594502838|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
164583913|NCT03455543|594502836|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
164583914|NCT03455543|594502837|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
164275841|NCT02292706|593377456|FG001|Overall Study|Virologic relapse or reinfection|0|||
164275842|NCT02292706|593377457|FG002|Overall Study|Virologic relapse or reinfection|0|||
164275843|NCT02292706|593377458|FG003|Overall Study|Virologic relapse or reinfection|1|||
164275844|NCT02292706|593377459|FG004|Overall Study|Virologic relapse or reinfection|0|||
164343200|NCT01090492|593632971|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
164343201|NCT01090492|593632972|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
164275845|NCT02292706|593377460|FG005|Overall Study|Virologic relapse or reinfection|1|||
164275846|NCT02292706|593377461|FG006|Overall Study|Virologic relapse or reinfection|0|||
164275847|NCT02292706|593377462|FG007|Overall Study|Virologic relapse or reinfection|0|||
164275848|NCT02188849|593377466|FG000|Overall Study|Lost to Follow-up|3|||
164275849|NCT02188849|593377467|FG001|Overall Study|Lost to Follow-up|8|||
164275850|NCT05740618|593378637|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|1|||
164275851|NCT05740618|593378637|FG000|Overall Study|Physician Decision|1|||
164275852|NCT04588389|593378638|FG000|Overall Study|Issues with anesthesia during surgery|2|||
164275853|NCT04588389|593378639|FG001|Overall Study|Issues with anesthesia during surgery|0|||
164275854|NCT04588389|593378640|FG002|Overall Study|Issues with anesthesia during surgery|0|||
164275855|NCT02354235|593378641|FG000|Overall Study|Adverse Event|2|||
164275856|NCT02354235|593378642|FG001|Overall Study|Adverse Event|2|||
164275857|NCT02354235|593378641|FG000|Overall Study|Physician Decision|0|||
164275858|NCT02354235|593378642|FG001|Overall Study|Physician Decision|1|||
164275859|NCT02354235|593378641|FG000|Overall Study|Withdrawal by Subject|1|||
164275860|NCT02354235|593378642|FG001|Overall Study|Withdrawal by Subject|3|||
164275861|NCT02354235|593378641|FG000|Overall Study|Conflict with the stopping criteria|0|||
164275862|NCT02354235|593378642|FG001|Overall Study|Conflict with the stopping criteria|1|||
164275863|NCT06045507|593378644|FG000|Overall Study|Death|0|||
164275864|NCT06045507|593378645|FG001|Overall Study|Death|0|||
164275865|NCT06045507|593378646|FG002|Overall Study|Death|1|||
164275866|NCT06045507|593378647|FG003|Overall Study|Death|0|||
164275867|NCT06045507|593378644|FG000|Overall Study|Lost to Follow-up|3|||
164275868|NCT06045507|593378645|FG001|Overall Study|Lost to Follow-up|3|||
164275869|NCT06045507|593378646|FG002|Overall Study|Lost to Follow-up|0|||
164275870|NCT06045507|593378647|FG003|Overall Study|Lost to Follow-up|0|||
164275871|NCT06045507|593378644|FG000|Overall Study|Randomized by mistake (no study treatment given)|0|||
164275872|NCT06045507|593378645|FG001|Overall Study|Randomized by mistake (no study treatment given)|1|||
164275873|NCT06045507|593378646|FG002|Overall Study|Randomized by mistake (no study treatment given)|1|||
164275874|NCT06045507|593378647|FG003|Overall Study|Randomized by mistake (no study treatment given)|0|||
164275875|NCT06045507|593378644|FG000|Overall Study|Withdrawal by Subject|4|||
164275876|NCT06045507|593378645|FG001|Overall Study|Withdrawal by Subject|1|||
164275877|NCT06045507|593378646|FG002|Overall Study|Withdrawal by Subject|0|||
164275878|NCT06045507|593378647|FG003|Overall Study|Withdrawal by Subject|2|||
164275879|NCT06045507|593378644|FG000|Overall Study|Miscellaneous|2|||
164275880|NCT06045507|593378645|FG001|Overall Study|Miscellaneous|0|||
164275881|NCT06045507|593378646|FG002|Overall Study|Miscellaneous|0|||
164275882|NCT06045507|593378647|FG003|Overall Study|Miscellaneous|1|||
164583915|NCT03455543|594502838|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
164275883|NCT00902174|593378652|FG000|Overall Study|Adverse Event|27|||
164275884|NCT00902174|593378653|FG001|Overall Study|Adverse Event|7|||
164275885|NCT00902174|593378652|FG000|Overall Study|Lack of Efficacy|1|||
164583916|NCT03455543|594502836|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
164583917|NCT03455543|594502837|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
164583918|NCT03455543|594502838|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
164583919|NCT03455543|594502836|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
164583920|NCT03455543|594502837|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
164583921|NCT03455543|594502838|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
164583922|NCT03455543|594502836|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
164583923|NCT03455543|594502837|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
164583924|NCT03455543|594502838|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
164583925|NCT04382651|594502839|FG000|Overall Study|Death|26|||
164583926|NCT04382651|594502840|FG001|Overall Study|Death|23|||
164583927|NCT04382651|594502839|FG000|Overall Study|Lost to Follow-up|3|||
164583928|NCT04382651|594502840|FG001|Overall Study|Lost to Follow-up|4|||
164583929|NCT04382651|594502839|FG000|Overall Study|Withdrawal by Subject|2|||
164583930|NCT04382651|594502840|FG001|Overall Study|Withdrawal by Subject|0|||
164583931|NCT04382651|594502839|FG000|Overall Study|Physician Decision|0|||
164583932|NCT04382651|594502840|FG001|Overall Study|Physician Decision|1|||
164583933|NCT02612077|594502841|FG000|Overall Study|Adverse Event|3|||
164583934|NCT02612077|594502841|FG000|Overall Study|Withdrawal by Subject|9|||
164583935|NCT02612077|594502841|FG000|Overall Study|Protocol Violation|28|||
164583936|NCT02612077|594502841|FG000|Overall Study|Lost to Follow-up|20|||
164583937|NCT02612077|594502841|FG000|Overall Study|Death|377|||
164583938|NCT02612077|594502841|FG000|Overall Study|Moved or Changed Medical Team|23|||
164583939|NCT02612077|594502841|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
164583940|NCT02612077|594502841|FG000|Overall Study|Disease Progression|3|||
164583941|NCT02612077|594502841|FG000|Overall Study|Unknown reason|2|||
164275886|NCT00902174|593378653|FG001|Overall Study|Lack of Efficacy|5|||
164275887|NCT00902174|593378652|FG000|Overall Study|Death|2|||
164275888|NCT00902174|593378653|FG001|Overall Study|Death|2|||
164275889|NCT00902174|593378652|FG000|Overall Study|Withdrawal by Subject|2|||
164275890|NCT00902174|593378653|FG001|Overall Study|Withdrawal by Subject|1|||
164275891|NCT00902174|593378652|FG000|Overall Study|Abnormal labs|1|||
164431574|NCT00817635|593951389|FG004|Overall Study|Administrative Problems|1|||
164431575|NCT00817635|593951385|FG000|Overall Study|Protocol Violation|5|||
164431576|NCT00817635|593951386|FG001|Overall Study|Protocol Violation|1|||
164431577|NCT00817635|593951387|FG002|Overall Study|Protocol Violation|3|||
164431578|NCT00817635|593951388|FG003|Overall Study|Protocol Violation|2|||
164431579|NCT00817635|593951389|FG004|Overall Study|Protocol Violation|3|||
164431580|NCT00686517|593951390|FG000|Treatment|Serious Adverse Event|1|||
164275892|NCT00902174|593378653|FG001|Overall Study|Abnormal labs|1|||
164275893|NCT00902174|593378652|FG000|Overall Study|Protocol Violation|1|||
164275894|NCT00902174|593378653|FG001|Overall Study|Protocol Violation|1|||
164275895|NCT00902174|593378652|FG000|Overall Study|Administration problem|0|||
164275896|NCT00902174|593378653|FG001|Overall Study|Administration problem|1|||
164275897|NCT03688100|593378654|FG000|Overall Study|Lost to Follow-up|21|||
164275898|NCT03688100|593378655|FG001|Overall Study|Lost to Follow-up|15|||
164343202|NCT01090492|593632965|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343203|NCT01090492|593632966|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343204|NCT01090492|593632967|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
164431581|NCT00686517|593951391|FG001|Treatment|Serious Adverse Event|2|||
164431582|NCT00686517|593951392|FG002|Treatment|Serious Adverse Event|1|||
164431583|NCT00686517|593951390|FG000|Treatment|Adverse Event|2|||
164431584|NCT00686517|593951391|FG001|Treatment|Adverse Event|0|||
164431585|NCT00686517|593951392|FG002|Treatment|Adverse Event|0|||
164431586|NCT00686517|593951390|FG000|Treatment|Poor Protocol Compliance|1|||
164431587|NCT00686517|593951391|FG001|Treatment|Poor Protocol Compliance|0|||
164431588|NCT00686517|593951392|FG002|Treatment|Poor Protocol Compliance|0|||
164431589|NCT00686517|593951390|FG000|Treatment|Protocol Violation|2|||
164431590|NCT00686517|593951391|FG001|Treatment|Protocol Violation|1|||
164431591|NCT00686517|593951392|FG002|Treatment|Protocol Violation|0|||
164431592|NCT01720446|593951393|FG000|Overall Study|Lost to Follow-up|12|||
164431593|NCT01720446|593951394|FG001|Overall Study|Lost to Follow-up|6|||
164431594|NCT01720446|593951395|FG002|Overall Study|Lost to Follow-up|16|||
164431595|NCT01720446|593951396|FG003|Overall Study|Lost to Follow-up|16|||
164431596|NCT01720446|593951393|FG000|Overall Study|Withdrawal by Subject|2|||
164431597|NCT01720446|593951394|FG001|Overall Study|Withdrawal by Subject|5|||
164431598|NCT01720446|593951395|FG002|Overall Study|Withdrawal by Subject|4|||
164431599|NCT01720446|593951396|FG003|Overall Study|Withdrawal by Subject|4|||
164431600|NCT01803646|593951397|FG000|Overall Study|Protocol Violation|1|||
164431601|NCT01803646|593951398|FG001|Overall Study|Protocol Violation|0|||
164431602|NCT01803646|593951397|FG000|Overall Study|Adverse Event|1|||
164431603|NCT01803646|593951398|FG001|Overall Study|Adverse Event|1|||
164431604|NCT01803646|593951397|FG000|Overall Study|Withdrawal by Subject|9|||
164431605|NCT01803646|593951398|FG001|Overall Study|Withdrawal by Subject|6|||
164431606|NCT01803646|593951397|FG000|Overall Study|Randomization error|1|||
164275899|NCT03688100|593378656|FG002|Overall Study|Lost to Follow-up|15|||
164343205|NCT01090492|593632968|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343206|NCT01090492|593632969|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343207|NCT01090492|593632970|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343208|NCT01090492|593632971|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343209|NCT01090492|593632972|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343210|NCT01090492|593632965|FG000|First Intervention Period (4 Weeks)|Other|0|||
164343211|NCT01090492|593632966|FG001|First Intervention Period (4 Weeks)|Other|0|||
164343212|NCT01090492|593632967|FG002|First Intervention Period (4 Weeks)|Other|1|||
164343213|NCT01090492|593632968|FG003|First Intervention Period (4 Weeks)|Other|1|||
164343214|NCT01090492|593632969|FG004|First Intervention Period (4 Weeks)|Other|2|||
164431607|NCT01803646|593951398|FG001|Overall Study|Randomization error|2|||
164431608|NCT01803646|593951397|FG000|Overall Study|Lost to Follow-up|5|||
164431609|NCT01803646|593951398|FG001|Overall Study|Lost to Follow-up|1|||
164431610|NCT01167426|593951399|FG000|Overall Study|Lost to Follow-up|6|||
164431611|NCT01167426|593951399|FG000|Overall Study|Protocol Violation|1|||
164431612|NCT01167426|593951399|FG000|Overall Study|Withdrawal by Subject|2|||
164343215|NCT01090492|593632970|FG005|First Intervention Period (4 Weeks)|Other|0|||
164343216|NCT01090492|593632971|FG006|First Intervention Period (4 Weeks)|Other|0|||
164343217|NCT01090492|593632972|FG007|First Intervention Period (4 Weeks)|Other|0|||
164343218|NCT01090492|593632965|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
164343219|NCT01090492|593632966|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
164431613|NCT01167426|593951399|FG000|Overall Study|Sponsor Decision|1|||
164343220|NCT01090492|593632967|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
164431614|NCT02993471|593951400|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
164431615|NCT02993471|593951400|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
164431616|NCT03999554|593951402|FG000|Overall Study|Lost to Follow-up|4|||
164275900|NCT03688100|593378657|FG003|Overall Study|Lost to Follow-up|18|||
164343221|NCT01090492|593632968|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
164431617|NCT03999554|593951403|FG001|Overall Study|Lost to Follow-up|5|||
164431618|NCT03999554|593951404|FG002|Overall Study|Lost to Follow-up|4|||
164431619|NCT03999554|593951405|FG003|Overall Study|Lost to Follow-up|5|||
164431620|NCT03999554|593951406|FG004|Overall Study|Lost to Follow-up|8|||
164431621|NCT03999554|593951402|FG000|Overall Study|Protocol Violation|0|||
164431622|NCT03999554|593951403|FG001|Overall Study|Protocol Violation|0|||
164431623|NCT03999554|593951404|FG002|Overall Study|Protocol Violation|5|||
164431624|NCT03999554|593951405|FG003|Overall Study|Protocol Violation|0|||
164431625|NCT03999554|593951406|FG004|Overall Study|Protocol Violation|0|||
164431626|NCT03999554|593951402|FG000|Overall Study|Pregnancy|0|||
164431627|NCT03999554|593951403|FG001|Overall Study|Pregnancy|0|||
164275901|NCT03688100|593378654|FG000|Overall Study|Withdrawal by Subject|19|||
164275902|NCT03688100|593378655|FG001|Overall Study|Withdrawal by Subject|16|||
164275903|NCT03688100|593378656|FG002|Overall Study|Withdrawal by Subject|0|||
164275904|NCT03688100|593378657|FG003|Overall Study|Withdrawal by Subject|0|||
164275905|NCT03688100|593378654|FG000|Overall Study|Death|36|||
164275906|NCT03688100|593378655|FG001|Overall Study|Death|27|||
164275907|NCT03688100|593378656|FG002|Overall Study|Death|0|||
164275908|NCT03688100|593378657|FG003|Overall Study|Death|0|||
164275909|NCT02479139|593378663|FG000|Overall Study|Lost to Follow-up|2|||
164275910|NCT02479139|593378664|FG001|Overall Study|Lost to Follow-up|4|||
164275911|NCT02479139|593378665|FG002|Overall Study|Lost to Follow-up|4|||
164275912|NCT02479139|593378666|FG003|Overall Study|Lost to Follow-up|2|||
164275913|NCT02479139|593378667|FG004|Overall Study|Lost to Follow-up|3|||
164275914|NCT02479139|593378668|FG005|Overall Study|Lost to Follow-up|5|||
164275915|NCT02479139|593378663|FG000|Overall Study|Withdrew Consent|5|||
164431628|NCT03999554|593951404|FG002|Overall Study|Pregnancy|1|||
164431629|NCT03999554|593951405|FG003|Overall Study|Pregnancy|0|||
164431630|NCT03999554|593951406|FG004|Overall Study|Pregnancy|0|||
164431631|NCT03999554|593951402|FG000|Overall Study|Withdrawal by Subject|2|||
164431632|NCT03999554|593951403|FG001|Overall Study|Withdrawal by Subject|2|||
164431633|NCT03999554|593951404|FG002|Overall Study|Withdrawal by Subject|2|||
164431634|NCT03999554|593951405|FG003|Overall Study|Withdrawal by Subject|1|||
164431635|NCT03999554|593951406|FG004|Overall Study|Withdrawal by Subject|1|||
164431636|NCT03999554|593951402|FG000|Overall Study|failure to comply with protocol requirements|0|||
164431637|NCT03999554|593951403|FG001|Overall Study|failure to comply with protocol requirements|0|||
164275916|NCT02479139|593378664|FG001|Overall Study|Withdrew Consent|6|||
164275917|NCT02479139|593378665|FG002|Overall Study|Withdrew Consent|1|||
164275918|NCT02479139|593378666|FG003|Overall Study|Withdrew Consent|4|||
164275919|NCT02479139|593378667|FG004|Overall Study|Withdrew Consent|1|||
164275920|NCT02479139|593378668|FG005|Overall Study|Withdrew Consent|1|||
164275921|NCT02479139|593378663|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
164275922|NCT02479139|593378664|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
164275923|NCT02479139|593378665|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
164275924|NCT02479139|593378666|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
164275925|NCT02479139|593378667|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
164275926|NCT02479139|593378668|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
164275927|NCT02479139|593378663|FG000|Overall Study|Other Miscellaneous Reasons|1|||
164275928|NCT02479139|593378664|FG001|Overall Study|Other Miscellaneous Reasons|0|||
164275929|NCT02479139|593378665|FG002|Overall Study|Other Miscellaneous Reasons|1|||
164275930|NCT02479139|593378666|FG003|Overall Study|Other Miscellaneous Reasons|1|||
164275931|NCT02479139|593378667|FG004|Overall Study|Other Miscellaneous Reasons|1|||
164275932|NCT02479139|593378668|FG005|Overall Study|Other Miscellaneous Reasons|0|||
164275933|NCT00084656|593378671|FG000|Overall Study|Other reasons|0|||
164275934|NCT00084656|593378672|FG001|Overall Study|Other reasons|12|||
164275935|NCT00084656|593378673|FG002|Overall Study|Other reasons|11|||
164275936|NCT00084656|593378671|FG000|Overall Study|Withdrawal by Subject|15|||
164275937|NCT00084656|593378672|FG001|Overall Study|Withdrawal by Subject|4|||
164275938|NCT00084656|593378673|FG002|Overall Study|Withdrawal by Subject|4|||
164275939|NCT00084656|593378671|FG000|Overall Study|Disease relapse|0|||
164275940|NCT00084656|593378672|FG001|Overall Study|Disease relapse|9|||
164275941|NCT00084656|593378673|FG002|Overall Study|Disease relapse|10|||
164431638|NCT03999554|593951404|FG002|Overall Study|failure to comply with protocol requirements|0|||
164431639|NCT03999554|593951405|FG003|Overall Study|failure to comply with protocol requirements|1|||
164431640|NCT03999554|593951406|FG004|Overall Study|failure to comply with protocol requirements|0|||
164431641|NCT02082158|593951407|FG000|Overall Study|Withdrawal by Subject|0|||
164431642|NCT02082158|593951408|FG001|Overall Study|Withdrawal by Subject|0|||
164431643|NCT02082158|593951409|FG002|Overall Study|Withdrawal by Subject|0|||
164275942|NCT00084656|593378671|FG000|Overall Study|Disease progression|9|||
164275943|NCT00084656|593378672|FG001|Overall Study|Disease progression|0|||
164275944|NCT00084656|593378673|FG002|Overall Study|Disease progression|0|||
164431644|NCT02082158|593951410|FG003|Overall Study|Withdrawal by Subject|0|||
164275945|NCT00084656|593378671|FG000|Overall Study|Lost to Follow-up|1|||
164431645|NCT02082158|593951411|FG004|Overall Study|Withdrawal by Subject|1|||
164431646|NCT02082158|593951412|FG005|Overall Study|Withdrawal by Subject|0|||
164431647|NCT02082158|593951407|FG000|Overall Study|Failed Fit-testing|8|||
164431648|NCT02082158|593951408|FG001|Overall Study|Failed Fit-testing|8|||
164275946|NCT00084656|593378672|FG001|Overall Study|Lost to Follow-up|0|||
164275947|NCT00084656|593378673|FG002|Overall Study|Lost to Follow-up|1|||
164275948|NCT00989781|593378674|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
164275949|NCT00989781|593378675|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
164275950|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
164275951|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
164275952|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
164275953|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
164275954|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
164689524|NCT00401245|594887731|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
164689525|NCT00401245|594887732|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
164689526|NCT02426541|594887733|FG000|Overall Study|Protocol Violation|1|||
164689527|NCT02426541|594887734|FG001|Overall Study|Protocol Violation|0|||
164689528|NCT02344745|594887736|FG000|Overall Study|Data collection sheets were lost|2|||
164689529|NCT02344745|594887737|FG001|Overall Study|Data collection sheets were lost|0|||
164689530|NCT02788513|594887738|FG000|Overall Study|Withdrawal by Subject|3|||
164689531|NCT02788513|594887739|FG001|Overall Study|Withdrawal by Subject|0|||
164689532|NCT02788513|594887740|FG002|Overall Study|Withdrawal by Subject|2|||
164689533|NCT02788513|594887741|FG003|Overall Study|Withdrawal by Subject|3|||
164689534|NCT02788513|594887742|FG004|Overall Study|Withdrawal by Subject|1|||
164689535|NCT02788513|594887738|FG000|Overall Study|Lost to Follow-up|1|||
164689536|NCT02788513|594887739|FG001|Overall Study|Lost to Follow-up|0|||
164689537|NCT02788513|594887740|FG002|Overall Study|Lost to Follow-up|0|||
164689538|NCT02788513|594887741|FG003|Overall Study|Lost to Follow-up|0|||
164431649|NCT02082158|593951409|FG002|Overall Study|Failed Fit-testing|14|||
164431650|NCT02082158|593951410|FG003|Overall Study|Failed Fit-testing|4|||
164431651|NCT02082158|593951411|FG004|Overall Study|Failed Fit-testing|3|||
164431652|NCT02082158|593951412|FG005|Overall Study|Failed Fit-testing|7|||
164431653|NCT00742274|593951415|FG000|Overall Study|Death|1|||
164431654|NCT00742274|593951416|FG001|Overall Study|Death|0|||
164431655|NCT00742274|593951415|FG000|Overall Study|Withdrawal by Subject|1|||
164431656|NCT00742274|593951416|FG001|Overall Study|Withdrawal by Subject|2|||
164431657|NCT00742274|593951415|FG000|Overall Study|Removed for medical reasons|1|||
164431658|NCT00742274|593951416|FG001|Overall Study|Removed for medical reasons|1|||
164431659|NCT01101165|593951417|FG000|Period 1|Adverse Event|1|||
164431660|NCT01101165|593951418|FG001|Period 1|Adverse Event|2|||
164431661|NCT01101165|593951417|FG000|Period 1|Withdrawal by Subject|0|||
164431662|NCT01101165|593951418|FG001|Period 1|Withdrawal by Subject|2|||
164431663|NCT01101165|593951417|FG000|Period 1|Positive Drug Screen|0|||
164431664|NCT01101165|593951418|FG001|Period 1|Positive Drug Screen|1|||
164431665|NCT01101165|593951417|FG000|Period 1|Lost to Follow-up|1|||
164431666|NCT01101165|593951418|FG001|Period 1|Lost to Follow-up|0|||
164431667|NCT01101165|593951417|FG000|Period 2|Withdrawal by Subject|3|||
164431668|NCT01101165|593951418|FG001|Period 2|Withdrawal by Subject|1|||
164431669|NCT01101165|593951417|FG000|Period 2|Adverse Event|1|||
164431670|NCT01101165|593951418|FG001|Period 2|Adverse Event|0|||
164431671|NCT00619151|593951420|FG000|Overall Study|Study terminated prior to followup|1|||
164431672|NCT00619151|593951421|FG001|Overall Study|Study terminated prior to followup|0|||
164431673|NCT03256344|593951435|FG000|Overall Study|Death|6|||
164431674|NCT03256344|593951436|FG001|Overall Study|Death|22|||
164431675|NCT03256344|593951435|FG000|Overall Study|Withdrawal by Subject|3|||
164431676|NCT03256344|593951436|FG001|Overall Study|Withdrawal by Subject|3|||
164431677|NCT03256344|593951435|FG000|Overall Study|Sponsor Decision|1|||
164431678|NCT03256344|593951436|FG001|Overall Study|Sponsor Decision|0|||
164689539|NCT02788513|594887742|FG004|Overall Study|Lost to Follow-up|1|||
164689540|NCT02788513|594887738|FG000|Overall Study|Adverse Event|5|||
164689541|NCT02788513|594887739|FG001|Overall Study|Adverse Event|8|||
164689542|NCT02788513|594887740|FG002|Overall Study|Adverse Event|4|||
164689543|NCT02788513|594887741|FG003|Overall Study|Adverse Event|2|||
164689544|NCT02788513|594887742|FG004|Overall Study|Adverse Event|2|||
164431679|NCT03124108|593951437|FG000|Overall Study|Adverse Event|0|||
164689545|NCT02788513|594887738|FG000|Overall Study|Protocol Violation|0|||
164689546|NCT02788513|594887739|FG001|Overall Study|Protocol Violation|0|||
164689547|NCT02788513|594887740|FG002|Overall Study|Protocol Violation|1|||
164689548|NCT02788513|594887741|FG003|Overall Study|Protocol Violation|1|||
164689549|NCT02788513|594887742|FG004|Overall Study|Protocol Violation|0|||
164689550|NCT02788513|594887738|FG000|Overall Study|Subject decided to stop taking treatment|0|||
164689551|NCT02788513|594887739|FG001|Overall Study|Subject decided to stop taking treatment|0|||
164689552|NCT02788513|594887740|FG002|Overall Study|Subject decided to stop taking treatment|1|||
164275955|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
164275956|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
164431680|NCT03124108|593951438|FG001|Overall Study|Adverse Event|1|||
164431681|NCT03124108|593951439|FG002|Overall Study|Adverse Event|0|||
164431682|NCT00880906|593951447|FG000|Overall Study|Lost to Follow-up|0|||
164431683|NCT00880906|593951448|FG001|Overall Study|Lost to Follow-up|1|||
164431684|NCT00880906|593951447|FG000|Overall Study|Did not meet criteria following patholog|12|||
164431685|NCT00880906|593951448|FG001|Overall Study|Did not meet criteria following patholog|6|||
164431686|NCT04163458|593951450|FG000|Overall Study|Protocol Deviation|7|||
164431687|NCT04163458|593951451|FG001|Overall Study|Protocol Deviation|13|||
164431688|NCT04163458|593951450|FG000|Overall Study|Adverse Event|5|||
164275957|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
164275958|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
164275959|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
164275960|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
164275961|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
164275962|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
164275963|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
164343222|NCT01090492|593632969|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
164343223|NCT01090492|593632970|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
164343224|NCT01090492|593632971|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
164343225|NCT01090492|593632972|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
164343226|NCT01090492|593632965|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
164343227|NCT01090492|593632966|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
164583942|NCT00940342|594502842|FG000|Overall Study|Adverse Event|0|||
164583943|NCT00940342|594502843|FG001|Overall Study|Adverse Event|2|||
164583944|NCT00940342|594502844|FG002|Overall Study|Adverse Event|1|||
164583945|NCT05121103|594502849|FG000|Overall Study|Progressive disease|2|||
164343228|NCT01090492|593632967|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
164343229|NCT01090492|593632968|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
164343230|NCT01090492|593632969|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
164343231|NCT01090492|593632970|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
164343232|NCT01090492|593632971|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
164343233|NCT01090492|593632972|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
164343234|NCT01090492|593632965|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
164583946|NCT05121103|594502850|FG001|Overall Study|Progressive disease|1|||
164583947|NCT05121103|594502851|FG002|Overall Study|Progressive disease|6|||
164343235|NCT01090492|593632966|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
164343236|NCT01090492|593632967|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
164583948|NCT05121103|594502849|FG000|Overall Study|Physician Decision|2|||
164343237|NCT01090492|593632968|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
164343238|NCT01090492|593632969|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
164583949|NCT05121103|594502850|FG001|Overall Study|Physician Decision|1|||
164583950|NCT05121103|594502851|FG002|Overall Study|Physician Decision|0|||
164583951|NCT05121103|594502849|FG000|Overall Study|Withdrawal by Subject|0|||
164583952|NCT05121103|594502850|FG001|Overall Study|Withdrawal by Subject|1|||
164583953|NCT05121103|594502851|FG002|Overall Study|Withdrawal by Subject|0|||
164583954|NCT05897853|594502860|FG000|Overall Study|Lost to Follow-up|2|||
164583955|NCT05897853|594502861|FG001|Overall Study|Lost to Follow-up|0|||
164583956|NCT05897853|594502860|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
164583957|NCT05897853|594502861|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
164583958|NCT01450137|594502862|FG000|Up to Week 12|Adverse Event|2|||
164583959|NCT01450137|594502863|FG001|Up to Week 12|Adverse Event|1|||
164583960|NCT01450137|594502862|FG000|Up to Week 12|Withdrawal by Subject|0|||
164583961|NCT01450137|594502863|FG001|Up to Week 12|Withdrawal by Subject|2|||
164583962|NCT01450137|594502862|FG000|Week 12 to Study End|Death|0|||
164583963|NCT01450137|594502863|FG001|Week 12 to Study End|Death|1|||
164583964|NCT01450137|594502862|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
164343239|NCT01090492|593632970|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
164343240|NCT01090492|593632971|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
164343241|NCT01090492|593632972|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
164343242|NCT01090492|593632965|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
164343243|NCT01090492|593632966|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
164343244|NCT01090492|593632967|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
164343245|NCT01090492|593632968|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
164343246|NCT01090492|593632969|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
164343247|NCT01090492|593632970|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
164343248|NCT01090492|593632971|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
164343249|NCT01090492|593632972|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
164343250|NCT01090492|593632965|FG000|Second Intervention Period (4 Weeks)|Other|0|||
164343251|NCT01090492|593632966|FG001|Second Intervention Period (4 Weeks)|Other|1|||
164343252|NCT01090492|593632967|FG002|Second Intervention Period (4 Weeks)|Other|1|||
164343253|NCT01090492|593632968|FG003|Second Intervention Period (4 Weeks)|Other|0|||
164343254|NCT01090492|593632969|FG004|Second Intervention Period (4 Weeks)|Other|0|||
164343255|NCT01090492|593632970|FG005|Second Intervention Period (4 Weeks)|Other|0|||
164343256|NCT01090492|593632971|FG006|Second Intervention Period (4 Weeks)|Other|0|||
164343257|NCT01090492|593632972|FG007|Second Intervention Period (4 Weeks)|Other|0|||
164343258|NCT01090492|593632965|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
164343259|NCT01090492|593632966|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
164343260|NCT01090492|593632967|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
164343261|NCT01090492|593632968|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
164275964|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
164275965|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
164275966|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
164275967|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
164275968|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
164275969|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
164275970|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
164275971|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
164275972|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
164275973|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
164275974|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
164275975|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
164275976|NCT01532869|593378676|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
164275977|NCT01532869|593378677|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
164275978|NCT01532869|593378676|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
164275979|NCT01532869|593378677|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
164275980|NCT01532869|593378676|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
164275981|NCT01532869|593378677|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
164275982|NCT01532869|593378676|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
164275983|NCT01532869|593378677|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
164275984|NCT01331291|593378678|FG000|Overall Study|Lack of Efficacy|2|||
164275985|NCT01331291|593378679|FG001|Overall Study|Lack of Efficacy|8|||
164275986|NCT01331291|593378678|FG000|Overall Study|Death|0|||
164275987|NCT01331291|593378679|FG001|Overall Study|Death|1|||
164275988|NCT01389323|593378685|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
164275989|NCT01389323|593378685|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
164275990|NCT01389323|593378685|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
164275991|NCT01389323|593378685|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
164343262|NCT01090492|593632969|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
164431689|NCT04163458|593951451|FG001|Overall Study|Adverse Event|8|||
164431690|NCT04163458|593951450|FG000|Overall Study|Due to COVID-19 pandemic|4|||
164431691|NCT04163458|593951451|FG001|Overall Study|Due to COVID-19 pandemic|2|||
164431692|NCT04163458|593951450|FG000|Overall Study|Participant withdrew consent|2|||
164431693|NCT04163458|593951451|FG001|Overall Study|Participant withdrew consent|3|||
164431694|NCT04163458|593951450|FG000|Overall Study|Randomization failure|2|||
164343263|NCT01090492|593632970|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
164343264|NCT01090492|593632971|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
164343265|NCT01090492|593632972|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
164343266|NCT01090492|593632965|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343267|NCT01090492|593632966|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343268|NCT01090492|593632967|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343269|NCT01090492|593632968|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343270|NCT01090492|593632969|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343271|NCT01090492|593632970|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343272|NCT01090492|593632971|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
164343273|NCT01090492|593632972|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343274|NCT00868608|593632975|FG000|Overall Study|Withdrawal by Subject|3|||
164343275|NCT00868608|593632976|FG001|Overall Study|Withdrawal by Subject|1|||
164343276|NCT00868608|593632977|FG002|Overall Study|Withdrawal by Subject|0|||
164343277|NCT00868608|593632975|FG000|Overall Study|Lost to Follow-up|3|||
164343278|NCT00868608|593632976|FG001|Overall Study|Lost to Follow-up|0|||
164343279|NCT00868608|593632977|FG002|Overall Study|Lost to Follow-up|1|||
164343280|NCT00868608|593632975|FG000|Overall Study|Death|16|||
164343281|NCT00868608|593632976|FG001|Overall Study|Death|2|||
164343282|NCT00868608|593632977|FG002|Overall Study|Death|4|||
164343283|NCT00868608|593632975|FG000|Overall Study|Other - Unspecified|1|||
164583965|NCT01450137|594502863|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
164583966|NCT02609399|594502864|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
164583967|NCT02609399|594502865|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
164583968|NCT02609399|594502864|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
164583969|NCT02609399|594502865|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
164275992|NCT01389323|593378685|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
164275993|NCT01389323|593378685|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
164343284|NCT00868608|593632976|FG001|Overall Study|Other - Unspecified|0|||
164583970|NCT02609399|594502864|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
164583971|NCT02609399|594502865|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
164431695|NCT04163458|593951451|FG001|Overall Study|Randomization failure|2|||
164431696|NCT04163458|593951450|FG000|Overall Study|Other|4|||
164275994|NCT01389323|593378685|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
164275995|NCT01389323|593378685|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
164275996|NCT01389323|593378685|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
164275997|NCT01389323|593378685|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
164275998|NCT01389323|593378685|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
164275999|NCT01805037|593378687|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
164276000|NCT01805037|593378688|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
164276001|NCT01805037|593378687|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
164583972|NCT04458857|594502866|FG000|Overall Study|Adverse Event|0|||
164583973|NCT04458857|594502867|FG001|Overall Study|Adverse Event|1|||
164583974|NCT04458857|594502868|FG002|Overall Study|Adverse Event|0|||
164583975|NCT04458857|594502866|FG000|Overall Study|Withdrawal by Subject|2|||
164583976|NCT04458857|594502867|FG001|Overall Study|Withdrawal by Subject|0|||
164583977|NCT04458857|594502868|FG002|Overall Study|Withdrawal by Subject|0|||
164583978|NCT04458857|594502866|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164583979|NCT04458857|594502867|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164583980|NCT04458857|594502868|FG002|Overall Study|Withdrawal by parent/guardian|1|||
164583981|NCT04458857|594502866|FG000|Overall Study|Non-compliance with study drug|0|||
164583982|NCT04458857|594502867|FG001|Overall Study|Non-compliance with study drug|1|||
164583983|NCT04458857|594502868|FG002|Overall Study|Non-compliance with study drug|0|||
164583984|NCT04458857|594502866|FG000|Overall Study|Lost to Follow-up|4|||
164583985|NCT04458857|594502867|FG001|Overall Study|Lost to Follow-up|1|||
164583986|NCT04458857|594502868|FG002|Overall Study|Lost to Follow-up|0|||
164583987|NCT00853905|594502873|FG000|Overall Study|Lost to Follow-up|1|||
164583988|NCT00853905|594502874|FG001|Overall Study|Lost to Follow-up|3|||
164583989|NCT00853905|594502873|FG000|Overall Study|Withdrawal by Subject|0|||
164583990|NCT00853905|594502874|FG001|Overall Study|Withdrawal by Subject|1|||
164276002|NCT01805037|593378688|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
164583991|NCT00853905|594502873|FG000|Overall Study|never had surgery|1|||
164276003|NCT01805037|593378687|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
164276004|NCT01805037|593378688|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
164276005|NCT01805037|593378687|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
164276006|NCT01805037|593378688|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
164276007|NCT01805037|593378687|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
164276008|NCT01805037|593378688|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
164276009|NCT01805037|593378687|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
164276010|NCT01805037|593378688|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
164276011|NCT01805037|593378687|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
164276012|NCT01805037|593378688|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
164276013|NCT01805037|593378687|FG000|Follow Up (up to 3 Years)|Death|0|||
164276014|NCT01805037|593378688|FG001|Follow Up (up to 3 Years)|Death|2|||
164276015|NCT01805037|593378687|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
164276016|NCT01805037|593378688|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
164276017|NCT01805037|593378687|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
164276018|NCT01805037|593378688|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
164276019|NCT04566692|593378689|FG000|Overall Study|Adverse Event|2|||
164343285|NCT00868608|593632977|FG002|Overall Study|Other - Unspecified|0|||
164583992|NCT00853905|594502874|FG001|Overall Study|never had surgery|0|||
164583993|NCT00847561|594502877|FG000|Overall Study|Withdrawal by Subject|4|||
164583994|NCT00847561|594502878|FG001|Overall Study|Withdrawal by Subject|3|||
164583995|NCT00847561|594502877|FG000|Overall Study|Unable to schedule|9|||
164583996|NCT00847561|594502878|FG001|Overall Study|Unable to schedule|1|||
164276020|NCT04566692|593378690|FG001|Overall Study|Adverse Event|0|||
164276021|NCT04566692|593378689|FG000|Overall Study|Withdrawal by Subject|1|||
164276022|NCT04566692|593378690|FG001|Overall Study|Withdrawal by Subject|1|||
164583997|NCT01333189|594502879|FG000|Overall Study|Time constraints|1|||
164276023|NCT01183468|593378691|FG000|Overall Study|Lost to Follow-up|2|||
164343286|NCT00911547|593632978|FG000|Overall Study|Adverse Event|8|||
164583998|NCT01333189|594502880|FG001|Overall Study|Time constraints|0|||
164583999|NCT01333189|594502879|FG000|Overall Study|Adverse Event|1|||
164584000|NCT01333189|594502880|FG001|Overall Study|Adverse Event|0|||
164584001|NCT01333189|594502879|FG000|Overall Study|Transportation difficulties|0|||
164584002|NCT01333189|594502880|FG001|Overall Study|Transportation difficulties|1|||
164584003|NCT01333189|594502879|FG000|Overall Study|Moved from region|0|||
164584004|NCT01333189|594502880|FG001|Overall Study|Moved from region|1|||
164584005|NCT01739595|594502882|FG000|Overall Study|Adverse Event|3|||
164584006|NCT01739595|594502883|FG001|Overall Study|Adverse Event|0|||
164276024|NCT01183468|593378692|FG001|Overall Study|Lost to Follow-up|1|||
164276025|NCT01183468|593378693|FG002|Overall Study|Lost to Follow-up|0|||
164276026|NCT01183468|593378694|FG003|Overall Study|Lost to Follow-up|0|||
164584007|NCT01739595|594502884|FG002|Overall Study|Adverse Event|0|||
164584008|NCT01739595|594502882|FG000|Overall Study|Lost to Follow-up|2|||
164431697|NCT04163458|593951451|FG001|Overall Study|Other|2|||
164431698|NCT03885596|593951458|FG000|Overall Study|Withdrawal by Subject|2|||
164431699|NCT03885596|593951459|FG001|Overall Study|Withdrawal by Subject|1|||
164431700|NCT03885596|593951460|FG002|Overall Study|Withdrawal by Subject|0|||
164431701|NCT03885596|593951461|FG003|Overall Study|Withdrawal by Subject|0|||
164276027|NCT01183468|593378691|FG000|Overall Study|Physician Decision|1|||
164276028|NCT01183468|593378692|FG001|Overall Study|Physician Decision|0|||
164276029|NCT01183468|593378693|FG002|Overall Study|Physician Decision|0|||
164276030|NCT01183468|593378694|FG003|Overall Study|Physician Decision|0|||
164276031|NCT01183468|593378691|FG000|Overall Study|Withdrawal by Subject|0|||
164276032|NCT01183468|593378692|FG001|Overall Study|Withdrawal by Subject|1|||
164276033|NCT01183468|593378693|FG002|Overall Study|Withdrawal by Subject|0|||
164276034|NCT01183468|593378694|FG003|Overall Study|Withdrawal by Subject|0|||
164276035|NCT00590577|593378695|FG000|Overall Study|Lack of Efficacy|31|||
164276036|NCT00590577|593378696|FG001|Overall Study|Lack of Efficacy|28|||
164276037|NCT00590577|593378697|FG002|Overall Study|Lack of Efficacy|23|||
164276038|NCT00590577|593378698|FG003|Overall Study|Lack of Efficacy|45|||
164276039|NCT00590577|593378695|FG000|Overall Study|Withdrawal by Subject|23|||
164276040|NCT00590577|593378696|FG001|Overall Study|Withdrawal by Subject|28|||
164276041|NCT00590577|593378697|FG002|Overall Study|Withdrawal by Subject|30|||
164276042|NCT00590577|593378698|FG003|Overall Study|Withdrawal by Subject|26|||
164276043|NCT00590577|593378695|FG000|Overall Study|Adverse Event|10|||
164276044|NCT00590577|593378696|FG001|Overall Study|Adverse Event|10|||
164276045|NCT00590577|593378697|FG002|Overall Study|Adverse Event|13|||
164276046|NCT00590577|593378698|FG003|Overall Study|Adverse Event|11|||
164276047|NCT00590577|593378695|FG000|Overall Study|Lost to Follow-up|12|||
164276048|NCT00590577|593378696|FG001|Overall Study|Lost to Follow-up|6|||
164276049|NCT00590577|593378697|FG002|Overall Study|Lost to Follow-up|6|||
164276050|NCT00590577|593378698|FG003|Overall Study|Lost to Follow-up|9|||
164276051|NCT00590577|593378695|FG000|Overall Study|Pregnancy|0|||
164276052|NCT00590577|593378696|FG001|Overall Study|Pregnancy|1|||
164276053|NCT00590577|593378697|FG002|Overall Study|Pregnancy|0|||
164431702|NCT03852433|593951462|FG000|Overall Study|Withdrawal of consent|5|||
164431703|NCT03852433|593951463|FG001|Overall Study|Withdrawal of consent|8|||
164276054|NCT00590577|593378698|FG003|Overall Study|Pregnancy|0|||
164276055|NCT00590577|593378695|FG000|Overall Study|Various reasons|1|||
164431704|NCT03852433|593951464|FG002|Overall Study|Withdrawal of consent|1|||
164431705|NCT03852433|593951465|FG003|Overall Study|Withdrawal of consent|1|||
164431706|NCT03852433|593951462|FG000|Overall Study|Adverse Event|1|||
164431707|NCT03852433|593951463|FG001|Overall Study|Adverse Event|1|||
164431708|NCT03852433|593951464|FG002|Overall Study|Adverse Event|1|||
164431709|NCT03852433|593951465|FG003|Overall Study|Adverse Event|1|||
164431710|NCT03852433|593951462|FG000|Overall Study|Lost to Follow-up|0|||
164431711|NCT03852433|593951463|FG001|Overall Study|Lost to Follow-up|1|||
164431712|NCT03852433|593951464|FG002|Overall Study|Lost to Follow-up|0|||
164431713|NCT03852433|593951465|FG003|Overall Study|Lost to Follow-up|1|||
164431714|NCT03852433|593951462|FG000|Overall Study|Pregnancy|0|||
164431715|NCT03852433|593951463|FG001|Overall Study|Pregnancy|1|||
164431716|NCT03852433|593951464|FG002|Overall Study|Pregnancy|1|||
164431717|NCT03852433|593951465|FG003|Overall Study|Pregnancy|0|||
164431718|NCT03852433|593951462|FG000|Overall Study|Protocol Violation|0|||
164276056|NCT00590577|593378696|FG001|Overall Study|Various reasons|3|||
164276057|NCT00590577|593378697|FG002|Overall Study|Various reasons|1|||
164276058|NCT00590577|593378698|FG003|Overall Study|Various reasons|2|||
164276059|NCT04033068|593378703|FG000|Overall Study|Withdrawal by Subject|0|||
164276060|NCT04033068|593378704|FG001|Overall Study|Withdrawal by Subject|0|||
164276061|NCT04033068|593378705|FG002|Overall Study|Withdrawal by Subject|1|||
164276062|NCT04033068|593378706|FG003|Overall Study|Withdrawal by Subject|0|||
164276063|NCT04033068|593378703|FG000|Overall Study|Lost to Follow-up|0|||
164276064|NCT04033068|593378704|FG001|Overall Study|Lost to Follow-up|1|||
164276065|NCT04033068|593378705|FG002|Overall Study|Lost to Follow-up|0|||
164276066|NCT04033068|593378706|FG003|Overall Study|Lost to Follow-up|0|||
164276067|NCT04033068|593378703|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
164276068|NCT04033068|593378704|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
164276069|NCT04033068|593378705|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
164276070|NCT04033068|593378706|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
164276071|NCT01817959|593378707|FG000|Overall Study|Graft loss|1|||
164276072|NCT01817959|593378708|FG001|Overall Study|Graft loss|1|||
164276073|NCT01817959|593378707|FG000|Overall Study|forbidden medication|1|||
164276074|NCT01817959|593378708|FG001|Overall Study|forbidden medication|1|||
164276075|NCT01817959|593378707|FG000|Overall Study|Adverse Event|1|||
164276076|NCT01817959|593378708|FG001|Overall Study|Adverse Event|0|||
164276077|NCT01817959|593378707|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
164276078|NCT01817959|593378708|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
164276079|NCT03235089|593378709|FG000|Overall Study|Lost to Follow-up|1|||
164276080|NCT03235089|593378710|FG001|Overall Study|Lost to Follow-up|1|||
164276081|NCT03235089|593378709|FG000|Overall Study|Physician Decision|2|||
164431719|NCT03852433|593951463|FG001|Overall Study|Protocol Violation|0|||
164584009|NCT01739595|594502883|FG001|Overall Study|Lost to Follow-up|0|||
164276082|NCT03235089|593378710|FG001|Overall Study|Physician Decision|2|||
164276083|NCT03238924|593378715|FG000|Overall Study|Withdrawal by Subject|2|||
164276084|NCT03238924|593378716|FG001|Overall Study|Withdrawal by Subject|2|||
164276085|NCT03576716|593378717|FG000|Overall Study|Withdrawal by Subject|0|||
164276086|NCT03576716|593378718|FG001|Overall Study|Withdrawal by Subject|1|||
164276087|NCT00559988|593378719|FG000|Overall Study|Death|147|||
164276088|NCT00559988|593378720|FG001|Overall Study|Death|140|||
164276089|NCT00559988|593378719|FG000|Overall Study|Withdrawal by Subject|152|||
164276090|NCT00559988|593378720|FG001|Overall Study|Withdrawal by Subject|139|||
164276091|NCT00559988|593378719|FG000|Overall Study|Lost to Follow-up|42|||
164276092|NCT00559988|593378720|FG001|Overall Study|Lost to Follow-up|56|||
164276093|NCT00559988|593378719|FG000|Overall Study|ICD device explanted|10|||
164276094|NCT00559988|593378720|FG001|Overall Study|ICD device explanted|17|||
164276095|NCT01123707|593378722|FG000|Overall Study|Lost to Follow-up|3|||
164276096|NCT01123707|593378723|FG001|Overall Study|Lost to Follow-up|1|||
164276097|NCT01123707|593378724|FG002|Overall Study|Lost to Follow-up|3|||
164276098|NCT01123707|593378725|FG003|Overall Study|Lost to Follow-up|2|||
164276099|NCT01123707|593378722|FG000|Overall Study|Adverse Event|5|||
164276100|NCT01123707|593378723|FG001|Overall Study|Adverse Event|7|||
164276101|NCT01123707|593378724|FG002|Overall Study|Adverse Event|5|||
164276102|NCT01123707|593378725|FG003|Overall Study|Adverse Event|3|||
164276103|NCT01123707|593378722|FG000|Overall Study|Sponsor Discontinued Study|30|||
164276104|NCT01123707|593378723|FG001|Overall Study|Sponsor Discontinued Study|24|||
164276105|NCT01123707|593378724|FG002|Overall Study|Sponsor Discontinued Study|25|||
164431720|NCT03852433|593951464|FG002|Overall Study|Protocol Violation|1|||
164431721|NCT03852433|593951465|FG003|Overall Study|Protocol Violation|1|||
164431722|NCT03852433|593951462|FG000|Overall Study|Death|0|||
164584010|NCT01739595|594502884|FG002|Overall Study|Lost to Follow-up|0|||
164584011|NCT01739595|594502882|FG000|Overall Study|Withdrawal by Subject|2|||
164584012|NCT01739595|594502883|FG001|Overall Study|Withdrawal by Subject|1|||
164584013|NCT01739595|594502884|FG002|Overall Study|Withdrawal by Subject|2|||
164584014|NCT01739595|594502882|FG000|Overall Study|Eligibility issue|3|||
164584015|NCT01739595|594502883|FG001|Overall Study|Eligibility issue|0|||
164584016|NCT01739595|594502884|FG002|Overall Study|Eligibility issue|0|||
164584017|NCT01739595|594502882|FG000|Overall Study|Protocol Violation|1|||
164584018|NCT01739595|594502883|FG001|Overall Study|Protocol Violation|0|||
164584019|NCT01739595|594502884|FG002|Overall Study|Protocol Violation|0|||
164584020|NCT01739595|594502882|FG000|Overall Study|Lab assessment|1|||
164584021|NCT01739595|594502883|FG001|Overall Study|Lab assessment|0|||
164584022|NCT01739595|594502884|FG002|Overall Study|Lab assessment|0|||
164584023|NCT01739595|594502882|FG000|Overall Study|Drug discrepancy|1|||
164584024|NCT01739595|594502883|FG001|Overall Study|Drug discrepancy|0|||
164584025|NCT01739595|594502884|FG002|Overall Study|Drug discrepancy|0|||
164584026|NCT04285723|594502890|FG000|Overall Study|Subject decision|1|||
164584027|NCT04285723|594502891|FG001|Overall Study|Subject decision|2|||
164584028|NCT04285723|594502890|FG000|Overall Study|Physician Decision|1|||
164584029|NCT04285723|594502891|FG001|Overall Study|Physician Decision|0|||
164584030|NCT04285723|594502890|FG000|Overall Study|No efficiency|1|||
164584031|NCT04285723|594502891|FG001|Overall Study|No efficiency|0|||
164584032|NCT00778999|594502892|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
164584033|NCT00778999|594502893|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
164584034|NCT00778999|594502892|FG000|Overall Study|Did not receive recFSH|14|||
164584035|NCT00778999|594502893|FG001|Overall Study|Did not receive recFSH|20|||
164584036|NCT02032524|594502894|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
164584037|NCT02032524|594502895|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
164584038|NCT02032524|594502896|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
164584039|NCT02032524|594502897|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
164584040|NCT02032524|594502898|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
164584041|NCT02032524|594502899|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
164584042|NCT02032524|594502894|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
164584043|NCT02032524|594502895|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
164584044|NCT02032524|594502896|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
164584045|NCT02032524|594502897|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
164584046|NCT02032524|594502898|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
164584047|NCT02032524|594502899|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
164584048|NCT02032524|594502894|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
164276106|NCT01123707|593378725|FG003|Overall Study|Sponsor Discontinued Study|40|||
164276107|NCT01123707|593378722|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
164276108|NCT01123707|593378723|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
164276109|NCT01123707|593378724|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
164276110|NCT01123707|593378725|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
164276111|NCT01123707|593378722|FG000|Overall Study|Investigator Withdrew Participant|0|||
164431723|NCT03852433|593951463|FG001|Overall Study|Death|0|||
164584049|NCT02032524|594502895|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
164584050|NCT02032524|594502896|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
164584051|NCT02032524|594502897|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
164343287|NCT00911547|593632979|FG001|Overall Study|Adverse Event|27|||
164343288|NCT00911547|593632980|FG002|Overall Study|Adverse Event|11|||
164343289|NCT00911547|593632981|FG003|Overall Study|Adverse Event|6|||
164343290|NCT00911547|593632978|FG000|Overall Study|Lost to Follow-up|0|||
164343291|NCT00911547|593632979|FG001|Overall Study|Lost to Follow-up|0|||
164343292|NCT00911547|593632980|FG002|Overall Study|Lost to Follow-up|2|||
164343293|NCT00911547|593632981|FG003|Overall Study|Lost to Follow-up|1|||
164343294|NCT00911547|593632978|FG000|Overall Study|Protocol Violation|0|||
164343295|NCT00911547|593632979|FG001|Overall Study|Protocol Violation|5|||
164343296|NCT00911547|593632980|FG002|Overall Study|Protocol Violation|5|||
164343297|NCT00911547|593632981|FG003|Overall Study|Protocol Violation|1|||
164343298|NCT00911547|593632978|FG000|Overall Study|Withdrawal by Subject|3|||
164343299|NCT00911547|593632979|FG001|Overall Study|Withdrawal by Subject|10|||
164343300|NCT00911547|593632980|FG002|Overall Study|Withdrawal by Subject|4|||
164343301|NCT00911547|593632981|FG003|Overall Study|Withdrawal by Subject|8|||
164343302|NCT00457301|593632982|FG000|Overall Study|Withdrawal by Subject|3|||
164343303|NCT00457301|593632983|FG001|Overall Study|Withdrawal by Subject|3|||
164343304|NCT00457301|593632982|FG000|Overall Study|Censored out of the study|15|||
164343305|NCT00457301|593632983|FG001|Overall Study|Censored out of the study|14|||
164343306|NCT00457301|593632982|FG000|Overall Study|Death|5|||
164343307|NCT00457301|593632983|FG001|Overall Study|Death|7|||
164343308|NCT00191269|593632984|FG000|Overall Study|Protocol Violation|0|||
164343309|NCT00191269|593632985|FG001|Overall Study|Protocol Violation|2|||
164343310|NCT00191269|593632984|FG000|Overall Study|Adverse Event|1|||
164343311|NCT00191269|593632985|FG001|Overall Study|Adverse Event|4|||
164343312|NCT00191269|593632984|FG000|Overall Study|Progression of Disease|4|||
164343313|NCT00191269|593632985|FG001|Overall Study|Progression of Disease|42|||
164343314|NCT00191269|593632984|FG000|Overall Study|Lack of Efficacy|1|||
164343315|NCT00191269|593632985|FG001|Overall Study|Lack of Efficacy|5|||
164343316|NCT00191269|593632984|FG000|Overall Study|Withdrawal by Subject|0|||
164343317|NCT00191269|593632985|FG001|Overall Study|Withdrawal by Subject|1|||
164343318|NCT00191269|593632984|FG000|Overall Study|Pathologic Aggrevation|0|||
164343319|NCT00191269|593632985|FG001|Overall Study|Pathologic Aggrevation|1|||
164343320|NCT00191269|593632984|FG000|Overall Study|Physician Decision|0|||
164343321|NCT00191269|593632985|FG001|Overall Study|Physician Decision|3|||
164343322|NCT03583697|593632988|FG000|Overall Study|Withdrawal by Subject|0|||
164343323|NCT03583697|593632989|FG001|Overall Study|Withdrawal by Subject|0|||
164343324|NCT03583697|593632990|FG002|Overall Study|Withdrawal by Subject|1|||
164343325|NCT03583697|593632988|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
164343326|NCT03583697|593632989|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
164343327|NCT03583697|593632990|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
164343328|NCT00365508|593632991|FG000|Overall Study|Lost to Follow-up|139|||
164343329|NCT00365508|593632992|FG001|Overall Study|Lost to Follow-up|154|||
164343330|NCT00404235|593632995|FG000|Overall Study|Withdrawal by Subject|1|||
164343331|NCT00404235|593632996|FG001|Overall Study|Withdrawal by Subject|2|||
164343332|NCT00679432|593632997|FG000|Overall Study|Adverse Event|5|||
164343333|NCT00679432|593632998|FG001|Overall Study|Adverse Event|6|||
164343334|NCT00679432|593632999|FG002|Overall Study|Adverse Event|10|||
164343335|NCT00679432|593633000|FG003|Overall Study|Adverse Event|7|||
164343336|NCT00679432|593632997|FG000|Overall Study|Protocol Violation|1|||
164343337|NCT00679432|593632998|FG001|Overall Study|Protocol Violation|1|||
164343338|NCT00679432|593632999|FG002|Overall Study|Protocol Violation|2|||
164343339|NCT00679432|593633000|FG003|Overall Study|Protocol Violation|1|||
164343340|NCT00679432|593632997|FG000|Overall Study|Withdrawal by Subject|8|||
164343341|NCT00679432|593632998|FG001|Overall Study|Withdrawal by Subject|11|||
164343342|NCT00679432|593632999|FG002|Overall Study|Withdrawal by Subject|10|||
164343343|NCT00679432|593633000|FG003|Overall Study|Withdrawal by Subject|9|||
164343344|NCT00679432|593632997|FG000|Overall Study|Lost to Follow-up|1|||
164343345|NCT00679432|593632998|FG001|Overall Study|Lost to Follow-up|5|||
164343346|NCT00679432|593632999|FG002|Overall Study|Lost to Follow-up|4|||
164343347|NCT00679432|593633000|FG003|Overall Study|Lost to Follow-up|2|||
164343348|NCT00679432|593632997|FG000|Overall Study|Physician Decision|3|||
164343349|NCT00679432|593632998|FG001|Overall Study|Physician Decision|2|||
164343350|NCT00679432|593632999|FG002|Overall Study|Physician Decision|2|||
164343351|NCT00679432|593633000|FG003|Overall Study|Physician Decision|2|||
164343352|NCT00679432|593632997|FG000|Overall Study|Sponsor decision|1|||
164343353|NCT00679432|593632998|FG001|Overall Study|Sponsor decision|0|||
164343354|NCT00679432|593632999|FG002|Overall Study|Sponsor decision|0|||
164343355|NCT00679432|593633000|FG003|Overall Study|Sponsor decision|0|||
164343356|NCT00679432|593632997|FG000|Overall Study|Lack of Efficacy|13|||
164343357|NCT00679432|593632998|FG001|Overall Study|Lack of Efficacy|9|||
164343358|NCT00679432|593632999|FG002|Overall Study|Lack of Efficacy|14|||
164343359|NCT00679432|593633000|FG003|Overall Study|Lack of Efficacy|8|||
164343360|NCT00679432|593632997|FG000|Overall Study|Infectious colitis, normal histology|5|||
164343361|NCT00679432|593632998|FG001|Overall Study|Infectious colitis, normal histology|4|||
164343362|NCT00679432|593632999|FG002|Overall Study|Infectious colitis, normal histology|8|||
164343363|NCT00679432|593633000|FG003|Overall Study|Infectious colitis, normal histology|3|||
164431724|NCT03852433|593951464|FG002|Overall Study|Death|1|||
164276112|NCT01123707|593378723|FG001|Overall Study|Investigator Withdrew Participant|1|||
164276113|NCT01123707|593378724|FG002|Overall Study|Investigator Withdrew Participant|1|||
164276114|NCT01123707|593378725|FG003|Overall Study|Investigator Withdrew Participant|1|||
164276115|NCT01123707|593378722|FG000|Overall Study|Subject Withdrew Consent|4|||
164276116|NCT01123707|593378723|FG001|Overall Study|Subject Withdrew Consent|5|||
164276117|NCT01123707|593378724|FG002|Overall Study|Subject Withdrew Consent|1|||
164276118|NCT01123707|593378725|FG003|Overall Study|Subject Withdrew Consent|2|||
164276119|NCT01123707|593378722|FG000|Overall Study|Lack of Efficacy|1|||
164276120|NCT01123707|593378723|FG001|Overall Study|Lack of Efficacy|2|||
164276121|NCT01123707|593378724|FG002|Overall Study|Lack of Efficacy|1|||
164276122|NCT01123707|593378725|FG003|Overall Study|Lack of Efficacy|0|||
164276123|NCT01123707|593378722|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
164276124|NCT01123707|593378723|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
164276125|NCT01123707|593378724|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
164276126|NCT01123707|593378725|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
164276127|NCT01990612|593378730|FG000|Overall Study|Lost to Follow-up|2|||
164276128|NCT01990612|593378731|FG001|Overall Study|Lost to Follow-up|1|||
164276129|NCT01990612|593378730|FG000|Overall Study|Withdrawal by Subject|5|||
164276130|NCT01990612|593378731|FG001|Overall Study|Withdrawal by Subject|2|||
164276131|NCT02725866|593378732|FG000|Overall Study|Failure to return|6|||
164276132|NCT02725866|593378732|FG000|Overall Study|Withdrew consent|3|||
164276133|NCT02725866|593378732|FG000|Overall Study|Insufficient virological response|1|||
164276134|NCT02725866|593378732|FG000|Overall Study|Other, not specified|4|||
164276135|NCT02980133|593378736|FG000|Overall Study|Other than specified|1|||
164276136|NCT02980133|593378737|FG001|Overall Study|Other than specified|1|||
164276137|NCT02980133|593378738|FG002|Overall Study|Other than specified|2|||
164276138|NCT02980133|593378739|FG003|Overall Study|Other than specified|2|||
164276139|NCT02980133|593378736|FG000|Overall Study|Lost to Follow-up|0|||
164276140|NCT02980133|593378737|FG001|Overall Study|Lost to Follow-up|0|||
164276141|NCT02980133|593378738|FG002|Overall Study|Lost to Follow-up|1|||
164276142|NCT02980133|593378739|FG003|Overall Study|Lost to Follow-up|3|||
164276143|NCT02980133|593378736|FG000|Overall Study|Protocol Violation|0|||
164276144|NCT02980133|593378737|FG001|Overall Study|Protocol Violation|1|||
164276145|NCT02980133|593378738|FG002|Overall Study|Protocol Violation|0|||
164276146|NCT02980133|593378739|FG003|Overall Study|Protocol Violation|0|||
164276147|NCT02980133|593378736|FG000|Overall Study|Withdrawal by parent/guardian|6|||
164276148|NCT02980133|593378737|FG001|Overall Study|Withdrawal by parent/guardian|3|||
164276149|NCT02980133|593378738|FG002|Overall Study|Withdrawal by parent/guardian|3|||
164276150|NCT02980133|593378739|FG003|Overall Study|Withdrawal by parent/guardian|1|||
164276151|NCT02980133|593378736|FG000|Overall Study|Withdrawal by Subject|0|||
164276152|NCT02980133|593378737|FG001|Overall Study|Withdrawal by Subject|0|||
164276153|NCT02980133|593378738|FG002|Overall Study|Withdrawal by Subject|1|||
164276154|NCT02980133|593378739|FG003|Overall Study|Withdrawal by Subject|0|||
164276155|NCT03208088|593378744|FG000|Period 2|Withdrawal by Subject|0|||
164276156|NCT03208088|593378745|FG001|Period 2|Withdrawal by Subject|0|||
164276157|NCT03208088|593378746|FG002|Period 2|Withdrawal by Subject|0|||
164276158|NCT03208088|593378747|FG003|Period 2|Withdrawal by Subject|0|||
164431725|NCT03852433|593951465|FG003|Overall Study|Death|0|||
164584052|NCT02032524|594502898|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
164584053|NCT02032524|594502899|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
164584054|NCT02032524|594502894|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
164584055|NCT02032524|594502895|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
164584056|NCT02032524|594502896|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
164584057|NCT02032524|594502897|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
164584058|NCT02032524|594502898|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
164584059|NCT02032524|594502899|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
164584060|NCT02032524|594502894|FG000|Period 2: LTS13769 Study|Other|0|||
164584061|NCT02032524|594502895|FG001|Period 2: LTS13769 Study|Other|0|||
164584062|NCT02032524|594502896|FG002|Period 2: LTS13769 Study|Other|0|||
164584063|NCT02032524|594502897|FG003|Period 2: LTS13769 Study|Other|0|||
164584064|NCT02032524|594502898|FG004|Period 2: LTS13769 Study|Other|0|||
164584065|NCT02032524|594502899|FG005|Period 2: LTS13769 Study|Other|1|||
164584066|NCT02903511|594502903|FG000|Overall Study|Withdrawal by Subject|1|||
164584067|NCT02903511|594502904|FG001|Overall Study|Withdrawal by Subject|0|||
164584068|NCT02903511|594502903|FG000|Overall Study|Lost to Follow-up|3|||
164276159|NCT03208088|593378748|FG004|Period 2|Withdrawal by Subject|0|||
164276160|NCT03208088|593378749|FG005|Period 2|Withdrawal by Subject|0|||
164276161|NCT03208088|593378750|FG006|Period 2|Withdrawal by Subject|0|||
164276162|NCT03208088|593378751|FG007|Period 2|Withdrawal by Subject|0|||
164276163|NCT03208088|593378752|FG008|Period 2|Withdrawal by Subject|1|||
164276164|NCT03208088|593378753|FG009|Period 2|Withdrawal by Subject|0|||
164276165|NCT03208088|593378744|FG000|Period 3|Unsatisfactory Test Article|0|||
164276166|NCT03208088|593378745|FG001|Period 3|Unsatisfactory Test Article|0|||
164276167|NCT03208088|593378746|FG002|Period 3|Unsatisfactory Test Article|0|||
164276168|NCT03208088|593378747|FG003|Period 3|Unsatisfactory Test Article|1|||
164276169|NCT03208088|593378748|FG004|Period 3|Unsatisfactory Test Article|0|||
164276170|NCT03208088|593378749|FG005|Period 3|Unsatisfactory Test Article|0|||
164276171|NCT03208088|593378750|FG006|Period 3|Unsatisfactory Test Article|0|||
164276172|NCT03208088|593378751|FG007|Period 3|Unsatisfactory Test Article|0|||
164276173|NCT03208088|593378752|FG008|Period 3|Unsatisfactory Test Article|0|||
164276174|NCT03208088|593378753|FG009|Period 3|Unsatisfactory Test Article|0|||
164276175|NCT03208088|593378744|FG000|Period 4|Unsatisfactory Test Article|0|||
164276176|NCT03208088|593378745|FG001|Period 4|Unsatisfactory Test Article|0|||
164276177|NCT03208088|593378746|FG002|Period 4|Unsatisfactory Test Article|0|||
164276178|NCT03208088|593378747|FG003|Period 4|Unsatisfactory Test Article|1|||
164276179|NCT03208088|593378748|FG004|Period 4|Unsatisfactory Test Article|0|||
164276180|NCT03208088|593378749|FG005|Period 4|Unsatisfactory Test Article|0|||
164276181|NCT03208088|593378750|FG006|Period 4|Unsatisfactory Test Article|0|||
164276182|NCT03208088|593378751|FG007|Period 4|Unsatisfactory Test Article|0|||
164276183|NCT03208088|593378752|FG008|Period 4|Unsatisfactory Test Article|0|||
164276184|NCT03208088|593378753|FG009|Period 4|Unsatisfactory Test Article|0|||
164276185|NCT00605345|593378759|FG000|Overall Study|Withdrawal by Subject|1|||
164276186|NCT00605345|593378760|FG001|Overall Study|Withdrawal by Subject|0|||
164276187|NCT00605345|593378759|FG000|Overall Study|Adverse Event|0|||
164276188|NCT00605345|593378760|FG001|Overall Study|Adverse Event|1|||
164276189|NCT00605345|593378759|FG000|Overall Study|Protocol Violation|0|||
164276190|NCT00605345|593378760|FG001|Overall Study|Protocol Violation|2|||
164276191|NCT02577016|593378761|FG000|Overall Study|Adverse Event|2|||
164276192|NCT02577016|593378762|FG001|Overall Study|Adverse Event|1|||
164276193|NCT02577016|593378761|FG000|Overall Study|Physician Decision|0|||
164276194|NCT02577016|593378762|FG001|Overall Study|Physician Decision|1|||
164276195|NCT00666224|593380550|FG000|Double-Blind|Adverse Event|15|||
164276196|NCT00666224|593380551|FG001|Double-Blind|Adverse Event|5|||
164276197|NCT00666224|593380550|FG000|Double-Blind|Lost to Follow-up|2|||
164276198|NCT00666224|593380551|FG001|Double-Blind|Lost to Follow-up|2|||
164276199|NCT00666224|593380550|FG000|Double-Blind|Withdrawal by Subject|18|||
164276200|NCT00666224|593380551|FG001|Double-Blind|Withdrawal by Subject|14|||
164276201|NCT00666224|593380550|FG000|Double-Blind|Physician Decision|0|||
164276202|NCT00666224|593380551|FG001|Double-Blind|Physician Decision|3|||
164276203|NCT00666224|593380550|FG000|Double-Blind|Sponsor decision|1|||
164276204|NCT00666224|593380551|FG001|Double-Blind|Sponsor decision|0|||
164276205|NCT00666224|593380550|FG000|Double-Blind|Pregnancy|3|||
164276206|NCT00666224|593380551|FG001|Double-Blind|Pregnancy|2|||
164276207|NCT00666224|593380550|FG000|Double-Blind|Noncompliance|1|||
164276208|NCT00666224|593380551|FG001|Double-Blind|Noncompliance|0|||
164276209|NCT00666224|593380550|FG000|Double-Blind|Death|1|||
164276210|NCT00666224|593380551|FG001|Double-Blind|Death|0|||
164276211|NCT00666224|593380550|FG000|Double-Blind|Undefined/Unknown|4|||
164276212|NCT00666224|593380551|FG001|Double-Blind|Undefined/Unknown|1|||
164276213|NCT00666224|593380550|FG000|Open-Label|Adverse Event|8|||
164276214|NCT00666224|593380551|FG001|Open-Label|Adverse Event|43|||
164276215|NCT00666224|593380550|FG000|Open-Label|Lost to Follow-up|4|||
164276216|NCT00666224|593380551|FG001|Open-Label|Lost to Follow-up|5|||
164276217|NCT00666224|593380550|FG000|Open-Label|Withdrawal by Subject|12|||
164276218|NCT00666224|593380551|FG001|Open-Label|Withdrawal by Subject|25|||
164276219|NCT00666224|593380550|FG000|Open-Label|Physician Decision|7|||
164276220|NCT00666224|593380551|FG001|Open-Label|Physician Decision|5|||
164276221|NCT00666224|593380550|FG000|Open-Label|Pregnancy|1|||
164276222|NCT00666224|593380551|FG001|Open-Label|Pregnancy|5|||
164276223|NCT00666224|593380550|FG000|Open-Label|Noncompliance|2|||
164276224|NCT00666224|593380551|FG001|Open-Label|Noncompliance|1|||
164276225|NCT00666224|593380550|FG000|Open-Label|Undefined/Unknown|1|||
164276226|NCT00666224|593380551|FG001|Open-Label|Undefined/Unknown|1|||
164584069|NCT02903511|594502904|FG001|Overall Study|Lost to Follow-up|2|||
164584070|NCT00969618|594502905|FG000|Overall Study|Adverse Event|29|||
164584071|NCT00969618|594502905|FG000|Overall Study|Entry Criteria Not Met|3|||
164584072|NCT00969618|594502905|FG000|Overall Study|Lack of Efficacy|2|||
164584073|NCT00969618|594502905|FG000|Overall Study|Lost to Follow-up|7|||
164584074|NCT00969618|594502905|FG000|Overall Study|Physician Decision|1|||
164584075|NCT00969618|594502905|FG000|Overall Study|Protocol Violation|9|||
164584076|NCT00969618|594502905|FG000|Overall Study|Withdrawal by Subject|27|||
164276227|NCT03521141|593380552|FG000|Overall Study|Death|1|||
164276228|NCT03521141|593380553|FG001|Overall Study|Death|0|||
164276229|NCT03521141|593380554|FG002|Overall Study|Death|1|||
164276230|NCT03828617|593380556|FG000|Overall Study|Lost to Follow-up|22|||
164276231|NCT03828617|593380557|FG001|Overall Study|Lost to Follow-up|12|||
164431726|NCT03852433|593951462|FG000|Overall Study|Lack of Efficacy|0|||
164276232|NCT03828617|593380558|FG002|Overall Study|Lost to Follow-up|23|||
164276233|NCT03828617|593380559|FG003|Overall Study|Lost to Follow-up|7|||
164276234|NCT03828617|593380556|FG000|Overall Study|No longer met eligibility criteria|0|||
164276235|NCT03828617|593380557|FG001|Overall Study|No longer met eligibility criteria|1|||
164276236|NCT03828617|593380558|FG002|Overall Study|No longer met eligibility criteria|1|||
164276237|NCT03828617|593380559|FG003|Overall Study|No longer met eligibility criteria|3|||
164276238|NCT03828617|593380556|FG000|Overall Study|Protocol Violation|0|||
164276239|NCT03828617|593380557|FG001|Overall Study|Protocol Violation|2|||
164276240|NCT03828617|593380558|FG002|Overall Study|Protocol Violation|0|||
164276241|NCT03828617|593380559|FG003|Overall Study|Protocol Violation|0|||
164276242|NCT03828617|593380556|FG000|Overall Study|Withdrawal by Subject|2|||
164276243|NCT03828617|593380557|FG001|Overall Study|Withdrawal by Subject|0|||
164276244|NCT03828617|593380558|FG002|Overall Study|Withdrawal by Subject|2|||
164276245|NCT03828617|593380559|FG003|Overall Study|Withdrawal by Subject|0|||
164276246|NCT03354273|593380560|FG000|Overall Study|Adverse Event|5|||
164276247|NCT03354273|593380560|FG000|Overall Study|Screen Failure|21|||
164276248|NCT03354273|593380560|FG000|Overall Study|Withdrawal by Subject|34|||
164276249|NCT03354273|593380560|FG000|Overall Study|Technical Problems|30|||
164276250|NCT03354273|593380560|FG000|Overall Study|Lost to Follow-up|4|||
164276251|NCT03354273|593380560|FG000|Overall Study|Investigator Decision|3|||
164276252|NCT03354273|593380560|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
164276253|NCT03354273|593380560|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
164276254|NCT03354273|593380560|FG000|Overall Study|COVID-19 Restrictions|9|||
164276255|NCT03354273|593380560|FG000|Overall Study|Other|5|||
164276256|NCT00303485|593380561|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
164276257|NCT00303485|593380562|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
164276258|NCT00303485|593380561|FG000|Overall Study|Failure to return|0|||
164276259|NCT00303485|593380562|FG001|Overall Study|Failure to return|1|||
164276260|NCT00303485|593380561|FG000|Overall Study|Withdrawal by Subject|1|||
164584077|NCT01089725|594502906|FG000|Overall Study|Adverse Event|1|||
164584078|NCT01089725|594502907|FG001|Overall Study|Adverse Event|1|||
164584079|NCT01089725|594502908|FG002|Overall Study|Adverse Event|0|||
164584080|NCT01089725|594502909|FG003|Overall Study|Adverse Event|0|||
164276261|NCT00303485|593380562|FG001|Overall Study|Withdrawal by Subject|0|||
164276262|NCT00971243|593380567|FG000|Double Blind Period|Adverse Event|2|||
164276263|NCT00971243|593380568|FG001|Double Blind Period|Adverse Event|3|||
164276264|NCT00971243|593380569|FG002|Double Blind Period|Adverse Event|2|||
164276265|NCT00971243|593380570|FG003|Double Blind Period|Adverse Event|2|||
164276266|NCT00971243|593380571|FG004|Double Blind Period|Adverse Event|3|||
164276267|NCT00971243|593380567|FG000|Double Blind Period|Lost to Follow-up|0|||
164276268|NCT00971243|593380568|FG001|Double Blind Period|Lost to Follow-up|1|||
164276269|NCT00971243|593380569|FG002|Double Blind Period|Lost to Follow-up|1|||
164276270|NCT00971243|593380570|FG003|Double Blind Period|Lost to Follow-up|0|||
164276271|NCT00971243|593380571|FG004|Double Blind Period|Lost to Follow-up|1|||
164276272|NCT00971243|593380567|FG000|Double Blind Period|Physician Decision|10|||
164276273|NCT00971243|593380568|FG001|Double Blind Period|Physician Decision|6|||
164276274|NCT00971243|593380569|FG002|Double Blind Period|Physician Decision|7|||
164276275|NCT00971243|593380570|FG003|Double Blind Period|Physician Decision|6|||
164276276|NCT00971243|593380571|FG004|Double Blind Period|Physician Decision|7|||
164276277|NCT00971243|593380567|FG000|Double Blind Period|Protocol Violation|2|||
164276278|NCT00971243|593380568|FG001|Double Blind Period|Protocol Violation|0|||
164276279|NCT00971243|593380569|FG002|Double Blind Period|Protocol Violation|3|||
164276280|NCT00971243|593380570|FG003|Double Blind Period|Protocol Violation|2|||
164276281|NCT00971243|593380571|FG004|Double Blind Period|Protocol Violation|2|||
164276282|NCT00971243|593380567|FG000|Double Blind Period|Withdrawal by Subject|4|||
164276283|NCT00971243|593380568|FG001|Double Blind Period|Withdrawal by Subject|1|||
164276284|NCT00971243|593380569|FG002|Double Blind Period|Withdrawal by Subject|4|||
164584081|NCT01089725|594502910|FG004|Overall Study|Adverse Event|2|||
164584082|NCT01089725|594502906|FG000|Overall Study|Lack of Efficacy|4|||
164584083|NCT01089725|594502907|FG001|Overall Study|Lack of Efficacy|3|||
164584084|NCT01089725|594502908|FG002|Overall Study|Lack of Efficacy|1|||
164584085|NCT01089725|594502909|FG003|Overall Study|Lack of Efficacy|0|||
164584086|NCT01089725|594502910|FG004|Overall Study|Lack of Efficacy|4|||
164584087|NCT01089725|594502906|FG000|Overall Study|Lost to Follow-up|2|||
164584088|NCT01089725|594502907|FG001|Overall Study|Lost to Follow-up|2|||
164584089|NCT01089725|594502908|FG002|Overall Study|Lost to Follow-up|0|||
164584090|NCT01089725|594502909|FG003|Overall Study|Lost to Follow-up|3|||
164584091|NCT01089725|594502910|FG004|Overall Study|Lost to Follow-up|0|||
164584092|NCT01089725|594502906|FG000|Overall Study|Protocol Violation|0|||
164584093|NCT01089725|594502907|FG001|Overall Study|Protocol Violation|0|||
164584094|NCT01089725|594502908|FG002|Overall Study|Protocol Violation|1|||
164584095|NCT01089725|594502909|FG003|Overall Study|Protocol Violation|1|||
164584096|NCT01089725|594502910|FG004|Overall Study|Protocol Violation|0|||
164584097|NCT01089725|594502906|FG000|Overall Study|Withdrawal by Subject|5|||
164584098|NCT01089725|594502907|FG001|Overall Study|Withdrawal by Subject|5|||
164584099|NCT01089725|594502908|FG002|Overall Study|Withdrawal by Subject|4|||
164584100|NCT01089725|594502909|FG003|Overall Study|Withdrawal by Subject|5|||
164584101|NCT01089725|594502910|FG004|Overall Study|Withdrawal by Subject|4|||
164276285|NCT00971243|593380570|FG003|Double Blind Period|Withdrawal by Subject|4|||
164276286|NCT00971243|593380571|FG004|Double Blind Period|Withdrawal by Subject|4|||
164276287|NCT00971243|593380567|FG000|Double Blind Period|Other reasons|1|||
164276288|NCT00971243|593380568|FG001|Double Blind Period|Other reasons|0|||
164276289|NCT00971243|593380569|FG002|Double Blind Period|Other reasons|2|||
164276290|NCT00971243|593380570|FG003|Double Blind Period|Other reasons|0|||
164276291|NCT00971243|593380571|FG004|Double Blind Period|Other reasons|1|||
164276292|NCT00971243|593380567|FG000|Open-label Period|Adverse Event|1|||
164584102|NCT01089725|594502906|FG000|Overall Study|Study Terminated by Sponsor|51|||
164584103|NCT01089725|594502907|FG001|Overall Study|Study Terminated by Sponsor|56|||
164276293|NCT00971243|593380568|FG001|Open-label Period|Adverse Event|0|||
164276294|NCT00971243|593380569|FG002|Open-label Period|Adverse Event|1|||
164276295|NCT00971243|593380570|FG003|Open-label Period|Adverse Event|1|||
164276296|NCT00971243|593380571|FG004|Open-label Period|Adverse Event|0|||
164276297|NCT00971243|593380567|FG000|Open-label Period|Physician Decision|5|||
164276298|NCT00971243|593380568|FG001|Open-label Period|Physician Decision|9|||
164276299|NCT00971243|593380569|FG002|Open-label Period|Physician Decision|3|||
164276300|NCT00971243|593380570|FG003|Open-label Period|Physician Decision|7|||
164276301|NCT00971243|593380571|FG004|Open-label Period|Physician Decision|2|||
164276302|NCT00971243|593380567|FG000|Open-label Period|Protocol Violation|1|||
164276303|NCT00971243|593380568|FG001|Open-label Period|Protocol Violation|1|||
164276304|NCT00971243|593380569|FG002|Open-label Period|Protocol Violation|1|||
164276305|NCT00971243|593380570|FG003|Open-label Period|Protocol Violation|0|||
164276306|NCT00971243|593380571|FG004|Open-label Period|Protocol Violation|1|||
164276307|NCT00971243|593380567|FG000|Open-label Period|Withdrawal by Subject|1|||
164276308|NCT00971243|593380568|FG001|Open-label Period|Withdrawal by Subject|0|||
164276309|NCT00971243|593380569|FG002|Open-label Period|Withdrawal by Subject|0|||
164276310|NCT00971243|593380570|FG003|Open-label Period|Withdrawal by Subject|2|||
164276311|NCT00971243|593380571|FG004|Open-label Period|Withdrawal by Subject|1|||
164276312|NCT00971243|593380567|FG000|Open-label Period|Other reason|0|||
164276313|NCT00971243|593380568|FG001|Open-label Period|Other reason|0|||
164584104|NCT01089725|594502908|FG002|Overall Study|Study Terminated by Sponsor|53|||
164584105|NCT01089725|594502909|FG003|Overall Study|Study Terminated by Sponsor|68|||
164584106|NCT01089725|594502910|FG004|Overall Study|Study Terminated by Sponsor|68|||
164584107|NCT01089725|594502906|FG000|Overall Study|Randomized, but not treated|0|||
164584108|NCT01089725|594502907|FG001|Overall Study|Randomized, but not treated|1|||
164584109|NCT01089725|594502908|FG002|Overall Study|Randomized, but not treated|2|||
164584110|NCT01089725|594502909|FG003|Overall Study|Randomized, but not treated|1|||
164584111|NCT01089725|594502910|FG004|Overall Study|Randomized, but not treated|2|||
164584112|NCT01089725|594502906|FG000|Overall Study|Other|3|||
164584113|NCT01089725|594502907|FG001|Overall Study|Other|0|||
164584114|NCT01089725|594502908|FG002|Overall Study|Other|0|||
164584115|NCT01089725|594502909|FG003|Overall Study|Other|1|||
164584116|NCT01089725|594502910|FG004|Overall Study|Other|0|||
164584117|NCT03191396|594504547|FG000|Overall Study|Lost to Follow-up|0|||
164584118|NCT03191396|594504548|FG001|Overall Study|Lost to Follow-up|3|||
164584119|NCT03191396|594504547|FG000|Overall Study|Withdrawal by Subject|3|||
164584120|NCT03191396|594504548|FG001|Overall Study|Withdrawal by Subject|2|||
164584121|NCT01240811|594504549|FG000|Overall Study|Physician Decision|0|||
164584122|NCT01240811|594504550|FG001|Overall Study|Physician Decision|1|||
164584123|NCT01240811|594504551|FG002|Overall Study|Physician Decision|0|||
164584124|NCT01240811|594504549|FG000|Overall Study|Withdrawal by Subject|0|||
164584125|NCT01240811|594504550|FG001|Overall Study|Withdrawal by Subject|0|||
164584126|NCT01240811|594504551|FG002|Overall Study|Withdrawal by Subject|1|||
164584127|NCT01853228|594504570|FG000|Phase 1|Lack of Efficacy|8|||
164584128|NCT01853228|594504571|FG001|Phase 1|Lack of Efficacy|0|||
164584129|NCT01853228|594504570|FG000|Phase 1|Other|1|||
164584130|NCT01853228|594504571|FG001|Phase 1|Other|0|||
164584131|NCT01853228|594504570|FG000|Phase 2|Physician Decision|0|||
164584132|NCT01853228|594504571|FG001|Phase 2|Physician Decision|1|||
164584133|NCT01853228|594504570|FG000|Phase 2|Proceed To Transplant|0|||
164584134|NCT01853228|594504571|FG001|Phase 2|Proceed To Transplant|3|||
164584135|NCT01853228|594504570|FG000|Phase 2|Lack of Efficacy|0|||
164584136|NCT01853228|594504571|FG001|Phase 2|Lack of Efficacy|4|||
164584137|NCT02114203|594504577|FG000|Overall Study|Adverse Event|0|||
164584138|NCT02114203|594504578|FG001|Overall Study|Adverse Event|1|||
164584139|NCT02114203|594504579|FG002|Overall Study|Adverse Event|0|||
164584140|NCT02114203|594504577|FG000|Overall Study|Withdrawal by Subject|0|||
164584141|NCT02114203|594504578|FG001|Overall Study|Withdrawal by Subject|1|||
164584142|NCT02114203|594504579|FG002|Overall Study|Withdrawal by Subject|0|||
164584143|NCT01518699|594504580|FG000|Period 2|Protocol Violation|1|||
164584144|NCT01518699|594504581|FG001|Period 2|Protocol Violation|1|||
164584145|NCT01518699|594504582|FG002|Period 2|Protocol Violation|0|||
164584146|NCT01518699|594504583|FG003|Period 2|Protocol Violation|0|||
164276314|NCT00971243|593380569|FG002|Open-label Period|Other reason|0|||
164276315|NCT00971243|593380570|FG003|Open-label Period|Other reason|0|||
164276316|NCT00971243|593380571|FG004|Open-label Period|Other reason|2|||
164276317|NCT04099511|593380575|FG000|Overall Study|Lost to Follow-up|2|||
164584147|NCT01518699|594504584|FG004|Period 2|Protocol Violation|0|||
164584148|NCT01518699|594504585|FG005|Period 2|Protocol Violation|0|||
164584149|NCT01518699|594504580|FG000|Period 2|Lost to Follow-up|0|||
164584150|NCT01518699|594504581|FG001|Period 2|Lost to Follow-up|1|||
164584151|NCT01518699|594504582|FG002|Period 2|Lost to Follow-up|0|||
164584152|NCT01518699|594504583|FG003|Period 2|Lost to Follow-up|0|||
164276318|NCT04099511|593380576|FG001|Overall Study|Lost to Follow-up|2|||
164276319|NCT04099511|593380575|FG000|Overall Study|Withdrawal by Subject|8|||
164584153|NCT01518699|594504584|FG004|Period 2|Lost to Follow-up|0|||
164584154|NCT01518699|594504585|FG005|Period 2|Lost to Follow-up|0|||
164276320|NCT04099511|593380576|FG001|Overall Study|Withdrawal by Subject|4|||
164276321|NCT06581094|593380577|FG000|Overall Study|Lost to Follow-up|1|||
164276322|NCT06581094|593380578|FG001|Overall Study|Lost to Follow-up|1|||
164276323|NCT02942485|593380579|FG000|Overall Study|Lost to Follow-up|1|||
164276324|NCT02942485|593380580|FG001|Overall Study|Lost to Follow-up|0|||
164276325|NCT04302545|593380588|FG000|Overall Study|Lost to Follow-up|3|||
164276326|NCT04302545|593380589|FG001|Overall Study|Lost to Follow-up|4|||
164276327|NCT02516592|593380590|FG000|Overall Study|Patient withdrew consent|5|||
164276328|NCT02516592|593380591|FG001|Overall Study|Patient withdrew consent|2|||
164276329|NCT02516592|593380590|FG000|Overall Study|Protocol deviation|4|||
164276330|NCT02516592|593380591|FG001|Overall Study|Protocol deviation|4|||
164276331|NCT02516592|593380590|FG000|Overall Study|Lost to Follow-up|2|||
164276332|NCT02516592|593380591|FG001|Overall Study|Lost to Follow-up|3|||
164276333|NCT02516592|593380590|FG000|Overall Study|Patient/guardian decision|2|||
164276334|NCT02516592|593380591|FG001|Overall Study|Patient/guardian decision|1|||
164276335|NCT02516592|593380590|FG000|Overall Study|Adverse Event|1|||
164276336|NCT02516592|593380591|FG001|Overall Study|Adverse Event|2|||
164276337|NCT02516592|593380590|FG000|Overall Study|Abnormal test procedure result|1|||
164276338|NCT02516592|593380591|FG001|Overall Study|Abnormal test procedure result|0|||
164276339|NCT02516592|593380590|FG000|Overall Study|Death|1|||
164276340|NCT02516592|593380591|FG001|Overall Study|Death|1|||
164276341|NCT00764673|593380594|FG000|Overall Study|Death|1|||
164276342|NCT00764673|593380594|FG000|Overall Study|Lost to Follow-up|3|||
164276343|NCT00764673|593380594|FG000|Overall Study|Withdrawal by Subject|6|||
164276344|NCT00764673|593380594|FG000|Overall Study|Revision of Device|2|||
164276345|NCT01438177|593380595|FG000|Overall Study|Withdrawal by Subject|1|||
164276346|NCT01438177|593380595|FG000|Overall Study|Initiation of new therapy|1|||
164276347|NCT00619099|593380596|FG000|Overall Study|Progressive Disease|7|||
164276348|NCT00619099|593380597|FG001|Overall Study|Progressive Disease|5|||
164276349|NCT00619099|593380596|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
164276350|NCT00619099|593380597|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
164276351|NCT00619099|593380596|FG000|Overall Study|Adverse Event|4|||
164276352|NCT00619099|593380597|FG001|Overall Study|Adverse Event|3|||
164276353|NCT00619099|593380596|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
164276354|NCT00619099|593380597|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
164276355|NCT00619099|593380596|FG000|Overall Study|Withdrawal by Subject|10|||
164276356|NCT00619099|593380597|FG001|Overall Study|Withdrawal by Subject|2|||
164276357|NCT00619099|593380596|FG000|Overall Study|Physician Decision|9|||
164276358|NCT00619099|593380597|FG001|Overall Study|Physician Decision|6|||
164276359|NCT01270256|593380598|FG000|Overall Study|Withdrawal by Subject|1|||
164276360|NCT01270256|593380599|FG001|Overall Study|Withdrawal by Subject|0|||
164276361|NCT03927404|593380604|FG000|Overall Study|Withdrawal by Subject|1|||
164276362|NCT01229449|593380607|FG000|Overall Study|Withdrawal by Subject|0|||
164276363|NCT01229449|593380608|FG001|Overall Study|Withdrawal by Subject|3|||
164276364|NCT01229449|593380609|FG002|Overall Study|Withdrawal by Subject|0|||
164276365|NCT01229449|593380610|FG003|Overall Study|Withdrawal by Subject|1|||
164276366|NCT01229449|593380611|FG004|Overall Study|Withdrawal by Subject|1|||
164276367|NCT01229449|593380607|FG000|Overall Study|Lost to Follow-up|1|||
164276368|NCT01229449|593380608|FG001|Overall Study|Lost to Follow-up|1|||
164276369|NCT01229449|593380609|FG002|Overall Study|Lost to Follow-up|1|||
164276370|NCT01229449|593380610|FG003|Overall Study|Lost to Follow-up|0|||
164276371|NCT01229449|593380611|FG004|Overall Study|Lost to Follow-up|0|||
164276372|NCT01229449|593380607|FG000|Overall Study|Physician Decision|0|||
164276373|NCT01229449|593380608|FG001|Overall Study|Physician Decision|0|||
164343364|NCT00679432|593632997|FG000|Overall Study|Randomization error, return to prior Rx|0|||
164343365|NCT00679432|593632998|FG001|Overall Study|Randomization error, return to prior Rx|0|||
164343366|NCT00679432|593632999|FG002|Overall Study|Randomization error, return to prior Rx|3|||
164343367|NCT00679432|593633000|FG003|Overall Study|Randomization error, return to prior Rx|0|||
164343368|NCT00824720|593633001|FG000|Overall Study|failed plug insertion|3|||
164343369|NCT00824720|593633002|FG001|Overall Study|failed plug insertion|1|||
164276374|NCT01229449|593380609|FG002|Overall Study|Physician Decision|1|||
164276375|NCT01229449|593380610|FG003|Overall Study|Physician Decision|0|||
164276376|NCT01229449|593380611|FG004|Overall Study|Physician Decision|0|||
164276377|NCT03203291|593380613|FG000|Overall Study|Withdrawal by Subject|1|||
164276378|NCT01300260|593380614|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
164276379|NCT01300260|593380615|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
164276380|NCT01300260|593380614|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
164276381|NCT01300260|593380615|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
164276382|NCT01300260|593380614|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
164276383|NCT01300260|593380615|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
164276384|NCT05098509|593380618|FG000|Overall Study|Withdrawal by Subject|0|||
164276385|NCT05098509|593380619|FG001|Overall Study|Withdrawal by Subject|0|||
164343370|NCT00824720|593633003|FG002|Overall Study|failed plug insertion|0|||
164343371|NCT00824720|593633001|FG000|Overall Study|Protocol Violation|0|||
164343372|NCT00824720|593633002|FG001|Overall Study|Protocol Violation|0|||
164343373|NCT00824720|593633003|FG002|Overall Study|Protocol Violation|1|||
164276386|NCT05098509|593380620|FG002|Overall Study|Withdrawal by Subject|1|||
164584155|NCT01518699|594504580|FG000|Period 2|Adverse Event|1|||
164584156|NCT01518699|594504581|FG001|Period 2|Adverse Event|0|||
164584157|NCT01518699|594504582|FG002|Period 2|Adverse Event|0|||
164584158|NCT01518699|594504583|FG003|Period 2|Adverse Event|0|||
164584159|NCT01518699|594504584|FG004|Period 2|Adverse Event|0|||
164584160|NCT01518699|594504585|FG005|Period 2|Adverse Event|0|||
164584161|NCT01300286|594504587|FG000|Overall Study|did not get dosed|1|||
164584162|NCT03635190|594504588|FG000|Overall Study|Lost to Follow-up|4|||
164584163|NCT03635190|594504588|FG000|Overall Study|Death|3|||
164584164|NCT03635190|594504588|FG000|Overall Study|Withdrawal by Subject|1|||
164584165|NCT03635190|594504588|FG000|Overall Study|Patient moved and did not return for follow up|1|||
164584166|NCT03692910|594504589|FG000|Overall Study|Lost to Follow-up|4|||
164584167|NCT03692910|594504590|FG001|Overall Study|Lost to Follow-up|0|||
164584168|NCT03692910|594504591|FG002|Overall Study|Lost to Follow-up|0|||
164584169|NCT03692910|594504589|FG000|Overall Study|Withdrawal by Subject|2|||
164689553|NCT02788513|594887741|FG003|Overall Study|Subject decided to stop taking treatment|0|||
164276387|NCT05098509|593380621|FG003|Overall Study|Withdrawal by Subject|0|||
164276388|NCT05098509|593380618|FG000|Overall Study|Early study termination|1|||
164276389|NCT05098509|593380619|FG001|Overall Study|Early study termination|1|||
164276390|NCT05098509|593380620|FG002|Overall Study|Early study termination|1|||
164276391|NCT05098509|593380621|FG003|Overall Study|Early study termination|0|||
164276392|NCT01147848|593380622|FG000|Run-in Period|Screen Failure|623|||
164276393|NCT01147848|593380623|FG001|Run-in Period|Screen Failure|0|||
164276394|NCT01147848|593380624|FG002|Run-in Period|Screen Failure|0|||
164276395|NCT01147848|593380622|FG000|Run-in Period|Run-in Failure|135|||
164276396|NCT01147848|593380623|FG001|Run-in Period|Run-in Failure|0|||
164276397|NCT01147848|593380624|FG002|Run-in Period|Run-in Failure|0|||
164276398|NCT01147848|593380622|FG000|Randomized Phase|Adverse Event|0|||
164276399|NCT01147848|593380623|FG001|Randomized Phase|Adverse Event|6|||
164689554|NCT02788513|594887742|FG004|Overall Study|Subject decided to stop taking treatment|0|||
164689555|NCT02788513|594887738|FG000|Overall Study|Decision by the study team|0|||
164689556|NCT02788513|594887739|FG001|Overall Study|Decision by the study team|0|||
164689557|NCT02788513|594887740|FG002|Overall Study|Decision by the study team|0|||
164689558|NCT02788513|594887741|FG003|Overall Study|Decision by the study team|0|||
164689559|NCT02788513|594887742|FG004|Overall Study|Decision by the study team|1|||
164689560|NCT03230487|594887745|FG000|Overall Study|Adverse Event|0|||
164689561|NCT03230487|594887746|FG001|Overall Study|Adverse Event|0|||
164689562|NCT03230487|594887747|FG002|Overall Study|Adverse Event|0|||
164689563|NCT03230487|594887748|FG003|Overall Study|Adverse Event|1|||
164431727|NCT03852433|593951463|FG001|Overall Study|Lack of Efficacy|1|||
164431728|NCT03852433|593951464|FG002|Overall Study|Lack of Efficacy|0|||
164431729|NCT03852433|593951465|FG003|Overall Study|Lack of Efficacy|0|||
164431730|NCT03852433|593951462|FG000|Overall Study|Non-compliance with study drug|0|||
164431731|NCT03852433|593951463|FG001|Overall Study|Non-compliance with study drug|0|||
164431732|NCT03852433|593951464|FG002|Overall Study|Non-compliance with study drug|0|||
164431733|NCT03852433|593951465|FG003|Overall Study|Non-compliance with study drug|1|||
164431734|NCT03852433|593951462|FG000|Overall Study|Physician Decision|1|||
164431735|NCT03852433|593951463|FG001|Overall Study|Physician Decision|0|||
164431736|NCT03852433|593951464|FG002|Overall Study|Physician Decision|0|||
164431737|NCT03852433|593951465|FG003|Overall Study|Physician Decision|0|||
164431738|NCT03852433|593951462|FG000|Overall Study|Randomized but never treated|1|||
164431739|NCT03852433|593951463|FG001|Overall Study|Randomized but never treated|0|||
164431740|NCT03852433|593951464|FG002|Overall Study|Randomized but never treated|0|||
164431741|NCT03852433|593951465|FG003|Overall Study|Randomized but never treated|0|||
164431742|NCT04794179|593951474|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
164584170|NCT03692910|594504590|FG001|Overall Study|Withdrawal by Subject|0|||
164276400|NCT01147848|593380624|FG002|Randomized Phase|Adverse Event|8|||
164276401|NCT01147848|593380622|FG000|Randomized Phase|Lack of Efficacy|0|||
164276402|NCT01147848|593380623|FG001|Randomized Phase|Lack of Efficacy|20|||
164276403|NCT01147848|593380624|FG002|Randomized Phase|Lack of Efficacy|11|||
164431743|NCT04794179|593951475|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
164584171|NCT03692910|594504591|FG002|Overall Study|Withdrawal by Subject|0|||
164431744|NCT03781804|593951484|FG000|Overall Study|Adverse Event|2|||
164431745|NCT03781804|593951485|FG001|Overall Study|Adverse Event|2|||
164431746|NCT03781804|593951486|FG002|Overall Study|Adverse Event|3|||
164431747|NCT03781804|593951484|FG000|Overall Study|Lost to Follow-up|1|||
164431748|NCT03781804|593951485|FG001|Overall Study|Lost to Follow-up|1|||
164431749|NCT03781804|593951486|FG002|Overall Study|Lost to Follow-up|2|||
164431750|NCT03781804|593951484|FG000|Overall Study|Lack of Efficacy|4|||
164584172|NCT00486226|594504596|FG000|Overall Study|Death|3|||
164689564|NCT03230487|594887749|FG004|Overall Study|Adverse Event|0|||
164584173|NCT00486226|594504596|FG000|Overall Study|Adverse Event|1|||
164276404|NCT01147848|593380622|FG000|Randomized Phase|Protocol Violation|0|||
164276405|NCT01147848|593380623|FG001|Randomized Phase|Protocol Violation|7|||
164276406|NCT01147848|593380624|FG002|Randomized Phase|Protocol Violation|10|||
164276407|NCT01147848|593380622|FG000|Randomized Phase|Lost to Follow-up|0|||
164431751|NCT03781804|593951485|FG001|Overall Study|Lack of Efficacy|2|||
164431752|NCT03781804|593951486|FG002|Overall Study|Lack of Efficacy|9|||
164431753|NCT03781804|593951484|FG000|Overall Study|Protocol Violation|0|||
164431754|NCT03781804|593951485|FG001|Overall Study|Protocol Violation|0|||
164431755|NCT03781804|593951486|FG002|Overall Study|Protocol Violation|1|||
164431756|NCT03781804|593951484|FG000|Overall Study|Withdrawal by Subject|0|||
164431757|NCT03781804|593951485|FG001|Overall Study|Withdrawal by Subject|1|||
164431758|NCT03781804|593951486|FG002|Overall Study|Withdrawal by Subject|1|||
164431759|NCT03781804|593951484|FG000|Overall Study|Reason not provided|2|||
164431760|NCT03781804|593951485|FG001|Overall Study|Reason not provided|2|||
164431761|NCT03781804|593951486|FG002|Overall Study|Reason not provided|0|||
164431762|NCT03717194|593951487|FG000|Overall Study|Withdrawal by Subject|2|||
164431763|NCT03717194|593951488|FG001|Overall Study|Withdrawal by Subject|4|||
164431764|NCT03717194|593951487|FG000|Overall Study|Adverse Event|1|||
164431765|NCT03717194|593951488|FG001|Overall Study|Adverse Event|1|||
164431766|NCT04678830|593951489|FG000|Overall Study|Lack of Efficacy|2|||
164431767|NCT04678830|593951490|FG001|Overall Study|Lack of Efficacy|0|||
164431768|NCT04678830|593951489|FG000|Overall Study|Withdrawal by Subject|0|||
164431769|NCT04678830|593951490|FG001|Overall Study|Withdrawal by Subject|1|||
164431770|NCT03102242|593951492|FG000|Overall Study|Adverse Event|2|||
164431771|NCT00389519|593951493|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
164431772|NCT00389519|593951494|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
164431773|NCT00389519|593951495|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
164431774|NCT00389519|593951496|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
164431775|NCT00389519|593951493|FG000|Placebo Run-In|Withdrawal by Subject|19|||
164431776|NCT00389519|593951494|FG001|Placebo Run-In|Withdrawal by Subject|0|||
164431777|NCT00389519|593951495|FG002|Placebo Run-In|Withdrawal by Subject|0|||
164431778|NCT00389519|593951496|FG003|Placebo Run-In|Withdrawal by Subject|0|||
164431779|NCT00389519|593951493|FG000|Placebo Run-In|Reason not specified|40|||
164431780|NCT00389519|593951494|FG001|Placebo Run-In|Reason not specified|0|||
164431781|NCT00389519|593951495|FG002|Placebo Run-In|Reason not specified|0|||
164431782|NCT00389519|593951496|FG003|Placebo Run-In|Reason not specified|0|||
164431783|NCT00389519|593951493|FG000|Randomized|Did not receive study drug|2|||
164431784|NCT00389519|593951494|FG001|Randomized|Did not receive study drug|0|||
164431785|NCT00389519|593951495|FG002|Randomized|Did not receive study drug|0|||
164431786|NCT00389519|593951496|FG003|Randomized|Did not receive study drug|0|||
164431787|NCT00389519|593951493|FG000|Treated|Adverse Event|1|||
164431788|NCT00389519|593951494|FG001|Treated|Adverse Event|0|||
164431789|NCT00389519|593951495|FG002|Treated|Adverse Event|0|||
164431790|NCT00389519|593951496|FG003|Treated|Adverse Event|2|||
164431791|NCT00389519|593951493|FG000|Treated|Reason not specified|1|||
164431792|NCT00389519|593951494|FG001|Treated|Reason not specified|1|||
164431793|NCT00389519|593951495|FG002|Treated|Reason not specified|0|||
164431794|NCT00389519|593951496|FG003|Treated|Reason not specified|2|||
164431795|NCT03425539|593951497|FG000|Overall Study|Randomized but not treated|0|||
164431796|NCT03425539|593951498|FG001|Overall Study|Randomized but not treated|1|||
164431797|NCT03425539|593951497|FG000|Overall Study|Adverse Event|2|||
164431798|NCT03425539|593951498|FG001|Overall Study|Adverse Event|2|||
164431799|NCT03425539|593951497|FG000|Overall Study|Withdrawal by Subject|3|||
164431800|NCT03425539|593951498|FG001|Overall Study|Withdrawal by Subject|0|||
164584174|NCT00486226|594504596|FG000|Overall Study|Withdrawal by Subject|1|||
164584175|NCT00486226|594504596|FG000|Overall Study|Lost to Follow-up|8|||
164584176|NCT01259492|594504598|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
164584177|NCT01259492|594504599|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
164584178|NCT01259492|594504600|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
164584179|NCT01259492|594504601|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
164584180|NCT01259492|594504598|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
164584181|NCT01259492|594504599|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
164584182|NCT01259492|594504600|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
164584183|NCT01259492|594504601|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
164584184|NCT01259492|594504598|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
164584185|NCT01259492|594504599|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
164584186|NCT01259492|594504600|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
164584187|NCT01259492|594504601|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
164584188|NCT01259492|594504598|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
164584189|NCT01259492|594504599|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
164584190|NCT01259492|594504600|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
164584191|NCT01259492|594504601|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
164584192|NCT01259492|594504598|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
164584193|NCT01259492|594504599|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
164584194|NCT01259492|594504600|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
164584195|NCT01259492|594504601|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
164584196|NCT01259492|594504598|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
164584197|NCT01259492|594504599|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
164584198|NCT01259492|594504600|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
164276408|NCT01147848|593380623|FG001|Randomized Phase|Lost to Follow-up|5|||
164276409|NCT01147848|593380624|FG002|Randomized Phase|Lost to Follow-up|7|||
164276410|NCT01147848|593380622|FG000|Randomized Phase|Physician Decision|0|||
164276411|NCT01147848|593380623|FG001|Randomized Phase|Physician Decision|0|||
164276412|NCT01147848|593380624|FG002|Randomized Phase|Physician Decision|1|||
164276413|NCT01147848|593380622|FG000|Randomized Phase|Withdrawal by Subject|0|||
164276414|NCT01147848|593380623|FG001|Randomized Phase|Withdrawal by Subject|7|||
164276415|NCT01147848|593380624|FG002|Randomized Phase|Withdrawal by Subject|9|||
164276416|NCT02540265|593380625|FG000|Overall Study|Lost to Follow-up|0|||
164276417|NCT02540265|593380626|FG001|Overall Study|Lost to Follow-up|0|||
164276418|NCT02540265|593380627|FG002|Overall Study|Lost to Follow-up|1|||
164276419|NCT03157037|593380630|FG000|Overall Study|Death|1|||
164276420|NCT00324233|593380631|FG000|First Period|unable to insert catheter|1|||
164276421|NCT00324233|593380632|FG001|First Period|unable to insert catheter|0|||
164276422|NCT00324233|593380631|FG000|Second Period|unable to insert catheter|1|||
164276423|NCT00324233|593380632|FG001|Second Period|unable to insert catheter|1|||
164276424|NCT00324233|593380631|FG000|Second Period|Protocol Violation|4|||
164276425|NCT00324233|593380632|FG001|Second Period|Protocol Violation|6|||
164276426|NCT01972789|593380633|FG000|Overall Study|Adverse Event|11|||
164276427|NCT01972789|593380634|FG001|Overall Study|Adverse Event|4|||
164276428|NCT01972789|593380633|FG000|Overall Study|Subject withdrew consent|14|||
164276429|NCT01972789|593380634|FG001|Overall Study|Subject withdrew consent|12|||
164276430|NCT01972789|593380633|FG000|Overall Study|Lost to Follow-up|4|||
164343374|NCT01558271|593633006|FG000|Overall Study|Adverse Event|6|||
164343375|NCT01558271|593633007|FG001|Overall Study|Adverse Event|3|||
164343376|NCT01558271|593633008|FG002|Overall Study|Adverse Event|4|||
164343377|NCT01558271|593633006|FG000|Overall Study|Lost to Follow-up|1|||
164343378|NCT01558271|593633007|FG001|Overall Study|Lost to Follow-up|0|||
164343379|NCT01558271|593633008|FG002|Overall Study|Lost to Follow-up|0|||
164343380|NCT01558271|593633006|FG000|Overall Study|Protocol Violation|1|||
164343381|NCT01558271|593633007|FG001|Overall Study|Protocol Violation|0|||
164343382|NCT01558271|593633008|FG002|Overall Study|Protocol Violation|0|||
164343383|NCT01558271|593633006|FG000|Overall Study|Withdrawal by Subject|10|||
164343384|NCT01558271|593633007|FG001|Overall Study|Withdrawal by Subject|6|||
164343385|NCT01558271|593633008|FG002|Overall Study|Withdrawal by Subject|12|||
164343386|NCT01558271|593633006|FG000|Overall Study|Physician Decision|0|||
164343387|NCT01558271|593633007|FG001|Overall Study|Physician Decision|2|||
164343388|NCT01558271|593633008|FG002|Overall Study|Physician Decision|1|||
164343389|NCT02610725|593633009|FG000|Overall Study|Lost to Follow-up|197|||
164343390|NCT02610725|593633009|FG000|Overall Study|self-reported contraindication|9|||
164343391|NCT04094883|593633010|FG000|Overall Study|Withdrawal by Subject|1|||
164343392|NCT00743483|593633011|FG000|Baseline Period|Physician Decision|1|||
164343393|NCT00743483|593633011|FG000|Treatment Period|Adverse Event|1|||
164343394|NCT01084083|593633012|FG000|Overall Study|Adverse Event|5|||
164343395|NCT01084083|593633012|FG000|Overall Study|Death|1|||
164343396|NCT01084083|593633012|FG000|Overall Study|Withdrawal by Subject|2|||
164343397|NCT01084083|593633012|FG000|Overall Study|Complicating disease|1|||
164343398|NCT01084083|593633012|FG000|Overall Study|Other|2|||
164343399|NCT01084083|593633012|FG000|Overall Study|Never started assigned therapy|1|||
164343400|NCT00873912|593633014|FG000|Overall Study|Withdrawal by Subject|1|||
164343401|NCT00873912|593633015|FG001|Overall Study|Withdrawal by Subject|0|||
164343402|NCT00873912|593633014|FG000|Overall Study|Lost to Follow-up|2|||
164343403|NCT00873912|593633015|FG001|Overall Study|Lost to Follow-up|0|||
164343404|NCT01088997|593633018|FG000|Overall Study|Physician Decision|1|||
164343405|NCT01088997|593633019|FG001|Overall Study|Physician Decision|1|||
164343406|NCT01088997|593633018|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
164343407|NCT01088997|593633019|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
164343408|NCT01088997|593633018|FG000|Overall Study|Excluded prior to receiving drug|1|||
164343409|NCT01088997|593633019|FG001|Overall Study|Excluded prior to receiving drug|1|||
164343410|NCT05570500|593633022|FG000|Overall Study|Lost to Follow-up|7|||
164343411|NCT05570500|593633023|FG001|Overall Study|Lost to Follow-up|5|||
164343412|NCT01095731|593633024|FG000|Overall Study|Protocol Violation|1|||
164343413|NCT01095731|593633025|FG001|Overall Study|Protocol Violation|1|||
164343414|NCT01095731|593633024|FG000|Overall Study|Withdrawal by Subject|0|||
164343415|NCT01095731|593633025|FG001|Overall Study|Withdrawal by Subject|1|||
164343416|NCT02302807|593633028|FG000|Overall Study|Withdrawal by Subject|28|||
164343417|NCT02302807|593633029|FG001|Overall Study|Withdrawal by Subject|11|||
164276431|NCT01972789|593380634|FG001|Overall Study|Lost to Follow-up|7|||
164276432|NCT01972789|593380633|FG000|Overall Study|Death|7|||
164276433|NCT01972789|593380634|FG001|Overall Study|Death|5|||
164276434|NCT01972789|593380633|FG000|Overall Study|Protocol deviation|1|||
164276435|NCT01972789|593380634|FG001|Overall Study|Protocol deviation|0|||
164276436|NCT01972789|593380633|FG000|Overall Study|Physician Decision|3|||
164276437|NCT01972789|593380634|FG001|Overall Study|Physician Decision|2|||
164276438|NCT00498355|593380637|FG000|Overall Study|Lost to Follow-up|1|||
164276439|NCT03262441|593380642|FG000|Overall Study|Withdrawal by Subject|1|||
164343418|NCT02302807|593633028|FG000|Overall Study|Lost to Follow-up|4|||
164343419|NCT02302807|593633029|FG001|Overall Study|Lost to Follow-up|6|||
164431801|NCT03425539|593951497|FG000|Overall Study|Lost to Follow-up|0|||
164689565|NCT03230487|594887750|FG005|Overall Study|Adverse Event|0|||
164689566|NCT01933919|594887758|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
164276440|NCT01455194|593380650|FG000|Overall Study|Screen Failure|20|||
164276441|NCT01455194|593380651|FG001|Overall Study|Screen Failure|0|||
164276442|NCT01455194|593380652|FG002|Overall Study|Screen Failure|0|||
164276443|NCT01455194|593380653|FG003|Overall Study|Screen Failure|0|||
164276444|NCT01455194|593380650|FG000|Overall Study|Randomisation Failure|90|||
164276445|NCT01455194|593380651|FG001|Overall Study|Randomisation Failure|0|||
164276446|NCT01455194|593380652|FG002|Overall Study|Randomisation Failure|0|||
164276447|NCT01455194|593380653|FG003|Overall Study|Randomisation Failure|0|||
164276448|NCT01455194|593380650|FG000|Overall Study|Deterioration in asthma|12|||
164276449|NCT01455194|593380651|FG001|Overall Study|Deterioration in asthma|6|||
164276450|NCT01455194|593380652|FG002|Overall Study|Deterioration in asthma|14|||
164276451|NCT01455194|593380653|FG003|Overall Study|Deterioration in asthma|9|||
164276452|NCT01455194|593380650|FG000|Overall Study|Adverse Event|1|||
164276453|NCT01455194|593380651|FG001|Overall Study|Adverse Event|1|||
164276454|NCT01455194|593380652|FG002|Overall Study|Adverse Event|1|||
164276455|NCT01455194|593380653|FG003|Overall Study|Adverse Event|3|||
164276456|NCT01455194|593380650|FG000|Overall Study|Withdrawal by Subject|21|||
164276457|NCT01455194|593380651|FG001|Overall Study|Withdrawal by Subject|16|||
164276458|NCT01455194|593380652|FG002|Overall Study|Withdrawal by Subject|12|||
164276459|NCT01455194|593380653|FG003|Overall Study|Withdrawal by Subject|9|||
164276460|NCT01455194|593380650|FG000|Overall Study|Lost to Follow-up|2|||
164276461|NCT01455194|593380651|FG001|Overall Study|Lost to Follow-up|0|||
164276462|NCT01455194|593380652|FG002|Overall Study|Lost to Follow-up|1|||
164276463|NCT01455194|593380653|FG003|Overall Study|Lost to Follow-up|1|||
164276464|NCT01455194|593380650|FG000|Overall Study|Pregnancy|0|||
164276465|NCT01455194|593380651|FG001|Overall Study|Pregnancy|1|||
164276466|NCT01455194|593380652|FG002|Overall Study|Pregnancy|1|||
164276467|NCT01455194|593380653|FG003|Overall Study|Pregnancy|0|||
164276468|NCT01455194|593380650|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
164276469|NCT01455194|593380651|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
164343420|NCT02302807|593633028|FG000|Overall Study|Death|397|||
164343421|NCT02302807|593633029|FG001|Overall Study|Death|385|||
164343422|NCT02302807|593633028|FG000|Overall Study|Study Terminated By Sponsor|35|||
164343423|NCT02302807|593633029|FG001|Overall Study|Study Terminated By Sponsor|64|||
164343424|NCT02302807|593633028|FG000|Overall Study|Physician Decision|0|||
164343425|NCT02302807|593633029|FG001|Overall Study|Physician Decision|1|||
164343426|NCT04731363|593633033|FG000|Overall Study|Could not obtain samples|0|||
164343427|NCT04731363|593633034|FG001|Overall Study|Could not obtain samples|1|||
164343428|NCT04731363|593633035|FG002|Overall Study|Could not obtain samples|0|||
164343429|NCT04731363|593633036|FG003|Overall Study|Could not obtain samples|0|||
164343430|NCT04731363|593633033|FG000|Overall Study|Physician Decision|0|||
164343431|NCT04731363|593633034|FG001|Overall Study|Physician Decision|1|||
164343432|NCT04731363|593633035|FG002|Overall Study|Physician Decision|0|||
164343433|NCT04731363|593633036|FG003|Overall Study|Physician Decision|0|||
164343434|NCT00717197|593635232|FG000|Overall Study|Unable to purchase study drug|5|||
164343435|NCT00717197|593635232|FG000|Overall Study|Tumor Progression|1|||
164343436|NCT00717197|593635232|FG000|Overall Study|Physician Decision|1|||
164343437|NCT01898806|593635235|FG000|Overall Study|Withdrawal by Subject|2|||
164343438|NCT01898806|593635235|FG000|Overall Study|Physician Decision|1|||
164343439|NCT03003390|593635236|FG000|Overall Study|Physician Decision|2|||
164343440|NCT03003390|593635237|FG001|Overall Study|Physician Decision|0|||
164343441|NCT03003390|593635236|FG000|Overall Study|Parent refused intervention|2|||
164343442|NCT03003390|593635237|FG001|Overall Study|Parent refused intervention|0|||
164343443|NCT01648101|593635238|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
164343444|NCT01648101|593635239|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
164343445|NCT01648101|593635240|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
164343446|NCT01648101|593635238|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
164343447|NCT01648101|593635239|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
164343448|NCT01648101|593635240|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
164343449|NCT01648101|593635238|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
164343450|NCT01648101|593635239|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
164343451|NCT01648101|593635240|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
164431802|NCT03425539|593951498|FG001|Overall Study|Lost to Follow-up|1|||
164689567|NCT01933919|594887759|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
164276470|NCT01455194|593380652|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
164276471|NCT01455194|593380653|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
164276472|NCT01455194|593380650|FG000|Overall Study|Miscellaneous|4|||
164276473|NCT01455194|593380651|FG001|Overall Study|Miscellaneous|5|||
164276474|NCT01455194|593380652|FG002|Overall Study|Miscellaneous|1|||
164276475|NCT01455194|593380653|FG003|Overall Study|Miscellaneous|4|||
164343452|NCT01648101|593635238|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
164431803|NCT02040844|593951499|FG000|Overall Study|Adverse Event|0|||
164276476|NCT05090852|593380654|FG000|Overall Study|Physician Decision|5|||
164276477|NCT01196416|593380655|FG000|Overall Study|Withdrawal by Subject|2|||
164276478|NCT00504894|593380656|FG000|Overall Study|fMRI technical problems|1|||
164276479|NCT00504894|593380657|FG001|Overall Study|fMRI technical problems|1|||
164276480|NCT00504894|593380658|FG002|Overall Study|fMRI technical problems|0|||
164276481|NCT00504894|593380656|FG000|Overall Study|Withdrawal by Subject|0|||
164276482|NCT00504894|593380657|FG001|Overall Study|Withdrawal by Subject|1|||
164276483|NCT00504894|593380658|FG002|Overall Study|Withdrawal by Subject|0|||
164276484|NCT00504894|593380656|FG000|Overall Study|Infusion technical problems|0|||
164276485|NCT00504894|593380657|FG001|Overall Study|Infusion technical problems|1|||
164276486|NCT00504894|593380658|FG002|Overall Study|Infusion technical problems|0|||
164276487|NCT00504894|593380656|FG000|Overall Study|poor subject data|2|||
164276488|NCT00504894|593380657|FG001|Overall Study|poor subject data|0|||
164276489|NCT00504894|593380658|FG002|Overall Study|poor subject data|0|||
164276490|NCT00148941|593380659|FG000|Overall Study|Lost to Follow-up|17|||
164276491|NCT00148941|593380660|FG001|Overall Study|Lost to Follow-up|24|||
164584199|NCT01259492|594504601|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
164584200|NCT01259492|594504598|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
164584201|NCT01259492|594504599|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
164584202|NCT01259492|594504600|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
164584203|NCT01259492|594504601|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
164584204|NCT01259492|594504598|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
164584205|NCT01259492|594504599|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
164584206|NCT01259492|594504600|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
164584207|NCT01259492|594504601|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
164584208|NCT01259492|594504598|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
164584209|NCT01259492|594504599|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
164584210|NCT01259492|594504600|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
164584211|NCT01259492|594504601|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
164584212|NCT01259492|594504598|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
164584213|NCT01259492|594504599|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
164584214|NCT01259492|594504600|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
164584215|NCT01259492|594504601|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
164584216|NCT01259492|594504598|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
164584217|NCT01259492|594504599|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
164584218|NCT01259492|594504600|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
164584219|NCT01259492|594504601|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
164584220|NCT01259492|594504598|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
164584221|NCT01259492|594504599|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
164584222|NCT01259492|594504600|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
164584223|NCT01259492|594504601|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
164584224|NCT01259492|594504598|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
164584225|NCT01259492|594504599|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
164584226|NCT01259492|594504600|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
164584227|NCT01259492|594504601|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
164584228|NCT01259492|594504598|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
164584229|NCT01259492|594504599|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
164584230|NCT01259492|594504600|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
164584231|NCT01259492|594504601|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
164584232|NCT01259492|594504598|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
164584233|NCT01259492|594504599|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
164584234|NCT01259492|594504600|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
164584235|NCT01259492|594504601|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
164584236|NCT01259492|594504598|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
164584237|NCT01259492|594504599|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
164584238|NCT01259492|594504600|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
164584239|NCT01259492|594504601|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
164584240|NCT01259492|594504598|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
164584241|NCT01259492|594504599|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
164584242|NCT01259492|594504600|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
164584243|NCT01259492|594504601|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
164276492|NCT00148941|593380661|FG002|Overall Study|Lost to Follow-up|18|||
164276493|NCT00148941|593380662|FG003|Overall Study|Lost to Follow-up|22|||
164276494|NCT00148941|593380659|FG000|Overall Study|Withdrawal by Subject|1|||
164276495|NCT00148941|593380660|FG001|Overall Study|Withdrawal by Subject|0|||
164276496|NCT00148941|593380661|FG002|Overall Study|Withdrawal by Subject|1|||
164276497|NCT00148941|593380662|FG003|Overall Study|Withdrawal by Subject|0|||
164276498|NCT00148941|593380659|FG000|Overall Study|Other|0|||
164343453|NCT01648101|593635239|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
164343454|NCT01648101|593635240|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
164276499|NCT00148941|593380660|FG001|Overall Study|Other|0|||
164276500|NCT00148941|593380661|FG002|Overall Study|Other|1|||
164276501|NCT00148941|593380662|FG003|Overall Study|Other|2|||
164276502|NCT02673684|593380665|FG000|Overall Study|Study not completed d/t loss of funding|9|||
164276503|NCT02673684|593380666|FG001|Overall Study|Study not completed d/t loss of funding|8|||
164276504|NCT01092663|593380667|FG000|Overall Study|Withdrawal by Subject|3|||
164276505|NCT01092663|593380668|FG001|Overall Study|Withdrawal by Subject|2|||
164276506|NCT01092663|593380667|FG000|Overall Study|Glucose >300mg/dL|1|||
164276507|NCT01092663|593380668|FG001|Overall Study|Glucose >300mg/dL|0|||
164276508|NCT01092663|593380667|FG000|Overall Study|High fasting triglyceride|2|||
164276509|NCT01092663|593380668|FG001|Overall Study|High fasting triglyceride|0|||
164276510|NCT01092663|593380667|FG000|Overall Study|Adverse Event|1|||
164276511|NCT01092663|593380668|FG001|Overall Study|Adverse Event|1|||
164276512|NCT01092663|593380667|FG000|Overall Study|Protocol Violation|0|||
164276513|NCT01092663|593380668|FG001|Overall Study|Protocol Violation|1|||
164276514|NCT01008904|593380669|FG000|Overall Study|Lost to Follow-up|1|||
164276515|NCT01008904|593380669|FG000|Overall Study|Adverse Event|2|||
164276516|NCT01008904|593380669|FG000|Overall Study|unexpected unrelated surgery|1|||
164276517|NCT00788710|593380670|FG000|Overall Study|Adverse Event|1|||
164276518|NCT00788710|593380671|FG001|Overall Study|Adverse Event|3|||
164276519|NCT00788710|593380672|FG002|Overall Study|Adverse Event|4|||
164276520|NCT00788710|593380670|FG000|Overall Study|Lack of Efficacy|0|||
164276521|NCT00788710|593380671|FG001|Overall Study|Lack of Efficacy|0|||
164276522|NCT00788710|593380672|FG002|Overall Study|Lack of Efficacy|1|||
164276523|NCT00788710|593380670|FG000|Overall Study|Lost to Follow-up|0|||
164276524|NCT00788710|593380671|FG001|Overall Study|Lost to Follow-up|1|||
164276525|NCT00788710|593380672|FG002|Overall Study|Lost to Follow-up|0|||
164276526|NCT00788710|593380670|FG000|Overall Study|Physician Decision|2|||
164276527|NCT00788710|593380671|FG001|Overall Study|Physician Decision|1|||
164276528|NCT00788710|593380672|FG002|Overall Study|Physician Decision|0|||
164276529|NCT00788710|593380670|FG000|Overall Study|Protocol Violation|0|||
164276530|NCT00788710|593380671|FG001|Overall Study|Protocol Violation|1|||
164276531|NCT00788710|593380672|FG002|Overall Study|Protocol Violation|1|||
164276532|NCT00788710|593380670|FG000|Overall Study|Withdrawal by Subject|2|||
164276533|NCT00788710|593380671|FG001|Overall Study|Withdrawal by Subject|2|||
164276534|NCT00788710|593380672|FG002|Overall Study|Withdrawal by Subject|0|||
164276535|NCT04407234|593380673|FG000|Overall Study|Adverse Event|3|||
164276536|NCT04407234|593380674|FG001|Overall Study|Adverse Event|3|||
164276537|NCT03908970|593380675|FG000|Overall Study|Adverse Event|7|||
164276538|NCT03908970|593380676|FG001|Overall Study|Adverse Event|21|||
164276539|NCT03908970|593380675|FG000|Overall Study|Physician Decision|1|||
164276540|NCT03908970|593380676|FG001|Overall Study|Physician Decision|4|||
164276541|NCT03908970|593380675|FG000|Overall Study|Withdrawal by Subject|9|||
164276542|NCT03908970|593380676|FG001|Overall Study|Withdrawal by Subject|22|||
164276543|NCT00727558|593380682|FG000|Overall Study|Lens issue|0|||
164343455|NCT01648101|593635238|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
164343456|NCT01648101|593635239|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
164343457|NCT01648101|593635240|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
164343458|NCT01648101|593635238|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
164584244|NCT01259492|594504598|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
164584245|NCT01259492|594504599|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
164584246|NCT01259492|594504600|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
164584247|NCT01259492|594504601|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
164584248|NCT01259492|594504598|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
164584249|NCT01259492|594504599|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
164584250|NCT01259492|594504600|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
164584251|NCT01259492|594504601|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
164584252|NCT01259492|594504598|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
164584253|NCT01259492|594504599|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
164584254|NCT01259492|594504600|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
164584255|NCT01259492|594504601|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
164584256|NCT03042611|594504605|FG000|Core Phase|Withdrawal by Subject|13|||
164584257|NCT03042611|594504606|FG001|Core Phase|Withdrawal by Subject|4|||
164584258|NCT03042611|594504607|FG002|Core Phase|Withdrawal by Subject|0|||
164584259|NCT03042611|594504608|FG003|Core Phase|Withdrawal by Subject|0|||
164584260|NCT03042611|594504605|FG000|Core Phase|Death|232|||
164584261|NCT03042611|594504606|FG001|Core Phase|Death|110|||
164584262|NCT03042611|594504607|FG002|Core Phase|Death|0|||
164584263|NCT03042611|594504608|FG003|Core Phase|Death|0|||
164584264|NCT03042611|594504605|FG000|Core Phase|Lost to Follow-up|4|||
164276544|NCT00727558|593380683|FG001|Overall Study|Lens issue|1|||
164276545|NCT00727558|593380682|FG000|Overall Study|Adverse Event|0|||
164276546|NCT00727558|593380683|FG001|Overall Study|Adverse Event|1|||
164276547|NCT00727558|593380682|FG000|Overall Study|Subject unable to return for follow-up|1|||
164276548|NCT00727558|593380683|FG001|Overall Study|Subject unable to return for follow-up|1|||
164276549|NCT00727558|593380682|FG000|Overall Study|Lost to Follow-up|1|||
164276550|NCT00727558|593380683|FG001|Overall Study|Lost to Follow-up|0|||
164276551|NCT01717326|593380690|FG000|Overall Study|Death|0|||
164276552|NCT01717326|593380691|FG001|Overall Study|Death|0|||
164276553|NCT01717326|593380692|FG002|Overall Study|Death|0|||
164276554|NCT01717326|593380693|FG003|Overall Study|Death|0|||
164276555|NCT01717326|593380694|FG004|Overall Study|Death|0|||
164276556|NCT01717326|593380695|FG005|Overall Study|Death|0|||
164276557|NCT01717326|593380696|FG006|Overall Study|Death|0|||
164276558|NCT01717326|593380697|FG007|Overall Study|Death|0|||
164276559|NCT01717326|593380698|FG008|Overall Study|Death|0|||
164276560|NCT01717326|593380699|FG009|Overall Study|Death|0|||
164276561|NCT01717326|593380700|FG010|Overall Study|Death|1|||
164276562|NCT01717326|593380701|FG011|Overall Study|Death|0|||
164276563|NCT01717326|593380702|FG012|Overall Study|Death|0|||
164276564|NCT01717326|593380703|FG013|Overall Study|Death|0|||
164276565|NCT01717326|593380704|FG014|Overall Study|Death|0|||
164276566|NCT01717326|593380705|FG015|Overall Study|Death|0|||
164276567|NCT01717326|593380706|FG016|Overall Study|Death|0|||
164276568|NCT01717326|593380707|FG017|Overall Study|Death|0|||
164276569|NCT01717326|593380708|FG018|Overall Study|Death|0|||
164276570|NCT01717326|593380709|FG019|Overall Study|Death|0|||
164276571|NCT01717326|593380690|FG000|Overall Study|Lost to Follow-up|3|||
164276572|NCT01717326|593380691|FG001|Overall Study|Lost to Follow-up|0|||
164276573|NCT01717326|593380692|FG002|Overall Study|Lost to Follow-up|0|||
164276574|NCT01717326|593380693|FG003|Overall Study|Lost to Follow-up|2|||
164276575|NCT01717326|593380694|FG004|Overall Study|Lost to Follow-up|1|||
164276576|NCT01717326|593380695|FG005|Overall Study|Lost to Follow-up|0|||
164276577|NCT01717326|593380696|FG006|Overall Study|Lost to Follow-up|1|||
164276578|NCT01717326|593380697|FG007|Overall Study|Lost to Follow-up|0|||
164276579|NCT01717326|593380698|FG008|Overall Study|Lost to Follow-up|0|||
164276580|NCT01717326|593380699|FG009|Overall Study|Lost to Follow-up|0|||
164276581|NCT01717326|593380700|FG010|Overall Study|Lost to Follow-up|1|||
164276582|NCT01717326|593380701|FG011|Overall Study|Lost to Follow-up|0|||
164276583|NCT01717326|593380702|FG012|Overall Study|Lost to Follow-up|0|||
164276584|NCT01717326|593380703|FG013|Overall Study|Lost to Follow-up|0|||
164276585|NCT01717326|593380704|FG014|Overall Study|Lost to Follow-up|0|||
164276586|NCT01717326|593380705|FG015|Overall Study|Lost to Follow-up|2|||
164276587|NCT01717326|593380706|FG016|Overall Study|Lost to Follow-up|1|||
164276588|NCT01717326|593380707|FG017|Overall Study|Lost to Follow-up|0|||
164276589|NCT01717326|593380708|FG018|Overall Study|Lost to Follow-up|2|||
164276590|NCT01717326|593380709|FG019|Overall Study|Lost to Follow-up|3|||
164276591|NCT01717326|593380690|FG000|Overall Study|Physician Decision|0|||
164276592|NCT01717326|593380691|FG001|Overall Study|Physician Decision|0|||
164276593|NCT01717326|593380692|FG002|Overall Study|Physician Decision|0|||
164276594|NCT01717326|593380693|FG003|Overall Study|Physician Decision|0|||
164276595|NCT01717326|593380694|FG004|Overall Study|Physician Decision|0|||
164276596|NCT01717326|593380695|FG005|Overall Study|Physician Decision|0|||
164276597|NCT01717326|593380696|FG006|Overall Study|Physician Decision|0|||
164276598|NCT01717326|593380697|FG007|Overall Study|Physician Decision|0|||
164276599|NCT01717326|593380698|FG008|Overall Study|Physician Decision|0|||
164276600|NCT01717326|593380699|FG009|Overall Study|Physician Decision|1|||
164276601|NCT01717326|593380700|FG010|Overall Study|Physician Decision|0|||
164276602|NCT01717326|593380701|FG011|Overall Study|Physician Decision|0|||
164276603|NCT01717326|593380702|FG012|Overall Study|Physician Decision|0|||
164276604|NCT01717326|593380703|FG013|Overall Study|Physician Decision|0|||
164276605|NCT01717326|593380704|FG014|Overall Study|Physician Decision|0|||
164276606|NCT01717326|593380705|FG015|Overall Study|Physician Decision|0|||
164276607|NCT01717326|593380706|FG016|Overall Study|Physician Decision|0|||
164276608|NCT01717326|593380707|FG017|Overall Study|Physician Decision|0|||
164276609|NCT01717326|593380708|FG018|Overall Study|Physician Decision|0|||
164276610|NCT01717326|593380709|FG019|Overall Study|Physician Decision|0|||
164276611|NCT01717326|593380690|FG000|Overall Study|Protocol Violation|0|||
164276612|NCT01717326|593380691|FG001|Overall Study|Protocol Violation|0|||
164276613|NCT01717326|593380692|FG002|Overall Study|Protocol Violation|0|||
164276614|NCT01717326|593380693|FG003|Overall Study|Protocol Violation|0|||
164276615|NCT01717326|593380694|FG004|Overall Study|Protocol Violation|1|||
164276616|NCT01717326|593380695|FG005|Overall Study|Protocol Violation|0|||
164276617|NCT01717326|593380696|FG006|Overall Study|Protocol Violation|0|||
164276618|NCT01717326|593380697|FG007|Overall Study|Protocol Violation|0|||
164276619|NCT01717326|593380698|FG008|Overall Study|Protocol Violation|0|||
164276620|NCT01717326|593380699|FG009|Overall Study|Protocol Violation|0|||
164276621|NCT01717326|593380700|FG010|Overall Study|Protocol Violation|0|||
164276622|NCT01717326|593380701|FG011|Overall Study|Protocol Violation|0|||
164276623|NCT01717326|593380702|FG012|Overall Study|Protocol Violation|0|||
164276624|NCT01717326|593380703|FG013|Overall Study|Protocol Violation|0|||
164276625|NCT01717326|593380704|FG014|Overall Study|Protocol Violation|0|||
164276626|NCT01717326|593380705|FG015|Overall Study|Protocol Violation|0|||
164276627|NCT01717326|593380706|FG016|Overall Study|Protocol Violation|0|||
164276628|NCT01717326|593380707|FG017|Overall Study|Protocol Violation|0|||
164276629|NCT01717326|593380708|FG018|Overall Study|Protocol Violation|0|||
164276630|NCT01717326|593380709|FG019|Overall Study|Protocol Violation|0|||
164276631|NCT01717326|593380690|FG000|Overall Study|Withdrawal by Subject|0|||
164584265|NCT03042611|594504606|FG001|Core Phase|Lost to Follow-up|7|||
164584266|NCT03042611|594504607|FG002|Core Phase|Lost to Follow-up|0|||
164584267|NCT03042611|594504608|FG003|Core Phase|Lost to Follow-up|0|||
164584268|NCT03042611|594504605|FG000|Core Phase|Physician Decision|7|||
164584269|NCT03042611|594504606|FG001|Core Phase|Physician Decision|2|||
164584270|NCT03042611|594504607|FG002|Core Phase|Physician Decision|0|||
164276632|NCT01717326|593380691|FG001|Overall Study|Withdrawal by Subject|1|||
164276633|NCT01717326|593380692|FG002|Overall Study|Withdrawal by Subject|0|||
164276634|NCT01717326|593380693|FG003|Overall Study|Withdrawal by Subject|0|||
164276635|NCT01717326|593380694|FG004|Overall Study|Withdrawal by Subject|0|||
164276636|NCT01717326|593380695|FG005|Overall Study|Withdrawal by Subject|0|||
164276637|NCT01717326|593380696|FG006|Overall Study|Withdrawal by Subject|0|||
164276638|NCT01717326|593380697|FG007|Overall Study|Withdrawal by Subject|0|||
164276639|NCT01717326|593380698|FG008|Overall Study|Withdrawal by Subject|0|||
164276640|NCT01717326|593380699|FG009|Overall Study|Withdrawal by Subject|1|||
164276641|NCT01717326|593380700|FG010|Overall Study|Withdrawal by Subject|0|||
164584271|NCT03042611|594504608|FG003|Core Phase|Physician Decision|0|||
164276642|NCT01717326|593380701|FG011|Overall Study|Withdrawal by Subject|0|||
164276643|NCT01717326|593380702|FG012|Overall Study|Withdrawal by Subject|1|||
164276644|NCT01717326|593380703|FG013|Overall Study|Withdrawal by Subject|0|||
164276645|NCT01717326|593380704|FG014|Overall Study|Withdrawal by Subject|0|||
164276646|NCT01717326|593380705|FG015|Overall Study|Withdrawal by Subject|1|||
164276647|NCT01717326|593380706|FG016|Overall Study|Withdrawal by Subject|0|||
164276648|NCT01717326|593380707|FG017|Overall Study|Withdrawal by Subject|0|||
164276649|NCT01717326|593380708|FG018|Overall Study|Withdrawal by Subject|2|||
164276650|NCT01717326|593380709|FG019|Overall Study|Withdrawal by Subject|3|||
164276651|NCT02262754|593380711|FG000|Overall Study|Adverse Event|3|||
164276652|NCT02262754|593380712|FG001|Overall Study|Adverse Event|4|||
164276653|NCT02262754|593380713|FG002|Overall Study|Adverse Event|0|||
164276654|NCT02262754|593380711|FG000|Overall Study|Lack of Efficacy|2|||
164276655|NCT02262754|593380712|FG001|Overall Study|Lack of Efficacy|0|||
164276656|NCT02262754|593380713|FG002|Overall Study|Lack of Efficacy|1|||
164276657|NCT02262754|593380711|FG000|Overall Study|Lost to Follow-up|0|||
164276658|NCT02262754|593380712|FG001|Overall Study|Lost to Follow-up|0|||
164276659|NCT02262754|593380713|FG002|Overall Study|Lost to Follow-up|1|||
164276660|NCT02262754|593380711|FG000|Overall Study|No longer meets eligibility criteria|0|||
164276661|NCT02262754|593380712|FG001|Overall Study|No longer meets eligibility criteria|1|||
164276662|NCT02262754|593380713|FG002|Overall Study|No longer meets eligibility criteria|0|||
164276663|NCT02262754|593380711|FG000|Overall Study|Study terminated by sponsor|5|||
164276664|NCT02262754|593380712|FG001|Overall Study|Study terminated by sponsor|4|||
164276665|NCT02262754|593380713|FG002|Overall Study|Study terminated by sponsor|4|||
164276666|NCT02262754|593380711|FG000|Overall Study|Protocol Violation|1|||
164276667|NCT02262754|593380712|FG001|Overall Study|Protocol Violation|0|||
164276668|NCT02262754|593380713|FG002|Overall Study|Protocol Violation|0|||
164276669|NCT02262754|593380711|FG000|Overall Study|Withdrawal by Subject|1|||
164276670|NCT02262754|593380712|FG001|Overall Study|Withdrawal by Subject|0|||
164276671|NCT02262754|593380713|FG002|Overall Study|Withdrawal by Subject|1|||
164276672|NCT02262754|593380711|FG000|Overall Study|Other|4|||
164276673|NCT02262754|593380712|FG001|Overall Study|Other|0|||
164276674|NCT02262754|593380713|FG002|Overall Study|Other|2|||
164276675|NCT01299116|593380717|FG000|Overall Study|Lost to Follow-up|65|||
164276676|NCT01299116|593380718|FG001|Overall Study|Lost to Follow-up|9|||
164276677|NCT01299116|593380719|FG002|Overall Study|Lost to Follow-up|11|||
164584272|NCT03042611|594504605|FG000|Core Phase|Study Closed|0|||
164689568|NCT01933919|594887758|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
164689569|NCT01933919|594887759|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
164689570|NCT01933919|594887758|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
164689571|NCT01933919|594887759|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
164689572|NCT01933919|594887758|FG000|Open-label Long-term Phase|Adverse Event|2|||
164689573|NCT01933919|594887759|FG001|Open-label Long-term Phase|Adverse Event|0|||
164689574|NCT01933919|594887758|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
164689575|NCT01933919|594887759|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
164431804|NCT02040844|593951500|FG001|Overall Study|Adverse Event|0|||
164276678|NCT04079114|593380724|FG000|Overall Study|Study prematuely terminated.|166|||
164276679|NCT00629798|593380725|FG000|Overall Study|Not Treated|4|||
164584273|NCT03042611|594504606|FG001|Core Phase|Study Closed|1|||
164276680|NCT01108523|593380726|FG000|Overall Study|Protocol Violation|4|||
164276681|NCT00687531|593380727|FG000|Overall Study|Did not meet protocol eligibility|104|||
164584274|NCT03042611|594504607|FG002|Core Phase|Study Closed|0|||
164584275|NCT03042611|594504608|FG003|Core Phase|Study Closed|0|||
164584276|NCT03042611|594504605|FG000|Extension Phase|Death|0|||
164584277|NCT03042611|594504606|FG001|Extension Phase|Death|0|||
164584278|NCT03042611|594504607|FG002|Extension Phase|Death|34|||
164276682|NCT00687531|593380727|FG000|Overall Study|Adverse Event|5|||
164276683|NCT00687531|593380727|FG000|Overall Study|Lost to Follow-up|26|||
164276684|NCT00547521|593380730|FG000|Short Term Study (4 Months)|Adverse Event|1|||
164584279|NCT03042611|594504608|FG003|Extension Phase|Death|16|||
164431805|NCT02040844|593951501|FG002|Overall Study|Adverse Event|1|||
164431806|NCT02040844|593951499|FG000|Overall Study|Withdrawal by Subject|16|||
164431807|NCT02040844|593951500|FG001|Overall Study|Withdrawal by Subject|22|||
164431808|NCT02040844|593951501|FG002|Overall Study|Withdrawal by Subject|25|||
164431809|NCT02040844|593951499|FG000|Overall Study|Lost to Follow-up|12|||
164431810|NCT02040844|593951500|FG001|Overall Study|Lost to Follow-up|9|||
164431811|NCT02040844|593951501|FG002|Overall Study|Lost to Follow-up|13|||
164431812|NCT02040844|593951499|FG000|Overall Study|Missing|13|||
164689576|NCT01933919|594887758|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
164689577|NCT01933919|594887759|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
164689578|NCT01933919|594887758|FG000|Open-label Long-term Phase|Other|1|||
164689579|NCT01933919|594887759|FG001|Open-label Long-term Phase|Other|2|||
164689580|NCT01961882|594887760|FG000|Overall Study|Adverse Event|3|||
164689581|NCT01961882|594887761|FG001|Overall Study|Adverse Event|2|||
164689582|NCT01961882|594887760|FG000|Overall Study|Physician Decision|1|||
164689583|NCT01961882|594887761|FG001|Overall Study|Physician Decision|0|||
164689584|NCT01961882|594887760|FG000|Overall Study|Withdrawal by Subject|4|||
164689585|NCT01961882|594887761|FG001|Overall Study|Withdrawal by Subject|1|||
164689586|NCT01961882|594887760|FG000|Overall Study|Relapse of AML|39|||
164689587|NCT01961882|594887761|FG001|Overall Study|Relapse of AML|37|||
164689588|NCT01961882|594887760|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
164689589|NCT01961882|594887761|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
164689590|NCT01961882|594887760|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
164689591|NCT01961882|594887761|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
164689592|NCT01901848|594887762|FG000|Randomized and Treated|Lost to Follow-up|3|||
164689593|NCT01901848|594887763|FG001|Randomized and Treated|Lost to Follow-up|6|||
164689594|NCT01901848|594887762|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
164689595|NCT01901848|594887763|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
164689596|NCT02575339|594887764|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
164689597|NCT02575339|594887765|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
164689598|NCT02575339|594887766|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
164689599|NCT02575339|594887764|FG000|Study Treatment|Disease Progression|5|||
164689600|NCT02575339|594887765|FG001|Study Treatment|Disease Progression|2|||
164689601|NCT02575339|594887766|FG002|Study Treatment|Disease Progression|0|||
164431813|NCT02040844|593951500|FG001|Overall Study|Missing|3|||
164431814|NCT02040844|593951501|FG002|Overall Study|Missing|2|||
164431815|NCT02040844|593951499|FG000|Overall Study|Non-specified|8|||
164431816|NCT02040844|593951500|FG001|Overall Study|Non-specified|2|||
164431817|NCT02040844|593951501|FG002|Overall Study|Non-specified|5|||
164431818|NCT02040844|593951499|FG000|Overall Study|Concomitant medication|1|||
164431819|NCT02040844|593951500|FG001|Overall Study|Concomitant medication|3|||
164431820|NCT02040844|593951501|FG002|Overall Study|Concomitant medication|1|||
164431821|NCT00946192|593951502|FG000|Overall Study|Lost to Follow-up|6|||
164431822|NCT00946192|593951503|FG001|Overall Study|Lost to Follow-up|11|||
164431823|NCT00946192|593951504|FG002|Overall Study|Lost to Follow-up|9|||
164431824|NCT00946192|593951502|FG000|Overall Study|Withdrawal by Subject|10|||
164431825|NCT00946192|593951503|FG001|Overall Study|Withdrawal by Subject|7|||
164431826|NCT00946192|593951504|FG002|Overall Study|Withdrawal by Subject|3|||
164431827|NCT00946192|593951502|FG000|Overall Study|Did not start medication|2|||
164431828|NCT00946192|593951503|FG001|Overall Study|Did not start medication|0|||
164689602|NCT02575339|594887764|FG000|Study Treatment|Adverse Event|1|||
164689603|NCT02575339|594887765|FG001|Study Treatment|Adverse Event|2|||
164689604|NCT02575339|594887766|FG002|Study Treatment|Adverse Event|0|||
164689605|NCT02575339|594887764|FG000|Follow up|Death|6|||
164689606|NCT02575339|594887765|FG001|Follow up|Death|2|||
164689607|NCT02575339|594887766|FG002|Follow up|Death|0|||
164689608|NCT02575339|594887764|FG000|Follow up|Study Terminated|0|||
164689609|NCT02575339|594887765|FG001|Follow up|Study Terminated|2|||
164689610|NCT02575339|594887766|FG002|Follow up|Study Terminated|0|||
164689611|NCT02575339|594887764|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
164431829|NCT00946192|593951504|FG002|Overall Study|Did not start medication|0|||
164689612|NCT02575339|594887765|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
164689613|NCT02575339|594887766|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
164689614|NCT04675775|594887767|FG000|Overall Study|Withdrawal by Subject|7|||
164431830|NCT04159506|593951505|FG000|Overall Study|Lost to Follow-up|2|||
164431831|NCT04159506|593951506|FG001|Overall Study|Lost to Follow-up|5|||
164689615|NCT00684567|594887770|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
164276685|NCT00547521|593380731|FG001|Short Term Study (4 Months)|Adverse Event|0|||
164689616|NCT00684567|594887770|FG000|Monotherapy Period|Adverse Event|2|||
164689617|NCT00684567|594887770|FG000|Monotherapy Period|Death|1|||
164689618|NCT00684567|594887770|FG000|Monotherapy Period|Progression of primary disease|11|||
164276686|NCT00547521|593380730|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
164431832|NCT04257058|593952700|FG000|Overall Study|Lost to Follow-up|31|||
164431833|NCT03227757|593952701|FG000|Overall Study|Death|25|||
164431834|NCT03227757|593952701|FG000|Overall Study|Withdrawal|10|||
164689619|NCT02618382|594887771|FG000|Overall Study|Physician Decision|1|||
164689620|NCT02618382|594887771|FG000|Overall Study|Withdrawal by Subject|1|||
164689621|NCT02618382|594887771|FG000|Overall Study|Protocol Violation|1|||
164689622|NCT00965757|594887774|FG000|Double-blind Phase|Progression of concomitant disease|1|||
164689623|NCT00965757|594887775|FG001|Double-blind Phase|Progression of concomitant disease|2|||
164689624|NCT00965757|594887776|FG002|Double-blind Phase|Progression of concomitant disease|0|||
164689625|NCT00965757|594887777|FG003|Double-blind Phase|Progression of concomitant disease|0|||
164689626|NCT00965757|594887774|FG000|Double-blind Phase|Adverse drug reaction|2|||
164689627|NCT00965757|594887775|FG001|Double-blind Phase|Adverse drug reaction|1|||
164689628|NCT00965757|594887776|FG002|Double-blind Phase|Adverse drug reaction|0|||
164689629|NCT00965757|594887777|FG003|Double-blind Phase|Adverse drug reaction|0|||
164689630|NCT00965757|594887774|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
164689631|NCT00965757|594887775|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
164689632|NCT00965757|594887776|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
164276687|NCT00547521|593380731|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
164276688|NCT00547521|593380730|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
164276689|NCT00547521|593380731|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
164689633|NCT00965757|594887777|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
164689634|NCT00965757|594887774|FG000|Double-blind Phase|Lack of Efficacy|7|||
164689635|NCT00965757|594887775|FG001|Double-blind Phase|Lack of Efficacy|11|||
164276690|NCT00547521|593380730|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
164276691|NCT00547521|593380731|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
164276692|NCT00547521|593380730|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
164276693|NCT00547521|593380731|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
164276694|NCT00547521|593380730|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
164276695|NCT00547521|593380731|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
164431835|NCT03227757|593952701|FG000|Overall Study|Missed visits|1|||
164431836|NCT03227757|593952701|FG000|Overall Study|Lost to Follow-up|2|||
164431837|NCT05570006|593952702|FG000|Overall Study|Lost to Follow-up|2|||
164431838|NCT05570006|593952702|FG000|Overall Study|Withdrawal by Subject|5|||
164431839|NCT05570006|593952702|FG000|Overall Study|Other than Specified|5|||
164431840|NCT01144468|593952703|FG000|Overall Study|Lost to Follow-up|4|||
164431841|NCT01144468|593952704|FG001|Overall Study|Lost to Follow-up|7|||
164431842|NCT01144468|593952703|FG000|Overall Study|Adverse Event|3|||
164431843|NCT01144468|593952704|FG001|Overall Study|Adverse Event|2|||
164431844|NCT01144468|593952703|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
164431845|NCT01144468|593952704|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
164431846|NCT02960659|593952705|FG000|Overall Study|Withdrawal by Subject|1|||
164431847|NCT02960659|593952706|FG001|Overall Study|Withdrawal by Subject|0|||
164431848|NCT02960659|593952705|FG000|Overall Study|Poor compliance|0|||
164431849|NCT02960659|593952706|FG001|Overall Study|Poor compliance|1|||
164431850|NCT01875250|593952714|FG000|Overall Study|Adverse Event|2|||
164276696|NCT00547521|593380730|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
164276697|NCT00547521|593380731|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
164276698|NCT00547521|593380730|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
164276699|NCT00547521|593380731|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
164276700|NCT00547521|593380730|FG000|Long Term Extension (LTE) Study|Other|0|||
164276701|NCT00547521|593380731|FG001|Long Term Extension (LTE) Study|Other|2|||
164276702|NCT00547521|593380730|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
164276703|NCT00547521|593380731|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
164276704|NCT03077919|593382630|FG000|Overall Study|Lost to Follow-up|4|||
164276705|NCT03077919|593382631|FG001|Overall Study|Lost to Follow-up|1|||
164276706|NCT00826618|593382632|FG000|Overall Study|Withdrawal by Subject|1|||
164276707|NCT01487265|593382635|FG000|Overall Study|Adverse Event|8|||
164276708|NCT01487265|593382635|FG000|Overall Study|Withdrawal by Subject|5|||
164276709|NCT01487265|593382635|FG000|Overall Study|Disease Progression|21|||
164276710|NCT01487265|593382635|FG000|Overall Study|Death|2|||
164276711|NCT01487265|593382635|FG000|Overall Study|Still on Treatment|1|||
164276712|NCT00193180|593382644|FG000|Overall Study|Lack of Efficacy|1|||
164276713|NCT00193180|593382644|FG000|Overall Study|Adverse Event|8|||
164276714|NCT00193180|593382644|FG000|Overall Study|Protocol Violation|1|||
164431851|NCT01875250|593952715|FG001|Overall Study|Adverse Event|0|||
164431852|NCT03068468|593952718|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
164431853|NCT03068468|593952719|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
164431854|NCT03068468|593952720|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
164431855|NCT03068468|593952721|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
164431856|NCT03068468|593952718|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
164431857|NCT03068468|593952719|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
164431858|NCT03068468|593952720|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
164431859|NCT03068468|593952721|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
164276715|NCT02688985|593382652|FG000|Overall Study|Adverse Event|1|||
164276716|NCT02688985|593382653|FG001|Overall Study|Adverse Event|2|||
164276717|NCT02688985|593382654|FG002|Overall Study|Adverse Event|2|||
164276718|NCT02688985|593382655|FG003|Overall Study|Adverse Event|0|||
164276719|NCT02688985|593382656|FG004|Overall Study|Adverse Event|0|||
164276720|NCT02688985|593382652|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
164276721|NCT02688985|593382653|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
164276722|NCT02688985|593382654|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
164276723|NCT02688985|593382655|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
164276724|NCT02688985|593382656|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
164276725|NCT02688985|593382652|FG000|Overall Study|Death|0|||
164276726|NCT02688985|593382653|FG001|Overall Study|Death|0|||
164276727|NCT02688985|593382654|FG002|Overall Study|Death|0|||
164276728|NCT02688985|593382655|FG003|Overall Study|Death|0|||
164276729|NCT02688985|593382656|FG004|Overall Study|Death|1|||
164276730|NCT02688985|593382652|FG000|Overall Study|Lack of Efficacy|0|||
164276731|NCT02688985|593382653|FG001|Overall Study|Lack of Efficacy|0|||
164343459|NCT01648101|593635239|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
164343460|NCT01648101|593635240|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
164584280|NCT03042611|594504605|FG000|Extension Phase|Lost to Follow-up|0|||
164343461|NCT01648101|593635238|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
164343462|NCT01648101|593635239|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
164343463|NCT01648101|593635240|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
164343464|NCT01648101|593635238|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
164343465|NCT01648101|593635239|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
164343466|NCT01648101|593635240|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
164343467|NCT01648101|593635238|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
164343468|NCT01648101|593635239|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
164343469|NCT01648101|593635240|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
164343470|NCT01648101|593635238|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
164343471|NCT01648101|593635239|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
164343472|NCT01648101|593635240|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
164343473|NCT01648101|593635238|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
164343474|NCT01648101|593635239|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
164343475|NCT01648101|593635240|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
164343476|NCT02469298|593635253|FG000|Overall Study|Protocol Violation|0|||
164343477|NCT02469298|593635254|FG001|Overall Study|Protocol Violation|1|||
164343478|NCT02469298|593635255|FG002|Overall Study|Protocol Violation|1|||
164343479|NCT02469298|593635256|FG003|Overall Study|Protocol Violation|0|||
164343480|NCT02469298|593635253|FG000|Overall Study|Lost to Follow-up|1|||
164343481|NCT02469298|593635254|FG001|Overall Study|Lost to Follow-up|0|||
164343482|NCT02469298|593635255|FG002|Overall Study|Lost to Follow-up|1|||
164343483|NCT02469298|593635256|FG003|Overall Study|Lost to Follow-up|0|||
164343484|NCT02469298|593635253|FG000|Overall Study|Physician Decision|0|||
164343485|NCT02469298|593635254|FG001|Overall Study|Physician Decision|0|||
164343486|NCT02469298|593635255|FG002|Overall Study|Physician Decision|0|||
164343487|NCT02469298|593635256|FG003|Overall Study|Physician Decision|1|||
164343488|NCT02469298|593635253|FG000|Overall Study|Withdrawal by Subject|0|||
164343489|NCT02469298|593635254|FG001|Overall Study|Withdrawal by Subject|0|||
164343490|NCT02469298|593635255|FG002|Overall Study|Withdrawal by Subject|0|||
164343491|NCT02469298|593635256|FG003|Overall Study|Withdrawal by Subject|1|||
164343492|NCT00307294|593635257|FG000|Overall Study|Withdrawal by Subject|1|||
164343493|NCT03311724|593635258|FG000|Overall Study|Physician Decision|0|||
164343494|NCT03311724|593635259|FG001|Overall Study|Physician Decision|0|||
164343495|NCT03311724|593635260|FG002|Overall Study|Physician Decision|0|||
164343496|NCT03311724|593635261|FG003|Overall Study|Physician Decision|1|||
164343497|NCT03311724|593635258|FG000|Overall Study|Protocol Violation|1|||
164343498|NCT03311724|593635259|FG001|Overall Study|Protocol Violation|0|||
164343499|NCT03311724|593635260|FG002|Overall Study|Protocol Violation|1|||
164343500|NCT03311724|593635261|FG003|Overall Study|Protocol Violation|0|||
164343501|NCT03311724|593635258|FG000|Overall Study|Withdrawal by Subject|1|||
164343502|NCT03311724|593635259|FG001|Overall Study|Withdrawal by Subject|1|||
164343503|NCT03311724|593635260|FG002|Overall Study|Withdrawal by Subject|0|||
164343504|NCT03311724|593635261|FG003|Overall Study|Withdrawal by Subject|0|||
164343505|NCT03311724|593635258|FG000|Overall Study|Lost to Follow-up|1|||
164343506|NCT03311724|593635259|FG001|Overall Study|Lost to Follow-up|0|||
164343507|NCT03311724|593635260|FG002|Overall Study|Lost to Follow-up|0|||
164343508|NCT03311724|593635261|FG003|Overall Study|Lost to Follow-up|0|||
164584281|NCT03042611|594504606|FG001|Extension Phase|Lost to Follow-up|0|||
164584282|NCT03042611|594504607|FG002|Extension Phase|Lost to Follow-up|1|||
164584283|NCT03042611|594504608|FG003|Extension Phase|Lost to Follow-up|1|||
164584284|NCT03042611|594504605|FG000|Extension Phase|Study Closed|0|||
164584285|NCT03042611|594504606|FG001|Extension Phase|Study Closed|0|||
164584286|NCT03042611|594504607|FG002|Extension Phase|Study Closed|17|||
164584287|NCT03042611|594504608|FG003|Extension Phase|Study Closed|11|||
164343509|NCT03311724|593635258|FG000|Overall Study|Sponsor Decision|0|||
164584288|NCT00474630|594504609|FG000|Overall Study|Adverse Event|98|||
164276732|NCT02688985|593382654|FG002|Overall Study|Lack of Efficacy|0|||
164276733|NCT02688985|593382655|FG003|Overall Study|Lack of Efficacy|0|||
164343510|NCT03311724|593635259|FG001|Overall Study|Sponsor Decision|0|||
164276734|NCT02688985|593382656|FG004|Overall Study|Lack of Efficacy|1|||
164276735|NCT02688985|593382652|FG000|Overall Study|Lost to Follow-up|2|||
164276736|NCT02688985|593382653|FG001|Overall Study|Lost to Follow-up|0|||
164276737|NCT02688985|593382654|FG002|Overall Study|Lost to Follow-up|1|||
164276738|NCT02688985|593382655|FG003|Overall Study|Lost to Follow-up|1|||
164276739|NCT02688985|593382656|FG004|Overall Study|Lost to Follow-up|1|||
164276740|NCT02688985|593382652|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164276741|NCT02688985|593382653|FG001|Overall Study|Non-Compliance With Study Drug|3|||
164276742|NCT02688985|593382654|FG002|Overall Study|Non-Compliance With Study Drug|1|||
164276743|NCT02688985|593382655|FG003|Overall Study|Non-Compliance With Study Drug|0|||
164276744|NCT02688985|593382656|FG004|Overall Study|Non-Compliance With Study Drug|1|||
164276745|NCT02688985|593382652|FG000|Overall Study|Other|3|||
164276746|NCT02688985|593382653|FG001|Overall Study|Other|4|||
164276747|NCT02688985|593382654|FG002|Overall Study|Other|1|||
164276748|NCT02688985|593382655|FG003|Overall Study|Other|0|||
164276749|NCT02688985|593382656|FG004|Overall Study|Other|0|||
164276750|NCT02688985|593382652|FG000|Overall Study|Physician Decision|2|||
164276751|NCT02688985|593382653|FG001|Overall Study|Physician Decision|2|||
164276752|NCT02688985|593382654|FG002|Overall Study|Physician Decision|0|||
164276753|NCT02688985|593382655|FG003|Overall Study|Physician Decision|0|||
164276754|NCT02688985|593382656|FG004|Overall Study|Physician Decision|1|||
164276755|NCT02688985|593382652|FG000|Overall Study|Pregnancy|0|||
164276756|NCT02688985|593382653|FG001|Overall Study|Pregnancy|0|||
164276757|NCT02688985|593382654|FG002|Overall Study|Pregnancy|2|||
164276758|NCT02688985|593382655|FG003|Overall Study|Pregnancy|1|||
164276759|NCT02688985|593382656|FG004|Overall Study|Pregnancy|0|||
164276760|NCT02688985|593382652|FG000|Overall Study|Study Terminated By Sponsor|0|||
164276761|NCT02688985|593382653|FG001|Overall Study|Study Terminated By Sponsor|0|||
164276762|NCT02688985|593382654|FG002|Overall Study|Study Terminated By Sponsor|0|||
164276763|NCT02688985|593382655|FG003|Overall Study|Study Terminated By Sponsor|1|||
164276764|NCT02688985|593382656|FG004|Overall Study|Study Terminated By Sponsor|0|||
164276765|NCT02688985|593382652|FG000|Overall Study|Withdrawal by Subject|2|||
164276766|NCT02688985|593382653|FG001|Overall Study|Withdrawal by Subject|8|||
164276767|NCT02688985|593382654|FG002|Overall Study|Withdrawal by Subject|7|||
164276768|NCT02688985|593382655|FG003|Overall Study|Withdrawal by Subject|1|||
164276769|NCT02688985|593382656|FG004|Overall Study|Withdrawal by Subject|4|||
164276770|NCT01726582|593382657|FG000|Overall Study|Physician Decision|99|||
164276771|NCT01726582|593382657|FG000|Overall Study|Death|85|||
164276772|NCT02630472|593382658|FG000|Overall Study|Physician Decision|10|||
164276773|NCT02630472|593382659|FG001|Overall Study|Physician Decision|0|||
164276774|NCT01832155|593382664|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
164276775|NCT01832155|593382665|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
164276776|NCT01832155|593382664|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
164276777|NCT01832155|593382665|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
164276778|NCT00787189|593382666|FG000|Overall Study|Lost to Follow-up|2|||
164276779|NCT00787189|593382667|FG001|Overall Study|Lost to Follow-up|2|||
164276780|NCT01279616|593382668|FG000|Overall Study|donor could not be located|5|||
164276781|NCT01279616|593382668|FG000|Overall Study|no signs of sickle cell disease|2|||
164276782|NCT00413036|593382669|FG000|Overall Study|Adverse Event|44|||
164276783|NCT00413036|593382669|FG000|Overall Study|Lack of Efficacy|129|||
164276784|NCT00413036|593382669|FG000|Overall Study|Withdrawal by Subject|7|||
164276785|NCT00413036|593382669|FG000|Overall Study|Death|9|||
164276786|NCT00413036|593382669|FG000|Overall Study|Other|26|||
164276787|NCT00413036|593382669|FG000|Overall Study|Missing|2|||
164276788|NCT01369641|593382670|FG000|Overall Study|Withdrawal by Subject|1|||
164276789|NCT01483183|593382675|FG000|Overall Study|Physician Decision|0|||
164276790|NCT01483183|593382676|FG001|Overall Study|Physician Decision|0|||
164276791|NCT01483183|593382677|FG002|Overall Study|Physician Decision|0|||
164276792|NCT01483183|593382678|FG003|Overall Study|Physician Decision|0|||
164276793|NCT01483183|593382679|FG004|Overall Study|Physician Decision|0|||
164276794|NCT01483183|593382680|FG005|Overall Study|Physician Decision|0|||
164276795|NCT01483183|593382681|FG006|Overall Study|Physician Decision|2|||
164276796|NCT01483183|593382682|FG007|Overall Study|Physician Decision|0|||
164276797|NCT01483183|593382683|FG008|Overall Study|Physician Decision|0|||
164276798|NCT01483183|593382684|FG009|Overall Study|Physician Decision|0|||
164276799|NCT01483183|593382675|FG000|Overall Study|Withdrawal by Subject|0|||
164343511|NCT03311724|593635260|FG002|Overall Study|Sponsor Decision|1|||
164343512|NCT03311724|593635261|FG003|Overall Study|Sponsor Decision|0|||
164343513|NCT01433991|593635262|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
164343514|NCT01433991|593635263|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
164343515|NCT01433991|593635264|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
164343516|NCT01433991|593635265|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
164343517|NCT01433991|593635262|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
164343518|NCT01433991|593635263|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
164276800|NCT01483183|593382676|FG001|Overall Study|Withdrawal by Subject|0|||
164276801|NCT01483183|593382677|FG002|Overall Study|Withdrawal by Subject|0|||
164276802|NCT01483183|593382678|FG003|Overall Study|Withdrawal by Subject|0|||
164431860|NCT03068468|593952718|FG000|Placebo-Controlled Period|Adverse Event|16|||
164689636|NCT00965757|594887776|FG002|Double-blind Phase|Lack of Efficacy|0|||
164689637|NCT00965757|594887777|FG003|Double-blind Phase|Lack of Efficacy|0|||
164689638|NCT00965757|594887774|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
164689639|NCT00965757|594887775|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
164689640|NCT00965757|594887776|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
164689641|NCT00965757|594887777|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
164689642|NCT00965757|594887774|FG000|Double-blind Phase|Lost to Follow-up|0|||
164689643|NCT00965757|594887775|FG001|Double-blind Phase|Lost to Follow-up|1|||
164689644|NCT00965757|594887776|FG002|Double-blind Phase|Lost to Follow-up|0|||
164689645|NCT00965757|594887777|FG003|Double-blind Phase|Lost to Follow-up|0|||
164689646|NCT00965757|594887774|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
164689647|NCT00965757|594887775|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
164689648|NCT00965757|594887776|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
164689649|NCT00965757|594887777|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
164689650|NCT00965757|594887774|FG000|Double-blind Phase|Other|1|||
164689651|NCT00965757|594887775|FG001|Double-blind Phase|Other|0|||
164689652|NCT00965757|594887776|FG002|Double-blind Phase|Other|0|||
164689653|NCT00965757|594887777|FG003|Double-blind Phase|Other|0|||
164689654|NCT00965757|594887774|FG000|Extension Phase|Progression of concomitant disease|0|||
164689655|NCT00965757|594887775|FG001|Extension Phase|Progression of concomitant disease|0|||
164689656|NCT00965757|594887776|FG002|Extension Phase|Progression of concomitant disease|4|||
164689657|NCT00965757|594887777|FG003|Extension Phase|Progression of concomitant disease|2|||
164689658|NCT00965757|594887774|FG000|Extension Phase|Adverse drug reaction|0|||
164689659|NCT00965757|594887775|FG001|Extension Phase|Adverse drug reaction|0|||
164689660|NCT00965757|594887776|FG002|Extension Phase|Adverse drug reaction|6|||
164689661|NCT00965757|594887777|FG003|Extension Phase|Adverse drug reaction|3|||
164431861|NCT03068468|593952719|FG001|Placebo-Controlled Period|Adverse Event|21|||
164431862|NCT03068468|593952720|FG002|Placebo-Controlled Period|Adverse Event|0|||
164431863|NCT03068468|593952721|FG003|Placebo-Controlled Period|Adverse Event|0|||
164431864|NCT03068468|593952718|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
164431865|NCT03068468|593952719|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
164431866|NCT03068468|593952720|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
164431867|NCT03068468|593952721|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
164431868|NCT03068468|593952718|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
164431869|NCT03068468|593952719|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
164431870|NCT03068468|593952720|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
164431871|NCT03068468|593952721|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
164431872|NCT03068468|593952718|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
164431873|NCT03068468|593952719|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
164431874|NCT03068468|593952720|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
164431875|NCT03068468|593952721|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
164431876|NCT03068468|593952718|FG000|Placebo-Controlled Period|Death|0|||
164431877|NCT03068468|593952719|FG001|Placebo-Controlled Period|Death|1|||
164431878|NCT03068468|593952720|FG002|Placebo-Controlled Period|Death|0|||
164431879|NCT03068468|593952721|FG003|Placebo-Controlled Period|Death|0|||
164431880|NCT03068468|593952718|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
164431881|NCT03068468|593952719|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
164431882|NCT03068468|593952720|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
164431883|NCT03068468|593952721|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
164431884|NCT03068468|593952718|FG000|Open-Label Extension Period|Adverse Event|0|||
164431885|NCT03068468|593952719|FG001|Open-Label Extension Period|Adverse Event|0|||
164431886|NCT03068468|593952720|FG002|Open-Label Extension Period|Adverse Event|13|||
164431887|NCT03068468|593952721|FG003|Open-Label Extension Period|Adverse Event|17|||
164431888|NCT03068468|593952718|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
164431889|NCT03068468|593952719|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
164431890|NCT03068468|593952720|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
164431891|NCT03068468|593952721|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
164431892|NCT03068468|593952718|FG000|Open-Label Extension Period|Death|0|||
164431893|NCT03068468|593952719|FG001|Open-Label Extension Period|Death|0|||
164431894|NCT03068468|593952720|FG002|Open-Label Extension Period|Death|0|||
164431895|NCT03068468|593952721|FG003|Open-Label Extension Period|Death|1|||
164431896|NCT03068468|593952718|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
164431897|NCT03068468|593952719|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
164431898|NCT03068468|593952720|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
164431899|NCT03068468|593952721|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
164431900|NCT03068468|593952718|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
164431901|NCT03068468|593952719|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
164276803|NCT01483183|593382679|FG004|Overall Study|Withdrawal by Subject|0|||
164276804|NCT01483183|593382680|FG005|Overall Study|Withdrawal by Subject|0|||
164276805|NCT01483183|593382681|FG006|Overall Study|Withdrawal by Subject|0|||
164276806|NCT01483183|593382682|FG007|Overall Study|Withdrawal by Subject|0|||
164276807|NCT01483183|593382683|FG008|Overall Study|Withdrawal by Subject|0|||
164276808|NCT01483183|593382684|FG009|Overall Study|Withdrawal by Subject|1|||
164276809|NCT00239928|593382685|FG000|Overall Study|Lack of Efficacy|1|||
164276810|NCT00239928|593382685|FG000|Overall Study|Adverse Event|4|||
164276811|NCT00239928|593382685|FG000|Overall Study|Not need to continue study|3|||
164276812|NCT00239928|593382685|FG000|Overall Study|Withdrawal by Subject|2|||
164276813|NCT02524158|593382686|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
164276814|NCT02524158|593382687|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
164276815|NCT02524158|593382686|FG000|12-weeks Assessment|Lost to Follow-up|18|||
164276816|NCT02524158|593382687|FG001|12-weeks Assessment|Lost to Follow-up|12|||
164276817|NCT02524158|593382686|FG000|6-month Assessment|Withdrawal by Subject|1|||
164276818|NCT02524158|593382687|FG001|6-month Assessment|Withdrawal by Subject|1|||
164276819|NCT02524158|593382686|FG000|6-month Assessment|Lost to Follow-up|21|||
164276820|NCT02524158|593382687|FG001|6-month Assessment|Lost to Follow-up|20|||
164276821|NCT04427072|593382692|FG000|Randomized Treatment Phase|Progressive disease|9|||
164276822|NCT04427072|593382693|FG001|Randomized Treatment Phase|Progressive disease|4|||
164276823|NCT04427072|593382692|FG000|Randomized Treatment Phase|Adverse Event|3|||
164276824|NCT04427072|593382693|FG001|Randomized Treatment Phase|Adverse Event|1|||
164276825|NCT04427072|593382692|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
164276826|NCT04427072|593382693|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
164276827|NCT04427072|593382692|FG000|Randomized Treatment Phase|Death|0|||
164276828|NCT04427072|593382693|FG001|Randomized Treatment Phase|Death|1|||
164276829|NCT04427072|593382692|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
164276830|NCT04427072|593382693|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
164276831|NCT04427072|593382692|FG000|Extension Treatment Phase|Progressive disease|0|||
164276832|NCT04427072|593382693|FG001|Extension Treatment Phase|Progressive disease|5|||
164276833|NCT00300365|593382694|FG000|Overall Study|Lost to Follow-up|1|||
164276834|NCT00300365|593382695|FG001|Overall Study|Lost to Follow-up|0|||
164276835|NCT00300365|593382694|FG000|Overall Study|Physician Decision|2|||
164343519|NCT01433991|593635264|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
164343520|NCT01433991|593635265|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
164276836|NCT00300365|593382695|FG001|Overall Study|Physician Decision|0|||
164276837|NCT00300365|593382694|FG000|Overall Study|Withdrawal by Subject|1|||
164343521|NCT01433991|593635262|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
164343522|NCT01433991|593635263|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
164343523|NCT01433991|593635264|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
164343524|NCT01433991|593635265|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
164343525|NCT01433991|593635262|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
164343526|NCT01433991|593635263|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
164343527|NCT01433991|593635264|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
164343528|NCT01433991|593635265|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
164343529|NCT01433991|593635262|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
164343530|NCT01433991|593635263|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
164343531|NCT01433991|593635264|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
164343532|NCT01433991|593635265|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
164343533|NCT01433991|593635262|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
164343534|NCT01433991|593635263|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
164343535|NCT01433991|593635264|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
164343536|NCT01433991|593635265|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
164343537|NCT01433991|593635262|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
164343538|NCT01433991|593635263|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
164343539|NCT01433991|593635264|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
164343540|NCT01433991|593635265|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
164343541|NCT02955602|593635266|FG000|Overall Study|Adverse Event|0|||
164343542|NCT02955602|593635267|FG001|Overall Study|Adverse Event|3|||
164343543|NCT02955602|593635268|FG002|Overall Study|Adverse Event|0|||
164343544|NCT02955602|593635266|FG000|Overall Study|Withdrawal of informed consent|1|||
164343545|NCT02955602|593635267|FG001|Overall Study|Withdrawal of informed consent|3|||
164343546|NCT02955602|593635268|FG002|Overall Study|Withdrawal of informed consent|2|||
164343547|NCT02955602|593635266|FG000|Overall Study|Lost to Follow-up|0|||
164276838|NCT00300365|593382695|FG001|Overall Study|Withdrawal by Subject|0|||
164343548|NCT02955602|593635267|FG001|Overall Study|Lost to Follow-up|0|||
164343549|NCT02955602|593635268|FG002|Overall Study|Lost to Follow-up|1|||
164343550|NCT02955602|593635266|FG000|Overall Study|Other|0|||
164584289|NCT00474630|594504610|FG001|Overall Study|Adverse Event|26|||
164276839|NCT00300365|593382694|FG000|Overall Study|Adverse Event|0|||
164276840|NCT00300365|593382695|FG001|Overall Study|Adverse Event|2|||
164276841|NCT00077649|593382696|FG000|Overall Study|Adverse Event|5|||
164276842|NCT00077649|593382697|FG001|Overall Study|Adverse Event|1|||
164276843|NCT00077649|593382698|FG002|Overall Study|Adverse Event|7|||
164276844|NCT00077649|593382699|FG003|Overall Study|Adverse Event|9|||
164276845|NCT00077649|593382696|FG000|Overall Study|Lack of Efficacy|5|||
164276846|NCT00077649|593382697|FG001|Overall Study|Lack of Efficacy|3|||
164276847|NCT00077649|593382698|FG002|Overall Study|Lack of Efficacy|3|||
164276848|NCT00077649|593382699|FG003|Overall Study|Lack of Efficacy|2|||
164276849|NCT00077649|593382696|FG000|Overall Study|Withdrawal by Subject|0|||
164276850|NCT00077649|593382697|FG001|Overall Study|Withdrawal by Subject|1|||
164276851|NCT00077649|593382698|FG002|Overall Study|Withdrawal by Subject|1|||
164276852|NCT00077649|593382699|FG003|Overall Study|Withdrawal by Subject|2|||
164276853|NCT00077649|593382696|FG000|Overall Study|Lost to Follow-up|2|||
164276854|NCT00077649|593382697|FG001|Overall Study|Lost to Follow-up|2|||
164276855|NCT00077649|593382698|FG002|Overall Study|Lost to Follow-up|3|||
164276856|NCT00077649|593382699|FG003|Overall Study|Lost to Follow-up|2|||
164276857|NCT00077649|593382696|FG000|Overall Study|Abnormality of Laboratory Test|1|||
164276858|NCT00077649|593382697|FG001|Overall Study|Abnormality of Laboratory Test|2|||
164276859|NCT00077649|593382698|FG002|Overall Study|Abnormality of Laboratory Test|1|||
164276860|NCT00077649|593382699|FG003|Overall Study|Abnormality of Laboratory Test|2|||
164276861|NCT00077649|593382696|FG000|Overall Study|Randomized but never dosed|1|||
164276862|NCT00077649|593382697|FG001|Overall Study|Randomized but never dosed|0|||
164276863|NCT00077649|593382698|FG002|Overall Study|Randomized but never dosed|0|||
164276864|NCT00077649|593382699|FG003|Overall Study|Randomized but never dosed|0|||
164276865|NCT01727336|593382702|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
164276866|NCT01727336|593382703|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
164276867|NCT01727336|593382704|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
164276868|NCT01727336|593382705|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
164276869|NCT01727336|593382706|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
164276870|NCT01727336|593382707|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
164276871|NCT01727336|593382702|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
164276872|NCT01727336|593382703|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
164276873|NCT01727336|593382704|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
164276874|NCT01727336|593382705|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
164276875|NCT01727336|593382706|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
164276876|NCT01727336|593382707|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
164276877|NCT01727336|593382702|FG000|Part 2 Blinded|Death|0|||
164276878|NCT01727336|593382703|FG001|Part 2 Blinded|Death|0|||
164276879|NCT01727336|593382704|FG002|Part 2 Blinded|Death|0|||
164276880|NCT01727336|593382705|FG003|Part 2 Blinded|Death|0|||
164276881|NCT01727336|593382706|FG004|Part 2 Blinded|Death|20|||
164276882|NCT01727336|593382707|FG005|Part 2 Blinded|Death|16|||
164276883|NCT01727336|593382702|FG000|Part 2 Blinded|Lack of Efficacy|0|||
164276884|NCT01727336|593382703|FG001|Part 2 Blinded|Lack of Efficacy|0|||
164276885|NCT01727336|593382704|FG002|Part 2 Blinded|Lack of Efficacy|0|||
164276886|NCT01727336|593382705|FG003|Part 2 Blinded|Lack of Efficacy|0|||
164276887|NCT01727336|593382706|FG004|Part 2 Blinded|Lack of Efficacy|42|||
164276888|NCT01727336|593382707|FG005|Part 2 Blinded|Lack of Efficacy|44|||
164276889|NCT01727336|593382702|FG000|Part 2 Blinded|Lost to Follow-up|0|||
164276890|NCT01727336|593382703|FG001|Part 2 Blinded|Lost to Follow-up|0|||
164276891|NCT01727336|593382704|FG002|Part 2 Blinded|Lost to Follow-up|0|||
164276892|NCT01727336|593382705|FG003|Part 2 Blinded|Lost to Follow-up|0|||
164276893|NCT01727336|593382706|FG004|Part 2 Blinded|Lost to Follow-up|0|||
164276894|NCT01727336|593382707|FG005|Part 2 Blinded|Lost to Follow-up|1|||
164276895|NCT01727336|593382702|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
164276896|NCT01727336|593382703|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
164276897|NCT01727336|593382704|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
164276898|NCT01727336|593382705|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
164276899|NCT01727336|593382706|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
164276900|NCT01727336|593382707|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
164276901|NCT01727336|593382702|FG000|Part 2 Blinded|use of prohibited medications|0|||
164276902|NCT01727336|593382703|FG001|Part 2 Blinded|use of prohibited medications|0|||
164276903|NCT01727336|593382704|FG002|Part 2 Blinded|use of prohibited medications|0|||
164276904|NCT01727336|593382705|FG003|Part 2 Blinded|use of prohibited medications|0|||
164276905|NCT01727336|593382706|FG004|Part 2 Blinded|use of prohibited medications|1|||
164343551|NCT02955602|593635267|FG001|Overall Study|Other|1|||
164343552|NCT02955602|593635268|FG002|Overall Study|Other|3|||
164343553|NCT01581931|593635271|FG000|Washout|Adverse Event|0|||
164343554|NCT01581931|593635272|FG001|Washout|Adverse Event|1|||
164343555|NCT00395304|593635279|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164343556|NCT00395304|593635280|FG001|Treatment Period 1|Withdrawal by Subject|3|||
164343557|NCT00395304|593635281|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164343558|NCT00395304|593635282|FG003|Treatment Period 1|Withdrawal by Subject|2|||
164343559|NCT00395304|593635283|FG004|Treatment Period 1|Withdrawal by Subject|1|||
164343560|NCT00395304|593635284|FG005|Treatment Period 1|Withdrawal by Subject|1|||
164276906|NCT01727336|593382707|FG005|Part 2 Blinded|use of prohibited medications|3|||
164276907|NCT03550404|593382708|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
164431902|NCT03068468|593952720|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
164431903|NCT03068468|593952721|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
164431904|NCT03068468|593952718|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
164431905|NCT03068468|593952719|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
164431906|NCT03068468|593952720|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
164431907|NCT03068468|593952721|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
164431908|NCT03068468|593952718|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
164431909|NCT03068468|593952719|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
164431910|NCT03068468|593952720|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
164431911|NCT03068468|593952721|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
164431912|NCT03068468|593952718|FG000|Open-Label Extension Period|Reason not Specified|0|||
164431913|NCT03068468|593952719|FG001|Open-Label Extension Period|Reason not Specified|0|||
164431914|NCT03068468|593952720|FG002|Open-Label Extension Period|Reason not Specified|1|||
164431915|NCT03068468|593952721|FG003|Open-Label Extension Period|Reason not Specified|4|||
164431916|NCT03895034|593952723|FG000|Overall Study|Lost to Follow-up|2|||
164431917|NCT01118377|593952728|FG000|Overall Study|Did Not Receive Study Medication|1|||
164431918|NCT01118377|593952728|FG000|Overall Study|Death|38|||
164431919|NCT01118377|593952728|FG000|Overall Study|Failure to Return|3|||
164431920|NCT03140176|593952732|FG000|Overall Study|Reason missing|23|||
164431921|NCT03140176|593952732|FG000|Overall Study|Death|33|||
164431922|NCT03140176|593952732|FG000|Overall Study|Disease progression|1|||
164431923|NCT03140176|593952732|FG000|Overall Study|Physician Decision|1|||
164431924|NCT03140176|593952732|FG000|Overall Study|Withdrawal by Subject|1|||
164431925|NCT03140176|593952732|FG000|Overall Study|Lost to Follow-up|15|||
164431926|NCT01331824|593952734|FG000|Overall Study|Adverse Event|2|||
164431927|NCT01331824|593952734|FG000|Overall Study|Death|1|||
164431928|NCT01331824|593952734|FG000|Overall Study|Disease Progression|9|||
164431929|NCT01331824|593952734|FG000|Overall Study|Withdrawal by Subject|1|||
164431930|NCT03179787|593952740|FG000|Overall Study|Lost to Follow-up|15|||
164431931|NCT03179787|593952740|FG000|Overall Study|Case report failures|2|||
164431932|NCT03179787|593952740|FG000|Overall Study|Treatment not administered|1|||
164431933|NCT03181958|593952741|FG000|Overall Study|Lost to Follow-up|17|||
164431934|NCT03181958|593952742|FG001|Overall Study|Lost to Follow-up|21|||
164431935|NCT03181958|593952743|FG002|Overall Study|Lost to Follow-up|15|||
164431936|NCT00991276|593952753|FG000|First Intervention Period|Adverse Event|0|||
164431937|NCT00991276|593952754|FG001|First Intervention Period|Adverse Event|1|||
164276908|NCT03550404|593382709|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
164276909|NCT03550404|593382710|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
164276910|NCT03550404|593382708|FG000|Phase 2|Vacated position|1|||
164276911|NCT03550404|593382709|FG001|Phase 2|Vacated position|0|||
164276912|NCT03550404|593382710|FG002|Phase 2|Vacated position|0|||
164276913|NCT00820222|593382712|FG000|Overall Study|Lost to Follow-up|10|||
164276914|NCT00820222|593382713|FG001|Overall Study|Lost to Follow-up|9|||
164276915|NCT00820222|593382712|FG000|Overall Study|Withdrawal by Subject|19|||
164276916|NCT00820222|593382713|FG001|Overall Study|Withdrawal by Subject|21|||
164276917|NCT00820222|593382712|FG000|Overall Study|Physician Decision|93|||
164276918|NCT00820222|593382713|FG001|Overall Study|Physician Decision|88|||
164276919|NCT00820222|593382712|FG000|Overall Study|Sponsor Terminated Study|43|||
164276920|NCT00820222|593382713|FG001|Overall Study|Sponsor Terminated Study|65|||
164276921|NCT00820222|593382712|FG000|Overall Study|Unkown|11|||
164276922|NCT00820222|593382713|FG001|Overall Study|Unkown|7|||
164276923|NCT02690714|593382714|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
164276924|NCT02690714|593382714|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
164276925|NCT00666965|593382715|FG000|Overall Study|Adverse Event|0|||
164276926|NCT00666965|593382716|FG001|Overall Study|Adverse Event|2|||
164276927|NCT00666965|593382717|FG002|Overall Study|Adverse Event|1|||
164276928|NCT00666965|593382718|FG003|Overall Study|Adverse Event|9|||
164431938|NCT00991276|593952755|FG002|First Intervention Period|Adverse Event|0|||
164431939|NCT00991276|593952756|FG003|First Intervention Period|Adverse Event|1|||
164689662|NCT00965757|594887774|FG000|Extension Phase|Abnormal Laboratory Value|0|||
164689663|NCT00965757|594887775|FG001|Extension Phase|Abnormal Laboratory Value|0|||
164276929|NCT00666965|593382715|FG000|Overall Study|Lack of Efficacy|1|||
164276930|NCT00666965|593382716|FG001|Overall Study|Lack of Efficacy|1|||
164276931|NCT00666965|593382717|FG002|Overall Study|Lack of Efficacy|0|||
164276932|NCT00666965|593382718|FG003|Overall Study|Lack of Efficacy|0|||
164276933|NCT00666965|593382715|FG000|Overall Study|Protocol Violation|0|||
164276934|NCT00666965|593382716|FG001|Overall Study|Protocol Violation|0|||
164276935|NCT00666965|593382717|FG002|Overall Study|Protocol Violation|0|||
164276936|NCT00666965|593382718|FG003|Overall Study|Protocol Violation|2|||
164276937|NCT00666965|593382715|FG000|Overall Study|Discontinuation criteria|2|||
164276938|NCT00666965|593382716|FG001|Overall Study|Discontinuation criteria|1|||
164276939|NCT00666965|593382717|FG002|Overall Study|Discontinuation criteria|1|||
164276940|NCT00666965|593382718|FG003|Overall Study|Discontinuation criteria|2|||
164431940|NCT00991276|593952757|FG004|First Intervention Period|Adverse Event|0|||
164431941|NCT00991276|593952758|FG005|First Intervention Period|Adverse Event|0|||
164276941|NCT00666965|593382715|FG000|Overall Study|Withdrawal by Subject|0|||
164276942|NCT00666965|593382716|FG001|Overall Study|Withdrawal by Subject|0|||
164276943|NCT00666965|593382717|FG002|Overall Study|Withdrawal by Subject|0|||
164276944|NCT00666965|593382718|FG003|Overall Study|Withdrawal by Subject|2|||
164276945|NCT03596450|593382724|FG000|Overall Study|Death|9|||
164276946|NCT03596450|593382725|FG001|Overall Study|Death|9|||
164276947|NCT03596450|593382724|FG000|Overall Study|Protocol Violation|18|||
164276948|NCT03596450|593382725|FG001|Overall Study|Protocol Violation|26|||
164276949|NCT03596450|593382724|FG000|Overall Study|Lost to Follow-up|50|||
164276950|NCT03596450|593382725|FG001|Overall Study|Lost to Follow-up|56|||
164276951|NCT03596450|593382724|FG000|Overall Study|Adverse Event|14|||
164276952|NCT03596450|593382725|FG001|Overall Study|Adverse Event|7|||
164276953|NCT03596450|593382724|FG000|Overall Study|Withdrawal by Subject|38|||
164276954|NCT03596450|593382725|FG001|Overall Study|Withdrawal by Subject|36|||
164276955|NCT03596450|593382724|FG000|Overall Study|Accidentally Randomized|2|||
164276956|NCT03596450|593382725|FG001|Overall Study|Accidentally Randomized|0|||
164276957|NCT03596450|593382724|FG000|Overall Study|Other reasons|48|||
164276958|NCT03596450|593382725|FG001|Overall Study|Other reasons|53|||
164276959|NCT03596450|593382724|FG000|Overall Study|Pregnancy|2|||
164276960|NCT03596450|593382725|FG001|Overall Study|Pregnancy|0|||
164276961|NCT04058886|593382732|FG000|Overall Study|Withdrawal by Subject|4|||
164276962|NCT04058886|593382732|FG000|Overall Study|Inadequate deafness interpreter service|1|||
164276963|NCT00699335|593382735|FG000|Overall Study|Combination of multiple reasons|176|||
164276964|NCT00699335|593382735|FG000|Overall Study|Missing data|52|||
164276965|NCT02607228|593382741|FG000|Overall Study|Progressive Disease|4|||
164276966|NCT02607228|593382742|FG001|Overall Study|Progressive Disease|3|||
164276967|NCT02607228|593382743|FG002|Overall Study|Progressive Disease|1|||
164276968|NCT02607228|593382744|FG003|Overall Study|Progressive Disease|5|||
164276969|NCT02607228|593382745|FG004|Overall Study|Progressive Disease|4|||
164276970|NCT02607228|593382746|FG005|Overall Study|Progressive Disease|3|||
164276971|NCT02607228|593382747|FG006|Overall Study|Progressive Disease|1|||
164276972|NCT02607228|593382741|FG000|Overall Study|Adverse Event|1|||
164276973|NCT02607228|593382742|FG001|Overall Study|Adverse Event|0|||
164276974|NCT02607228|593382743|FG002|Overall Study|Adverse Event|1|||
164276975|NCT02607228|593382744|FG003|Overall Study|Adverse Event|0|||
164276976|NCT02607228|593382745|FG004|Overall Study|Adverse Event|1|||
164276977|NCT02607228|593382746|FG005|Overall Study|Adverse Event|1|||
164276978|NCT02607228|593382747|FG006|Overall Study|Adverse Event|1|||
164276979|NCT02607228|593382741|FG000|Overall Study|Investigator's Discretion|0|||
164276980|NCT02607228|593382742|FG001|Overall Study|Investigator's Discretion|0|||
164276981|NCT02607228|593382743|FG002|Overall Study|Investigator's Discretion|1|||
164276982|NCT02607228|593382744|FG003|Overall Study|Investigator's Discretion|0|||
164276983|NCT02607228|593382745|FG004|Overall Study|Investigator's Discretion|0|||
164276984|NCT02607228|593382746|FG005|Overall Study|Investigator's Discretion|1|||
164276985|NCT02607228|593382747|FG006|Overall Study|Investigator's Discretion|0|||
164276986|NCT02607228|593382741|FG000|Overall Study|Withdrew Consent|0|||
164276987|NCT02607228|593382742|FG001|Overall Study|Withdrew Consent|1|||
164276988|NCT02607228|593382743|FG002|Overall Study|Withdrew Consent|0|||
164276989|NCT02607228|593382744|FG003|Overall Study|Withdrew Consent|0|||
164276990|NCT02607228|593382745|FG004|Overall Study|Withdrew Consent|0|||
164276991|NCT02607228|593382746|FG005|Overall Study|Withdrew Consent|1|||
164276992|NCT02607228|593382747|FG006|Overall Study|Withdrew Consent|0|||
164276993|NCT02607228|593382741|FG000|Overall Study|Study Terminated by Sponsor|0|||
164276994|NCT02607228|593382742|FG001|Overall Study|Study Terminated by Sponsor|0|||
164276995|NCT02607228|593382743|FG002|Overall Study|Study Terminated by Sponsor|0|||
164276996|NCT02607228|593382744|FG003|Overall Study|Study Terminated by Sponsor|1|||
164276997|NCT02607228|593382745|FG004|Overall Study|Study Terminated by Sponsor|0|||
164276998|NCT02607228|593382746|FG005|Overall Study|Study Terminated by Sponsor|0|||
164276999|NCT02607228|593382747|FG006|Overall Study|Study Terminated by Sponsor|0|||
164277000|NCT00488826|593382752|FG000|Overall Study|Withdrawal by Subject|40|||
164277001|NCT00488826|593382753|FG001|Overall Study|Withdrawal by Subject|35|||
164277002|NCT00488826|593382754|FG002|Overall Study|Withdrawal by Subject|19|||
164277003|NCT00488826|593382752|FG000|Overall Study|Protocol Violation|0|||
164277004|NCT00488826|593382753|FG001|Overall Study|Protocol Violation|0|||
164277005|NCT00488826|593382754|FG002|Overall Study|Protocol Violation|2|||
164277006|NCT00488826|593382752|FG000|Overall Study|Adverse Event|9|||
164277007|NCT00488826|593382753|FG001|Overall Study|Adverse Event|15|||
164277008|NCT00488826|593382754|FG002|Overall Study|Adverse Event|4|||
164277009|NCT00488826|593382752|FG000|Overall Study|Lost to Follow-up|5|||
164277010|NCT00488826|593382753|FG001|Overall Study|Lost to Follow-up|1|||
164277011|NCT00488826|593382754|FG002|Overall Study|Lost to Follow-up|0|||
164277012|NCT00488826|593382752|FG000|Overall Study|Protocol Deviations|2|||
164277013|NCT00488826|593382753|FG001|Overall Study|Protocol Deviations|1|||
164277014|NCT00488826|593382754|FG002|Overall Study|Protocol Deviations|1|||
164277015|NCT02974842|593382757|FG000|Overall Study|Withdrawal by Subject|4|||
164277016|NCT02974842|593382757|FG000|Overall Study|Screen failures|4|||
164277017|NCT01959243|593382758|FG000|Overall Study|Investigator Decision|3|||
164277018|NCT01959243|593382759|FG001|Overall Study|Investigator Decision|0|||
164277019|NCT01959243|593382758|FG000|Overall Study|Adverse Event|5|||
164277020|NCT01959243|593382759|FG001|Overall Study|Adverse Event|2|||
164277021|NCT01959243|593382758|FG000|Overall Study|Administrative reasons|2|||
164277022|NCT01959243|593382759|FG001|Overall Study|Administrative reasons|1|||
164277023|NCT01959243|593382758|FG000|Overall Study|Lost to Follow-up|3|||
164277024|NCT01959243|593382759|FG001|Overall Study|Lost to Follow-up|1|||
164277025|NCT02126839|593382760|FG000|Overall Study|Adverse Event|0|||
164277026|NCT02126839|593382761|FG001|Overall Study|Adverse Event|1|||
164277027|NCT02126839|593382760|FG000|Overall Study|Withdrawal by Subject|1|||
164277028|NCT02126839|593382761|FG001|Overall Study|Withdrawal by Subject|0|||
164277029|NCT02126839|593382760|FG000|Overall Study|Withdrawal by parent/guardian|1|||
164277030|NCT02126839|593382761|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164277031|NCT02126839|593382760|FG000|Overall Study|Protocol Violation|2|||
164277032|NCT02126839|593382761|FG001|Overall Study|Protocol Violation|3|||
164277033|NCT02126839|593382760|FG000|Overall Study|Sponsor request|0|||
164277034|NCT02126839|593382761|FG001|Overall Study|Sponsor request|1|||
164277035|NCT02126839|593382760|FG000|Overall Study|Lost to Follow-up|1|||
164277036|NCT02126839|593382761|FG001|Overall Study|Lost to Follow-up|4|||
164277037|NCT02126839|593382760|FG000|Overall Study|Other|5|||
164277038|NCT02126839|593382761|FG001|Overall Study|Other|5|||
164277039|NCT00812565|593382764|FG000|Overall Study|Did Not Receive Study Medication|1|||
164277040|NCT00812565|593382765|FG001|Overall Study|Did Not Receive Study Medication|1|||
164277041|NCT00812565|593382766|FG002|Overall Study|Did Not Receive Study Medication|0|||
164277042|NCT00812565|593382767|FG003|Overall Study|Did Not Receive Study Medication|0|||
164277043|NCT00812565|593382768|FG004|Overall Study|Did Not Receive Study Medication|0|||
164277044|NCT00812565|593382769|FG005|Overall Study|Did Not Receive Study Medication|0|||
164277045|NCT00812565|593382770|FG006|Overall Study|Did Not Receive Study Medication|0|||
164277046|NCT00812565|593382771|FG007|Overall Study|Did Not Receive Study Medication|0|||
164277047|NCT00812565|593382764|FG000|Overall Study|Adverse Event|0|||
164277048|NCT00812565|593382765|FG001|Overall Study|Adverse Event|0|||
164277049|NCT00812565|593382766|FG002|Overall Study|Adverse Event|0|||
164277050|NCT00812565|593382767|FG003|Overall Study|Adverse Event|2|||
164277051|NCT00812565|593382768|FG004|Overall Study|Adverse Event|0|||
164277052|NCT00812565|593382769|FG005|Overall Study|Adverse Event|0|||
164277053|NCT00812565|593382770|FG006|Overall Study|Adverse Event|0|||
164277054|NCT00812565|593382771|FG007|Overall Study|Adverse Event|1|||
164277055|NCT00812565|593382764|FG000|Overall Study|Did Not Come to Study Visit|1|||
164277056|NCT00812565|593382765|FG001|Overall Study|Did Not Come to Study Visit|0|||
164277057|NCT00812565|593382766|FG002|Overall Study|Did Not Come to Study Visit|0|||
164277058|NCT00812565|593382767|FG003|Overall Study|Did Not Come to Study Visit|0|||
164277059|NCT00812565|593382768|FG004|Overall Study|Did Not Come to Study Visit|0|||
164277060|NCT00812565|593382769|FG005|Overall Study|Did Not Come to Study Visit|0|||
164277061|NCT00812565|593382770|FG006|Overall Study|Did Not Come to Study Visit|0|||
164277062|NCT00812565|593382771|FG007|Overall Study|Did Not Come to Study Visit|0|||
164277063|NCT00812565|593382764|FG000|Overall Study|Withdrawal of Consent|1|||
164277064|NCT00812565|593382765|FG001|Overall Study|Withdrawal of Consent|0|||
164277065|NCT00812565|593382766|FG002|Overall Study|Withdrawal of Consent|0|||
164277066|NCT00812565|593382767|FG003|Overall Study|Withdrawal of Consent|0|||
164277067|NCT00812565|593382768|FG004|Overall Study|Withdrawal of Consent|1|||
164277068|NCT00812565|593382769|FG005|Overall Study|Withdrawal of Consent|0|||
164277069|NCT00812565|593382770|FG006|Overall Study|Withdrawal of Consent|0|||
164277070|NCT00812565|593382771|FG007|Overall Study|Withdrawal of Consent|0|||
164277071|NCT00812565|593382764|FG000|Overall Study|Reason Not Specified|0|||
164277072|NCT00812565|593382765|FG001|Overall Study|Reason Not Specified|0|||
164277073|NCT00812565|593382766|FG002|Overall Study|Reason Not Specified|0|||
164277074|NCT00812565|593382767|FG003|Overall Study|Reason Not Specified|0|||
164277075|NCT00812565|593382768|FG004|Overall Study|Reason Not Specified|0|||
164277076|NCT00812565|593382769|FG005|Overall Study|Reason Not Specified|1|||
164277077|NCT00812565|593382770|FG006|Overall Study|Reason Not Specified|0|||
164277078|NCT00812565|593382771|FG007|Overall Study|Reason Not Specified|0|||
164277079|NCT02596945|593382772|FG000|Overall Study|No documentation of study drug dosing|3|||
164277080|NCT02596945|593382772|FG000|Overall Study|Other|32|||
164277081|NCT02596945|593382772|FG000|Overall Study|Change to hemodialysis|15|||
164277082|NCT02596945|593382772|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
164431942|NCT00991276|593952753|FG000|First Intervention Period|Protocol Violation|0|||
164431943|NCT00991276|593952754|FG001|First Intervention Period|Protocol Violation|0|||
164277083|NCT02596945|593382772|FG000|Overall Study|Withdrawal by Subject|1|||
164431944|NCT00991276|593952755|FG002|First Intervention Period|Protocol Violation|0|||
164431945|NCT00991276|593952756|FG003|First Intervention Period|Protocol Violation|0|||
164277084|NCT02596945|593382772|FG000|Overall Study|Missing|1|||
164277085|NCT00422383|593382773|FG000|Overall Study|Adverse Event|5|||
164277086|NCT00422383|593382774|FG001|Overall Study|Adverse Event|3|||
164277087|NCT00422383|593382775|FG002|Overall Study|Adverse Event|1|||
164277088|NCT00422383|593382776|FG003|Overall Study|Adverse Event|1|||
164277089|NCT00422383|593382777|FG004|Overall Study|Adverse Event|0|||
164277090|NCT00422383|593382773|FG000|Overall Study|Lack of Efficacy|4|||
164277091|NCT00422383|593382774|FG001|Overall Study|Lack of Efficacy|4|||
164277092|NCT00422383|593382775|FG002|Overall Study|Lack of Efficacy|2|||
164277093|NCT00422383|593382776|FG003|Overall Study|Lack of Efficacy|1|||
164277094|NCT00422383|593382777|FG004|Overall Study|Lack of Efficacy|1|||
164277095|NCT00422383|593382773|FG000|Overall Study|Lost to Follow-up|0|||
164277096|NCT00422383|593382774|FG001|Overall Study|Lost to Follow-up|1|||
164277097|NCT00422383|593382775|FG002|Overall Study|Lost to Follow-up|0|||
164277098|NCT00422383|593382776|FG003|Overall Study|Lost to Follow-up|0|||
164277099|NCT00422383|593382777|FG004|Overall Study|Lost to Follow-up|1|||
164277100|NCT00422383|593382773|FG000|Overall Study|Protocol Violation|1|||
164277101|NCT00422383|593382774|FG001|Overall Study|Protocol Violation|1|||
164277102|NCT00422383|593382775|FG002|Overall Study|Protocol Violation|1|||
164277103|NCT00422383|593382776|FG003|Overall Study|Protocol Violation|0|||
164277104|NCT00422383|593382777|FG004|Overall Study|Protocol Violation|0|||
164277105|NCT00422383|593382773|FG000|Overall Study|Withdrawal by Subject|5|||
164277106|NCT00422383|593382774|FG001|Overall Study|Withdrawal by Subject|5|||
164277107|NCT00422383|593382775|FG002|Overall Study|Withdrawal by Subject|0|||
164277108|NCT00422383|593382776|FG003|Overall Study|Withdrawal by Subject|0|||
164277109|NCT00422383|593382777|FG004|Overall Study|Withdrawal by Subject|1|||
164277110|NCT00566254|593382778|FG000|Overall Study|Adverse Event|3|||
164277111|NCT00566254|593382779|FG001|Overall Study|Adverse Event|1|||
164277112|NCT00566254|593382778|FG000|Overall Study|Protocol Violation|1|||
164277113|NCT00566254|593382779|FG001|Overall Study|Protocol Violation|3|||
164277114|NCT00566254|593382778|FG000|Overall Study|Withdrawal by Subject|1|||
164277115|NCT00566254|593382779|FG001|Overall Study|Withdrawal by Subject|2|||
164277116|NCT00566254|593382778|FG000|Overall Study|Lack of Efficacy|5|||
164277117|NCT00566254|593382779|FG001|Overall Study|Lack of Efficacy|6|||
164277118|NCT00566254|593382778|FG000|Overall Study|Other|0|||
164277119|NCT00566254|593382779|FG001|Overall Study|Other|2|||
164277120|NCT00238238|593382780|FG000|Overall Study|Withdrawal by Subject|0|||
164277121|NCT00238238|593382781|FG001|Overall Study|Withdrawal by Subject|3|||
164277122|NCT00238238|593382782|FG002|Overall Study|Withdrawal by Subject|0|||
164277123|NCT01007838|593382786|FG000|Overall Study|Withdrawal by Subject|1|||
164277124|NCT01007838|593382787|FG001|Overall Study|Withdrawal by Subject|0|||
164277125|NCT01007838|593382788|FG002|Overall Study|Withdrawal by Subject|0|||
164277126|NCT01007838|593382789|FG003|Overall Study|Withdrawal by Subject|0|||
164277127|NCT01007838|593382786|FG000|Overall Study|Physician Decision|1|||
164277128|NCT01007838|593382787|FG001|Overall Study|Physician Decision|0|||
164277129|NCT01007838|593382788|FG002|Overall Study|Physician Decision|0|||
164277130|NCT01007838|593382789|FG003|Overall Study|Physician Decision|0|||
164277131|NCT01007838|593382786|FG000|Overall Study|Started home haemodialysis|1|||
164277132|NCT01007838|593382787|FG001|Overall Study|Started home haemodialysis|0|||
164277133|NCT01007838|593382788|FG002|Overall Study|Started home haemodialysis|0|||
164277134|NCT01007838|593382789|FG003|Overall Study|Started home haemodialysis|0|||
164277135|NCT02277119|593382790|FG000|Overall Study|Lack of Efficacy|1|||
164277136|NCT02277119|593382791|FG001|Overall Study|Lack of Efficacy|1|||
164277137|NCT02277119|593382792|FG002|Overall Study|Lack of Efficacy|1|||
164277138|NCT02277119|593382790|FG000|Overall Study|Protocol Violation|2|||
164277139|NCT02277119|593382791|FG001|Overall Study|Protocol Violation|3|||
164277140|NCT02277119|593382792|FG002|Overall Study|Protocol Violation|7|||
164277141|NCT04699461|593382793|FG000|Overall Study|Withdrawal by Subject|1|||
164277142|NCT04699461|593382794|FG001|Overall Study|Withdrawal by Subject|0|||
164277143|NCT04699461|593382793|FG000|Overall Study|Study termination by sponsor|2|||
164277144|NCT04699461|593382794|FG001|Overall Study|Study termination by sponsor|1|||
164277145|NCT04699461|593382793|FG000|Overall Study|Death|1|||
164277146|NCT04699461|593382794|FG001|Overall Study|Death|0|||
164277147|NCT04699461|593382793|FG000|Overall Study|Radiographic progression|0|||
164277148|NCT04699461|593382794|FG001|Overall Study|Radiographic progression|1|||
164277149|NCT00761527|593382795|FG000|Overall Study|Adverse Event|3|||
164277150|NCT00761527|593382795|FG000|Overall Study|Poor Compliance|8|||
164277151|NCT00761527|593382795|FG000|Overall Study|Lost to Follow-up|9|||
164343561|NCT00395304|593635279|FG000|Treatment Period 1|Lost to Follow-up|1|||
164343562|NCT00395304|593635280|FG001|Treatment Period 1|Lost to Follow-up|0|||
164343563|NCT00395304|593635281|FG002|Treatment Period 1|Lost to Follow-up|0|||
164343564|NCT00395304|593635282|FG003|Treatment Period 1|Lost to Follow-up|1|||
164584290|NCT00474630|594504609|FG000|Overall Study|Lost to Follow-up|22|||
164584291|NCT00474630|594504610|FG001|Overall Study|Lost to Follow-up|15|||
164584292|NCT00474630|594504609|FG000|Overall Study|Withdrawal by Subject|21|||
164584293|NCT00474630|594504610|FG001|Overall Study|Withdrawal by Subject|15|||
164277152|NCT00761527|593382795|FG000|Overall Study|Unknown reason|2|||
164277153|NCT02301624|593382798|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
164277154|NCT02301624|593382799|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
164277155|NCT02301624|593382798|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
164277156|NCT02301624|593382799|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
164277157|NCT02301624|593382798|FG000|Open-label Maintenance Phase|Adverse Event|2|||
164277158|NCT02301624|593382799|FG001|Open-label Maintenance Phase|Adverse Event|5|||
164277159|NCT02301624|593382798|FG000|Open-label Maintenance Phase|Physician Decision|3|||
164277160|NCT02301624|593382799|FG001|Open-label Maintenance Phase|Physician Decision|3|||
164584294|NCT00474630|594504609|FG000|Overall Study|Protocol Violation|3|||
164431946|NCT00991276|593952757|FG004|First Intervention Period|Protocol Violation|2|||
164431947|NCT00991276|593952758|FG005|First Intervention Period|Protocol Violation|0|||
164431948|NCT00991276|593952753|FG000|First Intervention Period|Insufficient clinical response|0|||
164277161|NCT02301624|593382798|FG000|Open-label Maintenance Phase|Death|2|||
164277162|NCT02301624|593382799|FG001|Open-label Maintenance Phase|Death|1|||
164277163|NCT02301624|593382798|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
164277164|NCT02301624|593382799|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
164277165|NCT00895310|593382800|FG000|Overall Study|Withdrawal by Subject|1|||
164277166|NCT03738618|593384666|FG000|Overall Study|Protocol deviation|23|||
164431949|NCT00991276|593952754|FG001|First Intervention Period|Insufficient clinical response|0|||
164689664|NCT00965757|594887776|FG002|Extension Phase|Abnormal Laboratory Value|6|||
164689665|NCT00965757|594887777|FG003|Extension Phase|Abnormal Laboratory Value|1|||
164277167|NCT03738618|593384667|FG001|Overall Study|Protocol deviation|0|||
164431950|NCT00991276|593952755|FG002|First Intervention Period|Insufficient clinical response|0|||
164431951|NCT00991276|593952756|FG003|First Intervention Period|Insufficient clinical response|0|||
164431952|NCT00991276|593952757|FG004|First Intervention Period|Insufficient clinical response|1|||
164431953|NCT00991276|593952758|FG005|First Intervention Period|Insufficient clinical response|0|||
164431954|NCT00991276|593952753|FG000|First Intervention Period|Other|0|||
164431955|NCT00991276|593952754|FG001|First Intervention Period|Other|0|||
164431956|NCT00991276|593952755|FG002|First Intervention Period|Other|0|||
164431957|NCT00991276|593952756|FG003|First Intervention Period|Other|1|||
164431958|NCT00991276|593952757|FG004|First Intervention Period|Other|1|||
164431959|NCT00991276|593952758|FG005|First Intervention Period|Other|0|||
164431960|NCT00991276|593952753|FG000|First Intervention Period|Withdrawal by Subject|0|||
164431961|NCT00991276|593952754|FG001|First Intervention Period|Withdrawal by Subject|1|||
164431962|NCT00991276|593952755|FG002|First Intervention Period|Withdrawal by Subject|0|||
164431963|NCT00991276|593952756|FG003|First Intervention Period|Withdrawal by Subject|1|||
164431964|NCT00991276|593952757|FG004|First Intervention Period|Withdrawal by Subject|0|||
164431965|NCT00991276|593952758|FG005|First Intervention Period|Withdrawal by Subject|1|||
164431966|NCT00991276|593952753|FG000|First Intervention Period|Lost to Follow-up|0|||
164431967|NCT00991276|593952754|FG001|First Intervention Period|Lost to Follow-up|1|||
164431968|NCT00991276|593952755|FG002|First Intervention Period|Lost to Follow-up|0|||
164431969|NCT00991276|593952756|FG003|First Intervention Period|Lost to Follow-up|1|||
164431970|NCT00991276|593952757|FG004|First Intervention Period|Lost to Follow-up|0|||
164431971|NCT00991276|593952758|FG005|First Intervention Period|Lost to Follow-up|0|||
164431972|NCT00991276|593952753|FG000|Second Intervention Period|Adverse Event|0|||
164431973|NCT00991276|593952754|FG001|Second Intervention Period|Adverse Event|2|||
164431974|NCT00991276|593952755|FG002|Second Intervention Period|Adverse Event|0|||
164431975|NCT00991276|593952756|FG003|Second Intervention Period|Adverse Event|1|||
164431976|NCT00991276|593952757|FG004|Second Intervention Period|Adverse Event|1|||
164431977|NCT00991276|593952758|FG005|Second Intervention Period|Adverse Event|0|||
164431978|NCT00991276|593952753|FG000|Second Intervention Period|Protocol Violation|1|||
164431979|NCT00991276|593952754|FG001|Second Intervention Period|Protocol Violation|0|||
164431980|NCT00991276|593952755|FG002|Second Intervention Period|Protocol Violation|0|||
164431981|NCT00991276|593952756|FG003|Second Intervention Period|Protocol Violation|0|||
164431982|NCT00991276|593952757|FG004|Second Intervention Period|Protocol Violation|0|||
164431983|NCT00991276|593952758|FG005|Second Intervention Period|Protocol Violation|0|||
164431984|NCT00991276|593952753|FG000|Second Intervention Period|Other|0|||
164431985|NCT00991276|593952754|FG001|Second Intervention Period|Other|0|||
164277168|NCT03738618|593384666|FG000|Overall Study|Adverse Event|4|||
164277169|NCT03738618|593384667|FG001|Overall Study|Adverse Event|0|||
164277170|NCT03738618|593384666|FG000|Overall Study|Lost to Follow-up|2|||
164431986|NCT00991276|593952755|FG002|Second Intervention Period|Other|0|||
164431987|NCT00991276|593952756|FG003|Second Intervention Period|Other|1|||
164431988|NCT00991276|593952757|FG004|Second Intervention Period|Other|0|||
164431989|NCT00991276|593952758|FG005|Second Intervention Period|Other|1|||
164431990|NCT00991276|593952753|FG000|Third Intervention Period|Protocol Violation|1|||
164277171|NCT03738618|593384667|FG001|Overall Study|Lost to Follow-up|0|||
164431991|NCT00991276|593952754|FG001|Third Intervention Period|Protocol Violation|0|||
164431992|NCT00991276|593952755|FG002|Third Intervention Period|Protocol Violation|0|||
164431993|NCT00991276|593952756|FG003|Third Intervention Period|Protocol Violation|0|||
164431994|NCT00991276|593952757|FG004|Third Intervention Period|Protocol Violation|0|||
164584295|NCT00474630|594504610|FG001|Overall Study|Protocol Violation|4|||
164584296|NCT00474630|594504609|FG000|Overall Study|Lack of Efficacy|5|||
164584297|NCT00474630|594504610|FG001|Overall Study|Lack of Efficacy|6|||
164584298|NCT00474630|594504609|FG000|Overall Study|Drug noncompliance, other|11|||
164584299|NCT00474630|594504610|FG001|Overall Study|Drug noncompliance, other|4|||
164584300|NCT02397655|594504613|FG000|Overall Study|data not completed|1301|||
164584301|NCT00545818|594504627|FG000|Overall Study|Protocol Violation|1|||
164584302|NCT00545818|594504628|FG001|Overall Study|Protocol Violation|0|||
164584303|NCT00545818|594504627|FG000|Overall Study|Adverse Event|1|||
164584304|NCT00545818|594504628|FG001|Overall Study|Adverse Event|1|||
164584305|NCT00545818|594504627|FG000|Overall Study|Lost to Follow-up|1|||
164277172|NCT03738618|593384666|FG000|Overall Study|Randomization failure|1|||
164277173|NCT03738618|593384667|FG001|Overall Study|Randomization failure|0|||
164277174|NCT03738618|593384666|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
164277175|NCT03738618|593384667|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
164431995|NCT00991276|593952758|FG005|Third Intervention Period|Protocol Violation|0|||
164431996|NCT00991276|593952753|FG000|Third Intervention Period|Other|0|||
164431997|NCT00991276|593952754|FG001|Third Intervention Period|Other|0|||
164431998|NCT00991276|593952755|FG002|Third Intervention Period|Other|0|||
164431999|NCT00991276|593952756|FG003|Third Intervention Period|Other|0|||
164432000|NCT00991276|593952757|FG004|Third Intervention Period|Other|0|||
164432001|NCT00991276|593952758|FG005|Third Intervention Period|Other|1|||
164432002|NCT00991276|593952753|FG000|Third Intervention Period|Adverse Event|0|||
164432003|NCT00991276|593952754|FG001|Third Intervention Period|Adverse Event|0|||
164689666|NCT00965757|594887774|FG000|Extension Phase|Lack of Efficacy|0|||
164689667|NCT00965757|594887775|FG001|Extension Phase|Lack of Efficacy|0|||
164689668|NCT00965757|594887776|FG002|Extension Phase|Lack of Efficacy|8|||
164689669|NCT00965757|594887777|FG003|Extension Phase|Lack of Efficacy|12|||
164432004|NCT00991276|593952755|FG002|Third Intervention Period|Adverse Event|1|||
164432005|NCT00991276|593952756|FG003|Third Intervention Period|Adverse Event|0|||
164432006|NCT00991276|593952757|FG004|Third Intervention Period|Adverse Event|0|||
164432007|NCT00991276|593952758|FG005|Third Intervention Period|Adverse Event|0|||
164432008|NCT00991276|593952753|FG000|Third Intervention Period|Withdrawal by Subject|0|||
164432009|NCT00991276|593952754|FG001|Third Intervention Period|Withdrawal by Subject|0|||
164432010|NCT00991276|593952755|FG002|Third Intervention Period|Withdrawal by Subject|0|||
164432011|NCT00991276|593952756|FG003|Third Intervention Period|Withdrawal by Subject|1|||
164432012|NCT00991276|593952757|FG004|Third Intervention Period|Withdrawal by Subject|0|||
164432013|NCT00991276|593952758|FG005|Third Intervention Period|Withdrawal by Subject|0|||
164432014|NCT01268891|593952760|FG000|Overall Study|Adverse Event|3|||
164432015|NCT01268891|593952761|FG001|Overall Study|Adverse Event|7|||
164432016|NCT01268891|593952760|FG000|Overall Study|Lack of Efficacy|1|||
164432017|NCT01268891|593952761|FG001|Overall Study|Lack of Efficacy|0|||
164432018|NCT01268891|593952760|FG000|Overall Study|Withdrawal of Consent|3|||
164432019|NCT01268891|593952761|FG001|Overall Study|Withdrawal of Consent|1|||
164432020|NCT01268891|593952760|FG000|Overall Study|Administrative or other reason(s)|1|||
164432021|NCT01268891|593952761|FG001|Overall Study|Administrative or other reason(s)|0|||
164432022|NCT01063036|593952770|FG000|Participants Treated With Study Drug|Adverse Event|1|||
164432023|NCT01063036|593952770|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
164432024|NCT01063036|593952770|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
164432025|NCT01063036|593952770|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
164689670|NCT00965757|594887774|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
164689671|NCT00965757|594887775|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
164689672|NCT00965757|594887776|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
164689673|NCT00965757|594887777|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
164689674|NCT00965757|594887774|FG000|Extension Phase|Lost to Follow-up|0|||
164689675|NCT00965757|594887775|FG001|Extension Phase|Lost to Follow-up|0|||
164689676|NCT00965757|594887776|FG002|Extension Phase|Lost to Follow-up|0|||
164689677|NCT00965757|594887777|FG003|Extension Phase|Lost to Follow-up|1|||
164689678|NCT00965757|594887774|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
164689679|NCT00965757|594887775|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
164432026|NCT01063036|593952770|FG000|Participants Treated With Study Drug|Pregnancy|1|||
164432027|NCT01063036|593952770|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
164432028|NCT01063036|593952770|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
164277176|NCT03738618|593384666|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
164277177|NCT03738618|593384667|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
164277178|NCT00801229|593384674|FG000|Signed Consent|Withdrawal by Subject|2|||
164277179|NCT00801229|593384675|FG001|Signed Consent|Withdrawal by Subject|2|||
164277180|NCT00801229|593384674|FG000|Signed Consent|Found Ineligible|1|||
164277181|NCT00801229|593384675|FG001|Signed Consent|Found Ineligible|1|||
164277182|NCT00801229|593384674|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
164277183|NCT00801229|593384675|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
164432029|NCT01063036|593952770|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
164432030|NCT01107626|593952773|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
164432031|NCT01107626|593952774|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
164432032|NCT01107626|593952775|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
164432033|NCT01107626|593952776|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
164432034|NCT01107626|593952773|FG000|Step 1: Induction Therapy|Adverse Event|198|||
164432035|NCT01107626|593952774|FG001|Step 1: Induction Therapy|Adverse Event|0|||
164432036|NCT01107626|593952775|FG002|Step 1: Induction Therapy|Adverse Event|0|||
164432037|NCT01107626|593952776|FG003|Step 1: Induction Therapy|Adverse Event|0|||
164432038|NCT01107626|593952773|FG000|Step 1: Induction Therapy|Death|62|||
164432039|NCT01107626|593952774|FG001|Step 1: Induction Therapy|Death|0|||
164432040|NCT01107626|593952775|FG002|Step 1: Induction Therapy|Death|0|||
164277184|NCT00801229|593384674|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
164277185|NCT00801229|593384675|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
164277186|NCT00801229|593384674|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
164277187|NCT00801229|593384675|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
164277188|NCT00801229|593384674|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
164277189|NCT00801229|593384675|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
164277190|NCT00801229|593384674|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
164277191|NCT00801229|593384675|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
164277192|NCT00801229|593384674|FG000|Received Study Drug/Placebo|Adverse Event|1|||
164277193|NCT00801229|593384675|FG001|Received Study Drug/Placebo|Adverse Event|1|||
164277194|NCT02950480|593384678|FG000|Overall Study|Withdrawal by Subject|1|||
164277195|NCT02950480|593384679|FG001|Overall Study|Withdrawal by Subject|0|||
164277196|NCT01363661|593384680|FG000|Overall Study|Adverse Event|9|||
164277197|NCT01363661|593384681|FG001|Overall Study|Adverse Event|2|||
164277198|NCT01363661|593384680|FG000|Overall Study|Withdrawal by Subject|1|||
164277199|NCT01363661|593384681|FG001|Overall Study|Withdrawal by Subject|1|||
164277200|NCT01363661|593384680|FG000|Overall Study|Protocol Violation|1|||
164277201|NCT01363661|593384681|FG001|Overall Study|Protocol Violation|0|||
164277202|NCT01363661|593384680|FG000|Overall Study|Lost to Follow-up|3|||
164277203|NCT01363661|593384681|FG001|Overall Study|Lost to Follow-up|1|||
164277204|NCT00705367|593384682|FG000|Long-term Extension Period|Adverse Event|2|||
164432041|NCT01107626|593952776|FG003|Step 1: Induction Therapy|Death|0|||
164432042|NCT01107626|593952773|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
164432043|NCT01107626|593952774|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
164432044|NCT01107626|593952775|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
164432045|NCT01107626|593952776|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
164432046|NCT01107626|593952773|FG000|Step 1: Induction Therapy|Complicating disease|13|||
164432047|NCT01107626|593952774|FG001|Step 1: Induction Therapy|Complicating disease|0|||
164432048|NCT01107626|593952775|FG002|Step 1: Induction Therapy|Complicating disease|0|||
164432049|NCT01107626|593952776|FG003|Step 1: Induction Therapy|Complicating disease|0|||
164432050|NCT01107626|593952773|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
164432051|NCT01107626|593952774|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
164432052|NCT01107626|593952775|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
164432053|NCT01107626|593952776|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
164432054|NCT01107626|593952773|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
164432055|NCT01107626|593952774|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
164432056|NCT01107626|593952775|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
164432057|NCT01107626|593952776|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
164432058|NCT01107626|593952773|FG000|Step 1: Induction Therapy|Non-compliance|4|||
164432059|NCT01107626|593952774|FG001|Step 1: Induction Therapy|Non-compliance|0|||
164432060|NCT01107626|593952775|FG002|Step 1: Induction Therapy|Non-compliance|0|||
164432061|NCT01107626|593952776|FG003|Step 1: Induction Therapy|Non-compliance|0|||
164432062|NCT01107626|593952773|FG000|Step 1: Induction Therapy|Pain|4|||
164432063|NCT01107626|593952774|FG001|Step 1: Induction Therapy|Pain|0|||
164277205|NCT00705367|593384683|FG001|Long-term Extension Period|Adverse Event|0|||
164277206|NCT00705367|593384682|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
164277207|NCT00705367|593384683|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
164277208|NCT00705367|593384682|FG000|Long-term Extension Period|Lack of Efficacy|1|||
164277209|NCT00705367|593384683|FG001|Long-term Extension Period|Lack of Efficacy|0|||
164277210|NCT00705367|593384682|FG000|Long-term Extension Period|No longer met study criteria|1|||
164277211|NCT00705367|593384683|FG001|Long-term Extension Period|No longer met study criteria|0|||
164277212|NCT00705367|593384682|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
164277213|NCT00705367|593384683|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
164277214|NCT01959139|593384684|FG000|Phase II|Disease progression|0|||
164277215|NCT01959139|593384685|FG001|Phase II|Disease progression|0|||
164277216|NCT01959139|593384686|FG002|Phase II|Disease progression|26|||
164277217|NCT01959139|593384687|FG003|Phase II|Disease progression|34|||
164277218|NCT01959139|593384684|FG000|Phase II|Adverse Event|0|||
164277219|NCT01959139|593384685|FG001|Phase II|Adverse Event|0|||
164277220|NCT01959139|593384686|FG002|Phase II|Adverse Event|10|||
164277221|NCT01959139|593384687|FG003|Phase II|Adverse Event|11|||
164277222|NCT01959139|593384684|FG000|Phase II|Patient Refusal|0|||
164277223|NCT01959139|593384685|FG001|Phase II|Patient Refusal|0|||
164277224|NCT01959139|593384686|FG002|Phase II|Patient Refusal|5|||
164277225|NCT01959139|593384687|FG003|Phase II|Patient Refusal|4|||
164432064|NCT01107626|593952775|FG002|Step 1: Induction Therapy|Pain|0|||
164432065|NCT01107626|593952776|FG003|Step 1: Induction Therapy|Pain|0|||
164432066|NCT01107626|593952773|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
164432067|NCT01107626|593952774|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
164432068|NCT01107626|593952775|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
164432069|NCT01107626|593952776|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
164432070|NCT01107626|593952773|FG000|Step 1: Induction Therapy|Hospice care|1|||
164432071|NCT01107626|593952774|FG001|Step 1: Induction Therapy|Hospice care|0|||
164432072|NCT01107626|593952775|FG002|Step 1: Induction Therapy|Hospice care|0|||
164277226|NCT01959139|593384684|FG000|Phase II|Death|0|||
164277227|NCT01959139|593384685|FG001|Phase II|Death|0|||
164277228|NCT01959139|593384686|FG002|Phase II|Death|3|||
164277229|NCT01959139|593384687|FG003|Phase II|Death|1|||
164432073|NCT01107626|593952776|FG003|Step 1: Induction Therapy|Hospice care|0|||
164432074|NCT01107626|593952773|FG000|Step 1: Induction Therapy|Physician Decision|1|||
164432075|NCT01107626|593952774|FG001|Step 1: Induction Therapy|Physician Decision|0|||
164432076|NCT01107626|593952775|FG002|Step 1: Induction Therapy|Physician Decision|0|||
164432077|NCT01107626|593952776|FG003|Step 1: Induction Therapy|Physician Decision|0|||
164432078|NCT01107626|593952773|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
164432079|NCT01107626|593952774|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
164432080|NCT01107626|593952775|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
164432081|NCT01107626|593952776|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
164432082|NCT01107626|593952773|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
164432083|NCT01107626|593952774|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
164432084|NCT01107626|593952775|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
164432085|NCT01107626|593952776|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
164432086|NCT01107626|593952773|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
164432087|NCT01107626|593952774|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
164432088|NCT01107626|593952775|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
164432089|NCT01107626|593952776|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
164432090|NCT01107626|593952773|FG000|Step 2: Maintenance Therapy|Death|0|||
164432091|NCT01107626|593952774|FG001|Step 2: Maintenance Therapy|Death|8|||
164432092|NCT01107626|593952775|FG002|Step 2: Maintenance Therapy|Death|2|||
164432093|NCT01107626|593952776|FG003|Step 2: Maintenance Therapy|Death|13|||
164432094|NCT01107626|593952773|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
164432095|NCT01107626|593952774|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
164432096|NCT01107626|593952775|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
164432097|NCT01107626|593952776|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
164432098|NCT01107626|593952773|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
164432099|NCT01107626|593952774|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
164432100|NCT01107626|593952775|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
164432101|NCT01107626|593952776|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
164432102|NCT01107626|593952773|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
164432103|NCT01107626|593952774|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
164432104|NCT01107626|593952775|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
164432105|NCT01107626|593952776|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
164432106|NCT01107626|593952773|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
164432107|NCT01107626|593952774|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
164432108|NCT01107626|593952775|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
164432109|NCT01107626|593952776|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
164432110|NCT01107626|593952773|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
164432111|NCT01107626|593952774|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
164432112|NCT01107626|593952775|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
164432113|NCT01107626|593952776|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
164432114|NCT01107626|593952773|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
164432115|NCT01107626|593952774|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
164432116|NCT01107626|593952775|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
164432117|NCT01107626|593952776|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
164432118|NCT01107626|593952773|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
164432119|NCT01107626|593952774|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
164432120|NCT01107626|593952775|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
164432121|NCT01107626|593952776|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
164432122|NCT01107626|593952773|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
164432123|NCT01107626|593952774|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
164432124|NCT01107626|593952775|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
164432125|NCT01107626|593952776|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
164432126|NCT01107626|593952773|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
164432127|NCT01107626|593952774|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
164432128|NCT01107626|593952775|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
164432129|NCT01107626|593952776|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
164432130|NCT01107626|593952773|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
164277230|NCT01959139|593384684|FG000|Phase II|Other/Unknown|0|||
164432131|NCT01107626|593952774|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
164432132|NCT01107626|593952775|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
164432133|NCT01107626|593952776|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
164432134|NCT01107626|593952773|FG000|Step 2: Maintenance Therapy|Pain|0|||
164432135|NCT01107626|593952774|FG001|Step 2: Maintenance Therapy|Pain|0|||
164432136|NCT01107626|593952775|FG002|Step 2: Maintenance Therapy|Pain|0|||
164277231|NCT01959139|593384685|FG001|Phase II|Other/Unknown|0|||
164277232|NCT01959139|593384686|FG002|Phase II|Other/Unknown|8|||
164432137|NCT01107626|593952776|FG003|Step 2: Maintenance Therapy|Pain|1|||
164432138|NCT01107626|593952773|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
164432139|NCT01107626|593952774|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
164432140|NCT01107626|593952775|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
164432141|NCT01107626|593952776|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
164432142|NCT01977612|593952777|FG000|Overall Study|Lost to Follow-up|1|||
164432143|NCT01977612|593952778|FG001|Overall Study|Lost to Follow-up|1|||
164432144|NCT04381494|593952779|FG000|Overall Study|Early termination of trial|19|||
164432145|NCT04381494|593952779|FG000|Overall Study|Investigator's discretion|1|||
164432146|NCT04381494|593952779|FG000|Overall Study|Withdrawal by Subject|9|||
164432147|NCT04381494|593952779|FG000|Overall Study|NSCLC disease progression|4|||
164432148|NCT04381494|593952779|FG000|Overall Study|Device-Related Adverse Event|2|||
164432149|NCT02715258|593952781|FG000|Overall Study|Withdrawal by Subject|6|||
164432150|NCT02715258|593952782|FG001|Overall Study|Withdrawal by Subject|1|||
164432151|NCT02715258|593952781|FG000|Overall Study|Lost to Follow-up|7|||
164432152|NCT02715258|593952782|FG001|Overall Study|Lost to Follow-up|1|||
164432153|NCT02715258|593952781|FG000|Overall Study|Terminated by Sponsor|0|||
164432154|NCT02715258|593952782|FG001|Overall Study|Terminated by Sponsor|1|||
164432155|NCT02715258|593952781|FG000|Overall Study|Death|0|||
164432156|NCT02715258|593952782|FG001|Overall Study|Death|1|||
164432157|NCT02715258|593952781|FG000|Overall Study|Subject non-compliant|1|||
164432158|NCT02715258|593952782|FG001|Overall Study|Subject non-compliant|1|||
164432159|NCT02715258|593952781|FG000|Overall Study|GCP violation|2|||
164432160|NCT02715258|593952782|FG001|Overall Study|GCP violation|1|||
164432161|NCT04310579|593952789|FG000|Overall Study|Adverse Event|0|||
164432162|NCT04310579|593952790|FG001|Overall Study|Adverse Event|0|||
164432163|NCT04310579|593952791|FG002|Overall Study|Adverse Event|0|||
164432164|NCT04310579|593952792|FG003|Overall Study|Adverse Event|0|||
164432165|NCT04310579|593952793|FG004|Overall Study|Adverse Event|0|||
164432166|NCT04310579|593952794|FG005|Overall Study|Adverse Event|0|||
164432167|NCT04310579|593952795|FG006|Overall Study|Adverse Event|2|||
164277233|NCT01959139|593384687|FG003|Phase II|Other/Unknown|5|||
164277234|NCT01959139|593384684|FG000|Phase II|On treatment|0|||
164277235|NCT01959139|593384685|FG001|Phase II|On treatment|0|||
164277236|NCT01959139|593384686|FG002|Phase II|On treatment|4|||
164277237|NCT01959139|593384687|FG003|Phase II|On treatment|0|||
164277238|NCT02255461|593384690|FG000|Overall Study|Adverse Event|0|||
164277239|NCT02255461|593384691|FG001|Overall Study|Adverse Event|1|||
164277240|NCT02255461|593384692|FG002|Overall Study|Adverse Event|0|||
164277241|NCT02255461|593384693|FG003|Overall Study|Adverse Event|0|||
164277242|NCT02255461|593384694|FG004|Overall Study|Adverse Event|1|||
164277243|NCT02255461|593384690|FG000|Overall Study|Withdrawal by Subject|0|||
164277244|NCT02255461|593384691|FG001|Overall Study|Withdrawal by Subject|0|||
164277245|NCT02255461|593384692|FG002|Overall Study|Withdrawal by Subject|1|||
164277246|NCT02255461|593384693|FG003|Overall Study|Withdrawal by Subject|0|||
164277247|NCT02255461|593384694|FG004|Overall Study|Withdrawal by Subject|1|||
164277248|NCT02255461|593384690|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
164277249|NCT02255461|593384691|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
164277250|NCT02255461|593384692|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
164277251|NCT02255461|593384693|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
164277252|NCT02255461|593384694|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
164277253|NCT01378325|593384695|FG000|Overall Study|Protocol Violation|0|||
164277254|NCT01378325|593384696|FG001|Overall Study|Protocol Violation|1|||
164277255|NCT01559675|593384697|FG000|Overall Study|Protocol Violation|1|||
164277256|NCT01559675|593384698|FG001|Overall Study|Protocol Violation|2|||
164432168|NCT04310579|593952796|FG007|Overall Study|Adverse Event|0|||
164432169|NCT04310579|593952797|FG008|Overall Study|Adverse Event|1|||
164432170|NCT04310579|593952798|FG009|Overall Study|Adverse Event|1|||
164432171|NCT04310579|593952799|FG010|Overall Study|Adverse Event|0|||
164432172|NCT04310579|593952789|FG000|Overall Study|Withdrawal by Subject|0|||
164432173|NCT04310579|593952790|FG001|Overall Study|Withdrawal by Subject|0|||
164432174|NCT04310579|593952791|FG002|Overall Study|Withdrawal by Subject|0|||
164277257|NCT01559675|593384697|FG000|Overall Study|2nd operation on same patient excluded|14|||
164277258|NCT01559675|593384698|FG001|Overall Study|2nd operation on same patient excluded|12|||
164277259|NCT01496469|593384699|FG000|Overall Study|Adverse Event|1|||
164432175|NCT04310579|593952792|FG003|Overall Study|Withdrawal by Subject|0|||
164432176|NCT04310579|593952793|FG004|Overall Study|Withdrawal by Subject|0|||
164432177|NCT04310579|593952794|FG005|Overall Study|Withdrawal by Subject|1|||
164277260|NCT01496469|593384700|FG001|Overall Study|Adverse Event|0|||
164277261|NCT01496469|593384699|FG000|Overall Study|Protocol Violation|2|||
164277262|NCT01496469|593384700|FG001|Overall Study|Protocol Violation|0|||
164277263|NCT01496469|593384699|FG000|Overall Study|Lost to Follow-up|1|||
164432178|NCT04310579|593952795|FG006|Overall Study|Withdrawal by Subject|0|||
164432179|NCT04310579|593952796|FG007|Overall Study|Withdrawal by Subject|0|||
164432180|NCT04310579|593952797|FG008|Overall Study|Withdrawal by Subject|0|||
164432181|NCT04310579|593952798|FG009|Overall Study|Withdrawal by Subject|0|||
164432182|NCT04310579|593952799|FG010|Overall Study|Withdrawal by Subject|0|||
164277264|NCT01496469|593384700|FG001|Overall Study|Lost to Follow-up|1|||
164277265|NCT01496469|593384699|FG000|Overall Study|Withdrawal by Subject|4|||
164277266|NCT01496469|593384700|FG001|Overall Study|Withdrawal by Subject|4|||
164277267|NCT01496469|593384699|FG000|Overall Study|BP exceeds protocol limits|1|||
164277268|NCT01496469|593384700|FG001|Overall Study|BP exceeds protocol limits|2|||
164277269|NCT01496469|593384699|FG000|Overall Study|Other|1|||
164277270|NCT01496469|593384700|FG001|Overall Study|Other|1|||
164277271|NCT01357551|593384703|FG000|Overall Study|Withdrawal by Subject|6|||
164277272|NCT01357551|593384704|FG001|Overall Study|Withdrawal by Subject|4|||
164277273|NCT01357551|593384703|FG000|Overall Study|Death|0|||
164277274|NCT01357551|593384704|FG001|Overall Study|Death|1|||
164277275|NCT01357551|593384703|FG000|Overall Study|Lost to Follow-up|16|||
164277276|NCT01357551|593384704|FG001|Overall Study|Lost to Follow-up|6|||
164277277|NCT02219334|593384705|FG000|Overall Study|Withdrawal by Subject|1|||
164277278|NCT02219334|593384706|FG001|Overall Study|Withdrawal by Subject|0|||
164277279|NCT02219334|593384705|FG000|Overall Study|Protocol Violation|7|||
164277280|NCT02219334|593384706|FG001|Overall Study|Protocol Violation|3|||
164277281|NCT00891228|593384710|FG000|Overall Study|Adverse Event|0|||
164277282|NCT00891228|593384711|FG001|Overall Study|Adverse Event|2|||
164277283|NCT00891228|593384712|FG002|Overall Study|Adverse Event|3|||
164277284|NCT00891228|593384710|FG000|Overall Study|Withdrawal by Subject|2|||
164277285|NCT00891228|593384711|FG001|Overall Study|Withdrawal by Subject|4|||
164277286|NCT00891228|593384712|FG002|Overall Study|Withdrawal by Subject|5|||
164277287|NCT00891228|593384710|FG000|Overall Study|Protocol Violation|3|||
164277288|NCT00891228|593384711|FG001|Overall Study|Protocol Violation|1|||
164277289|NCT00891228|593384712|FG002|Overall Study|Protocol Violation|2|||
164277290|NCT00891228|593384710|FG000|Overall Study|Physician Decision|2|||
164277291|NCT00891228|593384711|FG001|Overall Study|Physician Decision|1|||
164277292|NCT00891228|593384712|FG002|Overall Study|Physician Decision|0|||
164277293|NCT00891228|593384710|FG000|Overall Study|Lost to Follow-up|4|||
164277294|NCT00891228|593384711|FG001|Overall Study|Lost to Follow-up|4|||
164277295|NCT00891228|593384712|FG002|Overall Study|Lost to Follow-up|5|||
164277296|NCT00891228|593384710|FG000|Overall Study|Pregnancy|0|||
164277297|NCT00891228|593384711|FG001|Overall Study|Pregnancy|1|||
164277298|NCT00891228|593384712|FG002|Overall Study|Pregnancy|0|||
164277299|NCT00930553|593384717|FG000|Overall Study|Adverse Event|1|||
164277300|NCT00930553|593384717|FG000|Overall Study|Lack of Efficacy|7|||
164277301|NCT00930553|593384717|FG000|Overall Study|Physician Decision|39|||
164277302|NCT00930553|593384717|FG000|Overall Study|Protocol Violation|1|||
164277303|NCT00930553|593384717|FG000|Overall Study|Pregnancy|1|||
164277304|NCT00930553|593384717|FG000|Overall Study|Withdrawal by Subject|88|||
164277305|NCT00930553|593384717|FG000|Overall Study|Lost to Follow-up|25|||
164277306|NCT00930553|593384717|FG000|Overall Study|Death|9|||
164277307|NCT00930553|593384717|FG000|Overall Study|Study terminated by sponsor|24|||
164432183|NCT04310579|593952789|FG000|Overall Study|Positive COVID-19 test|0|||
164432184|NCT04310579|593952790|FG001|Overall Study|Positive COVID-19 test|0|||
164277308|NCT00930553|593384717|FG000|Overall Study|Other than specified above|28|||
164277309|NCT01964963|593384718|FG000|Overall Study|Case Report Forms Uncollected|888|||
164277310|NCT01964963|593384718|FG000|Overall Study|Protocol Deviation|50|||
164277311|NCT01964963|593384718|FG000|Overall Study|Data Reliability was not Assured|5|||
164277312|NCT01235234|593384719|FG000|Overall Study|Adverse Event|2|||
164277313|NCT01235234|593384720|FG001|Overall Study|Adverse Event|2|||
164277314|NCT01235234|593384721|FG002|Overall Study|Adverse Event|1|||
164277315|NCT03704688|593384730|FG000|Overall Study|Adverse Event|0|||
164277316|NCT03704688|593384731|FG001|Overall Study|Adverse Event|0|||
164277317|NCT03704688|593384732|FG002|Overall Study|Adverse Event|0|||
164277318|NCT03704688|593384733|FG003|Overall Study|Adverse Event|4|||
164277319|NCT03704688|593384734|FG004|Overall Study|Adverse Event|1|||
164277320|NCT03704688|593384735|FG005|Overall Study|Adverse Event|0|||
164277321|NCT03704688|593384730|FG000|Overall Study|Disease Progression|0|||
164277322|NCT03704688|593384731|FG001|Overall Study|Disease Progression|0|||
164277323|NCT03704688|593384732|FG002|Overall Study|Disease Progression|0|||
164277324|NCT03704688|593384733|FG003|Overall Study|Disease Progression|3|||
164277325|NCT03704688|593384734|FG004|Overall Study|Disease Progression|1|||
164277326|NCT03704688|593384735|FG005|Overall Study|Disease Progression|0|||
164432185|NCT04310579|593952791|FG002|Overall Study|Positive COVID-19 test|0|||
164277327|NCT03704688|593384730|FG000|Overall Study|Death|0|||
164277328|NCT03704688|593384731|FG001|Overall Study|Death|0|||
164277329|NCT03704688|593384732|FG002|Overall Study|Death|0|||
164277330|NCT03704688|593384733|FG003|Overall Study|Death|0|||
164277331|NCT03704688|593384734|FG004|Overall Study|Death|3|||
164277332|NCT03704688|593384735|FG005|Overall Study|Death|0|||
164277333|NCT00847886|593384737|FG000|Overall Study|Adverse Event|0|||
164277334|NCT00847886|593384738|FG001|Overall Study|Adverse Event|1|||
164277335|NCT00183625|593384739|FG000|Overall Study|Withdrawal by Subject|18|||
164277336|NCT00183625|593384740|FG001|Overall Study|Withdrawal by Subject|18|||
164277337|NCT00183625|593384741|FG002|Overall Study|Withdrawal by Subject|19|||
164277338|NCT00183625|593384742|FG003|Overall Study|Withdrawal by Subject|14|||
164277339|NCT00842543|593384745|FG000|Overall Study|Withdrawal by Subject|2|||
164277340|NCT00842543|593384746|FG001|Overall Study|Withdrawal by Subject|0|||
164277341|NCT00842543|593384747|FG002|Overall Study|Withdrawal by Subject|3|||
164277342|NCT00842543|593384748|FG003|Overall Study|Withdrawal by Subject|4|||
164277343|NCT01835158|593384750|FG000|Overall Study|Withdrawal by Subject|1|||
164277344|NCT01835158|593384751|FG001|Overall Study|Withdrawal by Subject|6|||
164277345|NCT00596830|593384752|FG000|Overall Study|Death|258|||
164277346|NCT00596830|593384753|FG001|Overall Study|Death|247|||
164277347|NCT00596830|593384752|FG000|Overall Study|Lost to Follow-up|7|||
164277348|NCT00596830|593384753|FG001|Overall Study|Lost to Follow-up|11|||
164277349|NCT00596830|593384752|FG000|Overall Study|Withdrawal by Subject|22|||
164277350|NCT00596830|593384753|FG001|Overall Study|Withdrawal by Subject|12|||
164277351|NCT00596830|593384752|FG000|Overall Study|Study terminated by sponsor|51|||
164277352|NCT00596830|593384753|FG001|Overall Study|Study terminated by sponsor|62|||
164277353|NCT00596830|593384752|FG000|Overall Study|Follow-up was discontinued|1|||
164277354|NCT00596830|593384753|FG001|Overall Study|Follow-up was discontinued|0|||
164277355|NCT00596830|593384752|FG000|Overall Study|Randomized but not treated|3|||
164277356|NCT00596830|593384753|FG001|Overall Study|Randomized but not treated|7|||
164277357|NCT00887926|593384754|FG000|Overall Study|Withdrawal by Subject|0|||
164277358|NCT00887926|593384755|FG001|Overall Study|Withdrawal by Subject|1|||
164277359|NCT00887926|593384756|FG002|Overall Study|Withdrawal by Subject|0|||
164277360|NCT00887926|593384757|FG003|Overall Study|Withdrawal by Subject|0|||
164277361|NCT00293020|593384763|FG000|Overall Study|Withdrawal by Subject|34|||
164277362|NCT00293020|593384763|FG000|Overall Study|Adverse Event|30|||
164277363|NCT00293020|593384763|FG000|Overall Study|Death|32|||
164277364|NCT00293020|593384763|FG000|Overall Study|Lack of Efficacy|12|||
164277365|NCT00293020|593384763|FG000|Overall Study|Lost to Follow-up|4|||
164277366|NCT00293020|593384763|FG000|Overall Study|Protocol Violation|6|||
164277367|NCT00293020|593384763|FG000|Overall Study|Physician Decision|21|||
164277368|NCT00293020|593384763|FG000|Overall Study|Other Reason|22|||
164277369|NCT00293020|593384763|FG000|Overall Study|No dose taken|1|||
164277370|NCT01336023|593384764|FG000|Week 0 to Week 26|Adverse Event|8|||
164277371|NCT01336023|593384765|FG001|Week 0 to Week 26|Adverse Event|10|||
164277372|NCT01336023|593384766|FG002|Week 0 to Week 26|Adverse Event|24|||
164277373|NCT01336023|593384764|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
164277374|NCT01336023|593384765|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
164277375|NCT01336023|593384766|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
164277376|NCT01336023|593384764|FG000|Week 0 to Week 26|Protocol Violation|1|||
164277377|NCT01336023|593384765|FG001|Week 0 to Week 26|Protocol Violation|2|||
164277378|NCT01336023|593384766|FG002|Week 0 to Week 26|Protocol Violation|0|||
164277379|NCT01336023|593384764|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
164277380|NCT01336023|593384765|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
164277381|NCT01336023|593384766|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
164277382|NCT01336023|593384764|FG000|Week 0 to Week 26|Unclassified|5|||
164277383|NCT01336023|593384765|FG001|Week 0 to Week 26|Unclassified|16|||
164277384|NCT01336023|593384766|FG002|Week 0 to Week 26|Unclassified|9|||
164277385|NCT01336023|593384764|FG000|Week 27 to 52|Adverse Event|1|||
164277386|NCT01336023|593384765|FG001|Week 27 to 52|Adverse Event|5|||
164277387|NCT01336023|593384766|FG002|Week 27 to 52|Adverse Event|2|||
164277388|NCT01336023|593384764|FG000|Week 27 to 52|Protocol Violation|0|||
164277389|NCT01336023|593384765|FG001|Week 27 to 52|Protocol Violation|2|||
164277390|NCT01336023|593384766|FG002|Week 27 to 52|Protocol Violation|1|||
164277391|NCT01336023|593384764|FG000|Week 27 to 52|Withdrawal Criteria|14|||
164277392|NCT01336023|593384765|FG001|Week 27 to 52|Withdrawal Criteria|19|||
164277393|NCT01336023|593384766|FG002|Week 27 to 52|Withdrawal Criteria|16|||
164277394|NCT01336023|593384764|FG000|Week 27 to 52|Unclassified|13|||
164277395|NCT01336023|593384765|FG001|Week 27 to 52|Unclassified|18|||
164277396|NCT01336023|593384766|FG002|Week 27 to 52|Unclassified|9|||
164277397|NCT01894022|593384779|FG000|Overall Study|Death|1|||
164277398|NCT01894022|593384780|FG001|Overall Study|Death|0|||
164584306|NCT00545818|594504628|FG001|Overall Study|Lost to Follow-up|6|||
164584307|NCT02623361|594504629|FG000|Overall Study|Protocol Violation|0|||
164584308|NCT02623361|594504630|FG001|Overall Study|Protocol Violation|1|||
164584309|NCT02623361|594504629|FG000|Overall Study|Withdrawal by Subject|0|||
164584310|NCT02623361|594504630|FG001|Overall Study|Withdrawal by Subject|1|||
164584311|NCT00611455|594504631|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
164584312|NCT00611455|594504632|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
164584313|NCT00611455|594504633|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
164584314|NCT00611455|594504631|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
164584315|NCT00611455|594504632|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
164584316|NCT00611455|594504633|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
164584317|NCT00611455|594504631|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
164277399|NCT01894022|593384779|FG000|Overall Study|Adverse Event, non-fatal|1|||
164277400|NCT01894022|593384780|FG001|Overall Study|Adverse Event, non-fatal|0|||
164277401|NCT01894022|593384779|FG000|Overall Study|Study Closed/terminated|7|||
164277402|NCT01894022|593384780|FG001|Overall Study|Study Closed/terminated|10|||
164277403|NCT02202538|593384782|FG000|Overall Study|Withdrawal by Subject|5|||
164277404|NCT02202538|593384782|FG000|Overall Study|Did not meet all inclusion criteria|2|||
164277405|NCT02202538|593384782|FG000|Overall Study|Investigator Decision|1|||
164343565|NCT00395304|593635283|FG004|Treatment Period 1|Lost to Follow-up|0|||
164343566|NCT00395304|593635284|FG005|Treatment Period 1|Lost to Follow-up|1|||
164343567|NCT00395304|593635279|FG000|Treatment Period 1|Physician Decision|0|||
164343568|NCT00395304|593635280|FG001|Treatment Period 1|Physician Decision|1|||
164343569|NCT00395304|593635281|FG002|Treatment Period 1|Physician Decision|0|||
164343570|NCT00395304|593635282|FG003|Treatment Period 1|Physician Decision|0|||
164343571|NCT00395304|593635283|FG004|Treatment Period 1|Physician Decision|0|||
164343572|NCT00395304|593635284|FG005|Treatment Period 1|Physician Decision|0|||
164343573|NCT00395304|593635279|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164343574|NCT00395304|593635280|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164343575|NCT00395304|593635281|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164343576|NCT00395304|593635282|FG003|Treatment Period 2|Withdrawal by Subject|1|||
164343577|NCT00395304|593635283|FG004|Treatment Period 2|Withdrawal by Subject|0|||
164343578|NCT00395304|593635284|FG005|Treatment Period 2|Withdrawal by Subject|2|||
164343579|NCT00395304|593635279|FG000|Treatment Period 2|Lost to Follow-up|0|||
164343580|NCT00395304|593635280|FG001|Treatment Period 2|Lost to Follow-up|3|||
164343581|NCT00395304|593635281|FG002|Treatment Period 2|Lost to Follow-up|0|||
164343582|NCT00395304|593635282|FG003|Treatment Period 2|Lost to Follow-up|0|||
164343583|NCT00395304|593635283|FG004|Treatment Period 2|Lost to Follow-up|0|||
164343584|NCT00395304|593635284|FG005|Treatment Period 2|Lost to Follow-up|0|||
164343585|NCT00395304|593635279|FG000|Treatment Period 2|Physician Decision|0|||
164343586|NCT00395304|593635280|FG001|Treatment Period 2|Physician Decision|0|||
164343587|NCT00395304|593635281|FG002|Treatment Period 2|Physician Decision|1|||
164343588|NCT00395304|593635282|FG003|Treatment Period 2|Physician Decision|0|||
164343589|NCT00395304|593635283|FG004|Treatment Period 2|Physician Decision|0|||
164343590|NCT00395304|593635284|FG005|Treatment Period 2|Physician Decision|0|||
164343591|NCT00395304|593635279|FG000|Treatment Period 2|Other|0|||
164343592|NCT00395304|593635280|FG001|Treatment Period 2|Other|1|||
164343593|NCT00395304|593635281|FG002|Treatment Period 2|Other|0|||
164343594|NCT00395304|593635282|FG003|Treatment Period 2|Other|0|||
164343595|NCT00395304|593635283|FG004|Treatment Period 2|Other|0|||
164343596|NCT00395304|593635284|FG005|Treatment Period 2|Other|0|||
164343597|NCT00395304|593635279|FG000|Treatment Period 3|Withdrawal by Subject|0|||
164343598|NCT00395304|593635280|FG001|Treatment Period 3|Withdrawal by Subject|0|||
164343599|NCT00395304|593635281|FG002|Treatment Period 3|Withdrawal by Subject|0|||
164343600|NCT00395304|593635282|FG003|Treatment Period 3|Withdrawal by Subject|1|||
164343601|NCT00395304|593635283|FG004|Treatment Period 3|Withdrawal by Subject|0|||
164343602|NCT00395304|593635284|FG005|Treatment Period 3|Withdrawal by Subject|1|||
164343603|NCT00395304|593635279|FG000|Treatment Period 3|Lost to Follow-up|1|||
164343604|NCT00395304|593635280|FG001|Treatment Period 3|Lost to Follow-up|1|||
164343605|NCT00395304|593635281|FG002|Treatment Period 3|Lost to Follow-up|0|||
164343606|NCT00395304|593635282|FG003|Treatment Period 3|Lost to Follow-up|0|||
164343607|NCT00395304|593635283|FG004|Treatment Period 3|Lost to Follow-up|0|||
164343608|NCT00395304|593635284|FG005|Treatment Period 3|Lost to Follow-up|0|||
164343609|NCT00395304|593635279|FG000|Treatment Period 3|Physician Decision|0|||
164343610|NCT00395304|593635280|FG001|Treatment Period 3|Physician Decision|1|||
164343611|NCT00395304|593635281|FG002|Treatment Period 3|Physician Decision|0|||
164343612|NCT00395304|593635282|FG003|Treatment Period 3|Physician Decision|0|||
164343613|NCT00395304|593635283|FG004|Treatment Period 3|Physician Decision|0|||
164343614|NCT00395304|593635284|FG005|Treatment Period 3|Physician Decision|0|||
164343615|NCT00395304|593635279|FG000|Treatment Period 3|Other|0|||
164343616|NCT00395304|593635280|FG001|Treatment Period 3|Other|0|||
164343617|NCT00395304|593635281|FG002|Treatment Period 3|Other|0|||
164343618|NCT00395304|593635282|FG003|Treatment Period 3|Other|1|||
164343619|NCT00395304|593635283|FG004|Treatment Period 3|Other|0|||
164343620|NCT00395304|593635284|FG005|Treatment Period 3|Other|0|||
164343621|NCT00980057|593635293|FG000|Overall Study|Death|13|||
164343622|NCT00980057|593635294|FG001|Overall Study|Death|3|||
164343623|NCT00980057|593635293|FG000|Overall Study|Adverse Event|0|||
164343624|NCT00980057|593635294|FG001|Overall Study|Adverse Event|1|||
164343625|NCT00980057|593635293|FG000|Overall Study|Physician Decision|4|||
164343626|NCT00980057|593635294|FG001|Overall Study|Physician Decision|0|||
164343627|NCT00980057|593635293|FG000|Overall Study|Lost to Follow-up|1|||
164343628|NCT00980057|593635294|FG001|Overall Study|Lost to Follow-up|0|||
164343629|NCT00980057|593635293|FG000|Overall Study|Withdrawal by Subject|1|||
164343630|NCT00980057|593635294|FG001|Overall Study|Withdrawal by Subject|1|||
164343631|NCT02732119|593635295|FG000|Phase I|Adverse Event|1|||
164343632|NCT02732119|593635296|FG001|Phase I|Adverse Event|3|||
164343633|NCT02732119|593635297|FG002|Phase I|Adverse Event|1|||
164343634|NCT02732119|593635298|FG003|Phase I|Adverse Event|0|||
164343635|NCT02732119|593635299|FG004|Phase I|Adverse Event|0|||
164343636|NCT02732119|593635295|FG000|Phase I|Progressive disease|7|||
164343637|NCT02732119|593635296|FG001|Phase I|Progressive disease|3|||
164343638|NCT02732119|593635297|FG002|Phase I|Progressive disease|2|||
164343639|NCT02732119|593635298|FG003|Phase I|Progressive disease|0|||
164343640|NCT02732119|593635299|FG004|Phase I|Progressive disease|0|||
164343641|NCT02732119|593635295|FG000|Phase I|Protocol deviation|0|||
164343642|NCT02732119|593635296|FG001|Phase I|Protocol deviation|1|||
164343643|NCT02732119|593635297|FG002|Phase I|Protocol deviation|0|||
164277406|NCT04496453|593384783|FG000|Overall Study|Lost to Follow-up|6|||
164432186|NCT04310579|593952792|FG003|Overall Study|Positive COVID-19 test|0|||
164432187|NCT04310579|593952793|FG004|Overall Study|Positive COVID-19 test|0|||
164432188|NCT04310579|593952794|FG005|Overall Study|Positive COVID-19 test|0|||
164432189|NCT04310579|593952795|FG006|Overall Study|Positive COVID-19 test|0|||
164277407|NCT01846741|593384784|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
164277408|NCT01853878|593384785|FG000|Overall Study|Recurrence|2|||
164277409|NCT01853878|593384786|FG001|Overall Study|Recurrence|0|||
164277410|NCT01853878|593384785|FG000|Overall Study|Adverse Event|2|||
164432190|NCT04310579|593952796|FG007|Overall Study|Positive COVID-19 test|0|||
164432191|NCT04310579|593952797|FG008|Overall Study|Positive COVID-19 test|0|||
164432192|NCT04310579|593952798|FG009|Overall Study|Positive COVID-19 test|0|||
164432193|NCT04310579|593952799|FG010|Overall Study|Positive COVID-19 test|1|||
164432194|NCT01908634|593952803|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
164432195|NCT01908634|593952803|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
164432196|NCT01072357|593952804|FG000|Overall Study|Lost to Follow-up|0|||
164432197|NCT01072357|593952805|FG001|Overall Study|Lost to Follow-up|1|||
164432198|NCT01876511|593952806|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
164432199|NCT01876511|593952807|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
164432200|NCT01876511|593952808|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
164432201|NCT01876511|593952806|FG000|Overall Study|Death (unrelated)|3|||
164432202|NCT01876511|593952807|FG001|Overall Study|Death (unrelated)|0|||
164432203|NCT01876511|593952808|FG002|Overall Study|Death (unrelated)|2|||
164432204|NCT01876511|593952806|FG000|Overall Study|Drug-related Toxicity|5|||
164432205|NCT01876511|593952807|FG001|Overall Study|Drug-related Toxicity|1|||
164432206|NCT01876511|593952808|FG002|Overall Study|Drug-related Toxicity|6|||
164432207|NCT01876511|593952806|FG000|Overall Study|Patient Decision|3|||
164432208|NCT01876511|593952807|FG001|Overall Study|Patient Decision|0|||
164432209|NCT01876511|593952808|FG002|Overall Study|Patient Decision|6|||
164432210|NCT01876511|593952806|FG000|Overall Study|Physician Decision|1|||
164432211|NCT01876511|593952807|FG001|Overall Study|Physician Decision|0|||
164432212|NCT01876511|593952808|FG002|Overall Study|Physician Decision|1|||
164432213|NCT02131324|593952809|FG000|Overall Study|Withdrawal by Subject|1|||
164432214|NCT02131324|593952810|FG001|Overall Study|Withdrawal by Subject|2|||
164432215|NCT02131324|593952809|FG000|Overall Study|Lost to Follow-up|1|||
164432216|NCT02131324|593952810|FG001|Overall Study|Lost to Follow-up|1|||
164432217|NCT05790408|593952811|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
164277411|NCT01853878|593384786|FG001|Overall Study|Adverse Event|0|||
164277412|NCT01853878|593384785|FG000|Overall Study|Withdrawal by Subject|3|||
164277413|NCT01853878|593384786|FG001|Overall Study|Withdrawal by Subject|1|||
164277414|NCT01853878|593384785|FG000|Overall Study|Migrated/moved from the study area|1|||
164277415|NCT01853878|593384786|FG001|Overall Study|Migrated/moved from the study area|0|||
164277416|NCT01853878|593384785|FG000|Overall Study|Other|55|||
164277417|NCT01853878|593384786|FG001|Overall Study|Other|43|||
164277418|NCT01361178|593384787|FG000|Overall Study|Death|13|||
164277419|NCT01361178|593384788|FG001|Overall Study|Death|0|||
164277420|NCT00767819|593384791|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
164277421|NCT00767819|593384792|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
164277422|NCT00767819|593384793|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
164343644|NCT02732119|593635298|FG003|Phase I|Protocol deviation|0|||
164277423|NCT00767819|593384791|FG000|Overall Study|Withdrawal by Subject|1|||
164277424|NCT00767819|593384792|FG001|Overall Study|Withdrawal by Subject|1|||
164277425|NCT00767819|593384793|FG002|Overall Study|Withdrawal by Subject|0|||
164277426|NCT00767819|593384791|FG000|Overall Study|Administrative problems|0|||
164277427|NCT00767819|593384792|FG001|Overall Study|Administrative problems|1|||
164343645|NCT02732119|593635299|FG004|Phase I|Protocol deviation|0|||
164343646|NCT02732119|593635295|FG000|Phase I|Physician Decision|0|||
164343647|NCT02732119|593635296|FG001|Phase I|Physician Decision|3|||
164343648|NCT02732119|593635297|FG002|Phase I|Physician Decision|4|||
164343649|NCT02732119|593635298|FG003|Phase I|Physician Decision|0|||
164343650|NCT02732119|593635299|FG004|Phase I|Physician Decision|0|||
164277428|NCT00767819|593384793|FG002|Overall Study|Administrative problems|0|||
164343651|NCT02732119|593635295|FG000|Phase II|Adverse Event|0|||
164432218|NCT01048788|593952812|FG000|Overall Study|Adverse Event|5|||
164432219|NCT01048788|593952813|FG001|Overall Study|Adverse Event|1|||
164432220|NCT01048788|593952814|FG002|Overall Study|Adverse Event|1|||
164432221|NCT01048788|593952812|FG000|Overall Study|Lack of Efficacy|0|||
164432222|NCT01048788|593952813|FG001|Overall Study|Lack of Efficacy|0|||
164432223|NCT01048788|593952814|FG002|Overall Study|Lack of Efficacy|1|||
164432224|NCT01048788|593952812|FG000|Overall Study|Withdrawal by Subject|0|||
164277429|NCT00767819|593384791|FG000|Overall Study|Death|2|||
164343652|NCT02732119|593635296|FG001|Phase II|Adverse Event|0|||
164343653|NCT02732119|593635297|FG002|Phase II|Adverse Event|0|||
164432225|NCT01048788|593952813|FG001|Overall Study|Withdrawal by Subject|1|||
164432226|NCT01048788|593952814|FG002|Overall Study|Withdrawal by Subject|0|||
164432227|NCT01233050|593952815|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
164432228|NCT01233050|593952816|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
164432229|NCT01064817|593952817|FG000|Study Completion|Physician Decision|1|||
164432230|NCT01064817|593952818|FG001|Study Completion|Physician Decision|0|||
164432231|NCT01064817|593952817|FG000|Study Completion|Withdrawal by Subject|1|||
164432232|NCT01064817|593952818|FG001|Study Completion|Withdrawal by Subject|0|||
164432233|NCT03102710|593952821|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
164432234|NCT03102710|593952822|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
164432235|NCT03102710|593952823|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
164432236|NCT03102710|593952821|FG000|Overall Study|Technical issues during final MRI scan|0|||
164432237|NCT03102710|593952822|FG001|Overall Study|Technical issues during final MRI scan|1|||
164432238|NCT03102710|593952823|FG002|Overall Study|Technical issues during final MRI scan|0|||
164432239|NCT03102710|593952821|FG000|Overall Study|Nausea during MRI scan|0|||
164432240|NCT03102710|593952822|FG001|Overall Study|Nausea during MRI scan|1|||
164432241|NCT03102710|593952823|FG002|Overall Study|Nausea during MRI scan|0|||
164432242|NCT03102710|593952821|FG000|Overall Study|Subject unable to attend final session|0|||
164432243|NCT03102710|593952822|FG001|Overall Study|Subject unable to attend final session|1|||
164432244|NCT03102710|593952823|FG002|Overall Study|Subject unable to attend final session|0|||
164432245|NCT01368406|593952824|FG000|Overall Study|Lost to Follow-up|8|||
164432246|NCT01368406|593952825|FG001|Overall Study|Lost to Follow-up|4|||
164432247|NCT01368406|593952824|FG000|Overall Study|Withdrawal by Subject|8|||
164432248|NCT01368406|593952825|FG001|Overall Study|Withdrawal by Subject|4|||
164432249|NCT01368406|593952824|FG000|Overall Study|relapse of the disease|3|||
164432250|NCT01368406|593952825|FG001|Overall Study|relapse of the disease|2|||
164432251|NCT01368406|593952824|FG000|Overall Study|started working|2|||
164432252|NCT01368406|593952825|FG001|Overall Study|started working|3|||
164432253|NCT04582877|593952826|FG000|Overall Study|Did not use device measurement|5|||
164432254|NCT04582877|593952826|FG000|Overall Study|No fractional flow reserve test results|2|||
164432255|NCT04582877|593952826|FG000|Overall Study|Protocol Violation|1|||
164432256|NCT04044664|593952827|FG000|Stage 1|Adverse Event|3|||
164432257|NCT04044664|593952828|FG001|Stage 1|Adverse Event|3|||
164432258|NCT04044664|593952829|FG002|Stage 1|Adverse Event|1|||
164432259|NCT04044664|593952827|FG000|Stage 1|Lost to Follow-up|3|||
164432260|NCT04044664|593952828|FG001|Stage 1|Lost to Follow-up|2|||
164432261|NCT04044664|593952829|FG002|Stage 1|Lost to Follow-up|2|||
164432262|NCT04044664|593952827|FG000|Stage 1|Withdrawal by Subject|9|||
164432263|NCT04044664|593952828|FG001|Stage 1|Withdrawal by Subject|1|||
164432264|NCT04044664|593952829|FG002|Stage 1|Withdrawal by Subject|0|||
164432265|NCT04044664|593952827|FG000|Stage 1|noncompliance, personal reason|2|||
164432266|NCT04044664|593952828|FG001|Stage 1|noncompliance, personal reason|0|||
164432267|NCT04044664|593952829|FG002|Stage 1|noncompliance, personal reason|0|||
164432268|NCT04044664|593952827|FG000|Stage 1|randomization error|0|||
164432269|NCT04044664|593952828|FG001|Stage 1|randomization error|1|||
164432270|NCT04044664|593952829|FG002|Stage 1|randomization error|0|||
164277430|NCT00767819|593384792|FG001|Overall Study|Death|3|||
164277431|NCT00767819|593384793|FG002|Overall Study|Death|0|||
164277432|NCT00767819|593384791|FG000|Overall Study|Adverse Event|2|||
164277433|NCT00767819|593384792|FG001|Overall Study|Adverse Event|0|||
164277434|NCT00767819|593384793|FG002|Overall Study|Adverse Event|0|||
164277435|NCT00767819|593384791|FG000|Overall Study|Abnormal lab values|1|||
164277436|NCT00767819|593384792|FG001|Overall Study|Abnormal lab values|0|||
164277437|NCT00767819|593384793|FG002|Overall Study|Abnormal lab values|0|||
164277438|NCT00767819|593384791|FG000|Overall Study|Lost to Follow-up|1|||
164277439|NCT00767819|593384792|FG001|Overall Study|Lost to Follow-up|0|||
164277440|NCT00767819|593384793|FG002|Overall Study|Lost to Follow-up|0|||
164277441|NCT04294147|593384794|FG000|Overall Study|Protocol Violation|2|||
164277442|NCT04294147|593384795|FG001|Overall Study|Protocol Violation|0|||
164277443|NCT03916081|593384800|FG000|Overall Study|Adverse Event|1|||
164277444|NCT03916081|593384801|FG001|Overall Study|Adverse Event|0|||
164277445|NCT03916081|593384802|FG002|Overall Study|Adverse Event|0|||
164277446|NCT03916081|593384800|FG000|Overall Study|Physician Decision|0|||
164432271|NCT04044664|593952827|FG000|Stage 2|Adverse Event|2|||
164432272|NCT04044664|593952828|FG001|Stage 2|Adverse Event|0|||
164432273|NCT04044664|593952829|FG002|Stage 2|Adverse Event|0|||
164432274|NCT04044664|593952827|FG000|Stage 2|Lost to Follow-up|3|||
164432275|NCT04044664|593952828|FG001|Stage 2|Lost to Follow-up|2|||
164432276|NCT04044664|593952829|FG002|Stage 2|Lost to Follow-up|1|||
164432277|NCT04044664|593952827|FG000|Stage 2|Withdrawal by Subject|3|||
164432278|NCT04044664|593952828|FG001|Stage 2|Withdrawal by Subject|0|||
164432279|NCT04044664|593952829|FG002|Stage 2|Withdrawal by Subject|0|||
164432280|NCT04044664|593952827|FG000|Stage 2|protocol deviation|1|||
164432281|NCT04044664|593952828|FG001|Stage 2|protocol deviation|0|||
164277447|NCT03916081|593384801|FG001|Overall Study|Physician Decision|0|||
164277448|NCT03916081|593384802|FG002|Overall Study|Physician Decision|1|||
164432282|NCT04044664|593952829|FG002|Stage 2|protocol deviation|0|||
164432283|NCT00001575|593952833|FG000|Overall Study|Screening failures-Ph I portion|22|||
164432284|NCT00001575|593952833|FG000|Overall Study|Withdrawn/deaths|23|||
164432285|NCT00831792|593952836|FG000|Overall Study|Not Eligible|3|||
164432286|NCT00831792|593952836|FG000|Overall Study|Adverse Event|1|||
164432287|NCT00831792|593952836|FG000|Overall Study|Death|1|||
164277449|NCT03916081|593384800|FG000|Overall Study|Lost to Follow-up|0|||
164277450|NCT03916081|593384801|FG001|Overall Study|Lost to Follow-up|1|||
164277451|NCT03916081|593384802|FG002|Overall Study|Lost to Follow-up|0|||
164277452|NCT03916081|593384800|FG000|Overall Study|Withdrawal by Subject|3|||
164277453|NCT03916081|593384801|FG001|Overall Study|Withdrawal by Subject|0|||
164277454|NCT03916081|593384802|FG002|Overall Study|Withdrawal by Subject|1|||
164277455|NCT03916081|593384800|FG000|Overall Study|Worsening of AD|0|||
164277456|NCT03916081|593384801|FG001|Overall Study|Worsening of AD|0|||
164277457|NCT03916081|593384802|FG002|Overall Study|Worsening of AD|1|||
164277458|NCT01371305|593384806|FG000|Overall Study|Adverse Event|0|||
164277459|NCT01371305|593384807|FG001|Overall Study|Adverse Event|0|||
164277460|NCT01371305|593384808|FG002|Overall Study|Adverse Event|0|||
164277461|NCT01371305|593384809|FG003|Overall Study|Adverse Event|2|||
164277462|NCT01371305|593384810|FG004|Overall Study|Adverse Event|1|||
164277463|NCT01371305|593384811|FG005|Overall Study|Adverse Event|0|||
164277464|NCT01371305|593384806|FG000|Overall Study|Study terminated by sponsor|0|||
164277465|NCT01371305|593384807|FG001|Overall Study|Study terminated by sponsor|0|||
164277466|NCT01371305|593384808|FG002|Overall Study|Study terminated by sponsor|0|||
164277467|NCT01371305|593384809|FG003|Overall Study|Study terminated by sponsor|0|||
164277468|NCT01371305|593384810|FG004|Overall Study|Study terminated by sponsor|3|||
164277469|NCT01371305|593384811|FG005|Overall Study|Study terminated by sponsor|1|||
164277470|NCT01371305|593384806|FG000|Overall Study|Subject request|0|||
164277471|NCT01371305|593384807|FG001|Overall Study|Subject request|0|||
164277472|NCT01371305|593384808|FG002|Overall Study|Subject request|0|||
164277473|NCT01371305|593384809|FG003|Overall Study|Subject request|0|||
164277474|NCT01371305|593384810|FG004|Overall Study|Subject request|0|||
164277475|NCT01371305|593384811|FG005|Overall Study|Subject request|1|||
164277476|NCT04038567|593384812|FG000|Overall Study|Lost to Follow-up|6|||
164277477|NCT04038567|593384813|FG001|Overall Study|Lost to Follow-up|4|||
164277478|NCT04038567|593384814|FG002|Overall Study|Lost to Follow-up|5|||
164277479|NCT04038567|593384815|FG003|Overall Study|Lost to Follow-up|4|||
164277480|NCT04038567|593384816|FG004|Overall Study|Lost to Follow-up|6|||
164277481|NCT04038567|593384817|FG005|Overall Study|Lost to Follow-up|4|||
164277482|NCT04038567|593384818|FG006|Overall Study|Lost to Follow-up|4|||
164277483|NCT04038567|593384819|FG007|Overall Study|Lost to Follow-up|1|||
164277484|NCT04038567|593384812|FG000|Overall Study|Withdrawal by Subject|2|||
164277485|NCT04038567|593384813|FG001|Overall Study|Withdrawal by Subject|1|||
164277486|NCT04038567|593384814|FG002|Overall Study|Withdrawal by Subject|1|||
164277487|NCT04038567|593384815|FG003|Overall Study|Withdrawal by Subject|1|||
164277488|NCT04038567|593384816|FG004|Overall Study|Withdrawal by Subject|4|||
164277489|NCT04038567|593384817|FG005|Overall Study|Withdrawal by Subject|1|||
164277490|NCT04038567|593384818|FG006|Overall Study|Withdrawal by Subject|1|||
164277491|NCT04038567|593384819|FG007|Overall Study|Withdrawal by Subject|1|||
164277492|NCT04038567|593384812|FG000|Overall Study|missed survey window|1|||
164277493|NCT04038567|593384813|FG001|Overall Study|missed survey window|2|||
164277494|NCT04038567|593384814|FG002|Overall Study|missed survey window|0|||
164277495|NCT04038567|593384815|FG003|Overall Study|missed survey window|0|||
164277496|NCT04038567|593384816|FG004|Overall Study|missed survey window|1|||
164277497|NCT04038567|593384817|FG005|Overall Study|missed survey window|1|||
164277498|NCT04038567|593384818|FG006|Overall Study|missed survey window|2|||
164277499|NCT04038567|593384819|FG007|Overall Study|missed survey window|2|||
164277500|NCT04038567|593384812|FG000|Overall Study|technical issues|0|||
164277501|NCT04038567|593384813|FG001|Overall Study|technical issues|0|||
164277502|NCT04038567|593384814|FG002|Overall Study|technical issues|0|||
164277503|NCT04038567|593384815|FG003|Overall Study|technical issues|0|||
164277504|NCT04038567|593384816|FG004|Overall Study|technical issues|0|||
164277505|NCT04038567|593384817|FG005|Overall Study|technical issues|0|||
164277506|NCT04038567|593384818|FG006|Overall Study|technical issues|1|||
164277507|NCT04038567|593384819|FG007|Overall Study|technical issues|0|||
164432288|NCT00831792|593952836|FG000|Overall Study|Lack of Efficacy|1|||
164277508|NCT04038567|593384812|FG000|Overall Study|Medical issues (i.e., illness)|0|||
164277509|NCT04038567|593384813|FG001|Overall Study|Medical issues (i.e., illness)|1|||
164277510|NCT04038567|593384814|FG002|Overall Study|Medical issues (i.e., illness)|2|||
164277511|NCT04038567|593384815|FG003|Overall Study|Medical issues (i.e., illness)|1|||
164277512|NCT04038567|593384816|FG004|Overall Study|Medical issues (i.e., illness)|1|||
164277513|NCT04038567|593384817|FG005|Overall Study|Medical issues (i.e., illness)|1|||
164277514|NCT04038567|593384818|FG006|Overall Study|Medical issues (i.e., illness)|0|||
164277515|NCT04038567|593384819|FG007|Overall Study|Medical issues (i.e., illness)|0|||
164277516|NCT04038567|593384812|FG000|Overall Study|Death|0|||
164277517|NCT04038567|593384813|FG001|Overall Study|Death|0|||
164277518|NCT04038567|593384814|FG002|Overall Study|Death|0|||
164277519|NCT04038567|593384815|FG003|Overall Study|Death|1|||
164277520|NCT04038567|593384816|FG004|Overall Study|Death|1|||
164277521|NCT04038567|593384817|FG005|Overall Study|Death|0|||
164277522|NCT04038567|593384818|FG006|Overall Study|Death|0|||
164277523|NCT04038567|593384819|FG007|Overall Study|Death|1|||
164277524|NCT02726022|593384820|FG000|Overall Study|Adverse Event|14|||
164277525|NCT02726022|593384820|FG000|Overall Study|Treatment Failure|8|||
164432289|NCT03736785|593952837|FG000|Overall Study|Adverse Event|1|||
164277526|NCT02726022|593384820|FG000|Overall Study|Poor Compliance|13|||
164277527|NCT02726022|593384820|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
164277528|NCT00235716|593384821|FG000|Overall Study|Death|26|||
164277529|NCT00235716|593384822|FG001|Overall Study|Death|39|||
164277530|NCT00235716|593384823|FG002|Overall Study|Death|32|||
164277531|NCT00235716|593384824|FG003|Overall Study|Death|31|||
164277532|NCT00235716|593384821|FG000|Overall Study|Withdrawal by Subject|23|||
164277533|NCT00235716|593384822|FG001|Overall Study|Withdrawal by Subject|19|||
164277534|NCT00235716|593384823|FG002|Overall Study|Withdrawal by Subject|17|||
164277535|NCT00235716|593384824|FG003|Overall Study|Withdrawal by Subject|18|||
164277536|NCT00235716|593384821|FG000|Overall Study|Lost to Follow-up|12|||
164277537|NCT00235716|593384822|FG001|Overall Study|Lost to Follow-up|7|||
164277538|NCT00235716|593384823|FG002|Overall Study|Lost to Follow-up|14|||
164277539|NCT00235716|593384824|FG003|Overall Study|Lost to Follow-up|10|||
164277540|NCT00235716|593384821|FG000|Overall Study|Adverse Event|1|||
164277541|NCT00235716|593384822|FG001|Overall Study|Adverse Event|1|||
164277542|NCT00235716|593384823|FG002|Overall Study|Adverse Event|1|||
164277543|NCT00235716|593384824|FG003|Overall Study|Adverse Event|0|||
164277544|NCT00235716|593384821|FG000|Overall Study|Physician Decision|0|||
164277545|NCT00235716|593384822|FG001|Overall Study|Physician Decision|1|||
164277546|NCT00235716|593384823|FG002|Overall Study|Physician Decision|1|||
164277547|NCT00235716|593384824|FG003|Overall Study|Physician Decision|3|||
164277548|NCT02999633|593384825|FG000|Overall Study|Adverse Event|2|||
164277549|NCT02999633|593384825|FG000|Overall Study|Progressive disease|12|||
164277550|NCT01545050|593384826|FG000|Overall Study|Lack of Efficacy|0|||
164277551|NCT01545050|593384827|FG001|Overall Study|Lack of Efficacy|0|||
164277552|NCT01545050|593384828|FG002|Overall Study|Lack of Efficacy|0|||
164277553|NCT01545050|593384829|FG003|Overall Study|Lack of Efficacy|3|||
164277554|NCT01545050|593384830|FG004|Overall Study|Lack of Efficacy|2|||
164277555|NCT01545050|593384826|FG000|Overall Study|Adverse Event|1|||
164277556|NCT01545050|593384827|FG001|Overall Study|Adverse Event|1|||
164277557|NCT01545050|593384828|FG002|Overall Study|Adverse Event|2|||
164277558|NCT01545050|593384829|FG003|Overall Study|Adverse Event|2|||
164277559|NCT01545050|593384830|FG004|Overall Study|Adverse Event|0|||
164277560|NCT01545050|593384826|FG000|Overall Study|Discontinued study treatment|1|||
164343654|NCT02732119|593635298|FG003|Phase II|Adverse Event|3|||
164343655|NCT02732119|593635299|FG004|Phase II|Adverse Event|3|||
164343656|NCT02732119|593635295|FG000|Phase II|Death|0|||
164343657|NCT02732119|593635296|FG001|Phase II|Death|0|||
164343658|NCT02732119|593635297|FG002|Phase II|Death|0|||
164343659|NCT02732119|593635298|FG003|Phase II|Death|1|||
164343660|NCT02732119|593635299|FG004|Phase II|Death|0|||
164432290|NCT03736785|593952838|FG001|Overall Study|Adverse Event|1|||
164432291|NCT03736785|593952839|FG002|Overall Study|Adverse Event|1|||
164432292|NCT03736785|593952837|FG000|Overall Study|Death|1|||
164432293|NCT03736785|593952838|FG001|Overall Study|Death|0|||
164432294|NCT03736785|593952839|FG002|Overall Study|Death|1|||
164343661|NCT02732119|593635295|FG000|Phase II|Progressive dissease|0|||
164343662|NCT02732119|593635296|FG001|Phase II|Progressive dissease|0|||
164343663|NCT02732119|593635297|FG002|Phase II|Progressive dissease|0|||
164343664|NCT02732119|593635298|FG003|Phase II|Progressive dissease|30|||
164432295|NCT03736785|593952837|FG000|Overall Study|Lost to Follow-up|0|||
164432296|NCT03736785|593952838|FG001|Overall Study|Lost to Follow-up|2|||
164432297|NCT03736785|593952839|FG002|Overall Study|Lost to Follow-up|3|||
164432298|NCT03736785|593952837|FG000|Overall Study|Non compliance with study drug|1|||
164432299|NCT03736785|593952838|FG001|Overall Study|Non compliance with study drug|1|||
164584318|NCT00611455|594504632|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
164343665|NCT02732119|593635299|FG004|Phase II|Progressive dissease|23|||
164343666|NCT02732119|593635295|FG000|Phase II|Study terminated by sponsor|0|||
164277561|NCT01545050|593384827|FG001|Overall Study|Discontinued study treatment|0|||
164277562|NCT01545050|593384828|FG002|Overall Study|Discontinued study treatment|0|||
164277563|NCT01545050|593384829|FG003|Overall Study|Discontinued study treatment|0|||
164277564|NCT01545050|593384830|FG004|Overall Study|Discontinued study treatment|0|||
164277565|NCT01545050|593384826|FG000|Overall Study|Withdrawal by Subject|1|||
164277566|NCT01545050|593384827|FG001|Overall Study|Withdrawal by Subject|0|||
164277567|NCT01545050|593384828|FG002|Overall Study|Withdrawal by Subject|0|||
164277568|NCT01545050|593384829|FG003|Overall Study|Withdrawal by Subject|2|||
164277569|NCT01545050|593384830|FG004|Overall Study|Withdrawal by Subject|1|||
164277570|NCT01545050|593384826|FG000|Overall Study|Participant no longer meets study criteria|0|||
164277571|NCT01545050|593384827|FG001|Overall Study|Participant no longer meets study criteria|2|||
164343667|NCT02732119|593635296|FG001|Phase II|Study terminated by sponsor|0|||
164343668|NCT02732119|593635297|FG002|Phase II|Study terminated by sponsor|0|||
164343669|NCT02732119|593635298|FG003|Phase II|Study terminated by sponsor|2|||
164584319|NCT00611455|594504633|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
164277572|NCT01545050|593384828|FG002|Overall Study|Participant no longer meets study criteria|0|||
164343670|NCT02732119|593635299|FG004|Phase II|Study terminated by sponsor|2|||
164343671|NCT02732119|593635295|FG000|Phase II|Other|0|||
164432300|NCT03736785|593952839|FG002|Overall Study|Non compliance with study drug|0|||
164432301|NCT03736785|593952837|FG000|Overall Study|Physician Decision|0|||
164432302|NCT03736785|593952838|FG001|Overall Study|Physician Decision|1|||
164432303|NCT03736785|593952839|FG002|Overall Study|Physician Decision|1|||
164432304|NCT03736785|593952837|FG000|Overall Study|Protocol Violation|1|||
164432305|NCT03736785|593952838|FG001|Overall Study|Protocol Violation|4|||
164432306|NCT03736785|593952839|FG002|Overall Study|Protocol Violation|3|||
164432307|NCT03736785|593952837|FG000|Overall Study|Sponsor Decision|1|||
164432308|NCT03736785|593952838|FG001|Overall Study|Sponsor Decision|0|||
164432309|NCT03736785|593952839|FG002|Overall Study|Sponsor Decision|0|||
164432310|NCT03736785|593952837|FG000|Overall Study|Unknown/Missing data|3|||
164432311|NCT03736785|593952838|FG001|Overall Study|Unknown/Missing data|2|||
164432312|NCT03736785|593952839|FG002|Overall Study|Unknown/Missing data|1|||
164432313|NCT03736785|593952837|FG000|Overall Study|Withdrawal by Subject|9|||
164432314|NCT03736785|593952838|FG001|Overall Study|Withdrawal by Subject|6|||
164277573|NCT01545050|593384829|FG003|Overall Study|Participant no longer meets study criteria|0|||
164277574|NCT01545050|593384830|FG004|Overall Study|Participant no longer meets study criteria|1|||
164432315|NCT03736785|593952839|FG002|Overall Study|Withdrawal by Subject|4|||
164432316|NCT02974010|593952840|FG000|Overall Study|Lost to Follow-up|3|||
164432317|NCT02974010|593952841|FG001|Overall Study|Lost to Follow-up|1|||
164432318|NCT02974010|593952842|FG002|Overall Study|Lost to Follow-up|0|||
164432319|NCT02974010|593952843|FG003|Overall Study|Lost to Follow-up|0|||
164432320|NCT02974010|593952840|FG000|Overall Study|Withdrawal by Subject|2|||
164432321|NCT02974010|593952841|FG001|Overall Study|Withdrawal by Subject|1|||
164432322|NCT02974010|593952842|FG002|Overall Study|Withdrawal by Subject|0|||
164432323|NCT02974010|593952843|FG003|Overall Study|Withdrawal by Subject|0|||
164432324|NCT02974010|593952840|FG000|Overall Study|Adverse Event|0|||
164432325|NCT02974010|593952841|FG001|Overall Study|Adverse Event|1|||
164432326|NCT02974010|593952842|FG002|Overall Study|Adverse Event|0|||
164432327|NCT02974010|593952843|FG003|Overall Study|Adverse Event|0|||
164432328|NCT02974010|593952840|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
164277575|NCT01545050|593384826|FG000|Overall Study|Administrative reason by sponsor|4|||
164277576|NCT01545050|593384827|FG001|Overall Study|Administrative reason by sponsor|2|||
164277577|NCT01545050|593384828|FG002|Overall Study|Administrative reason by sponsor|3|||
164277578|NCT01545050|593384829|FG003|Overall Study|Administrative reason by sponsor|5|||
164277579|NCT01545050|593384830|FG004|Overall Study|Administrative reason by sponsor|5|||
164277580|NCT02249182|593384833|FG000|Treatment Phase|Lost to Follow-up|4|||
164277581|NCT02249182|593384834|FG001|Treatment Phase|Lost to Follow-up|0|||
164277582|NCT02249182|593384835|FG002|Treatment Phase|Lost to Follow-up|0|||
164277583|NCT02249182|593384836|FG003|Treatment Phase|Lost to Follow-up|0|||
164277584|NCT02249182|593384837|FG004|Treatment Phase|Lost to Follow-up|0|||
164277585|NCT03244826|593384846|FG000|Overall Study|Withdrawal by Subject|2|||
164277586|NCT03244826|593384847|FG001|Overall Study|Withdrawal by Subject|0|||
164277587|NCT03244826|593384846|FG000|Overall Study|Transplant delayed or withdrawn|12|||
164432329|NCT02974010|593952841|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
164432330|NCT02974010|593952842|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
164432331|NCT02974010|593952843|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
164432332|NCT02974010|593952840|FG000|Overall Study|Lack of Efficacy|0|||
164432333|NCT02974010|593952841|FG001|Overall Study|Lack of Efficacy|0|||
164432334|NCT02974010|593952842|FG002|Overall Study|Lack of Efficacy|1|||
164432335|NCT02974010|593952843|FG003|Overall Study|Lack of Efficacy|0|||
164277588|NCT03244826|593384847|FG001|Overall Study|Transplant delayed or withdrawn|10|||
164277589|NCT04356040|593384848|FG000|Overall Study|Death|2|||
164277590|NCT04356040|593384849|FG001|Overall Study|Death|0|||
164277591|NCT04356040|593384848|FG000|Overall Study|Lost to Follow-up|1|||
164277592|NCT04356040|593384849|FG001|Overall Study|Lost to Follow-up|0|||
164277593|NCT04356040|593384848|FG000|Overall Study|Physician Decision|0|||
164277594|NCT04356040|593384849|FG001|Overall Study|Physician Decision|1|||
164277595|NCT04356040|593384848|FG000|Overall Study|Withdrawal by Subject|13|||
164432336|NCT01080131|593952846|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
164432337|NCT01080131|593952847|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
164432338|NCT01080131|593952846|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
164432339|NCT01080131|593952847|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
164432340|NCT01080131|593952846|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
164432341|NCT01080131|593952847|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
164432342|NCT01080131|593952846|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
164432343|NCT01080131|593952847|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
164432344|NCT01080131|593952846|FG000|Core Study (0- 12 Weeks)|Death|1|||
164432345|NCT01080131|593952847|FG001|Core Study (0- 12 Weeks)|Death|0|||
164432346|NCT01080131|593952846|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
164432347|NCT01080131|593952847|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
164584320|NCT00611455|594504631|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
164584321|NCT00611455|594504632|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
164277596|NCT04356040|593384849|FG001|Overall Study|Withdrawal by Subject|1|||
164277597|NCT04356040|593384848|FG000|Overall Study|Enrollment Pause|10|||
164277598|NCT04356040|593384849|FG001|Overall Study|Enrollment Pause|0|||
164432348|NCT01080131|593952846|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
164277599|NCT04356040|593384848|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
164277600|NCT04356040|593384849|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
164277601|NCT04356040|593384848|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
164277602|NCT04356040|593384849|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
164277603|NCT04356040|593384848|FG000|Overall Study|PI left institution|3|||
164277604|NCT04356040|593384849|FG001|Overall Study|PI left institution|0|||
164277605|NCT00416455|593384850|FG000|Overall Study|PET / CT not done|3|||
164277606|NCT00416455|593384851|FG001|Overall Study|PET / CT not done|5|||
164343672|NCT02732119|593635296|FG001|Phase II|Other|0|||
164343673|NCT02732119|593635297|FG002|Phase II|Other|0|||
164343674|NCT02732119|593635298|FG003|Phase II|Other|2|||
164343675|NCT02732119|593635299|FG004|Phase II|Other|0|||
164343676|NCT02732119|593635295|FG000|Phase II|Physician Decision|0|||
164277607|NCT00416455|593384850|FG000|Overall Study|PET / CT poor quality|2|||
164277608|NCT00416455|593384851|FG001|Overall Study|PET / CT poor quality|1|||
164277609|NCT00416455|593384850|FG000|Overall Study|Inadequate pathology|11|||
164277610|NCT00416455|593384851|FG001|Overall Study|Inadequate pathology|2|||
164277611|NCT01008449|593384852|FG000|Overall Study|Lost to Follow-up|29|||
164277612|NCT01008449|593384853|FG001|Overall Study|Lost to Follow-up|19|||
164277613|NCT01114438|593384854|FG000|Overall Study|Adverse Event|10|||
164277614|NCT01114438|593384854|FG000|Overall Study|concomitant medication|1|||
164277615|NCT01114438|593384854|FG000|Overall Study|Physician Decision|1|||
164277616|NCT01114438|593384854|FG000|Overall Study|Withdrawal by Subject|2|||
164277617|NCT00428844|593384855|FG000|Completed Study Drug Treatment|Adverse Event|2|||
164277618|NCT00428844|593384856|FG001|Completed Study Drug Treatment|Adverse Event|4|||
164277619|NCT00428844|593384857|FG002|Completed Study Drug Treatment|Adverse Event|4|||
164277620|NCT00428844|593384855|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
164277621|NCT00428844|593384856|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
164277622|NCT00428844|593384857|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
164277623|NCT00428844|593384855|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
164277624|NCT00428844|593384856|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
164277625|NCT00428844|593384857|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
164277626|NCT00428844|593384855|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
164277627|NCT00428844|593384856|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
164277628|NCT00428844|593384857|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
164277629|NCT00428844|593384855|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
164277630|NCT00428844|593384856|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
164277631|NCT00428844|593384857|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
164277632|NCT00428844|593384855|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
164277633|NCT00428844|593384856|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
164277634|NCT00428844|593384857|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
164277635|NCT00428844|593384855|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
164277636|NCT00428844|593384856|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
164277637|NCT00428844|593384857|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
164277638|NCT00428844|593384855|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
164277639|NCT00428844|593384856|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
164277640|NCT00428844|593384857|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
164277641|NCT00428844|593384855|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
164277642|NCT00428844|593384856|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
164277643|NCT00428844|593384857|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
164277644|NCT03043651|593384862|FG000|Overall Study|Death|1|||
164277645|NCT03043651|593384862|FG000|Overall Study|Progressive Disease|2|||
164277646|NCT03043651|593384862|FG000|Overall Study|Adverse Event|2|||
164277647|NCT03043651|593384862|FG000|Overall Study|Withdrawal by Subject|4|||
164277648|NCT03043651|593384862|FG000|Overall Study|Study Terminated by Sponsor|39|||
164277649|NCT01345669|593384863|FG000|Overall Study|Primary tumour recurrence|53|||
164277650|NCT01345669|593384864|FG001|Overall Study|Primary tumour recurrence|32|||
164277651|NCT01345669|593384863|FG000|Overall Study|Second primary tumour|4|||
164343677|NCT02732119|593635296|FG001|Phase II|Physician Decision|0|||
164343678|NCT02732119|593635297|FG002|Phase II|Physician Decision|0|||
164343679|NCT02732119|593635298|FG003|Phase II|Physician Decision|8|||
164343680|NCT02732119|593635299|FG004|Phase II|Physician Decision|5|||
164343681|NCT00964860|593635300|FG000|Overall Study|Withdrawal by Subject|0|||
164343682|NCT00964860|593635301|FG001|Overall Study|Withdrawal by Subject|1|||
164343683|NCT02585960|593635302|FG000|PK/Safety Assessment Period|Physician Decision|0|||
164343684|NCT02585960|593635303|FG001|PK/Safety Assessment Period|Physician Decision|1|||
164277652|NCT01345669|593384864|FG001|Overall Study|Second primary tumour|3|||
164277653|NCT01345669|593384863|FG000|Overall Study|Adverse Event|63|||
164277654|NCT01345669|593384864|FG001|Overall Study|Adverse Event|9|||
164343685|NCT02585960|593635304|FG002|PK/Safety Assessment Period|Physician Decision|0|||
164343686|NCT02585960|593635302|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
164343687|NCT02585960|593635303|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
164343688|NCT02585960|593635304|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
164277655|NCT01345669|593384863|FG000|Overall Study|Protocol Violation|3|||
164277656|NCT01345669|593384864|FG001|Overall Study|Protocol Violation|1|||
164277657|NCT01345669|593384863|FG000|Overall Study|Lost to Follow-up|1|||
164277658|NCT01345669|593384864|FG001|Overall Study|Lost to Follow-up|1|||
164277659|NCT01345669|593384863|FG000|Overall Study|Withdrawal by Subject|52|||
164277660|NCT01345669|593384864|FG001|Overall Study|Withdrawal by Subject|13|||
164277661|NCT01345669|593384863|FG000|Overall Study|Other Reasons|111|||
164277662|NCT01345669|593384864|FG001|Overall Study|Other Reasons|60|||
164277663|NCT01793883|593384865|FG000|Overall Study|Withdrawal by Subject|3|||
164277664|NCT01793883|593384866|FG001|Overall Study|Withdrawal by Subject|7|||
164432349|NCT01080131|593952847|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
164277665|NCT01793883|593384867|FG002|Overall Study|Withdrawal by Subject|3|||
164277666|NCT01793883|593384865|FG000|Overall Study|Subject noncompliance|0|||
164277667|NCT01793883|593384866|FG001|Overall Study|Subject noncompliance|1|||
164277668|NCT01793883|593384867|FG002|Overall Study|Subject noncompliance|1|||
164277669|NCT01793883|593384865|FG000|Overall Study|Lost to Follow-up|5|||
164277670|NCT01793883|593384866|FG001|Overall Study|Lost to Follow-up|1|||
164277671|NCT01793883|593384867|FG002|Overall Study|Lost to Follow-up|3|||
164277672|NCT01793883|593384865|FG000|Overall Study|Randomized in error|1|||
164277673|NCT01793883|593384866|FG001|Overall Study|Randomized in error|0|||
164277674|NCT01793883|593384867|FG002|Overall Study|Randomized in error|0|||
164277675|NCT01793883|593384865|FG000|Overall Study|Unable to complete spriometry|1|||
164277676|NCT01793883|593384866|FG001|Overall Study|Unable to complete spriometry|0|||
164277677|NCT01793883|593384867|FG002|Overall Study|Unable to complete spriometry|0|||
164277678|NCT01793883|593384865|FG000|Overall Study|Unable to complete measurements|1|||
164277679|NCT01793883|593384866|FG001|Overall Study|Unable to complete measurements|0|||
164277680|NCT01793883|593384867|FG002|Overall Study|Unable to complete measurements|0|||
164277681|NCT01793883|593384865|FG000|Overall Study|Met exclusion criteria|1|||
164277682|NCT01793883|593384866|FG001|Overall Study|Met exclusion criteria|0|||
164277683|NCT01793883|593384867|FG002|Overall Study|Met exclusion criteria|0|||
164277684|NCT01793883|593384865|FG000|Overall Study|Dosing error|0|||
164277685|NCT01793883|593384866|FG001|Overall Study|Dosing error|1|||
164277686|NCT01793883|593384867|FG002|Overall Study|Dosing error|0|||
164277687|NCT01793883|593384865|FG000|Overall Study|Respiratory distress during spirometry|0|||
164277688|NCT01793883|593384866|FG001|Overall Study|Respiratory distress during spirometry|0|||
164277689|NCT01793883|593384867|FG002|Overall Study|Respiratory distress during spirometry|1|||
164277690|NCT02353728|593384870|FG000|Overall Study|Subject non-compliance|1|||
164277691|NCT02611817|593387734|FG000|Open-label Induction Phase|Reason not Specified|9|||
164277692|NCT02611817|593387735|FG001|Open-label Induction Phase|Reason not Specified|0|||
164277693|NCT02611817|593387736|FG002|Open-label Induction Phase|Reason not Specified|0|||
164277694|NCT02611817|593387734|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
164277695|NCT02611817|593387735|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
164277696|NCT02611817|593387736|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
164277697|NCT02611817|593387734|FG000|Open-label Induction Phase|Pregnancy|1|||
164277698|NCT02611817|593387735|FG001|Open-label Induction Phase|Pregnancy|0|||
164277699|NCT02611817|593387736|FG002|Open-label Induction Phase|Pregnancy|0|||
164277700|NCT02611817|593387734|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
164277701|NCT02611817|593387735|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
164277702|NCT02611817|593387736|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
164277703|NCT02611817|593387734|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
164277704|NCT02611817|593387735|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
164277705|NCT02611817|593387736|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
164277706|NCT02611817|593387734|FG000|Open-label Induction Phase|Protocol Violation|5|||
164277707|NCT02611817|593387735|FG001|Open-label Induction Phase|Protocol Violation|0|||
164277708|NCT02611817|593387736|FG002|Open-label Induction Phase|Protocol Violation|0|||
164277709|NCT02611817|593387734|FG000|Open-label Induction Phase|Adverse Event|16|||
164277710|NCT02611817|593387735|FG001|Open-label Induction Phase|Adverse Event|0|||
164277711|NCT02611817|593387736|FG002|Open-label Induction Phase|Adverse Event|0|||
164432350|NCT01080131|593952846|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
164432351|NCT01080131|593952847|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
164277712|NCT02611817|593387734|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
164432352|NCT01080131|593952846|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
164432353|NCT01080131|593952847|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
164432354|NCT01080131|593952846|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
164277713|NCT02611817|593387735|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
164277714|NCT02611817|593387736|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
164277715|NCT02611817|593387734|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
164277716|NCT02611817|593387735|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
164277717|NCT02611817|593387736|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
164277718|NCT02611817|593387734|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
164277719|NCT02611817|593387735|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
164277720|NCT02611817|593387736|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
164277721|NCT02611817|593387734|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
164277722|NCT02611817|593387735|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
164277723|NCT02611817|593387736|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
164277724|NCT02611817|593387734|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
164277725|NCT02611817|593387735|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
164277726|NCT02611817|593387736|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
164277727|NCT02611817|593387734|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
164277728|NCT02611817|593387735|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
164277729|NCT02611817|593387736|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
164277730|NCT02611817|593387734|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
164277731|NCT02611817|593387735|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
164277732|NCT02611817|593387736|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
164277733|NCT02475278|593387744|FG000|Overall Study|Lost to Follow-up|1|||
164277734|NCT02475278|593387744|FG000|Overall Study|Reason Not Specified|1|||
164277735|NCT03712787|593387745|FG000|Overall Study|Adverse Event|2|||
164277736|NCT03712787|593387746|FG001|Overall Study|Adverse Event|3|||
164277737|NCT03712787|593387747|FG002|Overall Study|Adverse Event|0|||
164277738|NCT03712787|593387748|FG003|Overall Study|Adverse Event|4|||
164277739|NCT03712787|593387745|FG000|Overall Study|Withdrawal by Subject|4|||
164277740|NCT03712787|593387746|FG001|Overall Study|Withdrawal by Subject|14|||
164277741|NCT03712787|593387747|FG002|Overall Study|Withdrawal by Subject|12|||
164277742|NCT03712787|593387748|FG003|Overall Study|Withdrawal by Subject|8|||
164277743|NCT03712787|593387745|FG000|Overall Study|Lost to Follow-up|1|||
164277744|NCT03712787|593387746|FG001|Overall Study|Lost to Follow-up|1|||
164277745|NCT03712787|593387747|FG002|Overall Study|Lost to Follow-up|2|||
164277746|NCT03712787|593387748|FG003|Overall Study|Lost to Follow-up|1|||
164277747|NCT03712787|593387745|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
164432355|NCT01080131|593952847|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
164432356|NCT01080131|593952846|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
164277748|NCT03712787|593387746|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
164277749|NCT03712787|593387747|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
164277750|NCT03712787|593387748|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
164277751|NCT03712787|593387745|FG000|Overall Study|COVID-19 Infection|0|||
164277752|NCT03712787|593387746|FG001|Overall Study|COVID-19 Infection|1|||
164432357|NCT01080131|593952847|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
164432358|NCT01080131|593952846|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
164432359|NCT01080131|593952847|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
164432360|NCT01080131|593952846|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
164432361|NCT01080131|593952847|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
164432362|NCT02449044|593952848|FG000|Overall Study|Lost to Follow-up|2|||
164432363|NCT02449044|593952848|FG000|Overall Study|Withdrawal by Subject|13|||
164432364|NCT02449044|593952848|FG000|Overall Study|Adverse Event|30|||
164432365|NCT02449044|593952848|FG000|Overall Study|Met Withdrawal Criteria|7|||
164432366|NCT02449044|593952848|FG000|Overall Study|Physician Decision|9|||
164432367|NCT02449044|593952848|FG000|Overall Study|Sponsor Discontinued Trial|3|||
164432368|NCT04057196|593954591|FG000|Overall Study|Withdrawal by Subject|3|||
164432369|NCT04057196|593954591|FG000|Overall Study|Death|3|||
164432370|NCT00739102|593954592|FG000|Overall Study|Death|5|||
164432371|NCT00739102|593954592|FG000|Overall Study|Withdrawal by Subject|10|||
164432372|NCT00149630|593954593|FG000|Overall Study|Incarceration|2|||
164432373|NCT00149630|593954594|FG001|Overall Study|Incarceration|0|||
164432374|NCT00149630|593954593|FG000|Overall Study|Treatment Programs|4|||
164432375|NCT00149630|593954594|FG001|Overall Study|Treatment Programs|5|||
164432376|NCT00149630|593954593|FG000|Overall Study|Adverse Event|2|||
164432377|NCT00149630|593954594|FG001|Overall Study|Adverse Event|0|||
164432378|NCT05298111|593954598|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
164432379|NCT05298111|593954599|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
164432380|NCT02001623|593954606|FG000|Overall Study|Disease Progression|2|||
164432381|NCT02001623|593954607|FG001|Overall Study|Disease Progression|2|||
164432382|NCT02001623|593954608|FG002|Overall Study|Disease Progression|3|||
164432383|NCT02001623|593954609|FG003|Overall Study|Disease Progression|2|||
164432384|NCT02001623|593954610|FG004|Overall Study|Disease Progression|3|||
164432385|NCT02001623|593954611|FG005|Overall Study|Disease Progression|2|||
164432386|NCT02001623|593954612|FG006|Overall Study|Disease Progression|3|||
164432387|NCT02001623|593954613|FG007|Overall Study|Disease Progression|3|||
164432388|NCT02001623|593954614|FG008|Overall Study|Disease Progression|7|||
164277753|NCT03712787|593387747|FG002|Overall Study|COVID-19 Infection|0|||
164277754|NCT03712787|593387748|FG003|Overall Study|COVID-19 Infection|0|||
164277755|NCT03712787|593387745|FG000|Overall Study|Other, Not Specified|79|||
164277756|NCT03712787|593387746|FG001|Overall Study|Other, Not Specified|77|||
164432389|NCT02001623|593954615|FG009|Overall Study|Disease Progression|40|||
164432390|NCT02001623|593954616|FG010|Overall Study|Disease Progression|5|||
164432391|NCT02001623|593954617|FG011|Overall Study|Disease Progression|9|||
164432392|NCT02001623|593954618|FG012|Overall Study|Disease Progression|9|||
164432393|NCT02001623|593954619|FG013|Overall Study|Disease Progression|20|||
164432394|NCT02001623|593954620|FG014|Overall Study|Disease Progression|9|||
164432395|NCT02001623|593954606|FG000|Overall Study|Physician Decision|0|||
164432396|NCT02001623|593954607|FG001|Overall Study|Physician Decision|0|||
164432397|NCT02001623|593954608|FG002|Overall Study|Physician Decision|0|||
164432398|NCT02001623|593954609|FG003|Overall Study|Physician Decision|0|||
164432399|NCT02001623|593954610|FG004|Overall Study|Physician Decision|0|||
164432400|NCT02001623|593954611|FG005|Overall Study|Physician Decision|0|||
164432401|NCT02001623|593954612|FG006|Overall Study|Physician Decision|0|||
164432402|NCT02001623|593954613|FG007|Overall Study|Physician Decision|0|||
164432403|NCT02001623|593954614|FG008|Overall Study|Physician Decision|3|||
164432404|NCT02001623|593954615|FG009|Overall Study|Physician Decision|2|||
164432405|NCT02001623|593954616|FG010|Overall Study|Physician Decision|3|||
164432406|NCT02001623|593954617|FG011|Overall Study|Physician Decision|3|||
164432407|NCT02001623|593954618|FG012|Overall Study|Physician Decision|1|||
164432408|NCT02001623|593954619|FG013|Overall Study|Physician Decision|2|||
164432409|NCT02001623|593954620|FG014|Overall Study|Physician Decision|1|||
164432410|NCT02001623|593954606|FG000|Overall Study|Death|0|||
164432411|NCT02001623|593954607|FG001|Overall Study|Death|1|||
164432412|NCT02001623|593954608|FG002|Overall Study|Death|0|||
164432413|NCT02001623|593954609|FG003|Overall Study|Death|0|||
164432414|NCT02001623|593954610|FG004|Overall Study|Death|0|||
164432415|NCT02001623|593954611|FG005|Overall Study|Death|0|||
164432416|NCT02001623|593954612|FG006|Overall Study|Death|0|||
164432417|NCT02001623|593954613|FG007|Overall Study|Death|0|||
164432418|NCT02001623|593954614|FG008|Overall Study|Death|0|||
164432419|NCT02001623|593954615|FG009|Overall Study|Death|0|||
164432420|NCT02001623|593954616|FG010|Overall Study|Death|0|||
164432421|NCT02001623|593954617|FG011|Overall Study|Death|0|||
164432422|NCT02001623|593954618|FG012|Overall Study|Death|0|||
164432423|NCT02001623|593954619|FG013|Overall Study|Death|0|||
164432424|NCT02001623|593954620|FG014|Overall Study|Death|0|||
164432425|NCT02001623|593954606|FG000|Overall Study|Adverse Event|0|||
164432426|NCT02001623|593954607|FG001|Overall Study|Adverse Event|0|||
164432427|NCT02001623|593954608|FG002|Overall Study|Adverse Event|0|||
164432428|NCT02001623|593954609|FG003|Overall Study|Adverse Event|0|||
164432429|NCT02001623|593954610|FG004|Overall Study|Adverse Event|0|||
164432430|NCT02001623|593954611|FG005|Overall Study|Adverse Event|1|||
164432431|NCT02001623|593954612|FG006|Overall Study|Adverse Event|0|||
164432432|NCT02001623|593954613|FG007|Overall Study|Adverse Event|3|||
164432433|NCT02001623|593954614|FG008|Overall Study|Adverse Event|4|||
164432434|NCT02001623|593954615|FG009|Overall Study|Adverse Event|6|||
164432435|NCT02001623|593954616|FG010|Overall Study|Adverse Event|4|||
164432436|NCT02001623|593954617|FG011|Overall Study|Adverse Event|0|||
164432437|NCT02001623|593954618|FG012|Overall Study|Adverse Event|3|||
164432438|NCT02001623|593954619|FG013|Overall Study|Adverse Event|5|||
164432439|NCT02001623|593954620|FG014|Overall Study|Adverse Event|6|||
164432440|NCT02001623|593954606|FG000|Overall Study|Other - Miscellaneous|0|||
164432441|NCT02001623|593954607|FG001|Overall Study|Other - Miscellaneous|0|||
164432442|NCT02001623|593954608|FG002|Overall Study|Other - Miscellaneous|0|||
164432443|NCT02001623|593954609|FG003|Overall Study|Other - Miscellaneous|0|||
164432444|NCT02001623|593954610|FG004|Overall Study|Other - Miscellaneous|0|||
164432445|NCT02001623|593954611|FG005|Overall Study|Other - Miscellaneous|0|||
164432446|NCT02001623|593954612|FG006|Overall Study|Other - Miscellaneous|0|||
164432447|NCT02001623|593954613|FG007|Overall Study|Other - Miscellaneous|0|||
164432448|NCT02001623|593954614|FG008|Overall Study|Other - Miscellaneous|0|||
164432449|NCT02001623|593954615|FG009|Overall Study|Other - Miscellaneous|1|||
164432450|NCT02001623|593954616|FG010|Overall Study|Other - Miscellaneous|0|||
164432451|NCT02001623|593954617|FG011|Overall Study|Other - Miscellaneous|0|||
164432452|NCT02001623|593954618|FG012|Overall Study|Other - Miscellaneous|0|||
164432453|NCT02001623|593954619|FG013|Overall Study|Other - Miscellaneous|1|||
164432454|NCT02001623|593954620|FG014|Overall Study|Other - Miscellaneous|0|||
164432455|NCT02001623|593954606|FG000|Overall Study|Withdrawal by Subject|1|||
164432456|NCT02001623|593954607|FG001|Overall Study|Withdrawal by Subject|0|||
164432457|NCT02001623|593954608|FG002|Overall Study|Withdrawal by Subject|0|||
164432458|NCT02001623|593954609|FG003|Overall Study|Withdrawal by Subject|0|||
164432459|NCT02001623|593954610|FG004|Overall Study|Withdrawal by Subject|0|||
164432460|NCT02001623|593954611|FG005|Overall Study|Withdrawal by Subject|0|||
164432461|NCT02001623|593954612|FG006|Overall Study|Withdrawal by Subject|0|||
164432462|NCT02001623|593954613|FG007|Overall Study|Withdrawal by Subject|0|||
164432463|NCT02001623|593954614|FG008|Overall Study|Withdrawal by Subject|1|||
164432464|NCT02001623|593954615|FG009|Overall Study|Withdrawal by Subject|3|||
164432465|NCT02001623|593954616|FG010|Overall Study|Withdrawal by Subject|2|||
164432466|NCT02001623|593954617|FG011|Overall Study|Withdrawal by Subject|2|||
164432467|NCT02001623|593954618|FG012|Overall Study|Withdrawal by Subject|1|||
164432468|NCT02001623|593954619|FG013|Overall Study|Withdrawal by Subject|5|||
164432469|NCT02001623|593954620|FG014|Overall Study|Withdrawal by Subject|2|||
164432470|NCT02001623|593954606|FG000|Overall Study|Lost to Follow-up|0|||
164432471|NCT02001623|593954607|FG001|Overall Study|Lost to Follow-up|0|||
164432472|NCT02001623|593954608|FG002|Overall Study|Lost to Follow-up|0|||
164432473|NCT02001623|593954609|FG003|Overall Study|Lost to Follow-up|0|||
164432474|NCT02001623|593954610|FG004|Overall Study|Lost to Follow-up|0|||
164277757|NCT03712787|593387747|FG002|Overall Study|Other, Not Specified|74|||
164277758|NCT03712787|593387748|FG003|Overall Study|Other, Not Specified|78|||
164277759|NCT01865448|593387749|FG000|Overall Study|Adverse Event|1|||
164277760|NCT01865448|593387750|FG001|Overall Study|Adverse Event|1|||
164277761|NCT01865448|593387749|FG000|Overall Study|Pregnancy|0|||
164277762|NCT01865448|593387750|FG001|Overall Study|Pregnancy|1|||
164277763|NCT01865448|593387749|FG000|Overall Study|dropout unrelated to study|1|||
164277764|NCT01865448|593387750|FG001|Overall Study|dropout unrelated to study|1|||
164277765|NCT03499314|593387751|FG000|Overall Study|Time Commitment|1|||
164277766|NCT03499314|593387752|FG001|Overall Study|Time Commitment|2|||
164277767|NCT03499314|593387751|FG000|Overall Study|Medical issue unrelated to research study|1|||
164277768|NCT03499314|593387752|FG001|Overall Study|Medical issue unrelated to research study|1|||
164277769|NCT01618695|593387753|FG000|Core Phase|Adverse Event|4|||
164277770|NCT01618695|593387754|FG001|Core Phase|Adverse Event|5|||
164277771|NCT01618695|593387755|FG002|Core Phase|Adverse Event|15|||
164277772|NCT01618695|593387756|FG003|Core Phase|Adverse Event|20|||
164277773|NCT01618695|593387753|FG000|Core Phase|Lost to Follow-up|0|||
164584322|NCT00611455|594504633|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164584323|NCT00611455|594504631|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
164584324|NCT00611455|594504632|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
164584325|NCT00611455|594504633|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
164584326|NCT00611455|594504631|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
164277774|NCT01618695|593387754|FG001|Core Phase|Lost to Follow-up|0|||
164277775|NCT01618695|593387755|FG002|Core Phase|Lost to Follow-up|1|||
164277776|NCT01618695|593387756|FG003|Core Phase|Lost to Follow-up|0|||
164277777|NCT01618695|593387753|FG000|Core Phase|Withdrawal by Subject|16|||
164277778|NCT01618695|593387754|FG001|Core Phase|Withdrawal by Subject|11|||
164277779|NCT01618695|593387755|FG002|Core Phase|Withdrawal by Subject|9|||
164277780|NCT01618695|593387756|FG003|Core Phase|Withdrawal by Subject|13|||
164277781|NCT01618695|593387753|FG000|Core Phase|Pregnancy|2|||
164277782|NCT01618695|593387754|FG001|Core Phase|Pregnancy|0|||
164277783|NCT01618695|593387755|FG002|Core Phase|Pregnancy|0|||
164277784|NCT01618695|593387756|FG003|Core Phase|Pregnancy|0|||
164277785|NCT01618695|593387753|FG000|Core Phase|Lack of Efficacy|1|||
164277786|NCT01618695|593387754|FG001|Core Phase|Lack of Efficacy|2|||
164277787|NCT01618695|593387755|FG002|Core Phase|Lack of Efficacy|1|||
164277788|NCT01618695|593387756|FG003|Core Phase|Lack of Efficacy|1|||
164277789|NCT01618695|593387753|FG000|Core Phase|Other than specified|1|||
164277790|NCT01618695|593387754|FG001|Core Phase|Other than specified|2|||
164277791|NCT01618695|593387755|FG002|Core Phase|Other than specified|2|||
164277792|NCT01618695|593387756|FG003|Core Phase|Other than specified|2|||
164277793|NCT01618695|593387753|FG000|Core Phase|Not treated|1|||
164277794|NCT01618695|593387754|FG001|Core Phase|Not treated|0|||
164277795|NCT01618695|593387755|FG002|Core Phase|Not treated|2|||
164277796|NCT01618695|593387756|FG003|Core Phase|Not treated|0|||
164277797|NCT01618695|593387753|FG000|Extension Phase|Lack of Efficacy|17|||
164277798|NCT01618695|593387754|FG001|Extension Phase|Lack of Efficacy|33|||
164277799|NCT01618695|593387755|FG002|Extension Phase|Lack of Efficacy|26|||
164277800|NCT01618695|593387756|FG003|Extension Phase|Lack of Efficacy|24|||
164277801|NCT01618695|593387753|FG000|Extension Phase|Pregnancy|2|||
164277802|NCT01618695|593387754|FG001|Extension Phase|Pregnancy|0|||
164277803|NCT01618695|593387755|FG002|Extension Phase|Pregnancy|1|||
164277804|NCT01618695|593387756|FG003|Extension Phase|Pregnancy|1|||
164277805|NCT01618695|593387753|FG000|Extension Phase|Withdrawal by Subject|43|||
164277806|NCT01618695|593387754|FG001|Extension Phase|Withdrawal by Subject|48|||
164277807|NCT01618695|593387755|FG002|Extension Phase|Withdrawal by Subject|42|||
164277808|NCT01618695|593387756|FG003|Extension Phase|Withdrawal by Subject|33|||
164277809|NCT01618695|593387753|FG000|Extension Phase|Adverse Event|18|||
164277810|NCT01618695|593387754|FG001|Extension Phase|Adverse Event|16|||
164277811|NCT01618695|593387755|FG002|Extension Phase|Adverse Event|9|||
164277812|NCT01618695|593387756|FG003|Extension Phase|Adverse Event|20|||
164277813|NCT01618695|593387753|FG000|Extension Phase|Lost to Follow-up|2|||
164277814|NCT01618695|593387754|FG001|Extension Phase|Lost to Follow-up|1|||
164584327|NCT00611455|594504632|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
164584328|NCT00611455|594504633|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
164584329|NCT00611455|594504631|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
164277815|NCT01618695|593387755|FG002|Extension Phase|Lost to Follow-up|1|||
164277816|NCT01618695|593387756|FG003|Extension Phase|Lost to Follow-up|1|||
164277817|NCT01618695|593387753|FG000|Extension Phase|Other than specified|13|||
164277818|NCT01618695|593387754|FG001|Extension Phase|Other than specified|18|||
164277819|NCT01618695|593387755|FG002|Extension Phase|Other than specified|13|||
164277820|NCT01618695|593387756|FG003|Extension Phase|Other than specified|18|||
164277821|NCT01016600|593387760|FG000|Overall Study|Did not start treatment|1|||
164277822|NCT01016600|593387761|FG001|Overall Study|Did not start treatment|0|||
164277823|NCT01016600|593387762|FG002|Overall Study|Did not start treatment|0|||
164277824|NCT01016600|593387763|FG003|Overall Study|Did not start treatment|0|||
164277825|NCT04794270|593387764|FG000|Period 1|Non Compliance|1|||
164277826|NCT04794270|593387765|FG001|Period 1|Non Compliance|0|||
164277827|NCT04794270|593387764|FG000|Period 1|Adverse Event|1|||
164689680|NCT00965757|594887776|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
164689681|NCT00965757|594887777|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
164689682|NCT00965757|594887774|FG000|Extension Phase|Protocol Violation|0|||
164689683|NCT00965757|594887775|FG001|Extension Phase|Protocol Violation|0|||
164689684|NCT00965757|594887776|FG002|Extension Phase|Protocol Violation|0|||
164689685|NCT00965757|594887777|FG003|Extension Phase|Protocol Violation|1|||
164689686|NCT00965757|594887774|FG000|Extension Phase|Other|0|||
164689687|NCT00965757|594887775|FG001|Extension Phase|Other|0|||
164689688|NCT00965757|594887776|FG002|Extension Phase|Other|2|||
164277828|NCT04794270|593387765|FG001|Period 1|Adverse Event|0|||
164277829|NCT04794270|593387764|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
164277830|NCT04794270|593387765|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
164277831|NCT01271725|593387767|FG000|Part A|Progressive disease according to RECIST|8|||
164689689|NCT00965757|594887777|FG003|Extension Phase|Other|1|||
164689690|NCT03807440|594887778|FG000|Overall Study|No documentation of index date 2|320|||
164689691|NCT03807440|594887778|FG000|Overall Study|No informed consent for index date 2|117|||
164689692|NCT01344018|594887779|FG000|Overall Study|Death|22|||
164689693|NCT01344018|594887780|FG001|Overall Study|Death|25|||
164689694|NCT01344018|594887779|FG000|Overall Study|Lost to Follow-up|4|||
164689695|NCT01344018|594887780|FG001|Overall Study|Lost to Follow-up|7|||
164689696|NCT04010227|594887782|FG000|Overall Study|Death|1|||
164689697|NCT04010227|594887783|FG001|Overall Study|Death|2|||
164277832|NCT01271725|593387768|FG001|Part A|Progressive disease according to RECIST|0|||
164277833|NCT01271725|593387767|FG000|Part A|Clinical signs/symptoms of progression|2|||
164277834|NCT01271725|593387768|FG001|Part A|Clinical signs/symptoms of progression|0|||
164277835|NCT01271725|593387767|FG000|Part A|Other Adverse Event|8|||
164277836|NCT01271725|593387768|FG001|Part A|Other Adverse Event|0|||
164277837|NCT01271725|593387767|FG000|Part A|Lost to Follow-up|1|||
164277838|NCT01271725|593387768|FG001|Part A|Lost to Follow-up|0|||
164277839|NCT01271725|593387767|FG000|Part A|Withdrawal by Subject|12|||
164277840|NCT01271725|593387768|FG001|Part A|Withdrawal by Subject|0|||
164277841|NCT01271725|593387767|FG000|Part A|Other than specified|3|||
164277842|NCT01271725|593387768|FG001|Part A|Other than specified|0|||
164277843|NCT01271725|593387767|FG000|Part A|Protocol Violation|1|||
164277844|NCT01271725|593387768|FG001|Part A|Protocol Violation|0|||
164277845|NCT01271725|593387767|FG000|Part B|Other than specified|0|||
164277846|NCT01271725|593387768|FG001|Part B|Other than specified|2|||
164277847|NCT01271725|593387767|FG000|Part B|Clinical signs/symptoms of progression|0|||
164277848|NCT01271725|593387768|FG001|Part B|Clinical signs/symptoms of progression|2|||
164277849|NCT01271725|593387767|FG000|Part B|Other Adverse Event|0|||
164277850|NCT01271725|593387768|FG001|Part B|Other Adverse Event|1|||
164277851|NCT01271725|593387767|FG000|Part B|Protocol Violation|0|||
164277852|NCT01271725|593387768|FG001|Part B|Protocol Violation|1|||
164277853|NCT01271725|593387767|FG000|Part B|Withdrawal by Subject|0|||
164277854|NCT01271725|593387768|FG001|Part B|Withdrawal by Subject|6|||
164277855|NCT00265317|593387771|FG000|Lead-In|Objective progression or relapse|6|||
164277856|NCT00265317|593387772|FG001|Lead-In|Objective progression or relapse|11|||
164277857|NCT00265317|593387773|FG002|Lead-In|Objective progression or relapse|0|||
164277858|NCT00265317|593387774|FG003|Lead-In|Objective progression or relapse|0|||
164277859|NCT00265317|593387771|FG000|Lead-In|Adverse Event|2|||
164277860|NCT00265317|593387772|FG001|Lead-In|Adverse Event|1|||
164277861|NCT00265317|593387773|FG002|Lead-In|Adverse Event|0|||
164277862|NCT00265317|593387774|FG003|Lead-In|Adverse Event|0|||
164277863|NCT00265317|593387771|FG000|Lead-In|Death|3|||
164277864|NCT00265317|593387772|FG001|Lead-In|Death|5|||
164277865|NCT00265317|593387773|FG002|Lead-In|Death|0|||
164277866|NCT00265317|593387774|FG003|Lead-In|Death|0|||
164277867|NCT00265317|593387771|FG000|Lead-In|Withdrawal/other than adverse event|1|||
164343689|NCT02585960|593635302|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
164343690|NCT02585960|593635303|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
164343691|NCT02585960|593635304|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
164343692|NCT02585960|593635302|FG000|PK/Safety Assessment Period|Other|4|||
164343693|NCT02585960|593635303|FG001|PK/Safety Assessment Period|Other|4|||
164343694|NCT02585960|593635304|FG002|PK/Safety Assessment Period|Other|0|||
164343695|NCT02585960|593635302|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
164343696|NCT02585960|593635303|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
164343697|NCT02585960|593635304|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
164343698|NCT02585960|593635302|FG000|PK/Safety Assessment Period|Screen Failure|0|||
164343699|NCT02585960|593635303|FG001|PK/Safety Assessment Period|Screen Failure|0|||
164343700|NCT02585960|593635304|FG002|PK/Safety Assessment Period|Screen Failure|1|||
164343701|NCT02585960|593635302|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
164343702|NCT02585960|593635303|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
164343703|NCT02585960|593635304|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
164343704|NCT02585960|593635302|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
164432475|NCT02001623|593954611|FG005|Overall Study|Lost to Follow-up|0|||
164277868|NCT00265317|593387772|FG001|Lead-In|Withdrawal/other than adverse event|0|||
164277869|NCT00265317|593387773|FG002|Lead-In|Withdrawal/other than adverse event|0|||
164277870|NCT00265317|593387774|FG003|Lead-In|Withdrawal/other than adverse event|0|||
164277871|NCT00265317|593387771|FG000|Phase 2|Objective progression or relapse|0|||
164277872|NCT00265317|593387772|FG001|Phase 2|Objective progression or relapse|0|||
164277873|NCT00265317|593387773|FG002|Phase 2|Objective progression or relapse|37|||
164277874|NCT00265317|593387774|FG003|Phase 2|Objective progression or relapse|38|||
164277875|NCT00265317|593387771|FG000|Phase 2|Global deterioration of health status|0|||
164277876|NCT00265317|593387772|FG001|Phase 2|Global deterioration of health status|0|||
164277877|NCT00265317|593387773|FG002|Phase 2|Global deterioration of health status|3|||
164277878|NCT00265317|593387774|FG003|Phase 2|Global deterioration of health status|0|||
164277879|NCT00265317|593387771|FG000|Phase 2|Adverse Event|0|||
164277880|NCT00265317|593387772|FG001|Phase 2|Adverse Event|0|||
164277881|NCT00265317|593387773|FG002|Phase 2|Adverse Event|7|||
164277882|NCT00265317|593387774|FG003|Phase 2|Adverse Event|5|||
164277883|NCT00265317|593387771|FG000|Phase 2|Death|0|||
164277884|NCT00265317|593387772|FG001|Phase 2|Death|0|||
164277885|NCT00265317|593387773|FG002|Phase 2|Death|12|||
164277886|NCT00265317|593387774|FG003|Phase 2|Death|15|||
164277887|NCT00265317|593387771|FG000|Phase 2|Protocol Violation|0|||
164277888|NCT00265317|593387772|FG001|Phase 2|Protocol Violation|0|||
164277889|NCT00265317|593387773|FG002|Phase 2|Protocol Violation|1|||
164277890|NCT00265317|593387774|FG003|Phase 2|Protocol Violation|4|||
164277891|NCT00265317|593387771|FG000|Phase 2|Lost to Follow-up|0|||
164277892|NCT00265317|593387772|FG001|Phase 2|Lost to Follow-up|0|||
164277893|NCT00265317|593387773|FG002|Phase 2|Lost to Follow-up|0|||
164277894|NCT00265317|593387774|FG003|Phase 2|Lost to Follow-up|1|||
164277895|NCT00265317|593387771|FG000|Phase 2|Withdrawal/other than adverse event|0|||
164277896|NCT00265317|593387772|FG001|Phase 2|Withdrawal/other than adverse event|0|||
164277897|NCT00265317|593387773|FG002|Phase 2|Withdrawal/other than adverse event|2|||
164277898|NCT00265317|593387774|FG003|Phase 2|Withdrawal/other than adverse event|1|||
164277899|NCT00265317|593387771|FG000|Phase 2|Study terminated by sponsor|0|||
164277900|NCT00265317|593387772|FG001|Phase 2|Study terminated by sponsor|0|||
164277901|NCT00265317|593387773|FG002|Phase 2|Study terminated by sponsor|1|||
164277902|NCT00265317|593387774|FG003|Phase 2|Study terminated by sponsor|0|||
164277903|NCT00265317|593387771|FG000|Phase 2|Other|0|||
164277904|NCT00265317|593387772|FG001|Phase 2|Other|0|||
164277905|NCT00265317|593387773|FG002|Phase 2|Other|1|||
164277906|NCT00265317|593387774|FG003|Phase 2|Other|1|||
164277907|NCT00732875|593387777|FG000|Overall Study|Adverse Event|16|||
164277908|NCT00732875|593387777|FG000|Overall Study|Withdrawal by Subject|6|||
164277909|NCT00732875|593387777|FG000|Overall Study|Lack of Efficacy|13|||
164277910|NCT03826186|593387778|FG000|Overall Study|Protocol Violation|2|||
164277911|NCT03826186|593387779|FG001|Overall Study|Protocol Violation|0|||
164277912|NCT03826186|593387778|FG000|Overall Study|Withdrawal by Subject|1|||
164277913|NCT03826186|593387779|FG001|Overall Study|Withdrawal by Subject|0|||
164277914|NCT02300259|593387780|FG000|Period 1|Adverse Event|0|||
164277915|NCT02300259|593387781|FG001|Period 1|Adverse Event|0|||
164277916|NCT02300259|593387782|FG002|Period 1|Adverse Event|1|||
164277917|NCT02300259|593387780|FG000|Period 1|Withdrawal by Subject|0|||
164277918|NCT02300259|593387781|FG001|Period 1|Withdrawal by Subject|0|||
164277919|NCT02300259|593387782|FG002|Period 1|Withdrawal by Subject|1|||
164277920|NCT02300259|593387780|FG000|Period 2|Adverse Event|1|||
164277921|NCT02300259|593387781|FG001|Period 2|Adverse Event|0|||
164277922|NCT02300259|593387782|FG002|Period 2|Adverse Event|0|||
164277923|NCT02300259|593387780|FG000|Period 2|Withdrawal by Subject|0|||
164277924|NCT02300259|593387781|FG001|Period 2|Withdrawal by Subject|0|||
164277925|NCT02300259|593387782|FG002|Period 2|Withdrawal by Subject|1|||
164277926|NCT02737475|593387783|FG000|Overall Study|Other reasons|0|||
164277927|NCT02737475|593387784|FG001|Overall Study|Other reasons|0|||
164277928|NCT02737475|593387785|FG002|Overall Study|Other reasons|0|||
164277929|NCT02737475|593387786|FG003|Overall Study|Other reasons|0|||
164277930|NCT02737475|593387787|FG004|Overall Study|Other reasons|1|||
164277931|NCT02737475|593387788|FG005|Overall Study|Other reasons|1|||
164277932|NCT02737475|593387789|FG006|Overall Study|Other reasons|0|||
164277933|NCT02737475|593387790|FG007|Overall Study|Other reasons|0|||
164343705|NCT02585960|593635303|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
164343706|NCT02585960|593635304|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
164277934|NCT02737475|593387791|FG008|Overall Study|Other reasons|1|||
164277935|NCT02737475|593387792|FG009|Overall Study|Other reasons|0|||
164277936|NCT02737475|593387793|FG010|Overall Study|Other reasons|1|||
164277937|NCT02737475|593387794|FG011|Overall Study|Other reasons|0|||
164277938|NCT02737475|593387795|FG012|Overall Study|Other reasons|0|||
164277939|NCT02737475|593387796|FG013|Overall Study|Other reasons|0|||
164277940|NCT02737475|593387797|FG014|Overall Study|Other reasons|0|||
164277941|NCT02737475|593387798|FG015|Overall Study|Other reasons|0|||
164277942|NCT02737475|593387799|FG016|Overall Study|Other reasons|0|||
164343707|NCT06333613|593635306|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
164277943|NCT02737475|593387800|FG017|Overall Study|Other reasons|0|||
164277944|NCT02737475|593387801|FG018|Overall Study|Other reasons|0|||
164277945|NCT02737475|593387802|FG019|Overall Study|Other reasons|0|||
164277946|NCT02737475|593387803|FG020|Overall Study|Other reasons|0|||
164432476|NCT02001623|593954612|FG006|Overall Study|Lost to Follow-up|0|||
164432477|NCT02001623|593954613|FG007|Overall Study|Lost to Follow-up|0|||
164432478|NCT02001623|593954614|FG008|Overall Study|Lost to Follow-up|0|||
164432479|NCT02001623|593954615|FG009|Overall Study|Lost to Follow-up|1|||
164432480|NCT02001623|593954616|FG010|Overall Study|Lost to Follow-up|0|||
164432481|NCT02001623|593954617|FG011|Overall Study|Lost to Follow-up|0|||
164432482|NCT02001623|593954618|FG012|Overall Study|Lost to Follow-up|0|||
164432483|NCT02001623|593954619|FG013|Overall Study|Lost to Follow-up|0|||
164432484|NCT02001623|593954620|FG014|Overall Study|Lost to Follow-up|0|||
164432485|NCT02001623|593954606|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
164432486|NCT02001623|593954607|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
164432487|NCT02001623|593954608|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
164432488|NCT02001623|593954609|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
164432489|NCT02001623|593954610|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
164432490|NCT02001623|593954611|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
164432491|NCT02001623|593954612|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
164432492|NCT02001623|593954613|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
164432493|NCT02001623|593954614|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
164432494|NCT02001623|593954615|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
164432495|NCT02001623|593954616|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
164432496|NCT02001623|593954617|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
164432497|NCT02001623|593954618|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
164432498|NCT02001623|593954619|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
164432499|NCT02001623|593954620|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
164432500|NCT02001623|593954606|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
164432501|NCT02001623|593954607|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
164432502|NCT02001623|593954608|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
164432503|NCT02001623|593954609|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
164432504|NCT02001623|593954610|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
164432505|NCT02001623|593954611|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
164432506|NCT02001623|593954612|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
164432507|NCT02001623|593954613|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
164432508|NCT02001623|593954614|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
164432509|NCT02001623|593954615|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
164432510|NCT02001623|593954616|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
164432511|NCT02001623|593954617|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
164432512|NCT02001623|593954618|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
164432513|NCT02001623|593954619|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
164432514|NCT02001623|593954620|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
164432515|NCT00109967|593954623|FG000|Overall Study|Cancel Prior to Treatment|2|||
164689698|NCT04010227|594887782|FG000|Overall Study|Medical Reasons|4|||
164689699|NCT04010227|594887783|FG001|Overall Study|Medical Reasons|3|||
164689700|NCT04010227|594887782|FG000|Overall Study|Withdrawal by Subject|2|||
164689701|NCT04010227|594887783|FG001|Overall Study|Withdrawal by Subject|0|||
164689702|NCT04010227|594887782|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
164689703|NCT04010227|594887783|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
164689704|NCT01332968|594887784|FG000|Induction Period|Adverse Event|23|||
164277947|NCT02737475|593387804|FG021|Overall Study|Other reasons|1|||
164277948|NCT02737475|593387805|FG022|Overall Study|Other reasons|0|||
164277949|NCT02737475|593387806|FG023|Overall Study|Other reasons|1|||
164277950|NCT02737475|593387807|FG024|Overall Study|Other reasons|1|||
164277951|NCT02737475|593387808|FG025|Overall Study|Other reasons|1|||
164277952|NCT02737475|593387809|FG026|Overall Study|Other reasons|0|||
164277953|NCT02737475|593387783|FG000|Overall Study|Death|1|||
164689705|NCT01332968|594887785|FG001|Induction Period|Adverse Event|26|||
164689706|NCT01332968|594887786|FG002|Induction Period|Adverse Event|0|||
164277954|NCT02737475|593387784|FG001|Overall Study|Death|0|||
164277955|NCT02737475|593387785|FG002|Overall Study|Death|0|||
164277956|NCT02737475|593387786|FG003|Overall Study|Death|1|||
164277957|NCT02737475|593387787|FG004|Overall Study|Death|0|||
164277958|NCT02737475|593387788|FG005|Overall Study|Death|0|||
164277959|NCT02737475|593387789|FG006|Overall Study|Death|0|||
164277960|NCT02737475|593387790|FG007|Overall Study|Death|2|||
164277961|NCT02737475|593387791|FG008|Overall Study|Death|0|||
164277962|NCT02737475|593387792|FG009|Overall Study|Death|0|||
164277963|NCT02737475|593387793|FG010|Overall Study|Death|0|||
164277964|NCT02737475|593387794|FG011|Overall Study|Death|4|||
164277965|NCT02737475|593387795|FG012|Overall Study|Death|2|||
164277966|NCT02737475|593387796|FG013|Overall Study|Death|2|||
164277967|NCT02737475|593387797|FG014|Overall Study|Death|0|||
164277968|NCT02737475|593387798|FG015|Overall Study|Death|2|||
164277969|NCT02737475|593387799|FG016|Overall Study|Death|2|||
164277970|NCT02737475|593387800|FG017|Overall Study|Death|2|||
164277971|NCT02737475|593387801|FG018|Overall Study|Death|1|||
164277972|NCT02737475|593387802|FG019|Overall Study|Death|0|||
164277973|NCT02737475|593387803|FG020|Overall Study|Death|0|||
164277974|NCT02737475|593387804|FG021|Overall Study|Death|0|||
164277975|NCT02737475|593387805|FG022|Overall Study|Death|0|||
164689707|NCT01332968|594887787|FG003|Induction Period|Adverse Event|0|||
164689708|NCT01332968|594887788|FG004|Induction Period|Adverse Event|0|||
164689709|NCT01332968|594887789|FG005|Induction Period|Adverse Event|0|||
164689710|NCT01332968|594887790|FG006|Induction Period|Adverse Event|0|||
164689711|NCT01332968|594887791|FG007|Induction Period|Adverse Event|0|||
164689712|NCT01332968|594887784|FG000|Induction Period|Death|1|||
164689713|NCT01332968|594887785|FG001|Induction Period|Death|4|||
164277976|NCT02737475|593387806|FG023|Overall Study|Death|0|||
164277977|NCT02737475|593387807|FG024|Overall Study|Death|0|||
164277978|NCT02737475|593387808|FG025|Overall Study|Death|0|||
164277979|NCT02737475|593387809|FG026|Overall Study|Death|0|||
164277980|NCT02737475|593387783|FG000|Overall Study|Participant withdrew consent|0|||
164277981|NCT02737475|593387784|FG001|Overall Study|Participant withdrew consent|0|||
164277982|NCT02737475|593387785|FG002|Overall Study|Participant withdrew consent|0|||
164277983|NCT02737475|593387786|FG003|Overall Study|Participant withdrew consent|0|||
164277984|NCT02737475|593387787|FG004|Overall Study|Participant withdrew consent|0|||
164277985|NCT02737475|593387788|FG005|Overall Study|Participant withdrew consent|2|||
164277986|NCT02737475|593387789|FG006|Overall Study|Participant withdrew consent|0|||
164277987|NCT02737475|593387790|FG007|Overall Study|Participant withdrew consent|0|||
164277988|NCT02737475|593387791|FG008|Overall Study|Participant withdrew consent|0|||
164277989|NCT02737475|593387792|FG009|Overall Study|Participant withdrew consent|0|||
164277990|NCT02737475|593387793|FG010|Overall Study|Participant withdrew consent|0|||
164277991|NCT02737475|593387794|FG011|Overall Study|Participant withdrew consent|0|||
164277992|NCT02737475|593387795|FG012|Overall Study|Participant withdrew consent|0|||
164277993|NCT02737475|593387796|FG013|Overall Study|Participant withdrew consent|0|||
164343708|NCT01847274|593635307|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
164343709|NCT01847274|593635308|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
164343710|NCT01847274|593635309|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
164343711|NCT01847274|593635310|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
164343712|NCT01847274|593635311|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
164343713|NCT01847274|593635312|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
164343714|NCT01847274|593635313|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
164432516|NCT00109967|593954624|FG001|Overall Study|Cancel Prior to Treatment|0|||
164432517|NCT00109967|593954623|FG000|Overall Study|Adverse Event|12|||
164432518|NCT00109967|593954624|FG001|Overall Study|Adverse Event|1|||
164432519|NCT00109967|593954623|FG000|Overall Study|Withdrawal by Subject|5|||
164432520|NCT00109967|593954624|FG001|Overall Study|Withdrawal by Subject|0|||
164432521|NCT00109967|593954623|FG000|Overall Study|Physician Decision|1|||
164432522|NCT00109967|593954624|FG001|Overall Study|Physician Decision|3|||
164432523|NCT00109967|593954623|FG000|Overall Study|Death|0|||
164432524|NCT00109967|593954624|FG001|Overall Study|Death|2|||
164432525|NCT01117480|593954626|FG000|Overall Study|Protocol Violation|8|||
164432526|NCT01117480|593954626|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
164432527|NCT02955069|593954627|FG000|Overall Study|Adverse Event|7|||
164432528|NCT02955069|593954628|FG001|Overall Study|Adverse Event|2|||
164432529|NCT02955069|593954627|FG000|Overall Study|Death|7|||
164432530|NCT02955069|593954628|FG001|Overall Study|Death|3|||
164432531|NCT02955069|593954627|FG000|Overall Study|Physician Decision|10|||
164432532|NCT02955069|593954628|FG001|Overall Study|Physician Decision|2|||
164432533|NCT02955069|593954627|FG000|Overall Study|Progressive disease|64|||
164432534|NCT02955069|593954628|FG001|Overall Study|Progressive disease|13|||
164432535|NCT02955069|593954627|FG000|Overall Study|Study terminated by sponsor|4|||
164689714|NCT01332968|594887786|FG002|Induction Period|Death|0|||
164343715|NCT01847274|593635314|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
164343716|NCT01847274|593635315|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
164343717|NCT01847274|593635316|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
164343718|NCT01847274|593635317|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
164343719|NCT01847274|593635307|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
164343720|NCT01847274|593635308|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
164343721|NCT01847274|593635309|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
164343722|NCT01847274|593635310|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
164432536|NCT02955069|593954628|FG001|Overall Study|Study terminated by sponsor|0|||
164432537|NCT02955069|593954627|FG000|Overall Study|Subject/Guardian decision|3|||
164432538|NCT02955069|593954628|FG001|Overall Study|Subject/Guardian decision|1|||
164432539|NCT04083976|593954629|FG000|Overall Study|Lost to Follow-up|3|||
164689715|NCT01332968|594887787|FG003|Induction Period|Death|0|||
164689716|NCT01332968|594887788|FG004|Induction Period|Death|0|||
164277994|NCT02737475|593387797|FG014|Overall Study|Participant withdrew consent|1|||
164277995|NCT02737475|593387798|FG015|Overall Study|Participant withdrew consent|0|||
164277996|NCT02737475|593387799|FG016|Overall Study|Participant withdrew consent|0|||
164432540|NCT04083976|593954630|FG001|Overall Study|Lost to Follow-up|0|||
164432541|NCT04083976|593954631|FG002|Overall Study|Lost to Follow-up|0|||
164432542|NCT04083976|593954632|FG003|Overall Study|Lost to Follow-up|1|||
164277997|NCT02737475|593387800|FG017|Overall Study|Participant withdrew consent|2|||
164277998|NCT02737475|593387801|FG018|Overall Study|Participant withdrew consent|1|||
164277999|NCT02737475|593387802|FG019|Overall Study|Participant withdrew consent|0|||
164278000|NCT02737475|593387803|FG020|Overall Study|Participant withdrew consent|2|||
164278001|NCT02737475|593387804|FG021|Overall Study|Participant withdrew consent|0|||
164278002|NCT02737475|593387805|FG022|Overall Study|Participant withdrew consent|0|||
164278003|NCT02737475|593387806|FG023|Overall Study|Participant withdrew consent|0|||
164278004|NCT02737475|593387807|FG024|Overall Study|Participant withdrew consent|0|||
164343723|NCT01847274|593635311|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
164343724|NCT01847274|593635312|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
164343725|NCT01847274|593635313|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
164343726|NCT01847274|593635314|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
164343727|NCT01847274|593635315|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
164343728|NCT01847274|593635316|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
164343729|NCT01847274|593635317|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
164343730|NCT01847274|593635307|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
164343731|NCT01847274|593635308|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
164343732|NCT01847274|593635309|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
164343733|NCT01847274|593635310|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
164343734|NCT01847274|593635311|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
164343735|NCT01847274|593635312|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
164343736|NCT01847274|593635313|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
164343737|NCT01847274|593635314|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
164343738|NCT01847274|593635315|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
164343739|NCT01847274|593635316|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
164343740|NCT01847274|593635317|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
164343741|NCT01847274|593635307|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
164343742|NCT01847274|593635308|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
164343743|NCT01847274|593635309|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
164343744|NCT01847274|593635310|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
164343745|NCT01847274|593635311|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
164343746|NCT01847274|593635312|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
164343747|NCT01847274|593635313|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
164343748|NCT01847274|593635314|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
164343749|NCT01847274|593635315|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
164343750|NCT01847274|593635316|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
164343751|NCT01847274|593635317|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
164343752|NCT01847274|593635307|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
164343753|NCT01847274|593635308|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
164343754|NCT01847274|593635309|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
164343755|NCT01847274|593635310|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
164343756|NCT01847274|593635311|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
164343757|NCT01847274|593635312|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
164343758|NCT01847274|593635313|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
164343759|NCT01847274|593635314|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
164343760|NCT01847274|593635315|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
164343761|NCT01847274|593635316|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
164343762|NCT01847274|593635317|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
164343763|NCT01847274|593635307|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
164343764|NCT01847274|593635308|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
164343765|NCT01847274|593635309|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
164343766|NCT01847274|593635310|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
164343767|NCT01847274|593635311|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
164343768|NCT01847274|593635312|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
164343769|NCT01847274|593635313|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
164343770|NCT01847274|593635314|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
164343771|NCT01847274|593635315|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
164343772|NCT01847274|593635316|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
164343773|NCT01847274|593635317|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
164432543|NCT04083976|593954629|FG000|Overall Study|Withdrawal by Subject|16|||
164432544|NCT04083976|593954630|FG001|Overall Study|Withdrawal by Subject|1|||
164432545|NCT04083976|593954631|FG002|Overall Study|Withdrawal by Subject|9|||
164689717|NCT01332968|594887789|FG005|Induction Period|Death|0|||
164278005|NCT02737475|593387808|FG025|Overall Study|Participant withdrew consent|0|||
164278006|NCT02737475|593387809|FG026|Overall Study|Participant withdrew consent|0|||
164689718|NCT01332968|594887790|FG006|Induction Period|Death|0|||
164689719|NCT01332968|594887791|FG007|Induction Period|Death|0|||
164689720|NCT01332968|594887784|FG000|Induction Period|Non-compliance|1|||
164689721|NCT01332968|594887785|FG001|Induction Period|Non-compliance|0|||
164278007|NCT02737475|593387783|FG000|Overall Study|Lost to Follow-up|0|||
164278008|NCT02737475|593387784|FG001|Overall Study|Lost to Follow-up|0|||
164278009|NCT02737475|593387785|FG002|Overall Study|Lost to Follow-up|0|||
164278010|NCT02737475|593387786|FG003|Overall Study|Lost to Follow-up|0|||
164689722|NCT01332968|594887786|FG002|Induction Period|Non-compliance|0|||
164689723|NCT01332968|594887787|FG003|Induction Period|Non-compliance|0|||
164689724|NCT01332968|594887788|FG004|Induction Period|Non-compliance|0|||
164689725|NCT01332968|594887789|FG005|Induction Period|Non-compliance|0|||
164689726|NCT01332968|594887790|FG006|Induction Period|Non-compliance|0|||
164689727|NCT01332968|594887791|FG007|Induction Period|Non-compliance|0|||
164689728|NCT01332968|594887784|FG000|Induction Period|Other|2|||
164689729|NCT01332968|594887785|FG001|Induction Period|Other|2|||
164689730|NCT01332968|594887786|FG002|Induction Period|Other|0|||
164689731|NCT01332968|594887787|FG003|Induction Period|Other|0|||
164689732|NCT01332968|594887788|FG004|Induction Period|Other|0|||
164689733|NCT01332968|594887789|FG005|Induction Period|Other|0|||
164689734|NCT01332968|594887790|FG006|Induction Period|Other|0|||
164689735|NCT01332968|594887791|FG007|Induction Period|Other|0|||
164689736|NCT01332968|594887784|FG000|Induction Period|Physician Decision|6|||
164689737|NCT01332968|594887785|FG001|Induction Period|Physician Decision|1|||
164689738|NCT01332968|594887786|FG002|Induction Period|Physician Decision|0|||
164432546|NCT04083976|593954632|FG003|Overall Study|Withdrawal by Subject|0|||
164432547|NCT04083976|593954629|FG000|Overall Study|Sponsor Decision|14|||
164432548|NCT04083976|593954630|FG001|Overall Study|Sponsor Decision|0|||
164432549|NCT04083976|593954631|FG002|Overall Study|Sponsor Decision|0|||
164432550|NCT04083976|593954632|FG003|Overall Study|Sponsor Decision|7|||
164432551|NCT04083976|593954629|FG000|Overall Study|Other|1|||
164432552|NCT04083976|593954630|FG001|Overall Study|Other|0|||
164432553|NCT04083976|593954631|FG002|Overall Study|Other|1|||
164432554|NCT04083976|593954632|FG003|Overall Study|Other|0|||
164432555|NCT03721016|593954633|FG000|Overall Study|Adverse Event|0|||
164432556|NCT03721016|593954634|FG001|Overall Study|Adverse Event|1|||
164432557|NCT03721016|593954635|FG002|Overall Study|Adverse Event|1|||
164432558|NCT03721016|593954633|FG000|Overall Study|Withdrawal by Subject|8|||
164432559|NCT03721016|593954634|FG001|Overall Study|Withdrawal by Subject|16|||
164432560|NCT03721016|593954635|FG002|Overall Study|Withdrawal by Subject|13|||
164432561|NCT03721016|593954633|FG000|Overall Study|Lost to Follow-up|4|||
164432562|NCT03721016|593954634|FG001|Overall Study|Lost to Follow-up|6|||
164432563|NCT03721016|593954635|FG002|Overall Study|Lost to Follow-up|5|||
164432564|NCT03721016|593954633|FG000|Overall Study|Physician Decision|0|||
164432565|NCT03721016|593954634|FG001|Overall Study|Physician Decision|1|||
164432566|NCT03721016|593954635|FG002|Overall Study|Physician Decision|2|||
164432567|NCT03721016|593954633|FG000|Overall Study|Protocol Violation|0|||
164432568|NCT03721016|593954634|FG001|Overall Study|Protocol Violation|1|||
164432569|NCT03721016|593954635|FG002|Overall Study|Protocol Violation|0|||
164689739|NCT01332968|594887787|FG003|Induction Period|Physician Decision|0|||
164689740|NCT01332968|594887788|FG004|Induction Period|Physician Decision|0|||
164689741|NCT01332968|594887789|FG005|Induction Period|Physician Decision|0|||
164689742|NCT01332968|594887790|FG006|Induction Period|Physician Decision|0|||
164689743|NCT01332968|594887791|FG007|Induction Period|Physician Decision|0|||
164689744|NCT01332968|594887784|FG000|Induction Period|Progressive Disease|15|||
164689745|NCT01332968|594887785|FG001|Induction Period|Progressive Disease|7|||
164278011|NCT02737475|593387787|FG004|Overall Study|Lost to Follow-up|0|||
164432570|NCT03721016|593954633|FG000|Overall Study|Site terminated by sponsor|3|||
164432571|NCT03721016|593954634|FG001|Overall Study|Site terminated by sponsor|7|||
164432572|NCT03721016|593954635|FG002|Overall Study|Site terminated by sponsor|6|||
164432573|NCT03721016|593954633|FG000|Overall Study|Subject exited early due to COVID-19|1|||
164432574|NCT03721016|593954634|FG001|Overall Study|Subject exited early due to COVID-19|0|||
164432575|NCT03721016|593954635|FG002|Overall Study|Subject exited early due to COVID-19|0|||
164432576|NCT03357341|593954636|FG000|Overall Study|Withdrawal by Subject|3|||
164432577|NCT03357341|593954637|FG001|Overall Study|Withdrawal by Subject|6|||
164432578|NCT03357341|593954636|FG000|Overall Study|Lost to Follow-up|4|||
164432579|NCT03357341|593954637|FG001|Overall Study|Lost to Follow-up|5|||
164432580|NCT03357341|593954636|FG000|Overall Study|Death|0|||
164432581|NCT03357341|593954637|FG001|Overall Study|Death|1|||
164689746|NCT01332968|594887786|FG002|Induction Period|Progressive Disease|0|||
164689747|NCT01332968|594887787|FG003|Induction Period|Progressive Disease|0|||
164689748|NCT01332968|594887788|FG004|Induction Period|Progressive Disease|0|||
164689749|NCT01332968|594887789|FG005|Induction Period|Progressive Disease|0|||
164689750|NCT01332968|594887790|FG006|Induction Period|Progressive Disease|0|||
164689751|NCT01332968|594887791|FG007|Induction Period|Progressive Disease|0|||
164689752|NCT01332968|594887784|FG000|Induction Period|Protocol Violation|3|||
164432582|NCT01693614|593954641|FG000|Overall Study|Adverse Event|7|||
164432583|NCT01693614|593954642|FG001|Overall Study|Adverse Event|11|||
164432584|NCT01693614|593954643|FG002|Overall Study|Adverse Event|5|||
164432585|NCT01693614|593954641|FG000|Overall Study|Disease progression|11|||
164432586|NCT01693614|593954642|FG001|Overall Study|Disease progression|8|||
164432587|NCT01693614|593954643|FG002|Overall Study|Disease progression|7|||
164432588|NCT01693614|593954641|FG000|Overall Study|Protocol Violation|5|||
164432589|NCT01693614|593954642|FG001|Overall Study|Protocol Violation|2|||
164432590|NCT01693614|593954643|FG002|Overall Study|Protocol Violation|1|||
164432591|NCT01693614|593954641|FG000|Overall Study|Death|1|||
164432592|NCT01693614|593954642|FG001|Overall Study|Death|0|||
164432593|NCT01693614|593954643|FG002|Overall Study|Death|0|||
164432594|NCT01693614|593954641|FG000|Overall Study|Physician Decision|1|||
164432595|NCT01693614|593954642|FG001|Overall Study|Physician Decision|1|||
164432596|NCT01693614|593954643|FG002|Overall Study|Physician Decision|4|||
164689753|NCT01332968|594887785|FG001|Induction Period|Protocol Violation|4|||
164689754|NCT01332968|594887786|FG002|Induction Period|Protocol Violation|0|||
164689755|NCT01332968|594887787|FG003|Induction Period|Protocol Violation|0|||
164689756|NCT01332968|594887788|FG004|Induction Period|Protocol Violation|0|||
164689757|NCT01332968|594887789|FG005|Induction Period|Protocol Violation|0|||
164689758|NCT01332968|594887790|FG006|Induction Period|Protocol Violation|0|||
164689759|NCT01332968|594887791|FG007|Induction Period|Protocol Violation|0|||
164689760|NCT01332968|594887784|FG000|Induction Period|Withdrawal by Subject|3|||
164689761|NCT01332968|594887785|FG001|Induction Period|Withdrawal by Subject|5|||
164689762|NCT01332968|594887786|FG002|Induction Period|Withdrawal by Subject|0|||
164689763|NCT01332968|594887787|FG003|Induction Period|Withdrawal by Subject|0|||
164689764|NCT01332968|594887788|FG004|Induction Period|Withdrawal by Subject|0|||
164278012|NCT02737475|593387788|FG005|Overall Study|Lost to Follow-up|0|||
164278013|NCT02737475|593387789|FG006|Overall Study|Lost to Follow-up|0|||
164278014|NCT02737475|593387790|FG007|Overall Study|Lost to Follow-up|0|||
164278015|NCT02737475|593387791|FG008|Overall Study|Lost to Follow-up|0|||
164278016|NCT02737475|593387792|FG009|Overall Study|Lost to Follow-up|0|||
164278017|NCT02737475|593387793|FG010|Overall Study|Lost to Follow-up|0|||
164278018|NCT02737475|593387794|FG011|Overall Study|Lost to Follow-up|0|||
164278019|NCT02737475|593387795|FG012|Overall Study|Lost to Follow-up|0|||
164278020|NCT02737475|593387796|FG013|Overall Study|Lost to Follow-up|0|||
164278021|NCT02737475|593387797|FG014|Overall Study|Lost to Follow-up|0|||
164278022|NCT02737475|593387798|FG015|Overall Study|Lost to Follow-up|1|||
164278023|NCT02737475|593387799|FG016|Overall Study|Lost to Follow-up|0|||
164278024|NCT02737475|593387800|FG017|Overall Study|Lost to Follow-up|0|||
164278025|NCT02737475|593387801|FG018|Overall Study|Lost to Follow-up|0|||
164278026|NCT02737475|593387802|FG019|Overall Study|Lost to Follow-up|0|||
164278027|NCT02737475|593387803|FG020|Overall Study|Lost to Follow-up|0|||
164278028|NCT02737475|593387804|FG021|Overall Study|Lost to Follow-up|0|||
164278029|NCT02737475|593387805|FG022|Overall Study|Lost to Follow-up|0|||
164278030|NCT02737475|593387806|FG023|Overall Study|Lost to Follow-up|0|||
164278031|NCT02737475|593387807|FG024|Overall Study|Lost to Follow-up|0|||
164278032|NCT02737475|593387808|FG025|Overall Study|Lost to Follow-up|0|||
164278033|NCT02737475|593387809|FG026|Overall Study|Lost to Follow-up|0|||
164278034|NCT02737475|593387783|FG000|Overall Study|Disease Progression|0|||
164278035|NCT02737475|593387784|FG001|Overall Study|Disease Progression|0|||
164278036|NCT02737475|593387785|FG002|Overall Study|Disease Progression|0|||
164278037|NCT02737475|593387786|FG003|Overall Study|Disease Progression|0|||
164278038|NCT02737475|593387787|FG004|Overall Study|Disease Progression|0|||
164278039|NCT02737475|593387788|FG005|Overall Study|Disease Progression|0|||
164278040|NCT02737475|593387789|FG006|Overall Study|Disease Progression|0|||
164278041|NCT02737475|593387790|FG007|Overall Study|Disease Progression|0|||
164278042|NCT02737475|593387791|FG008|Overall Study|Disease Progression|0|||
164278043|NCT02737475|593387792|FG009|Overall Study|Disease Progression|0|||
164278044|NCT02737475|593387793|FG010|Overall Study|Disease Progression|0|||
164278045|NCT02737475|593387794|FG011|Overall Study|Disease Progression|0|||
164278046|NCT02737475|593387795|FG012|Overall Study|Disease Progression|0|||
164278047|NCT02737475|593387796|FG013|Overall Study|Disease Progression|0|||
164432597|NCT01693614|593954641|FG000|Overall Study|Withdrawal by subject/guardian|0|||
164432598|NCT01693614|593954642|FG001|Overall Study|Withdrawal by subject/guardian|0|||
164432599|NCT01693614|593954643|FG002|Overall Study|Withdrawal by subject/guardian|2|||
164432600|NCT01693614|593954641|FG000|Overall Study|Withdrawal by Subject|1|||
164432601|NCT01693614|593954642|FG001|Overall Study|Withdrawal by Subject|0|||
164432602|NCT01693614|593954643|FG002|Overall Study|Withdrawal by Subject|5|||
164432603|NCT04618471|593954644|FG000|Overall Study|Screen Failure|62|||
164432604|NCT04618471|593954644|FG000|Overall Study|Withdrawal by Subject|6|||
164432605|NCT04618471|593954644|FG000|Overall Study|Physician Decision|2|||
164689765|NCT01332968|594887789|FG005|Induction Period|Withdrawal by Subject|0|||
164278048|NCT02737475|593387797|FG014|Overall Study|Disease Progression|0|||
164278049|NCT02737475|593387798|FG015|Overall Study|Disease Progression|0|||
164278050|NCT02737475|593387799|FG016|Overall Study|Disease Progression|0|||
164278051|NCT02737475|593387800|FG017|Overall Study|Disease Progression|0|||
164278052|NCT02737475|593387801|FG018|Overall Study|Disease Progression|0|||
164432606|NCT04618471|593954644|FG000|Overall Study|Lost to Follow-up|1|||
164689766|NCT01332968|594887790|FG006|Induction Period|Withdrawal by Subject|0|||
164278053|NCT02737475|593387802|FG019|Overall Study|Disease Progression|0|||
164278054|NCT02737475|593387803|FG020|Overall Study|Disease Progression|0|||
164278055|NCT02737475|593387804|FG021|Overall Study|Disease Progression|0|||
164278056|NCT02737475|593387805|FG022|Overall Study|Disease Progression|0|||
164278057|NCT02737475|593387806|FG023|Overall Study|Disease Progression|0|||
164278058|NCT02737475|593387807|FG024|Overall Study|Disease Progression|0|||
164278059|NCT02737475|593387808|FG025|Overall Study|Disease Progression|0|||
164278060|NCT02737475|593387809|FG026|Overall Study|Disease Progression|1|||
164278061|NCT02510001|593387810|FG000|Overall Study|Early disease progression|0|||
164278062|NCT02510001|593387811|FG001|Overall Study|Early disease progression|0|||
164278063|NCT02510001|593387812|FG002|Overall Study|Early disease progression|0|||
164278064|NCT02510001|593387813|FG003|Overall Study|Early disease progression|1|||
164278065|NCT02510001|593387814|FG004|Overall Study|Early disease progression|1|||
164278066|NCT02510001|593387815|FG005|Overall Study|Early disease progression|1|||
164278067|NCT02510001|593387816|FG006|Overall Study|Early disease progression|0|||
164278068|NCT02510001|593387817|FG007|Overall Study|Early disease progression|0|||
164278069|NCT02510001|593387810|FG000|Overall Study|Adverse Event|0|||
164278070|NCT02510001|593387811|FG001|Overall Study|Adverse Event|0|||
164278071|NCT02510001|593387812|FG002|Overall Study|Adverse Event|0|||
164278072|NCT02510001|593387813|FG003|Overall Study|Adverse Event|1|||
164278073|NCT02510001|593387814|FG004|Overall Study|Adverse Event|2|||
164278074|NCT02510001|593387815|FG005|Overall Study|Adverse Event|1|||
164278075|NCT02510001|593387816|FG006|Overall Study|Adverse Event|2|||
164278076|NCT02510001|593387817|FG007|Overall Study|Adverse Event|5|||
164278077|NCT02510001|593387810|FG000|Overall Study|Physician Decision|0|||
164278078|NCT02510001|593387811|FG001|Overall Study|Physician Decision|0|||
164278079|NCT02510001|593387812|FG002|Overall Study|Physician Decision|0|||
164278080|NCT02510001|593387813|FG003|Overall Study|Physician Decision|0|||
164278081|NCT02510001|593387814|FG004|Overall Study|Physician Decision|1|||
164278082|NCT02510001|593387815|FG005|Overall Study|Physician Decision|0|||
164278083|NCT02510001|593387816|FG006|Overall Study|Physician Decision|0|||
164278084|NCT02510001|593387817|FG007|Overall Study|Physician Decision|0|||
164278085|NCT02510001|593387810|FG000|Overall Study|Withdrawal by Subject|0|||
164278086|NCT02510001|593387811|FG001|Overall Study|Withdrawal by Subject|0|||
164278087|NCT02510001|593387812|FG002|Overall Study|Withdrawal by Subject|0|||
164278088|NCT02510001|593387813|FG003|Overall Study|Withdrawal by Subject|0|||
164278089|NCT02510001|593387814|FG004|Overall Study|Withdrawal by Subject|0|||
164278090|NCT02510001|593387815|FG005|Overall Study|Withdrawal by Subject|0|||
164278091|NCT02510001|593387816|FG006|Overall Study|Withdrawal by Subject|0|||
164343774|NCT01847274|593635307|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
164343775|NCT01847274|593635308|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
164343776|NCT01847274|593635309|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
164343777|NCT01847274|593635310|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
164343778|NCT01847274|593635311|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
164343779|NCT01847274|593635312|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
164343780|NCT01847274|593635313|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
164343781|NCT01847274|593635314|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
164343782|NCT01847274|593635315|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
164343783|NCT01847274|593635316|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
164343784|NCT01847274|593635317|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
164343785|NCT01847274|593635307|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
164343786|NCT01847274|593635308|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
164343787|NCT01847274|593635309|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
164343788|NCT01847274|593635310|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
164343789|NCT01847274|593635311|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
164343790|NCT01847274|593635312|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
164343791|NCT01847274|593635313|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
164343792|NCT01847274|593635314|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
164343793|NCT01847274|593635315|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
164343794|NCT01847274|593635316|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
164343795|NCT01847274|593635317|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
164343796|NCT01847274|593635307|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
164343797|NCT01847274|593635308|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
164343798|NCT01847274|593635309|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
164278092|NCT02510001|593387817|FG007|Overall Study|Withdrawal by Subject|2|||
164343799|NCT01847274|593635310|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
164343800|NCT01847274|593635311|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
164142993|NCT00863772|592884484|FG000|Overall Study|Lost to Follow-up|5|||
164278093|NCT00711971|593387840|FG000|Overall Study|Lost to Follow-up|3|||
164278094|NCT00711971|593387841|FG001|Overall Study|Lost to Follow-up|4|||
164278095|NCT00711971|593387842|FG002|Overall Study|Lost to Follow-up|1|||
164278096|NCT00887549|593387845|FG000|Induction Therapy|Adverse Event|8|||
164278097|NCT00887549|593387845|FG000|Induction Therapy|Physician Decision|1|||
164278098|NCT00887549|593387845|FG000|Induction Therapy|Progressive Disease|13|||
164278099|NCT00887549|593387845|FG000|Induction Therapy|Death due to Study Disease|4|||
164278100|NCT00887549|593387845|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
164278101|NCT00887549|593387845|FG000|Maintenance Therapy|Adverse Event|16|||
164278102|NCT00887549|593387845|FG000|Maintenance Therapy|Physician Decision|1|||
164278103|NCT00887549|593387845|FG000|Maintenance Therapy|Progressive Disease|25|||
164278104|NCT00887549|593387845|FG000|Maintenance Therapy|Death due to adverse event|1|||
164278105|NCT02097030|593387852|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
164278106|NCT02097030|593387853|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
164278107|NCT02097030|593387852|FG000|First Intervention (3 Days)|Visual Acuity|0|||
164278108|NCT02097030|593387853|FG001|First Intervention (3 Days)|Visual Acuity|1|||
164278109|NCT01919801|593387854|FG000|Overall Study|Withdrawal by Subject|1|||
164278110|NCT01919801|593387855|FG001|Overall Study|Withdrawal by Subject|0|||
164278111|NCT01919801|593387854|FG000|Overall Study|Physician Decision|0|||
164278112|NCT01919801|593387855|FG001|Overall Study|Physician Decision|1|||
164278113|NCT01919801|593387854|FG000|Overall Study|Lost to Follow-up|0|||
164278114|NCT01919801|593387855|FG001|Overall Study|Lost to Follow-up|1|||
164278115|NCT01919801|593387854|FG000|Overall Study|Other|0|||
164278116|NCT01919801|593387855|FG001|Overall Study|Other|1|||
164278117|NCT01677858|593387860|FG000|Overall Study|Adverse Event|0|||
164278118|NCT01677858|593387861|FG001|Overall Study|Adverse Event|0|||
164278119|NCT01677858|593387862|FG002|Overall Study|Adverse Event|2|||
164278120|NCT01677858|593387863|FG003|Overall Study|Adverse Event|3|||
164278121|NCT01677858|593387864|FG004|Overall Study|Adverse Event|13|||
164278122|NCT01677858|593387860|FG000|Overall Study|Death|0|||
164278123|NCT01677858|593387861|FG001|Overall Study|Death|0|||
164278124|NCT01677858|593387862|FG002|Overall Study|Death|0|||
164278125|NCT01677858|593387863|FG003|Overall Study|Death|0|||
164278126|NCT01677858|593387864|FG004|Overall Study|Death|1|||
164278127|NCT01677858|593387860|FG000|Overall Study|Physician Decision|1|||
164278128|NCT01677858|593387861|FG001|Overall Study|Physician Decision|0|||
164278129|NCT01677858|593387862|FG002|Overall Study|Physician Decision|2|||
164278130|NCT01677858|593387863|FG003|Overall Study|Physician Decision|0|||
164278131|NCT01677858|593387864|FG004|Overall Study|Physician Decision|12|||
164278132|NCT01677858|593387860|FG000|Overall Study|Progressive Disease|2|||
164278133|NCT01677858|593387861|FG001|Overall Study|Progressive Disease|1|||
164278134|NCT01677858|593387862|FG002|Overall Study|Progressive Disease|9|||
164278135|NCT01677858|593387863|FG003|Overall Study|Progressive Disease|3|||
164278136|NCT01677858|593387864|FG004|Overall Study|Progressive Disease|43|||
164278137|NCT01677858|593387860|FG000|Overall Study|Withdrawal by Subject|0|||
164278138|NCT01677858|593387861|FG001|Overall Study|Withdrawal by Subject|1|||
164278139|NCT01677858|593387862|FG002|Overall Study|Withdrawal by Subject|1|||
164278140|NCT01677858|593387863|FG003|Overall Study|Withdrawal by Subject|0|||
164278141|NCT01677858|593387864|FG004|Overall Study|Withdrawal by Subject|15|||
164278142|NCT01677858|593387860|FG000|Overall Study|Lost to Follow-up|0|||
164278143|NCT01677858|593387861|FG001|Overall Study|Lost to Follow-up|0|||
164278144|NCT01677858|593387862|FG002|Overall Study|Lost to Follow-up|0|||
164278145|NCT01677858|593387863|FG003|Overall Study|Lost to Follow-up|0|||
164278146|NCT01677858|593387864|FG004|Overall Study|Lost to Follow-up|1|||
164278147|NCT00988091|593387865|FG000|Double-blind Period|Withdrawal by Subject|15|||
164278148|NCT00988091|593387866|FG001|Double-blind Period|Withdrawal by Subject|13|||
164278149|NCT00988091|593387865|FG000|Double-blind Period|Lost to Follow-up|12|||
164278150|NCT00988091|593387866|FG001|Double-blind Period|Lost to Follow-up|14|||
164278151|NCT00988091|593387865|FG000|Double-blind Period|Other|8|||
164278152|NCT00988091|593387866|FG001|Double-blind Period|Other|8|||
164278153|NCT00988091|593387865|FG000|Double-blind Period|Adverse Event|6|||
164278154|NCT00988091|593387866|FG001|Double-blind Period|Adverse Event|9|||
164278155|NCT00988091|593387865|FG000|Double-blind Period|Use of exclusionary medication|2|||
164343801|NCT01847274|593635312|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
164343802|NCT01847274|593635313|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
164343803|NCT01847274|593635314|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
164343804|NCT01847274|593635315|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
164343805|NCT01847274|593635316|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
164343806|NCT01847274|593635317|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
164343807|NCT01847274|593635307|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
164343808|NCT01847274|593635308|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
164343809|NCT01847274|593635309|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
164343810|NCT01847274|593635310|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
164343811|NCT01847274|593635311|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
164343812|NCT01847274|593635312|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
164343813|NCT01847274|593635313|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
164278156|NCT00988091|593387866|FG001|Double-blind Period|Use of exclusionary medication|3|||
164278157|NCT00988091|593387865|FG000|Open-label Period|Adverse Event|4|||
164278158|NCT00988091|593387866|FG001|Open-label Period|Adverse Event|7|||
164278159|NCT00988091|593387865|FG000|Open-label Period|Use of exclusionary medication|1|||
164278160|NCT00988091|593387866|FG001|Open-label Period|Use of exclusionary medication|1|||
164278161|NCT00988091|593387865|FG000|Open-label Period|Protocol Violation|1|||
164278162|NCT00988091|593387866|FG001|Open-label Period|Protocol Violation|1|||
164278163|NCT00988091|593387865|FG000|Open-label Period|Withdrawal by Subject|10|||
164278164|NCT00988091|593387866|FG001|Open-label Period|Withdrawal by Subject|16|||
164278165|NCT00988091|593387865|FG000|Open-label Period|Lost to Follow-up|3|||
164278166|NCT00988091|593387866|FG001|Open-label Period|Lost to Follow-up|5|||
164278167|NCT00988091|593387865|FG000|Open-label Period|Other|2|||
164278168|NCT00988091|593387866|FG001|Open-label Period|Other|3|||
164278169|NCT03078855|593387870|FG000|Overall Study|Lack of Efficacy|62|||
164278170|NCT03078855|593387871|FG001|Overall Study|Lack of Efficacy|31|||
164278171|NCT03078855|593387870|FG000|Overall Study|Death|1|||
164278172|NCT03078855|593387871|FG001|Overall Study|Death|0|||
164278173|NCT03078855|593387870|FG000|Overall Study|Withdrawal by Subject|12|||
164278174|NCT03078855|593387871|FG001|Overall Study|Withdrawal by Subject|6|||
164278175|NCT03078855|593387870|FG000|Overall Study|Physician Decision|3|||
164278176|NCT03078855|593387871|FG001|Overall Study|Physician Decision|2|||
164278177|NCT03078855|593387870|FG000|Overall Study|Second Malignancy|4|||
164278178|NCT03078855|593387871|FG001|Overall Study|Second Malignancy|0|||
164278179|NCT03078855|593387870|FG000|Overall Study|Ineligible|2|||
164278180|NCT03078855|593387871|FG001|Overall Study|Ineligible|0|||
164278181|NCT03078855|593387870|FG000|Overall Study|Withdrew before day 1 treatment|2|||
164278182|NCT03078855|593387871|FG001|Overall Study|Withdrew before day 1 treatment|1|||
164278183|NCT00391027|593387872|FG000|Overall Study|Adverse Event|8|||
164278184|NCT00391027|593387873|FG001|Overall Study|Adverse Event|8|||
164278185|NCT00391027|593387872|FG000|Overall Study|Lack of Efficacy|3|||
164278186|NCT00391027|593387873|FG001|Overall Study|Lack of Efficacy|0|||
164278187|NCT00391027|593387872|FG000|Overall Study|Withdrawal by Subject|10|||
164278188|NCT00391027|593387873|FG001|Overall Study|Withdrawal by Subject|1|||
164278189|NCT00391027|593387872|FG000|Overall Study|Other|4|||
164278190|NCT00391027|593387873|FG001|Overall Study|Other|3|||
164278191|NCT03194646|593387874|FG000|Overall Study|Adverse Event|24|||
164278192|NCT03194646|593387875|FG001|Overall Study|Adverse Event|25|||
164278193|NCT03194646|593387876|FG002|Overall Study|Adverse Event|14|||
164278194|NCT03194646|593387877|FG003|Overall Study|Adverse Event|17|||
164278195|NCT03194646|593387874|FG000|Overall Study|Lack of Efficacy|4|||
164278196|NCT03194646|593387875|FG001|Overall Study|Lack of Efficacy|2|||
164278197|NCT03194646|593387876|FG002|Overall Study|Lack of Efficacy|2|||
164278198|NCT03194646|593387877|FG003|Overall Study|Lack of Efficacy|12|||
164278199|NCT03194646|593387874|FG000|Overall Study|Lost to Follow-up|30|||
164278200|NCT03194646|593387875|FG001|Overall Study|Lost to Follow-up|22|||
164278201|NCT03194646|593387876|FG002|Overall Study|Lost to Follow-up|12|||
164278202|NCT03194646|593387877|FG003|Overall Study|Lost to Follow-up|35|||
164278203|NCT03194646|593387874|FG000|Overall Study|Non-compliance with study drug|4|||
164278204|NCT03194646|593387875|FG001|Overall Study|Non-compliance with study drug|0|||
164278205|NCT03194646|593387876|FG002|Overall Study|Non-compliance with study drug|1|||
164278206|NCT03194646|593387877|FG003|Overall Study|Non-compliance with study drug|1|||
164278207|NCT03194646|593387874|FG000|Overall Study|Other|89|||
164278208|NCT03194646|593387875|FG001|Overall Study|Other|68|||
164278209|NCT03194646|593387876|FG002|Overall Study|Other|34|||
164278210|NCT03194646|593387877|FG003|Overall Study|Other|31|||
164278211|NCT03194646|593387874|FG000|Overall Study|Physician Decision|7|||
164278212|NCT03194646|593387875|FG001|Overall Study|Physician Decision|9|||
164278213|NCT03194646|593387876|FG002|Overall Study|Physician Decision|5|||
164278214|NCT03194646|593387877|FG003|Overall Study|Physician Decision|4|||
164432607|NCT04618471|593954644|FG000|Overall Study|Various other reasons|2|||
164432608|NCT04618471|593954644|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
164432609|NCT04304534|593954648|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
164432610|NCT04304534|593954649|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
164432611|NCT04304534|593954650|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
164432612|NCT04304534|593954651|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
164432613|NCT04304534|593954648|FG000|Overall Study|Non-Compliance with study drug|0|||
164432614|NCT04304534|593954649|FG001|Overall Study|Non-Compliance with study drug|1|||
164278215|NCT03194646|593387874|FG000|Overall Study|Pregnancy|4|||
164278216|NCT03194646|593387875|FG001|Overall Study|Pregnancy|5|||
164278217|NCT03194646|593387876|FG002|Overall Study|Pregnancy|1|||
164278218|NCT03194646|593387877|FG003|Overall Study|Pregnancy|2|||
164278219|NCT03194646|593387874|FG000|Overall Study|Protocol Violation|4|||
164278220|NCT03194646|593387875|FG001|Overall Study|Protocol Violation|2|||
164278221|NCT03194646|593387876|FG002|Overall Study|Protocol Violation|1|||
164278222|NCT03194646|593387877|FG003|Overall Study|Protocol Violation|1|||
164278223|NCT03194646|593387874|FG000|Overall Study|Site terminated by sponsor|0|||
164278224|NCT03194646|593387875|FG001|Overall Study|Site terminated by sponsor|0|||
164278225|NCT03194646|593387876|FG002|Overall Study|Site terminated by sponsor|2|||
164278226|NCT03194646|593387877|FG003|Overall Study|Site terminated by sponsor|0|||
164278227|NCT03194646|593387874|FG000|Overall Study|Study terminated by sponsor|62|||
164278228|NCT03194646|593387875|FG001|Overall Study|Study terminated by sponsor|61|||
164278229|NCT03194646|593387876|FG002|Overall Study|Study terminated by sponsor|30|||
164278230|NCT03194646|593387877|FG003|Overall Study|Study terminated by sponsor|34|||
164278231|NCT03194646|593387874|FG000|Overall Study|Withdrawal by Subject|75|||
164278232|NCT03194646|593387875|FG001|Overall Study|Withdrawal by Subject|74|||
164278233|NCT03194646|593387876|FG002|Overall Study|Withdrawal by Subject|36|||
164278234|NCT03194646|593387877|FG003|Overall Study|Withdrawal by Subject|131|||
164278235|NCT03194646|593387874|FG000|Overall Study|Missing|1|||
164278236|NCT03194646|593387875|FG001|Overall Study|Missing|0|||
164278237|NCT03194646|593387876|FG002|Overall Study|Missing|1|||
164278238|NCT03194646|593387877|FG003|Overall Study|Missing|12|||
164278239|NCT04869358|593387878|FG000|Overall Study|Wish to have children.|1|||
164278240|NCT04869358|593387879|FG001|Overall Study|Wish to have children.|0|||
164278241|NCT04869358|593387880|FG002|Overall Study|Wish to have children.|0|||
164278242|NCT04869358|593387881|FG003|Overall Study|Wish to have children.|0|||
164278243|NCT05232864|593387882|FG000|Overall Study|Adverse Event|0|||
164278244|NCT05232864|593387883|FG001|Overall Study|Adverse Event|1|||
164278245|NCT05232864|593387882|FG000|Overall Study|Study terminated by sponsor|16|||
164278246|NCT05232864|593387883|FG001|Overall Study|Study terminated by sponsor|14|||
164278247|NCT03068754|593387886|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
164278248|NCT03068754|593387887|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
164278249|NCT03068754|593387888|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
164278250|NCT03068754|593387889|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
164278251|NCT03068754|593387886|FG000|Randomized Treatment Period (RTP)|Death|2|||
164278252|NCT03068754|593387887|FG001|Randomized Treatment Period (RTP)|Death|2|||
164278253|NCT03068754|593387888|FG002|Randomized Treatment Period (RTP)|Death|0|||
164278254|NCT03068754|593387889|FG003|Randomized Treatment Period (RTP)|Death|0|||
164278255|NCT03068754|593387886|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
164278256|NCT03068754|593387887|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
164278257|NCT03068754|593387888|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
164278258|NCT03068754|593387889|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
164278259|NCT03068754|593387886|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
164278260|NCT03068754|593387887|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
164278261|NCT03068754|593387888|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
164278262|NCT03068754|593387889|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
164278263|NCT03068754|593387886|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
164278264|NCT03068754|593387887|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
164278265|NCT03068754|593387888|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
164278266|NCT03068754|593387889|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
164278267|NCT03068754|593387886|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
164278268|NCT03068754|593387887|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
164278269|NCT03068754|593387888|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
164278270|NCT03068754|593387889|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
164278271|NCT03068754|593387886|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
164278272|NCT03068754|593387887|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
164278273|NCT03068754|593387888|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
164278274|NCT03068754|593387889|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
164278275|NCT03068754|593387886|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
164278276|NCT03068754|593387887|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
164278277|NCT03068754|593387888|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
164278278|NCT03068754|593387889|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
164278279|NCT03068754|593387886|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
164343814|NCT01847274|593635314|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
164343815|NCT01847274|593635315|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
164343816|NCT01847274|593635316|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
164343817|NCT01847274|593635317|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
164343818|NCT01847274|593635307|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
164343819|NCT01847274|593635308|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
164343820|NCT01847274|593635309|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
164343821|NCT01847274|593635310|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
164343822|NCT01847274|593635311|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
164343823|NCT01847274|593635312|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
164343824|NCT01847274|593635313|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
164343825|NCT01847274|593635314|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
164278280|NCT03068754|593387887|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
164278281|NCT03068754|593387888|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
164343826|NCT01847274|593635315|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
164278282|NCT03068754|593387889|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
164278283|NCT03068754|593387886|FG000|Open Label Extension Period (OLE)|Death|0|||
164278284|NCT03068754|593387887|FG001|Open Label Extension Period (OLE)|Death|0|||
164278285|NCT03068754|593387888|FG002|Open Label Extension Period (OLE)|Death|0|||
164278286|NCT03068754|593387889|FG003|Open Label Extension Period (OLE)|Death|1|||
164278287|NCT03068754|593387886|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
164278288|NCT03068754|593387887|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
164278289|NCT03068754|593387888|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
164278290|NCT03068754|593387889|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
164278291|NCT03068754|593387886|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
164278292|NCT03068754|593387887|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
164278293|NCT03068754|593387888|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
164278294|NCT03068754|593387889|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
164278295|NCT03068754|593387886|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
164278296|NCT03068754|593387887|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
164278297|NCT03068754|593387888|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
164278298|NCT03068754|593387889|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
164278299|NCT03068754|593387886|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
164278300|NCT03068754|593387887|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
164278301|NCT03068754|593387888|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
164278302|NCT03068754|593387889|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
164278303|NCT01110382|593387890|FG000|Overall Study|Withdrawal by Subject|0|||
164278304|NCT01110382|593387891|FG001|Overall Study|Withdrawal by Subject|1|||
164278305|NCT01110382|593387890|FG000|Overall Study|Protocol Violation|0|||
164278306|NCT01110382|593387891|FG001|Overall Study|Protocol Violation|1|||
164278307|NCT00098306|593387892|FG000|Double Blind|Randomized, not treated|9|||
164278308|NCT00098306|593387893|FG001|Double Blind|Randomized, not treated|5|||
164278309|NCT00098306|593387894|FG002|Double Blind|Randomized, not treated|2|||
164278310|NCT00098306|593387895|FG003|Double Blind|Randomized, not treated|0|||
164278311|NCT00098306|593387896|FG004|Double Blind|Randomized, not treated|0|||
164278312|NCT00098306|593387897|FG005|Double Blind|Randomized, not treated|0|||
164278313|NCT00098306|593387898|FG006|Double Blind|Randomized, not treated|0|||
164278314|NCT00098306|593387892|FG000|Double Blind|Ongoing at cut-off date|151|||
164278315|NCT00098306|593387893|FG001|Double Blind|Ongoing at cut-off date|166|||
164278316|NCT00098306|593387894|FG002|Double Blind|Ongoing at cut-off date|72|||
164278317|NCT00098306|593387895|FG003|Double Blind|Ongoing at cut-off date|0|||
164278318|NCT00098306|593387896|FG004|Double Blind|Ongoing at cut-off date|0|||
164278319|NCT00098306|593387897|FG005|Double Blind|Ongoing at cut-off date|0|||
164278320|NCT00098306|593387898|FG006|Double Blind|Ongoing at cut-off date|0|||
164278321|NCT00098306|593387892|FG000|Double Blind|Adverse Event|11|||
164278322|NCT00098306|593387893|FG001|Double Blind|Adverse Event|10|||
164278323|NCT00098306|593387894|FG002|Double Blind|Adverse Event|6|||
164278324|NCT00098306|593387895|FG003|Double Blind|Adverse Event|0|||
164278325|NCT00098306|593387896|FG004|Double Blind|Adverse Event|0|||
164278326|NCT00098306|593387897|FG005|Double Blind|Adverse Event|0|||
164278327|NCT00098306|593387898|FG006|Double Blind|Adverse Event|0|||
164278328|NCT00098306|593387892|FG000|Double Blind|Lack of Efficacy|43|||
164278329|NCT00098306|593387893|FG001|Double Blind|Lack of Efficacy|34|||
164278330|NCT00098306|593387894|FG002|Double Blind|Lack of Efficacy|17|||
164278331|NCT00098306|593387895|FG003|Double Blind|Lack of Efficacy|0|||
164278332|NCT00098306|593387896|FG004|Double Blind|Lack of Efficacy|0|||
164278333|NCT00098306|593387897|FG005|Double Blind|Lack of Efficacy|0|||
164278334|NCT00098306|593387898|FG006|Double Blind|Lack of Efficacy|0|||
164278335|NCT00098306|593387892|FG000|Double Blind|Death|1|||
164278336|NCT00098306|593387893|FG001|Double Blind|Death|4|||
164278337|NCT00098306|593387894|FG002|Double Blind|Death|1|||
164278338|NCT00098306|593387895|FG003|Double Blind|Death|0|||
164278339|NCT00098306|593387896|FG004|Double Blind|Death|0|||
164278340|NCT00098306|593387897|FG005|Double Blind|Death|0|||
164278341|NCT00098306|593387898|FG006|Double Blind|Death|0|||
164278342|NCT00098306|593387892|FG000|Double Blind|Participant defaulted|19|||
164278343|NCT00098306|593387893|FG001|Double Blind|Participant defaulted|18|||
164278344|NCT00098306|593387894|FG002|Double Blind|Participant defaulted|11|||
164278345|NCT00098306|593387895|FG003|Double Blind|Participant defaulted|0|||
164278346|NCT00098306|593387896|FG004|Double Blind|Participant defaulted|0|||
164278347|NCT00098306|593387897|FG005|Double Blind|Participant defaulted|0|||
164278348|NCT00098306|593387898|FG006|Double Blind|Participant defaulted|0|||
164278349|NCT00098306|593387892|FG000|Double Blind|Un-specified|7|||
164278350|NCT00098306|593387893|FG001|Double Blind|Un-specified|3|||
164278351|NCT00098306|593387894|FG002|Double Blind|Un-specified|11|||
164278352|NCT00098306|593387895|FG003|Double Blind|Un-specified|0|||
164278353|NCT00098306|593387896|FG004|Double Blind|Un-specified|0|||
164278354|NCT00098306|593387897|FG005|Double Blind|Un-specified|0|||
164278355|NCT00098306|593387898|FG006|Double Blind|Un-specified|0|||
164278356|NCT00098306|593387892|FG000|Open Label|Lack of Efficacy|0|||
164278357|NCT00098306|593387893|FG001|Open Label|Lack of Efficacy|0|||
164278358|NCT00098306|593387894|FG002|Open Label|Lack of Efficacy|0|||
164278359|NCT00098306|593387895|FG003|Open Label|Lack of Efficacy|13|||
164278360|NCT00098306|593387896|FG004|Open Label|Lack of Efficacy|0|||
164278361|NCT00098306|593387897|FG005|Open Label|Lack of Efficacy|0|||
164278362|NCT00098306|593387898|FG006|Open Label|Lack of Efficacy|0|||
164278363|NCT00098306|593387892|FG000|Open Label|Adverse Event|0|||
164278364|NCT00098306|593387893|FG001|Open Label|Adverse Event|0|||
164278365|NCT00098306|593387894|FG002|Open Label|Adverse Event|0|||
164278366|NCT00098306|593387895|FG003|Open Label|Adverse Event|2|||
164278367|NCT00098306|593387896|FG004|Open Label|Adverse Event|0|||
164278368|NCT00098306|593387897|FG005|Open Label|Adverse Event|0|||
164343827|NCT01847274|593635316|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
164343828|NCT01847274|593635317|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
164343829|NCT01847274|593635307|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
164343830|NCT01847274|593635308|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
164343831|NCT01847274|593635309|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
164343832|NCT01847274|593635310|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
164343833|NCT01847274|593635311|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
164343834|NCT01847274|593635312|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
164343835|NCT01847274|593635313|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
164343836|NCT01847274|593635314|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
164343837|NCT01847274|593635315|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
164343838|NCT01847274|593635316|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
164343839|NCT01847274|593635317|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
164343840|NCT01847274|593635307|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
164343841|NCT01847274|593635308|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
164343842|NCT01847274|593635309|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
164343843|NCT01847274|593635310|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
164343844|NCT01847274|593635311|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
164343845|NCT01847274|593635312|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
164343846|NCT01847274|593635313|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
164343847|NCT01847274|593635314|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
164343848|NCT01847274|593635315|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
164343849|NCT01847274|593635316|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
164343850|NCT01847274|593635317|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
164343851|NCT01847274|593635307|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
164343852|NCT01847274|593635308|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
164343853|NCT01847274|593635309|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
164343854|NCT01847274|593635310|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
164343855|NCT01847274|593635311|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
164343856|NCT01847274|593635312|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
164343857|NCT01847274|593635313|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
164343858|NCT01847274|593635314|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
164343859|NCT01847274|593635315|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
164343860|NCT01847274|593635316|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
164343861|NCT01847274|593635317|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
164343862|NCT01847274|593635307|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
164343863|NCT01847274|593635308|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
164343864|NCT01847274|593635309|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
164343865|NCT01847274|593635310|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
164343866|NCT01847274|593635311|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
164343867|NCT01847274|593635312|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
164343868|NCT01847274|593635313|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
164343869|NCT01847274|593635314|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
164343870|NCT01847274|593635315|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
164343871|NCT01847274|593635316|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
164343872|NCT01847274|593635317|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
164343873|NCT01847274|593635307|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
164343874|NCT01847274|593635308|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
164343875|NCT01847274|593635309|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
164343876|NCT01847274|593635310|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
164343877|NCT01847274|593635311|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
164343878|NCT01847274|593635312|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
164343879|NCT01847274|593635313|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
164432615|NCT04304534|593954650|FG002|Overall Study|Non-Compliance with study drug|1|||
164278369|NCT00098306|593387898|FG006|Open Label|Adverse Event|0|||
164432616|NCT04304534|593954651|FG003|Overall Study|Non-Compliance with study drug|1|||
164432617|NCT04304534|593954648|FG000|Overall Study|Lost to Follow-up|0|||
164432618|NCT04304534|593954649|FG001|Overall Study|Lost to Follow-up|1|||
164278370|NCT00098306|593387892|FG000|Open Label|Death|0|||
164278371|NCT00098306|593387893|FG001|Open Label|Death|0|||
164278372|NCT00098306|593387894|FG002|Open Label|Death|0|||
164278373|NCT00098306|593387895|FG003|Open Label|Death|4|||
164278374|NCT00098306|593387896|FG004|Open Label|Death|0|||
164278375|NCT00098306|593387897|FG005|Open Label|Death|0|||
164278376|NCT00098306|593387898|FG006|Open Label|Death|0|||
164278377|NCT00098306|593387892|FG000|Open Label|Participant defaulted|0|||
164278378|NCT00098306|593387893|FG001|Open Label|Participant defaulted|0|||
164278379|NCT00098306|593387894|FG002|Open Label|Participant defaulted|0|||
164278380|NCT00098306|593387895|FG003|Open Label|Participant defaulted|24|||
164278381|NCT00098306|593387896|FG004|Open Label|Participant defaulted|0|||
164278382|NCT00098306|593387897|FG005|Open Label|Participant defaulted|0|||
164278383|NCT00098306|593387898|FG006|Open Label|Participant defaulted|0|||
164278384|NCT00098306|593387892|FG000|Open Label|Un-specified|0|||
164278385|NCT00098306|593387893|FG001|Open Label|Un-specified|0|||
164278386|NCT00098306|593387894|FG002|Open Label|Un-specified|0|||
164278387|NCT00098306|593387895|FG003|Open Label|Un-specified|15|||
164278388|NCT00098306|593387896|FG004|Open Label|Un-specified|0|||
164278389|NCT00098306|593387897|FG005|Open Label|Un-specified|0|||
164278390|NCT00098306|593387898|FG006|Open Label|Un-specified|0|||
164278391|NCT00098306|593387892|FG000|Open Label|Ongoing at cut-off date|0|||
164278392|NCT00098306|593387893|FG001|Open Label|Ongoing at cut-off date|0|||
164278393|NCT00098306|593387894|FG002|Open Label|Ongoing at cut-off date|0|||
164278394|NCT00098306|593387895|FG003|Open Label|Ongoing at cut-off date|269|||
164278395|NCT00098306|593387896|FG004|Open Label|Ongoing at cut-off date|62|||
164278396|NCT00098306|593387897|FG005|Open Label|Ongoing at cut-off date|0|||
164278397|NCT00098306|593387898|FG006|Open Label|Ongoing at cut-off date|0|||
164278398|NCT00098306|593387892|FG000|Observational Phase|Death|0|||
164278399|NCT00098306|593387893|FG001|Observational Phase|Death|0|||
164278400|NCT00098306|593387894|FG002|Observational Phase|Death|0|||
164278401|NCT00098306|593387895|FG003|Observational Phase|Death|0|||
164278402|NCT00098306|593387896|FG004|Observational Phase|Death|0|||
164278403|NCT00098306|593387897|FG005|Observational Phase|Death|5|||
164278404|NCT00098306|593387898|FG006|Observational Phase|Death|4|||
164278405|NCT00098306|593387892|FG000|Observational Phase|Participant defaulted|0|||
164278406|NCT00098306|593387893|FG001|Observational Phase|Participant defaulted|0|||
164278407|NCT00098306|593387894|FG002|Observational Phase|Participant defaulted|0|||
164278408|NCT00098306|593387895|FG003|Observational Phase|Participant defaulted|0|||
164278409|NCT00098306|593387896|FG004|Observational Phase|Participant defaulted|0|||
164278410|NCT00098306|593387897|FG005|Observational Phase|Participant defaulted|34|||
164278411|NCT00098306|593387898|FG006|Observational Phase|Participant defaulted|18|||
164278412|NCT00098306|593387892|FG000|Observational Phase|Un-specified|0|||
164278413|NCT00098306|593387893|FG001|Observational Phase|Un-specified|0|||
164278414|NCT00098306|593387894|FG002|Observational Phase|Un-specified|0|||
164278415|NCT00098306|593387895|FG003|Observational Phase|Un-specified|0|||
164278416|NCT00098306|593387896|FG004|Observational Phase|Un-specified|0|||
164278417|NCT00098306|593387897|FG005|Observational Phase|Un-specified|7|||
164278418|NCT00098306|593387898|FG006|Observational Phase|Un-specified|4|||
164278419|NCT00129467|593387899|FG000|Received Intervention|Death|1|||
164278420|NCT00129467|593387900|FG001|Received Intervention|Death|1|||
164278421|NCT00129467|593387899|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
164278422|NCT00129467|593387900|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
164278423|NCT00129467|593387899|FG000|Received Intervention|Delirium|2|||
164278424|NCT00129467|593387900|FG001|Received Intervention|Delirium|0|||
164278425|NCT00129467|593387899|FG000|Received Intervention|Withdrawal by Subject|1|||
164278426|NCT00129467|593387900|FG001|Received Intervention|Withdrawal by Subject|0|||
164278427|NCT00129467|593387899|FG000|Received Intervention|Nausea|1|||
164278428|NCT00129467|593387900|FG001|Received Intervention|Nausea|0|||
164278429|NCT00129467|593387899|FG000|Received Intervention|Intolerance to citalopram|0|||
164278430|NCT00129467|593387900|FG001|Received Intervention|Intolerance to citalopram|1|||
164278431|NCT00129467|593387899|FG000|Received Intervention|Dizzyness, fatigue|0|||
164278432|NCT00129467|593387900|FG001|Received Intervention|Dizzyness, fatigue|1|||
164278433|NCT00129467|593387899|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
164278434|NCT00129467|593387900|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
164278435|NCT00129467|593387899|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
164278436|NCT00129467|593387900|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
164278437|NCT01009086|593387901|FG000|Overall Study|Lack of Efficacy|16|||
164278438|NCT01009086|593387902|FG001|Overall Study|Lack of Efficacy|15|||
164278439|NCT01009086|593387903|FG002|Overall Study|Lack of Efficacy|9|||
164278440|NCT01009086|593387901|FG000|Overall Study|Lost to Follow-up|4|||
164278441|NCT01009086|593387902|FG001|Overall Study|Lost to Follow-up|5|||
164278442|NCT01009086|593387903|FG002|Overall Study|Lost to Follow-up|3|||
164278443|NCT01009086|593387901|FG000|Overall Study|Adverse Event|12|||
164278444|NCT01009086|593387902|FG001|Overall Study|Adverse Event|11|||
164278445|NCT01009086|593387903|FG002|Overall Study|Adverse Event|8|||
164278446|NCT01009086|593387901|FG000|Overall Study|Withdrawal by Subject|9|||
164278447|NCT01009086|593387902|FG001|Overall Study|Withdrawal by Subject|11|||
164278448|NCT01009086|593387903|FG002|Overall Study|Withdrawal by Subject|13|||
164278449|NCT01009086|593387901|FG000|Overall Study|Other|3|||
164278450|NCT01009086|593387902|FG001|Overall Study|Other|5|||
164278451|NCT01009086|593387903|FG002|Overall Study|Other|1|||
164278452|NCT02456857|593387905|FG000|Overall Study|Disease Progression|4|||
164278453|NCT00781859|593387906|FG000|Overall Study|Adverse Event|2|||
164278454|NCT00781859|593387907|FG001|Overall Study|Adverse Event|2|||
164278455|NCT00781859|593387906|FG000|Overall Study|Withdrawal by Subject|8|||
164278456|NCT00781859|593387907|FG001|Overall Study|Withdrawal by Subject|4|||
164278457|NCT00781859|593387906|FG000|Overall Study|Lost to Follow-up|6|||
164278458|NCT00781859|593387907|FG001|Overall Study|Lost to Follow-up|3|||
164278459|NCT00781859|593387906|FG000|Overall Study|Death|3|||
164278460|NCT00781859|593387907|FG001|Overall Study|Death|0|||
164278461|NCT01138501|593387908|FG000|Overall Study|Protocol Violation|2|||
164278462|NCT01138501|593387908|FG000|Overall Study|Withdrawal by Subject|3|||
164278463|NCT00360568|593387909|FG000|Overall Study|Adverse Event|1|||
164278464|NCT00360568|593387910|FG001|Overall Study|Adverse Event|2|||
164278465|NCT00360568|593387909|FG000|Overall Study|Lack of Efficacy|1|||
164278466|NCT00360568|593387910|FG001|Overall Study|Lack of Efficacy|0|||
164278467|NCT00360568|593387909|FG000|Overall Study|Withdrawal by Subject|0|||
164278468|NCT00360568|593387910|FG001|Overall Study|Withdrawal by Subject|3|||
164278469|NCT01220180|593387912|FG000|Overall Study|Lost to Follow-up|76|||
164278470|NCT01220180|593387912|FG000|Overall Study|Other|72|||
164278471|NCT01220180|593387912|FG000|Overall Study|Adverse Event|35|||
164278472|NCT01220180|593387912|FG000|Overall Study|Lack of Efficacy|22|||
164278473|NCT01220180|593387912|FG000|Overall Study|Death|1|||
164278474|NCT01220180|593387912|FG000|Overall Study|Randomized but not treated|1|||
164278475|NCT01990859|593387913|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
164278476|NCT01990859|593387913|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
164278477|NCT00348309|593387914|FG000|Overall Study|Adverse Event|56|||
164278478|NCT00348309|593387915|FG001|Overall Study|Adverse Event|28|||
164278479|NCT00348309|593387916|FG002|Overall Study|Adverse Event|63|||
164278480|NCT00348309|593387914|FG000|Overall Study|Lost to Follow-up|6|||
164278481|NCT00348309|593387915|FG001|Overall Study|Lost to Follow-up|7|||
164278482|NCT00348309|593387916|FG002|Overall Study|Lost to Follow-up|4|||
164343880|NCT01847274|593635314|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
164343881|NCT01847274|593635315|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
164343882|NCT01847274|593635316|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
164343883|NCT01847274|593635317|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
164343884|NCT02059395|593635319|FG000|Overall Study|Lost to Follow-up|2|||
164343885|NCT02059395|593635320|FG001|Overall Study|Lost to Follow-up|4|||
164343886|NCT00134082|593635321|FG000|Overall Study|Adverse Event|2|||
164343887|NCT00134082|593635321|FG000|Overall Study|Death|1|||
164432619|NCT04304534|593954650|FG002|Overall Study|Lost to Follow-up|2|||
164584330|NCT00611455|594504632|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
164584331|NCT00611455|594504633|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
164584332|NCT00611455|594504631|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
164584333|NCT00611455|594504632|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
164584334|NCT00611455|594504633|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
164584335|NCT00611455|594504631|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
164584336|NCT00611455|594504632|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
164584337|NCT00611455|594504633|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
164584338|NCT00611455|594504631|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
164584339|NCT00611455|594504632|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
164584340|NCT00611455|594504633|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
164584341|NCT00611455|594504631|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
164584342|NCT00611455|594504632|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
164584343|NCT00611455|594504633|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
164584344|NCT00611455|594504631|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
164584345|NCT00611455|594504632|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
164584346|NCT00611455|594504633|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
164584347|NCT00611455|594504631|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
164584348|NCT00611455|594504632|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
164584349|NCT00611455|594504633|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
164584350|NCT00611455|594504631|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
164278483|NCT00348309|593387914|FG000|Overall Study|Protocol Violation|7|||
164278484|NCT00348309|593387915|FG001|Overall Study|Protocol Violation|12|||
164278485|NCT00348309|593387916|FG002|Overall Study|Protocol Violation|7|||
164278486|NCT00348309|593387914|FG000|Overall Study|Withdrawal by Subject|33|||
164278487|NCT00348309|593387915|FG001|Overall Study|Withdrawal by Subject|37|||
164278488|NCT00348309|593387916|FG002|Overall Study|Withdrawal by Subject|40|||
164278489|NCT00348309|593387914|FG000|Overall Study|Non-compliance|8|||
164343888|NCT00724932|593635324|FG000|Overall Study|Lost to Follow-up|1|||
164278490|NCT00348309|593387915|FG001|Overall Study|Non-compliance|6|||
164278491|NCT00348309|593387916|FG002|Overall Study|Non-compliance|8|||
164278492|NCT00348309|593387914|FG000|Overall Study|Death of caregiver|1|||
164278493|NCT00348309|593387915|FG001|Overall Study|Death of caregiver|0|||
164278494|NCT00348309|593387916|FG002|Overall Study|Death of caregiver|1|||
164278495|NCT00348309|593387914|FG000|Overall Study|Lack of insight, dementia|1|||
164278496|NCT00348309|593387915|FG001|Overall Study|Lack of insight, dementia|0|||
164278497|NCT00348309|593387916|FG002|Overall Study|Lack of insight, dementia|0|||
164278498|NCT00348309|593387914|FG000|Overall Study|Wrong bottle allocated|1|||
164278499|NCT00348309|593387915|FG001|Overall Study|Wrong bottle allocated|0|||
164278500|NCT00348309|593387916|FG002|Overall Study|Wrong bottle allocated|0|||
164278501|NCT00348309|593387914|FG000|Overall Study|Caregiver sick|1|||
164278502|NCT00348309|593387915|FG001|Overall Study|Caregiver sick|0|||
164278503|NCT00348309|593387916|FG002|Overall Study|Caregiver sick|0|||
164584351|NCT00611455|594504632|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
164584352|NCT00611455|594504633|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
164584353|NCT00611455|594504631|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
164584354|NCT00611455|594504632|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
164584355|NCT00611455|594504633|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
164584356|NCT00611455|594504631|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
164584357|NCT00611455|594504632|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
164584358|NCT00611455|594504633|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
164584359|NCT00611455|594504631|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
164584360|NCT00611455|594504632|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
164689767|NCT01332968|594887791|FG007|Induction Period|Withdrawal by Subject|0|||
164689768|NCT01332968|594887784|FG000|Induction Period|Randomised but not treated|4|||
164278504|NCT00348309|593387914|FG000|Overall Study|Use of prohibited medication|5|||
164278505|NCT00348309|593387915|FG001|Overall Study|Use of prohibited medication|2|||
164278506|NCT00348309|593387916|FG002|Overall Study|Use of prohibited medication|2|||
164278507|NCT00348309|593387914|FG000|Overall Study|Caregiver withdrawal|3|||
164278508|NCT00348309|593387915|FG001|Overall Study|Caregiver withdrawal|0|||
164278509|NCT00348309|593387916|FG002|Overall Study|Caregiver withdrawal|7|||
164278510|NCT00348309|593387914|FG000|Overall Study|Unable to complete ET visit|1|||
164278511|NCT00348309|593387915|FG001|Overall Study|Unable to complete ET visit|0|||
164278512|NCT00348309|593387916|FG002|Overall Study|Unable to complete ET visit|0|||
164278513|NCT00348309|593387914|FG000|Overall Study|PI closing medical practice|1|||
164278514|NCT00348309|593387915|FG001|Overall Study|PI closing medical practice|0|||
164278515|NCT00348309|593387916|FG002|Overall Study|PI closing medical practice|0|||
164278516|NCT00348309|593387914|FG000|Overall Study|Principal investigator's decision|1|||
164278517|NCT00348309|593387915|FG001|Overall Study|Principal investigator's decision|0|||
164278518|NCT00348309|593387916|FG002|Overall Study|Principal investigator's decision|0|||
164278519|NCT00348309|593387914|FG000|Overall Study|No disponibility of medication|1|||
164278520|NCT00348309|593387915|FG001|Overall Study|No disponibility of medication|0|||
164278521|NCT00348309|593387916|FG002|Overall Study|No disponibility of medication|0|||
164278522|NCT00348309|593387914|FG000|Overall Study|Worsened neurodegenerative disease|1|||
164278523|NCT00348309|593387915|FG001|Overall Study|Worsened neurodegenerative disease|0|||
164278524|NCT00348309|593387916|FG002|Overall Study|Worsened neurodegenerative disease|0|||
164278525|NCT00348309|593387914|FG000|Overall Study|Cognitive and behaviour worsening|2|||
164278526|NCT00348309|593387915|FG001|Overall Study|Cognitive and behaviour worsening|0|||
164278527|NCT00348309|593387916|FG002|Overall Study|Cognitive and behaviour worsening|0|||
164278528|NCT00348309|593387914|FG000|Overall Study|Worsening of alzheimer|1|||
164278529|NCT00348309|593387915|FG001|Overall Study|Worsening of alzheimer|0|||
164278530|NCT00348309|593387916|FG002|Overall Study|Worsening of alzheimer|1|||
164278531|NCT00348309|593387914|FG000|Overall Study|Did not appear in time for Visit 3|1|||
164278532|NCT00348309|593387915|FG001|Overall Study|Did not appear in time for Visit 3|0|||
164278533|NCT00348309|593387916|FG002|Overall Study|Did not appear in time for Visit 3|0|||
164278534|NCT00348309|593387914|FG000|Overall Study|Participant died|2|||
164278535|NCT00348309|593387915|FG001|Overall Study|Participant died|1|||
164278536|NCT00348309|593387916|FG002|Overall Study|Participant died|1|||
164278537|NCT00348309|593387914|FG000|Overall Study|Decision of sponsor|1|||
164278538|NCT00348309|593387915|FG001|Overall Study|Decision of sponsor|0|||
164278539|NCT00348309|593387916|FG002|Overall Study|Decision of sponsor|0|||
164278540|NCT00348309|593387914|FG000|Overall Study|Ineffectiveness of treatment|0|||
164278541|NCT00348309|593387915|FG001|Overall Study|Ineffectiveness of treatment|1|||
164278542|NCT00348309|593387916|FG002|Overall Study|Ineffectiveness of treatment|0|||
164278543|NCT00348309|593387914|FG000|Overall Study|A foul of exclusion criteria|0|||
164278544|NCT00348309|593387915|FG001|Overall Study|A foul of exclusion criteria|1|||
164278545|NCT00348309|593387916|FG002|Overall Study|A foul of exclusion criteria|0|||
164278546|NCT00348309|593387914|FG000|Overall Study|Participant was hospitalized|0|||
164278547|NCT00348309|593387915|FG001|Overall Study|Participant was hospitalized|1|||
164278548|NCT00348309|593387916|FG002|Overall Study|Participant was hospitalized|0|||
164278549|NCT00348309|593387914|FG000|Overall Study|Sponsor refuseal|0|||
164432620|NCT04304534|593954651|FG003|Overall Study|Lost to Follow-up|3|||
164584361|NCT00611455|594504633|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
164278550|NCT00348309|593387915|FG001|Overall Study|Sponsor refuseal|1|||
164278551|NCT00348309|593387916|FG002|Overall Study|Sponsor refuseal|1|||
164278552|NCT00348309|593387914|FG000|Overall Study|Forgot often medication|0|||
164278553|NCT00348309|593387915|FG001|Overall Study|Forgot often medication|1|||
164278554|NCT00348309|593387916|FG002|Overall Study|Forgot often medication|0|||
164278555|NCT00348309|593387914|FG000|Overall Study|Medical Monitor decision|0|||
164278556|NCT00348309|593387915|FG001|Overall Study|Medical Monitor decision|0|||
164278557|NCT00348309|593387916|FG002|Overall Study|Medical Monitor decision|1|||
164278558|NCT00348309|593387914|FG000|Overall Study|Increased dose of Aricept|0|||
164278559|NCT00348309|593387915|FG001|Overall Study|Increased dose of Aricept|0|||
164278560|NCT00348309|593387916|FG002|Overall Study|Increased dose of Aricept|1|||
164278561|NCT00348309|593387914|FG000|Overall Study|Site closure|0|||
164278562|NCT00348309|593387915|FG001|Overall Study|Site closure|0|||
164278563|NCT00348309|593387916|FG002|Overall Study|Site closure|1|||
164278564|NCT00348309|593387914|FG000|Overall Study|Adverse event not attended|0|||
164278565|NCT00348309|593387915|FG001|Overall Study|Adverse event not attended|0|||
164278566|NCT00348309|593387916|FG002|Overall Study|Adverse event not attended|1|||
164278567|NCT00348309|593387914|FG000|Overall Study|ECG abnormal|0|||
164278568|NCT00348309|593387915|FG001|Overall Study|ECG abnormal|0|||
164278569|NCT00348309|593387916|FG002|Overall Study|ECG abnormal|2|||
164278570|NCT00348309|593387914|FG000|Overall Study|Cardiologist recommendations|0|||
164278571|NCT00348309|593387915|FG001|Overall Study|Cardiologist recommendations|0|||
164278572|NCT00348309|593387916|FG002|Overall Study|Cardiologist recommendations|1|||
164278573|NCT00348309|593387914|FG000|Overall Study|HCV career|0|||
164278574|NCT00348309|593387915|FG001|Overall Study|HCV career|0|||
164278575|NCT00348309|593387916|FG002|Overall Study|HCV career|1|||
164278576|NCT01364389|593387919|FG000|Overall Study|Withdrawal by Subject|0|||
164278577|NCT01364389|593387920|FG001|Overall Study|Withdrawal by Subject|1|||
164278578|NCT01364389|593387921|FG002|Overall Study|Withdrawal by Subject|0|||
164278579|NCT01364389|593387919|FG000|Overall Study|Protocol deviation|0|||
164278580|NCT01364389|593387920|FG001|Overall Study|Protocol deviation|0|||
164278581|NCT01364389|593387921|FG002|Overall Study|Protocol deviation|1|||
164343889|NCT00724932|593635325|FG001|Overall Study|Lost to Follow-up|0|||
164343890|NCT00724932|593635324|FG000|Overall Study|Not treated|4|||
164343891|NCT00724932|593635325|FG001|Overall Study|Not treated|3|||
164343892|NCT02021331|593635326|FG000|Overall Study|Adverse Event|0|||
164343893|NCT02021331|593635327|FG001|Overall Study|Adverse Event|2|||
164343894|NCT01488370|593635328|FG000|Overall Study|Protocol Violation|0|||
164343895|NCT01488370|593635329|FG001|Overall Study|Protocol Violation|1|||
164343896|NCT01488370|593635330|FG002|Overall Study|Protocol Violation|1|||
164343897|NCT02340975|593635343|FG000|Overall Study|Death|6|||
164343898|NCT02340975|593635344|FG001|Overall Study|Death|23|||
164343899|NCT02340975|593635345|FG002|Overall Study|Death|21|||
164343900|NCT02340975|593635346|FG003|Overall Study|Death|7|||
164343901|NCT02340975|593635347|FG004|Overall Study|Death|21|||
164343902|NCT02340975|593635348|FG005|Overall Study|Death|13|||
164343903|NCT02340975|593635343|FG000|Overall Study|Lost to Follow-up|0|||
164343904|NCT02340975|593635344|FG001|Overall Study|Lost to Follow-up|0|||
164343905|NCT02340975|593635345|FG002|Overall Study|Lost to Follow-up|0|||
164343906|NCT02340975|593635346|FG003|Overall Study|Lost to Follow-up|0|||
164343907|NCT02340975|593635347|FG004|Overall Study|Lost to Follow-up|2|||
164343908|NCT02340975|593635348|FG005|Overall Study|Lost to Follow-up|0|||
164343909|NCT02340975|593635343|FG000|Overall Study|Withdrawal by Subject|0|||
164343910|NCT02340975|593635344|FG001|Overall Study|Withdrawal by Subject|0|||
164343911|NCT02340975|593635345|FG002|Overall Study|Withdrawal by Subject|3|||
164278582|NCT01364389|593387919|FG000|Overall Study|Administrative problems|1|||
164278583|NCT01364389|593387920|FG001|Overall Study|Administrative problems|0|||
164278584|NCT01364389|593387921|FG002|Overall Study|Administrative problems|0|||
164278585|NCT01364389|593387919|FG000|Overall Study|Adverse Event|1|||
164278586|NCT01364389|593387920|FG001|Overall Study|Adverse Event|0|||
164278587|NCT01364389|593387921|FG002|Overall Study|Adverse Event|0|||
164343912|NCT02340975|593635346|FG003|Overall Study|Withdrawal by Subject|3|||
164584362|NCT00611455|594504631|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
164584363|NCT00611455|594504632|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
164278588|NCT01534195|593387922|FG000|Overall Study|Withdrawal by Subject|1|||
164278589|NCT01534195|593387923|FG001|Overall Study|Withdrawal by Subject|1|||
164278590|NCT02554981|593387924|FG000|Overall Study|Adverse Event|1|||
164278591|NCT02554981|593387924|FG000|Overall Study|Administrative Reasons|1|||
164278592|NCT02554981|593387924|FG000|Overall Study|Other Miscellaneous Reasons|3|||
164278593|NCT03068767|593387931|FG000|Overall Study|Lost to Follow-up|7|||
164343913|NCT02340975|593635347|FG004|Overall Study|Withdrawal by Subject|2|||
164343914|NCT02340975|593635348|FG005|Overall Study|Withdrawal by Subject|0|||
164343915|NCT02340975|593635343|FG000|Overall Study|Other|0|||
164343916|NCT02340975|593635344|FG001|Overall Study|Other|4|||
164343917|NCT02340975|593635345|FG002|Overall Study|Other|0|||
164343918|NCT02340975|593635346|FG003|Overall Study|Other|2|||
164343919|NCT02340975|593635347|FG004|Overall Study|Other|0|||
164343920|NCT02340975|593635348|FG005|Overall Study|Other|6|||
164343921|NCT01007812|593635351|FG000|Period 1, One Week|Lost to Follow-up|0|||
164343922|NCT01007812|593635352|FG001|Period 1, One Week|Lost to Follow-up|1|||
164343923|NCT01007812|593635351|FG000|Period 1, One Week|Discomfort|1|||
164343924|NCT01007812|593635352|FG001|Period 1, One Week|Discomfort|0|||
164343925|NCT01091974|593635353|FG000|Overall Study|Did not start intervention|3|||
164343926|NCT01091974|593635354|FG001|Overall Study|Did not start intervention|1|||
164343927|NCT01091974|593635355|FG002|Overall Study|Did not start intervention|3|||
164343928|NCT01091974|593635356|FG003|Overall Study|Did not start intervention|1|||
164343929|NCT01091974|593635353|FG000|Overall Study|resumed sleep medication|0|||
164343930|NCT01091974|593635354|FG001|Overall Study|resumed sleep medication|0|||
164343931|NCT01091974|593635355|FG002|Overall Study|resumed sleep medication|1|||
164343932|NCT01091974|593635356|FG003|Overall Study|resumed sleep medication|2|||
164343933|NCT01091974|593635353|FG000|Overall Study|Withdrawal by Subject|1|||
164343934|NCT01091974|593635354|FG001|Overall Study|Withdrawal by Subject|3|||
164343935|NCT01091974|593635355|FG002|Overall Study|Withdrawal by Subject|2|||
164343936|NCT01091974|593635356|FG003|Overall Study|Withdrawal by Subject|2|||
164343937|NCT01091974|593635353|FG000|Overall Study|side-effects|1|||
164343938|NCT01091974|593635354|FG001|Overall Study|side-effects|1|||
164343939|NCT01091974|593635355|FG002|Overall Study|side-effects|0|||
164343940|NCT01091974|593635356|FG003|Overall Study|side-effects|2|||
164343941|NCT03948581|593635357|FG000|Overall Study|Lost to Follow-up|0|||
164343942|NCT03948581|593635358|FG001|Overall Study|Lost to Follow-up|1|||
164343943|NCT01876420|593635359|FG000|Overall Study|Missed 30 day visit|1|||
164343944|NCT03173313|593635360|FG000|Overall Study|Lost to Follow-up|2|||
164343945|NCT03173313|593635361|FG001|Overall Study|Lost to Follow-up|3|||
164343946|NCT03173313|593635360|FG000|Overall Study|Withdrawal by Subject|0|||
164343947|NCT03173313|593635361|FG001|Overall Study|Withdrawal by Subject|1|||
164343948|NCT03173313|593635360|FG000|Overall Study|Death|5|||
164343949|NCT03173313|593635361|FG001|Overall Study|Death|0|||
164343950|NCT03173313|593635360|FG000|Overall Study|Physician Decision|1|||
164343951|NCT03173313|593635361|FG001|Overall Study|Physician Decision|0|||
164432621|NCT04304534|593954648|FG000|Overall Study|Unspecific|4|||
164432622|NCT04304534|593954649|FG001|Overall Study|Unspecific|2|||
164432623|NCT04304534|593954650|FG002|Overall Study|Unspecific|2|||
164343952|NCT03173313|593635360|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
164343953|NCT03173313|593635361|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
164343954|NCT03173313|593635360|FG000|Overall Study|Bone Fracture|1|||
164343955|NCT03173313|593635361|FG001|Overall Study|Bone Fracture|0|||
164343956|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
164343957|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
164343958|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
164278594|NCT03068767|593387932|FG001|Overall Study|Lost to Follow-up|3|||
164278595|NCT03068767|593387931|FG000|Overall Study|Protocol Violation|3|||
164278596|NCT03068767|593387932|FG001|Overall Study|Protocol Violation|0|||
164278597|NCT00061633|593387933|FG000|Overall Study|Adverse Event|1|||
164278598|NCT00061633|593387934|FG001|Overall Study|Adverse Event|2|||
164278599|NCT00061633|593387933|FG000|Overall Study|Withdrawal by Subject|2|||
164278600|NCT00061633|593387934|FG001|Overall Study|Withdrawal by Subject|2|||
164278601|NCT00061633|593387933|FG000|Overall Study|Lost to Follow-up|1|||
164278602|NCT00061633|593387934|FG001|Overall Study|Lost to Follow-up|4|||
164278603|NCT00061633|593387933|FG000|Overall Study|Other|1|||
164278604|NCT00061633|593387934|FG001|Overall Study|Other|1|||
164278605|NCT00061633|593387933|FG000|Overall Study|Never received study treatment|0|||
164278606|NCT00061633|593387934|FG001|Overall Study|Never received study treatment|2|||
164278607|NCT01431963|593387935|FG000|Overall Study|Adverse Event|18|||
164278608|NCT01431963|593387935|FG000|Overall Study|Lack of Efficacy|7|||
164278609|NCT01431963|593387935|FG000|Overall Study|Protocol Violation|1|||
164278610|NCT01431963|593387935|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
164278611|NCT01431963|593387935|FG000|Overall Study|Physician Decision|4|||
164278612|NCT01431963|593387935|FG000|Overall Study|Withdrawal by Subject|3|||
164278613|NCT01946152|593390381|FG000|Overall Study|Adverse Event|1|||
164278614|NCT01946152|593390382|FG001|Overall Study|Adverse Event|0|||
164278615|NCT01946152|593390383|FG002|Overall Study|Adverse Event|0|||
164343959|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
164343960|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
164343961|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
164343962|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
164343963|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
164343964|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
164343965|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
164432624|NCT04304534|593954651|FG003|Overall Study|Unspecific|2|||
164278616|NCT01946152|593390384|FG003|Overall Study|Adverse Event|0|||
164278617|NCT01946152|593390381|FG000|Overall Study|Withdrawal by Subject|0|||
164278618|NCT01946152|593390382|FG001|Overall Study|Withdrawal by Subject|2|||
164278619|NCT01946152|593390383|FG002|Overall Study|Withdrawal by Subject|0|||
164278620|NCT01946152|593390384|FG003|Overall Study|Withdrawal by Subject|0|||
164278621|NCT01946152|593390381|FG000|Overall Study|Progression|0|||
164278622|NCT01946152|593390382|FG001|Overall Study|Progression|1|||
164278623|NCT01946152|593390383|FG002|Overall Study|Progression|4|||
164278624|NCT01946152|593390384|FG003|Overall Study|Progression|7|||
164278625|NCT01946152|593390381|FG000|Overall Study|Physician Decision|0|||
164278626|NCT01946152|593390382|FG001|Overall Study|Physician Decision|0|||
164278627|NCT01946152|593390383|FG002|Overall Study|Physician Decision|1|||
164278628|NCT01946152|593390384|FG003|Overall Study|Physician Decision|0|||
164278629|NCT01946152|593390381|FG000|Overall Study|Second malignancy|0|||
164278630|NCT01946152|593390382|FG001|Overall Study|Second malignancy|0|||
164278631|NCT01946152|593390383|FG002|Overall Study|Second malignancy|1|||
164278632|NCT01946152|593390384|FG003|Overall Study|Second malignancy|0|||
164278633|NCT01946152|593390381|FG000|Overall Study|Adverse Event|0|||
164278634|NCT01946152|593390382|FG001|Overall Study|Adverse Event|0|||
164278635|NCT01946152|593390383|FG002|Overall Study|Adverse Event|0|||
164278636|NCT01946152|593390384|FG003|Overall Study|Adverse Event|1|||
164278637|NCT02291419|593390385|FG000|Overall Study|Early study termination|1|||
164278638|NCT02291419|593390386|FG001|Overall Study|Early study termination|5|||
164278639|NCT00931606|593390387|FG000|Overall Study|Death|1|||
164278640|NCT00931606|593390388|FG001|Overall Study|Death|3|||
164278641|NCT00931606|593390389|FG002|Overall Study|Death|2|||
164278642|NCT00931606|593390390|FG003|Overall Study|Death|0|||
164278643|NCT00931606|593390387|FG000|Overall Study|Lost to Follow-up|0|||
164278644|NCT00931606|593390388|FG001|Overall Study|Lost to Follow-up|1|||
164278645|NCT00931606|593390389|FG002|Overall Study|Lost to Follow-up|0|||
164278646|NCT00931606|593390390|FG003|Overall Study|Lost to Follow-up|0|||
164278647|NCT00931606|593390387|FG000|Overall Study|Physician Decision|0|||
164278648|NCT00931606|593390388|FG001|Overall Study|Physician Decision|0|||
164278649|NCT00931606|593390389|FG002|Overall Study|Physician Decision|3|||
164278650|NCT00931606|593390390|FG003|Overall Study|Physician Decision|0|||
164278651|NCT00931606|593390387|FG000|Overall Study|Sponsor Decision|1|||
164278652|NCT00931606|593390388|FG001|Overall Study|Sponsor Decision|4|||
164278653|NCT00931606|593390389|FG002|Overall Study|Sponsor Decision|0|||
164278654|NCT00931606|593390390|FG003|Overall Study|Sponsor Decision|2|||
164278655|NCT00931606|593390387|FG000|Overall Study|Withdrawal by Subject|3|||
164278656|NCT00931606|593390388|FG001|Overall Study|Withdrawal by Subject|1|||
164278657|NCT00931606|593390389|FG002|Overall Study|Withdrawal by Subject|1|||
164278658|NCT00931606|593390390|FG003|Overall Study|Withdrawal by Subject|1|||
164278659|NCT00871338|593390391|FG000|Prior to Booster|Withdrawal by Subject|1|||
164278660|NCT00871338|593390392|FG001|Prior to Booster|Withdrawal by Subject|3|||
164278661|NCT00871338|593390391|FG000|Prior to Booster|Lost to Follow-up|1|||
164278662|NCT00871338|593390392|FG001|Prior to Booster|Lost to Follow-up|0|||
164278663|NCT02391363|593390393|FG000|Overall Study|Lost to Follow-up|5|||
164278664|NCT02391363|593390394|FG001|Overall Study|Lost to Follow-up|5|||
164278665|NCT02391363|593390393|FG000|Overall Study|Withdrawal by Subject|6|||
164278666|NCT02391363|593390394|FG001|Overall Study|Withdrawal by Subject|3|||
164432625|NCT04304534|593954648|FG000|Overall Study|Technical Problems|2|||
164278667|NCT00799266|593390395|FG000|Overall Study|Adverse Event|0|||
164278668|NCT00799266|593390396|FG001|Overall Study|Adverse Event|1|||
164278669|NCT00799266|593390395|FG000|Overall Study|Subject withdrew consent|3|||
164278670|NCT00799266|593390396|FG001|Overall Study|Subject withdrew consent|0|||
164278671|NCT00872599|593390397|FG000|Second Washout Period|Adverse Event|1|||
164278672|NCT00872599|593390398|FG001|Second Washout Period|Adverse Event|1|||
164278673|NCT01504841|593390401|FG000|Overall Study|Withdrawal by Subject|1|||
164278674|NCT01504841|593390402|FG001|Overall Study|Withdrawal by Subject|1|||
164278675|NCT01504841|593390403|FG002|Overall Study|Withdrawal by Subject|0|||
164278676|NCT03149055|593390406|FG000|Overall Study|Not treated|4|||
164278677|NCT04440813|593390407|FG000|Overall Study|Lost to Follow-up|5|||
164278678|NCT04440813|593390408|FG001|Overall Study|Lost to Follow-up|5|||
164278679|NCT00660179|593390409|FG000|Overall Study|Death|44|||
164278680|NCT00660179|593390410|FG001|Overall Study|Death|47|||
164278681|NCT00660179|593390411|FG002|Overall Study|Death|34|||
164278682|NCT00660179|593390409|FG000|Overall Study|Withdrawal of consent|4|||
164142994|NCT00863772|592884485|FG001|Overall Study|Lost to Follow-up|1|||
164278683|NCT00660179|593390410|FG001|Overall Study|Withdrawal of consent|6|||
164278684|NCT00660179|593390411|FG002|Overall Study|Withdrawal of consent|4|||
164278685|NCT00660179|593390409|FG000|Overall Study|Lost to Follow-up|7|||
164278686|NCT00660179|593390410|FG001|Overall Study|Lost to Follow-up|5|||
164278687|NCT00660179|593390411|FG002|Overall Study|Lost to Follow-up|2|||
164278688|NCT00660179|593390409|FG000|Overall Study|Administrative reason|0|||
164278689|NCT00660179|593390410|FG001|Overall Study|Administrative reason|0|||
164278690|NCT00660179|593390411|FG002|Overall Study|Administrative reason|1|||
164278691|NCT00660179|593390409|FG000|Overall Study|Incorrect randomization|1|||
164278692|NCT00660179|593390410|FG001|Overall Study|Incorrect randomization|0|||
164278693|NCT00660179|593390411|FG002|Overall Study|Incorrect randomization|0|||
164278694|NCT00291018|593390416|FG000|Overall Study|Not Consented or Declined PAS|12|||
164278695|NCT00291018|593390417|FG001|Overall Study|Not Consented or Declined PAS|15|||
164278696|NCT00291018|593390418|FG002|Overall Study|Not Consented or Declined PAS|15|||
164278697|NCT00291018|593390416|FG000|Overall Study|Death|3|||
164278698|NCT00291018|593390417|FG001|Overall Study|Death|3|||
164278699|NCT00291018|593390418|FG002|Overall Study|Death|4|||
164278700|NCT00291018|593390416|FG000|Overall Study|Withdrawal by Subject|2|||
164278701|NCT00291018|593390417|FG001|Overall Study|Withdrawal by Subject|8|||
164278702|NCT00291018|593390418|FG002|Overall Study|Withdrawal by Subject|1|||
164278703|NCT00291018|593390416|FG000|Overall Study|Failures|5|||
164278704|NCT00291018|593390417|FG001|Overall Study|Failures|12|||
164278705|NCT00291018|593390418|FG002|Overall Study|Failures|5|||
164278706|NCT00291018|593390416|FG000|Overall Study|Lost to Follow-up|3|||
164278707|NCT00291018|593390417|FG001|Overall Study|Lost to Follow-up|4|||
164278708|NCT00291018|593390418|FG002|Overall Study|Lost to Follow-up|18|||
164278709|NCT01504412|593390419|FG000|Overall Study|Adverse Event|1|||
164278710|NCT01504412|593390420|FG001|Overall Study|Adverse Event|8|||
164278711|NCT01504412|593390421|FG002|Overall Study|Adverse Event|1|||
164278712|NCT01504412|593390422|FG003|Overall Study|Adverse Event|7|||
164278713|NCT01504412|593390423|FG004|Overall Study|Adverse Event|10|||
164278714|NCT01504412|593390419|FG000|Overall Study|Withdrawal by Subject|2|||
164278715|NCT01504412|593390420|FG001|Overall Study|Withdrawal by Subject|1|||
164278716|NCT01504412|593390421|FG002|Overall Study|Withdrawal by Subject|1|||
164278717|NCT01504412|593390422|FG003|Overall Study|Withdrawal by Subject|5|||
164278718|NCT01504412|593390423|FG004|Overall Study|Withdrawal by Subject|1|||
164278719|NCT01504412|593390419|FG000|Overall Study|Other|2|||
164278720|NCT01504412|593390420|FG001|Overall Study|Other|1|||
164278721|NCT01504412|593390421|FG002|Overall Study|Other|1|||
164278722|NCT01504412|593390422|FG003|Overall Study|Other|6|||
164278723|NCT01504412|593390423|FG004|Overall Study|Other|1|||
164278724|NCT01504412|593390419|FG000|Overall Study|Lost to Follow-up|0|||
164278725|NCT01504412|593390420|FG001|Overall Study|Lost to Follow-up|2|||
164278726|NCT01504412|593390421|FG002|Overall Study|Lost to Follow-up|0|||
164278727|NCT01504412|593390422|FG003|Overall Study|Lost to Follow-up|0|||
164278728|NCT01504412|593390423|FG004|Overall Study|Lost to Follow-up|0|||
164278729|NCT01504412|593390419|FG000|Overall Study|Lack of Efficacy|0|||
164278730|NCT01504412|593390420|FG001|Overall Study|Lack of Efficacy|0|||
164278731|NCT01504412|593390421|FG002|Overall Study|Lack of Efficacy|1|||
164278732|NCT01504412|593390422|FG003|Overall Study|Lack of Efficacy|0|||
164278733|NCT01504412|593390423|FG004|Overall Study|Lack of Efficacy|1|||
164278734|NCT01504412|593390419|FG000|Overall Study|Death|0|||
164278735|NCT01504412|593390420|FG001|Overall Study|Death|0|||
164278736|NCT01504412|593390421|FG002|Overall Study|Death|0|||
164278737|NCT01504412|593390422|FG003|Overall Study|Death|1|||
164278738|NCT01504412|593390423|FG004|Overall Study|Death|0|||
164278739|NCT00630344|593390424|FG000|Overall Study|Adverse Event|5|||
164278740|NCT00630344|593390424|FG000|Overall Study|Progressive Disease|19|||
164278741|NCT00630344|593390424|FG000|Overall Study|Physician Decision|9|||
164278742|NCT00630344|593390424|FG000|Overall Study|Withdrawal by Subject|1|||
164278743|NCT00630344|593390424|FG000|Overall Study|Intercurrent Illness|1|||
164278744|NCT00630344|593390424|FG000|Overall Study|Other|1|||
164278745|NCT05362058|593390429|FG000|Treatment Period|Adverse Event|3|||
164278746|NCT05362058|593390430|FG001|Treatment Period|Adverse Event|3|||
164278747|NCT05362058|593390429|FG000|Treatment Period|Assigned treatment by mistake|3|||
164278748|NCT05362058|593390430|FG001|Treatment Period|Assigned treatment by mistake|4|||
164278749|NCT05362058|593390429|FG000|Treatment Period|Death|1|||
164278750|NCT05362058|593390430|FG001|Treatment Period|Death|1|||
164278751|NCT05362058|593390429|FG000|Treatment Period|Lost to Follow-up|6|||
164278752|NCT05362058|593390430|FG001|Treatment Period|Lost to Follow-up|3|||
164278753|NCT05362058|593390429|FG000|Treatment Period|Non-compliance with study drug|0|||
164278754|NCT05362058|593390430|FG001|Treatment Period|Non-compliance with study drug|1|||
164278755|NCT05362058|593390429|FG000|Treatment Period|Physician Decision|1|||
164278756|NCT05362058|593390430|FG001|Treatment Period|Physician Decision|0|||
164278757|NCT05362058|593390429|FG000|Treatment Period|Protocol deviation|1|||
164278758|NCT05362058|593390430|FG001|Treatment Period|Protocol deviation|0|||
164278759|NCT05362058|593390429|FG000|Treatment Period|Withdrawal by Subject|10|||
164278760|NCT05362058|593390430|FG001|Treatment Period|Withdrawal by Subject|11|||
164278761|NCT05362058|593390429|FG000|Follow-Up Period|Death|1|||
164278762|NCT05362058|593390430|FG001|Follow-Up Period|Death|0|||
164278763|NCT05362058|593390429|FG000|Follow-Up Period|Lost to Follow-up|2|||
164278764|NCT05362058|593390430|FG001|Follow-Up Period|Lost to Follow-up|1|||
164278765|NCT05362058|593390429|FG000|Follow-Up Period|Protocol deviation|1|||
164278766|NCT05362058|593390430|FG001|Follow-Up Period|Protocol deviation|1|||
164278767|NCT05362058|593390429|FG000|Follow-Up Period|Withdrawal by Subject|0|||
164278768|NCT05362058|593390430|FG001|Follow-Up Period|Withdrawal by Subject|3|||
164278769|NCT03626545|593390437|FG000|Overall Study|Progressive disease|3|||
164278770|NCT03626545|593390438|FG001|Overall Study|Progressive disease|82|||
164278771|NCT03626545|593390439|FG002|Overall Study|Progressive disease|85|||
164278772|NCT03626545|593390437|FG000|Overall Study|Adverse Event|3|||
164278773|NCT03626545|593390438|FG001|Overall Study|Adverse Event|13|||
164278774|NCT03626545|593390439|FG002|Overall Study|Adverse Event|10|||
164278775|NCT03626545|593390437|FG000|Overall Study|Physician Decision|1|||
164278776|NCT03626545|593390438|FG001|Overall Study|Physician Decision|18|||
164278777|NCT03626545|593390439|FG002|Overall Study|Physician Decision|14|||
164278778|NCT03626545|593390437|FG000|Overall Study|Subject Decision|0|||
164278779|NCT03626545|593390438|FG001|Overall Study|Subject Decision|5|||
164278780|NCT03626545|593390439|FG002|Overall Study|Subject Decision|5|||
164278781|NCT03626545|593390437|FG000|Overall Study|Death|1|||
164278782|NCT03626545|593390438|FG001|Overall Study|Death|1|||
164278783|NCT03626545|593390439|FG002|Overall Study|Death|1|||
164278784|NCT03626545|593390437|FG000|Overall Study|Protocol Deviation|0|||
164278785|NCT03626545|593390438|FG001|Overall Study|Protocol Deviation|1|||
164278786|NCT03626545|593390439|FG002|Overall Study|Protocol Deviation|1|||
164278787|NCT03626545|593390437|FG000|Overall Study|Guardian Decision|0|||
164278788|NCT03626545|593390438|FG001|Overall Study|Guardian Decision|0|||
164278789|NCT03626545|593390439|FG002|Overall Study|Guardian Decision|1|||
164278790|NCT02462720|593390441|FG000|Part 2|Withdrawal by Subject|1|||
164278791|NCT02462720|593390442|FG001|Part 2|Withdrawal by Subject|0|||
164278792|NCT02462720|593390441|FG000|Part 2|Protocol Violation|0|||
164278793|NCT02462720|593390442|FG001|Part 2|Protocol Violation|1|||
164278794|NCT05173012|593390448|FG000|Overall Study|Adverse Event|2|||
164278795|NCT05173012|593390449|FG001|Overall Study|Adverse Event|3|||
164278796|NCT05173012|593390450|FG002|Overall Study|Adverse Event|4|||
164278797|NCT05173012|593390451|FG003|Overall Study|Adverse Event|13|||
164278798|NCT05173012|593390452|FG004|Overall Study|Adverse Event|0|||
164278799|NCT05173012|593390453|FG005|Overall Study|Adverse Event|0|||
164278800|NCT05173012|593390454|FG006|Overall Study|Adverse Event|2|||
164278801|NCT05173012|593390455|FG007|Overall Study|Adverse Event|4|||
164278802|NCT05173012|593390448|FG000|Overall Study|Lost to Follow-up|0|||
164278803|NCT05173012|593390449|FG001|Overall Study|Lost to Follow-up|0|||
164278804|NCT05173012|593390450|FG002|Overall Study|Lost to Follow-up|0|||
164278805|NCT05173012|593390451|FG003|Overall Study|Lost to Follow-up|1|||
164278806|NCT05173012|593390452|FG004|Overall Study|Lost to Follow-up|0|||
164278807|NCT05173012|593390453|FG005|Overall Study|Lost to Follow-up|0|||
164278808|NCT05173012|593390454|FG006|Overall Study|Lost to Follow-up|0|||
164278809|NCT05173012|593390455|FG007|Overall Study|Lost to Follow-up|0|||
164278810|NCT05173012|593390448|FG000|Overall Study|Withdrawal by Subject|1|||
164278811|NCT05173012|593390449|FG001|Overall Study|Withdrawal by Subject|0|||
164278812|NCT05173012|593390450|FG002|Overall Study|Withdrawal by Subject|1|||
164278813|NCT05173012|593390451|FG003|Overall Study|Withdrawal by Subject|3|||
164278814|NCT05173012|593390452|FG004|Overall Study|Withdrawal by Subject|1|||
164278815|NCT05173012|593390453|FG005|Overall Study|Withdrawal by Subject|0|||
164278816|NCT05173012|593390454|FG006|Overall Study|Withdrawal by Subject|1|||
164278817|NCT05173012|593390455|FG007|Overall Study|Withdrawal by Subject|0|||
164278818|NCT05173012|593390448|FG000|Overall Study|Protocol Deviation|0|||
164278819|NCT05173012|593390449|FG001|Overall Study|Protocol Deviation|0|||
164278820|NCT05173012|593390450|FG002|Overall Study|Protocol Deviation|0|||
164278821|NCT05173012|593390451|FG003|Overall Study|Protocol Deviation|1|||
164278822|NCT05173012|593390452|FG004|Overall Study|Protocol Deviation|0|||
164278823|NCT05173012|593390453|FG005|Overall Study|Protocol Deviation|0|||
164278824|NCT05173012|593390454|FG006|Overall Study|Protocol Deviation|0|||
164278825|NCT05173012|593390455|FG007|Overall Study|Protocol Deviation|0|||
164278826|NCT05173012|593390448|FG000|Overall Study|Other|0|||
164278827|NCT05173012|593390449|FG001|Overall Study|Other|0|||
164278828|NCT05173012|593390450|FG002|Overall Study|Other|0|||
164278829|NCT05173012|593390451|FG003|Overall Study|Other|2|||
164278830|NCT05173012|593390452|FG004|Overall Study|Other|0|||
164278831|NCT05173012|593390453|FG005|Overall Study|Other|0|||
164278832|NCT05173012|593390454|FG006|Overall Study|Other|0|||
164278833|NCT05173012|593390455|FG007|Overall Study|Other|0|||
164278834|NCT03668613|593390456|FG000|Overall Study|Adverse Event|1|||
164278835|NCT03668613|593390457|FG001|Overall Study|Adverse Event|2|||
164278836|NCT03668613|593390456|FG000|Overall Study|Lack of Efficacy|5|||
164343966|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
164343967|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
164432626|NCT04304534|593954649|FG001|Overall Study|Technical Problems|2|||
164278837|NCT03668613|593390457|FG001|Overall Study|Lack of Efficacy|1|||
164278838|NCT03668613|593390456|FG000|Overall Study|Pregnancy|0|||
164278839|NCT03668613|593390457|FG001|Overall Study|Pregnancy|2|||
164278840|NCT03668613|593390456|FG000|Overall Study|Protocol Violation|1|||
164278841|NCT03668613|593390457|FG001|Overall Study|Protocol Violation|0|||
164278842|NCT03668613|593390456|FG000|Overall Study|Physician Decision|1|||
164278843|NCT03668613|593390457|FG001|Overall Study|Physician Decision|0|||
164278844|NCT03668613|593390456|FG000|Overall Study|Withdrawal by Subject|2|||
164278845|NCT03668613|593390457|FG001|Overall Study|Withdrawal by Subject|1|||
164278846|NCT03668613|593390456|FG000|Overall Study|Guardian decision|1|||
164278847|NCT03668613|593390457|FG001|Overall Study|Guardian decision|0|||
164278848|NCT01858740|593390458|FG000|Overall Study|Death|4|||
164278849|NCT00517361|593390461|FG000|Overall Study|Death|6|||
164278850|NCT00517361|593390461|FG000|Overall Study|The study was terminated|5|||
164278851|NCT00286494|593390470|FG000|Overall Study|Hyperglycemic rescue|12|||
164278852|NCT00286494|593390471|FG001|Overall Study|Hyperglycemic rescue|19|||
164278853|NCT00286494|593390472|FG002|Overall Study|Hyperglycemic rescue|18|||
164278854|NCT00286494|593390470|FG000|Overall Study|Withdrawal by Subject|2|||
164278855|NCT00286494|593390471|FG001|Overall Study|Withdrawal by Subject|10|||
164278856|NCT00286494|593390472|FG002|Overall Study|Withdrawal by Subject|9|||
164432627|NCT04304534|593954650|FG002|Overall Study|Technical Problems|3|||
164432628|NCT04304534|593954651|FG003|Overall Study|Technical Problems|4|||
164432629|NCT04304534|593954648|FG000|Overall Study|Death|7|||
164432630|NCT04304534|593954649|FG001|Overall Study|Death|2|||
164278857|NCT00286494|593390470|FG000|Overall Study|Adverse Event|3|||
164278858|NCT00286494|593390471|FG001|Overall Study|Adverse Event|8|||
164278859|NCT00286494|593390472|FG002|Overall Study|Adverse Event|6|||
164278860|NCT00286494|593390470|FG000|Overall Study|Physician Decision|5|||
164278861|NCT00286494|593390471|FG001|Overall Study|Physician Decision|5|||
164278862|NCT00286494|593390472|FG002|Overall Study|Physician Decision|1|||
164278863|NCT00286494|593390470|FG000|Overall Study|Lost to Follow-up|3|||
164278864|NCT00286494|593390471|FG001|Overall Study|Lost to Follow-up|1|||
164278865|NCT00286494|593390472|FG002|Overall Study|Lost to Follow-up|3|||
164278866|NCT00286494|593390470|FG000|Overall Study|Protocol Violation|1|||
164278867|NCT00286494|593390471|FG001|Overall Study|Protocol Violation|1|||
164278868|NCT00286494|593390472|FG002|Overall Study|Protocol Violation|2|||
164278869|NCT04776317|593390473|FG000|Overall Study|Physician Decision|0|||
164278870|NCT04776317|593390474|FG001|Overall Study|Physician Decision|1|||
164278871|NCT04776317|593390475|FG002|Overall Study|Physician Decision|0|||
164278872|NCT04776317|593390476|FG003|Overall Study|Physician Decision|0|||
164278873|NCT04776317|593390477|FG004|Overall Study|Physician Decision|0|||
164278874|NCT04776317|593390478|FG005|Overall Study|Physician Decision|0|||
164278875|NCT04776317|593390479|FG006|Overall Study|Physician Decision|0|||
164278876|NCT04776317|593390480|FG007|Overall Study|Physician Decision|0|||
164278877|NCT04776317|593390481|FG008|Overall Study|Physician Decision|0|||
164278878|NCT04776317|593390482|FG009|Overall Study|Physician Decision|0|||
164278879|NCT04776317|593390483|FG010|Overall Study|Physician Decision|0|||
164278880|NCT04776317|593390484|FG011|Overall Study|Physician Decision|0|||
164278881|NCT04776317|593390485|FG012|Overall Study|Physician Decision|0|||
164278882|NCT04776317|593390486|FG013|Overall Study|Physician Decision|0|||
164278883|NCT04776317|593390487|FG014|Overall Study|Physician Decision|0|||
164278884|NCT04776317|593390473|FG000|Overall Study|Protocol Violation|0|||
164278885|NCT04776317|593390474|FG001|Overall Study|Protocol Violation|0|||
164278886|NCT04776317|593390475|FG002|Overall Study|Protocol Violation|1|||
164278887|NCT04776317|593390476|FG003|Overall Study|Protocol Violation|0|||
164278888|NCT04776317|593390477|FG004|Overall Study|Protocol Violation|0|||
164278889|NCT04776317|593390478|FG005|Overall Study|Protocol Violation|0|||
164278890|NCT04776317|593390479|FG006|Overall Study|Protocol Violation|0|||
164278891|NCT04776317|593390480|FG007|Overall Study|Protocol Violation|0|||
164278892|NCT04776317|593390481|FG008|Overall Study|Protocol Violation|0|||
164278893|NCT04776317|593390482|FG009|Overall Study|Protocol Violation|0|||
164278894|NCT04776317|593390483|FG010|Overall Study|Protocol Violation|0|||
164278895|NCT04776317|593390484|FG011|Overall Study|Protocol Violation|0|||
164278896|NCT04776317|593390485|FG012|Overall Study|Protocol Violation|0|||
164278897|NCT04776317|593390486|FG013|Overall Study|Protocol Violation|0|||
164278898|NCT04776317|593390487|FG014|Overall Study|Protocol Violation|0|||
164278899|NCT04776317|593390473|FG000|Overall Study|Withdrawal by Subject|0|||
164278900|NCT04776317|593390474|FG001|Overall Study|Withdrawal by Subject|0|||
164278901|NCT04776317|593390475|FG002|Overall Study|Withdrawal by Subject|0|||
164278902|NCT04776317|593390476|FG003|Overall Study|Withdrawal by Subject|0|||
164278903|NCT04776317|593390477|FG004|Overall Study|Withdrawal by Subject|1|||
164278904|NCT04776317|593390478|FG005|Overall Study|Withdrawal by Subject|0|||
164278905|NCT04776317|593390479|FG006|Overall Study|Withdrawal by Subject|0|||
164278906|NCT04776317|593390480|FG007|Overall Study|Withdrawal by Subject|0|||
164278907|NCT04776317|593390481|FG008|Overall Study|Withdrawal by Subject|0|||
164278908|NCT04776317|593390482|FG009|Overall Study|Withdrawal by Subject|0|||
164278909|NCT04776317|593390483|FG010|Overall Study|Withdrawal by Subject|0|||
164278910|NCT04776317|593390484|FG011|Overall Study|Withdrawal by Subject|0|||
164278911|NCT04776317|593390485|FG012|Overall Study|Withdrawal by Subject|0|||
164278912|NCT04776317|593390486|FG013|Overall Study|Withdrawal by Subject|0|||
164278913|NCT04776317|593390487|FG014|Overall Study|Withdrawal by Subject|0|||
164278914|NCT03100058|593390489|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
164278915|NCT03100058|593390490|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
164278916|NCT03100058|593390491|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
164278917|NCT03100058|593390492|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
164278918|NCT03100058|593390493|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
164278919|NCT03100058|593390494|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
164432631|NCT04304534|593954650|FG002|Overall Study|Death|4|||
164278920|NCT03100058|593390495|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
164278921|NCT03100058|593390496|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
164278922|NCT03100058|593390497|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
164278923|NCT03100058|593390498|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
164278924|NCT03100058|593390499|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
164278925|NCT03100058|593390500|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
164278926|NCT03100058|593390501|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
164278927|NCT03100058|593390489|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
164278928|NCT03100058|593390490|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
164432632|NCT04304534|593954651|FG003|Overall Study|Death|3|||
164278929|NCT03100058|593390491|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
164278930|NCT03100058|593390492|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
164278931|NCT03100058|593390493|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
164278932|NCT03100058|593390494|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
164278933|NCT03100058|593390495|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
164278934|NCT03100058|593390496|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
164278935|NCT03100058|593390497|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
164278936|NCT03100058|593390498|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
164278937|NCT03100058|593390499|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
164278938|NCT03100058|593390500|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
164278939|NCT03100058|593390501|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
164278940|NCT03100058|593390489|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
164278941|NCT03100058|593390490|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
164278942|NCT03100058|593390491|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
164278943|NCT03100058|593390492|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
164278944|NCT03100058|593390493|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
164278945|NCT03100058|593390494|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
164278946|NCT03100058|593390495|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
164278947|NCT03100058|593390496|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
164278948|NCT03100058|593390497|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
164278949|NCT03100058|593390498|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
164278950|NCT03100058|593390499|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
164278951|NCT03100058|593390500|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
164278952|NCT03100058|593390501|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
164278953|NCT03100058|593390489|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
164278954|NCT03100058|593390490|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
164278955|NCT03100058|593390491|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
164278956|NCT03100058|593390492|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
164278957|NCT03100058|593390493|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
164278958|NCT03100058|593390494|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
164278959|NCT03100058|593390495|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
164278960|NCT03100058|593390496|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
164278961|NCT03100058|593390497|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
164278962|NCT03100058|593390498|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
164278963|NCT03100058|593390499|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
164278964|NCT03100058|593390500|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
164278965|NCT03100058|593390501|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
164278966|NCT03100058|593390489|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
164278967|NCT03100058|593390490|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
164278968|NCT03100058|593390491|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
164278969|NCT03100058|593390492|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
164278970|NCT03100058|593390493|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
164278971|NCT03100058|593390494|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
164278972|NCT03100058|593390495|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
164278973|NCT03100058|593390496|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
164278974|NCT03100058|593390497|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
164278975|NCT03100058|593390498|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
164278976|NCT03100058|593390499|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
164278977|NCT03100058|593390500|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
164278978|NCT03100058|593390501|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
164278979|NCT03100058|593390489|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
164278980|NCT03100058|593390490|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
164278981|NCT03100058|593390491|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
164278982|NCT03100058|593390492|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
164278983|NCT03100058|593390493|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
164278984|NCT03100058|593390494|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
164278985|NCT03100058|593390495|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
164278986|NCT03100058|593390496|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
164278987|NCT03100058|593390497|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
164278988|NCT03100058|593390498|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
164278989|NCT03100058|593390499|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
164278990|NCT03100058|593390500|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
164278991|NCT03100058|593390501|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
164278992|NCT03100058|593390489|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
164278993|NCT03100058|593390490|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
164278994|NCT03100058|593390491|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
164278995|NCT03100058|593390492|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
164278996|NCT03100058|593390493|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
164278997|NCT03100058|593390494|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
164278998|NCT03100058|593390495|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
164278999|NCT03100058|593390496|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
164279000|NCT03100058|593390497|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
164279001|NCT03100058|593390498|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
164279002|NCT03100058|593390499|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
164279003|NCT03100058|593390500|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
164279004|NCT03100058|593390501|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
164279005|NCT03100058|593390489|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
164279006|NCT03100058|593390490|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
164279007|NCT03100058|593390491|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
164279008|NCT03100058|593390492|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
164279009|NCT03100058|593390493|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
164279010|NCT03100058|593390494|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
164279011|NCT03100058|593390495|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
164279012|NCT03100058|593390496|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
164279013|NCT03100058|593390497|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
164279014|NCT03100058|593390498|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
164279015|NCT03100058|593390499|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
164279016|NCT03100058|593390500|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
164279017|NCT03100058|593390501|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
164279018|NCT03100058|593390489|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
164279019|NCT03100058|593390490|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
164279020|NCT03100058|593390491|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
164279021|NCT03100058|593390492|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
164279022|NCT03100058|593390493|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
164279023|NCT03100058|593390494|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
164279024|NCT03100058|593390495|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
164279025|NCT03100058|593390496|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
164279026|NCT03100058|593390497|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
164279027|NCT03100058|593390498|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
164279028|NCT03100058|593390499|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
164279029|NCT03100058|593390500|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
164279030|NCT03100058|593390501|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
164279031|NCT03100058|593390489|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
164142995|NCT00863772|592884486|FG002|Overall Study|Lost to Follow-up|1|||
164279032|NCT03100058|593390490|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
164279033|NCT03100058|593390491|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
164279034|NCT03100058|593390492|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
164279035|NCT03100058|593390493|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
164279036|NCT03100058|593390494|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
164279037|NCT03100058|593390495|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
164279038|NCT03100058|593390496|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
164279039|NCT03100058|593390497|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
164279040|NCT03100058|593390498|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
164279041|NCT03100058|593390499|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
164279042|NCT03100058|593390500|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
164279043|NCT03100058|593390501|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
164279044|NCT03100058|593390489|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
164279045|NCT03100058|593390490|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
164279046|NCT03100058|593390491|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
164279047|NCT03100058|593390492|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
164279048|NCT03100058|593390493|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
164279049|NCT03100058|593390494|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
164279050|NCT03100058|593390495|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
164279051|NCT03100058|593390496|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
164279052|NCT03100058|593390497|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
164279053|NCT03100058|593390498|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
164279054|NCT03100058|593390499|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
164343968|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
164343969|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
164343970|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
164343971|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
164343972|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
164343973|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
164343974|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
164343975|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
164343976|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
164584364|NCT00611455|594504633|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
164584365|NCT00611455|594504631|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
164584366|NCT00611455|594504632|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
164584367|NCT00611455|594504633|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
164432633|NCT04304534|593954648|FG000|Overall Study|Withdrawal by Subject|7|||
164432634|NCT04304534|593954649|FG001|Overall Study|Withdrawal by Subject|2|||
164432635|NCT04304534|593954650|FG002|Overall Study|Withdrawal by Subject|7|||
164432636|NCT04304534|593954651|FG003|Overall Study|Withdrawal by Subject|4|||
164432637|NCT04304534|593954648|FG000|Overall Study|Physician Decision|4|||
164432638|NCT04304534|593954649|FG001|Overall Study|Physician Decision|9|||
164432639|NCT04304534|593954650|FG002|Overall Study|Physician Decision|9|||
164432640|NCT04304534|593954651|FG003|Overall Study|Physician Decision|5|||
164432641|NCT04304534|593954648|FG000|Overall Study|Subject Decision|34|||
164432642|NCT04304534|593954649|FG001|Overall Study|Subject Decision|25|||
164432643|NCT04304534|593954650|FG002|Overall Study|Subject Decision|25|||
164432644|NCT04304534|593954651|FG003|Overall Study|Subject Decision|26|||
164432645|NCT04304534|593954648|FG000|Overall Study|Adverse Event|35|||
164432646|NCT04304534|593954649|FG001|Overall Study|Adverse Event|40|||
164432647|NCT04304534|593954650|FG002|Overall Study|Adverse Event|39|||
164432648|NCT04304534|593954651|FG003|Overall Study|Adverse Event|44|||
164279055|NCT03100058|593390500|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
164279056|NCT03100058|593390501|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
164279057|NCT03100058|593390489|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
164279058|NCT03100058|593390490|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
164279059|NCT03100058|593390491|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
164279060|NCT03100058|593390492|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
164279061|NCT03100058|593390493|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
164279062|NCT03100058|593390494|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
164279063|NCT03100058|593390495|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
164279064|NCT03100058|593390496|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
164279065|NCT03100058|593390497|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
164279066|NCT03100058|593390498|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
164279067|NCT03100058|593390499|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
164279068|NCT03100058|593390500|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
164279069|NCT03100058|593390501|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
164279070|NCT03100058|593390489|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
164279071|NCT03100058|593390490|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
164279072|NCT03100058|593390491|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
164279073|NCT03100058|593390492|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
164279074|NCT03100058|593390493|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
164279075|NCT03100058|593390494|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
164279076|NCT03100058|593390495|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
164279077|NCT03100058|593390496|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
164279078|NCT03100058|593390497|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
164279079|NCT03100058|593390498|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
164279080|NCT03100058|593390499|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
164279081|NCT03100058|593390500|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
164343977|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
164343978|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
164343979|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
164432649|NCT04012853|593954652|FG000|Overall Study|Withdrawal by Subject|1|||
164584368|NCT00611455|594504631|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
164584369|NCT00611455|594504632|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
164279082|NCT03100058|593390501|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
164279083|NCT03100058|593390489|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
164432650|NCT04012853|593954653|FG001|Overall Study|Withdrawal by Subject|1|||
164432651|NCT04012853|593954652|FG000|Overall Study|Protocol Violation|1|||
164432652|NCT04012853|593954653|FG001|Overall Study|Protocol Violation|0|||
164584370|NCT00611455|594504633|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
164279084|NCT03100058|593390490|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
164279085|NCT03100058|593390491|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
164279086|NCT03100058|593390492|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
164279087|NCT03100058|593390493|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
164279088|NCT03100058|593390494|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
164279089|NCT03100058|593390495|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
164279090|NCT03100058|593390496|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
164279091|NCT03100058|593390497|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
164343980|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
164343981|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
164343982|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
164343983|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
164343984|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
164343985|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
164279092|NCT03100058|593390498|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
164279093|NCT03100058|593390499|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
164279094|NCT03100058|593390500|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
164279095|NCT03100058|593390501|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
164279096|NCT03100058|593390489|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
164279097|NCT03100058|593390490|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
164279098|NCT03100058|593390491|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
164343986|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
164343987|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
164343988|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
164343989|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
164343990|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
164343991|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
164343992|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
164343993|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
164343994|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
164343995|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
164343996|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
164432653|NCT04012853|593954652|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
164432654|NCT04012853|593954653|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
164432655|NCT01313182|593954654|FG000|Overall Study|Protocol Violation|66|||
164432656|NCT01313182|593954655|FG001|Overall Study|Protocol Violation|92|||
164432657|NCT01695317|593954656|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
164432658|NCT01695317|593954657|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
164432659|NCT01695317|593954656|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
164432660|NCT01695317|593954657|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
164432661|NCT00003656|593954658|FG000|Overall Study|Adverse Event|0|||
164432662|NCT00003656|593954659|FG001|Overall Study|Adverse Event|1|||
164432663|NCT00464672|593954660|FG000|Overall Study|withdrawal of consent|0|||
164432664|NCT00464672|593954661|FG001|Overall Study|withdrawal of consent|0|||
164432665|NCT00464672|593954662|FG002|Overall Study|withdrawal of consent|0|||
164432666|NCT00464672|593954663|FG003|Overall Study|withdrawal of consent|1|||
164432667|NCT00464672|593954664|FG004|Overall Study|withdrawal of consent|9|||
164432668|NCT00464672|593954665|FG005|Overall Study|withdrawal of consent|4|||
164432669|NCT00464672|593954660|FG000|Overall Study|Lost to Follow-up|25|||
164432670|NCT00464672|593954661|FG001|Overall Study|Lost to Follow-up|10|||
164432671|NCT00464672|593954662|FG002|Overall Study|Lost to Follow-up|0|||
164432672|NCT00464672|593954663|FG003|Overall Study|Lost to Follow-up|0|||
164432673|NCT00464672|593954664|FG004|Overall Study|Lost to Follow-up|1|||
164432674|NCT00464672|593954665|FG005|Overall Study|Lost to Follow-up|0|||
164432675|NCT04889118|593954666|FG000|Overall Study|Death|49|||
164432676|NCT04889118|593954667|FG001|Overall Study|Death|47|||
164279099|NCT03100058|593390492|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
164279100|NCT03100058|593390493|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
164343997|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
164343998|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
164343999|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
164344000|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
164344001|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
164344002|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
164344003|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
164432677|NCT04889118|593954666|FG000|Overall Study|Sponsor Decision|15|||
164432678|NCT04889118|593954667|FG001|Overall Study|Sponsor Decision|20|||
164432679|NCT00828672|593954668|FG000|Study Treatment|Lost to Follow-up|1|||
164279101|NCT03100058|593390494|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
164279102|NCT03100058|593390495|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
164279103|NCT03100058|593390496|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
164279104|NCT03100058|593390497|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
164279105|NCT03100058|593390498|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
164279106|NCT03100058|593390499|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
164279107|NCT03100058|593390500|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
164279108|NCT03100058|593390501|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
164279109|NCT03671304|593390504|FG000|Overall Study|study terminated|7|||
164279110|NCT01067144|593390505|FG000|Treatment|Did not receive allocated intervention|4|||
164279111|NCT01067144|593390506|FG001|Treatment|Did not receive allocated intervention|7|||
164279112|NCT01067144|593390505|FG000|Follow-up|Lost to Follow-up|22|||
164279113|NCT01067144|593390506|FG001|Follow-up|Lost to Follow-up|12|||
164279114|NCT01067144|593390505|FG000|Follow-up|Censored owing to second surgery|19|||
164279115|NCT01067144|593390506|FG001|Follow-up|Censored owing to second surgery|28|||
164279116|NCT01067144|593390505|FG000|Follow-up|Withdrawal by Subject|18|||
164279117|NCT01067144|593390506|FG001|Follow-up|Withdrawal by Subject|14|||
164279118|NCT01067144|593390505|FG000|Follow-up|Surgery cancelled|0|||
164279119|NCT01067144|593390506|FG001|Follow-up|Surgery cancelled|1|||
164279120|NCT01067144|593390505|FG000|Follow-up|Death|0|||
164279121|NCT01067144|593390506|FG001|Follow-up|Death|1|||
164279122|NCT02718716|593390508|FG000|Overall Study|Lack of Efficacy|1|||
164279123|NCT02718716|593390509|FG001|Overall Study|Lack of Efficacy|0|||
164279124|NCT02718716|593390510|FG002|Overall Study|Lack of Efficacy|0|||
164279125|NCT02718716|593390511|FG003|Overall Study|Lack of Efficacy|0|||
164279126|NCT02718716|593390512|FG004|Overall Study|Lack of Efficacy|0|||
164279127|NCT00646399|593390516|FG000|Overall Study|Death|63|||
164279128|NCT00646399|593390517|FG001|Overall Study|Death|53|||
164279129|NCT00646399|593390516|FG000|Overall Study|Withdrawal by Subject|9|||
164279130|NCT00646399|593390517|FG001|Overall Study|Withdrawal by Subject|10|||
164279131|NCT00646399|593390516|FG000|Overall Study|Other Reason|11|||
164279132|NCT00646399|593390517|FG001|Overall Study|Other Reason|11|||
164279133|NCT04765202|593390520|FG000|Overall Study|Lost to Follow-up|1|||
164279134|NCT04765202|593390521|FG001|Overall Study|Lost to Follow-up|1|||
164279135|NCT04765202|593390522|FG002|Overall Study|Lost to Follow-up|2|||
164279136|NCT04765202|593390523|FG003|Overall Study|Lost to Follow-up|2|||
164279137|NCT04765202|593390520|FG000|Overall Study|Physician Decision|0|||
164279138|NCT04765202|593390521|FG001|Overall Study|Physician Decision|0|||
164279139|NCT04765202|593390522|FG002|Overall Study|Physician Decision|1|||
164279140|NCT04765202|593390523|FG003|Overall Study|Physician Decision|1|||
164279141|NCT04929249|593390524|FG000|Overall Study|Adverse Event|2|||
164279142|NCT04929249|593390525|FG001|Overall Study|Adverse Event|1|||
164279143|NCT04929249|593390524|FG000|Overall Study|Death|2|||
164279144|NCT04929249|593390525|FG001|Overall Study|Death|1|||
164279145|NCT04929249|593390524|FG000|Overall Study|Lost to Follow-up|3|||
164279146|NCT04929249|593390525|FG001|Overall Study|Lost to Follow-up|11|||
164279147|NCT04929249|593390524|FG000|Overall Study|Technical problems|0|||
164279148|NCT04929249|593390525|FG001|Overall Study|Technical problems|1|||
164279149|NCT04929249|593390524|FG000|Overall Study|Subject decision|6|||
164279150|NCT04929249|593390525|FG001|Overall Study|Subject decision|8|||
164279151|NCT04929249|593390524|FG000|Overall Study|Withdrew consent|0|||
164279152|NCT04929249|593390525|FG001|Overall Study|Withdrew consent|8|||
164279153|NCT02332291|593390528|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
164279154|NCT02332291|593390529|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
164279155|NCT02332291|593390528|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
164279156|NCT02332291|593390529|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
164279157|NCT02332291|593390528|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
164279158|NCT02332291|593390529|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
164584371|NCT00611455|594504631|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
164279159|NCT02332291|593390528|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
164279160|NCT02332291|593390529|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
164279161|NCT02332291|593390528|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
164279162|NCT02332291|593390529|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
164584372|NCT00611455|594504632|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
164584373|NCT00611455|594504633|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
164584374|NCT03671369|594504634|FG000|Overall Study|Other|1|||
164584375|NCT03671369|594504634|FG000|Overall Study|Withdrawal by Subject|289|||
164584376|NCT03671369|594504634|FG000|Overall Study|Not willing to be vaccinated|1|||
164584377|NCT02732912|594504635|FG000|Overall Study|Discharged before night|2|||
164584378|NCT02732912|594504636|FG001|Overall Study|Discharged before night|6|||
164584379|NCT02732912|594504635|FG000|Overall Study|Incomplete completion of questionnaire|2|||
164584380|NCT02732912|594504636|FG001|Overall Study|Incomplete completion of questionnaire|3|||
164584381|NCT02732912|594504635|FG000|Overall Study|No outcome; discharged or refused|6|||
164279163|NCT02332291|593390528|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
164279164|NCT02332291|593390529|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
164279165|NCT01424228|593390532|FG000|Overall Study|Withdrawal by Subject|27|||
164279166|NCT01424228|593390533|FG001|Overall Study|Withdrawal by Subject|11|||
164279167|NCT01424228|593390532|FG000|Overall Study|Adverse Event|10|||
164279168|NCT01424228|593390533|FG001|Overall Study|Adverse Event|14|||
164279169|NCT01424228|593390532|FG000|Overall Study|Sponsor's decision|9|||
164279170|NCT01424228|593390533|FG001|Overall Study|Sponsor's decision|12|||
164279171|NCT01424228|593390532|FG000|Overall Study|Lack of Efficacy|5|||
164279172|NCT01424228|593390533|FG001|Overall Study|Lack of Efficacy|7|||
164279173|NCT01424228|593390532|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
164279174|NCT01424228|593390533|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
164279175|NCT01424228|593390532|FG000|Overall Study|Non-compliance|2|||
164279176|NCT01424228|593390533|FG001|Overall Study|Non-compliance|0|||
164279177|NCT01424228|593390532|FG000|Overall Study|Worsening of symptoms|1|||
164279178|NCT01424228|593390533|FG001|Overall Study|Worsening of symptoms|0|||
164279179|NCT01424228|593390532|FG000|Overall Study|Unplanned journey|0|||
164279180|NCT01424228|593390533|FG001|Overall Study|Unplanned journey|1|||
164279181|NCT00844558|593390534|FG000|Overall Study|Withdrawal by Subject|9|||
164279182|NCT00844558|593390535|FG001|Overall Study|Withdrawal by Subject|2|||
164279183|NCT00844558|593390534|FG000|Overall Study|Death|1|||
164279184|NCT00844558|593390535|FG001|Overall Study|Death|0|||
164279185|NCT00844558|593390534|FG000|Overall Study|Protocol Violation|1|||
164279186|NCT00844558|593390535|FG001|Overall Study|Protocol Violation|1|||
164279187|NCT00844558|593390534|FG000|Overall Study|Lost to Follow-up|0|||
164279188|NCT00844558|593390535|FG001|Overall Study|Lost to Follow-up|1|||
164279189|NCT00844558|593390534|FG000|Overall Study|Physician Decision|1|||
164279190|NCT00844558|593390535|FG001|Overall Study|Physician Decision|0|||
164279191|NCT02951429|593390536|FG000|Overall Study|Adverse Event|3|||
164279192|NCT02951429|593390537|FG001|Overall Study|Adverse Event|7|||
164279193|NCT02951429|593390536|FG000|Overall Study|Death|28|||
164279194|NCT02951429|593390537|FG001|Overall Study|Death|36|||
164279195|NCT02951429|593390536|FG000|Overall Study|Lack of Efficacy|0|||
164279196|NCT02951429|593390537|FG001|Overall Study|Lack of Efficacy|1|||
164279197|NCT02951429|593390536|FG000|Overall Study|Lost to Follow-up|0|||
164279198|NCT02951429|593390537|FG001|Overall Study|Lost to Follow-up|1|||
164279199|NCT02951429|593390536|FG000|Overall Study|Lung Transplantation|9|||
164279200|NCT02951429|593390537|FG001|Overall Study|Lung Transplantation|6|||
164279201|NCT02951429|593390536|FG000|Overall Study|Other|1|||
164279202|NCT02951429|593390537|FG001|Overall Study|Other|3|||
164279203|NCT02951429|593390536|FG000|Overall Study|Progressive Disease|1|||
164279204|NCT02951429|593390537|FG001|Overall Study|Progressive Disease|1|||
164279205|NCT02951429|593390536|FG000|Overall Study|Withdrawal by Subject|7|||
164279206|NCT02951429|593390537|FG001|Overall Study|Withdrawal by Subject|11|||
164279207|NCT02951429|593390536|FG000|Overall Study|Participant ongoing in the study|23|||
164279208|NCT02951429|593390537|FG001|Overall Study|Participant ongoing in the study|17|||
164279209|NCT01628965|593390540|FG000|Overall Study|Adverse Event|30|||
164279210|NCT01628965|593390540|FG000|Overall Study|Lack of Efficacy|7|||
164279211|NCT01628965|593390540|FG000|Overall Study|Withdrawal by Subject|3|||
164279212|NCT01628965|593390540|FG000|Overall Study|Lost to Follow-up|1|||
164279213|NCT01628965|593390540|FG000|Overall Study|Discontinuation criteria|8|||
164279214|NCT04356352|593390545|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
164279215|NCT04356352|593390546|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
164279216|NCT04356352|593390547|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
164279217|NCT04356352|593390545|FG000|Overall Study|Protocol Violation|0|||
164279218|NCT04356352|593390546|FG001|Overall Study|Protocol Violation|3|||
164279219|NCT04356352|593390547|FG002|Overall Study|Protocol Violation|1|||
164279220|NCT01983774|593390551|FG000|Overall Study|Lung Transplant|0|||
164279221|NCT01983774|593390552|FG001|Overall Study|Lung Transplant|1|||
164279222|NCT01983774|593390551|FG000|Overall Study|Lost to Follow-up|1|||
164279223|NCT01983774|593390552|FG001|Overall Study|Lost to Follow-up|0|||
164279224|NCT01339897|593390553|FG000|Overall Study|Adverse Event|1|||
164279225|NCT01339897|593390554|FG001|Overall Study|Adverse Event|0|||
164279226|NCT01339897|593390555|FG002|Overall Study|Adverse Event|0|||
164279227|NCT01339897|593390556|FG003|Overall Study|Adverse Event|1|||
164279228|NCT00847197|593390557|FG000|Overall Study|Adverse Event|21|||
164279229|NCT00847197|593390558|FG001|Overall Study|Adverse Event|3|||
164279230|NCT00847197|593390557|FG000|Overall Study|Protocol Violation|0|||
164279231|NCT00847197|593390558|FG001|Overall Study|Protocol Violation|1|||
164279232|NCT00847197|593390557|FG000|Overall Study|Withdrawal by Subject|3|||
164279233|NCT00847197|593390558|FG001|Overall Study|Withdrawal by Subject|1|||
164279234|NCT00622388|593390559|FG000|Overall Study|Disease Progression|47|||
164279235|NCT00622388|593390559|FG000|Overall Study|Adverse Event|6|||
164279236|NCT00622388|593390559|FG000|Overall Study|Protocol Violation|3|||
164279237|NCT00622388|593390559|FG000|Overall Study|Participant Refusal|1|||
164279238|NCT00622388|593390559|FG000|Overall Study|Death|3|||
164279239|NCT00622388|593390559|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
164689769|NCT01332968|594887785|FG001|Induction Period|Randomised but not treated|7|||
164689770|NCT01332968|594887786|FG002|Induction Period|Randomised but not treated|0|||
164689771|NCT01332968|594887787|FG003|Induction Period|Randomised but not treated|0|||
164689772|NCT01332968|594887788|FG004|Induction Period|Randomised but not treated|0|||
164689773|NCT01332968|594887789|FG005|Induction Period|Randomised but not treated|0|||
164689774|NCT01332968|594887790|FG006|Induction Period|Randomised but not treated|0|||
164689775|NCT01332968|594887791|FG007|Induction Period|Randomised but not treated|0|||
164689776|NCT01332968|594887784|FG000|Maintenance/Observation Period|Adverse Event|0|||
164689777|NCT01332968|594887785|FG001|Maintenance/Observation Period|Adverse Event|0|||
164689778|NCT01332968|594887786|FG002|Maintenance/Observation Period|Adverse Event|53|||
164689779|NCT01332968|594887787|FG003|Maintenance/Observation Period|Adverse Event|66|||
164689780|NCT01332968|594887788|FG004|Maintenance/Observation Period|Adverse Event|0|||
164689781|NCT01332968|594887789|FG005|Maintenance/Observation Period|Adverse Event|0|||
164279240|NCT00622388|593390559|FG000|Overall Study|Took Prohibited Medication|2|||
164279241|NCT00622388|593390559|FG000|Overall Study|Withdrew Consent|1|||
164279242|NCT00622388|593390559|FG000|Overall Study|Insurance Expired|1|||
164279243|NCT01068158|593390560|FG000|Overall Study|Withdrawal by Subject|1|||
164279244|NCT01068158|593390561|FG001|Overall Study|Withdrawal by Subject|2|||
164279245|NCT01068158|593390560|FG000|Overall Study|Lost to Follow-up|7|||
164279246|NCT01068158|593390561|FG001|Overall Study|Lost to Follow-up|0|||
164279247|NCT01068158|593390560|FG000|Overall Study|Protocol Violation|0|||
164279248|NCT01068158|593390561|FG001|Overall Study|Protocol Violation|2|||
164279249|NCT02478255|593390562|FG000|Overall Study|Physician Decision|6|||
164279250|NCT02478255|593390563|FG001|Overall Study|Physician Decision|0|||
164279251|NCT02478255|593390562|FG000|Overall Study|Withdrawal by Subject|2|||
164279252|NCT02478255|593390563|FG001|Overall Study|Withdrawal by Subject|0|||
164279253|NCT02813889|593392093|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
164279254|NCT02813889|593392094|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
164279255|NCT05128578|593392095|FG000|Overall Study|Withdrawal by Subject|9|||
164279256|NCT05128578|593392095|FG000|Overall Study|Lost to Follow-up|5|||
164279257|NCT01128244|593392099|FG000|Overall Study|Adverse Event|1|||
164279258|NCT01128244|593392099|FG000|Overall Study|Scheduling conflict|2|||
164279259|NCT02974257|593392100|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
164279260|NCT02974257|593392101|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
164279261|NCT02974257|593392100|FG000|Overall Study|Clinical indication for thiamine|1|||
164279262|NCT02974257|593392101|FG001|Overall Study|Clinical indication for thiamine|0|||
164279263|NCT02974257|593392100|FG000|Overall Study|Already on thiamine|1|||
164279264|NCT02974257|593392101|FG001|Overall Study|Already on thiamine|0|||
164279265|NCT02974257|593392100|FG000|Overall Study|Extubated prior to study drug|0|||
164279266|NCT02974257|593392101|FG001|Overall Study|Extubated prior to study drug|1|||
164279267|NCT02974257|593392100|FG000|Overall Study|Death|0|||
164279268|NCT02974257|593392101|FG001|Overall Study|Death|1|||
164279269|NCT00398567|593392102|FG000|Overall Study|Disease Progression|3|||
164279270|NCT00398567|593392103|FG001|Overall Study|Disease Progression|4|||
164279271|NCT00398567|593392104|FG002|Overall Study|Disease Progression|27|||
164279272|NCT00398567|593392102|FG000|Overall Study|Withdrawal by Subject|1|||
164279273|NCT00398567|593392103|FG001|Overall Study|Withdrawal by Subject|0|||
164279274|NCT00398567|593392104|FG002|Overall Study|Withdrawal by Subject|4|||
164279275|NCT00398567|593392102|FG000|Overall Study|Adverse Event|0|||
164344004|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
164344005|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
164344006|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
164344007|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
164344008|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
164344009|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
164344010|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
164344011|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
164344012|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
164344013|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
164344014|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
164344015|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
164344016|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
164344017|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
164344018|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
164344019|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
164344020|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
164344021|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
164432680|NCT00828672|593954669|FG001|Study Treatment|Lost to Follow-up|0|||
164689782|NCT01332968|594887790|FG006|Maintenance/Observation Period|Adverse Event|0|||
164279276|NCT00398567|593392103|FG001|Overall Study|Adverse Event|0|||
164279277|NCT00398567|593392104|FG002|Overall Study|Adverse Event|2|||
164279278|NCT00398567|593392102|FG000|Overall Study|Protocol Violation|0|||
164279279|NCT00398567|593392103|FG001|Overall Study|Protocol Violation|0|||
164279280|NCT00398567|593392104|FG002|Overall Study|Protocol Violation|1|||
164279281|NCT02837029|593392105|FG000|Screening|Failed to meet screening requirements.|7|||
164279282|NCT02837029|593392106|FG001|Screening|Failed to meet screening requirements.|3|||
164279283|NCT02837029|593392107|FG002|Screening|Failed to meet screening requirements.|0|||
164279284|NCT02837029|593392105|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
164279285|NCT02837029|593392106|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
164279286|NCT02837029|593392107|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
164279287|NCT02837029|593392105|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
164279288|NCT02837029|593392106|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
164279289|NCT02837029|593392107|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
164279290|NCT02837029|593392105|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
164279291|NCT02837029|593392106|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
164279292|NCT02837029|593392107|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
164279293|NCT02837029|593392105|FG000|Cycle 2 and Beyond|Adverse Event|1|||
164279294|NCT02837029|593392106|FG001|Cycle 2 and Beyond|Adverse Event|0|||
164279295|NCT02837029|593392107|FG002|Cycle 2 and Beyond|Adverse Event|0|||
164279296|NCT02837029|593392105|FG000|2 Year Follow-up|Death|6|||
164279297|NCT02837029|593392106|FG001|2 Year Follow-up|Death|7|||
164279298|NCT02837029|593392107|FG002|2 Year Follow-up|Death|0|||
164279299|NCT01363908|593392108|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
164279300|NCT01363908|593392109|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
164279301|NCT01363908|593392108|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
164279302|NCT01363908|593392109|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
164279303|NCT01363908|593392108|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
164279304|NCT01363908|593392109|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
164279305|NCT01363908|593392108|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
164279306|NCT01363908|593392109|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
164279307|NCT05258149|593392110|FG000|Period 1|Protocol Deviation|1|||
164279308|NCT05258149|593392111|FG001|Period 1|Protocol Deviation|0|||
164279309|NCT05258149|593392110|FG000|Period 1|Adverse Event|0|||
164279310|NCT05258149|593392111|FG001|Period 1|Adverse Event|1|||
164279311|NCT05258149|593392110|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
164279312|NCT05258149|593392111|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
164279313|NCT05258149|593392110|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
164279314|NCT05258149|593392111|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
164279315|NCT05258149|593392110|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
164279316|NCT05258149|593392111|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
164279317|NCT03437577|593392114|FG000|Pre-Randomization|Withdrawal by Subject|0|||
164279318|NCT03437577|593392115|FG001|Pre-Randomization|Withdrawal by Subject|0|||
164279319|NCT03437577|593392116|FG002|Pre-Randomization|Withdrawal by Subject|10|||
164279320|NCT03437577|593392114|FG000|Post-Randomization|Physician Decision|0|||
164279321|NCT03437577|593392115|FG001|Post-Randomization|Physician Decision|2|||
164279322|NCT03437577|593392116|FG002|Post-Randomization|Physician Decision|0|||
164279323|NCT04273893|593392124|FG000|Overall Study|Withdrawal by Subject|0|||
164279324|NCT04273893|593392125|FG001|Overall Study|Withdrawal by Subject|2|||
164279325|NCT04273893|593392124|FG000|Overall Study|Treatment of Disease Progression|0|||
164279326|NCT04273893|593392125|FG001|Overall Study|Treatment of Disease Progression|2|||
164279327|NCT04273893|593392124|FG000|Overall Study|Death|1|||
164279328|NCT04273893|593392125|FG001|Overall Study|Death|2|||
164279329|NCT04273893|593392124|FG000|Overall Study|Lost to Follow-up|0|||
164279330|NCT04273893|593392125|FG001|Overall Study|Lost to Follow-up|2|||
164279331|NCT04273893|593392124|FG000|Overall Study|Physician Decision|1|||
164279332|NCT04273893|593392125|FG001|Overall Study|Physician Decision|0|||
164279333|NCT04774926|593392126|FG000|Overall Study|Adverse Event|15|||
164279334|NCT04774926|593392126|FG000|Overall Study|Lost to Follow-up|3|||
164279335|NCT04774926|593392126|FG000|Overall Study|Physician Decision|6|||
164279336|NCT04774926|593392126|FG000|Overall Study|Withdrawal by Subject|3|||
164279337|NCT04774926|593392126|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
164279338|NCT01393639|593392127|FG000|Overall Study|Protocol Violation|0|||
164432681|NCT00828672|593954668|FG000|Study Treatment|Adverse Event|0|||
164279339|NCT01393639|593392128|FG001|Overall Study|Protocol Violation|0|||
164279340|NCT01393639|593392129|FG002|Overall Study|Protocol Violation|0|||
164279341|NCT01393639|593392130|FG003|Overall Study|Protocol Violation|1|||
164279342|NCT01393639|593392131|FG004|Overall Study|Protocol Violation|0|||
164279343|NCT01393639|593392132|FG005|Overall Study|Protocol Violation|0|||
164279344|NCT01393639|593392133|FG006|Overall Study|Protocol Violation|0|||
164584382|NCT02732912|594504636|FG001|Overall Study|No outcome; discharged or refused|9|||
164279345|NCT01393639|593392127|FG000|Overall Study|Other|0|||
164279346|NCT01393639|593392128|FG001|Overall Study|Other|2|||
164279347|NCT01393639|593392129|FG002|Overall Study|Other|0|||
164279348|NCT01393639|593392130|FG003|Overall Study|Other|2|||
164279349|NCT01393639|593392131|FG004|Overall Study|Other|1|||
164279350|NCT01393639|593392132|FG005|Overall Study|Other|0|||
164279351|NCT01393639|593392133|FG006|Overall Study|Other|1|||
164279352|NCT01393639|593392127|FG000|Overall Study|Withdrawal by Subject|1|||
164279353|NCT01393639|593392128|FG001|Overall Study|Withdrawal by Subject|1|||
164279354|NCT01393639|593392129|FG002|Overall Study|Withdrawal by Subject|0|||
164279355|NCT01393639|593392130|FG003|Overall Study|Withdrawal by Subject|0|||
164279356|NCT01393639|593392131|FG004|Overall Study|Withdrawal by Subject|0|||
164279357|NCT01393639|593392132|FG005|Overall Study|Withdrawal by Subject|0|||
164279358|NCT01393639|593392133|FG006|Overall Study|Withdrawal by Subject|1|||
164279359|NCT01393639|593392127|FG000|Overall Study|Medication error without associated AE|0|||
164279360|NCT01393639|593392128|FG001|Overall Study|Medication error without associated AE|0|||
164279361|NCT01393639|593392129|FG002|Overall Study|Medication error without associated AE|0|||
164279362|NCT01393639|593392130|FG003|Overall Study|Medication error without associated AE|0|||
164279363|NCT01393639|593392131|FG004|Overall Study|Medication error without associated AE|0|||
164279364|NCT01393639|593392132|FG005|Overall Study|Medication error without associated AE|0|||
164279365|NCT01393639|593392133|FG006|Overall Study|Medication error without associated AE|1|||
164279366|NCT01393639|593392127|FG000|Overall Study|Lost to Follow-up|0|||
164279367|NCT01393639|593392128|FG001|Overall Study|Lost to Follow-up|1|||
164279368|NCT01393639|593392129|FG002|Overall Study|Lost to Follow-up|0|||
164279369|NCT01393639|593392130|FG003|Overall Study|Lost to Follow-up|0|||
164279370|NCT01393639|593392131|FG004|Overall Study|Lost to Follow-up|0|||
164279371|NCT01393639|593392132|FG005|Overall Study|Lost to Follow-up|0|||
164279372|NCT01393639|593392133|FG006|Overall Study|Lost to Follow-up|1|||
164279373|NCT01393639|593392127|FG000|Overall Study|Lack of Efficacy|0|||
164279374|NCT01393639|593392128|FG001|Overall Study|Lack of Efficacy|0|||
164279375|NCT01393639|593392129|FG002|Overall Study|Lack of Efficacy|0|||
164279376|NCT01393639|593392130|FG003|Overall Study|Lack of Efficacy|0|||
164279377|NCT01393639|593392131|FG004|Overall Study|Lack of Efficacy|0|||
164279378|NCT01393639|593392132|FG005|Overall Study|Lack of Efficacy|0|||
164279379|NCT01393639|593392133|FG006|Overall Study|Lack of Efficacy|1|||
164279380|NCT01393639|593392127|FG000|Overall Study|Adverse Event|2|||
164279381|NCT01393639|593392128|FG001|Overall Study|Adverse Event|3|||
164279382|NCT01393639|593392129|FG002|Overall Study|Adverse Event|1|||
164279383|NCT01393639|593392130|FG003|Overall Study|Adverse Event|2|||
164279384|NCT01393639|593392131|FG004|Overall Study|Adverse Event|0|||
164279385|NCT01393639|593392132|FG005|Overall Study|Adverse Event|2|||
164279386|NCT01393639|593392133|FG006|Overall Study|Adverse Event|3|||
164279387|NCT00793325|593392137|FG000|Overall Study|Protocol Violation|18|||
164279388|NCT00793325|593392137|FG000|Overall Study|Lost to Follow-up|1|||
164279389|NCT01440816|593392138|FG000|Overall Study|Disease Progression|0|||
164279390|NCT01440816|593392139|FG001|Overall Study|Disease Progression|9|||
164279391|NCT01440816|593392138|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
164279392|NCT01440816|593392139|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
164279393|NCT03250182|593392149|FG000|Overall Study|Withdrawal by Subject|1|||
164279394|NCT00100789|593392152|FG000|Overall Study|Adverse Event|10|||
164279395|NCT00100789|593392152|FG000|Overall Study|Withdrawal by Subject|1|||
164279396|NCT00100789|593392152|FG000|Overall Study|Progression/relapse|42|||
164279397|NCT00100789|593392152|FG000|Overall Study|Death|2|||
164279398|NCT00100789|593392152|FG000|Overall Study|Not protocol specified|5|||
164279399|NCT00100789|593392152|FG000|Overall Study|Ineligible|3|||
164279400|NCT00100789|593392152|FG000|Overall Study|Never received treatment|1|||
164432682|NCT00828672|593954669|FG001|Study Treatment|Adverse Event|1|||
164432683|NCT00828672|593954668|FG000|Study Treatment|Complete response, no surgery|1|||
164279401|NCT02936843|593392153|FG000|Overall Study|Lost to Follow-up|3|||
164279402|NCT02936843|593392154|FG001|Overall Study|Lost to Follow-up|1|||
164279403|NCT02936843|593392153|FG000|Overall Study|Withdrawal by Subject|1|||
164279404|NCT02936843|593392154|FG001|Overall Study|Withdrawal by Subject|1|||
164279405|NCT03472950|593392155|FG000|Overall Study|Lost to Follow-up|0|||
164279406|NCT03472950|593392156|FG001|Overall Study|Lost to Follow-up|1|||
164279407|NCT03472950|593392155|FG000|Overall Study|Adverse Event|0|||
164279408|NCT03472950|593392156|FG001|Overall Study|Adverse Event|3|||
164279409|NCT01393821|593392157|FG000|Overall Study|Cancel|1|||
164279410|NCT01393821|593392158|FG001|Overall Study|Cancel|1|||
164432684|NCT00828672|593954669|FG001|Study Treatment|Complete response, no surgery|1|||
164432685|NCT00828672|593954668|FG000|Post-surgery (<30 Days)|No central review materials|0|||
164432686|NCT00828672|593954669|FG001|Post-surgery (<30 Days)|No central review materials|1|||
164279411|NCT01393821|593392157|FG000|Overall Study|not evaluable for primary endpoint|4|||
164279412|NCT01393821|593392158|FG001|Overall Study|not evaluable for primary endpoint|2|||
164279413|NCT03386487|593392171|FG000|Overall Study|Lost to Follow-up|5|||
164279414|NCT03386487|593392172|FG001|Overall Study|Lost to Follow-up|6|||
164279415|NCT03386487|593392171|FG000|Overall Study|Withdrawal by Subject|11|||
164279416|NCT03386487|593392172|FG001|Overall Study|Withdrawal by Subject|7|||
164279417|NCT03386487|593392171|FG000|Overall Study|Physician Decision|11|||
164279418|NCT03386487|593392172|FG001|Overall Study|Physician Decision|8|||
164279419|NCT01068769|593392174|FG000|Overall Study|Ineligible|1|||
164279420|NCT01948063|593392175|FG000|Overall Study|Boston MCI halted research protocol|0|||
164344022|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
164344023|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
164279421|NCT01948063|593392176|FG001|Overall Study|Boston MCI halted research protocol|1|||
164279422|NCT01948063|593392175|FG000|Overall Study|Discovered an enrollment in other study|0|||
164279423|NCT01948063|593392176|FG001|Overall Study|Discovered an enrollment in other study|1|||
164279424|NCT01948063|593392175|FG000|Overall Study|Blood samples were accidentally thawed|1|||
164344024|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
164344025|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
164344026|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Change of location|0|||
164344027|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Change of location|0|||
164344028|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Change of location|0|||
164344029|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Change of location|1|||
164344030|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Change of location|0|||
164344031|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
164344032|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
164344033|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
164344034|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
164344035|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
164344036|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
164344037|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
164344038|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
164344039|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
164344040|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
164344041|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
164344042|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
164344043|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
164279425|NCT01948063|593392176|FG001|Overall Study|Blood samples were accidentally thawed|0|||
164279426|NCT01858766|593392177|FG000|Overall Study|Randomized but Never Treated|0|||
164279427|NCT01858766|593392178|FG001|Overall Study|Randomized but Never Treated|0|||
164279428|NCT01858766|593392179|FG002|Overall Study|Randomized but Never Treated|0|||
164279429|NCT01858766|593392180|FG003|Overall Study|Randomized but Never Treated|0|||
164279430|NCT01858766|593392181|FG004|Overall Study|Randomized but Never Treated|0|||
164279431|NCT01858766|593392182|FG005|Overall Study|Randomized but Never Treated|1|||
164279432|NCT01858766|593392183|FG006|Overall Study|Randomized but Never Treated|0|||
164279433|NCT01858766|593392184|FG007|Overall Study|Randomized but Never Treated|0|||
164279434|NCT01858766|593392185|FG008|Overall Study|Randomized but Never Treated|0|||
164279435|NCT01858766|593392186|FG009|Overall Study|Randomized but Never Treated|0|||
164279436|NCT01858766|593392187|FG010|Overall Study|Randomized but Never Treated|0|||
164279437|NCT01858766|593392188|FG011|Overall Study|Randomized but Never Treated|0|||
164279438|NCT01858766|593392189|FG012|Overall Study|Randomized but Never Treated|0|||
164279439|NCT01858766|593392190|FG013|Overall Study|Randomized but Never Treated|0|||
164344044|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
164344045|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
164344046|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
164344047|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
164344048|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
164344049|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
164344050|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
164344051|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
164344052|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
164344053|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
164344054|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
164344055|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
164344056|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
164344057|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
164432687|NCT00601640|593954671|FG000|Overall Study|Withdrawal by Subject|3|||
164432688|NCT00601640|593954672|FG001|Overall Study|Withdrawal by Subject|0|||
164432689|NCT00601640|593954673|FG002|Overall Study|Withdrawal by Subject|7|||
164432690|NCT00601640|593954671|FG000|Overall Study|Death|1|||
164432691|NCT00601640|593954672|FG001|Overall Study|Death|0|||
164432692|NCT00601640|593954673|FG002|Overall Study|Death|0|||
164432693|NCT00601640|593954671|FG000|Overall Study|Adverse Event|0|||
164432694|NCT00601640|593954672|FG001|Overall Study|Adverse Event|4|||
164432695|NCT00601640|593954673|FG002|Overall Study|Adverse Event|2|||
164432696|NCT00601640|593954671|FG000|Overall Study|intercurrent illness|1|||
164279440|NCT01858766|593392191|FG014|Overall Study|Randomized but Never Treated|0|||
164279441|NCT01858766|593392192|FG015|Overall Study|Randomized but Never Treated|0|||
164279442|NCT01858766|593392193|FG016|Overall Study|Randomized but Never Treated|0|||
164279443|NCT01858766|593392194|FG017|Overall Study|Randomized but Never Treated|1|||
164279444|NCT01858766|593392195|FG018|Overall Study|Randomized but Never Treated|0|||
164279445|NCT01858766|593392177|FG000|Overall Study|Death|0|||
164279446|NCT01858766|593392178|FG001|Overall Study|Death|0|||
164279447|NCT01858766|593392179|FG002|Overall Study|Death|1|||
164279448|NCT01858766|593392180|FG003|Overall Study|Death|0|||
164279449|NCT01858766|593392181|FG004|Overall Study|Death|0|||
164279450|NCT01858766|593392182|FG005|Overall Study|Death|0|||
164279451|NCT01858766|593392183|FG006|Overall Study|Death|0|||
164279452|NCT01858766|593392184|FG007|Overall Study|Death|0|||
164279453|NCT01858766|593392185|FG008|Overall Study|Death|0|||
164279454|NCT01858766|593392186|FG009|Overall Study|Death|0|||
164279455|NCT01858766|593392187|FG010|Overall Study|Death|0|||
164279456|NCT01858766|593392188|FG011|Overall Study|Death|0|||
164279457|NCT01858766|593392189|FG012|Overall Study|Death|0|||
164279458|NCT01858766|593392190|FG013|Overall Study|Death|0|||
164279459|NCT01858766|593392191|FG014|Overall Study|Death|0|||
164279460|NCT01858766|593392192|FG015|Overall Study|Death|0|||
164279461|NCT01858766|593392193|FG016|Overall Study|Death|0|||
164279462|NCT01858766|593392194|FG017|Overall Study|Death|0|||
164279463|NCT01858766|593392195|FG018|Overall Study|Death|0|||
164279464|NCT01858766|593392177|FG000|Overall Study|Lack of Efficacy|1|||
164279465|NCT01858766|593392178|FG001|Overall Study|Lack of Efficacy|0|||
164279466|NCT01858766|593392179|FG002|Overall Study|Lack of Efficacy|0|||
164279467|NCT01858766|593392180|FG003|Overall Study|Lack of Efficacy|0|||
164279468|NCT01858766|593392181|FG004|Overall Study|Lack of Efficacy|1|||
164279469|NCT01858766|593392182|FG005|Overall Study|Lack of Efficacy|2|||
164279470|NCT01858766|593392183|FG006|Overall Study|Lack of Efficacy|0|||
164279471|NCT01858766|593392184|FG007|Overall Study|Lack of Efficacy|0|||
164279472|NCT01858766|593392185|FG008|Overall Study|Lack of Efficacy|0|||
164279473|NCT01858766|593392186|FG009|Overall Study|Lack of Efficacy|0|||
164279474|NCT01858766|593392187|FG010|Overall Study|Lack of Efficacy|0|||
164279475|NCT01858766|593392188|FG011|Overall Study|Lack of Efficacy|3|||
164279476|NCT01858766|593392189|FG012|Overall Study|Lack of Efficacy|5|||
164279477|NCT01858766|593392190|FG013|Overall Study|Lack of Efficacy|3|||
164279478|NCT01858766|593392191|FG014|Overall Study|Lack of Efficacy|5|||
164279479|NCT01858766|593392192|FG015|Overall Study|Lack of Efficacy|5|||
164279480|NCT01858766|593392193|FG016|Overall Study|Lack of Efficacy|2|||
164279481|NCT01858766|593392194|FG017|Overall Study|Lack of Efficacy|3|||
164279482|NCT01858766|593392195|FG018|Overall Study|Lack of Efficacy|3|||
164279483|NCT01858766|593392177|FG000|Overall Study|Lost to Follow-up|0|||
164279484|NCT01858766|593392178|FG001|Overall Study|Lost to Follow-up|0|||
164279485|NCT01858766|593392179|FG002|Overall Study|Lost to Follow-up|0|||
164279486|NCT01858766|593392180|FG003|Overall Study|Lost to Follow-up|0|||
164279487|NCT01858766|593392181|FG004|Overall Study|Lost to Follow-up|0|||
164279488|NCT01858766|593392182|FG005|Overall Study|Lost to Follow-up|1|||
164279489|NCT01858766|593392183|FG006|Overall Study|Lost to Follow-up|0|||
164279490|NCT01858766|593392184|FG007|Overall Study|Lost to Follow-up|2|||
164279491|NCT01858766|593392185|FG008|Overall Study|Lost to Follow-up|0|||
164279492|NCT01858766|593392186|FG009|Overall Study|Lost to Follow-up|0|||
164279493|NCT01858766|593392187|FG010|Overall Study|Lost to Follow-up|0|||
164279494|NCT01858766|593392188|FG011|Overall Study|Lost to Follow-up|1|||
164279495|NCT01858766|593392189|FG012|Overall Study|Lost to Follow-up|0|||
164279496|NCT01858766|593392190|FG013|Overall Study|Lost to Follow-up|0|||
164279497|NCT01858766|593392191|FG014|Overall Study|Lost to Follow-up|3|||
164279498|NCT01858766|593392192|FG015|Overall Study|Lost to Follow-up|1|||
164279499|NCT01858766|593392193|FG016|Overall Study|Lost to Follow-up|1|||
164279500|NCT01858766|593392194|FG017|Overall Study|Lost to Follow-up|0|||
164279501|NCT01858766|593392195|FG018|Overall Study|Lost to Follow-up|1|||
164432697|NCT00601640|593954672|FG001|Overall Study|intercurrent illness|0|||
164432698|NCT00601640|593954673|FG002|Overall Study|intercurrent illness|0|||
164432699|NCT00601640|593954671|FG000|Overall Study|change in eligibility status|0|||
164279502|NCT01858766|593392177|FG000|Overall Study|Withdrew Consent|0|||
164279503|NCT01858766|593392178|FG001|Overall Study|Withdrew Consent|0|||
164279504|NCT01858766|593392179|FG002|Overall Study|Withdrew Consent|0|||
164279505|NCT01858766|593392180|FG003|Overall Study|Withdrew Consent|0|||
164279506|NCT01858766|593392181|FG004|Overall Study|Withdrew Consent|0|||
164279507|NCT01858766|593392182|FG005|Overall Study|Withdrew Consent|0|||
164279508|NCT01858766|593392183|FG006|Overall Study|Withdrew Consent|0|||
164279509|NCT01858766|593392184|FG007|Overall Study|Withdrew Consent|0|||
164279510|NCT01858766|593392185|FG008|Overall Study|Withdrew Consent|0|||
164279511|NCT01858766|593392186|FG009|Overall Study|Withdrew Consent|0|||
164279512|NCT01858766|593392187|FG010|Overall Study|Withdrew Consent|0|||
164279513|NCT01858766|593392188|FG011|Overall Study|Withdrew Consent|1|||
164279514|NCT01858766|593392189|FG012|Overall Study|Withdrew Consent|0|||
164279515|NCT01858766|593392190|FG013|Overall Study|Withdrew Consent|0|||
164279516|NCT01858766|593392191|FG014|Overall Study|Withdrew Consent|0|||
164279517|NCT01858766|593392192|FG015|Overall Study|Withdrew Consent|0|||
164279518|NCT01858766|593392193|FG016|Overall Study|Withdrew Consent|0|||
164279519|NCT01858766|593392194|FG017|Overall Study|Withdrew Consent|0|||
164279520|NCT01858766|593392195|FG018|Overall Study|Withdrew Consent|0|||
164279521|NCT00894361|593392200|FG000|Overall Study|deaths and less than 2 years followup|24|||
164279522|NCT00894361|593392201|FG001|Overall Study|deaths and less than 2 years followup|64|||
164279523|NCT04207060|593392206|FG000|Overall Study|Lost to Follow-up|2|||
164279524|NCT04207060|593392207|FG001|Overall Study|Lost to Follow-up|0|||
164279525|NCT05438576|593392208|FG000|Overall Study|Death|1|||
164279526|NCT05438576|593392209|FG001|Overall Study|Death|1|||
164279527|NCT05438576|593392208|FG000|Overall Study|Withdrawal by Subject|4|||
164279528|NCT05438576|593392209|FG001|Overall Study|Withdrawal by Subject|2|||
164279529|NCT05438576|593392208|FG000|Overall Study|Not Eligible|2|||
164279530|NCT05438576|593392209|FG001|Overall Study|Not Eligible|1|||
164279531|NCT05438576|593392208|FG000|Overall Study|Did not complete baseline testing|22|||
164279532|NCT05438576|593392209|FG001|Overall Study|Did not complete baseline testing|4|||
164279533|NCT02881762|593392212|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
164279534|NCT02881762|593392213|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
164279535|NCT00245037|593392214|FG000|Overall Study|Death|17|||
164279536|NCT00296140|593392216|FG000|Overall Study|Lost to Follow-up|1|||
164279537|NCT00296140|593392217|FG001|Overall Study|Lost to Follow-up|0|||
164279538|NCT00296140|593392216|FG000|Overall Study|Withdrawal by Subject|1|||
164279539|NCT00296140|593392217|FG001|Overall Study|Withdrawal by Subject|0|||
164279540|NCT00296140|593392216|FG000|Overall Study|Discharge to Nursing Home|1|||
164279541|NCT00296140|593392217|FG001|Overall Study|Discharge to Nursing Home|0|||
164279542|NCT00774800|593392218|FG000|Intervention 4|Withdrawal by Subject|1|||
164279543|NCT01843062|593392219|FG000|Overall Study|Protocol Violation|1|||
164279544|NCT01843062|593392220|FG001|Overall Study|Protocol Violation|0|||
164279545|NCT01843062|593392219|FG000|Overall Study|New treatment following progression|2|||
164279546|NCT01843062|593392220|FG001|Overall Study|New treatment following progression|0|||
164279547|NCT01843062|593392219|FG000|Overall Study|Pregnancy|1|||
164279548|NCT01843062|593392220|FG001|Overall Study|Pregnancy|0|||
164279549|NCT01843062|593392219|FG000|Overall Study|Adverse Event|2|||
164279550|NCT01843062|593392220|FG001|Overall Study|Adverse Event|0|||
164279551|NCT01843062|593392219|FG000|Overall Study|Incorrect randomisation|1|||
164279552|NCT01843062|593392220|FG001|Overall Study|Incorrect randomisation|0|||
164279553|NCT01843062|593392219|FG000|Overall Study|Withdrawal by Subject|12|||
164279554|NCT01843062|593392220|FG001|Overall Study|Withdrawal by Subject|3|||
164279555|NCT01843062|593392219|FG000|Overall Study|Death|1|||
164279556|NCT01843062|593392220|FG001|Overall Study|Death|2|||
164279557|NCT01843062|593392219|FG000|Overall Study|Lost to Follow-up|2|||
164279558|NCT01843062|593392220|FG001|Overall Study|Lost to Follow-up|4|||
164279559|NCT00994422|593392221|FG000|Overall Study|Lost to Follow-up|7|||
164279560|NCT00994422|593392222|FG001|Overall Study|Lost to Follow-up|1|||
164279561|NCT02669212|593392223|FG000|Overall Study|Lost to Follow-up|1|||
164279562|NCT02669212|593392224|FG001|Overall Study|Lost to Follow-up|0|||
164279563|NCT02669212|593392223|FG000|Overall Study|Medical Condition|3|||
164279564|NCT02669212|593392224|FG001|Overall Study|Medical Condition|4|||
164279565|NCT02669212|593392223|FG000|Overall Study|Withdrawal by Subject|0|||
164279566|NCT02669212|593392224|FG001|Overall Study|Withdrawal by Subject|2|||
164279567|NCT02669212|593392223|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
164279568|NCT02669212|593392224|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
164279569|NCT03549104|593392227|FG000|Overall Study|Withdrawal by Subject|5|||
164279570|NCT03549104|593392228|FG001|Overall Study|Withdrawal by Subject|2|||
164279571|NCT03549104|593392227|FG000|Overall Study|Covid shelter in place|1|||
164279572|NCT03549104|593392228|FG001|Overall Study|Covid shelter in place|2|||
164279573|NCT04124705|593392229|FG000|Titration Period|Adverse Event|9|||
164279574|NCT04124705|593392230|FG001|Titration Period|Adverse Event|5|||
164279575|NCT04124705|593392229|FG000|Titration Period|Withdrawal by Subject|6|||
164279576|NCT04124705|593392230|FG001|Titration Period|Withdrawal by Subject|3|||
164279577|NCT04124705|593392229|FG000|Titration Period|Lost to Follow-up|0|||
164279578|NCT04124705|593392230|FG001|Titration Period|Lost to Follow-up|1|||
164279579|NCT04124705|593392229|FG000|Titration Period|Death|1|||
164279580|NCT04124705|593392230|FG001|Titration Period|Death|1|||
164279581|NCT04124705|593392229|FG000|Titration Period|Lack of Efficacy|2|||
164279582|NCT04124705|593392230|FG001|Titration Period|Lack of Efficacy|0|||
164279583|NCT04124705|593392229|FG000|Titration Period|Physician Decision|2|||
164279584|NCT04124705|593392230|FG001|Titration Period|Physician Decision|0|||
164279585|NCT04124705|593392229|FG000|Titration Period|Non-compliance with Study Drug|2|||
164279586|NCT04124705|593392230|FG001|Titration Period|Non-compliance with Study Drug|0|||
164279587|NCT04124705|593392229|FG000|Titration Period|Other|4|||
164279588|NCT04124705|593392230|FG001|Titration Period|Other|9|||
164584383|NCT01507545|594504638|FG000|Overall Study|Withdrawal by Subject|6|||
164584384|NCT01507545|594504639|FG001|Overall Study|Withdrawal by Subject|2|||
164584385|NCT01507545|594504638|FG000|Overall Study|Lost to Follow-up|1|||
164584386|NCT01507545|594504639|FG001|Overall Study|Lost to Follow-up|0|||
164279589|NCT04124705|593392229|FG000|Stabilization Period|Adverse Event|4|||
164279590|NCT04124705|593392230|FG001|Stabilization Period|Adverse Event|2|||
164344058|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
164279591|NCT04124705|593392229|FG000|Stabilization Period|Withdrawal by Subject|1|||
164279592|NCT04124705|593392230|FG001|Stabilization Period|Withdrawal by Subject|1|||
164279593|NCT04124705|593392229|FG000|Stabilization Period|Lost to Follow-up|0|||
164279594|NCT04124705|593392230|FG001|Stabilization Period|Lost to Follow-up|1|||
164279595|NCT04124705|593392229|FG000|Stabilization Period|Lack of Efficacy|4|||
164279596|NCT04124705|593392230|FG001|Stabilization Period|Lack of Efficacy|2|||
164279597|NCT04124705|593392229|FG000|Stabilization Period|Protocol Deviation|0|||
164279598|NCT04124705|593392230|FG001|Stabilization Period|Protocol Deviation|2|||
164279599|NCT04124705|593392229|FG000|Stabilization Period|Other|2|||
164279600|NCT04124705|593392230|FG001|Stabilization Period|Other|2|||
164279601|NCT00532298|593392231|FG000|Overall Study|Adverse Event|1|||
164279602|NCT00532298|593392232|FG001|Overall Study|Adverse Event|0|||
164279603|NCT00532298|593392233|FG002|Overall Study|Adverse Event|0|||
164279604|NCT00532298|593392234|FG003|Overall Study|Adverse Event|0|||
164279605|NCT00532298|593392235|FG004|Overall Study|Adverse Event|1|||
164279606|NCT00532298|593392236|FG005|Overall Study|Adverse Event|1|||
164279607|NCT00532298|593392231|FG000|Overall Study|Lost to Follow-up|1|||
164279608|NCT00532298|593392232|FG001|Overall Study|Lost to Follow-up|1|||
164279609|NCT00532298|593392233|FG002|Overall Study|Lost to Follow-up|1|||
164279610|NCT00532298|593392234|FG003|Overall Study|Lost to Follow-up|0|||
164279611|NCT00532298|593392235|FG004|Overall Study|Lost to Follow-up|0|||
164279612|NCT00532298|593392236|FG005|Overall Study|Lost to Follow-up|1|||
164279613|NCT00479856|593392237|FG000|Overall Study|Adverse Event|1|||
164279614|NCT00479856|593392237|FG000|Overall Study|Withdrawal by Subject|1|||
164279615|NCT00479856|593392237|FG000|Overall Study|Physician Decision|1|||
164279616|NCT04164732|593392239|FG000|Treatment run-in Period|Adverse Event|4|||
164279617|NCT04164732|593392240|FG001|Treatment run-in Period|Adverse Event|0|||
164279618|NCT04164732|593392241|FG002|Treatment run-in Period|Adverse Event|0|||
164279619|NCT04164732|593392239|FG000|Treatment run-in Period|Physician Decision|1|||
164279620|NCT04164732|593392240|FG001|Treatment run-in Period|Physician Decision|0|||
164279621|NCT04164732|593392241|FG002|Treatment run-in Period|Physician Decision|0|||
164279622|NCT04164732|593392239|FG000|Treatment run-in Period|Screen Failure|1|||
164279623|NCT04164732|593392240|FG001|Treatment run-in Period|Screen Failure|0|||
164279624|NCT04164732|593392241|FG002|Treatment run-in Period|Screen Failure|0|||
164279625|NCT04164732|593392239|FG000|Randomized Treatment Period|Adverse Event|0|||
164279626|NCT04164732|593392240|FG001|Randomized Treatment Period|Adverse Event|1|||
164279627|NCT04164732|593392241|FG002|Randomized Treatment Period|Adverse Event|0|||
164279628|NCT04164732|593392239|FG000|Randomized Treatment Period|Protocol Deviation|0|||
164279629|NCT04164732|593392240|FG001|Randomized Treatment Period|Protocol Deviation|1|||
164279630|NCT04164732|593392241|FG002|Randomized Treatment Period|Protocol Deviation|1|||
164279631|NCT04164732|593392239|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
164279632|NCT04164732|593392240|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
164279633|NCT04164732|593392241|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
164279634|NCT02141360|593392242|FG000|Overall Study|Withdrawal by Subject|6|||
164279635|NCT02141360|593392243|FG001|Overall Study|Withdrawal by Subject|0|||
164279636|NCT02141360|593392244|FG002|Overall Study|Withdrawal by Subject|0|||
164279637|NCT02141360|593392242|FG000|Overall Study|Study Terminated before Visit|1|||
164279638|NCT02141360|593392243|FG001|Overall Study|Study Terminated before Visit|0|||
164279639|NCT02141360|593392244|FG002|Overall Study|Study Terminated before Visit|0|||
164279640|NCT00661622|593392245|FG000|Overall Study|Protocol Violation|1|||
164279641|NCT00661622|593392246|FG001|Overall Study|Protocol Violation|0|||
164279642|NCT00932165|593392255|FG000|Overall Study|Lost to Follow-up|1|||
164279643|NCT03997825|593392260|FG000|Overall Study|Death|3|||
164279644|NCT03997825|593392260|FG000|Overall Study|Lost to Follow-up|10|||
164279645|NCT03997825|593392260|FG000|Overall Study|Withdrawal by Subject|3|||
164584387|NCT01507545|594504638|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
164584388|NCT01507545|594504639|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
164584389|NCT01507545|594504638|FG000|Overall Study|Progressive disease|60|||
164584390|NCT01507545|594504639|FG001|Overall Study|Progressive disease|27|||
164584391|NCT01507545|594504638|FG000|Overall Study|Other|6|||
164584392|NCT01507545|594504639|FG001|Overall Study|Other|4|||
164584393|NCT01753518|594504641|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
164584394|NCT01753518|594504642|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
164584395|NCT01753518|594504641|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
164584396|NCT01753518|594504642|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
164584397|NCT01753518|594504641|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
164279646|NCT03997825|593392260|FG000|Overall Study|Refused participation|1|||
164279647|NCT03824587|593392271|FG000|Run-in Period|Screen Failure|0|||
164279648|NCT03824587|593392272|FG001|Run-in Period|Screen Failure|275|||
164279649|NCT03824587|593392271|FG000|Treatment Period|Adverse Event|4|||
164279650|NCT03824587|593392272|FG001|Treatment Period|Adverse Event|1|||
164279651|NCT03824587|593392271|FG000|Treatment Period|Withdrawal by Subject|0|||
164279652|NCT03824587|593392272|FG001|Treatment Period|Withdrawal by Subject|1|||
164279653|NCT03824587|593392271|FG000|Treatment Period|Kidney Transplant|1|||
164279654|NCT03824587|593392272|FG001|Treatment Period|Kidney Transplant|1|||
164279655|NCT01300572|593392273|FG000|Overall Study|HAMA + post dosimetry|1|||
164279656|NCT01368081|593392274|FG000|Overall Study|Adverse Event|4|||
164279657|NCT01368081|593392275|FG001|Overall Study|Adverse Event|4|||
164279658|NCT01368081|593392276|FG002|Overall Study|Adverse Event|3|||
164279659|NCT01368081|593392277|FG003|Overall Study|Adverse Event|2|||
164279660|NCT01368081|593392278|FG004|Overall Study|Adverse Event|2|||
164279661|NCT01368081|593392279|FG005|Overall Study|Adverse Event|5|||
164279662|NCT01368081|593392280|FG006|Overall Study|Adverse Event|6|||
164279663|NCT01368081|593392281|FG007|Overall Study|Adverse Event|2|||
164279664|NCT01368081|593392282|FG008|Overall Study|Adverse Event|3|||
164279665|NCT01368081|593392283|FG009|Overall Study|Adverse Event|5|||
164279666|NCT01368081|593392284|FG010|Overall Study|Adverse Event|6|||
164279667|NCT01368081|593392285|FG011|Overall Study|Adverse Event|1|||
164279668|NCT01368081|593392286|FG012|Overall Study|Adverse Event|3|||
164279669|NCT01368081|593392274|FG000|Overall Study|Lack of Efficacy|0|||
164279670|NCT01368081|593392275|FG001|Overall Study|Lack of Efficacy|1|||
164279671|NCT01368081|593392276|FG002|Overall Study|Lack of Efficacy|0|||
164279672|NCT01368081|593392277|FG003|Overall Study|Lack of Efficacy|1|||
164279673|NCT01368081|593392278|FG004|Overall Study|Lack of Efficacy|0|||
164279674|NCT01368081|593392279|FG005|Overall Study|Lack of Efficacy|0|||
164279675|NCT01368081|593392280|FG006|Overall Study|Lack of Efficacy|0|||
164279676|NCT01368081|593392281|FG007|Overall Study|Lack of Efficacy|2|||
164279677|NCT01368081|593392282|FG008|Overall Study|Lack of Efficacy|0|||
164279678|NCT01368081|593392283|FG009|Overall Study|Lack of Efficacy|0|||
164279679|NCT01368081|593392284|FG010|Overall Study|Lack of Efficacy|0|||
164279680|NCT01368081|593392285|FG011|Overall Study|Lack of Efficacy|0|||
164279681|NCT01368081|593392286|FG012|Overall Study|Lack of Efficacy|0|||
164279682|NCT01368081|593392274|FG000|Overall Study|Protocol Violation|0|||
164279683|NCT01368081|593392275|FG001|Overall Study|Protocol Violation|0|||
164279684|NCT01368081|593392276|FG002|Overall Study|Protocol Violation|0|||
164279685|NCT01368081|593392277|FG003|Overall Study|Protocol Violation|0|||
164279686|NCT01368081|593392278|FG004|Overall Study|Protocol Violation|0|||
164279687|NCT01368081|593392279|FG005|Overall Study|Protocol Violation|1|||
164279688|NCT01368081|593392280|FG006|Overall Study|Protocol Violation|0|||
164279689|NCT01368081|593392281|FG007|Overall Study|Protocol Violation|1|||
164279690|NCT01368081|593392282|FG008|Overall Study|Protocol Violation|0|||
164279691|NCT01368081|593392283|FG009|Overall Study|Protocol Violation|0|||
164279692|NCT01368081|593392284|FG010|Overall Study|Protocol Violation|0|||
164279693|NCT01368081|593392285|FG011|Overall Study|Protocol Violation|0|||
164279694|NCT01368081|593392286|FG012|Overall Study|Protocol Violation|0|||
164279695|NCT01368081|593392274|FG000|Overall Study|Lost to Follow-up|0|||
164279696|NCT01368081|593392275|FG001|Overall Study|Lost to Follow-up|0|||
164584398|NCT01753518|594504642|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
164279697|NCT01368081|593392276|FG002|Overall Study|Lost to Follow-up|0|||
164279698|NCT01368081|593392277|FG003|Overall Study|Lost to Follow-up|0|||
164279699|NCT01368081|593392278|FG004|Overall Study|Lost to Follow-up|0|||
164279700|NCT01368081|593392279|FG005|Overall Study|Lost to Follow-up|0|||
164279701|NCT01368081|593392280|FG006|Overall Study|Lost to Follow-up|0|||
164279702|NCT01368081|593392281|FG007|Overall Study|Lost to Follow-up|0|||
164279703|NCT01368081|593392282|FG008|Overall Study|Lost to Follow-up|0|||
164279704|NCT01368081|593392283|FG009|Overall Study|Lost to Follow-up|0|||
164279705|NCT01368081|593392284|FG010|Overall Study|Lost to Follow-up|0|||
164279706|NCT01368081|593392285|FG011|Overall Study|Lost to Follow-up|0|||
164279707|NCT01368081|593392286|FG012|Overall Study|Lost to Follow-up|1|||
164279708|NCT01368081|593392274|FG000|Overall Study|Withdrawal by Subject|4|||
164279709|NCT01368081|593392275|FG001|Overall Study|Withdrawal by Subject|4|||
164279710|NCT01368081|593392276|FG002|Overall Study|Withdrawal by Subject|1|||
164279711|NCT01368081|593392277|FG003|Overall Study|Withdrawal by Subject|1|||
164279712|NCT01368081|593392278|FG004|Overall Study|Withdrawal by Subject|0|||
164279713|NCT01368081|593392279|FG005|Overall Study|Withdrawal by Subject|3|||
164279714|NCT01368081|593392280|FG006|Overall Study|Withdrawal by Subject|4|||
164279715|NCT01368081|593392281|FG007|Overall Study|Withdrawal by Subject|2|||
164279716|NCT01368081|593392282|FG008|Overall Study|Withdrawal by Subject|5|||
164279717|NCT01368081|593392283|FG009|Overall Study|Withdrawal by Subject|4|||
164279718|NCT01368081|593392284|FG010|Overall Study|Withdrawal by Subject|3|||
164279719|NCT01368081|593392285|FG011|Overall Study|Withdrawal by Subject|2|||
164279720|NCT01368081|593392286|FG012|Overall Study|Withdrawal by Subject|0|||
164279721|NCT01368081|593392274|FG000|Overall Study|Other reason not defined above|2|||
164279722|NCT01368081|593392275|FG001|Overall Study|Other reason not defined above|0|||
164279723|NCT01368081|593392276|FG002|Overall Study|Other reason not defined above|0|||
164279724|NCT01368081|593392277|FG003|Overall Study|Other reason not defined above|1|||
164279725|NCT01368081|593392278|FG004|Overall Study|Other reason not defined above|0|||
164279726|NCT01368081|593392279|FG005|Overall Study|Other reason not defined above|1|||
164279727|NCT01368081|593392280|FG006|Overall Study|Other reason not defined above|2|||
164279728|NCT01368081|593392281|FG007|Overall Study|Other reason not defined above|0|||
164279729|NCT01368081|593392282|FG008|Overall Study|Other reason not defined above|0|||
164279730|NCT01368081|593392283|FG009|Overall Study|Other reason not defined above|1|||
164279731|NCT01368081|593392284|FG010|Overall Study|Other reason not defined above|0|||
164279732|NCT01368081|593392285|FG011|Overall Study|Other reason not defined above|0|||
164279733|NCT01368081|593392286|FG012|Overall Study|Other reason not defined above|3|||
164279734|NCT02461745|593392288|FG000|Overall Study|Lack of Efficacy|9|||
164279735|NCT02461745|593392289|FG001|Overall Study|Lack of Efficacy|1|||
164279736|NCT02461745|593392288|FG000|Overall Study|Lost to Follow-up|2|||
164279737|NCT02461745|593392289|FG001|Overall Study|Lost to Follow-up|2|||
164279738|NCT02461745|593392288|FG000|Overall Study|Withdrawal by Subject|3|||
164279739|NCT02461745|593392289|FG001|Overall Study|Withdrawal by Subject|1|||
164279740|NCT02921087|593392290|FG000|Overall Study|Withdrawal by Subject|0|||
164279741|NCT02921087|593392291|FG001|Overall Study|Withdrawal by Subject|1|||
164279742|NCT02828436|593394144|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
164279743|NCT02828436|593394145|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
164279744|NCT02828436|593394144|FG000|Period 1|Lost to Follow-up|0|||
164279745|NCT02828436|593394145|FG001|Period 1|Lost to Follow-up|1|||
164279746|NCT02828436|593394144|FG000|Period 2|Withdrawal by Subject|4|||
164279747|NCT02828436|593394145|FG001|Period 2|Withdrawal by Subject|0|||
164279748|NCT02828436|593394144|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
164279749|NCT02828436|593394145|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
164279750|NCT02828436|593394144|FG000|Period 2|Lost to Follow-up|1|||
164279751|NCT02828436|593394145|FG001|Period 2|Lost to Follow-up|0|||
164279752|NCT02644343|593394146|FG000|Overall Study|Withdrawal by Subject|1|||
164279753|NCT00536471|593394147|FG000|Overall Study|Lost to Follow-up|48|||
164279754|NCT00536471|593394148|FG001|Overall Study|Lost to Follow-up|23|||
164279755|NCT00536471|593394149|FG002|Overall Study|Lost to Follow-up|48|||
164279756|NCT00536471|593394150|FG003|Overall Study|Lost to Follow-up|22|||
164279757|NCT00536471|593394147|FG000|Overall Study|Adverse Event|32|||
164279758|NCT00536471|593394148|FG001|Overall Study|Adverse Event|16|||
164279759|NCT00536471|593394149|FG002|Overall Study|Adverse Event|28|||
164279760|NCT00536471|593394150|FG003|Overall Study|Adverse Event|13|||
164279761|NCT00536471|593394147|FG000|Overall Study|Withdrawal by Subject|40|||
164279762|NCT00536471|593394148|FG001|Overall Study|Withdrawal by Subject|24|||
164279763|NCT00536471|593394149|FG002|Overall Study|Withdrawal by Subject|43|||
164279764|NCT00536471|593394150|FG003|Overall Study|Withdrawal by Subject|21|||
164279765|NCT00536471|593394147|FG000|Overall Study|Lack of Efficacy|17|||
164279766|NCT00536471|593394148|FG001|Overall Study|Lack of Efficacy|18|||
164279767|NCT00536471|593394149|FG002|Overall Study|Lack of Efficacy|11|||
164279768|NCT00536471|593394150|FG003|Overall Study|Lack of Efficacy|9|||
164279769|NCT00536471|593394147|FG000|Overall Study|Protocol Violation|8|||
164279770|NCT00536471|593394148|FG001|Overall Study|Protocol Violation|1|||
164279771|NCT00536471|593394149|FG002|Overall Study|Protocol Violation|2|||
164279772|NCT00536471|593394150|FG003|Overall Study|Protocol Violation|3|||
164279773|NCT00536471|593394147|FG000|Overall Study|Physician Decision|11|||
164279774|NCT00536471|593394148|FG001|Overall Study|Physician Decision|1|||
164279775|NCT00536471|593394149|FG002|Overall Study|Physician Decision|3|||
164279776|NCT00536471|593394150|FG003|Overall Study|Physician Decision|2|||
164279777|NCT00536471|593394147|FG000|Overall Study|Death|0|||
164279778|NCT00536471|593394148|FG001|Overall Study|Death|0|||
164279779|NCT00536471|593394149|FG002|Overall Study|Death|1|||
164279780|NCT00536471|593394150|FG003|Overall Study|Death|2|||
164279781|NCT00536471|593394147|FG000|Overall Study|Sponsor Decision|0|||
164279782|NCT00536471|593394148|FG001|Overall Study|Sponsor Decision|1|||
164279783|NCT00536471|593394149|FG002|Overall Study|Sponsor Decision|3|||
164279784|NCT00536471|593394150|FG003|Overall Study|Sponsor Decision|2|||
164279785|NCT00880191|593394158|FG000|Overall Study|Refused further treatment|4|||
164279786|NCT00880191|593394159|FG001|Overall Study|Refused further treatment|1|||
164279787|NCT00880191|593394158|FG000|Overall Study|Adverse Event|8|||
164279788|NCT00880191|593394159|FG001|Overall Study|Adverse Event|6|||
164279789|NCT00880191|593394158|FG000|Overall Study|Hospitalization/efficacy|1|||
164279790|NCT00880191|593394159|FG001|Overall Study|Hospitalization/efficacy|1|||
164279791|NCT00773747|593394164|FG000|Overall Study|Lack of Efficacy|112|||
164279792|NCT00773747|593394165|FG001|Overall Study|Lack of Efficacy|144|||
164279793|NCT00773747|593394164|FG000|Overall Study|Physician Decision|26|||
164344059|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
164344060|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
164344061|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Death|0|||
164344062|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Death|1|||
164344063|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Death|0|||
164344064|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Death|1|||
164344065|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Death|0|||
164344066|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Change of location|1|||
164344067|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Change of location|1|||
164344068|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Change of location|0|||
164279794|NCT00773747|593394165|FG001|Overall Study|Physician Decision|18|||
164279795|NCT00773747|593394164|FG000|Overall Study|Lost to Follow-up|0|||
164279796|NCT00773747|593394165|FG001|Overall Study|Lost to Follow-up|1|||
164279797|NCT00773747|593394164|FG000|Overall Study|Protocol Violation|2|||
164279798|NCT00773747|593394165|FG001|Overall Study|Protocol Violation|2|||
164279799|NCT00773747|593394164|FG000|Overall Study|Withdrawal by Subject|89|||
164279800|NCT00773747|593394165|FG001|Overall Study|Withdrawal by Subject|61|||
164279801|NCT00773747|593394164|FG000|Overall Study|Adverse Event|61|||
164279802|NCT00773747|593394165|FG001|Overall Study|Adverse Event|62|||
164279803|NCT00773747|593394164|FG000|Overall Study|Death|5|||
164279804|NCT00773747|593394165|FG001|Overall Study|Death|8|||
164279805|NCT00773747|593394164|FG000|Overall Study|Not Treated|2|||
164432700|NCT00601640|593954672|FG001|Overall Study|change in eligibility status|1|||
164432701|NCT00601640|593954673|FG002|Overall Study|change in eligibility status|1|||
164432702|NCT00543725|593954681|FG000|Overall Study|Adverse Event|18|||
164432703|NCT00543725|593954682|FG001|Overall Study|Adverse Event|27|||
164432704|NCT00543725|593954681|FG000|Overall Study|Sponsor's Decision|0|||
164432705|NCT00543725|593954682|FG001|Overall Study|Sponsor's Decision|1|||
164432706|NCT00543725|593954681|FG000|Overall Study|Subject Non-Compliant|4|||
164432707|NCT00543725|593954682|FG001|Overall Study|Subject Non-Compliant|4|||
164432708|NCT00543725|593954681|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
164432709|NCT00543725|593954682|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
164432710|NCT00543725|593954681|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
164432711|NCT00543725|593954682|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
164432712|NCT00543725|593954681|FG000|Overall Study|Protocol Violation|0|||
164279806|NCT00773747|593394165|FG001|Overall Study|Not Treated|0|||
164279807|NCT00836186|593394166|FG000|Overall Study|Blood could not be drawn|1|||
164279808|NCT04079816|593394167|FG000|Overall Study|Request of Subject|2|||
164279809|NCT04079816|593394167|FG000|Overall Study|Unable to draw samples|1|||
164279810|NCT03422536|593394168|FG000|Randomized|Physician Decision|1|||
164279811|NCT03422536|593394169|FG001|Randomized|Physician Decision|1|||
164279812|NCT03422536|593394168|FG000|Allocation - Received Intervention|Disease progression|19|||
164279813|NCT03422536|593394169|FG001|Allocation - Received Intervention|Disease progression|25|||
164279814|NCT03422536|593394168|FG000|Allocation - Received Intervention|Death|1|||
164279815|NCT03422536|593394169|FG001|Allocation - Received Intervention|Death|3|||
164279816|NCT03422536|593394168|FG000|Allocation - Received Intervention|Adverse Event|1|||
164279817|NCT03422536|593394169|FG001|Allocation - Received Intervention|Adverse Event|0|||
164432713|NCT00543725|593954682|FG001|Overall Study|Protocol Violation|1|||
164279818|NCT03422536|593394168|FG000|Allocation - Received Intervention|Physician Decision|1|||
164279819|NCT03422536|593394169|FG001|Allocation - Received Intervention|Physician Decision|1|||
164279820|NCT03422536|593394168|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
164279821|NCT03422536|593394169|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
164279822|NCT03422536|593394168|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
164279823|NCT03422536|593394169|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
164279824|NCT01973998|593394170|FG000|Overall Study|Death|2|||
164279825|NCT01973998|593394171|FG001|Overall Study|Death|2|||
164279826|NCT01636986|593394174|FG000|Overall Study|Withdrawal by Subject|0|||
164279827|NCT01636986|593394175|FG001|Overall Study|Withdrawal by Subject|1|||
164279828|NCT01636986|593394174|FG000|Overall Study|Corneal Staining|0|||
164279829|NCT01636986|593394175|FG001|Overall Study|Corneal Staining|1|||
164279830|NCT02160145|593394178|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
164279831|NCT02160145|593394179|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
164279832|NCT02160145|593394180|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
164279833|NCT02160145|593394178|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
164279834|NCT02160145|593394179|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
164279835|NCT02160145|593394180|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
164279836|NCT02160145|593394178|FG000|Randomized Double-blind Period|Subject decision|0|||
164279837|NCT02160145|593394179|FG001|Randomized Double-blind Period|Subject decision|21|||
164279838|NCT02160145|593394180|FG002|Randomized Double-blind Period|Subject decision|20|||
164279839|NCT02160145|593394178|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
164279840|NCT02160145|593394179|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
164279841|NCT02160145|593394180|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
164279842|NCT02160145|593394178|FG000|Randomized Double-blind Period|Physician Decision|0|||
164279843|NCT02160145|593394179|FG001|Randomized Double-blind Period|Physician Decision|7|||
164279844|NCT02160145|593394180|FG002|Randomized Double-blind Period|Physician Decision|5|||
164279845|NCT00395850|593394182|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
164279846|NCT00395850|593394183|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
164279847|NCT00395850|593394184|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
164279848|NCT00395850|593394185|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
164279849|NCT00395850|593394182|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
164279850|NCT00395850|593394183|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
164279851|NCT00395850|593394184|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
164432714|NCT00543725|593954681|FG000|Overall Study|Withdrawal by Subject|4|||
164432715|NCT00543725|593954682|FG001|Overall Study|Withdrawal by Subject|13|||
164584399|NCT01753518|594504641|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
164279852|NCT00395850|593394185|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
164279853|NCT00395850|593394182|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
164279854|NCT00395850|593394183|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
164279855|NCT00395850|593394184|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
164279856|NCT00395850|593394185|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
164279857|NCT00395850|593394182|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
164279858|NCT00395850|593394183|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
164279859|NCT00395850|593394184|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
164279860|NCT00395850|593394185|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
164279861|NCT00395850|593394182|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
164279862|NCT00395850|593394183|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
164279863|NCT00395850|593394184|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
164279864|NCT00395850|593394185|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
164279865|NCT00395850|593394182|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
164279866|NCT00395850|593394183|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
164279867|NCT00395850|593394184|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
164279868|NCT00395850|593394185|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
164279869|NCT00395850|593394182|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
164279870|NCT00395850|593394183|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
164279871|NCT00395850|593394184|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
164279872|NCT00395850|593394185|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
164279873|NCT02540993|593394190|FG000|Overall Study|Lost to Follow-up|5|||
164279874|NCT02540993|593394191|FG001|Overall Study|Lost to Follow-up|3|||
164279875|NCT02540993|593394190|FG000|Overall Study|Withdrawal by Subject|4|||
164279876|NCT02540993|593394191|FG001|Overall Study|Withdrawal by Subject|6|||
164279877|NCT02540993|593394190|FG000|Overall Study|GCP violations|33|||
164279878|NCT02540993|593394191|FG001|Overall Study|GCP violations|27|||
164279879|NCT00588094|593394194|FG000|Overall Study|Adverse Event|3|||
164279880|NCT00588094|593394194|FG000|Overall Study|Progression of Disease|2|||
164279881|NCT00705146|593394195|FG000|Overall Study|Lost to Follow-up|1|||
164344069|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Change of location|1|||
164344070|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Change of location|0|||
164344071|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
164344072|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
164344073|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
164344074|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
164344075|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
164432716|NCT00543725|593954681|FG000|Overall Study|Lost to Follow-up|15|||
164344076|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
164344077|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
164344078|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
164344079|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
164344080|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
164344081|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
164344082|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
164344083|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
164344084|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
164344085|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
164344086|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
164344087|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
164344088|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
164344089|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
164344090|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
164344091|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
164344092|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
164344093|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
164432717|NCT00543725|593954682|FG001|Overall Study|Lost to Follow-up|11|||
164279882|NCT00705146|593394196|FG001|Overall Study|Lost to Follow-up|1|||
164279883|NCT01620528|593394199|FG000|Treatment Period|Did Not Receive Study Drug|0|||
164279884|NCT01620528|593394200|FG001|Treatment Period|Did Not Receive Study Drug|0|||
164279885|NCT01620528|593394201|FG002|Treatment Period|Did Not Receive Study Drug|1|||
164279886|NCT01620528|593394199|FG000|Treatment Period|Withdrawal by Subject|35|||
164279887|NCT01620528|593394200|FG001|Treatment Period|Withdrawal by Subject|21|||
164279888|NCT01620528|593394201|FG002|Treatment Period|Withdrawal by Subject|16|||
164279889|NCT01620528|593394199|FG000|Treatment Period|Adverse Event|17|||
164279890|NCT01620528|593394200|FG001|Treatment Period|Adverse Event|13|||
164279891|NCT01620528|593394201|FG002|Treatment Period|Adverse Event|21|||
164279892|NCT01620528|593394199|FG000|Treatment Period|Lost to Follow-up|16|||
164279893|NCT01620528|593394200|FG001|Treatment Period|Lost to Follow-up|8|||
164279894|NCT01620528|593394201|FG002|Treatment Period|Lost to Follow-up|14|||
164279895|NCT01620528|593394199|FG000|Treatment Period|Other|9|||
164279896|NCT01620528|593394200|FG001|Treatment Period|Other|5|||
164279897|NCT01620528|593394201|FG002|Treatment Period|Other|7|||
164279898|NCT01620528|593394199|FG000|Treatment Period|Subject Noncompliant|11|||
164279899|NCT01620528|593394200|FG001|Treatment Period|Subject Noncompliant|2|||
164279900|NCT01620528|593394201|FG002|Treatment Period|Subject Noncompliant|2|||
164279901|NCT01620528|593394199|FG000|Treatment Period|Pregnancy|7|||
164279902|NCT01620528|593394200|FG001|Treatment Period|Pregnancy|2|||
164279903|NCT01620528|593394201|FG002|Treatment Period|Pregnancy|2|||
164279904|NCT01620528|593394199|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
164279905|NCT01620528|593394200|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
164279906|NCT01620528|593394201|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
164279907|NCT01620528|593394199|FG000|Treatment Period|Exclusionary Medication Received|0|||
164279908|NCT01620528|593394200|FG001|Treatment Period|Exclusionary Medication Received|1|||
164279909|NCT01620528|593394201|FG002|Treatment Period|Exclusionary Medication Received|0|||
164279910|NCT01620528|593394199|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
164279911|NCT01620528|593394200|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
164279912|NCT01620528|593394201|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
164279913|NCT01620528|593394199|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
164279914|NCT01620528|593394200|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
164279915|NCT01620528|593394201|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
164279916|NCT01620528|593394199|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
164279917|NCT01620528|593394200|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
164279918|NCT01620528|593394201|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
164279919|NCT01620528|593394199|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
164279920|NCT01620528|593394200|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
164279921|NCT01620528|593394201|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
164279922|NCT01620528|593394199|FG000|Post-Treatment Follow-Up Period|Other|6|||
164279923|NCT01620528|593394200|FG001|Post-Treatment Follow-Up Period|Other|4|||
164279924|NCT01620528|593394201|FG002|Post-Treatment Follow-Up Period|Other|2|||
164279925|NCT01457846|593394208|FG000|Overall Study|Death before treatment|1|||
164279926|NCT01457846|593394209|FG001|Overall Study|Death before treatment|2|||
164279927|NCT01457846|593394208|FG000|Overall Study|Did not receive treatment|0|||
164279928|NCT01457846|593394209|FG001|Overall Study|Did not receive treatment|1|||
164279929|NCT01457846|593394208|FG000|Overall Study|Death|27|||
164279930|NCT01457846|593394209|FG001|Overall Study|Death|16|||
164279931|NCT01457846|593394208|FG000|Overall Study|Unclassified reason for not completed|11|||
164279932|NCT01457846|593394209|FG001|Overall Study|Unclassified reason for not completed|10|||
164279933|NCT01457846|593394208|FG000|Overall Study|Withdrawal by Subject|1|||
164279934|NCT01457846|593394209|FG001|Overall Study|Withdrawal by Subject|1|||
164279935|NCT01457846|593394208|FG000|Overall Study|Lost to Follow-up|1|||
164279936|NCT01457846|593394209|FG001|Overall Study|Lost to Follow-up|0|||
164279937|NCT00383162|593394210|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
164279938|NCT00383162|593394211|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
164279939|NCT00383162|593394210|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
164279940|NCT00383162|593394211|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
164279941|NCT00383162|593394210|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
164279942|NCT00383162|593394211|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
164279943|NCT00383162|593394210|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
164279944|NCT00383162|593394211|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
164279945|NCT00383162|593394210|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
164279946|NCT00383162|593394211|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
164279947|NCT00383162|593394210|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
164279948|NCT00383162|593394211|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
164279949|NCT00383162|593394210|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
164279950|NCT00383162|593394211|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
164344094|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
164344095|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
164344096|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
164344097|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
164344098|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
164344099|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
164344100|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
164344101|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
164279951|NCT00383162|593394210|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
164279952|NCT00383162|593394211|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
164279953|NCT00383162|593394210|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
164279954|NCT00383162|593394211|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
164279955|NCT01153698|593394212|FG000|Overall Study|Adverse Event|12|||
164279956|NCT01153698|593394212|FG000|Overall Study|Lost to Follow-up|4|||
164279957|NCT01153698|593394212|FG000|Overall Study|Withdrawal by Subject|2|||
164279958|NCT01153698|593394212|FG000|Overall Study|Switch to other anticoagulants|4|||
164279959|NCT01153698|593394212|FG000|Overall Study|Other|2|||
164279960|NCT01153698|593394212|FG000|Overall Study|Not treated with Pradaxa|5|||
164279961|NCT05392803|593394216|FG000|Overall Study|Lost to Follow-up|0|||
164279962|NCT05392803|593394217|FG001|Overall Study|Lost to Follow-up|2|||
164279963|NCT00465647|593394218|FG000|Overall Study|Administrative|2|||
164279964|NCT00465647|593394219|FG001|Overall Study|Administrative|2|||
164279965|NCT00465647|593394220|FG002|Overall Study|Administrative|3|||
164279966|NCT00465647|593394221|FG003|Overall Study|Administrative|2|||
164279967|NCT00465647|593394218|FG000|Overall Study|Adverse Event|2|||
164279968|NCT00465647|593394219|FG001|Overall Study|Adverse Event|0|||
164279969|NCT00465647|593394220|FG002|Overall Study|Adverse Event|3|||
164279970|NCT00465647|593394221|FG003|Overall Study|Adverse Event|2|||
164279971|NCT00465647|593394218|FG000|Overall Study|Withdrawal by Subject|1|||
164279972|NCT00465647|593394219|FG001|Overall Study|Withdrawal by Subject|2|||
164279973|NCT00465647|593394220|FG002|Overall Study|Withdrawal by Subject|2|||
164279974|NCT00465647|593394221|FG003|Overall Study|Withdrawal by Subject|7|||
164279975|NCT00465647|593394218|FG000|Overall Study|"The other reasons included loss of IV"|8|||
164279976|NCT00465647|593394219|FG001|Overall Study|"The other reasons included loss of IV"|4|||
164279977|NCT00465647|593394220|FG002|Overall Study|"The other reasons included loss of IV"|3|||
164279978|NCT00465647|593394221|FG003|Overall Study|"The other reasons included loss of IV"|2|||
164279979|NCT01240135|593394222|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
164279980|NCT01240135|593394223|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
164279981|NCT01240135|593394222|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
164279982|NCT01240135|593394223|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
164279983|NCT02220712|593394224|FG000|Overall Study|Adverse Event|1|||
164279984|NCT02220712|593394224|FG000|Overall Study|Withdrawal by Subject|2|||
164279985|NCT02220712|593394224|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
164279986|NCT00760838|593394228|FG000|Overall Study|Adverse Event|1|||
164279987|NCT00760838|593394229|FG001|Overall Study|Adverse Event|1|||
164279988|NCT00760838|593394228|FG000|Overall Study|Lack of Efficacy|1|||
164279989|NCT00760838|593394229|FG001|Overall Study|Lack of Efficacy|0|||
164279990|NCT00760838|593394228|FG000|Overall Study|Lost to Follow-up|2|||
164279991|NCT00760838|593394229|FG001|Overall Study|Lost to Follow-up|0|||
164279992|NCT00760838|593394228|FG000|Overall Study|Withdrawal by Subject|1|||
164279993|NCT00760838|593394229|FG001|Overall Study|Withdrawal by Subject|1|||
164279994|NCT00923845|593394230|FG000|Induction Therapy|Poor performance status|0|||
164279995|NCT00923845|593394231|FG001|Induction Therapy|Poor performance status|2|||
164279996|NCT01743040|593394236|FG000|Overall Study|Death|1|||
164279997|NCT01743040|593394236|FG000|Overall Study|Lost to Follow-up|66|||
164279998|NCT01743040|593394236|FG000|Overall Study|Physician Decision|40|||
164279999|NCT01743040|593394236|FG000|Overall Study|Protocol Violation|1|||
164280000|NCT01743040|593394236|FG000|Overall Study|Withdrawal by Subject|121|||
164280001|NCT00830180|593394237|FG000|Overall Study|Adverse Event|6|||
164280002|NCT00830180|593394237|FG000|Overall Study|Death|11|||
164280003|NCT00830180|593394237|FG000|Overall Study|Insufficient clinical response|1|||
164280004|NCT00830180|593394237|FG000|Overall Study|Withdrawal by Subject|5|||
164280005|NCT00830180|593394237|FG000|Overall Study|Progressive disease|2|||
164280006|NCT00830180|593394237|FG000|Overall Study|Other - Unspecified|1|||
164280007|NCT01832532|593394238|FG000|Overall Study|Withdrawal by Subject|5|||
164280008|NCT01832532|593394239|FG001|Overall Study|Withdrawal by Subject|2|||
164280009|NCT00392990|593394241|FG000|Treatment on Study|Adverse Event|3|||
164280010|NCT00392990|593394242|FG001|Treatment on Study|Adverse Event|1|||
164344102|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
164344103|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
164344104|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
164280011|NCT00392990|593394241|FG000|Follow up for 2 Years|Death|4|||
164280012|NCT00392990|593394242|FG001|Follow up for 2 Years|Death|0|||
164280013|NCT01630889|593394245|FG000|Overall Study|Death|2|||
164280014|NCT01630889|593394245|FG000|Overall Study|Withdrawal by Subject|1|||
164280015|NCT01630889|593394245|FG000|Overall Study|Other than Specified|2|||
164280016|NCT01630889|593394245|FG000|Overall Study|Lost to Follow-up|4|||
164280017|NCT01630889|593394245|FG000|Overall Study|Other|1|||
164280018|NCT00991406|593394247|FG000|Overall Study|One participant did not respond to FES.|1|||
164280019|NCT03755661|593394248|FG000|Overall Study|Lost to Follow-up|1|||
164280020|NCT03755661|593394249|FG001|Overall Study|Lost to Follow-up|0|||
164280021|NCT02038075|593394250|FG000|Overall Study|Withdrawal by Subject|3|||
164280022|NCT02038075|593394251|FG001|Overall Study|Withdrawal by Subject|0|||
164280023|NCT04000581|593394252|FG000|Overall Study|Withdrawal by Subject|0|||
164344105|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
164344106|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
164344107|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
164344108|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
164344109|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
164344110|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
164344111|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
164344112|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
164344113|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
164344114|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
164280024|NCT04000581|593394253|FG001|Overall Study|Withdrawal by Subject|1|||
164344115|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
164344116|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
164344117|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
164344118|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
164344119|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
164344120|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
164344121|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Missing|0|||
164344122|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Missing|0|||
164344123|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Missing|2|||
164344124|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Missing|0|||
164344125|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Missing|0|||
164344126|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
164344127|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
164344128|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
164344129|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
164280025|NCT02519595|593394257|FG000|Overall Study|Protocol Violation|8|||
164280026|NCT02519595|593394258|FG001|Overall Study|Protocol Violation|22|||
164280027|NCT02519595|593394259|FG002|Overall Study|Protocol Violation|16|||
164280028|NCT03188510|593394262|FG000|Overall Study|Inappropriate behavior with site staff|0|||
164280029|NCT03188510|593394263|FG001|Overall Study|Inappropriate behavior with site staff|1|||
164280030|NCT03188510|593394264|FG002|Overall Study|Inappropriate behavior with site staff|0|||
164280031|NCT01736618|593394267|FG000|Overall Study|Death|294|||
164280032|NCT01736618|593394267|FG000|Overall Study|Lost to Follow-up|193|||
164280033|NCT01736618|593394267|FG000|Overall Study|Withdrawal by Subject|54|||
164344130|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
164344131|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
164344132|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
164344133|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
164344134|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
164344135|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
164344136|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
164344137|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
164344138|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
164344139|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
164344140|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
164344141|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
164344142|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
164344143|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
164344144|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
164344145|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
164344146|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
164344147|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
164344148|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
164344149|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
164344150|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
164344151|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
164344152|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
164344153|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
164344154|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
164344155|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
164344156|NCT00963937|593635372|FG000|Overall Study|Protocol Violation|1|||
164280034|NCT01736618|593394267|FG000|Overall Study|Subject unable to be followed at study location|223|||
164280035|NCT01736618|593394267|FG000|Overall Study|Physician Decision|33|||
164280036|NCT01736618|593394267|FG000|Overall Study|Transplant or removal of target organ|19|||
164280037|NCT01736618|593394267|FG000|Overall Study|Change in indication or condition|78|||
164280038|NCT01736618|593394267|FG000|Overall Study|Study device explant|103|||
164280039|NCT01736618|593394267|FG000|Overall Study|Unable to complete implant|2|||
164280040|NCT04167137|593394269|FG000|Overall Study|Disease progression|1|||
164280041|NCT04167137|593394270|FG001|Overall Study|Disease progression|1|||
164280042|NCT04167137|593394271|FG002|Overall Study|Disease progression|3|||
164280043|NCT04167137|593394272|FG003|Overall Study|Disease progression|3|||
164280044|NCT04167137|593394273|FG004|Overall Study|Disease progression|2|||
164280045|NCT04167137|593394274|FG005|Overall Study|Disease progression|3|||
164280046|NCT04167137|593394275|FG006|Overall Study|Disease progression|2|||
164280047|NCT04167137|593394276|FG007|Overall Study|Disease progression|2|||
164280048|NCT04167137|593394269|FG000|Overall Study|Withdrawal by Subject|1|||
164280049|NCT04167137|593394270|FG001|Overall Study|Withdrawal by Subject|0|||
164280050|NCT04167137|593394271|FG002|Overall Study|Withdrawal by Subject|0|||
164280051|NCT04167137|593394272|FG003|Overall Study|Withdrawal by Subject|1|||
164280052|NCT04167137|593394273|FG004|Overall Study|Withdrawal by Subject|0|||
164280053|NCT04167137|593394274|FG005|Overall Study|Withdrawal by Subject|2|||
164280054|NCT04167137|593394275|FG006|Overall Study|Withdrawal by Subject|1|||
164280055|NCT04167137|593394276|FG007|Overall Study|Withdrawal by Subject|0|||
164280056|NCT04167137|593394269|FG000|Overall Study|Adverse Event|0|||
164280057|NCT04167137|593394270|FG001|Overall Study|Adverse Event|0|||
164280058|NCT04167137|593394271|FG002|Overall Study|Adverse Event|0|||
164280059|NCT04167137|593394272|FG003|Overall Study|Adverse Event|0|||
164280060|NCT04167137|593394273|FG004|Overall Study|Adverse Event|0|||
164280061|NCT04167137|593394274|FG005|Overall Study|Adverse Event|1|||
164280062|NCT04167137|593394275|FG006|Overall Study|Adverse Event|0|||
164280063|NCT04167137|593394276|FG007|Overall Study|Adverse Event|1|||
164280064|NCT04167137|593394269|FG000|Overall Study|Physician Decision|0|||
164280065|NCT04167137|593394270|FG001|Overall Study|Physician Decision|0|||
164280066|NCT04167137|593394271|FG002|Overall Study|Physician Decision|0|||
164280067|NCT04167137|593394272|FG003|Overall Study|Physician Decision|1|||
164280068|NCT04167137|593394273|FG004|Overall Study|Physician Decision|0|||
164280069|NCT04167137|593394274|FG005|Overall Study|Physician Decision|0|||
164280070|NCT04167137|593394275|FG006|Overall Study|Physician Decision|1|||
164280071|NCT04167137|593394276|FG007|Overall Study|Physician Decision|0|||
164280072|NCT04167137|593394269|FG000|Overall Study|Death|0|||
164280073|NCT04167137|593394270|FG001|Overall Study|Death|1|||
164280074|NCT04167137|593394271|FG002|Overall Study|Death|0|||
164280075|NCT04167137|593394272|FG003|Overall Study|Death|0|||
164280076|NCT04167137|593394273|FG004|Overall Study|Death|0|||
164280077|NCT04167137|593394274|FG005|Overall Study|Death|0|||
164280078|NCT04167137|593394275|FG006|Overall Study|Death|0|||
164280079|NCT04167137|593394276|FG007|Overall Study|Death|0|||
164280080|NCT04167137|593394269|FG000|Overall Study|Study terminated by Sponsor|0|||
164280081|NCT04167137|593394270|FG001|Overall Study|Study terminated by Sponsor|0|||
164280082|NCT04167137|593394271|FG002|Overall Study|Study terminated by Sponsor|0|||
164280083|NCT04167137|593394272|FG003|Overall Study|Study terminated by Sponsor|0|||
164280084|NCT04167137|593394273|FG004|Overall Study|Study terminated by Sponsor|0|||
164280085|NCT04167137|593394274|FG005|Overall Study|Study terminated by Sponsor|0|||
164280086|NCT04167137|593394275|FG006|Overall Study|Study terminated by Sponsor|0|||
164280087|NCT04167137|593394276|FG007|Overall Study|Study terminated by Sponsor|1|||
164280088|NCT01748825|593394279|FG000|Dose Escalation|Refused further treatment|2|||
164280089|NCT01748825|593394280|FG001|Dose Escalation|Refused further treatment|2|||
164280090|NCT01748825|593394281|FG002|Dose Escalation|Refused further treatment|0|||
164280091|NCT01748825|593394282|FG003|Dose Escalation|Refused further treatment|0|||
164280092|NCT01748825|593394283|FG004|Dose Escalation|Refused further treatment|1|||
164280093|NCT01748825|593394284|FG005|Dose Escalation|Refused further treatment|2|||
164280094|NCT01748825|593394285|FG006|Dose Escalation|Refused further treatment|0|||
164280095|NCT01748825|593394286|FG007|Dose Escalation|Refused further treatment|0|||
164280096|NCT01748825|593394287|FG008|Dose Escalation|Refused further treatment|0|||
164280097|NCT01748825|593394288|FG009|Dose Escalation|Refused further treatment|0|||
164280098|NCT01748825|593394279|FG000|Dose Escalation|Switched to alternative treatment|0|||
164280099|NCT01748825|593394280|FG001|Dose Escalation|Switched to alternative treatment|0|||
164280100|NCT01748825|593394281|FG002|Dose Escalation|Switched to alternative treatment|0|||
164280101|NCT01748825|593394282|FG003|Dose Escalation|Switched to alternative treatment|1|||
164280102|NCT01748825|593394283|FG004|Dose Escalation|Switched to alternative treatment|0|||
164280103|NCT01748825|593394284|FG005|Dose Escalation|Switched to alternative treatment|0|||
164280104|NCT01748825|593394285|FG006|Dose Escalation|Switched to alternative treatment|0|||
164280105|NCT01748825|593394286|FG007|Dose Escalation|Switched to alternative treatment|0|||
164280106|NCT01748825|593394287|FG008|Dose Escalation|Switched to alternative treatment|0|||
164280107|NCT01748825|593394288|FG009|Dose Escalation|Switched to alternative treatment|0|||
164280108|NCT01748825|593394279|FG000|Dose Escalation|Adverse Event|0|||
164280109|NCT01748825|593394280|FG001|Dose Escalation|Adverse Event|0|||
164280110|NCT01748825|593394281|FG002|Dose Escalation|Adverse Event|0|||
164280111|NCT01748825|593394282|FG003|Dose Escalation|Adverse Event|0|||
164432718|NCT00543725|593954681|FG000|Overall Study|Other|3|||
164280112|NCT01748825|593394283|FG004|Dose Escalation|Adverse Event|0|||
164280113|NCT01748825|593394284|FG005|Dose Escalation|Adverse Event|0|||
164280114|NCT01748825|593394285|FG006|Dose Escalation|Adverse Event|1|||
164280115|NCT01748825|593394286|FG007|Dose Escalation|Adverse Event|0|||
164280116|NCT01748825|593394287|FG008|Dose Escalation|Adverse Event|0|||
164280117|NCT01748825|593394288|FG009|Dose Escalation|Adverse Event|0|||
164280118|NCT01748825|593394279|FG000|Dose Expansion|Refused further treatment|0|||
164280119|NCT01748825|593394280|FG001|Dose Expansion|Refused further treatment|0|||
164280120|NCT01748825|593394281|FG002|Dose Expansion|Refused further treatment|0|||
164280121|NCT01748825|593394282|FG003|Dose Expansion|Refused further treatment|0|||
164280122|NCT01748825|593394283|FG004|Dose Expansion|Refused further treatment|0|||
164280123|NCT01748825|593394284|FG005|Dose Expansion|Refused further treatment|0|||
164280124|NCT01748825|593394285|FG006|Dose Expansion|Refused further treatment|0|||
164280125|NCT01748825|593394286|FG007|Dose Expansion|Refused further treatment|0|||
164280126|NCT01748825|593394287|FG008|Dose Expansion|Refused further treatment|1|||
164280127|NCT01748825|593394288|FG009|Dose Expansion|Refused further treatment|1|||
164280128|NCT01748825|593394279|FG000|Dose Expansion|Switched to alternative treatment|0|||
164280129|NCT01748825|593394280|FG001|Dose Expansion|Switched to alternative treatment|0|||
164280130|NCT01748825|593394281|FG002|Dose Expansion|Switched to alternative treatment|0|||
164280131|NCT01748825|593394282|FG003|Dose Expansion|Switched to alternative treatment|0|||
164280132|NCT01748825|593394283|FG004|Dose Expansion|Switched to alternative treatment|0|||
164280133|NCT01748825|593394284|FG005|Dose Expansion|Switched to alternative treatment|0|||
164280134|NCT01748825|593394285|FG006|Dose Expansion|Switched to alternative treatment|0|||
164280135|NCT01748825|593394286|FG007|Dose Expansion|Switched to alternative treatment|0|||
164280136|NCT01748825|593394287|FG008|Dose Expansion|Switched to alternative treatment|0|||
164280137|NCT01748825|593394288|FG009|Dose Expansion|Switched to alternative treatment|1|||
164280138|NCT01748825|593394279|FG000|Dose Expansion|Adverse Event|0|||
164280139|NCT01748825|593394280|FG001|Dose Expansion|Adverse Event|0|||
164280140|NCT01748825|593394281|FG002|Dose Expansion|Adverse Event|0|||
164280141|NCT01748825|593394282|FG003|Dose Expansion|Adverse Event|0|||
164280142|NCT01748825|593394283|FG004|Dose Expansion|Adverse Event|0|||
164280143|NCT01748825|593394284|FG005|Dose Expansion|Adverse Event|0|||
164280144|NCT01748825|593394285|FG006|Dose Expansion|Adverse Event|0|||
164280145|NCT01748825|593394286|FG007|Dose Expansion|Adverse Event|0|||
164280146|NCT01748825|593394287|FG008|Dose Expansion|Adverse Event|0|||
164280147|NCT01748825|593394288|FG009|Dose Expansion|Adverse Event|3|||
164280148|NCT01748825|593394279|FG000|Dose Expansion|Physician Decision|0|||
164280149|NCT01748825|593394280|FG001|Dose Expansion|Physician Decision|0|||
164280150|NCT01748825|593394281|FG002|Dose Expansion|Physician Decision|0|||
164280151|NCT01748825|593394282|FG003|Dose Expansion|Physician Decision|0|||
164280152|NCT01748825|593394283|FG004|Dose Expansion|Physician Decision|0|||
164280153|NCT01748825|593394284|FG005|Dose Expansion|Physician Decision|0|||
164280154|NCT01748825|593394285|FG006|Dose Expansion|Physician Decision|0|||
164280155|NCT01748825|593394286|FG007|Dose Expansion|Physician Decision|0|||
164280156|NCT01748825|593394287|FG008|Dose Expansion|Physician Decision|1|||
164280157|NCT01748825|593394288|FG009|Dose Expansion|Physician Decision|0|||
164280158|NCT01730586|593394292|FG000|Overall Study|Progressive Disease|2|||
164280159|NCT01730586|593394292|FG000|Overall Study|Inadequate Trial|8|||
164280160|NCT01730586|593394292|FG000|Overall Study|Adverse Event|2|||
164280161|NCT01730586|593394292|FG000|Overall Study|Hospice|1|||
164280162|NCT00211887|593394293|FG000|Overall Study|Adverse Event|8|||
164280163|NCT00211887|593394294|FG001|Overall Study|Adverse Event|4|||
164280164|NCT00211887|593394295|FG002|Overall Study|Adverse Event|6|||
164280165|NCT00211887|593394293|FG000|Overall Study|Death|1|||
164280166|NCT00211887|593394294|FG001|Overall Study|Death|1|||
164280167|NCT00211887|593394295|FG002|Overall Study|Death|1|||
164280168|NCT00211887|593394293|FG000|Overall Study|Lost to Follow-up|28|||
164280169|NCT00211887|593394294|FG001|Overall Study|Lost to Follow-up|13|||
164280170|NCT00211887|593394295|FG002|Overall Study|Lost to Follow-up|9|||
164280171|NCT00211887|593394293|FG000|Overall Study|Non-medical reason|31|||
164280172|NCT00211887|593394294|FG001|Overall Study|Non-medical reason|14|||
164280173|NCT00211887|593394295|FG002|Overall Study|Non-medical reason|8|||
164280174|NCT00211887|593394293|FG000|Overall Study|Other medical reason|15|||
164280175|NCT00211887|593394294|FG001|Overall Study|Other medical reason|11|||
164280176|NCT00211887|593394295|FG002|Overall Study|Other medical reason|7|||
164280177|NCT00211887|593394293|FG000|Overall Study|Side effects|19|||
164280178|NCT00211887|593394294|FG001|Overall Study|Side effects|13|||
164280179|NCT00211887|593394295|FG002|Overall Study|Side effects|5|||
164280180|NCT03058692|593396382|FG000|Overall Study|Lost to Follow-up|2|||
164280181|NCT03058692|593396383|FG001|Overall Study|Lost to Follow-up|1|||
164280182|NCT03058692|593396382|FG000|Overall Study|Withdrawal by Subject|1|||
164280183|NCT03058692|593396383|FG001|Overall Study|Withdrawal by Subject|1|||
164280184|NCT05111249|593396388|FG000|Overall Study|Lost to Follow-up|0|||
164280185|NCT05111249|593396389|FG001|Overall Study|Lost to Follow-up|2|||
164280186|NCT05111249|593396388|FG000|Overall Study|Physician Decision|0|||
164280187|NCT05111249|593396389|FG001|Overall Study|Physician Decision|1|||
164280188|NCT05111249|593396388|FG000|Overall Study|Participant decision|1|||
164280189|NCT05111249|593396389|FG001|Overall Study|Participant decision|5|||
164280190|NCT01702025|593396397|FG000|Overall Study|Equipment failure|1|||
164280191|NCT01702025|593396398|FG001|Overall Study|Equipment failure|0|||
164280192|NCT01702025|593396399|FG002|Overall Study|Equipment failure|0|||
164280193|NCT01702025|593396400|FG003|Overall Study|Equipment failure|0|||
164689783|NCT01332968|594887791|FG007|Maintenance/Observation Period|Adverse Event|0|||
164280194|NCT01702025|593396397|FG000|Overall Study|Adverse Event|1|||
164280195|NCT01702025|593396398|FG001|Overall Study|Adverse Event|1|||
164280196|NCT01702025|593396399|FG002|Overall Study|Adverse Event|1|||
164280197|NCT01702025|593396400|FG003|Overall Study|Adverse Event|0|||
164280198|NCT02679755|593396401|FG000|Overall Study|Death|0|||
164280199|NCT02679755|593396402|FG001|Overall Study|Death|3|||
164280200|NCT02679755|593396401|FG000|Overall Study|Global deterioration of health status|1|||
164280201|NCT02679755|593396402|FG001|Overall Study|Global deterioration of health status|8|||
164280202|NCT02679755|593396401|FG000|Overall Study|Lost to Follow-up|1|||
164280203|NCT02679755|593396402|FG001|Overall Study|Lost to Follow-up|0|||
164280204|NCT02679755|593396401|FG000|Overall Study|Objective progression or relapse|24|||
164280205|NCT02679755|593396402|FG001|Overall Study|Objective progression or relapse|83|||
164280206|NCT02679755|593396401|FG000|Overall Study|Not defined|0|||
164280207|NCT02679755|593396402|FG001|Overall Study|Not defined|2|||
164280208|NCT02679755|593396401|FG000|Overall Study|Withdrawal by participant|6|||
164280209|NCT02679755|593396402|FG001|Overall Study|Withdrawal by participant|3|||
164280210|NCT02679755|593396401|FG000|Overall Study|Adverse Event|1|||
164280211|NCT02679755|593396402|FG001|Overall Study|Adverse Event|4|||
164280212|NCT02679755|593396401|FG000|Overall Study|Adverse events not related to study drug|1|||
164280213|NCT02679755|593396402|FG001|Overall Study|Adverse events not related to study drug|2|||
164280214|NCT01061359|593396403|FG000|Overall Study|Death|32|||
164280215|NCT01061359|593396403|FG000|Overall Study|Lost to Follow-up|1072|||
164280216|NCT01061359|593396403|FG000|Overall Study|Relapse|187|||
164280217|NCT01061359|593396403|FG000|Overall Study|Secondary neoplasm|11|||
164280218|NCT03038126|593396405|FG000|Overall Study|Death|1|||
164280219|NCT03038126|593396406|FG001|Overall Study|Death|1|||
164280220|NCT03038126|593396405|FG000|Overall Study|Withdrawal by Subject|5|||
164280221|NCT03038126|593396406|FG001|Overall Study|Withdrawal by Subject|0|||
164280222|NCT03038126|593396405|FG000|Overall Study|Lost to Follow-up|0|||
164280223|NCT03038126|593396406|FG001|Overall Study|Lost to Follow-up|1|||
164280224|NCT03038126|593396405|FG000|Overall Study|Long Term Hospitalization|2|||
164280225|NCT03038126|593396406|FG001|Overall Study|Long Term Hospitalization|0|||
164280226|NCT03038126|593396405|FG000|Overall Study|Too Ill to Participate|1|||
164280227|NCT03038126|593396406|FG001|Overall Study|Too Ill to Participate|2|||
164280228|NCT02610777|593396407|FG000|Overall Study|Lost to Follow-up|1|||
164280229|NCT02610777|593396408|FG001|Overall Study|Lost to Follow-up|0|||
164280230|NCT02610777|593396407|FG000|Overall Study|Site Terminated by Sponsor|9|||
164280231|NCT02610777|593396408|FG001|Overall Study|Site Terminated by Sponsor|8|||
164280232|NCT02610777|593396407|FG000|Overall Study|Withdrawal by Subject|2|||
164280233|NCT02610777|593396408|FG001|Overall Study|Withdrawal by Subject|2|||
164280234|NCT02610777|593396407|FG000|Overall Study|Reason not Specified|0|||
164280235|NCT02610777|593396408|FG001|Overall Study|Reason not Specified|1|||
164280236|NCT02610777|593396407|FG000|Overall Study|Death|50|||
164280237|NCT02610777|593396408|FG001|Overall Study|Death|47|||
164280238|NCT01724866|593396409|FG000|Overall Study|Adverse Event|0|||
164280239|NCT01724866|593396410|FG001|Overall Study|Adverse Event|0|||
164280240|NCT01724866|593396411|FG002|Overall Study|Adverse Event|1|||
164280241|NCT01724866|593396412|FG003|Overall Study|Adverse Event|1|||
164280242|NCT01724866|593396409|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
164280243|NCT01724866|593396410|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
164280244|NCT01724866|593396411|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
164280245|NCT01724866|593396412|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
164280246|NCT01724866|593396409|FG000|Overall Study|Investigator's Discretion|0|||
164280247|NCT01724866|593396410|FG001|Overall Study|Investigator's Discretion|1|||
164280248|NCT01724866|593396411|FG002|Overall Study|Investigator's Discretion|1|||
164280249|NCT01724866|593396412|FG003|Overall Study|Investigator's Discretion|0|||
164344157|NCT00963937|593635373|FG001|Overall Study|Protocol Violation|1|||
164689784|NCT01332968|594887784|FG000|Maintenance/Observation Period|Death|0|||
164344158|NCT00963937|593635374|FG002|Overall Study|Protocol Violation|0|||
164344159|NCT00963937|593635372|FG000|Overall Study|Physician Decision|18|||
164344160|NCT00963937|593635373|FG001|Overall Study|Physician Decision|10|||
164344161|NCT00963937|593635374|FG002|Overall Study|Physician Decision|4|||
164689785|NCT01332968|594887785|FG001|Maintenance/Observation Period|Death|0|||
164689786|NCT01332968|594887786|FG002|Maintenance/Observation Period|Death|5|||
164689787|NCT01332968|594887787|FG003|Maintenance/Observation Period|Death|6|||
164280250|NCT01724866|593396409|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
164280251|NCT01724866|593396410|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
164280252|NCT01724866|593396411|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
164280253|NCT01724866|593396412|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
164280254|NCT01724866|593396409|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
164344162|NCT04203498|593635375|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
164280255|NCT01724866|593396410|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
164280256|NCT01724866|593396411|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
164280257|NCT01724866|593396412|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
164280258|NCT00411671|593396417|FG000|Overall Study|Adverse Event|15|||
164280259|NCT00411671|593396417|FG000|Overall Study|Death|2|||
164280260|NCT00411671|593396417|FG000|Overall Study|Lost to Follow-up|3|||
164280261|NCT01173601|593396418|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
164280262|NCT01173601|593396419|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
164689788|NCT01332968|594887788|FG004|Maintenance/Observation Period|Death|0|||
164689789|NCT01332968|594887789|FG005|Maintenance/Observation Period|Death|0|||
164689790|NCT01332968|594887790|FG006|Maintenance/Observation Period|Death|0|||
164689791|NCT01332968|594887791|FG007|Maintenance/Observation Period|Death|0|||
164280263|NCT01173601|593396420|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
164280264|NCT01173601|593396421|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
164280265|NCT01173601|593396422|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
164280266|NCT01173601|593396418|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
164280267|NCT01173601|593396419|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
164280268|NCT01173601|593396420|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
164280269|NCT01173601|593396421|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
164280270|NCT01173601|593396422|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
164280271|NCT01173601|593396418|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
164280272|NCT01173601|593396419|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
164280273|NCT01173601|593396420|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
164280274|NCT01173601|593396421|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
164280275|NCT01173601|593396422|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
164280276|NCT01173601|593396418|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
164280277|NCT01173601|593396419|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
164280278|NCT01173601|593396420|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
164280279|NCT01173601|593396421|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
164280280|NCT01173601|593396422|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
164280281|NCT01173601|593396418|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
164280282|NCT01173601|593396419|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
164280283|NCT01173601|593396420|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
164280284|NCT01173601|593396421|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
164280285|NCT01173601|593396422|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
164280286|NCT01173601|593396418|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
164280287|NCT01173601|593396419|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
164280288|NCT01173601|593396420|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
164280289|NCT01173601|593396421|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
164280290|NCT01173601|593396422|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
164280291|NCT01173601|593396418|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
164280292|NCT01173601|593396419|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
164280293|NCT01173601|593396420|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
164280294|NCT01173601|593396421|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
164280295|NCT01173601|593396422|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
164280296|NCT01173601|593396418|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
164280297|NCT01173601|593396419|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
164280298|NCT01173601|593396420|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
164280299|NCT01173601|593396421|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
164280300|NCT01173601|593396422|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
164280301|NCT01173601|593396418|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
164280302|NCT01173601|593396419|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
164689792|NCT01332968|594887784|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
164280303|NCT01173601|593396420|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
164280304|NCT01173601|593396421|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
164280305|NCT01173601|593396422|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
164280306|NCT01173601|593396418|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
164280307|NCT01173601|593396419|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
164280308|NCT01173601|593396420|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
164280309|NCT01173601|593396421|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
164280310|NCT01173601|593396422|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
164280311|NCT01173601|593396418|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
164280312|NCT01173601|593396419|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
164280313|NCT01173601|593396420|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
164280314|NCT01173601|593396421|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
164280315|NCT01173601|593396422|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
164689793|NCT01332968|594887785|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
164280316|NCT01173601|593396418|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
164280317|NCT01173601|593396419|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
164280318|NCT01173601|593396420|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
164280319|NCT01173601|593396421|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
164280320|NCT01173601|593396422|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
164280321|NCT01173601|593396418|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
164280322|NCT01173601|593396419|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
164280323|NCT01173601|593396420|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
164280324|NCT01173601|593396421|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
164280325|NCT01173601|593396422|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
164280326|NCT01173601|593396418|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
164280327|NCT01173601|593396419|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
164280328|NCT01173601|593396420|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
164280329|NCT01173601|593396421|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
164280330|NCT01173601|593396422|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
164280331|NCT04737278|593396423|FG000|Overall Study|Lost to Follow-up|1|||
164280332|NCT04737278|593396424|FG001|Overall Study|Lost to Follow-up|1|||
164280333|NCT04737278|593396423|FG000|Overall Study|Withdrawal by Subject|1|||
164280334|NCT04737278|593396424|FG001|Overall Study|Withdrawal by Subject|0|||
164280335|NCT04737278|593396423|FG000|Overall Study|Protocol Violation|1|||
164280336|NCT04737278|593396424|FG001|Overall Study|Protocol Violation|1|||
164280337|NCT04737278|593396423|FG000|Overall Study|failure to complete questionnaire|1|||
164280338|NCT04737278|593396424|FG001|Overall Study|failure to complete questionnaire|1|||
164280339|NCT00546000|593396429|FG000|Overall Study|Adverse Event|1|||
164280340|NCT00546000|593396429|FG000|Overall Study|Lost to Follow-up|1|||
164280341|NCT00546000|593396429|FG000|Overall Study|Baseline HPA Axis Supression|2|||
164280342|NCT03688074|593396434|FG000|Overall Study|Adverse Event|0|||
164280343|NCT03688074|593396435|FG001|Overall Study|Adverse Event|1|||
164280344|NCT03688074|593396434|FG000|Overall Study|Other|1|||
164280345|NCT03688074|593396435|FG001|Overall Study|Other|0|||
164280346|NCT01362608|593396436|FG000|Overall Study|Protocol Violation|0|||
164280347|NCT01362608|593396437|FG001|Overall Study|Protocol Violation|1|||
164280348|NCT01362608|593396436|FG000|Overall Study|Lost to Follow-up|3|||
164280349|NCT01362608|593396437|FG001|Overall Study|Lost to Follow-up|1|||
164280350|NCT01362608|593396436|FG000|Overall Study|Withdrawal by Subject|1|||
164689794|NCT01332968|594887786|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
164280351|NCT01362608|593396437|FG001|Overall Study|Withdrawal by Subject|2|||
164280352|NCT01362608|593396436|FG000|Overall Study|Lack of Efficacy|0|||
164280353|NCT01362608|593396437|FG001|Overall Study|Lack of Efficacy|2|||
164280354|NCT01362608|593396436|FG000|Overall Study|Adverse Event|0|||
164280355|NCT01362608|593396437|FG001|Overall Study|Adverse Event|2|||
164280356|NCT04171219|593396445|FG000|Overall Study|Adverse Event|1|||
164280357|NCT04171219|593396446|FG001|Overall Study|Adverse Event|0|||
164280358|NCT04171219|593396445|FG000|Overall Study|Death|0|||
164280359|NCT04171219|593396446|FG001|Overall Study|Death|1|||
164280360|NCT04171219|593396445|FG000|Overall Study|Lack of Efficacy|9|||
164280361|NCT04171219|593396446|FG001|Overall Study|Lack of Efficacy|13|||
164280362|NCT04171219|593396445|FG000|Overall Study|Withdrawal by Subject|1|||
164280363|NCT04171219|593396446|FG001|Overall Study|Withdrawal by Subject|2|||
164280364|NCT04171219|593396445|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
164280365|NCT04171219|593396446|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
164280366|NCT04171219|593396445|FG000|Overall Study|Clinical PD/Patient choice|1|||
164280367|NCT04171219|593396446|FG001|Overall Study|Clinical PD/Patient choice|0|||
164280368|NCT04171219|593396445|FG000|Overall Study|Toxicity/ Patient choice|1|||
164280369|NCT04171219|593396446|FG001|Overall Study|Toxicity/ Patient choice|0|||
164280370|NCT04809285|593396447|FG000|Phase 1|Lost to Follow-up|6|||
164280371|NCT04809285|593396447|FG000|Phase 1|Protocol Violation|2|||
164280372|NCT04809285|593396447|FG000|Phase 1|Physician Decision|3|||
164280373|NCT04809285|593396447|FG000|Phase 1|Withdrawal by Subject|29|||
164280374|NCT04809285|593396447|FG000|Phase 2|Protocol Violation|3|||
164344163|NCT04203498|593635376|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
164280375|NCT04809285|593396447|FG000|Phase 2|Withdrawal by Subject|4|||
164280376|NCT03350815|593396448|FG000|Period 1|Adverse Event|10|||
164280377|NCT03350815|593396449|FG001|Period 1|Adverse Event|0|||
164280378|NCT03350815|593396450|FG002|Period 1|Adverse Event|0|||
164280379|NCT03350815|593396451|FG003|Period 1|Adverse Event|0|||
164280380|NCT03350815|593396448|FG000|Period 1|Technical problems|1|||
164344164|NCT04203498|593635375|FG000|Overall Study|Withdrawal of patient consent|7|||
164280381|NCT03350815|593396449|FG001|Period 1|Technical problems|0|||
164280382|NCT03350815|593396450|FG002|Period 1|Technical problems|0|||
164280383|NCT03350815|593396451|FG003|Period 1|Technical problems|0|||
164280384|NCT03350815|593396448|FG000|Period 1|Lost to Follow-up|3|||
164280385|NCT03350815|593396449|FG001|Period 1|Lost to Follow-up|0|||
164280386|NCT03350815|593396450|FG002|Period 1|Lost to Follow-up|0|||
164280387|NCT03350815|593396451|FG003|Period 1|Lost to Follow-up|0|||
164280388|NCT03350815|593396448|FG000|Period 1|Physician Decision|1|||
164280389|NCT03350815|593396449|FG001|Period 1|Physician Decision|0|||
164280390|NCT03350815|593396450|FG002|Period 1|Physician Decision|0|||
164280391|NCT03350815|593396451|FG003|Period 1|Physician Decision|0|||
164280392|NCT03350815|593396448|FG000|Period 1|Withdrawal by Subject|8|||
164280393|NCT03350815|593396449|FG001|Period 1|Withdrawal by Subject|0|||
164280394|NCT03350815|593396450|FG002|Period 1|Withdrawal by Subject|0|||
164280395|NCT03350815|593396451|FG003|Period 1|Withdrawal by Subject|0|||
164280396|NCT03350815|593396448|FG000|Period 1|Lack of Efficacy|15|||
164280397|NCT03350815|593396449|FG001|Period 1|Lack of Efficacy|0|||
164280398|NCT03350815|593396450|FG002|Period 1|Lack of Efficacy|0|||
164280399|NCT03350815|593396451|FG003|Period 1|Lack of Efficacy|0|||
164280400|NCT03350815|593396448|FG000|Period 1|Non-compliance with study treatment|2|||
164432719|NCT00543725|593954682|FG001|Overall Study|Other|3|||
164280401|NCT03350815|593396449|FG001|Period 1|Non-compliance with study treatment|0|||
164280402|NCT03350815|593396450|FG002|Period 1|Non-compliance with study treatment|0|||
164280403|NCT03350815|593396451|FG003|Period 1|Non-compliance with study treatment|0|||
164280404|NCT03350815|593396448|FG000|Period 1|Protocol Violation|3|||
164280405|NCT03350815|593396449|FG001|Period 1|Protocol Violation|0|||
164280406|NCT03350815|593396450|FG002|Period 1|Protocol Violation|0|||
164280407|NCT03350815|593396451|FG003|Period 1|Protocol Violation|0|||
164280408|NCT03350815|593396448|FG000|Period 2|Adverse Event|0|||
164280409|NCT03350815|593396449|FG001|Period 2|Adverse Event|3|||
164280410|NCT03350815|593396450|FG002|Period 2|Adverse Event|5|||
164280411|NCT03350815|593396451|FG003|Period 2|Adverse Event|0|||
164280412|NCT03350815|593396448|FG000|Period 2|Technical problem|0|||
164280413|NCT03350815|593396449|FG001|Period 2|Technical problem|1|||
164280414|NCT03350815|593396450|FG002|Period 2|Technical problem|0|||
164280415|NCT03350815|593396451|FG003|Period 2|Technical problem|0|||
164280416|NCT03350815|593396448|FG000|Period 2|Lost to Follow-up|0|||
164280417|NCT03350815|593396449|FG001|Period 2|Lost to Follow-up|3|||
164280418|NCT03350815|593396450|FG002|Period 2|Lost to Follow-up|3|||
164280419|NCT03350815|593396451|FG003|Period 2|Lost to Follow-up|0|||
164280420|NCT03350815|593396448|FG000|Period 2|Physician Decision|0|||
164280421|NCT03350815|593396449|FG001|Period 2|Physician Decision|0|||
164280422|NCT03350815|593396450|FG002|Period 2|Physician Decision|1|||
164280423|NCT03350815|593396451|FG003|Period 2|Physician Decision|0|||
164280424|NCT03350815|593396448|FG000|Period 2|Withdrawal by Subject|0|||
164280425|NCT03350815|593396449|FG001|Period 2|Withdrawal by Subject|3|||
164280426|NCT03350815|593396450|FG002|Period 2|Withdrawal by Subject|4|||
164280427|NCT03350815|593396451|FG003|Period 2|Withdrawal by Subject|0|||
164432720|NCT01250002|593954683|FG000|Overall Study|Change to open surgical procedure|4|||
164432721|NCT01250002|593954684|FG001|Overall Study|Change to open surgical procedure|3|||
164432722|NCT02317705|593954685|FG000|Overall Study|Withdrawal by Subject|3|||
164432723|NCT02317705|593954685|FG000|Overall Study|Physician Decision|1|||
164432724|NCT02317705|593954685|FG000|Overall Study|Drug not usable|1|||
164432725|NCT01599325|593954686|FG000|Primary Parent Phase|Adverse Event|5|||
164432726|NCT01599325|593954686|FG000|Primary Parent Phase|Disease Progression|7|||
164432727|NCT01599325|593954686|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
164432728|NCT01599325|593954686|FG000|Primary Parent Phase|Death|13|||
164432729|NCT01599325|593954686|FG000|Primary Parent Phase|Protocol Violation|1|||
164432730|NCT01599325|593954686|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
164432731|NCT01599325|593954686|FG000|Primary Parent Phase|Other|2|||
164432732|NCT01599325|593954686|FG000|Extension Phase|Study Closure|1|||
164432733|NCT01599325|593954686|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
164432734|NCT01599325|593954686|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
164280428|NCT03350815|593396448|FG000|Period 2|Lack of Efficacy|0|||
164280429|NCT03350815|593396449|FG001|Period 2|Lack of Efficacy|6|||
164432735|NCT01599325|593954686|FG000|Extension Phase|Disease Progression|1|||
164432736|NCT01599325|593954686|FG000|Extension Phase|Withdrawal by Subject|8|||
164432737|NCT01878890|593954687|FG000|Overall Study|Protocol Violation|0|||
164280430|NCT03350815|593396450|FG002|Period 2|Lack of Efficacy|2|||
164280431|NCT03350815|593396451|FG003|Period 2|Lack of Efficacy|0|||
164280432|NCT03350815|593396448|FG000|Period 2|Protocol Violation|0|||
164280433|NCT03350815|593396449|FG001|Period 2|Protocol Violation|0|||
164280434|NCT03350815|593396450|FG002|Period 2|Protocol Violation|1|||
164280435|NCT03350815|593396451|FG003|Period 2|Protocol Violation|0|||
164280436|NCT03350815|593396448|FG000|Period 2|New therapy for study indication|0|||
164280437|NCT03350815|593396449|FG001|Period 2|New therapy for study indication|0|||
164280438|NCT03350815|593396450|FG002|Period 2|New therapy for study indication|1|||
164280439|NCT03350815|593396451|FG003|Period 2|New therapy for study indication|0|||
164280440|NCT03526146|593396452|FG000|Overall Study|Lost to Follow-up|5|||
164280441|NCT03526146|593396452|FG000|Overall Study|Withdrawal by Subject|6|||
164280442|NCT03526146|593396452|FG000|Overall Study|class canceled due to COVID-19|4|||
164432738|NCT01878890|593954688|FG001|Overall Study|Protocol Violation|1|||
164432739|NCT01878890|593954689|FG002|Overall Study|Protocol Violation|0|||
164432740|NCT01878890|593954690|FG003|Overall Study|Protocol Violation|0|||
164280443|NCT01442714|593396455|FG000|Overall Study|Death|11|||
164280444|NCT01442714|593396455|FG000|Overall Study|Withdrawal by Subject|1|||
164280445|NCT01979952|593396466|FG000|Overall Study|Adverse Event|4|||
164280446|NCT01979952|593396467|FG001|Overall Study|Adverse Event|5|||
164280447|NCT01979952|593396466|FG000|Overall Study|Protocol Violation|1|||
164280448|NCT01979952|593396467|FG001|Overall Study|Protocol Violation|0|||
164280449|NCT01979952|593396466|FG000|Overall Study|Withdrawal by Subject|2|||
164280450|NCT01979952|593396467|FG001|Overall Study|Withdrawal by Subject|1|||
164280451|NCT01979952|593396466|FG000|Overall Study|Other than specified above|1|||
164280452|NCT01979952|593396467|FG001|Overall Study|Other than specified above|0|||
164280453|NCT00203424|593396469|FG000|Treatment Period|Withdrawal by Subject|4|||
164280454|NCT00203424|593396469|FG000|Treatment Period|Adverse Event|5|||
164280455|NCT00203424|593396469|FG000|Treatment Period|progressive disease|2|||
164280456|NCT00203424|593396469|FG000|Follow-up Period|Withdrawal by Subject|1|||
164280457|NCT00203424|593396469|FG000|Follow-up Period|progressive disease|4|||
164280458|NCT00203424|593396469|FG000|Follow-up Period|Lost to Follow-up|1|||
164280459|NCT01053988|593396470|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
164280460|NCT01053988|593396471|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164280461|NCT01053988|593396472|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164280462|NCT01053988|593396473|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164280463|NCT01053988|593396474|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164280464|NCT01053988|593396475|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164280465|NCT01053988|593396470|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
164280466|NCT01053988|593396471|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
164280467|NCT01053988|593396472|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
164280468|NCT01053988|593396473|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
164280469|NCT01053988|593396474|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
164280470|NCT01053988|593396475|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
164280471|NCT01053988|593396470|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
164280472|NCT01053988|593396471|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164280473|NCT01053988|593396472|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164280474|NCT01053988|593396473|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164280475|NCT01053988|593396474|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164280476|NCT01053988|593396475|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164280477|NCT01053988|593396470|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
164280478|NCT01053988|593396471|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
164280479|NCT01053988|593396472|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
164280480|NCT01053988|593396473|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
164280481|NCT01053988|593396474|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
164280482|NCT01053988|593396475|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
164280483|NCT01053988|593396470|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
164280484|NCT01053988|593396471|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
164280485|NCT01053988|593396472|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
164280486|NCT01053988|593396473|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
164280487|NCT01053988|593396474|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
164280488|NCT01053988|593396475|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
164280489|NCT01053988|593396470|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
164280490|NCT01053988|593396471|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164280491|NCT01053988|593396472|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164280492|NCT01053988|593396473|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164280493|NCT01053988|593396474|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164280494|NCT01053988|593396475|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164280495|NCT01053988|593396470|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
164280496|NCT01053988|593396471|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
164280497|NCT01053988|593396472|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
164280498|NCT01053988|593396473|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
164280499|NCT01053988|593396474|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
164280500|NCT01053988|593396475|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
164280501|NCT01053988|593396470|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
164280502|NCT01053988|593396471|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
164280503|NCT01053988|593396472|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
164344165|NCT04203498|593635376|FG001|Overall Study|Withdrawal of patient consent|2|||
164584400|NCT01753518|594504642|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
164584401|NCT03249350|594504643|FG000|Overall Study|Participant did not initiate treatment|5|||
164584402|NCT03249350|594504644|FG001|Overall Study|Participant did not initiate treatment|8|||
164584403|NCT01716169|594504646|FG000|Overall Study|Adverse Event|1|||
164584404|NCT01716169|594504646|FG000|Overall Study|Lost to Follow-up|1|||
164432741|NCT01710514|593954695|FG000|Overall Study|Adverse Event|6|||
164432742|NCT01710514|593954696|FG001|Overall Study|Adverse Event|7|||
164432743|NCT01710514|593954695|FG000|Overall Study|Withdrawal by Subject|1|||
164432744|NCT01710514|593954696|FG001|Overall Study|Withdrawal by Subject|0|||
164432745|NCT00853827|593954698|FG000|Single Blind Period (1 Week)|Other|4|||
164432746|NCT00853827|593954699|FG001|Single Blind Period (1 Week)|Other|0|||
164432747|NCT00853827|593954698|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
164432748|NCT00853827|593954699|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
164432749|NCT00853827|593954698|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
164432750|NCT00853827|593954699|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
164432751|NCT00853827|593954698|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
164432752|NCT00853827|593954699|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
164432753|NCT00853827|593954698|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
164432754|NCT00853827|593954699|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
164432755|NCT00853827|593954698|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
164432756|NCT00853827|593954699|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
164432757|NCT00853827|593954698|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
164432758|NCT00853827|593954699|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
164432759|NCT00853827|593954698|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
164432760|NCT00853827|593954699|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
164432761|NCT00853827|593954698|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
164432762|NCT00853827|593954699|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
164432763|NCT00853827|593954698|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
164432764|NCT00853827|593954699|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
164432765|NCT00853827|593954698|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
164432766|NCT00853827|593954699|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
164432767|NCT00853827|593954698|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
164432768|NCT00853827|593954699|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
164432769|NCT00853827|593954698|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
164432770|NCT00853827|593954699|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
164432771|NCT00853827|593954698|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
164432772|NCT00853827|593954699|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
164432773|NCT00853827|593954698|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
164432774|NCT00853827|593954699|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
164432775|NCT00853827|593954698|FG000|Double Blind Period (103 Weeks)|Death|1|||
164432776|NCT00853827|593954699|FG001|Double Blind Period (103 Weeks)|Death|6|||
164432777|NCT05576051|593954707|FG000|Overall Study|Lack of Efficacy|543|||
164432778|NCT05576051|593954708|FG001|Overall Study|Lack of Efficacy|343|||
164432779|NCT05576051|593954709|FG002|Overall Study|Lack of Efficacy|108|||
164432780|NCT05576051|593954710|FG003|Overall Study|Lack of Efficacy|72|||
164432781|NCT05576051|593954711|FG004|Overall Study|Lack of Efficacy|28|||
164432782|NCT05576051|593954712|FG005|Overall Study|Lack of Efficacy|50|||
164432783|NCT05576051|593954707|FG000|Overall Study|Safety|78|||
164432784|NCT05576051|593954708|FG001|Overall Study|Safety|74|||
164432785|NCT05576051|593954709|FG002|Overall Study|Safety|16|||
164432786|NCT05576051|593954710|FG003|Overall Study|Safety|14|||
164432787|NCT05576051|593954711|FG004|Overall Study|Safety|4|||
164432788|NCT05576051|593954712|FG005|Overall Study|Safety|5|||
164432789|NCT05576051|593954707|FG000|Overall Study|Efficacy + Safety|10|||
164432790|NCT05576051|593954708|FG001|Overall Study|Efficacy + Safety|7|||
164432791|NCT05576051|593954709|FG002|Overall Study|Efficacy + Safety|3|||
164280504|NCT01053988|593396473|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
164280505|NCT01053988|593396474|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
164280506|NCT01053988|593396475|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
164280507|NCT01053988|593396470|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
164280508|NCT01053988|593396471|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
164280509|NCT01053988|593396472|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
164280510|NCT01053988|593396473|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
164280511|NCT01053988|593396474|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
164280512|NCT01053988|593396475|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
164280513|NCT01053988|593396470|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
164432792|NCT05576051|593954710|FG003|Overall Study|Efficacy + Safety|0|||
164432793|NCT05576051|593954711|FG004|Overall Study|Efficacy + Safety|0|||
164432794|NCT05576051|593954712|FG005|Overall Study|Efficacy + Safety|0|||
164432795|NCT05576051|593954707|FG000|Overall Study|Other|231|||
164432796|NCT05576051|593954708|FG001|Overall Study|Other|127|||
164432797|NCT05576051|593954709|FG002|Overall Study|Other|35|||
164432798|NCT05576051|593954710|FG003|Overall Study|Other|14|||
164432799|NCT05576051|593954711|FG004|Overall Study|Other|6|||
164432800|NCT05576051|593954712|FG005|Overall Study|Other|0|||
164280514|NCT01053988|593396471|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
164280515|NCT01053988|593396472|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
164280516|NCT01053988|593396473|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
164280517|NCT01053988|593396474|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
164280518|NCT01053988|593396475|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
164280519|NCT01053988|593396470|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
164280520|NCT01053988|593396471|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
164280521|NCT01053988|593396472|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
164280522|NCT01053988|593396473|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
164280523|NCT01053988|593396474|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
164280524|NCT01053988|593396475|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
164280525|NCT01053988|593396470|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164280526|NCT01053988|593396471|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
164280527|NCT01053988|593396472|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164280528|NCT01053988|593396473|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
164280529|NCT01053988|593396474|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
164280530|NCT01053988|593396475|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
164280531|NCT01053988|593396470|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
164280532|NCT01053988|593396471|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
164280533|NCT01053988|593396472|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
164280534|NCT01053988|593396473|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
164280535|NCT01053988|593396474|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
164280536|NCT01053988|593396475|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
164280537|NCT01053988|593396470|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
164280538|NCT01053988|593396471|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
164280539|NCT01053988|593396472|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
164280540|NCT01053988|593396473|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
164280541|NCT01053988|593396474|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
164280542|NCT01053988|593396475|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
164280543|NCT01922271|593396477|FG000|WASHOUT Period|Withdrawal by Subject|1|||
164280544|NCT01922271|593396478|FG001|WASHOUT Period|Withdrawal by Subject|0|||
164280545|NCT00719355|593396479|FG000|Overall Study|Death|0|||
164280546|NCT00719355|593396480|FG001|Overall Study|Death|1|||
164280547|NCT00719355|593396479|FG000|Overall Study|Medical|14|||
164280548|NCT00719355|593396480|FG001|Overall Study|Medical|5|||
164280549|NCT00719355|593396479|FG000|Overall Study|Compliance|4|||
164280550|NCT00719355|593396480|FG001|Overall Study|Compliance|6|||
164280551|NCT00719355|593396479|FG000|Overall Study|Moved|0|||
164280552|NCT00719355|593396480|FG001|Overall Study|Moved|1|||
164344166|NCT04203498|593635375|FG000|Overall Study|Adverse Event|4|||
164344167|NCT04203498|593635376|FG001|Overall Study|Adverse Event|1|||
164344168|NCT04203498|593635375|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
164344169|NCT04203498|593635376|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
164344170|NCT04203498|593635375|FG000|Overall Study|Did not receive IMP|2|||
164344171|NCT04203498|593635376|FG001|Overall Study|Did not receive IMP|0|||
164344172|NCT02106975|593635377|FG000|Overall Study|Death|25|||
164344173|NCT02106975|593635378|FG001|Overall Study|Death|39|||
164344174|NCT00622401|593635379|FG000|Overall Study|Disease progression prior to treatment|3|||
164344175|NCT00622401|593635380|FG001|Overall Study|Disease progression prior to treatment|2|||
164344176|NCT00622401|593635381|FG002|Overall Study|Disease progression prior to treatment|0|||
164344177|NCT03546062|593635382|FG000|Overall Study|Adverse Event|6|||
164344178|NCT03546062|593635383|FG001|Overall Study|Adverse Event|5|||
164344179|NCT03546062|593635384|FG002|Overall Study|Adverse Event|8|||
164344180|NCT00181155|593635385|FG000|Overall Study|Physician Decision|1|||
164344181|NCT00181155|593635386|FG001|Overall Study|Physician Decision|0|||
164344182|NCT00181155|593635385|FG000|Overall Study|Withdrawal by Subject|1|||
164344183|NCT00181155|593635386|FG001|Overall Study|Withdrawal by Subject|0|||
164344184|NCT02572401|593635387|FG000|Overall Study|Lost to Follow-up|5|||
164344185|NCT02572401|593635388|FG001|Overall Study|Lost to Follow-up|8|||
164344186|NCT02572401|593635389|FG002|Overall Study|Lost to Follow-up|9|||
164344187|NCT02572401|593635390|FG003|Overall Study|Lost to Follow-up|9|||
164344188|NCT02572401|593635387|FG000|Overall Study|Death|0|||
164344189|NCT02572401|593635388|FG001|Overall Study|Death|0|||
164344190|NCT02572401|593635389|FG002|Overall Study|Death|0|||
164344191|NCT02572401|593635390|FG003|Overall Study|Death|1|||
164344192|NCT01768286|593635396|FG000|Overall Study|Randomized But Not Treated|0|||
164344193|NCT01768286|593635397|FG001|Overall Study|Randomized But Not Treated|0|||
164344194|NCT01768286|593635398|FG002|Overall Study|Randomized But Not Treated|1|||
164344195|NCT01768286|593635399|FG003|Overall Study|Randomized But Not Treated|0|||
164344196|NCT01768286|593635396|FG000|Overall Study|Lack of Efficacy|7|||
164344197|NCT01768286|593635397|FG001|Overall Study|Lack of Efficacy|4|||
164344198|NCT01768286|593635398|FG002|Overall Study|Lack of Efficacy|0|||
164280553|NCT01856582|593396481|FG000|Overall Study|Died prior to Boost infusion|1|||
164280554|NCT01824355|593396482|FG000|Overall Study|Adverse Event|2|||
164280555|NCT01824355|593396482|FG000|Overall Study|unevaluable reference method results per|1|||
164280556|NCT01331109|593396483|FG000|Overall Study|Adverse Event|6|||
164280557|NCT01331109|593396483|FG000|Overall Study|Lack of Efficacy|2|||
164280558|NCT01331109|593396483|FG000|Overall Study|Protocol Violation|3|||
164280559|NCT01331109|593396483|FG000|Overall Study|Withdrawal by Subject|7|||
164280560|NCT01331109|593396483|FG000|Overall Study|Lost to Follow-up|1|||
164280561|NCT01331109|593396483|FG000|Overall Study|Study Terminated by Sponsor|38|||
164280562|NCT03688620|593396489|FG000|Overall Study|Other|0|||
164280563|NCT03688620|593396490|FG001|Overall Study|Other|0|||
164280564|NCT03688620|593396491|FG002|Overall Study|Other|1|||
164280565|NCT03688620|593396489|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
164280566|NCT03688620|593396490|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
164280567|NCT03688620|593396491|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
164280568|NCT03688620|593396489|FG000|Overall Study|Lost to Follow-up|16|||
164280569|NCT03688620|593396490|FG001|Overall Study|Lost to Follow-up|0|||
164280570|NCT03688620|593396491|FG002|Overall Study|Lost to Follow-up|1|||
164280571|NCT03688620|593396489|FG000|Overall Study|Withdrawal by Subject|0|||
164280572|NCT03688620|593396490|FG001|Overall Study|Withdrawal by Subject|0|||
164280573|NCT03688620|593396491|FG002|Overall Study|Withdrawal by Subject|6|||
164280574|NCT02828020|593396492|FG000|Treatment Period|Adverse Event|3|||
164280575|NCT02828020|593396493|FG001|Treatment Period|Adverse Event|1|||
164280576|NCT02828020|593396494|FG002|Treatment Period|Adverse Event|1|||
164280577|NCT02828020|593396492|FG000|Treatment Period|Withdrawal of Consent|10|||
164280578|NCT02828020|593396493|FG001|Treatment Period|Withdrawal of Consent|14|||
164280579|NCT02828020|593396494|FG002|Treatment Period|Withdrawal of Consent|9|||
164280580|NCT02828020|593396492|FG000|Treatment Period|Lost to Follow-up|21|||
164280581|NCT02828020|593396493|FG001|Treatment Period|Lost to Follow-up|24|||
164280582|NCT02828020|593396494|FG002|Treatment Period|Lost to Follow-up|18|||
164280583|NCT02828020|593396492|FG000|Treatment Period|Lack of Qualifying Event|44|||
164280584|NCT02828020|593396493|FG001|Treatment Period|Lack of Qualifying Event|53|||
164280585|NCT02828020|593396494|FG002|Treatment Period|Lack of Qualifying Event|43|||
164280586|NCT02828020|593396492|FG000|Treatment Period|Pregnancy|0|||
164280587|NCT02828020|593396493|FG001|Treatment Period|Pregnancy|2|||
164280588|NCT02828020|593396494|FG002|Treatment Period|Pregnancy|0|||
164280589|NCT02828020|593396492|FG000|Treatment Period|Protocol Violation|2|||
164280590|NCT02828020|593396493|FG001|Treatment Period|Protocol Violation|4|||
164280591|NCT02828020|593396494|FG002|Treatment Period|Protocol Violation|7|||
164280592|NCT02828020|593396492|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
164280593|NCT02828020|593396493|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
164280594|NCT02828020|593396494|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
164280595|NCT02828020|593396492|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
164280596|NCT02828020|593396493|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
164280597|NCT02828020|593396494|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
164280598|NCT02828020|593396492|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
164280599|NCT02828020|593396493|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
164280600|NCT02828020|593396494|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
164280601|NCT02828020|593396492|FG000|Safety Follow-up Period|Protocol Violation|0|||
164280602|NCT02828020|593396493|FG001|Safety Follow-up Period|Protocol Violation|2|||
164280603|NCT02828020|593396494|FG002|Safety Follow-up Period|Protocol Violation|1|||
164280604|NCT02828020|593396492|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
164280605|NCT02828020|593396493|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
164280606|NCT02828020|593396494|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
164280607|NCT01183065|593396496|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
164280608|NCT02578186|593396497|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
164280609|NCT02578186|593396498|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
164280610|NCT02578186|593396497|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
164280611|NCT02578186|593396498|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
164280612|NCT03657095|593396499|FG000|Overall Study|Withdrawal by Subject|1|||
164280613|NCT03657095|593396500|FG001|Overall Study|Withdrawal by Subject|1|||
164280614|NCT03657095|593396499|FG000|Overall Study|Adverse Event|0|||
164280615|NCT03657095|593396500|FG001|Overall Study|Adverse Event|3|||
164344199|NCT01768286|593635399|FG003|Overall Study|Lack of Efficacy|1|||
164280616|NCT03657095|593396499|FG000|Overall Study|Study Terminated by Sponsor|58|||
164280617|NCT03657095|593396500|FG001|Overall Study|Study Terminated by Sponsor|49|||
164280618|NCT01894243|593396501|FG000|Overall Study|Adverse Event|0|||
164344200|NCT01768286|593635396|FG000|Overall Study|Withdrew Consent|0|||
164344201|NCT01768286|593635397|FG001|Overall Study|Withdrew Consent|0|||
164344202|NCT01768286|593635398|FG002|Overall Study|Withdrew Consent|1|||
164344203|NCT01768286|593635399|FG003|Overall Study|Withdrew Consent|0|||
164344204|NCT02243696|593635400|FG000|Overall Study|Death|282|||
164344205|NCT02243696|593635400|FG000|Overall Study|Withdrawal by Subject|79|||
164344206|NCT02243696|593635400|FG000|Overall Study|Lost to Follow-up|57|||
164344207|NCT02243696|593635400|FG000|Overall Study|Subject No Longer has Study System|42|||
164344208|NCT02243696|593635400|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
164344209|NCT02243696|593635400|FG000|Overall Study|Study Terminated for EP PASSION|961|||
164344210|NCT00622284|593635401|FG000|Overall Study|Lack of Efficacy|45|||
164344211|NCT00622284|593635402|FG001|Overall Study|Lack of Efficacy|15|||
164344212|NCT00622284|593635401|FG000|Overall Study|Adverse Event|61|||
164344213|NCT00622284|593635402|FG001|Overall Study|Adverse Event|90|||
164344214|NCT00622284|593635401|FG000|Overall Study|Protocol Violation|12|||
164344215|NCT00622284|593635402|FG001|Overall Study|Protocol Violation|5|||
164344216|NCT00622284|593635401|FG000|Overall Study|Lost to Follow-up|11|||
164344217|NCT00622284|593635402|FG001|Overall Study|Lost to Follow-up|13|||
164344218|NCT00622284|593635401|FG000|Overall Study|Withdrawal by Subject|27|||
164344219|NCT00622284|593635402|FG001|Overall Study|Withdrawal by Subject|24|||
164344220|NCT00622284|593635401|FG000|Overall Study|Other reason (not specified)|33|||
164344221|NCT00622284|593635402|FG001|Overall Study|Other reason (not specified)|24|||
164344222|NCT02935842|593635403|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
164344223|NCT02935842|593635404|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
164344224|NCT02935842|593635405|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
164344225|NCT02935842|593635406|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
164344226|NCT02935842|593635403|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
164344227|NCT02935842|593635404|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
164344228|NCT02935842|593635405|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
164344229|NCT02935842|593635406|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
164344230|NCT02935842|593635403|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
164344231|NCT02935842|593635404|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
164344232|NCT02935842|593635405|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
164344233|NCT02935842|593635406|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
164344234|NCT02935842|593635403|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
164344235|NCT02935842|593635404|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
164344236|NCT02935842|593635405|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
164344237|NCT02935842|593635406|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
164344238|NCT02935842|593635403|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
164344239|NCT02935842|593635404|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
164344240|NCT02935842|593635405|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
164344241|NCT02935842|593635406|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
164344242|NCT01201850|593635409|FG000|Overall Study|Tumor progression|4|||
164344243|NCT04066023|593635410|FG000|Overall Study|Adverse Event|0|||
164344244|NCT04066023|593635411|FG001|Overall Study|Adverse Event|0|||
164344245|NCT04066023|593635412|FG002|Overall Study|Adverse Event|1|||
164344246|NCT04066023|593635410|FG000|Overall Study|Sponsor decision|3|||
164344247|NCT04066023|593635411|FG001|Overall Study|Sponsor decision|6|||
164344248|NCT04066023|593635412|FG002|Overall Study|Sponsor decision|2|||
164344249|NCT04066023|593635410|FG000|Overall Study|Physician Decision|0|||
164344250|NCT04066023|593635411|FG001|Overall Study|Physician Decision|0|||
164344251|NCT04066023|593635412|FG002|Overall Study|Physician Decision|1|||
164344252|NCT04066023|593635410|FG000|Overall Study|Lost to Follow-up|0|||
164344253|NCT04066023|593635411|FG001|Overall Study|Lost to Follow-up|1|||
164344254|NCT04066023|593635412|FG002|Overall Study|Lost to Follow-up|1|||
164344255|NCT04066023|593635410|FG000|Overall Study|Noncompliance|0|||
164344256|NCT04066023|593635411|FG001|Overall Study|Noncompliance|1|||
164344257|NCT04066023|593635412|FG002|Overall Study|Noncompliance|1|||
164344258|NCT01552694|593635413|FG000|Overall Study|Lost to Follow-up|0|||
164344259|NCT01552694|593635414|FG001|Overall Study|Lost to Follow-up|1|||
164344260|NCT01552694|593635413|FG000|Overall Study|Protocol Violation|0|||
164344261|NCT01552694|593635414|FG001|Overall Study|Protocol Violation|1|||
164344262|NCT03338010|593635415|FG000|Overall Study|Withdrawal by Subject|14|||
164344263|NCT03338010|593635416|FG001|Overall Study|Withdrawal by Subject|8|||
164344264|NCT03338010|593635415|FG000|Overall Study|Lost to Follow-up|4|||
164344265|NCT03338010|593635416|FG001|Overall Study|Lost to Follow-up|2|||
164344266|NCT03338010|593635415|FG000|Overall Study|Adverse Event|3|||
164344267|NCT03338010|593635416|FG001|Overall Study|Adverse Event|2|||
164344268|NCT03338010|593635415|FG000|Overall Study|Physician Decision|2|||
164344269|NCT03338010|593635416|FG001|Overall Study|Physician Decision|2|||
164344270|NCT03338010|593635415|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164344271|NCT03338010|593635416|FG001|Overall Study|Non-Compliance with Study Drug|3|||
164344272|NCT03338010|593635415|FG000|Overall Study|Protocol Violation|0|||
164344273|NCT03338010|593635416|FG001|Overall Study|Protocol Violation|1|||
164344274|NCT00293033|593635421|FG000|Open-label Titration Period|Adverse Event|10|||
164344275|NCT00293033|593635421|FG000|Open-label Titration Period|Death|3|||
164344276|NCT00293033|593635421|FG000|Open-label Titration Period|Lack of Efficacy|5|||
164344277|NCT00293033|593635421|FG000|Open-label Titration Period|Protocol Violation|2|||
164344278|NCT00293033|593635421|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
164344279|NCT00293033|593635421|FG000|Open-label Titration Period|Noncompliance and other|27|||
164344280|NCT00293033|593635421|FG000|Double-blind Treatment Period|Adverse Event|3|||
164280619|NCT01894243|593396502|FG001|Overall Study|Adverse Event|1|||
164280620|NCT01894243|593396503|FG002|Overall Study|Adverse Event|2|||
164280621|NCT01894243|593396501|FG000|Overall Study|Death|0|||
164280622|NCT01894243|593396502|FG001|Overall Study|Death|0|||
164280623|NCT01894243|593396503|FG002|Overall Study|Death|3|||
164280624|NCT01894243|593396501|FG000|Overall Study|Lack of Efficacy|3|||
164280625|NCT01894243|593396502|FG001|Overall Study|Lack of Efficacy|3|||
164280626|NCT01894243|593396503|FG002|Overall Study|Lack of Efficacy|1|||
164280627|NCT01894243|593396501|FG000|Overall Study|Condition under investigation worsened|8|||
164280628|NCT01894243|593396502|FG001|Overall Study|Condition under investigation worsened|6|||
164280629|NCT01894243|593396503|FG002|Overall Study|Condition under investigation worsened|2|||
164280630|NCT01894243|593396501|FG000|Overall Study|Subject decision|1|||
164280631|NCT01894243|593396502|FG001|Overall Study|Subject decision|0|||
164280632|NCT01894243|593396503|FG002|Overall Study|Subject decision|0|||
164280633|NCT01894243|593396501|FG000|Overall Study|Other|1|||
164280634|NCT01894243|593396502|FG001|Overall Study|Other|0|||
164280635|NCT01894243|593396503|FG002|Overall Study|Other|0|||
164280636|NCT00828750|593396506|FG000|Overall Study|Lack of Efficacy|3|||
164280637|NCT00828750|593396506|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
164280638|NCT04006392|593396507|FG000|Overall Study|Lost to Follow-up|0|||
164280639|NCT04006392|593396508|FG001|Overall Study|Lost to Follow-up|1|||
164280640|NCT01067469|593396509|FG000|Overall Study|Withdrawal by Subject|0|||
164280641|NCT01067469|593396510|FG001|Overall Study|Withdrawal by Subject|1|||
164280642|NCT01067469|593396509|FG000|Overall Study|Disease Progression|0|||
164280643|NCT01067469|593396510|FG001|Overall Study|Disease Progression|1|||
164280644|NCT01620944|593396511|FG000|Overall Study|Early termination of Study|2|||
164280645|NCT01620944|593396512|FG001|Overall Study|Early termination of Study|1|||
164280646|NCT04378114|593396513|FG000|Overall Study|Withdrawal by Subject|5|||
164280647|NCT00825812|593396514|FG000|Overall Study|Never entered follow up|0|||
164280648|NCT00825812|593396515|FG001|Overall Study|Never entered follow up|0|||
164280649|NCT00825812|593396516|FG002|Overall Study|Never entered follow up|0|||
164280650|NCT00825812|593396517|FG003|Overall Study|Never entered follow up|1|||
164280651|NCT00825812|593396514|FG000|Overall Study|Adverse Event|0|||
164280652|NCT00825812|593396515|FG001|Overall Study|Adverse Event|0|||
164280653|NCT00825812|593396516|FG002|Overall Study|Adverse Event|0|||
164280654|NCT00825812|593396517|FG003|Overall Study|Adverse Event|1|||
164280655|NCT00825812|593396514|FG000|Overall Study|Subject withdrew consent|0|||
164280656|NCT00825812|593396515|FG001|Overall Study|Subject withdrew consent|0|||
164280657|NCT00825812|593396516|FG002|Overall Study|Subject withdrew consent|3|||
164280658|NCT00825812|593396517|FG003|Overall Study|Subject withdrew consent|2|||
164280659|NCT00825812|593396514|FG000|Overall Study|Non-compliance with protocol|0|||
164280660|NCT00825812|593396515|FG001|Overall Study|Non-compliance with protocol|0|||
164280661|NCT00825812|593396516|FG002|Overall Study|Non-compliance with protocol|0|||
164280662|NCT00825812|593396517|FG003|Overall Study|Non-compliance with protocol|1|||
164280663|NCT00825812|593396514|FG000|Overall Study|Administrative|0|||
164280664|NCT00825812|593396515|FG001|Overall Study|Administrative|1|||
164280665|NCT00825812|593396516|FG002|Overall Study|Administrative|3|||
164280666|NCT00825812|593396517|FG003|Overall Study|Administrative|5|||
164280667|NCT00986362|593396519|FG000|Overall Study|Death|2|||
164280668|NCT00986362|593396520|FG001|Overall Study|Death|0|||
164280669|NCT00986362|593396519|FG000|Overall Study|Lost to Follow-up|0|||
164280670|NCT00986362|593396520|FG001|Overall Study|Lost to Follow-up|1|||
164280671|NCT03597061|593396521|FG000|Overall Study|Lost to Follow-up|1|||
164280672|NCT03597061|593396522|FG001|Overall Study|Lost to Follow-up|0|||
164280673|NCT03597061|593396521|FG000|Overall Study|Protocol Violation|0|||
164280674|NCT03597061|593396522|FG001|Overall Study|Protocol Violation|1|||
164344281|NCT00293033|593635421|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
164280675|NCT00895453|593396527|FG000|Overall Study|Lost to Follow-up|25|||
164344282|NCT00293033|593635421|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
164344283|NCT00293033|593635421|FG000|Double-blind Treatment Period|Noncompliance|4|||
164344284|NCT01980940|593635423|FG000|Overall Study|Protocol Violation|0|||
164584405|NCT01716169|594504646|FG000|Overall Study|Withdrawal by Subject|1|||
164584406|NCT01716169|594504646|FG000|Overall Study|inconsistent dressing application|1|||
164584407|NCT00553787|594504647|FG000|Overall Study|Adverse Event|34|||
164584408|NCT00553787|594504648|FG001|Overall Study|Adverse Event|21|||
164584409|NCT00553787|594504649|FG002|Overall Study|Adverse Event|67|||
164584410|NCT00553787|594504647|FG000|Overall Study|Lost to Follow-up|132|||
164584411|NCT00553787|594504648|FG001|Overall Study|Lost to Follow-up|44|||
164584412|NCT00553787|594504649|FG002|Overall Study|Lost to Follow-up|78|||
164584413|NCT00553787|594504647|FG000|Overall Study|Withdrawal by Subject|151|||
164584414|NCT00553787|594504648|FG001|Overall Study|Withdrawal by Subject|40|||
164584415|NCT00553787|594504649|FG002|Overall Study|Withdrawal by Subject|83|||
164280676|NCT00895453|593396528|FG001|Overall Study|Lost to Follow-up|25|||
164280677|NCT00895453|593396529|FG002|Overall Study|Lost to Follow-up|23|||
164280678|NCT00850538|593396530|FG000|Overall Study|unable/unwilling to complete MRI|13|||
164280679|NCT00850538|593396530|FG000|Overall Study|specimen missed due to scheduling error|14|||
164280680|NCT00850538|593396530|FG000|Overall Study|specimen unusable|7|||
164280681|NCT00850538|593396530|FG000|Overall Study|Withdrawal by Subject|3|||
164280682|NCT00850538|593396530|FG000|Overall Study|radiology error|2|||
164280683|NCT00850538|593396530|FG000|Overall Study|Protocol Violation|2|||
164280684|NCT01088399|593396531|FG000|Overall Study|Adverse Event|211|||
164280685|NCT01088399|593396532|FG001|Overall Study|Adverse Event|16|||
164280686|NCT01088399|593396533|FG002|Overall Study|Adverse Event|0|||
164280687|NCT01088399|593396531|FG000|Overall Study|Death|204|||
164280688|NCT01088399|593396532|FG001|Overall Study|Death|45|||
164280689|NCT01088399|593396533|FG002|Overall Study|Death|0|||
164280690|NCT01088399|593396531|FG000|Overall Study|Lack of Efficacy|298|||
164280691|NCT01088399|593396532|FG001|Overall Study|Lack of Efficacy|7|||
164280692|NCT01088399|593396533|FG002|Overall Study|Lack of Efficacy|5|||
164280693|NCT01088399|593396531|FG000|Overall Study|Lost to Follow-up|1070|||
164280694|NCT01088399|593396532|FG001|Overall Study|Lost to Follow-up|278|||
164280695|NCT01088399|593396533|FG002|Overall Study|Lost to Follow-up|58|||
164280696|NCT01088399|593396531|FG000|Overall Study|Physician Decision|531|||
164280697|NCT01088399|593396532|FG001|Overall Study|Physician Decision|88|||
164280698|NCT01088399|593396533|FG002|Overall Study|Physician Decision|16|||
164280699|NCT01088399|593396531|FG000|Overall Study|Withdrawal by Subject|544|||
164280700|NCT01088399|593396532|FG001|Overall Study|Withdrawal by Subject|195|||
164280701|NCT01088399|593396533|FG002|Overall Study|Withdrawal by Subject|33|||
164280702|NCT01088399|593396531|FG000|Overall Study|Change to or start of somatropin therapy|234|||
164280703|NCT01088399|593396532|FG001|Overall Study|Change to or start of somatropin therapy|17|||
164280704|NCT01088399|593396533|FG002|Overall Study|Change to or start of somatropin therapy|12|||
164280705|NCT01088399|593396531|FG000|Overall Study|Sponsor decision|1573|||
164280706|NCT01088399|593396532|FG001|Overall Study|Sponsor decision|298|||
164280707|NCT01088399|593396533|FG002|Overall Study|Sponsor decision|7|||
164280708|NCT01088399|593396531|FG000|Overall Study|Protocol Violation|10|||
164280709|NCT01088399|593396532|FG001|Overall Study|Protocol Violation|1|||
164280710|NCT01088399|593396533|FG002|Overall Study|Protocol Violation|0|||
164280711|NCT01088399|593396531|FG000|Overall Study|Enrollment criteria not met|48|||
164280712|NCT01088399|593396532|FG001|Overall Study|Enrollment criteria not met|119|||
164280713|NCT01088399|593396533|FG002|Overall Study|Enrollment criteria not met|70|||
164280714|NCT01088399|593396531|FG000|Overall Study|Study summary visit not completed|2398|||
164280715|NCT01088399|593396532|FG001|Overall Study|Study summary visit not completed|283|||
164280716|NCT01088399|593396533|FG002|Overall Study|Study summary visit not completed|80|||
164280717|NCT03193736|593396534|FG000|Overall Study|Death|2|||
164280718|NCT03193736|593396534|FG000|Overall Study|Withdrawal by Subject|1|||
164280719|NCT03193736|593396534|FG000|Overall Study|Lost to Follow-up|1|||
164280720|NCT03193736|593396534|FG000|Overall Study|implant not received|1|||
164280721|NCT00852241|593396535|FG000|Overall Study|Physician Decision|18|||
164280722|NCT02697435|593396536|FG000|Overall Study|Withdrawal by Subject|1|||
164280723|NCT02697435|593396537|FG001|Overall Study|Withdrawal by Subject|0|||
164280724|NCT02697435|593396536|FG000|Overall Study|Physician Decision|0|||
164280725|NCT02697435|593396537|FG001|Overall Study|Physician Decision|4|||
164280726|NCT03777059|593397778|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
164280727|NCT03777059|593397779|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
164280728|NCT03777059|593397780|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
164280729|NCT03777059|593397781|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
164280730|NCT03777059|593397778|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
164280731|NCT03777059|593397779|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
164432801|NCT01664104|593954713|FG000|Overall Study|Adverse Event|6|||
164432802|NCT01664104|593954713|FG000|Overall Study|Lack of Efficacy|2|||
164432803|NCT01664104|593954713|FG000|Overall Study|Withdrawal by Subject|1|||
164432804|NCT01664104|593954713|FG000|Overall Study|Lost to Follow-up|4|||
164432805|NCT01664104|593954713|FG000|Overall Study|Other|1|||
164432806|NCT01664104|593954713|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
164432807|NCT01194258|593954714|FG000|Titration Period|Withdrawal by Subject|6|||
164432808|NCT01194258|593954715|FG001|Titration Period|Withdrawal by Subject|0|||
164584416|NCT00553787|594504647|FG000|Overall Study|Lack of Efficacy|31|||
164280732|NCT03777059|593397780|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
164280733|NCT03777059|593397781|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
164432809|NCT01194258|593954716|FG002|Titration Period|Withdrawal by Subject|0|||
164432810|NCT01194258|593954717|FG003|Titration Period|Withdrawal by Subject|0|||
164584417|NCT00553787|594504648|FG001|Overall Study|Lack of Efficacy|1|||
164584418|NCT00553787|594504649|FG002|Overall Study|Lack of Efficacy|3|||
164280734|NCT03777059|593397778|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
164280735|NCT03777059|593397779|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
164280736|NCT03777059|593397780|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
164280737|NCT03777059|593397781|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
164280738|NCT03777059|593397778|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
164280739|NCT03777059|593397779|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
164280740|NCT03777059|593397780|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
164280741|NCT03777059|593397781|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
164280742|NCT03777059|593397778|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
164432811|NCT01194258|593954718|FG004|Titration Period|Withdrawal by Subject|0|||
164280743|NCT03777059|593397779|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
164280744|NCT03777059|593397780|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
164280745|NCT03777059|593397781|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
164280746|NCT03777059|593397778|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
164280747|NCT03777059|593397779|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
164280748|NCT03777059|593397780|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
164280749|NCT03777059|593397781|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
164280750|NCT03777059|593397778|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
164280751|NCT03777059|593397779|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
164280752|NCT03777059|593397780|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
164280753|NCT03777059|593397781|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
164280754|NCT03777059|593397778|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
164280755|NCT03777059|593397779|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
164280756|NCT03777059|593397780|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
164280757|NCT03777059|593397781|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
164280758|NCT03777059|593397778|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
164280759|NCT03777059|593397779|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
164280760|NCT03777059|593397780|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
164280761|NCT03777059|593397781|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
164280762|NCT03777059|593397778|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
164280763|NCT03777059|593397779|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
164280764|NCT03777059|593397780|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
164280765|NCT03777059|593397781|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
164280766|NCT03777059|593397778|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
164280767|NCT03777059|593397779|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
164280768|NCT03777059|593397780|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
164280769|NCT03777059|593397781|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
164280770|NCT03056339|593397785|FG000|Overall Study|Failed Requirements|0|||
164280771|NCT03056339|593397786|FG001|Overall Study|Failed Requirements|2|||
164280772|NCT03056339|593397787|FG002|Overall Study|Failed Requirements|7|||
164280773|NCT03056339|593397788|FG003|Overall Study|Failed Requirements|1|||
164280774|NCT04506502|593397792|FG000|Overall Study|Withdrawal by Subject|1|||
164280775|NCT04506502|593397792|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
164280776|NCT01449006|593397793|FG000|Overall Study|Lost to Follow-up|1|||
164280777|NCT01449006|593397794|FG001|Overall Study|Lost to Follow-up|0|||
164280778|NCT01449006|593397793|FG000|Overall Study|Withdrawal by Subject|1|||
164280779|NCT01449006|593397794|FG001|Overall Study|Withdrawal by Subject|0|||
164280780|NCT01449006|593397793|FG000|Overall Study|Protocol Violation|1|||
164280781|NCT01449006|593397794|FG001|Overall Study|Protocol Violation|0|||
164280782|NCT02517541|593397797|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
164280783|NCT02517541|593397797|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
164280784|NCT02517541|593397797|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
164280785|NCT02517541|593397797|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
164280786|NCT02517541|593397797|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
164280787|NCT02517541|593397797|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
164280788|NCT02034877|593397800|FG000|Overall Study|Lost to Follow-up|0|||
164280789|NCT02034877|593397801|FG001|Overall Study|Lost to Follow-up|3|||
164280790|NCT02034877|593397800|FG000|Overall Study|No Longer Willing to Participate|0|||
164280791|NCT02034877|593397801|FG001|Overall Study|No Longer Willing to Participate|3|||
164280792|NCT01036321|593397808|FG000|Overall Study|Ineligible after randomization|0|||
164280793|NCT01036321|593397809|FG001|Overall Study|Ineligible after randomization|1|||
164280794|NCT01036321|593397808|FG000|Overall Study|Withdrawal by Subject|3|||
164280795|NCT01036321|593397809|FG001|Overall Study|Withdrawal by Subject|2|||
164280796|NCT01036321|593397808|FG000|Overall Study|Adverse Event|2|||
164280797|NCT01036321|593397809|FG001|Overall Study|Adverse Event|1|||
164280798|NCT00381693|593397810|FG000|Overall Study|Death|1|||
164280799|NCT00381693|593397810|FG000|Overall Study|Adverse Event|4|||
164280800|NCT00381693|593397810|FG000|Overall Study|Patient Choice|1|||
164280801|NCT00381693|593397810|FG000|Overall Study|Progression|2|||
164280802|NCT01687101|593397811|FG000|Overall Study|Lost to Follow-up|7|||
164280803|NCT02598297|593397812|FG000|Overall Study|Study terminated by Sponsor|21|||
164280804|NCT02598297|593397813|FG001|Overall Study|Study terminated by Sponsor|23|||
164280805|NCT02598297|593397812|FG000|Overall Study|Adverse Event|1|||
164280806|NCT02598297|593397813|FG001|Overall Study|Adverse Event|1|||
164280807|NCT02598297|593397812|FG000|Overall Study|Physician Decision|1|||
164280808|NCT02598297|593397813|FG001|Overall Study|Physician Decision|0|||
164280809|NCT02598297|593397812|FG000|Overall Study|Subject/guardian decision|1|||
164280810|NCT02598297|593397813|FG001|Overall Study|Subject/guardian decision|0|||
164280811|NCT02598297|593397812|FG000|Overall Study|Followed for survival|1|||
164280812|NCT02598297|593397813|FG001|Overall Study|Followed for survival|0|||
164280813|NCT02003534|593397819|FG000|Overall Study|Lost to Follow-up|47|||
164280814|NCT03040674|593397820|FG000|Overall Study|Lost to Follow-up|225|||
164280815|NCT03040674|593397820|FG000|Overall Study|Death|23|||
164280816|NCT02206035|593397822|FG000|Overall Study|Physician Decision|10|||
164280817|NCT02206035|593397823|FG001|Overall Study|Physician Decision|0|||
164280818|NCT02206035|593397824|FG002|Overall Study|Physician Decision|175|||
164280819|NCT01934010|593397825|FG000|Overall Study|Adverse Event|1|||
164280820|NCT01934010|593397826|FG001|Overall Study|Adverse Event|1|||
164280821|NCT01934010|593397827|FG002|Overall Study|Adverse Event|0|||
164280822|NCT01934010|593397825|FG000|Overall Study|Withdrawal by Subject|15|||
164280823|NCT01934010|593397826|FG001|Overall Study|Withdrawal by Subject|6|||
164280824|NCT01934010|593397827|FG002|Overall Study|Withdrawal by Subject|2|||
164280825|NCT01934010|593397825|FG000|Overall Study|Lost to Follow-up|7|||
164280826|NCT01934010|593397826|FG001|Overall Study|Lost to Follow-up|4|||
164280827|NCT01934010|593397827|FG002|Overall Study|Lost to Follow-up|0|||
164280828|NCT04112303|593397828|FG000|Overall Study|Death|1|||
164280829|NCT01685697|593397829|FG000|Overall Study|Protocol Violation|3|||
164280830|NCT01685697|593397830|FG001|Overall Study|Protocol Violation|3|||
164280831|NCT02703324|593397831|FG000|Period Two|Withdrawal by Subject|0|||
164280832|NCT02703324|593397832|FG001|Period Two|Withdrawal by Subject|0|||
164280833|NCT02703324|593397833|FG002|Period Two|Withdrawal by Subject|1|||
164280834|NCT02703324|593397834|FG003|Period Two|Withdrawal by Subject|0|||
164280835|NCT02703324|593397835|FG004|Period Two|Withdrawal by Subject|0|||
164280836|NCT02703324|593397836|FG005|Period Two|Withdrawal by Subject|0|||
164280837|NCT04303572|593397839|FG000|Overall Study|Study closed due to poor enrollment|1|||
164280838|NCT03517228|593397842|FG000|Overall Study|Withdrawal by Subject|2|||
164280839|NCT03517228|593397842|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
164280840|NCT03517228|593397842|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
164280841|NCT03517228|593397842|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
164280842|NCT03517228|593397842|FG000|Overall Study|Canceled due to device being updated|1|||
164280843|NCT03517228|593397842|FG000|Overall Study|No V Cares in stock|1|||
164280844|NCT03517228|593397842|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
164280845|NCT03781414|593397852|FG000|Overall Study|Study terminated by sponsor|39|||
164280846|NCT03781414|593397853|FG001|Overall Study|Study terminated by sponsor|34|||
164280847|NCT03781414|593397854|FG002|Overall Study|Study terminated by sponsor|25|||
164280848|NCT03781414|593397852|FG000|Overall Study|Adverse Event|3|||
164280849|NCT03781414|593397853|FG001|Overall Study|Adverse Event|6|||
164280850|NCT03781414|593397854|FG002|Overall Study|Adverse Event|3|||
164280851|NCT03781414|593397852|FG000|Overall Study|Physician Decision|2|||
164280852|NCT03781414|593397853|FG001|Overall Study|Physician Decision|0|||
164280853|NCT03781414|593397854|FG002|Overall Study|Physician Decision|1|||
164280854|NCT03781414|593397852|FG000|Overall Study|Withdrawal by Subject|2|||
164280855|NCT03781414|593397853|FG001|Overall Study|Withdrawal by Subject|3|||
164280856|NCT03781414|593397854|FG002|Overall Study|Withdrawal by Subject|3|||
164280857|NCT03781414|593397852|FG000|Overall Study|Death|1|||
164280858|NCT03781414|593397853|FG001|Overall Study|Death|4|||
164280859|NCT03781414|593397854|FG002|Overall Study|Death|0|||
164280860|NCT03781414|593397852|FG000|Overall Study|Lost to Follow-up|1|||
164280861|NCT03781414|593397853|FG001|Overall Study|Lost to Follow-up|1|||
164280862|NCT03781414|593397854|FG002|Overall Study|Lost to Follow-up|0|||
164280863|NCT06041919|593397855|FG000|Overall Study|Lost to Follow-up|1|||
164280864|NCT06041919|593397856|FG001|Overall Study|Lost to Follow-up|0|||
164280865|NCT06041919|593397857|FG002|Overall Study|Lost to Follow-up|0|||
164280866|NCT06041919|593397858|FG003|Overall Study|Lost to Follow-up|0|||
164280867|NCT06041919|593397859|FG004|Overall Study|Lost to Follow-up|0|||
164344285|NCT01980940|593635424|FG001|Overall Study|Protocol Violation|0|||
164344286|NCT01980940|593635425|FG002|Overall Study|Protocol Violation|0|||
164584419|NCT00553787|594504647|FG000|Overall Study|Pregnancy|0|||
164584420|NCT00553787|594504648|FG001|Overall Study|Pregnancy|1|||
164280868|NCT06041919|593397855|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
164280869|NCT06041919|593397856|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
164280870|NCT06041919|593397857|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
164280871|NCT06041919|593397858|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
164280872|NCT06041919|593397859|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
164280873|NCT02576795|593397860|FG000|Overall Study|Lost to Follow-up|0|||
164280874|NCT02576795|593397861|FG001|Overall Study|Lost to Follow-up|0|||
164280875|NCT02576795|593397862|FG002|Overall Study|Lost to Follow-up|1|||
164280876|NCT02576795|593397863|FG003|Overall Study|Lost to Follow-up|0|||
164280877|NCT01620762|593397866|FG000|Overall Study|Protocol Violation|1|||
164280878|NCT01620762|593397867|FG001|Overall Study|Protocol Violation|1|||
164280879|NCT01620762|593397868|FG002|Overall Study|Protocol Violation|1|||
164344287|NCT01980940|593635426|FG003|Overall Study|Protocol Violation|0|||
164280880|NCT01620762|593397866|FG000|Overall Study|Adverse Event|9|||
164280881|NCT01620762|593397867|FG001|Overall Study|Adverse Event|5|||
164280882|NCT01620762|593397868|FG002|Overall Study|Adverse Event|2|||
164584421|NCT00553787|594504649|FG002|Overall Study|Pregnancy|2|||
164280883|NCT01620762|593397866|FG000|Overall Study|Withdrawal by Subject|23|||
164280884|NCT01620762|593397867|FG001|Overall Study|Withdrawal by Subject|26|||
164280885|NCT01620762|593397868|FG002|Overall Study|Withdrawal by Subject|27|||
164280886|NCT01620762|593397866|FG000|Overall Study|Lost to Follow-up|11|||
164280887|NCT01620762|593397867|FG001|Overall Study|Lost to Follow-up|17|||
164280888|NCT01620762|593397868|FG002|Overall Study|Lost to Follow-up|10|||
164280889|NCT01620762|593397866|FG000|Overall Study|Protocol deviation|1|||
164280890|NCT01620762|593397867|FG001|Overall Study|Protocol deviation|1|||
164280891|NCT01620762|593397868|FG002|Overall Study|Protocol deviation|6|||
164280892|NCT01620762|593397866|FG000|Overall Study|Subject deterioration|0|||
164280893|NCT01620762|593397867|FG001|Overall Study|Subject deterioration|1|||
164280894|NCT01620762|593397868|FG002|Overall Study|Subject deterioration|1|||
164280895|NCT01620762|593397866|FG000|Overall Study|Non-specified|3|||
164280896|NCT01620762|593397867|FG001|Overall Study|Non-specified|6|||
164280897|NCT01620762|593397868|FG002|Overall Study|Non-specified|5|||
164280898|NCT01620762|593397866|FG000|Overall Study|Use of prohibted therapies|0|||
164280899|NCT01620762|593397867|FG001|Overall Study|Use of prohibted therapies|1|||
164280900|NCT01620762|593397868|FG002|Overall Study|Use of prohibted therapies|1|||
164280901|NCT03664765|593397869|FG000|Overall Study|Withdrawal by Subject|4|||
164280902|NCT03664765|593397870|FG001|Overall Study|Withdrawal by Subject|1|||
164280903|NCT03664765|593397869|FG000|Overall Study|Lost to Follow-up|0|||
164280904|NCT03664765|593397870|FG001|Overall Study|Lost to Follow-up|1|||
164280905|NCT01128946|593397876|FG000|Period I|Protocol Violation|0|||
164280906|NCT01128946|593397877|FG001|Period I|Protocol Violation|1|||
164280907|NCT01128946|593397878|FG002|Period I|Protocol Violation|0|||
164280908|NCT01128946|593397879|FG003|Period I|Protocol Violation|0|||
164280909|NCT01128946|593397876|FG000|Period I|Withdrawal by Subject|0|||
164280910|NCT01128946|593397877|FG001|Period I|Withdrawal by Subject|0|||
164280911|NCT01128946|593397878|FG002|Period I|Withdrawal by Subject|1|||
164280912|NCT01128946|593397879|FG003|Period I|Withdrawal by Subject|1|||
164280913|NCT01128946|593397876|FG000|Period II|Protocol Violation|0|||
164280914|NCT01128946|593397877|FG001|Period II|Protocol Violation|1|||
164280915|NCT01128946|593397878|FG002|Period II|Protocol Violation|0|||
164280916|NCT01128946|593397879|FG003|Period II|Protocol Violation|0|||
164280917|NCT01128946|593397876|FG000|Period II|Withdrawal by Subject|0|||
164280918|NCT01128946|593397877|FG001|Period II|Withdrawal by Subject|0|||
164280919|NCT01128946|593397878|FG002|Period II|Withdrawal by Subject|0|||
164280920|NCT01128946|593397879|FG003|Period II|Withdrawal by Subject|1|||
164280921|NCT01128946|593397876|FG000|Period III|Protocol Violation|1|||
164280922|NCT01128946|593397877|FG001|Period III|Protocol Violation|0|||
164280923|NCT01128946|593397878|FG002|Period III|Protocol Violation|0|||
164280924|NCT01128946|593397879|FG003|Period III|Protocol Violation|0|||
164280925|NCT00527904|593397880|FG000|Overall Study|Adverse Event|45|||
164280926|NCT00527904|593397880|FG000|Overall Study|Withdrawal by Subject|21|||
164280927|NCT00527904|593397880|FG000|Overall Study|Lost to Follow-up|8|||
164280928|NCT00527904|593397880|FG000|Overall Study|misc|22|||
164280929|NCT02873338|593397884|FG000|Overall Study|Adverse Event|0|||
164280930|NCT02873338|593397885|FG001|Overall Study|Adverse Event|2|||
164280931|NCT02873338|593397886|FG002|Overall Study|Adverse Event|1|||
164280932|NCT02873338|593397884|FG000|Overall Study|Death|2|||
164280933|NCT02873338|593397885|FG001|Overall Study|Death|1|||
164280934|NCT02873338|593397886|FG002|Overall Study|Death|1|||
164280935|NCT02873338|593397884|FG000|Overall Study|Withdrawal by Subject|2|||
164280936|NCT02873338|593397885|FG001|Overall Study|Withdrawal by Subject|1|||
164280937|NCT02873338|593397886|FG002|Overall Study|Withdrawal by Subject|3|||
164280938|NCT02873338|593397884|FG000|Overall Study|Lack of Efficacy|0|||
164280939|NCT02873338|593397885|FG001|Overall Study|Lack of Efficacy|2|||
164280940|NCT02873338|593397886|FG002|Overall Study|Lack of Efficacy|0|||
164280941|NCT02873338|593397884|FG000|Overall Study|Other or Missing|14|||
164280942|NCT02873338|593397885|FG001|Overall Study|Other or Missing|15|||
164280943|NCT02873338|593397886|FG002|Overall Study|Other or Missing|13|||
164280944|NCT00766051|593397888|FG000|Overall Study|Withdrawal by Subject|2|||
164280945|NCT00766051|593397889|FG001|Overall Study|Withdrawal by Subject|0|||
164280946|NCT01320202|593397890|FG000|Overall Study|Adverse Event|5|||
164432812|NCT01194258|593954714|FG000|Titration Period|Lost to Follow-up|2|||
164432813|NCT01194258|593954715|FG001|Titration Period|Lost to Follow-up|0|||
164280947|NCT01320202|593397891|FG001|Overall Study|Adverse Event|5|||
164280948|NCT01320202|593397890|FG000|Overall Study|Death|5|||
164280949|NCT01320202|593397891|FG001|Overall Study|Death|3|||
164280950|NCT01320202|593397890|FG000|Overall Study|Lost to Follow-up|1|||
164280951|NCT01320202|593397891|FG001|Overall Study|Lost to Follow-up|0|||
164280952|NCT01320202|593397890|FG000|Overall Study|Physician Decision|3|||
164280953|NCT01320202|593397891|FG001|Overall Study|Physician Decision|1|||
164280954|NCT01320202|593397890|FG000|Overall Study|Protocol Violation|2|||
164280955|NCT01320202|593397891|FG001|Overall Study|Protocol Violation|1|||
164280956|NCT01320202|593397890|FG000|Overall Study|Withdrawal by Subject|10|||
164280957|NCT01320202|593397891|FG001|Overall Study|Withdrawal by Subject|3|||
164280958|NCT01320202|593397890|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
164280959|NCT01320202|593397891|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
164584422|NCT00553787|594504647|FG000|Overall Study|non compliance|4|||
164280960|NCT01320202|593397890|FG000|Overall Study|kidney transplant|1|||
164280961|NCT01320202|593397891|FG001|Overall Study|kidney transplant|2|||
164280962|NCT01320202|593397890|FG000|Overall Study|blood transfusion|1|||
164280963|NCT01320202|593397891|FG001|Overall Study|blood transfusion|7|||
164280964|NCT01320202|593397890|FG000|Overall Study|moved/changed dialysis|5|||
164280965|NCT01320202|593397891|FG001|Overall Study|moved/changed dialysis|2|||
164280966|NCT01320202|593397890|FG000|Overall Study|sponsor request|2|||
164280967|NCT01320202|593397891|FG001|Overall Study|sponsor request|0|||
164280968|NCT01320202|593397890|FG000|Overall Study|ineligible|3|||
164280969|NCT01320202|593397891|FG001|Overall Study|ineligible|0|||
164280970|NCT01320202|593397890|FG000|Overall Study|regained renal function|1|||
164280971|NCT01320202|593397891|FG001|Overall Study|regained renal function|0|||
164280972|NCT00635882|593397892|FG000|Overall Study|Protocol Violation|1|||
164280973|NCT00635882|593397893|FG001|Overall Study|Protocol Violation|0|||
164280974|NCT00635882|593397894|FG002|Overall Study|Protocol Violation|0|||
164280975|NCT00635882|593397895|FG003|Overall Study|Protocol Violation|0|||
164280976|NCT00635882|593397896|FG004|Overall Study|Protocol Violation|0|||
164280977|NCT00635882|593397897|FG005|Overall Study|Protocol Violation|0|||
164280978|NCT02006979|593397898|FG000|Overall Study|Withdrawal by Subject|1|||
164280979|NCT02006979|593397899|FG001|Overall Study|Withdrawal by Subject|1|||
164280980|NCT02006979|593397898|FG000|Overall Study|Protocol Violation|0|||
164280981|NCT02006979|593397899|FG001|Overall Study|Protocol Violation|1|||
164280982|NCT03477838|593397904|FG000|Overall Study|Lost to Follow-up|14|||
164280983|NCT04230213|593397911|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
164280984|NCT04230213|593397912|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
164280985|NCT04230213|593397913|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
164280986|NCT04230213|593397911|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
164280987|NCT04230213|593397912|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
164280988|NCT04230213|593397913|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
164280989|NCT04230213|593397911|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
164280990|NCT04230213|593397912|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
164280991|NCT04230213|593397913|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
164280992|NCT04230213|593397911|FG000|TP2: Week 10 to Week 16|Other|0|||
164280993|NCT04230213|593397912|FG001|TP2: Week 10 to Week 16|Other|2|||
164280994|NCT04230213|593397913|FG002|TP2: Week 10 to Week 16|Other|1|||
164280995|NCT04230213|593397911|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
164280996|NCT04230213|593397912|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
164280997|NCT04230213|593397913|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
164280998|NCT04230213|593397911|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
164280999|NCT04230213|593397912|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
164281000|NCT04230213|593397913|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
164281001|NCT04230213|593397911|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
164281002|NCT04230213|593397912|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
164281003|NCT04230213|593397913|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
164281004|NCT04230213|593397911|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
164281005|NCT04230213|593397912|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
164281006|NCT04230213|593397913|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
164281007|NCT04230213|593397911|FG000|TP3: Week 16 to Week 22|Other|0|||
164281008|NCT04230213|593397912|FG001|TP3: Week 16 to Week 22|Other|1|||
164281009|NCT04230213|593397913|FG002|TP3: Week 16 to Week 22|Other|3|||
164281010|NCT04230213|593397911|FG000|TP4: Week 22 to Week 32|Other|0|||
164281011|NCT04230213|593397912|FG001|TP4: Week 22 to Week 32|Other|5|||
164281012|NCT04230213|593397913|FG002|TP4: Week 22 to Week 32|Other|5|||
164281013|NCT04230213|593397911|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
164281014|NCT04230213|593397912|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
164281015|NCT04230213|593397913|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
164281016|NCT04230213|593397911|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
164281017|NCT04230213|593397912|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
164584423|NCT00553787|594504648|FG001|Overall Study|non compliance|0|||
164584424|NCT00553787|594504649|FG002|Overall Study|non compliance|11|||
164584425|NCT00553787|594504647|FG000|Overall Study|Requirement for restricted medication|8|||
164281018|NCT04230213|593397913|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
164281019|NCT04230213|593397911|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
164281020|NCT04230213|593397912|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
164281021|NCT04230213|593397913|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
164281022|NCT04230213|593397911|FG000|Follow up: Week 32 to Week 36|Other|0|||
164281023|NCT04230213|593397912|FG001|Follow up: Week 32 to Week 36|Other|1|||
164281024|NCT04230213|593397913|FG002|Follow up: Week 32 to Week 36|Other|1|||
164281025|NCT00619307|593397925|FG000|Overall Study|Adverse Event|0|||
164281026|NCT00619307|593397926|FG001|Overall Study|Adverse Event|1|||
164281027|NCT00619307|593397925|FG000|Overall Study|Lost to Follow-up|0|||
164281028|NCT00619307|593397926|FG001|Overall Study|Lost to Follow-up|1|||
164281029|NCT00619307|593397925|FG000|Overall Study|Protocol Violation|3|||
164281030|NCT00619307|593397926|FG001|Overall Study|Protocol Violation|0|||
164344288|NCT01980940|593635427|FG004|Overall Study|Protocol Violation|0|||
164281031|NCT00619307|593397925|FG000|Overall Study|Withdrew consent|1|||
164344289|NCT01980940|593635428|FG005|Overall Study|Protocol Violation|2|||
164344290|NCT01980940|593635429|FG006|Overall Study|Protocol Violation|0|||
164344291|NCT01980940|593635430|FG007|Overall Study|Protocol Violation|0|||
164344292|NCT00837811|593635431|FG000|Overall Study|Adverse Event|4|||
164344293|NCT00837811|593635432|FG001|Overall Study|Adverse Event|6|||
164344294|NCT00837811|593635433|FG002|Overall Study|Adverse Event|0|||
164344295|NCT00837811|593635431|FG000|Overall Study|Death|1|||
164344296|NCT00837811|593635432|FG001|Overall Study|Death|1|||
164344297|NCT00837811|593635433|FG002|Overall Study|Death|0|||
164344298|NCT00837811|593635431|FG000|Overall Study|Lack of Efficacy|0|||
164344299|NCT00837811|593635432|FG001|Overall Study|Lack of Efficacy|11|||
164344300|NCT00837811|593635433|FG002|Overall Study|Lack of Efficacy|0|||
164344301|NCT00837811|593635431|FG000|Overall Study|Lost to Follow-up|1|||
164344302|NCT00837811|593635432|FG001|Overall Study|Lost to Follow-up|3|||
164344303|NCT00837811|593635433|FG002|Overall Study|Lost to Follow-up|0|||
164344304|NCT00837811|593635431|FG000|Overall Study|Physician Decision|0|||
164344305|NCT00837811|593635432|FG001|Overall Study|Physician Decision|2|||
164344306|NCT00837811|593635433|FG002|Overall Study|Physician Decision|1|||
164344307|NCT00837811|593635431|FG000|Overall Study|Withdrawal by Subject|1|||
164344308|NCT00837811|593635432|FG001|Overall Study|Withdrawal by Subject|9|||
164344309|NCT00837811|593635433|FG002|Overall Study|Withdrawal by Subject|0|||
164344310|NCT00837811|593635431|FG000|Overall Study|Sponsor Decision|0|||
164344311|NCT00837811|593635432|FG001|Overall Study|Sponsor Decision|2|||
164344312|NCT00837811|593635433|FG002|Overall Study|Sponsor Decision|0|||
164344313|NCT00691015|593636910|FG000|Overall Study|Refused further treatment|1|||
164344314|NCT01397084|593636911|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
164344315|NCT01397084|593636911|FG000|Overall Study|Protocol Violation|2|||
164344316|NCT01397084|593636911|FG000|Overall Study|Adverse Event|2|||
164344317|NCT01397084|593636911|FG000|Overall Study|Withdrawal by Subject|1|||
164344318|NCT01397084|593636911|FG000|Overall Study|Lost to Follow-up|1|||
164344319|NCT01397084|593636911|FG000|Overall Study|Used other proton pump inhibitor|1|||
164344320|NCT04160195|593636914|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
164344321|NCT04160195|593636915|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
164344322|NCT03130257|593636918|FG000|Overall Study|Withdrawal by Subject|1|||
164344323|NCT03130257|593636919|FG001|Overall Study|Withdrawal by Subject|0|||
164344324|NCT03130257|593636920|FG002|Overall Study|Withdrawal by Subject|2|||
164344325|NCT03766581|593636921|FG000|Randomization|Other reasons|2|||
164344326|NCT03766581|593636922|FG001|Randomization|Other reasons|1|||
164344327|NCT03766581|593636923|FG002|Randomization|Other reasons|0|||
164344328|NCT03766581|593636924|FG003|Randomization|Other reasons|1|||
164344329|NCT03766581|593636925|FG004|Randomization|Other reasons|0|||
164344330|NCT03766581|593636926|FG005|Randomization|Other reasons|0|||
164344331|NCT03766581|593636927|FG006|Randomization|Other reasons|0|||
164584426|NCT00553787|594504648|FG001|Overall Study|Requirement for restricted medication|7|||
164584427|NCT00553787|594504649|FG002|Overall Study|Requirement for restricted medication|5|||
164584428|NCT00553787|594504647|FG000|Overall Study|Other|18|||
164584429|NCT00553787|594504648|FG001|Overall Study|Other|10|||
164584430|NCT00553787|594504649|FG002|Overall Study|Other|13|||
164584431|NCT00514449|594504650|FG000|Overall Study|Withdrawal by Subject|1|||
164584432|NCT00514449|594504651|FG001|Overall Study|Withdrawal by Subject|2|||
164584433|NCT00514449|594504650|FG000|Overall Study|Protocol Violation|1|||
164584434|NCT00514449|594504651|FG001|Overall Study|Protocol Violation|2|||
164584435|NCT00514449|594504650|FG000|Overall Study|Lost to Follow-up|1|||
164584436|NCT00514449|594504651|FG001|Overall Study|Lost to Follow-up|0|||
164584437|NCT00301067|594504653|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
164584438|NCT00301067|594504654|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
164584439|NCT00301067|594504655|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
164584440|NCT00301067|594504656|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
164584441|NCT00301067|594504653|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
164584442|NCT00301067|594504654|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
164584443|NCT00301067|594504655|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
164584444|NCT00301067|594504656|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
164584445|NCT00301067|594504653|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
164584446|NCT00301067|594504654|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
164584447|NCT00301067|594504655|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
164584448|NCT00301067|594504656|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
164584449|NCT00301067|594504653|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
164584450|NCT00301067|594504654|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
164584451|NCT00301067|594504655|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
164584452|NCT00301067|594504656|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
164344332|NCT03766581|593636928|FG007|Randomization|Other reasons|0|||
164344333|NCT03766581|593636921|FG000|Randomization|Participant no longer meets study criteria|5|||
164584453|NCT00301067|594504653|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
164584454|NCT00301067|594504654|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
164584455|NCT00301067|594504655|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
164584456|NCT00301067|594504656|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
164584457|NCT00301067|594504653|FG000|Follow up Until Death|Alive at last data cut point|1|||
164584458|NCT00301067|594504654|FG001|Follow up Until Death|Alive at last data cut point|0|||
164584459|NCT00301067|594504655|FG002|Follow up Until Death|Alive at last data cut point|0|||
164584460|NCT00301067|594504656|FG003|Follow up Until Death|Alive at last data cut point|1|||
164584461|NCT00149825|594504657|FG000|Overall Study|Intolerance to medication side effects|1|||
164584462|NCT00149825|594504658|FG001|Overall Study|Intolerance to medication side effects|2|||
164584463|NCT00149825|594504657|FG000|Overall Study|Time commitments|2|||
164584464|NCT00149825|594504658|FG001|Overall Study|Time commitments|1|||
164584465|NCT00149825|594504657|FG000|Overall Study|Not liking insomnia therapy|1|||
164584466|NCT00149825|594504658|FG001|Overall Study|Not liking insomnia therapy|0|||
164584467|NCT00149825|594504657|FG000|Overall Study|Other|1|||
164584468|NCT00149825|594504658|FG001|Overall Study|Other|0|||
164584469|NCT01457339|594504659|FG000|Period 3 (100 mg)|Adverse Event|0|||
164584470|NCT01457339|594504660|FG001|Period 3 (100 mg)|Adverse Event|1|||
164584471|NCT01457339|594504659|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
164584472|NCT01457339|594504660|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
164584473|NCT01457339|594504659|FG000|Period 6 (250 mg)|Family Emergency|1|||
164584474|NCT01457339|594504660|FG001|Period 6 (250 mg)|Family Emergency|0|||
164432814|NCT01194258|593954716|FG002|Titration Period|Lost to Follow-up|0|||
164432815|NCT01194258|593954717|FG003|Titration Period|Lost to Follow-up|0|||
164432816|NCT01194258|593954718|FG004|Titration Period|Lost to Follow-up|0|||
164432817|NCT01194258|593954714|FG000|Titration Period|Titration failure|3|||
164281032|NCT00619307|593397926|FG001|Overall Study|Withdrew consent|0|||
164281033|NCT00619307|593397925|FG000|Overall Study|Severe migraine|0|||
164281034|NCT00619307|593397926|FG001|Overall Study|Severe migraine|1|||
164281035|NCT00619307|593397925|FG000|Overall Study|MS attack plus steroids|0|||
164281036|NCT00619307|593397926|FG001|Overall Study|MS attack plus steroids|1|||
164281037|NCT00861471|593397929|FG000|Overall Study|Withdrawal by Subject|1|||
164281038|NCT00861471|593397929|FG000|Overall Study|Adverse Event|2|||
164281039|NCT00861471|593397929|FG000|Overall Study|Lack of Efficacy|3|||
164281040|NCT00861471|593397929|FG000|Overall Study|treatment for lumbar laminectomy|1|||
164281041|NCT00861471|593397929|FG000|Overall Study|Physician Decision|2|||
164281042|NCT02069392|593397932|FG000|Overall Study|Withdrawal by Subject|4|||
164281043|NCT02069392|593397933|FG001|Overall Study|Withdrawal by Subject|2|||
164281044|NCT00269633|593397934|FG000|Overall Study|Withdrawal by Subject|1|||
164281045|NCT00269633|593397935|FG001|Overall Study|Withdrawal by Subject|0|||
164281046|NCT01574651|593397936|FG000|Overall Study|Lost to Follow-up|2|||
164281047|NCT01574651|593397937|FG001|Overall Study|Lost to Follow-up|4|||
164281048|NCT01574651|593397936|FG000|Overall Study|Administrative problems|0|||
164281049|NCT01574651|593397937|FG001|Overall Study|Administrative problems|1|||
164281050|NCT01574651|593397936|FG000|Overall Study|Death|3|||
164281051|NCT01574651|593397937|FG001|Overall Study|Death|3|||
164281052|NCT01574651|593397936|FG000|Overall Study|Patient's inability to use the device|0|||
164281053|NCT01574651|593397937|FG001|Overall Study|Patient's inability to use the device|1|||
164281054|NCT01574651|593397936|FG000|Overall Study|Adverse Event|36|||
164281055|NCT01574651|593397937|FG001|Overall Study|Adverse Event|27|||
164281056|NCT01574651|593397936|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164281057|NCT01574651|593397937|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164281058|NCT01574651|593397936|FG000|Overall Study|Abnormal test procedure result(s)|1|||
164281059|NCT01574651|593397937|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164281060|NCT01574651|593397936|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
164281061|NCT01574651|593397937|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164281062|NCT01574651|593397936|FG000|Overall Study|Protocol Violation|3|||
164281063|NCT01574651|593397937|FG001|Overall Study|Protocol Violation|5|||
164281064|NCT01574651|593397936|FG000|Overall Study|Withdrawal by Subject|9|||
164281065|NCT01574651|593397937|FG001|Overall Study|Withdrawal by Subject|10|||
164281066|NCT04412707|593397938|FG000|Cycle 1|Death|0|||
164584475|NCT01457339|594504659|FG000|Period 6 (250 mg)|Personal appointment|0|||
164584476|NCT01457339|594504660|FG001|Period 6 (250 mg)|Personal appointment|1|||
164432818|NCT01194258|593954715|FG001|Titration Period|Titration failure|0|||
164432819|NCT01194258|593954716|FG002|Titration Period|Titration failure|0|||
164432820|NCT01194258|593954717|FG003|Titration Period|Titration failure|0|||
164432821|NCT01194258|593954718|FG004|Titration Period|Titration failure|0|||
164281067|NCT04412707|593397939|FG001|Cycle 1|Death|3|||
164281068|NCT04412707|593397938|FG000|Cycle 1|Disease progression|1|||
164281069|NCT04412707|593397939|FG001|Cycle 1|Disease progression|2|||
164281070|NCT04412707|593397938|FG000|Cycle 2|Death|0|||
164584477|NCT00995371|594504661|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
164432822|NCT01194258|593954714|FG000|Period 1 (12 Weeks)|Death|0|||
164584478|NCT00995371|594504662|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
164281071|NCT04412707|593397939|FG001|Cycle 2|Death|1|||
164281072|NCT04412707|593397938|FG000|Cycle 2|Disease progression|3|||
164432823|NCT01194258|593954715|FG001|Period 1 (12 Weeks)|Death|0|||
164432824|NCT01194258|593954716|FG002|Period 1 (12 Weeks)|Death|0|||
164432825|NCT01194258|593954717|FG003|Period 1 (12 Weeks)|Death|0|||
164432826|NCT01194258|593954718|FG004|Period 1 (12 Weeks)|Death|1|||
164432827|NCT01194258|593954714|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
164432828|NCT01194258|593954715|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
164432829|NCT01194258|593954716|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
164432830|NCT01194258|593954717|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
164432831|NCT01194258|593954718|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
164432832|NCT01194258|593954714|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
164432833|NCT01194258|593954715|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
164432834|NCT01194258|593954716|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
164432835|NCT01194258|593954717|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
164432836|NCT01194258|593954718|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
164432837|NCT01194258|593954714|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
164432838|NCT01194258|593954715|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
164432839|NCT01194258|593954716|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
164432840|NCT01194258|593954717|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
164432841|NCT01194258|593954718|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
164432842|NCT01467700|593954719|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
164432843|NCT01467700|593954720|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
164432844|NCT01467700|593954721|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
164432845|NCT01467700|593954722|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
164432846|NCT01467700|593954719|FG000|Overall Study|Major Protocol Deviation|3|||
164432847|NCT01467700|593954720|FG001|Overall Study|Major Protocol Deviation|3|||
164432848|NCT01467700|593954721|FG002|Overall Study|Major Protocol Deviation|2|||
164281073|NCT04412707|593397939|FG001|Cycle 2|Disease progression|0|||
164281074|NCT04412707|593397938|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
164281075|NCT04412707|593397939|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
164281076|NCT04412707|593397938|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
164281077|NCT04412707|593397939|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
164281078|NCT04412707|593397938|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
164281079|NCT04412707|593397939|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
164281080|NCT04412707|593397938|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
164281081|NCT04412707|593397939|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
164281082|NCT00855959|593400541|FG000|Overall Study|Adverse Event|2|||
164281083|NCT00855959|593400541|FG000|Overall Study|Lost to Follow-up|2|||
164281084|NCT00855959|593400541|FG000|Overall Study|Withdrawal by Subject|3|||
164281085|NCT00855959|593400541|FG000|Overall Study|Pregnancy|1|||
164281086|NCT00855959|593400541|FG000|Overall Study|Incorrect enrolment|1|||
164281087|NCT01424501|593400542|FG000|Overall Study|Withdrawal by Subject|1|||
164281088|NCT01424501|593400543|FG001|Overall Study|Withdrawal by Subject|0|||
164584479|NCT00306891|594504663|FG000|Part A|Withdrawal by Subject|1|||
164584480|NCT00306891|594504664|FG001|Part A|Withdrawal by Subject|1|||
164584481|NCT00306891|594504665|FG002|Part A|Withdrawal by Subject|0|||
164281089|NCT01424501|593400544|FG002|Overall Study|Withdrawal by Subject|1|||
164432849|NCT01467700|593954722|FG003|Overall Study|Major Protocol Deviation|3|||
164432850|NCT01467700|593954719|FG000|Overall Study|Lost to Follow-up|6|||
164432851|NCT01467700|593954720|FG001|Overall Study|Lost to Follow-up|5|||
164432852|NCT01467700|593954721|FG002|Overall Study|Lost to Follow-up|2|||
164584482|NCT00306891|594504666|FG003|Part A|Withdrawal by Subject|0|||
164584483|NCT00306891|594504663|FG000|Part A|Condition under investigation worsened|2|||
164584484|NCT00306891|594504664|FG001|Part A|Condition under investigation worsened|2|||
164584485|NCT00306891|594504665|FG002|Part A|Condition under investigation worsened|0|||
164584486|NCT00306891|594504666|FG003|Part A|Condition under investigation worsened|0|||
164584487|NCT00306891|594504663|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
164584488|NCT00306891|594504664|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
164584489|NCT00306891|594504665|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
164584490|NCT00306891|594504666|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
164584491|NCT00306891|594504663|FG000|Part A|Partial bowel obstruction|1|||
164584492|NCT00306891|594504664|FG001|Part A|Partial bowel obstruction|0|||
164584493|NCT00306891|594504665|FG002|Part A|Partial bowel obstruction|0|||
164584494|NCT00306891|594504666|FG003|Part A|Partial bowel obstruction|0|||
164584495|NCT00306891|594504663|FG000|Part A|Reaccumul. of ascites following drainage|0|||
164584496|NCT00306891|594504664|FG001|Part A|Reaccumul. of ascites following drainage|1|||
164584497|NCT00306891|594504665|FG002|Part A|Reaccumul. of ascites following drainage|0|||
164584498|NCT00306891|594504666|FG003|Part A|Reaccumul. of ascites following drainage|0|||
164584499|NCT00306891|594504663|FG000|Part A|Suspicion of second malignancy|0|||
164584500|NCT00306891|594504664|FG001|Part A|Suspicion of second malignancy|1|||
164432853|NCT01467700|593954722|FG003|Overall Study|Lost to Follow-up|3|||
164432854|NCT01467700|593954719|FG000|Overall Study|Voluntary Withdrawal|5|||
164432855|NCT01467700|593954720|FG001|Overall Study|Voluntary Withdrawal|7|||
164432856|NCT01467700|593954721|FG002|Overall Study|Voluntary Withdrawal|6|||
164432857|NCT01467700|593954722|FG003|Overall Study|Voluntary Withdrawal|2|||
164281090|NCT01424501|593400545|FG003|Overall Study|Withdrawal by Subject|0|||
164281091|NCT01424501|593400546|FG004|Overall Study|Withdrawal by Subject|0|||
164281092|NCT01424501|593400547|FG005|Overall Study|Withdrawal by Subject|0|||
164281093|NCT01424501|593400542|FG000|Overall Study|Lost to Follow-up|0|||
164281094|NCT01424501|593400543|FG001|Overall Study|Lost to Follow-up|1|||
164281095|NCT01424501|593400544|FG002|Overall Study|Lost to Follow-up|1|||
164281096|NCT01424501|593400545|FG003|Overall Study|Lost to Follow-up|0|||
164281097|NCT01424501|593400546|FG004|Overall Study|Lost to Follow-up|0|||
164281098|NCT01424501|593400547|FG005|Overall Study|Lost to Follow-up|0|||
164281099|NCT00699608|593400548|FG000|First Intervention|Withdrawal by Subject|0|||
164281100|NCT00699608|593400549|FG001|First Intervention|Withdrawal by Subject|0|||
164281101|NCT00699608|593400550|FG002|First Intervention|Withdrawal by Subject|1|||
164281102|NCT00699608|593400551|FG003|First Intervention|Withdrawal by Subject|0|||
164281103|NCT00699608|593400552|FG004|First Intervention|Withdrawal by Subject|0|||
164432858|NCT01467700|593954719|FG000|Overall Study|Study Termination|6|||
164432859|NCT01467700|593954720|FG001|Overall Study|Study Termination|5|||
164432860|NCT01467700|593954721|FG002|Overall Study|Study Termination|10|||
164432861|NCT01467700|593954722|FG003|Overall Study|Study Termination|7|||
164432862|NCT01467700|593954719|FG000|Overall Study|Pregnancy|0|||
164432863|NCT01467700|593954720|FG001|Overall Study|Pregnancy|1|||
164432864|NCT01467700|593954721|FG002|Overall Study|Pregnancy|1|||
164432865|NCT01467700|593954722|FG003|Overall Study|Pregnancy|0|||
164432866|NCT01467700|593954719|FG000|Overall Study|Lack of Efficacy|2|||
164432867|NCT01467700|593954720|FG001|Overall Study|Lack of Efficacy|0|||
164432868|NCT01467700|593954721|FG002|Overall Study|Lack of Efficacy|2|||
164432869|NCT01467700|593954722|FG003|Overall Study|Lack of Efficacy|1|||
164432870|NCT01467700|593954719|FG000|Overall Study|Reason not Specified|1|||
164432871|NCT01467700|593954720|FG001|Overall Study|Reason not Specified|3|||
164432872|NCT01467700|593954721|FG002|Overall Study|Reason not Specified|2|||
164281104|NCT00699608|593400553|FG005|First Intervention|Withdrawal by Subject|0|||
164281105|NCT00699608|593400548|FG000|First Intervention|Protocol Violation|0|||
164281106|NCT00699608|593400549|FG001|First Intervention|Protocol Violation|0|||
164281107|NCT00699608|593400550|FG002|First Intervention|Protocol Violation|0|||
164281108|NCT00699608|593400551|FG003|First Intervention|Protocol Violation|0|||
164281109|NCT00699608|593400552|FG004|First Intervention|Protocol Violation|1|||
164281110|NCT00699608|593400553|FG005|First Intervention|Protocol Violation|0|||
164281111|NCT00699608|593400548|FG000|Second Intervention|Adverse Event|0|||
164281112|NCT00699608|593400549|FG001|Second Intervention|Adverse Event|0|||
164281113|NCT00699608|593400550|FG002|Second Intervention|Adverse Event|1|||
164281114|NCT00699608|593400551|FG003|Second Intervention|Adverse Event|0|||
164281115|NCT00699608|593400552|FG004|Second Intervention|Adverse Event|0|||
164281116|NCT00699608|593400553|FG005|Second Intervention|Adverse Event|0|||
164281117|NCT00699608|593400548|FG000|Second Intervention|Withdrawal by Subject|0|||
164281118|NCT00699608|593400549|FG001|Second Intervention|Withdrawal by Subject|0|||
164281119|NCT00699608|593400550|FG002|Second Intervention|Withdrawal by Subject|0|||
164281120|NCT00699608|593400551|FG003|Second Intervention|Withdrawal by Subject|1|||
164281121|NCT00699608|593400552|FG004|Second Intervention|Withdrawal by Subject|0|||
164281122|NCT00699608|593400553|FG005|Second Intervention|Withdrawal by Subject|0|||
164432873|NCT01467700|593954722|FG003|Overall Study|Reason not Specified|8|||
164432874|NCT00121199|593954725|FG000|Overall Study|Adverse Event|11|||
164432875|NCT00121199|593954725|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
164432876|NCT00121199|593954725|FG000|Overall Study|Progression/Relapse|1|||
164432877|NCT00121199|593954725|FG000|Overall Study|Death|3|||
164432878|NCT00121199|593954725|FG000|Overall Study|Other - Not Protocol Specified|3|||
164281123|NCT04306510|593400558|FG000|Overall Study|Voluntarily withdrawal|1|||
164281124|NCT04306510|593400558|FG000|Overall Study|Enrolled but Not Treated|1|||
164281125|NCT04720417|593400559|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
164281126|NCT03329092|593400560|FG000|Overall Study|Other|2|||
164281127|NCT03329092|593400561|FG001|Overall Study|Other|2|||
164281128|NCT03329092|593400560|FG000|Overall Study|Withdrawal by Subject|16|||
164281129|NCT03329092|593400561|FG001|Overall Study|Withdrawal by Subject|3|||
164281130|NCT03329092|593400560|FG000|Overall Study|Physician Decision|1|||
164584501|NCT00306891|594504665|FG002|Part A|Suspicion of second malignancy|0|||
164584502|NCT00306891|594504666|FG003|Part A|Suspicion of second malignancy|0|||
164584503|NCT00306891|594504663|FG000|Part A|QTC interval outwith elig. criteria|1|||
164281131|NCT03329092|593400561|FG001|Overall Study|Physician Decision|0|||
164281132|NCT03329092|593400560|FG000|Overall Study|Death|17|||
164281133|NCT03329092|593400561|FG001|Overall Study|Death|11|||
164281134|NCT03329092|593400560|FG000|Overall Study|Adverse Event|3|||
164281135|NCT03329092|593400561|FG001|Overall Study|Adverse Event|1|||
164281136|NCT03329092|593400560|FG000|Overall Study|Lost to Follow-up|1|||
164281137|NCT03329092|593400561|FG001|Overall Study|Lost to Follow-up|1|||
164432879|NCT00121199|593954725|FG000|Overall Study|Ineligible|9|||
164432880|NCT03168438|593954726|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
164432881|NCT03168438|593954727|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
164432882|NCT01348087|593954731|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
164281138|NCT04878211|593400562|FG000|Overall Study|Lost to Follow-up|0|||
164281139|NCT04878211|593400563|FG001|Overall Study|Lost to Follow-up|0|||
164281140|NCT04878211|593400564|FG002|Overall Study|Lost to Follow-up|0|||
164281141|NCT04878211|593400565|FG003|Overall Study|Lost to Follow-up|1|||
164281142|NCT04878211|593400566|FG004|Overall Study|Lost to Follow-up|0|||
164281143|NCT04878211|593400567|FG005|Overall Study|Lost to Follow-up|1|||
164281144|NCT04878211|593400562|FG000|Overall Study|Protocol deviation|1|||
164281145|NCT04878211|593400563|FG001|Overall Study|Protocol deviation|0|||
164281146|NCT04878211|593400564|FG002|Overall Study|Protocol deviation|0|||
164281147|NCT04878211|593400565|FG003|Overall Study|Protocol deviation|0|||
164281148|NCT04878211|593400566|FG004|Overall Study|Protocol deviation|0|||
164281149|NCT04878211|593400567|FG005|Overall Study|Protocol deviation|0|||
164281150|NCT04878211|593400562|FG000|Overall Study|Study terminated by sponsor|0|||
164281151|NCT04878211|593400563|FG001|Overall Study|Study terminated by sponsor|0|||
164281152|NCT04878211|593400564|FG002|Overall Study|Study terminated by sponsor|0|||
164281153|NCT04878211|593400565|FG003|Overall Study|Study terminated by sponsor|0|||
164281154|NCT04878211|593400566|FG004|Overall Study|Study terminated by sponsor|9|||
164281155|NCT04878211|593400567|FG005|Overall Study|Study terminated by sponsor|4|||
164281156|NCT04878211|593400562|FG000|Overall Study|Subject decision|0|||
164281157|NCT04878211|593400563|FG001|Overall Study|Subject decision|0|||
164281158|NCT04878211|593400564|FG002|Overall Study|Subject decision|0|||
164281159|NCT04878211|593400565|FG003|Overall Study|Subject decision|0|||
164281160|NCT04878211|593400566|FG004|Overall Study|Subject decision|1|||
164281161|NCT04878211|593400567|FG005|Overall Study|Subject decision|0|||
164281162|NCT03574779|593400568|FG000|Overall Study|Screening failure|13|||
164281163|NCT03574779|593400569|FG001|Overall Study|Screening failure|83|||
164432883|NCT01348087|593954731|FG000|Overall Study|Administrative problems|79|||
164432884|NCT01348087|593954731|FG000|Overall Study|protocol deviation|1|||
164432885|NCT01348087|593954731|FG000|Overall Study|Lost to Follow-up|1|||
164432886|NCT01348087|593954731|FG000|Overall Study|Subject withdrew consent|7|||
164432887|NCT01348087|593954731|FG000|Overall Study|Adverse Event|25|||
164432888|NCT02081391|593954734|FG000|12-hour Treatment|Withdrawal by Subject|3|||
164432889|NCT02081391|593954735|FG001|12-hour Treatment|Withdrawal by Subject|2|||
164584504|NCT00306891|594504664|FG001|Part A|QTC interval outwith elig. criteria|0|||
164281164|NCT00856544|593400570|FG000|Overall Study|Randomized but not treated|3|||
164281165|NCT00856544|593400571|FG001|Overall Study|Randomized but not treated|0|||
164281166|NCT00856544|593400572|FG002|Overall Study|Randomized but not treated|0|||
164344334|NCT03766581|593636922|FG001|Randomization|Participant no longer meets study criteria|3|||
164344335|NCT03766581|593636923|FG002|Randomization|Participant no longer meets study criteria|4|||
164344336|NCT03766581|593636924|FG003|Randomization|Participant no longer meets study criteria|0|||
164344337|NCT03766581|593636925|FG004|Randomization|Participant no longer meets study criteria|2|||
164344338|NCT03766581|593636926|FG005|Randomization|Participant no longer meets study criteria|3|||
164344339|NCT03766581|593636927|FG006|Randomization|Participant no longer meets study criteria|0|||
164344340|NCT03766581|593636928|FG007|Randomization|Participant no longer meets study criteria|1|||
164344341|NCT03766581|593636921|FG000|Randomization|Participant request to discontinue study treatment|1|||
164344342|NCT03766581|593636922|FG001|Randomization|Participant request to discontinue study treatment|0|||
164344343|NCT03766581|593636923|FG002|Randomization|Participant request to discontinue study treatment|0|||
164344344|NCT03766581|593636924|FG003|Randomization|Participant request to discontinue study treatment|0|||
164344345|NCT03766581|593636925|FG004|Randomization|Participant request to discontinue study treatment|1|||
164344346|NCT03766581|593636926|FG005|Randomization|Participant request to discontinue study treatment|2|||
164344347|NCT03766581|593636927|FG006|Randomization|Participant request to discontinue study treatment|0|||
164344348|NCT03766581|593636928|FG007|Randomization|Participant request to discontinue study treatment|0|||
164344349|NCT03766581|593636921|FG000|Randomization|Participant withdrew consent|1|||
164344350|NCT03766581|593636922|FG001|Randomization|Participant withdrew consent|0|||
164584505|NCT00306891|594504665|FG002|Part A|QTC interval outwith elig. criteria|0|||
164344351|NCT03766581|593636923|FG002|Randomization|Participant withdrew consent|1|||
164432890|NCT02081391|593954736|FG002|12-hour Treatment|Withdrawal by Subject|0|||
164584506|NCT00306891|594504666|FG003|Part A|QTC interval outwith elig. criteria|0|||
164584507|NCT00306891|594504663|FG000|Part B|Death|0|||
164584508|NCT00306891|594504664|FG001|Part B|Death|0|||
164584509|NCT00306891|594504665|FG002|Part B|Death|1|||
164584510|NCT00306891|594504666|FG003|Part B|Death|2|||
164584511|NCT00306891|594504663|FG000|Part B|Adverse Event|0|||
164584512|NCT00306891|594504664|FG001|Part B|Adverse Event|0|||
164584513|NCT00306891|594504665|FG002|Part B|Adverse Event|5|||
164584514|NCT00306891|594504666|FG003|Part B|Adverse Event|5|||
164584515|NCT00306891|594504663|FG000|Part B|Withdrawal by Subject|0|||
164584516|NCT00306891|594504664|FG001|Part B|Withdrawal by Subject|0|||
164584517|NCT00306891|594504665|FG002|Part B|Withdrawal by Subject|3|||
164281167|NCT00856544|593400573|FG003|Overall Study|Randomized but not treated|0|||
164281168|NCT00856544|593400570|FG000|Overall Study|Death|0|||
164281169|NCT00856544|593400571|FG001|Overall Study|Death|2|||
164281170|NCT00856544|593400572|FG002|Overall Study|Death|0|||
164281171|NCT00856544|593400573|FG003|Overall Study|Death|0|||
164281172|NCT00856544|593400570|FG000|Overall Study|Adverse Event|20|||
164584518|NCT00306891|594504666|FG003|Part B|Withdrawal by Subject|1|||
164432891|NCT02081391|593954737|FG003|12-hour Treatment|Withdrawal by Subject|0|||
164432892|NCT02081391|593954734|FG000|12-hour Treatment|Physician Decision|4|||
164432893|NCT02081391|593954735|FG001|12-hour Treatment|Physician Decision|1|||
164281173|NCT00856544|593400571|FG001|Overall Study|Adverse Event|29|||
164281174|NCT00856544|593400572|FG002|Overall Study|Adverse Event|2|||
164281175|NCT00856544|593400573|FG003|Overall Study|Adverse Event|3|||
164281176|NCT00856544|593400570|FG000|Overall Study|Lack of Efficacy|16|||
164281177|NCT00856544|593400571|FG001|Overall Study|Lack of Efficacy|12|||
164281178|NCT00856544|593400572|FG002|Overall Study|Lack of Efficacy|3|||
164432894|NCT02081391|593954736|FG002|12-hour Treatment|Physician Decision|0|||
164432895|NCT02081391|593954737|FG003|12-hour Treatment|Physician Decision|0|||
164432896|NCT02081391|593954734|FG000|12-hour Treatment|Lack of Efficacy|3|||
164281179|NCT00856544|593400573|FG003|Overall Study|Lack of Efficacy|3|||
164281180|NCT00856544|593400570|FG000|Overall Study|Other|9|||
164281181|NCT00856544|593400571|FG001|Overall Study|Other|16|||
164281182|NCT00856544|593400572|FG002|Overall Study|Other|1|||
164281183|NCT00856544|593400573|FG003|Overall Study|Other|6|||
164281184|NCT00856544|593400570|FG000|Overall Study|Lost to Follow-up|1|||
164281185|NCT00856544|593400571|FG001|Overall Study|Lost to Follow-up|2|||
164281186|NCT00856544|593400572|FG002|Overall Study|Lost to Follow-up|2|||
164281187|NCT00856544|593400573|FG003|Overall Study|Lost to Follow-up|0|||
164281188|NCT00856544|593400570|FG000|Overall Study|Withdrawal by Subject|8|||
164281189|NCT00856544|593400571|FG001|Overall Study|Withdrawal by Subject|5|||
164281190|NCT00856544|593400572|FG002|Overall Study|Withdrawal by Subject|0|||
164281191|NCT00856544|593400573|FG003|Overall Study|Withdrawal by Subject|1|||
164281192|NCT03755882|593400574|FG000|Period 1|Protocol Violation|1|||
164281193|NCT03755882|593400575|FG001|Period 1|Protocol Violation|0|||
164281194|NCT03755882|593400574|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
164281195|NCT03755882|593400575|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
164281196|NCT00377858|593400582|FG000|Overall Study|Withdrawal by Subject|12|||
164281197|NCT00377858|593400583|FG001|Overall Study|Withdrawal by Subject|11|||
164281198|NCT00377858|593400582|FG000|Overall Study|Lost to Follow-up|6|||
164281199|NCT00377858|593400583|FG001|Overall Study|Lost to Follow-up|1|||
164281200|NCT00377858|593400582|FG000|Overall Study|Physician Decision|5|||
164281201|NCT00377858|593400583|FG001|Overall Study|Physician Decision|5|||
164281202|NCT00377858|593400582|FG000|Overall Study|Protocol Violation|3|||
164281203|NCT00377858|593400583|FG001|Overall Study|Protocol Violation|4|||
164281204|NCT00377858|593400582|FG000|Overall Study|Adverse Event|2|||
164281205|NCT00377858|593400583|FG001|Overall Study|Adverse Event|1|||
164281206|NCT00377858|593400582|FG000|Overall Study|Entry Criteria Not Met|2|||
164281207|NCT00377858|593400583|FG001|Overall Study|Entry Criteria Not Met|0|||
164281208|NCT00377858|593400582|FG000|Overall Study|Sponsor Decision|1|||
164281209|NCT00377858|593400583|FG001|Overall Study|Sponsor Decision|2|||
164281210|NCT00377858|593400582|FG000|Overall Study|Death|0|||
164281211|NCT00377858|593400583|FG001|Overall Study|Death|3|||
164281212|NCT02506192|593400584|FG000|Overall Study|Withdrawal by Subject|1|||
164281213|NCT02506192|593400585|FG001|Overall Study|Withdrawal by Subject|1|||
164281214|NCT04042909|593400586|FG000|Overall Study|Withdrawal by Subject|1|||
164281215|NCT04042909|593400587|FG001|Overall Study|Withdrawal by Subject|0|||
164281216|NCT04042909|593400588|FG002|Overall Study|Withdrawal by Subject|0|||
164281217|NCT04042909|593400586|FG000|Overall Study|duplicate cases|2|||
164281218|NCT04042909|593400587|FG001|Overall Study|duplicate cases|0|||
164281219|NCT04042909|593400588|FG002|Overall Study|duplicate cases|0|||
164281220|NCT04042909|593400586|FG000|Overall Study|technical problem|0|||
164281221|NCT04042909|593400587|FG001|Overall Study|technical problem|1|||
164281222|NCT04042909|593400588|FG002|Overall Study|technical problem|0|||
164281223|NCT06312592|593400589|FG000|Overall Study|Lost to Follow-up|29|||
164281224|NCT06312592|593400590|FG001|Overall Study|Lost to Follow-up|13|||
164281225|NCT03785405|593400591|FG000|Overall Study|Adverse Event|16|||
164281226|NCT03785405|593400592|FG001|Overall Study|Adverse Event|1|||
164281227|NCT03785405|593400591|FG000|Overall Study|Death|6|||
164281228|NCT03785405|593400592|FG001|Overall Study|Death|4|||
164432897|NCT02081391|593954735|FG001|12-hour Treatment|Lack of Efficacy|0|||
164432898|NCT02081391|593954736|FG002|12-hour Treatment|Lack of Efficacy|0|||
164432899|NCT02081391|593954737|FG003|12-hour Treatment|Lack of Efficacy|0|||
164281229|NCT03785405|593400591|FG000|Overall Study|Guardian decision|4|||
164281230|NCT03785405|593400592|FG001|Overall Study|Guardian decision|1|||
164281231|NCT03785405|593400591|FG000|Overall Study|Lost to Follow-up|1|||
164281232|NCT03785405|593400592|FG001|Overall Study|Lost to Follow-up|0|||
164281233|NCT03785405|593400591|FG000|Overall Study|Physician Decision|8|||
164281234|NCT03785405|593400592|FG001|Overall Study|Physician Decision|5|||
164281235|NCT03785405|593400591|FG000|Overall Study|Participant decision|2|||
164281236|NCT03785405|593400592|FG001|Overall Study|Participant decision|0|||
164281237|NCT03785405|593400591|FG000|Overall Study|Other|1|||
164281238|NCT03785405|593400592|FG001|Overall Study|Other|0|||
164281239|NCT03785405|593400591|FG000|Overall Study|No treatment was received|0|||
164281240|NCT03785405|593400592|FG001|Overall Study|No treatment was received|1|||
164281241|NCT03705559|593400593|FG000|Overall Study|COVID Shut down|1|||
164432900|NCT02081391|593954734|FG000|12-hour Treatment|Adverse Event|4|||
164432901|NCT02081391|593954735|FG001|12-hour Treatment|Adverse Event|2|||
164281242|NCT01147055|593400594|FG000|First Intervention Period|Lost to Follow-up|1|||
164281243|NCT01147055|593400595|FG001|First Intervention Period|Lost to Follow-up|0|||
164281244|NCT03724890|593400596|FG000|Overall Study|Death|2|||
164281245|NCT03724890|593400597|FG001|Overall Study|Death|6|||
164281246|NCT03724890|593400598|FG002|Overall Study|Death|3|||
164281247|NCT03724890|593400599|FG003|Overall Study|Death|5|||
164281248|NCT03724890|593400600|FG004|Overall Study|Death|2|||
164281249|NCT03724890|593400601|FG005|Overall Study|Death|0|||
164281250|NCT03724890|593400602|FG006|Overall Study|Death|2|||
164281251|NCT03724890|593400603|FG007|Overall Study|Death|3|||
164281252|NCT03724890|593400604|FG008|Overall Study|Death|4|||
164584519|NCT00306891|594504663|FG000|Part B|Condition under investigation worsened|0|||
164584520|NCT00306891|594504664|FG001|Part B|Condition under investigation worsened|0|||
164584521|NCT00306891|594504665|FG002|Part B|Condition under investigation worsened|2|||
164584522|NCT00306891|594504666|FG003|Part B|Condition under investigation worsened|8|||
164584523|NCT00306891|594504663|FG000|Part B|Development of study specific disc crit.|0|||
164584524|NCT00306891|594504664|FG001|Part B|Development of study specific disc crit.|0|||
164584525|NCT00306891|594504665|FG002|Part B|Development of study specific disc crit.|0|||
164584526|NCT00306891|594504666|FG003|Part B|Development of study specific disc crit.|1|||
164584527|NCT00673673|594504667|FG000|Overall Study|Progressive disease|27|||
164584528|NCT00673673|594504667|FG000|Overall Study|Adverse Event|4|||
164584529|NCT00673673|594504667|FG000|Overall Study|Withdrawal by Subject|3|||
164584530|NCT00673673|594504667|FG000|Overall Study|Investigators' discretion|2|||
164584531|NCT04538950|594504676|FG000|Overall Study|Pulmonary Issues|2|||
164584532|NCT04538950|594504676|FG000|Overall Study|illness|2|||
164584533|NCT04579393|594504679|FG000|Overall Study|Withdrawal by Subject|2|||
164584534|NCT04579393|594504680|FG001|Overall Study|Withdrawal by Subject|2|||
164584535|NCT04579393|594504679|FG000|Overall Study|Death|1|||
164584536|NCT04579393|594504680|FG001|Overall Study|Death|3|||
164584537|NCT01282814|594504683|FG000|First Intervention|Emesis During Dosing Interval|0|||
164584538|NCT01282814|594504684|FG001|First Intervention|Emesis During Dosing Interval|3|||
164281253|NCT03724890|593400605|FG009|Overall Study|Death|2|||
164281254|NCT03724890|593400606|FG010|Overall Study|Death|2|||
164281255|NCT03724890|593400596|FG000|Overall Study|Lost to Follow-up|0|||
164281256|NCT03724890|593400597|FG001|Overall Study|Lost to Follow-up|3|||
164281257|NCT03724890|593400598|FG002|Overall Study|Lost to Follow-up|0|||
164281258|NCT03724890|593400599|FG003|Overall Study|Lost to Follow-up|1|||
164281259|NCT03724890|593400600|FG004|Overall Study|Lost to Follow-up|2|||
164281260|NCT03724890|593400601|FG005|Overall Study|Lost to Follow-up|2|||
164281261|NCT03724890|593400602|FG006|Overall Study|Lost to Follow-up|1|||
164281262|NCT03724890|593400603|FG007|Overall Study|Lost to Follow-up|0|||
164281263|NCT03724890|593400604|FG008|Overall Study|Lost to Follow-up|2|||
164281264|NCT03724890|593400605|FG009|Overall Study|Lost to Follow-up|0|||
164281265|NCT03724890|593400606|FG010|Overall Study|Lost to Follow-up|0|||
164281266|NCT03724890|593400596|FG000|Overall Study|Withdrawal by Subject|1|||
164281267|NCT03724890|593400597|FG001|Overall Study|Withdrawal by Subject|2|||
164584539|NCT01282814|594504683|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
164584540|NCT01282814|594504684|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
164584541|NCT02704429|594504687|FG000|Part A: 24 Weeks|Adverse Event|3|||
164584542|NCT02704429|594504688|FG001|Part A: 24 Weeks|Adverse Event|0|||
164584543|NCT02704429|594504687|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
164584544|NCT02704429|594504688|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
164584545|NCT00104104|594504689|FG000|Overall Study|Adverse Event|8|||
164584546|NCT00104104|594504690|FG001|Overall Study|Adverse Event|8|||
164584547|NCT00104104|594504689|FG000|Overall Study|Abnormal laboratory value(s)|20|||
164584548|NCT00104104|594504690|FG001|Overall Study|Abnormal laboratory value(s)|14|||
164584549|NCT00104104|594504689|FG000|Overall Study|Lack of Efficacy|0|||
164584550|NCT00104104|594504690|FG001|Overall Study|Lack of Efficacy|3|||
164584551|NCT00104104|594504689|FG000|Overall Study|Condition no longer requires study drug|7|||
164584552|NCT00104104|594504690|FG001|Overall Study|Condition no longer requires study drug|4|||
164584553|NCT00104104|594504689|FG000|Overall Study|Protocol Violation|5|||
164584554|NCT00104104|594504690|FG001|Overall Study|Protocol Violation|2|||
164584555|NCT00104104|594504689|FG000|Overall Study|Withdrawal by Subject|11|||
164584556|NCT00104104|594504690|FG001|Overall Study|Withdrawal by Subject|15|||
164281268|NCT03724890|593400598|FG002|Overall Study|Withdrawal by Subject|1|||
164281269|NCT03724890|593400599|FG003|Overall Study|Withdrawal by Subject|0|||
164584557|NCT00104104|594504689|FG000|Overall Study|Lost to Follow-up|3|||
164584558|NCT00104104|594504690|FG001|Overall Study|Lost to Follow-up|7|||
164584559|NCT00104104|594504689|FG000|Overall Study|Administrative problems|12|||
164584560|NCT00104104|594504690|FG001|Overall Study|Administrative problems|13|||
164281270|NCT03724890|593400600|FG004|Overall Study|Withdrawal by Subject|0|||
164281271|NCT03724890|593400601|FG005|Overall Study|Withdrawal by Subject|1|||
164281272|NCT03724890|593400602|FG006|Overall Study|Withdrawal by Subject|0|||
164281273|NCT03724890|593400603|FG007|Overall Study|Withdrawal by Subject|0|||
164281274|NCT03724890|593400604|FG008|Overall Study|Withdrawal by Subject|2|||
164584561|NCT00104104|594504689|FG000|Overall Study|Death|9|||
164584562|NCT00104104|594504690|FG001|Overall Study|Death|6|||
164281275|NCT03724890|593400605|FG009|Overall Study|Withdrawal by Subject|2|||
164281276|NCT03724890|593400606|FG010|Overall Study|Withdrawal by Subject|1|||
164281277|NCT03724890|593400596|FG000|Overall Study|Other|1|||
164281278|NCT03724890|593400597|FG001|Overall Study|Other|0|||
164281279|NCT03724890|593400598|FG002|Overall Study|Other|0|||
164281280|NCT03724890|593400599|FG003|Overall Study|Other|0|||
164281281|NCT03724890|593400600|FG004|Overall Study|Other|0|||
164281282|NCT03724890|593400601|FG005|Overall Study|Other|0|||
164281283|NCT03724890|593400602|FG006|Overall Study|Other|0|||
164281284|NCT03724890|593400603|FG007|Overall Study|Other|1|||
164281285|NCT03724890|593400604|FG008|Overall Study|Other|1|||
164281286|NCT03724890|593400605|FG009|Overall Study|Other|0|||
164281287|NCT03724890|593400606|FG010|Overall Study|Other|2|||
164281288|NCT02362464|593400608|FG000|Overall Study|Switched to alternative therapy|1|||
164281289|NCT02362464|593400608|FG000|Overall Study|Refused further treatment|1|||
164281290|NCT02362464|593400608|FG000|Overall Study|Physician Decision|4|||
164281291|NCT02123823|593400609|FG000|Overall Study|Lack of Efficacy|0|||
164281292|NCT02123823|593400610|FG001|Overall Study|Lack of Efficacy|2|||
164281293|NCT02123823|593400611|FG002|Overall Study|Lack of Efficacy|8|||
164281294|NCT02123823|593400612|FG003|Overall Study|Lack of Efficacy|10|||
164281295|NCT02123823|593400609|FG000|Overall Study|Progressive disease|3|||
164281296|NCT02123823|593400610|FG001|Overall Study|Progressive disease|19|||
164281297|NCT02123823|593400611|FG002|Overall Study|Progressive disease|52|||
164281298|NCT02123823|593400612|FG003|Overall Study|Progressive disease|53|||
164281299|NCT02123823|593400609|FG000|Overall Study|Withdrawal by Subject|0|||
164281300|NCT02123823|593400610|FG001|Overall Study|Withdrawal by Subject|0|||
164281301|NCT02123823|593400611|FG002|Overall Study|Withdrawal by Subject|7|||
164281302|NCT02123823|593400612|FG003|Overall Study|Withdrawal by Subject|2|||
164281303|NCT02123823|593400609|FG000|Overall Study|Adverse Event|0|||
164281304|NCT02123823|593400610|FG001|Overall Study|Adverse Event|0|||
164281305|NCT02123823|593400611|FG002|Overall Study|Adverse Event|3|||
164281306|NCT02123823|593400612|FG003|Overall Study|Adverse Event|5|||
164281307|NCT01635855|593400647|FG000|Overall Study|Withdrawal by Subject|4|||
164281308|NCT02104947|593400650|FG000|Overall Study|Withdrawal by Subject|10|||
164281309|NCT02104947|593400651|FG001|Overall Study|Withdrawal by Subject|3|||
164281310|NCT02104947|593400650|FG000|Overall Study|Lost to Follow-up|4|||
164281311|NCT02104947|593400651|FG001|Overall Study|Lost to Follow-up|4|||
164281312|NCT02104947|593400650|FG000|Overall Study|Protocol Violation|6|||
164281313|NCT02104947|593400651|FG001|Overall Study|Protocol Violation|8|||
164281314|NCT02104947|593400650|FG000|Overall Study|Adverse Event|57|||
164281315|NCT02104947|593400651|FG001|Overall Study|Adverse Event|38|||
164281316|NCT02104947|593400650|FG000|Overall Study|Other than stated above|2|||
164281317|NCT02104947|593400651|FG001|Overall Study|Other than stated above|3|||
164281318|NCT01844778|593400652|FG000|Overall Study|Protocol deviation|0|||
164584563|NCT01707147|594504692|FG000|Overall Study|Administered Trajenta prior to contract|5|||
164584564|NCT01707147|594504692|FG000|Overall Study|Patients who have not taken Trajenta|1|||
164584565|NCT01707147|594504692|FG000|Overall Study|Follow-up failure|17|||
164584566|NCT01707147|594504692|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
164584567|NCT01326962|594504696|FG000|Overall Study|Adverse Event|1|||
164584568|NCT01326962|594504696|FG000|Overall Study|Withdrawal by Subject|1|||
164584569|NCT01326962|594504696|FG000|Overall Study|Lost to Follow-up|3|||
164584570|NCT01326962|594504696|FG000|Overall Study|Other|2|||
164584571|NCT02053246|594504697|FG000|Overall Study|Withdrawal by Subject|3|||
164584572|NCT02053246|594504697|FG000|Overall Study|Physician Decision|1|||
164584573|NCT02707757|594504698|FG000|Overall Study|Protocol Violation|3|||
164584574|NCT02707757|594504699|FG001|Overall Study|Protocol Violation|2|||
164584575|NCT02707757|594504698|FG000|Overall Study|Withdrawal by Subject|2|||
164584576|NCT02707757|594504699|FG001|Overall Study|Withdrawal by Subject|0|||
164584577|NCT02707757|594504698|FG000|Overall Study|Death|0|||
164584578|NCT02707757|594504699|FG001|Overall Study|Death|1|||
164584579|NCT02707757|594504698|FG000|Overall Study|Adverse Event|6|||
164584580|NCT02707757|594504699|FG001|Overall Study|Adverse Event|4|||
164584581|NCT02707757|594504698|FG000|Overall Study|Renal transplant/elective operation|1|||
164584582|NCT02707757|594504699|FG001|Overall Study|Renal transplant/elective operation|5|||
164584583|NCT01318902|594504700|FG000|Overall Study|Symptomatic Deterioration|0|||
164584584|NCT01318902|594504701|FG001|Overall Study|Symptomatic Deterioration|1|||
164584585|NCT01318902|594504702|FG002|Overall Study|Symptomatic Deterioration|1|||
164281319|NCT01844778|593400653|FG001|Overall Study|Protocol deviation|1|||
164281320|NCT01844778|593400654|FG002|Overall Study|Protocol deviation|2|||
164584586|NCT01318902|594504703|FG003|Overall Study|Symptomatic Deterioration|2|||
164584587|NCT01318902|594504700|FG000|Overall Study|Withdrawal by Patient|0|||
164584588|NCT01318902|594504701|FG001|Overall Study|Withdrawal by Patient|1|||
164584589|NCT01318902|594504702|FG002|Overall Study|Withdrawal by Patient|0|||
164584590|NCT01318902|594504703|FG003|Overall Study|Withdrawal by Patient|3|||
164281321|NCT01844778|593400652|FG000|Overall Study|Withdrawal by Subject|2|||
164281322|NCT01844778|593400653|FG001|Overall Study|Withdrawal by Subject|0|||
164281323|NCT01844778|593400654|FG002|Overall Study|Withdrawal by Subject|0|||
164281324|NCT01844778|593400652|FG000|Overall Study|Adverse Event|0|||
164281325|NCT01844778|593400653|FG001|Overall Study|Adverse Event|2|||
164432902|NCT02081391|593954736|FG002|12-hour Treatment|Adverse Event|0|||
164432903|NCT02081391|593954737|FG003|12-hour Treatment|Adverse Event|0|||
164432904|NCT02081391|593954734|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
164432905|NCT02081391|593954735|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
164432906|NCT02081391|593954736|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
164432907|NCT02081391|593954737|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
164432908|NCT02081391|593954734|FG000|12-hour Treatment|Further reasons|2|||
164432909|NCT02081391|593954735|FG001|12-hour Treatment|Further reasons|1|||
164432910|NCT02081391|593954736|FG002|12-hour Treatment|Further reasons|0|||
164432911|NCT02081391|593954737|FG003|12-hour Treatment|Further reasons|0|||
164432912|NCT02081391|593954734|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
164432913|NCT02081391|593954735|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
164432914|NCT02081391|593954736|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
164432915|NCT02081391|593954737|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
164432916|NCT02081391|593954734|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
164432917|NCT02081391|593954735|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
164432918|NCT02081391|593954736|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
164432919|NCT02081391|593954737|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
164432920|NCT02081391|593954734|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
164432921|NCT02081391|593954735|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
164432922|NCT02081391|593954736|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
164432923|NCT02081391|593954737|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
164432924|NCT02081391|593954734|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
164432925|NCT02081391|593954735|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
164432926|NCT02081391|593954736|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
164432927|NCT02081391|593954737|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
164432928|NCT02081391|593954734|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
164432929|NCT02081391|593954735|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
164584591|NCT01318902|594504700|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
164584592|NCT01318902|594504701|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
164584593|NCT01318902|594504702|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
164584594|NCT01318902|594504703|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
164584595|NCT01318902|594504700|FG000|Overall Study|Adverse Event|0|||
164344352|NCT03766581|593636924|FG003|Randomization|Participant withdrew consent|2|||
164584596|NCT01318902|594504701|FG001|Overall Study|Adverse Event|1|||
164584597|NCT01318902|594504702|FG002|Overall Study|Adverse Event|0|||
164584598|NCT01318902|594504703|FG003|Overall Study|Adverse Event|0|||
164584599|NCT01318902|594504700|FG000|Overall Study|Terminated by Sponsor|0|||
164584600|NCT01318902|594504701|FG001|Overall Study|Terminated by Sponsor|0|||
164584601|NCT01318902|594504702|FG002|Overall Study|Terminated by Sponsor|1|||
164584602|NCT01318902|594504703|FG003|Overall Study|Terminated by Sponsor|0|||
164584603|NCT01894516|594505980|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
164584604|NCT01894516|594505981|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
164584605|NCT01894516|594505982|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
164584606|NCT01894516|594505983|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
164344353|NCT03766581|593636925|FG004|Randomization|Participant withdrew consent|1|||
164344354|NCT03766581|593636926|FG005|Randomization|Participant withdrew consent|1|||
164344355|NCT03766581|593636927|FG006|Randomization|Participant withdrew consent|0|||
164344356|NCT03766581|593636928|FG007|Randomization|Participant withdrew consent|0|||
164344357|NCT03766581|593636921|FG000|Treatment|Adverse Event|82|||
164344358|NCT03766581|593636922|FG001|Treatment|Adverse Event|44|||
164344359|NCT03766581|593636923|FG002|Treatment|Adverse Event|47|||
164344360|NCT03766581|593636924|FG003|Treatment|Adverse Event|46|||
164344361|NCT03766581|593636925|FG004|Treatment|Adverse Event|50|||
164344362|NCT03766581|593636926|FG005|Treatment|Adverse Event|77|||
164344363|NCT03766581|593636927|FG006|Treatment|Adverse Event|5|||
164584607|NCT01894516|594505980|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
164344364|NCT03766581|593636928|FG007|Treatment|Adverse Event|2|||
164344365|NCT03766581|593636921|FG000|Treatment|Participant request to discontinue treatment|34|||
164584608|NCT01894516|594505981|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
164584609|NCT01894516|594505982|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
164584610|NCT01894516|594505983|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
164584611|NCT01894516|594505980|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
164584612|NCT01894516|594505981|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
164584613|NCT01894516|594505982|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
164584614|NCT01894516|594505983|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
164584615|NCT01894516|594505980|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
164584616|NCT01894516|594505981|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
164584617|NCT01894516|594505982|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
164584618|NCT01894516|594505983|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
164584619|NCT01894516|594505980|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
164584620|NCT01894516|594505981|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
164584621|NCT01894516|594505982|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
164584622|NCT01894516|594505983|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
164584623|NCT01894516|594505980|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
164584624|NCT01894516|594505981|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
164584625|NCT01894516|594505982|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
164584626|NCT01894516|594505983|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
164584627|NCT01894516|594505980|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
164584628|NCT01894516|594505981|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
164584629|NCT01894516|594505982|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
164584630|NCT01894516|594505983|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
164584631|NCT01894516|594505980|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
164584632|NCT01894516|594505981|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
164344366|NCT03766581|593636922|FG001|Treatment|Participant request to discontinue treatment|6|||
164344367|NCT03766581|593636923|FG002|Treatment|Participant request to discontinue treatment|10|||
164344368|NCT03766581|593636924|FG003|Treatment|Participant request to discontinue treatment|10|||
164344369|NCT03766581|593636925|FG004|Treatment|Participant request to discontinue treatment|14|||
164344370|NCT03766581|593636926|FG005|Treatment|Participant request to discontinue treatment|15|||
164584633|NCT01894516|594505982|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
164584634|NCT01894516|594505983|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
164584635|NCT00375934|594505988|FG000|Overall Study|Adverse Event|1|||
164344371|NCT03766581|593636927|FG006|Treatment|Participant request to discontinue treatment|0|||
164344372|NCT03766581|593636928|FG007|Treatment|Participant request to discontinue treatment|1|||
164344373|NCT03766581|593636921|FG000|Treatment|Participant withdrew consent|11|||
164344374|NCT03766581|593636922|FG001|Treatment|Participant withdrew consent|4|||
164344375|NCT03766581|593636923|FG002|Treatment|Participant withdrew consent|5|||
164344376|NCT03766581|593636924|FG003|Treatment|Participant withdrew consent|5|||
164344377|NCT03766581|593636925|FG004|Treatment|Participant withdrew consent|4|||
164344378|NCT03766581|593636926|FG005|Treatment|Participant withdrew consent|4|||
164344379|NCT03766581|593636927|FG006|Treatment|Participant withdrew consent|0|||
164344380|NCT03766581|593636928|FG007|Treatment|Participant withdrew consent|0|||
164344381|NCT03766581|593636921|FG000|Treatment|Death|1|||
164344382|NCT03766581|593636922|FG001|Treatment|Death|0|||
164344383|NCT03766581|593636923|FG002|Treatment|Death|0|||
164344384|NCT03766581|593636924|FG003|Treatment|Death|0|||
164344385|NCT03766581|593636925|FG004|Treatment|Death|0|||
164344386|NCT03766581|593636926|FG005|Treatment|Death|0|||
164344387|NCT03766581|593636927|FG006|Treatment|Death|0|||
164344388|NCT03766581|593636928|FG007|Treatment|Death|0|||
164344389|NCT03766581|593636921|FG000|Treatment|Lost to Follow-up|1|||
164344390|NCT03766581|593636922|FG001|Treatment|Lost to Follow-up|0|||
164344391|NCT03766581|593636923|FG002|Treatment|Lost to Follow-up|0|||
164344392|NCT03766581|593636924|FG003|Treatment|Lost to Follow-up|1|||
164344393|NCT03766581|593636925|FG004|Treatment|Lost to Follow-up|0|||
164344394|NCT03766581|593636926|FG005|Treatment|Lost to Follow-up|0|||
164344395|NCT03766581|593636927|FG006|Treatment|Lost to Follow-up|0|||
164344396|NCT03766581|593636928|FG007|Treatment|Lost to Follow-up|0|||
164344397|NCT03766581|593636921|FG000|Treatment|Poor/Non compliance|2|||
164344398|NCT03766581|593636922|FG001|Treatment|Poor/Non compliance|2|||
164344399|NCT03766581|593636923|FG002|Treatment|Poor/Non compliance|1|||
164281326|NCT01844778|593400654|FG002|Overall Study|Adverse Event|2|||
164281327|NCT00095173|593400659|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
164281328|NCT00095173|593400660|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
164281329|NCT00095173|593400661|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
164281330|NCT00095173|593400662|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
164281331|NCT00095173|593400663|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
164281332|NCT00095173|593400664|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
164281333|NCT00095173|593400659|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
164281334|NCT00095173|593400660|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
164432930|NCT02081391|593954736|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
164432931|NCT02081391|593954737|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
164432932|NCT02081391|593954734|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
164432933|NCT02081391|593954735|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
164432934|NCT02081391|593954736|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
164432935|NCT02081391|593954737|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
164432936|NCT01458275|593954738|FG000|Overall Study|Adverse Event|3|||
164432937|NCT01458275|593954739|FG001|Overall Study|Adverse Event|4|||
164432938|NCT01458275|593954740|FG002|Overall Study|Adverse Event|1|||
164432939|NCT01458275|593954738|FG000|Overall Study|Lost to Follow-up|3|||
164432940|NCT01458275|593954739|FG001|Overall Study|Lost to Follow-up|2|||
164432941|NCT01458275|593954740|FG002|Overall Study|Lost to Follow-up|5|||
164432942|NCT01458275|593954738|FG000|Overall Study|Protocol Violation|5|||
164432943|NCT01458275|593954739|FG001|Overall Study|Protocol Violation|5|||
164432944|NCT01458275|593954740|FG002|Overall Study|Protocol Violation|2|||
164432945|NCT01458275|593954738|FG000|Overall Study|Withdrawal by Subject|3|||
164432946|NCT01458275|593954739|FG001|Overall Study|Withdrawal by Subject|2|||
164432947|NCT01458275|593954740|FG002|Overall Study|Withdrawal by Subject|1|||
164432948|NCT00751036|593954741|FG000|Overall Study|Disease Progression|28|||
164432949|NCT00751036|593954742|FG001|Overall Study|Disease Progression|29|||
164432950|NCT00751036|593954741|FG000|Overall Study|Adverse Event|6|||
164432951|NCT00751036|593954742|FG001|Overall Study|Adverse Event|4|||
164432952|NCT00751036|593954741|FG000|Overall Study|Administrative Problems|3|||
164432953|NCT00751036|593954742|FG001|Overall Study|Administrative Problems|4|||
164432954|NCT00751036|593954741|FG000|Overall Study|Withdrawal by Subject|5|||
164432955|NCT00751036|593954742|FG001|Overall Study|Withdrawal by Subject|2|||
164432956|NCT00751036|593954741|FG000|Overall Study|Death|3|||
164432957|NCT00751036|593954742|FG001|Overall Study|Death|3|||
164432958|NCT00751036|593954741|FG000|Overall Study|Lost to Follow-up|0|||
164432959|NCT00751036|593954742|FG001|Overall Study|Lost to Follow-up|1|||
164432960|NCT00751036|593954741|FG000|Overall Study|Protocol Violation|1|||
164432961|NCT00751036|593954742|FG001|Overall Study|Protocol Violation|0|||
164432962|NCT00751036|593954741|FG000|Overall Study|Missing end of Treatment Page|2|||
164432963|NCT00751036|593954742|FG001|Overall Study|Missing end of Treatment Page|3|||
164432964|NCT03410992|593957119|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
164432965|NCT03410992|593957120|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
164432966|NCT03410992|593957121|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
164432967|NCT03410992|593957122|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
164432968|NCT03410992|593957123|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
164432969|NCT03410992|593957124|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
164432970|NCT03410992|593957125|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
164432971|NCT03410992|593957126|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
164432972|NCT03410992|593957127|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
164432973|NCT03410992|593957128|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
164432974|NCT03410992|593957129|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
164432975|NCT03410992|593957119|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
164432976|NCT03410992|593957120|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
164432977|NCT03410992|593957121|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
164432978|NCT03410992|593957122|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
164432979|NCT03410992|593957123|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
164584636|NCT00375934|594505989|FG001|Overall Study|Adverse Event|1|||
164584637|NCT00375934|594505988|FG000|Overall Study|Withdrawal by Subject|2|||
164584638|NCT00375934|594505989|FG001|Overall Study|Withdrawal by Subject|2|||
164584639|NCT00375934|594505988|FG000|Overall Study|Lack of Efficacy|0|||
164584640|NCT00375934|594505989|FG001|Overall Study|Lack of Efficacy|2|||
164584641|NCT00375934|594505988|FG000|Overall Study|Physician Decision|0|||
164584642|NCT00375934|594505989|FG001|Overall Study|Physician Decision|1|||
164584643|NCT00893113|594505991|FG000|Overall Study|Lost to Follow-up|4|||
164584644|NCT00893113|594505992|FG001|Overall Study|Lost to Follow-up|8|||
164584645|NCT00893113|594505991|FG000|Overall Study|Early Termination|1|||
164584646|NCT00893113|594505992|FG001|Overall Study|Early Termination|1|||
164584647|NCT00893113|594505991|FG000|Overall Study|Withdrew Consent|8|||
164584648|NCT00893113|594505992|FG001|Overall Study|Withdrew Consent|7|||
164584649|NCT00500149|594505998|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
164281335|NCT00095173|593400661|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
164281336|NCT00095173|593400662|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
164281337|NCT00095173|593400663|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
164281338|NCT00095173|593400664|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
164281339|NCT00095173|593400659|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
164281340|NCT00095173|593400660|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
164281341|NCT00095173|593400661|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
164584650|NCT00500149|594505999|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
164584651|NCT00500149|594505998|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
164281342|NCT00095173|593400662|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
164344400|NCT03766581|593636924|FG003|Treatment|Poor/Non compliance|1|||
164344401|NCT03766581|593636925|FG004|Treatment|Poor/Non compliance|1|||
164344402|NCT03766581|593636926|FG005|Treatment|Poor/Non compliance|1|||
164584652|NCT00500149|594505999|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
164584653|NCT00500149|594505998|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
164584654|NCT00500149|594505999|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
164584655|NCT00500149|594505998|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
164584656|NCT00500149|594505999|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
164584657|NCT00500149|594505998|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
164584658|NCT00500149|594505999|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
164584659|NCT00500149|594505998|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
164584660|NCT00500149|594505999|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
164584661|NCT00500149|594505998|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
164689795|NCT01332968|594887787|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
164689796|NCT01332968|594887788|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
164689797|NCT01332968|594887789|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
164689798|NCT01332968|594887790|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
164689799|NCT01332968|594887791|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
164689800|NCT01332968|594887784|FG000|Maintenance/Observation Period|Non-compliance|0|||
164689801|NCT01332968|594887785|FG001|Maintenance/Observation Period|Non-compliance|0|||
164689802|NCT01332968|594887786|FG002|Maintenance/Observation Period|Non-compliance|4|||
164689803|NCT01332968|594887787|FG003|Maintenance/Observation Period|Non-compliance|3|||
164689804|NCT01332968|594887788|FG004|Maintenance/Observation Period|Non-compliance|0|||
164689805|NCT01332968|594887789|FG005|Maintenance/Observation Period|Non-compliance|0|||
164689806|NCT01332968|594887790|FG006|Maintenance/Observation Period|Non-compliance|0|||
164689807|NCT01332968|594887791|FG007|Maintenance/Observation Period|Non-compliance|0|||
164689808|NCT01332968|594887784|FG000|Maintenance/Observation Period|Other|0|||
164689809|NCT01332968|594887785|FG001|Maintenance/Observation Period|Other|0|||
164689810|NCT01332968|594887786|FG002|Maintenance/Observation Period|Other|4|||
164689811|NCT01332968|594887787|FG003|Maintenance/Observation Period|Other|7|||
164689812|NCT01332968|594887788|FG004|Maintenance/Observation Period|Other|0|||
164689813|NCT01332968|594887789|FG005|Maintenance/Observation Period|Other|0|||
164689814|NCT01332968|594887790|FG006|Maintenance/Observation Period|Other|0|||
164689815|NCT01332968|594887791|FG007|Maintenance/Observation Period|Other|0|||
164689816|NCT01332968|594887784|FG000|Maintenance/Observation Period|Physician Decision|0|||
164689817|NCT01332968|594887785|FG001|Maintenance/Observation Period|Physician Decision|0|||
164689818|NCT01332968|594887786|FG002|Maintenance/Observation Period|Physician Decision|14|||
164689819|NCT01332968|594887787|FG003|Maintenance/Observation Period|Physician Decision|19|||
164689820|NCT01332968|594887788|FG004|Maintenance/Observation Period|Physician Decision|0|||
164689821|NCT01332968|594887789|FG005|Maintenance/Observation Period|Physician Decision|1|||
164689822|NCT01332968|594887790|FG006|Maintenance/Observation Period|Physician Decision|0|||
164689823|NCT01332968|594887791|FG007|Maintenance/Observation Period|Physician Decision|0|||
164689824|NCT01332968|594887784|FG000|Maintenance/Observation Period|Progressive Disease|0|||
164689825|NCT01332968|594887785|FG001|Maintenance/Observation Period|Progressive Disease|0|||
164689826|NCT01332968|594887786|FG002|Maintenance/Observation Period|Progressive Disease|72|||
164689827|NCT01332968|594887787|FG003|Maintenance/Observation Period|Progressive Disease|40|||
164689828|NCT01332968|594887788|FG004|Maintenance/Observation Period|Progressive Disease|0|||
164689829|NCT01332968|594887789|FG005|Maintenance/Observation Period|Progressive Disease|0|||
164689830|NCT01332968|594887790|FG006|Maintenance/Observation Period|Progressive Disease|0|||
164689831|NCT01332968|594887791|FG007|Maintenance/Observation Period|Progressive Disease|0|||
164689832|NCT01332968|594887784|FG000|Maintenance/Observation Period|Protocol Violation|0|||
164689833|NCT01332968|594887785|FG001|Maintenance/Observation Period|Protocol Violation|0|||
164689834|NCT01332968|594887786|FG002|Maintenance/Observation Period|Protocol Violation|1|||
164689835|NCT01332968|594887787|FG003|Maintenance/Observation Period|Protocol Violation|1|||
164689836|NCT01332968|594887788|FG004|Maintenance/Observation Period|Protocol Violation|0|||
164689837|NCT01332968|594887789|FG005|Maintenance/Observation Period|Protocol Violation|0|||
164689838|NCT01332968|594887790|FG006|Maintenance/Observation Period|Protocol Violation|0|||
164689839|NCT01332968|594887791|FG007|Maintenance/Observation Period|Protocol Violation|0|||
164689840|NCT01332968|594887784|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
164584662|NCT00500149|594505999|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
164584663|NCT01157169|594506000|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
164584664|NCT01157169|594506001|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
164584665|NCT01157169|594506000|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
164584666|NCT01157169|594506001|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
164584667|NCT00663858|594506002|FG000|Overall Study|Adverse Event|9|||
164584668|NCT00663858|594506003|FG001|Overall Study|Adverse Event|1|||
164584669|NCT00663858|594506004|FG002|Overall Study|Adverse Event|6|||
164584670|NCT00663858|594506002|FG000|Overall Study|Lack of Efficacy|5|||
164584671|NCT00663858|594506003|FG001|Overall Study|Lack of Efficacy|1|||
164584672|NCT00663858|594506004|FG002|Overall Study|Lack of Efficacy|3|||
164584673|NCT00663858|594506002|FG000|Overall Study|Withdrawal by Subject|7|||
164584674|NCT00663858|594506003|FG001|Overall Study|Withdrawal by Subject|3|||
164584675|NCT00663858|594506004|FG002|Overall Study|Withdrawal by Subject|3|||
164584676|NCT00663858|594506002|FG000|Overall Study|Protocol Violation|5|||
164584677|NCT00663858|594506003|FG001|Overall Study|Protocol Violation|3|||
164584678|NCT00663858|594506004|FG002|Overall Study|Protocol Violation|4|||
164584679|NCT00663858|594506002|FG000|Overall Study|Other|8|||
164584680|NCT00663858|594506003|FG001|Overall Study|Other|2|||
164584681|NCT00663858|594506004|FG002|Overall Study|Other|4|||
164584682|NCT02940886|594506005|FG000|Overall Study|Adverse Event|7|||
164584683|NCT02940886|594506006|FG001|Overall Study|Adverse Event|3|||
164584684|NCT02940886|594506005|FG000|Overall Study|Protocol Violation|0|||
164584685|NCT02940886|594506006|FG001|Overall Study|Protocol Violation|2|||
164584686|NCT02940886|594506005|FG000|Overall Study|Withdrawal by Subject|28|||
164584687|NCT02940886|594506006|FG001|Overall Study|Withdrawal by Subject|20|||
164584688|NCT02940886|594506005|FG000|Overall Study|Death|1|||
164584689|NCT02940886|594506006|FG001|Overall Study|Death|0|||
164584690|NCT02940886|594506005|FG000|Overall Study|Lack of Efficacy|1|||
164584691|NCT02940886|594506006|FG001|Overall Study|Lack of Efficacy|0|||
164584692|NCT02940886|594506005|FG000|Overall Study|Lost to Follow-up|49|||
164584693|NCT02940886|594506006|FG001|Overall Study|Lost to Follow-up|21|||
164584694|NCT02940886|594506005|FG000|Overall Study|Physician Decision|9|||
164584695|NCT02940886|594506006|FG001|Overall Study|Physician Decision|4|||
164584696|NCT02940886|594506005|FG000|Overall Study|Sponsor decision|0|||
164584697|NCT02940886|594506006|FG001|Overall Study|Sponsor decision|1|||
164584698|NCT02940886|594506005|FG000|Overall Study|No treatment|7|||
164584699|NCT02940886|594506006|FG001|Overall Study|No treatment|2|||
164584700|NCT02940886|594506005|FG000|Overall Study|Enrolment error|0|||
164584701|NCT02940886|594506006|FG001|Overall Study|Enrolment error|1|||
164584702|NCT00950690|594506009|FG000|Overall Study|Death|4|||
164584703|NCT00950690|594506009|FG000|Overall Study|Adverse Event|15|||
164584704|NCT00950690|594506009|FG000|Overall Study|Lack of Efficacy|22|||
164584705|NCT00950690|594506009|FG000|Overall Study|Lost to Follow-up|40|||
164584706|NCT00950690|594506009|FG000|Overall Study|Other|163|||
164584707|NCT01713036|594506010|FG000|Overall Study|Death|1|||
164584708|NCT00092547|594506011|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
164584709|NCT00092547|594506012|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
164584710|NCT00092547|594506013|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
164584711|NCT00092547|594506011|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
164584712|NCT00092547|594506012|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
164584713|NCT00092547|594506013|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
164584714|NCT00092547|594506011|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
164584715|NCT00092547|594506012|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
164584716|NCT00092547|594506013|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
164584717|NCT00092547|594506011|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
164584718|NCT00092547|594506012|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
164584719|NCT00092547|594506013|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
164584720|NCT00092547|594506011|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
164584721|NCT00092547|594506012|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
164584722|NCT00092547|594506013|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
164584723|NCT00092547|594506011|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
164584724|NCT00092547|594506012|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
164584725|NCT00092547|594506013|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
164584726|NCT00092547|594506011|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
164584727|NCT00092547|594506012|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
164584728|NCT00092547|594506013|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
164584729|NCT00092547|594506011|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
164584730|NCT00092547|594506012|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
164584731|NCT00092547|594506013|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
164584732|NCT00092547|594506011|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
164584733|NCT00092547|594506012|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
164584734|NCT00092547|594506013|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
164584735|NCT00092547|594506011|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
164584736|NCT00092547|594506012|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
164584737|NCT00092547|594506013|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
164584738|NCT00092547|594506011|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
164584739|NCT00092547|594506012|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
164584740|NCT00092547|594506013|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
164584741|NCT00092547|594506011|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
164584742|NCT00092547|594506012|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
164584743|NCT00092547|594506013|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
164584744|NCT00092547|594506011|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
164584745|NCT00092547|594506012|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
164584746|NCT00092547|594506013|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
164584747|NCT00092547|594506011|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
164584748|NCT00092547|594506012|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
164584749|NCT00092547|594506013|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
164584750|NCT00092547|594506011|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
164584751|NCT00092547|594506012|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
164584752|NCT00092547|594506013|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
164584753|NCT00092547|594506011|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
164584754|NCT00092547|594506012|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
164584755|NCT00092547|594506013|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
164584756|NCT00092547|594506011|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
164584757|NCT00092547|594506012|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
164584758|NCT00092547|594506013|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
164584759|NCT00092547|594506011|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
164584760|NCT00092547|594506012|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
164584761|NCT00092547|594506013|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
164584762|NCT00092547|594506011|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
164584763|NCT00092547|594506012|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
164584764|NCT00092547|594506013|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
164584765|NCT00092547|594506011|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
164584766|NCT00092547|594506012|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
164584767|NCT00092547|594506013|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
164584768|NCT00092547|594506011|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
164584769|NCT00092547|594506012|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
164584770|NCT00092547|594506013|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
164584771|NCT01166659|594506014|FG000|Overall Study|Subject Decision|8|||
164584772|NCT01166659|594506014|FG000|Overall Study|Investigator Decision|2|||
164584773|NCT01166659|594506014|FG000|Overall Study|Death|1|||
164584774|NCT01166659|594506014|FG000|Overall Study|Lost to Follow-up|1|||
164584775|NCT01166659|594506014|FG000|Overall Study|Study Closed at Site|1|||
164584776|NCT00958568|594506025|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
164584777|NCT00958568|594506026|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
164584778|NCT00958568|594506027|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
164584779|NCT00958568|594506028|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
164584780|NCT00958568|594506025|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
164584781|NCT00958568|594506026|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
164584782|NCT00958568|594506027|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
164584783|NCT00958568|594506028|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
164584784|NCT00958568|594506025|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
164584785|NCT00958568|594506026|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
164584786|NCT00958568|594506027|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
164584787|NCT00958568|594506028|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
164584788|NCT00958568|594506025|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
164584789|NCT00958568|594506026|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
164584790|NCT00958568|594506027|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
164584791|NCT00958568|594506028|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
164584792|NCT00958568|594506025|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
164584793|NCT00958568|594506026|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
164584794|NCT00958568|594506027|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
164584795|NCT00958568|594506028|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
164584796|NCT00958568|594506025|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
164584797|NCT00958568|594506026|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
164584798|NCT00958568|594506027|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
164584799|NCT00958568|594506028|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
164281343|NCT00095173|593400663|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
164432980|NCT03410992|593957124|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
164432981|NCT03410992|593957125|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
164432982|NCT03410992|593957126|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
164584800|NCT00958568|594506025|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
164584801|NCT00958568|594506026|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
164584802|NCT00958568|594506027|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
164584803|NCT00958568|594506028|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
164584804|NCT00958568|594506025|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
164584805|NCT00958568|594506026|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
164584806|NCT00958568|594506027|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
164584807|NCT00958568|594506028|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
164584808|NCT00958568|594506025|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
164584809|NCT00958568|594506026|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
164584810|NCT00958568|594506027|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
164584811|NCT00958568|594506028|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
164584812|NCT00958568|594506025|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
164584813|NCT00958568|594506026|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
164584814|NCT00958568|594506027|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
164584815|NCT00958568|594506028|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
164584816|NCT00958568|594506025|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
164584817|NCT00958568|594506026|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
164584818|NCT00958568|594506027|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
164432983|NCT03410992|593957127|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
164432984|NCT03410992|593957128|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
164432985|NCT03410992|593957129|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
164432986|NCT03410992|593957119|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
164432987|NCT03410992|593957120|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
164432988|NCT03410992|593957121|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
164432989|NCT03410992|593957122|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
164432990|NCT03410992|593957123|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
164432991|NCT03410992|593957124|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
164432992|NCT03410992|593957125|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
164432993|NCT03410992|593957126|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
164432994|NCT03410992|593957127|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
164584819|NCT00958568|594506028|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
164584820|NCT00958568|594506025|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
164584821|NCT00958568|594506026|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
164584822|NCT00958568|594506027|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
164584823|NCT00958568|594506028|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
164584824|NCT00958568|594506025|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
164584825|NCT00958568|594506026|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
164584826|NCT00958568|594506027|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
164584827|NCT00958568|594506028|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
164584828|NCT00958568|594506025|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
164584829|NCT00958568|594506026|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
164584830|NCT00958568|594506027|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
164584831|NCT00958568|594506028|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
164584832|NCT00958568|594506025|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
164584833|NCT00958568|594506026|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
164584834|NCT00958568|594506027|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
164584835|NCT00958568|594506028|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
164584836|NCT00958568|594506025|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
164584837|NCT00958568|594506026|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
164584838|NCT00958568|594506027|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
164584839|NCT00958568|594506028|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
164584840|NCT00958568|594506025|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
164432995|NCT03410992|593957128|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
164584841|NCT00958568|594506026|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
164584842|NCT00958568|594506027|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
164584843|NCT00958568|594506028|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
164584844|NCT00958568|594506025|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
164584845|NCT00958568|594506026|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
164584846|NCT00958568|594506027|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
164584847|NCT00958568|594506028|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
164584848|NCT00958568|594506025|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
164432996|NCT03410992|593957129|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
164432997|NCT03410992|593957119|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
164432998|NCT03410992|593957120|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
164432999|NCT03410992|593957121|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
164433000|NCT03410992|593957122|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
164433001|NCT03410992|593957123|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
164433002|NCT03410992|593957124|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
164433003|NCT03410992|593957125|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
164433004|NCT03410992|593957126|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
164584849|NCT00958568|594506026|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
164584850|NCT00958568|594506027|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
164584851|NCT00958568|594506028|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
164584852|NCT00958568|594506025|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
164584853|NCT00958568|594506026|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
164584854|NCT00958568|594506027|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
164584855|NCT00958568|594506028|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
164584856|NCT00958568|594506025|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
164584857|NCT00958568|594506026|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
164584858|NCT00958568|594506027|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
164584859|NCT00958568|594506028|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
164584860|NCT00958568|594506025|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
164584861|NCT00958568|594506026|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
164344403|NCT03766581|593636927|FG006|Treatment|Poor/Non compliance|0|||
164344404|NCT03766581|593636928|FG007|Treatment|Poor/Non compliance|0|||
164344405|NCT03766581|593636921|FG000|Treatment|Participant no longer meets study criteria|9|||
164344406|NCT03766581|593636922|FG001|Treatment|Participant no longer meets study criteria|1|||
164344407|NCT03766581|593636923|FG002|Treatment|Participant no longer meets study criteria|5|||
164344408|NCT03766581|593636924|FG003|Treatment|Participant no longer meets study criteria|4|||
164344409|NCT03766581|593636925|FG004|Treatment|Participant no longer meets study criteria|4|||
164344410|NCT03766581|593636926|FG005|Treatment|Participant no longer meets study criteria|4|||
164344411|NCT03766581|593636927|FG006|Treatment|Participant no longer meets study criteria|2|||
164344412|NCT03766581|593636928|FG007|Treatment|Participant no longer meets study criteria|0|||
164344413|NCT03766581|593636921|FG000|Treatment|Other reasons|13|||
164344414|NCT03766581|593636922|FG001|Treatment|Other reasons|8|||
164344415|NCT03766581|593636923|FG002|Treatment|Other reasons|3|||
164344416|NCT03766581|593636924|FG003|Treatment|Other reasons|7|||
164344417|NCT03766581|593636925|FG004|Treatment|Other reasons|3|||
164344418|NCT03766581|593636926|FG005|Treatment|Other reasons|3|||
164344419|NCT03766581|593636927|FG006|Treatment|Other reasons|0|||
164344420|NCT03766581|593636928|FG007|Treatment|Other reasons|0|||
164344421|NCT03716024|593636929|FG000|Overall Study|Randomized, not Treated|7|||
164344422|NCT03716024|593636930|FG001|Overall Study|Randomized, not Treated|8|||
164344423|NCT03716024|593636929|FG000|Overall Study|Adverse Event|1|||
164344424|NCT03716024|593636930|FG001|Overall Study|Adverse Event|2|||
164344425|NCT03716024|593636929|FG000|Overall Study|Treatment Failure|1|||
164344426|NCT03716024|593636930|FG001|Overall Study|Treatment Failure|0|||
164344427|NCT03716024|593636929|FG000|Overall Study|Lost to Follow-up|2|||
164344428|NCT03716024|593636930|FG001|Overall Study|Lost to Follow-up|6|||
164344429|NCT03716024|593636929|FG000|Overall Study|Withdrawal by Subject|0|||
164344430|NCT03716024|593636930|FG001|Overall Study|Withdrawal by Subject|1|||
164344431|NCT03716024|593636929|FG000|Overall Study|Missing Reason|0|||
164344432|NCT03716024|593636930|FG001|Overall Study|Missing Reason|1|||
164344433|NCT00867568|593636931|FG000|Overall Study|Lack of Efficacy|10|||
164433005|NCT03410992|593957127|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
164433006|NCT03410992|593957128|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
164433007|NCT03410992|593957129|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
164433008|NCT03410992|593957119|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
164433009|NCT03410992|593957120|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
164433010|NCT03410992|593957121|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
164433011|NCT03410992|593957122|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
164433012|NCT03410992|593957123|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
164433013|NCT03410992|593957124|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
164433014|NCT03410992|593957125|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
164433015|NCT03410992|593957126|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
164433016|NCT03410992|593957127|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
164433017|NCT03410992|593957128|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
164433018|NCT03410992|593957129|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
164433019|NCT03410992|593957119|FG000|Week 16 Assessment|Incorrect escapers|0|||
164433020|NCT03410992|593957120|FG001|Week 16 Assessment|Incorrect escapers|6|||
164433021|NCT03410992|593957121|FG002|Week 16 Assessment|Incorrect escapers|0|||
164433022|NCT03410992|593957122|FG003|Week 16 Assessment|Incorrect escapers|0|||
164433023|NCT03410992|593957123|FG004|Week 16 Assessment|Incorrect escapers|0|||
164433024|NCT03410992|593957124|FG005|Week 16 Assessment|Incorrect escapers|0|||
164433025|NCT03410992|593957125|FG006|Week 16 Assessment|Incorrect escapers|0|||
164433026|NCT03410992|593957126|FG007|Week 16 Assessment|Incorrect escapers|0|||
164433027|NCT03410992|593957127|FG008|Week 16 Assessment|Incorrect escapers|0|||
164433028|NCT03410992|593957128|FG009|Week 16 Assessment|Incorrect escapers|0|||
164433029|NCT03410992|593957129|FG010|Week 16 Assessment|Incorrect escapers|0|||
164689841|NCT01332968|594887785|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
164689842|NCT01332968|594887786|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
164689843|NCT01332968|594887787|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
164689844|NCT01332968|594887788|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
164689845|NCT01332968|594887789|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
164689846|NCT01332968|594887790|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
164689847|NCT01332968|594887791|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
164689848|NCT01332968|594887784|FG000|Follow-Up Period|Adverse Event|0|||
164689849|NCT01332968|594887785|FG001|Follow-Up Period|Adverse Event|0|||
164689850|NCT01332968|594887786|FG002|Follow-Up Period|Adverse Event|0|||
164689851|NCT01332968|594887787|FG003|Follow-Up Period|Adverse Event|0|||
164689852|NCT01332968|594887788|FG004|Follow-Up Period|Adverse Event|0|||
164689853|NCT01332968|594887789|FG005|Follow-Up Period|Adverse Event|0|||
164689854|NCT01332968|594887790|FG006|Follow-Up Period|Adverse Event|0|||
164689855|NCT01332968|594887791|FG007|Follow-Up Period|Adverse Event|4|||
164689856|NCT01332968|594887784|FG000|Follow-Up Period|Death|0|||
164689857|NCT01332968|594887785|FG001|Follow-Up Period|Death|0|||
164689858|NCT01332968|594887786|FG002|Follow-Up Period|Death|0|||
164689859|NCT01332968|594887787|FG003|Follow-Up Period|Death|0|||
164689860|NCT01332968|594887788|FG004|Follow-Up Period|Death|0|||
164689861|NCT01332968|594887789|FG005|Follow-Up Period|Death|0|||
164689862|NCT01332968|594887790|FG006|Follow-Up Period|Death|27|||
164433030|NCT03410992|593957119|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
164433031|NCT03410992|593957120|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
164433032|NCT03410992|593957121|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
164433033|NCT03410992|593957122|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
164433034|NCT03410992|593957123|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
164433035|NCT03410992|593957124|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
164433036|NCT03410992|593957125|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
164433037|NCT03410992|593957126|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
164433038|NCT03410992|593957127|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
164433039|NCT03410992|593957128|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
164433040|NCT03410992|593957129|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
164433041|NCT03410992|593957119|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
164433042|NCT03410992|593957120|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
164433043|NCT03410992|593957121|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
164689863|NCT01332968|594887791|FG007|Follow-Up Period|Death|30|||
164689864|NCT01332968|594887784|FG000|Follow-Up Period|Lost to Follow-up|0|||
164689865|NCT01332968|594887785|FG001|Follow-Up Period|Lost to Follow-up|0|||
164689866|NCT01332968|594887786|FG002|Follow-Up Period|Lost to Follow-up|0|||
164689867|NCT01332968|594887787|FG003|Follow-Up Period|Lost to Follow-up|0|||
164689868|NCT01332968|594887788|FG004|Follow-Up Period|Lost to Follow-up|0|||
164689869|NCT01332968|594887789|FG005|Follow-Up Period|Lost to Follow-up|0|||
164689870|NCT01332968|594887790|FG006|Follow-Up Period|Lost to Follow-up|11|||
164689871|NCT01332968|594887791|FG007|Follow-Up Period|Lost to Follow-up|15|||
164689872|NCT01332968|594887784|FG000|Follow-Up Period|Non-compliance|0|||
164689873|NCT01332968|594887785|FG001|Follow-Up Period|Non-compliance|0|||
164584862|NCT00958568|594506027|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
164584863|NCT00958568|594506028|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
164584864|NCT00958568|594506025|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
164584865|NCT00958568|594506026|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
164584866|NCT00958568|594506027|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
164584867|NCT00958568|594506028|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
164584868|NCT00958568|594506025|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
164584869|NCT00958568|594506026|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
164584870|NCT00958568|594506027|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
164584871|NCT00958568|594506028|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
164584872|NCT00958568|594506025|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
164584873|NCT00958568|594506026|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
164584874|NCT00958568|594506027|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
164584875|NCT00958568|594506028|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
164584876|NCT00958568|594506025|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
164584877|NCT00958568|594506026|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
164584878|NCT00958568|594506027|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
164584879|NCT00958568|594506028|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
164584880|NCT00958568|594506025|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
164584881|NCT00958568|594506026|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
164584882|NCT00958568|594506027|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
164584883|NCT00958568|594506028|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
164584884|NCT00958568|594506025|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
164584885|NCT00958568|594506026|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
164584886|NCT00958568|594506027|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
164584887|NCT00958568|594506028|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
164689874|NCT01332968|594887786|FG002|Follow-Up Period|Non-compliance|0|||
164689875|NCT01332968|594887787|FG003|Follow-Up Period|Non-compliance|0|||
164689876|NCT01332968|594887788|FG004|Follow-Up Period|Non-compliance|0|||
164689877|NCT01332968|594887789|FG005|Follow-Up Period|Non-compliance|0|||
164584888|NCT00958568|594506025|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
164584889|NCT00958568|594506026|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
164584890|NCT00958568|594506027|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
164584891|NCT00958568|594506028|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
164584892|NCT00915005|594506029|FG000|Overall Study|Withdrawal by Subject|4|||
164584893|NCT00915005|594506030|FG001|Overall Study|Withdrawal by Subject|4|||
164584894|NCT00915005|594506029|FG000|Overall Study|Patient preferred protons therapy|6|||
164584895|NCT00915005|594506030|FG001|Overall Study|Patient preferred protons therapy|0|||
164584896|NCT00915005|594506029|FG000|Overall Study|Insurance denial|3|||
164689878|NCT01332968|594887790|FG006|Follow-Up Period|Non-compliance|4|||
164689879|NCT01332968|594887791|FG007|Follow-Up Period|Non-compliance|9|||
164689880|NCT01332968|594887784|FG000|Follow-Up Period|Other|0|||
164689881|NCT01332968|594887785|FG001|Follow-Up Period|Other|0|||
164689882|NCT01332968|594887786|FG002|Follow-Up Period|Other|0|||
164584897|NCT00915005|594506030|FG001|Overall Study|Insurance denial|15|||
164584898|NCT03952650|594506033|FG000|Overall Study|TRAVEL|0|||
164584899|NCT03952650|594506034|FG001|Overall Study|TRAVEL|4|||
164584900|NCT03952650|594506035|FG002|Overall Study|TRAVEL|0|||
164584901|NCT03952650|594506036|FG003|Overall Study|TRAVEL|4|||
164584902|NCT03952650|594506037|FG004|Overall Study|TRAVEL|0|||
164584903|NCT03952650|594506038|FG005|Overall Study|TRAVEL|3|||
164584904|NCT03952650|594506039|FG006|Overall Study|TRAVEL|2|||
164584905|NCT03952650|594506033|FG000|Overall Study|Withdrawal by Subject|0|||
164584906|NCT03952650|594506034|FG001|Overall Study|Withdrawal by Subject|2|||
164584907|NCT03952650|594506035|FG002|Overall Study|Withdrawal by Subject|0|||
164584908|NCT03952650|594506036|FG003|Overall Study|Withdrawal by Subject|3|||
164584909|NCT03952650|594506037|FG004|Overall Study|Withdrawal by Subject|0|||
164584910|NCT03952650|594506038|FG005|Overall Study|Withdrawal by Subject|1|||
164584911|NCT03952650|594506039|FG006|Overall Study|Withdrawal by Subject|1|||
164584912|NCT03952650|594506033|FG000|Overall Study|Lost to Follow-up|0|||
164584913|NCT03952650|594506034|FG001|Overall Study|Lost to Follow-up|1|||
164584914|NCT03952650|594506035|FG002|Overall Study|Lost to Follow-up|0|||
164584915|NCT03952650|594506036|FG003|Overall Study|Lost to Follow-up|0|||
164584916|NCT03952650|594506037|FG004|Overall Study|Lost to Follow-up|0|||
164584917|NCT03952650|594506038|FG005|Overall Study|Lost to Follow-up|1|||
164584918|NCT03952650|594506039|FG006|Overall Study|Lost to Follow-up|1|||
164584919|NCT03952650|594506033|FG000|Overall Study|Received wrong vaccine and travelled|0|||
164584920|NCT03952650|594506034|FG001|Overall Study|Received wrong vaccine and travelled|0|||
164281344|NCT00095173|593400664|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
164281345|NCT00095173|593400659|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
164281346|NCT00095173|593400660|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
164281347|NCT00095173|593400661|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
164281348|NCT00095173|593400662|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
164281349|NCT00095173|593400663|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
164281350|NCT00095173|593400664|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
164281351|NCT00095173|593400659|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
164281352|NCT00095173|593400660|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
164689883|NCT01332968|594887787|FG003|Follow-Up Period|Other|0|||
164281353|NCT00095173|593400661|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
164689884|NCT01332968|594887788|FG004|Follow-Up Period|Other|0|||
164689885|NCT01332968|594887789|FG005|Follow-Up Period|Other|0|||
164281354|NCT00095173|593400662|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
164433044|NCT03410992|593957122|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
164433045|NCT03410992|593957123|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
164433046|NCT03410992|593957124|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
164433047|NCT03410992|593957125|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
164433048|NCT03410992|593957126|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
164433049|NCT03410992|593957127|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
164433050|NCT03410992|593957128|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
164433051|NCT03410992|593957129|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
164433052|NCT03410992|593957119|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
164433053|NCT03410992|593957120|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
164433054|NCT03410992|593957121|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
164433055|NCT03410992|593957122|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
164433056|NCT03410992|593957123|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
164433057|NCT03410992|593957124|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
164433058|NCT03410992|593957125|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
164433059|NCT03410992|593957126|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
164433060|NCT03410992|593957127|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
164433061|NCT03410992|593957128|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
164433062|NCT03410992|593957129|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
164433063|NCT03410992|593957119|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
164433064|NCT03410992|593957120|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
164433065|NCT03410992|593957121|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
164433066|NCT03410992|593957122|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
164433067|NCT03410992|593957123|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
164433068|NCT03410992|593957124|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
164433069|NCT03410992|593957125|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
164433070|NCT03410992|593957126|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
164433071|NCT03410992|593957127|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
164433072|NCT03410992|593957128|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
164433073|NCT03410992|593957129|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
164584921|NCT03952650|594506035|FG002|Overall Study|Received wrong vaccine and travelled|0|||
164584922|NCT03952650|594506036|FG003|Overall Study|Received wrong vaccine and travelled|0|||
164584923|NCT03952650|594506037|FG004|Overall Study|Received wrong vaccine and travelled|0|||
164584924|NCT03952650|594506038|FG005|Overall Study|Received wrong vaccine and travelled|1|||
164584925|NCT03952650|594506039|FG006|Overall Study|Received wrong vaccine and travelled|0|||
164584926|NCT03952650|594506033|FG000|Overall Study|Unable to make study visit|0|||
164584927|NCT03952650|594506034|FG001|Overall Study|Unable to make study visit|0|||
164584928|NCT03952650|594506035|FG002|Overall Study|Unable to make study visit|0|||
164584929|NCT03952650|594506036|FG003|Overall Study|Unable to make study visit|0|||
164584930|NCT03952650|594506037|FG004|Overall Study|Unable to make study visit|0|||
164584931|NCT03952650|594506038|FG005|Overall Study|Unable to make study visit|1|||
164584932|NCT03952650|594506039|FG006|Overall Study|Unable to make study visit|0|||
164584933|NCT01873742|594506044|FG000|Overall Study|Lost to Follow-up|68|||
164584934|NCT01873742|594506045|FG001|Overall Study|Lost to Follow-up|76|||
164584935|NCT00790296|594506046|FG000|Overall Study|Did not meet study eligibility criteria|1|||
164584936|NCT00790296|594506047|FG001|Overall Study|Did not meet study eligibility criteria|1|||
164584937|NCT00790296|594506046|FG000|Overall Study|Adverse Event|0|||
164584938|NCT00790296|594506047|FG001|Overall Study|Adverse Event|1|||
164584939|NCT01022853|594506048|FG000|Overall Study|Progressive disease|2|||
164584940|NCT01022853|594506049|FG001|Overall Study|Progressive disease|3|||
164584941|NCT01022853|594506050|FG002|Overall Study|Progressive disease|11|||
164584942|NCT01022853|594506051|FG003|Overall Study|Progressive disease|7|||
164584943|NCT01022853|594506052|FG004|Overall Study|Progressive disease|1|||
164584944|NCT01022853|594506048|FG000|Overall Study|Dose-limiting toxicity|0|||
164584945|NCT01022853|594506049|FG001|Overall Study|Dose-limiting toxicity|0|||
164584946|NCT01022853|594506050|FG002|Overall Study|Dose-limiting toxicity|0|||
164584947|NCT01022853|594506051|FG003|Overall Study|Dose-limiting toxicity|0|||
164584948|NCT01022853|594506052|FG004|Overall Study|Dose-limiting toxicity|1|||
164584949|NCT01022853|594506048|FG000|Overall Study|Withdrawal by Subject|0|||
164584950|NCT01022853|594506049|FG001|Overall Study|Withdrawal by Subject|1|||
164584951|NCT01022853|594506050|FG002|Overall Study|Withdrawal by Subject|1|||
164584952|NCT01022853|594506051|FG003|Overall Study|Withdrawal by Subject|1|||
164584953|NCT01022853|594506052|FG004|Overall Study|Withdrawal by Subject|0|||
164584954|NCT01022853|594506048|FG000|Overall Study|Other not stated above|1|||
164584955|NCT01022853|594506049|FG001|Overall Study|Other not stated above|0|||
164584956|NCT01022853|594506050|FG002|Overall Study|Other not stated above|1|||
164584957|NCT01022853|594506051|FG003|Overall Study|Other not stated above|0|||
164584958|NCT01022853|594506052|FG004|Overall Study|Other not stated above|0|||
164584959|NCT01971476|594506053|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
164584960|NCT01971476|594506054|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
164584961|NCT01971476|594506055|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
164584962|NCT01971476|594506053|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
164584963|NCT01971476|594506054|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
164584964|NCT01971476|594506055|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
164584965|NCT01971476|594506053|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
164584966|NCT01971476|594506054|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
164584967|NCT01971476|594506055|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
164584968|NCT01651052|594506056|FG000|Overall Study|Death|21|||
164584969|NCT01651052|594506056|FG000|Overall Study|Explant|1|||
164584970|NCT01651052|594506056|FG000|Overall Study|Withdrawal by Subject|1|||
164584971|NCT01651052|594506056|FG000|Overall Study|Lost to Follow-up|3|||
164584972|NCT04156646|594506066|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
164584973|NCT04156646|594506067|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
164584974|NCT01208181|594506074|FG000|Part 1|Withdrawal by Subject|11|||
164584975|NCT01208181|594506075|FG001|Part 1|Withdrawal by Subject|10|||
164584976|NCT01208181|594506076|FG002|Part 1|Withdrawal by Subject|0|||
164584977|NCT01208181|594506077|FG003|Part 1|Withdrawal by Subject|0|||
164584978|NCT01208181|594506078|FG004|Part 1|Withdrawal by Subject|0|||
164584979|NCT01208181|594506074|FG000|Part 1|Technical problem|5|||
164584980|NCT01208181|594506075|FG001|Part 1|Technical problem|0|||
164584981|NCT01208181|594506076|FG002|Part 1|Technical problem|0|||
164584982|NCT01208181|594506077|FG003|Part 1|Technical problem|0|||
164584983|NCT01208181|594506078|FG004|Part 1|Technical problem|0|||
164584984|NCT01208181|594506074|FG000|Part 1|Protocol Violation|10|||
164584985|NCT01208181|594506075|FG001|Part 1|Protocol Violation|5|||
164584986|NCT01208181|594506076|FG002|Part 1|Protocol Violation|0|||
164584987|NCT01208181|594506077|FG003|Part 1|Protocol Violation|0|||
164584988|NCT01208181|594506078|FG004|Part 1|Protocol Violation|0|||
164584989|NCT01208181|594506074|FG000|Part 1|Physician Decision|4|||
164584990|NCT01208181|594506075|FG001|Part 1|Physician Decision|0|||
164584991|NCT01208181|594506076|FG002|Part 1|Physician Decision|0|||
164584992|NCT01208181|594506077|FG003|Part 1|Physician Decision|0|||
164584993|NCT01208181|594506078|FG004|Part 1|Physician Decision|0|||
164584994|NCT01208181|594506074|FG000|Part 1|Non-compliance with study drug|1|||
164433074|NCT03410992|593957119|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
164584995|NCT01208181|594506075|FG001|Part 1|Non-compliance with study drug|1|||
164584996|NCT01208181|594506076|FG002|Part 1|Non-compliance with study drug|0|||
164584997|NCT01208181|594506077|FG003|Part 1|Non-compliance with study drug|0|||
164584998|NCT01208181|594506078|FG004|Part 1|Non-compliance with study drug|0|||
164584999|NCT01208181|594506074|FG000|Part 1|Lost to Follow-up|5|||
164585000|NCT01208181|594506075|FG001|Part 1|Lost to Follow-up|3|||
164585001|NCT01208181|594506076|FG002|Part 1|Lost to Follow-up|0|||
164585002|NCT01208181|594506077|FG003|Part 1|Lost to Follow-up|0|||
164281355|NCT00095173|593400663|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
164281356|NCT00095173|593400664|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
164281357|NCT00095173|593400659|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
164281358|NCT00095173|593400660|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
164281359|NCT00095173|593400661|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
164281360|NCT00095173|593400662|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
164281361|NCT00095173|593400663|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
164585003|NCT01208181|594506078|FG004|Part 1|Lost to Follow-up|1|||
164585004|NCT01208181|594506074|FG000|Part 1|Lack of Efficacy|37|||
164585005|NCT01208181|594506075|FG001|Part 1|Lack of Efficacy|12|||
164585006|NCT01208181|594506076|FG002|Part 1|Lack of Efficacy|0|||
164585007|NCT01208181|594506077|FG003|Part 1|Lack of Efficacy|0|||
164585008|NCT01208181|594506078|FG004|Part 1|Lack of Efficacy|17|||
164585009|NCT01208181|594506074|FG000|Part 1|Adverse Event|26|||
164585010|NCT01208181|594506075|FG001|Part 1|Adverse Event|24|||
164585011|NCT01208181|594506076|FG002|Part 1|Adverse Event|0|||
164585012|NCT01208181|594506077|FG003|Part 1|Adverse Event|0|||
164585013|NCT01208181|594506078|FG004|Part 1|Adverse Event|4|||
164585014|NCT01208181|594506074|FG000|Part 2|Adverse Event|0|||
164585015|NCT01208181|594506075|FG001|Part 2|Adverse Event|0|||
164585016|NCT01208181|594506076|FG002|Part 2|Adverse Event|6|||
164585017|NCT01208181|594506077|FG003|Part 2|Adverse Event|7|||
164585018|NCT01208181|594506078|FG004|Part 2|Adverse Event|0|||
164585019|NCT01208181|594506074|FG000|Part 2|Withdrawal by Subject|0|||
164585020|NCT01208181|594506075|FG001|Part 2|Withdrawal by Subject|0|||
164585021|NCT01208181|594506076|FG002|Part 2|Withdrawal by Subject|1|||
164585022|NCT01208181|594506077|FG003|Part 2|Withdrawal by Subject|1|||
164585023|NCT01208181|594506078|FG004|Part 2|Withdrawal by Subject|0|||
164585024|NCT01208181|594506074|FG000|Part 2|Protocol Violation|0|||
164585025|NCT01208181|594506075|FG001|Part 2|Protocol Violation|0|||
164585026|NCT01208181|594506076|FG002|Part 2|Protocol Violation|1|||
164585027|NCT01208181|594506077|FG003|Part 2|Protocol Violation|0|||
164585028|NCT01208181|594506078|FG004|Part 2|Protocol Violation|0|||
164585029|NCT01208181|594506074|FG000|Part 2|Physician Decision|0|||
164585030|NCT01208181|594506075|FG001|Part 2|Physician Decision|0|||
164585031|NCT01208181|594506076|FG002|Part 2|Physician Decision|1|||
164433075|NCT03410992|593957120|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
164433076|NCT03410992|593957121|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
164433077|NCT03410992|593957122|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
164433078|NCT03410992|593957123|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
164433079|NCT03410992|593957124|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
164433080|NCT03410992|593957125|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
164433081|NCT03410992|593957126|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
164433082|NCT03410992|593957127|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
164433083|NCT03410992|593957128|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
164433084|NCT03410992|593957129|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
164433085|NCT03410992|593957119|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
164433086|NCT03410992|593957120|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
164433087|NCT03410992|593957121|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
164433088|NCT03410992|593957122|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
164433089|NCT03410992|593957123|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
164433090|NCT03410992|593957124|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
164433091|NCT03410992|593957125|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
164433092|NCT03410992|593957126|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
164433093|NCT03410992|593957127|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
164433094|NCT03410992|593957128|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
164433095|NCT03410992|593957129|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
164433096|NCT04988295|593957132|FG000|Overall Study|Withdrawal by Subject|9|||
164344434|NCT00867568|593636931|FG000|Overall Study|Adverse Event|4|||
164344435|NCT00867568|593636931|FG000|Overall Study|Withdrawal by Subject|1|||
164344436|NCT01056653|593636932|FG000|Overall Study|Lost to Follow-up|0|||
164344437|NCT01056653|593636933|FG001|Overall Study|Lost to Follow-up|0|||
164344438|NCT01056653|593636934|FG002|Overall Study|Lost to Follow-up|2|||
164344439|NCT05275400|593636935|FG000|Treatment Period|Adverse Event|7|||
164344440|NCT05275400|593636936|FG001|Treatment Period|Adverse Event|1|||
164344441|NCT05275400|593636935|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
164344442|NCT05275400|593636936|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
164344443|NCT05275400|593636935|FG000|Treatment Period|Death|5|||
164344444|NCT05275400|593636936|FG001|Treatment Period|Death|2|||
164344445|NCT05275400|593636935|FG000|Treatment Period|Protocol Violation|1|||
164344446|NCT05275400|593636936|FG001|Treatment Period|Protocol Violation|0|||
164344447|NCT05275400|593636935|FG000|Treatment Period|Physician Decision|5|||
164344448|NCT05275400|593636936|FG001|Treatment Period|Physician Decision|4|||
164344449|NCT05275400|593636935|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
164344450|NCT05275400|593636936|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
164344451|NCT05275400|593636935|FG000|Treatment Period|Withdrawal by Subject|30|||
164344452|NCT05275400|593636936|FG001|Treatment Period|Withdrawal by Subject|12|||
164344453|NCT05275400|593636935|FG000|Treatment Period|Lost to Follow-up|1|||
164344454|NCT05275400|593636936|FG001|Treatment Period|Lost to Follow-up|5|||
164344455|NCT05275400|593636935|FG000|Treatment Period|Lack of Efficacy|1|||
164344456|NCT05275400|593636936|FG001|Treatment Period|Lack of Efficacy|0|||
164344457|NCT05275400|593636935|FG000|Treatment Period|Sponsor Decision|1|||
164344458|NCT05275400|593636936|FG001|Treatment Period|Sponsor Decision|0|||
164344459|NCT05275400|593636935|FG000|Follow-Up Period|Death|2|||
164344460|NCT05275400|593636936|FG001|Follow-Up Period|Death|0|||
164433097|NCT04988295|593957133|FG001|Overall Study|Withdrawal by Subject|29|||
164433098|NCT04988295|593957134|FG002|Overall Study|Withdrawal by Subject|6|||
164433099|NCT04988295|593957135|FG003|Overall Study|Withdrawal by Subject|0|||
164433100|NCT04988295|593957132|FG000|Overall Study|Lost to Follow-up|1|||
164433101|NCT04988295|593957133|FG001|Overall Study|Lost to Follow-up|0|||
164433102|NCT04988295|593957134|FG002|Overall Study|Lost to Follow-up|0|||
164433103|NCT04988295|593957135|FG003|Overall Study|Lost to Follow-up|0|||
164689886|NCT01332968|594887790|FG006|Follow-Up Period|Other|18|||
164689887|NCT01332968|594887791|FG007|Follow-Up Period|Other|21|||
164689888|NCT01332968|594887784|FG000|Follow-Up Period|Physician Decision|0|||
164689889|NCT01332968|594887785|FG001|Follow-Up Period|Physician Decision|0|||
164689890|NCT01332968|594887786|FG002|Follow-Up Period|Physician Decision|0|||
164689891|NCT01332968|594887787|FG003|Follow-Up Period|Physician Decision|0|||
164689892|NCT01332968|594887788|FG004|Follow-Up Period|Physician Decision|0|||
164344461|NCT05275400|593636935|FG000|Follow-Up Period|Protocol Violation|1|||
164689893|NCT01332968|594887789|FG005|Follow-Up Period|Physician Decision|0|||
164689894|NCT01332968|594887790|FG006|Follow-Up Period|Physician Decision|12|||
164344462|NCT05275400|593636936|FG001|Follow-Up Period|Protocol Violation|0|||
164344463|NCT05275400|593636935|FG000|Follow-Up Period|Withdrawal by Subject|3|||
164344464|NCT05275400|593636936|FG001|Follow-Up Period|Withdrawal by Subject|0|||
164344465|NCT01651039|593636938|FG000|Overall Study|Non-evaluables|5|||
164344466|NCT01651039|593636938|FG000|Overall Study|Physician Decision|2|||
164344467|NCT01651039|593636938|FG000|Overall Study|Withdrawal by Subject|1|||
164433104|NCT04988295|593957132|FG000|Overall Study|Study participation ongoing|186|||
164433105|NCT04988295|593957133|FG001|Overall Study|Study participation ongoing|169|||
164433106|NCT04988295|593957134|FG002|Overall Study|Study participation ongoing|99|||
164433107|NCT04988295|593957135|FG003|Overall Study|Study participation ongoing|119|||
164689895|NCT01332968|594887791|FG007|Follow-Up Period|Physician Decision|15|||
164689896|NCT01332968|594887784|FG000|Follow-Up Period|Progressive Disease|0|||
164689897|NCT01332968|594887785|FG001|Follow-Up Period|Progressive Disease|0|||
164689898|NCT01332968|594887786|FG002|Follow-Up Period|Progressive Disease|0|||
164689899|NCT01332968|594887787|FG003|Follow-Up Period|Progressive Disease|0|||
164281362|NCT00095173|593400664|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
164281363|NCT00095173|593400659|FG000|Open-Label Extension Phase (Period C)|Death|0|||
164281364|NCT00095173|593400660|FG001|Open-Label Extension Phase (Period C)|Death|0|||
164281365|NCT00095173|593400661|FG002|Open-Label Extension Phase (Period C)|Death|0|||
164281366|NCT00095173|593400662|FG003|Open-Label Extension Phase (Period C)|Death|0|||
164281367|NCT00095173|593400663|FG004|Open-Label Extension Phase (Period C)|Death|0|||
164281368|NCT00095173|593400664|FG005|Open-Label Extension Phase (Period C)|Death|1|||
164281369|NCT00095173|593400659|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
164281370|NCT00095173|593400660|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
164281371|NCT00095173|593400661|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
164585032|NCT01208181|594506077|FG003|Part 2|Physician Decision|2|||
164585033|NCT01208181|594506078|FG004|Part 2|Physician Decision|0|||
164585034|NCT01208181|594506074|FG000|Part 2|Non-compliance with study drug|0|||
164585035|NCT01208181|594506075|FG001|Part 2|Non-compliance with study drug|0|||
164585036|NCT01208181|594506076|FG002|Part 2|Non-compliance with study drug|1|||
164585037|NCT01208181|594506077|FG003|Part 2|Non-compliance with study drug|1|||
164689900|NCT01332968|594887788|FG004|Follow-Up Period|Progressive Disease|0|||
164689901|NCT01332968|594887789|FG005|Follow-Up Period|Progressive Disease|0|||
164689902|NCT01332968|594887790|FG006|Follow-Up Period|Progressive Disease|126|||
164689903|NCT01332968|594887791|FG007|Follow-Up Period|Progressive Disease|106|||
164689904|NCT01332968|594887784|FG000|Follow-Up Period|Protocol Violation|0|||
164689905|NCT01332968|594887785|FG001|Follow-Up Period|Protocol Violation|0|||
164281372|NCT00095173|593400662|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
164281373|NCT00095173|593400663|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
164281374|NCT00095173|593400664|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
164281375|NCT00095173|593400659|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
164281376|NCT00095173|593400660|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
164585038|NCT01208181|594506078|FG004|Part 2|Non-compliance with study drug|0|||
164585039|NCT01208181|594506074|FG000|Part 2|Lost to Follow-up|0|||
164585040|NCT01208181|594506075|FG001|Part 2|Lost to Follow-up|0|||
164585041|NCT01208181|594506076|FG002|Part 2|Lost to Follow-up|1|||
164585042|NCT01208181|594506077|FG003|Part 2|Lost to Follow-up|2|||
164585043|NCT01208181|594506078|FG004|Part 2|Lost to Follow-up|0|||
164585044|NCT01208181|594506074|FG000|Part 2|Lack of Efficacy|0|||
164585045|NCT01208181|594506075|FG001|Part 2|Lack of Efficacy|0|||
164585046|NCT01208181|594506076|FG002|Part 2|Lack of Efficacy|5|||
164585047|NCT01208181|594506077|FG003|Part 2|Lack of Efficacy|7|||
164585048|NCT01208181|594506078|FG004|Part 2|Lack of Efficacy|0|||
164281377|NCT00095173|593400661|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
164281378|NCT00095173|593400662|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
164281379|NCT00095173|593400663|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
164281380|NCT00095173|593400664|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
164585049|NCT00942708|594506079|FG000|Overall Study|Withdrawal by Subject|1|||
164585050|NCT01645930|594506085|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
164585051|NCT01645930|594506085|FG000|Overall Study|Progressive Disease|12|||
164585052|NCT01645930|594506085|FG000|Overall Study|Adverse Event|4|||
164689906|NCT01332968|594887786|FG002|Follow-Up Period|Protocol Violation|0|||
164689907|NCT01332968|594887787|FG003|Follow-Up Period|Protocol Violation|0|||
164689908|NCT01332968|594887788|FG004|Follow-Up Period|Protocol Violation|0|||
164689909|NCT01332968|594887789|FG005|Follow-Up Period|Protocol Violation|0|||
164689910|NCT01332968|594887790|FG006|Follow-Up Period|Protocol Violation|1|||
164689911|NCT01332968|594887791|FG007|Follow-Up Period|Protocol Violation|0|||
164689912|NCT01332968|594887784|FG000|Follow-Up Period|Withdrawal by Subject|0|||
164689913|NCT01332968|594887785|FG001|Follow-Up Period|Withdrawal by Subject|0|||
164689914|NCT01332968|594887786|FG002|Follow-Up Period|Withdrawal by Subject|0|||
164281381|NCT00095173|593400659|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
164281382|NCT00095173|593400660|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
164689915|NCT01332968|594887787|FG003|Follow-Up Period|Withdrawal by Subject|0|||
164689916|NCT01332968|594887788|FG004|Follow-Up Period|Withdrawal by Subject|0|||
164689917|NCT01332968|594887789|FG005|Follow-Up Period|Withdrawal by Subject|0|||
164689918|NCT01332968|594887790|FG006|Follow-Up Period|Withdrawal by Subject|29|||
164689919|NCT01332968|594887791|FG007|Follow-Up Period|Withdrawal by Subject|32|||
164689920|NCT01332968|594887784|FG000|Follow-Up Period|No reason provided|0|||
164689921|NCT01332968|594887785|FG001|Follow-Up Period|No reason provided|0|||
164689922|NCT01332968|594887786|FG002|Follow-Up Period|No reason provided|0|||
164689923|NCT01332968|594887787|FG003|Follow-Up Period|No reason provided|0|||
164689924|NCT01332968|594887788|FG004|Follow-Up Period|No reason provided|0|||
164689925|NCT01332968|594887789|FG005|Follow-Up Period|No reason provided|0|||
164689926|NCT01332968|594887790|FG006|Follow-Up Period|No reason provided|2|||
164689927|NCT01332968|594887791|FG007|Follow-Up Period|No reason provided|3|||
164689928|NCT00721955|594887796|FG000|Overall Study|Adverse Event|0|||
164689929|NCT00721955|594887797|FG001|Overall Study|Adverse Event|0|||
164689930|NCT00721955|594887798|FG002|Overall Study|Adverse Event|2|||
164281383|NCT00095173|593400661|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
164281384|NCT00095173|593400662|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
164281385|NCT00095173|593400663|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
164689931|NCT04194008|594887803|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
164689932|NCT04194008|594887803|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
164689933|NCT04194008|594887803|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
164689934|NCT04194008|594887803|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
164281386|NCT00095173|593400664|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
164281387|NCT00095173|593400659|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
164281388|NCT00095173|593400660|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
164281389|NCT00095173|593400661|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
164281390|NCT00095173|593400662|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
164281391|NCT00095173|593400663|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
164281392|NCT00095173|593400664|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
164281393|NCT00095173|593400659|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
164281394|NCT00095173|593400660|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
164344468|NCT01651039|593636938|FG000|Overall Study|Progressive Disease|22|||
164689935|NCT04194008|594887803|FG000|Treatment Phase With Nerivio|Missing data|4|||
164585053|NCT01645930|594506085|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
164585054|NCT01645930|594506085|FG000|Overall Study|Withdrawal by Participant|2|||
164585055|NCT01645930|594506085|FG000|Overall Study|Reason not Defined|1|||
164585056|NCT02263365|594506086|FG000|Overall Study|Physician Decision|22|||
164585057|NCT02263365|594506087|FG001|Overall Study|Physician Decision|18|||
164585058|NCT00393458|594506090|FG000|Overall Study|Adverse Event|35|||
164585059|NCT00393458|594506091|FG001|Overall Study|Adverse Event|24|||
164585060|NCT00393458|594506092|FG002|Overall Study|Adverse Event|40|||
164585061|NCT00393458|594506093|FG003|Overall Study|Adverse Event|35|||
164585062|NCT00393458|594506090|FG000|Overall Study|Subject withdrew consent|27|||
164585063|NCT00393458|594506091|FG001|Overall Study|Subject withdrew consent|40|||
164585064|NCT00393458|594506092|FG002|Overall Study|Subject withdrew consent|33|||
164585065|NCT00393458|594506093|FG003|Overall Study|Subject withdrew consent|50|||
164585066|NCT00393458|594506090|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
164585067|NCT00393458|594506091|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
164585068|NCT00393458|594506092|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
164585069|NCT00393458|594506093|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
164585070|NCT00393458|594506090|FG000|Overall Study|Protocol deviation|11|||
164585071|NCT00393458|594506091|FG001|Overall Study|Protocol deviation|11|||
164585072|NCT00393458|594506092|FG002|Overall Study|Protocol deviation|11|||
164585073|NCT00393458|594506093|FG003|Overall Study|Protocol deviation|10|||
164585074|NCT00393458|594506090|FG000|Overall Study|Administrative problems|7|||
164585075|NCT00393458|594506091|FG001|Overall Study|Administrative problems|8|||
164585076|NCT00393458|594506092|FG002|Overall Study|Administrative problems|5|||
164585077|NCT00393458|594506093|FG003|Overall Study|Administrative problems|2|||
164585078|NCT00393458|594506090|FG000|Overall Study|Lost to Follow-up|5|||
164585079|NCT00393458|594506091|FG001|Overall Study|Lost to Follow-up|6|||
164585080|NCT00393458|594506092|FG002|Overall Study|Lost to Follow-up|5|||
164585081|NCT00393458|594506093|FG003|Overall Study|Lost to Follow-up|3|||
164585082|NCT00393458|594506090|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164585083|NCT00393458|594506091|FG001|Overall Study|Abnormal laboratory value(s)|1|||
164585084|NCT00393458|594506092|FG002|Overall Study|Abnormal laboratory value(s)|0|||
164585085|NCT00393458|594506093|FG003|Overall Study|Abnormal laboratory value(s)|0|||
164585086|NCT00393458|594506090|FG000|Overall Study|Death|1|||
164585087|NCT00393458|594506091|FG001|Overall Study|Death|1|||
164585088|NCT00393458|594506092|FG002|Overall Study|Death|5|||
164585089|NCT00393458|594506093|FG003|Overall Study|Death|5|||
164585090|NCT00393458|594506090|FG000|Overall Study|Abnormal test procedure result(s)|0|||
164585091|NCT00393458|594506091|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164585092|NCT00393458|594506092|FG002|Overall Study|Abnormal test procedure result(s)|1|||
164585093|NCT00393458|594506093|FG003|Overall Study|Abnormal test procedure result(s)|2|||
164585094|NCT00393458|594506090|FG000|Overall Study|Subject no longer requires study drug|0|||
164585095|NCT00393458|594506091|FG001|Overall Study|Subject no longer requires study drug|1|||
164585096|NCT00393458|594506092|FG002|Overall Study|Subject no longer requires study drug|0|||
164585097|NCT00393458|594506093|FG003|Overall Study|Subject no longer requires study drug|0|||
164585098|NCT02519231|594506100|FG000|Overall Study|Lost to Follow-up|2|||
164585099|NCT02519231|594506101|FG001|Overall Study|Lost to Follow-up|5|||
164585100|NCT02519231|594506100|FG000|Overall Study|Withdrawal by Subject|0|||
164585101|NCT02519231|594506101|FG001|Overall Study|Withdrawal by Subject|1|||
164585102|NCT00447421|594506102|FG000|Overall Study|Lack of Efficacy|1|||
164585103|NCT00447421|594506102|FG000|Overall Study|Adverse Event|3|||
164585104|NCT00447421|594506102|FG000|Overall Study|Sponsor Decision|2|||
164585105|NCT02725177|594506103|FG000|Overall Study|Physician Decision|4|||
164585106|NCT02725177|594506103|FG000|Overall Study|Adverse Event|1|||
164585107|NCT01056523|594506104|FG000|Overall Study|Death|1|||
164585108|NCT01056523|594506105|FG001|Overall Study|Death|0|||
164585109|NCT01056523|594506106|FG002|Overall Study|Death|2|||
164585110|NCT01056523|594506107|FG003|Overall Study|Death|3|||
164585111|NCT01056523|594506108|FG004|Overall Study|Death|0|||
164585112|NCT01056523|594506109|FG005|Overall Study|Death|0|||
164585113|NCT01056523|594506110|FG006|Overall Study|Death|1|||
164585114|NCT01988012|594507876|FG000|Overall Study|Adverse Event|5|||
164585115|NCT01988012|594507876|FG000|Overall Study|Insufficient Therapeutic Response|3|||
164585116|NCT01988012|594507876|FG000|Overall Study|Patient Withdrawal of Consent|4|||
164585117|NCT01988012|594507876|FG000|Overall Study|Lost to Follow-up|1|||
164281395|NCT00095173|593400661|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
164585118|NCT01988012|594507876|FG000|Overall Study|Physician Decision|1|||
164585119|NCT01988012|594507876|FG000|Overall Study|Protocol Violation|1|||
164585120|NCT01058369|594507877|FG000|Overall Study|Adverse Event|1|||
164585121|NCT01058369|594507877|FG000|Overall Study|Early termination study|1|||
164585122|NCT01666444|594507880|FG000|Overall Study|Did not initiate treatment|2|||
164585123|NCT01666444|594507881|FG001|Overall Study|Did not initiate treatment|1|||
164585124|NCT01650779|594507883|FG000|Overall Study|Withdrawal by Subject|1|||
164585125|NCT03567291|594507885|FG000|Period I|Adverse Event|14|||
164585126|NCT03567291|594507886|FG001|Period I|Adverse Event|0|||
164689936|NCT04194008|594887803|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
164689937|NCT01785615|594887804|FG000|Dietary Phase|Lost to Follow-up|0|||
164689938|NCT01785615|594887805|FG001|Dietary Phase|Lost to Follow-up|0|||
164689939|NCT01785615|594887806|FG002|Dietary Phase|Lost to Follow-up|0|||
164689940|NCT01785615|594887807|FG003|Dietary Phase|Lost to Follow-up|24|||
164689941|NCT02522780|594887808|FG000|Overall Study|Consent withdrawn by subject|5|||
164689942|NCT02522780|594887809|FG001|Overall Study|Consent withdrawn by subject|7|||
164689943|NCT02522780|594887808|FG000|Overall Study|Protocol deviation|1|||
164689944|NCT02522780|594887809|FG001|Overall Study|Protocol deviation|3|||
164689945|NCT02522780|594887808|FG000|Overall Study|Subject refused endoscopic procedure|0|||
164689946|NCT02522780|594887809|FG001|Overall Study|Subject refused endoscopic procedure|1|||
164689947|NCT02522780|594887808|FG000|Overall Study|Adverse event, non-fatal|11|||
164689948|NCT02522780|594887809|FG001|Overall Study|Adverse event, non-fatal|16|||
164689949|NCT00926367|594887810|FG000|Overall Study|Withdrawal by Subject|0|||
164689950|NCT00926367|594887811|FG001|Overall Study|Withdrawal by Subject|1|||
164689951|NCT00926367|594887810|FG000|Overall Study|Lost to Follow-up|1|||
164689952|NCT00926367|594887811|FG001|Overall Study|Lost to Follow-up|0|||
164689953|NCT00926367|594887810|FG000|Overall Study|Skin Irritation|1|||
164689954|NCT00926367|594887811|FG001|Overall Study|Skin Irritation|2|||
164689955|NCT01517867|594887812|FG000|Overall Study|never started treatment|29|||
164281396|NCT00095173|593400662|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
164281397|NCT00095173|593400663|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
164281398|NCT00095173|593400664|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
164281399|NCT00095173|593400659|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
164281400|NCT00095173|593400660|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
164281401|NCT00095173|593400661|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
164281402|NCT00095173|593400662|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
164281403|NCT00095173|593400663|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
164281404|NCT00095173|593400664|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
164585127|NCT03567291|594507887|FG002|Period I|Adverse Event|0|||
164585128|NCT03567291|594507888|FG003|Period I|Adverse Event|0|||
164585129|NCT03567291|594507885|FG000|Period I|Protocol Violation|1|||
164585130|NCT03567291|594507886|FG001|Period I|Protocol Violation|0|||
164585131|NCT03567291|594507887|FG002|Period I|Protocol Violation|0|||
164585132|NCT03567291|594507888|FG003|Period I|Protocol Violation|0|||
164689956|NCT01517867|594887813|FG001|Overall Study|never started treatment|32|||
164689957|NCT01517867|594887812|FG000|Overall Study|Withdrawal by Subject|34|||
164281405|NCT00095173|593400659|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
164281406|NCT00095173|593400660|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
164281407|NCT00095173|593400661|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
164281408|NCT00095173|593400662|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
164281409|NCT00095173|593400663|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
164281410|NCT00095173|593400664|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
164281411|NCT00095173|593400659|FG000|Open-Label Extension Phase (Period C)|Other|0|||
164689958|NCT01517867|594887813|FG001|Overall Study|Withdrawal by Subject|30|||
164689959|NCT01517867|594887812|FG000|Overall Study|Still in treatment at study end|0|||
164689960|NCT01517867|594887813|FG001|Overall Study|Still in treatment at study end|3|||
164689961|NCT01266603|594887814|FG000|Overall Study|Adverse Event|1|||
164689962|NCT01266603|594887814|FG000|Overall Study|Lack of Efficacy|14|||
164689963|NCT01266603|594887814|FG000|Overall Study|Withdrawal by Subject|1|||
164689964|NCT01266603|594887814|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
164689965|NCT02725411|594887817|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
164689966|NCT02725411|594887818|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
164689967|NCT02725411|594887819|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
164689968|NCT02725411|594887817|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
164689969|NCT02725411|594887818|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
164689970|NCT02725411|594887819|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
164689971|NCT02725411|594887817|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
164689972|NCT02725411|594887818|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
164689973|NCT02725411|594887819|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
164689974|NCT02725411|594887817|FG000|Treatment Period (56 Weeks)|Other|1|||
164689975|NCT02725411|594887818|FG001|Treatment Period (56 Weeks)|Other|4|||
164689976|NCT02725411|594887819|FG002|Treatment Period (56 Weeks)|Other|5|||
164689977|NCT02725411|594887817|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
164689978|NCT02725411|594887818|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
164689979|NCT02725411|594887819|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
164689980|NCT02725411|594887817|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
164689981|NCT02725411|594887818|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
164689982|NCT02725411|594887819|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
164689983|NCT02725411|594887817|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
164689984|NCT02725411|594887818|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
164689985|NCT02725411|594887819|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
164689986|NCT02725411|594887817|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
164689987|NCT02725411|594887818|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
164689988|NCT02725411|594887819|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
164689989|NCT02725411|594887817|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
164689990|NCT02725411|594887818|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
164689991|NCT02725411|594887819|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
164689992|NCT02725411|594887817|FG000|Follow-up Period (24 Weeks)|Other|1|||
164689993|NCT02725411|594887818|FG001|Follow-up Period (24 Weeks)|Other|4|||
164689994|NCT02725411|594887819|FG002|Follow-up Period (24 Weeks)|Other|2|||
164689995|NCT02725411|594887817|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
164689996|NCT02725411|594887818|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
164689997|NCT02725411|594887819|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
164689998|NCT04307849|594887820|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
164689999|NCT04307849|594887821|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
164690000|NCT04307849|594887822|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
164690001|NCT04307849|594887823|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
164690002|NCT04307849|594887824|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
164690003|NCT04307849|594887825|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
164690004|NCT04307849|594887820|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
164690005|NCT04307849|594887821|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
164690006|NCT04307849|594887822|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
164690007|NCT04307849|594887823|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
164690008|NCT04307849|594887824|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
164690009|NCT04307849|594887825|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
164690010|NCT04307849|594887820|FG000|Overall Study|Family member did not want them to continue|0|||
164690011|NCT04307849|594887821|FG001|Overall Study|Family member did not want them to continue|0|||
164690012|NCT04307849|594887822|FG002|Overall Study|Family member did not want them to continue|1|||
164690013|NCT04307849|594887823|FG003|Overall Study|Family member did not want them to continue|0|||
164690014|NCT04307849|594887824|FG004|Overall Study|Family member did not want them to continue|0|||
164690015|NCT04307849|594887825|FG005|Overall Study|Family member did not want them to continue|0|||
164281412|NCT00095173|593400660|FG001|Open-Label Extension Phase (Period C)|Other|0|||
164281413|NCT00095173|593400661|FG002|Open-Label Extension Phase (Period C)|Other|0|||
164585133|NCT03567291|594507885|FG000|Period I|Withdrawal by Subject|23|||
164585134|NCT03567291|594507886|FG001|Period I|Withdrawal by Subject|0|||
164585135|NCT03567291|594507887|FG002|Period I|Withdrawal by Subject|0|||
164585136|NCT03567291|594507888|FG003|Period I|Withdrawal by Subject|0|||
164585137|NCT03567291|594507885|FG000|Period I|Lost to Follow-up|2|||
164585138|NCT03567291|594507886|FG001|Period I|Lost to Follow-up|0|||
164585139|NCT03567291|594507887|FG002|Period I|Lost to Follow-up|0|||
164585140|NCT03567291|594507888|FG003|Period I|Lost to Follow-up|0|||
164690016|NCT04307849|594887820|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
164690017|NCT04307849|594887821|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
164585141|NCT03567291|594507885|FG000|Period I|Terminated by sponsor|44|||
164585142|NCT03567291|594507886|FG001|Period I|Terminated by sponsor|0|||
164690018|NCT04307849|594887822|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
164690019|NCT04307849|594887823|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
164690020|NCT04307849|594887824|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
164690021|NCT04307849|594887825|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
164690022|NCT02654015|594887828|FG000|Overall Study|Death|12|||
164690023|NCT02654015|594887828|FG000|Overall Study|Lost to Follow-up|3|||
164690024|NCT02418754|594887829|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
164690025|NCT02418754|594887830|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
164690026|NCT02418754|594887831|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
164690027|NCT02418754|594887832|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
164690028|NCT02418754|594887833|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
164690029|NCT02418754|594887829|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
164690030|NCT02418754|594887830|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
164690031|NCT02418754|594887831|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
164690032|NCT02418754|594887832|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
164585143|NCT03567291|594507887|FG002|Period I|Terminated by sponsor|0|||
164585144|NCT03567291|594507888|FG003|Period I|Terminated by sponsor|0|||
164585145|NCT03567291|594507885|FG000|Period I|Missing or unknown|7|||
164585146|NCT03567291|594507886|FG001|Period I|Missing or unknown|0|||
164585147|NCT03567291|594507887|FG002|Period I|Missing or unknown|0|||
164585148|NCT03567291|594507888|FG003|Period I|Missing or unknown|0|||
164585149|NCT03567291|594507885|FG000|Period II|Adverse Event|0|||
164585150|NCT03567291|594507886|FG001|Period II|Adverse Event|1|||
164585151|NCT03567291|594507887|FG002|Period II|Adverse Event|0|||
164585152|NCT03567291|594507888|FG003|Period II|Adverse Event|0|||
164585153|NCT03567291|594507885|FG000|Period II|Missing or unknown|0|||
164585154|NCT03567291|594507886|FG001|Period II|Missing or unknown|2|||
164585155|NCT03567291|594507887|FG002|Period II|Missing or unknown|1|||
164585156|NCT03567291|594507888|FG003|Period II|Missing or unknown|0|||
164585157|NCT03567291|594507885|FG000|Period III|Adverse Event|0|||
164585158|NCT03567291|594507886|FG001|Period III|Adverse Event|0|||
164585159|NCT03567291|594507887|FG002|Period III|Adverse Event|0|||
164585160|NCT03567291|594507888|FG003|Period III|Adverse Event|4|||
164585161|NCT03567291|594507885|FG000|Period III|Withdrawal by Subject|0|||
164585162|NCT03567291|594507886|FG001|Period III|Withdrawal by Subject|0|||
164585163|NCT03567291|594507887|FG002|Period III|Withdrawal by Subject|0|||
164585164|NCT03567291|594507888|FG003|Period III|Withdrawal by Subject|4|||
164585165|NCT03567291|594507885|FG000|Period III|Lost to Follow-up|0|||
164585166|NCT03567291|594507886|FG001|Period III|Lost to Follow-up|0|||
164585167|NCT03567291|594507887|FG002|Period III|Lost to Follow-up|0|||
164585168|NCT03567291|594507888|FG003|Period III|Lost to Follow-up|1|||
164585169|NCT03567291|594507885|FG000|Period III|Terminated by sponsor|0|||
164585170|NCT03567291|594507886|FG001|Period III|Terminated by sponsor|0|||
164585171|NCT03567291|594507887|FG002|Period III|Terminated by sponsor|0|||
164585172|NCT03567291|594507888|FG003|Period III|Terminated by sponsor|68|||
164585173|NCT03567291|594507885|FG000|Period III|Missing or unknown|0|||
164690033|NCT02418754|594887833|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
164690034|NCT02418754|594887829|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
164690035|NCT02418754|594887830|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
164690036|NCT02418754|594887831|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
164690037|NCT02418754|594887832|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
164690038|NCT02418754|594887833|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
164690039|NCT02418754|594887829|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
164690040|NCT02418754|594887830|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
164690041|NCT02418754|594887831|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
164690042|NCT02418754|594887832|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
164585174|NCT03567291|594507886|FG001|Period III|Missing or unknown|0|||
164585175|NCT03567291|594507887|FG002|Period III|Missing or unknown|0|||
164585176|NCT03567291|594507888|FG003|Period III|Missing or unknown|8|||
164690043|NCT02418754|594887833|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
164690044|NCT02418754|594887829|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
164690045|NCT02418754|594887830|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
164142996|NCT00863772|592884484|FG000|Overall Study|Protocol Violation|2|||
164585177|NCT01103349|594507891|FG000|Overall Study|Adverse Event|8|||
164585178|NCT01103349|594507892|FG001|Overall Study|Adverse Event|5|||
164585179|NCT01103349|594507893|FG002|Overall Study|Adverse Event|3|||
164690046|NCT02418754|594887831|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
164690047|NCT02418754|594887832|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
164690048|NCT02418754|594887833|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
164690049|NCT02418754|594887829|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
164690050|NCT02418754|594887830|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
164585180|NCT01103349|594507891|FG000|Overall Study|Consent withdrawn|1|||
164585181|NCT01103349|594507892|FG001|Overall Study|Consent withdrawn|0|||
164585182|NCT01103349|594507893|FG002|Overall Study|Consent withdrawn|0|||
164585183|NCT01103349|594507891|FG000|Overall Study|Incorrectly included in the trial|1|||
164585184|NCT01103349|594507892|FG001|Overall Study|Incorrectly included in the trial|0|||
164585185|NCT01103349|594507893|FG002|Overall Study|Incorrectly included in the trial|0|||
164585186|NCT01103349|594507891|FG000|Overall Study|Withdrawal by Subject|1|||
164585187|NCT01103349|594507892|FG001|Overall Study|Withdrawal by Subject|1|||
164585188|NCT01103349|594507893|FG002|Overall Study|Withdrawal by Subject|0|||
164585189|NCT01103349|594507891|FG000|Overall Study|did not want to take trial medication|0|||
164585190|NCT01103349|594507892|FG001|Overall Study|did not want to take trial medication|1|||
164585191|NCT01103349|594507893|FG002|Overall Study|did not want to take trial medication|0|||
164585192|NCT01103349|594507891|FG000|Overall Study|forgot to take medication|0|||
164585193|NCT01103349|594507892|FG001|Overall Study|forgot to take medication|0|||
164585194|NCT01103349|594507893|FG002|Overall Study|forgot to take medication|1|||
164585195|NCT01736683|594507899|FG000|Overall Study|Disease Relapse|0|||
164585196|NCT01736683|594507900|FG001|Overall Study|Disease Relapse|0|||
164585197|NCT01736683|594507901|FG002|Overall Study|Disease Relapse|2|||
164585198|NCT01736683|594507902|FG003|Overall Study|Disease Relapse|1|||
164585199|NCT01736683|594507903|FG004|Overall Study|Disease Relapse|0|||
164585200|NCT01736683|594507899|FG000|Overall Study|Adverse Event|0|||
164585201|NCT01736683|594507900|FG001|Overall Study|Adverse Event|2|||
164585202|NCT01736683|594507901|FG002|Overall Study|Adverse Event|2|||
164585203|NCT01736683|594507902|FG003|Overall Study|Adverse Event|3|||
164585204|NCT01736683|594507903|FG004|Overall Study|Adverse Event|2|||
164585205|NCT01736683|594507899|FG000|Overall Study|Withdrawal by Subject|0|||
164585206|NCT01736683|594507900|FG001|Overall Study|Withdrawal by Subject|0|||
164585207|NCT01736683|594507901|FG002|Overall Study|Withdrawal by Subject|3|||
164585208|NCT01736683|594507902|FG003|Overall Study|Withdrawal by Subject|1|||
164585209|NCT01736683|594507903|FG004|Overall Study|Withdrawal by Subject|1|||
164585210|NCT01736683|594507899|FG000|Overall Study|Lack of Therapeutic Effect|7|||
164585211|NCT01736683|594507900|FG001|Overall Study|Lack of Therapeutic Effect|4|||
164585212|NCT01736683|594507901|FG002|Overall Study|Lack of Therapeutic Effect|13|||
164585213|NCT01736683|594507902|FG003|Overall Study|Lack of Therapeutic Effect|20|||
164585214|NCT01736683|594507903|FG004|Overall Study|Lack of Therapeutic Effect|1|||
164585215|NCT01736683|594507899|FG000|Overall Study|Progressive Disease|0|||
164585216|NCT01736683|594507900|FG001|Overall Study|Progressive Disease|0|||
164585217|NCT01736683|594507901|FG002|Overall Study|Progressive Disease|0|||
164585218|NCT01736683|594507902|FG003|Overall Study|Progressive Disease|1|||
164585219|NCT01736683|594507903|FG004|Overall Study|Progressive Disease|0|||
164585220|NCT01736683|594507899|FG000|Overall Study|Other|0|||
164585221|NCT01736683|594507900|FG001|Overall Study|Other|0|||
164585222|NCT01736683|594507901|FG002|Overall Study|Other|1|||
164585223|NCT01736683|594507902|FG003|Overall Study|Other|9|||
164585224|NCT01736683|594507903|FG004|Overall Study|Other|1|||
164585225|NCT01936649|594507913|FG000|Overall Study|Withdrawal by Subject|4|||
164585226|NCT01936649|594507913|FG000|Overall Study|Physician Decision|2|||
164585227|NCT01936649|594507913|FG000|Overall Study|Protocol Violation|2|||
164585228|NCT01936649|594507913|FG000|Overall Study|Other than specified above|5|||
164585229|NCT03554005|594507916|FG000|Overall Study|Not in participant's best interest|0|||
164585230|NCT03554005|594507917|FG001|Overall Study|Not in participant's best interest|0|||
164585231|NCT03554005|594507918|FG002|Overall Study|Not in participant's best interest|0|||
164585232|NCT03554005|594507919|FG003|Overall Study|Not in participant's best interest|0|||
164585233|NCT03554005|594507920|FG004|Overall Study|Not in participant's best interest|0|||
164585234|NCT03554005|594507921|FG005|Overall Study|Not in participant's best interest|1|||
164585235|NCT03554005|594507916|FG000|Overall Study|Disease Progression|1|||
164585236|NCT03554005|594507917|FG001|Overall Study|Disease Progression|1|||
164690051|NCT02418754|594887831|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
164690052|NCT02418754|594887832|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
164690053|NCT02418754|594887833|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
164690054|NCT02418754|594887829|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
164585237|NCT03554005|594507918|FG002|Overall Study|Disease Progression|1|||
164585238|NCT03554005|594507919|FG003|Overall Study|Disease Progression|1|||
164585239|NCT03554005|594507920|FG004|Overall Study|Disease Progression|5|||
164585240|NCT03554005|594507921|FG005|Overall Study|Disease Progression|6|||
164585241|NCT03554005|594507916|FG000|Overall Study|Adverse Event|0|||
164585242|NCT03554005|594507917|FG001|Overall Study|Adverse Event|0|||
164585243|NCT03554005|594507918|FG002|Overall Study|Adverse Event|0|||
164585244|NCT03554005|594507919|FG003|Overall Study|Adverse Event|0|||
164585245|NCT03554005|594507920|FG004|Overall Study|Adverse Event|0|||
164585246|NCT03554005|594507921|FG005|Overall Study|Adverse Event|3|||
164585247|NCT03554005|594507916|FG000|Overall Study|Physician Decision|0|||
164585248|NCT03554005|594507917|FG001|Overall Study|Physician Decision|0|||
164585249|NCT03554005|594507918|FG002|Overall Study|Physician Decision|0|||
164585250|NCT03554005|594507919|FG003|Overall Study|Physician Decision|0|||
164585251|NCT03554005|594507920|FG004|Overall Study|Physician Decision|1|||
164690055|NCT02418754|594887830|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
164690056|NCT02418754|594887831|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
164585252|NCT03554005|594507921|FG005|Overall Study|Physician Decision|0|||
164585253|NCT03554005|594507916|FG000|Overall Study|Other|0|||
164585254|NCT03554005|594507917|FG001|Overall Study|Other|0|||
164585255|NCT03554005|594507918|FG002|Overall Study|Other|0|||
164585256|NCT03554005|594507919|FG003|Overall Study|Other|0|||
164585257|NCT03554005|594507920|FG004|Overall Study|Other|0|||
164585258|NCT03554005|594507921|FG005|Overall Study|Other|1|||
164585259|NCT00631488|594507922|FG000|Overall Study|Adverse Event|1|||
164585260|NCT00631488|594507923|FG001|Overall Study|Adverse Event|0|||
164585261|NCT00631488|594507924|FG002|Overall Study|Adverse Event|0|||
164585262|NCT00631488|594507922|FG000|Overall Study|Lost to Follow-up|2|||
164585263|NCT00631488|594507923|FG001|Overall Study|Lost to Follow-up|2|||
164585264|NCT00631488|594507924|FG002|Overall Study|Lost to Follow-up|0|||
164585265|NCT00631488|594507922|FG000|Overall Study|Physician Decision|1|||
164585266|NCT00631488|594507923|FG001|Overall Study|Physician Decision|0|||
164585267|NCT00631488|594507924|FG002|Overall Study|Physician Decision|1|||
164585268|NCT00631488|594507922|FG000|Overall Study|Protocol Violation|0|||
164585269|NCT00631488|594507923|FG001|Overall Study|Protocol Violation|0|||
164585270|NCT00631488|594507924|FG002|Overall Study|Protocol Violation|1|||
164585271|NCT02855411|594507930|FG000|Overall Study|Study terminated by sponsor|21|||
164585272|NCT02855411|594507930|FG000|Overall Study|Does not meet entrance criteria|14|||
164585273|NCT00589472|594507933|FG000|Overall Study|Adverse Event|1|||
164585274|NCT00117338|594507934|FG000|Overall Study|Adverse Event|0|||
164585275|NCT00117338|594507935|FG001|Overall Study|Adverse Event|1|||
164585276|NCT00117338|594507934|FG000|Overall Study|Protocol Violation|3|||
164585277|NCT00117338|594507935|FG001|Overall Study|Protocol Violation|2|||
164585278|NCT00117338|594507934|FG000|Overall Study|Withdrawal by Subject|1|||
164585279|NCT00117338|594507935|FG001|Overall Study|Withdrawal by Subject|0|||
164585280|NCT00117338|594507934|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
164585281|NCT00117338|594507935|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
164585282|NCT00117338|594507934|FG000|Overall Study|Lack of Efficacy|0|||
164585283|NCT00117338|594507935|FG001|Overall Study|Lack of Efficacy|1|||
164585284|NCT01380093|594507936|FG000|Naloxone Challenge Phase|Screen failures|21|||
164585285|NCT01380093|594507937|FG001|Naloxone Challenge Phase|Screen failures|0|||
164433108|NCT00943605|593957138|FG000|Overall Study|Study termination|30|||
164433109|NCT00943605|593957139|FG001|Overall Study|Study termination|30|||
164433110|NCT02232178|593957141|FG000|Overall Study|Lost to Follow-up|0|||
164433111|NCT02232178|593957142|FG001|Overall Study|Lost to Follow-up|1|||
164433112|NCT02232178|593957143|FG002|Overall Study|Lost to Follow-up|0|||
164433113|NCT02232178|593957141|FG000|Overall Study|ineligibility|0|||
164433114|NCT02232178|593957142|FG001|Overall Study|ineligibility|0|||
164433115|NCT02232178|593957143|FG002|Overall Study|ineligibility|1|||
164433116|NCT02232178|593957141|FG000|Overall Study|surgical complication|1|||
164433117|NCT02232178|593957142|FG001|Overall Study|surgical complication|0|||
164433118|NCT02232178|593957143|FG002|Overall Study|surgical complication|0|||
164433119|NCT01956669|593957146|FG000|Overall Study|Disease Progression|12|||
164433120|NCT01956669|593957147|FG001|Overall Study|Disease Progression|7|||
164433121|NCT01956669|593957148|FG002|Overall Study|Disease Progression|7|||
164433122|NCT01956669|593957149|FG003|Overall Study|Disease Progression|8|||
164690057|NCT02418754|594887832|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
164690058|NCT02418754|594887833|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
164690059|NCT02418754|594887829|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
164690060|NCT02418754|594887830|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
164585286|NCT01380093|594507938|FG002|Naloxone Challenge Phase|Screen failures|0|||
164585287|NCT01380093|594507939|FG003|Naloxone Challenge Phase|Screen failures|0|||
164585288|NCT01380093|594507940|FG004|Naloxone Challenge Phase|Screen failures|0|||
164585289|NCT01380093|594507941|FG005|Naloxone Challenge Phase|Screen failures|0|||
164585290|NCT01380093|594507942|FG006|Naloxone Challenge Phase|Screen failures|0|||
164585291|NCT01380093|594507943|FG007|Naloxone Challenge Phase|Screen failures|0|||
164690061|NCT02418754|594887831|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
164690062|NCT02418754|594887832|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
164585292|NCT01380093|594507944|FG008|Naloxone Challenge Phase|Screen failures|0|||
164585293|NCT01380093|594507936|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
164585294|NCT01380093|594507937|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
164433123|NCT01956669|593957150|FG004|Overall Study|Disease Progression|4|||
164433124|NCT01956669|593957151|FG005|Overall Study|Disease Progression|3|||
164433125|NCT01956669|593957152|FG006|Overall Study|Disease Progression|5|||
164433126|NCT01956669|593957146|FG000|Overall Study|Adverse Event|0|||
164585295|NCT01380093|594507938|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
164585296|NCT01380093|594507939|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
164585297|NCT01380093|594507940|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
164585298|NCT01380093|594507941|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
164585299|NCT01380093|594507942|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
164585300|NCT01380093|594507943|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
164585301|NCT01380093|594507944|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
164585302|NCT01380093|594507936|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
164585303|NCT01380093|594507937|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
164585304|NCT01380093|594507938|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
164585305|NCT01380093|594507939|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
164585306|NCT01380093|594507940|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
164585307|NCT01380093|594507941|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
164585308|NCT01380093|594507942|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
164585309|NCT01380093|594507943|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
164585310|NCT01380093|594507944|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
164585311|NCT01380093|594507936|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
164585312|NCT01380093|594507937|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
164585313|NCT01380093|594507938|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
164585314|NCT01380093|594507939|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
164585315|NCT01380093|594507940|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
164585316|NCT01380093|594507941|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
164585317|NCT01380093|594507942|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
164585318|NCT01380093|594507943|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
164585319|NCT01380093|594507944|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
164585320|NCT01380093|594507936|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
164585321|NCT01380093|594507937|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
164585322|NCT01380093|594507938|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
164585323|NCT01380093|594507939|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
164585324|NCT01380093|594507940|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
164585325|NCT01380093|594507941|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
164585326|NCT01380093|594507942|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
164585327|NCT01380093|594507943|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
164585328|NCT01380093|594507944|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
164585329|NCT01380093|594507936|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
164585330|NCT01380093|594507937|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
164585331|NCT01380093|594507938|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
164585332|NCT01380093|594507939|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
164585333|NCT01380093|594507940|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
164585334|NCT01380093|594507941|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
164585335|NCT01380093|594507942|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
164585336|NCT01380093|594507943|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
164585337|NCT01380093|594507944|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
164585338|NCT01380093|594507936|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
164585339|NCT01380093|594507937|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
164585340|NCT01380093|594507938|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
164585341|NCT01380093|594507939|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
164585342|NCT01380093|594507940|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
164585343|NCT01380093|594507941|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
164344469|NCT03727230|593636939|FG000|Overall Study|Lost to Follow-up|12|||
164585344|NCT01380093|594507942|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
164585345|NCT01380093|594507943|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
164585346|NCT01380093|594507944|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
164585347|NCT01380093|594507936|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
164585348|NCT01380093|594507937|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
164585349|NCT01380093|594507938|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
164585350|NCT01380093|594507939|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
164585351|NCT01380093|594507940|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
164585352|NCT01380093|594507941|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
164585353|NCT01380093|594507942|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
164585354|NCT01380093|594507943|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
164585355|NCT01380093|594507944|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
164585356|NCT01380093|594507936|FG000|Treatment Phase: Second Intervention|Other|0|||
164585357|NCT01380093|594507937|FG001|Treatment Phase: Second Intervention|Other|0|||
164585358|NCT01380093|594507938|FG002|Treatment Phase: Second Intervention|Other|0|||
164585359|NCT01380093|594507939|FG003|Treatment Phase: Second Intervention|Other|1|||
164585360|NCT01380093|594507940|FG004|Treatment Phase: Second Intervention|Other|0|||
164281414|NCT00095173|593400662|FG003|Open-Label Extension Phase (Period C)|Other|4|||
164281415|NCT00095173|593400663|FG004|Open-Label Extension Phase (Period C)|Other|6|||
164281416|NCT00095173|593400664|FG005|Open-Label Extension Phase (Period C)|Other|8|||
164281417|NCT02161757|593400671|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
164281418|NCT02161757|593400672|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
164281419|NCT02161757|593400673|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
164281420|NCT02161757|593400671|FG000|Treatment Through Study Completion|Adverse Event|1|||
164281421|NCT02161757|593400672|FG001|Treatment Through Study Completion|Adverse Event|1|||
164281422|NCT02161757|593400673|FG002|Treatment Through Study Completion|Adverse Event|0|||
164281423|NCT02161757|593400671|FG000|Treatment Through Study Completion|Protocol Violation|0|||
164281424|NCT02161757|593400672|FG001|Treatment Through Study Completion|Protocol Violation|1|||
164281425|NCT02161757|593400673|FG002|Treatment Through Study Completion|Protocol Violation|2|||
164281426|NCT02161757|593400671|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
164281427|NCT02161757|593400672|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
164281428|NCT02161757|593400673|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
164281429|NCT02161757|593400671|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
164281430|NCT02161757|593400672|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
164281431|NCT02161757|593400673|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
164344470|NCT03600818|593636940|FG000|Overall Study|Adverse Event|4|||
164585361|NCT01380093|594507941|FG005|Treatment Phase: Second Intervention|Other|0|||
164585362|NCT01380093|594507942|FG006|Treatment Phase: Second Intervention|Other|0|||
164585363|NCT01380093|594507943|FG007|Treatment Phase: Second Intervention|Other|0|||
164585364|NCT01380093|594507944|FG008|Treatment Phase: Second Intervention|Other|0|||
164585365|NCT01380093|594507936|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
164585366|NCT01380093|594507937|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
164585367|NCT01380093|594507938|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
164281432|NCT02161757|593400671|FG000|Treatment Through Study Completion|Other|20|||
164281433|NCT02161757|593400672|FG001|Treatment Through Study Completion|Other|19|||
164281434|NCT02161757|593400673|FG002|Treatment Through Study Completion|Other|12|||
164281435|NCT02161757|593400671|FG000|Treatment Through Study Completion|Death|2|||
164281436|NCT02161757|593400672|FG001|Treatment Through Study Completion|Death|1|||
164281437|NCT02161757|593400673|FG002|Treatment Through Study Completion|Death|1|||
164281438|NCT00391625|593400674|FG000|Month 14|Withdrawal by Subject|1|||
164281439|NCT00391625|593400674|FG000|Month 50|Physician Decision|1|||
164281440|NCT02106403|593400681|FG000|Follow-Up Visit 3|Other Reason|0|||
164281441|NCT02106403|593400682|FG001|Follow-Up Visit 3|Other Reason|0|||
164281442|NCT02106403|593400683|FG002|Follow-Up Visit 3|Other Reason|0|||
164281443|NCT02106403|593400684|FG003|Follow-Up Visit 3|Other Reason|0|||
164281444|NCT02106403|593400685|FG004|Follow-Up Visit 3|Other Reason|0|||
164281445|NCT02106403|593400686|FG005|Follow-Up Visit 3|Other Reason|1|||
164281446|NCT02343406|593400687|FG000|Overall Study|Progressive disease|72|||
164281447|NCT02343406|593400688|FG001|Overall Study|Progressive disease|70|||
164585368|NCT01380093|594507939|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
164585369|NCT01380093|594507940|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
164585370|NCT01380093|594507941|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
164281448|NCT02343406|593400689|FG002|Overall Study|Progressive disease|43|||
164281449|NCT02343406|593400690|FG003|Overall Study|Progressive disease|15|||
164281450|NCT02343406|593400691|FG004|Overall Study|Progressive disease|5|||
164281451|NCT02343406|593400687|FG000|Overall Study|Adverse Event|6|||
164281452|NCT02343406|593400688|FG001|Overall Study|Adverse Event|8|||
164281453|NCT02343406|593400689|FG002|Overall Study|Adverse Event|6|||
164281454|NCT02343406|593400690|FG003|Overall Study|Adverse Event|3|||
164281455|NCT02343406|593400691|FG004|Overall Study|Adverse Event|0|||
164281456|NCT02343406|593400687|FG000|Overall Study|Withdrawal by Subject|6|||
164281457|NCT02343406|593400688|FG001|Overall Study|Withdrawal by Subject|4|||
164281458|NCT02343406|593400689|FG002|Overall Study|Withdrawal by Subject|8|||
164281459|NCT02343406|593400690|FG003|Overall Study|Withdrawal by Subject|3|||
164281460|NCT02343406|593400691|FG004|Overall Study|Withdrawal by Subject|0|||
164281461|NCT02343406|593400687|FG000|Overall Study|Death|2|||
164281462|NCT02343406|593400688|FG001|Overall Study|Death|1|||
164281463|NCT02343406|593400689|FG002|Overall Study|Death|0|||
164281464|NCT02343406|593400690|FG003|Overall Study|Death|0|||
164281465|NCT02343406|593400691|FG004|Overall Study|Death|0|||
164281466|NCT02343406|593400687|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
164281467|NCT02343406|593400688|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
164281468|NCT02343406|593400689|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
164281469|NCT02343406|593400690|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
164281470|NCT02343406|593400691|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
164281471|NCT02343406|593400687|FG000|Overall Study|Other primary malignancy|0|||
164281472|NCT02343406|593400688|FG001|Overall Study|Other primary malignancy|1|||
164281473|NCT02343406|593400689|FG002|Overall Study|Other primary malignancy|0|||
164281474|NCT02343406|593400690|FG003|Overall Study|Other primary malignancy|0|||
164281475|NCT02343406|593400691|FG004|Overall Study|Other primary malignancy|0|||
164281476|NCT02343406|593400687|FG000|Overall Study|Other, not specified|2|||
164281477|NCT02343406|593400688|FG001|Overall Study|Other, not specified|1|||
164281478|NCT02343406|593400689|FG002|Overall Study|Other, not specified|1|||
164585371|NCT01380093|594507942|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
164281479|NCT02343406|593400690|FG003|Overall Study|Other, not specified|4|||
164281480|NCT02343406|593400691|FG004|Overall Study|Other, not specified|0|||
164281481|NCT00874848|593400692|FG000|Overall Study|Adverse Event|13|||
164281482|NCT00874848|593400693|FG001|Overall Study|Adverse Event|2|||
164281483|NCT00874848|593400692|FG000|Overall Study|Progressive neoplastic disease|38|||
164281484|NCT00874848|593400693|FG001|Overall Study|Progressive neoplastic disease|18|||
164281485|NCT00874848|593400692|FG000|Overall Study|Withdrawal by Subject|7|||
164585372|NCT01380093|594507943|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
164585373|NCT01380093|594507944|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
164585374|NCT01380093|594507936|FG000|Treatment Phase: Third Intervention|Other|0|||
164585375|NCT01380093|594507937|FG001|Treatment Phase: Third Intervention|Other|0|||
164585376|NCT01380093|594507938|FG002|Treatment Phase: Third Intervention|Other|0|||
164585377|NCT01380093|594507939|FG003|Treatment Phase: Third Intervention|Other|0|||
164585378|NCT01380093|594507940|FG004|Treatment Phase: Third Intervention|Other|0|||
164281486|NCT00874848|593400693|FG001|Overall Study|Withdrawal by Subject|4|||
164281487|NCT00874848|593400692|FG000|Overall Study|Noncompliance|1|||
164281488|NCT00874848|593400693|FG001|Overall Study|Noncompliance|1|||
164281489|NCT00874848|593400692|FG000|Overall Study|Failure to comply with protocol|0|||
164281490|NCT00874848|593400693|FG001|Overall Study|Failure to comply with protocol|1|||
164585379|NCT01380093|594507941|FG005|Treatment Phase: Third Intervention|Other|0|||
164585380|NCT01380093|594507942|FG006|Treatment Phase: Third Intervention|Other|0|||
164585381|NCT01380093|594507943|FG007|Treatment Phase: Third Intervention|Other|0|||
164585382|NCT01380093|594507944|FG008|Treatment Phase: Third Intervention|Other|1|||
164585383|NCT01342640|594507945|FG000|Overall Study|Adverse Event|3|||
164585384|NCT01342640|594507945|FG000|Overall Study|Protocol Violation|16|||
164585385|NCT01342640|594507945|FG000|Overall Study|Lost to Follow-up|21|||
164585386|NCT01342640|594507945|FG000|Overall Study|Other|1|||
164585387|NCT03988751|594507948|FG000|Overall Study|Withdrawal by Subject|1|||
164585388|NCT03988751|594507949|FG001|Overall Study|Withdrawal by Subject|0|||
164281491|NCT00874848|593400692|FG000|Overall Study|Physician Decision|0|||
164281492|NCT00874848|593400693|FG001|Overall Study|Physician Decision|2|||
164281493|NCT01496846|593400694|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
164281494|NCT01496846|593400695|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
164281495|NCT01496846|593400696|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
164281496|NCT01496846|593400697|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
164281497|NCT01496846|593400698|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
164585389|NCT03988751|594507948|FG000|Overall Study|Protocol Violation|0|||
164585390|NCT03988751|594507949|FG001|Overall Study|Protocol Violation|1|||
164585391|NCT00844883|594507950|FG000|Overall Study|Bridged to liver transplant|3|||
164585392|NCT00844883|594507950|FG000|Overall Study|Bridged to resection|1|||
164585393|NCT02240628|594507953|FG000|Overall Study|Physician Decision|6|||
164585394|NCT02240628|594507954|FG001|Overall Study|Physician Decision|5|||
164585395|NCT00850499|594507955|FG000|Overall Study|Adverse Event|3|||
164585396|NCT00850499|594507956|FG001|Overall Study|Adverse Event|1|||
164585397|NCT00850499|594507955|FG000|Overall Study|Lack of Efficacy|0|||
164585398|NCT00850499|594507956|FG001|Overall Study|Lack of Efficacy|1|||
164585399|NCT00552305|594507957|FG000|Overall Study|Adverse Event|43|||
164585400|NCT00552305|594507957|FG000|Overall Study|Lack of Efficacy|120|||
164585401|NCT00552305|594507957|FG000|Overall Study|Lost to Follow-up|4|||
164585402|NCT00552305|594507957|FG000|Overall Study|Protocol Violation|3|||
164585403|NCT00552305|594507957|FG000|Overall Study|Withdrawal by Subject|44|||
164585404|NCT00552305|594507957|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
164585405|NCT00552305|594507957|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
164585406|NCT00552305|594507957|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
164585407|NCT00552305|594507957|FG000|Overall Study|Unsatisfactory compliance|11|||
164585408|NCT00552305|594507957|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
164585409|NCT00552305|594507957|FG000|Overall Study|AE/Other: prohibited drug required|1|||
164585410|NCT00552305|594507957|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
164585411|NCT00552305|594507957|FG000|Overall Study|Other: Site closed|4|||
164585412|NCT00552305|594507957|FG000|Overall Study|Other: Personal problems|1|||
164585413|NCT00552305|594507957|FG000|Overall Study|Other: Unable to attend visits|1|||
164585414|NCT00552305|594507957|FG000|Overall Study|Other: Subject underwent surgery|4|||
164585415|NCT00552305|594507957|FG000|Overall Study|Other: Subject became pregnant|1|||
164585416|NCT00552305|594507957|FG000|Overall Study|Other: Health problems, not drug related|1|||
164585417|NCT00552305|594507957|FG000|Overall Study|Other: Subject moved from area|2|||
164585418|NCT00552305|594507957|FG000|Overall Study|Other: Subject incarcerated|1|||
164585419|NCT00552305|594507957|FG000|Overall Study|Other: Subject went to rehab|1|||
164585420|NCT01703819|594507958|FG000|Overall Study|Adverse Event|0|||
164585421|NCT01703819|594507959|FG001|Overall Study|Adverse Event|1|||
164585422|NCT01703819|594507958|FG000|Overall Study|Withdrawal by Subject|0|||
164585423|NCT01703819|594507959|FG001|Overall Study|Withdrawal by Subject|1|||
164585424|NCT01302041|594507960|FG000|Overall Study|Death|5|||
164585425|NCT01302041|594507960|FG000|Overall Study|Withdrawal by Subject|4|||
164585426|NCT01302041|594507960|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
164585427|NCT01302041|594507960|FG000|Overall Study|Other-Miscellaneous Reason|2|||
164585428|NCT02234583|594507965|FG000|Overall Study|Adverse Event|172|||
164585429|NCT02234583|594507966|FG001|Overall Study|Adverse Event|156|||
164585430|NCT02234583|594507965|FG000|Overall Study|Withdrawal by Subject|109|||
164585431|NCT02234583|594507966|FG001|Overall Study|Withdrawal by Subject|157|||
164585432|NCT02234583|594507965|FG000|Overall Study|Lost to Follow-up|0|||
164585433|NCT02234583|594507966|FG001|Overall Study|Lost to Follow-up|1|||
164585434|NCT02234583|594507965|FG000|Overall Study|Lack of Efficacy|58|||
164585435|NCT02234583|594507966|FG001|Overall Study|Lack of Efficacy|103|||
164585436|NCT02234583|594507965|FG000|Overall Study|Protocol Violation|35|||
164585437|NCT02234583|594507966|FG001|Overall Study|Protocol Violation|42|||
164585438|NCT02234583|594507965|FG000|Overall Study|Other|39|||
164585439|NCT02234583|594507966|FG001|Overall Study|Other|97|||
164585440|NCT01849250|594507967|FG000|Overall Study|Withdrawal by Subject|1|||
164585441|NCT01849250|594507968|FG001|Overall Study|Withdrawal by Subject|0|||
164585442|NCT01849250|594507967|FG000|Overall Study|Not Evaluable|5|||
164585443|NCT01849250|594507968|FG001|Overall Study|Not Evaluable|3|||
164585444|NCT01849250|594507967|FG000|Overall Study|Screen Failure|1|||
164585445|NCT01849250|594507968|FG001|Overall Study|Screen Failure|0|||
164585446|NCT00771030|594507971|FG000|Overall Study|Adverse Event|0|||
164585447|NCT00771030|594507972|FG001|Overall Study|Adverse Event|1|||
164585448|NCT00771030|594507973|FG002|Overall Study|Adverse Event|0|||
164585449|NCT00771030|594507974|FG003|Overall Study|Adverse Event|0|||
164585450|NCT00771030|594507975|FG004|Overall Study|Adverse Event|0|||
164585451|NCT00771030|594507976|FG005|Overall Study|Adverse Event|0|||
164585452|NCT00771030|594507977|FG006|Overall Study|Adverse Event|0|||
164585453|NCT01839188|594507978|FG000|Overall Study|Withdrawal by Subject|1|||
164585454|NCT01671488|594507985|FG000|Overall Study|Withdrawal by Subject|1|||
164585455|NCT03503773|594507986|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
164585456|NCT03503773|594507987|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
164585457|NCT03503773|594507986|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
164585458|NCT03503773|594507987|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
164585459|NCT03503773|594507986|FG000|Overall Study|Not completing the primary ABPM|3|||
164433127|NCT01956669|593957147|FG001|Overall Study|Adverse Event|2|||
164433128|NCT01956669|593957148|FG002|Overall Study|Adverse Event|2|||
164433129|NCT01956669|593957149|FG003|Overall Study|Adverse Event|1|||
164433130|NCT01956669|593957150|FG004|Overall Study|Adverse Event|0|||
164433131|NCT01956669|593957151|FG005|Overall Study|Adverse Event|0|||
164433132|NCT01956669|593957152|FG006|Overall Study|Adverse Event|0|||
164585460|NCT03503773|594507987|FG001|Overall Study|Not completing the primary ABPM|1|||
164585461|NCT03503773|594507986|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
164433133|NCT01956669|593957146|FG000|Overall Study|Physician Decision|0|||
164433134|NCT01956669|593957147|FG001|Overall Study|Physician Decision|2|||
164585462|NCT03503773|594507987|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
164585463|NCT02498821|594507988|FG000|Overall Study|Screen failure|3|||
164585464|NCT02498821|594507989|FG001|Overall Study|Screen failure|5|||
164585465|NCT01478347|594507990|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
164585466|NCT01478347|594507990|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
164585467|NCT01478347|594507990|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
164585468|NCT02613572|594507991|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
164585469|NCT02613572|594507992|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
164585470|NCT02613572|594507993|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
164585471|NCT02613572|594507991|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
164585472|NCT02613572|594507992|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
164585473|NCT02613572|594507993|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
164585474|NCT00312377|594507998|FG000|Overall Study|Death|403|||
164585475|NCT00312377|594507999|FG001|Overall Study|Death|418|||
164585476|NCT00312377|594507998|FG000|Overall Study|Withdrawal by Subject|23|||
164585477|NCT00312377|594507999|FG001|Overall Study|Withdrawal by Subject|30|||
164585478|NCT00312377|594507998|FG000|Overall Study|Lost to Follow-up|9|||
164585479|NCT00312377|594507999|FG001|Overall Study|Lost to Follow-up|12|||
164585480|NCT00312377|594507998|FG000|Overall Study|Non-compliance|0|||
164585481|NCT00312377|594507999|FG001|Overall Study|Non-compliance|2|||
164585482|NCT00312377|594507998|FG000|Overall Study|Randomised but never received treatment|6|||
164585483|NCT00312377|594507999|FG001|Overall Study|Randomised but never received treatment|6|||
164585484|NCT00312377|594507998|FG000|Overall Study|Discontinue treatment survival follow up|202|||
164585485|NCT00312377|594507999|FG001|Overall Study|Discontinue treatment survival follow up|200|||
164585486|NCT00312377|594507998|FG000|Overall Study|Site ended participation in study|1|||
164585487|NCT00312377|594507999|FG001|Overall Study|Site ended participation in study|0|||
164585488|NCT00231478|594508000|FG000|Overall Study|Protocol Violation|3|||
164585489|NCT00231478|594508001|FG001|Overall Study|Protocol Violation|2|||
164690063|NCT02418754|594887833|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
164690064|NCT02418754|594887829|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
164690065|NCT02418754|594887830|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
164690066|NCT02418754|594887831|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
164690067|NCT02418754|594887832|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
164690068|NCT02418754|594887833|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
164690069|NCT02418754|594887829|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
164690070|NCT02418754|594887830|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
164690071|NCT02418754|594887831|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
164690072|NCT02418754|594887832|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
164690073|NCT02418754|594887833|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
164690074|NCT02418754|594887829|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
164690075|NCT02418754|594887830|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
164690076|NCT02418754|594887831|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
164690077|NCT02418754|594887832|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
164690078|NCT02418754|594887833|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
164690079|NCT00761176|594887838|FG000|Overall Study|Death|1|||
164690080|NCT00761176|594887839|FG001|Overall Study|Death|0|||
164690081|NCT00761176|594887838|FG000|Overall Study|Withdrawal by Subject|1|||
164690082|NCT00761176|594887839|FG001|Overall Study|Withdrawal by Subject|1|||
164690083|NCT02762994|594887840|FG000|Overall Study|Withdrawal by Subject|0|||
164690084|NCT02762994|594887841|FG001|Overall Study|Withdrawal by Subject|1|||
164690085|NCT02762994|594887842|FG002|Overall Study|Withdrawal by Subject|2|||
164690086|NCT02762994|594887843|FG003|Overall Study|Withdrawal by Subject|0|||
164690087|NCT02762994|594887840|FG000|Overall Study|Protocol Violation|1|||
164690088|NCT02762994|594887841|FG001|Overall Study|Protocol Violation|0|||
164690089|NCT02762994|594887842|FG002|Overall Study|Protocol Violation|0|||
164690090|NCT02762994|594887843|FG003|Overall Study|Protocol Violation|2|||
164690091|NCT05103657|594887846|FG000|Overall Study|Other reasons than listed|9|||
164690092|NCT05103657|594887847|FG001|Overall Study|Other reasons than listed|8|||
164690093|NCT05103657|594887846|FG000|Overall Study|Protocol deviation|2|||
164690094|NCT05103657|594887847|FG001|Overall Study|Protocol deviation|2|||
164690095|NCT05103657|594887846|FG000|Overall Study|No reason available|5|||
164690096|NCT05103657|594887847|FG001|Overall Study|No reason available|4|||
164690097|NCT05103657|594887846|FG000|Overall Study|Burden of study procedures|3|||
164690098|NCT05103657|594887847|FG001|Overall Study|Burden of study procedures|1|||
164690099|NCT05103657|594887846|FG000|Overall Study|Perceived lack of efficacy|1|||
164690100|NCT05103657|594887847|FG001|Overall Study|Perceived lack of efficacy|1|||
164690101|NCT05103657|594887846|FG000|Overall Study|Adverse Event|6|||
164690102|NCT05103657|594887847|FG001|Overall Study|Adverse Event|14|||
164690103|NCT05103657|594887846|FG000|Overall Study|Not Treated|1|||
164690104|NCT05103657|594887847|FG001|Overall Study|Not Treated|1|||
164690105|NCT02020967|594887848|FG000|Overall Study|Withdrawal by Subject|51|||
164690106|NCT00860262|594887852|FG000|Overall Study|Adverse Event|9|||
164690107|NCT00860262|594887853|FG001|Overall Study|Adverse Event|6|||
164690108|NCT00860262|594887854|FG002|Overall Study|Adverse Event|7|||
164690109|NCT00860262|594887852|FG000|Overall Study|Protocol Violation|0|||
164690110|NCT00860262|594887853|FG001|Overall Study|Protocol Violation|1|||
164690111|NCT00860262|594887854|FG002|Overall Study|Protocol Violation|0|||
164690112|NCT00860262|594887852|FG000|Overall Study|Lost to Follow-up|2|||
164690113|NCT00860262|594887853|FG001|Overall Study|Lost to Follow-up|0|||
164690114|NCT00860262|594887854|FG002|Overall Study|Lost to Follow-up|1|||
164690115|NCT00860262|594887852|FG000|Overall Study|Withdrawal by Subject|4|||
164690116|NCT00860262|594887853|FG001|Overall Study|Withdrawal by Subject|8|||
164690117|NCT00860262|594887854|FG002|Overall Study|Withdrawal by Subject|6|||
164690118|NCT00860262|594887852|FG000|Overall Study|Lack of Efficacy|0|||
164690119|NCT00860262|594887853|FG001|Overall Study|Lack of Efficacy|4|||
164690120|NCT00860262|594887854|FG002|Overall Study|Lack of Efficacy|3|||
164690121|NCT00860262|594887852|FG000|Overall Study|Other|5|||
164690122|NCT00860262|594887853|FG001|Overall Study|Other|3|||
164690123|NCT00860262|594887854|FG002|Overall Study|Other|1|||
164690124|NCT01183884|594887855|FG000|Overall Study|Progressive Disease|26|||
164690125|NCT01183884|594887855|FG000|Overall Study|Adverse Event|3|||
164690126|NCT01183884|594887855|FG000|Overall Study|Withdrawal by Subject|1|||
164690127|NCT01183884|594887855|FG000|Overall Study|Other Complicating Disease|3|||
164690128|NCT01183884|594887855|FG000|Overall Study|Not Treated|1|||
164690129|NCT01183884|594887855|FG000|Overall Study|Other|4|||
164690130|NCT02169336|594887856|FG000|Overall Study|Lack of Efficacy|1|||
164690131|NCT02169336|594887857|FG001|Overall Study|Lack of Efficacy|1|||
164690132|NCT02169336|594887858|FG002|Overall Study|Lack of Efficacy|0|||
164690133|NCT02169336|594887856|FG000|Overall Study|Adverse Event|2|||
164690134|NCT02169336|594887857|FG001|Overall Study|Adverse Event|3|||
164690135|NCT02169336|594887858|FG002|Overall Study|Adverse Event|1|||
164690136|NCT02169336|594887856|FG000|Overall Study|Withdrawal by Subject|1|||
164690137|NCT02169336|594887857|FG001|Overall Study|Withdrawal by Subject|0|||
164344471|NCT03600818|593636941|FG001|Overall Study|Adverse Event|7|||
164344472|NCT03600818|593636940|FG000|Overall Study|Lack of Efficacy|9|||
164344473|NCT03600818|593636941|FG001|Overall Study|Lack of Efficacy|4|||
164433135|NCT01956669|593957148|FG002|Overall Study|Physician Decision|0|||
164433136|NCT01956669|593957149|FG003|Overall Study|Physician Decision|0|||
164433137|NCT01956669|593957150|FG004|Overall Study|Physician Decision|0|||
164433138|NCT01956669|593957151|FG005|Overall Study|Physician Decision|1|||
164433139|NCT01956669|593957152|FG006|Overall Study|Physician Decision|0|||
164433140|NCT01956669|593957146|FG000|Overall Study|Withdrawal by Subject|0|||
164433141|NCT01956669|593957147|FG001|Overall Study|Withdrawal by Subject|0|||
164433142|NCT01956669|593957148|FG002|Overall Study|Withdrawal by Subject|1|||
164433143|NCT01956669|593957149|FG003|Overall Study|Withdrawal by Subject|1|||
164433144|NCT01956669|593957150|FG004|Overall Study|Withdrawal by Subject|0|||
164433145|NCT01956669|593957151|FG005|Overall Study|Withdrawal by Subject|0|||
164690138|NCT02169336|594887858|FG002|Overall Study|Withdrawal by Subject|0|||
164690139|NCT02169336|594887856|FG000|Overall Study|Physician Decision|0|||
164690140|NCT02169336|594887857|FG001|Overall Study|Physician Decision|0|||
164690141|NCT02169336|594887858|FG002|Overall Study|Physician Decision|1|||
164690142|NCT02169336|594887856|FG000|Overall Study|Subject declined to continue dosing|0|||
164690143|NCT02169336|594887857|FG001|Overall Study|Subject declined to continue dosing|0|||
164690144|NCT02169336|594887858|FG002|Overall Study|Subject declined to continue dosing|1|||
164690145|NCT01598896|594887859|FG000|Overall Study|Withdrawal by Subject|0|||
164690146|NCT01598896|594887860|FG001|Overall Study|Withdrawal by Subject|1|||
164690147|NCT01598896|594887859|FG000|Overall Study|Lack of Efficacy|0|||
164690148|NCT01598896|594887860|FG001|Overall Study|Lack of Efficacy|1|||
164690149|NCT00420095|594887861|FG000|Overall Study|Adverse Event|1|||
164690150|NCT00420095|594887862|FG001|Overall Study|Adverse Event|0|||
164690151|NCT00420095|594887861|FG000|Overall Study|Protocol Violation|1|||
164690152|NCT00420095|594887862|FG001|Overall Study|Protocol Violation|1|||
164690153|NCT00420095|594887861|FG000|Overall Study|Lost to Follow-up|1|||
164690154|NCT00420095|594887862|FG001|Overall Study|Lost to Follow-up|0|||
164690155|NCT00393705|594887863|FG000|Overall Study|Adverse Event|0|||
164690156|NCT00393705|594887864|FG001|Overall Study|Adverse Event|2|||
164690157|NCT00393705|594887863|FG000|Overall Study|Death|0|||
164690158|NCT00393705|594887864|FG001|Overall Study|Death|1|||
164690159|NCT00393705|594887863|FG000|Overall Study|Lost to Follow-up|2|||
164690160|NCT00393705|594887864|FG001|Overall Study|Lost to Follow-up|2|||
164690161|NCT00393705|594887863|FG000|Overall Study|Entry Criteria Not Met|10|||
164690162|NCT00393705|594887864|FG001|Overall Study|Entry Criteria Not Met|10|||
164690163|NCT00393705|594887863|FG000|Overall Study|Protocol Violation|4|||
164690164|NCT00393705|594887864|FG001|Overall Study|Protocol Violation|3|||
164690165|NCT00393705|594887863|FG000|Overall Study|Withdrawal by Subject|5|||
164690166|NCT00393705|594887864|FG001|Overall Study|Withdrawal by Subject|3|||
164690167|NCT00393705|594887863|FG000|Overall Study|Physician Decision|2|||
164690168|NCT00393705|594887864|FG001|Overall Study|Physician Decision|2|||
164690169|NCT00642811|594887865|FG000|Overall Study|Adverse Event|2|||
164690170|NCT00642811|594887866|FG001|Overall Study|Adverse Event|3|||
164690171|NCT00642811|594887867|FG002|Overall Study|Adverse Event|0|||
164690172|NCT00642811|594887868|FG003|Overall Study|Adverse Event|0|||
164690173|NCT00642811|594887869|FG004|Overall Study|Adverse Event|0|||
164690174|NCT00642811|594887870|FG005|Overall Study|Adverse Event|1|||
164690175|NCT00642811|594887865|FG000|Overall Study|Developement of discontinuation criteria|0|||
164690176|NCT00642811|594887866|FG001|Overall Study|Developement of discontinuation criteria|0|||
164690177|NCT00642811|594887867|FG002|Overall Study|Developement of discontinuation criteria|0|||
164690178|NCT00642811|594887868|FG003|Overall Study|Developement of discontinuation criteria|0|||
164690179|NCT00642811|594887869|FG004|Overall Study|Developement of discontinuation criteria|1|||
164690180|NCT00642811|594887870|FG005|Overall Study|Developement of discontinuation criteria|0|||
164690181|NCT00642811|594887865|FG000|Overall Study|Severe Non-compliance to protocol|1|||
164690182|NCT00642811|594887866|FG001|Overall Study|Severe Non-compliance to protocol|0|||
164690183|NCT00642811|594887867|FG002|Overall Study|Severe Non-compliance to protocol|0|||
164690184|NCT00642811|594887868|FG003|Overall Study|Severe Non-compliance to protocol|0|||
164690185|NCT00642811|594887869|FG004|Overall Study|Severe Non-compliance to protocol|0|||
164690186|NCT00642811|594887870|FG005|Overall Study|Severe Non-compliance to protocol|0|||
164690187|NCT00642811|594887865|FG000|Overall Study|Other|0|||
164690188|NCT00642811|594887866|FG001|Overall Study|Other|1|||
164690189|NCT00642811|594887867|FG002|Overall Study|Other|0|||
164690190|NCT00642811|594887868|FG003|Overall Study|Other|1|||
164690191|NCT00642811|594887869|FG004|Overall Study|Other|0|||
164690192|NCT00642811|594887870|FG005|Overall Study|Other|0|||
164690193|NCT04553406|594887873|FG000|Overall Study|Study Discontinuation|0|||
164690194|NCT04553406|594887874|FG001|Overall Study|Study Discontinuation|1|||
164690195|NCT03370510|594887875|FG000|Overall Study|COVID-19|2|||
164690196|NCT03370510|594887876|FG001|Overall Study|COVID-19|0|||
164690197|NCT01525628|594887877|FG000|Overall Study|Adverse Event|1|||
164433146|NCT01956669|593957152|FG006|Overall Study|Withdrawal by Subject|1|||
164433147|NCT01570751|593957153|FG000|Period A (16 Weeks)|Protocol Violation|1|||
164690198|NCT01525628|594887878|FG001|Overall Study|Adverse Event|1|||
164690199|NCT01525628|594887879|FG002|Overall Study|Adverse Event|2|||
164690200|NCT01525628|594887880|FG003|Overall Study|Adverse Event|0|||
164690201|NCT01525628|594887881|FG004|Overall Study|Adverse Event|1|||
164690202|NCT01525628|594887877|FG000|Overall Study|Lack of Efficacy|0|||
164585490|NCT00231478|594508000|FG000|Overall Study|Refused Treatment|1|||
164585491|NCT00231478|594508001|FG001|Overall Study|Refused Treatment|1|||
164585492|NCT00231478|594508000|FG000|Overall Study|Withdrawal by Subject|1|||
164585493|NCT00231478|594508001|FG001|Overall Study|Withdrawal by Subject|0|||
164281498|NCT01496846|593400699|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
164281499|NCT01772576|593400703|FG000|Overall Study|Death|15|||
164281500|NCT01772576|593400703|FG000|Overall Study|Protocol Violation|1|||
164281501|NCT01772576|593400703|FG000|Overall Study|Lost to Follow-up|3|||
164281502|NCT01772576|593400703|FG000|Overall Study|Study device not used|3|||
164281503|NCT01772576|593400703|FG000|Overall Study|Adverse Event|6|||
164281504|NCT01772576|593400703|FG000|Overall Study|Withdrawal by Subject|6|||
164281505|NCT03301350|593400715|FG000|Overall Study|Withdrawal by Subject|4|||
164281506|NCT03301350|593400715|FG000|Overall Study|Adverse Event|1|||
164281507|NCT03301350|593400715|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
164281508|NCT03301350|593400715|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
164281509|NCT03301350|593400715|FG000|Overall Study|no detail provided|1|||
164281510|NCT00379912|593400716|FG000|Overall Study|Lack of Efficacy|1|||
164281511|NCT00379912|593400717|FG001|Overall Study|Lack of Efficacy|0|||
164281512|NCT04698993|593400718|FG000|Overall Study|PCR results not accessible|2|||
164281513|NCT04698993|593400719|FG001|Overall Study|PCR results not accessible|7|||
164281514|NCT04698993|593400718|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
164281515|NCT04698993|593400719|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
164585494|NCT00231478|594508000|FG000|Overall Study|Adverse Event|0|||
164690203|NCT01525628|594887878|FG001|Overall Study|Lack of Efficacy|2|||
164281516|NCT01371734|593400720|FG000|Overall Study|Other|2|||
164281517|NCT01371734|593400721|FG001|Overall Study|Other|1|||
164281518|NCT01371734|593400722|FG002|Overall Study|Other|2|||
164281519|NCT01371734|593400720|FG000|Overall Study|Withdrawal by Subject|3|||
164281520|NCT01371734|593400721|FG001|Overall Study|Withdrawal by Subject|4|||
164281521|NCT01371734|593400722|FG002|Overall Study|Withdrawal by Subject|9|||
164585495|NCT00231478|594508001|FG001|Overall Study|Adverse Event|1|||
164585496|NCT00231478|594508000|FG000|Overall Study|Administrative|3|||
164585497|NCT00231478|594508001|FG001|Overall Study|Administrative|2|||
164585498|NCT05258058|594508004|FG000|Overall Study|Withdrawal by Subject|2|||
164585499|NCT01001494|594508005|FG000|Overall Study|Adverse Event|8|||
164585500|NCT01001494|594508006|FG001|Overall Study|Adverse Event|4|||
164585501|NCT01001494|594508007|FG002|Overall Study|Adverse Event|6|||
164585502|NCT01001494|594508005|FG000|Overall Study|Protocol Violation|0|||
164585503|NCT01001494|594508006|FG001|Overall Study|Protocol Violation|1|||
164585504|NCT01001494|594508007|FG002|Overall Study|Protocol Violation|1|||
164585505|NCT01001494|594508005|FG000|Overall Study|Lost to Follow-up|2|||
164585506|NCT01001494|594508006|FG001|Overall Study|Lost to Follow-up|0|||
164585507|NCT01001494|594508007|FG002|Overall Study|Lost to Follow-up|1|||
164585508|NCT01001494|594508005|FG000|Overall Study|Withdrawal by Subject|9|||
164585509|NCT01001494|594508006|FG001|Overall Study|Withdrawal by Subject|7|||
164585510|NCT01001494|594508007|FG002|Overall Study|Withdrawal by Subject|17|||
164585511|NCT01001494|594508005|FG000|Overall Study|COPD exacerbation|3|||
164585512|NCT01001494|594508006|FG001|Overall Study|COPD exacerbation|4|||
164585513|NCT01001494|594508007|FG002|Overall Study|COPD exacerbation|5|||
164585514|NCT01001494|594508005|FG000|Overall Study|Lack of Efficacy|2|||
164690204|NCT01525628|594887879|FG002|Overall Study|Lack of Efficacy|2|||
164690205|NCT01525628|594887880|FG003|Overall Study|Lack of Efficacy|1|||
164690206|NCT01525628|594887881|FG004|Overall Study|Lack of Efficacy|2|||
164690207|NCT01525628|594887877|FG000|Overall Study|Protocol Violation|0|||
164690208|NCT01525628|594887878|FG001|Overall Study|Protocol Violation|0|||
164690209|NCT01525628|594887879|FG002|Overall Study|Protocol Violation|1|||
164690210|NCT01525628|594887880|FG003|Overall Study|Protocol Violation|0|||
164690211|NCT01525628|594887881|FG004|Overall Study|Protocol Violation|0|||
164690212|NCT01525628|594887877|FG000|Overall Study|Lost to Follow-up|1|||
164690213|NCT01525628|594887878|FG001|Overall Study|Lost to Follow-up|1|||
164690214|NCT01525628|594887879|FG002|Overall Study|Lost to Follow-up|0|||
164690215|NCT01525628|594887880|FG003|Overall Study|Lost to Follow-up|0|||
164690216|NCT01525628|594887881|FG004|Overall Study|Lost to Follow-up|0|||
164690217|NCT01525628|594887877|FG000|Overall Study|Withdrawal by Subject|0|||
164690218|NCT01525628|594887878|FG001|Overall Study|Withdrawal by Subject|1|||
164690219|NCT01525628|594887879|FG002|Overall Study|Withdrawal by Subject|0|||
164690220|NCT01525628|594887880|FG003|Overall Study|Withdrawal by Subject|0|||
164690221|NCT01525628|594887881|FG004|Overall Study|Withdrawal by Subject|0|||
164690222|NCT01525628|594887877|FG000|Overall Study|Other reason not defined above|0|||
164690223|NCT01525628|594887878|FG001|Overall Study|Other reason not defined above|0|||
164690224|NCT01525628|594887879|FG002|Overall Study|Other reason not defined above|0|||
164690225|NCT01525628|594887880|FG003|Overall Study|Other reason not defined above|3|||
164690226|NCT01525628|594887881|FG004|Overall Study|Other reason not defined above|0|||
164690227|NCT02614898|594887882|FG000|Overall Study|Participated until study termination|10|||
164690228|NCT02614898|594887883|FG001|Overall Study|Participated until study termination|26|||
164585515|NCT01001494|594508006|FG001|Overall Study|Lack of Efficacy|0|||
164585516|NCT01001494|594508007|FG002|Overall Study|Lack of Efficacy|8|||
164281522|NCT01371734|593400720|FG000|Overall Study|Lost to Follow-up|5|||
164281523|NCT01371734|593400721|FG001|Overall Study|Lost to Follow-up|3|||
164281524|NCT01371734|593400722|FG002|Overall Study|Lost to Follow-up|1|||
164281525|NCT01371734|593400720|FG000|Overall Study|Protocol Violation|3|||
164281526|NCT01371734|593400721|FG001|Overall Study|Protocol Violation|1|||
164281527|NCT01371734|593400722|FG002|Overall Study|Protocol Violation|2|||
164281528|NCT01371734|593400720|FG000|Overall Study|Adverse Event|8|||
164281529|NCT01371734|593400721|FG001|Overall Study|Adverse Event|8|||
164281530|NCT01371734|593400722|FG002|Overall Study|Adverse Event|3|||
164281531|NCT01371734|593400720|FG000|Overall Study|Lack of Efficacy|2|||
164281532|NCT01371734|593400721|FG001|Overall Study|Lack of Efficacy|2|||
164281533|NCT01371734|593400722|FG002|Overall Study|Lack of Efficacy|0|||
164281534|NCT00958165|593400723|FG000|Overall Study|Lost to Follow-up|5|||
164281535|NCT00958165|593400723|FG000|Overall Study|Not eligible|9|||
164281536|NCT00145574|593400724|FG000|Double Blind|Adverse Event|0|||
164585517|NCT01001494|594508005|FG000|Overall Study|Other|0|||
164585518|NCT01001494|594508006|FG001|Overall Study|Other|1|||
164585519|NCT01001494|594508007|FG002|Overall Study|Other|3|||
164585520|NCT02179398|594508008|FG000|Overall Study|Lack of obligatory data|3|||
164585521|NCT02179398|594508009|FG001|Overall Study|Lack of obligatory data|3|||
164585522|NCT02179398|594508008|FG000|Overall Study|Lost to Follow-up|0|||
164585523|NCT02179398|594508009|FG001|Overall Study|Lost to Follow-up|1|||
164585524|NCT01524289|594508010|FG000|Overall Study|Lost to Follow-up|0|||
164585525|NCT01524289|594508011|FG001|Overall Study|Lost to Follow-up|1|||
164585526|NCT01524289|594508010|FG000|Overall Study|Physician Decision|1|||
164585527|NCT01524289|594508011|FG001|Overall Study|Physician Decision|0|||
164585528|NCT01524289|594508010|FG000|Overall Study|Protocol Violation|5|||
164585529|NCT01524289|594508011|FG001|Overall Study|Protocol Violation|1|||
164585530|NCT01524289|594508010|FG000|Overall Study|Withdrawal by Subject|11|||
164585531|NCT01524289|594508011|FG001|Overall Study|Withdrawal by Subject|7|||
164585532|NCT01524289|594508010|FG000|Overall Study|Adverse Event|12|||
164585533|NCT01524289|594508011|FG001|Overall Study|Adverse Event|5|||
164585534|NCT01524289|594508010|FG000|Overall Study|Did not take study medication|1|||
164585535|NCT01524289|594508011|FG001|Overall Study|Did not take study medication|0|||
164585536|NCT01787591|594508019|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
164585537|NCT01787591|594508020|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
164585538|NCT01787591|594508021|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
164585539|NCT01787591|594508022|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
164585540|NCT00815308|594508023|FG000|Overall Study|Adverse Event|4|||
164585541|NCT00815308|594508023|FG000|Overall Study|Withdrawal by Subject|0|||
164585542|NCT00815308|594508023|FG000|Overall Study|Protocol Violation|6|||
164585543|NCT03429556|594508024|FG000|Overall Study|Lost to Follow-up|0|||
164585544|NCT03429556|594508025|FG001|Overall Study|Lost to Follow-up|1|||
164585545|NCT03429556|594508026|FG002|Overall Study|Lost to Follow-up|0|||
164585546|NCT03429556|594508027|FG003|Overall Study|Lost to Follow-up|0|||
164585547|NCT00377299|594508030|FG000|Overall Study|Lost to Follow-up|14|||
164585548|NCT00377299|594508031|FG001|Overall Study|Lost to Follow-up|19|||
164585549|NCT00377299|594508030|FG000|Overall Study|Adverse Event|0|||
164585550|NCT00377299|594508031|FG001|Overall Study|Adverse Event|1|||
164585551|NCT00377299|594508030|FG000|Overall Study|Withdrawal by Subject|5|||
164585552|NCT00377299|594508031|FG001|Overall Study|Withdrawal by Subject|4|||
164585553|NCT02209597|594508034|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
164585554|NCT02209597|594508034|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
164585555|NCT02209597|594508034|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
164585556|NCT02209597|594508034|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
164585557|NCT04799782|594508035|FG000|Washout|Physician Decision|2|||
164585558|NCT04799782|594508036|FG001|Washout|Physician Decision|0|||
164585559|NCT04799782|594508035|FG000|Washout|Withdrawal by Subject|0|||
164585560|NCT04799782|594508036|FG001|Washout|Withdrawal by Subject|2|||
164690229|NCT02614898|594887882|FG000|Overall Study|Lost to Follow-up|0|||
164690230|NCT02614898|594887883|FG001|Overall Study|Lost to Follow-up|2|||
164690231|NCT02614898|594887882|FG000|Overall Study|Physician Decision|1|||
164690232|NCT02614898|594887883|FG001|Overall Study|Physician Decision|8|||
164690233|NCT02614898|594887882|FG000|Overall Study|Study Terminated by Sponsor|3|||
164690234|NCT02614898|594887883|FG001|Overall Study|Study Terminated by Sponsor|0|||
164690235|NCT02614898|594887882|FG000|Overall Study|Withdrawal by Subject|0|||
164690236|NCT02614898|594887883|FG001|Overall Study|Withdrawal by Subject|2|||
164690237|NCT02614898|594887882|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
164690238|NCT02614898|594887883|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
164690239|NCT02614898|594887882|FG000|Overall Study|Other-Additional Information Unavailable|0|||
164690240|NCT02614898|594887883|FG001|Overall Study|Other-Additional Information Unavailable|11|||
164690241|NCT02614898|594887882|FG000|Overall Study|Missing|0|||
164585561|NCT04799782|594508035|FG000|Washout|Lost to Follow-up|0|||
164585562|NCT04799782|594508036|FG001|Washout|Lost to Follow-up|1|||
164690242|NCT02614898|594887883|FG001|Overall Study|Missing|1|||
164281537|NCT00145574|593400725|FG001|Double Blind|Adverse Event|3|||
164585563|NCT02050048|594508040|FG000|Overall Study|Lost to Follow-up|0|||
164281538|NCT00145574|593400726|FG002|Double Blind|Adverse Event|1|||
164281539|NCT00145574|593400724|FG000|Double Blind|Withdrawal by Subject|1|||
164585564|NCT02050048|594508041|FG001|Overall Study|Lost to Follow-up|1|||
164585565|NCT02050048|594508040|FG000|Overall Study|Death|1|||
164281540|NCT00145574|593400725|FG001|Double Blind|Withdrawal by Subject|1|||
164281541|NCT00145574|593400726|FG002|Double Blind|Withdrawal by Subject|1|||
164281542|NCT00145574|593400724|FG000|Double Blind|required restricted medicine|0|||
164281543|NCT00145574|593400725|FG001|Double Blind|required restricted medicine|1|||
164281544|NCT00145574|593400726|FG002|Double Blind|required restricted medicine|0|||
164281545|NCT00145574|593400724|FG000|Open Label Long-term Extension|Adverse Event|0|||
164281546|NCT00145574|593400725|FG001|Open Label Long-term Extension|Adverse Event|0|||
164281547|NCT00145574|593400726|FG002|Open Label Long-term Extension|Adverse Event|5|||
164281548|NCT00145574|593400724|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
164585566|NCT02050048|594508041|FG001|Overall Study|Death|0|||
164585567|NCT02050048|594508040|FG000|Overall Study|Ineligible after ERCP|4|||
164585568|NCT02050048|594508041|FG001|Overall Study|Ineligible after ERCP|1|||
164585569|NCT01589094|594508046|FG000|Overall Study|Did not receive treatment|2|||
164585570|NCT05270694|594510015|FG000|Overall Study|Death|1|||
164585571|NCT05270694|594510015|FG000|Overall Study|Medical issues impacted ability to participate|2|||
164585572|NCT05270694|594510015|FG000|Overall Study|Lost to Follow-up|3|||
164585573|NCT05270694|594510015|FG000|Overall Study|Withdrawal by Subject|3|||
164585574|NCT04267562|594510018|FG000|Assessed for Eligibility|Screen Failure|64|||
164585575|NCT04267562|594510018|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
164585576|NCT04267562|594510018|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
164585577|NCT04267562|594510018|FG000|Assessed for Eligibility|Site closure|6|||
164585578|NCT04267562|594510018|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
164585579|NCT04267562|594510018|FG000|Assessed for Eligibility|Physician Decision|1|||
164585580|NCT04267562|594510018|FG000|Month 24|Elective hysterectomy|1|||
164585581|NCT04267562|594510018|FG000|Month 24|Lost to Follow-up|1|||
164585582|NCT04267562|594510018|FG000|Month 36|Elective hysterectomy|2|||
164585583|NCT04267562|594510018|FG000|Month 36|Lost to Follow-up|3|||
164585584|NCT02241512|594510025|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
164585585|NCT02241512|594510026|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
164585586|NCT00641043|594510027|FG000|Overall Study|Adverse Event|6|||
164585587|NCT00641043|594510028|FG001|Overall Study|Adverse Event|4|||
164585588|NCT00641043|594510027|FG000|Overall Study|Protocol Violation|2|||
164585589|NCT00641043|594510028|FG001|Overall Study|Protocol Violation|3|||
164585590|NCT00641043|594510027|FG000|Overall Study|Lost to Follow-up|3|||
164585591|NCT00641043|594510028|FG001|Overall Study|Lost to Follow-up|2|||
164585592|NCT00641043|594510027|FG000|Overall Study|Withdrawal by Subject|4|||
164585593|NCT00641043|594510028|FG001|Overall Study|Withdrawal by Subject|4|||
164585594|NCT00641043|594510027|FG000|Overall Study|Other incl. lack of efficacy|4|||
164433148|NCT01570751|593957154|FG001|Period A (16 Weeks)|Protocol Violation|1|||
164585595|NCT00641043|594510028|FG001|Overall Study|Other incl. lack of efficacy|2|||
164585596|NCT04275310|594510029|FG000|Overall Study|Non-randomized due to running out of funding|4|||
164585597|NCT04275310|594510030|FG001|Overall Study|Non-randomized due to running out of funding|0|||
164585598|NCT00972244|594510031|FG000|Overall Study|Incorrect Enrolment|1|||
164433149|NCT01570751|593957153|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
164585599|NCT00972244|594510032|FG001|Overall Study|Incorrect Enrolment|0|||
164585600|NCT00972244|594510033|FG002|Overall Study|Incorrect Enrolment|0|||
164585601|NCT00972244|594510034|FG003|Overall Study|Incorrect Enrolment|0|||
164585602|NCT00972244|594510035|FG004|Overall Study|Incorrect Enrolment|0|||
164585603|NCT00972244|594510031|FG000|Overall Study|Adverse Event|0|||
164585604|NCT00972244|594510032|FG001|Overall Study|Adverse Event|1|||
164585605|NCT00972244|594510033|FG002|Overall Study|Adverse Event|1|||
164585606|NCT00972244|594510034|FG003|Overall Study|Adverse Event|0|||
164585607|NCT00972244|594510035|FG004|Overall Study|Adverse Event|0|||
164585608|NCT00972244|594510031|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
164585609|NCT00972244|594510032|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
164585610|NCT00972244|594510033|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
164585611|NCT00972244|594510034|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
164585612|NCT00972244|594510035|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
164690243|NCT00787605|594887884|FG000|Overall Study|Administrative Problems|3|||
164690244|NCT00787605|594887885|FG001|Overall Study|Administrative Problems|0|||
164690245|NCT00787605|594887884|FG000|Overall Study|Adverse Event|14|||
164690246|NCT00787605|594887885|FG001|Overall Study|Adverse Event|25|||
164690247|NCT00787605|594887884|FG000|Overall Study|Lost to Follow-up|3|||
164690248|NCT00787605|594887885|FG001|Overall Study|Lost to Follow-up|6|||
164690249|NCT00787605|594887884|FG000|Overall Study|Protocol Violation|7|||
164690250|NCT00787605|594887885|FG001|Overall Study|Protocol Violation|3|||
164690251|NCT00787605|594887884|FG000|Overall Study|Withdrawal by Subject|6|||
164690252|NCT00787605|594887885|FG001|Overall Study|Withdrawal by Subject|13|||
164690253|NCT00787605|594887884|FG000|Overall Study|Lack of Efficacy|13|||
164690254|NCT00787605|594887885|FG001|Overall Study|Lack of Efficacy|9|||
164690255|NCT01223027|594887888|FG000|Overall Study|Adverse Event|20|||
164690256|NCT01223027|594887889|FG001|Overall Study|Adverse Event|10|||
164690257|NCT01223027|594887888|FG000|Overall Study|Death|42|||
164690258|NCT01223027|594887889|FG001|Overall Study|Death|42|||
164690259|NCT01223027|594887888|FG000|Overall Study|Lost to Follow-up|2|||
164690260|NCT01223027|594887889|FG001|Overall Study|Lost to Follow-up|1|||
164690261|NCT01223027|594887888|FG000|Overall Study|Physician Decision|4|||
164690262|NCT01223027|594887889|FG001|Overall Study|Physician Decision|8|||
164690263|NCT01223027|594887888|FG000|Overall Study|Progressive Disease|167|||
164690264|NCT01223027|594887889|FG001|Overall Study|Progressive Disease|183|||
164690265|NCT01223027|594887888|FG000|Overall Study|Protocol Violation|2|||
164690266|NCT01223027|594887889|FG001|Overall Study|Protocol Violation|1|||
164690267|NCT01223027|594887888|FG000|Overall Study|Subject/guardian decicion|18|||
164690268|NCT01223027|594887889|FG001|Overall Study|Subject/guardian decicion|16|||
164690269|NCT01223027|594887888|FG000|Overall Study|New therapy for study indication|17|||
164690270|NCT01223027|594887889|FG001|Overall Study|New therapy for study indication|8|||
164690271|NCT01223027|594887888|FG000|Overall Study|Study terminated by sponsor|2|||
164690272|NCT01223027|594887889|FG001|Overall Study|Study terminated by sponsor|8|||
164690273|NCT03493919|594887890|FG000|Overall Study|Other|2|||
164690274|NCT03493919|594887891|FG001|Overall Study|Other|0|||
164690275|NCT03493919|594887892|FG002|Overall Study|Other|1|||
164690276|NCT03493919|594887893|FG003|Overall Study|Other|0|||
164690277|NCT03493919|594887890|FG000|Overall Study|Withdrawal by Subject|9|||
164690278|NCT03493919|594887891|FG001|Overall Study|Withdrawal by Subject|3|||
164690279|NCT03493919|594887892|FG002|Overall Study|Withdrawal by Subject|1|||
164690280|NCT03493919|594887893|FG003|Overall Study|Withdrawal by Subject|1|||
164690281|NCT03493919|594887890|FG000|Overall Study|Lost to Follow-up|5|||
164690282|NCT03493919|594887891|FG001|Overall Study|Lost to Follow-up|0|||
164690283|NCT03493919|594887892|FG002|Overall Study|Lost to Follow-up|0|||
164690284|NCT03493919|594887893|FG003|Overall Study|Lost to Follow-up|3|||
164690285|NCT03493919|594887890|FG000|Overall Study|Adverse Event|0|||
164690286|NCT03493919|594887891|FG001|Overall Study|Adverse Event|1|||
164690287|NCT03493919|594887892|FG002|Overall Study|Adverse Event|0|||
164690288|NCT03493919|594887893|FG003|Overall Study|Adverse Event|0|||
164690289|NCT03431337|594889622|FG000|Overall Study|Lost to Follow-up|21|||
164690290|NCT03431337|594889623|FG001|Overall Study|Lost to Follow-up|19|||
164690291|NCT03431337|594889622|FG000|Overall Study|Withdrawal by Subject|8|||
164690292|NCT03431337|594889623|FG001|Overall Study|Withdrawal by Subject|3|||
164690293|NCT00460109|594889629|FG000|Overall Study|Death|1|||
164690294|NCT04167618|594889630|FG000|Overall Study|Trial terminated by sponsor|1|||
164690295|NCT04167618|594889631|FG001|Overall Study|Trial terminated by sponsor|1|||
164690296|NCT02994394|594889632|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
164690297|NCT02994394|594889633|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
164690298|NCT02994394|594889634|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
164690299|NCT02994394|594889635|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
164690300|NCT02994394|594889636|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
164690301|NCT02994394|594889637|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
164690302|NCT02994394|594889632|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
164585613|NCT00972244|594510031|FG000|Overall Study|Withdrawal by Subject|1|||
164585614|NCT00972244|594510032|FG001|Overall Study|Withdrawal by Subject|2|||
164585615|NCT00972244|594510033|FG002|Overall Study|Withdrawal by Subject|1|||
164690303|NCT02994394|594889633|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
164690304|NCT02994394|594889634|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
164690305|NCT02994394|594889635|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
164690306|NCT02994394|594889636|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
164281549|NCT00145574|593400725|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
164281550|NCT00145574|593400726|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
164281551|NCT00145574|593400724|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
164281552|NCT00145574|593400725|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
164281553|NCT00145574|593400726|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
164281554|NCT00145574|593400724|FG000|Open Label Long-term Extension|required restricted medicine|0|||
164281555|NCT00145574|593400725|FG001|Open Label Long-term Extension|required restricted medicine|0|||
164281556|NCT00145574|593400726|FG002|Open Label Long-term Extension|required restricted medicine|1|||
164281557|NCT00621140|593400727|FG000|Overall Study|Adverse Event|4|||
164281558|NCT00621140|593400728|FG001|Overall Study|Adverse Event|5|||
164281559|NCT00621140|593400727|FG000|Overall Study|Lost to Follow-up|1|||
164281560|NCT00621140|593400728|FG001|Overall Study|Lost to Follow-up|2|||
164281561|NCT00621140|593400727|FG000|Overall Study|Withdrawal by Subject|4|||
164281562|NCT00621140|593400728|FG001|Overall Study|Withdrawal by Subject|6|||
164281563|NCT00621140|593400727|FG000|Overall Study|Other incl. lack of efficacy|6|||
164281564|NCT00621140|593400728|FG001|Overall Study|Other incl. lack of efficacy|5|||
164281565|NCT01298765|593400730|FG000|Titration Period|Adverse Event|26|||
164281566|NCT01298765|593400730|FG000|Titration Period|Death|1|||
164281567|NCT01298765|593400730|FG000|Titration Period|Lack of Efficacy|21|||
164281568|NCT01298765|593400730|FG000|Titration Period|Lost to Follow-up|9|||
164281569|NCT01298765|593400730|FG000|Titration Period|Physician Decision|1|||
164281570|NCT01298765|593400730|FG000|Titration Period|Withdrawal by Subject|10|||
164281571|NCT01298765|593400730|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
164281572|NCT01298765|593400730|FG000|Long-Term Treatment Period|Adverse Event|19|||
164281573|NCT01298765|593400730|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
164281574|NCT01298765|593400730|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
164585616|NCT00972244|594510034|FG003|Overall Study|Withdrawal by Subject|0|||
164585617|NCT00972244|594510035|FG004|Overall Study|Withdrawal by Subject|1|||
164585618|NCT00972244|594510031|FG000|Overall Study|Safety|0|||
164585619|NCT00972244|594510032|FG001|Overall Study|Safety|0|||
164585620|NCT00972244|594510033|FG002|Overall Study|Safety|0|||
164585621|NCT00972244|594510034|FG003|Overall Study|Safety|0|||
164585622|NCT00972244|594510035|FG004|Overall Study|Safety|1|||
164585623|NCT00972244|594510031|FG000|Overall Study|Death|1|||
164585624|NCT00972244|594510032|FG001|Overall Study|Death|0|||
164585625|NCT00972244|594510033|FG002|Overall Study|Death|0|||
164585626|NCT00972244|594510034|FG003|Overall Study|Death|0|||
164585627|NCT00972244|594510035|FG004|Overall Study|Death|0|||
164585628|NCT00972244|594510031|FG000|Overall Study|Various|0|||
164690307|NCT02994394|594889637|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
164690308|NCT03619876|594889638|FG000|Overall Study|Withdrawal by Subject|1|||
164690309|NCT03619876|594889639|FG001|Overall Study|Withdrawal by Subject|2|||
164690310|NCT03619876|594889638|FG000|Overall Study|Withdrawal due to incidental finding|0|||
164690311|NCT03619876|594889639|FG001|Overall Study|Withdrawal due to incidental finding|2|||
164690312|NCT04982445|594889641|FG000|Overall Study|Protocol Violation|1|||
164690313|NCT04982445|594889641|FG000|Overall Study|Withdrawal by Subject|4|||
164690314|NCT04982445|594889641|FG000|Overall Study|Lost to Follow-up|1|||
164690315|NCT02014441|594889645|FG000|Overall Study|Withdrawal by Subject|12|||
164690316|NCT00114231|594889646|FG000|Overall Study|No consent|2|||
164690317|NCT00114231|594889647|FG001|Overall Study|No consent|0|||
164690318|NCT00114231|594889646|FG000|Overall Study|QARC requirement not met|1|||
164690319|NCT00114231|594889647|FG001|Overall Study|QARC requirement not met|0|||
164690320|NCT00114231|594889646|FG000|Overall Study|Suspected metastatic disease|1|||
164690321|NCT00114231|594889647|FG001|Overall Study|Suspected metastatic disease|0|||
164690322|NCT00114231|594889646|FG000|Overall Study|No adenocarcinoma|1|||
164690323|NCT00114231|594889647|FG001|Overall Study|No adenocarcinoma|0|||
164690324|NCT00114231|594889646|FG000|Overall Study|Low creatinine clearance|0|||
164690325|NCT00114231|594889647|FG001|Overall Study|Low creatinine clearance|1|||
164690326|NCT00114231|594889646|FG000|Overall Study|Tumor size > 4cm|1|||
164690327|NCT00114231|594889647|FG001|Overall Study|Tumor size > 4cm|0|||
164690328|NCT00114231|594889646|FG000|Overall Study|Tumor fixed on digital exam|0|||
164690329|NCT00114231|594889647|FG001|Overall Study|Tumor fixed on digital exam|1|||
164690330|NCT00114231|594889646|FG000|Overall Study|No Absolute Neutrophil Count|2|||
164690331|NCT00114231|594889647|FG001|Overall Study|No Absolute Neutrophil Count|0|||
164690332|NCT00114231|594889646|FG000|Overall Study|Biopsy done after registration|1|||
164690333|NCT00114231|594889647|FG001|Overall Study|Biopsy done after registration|0|||
164690334|NCT03330236|594889652|FG000|Overall Study|Death|2|||
164690335|NCT03330236|594889653|FG001|Overall Study|Death|1|||
164690336|NCT03330236|594889652|FG000|Overall Study|Withdrawal by Subject|2|||
164690337|NCT03330236|594889653|FG001|Overall Study|Withdrawal by Subject|4|||
164690338|NCT03330236|594889652|FG000|Overall Study|Lost to Follow-up|0|||
164690339|NCT03330236|594889653|FG001|Overall Study|Lost to Follow-up|2|||
164690340|NCT03330236|594889652|FG000|Overall Study|Physician Decision|2|||
164690341|NCT03330236|594889653|FG001|Overall Study|Physician Decision|0|||
164690342|NCT03330236|594889652|FG000|Overall Study|Protocol Violation|4|||
164690343|NCT03330236|594889653|FG001|Overall Study|Protocol Violation|3|||
164690344|NCT03330236|594889652|FG000|Overall Study|SedLine malfunction/blinding|19|||
164690345|NCT03330236|594889653|FG001|Overall Study|SedLine malfunction/blinding|14|||
164690346|NCT03330236|594889652|FG000|Overall Study|Volatile anesthetics used|11|||
164690347|NCT03330236|594889653|FG001|Overall Study|Volatile anesthetics used|8|||
164690348|NCT03330236|594889652|FG000|Overall Study|Surgery aborted/converted to open|60|||
164690349|NCT03330236|594889653|FG001|Overall Study|Surgery aborted/converted to open|52|||
164690350|NCT00763555|594889659|FG000|Overall Study|Adverse Event|2|||
164690351|NCT00763555|594889660|FG001|Overall Study|Adverse Event|1|||
164690352|NCT00763555|594889659|FG000|Overall Study|Withdrawal by Subject|2|||
164690353|NCT00763555|594889660|FG001|Overall Study|Withdrawal by Subject|6|||
164690354|NCT00763555|594889659|FG000|Overall Study|Lost to Follow-up|0|||
164690355|NCT00763555|594889660|FG001|Overall Study|Lost to Follow-up|3|||
164690356|NCT01729026|594889661|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
164690357|NCT01729026|594889662|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
164690358|NCT01729026|594889661|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
164690359|NCT01729026|594889662|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
164585629|NCT00972244|594510032|FG001|Overall Study|Various|0|||
164585630|NCT00972244|594510033|FG002|Overall Study|Various|0|||
164585631|NCT00972244|594510034|FG003|Overall Study|Various|0|||
164690360|NCT02940730|594889672|FG000|Intervention 2|Physician Decision|7|||
164690361|NCT02940730|594889673|FG001|Intervention 2|Physician Decision|0|||
164690362|NCT01522950|594889674|FG000|Overall Study|Withdrawal by Subject|3|||
164690363|NCT01522950|594889675|FG001|Overall Study|Withdrawal by Subject|2|||
164690364|NCT01522950|594889676|FG002|Overall Study|Withdrawal by Subject|1|||
164690365|NCT01522950|594889674|FG000|Overall Study|Adverse Event|3|||
164585632|NCT00972244|594510035|FG004|Overall Study|Various|2|||
164585633|NCT00283712|594510040|FG000|Overall Study|Death|0|||
164344474|NCT03600818|593636940|FG000|Overall Study|Withdrawal by Subject|4|||
164344475|NCT03600818|593636941|FG001|Overall Study|Withdrawal by Subject|3|||
164344476|NCT03600818|593636940|FG000|Overall Study|Other-unspecified|5|||
164344477|NCT03600818|593636941|FG001|Overall Study|Other-unspecified|3|||
164344478|NCT03600818|593636940|FG000|Overall Study|Randomized and not treated|0|||
164344479|NCT03600818|593636941|FG001|Overall Study|Randomized and not treated|1|||
164344480|NCT01706146|593636942|FG000|Overall Study|Withdrawal by Subject|1|||
164344481|NCT01706146|593636942|FG000|Overall Study|Adverse Event|3|||
164344482|NCT01706146|593636942|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
164344483|NCT02582983|593636946|FG000|Overall Study|Death|3|||
164344484|NCT02582983|593636946|FG000|Overall Study|Withdrawal by Subject|2|||
164344485|NCT02582983|593636946|FG000|Overall Study|Adverse Event|1|||
164344486|NCT04930965|593636947|FG000|Overall Study|Lost to Follow-up|7|||
164344487|NCT04930965|593636948|FG001|Overall Study|Lost to Follow-up|5|||
164344488|NCT04377620|593636949|FG000|Overall Study|Death|42|||
164344489|NCT04377620|593636950|FG001|Overall Study|Death|48|||
164344490|NCT04377620|593636951|FG002|Overall Study|Death|36|||
164344491|NCT04377620|593636949|FG000|Overall Study|Withdrawal by Subject|0|||
164344492|NCT04377620|593636950|FG001|Overall Study|Withdrawal by Subject|2|||
164344493|NCT04377620|593636951|FG002|Overall Study|Withdrawal by Subject|0|||
164344494|NCT05209360|593636952|FG000|Overall Study|Withdrawal by Subject|0|||
164344495|NCT05209360|593636953|FG001|Overall Study|Withdrawal by Subject|0|||
164344496|NCT05209360|593636954|FG002|Overall Study|Withdrawal by Subject|1|||
164344497|NCT05209360|593636955|FG003|Overall Study|Withdrawal by Subject|0|||
164344498|NCT05209360|593636956|FG004|Overall Study|Withdrawal by Subject|0|||
164344499|NCT05209360|593636957|FG005|Overall Study|Withdrawal by Subject|0|||
164344500|NCT04189081|593636959|FG000|Overall Study|Lost to Follow-up|1|||
164344501|NCT04189081|593636960|FG001|Overall Study|Lost to Follow-up|0|||
164344502|NCT04189081|593636961|FG002|Overall Study|Lost to Follow-up|0|||
164344503|NCT04189081|593636959|FG000|Overall Study|Withdrawal by Subject|0|||
164433150|NCT01570751|593957154|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
164585634|NCT00283712|594510041|FG001|Overall Study|Death|1|||
164585635|NCT00090285|594510043|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
164585636|NCT00090285|594510044|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
164585637|NCT00090285|594510045|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
164585638|NCT00090285|594510046|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
164585639|NCT00090285|594510047|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
164585640|NCT00090285|594510048|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
164585641|NCT00090285|594510043|FG000|Base Study Vaccination Period|Adverse Event|2|||
164585642|NCT00090285|594510044|FG001|Base Study Vaccination Period|Adverse Event|4|||
164585643|NCT00090285|594510045|FG002|Base Study Vaccination Period|Adverse Event|0|||
164585644|NCT00090285|594510046|FG003|Base Study Vaccination Period|Adverse Event|0|||
164585645|NCT00090285|594510047|FG004|Base Study Vaccination Period|Adverse Event|0|||
164585646|NCT00090285|594510048|FG005|Base Study Vaccination Period|Adverse Event|0|||
164585647|NCT00090285|594510043|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
164585648|NCT00090285|594510044|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
164585649|NCT00090285|594510045|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
164585650|NCT00090285|594510046|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
164585651|NCT00090285|594510047|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
164690366|NCT01522950|594889675|FG001|Overall Study|Adverse Event|1|||
164690367|NCT01522950|594889676|FG002|Overall Study|Adverse Event|1|||
164690368|NCT01522950|594889674|FG000|Overall Study|Protocol Violation|0|||
164690369|NCT01522950|594889675|FG001|Overall Study|Protocol Violation|0|||
164690370|NCT01522950|594889676|FG002|Overall Study|Protocol Violation|2|||
164690371|NCT01522950|594889674|FG000|Overall Study|Death|0|||
164690372|NCT01522950|594889675|FG001|Overall Study|Death|1|||
164690373|NCT01522950|594889676|FG002|Overall Study|Death|1|||
164344504|NCT04189081|593636960|FG001|Overall Study|Withdrawal by Subject|0|||
164344505|NCT04189081|593636961|FG002|Overall Study|Withdrawal by Subject|1|||
164344506|NCT00044083|593636962|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
164344507|NCT00044083|593636963|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
164344508|NCT00044083|593636962|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
164344509|NCT00044083|593636963|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
164344510|NCT00044083|593636962|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
164585652|NCT00090285|594510048|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
164585653|NCT00090285|594510043|FG000|Base Study Vaccination Period|Protocol Violation|2|||
164585654|NCT00090285|594510044|FG001|Base Study Vaccination Period|Protocol Violation|3|||
164585655|NCT00090285|594510045|FG002|Base Study Vaccination Period|Protocol Violation|0|||
164585656|NCT00090285|594510046|FG003|Base Study Vaccination Period|Protocol Violation|0|||
164585657|NCT00090285|594510047|FG004|Base Study Vaccination Period|Protocol Violation|0|||
164585658|NCT00090285|594510048|FG005|Base Study Vaccination Period|Protocol Violation|0|||
164585659|NCT00090285|594510043|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
164585660|NCT00090285|594510044|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
164585661|NCT00090285|594510045|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
164585662|NCT00090285|594510046|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
164585663|NCT00090285|594510047|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
164585664|NCT00090285|594510048|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
164585665|NCT00090285|594510043|FG000|Base Study Vaccination Period|Uncooperative|2|||
164585666|NCT00090285|594510044|FG001|Base Study Vaccination Period|Uncooperative|2|||
164585667|NCT00090285|594510045|FG002|Base Study Vaccination Period|Uncooperative|0|||
164585668|NCT00090285|594510046|FG003|Base Study Vaccination Period|Uncooperative|0|||
164585669|NCT00090285|594510047|FG004|Base Study Vaccination Period|Uncooperative|0|||
164585670|NCT00090285|594510048|FG005|Base Study Vaccination Period|Uncooperative|0|||
164585671|NCT00090285|594510043|FG000|Base Study Vaccination Period|Moved|20|||
164585672|NCT00090285|594510044|FG001|Base Study Vaccination Period|Moved|21|||
164585673|NCT00090285|594510045|FG002|Base Study Vaccination Period|Moved|0|||
164585674|NCT00090285|594510046|FG003|Base Study Vaccination Period|Moved|0|||
164585675|NCT00090285|594510047|FG004|Base Study Vaccination Period|Moved|0|||
164585676|NCT00090285|594510048|FG005|Base Study Vaccination Period|Moved|0|||
164585677|NCT00090285|594510043|FG000|Base Study Vaccination Period|Site Terminated|1|||
164585678|NCT00090285|594510044|FG001|Base Study Vaccination Period|Site Terminated|0|||
164585679|NCT00090285|594510045|FG002|Base Study Vaccination Period|Site Terminated|0|||
164585680|NCT00090285|594510046|FG003|Base Study Vaccination Period|Site Terminated|0|||
164585681|NCT00090285|594510047|FG004|Base Study Vaccination Period|Site Terminated|0|||
164585682|NCT00090285|594510048|FG005|Base Study Vaccination Period|Site Terminated|0|||
164585683|NCT00090285|594510043|FG000|Base Study Vaccination Period|Other|2|||
164585684|NCT00090285|594510044|FG001|Base Study Vaccination Period|Other|2|||
164585685|NCT00090285|594510045|FG002|Base Study Vaccination Period|Other|0|||
164585686|NCT00090285|594510046|FG003|Base Study Vaccination Period|Other|0|||
164585687|NCT00090285|594510047|FG004|Base Study Vaccination Period|Other|0|||
164585688|NCT00090285|594510048|FG005|Base Study Vaccination Period|Other|0|||
164585689|NCT00090285|594510043|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
164585690|NCT00090285|594510044|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
164585691|NCT00090285|594510045|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
164585692|NCT00090285|594510046|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
164585693|NCT00090285|594510047|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
164585694|NCT00090285|594510048|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
164585695|NCT00090285|594510043|FG000|Base Study Vaccination Period|HIV positive|1|||
164585696|NCT00090285|594510044|FG001|Base Study Vaccination Period|HIV positive|1|||
164585697|NCT00090285|594510045|FG002|Base Study Vaccination Period|HIV positive|0|||
164585698|NCT00090285|594510046|FG003|Base Study Vaccination Period|HIV positive|0|||
164585699|NCT00090285|594510047|FG004|Base Study Vaccination Period|HIV positive|0|||
164585700|NCT00090285|594510048|FG005|Base Study Vaccination Period|HIV positive|0|||
164585701|NCT00090285|594510043|FG000|Base Study Follow-up Period|Adverse Event|3|||
164585702|NCT00090285|594510044|FG001|Base Study Follow-up Period|Adverse Event|10|||
164690374|NCT01522950|594889674|FG000|Overall Study|Study Medication Sensitivity|0|||
164690375|NCT01522950|594889675|FG001|Overall Study|Study Medication Sensitivity|1|||
164433151|NCT01570751|593957153|FG000|Period A (16 Weeks)|Unclassified|2|||
164433152|NCT01570751|593957154|FG001|Period A (16 Weeks)|Unclassified|3|||
164344511|NCT00044083|593636963|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
164344512|NCT00044083|593636962|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
164281575|NCT01298765|593400730|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
164281576|NCT01298765|593400730|FG000|Long-Term Treatment Period|Physician Decision|1|||
164281577|NCT01298765|593400730|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
164281578|NCT03565237|593400731|FG000|Overall Study|Non-compliance of Investigational Product|1|||
164281579|NCT03565237|593400731|FG000|Overall Study|Physician Decision|1|||
164281580|NCT01140061|593400734|FG000|Part I|Adverse Event|1|||
164281581|NCT01140061|593400735|FG001|Part I|Adverse Event|0|||
164281582|NCT01140061|593400736|FG002|Part I|Adverse Event|0|||
164281583|NCT01140061|593400737|FG003|Part I|Adverse Event|0|||
164281584|NCT01140061|593400738|FG004|Part I|Adverse Event|0|||
164281585|NCT01140061|593400739|FG005|Part I|Adverse Event|0|||
164281586|NCT01140061|593400740|FG006|Part I|Adverse Event|0|||
164281587|NCT01140061|593400741|FG007|Part I|Adverse Event|0|||
164281588|NCT01140061|593400742|FG008|Part I|Adverse Event|0|||
164281589|NCT01140061|593400743|FG009|Part I|Adverse Event|0|||
164281590|NCT01140061|593400734|FG000|Extension|Laboratory Adverse Event|0|||
164281591|NCT01140061|593400735|FG001|Extension|Laboratory Adverse Event|0|||
164281592|NCT01140061|593400736|FG002|Extension|Laboratory Adverse Event|0|||
164281593|NCT01140061|593400737|FG003|Extension|Laboratory Adverse Event|0|||
164281594|NCT01140061|593400738|FG004|Extension|Laboratory Adverse Event|0|||
164281595|NCT01140061|593400739|FG005|Extension|Laboratory Adverse Event|0|||
164281596|NCT01140061|593400740|FG006|Extension|Laboratory Adverse Event|0|||
164281597|NCT01140061|593400741|FG007|Extension|Laboratory Adverse Event|0|||
164281598|NCT01140061|593400742|FG008|Extension|Laboratory Adverse Event|0|||
164281599|NCT01140061|593400743|FG009|Extension|Laboratory Adverse Event|1|||
164281600|NCT00428389|593400744|FG000|Core Phase|Adverse Event|6|||
164281601|NCT00428389|593400745|FG001|Core Phase|Adverse Event|4|||
164281602|NCT00428389|593400744|FG000|Core Phase|Lack of Efficacy|2|||
164281603|NCT00428389|593400745|FG001|Core Phase|Lack of Efficacy|0|||
164281604|NCT00428389|593400744|FG000|Core Phase|Abnormal test procedure result(s)|0|||
164281605|NCT00428389|593400745|FG001|Core Phase|Abnormal test procedure result(s)|1|||
164281606|NCT00428389|593400744|FG000|Core Phase|Withdrawal by Subject|3|||
164281607|NCT00428389|593400745|FG001|Core Phase|Withdrawal by Subject|4|||
164281608|NCT00428389|593400744|FG000|Core Phase|Protocol deviation|0|||
164281609|NCT00428389|593400745|FG001|Core Phase|Protocol deviation|2|||
164281610|NCT00428389|593400744|FG000|Extension Phase|Adverse Event|17|||
164281611|NCT00428389|593400745|FG001|Extension Phase|Adverse Event|11|||
164281612|NCT00428389|593400744|FG000|Extension Phase|Lack of Efficacy|4|||
164690376|NCT01522950|594889676|FG002|Overall Study|Study Medication Sensitivity|0|||
164281613|NCT00428389|593400745|FG001|Extension Phase|Lack of Efficacy|3|||
164281614|NCT00428389|593400744|FG000|Extension Phase|Withdrawal by Subject|6|||
164281615|NCT00428389|593400745|FG001|Extension Phase|Withdrawal by Subject|6|||
164281616|NCT00428389|593400744|FG000|Extension Phase|Lost to Follow-up|0|||
164281617|NCT00428389|593400745|FG001|Extension Phase|Lost to Follow-up|3|||
164281618|NCT00428389|593400744|FG000|Extension Phase|Death|1|||
164281619|NCT00428389|593400745|FG001|Extension Phase|Death|0|||
164281620|NCT00428389|593400744|FG000|Extension Phase|Protocol Violation|3|||
164281621|NCT00428389|593400745|FG001|Extension Phase|Protocol Violation|2|||
164281622|NCT00428389|593400744|FG000|Extension Phase|Administrative problems|1|||
164281623|NCT00428389|593400745|FG001|Extension Phase|Administrative problems|1|||
164281624|NCT03302247|593400746|FG000|Overall Study|the study has closed prematurely|2|||
164281625|NCT03302247|593400746|FG000|Overall Study|Death|1|||
164281626|NCT02669121|593400747|FG000|Overall Study|Adverse Event|4|||
164281627|NCT02669121|593400748|FG001|Overall Study|Adverse Event|5|||
164281628|NCT02669121|593400747|FG000|Overall Study|Lost to Follow-up|15|||
164281629|NCT02669121|593400748|FG001|Overall Study|Lost to Follow-up|27|||
164281630|NCT02669121|593400747|FG000|Overall Study|Withdrawal by Subject|132|||
164281631|NCT02669121|593400748|FG001|Overall Study|Withdrawal by Subject|140|||
164281632|NCT02669121|593400747|FG000|Overall Study|Pregnancy|0|||
164281633|NCT02669121|593400748|FG001|Overall Study|Pregnancy|1|||
164281634|NCT02669121|593400747|FG000|Overall Study|Discharged from US Military Active Service|117|||
164281635|NCT02669121|593400748|FG001|Overall Study|Discharged from US Military Active Service|91|||
164281636|NCT02669121|593400747|FG000|Overall Study|Reason not Specified|22|||
164281637|NCT02669121|593400748|FG001|Overall Study|Reason not Specified|18|||
164281638|NCT02708355|593400749|FG000|Overall Study|Adverse Event|1|||
164281639|NCT02708355|593400750|FG001|Overall Study|Adverse Event|0|||
164281640|NCT02708355|593400751|FG002|Overall Study|Adverse Event|0|||
164281641|NCT04384523|593400752|FG000|Overall Study|Lost to Follow-up|0|||
164690377|NCT00809965|594889678|FG000|Overall Study|Death|194|||
164690378|NCT00809965|594889679|FG001|Overall Study|Death|147|||
164690379|NCT00809965|594889680|FG002|Overall Study|Death|196|||
164690380|NCT00809965|594889678|FG000|Overall Study|Lost to Follow-up|17|||
164281642|NCT04384523|593400753|FG001|Overall Study|Lost to Follow-up|0|||
164281643|NCT04384523|593400754|FG002|Overall Study|Lost to Follow-up|0|||
164281644|NCT04384523|593400755|FG003|Overall Study|Lost to Follow-up|0|||
164281645|NCT04384523|593400756|FG004|Overall Study|Lost to Follow-up|0|||
164281646|NCT04384523|593400757|FG005|Overall Study|Lost to Follow-up|1|||
164281647|NCT04384523|593400752|FG000|Overall Study|Protocol Violation|0|||
164585703|NCT00090285|594510045|FG002|Base Study Follow-up Period|Adverse Event|0|||
164585704|NCT00090285|594510046|FG003|Base Study Follow-up Period|Adverse Event|0|||
164585705|NCT00090285|594510047|FG004|Base Study Follow-up Period|Adverse Event|0|||
164585706|NCT00090285|594510048|FG005|Base Study Follow-up Period|Adverse Event|0|||
164585707|NCT00090285|594510043|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
164585708|NCT00090285|594510044|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
164585709|NCT00090285|594510045|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
164585710|NCT00090285|594510046|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
164585711|NCT00090285|594510047|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
164585712|NCT00090285|594510048|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
164585713|NCT00090285|594510043|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
164585714|NCT00090285|594510044|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
164585715|NCT00090285|594510045|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
164585716|NCT00090285|594510046|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
164585717|NCT00090285|594510047|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
164585718|NCT00090285|594510048|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
164585719|NCT00090285|594510043|FG000|Base Study Follow-up Period|Moved|41|||
164585720|NCT00090285|594510044|FG001|Base Study Follow-up Period|Moved|36|||
164585721|NCT00090285|594510045|FG002|Base Study Follow-up Period|Moved|0|||
164585722|NCT00090285|594510046|FG003|Base Study Follow-up Period|Moved|0|||
164585723|NCT00090285|594510047|FG004|Base Study Follow-up Period|Moved|0|||
164585724|NCT00090285|594510048|FG005|Base Study Follow-up Period|Moved|0|||
164585725|NCT00090285|594510043|FG000|Base Study Follow-up Period|Other|2|||
164585726|NCT00090285|594510044|FG001|Base Study Follow-up Period|Other|0|||
164585727|NCT00090285|594510045|FG002|Base Study Follow-up Period|Other|0|||
164585728|NCT00090285|594510046|FG003|Base Study Follow-up Period|Other|0|||
164585729|NCT00090285|594510047|FG004|Base Study Follow-up Period|Other|0|||
164585730|NCT00090285|594510048|FG005|Base Study Follow-up Period|Other|0|||
164585731|NCT00090285|594510043|FG000|Base Study Follow-up Period|Protocol Violation|1|||
164585732|NCT00090285|594510044|FG001|Base Study Follow-up Period|Protocol Violation|0|||
164585733|NCT00090285|594510045|FG002|Base Study Follow-up Period|Protocol Violation|0|||
164585734|NCT00090285|594510046|FG003|Base Study Follow-up Period|Protocol Violation|0|||
164585735|NCT00090285|594510047|FG004|Base Study Follow-up Period|Protocol Violation|0|||
164585736|NCT00090285|594510048|FG005|Base Study Follow-up Period|Protocol Violation|0|||
164585737|NCT00090285|594510043|FG000|Base Study Follow-up Period|Uncooperative|3|||
164585738|NCT00090285|594510044|FG001|Base Study Follow-up Period|Uncooperative|4|||
164690381|NCT00809965|594889679|FG001|Overall Study|Lost to Follow-up|10|||
164281648|NCT04384523|593400753|FG001|Overall Study|Protocol Violation|1|||
164690382|NCT00809965|594889680|FG002|Overall Study|Lost to Follow-up|18|||
164690383|NCT00809965|594889678|FG000|Overall Study|Withdrawal by Subject|405|||
164690384|NCT00809965|594889679|FG001|Overall Study|Withdrawal by Subject|448|||
164690385|NCT00809965|594889680|FG002|Overall Study|Withdrawal by Subject|441|||
164690386|NCT00809965|594889678|FG000|Overall Study|Other Reason|167|||
164690387|NCT00809965|594889679|FG001|Overall Study|Other Reason|170|||
164690388|NCT00809965|594889680|FG002|Overall Study|Other Reason|189|||
164690389|NCT00483548|594889681|FG000|Overall Study|Randomized; not treated with study drug|1|||
164690390|NCT00483548|594889682|FG001|Overall Study|Randomized; not treated with study drug|3|||
164690391|NCT00483548|594889681|FG000|Overall Study|Adverse Event|25|||
164690392|NCT00483548|594889682|FG001|Overall Study|Adverse Event|14|||
164690393|NCT00483548|594889681|FG000|Overall Study|Laboratory abnormality|1|||
164690394|NCT00483548|594889682|FG001|Overall Study|Laboratory abnormality|2|||
164690395|NCT00483548|594889681|FG000|Overall Study|Lack of Efficacy|4|||
164281649|NCT04384523|593400754|FG002|Overall Study|Protocol Violation|0|||
164281650|NCT04384523|593400755|FG003|Overall Study|Protocol Violation|0|||
164281651|NCT04384523|593400756|FG004|Overall Study|Protocol Violation|0|||
164281652|NCT04384523|593400757|FG005|Overall Study|Protocol Violation|0|||
164281653|NCT04384523|593400752|FG000|Overall Study|Withdrawal by Subject|1|||
164281654|NCT04384523|593400753|FG001|Overall Study|Withdrawal by Subject|0|||
164281655|NCT04384523|593400754|FG002|Overall Study|Withdrawal by Subject|0|||
164281656|NCT04384523|593400755|FG003|Overall Study|Withdrawal by Subject|0|||
164281657|NCT04384523|593400756|FG004|Overall Study|Withdrawal by Subject|0|||
164281658|NCT04384523|593400757|FG005|Overall Study|Withdrawal by Subject|0|||
164690396|NCT00483548|594889682|FG001|Overall Study|Lack of Efficacy|8|||
164690397|NCT00483548|594889681|FG000|Overall Study|Protocol Violation|11|||
164690398|NCT00483548|594889682|FG001|Overall Study|Protocol Violation|7|||
164690399|NCT00483548|594889681|FG000|Overall Study|Pregnancy|1|||
164690400|NCT00483548|594889682|FG001|Overall Study|Pregnancy|0|||
164690401|NCT00483548|594889681|FG000|Overall Study|Protocol required discontinuation|6|||
164690402|NCT00483548|594889682|FG001|Overall Study|Protocol required discontinuation|6|||
164690403|NCT00483548|594889681|FG000|Overall Study|Unable to comply with protocol schedule|1|||
164690404|NCT00483548|594889682|FG001|Overall Study|Unable to comply with protocol schedule|0|||
164690405|NCT00483548|594889681|FG000|Overall Study|Non-compliance with medication|2|||
164690406|NCT00483548|594889682|FG001|Overall Study|Non-compliance with medication|0|||
164690407|NCT00483548|594889681|FG000|Overall Study|Lost to Follow-up|3|||
164690408|NCT00483548|594889682|FG001|Overall Study|Lost to Follow-up|4|||
164690409|NCT00483548|594889681|FG000|Overall Study|Withdrawal by Subject|5|||
164690410|NCT00483548|594889682|FG001|Overall Study|Withdrawal by Subject|2|||
164281659|NCT03216746|593400758|FG000|Overall Study|Lost to Follow-up|6|||
164281660|NCT03216746|593400759|FG001|Overall Study|Lost to Follow-up|8|||
164281661|NCT03216746|593400760|FG002|Overall Study|Lost to Follow-up|5|||
164281662|NCT03216746|593400761|FG003|Overall Study|Lost to Follow-up|6|||
164281663|NCT02687581|593400762|FG000|Overall Study|Withdrawal by Subject|1|||
164281664|NCT02687581|593400763|FG001|Overall Study|Withdrawal by Subject|0|||
164281665|NCT02687581|593400764|FG002|Overall Study|Withdrawal by Subject|0|||
164281666|NCT02687581|593400765|FG003|Overall Study|Withdrawal by Subject|1|||
164281667|NCT02687581|593400762|FG000|Overall Study|Lost to Follow-up|2|||
164281668|NCT02687581|593400763|FG001|Overall Study|Lost to Follow-up|2|||
164281669|NCT02687581|593400764|FG002|Overall Study|Lost to Follow-up|0|||
164281670|NCT02687581|593400765|FG003|Overall Study|Lost to Follow-up|0|||
164281671|NCT02687581|593400762|FG000|Overall Study|the device is too small for the patient.|1|||
164281672|NCT02687581|593400763|FG001|Overall Study|the device is too small for the patient.|0|||
164281673|NCT02687581|593400764|FG002|Overall Study|the device is too small for the patient.|0|||
164281674|NCT02687581|593400765|FG003|Overall Study|the device is too small for the patient.|0|||
164281675|NCT00835341|593400766|FG000|Overall Study|Lost to Follow-up|3|||
164281676|NCT00835341|593400767|FG001|Overall Study|Lost to Follow-up|12|||
164281677|NCT00195663|593400769|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
164281678|NCT00195663|593400770|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
164281679|NCT00195663|593400771|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
164281680|NCT00195663|593400769|FG000|2-year Double-blind Treatment Period|Death|0|||
164281681|NCT00195663|593400770|FG001|2-year Double-blind Treatment Period|Death|2|||
164281682|NCT00195663|593400771|FG002|2-year Double-blind Treatment Period|Death|0|||
164281683|NCT00195663|593400769|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
164281684|NCT00195663|593400770|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
164281685|NCT00195663|593400771|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
164281686|NCT00195663|593400769|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
164281687|NCT00195663|593400770|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
164690411|NCT05552261|594889685|FG000|Overall Study|Withdrawal by Subject|1|||
164694670|NCT01546142|594905313|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
164281688|NCT00195663|593400771|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
164281689|NCT00195663|593400769|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
164281690|NCT00195663|593400770|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
164585739|NCT00090285|594510045|FG002|Base Study Follow-up Period|Uncooperative|0|||
164585740|NCT00090285|594510046|FG003|Base Study Follow-up Period|Uncooperative|0|||
164585741|NCT00090285|594510047|FG004|Base Study Follow-up Period|Uncooperative|0|||
164585742|NCT00090285|594510048|FG005|Base Study Follow-up Period|Uncooperative|0|||
164585743|NCT00090285|594510043|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
164585744|NCT00090285|594510044|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
164281691|NCT00195663|593400771|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
164281692|NCT00195663|593400769|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
164281693|NCT00195663|593400770|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
164281694|NCT00195663|593400771|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
164281695|NCT00195663|593400769|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
164281696|NCT00195663|593400770|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
164281697|NCT00195663|593400771|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
164281698|NCT00195663|593400769|FG000|2-year Double-blind Treatment Period|Recovery|1|||
164281699|NCT00195663|593400770|FG001|2-year Double-blind Treatment Period|Recovery|0|||
164281700|NCT00195663|593400771|FG002|2-year Double-blind Treatment Period|Recovery|1|||
164281701|NCT00195663|593400769|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
164281702|NCT00195663|593400770|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
164281703|NCT00195663|593400771|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
164281704|NCT00195663|593400769|FG000|Open-Label Extension Period|Adverse Event|21|||
164281705|NCT00195663|593400770|FG001|Open-Label Extension Period|Adverse Event|32|||
164281706|NCT00195663|593400771|FG002|Open-Label Extension Period|Adverse Event|36|||
164281707|NCT00195663|593400769|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
164281708|NCT00195663|593400770|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
164281709|NCT00195663|593400771|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
164281710|NCT00195663|593400769|FG000|Open-Label Extension Period|Recovery|0|||
164281711|NCT00195663|593400770|FG001|Open-Label Extension Period|Recovery|2|||
164281712|NCT00195663|593400771|FG002|Open-Label Extension Period|Recovery|2|||
164281713|NCT00195663|593400769|FG000|Open-Label Extension Period|Protocol Violation|3|||
164281714|NCT00195663|593400770|FG001|Open-Label Extension Period|Protocol Violation|4|||
164281715|NCT00195663|593400771|FG002|Open-Label Extension Period|Protocol Violation|4|||
164281716|NCT00195663|593400769|FG000|Open-Label Extension Period|Death|2|||
164281717|NCT00195663|593400770|FG001|Open-Label Extension Period|Death|2|||
164281718|NCT00195663|593400771|FG002|Open-Label Extension Period|Death|2|||
164281719|NCT00195663|593400769|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
164281720|NCT00195663|593400770|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
164281721|NCT00195663|593400771|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
164281722|NCT00195663|593400769|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
164281723|NCT00195663|593400770|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
164585745|NCT00090285|594510045|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
164281724|NCT00195663|593400771|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
164281725|NCT00195663|593400769|FG000|Open-Label Extension Period|Administrative reasons|11|||
164281726|NCT00195663|593400770|FG001|Open-Label Extension Period|Administrative reasons|11|||
164281727|NCT00195663|593400771|FG002|Open-Label Extension Period|Administrative reasons|13|||
164281728|NCT03214406|593400772|FG000|Overall Study|did not meet enrollment criteria|9|||
164281729|NCT03214406|593400773|FG001|Overall Study|did not meet enrollment criteria|13|||
164281730|NCT03214406|593400772|FG000|Overall Study|Withdrawal by Subject|1|||
164281731|NCT03214406|593400773|FG001|Overall Study|Withdrawal by Subject|0|||
164281732|NCT03214406|593400772|FG000|Overall Study|Lost to Follow-up|0|||
164281733|NCT03214406|593400773|FG001|Overall Study|Lost to Follow-up|2|||
164281734|NCT01098305|593400774|FG000|Overall Study|Lost to Follow-up|31|||
164281735|NCT01098305|593400775|FG001|Overall Study|Lost to Follow-up|33|||
164585746|NCT00090285|594510046|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
164585747|NCT00090285|594510047|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
164585748|NCT00090285|594510048|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
164585749|NCT00090285|594510043|FG000|Extension 1|Adverse Event|0|||
164585750|NCT00090285|594510044|FG001|Extension 1|Adverse Event|0|||
164585751|NCT00090285|594510045|FG002|Extension 1|Adverse Event|2|||
164585752|NCT00090285|594510046|FG003|Extension 1|Adverse Event|0|||
164585753|NCT00090285|594510047|FG004|Extension 1|Adverse Event|0|||
164585754|NCT00090285|594510048|FG005|Extension 1|Adverse Event|0|||
164585755|NCT00090285|594510043|FG000|Extension 1|Lost to Follow-up|0|||
164585756|NCT00090285|594510044|FG001|Extension 1|Lost to Follow-up|0|||
164585757|NCT00090285|594510045|FG002|Extension 1|Lost to Follow-up|35|||
164585758|NCT00090285|594510046|FG003|Extension 1|Lost to Follow-up|0|||
164585759|NCT00090285|594510047|FG004|Extension 1|Lost to Follow-up|0|||
164585760|NCT00090285|594510048|FG005|Extension 1|Lost to Follow-up|0|||
164585761|NCT00090285|594510043|FG000|Extension 1|Withdrawal by Subject|0|||
164585762|NCT00090285|594510044|FG001|Extension 1|Withdrawal by Subject|0|||
164585763|NCT00090285|594510045|FG002|Extension 1|Withdrawal by Subject|13|||
164281736|NCT04310566|593400782|FG000|Period 1|Study Termination due to COVID-19|15|||
164281737|NCT04310566|593400783|FG001|Period 1|Study Termination due to COVID-19|17|||
164585764|NCT00090285|594510046|FG003|Extension 1|Withdrawal by Subject|1|||
164690412|NCT05552261|594889685|FG000|Overall Study|Failure to return to the study clinic within the allowed study window for the Month 30 visit|2|||
164281738|NCT04310566|593400782|FG000|Period 1|Protocol Violation|0|||
164281739|NCT04310566|593400783|FG001|Period 1|Protocol Violation|1|||
164281740|NCT04310566|593400782|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
164281741|NCT04310566|593400783|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
164690413|NCT02916693|594889686|FG000|Overall Study|Lost to Follow-up|7|||
164690414|NCT00979212|594889690|FG000|Overall Study|Protocol Violation|1|||
164690415|NCT00979212|594889691|FG001|Overall Study|Protocol Violation|8|||
164690416|NCT00979212|594889690|FG000|Overall Study|No protocol therapy received|1|||
164690417|NCT00979212|594889691|FG001|Overall Study|No protocol therapy received|0|||
164690418|NCT00035555|594889692|FG000|Overall Study|Adverse Event|5|||
164690419|NCT00035555|594889693|FG001|Overall Study|Adverse Event|8|||
164690420|NCT00035555|594889694|FG002|Overall Study|Adverse Event|9|||
164690421|NCT00035555|594889692|FG000|Overall Study|Allograft loss|1|||
164690422|NCT00035555|594889693|FG001|Overall Study|Allograft loss|1|||
164690423|NCT00035555|594889694|FG002|Overall Study|Allograft loss|2|||
164690424|NCT00035555|594889692|FG000|Overall Study|Death|0|||
164690425|NCT00035555|594889693|FG001|Overall Study|Death|0|||
164690426|NCT00035555|594889694|FG002|Overall Study|Death|2|||
164690427|NCT00035555|594889692|FG000|Overall Study|Lost to Follow-up|0|||
164690428|NCT00035555|594889693|FG001|Overall Study|Lost to Follow-up|0|||
164690429|NCT00035555|594889694|FG002|Overall Study|Lost to Follow-up|1|||
164690430|NCT00035555|594889692|FG000|Overall Study|Noncompliance|0|||
164690431|NCT00035555|594889693|FG001|Overall Study|Noncompliance|1|||
164690432|NCT00035555|594889694|FG002|Overall Study|Noncompliance|1|||
164690433|NCT00035555|594889692|FG000|Overall Study|Prohibited medication|1|||
164690434|NCT00035555|594889693|FG001|Overall Study|Prohibited medication|1|||
164690435|NCT00035555|594889694|FG002|Overall Study|Prohibited medication|0|||
164690436|NCT00035555|594889692|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
164690437|NCT00035555|594889693|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
164690438|NCT00035555|594889694|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
164690439|NCT00035555|594889692|FG000|Overall Study|Withdrawal by Subject|2|||
164690440|NCT00035555|594889693|FG001|Overall Study|Withdrawal by Subject|0|||
164690441|NCT00035555|594889694|FG002|Overall Study|Withdrawal by Subject|2|||
164690442|NCT00035555|594889692|FG000|Overall Study|Investigator deemed not a good candidate|0|||
164690443|NCT00035555|594889693|FG001|Overall Study|Investigator deemed not a good candidate|0|||
164690444|NCT00035555|594889694|FG002|Overall Study|Investigator deemed not a good candidate|1|||
164690445|NCT00035555|594889692|FG000|Overall Study|Received cyclosporin in error|0|||
164690446|NCT00035555|594889693|FG001|Overall Study|Received cyclosporin in error|0|||
164690447|NCT00035555|594889694|FG002|Overall Study|Received cyclosporin in error|1|||
164690448|NCT00337428|594889695|FG000|Overall Study|Withdrawal by Subject|1|||
164690449|NCT00337428|594889696|FG001|Overall Study|Withdrawal by Subject|2|||
164690450|NCT00337428|594889695|FG000|Overall Study|Lack of Time|1|||
164690451|NCT00337428|594889696|FG001|Overall Study|Lack of Time|1|||
164690452|NCT00337428|594889695|FG000|Overall Study|Unwilling to Continue|1|||
164690453|NCT00337428|594889696|FG001|Overall Study|Unwilling to Continue|0|||
164690454|NCT00337428|594889695|FG000|Overall Study|Anorexia|1|||
164690455|NCT00337428|594889696|FG001|Overall Study|Anorexia|0|||
164690456|NCT03223909|594889697|FG000|Overall Study|Protocol Violation|48|||
164690457|NCT03223909|594889698|FG001|Overall Study|Protocol Violation|45|||
164690458|NCT03223909|594889699|FG002|Overall Study|Protocol Violation|16|||
164690459|NCT01628549|594889704|FG000|Overall Study|Adverse Event|1|||
164690460|NCT01628549|594889705|FG001|Overall Study|Adverse Event|1|||
164690461|NCT01628549|594889706|FG002|Overall Study|Adverse Event|0|||
164690462|NCT01628549|594889707|FG003|Overall Study|Adverse Event|4|||
164690463|NCT01628549|594889704|FG000|Overall Study|Lost to Follow-up|3|||
164690464|NCT01628549|594889705|FG001|Overall Study|Lost to Follow-up|4|||
164281742|NCT04310566|593400782|FG000|Period 1|Lost to Follow-up|1|||
164281743|NCT04310566|593400783|FG001|Period 1|Lost to Follow-up|0|||
164281744|NCT04310566|593400782|FG000|Period 1|Withdrawal by Subject|0|||
164281745|NCT04310566|593400783|FG001|Period 1|Withdrawal by Subject|1|||
164281746|NCT04310566|593400782|FG000|Period 2|Study Termination|7|||
164281747|NCT04310566|593400783|FG001|Period 2|Study Termination|5|||
164690465|NCT01628549|594889706|FG002|Overall Study|Lost to Follow-up|3|||
164690466|NCT01628549|594889707|FG003|Overall Study|Lost to Follow-up|3|||
164690467|NCT01628549|594889704|FG000|Overall Study|Withdrawal by Subject|3|||
164690468|NCT01628549|594889705|FG001|Overall Study|Withdrawal by Subject|4|||
164690469|NCT01628549|594889706|FG002|Overall Study|Withdrawal by Subject|4|||
164690470|NCT01628549|594889707|FG003|Overall Study|Withdrawal by Subject|1|||
164281748|NCT04677504|593400785|FG000|Overall Study|Death|51|||
164281749|NCT04677504|593400786|FG001|Overall Study|Death|49|||
164690471|NCT01628549|594889704|FG000|Overall Study|Protocol Violation|2|||
164690472|NCT01628549|594889705|FG001|Overall Study|Protocol Violation|1|||
164690473|NCT01628549|594889706|FG002|Overall Study|Protocol Violation|1|||
164690474|NCT01628549|594889707|FG003|Overall Study|Protocol Violation|0|||
164690475|NCT01628549|594889704|FG000|Overall Study|withdrawn for noncompliance|0|||
164281750|NCT04677504|593400785|FG000|Overall Study|Progressive Disease|1|||
164281751|NCT04677504|593400786|FG001|Overall Study|Progressive Disease|0|||
164281752|NCT04677504|593400785|FG000|Overall Study|Symptomatic Deterioration|1|||
164281753|NCT04677504|593400786|FG001|Overall Study|Symptomatic Deterioration|0|||
164281754|NCT04677504|593400785|FG000|Overall Study|Withdrawal by Subject|2|||
164281755|NCT04677504|593400786|FG001|Overall Study|Withdrawal by Subject|5|||
164281756|NCT04677504|593400785|FG000|Overall Study|Study Terminated By Sponsor|28|||
164281757|NCT04677504|593400786|FG001|Overall Study|Study Terminated By Sponsor|24|||
164281758|NCT04677504|593400785|FG000|Overall Study|Adverse Event|0|||
164585765|NCT00090285|594510047|FG004|Extension 1|Withdrawal by Subject|0|||
164585766|NCT00090285|594510048|FG005|Extension 1|Withdrawal by Subject|0|||
164585767|NCT00090285|594510043|FG000|Extension 1|Other|0|||
164585768|NCT00090285|594510044|FG001|Extension 1|Other|0|||
164585769|NCT00090285|594510045|FG002|Extension 1|Other|4|||
164585770|NCT00090285|594510046|FG003|Extension 1|Other|0|||
164585771|NCT00090285|594510047|FG004|Extension 1|Other|0|||
164585772|NCT00090285|594510048|FG005|Extension 1|Other|0|||
164585773|NCT00090285|594510043|FG000|Extension 1|Moved|0|||
164585774|NCT00090285|594510044|FG001|Extension 1|Moved|0|||
164585775|NCT00090285|594510045|FG002|Extension 1|Moved|3|||
164585776|NCT00090285|594510046|FG003|Extension 1|Moved|0|||
164585777|NCT00090285|594510047|FG004|Extension 1|Moved|0|||
164585778|NCT00090285|594510048|FG005|Extension 1|Moved|0|||
164585779|NCT00090285|594510043|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
164585780|NCT00090285|594510044|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
164585781|NCT00090285|594510045|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
164585782|NCT00090285|594510046|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
164585783|NCT00090285|594510047|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
164585784|NCT00090285|594510048|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
164585785|NCT00090285|594510043|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
164585786|NCT00090285|594510044|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
164585787|NCT00090285|594510045|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
164585788|NCT00090285|594510046|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
164585789|NCT00090285|594510047|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
164585790|NCT00090285|594510048|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
164585791|NCT00090285|594510043|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
164281759|NCT04677504|593400786|FG001|Overall Study|Adverse Event|1|||
164281760|NCT03182907|593400794|FG000|Overall Study|Death|3|||
164281761|NCT03182907|593400795|FG001|Overall Study|Death|0|||
164281762|NCT03182907|593400794|FG000|Overall Study|Protocol Violation|4|||
164281763|NCT03182907|593400795|FG001|Overall Study|Protocol Violation|0|||
164281764|NCT03182907|593400794|FG000|Overall Study|Lost to Follow-up|1|||
164281765|NCT03182907|593400795|FG001|Overall Study|Lost to Follow-up|0|||
164281766|NCT03182907|593400794|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164281767|NCT03182907|593400795|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
164585792|NCT00090285|594510044|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
164585793|NCT00090285|594510045|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
164585794|NCT00090285|594510046|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
164585795|NCT00090285|594510047|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
164585796|NCT00090285|594510048|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
164585797|NCT00090285|594510043|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
164585798|NCT00090285|594510044|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
164585799|NCT00090285|594510045|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
164585800|NCT00090285|594510046|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
164585801|NCT00090285|594510047|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
164585802|NCT00090285|594510048|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
164585803|NCT02046564|594510049|FG000|Overall Study|Adverse Event|6|||
164585804|NCT02046564|594510050|FG001|Overall Study|Adverse Event|3|||
164585805|NCT02046564|594510049|FG000|Overall Study|Physician Decision|0|||
164585806|NCT02046564|594510050|FG001|Overall Study|Physician Decision|1|||
164585807|NCT02046564|594510049|FG000|Overall Study|Protocol Violation|3|||
164585808|NCT02046564|594510050|FG001|Overall Study|Protocol Violation|1|||
164585809|NCT02046564|594510049|FG000|Overall Study|Withdrawal by Subject|4|||
164585810|NCT02046564|594510050|FG001|Overall Study|Withdrawal by Subject|10|||
164585811|NCT02046564|594510049|FG000|Overall Study|Subject met withdrawal criteria|2|||
164585812|NCT02046564|594510050|FG001|Overall Study|Subject met withdrawal criteria|5|||
164585813|NCT00907478|594510051|FG000|Overall Study|Ineligibility determined|0|||
164585814|NCT00907478|594510052|FG001|Overall Study|Ineligibility determined|0|||
164585815|NCT00907478|594510053|FG002|Overall Study|Ineligibility determined|1|||
164585816|NCT00907478|594510051|FG000|Overall Study|Noncompliance|0|||
164585817|NCT00907478|594510052|FG001|Overall Study|Noncompliance|0|||
164585818|NCT00907478|594510053|FG002|Overall Study|Noncompliance|1|||
164585819|NCT00907478|594510051|FG000|Overall Study|Adverse Event|3|||
164585820|NCT00907478|594510052|FG001|Overall Study|Adverse Event|1|||
164585821|NCT00907478|594510053|FG002|Overall Study|Adverse Event|2|||
164585822|NCT00907478|594510051|FG000|Overall Study|Withdrawal by Subject|8|||
164585823|NCT00907478|594510052|FG001|Overall Study|Withdrawal by Subject|9|||
164585824|NCT00907478|594510053|FG002|Overall Study|Withdrawal by Subject|6|||
164281768|NCT01711645|593400796|FG000|Overall Study|Withdrawal by Subject|8|||
164281769|NCT01711645|593400796|FG000|Overall Study|Lost to Follow-up|6|||
164281770|NCT01711645|593400796|FG000|Overall Study|Physician Decision|5|||
164281771|NCT03170193|593400799|FG000|Overall Study|Withdrawal by Subject|0|||
164281772|NCT03170193|593400800|FG001|Overall Study|Withdrawal by Subject|0|||
164281773|NCT03170193|593400801|FG002|Overall Study|Withdrawal by Subject|0|||
164281774|NCT03170193|593400802|FG003|Overall Study|Withdrawal by Subject|1|||
164281775|NCT03170193|593400803|FG004|Overall Study|Withdrawal by Subject|0|||
164281776|NCT03170193|593400804|FG005|Overall Study|Withdrawal by Subject|0|||
164281777|NCT03170193|593400805|FG006|Overall Study|Withdrawal by Subject|0|||
164281778|NCT03170193|593400799|FG000|Overall Study|Lost to Follow-up|1|||
164281779|NCT03170193|593400800|FG001|Overall Study|Lost to Follow-up|1|||
164281780|NCT03170193|593400801|FG002|Overall Study|Lost to Follow-up|0|||
164281781|NCT03170193|593400802|FG003|Overall Study|Lost to Follow-up|0|||
164281782|NCT03170193|593400803|FG004|Overall Study|Lost to Follow-up|0|||
164281783|NCT03170193|593400804|FG005|Overall Study|Lost to Follow-up|0|||
164281784|NCT03170193|593400805|FG006|Overall Study|Lost to Follow-up|0|||
164281785|NCT03848949|593400809|FG000|Overall Study|Lost to Follow-up|5|||
164281786|NCT03848949|593400810|FG001|Overall Study|Lost to Follow-up|7|||
164281787|NCT00118430|593400811|FG000|Overall Study|Withdrawal by Subject|6|||
164281788|NCT00118430|593400812|FG001|Overall Study|Withdrawal by Subject|2|||
164281789|NCT00118430|593400813|FG002|Overall Study|Withdrawal by Subject|0|||
164281790|NCT00118430|593400811|FG000|Overall Study|Lost to Follow-up|15|||
164281791|NCT00118430|593400812|FG001|Overall Study|Lost to Follow-up|22|||
164281792|NCT00118430|593400813|FG002|Overall Study|Lost to Follow-up|28|||
164281793|NCT00534976|593400814|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
164281794|NCT00534976|593400815|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
164281795|NCT00534976|593400814|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
164281796|NCT00534976|593400815|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
164281797|NCT00534976|593400814|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
164281798|NCT00534976|593400815|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
164281799|NCT02147288|593400816|FG000|Overall Study|post-operative hematoma|1|||
164281800|NCT02147288|593400817|FG001|Overall Study|post-operative hematoma|1|||
164281801|NCT02147288|593400818|FG002|Overall Study|post-operative hematoma|0|||
164281802|NCT02147288|593400819|FG003|Overall Study|post-operative hematoma|0|||
164281803|NCT02147288|593400820|FG004|Overall Study|post-operative hematoma|0|||
164281804|NCT02147288|593400821|FG005|Overall Study|post-operative hematoma|0|||
164281805|NCT02147288|593400822|FG006|Overall Study|post-operative hematoma|0|||
164281806|NCT02147288|593400823|FG007|Overall Study|post-operative hematoma|0|||
164281807|NCT02147288|593400824|FG008|Overall Study|post-operative hematoma|0|||
164281808|NCT02147288|593400825|FG009|Overall Study|post-operative hematoma|0|||
164281809|NCT02147288|593400816|FG000|Overall Study|complications from concurrent hernia rep|0|||
164281810|NCT02147288|593400817|FG001|Overall Study|complications from concurrent hernia rep|1|||
164281811|NCT02147288|593400818|FG002|Overall Study|complications from concurrent hernia rep|0|||
164281812|NCT02147288|593400819|FG003|Overall Study|complications from concurrent hernia rep|0|||
164281813|NCT02147288|593400820|FG004|Overall Study|complications from concurrent hernia rep|0|||
164281814|NCT02147288|593400821|FG005|Overall Study|complications from concurrent hernia rep|0|||
164281815|NCT02147288|593400822|FG006|Overall Study|complications from concurrent hernia rep|0|||
164281816|NCT02147288|593400823|FG007|Overall Study|complications from concurrent hernia rep|0|||
164281817|NCT02147288|593400824|FG008|Overall Study|complications from concurrent hernia rep|0|||
164281818|NCT02147288|593400825|FG009|Overall Study|complications from concurrent hernia rep|0|||
164281819|NCT00965419|593400826|FG000|Open Label Treatment for Responders|Adverse Event|33|||
164433153|NCT01570751|593957153|FG000|Period B (16 Weeks)|Adverse Event|1|||
164433154|NCT01570751|593957154|FG001|Period B (16 Weeks)|Adverse Event|0|||
164433155|NCT01570751|593957153|FG000|Period B (16 Weeks)|Protocol Violation|0|||
164433156|NCT01570751|593957154|FG001|Period B (16 Weeks)|Protocol Violation|1|||
164433157|NCT00930813|593957155|FG000|Overall Study|Death|4|||
164433158|NCT00930813|593957156|FG001|Overall Study|Death|5|||
164433159|NCT00930813|593957155|FG000|Overall Study|Withdrawal by Subject|2|||
164433160|NCT00930813|593957156|FG001|Overall Study|Withdrawal by Subject|5|||
164433161|NCT00930813|593957155|FG000|Overall Study|Lost to Follow-up|2|||
164281820|NCT00965419|593400826|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
164281821|NCT00965419|593400826|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
164690476|NCT01628549|594889705|FG001|Overall Study|withdrawn for noncompliance|2|||
164281822|NCT00965419|593400826|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
164433162|NCT00930813|593957156|FG001|Overall Study|Lost to Follow-up|4|||
164433163|NCT01131494|593957161|FG000|Overall Study|Withdrawal by Subject|2|||
164690477|NCT01628549|594889706|FG002|Overall Study|withdrawn for noncompliance|1|||
164690478|NCT01628549|594889707|FG003|Overall Study|withdrawn for noncompliance|0|||
164281823|NCT00965419|593400826|FG000|Open Label Treatment for Responders|Physician Decision|6|||
164433164|NCT05419557|593957163|FG000|Overall Study|Lost to Follow-up|11|||
164433165|NCT05419557|593957164|FG001|Overall Study|Lost to Follow-up|4|||
164433166|NCT01196988|593957165|FG000|Overall Study|Adverse Event|1|||
164281824|NCT00965419|593400826|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
164281825|NCT00965419|593400826|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
164281826|NCT00965419|593400826|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
164281827|NCT00965419|593400826|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
164281828|NCT00965419|593400826|FG000|Follow-up Phase|Adverse Event|9|||
164281829|NCT00965419|593400826|FG000|Follow-up Phase|Protocol Violation|4|||
164281830|NCT00965419|593400826|FG000|Follow-up Phase|Withdrawal by Subject|8|||
164281831|NCT00965419|593400826|FG000|Follow-up Phase|Physician Decision|4|||
164281832|NCT00965419|593400826|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
164281833|NCT00965419|593400826|FG000|Follow-up Phase|Lack of Efficacy|28|||
164281834|NCT00615017|593402478|FG000|Overall Study|Adverse Event|0|||
164281835|NCT00615017|593402479|FG001|Overall Study|Adverse Event|1|||
164281836|NCT00615017|593402480|FG002|Overall Study|Adverse Event|2|||
164281837|NCT00615017|593402481|FG003|Overall Study|Adverse Event|0|||
164281838|NCT00615017|593402482|FG004|Overall Study|Adverse Event|0|||
164281839|NCT00615017|593402483|FG005|Overall Study|Adverse Event|1|||
164281840|NCT00615017|593402478|FG000|Overall Study|Death|0|||
164281841|NCT00615017|593402479|FG001|Overall Study|Death|0|||
164281842|NCT00615017|593402480|FG002|Overall Study|Death|2|||
164281843|NCT00615017|593402481|FG003|Overall Study|Death|0|||
164281844|NCT00615017|593402482|FG004|Overall Study|Death|1|||
164281845|NCT00615017|593402483|FG005|Overall Study|Death|1|||
164281846|NCT00615017|593402478|FG000|Overall Study|Sepsis resolved|0|||
164281847|NCT00615017|593402479|FG001|Overall Study|Sepsis resolved|0|||
164281848|NCT00615017|593402480|FG002|Overall Study|Sepsis resolved|1|||
164281849|NCT00615017|593402481|FG003|Overall Study|Sepsis resolved|0|||
164281850|NCT00615017|593402482|FG004|Overall Study|Sepsis resolved|0|||
164690479|NCT01628549|594889704|FG000|Overall Study|abnormal laboratory test results|0|||
164281851|NCT00615017|593402483|FG005|Overall Study|Sepsis resolved|0|||
164281852|NCT00615017|593402478|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
164281853|NCT00615017|593402479|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
164281854|NCT00615017|593402480|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
164281855|NCT00615017|593402481|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
164281856|NCT00615017|593402482|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
164281857|NCT00615017|593402483|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
164281858|NCT00615017|593402478|FG000|Overall Study|Physician discontinued drug|0|||
164281859|NCT00615017|593402479|FG001|Overall Study|Physician discontinued drug|0|||
164281860|NCT00615017|593402480|FG002|Overall Study|Physician discontinued drug|0|||
164281861|NCT00615017|593402481|FG003|Overall Study|Physician discontinued drug|0|||
164281862|NCT00615017|593402482|FG004|Overall Study|Physician discontinued drug|0|||
164281863|NCT00615017|593402483|FG005|Overall Study|Physician discontinued drug|1|||
164281864|NCT00806988|593402484|FG000|Overall Study|Death|15|||
164281865|NCT00806988|593402485|FG001|Overall Study|Death|16|||
164281866|NCT00806988|593402484|FG000|Overall Study|Withdrawal by Subject|8|||
164281867|NCT00806988|593402485|FG001|Overall Study|Withdrawal by Subject|8|||
164281868|NCT00806988|593402484|FG000|Overall Study|Lost to Follow-up|4|||
164281869|NCT00806988|593402485|FG001|Overall Study|Lost to Follow-up|19|||
164281870|NCT04775953|593402487|FG000|Overall Study|Lost to Follow-up|6|||
164281871|NCT04775953|593402488|FG001|Overall Study|Lost to Follow-up|11|||
164281872|NCT04775953|593402487|FG000|Overall Study|Death|5|||
164281873|NCT04775953|593402488|FG001|Overall Study|Death|4|||
164281874|NCT04775953|593402487|FG000|Overall Study|Withdrawal by Subject|3|||
164281875|NCT04775953|593402488|FG001|Overall Study|Withdrawal by Subject|3|||
164281876|NCT04775953|593402487|FG000|Overall Study|Protocol Violation|2|||
164281877|NCT04775953|593402488|FG001|Overall Study|Protocol Violation|0|||
164281878|NCT04775953|593402487|FG000|Overall Study|Participant non-compliance|0|||
164281879|NCT04775953|593402488|FG001|Overall Study|Participant non-compliance|1|||
164281880|NCT01698814|593402489|FG000|Overall Study|Adverse Event|0|||
164281881|NCT01698814|593402490|FG001|Overall Study|Adverse Event|2|||
164281882|NCT01698814|593402489|FG000|Overall Study|Lost to Follow-up|0|||
164690480|NCT01628549|594889705|FG001|Overall Study|abnormal laboratory test results|0|||
164281883|NCT01698814|593402490|FG001|Overall Study|Lost to Follow-up|1|||
164281884|NCT01698814|593402489|FG000|Overall Study|Pregnancy|1|||
164281885|NCT01698814|593402490|FG001|Overall Study|Pregnancy|0|||
164281886|NCT01698814|593402489|FG000|Overall Study|Randomized in error|1|||
164281887|NCT01698814|593402490|FG001|Overall Study|Randomized in error|0|||
164281888|NCT00368641|593402491|FG000|Overall Study|Adverse Event|2|||
164281889|NCT00368641|593402492|FG001|Overall Study|Adverse Event|1|||
164281890|NCT00368641|593402491|FG000|Overall Study|Death|1|||
164281891|NCT00368641|593402492|FG001|Overall Study|Death|0|||
164281892|NCT00368641|593402491|FG000|Overall Study|Withdrawal by Subject|1|||
164142997|NCT00863772|592884485|FG001|Overall Study|Protocol Violation|0|||
164281893|NCT00368641|593402492|FG001|Overall Study|Withdrawal by Subject|0|||
164281894|NCT00368641|593402491|FG000|Overall Study|Sponsor decision to terminate study|2|||
164281895|NCT00368641|593402492|FG001|Overall Study|Sponsor decision to terminate study|5|||
164281896|NCT04014062|593402493|FG000|Period I: Dosing|Medical Grounds|4|||
164281897|NCT04014062|593402494|FG001|Period I: Dosing|Medical Grounds|5|||
164281898|NCT04014062|593402493|FG000|Period I: Dosing|Withdrawal by Subject|3|||
164281899|NCT04014062|593402494|FG001|Period I: Dosing|Withdrawal by Subject|1|||
164281900|NCT01980095|593402495|FG000|Overall Study|Lost to Follow-up|6|||
164281901|NCT01980095|593402496|FG001|Overall Study|Lost to Follow-up|7|||
164281902|NCT01980095|593402495|FG000|Overall Study|Withdrawal by Subject|2|||
164281903|NCT01980095|593402496|FG001|Overall Study|Withdrawal by Subject|3|||
164281904|NCT01980095|593402495|FG000|Overall Study|Poor compliance|5|||
164690481|NCT01628549|594889706|FG002|Overall Study|abnormal laboratory test results|1|||
164690482|NCT01628549|594889707|FG003|Overall Study|abnormal laboratory test results|0|||
164690483|NCT01628549|594889704|FG000|Overall Study|positive pregnancy test|0|||
164690484|NCT01628549|594889705|FG001|Overall Study|positive pregnancy test|0|||
164690485|NCT01628549|594889706|FG002|Overall Study|positive pregnancy test|0|||
164281905|NCT01980095|593402496|FG001|Overall Study|Poor compliance|0|||
164281906|NCT01980095|593402495|FG000|Overall Study|Safety issue|0|||
164281907|NCT01980095|593402496|FG001|Overall Study|Safety issue|1|||
164281908|NCT01980095|593402495|FG000|Overall Study|Study drug discontinued|1|||
164281909|NCT01980095|593402496|FG001|Overall Study|Study drug discontinued|0|||
164281910|NCT01980095|593402495|FG000|Overall Study|Randomized by mistake|1|||
164281911|NCT01980095|593402496|FG001|Overall Study|Randomized by mistake|0|||
164281912|NCT02783599|593402503|FG000|Overall Study|Progressive disease|23|||
164281913|NCT02783599|593402503|FG000|Overall Study|Surgical Resection|10|||
164281914|NCT02783599|593402503|FG000|Overall Study|Adverse Event|4|||
164281915|NCT02783599|593402503|FG000|Overall Study|Physician Decision|2|||
164281916|NCT02783599|593402503|FG000|Overall Study|Death|1|||
164281917|NCT01564732|593402504|FG000|Overall Study|Early termination by the study sponsor|6|||
164281918|NCT01564732|593402505|FG001|Overall Study|Early termination by the study sponsor|5|||
164281919|NCT04343755|593402506|FG000|Overall Study|Death|11|||
164281920|NCT04343755|593402506|FG000|Overall Study|Screen Failure|1|||
164281921|NCT00394706|593402507|FG000|Overall Study|Withdrawal by Subject|2|||
164281922|NCT00394706|593402508|FG001|Overall Study|Withdrawal by Subject|0|||
164281923|NCT00394706|593402509|FG002|Overall Study|Withdrawal by Subject|1|||
164281924|NCT00394706|593402510|FG003|Overall Study|Withdrawal by Subject|0|||
164281925|NCT00394706|593402511|FG004|Overall Study|Withdrawal by Subject|0|||
164281926|NCT00394706|593402512|FG005|Overall Study|Withdrawal by Subject|2|||
164281927|NCT00394706|593402513|FG006|Overall Study|Withdrawal by Subject|1|||
164281928|NCT00394706|593402514|FG007|Overall Study|Withdrawal by Subject|0|||
164281929|NCT00394706|593402507|FG000|Overall Study|Lost to Follow-up|2|||
164281930|NCT00394706|593402508|FG001|Overall Study|Lost to Follow-up|2|||
164281931|NCT00394706|593402509|FG002|Overall Study|Lost to Follow-up|8|||
164281932|NCT00394706|593402510|FG003|Overall Study|Lost to Follow-up|1|||
164281933|NCT00394706|593402511|FG004|Overall Study|Lost to Follow-up|2|||
164281934|NCT00394706|593402512|FG005|Overall Study|Lost to Follow-up|5|||
164281935|NCT00394706|593402513|FG006|Overall Study|Lost to Follow-up|2|||
164281936|NCT00394706|593402514|FG007|Overall Study|Lost to Follow-up|0|||
164281937|NCT03920254|593402515|FG000|Overall Study|Adverse Event|1|||
164281938|NCT03920254|593402516|FG001|Overall Study|Adverse Event|0|||
164281939|NCT03920254|593402517|FG002|Overall Study|Adverse Event|0|||
164281940|NCT03920254|593402515|FG000|Overall Study|Physician Decision|0|||
164281941|NCT03920254|593402516|FG001|Overall Study|Physician Decision|1|||
164281942|NCT03920254|593402517|FG002|Overall Study|Physician Decision|2|||
164281943|NCT03920254|593402515|FG000|Overall Study|Study Terminated By Sponsor|12|||
164281944|NCT03920254|593402516|FG001|Overall Study|Study Terminated By Sponsor|17|||
164281945|NCT03920254|593402517|FG002|Overall Study|Study Terminated By Sponsor|12|||
164281946|NCT03920254|593402515|FG000|Overall Study|Withdrawal by Subject|0|||
164281947|NCT03920254|593402516|FG001|Overall Study|Withdrawal by Subject|0|||
164281948|NCT03920254|593402517|FG002|Overall Study|Withdrawal by Subject|1|||
164281949|NCT05274269|593402518|FG000|Overall Study|Adverse Event|0|||
164281950|NCT05274269|593402519|FG001|Overall Study|Adverse Event|3|||
164281951|NCT05274269|593402518|FG000|Overall Study|Death|0|||
164690486|NCT01628549|594889707|FG003|Overall Study|positive pregnancy test|1|||
164690487|NCT00177164|594889715|FG000|Overall Study|Protocol Violation|0|||
164690488|NCT00177164|594889716|FG001|Overall Study|Protocol Violation|7|||
164690489|NCT00177164|594889715|FG000|Overall Study|Lost to Follow-up|4|||
164690490|NCT00177164|594889716|FG001|Overall Study|Lost to Follow-up|5|||
164690491|NCT00177164|594889715|FG000|Overall Study|increase in alcohol and drug use|1|||
164281952|NCT05274269|593402519|FG001|Overall Study|Death|1|||
164281953|NCT05274269|593402518|FG000|Overall Study|Other|0|||
164281954|NCT05274269|593402519|FG001|Overall Study|Other|2|||
164281955|NCT05274269|593402518|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
164281956|NCT05274269|593402519|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
164281957|NCT00108862|593402520|FG000|Overall Study|Death|31|||
164281958|NCT00108862|593402521|FG001|Overall Study|Death|37|||
164281959|NCT00108862|593402520|FG000|Overall Study|Withdrawal by Subject|10|||
164690492|NCT00177164|594889716|FG001|Overall Study|increase in alcohol and drug use|2|||
164281960|NCT00108862|593402521|FG001|Overall Study|Withdrawal by Subject|6|||
164281961|NCT00108862|593402520|FG000|Overall Study|Lost to Follow-up|27|||
164281962|NCT00108862|593402521|FG001|Overall Study|Lost to Follow-up|19|||
164690493|NCT00177164|594889715|FG000|Overall Study|Adverse Event|1|||
164281963|NCT01746368|593402525|FG000|Overall Study|Lost to Follow-up|2|||
164344513|NCT00044083|593636963|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
164344514|NCT00044083|593636962|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
164344515|NCT00044083|593636963|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
164344516|NCT00044083|593636962|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
164344517|NCT00044083|593636963|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
164344518|NCT00044083|593636962|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
164344519|NCT00044083|593636963|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
164344520|NCT00044083|593636962|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
164344521|NCT00044083|593636963|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
164344522|NCT00044083|593636962|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
164344523|NCT00044083|593636963|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
164344524|NCT00044083|593636962|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
164344525|NCT00044083|593636963|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
164433167|NCT01196988|593957166|FG001|Overall Study|Adverse Event|2|||
164433168|NCT01196988|593957167|FG002|Overall Study|Adverse Event|0|||
164433169|NCT01196988|593957168|FG003|Overall Study|Adverse Event|0|||
164433170|NCT01196988|593957165|FG000|Overall Study|Withdrawal by Subject|5|||
164433171|NCT01196988|593957166|FG001|Overall Study|Withdrawal by Subject|1|||
164433172|NCT01196988|593957167|FG002|Overall Study|Withdrawal by Subject|4|||
164433173|NCT01196988|593957168|FG003|Overall Study|Withdrawal by Subject|0|||
164433174|NCT01196988|593957165|FG000|Overall Study|Lost to Follow-up|16|||
164433175|NCT01196988|593957166|FG001|Overall Study|Lost to Follow-up|29|||
164433176|NCT01196988|593957167|FG002|Overall Study|Lost to Follow-up|21|||
164433177|NCT01196988|593957168|FG003|Overall Study|Lost to Follow-up|1|||
164433178|NCT01196988|593957165|FG000|Overall Study|Other|2|||
164433179|NCT01196988|593957166|FG001|Overall Study|Other|0|||
164433180|NCT01196988|593957167|FG002|Overall Study|Other|0|||
164433181|NCT01196988|593957168|FG003|Overall Study|Other|0|||
164433182|NCT00588666|593957169|FG000|Overall Study|Adverse Event|4|||
164433183|NCT02281318|593957170|FG000|Overall Study|Adverse Event|2|||
164433184|NCT02281318|593957171|FG001|Overall Study|Adverse Event|2|||
164433185|NCT02281318|593957170|FG000|Overall Study|Lack of Efficacy|2|||
164433186|NCT02281318|593957171|FG001|Overall Study|Lack of Efficacy|0|||
164433187|NCT02281318|593957170|FG000|Overall Study|Lost to Follow-up|2|||
164690494|NCT00177164|594889716|FG001|Overall Study|Adverse Event|0|||
164690495|NCT00177164|594889715|FG000|Overall Study|discharge from hospital|1|||
164690496|NCT00177164|594889716|FG001|Overall Study|discharge from hospital|0|||
164690497|NCT00177164|594889715|FG000|Overall Study|Lack of Efficacy|2|||
164690498|NCT00177164|594889716|FG001|Overall Study|Lack of Efficacy|1|||
164281964|NCT01746368|593402526|FG001|Overall Study|Lost to Follow-up|0|||
164281965|NCT01746368|593402525|FG000|Overall Study|Withdrawal by Subject|0|||
164281966|NCT01746368|593402526|FG001|Overall Study|Withdrawal by Subject|1|||
164281967|NCT05636852|593402527|FG000|Overall Study|Withdrawal by Subject|1|||
164281968|NCT05636852|593402527|FG000|Overall Study|Other than specified|1|||
164281969|NCT03534141|593402528|FG000|Overall Study|Enrolled in other clinical trial|1|||
164344526|NCT00288054|593636967|FG000|Overall Study|Protocol Violation|2|||
164344527|NCT00288054|593636967|FG000|Overall Study|Lack of Efficacy|16|||
164344528|NCT00288054|593636967|FG000|Overall Study|Adverse Event|3|||
164433188|NCT02281318|593957171|FG001|Overall Study|Lost to Follow-up|1|||
164281970|NCT03534141|593402529|FG001|Overall Study|Enrolled in other clinical trial|0|||
164281971|NCT03534141|593402528|FG000|Overall Study|Liver transplant aborted after randomization|0|||
164281972|NCT03534141|593402529|FG001|Overall Study|Liver transplant aborted after randomization|2|||
164281973|NCT03534141|593402528|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
164281974|NCT03534141|593402529|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
164281975|NCT00709618|593402530|FG000|Overall Study|Withdrawal by Subject|4|||
164281976|NCT00709618|593402530|FG000|Overall Study|Lost to Follow-up|1|||
164281977|NCT00709618|593402530|FG000|Overall Study|Study Closed/Terminated|25|||
164281978|NCT00687804|593402531|FG000|Core Study|Adverse Event|5|||
164281979|NCT00687804|593402532|FG001|Core Study|Adverse Event|3|||
164281980|NCT00687804|593402533|FG002|Core Study|Adverse Event|3|||
164344529|NCT00288054|593636967|FG000|Overall Study|Withdrawal by Subject|1|||
164344530|NCT00288054|593636967|FG000|Overall Study|Not protocol specified|2|||
164433189|NCT02281318|593957170|FG000|Overall Study|Physician Decision|2|||
164433190|NCT02281318|593957171|FG001|Overall Study|Physician Decision|0|||
164433191|NCT02281318|593957170|FG000|Overall Study|Withdrawal by Subject|6|||
164433192|NCT02281318|593957171|FG001|Overall Study|Withdrawal by Subject|2|||
164433193|NCT05257798|593957172|FG000|Follow-up Phase|Lost to Follow-up|1|||
164690499|NCT00177164|594889715|FG000|Overall Study|Pregnancy|0|||
164433194|NCT05257798|593957173|FG001|Follow-up Phase|Lost to Follow-up|0|||
164690500|NCT00177164|594889716|FG001|Overall Study|Pregnancy|1|||
164690501|NCT05070754|594889720|FG000|Overall Study|Withdrawal by Subject|0|||
164142998|NCT00863772|592884486|FG002|Overall Study|Protocol Violation|2|||
164433195|NCT00703911|593957174|FG000|Overall Study|Death|1|||
164690502|NCT05070754|594889721|FG001|Overall Study|Withdrawal by Subject|0|||
164690503|NCT05070754|594889722|FG002|Overall Study|Withdrawal by Subject|0|||
164281981|NCT00687804|593402531|FG000|Core Study|Abnormal laboratory value(s)|1|||
164690504|NCT05070754|594889723|FG003|Overall Study|Withdrawal by Subject|1|||
164690505|NCT05070754|594889720|FG000|Overall Study|Protocol Violation|0|||
164690506|NCT05070754|594889721|FG001|Overall Study|Protocol Violation|0|||
164690507|NCT05070754|594889722|FG002|Overall Study|Protocol Violation|0|||
164690508|NCT05070754|594889723|FG003|Overall Study|Protocol Violation|1|||
164690509|NCT01398787|594889724|FG000|Overall Study|Adverse Event|1|||
164690510|NCT02351167|594889725|FG000|Overall Study|Withdrawal by Subject|19|||
164281982|NCT00687804|593402532|FG001|Core Study|Abnormal laboratory value(s)|0|||
164281983|NCT00687804|593402533|FG002|Core Study|Abnormal laboratory value(s)|0|||
164281984|NCT00687804|593402531|FG000|Core Study|Lack of Efficacy|1|||
164281985|NCT00687804|593402532|FG001|Core Study|Lack of Efficacy|1|||
164281986|NCT00687804|593402533|FG002|Core Study|Lack of Efficacy|1|||
164281987|NCT00687804|593402531|FG000|Core Study|Withdrawal by Subject|4|||
164281988|NCT00687804|593402532|FG001|Core Study|Withdrawal by Subject|7|||
164281989|NCT00687804|593402533|FG002|Core Study|Withdrawal by Subject|7|||
164281990|NCT00687804|593402531|FG000|Core Study|Lost to Follow-up|0|||
164281991|NCT00687804|593402532|FG001|Core Study|Lost to Follow-up|1|||
164281992|NCT00687804|593402533|FG002|Core Study|Lost to Follow-up|0|||
164281993|NCT00687804|593402531|FG000|Core Study|Death|2|||
164281994|NCT00687804|593402532|FG001|Core Study|Death|2|||
164281995|NCT00687804|593402533|FG002|Core Study|Death|2|||
164281996|NCT00687804|593402531|FG000|Core Study|Protocol Violation|1|||
164281997|NCT00687804|593402532|FG001|Core Study|Protocol Violation|1|||
164281998|NCT00687804|593402533|FG002|Core Study|Protocol Violation|0|||
164281999|NCT00687804|593402531|FG000|Open-Label Extension Study|Adverse Event|2|||
164282000|NCT00687804|593402532|FG001|Open-Label Extension Study|Adverse Event|2|||
164282001|NCT00687804|593402533|FG002|Open-Label Extension Study|Adverse Event|2|||
164282002|NCT00687804|593402531|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
164282003|NCT00687804|593402532|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
164282004|NCT00687804|593402533|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
164690511|NCT02351167|594889726|FG001|Overall Study|Withdrawal by Subject|18|||
164690512|NCT02351167|594889727|FG002|Overall Study|Withdrawal by Subject|21|||
164690513|NCT00529217|594889728|FG000|Overall Study|Lack of Efficacy|2|||
164690514|NCT00529217|594889728|FG000|Overall Study|Unable to adhere to study schedule|2|||
164690515|NCT00194792|594889731|FG000|Overall Study|Withdrawal by Subject|1|||
164690516|NCT02448563|594889732|FG000|Overall Study|Lost to Follow-up|16|||
164690517|NCT02448563|594889733|FG001|Overall Study|Lost to Follow-up|10|||
164690518|NCT02448563|594889732|FG000|Overall Study|Withdrawal by Subject|0|||
164690519|NCT02448563|594889733|FG001|Overall Study|Withdrawal by Subject|1|||
164690520|NCT00702507|594889735|FG000|Initial Treatment Phase|Adverse Event|2|||
164690521|NCT00702507|594889735|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
164690522|NCT00702507|594889735|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
164690523|NCT00702507|594889735|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
164690524|NCT00702507|594889735|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
164690525|NCT00702507|594889735|FG000|Follow-up Phase|Protocol Violation|2|||
164690526|NCT00702507|594889735|FG000|Follow-up Phase|Lost to Follow-up|23|||
164690527|NCT00702507|594889735|FG000|Follow-up Phase|Late Enrollment|1|||
164690528|NCT02308696|594889736|FG000|Overall Study|Lost to Follow-up|28|||
164690529|NCT02308696|594889737|FG001|Overall Study|Lost to Follow-up|21|||
164690530|NCT02308696|594889736|FG000|Overall Study|Death|8|||
164690531|NCT02308696|594889737|FG001|Overall Study|Death|4|||
164690532|NCT02308696|594889736|FG000|Overall Study|Moved to a Higher Level of Care|17|||
164282005|NCT00687804|593402531|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
164282006|NCT00687804|593402532|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
164282007|NCT00687804|593402533|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
164282008|NCT00687804|593402531|FG000|Open-Label Extension Study|Administrative problems|1|||
164690533|NCT02308696|594889737|FG001|Overall Study|Moved to a Higher Level of Care|6|||
164690534|NCT00113919|594889738|FG000|Overall Study|Physician Decision|8|||
164690535|NCT00113919|594889738|FG000|Overall Study|Death|6|||
164282009|NCT00687804|593402532|FG001|Open-Label Extension Study|Administrative problems|1|||
164282010|NCT00687804|593402533|FG002|Open-Label Extension Study|Administrative problems|0|||
164282011|NCT00687804|593402531|FG000|Open-Label Extension Study|Death|2|||
164282012|NCT00687804|593402532|FG001|Open-Label Extension Study|Death|3|||
164282013|NCT00687804|593402533|FG002|Open-Label Extension Study|Death|3|||
164282014|NCT04390880|593402535|FG000|Overall Study|Withdrawal by Subject|1|||
164282015|NCT02557542|593402536|FG000|Overall Study|Poor recruitment|3|||
164282016|NCT02557542|593402537|FG001|Overall Study|Poor recruitment|0|||
164282017|NCT00195091|593402538|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
164282018|NCT00475709|593402544|FG000|Overall Study|Did not meet eligibility criteria|8|||
164282019|NCT00475709|593402544|FG000|Overall Study|Death|41|||
164282020|NCT00475709|593402544|FG000|Overall Study|Device Explant|6|||
164690536|NCT00372996|594889739|FG000|Overall Study|Death|11|||
164690537|NCT00372996|594889740|FG001|Overall Study|Death|4|||
164690538|NCT00372996|594889741|FG002|Overall Study|Death|8|||
164690539|NCT00372996|594889742|FG003|Overall Study|Death|7|||
164690540|NCT00372996|594889739|FG000|Overall Study|Lost to Follow-up|0|||
164690541|NCT00372996|594889740|FG001|Overall Study|Lost to Follow-up|2|||
164690542|NCT00372996|594889741|FG002|Overall Study|Lost to Follow-up|0|||
164282021|NCT00475709|593402544|FG000|Overall Study|Lost to Follow-up|21|||
164282022|NCT00555672|593402547|FG000|Overall Study|Death|0|||
164690543|NCT00372996|594889742|FG003|Overall Study|Lost to Follow-up|1|||
164690544|NCT00372996|594889739|FG000|Overall Study|Withdrawal by Subject|12|||
164690545|NCT00372996|594889740|FG001|Overall Study|Withdrawal by Subject|6|||
164690546|NCT00372996|594889741|FG002|Overall Study|Withdrawal by Subject|9|||
164690547|NCT00372996|594889742|FG003|Overall Study|Withdrawal by Subject|5|||
164690548|NCT00372996|594889739|FG000|Overall Study|Study Terminated by Sponsor|4|||
164690549|NCT00372996|594889740|FG001|Overall Study|Study Terminated by Sponsor|0|||
164690550|NCT00372996|594889741|FG002|Overall Study|Study Terminated by Sponsor|4|||
164690551|NCT00372996|594889742|FG003|Overall Study|Study Terminated by Sponsor|0|||
164690552|NCT00372996|594889739|FG000|Overall Study|Other|10|||
164690553|NCT00372996|594889740|FG001|Overall Study|Other|2|||
164690554|NCT00372996|594889741|FG002|Overall Study|Other|7|||
164690555|NCT00372996|594889742|FG003|Overall Study|Other|7|||
164690556|NCT02914457|594889743|FG000|Overall Study|Withdrawal by Subject|1|||
164690557|NCT02914457|594889743|FG000|Overall Study|Physician Decision|1|||
164690558|NCT02914457|594889743|FG000|Overall Study|No veins available for lead placement|1|||
164690559|NCT02914457|594889743|FG000|Overall Study|Electrical instability of patient|1|||
164690560|NCT02914457|594889743|FG000|Overall Study|ECG acquisition error due to sweating|1|||
164690561|NCT02914457|594889743|FG000|Overall Study|Protocol Violation|1|||
164690562|NCT01055886|594889747|FG000|Overall Study|Withdrawal by Subject|4|||
164690563|NCT01055886|594889748|FG001|Overall Study|Withdrawal by Subject|9|||
164690564|NCT01055886|594889747|FG000|Overall Study|Lost to Follow-up|1|||
164690565|NCT01055886|594889748|FG001|Overall Study|Lost to Follow-up|1|||
164690566|NCT01055886|594889747|FG000|Overall Study|Withdrawal by PI|0|||
164690567|NCT01055886|594889748|FG001|Overall Study|Withdrawal by PI|1|||
164690568|NCT04254809|594889751|FG000|Overall Study|Lost to Follow-up|5|||
164690569|NCT04254809|594889752|FG001|Overall Study|Lost to Follow-up|10|||
164690570|NCT02972515|594889753|FG000|Overall Study|Lost to Follow-up|78|||
164690571|NCT01928615|594889754|FG000|Overall Study|Study Terminated by Sponsor|2|||
164690572|NCT04531527|594889755|FG000|Overall Study|Found to be Ineligible|3|||
164690573|NCT02608476|594889760|FG000|Overall Study|Withdrawal by Subject|30|||
164690574|NCT02608476|594889761|FG001|Overall Study|Withdrawal by Subject|37|||
164690575|NCT02608476|594889760|FG000|Overall Study|Lost to Follow-up|24|||
164690576|NCT02608476|594889761|FG001|Overall Study|Lost to Follow-up|24|||
164690577|NCT02608476|594889760|FG000|Overall Study|Adverse Event|2|||
164690578|NCT02608476|594889761|FG001|Overall Study|Adverse Event|8|||
164690579|NCT02608476|594889760|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
164690580|NCT02608476|594889761|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
164690581|NCT02608476|594889760|FG000|Overall Study|Noncompliance with treatment|1|||
164690582|NCT02608476|594889761|FG001|Overall Study|Noncompliance with treatment|5|||
164690583|NCT02608476|594889760|FG000|Overall Study|Lack of Efficacy|3|||
164690584|NCT02608476|594889761|FG001|Overall Study|Lack of Efficacy|1|||
164690585|NCT02608476|594889760|FG000|Overall Study|Other|0|||
164690586|NCT02608476|594889761|FG001|Overall Study|Other|1|||
164690587|NCT02608476|594889760|FG000|Overall Study|Physician Decision|1|||
164690588|NCT02608476|594889761|FG001|Overall Study|Physician Decision|0|||
164690589|NCT02608476|594889760|FG000|Overall Study|Pregnancy|0|||
164690590|NCT02608476|594889761|FG001|Overall Study|Pregnancy|1|||
164690591|NCT02608476|594889760|FG000|Overall Study|Progressive disease|1|||
164690592|NCT02608476|594889761|FG001|Overall Study|Progressive disease|0|||
164690593|NCT00676494|594889762|FG000|Overall Study|Missed Visit|8|||
164690594|NCT00676494|594889762|FG000|Overall Study|Withdrawal by Subject|6|||
164690595|NCT01203917|594889764|FG000|Overall Study|Death|29|||
164690596|NCT01203917|594889764|FG000|Overall Study|Lost to Follow-up|2|||
164282023|NCT00555672|593402548|FG001|Overall Study|Death|2|||
164282024|NCT00555672|593402547|FG000|Overall Study|Adverse Event|8|||
164282025|NCT00555672|593402548|FG001|Overall Study|Adverse Event|2|||
164282026|NCT00555672|593402547|FG000|Overall Study|Objective progression or relapse|11|||
164282027|NCT00555672|593402548|FG001|Overall Study|Objective progression or relapse|5|||
164282028|NCT00555672|593402547|FG000|Overall Study|Other|3|||
164433196|NCT00703911|593957174|FG000|Overall Study|Physician Decision|6|||
164690597|NCT01203917|594889764|FG000|Overall Study|Withdrawal by Subject|3|||
164690598|NCT01203917|594889764|FG000|Overall Study|Due to objective disease progression|1|||
164690599|NCT01203917|594889764|FG000|Overall Study|Due to EGFR M+I patient|1|||
164690600|NCT03310619|594889765|FG000|Pre-Treatment Period|Death|1|||
164690601|NCT03310619|594889766|FG001|Pre-Treatment Period|Death|0|||
164690602|NCT03310619|594889767|FG002|Pre-Treatment Period|Death|0|||
164690603|NCT03310619|594889768|FG003|Pre-Treatment Period|Death|0|||
164282029|NCT00555672|593402548|FG001|Overall Study|Other|1|||
164282030|NCT00555672|593402547|FG000|Overall Study|Participant refused|2|||
164282031|NCT00555672|593402548|FG001|Overall Study|Participant refused|0|||
164282032|NCT04526145|593402549|FG000|Overall Study|Withdrawal by Subject|5|||
164690604|NCT03310619|594889769|FG004|Pre-Treatment Period|Death|1|||
164690605|NCT03310619|594889770|FG005|Pre-Treatment Period|Death|0|||
164690606|NCT03310619|594889771|FG006|Pre-Treatment Period|Death|0|||
164690607|NCT03310619|594889772|FG007|Pre-Treatment Period|Death|0|||
164690608|NCT03310619|594889765|FG000|Pre-Treatment Period|Other reasons|2|||
164690609|NCT03310619|594889766|FG001|Pre-Treatment Period|Other reasons|1|||
164282033|NCT01415401|593402557|FG000|Overall Study|Adverse Event|5|||
164282034|NCT01415401|593402557|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
164282035|NCT01415401|593402557|FG000|Overall Study|Terminated by Sponsor|1|||
164282036|NCT00548145|593402559|FG000|Overall Study|Death|0|||
164282037|NCT00548145|593402560|FG001|Overall Study|Death|1|||
164282038|NCT00548145|593402559|FG000|Overall Study|Withdrawal by Subject|0|||
164282039|NCT00548145|593402560|FG001|Overall Study|Withdrawal by Subject|2|||
164690610|NCT03310619|594889767|FG002|Pre-Treatment Period|Other reasons|2|||
164690611|NCT03310619|594889768|FG003|Pre-Treatment Period|Other reasons|0|||
164690612|NCT03310619|594889769|FG004|Pre-Treatment Period|Other reasons|0|||
164690613|NCT03310619|594889770|FG005|Pre-Treatment Period|Other reasons|0|||
164690614|NCT03310619|594889771|FG006|Pre-Treatment Period|Other reasons|2|||
164690615|NCT03310619|594889772|FG007|Pre-Treatment Period|Other reasons|0|||
164690616|NCT03310619|594889765|FG000|Treatment Period|Death|1|||
164690617|NCT03310619|594889766|FG001|Treatment Period|Death|2|||
164690618|NCT03310619|594889767|FG002|Treatment Period|Death|0|||
164690619|NCT03310619|594889768|FG003|Treatment Period|Death|0|||
164690620|NCT03310619|594889769|FG004|Treatment Period|Death|1|||
164690621|NCT03310619|594889770|FG005|Treatment Period|Death|0|||
164690622|NCT03310619|594889771|FG006|Treatment Period|Death|2|||
164690623|NCT03310619|594889772|FG007|Treatment Period|Death|0|||
164690624|NCT03310619|594889765|FG000|Treatment Period|Adverse Event|0|||
164690625|NCT03310619|594889766|FG001|Treatment Period|Adverse Event|1|||
164690626|NCT03310619|594889767|FG002|Treatment Period|Adverse Event|4|||
164690627|NCT03310619|594889768|FG003|Treatment Period|Adverse Event|1|||
164690628|NCT03310619|594889769|FG004|Treatment Period|Adverse Event|0|||
164690629|NCT03310619|594889770|FG005|Treatment Period|Adverse Event|0|||
164690630|NCT03310619|594889771|FG006|Treatment Period|Adverse Event|0|||
164690631|NCT03310619|594889772|FG007|Treatment Period|Adverse Event|0|||
164690632|NCT03310619|594889765|FG000|Treatment Period|Withdrawal by participant|0|||
164690633|NCT03310619|594889766|FG001|Treatment Period|Withdrawal by participant|0|||
164690634|NCT03310619|594889767|FG002|Treatment Period|Withdrawal by participant|1|||
164690635|NCT03310619|594889768|FG003|Treatment Period|Withdrawal by participant|0|||
164690636|NCT03310619|594889769|FG004|Treatment Period|Withdrawal by participant|0|||
164282040|NCT00548145|593402559|FG000|Overall Study|Physician Decision|1|||
164282041|NCT00548145|593402560|FG001|Overall Study|Physician Decision|1|||
164282042|NCT00206440|593402563|FG000|Overall Study|Protocol Violation|1|||
164282043|NCT00206440|593402564|FG001|Overall Study|Protocol Violation|2|||
164282044|NCT00206440|593402563|FG000|Overall Study|Adverse Event|4|||
164282045|NCT00206440|593402564|FG001|Overall Study|Adverse Event|2|||
164282046|NCT01746225|593402565|FG000|Overall Study|Death|1|||
164282047|NCT01746225|593402566|FG001|Overall Study|Death|0|||
164282048|NCT01746225|593402567|FG002|Overall Study|Death|1|||
164585825|NCT00907478|594510051|FG000|Overall Study|Requirement for alternative therapy|1|||
164585826|NCT00907478|594510052|FG001|Overall Study|Requirement for alternative therapy|2|||
164585827|NCT00907478|594510053|FG002|Overall Study|Requirement for alternative therapy|3|||
164585828|NCT00907478|594510051|FG000|Overall Study|Physician Decision|2|||
164585829|NCT00907478|594510052|FG001|Overall Study|Physician Decision|0|||
164585830|NCT00907478|594510053|FG002|Overall Study|Physician Decision|3|||
164585831|NCT00907478|594510051|FG000|Overall Study|Death|4|||
164585832|NCT00907478|594510052|FG001|Overall Study|Death|2|||
164585833|NCT00907478|594510053|FG002|Overall Study|Death|1|||
164585834|NCT00907478|594510051|FG000|Overall Study|Protocol-specified criteria|5|||
164585835|NCT00907478|594510052|FG001|Overall Study|Protocol-specified criteria|2|||
164585836|NCT00907478|594510053|FG002|Overall Study|Protocol-specified criteria|3|||
164585837|NCT00907478|594510051|FG000|Overall Study|Pregnancy|0|||
164585838|NCT00907478|594510052|FG001|Overall Study|Pregnancy|1|||
164585839|NCT00907478|594510053|FG002|Overall Study|Pregnancy|1|||
164585840|NCT00907478|594510051|FG000|Overall Study|Lost to Follow-up|1|||
164585841|NCT00907478|594510052|FG001|Overall Study|Lost to Follow-up|0|||
164585842|NCT00907478|594510053|FG002|Overall Study|Lost to Follow-up|0|||
164585843|NCT00907478|594510051|FG000|Overall Study|Other|3|||
164690637|NCT03310619|594889770|FG005|Treatment Period|Withdrawal by participant|0|||
164690638|NCT03310619|594889771|FG006|Treatment Period|Withdrawal by participant|0|||
164690639|NCT03310619|594889772|FG007|Treatment Period|Withdrawal by participant|0|||
164282049|NCT01746225|593402565|FG000|Overall Study|Withdrawal by Subject|5|||
164282050|NCT01746225|593402566|FG001|Overall Study|Withdrawal by Subject|15|||
164282051|NCT01746225|593402567|FG002|Overall Study|Withdrawal by Subject|19|||
164585844|NCT00907478|594510052|FG001|Overall Study|Other|0|||
164585845|NCT00907478|594510053|FG002|Overall Study|Other|1|||
164585846|NCT02747043|594510054|FG000|Overall Study|Other|1|||
164690640|NCT03310619|594889765|FG000|Treatment Period|Lost to Follow-up|0|||
164690641|NCT03310619|594889766|FG001|Treatment Period|Lost to Follow-up|0|||
164690642|NCT03310619|594889767|FG002|Treatment Period|Lost to Follow-up|0|||
164282052|NCT01746225|593402565|FG000|Overall Study|Physician Decision|14|||
164282053|NCT01746225|593402566|FG001|Overall Study|Physician Decision|11|||
164282054|NCT01746225|593402567|FG002|Overall Study|Physician Decision|3|||
164585847|NCT02747043|594510055|FG001|Overall Study|Other|1|||
164585848|NCT02747043|594510054|FG000|Overall Study|Adverse Event|3|||
164585849|NCT02747043|594510055|FG001|Overall Study|Adverse Event|1|||
164585850|NCT02747043|594510054|FG000|Overall Study|Withdrawal by Subject|1|||
164585851|NCT02747043|594510055|FG001|Overall Study|Withdrawal by Subject|1|||
164585852|NCT02747043|594510054|FG000|Overall Study|Physician Decision|1|||
164690643|NCT03310619|594889768|FG003|Treatment Period|Lost to Follow-up|0|||
164690644|NCT03310619|594889769|FG004|Treatment Period|Lost to Follow-up|0|||
164690645|NCT03310619|594889770|FG005|Treatment Period|Lost to Follow-up|0|||
164690646|NCT03310619|594889771|FG006|Treatment Period|Lost to Follow-up|0|||
164690647|NCT03310619|594889772|FG007|Treatment Period|Lost to Follow-up|1|||
164690648|NCT03310619|594889765|FG000|Treatment Period|Study terminated by sponsor|0|||
164690649|NCT03310619|594889766|FG001|Treatment Period|Study terminated by sponsor|0|||
164690650|NCT03310619|594889767|FG002|Treatment Period|Study terminated by sponsor|0|||
164690651|NCT03310619|594889768|FG003|Treatment Period|Study terminated by sponsor|0|||
164690652|NCT03310619|594889769|FG004|Treatment Period|Study terminated by sponsor|0|||
164690653|NCT03310619|594889770|FG005|Treatment Period|Study terminated by sponsor|0|||
164690654|NCT03310619|594889771|FG006|Treatment Period|Study terminated by sponsor|0|||
164690655|NCT03310619|594889772|FG007|Treatment Period|Study terminated by sponsor|1|||
164690656|NCT03310619|594889765|FG000|Treatment Period|Physician Decision|0|||
164690657|NCT03310619|594889766|FG001|Treatment Period|Physician Decision|0|||
164690658|NCT03310619|594889767|FG002|Treatment Period|Physician Decision|0|||
164690659|NCT03310619|594889768|FG003|Treatment Period|Physician Decision|0|||
164690660|NCT03310619|594889769|FG004|Treatment Period|Physician Decision|3|||
164690661|NCT03310619|594889770|FG005|Treatment Period|Physician Decision|0|||
164585853|NCT02747043|594510055|FG001|Overall Study|Physician Decision|1|||
164585854|NCT02747043|594510054|FG000|Overall Study|Protocol Violation|0|||
164585855|NCT02747043|594510055|FG001|Overall Study|Protocol Violation|1|||
164585856|NCT02747043|594510054|FG000|Overall Study|Disease progression|4|||
164585857|NCT02747043|594510055|FG001|Overall Study|Disease progression|0|||
164585858|NCT03648476|594510058|FG000|Overall Study|Withdrawal by Subject|2|||
164585859|NCT03648476|594510059|FG001|Overall Study|Withdrawal by Subject|1|||
164585860|NCT00907881|594510060|FG000|Overall Study|Lost to Follow-up|59|||
164585861|NCT00907881|594510060|FG000|Overall Study|Noncompliance|5|||
164585862|NCT00907881|594510060|FG000|Overall Study|Withdrawal by Subject|5|||
164585863|NCT00907881|594510060|FG000|Overall Study|Protocol Violation|1|||
164585864|NCT00907881|594510060|FG000|Overall Study|Missing discontinuation information|15|||
164585865|NCT01097616|594510061|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
164585866|NCT01097616|594510062|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
164585867|NCT01097616|594510063|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
164585868|NCT01097616|594510064|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
164585869|NCT01097616|594510065|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
164585870|NCT01097616|594510066|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
164585871|NCT01097616|594510067|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
164585872|NCT01097616|594510068|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
164585873|NCT01097616|594510061|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
164585874|NCT01097616|594510062|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
164585875|NCT01097616|594510063|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
164585876|NCT01097616|594510064|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
164585877|NCT01097616|594510065|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
164585878|NCT01097616|594510066|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
164585879|NCT01097616|594510067|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
164585880|NCT01097616|594510068|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
164585881|NCT01097616|594510061|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
164690662|NCT03310619|594889771|FG006|Treatment Period|Physician Decision|0|||
164690663|NCT03310619|594889772|FG007|Treatment Period|Physician Decision|0|||
164690664|NCT03310619|594889765|FG000|Treatment Period|Other reasons|1|||
164690665|NCT03310619|594889766|FG001|Treatment Period|Other reasons|0|||
164690666|NCT03310619|594889767|FG002|Treatment Period|Other reasons|2|||
164690667|NCT03310619|594889768|FG003|Treatment Period|Other reasons|0|||
164690668|NCT03310619|594889769|FG004|Treatment Period|Other reasons|0|||
164690669|NCT03310619|594889770|FG005|Treatment Period|Other reasons|0|||
164690670|NCT03310619|594889771|FG006|Treatment Period|Other reasons|0|||
164690671|NCT03310619|594889772|FG007|Treatment Period|Other reasons|0|||
164690672|NCT00152516|594889777|FG000|Overall Study|Adverse Event|18|||
164690673|NCT00152516|594889777|FG000|Overall Study|Lack and Loss of Efficacy|30|||
164690674|NCT00152516|594889777|FG000|Overall Study|Lost to Follow-up|5|||
164690675|NCT00152516|594889777|FG000|Overall Study|Withdrawal by Subject|8|||
164690676|NCT00152516|594889777|FG000|Overall Study|Protocol Violation|3|||
164690677|NCT00152516|594889777|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
164690678|NCT00152516|594889777|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
164690679|NCT00152516|594889777|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
164282055|NCT01746225|593402565|FG000|Overall Study|Adverse Event|15|||
164282056|NCT01746225|593402566|FG001|Overall Study|Adverse Event|12|||
164282057|NCT01746225|593402567|FG002|Overall Study|Adverse Event|17|||
164282058|NCT01746225|593402565|FG000|Overall Study|Continuing Treatment|5|||
164282059|NCT01746225|593402566|FG001|Overall Study|Continuing Treatment|8|||
164282060|NCT01746225|593402567|FG002|Overall Study|Continuing Treatment|3|||
164282061|NCT00595478|593402568|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
164282062|NCT00595478|593402569|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
164282063|NCT00595478|593402568|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
164282064|NCT00595478|593402569|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
164585882|NCT01097616|594510062|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
164585883|NCT01097616|594510063|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
164690680|NCT00152516|594889777|FG000|Overall Study|Other: Non-Compliance|2|||
164690681|NCT00152516|594889777|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
164690682|NCT00152516|594889777|FG000|Overall Study|Other: Moved Out Of State|1|||
164282065|NCT02713828|593402570|FG000|Overall Study|Death|2|||
164282066|NCT02713828|593402571|FG001|Overall Study|Death|0|||
164585884|NCT01097616|594510064|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
164585885|NCT01097616|594510065|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
164585886|NCT01097616|594510066|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
164585887|NCT01097616|594510067|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
164585888|NCT01097616|594510068|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
164585889|NCT01097616|594510061|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
164585890|NCT01097616|594510062|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
164585891|NCT01097616|594510063|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
164585892|NCT01097616|594510064|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
164585893|NCT01097616|594510065|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
164585894|NCT01097616|594510066|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
164585895|NCT01097616|594510067|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
164585896|NCT01097616|594510068|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
164585897|NCT01097616|594510061|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
164585898|NCT01097616|594510062|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
164585899|NCT01097616|594510063|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
164585900|NCT01097616|594510064|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
164585901|NCT01097616|594510065|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
164585902|NCT01097616|594510066|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
164585903|NCT01097616|594510067|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
164585904|NCT01097616|594510068|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
164585905|NCT01097616|594510061|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
164585906|NCT01097616|594510062|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
164585907|NCT01097616|594510063|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
164585908|NCT01097616|594510064|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
164585909|NCT01097616|594510065|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
164585910|NCT01097616|594510066|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
164585911|NCT01097616|594510067|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
164585912|NCT01097616|594510068|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
164585913|NCT01097616|594510061|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
164585914|NCT01097616|594510062|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
164585915|NCT01097616|594510063|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
164585916|NCT01097616|594510064|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
164585917|NCT01097616|594510065|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
164585918|NCT01097616|594510066|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
164585919|NCT01097616|594510067|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
164585920|NCT01097616|594510068|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
164585921|NCT01097616|594510061|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
164585922|NCT01097616|594510062|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
164585923|NCT01097616|594510063|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
164585924|NCT01097616|594510064|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
164585925|NCT01097616|594510065|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
164585926|NCT01097616|594510066|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
164585927|NCT01097616|594510067|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
164585928|NCT01097616|594510068|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
164585929|NCT01097616|594510061|FG000|Optional DB EXT Phase|Adverse Event|0|||
164585930|NCT01097616|594510062|FG001|Optional DB EXT Phase|Adverse Event|7|||
164585931|NCT01097616|594510063|FG002|Optional DB EXT Phase|Adverse Event|2|||
164690683|NCT00152516|594889777|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
164282067|NCT02713828|593402570|FG000|Overall Study|Withdrawal by Subject|1|||
164282068|NCT02713828|593402571|FG001|Overall Study|Withdrawal by Subject|0|||
164282069|NCT02713828|593402570|FG000|Overall Study|study terminated but patient allowed to|2|||
164282070|NCT02713828|593402571|FG001|Overall Study|study terminated but patient allowed to|0|||
164282071|NCT04090242|593402572|FG000|Overall Study|Withdrawal by Subject|1|||
164282072|NCT04090242|593402573|FG001|Overall Study|Withdrawal by Subject|0|||
164282073|NCT02513472|593402574|FG000|Overall Study|Radiological Disease Progression|45|||
164282074|NCT02513472|593402575|FG001|Overall Study|Radiological Disease Progression|57|||
164282075|NCT02513472|593402574|FG000|Overall Study|Clinical Disease Progression|5|||
164282076|NCT02513472|593402575|FG001|Overall Study|Clinical Disease Progression|13|||
164282077|NCT02513472|593402574|FG000|Overall Study|Adverse Event|8|||
164282078|NCT02513472|593402575|FG001|Overall Study|Adverse Event|11|||
164282079|NCT02513472|593402574|FG000|Overall Study|Withdrawal by Subject|0|||
164282080|NCT02513472|593402575|FG001|Overall Study|Withdrawal by Subject|4|||
164282081|NCT02513472|593402574|FG000|Overall Study|Subject Choice|2|||
164282082|NCT02513472|593402575|FG001|Overall Study|Subject Choice|7|||
164282083|NCT02513472|593402574|FG000|Overall Study|Treatment Completed as per Protocol|3|||
164282084|NCT02513472|593402575|FG001|Overall Study|Treatment Completed as per Protocol|3|||
164282085|NCT02513472|593402574|FG000|Overall Study|Other|3|||
164282086|NCT02513472|593402575|FG001|Overall Study|Other|6|||
164282087|NCT01019369|593402576|FG000|Overall Study|Lost to Follow-up|10|||
164282088|NCT01019369|593402577|FG001|Overall Study|Lost to Follow-up|6|||
164282089|NCT01019369|593402576|FG000|Overall Study|Withdrawal by Subject|0|||
164282090|NCT01019369|593402577|FG001|Overall Study|Withdrawal by Subject|1|||
164282091|NCT04405076|593402578|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
164282092|NCT04405076|593402579|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
164282093|NCT04405076|593402580|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
164282094|NCT04405076|593402581|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
164282095|NCT04405076|593402582|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
164282096|NCT04405076|593402583|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
164282097|NCT04405076|593402584|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
164282098|NCT04405076|593402585|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
164282099|NCT04405076|593402586|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
164282100|NCT04405076|593402578|FG000|Part A (Blinded Phase)|Physician Decision|1|||
164282101|NCT04405076|593402579|FG001|Part A (Blinded Phase)|Physician Decision|2|||
164282102|NCT04405076|593402580|FG002|Part A (Blinded Phase)|Physician Decision|0|||
164282103|NCT04405076|593402581|FG003|Part A (Blinded Phase)|Physician Decision|0|||
164282104|NCT04405076|593402582|FG004|Part A (Blinded Phase)|Physician Decision|0|||
164282105|NCT04405076|593402583|FG005|Part A (Blinded Phase)|Physician Decision|0|||
164282106|NCT04405076|593402584|FG006|Part A (Blinded Phase)|Physician Decision|0|||
164282107|NCT04405076|593402585|FG007|Part A (Blinded Phase)|Physician Decision|0|||
164282108|NCT04405076|593402586|FG008|Part A (Blinded Phase)|Physician Decision|0|||
164282109|NCT04405076|593402578|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
164282110|NCT04405076|593402579|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
164282111|NCT04405076|593402580|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
164282112|NCT04405076|593402581|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
164282113|NCT04405076|593402582|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
164282114|NCT04405076|593402583|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
164282115|NCT04405076|593402584|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
164282116|NCT04405076|593402585|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
164282117|NCT04405076|593402586|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
164282118|NCT04405076|593402578|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
164282119|NCT04405076|593402579|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
164282120|NCT04405076|593402580|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
164433197|NCT00703911|593957174|FG000|Overall Study|Lost to Follow-up|1|||
164433198|NCT00703911|593957174|FG000|Overall Study|Withdrawal by Subject|2|||
164585932|NCT01097616|594510064|FG003|Optional DB EXT Phase|Adverse Event|0|||
164585933|NCT01097616|594510065|FG004|Optional DB EXT Phase|Adverse Event|0|||
164585934|NCT01097616|594510066|FG005|Optional DB EXT Phase|Adverse Event|0|||
164585935|NCT01097616|594510067|FG006|Optional DB EXT Phase|Adverse Event|0|||
164585936|NCT01097616|594510068|FG007|Optional DB EXT Phase|Adverse Event|0|||
164585937|NCT01097616|594510061|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
164585938|NCT01097616|594510062|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
164585939|NCT01097616|594510063|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
164585940|NCT01097616|594510064|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
164585941|NCT01097616|594510065|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
164585942|NCT01097616|594510066|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
164585943|NCT01097616|594510067|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
164585944|NCT01097616|594510068|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
164585945|NCT01097616|594510061|FG000|Optional DB EXT Phase|Protocol Violation|0|||
164585946|NCT01097616|594510062|FG001|Optional DB EXT Phase|Protocol Violation|2|||
164585947|NCT01097616|594510063|FG002|Optional DB EXT Phase|Protocol Violation|3|||
164585948|NCT01097616|594510064|FG003|Optional DB EXT Phase|Protocol Violation|0|||
164690684|NCT00152516|594889777|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
164690685|NCT02387762|594889784|FG000|Overall Study|Withdrawal by Subject|1|||
164690686|NCT02387762|594889785|FG001|Overall Study|Withdrawal by Subject|0|||
164690687|NCT04203667|594889786|FG000|Overall Study|Withdrawal by Subject|1|||
164690688|NCT04203667|594889786|FG000|Overall Study|Lost to Follow-up|1|||
164690689|NCT04203667|594889786|FG000|Overall Study|Death|1|||
164690690|NCT04203667|594889786|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
164690691|NCT01160640|594889787|FG000|Overall Study|Physician Decision|3|||
164690692|NCT01160640|594889788|FG001|Overall Study|Physician Decision|3|||
164690693|NCT01160640|594889787|FG000|Overall Study|Incarceration|1|||
164690694|NCT01160640|594889788|FG001|Overall Study|Incarceration|0|||
164690695|NCT01160640|594889787|FG000|Overall Study|Withdrawal by Subject|0|||
164690696|NCT01160640|594889788|FG001|Overall Study|Withdrawal by Subject|3|||
164690697|NCT04428645|594889791|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
164690698|NCT03168906|594889794|FG000|Overall Study|Lack of Efficacy|6|||
164690699|NCT03168906|594889795|FG001|Overall Study|Lack of Efficacy|6|||
164690700|NCT03840382|594889798|FG000|Overall Study|Lost to Follow-up|11|||
164690701|NCT00434590|594889799|FG000|Overall Study|Administrative problems|5|||
164690702|NCT00434590|594889800|FG001|Overall Study|Administrative problems|5|||
164690703|NCT02839798|594891639|FG000|Overall Study|Withdrawal by Subject|2|||
164690704|NCT04129944|594891641|FG000|Overall Study|Death|0|||
164690705|NCT04129944|594891642|FG001|Overall Study|Death|0|||
164690706|NCT04129944|594891643|FG002|Overall Study|Death|0|||
164690707|NCT04129944|594891644|FG003|Overall Study|Death|1|||
164690708|NCT04129944|594891641|FG000|Overall Study|Lost to Follow-up|1|||
164690709|NCT04129944|594891642|FG001|Overall Study|Lost to Follow-up|0|||
164690710|NCT04129944|594891643|FG002|Overall Study|Lost to Follow-up|0|||
164690711|NCT04129944|594891644|FG003|Overall Study|Lost to Follow-up|0|||
164690712|NCT04129944|594891641|FG000|Overall Study|Withdrawal by Subject|1|||
164690713|NCT04129944|594891642|FG001|Overall Study|Withdrawal by Subject|0|||
164690714|NCT04129944|594891643|FG002|Overall Study|Withdrawal by Subject|1|||
164690715|NCT04129944|594891644|FG003|Overall Study|Withdrawal by Subject|2|||
164690716|NCT01560819|594891645|FG000|Overall Study|Physician Decision|1|||
164690717|NCT01560819|594891646|FG001|Overall Study|Physician Decision|0|||
164690718|NCT00996437|594891648|FG000|Overall Study|Death|1|||
164690719|NCT00996437|594891649|FG001|Overall Study|Death|0|||
164690720|NCT00996437|594891648|FG000|Overall Study|Dropped|2|||
164690721|NCT00996437|594891649|FG001|Overall Study|Dropped|2|||
164690722|NCT00996437|594891648|FG000|Overall Study|Missed|2|||
164690723|NCT00996437|594891649|FG001|Overall Study|Missed|5|||
164690724|NCT02576717|594891650|FG000|Overall Study|Other Reasons|16|||
164690725|NCT02576717|594891651|FG001|Overall Study|Other Reasons|18|||
164690726|NCT02576717|594891652|FG002|Overall Study|Other Reasons|15|||
164690727|NCT02576717|594891650|FG000|Overall Study|Covid-19 Pandemic|0|||
164690728|NCT02576717|594891651|FG001|Overall Study|Covid-19 Pandemic|1|||
164690729|NCT02576717|594891652|FG002|Overall Study|Covid-19 Pandemic|1|||
164690730|NCT02576717|594891650|FG000|Overall Study|Sponsor Decision|0|||
164690731|NCT02576717|594891651|FG001|Overall Study|Sponsor Decision|0|||
164690732|NCT02576717|594891652|FG002|Overall Study|Sponsor Decision|1|||
164690733|NCT02576717|594891650|FG000|Overall Study|Physician Decision|3|||
164690734|NCT02576717|594891651|FG001|Overall Study|Physician Decision|8|||
164690735|NCT02576717|594891652|FG002|Overall Study|Physician Decision|9|||
164690736|NCT02576717|594891650|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
164690737|NCT02576717|594891651|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
164690738|NCT02576717|594891652|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
164690739|NCT02576717|594891650|FG000|Overall Study|Death|3|||
164690740|NCT02576717|594891651|FG001|Overall Study|Death|5|||
164690741|NCT02576717|594891652|FG002|Overall Study|Death|3|||
164690742|NCT02576717|594891650|FG000|Overall Study|Lost to Follow-up|9|||
164690743|NCT02576717|594891651|FG001|Overall Study|Lost to Follow-up|10|||
164344531|NCT02197247|593636971|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
164344532|NCT02197247|593636971|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
164344533|NCT02197247|593636971|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
164344534|NCT02197247|593636971|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
164344535|NCT02197247|593636971|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
164690744|NCT02576717|594891652|FG002|Overall Study|Lost to Follow-up|19|||
164690745|NCT02576717|594891650|FG000|Overall Study|Protocol Violation|4|||
164690746|NCT02576717|594891651|FG001|Overall Study|Protocol Violation|0|||
164690747|NCT02576717|594891652|FG002|Overall Study|Protocol Violation|5|||
164690748|NCT02576717|594891650|FG000|Overall Study|Lack of Efficacy|24|||
164690749|NCT02576717|594891651|FG001|Overall Study|Lack of Efficacy|28|||
164690750|NCT02576717|594891652|FG002|Overall Study|Lack of Efficacy|20|||
164690751|NCT02576717|594891650|FG000|Overall Study|Adverse Event|26|||
164690752|NCT02576717|594891651|FG001|Overall Study|Adverse Event|32|||
164690753|NCT02576717|594891652|FG002|Overall Study|Adverse Event|26|||
164690754|NCT01363011|594891653|FG000|Main Study|Adverse Event|2|||
164690755|NCT01363011|594891654|FG001|Main Study|Adverse Event|3|||
164690756|NCT01363011|594891653|FG000|Main Study|Investigator's Discretion|1|||
164690757|NCT01363011|594891654|FG001|Main Study|Investigator's Discretion|1|||
164690758|NCT01363011|594891653|FG000|Main Study|Withdrew Consent|1|||
164690759|NCT01363011|594891654|FG001|Main Study|Withdrew Consent|4|||
164690760|NCT01363011|594891653|FG000|Main Study|Protocol Violation|0|||
164690761|NCT01363011|594891654|FG001|Main Study|Protocol Violation|1|||
164690762|NCT01363011|594891653|FG000|Extension Phase|Adverse Event|1|||
164690763|NCT01363011|594891654|FG001|Extension Phase|Adverse Event|1|||
164690764|NCT01363011|594891653|FG000|Extension Phase|Lack of Efficacy|0|||
164690765|NCT01363011|594891654|FG001|Extension Phase|Lack of Efficacy|1|||
164690766|NCT01363011|594891653|FG000|Extension Phase|Investigator's Discretion|2|||
164690767|NCT01363011|594891654|FG001|Extension Phase|Investigator's Discretion|2|||
164690768|NCT01363011|594891653|FG000|Extension Phase|Withdrew Consent|0|||
164690769|NCT01363011|594891654|FG001|Extension Phase|Withdrew Consent|1|||
164690770|NCT01363011|594891653|FG000|Extension Phase|Lost to Follow-up|0|||
164690771|NCT01363011|594891654|FG001|Extension Phase|Lost to Follow-up|2|||
164690772|NCT01363011|594891653|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
164690773|NCT01363011|594891654|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
164690774|NCT00407745|594891655|FG000|Overall Study|Lack of Efficacy|1|||
164690775|NCT00407745|594891656|FG001|Overall Study|Lack of Efficacy|2|||
164690776|NCT00407745|594891655|FG000|Overall Study|Withdrawal by Subject|3|||
164690777|NCT00407745|594891656|FG001|Overall Study|Withdrawal by Subject|3|||
164690778|NCT00407745|594891655|FG000|Overall Study|Protocol Violation|5|||
164690779|NCT00407745|594891656|FG001|Overall Study|Protocol Violation|3|||
164690780|NCT00407745|594891655|FG000|Overall Study|Adverse Event|8|||
164690781|NCT00407745|594891656|FG001|Overall Study|Adverse Event|8|||
164690782|NCT00407745|594891655|FG000|Overall Study|Other|2|||
164690783|NCT00407745|594891656|FG001|Overall Study|Other|0|||
164690784|NCT00407745|594891655|FG000|Overall Study|Randomized, unknown if treated|0|||
164690785|NCT00407745|594891656|FG001|Overall Study|Randomized, unknown if treated|1|||
164690786|NCT02960438|594891657|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
164690787|NCT02960438|594891658|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
164690788|NCT02960438|594891659|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
164690789|NCT02960438|594891660|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
164690790|NCT02960438|594891657|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
164690791|NCT02960438|594891658|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
164282121|NCT04405076|593402581|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
164282122|NCT04405076|593402582|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
164282123|NCT04405076|593402583|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
164282124|NCT04405076|593402584|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
164282125|NCT04405076|593402585|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
164282126|NCT04405076|593402586|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
164282127|NCT04405076|593402578|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
164282128|NCT04405076|593402579|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
164282129|NCT04405076|593402580|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
164282130|NCT04405076|593402581|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
164282131|NCT04405076|593402582|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
164282132|NCT04405076|593402583|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
164282133|NCT04405076|593402584|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
164282134|NCT04405076|593402585|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
164282135|NCT04405076|593402586|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
164282136|NCT04405076|593402578|FG000|Part A (Blinded Phase)|Other than Specified|0|||
164282137|NCT04405076|593402579|FG001|Part A (Blinded Phase)|Other than Specified|0|||
164282138|NCT04405076|593402580|FG002|Part A (Blinded Phase)|Other than Specified|3|||
164282139|NCT04405076|593402581|FG003|Part A (Blinded Phase)|Other than Specified|0|||
164282140|NCT04405076|593402582|FG004|Part A (Blinded Phase)|Other than Specified|0|||
164282141|NCT04405076|593402583|FG005|Part A (Blinded Phase)|Other than Specified|0|||
164282142|NCT04405076|593402584|FG006|Part A (Blinded Phase)|Other than Specified|0|||
164282143|NCT04405076|593402585|FG007|Part A (Blinded Phase)|Other than Specified|0|||
164282144|NCT04405076|593402586|FG008|Part A (Blinded Phase)|Other than Specified|0|||
164282145|NCT04405076|593402578|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
164282146|NCT04405076|593402579|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
164282147|NCT04405076|593402580|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
164690792|NCT02960438|594891659|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
164690793|NCT02960438|594891660|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
164690794|NCT02960438|594891657|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
164690795|NCT02960438|594891658|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
164690796|NCT02960438|594891659|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
164282148|NCT04405076|593402581|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
164282149|NCT04405076|593402582|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
164282150|NCT04405076|593402583|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
164282151|NCT04405076|593402584|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
164282152|NCT04405076|593402585|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
164282153|NCT04405076|593402586|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
164282154|NCT04405076|593402578|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
164282155|NCT04405076|593402579|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
164282156|NCT04405076|593402580|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
164282157|NCT04405076|593402581|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
164282158|NCT04405076|593402582|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
164282159|NCT04405076|593402583|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
164282160|NCT04405076|593402584|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
164282161|NCT04405076|593402585|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
164282162|NCT04405076|593402586|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
164282163|NCT04405076|593402578|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
164282164|NCT04405076|593402579|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
164282165|NCT04405076|593402580|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
164282166|NCT04405076|593402581|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
164282167|NCT04405076|593402582|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
164282168|NCT04405076|593402583|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
164282169|NCT04405076|593402584|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
164282170|NCT04405076|593402585|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
164282171|NCT04405076|593402586|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
164282172|NCT04405076|593402578|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
164282173|NCT04405076|593402579|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
164282174|NCT04405076|593402580|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
164282175|NCT04405076|593402581|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
164282176|NCT04405076|593402582|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
164282177|NCT04405076|593402583|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
164282178|NCT04405076|593402584|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
164282179|NCT04405076|593402585|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
164282180|NCT04405076|593402586|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
164282181|NCT04405076|593402578|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
164282182|NCT04405076|593402579|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
164282183|NCT04405076|593402580|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
164282184|NCT04405076|593402581|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
164282185|NCT04405076|593402582|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
164282186|NCT04405076|593402583|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
164282187|NCT04405076|593402584|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
164282188|NCT04405076|593402585|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
164282189|NCT04405076|593402586|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
164282190|NCT01380834|593402587|FG000|Overall Study|Physician Decision|1|||
164282191|NCT01380834|593402588|FG001|Overall Study|Physician Decision|0|||
164282192|NCT00604695|593402589|FG000|Overall Study|Did not receive first bolus.|0|||
164282193|NCT00604695|593402590|FG001|Overall Study|Did not receive first bolus.|4|||
164282194|NCT00172042|593402598|FG000|Overall Study|Adverse Event|27|||
164282195|NCT00172042|593402599|FG001|Overall Study|Adverse Event|13|||
164433199|NCT03055767|593957175|FG000|Open-Label Period|Lost to Follow-up|0|||
164433200|NCT03055767|593957176|FG001|Open-Label Period|Lost to Follow-up|0|||
164433201|NCT03055767|593957177|FG002|Open-Label Period|Lost to Follow-up|2|||
164690797|NCT02960438|594891660|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
164690798|NCT02960438|594891657|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
164690799|NCT02960438|594891658|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
164690800|NCT02960438|594891659|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
164690801|NCT02960438|594891660|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
164690802|NCT02960438|594891657|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
164690803|NCT02960438|594891658|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
164690804|NCT02960438|594891659|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
164690805|NCT02960438|594891660|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
164690806|NCT02960438|594891657|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
164690807|NCT02960438|594891658|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
164690808|NCT02960438|594891659|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
164690809|NCT02960438|594891660|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
164690810|NCT02960438|594891657|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
164690811|NCT02960438|594891658|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
164690812|NCT02960438|594891659|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
164690813|NCT02960438|594891660|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
164690814|NCT02960438|594891657|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
164690815|NCT02960438|594891658|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
164690816|NCT02960438|594891659|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
164690817|NCT02960438|594891660|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
164690818|NCT02960438|594891657|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
164690819|NCT02960438|594891658|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
164690820|NCT02960438|594891659|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
164690821|NCT02960438|594891660|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
164690822|NCT02960438|594891657|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
164690823|NCT02960438|594891658|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
164690824|NCT02960438|594891659|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
164690825|NCT02960438|594891660|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
164690826|NCT02960438|594891657|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
164690827|NCT02960438|594891658|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
164690828|NCT02960438|594891659|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
164690829|NCT02960438|594891660|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
164690830|NCT02960438|594891657|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
164690831|NCT02960438|594891658|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
164690832|NCT02960438|594891659|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
164690833|NCT02960438|594891660|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
164690834|NCT00298740|594891665|FG000|Overall Study|Lack of Efficacy|6|||
164690835|NCT00298740|594891665|FG000|Overall Study|Withdrawal by Subject|3|||
164690836|NCT03449199|594891666|FG000|Overall Study|Lost to Follow-up|1|||
164690837|NCT03449199|594891667|FG001|Overall Study|Lost to Follow-up|1|||
164690838|NCT03449199|594891668|FG002|Overall Study|Lost to Follow-up|0|||
164690839|NCT03449199|594891666|FG000|Overall Study|Protocol Deviation|0|||
164690840|NCT03449199|594891667|FG001|Overall Study|Protocol Deviation|0|||
164690841|NCT03449199|594891668|FG002|Overall Study|Protocol Deviation|1|||
164690842|NCT03449199|594891666|FG000|Overall Study|Withdrawal by Subject|0|||
164690843|NCT03449199|594891667|FG001|Overall Study|Withdrawal by Subject|0|||
164690844|NCT03449199|594891668|FG002|Overall Study|Withdrawal by Subject|1|||
164690845|NCT03136406|594891669|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
164690846|NCT01201759|594891670|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
164690847|NCT01201759|594891671|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
164690848|NCT01201759|594891670|FG000|Visit 3 - Washout|Adverse Event|0|||
164690849|NCT01201759|594891671|FG001|Visit 3 - Washout|Adverse Event|3|||
164690850|NCT01201759|594891670|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
164690851|NCT01201759|594891671|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
164690852|NCT01201759|594891670|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
164690853|NCT01201759|594891671|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
164690854|NCT00906373|594891672|FG000|Overall Study|Withdrawal by Subject|0|||
164690855|NCT00906373|594891673|FG001|Overall Study|Withdrawal by Subject|5|||
164690856|NCT00906373|594891672|FG000|Overall Study|Other|0|||
164690857|NCT00906373|594891673|FG001|Overall Study|Other|1|||
164690858|NCT00906373|594891672|FG000|Overall Study|Still on treatment at cutoff date|0|||
164690859|NCT00906373|594891673|FG001|Overall Study|Still on treatment at cutoff date|2|||
164690860|NCT00848042|594891674|FG000|Overall Study|Death|1|||
164282196|NCT00172042|593402598|FG000|Overall Study|Abnormal laboratory value(s)|5|||
164282197|NCT00172042|593402599|FG001|Overall Study|Abnormal laboratory value(s)|1|||
164282198|NCT00172042|593402598|FG000|Overall Study|Abnormal test procedure(s)|0|||
164690861|NCT00848042|594891675|FG001|Overall Study|Death|2|||
164690862|NCT00848042|594891676|FG002|Overall Study|Death|0|||
164690863|NCT00848042|594891674|FG000|Overall Study|Other Therapy|3|||
164690864|NCT00848042|594891675|FG001|Overall Study|Other Therapy|0|||
164690865|NCT00848042|594891676|FG002|Overall Study|Other Therapy|0|||
164690866|NCT02744755|594891677|FG000|Study Period 1|Protocol Violation|2|||
164690867|NCT02744755|594891678|FG001|Study Period 1|Protocol Violation|1|||
164690868|NCT02744755|594891677|FG000|Study Period 1|not defined|0|||
164690869|NCT02744755|594891678|FG001|Study Period 1|not defined|1|||
164690870|NCT02744755|594891677|FG000|Study Period 1|Pregnancy|1|||
164690871|NCT02744755|594891678|FG001|Study Period 1|Pregnancy|0|||
164690872|NCT02744755|594891677|FG000|Study Period 1|Adverse Event|1|||
164690873|NCT02744755|594891678|FG001|Study Period 1|Adverse Event|1|||
164690874|NCT02744755|594891677|FG000|Study Period 1|Lost to Follow-up|1|||
164690875|NCT02744755|594891678|FG001|Study Period 1|Lost to Follow-up|1|||
164690876|NCT02744755|594891677|FG000|Study Period 1|Lack of Efficacy|1|||
164690877|NCT02744755|594891678|FG001|Study Period 1|Lack of Efficacy|0|||
164690878|NCT02744755|594891677|FG000|Study Period 1|Withdrawal by Subject|8|||
164690879|NCT02744755|594891678|FG001|Study Period 1|Withdrawal by Subject|4|||
164690880|NCT02744755|594891677|FG000|Study Period 2|Adverse Event|5|||
164690881|NCT02744755|594891678|FG001|Study Period 2|Adverse Event|0|||
164690882|NCT02744755|594891677|FG000|Study Period 2|Protocol Violation|1|||
164690883|NCT02744755|594891678|FG001|Study Period 2|Protocol Violation|0|||
164690884|NCT02744755|594891677|FG000|Study Period 2|not defined|3|||
164690885|NCT02744755|594891678|FG001|Study Period 2|not defined|2|||
164690886|NCT02744755|594891677|FG000|Study Period 2|Lost to Follow-up|0|||
164690887|NCT02744755|594891678|FG001|Study Period 2|Lost to Follow-up|2|||
164690888|NCT02744755|594891677|FG000|Study Period 2|Withdrawal by Subject|2|||
164690889|NCT02744755|594891678|FG001|Study Period 2|Withdrawal by Subject|2|||
164690890|NCT02744755|594891677|FG000|Study Period 2|Lack of Efficacy|3|||
164690891|NCT02744755|594891678|FG001|Study Period 2|Lack of Efficacy|2|||
164690892|NCT01652729|594891679|FG000|Overall Study|Withdrawal by Subject|14|||
164690893|NCT01652729|594891680|FG001|Overall Study|Withdrawal by Subject|7|||
164690894|NCT01652729|594891681|FG002|Overall Study|Withdrawal by Subject|7|||
164690895|NCT01652729|594891679|FG000|Overall Study|Adverse Event|4|||
164690896|NCT01652729|594891680|FG001|Overall Study|Adverse Event|0|||
164690897|NCT01652729|594891681|FG002|Overall Study|Adverse Event|3|||
164690898|NCT01652729|594891679|FG000|Overall Study|Physician Decision|1|||
164690899|NCT01652729|594891680|FG001|Overall Study|Physician Decision|0|||
164690900|NCT01652729|594891681|FG002|Overall Study|Physician Decision|1|||
164690901|NCT01652729|594891679|FG000|Overall Study|Protocol Violation|1|||
164690902|NCT01652729|594891680|FG001|Overall Study|Protocol Violation|0|||
164690903|NCT01652729|594891681|FG002|Overall Study|Protocol Violation|0|||
164690904|NCT01652729|594891679|FG000|Overall Study|Lost to Follow-up|6|||
164690905|NCT01652729|594891680|FG001|Overall Study|Lost to Follow-up|6|||
164690906|NCT01652729|594891681|FG002|Overall Study|Lost to Follow-up|3|||
164690907|NCT01652729|594891679|FG000|Overall Study|Administrative|1|||
164690908|NCT01652729|594891680|FG001|Overall Study|Administrative|0|||
164690909|NCT01652729|594891681|FG002|Overall Study|Administrative|0|||
164690910|NCT04364737|594891683|FG000|Overall Study|Withdrawal by Subject|4|||
164690911|NCT04364737|594891684|FG001|Overall Study|Withdrawal by Subject|9|||
164690912|NCT04364737|594891683|FG000|Overall Study|Lost to Follow-up|1|||
164690913|NCT04364737|594891684|FG001|Overall Study|Lost to Follow-up|1|||
164690914|NCT01220609|594891685|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
164690915|NCT01220609|594891685|FG000|Overall Study|Ineligible- Wrong cell type|1|||
164690916|NCT01220609|594891685|FG000|Overall Study|Ineligible-Never treated|1|||
164690917|NCT00112294|594891686|FG000|Overall Study|Still on study|5|||
164690918|NCT00112294|594891687|FG001|Overall Study|Still on study|0|||
164690919|NCT01190930|594891691|FG000|Induction|Adverse Event|17|||
164690920|NCT01190930|594891692|FG001|Induction|Adverse Event|0|||
164690921|NCT01190930|594891693|FG002|Induction|Adverse Event|0|||
164690922|NCT01190930|594891694|FG003|Induction|Adverse Event|0|||
164690923|NCT01190930|594891695|FG004|Induction|Adverse Event|0|||
164690924|NCT01190930|594891696|FG005|Induction|Adverse Event|0|||
164690925|NCT01190930|594891697|FG006|Induction|Adverse Event|0|||
164690926|NCT01190930|594891698|FG007|Induction|Adverse Event|0|||
164690927|NCT01190930|594891699|FG008|Induction|Adverse Event|0|||
164690928|NCT01190930|594891700|FG009|Induction|Adverse Event|0|||
164690929|NCT01190930|594891691|FG000|Induction|Death|34|||
164690930|NCT01190930|594891692|FG001|Induction|Death|0|||
164690931|NCT01190930|594891693|FG002|Induction|Death|0|||
164690932|NCT01190930|594891694|FG003|Induction|Death|0|||
164690933|NCT01190930|594891695|FG004|Induction|Death|0|||
164690934|NCT01190930|594891696|FG005|Induction|Death|0|||
164690935|NCT01190930|594891697|FG006|Induction|Death|0|||
164690936|NCT01190930|594891698|FG007|Induction|Death|0|||
164690937|NCT01190930|594891699|FG008|Induction|Death|0|||
164690938|NCT01190930|594891700|FG009|Induction|Death|0|||
164690939|NCT01190930|594891691|FG000|Induction|Lost to Follow-up|1|||
164690940|NCT01190930|594891692|FG001|Induction|Lost to Follow-up|0|||
164690941|NCT01190930|594891693|FG002|Induction|Lost to Follow-up|0|||
164690942|NCT01190930|594891694|FG003|Induction|Lost to Follow-up|0|||
164690943|NCT01190930|594891695|FG004|Induction|Lost to Follow-up|0|||
164690944|NCT01190930|594891696|FG005|Induction|Lost to Follow-up|0|||
164690945|NCT01190930|594891697|FG006|Induction|Lost to Follow-up|0|||
164690946|NCT01190930|594891698|FG007|Induction|Lost to Follow-up|0|||
164690947|NCT01190930|594891699|FG008|Induction|Lost to Follow-up|0|||
164690948|NCT01190930|594891700|FG009|Induction|Lost to Follow-up|0|||
164690949|NCT01190930|594891691|FG000|Induction|Physician Decision|125|||
164690950|NCT01190930|594891692|FG001|Induction|Physician Decision|3|||
164690951|NCT01190930|594891693|FG002|Induction|Physician Decision|0|||
164690952|NCT01190930|594891694|FG003|Induction|Physician Decision|0|||
164690953|NCT01190930|594891695|FG004|Induction|Physician Decision|0|||
164690954|NCT01190930|594891696|FG005|Induction|Physician Decision|0|||
164690955|NCT01190930|594891697|FG006|Induction|Physician Decision|0|||
164690956|NCT01190930|594891698|FG007|Induction|Physician Decision|0|||
164690957|NCT01190930|594891699|FG008|Induction|Physician Decision|0|||
164690958|NCT01190930|594891700|FG009|Induction|Physician Decision|0|||
164690959|NCT01190930|594891691|FG000|Induction|Withdrawal by Subject|9|||
164690960|NCT01190930|594891692|FG001|Induction|Withdrawal by Subject|0|||
164690961|NCT01190930|594891693|FG002|Induction|Withdrawal by Subject|0|||
164690962|NCT01190930|594891694|FG003|Induction|Withdrawal by Subject|0|||
164282199|NCT00172042|593402599|FG001|Overall Study|Abnormal test procedure(s)|3|||
164282200|NCT00172042|593402598|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
164282201|NCT00172042|593402599|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
164690963|NCT01190930|594891695|FG004|Induction|Withdrawal by Subject|0|||
164282202|NCT00172042|593402598|FG000|Overall Study|Patient no longer requires study drug|10|||
164282203|NCT00172042|593402599|FG001|Overall Study|Patient no longer requires study drug|8|||
164282204|NCT00172042|593402598|FG000|Overall Study|Protocol Violation|8|||
164282205|NCT00172042|593402599|FG001|Overall Study|Protocol Violation|7|||
164282206|NCT00172042|593402598|FG000|Overall Study|Withdrawal by Subject|37|||
164282207|NCT00172042|593402599|FG001|Overall Study|Withdrawal by Subject|25|||
164282208|NCT00172042|593402598|FG000|Overall Study|Lost to Follow-up|3|||
164282209|NCT00172042|593402599|FG001|Overall Study|Lost to Follow-up|5|||
164282210|NCT00172042|593402598|FG000|Overall Study|Administrative problems|13|||
164282211|NCT00172042|593402599|FG001|Overall Study|Administrative problems|10|||
164282212|NCT00172042|593402598|FG000|Overall Study|Death|42|||
164282213|NCT00172042|593402599|FG001|Overall Study|Death|42|||
164282214|NCT00384332|593402600|FG000|Overall Study|Lost to Follow-up|4|||
164282215|NCT00384332|593402601|FG001|Overall Study|Lost to Follow-up|0|||
164690964|NCT01190930|594891696|FG005|Induction|Withdrawal by Subject|0|||
164690965|NCT01190930|594891697|FG006|Induction|Withdrawal by Subject|0|||
164690966|NCT01190930|594891698|FG007|Induction|Withdrawal by Subject|0|||
164690967|NCT01190930|594891699|FG008|Induction|Withdrawal by Subject|0|||
164690968|NCT01190930|594891700|FG009|Induction|Withdrawal by Subject|0|||
164690969|NCT01190930|594891691|FG000|Induction|Refusal|235|||
164690970|NCT01190930|594891692|FG001|Induction|Refusal|0|||
164690971|NCT01190930|594891693|FG002|Induction|Refusal|0|||
164690972|NCT01190930|594891694|FG003|Induction|Refusal|0|||
164690973|NCT01190930|594891695|FG004|Induction|Refusal|0|||
164690974|NCT01190930|594891696|FG005|Induction|Refusal|0|||
164690975|NCT01190930|594891697|FG006|Induction|Refusal|0|||
164690976|NCT01190930|594891698|FG007|Induction|Refusal|0|||
164690977|NCT01190930|594891699|FG008|Induction|Refusal|0|||
164690978|NCT01190930|594891700|FG009|Induction|Refusal|0|||
164690979|NCT01190930|594891691|FG000|Induction|Inevaluable|23|||
164690980|NCT01190930|594891692|FG001|Induction|Inevaluable|1|||
164690981|NCT01190930|594891693|FG002|Induction|Inevaluable|0|||
164690982|NCT01190930|594891694|FG003|Induction|Inevaluable|0|||
164690983|NCT01190930|594891695|FG004|Induction|Inevaluable|0|||
164690984|NCT01190930|594891696|FG005|Induction|Inevaluable|0|||
164690985|NCT01190930|594891697|FG006|Induction|Inevaluable|0|||
164690986|NCT01190930|594891698|FG007|Induction|Inevaluable|0|||
164690987|NCT01190930|594891699|FG008|Induction|Inevaluable|0|||
164690988|NCT01190930|594891700|FG009|Induction|Inevaluable|0|||
164690989|NCT01190930|594891691|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
164690990|NCT01190930|594891692|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
164690991|NCT01190930|594891693|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
164690992|NCT01190930|594891694|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
164690993|NCT01190930|594891695|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
164690994|NCT01190930|594891696|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
164690995|NCT01190930|594891697|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
164690996|NCT01190930|594891698|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
164690997|NCT01190930|594891699|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
164690998|NCT01190930|594891700|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
164690999|NCT01190930|594891691|FG000|Induction|High Risk Downs|80|||
164691000|NCT01190930|594891692|FG001|Induction|High Risk Downs|0|||
164691001|NCT01190930|594891693|FG002|Induction|High Risk Downs|0|||
164691002|NCT01190930|594891694|FG003|Induction|High Risk Downs|0|||
164691003|NCT01190930|594891695|FG004|Induction|High Risk Downs|0|||
164691004|NCT01190930|594891696|FG005|Induction|High Risk Downs|0|||
164691005|NCT01190930|594891697|FG006|Induction|High Risk Downs|0|||
164691006|NCT01190930|594891698|FG007|Induction|High Risk Downs|0|||
164691007|NCT01190930|594891699|FG008|Induction|High Risk Downs|0|||
164691008|NCT01190930|594891700|FG009|Induction|High Risk Downs|0|||
164691009|NCT01190930|594891691|FG000|Induction|Enrollment onto another COG Protocol|1|||
164691010|NCT01190930|594891692|FG001|Induction|Enrollment onto another COG Protocol|0|||
164691011|NCT01190930|594891693|FG002|Induction|Enrollment onto another COG Protocol|0|||
164691012|NCT01190930|594891694|FG003|Induction|Enrollment onto another COG Protocol|0|||
164691013|NCT01190930|594891695|FG004|Induction|Enrollment onto another COG Protocol|0|||
164691014|NCT01190930|594891696|FG005|Induction|Enrollment onto another COG Protocol|0|||
164691015|NCT01190930|594891697|FG006|Induction|Enrollment onto another COG Protocol|0|||
164691016|NCT01190930|594891698|FG007|Induction|Enrollment onto another COG Protocol|0|||
164691017|NCT01190930|594891699|FG008|Induction|Enrollment onto another COG Protocol|0|||
164691018|NCT01190930|594891700|FG009|Induction|Enrollment onto another COG Protocol|0|||
164691019|NCT01190930|594891691|FG000|Induction|Average Risk|1847|||
164691020|NCT01190930|594891692|FG001|Induction|Average Risk|0|||
164691021|NCT01190930|594891693|FG002|Induction|Average Risk|0|||
164691022|NCT01190930|594891694|FG003|Induction|Average Risk|0|||
164691023|NCT01190930|594891695|FG004|Induction|Average Risk|0|||
164691024|NCT01190930|594891696|FG005|Induction|Average Risk|0|||
164691025|NCT01190930|594891697|FG006|Induction|Average Risk|0|||
164691026|NCT01190930|594891698|FG007|Induction|Average Risk|0|||
164691027|NCT01190930|594891699|FG008|Induction|Average Risk|0|||
164691028|NCT01190930|594891700|FG009|Induction|Average Risk|0|||
164691029|NCT01190930|594891691|FG000|Induction|High Risk|1227|||
164691030|NCT01190930|594891692|FG001|Induction|High Risk|0|||
164691031|NCT01190930|594891693|FG002|Induction|High Risk|0|||
164691032|NCT01190930|594891694|FG003|Induction|High Risk|0|||
164691033|NCT01190930|594891695|FG004|Induction|High Risk|0|||
164691034|NCT01190930|594891696|FG005|Induction|High Risk|0|||
164691035|NCT01190930|594891697|FG006|Induction|High Risk|0|||
164691036|NCT01190930|594891698|FG007|Induction|High Risk|0|||
164691037|NCT01190930|594891699|FG008|Induction|High Risk|0|||
164691038|NCT01190930|594891700|FG009|Induction|High Risk|0|||
164691039|NCT01190930|594891691|FG000|Induction|Low Risk|443|||
164691040|NCT01190930|594891692|FG001|Induction|Low Risk|0|||
164691041|NCT01190930|594891693|FG002|Induction|Low Risk|0|||
164282216|NCT00375518|593402602|FG000|Overall Study|Withdrawal by Subject|2|||
164691042|NCT01190930|594891694|FG003|Induction|Low Risk|0|||
164691043|NCT01190930|594891695|FG004|Induction|Low Risk|0|||
164691044|NCT01190930|594891696|FG005|Induction|Low Risk|0|||
164691045|NCT01190930|594891697|FG006|Induction|Low Risk|0|||
164691046|NCT01190930|594891698|FG007|Induction|Low Risk|0|||
164691047|NCT01190930|594891699|FG008|Induction|Low Risk|0|||
164691048|NCT01190930|594891700|FG009|Induction|Low Risk|0|||
164691049|NCT01190930|594891691|FG000|Induction|Very High Risk|1012|||
164282217|NCT00375518|593402603|FG001|Overall Study|Withdrawal by Subject|10|||
164691050|NCT01190930|594891692|FG001|Induction|Very High Risk|0|||
164691051|NCT01190930|594891693|FG002|Induction|Very High Risk|0|||
164691052|NCT01190930|594891694|FG003|Induction|Very High Risk|0|||
164691053|NCT01190930|594891695|FG004|Induction|Very High Risk|0|||
164691054|NCT01190930|594891696|FG005|Induction|Very High Risk|0|||
164691055|NCT01190930|594891697|FG006|Induction|Very High Risk|0|||
164691056|NCT01190930|594891698|FG007|Induction|Very High Risk|0|||
164691057|NCT01190930|594891699|FG008|Induction|Very High Risk|0|||
164691058|NCT01190930|594891700|FG009|Induction|Very High Risk|0|||
164691059|NCT01190930|594891691|FG000|Induction|Philadelphia chromosome-positive|99|||
164691060|NCT01190930|594891692|FG001|Induction|Philadelphia chromosome-positive|0|||
164691061|NCT01190930|594891693|FG002|Induction|Philadelphia chromosome-positive|0|||
164691062|NCT01190930|594891694|FG003|Induction|Philadelphia chromosome-positive|0|||
164691063|NCT01190930|594891695|FG004|Induction|Philadelphia chromosome-positive|0|||
164691064|NCT01190930|594891696|FG005|Induction|Philadelphia chromosome-positive|0|||
164691065|NCT01190930|594891697|FG006|Induction|Philadelphia chromosome-positive|0|||
164691066|NCT01190930|594891698|FG007|Induction|Philadelphia chromosome-positive|0|||
164691067|NCT01190930|594891699|FG008|Induction|Philadelphia chromosome-positive|0|||
164691068|NCT01190930|594891700|FG009|Induction|Philadelphia chromosome-positive|0|||
164691069|NCT01190930|594891691|FG000|Induction|Incomplete Induction data|63|||
164691070|NCT01190930|594891692|FG001|Induction|Incomplete Induction data|0|||
164691071|NCT01190930|594891693|FG002|Induction|Incomplete Induction data|0|||
164691072|NCT01190930|594891694|FG003|Induction|Incomplete Induction data|0|||
164691073|NCT01190930|594891695|FG004|Induction|Incomplete Induction data|0|||
164691074|NCT01190930|594891696|FG005|Induction|Incomplete Induction data|0|||
164691075|NCT01190930|594891697|FG006|Induction|Incomplete Induction data|0|||
164691076|NCT01190930|594891698|FG007|Induction|Incomplete Induction data|0|||
164691077|NCT01190930|594891699|FG008|Induction|Incomplete Induction data|0|||
164691078|NCT01190930|594891700|FG009|Induction|Incomplete Induction data|0|||
164691079|NCT01190930|594891691|FG000|Induction|Progressive disease|0|||
164691080|NCT01190930|594891692|FG001|Induction|Progressive disease|1|||
164691081|NCT01190930|594891693|FG002|Induction|Progressive disease|0|||
164691082|NCT01190930|594891694|FG003|Induction|Progressive disease|0|||
164691083|NCT01190930|594891695|FG004|Induction|Progressive disease|0|||
164691084|NCT01190930|594891696|FG005|Induction|Progressive disease|0|||
164282218|NCT00375518|593402602|FG000|Overall Study|Patient Not Treated|6|||
164282219|NCT00375518|593402603|FG001|Overall Study|Patient Not Treated|6|||
164282220|NCT00375518|593402602|FG000|Overall Study|Death|0|||
164282221|NCT00375518|593402603|FG001|Overall Study|Death|1|||
164691085|NCT01190930|594891697|FG006|Induction|Progressive disease|0|||
164691086|NCT01190930|594891698|FG007|Induction|Progressive disease|0|||
164691087|NCT01190930|594891699|FG008|Induction|Progressive disease|0|||
164691088|NCT01190930|594891700|FG009|Induction|Progressive disease|0|||
164691089|NCT01190930|594891691|FG000|Induction|No treatment|3|||
164691090|NCT01190930|594891692|FG001|Induction|No treatment|0|||
164282222|NCT01771250|593402604|FG000|Period 1|Met exclusion criteria|1|||
164282223|NCT01771250|593402605|FG001|Period 1|Met exclusion criteria|0|||
164282224|NCT02058563|593402606|FG000|Overall Study|Lost to Follow-up|26|||
164282225|NCT02058563|593402607|FG001|Overall Study|Lost to Follow-up|22|||
164282226|NCT02058563|593402606|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
164282227|NCT02058563|593402607|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
164282228|NCT02058563|593402606|FG000|Overall Study|Consent Withdrawal|1|||
164282229|NCT02058563|593402607|FG001|Overall Study|Consent Withdrawal|1|||
164282230|NCT02058563|593402606|FG000|Overall Study|Other (patient incarcerated)|0|||
164282231|NCT02058563|593402607|FG001|Overall Study|Other (patient incarcerated)|1|||
164282232|NCT00166439|593402608|FG000|Overall Study|Ineligible|5|||
164282233|NCT01180296|593402609|FG000|Overall Study|Protocol Violation|1|||
164282234|NCT01180296|593402610|FG001|Overall Study|Protocol Violation|2|||
164282235|NCT02560012|593402611|FG000|Overall Study|Study Terminated|2|||
164282236|NCT00483938|593402612|FG000|Overall Study|Protocol Violation|0|||
164282237|NCT00483938|593402613|FG001|Overall Study|Protocol Violation|0|||
164282238|NCT00483938|593402614|FG002|Overall Study|Protocol Violation|0|||
164282239|NCT00483938|593402615|FG003|Overall Study|Protocol Violation|0|||
164282240|NCT00483938|593402616|FG004|Overall Study|Protocol Violation|0|||
164282241|NCT00483938|593402617|FG005|Overall Study|Protocol Violation|0|||
164282242|NCT00483938|593402618|FG006|Overall Study|Protocol Violation|3|||
164282243|NCT00483938|593402612|FG000|Overall Study|Withdrawal by Subject|1|||
164282244|NCT00483938|593402613|FG001|Overall Study|Withdrawal by Subject|6|||
164282245|NCT00483938|593402614|FG002|Overall Study|Withdrawal by Subject|0|||
164282246|NCT00483938|593402615|FG003|Overall Study|Withdrawal by Subject|0|||
164282247|NCT00483938|593402616|FG004|Overall Study|Withdrawal by Subject|1|||
164282248|NCT00483938|593402617|FG005|Overall Study|Withdrawal by Subject|3|||
164282249|NCT00483938|593402618|FG006|Overall Study|Withdrawal by Subject|2|||
164282250|NCT00483938|593402612|FG000|Overall Study|Lost to Follow-up|1|||
164282251|NCT00483938|593402613|FG001|Overall Study|Lost to Follow-up|2|||
164282252|NCT00483938|593402614|FG002|Overall Study|Lost to Follow-up|0|||
164691091|NCT01190930|594891693|FG002|Induction|No treatment|0|||
164691092|NCT01190930|594891694|FG003|Induction|No treatment|0|||
164282253|NCT00483938|593402615|FG003|Overall Study|Lost to Follow-up|2|||
164282254|NCT00483938|593402616|FG004|Overall Study|Lost to Follow-up|1|||
164691093|NCT01190930|594891695|FG004|Induction|No treatment|0|||
164282255|NCT00483938|593402617|FG005|Overall Study|Lost to Follow-up|1|||
164282256|NCT00483938|593402618|FG006|Overall Study|Lost to Follow-up|3|||
164282257|NCT00483938|593402612|FG000|Overall Study|Death|0|||
164282258|NCT00483938|593402613|FG001|Overall Study|Death|2|||
164282259|NCT00483938|593402614|FG002|Overall Study|Death|0|||
164282260|NCT00483938|593402615|FG003|Overall Study|Death|0|||
164282261|NCT00483938|593402616|FG004|Overall Study|Death|0|||
164282262|NCT00483938|593402617|FG005|Overall Study|Death|0|||
164691094|NCT01190930|594891696|FG005|Induction|No treatment|0|||
164282263|NCT00483938|593402618|FG006|Overall Study|Death|0|||
164282264|NCT00483938|593402612|FG000|Overall Study|Other|3|||
164282265|NCT00483938|593402613|FG001|Overall Study|Other|9|||
164282266|NCT00483938|593402614|FG002|Overall Study|Other|0|||
164282267|NCT00483938|593402615|FG003|Overall Study|Other|4|||
164282268|NCT00483938|593402616|FG004|Overall Study|Other|0|||
164282269|NCT00483938|593402617|FG005|Overall Study|Other|4|||
164282270|NCT00483938|593402618|FG006|Overall Study|Other|32|||
164282271|NCT03052816|593402619|FG000|Overall Study|Withdrawal by Subject|1|||
164282272|NCT03052816|593402620|FG001|Overall Study|Withdrawal by Subject|0|||
164282273|NCT03052816|593402619|FG000|Overall Study|Desired opioids|2|||
164282274|NCT03052816|593402620|FG001|Overall Study|Desired opioids|0|||
164282275|NCT00264537|593402631|FG000|Overall Study|Death|0|||
164282276|NCT00264537|593402632|FG001|Overall Study|Death|3|||
164282277|NCT00264537|593402633|FG002|Overall Study|Death|3|||
164282278|NCT00264537|593402634|FG003|Overall Study|Death|2|||
164282279|NCT00264537|593402631|FG000|Overall Study|Lost to Follow-up|3|||
164282280|NCT00264537|593402632|FG001|Overall Study|Lost to Follow-up|4|||
164282281|NCT00264537|593402633|FG002|Overall Study|Lost to Follow-up|7|||
164282282|NCT00264537|593402634|FG003|Overall Study|Lost to Follow-up|6|||
164282283|NCT00264537|593402631|FG000|Overall Study|Adverse Event|21|||
164282284|NCT00264537|593402632|FG001|Overall Study|Adverse Event|32|||
164282285|NCT00264537|593402633|FG002|Overall Study|Adverse Event|24|||
164282286|NCT00264537|593402634|FG003|Overall Study|Adverse Event|34|||
164282287|NCT00264537|593402631|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
164344536|NCT02197247|593636971|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
164585949|NCT01097616|594510065|FG004|Optional DB EXT Phase|Protocol Violation|0|||
164585950|NCT01097616|594510066|FG005|Optional DB EXT Phase|Protocol Violation|0|||
164585951|NCT01097616|594510067|FG006|Optional DB EXT Phase|Protocol Violation|0|||
164585952|NCT01097616|594510068|FG007|Optional DB EXT Phase|Protocol Violation|0|||
164585953|NCT01097616|594510061|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
164585954|NCT01097616|594510062|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
164585955|NCT01097616|594510063|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
164585956|NCT01097616|594510064|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
164585957|NCT01097616|594510065|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
164585958|NCT01097616|594510066|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
164585959|NCT01097616|594510067|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
164585960|NCT01097616|594510068|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
164585961|NCT01097616|594510061|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
164585962|NCT01097616|594510062|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
164585963|NCT01097616|594510063|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
164585964|NCT01097616|594510064|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
164585965|NCT01097616|594510065|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
164585966|NCT01097616|594510066|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
164585967|NCT01097616|594510067|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
164585968|NCT01097616|594510068|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
164585969|NCT01097616|594510061|FG000|Optional DB EXT Phase|Physician Decision|1|||
164585970|NCT01097616|594510062|FG001|Optional DB EXT Phase|Physician Decision|0|||
164585971|NCT01097616|594510063|FG002|Optional DB EXT Phase|Physician Decision|0|||
164585972|NCT01097616|594510064|FG003|Optional DB EXT Phase|Physician Decision|0|||
164585973|NCT01097616|594510065|FG004|Optional DB EXT Phase|Physician Decision|0|||
164585974|NCT01097616|594510066|FG005|Optional DB EXT Phase|Physician Decision|0|||
164585975|NCT01097616|594510067|FG006|Optional DB EXT Phase|Physician Decision|0|||
164585976|NCT01097616|594510068|FG007|Optional DB EXT Phase|Physician Decision|0|||
164585977|NCT01097616|594510061|FG000|DB RO Phase|Adverse Event|0|||
164585978|NCT01097616|594510062|FG001|DB RO Phase|Adverse Event|0|||
164585979|NCT01097616|594510063|FG002|DB RO Phase|Adverse Event|0|||
164585980|NCT01097616|594510064|FG003|DB RO Phase|Adverse Event|0|||
164585981|NCT01097616|594510065|FG004|DB RO Phase|Adverse Event|0|||
164585982|NCT01097616|594510066|FG005|DB RO Phase|Adverse Event|0|||
164585983|NCT01097616|594510067|FG006|DB RO Phase|Adverse Event|1|||
164585984|NCT01097616|594510068|FG007|DB RO Phase|Adverse Event|0|||
164585985|NCT01097616|594510061|FG000|DB RO Phase|Withdrawal by Subject|0|||
164585986|NCT01097616|594510062|FG001|DB RO Phase|Withdrawal by Subject|0|||
164585987|NCT01097616|594510063|FG002|DB RO Phase|Withdrawal by Subject|0|||
164585988|NCT01097616|594510064|FG003|DB RO Phase|Withdrawal by Subject|0|||
164585989|NCT01097616|594510065|FG004|DB RO Phase|Withdrawal by Subject|0|||
164282288|NCT00264537|593402632|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
164282289|NCT00264537|593402633|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
164282290|NCT00264537|593402634|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
164282291|NCT00264537|593402631|FG000|Overall Study|Other|21|||
164282292|NCT00264537|593402632|FG001|Overall Study|Other|11|||
164282293|NCT00264537|593402633|FG002|Overall Study|Other|10|||
164282294|NCT00264537|593402634|FG003|Overall Study|Other|11|||
164282295|NCT00264537|593402631|FG000|Overall Study|Not treated|0|||
164282296|NCT00264537|593402632|FG001|Overall Study|Not treated|2|||
164282297|NCT00264537|593402633|FG002|Overall Study|Not treated|1|||
164282298|NCT00264537|593402634|FG003|Overall Study|Not treated|0|||
164282299|NCT00447226|593404354|FG000|12-Week Open-label Phase|Adverse Event|0|||
164282300|NCT00447226|593404355|FG001|12-Week Open-label Phase|Adverse Event|3|||
164282301|NCT00447226|593404354|FG000|12-Week Open-label Phase|Protocol Violation|0|||
164282302|NCT00447226|593404355|FG001|12-Week Open-label Phase|Protocol Violation|1|||
164282303|NCT00447226|593404354|FG000|12-Week Open-label Phase|Disease Progression|0|||
164282304|NCT00447226|593404355|FG001|12-Week Open-label Phase|Disease Progression|20|||
164282305|NCT00447226|593404354|FG000|12-Week Open-label Phase|Physician Decision|0|||
164282306|NCT00447226|593404355|FG001|12-Week Open-label Phase|Physician Decision|1|||
164282307|NCT00447226|593404354|FG000|Double-blind Phase|Disease Progression|4|||
164282308|NCT00447226|593404355|FG001|Double-blind Phase|Disease Progression|3|||
164282309|NCT03449758|593404356|FG000|Overall Study|Major protocol deviation|1|||
164282310|NCT03449758|593404356|FG000|Overall Study|Treatment inefficacy|5|||
164282311|NCT03449758|593404356|FG000|Overall Study|Adverse Event|9|||
164282312|NCT03449758|593404356|FG000|Overall Study|Consent withdrawal|1|||
164282313|NCT03449758|593404356|FG000|Overall Study|Other unspecified reason|3|||
164282314|NCT00584012|593404359|FG000|Overall Study|Withdrawal by Subject|1|||
164282315|NCT03937713|593404362|FG000|Overall Study|Withdrawal by Subject|3|||
164282316|NCT03937713|593404363|FG001|Overall Study|Withdrawal by Subject|6|||
164282317|NCT03937713|593404362|FG000|Overall Study|Lost to Follow-up|1|||
164282318|NCT03937713|593404363|FG001|Overall Study|Lost to Follow-up|0|||
164282319|NCT02871635|593404364|FG000|Overall Study|Primary lack of efficacy|4|||
164282320|NCT02871635|593404365|FG001|Overall Study|Primary lack of efficacy|4|||
164282321|NCT02871635|593404364|FG000|Overall Study|Protocol Violation|3|||
164282322|NCT02871635|593404365|FG001|Overall Study|Protocol Violation|1|||
164282323|NCT02871635|593404364|FG000|Overall Study|Lost to Follow-up|1|||
164282324|NCT02871635|593404365|FG001|Overall Study|Lost to Follow-up|2|||
164282325|NCT02871635|593404364|FG000|Overall Study|Pregnancy|0|||
164344537|NCT02197247|593636971|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
164344538|NCT02197247|593636971|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
164585990|NCT01097616|594510066|FG005|DB RO Phase|Withdrawal by Subject|1|||
164585991|NCT01097616|594510067|FG006|DB RO Phase|Withdrawal by Subject|0|||
164585992|NCT01097616|594510068|FG007|DB RO Phase|Withdrawal by Subject|0|||
164585993|NCT01097616|594510061|FG000|DB RO Phase|Lost to Follow-up|0|||
164585994|NCT01097616|594510062|FG001|DB RO Phase|Lost to Follow-up|0|||
164585995|NCT01097616|594510063|FG002|DB RO Phase|Lost to Follow-up|0|||
164585996|NCT01097616|594510064|FG003|DB RO Phase|Lost to Follow-up|1|||
164585997|NCT01097616|594510065|FG004|DB RO Phase|Lost to Follow-up|1|||
164585998|NCT01097616|594510066|FG005|DB RO Phase|Lost to Follow-up|0|||
164585999|NCT01097616|594510067|FG006|DB RO Phase|Lost to Follow-up|0|||
164586000|NCT01097616|594510068|FG007|DB RO Phase|Lost to Follow-up|1|||
164586001|NCT01097616|594510061|FG000|DB RO Phase|Not Treated in RO|0|||
164586002|NCT01097616|594510062|FG001|DB RO Phase|Not Treated in RO|0|||
164586003|NCT01097616|594510063|FG002|DB RO Phase|Not Treated in RO|0|||
164586004|NCT01097616|594510064|FG003|DB RO Phase|Not Treated in RO|0|||
164586005|NCT01097616|594510065|FG004|DB RO Phase|Not Treated in RO|0|||
164586006|NCT01097616|594510066|FG005|DB RO Phase|Not Treated in RO|1|||
164586007|NCT01097616|594510067|FG006|DB RO Phase|Not Treated in RO|0|||
164586008|NCT01097616|594510068|FG007|DB RO Phase|Not Treated in RO|0|||
164586009|NCT00670111|594510069|FG000|Enrollment to One Month|Testing Failure|0|||
164586010|NCT00670111|594510070|FG001|Enrollment to One Month|Testing Failure|0|||
164586011|NCT00670111|594510071|FG002|Enrollment to One Month|Testing Failure|13|||
164586012|NCT00670111|594510069|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
164586013|NCT00670111|594510070|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
164586014|NCT00670111|594510071|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
164586015|NCT00670111|594510069|FG000|Enrollment to One Month|Physician Decision|1|||
164586016|NCT00670111|594510070|FG001|Enrollment to One Month|Physician Decision|0|||
164586017|NCT00670111|594510071|FG002|Enrollment to One Month|Physician Decision|0|||
164586018|NCT02441803|594510073|FG000|Overall Study|Physician Decision|0|||
164586019|NCT02441803|594510074|FG001|Overall Study|Physician Decision|2|||
164586020|NCT02441803|594510075|FG002|Overall Study|Physician Decision|2|||
164691095|NCT01190930|594891697|FG006|Induction|No treatment|0|||
164691096|NCT01190930|594891698|FG007|Induction|No treatment|0|||
164282326|NCT02871635|593404365|FG001|Overall Study|Pregnancy|2|||
164282327|NCT02871635|593404364|FG000|Overall Study|Physician Decision|1|||
164282328|NCT02871635|593404365|FG001|Overall Study|Physician Decision|1|||
164282329|NCT02871635|593404364|FG000|Overall Study|Withdrawal by Subject|3|||
164282330|NCT02871635|593404365|FG001|Overall Study|Withdrawal by Subject|4|||
164282331|NCT02871635|593404364|FG000|Overall Study|Adverse Event|4|||
164282332|NCT02871635|593404365|FG001|Overall Study|Adverse Event|4|||
164282333|NCT02871635|593404364|FG000|Overall Study|Secondary lack of efficacy|2|||
164282334|NCT02871635|593404365|FG001|Overall Study|Secondary lack of efficacy|1|||
164282335|NCT02420379|593404366|FG000|Overall Study|Withdrawal by Subject|0|||
164282336|NCT02420379|593404367|FG001|Overall Study|Withdrawal by Subject|3|||
164282337|NCT02420379|593404366|FG000|Overall Study|Unable to complete due to schooling|0|||
164282338|NCT02420379|593404367|FG001|Overall Study|Unable to complete due to schooling|1|||
164433202|NCT03055767|593957178|FG003|Open-Label Period|Lost to Follow-up|0|||
164433203|NCT03055767|593957175|FG000|Open-Label Period|Withdrawal by Subject|0|||
164433204|NCT03055767|593957176|FG001|Open-Label Period|Withdrawal by Subject|0|||
164433205|NCT03055767|593957177|FG002|Open-Label Period|Withdrawal by Subject|0|||
164433206|NCT03055767|593957178|FG003|Open-Label Period|Withdrawal by Subject|1|||
164433207|NCT02759731|593957181|FG000|Overall Study|Did not complete treatment.|8|||
164433208|NCT00763282|593957187|FG000|Overall Study|Withdrawal by Subject|6|||
164433209|NCT00763282|593957188|FG001|Overall Study|Withdrawal by Subject|5|||
164433210|NCT00763282|593957187|FG000|Overall Study|Death|4|||
164433211|NCT00763282|593957188|FG001|Overall Study|Death|3|||
164433212|NCT00763282|593957187|FG000|Overall Study|Lost to Follow-up|22|||
164433213|NCT00763282|593957188|FG001|Overall Study|Lost to Follow-up|26|||
164691097|NCT01190930|594891699|FG008|Induction|No treatment|0|||
164691098|NCT01190930|594891700|FG009|Induction|No treatment|0|||
164691099|NCT01190930|594891691|FG000|Induction|Ineligible|69|||
164691100|NCT01190930|594891692|FG001|Induction|Ineligible|4|||
164691101|NCT01190930|594891693|FG002|Induction|Ineligible|0|||
164691102|NCT01190930|594891694|FG003|Induction|Ineligible|0|||
164691103|NCT01190930|594891695|FG004|Induction|Ineligible|0|||
164691104|NCT01190930|594891696|FG005|Induction|Ineligible|0|||
164691105|NCT01190930|594891697|FG006|Induction|Ineligible|0|||
164691106|NCT01190930|594891698|FG007|Induction|Ineligible|0|||
164691107|NCT01190930|594891699|FG008|Induction|Ineligible|0|||
164691108|NCT01190930|594891700|FG009|Induction|Ineligible|0|||
164691109|NCT01190930|594891691|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
164691110|NCT01190930|594891692|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
164691111|NCT01190930|594891693|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
164691112|NCT01190930|594891694|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
164691113|NCT01190930|594891695|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
164691114|NCT01190930|594891696|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
164691115|NCT01190930|594891697|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
164691116|NCT01190930|594891698|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
164691117|NCT01190930|594891699|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
164691118|NCT01190930|594891700|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
164691119|NCT01190930|594891691|FG000|Post Induction Pre-Maintenance|Death|0|||
164691120|NCT01190930|594891692|FG001|Post Induction Pre-Maintenance|Death|0|||
164691121|NCT01190930|594891693|FG002|Post Induction Pre-Maintenance|Death|8|||
164691122|NCT01190930|594891694|FG003|Post Induction Pre-Maintenance|Death|4|||
164691123|NCT01190930|594891695|FG004|Post Induction Pre-Maintenance|Death|0|||
164691124|NCT01190930|594891696|FG005|Post Induction Pre-Maintenance|Death|0|||
164691125|NCT01190930|594891697|FG006|Post Induction Pre-Maintenance|Death|0|||
164691126|NCT01190930|594891698|FG007|Post Induction Pre-Maintenance|Death|0|||
164691127|NCT01190930|594891699|FG008|Post Induction Pre-Maintenance|Death|0|||
164691128|NCT01190930|594891700|FG009|Post Induction Pre-Maintenance|Death|0|||
164691129|NCT01190930|594891691|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
164691130|NCT01190930|594891692|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
164282339|NCT02420379|593404366|FG000|Overall Study|Transitioned to commercial drug|1|||
164433214|NCT00957229|593957189|FG000|Study Start|Adverse Event|0|||
164433215|NCT00957229|593957190|FG001|Study Start|Adverse Event|3|||
164586021|NCT02873221|594510077|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
164586022|NCT02873221|594510078|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
164586023|NCT02873221|594510079|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
164586024|NCT02873221|594510077|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
164586025|NCT02873221|594510078|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
164586026|NCT02873221|594510079|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
164586027|NCT02873221|594510077|FG000|Treatment Period|Protocol Violation|2|||
164586028|NCT02873221|594510078|FG001|Treatment Period|Protocol Violation|5|||
164586029|NCT02873221|594510079|FG002|Treatment Period|Protocol Violation|8|||
164586030|NCT02873221|594510077|FG000|Treatment Period|Pregnancy|4|||
164586031|NCT02873221|594510078|FG001|Treatment Period|Pregnancy|6|||
164586032|NCT02873221|594510079|FG002|Treatment Period|Pregnancy|3|||
164586033|NCT02873221|594510077|FG000|Treatment Period|Lack of Qualifying Event|0|||
164586034|NCT02873221|594510078|FG001|Treatment Period|Lack of Qualifying Event|3|||
164586035|NCT02873221|594510079|FG002|Treatment Period|Lack of Qualifying Event|1|||
164586036|NCT02873221|594510077|FG000|Treatment Period|Withdrawal of Consent|52|||
164586037|NCT02873221|594510078|FG001|Treatment Period|Withdrawal of Consent|51|||
164586038|NCT02873221|594510079|FG002|Treatment Period|Withdrawal of Consent|41|||
164691131|NCT01190930|594891693|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
164691132|NCT01190930|594891694|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
164691133|NCT01190930|594891695|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
164691134|NCT01190930|594891696|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
164691135|NCT01190930|594891697|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
164282340|NCT02420379|593404367|FG001|Overall Study|Transitioned to commercial drug|0|||
164282341|NCT01402817|593404368|FG000|Overall Study|Withdrawal by Subject|3|||
164282342|NCT01402817|593404368|FG000|Overall Study|Study Suspended by FDA|8|||
164282343|NCT00502671|593404369|FG000|Overall Study|Disease Progression|13|||
164282344|NCT00502671|593404369|FG000|Overall Study|Personal Reasons|22|||
164282345|NCT00502671|593404369|FG000|Overall Study|Lost to Follow-up|7|||
164282346|NCT00502671|593404369|FG000|Overall Study|Protocol Violation|16|||
164282347|NCT00502671|593404369|FG000|Overall Study|Adverse Event|19|||
164282348|NCT00681629|593404376|FG000|Overall Study|Study termination|4|||
164282349|NCT00681629|593404377|FG001|Overall Study|Study termination|2|||
164282350|NCT00681629|593404376|FG000|Overall Study|Adverse Event|1|||
164691136|NCT01190930|594891698|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
164691137|NCT01190930|594891699|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
164691138|NCT01190930|594891700|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
164691139|NCT01190930|594891691|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
164691140|NCT01190930|594891692|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
164691141|NCT01190930|594891693|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
164691142|NCT01190930|594891694|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
164691143|NCT01190930|594891695|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
164691144|NCT01190930|594891696|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
164691145|NCT01190930|594891697|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
164691146|NCT01190930|594891698|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
164691147|NCT01190930|594891699|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
164691148|NCT01190930|594891700|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
164691149|NCT01190930|594891691|FG000|Post Induction Pre-Maintenance|Refusal|0|||
164691150|NCT01190930|594891692|FG001|Post Induction Pre-Maintenance|Refusal|2|||
164691151|NCT01190930|594891693|FG002|Post Induction Pre-Maintenance|Refusal|694|||
164691152|NCT01190930|594891694|FG003|Post Induction Pre-Maintenance|Refusal|4|||
164691153|NCT01190930|594891695|FG004|Post Induction Pre-Maintenance|Refusal|0|||
164691154|NCT01190930|594891696|FG005|Post Induction Pre-Maintenance|Refusal|3|||
164691155|NCT01190930|594891697|FG006|Post Induction Pre-Maintenance|Refusal|0|||
164691156|NCT01190930|594891698|FG007|Post Induction Pre-Maintenance|Refusal|0|||
164691157|NCT01190930|594891699|FG008|Post Induction Pre-Maintenance|Refusal|0|||
164691158|NCT01190930|594891700|FG009|Post Induction Pre-Maintenance|Refusal|0|||
164282351|NCT00681629|593404377|FG001|Overall Study|Adverse Event|0|||
164282352|NCT01410890|593404379|FG000|Overall Study|Withdrawal by Subject|0|||
164282353|NCT01410890|593404380|FG001|Overall Study|Withdrawal by Subject|1|||
164282354|NCT00412893|593404381|FG000|Overall Study|Adverse Event|31|||
164282355|NCT00412893|593404382|FG001|Overall Study|Adverse Event|53|||
164282356|NCT00412893|593404381|FG000|Overall Study|Death|17|||
164282357|NCT00412893|593404382|FG001|Overall Study|Death|21|||
164282358|NCT00412893|593404381|FG000|Overall Study|Insufficient Therapeutic Response|39|||
164282359|NCT00412893|593404382|FG001|Overall Study|Insufficient Therapeutic Response|23|||
164282360|NCT00412893|593404381|FG000|Overall Study|Lost to Follow-up|2|||
164282361|NCT00412893|593404382|FG001|Overall Study|Lost to Follow-up|1|||
164282362|NCT00412893|593404381|FG000|Overall Study|Violation of Selection at Entry|17|||
164282363|NCT00412893|593404382|FG001|Overall Study|Violation of Selection at Entry|10|||
164282364|NCT00412893|593404381|FG000|Overall Study|Other Protocol Violation|10|||
164282365|NCT00412893|593404382|FG001|Overall Study|Other Protocol Violation|6|||
164282366|NCT00412893|593404381|FG000|Overall Study|Did Not Cooperate|12|||
164282367|NCT00412893|593404382|FG001|Overall Study|Did Not Cooperate|9|||
164282368|NCT00412893|593404381|FG000|Overall Study|Administrative Reason|12|||
164282369|NCT00412893|593404382|FG001|Overall Study|Administrative Reason|15|||
164282370|NCT00412893|593404381|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
164282371|NCT00412893|593404382|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
164282372|NCT02305238|593404385|FG000|Overall Study|Death|2|||
164282373|NCT02305238|593404386|FG001|Overall Study|Death|1|||
164282374|NCT02305238|593404387|FG002|Overall Study|Death|0|||
164282375|NCT02305238|593404385|FG000|Overall Study|Progressive disease|4|||
164282376|NCT02305238|593404386|FG001|Overall Study|Progressive disease|4|||
164691159|NCT01190930|594891691|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
164691160|NCT01190930|594891692|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
164282377|NCT02305238|593404387|FG002|Overall Study|Progressive disease|0|||
164282378|NCT02305238|593404385|FG000|Overall Study|Logistical difficulties|1|||
164282379|NCT02305238|593404386|FG001|Overall Study|Logistical difficulties|3|||
164282380|NCT02305238|593404387|FG002|Overall Study|Logistical difficulties|0|||
164282381|NCT02305238|593404385|FG000|Overall Study|Protocol Violation|0|||
164282382|NCT02305238|593404386|FG001|Overall Study|Protocol Violation|3|||
164282383|NCT02305238|593404387|FG002|Overall Study|Protocol Violation|0|||
164282384|NCT02305238|593404385|FG000|Overall Study|Physician Decision|2|||
164282385|NCT02305238|593404386|FG001|Overall Study|Physician Decision|1|||
164282386|NCT02305238|593404387|FG002|Overall Study|Physician Decision|0|||
164282387|NCT02305238|593404385|FG000|Overall Study|Adverse Event|4|||
164282388|NCT02305238|593404386|FG001|Overall Study|Adverse Event|2|||
164282389|NCT02305238|593404387|FG002|Overall Study|Adverse Event|0|||
164282390|NCT02305238|593404385|FG000|Overall Study|Withdrawal by Subject|3|||
164282391|NCT02305238|593404386|FG001|Overall Study|Withdrawal by Subject|4|||
164282392|NCT02305238|593404387|FG002|Overall Study|Withdrawal by Subject|0|||
164282393|NCT02305238|593404385|FG000|Overall Study|Randomized failure|0|||
164282394|NCT02305238|593404386|FG001|Overall Study|Randomized failure|0|||
164282395|NCT02305238|593404387|FG002|Overall Study|Randomized failure|8|||
164282396|NCT02305238|593404385|FG000|Overall Study|Required procedure failed|0|||
164282397|NCT02305238|593404386|FG001|Overall Study|Required procedure failed|1|||
164282398|NCT02305238|593404387|FG002|Overall Study|Required procedure failed|0|||
164282399|NCT01746173|593404388|FG000|Overall Study|Disease Progression|2|||
164282400|NCT02218008|593404393|FG000|Stage 1 (S1)|Adverse Event|6|||
164282401|NCT02218008|593404394|FG001|Stage 1 (S1)|Adverse Event|5|||
164282402|NCT02218008|593404395|FG002|Stage 1 (S1)|Adverse Event|11|||
164282403|NCT02218008|593404396|FG003|Stage 1 (S1)|Adverse Event|0|||
164282404|NCT02218008|593404397|FG004|Stage 1 (S1)|Adverse Event|0|||
164282405|NCT02218008|593404398|FG005|Stage 1 (S1)|Adverse Event|0|||
164282406|NCT02218008|593404393|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
164282407|NCT02218008|593404394|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
164691161|NCT01190930|594891693|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
164691162|NCT01190930|594891694|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
164691163|NCT01190930|594891695|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
164691164|NCT01190930|594891696|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
164691165|NCT01190930|594891697|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
164691166|NCT01190930|594891698|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
164691167|NCT01190930|594891699|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
164282408|NCT02218008|593404395|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
164282409|NCT02218008|593404396|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
164282410|NCT02218008|593404397|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
164282411|NCT02218008|593404398|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
164282412|NCT02218008|593404393|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
164282413|NCT02218008|593404394|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
164282414|NCT02218008|593404395|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
164282415|NCT02218008|593404396|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
164282416|NCT02218008|593404397|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
164282417|NCT02218008|593404398|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
164282418|NCT02218008|593404393|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
164282419|NCT02218008|593404394|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
164282420|NCT02218008|593404395|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
164282421|NCT02218008|593404396|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
164282422|NCT02218008|593404397|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
164282423|NCT02218008|593404398|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
164282424|NCT02218008|593404393|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
164282425|NCT02218008|593404394|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
164282426|NCT02218008|593404395|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
164282427|NCT02218008|593404396|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
164282428|NCT02218008|593404397|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
164282429|NCT02218008|593404398|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
164282430|NCT02218008|593404393|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
164282431|NCT02218008|593404394|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
164282432|NCT02218008|593404395|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
164282433|NCT02218008|593404396|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
164282434|NCT02218008|593404397|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
164282435|NCT02218008|593404398|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
164282436|NCT02218008|593404393|FG000|Stage 1 (S1)|Pregnancy|0|||
164691168|NCT01190930|594891700|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
164691169|NCT01190930|594891691|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
164691170|NCT01190930|594891692|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
164691171|NCT01190930|594891693|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
164691172|NCT01190930|594891694|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
164282437|NCT02218008|593404394|FG001|Stage 1 (S1)|Pregnancy|0|||
164282438|NCT02218008|593404395|FG002|Stage 1 (S1)|Pregnancy|1|||
164282439|NCT02218008|593404396|FG003|Stage 1 (S1)|Pregnancy|0|||
164282440|NCT02218008|593404397|FG004|Stage 1 (S1)|Pregnancy|0|||
164282441|NCT02218008|593404398|FG005|Stage 1 (S1)|Pregnancy|0|||
164282442|NCT02218008|593404393|FG000|Stage 1 (S1)|Protocol Violation|0|||
164282443|NCT02218008|593404394|FG001|Stage 1 (S1)|Protocol Violation|0|||
164282444|NCT02218008|593404395|FG002|Stage 1 (S1)|Protocol Violation|1|||
164282445|NCT02218008|593404396|FG003|Stage 1 (S1)|Protocol Violation|0|||
164282446|NCT02218008|593404397|FG004|Stage 1 (S1)|Protocol Violation|0|||
164282447|NCT02218008|593404398|FG005|Stage 1 (S1)|Protocol Violation|0|||
164282448|NCT02218008|593404393|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
164282449|NCT02218008|593404394|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
164282450|NCT02218008|593404395|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
164282451|NCT02218008|593404396|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
164282452|NCT02218008|593404397|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
164282453|NCT02218008|593404398|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
164282454|NCT02218008|593404393|FG000|Stage 2 (S2)|Adverse Event|0|||
164282455|NCT02218008|593404394|FG001|Stage 2 (S2)|Adverse Event|0|||
164282456|NCT02218008|593404395|FG002|Stage 2 (S2)|Adverse Event|0|||
164282457|NCT02218008|593404396|FG003|Stage 2 (S2)|Adverse Event|2|||
164282458|NCT02218008|593404397|FG004|Stage 2 (S2)|Adverse Event|3|||
164282459|NCT02218008|593404398|FG005|Stage 2 (S2)|Adverse Event|3|||
164282460|NCT02218008|593404393|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
164282461|NCT02218008|593404394|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
164282462|NCT02218008|593404395|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
164282463|NCT02218008|593404396|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
164282464|NCT02218008|593404397|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
164282465|NCT02218008|593404398|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
164282466|NCT02218008|593404393|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
164282467|NCT02218008|593404394|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
164282468|NCT02218008|593404395|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
164282469|NCT02218008|593404396|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
164282470|NCT02218008|593404397|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
164282471|NCT02218008|593404398|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
164282472|NCT02218008|593404393|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
164282473|NCT02218008|593404394|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
164282474|NCT02218008|593404395|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
164282475|NCT02218008|593404396|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
164586039|NCT02873221|594510077|FG000|Treatment Period|Lack of Efficacy|0|||
164586040|NCT02873221|594510078|FG001|Treatment Period|Lack of Efficacy|17|||
164586041|NCT02873221|594510079|FG002|Treatment Period|Lack of Efficacy|12|||
164282476|NCT02218008|593404397|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
164282477|NCT02218008|593404398|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
164586042|NCT02873221|594510077|FG000|Treatment Period|Adverse Event|4|||
164586043|NCT02873221|594510078|FG001|Treatment Period|Adverse Event|9|||
164586044|NCT02873221|594510079|FG002|Treatment Period|Adverse Event|11|||
164586045|NCT02873221|594510077|FG000|Treatment Period|Lost to Follow-up|26|||
164586046|NCT02873221|594510078|FG001|Treatment Period|Lost to Follow-up|30|||
164586047|NCT02873221|594510079|FG002|Treatment Period|Lost to Follow-up|26|||
164586048|NCT02873221|594510077|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
164586049|NCT02873221|594510078|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
164586050|NCT02873221|594510079|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
164586051|NCT02873221|594510077|FG000|Safety Follow-up Period|Protocol Violation|0|||
164586052|NCT02873221|594510078|FG001|Safety Follow-up Period|Protocol Violation|0|||
164586053|NCT02873221|594510079|FG002|Safety Follow-up Period|Protocol Violation|1|||
164586054|NCT02873221|594510077|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
164586055|NCT02873221|594510078|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
164586056|NCT02873221|594510079|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
164586057|NCT02873221|594510077|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
164586058|NCT02873221|594510078|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
164586059|NCT02873221|594510079|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
164586060|NCT01325493|594510080|FG000|Overall Study|Protocol Violation|0|||
164586061|NCT01325493|594510081|FG001|Overall Study|Protocol Violation|1|||
164586062|NCT01325493|594510080|FG000|Overall Study|loss of neuromonitoring signals|0|||
164586063|NCT01325493|594510081|FG001|Overall Study|loss of neuromonitoring signals|2|||
164586064|NCT01325493|594510080|FG000|Overall Study|Allergy|1|||
164586065|NCT01325493|594510081|FG001|Overall Study|Allergy|0|||
164586066|NCT02927171|594510082|FG000|Overall Study|Lost to Follow-up|0|||
164586067|NCT02927171|594510083|FG001|Overall Study|Lost to Follow-up|1|||
164586068|NCT04530825|594510088|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
164586069|NCT04530825|594510089|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
164282478|NCT02218008|593404393|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
164282479|NCT02218008|593404394|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
164586070|NCT04530825|594510090|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
164586071|NCT04530825|594510091|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
164586072|NCT04530825|594510088|FG000|Overall Study|Did not complete follow-up|3|||
164586073|NCT04530825|594510089|FG001|Overall Study|Did not complete follow-up|0|||
164586074|NCT04530825|594510090|FG002|Overall Study|Did not complete follow-up|0|||
164586075|NCT04530825|594510091|FG003|Overall Study|Did not complete follow-up|0|||
164586076|NCT04101422|594510093|FG000|Overall Study|Ineligible|1|||
164586077|NCT04101422|594510094|FG001|Overall Study|Ineligible|0|||
164586078|NCT04101422|594510095|FG002|Overall Study|Ineligible|9|||
164586079|NCT04101422|594510096|FG003|Overall Study|Ineligible|0|||
164586080|NCT04101422|594510093|FG000|Overall Study|Withdrawal by Subject|0|||
164586081|NCT04101422|594510094|FG001|Overall Study|Withdrawal by Subject|0|||
164586082|NCT04101422|594510095|FG002|Overall Study|Withdrawal by Subject|1|||
164586083|NCT04101422|594510096|FG003|Overall Study|Withdrawal by Subject|0|||
164586084|NCT04101422|594510093|FG000|Overall Study|Not attending to the stimuli|0|||
164586085|NCT04101422|594510094|FG001|Overall Study|Not attending to the stimuli|0|||
164586086|NCT04101422|594510095|FG002|Overall Study|Not attending to the stimuli|4|||
164586087|NCT04101422|594510096|FG003|Overall Study|Not attending to the stimuli|0|||
164586088|NCT04101422|594510093|FG000|Overall Study|Did not download app|0|||
164586089|NCT04101422|594510094|FG001|Overall Study|Did not download app|0|||
164586090|NCT04101422|594510095|FG002|Overall Study|Did not download app|0|||
164586091|NCT04101422|594510096|FG003|Overall Study|Did not download app|17|||
164586092|NCT04101422|594510093|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
164586093|NCT04101422|594510094|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
164586094|NCT04101422|594510095|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
164586095|NCT04101422|594510096|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
164586096|NCT00718861|594510099|FG000|Overall Study|Withdrawal by Subject|15|||
164586097|NCT00718861|594510100|FG001|Overall Study|Withdrawal by Subject|10|||
164586098|NCT00718861|594510099|FG000|Overall Study|Adverse Event|2|||
164586099|NCT00718861|594510100|FG001|Overall Study|Adverse Event|1|||
164586100|NCT00718861|594510099|FG000|Overall Study|Lost to Follow-up|2|||
164586101|NCT00718861|594510100|FG001|Overall Study|Lost to Follow-up|1|||
164586102|NCT00718861|594510099|FG000|Overall Study|Administrative Problems|1|||
164586103|NCT00718861|594510100|FG001|Overall Study|Administrative Problems|1|||
164586104|NCT00718861|594510099|FG000|Overall Study|Death|1|||
164586105|NCT00718861|594510100|FG001|Overall Study|Death|5|||
164586106|NCT01749735|594510101|FG000|Overall Study|Withdrawal by Subject|1|||
164691173|NCT01190930|594891695|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
164691174|NCT01190930|594891696|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
164691175|NCT01190930|594891697|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
164691176|NCT01190930|594891698|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
164691177|NCT01190930|594891699|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
164691178|NCT01190930|594891700|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
164691179|NCT01190930|594891691|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
164691180|NCT01190930|594891692|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
164691181|NCT01190930|594891693|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
164691182|NCT01190930|594891694|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
164691183|NCT01190930|594891695|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
164691184|NCT01190930|594891696|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
164691185|NCT01190930|594891697|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
164691186|NCT01190930|594891698|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
164691187|NCT01190930|594891699|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
164691188|NCT01190930|594891700|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
164691189|NCT01190930|594891691|FG000|Post Induction Pre-Maintenance|Relapse|0|||
164691190|NCT01190930|594891692|FG001|Post Induction Pre-Maintenance|Relapse|0|||
164691191|NCT01190930|594891693|FG002|Post Induction Pre-Maintenance|Relapse|1|||
164691192|NCT01190930|594891694|FG003|Post Induction Pre-Maintenance|Relapse|0|||
164691193|NCT01190930|594891695|FG004|Post Induction Pre-Maintenance|Relapse|0|||
164691194|NCT01190930|594891696|FG005|Post Induction Pre-Maintenance|Relapse|0|||
164691195|NCT01190930|594891697|FG006|Post Induction Pre-Maintenance|Relapse|0|||
164691196|NCT01190930|594891698|FG007|Post Induction Pre-Maintenance|Relapse|0|||
164691197|NCT01190930|594891699|FG008|Post Induction Pre-Maintenance|Relapse|0|||
164691198|NCT01190930|594891700|FG009|Post Induction Pre-Maintenance|Relapse|0|||
164586107|NCT01749735|594510102|FG001|Overall Study|Withdrawal by Subject|0|||
164586108|NCT04230486|594510109|FG000|Overall Study|Screen Failure|1|||
164586109|NCT04504032|594510110|FG000|Overall Study|Adverse Event|1|||
164586110|NCT04504032|594510111|FG001|Overall Study|Adverse Event|2|||
164586111|NCT04504032|594510110|FG000|Overall Study|Lost to Follow-up|6|||
164691199|NCT01190930|594891691|FG000|Maintenance|Adverse Event|0|||
164586112|NCT04504032|594510111|FG001|Overall Study|Lost to Follow-up|9|||
164586113|NCT04504032|594510110|FG000|Overall Study|Protocol Violation|2|||
164691200|NCT01190930|594891692|FG001|Maintenance|Adverse Event|0|||
164691201|NCT01190930|594891693|FG002|Maintenance|Adverse Event|0|||
164282480|NCT02218008|593404395|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
164282481|NCT02218008|593404396|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
164282482|NCT02218008|593404397|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
164282483|NCT02218008|593404398|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
164282484|NCT00408434|593404403|FG000|Overall Study|Adverse Event|0|||
164282485|NCT00408434|593404404|FG001|Overall Study|Adverse Event|0|||
164586114|NCT04504032|594510111|FG001|Overall Study|Protocol Violation|0|||
164691202|NCT01190930|594891694|FG003|Maintenance|Adverse Event|0|||
164691203|NCT01190930|594891695|FG004|Maintenance|Adverse Event|0|||
164691204|NCT01190930|594891696|FG005|Maintenance|Adverse Event|1|||
164691205|NCT01190930|594891697|FG006|Maintenance|Adverse Event|1|||
164691206|NCT01190930|594891698|FG007|Maintenance|Adverse Event|3|||
164691207|NCT01190930|594891699|FG008|Maintenance|Adverse Event|3|||
164691208|NCT01190930|594891700|FG009|Maintenance|Adverse Event|0|||
164691209|NCT01190930|594891691|FG000|Maintenance|Death|0|||
164691210|NCT01190930|594891692|FG001|Maintenance|Death|0|||
164691211|NCT01190930|594891693|FG002|Maintenance|Death|0|||
164691212|NCT01190930|594891694|FG003|Maintenance|Death|1|||
164691213|NCT01190930|594891695|FG004|Maintenance|Death|0|||
164691214|NCT01190930|594891696|FG005|Maintenance|Death|0|||
164691215|NCT01190930|594891697|FG006|Maintenance|Death|2|||
164691216|NCT01190930|594891698|FG007|Maintenance|Death|2|||
164691217|NCT01190930|594891699|FG008|Maintenance|Death|2|||
164691218|NCT01190930|594891700|FG009|Maintenance|Death|2|||
164691219|NCT01190930|594891691|FG000|Maintenance|Lost to Follow-up|0|||
164691220|NCT01190930|594891692|FG001|Maintenance|Lost to Follow-up|0|||
164691221|NCT01190930|594891693|FG002|Maintenance|Lost to Follow-up|0|||
164691222|NCT01190930|594891694|FG003|Maintenance|Lost to Follow-up|0|||
164691223|NCT01190930|594891695|FG004|Maintenance|Lost to Follow-up|0|||
164691224|NCT01190930|594891696|FG005|Maintenance|Lost to Follow-up|0|||
164691225|NCT01190930|594891697|FG006|Maintenance|Lost to Follow-up|1|||
164691226|NCT01190930|594891698|FG007|Maintenance|Lost to Follow-up|1|||
164691227|NCT01190930|594891699|FG008|Maintenance|Lost to Follow-up|1|||
164691228|NCT01190930|594891700|FG009|Maintenance|Lost to Follow-up|0|||
164691229|NCT01190930|594891691|FG000|Maintenance|Physician Decision|0|||
164691230|NCT01190930|594891692|FG001|Maintenance|Physician Decision|1|||
164691231|NCT01190930|594891693|FG002|Maintenance|Physician Decision|0|||
164691232|NCT01190930|594891694|FG003|Maintenance|Physician Decision|5|||
164691233|NCT01190930|594891695|FG004|Maintenance|Physician Decision|9|||
164282486|NCT00408434|593404405|FG002|Overall Study|Adverse Event|1|||
164282487|NCT00408434|593404406|FG003|Overall Study|Adverse Event|0|||
164282488|NCT00408434|593404407|FG004|Overall Study|Adverse Event|0|||
164586115|NCT04504032|594510110|FG000|Overall Study|Study terminated by sponsor|1|||
164586116|NCT04504032|594510111|FG001|Overall Study|Study terminated by sponsor|2|||
164586117|NCT04504032|594510110|FG000|Overall Study|Withdrawal by Subject|9|||
164586118|NCT04504032|594510111|FG001|Overall Study|Withdrawal by Subject|11|||
164586119|NCT04504032|594510110|FG000|Overall Study|Disease progression prior to dosing|15|||
164586120|NCT04504032|594510111|FG001|Overall Study|Disease progression prior to dosing|3|||
164586121|NCT04504032|594510110|FG000|Overall Study|Drug supply issues|1|||
164586122|NCT04504032|594510111|FG001|Overall Study|Drug supply issues|1|||
164586123|NCT04504032|594510110|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
164691234|NCT01190930|594891696|FG005|Maintenance|Physician Decision|4|||
164691235|NCT01190930|594891697|FG006|Maintenance|Physician Decision|8|||
164691236|NCT01190930|594891698|FG007|Maintenance|Physician Decision|8|||
164691237|NCT01190930|594891699|FG008|Maintenance|Physician Decision|10|||
164691238|NCT01190930|594891700|FG009|Maintenance|Physician Decision|17|||
164691239|NCT01190930|594891691|FG000|Maintenance|Withdrawal by Subject|0|||
164691240|NCT01190930|594891692|FG001|Maintenance|Withdrawal by Subject|0|||
164691241|NCT01190930|594891693|FG002|Maintenance|Withdrawal by Subject|0|||
164691242|NCT01190930|594891694|FG003|Maintenance|Withdrawal by Subject|0|||
164691243|NCT01190930|594891695|FG004|Maintenance|Withdrawal by Subject|0|||
164691244|NCT01190930|594891696|FG005|Maintenance|Withdrawal by Subject|0|||
164282489|NCT00408434|593404408|FG005|Overall Study|Adverse Event|0|||
164282490|NCT00408434|593404409|FG006|Overall Study|Adverse Event|0|||
164282491|NCT00408434|593404403|FG000|Overall Study|Progressive disease|6|||
164282492|NCT00408434|593404404|FG001|Overall Study|Progressive disease|3|||
164282493|NCT00408434|593404405|FG002|Overall Study|Progressive disease|4|||
164282494|NCT00408434|593404406|FG003|Overall Study|Progressive disease|3|||
164282495|NCT00408434|593404407|FG004|Overall Study|Progressive disease|3|||
164282496|NCT00408434|593404408|FG005|Overall Study|Progressive disease|1|||
164282497|NCT00408434|593404409|FG006|Overall Study|Progressive disease|4|||
164282498|NCT00408434|593404403|FG000|Overall Study|Other|0|||
164282499|NCT00408434|593404404|FG001|Overall Study|Other|0|||
164282500|NCT00408434|593404405|FG002|Overall Study|Other|1|||
164282501|NCT00408434|593404406|FG003|Overall Study|Other|0|||
164282502|NCT00408434|593404407|FG004|Overall Study|Other|2|||
164282503|NCT00408434|593404408|FG005|Overall Study|Other|1|||
164282504|NCT00408434|593404409|FG006|Overall Study|Other|0|||
164282505|NCT00408434|593404403|FG000|Overall Study|Terminated by Investigator|0|||
164282506|NCT00408434|593404404|FG001|Overall Study|Terminated by Investigator|0|||
164282507|NCT00408434|593404405|FG002|Overall Study|Terminated by Investigator|0|||
164282508|NCT00408434|593404406|FG003|Overall Study|Terminated by Investigator|0|||
164282509|NCT00408434|593404407|FG004|Overall Study|Terminated by Investigator|1|||
164282510|NCT00408434|593404408|FG005|Overall Study|Terminated by Investigator|1|||
164282511|NCT00408434|593404409|FG006|Overall Study|Terminated by Investigator|0|||
164282512|NCT04039217|593404410|FG000|Overall Study|Lost to Follow-up|1|||
164282513|NCT00106353|593404411|FG000|Part 1|Disease progression|3|||
164282514|NCT00106353|593404412|FG001|Part 1|Disease progression|4|||
164282515|NCT00106353|593404413|FG002|Part 1|Disease progression|1|||
164282516|NCT00106353|593404414|FG003|Part 1|Disease progression|3|||
164282517|NCT00106353|593404415|FG004|Part 1|Disease progression|0|||
164282518|NCT00106353|593404416|FG005|Part 1|Disease progression|0|||
164282519|NCT00106353|593404417|FG006|Part 1|Disease progression|0|||
164282520|NCT00106353|593404411|FG000|Part 1|Withdrawal by Subject|0|||
164282521|NCT00106353|593404412|FG001|Part 1|Withdrawal by Subject|0|||
164282522|NCT00106353|593404413|FG002|Part 1|Withdrawal by Subject|1|||
164282523|NCT00106353|593404414|FG003|Part 1|Withdrawal by Subject|2|||
164282524|NCT00106353|593404415|FG004|Part 1|Withdrawal by Subject|0|||
164282525|NCT00106353|593404416|FG005|Part 1|Withdrawal by Subject|0|||
164282526|NCT00106353|593404417|FG006|Part 1|Withdrawal by Subject|0|||
164344539|NCT00444912|593636972|FG000|Overall Study|Death|1|||
164344540|NCT00444912|593636973|FG001|Overall Study|Death|2|||
164282527|NCT00106353|593404411|FG000|Part 1|Symptomatic deterioration|0|||
164282528|NCT00106353|593404412|FG001|Part 1|Symptomatic deterioration|0|||
164282529|NCT00106353|593404413|FG002|Part 1|Symptomatic deterioration|1|||
164344541|NCT00444912|593636972|FG000|Overall Study|Lost to Follow-up|1|||
164691245|NCT01190930|594891697|FG006|Maintenance|Withdrawal by Subject|2|||
164691246|NCT01190930|594891698|FG007|Maintenance|Withdrawal by Subject|1|||
164691247|NCT01190930|594891699|FG008|Maintenance|Withdrawal by Subject|4|||
164282530|NCT00106353|593404414|FG003|Part 1|Symptomatic deterioration|0|||
164282531|NCT00106353|593404415|FG004|Part 1|Symptomatic deterioration|0|||
164282532|NCT00106353|593404416|FG005|Part 1|Symptomatic deterioration|0|||
164282533|NCT00106353|593404417|FG006|Part 1|Symptomatic deterioration|0|||
164282534|NCT00106353|593404411|FG000|Part 1|Entered follow-up phase|1|||
164282535|NCT00106353|593404412|FG001|Part 1|Entered follow-up phase|1|||
164282536|NCT00106353|593404413|FG002|Part 1|Entered follow-up phase|0|||
164282537|NCT00106353|593404414|FG003|Part 1|Entered follow-up phase|1|||
164282538|NCT00106353|593404415|FG004|Part 1|Entered follow-up phase|0|||
164282539|NCT00106353|593404416|FG005|Part 1|Entered follow-up phase|0|||
164282540|NCT00106353|593404417|FG006|Part 1|Entered follow-up phase|0|||
164282541|NCT00106353|593404411|FG000|Part 1|Adverse Event|0|||
164282542|NCT00106353|593404412|FG001|Part 1|Adverse Event|0|||
164282543|NCT00106353|593404413|FG002|Part 1|Adverse Event|0|||
164282544|NCT00106353|593404414|FG003|Part 1|Adverse Event|1|||
164282545|NCT00106353|593404415|FG004|Part 1|Adverse Event|0|||
164282546|NCT00106353|593404416|FG005|Part 1|Adverse Event|0|||
164282547|NCT00106353|593404417|FG006|Part 1|Adverse Event|0|||
164282548|NCT00106353|593404411|FG000|Part 2|Disease progression|0|||
164282549|NCT00106353|593404412|FG001|Part 2|Disease progression|0|||
164282550|NCT00106353|593404413|FG002|Part 2|Disease progression|0|||
164282551|NCT00106353|593404414|FG003|Part 2|Disease progression|0|||
164282552|NCT00106353|593404415|FG004|Part 2|Disease progression|8|||
164282553|NCT00106353|593404416|FG005|Part 2|Disease progression|14|||
164282554|NCT00106353|593404417|FG006|Part 2|Disease progression|13|||
164282555|NCT00106353|593404411|FG000|Part 2|Death|0|||
164282556|NCT00106353|593404412|FG001|Part 2|Death|0|||
164282557|NCT00106353|593404413|FG002|Part 2|Death|0|||
164282558|NCT00106353|593404414|FG003|Part 2|Death|0|||
164282559|NCT00106353|593404415|FG004|Part 2|Death|3|||
164282560|NCT00106353|593404416|FG005|Part 2|Death|0|||
164282561|NCT00106353|593404417|FG006|Part 2|Death|1|||
164282562|NCT00106353|593404411|FG000|Part 2|Symptomatic deterioration|0|||
164282563|NCT00106353|593404412|FG001|Part 2|Symptomatic deterioration|0|||
164691248|NCT01190930|594891700|FG009|Maintenance|Withdrawal by Subject|1|||
164691249|NCT01190930|594891691|FG000|Maintenance|Refusal|0|||
164282564|NCT00106353|593404413|FG002|Part 2|Symptomatic deterioration|0|||
164282565|NCT00106353|593404414|FG003|Part 2|Symptomatic deterioration|0|||
164282566|NCT00106353|593404415|FG004|Part 2|Symptomatic deterioration|3|||
164282567|NCT00106353|593404416|FG005|Part 2|Symptomatic deterioration|0|||
164282568|NCT00106353|593404417|FG006|Part 2|Symptomatic deterioration|0|||
164282569|NCT00106353|593404411|FG000|Part 2|Adverse Event|0|||
164282570|NCT00106353|593404412|FG001|Part 2|Adverse Event|0|||
164282571|NCT00106353|593404413|FG002|Part 2|Adverse Event|0|||
164282572|NCT00106353|593404414|FG003|Part 2|Adverse Event|0|||
164282573|NCT00106353|593404415|FG004|Part 2|Adverse Event|0|||
164282574|NCT00106353|593404416|FG005|Part 2|Adverse Event|2|||
164282575|NCT00106353|593404417|FG006|Part 2|Adverse Event|1|||
164282576|NCT00106353|593404411|FG000|Part 2|Other|0|||
164282577|NCT00106353|593404412|FG001|Part 2|Other|0|||
164282578|NCT00106353|593404413|FG002|Part 2|Other|0|||
164282579|NCT00106353|593404414|FG003|Part 2|Other|0|||
164282580|NCT00106353|593404415|FG004|Part 2|Other|1|||
164282581|NCT00106353|593404416|FG005|Part 2|Other|1|||
164282582|NCT00106353|593404417|FG006|Part 2|Other|1|||
164282583|NCT00106353|593404411|FG000|Part 2|Withdrawal by Subject|0|||
164282584|NCT00106353|593404412|FG001|Part 2|Withdrawal by Subject|0|||
164282585|NCT00106353|593404413|FG002|Part 2|Withdrawal by Subject|0|||
164282586|NCT00106353|593404414|FG003|Part 2|Withdrawal by Subject|0|||
164282587|NCT00106353|593404415|FG004|Part 2|Withdrawal by Subject|1|||
164282588|NCT00106353|593404416|FG005|Part 2|Withdrawal by Subject|0|||
164282589|NCT00106353|593404417|FG006|Part 2|Withdrawal by Subject|0|||
164282590|NCT00106353|593404411|FG000|Part 2|Physician Decision|0|||
164282591|NCT00106353|593404412|FG001|Part 2|Physician Decision|0|||
164282592|NCT00106353|593404413|FG002|Part 2|Physician Decision|0|||
164282593|NCT00106353|593404414|FG003|Part 2|Physician Decision|0|||
164282594|NCT00106353|593404415|FG004|Part 2|Physician Decision|0|||
164282595|NCT00106353|593404416|FG005|Part 2|Physician Decision|1|||
164282596|NCT00106353|593404417|FG006|Part 2|Physician Decision|0|||
164282597|NCT01278797|593404418|FG000|Period 1|Adverse Event|0|||
164282598|NCT01278797|593404419|FG001|Period 1|Adverse Event|1|||
164282599|NCT01278797|593404418|FG000|Period 1|Protocol Violation|1|||
164282600|NCT01278797|593404419|FG001|Period 1|Protocol Violation|0|||
164282601|NCT00588354|593404420|FG000|Baseline to 2 Weeks|Adverse Event|1|||
164282602|NCT00588354|593404421|FG001|Baseline to 2 Weeks|Adverse Event|0|||
164282603|NCT00588354|593404420|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
164282604|NCT00588354|593404421|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
164282605|NCT00588354|593404420|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
164282606|NCT00588354|593404421|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
164282607|NCT01371552|593404422|FG000|Part 1, First 3 Days|Inconvenience|0|||
164282608|NCT01371552|593404423|FG001|Part 1, First 3 Days|Inconvenience|0|||
164282609|NCT01371552|593404424|FG002|Part 1, First 3 Days|Inconvenience|1|||
164282610|NCT01371552|593404425|FG003|Part 1, First 3 Days|Inconvenience|0|||
164282611|NCT01371552|593404426|FG004|Part 1, First 3 Days|Inconvenience|0|||
164282612|NCT01371552|593404427|FG005|Part 1, First 3 Days|Inconvenience|0|||
164282613|NCT03364309|593404428|FG000|Induction Period|Adverse Event|4|||
164282614|NCT03364309|593404429|FG001|Induction Period|Adverse Event|0|||
164282615|NCT03364309|593404430|FG002|Induction Period|Adverse Event|1|||
164282616|NCT03364309|593404431|FG003|Induction Period|Adverse Event|0|||
164282617|NCT03364309|593404432|FG004|Induction Period|Adverse Event|0|||
164282618|NCT03364309|593404433|FG005|Induction Period|Adverse Event|0|||
164282619|NCT03364309|593404434|FG006|Induction Period|Adverse Event|0|||
164282620|NCT03364309|593404435|FG007|Induction Period|Adverse Event|0|||
164282621|NCT03364309|593404436|FG008|Induction Period|Adverse Event|0|||
164282622|NCT03364309|593404437|FG009|Induction Period|Adverse Event|0|||
164282623|NCT03364309|593404438|FG010|Induction Period|Adverse Event|0|||
164282624|NCT03364309|593404439|FG011|Induction Period|Adverse Event|0|||
164282625|NCT03364309|593404440|FG012|Induction Period|Adverse Event|0|||
164282626|NCT03364309|593404441|FG013|Induction Period|Adverse Event|0|||
164282627|NCT03364309|593404442|FG014|Induction Period|Adverse Event|0|||
164282628|NCT03364309|593404443|FG015|Induction Period|Adverse Event|0|||
164282629|NCT03364309|593404444|FG016|Induction Period|Adverse Event|0|||
164282630|NCT03364309|593404445|FG017|Induction Period|Adverse Event|0|||
164282631|NCT03364309|593404446|FG018|Induction Period|Adverse Event|0|||
164282632|NCT03364309|593404428|FG000|Induction Period|Withdrawal by Subject|1|||
164282633|NCT03364309|593404429|FG001|Induction Period|Withdrawal by Subject|3|||
164282634|NCT03364309|593404430|FG002|Induction Period|Withdrawal by Subject|0|||
164282635|NCT03364309|593404431|FG003|Induction Period|Withdrawal by Subject|0|||
164282636|NCT03364309|593404432|FG004|Induction Period|Withdrawal by Subject|0|||
164282637|NCT03364309|593404433|FG005|Induction Period|Withdrawal by Subject|0|||
164282638|NCT03364309|593404434|FG006|Induction Period|Withdrawal by Subject|0|||
164282639|NCT03364309|593404435|FG007|Induction Period|Withdrawal by Subject|0|||
164282640|NCT03364309|593404436|FG008|Induction Period|Withdrawal by Subject|0|||
164282641|NCT03364309|593404437|FG009|Induction Period|Withdrawal by Subject|0|||
164282642|NCT03364309|593404438|FG010|Induction Period|Withdrawal by Subject|0|||
164282643|NCT03364309|593404439|FG011|Induction Period|Withdrawal by Subject|0|||
164282644|NCT03364309|593404440|FG012|Induction Period|Withdrawal by Subject|0|||
164282645|NCT03364309|593404441|FG013|Induction Period|Withdrawal by Subject|0|||
164282646|NCT03364309|593404442|FG014|Induction Period|Withdrawal by Subject|0|||
164282647|NCT03364309|593404443|FG015|Induction Period|Withdrawal by Subject|0|||
164282648|NCT03364309|593404444|FG016|Induction Period|Withdrawal by Subject|0|||
164282649|NCT03364309|593404445|FG017|Induction Period|Withdrawal by Subject|0|||
164282650|NCT03364309|593404446|FG018|Induction Period|Withdrawal by Subject|0|||
164282651|NCT03364309|593404428|FG000|Induction Period|Lost to Follow-up|1|||
164282652|NCT03364309|593404429|FG001|Induction Period|Lost to Follow-up|0|||
164282653|NCT03364309|593404430|FG002|Induction Period|Lost to Follow-up|0|||
164282654|NCT03364309|593404431|FG003|Induction Period|Lost to Follow-up|0|||
164282655|NCT03364309|593404432|FG004|Induction Period|Lost to Follow-up|0|||
164282656|NCT03364309|593404433|FG005|Induction Period|Lost to Follow-up|0|||
164282657|NCT03364309|593404434|FG006|Induction Period|Lost to Follow-up|0|||
164282658|NCT03364309|593404435|FG007|Induction Period|Lost to Follow-up|0|||
164282659|NCT03364309|593404436|FG008|Induction Period|Lost to Follow-up|0|||
164282660|NCT03364309|593404437|FG009|Induction Period|Lost to Follow-up|0|||
164282661|NCT03364309|593404438|FG010|Induction Period|Lost to Follow-up|0|||
164282662|NCT03364309|593404439|FG011|Induction Period|Lost to Follow-up|0|||
164282663|NCT03364309|593404440|FG012|Induction Period|Lost to Follow-up|0|||
164282664|NCT03364309|593404441|FG013|Induction Period|Lost to Follow-up|0|||
164282665|NCT03364309|593404442|FG014|Induction Period|Lost to Follow-up|0|||
164282666|NCT03364309|593404443|FG015|Induction Period|Lost to Follow-up|0|||
164282667|NCT03364309|593404444|FG016|Induction Period|Lost to Follow-up|0|||
164282668|NCT03364309|593404445|FG017|Induction Period|Lost to Follow-up|0|||
164282669|NCT03364309|593404446|FG018|Induction Period|Lost to Follow-up|0|||
164282670|NCT03364309|593404428|FG000|Induction Period|Physician Decision|0|||
164282671|NCT03364309|593404429|FG001|Induction Period|Physician Decision|1|||
164282672|NCT03364309|593404430|FG002|Induction Period|Physician Decision|0|||
164282673|NCT03364309|593404431|FG003|Induction Period|Physician Decision|0|||
164282674|NCT03364309|593404432|FG004|Induction Period|Physician Decision|0|||
164282675|NCT03364309|593404433|FG005|Induction Period|Physician Decision|0|||
164282676|NCT03364309|593404434|FG006|Induction Period|Physician Decision|0|||
164282677|NCT03364309|593404435|FG007|Induction Period|Physician Decision|0|||
164282678|NCT03364309|593404436|FG008|Induction Period|Physician Decision|0|||
164282679|NCT03364309|593404437|FG009|Induction Period|Physician Decision|0|||
164282680|NCT03364309|593404438|FG010|Induction Period|Physician Decision|0|||
164282681|NCT03364309|593404439|FG011|Induction Period|Physician Decision|0|||
164282682|NCT03364309|593404440|FG012|Induction Period|Physician Decision|0|||
164282683|NCT03364309|593404441|FG013|Induction Period|Physician Decision|0|||
164282684|NCT03364309|593404442|FG014|Induction Period|Physician Decision|0|||
164282685|NCT03364309|593404443|FG015|Induction Period|Physician Decision|0|||
164282686|NCT03364309|593404444|FG016|Induction Period|Physician Decision|0|||
164282687|NCT03364309|593404445|FG017|Induction Period|Physician Decision|0|||
164282688|NCT03364309|593404446|FG018|Induction Period|Physician Decision|0|||
164282689|NCT03364309|593404428|FG000|Maintenance Period|Withdrawal by Subject|0|||
164282690|NCT03364309|593404429|FG001|Maintenance Period|Withdrawal by Subject|0|||
164282691|NCT03364309|593404430|FG002|Maintenance Period|Withdrawal by Subject|0|||
164282692|NCT03364309|593404431|FG003|Maintenance Period|Withdrawal by Subject|1|||
164282693|NCT03364309|593404432|FG004|Maintenance Period|Withdrawal by Subject|3|||
164282694|NCT03364309|593404433|FG005|Maintenance Period|Withdrawal by Subject|1|||
164282695|NCT03364309|593404434|FG006|Maintenance Period|Withdrawal by Subject|3|||
164282696|NCT03364309|593404435|FG007|Maintenance Period|Withdrawal by Subject|0|||
164282697|NCT03364309|593404436|FG008|Maintenance Period|Withdrawal by Subject|1|||
164282698|NCT03364309|593404437|FG009|Maintenance Period|Withdrawal by Subject|1|||
164282699|NCT03364309|593404438|FG010|Maintenance Period|Withdrawal by Subject|2|||
164282700|NCT03364309|593404439|FG011|Maintenance Period|Withdrawal by Subject|0|||
164282701|NCT03364309|593404440|FG012|Maintenance Period|Withdrawal by Subject|0|||
164282702|NCT03364309|593404441|FG013|Maintenance Period|Withdrawal by Subject|0|||
164282703|NCT03364309|593404442|FG014|Maintenance Period|Withdrawal by Subject|0|||
164282704|NCT03364309|593404443|FG015|Maintenance Period|Withdrawal by Subject|0|||
164282705|NCT03364309|593404444|FG016|Maintenance Period|Withdrawal by Subject|0|||
164282706|NCT03364309|593404445|FG017|Maintenance Period|Withdrawal by Subject|0|||
164282707|NCT03364309|593404446|FG018|Maintenance Period|Withdrawal by Subject|0|||
164691250|NCT01190930|594891692|FG001|Maintenance|Refusal|1|||
164691251|NCT01190930|594891693|FG002|Maintenance|Refusal|0|||
164691252|NCT01190930|594891694|FG003|Maintenance|Refusal|2|||
164691253|NCT01190930|594891695|FG004|Maintenance|Refusal|0|||
164691254|NCT01190930|594891696|FG005|Maintenance|Refusal|4|||
164691255|NCT01190930|594891697|FG006|Maintenance|Refusal|5|||
164691256|NCT01190930|594891698|FG007|Maintenance|Refusal|17|||
164691257|NCT01190930|594891699|FG008|Maintenance|Refusal|13|||
164691258|NCT01190930|594891700|FG009|Maintenance|Refusal|6|||
164691259|NCT01190930|594891691|FG000|Maintenance|second malignant neoplasm|0|||
164691260|NCT01190930|594891692|FG001|Maintenance|second malignant neoplasm|0|||
164691261|NCT01190930|594891693|FG002|Maintenance|second malignant neoplasm|0|||
164691262|NCT01190930|594891694|FG003|Maintenance|second malignant neoplasm|1|||
164691263|NCT01190930|594891695|FG004|Maintenance|second malignant neoplasm|0|||
164691264|NCT01190930|594891696|FG005|Maintenance|second malignant neoplasm|1|||
164691265|NCT01190930|594891697|FG006|Maintenance|second malignant neoplasm|0|||
164691266|NCT01190930|594891698|FG007|Maintenance|second malignant neoplasm|0|||
164691267|NCT01190930|594891699|FG008|Maintenance|second malignant neoplasm|1|||
164691268|NCT01190930|594891700|FG009|Maintenance|second malignant neoplasm|0|||
164691269|NCT01190930|594891691|FG000|Maintenance|Inevaluable|0|||
164691270|NCT01190930|594891692|FG001|Maintenance|Inevaluable|0|||
164691271|NCT01190930|594891693|FG002|Maintenance|Inevaluable|0|||
164691272|NCT01190930|594891694|FG003|Maintenance|Inevaluable|0|||
164691273|NCT01190930|594891695|FG004|Maintenance|Inevaluable|0|||
164691274|NCT01190930|594891696|FG005|Maintenance|Inevaluable|1|||
164691275|NCT01190930|594891697|FG006|Maintenance|Inevaluable|1|||
164691276|NCT01190930|594891698|FG007|Maintenance|Inevaluable|1|||
164691277|NCT01190930|594891699|FG008|Maintenance|Inevaluable|0|||
164691278|NCT01190930|594891700|FG009|Maintenance|Inevaluable|0|||
164691279|NCT01190930|594891691|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
164691280|NCT01190930|594891692|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
164691281|NCT01190930|594891693|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
164691282|NCT01190930|594891694|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
164691283|NCT01190930|594891695|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
164691284|NCT01190930|594891696|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
164691285|NCT01190930|594891697|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
164691286|NCT01190930|594891698|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
164691287|NCT01190930|594891699|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
164691288|NCT01190930|594891700|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
164691289|NCT01190930|594891691|FG000|Maintenance|Relapse|0|||
164691290|NCT01190930|594891692|FG001|Maintenance|Relapse|0|||
164691291|NCT01190930|594891693|FG002|Maintenance|Relapse|0|||
164691292|NCT01190930|594891694|FG003|Maintenance|Relapse|2|||
164691293|NCT01190930|594891695|FG004|Maintenance|Relapse|0|||
164691294|NCT01190930|594891696|FG005|Maintenance|Relapse|1|||
164691295|NCT01190930|594891697|FG006|Maintenance|Relapse|6|||
164691296|NCT01190930|594891698|FG007|Maintenance|Relapse|13|||
164691297|NCT01190930|594891699|FG008|Maintenance|Relapse|11|||
164691298|NCT01190930|594891700|FG009|Maintenance|Relapse|11|||
164691299|NCT01190930|594891691|FG000|Maintenance|Still on therapy|0|||
164691300|NCT01190930|594891692|FG001|Maintenance|Still on therapy|8|||
164691301|NCT01190930|594891693|FG002|Maintenance|Still on therapy|0|||
164691302|NCT01190930|594891694|FG003|Maintenance|Still on therapy|29|||
164691303|NCT01190930|594891695|FG004|Maintenance|Still on therapy|0|||
164691304|NCT01190930|594891696|FG005|Maintenance|Still on therapy|0|||
164691305|NCT01190930|594891697|FG006|Maintenance|Still on therapy|0|||
164691306|NCT01190930|594891698|FG007|Maintenance|Still on therapy|0|||
164691307|NCT01190930|594891699|FG008|Maintenance|Still on therapy|0|||
164691308|NCT01190930|594891700|FG009|Maintenance|Still on therapy|0|||
164691309|NCT02418455|594891701|FG000|48-Week Treatment Period|Other- Not Specified|1|||
164691310|NCT02418455|594891701|FG000|Continuation Period|Sponsor Decision|7|||
164691311|NCT02001051|594891704|FG000|Overall Study|Deemed not eligible following enrollment|0|||
164691312|NCT02001051|594891705|FG001|Overall Study|Deemed not eligible following enrollment|1|||
164691313|NCT04205162|594891723|FG000|Overall Study|Lost to Follow-up|1|||
164691314|NCT04205162|594891724|FG001|Overall Study|Lost to Follow-up|0|||
164691315|NCT04205162|594891723|FG000|Overall Study|Withdrawal by Subject|2|||
164691316|NCT04205162|594891724|FG001|Overall Study|Withdrawal by Subject|0|||
164344542|NCT00444912|593636973|FG001|Overall Study|Lost to Follow-up|0|||
164344543|NCT00444912|593636972|FG000|Overall Study|Participant Failed Mobilization|1|||
164344544|NCT00444912|593636973|FG001|Overall Study|Participant Failed Mobilization|0|||
164344545|NCT03758066|593636974|FG000|Overall Study|Lost to Follow-up|14|||
164344546|NCT03706079|593636981|FG000|Predecessor Study|Death|0|||
164344547|NCT03706079|593636982|FG001|Predecessor Study|Death|2|||
164344548|NCT03706079|593636983|FG002|Predecessor Study|Death|0|||
164344549|NCT03706079|593636984|FG003|Predecessor Study|Death|1|||
164344550|NCT03706079|593636985|FG004|Predecessor Study|Death|0|||
164344551|NCT03706079|593636986|FG005|Predecessor Study|Death|0|||
164344552|NCT03706079|593636981|FG000|Predecessor Study|Lost to Follow-up|5|||
164344553|NCT03706079|593636982|FG001|Predecessor Study|Lost to Follow-up|2|||
164344554|NCT03706079|593636983|FG002|Predecessor Study|Lost to Follow-up|0|||
164344555|NCT03706079|593636984|FG003|Predecessor Study|Lost to Follow-up|0|||
164344556|NCT03706079|593636985|FG004|Predecessor Study|Lost to Follow-up|1|||
164344557|NCT03706079|593636986|FG005|Predecessor Study|Lost to Follow-up|0|||
164344558|NCT03706079|593636981|FG000|Predecessor Study|Withdrawal by Subject|8|||
164344559|NCT03706079|593636982|FG001|Predecessor Study|Withdrawal by Subject|15|||
164344560|NCT03706079|593636983|FG002|Predecessor Study|Withdrawal by Subject|0|||
164344561|NCT03706079|593636984|FG003|Predecessor Study|Withdrawal by Subject|5|||
164344562|NCT03706079|593636985|FG004|Predecessor Study|Withdrawal by Subject|2|||
164344563|NCT03706079|593636986|FG005|Predecessor Study|Withdrawal by Subject|0|||
164344564|NCT03706079|593636981|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
164344565|NCT03706079|593636982|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
164344566|NCT03706079|593636983|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
164433216|NCT00957229|593957189|FG000|Study Start|Disease Progression|1|||
164586124|NCT04504032|594510111|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
164586125|NCT04983901|594510112|FG000|Overall Study|Death|1|||
164586126|NCT04983901|594510113|FG001|Overall Study|Death|4|||
164586127|NCT04983901|594510112|FG000|Overall Study|Lost to Follow-up|3|||
164586128|NCT04983901|594510113|FG001|Overall Study|Lost to Follow-up|0|||
164586129|NCT04983901|594510112|FG000|Overall Study|Protocol Violation|1|||
164586130|NCT04983901|594510113|FG001|Overall Study|Protocol Violation|0|||
164586131|NCT04983901|594510112|FG000|Overall Study|Withdrawal by Subject|1|||
164586132|NCT04983901|594510113|FG001|Overall Study|Withdrawal by Subject|2|||
164586133|NCT01174784|594510114|FG000|Overall Study|Screen fails|4|||
164586134|NCT02416908|594510115|FG000|Dose Escalation Phase|Adverse Event|0|||
164586135|NCT02416908|594510116|FG001|Dose Escalation Phase|Adverse Event|0|||
164586136|NCT02416908|594510117|FG002|Dose Escalation Phase|Adverse Event|3|||
164586137|NCT02416908|594510118|FG003|Dose Escalation Phase|Adverse Event|0|||
164586138|NCT02416908|594510115|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
164586139|NCT02416908|594510116|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
164586140|NCT02416908|594510117|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
164586141|NCT02416908|594510118|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
164586142|NCT01214434|594510121|FG000|Overall Study|Withdrawal by Subject|1|||
164586143|NCT01214434|594510122|FG001|Overall Study|Withdrawal by Subject|0|||
164586144|NCT01214434|594510121|FG000|Overall Study|Lost to Follow-up|2|||
164586145|NCT01214434|594510122|FG001|Overall Study|Lost to Follow-up|2|||
164586146|NCT01214434|594510121|FG000|Overall Study|Site error|1|||
164691317|NCT04205162|594891723|FG000|Overall Study|University closure due to COVID-19|1|||
164691318|NCT04205162|594891724|FG001|Overall Study|University closure due to COVID-19|0|||
164586147|NCT01214434|594510122|FG001|Overall Study|Site error|0|||
164586148|NCT03792750|594510124|FG000|Overall Study|Death|3|||
164586149|NCT02285010|594510125|FG000|Overall Study|not abdominal hysterectomy|2|||
164586150|NCT02285010|594510126|FG001|Overall Study|not abdominal hysterectomy|0|||
164691319|NCT01999894|594891725|FG000|Overall Study|Adverse Event|9|||
164691320|NCT01999894|594891725|FG000|Overall Study|Lack of Efficacy|5|||
164691321|NCT01999894|594891725|FG000|Overall Study|Protocol Violation|1|||
164691322|NCT01999894|594891725|FG000|Overall Study|Withdrawal by Subject|7|||
164691323|NCT01999894|594891725|FG000|Overall Study|Lost to Follow-up|10|||
164691324|NCT01999894|594891725|FG000|Overall Study|Other Reason|3|||
164691325|NCT01999894|594891725|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
164282708|NCT03364309|593404428|FG000|Maintenance Period|Adverse Event|0|||
164282709|NCT03364309|593404429|FG001|Maintenance Period|Adverse Event|0|||
164282710|NCT03364309|593404430|FG002|Maintenance Period|Adverse Event|0|||
164282711|NCT03364309|593404431|FG003|Maintenance Period|Adverse Event|0|||
164282712|NCT03364309|593404432|FG004|Maintenance Period|Adverse Event|2|||
164282713|NCT03364309|593404433|FG005|Maintenance Period|Adverse Event|0|||
164691326|NCT01546519|594891727|FG000|Overall Study|Adverse Event|0|||
164691327|NCT01546519|594891728|FG001|Overall Study|Adverse Event|0|||
164691328|NCT01546519|594891729|FG002|Overall Study|Adverse Event|1|||
164691329|NCT01546519|594891730|FG003|Overall Study|Adverse Event|1|||
164691330|NCT01546519|594891727|FG000|Overall Study|Death|0|||
164691331|NCT01546519|594891728|FG001|Overall Study|Death|1|||
164691332|NCT01546519|594891729|FG002|Overall Study|Death|3|||
164691333|NCT01546519|594891730|FG003|Overall Study|Death|1|||
164691334|NCT01546519|594891727|FG000|Overall Study|related to disease progression|2|||
164691335|NCT01546519|594891728|FG001|Overall Study|related to disease progression|2|||
164691336|NCT01546519|594891729|FG002|Overall Study|related to disease progression|2|||
164691337|NCT01546519|594891730|FG003|Overall Study|related to disease progression|1|||
164691338|NCT01546519|594891727|FG000|Overall Study|Physician Decision|6|||
164691339|NCT01546519|594891728|FG001|Overall Study|Physician Decision|5|||
164691340|NCT01546519|594891729|FG002|Overall Study|Physician Decision|2|||
164691341|NCT01546519|594891730|FG003|Overall Study|Physician Decision|3|||
164691342|NCT01546519|594891727|FG000|Overall Study|Withdrawal by Subject|1|||
164691343|NCT01546519|594891728|FG001|Overall Study|Withdrawal by Subject|0|||
164691344|NCT01546519|594891729|FG002|Overall Study|Withdrawal by Subject|0|||
164691345|NCT01546519|594891730|FG003|Overall Study|Withdrawal by Subject|0|||
164691346|NCT01077258|594891736|FG000|Overall Study|Lost to Follow-up|1390|||
164691347|NCT01077258|594891736|FG000|Overall Study|Adverse drug reaction|218|||
164691348|NCT01077258|594891736|FG000|Overall Study|Lack of Efficacy|663|||
164691349|NCT01077258|594891736|FG000|Overall Study|Clinical remission|37|||
164691350|NCT01077258|594891736|FG000|Overall Study|Other reasons|260|||
164691351|NCT00434837|594891737|FG000|Overall Study|Lost to Follow-up|20|||
164691352|NCT00434837|594891738|FG001|Overall Study|Lost to Follow-up|23|||
164691353|NCT00434837|594891739|FG002|Overall Study|Lost to Follow-up|30|||
164691354|NCT00726895|594891741|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
164691355|NCT00726895|594891742|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
164691356|NCT01881737|594891744|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
164691357|NCT01881737|594891744|FG000|Overall Study|Withdrawal by Subject|1|||
164691358|NCT01881737|594891744|FG000|Overall Study|Worsening of baseline behavior|1|||
164691359|NCT01450800|594891755|FG000|Overall Study|Protocol Violation|1|||
164691360|NCT01450800|594891756|FG001|Overall Study|Protocol Violation|3|||
164691361|NCT03023137|594891757|FG000|Overall Study|Multiple pregnancy|2|||
164691362|NCT03023137|594891758|FG001|Overall Study|Multiple pregnancy|4|||
164691363|NCT03023137|594891757|FG000|Overall Study|Lost to Follow-up|1|||
164691364|NCT03023137|594891758|FG001|Overall Study|Lost to Follow-up|1|||
164691365|NCT03023137|594891757|FG000|Overall Study|Protocol Violation|0|||
164691366|NCT03023137|594891758|FG001|Overall Study|Protocol Violation|4|||
164691367|NCT03023137|594891757|FG000|Overall Study|Lost the baby in a car accident|1|||
164691368|NCT03023137|594891758|FG001|Overall Study|Lost the baby in a car accident|0|||
164691369|NCT03496298|594891759|FG000|Overall Study|Adverse Event|49|||
164691370|NCT03496298|594891760|FG001|Overall Study|Adverse Event|68|||
164691371|NCT03496298|594891761|FG002|Overall Study|Adverse Event|79|||
164691372|NCT03496298|594891759|FG000|Overall Study|Study terminated by Sponsor|1050|||
164691373|NCT03496298|594891760|FG001|Overall Study|Study terminated by Sponsor|1063|||
164691374|NCT03496298|594891761|FG002|Overall Study|Study terminated by Sponsor|1071|||
164691375|NCT03496298|594891759|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
164282714|NCT03364309|593404434|FG006|Maintenance Period|Adverse Event|3|||
164282715|NCT03364309|593404435|FG007|Maintenance Period|Adverse Event|0|||
164282716|NCT03364309|593404436|FG008|Maintenance Period|Adverse Event|1|||
164282717|NCT03364309|593404437|FG009|Maintenance Period|Adverse Event|0|||
164691376|NCT03496298|594891760|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
164691377|NCT03496298|594891761|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
164282718|NCT03364309|593404438|FG010|Maintenance Period|Adverse Event|2|||
164282719|NCT03364309|593404439|FG011|Maintenance Period|Adverse Event|0|||
164691378|NCT03496298|594891759|FG000|Overall Study|Withdrawal by Subject|176|||
164282720|NCT03364309|593404440|FG012|Maintenance Period|Adverse Event|0|||
164282721|NCT03364309|593404441|FG013|Maintenance Period|Adverse Event|0|||
164691379|NCT03496298|594891760|FG001|Overall Study|Withdrawal by Subject|154|||
164691380|NCT03496298|594891761|FG002|Overall Study|Withdrawal by Subject|151|||
164691381|NCT03496298|594891759|FG000|Overall Study|Other|29|||
164282722|NCT03364309|593404442|FG014|Maintenance Period|Adverse Event|0|||
164282723|NCT03364309|593404443|FG015|Maintenance Period|Adverse Event|0|||
164282724|NCT03364309|593404444|FG016|Maintenance Period|Adverse Event|0|||
164282725|NCT03364309|593404445|FG017|Maintenance Period|Adverse Event|0|||
164282726|NCT03364309|593404446|FG018|Maintenance Period|Adverse Event|0|||
164282727|NCT03364309|593404428|FG000|Maintenance Period|Relapsed|0|||
164282728|NCT03364309|593404429|FG001|Maintenance Period|Relapsed|0|||
164282729|NCT03364309|593404430|FG002|Maintenance Period|Relapsed|0|||
164282730|NCT03364309|593404431|FG003|Maintenance Period|Relapsed|43|||
164282731|NCT03364309|593404432|FG004|Maintenance Period|Relapsed|7|||
164282732|NCT03364309|593404433|FG005|Maintenance Period|Relapsed|45|||
164282733|NCT03364309|593404434|FG006|Maintenance Period|Relapsed|10|||
164282734|NCT03364309|593404435|FG007|Maintenance Period|Relapsed|2|||
164282735|NCT03364309|593404436|FG008|Maintenance Period|Relapsed|0|||
164282736|NCT03364309|593404437|FG009|Maintenance Period|Relapsed|0|||
164282737|NCT03364309|593404438|FG010|Maintenance Period|Relapsed|0|||
164282738|NCT03364309|593404439|FG011|Maintenance Period|Relapsed|0|||
164282739|NCT03364309|593404440|FG012|Maintenance Period|Relapsed|0|||
164282740|NCT03364309|593404441|FG013|Maintenance Period|Relapsed|0|||
164282741|NCT03364309|593404442|FG014|Maintenance Period|Relapsed|0|||
164282742|NCT03364309|593404443|FG015|Maintenance Period|Relapsed|0|||
164282743|NCT03364309|593404444|FG016|Maintenance Period|Relapsed|0|||
164282744|NCT03364309|593404445|FG017|Maintenance Period|Relapsed|0|||
164282745|NCT03364309|593404446|FG018|Maintenance Period|Relapsed|0|||
164282746|NCT03364309|593404428|FG000|Maintenance Period|Lack of Efficacy|0|||
164282747|NCT03364309|593404429|FG001|Maintenance Period|Lack of Efficacy|0|||
164282748|NCT03364309|593404430|FG002|Maintenance Period|Lack of Efficacy|0|||
164282749|NCT03364309|593404431|FG003|Maintenance Period|Lack of Efficacy|0|||
164691382|NCT03496298|594891760|FG001|Overall Study|Other|20|||
164691383|NCT03496298|594891761|FG002|Overall Study|Other|23|||
164691384|NCT03496298|594891759|FG000|Overall Study|Randomized and not treated|1|||
164691385|NCT03496298|594891760|FG001|Overall Study|Randomized and not treated|1|||
164691386|NCT03496298|594891761|FG002|Overall Study|Randomized and not treated|1|||
164691387|NCT02058160|594891764|FG000|Overall Study|Randomized but not treated|2|||
164691388|NCT02058160|594891765|FG001|Overall Study|Randomized but not treated|4|||
164691389|NCT02058160|594891764|FG000|Overall Study|Poor compliance to protocol|4|||
164691390|NCT02058160|594891765|FG001|Overall Study|Poor compliance to protocol|1|||
164691391|NCT02058160|594891764|FG000|Overall Study|Adverse Event|12|||
164691392|NCT02058160|594891765|FG001|Overall Study|Adverse Event|3|||
164691393|NCT02058160|594891764|FG000|Overall Study|Lost to Follow-up|1|||
164691394|NCT02058160|594891765|FG001|Overall Study|Lost to Follow-up|0|||
164691395|NCT02058160|594891764|FG000|Overall Study|Other than specified above|12|||
164691396|NCT02058160|594891765|FG001|Overall Study|Other than specified above|6|||
164691397|NCT02260635|594891766|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
164691398|NCT02260635|594891767|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
164691399|NCT02260635|594891766|FG000|Open-Label Extension|Study Termination|25|||
164691400|NCT02260635|594891767|FG001|Open-Label Extension|Study Termination|25|||
164691401|NCT02260635|594891766|FG000|Open-Label Extension|Withdrawal by Subject|1|||
164691402|NCT02260635|594891767|FG001|Open-Label Extension|Withdrawal by Subject|0|||
164691403|NCT04106817|594891768|FG000|Overall Study|Lost to Follow-up|1|||
164691404|NCT04106817|594891769|FG001|Overall Study|Lost to Follow-up|0|||
164691405|NCT04106817|594891770|FG002|Overall Study|Lost to Follow-up|0|||
164282750|NCT03364309|593404432|FG004|Maintenance Period|Lack of Efficacy|0|||
164282751|NCT03364309|593404433|FG005|Maintenance Period|Lack of Efficacy|0|||
164282752|NCT03364309|593404434|FG006|Maintenance Period|Lack of Efficacy|0|||
164282753|NCT03364309|593404435|FG007|Maintenance Period|Lack of Efficacy|0|||
164282754|NCT03364309|593404436|FG008|Maintenance Period|Lack of Efficacy|1|||
164282755|NCT03364309|593404437|FG009|Maintenance Period|Lack of Efficacy|3|||
164282756|NCT03364309|593404438|FG010|Maintenance Period|Lack of Efficacy|2|||
164282757|NCT03364309|593404439|FG011|Maintenance Period|Lack of Efficacy|0|||
164282758|NCT03364309|593404440|FG012|Maintenance Period|Lack of Efficacy|0|||
164282759|NCT03364309|593404441|FG013|Maintenance Period|Lack of Efficacy|0|||
164282760|NCT03364309|593404442|FG014|Maintenance Period|Lack of Efficacy|0|||
164282761|NCT03364309|593404443|FG015|Maintenance Period|Lack of Efficacy|0|||
164282762|NCT03364309|593404444|FG016|Maintenance Period|Lack of Efficacy|0|||
164282763|NCT03364309|593404445|FG017|Maintenance Period|Lack of Efficacy|0|||
164691406|NCT04660032|594891771|FG000|Overall Study|Protocol Violation|1|||
164691407|NCT04660032|594891772|FG001|Overall Study|Protocol Violation|1|||
164282764|NCT03364309|593404446|FG018|Maintenance Period|Lack of Efficacy|0|||
164282765|NCT03364309|593404428|FG000|Maintenance Period|Death|0|||
164282766|NCT03364309|593404429|FG001|Maintenance Period|Death|0|||
164282767|NCT03364309|593404430|FG002|Maintenance Period|Death|0|||
164282768|NCT03364309|593404431|FG003|Maintenance Period|Death|0|||
164691408|NCT00090753|594891773|FG000|First Treatment Period|Adverse Event|20|||
164691409|NCT00090753|594891774|FG001|First Treatment Period|Adverse Event|8|||
164691410|NCT00090753|594891773|FG000|First Treatment Period|Death|88|||
164691411|NCT00090753|594891774|FG001|First Treatment Period|Death|62|||
164282769|NCT03364309|593404432|FG004|Maintenance Period|Death|0|||
164282770|NCT03364309|593404433|FG005|Maintenance Period|Death|0|||
164282771|NCT03364309|593404434|FG006|Maintenance Period|Death|0|||
164282772|NCT03364309|593404435|FG007|Maintenance Period|Death|0|||
164282773|NCT03364309|593404436|FG008|Maintenance Period|Death|1|||
164282774|NCT03364309|593404437|FG009|Maintenance Period|Death|0|||
164282775|NCT03364309|593404438|FG010|Maintenance Period|Death|0|||
164282776|NCT03364309|593404439|FG011|Maintenance Period|Death|0|||
164282777|NCT03364309|593404440|FG012|Maintenance Period|Death|0|||
164282778|NCT03364309|593404441|FG013|Maintenance Period|Death|0|||
164282779|NCT03364309|593404442|FG014|Maintenance Period|Death|0|||
164282780|NCT03364309|593404443|FG015|Maintenance Period|Death|0|||
164282781|NCT03364309|593404444|FG016|Maintenance Period|Death|0|||
164282782|NCT03364309|593404445|FG017|Maintenance Period|Death|0|||
164282783|NCT03364309|593404446|FG018|Maintenance Period|Death|0|||
164282784|NCT03364309|593404428|FG000|Maintenance Period|Lost to Follow-up|0|||
164344567|NCT03706079|593636984|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
164344568|NCT03706079|593636985|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
164344569|NCT03706079|593636986|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
164344570|NCT03706079|593636981|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
164344571|NCT03706079|593636982|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
164344572|NCT03706079|593636983|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
164344573|NCT03706079|593636984|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
164344574|NCT03706079|593636985|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
164344575|NCT03706079|593636986|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
164344576|NCT03706079|593636981|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
164282785|NCT03364309|593404429|FG001|Maintenance Period|Lost to Follow-up|0|||
164282786|NCT03364309|593404430|FG002|Maintenance Period|Lost to Follow-up|0|||
164282787|NCT03364309|593404431|FG003|Maintenance Period|Lost to Follow-up|0|||
164282788|NCT03364309|593404432|FG004|Maintenance Period|Lost to Follow-up|0|||
164282789|NCT03364309|593404433|FG005|Maintenance Period|Lost to Follow-up|0|||
164282790|NCT03364309|593404434|FG006|Maintenance Period|Lost to Follow-up|0|||
164282791|NCT03364309|593404435|FG007|Maintenance Period|Lost to Follow-up|0|||
164282792|NCT03364309|593404436|FG008|Maintenance Period|Lost to Follow-up|1|||
164282793|NCT03364309|593404437|FG009|Maintenance Period|Lost to Follow-up|0|||
164691412|NCT00090753|594891773|FG000|First Treatment Period|Lack of Efficacy|2|||
164691413|NCT00090753|594891774|FG001|First Treatment Period|Lack of Efficacy|1|||
164691414|NCT00090753|594891773|FG000|First Treatment Period|Refused Treatment|32|||
164691415|NCT00090753|594891774|FG001|First Treatment Period|Refused Treatment|25|||
164691416|NCT00090753|594891773|FG000|First Treatment Period|Lost to Follow-up|4|||
164691417|NCT00090753|594891774|FG001|First Treatment Period|Lost to Follow-up|4|||
164691418|NCT00090753|594891773|FG000|First Treatment Period|Renal Transplant|70|||
164282794|NCT03364309|593404438|FG010|Maintenance Period|Lost to Follow-up|0|||
164282795|NCT03364309|593404439|FG011|Maintenance Period|Lost to Follow-up|0|||
164282796|NCT03364309|593404440|FG012|Maintenance Period|Lost to Follow-up|0|||
164282797|NCT03364309|593404441|FG013|Maintenance Period|Lost to Follow-up|0|||
164282798|NCT03364309|593404442|FG014|Maintenance Period|Lost to Follow-up|0|||
164282799|NCT03364309|593404443|FG015|Maintenance Period|Lost to Follow-up|0|||
164282800|NCT03364309|593404444|FG016|Maintenance Period|Lost to Follow-up|0|||
164282801|NCT03364309|593404445|FG017|Maintenance Period|Lost to Follow-up|0|||
164282802|NCT03364309|593404446|FG018|Maintenance Period|Lost to Follow-up|0|||
164282803|NCT03364309|593404428|FG000|Maintenance Period|Miscellaneous|0|||
164282804|NCT03364309|593404429|FG001|Maintenance Period|Miscellaneous|0|||
164282805|NCT03364309|593404430|FG002|Maintenance Period|Miscellaneous|0|||
164282806|NCT03364309|593404431|FG003|Maintenance Period|Miscellaneous|0|||
164282807|NCT03364309|593404432|FG004|Maintenance Period|Miscellaneous|0|||
164282808|NCT03364309|593404433|FG005|Maintenance Period|Miscellaneous|0|||
164282809|NCT03364309|593404434|FG006|Maintenance Period|Miscellaneous|0|||
164282810|NCT03364309|593404435|FG007|Maintenance Period|Miscellaneous|0|||
164282811|NCT03364309|593404436|FG008|Maintenance Period|Miscellaneous|1|||
164282812|NCT03364309|593404437|FG009|Maintenance Period|Miscellaneous|0|||
164282813|NCT03364309|593404438|FG010|Maintenance Period|Miscellaneous|0|||
164282814|NCT03364309|593404439|FG011|Maintenance Period|Miscellaneous|0|||
164282815|NCT03364309|593404440|FG012|Maintenance Period|Miscellaneous|0|||
164282816|NCT03364309|593404441|FG013|Maintenance Period|Miscellaneous|0|||
164282817|NCT03364309|593404442|FG014|Maintenance Period|Miscellaneous|0|||
164282818|NCT03364309|593404443|FG015|Maintenance Period|Miscellaneous|0|||
164282819|NCT03364309|593404444|FG016|Maintenance Period|Miscellaneous|0|||
164282820|NCT03364309|593404445|FG017|Maintenance Period|Miscellaneous|0|||
164691419|NCT00090753|594891774|FG001|First Treatment Period|Renal Transplant|50|||
164691420|NCT00090753|594891773|FG000|First Treatment Period|Mircera Commercialization|1|||
164691421|NCT00090753|594891774|FG001|First Treatment Period|Mircera Commercialization|0|||
164691422|NCT00090753|594891773|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
164691423|NCT00090753|594891774|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
164691424|NCT00090753|594891773|FG000|Extended Treatment Period|Adverse Event|11|||
164691425|NCT00090753|594891774|FG001|Extended Treatment Period|Adverse Event|0|||
164691426|NCT00090753|594891773|FG000|Extended Treatment Period|Death|58|||
164691427|NCT00090753|594891774|FG001|Extended Treatment Period|Death|30|||
164691428|NCT00090753|594891773|FG000|Extended Treatment Period|Lack of Efficacy|1|||
164691429|NCT00090753|594891774|FG001|Extended Treatment Period|Lack of Efficacy|0|||
164691430|NCT00090753|594891773|FG000|Extended Treatment Period|Refused Treatment|18|||
164691431|NCT00090753|594891774|FG001|Extended Treatment Period|Refused Treatment|12|||
164691432|NCT00090753|594891773|FG000|Extended Treatment Period|Lost to Follow-up|3|||
164691433|NCT00090753|594891774|FG001|Extended Treatment Period|Lost to Follow-up|1|||
164691434|NCT00090753|594891773|FG000|Extended Treatment Period|Renal Transplant|15|||
164691435|NCT00090753|594891774|FG001|Extended Treatment Period|Renal Transplant|12|||
164691436|NCT00090753|594891773|FG000|Extended Treatment Period|Mircera Commercialization|188|||
164282821|NCT03364309|593404446|FG018|Maintenance Period|Miscellaneous|0|||
164282822|NCT03364309|593404428|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282823|NCT03364309|593404429|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282824|NCT03364309|593404430|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282825|NCT03364309|593404431|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164344577|NCT03706079|593636982|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
164344578|NCT03706079|593636983|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
164691437|NCT00090753|594891774|FG001|Extended Treatment Period|Mircera Commercialization|93|||
164691438|NCT00090753|594891773|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
164282826|NCT03364309|593404432|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282827|NCT03364309|593404433|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282828|NCT03364309|593404434|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282829|NCT03364309|593404435|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164691439|NCT00090753|594891774|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
164433217|NCT00957229|593957190|FG001|Study Start|Disease Progression|0|||
164433218|NCT00957229|593957189|FG000|Reallocated to or Continued Vismodegib|Death|1|||
164433219|NCT00957229|593957190|FG001|Reallocated to or Continued Vismodegib|Death|1|||
164586151|NCT02285010|594510125|FG000|Overall Study|Not spinal anesthesia|3|||
164586152|NCT02285010|594510126|FG001|Overall Study|Not spinal anesthesia|1|||
164586153|NCT03245814|594510133|FG000|Overall Study|Lost to Follow-up|5|||
164282830|NCT03364309|593404436|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282831|NCT03364309|593404437|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164586154|NCT03245814|594510134|FG001|Overall Study|Lost to Follow-up|8|||
164586155|NCT03245814|594510133|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
164282832|NCT03364309|593404438|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282833|NCT03364309|593404439|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282834|NCT03364309|593404440|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282835|NCT03364309|593404441|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
164282836|NCT03364309|593404442|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
164282837|NCT03364309|593404443|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
164282838|NCT03364309|593404444|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282839|NCT03364309|593404445|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282840|NCT03364309|593404446|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282841|NCT03364309|593404428|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282842|NCT03364309|593404429|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282843|NCT03364309|593404430|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282844|NCT03364309|593404431|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282845|NCT03364309|593404432|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282846|NCT03364309|593404433|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282847|NCT03364309|593404434|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282848|NCT03364309|593404435|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282849|NCT03364309|593404436|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282850|NCT03364309|593404437|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282851|NCT03364309|593404438|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282852|NCT03364309|593404439|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282853|NCT03364309|593404440|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282854|NCT03364309|593404441|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282855|NCT03364309|593404442|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
164282856|NCT03364309|593404443|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282857|NCT03364309|593404444|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282858|NCT03364309|593404445|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282859|NCT03364309|593404446|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282860|NCT03364309|593404428|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
164282861|NCT03364309|593404429|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
164282862|NCT03364309|593404430|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
164282863|NCT03364309|593404431|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
164282864|NCT03364309|593404432|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
164282865|NCT03364309|593404433|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
164282866|NCT03364309|593404434|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
164282867|NCT03364309|593404435|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
164282868|NCT03364309|593404436|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
164282869|NCT03364309|593404437|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
164586156|NCT03245814|594510134|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
164282870|NCT03364309|593404438|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
164282871|NCT03364309|593404439|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
164282872|NCT03364309|593404440|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
164433220|NCT00957229|593957189|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
164433221|NCT00957229|593957190|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
164433222|NCT00606580|593957191|FG000|Overall Study|Lost to Follow-up|1|||
164586157|NCT01164501|594510135|FG000|Overall Study|Not treated|2|||
164586158|NCT01164501|594510136|FG001|Overall Study|Not treated|0|||
164586159|NCT01164501|594510137|FG002|Overall Study|Not treated|1|||
164586160|NCT01164501|594510135|FG000|Overall Study|Adverse Event|18|||
164586161|NCT01164501|594510136|FG001|Overall Study|Adverse Event|4|||
164586162|NCT01164501|594510137|FG002|Overall Study|Adverse Event|21|||
164586163|NCT01164501|594510135|FG000|Overall Study|Lack of Efficacy|0|||
164586164|NCT01164501|594510136|FG001|Overall Study|Lack of Efficacy|0|||
164586165|NCT01164501|594510137|FG002|Overall Study|Lack of Efficacy|1|||
164586166|NCT01164501|594510135|FG000|Overall Study|Non compliant with protocol|1|||
164586167|NCT01164501|594510136|FG001|Overall Study|Non compliant with protocol|1|||
164586168|NCT01164501|594510137|FG002|Overall Study|Non compliant with protocol|4|||
164586169|NCT01164501|594510135|FG000|Overall Study|Lost to Follow-up|3|||
164586170|NCT01164501|594510136|FG001|Overall Study|Lost to Follow-up|0|||
164586171|NCT01164501|594510137|FG002|Overall Study|Lost to Follow-up|3|||
164586172|NCT01164501|594510135|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
164586173|NCT01164501|594510136|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
164691440|NCT00756717|594891783|FG000|Overall Study|Withdrawal by Subject|2|||
164691441|NCT00250705|594891784|FG000|Overall Study|Lack of Efficacy|2|||
164691442|NCT00587431|594891785|FG000|Overall Study|Adverse Event|1|||
164691443|NCT00587431|594891786|FG001|Overall Study|Adverse Event|0|||
164691444|NCT00587431|594891785|FG000|Overall Study|Withdrawal by Subject|0|||
164691445|NCT00587431|594891786|FG001|Overall Study|Withdrawal by Subject|1|||
164691446|NCT05467982|594891787|FG000|Overall Study|Death|0|||
164282873|NCT03364309|593404441|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
164282874|NCT03364309|593404442|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
164282875|NCT03364309|593404443|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
164282876|NCT03364309|593404444|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
164282877|NCT03364309|593404445|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
164282878|NCT03364309|593404446|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
164282879|NCT03364309|593404428|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282880|NCT03364309|593404429|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282881|NCT03364309|593404430|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282882|NCT03364309|593404431|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282883|NCT03364309|593404432|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282884|NCT03364309|593404433|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164691447|NCT05467982|594891788|FG001|Overall Study|Death|1|||
164691448|NCT05467982|594891787|FG000|Overall Study|Lost to Follow-up|3|||
164691449|NCT05467982|594891788|FG001|Overall Study|Lost to Follow-up|1|||
164691450|NCT03185741|594891789|FG000|Baseline|Withdrawal by Subject|1|||
164691451|NCT03185741|594891790|FG001|Baseline|Withdrawal by Subject|3|||
164691452|NCT03185741|594891791|FG002|Baseline|Withdrawal by Subject|2|||
164691453|NCT03185741|594891789|FG000|Baseline|Lost to Follow-up|1|||
164282885|NCT03364309|593404434|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282886|NCT03364309|593404435|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282887|NCT03364309|593404436|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282888|NCT03364309|593404437|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282889|NCT03364309|593404438|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282890|NCT03364309|593404439|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282891|NCT03364309|593404440|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282892|NCT03364309|593404441|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282893|NCT03364309|593404442|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282894|NCT03364309|593404443|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282895|NCT03364309|593404444|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
164282896|NCT03364309|593404445|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
164282897|NCT03364309|593404446|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
164282898|NCT03364309|593404428|FG000|Post-Treatment Followup Period|Adverse Event|0|||
164282899|NCT03364309|593404429|FG001|Post-Treatment Followup Period|Adverse Event|0|||
164282900|NCT03364309|593404430|FG002|Post-Treatment Followup Period|Adverse Event|0|||
164344579|NCT03706079|593636984|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
164344580|NCT03706079|593636985|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
164344581|NCT03706079|593636986|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
164344582|NCT03706079|593636981|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
164344583|NCT03706079|593636982|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
164344584|NCT03706079|593636983|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
164344585|NCT03706079|593636984|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
164344586|NCT03706079|593636985|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
164344587|NCT03706079|593636986|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
164344588|NCT03706079|593636981|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
164344589|NCT03706079|593636982|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
164344590|NCT03706079|593636983|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
164344591|NCT03706079|593636984|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
164344592|NCT03706079|593636985|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
164433223|NCT00606580|593957192|FG001|Overall Study|Lost to Follow-up|1|||
164691454|NCT03185741|594891790|FG001|Baseline|Lost to Follow-up|2|||
164691455|NCT03185741|594891791|FG002|Baseline|Lost to Follow-up|3|||
164344593|NCT03706079|593636986|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
164344594|NCT03706079|593636981|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
164344595|NCT03706079|593636982|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
164344596|NCT03706079|593636983|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
164344597|NCT03706079|593636984|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
164344598|NCT03706079|593636985|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
164344599|NCT03706079|593636986|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
164344600|NCT03706079|593636981|FG000|Long Term Extension (DESTINATION)|Death|8|||
164344601|NCT03706079|593636982|FG001|Long Term Extension (DESTINATION)|Death|2|||
164344602|NCT03706079|593636983|FG002|Long Term Extension (DESTINATION)|Death|2|||
164344603|NCT03706079|593636984|FG003|Long Term Extension (DESTINATION)|Death|1|||
164344604|NCT03706079|593636985|FG004|Long Term Extension (DESTINATION)|Death|0|||
164344605|NCT03706079|593636986|FG005|Long Term Extension (DESTINATION)|Death|0|||
164344606|NCT00329238|593636987|FG000|Overall Study|Adverse Event|147|||
164344607|NCT00329238|593636988|FG001|Overall Study|Adverse Event|129|||
164344608|NCT00329238|593636987|FG000|Overall Study|Protocol Violation|23|||
164344609|NCT00329238|593636988|FG001|Overall Study|Protocol Violation|34|||
164344610|NCT00329238|593636987|FG000|Overall Study|Lost to Follow-up|2|||
164344611|NCT00329238|593636988|FG001|Overall Study|Lost to Follow-up|6|||
164344612|NCT00329238|593636987|FG000|Overall Study|Withdrawal by Subject|64|||
164691456|NCT03185741|594891789|FG000|3Month|Death|1|||
164691457|NCT03185741|594891790|FG001|3Month|Death|1|||
164691458|NCT03185741|594891791|FG002|3Month|Death|2|||
164691459|NCT03185741|594891789|FG000|3Month|Withdrawal by Subject|1|||
164691460|NCT03185741|594891790|FG001|3Month|Withdrawal by Subject|5|||
164691461|NCT03185741|594891791|FG002|3Month|Withdrawal by Subject|1|||
164691462|NCT03185741|594891789|FG000|3Month|Lost to Follow-up|7|||
164691463|NCT03185741|594891790|FG001|3Month|Lost to Follow-up|9|||
164691464|NCT03185741|594891791|FG002|3Month|Lost to Follow-up|8|||
164691465|NCT03185741|594891789|FG000|3Month|Unavailable for 3Month|11|||
164691466|NCT03185741|594891790|FG001|3Month|Unavailable for 3Month|10|||
164691467|NCT03185741|594891791|FG002|3Month|Unavailable for 3Month|11|||
164691468|NCT03185741|594891789|FG000|3Month|Protocol Violation|0|||
164691469|NCT03185741|594891790|FG001|3Month|Protocol Violation|0|||
164691470|NCT03185741|594891791|FG002|3Month|Protocol Violation|3|||
164691471|NCT03185741|594891789|FG000|6Month|Death|1|||
164691472|NCT03185741|594891790|FG001|6Month|Death|1|||
164691473|NCT03185741|594891791|FG002|6Month|Death|2|||
164691474|NCT03185741|594891789|FG000|6Month|Withdrawal by Subject|2|||
164691475|NCT03185741|594891790|FG001|6Month|Withdrawal by Subject|3|||
164691476|NCT03185741|594891791|FG002|6Month|Withdrawal by Subject|1|||
164691477|NCT03185741|594891789|FG000|6Month|Lost to Follow-up|16|||
164691478|NCT03185741|594891790|FG001|6Month|Lost to Follow-up|15|||
164691479|NCT03185741|594891791|FG002|6Month|Lost to Follow-up|16|||
164691480|NCT03573336|594891794|FG000|Overall Study|Study terminated|2|||
164691481|NCT03573336|594891795|FG001|Overall Study|Study terminated|4|||
164691482|NCT03573336|594891796|FG002|Overall Study|Study terminated|2|||
164691483|NCT03108820|594891797|FG000|Overall Study|Lost to Follow-up|30|||
164691484|NCT03108820|594891798|FG001|Overall Study|Lost to Follow-up|28|||
164691485|NCT03108820|594891797|FG000|Overall Study|Withdrawal by Subject|32|||
164691486|NCT03108820|594891798|FG001|Overall Study|Withdrawal by Subject|24|||
164691487|NCT03108820|594891797|FG000|Overall Study|Death|6|||
164691488|NCT03108820|594891798|FG001|Overall Study|Death|11|||
164691489|NCT01488448|594891804|FG000|Overall Study|Withdrawal by Subject|3|||
164691490|NCT01488448|594891805|FG001|Overall Study|Withdrawal by Subject|1|||
164691491|NCT01488448|594891804|FG000|Overall Study|Adverse Event|9|||
164691492|NCT01488448|594891805|FG001|Overall Study|Adverse Event|4|||
164143313|NCT05246670|592886587|FG001|Overall Study|Protocol Violation|0|||
164691493|NCT01488448|594891804|FG000|Overall Study|Physician Decision|4|||
164691494|NCT01488448|594891805|FG001|Overall Study|Physician Decision|9|||
164691495|NCT01488448|594891804|FG000|Overall Study|Protocol Violation|4|||
164691496|NCT01488448|594891805|FG001|Overall Study|Protocol Violation|3|||
164691497|NCT00654641|594891806|FG000|Overall Study|Lost to Follow-up|2|||
164691498|NCT00654641|594891807|FG001|Overall Study|Lost to Follow-up|3|||
164691499|NCT01992094|594891808|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
164344613|NCT00329238|593636988|FG001|Overall Study|Withdrawal by Subject|58|||
164344614|NCT00329238|593636987|FG000|Overall Study|Other reason (not specified)|40|||
164344615|NCT00329238|593636988|FG001|Overall Study|Other reason (not specified)|54|||
164344616|NCT01306942|593636999|FG000|Phase I|Adverse Event|2|||
164344617|NCT01306942|593637000|FG001|Phase I|Adverse Event|2|||
164691500|NCT01992094|594891809|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
164691501|NCT01992094|594891810|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
164691502|NCT01992094|594891808|FG000|Overall Study|Adverse Event|1|||
164691503|NCT01992094|594891809|FG001|Overall Study|Adverse Event|0|||
164691504|NCT01992094|594891810|FG002|Overall Study|Adverse Event|0|||
164691505|NCT01992094|594891808|FG000|Overall Study|Death|5|||
164691506|NCT01992094|594891809|FG001|Overall Study|Death|5|||
164691507|NCT01992094|594891810|FG002|Overall Study|Death|2|||
164691508|NCT01992094|594891808|FG000|Overall Study|Lost to Follow-up|26|||
164691509|NCT01992094|594891809|FG001|Overall Study|Lost to Follow-up|9|||
164691510|NCT01992094|594891810|FG002|Overall Study|Lost to Follow-up|13|||
164691511|NCT01992094|594891808|FG000|Overall Study|OTHER|4|||
164691512|NCT01992094|594891809|FG001|Overall Study|OTHER|0|||
164691513|NCT01992094|594891810|FG002|Overall Study|OTHER|0|||
164691514|NCT01992094|594891808|FG000|Overall Study|Protocol Violation|1|||
164691515|NCT01992094|594891809|FG001|Overall Study|Protocol Violation|0|||
164691516|NCT01992094|594891810|FG002|Overall Study|Protocol Violation|1|||
164691517|NCT01992094|594891808|FG000|Overall Study|Withdrawal by Subject|7|||
164691518|NCT01992094|594891809|FG001|Overall Study|Withdrawal by Subject|3|||
164691519|NCT01992094|594891810|FG002|Overall Study|Withdrawal by Subject|4|||
164691520|NCT01475487|594891811|FG000|Overall Study|had to leave early for personal reasons|2|||
164691521|NCT01475487|594891812|FG001|Overall Study|had to leave early for personal reasons|1|||
164691522|NCT03180528|594893204|FG000|Overall Study|Adverse Event|1|||
164691523|NCT03180528|594893204|FG000|Overall Study|Withdrawal by Subject|1|||
164691524|NCT03180528|594893204|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
164433224|NCT00606580|593957193|FG002|Overall Study|Lost to Follow-up|4|||
164433225|NCT00606580|593957191|FG000|Overall Study|Clinical failures|1|||
164433226|NCT00606580|593957192|FG001|Overall Study|Clinical failures|0|||
164433227|NCT00606580|593957193|FG002|Overall Study|Clinical failures|12|||
164433228|NCT00606580|593957191|FG000|Overall Study|Withdrawal by investigator|0|||
164433229|NCT00606580|593957192|FG001|Overall Study|Withdrawal by investigator|1|||
164433230|NCT00606580|593957193|FG002|Overall Study|Withdrawal by investigator|6|||
164433231|NCT00606580|593957191|FG000|Overall Study|Withdrawal by Subject|0|||
164433232|NCT00606580|593957192|FG001|Overall Study|Withdrawal by Subject|1|||
164433233|NCT00606580|593957193|FG002|Overall Study|Withdrawal by Subject|0|||
164433234|NCT04580303|593957194|FG000|Overall Study|Adverse Event|0|||
164433235|NCT04580303|593957195|FG001|Overall Study|Adverse Event|1|||
164433236|NCT04580303|593957196|FG002|Overall Study|Adverse Event|0|||
164433237|NCT04580303|593957197|FG003|Overall Study|Adverse Event|0|||
164433238|NCT04580303|593957194|FG000|Overall Study|Withdrawal by Subject|0|||
164433239|NCT04580303|593957195|FG001|Overall Study|Withdrawal by Subject|0|||
164433240|NCT04580303|593957196|FG002|Overall Study|Withdrawal by Subject|1|||
164691525|NCT02447887|594893205|FG000|Overall Study|Study was terminated|3|||
164691526|NCT03429049|594893206|FG000|Overall Study|Adverse Event|2|||
164691527|NCT03429049|594893207|FG001|Overall Study|Adverse Event|3|||
164691528|NCT03429049|594893206|FG000|Overall Study|Death|0|||
164691529|NCT03429049|594893207|FG001|Overall Study|Death|1|||
164691530|NCT03429049|594893206|FG000|Overall Study|Lack of Efficacy|4|||
164691531|NCT03429049|594893207|FG001|Overall Study|Lack of Efficacy|2|||
164691532|NCT03429049|594893206|FG000|Overall Study|Lost to Follow-up|9|||
164691533|NCT03429049|594893207|FG001|Overall Study|Lost to Follow-up|8|||
164691534|NCT03429049|594893206|FG000|Overall Study|Physician Decision|1|||
164691535|NCT03429049|594893207|FG001|Overall Study|Physician Decision|0|||
164691536|NCT03429049|594893206|FG000|Overall Study|Protocol Violation|3|||
164691537|NCT03429049|594893207|FG001|Overall Study|Protocol Violation|0|||
164691538|NCT03429049|594893206|FG000|Overall Study|Sponsor Decision|2|||
164691539|NCT03429049|594893207|FG001|Overall Study|Sponsor Decision|0|||
164691540|NCT03429049|594893206|FG000|Overall Study|Withdrawal by Subject|4|||
164691541|NCT03429049|594893207|FG001|Overall Study|Withdrawal by Subject|20|||
164691542|NCT03429049|594893206|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
164691543|NCT03429049|594893207|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
164691544|NCT04703855|594893208|FG000|Overall Study|Heart Transplant|1|||
164691545|NCT02012452|594893211|FG000|Overall Study|Lost to Follow-up|2|||
164691546|NCT02012452|594893212|FG001|Overall Study|Lost to Follow-up|1|||
164691547|NCT02012452|594893211|FG000|Overall Study|Withdrawal by Subject|4|||
164691548|NCT02012452|594893212|FG001|Overall Study|Withdrawal by Subject|0|||
164691549|NCT04403399|594893213|FG000|Period 2|Physician Decision|0|||
164691550|NCT04403399|594893214|FG001|Period 2|Physician Decision|1|||
164282901|NCT03364309|593404431|FG003|Post-Treatment Followup Period|Adverse Event|0|||
164282902|NCT03364309|593404432|FG004|Post-Treatment Followup Period|Adverse Event|0|||
164282903|NCT03364309|593404433|FG005|Post-Treatment Followup Period|Adverse Event|0|||
164282904|NCT03364309|593404434|FG006|Post-Treatment Followup Period|Adverse Event|0|||
164282905|NCT03364309|593404435|FG007|Post-Treatment Followup Period|Adverse Event|0|||
164691551|NCT00399893|594893215|FG000|Overall Study|Withdrawal by Subject|1|||
164691552|NCT00399893|594893216|FG001|Overall Study|Withdrawal by Subject|0|||
164691553|NCT04412057|594893217|FG000|Overall Study|Death|3|||
164691554|NCT04412057|594893218|FG001|Overall Study|Death|7|||
164691555|NCT04412057|594893217|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
164282906|NCT03364309|593404436|FG008|Post-Treatment Followup Period|Adverse Event|0|||
164282907|NCT03364309|593404437|FG009|Post-Treatment Followup Period|Adverse Event|0|||
164433241|NCT04580303|593957197|FG003|Overall Study|Withdrawal by Subject|0|||
164433242|NCT01833065|593957198|FG000|Overall Study|Adverse Event|6|||
164433243|NCT01833065|593957199|FG001|Overall Study|Adverse Event|1|||
164433244|NCT01833065|593957200|FG002|Overall Study|Adverse Event|0|||
164433245|NCT01833065|593957201|FG003|Overall Study|Adverse Event|2|||
164433246|NCT01833065|593957202|FG004|Overall Study|Adverse Event|3|||
164433247|NCT01833065|593957198|FG000|Overall Study|Protocol Violation|1|||
164691556|NCT04412057|594893218|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
164691557|NCT00831233|594893221|FG000|Overall Study|Adverse Event|0|||
164691558|NCT00831233|594893222|FG001|Overall Study|Adverse Event|1|||
164691559|NCT00831233|594893221|FG000|Overall Study|Protocol Violation|1|||
164691560|NCT00831233|594893222|FG001|Overall Study|Protocol Violation|0|||
164691561|NCT00831233|594893221|FG000|Overall Study|Selection Criteria Not Met|2|||
164691562|NCT00831233|594893222|FG001|Overall Study|Selection Criteria Not Met|0|||
164691563|NCT02457819|594893223|FG000|Overall Study|reason not given|8|||
164691564|NCT02457819|594893223|FG000|Overall Study|Withdrawal by Subject|24|||
164691565|NCT02457819|594893223|FG000|Overall Study|Protocol Violation|1|||
164691566|NCT02457819|594893223|FG000|Overall Study|non compliance with study drug|4|||
164691567|NCT02457819|594893223|FG000|Overall Study|Lost to Follow-up|10|||
164691568|NCT02457819|594893223|FG000|Overall Study|Lack of Efficacy|19|||
164691569|NCT02457819|594893223|FG000|Overall Study|Adverse Event|33|||
164282908|NCT03364309|593404438|FG010|Post-Treatment Followup Period|Adverse Event|0|||
164282909|NCT03364309|593404439|FG011|Post-Treatment Followup Period|Adverse Event|0|||
164282910|NCT03364309|593404440|FG012|Post-Treatment Followup Period|Adverse Event|0|||
164282911|NCT03364309|593404441|FG013|Post-Treatment Followup Period|Adverse Event|0|||
164282912|NCT03364309|593404442|FG014|Post-Treatment Followup Period|Adverse Event|0|||
164282913|NCT03364309|593404443|FG015|Post-Treatment Followup Period|Adverse Event|0|||
164282914|NCT03364309|593404444|FG016|Post-Treatment Followup Period|Adverse Event|2|||
164282915|NCT03364309|593404445|FG017|Post-Treatment Followup Period|Adverse Event|6|||
164282916|NCT03364309|593404446|FG018|Post-Treatment Followup Period|Adverse Event|1|||
164282917|NCT03364309|593404428|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282918|NCT03364309|593404429|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282919|NCT03364309|593404430|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282920|NCT03364309|593404431|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
164433248|NCT01833065|593957199|FG001|Overall Study|Protocol Violation|0|||
164586174|NCT01164501|594510137|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
164691570|NCT01064531|594893225|FG000|Overall Study|Lost to Follow-up|0|||
164691571|NCT01064531|594893226|FG001|Overall Study|Lost to Follow-up|2|||
164691572|NCT01064531|594893225|FG000|Overall Study|Physician Decision|0|||
164691573|NCT01064531|594893226|FG001|Overall Study|Physician Decision|1|||
164691574|NCT01064531|594893225|FG000|Overall Study|Withdrawal by Subject|2|||
164691575|NCT01064531|594893226|FG001|Overall Study|Withdrawal by Subject|2|||
164691576|NCT01064531|594893225|FG000|Overall Study|Revision due to femoral stem loosening|1|||
164691577|NCT01064531|594893226|FG001|Overall Study|Revision due to femoral stem loosening|0|||
164691578|NCT01064531|594893225|FG000|Overall Study|Revision due to dislocation|0|||
164691579|NCT01064531|594893226|FG001|Overall Study|Revision due to dislocation|1|||
164691580|NCT01064531|594893225|FG000|Overall Study|Death|0|||
164691581|NCT01064531|594893226|FG001|Overall Study|Death|1|||
164691582|NCT00573170|594893231|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
164691583|NCT00573170|594893232|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
164691584|NCT00573170|594893233|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
164691585|NCT00573170|594893234|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
164691586|NCT00573170|594893235|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
164691587|NCT00573170|594893236|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
164691588|NCT00573170|594893231|FG000|First Washout Period|Adverse Event|1|||
164691589|NCT00573170|594893232|FG001|First Washout Period|Adverse Event|1|||
164691590|NCT00573170|594893233|FG002|First Washout Period|Adverse Event|0|||
164691591|NCT00573170|594893234|FG003|First Washout Period|Adverse Event|0|||
164691592|NCT00573170|594893235|FG004|First Washout Period|Adverse Event|0|||
164691593|NCT00573170|594893236|FG005|First Washout Period|Adverse Event|1|||
164691594|NCT00573170|594893231|FG000|First Washout Period|Lack of Efficacy|0|||
164691595|NCT00573170|594893232|FG001|First Washout Period|Lack of Efficacy|0|||
164691596|NCT00573170|594893233|FG002|First Washout Period|Lack of Efficacy|0|||
164586175|NCT01164501|594510135|FG000|Overall Study|Other reason not defined above|9|||
164586176|NCT01164501|594510136|FG001|Overall Study|Other reason not defined above|1|||
164586177|NCT01164501|594510137|FG002|Overall Study|Other reason not defined above|4|||
164586178|NCT01096667|594510142|FG000|Overall Study|Lost to Follow-up|1|||
164586179|NCT01096667|594510143|FG001|Overall Study|Lost to Follow-up|1|||
164586180|NCT01096667|594510144|FG002|Overall Study|Lost to Follow-up|1|||
164586181|NCT01096667|594510145|FG003|Overall Study|Lost to Follow-up|0|||
164586182|NCT01096667|594510146|FG004|Overall Study|Lost to Follow-up|0|||
164586183|NCT01096667|594510142|FG000|Overall Study|Withdrawal by Subject|1|||
164586184|NCT01096667|594510143|FG001|Overall Study|Withdrawal by Subject|0|||
164586185|NCT01096667|594510144|FG002|Overall Study|Withdrawal by Subject|0|||
164586186|NCT01096667|594510145|FG003|Overall Study|Withdrawal by Subject|1|||
164586187|NCT01096667|594510146|FG004|Overall Study|Withdrawal by Subject|0|||
164586188|NCT01096667|594510142|FG000|Overall Study|Reason not available|0|||
164586189|NCT01096667|594510143|FG001|Overall Study|Reason not available|1|||
164586190|NCT01096667|594510144|FG002|Overall Study|Reason not available|1|||
164586191|NCT01096667|594510145|FG003|Overall Study|Reason not available|1|||
164586192|NCT01096667|594510146|FG004|Overall Study|Reason not available|0|||
164586193|NCT01096667|594510142|FG000|Overall Study|Protocol Violation|0|||
164586194|NCT01096667|594510143|FG001|Overall Study|Protocol Violation|0|||
164282921|NCT03364309|593404432|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282922|NCT03364309|593404433|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282923|NCT03364309|593404434|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282924|NCT03364309|593404435|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282925|NCT03364309|593404436|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282926|NCT03364309|593404437|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282927|NCT03364309|593404438|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282928|NCT03364309|593404439|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282929|NCT03364309|593404440|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282930|NCT03364309|593404441|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282931|NCT03364309|593404442|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282932|NCT03364309|593404443|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282933|NCT03364309|593404444|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282934|NCT03364309|593404445|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
164282935|NCT03364309|593404446|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282936|NCT03364309|593404428|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
164344618|NCT01306942|593637001|FG002|Phase I|Adverse Event|0|||
164344619|NCT01306942|593637002|FG003|Phase I|Adverse Event|0|||
164344620|NCT01306942|593636999|FG000|Phase I|Physician Decision|3|||
164344621|NCT01306942|593637000|FG001|Phase I|Physician Decision|1|||
164344622|NCT01306942|593637001|FG002|Phase I|Physician Decision|0|||
164344623|NCT01306942|593637002|FG003|Phase I|Physician Decision|0|||
164344624|NCT01306942|593636999|FG000|Phase II|Adverse Event|0|||
164344625|NCT01306942|593637000|FG001|Phase II|Adverse Event|0|||
164344626|NCT01306942|593637001|FG002|Phase II|Adverse Event|0|||
164344627|NCT01306942|593637002|FG003|Phase II|Adverse Event|6|||
164344628|NCT01306942|593636999|FG000|Phase II|Physician Decision|2|||
164344629|NCT01306942|593637000|FG001|Phase II|Physician Decision|0|||
164344630|NCT01306942|593637001|FG002|Phase II|Physician Decision|0|||
164344631|NCT01306942|593637002|FG003|Phase II|Physician Decision|5|||
164344632|NCT01306942|593636999|FG000|Phase II|Withdrawal by Subject|0|||
164344633|NCT01306942|593637000|FG001|Phase II|Withdrawal by Subject|0|||
164344634|NCT01306942|593637001|FG002|Phase II|Withdrawal by Subject|0|||
164344635|NCT01306942|593637002|FG003|Phase II|Withdrawal by Subject|2|||
164586195|NCT01096667|594510144|FG002|Overall Study|Protocol Violation|0|||
164586196|NCT01096667|594510145|FG003|Overall Study|Protocol Violation|1|||
164586197|NCT01096667|594510146|FG004|Overall Study|Protocol Violation|0|||
164586198|NCT01096667|594510142|FG000|Overall Study|Not treated|1|||
164586199|NCT01096667|594510143|FG001|Overall Study|Not treated|0|||
164586200|NCT01096667|594510144|FG002|Overall Study|Not treated|0|||
164586201|NCT01096667|594510145|FG003|Overall Study|Not treated|0|||
164586202|NCT01096667|594510146|FG004|Overall Study|Not treated|0|||
164586203|NCT00206518|594510147|FG000|Overall Study|Lack of Efficacy|6|||
164586204|NCT00206518|594510148|FG001|Overall Study|Lack of Efficacy|4|||
164586205|NCT00206518|594510147|FG000|Overall Study|Adverse Event|2|||
164586206|NCT00206518|594510148|FG001|Overall Study|Adverse Event|1|||
164586207|NCT00206518|594510147|FG000|Overall Study|Physician Decision|1|||
164586208|NCT00206518|594510148|FG001|Overall Study|Physician Decision|0|||
164586209|NCT00206518|594510147|FG000|Overall Study|Protocol Violation|1|||
164586210|NCT00206518|594510148|FG001|Overall Study|Protocol Violation|1|||
164586211|NCT02335450|594510149|FG000|Overall Study|Pregnancy|1|||
164586212|NCT01845077|594510150|FG000|Washout Period|Lost to Follow-up|0|||
164586213|NCT01845077|594510151|FG001|Washout Period|Lost to Follow-up|1|||
164586214|NCT01845077|594510152|FG002|Washout Period|Lost to Follow-up|0|||
164586215|NCT01845077|594510153|FG003|Washout Period|Lost to Follow-up|1|||
164586216|NCT01845077|594510154|FG004|Washout Period|Lost to Follow-up|0|||
164586217|NCT01845077|594510155|FG005|Washout Period|Lost to Follow-up|1|||
164586218|NCT01845077|594510150|FG000|Washout Period|Adverse Event|1|||
164586219|NCT01845077|594510151|FG001|Washout Period|Adverse Event|0|||
164586220|NCT01845077|594510152|FG002|Washout Period|Adverse Event|0|||
164586221|NCT01845077|594510153|FG003|Washout Period|Adverse Event|0|||
164586222|NCT01845077|594510154|FG004|Washout Period|Adverse Event|0|||
164586223|NCT01845077|594510155|FG005|Washout Period|Adverse Event|0|||
164586224|NCT01845077|594510150|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
164586225|NCT01845077|594510151|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
164586226|NCT01845077|594510152|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
164586227|NCT01845077|594510153|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
164586228|NCT01845077|594510154|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
164586229|NCT01845077|594510155|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
164586230|NCT01845077|594510150|FG000|Washout Period|Protocol Violation|0|||
164586231|NCT01845077|594510151|FG001|Washout Period|Protocol Violation|0|||
164586232|NCT01845077|594510152|FG002|Washout Period|Protocol Violation|0|||
164344636|NCT01306942|593636999|FG000|Phase II|Death|0|||
164586233|NCT01845077|594510153|FG003|Washout Period|Protocol Violation|1|||
164344637|NCT01306942|593637000|FG001|Phase II|Death|0|||
164344638|NCT01306942|593637001|FG002|Phase II|Death|0|||
164586234|NCT01845077|594510154|FG004|Washout Period|Protocol Violation|1|||
164282937|NCT03364309|593404429|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
164282938|NCT03364309|593404430|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
164282939|NCT03364309|593404431|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
164282940|NCT03364309|593404432|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
164282941|NCT03364309|593404433|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
164282942|NCT03364309|593404434|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
164282943|NCT03364309|593404435|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
164282944|NCT03364309|593404436|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
164586235|NCT01845077|594510155|FG005|Washout Period|Protocol Violation|0|||
164586236|NCT01879618|594510156|FG000|Overall Study|Does not meet entrance criteria|1|||
164586237|NCT01879618|594510156|FG000|Overall Study|Withdrawal by Subject|1|||
164586238|NCT01879618|594510156|FG000|Overall Study|Surgery;changed schedule; not available|8|||
164586239|NCT01879618|594510156|FG000|Overall Study|Protocol Violation|6|||
164586240|NCT01879618|594510156|FG000|Overall Study|Adverse Event|5|||
164586241|NCT00394914|594510157|FG000|Treatment Period|Adverse Event|0|||
164586242|NCT00394914|594510158|FG001|Treatment Period|Adverse Event|3|||
164586243|NCT00394914|594510159|FG002|Treatment Period|Adverse Event|1|||
164586244|NCT00394914|594510157|FG000|Treatment Period|Lost to Follow-up|0|||
164586245|NCT00394914|594510158|FG001|Treatment Period|Lost to Follow-up|1|||
164586246|NCT00394914|594510159|FG002|Treatment Period|Lost to Follow-up|0|||
164586247|NCT00394914|594510157|FG000|Treatment Period|Withdrawal by Subject|0|||
164586248|NCT00394914|594510158|FG001|Treatment Period|Withdrawal by Subject|2|||
164586249|NCT00394914|594510159|FG002|Treatment Period|Withdrawal by Subject|2|||
164586250|NCT00394914|594510157|FG000|Treatment Period|Noncompliance with protocol|0|||
164586251|NCT00394914|594510158|FG001|Treatment Period|Noncompliance with protocol|3|||
164586252|NCT00394914|594510159|FG002|Treatment Period|Noncompliance with protocol|2|||
164586253|NCT00394914|594510157|FG000|Treatment Period|Did not meet protocol eligibility|0|||
164586254|NCT00394914|594510158|FG001|Treatment Period|Did not meet protocol eligibility|1|||
164586255|NCT00394914|594510159|FG002|Treatment Period|Did not meet protocol eligibility|1|||
164586256|NCT00408681|594510164|FG000|Overall Study|Lack of Efficacy|2|||
164586257|NCT00408681|594510164|FG000|Overall Study|Adverse Event|7|||
164586258|NCT00465738|594510165|FG000|Overall Study|Lost to Follow-up|2|||
164586259|NCT00465738|594510166|FG001|Overall Study|Lost to Follow-up|0|||
164586260|NCT00465738|594510165|FG000|Overall Study|Adverse Event|0|||
164586261|NCT00465738|594510166|FG001|Overall Study|Adverse Event|1|||
164586262|NCT00465738|594510165|FG000|Overall Study|Withdrawal by Subject|2|||
164586263|NCT00465738|594510166|FG001|Overall Study|Withdrawal by Subject|0|||
164586264|NCT00465738|594510165|FG000|Overall Study|Other|2|||
164586265|NCT00465738|594510166|FG001|Overall Study|Other|5|||
164586266|NCT02489630|594510167|FG000|Overall Study|Oversedation|1|||
164586267|NCT02489630|594510168|FG001|Overall Study|Oversedation|1|||
164586268|NCT02489630|594510167|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
164586269|NCT02489630|594510168|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
164586270|NCT00734929|594510171|FG000|Overall Study|Lost to Follow-up|1|||
164586271|NCT00734929|594510172|FG001|Overall Study|Lost to Follow-up|2|||
164586272|NCT00734929|594510171|FG000|Overall Study|No intervention/ screen fail|5|||
164586273|NCT00734929|594510172|FG001|Overall Study|No intervention/ screen fail|3|||
164586274|NCT02961764|594510173|FG000|Overall Study|Protocol Violation|0|||
164586275|NCT02961764|594510174|FG001|Overall Study|Protocol Violation|1|||
164586276|NCT02961764|594510173|FG000|Overall Study|Death|2|||
164586277|NCT02961764|594510174|FG001|Overall Study|Death|0|||
164586278|NCT02961764|594510173|FG000|Overall Study|Lost to Follow-up|35|||
164586279|NCT02961764|594510174|FG001|Overall Study|Lost to Follow-up|24|||
164586280|NCT02961764|594510173|FG000|Overall Study|Withdrawal by Subject|2|||
164586281|NCT02961764|594510174|FG001|Overall Study|Withdrawal by Subject|0|||
164586282|NCT02369510|594510175|FG000|Overall Study|Spilled Medication|1|||
164586283|NCT02369510|594510176|FG001|Overall Study|Spilled Medication|2|||
164586284|NCT02369510|594510177|FG002|Overall Study|Spilled Medication|1|||
164586285|NCT02369510|594510175|FG000|Overall Study|Epidural Activation|1|||
164586286|NCT02369510|594510176|FG001|Overall Study|Epidural Activation|1|||
164586287|NCT02369510|594510177|FG002|Overall Study|Epidural Activation|5|||
164586288|NCT03067311|594510179|FG000|Overall Study|Lost to Follow-up|1|||
164586289|NCT03067311|594510180|FG001|Overall Study|Lost to Follow-up|1|||
164586290|NCT03067311|594510179|FG000|Overall Study|Moved away|1|||
164586291|NCT03067311|594510180|FG001|Overall Study|Moved away|1|||
164586292|NCT02160977|594510181|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
164586293|NCT02160977|594510182|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
164586294|NCT02160977|594510181|FG000|Three Months After Surgery|Lost to Follow-up|0|||
164586295|NCT02160977|594510182|FG001|Three Months After Surgery|Lost to Follow-up|2|||
164586296|NCT02160977|594510181|FG000|Six Months After Surgery|Lost to Follow-up|2|||
164586297|NCT02160977|594510182|FG001|Six Months After Surgery|Lost to Follow-up|1|||
164586298|NCT00907738|594510192|FG000|Overall Study|Adverse Event|2|||
164586299|NCT00907738|594510193|FG001|Overall Study|Adverse Event|0|||
164586300|NCT00907738|594510194|FG002|Overall Study|Adverse Event|1|||
164586301|NCT00907738|594510195|FG003|Overall Study|Adverse Event|0|||
164586302|NCT00907738|594510196|FG004|Overall Study|Adverse Event|0|||
164282945|NCT03364309|593404437|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
164282946|NCT03364309|593404438|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
164282947|NCT03364309|593404439|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
164282948|NCT03364309|593404440|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
164282949|NCT03364309|593404441|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
164282950|NCT03364309|593404442|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
164282951|NCT03364309|593404443|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
164282952|NCT03364309|593404444|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
164282953|NCT03364309|593404445|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
164282954|NCT03364309|593404446|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
164282955|NCT00167310|593404447|FG000|Overall Study|Protocol Violation|5|||
164282956|NCT00167310|593404448|FG001|Overall Study|Protocol Violation|3|||
164282957|NCT00167310|593404447|FG000|Overall Study|Withdrawal by Subject|3|||
164282958|NCT00167310|593404448|FG001|Overall Study|Withdrawal by Subject|7|||
164282959|NCT00615992|593404449|FG000|Overall Study|Protocol Violation|67|||
164282960|NCT04522141|593404451|FG000|Overall Study|Withdrawal by Subject|1|||
164282961|NCT04522141|593404452|FG001|Overall Study|Withdrawal by Subject|0|||
164282962|NCT03052049|593404453|FG000|Overall Study|Withdrawal by Subject|2|||
164282963|NCT03508609|593404454|FG000|Overall Study|Withdrawal by Subject|1|||
164282964|NCT02328027|593404455|FG000|Overall Study|Withdrawal by Subject|0|||
164282965|NCT02328027|593404456|FG001|Overall Study|Withdrawal by Subject|1|||
164282966|NCT03304873|593404457|FG000|Overall Study|Lost to Follow-up|1|||
164282967|NCT03304873|593404458|FG001|Overall Study|Lost to Follow-up|8|||
164282968|NCT03319212|593404459|FG000|Overall Study|Discontinued as moving out of local area|0|||
164282969|NCT03319212|593404460|FG001|Overall Study|Discontinued as moving out of local area|1|||
164282970|NCT03319212|593404459|FG000|Overall Study|Adverse Event|2|||
164282971|NCT03319212|593404460|FG001|Overall Study|Adverse Event|2|||
164282972|NCT03319212|593404459|FG000|Overall Study|Withdrawal by Subject|0|||
164282973|NCT03319212|593404460|FG001|Overall Study|Withdrawal by Subject|1|||
164344639|NCT01306942|593637002|FG003|Phase II|Death|1|||
164344640|NCT01306942|593636999|FG000|Phase II|Not finished treatment|0|||
164344641|NCT01306942|593637000|FG001|Phase II|Not finished treatment|0|||
164691597|NCT00573170|594893234|FG003|First Washout Period|Lack of Efficacy|0|||
164691598|NCT00573170|594893235|FG004|First Washout Period|Lack of Efficacy|0|||
164691599|NCT00573170|594893236|FG005|First Washout Period|Lack of Efficacy|1|||
164691600|NCT00573170|594893231|FG000|First Washout Period|Lost to Follow-up|1|||
164691601|NCT00573170|594893232|FG001|First Washout Period|Lost to Follow-up|1|||
164691602|NCT00573170|594893233|FG002|First Washout Period|Lost to Follow-up|0|||
164691603|NCT00573170|594893234|FG003|First Washout Period|Lost to Follow-up|2|||
164691604|NCT00573170|594893235|FG004|First Washout Period|Lost to Follow-up|0|||
164691605|NCT00573170|594893236|FG005|First Washout Period|Lost to Follow-up|2|||
164691606|NCT00573170|594893231|FG000|First Washout Period|Withdrawal by Subject|2|||
164691607|NCT00573170|594893232|FG001|First Washout Period|Withdrawal by Subject|0|||
164691608|NCT00573170|594893233|FG002|First Washout Period|Withdrawal by Subject|0|||
164691609|NCT00573170|594893234|FG003|First Washout Period|Withdrawal by Subject|2|||
164691610|NCT00573170|594893235|FG004|First Washout Period|Withdrawal by Subject|3|||
164691611|NCT00573170|594893236|FG005|First Washout Period|Withdrawal by Subject|3|||
164691612|NCT00573170|594893231|FG000|First Washout Period|Other|4|||
164691613|NCT00573170|594893232|FG001|First Washout Period|Other|0|||
164691614|NCT00573170|594893233|FG002|First Washout Period|Other|1|||
164691615|NCT00573170|594893234|FG003|First Washout Period|Other|1|||
164691616|NCT00573170|594893235|FG004|First Washout Period|Other|0|||
164691617|NCT00573170|594893236|FG005|First Washout Period|Other|0|||
164691618|NCT00573170|594893231|FG000|Second Washout Period|Adverse Event|1|||
164691619|NCT00573170|594893232|FG001|Second Washout Period|Adverse Event|0|||
164691620|NCT00573170|594893233|FG002|Second Washout Period|Adverse Event|0|||
164691621|NCT00573170|594893234|FG003|Second Washout Period|Adverse Event|0|||
164691622|NCT00573170|594893235|FG004|Second Washout Period|Adverse Event|1|||
164691623|NCT00573170|594893236|FG005|Second Washout Period|Adverse Event|0|||
164691624|NCT00573170|594893231|FG000|Second Washout Period|Protocol Violation|2|||
164691625|NCT00573170|594893232|FG001|Second Washout Period|Protocol Violation|1|||
164691626|NCT00573170|594893233|FG002|Second Washout Period|Protocol Violation|1|||
164691627|NCT00573170|594893234|FG003|Second Washout Period|Protocol Violation|0|||
164691628|NCT00573170|594893235|FG004|Second Washout Period|Protocol Violation|0|||
164691629|NCT00573170|594893236|FG005|Second Washout Period|Protocol Violation|0|||
164691630|NCT00573170|594893231|FG000|Second Washout Period|Withdrawal by Subject|1|||
164691631|NCT00573170|594893232|FG001|Second Washout Period|Withdrawal by Subject|1|||
164691632|NCT00573170|594893233|FG002|Second Washout Period|Withdrawal by Subject|2|||
164691633|NCT00573170|594893234|FG003|Second Washout Period|Withdrawal by Subject|0|||
164691634|NCT00573170|594893235|FG004|Second Washout Period|Withdrawal by Subject|1|||
164691635|NCT00573170|594893236|FG005|Second Washout Period|Withdrawal by Subject|0|||
164691636|NCT00573170|594893231|FG000|Second Washout Period|Lost to Follow-up|0|||
164691637|NCT00573170|594893232|FG001|Second Washout Period|Lost to Follow-up|0|||
164691638|NCT00573170|594893233|FG002|Second Washout Period|Lost to Follow-up|0|||
164282974|NCT03319212|593404459|FG000|Overall Study|Lost to Follow-up|0|||
164282975|NCT03319212|593404460|FG001|Overall Study|Lost to Follow-up|1|||
164282976|NCT03319212|593404459|FG000|Overall Study|Physician Decision|1|||
164282977|NCT03319212|593404460|FG001|Overall Study|Physician Decision|0|||
164282978|NCT00400569|593404461|FG000|Overall Study|Death|1|||
164282979|NCT01868477|593404463|FG000|Overall Study|Adverse Event|2|||
164282980|NCT01868477|593404464|FG001|Overall Study|Adverse Event|4|||
164282981|NCT01868477|593404463|FG000|Overall Study|Disease progression|1|||
164282982|NCT01868477|593404464|FG001|Overall Study|Disease progression|1|||
164282983|NCT01868477|593404463|FG000|Overall Study|Withdrawal by Subject|1|||
164282984|NCT01868477|593404464|FG001|Overall Study|Withdrawal by Subject|0|||
164282985|NCT02465203|593404466|FG000|Overall Study|Protocol Violation|1|||
164282986|NCT02465203|593404467|FG001|Overall Study|Protocol Violation|1|||
164282987|NCT02465203|593404468|FG002|Overall Study|Protocol Violation|1|||
164282988|NCT02465203|593404466|FG000|Overall Study|Study terminated by sponsor|50|||
164282989|NCT02465203|593404467|FG001|Overall Study|Study terminated by sponsor|34|||
164282990|NCT02465203|593404468|FG002|Overall Study|Study terminated by sponsor|11|||
164282991|NCT02465203|593404466|FG000|Overall Study|New therapy for study indication|4|||
164282992|NCT02465203|593404467|FG001|Overall Study|New therapy for study indication|0|||
164282993|NCT02465203|593404468|FG002|Overall Study|New therapy for study indication|0|||
164282994|NCT02465203|593404466|FG000|Overall Study|Patient/guardian decision|1|||
164282995|NCT02465203|593404467|FG001|Overall Study|Patient/guardian decision|1|||
164282996|NCT02465203|593404468|FG002|Overall Study|Patient/guardian decision|1|||
164282997|NCT00620113|593404469|FG000|Overall Study|Adverse Event|3|||
164282998|NCT00620113|593404470|FG001|Overall Study|Adverse Event|2|||
164282999|NCT00620113|593404471|FG002|Overall Study|Adverse Event|2|||
164283000|NCT00620113|593404472|FG003|Overall Study|Adverse Event|1|||
164283001|NCT00620113|593404469|FG000|Overall Study|Lack of Efficacy|2|||
164283002|NCT00620113|593404470|FG001|Overall Study|Lack of Efficacy|3|||
164283003|NCT00620113|593404471|FG002|Overall Study|Lack of Efficacy|0|||
164283004|NCT00620113|593404472|FG003|Overall Study|Lack of Efficacy|2|||
164283005|NCT00620113|593404469|FG000|Overall Study|Physician Decision|1|||
164691639|NCT00573170|594893234|FG003|Second Washout Period|Lost to Follow-up|1|||
164691640|NCT00573170|594893235|FG004|Second Washout Period|Lost to Follow-up|0|||
164691641|NCT00573170|594893236|FG005|Second Washout Period|Lost to Follow-up|0|||
164691642|NCT00573170|594893231|FG000|Second Washout Period|Other|1|||
164691643|NCT00573170|594893232|FG001|Second Washout Period|Other|2|||
164691644|NCT00573170|594893233|FG002|Second Washout Period|Other|1|||
164691645|NCT00573170|594893234|FG003|Second Washout Period|Other|4|||
164691646|NCT00573170|594893235|FG004|Second Washout Period|Other|6|||
164691647|NCT00573170|594893236|FG005|Second Washout Period|Other|2|||
164691648|NCT00573170|594893231|FG000|Third Treatment Period|Withdrawal by Subject|1|||
164691649|NCT00573170|594893232|FG001|Third Treatment Period|Withdrawal by Subject|0|||
164691650|NCT00573170|594893233|FG002|Third Treatment Period|Withdrawal by Subject|0|||
164691651|NCT00573170|594893234|FG003|Third Treatment Period|Withdrawal by Subject|0|||
164691652|NCT00573170|594893235|FG004|Third Treatment Period|Withdrawal by Subject|0|||
164691653|NCT00573170|594893236|FG005|Third Treatment Period|Withdrawal by Subject|0|||
164691654|NCT00573170|594893231|FG000|Third Treatment Period|Lost to Follow-up|0|||
164691655|NCT00573170|594893232|FG001|Third Treatment Period|Lost to Follow-up|0|||
164691656|NCT00573170|594893233|FG002|Third Treatment Period|Lost to Follow-up|0|||
164691657|NCT00573170|594893234|FG003|Third Treatment Period|Lost to Follow-up|0|||
164691658|NCT00573170|594893235|FG004|Third Treatment Period|Lost to Follow-up|0|||
164691659|NCT00573170|594893236|FG005|Third Treatment Period|Lost to Follow-up|2|||
164283006|NCT00620113|593404470|FG001|Overall Study|Physician Decision|0|||
164691660|NCT00779402|594893239|FG000|Treatment Phase 1|Disease Progression|1|||
164691661|NCT00779402|594893240|FG001|Treatment Phase 1|Disease Progression|0|||
164691662|NCT00779402|594893239|FG000|Treatment Phase 1|Adverse Event|2|||
164691663|NCT00779402|594893240|FG001|Treatment Phase 1|Adverse Event|0|||
164691664|NCT00779402|594893239|FG000|Treatment Phase 1|Protocol Violation|1|||
164283007|NCT00620113|593404471|FG002|Overall Study|Physician Decision|0|||
164283008|NCT00620113|593404472|FG003|Overall Study|Physician Decision|2|||
164691665|NCT00779402|594893240|FG001|Treatment Phase 1|Protocol Violation|0|||
164283009|NCT00620113|593404469|FG000|Overall Study|Protocol Violation|2|||
164283010|NCT00620113|593404470|FG001|Overall Study|Protocol Violation|1|||
164283011|NCT00620113|593404471|FG002|Overall Study|Protocol Violation|0|||
164283012|NCT00620113|593404472|FG003|Overall Study|Protocol Violation|0|||
164283013|NCT00620113|593404469|FG000|Overall Study|Withdrawal by Subject|5|||
164283014|NCT00620113|593404470|FG001|Overall Study|Withdrawal by Subject|1|||
164691666|NCT00779402|594893239|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
164283015|NCT00620113|593404471|FG002|Overall Study|Withdrawal by Subject|3|||
164691667|NCT00779402|594893240|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
164691668|NCT00779402|594893239|FG000|Treatment Phase 1|Lost to Follow-up|0|||
164691669|NCT00779402|594893240|FG001|Treatment Phase 1|Lost to Follow-up|1|||
164283016|NCT00620113|593404472|FG003|Overall Study|Withdrawal by Subject|5|||
164283017|NCT00042991|593404475|FG000|Overall Study|Adverse Event|1|||
164283018|NCT00042991|593404476|FG001|Overall Study|Adverse Event|4|||
164691670|NCT00779402|594893239|FG000|Treatment Phase 1|Death|0|||
164283019|NCT00042991|593404477|FG002|Overall Study|Adverse Event|2|||
164283020|NCT00042991|593404478|FG003|Overall Study|Adverse Event|0|||
164283021|NCT00042991|593404479|FG004|Overall Study|Adverse Event|0|||
164283022|NCT00042991|593404480|FG005|Overall Study|Adverse Event|1|||
164283023|NCT00042991|593404481|FG006|Overall Study|Adverse Event|0|||
164283024|NCT00042991|593404475|FG000|Overall Study|Withdrawal by Subject|0|||
164283025|NCT00042991|593404476|FG001|Overall Study|Withdrawal by Subject|7|||
164283026|NCT00042991|593404477|FG002|Overall Study|Withdrawal by Subject|2|||
164283027|NCT00042991|593404478|FG003|Overall Study|Withdrawal by Subject|0|||
164283028|NCT00042991|593404479|FG004|Overall Study|Withdrawal by Subject|1|||
164283029|NCT00042991|593404480|FG005|Overall Study|Withdrawal by Subject|0|||
164283030|NCT00042991|593404481|FG006|Overall Study|Withdrawal by Subject|0|||
164283031|NCT00042991|593404475|FG000|Overall Study|Disease Progression|5|||
164283032|NCT00042991|593404476|FG001|Overall Study|Disease Progression|29|||
164283033|NCT00042991|593404477|FG002|Overall Study|Disease Progression|2|||
164283034|NCT00042991|593404478|FG003|Overall Study|Disease Progression|2|||
164283035|NCT00042991|593404479|FG004|Overall Study|Disease Progression|1|||
164283036|NCT00042991|593404480|FG005|Overall Study|Disease Progression|4|||
164283037|NCT00042991|593404481|FG006|Overall Study|Disease Progression|2|||
164283038|NCT00042991|593404475|FG000|Overall Study|Alternative Therapy|0|||
164691671|NCT00779402|594893240|FG001|Treatment Phase 1|Death|1|||
164691672|NCT00779402|594893239|FG000|Treatment Phase 1|Intercurrent Illness|1|||
164691673|NCT00779402|594893240|FG001|Treatment Phase 1|Intercurrent Illness|1|||
164691674|NCT00779402|594893239|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
164691675|NCT00779402|594893240|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
164691676|NCT00779402|594893239|FG000|Treatment Phase 1|Other|4|||
164691677|NCT00779402|594893240|FG001|Treatment Phase 1|Other|2|||
164691678|NCT00779402|594893239|FG000|Treatment Phase 1|Closure of Study|3|||
164691679|NCT00779402|594893240|FG001|Treatment Phase 1|Closure of Study|2|||
164283039|NCT00042991|593404476|FG001|Overall Study|Alternative Therapy|0|||
164691680|NCT00779402|594893239|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
164691681|NCT00779402|594893240|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
164691682|NCT00779402|594893239|FG000|Surveillance Phase|Protocol Violation|0|||
164691683|NCT00779402|594893240|FG001|Surveillance Phase|Protocol Violation|1|||
164691684|NCT00779402|594893239|FG000|Surveillance Phase|Patient refused to continue|22|||
164691685|NCT00779402|594893240|FG001|Surveillance Phase|Patient refused to continue|14|||
164691686|NCT00779402|594893239|FG000|Surveillance Phase|Lost to Follow-up|2|||
164691687|NCT00779402|594893240|FG001|Surveillance Phase|Lost to Follow-up|1|||
164691688|NCT00779402|594893239|FG000|Surveillance Phase|Death|0|||
164691689|NCT00779402|594893240|FG001|Surveillance Phase|Death|1|||
164691690|NCT00779402|594893239|FG000|Surveillance Phase|Intercurrent Illness|2|||
164691691|NCT00779402|594893240|FG001|Surveillance Phase|Intercurrent Illness|0|||
164691692|NCT00779402|594893239|FG000|Surveillance Phase|Other|5|||
164691693|NCT00779402|594893240|FG001|Surveillance Phase|Other|5|||
164691694|NCT00779402|594893239|FG000|Surveillance Phase|Withdrawal by Subject|4|||
164691695|NCT00779402|594893240|FG001|Surveillance Phase|Withdrawal by Subject|1|||
164691696|NCT00779402|594893239|FG000|Surveillance Phase|Closure of study|5|||
164691697|NCT00779402|594893240|FG001|Surveillance Phase|Closure of study|6|||
164691698|NCT00779402|594893239|FG000|Surveillance Phase|Completed Protocol Visits|3|||
164691699|NCT00779402|594893240|FG001|Surveillance Phase|Completed Protocol Visits|2|||
164691700|NCT00779402|594893239|FG000|Long-term Follow-up|Patient refused to continue|2|||
164691701|NCT00779402|594893240|FG001|Long-term Follow-up|Patient refused to continue|0|||
164283040|NCT00042991|593404477|FG002|Overall Study|Alternative Therapy|0|||
164283041|NCT00042991|593404478|FG003|Overall Study|Alternative Therapy|0|||
164283042|NCT00042991|593404479|FG004|Overall Study|Alternative Therapy|1|||
164283043|NCT00042991|593404480|FG005|Overall Study|Alternative Therapy|0|||
164283044|NCT00042991|593404481|FG006|Overall Study|Alternative Therapy|0|||
164344642|NCT01306942|593637001|FG002|Phase II|Not finished treatment|0|||
164344643|NCT01306942|593637002|FG003|Phase II|Not finished treatment|1|||
164344644|NCT01306942|593636999|FG000|Phase II|Protocol Violation|0|||
164344645|NCT01306942|593637000|FG001|Phase II|Protocol Violation|0|||
164344646|NCT01306942|593637001|FG002|Phase II|Protocol Violation|0|||
164344647|NCT01306942|593637002|FG003|Phase II|Protocol Violation|1|||
164344648|NCT03988088|593637003|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
164344649|NCT03988088|593637004|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
164691702|NCT00779402|594893239|FG000|Long-term Follow-up|Other|5|||
164691703|NCT00779402|594893240|FG001|Long-term Follow-up|Other|0|||
164691704|NCT00779402|594893239|FG000|Long-term Follow-up|Closure of Study|8|||
164691705|NCT00779402|594893240|FG001|Long-term Follow-up|Closure of Study|4|||
164344650|NCT03988088|593637005|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
164691706|NCT00779402|594893239|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
164283045|NCT04072887|593404486|FG000|Overall Study|Withdrawal by Subject|3|||
164283046|NCT04072887|593404487|FG001|Overall Study|Withdrawal by Subject|8|||
164283047|NCT04072887|593404488|FG002|Overall Study|Withdrawal by Subject|1|||
164283048|NCT04072887|593404489|FG003|Overall Study|Withdrawal by Subject|3|||
164283049|NCT04072887|593404490|FG004|Overall Study|Withdrawal by Subject|3|||
164283050|NCT04072887|593404491|FG005|Overall Study|Withdrawal by Subject|13|||
164283051|NCT04072887|593404486|FG000|Overall Study|Adverse Event|2|||
164283052|NCT04072887|593404487|FG001|Overall Study|Adverse Event|4|||
164283053|NCT04072887|593404488|FG002|Overall Study|Adverse Event|1|||
164283054|NCT04072887|593404489|FG003|Overall Study|Adverse Event|4|||
164283055|NCT04072887|593404490|FG004|Overall Study|Adverse Event|0|||
164283056|NCT04072887|593404491|FG005|Overall Study|Adverse Event|1|||
164283057|NCT04072887|593404486|FG000|Overall Study|Physician Decision|2|||
164283058|NCT04072887|593404487|FG001|Overall Study|Physician Decision|0|||
164283059|NCT04072887|593404488|FG002|Overall Study|Physician Decision|0|||
164283060|NCT04072887|593404489|FG003|Overall Study|Physician Decision|0|||
164283061|NCT04072887|593404490|FG004|Overall Study|Physician Decision|0|||
164283062|NCT04072887|593404491|FG005|Overall Study|Physician Decision|1|||
164283063|NCT04072887|593404486|FG000|Overall Study|Lost to Follow-up|1|||
164283064|NCT04072887|593404487|FG001|Overall Study|Lost to Follow-up|3|||
164283065|NCT04072887|593404488|FG002|Overall Study|Lost to Follow-up|0|||
164283066|NCT04072887|593404489|FG003|Overall Study|Lost to Follow-up|0|||
164283067|NCT04072887|593404490|FG004|Overall Study|Lost to Follow-up|0|||
164283068|NCT04072887|593404491|FG005|Overall Study|Lost to Follow-up|0|||
164283069|NCT04072887|593404486|FG000|Overall Study|Death|0|||
164283070|NCT04072887|593404487|FG001|Overall Study|Death|2|||
164283071|NCT04072887|593404488|FG002|Overall Study|Death|0|||
164586303|NCT00907738|594510192|FG000|Overall Study|not specified or withdrew consent|3|||
164586304|NCT00907738|594510193|FG001|Overall Study|not specified or withdrew consent|0|||
164586305|NCT00907738|594510194|FG002|Overall Study|not specified or withdrew consent|0|||
164586306|NCT00907738|594510195|FG003|Overall Study|not specified or withdrew consent|0|||
164586307|NCT00907738|594510196|FG004|Overall Study|not specified or withdrew consent|0|||
164586308|NCT00907738|594510192|FG000|Overall Study|Disease progression|8|||
164586309|NCT00907738|594510193|FG001|Overall Study|Disease progression|1|||
164586310|NCT00907738|594510194|FG002|Overall Study|Disease progression|6|||
164586311|NCT00907738|594510195|FG003|Overall Study|Disease progression|4|||
164586312|NCT00907738|594510196|FG004|Overall Study|Disease progression|2|||
164586313|NCT05363293|594510197|FG000|Overall Study|Withdrawal by Subject|1|||
164586314|NCT05363293|594510198|FG001|Overall Study|Withdrawal by Subject|0|||
164586315|NCT05363293|594510199|FG002|Overall Study|Withdrawal by Subject|0|||
164586316|NCT05363293|594510200|FG003|Overall Study|Withdrawal by Subject|0|||
164586317|NCT05363293|594510201|FG004|Overall Study|Withdrawal by Subject|0|||
164586318|NCT05363293|594510202|FG005|Overall Study|Withdrawal by Subject|0|||
164586319|NCT05363293|594510203|FG006|Overall Study|Withdrawal by Subject|0|||
164586320|NCT05363293|594510204|FG007|Overall Study|Withdrawal by Subject|0|||
164586321|NCT05363293|594510205|FG008|Overall Study|Withdrawal by Subject|0|||
164586322|NCT05363293|594510206|FG009|Overall Study|Withdrawal by Subject|0|||
164586323|NCT04773041|594510207|FG000|Overall Study|Unable to data match|1|||
164586324|NCT04773041|594510208|FG001|Overall Study|Unable to data match|0|||
164586325|NCT04773041|594510209|FG002|Overall Study|Unable to data match|0|||
164586326|NCT00128206|594511796|FG000|Overall Study|Lost to Follow-up|137|||
164586327|NCT00128206|594511797|FG001|Overall Study|Lost to Follow-up|118|||
164586328|NCT00128206|594511796|FG000|Overall Study|Adverse Event|0|||
164586329|NCT00128206|594511797|FG001|Overall Study|Adverse Event|2|||
164586330|NCT03032068|594511800|FG000|Overall Study|Adverse Event|1|||
164586331|NCT01597622|594511801|FG000|Overall Study|Adverse Event|7|||
164586332|NCT01597622|594511801|FG000|Overall Study|Lack of Efficacy|3|||
164586333|NCT01597622|594511801|FG000|Overall Study|Protocol Violation|1|||
164586334|NCT01597622|594511801|FG000|Overall Study|Lost to Follow-up|1|||
164586335|NCT01597622|594511801|FG000|Overall Study|Investigator Discretion|5|||
164586336|NCT01597622|594511801|FG000|Overall Study|Withdrawal by Subject|20|||
164586337|NCT01597622|594511801|FG000|Overall Study|Death|1|||
164586338|NCT00408421|594511802|FG000|Treatment Initial Randomization|Adverse Event|5|||
164586339|NCT00408421|594511803|FG001|Treatment Initial Randomization|Adverse Event|9|||
164586340|NCT00408421|594511804|FG002|Treatment Initial Randomization|Adverse Event|0|||
164586341|NCT00408421|594511802|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
164586342|NCT00408421|594511803|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
164586343|NCT00408421|594511804|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
164586344|NCT00408421|594511802|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
164586345|NCT00408421|594511803|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
164586346|NCT00408421|594511804|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
164586347|NCT00408421|594511802|FG000|Treatment Initial Randomization|Physician Decision|1|||
164586348|NCT00408421|594511803|FG001|Treatment Initial Randomization|Physician Decision|0|||
164586349|NCT00408421|594511804|FG002|Treatment Initial Randomization|Physician Decision|0|||
164586350|NCT00408421|594511802|FG000|Treatment Initial Randomization|Protocol Violation|0|||
164586351|NCT00408421|594511803|FG001|Treatment Initial Randomization|Protocol Violation|1|||
164283072|NCT04072887|593404489|FG003|Overall Study|Death|2|||
164283073|NCT04072887|593404490|FG004|Overall Study|Death|3|||
164283074|NCT04072887|593404491|FG005|Overall Study|Death|0|||
164283075|NCT00856297|593404492|FG000|Overall Study|Unable to classify|2|||
164283076|NCT00856297|593404493|FG001|Overall Study|Unable to classify|0|||
164283077|NCT00856297|593404494|FG002|Overall Study|Unable to classify|0|||
164283078|NCT00856297|593404495|FG003|Overall Study|Unable to classify|0|||
164283079|NCT00856297|593404496|FG004|Overall Study|Unable to classify|0|||
164283080|NCT03369236|593404501|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
164283081|NCT03369236|593404502|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
164691707|NCT00779402|594893240|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
164691708|NCT01519947|594893241|FG000|Overall Study|Death|0|||
164691709|NCT01519947|594893242|FG001|Overall Study|Death|0|||
164691710|NCT01519947|594893243|FG002|Overall Study|Death|0|||
164691711|NCT01519947|594893244|FG003|Overall Study|Death|1|||
164691712|NCT01519947|594893241|FG000|Overall Study|Protocol Violation|0|||
164691713|NCT01519947|594893242|FG001|Overall Study|Protocol Violation|0|||
164691714|NCT01519947|594893243|FG002|Overall Study|Protocol Violation|2|||
164691715|NCT01519947|594893244|FG003|Overall Study|Protocol Violation|1|||
164691716|NCT01519947|594893241|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
164691717|NCT01519947|594893242|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
164691718|NCT01519947|594893243|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
164691719|NCT01519947|594893244|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
164691720|NCT01519947|594893241|FG000|Overall Study|Development of Anemia|0|||
164691721|NCT01519947|594893242|FG001|Overall Study|Development of Anemia|1|||
164691722|NCT01519947|594893243|FG002|Overall Study|Development of Anemia|0|||
164691723|NCT01519947|594893244|FG003|Overall Study|Development of Anemia|1|||
164691724|NCT01519947|594893241|FG000|Overall Study|Blood Transfusion|0|||
164691725|NCT01519947|594893242|FG001|Overall Study|Blood Transfusion|1|||
164691726|NCT01519947|594893243|FG002|Overall Study|Blood Transfusion|1|||
164691727|NCT01519947|594893244|FG003|Overall Study|Blood Transfusion|0|||
164691728|NCT01519947|594893241|FG000|Overall Study|Withdrawal by Subject|0|||
164691729|NCT01519947|594893242|FG001|Overall Study|Withdrawal by Subject|1|||
164691730|NCT01519947|594893243|FG002|Overall Study|Withdrawal by Subject|0|||
164691731|NCT01519947|594893244|FG003|Overall Study|Withdrawal by Subject|1|||
164691732|NCT01519947|594893241|FG000|Overall Study|Lost to Follow-up|0|||
164691733|NCT01519947|594893242|FG001|Overall Study|Lost to Follow-up|0|||
164691734|NCT01519947|594893243|FG002|Overall Study|Lost to Follow-up|3|||
164691735|NCT01519947|594893244|FG003|Overall Study|Lost to Follow-up|2|||
164691736|NCT01519947|594893241|FG000|Overall Study|Poor Response|1|||
164691737|NCT01519947|594893242|FG001|Overall Study|Poor Response|0|||
164691738|NCT01519947|594893243|FG002|Overall Study|Poor Response|0|||
164691739|NCT01519947|594893244|FG003|Overall Study|Poor Response|1|||
164691740|NCT01519947|594893241|FG000|Overall Study|Adverse Event|1|||
164691741|NCT01519947|594893242|FG001|Overall Study|Adverse Event|0|||
164283082|NCT03369236|593404501|FG000|Open-label Extension Period|Lack of Efficacy|2|||
164283083|NCT03369236|593404502|FG001|Open-label Extension Period|Lack of Efficacy|1|||
164283084|NCT03369236|593404501|FG000|Open-label Extension Period|Adverse Event|0|||
164283085|NCT03369236|593404502|FG001|Open-label Extension Period|Adverse Event|1|||
164283086|NCT03369236|593404501|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
164283087|NCT03369236|593404502|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
164283088|NCT00423449|593404503|FG000|Overall Study|Clinical Adverse Event|1|||
164283089|NCT00423449|593404504|FG001|Overall Study|Clinical Adverse Event|0|||
164283090|NCT00423449|593404505|FG002|Overall Study|Clinical Adverse Event|1|||
164283091|NCT00423449|593404506|FG003|Overall Study|Clinical Adverse Event|8|||
164283092|NCT00423449|593404507|FG004|Overall Study|Clinical Adverse Event|2|||
164283093|NCT00423449|593404503|FG000|Overall Study|Death|1|||
164283094|NCT00423449|593404504|FG001|Overall Study|Death|0|||
164283095|NCT00423449|593404505|FG002|Overall Study|Death|2|||
164283096|NCT00423449|593404506|FG003|Overall Study|Death|1|||
164283097|NCT00423449|593404507|FG004|Overall Study|Death|1|||
164283098|NCT00423449|593404503|FG000|Overall Study|Progressive Disease|1|||
164283099|NCT00423449|593404504|FG001|Overall Study|Progressive Disease|3|||
164283100|NCT00423449|593404505|FG002|Overall Study|Progressive Disease|8|||
164283101|NCT00423449|593404506|FG003|Overall Study|Progressive Disease|11|||
164691742|NCT01519947|594893243|FG002|Overall Study|Adverse Event|1|||
164691743|NCT01519947|594893244|FG003|Overall Study|Adverse Event|1|||
164691744|NCT00693225|594893245|FG000|Overall Study|Lost to Follow-up|1|||
164691745|NCT00693225|594893246|FG001|Overall Study|Lost to Follow-up|2|||
164691746|NCT00693225|594893245|FG000|Overall Study|Adverse Event|1|||
164691747|NCT00693225|594893246|FG001|Overall Study|Adverse Event|3|||
164283102|NCT00423449|593404507|FG004|Overall Study|Progressive Disease|4|||
164283103|NCT00423449|593404503|FG000|Overall Study|Laboratory Adverse Event|0|||
164283104|NCT00423449|593404504|FG001|Overall Study|Laboratory Adverse Event|1|||
164283105|NCT00423449|593404505|FG002|Overall Study|Laboratory Adverse Event|2|||
164691748|NCT01186016|594893249|FG000|Overall Study|Withdrawal by Subject|46|||
164283106|NCT00423449|593404506|FG003|Overall Study|Laboratory Adverse Event|0|||
164283107|NCT00423449|593404507|FG004|Overall Study|Laboratory Adverse Event|0|||
164283108|NCT00423449|593404503|FG000|Overall Study|Other|0|||
164283109|NCT00423449|593404504|FG001|Overall Study|Other|0|||
164283110|NCT00423449|593404505|FG002|Overall Study|Other|0|||
164283111|NCT00423449|593404506|FG003|Overall Study|Other|1|||
164283112|NCT00423449|593404507|FG004|Overall Study|Other|0|||
164283113|NCT00423449|593404503|FG000|Overall Study|Protocol Violation|0|||
164283114|NCT00423449|593404504|FG001|Overall Study|Protocol Violation|0|||
164283115|NCT00423449|593404505|FG002|Overall Study|Protocol Violation|2|||
164283116|NCT00423449|593404506|FG003|Overall Study|Protocol Violation|1|||
164283117|NCT00423449|593404507|FG004|Overall Study|Protocol Violation|0|||
164283118|NCT01153724|593404513|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164283119|NCT01153724|593404513|FG000|Treatment Period 2|Adverse Event|1|||
164283120|NCT01153724|593404513|FG000|Treatment Period 2|Other reason not defined above|1|||
164283121|NCT02508428|593404514|FG000|Overall Study|Death|32|||
164283122|NCT02508428|593404515|FG001|Overall Study|Death|33|||
164283123|NCT02508428|593404514|FG000|Overall Study|Liner revised|3|||
164283124|NCT02508428|593404515|FG001|Overall Study|Liner revised|19|||
164283125|NCT02508428|593404514|FG000|Overall Study|Incomplete follow-up|17|||
164283126|NCT02508428|593404515|FG001|Overall Study|Incomplete follow-up|15|||
164283127|NCT04371666|593404520|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
164283128|NCT04371666|593404521|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
164283129|NCT04371666|593404520|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
164283130|NCT04371666|593404521|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
164283131|NCT04371666|593404520|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
164283132|NCT04371666|593404521|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
164283133|NCT04371666|593404520|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
164283134|NCT04371666|593404521|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
164283135|NCT04371666|593404520|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
164283136|NCT04371666|593404521|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
164283137|NCT04371666|593404520|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
164283138|NCT04371666|593404521|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
164283139|NCT00445770|593404522|FG000|Overall Study|Adverse Event|9|||
164283140|NCT00445770|593404523|FG001|Overall Study|Adverse Event|15|||
164283141|NCT00445770|593404524|FG002|Overall Study|Adverse Event|19|||
164283142|NCT00445770|593404522|FG000|Overall Study|Lack of Efficacy|38|||
164283143|NCT00445770|593404523|FG001|Overall Study|Lack of Efficacy|13|||
164283144|NCT00445770|593404524|FG002|Overall Study|Lack of Efficacy|6|||
164283145|NCT00445770|593404522|FG000|Overall Study|Lost to Follow-up|0|||
164283146|NCT00445770|593404523|FG001|Overall Study|Lost to Follow-up|2|||
164283147|NCT00445770|593404524|FG002|Overall Study|Lost to Follow-up|0|||
164283148|NCT00445770|593404522|FG000|Overall Study|Other|6|||
164283149|NCT00445770|593404523|FG001|Overall Study|Other|5|||
164283150|NCT00445770|593404524|FG002|Overall Study|Other|6|||
164283151|NCT00947115|593404525|FG000|Overall Study|Missed reporting interval|3|||
164283152|NCT00947115|593404526|FG001|Overall Study|Missed reporting interval|4|||
164283153|NCT00947115|593404527|FG002|Overall Study|Missed reporting interval|2|||
164283154|NCT00947115|593404525|FG000|Overall Study|Physician Decision|0|||
164283155|NCT00947115|593404526|FG001|Overall Study|Physician Decision|2|||
164283156|NCT00947115|593404527|FG002|Overall Study|Physician Decision|0|||
164283157|NCT00947115|593404525|FG000|Overall Study|Death|0|||
164283158|NCT00947115|593404526|FG001|Overall Study|Death|1|||
164283159|NCT00947115|593404527|FG002|Overall Study|Death|1|||
164283160|NCT00947115|593404525|FG000|Overall Study|Migrated from study area|2|||
164283161|NCT00947115|593404526|FG001|Overall Study|Migrated from study area|0|||
164283162|NCT00947115|593404527|FG002|Overall Study|Migrated from study area|0|||
164586352|NCT00408421|594511804|FG002|Treatment Initial Randomization|Protocol Violation|0|||
164586353|NCT00408421|594511802|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
164283163|NCT00947115|593404525|FG000|Overall Study|Withdrawal by Subject|1|||
164283164|NCT00947115|593404526|FG001|Overall Study|Withdrawal by Subject|3|||
164283165|NCT00947115|593404527|FG002|Overall Study|Withdrawal by Subject|4|||
164283166|NCT00947115|593404525|FG000|Overall Study|Lost to Follow-up|11|||
164283167|NCT00947115|593404526|FG001|Overall Study|Lost to Follow-up|12|||
164586354|NCT00408421|594511803|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
164586355|NCT00408421|594511804|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
164283168|NCT00947115|593404527|FG002|Overall Study|Lost to Follow-up|8|||
164283169|NCT02092025|593404528|FG000|Overall Study|Case Report Forms Uncollected|44|||
164283170|NCT02092025|593404528|FG000|Overall Study|Protocol Deviation|24|||
164283171|NCT02927938|593404529|FG000|Overall Study|Death|0|||
164283172|NCT02927938|593404530|FG001|Overall Study|Death|1|||
164283173|NCT02927938|593404531|FG002|Overall Study|Death|0|||
164283174|NCT02927938|593404532|FG003|Overall Study|Death|4|||
164283175|NCT02927938|593404529|FG000|Overall Study|Early Study Termination|1|||
164433249|NCT01833065|593957200|FG002|Overall Study|Protocol Violation|0|||
164283176|NCT02927938|593404530|FG001|Overall Study|Early Study Termination|5|||
164283177|NCT02927938|593404531|FG002|Overall Study|Early Study Termination|4|||
164283178|NCT02927938|593404532|FG003|Overall Study|Early Study Termination|3|||
164283179|NCT00934128|593404535|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
164283180|NCT00934128|593404536|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
164283181|NCT00934128|593404535|FG000|First Intervention (2 Hours)|Adverse Event|4|||
164283182|NCT00934128|593404536|FG001|First Intervention (2 Hours)|Adverse Event|1|||
164283183|NCT00934128|593404535|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
164283184|NCT00934128|593404536|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
164283185|NCT00934128|593404535|FG000|Washout Period (1 Hour)|Patient preference|1|||
164283186|NCT00934128|593404536|FG001|Washout Period (1 Hour)|Patient preference|3|||
164283187|NCT00934128|593404535|FG000|Washout Period (1 Hour)|Pain|1|||
164283188|NCT00934128|593404536|FG001|Washout Period (1 Hour)|Pain|0|||
164283189|NCT00934128|593404535|FG000|Washout Period (1 Hour)|Too tired|1|||
164283190|NCT00934128|593404536|FG001|Washout Period (1 Hour)|Too tired|0|||
164283191|NCT00934128|593404535|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
164283192|NCT00934128|593404536|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
164283193|NCT00934128|593404535|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
164283194|NCT00934128|593404536|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
164283195|NCT03228212|593404537|FG000|Period 1|Adverse Event|1|||
164283196|NCT03228212|593404538|FG001|Period 1|Adverse Event|0|||
164283197|NCT03228212|593404537|FG000|Period 1|no longer meets eligibility criteria|0|||
164283198|NCT03228212|593404538|FG001|Period 1|no longer meets eligibility criteria|1|||
164283199|NCT03228212|593404537|FG000|Period 2|Lost to Follow-up|1|||
164283200|NCT03228212|593404538|FG001|Period 2|Lost to Follow-up|0|||
164283201|NCT02834247|593404539|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
164283202|NCT02834247|593404540|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
164283203|NCT02834247|593404541|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
164283204|NCT02834247|593404542|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
164283205|NCT02834247|593404539|FG000|Dose Escalation Phase|Death|5|||
164283206|NCT02834247|593404540|FG001|Dose Escalation Phase|Death|6|||
164283207|NCT02834247|593404541|FG002|Dose Escalation Phase|Death|5|||
164283208|NCT02834247|593404542|FG003|Dose Escalation Phase|Death|0|||
164283209|NCT02834247|593404539|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
164283210|NCT02834247|593404540|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
164283211|NCT02834247|593404541|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
164283212|NCT02834247|593404542|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
164283213|NCT02834247|593404539|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
164283214|NCT02834247|593404540|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
164283215|NCT02834247|593404541|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
164283216|NCT02834247|593404542|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
164283217|NCT02834247|593404539|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
164283218|NCT02834247|593404540|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
164283219|NCT02834247|593404541|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
164283220|NCT02834247|593404542|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
164283221|NCT02834247|593404539|FG000|Dose Expansion Phase|Death|0|||
164283222|NCT02834247|593404540|FG001|Dose Expansion Phase|Death|0|||
164283223|NCT02834247|593404541|FG002|Dose Expansion Phase|Death|0|||
164283224|NCT02834247|593404542|FG003|Dose Expansion Phase|Death|8|||
164283225|NCT02834247|593404539|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
164283226|NCT02834247|593404540|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
164283227|NCT02834247|593404541|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
164283228|NCT02834247|593404542|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
164283229|NCT02834247|593404539|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
164283230|NCT02834247|593404540|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
164283231|NCT02834247|593404541|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
164283232|NCT02834247|593404542|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
164283233|NCT02476006|593404543|FG000|Overall Study|Death|4|||
164283234|NCT02476006|593404543|FG000|Overall Study|Lack of treatment efficacy|2|||
164283235|NCT02476006|593404543|FG000|Overall Study|Pregnancy|1|||
164283236|NCT02476006|593404543|FG000|Overall Study|Participant did not wish to continue|39|||
164283237|NCT02476006|593404543|FG000|Overall Study|Adverse Event|41|||
164283238|NCT02476006|593404543|FG000|Overall Study|Poor compliance to study protocol|3|||
164283239|NCT02476006|593404543|FG000|Overall Study|Sponsor decision|6|||
164283240|NCT02476006|593404543|FG000|Overall Study|Lost to Follow-up|5|||
164283241|NCT02476006|593404543|FG000|Overall Study|Physician Decision|5|||
164283242|NCT02476006|593404543|FG000|Overall Study|Study ended treatment not available|4|||
164586356|NCT00408421|594511802|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
164283243|NCT02476006|593404543|FG000|Overall Study|Switched to commercial drug|4|||
164283244|NCT02476006|593404543|FG000|Overall Study|Excluded from study|1|||
164283245|NCT02476006|593404543|FG000|Overall Study|Protocol Violation|1|||
164283246|NCT02476006|593404543|FG000|Overall Study|Enrolled but not treated|4|||
164283247|NCT01807299|593404550|FG000|Overall Study|Protocol Violation|3|||
164283248|NCT01807299|593404551|FG001|Overall Study|Protocol Violation|1|||
164283249|NCT01807299|593404552|FG002|Overall Study|Protocol Violation|0|||
164283250|NCT01807299|593404553|FG003|Overall Study|Protocol Violation|2|||
164283251|NCT00811174|593404554|FG000|Overall Study|Protocol Violation|2|||
164283252|NCT00811174|593404554|FG000|Overall Study|Sponsors Decision|1|||
164283253|NCT02451943|593406271|FG000|Overall Study|Withdrawal by Subject|13|||
164283254|NCT02451943|593406272|FG001|Overall Study|Withdrawal by Subject|16|||
164283255|NCT02451943|593406271|FG000|Overall Study|Lost to Follow-up|3|||
164283256|NCT02451943|593406272|FG001|Overall Study|Lost to Follow-up|4|||
164283257|NCT02451943|593406271|FG000|Overall Study|Sponsor Decision|0|||
164283258|NCT02451943|593406272|FG001|Overall Study|Sponsor Decision|4|||
164283259|NCT03951077|593406273|FG000|Overall Study|Adverse Event|1|||
164283260|NCT03951077|593406274|FG001|Overall Study|Adverse Event|0|||
164283261|NCT03951077|593406275|FG002|Overall Study|Adverse Event|0|||
164283262|NCT03951077|593406276|FG003|Overall Study|Adverse Event|0|||
164283263|NCT03951077|593406277|FG004|Overall Study|Adverse Event|0|||
164283264|NCT03951077|593406278|FG005|Overall Study|Adverse Event|0|||
164283265|NCT03951077|593406273|FG000|Overall Study|Withdrawal by Subject|3|||
164283266|NCT03951077|593406274|FG001|Overall Study|Withdrawal by Subject|3|||
164283267|NCT03951077|593406275|FG002|Overall Study|Withdrawal by Subject|0|||
164283268|NCT03951077|593406276|FG003|Overall Study|Withdrawal by Subject|3|||
164283269|NCT03951077|593406277|FG004|Overall Study|Withdrawal by Subject|3|||
164283270|NCT03951077|593406278|FG005|Overall Study|Withdrawal by Subject|2|||
164283271|NCT03951077|593406273|FG000|Overall Study|Lost to Follow-up|1|||
164283272|NCT03951077|593406274|FG001|Overall Study|Lost to Follow-up|1|||
164283273|NCT03951077|593406275|FG002|Overall Study|Lost to Follow-up|2|||
164283274|NCT03951077|593406276|FG003|Overall Study|Lost to Follow-up|3|||
164283275|NCT03951077|593406277|FG004|Overall Study|Lost to Follow-up|2|||
164283276|NCT03951077|593406278|FG005|Overall Study|Lost to Follow-up|3|||
164283277|NCT03951077|593406273|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
164283278|NCT03951077|593406274|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
164283279|NCT03951077|593406275|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
164283280|NCT03951077|593406276|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
164283281|NCT03951077|593406277|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
164283282|NCT03951077|593406278|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
164283283|NCT03951077|593406273|FG000|Overall Study|Other, Not Specified|12|||
164283284|NCT03951077|593406274|FG001|Overall Study|Other, Not Specified|10|||
164283285|NCT03951077|593406275|FG002|Overall Study|Other, Not Specified|10|||
164283286|NCT03951077|593406276|FG003|Overall Study|Other, Not Specified|5|||
164283287|NCT03951077|593406277|FG004|Overall Study|Other, Not Specified|9|||
164283288|NCT03951077|593406278|FG005|Overall Study|Other, Not Specified|6|||
164283289|NCT03951077|593406273|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
164283290|NCT03951077|593406274|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
164283291|NCT03951077|593406275|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
164283292|NCT03951077|593406276|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
164283293|NCT03951077|593406277|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
164283294|NCT03951077|593406278|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
164283295|NCT00086047|593406280|FG000|Overall Study|Lost to Follow-up|7|||
164283296|NCT00086047|593406281|FG001|Overall Study|Lost to Follow-up|6|||
164283297|NCT00086047|593406280|FG000|Overall Study|Physician Decision|0|||
164283298|NCT00086047|593406281|FG001|Overall Study|Physician Decision|1|||
164283299|NCT01395901|593406282|FG000|Overall Study|Lost to Follow-up|4|||
164283300|NCT01395901|593406283|FG001|Overall Study|Lost to Follow-up|0|||
164283301|NCT01395901|593406282|FG000|Overall Study|Randomized but not received study drug|5|||
164283302|NCT01395901|593406283|FG001|Overall Study|Randomized but not received study drug|4|||
164283303|NCT01395901|593406282|FG000|Overall Study|Adverse Event|0|||
164283304|NCT01395901|593406283|FG001|Overall Study|Adverse Event|1|||
164283305|NCT01395901|593406282|FG000|Overall Study|Withdrawal of consent|1|||
164283306|NCT01395901|593406283|FG001|Overall Study|Withdrawal of consent|0|||
164283307|NCT03579940|593406288|FG000|Period 2|Withdrawal by Subject|0|||
164283308|NCT03579940|593406289|FG001|Period 2|Withdrawal by Subject|0|||
164283309|NCT03579940|593406290|FG002|Period 2|Withdrawal by Subject|1|||
164283310|NCT03579940|593406291|FG003|Period 2|Withdrawal by Subject|0|||
164283311|NCT03579940|593406292|FG004|Period 2|Withdrawal by Subject|0|||
164691749|NCT01186016|594893250|FG001|Overall Study|Withdrawal by Subject|29|||
164691750|NCT03750695|594893252|FG000|Overall Study|Lost to Follow-up|0|||
164691751|NCT03750695|594893253|FG001|Overall Study|Lost to Follow-up|1|||
164691752|NCT03173560|594893254|FG000|Overall Study|Death|70|||
164691753|NCT03173560|594893255|FG001|Overall Study|Death|60|||
164691754|NCT03173560|594893254|FG000|Overall Study|Lost to Follow-up|1|||
164691755|NCT03173560|594893255|FG001|Overall Study|Lost to Follow-up|4|||
164691756|NCT03173560|594893254|FG000|Overall Study|Withdrawal by Subject|10|||
164691757|NCT03173560|594893255|FG001|Overall Study|Withdrawal by Subject|5|||
164283312|NCT03579940|593406293|FG005|Period 2|Withdrawal by Subject|0|||
164283313|NCT03579940|593406294|FG006|Period 2|Withdrawal by Subject|0|||
164283314|NCT03579940|593406295|FG007|Period 2|Withdrawal by Subject|0|||
164283315|NCT03579940|593406296|FG008|Period 2|Withdrawal by Subject|0|||
164283316|NCT03579940|593406297|FG009|Period 2|Withdrawal by Subject|0|||
164283317|NCT03579940|593406298|FG010|Period 2|Withdrawal by Subject|0|||
164283318|NCT01217944|593406299|FG000|Overall Study|Protocol Violation|1|||
164283319|NCT01217944|593406300|FG001|Overall Study|Protocol Violation|1|||
164283320|NCT01217944|593406301|FG002|Overall Study|Protocol Violation|0|||
164586357|NCT00408421|594511803|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
164586358|NCT00408421|594511804|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
164586359|NCT00408421|594511802|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
164283321|NCT01217944|593406299|FG000|Overall Study|Lost to Follow-up|3|||
164283322|NCT01217944|593406300|FG001|Overall Study|Lost to Follow-up|1|||
164283323|NCT01217944|593406301|FG002|Overall Study|Lost to Follow-up|0|||
164283324|NCT01217944|593406299|FG000|Overall Study|Withdrawal by Subject|1|||
164283325|NCT01217944|593406300|FG001|Overall Study|Withdrawal by Subject|2|||
164283326|NCT01217944|593406301|FG002|Overall Study|Withdrawal by Subject|0|||
164283327|NCT01217944|593406299|FG000|Overall Study|Lack of Efficacy|1|||
164283328|NCT01217944|593406300|FG001|Overall Study|Lack of Efficacy|0|||
164283329|NCT01217944|593406301|FG002|Overall Study|Lack of Efficacy|0|||
164283330|NCT00853151|593406302|FG000|Overall Study|Adverse Event|1|||
164283331|NCT00853151|593406303|FG001|Overall Study|Adverse Event|4|||
164283332|NCT00853151|593406304|FG002|Overall Study|Adverse Event|2|||
164283333|NCT00853151|593406305|FG003|Overall Study|Adverse Event|0|||
164283334|NCT00853151|593406302|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
164283335|NCT00853151|593406303|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
164283336|NCT00853151|593406304|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
164283337|NCT00853151|593406305|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
164283338|NCT00853151|593406302|FG000|Overall Study|Lost to Follow-up|2|||
164283339|NCT00853151|593406303|FG001|Overall Study|Lost to Follow-up|0|||
164283340|NCT00853151|593406304|FG002|Overall Study|Lost to Follow-up|3|||
164283341|NCT00853151|593406305|FG003|Overall Study|Lost to Follow-up|0|||
164283342|NCT00853151|593406302|FG000|Overall Study|Death|1|||
164283343|NCT00853151|593406303|FG001|Overall Study|Death|0|||
164283344|NCT00853151|593406304|FG002|Overall Study|Death|0|||
164283345|NCT00853151|593406305|FG003|Overall Study|Death|1|||
164283346|NCT00853151|593406302|FG000|Overall Study|Protocol Violation|0|||
164283347|NCT00853151|593406303|FG001|Overall Study|Protocol Violation|0|||
164283348|NCT00853151|593406304|FG002|Overall Study|Protocol Violation|0|||
164283349|NCT00853151|593406305|FG003|Overall Study|Protocol Violation|1|||
164283350|NCT00853151|593406302|FG000|Overall Study|Withdrawal by Subject|5|||
164283351|NCT00853151|593406303|FG001|Overall Study|Withdrawal by Subject|4|||
164283352|NCT00853151|593406304|FG002|Overall Study|Withdrawal by Subject|2|||
164283353|NCT00853151|593406305|FG003|Overall Study|Withdrawal by Subject|1|||
164283354|NCT00853151|593406302|FG000|Overall Study|Physician Decision|0|||
164283355|NCT00853151|593406303|FG001|Overall Study|Physician Decision|2|||
164283356|NCT00853151|593406304|FG002|Overall Study|Physician Decision|1|||
164283357|NCT00853151|593406305|FG003|Overall Study|Physician Decision|0|||
164283358|NCT00853151|593406302|FG000|Overall Study|Sponsor Decision|0|||
164283359|NCT00853151|593406303|FG001|Overall Study|Sponsor Decision|3|||
164283360|NCT00853151|593406304|FG002|Overall Study|Sponsor Decision|0|||
164283361|NCT00853151|593406305|FG003|Overall Study|Sponsor Decision|0|||
164283362|NCT01751984|593406306|FG000|Overall Study|Adverse Event|5|||
164586360|NCT00408421|594511803|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
164586361|NCT00408421|594511804|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
164586362|NCT00408421|594511802|FG000|Treatment Re-Randomization|Adverse Event|2|||
164586363|NCT00408421|594511803|FG001|Treatment Re-Randomization|Adverse Event|2|||
164586364|NCT00408421|594511804|FG002|Treatment Re-Randomization|Adverse Event|4|||
164586365|NCT00408421|594511802|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
164586366|NCT00408421|594511803|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
164586367|NCT00408421|594511804|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
164283363|NCT01751984|593406307|FG001|Overall Study|Adverse Event|3|||
164283364|NCT01751984|593406306|FG000|Overall Study|Withdrawal by Subject|0|||
164283365|NCT01751984|593406307|FG001|Overall Study|Withdrawal by Subject|1|||
164283366|NCT01751984|593406306|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
164283367|NCT01751984|593406307|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
164283368|NCT00587158|593406308|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
164283369|NCT00587158|593406309|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
164283370|NCT00587158|593406308|FG000|Overall Study|Physician Decision|0|||
164283371|NCT00587158|593406309|FG001|Overall Study|Physician Decision|1|||
164283372|NCT00587158|593406308|FG000|Overall Study|Lost to Follow-up|1|||
164283373|NCT00587158|593406309|FG001|Overall Study|Lost to Follow-up|2|||
164283374|NCT00587158|593406308|FG000|Overall Study|Death|0|||
164283375|NCT00587158|593406309|FG001|Overall Study|Death|1|||
164586368|NCT00408421|594511802|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
164586369|NCT00408421|594511803|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
164283376|NCT00587158|593406308|FG000|Overall Study|Subject did not want to take study med|0|||
164283377|NCT00587158|593406309|FG001|Overall Study|Subject did not want to take study med|1|||
164283378|NCT01136408|593406310|FG000|Overall Study|Adverse Event|4|||
164283379|NCT01136408|593406311|FG001|Overall Study|Adverse Event|8|||
164283380|NCT01136408|593406312|FG002|Overall Study|Adverse Event|4|||
164283381|NCT01136408|593406310|FG000|Overall Study|Protocol Violation|1|||
164283382|NCT01136408|593406311|FG001|Overall Study|Protocol Violation|1|||
164283383|NCT01136408|593406312|FG002|Overall Study|Protocol Violation|1|||
164283384|NCT02274792|593406313|FG000|Overall Study|Withdrawal by Subject|13|||
164283385|NCT02274792|593406313|FG000|Overall Study|Lost to Follow-up|8|||
164283386|NCT02274792|593406313|FG000|Overall Study|Protocol Specified Criteria|2|||
164283387|NCT02274792|593406313|FG000|Overall Study|Sponsor Decision|2|||
164283388|NCT01510158|593406314|FG000|Overall Study|Adverse Event|7|||
164283389|NCT01510158|593406315|FG001|Overall Study|Adverse Event|8|||
164283390|NCT01510158|593406316|FG002|Overall Study|Adverse Event|5|||
164283391|NCT01510158|593406314|FG000|Overall Study|Gout flare|1|||
164283392|NCT01510158|593406315|FG001|Overall Study|Gout flare|0|||
164283393|NCT01510158|593406316|FG002|Overall Study|Gout flare|0|||
164283394|NCT01510158|593406314|FG000|Overall Study|Protocol Violation|17|||
164283395|NCT01510158|593406315|FG001|Overall Study|Protocol Violation|16|||
164283396|NCT01510158|593406316|FG002|Overall Study|Protocol Violation|24|||
164283397|NCT01510158|593406314|FG000|Overall Study|Sponsor terminated study.|2|||
164283398|NCT01510158|593406315|FG001|Overall Study|Sponsor terminated study.|0|||
164283399|NCT01510158|593406316|FG002|Overall Study|Sponsor terminated study.|2|||
164283400|NCT01510158|593406314|FG000|Overall Study|Lost to Follow-up|13|||
164283401|NCT01510158|593406315|FG001|Overall Study|Lost to Follow-up|16|||
164283402|NCT01510158|593406316|FG002|Overall Study|Lost to Follow-up|9|||
164283403|NCT01510158|593406314|FG000|Overall Study|Withdrawal by Subject|10|||
164283404|NCT01510158|593406315|FG001|Overall Study|Withdrawal by Subject|13|||
164283405|NCT01510158|593406316|FG002|Overall Study|Withdrawal by Subject|10|||
164283406|NCT01510158|593406314|FG000|Overall Study|Death|1|||
164283407|NCT01510158|593406315|FG001|Overall Study|Death|0|||
164283408|NCT01510158|593406316|FG002|Overall Study|Death|0|||
164283409|NCT03078556|593406317|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
164283410|NCT03078556|593406318|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
164283411|NCT03078556|593406319|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
164283412|NCT03078556|593406320|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
164283413|NCT03078556|593406317|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
164283414|NCT03078556|593406318|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
164283415|NCT03078556|593406319|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
164283416|NCT03078556|593406320|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
164283417|NCT03078556|593406317|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
164283418|NCT03078556|593406318|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
164283419|NCT03078556|593406319|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
164283420|NCT03078556|593406320|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
164283421|NCT03078556|593406317|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
164283422|NCT03078556|593406318|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
164283423|NCT03078556|593406319|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
164283424|NCT03078556|593406320|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
164283425|NCT00832416|593406321|FG000|Overall Study|Lack of Efficacy|17|||
164283426|NCT00832416|593406322|FG001|Overall Study|Lack of Efficacy|15|||
164283427|NCT00832416|593406323|FG002|Overall Study|Lack of Efficacy|13|||
164283428|NCT00832416|593406324|FG003|Overall Study|Lack of Efficacy|52|||
164283429|NCT00832416|593406321|FG000|Overall Study|Withdrawal by Subject|5|||
164283430|NCT00832416|593406322|FG001|Overall Study|Withdrawal by Subject|7|||
164283431|NCT00832416|593406323|FG002|Overall Study|Withdrawal by Subject|2|||
164283432|NCT00832416|593406324|FG003|Overall Study|Withdrawal by Subject|10|||
164283433|NCT00832416|593406321|FG000|Overall Study|Physician Decision|2|||
164283434|NCT00832416|593406322|FG001|Overall Study|Physician Decision|12|||
164283435|NCT00832416|593406323|FG002|Overall Study|Physician Decision|5|||
164283436|NCT00832416|593406324|FG003|Overall Study|Physician Decision|10|||
164283437|NCT00832416|593406321|FG000|Overall Study|Administrative|0|||
164283438|NCT00832416|593406322|FG001|Overall Study|Administrative|0|||
164283439|NCT00832416|593406323|FG002|Overall Study|Administrative|0|||
164283440|NCT00832416|593406324|FG003|Overall Study|Administrative|1|||
164283441|NCT00832416|593406321|FG000|Overall Study|Adverse Event|21|||
164283442|NCT00832416|593406322|FG001|Overall Study|Adverse Event|19|||
164283443|NCT00832416|593406323|FG002|Overall Study|Adverse Event|41|||
164283444|NCT00832416|593406324|FG003|Overall Study|Adverse Event|10|||
164283445|NCT00832416|593406321|FG000|Overall Study|Death|1|||
164283446|NCT00832416|593406322|FG001|Overall Study|Death|0|||
164283447|NCT00832416|593406323|FG002|Overall Study|Death|0|||
164283448|NCT00832416|593406324|FG003|Overall Study|Death|0|||
164283449|NCT04421482|593406331|FG000|Overall Study|Physician Decision|1|||
164283450|NCT05786508|593406334|FG000|Overall Study|Withdrawal by Subject|2|||
164283451|NCT05786508|593406335|FG001|Overall Study|Withdrawal by Subject|0|||
164283452|NCT04426318|593406336|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
164283453|NCT04426318|593406337|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
164283454|NCT02751580|593406338|FG000|Overall Study|Lost to Follow-up|4|||
164283455|NCT02751580|593406338|FG000|Overall Study|Death|2|||
164283456|NCT02588261|593406341|FG000|Overall Study|Study Terminated by Sponsor|157|||
164283457|NCT02588261|593406342|FG001|Overall Study|Study Terminated by Sponsor|142|||
164283458|NCT02588261|593406341|FG000|Overall Study|Protocol Deviation|1|||
164283459|NCT02588261|593406342|FG001|Overall Study|Protocol Deviation|0|||
164283460|NCT02588261|593406341|FG000|Overall Study|Death|1|||
164283461|NCT02588261|593406342|FG001|Overall Study|Death|2|||
164283462|NCT02588261|593406341|FG000|Overall Study|Withdrawal by Subject|12|||
164283463|NCT02588261|593406342|FG001|Overall Study|Withdrawal by Subject|8|||
164283464|NCT02588261|593406341|FG000|Overall Study|Noncompliance with Study Drug|0|||
164283465|NCT02588261|593406342|FG001|Overall Study|Noncompliance with Study Drug|1|||
164283466|NCT02588261|593406341|FG000|Overall Study|Miscellaneous|5|||
164283467|NCT02588261|593406342|FG001|Overall Study|Miscellaneous|4|||
164283468|NCT02588261|593406341|FG000|Overall Study|Progressive Disease|61|||
164283469|NCT02588261|593406342|FG001|Overall Study|Progressive Disease|82|||
164283470|NCT02588261|593406341|FG000|Overall Study|Adverse Event|29|||
164283471|NCT02588261|593406342|FG001|Overall Study|Adverse Event|24|||
164283472|NCT02588261|593406341|FG000|Overall Study|Lost to Follow-up|1|||
164283473|NCT02588261|593406342|FG001|Overall Study|Lost to Follow-up|0|||
164283474|NCT03781778|593406343|FG000|Overall Study|Withdrawal by Subject|2|||
164283475|NCT03781778|593406344|FG001|Overall Study|Withdrawal by Subject|2|||
164283476|NCT02287467|593406345|FG000|Overall Study|Protocol Violation|12|||
164283477|NCT02287467|593406346|FG001|Overall Study|Protocol Violation|9|||
164283478|NCT01456169|593406353|FG000|Overall Study|Adverse Event|1|||
164283479|NCT01456169|593406354|FG001|Overall Study|Adverse Event|2|||
164283480|NCT01456169|593406355|FG002|Overall Study|Adverse Event|7|||
164283481|NCT01456169|593406353|FG000|Overall Study|Major Protocol Deviation|3|||
164283482|NCT01456169|593406354|FG001|Overall Study|Major Protocol Deviation|2|||
164283483|NCT01456169|593406355|FG002|Overall Study|Major Protocol Deviation|3|||
164283484|NCT01456169|593406353|FG000|Overall Study|Voluntary Withdrawal|3|||
164283485|NCT01456169|593406354|FG001|Overall Study|Voluntary Withdrawal|0|||
164283486|NCT01456169|593406355|FG002|Overall Study|Voluntary Withdrawal|2|||
164283487|NCT01456169|593406353|FG000|Overall Study|Lack of Efficacy|2|||
164283488|NCT01456169|593406354|FG001|Overall Study|Lack of Efficacy|0|||
164283489|NCT01456169|593406355|FG002|Overall Study|Lack of Efficacy|0|||
164283490|NCT01456169|593406353|FG000|Overall Study|Other|1|||
164283491|NCT01456169|593406354|FG001|Overall Study|Other|1|||
164283492|NCT01456169|593406355|FG002|Overall Study|Other|0|||
164283493|NCT02292446|593406356|FG000|Overall Study|Adverse Event|12|||
164283494|NCT02292446|593406356|FG000|Overall Study|Death|1|||
164283495|NCT02292446|593406356|FG000|Overall Study|Disease progression|2|||
164283496|NCT02292446|593406356|FG000|Overall Study|Subject/guardian decision|2|||
164283497|NCT02292446|593406356|FG000|Overall Study|Withdrawal by Subject|3|||
164283498|NCT02652156|593406361|FG000|Overall Study|Physician Decision|1|||
164283499|NCT02652156|593406362|FG001|Overall Study|Physician Decision|0|||
164283500|NCT02652156|593406363|FG002|Overall Study|Physician Decision|0|||
164283501|NCT00496080|593406366|FG000|Overall Study|Lost to Follow-up|9|||
164283502|NCT00496080|593406366|FG000|Overall Study|Surgical re-intervention|7|||
164283503|NCT00496080|593406366|FG000|Overall Study|Withdrawal by Subject|5|||
164283504|NCT00496080|593406366|FG000|Overall Study|Physician Decision|6|||
164283505|NCT03329846|593406367|FG000|Overall Study|Disease progression|4|||
164283506|NCT03329846|593406368|FG001|Overall Study|Disease progression|6|||
164283507|NCT03329846|593406367|FG000|Overall Study|Study drug toxicity|1|||
164283508|NCT03329846|593406368|FG001|Overall Study|Study drug toxicity|0|||
164283509|NCT03329846|593406367|FG000|Overall Study|Participant request to discontinue treatment|0|||
164586370|NCT00408421|594511804|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
164586371|NCT00408421|594511802|FG000|Treatment Re-Randomization|Physician Decision|1|||
164283510|NCT03329846|593406368|FG001|Overall Study|Participant request to discontinue treatment|1|||
164283511|NCT03329846|593406367|FG000|Overall Study|Participant withdrew consent|1|||
164283512|NCT03329846|593406368|FG001|Overall Study|Participant withdrew consent|0|||
164283513|NCT03329846|593406367|FG000|Overall Study|Other reasons|2|||
164283514|NCT03329846|593406368|FG001|Overall Study|Other reasons|2|||
164283515|NCT00479336|593406369|FG000|Overall Study|Adverse Event|1|||
164283516|NCT00479336|593406370|FG001|Overall Study|Adverse Event|1|||
164283517|NCT00479336|593406371|FG002|Overall Study|Adverse Event|1|||
164283518|NCT00479336|593406372|FG003|Overall Study|Adverse Event|3|||
164283519|NCT00479336|593406369|FG000|Overall Study|Lack of Efficacy|1|||
164586372|NCT00408421|594511803|FG001|Treatment Re-Randomization|Physician Decision|3|||
164586373|NCT00408421|594511804|FG002|Treatment Re-Randomization|Physician Decision|0|||
164691758|NCT03173560|594893254|FG000|Overall Study|Other|0|||
164283520|NCT00479336|593406370|FG001|Overall Study|Lack of Efficacy|0|||
164283521|NCT00479336|593406371|FG002|Overall Study|Lack of Efficacy|0|||
164691759|NCT03173560|594893255|FG001|Overall Study|Other|1|||
164691760|NCT02174276|594893258|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
164691761|NCT02174276|594893259|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
164691762|NCT02174276|594893260|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
164691763|NCT02174276|594893261|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
164691764|NCT02174276|594893258|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
164691765|NCT02174276|594893259|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
164691766|NCT02174276|594893260|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
164283522|NCT00479336|593406372|FG003|Overall Study|Lack of Efficacy|0|||
164283523|NCT00479336|593406369|FG000|Overall Study|Protocol Violation|0|||
164283524|NCT00479336|593406370|FG001|Overall Study|Protocol Violation|1|||
164283525|NCT00479336|593406371|FG002|Overall Study|Protocol Violation|0|||
164283526|NCT00479336|593406372|FG003|Overall Study|Protocol Violation|0|||
164283527|NCT00479336|593406369|FG000|Overall Study|Withdrawal by Subject|1|||
164283528|NCT00479336|593406370|FG001|Overall Study|Withdrawal by Subject|2|||
164283529|NCT00479336|593406371|FG002|Overall Study|Withdrawal by Subject|0|||
164283530|NCT00479336|593406372|FG003|Overall Study|Withdrawal by Subject|0|||
164283531|NCT00479336|593406369|FG000|Overall Study|Physician Decision|0|||
164283532|NCT00479336|593406370|FG001|Overall Study|Physician Decision|1|||
164283533|NCT00479336|593406371|FG002|Overall Study|Physician Decision|0|||
164283534|NCT00479336|593406372|FG003|Overall Study|Physician Decision|2|||
164283535|NCT00479336|593406369|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
164283536|NCT00479336|593406370|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
164283537|NCT00479336|593406371|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
164283538|NCT00479336|593406372|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
164283539|NCT02741596|593406373|FG000|Overall Study|Adverse Event|1|||
164283540|NCT02741596|593406374|FG001|Overall Study|Adverse Event|5|||
164283541|NCT02741596|593406373|FG000|Overall Study|Lost to Follow-up|1|||
164283542|NCT02741596|593406374|FG001|Overall Study|Lost to Follow-up|1|||
164283543|NCT02741596|593406373|FG000|Overall Study|Physician Decision|2|||
164283544|NCT02741596|593406374|FG001|Overall Study|Physician Decision|1|||
164283545|NCT02741596|593406373|FG000|Overall Study|Pregnancy|3|||
164283546|NCT02741596|593406374|FG001|Overall Study|Pregnancy|1|||
164283547|NCT02741596|593406373|FG000|Overall Study|Other (Unspecified)|0|||
164283548|NCT02741596|593406374|FG001|Overall Study|Other (Unspecified)|3|||
164283549|NCT02741596|593406373|FG000|Overall Study|Subject withdrawn-Other|17|||
164283550|NCT02741596|593406374|FG001|Overall Study|Subject withdrawn-Other|4|||
164283551|NCT02741596|593406373|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
164283552|NCT02741596|593406374|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
164283553|NCT02021643|593406375|FG000|Overall Study|Enrolled but Never Treated|1|||
164283554|NCT02021643|593406376|FG001|Overall Study|Enrolled but Never Treated|0|||
164283555|NCT02021643|593406377|FG002|Overall Study|Enrolled but Never Treated|0|||
164283556|NCT02021643|593406378|FG003|Overall Study|Enrolled but Never Treated|0|||
164283557|NCT02021643|593406375|FG000|Overall Study|Adverse Event|0|||
164283558|NCT02021643|593406376|FG001|Overall Study|Adverse Event|1|||
164283559|NCT02021643|593406377|FG002|Overall Study|Adverse Event|0|||
164283560|NCT02021643|593406378|FG003|Overall Study|Adverse Event|0|||
164283561|NCT02021643|593406375|FG000|Overall Study|Death|0|||
164283562|NCT02021643|593406376|FG001|Overall Study|Death|1|||
164283563|NCT02021643|593406377|FG002|Overall Study|Death|0|||
164283564|NCT02021643|593406378|FG003|Overall Study|Death|0|||
164283565|NCT02021643|593406375|FG000|Overall Study|Investigator's Discretion|1|||
164283566|NCT02021643|593406376|FG001|Overall Study|Investigator's Discretion|0|||
164283567|NCT02021643|593406377|FG002|Overall Study|Investigator's Discretion|0|||
164283568|NCT02021643|593406378|FG003|Overall Study|Investigator's Discretion|0|||
164283569|NCT02021643|593406375|FG000|Overall Study|Lack of Efficacy|7|||
164283570|NCT02021643|593406376|FG001|Overall Study|Lack of Efficacy|6|||
164283571|NCT02021643|593406377|FG002|Overall Study|Lack of Efficacy|0|||
164283572|NCT02021643|593406378|FG003|Overall Study|Lack of Efficacy|12|||
164283573|NCT02021643|593406375|FG000|Overall Study|Lost to Follow-up|0|||
164283574|NCT02021643|593406376|FG001|Overall Study|Lost to Follow-up|1|||
164283575|NCT02021643|593406377|FG002|Overall Study|Lost to Follow-up|0|||
164283576|NCT02021643|593406378|FG003|Overall Study|Lost to Follow-up|0|||
164283577|NCT02021643|593406375|FG000|Overall Study|Withdrew Consent|0|||
164283578|NCT02021643|593406376|FG001|Overall Study|Withdrew Consent|1|||
164283579|NCT02021643|593406377|FG002|Overall Study|Withdrew Consent|0|||
164283580|NCT02021643|593406378|FG003|Overall Study|Withdrew Consent|0|||
164283581|NCT02631551|593406381|FG000|Overall Study|Adverse Event|1|||
164283582|NCT02631551|593406382|FG001|Overall Study|Adverse Event|2|||
164283583|NCT02631551|593406383|FG002|Overall Study|Adverse Event|4|||
164283584|NCT02631551|593406384|FG003|Overall Study|Adverse Event|0|||
164283585|NCT02631551|593406381|FG000|Overall Study|Lack of Efficacy|0|||
164283586|NCT02631551|593406382|FG001|Overall Study|Lack of Efficacy|0|||
164283587|NCT02631551|593406383|FG002|Overall Study|Lack of Efficacy|1|||
164283588|NCT02631551|593406384|FG003|Overall Study|Lack of Efficacy|0|||
164283589|NCT02631551|593406381|FG000|Overall Study|Lost to Follow-up|1|||
164283590|NCT02631551|593406382|FG001|Overall Study|Lost to Follow-up|2|||
164283591|NCT02631551|593406383|FG002|Overall Study|Lost to Follow-up|0|||
164283592|NCT02631551|593406384|FG003|Overall Study|Lost to Follow-up|3|||
164283593|NCT02631551|593406381|FG000|Overall Study|Withdrawal by Subject|2|||
164283594|NCT02631551|593406382|FG001|Overall Study|Withdrawal by Subject|2|||
164283595|NCT02631551|593406383|FG002|Overall Study|Withdrawal by Subject|0|||
164433250|NCT01833065|593957201|FG003|Overall Study|Protocol Violation|0|||
164283596|NCT02631551|593406384|FG003|Overall Study|Withdrawal by Subject|5|||
164283597|NCT02631551|593406381|FG000|Overall Study|Protocol deviation|3|||
164283598|NCT02631551|593406382|FG001|Overall Study|Protocol deviation|6|||
164283599|NCT02631551|593406383|FG002|Overall Study|Protocol deviation|3|||
164283600|NCT02631551|593406384|FG003|Overall Study|Protocol deviation|0|||
164283601|NCT02631551|593406381|FG000|Overall Study|Non-compliance with study procedures|0|||
164283602|NCT02631551|593406382|FG001|Overall Study|Non-compliance with study procedures|0|||
164283603|NCT02631551|593406383|FG002|Overall Study|Non-compliance with study procedures|1|||
164283604|NCT02631551|593406384|FG003|Overall Study|Non-compliance with study procedures|1|||
164283605|NCT02631551|593406381|FG000|Overall Study|Non-compliance with study drug|1|||
164283606|NCT02631551|593406382|FG001|Overall Study|Non-compliance with study drug|0|||
164283607|NCT02631551|593406383|FG002|Overall Study|Non-compliance with study drug|0|||
164283608|NCT02631551|593406384|FG003|Overall Study|Non-compliance with study drug|0|||
164283609|NCT02631551|593406381|FG000|Overall Study|Other, specific reasons not collected|5|||
164283610|NCT02631551|593406382|FG001|Overall Study|Other, specific reasons not collected|7|||
164283611|NCT02631551|593406383|FG002|Overall Study|Other, specific reasons not collected|2|||
164283612|NCT02631551|593406384|FG003|Overall Study|Other, specific reasons not collected|2|||
164283613|NCT01076036|593406387|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
164283614|NCT02221674|593406388|FG000|Overall Study|Lost to Follow-up|1|||
164283615|NCT02221674|593406389|FG001|Overall Study|Lost to Follow-up|0|||
164283616|NCT02221674|593406390|FG002|Overall Study|Lost to Follow-up|0|||
164283617|NCT05292131|593406391|FG000|Overall Study|Lost to Follow-up|1|||
164283618|NCT05292131|593406392|FG001|Overall Study|Lost to Follow-up|1|||
164283619|NCT05292131|593406391|FG000|Overall Study|Withdrawal by Subject|0|||
164283620|NCT05292131|593406392|FG001|Overall Study|Withdrawal by Subject|1|||
164283621|NCT01345188|593406393|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
164283622|NCT01345188|593406393|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
164283623|NCT04752358|593406394|FG000|Overall Study|Death|2|||
164283624|NCT04752358|593406395|FG001|Overall Study|Death|1|||
164283625|NCT04607837|593406396|FG000|Overall Study|Adverse Event|8|||
164283626|NCT04607837|593406397|FG001|Overall Study|Adverse Event|2|||
164283627|NCT04607837|593406396|FG000|Overall Study|Withdrawal by Subject|8|||
164283628|NCT04607837|593406397|FG001|Overall Study|Withdrawal by Subject|7|||
164283629|NCT04607837|593406396|FG000|Overall Study|Physician Decision|2|||
164283630|NCT04607837|593406397|FG001|Overall Study|Physician Decision|0|||
164283631|NCT04607837|593406396|FG000|Overall Study|Lack of Efficacy|2|||
164283632|NCT04607837|593406397|FG001|Overall Study|Lack of Efficacy|0|||
164283633|NCT04607837|593406396|FG000|Overall Study|Participant terminated by sponsor|1|||
164283634|NCT04607837|593406397|FG001|Overall Study|Participant terminated by sponsor|0|||
164283635|NCT04607837|593406396|FG000|Overall Study|Disease worsening|36|||
164283636|NCT04607837|593406397|FG001|Overall Study|Disease worsening|36|||
164283637|NCT04607837|593406396|FG000|Overall Study|Other|1|||
164283638|NCT04607837|593406397|FG001|Overall Study|Other|0|||
164283639|NCT00465452|593406407|FG000|Overall Study|Adverse Event|1|||
164283640|NCT05236257|593406411|FG000|Overall Study|Ongoing with study treatment|29|||
164283641|NCT05236257|593406412|FG001|Overall Study|Ongoing with study treatment|1|||
164283642|NCT05236257|593406411|FG000|Overall Study|Discontinued study treatment|22|||
164433251|NCT01833065|593957202|FG004|Overall Study|Protocol Violation|2|||
164433252|NCT01833065|593957198|FG000|Overall Study|Lost to Follow-up|1|||
164433253|NCT01833065|593957199|FG001|Overall Study|Lost to Follow-up|0|||
164433254|NCT01833065|593957200|FG002|Overall Study|Lost to Follow-up|0|||
164283643|NCT05236257|593406412|FG001|Overall Study|Discontinued study treatment|41|||
164283644|NCT05870865|593406413|FG000|Randomized|Did not receive study treatment|2|||
164283645|NCT05870865|593406414|FG001|Randomized|Did not receive study treatment|4|||
164283646|NCT05870865|593406415|FG002|Randomized|Did not receive study treatment|4|||
164283647|NCT05870865|593406416|FG003|Randomized|Did not receive study treatment|3|||
164283648|NCT05870865|593406413|FG000|Treatment Period|Adverse Event|1|||
164283649|NCT05870865|593406414|FG001|Treatment Period|Adverse Event|1|||
164283650|NCT05870865|593406415|FG002|Treatment Period|Adverse Event|1|||
164283651|NCT05870865|593406416|FG003|Treatment Period|Adverse Event|1|||
164283652|NCT05870865|593406413|FG000|Treatment Period|Lost to Follow-up|0|||
164283653|NCT05870865|593406414|FG001|Treatment Period|Lost to Follow-up|1|||
164283654|NCT05870865|593406415|FG002|Treatment Period|Lost to Follow-up|2|||
164691767|NCT02174276|594893261|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
164691768|NCT02174276|594893258|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
164283655|NCT05870865|593406416|FG003|Treatment Period|Lost to Follow-up|0|||
164283656|NCT05870865|593406413|FG000|Treatment Period|Protocol Violation|0|||
164283657|NCT05870865|593406414|FG001|Treatment Period|Protocol Violation|0|||
164283658|NCT05870865|593406415|FG002|Treatment Period|Protocol Violation|0|||
164283659|NCT05870865|593406416|FG003|Treatment Period|Protocol Violation|1|||
164283660|NCT05870865|593406413|FG000|Treatment Period|Withdrawal by Subject|0|||
164283661|NCT05870865|593406414|FG001|Treatment Period|Withdrawal by Subject|1|||
164283662|NCT05870865|593406415|FG002|Treatment Period|Withdrawal by Subject|1|||
164283663|NCT05870865|593406416|FG003|Treatment Period|Withdrawal by Subject|1|||
164283664|NCT03828019|593406419|FG000|Overall Study|Withdrawal by Subject|3|||
164283665|NCT03828019|593406420|FG001|Overall Study|Withdrawal by Subject|8|||
164283666|NCT03828019|593406419|FG000|Overall Study|Lost to Follow-up|1|||
164433255|NCT01833065|593957201|FG003|Overall Study|Lost to Follow-up|0|||
164283667|NCT03828019|593406420|FG001|Overall Study|Lost to Follow-up|6|||
164283668|NCT03828019|593406419|FG000|Overall Study|Incarcerated|1|||
164283669|NCT03828019|593406420|FG001|Overall Study|Incarcerated|0|||
164283670|NCT03828019|593406419|FG000|Overall Study|Adverse Event|0|||
164283671|NCT03828019|593406420|FG001|Overall Study|Adverse Event|1|||
164283672|NCT05715242|593406421|FG000|Overall Study|Lost to Follow-up|0|||
164283673|NCT05715242|593406422|FG001|Overall Study|Lost to Follow-up|0|||
164283674|NCT05715242|593406423|FG002|Overall Study|Lost to Follow-up|1|||
164283675|NCT05715242|593406424|FG003|Overall Study|Lost to Follow-up|0|||
164283676|NCT05715242|593406425|FG004|Overall Study|Lost to Follow-up|0|||
164283677|NCT05715242|593406426|FG005|Overall Study|Lost to Follow-up|1|||
164283678|NCT05715242|593406427|FG006|Overall Study|Lost to Follow-up|0|||
164283679|NCT05715242|593406428|FG007|Overall Study|Lost to Follow-up|0|||
164283680|NCT05715242|593406429|FG008|Overall Study|Lost to Follow-up|0|||
164283681|NCT05715242|593406430|FG009|Overall Study|Lost to Follow-up|0|||
164283682|NCT05715242|593406431|FG010|Overall Study|Lost to Follow-up|0|||
164283683|NCT05715242|593406432|FG011|Overall Study|Lost to Follow-up|0|||
164283684|NCT05715242|593406433|FG012|Overall Study|Lost to Follow-up|0|||
164283685|NCT05715242|593406434|FG013|Overall Study|Lost to Follow-up|0|||
164283686|NCT05715242|593406435|FG014|Overall Study|Lost to Follow-up|0|||
164283687|NCT05715242|593406436|FG015|Overall Study|Lost to Follow-up|0|||
164283688|NCT01090063|593406438|FG000|Screen|Screen Failed|4|||
164283689|NCT01090063|593406438|FG000|Treatment|Withdrawal by Subject|4|||
164283690|NCT02936635|593407686|FG000|Overall Study|Adverse Event|43|||
164283691|NCT02936635|593407687|FG001|Overall Study|Adverse Event|25|||
164283692|NCT02936635|593407686|FG000|Overall Study|Progressive Disease|10|||
164283693|NCT02936635|593407687|FG001|Overall Study|Progressive Disease|18|||
164283694|NCT02936635|593407686|FG000|Overall Study|Sponsor Discretion|10|||
164283695|NCT02936635|593407687|FG001|Overall Study|Sponsor Discretion|16|||
164283696|NCT02936635|593407686|FG000|Overall Study|Death|9|||
164283697|NCT02936635|593407687|FG001|Overall Study|Death|15|||
164283698|NCT02936635|593407686|FG000|Overall Study|Withdrawal by Subject|8|||
164283699|NCT02936635|593407687|FG001|Overall Study|Withdrawal by Subject|15|||
164283700|NCT02936635|593407686|FG000|Overall Study|Physician Decision|2|||
164283701|NCT02936635|593407687|FG001|Overall Study|Physician Decision|9|||
164283702|NCT02936635|593407686|FG000|Overall Study|Lost to Follow-up|1|||
164283703|NCT02936635|593407687|FG001|Overall Study|Lost to Follow-up|2|||
164283704|NCT02936635|593407686|FG000|Overall Study|Protocol Violation|1|||
164691769|NCT02174276|594893259|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
164283705|NCT02936635|593407687|FG001|Overall Study|Protocol Violation|0|||
164283706|NCT02936635|593407686|FG000|Overall Study|Lack of effect/Entry into other study|31|||
164283707|NCT02936635|593407687|FG001|Overall Study|Lack of effect/Entry into other study|65|||
164283708|NCT02407223|593407688|FG000|Overall Study|Adverse Event|1|||
164283709|NCT02407223|593407689|FG001|Overall Study|Adverse Event|0|||
164283710|NCT02407223|593407690|FG002|Overall Study|Adverse Event|1|||
164283711|NCT02407223|593407688|FG000|Overall Study|Lack of Efficacy|6|||
164283712|NCT02407223|593407689|FG001|Overall Study|Lack of Efficacy|6|||
164283713|NCT02407223|593407690|FG002|Overall Study|Lack of Efficacy|4|||
164283714|NCT02407223|593407688|FG000|Overall Study|Lost to Follow-up|1|||
164283715|NCT02407223|593407689|FG001|Overall Study|Lost to Follow-up|0|||
164283716|NCT02407223|593407690|FG002|Overall Study|Lost to Follow-up|2|||
164283717|NCT02407223|593407688|FG000|Overall Study|Withdrawal by Subject|2|||
164283718|NCT02407223|593407689|FG001|Overall Study|Withdrawal by Subject|4|||
164283719|NCT02407223|593407690|FG002|Overall Study|Withdrawal by Subject|4|||
164283720|NCT02407223|593407688|FG000|Overall Study|Study Terminated by Sponsor|77|||
164283721|NCT02407223|593407689|FG001|Overall Study|Study Terminated by Sponsor|80|||
164283722|NCT02407223|593407690|FG002|Overall Study|Study Terminated by Sponsor|86|||
164283723|NCT02407223|593407688|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
164283724|NCT02407223|593407689|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
164283725|NCT02407223|593407690|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
164283726|NCT02407223|593407688|FG000|Overall Study|Other|29|||
164283727|NCT02407223|593407689|FG001|Overall Study|Other|27|||
164283728|NCT02407223|593407690|FG002|Overall Study|Other|25|||
164283729|NCT01478971|593407691|FG000|Standard of Care Period|Adverse Event|1|||
164283730|NCT01478971|593407691|FG000|Standard of Care Period|Withdrawal by Subject|3|||
164283731|NCT01478971|593407691|FG000|Standard of Care Period|Death|8|||
164283732|NCT01478971|593407691|FG000|Standard of Care Period|Lost to Follow-up|9|||
164283733|NCT01478971|593407691|FG000|Standard of Care Period|Other|4|||
164283734|NCT01478971|593407691|FG000|Peginesatide Treatment Period|Adverse Event|1|||
164283735|NCT01478971|593407691|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
164283736|NCT01478971|593407691|FG000|Peginesatide Treatment Period|Death|4|||
164283737|NCT01478971|593407691|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
164283738|NCT01478971|593407691|FG000|Peginesatide Treatment Period|Other|4|||
164283739|NCT00763386|593407696|FG000|Overall Study|Adverse Event|43|||
164283740|NCT00763386|593407697|FG001|Overall Study|Adverse Event|33|||
164283741|NCT00763386|593407696|FG000|Overall Study|Death|1|||
164283742|NCT00763386|593407697|FG001|Overall Study|Death|2|||
164283743|NCT00763386|593407696|FG000|Overall Study|Lost to Follow-up|3|||
164283744|NCT00763386|593407697|FG001|Overall Study|Lost to Follow-up|3|||
164283745|NCT00763386|593407696|FG000|Overall Study|Withdrawal by Subject|0|||
164283746|NCT00763386|593407697|FG001|Overall Study|Withdrawal by Subject|1|||
164283747|NCT00763386|593407696|FG000|Overall Study|CRF missing|0|||
164283748|NCT00763386|593407697|FG001|Overall Study|CRF missing|1|||
164283749|NCT00763386|593407696|FG000|Overall Study|Study Prosthesis Removed|1|||
164283750|NCT00763386|593407697|FG001|Overall Study|Study Prosthesis Removed|0|||
164283751|NCT00922623|593407698|FG000|Overall Study|Other|4|||
164283752|NCT00922623|593407698|FG000|Overall Study|Lost to Follow-up|1|||
164283753|NCT02451917|593407699|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
164283754|NCT02451917|593407700|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
164283755|NCT02451917|593407699|FG000|First Intervention (24 Weeks)|Death|0|||
164283756|NCT02451917|593407700|FG001|First Intervention (24 Weeks)|Death|1|||
164283757|NCT02451917|593407699|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
164283758|NCT02451917|593407700|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
164283759|NCT00950846|593407704|FG000|Overall Study|Death|6|||
164283760|NCT00950846|593407704|FG000|Overall Study|Lost to Follow-up|3|||
164283761|NCT00950846|593407704|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
164283762|NCT02114606|593407705|FG000|Overall Study|Unable to swallow Cytosponge|6|||
164283763|NCT03361293|593407706|FG000|Overall Study|Lost to Follow-up|0|||
164283764|NCT03361293|593407707|FG001|Overall Study|Lost to Follow-up|2|||
164283765|NCT03361293|593407706|FG000|Overall Study|Withdrawal by Subject|1|||
164283766|NCT03361293|593407707|FG001|Overall Study|Withdrawal by Subject|3|||
164283767|NCT00571038|593407708|FG000|Overall Study|Lost to Follow-up|1|||
164283768|NCT00571038|593407709|FG001|Overall Study|Lost to Follow-up|4|||
164283769|NCT00571038|593407708|FG000|Overall Study|Death|7|||
164283770|NCT00571038|593407709|FG001|Overall Study|Death|5|||
164283771|NCT00571038|593407708|FG000|Overall Study|Withdrawal by Subject|1|||
164283772|NCT00571038|593407709|FG001|Overall Study|Withdrawal by Subject|3|||
164283773|NCT00571038|593407708|FG000|Overall Study|Moved out of state|2|||
164283774|NCT00571038|593407709|FG001|Overall Study|Moved out of state|2|||
164283775|NCT04829916|593407710|FG000|Overall Study|Withdrawal by Subject|1|||
164283776|NCT04829916|593407711|FG001|Overall Study|Withdrawal by Subject|0|||
164283777|NCT03594773|593407715|FG000|Overall Study|Withdrawal by Subject|3|||
164283778|NCT03594773|593407716|FG001|Overall Study|Withdrawal by Subject|2|||
164283779|NCT03594773|593407715|FG000|Overall Study|Lost to Follow-up|3|||
164283780|NCT03594773|593407716|FG001|Overall Study|Lost to Follow-up|4|||
164283781|NCT04854551|593407717|FG000|Overall Study|Withdrawal by Subject|1|||
164283782|NCT04854551|593407718|FG001|Overall Study|Withdrawal by Subject|1|||
164283783|NCT04390243|593407724|FG000|Overall Study|Death|1|||
164283784|NCT04390243|593407724|FG000|Overall Study|Disease Progression|4|||
164283785|NCT04390243|593407724|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
164283786|NCT01521507|593407731|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
164283787|NCT01521507|593407732|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
164283788|NCT01521507|593407731|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
164283789|NCT01521507|593407732|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
164283790|NCT01521507|593407731|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
164283791|NCT01521507|593407732|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
164283792|NCT01521507|593407731|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
164283793|NCT01521507|593407732|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
164283794|NCT01521507|593407731|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
164283795|NCT01521507|593407732|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
164283796|NCT01521507|593407731|FG000|Stage 2: Observational Design|Physician Decision|1|||
164283797|NCT01521507|593407732|FG001|Stage 2: Observational Design|Physician Decision|0|||
164433256|NCT01833065|593957202|FG004|Overall Study|Lost to Follow-up|3|||
164283798|NCT04034004|593407733|FG000|Overall Study|Withdrawal by Subject|1|||
164283799|NCT04034004|593407734|FG001|Overall Study|Withdrawal by Subject|2|||
164283800|NCT04034004|593407735|FG002|Overall Study|Withdrawal by Subject|2|||
164283801|NCT04034004|593407736|FG003|Overall Study|Withdrawal by Subject|3|||
164283802|NCT04034004|593407733|FG000|Overall Study|could not find vein to administer IV|2|||
164283803|NCT04034004|593407734|FG001|Overall Study|could not find vein to administer IV|1|||
164283804|NCT04034004|593407735|FG002|Overall Study|could not find vein to administer IV|0|||
164283805|NCT04034004|593407736|FG003|Overall Study|could not find vein to administer IV|0|||
164283806|NCT04034004|593407733|FG000|Overall Study|nurse accidentally unblinded subject|0|||
164283807|NCT04034004|593407734|FG001|Overall Study|nurse accidentally unblinded subject|0|||
164283808|NCT04034004|593407735|FG002|Overall Study|nurse accidentally unblinded subject|0|||
164283809|NCT04034004|593407736|FG003|Overall Study|nurse accidentally unblinded subject|1|||
164283810|NCT04317040|593407737|FG000|Overall Study|Lost to Follow-up|2|||
164283811|NCT04317040|593407738|FG001|Overall Study|Lost to Follow-up|0|||
164283812|NCT04317040|593407737|FG000|Overall Study|Death|16|||
164283813|NCT04317040|593407738|FG001|Overall Study|Death|18|||
164283814|NCT04317040|593407737|FG000|Overall Study|Withdrawal by Subject|0|||
164283815|NCT04317040|593407738|FG001|Overall Study|Withdrawal by Subject|1|||
164283816|NCT04317040|593407737|FG000|Overall Study|Incomplete assessments|0|||
164691770|NCT02174276|594893260|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
164691771|NCT02174276|594893261|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
164691772|NCT02174276|594893258|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
164691773|NCT02174276|594893259|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
164691774|NCT02174276|594893260|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
164283817|NCT04317040|593407738|FG001|Overall Study|Incomplete assessments|1|||
164283818|NCT03672292|593407739|FG000|Overall Study|Adverse Event|3|||
164283819|NCT03672292|593407740|FG001|Overall Study|Adverse Event|1|||
164283820|NCT03672292|593407739|FG000|Overall Study|Physician Decision|0|||
164283821|NCT03672292|593407740|FG001|Overall Study|Physician Decision|1|||
164283822|NCT03672292|593407739|FG000|Overall Study|Withdrawal by Subject|1|||
164283823|NCT03672292|593407740|FG001|Overall Study|Withdrawal by Subject|2|||
164283824|NCT00799903|593407741|FG000|Overall Study|Investigator Site Closed|25|||
164283825|NCT00799903|593407742|FG001|Overall Study|Investigator Site Closed|23|||
164283826|NCT00799903|593407741|FG000|Overall Study|Withdrawal by Subject|179|||
164283827|NCT00799903|593407742|FG001|Overall Study|Withdrawal by Subject|175|||
164283828|NCT00799903|593407741|FG000|Overall Study|Lost to Follow-up|69|||
164283829|NCT00799903|593407742|FG001|Overall Study|Lost to Follow-up|80|||
164283830|NCT02518971|593407743|FG000|Overall Study|Lost to Follow-up|0|||
164283831|NCT02518971|593407744|FG001|Overall Study|Lost to Follow-up|1|||
164283832|NCT02518971|593407743|FG000|Overall Study|Physician Decision|6|||
164283833|NCT02518971|593407744|FG001|Overall Study|Physician Decision|6|||
164283834|NCT02518971|593407743|FG000|Overall Study|Protocol Violation|6|||
164283835|NCT02518971|593407744|FG001|Overall Study|Protocol Violation|4|||
164283836|NCT02518971|593407743|FG000|Overall Study|Withdrawal by Subject|4|||
164283837|NCT02518971|593407744|FG001|Overall Study|Withdrawal by Subject|5|||
164691775|NCT02174276|594893261|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
164691776|NCT02174276|594893258|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
164344651|NCT03988088|593637006|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
164344652|NCT03988088|593637003|FG000|Open-Label Addendum|Lost to Follow-up|0|||
164344653|NCT03988088|593637004|FG001|Open-Label Addendum|Lost to Follow-up|0|||
164344654|NCT03988088|593637005|FG002|Open-Label Addendum|Lost to Follow-up|1|||
164344655|NCT03988088|593637006|FG003|Open-Label Addendum|Lost to Follow-up|0|||
164344656|NCT01546883|593637009|FG000|Overall Study|Withdrawal by Subject|3|||
164344657|NCT01546883|593637009|FG000|Overall Study|Adverse Event|4|||
164344658|NCT01546883|593637009|FG000|Overall Study|Lost to Follow-up|2|||
164344659|NCT01546883|593637009|FG000|Overall Study|early closure of study|2|||
164344660|NCT01546883|593637009|FG000|Overall Study|other unrelated illness|1|||
164344661|NCT03344796|593637010|FG000|Overall Study|Lost to Follow-up|0|||
164344662|NCT03344796|593637011|FG001|Overall Study|Lost to Follow-up|0|||
164344663|NCT03344796|593637012|FG002|Overall Study|Lost to Follow-up|0|||
164344664|NCT03344796|593637013|FG003|Overall Study|Lost to Follow-up|0|||
164344665|NCT03344796|593637014|FG004|Overall Study|Lost to Follow-up|0|||
164344666|NCT03344796|593637015|FG005|Overall Study|Lost to Follow-up|2|||
164344667|NCT00915278|593637016|FG000|Overall Study|Death|1|||
164344668|NCT00915278|593637017|FG001|Overall Study|Death|0|||
164344669|NCT00915278|593637018|FG002|Overall Study|Death|0|||
164344670|NCT00915278|593637019|FG003|Overall Study|Death|0|||
164344671|NCT00915278|593637020|FG004|Overall Study|Death|0|||
164344672|NCT00915278|593637021|FG005|Overall Study|Death|0|||
164344673|NCT00915278|593637016|FG000|Overall Study|Lost to Follow-up|0|||
164344674|NCT00915278|593637017|FG001|Overall Study|Lost to Follow-up|1|||
164344675|NCT00915278|593637018|FG002|Overall Study|Lost to Follow-up|0|||
164344676|NCT00915278|593637019|FG003|Overall Study|Lost to Follow-up|0|||
164344677|NCT00915278|593637020|FG004|Overall Study|Lost to Follow-up|0|||
164344678|NCT00915278|593637021|FG005|Overall Study|Lost to Follow-up|0|||
164344679|NCT00915278|593637016|FG000|Overall Study|Withdrawal by Subject|0|||
164344680|NCT00915278|593637017|FG001|Overall Study|Withdrawal by Subject|1|||
164344681|NCT00915278|593637018|FG002|Overall Study|Withdrawal by Subject|0|||
164344682|NCT00915278|593637019|FG003|Overall Study|Withdrawal by Subject|0|||
164344683|NCT00915278|593637020|FG004|Overall Study|Withdrawal by Subject|1|||
164344684|NCT00915278|593637021|FG005|Overall Study|Withdrawal by Subject|4|||
164344685|NCT00915278|593637016|FG000|Overall Study|Adverse Event|4|||
164283838|NCT02518971|593407743|FG000|Overall Study|Side effects|1|||
164283839|NCT02518971|593407744|FG001|Overall Study|Side effects|0|||
164344686|NCT00915278|593637017|FG001|Overall Study|Adverse Event|1|||
164344687|NCT00915278|593637018|FG002|Overall Study|Adverse Event|0|||
164344688|NCT00915278|593637019|FG003|Overall Study|Adverse Event|0|||
164344689|NCT00915278|593637020|FG004|Overall Study|Adverse Event|0|||
164344690|NCT00915278|593637021|FG005|Overall Study|Adverse Event|0|||
164283840|NCT02518971|593407743|FG000|Overall Study|medication lost in mail|0|||
164283841|NCT02518971|593407744|FG001|Overall Study|medication lost in mail|1|||
164283842|NCT02518971|593407743|FG000|Overall Study|eligibility criteria no longer met|6|||
164344691|NCT00915278|593637016|FG000|Overall Study|Progressive disease/clinical progression|0|||
164344692|NCT00915278|593637017|FG001|Overall Study|Progressive disease/clinical progression|0|||
164344693|NCT00915278|593637018|FG002|Overall Study|Progressive disease/clinical progression|0|||
164344694|NCT00915278|593637019|FG003|Overall Study|Progressive disease/clinical progression|3|||
164283843|NCT02518971|593407744|FG001|Overall Study|eligibility criteria no longer met|3|||
164283844|NCT03088917|593407745|FG000|Overall Study|In care/cured elsewhere|15|||
164283845|NCT03088917|593407745|FG000|Overall Study|Refuse re-evaluation|13|||
164283846|NCT03088917|593407745|FG000|Overall Study|Contact not established|13|||
164283847|NCT03088917|593407745|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
164283848|NCT03088917|593407745|FG000|Overall Study|Moved outside study region|50|||
164283849|NCT01514201|593407750|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
164283850|NCT01514201|593407751|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
164283851|NCT01514201|593407752|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
164283852|NCT01514201|593407753|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
164283853|NCT01514201|593407750|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
164283854|NCT01514201|593407751|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
164283855|NCT01514201|593407752|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
164283856|NCT01514201|593407753|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
164283857|NCT01514201|593407750|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
164283858|NCT01514201|593407751|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
164283859|NCT01514201|593407752|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
164283860|NCT01514201|593407753|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
164283861|NCT01514201|593407750|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
164283862|NCT01514201|593407751|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
164283863|NCT01514201|593407752|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
164283864|NCT01514201|593407753|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
164283865|NCT01514201|593407750|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
164283866|NCT01514201|593407751|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
164283867|NCT01514201|593407752|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
164283868|NCT01514201|593407753|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
164283869|NCT01514201|593407750|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
164283870|NCT01514201|593407751|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
164283871|NCT01514201|593407752|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
164283872|NCT01514201|593407753|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
164283873|NCT01514201|593407750|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
164283874|NCT01514201|593407751|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
164283875|NCT01514201|593407752|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
164283876|NCT01514201|593407753|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
164283877|NCT01514201|593407750|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
164283878|NCT01514201|593407751|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
164283879|NCT01514201|593407752|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
164283880|NCT01514201|593407753|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
164283881|NCT01514201|593407750|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
164283882|NCT01514201|593407751|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
164283883|NCT01514201|593407752|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
164283884|NCT01514201|593407753|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
164283885|NCT01514201|593407750|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
164283886|NCT01514201|593407751|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
164283887|NCT01514201|593407752|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
164283888|NCT01514201|593407753|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
164283889|NCT01514201|593407750|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
164283890|NCT01514201|593407751|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
164283891|NCT01514201|593407752|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
164283892|NCT01514201|593407753|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
164283893|NCT01514201|593407750|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
164283894|NCT01514201|593407751|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
164283895|NCT01514201|593407752|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
164283896|NCT01514201|593407753|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
164283897|NCT02735343|593407759|FG000|Overall Study|screen fail|0|||
164283898|NCT02735343|593407760|FG001|Overall Study|screen fail|2|||
164283899|NCT00566852|593407771|FG000|Overall Study|Protocol Violation|22|||
164283900|NCT00566852|593407772|FG001|Overall Study|Protocol Violation|24|||
164283901|NCT00566852|593407771|FG000|Overall Study|Death|95|||
164283902|NCT00566852|593407772|FG001|Overall Study|Death|78|||
164283903|NCT00566852|593407771|FG000|Overall Study|Withdrawal by Subject|30|||
164283904|NCT00566852|593407772|FG001|Overall Study|Withdrawal by Subject|25|||
164691777|NCT02174276|594893259|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
164283905|NCT00566852|593407771|FG000|Overall Study|Patient refusal|37|||
164283906|NCT00566852|593407772|FG001|Overall Study|Patient refusal|37|||
164283907|NCT00566852|593407771|FG000|Overall Study|Not tested due to disability|6|||
164283908|NCT00566852|593407772|FG001|Overall Study|Not tested due to disability|12|||
164283909|NCT00566852|593407771|FG000|Overall Study|Missing reason not specified|1|||
164433257|NCT01833065|593957198|FG000|Overall Study|Withdrawal by Subject|6|||
164433258|NCT01833065|593957199|FG001|Overall Study|Withdrawal by Subject|2|||
164433259|NCT01833065|593957200|FG002|Overall Study|Withdrawal by Subject|4|||
164433260|NCT01833065|593957201|FG003|Overall Study|Withdrawal by Subject|3|||
164691778|NCT02174276|594893260|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
164283910|NCT00566852|593407772|FG001|Overall Study|Missing reason not specified|2|||
164691779|NCT02174276|594893261|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
164691780|NCT02174276|594893258|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
164691781|NCT02174276|594893259|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
164691782|NCT02174276|594893260|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
164691783|NCT02174276|594893261|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
164691784|NCT02661022|594893262|FG000|Overall Study|Withdrawal by Subject|3|||
164691785|NCT02661022|594893263|FG001|Overall Study|Withdrawal by Subject|0|||
164283911|NCT00566852|593407771|FG000|Overall Study|Missing reason not reported|16|||
164283912|NCT00566852|593407772|FG001|Overall Study|Missing reason not reported|20|||
164283913|NCT04531241|593407777|FG000|Period 1|Withdrawal by Subject|2|||
164283914|NCT04531241|593407778|FG001|Period 1|Withdrawal by Subject|0|||
164283915|NCT04531241|593407777|FG000|Period 1|Dispesed incorrect lens power|1|||
164283916|NCT04531241|593407778|FG001|Period 1|Dispesed incorrect lens power|0|||
164283917|NCT04531241|593407777|FG000|Period 1|Protocol Violation|1|||
164283918|NCT04531241|593407778|FG001|Period 1|Protocol Violation|0|||
164283919|NCT04531241|593407777|FG000|Period 1|No longer eligible|0|||
164283920|NCT04531241|593407778|FG001|Period 1|No longer eligible|1|||
164283921|NCT04531241|593407777|FG000|Period 1|Lens Discomfort|0|||
164691786|NCT02661022|594893262|FG000|Overall Study|Adverse Event|1|||
164691787|NCT02661022|594893263|FG001|Overall Study|Adverse Event|1|||
164691788|NCT02661022|594893262|FG000|Overall Study|Physician Decision|1|||
164691789|NCT02661022|594893263|FG001|Overall Study|Physician Decision|0|||
164691790|NCT02661022|594893262|FG000|Overall Study|Progressive Disease|2|||
164691791|NCT02661022|594893263|FG001|Overall Study|Progressive Disease|1|||
164691792|NCT00725764|594893265|FG000|Overall Study|Withdrawal by Subject|2|||
164691793|NCT00725764|594893265|FG000|Overall Study|Physician Decision|1|||
164691794|NCT00725764|594893265|FG000|Overall Study|Progressive Disease|7|||
164691795|NCT00725764|594893265|FG000|Overall Study|Lost to Follow-up|1|||
164691796|NCT00725764|594893265|FG000|Overall Study|Death|1|||
164691797|NCT00725764|594893265|FG000|Overall Study|Participant non compliant with protocol|1|||
164691798|NCT00725764|594893265|FG000|Overall Study|Decline in performance status|1|||
164691799|NCT04480307|594893266|FG000|Overall Study|Withdrawal by Subject|0|||
164691800|NCT04480307|594893267|FG001|Overall Study|Withdrawal by Subject|1|||
164691801|NCT04480307|594893268|FG002|Overall Study|Withdrawal by Subject|0|||
164691802|NCT04480307|594893269|FG003|Overall Study|Withdrawal by Subject|0|||
164691803|NCT04480307|594893266|FG000|Overall Study|Adverse Event|0|||
164691804|NCT04480307|594893267|FG001|Overall Study|Adverse Event|0|||
164691805|NCT04480307|594893268|FG002|Overall Study|Adverse Event|0|||
164691806|NCT04480307|594893269|FG003|Overall Study|Adverse Event|1|||
164691807|NCT00609154|594893270|FG000|Overall Study|Protocol Violation|1|||
164691808|NCT00609154|594893271|FG001|Overall Study|Protocol Violation|2|||
164691809|NCT00609154|594893270|FG000|Overall Study|Unable to establish IV access|0|||
164691810|NCT00609154|594893271|FG001|Overall Study|Unable to establish IV access|4|||
164691811|NCT00609154|594893270|FG000|Overall Study|Adverse Event|0|||
164691812|NCT00609154|594893271|FG001|Overall Study|Adverse Event|2|||
164691813|NCT00732160|594893279|FG000|Overall Study|Adverse Event|1|||
164691814|NCT00732160|594893280|FG001|Overall Study|Adverse Event|0|||
164691815|NCT00732160|594893281|FG002|Overall Study|Adverse Event|1|||
164691816|NCT00732160|594893282|FG003|Overall Study|Adverse Event|1|||
164691817|NCT00732160|594893279|FG000|Overall Study|scheduling|4|||
164691818|NCT00732160|594893280|FG001|Overall Study|scheduling|4|||
164283922|NCT04531241|593407778|FG001|Period 1|Lens Discomfort|1|||
164283923|NCT04531241|593407777|FG000|Period 2|Covid-19 Related|1|||
164283924|NCT04531241|593407778|FG001|Period 2|Covid-19 Related|1|||
164283925|NCT02715609|593407780|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
164283926|NCT02715609|593407781|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
164283927|NCT02715609|593407782|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
164283928|NCT02715609|593407780|FG000|Overall Study|Withdrawal by Subject|0|||
164283929|NCT02715609|593407781|FG001|Overall Study|Withdrawal by Subject|0|||
164433261|NCT01833065|593957202|FG004|Overall Study|Withdrawal by Subject|11|||
164283930|NCT02715609|593407782|FG002|Overall Study|Withdrawal by Subject|1|||
164433262|NCT01833065|593957198|FG000|Overall Study|Subject's substantial non-compliance|0|||
164691819|NCT00732160|594893281|FG002|Overall Study|scheduling|2|||
164283931|NCT03983304|593407783|FG000|Overall Study|Withdrawal by Subject|5|||
164283932|NCT03983304|593407783|FG000|Overall Study|Lost to Follow-up|2|||
164283933|NCT01702246|593407784|FG000|Overall Study|Lost to Follow-up|2|||
164283934|NCT01702246|593407784|FG000|Overall Study|Withdrawal by Subject|2|||
164691820|NCT00732160|594893282|FG003|Overall Study|scheduling|1|||
164691821|NCT03507686|594893293|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
164586374|NCT00408421|594511802|FG000|Treatment Re-Randomization|Protocol Violation|1|||
164586375|NCT00408421|594511803|FG001|Treatment Re-Randomization|Protocol Violation|1|||
164586376|NCT00408421|594511804|FG002|Treatment Re-Randomization|Protocol Violation|0|||
164586377|NCT00408421|594511802|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
164586378|NCT00408421|594511803|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
164586379|NCT00408421|594511804|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
164586380|NCT00710034|594511807|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
164586381|NCT00710034|594511808|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
164586382|NCT00710034|594511807|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
164586383|NCT00710034|594511808|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
164586384|NCT00710034|594511807|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
164586385|NCT00710034|594511808|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
164586386|NCT00710034|594511807|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
164586387|NCT00710034|594511808|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
164586388|NCT00710034|594511807|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
164586389|NCT00710034|594511808|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
164586390|NCT00710034|594511807|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
164586391|NCT00710034|594511808|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
164586392|NCT00710034|594511807|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
164586393|NCT00710034|594511808|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
164586394|NCT00710034|594511807|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
164586395|NCT00710034|594511808|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
164586396|NCT00710034|594511807|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
164586397|NCT00710034|594511808|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
164586398|NCT00710034|594511807|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
164691822|NCT03507686|594893294|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
164691823|NCT03507686|594893293|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
164691824|NCT03507686|594893294|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
164691825|NCT03507686|594893293|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
164283935|NCT01702246|593407784|FG000|Overall Study|Physician Decision|1|||
164283936|NCT01518374|593407787|FG000|Overall Study|Withdrawal by Subject|2|||
164283937|NCT01518374|593407787|FG000|Overall Study|Protocol Violation|3|||
164283938|NCT01518374|593407787|FG000|Overall Study|Lost to Follow-up|2|||
164283939|NCT02023996|593407790|FG000|Overall Study|Protocol Violation|6|||
164283940|NCT04209205|593407791|FG000|Overall Study|Adverse Event|2|||
164283941|NCT04209205|593407792|FG001|Overall Study|Adverse Event|3|||
164283942|NCT04209205|593407791|FG000|Overall Study|Lost to Follow-up|3|||
164283943|NCT04209205|593407792|FG001|Overall Study|Lost to Follow-up|1|||
164283944|NCT04209205|593407791|FG000|Overall Study|Physician Decision|1|||
164283945|NCT04209205|593407792|FG001|Overall Study|Physician Decision|1|||
164283946|NCT04209205|593407791|FG000|Overall Study|Subject decision|10|||
164283947|NCT04209205|593407792|FG001|Overall Study|Subject decision|10|||
164283948|NCT04209205|593407791|FG000|Overall Study|Progressive disease|1|||
164283949|NCT04209205|593407792|FG001|Overall Study|Progressive disease|0|||
164283950|NCT04209205|593407791|FG000|Overall Study|Protocol deviation|0|||
164283951|NCT04209205|593407792|FG001|Overall Study|Protocol deviation|1|||
164283952|NCT04209205|593407791|FG000|Overall Study|New therapy for study indication|1|||
164283953|NCT04209205|593407792|FG001|Overall Study|New therapy for study indication|0|||
164283954|NCT04209205|593407791|FG000|Overall Study|Adverse event - placebo not switched|0|||
164283955|NCT04209205|593407792|FG001|Overall Study|Adverse event - placebo not switched|1|||
164283956|NCT04209205|593407791|FG000|Overall Study|Subject decision - placebo not switched|0|||
164283957|NCT04209205|593407792|FG001|Overall Study|Subject decision - placebo not switched|5|||
164283958|NCT04209205|593407791|FG000|Overall Study|Death - placebo not switched|0|||
164283959|NCT04209205|593407792|FG001|Overall Study|Death - placebo not switched|1|||
164283960|NCT03400176|593407793|FG000|Dose Escalation|Progressive disease|1|||
164283961|NCT03400176|593407794|FG001|Dose Escalation|Progressive disease|1|||
164691826|NCT03507686|594893294|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
164283962|NCT03400176|593407795|FG002|Dose Escalation|Progressive disease|0|||
164691827|NCT03507686|594893293|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
164691828|NCT03507686|594893294|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
164691829|NCT03507686|594893293|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
164691830|NCT03507686|594893294|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
164283963|NCT03400176|593407796|FG003|Dose Escalation|Progressive disease|0|||
164586399|NCT00710034|594511808|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
164586400|NCT00710034|594511807|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
164283964|NCT03400176|593407797|FG004|Dose Escalation|Progressive disease|1|||
164283965|NCT03400176|593407793|FG000|Dose Escalation|Patient decision|0|||
164283966|NCT03400176|593407794|FG001|Dose Escalation|Patient decision|0|||
164283967|NCT03400176|593407795|FG002|Dose Escalation|Patient decision|0|||
164283968|NCT03400176|593407796|FG003|Dose Escalation|Patient decision|0|||
164691831|NCT03507686|594893293|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
164283969|NCT03400176|593407797|FG004|Dose Escalation|Patient decision|1|||
164283970|NCT03400176|593407793|FG000|Dose Expansion|Patient decision|0|||
164283971|NCT03400176|593407794|FG001|Dose Expansion|Patient decision|0|||
164283972|NCT03400176|593407795|FG002|Dose Expansion|Patient decision|0|||
164283973|NCT03400176|593407796|FG003|Dose Expansion|Patient decision|1|||
164283974|NCT03400176|593407797|FG004|Dose Expansion|Patient decision|0|||
164283975|NCT03400176|593407793|FG000|Dose Expansion|Adverse Event|0|||
164283976|NCT03400176|593407794|FG001|Dose Expansion|Adverse Event|0|||
164283977|NCT03400176|593407795|FG002|Dose Expansion|Adverse Event|0|||
164283978|NCT03400176|593407796|FG003|Dose Expansion|Adverse Event|1|||
164283979|NCT03400176|593407797|FG004|Dose Expansion|Adverse Event|0|||
164283980|NCT03400176|593407793|FG000|Dose Expansion|Physician Decision|0|||
164283981|NCT03400176|593407794|FG001|Dose Expansion|Physician Decision|0|||
164283982|NCT03400176|593407795|FG002|Dose Expansion|Physician Decision|0|||
164283983|NCT03400176|593407796|FG003|Dose Expansion|Physician Decision|1|||
164283984|NCT03400176|593407797|FG004|Dose Expansion|Physician Decision|0|||
164283985|NCT03400176|593407793|FG000|Dose Expansion|Progressive disease|0|||
164283986|NCT03400176|593407794|FG001|Dose Expansion|Progressive disease|0|||
164283987|NCT03400176|593407795|FG002|Dose Expansion|Progressive disease|1|||
164283988|NCT03400176|593407796|FG003|Dose Expansion|Progressive disease|1|||
164283989|NCT03400176|593407797|FG004|Dose Expansion|Progressive disease|0|||
164283990|NCT00048347|593407804|FG000|Overall Study|Screen failure|2|||
164283991|NCT02863328|593407805|FG000|Overall Study|Lost to Follow-up|4|||
164283992|NCT02863328|593407806|FG001|Overall Study|Lost to Follow-up|10|||
164283993|NCT02863328|593407805|FG000|Overall Study|Withdrawal by Subject|7|||
164283994|NCT02863328|593407806|FG001|Overall Study|Withdrawal by Subject|12|||
164283995|NCT02863328|593407805|FG000|Overall Study|Died|0|||
164283996|NCT02863328|593407806|FG001|Overall Study|Died|1|||
164283997|NCT04565951|593407807|FG000|Overall Study|Lost to Follow-up|66|||
164283998|NCT04565951|593407808|FG001|Overall Study|Lost to Follow-up|38|||
164283999|NCT04565951|593407807|FG000|Overall Study|Withdrawal by Subject|14|||
164284000|NCT04565951|593407808|FG001|Overall Study|Withdrawal by Subject|7|||
164284001|NCT04565951|593407807|FG000|Overall Study|Death|0|||
164284002|NCT04565951|593407808|FG001|Overall Study|Death|1|||
164284003|NCT00429169|593407809|FG000|Overall Study|Lost to Follow-up|0|||
164284004|NCT00429169|593407810|FG001|Overall Study|Lost to Follow-up|1|||
164284005|NCT00429169|593407809|FG000|Overall Study|Ineligibility discovered after entry|2|||
164284006|NCT00429169|593407810|FG001|Overall Study|Ineligibility discovered after entry|1|||
164284007|NCT00999544|593409491|FG000|Overall Study|Withdrawal by Subject|1|||
164284008|NCT01392547|593409492|FG000|Overall Study|Adverse Event|2|||
164284009|NCT01392547|593409492|FG000|Overall Study|Non-compliance|2|||
164284010|NCT01392547|593409492|FG000|Overall Study|Withdrawal criteria|3|||
164284011|NCT01392547|593409492|FG000|Overall Study|Unclassified|1|||
164284012|NCT04864639|593409495|FG000|Overall Study|Death|1|||
164284013|NCT04864639|593409495|FG000|Overall Study|Lost to Follow-up|1|||
164284014|NCT04050618|593409496|FG000|First Intervention|Withdrawal by Subject|2|||
164284015|NCT04050618|593409497|FG001|First Intervention|Withdrawal by Subject|0|||
164284016|NCT04050618|593409496|FG000|Second Intervention|Withdrawal by Subject|1|||
164433263|NCT01833065|593957199|FG001|Overall Study|Subject's substantial non-compliance|1|||
164433264|NCT01833065|593957200|FG002|Overall Study|Subject's substantial non-compliance|0|||
164433265|NCT01833065|593957201|FG003|Overall Study|Subject's substantial non-compliance|0|||
164433266|NCT01833065|593957202|FG004|Overall Study|Subject's substantial non-compliance|0|||
164433267|NCT01833065|593957198|FG000|Overall Study|Trial terminated by sponsor|8|||
164433268|NCT01833065|593957199|FG001|Overall Study|Trial terminated by sponsor|8|||
164433269|NCT01833065|593957200|FG002|Overall Study|Trial terminated by sponsor|7|||
164433270|NCT01833065|593957201|FG003|Overall Study|Trial terminated by sponsor|3|||
164586401|NCT00710034|594511808|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
164586402|NCT00494871|594511809|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
164586403|NCT00494871|594511810|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
164586404|NCT00494871|594511809|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
164586405|NCT00494871|594511810|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
164586406|NCT00494871|594511809|FG000|Double-blind (DB) Treatment Period|Death|8|||
164586407|NCT00494871|594511810|FG001|Double-blind (DB) Treatment Period|Death|3|||
164586408|NCT00494871|594511809|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
164586409|NCT00494871|594511810|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
164586410|NCT00494871|594511809|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
164586411|NCT00494871|594511810|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
164586412|NCT00494871|594511809|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
164586413|NCT00494871|594511810|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
164586414|NCT00494871|594511809|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
164586415|NCT00494871|594511810|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
164586416|NCT00494871|594511809|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
164586417|NCT00494871|594511810|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
164284017|NCT04050618|593409497|FG001|Second Intervention|Withdrawal by Subject|0|||
164284018|NCT04404556|593409498|FG000|Intervention|Withdrawal by Subject|15|||
164284019|NCT04404556|593409499|FG001|Intervention|Withdrawal by Subject|3|||
164284020|NCT04404556|593409498|FG000|Intervention|Did not complete all intervention sessions|2|||
164284021|NCT04404556|593409499|FG001|Intervention|Did not complete all intervention sessions|1|||
164284022|NCT04404556|593409498|FG000|Post-Intervention|Missing Data|1|||
164284023|NCT04404556|593409499|FG001|Post-Intervention|Missing Data|2|||
164284024|NCT04404556|593409498|FG000|Follow-up 1|Withdrawal by Subject|5|||
164284025|NCT04404556|593409499|FG001|Follow-up 1|Withdrawal by Subject|1|||
164284026|NCT04404556|593409498|FG000|Follow-up 1|Missing Data|4|||
164284027|NCT04404556|593409499|FG001|Follow-up 1|Missing Data|7|||
164284028|NCT04404556|593409498|FG000|Follow-up 2|Withdrawal by Subject|1|||
164284029|NCT04404556|593409499|FG001|Follow-up 2|Withdrawal by Subject|1|||
164284030|NCT04404556|593409498|FG000|Follow-up 2|Missing Data|6|||
164284031|NCT04404556|593409499|FG001|Follow-up 2|Missing Data|5|||
164284032|NCT01101035|593409509|FG000|Overall Study|Adverse Event|191|||
164284033|NCT01101035|593409510|FG001|Overall Study|Adverse Event|172|||
164284034|NCT01101035|593409509|FG000|Overall Study|Major Protocol Deviation|52|||
164284035|NCT01101035|593409510|FG001|Overall Study|Major Protocol Deviation|46|||
164284036|NCT01101035|593409509|FG000|Overall Study|Lost to Follow-up|226|||
164284037|NCT01101035|593409510|FG001|Overall Study|Lost to Follow-up|223|||
164284038|NCT01101035|593409509|FG000|Overall Study|Voluntary Withdrawal|595|||
164284039|NCT01101035|593409510|FG001|Overall Study|Voluntary Withdrawal|587|||
164284040|NCT01101035|593409509|FG000|Overall Study|Reason not Specified|333|||
164284041|NCT01101035|593409510|FG001|Overall Study|Reason not Specified|363|||
164284042|NCT00713544|593409514|FG000|Overall Study|Adverse Event|5|||
164284043|NCT00713544|593409515|FG001|Overall Study|Adverse Event|3|||
164284044|NCT00713544|593409516|FG002|Overall Study|Adverse Event|7|||
164284045|NCT00713544|593409517|FG003|Overall Study|Adverse Event|7|||
164284046|NCT00713544|593409518|FG004|Overall Study|Adverse Event|3|||
164284047|NCT00713544|593409519|FG005|Overall Study|Adverse Event|5|||
164284048|NCT00713544|593409514|FG000|Overall Study|Withdrawal by Subject|2|||
164284049|NCT00713544|593409515|FG001|Overall Study|Withdrawal by Subject|0|||
164284050|NCT00713544|593409516|FG002|Overall Study|Withdrawal by Subject|3|||
164284051|NCT00713544|593409517|FG003|Overall Study|Withdrawal by Subject|2|||
164284052|NCT00713544|593409518|FG004|Overall Study|Withdrawal by Subject|3|||
164284053|NCT00713544|593409519|FG005|Overall Study|Withdrawal by Subject|1|||
164284054|NCT00713544|593409514|FG000|Overall Study|Protocol Violation|0|||
164284055|NCT00713544|593409515|FG001|Overall Study|Protocol Violation|0|||
164284056|NCT00713544|593409516|FG002|Overall Study|Protocol Violation|0|||
164284057|NCT00713544|593409517|FG003|Overall Study|Protocol Violation|0|||
164284058|NCT00713544|593409518|FG004|Overall Study|Protocol Violation|0|||
164284059|NCT00713544|593409519|FG005|Overall Study|Protocol Violation|1|||
164284060|NCT00713544|593409514|FG000|Overall Study|Physician Decision|0|||
164284061|NCT00713544|593409515|FG001|Overall Study|Physician Decision|0|||
164284062|NCT00713544|593409516|FG002|Overall Study|Physician Decision|0|||
164284063|NCT00713544|593409517|FG003|Overall Study|Physician Decision|0|||
164284064|NCT00713544|593409518|FG004|Overall Study|Physician Decision|0|||
164284065|NCT00713544|593409519|FG005|Overall Study|Physician Decision|2|||
164284066|NCT00713544|593409514|FG000|Overall Study|Lack of Efficacy|0|||
164284067|NCT00713544|593409515|FG001|Overall Study|Lack of Efficacy|1|||
164284068|NCT00713544|593409516|FG002|Overall Study|Lack of Efficacy|0|||
164284069|NCT00713544|593409517|FG003|Overall Study|Lack of Efficacy|1|||
164284070|NCT00713544|593409518|FG004|Overall Study|Lack of Efficacy|1|||
164284071|NCT00713544|593409519|FG005|Overall Study|Lack of Efficacy|0|||
164284072|NCT00713544|593409514|FG000|Overall Study|Lost to Follow-up|0|||
164691832|NCT03507686|594893294|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
164691833|NCT00585312|594893295|FG000|Overall Study|Adverse Event|3|||
164691834|NCT00585312|594893296|FG001|Overall Study|Adverse Event|0|||
164691835|NCT00585312|594893295|FG000|Overall Study|Lack of Efficacy|6|||
164691836|NCT00585312|594893296|FG001|Overall Study|Lack of Efficacy|11|||
164691837|NCT00585312|594893295|FG000|Overall Study|Lost to Follow-up|1|||
164691838|NCT00585312|594893296|FG001|Overall Study|Lost to Follow-up|1|||
164691839|NCT00585312|594893295|FG000|Overall Study|Reason not specified|2|||
164691840|NCT00585312|594893296|FG001|Overall Study|Reason not specified|0|||
164691841|NCT00585312|594893295|FG000|Overall Study|Withdrawal by Subject|5|||
164691842|NCT00585312|594893296|FG001|Overall Study|Withdrawal by Subject|1|||
164691843|NCT00585312|594893295|FG000|Overall Study|Study terminated by the sponsor|34|||
164691844|NCT00585312|594893296|FG001|Overall Study|Study terminated by the sponsor|31|||
164691845|NCT02539368|594893298|FG000|Overall Study|Death|4|||
164691846|NCT02539368|594893299|FG001|Overall Study|Death|2|||
164691847|NCT02539368|594893300|FG002|Overall Study|Death|1|||
164691848|NCT02539368|594893301|FG003|Overall Study|Death|0|||
164691849|NCT02539368|594893302|FG004|Overall Study|Death|0|||
164691850|NCT02539368|594893298|FG000|Overall Study|Withdrawal by Subject|44|||
164691851|NCT02539368|594893299|FG001|Overall Study|Withdrawal by Subject|35|||
164691852|NCT02539368|594893300|FG002|Overall Study|Withdrawal by Subject|9|||
164284073|NCT00713544|593409515|FG001|Overall Study|Lost to Follow-up|0|||
164284074|NCT00713544|593409516|FG002|Overall Study|Lost to Follow-up|1|||
164284075|NCT00713544|593409517|FG003|Overall Study|Lost to Follow-up|0|||
164284076|NCT00713544|593409518|FG004|Overall Study|Lost to Follow-up|0|||
164284077|NCT00713544|593409519|FG005|Overall Study|Lost to Follow-up|0|||
164284078|NCT00713544|593409514|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
164284079|NCT00713544|593409515|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
164284080|NCT00713544|593409516|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
164284081|NCT00713544|593409517|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
164284082|NCT00713544|593409518|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
164284083|NCT00713544|593409519|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
164284084|NCT00713544|593409514|FG000|Overall Study|Incorrect enrollment|0|||
164284085|NCT00713544|593409515|FG001|Overall Study|Incorrect enrollment|1|||
164284086|NCT00713544|593409516|FG002|Overall Study|Incorrect enrollment|0|||
164284087|NCT00713544|593409517|FG003|Overall Study|Incorrect enrollment|0|||
164284088|NCT00713544|593409518|FG004|Overall Study|Incorrect enrollment|0|||
164284089|NCT00713544|593409519|FG005|Overall Study|Incorrect enrollment|0|||
164284090|NCT00713544|593409514|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
164284091|NCT00713544|593409515|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
164284092|NCT00713544|593409516|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
164284093|NCT00713544|593409517|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
164284094|NCT00713544|593409518|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
164284095|NCT00713544|593409519|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
164284096|NCT00269919|593409520|FG000|Overall Study|Other|26|||
164284097|NCT00269919|593409520|FG000|Overall Study|Started but not treated|1|||
164284098|NCT01641601|593409521|FG000|Overall Study|Study discontinued.|3|||
164284099|NCT01641601|593409522|FG001|Overall Study|Study discontinued.|5|||
164284100|NCT01799226|593409526|FG000|Overall Study|Withdrawal by Subject|1|||
164284101|NCT01799226|593409527|FG001|Overall Study|Withdrawal by Subject|0|||
164284102|NCT01799226|593409526|FG000|Overall Study|Disqualified at Day 14|1|||
164284103|NCT01799226|593409527|FG001|Overall Study|Disqualified at Day 14|0|||
164284104|NCT02178995|593409528|FG000|Double Blind|Adverse Event|0|||
164284105|NCT02178995|593409529|FG001|Double Blind|Adverse Event|0|||
164284106|NCT02178995|593409530|FG002|Double Blind|Adverse Event|0|||
164284107|NCT02178995|593409531|FG003|Double Blind|Adverse Event|0|||
164284108|NCT02178995|593409532|FG004|Double Blind|Adverse Event|0|||
164284109|NCT02178995|593409533|FG005|Double Blind|Adverse Event|1|||
164284110|NCT02178995|593409534|FG006|Double Blind|Adverse Event|0|||
164284111|NCT02178995|593409535|FG007|Double Blind|Adverse Event|1|||
164284112|NCT02178995|593409536|FG008|Double Blind|Adverse Event|1|||
164284113|NCT02178995|593409528|FG000|Double Blind|Lost to Follow-up|0|||
164284114|NCT02178995|593409529|FG001|Double Blind|Lost to Follow-up|1|||
164284115|NCT02178995|593409530|FG002|Double Blind|Lost to Follow-up|0|||
164344695|NCT00915278|593637020|FG004|Overall Study|Progressive disease/clinical progression|1|||
164344696|NCT00915278|593637021|FG005|Overall Study|Progressive disease/clinical progression|2|||
164344697|NCT00915278|593637016|FG000|Overall Study|Infusion related AEs|0|||
164344698|NCT00915278|593637017|FG001|Overall Study|Infusion related AEs|0|||
164344699|NCT00915278|593637018|FG002|Overall Study|Infusion related AEs|0|||
164344700|NCT00915278|593637019|FG003|Overall Study|Infusion related AEs|0|||
164344701|NCT00915278|593637020|FG004|Overall Study|Infusion related AEs|0|||
164284116|NCT02178995|593409531|FG003|Double Blind|Lost to Follow-up|0|||
164284117|NCT02178995|593409532|FG004|Double Blind|Lost to Follow-up|0|||
164284118|NCT02178995|593409533|FG005|Double Blind|Lost to Follow-up|0|||
164284119|NCT02178995|593409534|FG006|Double Blind|Lost to Follow-up|0|||
164284120|NCT02178995|593409535|FG007|Double Blind|Lost to Follow-up|1|||
164284121|NCT02178995|593409536|FG008|Double Blind|Lost to Follow-up|0|||
164284122|NCT02178995|593409528|FG000|Open Label|Adverse Event|2|||
164284123|NCT02178995|593409529|FG001|Open Label|Adverse Event|0|||
164284124|NCT02178995|593409530|FG002|Open Label|Adverse Event|0|||
164284125|NCT02178995|593409531|FG003|Open Label|Adverse Event|0|||
164284126|NCT02178995|593409532|FG004|Open Label|Adverse Event|0|||
164284127|NCT02178995|593409533|FG005|Open Label|Adverse Event|0|||
164284128|NCT02178995|593409534|FG006|Open Label|Adverse Event|0|||
164284129|NCT02178995|593409535|FG007|Open Label|Adverse Event|0|||
164284130|NCT02178995|593409536|FG008|Open Label|Adverse Event|0|||
164284131|NCT01388907|593409544|FG000|Overall Study|Adverse Event|2|||
164284132|NCT01388907|593409545|FG001|Overall Study|Adverse Event|0|||
164284133|NCT00981461|593409546|FG000|Overall Study|Lost to Follow-up|5|||
164344702|NCT00915278|593637021|FG005|Overall Study|Infusion related AEs|2|||
164344703|NCT00915278|593637016|FG000|Overall Study|Admission to hospice|0|||
164344704|NCT00915278|593637017|FG001|Overall Study|Admission to hospice|0|||
164586418|NCT00494871|594511809|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
164586419|NCT00494871|594511810|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
164586420|NCT00494871|594511809|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
164586421|NCT00494871|594511810|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
164586422|NCT00494871|594511809|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
164586423|NCT00494871|594511810|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
164284134|NCT00981461|593409547|FG001|Overall Study|Lost to Follow-up|2|||
164284135|NCT01910402|593409548|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
164284136|NCT01910402|593409549|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
164284137|NCT01910402|593409550|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
164284138|NCT01910402|593409548|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
164284139|NCT01910402|593409549|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
164284140|NCT01910402|593409550|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
164284141|NCT01910402|593409548|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
164284142|NCT01910402|593409549|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
164284143|NCT01910402|593409550|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
164284144|NCT01910402|593409548|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
164284145|NCT01910402|593409549|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
164284146|NCT01910402|593409550|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
164691853|NCT02539368|594893301|FG003|Overall Study|Withdrawal by Subject|1|||
164691854|NCT02539368|594893302|FG004|Overall Study|Withdrawal by Subject|3|||
164284147|NCT01910402|593409548|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
164284148|NCT01910402|593409549|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
164284149|NCT01910402|593409550|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
164284150|NCT01910402|593409548|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
164284151|NCT01910402|593409549|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
164284152|NCT01910402|593409550|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
164284153|NCT01910402|593409548|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
164284154|NCT01910402|593409549|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
164284155|NCT01910402|593409550|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
164284156|NCT01910402|593409548|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
164284157|NCT01910402|593409549|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
164284158|NCT01910402|593409550|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
164284159|NCT01910402|593409548|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
164284160|NCT01910402|593409549|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
164284161|NCT01910402|593409550|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
164284162|NCT01910402|593409548|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
164284163|NCT01910402|593409549|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
164284164|NCT01910402|593409550|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
164284165|NCT01910402|593409548|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
164284166|NCT01910402|593409549|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
164284167|NCT01910402|593409550|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
164284168|NCT01910402|593409548|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
164284169|NCT01910402|593409549|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
164284170|NCT01910402|593409550|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
164284171|NCT01910402|593409548|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
164284172|NCT01910402|593409549|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
164284173|NCT01910402|593409550|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
164284174|NCT00483405|593409551|FG000|Overall Study|Adverse Event|8|||
164284175|NCT00483405|593409551|FG000|Overall Study|Lack of Efficacy|14|||
164284176|NCT00483405|593409551|FG000|Overall Study|Death|3|||
164284177|NCT00483405|593409551|FG000|Overall Study|Withdrawal by Subject|2|||
164691855|NCT02539368|594893298|FG000|Overall Study|Physician Decision|49|||
164691856|NCT02539368|594893299|FG001|Overall Study|Physician Decision|15|||
164691857|NCT02539368|594893300|FG002|Overall Study|Physician Decision|7|||
164691858|NCT02539368|594893301|FG003|Overall Study|Physician Decision|0|||
164691859|NCT02539368|594893302|FG004|Overall Study|Physician Decision|2|||
164691860|NCT02539368|594893298|FG000|Overall Study|Lost to Follow-up|96|||
164691861|NCT02539368|594893299|FG001|Overall Study|Lost to Follow-up|21|||
164691862|NCT02539368|594893300|FG002|Overall Study|Lost to Follow-up|16|||
164284178|NCT00483405|593409551|FG000|Overall Study|Other complicating disease|1|||
164284179|NCT03010319|593409552|FG000|Overall Study|Adverse Event|15|||
164284180|NCT03010319|593409553|FG001|Overall Study|Adverse Event|9|||
164284181|NCT03010319|593409552|FG000|Overall Study|Withdrawal by Subject|1|||
164284182|NCT03010319|593409553|FG001|Overall Study|Withdrawal by Subject|6|||
164284183|NCT03010319|593409552|FG000|Overall Study|Physician Decision|2|||
164284184|NCT03010319|593409553|FG001|Overall Study|Physician Decision|4|||
164284185|NCT03010319|593409552|FG000|Overall Study|Sponsor requested withdrawal|2|||
164284186|NCT03010319|593409553|FG001|Overall Study|Sponsor requested withdrawal|2|||
164284187|NCT03010319|593409552|FG000|Overall Study|Death|1|||
164284188|NCT03010319|593409553|FG001|Overall Study|Death|0|||
164284189|NCT03010319|593409552|FG000|Overall Study|Lost to Follow-up|0|||
164691863|NCT02539368|594893301|FG003|Overall Study|Lost to Follow-up|4|||
164691864|NCT02539368|594893302|FG004|Overall Study|Lost to Follow-up|3|||
164691865|NCT02539368|594893298|FG000|Overall Study|Adverse Event|44|||
164691866|NCT02539368|594893299|FG001|Overall Study|Adverse Event|5|||
164691867|NCT02539368|594893300|FG002|Overall Study|Adverse Event|9|||
164691868|NCT02539368|594893301|FG003|Overall Study|Adverse Event|0|||
164284190|NCT03010319|593409553|FG001|Overall Study|Lost to Follow-up|1|||
164284191|NCT03010319|593409552|FG000|Overall Study|Other Reason|5|||
164284192|NCT03010319|593409553|FG001|Overall Study|Other Reason|7|||
164284193|NCT02128724|593409554|FG000|Overall Study|Death|1|||
164284194|NCT02128724|593409555|FG001|Overall Study|Death|0|||
164284195|NCT02128724|593409556|FG002|Overall Study|Death|0|||
164284196|NCT02128724|593409557|FG003|Overall Study|Death|0|||
164284197|NCT02128724|593409554|FG000|Overall Study|Adverse Event|0|||
164284198|NCT02128724|593409555|FG001|Overall Study|Adverse Event|1|||
164284199|NCT02128724|593409556|FG002|Overall Study|Adverse Event|0|||
164284200|NCT02128724|593409557|FG003|Overall Study|Adverse Event|0|||
164284201|NCT02128724|593409554|FG000|Overall Study|Physician Decision|0|||
164284202|NCT02128724|593409555|FG001|Overall Study|Physician Decision|0|||
164284203|NCT02128724|593409556|FG002|Overall Study|Physician Decision|0|||
164284204|NCT02128724|593409557|FG003|Overall Study|Physician Decision|2|||
164284205|NCT02128724|593409554|FG000|Overall Study|Withdrawal by Subject|0|||
164284206|NCT02128724|593409555|FG001|Overall Study|Withdrawal by Subject|0|||
164284207|NCT02128724|593409556|FG002|Overall Study|Withdrawal by Subject|0|||
164284208|NCT02128724|593409557|FG003|Overall Study|Withdrawal by Subject|1|||
164284209|NCT01957202|593409559|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284210|NCT01957202|593409560|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
164284211|NCT01957202|593409561|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284212|NCT01957202|593409562|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284213|NCT01957202|593409563|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284214|NCT01957202|593409564|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284215|NCT01957202|593409565|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284216|NCT01957202|593409566|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284217|NCT01957202|593409567|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284218|NCT01957202|593409568|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284219|NCT01957202|593409569|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284220|NCT01957202|593409570|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284221|NCT01957202|593409571|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164586424|NCT00494871|594511809|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
164284222|NCT01957202|593409572|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284223|NCT01957202|593409573|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284224|NCT01957202|593409574|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284225|NCT01957202|593409575|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
164284226|NCT01957202|593409576|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284227|NCT01957202|593409559|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284228|NCT01957202|593409560|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284229|NCT01957202|593409561|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284230|NCT01957202|593409562|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284231|NCT01957202|593409563|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284232|NCT01957202|593409564|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284233|NCT01957202|593409565|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284234|NCT01957202|593409566|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284235|NCT01957202|593409567|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284236|NCT01957202|593409568|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284237|NCT01957202|593409569|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284238|NCT01957202|593409570|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284239|NCT01957202|593409571|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284240|NCT01957202|593409572|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284241|NCT01957202|593409573|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284242|NCT01957202|593409574|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284243|NCT01957202|593409575|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
164284244|NCT01957202|593409576|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284245|NCT02640547|593409579|FG000|Overall Study|Failure to Return|1|||
164284246|NCT02640547|593409579|FG000|Overall Study|Withdrawal by Subject|1|||
164284247|NCT02640547|593409579|FG000|Overall Study|Death|6|||
164284248|NCT02640547|593409579|FG000|Overall Study|Miscellaneous|3|||
164284249|NCT04098809|593409580|FG000|Overall Study|Withdrawal by Subject|1|||
164284250|NCT04098809|593409581|FG001|Overall Study|Withdrawal by Subject|3|||
164284251|NCT04098809|593409580|FG000|Overall Study|Physician Decision|2|||
164284252|NCT04098809|593409581|FG001|Overall Study|Physician Decision|1|||
164284253|NCT00193206|593409582|FG000|Preoperative Therapy|Lack of Efficacy|2|||
164284254|NCT00193206|593409582|FG000|Preoperative Therapy|Adverse Event|2|||
164284255|NCT00193206|593409582|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
164284256|NCT00193206|593409582|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
164284257|NCT00193206|593409582|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
164284258|NCT00193206|593409582|FG000|Postoperative Therapy|Physician Decision|3|||
164284259|NCT00193206|593409582|FG000|Postoperative Therapy|Intercurrent Illness|2|||
164284260|NCT00193206|593409582|FG000|Postoperative Therapy|Lack of Efficacy|1|||
164284261|NCT00193206|593409582|FG000|Postoperative Therapy|Protocol Violation|1|||
164284262|NCT01200368|593409587|FG000|Infant Series|Adverse Event|2|||
164284263|NCT01200368|593409588|FG001|Infant Series|Adverse Event|2|||
164691869|NCT02539368|594893302|FG004|Overall Study|Adverse Event|3|||
164691870|NCT02539368|594893298|FG000|Overall Study|Participant Non-compliant|13|||
164691871|NCT02539368|594893299|FG001|Overall Study|Participant Non-compliant|2|||
164691872|NCT02539368|594893300|FG002|Overall Study|Participant Non-compliant|1|||
164284264|NCT01200368|593409589|FG002|Infant Series|Adverse Event|3|||
164284265|NCT01200368|593409587|FG000|Infant Series|Withdrawal by Subject|0|||
164284266|NCT01200368|593409588|FG001|Infant Series|Withdrawal by Subject|2|||
164284267|NCT01200368|593409589|FG002|Infant Series|Withdrawal by Subject|2|||
164284268|NCT01200368|593409587|FG000|Infant Series|Did not meet entrance criteria|0|||
164284269|NCT01200368|593409588|FG001|Infant Series|Did not meet entrance criteria|1|||
164284270|NCT01200368|593409589|FG002|Infant Series|Did not meet entrance criteria|0|||
164284271|NCT01200368|593409587|FG000|Infant Series|Randomized, not vaccinated|0|||
164284272|NCT01200368|593409588|FG001|Infant Series|Randomized, not vaccinated|1|||
164284273|NCT01200368|593409589|FG002|Infant Series|Randomized, not vaccinated|1|||
164691873|NCT02539368|594893301|FG003|Overall Study|Participant Non-compliant|1|||
164691874|NCT02539368|594893302|FG004|Overall Study|Participant Non-compliant|0|||
164284274|NCT01200368|593409587|FG000|Infant Series|Other|1|||
164691875|NCT02539368|594893298|FG000|Overall Study|Other|145|||
164691876|NCT02539368|594893299|FG001|Overall Study|Other|18|||
164691877|NCT02539368|594893300|FG002|Overall Study|Other|24|||
164691878|NCT02539368|594893301|FG003|Overall Study|Other|1|||
164691879|NCT02539368|594893302|FG004|Overall Study|Other|3|||
164691880|NCT02539368|594893298|FG000|Overall Study|Missing|10|||
164284275|NCT01200368|593409588|FG001|Infant Series|Other|0|||
164284276|NCT01200368|593409589|FG002|Infant Series|Other|0|||
164284277|NCT01200368|593409587|FG000|After Infant Series|Adverse Event|6|||
164284278|NCT01200368|593409588|FG001|After Infant Series|Adverse Event|6|||
164691881|NCT02539368|594893299|FG001|Overall Study|Missing|3|||
164691882|NCT02539368|594893300|FG002|Overall Study|Missing|0|||
164691883|NCT02539368|594893301|FG003|Overall Study|Missing|0|||
164284279|NCT01200368|593409589|FG002|After Infant Series|Adverse Event|3|||
164284280|NCT01200368|593409587|FG000|After Infant Series|Withdrawal by Subject|10|||
164284281|NCT01200368|593409588|FG001|After Infant Series|Withdrawal by Subject|8|||
164284282|NCT01200368|593409589|FG002|After Infant Series|Withdrawal by Subject|4|||
164284283|NCT01200368|593409587|FG000|After Infant Series|Lost to Follow-up|1|||
164284284|NCT01200368|593409588|FG001|After Infant Series|Lost to Follow-up|0|||
164284285|NCT01200368|593409589|FG002|After Infant Series|Lost to Follow-up|0|||
164284286|NCT01200368|593409587|FG000|After Infant Series|Other|1|||
164284287|NCT01200368|593409588|FG001|After Infant Series|Other|2|||
164284288|NCT01200368|593409589|FG002|After Infant Series|Other|2|||
164284289|NCT01200368|593409587|FG000|Toddler Dose|Adverse Event|0|||
164284290|NCT01200368|593409588|FG001|Toddler Dose|Adverse Event|3|||
164284291|NCT01200368|593409589|FG002|Toddler Dose|Adverse Event|1|||
164284292|NCT01290757|593409591|FG000|Overall Study|Adverse Event|1|||
164284293|NCT01290757|593409592|FG001|Overall Study|Adverse Event|0|||
164284294|NCT01290757|593409591|FG000|Overall Study|Protocol Violation|1|||
164284295|NCT01290757|593409592|FG001|Overall Study|Protocol Violation|1|||
164284296|NCT01290757|593409591|FG000|Overall Study|Other|0|||
164284297|NCT01290757|593409592|FG001|Overall Study|Other|1|||
164284298|NCT00570310|593409593|FG000|Overall Study|Adverse Event|1|||
164284299|NCT00570310|593409594|FG001|Overall Study|Adverse Event|2|||
164284300|NCT00570310|593409593|FG000|Overall Study|Lack of Efficacy|1|||
164284301|NCT00570310|593409594|FG001|Overall Study|Lack of Efficacy|4|||
164284302|NCT03066193|593409597|FG000|Overall Study|Withdrawal by Subject|1|||
164284303|NCT00181766|593409607|FG000|Overall Study|Lost to Follow-up|6|||
164284304|NCT00181766|593409607|FG000|Overall Study|Adverse Event|4|||
164284305|NCT00181766|593409607|FG000|Overall Study|non-compliance|2|||
164284306|NCT00757237|593409612|FG000|Overall Study|Lost to Follow-up|0|||
164284307|NCT00757237|593409613|FG001|Overall Study|Lost to Follow-up|1|||
164284308|NCT00757237|593409612|FG000|Overall Study|Protocol Violation|0|||
164284309|NCT00757237|593409613|FG001|Overall Study|Protocol Violation|2|||
164284310|NCT00757237|593409612|FG000|Overall Study|Physician Decision|2|||
164284311|NCT00757237|593409613|FG001|Overall Study|Physician Decision|3|||
164284312|NCT00757237|593409612|FG000|Overall Study|Withdrawal by Subject|8|||
164284313|NCT00757237|593409613|FG001|Overall Study|Withdrawal by Subject|12|||
164284314|NCT00757237|593409612|FG000|Overall Study|Safety or Tolerability|3|||
164284315|NCT00757237|593409613|FG001|Overall Study|Safety or Tolerability|5|||
164284316|NCT00757237|593409612|FG000|Overall Study|Other|0|||
164284317|NCT00757237|593409613|FG001|Overall Study|Other|2|||
164284318|NCT01843023|593409614|FG000|Overall Study|Death|1|||
164284319|NCT01843023|593409615|FG001|Overall Study|Death|0|||
164284320|NCT01843023|593409614|FG000|Overall Study|Lost to Follow-up|24|||
164284321|NCT01843023|593409615|FG001|Overall Study|Lost to Follow-up|29|||
164284322|NCT01843023|593409614|FG000|Overall Study|Withdrawal by Subject|8|||
164284323|NCT01843023|593409615|FG001|Overall Study|Withdrawal by Subject|6|||
164284324|NCT01397461|593409617|FG000|Overall Study|Withdrawal by Subject|2|||
164284325|NCT01397461|593409618|FG001|Overall Study|Withdrawal by Subject|1|||
164284326|NCT01397461|593409619|FG002|Overall Study|Withdrawal by Subject|0|||
164284327|NCT01397461|593409617|FG000|Overall Study|Lost to Follow-up|0|||
164284328|NCT01397461|593409618|FG001|Overall Study|Lost to Follow-up|2|||
164284329|NCT01397461|593409619|FG002|Overall Study|Lost to Follow-up|1|||
164284330|NCT01397461|593409617|FG000|Overall Study|Lack of Efficacy|0|||
164284331|NCT01397461|593409618|FG001|Overall Study|Lack of Efficacy|3|||
164284332|NCT01397461|593409619|FG002|Overall Study|Lack of Efficacy|0|||
164284333|NCT01397461|593409617|FG000|Overall Study|Not treated|0|||
164284334|NCT01397461|593409618|FG001|Overall Study|Not treated|0|||
164284335|NCT01397461|593409619|FG002|Overall Study|Not treated|1|||
164284336|NCT04980612|593409636|FG000|Overall Study|Withdrawal by Subject|7|||
164284337|NCT04980612|593409637|FG001|Overall Study|Withdrawal by Subject|5|||
164284338|NCT05730387|593409638|FG000|Overall Study|Stillbirth|0|||
164284339|NCT05730387|593409639|FG001|Overall Study|Stillbirth|262|||
164284340|NCT05730387|593409638|FG000|Overall Study|Died during or after delivery|2|||
164284341|NCT05730387|593409639|FG001|Overall Study|Died during or after delivery|85|||
164284342|NCT05730387|593409638|FG000|Overall Study|Died after being admitted|0|||
164284343|NCT05730387|593409639|FG001|Overall Study|Died after being admitted|44|||
164284344|NCT05730387|593409638|FG000|Overall Study|Lost to Follow-up|69|||
164284345|NCT05730387|593409639|FG001|Overall Study|Lost to Follow-up|77|||
164284346|NCT03364738|593409642|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
164284347|NCT03364738|593409642|FG000|Overall Study|Withdrawal by Subject|1|||
164284348|NCT03364738|593409642|FG000|Overall Study|Adverse Event|1|||
164284349|NCT03245398|593409643|FG000|Overall Study|Travelled to another island|1|||
164589045|NCT02232516|594521371|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
164284350|NCT03245398|593409644|FG001|Overall Study|Travelled to another island|0|||
164284351|NCT00637416|593409645|FG000|Overall Study|Lost to Follow-up|1|||
164284352|NCT00637416|593409646|FG001|Overall Study|Lost to Follow-up|1|||
164284353|NCT00637416|593409645|FG000|Overall Study|Unable to take study drug|0|||
164284354|NCT00637416|593409646|FG001|Overall Study|Unable to take study drug|1|||
164284355|NCT04137731|593409647|FG000|Overall Study|Surgery Cancellation|1|||
164284356|NCT04137731|593409648|FG001|Overall Study|Surgery Cancellation|2|||
164284357|NCT04137731|593409647|FG000|Overall Study|Withdrawal by Subject|2|||
164284358|NCT04137731|593409648|FG001|Overall Study|Withdrawal by Subject|0|||
164284359|NCT04137731|593409647|FG000|Overall Study|Protocol Violation|0|||
164284360|NCT04137731|593409648|FG001|Overall Study|Protocol Violation|1|||
164284361|NCT00310817|593409652|FG000|Overall Study|AE or Death|3|||
164284362|NCT00310817|593409653|FG001|Overall Study|AE or Death|1|||
164284363|NCT00310817|593409654|FG002|Overall Study|AE or Death|0|||
164284364|NCT00310817|593409655|FG003|Overall Study|AE or Death|0|||
164284365|NCT00310817|593409652|FG000|Overall Study|Withdrawal by Subject|1|||
164284366|NCT00310817|593409653|FG001|Overall Study|Withdrawal by Subject|4|||
164284367|NCT00310817|593409654|FG002|Overall Study|Withdrawal by Subject|6|||
164284368|NCT00310817|593409655|FG003|Overall Study|Withdrawal by Subject|7|||
164284369|NCT00310817|593409652|FG000|Overall Study|Lost to Follow-up|2|||
164284370|NCT00310817|593409653|FG001|Overall Study|Lost to Follow-up|1|||
164284371|NCT00310817|593409654|FG002|Overall Study|Lost to Follow-up|0|||
164284372|NCT00310817|593409655|FG003|Overall Study|Lost to Follow-up|0|||
164284373|NCT00310817|593409652|FG000|Overall Study|Inappropriate Enrollment|1|||
164284374|NCT00310817|593409653|FG001|Overall Study|Inappropriate Enrollment|0|||
164284375|NCT00310817|593409654|FG002|Overall Study|Inappropriate Enrollment|1|||
164284376|NCT00310817|593409655|FG003|Overall Study|Inappropriate Enrollment|0|||
164284377|NCT00310817|593409652|FG000|Overall Study|Protocol Violation|1|||
164284378|NCT00310817|593409653|FG001|Overall Study|Protocol Violation|1|||
164284379|NCT00310817|593409654|FG002|Overall Study|Protocol Violation|1|||
164344705|NCT00915278|593637018|FG002|Overall Study|Admission to hospice|1|||
164344706|NCT00915278|593637019|FG003|Overall Study|Admission to hospice|0|||
164691884|NCT02539368|594893302|FG004|Overall Study|Missing|0|||
164691885|NCT03558139|594893304|FG000|Overall Study|Consent Withdrawn|1|||
164691886|NCT03558139|594893305|FG001|Overall Study|Consent Withdrawn|1|||
164691887|NCT03558139|594893306|FG002|Overall Study|Consent Withdrawn|4|||
164691888|NCT03558139|594893304|FG000|Overall Study|Death|5|||
164691889|NCT03558139|594893305|FG001|Overall Study|Death|3|||
164691890|NCT03558139|594893306|FG002|Overall Study|Death|8|||
164691891|NCT03558139|594893304|FG000|Overall Study|Lost to Follow-up|0|||
164691892|NCT03558139|594893305|FG001|Overall Study|Lost to Follow-up|0|||
164691893|NCT03558139|594893306|FG002|Overall Study|Lost to Follow-up|3|||
164691894|NCT03558139|594893304|FG000|Overall Study|Study Ended Per Protocol|0|||
164691895|NCT03558139|594893305|FG001|Overall Study|Study Ended Per Protocol|3|||
164691896|NCT03558139|594893306|FG002|Overall Study|Study Ended Per Protocol|6|||
164691897|NCT02752802|594893307|FG000|Overall Study|Contrast Volume Not Collected|1|||
164691898|NCT02752802|594893308|FG001|Overall Study|Contrast Volume Not Collected|0|||
164691899|NCT00251316|594893309|FG000|Overall Study|Physician Decision|2|||
164691900|NCT00251316|594893310|FG001|Overall Study|Physician Decision|3|||
164691901|NCT00398073|594893311|FG000|Overall Study|Withdrawal by Subject|1|||
164691902|NCT00398073|594893312|FG001|Overall Study|Withdrawal by Subject|0|||
164691903|NCT03689894|594893314|FG000|Overall Study|Adverse Event|1|||
164691904|NCT00569777|594893315|FG000|Overall Study|Withdrawal by Subject|4|||
164691905|NCT00569777|594893316|FG001|Overall Study|Withdrawal by Subject|0|||
164691906|NCT00569777|594893315|FG000|Overall Study|Adverse Event|3|||
164691907|NCT00569777|594893316|FG001|Overall Study|Adverse Event|0|||
164344707|NCT00915278|593637020|FG004|Overall Study|Admission to hospice|0|||
164344708|NCT00915278|593637021|FG005|Overall Study|Admission to hospice|0|||
164344709|NCT02412618|593637022|FG000|Overall Study|Withdrawal by Subject|1|||
164344710|NCT02412618|593637023|FG001|Overall Study|Withdrawal by Subject|1|||
164344711|NCT02412618|593637022|FG000|Overall Study|Expulsion|1|||
164344712|NCT02412618|593637023|FG001|Overall Study|Expulsion|1|||
164344713|NCT01253408|593637024|FG000|Overall Study|Adverse Event|0|||
164344714|NCT01253408|593637025|FG001|Overall Study|Adverse Event|1|||
164344715|NCT01253408|593637026|FG002|Overall Study|Adverse Event|0|||
164344716|NCT03408483|593637027|FG000|Overall Study|Physician Decision|3|||
164691908|NCT00569777|594893315|FG000|Overall Study|Lost to Follow-up|1|||
164691909|NCT00569777|594893316|FG001|Overall Study|Lost to Follow-up|0|||
164691910|NCT00569777|594893315|FG000|Overall Study|scheduled eye surgery|0|||
164691911|NCT00569777|594893316|FG001|Overall Study|scheduled eye surgery|1|||
164691912|NCT00569777|594893315|FG000|Overall Study|did not meet exclusion criteria|1|||
164691913|NCT00569777|594893316|FG001|Overall Study|did not meet exclusion criteria|2|||
164284380|NCT00310817|593409655|FG003|Overall Study|Protocol Violation|1|||
164284381|NCT00310817|593409652|FG000|Overall Study|Unable to classify|3|||
164284382|NCT00310817|593409653|FG001|Overall Study|Unable to classify|1|||
164284383|NCT00310817|593409654|FG002|Overall Study|Unable to classify|0|||
164284384|NCT00310817|593409655|FG003|Overall Study|Unable to classify|0|||
164284385|NCT01587040|593409658|FG000|Overall Study|Protocol Violation|0|||
164284386|NCT01587040|593409659|FG001|Overall Study|Protocol Violation|0|||
164344717|NCT03408483|593637028|FG001|Overall Study|Physician Decision|3|||
164284387|NCT01587040|593409660|FG002|Overall Study|Protocol Violation|1|||
164284388|NCT01587040|593409661|FG003|Overall Study|Protocol Violation|0|||
164284389|NCT01587040|593409658|FG000|Overall Study|Adverse Event|0|||
164284390|NCT01587040|593409659|FG001|Overall Study|Adverse Event|1|||
164284391|NCT01587040|593409660|FG002|Overall Study|Adverse Event|10|||
164284392|NCT01587040|593409661|FG003|Overall Study|Adverse Event|0|||
164284393|NCT01587040|593409658|FG000|Overall Study|Disease progression|12|||
164284394|NCT01587040|593409659|FG001|Overall Study|Disease progression|1|||
164284395|NCT01587040|593409660|FG002|Overall Study|Disease progression|15|||
164691914|NCT00569777|594893315|FG000|Overall Study|pregnant|1|||
164691915|NCT00569777|594893316|FG001|Overall Study|pregnant|0|||
164691916|NCT02056652|594893321|FG000|Overall Study|Withdrawal by Subject|1|||
164691917|NCT02056652|594893322|FG001|Overall Study|Withdrawal by Subject|0|||
164691918|NCT02056652|594893321|FG000|Overall Study|Lost to Follow-up|0|||
164691919|NCT02056652|594893322|FG001|Overall Study|Lost to Follow-up|3|||
164691920|NCT01214239|594893327|FG000|Overall Study|Adverse Event|3|||
164691921|NCT01214239|594893328|FG001|Overall Study|Adverse Event|4|||
164691922|NCT01214239|594893327|FG000|Overall Study|Protocol Violation|2|||
164691923|NCT01214239|594893328|FG001|Overall Study|Protocol Violation|1|||
164691924|NCT01214239|594893327|FG000|Overall Study|Lost to Follow-up|1|||
164691925|NCT01214239|594893328|FG001|Overall Study|Lost to Follow-up|1|||
164691926|NCT01214239|594893327|FG000|Overall Study|Withdrawal by Subject|4|||
164691927|NCT01214239|594893328|FG001|Overall Study|Withdrawal by Subject|9|||
164691928|NCT01214239|594893327|FG000|Overall Study|Lack of Efficacy|1|||
164691929|NCT01214239|594893328|FG001|Overall Study|Lack of Efficacy|2|||
164691930|NCT01214239|594893327|FG000|Overall Study|patient's private reason|1|||
164691931|NCT01214239|594893328|FG001|Overall Study|patient's private reason|1|||
164691932|NCT00810602|594893329|FG000|Overall Study|Withdrawal by Subject|8|||
164691933|NCT00810602|594893330|FG001|Overall Study|Withdrawal by Subject|3|||
164691934|NCT01142661|594893331|FG000|Overall Study|Adverse Event|2|||
164691935|NCT01142661|594893331|FG000|Overall Study|Withdrawal by Subject|1|||
164691936|NCT01142661|594893331|FG000|Overall Study|Physician Decision|1|||
164691937|NCT00965731|594893334|FG000|Overall Study|Death|0|||
164691938|NCT00965731|594893335|FG001|Overall Study|Death|4|||
164691939|NCT00965731|594893334|FG000|Overall Study|Withdrawal by Subject|0|||
164691940|NCT00965731|594893335|FG001|Overall Study|Withdrawal by Subject|1|||
164691941|NCT00965731|594893334|FG000|Overall Study|Other|7|||
164691942|NCT00965731|594893335|FG001|Overall Study|Other|15|||
164691943|NCT04773600|594893336|FG000|Overall Study|Withdrawal by Subject|15|||
164691944|NCT04773600|594893337|FG001|Overall Study|Withdrawal by Subject|9|||
164691945|NCT04773600|594893336|FG000|Overall Study|Lost to Follow-up|10|||
164691946|NCT04773600|594893337|FG001|Overall Study|Lost to Follow-up|6|||
164691947|NCT04773600|594893336|FG000|Overall Study|Adverse Event|8|||
164691948|NCT04773600|594893337|FG001|Overall Study|Adverse Event|2|||
164691949|NCT04773600|594893336|FG000|Overall Study|Lack of Efficacy|2|||
164691950|NCT04773600|594893337|FG001|Overall Study|Lack of Efficacy|3|||
164691951|NCT04773600|594893336|FG000|Overall Study|Noncompliance|2|||
164691952|NCT04773600|594893337|FG001|Overall Study|Noncompliance|0|||
164691953|NCT04773600|594893336|FG000|Overall Study|Protocol Violation|2|||
164691954|NCT04773600|594893337|FG001|Overall Study|Protocol Violation|0|||
164691955|NCT04773600|594893336|FG000|Overall Study|Physician Decision|0|||
164691956|NCT04773600|594893337|FG001|Overall Study|Physician Decision|1|||
164691957|NCT04773600|594893336|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
164691958|NCT04773600|594893337|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
164691959|NCT04773600|594893336|FG000|Overall Study|Emergency Travel Out of Country|1|||
164691960|NCT04773600|594893337|FG001|Overall Study|Emergency Travel Out of Country|0|||
164691961|NCT03581188|594895245|FG000|Overall Study|Inclusion criteria not met|3|||
164691962|NCT03581188|594895246|FG001|Overall Study|Inclusion criteria not met|2|||
164691963|NCT03581188|594895245|FG000|Overall Study|Lost to Follow-up|5|||
164691964|NCT03581188|594895246|FG001|Overall Study|Lost to Follow-up|5|||
164691965|NCT03581188|594895245|FG000|Overall Study|Discontinued intervention|11|||
164691966|NCT03581188|594895246|FG001|Overall Study|Discontinued intervention|8|||
164691967|NCT01923311|594895249|FG000|Overall Study|Pregnancy|1|||
164691968|NCT01923311|594895250|FG001|Overall Study|Pregnancy|0|||
164691969|NCT01923311|594895249|FG000|Overall Study|Investigator's Discretion|1|||
164691970|NCT01923311|594895250|FG001|Overall Study|Investigator's Discretion|0|||
164691971|NCT01923311|594895249|FG000|Overall Study|Non-Compliance with Study Drug|2|||
164691972|NCT01923311|594895250|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164691973|NCT01923311|594895249|FG000|Overall Study|Withdrew Consent|1|||
164691974|NCT01923311|594895250|FG001|Overall Study|Withdrew Consent|0|||
164691975|NCT01923311|594895249|FG000|Overall Study|Study Terminated by Sponsor|12|||
164284396|NCT01587040|593409661|FG003|Overall Study|Disease progression|3|||
164284397|NCT01587040|593409658|FG000|Overall Study|Other than specified|5|||
164691976|NCT01923311|594895250|FG001|Overall Study|Study Terminated by Sponsor|0|||
164691977|NCT00991510|594895252|FG000|Period I (Days 1-14)|Adverse Event|1|||
164691978|NCT00991510|594895253|FG001|Period I (Days 1-14)|Adverse Event|0|||
164284398|NCT01587040|593409659|FG001|Overall Study|Other than specified|1|||
164284399|NCT01587040|593409660|FG002|Overall Study|Other than specified|11|||
164691979|NCT00991510|594895252|FG000|Period III (Days 29-112)|Adverse Event|1|||
164284400|NCT01587040|593409661|FG003|Overall Study|Other than specified|1|||
164284401|NCT00367835|593409665|FG000|Overall Study|Adverse Event|14|||
164284402|NCT00367835|593409666|FG001|Overall Study|Adverse Event|1|||
164284403|NCT00367835|593409665|FG000|Overall Study|Protocol Violation|1|||
164284404|NCT00367835|593409666|FG001|Overall Study|Protocol Violation|7|||
164284405|NCT00367835|593409665|FG000|Overall Study|Withdrawal by Subject|7|||
164284406|NCT00367835|593409666|FG001|Overall Study|Withdrawal by Subject|6|||
164284407|NCT00367835|593409665|FG000|Overall Study|Lost to Follow-up|1|||
164284408|NCT00367835|593409666|FG001|Overall Study|Lost to Follow-up|4|||
164284409|NCT00367835|593409665|FG000|Overall Study|Lack of Efficacy|3|||
164284410|NCT00367835|593409666|FG001|Overall Study|Lack of Efficacy|12|||
164284411|NCT00367835|593409665|FG000|Overall Study|Subject in juvenile detention center|1|||
164284412|NCT00367835|593409666|FG001|Overall Study|Subject in juvenile detention center|0|||
164284413|NCT00367835|593409665|FG000|Overall Study|refused blood collection|1|||
164284414|NCT00367835|593409666|FG001|Overall Study|refused blood collection|0|||
164284415|NCT00367835|593409665|FG000|Overall Study|Did not respond to calls|1|||
164284416|NCT00367835|593409666|FG001|Overall Study|Did not respond to calls|0|||
164284417|NCT00367835|593409665|FG000|Overall Study|History of lead poisoning|0|||
164284418|NCT00367835|593409666|FG001|Overall Study|History of lead poisoning|1|||
164284419|NCT04346654|593409668|FG000|Overall Study|Adverse Event|2|||
164284420|NCT04346654|593409669|FG001|Overall Study|Adverse Event|0|||
164284421|NCT04346654|593409668|FG000|Overall Study|Non-response|1|||
164284422|NCT04346654|593409669|FG001|Overall Study|Non-response|1|||
164284423|NCT04346654|593409668|FG000|Overall Study|Withdrawal by Subject|2|||
164284424|NCT04346654|593409669|FG001|Overall Study|Withdrawal by Subject|0|||
164284425|NCT04346654|593409668|FG000|Overall Study|Lost to Follow-up|0|||
164284426|NCT04346654|593409669|FG001|Overall Study|Lost to Follow-up|1|||
164284427|NCT04346654|593409668|FG000|Overall Study|Pregnancy|0|||
164284428|NCT04346654|593409669|FG001|Overall Study|Pregnancy|1|||
164284429|NCT00999518|593409673|FG000|Overall Study|Adverse Event|1|||
164284430|NCT00999518|593409674|FG001|Overall Study|Adverse Event|6|||
164284431|NCT00999518|593409675|FG002|Overall Study|Adverse Event|3|||
164284432|NCT00999518|593409676|FG003|Overall Study|Adverse Event|1|||
164284433|NCT00999518|593409677|FG004|Overall Study|Adverse Event|2|||
164284434|NCT00999518|593409673|FG000|Overall Study|Lack of Efficacy|2|||
164284435|NCT00999518|593409674|FG001|Overall Study|Lack of Efficacy|0|||
164284436|NCT00999518|593409675|FG002|Overall Study|Lack of Efficacy|0|||
164284437|NCT00999518|593409676|FG003|Overall Study|Lack of Efficacy|2|||
164284438|NCT00999518|593409677|FG004|Overall Study|Lack of Efficacy|2|||
164284439|NCT00999518|593409673|FG000|Overall Study|Lost to Follow-up|0|||
164284440|NCT00999518|593409674|FG001|Overall Study|Lost to Follow-up|0|||
164284441|NCT00999518|593409675|FG002|Overall Study|Lost to Follow-up|0|||
164284442|NCT00999518|593409676|FG003|Overall Study|Lost to Follow-up|4|||
164284443|NCT00999518|593409677|FG004|Overall Study|Lost to Follow-up|1|||
164284444|NCT00999518|593409673|FG000|Overall Study|Did not meet entrance criteria|0|||
164284445|NCT00999518|593409674|FG001|Overall Study|Did not meet entrance criteria|0|||
164284446|NCT00999518|593409675|FG002|Overall Study|Did not meet entrance criteria|0|||
164284447|NCT00999518|593409676|FG003|Overall Study|Did not meet entrance criteria|0|||
164284448|NCT00999518|593409677|FG004|Overall Study|Did not meet entrance criteria|1|||
164284449|NCT00999518|593409673|FG000|Overall Study|Study terminated by sponsor|10|||
164284450|NCT00999518|593409674|FG001|Overall Study|Study terminated by sponsor|6|||
164284451|NCT00999518|593409675|FG002|Overall Study|Study terminated by sponsor|5|||
164284452|NCT00999518|593409676|FG003|Overall Study|Study terminated by sponsor|5|||
164284453|NCT00999518|593409677|FG004|Overall Study|Study terminated by sponsor|9|||
164284454|NCT00999518|593409673|FG000|Overall Study|Pregnancy|0|||
164284455|NCT00999518|593409674|FG001|Overall Study|Pregnancy|0|||
164284456|NCT00999518|593409675|FG002|Overall Study|Pregnancy|1|||
164284457|NCT00999518|593409676|FG003|Overall Study|Pregnancy|0|||
164586425|NCT00494871|594511810|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
164586426|NCT00494871|594511809|FG000|Follow-up (FU) Period|Adverse Event|1|||
164586427|NCT00494871|594511810|FG001|Follow-up (FU) Period|Adverse Event|1|||
164586428|NCT00494871|594511809|FG000|Follow-up (FU) Period|Death|13|||
164586429|NCT00494871|594511810|FG001|Follow-up (FU) Period|Death|12|||
164586430|NCT00494871|594511809|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
164284458|NCT00999518|593409677|FG004|Overall Study|Pregnancy|0|||
164284459|NCT00999518|593409673|FG000|Overall Study|Protocol Violation|0|||
164284460|NCT00999518|593409674|FG001|Overall Study|Protocol Violation|1|||
164284461|NCT00999518|593409675|FG002|Overall Study|Protocol Violation|0|||
164284462|NCT00999518|593409676|FG003|Overall Study|Protocol Violation|0|||
164586431|NCT00494871|594511810|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
164284463|NCT00999518|593409677|FG004|Overall Study|Protocol Violation|2|||
164284464|NCT00999518|593409673|FG000|Overall Study|Withdrawal by Subject|5|||
164284465|NCT00999518|593409674|FG001|Overall Study|Withdrawal by Subject|4|||
164284466|NCT00999518|593409675|FG002|Overall Study|Withdrawal by Subject|10|||
164284467|NCT00999518|593409676|FG003|Overall Study|Withdrawal by Subject|6|||
164284468|NCT00999518|593409677|FG004|Overall Study|Withdrawal by Subject|1|||
164284469|NCT00999518|593409673|FG000|Overall Study|Other|5|||
164284470|NCT00999518|593409674|FG001|Overall Study|Other|7|||
164284471|NCT00999518|593409675|FG002|Overall Study|Other|1|||
164284472|NCT00999518|593409676|FG003|Overall Study|Other|4|||
164284473|NCT00999518|593409677|FG004|Overall Study|Other|5|||
164284474|NCT00999518|593409673|FG000|Overall Study|Randomized but not Treated|1|||
164284475|NCT00999518|593409674|FG001|Overall Study|Randomized but not Treated|1|||
164284476|NCT00999518|593409675|FG002|Overall Study|Randomized but not Treated|2|||
164284477|NCT00999518|593409676|FG003|Overall Study|Randomized but not Treated|0|||
164284478|NCT00999518|593409677|FG004|Overall Study|Randomized but not Treated|1|||
164691980|NCT00991510|594895253|FG001|Period III (Days 29-112)|Adverse Event|1|||
164691981|NCT03710590|594895254|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
164691982|NCT03710590|594895255|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
164691983|NCT02488824|594895256|FG000|Overall Study|Adverse Event|1|||
164691984|NCT02488824|594895257|FG001|Overall Study|Adverse Event|1|||
164691985|NCT01976728|594895258|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
164691986|NCT01976728|594895259|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
164691987|NCT01976728|594895260|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
164691988|NCT01976728|594895261|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
164691989|NCT02356211|594895262|FG000|Overall Study|Withdrawal by Subject|2|||
164691990|NCT02356211|594895263|FG001|Overall Study|Withdrawal by Subject|2|||
164691991|NCT02356211|594895262|FG000|Overall Study|ineligible|1|||
164691992|NCT02356211|594895263|FG001|Overall Study|ineligible|8|||
164691993|NCT01563237|594895265|FG000|Overall Study|Lost to Follow-up|6|||
164691994|NCT01563237|594895266|FG001|Overall Study|Lost to Follow-up|0|||
164691995|NCT01563237|594895265|FG000|Overall Study|Withdrawal by Subject|1|||
164691996|NCT01563237|594895266|FG001|Overall Study|Withdrawal by Subject|0|||
164691997|NCT01563237|594895265|FG000|Overall Study|Adverse Event|1|||
164691998|NCT01563237|594895266|FG001|Overall Study|Adverse Event|0|||
164691999|NCT01563237|594895265|FG000|Overall Study|Medical Reasons|1|||
164692000|NCT01563237|594895266|FG001|Overall Study|Medical Reasons|0|||
164692001|NCT01563237|594895265|FG000|Overall Study|Death|1|||
164692002|NCT01563237|594895266|FG001|Overall Study|Death|0|||
164692003|NCT02211014|594895267|FG000|Overall Study|Adverse Event|0|||
164692004|NCT02211014|594895268|FG001|Overall Study|Adverse Event|2|||
164284479|NCT00859547|593411286|FG000|Overall Study|Lost to Follow-up|1|||
164284480|NCT00859547|593411286|FG000|Overall Study|Parent withdrew consent|1|||
164284481|NCT00786799|593411294|FG000|Overall Study|Lost to Follow-up|1|||
164284482|NCT00786799|593411295|FG001|Overall Study|Lost to Follow-up|1|||
164284483|NCT02544503|593411296|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
164284484|NCT02544503|593411297|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
164284485|NCT02544503|593411296|FG000|Overall Study|Lost to Follow-up|9|||
164284486|NCT02544503|593411297|FG001|Overall Study|Lost to Follow-up|0|||
164284487|NCT02544503|593411296|FG000|Overall Study|Withdrawal by Subject|1|||
164284488|NCT02544503|593411297|FG001|Overall Study|Withdrawal by Subject|0|||
164284489|NCT04640311|593411298|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
164284490|NCT04640311|593411299|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284491|NCT04640311|593411300|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284492|NCT04640311|593411301|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284493|NCT04640311|593411302|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284494|NCT04640311|593411303|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284495|NCT04640311|593411304|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284496|NCT04640311|593411305|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284497|NCT04640311|593411306|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284498|NCT04640311|593411307|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284499|NCT04640311|593411308|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284500|NCT04640311|593411309|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284501|NCT04640311|593411310|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284502|NCT04640311|593411298|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
164284503|NCT04640311|593411299|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
164284504|NCT04640311|593411300|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
164284505|NCT04640311|593411301|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
164692005|NCT02211014|594895267|FG000|Overall Study|Physician Decision|1|||
164692006|NCT02211014|594895268|FG001|Overall Study|Physician Decision|2|||
164692007|NCT02211014|594895267|FG000|Overall Study|Started another cancer therapy|1|||
164692008|NCT02211014|594895268|FG001|Overall Study|Started another cancer therapy|0|||
164692009|NCT02211014|594895267|FG000|Overall Study|Withdrawal by Subject|0|||
164692010|NCT02211014|594895268|FG001|Overall Study|Withdrawal by Subject|1|||
164284506|NCT04640311|593411302|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
164284507|NCT04640311|593411303|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
164284508|NCT04640311|593411304|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
164284509|NCT04640311|593411305|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
164284510|NCT04640311|593411306|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
164284511|NCT04640311|593411307|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
164284512|NCT04640311|593411308|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
164284513|NCT04640311|593411309|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
164284514|NCT04640311|593411310|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
164284515|NCT04640311|593411298|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284516|NCT04640311|593411299|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
164284517|NCT04640311|593411300|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284518|NCT04640311|593411301|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284519|NCT04640311|593411302|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284520|NCT04640311|593411303|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284521|NCT04640311|593411304|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284522|NCT04640311|593411305|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284523|NCT04640311|593411306|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284524|NCT04640311|593411307|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284525|NCT04640311|593411308|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284526|NCT04640311|593411309|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284527|NCT04640311|593411310|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284528|NCT04640311|593411298|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
164284529|NCT04640311|593411299|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
164284530|NCT04640311|593411300|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
164284531|NCT04640311|593411301|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284532|NCT04640311|593411302|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284533|NCT04640311|593411303|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284534|NCT04640311|593411304|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284535|NCT04640311|593411305|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284536|NCT04640311|593411306|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284537|NCT04640311|593411307|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284538|NCT04640311|593411308|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284539|NCT04640311|593411309|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284540|NCT04640311|593411310|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284541|NCT04640311|593411298|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
164284542|NCT04640311|593411299|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
164284543|NCT04640311|593411300|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
164284544|NCT04640311|593411301|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
164284545|NCT04640311|593411302|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
164284546|NCT04640311|593411303|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
164284547|NCT04640311|593411304|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
164284548|NCT04640311|593411305|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
164284549|NCT04640311|593411306|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
164284550|NCT04640311|593411307|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
164284551|NCT04640311|593411308|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
164284552|NCT04640311|593411309|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
164284553|NCT04640311|593411310|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
164284554|NCT04640311|593411298|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
164284555|NCT04640311|593411299|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
164284556|NCT04640311|593411300|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
164692011|NCT02211014|594895267|FG000|Overall Study|In agreement with patient, no benefit|0|||
164692012|NCT02211014|594895268|FG001|Overall Study|In agreement with patient, no benefit|1|||
164692013|NCT03036839|594895269|FG000|Overall Study|Adverse Event|0|||
164692014|NCT03036839|594895270|FG001|Overall Study|Adverse Event|0|||
164692015|NCT03036839|594895271|FG002|Overall Study|Adverse Event|1|||
164692016|NCT03036839|594895269|FG000|Overall Study|Death|3|||
164692017|NCT03036839|594895270|FG001|Overall Study|Death|0|||
164692018|NCT03036839|594895271|FG002|Overall Study|Death|3|||
164692019|NCT03036839|594895269|FG000|Overall Study|Withdrew Consent|0|||
164692020|NCT03036839|594895270|FG001|Overall Study|Withdrew Consent|0|||
164284557|NCT04640311|593411301|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
164284558|NCT04640311|593411302|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
164284559|NCT04640311|593411303|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
164284560|NCT04640311|593411304|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
164284561|NCT04640311|593411305|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
164284562|NCT04640311|593411306|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
164284563|NCT04640311|593411307|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
164284564|NCT04640311|593411308|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
164284565|NCT04640311|593411309|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
164284566|NCT04640311|593411310|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
164284567|NCT04640311|593411298|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284568|NCT04640311|593411299|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284569|NCT04640311|593411300|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284570|NCT04640311|593411301|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284571|NCT04640311|593411302|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284572|NCT04640311|593411303|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
164284573|NCT04640311|593411304|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284574|NCT04640311|593411305|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284575|NCT04640311|593411306|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
164284576|NCT04640311|593411307|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284577|NCT04640311|593411308|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284578|NCT04640311|593411309|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284579|NCT04640311|593411310|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284580|NCT04640311|593411298|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
164284581|NCT04640311|593411299|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
164284582|NCT04640311|593411300|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
164284583|NCT04640311|593411301|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
164284584|NCT04640311|593411302|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
164284585|NCT04640311|593411303|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
164284586|NCT04640311|593411304|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
164284587|NCT04640311|593411305|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
164284588|NCT04640311|593411306|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
164284589|NCT04640311|593411307|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
164284590|NCT04640311|593411308|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
164284591|NCT04640311|593411309|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
164284592|NCT04640311|593411310|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
164284593|NCT04640311|593411298|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
164284594|NCT04640311|593411299|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
164284595|NCT04640311|593411300|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
164284596|NCT04640311|593411301|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
164284597|NCT04640311|593411302|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
164284598|NCT04640311|593411303|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
164284599|NCT04640311|593411304|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
164284600|NCT04640311|593411305|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
164284601|NCT04640311|593411306|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
164284602|NCT04640311|593411307|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
164284603|NCT04640311|593411308|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
164284604|NCT04640311|593411309|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
164284605|NCT04640311|593411310|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
164284606|NCT03906071|593411311|FG000|Overall Study|Death|180|||
164284607|NCT03906071|593411312|FG001|Overall Study|Death|185|||
164284608|NCT03906071|593411311|FG000|Overall Study|Lost to Follow-up|3|||
164284609|NCT03906071|593411312|FG001|Overall Study|Lost to Follow-up|3|||
164284610|NCT03906071|593411311|FG000|Overall Study|Withdrawal by Subject|15|||
164284611|NCT03906071|593411312|FG001|Overall Study|Withdrawal by Subject|27|||
164284612|NCT03906071|593411311|FG000|Overall Study|Other|2|||
164284613|NCT03906071|593411312|FG001|Overall Study|Other|1|||
164284614|NCT02152761|593411313|FG000|Epoch: Treatment Epoch|Technical problems|0|||
164284615|NCT02152761|593411314|FG001|Epoch: Treatment Epoch|Technical problems|0|||
164284616|NCT02152761|593411315|FG002|Epoch: Treatment Epoch|Technical problems|0|||
164284617|NCT02152761|593411316|FG003|Epoch: Treatment Epoch|Technical problems|1|||
164284618|NCT02152761|593411313|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
164284619|NCT02152761|593411314|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
164344718|NCT03408483|593637027|FG000|Overall Study|Lost to Follow-up|3|||
164284620|NCT02152761|593411315|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
164284621|NCT02152761|593411316|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
164284622|NCT02152761|593411313|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
164284623|NCT02152761|593411314|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
164284624|NCT02152761|593411315|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
164284625|NCT02152761|593411316|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
164284626|NCT02152761|593411313|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
164284627|NCT02152761|593411314|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
164284628|NCT02152761|593411315|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
164284629|NCT02152761|593411316|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
164284630|NCT02152761|593411313|FG000|Epoch: Treatment Epoch|Death|0|||
164284631|NCT02152761|593411314|FG001|Epoch: Treatment Epoch|Death|3|||
164284632|NCT02152761|593411315|FG002|Epoch: Treatment Epoch|Death|1|||
164284633|NCT02152761|593411316|FG003|Epoch: Treatment Epoch|Death|0|||
164284634|NCT02152761|593411313|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
164284635|NCT02152761|593411314|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
164284636|NCT02152761|593411315|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
164284637|NCT02152761|593411316|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
164284638|NCT02152761|593411313|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
164284639|NCT02152761|593411314|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
164284640|NCT02152761|593411315|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
164284641|NCT02152761|593411316|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
164284642|NCT02152761|593411313|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
164284643|NCT02152761|593411314|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
164284644|NCT02152761|593411315|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
164284645|NCT02152761|593411316|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
164284646|NCT02152761|593411313|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
164284647|NCT02152761|593411314|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
164284648|NCT02152761|593411315|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
164284649|NCT02152761|593411316|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
164284650|NCT02152761|593411313|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
164284651|NCT02152761|593411314|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
164284652|NCT02152761|593411315|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
164284653|NCT02152761|593411316|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
164284654|NCT01797263|593411317|FG000|Overall Study|Withdrawal by Subject|21|||
164284655|NCT01797263|593411318|FG001|Overall Study|Withdrawal by Subject|25|||
164284656|NCT01797263|593411317|FG000|Overall Study|Death|1|||
164284657|NCT01797263|593411318|FG001|Overall Study|Death|0|||
164284658|NCT01797263|593411317|FG000|Overall Study|Lost to Follow-up|15|||
164284659|NCT01797263|593411318|FG001|Overall Study|Lost to Follow-up|15|||
164284660|NCT01485094|593411319|FG000|Overall Study|Adverse Event|1|||
164284661|NCT01485094|593411320|FG001|Overall Study|Adverse Event|1|||
164284662|NCT01485094|593411321|FG002|Overall Study|Adverse Event|1|||
164284663|NCT01485094|593411319|FG000|Overall Study|Lost to Follow-up|1|||
164284664|NCT01485094|593411320|FG001|Overall Study|Lost to Follow-up|0|||
164284665|NCT01485094|593411321|FG002|Overall Study|Lost to Follow-up|0|||
164284666|NCT01485094|593411319|FG000|Overall Study|Withdrawal by Subject|1|||
164284667|NCT01485094|593411320|FG001|Overall Study|Withdrawal by Subject|1|||
164284668|NCT01485094|593411321|FG002|Overall Study|Withdrawal by Subject|0|||
164284669|NCT00080301|593411326|FG000|Overall Study|Randomized but Never Treated|5|||
164284670|NCT00080301|593411327|FG001|Overall Study|Randomized but Never Treated|10|||
164284671|NCT00080301|593411326|FG000|Overall Study|Still on Treatment as of CSR date|0|||
164284672|NCT00080301|593411327|FG001|Overall Study|Still on Treatment as of CSR date|1|||
164284673|NCT00991939|593411328|FG000|Overall Study|Lost to Follow-up|0|||
164284674|NCT00991939|593411329|FG001|Overall Study|Lost to Follow-up|1|||
164284675|NCT00991939|593411328|FG000|Overall Study|Withdrawal by Subject|1|||
164284676|NCT00991939|593411329|FG001|Overall Study|Withdrawal by Subject|0|||
164284677|NCT00991939|593411328|FG000|Overall Study|Entire study terminated|4|||
164284678|NCT00991939|593411329|FG001|Overall Study|Entire study terminated|1|||
164586432|NCT00494871|594511809|FG000|Follow-up (FU) Period|Physician Decision|0|||
164284679|NCT01965704|593411330|FG000|Overall Study|Withdrawal by Subject|2|||
164284680|NCT01965704|593411331|FG001|Overall Study|Withdrawal by Subject|2|||
164284681|NCT01965704|593411332|FG002|Overall Study|Withdrawal by Subject|1|||
164284682|NCT01965704|593411333|FG003|Overall Study|Withdrawal by Subject|1|||
164284683|NCT01965704|593411330|FG000|Overall Study|Delivered at home|1|||
164284684|NCT01965704|593411331|FG001|Overall Study|Delivered at home|1|||
164284685|NCT01965704|593411332|FG002|Overall Study|Delivered at home|0|||
164284686|NCT01965704|593411333|FG003|Overall Study|Delivered at home|0|||
164284687|NCT01965704|593411330|FG000|Overall Study|Experienced complications|0|||
164284688|NCT01965704|593411331|FG001|Overall Study|Experienced complications|0|||
164284689|NCT01965704|593411332|FG002|Overall Study|Experienced complications|2|||
164284690|NCT01965704|593411333|FG003|Overall Study|Experienced complications|2|||
164284691|NCT01965704|593411330|FG000|Overall Study|Adverse Event|0|||
164284692|NCT01965704|593411331|FG001|Overall Study|Adverse Event|0|||
164284693|NCT01965704|593411332|FG002|Overall Study|Adverse Event|1|||
164284694|NCT01965704|593411333|FG003|Overall Study|Adverse Event|1|||
164284695|NCT01965704|593411330|FG000|Overall Study|Did not meet inclusion criteria|0|||
164284696|NCT01965704|593411331|FG001|Overall Study|Did not meet inclusion criteria|0|||
164284697|NCT01965704|593411332|FG002|Overall Study|Did not meet inclusion criteria|1|||
164284698|NCT01965704|593411333|FG003|Overall Study|Did not meet inclusion criteria|1|||
164284699|NCT02524171|593411335|FG000|6-month Follow-up|Lost to Follow-up|53|||
164284700|NCT02524171|593411336|FG001|6-month Follow-up|Lost to Follow-up|45|||
164284701|NCT02524171|593411335|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
164284702|NCT02524171|593411336|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
164284703|NCT02868554|593411341|FG000|Overall Study|Lost to Follow-up|3|||
164284704|NCT02868554|593411342|FG001|Overall Study|Lost to Follow-up|0|||
164284705|NCT02868554|593411343|FG002|Overall Study|Lost to Follow-up|1|||
164284706|NCT05150990|593411344|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
164284707|NCT05150990|593411345|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
164284708|NCT05150990|593411344|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
164284709|NCT05150990|593411345|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
164284710|NCT05150990|593411344|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
164284711|NCT05150990|593411345|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
164284712|NCT05150990|593411344|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
164284713|NCT05150990|593411345|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
164284714|NCT05150990|593411344|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
164284715|NCT05150990|593411345|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
164284716|NCT05150990|593411344|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
164284717|NCT05150990|593411345|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
164284718|NCT05150990|593411344|FG000|Overall Study|Death (unrelated to the intervention)|1|||
164284719|NCT05150990|593411345|FG001|Overall Study|Death (unrelated to the intervention)|2|||
164284720|NCT05447663|593411348|FG000|Overall Study|Study terminated by Sponsor|5|||
164344719|NCT03408483|593637028|FG001|Overall Study|Lost to Follow-up|0|||
164344720|NCT00923156|593637032|FG000|Overall Study|Adverse Event|0|||
164344721|NCT00923156|593637033|FG001|Overall Study|Adverse Event|2|||
164344722|NCT00923156|593637034|FG002|Overall Study|Adverse Event|1|||
164344723|NCT00923156|593637032|FG000|Overall Study|Abnormal laboratory values|0|||
164344724|NCT00923156|593637033|FG001|Overall Study|Abnormal laboratory values|0|||
164344725|NCT00923156|593637034|FG002|Overall Study|Abnormal laboratory values|1|||
164344726|NCT00923156|593637032|FG000|Overall Study|Withdrawal by Subject|0|||
164284721|NCT05447663|593411348|FG000|Overall Study|Death|2|||
164344727|NCT00923156|593637033|FG001|Overall Study|Withdrawal by Subject|1|||
164344728|NCT00923156|593637034|FG002|Overall Study|Withdrawal by Subject|0|||
164284722|NCT05447663|593411348|FG000|Overall Study|Withdrawal by Subject|1|||
164284723|NCT01100320|593411349|FG000|Period 1|Withdrawal by Subject|2|||
164284724|NCT01100320|593411350|FG001|Period 1|Withdrawal by Subject|4|||
164284725|NCT01100320|593411349|FG000|Period 1|Positive Drug Screen|1|||
164284726|NCT01100320|593411350|FG001|Period 1|Positive Drug Screen|1|||
164284727|NCT01100320|593411349|FG000|Period 1|Adverse Event|2|||
164284728|NCT01100320|593411350|FG001|Period 1|Adverse Event|2|||
164284729|NCT01100320|593411349|FG000|Period 2|Withdrawal by Subject|1|||
164284730|NCT01100320|593411350|FG001|Period 2|Withdrawal by Subject|1|||
164284731|NCT04181762|593411351|FG000|Overall Study|Adverse Event|1|||
164284732|NCT04181762|593411352|FG001|Overall Study|Adverse Event|3|||
164284733|NCT04181762|593411351|FG000|Overall Study|Lost to Follow-up|1|||
164284734|NCT04181762|593411352|FG001|Overall Study|Lost to Follow-up|1|||
164284735|NCT04181762|593411351|FG000|Overall Study|Physician Decision|1|||
164284736|NCT04181762|593411352|FG001|Overall Study|Physician Decision|3|||
164284737|NCT04181762|593411351|FG000|Overall Study|Pregnancy|0|||
164284738|NCT04181762|593411352|FG001|Overall Study|Pregnancy|1|||
164284739|NCT04181762|593411351|FG000|Overall Study|Lack of Efficacy|2|||
164284740|NCT04181762|593411352|FG001|Overall Study|Lack of Efficacy|2|||
164284741|NCT04181762|593411351|FG000|Overall Study|Study terminated by sponsor|95|||
164284742|NCT04181762|593411352|FG001|Overall Study|Study terminated by sponsor|97|||
164284743|NCT04181762|593411351|FG000|Overall Study|Subject decision|11|||
164284744|NCT04181762|593411352|FG001|Overall Study|Subject decision|4|||
164284745|NCT04181762|593411351|FG000|Overall Study|Death|1|||
164284746|NCT04181762|593411352|FG001|Overall Study|Death|1|||
164284747|NCT04181762|593411351|FG000|Overall Study|Protocol deviation|1|||
164284748|NCT04181762|593411352|FG001|Overall Study|Protocol deviation|0|||
164284749|NCT04181762|593411351|FG000|Overall Study|Withdrawal of informed consent|1|||
164284750|NCT04181762|593411352|FG001|Overall Study|Withdrawal of informed consent|3|||
164284751|NCT04669301|593411353|FG000|Overall Study|Lost to Follow-up|0|||
164284752|NCT04669301|593411354|FG001|Overall Study|Lost to Follow-up|1|||
164284753|NCT04669301|593411355|FG002|Overall Study|Lost to Follow-up|0|||
164284754|NCT04669301|593411353|FG000|Overall Study|Withdrawal by Subject|3|||
164284755|NCT04669301|593411354|FG001|Overall Study|Withdrawal by Subject|2|||
164284756|NCT04669301|593411355|FG002|Overall Study|Withdrawal by Subject|0|||
164284757|NCT02586727|593411356|FG000|Overall Study|Lost to Follow-up|1|||
164284758|NCT02586727|593411357|FG001|Overall Study|Lost to Follow-up|0|||
164284759|NCT05888181|593411358|FG000|Overall Study|Lost to Follow-up|1|||
164284760|NCT05888181|593411359|FG001|Overall Study|Lost to Follow-up|1|||
164284761|NCT05888181|593411360|FG002|Overall Study|Lost to Follow-up|0|||
164284762|NCT02534909|593411363|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
164284763|NCT00132808|593411366|FG000|Stratum I|Adverse Event|2|||
164284764|NCT00132808|593411367|FG001|Stratum I|Adverse Event|1|||
164284765|NCT00132808|593411368|FG002|Stratum I|Adverse Event|0|||
164284766|NCT00132808|593411366|FG000|Stratum I|Lost to Follow-up|3|||
164284767|NCT00132808|593411367|FG001|Stratum I|Lost to Follow-up|4|||
164284768|NCT00132808|593411368|FG002|Stratum I|Lost to Follow-up|1|||
164284769|NCT00132808|593411366|FG000|Stratum I|Withdrawal by Subject|4|||
164284770|NCT00132808|593411367|FG001|Stratum I|Withdrawal by Subject|7|||
164284771|NCT00132808|593411368|FG002|Stratum I|Withdrawal by Subject|3|||
164284772|NCT00132808|593411366|FG000|Stratum I|Abnormal test procedure result (s)|0|||
164284773|NCT00132808|593411367|FG001|Stratum I|Abnormal test procedure result (s)|0|||
164284774|NCT00132808|593411368|FG002|Stratum I|Abnormal test procedure result (s)|1|||
164284775|NCT00132808|593411366|FG000|Stratum II|Adverse Event|1|||
164284776|NCT00132808|593411367|FG001|Stratum II|Adverse Event|2|||
164284777|NCT00132808|593411368|FG002|Stratum II|Adverse Event|1|||
164284778|NCT00132808|593411366|FG000|Stratum II|Death|1|||
164284779|NCT00132808|593411367|FG001|Stratum II|Death|0|||
164284780|NCT00132808|593411368|FG002|Stratum II|Death|0|||
164284781|NCT00132808|593411366|FG000|Stratum II|Lost to Follow-up|2|||
164284782|NCT00132808|593411367|FG001|Stratum II|Lost to Follow-up|2|||
164284783|NCT00132808|593411368|FG002|Stratum II|Lost to Follow-up|1|||
164284784|NCT00132808|593411366|FG000|Stratum II|Protocol Violation|0|||
164284785|NCT00132808|593411367|FG001|Stratum II|Protocol Violation|2|||
164284786|NCT00132808|593411368|FG002|Stratum II|Protocol Violation|1|||
164586433|NCT00494871|594511810|FG001|Follow-up (FU) Period|Physician Decision|1|||
164586434|NCT00494871|594511809|FG000|Follow-up (FU) Period|Protocol Violation|1|||
164586435|NCT00494871|594511810|FG001|Follow-up (FU) Period|Protocol Violation|0|||
164284787|NCT00132808|593411366|FG000|Stratum II|Withdrawal by Subject|4|||
164284788|NCT00132808|593411367|FG001|Stratum II|Withdrawal by Subject|9|||
164284789|NCT00132808|593411368|FG002|Stratum II|Withdrawal by Subject|6|||
164284790|NCT00577824|593411372|FG000|Overall Study|Adverse Event|6|||
164284791|NCT00577824|593411373|FG001|Overall Study|Adverse Event|18|||
164284792|NCT00577824|593411374|FG002|Overall Study|Adverse Event|1|||
164284793|NCT00577824|593411372|FG000|Overall Study|Patient decision|0|||
164284794|NCT00577824|593411373|FG001|Overall Study|Patient decision|1|||
164586436|NCT00494871|594511809|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
164284795|NCT00577824|593411374|FG002|Overall Study|Patient decision|1|||
164284796|NCT00577824|593411372|FG000|Overall Study|Protocol Violation|1|||
164284797|NCT00577824|593411373|FG001|Overall Study|Protocol Violation|1|||
164284798|NCT00577824|593411374|FG002|Overall Study|Protocol Violation|0|||
164284799|NCT00362648|593411375|FG000|Overall Study|Adverse Event|12|||
164284800|NCT00362648|593411376|FG001|Overall Study|Adverse Event|21|||
164284801|NCT00362648|593411377|FG002|Overall Study|Adverse Event|1|||
164284802|NCT00362648|593411378|FG003|Overall Study|Adverse Event|0|||
164284803|NCT00362648|593411375|FG000|Overall Study|Lost to Follow-up|62|||
164586437|NCT00494871|594511810|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
164586438|NCT00494871|594511809|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
164586439|NCT00494871|594511810|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
164586440|NCT03270085|594511811|FG000|Overall Study|Withdrawal by Subject|1|||
164586441|NCT03270085|594511812|FG001|Overall Study|Withdrawal by Subject|0|||
164586442|NCT03825042|594511813|FG000|Overall Study|Adverse Event|1|||
164586443|NCT03825042|594511814|FG001|Overall Study|Adverse Event|0|||
164692021|NCT03036839|594895271|FG002|Overall Study|Withdrew Consent|1|||
164692022|NCT01316419|594895272|FG000|Overall Study|Not treated|103|||
164692023|NCT01316419|594895272|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
164692024|NCT01316419|594895272|FG000|Overall Study|Lost to Follow-up|19|||
164284804|NCT00362648|593411376|FG001|Overall Study|Lost to Follow-up|69|||
164284805|NCT00362648|593411377|FG002|Overall Study|Lost to Follow-up|4|||
164284806|NCT00362648|593411378|FG003|Overall Study|Lost to Follow-up|3|||
164284807|NCT00362648|593411375|FG000|Overall Study|Protocol Violation|4|||
164284808|NCT00362648|593411376|FG001|Overall Study|Protocol Violation|2|||
164284809|NCT00362648|593411377|FG002|Overall Study|Protocol Violation|2|||
164284810|NCT00362648|593411378|FG003|Overall Study|Protocol Violation|2|||
164284811|NCT00362648|593411375|FG000|Overall Study|Withdrawal by Subject|48|||
164284812|NCT00362648|593411376|FG001|Overall Study|Withdrawal by Subject|42|||
164284813|NCT00362648|593411377|FG002|Overall Study|Withdrawal by Subject|2|||
164284814|NCT00362648|593411378|FG003|Overall Study|Withdrawal by Subject|6|||
164284815|NCT02204072|593411379|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
164284816|NCT02204072|593411380|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
164284817|NCT02204072|593411381|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
164284818|NCT02204072|593411382|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
164284819|NCT02204072|593411383|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
164284820|NCT02204072|593411379|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
164284821|NCT02204072|593411380|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
164284822|NCT02204072|593411381|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
164284823|NCT02204072|593411382|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
164284824|NCT02204072|593411383|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
164284825|NCT02204072|593411379|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
164284826|NCT02204072|593411380|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
164284827|NCT02204072|593411381|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
164284828|NCT02204072|593411382|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
164284829|NCT02204072|593411383|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
164433271|NCT01833065|593957202|FG004|Overall Study|Trial terminated by sponsor|13|||
164692025|NCT00412737|594895273|FG000|Overall Study|Death|1|||
164692026|NCT00412737|594895274|FG001|Overall Study|Death|0|||
164692027|NCT00412737|594895273|FG000|Overall Study|Adverse Event|3|||
164692028|NCT00412737|594895274|FG001|Overall Study|Adverse Event|2|||
164284830|NCT02204072|593411379|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
164284831|NCT02204072|593411380|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
164284832|NCT02204072|593411381|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
164284833|NCT02204072|593411382|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
164284834|NCT02204072|593411383|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
164433272|NCT01833065|593957198|FG000|Overall Study|Others|2|||
164433273|NCT01833065|593957199|FG001|Overall Study|Others|1|||
164433274|NCT01833065|593957200|FG002|Overall Study|Others|1|||
164433275|NCT01833065|593957201|FG003|Overall Study|Others|1|||
164433276|NCT01833065|593957202|FG004|Overall Study|Others|4|||
164433277|NCT02299635|593957204|FG000|Overall Study|Adverse Event|2|||
164433278|NCT02299635|593957204|FG000|Overall Study|Death|1|||
164692029|NCT00412737|594895273|FG000|Overall Study|Refused Treatment|6|||
164692030|NCT00412737|594895274|FG001|Overall Study|Refused Treatment|2|||
164692031|NCT00412737|594895273|FG000|Overall Study|Failure to Return|6|||
164692032|NCT00412737|594895274|FG001|Overall Study|Failure to Return|2|||
164692033|NCT00983918|594895277|FG000|Overall Study|conversion to open cholecystectomy|0|||
164284835|NCT02978833|593411399|FG000|Overall Study|Study terminated|1|||
164433279|NCT02299635|593957204|FG000|Overall Study|Global deterioration of health status|1|||
164586444|NCT03825042|594511813|FG000|Overall Study|Withdrawal by Subject|1|||
164586445|NCT03825042|594511814|FG001|Overall Study|Withdrawal by Subject|0|||
164692034|NCT00983918|594895278|FG001|Overall Study|conversion to open cholecystectomy|2|||
164692035|NCT00983918|594895279|FG002|Overall Study|conversion to open cholecystectomy|2|||
164692036|NCT00983918|594895280|FG003|Overall Study|conversion to open cholecystectomy|2|||
164692037|NCT01345318|594895304|FG000|Overall Study|Adverse Event|16|||
164284836|NCT02978833|593411400|FG001|Overall Study|Study terminated|1|||
164284837|NCT00186901|593411401|FG000|Overall Study|Pregnancy|6|||
164284838|NCT00186901|593411402|FG001|Overall Study|Pregnancy|3|||
164284839|NCT00186901|593411403|FG002|Overall Study|Pregnancy|0|||
164284840|NCT00186901|593411401|FG000|Overall Study|Lost to Follow-up|6|||
164284841|NCT00186901|593411402|FG001|Overall Study|Lost to Follow-up|3|||
164284842|NCT00186901|593411403|FG002|Overall Study|Lost to Follow-up|0|||
164284843|NCT00186901|593411401|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
164284844|NCT00186901|593411402|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
164284845|NCT00186901|593411403|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
164284846|NCT00186901|593411401|FG000|Overall Study|ALL relapse or second malignancy|1|||
164284847|NCT00186901|593411402|FG001|Overall Study|ALL relapse or second malignancy|2|||
164284848|NCT00186901|593411403|FG002|Overall Study|ALL relapse or second malignancy|0|||
164284849|NCT00186901|593411401|FG000|Overall Study|Withdrawal by Subject|4|||
164284850|NCT00186901|593411402|FG001|Overall Study|Withdrawal by Subject|5|||
164284851|NCT00186901|593411403|FG002|Overall Study|Withdrawal by Subject|0|||
164284852|NCT00186901|593411401|FG000|Overall Study|Open label|3|||
164284853|NCT00186901|593411402|FG001|Overall Study|Open label|2|||
164284854|NCT00186901|593411403|FG002|Overall Study|Open label|0|||
164284855|NCT00186901|593411401|FG000|Overall Study|Limited adherence to study requirements|20|||
164284856|NCT00186901|593411402|FG001|Overall Study|Limited adherence to study requirements|23|||
164284857|NCT00186901|593411403|FG002|Overall Study|Limited adherence to study requirements|0|||
164284858|NCT00186901|593411401|FG000|Overall Study|Bone Mineral Density > 0|0|||
164284859|NCT00186901|593411402|FG001|Overall Study|Bone Mineral Density > 0|0|||
164284860|NCT00186901|593411403|FG002|Overall Study|Bone Mineral Density > 0|149|||
164284861|NCT01811186|593411404|FG000|Overall Study|Adverse Event|54|||
164284862|NCT01811186|593411405|FG001|Overall Study|Adverse Event|38|||
164284863|NCT01811186|593411404|FG000|Overall Study|Protocol Violation|5|||
164344729|NCT00923156|593637032|FG000|Overall Study|Death|0|||
164344730|NCT00923156|593637033|FG001|Overall Study|Death|1|||
164344731|NCT00923156|593637034|FG002|Overall Study|Death|0|||
164344732|NCT00923156|593637032|FG000|Overall Study|Lack of Efficacy|0|||
164344733|NCT00923156|593637033|FG001|Overall Study|Lack of Efficacy|0|||
164344734|NCT00923156|593637034|FG002|Overall Study|Lack of Efficacy|1|||
164344735|NCT03137537|593637035|FG000|Overall Study|Adverse Event|0|||
164344736|NCT03137537|593637036|FG001|Overall Study|Adverse Event|1|||
164344737|NCT02465515|593637040|FG000|Overall Study|Investigator site closed|4|||
164344738|NCT02465515|593637041|FG001|Overall Study|Investigator site closed|5|||
164344739|NCT02465515|593637040|FG000|Overall Study|Withdrawal by Subject|74|||
164344740|NCT02465515|593637041|FG001|Overall Study|Withdrawal by Subject|43|||
164344741|NCT02465515|593637040|FG000|Overall Study|Physician Decision|8|||
164344742|NCT02465515|593637041|FG001|Overall Study|Physician Decision|12|||
164344743|NCT02465515|593637040|FG000|Overall Study|Lost to Follow-up|68|||
164344744|NCT02465515|593637041|FG001|Overall Study|Lost to Follow-up|51|||
164344745|NCT00816595|593637042|FG000|Overall Study|Withdrawal by Subject|2|||
164344746|NCT00816595|593637043|FG001|Overall Study|Withdrawal by Subject|0|||
164344747|NCT00629707|593637044|FG000|Overall Study|Withdrawal by Subject|0|||
164344748|NCT00629707|593637045|FG001|Overall Study|Withdrawal by Subject|1|||
164344749|NCT00629707|593637044|FG000|Overall Study|Physician Decision|0|||
164344750|NCT00629707|593637045|FG001|Overall Study|Physician Decision|1|||
164344751|NCT00453063|593637046|FG000|Overall Study|Adverse Event|1|||
164344752|NCT00453063|593637047|FG001|Overall Study|Adverse Event|2|||
164344753|NCT00453063|593637046|FG000|Overall Study|Withdrawal by Subject|1|||
164344754|NCT00453063|593637047|FG001|Overall Study|Withdrawal by Subject|1|||
164344755|NCT00453063|593637046|FG000|Overall Study|Protocol Violation|1|||
164344756|NCT00453063|593637047|FG001|Overall Study|Protocol Violation|0|||
164344757|NCT01918774|593638831|FG000|Overall Study|Lost prior to first CBTw session|4|||
164344758|NCT01918774|593638831|FG000|Overall Study|Lost to Follow-up|1|||
164344759|NCT03000439|593638834|FG000|Open Label Part 1|Adverse Event|6|||
164344760|NCT03000439|593638835|FG001|Open Label Part 1|Adverse Event|0|||
164344761|NCT03000439|593638836|FG002|Open Label Part 1|Adverse Event|0|||
164344762|NCT03000439|593638837|FG003|Open Label Part 1|Adverse Event|0|||
164344763|NCT03000439|593638834|FG000|Open Label Part 1|Other|2|||
164344764|NCT03000439|593638835|FG001|Open Label Part 1|Other|0|||
164344765|NCT03000439|593638836|FG002|Open Label Part 1|Other|0|||
164344766|NCT03000439|593638837|FG003|Open Label Part 1|Other|0|||
164344767|NCT03000439|593638834|FG000|Open Label Part 1|Insufficient clinical response|16|||
164344768|NCT03000439|593638835|FG001|Open Label Part 1|Insufficient clinical response|0|||
164284864|NCT01811186|593411405|FG001|Overall Study|Protocol Violation|6|||
164284865|NCT01811186|593411404|FG000|Overall Study|Withdrawal by Subject|5|||
164344769|NCT03000439|593638836|FG002|Open Label Part 1|Insufficient clinical response|0|||
164344770|NCT03000439|593638837|FG003|Open Label Part 1|Insufficient clinical response|0|||
164344771|NCT03000439|593638834|FG000|Open Label Part 2|Other|0|||
164344772|NCT03000439|593638835|FG001|Open Label Part 2|Other|5|||
164344773|NCT03000439|593638836|FG002|Open Label Part 2|Other|0|||
164344774|NCT03000439|593638837|FG003|Open Label Part 2|Other|0|||
164344775|NCT03000439|593638834|FG000|Open Label Part 2|Insufficient clinical response|0|||
164586446|NCT00521339|594511816|FG000|Treatment Phase|Adverse Event|2|||
164586447|NCT00521339|594511817|FG001|Treatment Phase|Adverse Event|0|||
164586448|NCT00521339|594511818|FG002|Treatment Phase|Adverse Event|0|||
164586449|NCT00521339|594511816|FG000|Treatment Phase|Intolerability to study drug|2|||
164586450|NCT00521339|594511817|FG001|Treatment Phase|Intolerability to study drug|0|||
164586451|NCT00521339|594511818|FG002|Treatment Phase|Intolerability to study drug|0|||
164586452|NCT00521339|594511816|FG000|Treatment Phase|Lack of Efficacy|3|||
164586453|NCT00521339|594511817|FG001|Treatment Phase|Lack of Efficacy|0|||
164586454|NCT00521339|594511818|FG002|Treatment Phase|Lack of Efficacy|0|||
164586455|NCT00521339|594511816|FG000|Treatment Phase|Withdrawal by Subject|3|||
164586456|NCT00521339|594511817|FG001|Treatment Phase|Withdrawal by Subject|0|||
164284866|NCT01811186|593411405|FG001|Overall Study|Withdrawal by Subject|10|||
164284867|NCT01811186|593411404|FG000|Overall Study|Lack of Efficacy|3|||
164586457|NCT00521339|594511818|FG002|Treatment Phase|Withdrawal by Subject|0|||
164586458|NCT00521339|594511816|FG000|Treatment Phase|Lost to Follow-up|1|||
164586459|NCT00521339|594511817|FG001|Treatment Phase|Lost to Follow-up|0|||
164586460|NCT00521339|594511818|FG002|Treatment Phase|Lost to Follow-up|0|||
164586461|NCT00521339|594511816|FG000|Treatment Phase|Protocol Violation|1|||
164284868|NCT01811186|593411405|FG001|Overall Study|Lack of Efficacy|6|||
164284869|NCT01811186|593411404|FG000|Overall Study|Lost to Follow-up|4|||
164284870|NCT01811186|593411405|FG001|Overall Study|Lost to Follow-up|2|||
164284871|NCT00003199|593411414|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
164284872|NCT00003199|593411414|FG000|Overall Study|Lack of insurance clearance|2|||
164284873|NCT00003199|593411414|FG000|Overall Study|Screen fail|15|||
164284874|NCT01445080|593411415|FG000|Overall Study|Adverse Event|5|||
164284875|NCT01445080|593411416|FG001|Overall Study|Adverse Event|3|||
164284876|NCT01445080|593411417|FG002|Overall Study|Adverse Event|11|||
164284877|NCT01445080|593411418|FG003|Overall Study|Adverse Event|6|||
164284878|NCT01445080|593411419|FG004|Overall Study|Adverse Event|2|||
164284879|NCT01445080|593411420|FG005|Overall Study|Adverse Event|3|||
164284880|NCT01445080|593411421|FG006|Overall Study|Adverse Event|0|||
164284881|NCT01445080|593411422|FG007|Overall Study|Adverse Event|3|||
164284882|NCT01445080|593411423|FG008|Overall Study|Adverse Event|10|||
164284883|NCT01445080|593411415|FG000|Overall Study|Physician Decision|0|||
164284884|NCT01445080|593411416|FG001|Overall Study|Physician Decision|0|||
164284885|NCT01445080|593411417|FG002|Overall Study|Physician Decision|1|||
164284886|NCT01445080|593411418|FG003|Overall Study|Physician Decision|0|||
164284887|NCT01445080|593411419|FG004|Overall Study|Physician Decision|0|||
164284888|NCT01445080|593411420|FG005|Overall Study|Physician Decision|3|||
164284889|NCT01445080|593411421|FG006|Overall Study|Physician Decision|2|||
164284890|NCT01445080|593411422|FG007|Overall Study|Physician Decision|2|||
164284891|NCT01445080|593411423|FG008|Overall Study|Physician Decision|0|||
164284892|NCT01445080|593411415|FG000|Overall Study|Withdrawal by Subject|1|||
164284893|NCT01445080|593411416|FG001|Overall Study|Withdrawal by Subject|0|||
164284894|NCT01445080|593411417|FG002|Overall Study|Withdrawal by Subject|0|||
164284895|NCT01445080|593411418|FG003|Overall Study|Withdrawal by Subject|1|||
164284896|NCT01445080|593411419|FG004|Overall Study|Withdrawal by Subject|0|||
164284897|NCT01445080|593411420|FG005|Overall Study|Withdrawal by Subject|0|||
164284898|NCT01445080|593411421|FG006|Overall Study|Withdrawal by Subject|0|||
164284899|NCT01445080|593411422|FG007|Overall Study|Withdrawal by Subject|0|||
164284900|NCT01445080|593411423|FG008|Overall Study|Withdrawal by Subject|2|||
164284901|NCT01445080|593411415|FG000|Overall Study|Ineligible/Inevaluable|1|||
164284902|NCT01445080|593411416|FG001|Overall Study|Ineligible/Inevaluable|2|||
164284903|NCT01445080|593411417|FG002|Overall Study|Ineligible/Inevaluable|0|||
164284904|NCT01445080|593411418|FG003|Overall Study|Ineligible/Inevaluable|1|||
164284905|NCT01445080|593411419|FG004|Overall Study|Ineligible/Inevaluable|2|||
164692038|NCT01345318|594895304|FG000|Overall Study|Lack of Efficacy|17|||
164692039|NCT01345318|594895304|FG000|Overall Study|Lost to Follow-up|2|||
164692040|NCT01345318|594895304|FG000|Overall Study|Protocol Violation|1|||
164692041|NCT01345318|594895304|FG000|Overall Study|Withdrawal by Subject|41|||
164692042|NCT01345318|594895304|FG000|Overall Study|Other|3|||
164692043|NCT01685073|594895305|FG000|Overall Study|Lost to Follow-up|6|||
164692044|NCT01685073|594895306|FG001|Overall Study|Lost to Follow-up|8|||
164692045|NCT01685073|594895305|FG000|Overall Study|Withdrawal by Subject|24|||
164692046|NCT01685073|594895306|FG001|Overall Study|Withdrawal by Subject|24|||
164284906|NCT01445080|593411420|FG005|Overall Study|Ineligible/Inevaluable|3|||
164284907|NCT01445080|593411421|FG006|Overall Study|Ineligible/Inevaluable|0|||
164284908|NCT01445080|593411422|FG007|Overall Study|Ineligible/Inevaluable|0|||
164586462|NCT00521339|594511817|FG001|Treatment Phase|Protocol Violation|0|||
164586463|NCT00521339|594511818|FG002|Treatment Phase|Protocol Violation|0|||
164586464|NCT00521339|594511816|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
164284909|NCT01445080|593411423|FG008|Overall Study|Ineligible/Inevaluable|6|||
164284910|NCT03887221|593411424|FG000|Overall Study|Protocol Violation|1|||
164284911|NCT03887221|593411425|FG001|Overall Study|Protocol Violation|0|||
164433280|NCT02299635|593957204|FG000|Overall Study|Objective progression or relapse|10|||
164586465|NCT00521339|594511817|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
164692047|NCT03180801|594895309|FG000|Overall Study|Physician Decision|3|||
164284912|NCT02487030|593411426|FG000|Overall Study|Lack of Efficacy|2|||
164284913|NCT02487030|593411427|FG001|Overall Study|Lack of Efficacy|4|||
164586466|NCT00521339|594511818|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
164586467|NCT00521339|594511816|FG000|Treatment Extension Phase|Death|0|||
164586468|NCT00521339|594511817|FG001|Treatment Extension Phase|Death|0|||
164586469|NCT00521339|594511818|FG002|Treatment Extension Phase|Death|1|||
164586470|NCT03314519|594511819|FG000|Overall Study|Protocol Violation|3|||
164586471|NCT03314519|594511820|FG001|Overall Study|Protocol Violation|2|||
164586472|NCT04003155|594511823|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
164586473|NCT04003155|594511824|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
164586474|NCT04003155|594511825|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
164586475|NCT04003155|594511826|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
164586476|NCT04003155|594511827|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
164586477|NCT04003155|594511823|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
164586478|NCT04003155|594511824|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
164586479|NCT04003155|594511825|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
164586480|NCT04003155|594511826|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
164586481|NCT04003155|594511827|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
164586482|NCT04003155|594511823|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
164586483|NCT04003155|594511824|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
164586484|NCT04003155|594511825|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
164586485|NCT04003155|594511826|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
164586486|NCT04003155|594511827|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
164586487|NCT04003155|594511823|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
164586488|NCT04003155|594511824|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
164586489|NCT04003155|594511825|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
164586490|NCT04003155|594511826|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
164284914|NCT02487030|593411428|FG002|Overall Study|Lack of Efficacy|1|||
164284915|NCT02487030|593411429|FG003|Overall Study|Lack of Efficacy|0|||
164284916|NCT02487030|593411430|FG004|Overall Study|Lack of Efficacy|1|||
164284917|NCT02487030|593411431|FG005|Overall Study|Lack of Efficacy|0|||
164284918|NCT02487030|593411432|FG006|Overall Study|Lack of Efficacy|0|||
164284919|NCT02487030|593411426|FG000|Overall Study|Lost to Follow-up|0|||
164284920|NCT02487030|593411427|FG001|Overall Study|Lost to Follow-up|0|||
164284921|NCT02487030|593411428|FG002|Overall Study|Lost to Follow-up|1|||
164284922|NCT02487030|593411429|FG003|Overall Study|Lost to Follow-up|1|||
164284923|NCT02487030|593411430|FG004|Overall Study|Lost to Follow-up|0|||
164284924|NCT02487030|593411431|FG005|Overall Study|Lost to Follow-up|1|||
164284925|NCT02487030|593411432|FG006|Overall Study|Lost to Follow-up|0|||
164284926|NCT02487030|593411426|FG000|Overall Study|Adverse Event|0|||
164284927|NCT02487030|593411427|FG001|Overall Study|Adverse Event|0|||
164284928|NCT02487030|593411428|FG002|Overall Study|Adverse Event|0|||
164284929|NCT02487030|593411429|FG003|Overall Study|Adverse Event|1|||
164284930|NCT02487030|593411430|FG004|Overall Study|Adverse Event|0|||
164284931|NCT02487030|593411431|FG005|Overall Study|Adverse Event|0|||
164284932|NCT02487030|593411432|FG006|Overall Study|Adverse Event|0|||
164284933|NCT02487030|593411426|FG000|Overall Study|Death|0|||
164284934|NCT02487030|593411427|FG001|Overall Study|Death|0|||
164284935|NCT02487030|593411428|FG002|Overall Study|Death|0|||
164284936|NCT02487030|593411429|FG003|Overall Study|Death|0|||
164284937|NCT02487030|593411430|FG004|Overall Study|Death|1|||
164284938|NCT02487030|593411431|FG005|Overall Study|Death|0|||
164284939|NCT02487030|593411432|FG006|Overall Study|Death|0|||
164284940|NCT03857542|593411433|FG000|Overall Study|Adverse Event|1|||
164284941|NCT03857542|593411434|FG001|Overall Study|Adverse Event|3|||
164284942|NCT03857542|593411433|FG000|Overall Study|Withdrawal by Subject|2|||
164284943|NCT03857542|593411434|FG001|Overall Study|Withdrawal by Subject|1|||
164284944|NCT03857542|593411433|FG000|Overall Study|Lost to Follow-up|2|||
164284945|NCT03857542|593411434|FG001|Overall Study|Lost to Follow-up|1|||
164284946|NCT03857542|593411433|FG000|Overall Study|Reason not Specified|1|||
164586491|NCT04003155|594511827|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
164586492|NCT04003155|594511823|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
164586493|NCT04003155|594511824|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
164284947|NCT03857542|593411434|FG001|Overall Study|Reason not Specified|0|||
164284948|NCT02123576|593411435|FG000|Overall Study|Adverse Event|1|||
164284949|NCT02123576|593411436|FG001|Overall Study|Adverse Event|0|||
164284950|NCT00900029|593411437|FG000|Overall Study|Lost to Follow-up|0|||
164284951|NCT00900029|593411438|FG001|Overall Study|Lost to Follow-up|2|||
164284952|NCT00900029|593411439|FG002|Overall Study|Lost to Follow-up|1|||
164284953|NCT00900029|593411440|FG003|Overall Study|Lost to Follow-up|4|||
164284954|NCT00900029|593411441|FG004|Overall Study|Lost to Follow-up|4|||
164284955|NCT00900029|593411437|FG000|Overall Study|Withdrawal by Subject|2|||
164284956|NCT00900029|593411438|FG001|Overall Study|Withdrawal by Subject|2|||
164284957|NCT00900029|593411439|FG002|Overall Study|Withdrawal by Subject|1|||
164284958|NCT00900029|593411440|FG003|Overall Study|Withdrawal by Subject|1|||
164586494|NCT04003155|594511825|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
164586495|NCT04003155|594511826|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
164284959|NCT00900029|593411441|FG004|Overall Study|Withdrawal by Subject|1|||
164284960|NCT00900029|593411437|FG000|Overall Study|Adverse Event|0|||
164284961|NCT00900029|593411438|FG001|Overall Study|Adverse Event|0|||
164284962|NCT00900029|593411439|FG002|Overall Study|Adverse Event|1|||
164284963|NCT00900029|593411440|FG003|Overall Study|Adverse Event|1|||
164284964|NCT00900029|593411441|FG004|Overall Study|Adverse Event|1|||
164284965|NCT00900029|593411437|FG000|Overall Study|Death|1|||
164284966|NCT00900029|593411438|FG001|Overall Study|Death|0|||
164284967|NCT00900029|593411439|FG002|Overall Study|Death|0|||
164284968|NCT00900029|593411440|FG003|Overall Study|Death|1|||
164284969|NCT00900029|593411441|FG004|Overall Study|Death|0|||
164284970|NCT02709330|593411443|FG000|Overall Study|Death|5|||
164284971|NCT02709330|593411444|FG001|Overall Study|Death|0|||
164284972|NCT02709330|593411443|FG000|Overall Study|Lost to Follow-up|2|||
164284973|NCT02709330|593411444|FG001|Overall Study|Lost to Follow-up|0|||
164284974|NCT02709330|593411443|FG000|Overall Study|Physician Decision|2|||
164284975|NCT02709330|593411444|FG001|Overall Study|Physician Decision|0|||
164284976|NCT02709330|593411443|FG000|Overall Study|Withdrawal by Subject|4|||
164433281|NCT02299635|593957204|FG000|Overall Study|Withdrawal by Subject|2|||
164433282|NCT02299635|593957204|FG000|Overall Study|Other|3|||
164284977|NCT02709330|593411444|FG001|Overall Study|Withdrawal by Subject|0|||
164284978|NCT02587819|593411449|FG000|Overall Study|Adverse Event|1|||
164284979|NCT02587819|593411449|FG000|Overall Study|Lost to Follow-up|1|||
164284980|NCT05280717|593414342|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
164284981|NCT05280717|593414343|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
164284982|NCT05280717|593414344|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
164284983|NCT05280717|593414345|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
164284984|NCT05280717|593414346|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
164284985|NCT05280717|593414347|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
164284986|NCT05280717|593414348|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
164284987|NCT05280717|593414342|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
164284988|NCT05280717|593414343|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
164284989|NCT05280717|593414344|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
164284990|NCT05280717|593414345|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
164284991|NCT05280717|593414346|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
164284992|NCT05280717|593414347|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
164284993|NCT05280717|593414348|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
164284994|NCT05280717|593414342|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
164284995|NCT05280717|593414343|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
164284996|NCT05280717|593414344|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
164284997|NCT05280717|593414345|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
164284998|NCT05280717|593414346|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
164284999|NCT05280717|593414347|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
164285000|NCT05280717|593414348|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
164285001|NCT05280717|593414342|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
164285002|NCT05280717|593414343|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
164285003|NCT05280717|593414344|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
164285004|NCT05280717|593414345|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
164433283|NCT00927823|593957205|FG000|Continuous Dosing Period|Death|0|||
164433284|NCT00927823|593957206|FG001|Continuous Dosing Period|Death|0|||
164433285|NCT00927823|593957207|FG002|Continuous Dosing Period|Death|6|||
164285005|NCT05280717|593414346|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
164285006|NCT05280717|593414347|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
164285007|NCT05280717|593414348|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
164285008|NCT05280717|593414342|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
164285009|NCT05280717|593414343|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
164285010|NCT05280717|593414344|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
164285011|NCT05280717|593414345|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
164285012|NCT05280717|593414346|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
164285013|NCT05280717|593414347|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
164285014|NCT05280717|593414348|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
164285015|NCT05280717|593414342|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
164285016|NCT05280717|593414343|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
164285017|NCT05280717|593414344|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
164285018|NCT05280717|593414345|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
164285019|NCT05280717|593414346|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
164285020|NCT05280717|593414347|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
164285021|NCT05280717|593414348|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
164285022|NCT00337207|593414351|FG000|Overall Study|Withdrawal by Subject|3|||
164285023|NCT02562716|593414352|FG000|Overall Study|Adverse Event|7|||
164285024|NCT02562716|593414353|FG001|Overall Study|Adverse Event|14|||
164285025|NCT02562716|593414352|FG000|Overall Study|Withdrawal unrelated to AE|7|||
164285026|NCT02562716|593414353|FG001|Overall Study|Withdrawal unrelated to AE|1|||
164285027|NCT02562716|593414352|FG000|Overall Study|Progression|8|||
164285028|NCT02562716|593414353|FG001|Overall Study|Progression|10|||
164285029|NCT02562716|593414352|FG000|Overall Study|Death|2|||
164285030|NCT02562716|593414353|FG001|Overall Study|Death|1|||
164285031|NCT02562716|593414352|FG000|Overall Study|Not protocol specified|4|||
164285032|NCT02562716|593414353|FG001|Overall Study|Not protocol specified|2|||
164285033|NCT02753946|593414354|FG000|Overall Study|Adverse Event|7|||
164285034|NCT02753946|593414355|FG001|Overall Study|Adverse Event|6|||
164285035|NCT02753946|593414354|FG000|Overall Study|Withdrawal by Subject|6|||
164285036|NCT02753946|593414355|FG001|Overall Study|Withdrawal by Subject|1|||
164433286|NCT00927823|593957208|FG003|Continuous Dosing Period|Death|0|||
164433287|NCT00927823|593957205|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
164433288|NCT00927823|593957206|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
164433289|NCT00927823|593957207|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
164433290|NCT00927823|593957208|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
164433291|NCT00927823|593957205|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
164433292|NCT00927823|593957206|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
164433293|NCT00927823|593957207|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
164433294|NCT00927823|593957208|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
164433295|NCT00927823|593957205|FG000|Continuous Dosing Period|Other|1|||
164433296|NCT00927823|593957206|FG001|Continuous Dosing Period|Other|2|||
164433297|NCT00927823|593957207|FG002|Continuous Dosing Period|Other|9|||
164433298|NCT00927823|593957208|FG003|Continuous Dosing Period|Other|3|||
164433299|NCT00906698|593957209|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
164433300|NCT00906698|593957210|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
164433301|NCT00906698|593957211|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
164433302|NCT00906698|593957212|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
164433303|NCT00906698|593957213|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
164433304|NCT00906698|593957214|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
164433305|NCT00906698|593957209|FG000|Overall Study|Adverse Event|0|||
164433306|NCT00906698|593957210|FG001|Overall Study|Adverse Event|0|||
164433307|NCT00906698|593957211|FG002|Overall Study|Adverse Event|2|||
164433308|NCT00906698|593957212|FG003|Overall Study|Adverse Event|0|||
164433309|NCT00906698|593957213|FG004|Overall Study|Adverse Event|4|||
164433310|NCT00906698|593957214|FG005|Overall Study|Adverse Event|1|||
164433311|NCT00906698|593957209|FG000|Overall Study|Disease progression|3|||
164433312|NCT00906698|593957210|FG001|Overall Study|Disease progression|12|||
164433313|NCT00906698|593957211|FG002|Overall Study|Disease progression|4|||
164433314|NCT00906698|593957212|FG003|Overall Study|Disease progression|4|||
164433315|NCT00906698|593957213|FG004|Overall Study|Disease progression|12|||
164433316|NCT00906698|593957214|FG005|Overall Study|Disease progression|4|||
164433317|NCT00906698|593957209|FG000|Overall Study|Withdrawal by Subject|0|||
164285037|NCT02753946|593414354|FG000|Overall Study|Lack of Efficacy|1|||
164285038|NCT02753946|593414355|FG001|Overall Study|Lack of Efficacy|0|||
164285039|NCT02753946|593414354|FG000|Overall Study|Physician Decision|0|||
164285040|NCT02753946|593414355|FG001|Overall Study|Physician Decision|2|||
164433318|NCT00906698|593957210|FG001|Overall Study|Withdrawal by Subject|0|||
164433319|NCT00906698|593957211|FG002|Overall Study|Withdrawal by Subject|0|||
164433320|NCT00906698|593957212|FG003|Overall Study|Withdrawal by Subject|0|||
164433321|NCT00906698|593957213|FG004|Overall Study|Withdrawal by Subject|1|||
164433322|NCT00906698|593957214|FG005|Overall Study|Withdrawal by Subject|0|||
164586496|NCT04003155|594511827|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
164586497|NCT04003155|594511823|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
164586498|NCT04003155|594511824|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
164586499|NCT04003155|594511825|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
164586500|NCT04003155|594511826|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
164586501|NCT04003155|594511827|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
164586502|NCT04003155|594511823|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
164692048|NCT03180801|594895310|FG001|Overall Study|Physician Decision|3|||
164692049|NCT03180801|594895311|FG002|Overall Study|Physician Decision|1|||
164692050|NCT03180801|594895309|FG000|Overall Study|Non-compliance|1|||
164692051|NCT03180801|594895310|FG001|Overall Study|Non-compliance|4|||
164692052|NCT03180801|594895311|FG002|Overall Study|Non-compliance|0|||
164692053|NCT03180801|594895309|FG000|Overall Study|Inoculation Target Reached|1|||
164692054|NCT03180801|594895310|FG001|Overall Study|Inoculation Target Reached|1|||
164692055|NCT03180801|594895311|FG002|Overall Study|Inoculation Target Reached|3|||
164692056|NCT03180801|594895309|FG000|Overall Study|Adverse Event|1|||
164692057|NCT03180801|594895310|FG001|Overall Study|Adverse Event|0|||
164692058|NCT03180801|594895311|FG002|Overall Study|Adverse Event|2|||
164692059|NCT03180801|594895309|FG000|Overall Study|Withdrawal by Subject|2|||
164692060|NCT03180801|594895310|FG001|Overall Study|Withdrawal by Subject|2|||
164692061|NCT03180801|594895311|FG002|Overall Study|Withdrawal by Subject|1|||
164692062|NCT03180801|594895309|FG000|Overall Study|Lost to Follow-up|0|||
164692063|NCT03180801|594895310|FG001|Overall Study|Lost to Follow-up|2|||
164692064|NCT03180801|594895311|FG002|Overall Study|Lost to Follow-up|3|||
164692065|NCT01049412|594895312|FG000|Period I|Withdrawal by Subject|4|||
164692066|NCT01049412|594895313|FG001|Period I|Withdrawal by Subject|6|||
164692067|NCT01049412|594895312|FG000|Period I|Lost to Follow-up|2|||
164692068|NCT01049412|594895313|FG001|Period I|Lost to Follow-up|2|||
164692069|NCT01049412|594895312|FG000|Period I|Physician Decision|0|||
164692070|NCT01049412|594895313|FG001|Period I|Physician Decision|3|||
164692071|NCT01049412|594895312|FG000|Period I|Protocol Violation|1|||
164692072|NCT01049412|594895313|FG001|Period I|Protocol Violation|2|||
164692073|NCT01049412|594895312|FG000|Period I|Adverse Event|1|||
164692074|NCT01049412|594895313|FG001|Period I|Adverse Event|0|||
164692075|NCT01049412|594895312|FG000|Period II|Withdrawal by Subject|2|||
164692076|NCT01049412|594895313|FG001|Period II|Withdrawal by Subject|3|||
164692077|NCT01049412|594895312|FG000|Period II|Adverse Event|1|||
164692078|NCT01049412|594895313|FG001|Period II|Adverse Event|0|||
164692079|NCT01049412|594895312|FG000|Period II|Lost to Follow-up|1|||
164692080|NCT01049412|594895313|FG001|Period II|Lost to Follow-up|0|||
164692081|NCT05966090|594895316|FG000|Overall Study|Lost to Follow-up|6|||
164692082|NCT05966090|594895317|FG001|Overall Study|Lost to Follow-up|6|||
164692083|NCT05966090|594895316|FG000|Overall Study|Adverse Event|1|||
164692084|NCT05966090|594895317|FG001|Overall Study|Adverse Event|1|||
164692085|NCT05966090|594895316|FG000|Overall Study|Withdrawal by Subject|1|||
164692086|NCT05966090|594895317|FG001|Overall Study|Withdrawal by Subject|1|||
164692087|NCT05966090|594895316|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164692088|NCT05966090|594895317|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
164692089|NCT05966090|594895316|FG000|Overall Study|Other|1|||
164692090|NCT05966090|594895317|FG001|Overall Study|Other|1|||
164692091|NCT00804141|594895318|FG000|Overall Study|Adverse Event|157|||
164692092|NCT00804141|594895318|FG000|Overall Study|Death|4|||
164692093|NCT00804141|594895318|FG000|Overall Study|Failed to return|96|||
164692094|NCT00804141|594895318|FG000|Overall Study|Investigator request|8|||
164692095|NCT00804141|594895318|FG000|Overall Study|Protocol Violation|85|||
164692096|NCT00804141|594895318|FG000|Overall Study|Withdrawal by Subject|131|||
164692097|NCT00804141|594895318|FG000|Overall Study|Lack of Efficacy|46|||
164692098|NCT00804141|594895318|FG000|Overall Study|Other than specified|30|||
164586503|NCT04003155|594511824|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
164586504|NCT04003155|594511825|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
164586505|NCT04003155|594511826|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
164586506|NCT04003155|594511827|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
164586507|NCT04003155|594511823|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
164586508|NCT04003155|594511824|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
164285041|NCT00684996|593414356|FG000|Overall Study|Adverse Event|1|||
164692099|NCT00804141|594895318|FG000|Overall Study|Enrolled but not treated|6|||
164692100|NCT01142908|594895319|FG000|Overall Study|Lost to Follow-up|19|||
164285042|NCT00684996|593414356|FG000|Overall Study|Refusal unrelated to adverse event|1|||
164285043|NCT00684996|593414356|FG000|Overall Study|Progression/relapse|2|||
164285044|NCT00684996|593414356|FG000|Overall Study|Other reasons not protocol specified|1|||
164285045|NCT02519439|593414357|FG000|Overall Study|Study Termination|19|||
164285046|NCT02519439|593414357|FG000|Overall Study|Withdrawal by Subject|1|||
164285047|NCT02519439|593414357|FG000|Overall Study|Adverse Event|1|||
164285048|NCT03030417|593414362|FG000|Dose Expansion|Disease progression before treatment|0|||
164285049|NCT03030417|593414363|FG001|Dose Expansion|Disease progression before treatment|0|||
164285050|NCT03030417|593414364|FG002|Dose Expansion|Disease progression before treatment|0|||
164285051|NCT03030417|593414365|FG003|Dose Expansion|Disease progression before treatment|0|||
164285052|NCT03030417|593414366|FG004|Dose Expansion|Disease progression before treatment|0|||
164285053|NCT03030417|593414367|FG005|Dose Expansion|Disease progression before treatment|0|||
164285054|NCT03030417|593414368|FG006|Dose Expansion|Disease progression before treatment|0|||
164285055|NCT03030417|593414369|FG007|Dose Expansion|Disease progression before treatment|0|||
164285056|NCT03030417|593414370|FG008|Dose Expansion|Disease progression before treatment|0|||
164285057|NCT03030417|593414371|FG009|Dose Expansion|Disease progression before treatment|0|||
164285058|NCT03030417|593414372|FG010|Dose Expansion|Disease progression before treatment|0|||
164285059|NCT03030417|593414373|FG011|Dose Expansion|Disease progression before treatment|0|||
164285060|NCT03030417|593414374|FG012|Dose Expansion|Disease progression before treatment|1|||
164285061|NCT02175017|593414375|FG000|Overall Study|Did not receive the investigational product|1|||
164285062|NCT02175017|593414376|FG001|Overall Study|Did not receive the investigational product|2|||
164692101|NCT01142908|594895320|FG001|Overall Study|Lost to Follow-up|13|||
164692102|NCT01142908|594895319|FG000|Overall Study|Death|1|||
164692103|NCT01142908|594895320|FG001|Overall Study|Death|4|||
164692104|NCT01142908|594895319|FG000|Overall Study|Excluded - did not meet criteria|9|||
164692105|NCT01142908|594895320|FG001|Overall Study|Excluded - did not meet criteria|5|||
164692106|NCT01142908|594895319|FG000|Overall Study|Withdrawal by Subject|3|||
164692107|NCT01142908|594895320|FG001|Overall Study|Withdrawal by Subject|0|||
164692108|NCT03235479|594895322|FG000|Overall Study|Lost to Follow-up|8|||
164692109|NCT03235479|594895323|FG001|Overall Study|Lost to Follow-up|11|||
164692110|NCT03235479|594895322|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
164692111|NCT03235479|594895323|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
164692112|NCT03235479|594895322|FG000|Overall Study|Pregnancy|1|||
164692113|NCT03235479|594895323|FG001|Overall Study|Pregnancy|0|||
164692114|NCT03235479|594895322|FG000|Overall Study|Protocol Deviation|1|||
164692115|NCT03235479|594895323|FG001|Overall Study|Protocol Deviation|3|||
164692116|NCT03235479|594895322|FG000|Overall Study|Technical Problems|3|||
164692117|NCT03235479|594895323|FG001|Overall Study|Technical Problems|2|||
164692118|NCT03235479|594895322|FG000|Overall Study|Withdrawal by Subject|2|||
164692119|NCT03235479|594895323|FG001|Overall Study|Withdrawal by Subject|2|||
164692120|NCT03235479|594895322|FG000|Overall Study|Other Reasons|3|||
164692121|NCT03235479|594895323|FG001|Overall Study|Other Reasons|5|||
164285063|NCT02175017|593414375|FG000|Overall Study|Withdrawal by Subject|6|||
164285064|NCT02175017|593414376|FG001|Overall Study|Withdrawal by Subject|3|||
164285065|NCT02175017|593414375|FG000|Overall Study|Met an exclusion criteria|0|||
164285066|NCT02175017|593414376|FG001|Overall Study|Met an exclusion criteria|1|||
164344776|NCT03000439|593638835|FG001|Open Label Part 2|Insufficient clinical response|12|||
164344777|NCT03000439|593638836|FG002|Open Label Part 2|Insufficient clinical response|0|||
164344778|NCT03000439|593638837|FG003|Open Label Part 2|Insufficient clinical response|0|||
164344779|NCT03000439|593638834|FG000|Double Blind Phase|Adverse Event|0|||
164344780|NCT03000439|593638835|FG001|Double Blind Phase|Adverse Event|0|||
164586509|NCT04003155|594511825|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
164586510|NCT04003155|594511826|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
164586511|NCT04003155|594511827|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
164586512|NCT04003155|594511823|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
164586513|NCT04003155|594511824|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
164586514|NCT04003155|594511825|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
164586515|NCT04003155|594511826|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
164586516|NCT04003155|594511827|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
164586517|NCT01912872|594511831|FG000|Overall Study|Lost to Follow-up|2|||
164586518|NCT01912872|594511832|FG001|Overall Study|Lost to Follow-up|3|||
164692122|NCT03585959|594895335|FG000|Overall Study|Physician Decision|1|||
164692123|NCT03585959|594895335|FG000|Overall Study|Unsuccessful Procedure|2|||
164285067|NCT02175017|593414375|FG000|Overall Study|Adverse Event|3|||
164285068|NCT02175017|593414376|FG001|Overall Study|Adverse Event|10|||
164285069|NCT02175017|593414375|FG000|Overall Study|Disease progression|20|||
164285070|NCT02175017|593414376|FG001|Overall Study|Disease progression|27|||
164285071|NCT02175017|593414375|FG000|Overall Study|Other than above reasons|3|||
164285072|NCT02175017|593414376|FG001|Overall Study|Other than above reasons|0|||
164285073|NCT04915729|593414377|FG000|Overall Study|Lost to Follow-up|20|||
164285074|NCT04915729|593414378|FG001|Overall Study|Lost to Follow-up|10|||
164285075|NCT04915729|593414377|FG000|Overall Study|Withdrawal by Subject|12|||
164285076|NCT04915729|593414378|FG001|Overall Study|Withdrawal by Subject|5|||
164285077|NCT04915729|593414377|FG000|Overall Study|Death|34|||
164285078|NCT04915729|593414378|FG001|Overall Study|Death|44|||
164285079|NCT04915729|593414377|FG000|Overall Study|not treated|3|||
164285080|NCT04915729|593414378|FG001|Overall Study|not treated|6|||
164285081|NCT04915729|593414377|FG000|Overall Study|Investigator removed subject|1|||
164285082|NCT04915729|593414378|FG001|Overall Study|Investigator removed subject|2|||
164285083|NCT04915729|593414377|FG000|Overall Study|questionnaire result not evaluated|1|||
164285084|NCT04915729|593414378|FG001|Overall Study|questionnaire result not evaluated|0|||
164285085|NCT04915729|593414377|FG000|Overall Study|refuse of hospital visit|1|||
164285086|NCT04915729|593414378|FG001|Overall Study|refuse of hospital visit|3|||
164285087|NCT04915729|593414377|FG000|Overall Study|Subject withdrew|1|||
164285088|NCT04915729|593414378|FG001|Overall Study|Subject withdrew|0|||
164285089|NCT04961541|593414379|FG000|Overall Study|Adverse Event|0|||
164285090|NCT04961541|593414380|FG001|Overall Study|Adverse Event|0|||
164285091|NCT04961541|593414381|FG002|Overall Study|Adverse Event|0|||
164285092|NCT04961541|593414382|FG003|Overall Study|Adverse Event|0|||
164285093|NCT04961541|593414383|FG004|Overall Study|Adverse Event|0|||
164285094|NCT04961541|593414384|FG005|Overall Study|Adverse Event|1|||
164285095|NCT04961541|593414385|FG006|Overall Study|Adverse Event|0|||
164285096|NCT04961541|593414386|FG007|Overall Study|Adverse Event|0|||
164285097|NCT04961541|593414387|FG008|Overall Study|Adverse Event|0|||
164285098|NCT04961541|593414388|FG009|Overall Study|Adverse Event|0|||
164285099|NCT04961541|593414389|FG010|Overall Study|Adverse Event|0|||
164285100|NCT04961541|593414390|FG011|Overall Study|Adverse Event|0|||
164285101|NCT04961541|593414391|FG012|Overall Study|Adverse Event|0|||
164285102|NCT04961541|593414392|FG013|Overall Study|Adverse Event|0|||
164285103|NCT04961541|593414379|FG000|Overall Study|Lost to Follow-up|0|||
164285104|NCT04961541|593414380|FG001|Overall Study|Lost to Follow-up|0|||
164285105|NCT04961541|593414381|FG002|Overall Study|Lost to Follow-up|3|||
164285106|NCT04961541|593414382|FG003|Overall Study|Lost to Follow-up|0|||
164285107|NCT04961541|593414383|FG004|Overall Study|Lost to Follow-up|0|||
164285108|NCT04961541|593414384|FG005|Overall Study|Lost to Follow-up|0|||
164285109|NCT04961541|593414385|FG006|Overall Study|Lost to Follow-up|1|||
164285110|NCT04961541|593414386|FG007|Overall Study|Lost to Follow-up|1|||
164285111|NCT04961541|593414387|FG008|Overall Study|Lost to Follow-up|0|||
164285112|NCT04961541|593414388|FG009|Overall Study|Lost to Follow-up|1|||
164285113|NCT04961541|593414389|FG010|Overall Study|Lost to Follow-up|0|||
164285114|NCT04961541|593414390|FG011|Overall Study|Lost to Follow-up|0|||
164285115|NCT04961541|593414391|FG012|Overall Study|Lost to Follow-up|1|||
164285116|NCT04961541|593414392|FG013|Overall Study|Lost to Follow-up|0|||
164285117|NCT04961541|593414379|FG000|Overall Study|Withdrawal by Subject|0|||
164285118|NCT04961541|593414380|FG001|Overall Study|Withdrawal by Subject|0|||
164285119|NCT04961541|593414381|FG002|Overall Study|Withdrawal by Subject|1|||
164285120|NCT04961541|593414382|FG003|Overall Study|Withdrawal by Subject|1|||
164285121|NCT04961541|593414383|FG004|Overall Study|Withdrawal by Subject|0|||
164285122|NCT04961541|593414384|FG005|Overall Study|Withdrawal by Subject|0|||
164285123|NCT04961541|593414385|FG006|Overall Study|Withdrawal by Subject|0|||
164285124|NCT04961541|593414386|FG007|Overall Study|Withdrawal by Subject|0|||
164285125|NCT04961541|593414387|FG008|Overall Study|Withdrawal by Subject|0|||
164285126|NCT04961541|593414388|FG009|Overall Study|Withdrawal by Subject|1|||
164285127|NCT04961541|593414389|FG010|Overall Study|Withdrawal by Subject|0|||
164285128|NCT04961541|593414390|FG011|Overall Study|Withdrawal by Subject|0|||
164285129|NCT04961541|593414391|FG012|Overall Study|Withdrawal by Subject|0|||
164285130|NCT04961541|593414392|FG013|Overall Study|Withdrawal by Subject|0|||
164285131|NCT00466921|593414393|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
164285132|NCT00466921|593414393|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
164285133|NCT00466921|593414393|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
164285134|NCT00466921|593414393|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
164285135|NCT00466921|593414393|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
164285136|NCT00466921|593414393|FG000|Follow up for a Minimum of 1 Year|Death|6|||
164285137|NCT03305770|593414394|FG000|Overall Study|Physician Decision - prior to dispense|0|||
164285138|NCT03305770|593414395|FG001|Overall Study|Physician Decision - prior to dispense|1|||
164285139|NCT03305770|593414394|FG000|Overall Study|Subject moved|1|||
164285140|NCT03305770|593414395|FG001|Overall Study|Subject moved|0|||
164285141|NCT03539601|593414396|FG000|Overall Study|Withdraw by parent/guardian|1|||
164285142|NCT03539601|593414397|FG001|Overall Study|Withdraw by parent/guardian|0|||
164344781|NCT03000439|593638836|FG002|Double Blind Phase|Adverse Event|2|||
164344782|NCT03000439|593638837|FG003|Double Blind Phase|Adverse Event|1|||
164285143|NCT03539601|593414398|FG002|Overall Study|Withdraw by parent/guardian|1|||
164285144|NCT03539601|593414399|FG003|Overall Study|Withdraw by parent/guardian|0|||
164285145|NCT03539601|593414396|FG000|Overall Study|Adverse Event|0|||
164285146|NCT03539601|593414397|FG001|Overall Study|Adverse Event|2|||
164285147|NCT03539601|593414398|FG002|Overall Study|Adverse Event|0|||
164285148|NCT03539601|593414399|FG003|Overall Study|Adverse Event|0|||
164285149|NCT03539601|593414396|FG000|Overall Study|Lost to Follow-up|2|||
164285150|NCT03539601|593414397|FG001|Overall Study|Lost to Follow-up|4|||
164285151|NCT03539601|593414398|FG002|Overall Study|Lost to Follow-up|5|||
164285152|NCT03539601|593414399|FG003|Overall Study|Lost to Follow-up|0|||
164285153|NCT03539601|593414396|FG000|Overall Study|Withdrawal by Subject|2|||
164285154|NCT03539601|593414397|FG001|Overall Study|Withdrawal by Subject|0|||
164586519|NCT01912872|594511833|FG002|Overall Study|Lost to Follow-up|5|||
164586520|NCT01912872|594511834|FG003|Overall Study|Lost to Follow-up|5|||
164586521|NCT01912872|594511831|FG000|Overall Study|Other unspecified|3|||
164586522|NCT01912872|594511832|FG001|Overall Study|Other unspecified|1|||
164586523|NCT01912872|594511833|FG002|Overall Study|Other unspecified|3|||
164586524|NCT01912872|594511834|FG003|Overall Study|Other unspecified|0|||
164586525|NCT01912872|594511831|FG000|Overall Study|Informed consent withdrawn|0|||
164586526|NCT01912872|594511832|FG001|Overall Study|Informed consent withdrawn|0|||
164586527|NCT01912872|594511833|FG002|Overall Study|Informed consent withdrawn|1|||
164586528|NCT01912872|594511834|FG003|Overall Study|Informed consent withdrawn|1|||
164586529|NCT01912872|594511831|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
164285155|NCT03539601|593414398|FG002|Overall Study|Withdrawal by Subject|0|||
164285156|NCT03539601|593414399|FG003|Overall Study|Withdrawal by Subject|1|||
164285157|NCT03539601|593414396|FG000|Overall Study|Randomized but not treated|1|||
164285158|NCT03539601|593414397|FG001|Overall Study|Randomized but not treated|1|||
164285159|NCT03539601|593414398|FG002|Overall Study|Randomized but not treated|0|||
164285160|NCT03539601|593414399|FG003|Overall Study|Randomized but not treated|0|||
164285161|NCT03710642|593414403|FG000|Overall Study|Adverse Event|5|||
164285162|NCT03710642|593414404|FG001|Overall Study|Adverse Event|1|||
164285163|NCT03710642|593414403|FG000|Overall Study|non-site physician recommendation|1|||
164285164|NCT03710642|593414404|FG001|Overall Study|non-site physician recommendation|0|||
164285165|NCT03710642|593414403|FG000|Overall Study|Participant unwilling or unable to participate|1|||
164285166|NCT03710642|593414404|FG001|Overall Study|Participant unwilling or unable to participate|1|||
164285167|NCT03710642|593414403|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
164586530|NCT01912872|594511832|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
164586531|NCT01912872|594511833|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
164586532|NCT01912872|594511834|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
164586533|NCT01912872|594511831|FG000|Overall Study|Protocol Violation|0|||
164586534|NCT01912872|594511832|FG001|Overall Study|Protocol Violation|0|||
164586535|NCT01912872|594511833|FG002|Overall Study|Protocol Violation|1|||
164586536|NCT01912872|594511834|FG003|Overall Study|Protocol Violation|0|||
164586537|NCT01912872|594511831|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164586538|NCT01912872|594511832|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164586539|NCT01912872|594511833|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
164586540|NCT01912872|594511834|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
164586541|NCT01912872|594511831|FG000|Overall Study|Withdrawal of study medication|0|||
164285168|NCT03710642|593414404|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
164285169|NCT03710642|593414403|FG000|Overall Study|NA-no code provided|1|||
164285170|NCT03710642|593414404|FG001|Overall Study|NA-no code provided|0|||
164285171|NCT03710642|593414403|FG000|Overall Study|Withdrawal by Subject|1|||
164285172|NCT03710642|593414404|FG001|Overall Study|Withdrawal by Subject|0|||
164285173|NCT01970306|593414405|FG000|Overall Study|Not eligible|3|||
164586542|NCT01912872|594511832|FG001|Overall Study|Withdrawal of study medication|0|||
164586543|NCT01912872|594511833|FG002|Overall Study|Withdrawal of study medication|0|||
164586544|NCT01912872|594511834|FG003|Overall Study|Withdrawal of study medication|2|||
164586545|NCT01912872|594511831|FG000|Overall Study|Missing|0|||
164586546|NCT01912872|594511832|FG001|Overall Study|Missing|0|||
164586547|NCT01912872|594511833|FG002|Overall Study|Missing|0|||
164586548|NCT01912872|594511834|FG003|Overall Study|Missing|1|||
164586549|NCT00592358|594511835|FG000|Overall Study|Withdrawal by Subject|2|||
164586550|NCT00592358|594511835|FG000|Overall Study|Adverse Event|1|||
164586551|NCT00592358|594511835|FG000|Overall Study|Lack of Efficacy|2|||
164586552|NCT00592358|594511835|FG000|Overall Study|Inability to swallow pills|1|||
164586553|NCT00084682|594511836|FG000|Overall Study|Withdrawal by Subject|1|||
164586554|NCT00634543|594511841|FG000|Overall Study|Other|1|||
164586555|NCT00634543|594511842|FG001|Overall Study|Other|2|||
164586556|NCT00634543|594511841|FG000|Overall Study|Protocol Violation|3|||
164586557|NCT00634543|594511842|FG001|Overall Study|Protocol Violation|3|||
164586558|NCT00634543|594511841|FG000|Overall Study|Adverse Event|11|||
164586559|NCT00634543|594511842|FG001|Overall Study|Adverse Event|11|||
164586560|NCT00634543|594511841|FG000|Overall Study|Withdrawal by Subject|4|||
164586561|NCT00634543|594511842|FG001|Overall Study|Withdrawal by Subject|4|||
164586562|NCT00634543|594511841|FG000|Overall Study|Lost to Follow-up|0|||
164285174|NCT01970306|593414405|FG000|Overall Study|Not able to be treated|9|||
164285175|NCT00226811|593414406|FG000|Overall Study|Death|8|||
164285176|NCT00226811|593414406|FG000|Overall Study|Adverse Event|11|||
164285177|NCT00226811|593414406|FG000|Overall Study|Lack of Efficacy|55|||
164285178|NCT00226811|593414406|FG000|Overall Study|Withdrawal by Subject|2|||
164285179|NCT01427933|593414410|FG000|Overall Study|Withdrawal by Subject|5|||
164285180|NCT01427933|593414411|FG001|Overall Study|Withdrawal by Subject|8|||
164285181|NCT01427933|593414410|FG000|Overall Study|Lost to Follow-up|1|||
164285182|NCT01427933|593414411|FG001|Overall Study|Lost to Follow-up|5|||
164285183|NCT01427933|593414410|FG000|Overall Study|Other|1|||
164285184|NCT01427933|593414411|FG001|Overall Study|Other|0|||
164285185|NCT01427933|593414410|FG000|Overall Study|Investigator's Decision|1|||
164285186|NCT01427933|593414411|FG001|Overall Study|Investigator's Decision|0|||
164285187|NCT01633541|593414412|FG000|Overall Study|Death|1|||
164285188|NCT01633541|593414413|FG001|Overall Study|Death|0|||
164285189|NCT03472326|593414416|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
164285190|NCT03472326|593414417|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
164285191|NCT03472326|593414418|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
164285192|NCT03472326|593414419|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
164285193|NCT03472326|593414416|FG000|Part 2: Combination Therapy|Pregnancy|0|||
164285194|NCT03472326|593414417|FG001|Part 2: Combination Therapy|Pregnancy|0|||
164285195|NCT03472326|593414418|FG002|Part 2: Combination Therapy|Pregnancy|0|||
164285196|NCT03472326|593414419|FG003|Part 2: Combination Therapy|Pregnancy|1|||
164285197|NCT01010971|593414420|FG000|Overall Study|Adverse Event|2|||
164285198|NCT01010971|593414421|FG001|Overall Study|Adverse Event|4|||
164285199|NCT01010971|593414422|FG002|Overall Study|Adverse Event|3|||
164285200|NCT01010971|593414420|FG000|Overall Study|Withdrawal by Subject|0|||
164285201|NCT01010971|593414421|FG001|Overall Study|Withdrawal by Subject|2|||
164285202|NCT01010971|593414422|FG002|Overall Study|Withdrawal by Subject|5|||
164285203|NCT01010971|593414420|FG000|Overall Study|Lost to Follow-up|0|||
164285204|NCT01010971|593414421|FG001|Overall Study|Lost to Follow-up|2|||
164285205|NCT01010971|593414422|FG002|Overall Study|Lost to Follow-up|3|||
164285206|NCT01010971|593414420|FG000|Overall Study|Other|1|||
164285207|NCT01010971|593414421|FG001|Overall Study|Other|0|||
164285208|NCT01010971|593414422|FG002|Overall Study|Other|2|||
164285209|NCT00773513|593414424|FG000|Overall Study|Renal Transplant|254|||
164285210|NCT00773513|593414425|FG001|Overall Study|Renal Transplant|263|||
164285211|NCT00773513|593414424|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
164285212|NCT00773513|593414425|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
164285213|NCT00773513|593414424|FG000|Overall Study|Withdrew Consent|68|||
164285214|NCT00773513|593414425|FG001|Overall Study|Withdrew Consent|69|||
164285215|NCT00773513|593414424|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
164285216|NCT00773513|593414425|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
164285217|NCT00773513|593414424|FG000|Overall Study|Failure to Return|22|||
164285218|NCT00773513|593414425|FG001|Overall Study|Failure to Return|8|||
164285219|NCT00773513|593414424|FG000|Overall Study|Insufficient Therapeutic Response|1|||
164285220|NCT00773513|593414425|FG001|Overall Study|Insufficient Therapeutic Response|18|||
164285221|NCT00773513|593414424|FG000|Overall Study|Reason Not Specified|159|||
164285222|NCT00773513|593414425|FG001|Overall Study|Reason Not Specified|126|||
164285223|NCT00773513|593414424|FG000|Overall Study|Death|531|||
164285224|NCT00773513|593414425|FG001|Overall Study|Death|545|||
164285225|NCT02330055|593414427|FG000|Overall Study|technical issues|2|||
164285226|NCT02330055|593414428|FG001|Overall Study|technical issues|0|||
164285227|NCT02330055|593414427|FG000|Overall Study|participant forgot to wear device|5|||
164285228|NCT02330055|593414428|FG001|Overall Study|participant forgot to wear device|5|||
164285229|NCT02330055|593414427|FG000|Overall Study|data for less than 60 minutes|3|||
164285230|NCT02330055|593414428|FG001|Overall Study|data for less than 60 minutes|3|||
164285231|NCT02330055|593414427|FG000|Overall Study|participant did not sleep|0|||
164285232|NCT02330055|593414428|FG001|Overall Study|participant did not sleep|1|||
164586563|NCT00634543|594511842|FG001|Overall Study|Lost to Follow-up|1|||
164586564|NCT01013883|594511843|FG000|Overall Study|Lost to Follow-up|2|||
164285233|NCT05729568|593414430|FG000|Overall Study|Still on Study|52|||
164285234|NCT05729568|593414431|FG001|Overall Study|Still on Study|26|||
164285235|NCT05729568|593414430|FG000|Overall Study|Randomized but Never Treated|3|||
164285236|NCT05729568|593414431|FG001|Overall Study|Randomized but Never Treated|0|||
164285237|NCT05729568|593414430|FG000|Overall Study|Adverse Event|0|||
164285238|NCT05729568|593414431|FG001|Overall Study|Adverse Event|1|||
164586565|NCT01013883|594511844|FG001|Overall Study|Lost to Follow-up|2|||
164586566|NCT01371838|594511845|FG000|Overall Study|Withdrawal by Subject|27|||
164586567|NCT01371838|594511846|FG001|Overall Study|Withdrawal by Subject|33|||
164586568|NCT01371838|594511845|FG000|Overall Study|Lost to Follow-up|10|||
164586569|NCT01371838|594511846|FG001|Overall Study|Lost to Follow-up|20|||
164586570|NCT01371838|594511845|FG000|Overall Study|Death|3|||
164586571|NCT01371838|594511846|FG001|Overall Study|Death|4|||
164285239|NCT05729568|593414430|FG000|Overall Study|Investigator's Discretion|1|||
164285240|NCT05729568|593414431|FG001|Overall Study|Investigator's Discretion|0|||
164285241|NCT00550953|593414432|FG000|Overall Study|Adverse Event|4|||
164586572|NCT01371838|594511845|FG000|Overall Study|Protocol Violation|3|||
164586573|NCT01371838|594511846|FG001|Overall Study|Protocol Violation|0|||
164586574|NCT01371838|594511845|FG000|Overall Study|Investigator Decision|3|||
164586575|NCT01371838|594511846|FG001|Overall Study|Investigator Decision|8|||
164586576|NCT01371838|594511845|FG000|Overall Study|Last follow-up visit not conducted|2|||
164586577|NCT01371838|594511846|FG001|Overall Study|Last follow-up visit not conducted|0|||
164586578|NCT01371838|594511845|FG000|Overall Study|Lack of therapeutic response|0|||
164692124|NCT01098539|594895337|FG000|Overall Study|Adverse Event|26|||
164692125|NCT01098539|594895338|FG001|Overall Study|Adverse Event|26|||
164692126|NCT01098539|594895337|FG000|Overall Study|Protocol Violation|1|||
164692127|NCT01098539|594895338|FG001|Overall Study|Protocol Violation|4|||
164692128|NCT01098539|594895337|FG000|Overall Study|Noncompliance|3|||
164692129|NCT01098539|594895338|FG001|Overall Study|Noncompliance|5|||
164692130|NCT01098539|594895337|FG000|Overall Study|Lost to Follow-up|4|||
164692131|NCT01098539|594895338|FG001|Overall Study|Lost to Follow-up|4|||
164285242|NCT00550953|593414433|FG001|Overall Study|Adverse Event|3|||
164285243|NCT00550953|593414432|FG000|Overall Study|Not able to visit the site|2|||
164285244|NCT00550953|593414433|FG001|Overall Study|Not able to visit the site|3|||
164285245|NCT01502228|593414434|FG000|Overall Study|Death|1|||
164285246|NCT01221350|593414437|FG000|Overall Study|Discontinued intervention (GERD)|1|||
164285247|NCT01221350|593414438|FG001|Overall Study|Discontinued intervention (GERD)|0|||
164285248|NCT01221350|593414437|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
164285249|NCT01221350|593414438|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
164285250|NCT01221350|593414437|FG000|Overall Study|Withdrawal by Subject|4|||
164285251|NCT01221350|593414438|FG001|Overall Study|Withdrawal by Subject|2|||
164285252|NCT02326597|593414441|FG000|Overall Study|Lost to Follow-up|42|||
164285253|NCT02326597|593414442|FG001|Overall Study|Lost to Follow-up|32|||
164285254|NCT04739436|593414443|FG000|Overall Study|Lost to Follow-up|21|||
164285255|NCT04739436|593414444|FG001|Overall Study|Lost to Follow-up|23|||
164285256|NCT04739436|593414443|FG000|Overall Study|Withdrawal by Subject|4|||
164285257|NCT04739436|593414444|FG001|Overall Study|Withdrawal by Subject|6|||
164285258|NCT04739436|593414443|FG000|Overall Study|not randomized properly|1|||
164285259|NCT04739436|593414444|FG001|Overall Study|not randomized properly|0|||
164285260|NCT00428948|593414445|FG000|Overall Study|Lost to Follow-up|15|||
164285261|NCT00428948|593414446|FG001|Overall Study|Lost to Follow-up|8|||
164285262|NCT00428948|593414445|FG000|Overall Study|Adverse Event|148|||
164285263|NCT00428948|593414446|FG001|Overall Study|Adverse Event|24|||
164285264|NCT00428948|593414445|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
164285265|NCT00428948|593414446|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
164285266|NCT00428948|593414445|FG000|Overall Study|Investigator Withdrew Subject|3|||
164285267|NCT00428948|593414446|FG001|Overall Study|Investigator Withdrew Subject|4|||
164285268|NCT00428948|593414445|FG000|Overall Study|Subject Withdrew Consent|50|||
164285269|NCT00428948|593414446|FG001|Overall Study|Subject Withdrew Consent|30|||
164285270|NCT00428948|593414445|FG000|Overall Study|Protocol Deviation|1|||
164285271|NCT00428948|593414446|FG001|Overall Study|Protocol Deviation|1|||
164285272|NCT04752332|593414452|FG000|Overall Study|Adverse Event|3|||
164285273|NCT04752332|593414453|FG001|Overall Study|Adverse Event|1|||
164285274|NCT04752332|593414452|FG000|Overall Study|Disease Relapse|1|||
164285275|NCT04752332|593414453|FG001|Overall Study|Disease Relapse|0|||
164285276|NCT04752332|593414452|FG000|Overall Study|Non-compliance With Study Drug|2|||
164285277|NCT04752332|593414453|FG001|Overall Study|Non-compliance With Study Drug|0|||
164285278|NCT04752332|593414452|FG000|Overall Study|Physician Decision|2|||
164285279|NCT04752332|593414453|FG001|Overall Study|Physician Decision|1|||
164285280|NCT04752332|593414452|FG000|Overall Study|Protocol Violation|1|||
164285281|NCT04752332|593414453|FG001|Overall Study|Protocol Violation|1|||
164285282|NCT04752332|593414452|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
164285283|NCT04752332|593414453|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
164285284|NCT04752332|593414452|FG000|Overall Study|Study Terminated by Sponsor|10|||
164285285|NCT04752332|593414453|FG001|Overall Study|Study Terminated by Sponsor|48|||
164285286|NCT04752332|593414452|FG000|Overall Study|Withdrawal by Subject|11|||
164285287|NCT04752332|593414453|FG001|Overall Study|Withdrawal by Subject|3|||
164285288|NCT00924443|593414454|FG000|Overall Study|Physician Decision|2|||
164285289|NCT00924443|593414454|FG000|Overall Study|Protocol Violation|1|||
164285290|NCT02119663|593414459|FG000|Overall Study|Disease progression|26|||
164692132|NCT01098539|594895337|FG000|Overall Study|Withdrawal by Subject|12|||
164285291|NCT02119663|593414460|FG001|Overall Study|Disease progression|27|||
164285292|NCT02119663|593414459|FG000|Overall Study|Adverse Event|5|||
164285293|NCT02119663|593414460|FG001|Overall Study|Adverse Event|5|||
164285294|NCT02119663|593414459|FG000|Overall Study|Death|3|||
164586579|NCT01371838|594511846|FG001|Overall Study|Lack of therapeutic response|1|||
164586580|NCT01371838|594511845|FG000|Overall Study|Surgery|1|||
164692133|NCT01098539|594895338|FG001|Overall Study|Withdrawal by Subject|26|||
164285295|NCT02119663|593414460|FG001|Overall Study|Death|2|||
164285296|NCT02119663|593414459|FG000|Overall Study|Physician Decision|1|||
164285297|NCT02119663|593414460|FG001|Overall Study|Physician Decision|2|||
164285298|NCT02119663|593414459|FG000|Overall Study|Other unspecified|2|||
164285299|NCT02119663|593414460|FG001|Overall Study|Other unspecified|0|||
164692134|NCT01098539|594895337|FG000|Overall Study|Physician Decision|5|||
164285300|NCT02119663|593414459|FG000|Overall Study|Subject decision|0|||
164285301|NCT02119663|593414460|FG001|Overall Study|Subject decision|1|||
164285302|NCT02119663|593414459|FG000|Overall Study|Study Terminated by the Sponsor|3|||
164285303|NCT02119663|593414460|FG001|Overall Study|Study Terminated by the Sponsor|4|||
164285304|NCT01248949|593414461|FG000|Overall Study|Lost to Follow-up|2|||
164285305|NCT01248949|593414462|FG001|Overall Study|Lost to Follow-up|2|||
164285306|NCT01248949|593414463|FG002|Overall Study|Lost to Follow-up|2|||
164285307|NCT01248949|593414464|FG003|Overall Study|Lost to Follow-up|1|||
164285308|NCT01248949|593414465|FG004|Overall Study|Lost to Follow-up|0|||
164285309|NCT01248949|593414461|FG000|Overall Study|Withdrawal by Subject|5|||
164285310|NCT01248949|593414462|FG001|Overall Study|Withdrawal by Subject|3|||
164285311|NCT01248949|593414463|FG002|Overall Study|Withdrawal by Subject|11|||
164285312|NCT01248949|593414464|FG003|Overall Study|Withdrawal by Subject|3|||
164285313|NCT01248949|593414465|FG004|Overall Study|Withdrawal by Subject|1|||
164285314|NCT01248949|593414461|FG000|Overall Study|Death|22|||
164285315|NCT01248949|593414462|FG001|Overall Study|Death|7|||
164285316|NCT01248949|593414463|FG002|Overall Study|Death|21|||
164285317|NCT01248949|593414464|FG003|Overall Study|Death|6|||
164285318|NCT01248949|593414465|FG004|Overall Study|Death|2|||
164285319|NCT01248949|593414461|FG000|Overall Study|Alternative Therapy|1|||
164285320|NCT01248949|593414462|FG001|Overall Study|Alternative Therapy|0|||
164285321|NCT01248949|593414463|FG002|Overall Study|Alternative Therapy|0|||
164285322|NCT01248949|593414464|FG003|Overall Study|Alternative Therapy|0|||
164285323|NCT01248949|593414465|FG004|Overall Study|Alternative Therapy|0|||
164285324|NCT01248949|593414461|FG000|Overall Study|Alternative Therapy.|1|||
164285325|NCT01248949|593414462|FG001|Overall Study|Alternative Therapy.|0|||
164285326|NCT01248949|593414463|FG002|Overall Study|Alternative Therapy.|0|||
164285327|NCT01248949|593414464|FG003|Overall Study|Alternative Therapy.|0|||
164285328|NCT01248949|593414465|FG004|Overall Study|Alternative Therapy.|0|||
164285329|NCT01248949|593414461|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
164285330|NCT01248949|593414462|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
164285331|NCT01248949|593414463|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
164344783|NCT03000439|593638834|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
164344784|NCT03000439|593638835|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
164344785|NCT03000439|593638836|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
164344786|NCT03000439|593638837|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
164344787|NCT03000439|593638834|FG000|Double Blind Phase|Other|0|||
164344788|NCT03000439|593638835|FG001|Double Blind Phase|Other|0|||
164344789|NCT03000439|593638836|FG002|Double Blind Phase|Other|10|||
164344790|NCT03000439|593638837|FG003|Double Blind Phase|Other|11|||
164344791|NCT03000439|593638834|FG000|Double Blind Phase|Insufficient clinical response|0|||
164344792|NCT03000439|593638835|FG001|Double Blind Phase|Insufficient clinical response|0|||
164344793|NCT03000439|593638836|FG002|Double Blind Phase|Insufficient clinical response|0|||
164344794|NCT03000439|593638837|FG003|Double Blind Phase|Insufficient clinical response|2|||
164344795|NCT01389817|593638840|FG000|Overall Study|Physician Decision|1|||
164344796|NCT01389817|593638841|FG001|Overall Study|Physician Decision|0|||
164344797|NCT01389817|593638840|FG000|Overall Study|Lost to Follow-up|1|||
164344798|NCT01389817|593638841|FG001|Overall Study|Lost to Follow-up|0|||
164344799|NCT01389817|593638840|FG000|Overall Study|Withdrawal by Subject|2|||
164344800|NCT01389817|593638841|FG001|Overall Study|Withdrawal by Subject|0|||
164344801|NCT01749137|593638842|FG000|Overall Study|Adverse Event|4|||
164344802|NCT01749137|593638843|FG001|Overall Study|Adverse Event|4|||
164344803|NCT01749137|593638842|FG000|Overall Study|Lost to Follow-up|2|||
164344804|NCT01749137|593638843|FG001|Overall Study|Lost to Follow-up|3|||
164344805|NCT01749137|593638842|FG000|Overall Study|Physician Decision|1|||
164344806|NCT01749137|593638843|FG001|Overall Study|Physician Decision|0|||
164344807|NCT01749137|593638842|FG000|Overall Study|Withdrawal by Subject|8|||
164344808|NCT01749137|593638843|FG001|Overall Study|Withdrawal by Subject|4|||
164344809|NCT04980040|593638845|FG000|Overall Study|Violated the Inclusion Criteria|260|||
164344810|NCT04980040|593638845|FG000|Overall Study|Violated the Administration & Dosage|225|||
164344811|NCT04980040|593638845|FG000|Overall Study|Lost to Safety-Follow-up|4|||
164344812|NCT04980040|593638845|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
164344813|NCT01508650|593638846|FG000|Overall Study|Lost to Follow-up|0|||
164344814|NCT01508650|593638847|FG001|Overall Study|Lost to Follow-up|3|||
164344815|NCT02064894|593638848|FG000|Overall Study|Withdrawal by Subject|43|||
164586581|NCT01371838|594511846|FG001|Overall Study|Surgery|0|||
164344816|NCT02064894|593638849|FG001|Overall Study|Withdrawal by Subject|102|||
164344817|NCT02064894|593638850|FG002|Overall Study|Withdrawal by Subject|115|||
164433323|NCT00906698|593957209|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
164586582|NCT02616029|594511856|FG000|Overall Study|Adverse Event|1|||
164285332|NCT01248949|593414464|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
164285333|NCT01248949|593414465|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
164285334|NCT01248949|593414461|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
164285335|NCT01248949|593414462|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
164285336|NCT01248949|593414463|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
164285337|NCT01248949|593414464|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
164285338|NCT01248949|593414465|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
164285339|NCT01248949|593414461|FG000|Overall Study|Participant Went To Hospice|0|||
164285340|NCT01248949|593414462|FG001|Overall Study|Participant Went To Hospice|0|||
164285341|NCT01248949|593414463|FG002|Overall Study|Participant Went To Hospice|1|||
164285342|NCT01248949|593414464|FG003|Overall Study|Participant Went To Hospice|0|||
164285343|NCT01248949|593414465|FG004|Overall Study|Participant Went To Hospice|0|||
164285344|NCT01248949|593414461|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
164285345|NCT01248949|593414462|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
164285346|NCT01248949|593414463|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
164285347|NCT01248949|593414464|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
164285348|NCT01248949|593414465|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
164285349|NCT01248949|593414461|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
164285350|NCT01248949|593414462|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
164285351|NCT01248949|593414463|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
164285352|NCT01248949|593414464|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
164285353|NCT01248949|593414465|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
164285354|NCT01248949|593414461|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
164285355|NCT01248949|593414462|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
164285356|NCT01248949|593414463|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
164285357|NCT01248949|593414464|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
164285358|NCT01248949|593414465|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
164285359|NCT01248949|593414461|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
164285360|NCT01248949|593414462|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
164285361|NCT01248949|593414463|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
164285362|NCT01248949|593414464|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
164285363|NCT01248949|593414465|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
164285364|NCT00286429|593414466|FG000|Overall Study|Adverse Event|4|||
164285365|NCT00286429|593414467|FG001|Overall Study|Adverse Event|1|||
164285366|NCT00286429|593414468|FG002|Overall Study|Adverse Event|6|||
164285367|NCT00286429|593414466|FG000|Overall Study|Lack of Efficacy|52|||
164285368|NCT00286429|593414467|FG001|Overall Study|Lack of Efficacy|27|||
164285369|NCT00286429|593414468|FG002|Overall Study|Lack of Efficacy|25|||
164285370|NCT00286429|593414466|FG000|Overall Study|Lost to Follow-up|2|||
164285371|NCT00286429|593414467|FG001|Overall Study|Lost to Follow-up|4|||
164285372|NCT00286429|593414468|FG002|Overall Study|Lost to Follow-up|3|||
164285373|NCT00286429|593414466|FG000|Overall Study|Physician Decision|10|||
164285374|NCT00286429|593414467|FG001|Overall Study|Physician Decision|7|||
164285375|NCT00286429|593414468|FG002|Overall Study|Physician Decision|7|||
164285376|NCT00286429|593414466|FG000|Overall Study|Protocol Violation|3|||
164285377|NCT00286429|593414467|FG001|Overall Study|Protocol Violation|5|||
164285378|NCT00286429|593414468|FG002|Overall Study|Protocol Violation|4|||
164285379|NCT00286429|593414466|FG000|Overall Study|Withdrawal by Subject|3|||
164285380|NCT00286429|593414467|FG001|Overall Study|Withdrawal by Subject|2|||
164285381|NCT00286429|593414468|FG002|Overall Study|Withdrawal by Subject|6|||
164285382|NCT00286429|593414466|FG000|Overall Study|Administrative Error|1|||
164285383|NCT00286429|593414467|FG001|Overall Study|Administrative Error|1|||
164285384|NCT00286429|593414468|FG002|Overall Study|Administrative Error|1|||
164285385|NCT00286429|593414466|FG000|Overall Study|Administrative Decision|0|||
164285386|NCT00286429|593414467|FG001|Overall Study|Administrative Decision|1|||
164285387|NCT00286429|593414468|FG002|Overall Study|Administrative Decision|0|||
164285388|NCT03197376|593414471|FG000|Primary and Booster Phase|Adverse Event|0|||
164285389|NCT03197376|593414472|FG001|Primary and Booster Phase|Adverse Event|0|||
164285390|NCT03197376|593414473|FG002|Primary and Booster Phase|Adverse Event|0|||
164285391|NCT03197376|593414474|FG003|Primary and Booster Phase|Adverse Event|1|||
164285392|NCT03197376|593414471|FG000|Primary and Booster Phase|Death|1|||
164285393|NCT03197376|593414472|FG001|Primary and Booster Phase|Death|0|||
164285394|NCT03197376|593414473|FG002|Primary and Booster Phase|Death|0|||
164285395|NCT03197376|593414474|FG003|Primary and Booster Phase|Death|2|||
164344818|NCT01976338|593638851|FG000|Overall Study|Physician Decision|0|||
164344819|NCT01976338|593638852|FG001|Overall Study|Physician Decision|1|||
164344820|NCT01976338|593638851|FG000|Overall Study|Lost to Follow-up|3|||
164344821|NCT01976338|593638852|FG001|Overall Study|Lost to Follow-up|0|||
164344822|NCT01976338|593638851|FG000|Overall Study|Withdrawal by Subject|5|||
164344823|NCT01976338|593638852|FG001|Overall Study|Withdrawal by Subject|2|||
164344824|NCT01976338|593638851|FG000|Overall Study|Adverse Event|5|||
164344825|NCT01976338|593638852|FG001|Overall Study|Adverse Event|1|||
164344826|NCT01471171|593638854|FG000|Treatment Period 1|Adverse Event|4|||
164344827|NCT01471171|593638855|FG001|Treatment Period 1|Adverse Event|1|||
164285396|NCT03197376|593414471|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
164285397|NCT03197376|593414472|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
164285398|NCT03197376|593414473|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
164285399|NCT03197376|593414474|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
164285400|NCT03197376|593414471|FG000|Primary and Booster Phase|Physician Decision|1|||
164285401|NCT03197376|593414472|FG001|Primary and Booster Phase|Physician Decision|0|||
164285402|NCT03197376|593414473|FG002|Primary and Booster Phase|Physician Decision|1|||
164285403|NCT03197376|593414474|FG003|Primary and Booster Phase|Physician Decision|3|||
164285404|NCT03197376|593414471|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
164285405|NCT03197376|593414472|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
164285406|NCT03197376|593414473|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
164285407|NCT03197376|593414474|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
164285408|NCT03197376|593414471|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
164285409|NCT03197376|593414472|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
164285410|NCT03197376|593414473|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
164285411|NCT03197376|593414474|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
164285412|NCT03197376|593414471|FG000|Primary and Booster Phase|Not vaccine related|1|||
164285413|NCT03197376|593414472|FG001|Primary and Booster Phase|Not vaccine related|2|||
164285414|NCT03197376|593414473|FG002|Primary and Booster Phase|Not vaccine related|0|||
164285415|NCT03197376|593414474|FG003|Primary and Booster Phase|Not vaccine related|6|||
164285416|NCT03197376|593414471|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
164285417|NCT03197376|593414472|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
164285418|NCT03197376|593414473|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
164285419|NCT03197376|593414474|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
164285420|NCT03197376|593414471|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
164285421|NCT03197376|593414472|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
164285422|NCT03197376|593414473|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
164285423|NCT03197376|593414474|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
164285424|NCT03197376|593414471|FG000|Immune Persistence Phase|Not vaccine related|1|||
164285425|NCT03197376|593414472|FG001|Immune Persistence Phase|Not vaccine related|0|||
164285426|NCT03197376|593414473|FG002|Immune Persistence Phase|Not vaccine related|1|||
164285427|NCT03197376|593414474|FG003|Immune Persistence Phase|Not vaccine related|1|||
164285428|NCT01123395|593414477|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
164285429|NCT01123395|593414478|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
164285430|NCT00782483|593414485|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
164285431|NCT01052077|593414486|FG000|Phase A|Lost to Follow-up|22|||
164285432|NCT01052077|593414487|FG001|Phase A|Lost to Follow-up|0|||
164285433|NCT01052077|593414488|FG002|Phase A|Lost to Follow-up|0|||
164285434|NCT01052077|593414489|FG003|Phase A|Lost to Follow-up|0|||
164285435|NCT01052077|593414486|FG000|Phase A|Adverse Event|32|||
164285436|NCT01052077|593414487|FG001|Phase A|Adverse Event|0|||
164285437|NCT01052077|593414488|FG002|Phase A|Adverse Event|0|||
164285438|NCT01052077|593414489|FG003|Phase A|Adverse Event|0|||
164344828|NCT01471171|593638854|FG000|Treatment Period 2|Adverse Event|1|||
164344829|NCT01471171|593638855|FG001|Treatment Period 2|Adverse Event|0|||
164344830|NCT02864498|593638856|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
164344831|NCT02864498|593638857|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
164344832|NCT02864498|593638858|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
164344833|NCT02864498|593638856|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
164344834|NCT02864498|593638857|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
164344835|NCT02864498|593638858|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
164344836|NCT02864498|593638856|FG000|Overall Study|Investigator Discretion|0|||
164344837|NCT02864498|593638857|FG001|Overall Study|Investigator Discretion|2|||
164344838|NCT02864498|593638858|FG002|Overall Study|Investigator Discretion|1|||
164344839|NCT02864498|593638856|FG000|Overall Study|Lost to Follow-up|8|||
164344840|NCT02864498|593638857|FG001|Overall Study|Lost to Follow-up|6|||
164344841|NCT02864498|593638858|FG002|Overall Study|Lost to Follow-up|3|||
164344842|NCT02864498|593638856|FG000|Overall Study|Lack of Efficacy|5|||
164344843|NCT02864498|593638857|FG001|Overall Study|Lack of Efficacy|3|||
164344844|NCT02864498|593638858|FG002|Overall Study|Lack of Efficacy|3|||
164344845|NCT02864498|593638856|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
164344846|NCT02864498|593638857|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
164344847|NCT02864498|593638858|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
164344848|NCT02864498|593638856|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
164344849|NCT02864498|593638857|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
164344850|NCT02864498|593638858|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
164344851|NCT02864498|593638856|FG000|Overall Study|Subject moved out of the country.|0|||
164344852|NCT02864498|593638857|FG001|Overall Study|Subject moved out of the country.|0|||
164344853|NCT02864498|593638858|FG002|Overall Study|Subject moved out of the country.|1|||
164344854|NCT00705484|593638861|FG000|Overall Study|Adverse Event|28|||
164285439|NCT01052077|593414486|FG000|Phase A|Met Withdrawal Criteria|26|||
164285440|NCT01052077|593414487|FG001|Phase A|Met Withdrawal Criteria|0|||
164285441|NCT01052077|593414488|FG002|Phase A|Met Withdrawal Criteria|0|||
164285442|NCT01052077|593414489|FG003|Phase A|Met Withdrawal Criteria|0|||
164344855|NCT00705484|593638862|FG001|Overall Study|Adverse Event|27|||
164586583|NCT02616029|594511857|FG001|Overall Study|Adverse Event|0|||
164586584|NCT02616029|594511856|FG000|Overall Study|Death|0|||
164285443|NCT01052077|593414486|FG000|Phase A|Physician Decision|10|||
164285444|NCT01052077|593414487|FG001|Phase A|Physician Decision|0|||
164285445|NCT01052077|593414488|FG002|Phase A|Physician Decision|0|||
164285446|NCT01052077|593414489|FG003|Phase A|Physician Decision|0|||
164285447|NCT01052077|593414486|FG000|Phase A|Withdrawal by Subject|29|||
164285448|NCT01052077|593414487|FG001|Phase A|Withdrawal by Subject|0|||
164285449|NCT01052077|593414488|FG002|Phase A|Withdrawal by Subject|0|||
164285450|NCT01052077|593414489|FG003|Phase A|Withdrawal by Subject|0|||
164285451|NCT01052077|593414486|FG000|Phase A|Protocol Deviation|27|||
164285452|NCT01052077|593414487|FG001|Phase A|Protocol Deviation|0|||
164285453|NCT01052077|593414488|FG002|Phase A|Protocol Deviation|0|||
164285454|NCT01052077|593414489|FG003|Phase A|Protocol Deviation|0|||
164285455|NCT01052077|593414486|FG000|Phase B|Lost to Follow-up|0|||
164285456|NCT01052077|593414487|FG001|Phase B|Lost to Follow-up|2|||
164285457|NCT01052077|593414488|FG002|Phase B|Lost to Follow-up|3|||
164285458|NCT01052077|593414489|FG003|Phase B|Lost to Follow-up|0|||
164285459|NCT01052077|593414486|FG000|Phase B|Adverse Event|0|||
164285460|NCT01052077|593414487|FG001|Phase B|Adverse Event|9|||
164285461|NCT01052077|593414488|FG002|Phase B|Adverse Event|2|||
164285462|NCT01052077|593414489|FG003|Phase B|Adverse Event|0|||
164285463|NCT01052077|593414486|FG000|Phase B|Met Withdrawal Criteria|0|||
164285464|NCT01052077|593414487|FG001|Phase B|Met Withdrawal Criteria|2|||
164285465|NCT01052077|593414488|FG002|Phase B|Met Withdrawal Criteria|1|||
164285466|NCT01052077|593414489|FG003|Phase B|Met Withdrawal Criteria|0|||
164285467|NCT01052077|593414486|FG000|Phase B|Physician Decision|0|||
164285468|NCT01052077|593414487|FG001|Phase B|Physician Decision|1|||
164285469|NCT01052077|593414488|FG002|Phase B|Physician Decision|1|||
164285470|NCT01052077|593414489|FG003|Phase B|Physician Decision|0|||
164344856|NCT00705484|593638861|FG000|Overall Study|Lost to Follow-up|169|||
164344857|NCT00705484|593638862|FG001|Overall Study|Lost to Follow-up|250|||
164344858|NCT00705484|593638861|FG000|Overall Study|Withdrawal by Subject|96|||
164344859|NCT00705484|593638862|FG001|Overall Study|Withdrawal by Subject|72|||
164344860|NCT00705484|593638861|FG000|Overall Study|Administrative|89|||
164344861|NCT00705484|593638862|FG001|Overall Study|Administrative|59|||
164344862|NCT01606007|593638863|FG000|Overall Study|Reason 'Other' in the protocol|0|||
164344863|NCT01606007|593638864|FG001|Overall Study|Reason 'Other' in the protocol|1|||
164344864|NCT01606007|593638865|FG002|Overall Study|Reason 'Other' in the protocol|1|||
164344865|NCT01606007|593638863|FG000|Overall Study|Pregnancy|0|||
164344866|NCT01606007|593638864|FG001|Overall Study|Pregnancy|1|||
164344867|NCT01606007|593638865|FG002|Overall Study|Pregnancy|1|||
164586585|NCT02616029|594511857|FG001|Overall Study|Death|1|||
164285471|NCT01052077|593414486|FG000|Phase B|Withdrawal by Subject|0|||
164285472|NCT01052077|593414487|FG001|Phase B|Withdrawal by Subject|0|||
164285473|NCT01052077|593414488|FG002|Phase B|Withdrawal by Subject|5|||
164285474|NCT01052077|593414489|FG003|Phase B|Withdrawal by Subject|0|||
164344868|NCT01606007|593638863|FG000|Overall Study|Withdrawal by Subject|8|||
164344869|NCT01606007|593638864|FG001|Overall Study|Withdrawal by Subject|6|||
164586586|NCT02616029|594511856|FG000|Overall Study|Protocol Violation|1|||
164285475|NCT01052077|593414486|FG000|Phase B|Protocol Deviation|0|||
164285476|NCT01052077|593414487|FG001|Phase B|Protocol Deviation|3|||
164285477|NCT01052077|593414488|FG002|Phase B|Protocol Deviation|4|||
164285478|NCT01052077|593414489|FG003|Phase B|Protocol Deviation|0|||
164285479|NCT01052077|593414486|FG000|Phase B|Lack of Efficacy|0|||
164285480|NCT01052077|593414487|FG001|Phase B|Lack of Efficacy|1|||
164285481|NCT01052077|593414488|FG002|Phase B|Lack of Efficacy|0|||
164285482|NCT01052077|593414489|FG003|Phase B|Lack of Efficacy|0|||
164285483|NCT01052077|593414486|FG000|Phase A+|Lost to Follow-up|0|||
164285484|NCT01052077|593414487|FG001|Phase A+|Lost to Follow-up|0|||
164285485|NCT01052077|593414488|FG002|Phase A+|Lost to Follow-up|0|||
164285486|NCT01052077|593414489|FG003|Phase A+|Lost to Follow-up|8|||
164285487|NCT01052077|593414486|FG000|Phase A+|Adverse Event|0|||
164285488|NCT01052077|593414487|FG001|Phase A+|Adverse Event|0|||
164285489|NCT01052077|593414488|FG002|Phase A+|Adverse Event|0|||
164285490|NCT01052077|593414489|FG003|Phase A+|Adverse Event|4|||
164285491|NCT01052077|593414486|FG000|Phase A+|Met Withdrawal Criteria|0|||
164285492|NCT01052077|593414487|FG001|Phase A+|Met Withdrawal Criteria|0|||
164285493|NCT01052077|593414488|FG002|Phase A+|Met Withdrawal Criteria|0|||
164285494|NCT01052077|593414489|FG003|Phase A+|Met Withdrawal Criteria|2|||
164285495|NCT01052077|593414486|FG000|Phase A+|Withdrawal by Subject|0|||
164285496|NCT01052077|593414487|FG001|Phase A+|Withdrawal by Subject|0|||
164285497|NCT01052077|593414488|FG002|Phase A+|Withdrawal by Subject|0|||
164285498|NCT01052077|593414489|FG003|Phase A+|Withdrawal by Subject|7|||
164285499|NCT01099397|593414493|FG000|Overall Study|Lost to Follow-up|4|||
164285500|NCT01099397|593414493|FG000|Overall Study|Protocol Violation|4|||
164285501|NCT01099397|593414493|FG000|Overall Study|Withdrawal by Subject|5|||
164285502|NCT00950248|593414494|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
164285503|NCT00950248|593414495|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
164285504|NCT00950248|593414496|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
164285505|NCT00950248|593414494|FG000|Year 1: Baseline|worsening of symptoms|2|||
164285506|NCT00950248|593414495|FG001|Year 1: Baseline|worsening of symptoms|0|||
164285507|NCT00950248|593414496|FG002|Year 1: Baseline|worsening of symptoms|0|||
164285508|NCT00950248|593414494|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
164285509|NCT00950248|593414495|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
164285510|NCT00950248|593414496|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
164285511|NCT00950248|593414494|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
164285512|NCT00950248|593414495|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
164285513|NCT00950248|593414496|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
164692135|NCT01098539|594895338|FG001|Overall Study|Physician Decision|3|||
164692136|NCT03843125|594895339|FG000|Overall Study|Adverse Event|17|||
164692137|NCT03843125|594895340|FG001|Overall Study|Adverse Event|13|||
164285514|NCT00950248|593414494|FG000|Year 2&3 Treatment Randomization|Death|0|||
164285515|NCT00950248|593414495|FG001|Year 2&3 Treatment Randomization|Death|0|||
164285516|NCT00950248|593414496|FG002|Year 2&3 Treatment Randomization|Death|1|||
164285517|NCT00950248|593414494|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
164285518|NCT00950248|593414495|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
164285519|NCT00950248|593414496|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
164285520|NCT00650845|593414500|FG000|Overall Study|Withdrawal by Subject|5|||
164285521|NCT00650845|593414501|FG001|Overall Study|Withdrawal by Subject|0|||
164285522|NCT00650845|593414500|FG000|Overall Study|Protocol Violation|0|||
164285523|NCT00650845|593414501|FG001|Overall Study|Protocol Violation|13|||
164285524|NCT01594931|593416239|FG000|Overall Study|Adverse Event|3|||
164285525|NCT01594931|593416240|FG001|Overall Study|Adverse Event|1|||
164285526|NCT01594931|593416241|FG002|Overall Study|Adverse Event|1|||
164285527|NCT01594931|593416239|FG000|Overall Study|Withdrawal by Subject|2|||
164285528|NCT01594931|593416240|FG001|Overall Study|Withdrawal by Subject|1|||
164285529|NCT01594931|593416241|FG002|Overall Study|Withdrawal by Subject|1|||
164285530|NCT01594931|593416239|FG000|Overall Study|Lack of Efficacy|7|||
164285531|NCT01594931|593416240|FG001|Overall Study|Lack of Efficacy|2|||
164285532|NCT01594931|593416241|FG002|Overall Study|Lack of Efficacy|2|||
164285533|NCT01594931|593416239|FG000|Overall Study|Lost to Follow-up|4|||
164285534|NCT01594931|593416240|FG001|Overall Study|Lost to Follow-up|3|||
164285535|NCT01594931|593416241|FG002|Overall Study|Lost to Follow-up|3|||
164285536|NCT01594931|593416239|FG000|Overall Study|Protocol Violation|2|||
164285537|NCT01594931|593416240|FG001|Overall Study|Protocol Violation|1|||
164285538|NCT01594931|593416241|FG002|Overall Study|Protocol Violation|0|||
164285539|NCT01594931|593416239|FG000|Overall Study|No defiined|11|||
164285540|NCT01594931|593416240|FG001|Overall Study|No defiined|4|||
164285541|NCT01594931|593416241|FG002|Overall Study|No defiined|7|||
164285542|NCT01929226|593416246|FG000|Overall Study|Lost to Follow-up|4|||
164285543|NCT01929226|593416247|FG001|Overall Study|Lost to Follow-up|0|||
164285544|NCT01929226|593416246|FG000|Overall Study|Withdrawal by Subject|1|||
164285545|NCT01929226|593416247|FG001|Overall Study|Withdrawal by Subject|1|||
164285546|NCT01525615|593416248|FG000|Overall Study|Adverse Event|11|||
164285547|NCT01525615|593416249|FG001|Overall Study|Adverse Event|7|||
164285548|NCT01525615|593416250|FG002|Overall Study|Adverse Event|5|||
164285549|NCT01525615|593416248|FG000|Overall Study|Lost to Follow-up|1|||
164285550|NCT01525615|593416249|FG001|Overall Study|Lost to Follow-up|0|||
164285551|NCT01525615|593416250|FG002|Overall Study|Lost to Follow-up|0|||
164285552|NCT01525615|593416248|FG000|Overall Study|Withdrawal by Subject|1|||
164285553|NCT01525615|593416249|FG001|Overall Study|Withdrawal by Subject|0|||
164285554|NCT01525615|593416250|FG002|Overall Study|Withdrawal by Subject|0|||
164285555|NCT01525615|593416248|FG000|Overall Study|Other reason not described above|1|||
164285556|NCT01525615|593416249|FG001|Overall Study|Other reason not described above|0|||
164285557|NCT01525615|593416250|FG002|Overall Study|Other reason not described above|1|||
164285558|NCT01473732|593416251|FG000|Overall Study|Adverse Event|1|||
164285559|NCT01473732|593416252|FG001|Overall Study|Adverse Event|0|||
164285560|NCT01473732|593416251|FG000|Overall Study|Death|1|||
164285561|NCT01473732|593416252|FG001|Overall Study|Death|0|||
164285562|NCT04473963|593416272|FG000|Overall Study|Withdrawal by Subject|1|||
164285563|NCT04473963|593416273|FG001|Overall Study|Withdrawal by Subject|1|||
164285564|NCT04473963|593416274|FG002|Overall Study|Withdrawal by Subject|0|||
164285565|NCT04473963|593416272|FG000|Overall Study|Not inducible in AF|0|||
164285566|NCT04473963|593416273|FG001|Overall Study|Not inducible in AF|0|||
164285567|NCT04473963|593416274|FG002|Overall Study|Not inducible in AF|2|||
164285568|NCT04685798|593416275|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
164285569|NCT00592904|593416278|FG000|Overall Study|Adverse Event|15|||
164285570|NCT00592904|593416279|FG001|Overall Study|Adverse Event|25|||
164285571|NCT00592904|593416280|FG002|Overall Study|Adverse Event|13|||
164285572|NCT00592904|593416281|FG003|Overall Study|Adverse Event|5|||
164285573|NCT00592904|593416278|FG000|Overall Study|Protocol Violation|1|||
164285574|NCT00592904|593416279|FG001|Overall Study|Protocol Violation|1|||
164285575|NCT00592904|593416280|FG002|Overall Study|Protocol Violation|0|||
164285576|NCT00592904|593416281|FG003|Overall Study|Protocol Violation|1|||
164285577|NCT00592904|593416278|FG000|Overall Study|Withdrawal by Subject|4|||
164285578|NCT00592904|593416279|FG001|Overall Study|Withdrawal by Subject|16|||
164285579|NCT00592904|593416280|FG002|Overall Study|Withdrawal by Subject|1|||
164285580|NCT00592904|593416281|FG003|Overall Study|Withdrawal by Subject|2|||
164285581|NCT00592904|593416278|FG000|Overall Study|Lack of Efficacy|2|||
164285582|NCT00592904|593416279|FG001|Overall Study|Lack of Efficacy|7|||
164285583|NCT00592904|593416280|FG002|Overall Study|Lack of Efficacy|2|||
164285584|NCT00592904|593416281|FG003|Overall Study|Lack of Efficacy|3|||
164285585|NCT00592904|593416278|FG000|Overall Study|Physician Decision|0|||
164285586|NCT00592904|593416279|FG001|Overall Study|Physician Decision|3|||
164285587|NCT00592904|593416280|FG002|Overall Study|Physician Decision|1|||
164285588|NCT00592904|593416281|FG003|Overall Study|Physician Decision|0|||
164285589|NCT00592904|593416278|FG000|Overall Study|Other|3|||
164285590|NCT00592904|593416279|FG001|Overall Study|Other|3|||
164285591|NCT00592904|593416280|FG002|Overall Study|Other|0|||
164285592|NCT00592904|593416281|FG003|Overall Study|Other|0|||
164285593|NCT03018691|593416284|FG000|Overall Study|Adverse Event|1|||
164285594|NCT03018691|593416285|FG001|Overall Study|Adverse Event|1|||
164285595|NCT03018691|593416286|FG002|Overall Study|Adverse Event|4|||
164285596|NCT03018691|593416284|FG000|Overall Study|Lack of Efficacy|0|||
164285597|NCT03018691|593416285|FG001|Overall Study|Lack of Efficacy|0|||
164285598|NCT03018691|593416286|FG002|Overall Study|Lack of Efficacy|1|||
164285599|NCT03018691|593416284|FG000|Overall Study|Withdrawal by Subject|0|||
164285600|NCT03018691|593416285|FG001|Overall Study|Withdrawal by Subject|0|||
164285601|NCT03018691|593416286|FG002|Overall Study|Withdrawal by Subject|1|||
164285602|NCT03018691|593416284|FG000|Overall Study|Withdrawal by parent/guardian|1|||
164285603|NCT03018691|593416285|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164285604|NCT03018691|593416286|FG002|Overall Study|Withdrawal by parent/guardian|1|||
164285605|NCT03369418|593416287|FG000|Overall Study|Withdrawal by Subject|3|||
164285606|NCT03369418|593416288|FG001|Overall Study|Withdrawal by Subject|3|||
164285607|NCT02859246|593416289|FG000|Overall Study|Screen fails|3|||
164285608|NCT02859246|593416289|FG000|Overall Study|Adverse Event|1|||
164285609|NCT02859246|593416289|FG000|Overall Study|Withdrawal by Subject|1|||
164285610|NCT00740584|593416290|FG000|Overall Study|Withdrawal by Subject|1|||
164285611|NCT01461707|593416291|FG000|Overall Study|Withdrawal by Subject|1|||
164285612|NCT01461707|593416292|FG001|Overall Study|Withdrawal by Subject|0|||
164285613|NCT00855816|593416293|FG000|Overall Study|Withdrawal by Subject|22|||
164285614|NCT00855816|593416294|FG001|Overall Study|Withdrawal by Subject|15|||
164285615|NCT00855816|593416293|FG000|Overall Study|Lost to Follow-up|3|||
164344870|NCT01606007|593638865|FG002|Overall Study|Withdrawal by Subject|1|||
164344871|NCT01606007|593638863|FG000|Overall Study|Adverse Event|0|||
164344872|NCT01606007|593638864|FG001|Overall Study|Adverse Event|1|||
164344873|NCT01606007|593638865|FG002|Overall Study|Adverse Event|1|||
164285616|NCT00855816|593416294|FG001|Overall Study|Lost to Follow-up|5|||
164285617|NCT00855816|593416293|FG000|Overall Study|Death|1|||
164285618|NCT00855816|593416294|FG001|Overall Study|Death|0|||
164285619|NCT00855816|593416293|FG000|Overall Study|Became ineligible|0|||
164285620|NCT00855816|593416294|FG001|Overall Study|Became ineligible|1|||
164344874|NCT01606007|593638863|FG000|Overall Study|discontinue study treatment|0|||
164285621|NCT03573323|593416301|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
164285622|NCT03573323|593416302|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
164285623|NCT03573323|593416301|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
164285624|NCT03573323|593416302|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
164285625|NCT03573323|593416301|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
164285626|NCT03573323|593416302|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
164285627|NCT03573323|593416301|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
164285628|NCT03573323|593416302|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
164285629|NCT03573323|593416301|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
164285630|NCT03573323|593416302|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
164285631|NCT03573323|593416301|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
164285632|NCT03573323|593416302|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
164285633|NCT03573323|593416301|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
164285634|NCT03573323|593416302|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
164285635|NCT03573323|593416301|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
164285636|NCT03573323|593416302|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
164285637|NCT03573323|593416301|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
164285638|NCT03573323|593416302|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
164285639|NCT03573323|593416301|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
164285640|NCT03573323|593416302|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
164285641|NCT03573323|593416301|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
164285642|NCT03573323|593416302|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
164285643|NCT03573323|593416301|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
164285644|NCT03573323|593416302|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
164285645|NCT03573323|593416301|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
164285646|NCT03573323|593416302|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
164285647|NCT03573323|593416301|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
164285648|NCT03573323|593416302|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
164285649|NCT03573323|593416301|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
164285650|NCT03573323|593416302|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
164285651|NCT03573323|593416301|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
164285652|NCT03573323|593416302|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
164285653|NCT03573323|593416301|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
164285654|NCT03573323|593416302|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
164285655|NCT03573323|593416301|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
164285656|NCT03573323|593416302|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
164285657|NCT03573323|593416301|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
164285658|NCT03573323|593416302|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
164285659|NCT03188432|593416303|FG000|Overall Study|Death|3|||
164285660|NCT03188432|593416303|FG000|Overall Study|Withdrawal by Subject|15|||
164285661|NCT03188432|593416303|FG000|Overall Study|Did not complete protocol treatment|9|||
164285662|NCT01196026|593416309|FG000|Overall Study|Withdrawal by Subject|1|||
164285663|NCT01196026|593416310|FG001|Overall Study|Withdrawal by Subject|4|||
164285664|NCT01196026|593416311|FG002|Overall Study|Withdrawal by Subject|0|||
164285665|NCT01196026|593416312|FG003|Overall Study|Withdrawal by Subject|0|||
164285666|NCT01196026|593416313|FG004|Overall Study|Withdrawal by Subject|0|||
164285667|NCT01196026|593416314|FG005|Overall Study|Withdrawal by Subject|0|||
164285668|NCT01196026|593416309|FG000|Overall Study|Lost to Follow-up|0|||
164285669|NCT01196026|593416310|FG001|Overall Study|Lost to Follow-up|3|||
164285670|NCT01196026|593416311|FG002|Overall Study|Lost to Follow-up|0|||
164285671|NCT01196026|593416312|FG003|Overall Study|Lost to Follow-up|0|||
164285672|NCT01196026|593416313|FG004|Overall Study|Lost to Follow-up|1|||
164285673|NCT01196026|593416314|FG005|Overall Study|Lost to Follow-up|0|||
164285674|NCT01196026|593416309|FG000|Overall Study|Other|0|||
164285675|NCT01196026|593416310|FG001|Overall Study|Other|1|||
164285676|NCT01196026|593416311|FG002|Overall Study|Other|0|||
164285677|NCT01196026|593416312|FG003|Overall Study|Other|0|||
164285678|NCT01196026|593416313|FG004|Overall Study|Other|0|||
164285679|NCT01196026|593416314|FG005|Overall Study|Other|0|||
164285680|NCT02336230|593416325|FG000|Overall Study|Adverse Event|1|||
164285681|NCT02336230|593416325|FG000|Overall Study|Withdrawal of consent|1|||
164285682|NCT02336230|593416325|FG000|Overall Study|Death|9|||
164285683|NCT02336230|593416325|FG000|Overall Study|Dose not received due to shipping delay|1|||
164285684|NCT02336230|593416325|FG000|Overall Study|Discontinuation of MSC infusion|1|||
164285685|NCT01620086|593416332|FG000|Overall Study|Withdrawal by Subject|3|||
164285686|NCT01620086|593416333|FG001|Overall Study|Withdrawal by Subject|3|||
164285687|NCT01620086|593416334|FG002|Overall Study|Withdrawal by Subject|0|||
164285688|NCT01620086|593416332|FG000|Overall Study|failed study criteria|1|||
164285689|NCT01620086|593416333|FG001|Overall Study|failed study criteria|4|||
164586587|NCT02616029|594511857|FG001|Overall Study|Protocol Violation|0|||
164586588|NCT02616029|594511856|FG000|Overall Study|Withdrew Consent|1|||
164586589|NCT02616029|594511857|FG001|Overall Study|Withdrew Consent|0|||
164586590|NCT02616029|594511856|FG000|Overall Study|Enrolled and Never Treated|1|||
164586591|NCT02616029|594511857|FG001|Overall Study|Enrolled and Never Treated|1|||
164285690|NCT01620086|593416334|FG002|Overall Study|failed study criteria|0|||
164285691|NCT01620086|593416332|FG000|Overall Study|Physician Decision|1|||
164285692|NCT01620086|593416333|FG001|Overall Study|Physician Decision|0|||
164285693|NCT01620086|593416334|FG002|Overall Study|Physician Decision|0|||
164285694|NCT01695135|593416335|FG000|Double-blind Treatment Phase|Progressive disease|50|||
164285695|NCT01695135|593416336|FG001|Double-blind Treatment Phase|Progressive disease|110|||
164285696|NCT01695135|593416337|FG002|Double-blind Treatment Phase|Progressive disease|0|||
164285697|NCT01695135|593416338|FG003|Double-blind Treatment Phase|Progressive disease|0|||
164285698|NCT01695135|593416335|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
164285699|NCT01695135|593416336|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
164285700|NCT01695135|593416337|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
164285701|NCT01695135|593416338|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
164285702|NCT01695135|593416335|FG000|Double-blind Treatment Phase|Adverse Event|7|||
164285703|NCT01695135|593416336|FG001|Double-blind Treatment Phase|Adverse Event|7|||
164285704|NCT01695135|593416337|FG002|Double-blind Treatment Phase|Adverse Event|0|||
164285705|NCT01695135|593416338|FG003|Double-blind Treatment Phase|Adverse Event|0|||
164285706|NCT01695135|593416335|FG000|Double-blind Treatment Phase|Other|1|||
164285707|NCT01695135|593416336|FG001|Double-blind Treatment Phase|Other|3|||
164285708|NCT01695135|593416337|FG002|Double-blind Treatment Phase|Other|0|||
164285709|NCT01695135|593416338|FG003|Double-blind Treatment Phase|Other|0|||
164285710|NCT01695135|593416335|FG000|Double-blind Treatment Phase|Physician Decision|6|||
164285711|NCT01695135|593416336|FG001|Double-blind Treatment Phase|Physician Decision|3|||
164285712|NCT01695135|593416337|FG002|Double-blind Treatment Phase|Physician Decision|0|||
164285713|NCT01695135|593416338|FG003|Double-blind Treatment Phase|Physician Decision|0|||
164285714|NCT01695135|593416335|FG000|Double-blind Treatment Phase|Death|1|||
164285715|NCT01695135|593416336|FG001|Double-blind Treatment Phase|Death|1|||
164285716|NCT01695135|593416337|FG002|Double-blind Treatment Phase|Death|0|||
164285717|NCT01695135|593416338|FG003|Double-blind Treatment Phase|Death|0|||
164285718|NCT01695135|593416335|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
164285719|NCT01695135|593416336|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
164285720|NCT01695135|593416337|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
164285721|NCT01695135|593416338|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
164285722|NCT01695135|593416335|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
164285723|NCT01695135|593416336|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
164285724|NCT01695135|593416337|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
164285725|NCT01695135|593416338|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
164285726|NCT01695135|593416335|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
164285727|NCT01695135|593416336|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
164285728|NCT01695135|593416337|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
164586592|NCT00479466|594511858|FG000|Overall Study|Adverse Event|5|||
164586593|NCT00479466|594511859|FG001|Overall Study|Adverse Event|1|||
164586594|NCT00479466|594511860|FG002|Overall Study|Adverse Event|0|||
164586595|NCT00479466|594511861|FG003|Overall Study|Adverse Event|1|||
164586596|NCT00479466|594511862|FG004|Overall Study|Adverse Event|2|||
164586597|NCT00479466|594511863|FG005|Overall Study|Adverse Event|0|||
164586598|NCT00479466|594511858|FG000|Overall Study|Hyperglycemia|0|||
164285729|NCT01695135|593416338|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
164285730|NCT01695135|593416335|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
164285731|NCT01695135|593416336|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
164586599|NCT00479466|594511859|FG001|Overall Study|Hyperglycemia|0|||
164586600|NCT00479466|594511860|FG002|Overall Study|Hyperglycemia|0|||
164586601|NCT00479466|594511861|FG003|Overall Study|Hyperglycemia|0|||
164586602|NCT00479466|594511862|FG004|Overall Study|Hyperglycemia|0|||
164586603|NCT00479466|594511863|FG005|Overall Study|Hyperglycemia|1|||
164586604|NCT00479466|594511858|FG000|Overall Study|Lack of Efficacy|2|||
164586605|NCT00479466|594511859|FG001|Overall Study|Lack of Efficacy|0|||
164586606|NCT00479466|594511860|FG002|Overall Study|Lack of Efficacy|1|||
164586607|NCT00479466|594511861|FG003|Overall Study|Lack of Efficacy|0|||
164586608|NCT00479466|594511862|FG004|Overall Study|Lack of Efficacy|0|||
164586609|NCT00479466|594511863|FG005|Overall Study|Lack of Efficacy|0|||
164586610|NCT00479466|594511858|FG000|Overall Study|Lost to Follow-up|0|||
164586611|NCT00479466|594511859|FG001|Overall Study|Lost to Follow-up|1|||
164586612|NCT00479466|594511860|FG002|Overall Study|Lost to Follow-up|1|||
164586613|NCT00479466|594511861|FG003|Overall Study|Lost to Follow-up|0|||
164586614|NCT00479466|594511862|FG004|Overall Study|Lost to Follow-up|2|||
164586615|NCT00479466|594511863|FG005|Overall Study|Lost to Follow-up|2|||
164586616|NCT00479466|594511858|FG000|Overall Study|Physician Decision|2|||
164586617|NCT00479466|594511859|FG001|Overall Study|Physician Decision|1|||
164586618|NCT00479466|594511860|FG002|Overall Study|Physician Decision|1|||
164586619|NCT00479466|594511861|FG003|Overall Study|Physician Decision|0|||
164586620|NCT00479466|594511862|FG004|Overall Study|Physician Decision|0|||
164586621|NCT00479466|594511863|FG005|Overall Study|Physician Decision|0|||
164586622|NCT00479466|594511858|FG000|Overall Study|Pregnancy|0|||
164586623|NCT00479466|594511859|FG001|Overall Study|Pregnancy|0|||
164586624|NCT00479466|594511860|FG002|Overall Study|Pregnancy|0|||
164586625|NCT00479466|594511861|FG003|Overall Study|Pregnancy|0|||
164586626|NCT00479466|594511862|FG004|Overall Study|Pregnancy|1|||
164586627|NCT00479466|594511863|FG005|Overall Study|Pregnancy|0|||
164586628|NCT00479466|594511858|FG000|Overall Study|Protocol Violation|1|||
164586629|NCT00479466|594511859|FG001|Overall Study|Protocol Violation|0|||
164586630|NCT00479466|594511860|FG002|Overall Study|Protocol Violation|0|||
164586631|NCT00479466|594511861|FG003|Overall Study|Protocol Violation|0|||
164586632|NCT00479466|594511862|FG004|Overall Study|Protocol Violation|0|||
164586633|NCT00479466|594511863|FG005|Overall Study|Protocol Violation|0|||
164586634|NCT00479466|594511858|FG000|Overall Study|Withdrawal by Subject|3|||
164692138|NCT03843125|594895341|FG002|Overall Study|Adverse Event|5|||
164692139|NCT03843125|594895342|FG003|Overall Study|Adverse Event|9|||
164692140|NCT03843125|594895339|FG000|Overall Study|Death|0|||
164285732|NCT01695135|593416337|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
164285733|NCT01695135|593416338|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
164285734|NCT01695135|593416335|FG000|Open Label Extension Treatment Phase|Other|0|||
164285735|NCT01695135|593416336|FG001|Open Label Extension Treatment Phase|Other|0|||
164285736|NCT01695135|593416337|FG002|Open Label Extension Treatment Phase|Other|4|||
164285737|NCT01695135|593416338|FG003|Open Label Extension Treatment Phase|Other|7|||
164285738|NCT01695135|593416335|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
164285739|NCT01695135|593416336|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
164285740|NCT01695135|593416337|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
164285741|NCT01695135|593416338|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
164285742|NCT01695135|593416335|FG000|Open Label Extension Treatment Phase|Death|0|||
164285743|NCT01695135|593416336|FG001|Open Label Extension Treatment Phase|Death|0|||
164285744|NCT01695135|593416337|FG002|Open Label Extension Treatment Phase|Death|2|||
164285745|NCT01695135|593416338|FG003|Open Label Extension Treatment Phase|Death|7|||
164285746|NCT01695135|593416335|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
164285747|NCT01695135|593416336|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
164285748|NCT01695135|593416337|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
164285749|NCT01695135|593416338|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
164285750|NCT00580723|593416344|FG000|Overall Study|Did not want to participate in extension|3|||
164285751|NCT00580723|593416344|FG000|Overall Study|Lost to Follow-up|5|||
164285752|NCT01078441|593416349|FG000|Overall Study|Withdrawal by Subject|1|||
164285753|NCT00216671|593416350|FG000|Overall Study|Adverse Event|4|||
164285754|NCT00216671|593416351|FG001|Overall Study|Adverse Event|9|||
164285755|NCT00216671|593416350|FG000|Overall Study|Pregnancy|0|||
164285756|NCT00216671|593416351|FG001|Overall Study|Pregnancy|1|||
164344875|NCT01606007|593638864|FG001|Overall Study|discontinue study treatment|2|||
164344876|NCT01606007|593638865|FG002|Overall Study|discontinue study treatment|1|||
164344877|NCT01606007|593638863|FG000|Overall Study|Lost to Follow-up|6|||
164344878|NCT01606007|593638864|FG001|Overall Study|Lost to Follow-up|8|||
164344879|NCT01606007|593638865|FG002|Overall Study|Lost to Follow-up|5|||
164344880|NCT01606007|593638863|FG000|Overall Study|Poor/Non-compliance|1|||
164344881|NCT01606007|593638864|FG001|Overall Study|Poor/Non-compliance|0|||
164344882|NCT01606007|593638865|FG002|Overall Study|Poor/Non-compliance|0|||
164344883|NCT00851747|593638866|FG000|Overall Study|Physician Decision|6|||
164344884|NCT00851747|593638867|FG001|Overall Study|Physician Decision|6|||
164344885|NCT00851747|593638868|FG002|Overall Study|Physician Decision|6|||
164344886|NCT02499783|593638871|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
164344887|NCT02499783|593638872|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
164344888|NCT02499783|593638873|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
164344889|NCT02499783|593638871|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
164344890|NCT02499783|593638872|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
164344891|NCT02499783|593638873|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
164344892|NCT02499783|593638871|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
164344893|NCT02499783|593638872|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
164344894|NCT02499783|593638873|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
164344895|NCT02499783|593638871|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
164344896|NCT02499783|593638872|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
164344897|NCT02499783|593638873|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
164344898|NCT02499783|593638871|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
164344899|NCT02499783|593638872|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
164344900|NCT02499783|593638873|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
164586635|NCT00479466|594511859|FG001|Overall Study|Withdrawal by Subject|5|||
164692141|NCT03843125|594895340|FG001|Overall Study|Death|6|||
164344901|NCT02499783|593638871|FG000|DB Period: Weeks 0-8|Other|1|||
164344902|NCT02499783|593638872|FG001|DB Period: Weeks 0-8|Other|1|||
164344903|NCT02499783|593638873|FG002|DB Period: Weeks 0-8|Other|0|||
164344904|NCT02499783|593638871|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
164586636|NCT00479466|594511860|FG002|Overall Study|Withdrawal by Subject|0|||
164586637|NCT00479466|594511861|FG003|Overall Study|Withdrawal by Subject|2|||
164586638|NCT00479466|594511862|FG004|Overall Study|Withdrawal by Subject|3|||
164285757|NCT00216671|593416350|FG000|Overall Study|Withdrawal by Subject|4|||
164285758|NCT00216671|593416351|FG001|Overall Study|Withdrawal by Subject|2|||
164285759|NCT00216671|593416350|FG000|Overall Study|Refused Injections|3|||
164285760|NCT00216671|593416351|FG001|Overall Study|Refused Injections|13|||
164285761|NCT00216671|593416350|FG000|Overall Study|No Need to Continue Medication|1|||
164285762|NCT00216671|593416351|FG001|Overall Study|No Need to Continue Medication|1|||
164285763|NCT00216671|593416350|FG000|Overall Study|Insufficient Response|9|||
164285764|NCT00216671|593416351|FG001|Overall Study|Insufficient Response|4|||
164285765|NCT00216671|593416350|FG000|Overall Study|Lost to Follow-up|3|||
164285766|NCT00216671|593416351|FG001|Overall Study|Lost to Follow-up|5|||
164285767|NCT00216671|593416350|FG000|Overall Study|Non compliant|2|||
164285768|NCT00216671|593416351|FG001|Overall Study|Non compliant|2|||
164285769|NCT00216671|593416350|FG000|Overall Study|Ineligible|0|||
164285770|NCT00216671|593416351|FG001|Overall Study|Ineligible|2|||
164285771|NCT00216671|593416350|FG000|Overall Study|Physician Decision|1|||
164285772|NCT00216671|593416351|FG001|Overall Study|Physician Decision|1|||
164285773|NCT00216671|593416350|FG000|Overall Study|Protocol Violation|3|||
164285774|NCT00216671|593416351|FG001|Overall Study|Protocol Violation|5|||
164285775|NCT00216671|593416350|FG000|Overall Study|Relapse|1|||
164285776|NCT00216671|593416351|FG001|Overall Study|Relapse|0|||
164285777|NCT00216671|593416350|FG000|Overall Study|Investigator Illness|0|||
164285778|NCT00216671|593416351|FG001|Overall Study|Investigator Illness|1|||
164285779|NCT00216671|593416350|FG000|Overall Study|Patient Moved|0|||
164285780|NCT00216671|593416351|FG001|Overall Study|Patient Moved|1|||
164285781|NCT00216671|593416350|FG000|Overall Study|Ineligible, no efficacy data|2|||
164285782|NCT00216671|593416351|FG001|Overall Study|Ineligible, no efficacy data|2|||
164285783|NCT00216671|593416350|FG000|Overall Study|Insufficient Response Adverse Event|2|||
164285784|NCT00216671|593416351|FG001|Overall Study|Insufficient Response Adverse Event|1|||
164285785|NCT02714569|593416352|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
164285786|NCT02714569|593416353|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
164285787|NCT02714569|593416354|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
164285788|NCT02714569|593416355|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
164285789|NCT02714569|593416356|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
164285790|NCT02714569|593416357|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
164285791|NCT02714569|593416358|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
164285792|NCT02714569|593416359|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
164285793|NCT02714569|593416360|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
164285794|NCT02714569|593416361|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
164285795|NCT02714569|593416362|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
164285796|NCT02714569|593416352|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
164285797|NCT02714569|593416353|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
164285798|NCT02714569|593416354|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
164285799|NCT02714569|593416355|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
164285800|NCT02714569|593416356|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
164285801|NCT02714569|593416357|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
164285802|NCT02714569|593416358|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
164285803|NCT02714569|593416359|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
164285804|NCT02714569|593416360|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
164285805|NCT02714569|593416361|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
164285806|NCT02714569|593416362|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
164285807|NCT02714569|593416352|FG000|Part A Third Intervention|Adverse Event|0|||
164285808|NCT02714569|593416353|FG001|Part A Third Intervention|Adverse Event|0|||
164285809|NCT02714569|593416354|FG002|Part A Third Intervention|Adverse Event|1|||
164285810|NCT02714569|593416355|FG003|Part A Third Intervention|Adverse Event|0|||
164285811|NCT02714569|593416356|FG004|Part A Third Intervention|Adverse Event|0|||
164285812|NCT02714569|593416357|FG005|Part A Third Intervention|Adverse Event|0|||
164285813|NCT02714569|593416358|FG006|Part A Third Intervention|Adverse Event|0|||
164285814|NCT02714569|593416359|FG007|Part A Third Intervention|Adverse Event|0|||
164285815|NCT02714569|593416360|FG008|Part A Third Intervention|Adverse Event|0|||
164285816|NCT02714569|593416361|FG009|Part A Third Intervention|Adverse Event|0|||
164285817|NCT02714569|593416362|FG010|Part A Third Intervention|Adverse Event|0|||
164285818|NCT02714569|593416352|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
164285819|NCT02714569|593416353|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
164285820|NCT02714569|593416354|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
164285821|NCT02714569|593416355|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
164285822|NCT02714569|593416356|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
164285823|NCT02714569|593416357|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
164285824|NCT02714569|593416358|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
164285825|NCT02714569|593416359|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
164285826|NCT02714569|593416360|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
164285827|NCT02714569|593416361|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
164285828|NCT02714569|593416362|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
164285829|NCT02714569|593416352|FG000|Part B (Overall)|Lost to Follow-up|0|||
164285830|NCT02714569|593416353|FG001|Part B (Overall)|Lost to Follow-up|0|||
164285831|NCT02714569|593416354|FG002|Part B (Overall)|Lost to Follow-up|0|||
164285832|NCT02714569|593416355|FG003|Part B (Overall)|Lost to Follow-up|0|||
164285833|NCT02714569|593416356|FG004|Part B (Overall)|Lost to Follow-up|0|||
164285834|NCT02714569|593416357|FG005|Part B (Overall)|Lost to Follow-up|0|||
164285835|NCT02714569|593416358|FG006|Part B (Overall)|Lost to Follow-up|1|||
164285836|NCT02714569|593416359|FG007|Part B (Overall)|Lost to Follow-up|0|||
164285837|NCT02714569|593416360|FG008|Part B (Overall)|Lost to Follow-up|0|||
164285838|NCT02714569|593416361|FG009|Part B (Overall)|Lost to Follow-up|0|||
164285839|NCT02714569|593416362|FG010|Part B (Overall)|Lost to Follow-up|0|||
164285840|NCT02714569|593416352|FG000|Part B (Overall)|Withdrawal by Subject|0|||
164285841|NCT02714569|593416353|FG001|Part B (Overall)|Withdrawal by Subject|0|||
164285842|NCT02714569|593416354|FG002|Part B (Overall)|Withdrawal by Subject|0|||
164285843|NCT02714569|593416355|FG003|Part B (Overall)|Withdrawal by Subject|0|||
164285844|NCT02714569|593416356|FG004|Part B (Overall)|Withdrawal by Subject|0|||
164285845|NCT02714569|593416357|FG005|Part B (Overall)|Withdrawal by Subject|0|||
164285846|NCT02714569|593416358|FG006|Part B (Overall)|Withdrawal by Subject|0|||
164285847|NCT02714569|593416359|FG007|Part B (Overall)|Withdrawal by Subject|1|||
164285848|NCT02714569|593416360|FG008|Part B (Overall)|Withdrawal by Subject|0|||
164692142|NCT03843125|594895341|FG002|Overall Study|Death|2|||
164692143|NCT03843125|594895342|FG003|Overall Study|Death|0|||
164692144|NCT03843125|594895339|FG000|Overall Study|Lack of Efficacy|14|||
164692145|NCT03843125|594895340|FG001|Overall Study|Lack of Efficacy|11|||
164692146|NCT03843125|594895341|FG002|Overall Study|Lack of Efficacy|9|||
164692147|NCT03843125|594895342|FG003|Overall Study|Lack of Efficacy|4|||
164692148|NCT03843125|594895339|FG000|Overall Study|Lost to Follow-up|3|||
164692149|NCT03843125|594895340|FG001|Overall Study|Lost to Follow-up|4|||
164692150|NCT03843125|594895341|FG002|Overall Study|Lost to Follow-up|0|||
164692151|NCT03843125|594895342|FG003|Overall Study|Lost to Follow-up|2|||
164692152|NCT03843125|594895339|FG000|Overall Study|Other|12|||
164692153|NCT03843125|594895340|FG001|Overall Study|Other|14|||
164692154|NCT03843125|594895341|FG002|Overall Study|Other|3|||
164692155|NCT03843125|594895342|FG003|Overall Study|Other|4|||
164692156|NCT03843125|594895339|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
164692157|NCT03843125|594895340|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
164692158|NCT03843125|594895341|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
164692159|NCT03843125|594895342|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
164692160|NCT03843125|594895339|FG000|Overall Study|Study Terminated by Sponsor|318|||
164692161|NCT03843125|594895340|FG001|Overall Study|Study Terminated by Sponsor|318|||
164692162|NCT03843125|594895341|FG002|Overall Study|Study Terminated by Sponsor|163|||
164692163|NCT03843125|594895342|FG003|Overall Study|Study Terminated by Sponsor|163|||
164692164|NCT03843125|594895339|FG000|Overall Study|Withdrawal by Subject|23|||
164692165|NCT03843125|594895340|FG001|Overall Study|Withdrawal by Subject|12|||
164692166|NCT03843125|594895341|FG002|Overall Study|Withdrawal by Subject|6|||
164692167|NCT03843125|594895342|FG003|Overall Study|Withdrawal by Subject|9|||
164692168|NCT03843125|594895339|FG000|Overall Study|Missing data|0|||
164692169|NCT03843125|594895340|FG001|Overall Study|Missing data|1|||
164692170|NCT03843125|594895341|FG002|Overall Study|Missing data|1|||
164692171|NCT03843125|594895342|FG003|Overall Study|Missing data|0|||
164692172|NCT01386125|594895343|FG000|Overall Study|Lost to Follow-up|3|||
164692173|NCT01386125|594895344|FG001|Overall Study|Lost to Follow-up|9|||
164692174|NCT01386125|594895343|FG000|Overall Study|Physician Decision|0|||
164692175|NCT01386125|594895344|FG001|Overall Study|Physician Decision|1|||
164692176|NCT01386125|594895343|FG000|Overall Study|Protocol Violation|5|||
164692177|NCT01386125|594895344|FG001|Overall Study|Protocol Violation|7|||
164692178|NCT01386125|594895343|FG000|Overall Study|Disease Progress|1|||
164692179|NCT01386125|594895344|FG001|Overall Study|Disease Progress|2|||
164692180|NCT01386125|594895343|FG000|Overall Study|Withdrawal by Subject|13|||
164692181|NCT01386125|594895344|FG001|Overall Study|Withdrawal by Subject|12|||
164692182|NCT01386125|594895343|FG000|Overall Study|Adverse Event|2|||
164692183|NCT01386125|594895344|FG001|Overall Study|Adverse Event|5|||
164692184|NCT01386125|594895343|FG000|Overall Study|Lack of Efficacy|0|||
164692185|NCT01386125|594895344|FG001|Overall Study|Lack of Efficacy|1|||
164692186|NCT01386125|594895343|FG000|Overall Study|Participant Leaving Country|1|||
164692187|NCT01386125|594895344|FG001|Overall Study|Participant Leaving Country|0|||
164692188|NCT02359864|594895345|FG000|Overall Study|Withdrawal by Subject|1|||
164692189|NCT02359864|594895346|FG001|Overall Study|Withdrawal by Subject|0|||
164692190|NCT02427399|594895351|FG000|Overall Study|Protocol Violation|14|||
164692191|NCT02427399|594895352|FG001|Overall Study|Protocol Violation|16|||
164692192|NCT02427399|594895353|FG002|Overall Study|Protocol Violation|12|||
164692193|NCT02427399|594895354|FG003|Overall Study|Protocol Violation|18|||
164692194|NCT02427399|594895355|FG004|Overall Study|Protocol Violation|15|||
164692195|NCT00605176|594895356|FG000|Overall Study|Adverse Event|2|||
164692196|NCT00605176|594895357|FG001|Overall Study|Adverse Event|1|||
164692197|NCT00605176|594895358|FG002|Overall Study|Adverse Event|3|||
164692198|NCT00605176|594895356|FG000|Overall Study|Withdrawal by Subject|4|||
164285849|NCT02714569|593416361|FG009|Part B (Overall)|Withdrawal by Subject|1|||
164285850|NCT02714569|593416362|FG010|Part B (Overall)|Withdrawal by Subject|0|||
164285851|NCT02714569|593416352|FG000|Part B (Overall)|Adverse Event|0|||
164285852|NCT02714569|593416353|FG001|Part B (Overall)|Adverse Event|0|||
164285853|NCT02714569|593416354|FG002|Part B (Overall)|Adverse Event|0|||
164285854|NCT02714569|593416355|FG003|Part B (Overall)|Adverse Event|0|||
164285855|NCT02714569|593416356|FG004|Part B (Overall)|Adverse Event|0|||
164285856|NCT02714569|593416357|FG005|Part B (Overall)|Adverse Event|0|||
164285857|NCT02714569|593416358|FG006|Part B (Overall)|Adverse Event|0|||
164285858|NCT02714569|593416359|FG007|Part B (Overall)|Adverse Event|0|||
164285859|NCT02714569|593416360|FG008|Part B (Overall)|Adverse Event|0|||
164285860|NCT02714569|593416361|FG009|Part B (Overall)|Adverse Event|1|||
164285861|NCT02714569|593416362|FG010|Part B (Overall)|Adverse Event|0|||
164285862|NCT01684202|593416363|FG000|Dose-escalation Period|Adverse Event|0|||
164285863|NCT01684202|593416364|FG001|Dose-escalation Period|Adverse Event|1|||
164285864|NCT01684202|593416365|FG002|Dose-escalation Period|Adverse Event|0|||
164285865|NCT01684202|593416366|FG003|Dose-escalation Period|Adverse Event|0|||
164285866|NCT01684202|593416363|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
164285867|NCT01684202|593416364|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
164285868|NCT01684202|593416365|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
164285869|NCT01684202|593416366|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
164285870|NCT01684202|593416363|FG000|Maintenance Period|Adverse Event|1|||
164344905|NCT02499783|593638872|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
164344906|NCT02499783|593638873|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
164344907|NCT02499783|593638871|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
164344908|NCT02499783|593638872|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
164344909|NCT02499783|593638873|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
164344910|NCT02499783|593638871|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
164344911|NCT02499783|593638872|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
164344912|NCT02499783|593638873|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
164344913|NCT02499783|593638871|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
164344914|NCT02499783|593638872|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
164344915|NCT02499783|593638873|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
164344916|NCT02228460|593638874|FG000|Overall Study|Adverse Event|1|||
164344917|NCT02228460|593638874|FG000|Overall Study|Lost to Follow-up|1|||
164344918|NCT01243892|593638875|FG000|Overall Study|Did not meet eligibility criteria|2|||
164344919|NCT01243892|593638876|FG001|Overall Study|Did not meet eligibility criteria|0|||
164344920|NCT00119106|593638881|FG000|Overall Study|HIV infected at baseline|179|||
164344921|NCT00119106|593638882|FG001|Overall Study|HIV infected at baseline|178|||
164344922|NCT01866293|593638883|FG000|Overall Study|Adverse Event|2|||
164344923|NCT01010061|593638884|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
164344924|NCT01010061|593638885|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
164344925|NCT01010061|593638884|FG000|Overall Study|Disease Progression|2|||
164344926|NCT01010061|593638885|FG001|Overall Study|Disease Progression|8|||
164344927|NCT01010061|593638884|FG000|Overall Study|Withdrew Consent|5|||
164344928|NCT01010061|593638885|FG001|Overall Study|Withdrew Consent|1|||
164344929|NCT01010061|593638884|FG000|Overall Study|Death|3|||
164344930|NCT01010061|593638885|FG001|Overall Study|Death|6|||
164344931|NCT01010061|593638884|FG000|Overall Study|Administrative/Other|0|||
164344932|NCT01010061|593638885|FG001|Overall Study|Administrative/Other|1|||
164344933|NCT01010061|593638884|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
164344934|NCT01010061|593638885|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
164344935|NCT01010061|593638884|FG000|Overall Study|Insufficient Therapeutic Response|1|||
164344936|NCT01010061|593638885|FG001|Overall Study|Insufficient Therapeutic Response|5|||
164344937|NCT01010061|593638884|FG000|Overall Study|Violation of Selection Criteria|0|||
164344938|NCT01010061|593638885|FG001|Overall Study|Violation of Selection Criteria|1|||
164344939|NCT01010061|593638884|FG000|Overall Study|Did Not Receive Treatment|2|||
164344940|NCT01010061|593638885|FG001|Overall Study|Did Not Receive Treatment|2|||
164344941|NCT03066804|593638886|FG000|Overall Study|Physician Decision|0|||
164344942|NCT03066804|593638887|FG001|Overall Study|Physician Decision|4|||
164344943|NCT03066804|593638886|FG000|Overall Study|Death|23|||
164586639|NCT00479466|594511863|FG005|Overall Study|Withdrawal by Subject|1|||
164285871|NCT01684202|593416364|FG001|Maintenance Period|Adverse Event|1|||
164285872|NCT01684202|593416365|FG002|Maintenance Period|Adverse Event|1|||
164586640|NCT00532883|594511874|FG000|Overall Study|Adverse Event|1|||
164285873|NCT01684202|593416366|FG003|Maintenance Period|Adverse Event|1|||
164586641|NCT00532883|594511875|FG001|Overall Study|Adverse Event|0|||
164344944|NCT03066804|593638887|FG001|Overall Study|Death|17|||
164344945|NCT03066804|593638886|FG000|Overall Study|Withdrawal by Subject|19|||
164344946|NCT03066804|593638887|FG001|Overall Study|Withdrawal by Subject|25|||
164344947|NCT03066804|593638886|FG000|Overall Study|Lost to Follow-up|2|||
164285874|NCT01684202|593416363|FG000|Maintenance Period|Physician Decision|0|||
164285875|NCT01684202|593416364|FG001|Maintenance Period|Physician Decision|1|||
164344948|NCT03066804|593638887|FG001|Overall Study|Lost to Follow-up|0|||
164586642|NCT00532883|594511876|FG002|Overall Study|Adverse Event|0|||
164285876|NCT01684202|593416365|FG002|Maintenance Period|Physician Decision|0|||
164285877|NCT01684202|593416366|FG003|Maintenance Period|Physician Decision|0|||
164285878|NCT01684202|593416363|FG000|Maintenance Period|Withdrawal by Subject|0|||
164285879|NCT01684202|593416364|FG001|Maintenance Period|Withdrawal by Subject|1|||
164285880|NCT01684202|593416365|FG002|Maintenance Period|Withdrawal by Subject|0|||
164285881|NCT01684202|593416366|FG003|Maintenance Period|Withdrawal by Subject|0|||
164285882|NCT00191308|593416367|FG000|Overall Study|Adverse Event|1|||
164285883|NCT00779025|593416368|FG000|Overall Study|Withdrawal by Subject|1|||
164285884|NCT02741635|593416369|FG000|Overall Study|Withdrawal by Subject|1|||
164285885|NCT03797586|593416370|FG000|Overall Study|Lost to Follow-up|3|||
164285886|NCT03797586|593416371|FG001|Overall Study|Lost to Follow-up|6|||
164285887|NCT03797586|593416370|FG000|Overall Study|Death|1|||
164285888|NCT03797586|593416371|FG001|Overall Study|Death|1|||
164285889|NCT03797586|593416370|FG000|Overall Study|Adverse Event|0|||
164285890|NCT03797586|593416371|FG001|Overall Study|Adverse Event|2|||
164285891|NCT02864901|593416372|FG000|Overall Study|Withdrawal by Subject|1|||
164285892|NCT02864901|593416373|FG001|Overall Study|Withdrawal by Subject|0|||
164285893|NCT01219985|593416378|FG000|Overall Study|Physician Decision|20|||
164285894|NCT01369784|593416379|FG000|Overall Study|Protocol Violation|12|||
164285895|NCT03359174|593416380|FG000|Overall Study|Adverse Event|1|||
164285896|NCT02680665|593416381|FG000|Overall Study|No visit after the first prescription|5|||
164285897|NCT02905266|593416382|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
164285898|NCT02905266|593416383|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
164285899|NCT02905266|593416382|FG000|Treatment Phase Part 1|Disease Progression|6|||
164285900|NCT02905266|593416383|FG001|Treatment Phase Part 1|Disease Progression|7|||
164285901|NCT02905266|593416382|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
164285902|NCT02905266|593416383|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
164285903|NCT02905266|593416382|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
164285904|NCT02905266|593416383|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
164285905|NCT02905266|593416382|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
164285906|NCT02905266|593416383|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
164285907|NCT02905266|593416382|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
164285908|NCT02905266|593416383|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
164285909|NCT02905266|593416382|FG000|Transition From Part 1 to Part 2|Death|0|||
164285910|NCT02905266|593416383|FG001|Transition From Part 1 to Part 2|Death|1|||
164285911|NCT02905266|593416382|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
164285912|NCT02905266|593416383|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
164285913|NCT02905266|593416382|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
164285914|NCT02905266|593416383|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
164285915|NCT02905266|593416382|FG000|Maintenance Phase Part 2|Disease Progression|9|||
164285916|NCT02905266|593416383|FG001|Maintenance Phase Part 2|Disease Progression|2|||
164285917|NCT02905266|593416382|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
164285918|NCT02905266|593416383|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
164285919|NCT02905266|593416382|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
164285920|NCT02905266|593416383|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
164285921|NCT00596752|593416386|FG000|Overall Study|Other Reason|44|||
164285922|NCT00596752|593416387|FG001|Overall Study|Other Reason|49|||
164285923|NCT00596752|593416386|FG000|Overall Study|Adverse Event|34|||
164285924|NCT00596752|593416387|FG001|Overall Study|Adverse Event|34|||
164285925|NCT00596752|593416386|FG000|Overall Study|Lost to Follow-up|22|||
164285926|NCT00596752|593416387|FG001|Overall Study|Lost to Follow-up|38|||
164285927|NCT00596752|593416386|FG000|Overall Study|Withdrawal by Subject|12|||
164285928|NCT00596752|593416387|FG001|Overall Study|Withdrawal by Subject|9|||
164285929|NCT00596752|593416386|FG000|Overall Study|Unsatisfactory Compliance|9|||
164586643|NCT00532883|594511877|FG003|Overall Study|Adverse Event|1|||
164285930|NCT00596752|593416387|FG001|Overall Study|Unsatisfactory Compliance|6|||
164285931|NCT00596752|593416386|FG000|Overall Study|Lack of Efficacy|4|||
164285932|NCT00596752|593416387|FG001|Overall Study|Lack of Efficacy|7|||
164285933|NCT00596752|593416386|FG000|Overall Study|Protocol Violation|1|||
164285934|NCT00596752|593416387|FG001|Overall Study|Protocol Violation|0|||
164285935|NCT04445662|593416392|FG000|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|1|||
164285936|NCT04445662|593416393|FG001|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|0|||
164586644|NCT00532883|594511874|FG000|Overall Study|Lost to Follow-up|1|||
164285937|NCT04445662|593416392|FG000|On treatment (0-12 weeks)|Withdrawal by Subject|2|||
164285938|NCT04445662|593416393|FG001|On treatment (0-12 weeks)|Withdrawal by Subject|5|||
164285939|NCT04445662|593416392|FG000|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|1|||
164586645|NCT00532883|594511875|FG001|Overall Study|Lost to Follow-up|1|||
164285940|NCT04445662|593416393|FG001|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|0|||
164285941|NCT04445662|593416392|FG000|Post-treatment (12-24 weeks)|Death|1|||
164586646|NCT00532883|594511876|FG002|Overall Study|Lost to Follow-up|1|||
164285942|NCT04445662|593416393|FG001|Post-treatment (12-24 weeks)|Death|0|||
164586647|NCT00532883|594511877|FG003|Overall Study|Lost to Follow-up|0|||
164285943|NCT01870726|593416394|FG000|Overall Study|Withdrawal of informed consent|0|||
164285944|NCT01870726|593416395|FG001|Overall Study|Withdrawal of informed consent|0|||
164285945|NCT01870726|593416396|FG002|Overall Study|Withdrawal of informed consent|0|||
164285946|NCT01870726|593416397|FG003|Overall Study|Withdrawal of informed consent|1|||
164285947|NCT01870726|593416398|FG004|Overall Study|Withdrawal of informed consent|0|||
164285948|NCT01870726|593416399|FG005|Overall Study|Withdrawal of informed consent|0|||
164285949|NCT01870726|593416400|FG006|Overall Study|Withdrawal of informed consent|0|||
164285950|NCT01870726|593416394|FG000|Overall Study|Withdrawal by Subject|0|||
164285951|NCT01870726|593416395|FG001|Overall Study|Withdrawal by Subject|1|||
164285952|NCT01870726|593416396|FG002|Overall Study|Withdrawal by Subject|0|||
164285953|NCT01870726|593416397|FG003|Overall Study|Withdrawal by Subject|0|||
164285954|NCT01870726|593416398|FG004|Overall Study|Withdrawal by Subject|0|||
164285955|NCT01870726|593416399|FG005|Overall Study|Withdrawal by Subject|0|||
164285956|NCT01870726|593416400|FG006|Overall Study|Withdrawal by Subject|0|||
164285957|NCT01870726|593416394|FG000|Overall Study|Adverse Event|0|||
164285958|NCT01870726|593416395|FG001|Overall Study|Adverse Event|0|||
164285959|NCT01870726|593416396|FG002|Overall Study|Adverse Event|0|||
164285960|NCT01870726|593416397|FG003|Overall Study|Adverse Event|0|||
164285961|NCT01870726|593416398|FG004|Overall Study|Adverse Event|1|||
164285962|NCT01870726|593416399|FG005|Overall Study|Adverse Event|1|||
164285963|NCT01870726|593416400|FG006|Overall Study|Adverse Event|0|||
164285964|NCT01870726|593416394|FG000|Overall Study|Progressive disease|5|||
164285965|NCT01870726|593416395|FG001|Overall Study|Progressive disease|5|||
164285966|NCT01870726|593416396|FG002|Overall Study|Progressive disease|4|||
164285967|NCT01870726|593416397|FG003|Overall Study|Progressive disease|5|||
164285968|NCT01870726|593416398|FG004|Overall Study|Progressive disease|6|||
164285969|NCT01870726|593416399|FG005|Overall Study|Progressive disease|4|||
164285970|NCT01870726|593416400|FG006|Overall Study|Progressive disease|10|||
164285971|NCT03245775|593416403|FG000|Overall Study|Lost to Follow-up|25|||
164285972|NCT03245775|593416404|FG001|Overall Study|Lost to Follow-up|26|||
164285973|NCT03245775|593416405|FG002|Overall Study|Lost to Follow-up|16|||
164285974|NCT03245775|593416406|FG003|Overall Study|Lost to Follow-up|16|||
164285975|NCT03691571|593416409|FG000|Overall Study|Withdrawal by Subject|9|||
164285976|NCT03691571|593416410|FG001|Overall Study|Withdrawal by Subject|2|||
164285977|NCT02363959|593416411|FG000|Overall Study|Medical instability|1|||
164285978|NCT02363959|593416412|FG001|Overall Study|Medical instability|0|||
164285979|NCT00940498|593416416|FG000|Overall Study|Death|2|||
164285980|NCT00940498|593416417|FG001|Overall Study|Death|0|||
164285981|NCT00940498|593416418|FG002|Overall Study|Death|0|||
164285982|NCT00940498|593416419|FG003|Overall Study|Death|1|||
164285983|NCT00940498|593416420|FG004|Overall Study|Death|5|||
164285984|NCT00940498|593416421|FG005|Overall Study|Death|0|||
164285985|NCT00940498|593416422|FG006|Overall Study|Death|1|||
164285986|NCT00940498|593416423|FG007|Overall Study|Death|0|||
164285987|NCT00940498|593416416|FG000|Overall Study|Lost to Follow-up|1|||
164285988|NCT00940498|593416417|FG001|Overall Study|Lost to Follow-up|1|||
164285989|NCT00940498|593416418|FG002|Overall Study|Lost to Follow-up|2|||
164285990|NCT00940498|593416419|FG003|Overall Study|Lost to Follow-up|0|||
164285991|NCT00940498|593416420|FG004|Overall Study|Lost to Follow-up|1|||
164285992|NCT00940498|593416421|FG005|Overall Study|Lost to Follow-up|0|||
164285993|NCT00940498|593416422|FG006|Overall Study|Lost to Follow-up|0|||
164285994|NCT00940498|593416423|FG007|Overall Study|Lost to Follow-up|1|||
164285995|NCT00940498|593416416|FG000|Overall Study|Disease Progression|0|||
164285996|NCT00940498|593416417|FG001|Overall Study|Disease Progression|0|||
164285997|NCT00940498|593416418|FG002|Overall Study|Disease Progression|1|||
164285998|NCT00940498|593416419|FG003|Overall Study|Disease Progression|1|||
164285999|NCT00940498|593416420|FG004|Overall Study|Disease Progression|0|||
164286000|NCT00940498|593416421|FG005|Overall Study|Disease Progression|1|||
164286001|NCT00940498|593416422|FG006|Overall Study|Disease Progression|0|||
164286002|NCT00940498|593416423|FG007|Overall Study|Disease Progression|0|||
164286003|NCT00940498|593416416|FG000|Overall Study|Physician Decision|0|||
164286004|NCT00940498|593416417|FG001|Overall Study|Physician Decision|0|||
164286005|NCT00940498|593416418|FG002|Overall Study|Physician Decision|0|||
164286006|NCT00940498|593416419|FG003|Overall Study|Physician Decision|0|||
164286007|NCT00940498|593416420|FG004|Overall Study|Physician Decision|2|||
164286008|NCT00940498|593416421|FG005|Overall Study|Physician Decision|0|||
164286009|NCT00940498|593416422|FG006|Overall Study|Physician Decision|0|||
164286010|NCT00940498|593416423|FG007|Overall Study|Physician Decision|0|||
164286011|NCT00940498|593416416|FG000|Overall Study|Not treated due to disease related pain|0|||
164286012|NCT00940498|593416417|FG001|Overall Study|Not treated due to disease related pain|0|||
164286013|NCT00940498|593416418|FG002|Overall Study|Not treated due to disease related pain|0|||
164286014|NCT00940498|593416419|FG003|Overall Study|Not treated due to disease related pain|0|||
164286015|NCT00940498|593416420|FG004|Overall Study|Not treated due to disease related pain|1|||
164286016|NCT00940498|593416421|FG005|Overall Study|Not treated due to disease related pain|0|||
164286017|NCT00940498|593416422|FG006|Overall Study|Not treated due to disease related pain|0|||
164286018|NCT00940498|593416423|FG007|Overall Study|Not treated due to disease related pain|0|||
164286019|NCT03310723|593418207|FG000|Overall Study|Withdrawal by Subject|0|||
164286020|NCT03310723|593418208|FG001|Overall Study|Withdrawal by Subject|1|||
164586648|NCT00532883|594511874|FG000|Overall Study|Withdrawal by Subject|0|||
164586649|NCT00532883|594511875|FG001|Overall Study|Withdrawal by Subject|1|||
164586650|NCT00532883|594511876|FG002|Overall Study|Withdrawal by Subject|1|||
164586651|NCT00532883|594511877|FG003|Overall Study|Withdrawal by Subject|0|||
164586652|NCT00532883|594511874|FG000|Overall Study|Subject was Nonadherent|0|||
164586653|NCT00532883|594511875|FG001|Overall Study|Subject was Nonadherent|1|||
164586654|NCT00532883|594511876|FG002|Overall Study|Subject was Nonadherent|1|||
164586655|NCT00532883|594511877|FG003|Overall Study|Subject was Nonadherent|0|||
164586656|NCT00532883|594511874|FG000|Overall Study|Early Study Termination|4|||
164586657|NCT00532883|594511875|FG001|Overall Study|Early Study Termination|4|||
164586658|NCT00532883|594511876|FG002|Overall Study|Early Study Termination|1|||
164586659|NCT00532883|594511877|FG003|Overall Study|Early Study Termination|4|||
164586660|NCT02902809|594511880|FG000|Overall Study|Discontinuation of asthma program|28|||
164586661|NCT00532259|594511881|FG000|Overall Study|Withdrawal by Subject|2|||
164586662|NCT00532259|594511881|FG000|Overall Study|Adverse Event|1|||
164586663|NCT00532259|594511881|FG000|Overall Study|Death|1|||
164692199|NCT00605176|594895357|FG001|Overall Study|Withdrawal by Subject|2|||
164692200|NCT00605176|594895358|FG002|Overall Study|Withdrawal by Subject|4|||
164344949|NCT03066804|593638886|FG000|Overall Study|Adverse Event|2|||
164344950|NCT03066804|593638887|FG001|Overall Study|Adverse Event|3|||
164344951|NCT03066804|593638886|FG000|Overall Study|Technical problems|5|||
164344952|NCT03066804|593638887|FG001|Overall Study|Technical problems|1|||
164344953|NCT00730132|593638892|FG000|Overall Study|Protocol Violation|154|||
164344954|NCT00730132|593638892|FG000|Overall Study|Death|1|||
164344955|NCT03982368|593638893|FG000|Overall Study|Adverse Event|6|||
164344956|NCT03982368|593638894|FG001|Overall Study|Adverse Event|4|||
164344957|NCT03982368|593638895|FG002|Overall Study|Adverse Event|3|||
164344958|NCT03982368|593638893|FG000|Overall Study|Lost to Follow-up|2|||
164344959|NCT03982368|593638894|FG001|Overall Study|Lost to Follow-up|1|||
164344960|NCT03982368|593638895|FG002|Overall Study|Lost to Follow-up|0|||
164344961|NCT03982368|593638893|FG000|Overall Study|Withdrawal by Subject|1|||
164344962|NCT03982368|593638894|FG001|Overall Study|Withdrawal by Subject|2|||
164344963|NCT03982368|593638895|FG002|Overall Study|Withdrawal by Subject|0|||
164344964|NCT03982368|593638893|FG000|Overall Study|unknow|4|||
164344965|NCT03982368|593638894|FG001|Overall Study|unknow|0|||
164344966|NCT03982368|593638895|FG002|Overall Study|unknow|2|||
164344967|NCT03570697|593638896|FG000|Overall Study|Lost to Follow-up|0|||
164344968|NCT03570697|593638897|FG001|Overall Study|Lost to Follow-up|1|||
164344969|NCT03570697|593638896|FG000|Overall Study|Death|2|||
164344970|NCT03570697|593638897|FG001|Overall Study|Death|0|||
164344971|NCT03570697|593638896|FG000|Overall Study|Withdrawal by Subject|4|||
164344972|NCT03570697|593638897|FG001|Overall Study|Withdrawal by Subject|2|||
164344973|NCT00518284|593638898|FG000|Overall Study|Adverse Event|0|||
164344974|NCT00518284|593638899|FG001|Overall Study|Adverse Event|1|||
164344975|NCT00518284|593638900|FG002|Overall Study|Adverse Event|0|||
164344976|NCT00518284|593638901|FG003|Overall Study|Adverse Event|0|||
164344977|NCT00518284|593638898|FG000|Overall Study|Study Termination|0|||
164344978|NCT00518284|593638899|FG001|Overall Study|Study Termination|2|||
164344979|NCT00518284|593638900|FG002|Overall Study|Study Termination|1|||
164344980|NCT00518284|593638901|FG003|Overall Study|Study Termination|2|||
164344981|NCT01849783|593638902|FG000|Overall Study|Adverse Event|5|||
164344982|NCT01849783|593638902|FG000|Overall Study|Death|2|||
164344983|NCT01849783|593638902|FG000|Overall Study|Physician Decision|1|||
164344984|NCT01849783|593638902|FG000|Overall Study|Withdrawal by Subject|1|||
164344985|NCT01849783|593638902|FG000|Overall Study|Unable to comply|2|||
164344986|NCT01849783|593638902|FG000|Overall Study|Disease progression|11|||
164344987|NCT02571777|593638903|FG000|Overall Study|Subject/guardian decision|34|||
164344988|NCT02571777|593638904|FG001|Overall Study|Subject/guardian decision|26|||
164344989|NCT02571777|593638905|FG002|Overall Study|Subject/guardian decision|26|||
164344990|NCT02571777|593638906|FG003|Overall Study|Subject/guardian decision|25|||
164344991|NCT02571777|593638907|FG004|Overall Study|Subject/guardian decision|27|||
164344992|NCT02571777|593638903|FG000|Overall Study|Protocol Deviation|2|||
164344993|NCT02571777|593638904|FG001|Overall Study|Protocol Deviation|3|||
164344994|NCT02571777|593638905|FG002|Overall Study|Protocol Deviation|4|||
164344995|NCT02571777|593638906|FG003|Overall Study|Protocol Deviation|8|||
164344996|NCT02571777|593638907|FG004|Overall Study|Protocol Deviation|4|||
164344997|NCT02571777|593638903|FG000|Overall Study|Death|1|||
164344998|NCT02571777|593638904|FG001|Overall Study|Death|1|||
164344999|NCT02571777|593638905|FG002|Overall Study|Death|4|||
164345000|NCT02571777|593638906|FG003|Overall Study|Death|0|||
164345001|NCT02571777|593638907|FG004|Overall Study|Death|0|||
164345002|NCT02571777|593638903|FG000|Overall Study|Lost to Follow-up|1|||
164586664|NCT00532259|594511881|FG000|Overall Study|Lack of Efficacy|21|||
164345003|NCT02571777|593638904|FG001|Overall Study|Lost to Follow-up|1|||
164586665|NCT00532259|594511881|FG000|Overall Study|Lost to Follow-up|3|||
164586666|NCT00532259|594511881|FG000|Overall Study|Physician Decision|3|||
164345004|NCT02571777|593638905|FG002|Overall Study|Lost to Follow-up|2|||
164345005|NCT02571777|593638906|FG003|Overall Study|Lost to Follow-up|0|||
164345006|NCT02571777|593638907|FG004|Overall Study|Lost to Follow-up|1|||
164345007|NCT02571777|593638903|FG000|Overall Study|Physician Decision|1|||
164286021|NCT03310723|593418207|FG000|Overall Study|Protocol Violation|0|||
164286022|NCT03310723|593418208|FG001|Overall Study|Protocol Violation|2|||
164286023|NCT02098746|593418209|FG000|Overall Study|Changes of Investigator|2|||
164286024|NCT02098746|593418209|FG000|Overall Study|Other Miscellaneous Reasons|1|||
164286025|NCT02098746|593418209|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
164286026|NCT02098746|593418209|FG000|Overall Study|Data Not Available After Treatment|1|||
164286027|NCT00217425|593418210|FG000|Overall Study|Never started treatment|2|||
164286028|NCT00217425|593418210|FG000|Overall Study|Patient ineligible|5|||
164345008|NCT02571777|593638904|FG001|Overall Study|Physician Decision|7|||
164286029|NCT00217425|593418210|FG000|Overall Study|Lack of Efficacy|13|||
164286030|NCT00217425|593418210|FG000|Overall Study|Adverse Event|8|||
164286031|NCT00217425|593418210|FG000|Overall Study|Withdrawal by Subject|4|||
164286032|NCT00217425|593418210|FG000|Overall Study|Other complicating disease|1|||
164286033|NCT00217425|593418210|FG000|Overall Study|Other|4|||
164286034|NCT00671034|593418213|FG000|Overall Study|Adverse Event|5|||
164286035|NCT00671034|593418214|FG001|Overall Study|Adverse Event|7|||
164286036|NCT00671034|593418215|FG002|Overall Study|Adverse Event|1|||
164286037|NCT00671034|593418213|FG000|Overall Study|Death|3|||
164286038|NCT00671034|593418214|FG001|Overall Study|Death|2|||
164286039|NCT00671034|593418215|FG002|Overall Study|Death|1|||
164286040|NCT00671034|593418213|FG000|Overall Study|Physician Decision|12|||
164286041|NCT00671034|593418214|FG001|Overall Study|Physician Decision|4|||
164286042|NCT00671034|593418215|FG002|Overall Study|Physician Decision|5|||
164286043|NCT00671034|593418213|FG000|Overall Study|VHR ALL feature|8|||
164286044|NCT00671034|593418214|FG001|Overall Study|VHR ALL feature|3|||
164286045|NCT00671034|593418215|FG002|Overall Study|VHR ALL feature|5|||
164286046|NCT00671034|593418213|FG000|Overall Study|Refusal|5|||
164286047|NCT00671034|593418214|FG001|Overall Study|Refusal|3|||
164286048|NCT00671034|593418215|FG002|Overall Study|Refusal|5|||
164286049|NCT00671034|593418213|FG000|Overall Study|includes Alternative therapy, etc.|6|||
164286050|NCT00671034|593418214|FG001|Overall Study|includes Alternative therapy, etc.|1|||
164286051|NCT00671034|593418215|FG002|Overall Study|includes Alternative therapy, etc.|7|||
164286052|NCT00330759|593418216|FG000|Overall Study|Death|316|||
164286053|NCT00330759|593418217|FG001|Overall Study|Death|310|||
164286054|NCT00330759|593418216|FG000|Overall Study|Disease progression|104|||
164286055|NCT00330759|593418217|FG001|Overall Study|Disease progression|126|||
164286056|NCT00330759|593418216|FG000|Overall Study|Withdrawal by Subject|143|||
164286057|NCT00330759|593418217|FG001|Overall Study|Withdrawal by Subject|124|||
164286058|NCT00330759|593418216|FG000|Overall Study|Adverse Event|48|||
164286059|NCT00330759|593418217|FG001|Overall Study|Adverse Event|36|||
164286060|NCT00330759|593418216|FG000|Overall Study|Participant request|31|||
164286061|NCT00330759|593418217|FG001|Overall Study|Participant request|22|||
164286062|NCT00330759|593418216|FG000|Overall Study|Lost to Follow-up|16|||
164286063|NCT00330759|593418217|FG001|Overall Study|Lost to Follow-up|22|||
164433324|NCT00906698|593957210|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
164433325|NCT00906698|593957211|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
164433326|NCT00906698|593957212|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
164433327|NCT00906698|593957213|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
164433328|NCT00906698|593957214|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
164433329|NCT03095508|593957215|FG000|Overall Study|Adverse Event|0|||
164286064|NCT00330759|593418216|FG000|Overall Study|Noncompliance|15|||
164286065|NCT00330759|593418217|FG001|Overall Study|Noncompliance|17|||
164286066|NCT00330759|593418216|FG000|Overall Study|Physician Decision|1|||
164345009|NCT02571777|593638905|FG002|Overall Study|Physician Decision|5|||
164345010|NCT02571777|593638906|FG003|Overall Study|Physician Decision|2|||
164345011|NCT02571777|593638907|FG004|Overall Study|Physician Decision|4|||
164345012|NCT02571777|593638903|FG000|Overall Study|Pregnancy|0|||
164345013|NCT02571777|593638904|FG001|Overall Study|Pregnancy|0|||
164345014|NCT02571777|593638905|FG002|Overall Study|Pregnancy|0|||
164345015|NCT02571777|593638906|FG003|Overall Study|Pregnancy|2|||
164345016|NCT02571777|593638907|FG004|Overall Study|Pregnancy|0|||
164345017|NCT00801632|593638908|FG000|Overall Study|Re-transplant|1|||
164433330|NCT03095508|593957216|FG001|Overall Study|Adverse Event|1|||
164286067|NCT00330759|593418217|FG001|Overall Study|Physician Decision|2|||
164286068|NCT00330759|593418216|FG000|Overall Study|Protocol deviation|0|||
164286069|NCT00330759|593418217|FG001|Overall Study|Protocol deviation|2|||
164286070|NCT00330759|593418216|FG000|Overall Study|Ineligibility determined|2|||
164286071|NCT00330759|593418217|FG001|Overall Study|Ineligibility determined|1|||
164286072|NCT00330759|593418216|FG000|Overall Study|Other|36|||
164286073|NCT00330759|593418217|FG001|Overall Study|Other|44|||
164345018|NCT05393895|593638912|FG000|Overall Study|Adverse Event|2|||
164345019|NCT05393895|593638913|FG001|Overall Study|Adverse Event|3|||
164286074|NCT02380287|593418219|FG000|Overall Study|Adverse Event|0|||
164286075|NCT02380287|593418220|FG001|Overall Study|Adverse Event|0|||
164286076|NCT02380287|593418221|FG002|Overall Study|Adverse Event|1|||
164286077|NCT02380287|593418222|FG003|Overall Study|Adverse Event|0|||
164286078|NCT02380287|593418223|FG004|Overall Study|Adverse Event|0|||
164345020|NCT05393895|593638912|FG000|Overall Study|Lost to Follow-up|4|||
164345021|NCT05393895|593638913|FG001|Overall Study|Lost to Follow-up|3|||
164433331|NCT00335556|593957217|FG000|Overall Study|Death|0|||
164286079|NCT02380287|593418224|FG005|Overall Study|Adverse Event|0|||
164286080|NCT02380287|593418225|FG006|Overall Study|Adverse Event|0|||
164286081|NCT02380287|593418226|FG007|Overall Study|Adverse Event|0|||
164286082|NCT01508312|593418227|FG000|Overall Study|Lost to Follow-up|1|||
164286083|NCT01508312|593418228|FG001|Overall Study|Lost to Follow-up|0|||
164286084|NCT01508312|593418229|FG002|Overall Study|Lost to Follow-up|0|||
164286085|NCT01508312|593418230|FG003|Overall Study|Lost to Follow-up|0|||
164286086|NCT01508312|593418227|FG000|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
164286087|NCT01508312|593418228|FG001|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|1|||
164286088|NCT01508312|593418229|FG002|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
164286089|NCT01508312|593418230|FG003|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
164286090|NCT01508312|593418227|FG000|Overall Study|Adverse Event|0|||
164286091|NCT01508312|593418228|FG001|Overall Study|Adverse Event|0|||
164286092|NCT01508312|593418229|FG002|Overall Study|Adverse Event|2|||
164286093|NCT01508312|593418230|FG003|Overall Study|Adverse Event|0|||
164286094|NCT01508312|593418227|FG000|Overall Study|Lack of Efficacy|0|||
164286095|NCT01508312|593418228|FG001|Overall Study|Lack of Efficacy|0|||
164286096|NCT01508312|593418229|FG002|Overall Study|Lack of Efficacy|1|||
164286097|NCT01508312|593418230|FG003|Overall Study|Lack of Efficacy|0|||
164286098|NCT01508312|593418227|FG000|Overall Study|Withdrawal by Subject|0|||
164286099|NCT01508312|593418228|FG001|Overall Study|Withdrawal by Subject|0|||
164286100|NCT01508312|593418229|FG002|Overall Study|Withdrawal by Subject|1|||
164286101|NCT01508312|593418230|FG003|Overall Study|Withdrawal by Subject|0|||
164286102|NCT02322281|593418233|FG000|Overall Study|Progressive Disease|42|||
164286103|NCT02322281|593418234|FG001|Overall Study|Progressive Disease|14|||
164286104|NCT02322281|593418235|FG002|Overall Study|Progressive Disease|49|||
164286105|NCT02322281|593418233|FG000|Overall Study|Adverse Event|3|||
164286106|NCT02322281|593418234|FG001|Overall Study|Adverse Event|4|||
164286107|NCT02322281|593418235|FG002|Overall Study|Adverse Event|6|||
164286108|NCT02322281|593418233|FG000|Overall Study|Death|3|||
164286109|NCT02322281|593418234|FG001|Overall Study|Death|3|||
164286110|NCT02322281|593418235|FG002|Overall Study|Death|3|||
164286111|NCT02322281|593418233|FG000|Overall Study|Withdrawal by Subject|1|||
164286112|NCT02322281|593418234|FG001|Overall Study|Withdrawal by Subject|1|||
164286113|NCT02322281|593418235|FG002|Overall Study|Withdrawal by Subject|6|||
164286114|NCT02322281|593418233|FG000|Overall Study|Physician Decision|2|||
164286115|NCT02322281|593418234|FG001|Overall Study|Physician Decision|0|||
164286116|NCT02322281|593418235|FG002|Overall Study|Physician Decision|5|||
164286117|NCT02322281|593418233|FG000|Overall Study|Study Terminated by Sponsor|2|||
164286118|NCT02322281|593418234|FG001|Overall Study|Study Terminated by Sponsor|0|||
164286119|NCT02322281|593418235|FG002|Overall Study|Study Terminated by Sponsor|0|||
164286120|NCT02322281|593418233|FG000|Overall Study|Missing|0|||
164286121|NCT02322281|593418234|FG001|Overall Study|Missing|0|||
164286122|NCT02322281|593418235|FG002|Overall Study|Missing|1|||
164286123|NCT02322281|593418233|FG000|Overall Study|Miscellaneous|0|||
164286124|NCT02322281|593418234|FG001|Overall Study|Miscellaneous|0|||
164286125|NCT02322281|593418235|FG002|Overall Study|Miscellaneous|4|||
164286126|NCT00936702|593418236|FG000|Overall Study|Disease progression|34|||
164286127|NCT00936702|593418236|FG000|Overall Study|Adverse Event|8|||
164286128|NCT00936702|593418236|FG000|Overall Study|Withdrawal by Subject|2|||
164286129|NCT00936702|593418236|FG000|Overall Study|Alternative Treatment|1|||
164286130|NCT00936702|593418236|FG000|Overall Study|Other|1|||
164286131|NCT00824473|593418237|FG000|Overall Study|Adverse Event|4|||
164286132|NCT00824473|593418238|FG001|Overall Study|Adverse Event|5|||
164286133|NCT00824473|593418237|FG000|Overall Study|Lack of Efficacy|2|||
164286134|NCT00824473|593418238|FG001|Overall Study|Lack of Efficacy|2|||
164286135|NCT00824473|593418237|FG000|Overall Study|Protocol Violation|2|||
164286136|NCT00824473|593418238|FG001|Overall Study|Protocol Violation|0|||
164286137|NCT00824473|593418237|FG000|Overall Study|Non-Compliance|4|||
164286138|NCT00824473|593418238|FG001|Overall Study|Non-Compliance|2|||
164286139|NCT00824473|593418237|FG000|Overall Study|Withdrawal by Subject|2|||
164286140|NCT00824473|593418238|FG001|Overall Study|Withdrawal by Subject|3|||
164286141|NCT00824473|593418237|FG000|Overall Study|Other|1|||
164286142|NCT00824473|593418238|FG001|Overall Study|Other|1|||
164286143|NCT01359904|593418239|FG000|Overall Study|Withdrawal by Subject|1|||
164286144|NCT01359904|593418240|FG001|Overall Study|Withdrawal by Subject|0|||
164286145|NCT00466440|593418241|FG000|Overall Study|Adverse Event|0|||
164286146|NCT00466440|593418242|FG001|Overall Study|Adverse Event|3|||
164286147|NCT00466440|593418243|FG002|Overall Study|Adverse Event|1|||
164286148|NCT00466440|593418241|FG000|Overall Study|Death|1|||
164286149|NCT00466440|593418242|FG001|Overall Study|Death|1|||
164286150|NCT00466440|593418243|FG002|Overall Study|Death|0|||
164286151|NCT00466440|593418241|FG000|Overall Study|Progressive disease|13|||
164286152|NCT00466440|593418242|FG001|Overall Study|Progressive disease|5|||
164286153|NCT00466440|593418243|FG002|Overall Study|Progressive disease|4|||
164286154|NCT00466440|593418241|FG000|Overall Study|Lost to Follow-up|0|||
164286155|NCT00466440|593418242|FG001|Overall Study|Lost to Follow-up|1|||
164286156|NCT00466440|593418243|FG002|Overall Study|Lost to Follow-up|0|||
164286157|NCT00466440|593418241|FG000|Overall Study|Physician Decision|0|||
164286158|NCT00466440|593418242|FG001|Overall Study|Physician Decision|1|||
164286159|NCT00466440|593418243|FG002|Overall Study|Physician Decision|2|||
164286160|NCT00466440|593418241|FG000|Overall Study|Protocol entry criteria not met|0|||
164286161|NCT00466440|593418242|FG001|Overall Study|Protocol entry criteria not met|0|||
164286162|NCT00466440|593418243|FG002|Overall Study|Protocol entry criteria not met|4|||
164286163|NCT00466440|593418241|FG000|Overall Study|Withdrawal by Subject|0|||
164286164|NCT00466440|593418242|FG001|Overall Study|Withdrawal by Subject|1|||
164286165|NCT00466440|593418243|FG002|Overall Study|Withdrawal by Subject|0|||
164286166|NCT00466440|593418241|FG000|Overall Study|Sponsor decision|0|||
164286167|NCT00466440|593418242|FG001|Overall Study|Sponsor decision|0|||
164286168|NCT00466440|593418243|FG002|Overall Study|Sponsor decision|1|||
164286169|NCT03191630|593418246|FG000|Overall Study|Lost to Follow-up|7|||
164286170|NCT03191630|593418247|FG001|Overall Study|Lost to Follow-up|7|||
164286171|NCT01550757|593418248|FG000|Overall Study|Lost to Follow-up|21|||
164286172|NCT01550757|593418249|FG001|Overall Study|Lost to Follow-up|14|||
164286173|NCT01550757|593418250|FG002|Overall Study|Lost to Follow-up|42|||
164286174|NCT01550757|593418251|FG003|Overall Study|Lost to Follow-up|53|||
164286175|NCT01550757|593418248|FG000|Overall Study|Withdrawal by Subject|2|||
164286176|NCT01550757|593418249|FG001|Overall Study|Withdrawal by Subject|0|||
164286177|NCT01550757|593418250|FG002|Overall Study|Withdrawal by Subject|3|||
164286178|NCT01550757|593418251|FG003|Overall Study|Withdrawal by Subject|1|||
164286179|NCT02342223|593418252|FG000|Overall Study|Lost to Follow-up|1|||
164286180|NCT01426958|593418253|FG000|Overall Study|Adverse Event|2|||
164286181|NCT01172535|593418256|FG000|Overall Study|Death|3|||
164286182|NCT01172535|593418256|FG000|Overall Study|Withdrawal by Subject|2|||
164286183|NCT01172535|593418256|FG000|Overall Study|Lost to Follow-up|1|||
164286184|NCT01172535|593418256|FG000|Overall Study|Ineligible at study entry|1|||
164286185|NCT01172535|593418256|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
164286186|NCT00413218|593418259|FG000|Overall Study|Randomized but didn't receive study drug|2|||
164286187|NCT00413218|593418260|FG001|Overall Study|Randomized but didn't receive study drug|8|||
164286188|NCT00413218|593418259|FG000|Overall Study|Death|57|||
164286189|NCT00413218|593418260|FG001|Overall Study|Death|56|||
164286190|NCT00413218|593418259|FG000|Overall Study|Lost to Follow-up|14|||
164286191|NCT00413218|593418260|FG001|Overall Study|Lost to Follow-up|17|||
164286192|NCT00413218|593418259|FG000|Overall Study|Admin|20|||
164286193|NCT00413218|593418260|FG001|Overall Study|Admin|14|||
164286194|NCT00413218|593418259|FG000|Overall Study|Missing|1|||
164286195|NCT00413218|593418260|FG001|Overall Study|Missing|0|||
164286196|NCT00413218|593418259|FG000|Overall Study|Withdrawal by Subject|9|||
164286197|NCT00413218|593418260|FG001|Overall Study|Withdrawal by Subject|1|||
164286198|NCT00837213|593418261|FG000|Overall Study|Lost to Follow-up|3|||
164286199|NCT00837213|593418262|FG001|Overall Study|Lost to Follow-up|2|||
164286200|NCT00837213|593418261|FG000|Overall Study|Withdrawal by Subject|2|||
164286201|NCT00837213|593418262|FG001|Overall Study|Withdrawal by Subject|2|||
164286202|NCT00837213|593418261|FG000|Overall Study|not stated|1|||
164286203|NCT00837213|593418262|FG001|Overall Study|not stated|1|||
164286204|NCT01479868|593418263|FG000|Overall Study|Adverse Event|1|||
164286205|NCT01479868|593418263|FG000|Overall Study|Lost to Follow-up|4|||
164286206|NCT01479868|593418263|FG000|Overall Study|Protocol Violation|1|||
164286207|NCT01479868|593418263|FG000|Overall Study|Withdrawal by Subject|1|||
164286208|NCT01479868|593418263|FG000|Overall Study|Sponsor's Decision|1|||
164345022|NCT05393895|593638912|FG000|Overall Study|Protocol Violation|1|||
164345023|NCT05393895|593638913|FG001|Overall Study|Protocol Violation|0|||
164345024|NCT05393895|593638912|FG000|Overall Study|Withdrawal by Subject|1|||
164345025|NCT05393895|593638913|FG001|Overall Study|Withdrawal by Subject|4|||
164345026|NCT03851705|593638917|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
164345027|NCT03851705|593638918|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
164345028|NCT03851705|593638919|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
164345029|NCT03851705|593638920|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
164345030|NCT03851705|593638917|FG000|Part 1: Double-Blind Period|Other reason|1|||
164286209|NCT01479868|593418263|FG000|Overall Study|Initiation of new HCV Therapy|1|||
164286210|NCT01618669|593418264|FG000|Overall Study|Lost to Follow-up|1|||
164286211|NCT01618669|593418265|FG001|Overall Study|Lost to Follow-up|1|||
164286212|NCT01618669|593418264|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
164286213|NCT01618669|593418265|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
164286214|NCT01618669|593418264|FG000|Overall Study|Adverse Event|16|||
164286215|NCT01618669|593418265|FG001|Overall Study|Adverse Event|7|||
164286216|NCT01618669|593418264|FG000|Overall Study|Protocol Violation|5|||
164286217|NCT01618669|593418265|FG001|Overall Study|Protocol Violation|3|||
164345031|NCT03851705|593638918|FG001|Part 1: Double-Blind Period|Other reason|0|||
164345032|NCT03851705|593638919|FG002|Part 1: Double-Blind Period|Other reason|0|||
164433332|NCT00335556|593957218|FG001|Overall Study|Death|5|||
164286218|NCT01618669|593418264|FG000|Overall Study|Withdrawal by Subject|9|||
164286219|NCT01618669|593418265|FG001|Overall Study|Withdrawal by Subject|9|||
164286220|NCT01618669|593418264|FG000|Overall Study|Miscellaneous Reason|0|||
164286221|NCT01618669|593418265|FG001|Overall Study|Miscellaneous Reason|1|||
164286222|NCT01508169|593418266|FG000|Overall Study|Adverse Event|1|||
164286223|NCT01508169|593418267|FG001|Overall Study|Adverse Event|0|||
164286224|NCT01508169|593418266|FG000|Overall Study|Withdrawal by Subject|1|||
164286225|NCT01508169|593418267|FG001|Overall Study|Withdrawal by Subject|0|||
164286226|NCT01508169|593418266|FG000|Overall Study|Lost to Follow-up|1|||
164286227|NCT01508169|593418267|FG001|Overall Study|Lost to Follow-up|2|||
164286228|NCT03600740|593418273|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
164286229|NCT02396212|593418274|FG000|Overall Study|Adverse Event|1|||
164286230|NCT02396212|593418274|FG000|Overall Study|Lack of Efficacy|2|||
164286231|NCT04950465|593418275|FG000|Overall Study|Lost to Follow-up|1|||
164286232|NCT04950465|593418276|FG001|Overall Study|Lost to Follow-up|0|||
164286233|NCT04950465|593418277|FG002|Overall Study|Lost to Follow-up|0|||
164286234|NCT01788566|593418284|FG000|Overall Study|Death|4|||
164286235|NCT01788566|593418284|FG000|Overall Study|Adverse Event|1|||
164286236|NCT01788566|593418284|FG000|Overall Study|Clinical Progressive Disease|3|||
164286237|NCT00556998|593418287|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
164286238|NCT00556998|593418287|FG000|Voriconazole Intravenous (IV)|Other|4|||
164286239|NCT00556998|593418287|FG000|Voriconazole Oral|Adverse Event|1|||
164286240|NCT00556998|593418287|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
164286241|NCT02721875|593418288|FG000|Overall Study|Progressive disease/relapse|1|||
164286242|NCT02721875|593418289|FG001|Overall Study|Progressive disease/relapse|0|||
164286243|NCT02888106|593418290|FG000|Overall Study|Withdrawal by Subject|1|||
164286244|NCT02888106|593418291|FG001|Overall Study|Withdrawal by Subject|2|||
164286245|NCT02888106|593418292|FG002|Overall Study|Withdrawal by Subject|0|||
164286246|NCT02888106|593418293|FG003|Overall Study|Withdrawal by Subject|1|||
164286247|NCT02888106|593418294|FG004|Overall Study|Withdrawal by Subject|0|||
164286248|NCT02888106|593418295|FG005|Overall Study|Withdrawal by Subject|0|||
164286249|NCT02888106|593418290|FG000|Overall Study|Lost to Follow-up|1|||
164286250|NCT02888106|593418291|FG001|Overall Study|Lost to Follow-up|0|||
164286251|NCT02888106|593418292|FG002|Overall Study|Lost to Follow-up|0|||
164286252|NCT02888106|593418293|FG003|Overall Study|Lost to Follow-up|1|||
164286253|NCT02888106|593418294|FG004|Overall Study|Lost to Follow-up|0|||
164286254|NCT02888106|593418295|FG005|Overall Study|Lost to Follow-up|1|||
164286255|NCT02888106|593418290|FG000|Overall Study|Adverse Event|2|||
164286256|NCT02888106|593418291|FG001|Overall Study|Adverse Event|0|||
164286257|NCT02888106|593418292|FG002|Overall Study|Adverse Event|0|||
164286258|NCT02888106|593418293|FG003|Overall Study|Adverse Event|0|||
164286259|NCT02888106|593418294|FG004|Overall Study|Adverse Event|0|||
164286260|NCT02888106|593418295|FG005|Overall Study|Adverse Event|0|||
164286261|NCT02888106|593418290|FG000|Overall Study|Withdrawal of consent|0|||
164286262|NCT02888106|593418291|FG001|Overall Study|Withdrawal of consent|0|||
164286263|NCT02888106|593418292|FG002|Overall Study|Withdrawal of consent|0|||
164345033|NCT03851705|593638920|FG003|Part 1: Double-Blind Period|Other reason|0|||
164345034|NCT03851705|593638917|FG000|Part 2: Open-Label Period|Other reason|0|||
164345035|NCT03851705|593638918|FG001|Part 2: Open-Label Period|Other reason|0|||
164345036|NCT03851705|593638919|FG002|Part 2: Open-Label Period|Other reason|0|||
164345037|NCT03851705|593638920|FG003|Part 2: Open-Label Period|Other reason|1|||
164345038|NCT03851705|593638917|FG000|Part 2: Open-Label Period|Death|0|||
164345039|NCT03851705|593638918|FG001|Part 2: Open-Label Period|Death|0|||
164345040|NCT03851705|593638919|FG002|Part 2: Open-Label Period|Death|3|||
164286264|NCT02888106|593418293|FG003|Overall Study|Withdrawal of consent|0|||
164286265|NCT02888106|593418294|FG004|Overall Study|Withdrawal of consent|1|||
164286266|NCT02888106|593418295|FG005|Overall Study|Withdrawal of consent|0|||
164286267|NCT02888106|593418290|FG000|Overall Study|Pregnancy|1|||
164286268|NCT02888106|593418291|FG001|Overall Study|Pregnancy|0|||
164286269|NCT02888106|593418292|FG002|Overall Study|Pregnancy|0|||
164286270|NCT02888106|593418293|FG003|Overall Study|Pregnancy|0|||
164286271|NCT02888106|593418294|FG004|Overall Study|Pregnancy|0|||
164286272|NCT02888106|593418295|FG005|Overall Study|Pregnancy|0|||
164286273|NCT00857285|593418296|FG000|Overall Study|Adverse Event|4|||
164286274|NCT00857285|593418297|FG001|Overall Study|Adverse Event|2|||
164286275|NCT00857285|593418296|FG000|Overall Study|Lack of Efficacy|0|||
164286276|NCT00857285|593418297|FG001|Overall Study|Lack of Efficacy|2|||
164286277|NCT00857285|593418296|FG000|Overall Study|Protocol Violation|3|||
164345041|NCT03851705|593638920|FG003|Part 2: Open-Label Period|Death|0|||
164286278|NCT00857285|593418297|FG001|Overall Study|Protocol Violation|1|||
164286279|NCT00857285|593418296|FG000|Overall Study|Withdrawal by Subject|4|||
164286280|NCT00857285|593418297|FG001|Overall Study|Withdrawal by Subject|0|||
164286281|NCT00857285|593418296|FG000|Overall Study|Randomization criteria not met|1|||
164286282|NCT00857285|593418297|FG001|Overall Study|Randomization criteria not met|1|||
164286283|NCT01425801|593418303|FG000|Period 1|Withdrawal by Subject|0|||
164345042|NCT03851705|593638917|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
164345043|NCT03851705|593638918|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
164345044|NCT03851705|593638919|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
164286284|NCT01425801|593418304|FG001|Period 1|Withdrawal by Subject|0|||
164286285|NCT01425801|593418305|FG002|Period 1|Withdrawal by Subject|0|||
164286286|NCT01425801|593418306|FG003|Period 1|Withdrawal by Subject|0|||
164286287|NCT01425801|593418307|FG004|Period 1|Withdrawal by Subject|1|||
164286288|NCT01425801|593418308|FG005|Period 1|Withdrawal by Subject|0|||
164345045|NCT03851705|593638920|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
164286289|NCT01425801|593418303|FG000|Period 2|Withdrawal by Subject|0|||
164286290|NCT01425801|593418304|FG001|Period 2|Withdrawal by Subject|0|||
164286291|NCT01425801|593418305|FG002|Period 2|Withdrawal by Subject|0|||
164286292|NCT01425801|593418306|FG003|Period 2|Withdrawal by Subject|0|||
164286293|NCT01425801|593418307|FG004|Period 2|Withdrawal by Subject|1|||
164286294|NCT01425801|593418308|FG005|Period 2|Withdrawal by Subject|0|||
164286295|NCT01425801|593418303|FG000|Period 3|Stability criteria not fullfilled|0|||
164286296|NCT01425801|593418304|FG001|Period 3|Stability criteria not fullfilled|0|||
164286297|NCT01425801|593418305|FG002|Period 3|Stability criteria not fullfilled|1|||
164286298|NCT01425801|593418306|FG003|Period 3|Stability criteria not fullfilled|0|||
164286299|NCT01425801|593418307|FG004|Period 3|Stability criteria not fullfilled|0|||
164286300|NCT01425801|593418308|FG005|Period 3|Stability criteria not fullfilled|0|||
164286301|NCT01425801|593418303|FG000|Period 4|Not able to maintain visit schedule|0|||
164286302|NCT01425801|593418304|FG001|Period 4|Not able to maintain visit schedule|0|||
164286303|NCT01425801|593418305|FG002|Period 4|Not able to maintain visit schedule|1|||
164286304|NCT01425801|593418306|FG003|Period 4|Not able to maintain visit schedule|0|||
164286305|NCT01425801|593418307|FG004|Period 4|Not able to maintain visit schedule|0|||
164286306|NCT01425801|593418308|FG005|Period 4|Not able to maintain visit schedule|0|||
164286307|NCT03386721|593418309|FG000|Overall Study|Death|12|||
164286308|NCT03386721|593418310|FG001|Overall Study|Death|21|||
164286309|NCT03386721|593418311|FG002|Overall Study|Death|2|||
164286310|NCT03386721|593418312|FG003|Overall Study|Death|5|||
164286311|NCT03386721|593418313|FG004|Overall Study|Death|1|||
164286312|NCT03386721|593418314|FG005|Overall Study|Death|12|||
164286313|NCT03386721|593418315|FG006|Overall Study|Death|1|||
164286314|NCT03386721|593418316|FG007|Overall Study|Death|1|||
164286315|NCT03386721|593418317|FG008|Overall Study|Death|12|||
164286316|NCT03386721|593418318|FG009|Overall Study|Death|20|||
164286317|NCT03386721|593418319|FG010|Overall Study|Death|21|||
164286318|NCT03386721|593418320|FG011|Overall Study|Death|21|||
164286319|NCT03386721|593418321|FG012|Overall Study|Death|14|||
164286320|NCT03386721|593418322|FG013|Overall Study|Death|2|||
164286321|NCT03386721|593418323|FG014|Overall Study|Death|1|||
164286322|NCT03386721|593418309|FG000|Overall Study|Lost to Follow-up|1|||
164286323|NCT03386721|593418310|FG001|Overall Study|Lost to Follow-up|3|||
164286324|NCT03386721|593418311|FG002|Overall Study|Lost to Follow-up|0|||
164286325|NCT03386721|593418312|FG003|Overall Study|Lost to Follow-up|0|||
164286326|NCT03386721|593418313|FG004|Overall Study|Lost to Follow-up|0|||
164286327|NCT03386721|593418314|FG005|Overall Study|Lost to Follow-up|2|||
164286328|NCT03386721|593418315|FG006|Overall Study|Lost to Follow-up|1|||
164286329|NCT03386721|593418316|FG007|Overall Study|Lost to Follow-up|0|||
164286330|NCT03386721|593418317|FG008|Overall Study|Lost to Follow-up|1|||
164286331|NCT03386721|593418318|FG009|Overall Study|Lost to Follow-up|2|||
164286332|NCT03386721|593418319|FG010|Overall Study|Lost to Follow-up|1|||
164286333|NCT03386721|593418320|FG011|Overall Study|Lost to Follow-up|0|||
164286334|NCT03386721|593418321|FG012|Overall Study|Lost to Follow-up|0|||
164286335|NCT03386721|593418322|FG013|Overall Study|Lost to Follow-up|0|||
164286336|NCT03386721|593418323|FG014|Overall Study|Lost to Follow-up|0|||
164286337|NCT03386721|593418309|FG000|Overall Study|Reason not specified|3|||
164286338|NCT03386721|593418310|FG001|Overall Study|Reason not specified|0|||
164286339|NCT03386721|593418311|FG002|Overall Study|Reason not specified|0|||
164286340|NCT03386721|593418312|FG003|Overall Study|Reason not specified|0|||
164286341|NCT03386721|593418313|FG004|Overall Study|Reason not specified|0|||
164345046|NCT03617185|593638921|FG000|Baseline|Lost to Follow-up|0|||
164345047|NCT03617185|593638922|FG001|Baseline|Lost to Follow-up|2|||
164345048|NCT03617185|593638923|FG002|Baseline|Lost to Follow-up|1|||
164345049|NCT03617185|593638924|FG003|Baseline|Lost to Follow-up|1|||
164345050|NCT03617185|593638921|FG000|Baseline|Withdrawal by Subject|0|||
164345051|NCT03617185|593638922|FG001|Baseline|Withdrawal by Subject|1|||
164345052|NCT03617185|593638923|FG002|Baseline|Withdrawal by Subject|0|||
164345053|NCT03617185|593638924|FG003|Baseline|Withdrawal by Subject|1|||
164345054|NCT03617185|593638921|FG000|Baseline|Driving Distance/Travel|0|||
164345055|NCT03617185|593638922|FG001|Baseline|Driving Distance/Travel|0|||
164345056|NCT03617185|593638923|FG002|Baseline|Driving Distance/Travel|2|||
164345057|NCT03617185|593638924|FG003|Baseline|Driving Distance/Travel|0|||
164345058|NCT03617185|593638921|FG000|Baseline|Family Obligations|0|||
164345059|NCT03617185|593638922|FG001|Baseline|Family Obligations|0|||
164692201|NCT00605176|594895356|FG000|Overall Study|Lost to Follow-up|2|||
164286342|NCT03386721|593418314|FG005|Overall Study|Reason not specified|3|||
164286343|NCT03386721|593418315|FG006|Overall Study|Reason not specified|1|||
164286344|NCT03386721|593418316|FG007|Overall Study|Reason not specified|0|||
164286345|NCT03386721|593418317|FG008|Overall Study|Reason not specified|0|||
164286346|NCT03386721|593418318|FG009|Overall Study|Reason not specified|1|||
164286347|NCT03386721|593418319|FG010|Overall Study|Reason not specified|2|||
164286348|NCT03386721|593418320|FG011|Overall Study|Reason not specified|6|||
164286349|NCT03386721|593418321|FG012|Overall Study|Reason not specified|1|||
164286350|NCT03386721|593418322|FG013|Overall Study|Reason not specified|0|||
164286351|NCT03386721|593418323|FG014|Overall Study|Reason not specified|0|||
164286352|NCT03386721|593418309|FG000|Overall Study|Progressive Disease|0|||
164345060|NCT03617185|593638923|FG002|Baseline|Family Obligations|0|||
164345061|NCT03617185|593638924|FG003|Baseline|Family Obligations|1|||
164345062|NCT03617185|593638921|FG000|3 Months|Lost to Follow-up|4|||
164345063|NCT03617185|593638922|FG001|3 Months|Lost to Follow-up|1|||
164345064|NCT03617185|593638923|FG002|3 Months|Lost to Follow-up|0|||
164345065|NCT03617185|593638924|FG003|3 Months|Lost to Follow-up|2|||
164345066|NCT03617185|593638921|FG000|3 Months|Withdrawal by Subject|1|||
164345067|NCT03617185|593638922|FG001|3 Months|Withdrawal by Subject|3|||
164345068|NCT03617185|593638923|FG002|3 Months|Withdrawal by Subject|0|||
164345069|NCT03617185|593638924|FG003|3 Months|Withdrawal by Subject|0|||
164345070|NCT03617185|593638921|FG000|3 Months|Driving Distance/Travel|1|||
164345071|NCT03617185|593638922|FG001|3 Months|Driving Distance/Travel|0|||
164345072|NCT03617185|593638923|FG002|3 Months|Driving Distance/Travel|0|||
164345073|NCT03617185|593638924|FG003|3 Months|Driving Distance/Travel|0|||
164345074|NCT03617185|593638921|FG000|3 Months|Family Obligations|0|||
164345075|NCT03617185|593638922|FG001|3 Months|Family Obligations|0|||
164286353|NCT03386721|593418310|FG001|Overall Study|Progressive Disease|0|||
164286354|NCT03386721|593418311|FG002|Overall Study|Progressive Disease|1|||
164286355|NCT03386721|593418312|FG003|Overall Study|Progressive Disease|0|||
164286356|NCT03386721|593418313|FG004|Overall Study|Progressive Disease|0|||
164286357|NCT03386721|593418314|FG005|Overall Study|Progressive Disease|1|||
164286358|NCT03386721|593418315|FG006|Overall Study|Progressive Disease|0|||
164286359|NCT03386721|593418316|FG007|Overall Study|Progressive Disease|0|||
164286360|NCT03386721|593418317|FG008|Overall Study|Progressive Disease|2|||
164286361|NCT03386721|593418318|FG009|Overall Study|Progressive Disease|1|||
164286362|NCT03386721|593418319|FG010|Overall Study|Progressive Disease|1|||
164286363|NCT03386721|593418320|FG011|Overall Study|Progressive Disease|0|||
164286364|NCT03386721|593418321|FG012|Overall Study|Progressive Disease|1|||
164286365|NCT03386721|593418322|FG013|Overall Study|Progressive Disease|0|||
164286366|NCT03386721|593418323|FG014|Overall Study|Progressive Disease|0|||
164286367|NCT03386721|593418309|FG000|Overall Study|Site Terminated by Sponsor|5|||
164286368|NCT03386721|593418310|FG001|Overall Study|Site Terminated by Sponsor|5|||
164286369|NCT03386721|593418311|FG002|Overall Study|Site Terminated by Sponsor|0|||
164286370|NCT03386721|593418312|FG003|Overall Study|Site Terminated by Sponsor|0|||
164286371|NCT03386721|593418313|FG004|Overall Study|Site Terminated by Sponsor|1|||
164286372|NCT03386721|593418314|FG005|Overall Study|Site Terminated by Sponsor|3|||
164286373|NCT03386721|593418315|FG006|Overall Study|Site Terminated by Sponsor|0|||
164286374|NCT03386721|593418316|FG007|Overall Study|Site Terminated by Sponsor|1|||
164286375|NCT03386721|593418317|FG008|Overall Study|Site Terminated by Sponsor|4|||
164286376|NCT03386721|593418318|FG009|Overall Study|Site Terminated by Sponsor|5|||
164286377|NCT03386721|593418319|FG010|Overall Study|Site Terminated by Sponsor|3|||
164286378|NCT03386721|593418320|FG011|Overall Study|Site Terminated by Sponsor|11|||
164286379|NCT03386721|593418321|FG012|Overall Study|Site Terminated by Sponsor|6|||
164286380|NCT03386721|593418322|FG013|Overall Study|Site Terminated by Sponsor|0|||
164286381|NCT03386721|593418323|FG014|Overall Study|Site Terminated by Sponsor|0|||
164286382|NCT03386721|593418309|FG000|Overall Study|Symptomatic Deterioration|0|||
164286383|NCT03386721|593418310|FG001|Overall Study|Symptomatic Deterioration|0|||
164286384|NCT03386721|593418311|FG002|Overall Study|Symptomatic Deterioration|0|||
164286385|NCT03386721|593418312|FG003|Overall Study|Symptomatic Deterioration|0|||
164286386|NCT03386721|593418313|FG004|Overall Study|Symptomatic Deterioration|0|||
164286387|NCT03386721|593418314|FG005|Overall Study|Symptomatic Deterioration|0|||
164286388|NCT03386721|593418315|FG006|Overall Study|Symptomatic Deterioration|0|||
164286389|NCT03386721|593418316|FG007|Overall Study|Symptomatic Deterioration|0|||
164286390|NCT03386721|593418317|FG008|Overall Study|Symptomatic Deterioration|1|||
164286391|NCT03386721|593418318|FG009|Overall Study|Symptomatic Deterioration|0|||
164286392|NCT03386721|593418319|FG010|Overall Study|Symptomatic Deterioration|0|||
164286393|NCT03386721|593418320|FG011|Overall Study|Symptomatic Deterioration|1|||
164286394|NCT03386721|593418321|FG012|Overall Study|Symptomatic Deterioration|0|||
164286395|NCT03386721|593418322|FG013|Overall Study|Symptomatic Deterioration|0|||
164286396|NCT03386721|593418323|FG014|Overall Study|Symptomatic Deterioration|0|||
164286397|NCT03386721|593418309|FG000|Overall Study|Withdrawal by Subject|1|||
164286398|NCT03386721|593418310|FG001|Overall Study|Withdrawal by Subject|2|||
164286399|NCT03386721|593418311|FG002|Overall Study|Withdrawal by Subject|0|||
164286400|NCT03386721|593418312|FG003|Overall Study|Withdrawal by Subject|0|||
164286401|NCT03386721|593418313|FG004|Overall Study|Withdrawal by Subject|0|||
164286402|NCT03386721|593418314|FG005|Overall Study|Withdrawal by Subject|0|||
164286403|NCT03386721|593418315|FG006|Overall Study|Withdrawal by Subject|0|||
164286404|NCT03386721|593418316|FG007|Overall Study|Withdrawal by Subject|0|||
164286405|NCT03386721|593418317|FG008|Overall Study|Withdrawal by Subject|2|||
164345076|NCT03617185|593638923|FG002|3 Months|Family Obligations|0|||
164345077|NCT03617185|593638924|FG003|3 Months|Family Obligations|1|||
164692202|NCT00605176|594895357|FG001|Overall Study|Lost to Follow-up|2|||
164286406|NCT03386721|593418318|FG009|Overall Study|Withdrawal by Subject|1|||
164286407|NCT03386721|593418319|FG010|Overall Study|Withdrawal by Subject|3|||
164286408|NCT03386721|593418320|FG011|Overall Study|Withdrawal by Subject|2|||
164286409|NCT03386721|593418321|FG012|Overall Study|Withdrawal by Subject|3|||
164345078|NCT03617185|593638921|FG000|12 Months|Lost to Follow-up|3|||
164345079|NCT03617185|593638922|FG001|12 Months|Lost to Follow-up|1|||
164286410|NCT03386721|593418322|FG013|Overall Study|Withdrawal by Subject|0|||
164286411|NCT03386721|593418323|FG014|Overall Study|Withdrawal by Subject|0|||
164286412|NCT03066596|593418324|FG000|Overall Study|Withdrawal by Subject|4|||
164286413|NCT03066596|593418325|FG001|Overall Study|Withdrawal by Subject|2|||
164286414|NCT03066596|593418324|FG000|Overall Study|Lost to Follow-up|14|||
164286415|NCT03066596|593418325|FG001|Overall Study|Lost to Follow-up|10|||
164286416|NCT00700713|593418326|FG000|Overall Study|Protocol Violation|1|||
164286417|NCT00700713|593418327|FG001|Overall Study|Protocol Violation|0|||
164286418|NCT00700713|593418328|FG002|Overall Study|Protocol Violation|1|||
164286419|NCT00700713|593418326|FG000|Overall Study|Withdrawal by Subject|0|||
164692203|NCT00605176|594895358|FG002|Overall Study|Lost to Follow-up|1|||
164692204|NCT00605176|594895356|FG000|Overall Study|Non-complicance with study procedures|1|||
164286420|NCT00700713|593418327|FG001|Overall Study|Withdrawal by Subject|0|||
164286421|NCT00700713|593418328|FG002|Overall Study|Withdrawal by Subject|1|||
164286422|NCT02959437|593418329|FG000|Overall Study|Death|33|||
164286423|NCT02959437|593418330|FG001|Overall Study|Death|3|||
164286424|NCT02959437|593418331|FG002|Overall Study|Death|0|||
164286425|NCT02959437|593418332|FG003|Overall Study|Death|0|||
164286426|NCT02959437|593418329|FG000|Overall Study|Lost to Follow-up|3|||
164286427|NCT02959437|593418330|FG001|Overall Study|Lost to Follow-up|1|||
164286428|NCT02959437|593418331|FG002|Overall Study|Lost to Follow-up|0|||
164692205|NCT00605176|594895357|FG001|Overall Study|Non-complicance with study procedures|0|||
164692206|NCT00605176|594895358|FG002|Overall Study|Non-complicance with study procedures|0|||
164692207|NCT00605176|594895356|FG000|Overall Study|Use of concomitant therapy|1|||
164692208|NCT00605176|594895357|FG001|Overall Study|Use of concomitant therapy|0|||
164286429|NCT02959437|593418332|FG003|Overall Study|Lost to Follow-up|0|||
164286430|NCT02959437|593418329|FG000|Overall Study|Withdrawal by Subject|11|||
164286431|NCT02959437|593418330|FG001|Overall Study|Withdrawal by Subject|3|||
164286432|NCT02959437|593418331|FG002|Overall Study|Withdrawal by Subject|0|||
164286433|NCT02959437|593418332|FG003|Overall Study|Withdrawal by Subject|0|||
164286434|NCT02959437|593418329|FG000|Overall Study|Progressive Disease|9|||
164286435|NCT02959437|593418330|FG001|Overall Study|Progressive Disease|1|||
164286436|NCT02959437|593418331|FG002|Overall Study|Progressive Disease|0|||
164286437|NCT02959437|593418332|FG003|Overall Study|Progressive Disease|0|||
164286438|NCT02959437|593418329|FG000|Overall Study|Study Terminated by Sponsor|4|||
164286439|NCT02959437|593418330|FG001|Overall Study|Study Terminated by Sponsor|0|||
164286440|NCT02959437|593418331|FG002|Overall Study|Study Terminated by Sponsor|0|||
164286441|NCT02959437|593418332|FG003|Overall Study|Study Terminated by Sponsor|0|||
164286442|NCT02959437|593418329|FG000|Overall Study|Other Unspecified|2|||
164286443|NCT02959437|593418330|FG001|Overall Study|Other Unspecified|0|||
164286444|NCT02959437|593418331|FG002|Overall Study|Other Unspecified|0|||
164286445|NCT02959437|593418332|FG003|Overall Study|Other Unspecified|0|||
164286446|NCT02728089|593418333|FG000|Overall Study|Physician Decision|2|||
164286447|NCT02728089|593418333|FG000|Overall Study|Withdrawal by Subject|1|||
164286448|NCT04089761|593418336|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
164692209|NCT00605176|594895358|FG002|Overall Study|Use of concomitant therapy|1|||
164692210|NCT00605176|594895356|FG000|Overall Study|Other (not due to AE)|1|||
164692211|NCT00605176|594895357|FG001|Overall Study|Other (not due to AE)|1|||
164692212|NCT00605176|594895358|FG002|Overall Study|Other (not due to AE)|0|||
164692213|NCT01086969|594895359|FG000|Overall Study|Withdrawal by Subject|1|||
164692214|NCT01086969|594895360|FG001|Overall Study|Withdrawal by Subject|2|||
164692215|NCT01086969|594895361|FG002|Overall Study|Withdrawal by Subject|0|||
164692216|NCT04974580|594895366|FG000|Overall Study|Lost to Follow-up|33|||
164692217|NCT04974580|594895367|FG001|Overall Study|Lost to Follow-up|39|||
164692218|NCT04974580|594895368|FG002|Overall Study|Lost to Follow-up|30|||
164692219|NCT04974580|594895369|FG003|Overall Study|Lost to Follow-up|29|||
164692220|NCT00109850|594895382|FG000|Overall Study|Adverse Event|1|||
164692221|NCT00109850|594895382|FG000|Overall Study|Death|2|||
164692222|NCT00109850|594895382|FG000|Overall Study|Ineligible|1|||
164692223|NCT00129116|594895383|FG000|Primary Phase|Lost to Follow-up|1|||
164692224|NCT00129116|594895384|FG001|Primary Phase|Lost to Follow-up|1|||
164286449|NCT04089761|593418336|FG000|"Run In Phase"|Lost to Follow-up|1|||
164286450|NCT04089761|593418336|FG000|"Treatment Phase"|No evaluable data|5|||
164286451|NCT04089761|593418336|FG000|"Treatment Phase"|Lost to Follow-up|1|||
164286452|NCT03868943|593418338|FG000|Overall Study|Adverse Event|1|||
164286453|NCT04896593|593418339|FG000|Overall Study|Withdrawal by Subject|2|||
164692225|NCT00129116|594895385|FG002|Primary Phase|Lost to Follow-up|0|||
164692226|NCT00129116|594895386|FG003|Primary Phase|Lost to Follow-up|1|||
164286454|NCT04896593|593418339|FG000|Overall Study|Lost to Follow-up|1|||
164286455|NCT04896593|593418339|FG000|Overall Study|Did not complete onboarding|2|||
164286456|NCT02915978|593418340|FG000|Overall Study|Adverse Event|2|||
164286457|NCT02915978|593418341|FG001|Overall Study|Adverse Event|1|||
164286458|NCT02915978|593418342|FG002|Overall Study|Adverse Event|0|||
164286459|NCT02451124|593418343|FG000|Overall Study|Withdrawal by Subject|1|||
164286460|NCT00892775|593418344|FG000|Overall Study|Protocol Violation|1|||
164286461|NCT00892775|593418345|FG001|Overall Study|Protocol Violation|0|||
164692227|NCT00129116|594895387|FG004|Primary Phase|Lost to Follow-up|1|||
164692228|NCT00129116|594895383|FG000|Primary Phase|Protocol Violation|0|||
164692229|NCT00129116|594895384|FG001|Primary Phase|Protocol Violation|1|||
164692230|NCT00129116|594895385|FG002|Primary Phase|Protocol Violation|0|||
164692231|NCT00129116|594895386|FG003|Primary Phase|Protocol Violation|0|||
164692232|NCT00129116|594895387|FG004|Primary Phase|Protocol Violation|0|||
164692233|NCT00129116|594895383|FG000|Primary Phase|Adverse Event|1|||
164692234|NCT00129116|594895384|FG001|Primary Phase|Adverse Event|1|||
164692235|NCT00129116|594895385|FG002|Primary Phase|Adverse Event|0|||
164692236|NCT00129116|594895386|FG003|Primary Phase|Adverse Event|0|||
164692237|NCT00129116|594895387|FG004|Primary Phase|Adverse Event|0|||
164692238|NCT00129116|594895383|FG000|Primary Phase|Withdrawal by Subject|0|||
164692239|NCT00129116|594895384|FG001|Primary Phase|Withdrawal by Subject|1|||
164692240|NCT00129116|594895385|FG002|Primary Phase|Withdrawal by Subject|0|||
164692241|NCT00129116|594895386|FG003|Primary Phase|Withdrawal by Subject|0|||
164692242|NCT00129116|594895387|FG004|Primary Phase|Withdrawal by Subject|0|||
164692243|NCT00129116|594895383|FG000|Primary Phase|Other|0|||
164692244|NCT00129116|594895384|FG001|Primary Phase|Other|0|||
164692245|NCT00129116|594895385|FG002|Primary Phase|Other|1|||
164692246|NCT00129116|594895386|FG003|Primary Phase|Other|0|||
164692247|NCT00129116|594895387|FG004|Primary Phase|Other|0|||
164692248|NCT00129116|594895383|FG000|Booster Phase|Lost to Follow-up|2|||
164692249|NCT00129116|594895384|FG001|Booster Phase|Lost to Follow-up|0|||
164692250|NCT00129116|594895385|FG002|Booster Phase|Lost to Follow-up|0|||
164692251|NCT00129116|594895386|FG003|Booster Phase|Lost to Follow-up|0|||
164692252|NCT00129116|594895387|FG004|Booster Phase|Lost to Follow-up|1|||
164692253|NCT01263561|594895388|FG000|Overall Study|Death|1|||
164692254|NCT01263561|594895389|FG001|Overall Study|Death|2|||
164692255|NCT00879684|594895390|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
164692256|NCT00879684|594895391|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
164692257|NCT00879684|594895392|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
164692258|NCT00879684|594895393|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
164692259|NCT00879684|594895394|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
164692260|NCT00879684|594895395|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
164692261|NCT00879684|594895396|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
164692262|NCT00879684|594895390|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
164692263|NCT00879684|594895391|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
164692264|NCT00879684|594895392|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
164692265|NCT00879684|594895393|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
164286462|NCT00892775|593418344|FG000|Overall Study|Subject difficulties with blood drawing|1|||
164286463|NCT00892775|593418345|FG001|Overall Study|Subject difficulties with blood drawing|0|||
164286464|NCT00892775|593418344|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
164286465|NCT00892775|593418345|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
164286466|NCT00892775|593418344|FG000|Overall Study|Migrated/ moved from study area|1|||
164286467|NCT00892775|593418345|FG001|Overall Study|Migrated/ moved from study area|0|||
164286468|NCT00892775|593418344|FG000|Overall Study|Withdrawal by Subject|0|||
164286469|NCT00892775|593418345|FG001|Overall Study|Withdrawal by Subject|1|||
164286470|NCT00892775|593418344|FG000|Overall Study|Lost to Follow-up|1|||
164286471|NCT00892775|593418345|FG001|Overall Study|Lost to Follow-up|0|||
164286472|NCT00103740|593418346|FG000|Period 1 - Core|Adverse Event|1|||
164286473|NCT00103740|593418347|FG001|Period 1 - Core|Adverse Event|0|||
164286474|NCT00103740|593418346|FG000|Period 1 - Core|Protocol Violation|3|||
164286475|NCT00103740|593418347|FG001|Period 1 - Core|Protocol Violation|2|||
164286476|NCT00103740|593418346|FG000|Period 1 - Core|Patient withdrew consent|3|||
164286477|NCT00103740|593418347|FG001|Period 1 - Core|Patient withdrew consent|2|||
164286478|NCT00103740|593418346|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
164286479|NCT00103740|593418347|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
164286480|NCT00103740|593418346|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
164345080|NCT03617185|593638923|FG002|12 Months|Lost to Follow-up|3|||
164345081|NCT03617185|593638924|FG003|12 Months|Lost to Follow-up|0|||
164345082|NCT03617185|593638921|FG000|12 Months|Withdrawal by Subject|0|||
164345083|NCT03617185|593638922|FG001|12 Months|Withdrawal by Subject|0|||
164345084|NCT03617185|593638923|FG002|12 Months|Withdrawal by Subject|0|||
164345085|NCT03617185|593638924|FG003|12 Months|Withdrawal by Subject|1|||
164345086|NCT03617185|593638921|FG000|12 Months|Driving Distance/Travel|0|||
164692266|NCT00879684|594895394|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
164692267|NCT00879684|594895395|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
164692268|NCT00879684|594895396|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
164345087|NCT03617185|593638922|FG001|12 Months|Driving Distance/Travel|0|||
164345088|NCT03617185|593638923|FG002|12 Months|Driving Distance/Travel|1|||
164345089|NCT03617185|593638924|FG003|12 Months|Driving Distance/Travel|0|||
164692269|NCT00879684|594895390|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
164692270|NCT00879684|594895391|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
164692271|NCT00879684|594895392|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
164286481|NCT00103740|593418347|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
164286482|NCT00103740|593418346|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
164286483|NCT00103740|593418347|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
164286484|NCT00103740|593418346|FG000|Period 2 - Extended Observation Period|Death|6|||
164286485|NCT00103740|593418347|FG001|Period 2 - Extended Observation Period|Death|2|||
164286486|NCT00103740|593418346|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
164286487|NCT00103740|593418347|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
164286488|NCT01463306|593418348|FG000|Overall Study|Adverse Event|6|||
164286489|NCT01463306|593418349|FG001|Overall Study|Adverse Event|9|||
164286490|NCT01463306|593418350|FG002|Overall Study|Adverse Event|3|||
164286491|NCT01463306|593418348|FG000|Overall Study|Death|3|||
164692272|NCT00879684|594895393|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
164692273|NCT00879684|594895394|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
164692274|NCT00879684|594895395|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
164692275|NCT00879684|594895396|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
164692276|NCT00879684|594895390|FG000|Stage 1: Dose Escalation|Death|0|||
164692277|NCT00879684|594895391|FG001|Stage 1: Dose Escalation|Death|0|||
164692278|NCT00879684|594895392|FG002|Stage 1: Dose Escalation|Death|1|||
164692279|NCT00879684|594895393|FG003|Stage 1: Dose Escalation|Death|0|||
164692280|NCT00879684|594895394|FG004|Stage 1: Dose Escalation|Death|0|||
164692281|NCT00879684|594895395|FG005|Stage 1: Dose Escalation|Death|0|||
164286492|NCT01463306|593418349|FG001|Overall Study|Death|3|||
164286493|NCT01463306|593418350|FG002|Overall Study|Death|0|||
164286494|NCT01463306|593418348|FG000|Overall Study|Lack of Efficacy|22|||
164286495|NCT01463306|593418349|FG001|Overall Study|Lack of Efficacy|16|||
164286496|NCT01463306|593418350|FG002|Overall Study|Lack of Efficacy|1|||
164286497|NCT01463306|593418348|FG000|Overall Study|Lost to Follow-up|5|||
164286498|NCT01463306|593418349|FG001|Overall Study|Lost to Follow-up|2|||
164286499|NCT01463306|593418350|FG002|Overall Study|Lost to Follow-up|0|||
164286500|NCT01463306|593418348|FG000|Overall Study|Protocol Violation|4|||
164692282|NCT00879684|594895396|FG006|Stage 1: Dose Escalation|Death|0|||
164692283|NCT00879684|594895390|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
164692284|NCT00879684|594895391|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
164692285|NCT00879684|594895392|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
164692286|NCT00879684|594895393|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
164286501|NCT01463306|593418349|FG001|Overall Study|Protocol Violation|0|||
164286502|NCT01463306|593418350|FG002|Overall Study|Protocol Violation|0|||
164692287|NCT00879684|594895394|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
164692288|NCT00879684|594895395|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
164692289|NCT00879684|594895396|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
164692290|NCT00879684|594895390|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
164692291|NCT00879684|594895391|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
164692292|NCT00879684|594895392|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
164692293|NCT00879684|594895393|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
164692294|NCT00879684|594895394|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
164692295|NCT00879684|594895395|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
164692296|NCT00879684|594895396|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
164692297|NCT00879684|594895390|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
164692298|NCT00879684|594895391|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
164692299|NCT00879684|594895392|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
164692300|NCT00879684|594895393|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
164692301|NCT00879684|594895394|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
164286503|NCT01463306|593418348|FG000|Overall Study|Withdrawal by Subject|19|||
164286504|NCT01463306|593418349|FG001|Overall Study|Withdrawal by Subject|9|||
164286505|NCT01463306|593418350|FG002|Overall Study|Withdrawal by Subject|1|||
164286506|NCT01463306|593418348|FG000|Overall Study|Other|26|||
164286507|NCT01463306|593418349|FG001|Overall Study|Other|13|||
164286508|NCT01463306|593418350|FG002|Overall Study|Other|0|||
164286509|NCT01463306|593418348|FG000|Overall Study|Approval expiry at site|1|||
164286510|NCT01463306|593418349|FG001|Overall Study|Approval expiry at site|0|||
164286511|NCT01463306|593418350|FG002|Overall Study|Approval expiry at site|0|||
164692302|NCT00879684|594895395|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
164692303|NCT00879684|594895396|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
164692304|NCT00708682|594895397|FG000|Infant Series|Adverse Event|1|||
164692305|NCT00708682|594895397|FG000|Infant Series|Lost to Follow-up|4|||
164286512|NCT00250276|593418354|FG000|Overall Study|Serious Adverse Event|0|||
164286513|NCT00250276|593418355|FG001|Overall Study|Serious Adverse Event|0|||
164286514|NCT00250276|593418356|FG002|Overall Study|Serious Adverse Event|1|||
164286515|NCT00250276|593418357|FG003|Overall Study|Serious Adverse Event|0|||
164286516|NCT00250276|593418354|FG000|Overall Study|Non-serious Adverse Event|2|||
164286517|NCT00250276|593418355|FG001|Overall Study|Non-serious Adverse Event|0|||
164286518|NCT00250276|593418356|FG002|Overall Study|Non-serious Adverse Event|0|||
164286519|NCT00250276|593418357|FG003|Overall Study|Non-serious Adverse Event|2|||
164286520|NCT00250276|593418354|FG000|Overall Study|Protocol Violation|0|||
164286521|NCT00250276|593418355|FG001|Overall Study|Protocol Violation|1|||
164286522|NCT00250276|593418356|FG002|Overall Study|Protocol Violation|0|||
164286523|NCT00250276|593418357|FG003|Overall Study|Protocol Violation|0|||
164286524|NCT00250276|593418354|FG000|Overall Study|Withdrawal by Subject|1|||
164286525|NCT00250276|593418355|FG001|Overall Study|Withdrawal by Subject|2|||
164286526|NCT00250276|593418356|FG002|Overall Study|Withdrawal by Subject|3|||
164286527|NCT00250276|593418357|FG003|Overall Study|Withdrawal by Subject|2|||
164286528|NCT00250276|593418354|FG000|Overall Study|Migrated/moved from study area|3|||
164286529|NCT00250276|593418355|FG001|Overall Study|Migrated/moved from study area|0|||
164692306|NCT00708682|594895397|FG000|Infant Series|Protocol Violation|1|||
164692307|NCT00708682|594895397|FG000|Infant Series|Parent/legal guardian request|6|||
164692308|NCT00708682|594895397|FG000|Infant Series|Failed to return|2|||
164692309|NCT00708682|594895397|FG000|Infant Series|Other|19|||
164286530|NCT00250276|593418356|FG002|Overall Study|Migrated/moved from study area|2|||
164286531|NCT00250276|593418357|FG003|Overall Study|Migrated/moved from study area|7|||
164692310|NCT00708682|594895397|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
164692311|NCT00708682|594895397|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
164692312|NCT00708682|594895397|FG000|Toddler Dose|Lost to Follow-up|3|||
164692313|NCT00708682|594895397|FG000|Toddler Dose|Failed to Return|4|||
164345090|NCT01964430|593638926|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
164345091|NCT01964430|593638927|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
164345092|NCT01964430|593638926|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
164345093|NCT01964430|593638927|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
164345094|NCT01964430|593638926|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
164345095|NCT01964430|593638927|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
164345096|NCT01964430|593638926|FG000|Treatment Period|Adverse Event|71|||
164345097|NCT01964430|593638927|FG001|Treatment Period|Adverse Event|37|||
164345098|NCT01964430|593638926|FG000|Treatment Period|Withdrawal by Subject|36|||
164345099|NCT01964430|593638927|FG001|Treatment Period|Withdrawal by Subject|27|||
164345100|NCT01964430|593638926|FG000|Treatment Period|Death|1|||
164345101|NCT01964430|593638927|FG001|Treatment Period|Death|3|||
164345102|NCT01964430|593638926|FG000|Treatment Period|Protocol Deviation|0|||
164345103|NCT01964430|593638927|FG001|Treatment Period|Protocol Deviation|1|||
164345104|NCT01964430|593638926|FG000|Treatment Period|Physician Decision|5|||
164345105|NCT01964430|593638927|FG001|Treatment Period|Physician Decision|4|||
164345106|NCT01964430|593638926|FG000|Treatment Period|Disease Relapse|28|||
164345107|NCT01964430|593638927|FG001|Treatment Period|Disease Relapse|38|||
164345108|NCT01964430|593638926|FG000|Treatment Period|Other reasons|1|||
164345109|NCT01964430|593638927|FG001|Treatment Period|Other reasons|3|||
164345110|NCT02591290|593638928|FG000|Overall Study|Withdrawal by Subject|2|||
164345111|NCT02571075|593638929|FG000|Overall Study|Lost to Follow-up|20|||
164345112|NCT02571075|593638930|FG001|Overall Study|Lost to Follow-up|24|||
164345113|NCT00913497|593638933|FG000|Overall Study|Adverse Event|1|||
164345114|NCT00913497|593638933|FG000|Overall Study|Withdrawal by Subject|2|||
164345115|NCT03190915|593638934|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
164345116|NCT03190915|593638934|FG000|Overall Study|Progressive Disease|3|||
164345117|NCT02021773|593638946|FG000|Overall Study|Adverse Event|1|||
164345118|NCT02021773|593638947|FG001|Overall Study|Adverse Event|4|||
164345119|NCT02021773|593638948|FG002|Overall Study|Adverse Event|3|||
164345120|NCT02021773|593638946|FG000|Overall Study|Lack of Efficacy|2|||
164345121|NCT02021773|593638947|FG001|Overall Study|Lack of Efficacy|2|||
164345122|NCT02021773|593638948|FG002|Overall Study|Lack of Efficacy|2|||
164345123|NCT02021773|593638946|FG000|Overall Study|Protocol Violation|2|||
164345124|NCT02021773|593638947|FG001|Overall Study|Protocol Violation|3|||
164345125|NCT02021773|593638948|FG002|Overall Study|Protocol Violation|1|||
164345126|NCT02021773|593638946|FG000|Overall Study|Withdrawal by Subject|3|||
164345127|NCT02021773|593638947|FG001|Overall Study|Withdrawal by Subject|4|||
164345128|NCT02021773|593638948|FG002|Overall Study|Withdrawal by Subject|5|||
164345129|NCT02021773|593638946|FG000|Overall Study|Lost to Follow-up|1|||
164345130|NCT02021773|593638947|FG001|Overall Study|Lost to Follow-up|3|||
164345131|NCT02021773|593638948|FG002|Overall Study|Lost to Follow-up|0|||
164345132|NCT02021773|593638946|FG000|Overall Study|Reason not specified|3|||
164345133|NCT02021773|593638947|FG001|Overall Study|Reason not specified|0|||
164345134|NCT02021773|593638948|FG002|Overall Study|Reason not specified|0|||
164345135|NCT00478231|593638952|FG000|Overall Study|Death|7|||
164345136|NCT00478231|593638952|FG000|Overall Study|Lack of Efficacy|47|||
164692314|NCT00239005|594895404|FG000|Overall Study|Adverse Event|6|||
164345137|NCT00478231|593638952|FG000|Overall Study|Lost to Follow-up|7|||
164345138|NCT00478231|593638952|FG000|Overall Study|Withdrawal by Subject|6|||
164345139|NCT00478231|593638952|FG000|Overall Study|Other|9|||
164286532|NCT00250276|593418354|FG000|Overall Study|Lost to Follow-up|11|||
164345140|NCT00478231|593638952|FG000|Overall Study|Adverse Event|5|||
164345141|NCT00478231|593638952|FG000|Overall Study|Randomized, not treated|3|||
164345142|NCT00191139|593638955|FG000|Overall Study|Adverse Event|2|||
164692315|NCT00239005|594895405|FG001|Overall Study|Adverse Event|6|||
164692316|NCT00239005|594895404|FG000|Overall Study|Withdrawal by Subject|3|||
164692317|NCT00239005|594895405|FG001|Overall Study|Withdrawal by Subject|4|||
164692318|NCT00239005|594895404|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
164692319|NCT00239005|594895405|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
164692320|NCT00239005|594895404|FG000|Overall Study|Protocol Violation|1|||
164692321|NCT00239005|594895405|FG001|Overall Study|Protocol Violation|0|||
164692322|NCT00239005|594895404|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
164692323|NCT00239005|594895405|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
164692324|NCT00239005|594895404|FG000|Overall Study|Lost to Follow-up|0|||
164692325|NCT00239005|594895405|FG001|Overall Study|Lost to Follow-up|1|||
164692326|NCT00987831|594895407|FG000|Overall Study|Never flared in 12 months|1|||
164692327|NCT00987831|594895408|FG001|Overall Study|Never flared in 12 months|0|||
164692328|NCT00987831|594895409|FG002|Overall Study|Never flared in 12 months|0|||
164692329|NCT00987831|594895407|FG000|Overall Study|Lost to Follow-up|0|||
164692330|NCT00987831|594895408|FG001|Overall Study|Lost to Follow-up|3|||
164692331|NCT00987831|594895409|FG002|Overall Study|Lost to Follow-up|0|||
164692332|NCT03253094|594895410|FG000|Overall Study|Adverse Event|2|||
164692333|NCT03253094|594895411|FG001|Overall Study|Adverse Event|0|||
164692334|NCT03253094|594895412|FG002|Overall Study|Adverse Event|0|||
164692335|NCT03253094|594895413|FG003|Overall Study|Adverse Event|0|||
164692336|NCT03253094|594895414|FG004|Overall Study|Adverse Event|0|||
164692337|NCT03253094|594895415|FG005|Overall Study|Adverse Event|0|||
164692338|NCT03253094|594895410|FG000|Overall Study|Lack of Efficacy|0|||
164692339|NCT03253094|594895411|FG001|Overall Study|Lack of Efficacy|0|||
164692340|NCT03253094|594895412|FG002|Overall Study|Lack of Efficacy|2|||
164692341|NCT03253094|594895413|FG003|Overall Study|Lack of Efficacy|1|||
164692342|NCT03253094|594895414|FG004|Overall Study|Lack of Efficacy|2|||
164692343|NCT03253094|594895415|FG005|Overall Study|Lack of Efficacy|1|||
164692344|NCT03253094|594895410|FG000|Overall Study|Lost to Follow-up|0|||
164692345|NCT03253094|594895411|FG001|Overall Study|Lost to Follow-up|0|||
164692346|NCT03253094|594895412|FG002|Overall Study|Lost to Follow-up|1|||
164692347|NCT03253094|594895413|FG003|Overall Study|Lost to Follow-up|1|||
164692348|NCT03253094|594895414|FG004|Overall Study|Lost to Follow-up|0|||
164692349|NCT03253094|594895415|FG005|Overall Study|Lost to Follow-up|1|||
164692350|NCT03253094|594895410|FG000|Overall Study|Physician Decision|1|||
164692351|NCT03253094|594895411|FG001|Overall Study|Physician Decision|0|||
164692352|NCT03253094|594895412|FG002|Overall Study|Physician Decision|0|||
164692353|NCT03253094|594895413|FG003|Overall Study|Physician Decision|1|||
164692354|NCT03253094|594895414|FG004|Overall Study|Physician Decision|0|||
164692355|NCT03253094|594895415|FG005|Overall Study|Physician Decision|2|||
164692356|NCT03253094|594895410|FG000|Overall Study|Withdrawal by Subject|1|||
164692357|NCT03253094|594895411|FG001|Overall Study|Withdrawal by Subject|2|||
164692358|NCT03253094|594895412|FG002|Overall Study|Withdrawal by Subject|1|||
164692359|NCT03253094|594895413|FG003|Overall Study|Withdrawal by Subject|0|||
164692360|NCT03253094|594895414|FG004|Overall Study|Withdrawal by Subject|3|||
164692361|NCT03253094|594895415|FG005|Overall Study|Withdrawal by Subject|0|||
164692362|NCT03253094|594895410|FG000|Overall Study|Other|0|||
164692363|NCT03253094|594895411|FG001|Overall Study|Other|1|||
164692364|NCT03253094|594895412|FG002|Overall Study|Other|2|||
164692365|NCT03253094|594895413|FG003|Overall Study|Other|1|||
164692366|NCT03253094|594895414|FG004|Overall Study|Other|0|||
164692367|NCT03253094|594895415|FG005|Overall Study|Other|0|||
164692368|NCT00824369|594895416|FG000|Overall Study|Nolonger willing to participate in study|1|||
164692369|NCT00824369|594895417|FG001|Overall Study|Nolonger willing to participate in study|0|||
164692370|NCT00824369|594895418|FG002|Overall Study|Nolonger willing to participate in study|1|||
164692371|NCT00824369|594895419|FG003|Overall Study|Nolonger willing to participate in study|2|||
164692372|NCT00824369|594895420|FG004|Overall Study|Nolonger willing to participate in study|0|||
164692373|NCT00824369|594895421|FG005|Overall Study|Nolonger willing to participate in study|1|||
164692374|NCT00824369|594895416|FG000|Overall Study|Lost to Follow-up|0|||
164692375|NCT00824369|594895417|FG001|Overall Study|Lost to Follow-up|0|||
164692376|NCT00824369|594895418|FG002|Overall Study|Lost to Follow-up|0|||
164345143|NCT00191139|593638956|FG001|Overall Study|Adverse Event|6|||
164345144|NCT00191139|593638955|FG000|Overall Study|Death|2|||
164345145|NCT00191139|593638956|FG001|Overall Study|Death|0|||
164345146|NCT00191139|593638955|FG000|Overall Study|Withdrawal by Subject|0|||
164345147|NCT00191139|593638956|FG001|Overall Study|Withdrawal by Subject|3|||
164345148|NCT00191139|593638955|FG000|Overall Study|Disease Progression|0|||
164345149|NCT00191139|593638956|FG001|Overall Study|Disease Progression|1|||
164692377|NCT00824369|594895419|FG003|Overall Study|Lost to Follow-up|0|||
164692378|NCT00824369|594895420|FG004|Overall Study|Lost to Follow-up|1|||
164692379|NCT00824369|594895421|FG005|Overall Study|Lost to Follow-up|0|||
164692380|NCT02413294|594895422|FG000|Overall Study|Withdrawal by Subject|1|||
164692381|NCT02625974|594895423|FG000|Part 1|Lost to Follow-up|9|||
164692382|NCT02625974|594895424|FG001|Part 1|Lost to Follow-up|3|||
164692383|NCT02625974|594895423|FG000|Part 2|Lost to Follow-up|4|||
164345150|NCT00191139|593638955|FG000|Overall Study|Other|1|||
164692384|NCT02625974|594895424|FG001|Part 2|Lost to Follow-up|6|||
164692385|NCT02625974|594895423|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
164692386|NCT02625974|594895424|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
164692387|NCT03941834|594896929|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
164692388|NCT03941834|594896930|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
164692389|NCT03941834|594896931|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
164692390|NCT03941834|594896929|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
164692391|NCT03941834|594896930|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
164692392|NCT03941834|594896931|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
164692393|NCT03941834|594896929|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
164692394|NCT03941834|594896930|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
164692395|NCT03941834|594896931|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
164692396|NCT03941834|594896929|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
164692397|NCT03941834|594896930|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
164692398|NCT03941834|594896931|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
164692399|NCT03941834|594896929|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
164286533|NCT00250276|593418355|FG001|Overall Study|Lost to Follow-up|18|||
164286534|NCT00250276|593418356|FG002|Overall Study|Lost to Follow-up|13|||
164286535|NCT00250276|593418357|FG003|Overall Study|Lost to Follow-up|8|||
164286536|NCT00983385|593418363|FG000|Observation Period|Not eligible to be dosed|20|||
164286537|NCT00983385|593418363|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
164286538|NCT00163020|593418364|FG000|Overall Study|Lost to Follow-up|0|||
164286539|NCT00163020|593418365|FG001|Overall Study|Lost to Follow-up|2|||
164286540|NCT00985673|593420666|FG000|Overall Study|Lost to Follow-up|6|||
164286541|NCT00985673|593420667|FG001|Overall Study|Lost to Follow-up|7|||
164286542|NCT00985673|593420668|FG002|Overall Study|Lost to Follow-up|6|||
164286543|NCT00985673|593420669|FG003|Overall Study|Lost to Follow-up|10|||
164286544|NCT00985673|593420670|FG004|Overall Study|Lost to Follow-up|5|||
164286545|NCT00985673|593420671|FG005|Overall Study|Lost to Follow-up|3|||
164286546|NCT00985673|593420666|FG000|Overall Study|Withdrawal by Subject|0|||
164286547|NCT00985673|593420667|FG001|Overall Study|Withdrawal by Subject|4|||
164286548|NCT00985673|593420668|FG002|Overall Study|Withdrawal by Subject|5|||
164286549|NCT00985673|593420669|FG003|Overall Study|Withdrawal by Subject|2|||
164286550|NCT00985673|593420670|FG004|Overall Study|Withdrawal by Subject|2|||
164286551|NCT00985673|593420671|FG005|Overall Study|Withdrawal by Subject|3|||
164286552|NCT00985673|593420666|FG000|Overall Study|Other|1|||
164286553|NCT00985673|593420667|FG001|Overall Study|Other|0|||
164286554|NCT00985673|593420668|FG002|Overall Study|Other|1|||
164286555|NCT00985673|593420669|FG003|Overall Study|Other|0|||
164692400|NCT03941834|594896930|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
164692401|NCT03941834|594896931|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
164692402|NCT03941834|594896929|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
164692403|NCT03941834|594896930|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
164692404|NCT03941834|594896931|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
164692405|NCT00802178|594896934|FG000|Overall Study|Lack of Efficacy|36|||
164692406|NCT00802178|594896934|FG000|Overall Study|Insufficient tolerability (IT)|17|||
164692407|NCT00802178|594896934|FG000|Overall Study|Withdrawal by Subject|18|||
164692408|NCT00802178|594896934|FG000|Overall Study|Other|32|||
164692409|NCT00802178|594896934|FG000|Overall Study|Lack of efficacy and patient wish|1|||
164692410|NCT00802178|594896934|FG000|Overall Study|IT and patient wish|8|||
164692411|NCT00802178|594896934|FG000|Overall Study|Patients wish and other reason|1|||
164692412|NCT01606228|594896935|FG000|Overall Study|Lost to Follow-up|20|||
164692413|NCT01606228|594896935|FG000|Overall Study|Withdrawal by Subject|3|||
164692414|NCT01606228|594896935|FG000|Overall Study|Non-compliant|3|||
164692415|NCT01606228|594896935|FG000|Overall Study|Lack of Efficacy|2|||
164692416|NCT01606228|594896935|FG000|Overall Study|Adverse Event|1|||
164692417|NCT01115855|594896936|FG000|Overall Study|Adverse Event|16|||
164692418|NCT01115855|594896937|FG001|Overall Study|Adverse Event|18|||
164692419|NCT01115855|594896936|FG000|Overall Study|Death|6|||
164692420|NCT01115855|594896937|FG001|Overall Study|Death|5|||
164692421|NCT01115855|594896936|FG000|Overall Study|Lab Abnormality|1|||
164692422|NCT01115855|594896937|FG001|Overall Study|Lab Abnormality|1|||
164692423|NCT01115855|594896936|FG000|Overall Study|Protocol Violation|0|||
164692424|NCT01115855|594896937|FG001|Overall Study|Protocol Violation|1|||
164692425|NCT01115855|594896936|FG000|Overall Study|Withdrawal by Subject|5|||
164692426|NCT01115855|594896937|FG001|Overall Study|Withdrawal by Subject|5|||
164692427|NCT01115855|594896936|FG000|Overall Study|Other|8|||
164692428|NCT01115855|594896937|FG001|Overall Study|Other|6|||
164286556|NCT00985673|593420670|FG004|Overall Study|Other|1|||
164286557|NCT00985673|593420671|FG005|Overall Study|Other|0|||
164286558|NCT02252146|593420672|FG000|Overall Study|Lack of Efficacy|4|||
164286559|NCT02252146|593420672|FG000|Overall Study|Entered hospice care|1|||
164286560|NCT02252146|593420672|FG000|Overall Study|Inability to travel to study site|1|||
164286561|NCT00531284|593420673|FG000|Overall Study|Progressive Disease|1|||
164286562|NCT00531284|593420674|FG001|Overall Study|Progressive Disease|3|||
164692429|NCT04100096|594896938|FG000|Overall Study|Adverse Event|19|||
164692430|NCT04100096|594896939|FG001|Overall Study|Adverse Event|7|||
164286563|NCT00531284|593420675|FG002|Overall Study|Progressive Disease|5|||
164692431|NCT04100096|594896938|FG000|Overall Study|Lack of Efficacy|0|||
164692432|NCT04100096|594896939|FG001|Overall Study|Lack of Efficacy|1|||
164692433|NCT04100096|594896938|FG000|Overall Study|Lost to Follow-up|13|||
164692434|NCT04100096|594896939|FG001|Overall Study|Lost to Follow-up|11|||
164692435|NCT04100096|594896938|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164692436|NCT04100096|594896939|FG001|Overall Study|Non-Compliance With Study Drug|3|||
164692437|NCT04100096|594896938|FG000|Overall Study|Protocol Deviation|1|||
164692438|NCT04100096|594896939|FG001|Overall Study|Protocol Deviation|1|||
164692439|NCT04100096|594896938|FG000|Overall Study|Withdrawal by Participant|13|||
164692440|NCT04100096|594896939|FG001|Overall Study|Withdrawal by Participant|15|||
164692441|NCT01684215|594896940|FG000|Phase 1, Part 1|Adverse Event|1|||
164692442|NCT01684215|594896941|FG001|Phase 1, Part 1|Adverse Event|0|||
164286564|NCT00531284|593420676|FG003|Overall Study|Progressive Disease|42|||
164286565|NCT00531284|593420677|FG004|Overall Study|Progressive Disease|4|||
164286566|NCT00531284|593420678|FG005|Overall Study|Progressive Disease|4|||
164286567|NCT00531284|593420679|FG006|Overall Study|Progressive Disease|3|||
164286568|NCT00531284|593420680|FG007|Overall Study|Progressive Disease|8|||
164286569|NCT00531284|593420681|FG008|Overall Study|Progressive Disease|6|||
164286570|NCT00531284|593420682|FG009|Overall Study|Progressive Disease|3|||
164286571|NCT00531284|593420683|FG010|Overall Study|Progressive Disease|3|||
164286572|NCT00531284|593420684|FG011|Overall Study|Progressive Disease|14|||
164286573|NCT00531284|593420685|FG012|Overall Study|Progressive Disease|2|||
164286574|NCT00531284|593420686|FG013|Overall Study|Progressive Disease|1|||
164286575|NCT00531284|593420687|FG014|Overall Study|Progressive Disease|2|||
164286576|NCT00531284|593420688|FG015|Overall Study|Progressive Disease|11|||
164286577|NCT00531284|593420689|FG016|Overall Study|Progressive Disease|5|||
164286578|NCT00531284|593420673|FG000|Overall Study|Adverse Event|0|||
164286579|NCT00531284|593420674|FG001|Overall Study|Adverse Event|1|||
164286580|NCT00531284|593420675|FG002|Overall Study|Adverse Event|1|||
164286581|NCT00531284|593420676|FG003|Overall Study|Adverse Event|7|||
164286582|NCT00531284|593420677|FG004|Overall Study|Adverse Event|0|||
164286583|NCT00531284|593420678|FG005|Overall Study|Adverse Event|2|||
164286584|NCT00531284|593420679|FG006|Overall Study|Adverse Event|3|||
164286585|NCT00531284|593420680|FG007|Overall Study|Adverse Event|2|||
164286586|NCT00531284|593420681|FG008|Overall Study|Adverse Event|3|||
164286587|NCT00531284|593420682|FG009|Overall Study|Adverse Event|0|||
164286588|NCT00531284|593420683|FG010|Overall Study|Adverse Event|0|||
164286589|NCT00531284|593420684|FG011|Overall Study|Adverse Event|5|||
164286590|NCT00531284|593420685|FG012|Overall Study|Adverse Event|0|||
164286591|NCT00531284|593420686|FG013|Overall Study|Adverse Event|1|||
164286592|NCT00531284|593420687|FG014|Overall Study|Adverse Event|1|||
164286593|NCT00531284|593420688|FG015|Overall Study|Adverse Event|0|||
164286594|NCT00531284|593420689|FG016|Overall Study|Adverse Event|2|||
164286595|NCT00531284|593420673|FG000|Overall Study|Withdrawal by Subject|1|||
164286596|NCT00531284|593420674|FG001|Overall Study|Withdrawal by Subject|0|||
164286597|NCT00531284|593420675|FG002|Overall Study|Withdrawal by Subject|0|||
164286598|NCT00531284|593420676|FG003|Overall Study|Withdrawal by Subject|4|||
164286599|NCT00531284|593420677|FG004|Overall Study|Withdrawal by Subject|0|||
164286600|NCT00531284|593420678|FG005|Overall Study|Withdrawal by Subject|0|||
164286601|NCT00531284|593420679|FG006|Overall Study|Withdrawal by Subject|0|||
164286602|NCT00531284|593420680|FG007|Overall Study|Withdrawal by Subject|0|||
164286603|NCT00531284|593420681|FG008|Overall Study|Withdrawal by Subject|0|||
164286604|NCT00531284|593420682|FG009|Overall Study|Withdrawal by Subject|0|||
164286605|NCT00531284|593420683|FG010|Overall Study|Withdrawal by Subject|0|||
164286606|NCT00531284|593420684|FG011|Overall Study|Withdrawal by Subject|3|||
164286607|NCT00531284|593420685|FG012|Overall Study|Withdrawal by Subject|0|||
164286608|NCT00531284|593420686|FG013|Overall Study|Withdrawal by Subject|1|||
164286609|NCT00531284|593420687|FG014|Overall Study|Withdrawal by Subject|0|||
164286610|NCT00531284|593420688|FG015|Overall Study|Withdrawal by Subject|1|||
164286611|NCT00531284|593420689|FG016|Overall Study|Withdrawal by Subject|1|||
164692443|NCT01684215|594896942|FG002|Phase 1, Part 1|Adverse Event|0|||
164692444|NCT01684215|594896943|FG003|Phase 1, Part 1|Adverse Event|0|||
164692445|NCT01684215|594896940|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
164692446|NCT01684215|594896941|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
164692447|NCT01684215|594896942|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
164286612|NCT00531284|593420673|FG000|Overall Study|Other|1|||
164286613|NCT00531284|593420674|FG001|Overall Study|Other|0|||
164286614|NCT00531284|593420675|FG002|Overall Study|Other|0|||
164692448|NCT01684215|594896943|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
164692449|NCT01684215|594896940|FG000|Phase 1, Part 2|Adverse Event|0|||
164286615|NCT00531284|593420676|FG003|Overall Study|Other|10|||
164286616|NCT00531284|593420677|FG004|Overall Study|Other|2|||
164286617|NCT00531284|593420678|FG005|Overall Study|Other|1|||
164286618|NCT00531284|593420679|FG006|Overall Study|Other|0|||
164286619|NCT00531284|593420680|FG007|Overall Study|Other|0|||
164286620|NCT00531284|593420681|FG008|Overall Study|Other|2|||
164286621|NCT00531284|593420682|FG009|Overall Study|Other|1|||
164286622|NCT00531284|593420683|FG010|Overall Study|Other|0|||
164286623|NCT00531284|593420684|FG011|Overall Study|Other|2|||
164286624|NCT00531284|593420685|FG012|Overall Study|Other|0|||
164692450|NCT01684215|594896941|FG001|Phase 1, Part 2|Adverse Event|0|||
164692451|NCT01684215|594896942|FG002|Phase 1, Part 2|Adverse Event|1|||
164286625|NCT00531284|593420686|FG013|Overall Study|Other|0|||
164286626|NCT00531284|593420687|FG014|Overall Study|Other|1|||
164692452|NCT01684215|594896943|FG003|Phase 1, Part 2|Adverse Event|0|||
164692453|NCT01684215|594896940|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
164692454|NCT01684215|594896941|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
164692455|NCT01684215|594896942|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
164692456|NCT01684215|594896943|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
164692457|NCT01684215|594896940|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
164692458|NCT01684215|594896941|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
164692459|NCT01684215|594896942|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
164692460|NCT01684215|594896943|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
164692461|NCT01684215|594896940|FG000|Phase 2|Death|0|||
164692462|NCT01684215|594896941|FG001|Phase 2|Death|0|||
164692463|NCT01684215|594896942|FG002|Phase 2|Death|0|||
164692464|NCT01684215|594896943|FG003|Phase 2|Death|8|||
164692465|NCT01684215|594896940|FG000|Phase 2|Study terminated by sponsor|0|||
164692466|NCT01684215|594896941|FG001|Phase 2|Study terminated by sponsor|0|||
164692467|NCT01684215|594896942|FG002|Phase 2|Study terminated by sponsor|0|||
164692468|NCT01684215|594896943|FG003|Phase 2|Study terminated by sponsor|30|||
164692469|NCT01684215|594896940|FG000|Phase 2|Enrolled but not treated|0|||
164692470|NCT01684215|594896941|FG001|Phase 2|Enrolled but not treated|0|||
164286627|NCT00531284|593420688|FG015|Overall Study|Other|0|||
164286628|NCT00531284|593420689|FG016|Overall Study|Other|0|||
164286629|NCT03057496|593420690|FG000|Overall Study|Withdrawal by Subject|8|||
164692471|NCT01684215|594896942|FG002|Phase 2|Enrolled but not treated|0|||
164692472|NCT01684215|594896943|FG003|Phase 2|Enrolled but not treated|1|||
164692473|NCT01684215|594896940|FG000|Phase 2|Lost to Follow-up|0|||
164286630|NCT03057496|593420690|FG000|Overall Study|Lost to Follow-up|5|||
164692474|NCT01684215|594896941|FG001|Phase 2|Lost to Follow-up|0|||
164286631|NCT03057496|593420690|FG000|Overall Study|Did not use device during home trial|3|||
164286632|NCT03057496|593420690|FG000|Overall Study|Device failure|2|||
164286633|NCT00280917|593420691|FG000|Overall Study|Adverse Event|1|||
164286634|NCT00280917|593420692|FG001|Overall Study|Adverse Event|1|||
164286635|NCT00280917|593420693|FG002|Overall Study|Adverse Event|4|||
164286636|NCT00280917|593420694|FG003|Overall Study|Adverse Event|1|||
164286637|NCT00280917|593420691|FG000|Overall Study|Change Therapy|1|||
164286638|NCT00280917|593420692|FG001|Overall Study|Change Therapy|2|||
164286639|NCT00280917|593420693|FG002|Overall Study|Change Therapy|0|||
164286640|NCT00280917|593420694|FG003|Overall Study|Change Therapy|0|||
164286641|NCT00280917|593420691|FG000|Overall Study|Withdrawal by Subject|0|||
164286642|NCT00280917|593420692|FG001|Overall Study|Withdrawal by Subject|2|||
164286643|NCT00280917|593420693|FG002|Overall Study|Withdrawal by Subject|0|||
164286644|NCT00280917|593420694|FG003|Overall Study|Withdrawal by Subject|1|||
164286645|NCT00280917|593420691|FG000|Overall Study|Noncompliance|0|||
164286646|NCT00280917|593420692|FG001|Overall Study|Noncompliance|1|||
164286647|NCT00280917|593420693|FG002|Overall Study|Noncompliance|2|||
164286648|NCT00280917|593420694|FG003|Overall Study|Noncompliance|0|||
164286649|NCT00997035|593420700|FG000|3-week Followup Visit|Lost to Follow-up|9|||
164286650|NCT00997035|593420701|FG001|3-week Followup Visit|Lost to Follow-up|6|||
164286651|NCT00997035|593420700|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
164286652|NCT00997035|593420701|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
164286653|NCT02471014|593420702|FG000|Overall Study|Lost to Follow-up|2|||
164286654|NCT02471014|593420703|FG001|Overall Study|Lost to Follow-up|2|||
164286655|NCT02222558|593420711|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
164286656|NCT02222558|593420712|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
164345151|NCT00191139|593638956|FG001|Overall Study|Other|2|||
164345152|NCT01817530|593638957|FG000|Overall Study|Exclusionary Medication Received|0|||
164692475|NCT01684215|594896942|FG002|Phase 2|Lost to Follow-up|0|||
164692476|NCT01684215|594896943|FG003|Phase 2|Lost to Follow-up|4|||
164692477|NCT00784134|594896944|FG000|Overall Study|Lost to Follow-up|3|||
164286657|NCT02222558|593420713|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
164286658|NCT02222558|593420714|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
164286659|NCT02222558|593420715|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
164286660|NCT02222558|593420716|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
164286661|NCT02222558|593420711|FG000|Period 3|Withdrawal by Subject|0|||
164286662|NCT02222558|593420712|FG001|Period 3|Withdrawal by Subject|0|||
164345153|NCT01817530|593638958|FG001|Overall Study|Exclusionary Medication Received|0|||
164286663|NCT02222558|593420713|FG002|Period 3|Withdrawal by Subject|0|||
164286664|NCT02222558|593420714|FG003|Period 3|Withdrawal by Subject|0|||
164345154|NCT01817530|593638959|FG002|Overall Study|Exclusionary Medication Received|0|||
164692478|NCT00784134|594896945|FG001|Overall Study|Lost to Follow-up|6|||
164692479|NCT03785145|594896946|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
164692480|NCT03785145|594896947|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
164692481|NCT03785145|594896946|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
164692482|NCT03785145|594896947|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
164286665|NCT02222558|593420715|FG004|Period 3|Withdrawal by Subject|0|||
164286666|NCT02222558|593420716|FG005|Period 3|Withdrawal by Subject|1|||
164286667|NCT02532465|593420717|FG000|Overall Study|Protocol Violation|1|||
164286668|NCT02532465|593420718|FG001|Overall Study|Protocol Violation|0|||
164286669|NCT02532465|593420717|FG000|Overall Study|Lack of Efficacy|0|||
164286670|NCT02532465|593420718|FG001|Overall Study|Lack of Efficacy|1|||
164286671|NCT00354679|593420723|FG000|Overall Study|Patient Not Treated|1|||
164286672|NCT03456076|593420724|FG000|Overall Study|Withdrawal by Subject|5|||
164286673|NCT03456076|593420725|FG001|Overall Study|Withdrawal by Subject|9|||
164286674|NCT03456076|593420724|FG000|Overall Study|Protocol deviation|0|||
164286675|NCT03456076|593420725|FG001|Overall Study|Protocol deviation|1|||
164586667|NCT00532259|594511881|FG000|Overall Study|Protocol Violation|1|||
164586668|NCT00871858|594511882|FG000|Overall Study|Protocol Violation|3|||
164286676|NCT03456076|593420724|FG000|Overall Study|Lost to Follow-up|0|||
164286677|NCT03456076|593420725|FG001|Overall Study|Lost to Follow-up|1|||
164286678|NCT03456076|593420724|FG000|Overall Study|Death|2|||
164286679|NCT03456076|593420725|FG001|Overall Study|Death|5|||
164286680|NCT03456076|593420724|FG000|Overall Study|Study ongoing|123|||
164286681|NCT03456076|593420725|FG001|Overall Study|Study ongoing|111|||
164286682|NCT03187132|593420731|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
164286683|NCT03187132|593420732|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
164286684|NCT03187132|593420731|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
164286685|NCT03187132|593420732|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
164286686|NCT03187132|593420731|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
164286687|NCT03187132|593420732|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
164286688|NCT03187132|593420731|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
164286689|NCT03187132|593420732|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
164586669|NCT00871858|594511883|FG001|Overall Study|Protocol Violation|4|||
164586670|NCT00871858|594511882|FG000|Overall Study|Adverse Event|1|||
164586671|NCT00871858|594511883|FG001|Overall Study|Adverse Event|1|||
164586672|NCT00871858|594511882|FG000|Overall Study|Withdrawal by Subject|1|||
164586673|NCT00871858|594511883|FG001|Overall Study|Withdrawal by Subject|1|||
164586674|NCT00871858|594511882|FG000|Overall Study|Lost to Follow-up|0|||
164586675|NCT00871858|594511883|FG001|Overall Study|Lost to Follow-up|1|||
164586676|NCT02795767|594511888|FG000|Overall Study|Received Commercial Emicizumab|1|||
164586677|NCT02795767|594511889|FG001|Overall Study|Received Commercial Emicizumab|0|||
164586678|NCT02795767|594511890|FG002|Overall Study|Received Commercial Emicizumab|0|||
164586679|NCT04983940|594511891|FG000|Overall Study|Lost to Follow-up|14|||
164586680|NCT04983940|594511891|FG000|Overall Study|Lack of Efficacy|2|||
164586681|NCT01004146|594511898|FG000|Overall Study|Withdrawal by Subject|4|||
164586682|NCT01004146|594511899|FG001|Overall Study|Withdrawal by Subject|5|||
164586683|NCT01855789|594511910|FG000|1) Baseline up to Week 24|Adverse Event|37|||
164586684|NCT01855789|594511911|FG001|1) Baseline up to Week 24|Adverse Event|0|||
164586685|NCT01855789|594511912|FG002|1) Baseline up to Week 24|Adverse Event|0|||
164586686|NCT01855789|594511913|FG003|1) Baseline up to Week 24|Adverse Event|0|||
164586687|NCT01855789|594511910|FG000|1) Baseline up to Week 24|Death|2|||
164586688|NCT01855789|594511911|FG001|1) Baseline up to Week 24|Death|0|||
164586689|NCT01855789|594511912|FG002|1) Baseline up to Week 24|Death|0|||
164586690|NCT01855789|594511913|FG003|1) Baseline up to Week 24|Death|0|||
164586691|NCT01855789|594511910|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
164586692|NCT01855789|594511911|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
164586693|NCT01855789|594511912|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
164586694|NCT01855789|594511913|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
164586695|NCT01855789|594511910|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
164586696|NCT01855789|594511911|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
164586697|NCT01855789|594511912|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
164586698|NCT01855789|594511913|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
164586699|NCT01855789|594511910|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
164586700|NCT01855789|594511911|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
164586701|NCT01855789|594511912|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
164586702|NCT01855789|594511913|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
164586703|NCT01855789|594511910|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
164586704|NCT01855789|594511911|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
164586705|NCT01855789|594511912|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
164586706|NCT01855789|594511913|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
164586707|NCT01855789|594511910|FG000|1) Baseline up to Week 24|Physician Decision|4|||
164586708|NCT01855789|594511911|FG001|1) Baseline up to Week 24|Physician Decision|0|||
164586709|NCT01855789|594511912|FG002|1) Baseline up to Week 24|Physician Decision|0|||
164586710|NCT01855789|594511913|FG003|1) Baseline up to Week 24|Physician Decision|0|||
164586711|NCT01855789|594511910|FG000|1) Baseline up to Week 24|Pregnancy|1|||
164586712|NCT01855789|594511911|FG001|1) Baseline up to Week 24|Pregnancy|0|||
164286690|NCT03187132|593420731|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
164586713|NCT01855789|594511912|FG002|1) Baseline up to Week 24|Pregnancy|0|||
164586714|NCT01855789|594511913|FG003|1) Baseline up to Week 24|Pregnancy|0|||
164586715|NCT01855789|594511910|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
164286691|NCT03187132|593420732|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
164286692|NCT03187132|593420731|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
164286693|NCT03187132|593420732|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
164286694|NCT03187132|593420731|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
164286695|NCT03187132|593420732|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
164286696|NCT03187132|593420731|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
164286697|NCT03187132|593420732|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
164286698|NCT03187132|593420731|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
164286699|NCT03187132|593420732|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
164286700|NCT03187132|593420731|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
164286701|NCT03187132|593420732|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
164286702|NCT03187132|593420731|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
164286703|NCT03187132|593420732|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
164286704|NCT02045095|593420733|FG000|Overall Study|Other|0|||
164286705|NCT02045095|593420734|FG001|Overall Study|Other|0|||
164286706|NCT02045095|593420735|FG002|Overall Study|Other|1|||
164286707|NCT02045095|593420736|FG003|Overall Study|Other|0|||
164286708|NCT02045095|593420737|FG004|Overall Study|Other|0|||
164286709|NCT02045095|593420738|FG005|Overall Study|Other|2|||
164286710|NCT02045095|593420739|FG006|Overall Study|Other|0|||
164286711|NCT02045095|593420733|FG000|Overall Study|Progressive Disease|3|||
164286712|NCT02045095|593420734|FG001|Overall Study|Progressive Disease|3|||
164286713|NCT02045095|593420735|FG002|Overall Study|Progressive Disease|2|||
164286714|NCT02045095|593420736|FG003|Overall Study|Progressive Disease|4|||
164286715|NCT02045095|593420737|FG004|Overall Study|Progressive Disease|2|||
164286716|NCT02045095|593420738|FG005|Overall Study|Progressive Disease|4|||
164286717|NCT02045095|593420739|FG006|Overall Study|Progressive Disease|1|||
164286718|NCT02045095|593420733|FG000|Overall Study|Withdrawal by Subject|0|||
164286719|NCT02045095|593420734|FG001|Overall Study|Withdrawal by Subject|0|||
164286720|NCT02045095|593420735|FG002|Overall Study|Withdrawal by Subject|0|||
164286721|NCT02045095|593420736|FG003|Overall Study|Withdrawal by Subject|0|||
164286722|NCT02045095|593420737|FG004|Overall Study|Withdrawal by Subject|3|||
164286723|NCT02045095|593420738|FG005|Overall Study|Withdrawal by Subject|0|||
164692483|NCT03785145|594896946|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
164692484|NCT03785145|594896947|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
164692485|NCT03785145|594896946|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
164692486|NCT03785145|594896947|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
164692487|NCT03785145|594896946|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
164692488|NCT03785145|594896947|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
164692489|NCT03785145|594896946|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
164692490|NCT03785145|594896947|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
164692491|NCT03785145|594896946|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
164692492|NCT03785145|594896947|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
164692493|NCT03785145|594896946|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
164692494|NCT03785145|594896947|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
164692495|NCT03785145|594896946|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
164692496|NCT03785145|594896947|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
164692497|NCT03785145|594896946|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
164286724|NCT02045095|593420739|FG006|Overall Study|Withdrawal by Subject|0|||
164286725|NCT02045095|593420733|FG000|Overall Study|Adverse Event|0|||
164286726|NCT02045095|593420734|FG001|Overall Study|Adverse Event|1|||
164286727|NCT02045095|593420735|FG002|Overall Study|Adverse Event|1|||
164286728|NCT02045095|593420736|FG003|Overall Study|Adverse Event|0|||
164286729|NCT02045095|593420737|FG004|Overall Study|Adverse Event|0|||
164286730|NCT02045095|593420738|FG005|Overall Study|Adverse Event|2|||
164286731|NCT02045095|593420739|FG006|Overall Study|Adverse Event|0|||
164286732|NCT02525588|593420740|FG000|Overall Study|Death|3|||
164286733|NCT02525588|593420741|FG001|Overall Study|Death|1|||
164286734|NCT02525588|593420740|FG000|Overall Study|Lost to Follow-up|2|||
164286735|NCT02525588|593420741|FG001|Overall Study|Lost to Follow-up|0|||
164286736|NCT02525588|593420740|FG000|Overall Study|Withdrawal by Subject|1|||
164286737|NCT02525588|593420741|FG001|Overall Study|Withdrawal by Subject|1|||
164286738|NCT02525588|593420740|FG000|Overall Study|Adverse Event|0|||
164286739|NCT02525588|593420741|FG001|Overall Study|Adverse Event|1|||
164286740|NCT00714415|593420751|FG000|Overall Study|Lack of Efficacy|1|||
164286741|NCT00714415|593420752|FG001|Overall Study|Lack of Efficacy|0|||
164286742|NCT00714415|593420751|FG000|Overall Study|Death|1|||
164286743|NCT00714415|593420752|FG001|Overall Study|Death|0|||
164286744|NCT01450761|593420755|FG000|Randomization|Subject no longer meets study criteria|1|||
164286745|NCT01450761|593420756|FG001|Randomization|Subject no longer meets study criteria|2|||
164286746|NCT01450761|593420755|FG000|Randomization|Withdrawal by Subject|2|||
164286747|NCT01450761|593420756|FG001|Randomization|Withdrawal by Subject|0|||
164286748|NCT01450761|593420755|FG000|Randomization|Disease progression|0|||
164286749|NCT01450761|593420756|FG001|Randomization|Disease progression|2|||
164286750|NCT01450761|593420755|FG000|Randomization|Adverse Event unrelated to study drug|1|||
164286751|NCT01450761|593420756|FG001|Randomization|Adverse Event unrelated to study drug|0|||
164286752|NCT01450761|593420755|FG000|Randomization|Other|0|||
164286753|NCT01450761|593420756|FG001|Randomization|Other|1|||
164286754|NCT01450761|593420755|FG000|Lead-in Chemotherapy|Disease progression|33|||
164286755|NCT01450761|593420756|FG001|Lead-in Chemotherapy|Disease progression|32|||
164286756|NCT01450761|593420755|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
164286757|NCT01450761|593420756|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
164286758|NCT01450761|593420755|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
164286759|NCT01450761|593420756|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
164692498|NCT03785145|594896947|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
164692499|NCT03785145|594896946|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
164692500|NCT03785145|594896947|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
164692501|NCT01124695|594896951|FG000|Overall Study|Disease progression|77|||
164692502|NCT01124695|594896951|FG000|Overall Study|Adverse Event|11|||
164692503|NCT01124695|594896951|FG000|Overall Study|Death|1|||
164692504|NCT01124695|594896951|FG000|Overall Study|Withdrawal by Subject|7|||
164692505|NCT01124695|594896951|FG000|Overall Study|Physician Decision|3|||
164692506|NCT01124695|594896951|FG000|Overall Study|Alternative therapy|9|||
164692507|NCT01124695|594896951|FG000|Overall Study|No documentation that patient went off treatment|4|||
164692508|NCT01124695|594896951|FG000|Overall Study|Ineligible|9|||
164692509|NCT01124695|594896951|FG000|Overall Study|Ineligible and never start treatment|2|||
164692510|NCT00097786|594896952|FG000|Overall Study|lost to follow-up for all-cause death|296|||
164692511|NCT00097786|594896953|FG001|Overall Study|lost to follow-up for all-cause death|292|||
164692512|NCT00097786|594896954|FG002|Overall Study|lost to follow-up for all-cause death|313|||
164692513|NCT00097786|594896955|FG003|Overall Study|lost to follow-up for all-cause death|310|||
164692514|NCT02668822|594896956|FG000|Overall Study|Protocol Violation|2|||
164692515|NCT02668822|594896957|FG001|Overall Study|Protocol Violation|0|||
164692516|NCT02668822|594896956|FG000|Overall Study|Study Terminated by Sponsor|7|||
164692517|NCT02668822|594896957|FG001|Overall Study|Study Terminated by Sponsor|9|||
164692518|NCT01647711|594896960|FG000|Overall Study|Progressive disease|6|||
164692519|NCT01647711|594896961|FG001|Overall Study|Progressive disease|2|||
164692520|NCT01647711|594896962|FG002|Overall Study|Progressive disease|6|||
164692521|NCT01647711|594896963|FG003|Overall Study|Progressive disease|8|||
164692522|NCT01647711|594896964|FG004|Overall Study|Progressive disease|2|||
164692523|NCT01647711|594896960|FG000|Overall Study|Other adverse event|0|||
164692524|NCT01647711|594896961|FG001|Overall Study|Other adverse event|0|||
164692525|NCT01647711|594896962|FG002|Overall Study|Other adverse event|2|||
164692526|NCT01647711|594896963|FG003|Overall Study|Other adverse event|0|||
164692527|NCT01647711|594896964|FG004|Overall Study|Other adverse event|2|||
164692528|NCT01647711|594896960|FG000|Overall Study|Protocol Violation|0|||
164692529|NCT01647711|594896961|FG001|Overall Study|Protocol Violation|0|||
164692530|NCT01647711|594896962|FG002|Overall Study|Protocol Violation|0|||
164692531|NCT01647711|594896963|FG003|Overall Study|Protocol Violation|0|||
164692532|NCT01647711|594896964|FG004|Overall Study|Protocol Violation|1|||
164692533|NCT01647711|594896960|FG000|Overall Study|Refused to continue taking medication|0|||
164692534|NCT01647711|594896961|FG001|Overall Study|Refused to continue taking medication|0|||
164692535|NCT01647711|594896962|FG002|Overall Study|Refused to continue taking medication|0|||
164692536|NCT01647711|594896963|FG003|Overall Study|Refused to continue taking medication|2|||
164692537|NCT01647711|594896964|FG004|Overall Study|Refused to continue taking medication|1|||
164692538|NCT01647711|594896960|FG000|Overall Study|Other reason not defined|0|||
164692539|NCT01647711|594896961|FG001|Overall Study|Other reason not defined|1|||
164692540|NCT01647711|594896962|FG002|Overall Study|Other reason not defined|1|||
164692541|NCT01647711|594896963|FG003|Overall Study|Other reason not defined|1|||
164692542|NCT01647711|594896964|FG004|Overall Study|Other reason not defined|0|||
164692543|NCT01796964|594896967|FG000|Overall Study|Adverse Event|1|||
164692544|NCT01796964|594896968|FG001|Overall Study|Adverse Event|1|||
164692545|NCT01796964|594896967|FG000|Overall Study|Death|1|||
164692546|NCT01796964|594896968|FG001|Overall Study|Death|0|||
164692547|NCT01796964|594896967|FG000|Overall Study|Protocol Violation|0|||
164692548|NCT01796964|594896968|FG001|Overall Study|Protocol Violation|1|||
164286760|NCT01450761|593420755|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
164692549|NCT01796964|594896967|FG000|Overall Study|Withdrawal by Subject|1|||
164692550|NCT01796964|594896968|FG001|Overall Study|Withdrawal by Subject|1|||
164692551|NCT04025684|594896969|FG000|Overall Study|Withdrawal by Subject|1|||
164692552|NCT04025684|594896970|FG001|Overall Study|Withdrawal by Subject|1|||
164692553|NCT04025684|594896971|FG002|Overall Study|Withdrawal by Subject|0|||
164692554|NCT04025684|594896972|FG003|Overall Study|Withdrawal by Subject|0|||
164692555|NCT04025684|594896969|FG000|Overall Study|Multiple reasons|1|||
164286761|NCT01450761|593420756|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
164286762|NCT01450761|593420755|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
164345155|NCT01817530|593638960|FG003|Overall Study|Exclusionary Medication Received|0|||
164692556|NCT04025684|594896970|FG001|Overall Study|Multiple reasons|3|||
164692557|NCT04025684|594896971|FG002|Overall Study|Multiple reasons|0|||
164286763|NCT01450761|593420756|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
164286764|NCT01450761|593420755|FG000|Lead-in Chemotherapy|Death|3|||
164286765|NCT01450761|593420756|FG001|Lead-in Chemotherapy|Death|3|||
164286766|NCT01450761|593420755|FG000|Lead-in Chemotherapy|Other|2|||
164286767|NCT01450761|593420756|FG001|Lead-in Chemotherapy|Other|2|||
164286768|NCT01450761|593420755|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
164286769|NCT01450761|593420756|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
164286770|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
164286771|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
164286772|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
164286773|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
164286774|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
164286775|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
164286776|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
164286777|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
164286778|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
164286779|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
164286780|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|Death|5|||
164286781|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|Death|6|||
164286782|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
164286783|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
164286784|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
164286785|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
164286786|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
164286787|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
164286788|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
164286789|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
164286790|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
164286791|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
164286792|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
164286793|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
164286794|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
164286795|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
164286796|NCT01818596|593420757|FG000|Overall Study|Enrolled but Not Treated|4|||
164286797|NCT01818596|593420758|FG001|Overall Study|Enrolled but Not Treated|0|||
164286798|NCT01818596|593420757|FG000|Overall Study|Adverse Event|7|||
164286799|NCT01818596|593420758|FG001|Overall Study|Adverse Event|0|||
164286800|NCT01818596|593420757|FG000|Overall Study|Death|3|||
164286801|NCT01818596|593420758|FG001|Overall Study|Death|0|||
164286802|NCT01818596|593420757|FG000|Overall Study|Investigator's Discretion|4|||
164286803|NCT01818596|593420758|FG001|Overall Study|Investigator's Discretion|0|||
164286804|NCT01818596|593420757|FG000|Overall Study|Protocol Violation|1|||
164286805|NCT01818596|593420758|FG001|Overall Study|Protocol Violation|0|||
164286806|NCT01818596|593420757|FG000|Overall Study|Withdrew Consent|5|||
164286807|NCT01818596|593420758|FG001|Overall Study|Withdrew Consent|0|||
164286808|NCT01818596|593420757|FG000|Overall Study|Lost to Follow-up|7|||
164286809|NCT01818596|593420758|FG001|Overall Study|Lost to Follow-up|0|||
164286810|NCT04435366|593420762|FG000|Year 1 (12 Months)|Adverse Event|3|||
164286811|NCT04435366|593420763|FG001|Year 1 (12 Months)|Adverse Event|0|||
164286812|NCT04435366|593420764|FG002|Year 1 (12 Months)|Adverse Event|2|||
164286813|NCT04435366|593420762|FG000|Year 1 (12 Months)|Death|2|||
164286814|NCT04435366|593420763|FG001|Year 1 (12 Months)|Death|0|||
164286815|NCT04435366|593420764|FG002|Year 1 (12 Months)|Death|1|||
164286816|NCT04435366|593420762|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
164286817|NCT04435366|593420763|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
164286818|NCT04435366|593420764|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
164286819|NCT04435366|593420762|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
164286820|NCT04435366|593420763|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
164286821|NCT04435366|593420764|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
164286822|NCT04435366|593420762|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
164286823|NCT04435366|593420763|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
164286824|NCT04435366|593420764|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
164286825|NCT04435366|593420762|FG000|Year 1 (12 Months)|Not treated|0|||
164286826|NCT04435366|593420763|FG001|Year 1 (12 Months)|Not treated|0|||
164286827|NCT04435366|593420764|FG002|Year 1 (12 Months)|Not treated|1|||
164286828|NCT04435366|593420762|FG000|Year 2 (12 Months)|Death|1|||
164286829|NCT04435366|593420763|FG001|Year 2 (12 Months)|Death|4|||
164286830|NCT04435366|593420764|FG002|Year 2 (12 Months)|Death|6|||
164286831|NCT04435366|593420762|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
164286832|NCT04435366|593420763|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
164286833|NCT04435366|593420764|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
164345156|NCT01817530|593638961|FG004|Overall Study|Exclusionary Medication Received|1|||
164286834|NCT04435366|593420762|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
164286835|NCT04435366|593420763|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
164286836|NCT04435366|593420764|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
164286837|NCT04435366|593420762|FG000|Year 2 (12 Months)|Adverse Event|2|||
164286838|NCT04435366|593420763|FG001|Year 2 (12 Months)|Adverse Event|1|||
164286839|NCT04435366|593420764|FG002|Year 2 (12 Months)|Adverse Event|6|||
164286840|NCT04497116|593420766|FG000|Overall Study|Lost to Follow-up|1|||
164286841|NCT04497116|593420767|FG001|Overall Study|Lost to Follow-up|0|||
164286842|NCT04497116|593420768|FG002|Overall Study|Lost to Follow-up|0|||
164286843|NCT04497116|593420769|FG003|Overall Study|Lost to Follow-up|0|||
164286844|NCT04497116|593420770|FG004|Overall Study|Lost to Follow-up|0|||
164286845|NCT04497116|593420771|FG005|Overall Study|Lost to Follow-up|0|||
164286846|NCT04497116|593420772|FG006|Overall Study|Lost to Follow-up|0|||
164286847|NCT04497116|593420773|FG007|Overall Study|Lost to Follow-up|3|||
164286848|NCT04497116|593420774|FG008|Overall Study|Lost to Follow-up|3|||
164286849|NCT04497116|593420775|FG009|Overall Study|Lost to Follow-up|0|||
164286850|NCT04497116|593420776|FG010|Overall Study|Lost to Follow-up|0|||
164286851|NCT04497116|593420777|FG011|Overall Study|Lost to Follow-up|0|||
164286852|NCT04497116|593420778|FG012|Overall Study|Lost to Follow-up|0|||
164286853|NCT04497116|593420779|FG013|Overall Study|Lost to Follow-up|0|||
164286854|NCT04497116|593420780|FG014|Overall Study|Lost to Follow-up|0|||
164286855|NCT04497116|593420781|FG015|Overall Study|Lost to Follow-up|0|||
164286856|NCT04497116|593420782|FG016|Overall Study|Lost to Follow-up|0|||
164286857|NCT04497116|593420783|FG017|Overall Study|Lost to Follow-up|0|||
164286858|NCT04497116|593420784|FG018|Overall Study|Lost to Follow-up|0|||
164286859|NCT04497116|593420785|FG019|Overall Study|Lost to Follow-up|0|||
164286860|NCT04497116|593420786|FG020|Overall Study|Lost to Follow-up|0|||
164286861|NCT04497116|593420787|FG021|Overall Study|Lost to Follow-up|0|||
164286862|NCT04497116|593420788|FG022|Overall Study|Lost to Follow-up|1|||
164286863|NCT04497116|593420789|FG023|Overall Study|Lost to Follow-up|0|||
164286864|NCT04497116|593420790|FG024|Overall Study|Lost to Follow-up|0|||
164286865|NCT04497116|593420766|FG000|Overall Study|Sponsor decision to terminate study|0|||
164286866|NCT04497116|593420767|FG001|Overall Study|Sponsor decision to terminate study|0|||
164286867|NCT04497116|593420768|FG002|Overall Study|Sponsor decision to terminate study|0|||
164286868|NCT04497116|593420769|FG003|Overall Study|Sponsor decision to terminate study|0|||
164286869|NCT04497116|593420770|FG004|Overall Study|Sponsor decision to terminate study|0|||
164286870|NCT04497116|593420771|FG005|Overall Study|Sponsor decision to terminate study|0|||
164286871|NCT04497116|593420772|FG006|Overall Study|Sponsor decision to terminate study|1|||
164286872|NCT04497116|593420773|FG007|Overall Study|Sponsor decision to terminate study|0|||
164286873|NCT04497116|593420774|FG008|Overall Study|Sponsor decision to terminate study|0|||
164286874|NCT04497116|593420775|FG009|Overall Study|Sponsor decision to terminate study|1|||
164286875|NCT04497116|593420776|FG010|Overall Study|Sponsor decision to terminate study|0|||
164286876|NCT04497116|593420777|FG011|Overall Study|Sponsor decision to terminate study|0|||
164286877|NCT04497116|593420778|FG012|Overall Study|Sponsor decision to terminate study|0|||
164286878|NCT04497116|593420779|FG013|Overall Study|Sponsor decision to terminate study|0|||
164286879|NCT04497116|593420780|FG014|Overall Study|Sponsor decision to terminate study|0|||
164286880|NCT04497116|593420781|FG015|Overall Study|Sponsor decision to terminate study|0|||
164286881|NCT04497116|593420782|FG016|Overall Study|Sponsor decision to terminate study|0|||
164286882|NCT04497116|593420783|FG017|Overall Study|Sponsor decision to terminate study|0|||
164692558|NCT04025684|594896972|FG003|Overall Study|Multiple reasons|1|||
164692559|NCT00868296|594896973|FG000|Overall Study|Adverse Event|0|||
164692560|NCT00868296|594896974|FG001|Overall Study|Adverse Event|2|||
164286883|NCT04497116|593420784|FG018|Overall Study|Sponsor decision to terminate study|0|||
164286884|NCT04497116|593420785|FG019|Overall Study|Sponsor decision to terminate study|1|||
164286885|NCT04497116|593420786|FG020|Overall Study|Sponsor decision to terminate study|0|||
164286886|NCT04497116|593420787|FG021|Overall Study|Sponsor decision to terminate study|0|||
164286887|NCT04497116|593420788|FG022|Overall Study|Sponsor decision to terminate study|0|||
164286888|NCT04497116|593420789|FG023|Overall Study|Sponsor decision to terminate study|0|||
164286889|NCT04497116|593420790|FG024|Overall Study|Sponsor decision to terminate study|0|||
164286890|NCT04497116|593420766|FG000|Overall Study|Death|4|||
164286891|NCT04497116|593420767|FG001|Overall Study|Death|5|||
164286892|NCT04497116|593420768|FG002|Overall Study|Death|2|||
164286893|NCT04497116|593420769|FG003|Overall Study|Death|2|||
164286894|NCT04497116|593420770|FG004|Overall Study|Death|1|||
164286895|NCT04497116|593420771|FG005|Overall Study|Death|1|||
164286896|NCT04497116|593420772|FG006|Overall Study|Death|3|||
164286897|NCT04497116|593420773|FG007|Overall Study|Death|10|||
164286898|NCT04497116|593420774|FG008|Overall Study|Death|37|||
164286899|NCT04497116|593420775|FG009|Overall Study|Death|17|||
164286900|NCT04497116|593420776|FG010|Overall Study|Death|2|||
164286901|NCT04497116|593420777|FG011|Overall Study|Death|1|||
164286902|NCT04497116|593420778|FG012|Overall Study|Death|1|||
164286903|NCT04497116|593420779|FG013|Overall Study|Death|3|||
164286904|NCT04497116|593420780|FG014|Overall Study|Death|18|||
164286905|NCT04497116|593420781|FG015|Overall Study|Death|3|||
164286906|NCT04497116|593420782|FG016|Overall Study|Death|2|||
164286907|NCT04497116|593420783|FG017|Overall Study|Death|1|||
164286908|NCT04497116|593420784|FG018|Overall Study|Death|4|||
164286909|NCT04497116|593420785|FG019|Overall Study|Death|17|||
164286910|NCT04497116|593420786|FG020|Overall Study|Death|1|||
164286911|NCT04497116|593420787|FG021|Overall Study|Death|0|||
164286912|NCT04497116|593420788|FG022|Overall Study|Death|3|||
164286913|NCT04497116|593420789|FG023|Overall Study|Death|5|||
164286914|NCT04497116|593420790|FG024|Overall Study|Death|4|||
164286915|NCT04497116|593420766|FG000|Overall Study|Withdrawal by Subject|1|||
164286916|NCT04497116|593420767|FG001|Overall Study|Withdrawal by Subject|0|||
164286917|NCT04497116|593420768|FG002|Overall Study|Withdrawal by Subject|1|||
164286918|NCT04497116|593420769|FG003|Overall Study|Withdrawal by Subject|0|||
164286919|NCT04497116|593420770|FG004|Overall Study|Withdrawal by Subject|0|||
164286920|NCT04497116|593420771|FG005|Overall Study|Withdrawal by Subject|0|||
164286921|NCT04497116|593420772|FG006|Overall Study|Withdrawal by Subject|0|||
164286922|NCT04497116|593420773|FG007|Overall Study|Withdrawal by Subject|7|||
164286923|NCT04497116|593420774|FG008|Overall Study|Withdrawal by Subject|14|||
164286924|NCT04497116|593420775|FG009|Overall Study|Withdrawal by Subject|3|||
164286925|NCT04497116|593420776|FG010|Overall Study|Withdrawal by Subject|3|||
164286926|NCT04497116|593420777|FG011|Overall Study|Withdrawal by Subject|0|||
164286927|NCT04497116|593420778|FG012|Overall Study|Withdrawal by Subject|1|||
164286928|NCT04497116|593420779|FG013|Overall Study|Withdrawal by Subject|0|||
164286929|NCT04497116|593420780|FG014|Overall Study|Withdrawal by Subject|7|||
164286930|NCT04497116|593420781|FG015|Overall Study|Withdrawal by Subject|1|||
164286931|NCT04497116|593420782|FG016|Overall Study|Withdrawal by Subject|3|||
164286932|NCT04497116|593420783|FG017|Overall Study|Withdrawal by Subject|1|||
164286933|NCT04497116|593420784|FG018|Overall Study|Withdrawal by Subject|1|||
164286934|NCT04497116|593420785|FG019|Overall Study|Withdrawal by Subject|5|||
164286935|NCT04497116|593420786|FG020|Overall Study|Withdrawal by Subject|2|||
164286936|NCT04497116|593420787|FG021|Overall Study|Withdrawal by Subject|2|||
164286937|NCT04497116|593420788|FG022|Overall Study|Withdrawal by Subject|2|||
164286938|NCT04497116|593420789|FG023|Overall Study|Withdrawal by Subject|4|||
164286939|NCT04497116|593420790|FG024|Overall Study|Withdrawal by Subject|3|||
164286940|NCT04497116|593420766|FG000|Overall Study|Physician Decision|0|||
164286941|NCT04497116|593420767|FG001|Overall Study|Physician Decision|0|||
164286942|NCT04497116|593420768|FG002|Overall Study|Physician Decision|0|||
164286943|NCT04497116|593420769|FG003|Overall Study|Physician Decision|0|||
164286944|NCT04497116|593420770|FG004|Overall Study|Physician Decision|0|||
164286945|NCT04497116|593420771|FG005|Overall Study|Physician Decision|0|||
164286946|NCT04497116|593420772|FG006|Overall Study|Physician Decision|0|||
164286947|NCT04497116|593420773|FG007|Overall Study|Physician Decision|0|||
164286948|NCT04497116|593420774|FG008|Overall Study|Physician Decision|0|||
164286949|NCT04497116|593420775|FG009|Overall Study|Physician Decision|0|||
164286950|NCT04497116|593420776|FG010|Overall Study|Physician Decision|0|||
164286951|NCT04497116|593420777|FG011|Overall Study|Physician Decision|0|||
164286952|NCT04497116|593420778|FG012|Overall Study|Physician Decision|0|||
164286953|NCT04497116|593420779|FG013|Overall Study|Physician Decision|0|||
164286954|NCT04497116|593420780|FG014|Overall Study|Physician Decision|0|||
164286955|NCT04497116|593420781|FG015|Overall Study|Physician Decision|0|||
164286956|NCT04497116|593420782|FG016|Overall Study|Physician Decision|0|||
164286957|NCT04497116|593420783|FG017|Overall Study|Physician Decision|0|||
164692561|NCT00868296|594896973|FG000|Overall Study|Withdrawal by Subject|0|||
164692562|NCT00868296|594896974|FG001|Overall Study|Withdrawal by Subject|1|||
164286958|NCT04497116|593420784|FG018|Overall Study|Physician Decision|0|||
164286959|NCT04497116|593420785|FG019|Overall Study|Physician Decision|0|||
164286960|NCT04497116|593420786|FG020|Overall Study|Physician Decision|0|||
164286961|NCT04497116|593420787|FG021|Overall Study|Physician Decision|0|||
164286962|NCT04497116|593420788|FG022|Overall Study|Physician Decision|0|||
164286963|NCT04497116|593420789|FG023|Overall Study|Physician Decision|1|||
164286964|NCT04497116|593420790|FG024|Overall Study|Physician Decision|0|||
164286965|NCT04497116|593420766|FG000|Overall Study|Clinical Progression Related|0|||
164286966|NCT04497116|593420767|FG001|Overall Study|Clinical Progression Related|0|||
164286967|NCT04497116|593420768|FG002|Overall Study|Clinical Progression Related|0|||
164286968|NCT04497116|593420769|FG003|Overall Study|Clinical Progression Related|0|||
164286969|NCT04497116|593420770|FG004|Overall Study|Clinical Progression Related|0|||
164286970|NCT04497116|593420771|FG005|Overall Study|Clinical Progression Related|0|||
164286971|NCT04497116|593420772|FG006|Overall Study|Clinical Progression Related|0|||
164286972|NCT04497116|593420773|FG007|Overall Study|Clinical Progression Related|0|||
164286973|NCT04497116|593420774|FG008|Overall Study|Clinical Progression Related|0|||
164286974|NCT04497116|593420775|FG009|Overall Study|Clinical Progression Related|1|||
164286975|NCT04497116|593420776|FG010|Overall Study|Clinical Progression Related|0|||
164286976|NCT04497116|593420777|FG011|Overall Study|Clinical Progression Related|0|||
164286977|NCT04497116|593420778|FG012|Overall Study|Clinical Progression Related|0|||
164286978|NCT04497116|593420779|FG013|Overall Study|Clinical Progression Related|0|||
164286979|NCT04497116|593420780|FG014|Overall Study|Clinical Progression Related|0|||
164286980|NCT04497116|593420781|FG015|Overall Study|Clinical Progression Related|0|||
164286981|NCT04497116|593420782|FG016|Overall Study|Clinical Progression Related|0|||
164286982|NCT04497116|593420783|FG017|Overall Study|Clinical Progression Related|0|||
164692563|NCT03110380|594896975|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
164692564|NCT03110380|594896976|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
164692565|NCT03110380|594896977|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
164692566|NCT03110380|594896978|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
164692567|NCT03110380|594896975|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
164692568|NCT03110380|594896976|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
164692569|NCT03110380|594896977|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164692570|NCT03110380|594896978|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164692571|NCT03110380|594896975|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
164692572|NCT03110380|594896976|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
164286983|NCT04497116|593420784|FG018|Overall Study|Clinical Progression Related|0|||
164286984|NCT04497116|593420785|FG019|Overall Study|Clinical Progression Related|0|||
164286985|NCT04497116|593420786|FG020|Overall Study|Clinical Progression Related|0|||
164286986|NCT04497116|593420787|FG021|Overall Study|Clinical Progression Related|0|||
164286987|NCT04497116|593420788|FG022|Overall Study|Clinical Progression Related|0|||
164286988|NCT04497116|593420789|FG023|Overall Study|Clinical Progression Related|0|||
164286989|NCT04497116|593420790|FG024|Overall Study|Clinical Progression Related|0|||
164286990|NCT05963022|593420794|FG000|Overall Study|Adverse Event|0|||
164286991|NCT05963022|593420795|FG001|Overall Study|Adverse Event|1|||
164286992|NCT05963022|593420796|FG002|Overall Study|Adverse Event|1|||
164286993|NCT05963022|593420797|FG003|Overall Study|Adverse Event|0|||
164286994|NCT05963022|593420794|FG000|Overall Study|Protocol Violation|0|||
164286995|NCT05963022|593420795|FG001|Overall Study|Protocol Violation|3|||
164286996|NCT05963022|593420796|FG002|Overall Study|Protocol Violation|0|||
164286997|NCT05963022|593420797|FG003|Overall Study|Protocol Violation|0|||
164286998|NCT05963022|593420794|FG000|Overall Study|Pregnancy|0|||
164286999|NCT05963022|593420795|FG001|Overall Study|Pregnancy|1|||
164287000|NCT05963022|593420796|FG002|Overall Study|Pregnancy|1|||
164287001|NCT05963022|593420797|FG003|Overall Study|Pregnancy|1|||
164287002|NCT05963022|593420794|FG000|Overall Study|Withdrawal by Subject|0|||
164287003|NCT05963022|593420795|FG001|Overall Study|Withdrawal by Subject|0|||
164287004|NCT05963022|593420796|FG002|Overall Study|Withdrawal by Subject|2|||
164287005|NCT05963022|593420797|FG003|Overall Study|Withdrawal by Subject|1|||
164287006|NCT05963022|593420794|FG000|Overall Study|Lost to Follow-up|0|||
164287007|NCT05963022|593420795|FG001|Overall Study|Lost to Follow-up|0|||
164287008|NCT05963022|593420796|FG002|Overall Study|Lost to Follow-up|0|||
164287009|NCT05963022|593420797|FG003|Overall Study|Lost to Follow-up|1|||
164287010|NCT05963022|593420794|FG000|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
164287011|NCT05963022|593420795|FG001|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
164287012|NCT05963022|593420796|FG002|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
164287013|NCT05963022|593420797|FG003|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|1|||
164287014|NCT02698826|593420800|FG000|Overall Study|Death|13|||
164287015|NCT02698826|593420800|FG000|Overall Study|Adverse Event|1|||
164287016|NCT02915263|593420805|FG000|Overall Study|Covid|3|||
164287017|NCT02915263|593420806|FG001|Overall Study|Covid|2|||
164287018|NCT02478463|593420807|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
164287019|NCT02478463|593420807|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
164287020|NCT02478463|593420807|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
164287021|NCT01358825|593420808|FG000|Overall Study|Blood sample not drawn|0|||
164287022|NCT01358825|593420809|FG001|Overall Study|Blood sample not drawn|1|||
164287023|NCT01177007|593420813|FG000|Overall Study|Lost to Follow-up|2|||
164692573|NCT03110380|594896977|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
164692574|NCT03110380|594896978|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
164692575|NCT03110380|594896975|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
164692576|NCT03110380|594896976|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
164287024|NCT01177007|593420813|FG000|Overall Study|Death|4|||
164287025|NCT01177007|593420813|FG000|Overall Study|Entered hospice care|5|||
164345157|NCT01817530|593638962|FG005|Overall Study|Exclusionary Medication Received|0|||
164345158|NCT01817530|593638963|FG006|Overall Study|Exclusionary Medication Received|0|||
164345159|NCT01817530|593638964|FG007|Overall Study|Exclusionary Medication Received|0|||
164345160|NCT01817530|593638957|FG000|Overall Study|Adverse Event|6|||
164345161|NCT01817530|593638958|FG001|Overall Study|Adverse Event|3|||
164345162|NCT01817530|593638959|FG002|Overall Study|Adverse Event|2|||
164692577|NCT03110380|594896977|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
164692578|NCT03110380|594896978|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
164692579|NCT03110380|594896975|FG000|Double-Blind Treatment Phase|Death|2|||
164287026|NCT01177007|593420813|FG000|Overall Study|Required additional Y90 treatment|6|||
164287027|NCT01177007|593420813|FG000|Overall Study|Change in treatment modality|21|||
164287028|NCT01702558|593420814|FG000|Overall Study|Withdrawal by Subject|0|||
164287029|NCT01702558|593420815|FG001|Overall Study|Withdrawal by Subject|0|||
164287030|NCT01702558|593420816|FG002|Overall Study|Withdrawal by Subject|0|||
164287031|NCT01702558|593420817|FG003|Overall Study|Withdrawal by Subject|12|||
164287032|NCT01702558|593420818|FG004|Overall Study|Withdrawal by Subject|4|||
164287033|NCT01702558|593420814|FG000|Overall Study|Lost to Follow-up|0|||
164287034|NCT01702558|593420815|FG001|Overall Study|Lost to Follow-up|0|||
164287035|NCT01702558|593420816|FG002|Overall Study|Lost to Follow-up|0|||
164692580|NCT03110380|594896976|FG001|Double-Blind Treatment Phase|Death|1|||
164692581|NCT03110380|594896977|FG002|Double-Blind Treatment Phase|Death|0|||
164287036|NCT01702558|593420817|FG003|Overall Study|Lost to Follow-up|3|||
164287037|NCT01702558|593420818|FG004|Overall Study|Lost to Follow-up|0|||
164287038|NCT01702558|593420814|FG000|Overall Study|Death|4|||
164287039|NCT01702558|593420815|FG001|Overall Study|Death|3|||
164287040|NCT01702558|593420816|FG002|Overall Study|Death|3|||
164287041|NCT01702558|593420817|FG003|Overall Study|Death|16|||
164287042|NCT01702558|593420818|FG004|Overall Study|Death|20|||
164287043|NCT01702558|593420814|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
164287044|NCT01702558|593420815|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
164287045|NCT01702558|593420816|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
164287046|NCT01702558|593420817|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
164287047|NCT01702558|593420818|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
164287048|NCT01702558|593420814|FG000|Overall Study|Study Terminated by Sponsor|0|||
164287049|NCT01702558|593420815|FG001|Overall Study|Study Terminated by Sponsor|1|||
164287050|NCT01702558|593420816|FG002|Overall Study|Study Terminated by Sponsor|0|||
164345163|NCT01817530|593638960|FG003|Overall Study|Adverse Event|5|||
164345164|NCT01817530|593638961|FG004|Overall Study|Adverse Event|0|||
164345165|NCT01817530|593638962|FG005|Overall Study|Adverse Event|10|||
164287051|NCT01702558|593420817|FG003|Overall Study|Study Terminated by Sponsor|0|||
164692582|NCT03110380|594896978|FG003|Double-Blind Treatment Phase|Death|0|||
164692583|NCT03110380|594896975|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
164692584|NCT03110380|594896976|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
164692585|NCT03110380|594896977|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
164692586|NCT03110380|594896978|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
164692587|NCT03110380|594896975|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
164692588|NCT03110380|594896976|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
164692589|NCT03110380|594896977|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
164692590|NCT03110380|594896978|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
164692591|NCT03110380|594896975|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
164692592|NCT03110380|594896976|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
164692593|NCT03110380|594896977|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
164692594|NCT03110380|594896978|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
164692595|NCT03110380|594896975|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
164692596|NCT03110380|594896976|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
164692597|NCT03110380|594896977|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
164692598|NCT03110380|594896978|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
164692599|NCT03110380|594896975|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
164692600|NCT03110380|594896976|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
164692601|NCT03110380|594896977|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
164692602|NCT03110380|594896978|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
164345166|NCT01817530|593638963|FG006|Overall Study|Adverse Event|5|||
164345167|NCT01817530|593638964|FG007|Overall Study|Adverse Event|8|||
164345168|NCT01817530|593638957|FG000|Overall Study|Subject Noncompliant|3|||
164345169|NCT01817530|593638958|FG001|Overall Study|Subject Noncompliant|1|||
164345170|NCT01817530|593638959|FG002|Overall Study|Subject Noncompliant|0|||
164345171|NCT01817530|593638960|FG003|Overall Study|Subject Noncompliant|4|||
164345172|NCT01817530|593638961|FG004|Overall Study|Subject Noncompliant|0|||
164345173|NCT01817530|593638962|FG005|Overall Study|Subject Noncompliant|1|||
164345174|NCT01817530|593638963|FG006|Overall Study|Subject Noncompliant|1|||
164345175|NCT01817530|593638964|FG007|Overall Study|Subject Noncompliant|1|||
164345176|NCT01817530|593638957|FG000|Overall Study|Lack of Efficacy|1|||
164345177|NCT01817530|593638958|FG001|Overall Study|Lack of Efficacy|0|||
164345178|NCT01817530|593638959|FG002|Overall Study|Lack of Efficacy|0|||
164345179|NCT01817530|593638960|FG003|Overall Study|Lack of Efficacy|0|||
164345180|NCT01817530|593638961|FG004|Overall Study|Lack of Efficacy|0|||
164345181|NCT01817530|593638962|FG005|Overall Study|Lack of Efficacy|1|||
164345182|NCT01817530|593638963|FG006|Overall Study|Lack of Efficacy|0|||
164692603|NCT03110380|594896975|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
164692604|NCT03110380|594896976|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
164692605|NCT03110380|594896977|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
164345183|NCT01817530|593638964|FG007|Overall Study|Lack of Efficacy|1|||
164345184|NCT01817530|593638957|FG000|Overall Study|Pregnancy|0|||
164692606|NCT03110380|594896978|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
164692607|NCT01292837|594896979|FG000|Overall Study|Adverse Event|1|||
164345185|NCT01817530|593638958|FG001|Overall Study|Pregnancy|0|||
164345186|NCT01817530|593638959|FG002|Overall Study|Pregnancy|0|||
164345187|NCT01817530|593638960|FG003|Overall Study|Pregnancy|0|||
164345188|NCT01817530|593638961|FG004|Overall Study|Pregnancy|0|||
164345189|NCT01817530|593638962|FG005|Overall Study|Pregnancy|1|||
164692608|NCT01292837|594896979|FG000|Overall Study|Further treatment determined|1|||
164692609|NCT05889039|594896981|FG000|Overall Study|error in completing survey|0|||
164692610|NCT05889039|594896982|FG001|Overall Study|error in completing survey|2|||
164692611|NCT05889039|594896983|FG002|Overall Study|error in completing survey|0|||
164692612|NCT05889039|594896984|FG003|Overall Study|error in completing survey|0|||
164692613|NCT05889039|594896981|FG000|Overall Study|Lost to Follow-up|4|||
164692614|NCT05889039|594896982|FG001|Overall Study|Lost to Follow-up|0|||
164692615|NCT05889039|594896983|FG002|Overall Study|Lost to Follow-up|0|||
164692616|NCT05889039|594896984|FG003|Overall Study|Lost to Follow-up|0|||
164692617|NCT00515216|594896986|FG000|Overall Study|Withdrawal by Subject|1|||
164692618|NCT02795676|594896987|FG000|Overall Study|Adverse Event|2|||
164692619|NCT02795676|594896988|FG001|Overall Study|Adverse Event|0|||
164692620|NCT02795676|594896987|FG000|Overall Study|Withdrawal by Subject|3|||
164692621|NCT02795676|594896988|FG001|Overall Study|Withdrawal by Subject|1|||
164692622|NCT01115933|594896991|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
164692623|NCT01609582|594896996|FG000|Overall Study|Adverse Event|20|||
164692624|NCT01609582|594896997|FG001|Overall Study|Adverse Event|18|||
164692625|NCT01609582|594896996|FG000|Overall Study|Lost to Follow-up|10|||
164692626|NCT01609582|594896997|FG001|Overall Study|Lost to Follow-up|10|||
164692627|NCT01609582|594896996|FG000|Overall Study|Withdrawal by Subject|21|||
164692628|NCT01609582|594896997|FG001|Overall Study|Withdrawal by Subject|15|||
164692629|NCT01609582|594896996|FG000|Overall Study|Study Terminated by Sponsor|1543|||
164692630|NCT01609582|594896997|FG001|Overall Study|Study Terminated by Sponsor|1548|||
164692631|NCT01609582|594896996|FG000|Overall Study|Other|9|||
164692632|NCT01609582|594896997|FG001|Overall Study|Other|10|||
164692633|NCT01609582|594896996|FG000|Overall Study|Randomized, but not treated|0|||
164692634|NCT01609582|594896997|FG001|Overall Study|Randomized, but not treated|3|||
164692635|NCT00819767|594896998|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164692636|NCT00819767|594896999|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164692637|NCT00685750|594897000|FG000|Overall Study|Tumor sampling failure|0|||
164692638|NCT00685750|594897001|FG001|Overall Study|Tumor sampling failure|0|||
164692639|NCT00685750|594897002|FG002|Overall Study|Tumor sampling failure|1|||
164692640|NCT00685750|594897003|FG003|Overall Study|Tumor sampling failure|0|||
164287052|NCT01702558|593420818|FG004|Overall Study|Study Terminated by Sponsor|1|||
164287053|NCT01702558|593420814|FG000|Overall Study|Other|0|||
164287054|NCT01702558|593420815|FG001|Overall Study|Other|0|||
164287055|NCT01702558|593420816|FG002|Overall Study|Other|0|||
164287056|NCT01702558|593420817|FG003|Overall Study|Other|16|||
164287057|NCT01702558|593420818|FG004|Overall Study|Other|17|||
164692641|NCT00685750|594897004|FG004|Overall Study|Tumor sampling failure|0|||
164692642|NCT00685750|594897005|FG005|Overall Study|Tumor sampling failure|0|||
164692643|NCT00685750|594897006|FG006|Overall Study|Tumor sampling failure|0|||
164692644|NCT00685750|594897000|FG000|Overall Study|Patient didn't receive the treatment|0|||
164692645|NCT00685750|594897001|FG001|Overall Study|Patient didn't receive the treatment|0|||
164692646|NCT00685750|594897002|FG002|Overall Study|Patient didn't receive the treatment|0|||
164692647|NCT00685750|594897003|FG003|Overall Study|Patient didn't receive the treatment|0|||
164692648|NCT00685750|594897004|FG004|Overall Study|Patient didn't receive the treatment|0|||
164692649|NCT00685750|594897005|FG005|Overall Study|Patient didn't receive the treatment|0|||
164692650|NCT00685750|594897006|FG006|Overall Study|Patient didn't receive the treatment|1|||
164692651|NCT00685750|594897000|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164692652|NCT00685750|594897001|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164692653|NCT00685750|594897002|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
164692654|NCT00685750|594897003|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
164692655|NCT00685750|594897004|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
164692656|NCT00685750|594897005|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
164692657|NCT00685750|594897006|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
164692658|NCT00220727|594897027|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
164692659|NCT00220727|594897028|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
164692660|NCT02508116|594897029|FG000|Overall Study|Lost to Follow-up|2|||
164692661|NCT02508116|594897030|FG001|Overall Study|Lost to Follow-up|3|||
164692662|NCT02508116|594897029|FG000|Overall Study|Withdrawal by Subject|3|||
164287058|NCT03259087|593420824|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
164287059|NCT03259087|593420825|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
164287060|NCT03259087|593420826|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
164287061|NCT03259087|593420827|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
164287062|NCT03259087|593420828|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
164692663|NCT02508116|594897030|FG001|Overall Study|Withdrawal by Subject|2|||
164692664|NCT02508116|594897029|FG000|Overall Study|Protocol Violation|1|||
164692665|NCT02508116|594897030|FG001|Overall Study|Protocol Violation|2|||
164692666|NCT02508116|594897029|FG000|Overall Study|Physician Decision|2|||
164692667|NCT02508116|594897030|FG001|Overall Study|Physician Decision|0|||
164692668|NCT04234464|594897031|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
164692669|NCT04234464|594897032|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
164692670|NCT00476593|594897033|FG000|Overall Study|Lost to Follow-up|10|||
164692671|NCT00476593|594897034|FG001|Overall Study|Lost to Follow-up|2|||
164692672|NCT00476593|594897035|FG002|Overall Study|Lost to Follow-up|8|||
164692673|NCT00476593|594897036|FG003|Overall Study|Lost to Follow-up|22|||
164692674|NCT03430011|594897037|FG000|Pre-Treatment|Death|1|||
164692675|NCT03430011|594897038|FG001|Pre-Treatment|Death|0|||
164692676|NCT03430011|594897039|FG002|Pre-Treatment|Death|0|||
164692677|NCT03430011|594897040|FG003|Pre-Treatment|Death|0|||
164692678|NCT03430011|594897041|FG004|Pre-Treatment|Death|1|||
164692679|NCT03430011|594897042|FG005|Pre-Treatment|Death|0|||
164692680|NCT03430011|594897043|FG006|Pre-Treatment|Death|1|||
164692681|NCT03430011|594897044|FG007|Pre-Treatment|Death|0|||
164692682|NCT03430011|594897037|FG000|Pre-Treatment|Screen Fail|0|||
164287063|NCT03259087|593420824|FG000|Period 2 of Part 2|Adverse Event|0|||
164287064|NCT03259087|593420825|FG001|Period 2 of Part 2|Adverse Event|0|||
164287065|NCT03259087|593420826|FG002|Period 2 of Part 2|Adverse Event|0|||
164287066|NCT03259087|593420827|FG003|Period 2 of Part 2|Adverse Event|0|||
164287067|NCT03259087|593420828|FG004|Period 2 of Part 2|Adverse Event|1|||
164287068|NCT04524858|593420829|FG000|Overall Study|Adverse Event|1|||
164287069|NCT03571204|593420830|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
164287070|NCT03571204|593420831|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
164287071|NCT03571204|593420832|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
164287072|NCT03571204|593420830|FG000|Overall Study|Physician Decision|0|||
164287073|NCT03571204|593420831|FG001|Overall Study|Physician Decision|1|||
164287074|NCT03571204|593420832|FG002|Overall Study|Physician Decision|0|||
164287075|NCT01623115|593420833|FG000|Overall Study|Randomized but not treated|0|||
164287076|NCT01623115|593420834|FG001|Overall Study|Randomized but not treated|1|||
164287077|NCT01623115|593420833|FG000|Overall Study|Physician Decision|1|||
164287078|NCT01623115|593420834|FG001|Overall Study|Physician Decision|0|||
164287079|NCT01623115|593420833|FG000|Overall Study|Participants moved|1|||
164287080|NCT01623115|593420834|FG001|Overall Study|Participants moved|5|||
164287081|NCT01623115|593420833|FG000|Overall Study|Adverse Event|10|||
164287082|NCT01623115|593420834|FG001|Overall Study|Adverse Event|13|||
164287083|NCT01623115|593420833|FG000|Overall Study|Poor compliance to protocol|4|||
164287084|NCT01623115|593420834|FG001|Overall Study|Poor compliance to protocol|10|||
164287085|NCT01623115|593420833|FG000|Overall Study|Consent withdrawn by participant|2|||
164287086|NCT01623115|593420834|FG001|Overall Study|Consent withdrawn by participant|6|||
164287087|NCT01623115|593420833|FG000|Overall Study|Related to study drug administration|0|||
164287088|NCT01623115|593420834|FG001|Overall Study|Related to study drug administration|2|||
164287089|NCT01623115|593420833|FG000|Overall Study|Last visit outside protocol visit window|14|||
164287090|NCT01623115|593420834|FG001|Overall Study|Last visit outside protocol visit window|26|||
164287091|NCT01623115|593420833|FG000|Overall Study|Site closure|1|||
164287092|NCT01623115|593420834|FG001|Overall Study|Site closure|7|||
164287093|NCT01623115|593420833|FG000|Overall Study|Death|0|||
164287094|NCT01623115|593420834|FG001|Overall Study|Death|4|||
164287095|NCT01623115|593420833|FG000|Overall Study|Other than specified above|0|||
164287096|NCT01623115|593420834|FG001|Overall Study|Other than specified above|3|||
164287097|NCT04797780|593420835|FG000|Overall Study|Lost to Follow-up|1|||
164287098|NCT04797780|593420836|FG001|Overall Study|Lost to Follow-up|1|||
164287099|NCT04797780|593420835|FG000|Overall Study|Withdrawal by Subject|14|||
164287100|NCT04797780|593420836|FG001|Overall Study|Withdrawal by Subject|9|||
164287101|NCT04797780|593420835|FG000|Overall Study|Death|49|||
164287102|NCT04797780|593420836|FG001|Overall Study|Death|20|||
164287103|NCT02940496|593420837|FG000|Overall Study|Adverse Event|1|||
164287104|NCT02940496|593420838|FG001|Overall Study|Adverse Event|0|||
164287105|NCT02940496|593420837|FG000|Overall Study|Death|2|||
164287106|NCT02940496|593420838|FG001|Overall Study|Death|0|||
164287107|NCT02940496|593420837|FG000|Overall Study|Hospice Care|1|||
164287108|NCT02940496|593420838|FG001|Overall Study|Hospice Care|0|||
164287109|NCT02940496|593420837|FG000|Overall Study|No MRE Done|1|||
164287110|NCT02940496|593420838|FG001|Overall Study|No MRE Done|0|||
164287111|NCT02940496|593420837|FG000|Overall Study|MRE Failure|1|||
164287112|NCT02940496|593420838|FG001|Overall Study|MRE Failure|0|||
164287113|NCT05973006|593420839|FG000|Overall Study|Early termination|3|||
164287114|NCT05973006|593420840|FG001|Overall Study|Early termination|9|||
164287115|NCT05167825|593420841|FG000|Overall Study|Ongoing|3|||
164692683|NCT03430011|594897038|FG001|Pre-Treatment|Screen Fail|0|||
164692684|NCT03430011|594897039|FG002|Pre-Treatment|Screen Fail|0|||
164287116|NCT01807598|593420842|FG000|Overall Study|Withdrawal by Subject|4|||
164287117|NCT01807598|593420842|FG000|Overall Study|Adverse Event|1|||
164287118|NCT01807598|593420842|FG000|Overall Study|Other Physician Decision|1|||
164287119|NCT03622814|593420854|FG000|Overall Study|Lost to Follow-up|8|||
164287120|NCT03622814|593420855|FG001|Overall Study|Lost to Follow-up|14|||
164287121|NCT04417361|593420856|FG000|Overall Study|Withdrawal by Subject|1|||
164287122|NCT04417361|593420857|FG001|Overall Study|Withdrawal by Subject|0|||
164692685|NCT03430011|594897040|FG003|Pre-Treatment|Screen Fail|0|||
164692686|NCT03430011|594897041|FG004|Pre-Treatment|Screen Fail|1|||
164692687|NCT03430011|594897042|FG005|Pre-Treatment|Screen Fail|0|||
164287123|NCT04417361|593420856|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
164287124|NCT04417361|593420857|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
164287125|NCT00165672|593420858|FG000|Overall Study|Adverse Event|0|||
164287126|NCT00165672|593420859|FG001|Overall Study|Adverse Event|1|||
164287127|NCT04186871|593420862|FG000|Overall Study|Lack of Efficacy|0|||
164287128|NCT04186871|593420863|FG001|Overall Study|Lack of Efficacy|1|||
164287129|NCT04186871|593420864|FG002|Overall Study|Lack of Efficacy|0|||
164287130|NCT04186871|593420865|FG003|Overall Study|Lack of Efficacy|0|||
164287131|NCT04186871|593420866|FG004|Overall Study|Lack of Efficacy|1|||
164287132|NCT04186871|593420867|FG005|Overall Study|Lack of Efficacy|1|||
164287133|NCT04186871|593420862|FG000|Overall Study|Adverse Event|1|||
164287134|NCT04186871|593420863|FG001|Overall Study|Adverse Event|1|||
164287135|NCT04186871|593420864|FG002|Overall Study|Adverse Event|0|||
164287136|NCT04186871|593420865|FG003|Overall Study|Adverse Event|0|||
164287137|NCT04186871|593420866|FG004|Overall Study|Adverse Event|0|||
164287138|NCT04186871|593420867|FG005|Overall Study|Adverse Event|2|||
164287139|NCT04186871|593420862|FG000|Overall Study|Study terminated by sponsor|1|||
164287140|NCT04186871|593420863|FG001|Overall Study|Study terminated by sponsor|2|||
164287141|NCT04186871|593420864|FG002|Overall Study|Study terminated by sponsor|0|||
164287142|NCT04186871|593420865|FG003|Overall Study|Study terminated by sponsor|1|||
164287143|NCT04186871|593420866|FG004|Overall Study|Study terminated by sponsor|0|||
164287144|NCT04186871|593420867|FG005|Overall Study|Study terminated by sponsor|0|||
164287145|NCT04186871|593420862|FG000|Overall Study|Other reasons|0|||
164287146|NCT04186871|593420863|FG001|Overall Study|Other reasons|0|||
164287147|NCT04186871|593420864|FG002|Overall Study|Other reasons|0|||
164287148|NCT04186871|593420865|FG003|Overall Study|Other reasons|0|||
164287149|NCT04186871|593420866|FG004|Overall Study|Other reasons|0|||
164287150|NCT04186871|593420867|FG005|Overall Study|Other reasons|1|||
164287151|NCT04186871|593420862|FG000|Overall Study|Withdrawal by Subject|0|||
164287152|NCT04186871|593420863|FG001|Overall Study|Withdrawal by Subject|0|||
164287153|NCT04186871|593420864|FG002|Overall Study|Withdrawal by Subject|0|||
164287154|NCT04186871|593420865|FG003|Overall Study|Withdrawal by Subject|0|||
164287155|NCT04186871|593420866|FG004|Overall Study|Withdrawal by Subject|0|||
164287156|NCT04186871|593420867|FG005|Overall Study|Withdrawal by Subject|1|||
164287157|NCT04186871|593420862|FG000|Overall Study|Lost to Follow-up|0|||
164287158|NCT04186871|593420863|FG001|Overall Study|Lost to Follow-up|0|||
164287159|NCT04186871|593420864|FG002|Overall Study|Lost to Follow-up|0|||
164287160|NCT04186871|593420865|FG003|Overall Study|Lost to Follow-up|0|||
164287161|NCT04186871|593420866|FG004|Overall Study|Lost to Follow-up|0|||
164287162|NCT04186871|593420867|FG005|Overall Study|Lost to Follow-up|1|||
164287163|NCT00555217|593420869|FG000|Overall Study|Withdrawal by Subject|35|||
164287164|NCT00555217|593420870|FG001|Overall Study|Withdrawal by Subject|31|||
164287165|NCT00555217|593420869|FG000|Overall Study|Lost to Follow-up|19|||
164287166|NCT00555217|593420870|FG001|Overall Study|Lost to Follow-up|20|||
164287167|NCT00555217|593420869|FG000|Overall Study|close out sites|21|||
164287168|NCT00555217|593420870|FG001|Overall Study|close out sites|17|||
164287169|NCT01546688|593420871|FG000|Overall Study|Adverse Event|0|||
164287170|NCT01546688|593420872|FG001|Overall Study|Adverse Event|4|||
164287171|NCT01546688|593420871|FG000|Overall Study|Withdrawal by Subject|2|||
164287172|NCT01546688|593420872|FG001|Overall Study|Withdrawal by Subject|1|||
164287173|NCT01546688|593420871|FG000|Overall Study|Lack of Efficacy|1|||
164287174|NCT01546688|593420872|FG001|Overall Study|Lack of Efficacy|0|||
164287175|NCT03543137|593420874|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
164287176|NCT03543137|593420875|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
164287177|NCT03543137|593420874|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
164287178|NCT03543137|593420875|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
164287179|NCT03543137|593420874|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
164287180|NCT03543137|593420875|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
164287181|NCT01045694|593420877|FG000|Overall Study|Withdrawal by Subject|2|||
164287182|NCT01657292|593420882|FG000|Overall Study|Adverse Event|6|||
164287183|NCT01657292|593420882|FG000|Overall Study|Withdrawal by Subject|2|||
164287184|NCT01657292|593420882|FG000|Overall Study|Violation of eligibility criteria|1|||
164287185|NCT01657292|593420882|FG000|Overall Study|Change of therapy|1|||
164287186|NCT01900652|593420883|FG000|Overall Study|Progressive Disease|1|||
164287187|NCT01900652|593420884|FG001|Overall Study|Progressive Disease|0|||
164287188|NCT01900652|593420883|FG000|Overall Study|Consent withdrawn by subject|1|||
164287189|NCT01900652|593420884|FG001|Overall Study|Consent withdrawn by subject|1|||
164287190|NCT01900652|593420883|FG000|Overall Study|Death|3|||
164287191|NCT01900652|593420884|FG001|Overall Study|Death|0|||
164287192|NCT01900652|593420883|FG000|Overall Study|Adverse Event|2|||
164287193|NCT01900652|593420884|FG001|Overall Study|Adverse Event|1|||
164287194|NCT01900652|593420883|FG000|Overall Study|Physician Decision|1|||
164287195|NCT01900652|593420884|FG001|Overall Study|Physician Decision|1|||
164287196|NCT03761810|593420885|FG000|Overall Study|Adverse Event|12|||
164287197|NCT03761810|593420886|FG001|Overall Study|Adverse Event|0|||
164287198|NCT03761810|593420885|FG000|Overall Study|Lost to Follow-up|15|||
164287199|NCT03761810|593420886|FG001|Overall Study|Lost to Follow-up|7|||
164287200|NCT03761810|593420885|FG000|Overall Study|Pregnancy|1|||
164287201|NCT03761810|593420886|FG001|Overall Study|Pregnancy|0|||
164287202|NCT03761810|593420885|FG000|Overall Study|Withdrawal by Subject|14|||
164287203|NCT03761810|593420886|FG001|Overall Study|Withdrawal by Subject|5|||
164287204|NCT03761810|593420885|FG000|Overall Study|Physician Decision|1|||
164287205|NCT03761810|593420886|FG001|Overall Study|Physician Decision|0|||
164287206|NCT03761810|593420885|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
164287207|NCT03761810|593420886|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164287208|NCT03761810|593420885|FG000|Overall Study|Other Than Specified|1|||
164287209|NCT03761810|593420886|FG001|Overall Study|Other Than Specified|0|||
164287210|NCT04178720|593420887|FG000|Overall Study|Withdrawal by Subject|2|||
164287211|NCT04178720|593420888|FG001|Overall Study|Withdrawal by Subject|0|||
164287212|NCT04178720|593420887|FG000|Overall Study|Relocation|0|||
164287213|NCT04178720|593420888|FG001|Overall Study|Relocation|1|||
164287214|NCT00869518|593420889|FG000|Overall Study|Lost to Follow-up|1|||
164287215|NCT00869518|593420890|FG001|Overall Study|Lost to Follow-up|1|||
164287216|NCT03566082|593420891|FG000|Overall Study|Death|7|||
164287217|NCT03566082|593420891|FG000|Overall Study|Failures (revision required)|2|||
164287218|NCT03566082|593420891|FG000|Overall Study|Lost to Follow-up|8|||
164287219|NCT02663622|593420892|FG000|Overall Study|Death|3|||
164287220|NCT02663622|593420893|FG001|Overall Study|Death|1|||
164287221|NCT02663622|593420894|FG002|Overall Study|Death|1|||
164287222|NCT02663622|593420895|FG003|Overall Study|Death|8|||
164287223|NCT02663622|593420892|FG000|Overall Study|Protocol Violation|0|||
164287224|NCT02663622|593420893|FG001|Overall Study|Protocol Violation|0|||
164287225|NCT02663622|593420894|FG002|Overall Study|Protocol Violation|0|||
164287226|NCT02663622|593420895|FG003|Overall Study|Protocol Violation|1|||
164287227|NCT00930930|593420897|FG000|Overall Study|Death|1|||
164287228|NCT00930930|593420898|FG001|Overall Study|Death|0|||
164287229|NCT00930930|593420897|FG000|Overall Study|Physician Decision|1|||
164287230|NCT00930930|593420898|FG001|Overall Study|Physician Decision|0|||
164287231|NCT00930930|593420897|FG000|Overall Study|Adverse Event|13|||
164287232|NCT00930930|593420898|FG001|Overall Study|Adverse Event|3|||
164287233|NCT00930930|593420897|FG000|Overall Study|Withdrawal by Subject|3|||
164287234|NCT00930930|593420898|FG001|Overall Study|Withdrawal by Subject|1|||
164287235|NCT00930930|593420897|FG000|Overall Study|Disease progression|2|||
164287236|NCT00930930|593420898|FG001|Overall Study|Disease progression|3|||
164287237|NCT00930930|593420897|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
164287238|NCT00930930|593420898|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
164287239|NCT00930930|593420897|FG000|Overall Study|patients not compliant|1|||
164287240|NCT00930930|593420898|FG001|Overall Study|patients not compliant|1|||
164287241|NCT01633788|593422656|FG000|Overall Study|Adverse Event|1|||
164287242|NCT01633788|593422657|FG001|Overall Study|Adverse Event|3|||
164287243|NCT01633788|593422658|FG002|Overall Study|Adverse Event|3|||
164287244|NCT01633788|593422659|FG003|Overall Study|Adverse Event|3|||
164287245|NCT01633788|593422656|FG000|Overall Study|Lost to Follow-up|2|||
164287246|NCT01633788|593422657|FG001|Overall Study|Lost to Follow-up|2|||
164287247|NCT01633788|593422658|FG002|Overall Study|Lost to Follow-up|2|||
164287248|NCT01633788|593422659|FG003|Overall Study|Lost to Follow-up|0|||
164287249|NCT01633788|593422656|FG000|Overall Study|Personal Reasons|3|||
164287250|NCT01633788|593422657|FG001|Overall Study|Personal Reasons|1|||
164287251|NCT01633788|593422658|FG002|Overall Study|Personal Reasons|1|||
164287252|NCT01633788|593422659|FG003|Overall Study|Personal Reasons|3|||
164287253|NCT01633788|593422656|FG000|Overall Study|Protocol Violation|1|||
164287254|NCT01633788|593422657|FG001|Overall Study|Protocol Violation|0|||
164287255|NCT01633788|593422658|FG002|Overall Study|Protocol Violation|1|||
164287256|NCT01633788|593422659|FG003|Overall Study|Protocol Violation|0|||
164287257|NCT01633788|593422656|FG000|Overall Study|Other Reasons|0|||
164287258|NCT01633788|593422657|FG001|Overall Study|Other Reasons|2|||
164287259|NCT01633788|593422658|FG002|Overall Study|Other Reasons|3|||
164287260|NCT01633788|593422659|FG003|Overall Study|Other Reasons|7|||
164287261|NCT01467505|593422663|FG000|Overall Study|Adverse Event|1|||
164287262|NCT01467505|593422664|FG001|Overall Study|Adverse Event|0|||
164287263|NCT01467505|593422663|FG000|Overall Study|Withdrawal by Subject|4|||
164287264|NCT01467505|593422664|FG001|Overall Study|Withdrawal by Subject|0|||
164287265|NCT01467505|593422663|FG000|Overall Study|Study Terminated by Sponsor|28|||
164287266|NCT01467505|593422664|FG001|Overall Study|Study Terminated by Sponsor|3|||
164287267|NCT00227721|593422665|FG000|Overall Study|On study, but never treated.|1|||
164287268|NCT01389882|593422670|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
164287269|NCT01389882|593422671|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
164287270|NCT01389882|593422670|FG000|Overall Study|Withdrawal by Subject|0|||
164345190|NCT01817530|593638963|FG006|Overall Study|Pregnancy|0|||
164345191|NCT01817530|593638964|FG007|Overall Study|Pregnancy|0|||
164345192|NCT01817530|593638957|FG000|Overall Study|Other|0|||
164287271|NCT01389882|593422671|FG001|Overall Study|Withdrawal by Subject|1|||
164287272|NCT03790111|593422672|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
164287273|NCT03811340|593422674|FG000|Overall Study|subjects did not complete the survey.|90|||
164287274|NCT01045967|593422675|FG000|Second Intervention|Protocol Violation|0|||
164287275|NCT01045967|593422676|FG001|Second Intervention|Protocol Violation|1|||
164345193|NCT01817530|593638958|FG001|Overall Study|Other|1|||
164287276|NCT00383786|593422677|FG000|Overall Study|Protocol Violation|2|||
164287277|NCT00383786|593422678|FG001|Overall Study|Protocol Violation|6|||
164287278|NCT00383786|593422677|FG000|Overall Study|Withdrawal by Subject|2|||
164287279|NCT00383786|593422678|FG001|Overall Study|Withdrawal by Subject|5|||
164287280|NCT00383786|593422677|FG000|Overall Study|Physician Decision|0|||
164287281|NCT00383786|593422678|FG001|Overall Study|Physician Decision|1|||
164287282|NCT02219464|593422682|FG000|Overall Study|Withdrawal by Subject|1|||
164287283|NCT02219464|593422683|FG001|Overall Study|Withdrawal by Subject|0|||
164287284|NCT02219464|593422682|FG000|Overall Study|case cancelled|1|||
164287285|NCT02219464|593422683|FG001|Overall Study|case cancelled|0|||
164287286|NCT02219464|593422682|FG000|Overall Study|catheter malfunction|1|||
164287287|NCT02219464|593422683|FG001|Overall Study|catheter malfunction|0|||
164287288|NCT00984256|593422684|FG000|Overall Study|Withdrawal by Subject|0|||
164287289|NCT00984256|593422685|FG001|Overall Study|Withdrawal by Subject|1|||
164287290|NCT02544321|593422691|FG000|Overall Study|Withdrawal by Subject|1|||
164287291|NCT02544321|593422692|FG001|Overall Study|Withdrawal by Subject|2|||
164287292|NCT02544321|593422691|FG000|Overall Study|Adverse Event|1|||
164287293|NCT02544321|593422692|FG001|Overall Study|Adverse Event|1|||
164287294|NCT02544321|593422691|FG000|Overall Study|Protocol Violation|0|||
164287295|NCT02544321|593422692|FG001|Overall Study|Protocol Violation|1|||
164287296|NCT03529110|593422693|FG000|Overall Study|Progressive Disease|66|||
164287297|NCT03529110|593422694|FG001|Overall Study|Progressive Disease|158|||
164287298|NCT03529110|593422693|FG000|Overall Study|Clinical Progression|4|||
164287299|NCT03529110|593422694|FG001|Overall Study|Clinical Progression|12|||
164287300|NCT03529110|593422693|FG000|Overall Study|Adverse Event|35|||
164287301|NCT03529110|593422694|FG001|Overall Study|Adverse Event|17|||
164287302|NCT03529110|593422693|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
164287303|NCT03529110|593422694|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
164287304|NCT03529110|593422693|FG000|Overall Study|Lack of Efficacy|3|||
164287305|NCT03529110|593422694|FG001|Overall Study|Lack of Efficacy|3|||
164287306|NCT03529110|593422693|FG000|Overall Study|Physician Decision|2|||
164287307|NCT03529110|593422694|FG001|Overall Study|Physician Decision|8|||
164287308|NCT03529110|593422693|FG000|Overall Study|Miscellaneous|2|||
164287309|NCT03529110|593422694|FG001|Overall Study|Miscellaneous|5|||
164287310|NCT03493945|593422695|FG000|Phase I Dose Escalation|Ineligible|0|||
164287311|NCT03493945|593422696|FG001|Phase I Dose Escalation|Ineligible|0|||
164287312|NCT03493945|593422697|FG002|Phase I Dose Escalation|Ineligible|1|||
164287313|NCT03493945|593422698|FG003|Phase I Dose Escalation|Ineligible|0|||
164287314|NCT03493945|593422699|FG004|Phase I Dose Escalation|Ineligible|0|||
164287315|NCT03493945|593422700|FG005|Phase I Dose Escalation|Ineligible|0|||
164287316|NCT03493945|593422701|FG006|Phase I Dose Escalation|Ineligible|0|||
164287317|NCT03493945|593422695|FG000|Phase I Dose Escalation|New therapy|0|||
164287318|NCT03493945|593422696|FG001|Phase I Dose Escalation|New therapy|1|||
164287319|NCT03493945|593422697|FG002|Phase I Dose Escalation|New therapy|0|||
164287320|NCT03493945|593422698|FG003|Phase I Dose Escalation|New therapy|0|||
164287321|NCT03493945|593422699|FG004|Phase I Dose Escalation|New therapy|0|||
164287322|NCT03493945|593422700|FG005|Phase I Dose Escalation|New therapy|0|||
164287323|NCT03493945|593422701|FG006|Phase I Dose Escalation|New therapy|0|||
164287324|NCT03493945|593422695|FG000|Phase II Dose Expansion|Refused further treatment|0|||
164287325|NCT03493945|593422696|FG001|Phase II Dose Expansion|Refused further treatment|0|||
164287326|NCT03493945|593422697|FG002|Phase II Dose Expansion|Refused further treatment|0|||
164287327|NCT03493945|593422698|FG003|Phase II Dose Expansion|Refused further treatment|0|||
164345194|NCT01817530|593638959|FG002|Overall Study|Other|0|||
164345195|NCT01817530|593638960|FG003|Overall Study|Other|0|||
164345196|NCT01817530|593638961|FG004|Overall Study|Other|1|||
164345197|NCT01817530|593638962|FG005|Overall Study|Other|0|||
164345198|NCT01817530|593638963|FG006|Overall Study|Other|5|||
164287328|NCT03493945|593422699|FG004|Phase II Dose Expansion|Refused further treatment|1|||
164287329|NCT03493945|593422700|FG005|Phase II Dose Expansion|Refused further treatment|1|||
164287330|NCT03493945|593422701|FG006|Phase II Dose Expansion|Refused further treatment|0|||
164287331|NCT03493945|593422695|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
164287332|NCT03493945|593422696|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
164287333|NCT03493945|593422697|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
164345199|NCT01817530|593638964|FG007|Overall Study|Other|0|||
164287334|NCT03493945|593422698|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
164287335|NCT03493945|593422699|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
164287336|NCT03493945|593422700|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
164287337|NCT03493945|593422701|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
164287338|NCT05104450|593422702|FG000|Overall Study|Death|1|||
164287339|NCT05104450|593422703|FG001|Overall Study|Death|2|||
164287340|NCT05104450|593422702|FG000|Overall Study|Withdrawal by Subject|3|||
164345200|NCT01817530|593638957|FG000|Overall Study|Surgery or Invasive Intervention|1|||
164345201|NCT01817530|593638958|FG001|Overall Study|Surgery or Invasive Intervention|0|||
164287341|NCT05104450|593422703|FG001|Overall Study|Withdrawal by Subject|1|||
164287342|NCT01584232|593422704|FG000|Overall Study|Adverse Event|3|||
164287343|NCT01584232|593422705|FG001|Overall Study|Adverse Event|1|||
164287344|NCT01584232|593422704|FG000|Overall Study|Withdrawal by Subject|2|||
164287345|NCT01584232|593422705|FG001|Overall Study|Withdrawal by Subject|1|||
164287346|NCT01584232|593422704|FG000|Overall Study|Physician Decision|2|||
164287347|NCT01584232|593422705|FG001|Overall Study|Physician Decision|1|||
164287348|NCT01584232|593422704|FG000|Overall Study|Lost to Follow-up|1|||
164287349|NCT01584232|593422705|FG001|Overall Study|Lost to Follow-up|0|||
164287350|NCT01307319|593422706|FG000|Overall Study|Adverse Event|2|||
164287351|NCT01307319|593422707|FG001|Overall Study|Adverse Event|2|||
164287352|NCT01307319|593422708|FG002|Overall Study|Adverse Event|1|||
164287353|NCT01307319|593422706|FG000|Overall Study|Lost to Follow-up|1|||
164287354|NCT01307319|593422707|FG001|Overall Study|Lost to Follow-up|0|||
164287355|NCT01307319|593422708|FG002|Overall Study|Lost to Follow-up|1|||
164287356|NCT01307319|593422706|FG000|Overall Study|Protocol Violation|1|||
164287357|NCT01307319|593422707|FG001|Overall Study|Protocol Violation|1|||
164287358|NCT01307319|593422708|FG002|Overall Study|Protocol Violation|0|||
164287359|NCT01307319|593422706|FG000|Overall Study|Withdrawal by Subject|0|||
164287360|NCT01307319|593422707|FG001|Overall Study|Withdrawal by Subject|1|||
164287361|NCT01307319|593422708|FG002|Overall Study|Withdrawal by Subject|2|||
164287362|NCT01307319|593422706|FG000|Overall Study|Other|0|||
164287363|NCT01307319|593422707|FG001|Overall Study|Other|4|||
164287364|NCT01307319|593422708|FG002|Overall Study|Other|3|||
164287365|NCT02735239|593422710|FG000|Overall Study|Adverse Event|0|||
164287366|NCT02735239|593422711|FG001|Overall Study|Adverse Event|0|||
164287367|NCT02735239|593422712|FG002|Overall Study|Adverse Event|4|||
164287368|NCT02735239|593422713|FG003|Overall Study|Adverse Event|0|||
164287369|NCT02735239|593422714|FG004|Overall Study|Adverse Event|0|||
164287370|NCT02735239|593422715|FG005|Overall Study|Adverse Event|0|||
164287371|NCT02735239|593422710|FG000|Overall Study|Death|1|||
164287372|NCT02735239|593422711|FG001|Overall Study|Death|1|||
164287373|NCT02735239|593422712|FG002|Overall Study|Death|0|||
164287374|NCT02735239|593422713|FG003|Overall Study|Death|0|||
164287375|NCT02735239|593422714|FG004|Overall Study|Death|0|||
164287376|NCT02735239|593422715|FG005|Overall Study|Death|0|||
164287377|NCT02735239|593422710|FG000|Overall Study|Physician Decision|0|||
164287378|NCT02735239|593422711|FG001|Overall Study|Physician Decision|0|||
164287379|NCT02735239|593422712|FG002|Overall Study|Physician Decision|1|||
164287380|NCT02735239|593422713|FG003|Overall Study|Physician Decision|0|||
164287381|NCT02735239|593422714|FG004|Overall Study|Physician Decision|0|||
164287382|NCT02735239|593422715|FG005|Overall Study|Physician Decision|0|||
164287383|NCT02735239|593422710|FG000|Overall Study|Progressive disease|3|||
164287384|NCT02735239|593422711|FG001|Overall Study|Progressive disease|1|||
164287385|NCT02735239|593422712|FG002|Overall Study|Progressive disease|3|||
164287386|NCT02735239|593422713|FG003|Overall Study|Progressive disease|0|||
164287387|NCT02735239|593422714|FG004|Overall Study|Progressive disease|0|||
164287388|NCT02735239|593422715|FG005|Overall Study|Progressive disease|2|||
164287389|NCT02735239|593422710|FG000|Overall Study|Withdrawal by Subject|0|||
164287390|NCT02735239|593422711|FG001|Overall Study|Withdrawal by Subject|1|||
164287391|NCT02735239|593422712|FG002|Overall Study|Withdrawal by Subject|0|||
164287392|NCT02735239|593422713|FG003|Overall Study|Withdrawal by Subject|0|||
164287393|NCT02735239|593422714|FG004|Overall Study|Withdrawal by Subject|0|||
164287394|NCT02735239|593422715|FG005|Overall Study|Withdrawal by Subject|0|||
164287395|NCT02152631|593422721|FG000|Overall Study|Adverse Event|32|||
164287396|NCT02152631|593422722|FG001|Overall Study|Adverse Event|4|||
164287397|NCT02152631|593422721|FG000|Overall Study|Withdrawal by Subject|13|||
164287398|NCT02152631|593422722|FG001|Overall Study|Withdrawal by Subject|16|||
164287399|NCT02152631|593422721|FG000|Overall Study|Noncompliance with study drug|1|||
164287400|NCT02152631|593422722|FG001|Overall Study|Noncompliance with study drug|0|||
164287401|NCT02152631|593422721|FG000|Overall Study|Physician Decision|1|||
164287402|NCT02152631|593422722|FG001|Overall Study|Physician Decision|2|||
164287403|NCT02152631|593422721|FG000|Overall Study|Lost to Follow-up|0|||
164287404|NCT02152631|593422722|FG001|Overall Study|Lost to Follow-up|1|||
164287405|NCT02152631|593422721|FG000|Overall Study|On Treatment|19|||
164287406|NCT02152631|593422722|FG001|Overall Study|On Treatment|3|||
164287407|NCT00404651|593422727|FG000|Overall Study|Serious Adverse Event|0|||
164287408|NCT00404651|593422728|FG001|Overall Study|Serious Adverse Event|0|||
164287409|NCT00404651|593422729|FG002|Overall Study|Serious Adverse Event|2|||
164287410|NCT00404651|593422730|FG003|Overall Study|Serious Adverse Event|0|||
164287411|NCT00404651|593422727|FG000|Overall Study|Protocol Violation|10|||
164287412|NCT00404651|593422728|FG001|Overall Study|Protocol Violation|5|||
164287413|NCT00404651|593422729|FG002|Overall Study|Protocol Violation|14|||
164287414|NCT00404651|593422730|FG003|Overall Study|Protocol Violation|5|||
164287415|NCT00404651|593422727|FG000|Overall Study|Lost to Follow-up|15|||
164287416|NCT00404651|593422728|FG001|Overall Study|Lost to Follow-up|11|||
164287417|NCT00404651|593422729|FG002|Overall Study|Lost to Follow-up|13|||
164287418|NCT00404651|593422730|FG003|Overall Study|Lost to Follow-up|10|||
164287419|NCT00404651|593422727|FG000|Overall Study|Withdrawal by Subject|14|||
164287420|NCT00404651|593422728|FG001|Overall Study|Withdrawal by Subject|12|||
164287421|NCT00404651|593422729|FG002|Overall Study|Withdrawal by Subject|16|||
164287422|NCT00404651|593422730|FG003|Overall Study|Withdrawal by Subject|6|||
164287423|NCT02073682|593422755|FG000|Overall Study|Low Creatinine Clearance|1|||
164287424|NCT02073682|593422756|FG001|Overall Study|Low Creatinine Clearance|2|||
164287425|NCT02073682|593422755|FG000|Overall Study|Death|86|||
164287426|NCT02073682|593422756|FG001|Overall Study|Death|100|||
164287427|NCT02073682|593422755|FG000|Overall Study|Cancer Cured|10|||
164287428|NCT02073682|593422756|FG001|Overall Study|Cancer Cured|15|||
164287429|NCT02073682|593422755|FG000|Overall Study|ID: Patient Noncompliance|1|||
164287430|NCT02073682|593422756|FG001|Overall Study|ID: Patient Noncompliance|2|||
164287431|NCT02073682|593422755|FG000|Overall Study|ID: Palliative Treatment Only|10|||
164287432|NCT02073682|593422756|FG001|Overall Study|ID: Palliative Treatment Only|7|||
164287433|NCT02073682|593422755|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
164287434|NCT02073682|593422756|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
164287435|NCT02073682|593422755|FG000|Overall Study|Platelet Count <50,000/mL|1|||
164287436|NCT02073682|593422756|FG001|Overall Study|Platelet Count <50,000/mL|2|||
164287437|NCT02073682|593422755|FG000|Overall Study|Surgery/Medical Procedure|3|||
164287438|NCT02073682|593422756|FG001|Overall Study|Surgery/Medical Procedure|1|||
164287439|NCT02073682|593422755|FG000|Overall Study|Withdrawal by Subject|6|||
164287440|NCT02073682|593422756|FG001|Overall Study|Withdrawal by Subject|8|||
164287441|NCT02073682|593422755|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
164287442|NCT02073682|593422756|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
164287443|NCT02073682|593422755|FG000|Overall Study|Cancer Progression|53|||
164287444|NCT02073682|593422756|FG001|Overall Study|Cancer Progression|33|||
164287445|NCT02073682|593422755|FG000|Overall Study|Protocol Violation|1|||
164287446|NCT02073682|593422756|FG001|Overall Study|Protocol Violation|0|||
164287447|NCT02073682|593422755|FG000|Overall Study|Adverse Event|79|||
164287448|NCT02073682|593422756|FG001|Overall Study|Adverse Event|62|||
164287449|NCT02073682|593422755|FG000|Overall Study|No reason provided|11|||
164287450|NCT02073682|593422756|FG001|Overall Study|No reason provided|9|||
164287451|NCT02073682|593422755|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
164287452|NCT02073682|593422756|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
164287453|NCT02073682|593422755|FG000|Overall Study|Lost to Follow-up|1|||
164287454|NCT02073682|593422756|FG001|Overall Study|Lost to Follow-up|1|||
164287455|NCT02073682|593422755|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
164287456|NCT02073682|593422756|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
164287457|NCT03801174|593422757|FG000|Overall Study|Withdrawal by Subject|14|||
164287458|NCT03801174|593422758|FG001|Overall Study|Withdrawal by Subject|15|||
164287459|NCT03801174|593422757|FG000|Overall Study|Death|1|||
164287460|NCT03801174|593422758|FG001|Overall Study|Death|0|||
164287461|NCT03801174|593422757|FG000|Overall Study|Pregnancy|2|||
164287462|NCT03801174|593422758|FG001|Overall Study|Pregnancy|2|||
164287463|NCT03801174|593422757|FG000|Overall Study|Lost to Follow-up|19|||
164287464|NCT03801174|593422758|FG001|Overall Study|Lost to Follow-up|10|||
164287465|NCT03801174|593422757|FG000|Overall Study|Other|4|||
164287466|NCT03801174|593422758|FG001|Overall Study|Other|3|||
164287467|NCT03801174|593422757|FG000|Overall Study|Lack of Efficacy|4|||
164287468|NCT03801174|593422758|FG001|Overall Study|Lack of Efficacy|0|||
164287469|NCT03801174|593422757|FG000|Overall Study|Unwilling to complete activities|5|||
164287470|NCT03801174|593422758|FG001|Overall Study|Unwilling to complete activities|6|||
164287471|NCT03801174|593422757|FG000|Overall Study|Moved out of area|3|||
164287472|NCT03801174|593422758|FG001|Overall Study|Moved out of area|0|||
164287473|NCT04112810|593422763|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
164287474|NCT01687296|593422765|FG000|Overall Study|Lack of Efficacy|1|||
164287475|NCT01687296|593422766|FG001|Overall Study|Lack of Efficacy|1|||
164287476|NCT01687296|593422765|FG000|Overall Study|Protocol Violation|0|||
164287477|NCT01687296|593422766|FG001|Overall Study|Protocol Violation|1|||
164287478|NCT01687296|593422765|FG000|Overall Study|Withdrawal by Subject|6|||
164287479|NCT01687296|593422766|FG001|Overall Study|Withdrawal by Subject|3|||
164287480|NCT01539759|593422767|FG000|Overall Study|Lost to Follow-up|6|||
164287481|NCT01539759|593422768|FG001|Overall Study|Lost to Follow-up|8|||
164287482|NCT03201419|593422776|FG000|Overall Study|Adverse Event|3|||
164287483|NCT03201419|593422777|FG001|Overall Study|Adverse Event|1|||
164287484|NCT03201419|593422778|FG002|Overall Study|Adverse Event|0|||
164287485|NCT03201419|593422779|FG003|Overall Study|Adverse Event|0|||
164287486|NCT03201419|593422780|FG004|Overall Study|Adverse Event|1|||
164287487|NCT03201419|593422781|FG005|Overall Study|Adverse Event|1|||
164287488|NCT03201419|593422782|FG006|Overall Study|Adverse Event|5|||
164287489|NCT03201419|593422783|FG007|Overall Study|Adverse Event|0|||
164287490|NCT03201419|593422784|FG008|Overall Study|Adverse Event|0|||
164287491|NCT03201419|593422776|FG000|Overall Study|Lost to Follow-up|1|||
164287492|NCT03201419|593422777|FG001|Overall Study|Lost to Follow-up|0|||
164287493|NCT03201419|593422778|FG002|Overall Study|Lost to Follow-up|0|||
164287494|NCT03201419|593422779|FG003|Overall Study|Lost to Follow-up|0|||
164287495|NCT03201419|593422780|FG004|Overall Study|Lost to Follow-up|0|||
164287496|NCT03201419|593422781|FG005|Overall Study|Lost to Follow-up|0|||
164287497|NCT03201419|593422782|FG006|Overall Study|Lost to Follow-up|0|||
164287498|NCT03201419|593422783|FG007|Overall Study|Lost to Follow-up|0|||
164287499|NCT03201419|593422784|FG008|Overall Study|Lost to Follow-up|0|||
164287500|NCT03201419|593422776|FG000|Overall Study|Protocol Deviation|0|||
164287501|NCT03201419|593422777|FG001|Overall Study|Protocol Deviation|0|||
164287502|NCT03201419|593422778|FG002|Overall Study|Protocol Deviation|0|||
164287503|NCT03201419|593422779|FG003|Overall Study|Protocol Deviation|0|||
164287504|NCT03201419|593422780|FG004|Overall Study|Protocol Deviation|0|||
164287505|NCT03201419|593422781|FG005|Overall Study|Protocol Deviation|0|||
164287506|NCT03201419|593422782|FG006|Overall Study|Protocol Deviation|1|||
164287507|NCT03201419|593422783|FG007|Overall Study|Protocol Deviation|0|||
164287508|NCT03201419|593422784|FG008|Overall Study|Protocol Deviation|0|||
164287509|NCT03201419|593422776|FG000|Overall Study|Withdrawal by Subject|4|||
164287510|NCT03201419|593422777|FG001|Overall Study|Withdrawal by Subject|2|||
164287511|NCT03201419|593422778|FG002|Overall Study|Withdrawal by Subject|1|||
164287512|NCT03201419|593422779|FG003|Overall Study|Withdrawal by Subject|0|||
164287513|NCT03201419|593422780|FG004|Overall Study|Withdrawal by Subject|0|||
164287514|NCT03201419|593422781|FG005|Overall Study|Withdrawal by Subject|0|||
164287515|NCT03201419|593422782|FG006|Overall Study|Withdrawal by Subject|0|||
164287516|NCT03201419|593422783|FG007|Overall Study|Withdrawal by Subject|1|||
164287517|NCT03201419|593422784|FG008|Overall Study|Withdrawal by Subject|2|||
164287518|NCT03201419|593422776|FG000|Overall Study|Other|0|||
164287519|NCT03201419|593422777|FG001|Overall Study|Other|0|||
164287520|NCT03201419|593422778|FG002|Overall Study|Other|1|||
164287521|NCT03201419|593422779|FG003|Overall Study|Other|0|||
164287522|NCT03201419|593422780|FG004|Overall Study|Other|0|||
164287523|NCT03201419|593422781|FG005|Overall Study|Other|0|||
164287524|NCT03201419|593422782|FG006|Overall Study|Other|0|||
164287525|NCT03201419|593422783|FG007|Overall Study|Other|0|||
164287526|NCT03201419|593422784|FG008|Overall Study|Other|0|||
164287527|NCT03635424|593422785|FG000|Overall Study|Adverse Event|1|||
164287528|NCT03635424|593422785|FG000|Overall Study|Death|1|||
164287529|NCT03635424|593422785|FG000|Overall Study|Device not implanted|1|||
164287530|NCT02701283|593422786|FG000|Overall Study|Death|25|||
164287531|NCT02701283|593422787|FG001|Overall Study|Death|29|||
164287532|NCT02701283|593422788|FG002|Overall Study|Death|19|||
164287533|NCT02701283|593422786|FG000|Overall Study|Lost to Follow-up|3|||
164287534|NCT02701283|593422787|FG001|Overall Study|Lost to Follow-up|8|||
164287535|NCT02701283|593422788|FG002|Overall Study|Lost to Follow-up|1|||
164287536|NCT02701283|593422786|FG000|Overall Study|Withdrawal by Subject|12|||
164287537|NCT02701283|593422787|FG001|Overall Study|Withdrawal by Subject|41|||
164287538|NCT02701283|593422788|FG002|Overall Study|Withdrawal by Subject|1|||
164287539|NCT02701283|593422786|FG000|Overall Study|Missed 2-year visit|22|||
164287540|NCT02701283|593422787|FG001|Overall Study|Missed 2-year visit|27|||
164287541|NCT02701283|593422788|FG002|Overall Study|Missed 2-year visit|0|||
164287542|NCT02701283|593422786|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
164287543|NCT02701283|593422787|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
164287544|NCT02701283|593422788|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
164287545|NCT04544956|593422789|FG000|Overall Study|Withdrawal by Subject|1|||
164287546|NCT04266795|593422790|FG000|Overall Study|Adverse Event|10|||
164287547|NCT04266795|593422791|FG001|Overall Study|Adverse Event|19|||
164287548|NCT04266795|593422790|FG000|Overall Study|Death|7|||
164287549|NCT04266795|593422791|FG001|Overall Study|Death|8|||
164287550|NCT04266795|593422790|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
164287551|NCT04266795|593422791|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
164287552|NCT04266795|593422790|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
164287553|NCT04266795|593422791|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164287554|NCT04266795|593422790|FG000|Overall Study|Progressive Disease|12|||
164287555|NCT04266795|593422791|FG001|Overall Study|Progressive Disease|9|||
164287556|NCT04266795|593422790|FG000|Overall Study|Withdrawal by Patient|5|||
164287557|NCT04266795|593422791|FG001|Overall Study|Withdrawal by Patient|6|||
164287558|NCT04266795|593422790|FG000|Overall Study|Disease Relapse|3|||
164287559|NCT04266795|593422791|FG001|Overall Study|Disease Relapse|6|||
164287560|NCT04266795|593422790|FG000|Overall Study|Reason not Specified|12|||
164287561|NCT04266795|593422791|FG001|Overall Study|Reason not Specified|10|||
164287562|NCT04266795|593422790|FG000|Overall Study|Participants Ongoing on Treatment|25|||
164287563|NCT04266795|593422791|FG001|Overall Study|Participants Ongoing on Treatment|23|||
164287564|NCT00699660|593422794|FG000|Overall Study|Lost to Follow-up|4|||
164287565|NCT00699660|593422795|FG001|Overall Study|Lost to Follow-up|2|||
164287566|NCT00699660|593422794|FG000|Overall Study|missing reports and recording failures|10|||
164287567|NCT00699660|593422795|FG001|Overall Study|missing reports and recording failures|6|||
164287568|NCT03915470|593422796|FG000|Overall Study|Death|3|||
164287569|NCT03915470|593422797|FG001|Overall Study|Death|1|||
164287570|NCT03915470|593422796|FG000|Overall Study|Adverse Event|1|||
164287571|NCT03915470|593422797|FG001|Overall Study|Adverse Event|0|||
164287572|NCT03915470|593422796|FG000|Overall Study|Physician Decision|1|||
164287573|NCT03915470|593422797|FG001|Overall Study|Physician Decision|0|||
164287574|NCT03915470|593422796|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
164287575|NCT03915470|593422797|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
164586716|NCT01855789|594511911|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
164586717|NCT01855789|594511912|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
164586718|NCT01855789|594511913|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
164692688|NCT03430011|594897043|FG006|Pre-Treatment|Screen Fail|0|||
164692689|NCT03430011|594897044|FG007|Pre-Treatment|Screen Fail|0|||
164287576|NCT03160898|593422798|FG000|Overall Study|Adverse Event|4|||
164287577|NCT03160898|593422799|FG001|Overall Study|Adverse Event|8|||
164287578|NCT03160898|593422800|FG002|Overall Study|Adverse Event|7|||
164287579|NCT03160898|593422801|FG003|Overall Study|Adverse Event|10|||
164287580|NCT03160898|593422798|FG000|Overall Study|Death|1|||
164287581|NCT03160898|593422799|FG001|Overall Study|Death|0|||
164287582|NCT03160898|593422800|FG002|Overall Study|Death|0|||
164287583|NCT03160898|593422801|FG003|Overall Study|Death|1|||
164287584|NCT03160898|593422798|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
164287585|NCT03160898|593422799|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
164287586|NCT03160898|593422800|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
164287587|NCT03160898|593422801|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
164287588|NCT03160898|593422798|FG000|Overall Study|Lost to Follow-up|1|||
164287589|NCT03160898|593422799|FG001|Overall Study|Lost to Follow-up|1|||
164287590|NCT03160898|593422800|FG002|Overall Study|Lost to Follow-up|1|||
164287591|NCT03160898|593422801|FG003|Overall Study|Lost to Follow-up|2|||
164287592|NCT03160898|593422798|FG000|Overall Study|Physician Decision|1|||
164287593|NCT03160898|593422799|FG001|Overall Study|Physician Decision|0|||
164287594|NCT03160898|593422800|FG002|Overall Study|Physician Decision|0|||
164287595|NCT03160898|593422801|FG003|Overall Study|Physician Decision|1|||
164287596|NCT03160898|593422798|FG000|Overall Study|Progressive Disease|4|||
164287597|NCT03160898|593422799|FG001|Overall Study|Progressive Disease|1|||
164287598|NCT03160898|593422800|FG002|Overall Study|Progressive Disease|2|||
164287599|NCT03160898|593422801|FG003|Overall Study|Progressive Disease|1|||
164287600|NCT03160898|593422798|FG000|Overall Study|Protocol Violation|1|||
164287601|NCT03160898|593422799|FG001|Overall Study|Protocol Violation|0|||
164287602|NCT03160898|593422800|FG002|Overall Study|Protocol Violation|2|||
164287603|NCT03160898|593422801|FG003|Overall Study|Protocol Violation|0|||
164287604|NCT03160898|593422798|FG000|Overall Study|Sponsor Discretion|2|||
164287605|NCT03160898|593422799|FG001|Overall Study|Sponsor Discretion|0|||
164287606|NCT03160898|593422800|FG002|Overall Study|Sponsor Discretion|0|||
164287607|NCT03160898|593422801|FG003|Overall Study|Sponsor Discretion|0|||
164287608|NCT03160898|593422798|FG000|Overall Study|Withdrawal by Subject|1|||
164287609|NCT03160898|593422799|FG001|Overall Study|Withdrawal by Subject|3|||
164287610|NCT03160898|593422800|FG002|Overall Study|Withdrawal by Subject|2|||
164287611|NCT03160898|593422801|FG003|Overall Study|Withdrawal by Subject|1|||
164287612|NCT03160898|593422798|FG000|Overall Study|Other|2|||
164287613|NCT03160898|593422799|FG001|Overall Study|Other|0|||
164287614|NCT03160898|593422800|FG002|Overall Study|Other|2|||
164287615|NCT03160898|593422801|FG003|Overall Study|Other|2|||
164287616|NCT03405818|593422804|FG000|Overall Study|Withdrawal by Subject|4|||
164287617|NCT03405818|593422804|FG000|Overall Study|Lost to Follow-up|4|||
164287618|NCT00434109|593422805|FG000|Overall Study|Physician Decision|9|||
164287619|NCT00434109|593422805|FG000|Overall Study|Adverse Event|5|||
164287620|NCT00434109|593422805|FG000|Overall Study|Protocol Violation|1|||
164287621|NCT00434109|593422805|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
164287622|NCT00549445|593422808|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
164287623|NCT00549445|593422809|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
164287624|NCT03932760|593422810|FG000|Overall Study|Became Ineligible|2|||
164287625|NCT03932760|593422811|FG001|Overall Study|Became Ineligible|5|||
164287626|NCT03932760|593422810|FG000|Overall Study|Withdrawal by Subject|6|||
164287627|NCT03932760|593422811|FG001|Overall Study|Withdrawal by Subject|6|||
164287628|NCT03922620|593422812|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
164287629|NCT03922620|593422813|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
164287630|NCT04725500|593422814|FG000|Screening|Screen Failure|26|||
164287631|NCT04725500|593422814|FG000|Screening|Withdrawal by Subject|1|||
164287632|NCT04725500|593422814|FG000|2 Week Take Home|Screen Fail|5|||
164287633|NCT00511238|593422817|FG000|Overall Study|Adverse Event|13|||
164287634|NCT00511238|593422818|FG001|Overall Study|Adverse Event|33|||
164287635|NCT00511238|593422817|FG000|Overall Study|Withdrawal by Subject|2|||
164287636|NCT00511238|593422818|FG001|Overall Study|Withdrawal by Subject|22|||
164287637|NCT00511238|593422817|FG000|Overall Study|Progressive Disease|23|||
164287638|NCT00511238|593422818|FG001|Overall Study|Progressive Disease|157|||
164287639|NCT00511238|593422817|FG000|Overall Study|various reasons|4|||
164287640|NCT00511238|593422818|FG001|Overall Study|various reasons|14|||
164287641|NCT03553758|593424486|FG000|Overall Study|Lost to Follow-up|1|||
164287642|NCT02614729|593424487|FG000|Overall Study|Withdrawal by Subject|1|||
164287643|NCT02614729|593424488|FG001|Overall Study|Withdrawal by Subject|0|||
164287644|NCT00527735|593424494|FG000|Overall Study|Disease progression|47|||
164287645|NCT00527735|593424495|FG001|Overall Study|Disease progression|61|||
164287646|NCT00527735|593424496|FG002|Overall Study|Disease progression|53|||
164287647|NCT00527735|593424494|FG000|Overall Study|Death|23|||
164287648|NCT00527735|593424495|FG001|Overall Study|Death|13|||
164287649|NCT00527735|593424496|FG002|Overall Study|Death|15|||
164287650|NCT00527735|593424494|FG000|Overall Study|Completed treatment in treatment phase|14|||
164287651|NCT00527735|593424495|FG001|Overall Study|Completed treatment in treatment phase|13|||
164287652|NCT00527735|593424496|FG002|Overall Study|Completed treatment in treatment phase|18|||
164287653|NCT00527735|593424494|FG000|Overall Study|Adverse Event|10|||
164287654|NCT00527735|593424495|FG001|Overall Study|Adverse Event|6|||
164287655|NCT00527735|593424496|FG002|Overall Study|Adverse Event|7|||
164287656|NCT00527735|593424494|FG000|Overall Study|Not identified|5|||
164287657|NCT00527735|593424495|FG001|Overall Study|Not identified|5|||
164287658|NCT00527735|593424496|FG002|Overall Study|Not identified|5|||
164287659|NCT00527735|593424494|FG000|Overall Study|Withdrawal by Subject|5|||
164287660|NCT00527735|593424495|FG001|Overall Study|Withdrawal by Subject|4|||
164287661|NCT00527735|593424496|FG002|Overall Study|Withdrawal by Subject|3|||
164287662|NCT00527735|593424494|FG000|Overall Study|No longer met study criteria|2|||
164287663|NCT00527735|593424495|FG001|Overall Study|No longer met study criteria|2|||
164287664|NCT00527735|593424496|FG002|Overall Study|No longer met study criteria|1|||
164287665|NCT00527735|593424494|FG000|Overall Study|Lost to Follow-up|0|||
164287666|NCT00527735|593424495|FG001|Overall Study|Lost to Follow-up|0|||
164287667|NCT00527735|593424496|FG002|Overall Study|Lost to Follow-up|3|||
164287668|NCT00527735|593424494|FG000|Overall Study|Poor compliance or noncompliance|0|||
164287669|NCT00527735|593424495|FG001|Overall Study|Poor compliance or noncompliance|1|||
164287670|NCT00527735|593424496|FG002|Overall Study|Poor compliance or noncompliance|1|||
164287671|NCT00527735|593424494|FG000|Overall Study|Completed treatment during maintenance|2|||
164287672|NCT00527735|593424495|FG001|Overall Study|Completed treatment during maintenance|2|||
164287673|NCT00527735|593424496|FG002|Overall Study|Completed treatment during maintenance|1|||
164287674|NCT01121146|593424500|FG000|Overall Study|Death|17|||
164287675|NCT01121146|593424501|FG001|Overall Study|Death|15|||
164287676|NCT01121146|593424500|FG000|Overall Study|Adverse Event|2|||
164287677|NCT01121146|593424501|FG001|Overall Study|Adverse Event|11|||
164287678|NCT01121146|593424500|FG000|Overall Study|Lost to Follow-up|7|||
164287679|NCT01121146|593424501|FG001|Overall Study|Lost to Follow-up|16|||
164287680|NCT01276639|593424502|FG000|Week 0 to 16|Death|1|||
164287681|NCT01276639|593424503|FG001|Week 0 to 16|Death|0|||
164287682|NCT01276639|593424504|FG002|Week 0 to 16|Death|0|||
164287683|NCT01276639|593424505|FG003|Week 0 to 16|Death|0|||
164287684|NCT01276639|593424506|FG004|Week 0 to 16|Death|0|||
164287685|NCT01276639|593424502|FG000|Week 0 to 16|Adverse Event|11|||
164287686|NCT01276639|593424503|FG001|Week 0 to 16|Adverse Event|8|||
164287687|NCT01276639|593424504|FG002|Week 0 to 16|Adverse Event|11|||
164287688|NCT01276639|593424505|FG003|Week 0 to 16|Adverse Event|0|||
164287689|NCT01276639|593424506|FG004|Week 0 to 16|Adverse Event|0|||
164287690|NCT01276639|593424502|FG000|Week 0 to 16|Lack of Efficacy|20|||
164287691|NCT01276639|593424503|FG001|Week 0 to 16|Lack of Efficacy|15|||
164287692|NCT01276639|593424504|FG002|Week 0 to 16|Lack of Efficacy|25|||
164287693|NCT01276639|593424505|FG003|Week 0 to 16|Lack of Efficacy|0|||
164287694|NCT01276639|593424506|FG004|Week 0 to 16|Lack of Efficacy|0|||
164287695|NCT01276639|593424502|FG000|Week 0 to 16|Lost to Follow-up|3|||
164287696|NCT01276639|593424503|FG001|Week 0 to 16|Lost to Follow-up|5|||
164287697|NCT01276639|593424504|FG002|Week 0 to 16|Lost to Follow-up|3|||
164287698|NCT01276639|593424505|FG003|Week 0 to 16|Lost to Follow-up|0|||
164287699|NCT01276639|593424506|FG004|Week 0 to 16|Lost to Follow-up|0|||
164287700|NCT01276639|593424502|FG000|Week 0 to 16|Withdrawal by Subject|8|||
164287701|NCT01276639|593424503|FG001|Week 0 to 16|Withdrawal by Subject|5|||
164287702|NCT01276639|593424504|FG002|Week 0 to 16|Withdrawal by Subject|4|||
164287703|NCT01276639|593424505|FG003|Week 0 to 16|Withdrawal by Subject|0|||
164287704|NCT01276639|593424506|FG004|Week 0 to 16|Withdrawal by Subject|0|||
164287705|NCT01276639|593424502|FG000|Week 0 to 16|Other|7|||
164287706|NCT01276639|593424503|FG001|Week 0 to 16|Other|7|||
164287707|NCT01276639|593424504|FG002|Week 0 to 16|Other|2|||
164287708|NCT01276639|593424505|FG003|Week 0 to 16|Other|0|||
164287709|NCT01276639|593424506|FG004|Week 0 to 16|Other|0|||
164287710|NCT01276639|593424502|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
164287711|NCT01276639|593424503|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
164287712|NCT01276639|593424504|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
164287713|NCT01276639|593424505|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
164287714|NCT01276639|593424506|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
164287715|NCT01276639|593424502|FG000|Week 16 to 52|Death|1|||
164287716|NCT01276639|593424503|FG001|Week 16 to 52|Death|0|||
164287717|NCT01276639|593424504|FG002|Week 16 to 52|Death|0|||
164287718|NCT01276639|593424505|FG003|Week 16 to 52|Death|0|||
164287719|NCT01276639|593424506|FG004|Week 16 to 52|Death|0|||
164287720|NCT01276639|593424502|FG000|Week 16 to 52|Adverse Event|10|||
164287721|NCT01276639|593424503|FG001|Week 16 to 52|Adverse Event|13|||
164287722|NCT01276639|593424504|FG002|Week 16 to 52|Adverse Event|0|||
164287723|NCT01276639|593424505|FG003|Week 16 to 52|Adverse Event|1|||
164287724|NCT01276639|593424506|FG004|Week 16 to 52|Adverse Event|3|||
164287725|NCT01276639|593424502|FG000|Week 16 to 52|Lack of Efficacy|99|||
164287726|NCT01276639|593424503|FG001|Week 16 to 52|Lack of Efficacy|71|||
164287727|NCT01276639|593424504|FG002|Week 16 to 52|Lack of Efficacy|0|||
164287728|NCT01276639|593424505|FG003|Week 16 to 52|Lack of Efficacy|14|||
164287729|NCT01276639|593424506|FG004|Week 16 to 52|Lack of Efficacy|13|||
164287730|NCT01276639|593424502|FG000|Week 16 to 52|Lost to Follow-up|3|||
164287731|NCT01276639|593424503|FG001|Week 16 to 52|Lost to Follow-up|1|||
164287732|NCT01276639|593424504|FG002|Week 16 to 52|Lost to Follow-up|0|||
164287733|NCT01276639|593424505|FG003|Week 16 to 52|Lost to Follow-up|0|||
164287734|NCT01276639|593424506|FG004|Week 16 to 52|Lost to Follow-up|1|||
164287735|NCT01276639|593424502|FG000|Week 16 to 52|Withdrawal by Subject|4|||
164287736|NCT01276639|593424503|FG001|Week 16 to 52|Withdrawal by Subject|4|||
164287737|NCT01276639|593424504|FG002|Week 16 to 52|Withdrawal by Subject|0|||
164287738|NCT01276639|593424505|FG003|Week 16 to 52|Withdrawal by Subject|0|||
164287739|NCT01276639|593424506|FG004|Week 16 to 52|Withdrawal by Subject|1|||
164287740|NCT01276639|593424502|FG000|Week 16 to 52|Other|10|||
164287741|NCT01276639|593424503|FG001|Week 16 to 52|Other|12|||
164287742|NCT01276639|593424504|FG002|Week 16 to 52|Other|0|||
164287743|NCT01276639|593424505|FG003|Week 16 to 52|Other|1|||
164287744|NCT01276639|593424506|FG004|Week 16 to 52|Other|3|||
164287745|NCT01132807|593424511|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
164287746|NCT01132807|593424512|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
164287747|NCT01132807|593424513|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
164287748|NCT01132807|593424511|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
164287749|NCT01132807|593424512|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
164287750|NCT01132807|593424513|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
164287751|NCT01380769|593424514|FG000|Overall Study|Withdrawal by Subject|7|||
164287752|NCT01380769|593424515|FG001|Overall Study|Withdrawal by Subject|11|||
164287753|NCT01380769|593424514|FG000|Overall Study|Physician Decision|1|||
164287754|NCT01380769|593424515|FG001|Overall Study|Physician Decision|1|||
164287755|NCT01380769|593424514|FG000|Overall Study|Adverse Event|1|||
164287756|NCT01380769|593424515|FG001|Overall Study|Adverse Event|1|||
164287757|NCT01380769|593424514|FG000|Overall Study|Protocol Violation|0|||
164287758|NCT01380769|593424515|FG001|Overall Study|Protocol Violation|1|||
164287759|NCT03654690|593424517|FG000|Overall Study|Withdrawal by Subject|1|||
164287760|NCT03654690|593424518|FG001|Overall Study|Withdrawal by Subject|0|||
164287761|NCT03654690|593424519|FG002|Overall Study|Withdrawal by Subject|0|||
164287762|NCT01080807|593424526|FG000|Overall Study|Adverse Event|9|||
164287763|NCT01080807|593424527|FG001|Overall Study|Adverse Event|1|||
164287764|NCT01080807|593424526|FG000|Overall Study|Lack of Efficacy|0|||
164287765|NCT01080807|593424527|FG001|Overall Study|Lack of Efficacy|1|||
164287766|NCT01080807|593424526|FG000|Overall Study|Withdrawal by Subject|7|||
164287767|NCT01080807|593424527|FG001|Overall Study|Withdrawal by Subject|2|||
164287768|NCT01080807|593424526|FG000|Overall Study|Protocol Violation|7|||
164287769|NCT01080807|593424527|FG001|Overall Study|Protocol Violation|6|||
164287770|NCT01080807|593424526|FG000|Overall Study|Lost to Follow-up|6|||
164287771|NCT01080807|593424527|FG001|Overall Study|Lost to Follow-up|4|||
164287772|NCT01080807|593424526|FG000|Overall Study|Noncompliance with drug administration|1|||
164287773|NCT01080807|593424527|FG001|Overall Study|Noncompliance with drug administration|1|||
164287774|NCT01080807|593424526|FG000|Overall Study|Noncompliance to study procedures|1|||
164345202|NCT01817530|593638959|FG002|Overall Study|Surgery or Invasive Intervention|0|||
164345203|NCT01817530|593638960|FG003|Overall Study|Surgery or Invasive Intervention|0|||
164345204|NCT01817530|593638961|FG004|Overall Study|Surgery or Invasive Intervention|1|||
164345205|NCT01817530|593638962|FG005|Overall Study|Surgery or Invasive Intervention|1|||
164345206|NCT01817530|593638963|FG006|Overall Study|Surgery or Invasive Intervention|1|||
164345207|NCT01817530|593638964|FG007|Overall Study|Surgery or Invasive Intervention|0|||
164345208|NCT01817530|593638957|FG000|Overall Study|Consent Withdrawn by Subject|3|||
164345209|NCT01817530|593638958|FG001|Overall Study|Consent Withdrawn by Subject|4|||
164345210|NCT01817530|593638959|FG002|Overall Study|Consent Withdrawn by Subject|7|||
164345211|NCT01817530|593638960|FG003|Overall Study|Consent Withdrawn by Subject|3|||
164586719|NCT01855789|594511910|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
164586720|NCT01855789|594511911|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
164586721|NCT01855789|594511912|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
164586722|NCT01855789|594511913|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
164586723|NCT01855789|594511910|FG000|1) Baseline up to Week 24|Other|4|||
164586724|NCT01855789|594511911|FG001|1) Baseline up to Week 24|Other|0|||
164287775|NCT01080807|593424527|FG001|Overall Study|Noncompliance to study procedures|1|||
164287776|NCT01080807|593424526|FG000|Overall Study|Began working day shift|0|||
164287777|NCT01080807|593424527|FG001|Overall Study|Began working day shift|2|||
164287778|NCT01080807|593424526|FG000|Overall Study|Laid off or terminated from job|1|||
164287779|NCT01080807|593424527|FG001|Overall Study|Laid off or terminated from job|2|||
164287780|NCT01080807|593424526|FG000|Overall Study|Stopped working consistent night shifts|0|||
164287781|NCT01080807|593424527|FG001|Overall Study|Stopped working consistent night shifts|1|||
164287782|NCT01080807|593424526|FG000|Overall Study|Work schedule changing|1|||
164287783|NCT01080807|593424527|FG001|Overall Study|Work schedule changing|1|||
164287784|NCT01080807|593424526|FG000|Overall Study|Work schedule and travel|0|||
164287785|NCT01080807|593424527|FG001|Overall Study|Work schedule and travel|1|||
164586725|NCT01855789|594511912|FG002|1) Baseline up to Week 24|Other|0|||
164287786|NCT01080807|593424526|FG000|Overall Study|Switched to first shift|1|||
164287787|NCT01080807|593424527|FG001|Overall Study|Switched to first shift|0|||
164287788|NCT01080807|593424526|FG000|Overall Study|Moved away without notifying center|1|||
164287789|NCT01080807|593424527|FG001|Overall Study|Moved away without notifying center|0|||
164287790|NCT03922581|593424535|FG000|Overall Study|Lost to Follow-up|20|||
164287791|NCT03922581|593424536|FG001|Overall Study|Lost to Follow-up|9|||
164287792|NCT03922581|593424535|FG000|Overall Study|Physician Decision|1|||
164287793|NCT03922581|593424536|FG001|Overall Study|Physician Decision|1|||
164287794|NCT03922581|593424535|FG000|Overall Study|Withdrawal by Subject|1|||
164287795|NCT03922581|593424536|FG001|Overall Study|Withdrawal by Subject|0|||
164287796|NCT00764699|593424539|FG000|Overall Study|PI left and study terminated|3|||
164287797|NCT02223715|593424540|FG000|Overall Study|Death|31|||
164287798|NCT02223715|593424540|FG000|Overall Study|Lost to Follow-up|73|||
164287799|NCT01745367|593424541|FG000|Overall Study|Death|1|||
164287800|NCT01745367|593424542|FG001|Overall Study|Death|0|||
164287801|NCT01745367|593424541|FG000|Overall Study|Withdrawal by Subject|1|||
164287802|NCT01745367|593424542|FG001|Overall Study|Withdrawal by Subject|2|||
164287803|NCT01745367|593424541|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
164287804|NCT01745367|593424542|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
164287805|NCT01745367|593424541|FG000|Overall Study|Other Reasons Unspecified|0|||
164287806|NCT01745367|593424542|FG001|Overall Study|Other Reasons Unspecified|2|||
164287807|NCT02366312|593424546|FG000|Overall Study|Lost to Follow-up|0|||
164287808|NCT02366312|593424547|FG001|Overall Study|Lost to Follow-up|1|||
164287809|NCT00965081|593424548|FG000|Overall Study|Adverse Event|14|||
164287810|NCT00965081|593424549|FG001|Overall Study|Adverse Event|9|||
164287811|NCT00965081|593424548|FG000|Overall Study|Lack of Efficacy|2|||
164287812|NCT00965081|593424549|FG001|Overall Study|Lack of Efficacy|5|||
164287813|NCT00965081|593424548|FG000|Overall Study|Lost to Follow-up|4|||
164287814|NCT00965081|593424549|FG001|Overall Study|Lost to Follow-up|5|||
164287815|NCT00965081|593424548|FG000|Overall Study|Physician Decision|2|||
164287816|NCT00965081|593424549|FG001|Overall Study|Physician Decision|0|||
164287817|NCT00965081|593424548|FG000|Overall Study|Protocol Violation|2|||
164287818|NCT00965081|593424549|FG001|Overall Study|Protocol Violation|5|||
164287819|NCT00965081|593424548|FG000|Overall Study|Sponsor Decision|1|||
164287820|NCT00965081|593424549|FG001|Overall Study|Sponsor Decision|0|||
164287821|NCT00965081|593424548|FG000|Overall Study|Withdrawal by Subject|4|||
164287822|NCT00965081|593424549|FG001|Overall Study|Withdrawal by Subject|7|||
164287823|NCT00965081|593424548|FG000|Overall Study|Switched to Rescue Arm|5|||
164287824|NCT00965081|593424549|FG001|Overall Study|Switched to Rescue Arm|12|||
164287825|NCT01076959|593424563|FG000|Overall Study|Adverse Event|767|||
164287826|NCT01076959|593424563|FG000|Overall Study|Lack of Efficacy|849|||
164287827|NCT01076959|593424563|FG000|Overall Study|Non-compliance|274|||
164287828|NCT01076959|593424563|FG000|Overall Study|Lost to Follow-up|241|||
164287829|NCT01076959|593424563|FG000|Overall Study|Other|119|||
164287830|NCT02491983|593424564|FG000|Overall Study|Physician Decision|1|||
164287831|NCT02491983|593424565|FG001|Overall Study|Physician Decision|0|||
164287832|NCT02491983|593424564|FG000|Overall Study|Not meet selection criteria|1|||
164287833|NCT02491983|593424565|FG001|Overall Study|Not meet selection criteria|0|||
164287834|NCT02491983|593424564|FG000|Overall Study|Withdrawal by Subject|0|||
164287835|NCT02491983|593424565|FG001|Overall Study|Withdrawal by Subject|1|||
164287836|NCT02021565|593424566|FG000|Baseline Through Intervention|Death|0|||
164287837|NCT02021565|593424567|FG001|Baseline Through Intervention|Death|1|||
164287838|NCT02021565|593424566|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
164287839|NCT02021565|593424567|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
164287840|NCT02021565|593424566|FG000|Baseline Through Intervention|Protocol Violation|0|||
164287841|NCT02021565|593424567|FG001|Baseline Through Intervention|Protocol Violation|7|||
164287842|NCT02021565|593424566|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
164287843|NCT02021565|593424567|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
164287844|NCT02021565|593424566|FG000|3-month Follow-up|Death|3|||
164287845|NCT02021565|593424567|FG001|3-month Follow-up|Death|0|||
164287846|NCT02021565|593424566|FG000|3-month Follow-up|Withdrawal by Subject|4|||
164287847|NCT02021565|593424567|FG001|3-month Follow-up|Withdrawal by Subject|0|||
164287848|NCT02021565|593424566|FG000|3-month Follow-up|Protocol Violation|3|||
164287849|NCT02021565|593424567|FG001|3-month Follow-up|Protocol Violation|2|||
164287850|NCT03575403|593424570|FG000|Overall Study|Adverse Event|1|||
164287851|NCT03575403|593424571|FG001|Overall Study|Adverse Event|0|||
164287852|NCT03575403|593424572|FG002|Overall Study|Adverse Event|0|||
164287853|NCT03575403|593424570|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
164287854|NCT03575403|593424571|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
164287855|NCT03575403|593424572|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
164287856|NCT02292719|593424573|FG000|Overall Study|Withdrawal by Subject|0|||
164287857|NCT02292719|593424574|FG001|Overall Study|Withdrawal by Subject|0|||
164287858|NCT02292719|593424575|FG002|Overall Study|Withdrawal by Subject|0|||
164287859|NCT02292719|593424576|FG003|Overall Study|Withdrawal by Subject|1|||
164287860|NCT02292719|593424577|FG004|Overall Study|Withdrawal by Subject|1|||
164287861|NCT02292719|593424578|FG005|Overall Study|Withdrawal by Subject|0|||
164287862|NCT02292719|593424573|FG000|Overall Study|Subject enrolled in new study.|0|||
164287863|NCT02292719|593424574|FG001|Overall Study|Subject enrolled in new study.|0|||
164287864|NCT02292719|593424575|FG002|Overall Study|Subject enrolled in new study.|1|||
164287865|NCT02292719|593424576|FG003|Overall Study|Subject enrolled in new study.|0|||
164287866|NCT02292719|593424577|FG004|Overall Study|Subject enrolled in new study.|0|||
164287867|NCT02292719|593424578|FG005|Overall Study|Subject enrolled in new study.|0|||
164287868|NCT01332994|593424579|FG000|Overall Study|Adverse Event|34|||
164287869|NCT01332994|593424579|FG000|Overall Study|Death|1|||
164287870|NCT01332994|593424579|FG000|Overall Study|Lack of Efficacy|1|||
164287871|NCT01332994|593424579|FG000|Overall Study|Lost to Follow-up|4|||
164287872|NCT01332994|593424579|FG000|Overall Study|Protocol Violation|6|||
164287873|NCT01332994|593424579|FG000|Overall Study|Withdrawal by Subject|15|||
164287874|NCT01332994|593424579|FG000|Overall Study|Administrative Problem|2|||
164287875|NCT01332994|593424579|FG000|Overall Study|Other|8|||
164287876|NCT00731679|593424581|FG000|Overall Study|Adverse Event|7|||
164287877|NCT00731679|593424582|FG001|Overall Study|Adverse Event|8|||
164287878|NCT00731679|593424581|FG000|Overall Study|Withdrawal by Subject|8|||
164287879|NCT00731679|593424582|FG001|Overall Study|Withdrawal by Subject|8|||
164287880|NCT00731679|593424581|FG000|Overall Study|Lost to Follow-up|7|||
164287881|NCT00731679|593424582|FG001|Overall Study|Lost to Follow-up|8|||
164287882|NCT00731679|593424581|FG000|Overall Study|Noncompliance|0|||
164287883|NCT00731679|593424582|FG001|Overall Study|Noncompliance|1|||
164287884|NCT00731679|593424581|FG000|Overall Study|Pregnancy|0|||
164287885|NCT00731679|593424582|FG001|Overall Study|Pregnancy|1|||
164287886|NCT03089580|593424588|FG000|Overall Study|Lost to Follow-up|2|||
164287887|NCT03087513|593424589|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
164287888|NCT04170543|593424590|FG000|Overall Study|Death|1|||
164287889|NCT04170543|593424591|FG001|Overall Study|Death|1|||
164287890|NCT04170543|593424592|FG002|Overall Study|Death|1|||
164287891|NCT04170543|593424593|FG003|Overall Study|Death|1|||
164287892|NCT04170543|593424594|FG004|Overall Study|Death|1|||
164287893|NCT04170543|593424590|FG000|Overall Study|Lost to Follow-up|3|||
164287894|NCT04170543|593424591|FG001|Overall Study|Lost to Follow-up|3|||
164287895|NCT04170543|593424592|FG002|Overall Study|Lost to Follow-up|0|||
164287896|NCT04170543|593424593|FG003|Overall Study|Lost to Follow-up|3|||
164287897|NCT04170543|593424594|FG004|Overall Study|Lost to Follow-up|1|||
164287898|NCT04170543|593424590|FG000|Overall Study|Withdrawal by Subject|13|||
164287899|NCT04170543|593424591|FG001|Overall Study|Withdrawal by Subject|6|||
164287900|NCT04170543|593424592|FG002|Overall Study|Withdrawal by Subject|5|||
164287901|NCT04170543|593424593|FG003|Overall Study|Withdrawal by Subject|4|||
164287902|NCT04170543|593424594|FG004|Overall Study|Withdrawal by Subject|9|||
164287903|NCT04170543|593424590|FG000|Overall Study|Not able to transition to phase 2b|8|||
164287904|NCT04170543|593424591|FG001|Overall Study|Not able to transition to phase 2b|0|||
164287905|NCT04170543|593424592|FG002|Overall Study|Not able to transition to phase 2b|10|||
164287906|NCT04170543|593424593|FG003|Overall Study|Not able to transition to phase 2b|0|||
164287907|NCT04170543|593424594|FG004|Overall Study|Not able to transition to phase 2b|6|||
164287908|NCT04170543|593424590|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
164287909|NCT04170543|593424591|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
164287910|NCT04170543|593424592|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
164287911|NCT04170543|593424593|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
164287912|NCT04170543|593424594|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
164287913|NCT04170543|593424590|FG000|Overall Study|Not Treated|0|||
164287914|NCT04170543|593424591|FG001|Overall Study|Not Treated|0|||
164287915|NCT04170543|593424592|FG002|Overall Study|Not Treated|0|||
164287916|NCT04170543|593424593|FG003|Overall Study|Not Treated|0|||
164287917|NCT04170543|593424594|FG004|Overall Study|Not Treated|2|||
164287918|NCT04170543|593424590|FG000|Overall Study|(CRF)|16|||
164287919|NCT04170543|593424591|FG001|Overall Study|(CRF)|15|||
164287920|NCT04170543|593424592|FG002|Overall Study|(CRF)|12|||
164287921|NCT04170543|593424593|FG003|Overall Study|(CRF)|17|||
164287922|NCT04170543|593424594|FG004|Overall Study|(CRF)|17|||
164345212|NCT01817530|593638961|FG004|Overall Study|Consent Withdrawn by Subject|5|||
164345213|NCT01817530|593638962|FG005|Overall Study|Consent Withdrawn by Subject|3|||
164345214|NCT01817530|593638963|FG006|Overall Study|Consent Withdrawn by Subject|3|||
164345215|NCT01817530|593638964|FG007|Overall Study|Consent Withdrawn by Subject|10|||
164345216|NCT01817530|593638957|FG000|Overall Study|Lost to Follow-up|1|||
164287923|NCT04170543|593424590|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
164287924|NCT04170543|593424591|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
164287925|NCT04170543|593424592|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
164287926|NCT04170543|593424593|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
164287927|NCT04170543|593424594|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
164287928|NCT00770601|593424595|FG000|Overall Study|Withdrawal by Subject|1|||
164287929|NCT04628780|593424596|FG000|Overall Study|Death|0|||
164287930|NCT04628780|593424597|FG001|Overall Study|Death|1|||
164287931|NCT04628780|593424598|FG002|Overall Study|Death|0|||
164287932|NCT04628780|593424599|FG003|Overall Study|Death|0|||
164287933|NCT04628780|593424600|FG004|Overall Study|Death|1|||
164287934|NCT04628780|593424601|FG005|Overall Study|Death|0|||
164287935|NCT04628780|593424596|FG000|Overall Study|Physician Decision|2|||
164287936|NCT04628780|593424597|FG001|Overall Study|Physician Decision|0|||
164287937|NCT04628780|593424598|FG002|Overall Study|Physician Decision|0|||
164287938|NCT04628780|593424599|FG003|Overall Study|Physician Decision|0|||
164287939|NCT04628780|593424600|FG004|Overall Study|Physician Decision|2|||
164287940|NCT04628780|593424601|FG005|Overall Study|Physician Decision|0|||
164287941|NCT04628780|593424596|FG000|Overall Study|Progressive disease|2|||
164287942|NCT04628780|593424597|FG001|Overall Study|Progressive disease|2|||
164287943|NCT04628780|593424598|FG002|Overall Study|Progressive disease|2|||
164287944|NCT04628780|593424599|FG003|Overall Study|Progressive disease|3|||
164287945|NCT04628780|593424600|FG004|Overall Study|Progressive disease|9|||
164287946|NCT04628780|593424601|FG005|Overall Study|Progressive disease|4|||
164287947|NCT04628780|593424596|FG000|Overall Study|Withdrawal by Subject|0|||
164287948|NCT04628780|593424597|FG001|Overall Study|Withdrawal by Subject|1|||
164287949|NCT04628780|593424598|FG002|Overall Study|Withdrawal by Subject|2|||
164287950|NCT04628780|593424599|FG003|Overall Study|Withdrawal by Subject|0|||
164287951|NCT04628780|593424600|FG004|Overall Study|Withdrawal by Subject|3|||
164287952|NCT04628780|593424601|FG005|Overall Study|Withdrawal by Subject|1|||
164287953|NCT04628780|593424596|FG000|Overall Study|Global deterioration of health status|0|||
164287954|NCT04628780|593424597|FG001|Overall Study|Global deterioration of health status|0|||
164287955|NCT04628780|593424598|FG002|Overall Study|Global deterioration of health status|0|||
164287956|NCT04628780|593424599|FG003|Overall Study|Global deterioration of health status|0|||
164287957|NCT04628780|593424600|FG004|Overall Study|Global deterioration of health status|1|||
164287958|NCT04628780|593424601|FG005|Overall Study|Global deterioration of health status|1|||
164287959|NCT03269994|593424603|FG000|Overall Study|Withdrawal by Subject|4|||
164287960|NCT03269994|593424604|FG001|Overall Study|Withdrawal by Subject|5|||
164287961|NCT03269994|593424603|FG000|Overall Study|Unresectable at surgery|39|||
164287962|NCT03269994|593424604|FG001|Overall Study|Unresectable at surgery|58|||
164287963|NCT03269994|593424603|FG000|Overall Study|Patient canceled surgery|5|||
164287964|NCT03269994|593424604|FG001|Overall Study|Patient canceled surgery|14|||
164287965|NCT03269994|593424603|FG000|Overall Study|Preoperative progression|14|||
164287966|NCT03269994|593424604|FG001|Overall Study|Preoperative progression|9|||
164287967|NCT03269994|593424603|FG000|Overall Study|Preoperative infection|10|||
164287968|NCT03269994|593424604|FG001|Overall Study|Preoperative infection|4|||
164287969|NCT03269994|593424603|FG000|Overall Study|Kidney insufficiency|1|||
164287970|NCT03269994|593424604|FG001|Overall Study|Kidney insufficiency|0|||
164287971|NCT03269994|593424603|FG000|Overall Study|Drug allergy|0|||
164287972|NCT03269994|593424604|FG001|Overall Study|Drug allergy|2|||
164287973|NCT03269994|593424603|FG000|Overall Study|Operation changed to different resection|9|||
164287974|NCT03269994|593424604|FG001|Overall Study|Operation changed to different resection|0|||
164287975|NCT03269994|593424603|FG000|Overall Study|Preoperative steroid|0|||
164345217|NCT01817530|593638958|FG001|Overall Study|Lost to Follow-up|4|||
164345218|NCT01817530|593638959|FG002|Overall Study|Lost to Follow-up|2|||
164345219|NCT01817530|593638960|FG003|Overall Study|Lost to Follow-up|1|||
164345220|NCT01817530|593638961|FG004|Overall Study|Lost to Follow-up|3|||
164345221|NCT01817530|593638962|FG005|Overall Study|Lost to Follow-up|2|||
164345222|NCT01817530|593638963|FG006|Overall Study|Lost to Follow-up|8|||
164345223|NCT01817530|593638964|FG007|Overall Study|Lost to Follow-up|4|||
164345224|NCT00566995|593638966|FG000|Overall Study|Toxicity|4|||
164345225|NCT00566995|593638966|FG000|Overall Study|Withdrew consent|3|||
164345226|NCT02657369|593638967|FG000|Overall Study|Death|27|||
164345227|NCT02657369|593638967|FG000|Overall Study|Study terminated by sponsor|7|||
164345228|NCT00481078|593638968|FG000|Overall Study|Progression of disease|11|||
164345229|NCT00481078|593638969|FG001|Overall Study|Progression of disease|11|||
164345230|NCT00481078|593638968|FG000|Overall Study|Adverse Event|15|||
164345231|NCT00481078|593638969|FG001|Overall Study|Adverse Event|3|||
164345232|NCT00481078|593638968|FG000|Overall Study|Death|5|||
164345233|NCT00481078|593638969|FG001|Overall Study|Death|3|||
164345234|NCT00481078|593638968|FG000|Overall Study|Intercurrent illness|1|||
164345235|NCT00481078|593638969|FG001|Overall Study|Intercurrent illness|0|||
164345236|NCT00481078|593638968|FG000|Overall Study|Withdrawal by Subject|7|||
164345237|NCT00481078|593638969|FG001|Overall Study|Withdrawal by Subject|1|||
164345238|NCT00481078|593638968|FG000|Overall Study|Information not available|1|||
164287976|NCT03269994|593424604|FG001|Overall Study|Preoperative steroid|3|||
164287977|NCT03269994|593424603|FG000|Overall Study|Accrual Closed|2|||
164287978|NCT03269994|593424604|FG001|Overall Study|Accrual Closed|0|||
164287979|NCT03269994|593424603|FG000|Overall Study|Operation changed to different resection|0|||
164287980|NCT03269994|593424604|FG001|Overall Study|Operation changed to different resection|10|||
164287981|NCT01987102|593424608|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
164287982|NCT01987102|593424609|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
164345239|NCT00481078|593638969|FG001|Overall Study|Information not available|0|||
164345240|NCT00481078|593638968|FG000|Overall Study|Received other treatment|2|||
164345241|NCT00481078|593638969|FG001|Overall Study|Received other treatment|1|||
164345242|NCT00481078|593638968|FG000|Overall Study|Brain metastasis|0|||
164345243|NCT00481078|593638969|FG001|Overall Study|Brain metastasis|1|||
164287983|NCT01987102|593424608|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
164287984|NCT01987102|593424609|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
164287985|NCT01987102|593424608|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
164287986|NCT01987102|593424609|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
164287987|NCT01987102|593424608|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
164287988|NCT01987102|593424609|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
164287989|NCT01987102|593424608|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
164287990|NCT01987102|593424609|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
164287991|NCT01987102|593424608|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
164287992|NCT01987102|593424609|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
164287993|NCT01288989|593424610|FG000|Overall Study|Death|0|||
164287994|NCT01288989|593424611|FG001|Overall Study|Death|0|||
164287995|NCT01288989|593424612|FG002|Overall Study|Death|0|||
164287996|NCT01288989|593424613|FG003|Overall Study|Death|1|||
164287997|NCT01288989|593424614|FG004|Overall Study|Death|0|||
164287998|NCT01288989|593424610|FG000|Overall Study|Dose limiting toxicity|1|||
164287999|NCT01288989|593424611|FG001|Overall Study|Dose limiting toxicity|0|||
164288000|NCT01288989|593424612|FG002|Overall Study|Dose limiting toxicity|0|||
164288001|NCT01288989|593424613|FG003|Overall Study|Dose limiting toxicity|0|||
164288002|NCT01288989|593424614|FG004|Overall Study|Dose limiting toxicity|0|||
164288003|NCT01288989|593424610|FG000|Overall Study|Adverse Event|0|||
164288004|NCT01288989|593424611|FG001|Overall Study|Adverse Event|0|||
164288005|NCT01288989|593424612|FG002|Overall Study|Adverse Event|0|||
164288006|NCT01288989|593424613|FG003|Overall Study|Adverse Event|0|||
164288007|NCT01288989|593424614|FG004|Overall Study|Adverse Event|2|||
164288008|NCT01288989|593424610|FG000|Overall Study|Physician Decision|0|||
164288009|NCT01288989|593424611|FG001|Overall Study|Physician Decision|0|||
164288010|NCT01288989|593424612|FG002|Overall Study|Physician Decision|0|||
164288011|NCT01288989|593424613|FG003|Overall Study|Physician Decision|0|||
164288012|NCT01288989|593424614|FG004|Overall Study|Physician Decision|1|||
164288013|NCT01288989|593424610|FG000|Overall Study|Withdrawal by Subject|0|||
164288014|NCT01288989|593424611|FG001|Overall Study|Withdrawal by Subject|0|||
164288015|NCT01288989|593424612|FG002|Overall Study|Withdrawal by Subject|0|||
164288016|NCT01288989|593424613|FG003|Overall Study|Withdrawal by Subject|0|||
164288017|NCT01288989|593424614|FG004|Overall Study|Withdrawal by Subject|3|||
164288018|NCT04378270|593424615|FG000|Overall Study|Lack of Efficacy|1|||
164288019|NCT04378270|593424615|FG000|Overall Study|Withdrawal by Subject|1|||
164288020|NCT04378270|593424615|FG000|Overall Study|Screen Failure|1|||
164288021|NCT04378270|593424615|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
164288022|NCT01327599|593424616|FG000|Overall Study|Adverse Event|1|||
164288023|NCT01327599|593424616|FG000|Overall Study|Could Not Attend Visit|1|||
164288024|NCT01327599|593424616|FG000|Overall Study|Withdrawal of Consent|1|||
164288025|NCT01132313|593424617|FG000|Overall Study|Lack of Efficacy|1|||
164288026|NCT01132313|593424618|FG001|Overall Study|Lack of Efficacy|0|||
164288027|NCT01132313|593424619|FG002|Overall Study|Lack of Efficacy|0|||
164288028|NCT01132313|593424620|FG003|Overall Study|Lack of Efficacy|0|||
164288029|NCT01132313|593424621|FG004|Overall Study|Lack of Efficacy|0|||
164288030|NCT01132313|593424622|FG005|Overall Study|Lack of Efficacy|0|||
164288031|NCT01132313|593424623|FG006|Overall Study|Lack of Efficacy|0|||
164288032|NCT01132313|593424624|FG007|Overall Study|Lack of Efficacy|3|||
164288033|NCT01132313|593424625|FG008|Overall Study|Lack of Efficacy|14|||
164288034|NCT01132313|593424626|FG009|Overall Study|Lack of Efficacy|16|||
164345244|NCT00074152|593638970|FG000|Overall Study|Death|21|||
164345245|NCT00074152|593638971|FG001|Overall Study|Death|9|||
164345246|NCT00074152|593638970|FG000|Overall Study|Lack of Efficacy|34|||
164345247|NCT00074152|593638971|FG001|Overall Study|Lack of Efficacy|24|||
164345248|NCT00228384|593638972|FG000|Overall Study|Death|9|||
164345249|NCT00228384|593638973|FG001|Overall Study|Death|3|||
164345250|NCT00228384|593638972|FG000|Overall Study|Lost to Follow-up|6|||
164345251|NCT00228384|593638973|FG001|Overall Study|Lost to Follow-up|10|||
164345252|NCT00228384|593638972|FG000|Overall Study|Surgical Intervention (bypass)|5|||
164345253|NCT00228384|593638973|FG001|Overall Study|Surgical Intervention (bypass)|5|||
164288035|NCT01132313|593424627|FG010|Overall Study|Lack of Efficacy|0|||
164288036|NCT01132313|593424628|FG011|Overall Study|Lack of Efficacy|0|||
164288037|NCT01132313|593424617|FG000|Overall Study|Not treated|2|||
164288038|NCT01132313|593424618|FG001|Overall Study|Not treated|0|||
164288039|NCT01132313|593424619|FG002|Overall Study|Not treated|0|||
164288040|NCT01132313|593424620|FG003|Overall Study|Not treated|0|||
164288041|NCT01132313|593424621|FG004|Overall Study|Not treated|2|||
164288042|NCT01132313|593424622|FG005|Overall Study|Not treated|1|||
164288043|NCT01132313|593424623|FG006|Overall Study|Not treated|3|||
164288044|NCT01132313|593424624|FG007|Overall Study|Not treated|0|||
164288045|NCT01132313|593424625|FG008|Overall Study|Not treated|0|||
164288046|NCT01132313|593424626|FG009|Overall Study|Not treated|0|||
164288047|NCT01132313|593424627|FG010|Overall Study|Not treated|0|||
164288048|NCT01132313|593424628|FG011|Overall Study|Not treated|0|||
164288049|NCT01132313|593424617|FG000|Overall Study|Adverse Event|0|||
164345254|NCT00228384|593638972|FG000|Overall Study|Withdrawal by Subject|9|||
164345255|NCT00228384|593638973|FG001|Overall Study|Withdrawal by Subject|10|||
164288050|NCT01132313|593424618|FG001|Overall Study|Adverse Event|0|||
164288051|NCT01132313|593424619|FG002|Overall Study|Adverse Event|4|||
164288052|NCT01132313|593424620|FG003|Overall Study|Adverse Event|10|||
164288053|NCT01132313|593424621|FG004|Overall Study|Adverse Event|19|||
164288054|NCT01132313|593424622|FG005|Overall Study|Adverse Event|6|||
164288055|NCT01132313|593424623|FG006|Overall Study|Adverse Event|5|||
164288056|NCT01132313|593424624|FG007|Overall Study|Adverse Event|3|||
164288057|NCT01132313|593424625|FG008|Overall Study|Adverse Event|7|||
164288058|NCT01132313|593424626|FG009|Overall Study|Adverse Event|2|||
164288059|NCT01132313|593424627|FG010|Overall Study|Adverse Event|0|||
164288060|NCT01132313|593424628|FG011|Overall Study|Adverse Event|0|||
164288061|NCT01132313|593424617|FG000|Overall Study|Protocol Violation|0|||
164288062|NCT01132313|593424618|FG001|Overall Study|Protocol Violation|0|||
164288063|NCT01132313|593424619|FG002|Overall Study|Protocol Violation|0|||
164288064|NCT01132313|593424620|FG003|Overall Study|Protocol Violation|1|||
164288065|NCT01132313|593424621|FG004|Overall Study|Protocol Violation|0|||
164345256|NCT00228384|593638972|FG000|Overall Study|Physician Decision|0|||
164345257|NCT00228384|593638973|FG001|Overall Study|Physician Decision|1|||
164345258|NCT01785069|593638974|FG000|Overall Study|Implanted with nonstudy device|1|||
164288066|NCT01132313|593424622|FG005|Overall Study|Protocol Violation|0|||
164288067|NCT01132313|593424623|FG006|Overall Study|Protocol Violation|0|||
164288068|NCT01132313|593424624|FG007|Overall Study|Protocol Violation|0|||
164288069|NCT01132313|593424625|FG008|Overall Study|Protocol Violation|0|||
164288070|NCT01132313|593424626|FG009|Overall Study|Protocol Violation|0|||
164288071|NCT01132313|593424627|FG010|Overall Study|Protocol Violation|0|||
164288072|NCT01132313|593424628|FG011|Overall Study|Protocol Violation|0|||
164288073|NCT01132313|593424617|FG000|Overall Study|Lost to Follow-up|0|||
164288074|NCT01132313|593424618|FG001|Overall Study|Lost to Follow-up|0|||
164288075|NCT01132313|593424619|FG002|Overall Study|Lost to Follow-up|1|||
164288076|NCT01132313|593424620|FG003|Overall Study|Lost to Follow-up|0|||
164288077|NCT01132313|593424621|FG004|Overall Study|Lost to Follow-up|0|||
164288078|NCT01132313|593424622|FG005|Overall Study|Lost to Follow-up|0|||
164288079|NCT01132313|593424623|FG006|Overall Study|Lost to Follow-up|0|||
164288080|NCT01132313|593424624|FG007|Overall Study|Lost to Follow-up|1|||
164288081|NCT01132313|593424625|FG008|Overall Study|Lost to Follow-up|0|||
164288082|NCT01132313|593424626|FG009|Overall Study|Lost to Follow-up|0|||
164288083|NCT01132313|593424627|FG010|Overall Study|Lost to Follow-up|0|||
164288084|NCT01132313|593424628|FG011|Overall Study|Lost to Follow-up|0|||
164345259|NCT01785069|593638975|FG001|Overall Study|Implanted with nonstudy device|2|||
164345260|NCT01785069|593638976|FG002|Overall Study|Implanted with nonstudy device|1|||
164345261|NCT01785069|593638977|FG003|Overall Study|Implanted with nonstudy device|0|||
164345262|NCT01785069|593638974|FG000|Overall Study|Death|0|||
164345263|NCT01785069|593638975|FG001|Overall Study|Death|0|||
164345264|NCT01785069|593638976|FG002|Overall Study|Death|2|||
164345265|NCT01785069|593638977|FG003|Overall Study|Death|0|||
164345266|NCT01785069|593638974|FG000|Overall Study|Subject choice|2|||
164345267|NCT01785069|593638975|FG001|Overall Study|Subject choice|2|||
164345268|NCT01785069|593638976|FG002|Overall Study|Subject choice|0|||
164345269|NCT01785069|593638977|FG003|Overall Study|Subject choice|1|||
164345270|NCT01785069|593638974|FG000|Overall Study|Lost to Follow-up|1|||
164345271|NCT01785069|593638975|FG001|Overall Study|Lost to Follow-up|2|||
164345272|NCT01785069|593638976|FG002|Overall Study|Lost to Follow-up|4|||
164345273|NCT01785069|593638977|FG003|Overall Study|Lost to Follow-up|1|||
164345274|NCT01785069|593638974|FG000|Overall Study|Reason not Specified|1|||
164345275|NCT01785069|593638975|FG001|Overall Study|Reason not Specified|2|||
164345276|NCT01785069|593638976|FG002|Overall Study|Reason not Specified|1|||
164345277|NCT01785069|593638977|FG003|Overall Study|Reason not Specified|4|||
164345278|NCT01785069|593638974|FG000|Overall Study|Not evaluable|7|||
164345279|NCT01785069|593638975|FG001|Overall Study|Not evaluable|4|||
164288085|NCT01132313|593424617|FG000|Overall Study|Withdrawal by Subject|0|||
164692690|NCT03430011|594897037|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
164692691|NCT03430011|594897038|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
164692692|NCT03430011|594897039|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
164288086|NCT01132313|593424618|FG001|Overall Study|Withdrawal by Subject|0|||
164288087|NCT01132313|593424619|FG002|Overall Study|Withdrawal by Subject|3|||
164288088|NCT01132313|593424620|FG003|Overall Study|Withdrawal by Subject|3|||
164288089|NCT01132313|593424621|FG004|Overall Study|Withdrawal by Subject|6|||
164288090|NCT01132313|593424622|FG005|Overall Study|Withdrawal by Subject|0|||
164433333|NCT00335556|593957219|FG002|Overall Study|Death|0|||
164288091|NCT01132313|593424623|FG006|Overall Study|Withdrawal by Subject|1|||
164288092|NCT01132313|593424624|FG007|Overall Study|Withdrawal by Subject|0|||
164288093|NCT01132313|593424625|FG008|Overall Study|Withdrawal by Subject|0|||
164288094|NCT01132313|593424626|FG009|Overall Study|Withdrawal by Subject|2|||
164288095|NCT01132313|593424627|FG010|Overall Study|Withdrawal by Subject|0|||
164345280|NCT01785069|593638976|FG002|Overall Study|Not evaluable|5|||
164345281|NCT01785069|593638977|FG003|Overall Study|Not evaluable|8|||
164345282|NCT03288129|593638978|FG000|Overall Study|Adverse Event|10|||
164345283|NCT03288129|593638978|FG000|Overall Study|Lost to Follow-up|3|||
164345284|NCT03288129|593638978|FG000|Overall Study|Withdrawal by Subject|3|||
164692693|NCT03430011|594897040|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
164692694|NCT03430011|594897041|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
164692695|NCT03430011|594897042|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
164692696|NCT03430011|594897043|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
164288096|NCT01132313|593424628|FG011|Overall Study|Withdrawal by Subject|0|||
164288097|NCT01132313|593424617|FG000|Overall Study|Lack of antiviral response|0|||
164288098|NCT01132313|593424618|FG001|Overall Study|Lack of antiviral response|0|||
164288099|NCT01132313|593424619|FG002|Overall Study|Lack of antiviral response|12|||
164288100|NCT01132313|593424620|FG003|Overall Study|Lack of antiviral response|18|||
164288101|NCT01132313|593424621|FG004|Overall Study|Lack of antiviral response|18|||
164692697|NCT03430011|594897044|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
164288102|NCT01132313|593424622|FG005|Overall Study|Lack of antiviral response|18|||
164288103|NCT01132313|593424623|FG006|Overall Study|Lack of antiviral response|21|||
164288104|NCT01132313|593424624|FG007|Overall Study|Lack of antiviral response|0|||
164288105|NCT01132313|593424625|FG008|Overall Study|Lack of antiviral response|0|||
164288106|NCT01132313|593424626|FG009|Overall Study|Lack of antiviral response|0|||
164288107|NCT01132313|593424627|FG010|Overall Study|Lack of antiviral response|1|||
164288108|NCT01132313|593424628|FG011|Overall Study|Lack of antiviral response|0|||
164288109|NCT01132313|593424617|FG000|Overall Study|Other reason not defined above|0|||
164288110|NCT01132313|593424618|FG001|Overall Study|Other reason not defined above|0|||
164288111|NCT01132313|593424619|FG002|Overall Study|Other reason not defined above|0|||
164288112|NCT01132313|593424620|FG003|Overall Study|Other reason not defined above|0|||
164288113|NCT01132313|593424621|FG004|Overall Study|Other reason not defined above|0|||
164288114|NCT01132313|593424622|FG005|Overall Study|Other reason not defined above|0|||
164288115|NCT01132313|593424623|FG006|Overall Study|Other reason not defined above|0|||
164288116|NCT01132313|593424624|FG007|Overall Study|Other reason not defined above|1|||
164288117|NCT01132313|593424625|FG008|Overall Study|Other reason not defined above|0|||
164288118|NCT01132313|593424626|FG009|Overall Study|Other reason not defined above|0|||
164288119|NCT01132313|593424627|FG010|Overall Study|Other reason not defined above|0|||
164288120|NCT01132313|593424628|FG011|Overall Study|Other reason not defined above|0|||
164288121|NCT01236521|593424629|FG000|Overall Study|Withdrawal by Subject|12|||
164288122|NCT01236521|593424630|FG001|Overall Study|Withdrawal by Subject|17|||
164288123|NCT01236521|593424629|FG000|Overall Study|Death|2|||
164288124|NCT01236521|593424630|FG001|Overall Study|Death|1|||
164288125|NCT01236521|593424629|FG000|Overall Study|Lost to Follow-up|9|||
164288126|NCT01236521|593424630|FG001|Overall Study|Lost to Follow-up|7|||
164288127|NCT04661150|593424641|FG000|Overall Study|Ongoing in study|19|||
164288128|NCT04661150|593424642|FG001|Overall Study|Ongoing in study|20|||
164288129|NCT04661150|593424641|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
164288130|NCT04661150|593424642|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
164288131|NCT04661150|593424641|FG000|Overall Study|Death|2|||
164288132|NCT04661150|593424642|FG001|Overall Study|Death|0|||
164288133|NCT04965688|593424643|FG000|Overall Study|Withdrawal by Subject|2|||
164288134|NCT05864586|593424644|FG000|Overall Study|Ineligible|4|||
164288135|NCT05864586|593424645|FG001|Overall Study|Ineligible|12|||
164288136|NCT05864586|593424644|FG000|Overall Study|Pregnancy|0|||
164288137|NCT05864586|593424645|FG001|Overall Study|Pregnancy|1|||
164288138|NCT05864586|593424644|FG000|Overall Study|Withdrawal by Subject|0|||
164288139|NCT05864586|593424645|FG001|Overall Study|Withdrawal by Subject|1|||
164288140|NCT00369577|593424646|FG000|Overall Study|Withdrawal by Subject|0|||
164288141|NCT00369577|593424647|FG001|Overall Study|Withdrawal by Subject|0|||
164288142|NCT00369577|593424648|FG002|Overall Study|Withdrawal by Subject|1|||
164288143|NCT04618744|593424649|FG000|Overall Study|Adverse Event|0|||
164288144|NCT04618744|593424650|FG001|Overall Study|Adverse Event|1|||
164288145|NCT04618744|593424649|FG000|Overall Study|Withdrawal by Subject|0|||
164288146|NCT04618744|593424650|FG001|Overall Study|Withdrawal by Subject|1|||
164288147|NCT02719171|593426858|FG000|Overall Study|Adverse Event|1|||
164288148|NCT02719171|593426859|FG001|Overall Study|Adverse Event|2|||
164288149|NCT02719171|593426860|FG002|Overall Study|Adverse Event|0|||
164288150|NCT02719171|593426861|FG003|Overall Study|Adverse Event|0|||
164288151|NCT02719171|593426862|FG004|Overall Study|Adverse Event|2|||
164288152|NCT02719171|593426858|FG000|Overall Study|Lost to Follow-up|0|||
164288153|NCT02719171|593426859|FG001|Overall Study|Lost to Follow-up|0|||
164288154|NCT02719171|593426860|FG002|Overall Study|Lost to Follow-up|1|||
164288155|NCT02719171|593426861|FG003|Overall Study|Lost to Follow-up|0|||
164288156|NCT02719171|593426862|FG004|Overall Study|Lost to Follow-up|0|||
164288157|NCT02719171|593426858|FG000|Overall Study|Subject Withdrawal|0|||
164288158|NCT02719171|593426859|FG001|Overall Study|Subject Withdrawal|2|||
164288159|NCT02719171|593426860|FG002|Overall Study|Subject Withdrawal|2|||
164288160|NCT02719171|593426861|FG003|Overall Study|Subject Withdrawal|1|||
164288161|NCT02719171|593426862|FG004|Overall Study|Subject Withdrawal|0|||
164433334|NCT00335556|593957220|FG003|Overall Study|Death|0|||
164288162|NCT02719171|593426858|FG000|Overall Study|Other|0|||
164288163|NCT02719171|593426859|FG001|Overall Study|Other|0|||
164288164|NCT02719171|593426860|FG002|Overall Study|Other|0|||
164288165|NCT02719171|593426861|FG003|Overall Study|Other|1|||
164288166|NCT02719171|593426862|FG004|Overall Study|Other|0|||
164288167|NCT02807623|593426863|FG000|Overall Study|Lost to Follow-up|23|||
164288168|NCT02807623|593426864|FG001|Overall Study|Lost to Follow-up|18|||
164288169|NCT02807623|593426865|FG002|Overall Study|Lost to Follow-up|22|||
164288170|NCT02807623|593426863|FG000|Overall Study|Drug intolerance|0|||
164288171|NCT02807623|593426864|FG001|Overall Study|Drug intolerance|1|||
164288172|NCT02807623|593426865|FG002|Overall Study|Drug intolerance|0|||
164288173|NCT02807623|593426863|FG000|Overall Study|incomplete blood draw|0|||
164288174|NCT02807623|593426864|FG001|Overall Study|incomplete blood draw|2|||
164288175|NCT02807623|593426865|FG002|Overall Study|incomplete blood draw|1|||
164288176|NCT04002960|593426870|FG000|Overall Study|Withdrawn prior to Completion|2|||
164288177|NCT02107703|593426871|FG000|Overall Study|Withdrawal by Subject|46|||
164288178|NCT02107703|593426872|FG001|Overall Study|Withdrawal by Subject|21|||
164288179|NCT02107703|593426871|FG000|Overall Study|Lost to Follow-up|20|||
164288180|NCT02107703|593426872|FG001|Overall Study|Lost to Follow-up|9|||
164288181|NCT02107703|593426871|FG000|Overall Study|On study treatment/follow up|48|||
164288182|NCT02107703|593426872|FG001|Overall Study|On study treatment/follow up|5|||
164288183|NCT01020786|593426881|FG000|Induction Period|Entry Criteria Not Met|2|||
164288184|NCT01020786|593426881|FG000|Induction Period|Adverse Event|10|||
164288185|NCT01020786|593426881|FG000|Induction Period|Progressive Disease|31|||
164288186|NCT01020786|593426881|FG000|Induction Period|Investigator Decision|3|||
164288187|NCT01020786|593426881|FG000|Induction Period|Withdrawal by Subject|3|||
164288188|NCT01020786|593426881|FG000|Maintenance Period|Adverse Event|8|||
164288189|NCT01020786|593426881|FG000|Maintenance Period|Progressive Disease|43|||
164288190|NCT01020786|593426881|FG000|Maintenance Period|Withdrawal by Subject|8|||
164288191|NCT01020786|593426881|FG000|Maintenance Period|Sponsor Decision|1|||
164288192|NCT01176058|593426884|FG000|Overall Study|Adverse Event|1|||
164288193|NCT01176058|593426885|FG001|Overall Study|Adverse Event|0|||
164288194|NCT01176058|593426884|FG000|Overall Study|Insufficient clinical response|2|||
164288195|NCT01176058|593426885|FG001|Overall Study|Insufficient clinical response|2|||
164288196|NCT01176058|593426884|FG000|Overall Study|Insufficient mycological response|0|||
164288197|NCT01176058|593426885|FG001|Overall Study|Insufficient mycological response|1|||
164288198|NCT01176058|593426884|FG000|Overall Study|Withdrawal by Subject|1|||
164288199|NCT01176058|593426885|FG001|Overall Study|Withdrawal by Subject|0|||
164288200|NCT00256724|593426888|FG000|Overall Study|Physician Decision|2|||
164288201|NCT00256724|593426889|FG001|Overall Study|Physician Decision|5|||
164288202|NCT00256724|593426888|FG000|Overall Study|Protocol Violation|3|||
164288203|NCT00256724|593426889|FG001|Overall Study|Protocol Violation|3|||
164288204|NCT01217463|593426890|FG000|Overall Study|Adverse Event|8|||
164288205|NCT01217463|593426891|FG001|Overall Study|Adverse Event|5|||
164288206|NCT01217463|593426890|FG000|Overall Study|Physician Decision|0|||
164288207|NCT01217463|593426891|FG001|Overall Study|Physician Decision|1|||
164288208|NCT01217463|593426890|FG000|Overall Study|Withdrawal by Subject|3|||
164288209|NCT01217463|593426891|FG001|Overall Study|Withdrawal by Subject|0|||
164288210|NCT01217463|593426890|FG000|Overall Study|Surgery on the Target Limb|0|||
164288211|NCT01217463|593426891|FG001|Overall Study|Surgery on the Target Limb|1|||
164288212|NCT01217463|593426890|FG000|Overall Study|Patient Non-compliant|1|||
164288213|NCT01217463|593426891|FG001|Overall Study|Patient Non-compliant|0|||
164288214|NCT01217463|593426890|FG000|Overall Study|Other|1|||
164288215|NCT01217463|593426891|FG001|Overall Study|Other|1|||
164288216|NCT01879683|593426892|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
164288217|NCT01338818|593426894|FG000|Overall Study|Adverse Event|8|||
164288218|NCT01338818|593426894|FG000|Overall Study|Lack of Efficacy|5|||
164288219|NCT01338818|593426894|FG000|Overall Study|no longer require study drug|1|||
164288220|NCT01338818|593426894|FG000|Overall Study|Withdrawal by Subject|11|||
164288221|NCT01338818|593426894|FG000|Overall Study|Lost to Follow-up|4|||
164288222|NCT01338818|593426894|FG000|Overall Study|Administrative problems|3|||
164288223|NCT01338818|593426894|FG000|Overall Study|Protocol Deviation|4|||
164288224|NCT05202418|593426895|FG000|Overall Study|Withdrawal by Subject|2|||
164288225|NCT05202418|593426896|FG001|Overall Study|Withdrawal by Subject|1|||
164288226|NCT05202418|593426895|FG000|Overall Study|Lost to Follow-up|1|||
164288227|NCT05202418|593426896|FG001|Overall Study|Lost to Follow-up|1|||
164288228|NCT03901144|593426897|FG000|Overall Study|Lost to Follow-up|1|||
164288229|NCT03901144|593426898|FG001|Overall Study|Lost to Follow-up|1|||
164288230|NCT03901144|593426899|FG002|Overall Study|Lost to Follow-up|1|||
164288231|NCT03901144|593426900|FG003|Overall Study|Lost to Follow-up|1|||
164288232|NCT00279916|593426902|FG000|Overall Study|Withdrawal by Subject|4|||
164288233|NCT00279916|593426903|FG001|Overall Study|Withdrawal by Subject|3|||
164288234|NCT00279916|593426902|FG000|Overall Study|Lost to Follow-up|3|||
164288235|NCT00279916|593426903|FG001|Overall Study|Lost to Follow-up|2|||
164288236|NCT02488005|593426908|FG000|Overall Study|Lost to Follow-up|2|||
164288237|NCT00650767|593426913|FG000|Overall Study|Adverse Event|0|||
164288238|NCT00650767|593426914|FG001|Overall Study|Adverse Event|3|||
164288239|NCT00650767|593426915|FG002|Overall Study|Adverse Event|10|||
164288240|NCT00650767|593426916|FG003|Overall Study|Adverse Event|8|||
164288241|NCT00650767|593426913|FG000|Overall Study|Death|1|||
164288242|NCT00650767|593426914|FG001|Overall Study|Death|0|||
164288243|NCT00650767|593426915|FG002|Overall Study|Death|0|||
164288244|NCT00650767|593426916|FG003|Overall Study|Death|0|||
164288245|NCT00650767|593426913|FG000|Overall Study|Withdrawal by Subject|2|||
164288246|NCT00650767|593426914|FG001|Overall Study|Withdrawal by Subject|4|||
164288247|NCT00650767|593426915|FG002|Overall Study|Withdrawal by Subject|3|||
164288248|NCT00650767|593426916|FG003|Overall Study|Withdrawal by Subject|3|||
164288249|NCT00650767|593426913|FG000|Overall Study|Lost to Follow-up|1|||
164288250|NCT00650767|593426914|FG001|Overall Study|Lost to Follow-up|1|||
164288251|NCT00650767|593426915|FG002|Overall Study|Lost to Follow-up|1|||
164288252|NCT00650767|593426916|FG003|Overall Study|Lost to Follow-up|0|||
164288253|NCT00650767|593426913|FG000|Overall Study|Other|1|||
164288254|NCT00650767|593426914|FG001|Overall Study|Other|1|||
164288255|NCT00650767|593426915|FG002|Overall Study|Other|0|||
164288256|NCT00650767|593426916|FG003|Overall Study|Other|0|||
164288257|NCT03384940|593426917|FG000|Overall Study|Progressive disease|36|||
164288258|NCT03384940|593426918|FG001|Overall Study|Progressive disease|11|||
164288259|NCT03384940|593426919|FG002|Overall Study|Progressive disease|13|||
164288260|NCT03384940|593426917|FG000|Overall Study|Clinical progression|4|||
164288261|NCT03384940|593426918|FG001|Overall Study|Clinical progression|0|||
164288262|NCT03384940|593426919|FG002|Overall Study|Clinical progression|3|||
164288263|NCT03384940|593426917|FG000|Overall Study|Adverse Event|7|||
164288264|NCT03384940|593426918|FG001|Overall Study|Adverse Event|1|||
164288265|NCT03384940|593426919|FG002|Overall Study|Adverse Event|1|||
164288266|NCT03384940|593426917|FG000|Overall Study|Withdrawal by Subject|3|||
164288267|NCT03384940|593426918|FG001|Overall Study|Withdrawal by Subject|1|||
164288268|NCT03384940|593426919|FG002|Overall Study|Withdrawal by Subject|0|||
164288269|NCT03384940|593426917|FG000|Overall Study|Physician Decision|1|||
164288270|NCT03384940|593426918|FG001|Overall Study|Physician Decision|1|||
164288271|NCT03384940|593426919|FG002|Overall Study|Physician Decision|0|||
164288272|NCT03384940|593426917|FG000|Overall Study|Death|2|||
164288273|NCT03384940|593426918|FG001|Overall Study|Death|1|||
164288274|NCT03384940|593426919|FG002|Overall Study|Death|0|||
164288275|NCT03384940|593426917|FG000|Overall Study|Other|0|||
164288276|NCT03384940|593426918|FG001|Overall Study|Other|0|||
164288277|NCT03384940|593426919|FG002|Overall Study|Other|1|||
164288278|NCT03649074|593426922|FG000|Overall Study|Lost to Follow-up|2|||
164288279|NCT03649074|593426923|FG001|Overall Study|Lost to Follow-up|1|||
164288280|NCT03649074|593426922|FG000|Overall Study|Adverse Event|1|||
164288281|NCT03649074|593426923|FG001|Overall Study|Adverse Event|0|||
164288282|NCT03649074|593426922|FG000|Overall Study|Physician Decision|1|||
164288283|NCT03649074|593426923|FG001|Overall Study|Physician Decision|0|||
164288284|NCT03649074|593426922|FG000|Overall Study|Withdrawal by Subject|0|||
164288285|NCT03649074|593426923|FG001|Overall Study|Withdrawal by Subject|2|||
164288286|NCT03649074|593426922|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
164288287|NCT03649074|593426923|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
164288288|NCT03649074|593426922|FG000|Overall Study|Other|1|||
164288289|NCT03649074|593426923|FG001|Overall Study|Other|0|||
164288290|NCT04303559|593426924|FG000|Overall Study|Study closed due to poor enrollment.|1|||
164288291|NCT01156714|593426927|FG000|Overall Study|Withdrawal by Subject|9|||
164288292|NCT01156714|593426928|FG001|Overall Study|Withdrawal by Subject|4|||
164288293|NCT01156714|593426929|FG002|Overall Study|Withdrawal by Subject|3|||
164288294|NCT03775486|593426931|FG000|Initial Therapy Phase|Other reason provided|0|||
164288295|NCT03775486|593426932|FG001|Initial Therapy Phase|Other reason provided|15|||
164288296|NCT03775486|593426931|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
164288297|NCT03775486|593426932|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
164288298|NCT03775486|593426931|FG000|Initial Therapy Phase|Protocol Violation|0|||
164586726|NCT01855789|594511913|FG003|1) Baseline up to Week 24|Other|0|||
164586727|NCT01855789|594511910|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
164586728|NCT01855789|594511911|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
164288299|NCT03775486|593426932|FG001|Initial Therapy Phase|Protocol Violation|2|||
164288300|NCT03775486|593426931|FG000|Initial Therapy Phase|Adverse Event|0|||
164586729|NCT01855789|594511912|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
164288301|NCT03775486|593426932|FG001|Initial Therapy Phase|Adverse Event|34|||
164288302|NCT03775486|593426931|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
164288303|NCT03775486|593426932|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
164288304|NCT03775486|593426931|FG000|Maintenance Phase|Withdrawal by Subject|13|||
164288305|NCT03775486|593426932|FG001|Maintenance Phase|Withdrawal by Subject|12|||
164288306|NCT03775486|593426931|FG000|Maintenance Phase|Death|44|||
164288307|NCT03775486|593426932|FG001|Maintenance Phase|Death|45|||
164288308|NCT00801216|593426933|FG000|Overall Study|Screening Failure|2|||
164288309|NCT05907395|593426934|FG000|Period 1|No longer met eligibility criteria|0|||
164288310|NCT05907395|593426935|FG001|Period 1|No longer met eligibility criteria|1|||
164288311|NCT05907395|593426936|FG002|Period 1|No longer met eligibility criteria|0|||
164288312|NCT05907395|593426937|FG003|Period 1|No longer met eligibility criteria|0|||
164288313|NCT05907395|593426938|FG004|Period 1|No longer met eligibility criteria|0|||
164288314|NCT05907395|593426939|FG005|Period 1|No longer met eligibility criteria|1|||
164288315|NCT05907395|593426940|FG006|Period 1|No longer met eligibility criteria|1|||
164288316|NCT05907395|593426941|FG007|Period 1|No longer met eligibility criteria|0|||
164586730|NCT01855789|594511913|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
164288317|NCT05907395|593426942|FG008|Period 1|No longer met eligibility criteria|0|||
164288318|NCT05907395|593426943|FG009|Period 1|No longer met eligibility criteria|0|||
164288319|NCT05907395|593426944|FG010|Period 1|No longer met eligibility criteria|0|||
164288320|NCT05907395|593426945|FG011|Period 1|No longer met eligibility criteria|0|||
164288321|NCT05907395|593426934|FG000|Period 2|Adverse Event|0|||
164288322|NCT05907395|593426935|FG001|Period 2|Adverse Event|0|||
164288323|NCT05907395|593426936|FG002|Period 2|Adverse Event|0|||
164288324|NCT05907395|593426937|FG003|Period 2|Adverse Event|1|||
164288325|NCT05907395|593426938|FG004|Period 2|Adverse Event|0|||
164288326|NCT05907395|593426939|FG005|Period 2|Adverse Event|0|||
164288327|NCT05907395|593426940|FG006|Period 2|Adverse Event|0|||
164288328|NCT05907395|593426941|FG007|Period 2|Adverse Event|1|||
164288329|NCT05907395|593426942|FG008|Period 2|Adverse Event|0|||
164288330|NCT05907395|593426943|FG009|Period 2|Adverse Event|0|||
164288331|NCT05907395|593426944|FG010|Period 2|Adverse Event|0|||
164288332|NCT05907395|593426945|FG011|Period 2|Adverse Event|0|||
164288333|NCT05907395|593426934|FG000|Period 2|Personal reason|0|||
164288334|NCT05907395|593426935|FG001|Period 2|Personal reason|0|||
164288335|NCT05907395|593426936|FG002|Period 2|Personal reason|0|||
164288336|NCT05907395|593426937|FG003|Period 2|Personal reason|0|||
164288337|NCT05907395|593426938|FG004|Period 2|Personal reason|0|||
164288338|NCT05907395|593426939|FG005|Period 2|Personal reason|0|||
164288339|NCT05907395|593426940|FG006|Period 2|Personal reason|0|||
164288340|NCT05907395|593426941|FG007|Period 2|Personal reason|0|||
164288341|NCT05907395|593426942|FG008|Period 2|Personal reason|0|||
164288342|NCT05907395|593426943|FG009|Period 2|Personal reason|1|||
164288343|NCT05907395|593426944|FG010|Period 2|Personal reason|0|||
164288344|NCT05907395|593426945|FG011|Period 2|Personal reason|0|||
164288345|NCT05907395|593426934|FG000|Period 3|Adverse Event|0|||
164288346|NCT05907395|593426935|FG001|Period 3|Adverse Event|0|||
164288347|NCT05907395|593426936|FG002|Period 3|Adverse Event|0|||
164288348|NCT05907395|593426937|FG003|Period 3|Adverse Event|0|||
164288349|NCT05907395|593426938|FG004|Period 3|Adverse Event|1|||
164288350|NCT05907395|593426939|FG005|Period 3|Adverse Event|0|||
164288351|NCT05907395|593426940|FG006|Period 3|Adverse Event|0|||
164288352|NCT05907395|593426941|FG007|Period 3|Adverse Event|0|||
164288353|NCT05907395|593426942|FG008|Period 3|Adverse Event|0|||
164288354|NCT05907395|593426943|FG009|Period 3|Adverse Event|0|||
164288355|NCT05907395|593426944|FG010|Period 3|Adverse Event|0|||
164288356|NCT05907395|593426945|FG011|Period 3|Adverse Event|0|||
164288357|NCT05214768|593426946|FG000|Induction Period|Withdrawal by Subject|1|||
164288358|NCT05214768|593426947|FG001|Induction Period|Withdrawal by Subject|0|||
164288359|NCT05214768|593426948|FG002|Induction Period|Withdrawal by Subject|0|||
164288360|NCT05214768|593426949|FG003|Induction Period|Withdrawal by Subject|0|||
164288361|NCT05214768|593426950|FG004|Induction Period|Withdrawal by Subject|0|||
164288362|NCT05214768|593426951|FG005|Induction Period|Withdrawal by Subject|0|||
164288363|NCT05214768|593426946|FG000|Induction Period|Physician Decision|1|||
164288364|NCT05214768|593426947|FG001|Induction Period|Physician Decision|0|||
164288365|NCT05214768|593426948|FG002|Induction Period|Physician Decision|0|||
164288366|NCT05214768|593426949|FG003|Induction Period|Physician Decision|0|||
164288367|NCT05214768|593426950|FG004|Induction Period|Physician Decision|0|||
164288368|NCT05214768|593426951|FG005|Induction Period|Physician Decision|0|||
164288369|NCT05214768|593426946|FG000|Maintenance Period|Other Reasons|0|||
164288370|NCT05214768|593426947|FG001|Maintenance Period|Other Reasons|0|||
164288371|NCT05214768|593426948|FG002|Maintenance Period|Other Reasons|1|||
164288372|NCT05214768|593426949|FG003|Maintenance Period|Other Reasons|1|||
164345285|NCT03288129|593638978|FG000|Overall Study|Withdrawal of consent/assent|1|||
164345286|NCT03288129|593638978|FG000|Overall Study|Other|5|||
164345287|NCT01744197|593638981|FG000|Overall Study|Received 1 patch|2|||
164345288|NCT01744197|593638982|FG001|Overall Study|Received 1 patch|1|||
164345289|NCT01744197|593638981|FG000|Overall Study|No patch received|2|||
164345290|NCT01744197|593638982|FG001|Overall Study|No patch received|2|||
164345291|NCT03305575|593640925|FG000|Overall Study|Physician Decision|1|||
164345292|NCT03305575|593640926|FG001|Overall Study|Physician Decision|0|||
164345293|NCT02871297|593640934|FG000|Overall Study|Adverse Event|34|||
164692698|NCT03430011|594897037|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
164288373|NCT05214768|593426950|FG004|Maintenance Period|Other Reasons|0|||
164288374|NCT05214768|593426951|FG005|Maintenance Period|Other Reasons|0|||
164288375|NCT05214768|593426946|FG000|Maintenance Period|Withdrawal by Subject|0|||
164288376|NCT05214768|593426947|FG001|Maintenance Period|Withdrawal by Subject|0|||
164288377|NCT05214768|593426948|FG002|Maintenance Period|Withdrawal by Subject|0|||
164288378|NCT05214768|593426949|FG003|Maintenance Period|Withdrawal by Subject|1|||
164288379|NCT05214768|593426950|FG004|Maintenance Period|Withdrawal by Subject|0|||
164288380|NCT05214768|593426951|FG005|Maintenance Period|Withdrawal by Subject|0|||
164288381|NCT05214768|593426946|FG000|Maintenance Period|Lack of Efficacy|0|||
164288382|NCT05214768|593426947|FG001|Maintenance Period|Lack of Efficacy|0|||
164288383|NCT05214768|593426948|FG002|Maintenance Period|Lack of Efficacy|1|||
164288384|NCT05214768|593426949|FG003|Maintenance Period|Lack of Efficacy|0|||
164288385|NCT05214768|593426950|FG004|Maintenance Period|Lack of Efficacy|1|||
164345294|NCT02871297|593640934|FG000|Overall Study|Lack of Efficacy|10|||
164345295|NCT02871297|593640934|FG000|Overall Study|Non-compliance with study drug|15|||
164288386|NCT05214768|593426951|FG005|Maintenance Period|Lack of Efficacy|0|||
164288387|NCT05214768|593426946|FG000|Open Label Extension Period|Physician Decision|0|||
164288388|NCT05214768|593426947|FG001|Open Label Extension Period|Physician Decision|0|||
164288389|NCT05214768|593426948|FG002|Open Label Extension Period|Physician Decision|0|||
164288390|NCT05214768|593426949|FG003|Open Label Extension Period|Physician Decision|0|||
164288391|NCT05214768|593426950|FG004|Open Label Extension Period|Physician Decision|0|||
164288392|NCT05214768|593426951|FG005|Open Label Extension Period|Physician Decision|1|||
164288393|NCT05214768|593426946|FG000|Open Label Extension Period|Lack of Efficacy|0|||
164288394|NCT05214768|593426947|FG001|Open Label Extension Period|Lack of Efficacy|0|||
164288395|NCT05214768|593426948|FG002|Open Label Extension Period|Lack of Efficacy|0|||
164288396|NCT05214768|593426949|FG003|Open Label Extension Period|Lack of Efficacy|0|||
164288397|NCT05214768|593426950|FG004|Open Label Extension Period|Lack of Efficacy|0|||
164288398|NCT05214768|593426951|FG005|Open Label Extension Period|Lack of Efficacy|1|||
164288399|NCT05214768|593426946|FG000|Open Label Extension Period|Ongoing Study|0|||
164288400|NCT05214768|593426947|FG001|Open Label Extension Period|Ongoing Study|0|||
164288401|NCT05214768|593426948|FG002|Open Label Extension Period|Ongoing Study|0|||
164288402|NCT05214768|593426949|FG003|Open Label Extension Period|Ongoing Study|0|||
164288403|NCT05214768|593426950|FG004|Open Label Extension Period|Ongoing Study|0|||
164288404|NCT05214768|593426951|FG005|Open Label Extension Period|Ongoing Study|42|||
164288405|NCT05481359|593426952|FG000|Overall Study|Lost to Follow-up|3|||
164288406|NCT05481359|593426952|FG000|Overall Study|Withdrawal by Subject|1|||
164288407|NCT03043872|593426957|FG000|Overall Study|Withdrawal by Subject|6|||
164288408|NCT03043872|593426958|FG001|Overall Study|Withdrawal by Subject|6|||
164288409|NCT03043872|593426959|FG002|Overall Study|Withdrawal by Subject|15|||
164288410|NCT03043872|593426957|FG000|Overall Study|Lost to Follow-up|2|||
164288411|NCT03043872|593426958|FG001|Overall Study|Lost to Follow-up|1|||
164288412|NCT03043872|593426959|FG002|Overall Study|Lost to Follow-up|1|||
164288413|NCT03043872|593426957|FG000|Overall Study|Death|270|||
164288414|NCT03043872|593426958|FG001|Overall Study|Death|269|||
164288415|NCT03043872|593426959|FG002|Overall Study|Death|296|||
164288416|NCT02777827|593426961|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
164288417|NCT02777827|593426962|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
164288418|NCT02777827|593426963|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
164288419|NCT02777827|593426964|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
164288420|NCT02777827|593426965|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
164288421|NCT02777827|593426966|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
164288422|NCT04551066|593426967|FG000|Overall Study|Death|5|||
164288423|NCT04551066|593426968|FG001|Overall Study|Death|3|||
164288424|NCT04551066|593426967|FG000|Overall Study|Lost to Follow-up|1|||
164288425|NCT04551066|593426968|FG001|Overall Study|Lost to Follow-up|0|||
164288426|NCT04551066|593426967|FG000|Overall Study|Sponsor Decision|104|||
164288427|NCT04551066|593426968|FG001|Overall Study|Sponsor Decision|117|||
164288428|NCT04551066|593426967|FG000|Overall Study|Withdrawal by Subject|8|||
164288429|NCT04551066|593426968|FG001|Overall Study|Withdrawal by Subject|2|||
164288430|NCT04551066|593426967|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|2|||
164288431|NCT04551066|593426968|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
164288432|NCT04551066|593426967|FG000|Overall Study|Adverse Event|2|||
164288433|NCT04551066|593426968|FG001|Overall Study|Adverse Event|0|||
164288434|NCT04551066|593426967|FG000|Overall Study|Physician Decision|2|||
164288435|NCT04551066|593426968|FG001|Overall Study|Physician Decision|0|||
164288436|NCT04551066|593426967|FG000|Overall Study|Protocol Violation|1|||
164288437|NCT04551066|593426968|FG001|Overall Study|Protocol Violation|0|||
164288438|NCT04551066|593426967|FG000|Overall Study|Lack of Efficacy|0|||
164288439|NCT04551066|593426968|FG001|Overall Study|Lack of Efficacy|1|||
164288440|NCT04551066|593426967|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
164288441|NCT04551066|593426968|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
164288442|NCT04491136|593426969|FG000|Overall Study|Patient withdraw informed consent|9|||
164288443|NCT04491136|593426969|FG000|Overall Study|Adverse Event|2|||
164288444|NCT04491136|593426969|FG000|Overall Study|Death|3|||
164288445|NCT04491136|593426969|FG000|Overall Study|Lost to Follow-up|3|||
164288446|NCT04491136|593426969|FG000|Overall Study|Physician Decision|45|||
164288447|NCT04491136|593426969|FG000|Overall Study|sponsor terminated the study early|16|||
164288448|NCT04491136|593426969|FG000|Overall Study|Patient/guardian's decision|1|||
164288449|NCT00319254|593426972|FG000|Overall Study|Withdrawal by Subject|4|||
164692699|NCT03430011|594897038|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
164288450|NCT00319254|593426972|FG000|Overall Study|Death|46|||
164288451|NCT00319254|593426972|FG000|Overall Study|Lost to Follow-up|2|||
164288452|NCT00319254|593426972|FG000|Overall Study|Enrolled, Not Treated|2|||
164288453|NCT01712204|593426976|FG000|Overall Study|Adverse Event|3|||
164288454|NCT01712204|593426977|FG001|Overall Study|Adverse Event|1|||
164288455|NCT01712204|593426976|FG000|Overall Study|Withdrawal by Subject|3|||
164288456|NCT01712204|593426977|FG001|Overall Study|Withdrawal by Subject|3|||
164288457|NCT01712204|593426976|FG000|Overall Study|Lost to Follow-up|1|||
164288458|NCT01712204|593426977|FG001|Overall Study|Lost to Follow-up|0|||
164288459|NCT01712204|593426976|FG000|Overall Study|Protocol Violation|1|||
164288460|NCT01712204|593426977|FG001|Overall Study|Protocol Violation|1|||
164288461|NCT02452424|593426978|FG000|Overall Study|Death|2|||
164288462|NCT02452424|593426979|FG001|Overall Study|Death|2|||
164288463|NCT02452424|593426980|FG002|Overall Study|Death|2|||
164288464|NCT02452424|593426981|FG003|Overall Study|Death|6|||
164288465|NCT02452424|593426982|FG004|Overall Study|Death|2|||
164288466|NCT02452424|593426983|FG005|Overall Study|Death|0|||
164288467|NCT02452424|593426984|FG006|Overall Study|Death|5|||
164288468|NCT02452424|593426985|FG007|Overall Study|Death|1|||
164288469|NCT02452424|593426986|FG008|Overall Study|Death|3|||
164288470|NCT02452424|593426987|FG009|Overall Study|Death|1|||
164288471|NCT02452424|593426988|FG010|Overall Study|Death|0|||
164288472|NCT02452424|593426978|FG000|Overall Study|Lost to Follow-up|0|||
164288473|NCT02452424|593426979|FG001|Overall Study|Lost to Follow-up|1|||
164288474|NCT02452424|593426980|FG002|Overall Study|Lost to Follow-up|1|||
164288475|NCT02452424|593426981|FG003|Overall Study|Lost to Follow-up|0|||
164288476|NCT02452424|593426982|FG004|Overall Study|Lost to Follow-up|0|||
164288477|NCT02452424|593426983|FG005|Overall Study|Lost to Follow-up|0|||
164288478|NCT02452424|593426984|FG006|Overall Study|Lost to Follow-up|0|||
164288479|NCT02452424|593426985|FG007|Overall Study|Lost to Follow-up|0|||
164288480|NCT02452424|593426986|FG008|Overall Study|Lost to Follow-up|0|||
164288481|NCT02452424|593426987|FG009|Overall Study|Lost to Follow-up|0|||
164288482|NCT02452424|593426988|FG010|Overall Study|Lost to Follow-up|0|||
164288483|NCT02452424|593426978|FG000|Overall Study|Withdrawal by Subject|0|||
164288484|NCT02452424|593426979|FG001|Overall Study|Withdrawal by Subject|0|||
164288485|NCT02452424|593426980|FG002|Overall Study|Withdrawal by Subject|3|||
164288486|NCT02452424|593426981|FG003|Overall Study|Withdrawal by Subject|2|||
164288487|NCT02452424|593426982|FG004|Overall Study|Withdrawal by Subject|0|||
164288488|NCT02452424|593426983|FG005|Overall Study|Withdrawal by Subject|0|||
164288489|NCT02452424|593426984|FG006|Overall Study|Withdrawal by Subject|1|||
164288490|NCT02452424|593426985|FG007|Overall Study|Withdrawal by Subject|0|||
164288491|NCT02452424|593426986|FG008|Overall Study|Withdrawal by Subject|1|||
164288492|NCT02452424|593426987|FG009|Overall Study|Withdrawal by Subject|1|||
164288493|NCT02452424|593426988|FG010|Overall Study|Withdrawal by Subject|0|||
164288494|NCT02452424|593426978|FG000|Overall Study|Other|0|||
164288495|NCT02452424|593426979|FG001|Overall Study|Other|0|||
164288496|NCT02452424|593426980|FG002|Overall Study|Other|1|||
164288497|NCT02452424|593426981|FG003|Overall Study|Other|0|||
164288498|NCT02452424|593426982|FG004|Overall Study|Other|0|||
164288499|NCT02452424|593426983|FG005|Overall Study|Other|1|||
164288500|NCT02452424|593426984|FG006|Overall Study|Other|4|||
164288501|NCT02452424|593426985|FG007|Overall Study|Other|3|||
164288502|NCT02452424|593426986|FG008|Overall Study|Other|0|||
164288503|NCT02452424|593426987|FG009|Overall Study|Other|0|||
164288504|NCT02452424|593426988|FG010|Overall Study|Other|1|||
164288505|NCT02452424|593426978|FG000|Overall Study|Progressive disease (per RECIST)|0|||
164288506|NCT02452424|593426979|FG001|Overall Study|Progressive disease (per RECIST)|0|||
164288507|NCT02452424|593426980|FG002|Overall Study|Progressive disease (per RECIST)|0|||
164288508|NCT02452424|593426981|FG003|Overall Study|Progressive disease (per RECIST)|0|||
164288509|NCT02452424|593426982|FG004|Overall Study|Progressive disease (per RECIST)|0|||
164288510|NCT02452424|593426983|FG005|Overall Study|Progressive disease (per RECIST)|0|||
164288511|NCT02452424|593426984|FG006|Overall Study|Progressive disease (per RECIST)|0|||
164288512|NCT02452424|593426985|FG007|Overall Study|Progressive disease (per RECIST)|0|||
164288513|NCT02452424|593426986|FG008|Overall Study|Progressive disease (per RECIST)|2|||
164288514|NCT02452424|593426987|FG009|Overall Study|Progressive disease (per RECIST)|0|||
164288515|NCT02452424|593426988|FG010|Overall Study|Progressive disease (per RECIST)|0|||
164288516|NCT02452424|593426978|FG000|Overall Study|Adverse Event|0|||
164288517|NCT02452424|593426979|FG001|Overall Study|Adverse Event|0|||
164288518|NCT02452424|593426980|FG002|Overall Study|Adverse Event|0|||
164288519|NCT02452424|593426981|FG003|Overall Study|Adverse Event|0|||
164288520|NCT02452424|593426982|FG004|Overall Study|Adverse Event|0|||
164288521|NCT02452424|593426983|FG005|Overall Study|Adverse Event|0|||
164288522|NCT02452424|593426984|FG006|Overall Study|Adverse Event|0|||
164288523|NCT02452424|593426985|FG007|Overall Study|Adverse Event|0|||
164288524|NCT02452424|593426986|FG008|Overall Study|Adverse Event|0|||
164288525|NCT02452424|593426987|FG009|Overall Study|Adverse Event|0|||
164288526|NCT02452424|593426988|FG010|Overall Study|Adverse Event|1|||
164288527|NCT01059318|593426989|FG000|Core Study (26 Week)|Adverse Event|3|||
164288528|NCT01059318|593426989|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
164288529|NCT01059318|593426989|FG000|Extension (36 Week)|Adverse Event|3|||
164288530|NCT03790917|593426990|FG000|Overall Study|Death|1|||
164288531|NCT00291486|593426992|FG000|Overall Study|Adverse Event|0|||
164288532|NCT00291486|593426993|FG001|Overall Study|Adverse Event|3|||
164288533|NCT00291486|593426994|FG002|Overall Study|Adverse Event|0|||
164288534|NCT00291486|593426995|FG003|Overall Study|Adverse Event|1|||
164288535|NCT00291486|593426996|FG004|Overall Study|Adverse Event|0|||
164288536|NCT00291486|593426992|FG000|Overall Study|Withdrawal by Subject|0|||
164288537|NCT00291486|593426993|FG001|Overall Study|Withdrawal by Subject|0|||
164288538|NCT00291486|593426994|FG002|Overall Study|Withdrawal by Subject|0|||
164288539|NCT00291486|593426995|FG003|Overall Study|Withdrawal by Subject|0|||
164288540|NCT00291486|593426996|FG004|Overall Study|Withdrawal by Subject|1|||
164288541|NCT00291486|593426992|FG000|Overall Study|Disease progression|1|||
164288542|NCT00291486|593426993|FG001|Overall Study|Disease progression|0|||
164288543|NCT00291486|593426994|FG002|Overall Study|Disease progression|1|||
164288544|NCT00291486|593426995|FG003|Overall Study|Disease progression|0|||
164288545|NCT00291486|593426996|FG004|Overall Study|Disease progression|0|||
164288546|NCT01150097|593426998|FG000|Months 24 to 36 Post-transplantation|Death|2|||
164288547|NCT01150097|593426999|FG001|Months 24 to 36 Post-transplantation|Death|0|||
164288548|NCT01150097|593427000|FG002|Months 24 to 36 Post-transplantation|Death|0|||
164288549|NCT01150097|593426998|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
164288550|NCT01150097|593426999|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
164288551|NCT01150097|593427000|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
164288552|NCT01150097|593426998|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
164288553|NCT01150097|593426999|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
164288554|NCT01150097|593427000|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
164288555|NCT01150097|593426998|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
164288556|NCT01150097|593426999|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
164288557|NCT01150097|593427000|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
164288558|NCT01150097|593426998|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
164288559|NCT01150097|593426999|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
164288560|NCT01150097|593427000|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
164288561|NCT01150097|593426998|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
164288562|NCT01150097|593426999|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
164288563|NCT01150097|593427000|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
164288564|NCT01150097|593426998|FG000|Months 24 to 48 Post-transplantation|Death|2|||
164288565|NCT01150097|593426999|FG001|Months 24 to 48 Post-transplantation|Death|0|||
164288566|NCT01150097|593427000|FG002|Months 24 to 48 Post-transplantation|Death|0|||
164288567|NCT01408459|593427004|FG000|Overall Study|Withdrawal by Subject|1|||
164288568|NCT01408459|593427005|FG001|Overall Study|Withdrawal by Subject|1|||
164288569|NCT00543387|593427008|FG000|Panel 1 + Panel 2|Adverse Event|0|||
164288570|NCT00543387|593427009|FG001|Panel 1 + Panel 2|Adverse Event|1|||
164288571|NCT00543387|593427010|FG002|Panel 1 + Panel 2|Adverse Event|0|||
164288572|NCT00543387|593427011|FG003|Panel 1 + Panel 2|Adverse Event|0|||
164288573|NCT00543387|593427012|FG004|Panel 1 + Panel 2|Adverse Event|0|||
164288574|NCT00543387|593427013|FG005|Panel 1 + Panel 2|Adverse Event|0|||
164288575|NCT00543387|593427014|FG006|Panel 1 + Panel 2|Adverse Event|0|||
164288576|NCT00543387|593427015|FG007|Panel 1 + Panel 2|Adverse Event|1|||
164288577|NCT00543387|593427016|FG008|Panel 1 + Panel 2|Adverse Event|1|||
164288578|NCT00543387|593427017|FG009|Panel 1 + Panel 2|Adverse Event|0|||
164288579|NCT00543387|593427018|FG010|Panel 1 + Panel 2|Adverse Event|0|||
164288580|NCT00543387|593427008|FG000|Panel 1 + Panel 2|Physician Decision|0|||
164288581|NCT00543387|593427009|FG001|Panel 1 + Panel 2|Physician Decision|0|||
164288582|NCT00543387|593427010|FG002|Panel 1 + Panel 2|Physician Decision|1|||
164288583|NCT00543387|593427011|FG003|Panel 1 + Panel 2|Physician Decision|0|||
164288584|NCT00543387|593427012|FG004|Panel 1 + Panel 2|Physician Decision|0|||
164288585|NCT00543387|593427013|FG005|Panel 1 + Panel 2|Physician Decision|0|||
164288586|NCT00543387|593427014|FG006|Panel 1 + Panel 2|Physician Decision|0|||
164288587|NCT00543387|593427015|FG007|Panel 1 + Panel 2|Physician Decision|1|||
164288588|NCT00543387|593427016|FG008|Panel 1 + Panel 2|Physician Decision|0|||
164288589|NCT00543387|593427017|FG009|Panel 1 + Panel 2|Physician Decision|0|||
164288590|NCT00543387|593427018|FG010|Panel 1 + Panel 2|Physician Decision|0|||
164288591|NCT00543387|593427008|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
164288592|NCT00543387|593427009|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
164288593|NCT00543387|593427010|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
164288594|NCT00543387|593427011|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
164288595|NCT00543387|593427012|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
164288596|NCT00543387|593427013|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
164288597|NCT00543387|593427014|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
164288598|NCT00543387|593427015|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
164288599|NCT00543387|593427016|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
164288600|NCT00543387|593427017|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
164288601|NCT00543387|593427018|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
164288602|NCT00543387|593427008|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
164288603|NCT00543387|593427009|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
164288604|NCT00543387|593427010|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
164288605|NCT00543387|593427011|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
164288606|NCT00543387|593427012|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
164288607|NCT00543387|593427013|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
164288608|NCT00543387|593427014|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
164288609|NCT00543387|593427015|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
164288610|NCT00543387|593427016|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
164288611|NCT00543387|593427017|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
164288612|NCT00543387|593427018|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
164288613|NCT00543387|593427008|FG000|Crossover Participants|Progressive Disease|0|||
164288614|NCT00543387|593427009|FG001|Crossover Participants|Progressive Disease|0|||
164288615|NCT00543387|593427010|FG002|Crossover Participants|Progressive Disease|0|||
164288616|NCT00543387|593427011|FG003|Crossover Participants|Progressive Disease|0|||
164288617|NCT00543387|593427012|FG004|Crossover Participants|Progressive Disease|0|||
164288618|NCT00543387|593427013|FG005|Crossover Participants|Progressive Disease|0|||
164288619|NCT00543387|593427014|FG006|Crossover Participants|Progressive Disease|0|||
164288620|NCT00543387|593427015|FG007|Crossover Participants|Progressive Disease|0|||
164288621|NCT00543387|593427016|FG008|Crossover Participants|Progressive Disease|0|||
164288622|NCT00543387|593427017|FG009|Crossover Participants|Progressive Disease|1|||
164288623|NCT00543387|593427018|FG010|Crossover Participants|Progressive Disease|2|||
164288624|NCT00543387|593427008|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
164288625|NCT00543387|593427009|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
164288626|NCT00543387|593427010|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
164288627|NCT00543387|593427011|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
164288628|NCT00543387|593427012|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
164288629|NCT00543387|593427013|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
164288630|NCT00543387|593427014|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
164288631|NCT00543387|593427015|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
164288632|NCT00543387|593427016|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
164288633|NCT00543387|593427017|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
164288634|NCT00543387|593427018|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
164288635|NCT01223183|593427028|FG000|Imaging Day 1|Physician Decision|0|||
164288636|NCT01223183|593427029|FG001|Imaging Day 1|Physician Decision|1|||
164288637|NCT01223183|593427028|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
164288638|NCT01223183|593427029|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
164288639|NCT01223183|593427028|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
164288640|NCT01223183|593427029|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
164288641|NCT01279681|593427030|FG000|Overall Study|Disease Progression|9|||
164288642|NCT01279681|593427031|FG001|Overall Study|Disease Progression|6|||
164288643|NCT01279681|593427030|FG000|Overall Study|Withdrawal by Subject|3|||
164288644|NCT01279681|593427031|FG001|Overall Study|Withdrawal by Subject|4|||
164288645|NCT01279681|593427030|FG000|Overall Study|Adverse Event|2|||
164288646|NCT01279681|593427031|FG001|Overall Study|Adverse Event|3|||
164288647|NCT01279681|593427030|FG000|Overall Study|Death|0|||
164288648|NCT01279681|593427031|FG001|Overall Study|Death|1|||
164288649|NCT01279681|593427030|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
164288650|NCT01279681|593427031|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
164288651|NCT01279681|593427030|FG000|Overall Study|Physician Decision|1|||
164288652|NCT01279681|593427031|FG001|Overall Study|Physician Decision|0|||
164288653|NCT01279681|593427030|FG000|Overall Study|Other Reason|0|||
164288654|NCT01279681|593427031|FG001|Overall Study|Other Reason|2|||
164288655|NCT01943591|593427032|FG000|Overall Study|Lost to Follow-up|3|||
164288656|NCT01943591|593427033|FG001|Overall Study|Lost to Follow-up|4|||
164288657|NCT01943591|593427032|FG000|Overall Study|Death|2|||
164288658|NCT01943591|593427033|FG001|Overall Study|Death|7|||
164288659|NCT03772665|593427034|FG000|Overall Study|Protocol Violation|1|||
164288660|NCT03772665|593427035|FG001|Overall Study|Protocol Violation|0|||
164288661|NCT01232868|593428190|FG000|Overall Study|Lost to Follow-up|2|||
164288662|NCT01232868|593428191|FG001|Overall Study|Lost to Follow-up|4|||
164288663|NCT04481243|593428193|FG000|Overall Study|Withdrawal by Subject|4|||
164288664|NCT02539797|593428194|FG000|Overall Study|Lost to Follow-up|0|||
164288665|NCT02539797|593428195|FG001|Overall Study|Lost to Follow-up|1|||
164288666|NCT02539797|593428196|FG002|Overall Study|Lost to Follow-up|0|||
164288667|NCT02796677|593428201|FG000|Overall Study|Adverse Event|11|||
164288668|NCT02796677|593428202|FG001|Overall Study|Adverse Event|22|||
164288669|NCT02796677|593428203|FG002|Overall Study|Adverse Event|14|||
164288670|NCT02796677|593428204|FG003|Overall Study|Adverse Event|14|||
164288671|NCT02796677|593428201|FG000|Overall Study|Protocol Violation|7|||
164288672|NCT02796677|593428202|FG001|Overall Study|Protocol Violation|5|||
164288673|NCT02796677|593428203|FG002|Overall Study|Protocol Violation|4|||
164288674|NCT02796677|593428204|FG003|Overall Study|Protocol Violation|8|||
164288675|NCT02796677|593428201|FG000|Overall Study|Lost to Follow-up|1|||
164288676|NCT02796677|593428202|FG001|Overall Study|Lost to Follow-up|5|||
164288677|NCT02796677|593428203|FG002|Overall Study|Lost to Follow-up|2|||
164288678|NCT02796677|593428204|FG003|Overall Study|Lost to Follow-up|2|||
164288679|NCT02796677|593428201|FG000|Overall Study|Lack of Efficacy|7|||
164288680|NCT02796677|593428202|FG001|Overall Study|Lack of Efficacy|9|||
164288681|NCT02796677|593428203|FG002|Overall Study|Lack of Efficacy|14|||
164288682|NCT02796677|593428204|FG003|Overall Study|Lack of Efficacy|20|||
164288683|NCT02796677|593428201|FG000|Overall Study|Withdrawal by Subject|4|||
164288684|NCT02796677|593428202|FG001|Overall Study|Withdrawal by Subject|14|||
164288685|NCT02796677|593428203|FG002|Overall Study|Withdrawal by Subject|6|||
164288686|NCT02796677|593428204|FG003|Overall Study|Withdrawal by Subject|7|||
164288687|NCT02796677|593428201|FG000|Overall Study|Progressive disease|6|||
164288688|NCT02796677|593428202|FG001|Overall Study|Progressive disease|15|||
164288689|NCT02796677|593428203|FG002|Overall Study|Progressive disease|13|||
164288690|NCT02796677|593428204|FG003|Overall Study|Progressive disease|18|||
164288691|NCT02796677|593428201|FG000|Overall Study|Reason not mentioned|2|||
164288692|NCT02796677|593428202|FG001|Overall Study|Reason not mentioned|3|||
164288693|NCT02796677|593428203|FG002|Overall Study|Reason not mentioned|0|||
164288694|NCT02796677|593428204|FG003|Overall Study|Reason not mentioned|5|||
164288695|NCT00961181|593428207|FG000|Overall Study|Death|2|||
164345296|NCT02871297|593640934|FG000|Overall Study|Protocol Violation|3|||
164345297|NCT02871297|593640934|FG000|Overall Study|Withdrawal by Subject|20|||
164288696|NCT00961181|593428207|FG000|Overall Study|Withdrawal by Subject|2|||
164288697|NCT00961181|593428207|FG000|Overall Study|Lost to Follow-up|1|||
164288698|NCT01777308|593428208|FG000|Overall Study|Withdrawal by Subject|5|||
164288699|NCT01777308|593428209|FG001|Overall Study|Withdrawal by Subject|1|||
164288700|NCT01777308|593428208|FG000|Overall Study|Migrated/moved from study area|1|||
164288701|NCT01777308|593428209|FG001|Overall Study|Migrated/moved from study area|0|||
164288702|NCT01777308|593428208|FG000|Overall Study|Lost to Follow-up|7|||
164288703|NCT01777308|593428209|FG001|Overall Study|Lost to Follow-up|2|||
164288704|NCT01777308|593428208|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
164288705|NCT01777308|593428209|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
164288706|NCT03212326|593428211|FG000|Overall Study|Physician Decision|4|||
164288707|NCT01131507|593428225|FG000|Overall Study|Adverse Event|1|||
164288708|NCT01131507|593428225|FG000|Overall Study|Lost to Follow-up|1|||
164288709|NCT01131507|593428225|FG000|Overall Study|Withdrawal by Subject|1|||
164288710|NCT01517750|593428226|FG000|Overall Study|Lost to Follow-up|1|||
164288711|NCT01517750|593428227|FG001|Overall Study|Lost to Follow-up|2|||
164288712|NCT01517750|593428228|FG002|Overall Study|Lost to Follow-up|4|||
164288713|NCT01517750|593428229|FG003|Overall Study|Lost to Follow-up|1|||
164288714|NCT01855412|593428231|FG000|Overall Study|Death|77|||
164288715|NCT01855412|593428232|FG001|Overall Study|Death|123|||
164288716|NCT01855412|593428233|FG002|Overall Study|Death|30|||
164288717|NCT01855412|593428231|FG000|Overall Study|Lost to Follow-up|28|||
164288718|NCT01855412|593428232|FG001|Overall Study|Lost to Follow-up|46|||
164288719|NCT01855412|593428233|FG002|Overall Study|Lost to Follow-up|15|||
164288720|NCT01855412|593428231|FG000|Overall Study|Withdrawal by Subject|77|||
164288721|NCT01855412|593428232|FG001|Overall Study|Withdrawal by Subject|123|||
164288722|NCT01855412|593428233|FG002|Overall Study|Withdrawal by Subject|24|||
164288723|NCT01855412|593428231|FG000|Overall Study|Physician Decision|25|||
164288724|NCT01855412|593428232|FG001|Overall Study|Physician Decision|31|||
164288725|NCT01855412|593428233|FG002|Overall Study|Physician Decision|3|||
164288726|NCT01855412|593428231|FG000|Overall Study|Site Closure|4|||
164288727|NCT01855412|593428232|FG001|Overall Study|Site Closure|18|||
164288728|NCT01855412|593428233|FG002|Overall Study|Site Closure|1|||
164288729|NCT01855412|593428231|FG000|Overall Study|Reason not Specified|1|||
164288730|NCT01855412|593428232|FG001|Overall Study|Reason not Specified|2|||
164345298|NCT02871297|593640934|FG000|Overall Study|Lost to Follow-up|13|||
164345299|NCT02871297|593640934|FG000|Overall Study|Rolled over to 13546A|2|||
164345300|NCT02871297|593640934|FG000|Overall Study|Other than specified|39|||
164345301|NCT02966028|593640938|FG000|Overall Study|Adverse Event|7|||
164345302|NCT02966028|593640939|FG001|Overall Study|Adverse Event|13|||
164345303|NCT02966028|593640940|FG002|Overall Study|Adverse Event|10|||
164345304|NCT02966028|593640938|FG000|Overall Study|Physician Decision|1|||
164345305|NCT02966028|593640939|FG001|Overall Study|Physician Decision|0|||
164345306|NCT02966028|593640940|FG002|Overall Study|Physician Decision|2|||
164288731|NCT01855412|593428233|FG002|Overall Study|Reason not Specified|3|||
164288732|NCT05030350|593428239|FG000|Overall Study|Adverse Event|13|||
164288733|NCT05030350|593428239|FG000|Overall Study|Lack of Efficacy|8|||
164288734|NCT05030350|593428239|FG000|Overall Study|Lost to Follow-up|35|||
164288735|NCT05030350|593428239|FG000|Overall Study|Pregnancy|2|||
164288736|NCT05030350|593428239|FG000|Overall Study|Protocol Violation|2|||
164288737|NCT05030350|593428239|FG000|Overall Study|Withdrawal by Subject|60|||
164288738|NCT05030350|593428239|FG000|Overall Study|Study terminated by sponsor|349|||
164288739|NCT05030350|593428239|FG000|Overall Study|Positive Drug Screen|4|||
164288740|NCT05030350|593428239|FG000|Overall Study|Other|8|||
164288741|NCT00742183|593428240|FG000|Overall Study|Adverse Event|2|||
164288742|NCT00742183|593428241|FG001|Overall Study|Adverse Event|2|||
164345307|NCT02966028|593640938|FG000|Overall Study|Withdrawal by Subject|7|||
164345308|NCT02966028|593640939|FG001|Overall Study|Withdrawal by Subject|5|||
164288743|NCT00742183|593428240|FG000|Overall Study|Death|1|||
164288744|NCT00742183|593428241|FG001|Overall Study|Death|0|||
164288745|NCT00742183|593428240|FG000|Overall Study|Physician Decision|0|||
164288746|NCT00742183|593428241|FG001|Overall Study|Physician Decision|2|||
164288747|NCT00742183|593428240|FG000|Overall Study|Lost to Follow-up|4|||
164288748|NCT00742183|593428241|FG001|Overall Study|Lost to Follow-up|4|||
164288749|NCT00742183|593428240|FG000|Overall Study|Required skin-graft|1|||
164288750|NCT00742183|593428241|FG001|Overall Study|Required skin-graft|1|||
164288751|NCT00742183|593428240|FG000|Overall Study|Withdrawal by Subject|1|||
164288752|NCT00742183|593428241|FG001|Overall Study|Withdrawal by Subject|0|||
164288753|NCT00742183|593428240|FG000|Overall Study|Lack of Efficacy|0|||
164288754|NCT00742183|593428241|FG001|Overall Study|Lack of Efficacy|3|||
164288755|NCT03985761|593428245|FG000|Overall Study|Withdrawal by Subject|2|||
164288756|NCT03985761|593428246|FG001|Overall Study|Withdrawal by Subject|3|||
164288757|NCT01367834|593428247|FG000|Overall Study|Withdrawal by Subject|2|||
164288758|NCT01367834|593428248|FG001|Overall Study|Withdrawal by Subject|2|||
164288759|NCT01367834|593428247|FG000|Overall Study|Study was ended.|0|||
164288760|NCT01367834|593428248|FG001|Overall Study|Study was ended.|1|||
164288761|NCT01569841|593428251|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
164288762|NCT01569841|593428252|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
164288763|NCT01858363|593428253|FG000|Overall Study|Death|35|||
164288764|NCT01858363|593428254|FG001|Overall Study|Death|9|||
164288765|NCT01858363|593428253|FG000|Overall Study|Withdrawal by Subject|28|||
164288766|NCT01858363|593428254|FG001|Overall Study|Withdrawal by Subject|14|||
164288767|NCT01858363|593428253|FG000|Overall Study|Lost to Follow-up|13|||
164288768|NCT01858363|593428254|FG001|Overall Study|Lost to Follow-up|3|||
164288769|NCT00057863|593428259|FG000|Overall Study|Death|1|||
164288770|NCT00057863|593428259|FG000|Overall Study|Withdrawal by Subject|2|||
164288771|NCT00764361|593428260|FG000|Overall Study|Withdrawal by Subject|2|||
164288772|NCT00764361|593428261|FG001|Overall Study|Withdrawal by Subject|3|||
164288773|NCT00764361|593428260|FG000|Overall Study|Adverse Event|0|||
164288774|NCT00764361|593428261|FG001|Overall Study|Adverse Event|1|||
164288775|NCT02090426|593428263|FG000|Overall Study|Lost to Follow-up|12|||
164288776|NCT02090426|593428264|FG001|Overall Study|Lost to Follow-up|6|||
164288777|NCT01141712|593428268|FG000|Overall Study|Disease progression|3|||
164288778|NCT03480152|593428269|FG000|Phase I|Signed consent. Died before treatment.|1|||
164288779|NCT03480152|593428270|FG001|Phase I|Signed consent. Died before treatment.|0|||
164288780|NCT03480152|593428271|FG002|Phase I|Signed consent. Died before treatment.|0|||
164288781|NCT01308736|593428278|FG000|Overall Study|Did not attend a single session|6|||
164288782|NCT01308736|593428279|FG001|Overall Study|Did not attend a single session|5|||
164288783|NCT03634085|593428280|FG000|Overall Study|Adverse Event|1|||
164288784|NCT03634085|593428281|FG001|Overall Study|Adverse Event|0|||
164288785|NCT03634085|593428280|FG000|Overall Study|Withdrawal by Subject|0|||
164288786|NCT03634085|593428281|FG001|Overall Study|Withdrawal by Subject|2|||
164288787|NCT04276233|593428282|FG000|Overall Study|Adverse Event|1|||
164288788|NCT04276233|593428282|FG000|Overall Study|Lost to Follow-up|3|||
164288789|NCT04276233|593428282|FG000|Overall Study|Physician Decision|4|||
164288790|NCT04276233|593428282|FG000|Overall Study|Withdrawal by Subject|2|||
164288791|NCT01946139|593428291|FG000|Overall Study|Withdrawal by Subject|8|||
164288792|NCT01946139|593428291|FG000|Overall Study|ineligible|8|||
164288793|NCT01946139|593428291|FG000|Overall Study|Specimens not available|4|||
164288794|NCT00101686|593428298|FG000|Overall Study|Progressive Disease|37|||
164288795|NCT00101686|593428299|FG001|Overall Study|Progressive Disease|28|||
164288796|NCT00101686|593428300|FG002|Overall Study|Progressive Disease|37|||
164288797|NCT00101686|593428301|FG003|Overall Study|Progressive Disease|38|||
164288798|NCT00101686|593428302|FG004|Overall Study|Progressive Disease|28|||
164288799|NCT00101686|593428303|FG005|Overall Study|Progressive Disease|25|||
164288800|NCT00101686|593428304|FG006|Overall Study|Progressive Disease|5|||
164288801|NCT00101686|593428305|FG007|Overall Study|Progressive Disease|7|||
164288802|NCT00101686|593428306|FG008|Overall Study|Progressive Disease|10|||
164288803|NCT00101686|593428307|FG009|Overall Study|Progressive Disease|8|||
164288804|NCT00101686|593428298|FG000|Overall Study|initiation other anti-cancer treatment|4|||
164288805|NCT00101686|593428299|FG001|Overall Study|initiation other anti-cancer treatment|3|||
164288806|NCT00101686|593428300|FG002|Overall Study|initiation other anti-cancer treatment|4|||
164288807|NCT00101686|593428301|FG003|Overall Study|initiation other anti-cancer treatment|3|||
164288808|NCT00101686|593428302|FG004|Overall Study|initiation other anti-cancer treatment|1|||
164288809|NCT00101686|593428303|FG005|Overall Study|initiation other anti-cancer treatment|1|||
164288810|NCT00101686|593428304|FG006|Overall Study|initiation other anti-cancer treatment|2|||
164288811|NCT00101686|593428305|FG007|Overall Study|initiation other anti-cancer treatment|2|||
164288812|NCT00101686|593428306|FG008|Overall Study|initiation other anti-cancer treatment|3|||
164288813|NCT00101686|593428307|FG009|Overall Study|initiation other anti-cancer treatment|3|||
164288814|NCT00101686|593428298|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
164288815|NCT00101686|593428299|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
164288816|NCT00101686|593428300|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
164288817|NCT00101686|593428301|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
164288818|NCT00101686|593428302|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
164288819|NCT00101686|593428303|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
164288820|NCT00101686|593428304|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
164288821|NCT00101686|593428305|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
164288822|NCT00101686|593428306|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
164288823|NCT00101686|593428307|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
164288824|NCT00101686|593428298|FG000|Overall Study|unacceptable toxicity|3|||
164288825|NCT00101686|593428299|FG001|Overall Study|unacceptable toxicity|9|||
164288826|NCT00101686|593428300|FG002|Overall Study|unacceptable toxicity|10|||
164288827|NCT00101686|593428301|FG003|Overall Study|unacceptable toxicity|6|||
164288828|NCT00101686|593428302|FG004|Overall Study|unacceptable toxicity|16|||
164288829|NCT00101686|593428303|FG005|Overall Study|unacceptable toxicity|10|||
164288830|NCT00101686|593428304|FG006|Overall Study|unacceptable toxicity|4|||
164288831|NCT00101686|593428305|FG007|Overall Study|unacceptable toxicity|2|||
164288832|NCT00101686|593428306|FG008|Overall Study|unacceptable toxicity|1|||
164288833|NCT00101686|593428307|FG009|Overall Study|unacceptable toxicity|4|||
164288834|NCT00101686|593428298|FG000|Overall Study|Randomized but did not receive treament|1|||
164288835|NCT00101686|593428299|FG001|Overall Study|Randomized but did not receive treament|6|||
164288836|NCT00101686|593428300|FG002|Overall Study|Randomized but did not receive treament|2|||
164288837|NCT00101686|593428301|FG003|Overall Study|Randomized but did not receive treament|2|||
164288838|NCT00101686|593428302|FG004|Overall Study|Randomized but did not receive treament|2|||
164288839|NCT00101686|593428303|FG005|Overall Study|Randomized but did not receive treament|2|||
164288840|NCT00101686|593428304|FG006|Overall Study|Randomized but did not receive treament|0|||
164288841|NCT00101686|593428305|FG007|Overall Study|Randomized but did not receive treament|1|||
164288842|NCT00101686|593428306|FG008|Overall Study|Randomized but did not receive treament|0|||
164345309|NCT02966028|593640940|FG002|Overall Study|Withdrawal by Subject|5|||
164345310|NCT02966028|593640938|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
164345311|NCT02966028|593640939|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
164345312|NCT02966028|593640940|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
164288843|NCT00101686|593428307|FG009|Overall Study|Randomized but did not receive treament|1|||
164288844|NCT00101686|593428298|FG000|Overall Study|intercurrent non-cancer related illness|0|||
164288845|NCT00101686|593428299|FG001|Overall Study|intercurrent non-cancer related illness|0|||
164288846|NCT00101686|593428300|FG002|Overall Study|intercurrent non-cancer related illness|2|||
164288847|NCT00101686|593428301|FG003|Overall Study|intercurrent non-cancer related illness|0|||
164288848|NCT00101686|593428302|FG004|Overall Study|intercurrent non-cancer related illness|1|||
164288849|NCT00101686|593428303|FG005|Overall Study|intercurrent non-cancer related illness|3|||
164288850|NCT00101686|593428304|FG006|Overall Study|intercurrent non-cancer related illness|1|||
164288851|NCT00101686|593428305|FG007|Overall Study|intercurrent non-cancer related illness|0|||
164288852|NCT00101686|593428306|FG008|Overall Study|intercurrent non-cancer related illness|1|||
164288853|NCT00101686|593428307|FG009|Overall Study|intercurrent non-cancer related illness|1|||
164288854|NCT00101686|593428298|FG000|Overall Study|Physician Decision|10|||
164288855|NCT00101686|593428299|FG001|Overall Study|Physician Decision|13|||
164288856|NCT00101686|593428300|FG002|Overall Study|Physician Decision|6|||
164288857|NCT00101686|593428301|FG003|Overall Study|Physician Decision|7|||
164288858|NCT00101686|593428302|FG004|Overall Study|Physician Decision|8|||
164288859|NCT00101686|593428303|FG005|Overall Study|Physician Decision|9|||
164288860|NCT00101686|593428304|FG006|Overall Study|Physician Decision|5|||
164288861|NCT00101686|593428305|FG007|Overall Study|Physician Decision|5|||
164288862|NCT00101686|593428306|FG008|Overall Study|Physician Decision|1|||
164288863|NCT00101686|593428307|FG009|Overall Study|Physician Decision|1|||
164288864|NCT00101686|593428298|FG000|Overall Study|Other|1|||
164288865|NCT00101686|593428299|FG001|Overall Study|Other|4|||
164288866|NCT00101686|593428300|FG002|Overall Study|Other|1|||
164288867|NCT00101686|593428301|FG003|Overall Study|Other|6|||
164288868|NCT00101686|593428302|FG004|Overall Study|Other|2|||
164288869|NCT00101686|593428303|FG005|Overall Study|Other|12|||
164288870|NCT00101686|593428304|FG006|Overall Study|Other|1|||
164288871|NCT00101686|593428305|FG007|Overall Study|Other|5|||
164288872|NCT00101686|593428306|FG008|Overall Study|Other|3|||
164288873|NCT00101686|593428307|FG009|Overall Study|Other|3|||
164288874|NCT00101686|593428298|FG000|Overall Study|Withdrawal by Subject|9|||
164288875|NCT00101686|593428299|FG001|Overall Study|Withdrawal by Subject|8|||
164288876|NCT00101686|593428300|FG002|Overall Study|Withdrawal by Subject|6|||
164288877|NCT00101686|593428301|FG003|Overall Study|Withdrawal by Subject|8|||
164288878|NCT00101686|593428302|FG004|Overall Study|Withdrawal by Subject|8|||
164288879|NCT00101686|593428303|FG005|Overall Study|Withdrawal by Subject|7|||
164288880|NCT00101686|593428304|FG006|Overall Study|Withdrawal by Subject|7|||
164288881|NCT00101686|593428305|FG007|Overall Study|Withdrawal by Subject|7|||
164288882|NCT00101686|593428306|FG008|Overall Study|Withdrawal by Subject|8|||
164288883|NCT00101686|593428307|FG009|Overall Study|Withdrawal by Subject|9|||
164288884|NCT00296816|593428308|FG000|Overall Study|Disease Progression|37|||
164288885|NCT00296816|593428308|FG000|Overall Study|Adverse Event|18|||
164288886|NCT00296816|593428308|FG000|Overall Study|Investigator/Participant request|5|||
164288887|NCT00296816|593428308|FG000|Overall Study|Non-compliance|1|||
164288888|NCT00296816|593428308|FG000|Overall Study|Missing for end of treatment|4|||
164288889|NCT00296816|593428308|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
164288890|NCT00296816|593428308|FG000|Overall Study|Poor performance status|1|||
164288891|NCT00296816|593428308|FG000|Overall Study|Relocation to Florida|1|||
164288892|NCT00296816|593428308|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
164288893|NCT00296816|593428308|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
164288894|NCT00296816|593428308|FG000|Overall Study|Neuropathy/patient preference|1|||
164288895|NCT00296816|593428308|FG000|Overall Study|Proteinuria|1|||
164288896|NCT00296816|593428308|FG000|Overall Study|ineligibility due to radiation treatment|1|||
164288897|NCT01292187|593428309|FG000|Overall Study|Adverse Event|10|||
164288898|NCT01292187|593428310|FG001|Overall Study|Adverse Event|5|||
164288899|NCT01292187|593428309|FG000|Overall Study|Withdrawal by Subject|6|||
164288900|NCT01292187|593428310|FG001|Overall Study|Withdrawal by Subject|5|||
164288901|NCT01292187|593428309|FG000|Overall Study|All other reasons|1|||
164288902|NCT01292187|593428310|FG001|Overall Study|All other reasons|3|||
164288903|NCT01814527|593428312|FG000|Overall Study|RTP greater than 30 days|6|||
164288904|NCT01814527|593428313|FG001|Overall Study|RTP greater than 30 days|1|||
164288905|NCT00687401|593428314|FG000|Overall Study|Protocol Violation|7|||
164288906|NCT00687401|593428314|FG000|Overall Study|Adverse Event|6|||
164288907|NCT00687401|593428314|FG000|Overall Study|Lack of Efficacy|6|||
164288908|NCT00687401|593428314|FG000|Overall Study|Withdrawal by Subject|4|||
164288909|NCT00687401|593428314|FG000|Overall Study|Did not return for visit|3|||
164288910|NCT00687401|593428314|FG000|Overall Study|For reasons different from those above|4|||
164288911|NCT02520726|593428315|FG000|Overall Study|Lost to Follow-up|3|||
164288912|NCT02520726|593428316|FG001|Overall Study|Lost to Follow-up|2|||
164288913|NCT00721396|593428317|FG000|Overall Study|Adverse Event|4|||
164288914|NCT00721396|593428318|FG001|Overall Study|Adverse Event|7|||
164288915|NCT00721396|593428319|FG002|Overall Study|Adverse Event|2|||
164288916|NCT00721396|593428320|FG003|Overall Study|Adverse Event|0|||
164288917|NCT00721396|593428317|FG000|Overall Study|Withdrawal by Subject|12|||
164288918|NCT00721396|593428318|FG001|Overall Study|Withdrawal by Subject|15|||
164288919|NCT00721396|593428319|FG002|Overall Study|Withdrawal by Subject|3|||
164288920|NCT00721396|593428320|FG003|Overall Study|Withdrawal by Subject|7|||
164288921|NCT00721396|593428317|FG000|Overall Study|Lost to Follow-up|7|||
164288922|NCT00721396|593428318|FG001|Overall Study|Lost to Follow-up|9|||
164288923|NCT00721396|593428319|FG002|Overall Study|Lost to Follow-up|3|||
164288924|NCT00721396|593428320|FG003|Overall Study|Lost to Follow-up|3|||
164288925|NCT00721396|593428317|FG000|Overall Study|Protocol Violation|4|||
164288926|NCT00721396|593428318|FG001|Overall Study|Protocol Violation|3|||
164288927|NCT00721396|593428319|FG002|Overall Study|Protocol Violation|1|||
164288928|NCT00721396|593428320|FG003|Overall Study|Protocol Violation|0|||
164288929|NCT00721396|593428317|FG000|Overall Study|Inappropriate enrollment|0|||
164288930|NCT00721396|593428318|FG001|Overall Study|Inappropriate enrollment|2|||
164288931|NCT00721396|593428319|FG002|Overall Study|Inappropriate enrollment|0|||
164288932|NCT00721396|593428320|FG003|Overall Study|Inappropriate enrollment|0|||
164288933|NCT00721396|593428317|FG000|Overall Study|Administrative reason|3|||
164288934|NCT00721396|593428318|FG001|Overall Study|Administrative reason|0|||
164288935|NCT00721396|593428319|FG002|Overall Study|Administrative reason|1|||
164288936|NCT00721396|593428320|FG003|Overall Study|Administrative reason|0|||
164288937|NCT00430716|593428324|FG000|Double Blind Phase|Death|1|||
164288938|NCT00430716|593428325|FG001|Double Blind Phase|Death|0|||
164288939|NCT00430716|593428326|FG002|Double Blind Phase|Death|0|||
164288940|NCT00430716|593428324|FG000|Double Blind Phase|No longer willing to participate|2|||
164288941|NCT00430716|593428325|FG001|Double Blind Phase|No longer willing to participate|1|||
164288942|NCT00430716|593428326|FG002|Double Blind Phase|No longer willing to participate|1|||
164288943|NCT00430716|593428324|FG000|Double Blind Phase|Other|0|||
164288944|NCT00430716|593428325|FG001|Double Blind Phase|Other|2|||
164288945|NCT00430716|593428326|FG002|Double Blind Phase|Other|0|||
164288946|NCT00430716|593428324|FG000|Double Blind Phase|Study terminated by sponsor|1|||
164288947|NCT00430716|593428325|FG001|Double Blind Phase|Study terminated by sponsor|1|||
164288948|NCT00430716|593428326|FG002|Double Blind Phase|Study terminated by sponsor|2|||
164288949|NCT00430716|593428324|FG000|Double Blind Phase|Adverse Event|1|||
164288950|NCT00430716|593428325|FG001|Double Blind Phase|Adverse Event|1|||
164288951|NCT00430716|593428326|FG002|Double Blind Phase|Adverse Event|3|||
164288952|NCT00430716|593428324|FG000|Double Blind Phase|Not treated|1|||
164288953|NCT00430716|593428325|FG001|Double Blind Phase|Not treated|0|||
164288954|NCT00430716|593428326|FG002|Double Blind Phase|Not treated|0|||
164288955|NCT00430716|593428324|FG000|Open Label Phase|Lost to Follow-up|1|||
164288956|NCT00430716|593428325|FG001|Open Label Phase|Lost to Follow-up|0|||
164288957|NCT00430716|593428326|FG002|Open Label Phase|Lost to Follow-up|1|||
164288958|NCT00430716|593428324|FG000|Open Label Phase|No longer willing to participate|0|||
164288959|NCT00430716|593428325|FG001|Open Label Phase|No longer willing to participate|1|||
164288960|NCT00430716|593428326|FG002|Open Label Phase|No longer willing to participate|1|||
164288961|NCT00430716|593428324|FG000|Open Label Phase|Other|3|||
164288962|NCT00430716|593428325|FG001|Open Label Phase|Other|1|||
164288963|NCT00430716|593428326|FG002|Open Label Phase|Other|1|||
164288964|NCT00430716|593428324|FG000|Open Label Phase|Protocol Violation|1|||
164288965|NCT00430716|593428325|FG001|Open Label Phase|Protocol Violation|0|||
164288966|NCT00430716|593428326|FG002|Open Label Phase|Protocol Violation|0|||
164288967|NCT00430716|593428324|FG000|Open Label Phase|Study terminated by sponsor|4|||
164288968|NCT00430716|593428325|FG001|Open Label Phase|Study terminated by sponsor|5|||
164288969|NCT00430716|593428326|FG002|Open Label Phase|Study terminated by sponsor|4|||
164288970|NCT00782717|593428327|FG000|Overall Study|Adverse Event|2|||
164288971|NCT00782717|593428328|FG001|Overall Study|Adverse Event|5|||
164288972|NCT00782717|593428327|FG000|Overall Study|Patient decision unrelated to AE|6|||
164288973|NCT00782717|593428328|FG001|Overall Study|Patient decision unrelated to AE|3|||
164288974|NCT00782717|593428327|FG000|Overall Study|Noncompliance|2|||
164288975|NCT00782717|593428328|FG001|Overall Study|Noncompliance|1|||
164345313|NCT04115839|593640941|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
164345314|NCT04115839|593640942|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
164345315|NCT04115839|593640943|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
164345316|NCT04115839|593640944|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
164345317|NCT04115839|593640945|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
164345318|NCT04115839|593640946|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
164345319|NCT04115839|593640947|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
164345320|NCT04115839|593640941|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
164345321|NCT04115839|593640942|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
164345322|NCT04115839|593640943|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
164288976|NCT00782717|593428327|FG000|Overall Study|Treatment failure|3|||
164288977|NCT00782717|593428328|FG001|Overall Study|Treatment failure|14|||
164288978|NCT00782717|593428327|FG000|Overall Study|Enrollment close prior to surgery|1|||
164288979|NCT00782717|593428328|FG001|Overall Study|Enrollment close prior to surgery|0|||
164288980|NCT00782717|593428327|FG000|Overall Study|Did not meet entrance criteria|1|||
164288981|NCT00782717|593428328|FG001|Overall Study|Did not meet entrance criteria|3|||
164288982|NCT00782717|593428327|FG000|Overall Study|Exited in error|0|||
164288983|NCT00782717|593428328|FG001|Overall Study|Exited in error|2|||
164288984|NCT02446717|593428329|FG000|Overall Study|Adverse Event|0|||
164288985|NCT02446717|593428330|FG001|Overall Study|Adverse Event|0|||
164288986|NCT02446717|593428331|FG002|Overall Study|Adverse Event|1|||
164288987|NCT02446717|593428332|FG003|Overall Study|Adverse Event|0|||
164288988|NCT02446717|593428333|FG004|Overall Study|Adverse Event|0|||
164288989|NCT02446717|593428329|FG000|Overall Study|Lost to Follow-up|0|||
164288990|NCT02446717|593428330|FG001|Overall Study|Lost to Follow-up|1|||
164288991|NCT02446717|593428331|FG002|Overall Study|Lost to Follow-up|1|||
164288992|NCT02446717|593428332|FG003|Overall Study|Lost to Follow-up|0|||
164288993|NCT02446717|593428333|FG004|Overall Study|Lost to Follow-up|1|||
164288994|NCT02446717|593428329|FG000|Overall Study|Withdrew consent|0|||
164288995|NCT02446717|593428330|FG001|Overall Study|Withdrew consent|0|||
164288996|NCT02446717|593428331|FG002|Overall Study|Withdrew consent|0|||
164288997|NCT02446717|593428332|FG003|Overall Study|Withdrew consent|1|||
164288998|NCT02446717|593428333|FG004|Overall Study|Withdrew consent|0|||
164288999|NCT00154297|593428340|FG000|Overall Study|Death|5|||
164289000|NCT00154297|593428341|FG001|Overall Study|Death|2|||
164289001|NCT00154297|593428340|FG000|Overall Study|Withdrawal by Subject|0|||
164289002|NCT00154297|593428341|FG001|Overall Study|Withdrawal by Subject|5|||
164289003|NCT00154297|593428340|FG000|Overall Study|Lost to Follow-up|3|||
164289004|NCT00154297|593428341|FG001|Overall Study|Lost to Follow-up|0|||
164289005|NCT03116685|593428344|FG000|Overall Study|Physician Decision|0|||
164289006|NCT03116685|593428345|FG001|Overall Study|Physician Decision|1|||
164289007|NCT00398320|593428346|FG000|Overall Study|Death|1|||
164289008|NCT00398320|593428346|FG000|Overall Study|Adverse Event|4|||
164289009|NCT00398320|593428346|FG000|Overall Study|Physician Decision|1|||
164289010|NCT00064792|593428347|FG000|Overall Study|Withdrawal by Subject|2|||
164289011|NCT00064792|593428348|FG001|Overall Study|Withdrawal by Subject|0|||
164289012|NCT00064792|593428347|FG000|Overall Study|Adverse Event|3|||
164289013|NCT00064792|593428348|FG001|Overall Study|Adverse Event|0|||
164289014|NCT00992459|593428352|FG000|Overall Study|Withdrawal by Subject|0|||
164289015|NCT00992459|593428353|FG001|Overall Study|Withdrawal by Subject|1|||
164289016|NCT00992459|593428352|FG000|Overall Study|Adverse Event|1|||
164289017|NCT00992459|593428353|FG001|Overall Study|Adverse Event|0|||
164289018|NCT04177212|593428356|FG000|Overall Study|Withdrawal by Subject|9|||
164289019|NCT04177212|593428357|FG001|Overall Study|Withdrawal by Subject|7|||
164289020|NCT04177212|593428356|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
164289021|NCT04177212|593428357|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
164289022|NCT04177212|593428356|FG000|Overall Study|Physician Decision|1|||
164289023|NCT04177212|593428357|FG001|Overall Study|Physician Decision|0|||
164289024|NCT04177212|593428356|FG000|Overall Study|Lost to Follow-up|0|||
164289025|NCT04177212|593428357|FG001|Overall Study|Lost to Follow-up|3|||
164289026|NCT04177212|593428356|FG000|Overall Study|Adverse Event|0|||
164289027|NCT04177212|593428357|FG001|Overall Study|Adverse Event|1|||
164289028|NCT04177212|593428356|FG000|Overall Study|Other|1|||
164289029|NCT04177212|593428357|FG001|Overall Study|Other|2|||
164289030|NCT01792115|593428358|FG000|Overall Study|Lost to Follow-up|0|||
164289031|NCT01792115|593428359|FG001|Overall Study|Lost to Follow-up|1|||
164289032|NCT01792115|593428360|FG002|Overall Study|Lost to Follow-up|0|||
164289033|NCT02831764|593429665|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
164289034|NCT02831764|593429666|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
164289035|NCT02831764|593429667|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
164289036|NCT02831764|593429668|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
164289037|NCT02831764|593429669|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
164289038|NCT02831764|593429665|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
164289039|NCT02831764|593429666|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
164289040|NCT02831764|593429667|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
164289041|NCT02831764|593429668|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
164289042|NCT02831764|593429669|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
164289043|NCT02831764|593429665|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
164289044|NCT02831764|593429666|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
164289045|NCT02831764|593429667|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
164289046|NCT02831764|593429668|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
164345323|NCT04115839|593640944|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
164345324|NCT04115839|593640945|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
164289047|NCT02831764|593429669|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
164289048|NCT02831764|593429665|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
164289049|NCT02831764|593429666|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
164289050|NCT02831764|593429667|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
164289051|NCT02831764|593429668|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
164289052|NCT02831764|593429669|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
164289053|NCT02831764|593429665|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
164289054|NCT02831764|593429666|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
164289055|NCT02831764|593429667|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
164289056|NCT02831764|593429668|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
164289057|NCT02831764|593429669|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
164289058|NCT02831764|593429665|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
164289059|NCT02831764|593429666|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
164289060|NCT02831764|593429667|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
164289061|NCT02831764|593429668|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
164289062|NCT02831764|593429669|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
164289063|NCT02831764|593429665|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
164289064|NCT02831764|593429666|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
164289065|NCT02831764|593429667|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
164289066|NCT02831764|593429668|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
164289067|NCT02831764|593429669|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
164289068|NCT02831764|593429665|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
164289069|NCT02831764|593429666|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
164289070|NCT02831764|593429667|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
164289071|NCT02831764|593429668|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
164289072|NCT02831764|593429669|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
164289073|NCT02831764|593429665|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
164289074|NCT02831764|593429666|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
164289075|NCT02831764|593429667|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
164289076|NCT02831764|593429668|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
164289077|NCT02831764|593429669|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
164289078|NCT02831764|593429665|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
164289079|NCT02831764|593429666|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
164289080|NCT02831764|593429667|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
164289081|NCT02831764|593429668|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
164289082|NCT02831764|593429669|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
164289083|NCT02831764|593429665|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
164289084|NCT02831764|593429666|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
164289085|NCT02831764|593429667|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
164289086|NCT02831764|593429668|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
164289087|NCT02831764|593429669|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
164289088|NCT02831764|593429665|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
164289089|NCT02831764|593429666|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
164289090|NCT02831764|593429667|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
164289091|NCT02831764|593429668|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
164289092|NCT02831764|593429669|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
164289093|NCT02831764|593429665|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
164289094|NCT02831764|593429666|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
164289095|NCT02831764|593429667|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
164289096|NCT02831764|593429668|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
164289097|NCT02831764|593429669|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
164289098|NCT02831764|593429665|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
164289099|NCT02831764|593429666|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
164289100|NCT02831764|593429667|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
164289101|NCT02831764|593429668|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
164289102|NCT02831764|593429669|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
164289103|NCT02831764|593429665|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
164289104|NCT02831764|593429666|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
164289105|NCT02831764|593429667|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
164289106|NCT02831764|593429668|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
164289107|NCT02831764|593429669|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
164289108|NCT02831764|593429665|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
164289109|NCT02831764|593429666|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
164289110|NCT02831764|593429667|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
164289111|NCT02831764|593429668|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
164289112|NCT02831764|593429669|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
164289113|NCT02831764|593429665|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
164289114|NCT02831764|593429666|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
164289115|NCT02831764|593429667|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
164289116|NCT02831764|593429668|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
164289117|NCT02831764|593429669|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
164289118|NCT02831764|593429665|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
164433335|NCT00335556|593957221|FG004|Overall Study|Death|1|||
164289119|NCT02831764|593429666|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
164289120|NCT02831764|593429667|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
164289121|NCT02831764|593429668|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
164289122|NCT02831764|593429669|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
164289123|NCT02831764|593429665|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
164289124|NCT02831764|593429666|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
164289125|NCT02831764|593429667|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
164289126|NCT02831764|593429668|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
164289127|NCT02831764|593429669|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
164289128|NCT01790594|593429673|FG000|Overall Study|Death|1|||
164289129|NCT01790594|593429674|FG001|Overall Study|Death|0|||
164289130|NCT01790594|593429675|FG002|Overall Study|Death|0|||
164289131|NCT01790594|593429673|FG000|Overall Study|Physician Decision|2|||
164289132|NCT01790594|593429674|FG001|Overall Study|Physician Decision|1|||
164289133|NCT01790594|593429675|FG002|Overall Study|Physician Decision|0|||
164289134|NCT01790594|593429673|FG000|Overall Study|Withdrawal by Subject|2|||
164289135|NCT01790594|593429674|FG001|Overall Study|Withdrawal by Subject|0|||
164289136|NCT01790594|593429675|FG002|Overall Study|Withdrawal by Subject|0|||
164289137|NCT01790594|593429673|FG000|Overall Study|Transplant was not done|0|||
164289138|NCT01790594|593429674|FG001|Overall Study|Transplant was not done|0|||
164289139|NCT01790594|593429675|FG002|Overall Study|Transplant was not done|3|||
164289140|NCT01790594|593429673|FG000|Overall Study|Terminated prior to week 76|0|||
164289141|NCT01790594|593429674|FG001|Overall Study|Terminated prior to week 76|2|||
164289142|NCT01790594|593429675|FG002|Overall Study|Terminated prior to week 76|0|||
164289143|NCT03347123|593429676|FG000|Overall Study|Death|1|||
164289144|NCT03347123|593429677|FG001|Overall Study|Death|2|||
164289145|NCT03347123|593429678|FG002|Overall Study|Death|0|||
164289146|NCT03347123|593429679|FG003|Overall Study|Death|0|||
164289147|NCT03347123|593429680|FG004|Overall Study|Death|0|||
164289148|NCT03347123|593429681|FG005|Overall Study|Death|0|||
164289149|NCT03347123|593429682|FG006|Overall Study|Death|0|||
164289150|NCT03347123|593429676|FG000|Overall Study|Withdrawal by Subject|1|||
164289151|NCT03347123|593429677|FG001|Overall Study|Withdrawal by Subject|0|||
164289152|NCT03347123|593429678|FG002|Overall Study|Withdrawal by Subject|0|||
164289153|NCT03347123|593429679|FG003|Overall Study|Withdrawal by Subject|0|||
164289154|NCT03347123|593429680|FG004|Overall Study|Withdrawal by Subject|0|||
164289155|NCT03347123|593429681|FG005|Overall Study|Withdrawal by Subject|0|||
164289156|NCT03347123|593429682|FG006|Overall Study|Withdrawal by Subject|0|||
164289157|NCT03347123|593429676|FG000|Overall Study|Reason not Specified|3|||
164289158|NCT03347123|593429677|FG001|Overall Study|Reason not Specified|4|||
164289159|NCT03347123|593429678|FG002|Overall Study|Reason not Specified|0|||
164289160|NCT03347123|593429679|FG003|Overall Study|Reason not Specified|0|||
164289161|NCT03347123|593429680|FG004|Overall Study|Reason not Specified|0|||
164289162|NCT03347123|593429681|FG005|Overall Study|Reason not Specified|0|||
164289163|NCT03347123|593429682|FG006|Overall Study|Reason not Specified|0|||
164289164|NCT00346216|593429685|FG000|Overall Study|Other|181|||
164289165|NCT00346216|593429686|FG001|Overall Study|Other|231|||
164289166|NCT00346216|593429687|FG002|Overall Study|Other|205|||
164289167|NCT00346216|593429685|FG000|Overall Study|No longer willing to participate|600|||
164289168|NCT00346216|593429686|FG001|Overall Study|No longer willing to participate|606|||
164289169|NCT00346216|593429687|FG002|Overall Study|No longer willing to participate|585|||
164289170|NCT00346216|593429685|FG000|Overall Study|Withdrawal by Subject|661|||
164289171|NCT00346216|593429686|FG001|Overall Study|Withdrawal by Subject|692|||
164289172|NCT00346216|593429687|FG002|Overall Study|Withdrawal by Subject|651|||
164289173|NCT00346216|593429685|FG000|Overall Study|Lost to Follow-up|611|||
164289174|NCT00346216|593429686|FG001|Overall Study|Lost to Follow-up|588|||
164289175|NCT00346216|593429687|FG002|Overall Study|Lost to Follow-up|542|||
164289176|NCT00346216|593429685|FG000|Overall Study|Physician Decision|80|||
164289177|NCT00346216|593429686|FG001|Overall Study|Physician Decision|76|||
164289178|NCT00346216|593429687|FG002|Overall Study|Physician Decision|59|||
164289179|NCT00346216|593429685|FG000|Overall Study|Does not meet entrance criteria|13|||
164289180|NCT00346216|593429686|FG001|Overall Study|Does not meet entrance criteria|10|||
164289181|NCT00346216|593429687|FG002|Overall Study|Does not meet entrance criteria|8|||
164289182|NCT00346216|593429685|FG000|Overall Study|Death|189|||
164289183|NCT00346216|593429686|FG001|Overall Study|Death|192|||
164289184|NCT00346216|593429687|FG002|Overall Study|Death|228|||
164289185|NCT00346216|593429685|FG000|Overall Study|Study terminated by sponsor|11|||
164289186|NCT00346216|593429686|FG001|Overall Study|Study terminated by sponsor|4|||
164289187|NCT00346216|593429687|FG002|Overall Study|Study terminated by sponsor|8|||
164289188|NCT00346216|593429685|FG000|Overall Study|Missing Subject Summary Status|62|||
164289189|NCT00346216|593429686|FG001|Overall Study|Missing Subject Summary Status|61|||
164289190|NCT00346216|593429687|FG002|Overall Study|Missing Subject Summary Status|62|||
164289191|NCT03431441|593429688|FG000|Overall Study|Withdrawal by Subject|2|||
164289192|NCT03431441|593429688|FG000|Overall Study|Adverse Event|2|||
164289193|NCT03431441|593429688|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
164289194|NCT01794000|593429694|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
164289195|NCT01794000|593429695|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
164289196|NCT01794000|593429694|FG000|Double-Blind Phase (DBP)|Death|1|||
164289197|NCT01794000|593429695|FG001|Double-Blind Phase (DBP)|Death|2|||
164289198|NCT01794000|593429694|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
164289199|NCT01794000|593429695|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
164289200|NCT01794000|593429694|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
164289201|NCT01794000|593429695|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
164289202|NCT01794000|593429694|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
164289203|NCT01794000|593429695|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
164289204|NCT01794000|593429694|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
164289205|NCT01794000|593429695|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
164289206|NCT01794000|593429694|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
164289207|NCT01794000|593429695|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
164289208|NCT01794000|593429694|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
164289209|NCT01794000|593429695|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
164289210|NCT00255190|593429696|FG000|Overall Study|Adverse Event|17|||
164289211|NCT00255190|593429697|FG001|Overall Study|Adverse Event|36|||
164289212|NCT00255190|593429696|FG000|Overall Study|Protocol Violation|2|||
164289213|NCT00255190|593429697|FG001|Overall Study|Protocol Violation|2|||
164289214|NCT00255190|593429696|FG000|Overall Study|Lost to Follow-up|10|||
164289215|NCT00255190|593429697|FG001|Overall Study|Lost to Follow-up|27|||
164289216|NCT00255190|593429696|FG000|Overall Study|Withdrew Consent|17|||
164289217|NCT00255190|593429697|FG001|Overall Study|Withdrew Consent|48|||
164289218|NCT00255190|593429696|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
164289219|NCT00255190|593429697|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
164289220|NCT00255190|593429696|FG000|Overall Study|Erosive esophagitis not healed|0|||
164289221|NCT00255190|593429697|FG001|Overall Study|Erosive esophagitis not healed|20|||
164289222|NCT00255190|593429696|FG000|Overall Study|Various|4|||
164289223|NCT00255190|593429697|FG001|Overall Study|Various|23|||
164289224|NCT01156480|593429698|FG000|Overall Study|change in diagnosis|0|||
164289225|NCT01156480|593429699|FG001|Overall Study|change in diagnosis|1|||
164289226|NCT04537793|593429700|FG000|Part B (24 Weeks)|Adverse Event|0|||
164289227|NCT04537793|593429701|FG001|Part B (24 Weeks)|Adverse Event|1|||
164289228|NCT01255423|593429702|FG000|Overall Study|Abnormal Laboratory value|3|||
164289229|NCT01255423|593429703|FG001|Overall Study|Abnormal Laboratory value|2|||
164289230|NCT01255423|593429702|FG000|Overall Study|Use of prohibited medications|0|||
164289231|NCT01255423|593429703|FG001|Overall Study|Use of prohibited medications|1|||
164289232|NCT05470387|593429704|FG000|Overall Study|Protocol Violation|0|||
164289233|NCT05470387|593429705|FG001|Overall Study|Protocol Violation|3|||
164289234|NCT00988598|593429706|FG000|Overall Study|Withdrawal by Subject|2|||
164289235|NCT00988598|593429707|FG001|Overall Study|Withdrawal by Subject|0|||
164289236|NCT03367858|593429708|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
164289237|NCT03367858|593429709|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
164289238|NCT03367858|593429708|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
164289239|NCT03367858|593429709|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
164289240|NCT03367858|593429708|FG000|3 Month Follow Up|Lost to Follow-up|8|||
164289241|NCT03367858|593429709|FG001|3 Month Follow Up|Lost to Follow-up|3|||
164289242|NCT03367858|593429708|FG000|3 Month Follow Up|Moved out of study area|2|||
164289243|NCT03367858|593429709|FG001|3 Month Follow Up|Moved out of study area|6|||
164289244|NCT03367858|593429708|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
164289245|NCT03367858|593429709|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
164433336|NCT00335556|593957222|FG005|Overall Study|Death|0|||
164289246|NCT03367858|593429708|FG000|3 Month Follow Up|MRI contraindication|2|||
164289247|NCT03367858|593429709|FG001|3 Month Follow Up|MRI contraindication|1|||
164289248|NCT03367858|593429708|FG000|3 Month Follow Up|Incarcerated|0|||
164289249|NCT03367858|593429709|FG001|3 Month Follow Up|Incarcerated|1|||
164289250|NCT03367858|593429708|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
164289251|NCT03367858|593429709|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
164289252|NCT03367858|593429708|FG000|6 Month Follow Up|Lost to Follow-up|5|||
164289253|NCT03367858|593429709|FG001|6 Month Follow Up|Lost to Follow-up|2|||
164289254|NCT03367858|593429708|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
164289255|NCT03367858|593429709|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
164289256|NCT03367858|593429708|FG000|12 Month Follow Up|Lost to Follow-up|3|||
164289257|NCT03367858|593429709|FG001|12 Month Follow Up|Lost to Follow-up|3|||
164289258|NCT03367858|593429708|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
164289259|NCT03367858|593429709|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
164289260|NCT01859923|593429719|FG000|Overall Study|Adverse Event|0|||
164289261|NCT01859923|593429720|FG001|Overall Study|Adverse Event|0|||
164289262|NCT01859923|593429721|FG002|Overall Study|Adverse Event|1|||
164289263|NCT01859923|593429722|FG003|Overall Study|Adverse Event|1|||
164289264|NCT02079038|593429727|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
164289265|NCT02079038|593429728|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
164289266|NCT02079038|593429727|FG000|Modified Intent to Treat Population|Death|1|||
164289267|NCT02079038|593429728|FG001|Modified Intent to Treat Population|Death|0|||
164289268|NCT02079038|593429727|FG000|Completed 6 Months|Lost to Follow-up|2|||
164289269|NCT02079038|593429728|FG001|Completed 6 Months|Lost to Follow-up|1|||
164289270|NCT00985465|593429729|FG000|Overall Study|Withdrawal by Subject|1|||
164289271|NCT00985465|593429730|FG001|Overall Study|Withdrawal by Subject|2|||
164289272|NCT00985465|593429729|FG000|Overall Study|Considered to be part of the other group|0|||
164289273|NCT00985465|593429730|FG001|Overall Study|Considered to be part of the other group|1|||
164289274|NCT01054456|593429733|FG000|Overall Study|Other|1|||
164289275|NCT04701333|593429734|FG000|Overall Study|Lost to Follow-up|3|||
164289276|NCT04701333|593429735|FG001|Overall Study|Lost to Follow-up|7|||
164289277|NCT04701333|593429734|FG000|Overall Study|Withdrawal by Subject|0|||
164289278|NCT04701333|593429735|FG001|Overall Study|Withdrawal by Subject|1|||
164289279|NCT01012258|593429736|FG000|Overall Study|Death|14|||
164289280|NCT01012258|593429736|FG000|Overall Study|Lost to Follow-up|1|||
164289281|NCT01012258|593429736|FG000|Overall Study|Adverse Event|1|||
164289282|NCT01012258|593429736|FG000|Overall Study|Progressive Disease (PD)|18|||
164289283|NCT01012258|593429736|FG000|Overall Study|Symptomatic Deterioration|1|||
164289284|NCT01012258|593429736|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
164289285|NCT01012258|593429736|FG000|Overall Study|Another Tumor Discovered|1|||
164289286|NCT01012258|593429736|FG000|Overall Study|Ongoing|29|||
164289287|NCT02366195|593429739|FG000|Overall Study|Protocol-specified criteria|3|||
164289288|NCT02366195|593429739|FG000|Overall Study|Withdrawal by Subject|9|||
164289289|NCT02366195|593429739|FG000|Overall Study|Lost to Follow-up|1|||
164289290|NCT02366195|593429739|FG000|Overall Study|Death|41|||
164289291|NCT00113841|593429740|FG000|Overall Study|Disease progression|0|||
164289292|NCT00113841|593429741|FG001|Overall Study|Disease progression|2|||
164289293|NCT00113841|593429740|FG000|Overall Study|Non-compliant|1|||
164289294|NCT00113841|593429741|FG001|Overall Study|Non-compliant|0|||
164289295|NCT00148759|593429742|FG000|Overall Study|Withdrawal by Subject|1|||
164289296|NCT00148759|593429743|FG001|Overall Study|Withdrawal by Subject|1|||
164289297|NCT00148759|593429742|FG000|Overall Study|Lost to Follow-up|1|||
164289298|NCT00148759|593429743|FG001|Overall Study|Lost to Follow-up|0|||
164289299|NCT03948334|593429750|FG000|Overall Study|Adverse Event|1|||
164289300|NCT03948334|593429751|FG001|Overall Study|Adverse Event|4|||
164289301|NCT03948334|593429750|FG000|Overall Study|Lack of Efficacy|2|||
164289302|NCT03948334|593429751|FG001|Overall Study|Lack of Efficacy|0|||
164289303|NCT03948334|593429750|FG000|Overall Study|Lost to Follow-up|1|||
164289304|NCT03948334|593429751|FG001|Overall Study|Lost to Follow-up|0|||
164289305|NCT03948334|593429750|FG000|Overall Study|Physician Decision|1|||
164289306|NCT03948334|593429751|FG001|Overall Study|Physician Decision|0|||
164289307|NCT03948334|593429750|FG000|Overall Study|Pregnancy|0|||
164289308|NCT03948334|593429751|FG001|Overall Study|Pregnancy|1|||
164289309|NCT03948334|593429750|FG000|Overall Study|Protocol Deviation|1|||
164289310|NCT03948334|593429751|FG001|Overall Study|Protocol Deviation|0|||
164289311|NCT03948334|593429750|FG000|Overall Study|Study terminated by Sponsor|50|||
164289312|NCT03948334|593429751|FG001|Overall Study|Study terminated by Sponsor|51|||
164289313|NCT03948334|593429750|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
164289314|NCT03948334|593429751|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
164289315|NCT05114473|593429752|FG000|Overall Study|Lost to Follow-up|2|||
164289316|NCT05114473|593429753|FG001|Overall Study|Lost to Follow-up|2|||
164289317|NCT05114473|593429754|FG002|Overall Study|Lost to Follow-up|0|||
164289318|NCT02800863|593429761|FG000|Overall Study|Adverse Event|14|||
164289319|NCT02800863|593429761|FG000|Overall Study|Another Device Implanted|1|||
164289320|NCT02800863|593429761|FG000|Overall Study|Device Explanted|1|||
164289321|NCT02800863|593429761|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
164289322|NCT02800863|593429761|FG000|Overall Study|Health Issues|1|||
164289323|NCT02800863|593429761|FG000|Overall Study|Insurance Denial|8|||
164289324|NCT02800863|593429761|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
164289325|NCT02800863|593429761|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
164289326|NCT02800863|593429761|FG000|Overall Study|Screen Failure|1|||
164289327|NCT02800863|593429761|FG000|Overall Study|Sponsor Request|6|||
164289328|NCT02800863|593429761|FG000|Overall Study|Death|3|||
164289329|NCT02800863|593429761|FG000|Overall Study|Subject Implant at Another Facility|1|||
164289330|NCT02800863|593429761|FG000|Overall Study|Lost to Follow-up|26|||
164289331|NCT02800863|593429761|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
164289332|NCT02800863|593429761|FG000|Overall Study|Subject and/or Family Request|64|||
164289333|NCT02800863|593429761|FG000|Overall Study|Trial Failure|81|||
164289334|NCT02800863|593429761|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
164289335|NCT04332107|593429765|FG000|Day 3|Lost to Follow-up|23|||
164289336|NCT04332107|593429766|FG001|Day 3|Lost to Follow-up|14|||
164289337|NCT04332107|593429765|FG000|Day 3|Missing outcome data|3|||
164289338|NCT04332107|593429766|FG001|Day 3|Missing outcome data|6|||
164289339|NCT04332107|593429765|FG000|Day 14|Lost to Follow-up|13|||
164289340|NCT04332107|593429766|FG001|Day 14|Lost to Follow-up|4|||
164289341|NCT04332107|593429765|FG000|Day 14|Missing outcome data|4|||
164289342|NCT04332107|593429766|FG001|Day 14|Missing outcome data|4|||
164289343|NCT04332107|593429765|FG000|Day 21|Lost to Follow-up|10|||
164289344|NCT04332107|593429766|FG001|Day 21|Lost to Follow-up|2|||
164289345|NCT01670721|593429769|FG000|Overall Study|Participant's decision|15|||
164289346|NCT01670721|593429769|FG000|Overall Study|Other than specified above|38|||
164289347|NCT03061201|593429770|FG000|Overall Study|Participants Terminated at Month 36|0|||
164289348|NCT03061201|593429771|FG001|Overall Study|Participants Terminated at Month 36|1|||
164289349|NCT03061201|593429772|FG002|Overall Study|Participants Terminated at Month 36|0|||
164289350|NCT03061201|593429773|FG003|Overall Study|Participants Terminated at Month 36|1|||
164289351|NCT03061201|593429770|FG000|Overall Study|Lost to Follow-up|1|||
164289352|NCT03061201|593429771|FG001|Overall Study|Lost to Follow-up|0|||
164289353|NCT03061201|593429772|FG002|Overall Study|Lost to Follow-up|0|||
164289354|NCT03061201|593429773|FG003|Overall Study|Lost to Follow-up|0|||
164289355|NCT01572480|593429774|FG000|Participants Enrolled|Withdrawal by Subject|1|||
164289356|NCT01572480|593429774|FG000|Drug Administration|Discontinued drug/Off Study|1|||
164289357|NCT01572480|593429774|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
164289358|NCT01572480|593429774|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
164289359|NCT05081219|593429775|FG000|Overall Study|Withdrawal by Subject|4|||
164289360|NCT05081219|593429776|FG001|Overall Study|Withdrawal by Subject|0|||
164289361|NCT05081219|593429777|FG002|Overall Study|Withdrawal by Subject|0|||
164289362|NCT05081219|593429778|FG003|Overall Study|Withdrawal by Subject|1|||
164289363|NCT03446313|593429779|FG000|Overall Study|Lost to Follow-up|1|||
164289364|NCT03446313|593429780|FG001|Overall Study|Lost to Follow-up|2|||
164345325|NCT04115839|593640946|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
164345326|NCT04115839|593640947|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
164345327|NCT04115839|593640941|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
164345328|NCT04115839|593640942|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
164345329|NCT04115839|593640943|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
164345330|NCT04115839|593640944|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
164345331|NCT04115839|593640945|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
164345332|NCT04115839|593640946|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
164345333|NCT04115839|593640947|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
164345334|NCT04115839|593640941|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
164345335|NCT04115839|593640942|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
164345336|NCT04115839|593640943|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
164345337|NCT04115839|593640944|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
164345338|NCT04115839|593640945|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
164692700|NCT03430011|594897039|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
164692701|NCT03430011|594897040|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
164692702|NCT03430011|594897041|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
164692703|NCT03430011|594897042|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
164692704|NCT03430011|594897043|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
164692705|NCT03430011|594897044|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
164692706|NCT03430011|594897037|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
164692707|NCT03430011|594897038|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
164692708|NCT03430011|594897039|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
164692709|NCT03430011|594897040|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
164692710|NCT03430011|594897041|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
164692711|NCT03430011|594897042|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
164692712|NCT03430011|594897043|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
164692713|NCT03430011|594897044|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
164289365|NCT03446313|593429779|FG000|Overall Study|Failed primary screening|3|||
164289366|NCT03446313|593429780|FG001|Overall Study|Failed primary screening|0|||
164433337|NCT00335556|593957217|FG000|Overall Study|Lack of Efficacy|0|||
164692714|NCT03430011|594897037|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
164289367|NCT03446313|593429779|FG000|Overall Study|Diagnosed with terminal cancer|1|||
164289368|NCT03446313|593429780|FG001|Overall Study|Diagnosed with terminal cancer|0|||
164289369|NCT03446313|593429779|FG000|Overall Study|Excluded from analysis|1|||
164289370|NCT03446313|593429780|FG001|Overall Study|Excluded from analysis|1|||
164289371|NCT06235905|593429782|FG000|Overall Study|Adverse Event|1|||
164289372|NCT06235905|593429782|FG000|Overall Study|Non-compliant with protocol procedures|1|||
164289373|NCT00866814|593429784|FG000|Overall Study|Lost to Follow-up|12|||
164289374|NCT00866814|593429784|FG000|Overall Study|Adverse Event|2|||
164289375|NCT00866814|593429784|FG000|Overall Study|Physician Decision|1|||
164289376|NCT00866814|593429784|FG000|Overall Study|Death|1|||
164289377|NCT00866814|593429784|FG000|Overall Study|No longer wished to participate|1|||
164289378|NCT00866814|593429784|FG000|Overall Study|Unable to meet follow-up requirements|2|||
164289379|NCT00866814|593429784|FG000|Overall Study|Moved to area without study site|1|||
164289380|NCT03858049|593431806|FG000|Overall Study|Adverse Event|16|||
164289381|NCT03858049|593431807|FG001|Overall Study|Adverse Event|9|||
164289382|NCT03858049|593431806|FG000|Overall Study|Other|1|||
164289383|NCT03858049|593431807|FG001|Overall Study|Other|1|||
164289384|NCT02079740|593431808|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
164289385|NCT02079740|593431809|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
164289386|NCT02079740|593431810|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
164289387|NCT02079740|593431811|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
164289388|NCT02079740|593431812|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
164289389|NCT02079740|593431813|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
164289390|NCT02079740|593431814|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
164289391|NCT02079740|593431815|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
164289392|NCT02079740|593431816|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
164289393|NCT02079740|593431817|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
164289394|NCT02079740|593431818|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
164289395|NCT02079740|593431819|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
164289396|NCT02079740|593431820|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
164289397|NCT02079740|593431808|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
164289398|NCT02079740|593431809|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
164289399|NCT02079740|593431810|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
164289400|NCT02079740|593431811|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
164289401|NCT02079740|593431812|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
164289402|NCT02079740|593431813|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
164289403|NCT02079740|593431814|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
164289404|NCT02079740|593431815|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
164289405|NCT02079740|593431816|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
164289406|NCT02079740|593431817|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
164289407|NCT02079740|593431818|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
164289408|NCT02079740|593431819|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
164289409|NCT02079740|593431820|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
164289410|NCT02079740|593431808|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
164289411|NCT02079740|593431809|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
164289412|NCT02079740|593431810|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
164289413|NCT02079740|593431811|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
164289414|NCT02079740|593431812|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
164289415|NCT02079740|593431813|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
164289416|NCT02079740|593431814|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
164289417|NCT02079740|593431815|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
164289418|NCT02079740|593431816|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
164289419|NCT02079740|593431817|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
164289420|NCT02079740|593431818|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
164289421|NCT02079740|593431819|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
164289422|NCT02079740|593431820|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
164289423|NCT02079740|593431808|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
164289424|NCT02079740|593431809|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
164289425|NCT02079740|593431810|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
164289426|NCT02079740|593431811|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
164289427|NCT02079740|593431812|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
164289428|NCT02079740|593431813|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
164289429|NCT02079740|593431814|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
164289430|NCT02079740|593431815|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
164289431|NCT02079740|593431816|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
164289432|NCT02079740|593431817|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
164433338|NCT00335556|593957218|FG001|Overall Study|Lack of Efficacy|19|||
164289433|NCT02079740|593431818|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
164289434|NCT02079740|593431819|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
164289435|NCT02079740|593431820|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
164289436|NCT02079740|593431808|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
164289437|NCT02079740|593431809|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
164289438|NCT02079740|593431810|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
164289439|NCT02079740|593431811|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
164289440|NCT02079740|593431812|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
164289441|NCT02079740|593431813|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
164289442|NCT02079740|593431814|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
164289443|NCT02079740|593431815|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
164289444|NCT02079740|593431816|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
164289445|NCT02079740|593431817|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
164289446|NCT02079740|593431818|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
164289447|NCT02079740|593431819|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
164289448|NCT02079740|593431820|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
164289449|NCT01474317|593431825|FG000|Overall Study|Adverse Event|1|||
164289450|NCT01474317|593431825|FG000|Overall Study|Subject ineligible for study|1|||
164289451|NCT00387881|593431826|FG000|Overall Study|Lost to Follow-up|23|||
164289452|NCT00387881|593431827|FG001|Overall Study|Lost to Follow-up|23|||
164289453|NCT00387881|593431826|FG000|Overall Study|Protocol Violation|2|||
164289454|NCT00387881|593431827|FG001|Overall Study|Protocol Violation|12|||
164289455|NCT00387881|593431826|FG000|Overall Study|Withdrawal by Subject|15|||
164289456|NCT00387881|593431827|FG001|Overall Study|Withdrawal by Subject|18|||
164289457|NCT00387881|593431826|FG000|Overall Study|Sponsor terminated Study|0|||
164289458|NCT00387881|593431827|FG001|Overall Study|Sponsor terminated Study|1|||
164289459|NCT00387881|593431826|FG000|Overall Study|Not eligible|6|||
164289460|NCT00387881|593431827|FG001|Overall Study|Not eligible|7|||
164289461|NCT00387881|593431826|FG000|Overall Study|No opportunity to treat headache|32|||
164289462|NCT00387881|593431827|FG001|Overall Study|No opportunity to treat headache|34|||
164289463|NCT00387881|593431826|FG000|Overall Study|Not otherwise specified|11|||
164289464|NCT00387881|593431827|FG001|Overall Study|Not otherwise specified|7|||
164289465|NCT00453154|593431830|FG000|Double BIind Maintenance|Adverse Event|0|||
164289466|NCT00453154|593431831|FG001|Double BIind Maintenance|Adverse Event|0|||
164289467|NCT00453154|593431832|FG002|Double BIind Maintenance|Adverse Event|3|||
164289468|NCT00453154|593431833|FG003|Double BIind Maintenance|Adverse Event|12|||
164289469|NCT00453154|593431830|FG000|Double BIind Maintenance|Death|0|||
164289470|NCT00453154|593431831|FG001|Double BIind Maintenance|Death|0|||
164289471|NCT00453154|593431832|FG002|Double BIind Maintenance|Death|2|||
164289472|NCT00453154|593431833|FG003|Double BIind Maintenance|Death|1|||
164289473|NCT00453154|593431830|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
164289474|NCT00453154|593431831|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
164289475|NCT00453154|593431832|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
164289476|NCT00453154|593431833|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
164289477|NCT00453154|593431830|FG000|Double BIind Maintenance|Progression|0|||
164289478|NCT00453154|593431831|FG001|Double BIind Maintenance|Progression|0|||
164289479|NCT00453154|593431832|FG002|Double BIind Maintenance|Progression|29|||
164289480|NCT00453154|593431833|FG003|Double BIind Maintenance|Progression|26|||
164289481|NCT00453154|593431830|FG000|Double BIind Maintenance|Medical Issues|0|||
164289482|NCT00453154|593431831|FG001|Double BIind Maintenance|Medical Issues|0|||
164289483|NCT00453154|593431832|FG002|Double BIind Maintenance|Medical Issues|3|||
164289484|NCT00453154|593431833|FG003|Double BIind Maintenance|Medical Issues|1|||
164289485|NCT00453154|593431830|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
164289486|NCT00453154|593431831|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
164289487|NCT00453154|593431832|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
164289488|NCT00453154|593431833|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
164289489|NCT03629886|593431835|FG000|Overall Study|Migrated / moved from the study area|0|||
164289490|NCT03629886|593431836|FG001|Overall Study|Migrated / moved from the study area|55|||
164289491|NCT03629886|593431835|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
164289492|NCT03629886|593431836|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
164289493|NCT03629886|593431835|FG000|Overall Study|Study vaccine not administrated|0|||
164289494|NCT03629886|593431836|FG001|Overall Study|Study vaccine not administrated|3|||
164289495|NCT03629886|593431835|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
164289496|NCT03629886|593431836|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
164289497|NCT03629886|593431835|FG000|Overall Study|Refused vaccination step of the study|0|||
164289498|NCT03629886|593431836|FG001|Overall Study|Refused vaccination step of the study|44|||
164289499|NCT05473026|593431838|FG000|Overall Study|Lost to Follow-up|5|||
164692715|NCT03430011|594897038|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
164692716|NCT03430011|594897039|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
164289500|NCT05473026|593431839|FG001|Overall Study|Lost to Follow-up|2|||
164692717|NCT03430011|594897040|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
164692718|NCT03430011|594897041|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
164289501|NCT02038153|593431840|FG000|Overall Study|Withdrawal by Subject|1|||
164289502|NCT03683173|593431841|FG000|Completed Follow-up|Unavailable|235|||
164289503|NCT03683173|593431842|FG001|Completed Follow-up|Unavailable|217|||
164289504|NCT03683173|593431841|FG000|Completed Follow-up|Refused|69|||
164289505|NCT03683173|593431842|FG001|Completed Follow-up|Refused|59|||
164289506|NCT03683173|593431841|FG000|Completed Follow-up|Disconnected phone|65|||
164289507|NCT03683173|593431842|FG001|Completed Follow-up|Disconnected phone|95|||
164289508|NCT03683173|593431841|FG000|Completed Follow-up|Health issue/deceased|10|||
164289509|NCT03683173|593431842|FG001|Completed Follow-up|Health issue/deceased|4|||
164289510|NCT03683173|593431841|FG000|Completed Follow-up|Moved away|8|||
164289511|NCT03683173|593431842|FG001|Completed Follow-up|Moved away|1|||
164289512|NCT02647281|593431843|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
164289513|NCT02647281|593431844|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
164289514|NCT02647281|593431845|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
164289515|NCT02647281|593431846|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
164289516|NCT02647281|593431847|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
164289517|NCT02647281|593431848|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
164289518|NCT02647281|593431849|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
164289519|NCT02647281|593431850|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
164289520|NCT02647281|593431851|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
164289521|NCT01050634|593431852|FG000|Overall Study|Enrolled, but Not Treated|56|||
164289522|NCT01050634|593431852|FG000|Overall Study|Death|2|||
164289523|NCT01050634|593431852|FG000|Overall Study|Adverse Event|42|||
164289524|NCT01050634|593431852|FG000|Overall Study|Lost to Follow-up|2|||
164289525|NCT01050634|593431852|FG000|Overall Study|Other|21|||
164289526|NCT01050634|593431852|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
164289527|NCT00496015|593431853|FG000|Overall Study|Other|1|||
164289528|NCT00496015|593431854|FG001|Overall Study|Other|0|||
164289529|NCT00496015|593431855|FG002|Overall Study|Other|0|||
164289530|NCT00496015|593431856|FG003|Overall Study|Other|1|||
164289531|NCT00496015|593431857|FG004|Overall Study|Other|0|||
164289532|NCT02730728|593431860|FG000|Overall Study|Withdrawal by Subject|0|||
164289533|NCT02730728|593431861|FG001|Overall Study|Withdrawal by Subject|1|||
164289534|NCT02730728|593431862|FG002|Overall Study|Withdrawal by Subject|0|||
164289535|NCT02730728|593431860|FG000|Overall Study|Lack of Efficacy|0|||
164289536|NCT02730728|593431861|FG001|Overall Study|Lack of Efficacy|1|||
164289537|NCT02730728|593431862|FG002|Overall Study|Lack of Efficacy|1|||
164289538|NCT02711137|593431866|FG000|Overall Study|Death|1|||
164289539|NCT02711137|593431867|FG001|Overall Study|Death|4|||
164289540|NCT02711137|593431868|FG002|Overall Study|Death|5|||
164289541|NCT02711137|593431869|FG003|Overall Study|Death|5|||
164289542|NCT02711137|593431870|FG004|Overall Study|Death|3|||
164289543|NCT02711137|593431871|FG005|Overall Study|Death|1|||
164289544|NCT02711137|593431872|FG006|Overall Study|Death|61|||
164289545|NCT02711137|593431873|FG007|Overall Study|Death|3|||
164289546|NCT02711137|593431874|FG008|Overall Study|Death|0|||
164289547|NCT02711137|593431875|FG009|Overall Study|Death|1|||
164289548|NCT02711137|593431876|FG010|Overall Study|Death|1|||
164289549|NCT02711137|593431877|FG011|Overall Study|Death|1|||
164289550|NCT02711137|593431878|FG012|Overall Study|Death|0|||
164289551|NCT02711137|593431879|FG013|Overall Study|Death|0|||
164289552|NCT02711137|593431880|FG014|Overall Study|Death|0|||
164289553|NCT02711137|593431866|FG000|Overall Study|Study Terminated by Sponsor|0|||
164289554|NCT02711137|593431867|FG001|Overall Study|Study Terminated by Sponsor|0|||
164289555|NCT02711137|593431868|FG002|Overall Study|Study Terminated by Sponsor|1|||
164289556|NCT02711137|593431869|FG003|Overall Study|Study Terminated by Sponsor|0|||
164289557|NCT02711137|593431870|FG004|Overall Study|Study Terminated by Sponsor|0|||
164289558|NCT02711137|593431871|FG005|Overall Study|Study Terminated by Sponsor|0|||
164289559|NCT02711137|593431872|FG006|Overall Study|Study Terminated by Sponsor|1|||
164289560|NCT02711137|593431873|FG007|Overall Study|Study Terminated by Sponsor|0|||
164289561|NCT02711137|593431874|FG008|Overall Study|Study Terminated by Sponsor|0|||
164289562|NCT02711137|593431875|FG009|Overall Study|Study Terminated by Sponsor|0|||
164289563|NCT02711137|593431876|FG010|Overall Study|Study Terminated by Sponsor|0|||
164289564|NCT02711137|593431877|FG011|Overall Study|Study Terminated by Sponsor|0|||
164289565|NCT02711137|593431878|FG012|Overall Study|Study Terminated by Sponsor|0|||
164289566|NCT02711137|593431879|FG013|Overall Study|Study Terminated by Sponsor|0|||
164289567|NCT02711137|593431880|FG014|Overall Study|Study Terminated by Sponsor|0|||
164289568|NCT02711137|593431866|FG000|Overall Study|Physician Decision|1|||
164289569|NCT02711137|593431867|FG001|Overall Study|Physician Decision|0|||
164289570|NCT02711137|593431868|FG002|Overall Study|Physician Decision|2|||
164289571|NCT02711137|593431869|FG003|Overall Study|Physician Decision|1|||
164289572|NCT02711137|593431870|FG004|Overall Study|Physician Decision|1|||
164289573|NCT02711137|593431871|FG005|Overall Study|Physician Decision|0|||
164289574|NCT02711137|593431872|FG006|Overall Study|Physician Decision|12|||
164289575|NCT02711137|593431873|FG007|Overall Study|Physician Decision|2|||
164289576|NCT02711137|593431874|FG008|Overall Study|Physician Decision|1|||
164289577|NCT02711137|593431875|FG009|Overall Study|Physician Decision|1|||
164586731|NCT01855789|594511910|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
164586732|NCT01855789|594511911|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
164289578|NCT02711137|593431876|FG010|Overall Study|Physician Decision|3|||
164289579|NCT02711137|593431877|FG011|Overall Study|Physician Decision|2|||
164289580|NCT02711137|593431878|FG012|Overall Study|Physician Decision|1|||
164289581|NCT02711137|593431879|FG013|Overall Study|Physician Decision|1|||
164289582|NCT02711137|593431880|FG014|Overall Study|Physician Decision|2|||
164289583|NCT02711137|593431866|FG000|Overall Study|Other|0|||
164289584|NCT02711137|593431867|FG001|Overall Study|Other|1|||
164289585|NCT02711137|593431868|FG002|Overall Study|Other|0|||
164289586|NCT02711137|593431869|FG003|Overall Study|Other|0|||
164289587|NCT02711137|593431870|FG004|Overall Study|Other|0|||
164289588|NCT02711137|593431871|FG005|Overall Study|Other|0|||
164289589|NCT02711137|593431872|FG006|Overall Study|Other|3|||
164289590|NCT02711137|593431873|FG007|Overall Study|Other|0|||
164289591|NCT02711137|593431874|FG008|Overall Study|Other|0|||
164289592|NCT02711137|593431875|FG009|Overall Study|Other|0|||
164289593|NCT02711137|593431876|FG010|Overall Study|Other|0|||
164289594|NCT02711137|593431877|FG011|Overall Study|Other|0|||
164289595|NCT02711137|593431878|FG012|Overall Study|Other|0|||
164289596|NCT02711137|593431879|FG013|Overall Study|Other|0|||
164289597|NCT02711137|593431880|FG014|Overall Study|Other|1|||
164289598|NCT02711137|593431866|FG000|Overall Study|Withdrawal by Subject|1|||
164289599|NCT02711137|593431867|FG001|Overall Study|Withdrawal by Subject|0|||
164289600|NCT02711137|593431868|FG002|Overall Study|Withdrawal by Subject|0|||
164289601|NCT02711137|593431869|FG003|Overall Study|Withdrawal by Subject|1|||
164289602|NCT02711137|593431870|FG004|Overall Study|Withdrawal by Subject|1|||
164289603|NCT02711137|593431871|FG005|Overall Study|Withdrawal by Subject|0|||
164289604|NCT02711137|593431872|FG006|Overall Study|Withdrawal by Subject|7|||
164289605|NCT02711137|593431873|FG007|Overall Study|Withdrawal by Subject|0|||
164289606|NCT02711137|593431874|FG008|Overall Study|Withdrawal by Subject|0|||
164289607|NCT02711137|593431875|FG009|Overall Study|Withdrawal by Subject|0|||
164289608|NCT02711137|593431876|FG010|Overall Study|Withdrawal by Subject|0|||
164289609|NCT02711137|593431877|FG011|Overall Study|Withdrawal by Subject|0|||
164289610|NCT02711137|593431878|FG012|Overall Study|Withdrawal by Subject|0|||
164289611|NCT02711137|593431879|FG013|Overall Study|Withdrawal by Subject|1|||
164289612|NCT02711137|593431880|FG014|Overall Study|Withdrawal by Subject|0|||
164289613|NCT02711137|593431866|FG000|Overall Study|Lost to Follow-up|1|||
164289614|NCT02711137|593431867|FG001|Overall Study|Lost to Follow-up|0|||
164289615|NCT02711137|593431868|FG002|Overall Study|Lost to Follow-up|0|||
164289616|NCT02711137|593431869|FG003|Overall Study|Lost to Follow-up|0|||
164289617|NCT02711137|593431870|FG004|Overall Study|Lost to Follow-up|0|||
164289618|NCT02711137|593431871|FG005|Overall Study|Lost to Follow-up|0|||
164289619|NCT02711137|593431872|FG006|Overall Study|Lost to Follow-up|2|||
164289620|NCT02711137|593431873|FG007|Overall Study|Lost to Follow-up|0|||
164289621|NCT02711137|593431874|FG008|Overall Study|Lost to Follow-up|0|||
164289622|NCT02711137|593431875|FG009|Overall Study|Lost to Follow-up|0|||
164289623|NCT02711137|593431876|FG010|Overall Study|Lost to Follow-up|0|||
164289624|NCT02711137|593431877|FG011|Overall Study|Lost to Follow-up|0|||
164289625|NCT02711137|593431878|FG012|Overall Study|Lost to Follow-up|0|||
164289626|NCT02711137|593431879|FG013|Overall Study|Lost to Follow-up|0|||
164289627|NCT02711137|593431880|FG014|Overall Study|Lost to Follow-up|0|||
164289628|NCT03956550|593431881|FG000|Overall Study|Sponsor decision|65|||
164289629|NCT03956550|593431882|FG001|Overall Study|Sponsor decision|66|||
164289630|NCT03956550|593431883|FG002|Overall Study|Sponsor decision|64|||
164289631|NCT03956550|593431881|FG000|Overall Study|Adverse Event|0|||
164289632|NCT03956550|593431882|FG001|Overall Study|Adverse Event|1|||
164289633|NCT03956550|593431883|FG002|Overall Study|Adverse Event|0|||
164289634|NCT03956550|593431881|FG000|Overall Study|Withdrawal by Subject|5|||
164289635|NCT03956550|593431882|FG001|Overall Study|Withdrawal by Subject|5|||
164289636|NCT03956550|593431883|FG002|Overall Study|Withdrawal by Subject|6|||
164289637|NCT03400852|593431884|FG000|Blinded Treatment Period|Physician Decision|0|||
164289638|NCT03400852|593431885|FG001|Blinded Treatment Period|Physician Decision|1|||
164289639|NCT03400852|593431886|FG002|Blinded Treatment Period|Physician Decision|0|||
164289640|NCT03400852|593431884|FG000|Blinded Treatment Period|Adverse Event|1|||
164289641|NCT03400852|593431885|FG001|Blinded Treatment Period|Adverse Event|1|||
164289642|NCT03400852|593431886|FG002|Blinded Treatment Period|Adverse Event|0|||
164289643|NCT03400852|593431884|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
164289644|NCT03400852|593431885|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
164345339|NCT04115839|593640946|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
164289645|NCT03400852|593431886|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
164289646|NCT03400852|593431884|FG000|Open Label Period|Physician Decision|0|||
164289647|NCT03400852|593431885|FG001|Open Label Period|Physician Decision|0|||
164289648|NCT03400852|593431886|FG002|Open Label Period|Physician Decision|1|||
164289649|NCT03400852|593431884|FG000|Open Label Period|Study terminated by sponsor|0|||
164289650|NCT03400852|593431885|FG001|Open Label Period|Study terminated by sponsor|0|||
164289651|NCT03400852|593431886|FG002|Open Label Period|Study terminated by sponsor|21|||
164289652|NCT00248495|593431887|FG000|Overall Study|Withdrawal by Subject|1|||
164289653|NCT01285401|593431888|FG000|Overall Study|Prematurely withdrawn from the study|17|||
164289654|NCT01285401|593431889|FG001|Overall Study|Prematurely withdrawn from the study|29|||
164289655|NCT03719131|593431893|FG000|Overall Study|Death|1|||
164289656|NCT03719131|593431894|FG001|Overall Study|Death|2|||
164289657|NCT04244253|593431895|FG000|Overall Study|Adverse Event|2|||
164289658|NCT04244253|593431896|FG001|Overall Study|Adverse Event|2|||
164289659|NCT04244253|593431897|FG002|Overall Study|Adverse Event|4|||
164289660|NCT04244253|593431895|FG000|Overall Study|Protocol Violation|1|||
164289661|NCT04244253|593431896|FG001|Overall Study|Protocol Violation|2|||
164289662|NCT04244253|593431897|FG002|Overall Study|Protocol Violation|1|||
164289663|NCT04244253|593431895|FG000|Overall Study|Withdrawal by Subject|0|||
164289664|NCT04244253|593431896|FG001|Overall Study|Withdrawal by Subject|1|||
164289665|NCT04244253|593431897|FG002|Overall Study|Withdrawal by Subject|6|||
164289666|NCT04244253|593431895|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164289667|NCT04244253|593431896|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164289668|NCT04244253|593431897|FG002|Overall Study|Non-Compliance With Study Drug|1|||
164289669|NCT01544920|593431898|FG000|Overall Study|Adverse Event|0|||
164289670|NCT01544920|593431899|FG001|Overall Study|Adverse Event|3|||
164289671|NCT01544920|593431898|FG000|Overall Study|Death|0|||
164289672|NCT01544920|593431899|FG001|Overall Study|Death|1|||
164289673|NCT01544920|593431898|FG000|Overall Study|Lost to Follow-up|11|||
164289674|NCT01544920|593431899|FG001|Overall Study|Lost to Follow-up|12|||
164289675|NCT01544920|593431898|FG000|Overall Study|Protocol Violation|0|||
164289676|NCT01544920|593431899|FG001|Overall Study|Protocol Violation|2|||
164289677|NCT01544920|593431898|FG000|Overall Study|Physician Decision|4|||
164289678|NCT01544920|593431899|FG001|Overall Study|Physician Decision|1|||
164289679|NCT01544920|593431898|FG000|Overall Study|Withdrawal by Subject|4|||
164289680|NCT01544920|593431899|FG001|Overall Study|Withdrawal by Subject|4|||
164289681|NCT03001557|593431903|FG000|Core Phase|Randomized but not treated|0|||
164289682|NCT03001557|593431904|FG001|Core Phase|Randomized but not treated|0|||
164289683|NCT03001557|593431905|FG002|Core Phase|Randomized but not treated|1|||
164289684|NCT03001557|593431906|FG003|Core Phase|Randomized but not treated|0|||
164289685|NCT03001557|593431907|FG004|Core Phase|Randomized but not treated|0|||
164289686|NCT03001557|593431908|FG005|Core Phase|Randomized but not treated|0|||
164289687|NCT03001557|593431909|FG006|Core Phase|Randomized but not treated|0|||
164289688|NCT03001557|593431910|FG007|Core Phase|Randomized but not treated|0|||
164289689|NCT03001557|593431903|FG000|Extension Phase|Adverse Event|0|||
164289690|NCT03001557|593431904|FG001|Extension Phase|Adverse Event|0|||
164289691|NCT03001557|593431905|FG002|Extension Phase|Adverse Event|0|||
164289692|NCT03001557|593431906|FG003|Extension Phase|Adverse Event|0|||
164289693|NCT03001557|593431907|FG004|Extension Phase|Adverse Event|0|||
164289694|NCT03001557|593431908|FG005|Extension Phase|Adverse Event|2|||
164345340|NCT04115839|593640947|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
164345341|NCT04115839|593640941|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
164345342|NCT04115839|593640942|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
164289695|NCT03001557|593431909|FG006|Extension Phase|Adverse Event|0|||
164289696|NCT03001557|593431910|FG007|Extension Phase|Adverse Event|0|||
164345343|NCT04115839|593640943|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
164289697|NCT03001557|593431903|FG000|Extension Phase|Withdrawal by Subject|0|||
164289698|NCT03001557|593431904|FG001|Extension Phase|Withdrawal by Subject|0|||
164289699|NCT03001557|593431905|FG002|Extension Phase|Withdrawal by Subject|0|||
164345344|NCT04115839|593640944|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
164345345|NCT04115839|593640945|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
164345346|NCT04115839|593640946|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
164345347|NCT04115839|593640947|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
164345348|NCT04115839|593640941|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
164345349|NCT04115839|593640942|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
164345350|NCT04115839|593640943|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
164345351|NCT04115839|593640944|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
164345352|NCT04115839|593640945|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
164345353|NCT04115839|593640946|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
164345354|NCT04115839|593640947|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
164345355|NCT02820753|593640949|FG000|2 Month|Withdrawal by Subject|3|||
164345356|NCT02820753|593640950|FG001|2 Month|Withdrawal by Subject|3|||
164345357|NCT02820753|593640949|FG000|2 Month|Lost to Follow-up|24|||
164433339|NCT00335556|593957219|FG002|Overall Study|Lack of Efficacy|3|||
164289700|NCT03001557|593431906|FG003|Extension Phase|Withdrawal by Subject|0|||
164289701|NCT03001557|593431907|FG004|Extension Phase|Withdrawal by Subject|0|||
164289702|NCT03001557|593431908|FG005|Extension Phase|Withdrawal by Subject|1|||
164289703|NCT03001557|593431909|FG006|Extension Phase|Withdrawal by Subject|5|||
164289704|NCT03001557|593431910|FG007|Extension Phase|Withdrawal by Subject|2|||
164345358|NCT02820753|593640950|FG001|2 Month|Lost to Follow-up|26|||
164345359|NCT02820753|593640949|FG000|2 Month|Stopped per NIH Hold|51|||
164345360|NCT02820753|593640950|FG001|2 Month|Stopped per NIH Hold|13|||
164289705|NCT03001557|593431903|FG000|Extension Phase|Lost to Follow-up|0|||
164289706|NCT03001557|593431904|FG001|Extension Phase|Lost to Follow-up|0|||
164289707|NCT03001557|593431905|FG002|Extension Phase|Lost to Follow-up|0|||
164289708|NCT03001557|593431906|FG003|Extension Phase|Lost to Follow-up|0|||
164289709|NCT03001557|593431907|FG004|Extension Phase|Lost to Follow-up|0|||
164289710|NCT03001557|593431908|FG005|Extension Phase|Lost to Follow-up|0|||
164289711|NCT03001557|593431909|FG006|Extension Phase|Lost to Follow-up|2|||
164289712|NCT03001557|593431910|FG007|Extension Phase|Lost to Follow-up|1|||
164289713|NCT03001557|593431903|FG000|Extension Phase|Administrative Reason|0|||
164289714|NCT03001557|593431904|FG001|Extension Phase|Administrative Reason|0|||
164289715|NCT03001557|593431905|FG002|Extension Phase|Administrative Reason|0|||
164289716|NCT03001557|593431906|FG003|Extension Phase|Administrative Reason|0|||
164289717|NCT03001557|593431907|FG004|Extension Phase|Administrative Reason|0|||
164289718|NCT03001557|593431908|FG005|Extension Phase|Administrative Reason|1|||
164289719|NCT03001557|593431909|FG006|Extension Phase|Administrative Reason|3|||
164289720|NCT03001557|593431910|FG007|Extension Phase|Administrative Reason|3|||
164289721|NCT03001557|593431903|FG000|Extension Phase|Loss of caregiver|0|||
164289722|NCT03001557|593431904|FG001|Extension Phase|Loss of caregiver|0|||
164289723|NCT03001557|593431905|FG002|Extension Phase|Loss of caregiver|0|||
164289724|NCT03001557|593431906|FG003|Extension Phase|Loss of caregiver|0|||
164289725|NCT03001557|593431907|FG004|Extension Phase|Loss of caregiver|0|||
164289726|NCT03001557|593431908|FG005|Extension Phase|Loss of caregiver|0|||
164289727|NCT03001557|593431909|FG006|Extension Phase|Loss of caregiver|1|||
164289728|NCT03001557|593431910|FG007|Extension Phase|Loss of caregiver|0|||
164289729|NCT03001557|593431903|FG000|Extension Phase|Others|0|||
164289730|NCT03001557|593431904|FG001|Extension Phase|Others|0|||
164289731|NCT03001557|593431905|FG002|Extension Phase|Others|0|||
164289732|NCT03001557|593431906|FG003|Extension Phase|Others|0|||
164289733|NCT03001557|593431907|FG004|Extension Phase|Others|0|||
164289734|NCT03001557|593431908|FG005|Extension Phase|Others|1|||
164289735|NCT03001557|593431909|FG006|Extension Phase|Others|3|||
164289736|NCT03001557|593431910|FG007|Extension Phase|Others|0|||
164289737|NCT01272232|593431911|FG000|Weeks 0-56|Adverse Event|39|||
164289738|NCT01272232|593431912|FG001|Weeks 0-56|Adverse Event|18|||
164289739|NCT01272232|593431913|FG002|Weeks 0-56|Adverse Event|7|||
164289740|NCT01272232|593431911|FG000|Weeks 0-56|Lack of Efficacy|0|||
164289741|NCT01272232|593431912|FG001|Weeks 0-56|Lack of Efficacy|0|||
164289742|NCT01272232|593431913|FG002|Weeks 0-56|Lack of Efficacy|3|||
164289743|NCT01272232|593431911|FG000|Weeks 0-56|Protocol Violation|12|||
164289744|NCT01272232|593431912|FG001|Weeks 0-56|Protocol Violation|8|||
164289745|NCT01272232|593431913|FG002|Weeks 0-56|Protocol Violation|13|||
164289746|NCT01272232|593431911|FG000|Weeks 0-56|Withdrawal criteria|32|||
164289747|NCT01272232|593431912|FG001|Weeks 0-56|Withdrawal criteria|14|||
164289748|NCT01272232|593431913|FG002|Weeks 0-56|Withdrawal criteria|37|||
164289749|NCT01272232|593431911|FG000|Weeks 0-56|Unclassified|16|||
164289750|NCT01272232|593431912|FG001|Weeks 0-56|Unclassified|7|||
164289751|NCT01272232|593431913|FG002|Weeks 0-56|Unclassified|12|||
164289752|NCT01272232|593431911|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
164289753|NCT01272232|593431912|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
164289754|NCT01272232|593431913|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
164289755|NCT01272232|593431911|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
164289756|NCT01272232|593431912|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
164289757|NCT01272232|593431913|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
164289758|NCT01272232|593431911|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
164289759|NCT01272232|593431912|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
164289760|NCT01272232|593431913|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
164289761|NCT01272232|593431911|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
164289762|NCT01272232|593431912|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
164289763|NCT01272232|593431913|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
164289764|NCT01272232|593431911|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
164289765|NCT01272232|593431912|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
164289766|NCT01272232|593431913|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
164289767|NCT02159066|593431914|FG000|Part I|Adverse Event|7|||
164289768|NCT02159066|593431915|FG001|Part I|Adverse Event|5|||
164289769|NCT02159066|593431916|FG002|Part I|Adverse Event|0|||
164289770|NCT02159066|593431917|FG003|Part I|Adverse Event|0|||
164289771|NCT02159066|593431918|FG004|Part I|Adverse Event|0|||
164289772|NCT02159066|593431919|FG005|Part I|Adverse Event|0|||
164433340|NCT00335556|593957220|FG003|Overall Study|Lack of Efficacy|3|||
164433341|NCT00335556|593957221|FG004|Overall Study|Lack of Efficacy|0|||
164289773|NCT02159066|593431914|FG000|Part I|Death|11|||
164289774|NCT02159066|593431915|FG001|Part I|Death|9|||
164289775|NCT02159066|593431916|FG002|Part I|Death|0|||
164289776|NCT02159066|593431917|FG003|Part I|Death|0|||
164289777|NCT02159066|593431918|FG004|Part I|Death|0|||
164289778|NCT02159066|593431919|FG005|Part I|Death|0|||
164289779|NCT02159066|593431914|FG000|Part I|Progressive Disease|37|||
164289780|NCT02159066|593431915|FG001|Part I|Progressive Disease|46|||
164289781|NCT02159066|593431916|FG002|Part I|Progressive Disease|0|||
164289782|NCT02159066|593431917|FG003|Part I|Progressive Disease|0|||
164289783|NCT02159066|593431918|FG004|Part I|Progressive Disease|0|||
164289784|NCT02159066|593431919|FG005|Part I|Progressive Disease|0|||
164289785|NCT02159066|593431914|FG000|Part I|New Therapy for Study Indication|5|||
164289786|NCT02159066|593431915|FG001|Part I|New Therapy for Study Indication|4|||
164289787|NCT02159066|593431916|FG002|Part I|New Therapy for Study Indication|0|||
164289788|NCT02159066|593431917|FG003|Part I|New Therapy for Study Indication|0|||
164289789|NCT02159066|593431918|FG004|Part I|New Therapy for Study Indication|0|||
164289790|NCT02159066|593431919|FG005|Part I|New Therapy for Study Indication|0|||
164289791|NCT02159066|593431914|FG000|Part I|Termination of participants from the study|3|||
164289792|NCT02159066|593431915|FG001|Part I|Termination of participants from the study|3|||
164289793|NCT02159066|593431916|FG002|Part I|Termination of participants from the study|0|||
164289794|NCT02159066|593431917|FG003|Part I|Termination of participants from the study|0|||
164289795|NCT02159066|593431918|FG004|Part I|Termination of participants from the study|0|||
164289796|NCT02159066|593431919|FG005|Part I|Termination of participants from the study|0|||
164289797|NCT02159066|593431914|FG000|Part I|Physician Decision|2|||
164289798|NCT02159066|593431915|FG001|Part I|Physician Decision|9|||
164289799|NCT02159066|593431916|FG002|Part I|Physician Decision|0|||
164289800|NCT02159066|593431917|FG003|Part I|Physician Decision|0|||
164289801|NCT02159066|593431918|FG004|Part I|Physician Decision|0|||
164289802|NCT02159066|593431919|FG005|Part I|Physician Decision|0|||
164289803|NCT02159066|593431914|FG000|Part I|Participant/Guardian Decision|9|||
164289804|NCT02159066|593431915|FG001|Part I|Participant/Guardian Decision|3|||
164289805|NCT02159066|593431916|FG002|Part I|Participant/Guardian Decision|0|||
164289806|NCT02159066|593431917|FG003|Part I|Participant/Guardian Decision|0|||
164289807|NCT02159066|593431918|FG004|Part I|Participant/Guardian Decision|0|||
164289808|NCT02159066|593431919|FG005|Part I|Participant/Guardian Decision|0|||
164289809|NCT02159066|593431914|FG000|Part I|Missing Data|1|||
164289810|NCT02159066|593431915|FG001|Part I|Missing Data|0|||
164289811|NCT02159066|593431916|FG002|Part I|Missing Data|0|||
164289812|NCT02159066|593431917|FG003|Part I|Missing Data|0|||
164289813|NCT02159066|593431918|FG004|Part I|Missing Data|0|||
164289814|NCT02159066|593431919|FG005|Part I|Missing Data|0|||
164289815|NCT02159066|593431914|FG000|Part II|Adverse Event|0|||
164289816|NCT02159066|593431915|FG001|Part II|Adverse Event|0|||
164289817|NCT02159066|593431916|FG002|Part II|Adverse Event|1|||
164289818|NCT02159066|593431917|FG003|Part II|Adverse Event|0|||
164289819|NCT02159066|593431918|FG004|Part II|Adverse Event|1|||
164289820|NCT02159066|593431919|FG005|Part II|Adverse Event|1|||
164289821|NCT02159066|593431914|FG000|Part II|Death|0|||
164289822|NCT02159066|593431915|FG001|Part II|Death|0|||
164289823|NCT02159066|593431916|FG002|Part II|Death|1|||
164289824|NCT02159066|593431917|FG003|Part II|Death|0|||
164289825|NCT02159066|593431918|FG004|Part II|Death|2|||
164289826|NCT02159066|593431919|FG005|Part II|Death|1|||
164289827|NCT02159066|593431914|FG000|Part II|Progressive Disease|0|||
164289828|NCT02159066|593431915|FG001|Part II|Progressive Disease|0|||
164289829|NCT02159066|593431916|FG002|Part II|Progressive Disease|35|||
164289830|NCT02159066|593431917|FG003|Part II|Progressive Disease|1|||
164289831|NCT02159066|593431918|FG004|Part II|Progressive Disease|7|||
164289832|NCT02159066|593431919|FG005|Part II|Progressive Disease|4|||
164289833|NCT02159066|593431914|FG000|Part II|New Therapy for Study Indication|0|||
164289834|NCT02159066|593431915|FG001|Part II|New Therapy for Study Indication|0|||
164289835|NCT02159066|593431916|FG002|Part II|New Therapy for Study Indication|0|||
164289836|NCT02159066|593431917|FG003|Part II|New Therapy for Study Indication|0|||
164289837|NCT02159066|593431918|FG004|Part II|New Therapy for Study Indication|1|||
164289838|NCT02159066|593431919|FG005|Part II|New Therapy for Study Indication|0|||
164289839|NCT02159066|593431914|FG000|Part II|Physician Decision|0|||
164289840|NCT02159066|593431915|FG001|Part II|Physician Decision|0|||
164289841|NCT02159066|593431916|FG002|Part II|Physician Decision|1|||
164289842|NCT02159066|593431917|FG003|Part II|Physician Decision|0|||
164289843|NCT02159066|593431918|FG004|Part II|Physician Decision|0|||
164289844|NCT02159066|593431919|FG005|Part II|Physician Decision|0|||
164289845|NCT02159066|593431914|FG000|Part II|Participant/Guardian Decision|0|||
164289846|NCT02159066|593431915|FG001|Part II|Participant/Guardian Decision|0|||
164289847|NCT02159066|593431916|FG002|Part II|Participant/Guardian Decision|0|||
164289848|NCT02159066|593431917|FG003|Part II|Participant/Guardian Decision|0|||
164289849|NCT02159066|593431918|FG004|Part II|Participant/Guardian Decision|2|||
164289850|NCT02159066|593431919|FG005|Part II|Participant/Guardian Decision|0|||
164289851|NCT00796666|593431920|FG000|Overall Study|Death|2|||
164289852|NCT00796666|593431921|FG001|Overall Study|Death|4|||
164289853|NCT00796666|593431920|FG000|Overall Study|Withdrawal by Subject|2|||
164289854|NCT00796666|593431921|FG001|Overall Study|Withdrawal by Subject|0|||
164289855|NCT00796666|593431920|FG000|Overall Study|Adverse Event|7|||
164289856|NCT00796666|593431921|FG001|Overall Study|Adverse Event|5|||
164289857|NCT00796666|593431920|FG000|Overall Study|Protocol Violation|1|||
164289858|NCT00796666|593431921|FG001|Overall Study|Protocol Violation|0|||
164289859|NCT00796666|593431920|FG000|Overall Study|Other|1|||
164289860|NCT00796666|593431921|FG001|Overall Study|Other|0|||
164289861|NCT00796666|593431920|FG000|Overall Study|Terminated by sponsor|53|||
164289862|NCT00796666|593431921|FG001|Overall Study|Terminated by sponsor|55|||
164289863|NCT00796666|593431920|FG000|Overall Study|Randomized and not treated|1|||
164289864|NCT00796666|593431921|FG001|Overall Study|Randomized and not treated|0|||
164289865|NCT00628030|593431923|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
164289866|NCT00628030|593431924|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
164289867|NCT00628030|593431923|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
164289868|NCT00628030|593431924|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
164289869|NCT00628030|593431923|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
164289870|NCT00628030|593431924|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
164289871|NCT01894607|593431931|FG000|Overall Study|Ineligible|1|||
164289872|NCT01787461|593431934|FG000|Overall Study|Adverse Event|4|||
164289873|NCT01787461|593431935|FG001|Overall Study|Adverse Event|3|||
164289874|NCT01787461|593431934|FG000|Overall Study|Lost to Follow-up|3|||
164289875|NCT01787461|593431935|FG001|Overall Study|Lost to Follow-up|2|||
164289876|NCT01787461|593431934|FG000|Overall Study|No longer met eligibility criteria|1|||
164289877|NCT01787461|593431935|FG001|Overall Study|No longer met eligibility criteria|0|||
164289878|NCT01787461|593431934|FG000|Overall Study|Withdrawal by Subject|3|||
164289879|NCT01787461|593431935|FG001|Overall Study|Withdrawal by Subject|4|||
164289880|NCT01787461|593431934|FG000|Overall Study|Protocol Violation|3|||
164289881|NCT01787461|593431935|FG001|Overall Study|Protocol Violation|0|||
164289882|NCT03259555|593431936|FG000|Overall Study|Adverse Event|6|||
164289883|NCT03259555|593431937|FG001|Overall Study|Adverse Event|4|||
164289884|NCT03259555|593431936|FG000|Overall Study|Lack of Efficacy|6|||
164289885|NCT03259555|593431937|FG001|Overall Study|Lack of Efficacy|4|||
164289886|NCT03259555|593431936|FG000|Overall Study|Lost to Follow-up|0|||
164289887|NCT03259555|593431937|FG001|Overall Study|Lost to Follow-up|2|||
164289888|NCT03259555|593431936|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164289889|NCT03259555|593431937|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164289890|NCT03259555|593431936|FG000|Overall Study|Progressive Disease|0|||
164289891|NCT03259555|593431937|FG001|Overall Study|Progressive Disease|2|||
164289892|NCT03259555|593431936|FG000|Overall Study|Withdrawal by Subject|19|||
164289893|NCT03259555|593431937|FG001|Overall Study|Withdrawal by Subject|16|||
164289894|NCT03259555|593431936|FG000|Overall Study|Physician Decision|1|||
164289895|NCT03259555|593431937|FG001|Overall Study|Physician Decision|2|||
164289896|NCT03259555|593431936|FG000|Overall Study|Other|1|||
164289897|NCT03259555|593431937|FG001|Overall Study|Other|0|||
164289898|NCT03957551|593431938|FG000|Overall Study|Adverse Event|2|||
164289899|NCT03957551|593431939|FG001|Overall Study|Adverse Event|2|||
164289900|NCT03957551|593431940|FG002|Overall Study|Adverse Event|6|||
164289901|NCT03957551|593431938|FG000|Overall Study|Physician Decision|1|||
164289902|NCT03957551|593431939|FG001|Overall Study|Physician Decision|0|||
164289903|NCT03957551|593431940|FG002|Overall Study|Physician Decision|2|||
164289904|NCT03957551|593431938|FG000|Overall Study|Withdrawal by Subject|1|||
164289905|NCT03957551|593431939|FG001|Overall Study|Withdrawal by Subject|0|||
164289906|NCT03957551|593431940|FG002|Overall Study|Withdrawal by Subject|2|||
164289907|NCT03957551|593431938|FG000|Overall Study|Disease progression|1|||
164289908|NCT03957551|593431939|FG001|Overall Study|Disease progression|0|||
164289909|NCT03957551|593431940|FG002|Overall Study|Disease progression|8|||
164289910|NCT02717494|593431943|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
164692719|NCT03430011|594897042|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
164692720|NCT03430011|594897043|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
164692721|NCT03430011|594897044|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
164692722|NCT03430011|594897037|FG000|JCARH125 Treatment|Death|4|||
164692723|NCT03430011|594897038|FG001|JCARH125 Treatment|Death|19|||
164692724|NCT03430011|594897039|FG002|JCARH125 Treatment|Death|10|||
164692725|NCT03430011|594897040|FG003|JCARH125 Treatment|Death|8|||
164692726|NCT03430011|594897041|FG004|JCARH125 Treatment|Death|5|||
164692727|NCT03430011|594897042|FG005|JCARH125 Treatment|Death|3|||
164692728|NCT03430011|594897043|FG006|JCARH125 Treatment|Death|4|||
164692729|NCT03430011|594897044|FG007|JCARH125 Treatment|Death|2|||
164692730|NCT03430011|594897037|FG000|JCARH125 Treatment|Other reasons|1|||
164692731|NCT03430011|594897038|FG001|JCARH125 Treatment|Other reasons|0|||
164692732|NCT03430011|594897039|FG002|JCARH125 Treatment|Other reasons|4|||
164692733|NCT03430011|594897040|FG003|JCARH125 Treatment|Other reasons|2|||
164692734|NCT03430011|594897041|FG004|JCARH125 Treatment|Other reasons|2|||
164692735|NCT03430011|594897042|FG005|JCARH125 Treatment|Other reasons|1|||
164692736|NCT03430011|594897043|FG006|JCARH125 Treatment|Other reasons|3|||
164692737|NCT03430011|594897044|FG007|JCARH125 Treatment|Other reasons|2|||
164692738|NCT00559364|594897046|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
164692739|NCT00559364|594897047|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
164289911|NCT02717494|593431944|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
164289912|NCT02717494|593431945|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
164289913|NCT02717494|593431943|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
164289914|NCT02717494|593431944|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
164345361|NCT02820753|593640949|FG000|6 Month|Withdrawal by Subject|2|||
164692740|NCT04126343|594897048|FG000|Overall Study|Adverse Event|0|||
164692741|NCT04126343|594897049|FG001|Overall Study|Adverse Event|0|||
164692742|NCT04126343|594897050|FG002|Overall Study|Adverse Event|0|||
164692743|NCT04126343|594897051|FG003|Overall Study|Adverse Event|0|||
164692744|NCT04126343|594897052|FG004|Overall Study|Adverse Event|0|||
164289915|NCT02717494|593431945|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
164289916|NCT02717494|593431943|FG000|First Intervention (Step 1)|Death|0|||
164289917|NCT02717494|593431944|FG001|First Intervention (Step 1)|Death|0|||
164289918|NCT02717494|593431945|FG002|First Intervention (Step 1)|Death|1|||
164289919|NCT02717494|593431943|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
164433342|NCT00335556|593957222|FG005|Overall Study|Lack of Efficacy|1|||
164289920|NCT02717494|593431944|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
164289921|NCT02717494|593431945|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
164289922|NCT01125800|593431947|FG000|Phase I|Protocol Violation|0|||
164289923|NCT01125800|593431948|FG001|Phase I|Protocol Violation|3|||
164289924|NCT01125800|593431949|FG002|Phase I|Protocol Violation|1|||
164289925|NCT01125800|593431950|FG003|Phase I|Protocol Violation|1|||
164289926|NCT01125800|593431951|FG004|Phase I|Protocol Violation|0|||
164289927|NCT01125800|593431947|FG000|Phase I|Adverse Event|2|||
164289928|NCT01125800|593431948|FG001|Phase I|Adverse Event|2|||
164289929|NCT01125800|593431949|FG002|Phase I|Adverse Event|1|||
164289930|NCT01125800|593431950|FG003|Phase I|Adverse Event|7|||
164289931|NCT01125800|593431951|FG004|Phase I|Adverse Event|0|||
164289932|NCT01125800|593431947|FG000|Phase I|Administrative problems|1|||
164289933|NCT01125800|593431948|FG001|Phase I|Administrative problems|0|||
164289934|NCT01125800|593431949|FG002|Phase I|Administrative problems|0|||
164289935|NCT01125800|593431950|FG003|Phase I|Administrative problems|0|||
164289936|NCT01125800|593431951|FG004|Phase I|Administrative problems|0|||
164289937|NCT01125800|593431947|FG000|Phase I|Withdrawal by Subject|0|||
164289938|NCT01125800|593431948|FG001|Phase I|Withdrawal by Subject|0|||
164289939|NCT01125800|593431949|FG002|Phase I|Withdrawal by Subject|1|||
164289940|NCT01125800|593431950|FG003|Phase I|Withdrawal by Subject|0|||
164289941|NCT01125800|593431951|FG004|Phase I|Withdrawal by Subject|0|||
164289942|NCT01125800|593431947|FG000|Phase I|Disease progression|5|||
164289943|NCT01125800|593431948|FG001|Phase I|Disease progression|4|||
164289944|NCT01125800|593431949|FG002|Phase I|Disease progression|1|||
164289945|NCT01125800|593431950|FG003|Phase I|Disease progression|3|||
164289946|NCT01125800|593431951|FG004|Phase I|Disease progression|0|||
164289947|NCT01125800|593431947|FG000|Phase II|Protocol Violation|0|||
164289948|NCT01125800|593431948|FG001|Phase II|Protocol Violation|0|||
164289949|NCT01125800|593431949|FG002|Phase II|Protocol Violation|0|||
164289950|NCT01125800|593431950|FG003|Phase II|Protocol Violation|0|||
164289951|NCT01125800|593431951|FG004|Phase II|Protocol Violation|1|||
164289952|NCT01125800|593431947|FG000|Phase II|Adverse Event|0|||
164289953|NCT01125800|593431948|FG001|Phase II|Adverse Event|0|||
164289954|NCT01125800|593431949|FG002|Phase II|Adverse Event|0|||
164289955|NCT01125800|593431950|FG003|Phase II|Adverse Event|0|||
164289956|NCT01125800|593431951|FG004|Phase II|Adverse Event|2|||
164289957|NCT01125800|593431947|FG000|Phase II|Disease progression|0|||
164289958|NCT01125800|593431948|FG001|Phase II|Disease progression|0|||
164289959|NCT01125800|593431949|FG002|Phase II|Disease progression|0|||
164289960|NCT01125800|593431950|FG003|Phase II|Disease progression|1|||
164289961|NCT01125800|593431951|FG004|Phase II|Disease progression|8|||
164289962|NCT01808196|593431954|FG000|Overall Study|Lost to Follow-up|1|||
164289963|NCT00479713|593431955|FG000|Overall Study|Adverse Event|8|||
164289964|NCT00479713|593431956|FG001|Overall Study|Adverse Event|6|||
164289965|NCT00479713|593431955|FG000|Overall Study|Death|1|||
164289966|NCT00479713|593431956|FG001|Overall Study|Death|0|||
164289967|NCT00479713|593431955|FG000|Overall Study|Lost to Follow-up|0|||
164289968|NCT00479713|593431956|FG001|Overall Study|Lost to Follow-up|1|||
164289969|NCT00479713|593431955|FG000|Overall Study|Protocol Violation|0|||
164289970|NCT00479713|593431956|FG001|Overall Study|Protocol Violation|1|||
164289971|NCT00479713|593431955|FG000|Overall Study|Withdrawal by Subject|4|||
164289972|NCT00479713|593431956|FG001|Overall Study|Withdrawal by Subject|1|||
164289973|NCT00141102|593431961|FG000|Overall Study|Adverse Event|233|||
164289974|NCT00141102|593431962|FG001|Overall Study|Adverse Event|305|||
164289975|NCT00141102|593431961|FG000|Overall Study|Laboratory Abnormality|9|||
164289976|NCT00141102|593431962|FG001|Overall Study|Laboratory Abnormality|33|||
164289977|NCT00141102|593431961|FG000|Overall Study|Lack of Efficacy|21|||
164289978|NCT00141102|593431962|FG001|Overall Study|Lack of Efficacy|26|||
164289979|NCT00141102|593431961|FG000|Overall Study|Lost to Follow-up|29|||
164433343|NCT00335556|593957217|FG000|Overall Study|Physician Decision|0|||
164289980|NCT00141102|593431962|FG001|Overall Study|Lost to Follow-up|32|||
164289981|NCT00141102|593431961|FG000|Overall Study|Other|87|||
164289982|NCT00141102|593431962|FG001|Overall Study|Other|76|||
164289983|NCT00141102|593431961|FG000|Overall Study|Withdrawal by Subject|112|||
164289984|NCT00141102|593431962|FG001|Overall Study|Withdrawal by Subject|142|||
164433344|NCT00335556|593957218|FG001|Overall Study|Physician Decision|6|||
164289985|NCT00141102|593431961|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
164289986|NCT00141102|593431962|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
164289987|NCT00141102|593431961|FG000|Overall Study|Death|2|||
164289988|NCT00141102|593431962|FG001|Overall Study|Death|2|||
164289989|NCT05477485|593431963|FG000|Overall Study|Lost to Follow-up|0|||
164289990|NCT05477485|593431964|FG001|Overall Study|Lost to Follow-up|4|||
164433345|NCT00335556|593957219|FG002|Overall Study|Physician Decision|2|||
164289991|NCT05274958|593431965|FG000|Overall Study|Only completed 1 set of PROMs|22|||
164289992|NCT05274958|593431966|FG001|Overall Study|Only completed 1 set of PROMs|35|||
164289993|NCT01505374|593431967|FG000|Overall Study|Lost to Follow-up|1|||
164289994|NCT01505374|593431968|FG001|Overall Study|Lost to Follow-up|0|||
164289995|NCT00176462|593431974|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
164289996|NCT00176462|593431975|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
164289997|NCT00176462|593431974|FG000|Induction (4 Weeks)|Death|1|||
164289998|NCT00176462|593431975|FG001|Induction (4 Weeks)|Death|2|||
164289999|NCT00176462|593431974|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
164290000|NCT00176462|593431975|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
164290001|NCT00176462|593431974|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
164290002|NCT00176462|593431975|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
164290003|NCT00176462|593431974|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
164290004|NCT00176462|593431975|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
164290005|NCT00176462|593431974|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
164290006|NCT00176462|593431975|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
164290007|NCT00176462|593431974|FG000|Consolidation (12 Weeks)|Not documented|0|||
164290008|NCT00176462|593431975|FG001|Consolidation (12 Weeks)|Not documented|1|||
164290009|NCT00176462|593431974|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
164290010|NCT00176462|593431975|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
164290011|NCT00176462|593431974|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
164290012|NCT00176462|593431975|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
164345362|NCT02820753|593640950|FG001|6 Month|Withdrawal by Subject|2|||
164345363|NCT02820753|593640949|FG000|6 Month|Lost to Follow-up|20|||
164345364|NCT02820753|593640950|FG001|6 Month|Lost to Follow-up|27|||
164345365|NCT02820753|593640949|FG000|6 Month|Stopped per NIH Hold|81|||
164345366|NCT02820753|593640950|FG001|6 Month|Stopped per NIH Hold|81|||
164345367|NCT02820753|593640949|FG000|6 Month|Death|0|||
164345368|NCT02820753|593640950|FG001|6 Month|Death|1|||
164345369|NCT01408485|593640951|FG000|Overall Study|Withdrawal by Subject|21|||
164345370|NCT01652703|593640952|FG000|Overall Study|Withdrawal by Subject|0|||
164345371|NCT01652703|593640953|FG001|Overall Study|Withdrawal by Subject|1|||
164692745|NCT04126343|594897053|FG005|Overall Study|Adverse Event|1|||
164692746|NCT04126343|594897048|FG000|Overall Study|Withdrawal by Subject|0|||
164692747|NCT04126343|594897049|FG001|Overall Study|Withdrawal by Subject|0|||
164345372|NCT01652703|593640954|FG002|Overall Study|Withdrawal by Subject|3|||
164345373|NCT01652703|593640955|FG003|Overall Study|Withdrawal by Subject|1|||
164345374|NCT01652703|593640956|FG004|Overall Study|Withdrawal by Subject|0|||
164345375|NCT01652703|593640957|FG005|Overall Study|Withdrawal by Subject|1|||
164345376|NCT01652703|593640952|FG000|Overall Study|Other|0|||
164345377|NCT01652703|593640953|FG001|Overall Study|Other|0|||
164345378|NCT01652703|593640954|FG002|Overall Study|Other|0|||
164345379|NCT01652703|593640955|FG003|Overall Study|Other|1|||
164345380|NCT01652703|593640956|FG004|Overall Study|Other|1|||
164345381|NCT01652703|593640957|FG005|Overall Study|Other|1|||
164345382|NCT02151591|593640958|FG000|Overall Study|Lost to Follow-up|6|||
164345383|NCT02151591|593640959|FG001|Overall Study|Lost to Follow-up|3|||
164345384|NCT02380677|593640960|FG000|Overall Study|Adverse Event|0|||
164345385|NCT02380677|593640961|FG001|Overall Study|Adverse Event|0|||
164345386|NCT02380677|593640962|FG002|Overall Study|Adverse Event|0|||
164345387|NCT02380677|593640963|FG003|Overall Study|Adverse Event|1|||
164345388|NCT02380677|593640964|FG004|Overall Study|Adverse Event|1|||
164345389|NCT02380677|593640965|FG005|Overall Study|Adverse Event|4|||
164345390|NCT02380677|593640966|FG006|Overall Study|Adverse Event|2|||
164345391|NCT02380677|593640967|FG007|Overall Study|Adverse Event|2|||
164345392|NCT02380677|593640968|FG008|Overall Study|Adverse Event|2|||
164692748|NCT04126343|594897050|FG002|Overall Study|Withdrawal by Subject|0|||
164290013|NCT02679287|593431978|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
164290014|NCT02679287|593431979|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
164345393|NCT02380677|593640969|FG009|Overall Study|Adverse Event|1|||
164345394|NCT02380677|593640970|FG010|Overall Study|Adverse Event|2|||
164345395|NCT02380677|593640971|FG011|Overall Study|Adverse Event|1|||
164345396|NCT02380677|593640960|FG000|Overall Study|Physician Decision|1|||
164345397|NCT02380677|593640961|FG001|Overall Study|Physician Decision|0|||
164345398|NCT02380677|593640962|FG002|Overall Study|Physician Decision|1|||
164345399|NCT02380677|593640963|FG003|Overall Study|Physician Decision|1|||
164345400|NCT02380677|593640964|FG004|Overall Study|Physician Decision|0|||
164345401|NCT02380677|593640965|FG005|Overall Study|Physician Decision|0|||
164345402|NCT02380677|593640966|FG006|Overall Study|Physician Decision|0|||
164345403|NCT02380677|593640967|FG007|Overall Study|Physician Decision|0|||
164345404|NCT02380677|593640968|FG008|Overall Study|Physician Decision|0|||
164345405|NCT02380677|593640969|FG009|Overall Study|Physician Decision|0|||
164345406|NCT02380677|593640970|FG010|Overall Study|Physician Decision|0|||
164345407|NCT02380677|593640971|FG011|Overall Study|Physician Decision|0|||
164345408|NCT02380677|593640960|FG000|Overall Study|Lack of Efficacy|0|||
164345409|NCT02380677|593640961|FG001|Overall Study|Lack of Efficacy|1|||
164692749|NCT04126343|594897051|FG003|Overall Study|Withdrawal by Subject|1|||
164692750|NCT04126343|594897052|FG004|Overall Study|Withdrawal by Subject|0|||
164290015|NCT02679287|593431978|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
164290016|NCT02679287|593431979|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
164290017|NCT02679287|593431978|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
164290018|NCT02679287|593431979|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
164290019|NCT02679287|593431978|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
164290020|NCT02679287|593431979|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
164290021|NCT02679287|593431978|FG000|Period 2|Work/Scheduling Conflict|1|||
164290022|NCT02679287|593431979|FG001|Period 2|Work/Scheduling Conflict|0|||
164290023|NCT02679287|593431978|FG000|Period 2|Disliked Mobile System|2|||
164290024|NCT02679287|593431979|FG001|Period 2|Disliked Mobile System|0|||
164290025|NCT02679287|593431978|FG000|Period 3|Work/Scheduling Conflict|0|||
164290026|NCT02679287|593431979|FG001|Period 3|Work/Scheduling Conflict|1|||
164290027|NCT00320515|593431982|FG000|Overall Study|Death|33|||
164290028|NCT00320515|593431982|FG000|Overall Study|Lost to Follow-up|6|||
164290029|NCT00320515|593431982|FG000|Overall Study|Physician Decision|2|||
164290030|NCT00320515|593431982|FG000|Overall Study|Withdrawal by Subject|8|||
164290031|NCT01114828|593431983|FG000|Overall Study|Adverse Event|1|||
164290032|NCT01114828|593431984|FG001|Overall Study|Adverse Event|1|||
164290033|NCT01114828|593431983|FG000|Overall Study|Lack of Efficacy|0|||
164290034|NCT01114828|593431984|FG001|Overall Study|Lack of Efficacy|2|||
164290035|NCT01114828|593431983|FG000|Overall Study|Protocol Violation|2|||
164586733|NCT01855789|594511912|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
164586734|NCT01855789|594511913|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
164586735|NCT01855789|594511910|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
164290036|NCT01114828|593431984|FG001|Overall Study|Protocol Violation|0|||
164290037|NCT01114828|593431983|FG000|Overall Study|Withdrawal by Subject|0|||
164290038|NCT01114828|593431984|FG001|Overall Study|Withdrawal by Subject|1|||
164290039|NCT00794950|593431985|FG000|BCG Induction|Withdrawal by Subject|2|||
164290040|NCT00794950|593431985|FG000|BCG Induction|ineligible|3|||
164290041|NCT00794950|593431985|FG000|BCG Induction|noncompliant w. BCG|1|||
164290042|NCT00794950|593431985|FG000|BCG Induction|Adverse Event|1|||
164290043|NCT00794950|593431985|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
164290044|NCT00794950|593431985|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
164290045|NCT00794950|593431985|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
164290046|NCT00794950|593431985|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
164290047|NCT02485704|593431986|FG000|Overall Study|Lost to Follow-up|4|||
164290048|NCT02485704|593431987|FG001|Overall Study|Lost to Follow-up|5|||
164290049|NCT02485704|593431986|FG000|Overall Study|Withdrawal by Subject|0|||
164290050|NCT02485704|593431987|FG001|Overall Study|Withdrawal by Subject|3|||
164290051|NCT02485704|593431986|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
164290052|NCT02485704|593431987|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
164290053|NCT00851786|593431990|FG000|Overall Study|Withdrawal by Subject|0|||
164290054|NCT00851786|593431991|FG001|Overall Study|Withdrawal by Subject|1|||
164290055|NCT00851786|593431990|FG000|Overall Study|Protocol Violation|0|||
164290056|NCT00851786|593431991|FG001|Overall Study|Protocol Violation|1|||
164290057|NCT00851786|593431990|FG000|Overall Study|Lost to Follow-up|1|||
164290058|NCT00851786|593431991|FG001|Overall Study|Lost to Follow-up|0|||
164290059|NCT00851786|593431990|FG000|Overall Study|Incarceration|1|||
164290060|NCT00851786|593431991|FG001|Overall Study|Incarceration|0|||
164290061|NCT00851786|593431990|FG000|Overall Study|Site Closure|1|||
164290062|NCT00851786|593431991|FG001|Overall Study|Site Closure|0|||
164290063|NCT00851786|593431990|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
164290064|NCT00851786|593431991|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
164290065|NCT04617782|593433859|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
164290066|NCT04617782|593433859|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
164290067|NCT04617782|593433859|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
164290068|NCT04617782|593433859|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
164290069|NCT04617782|593433859|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
164290070|NCT04617782|593433859|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
164290071|NCT01405768|593433872|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
164290072|NCT01405768|593433873|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
164290073|NCT04388111|593433876|FG000|Overall Study|Lost to Follow-up|5|||
164290074|NCT04388111|593433877|FG001|Overall Study|Lost to Follow-up|3|||
164290075|NCT04388111|593433876|FG000|Overall Study|Adverse Event|1|||
164290076|NCT04388111|593433877|FG001|Overall Study|Adverse Event|1|||
164290077|NCT04388111|593433876|FG000|Overall Study|Protocol Violation|2|||
164290078|NCT04388111|593433877|FG001|Overall Study|Protocol Violation|4|||
164290079|NCT04388111|593433876|FG000|Overall Study|Withdrawal by Subject|1|||
164290080|NCT04388111|593433877|FG001|Overall Study|Withdrawal by Subject|0|||
164290081|NCT03360682|593433893|FG000|Overall Study|Adverse Event|3|||
164290082|NCT02420093|593433894|FG000|Overall Study|Withdrawal by Subject|1|||
164290083|NCT02420093|593433895|FG001|Overall Study|Withdrawal by Subject|1|||
164290084|NCT03244917|593433897|FG000|Overall Study|Lost to Follow-up|2|||
164290085|NCT03244917|593433898|FG001|Overall Study|Lost to Follow-up|2|||
164290086|NCT01147666|593433899|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
164290087|NCT01147666|593433900|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
164290088|NCT01147666|593433901|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
164290089|NCT01147666|593433902|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
164290090|NCT01147666|593433903|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
164290091|NCT01147666|593433904|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
164290092|NCT01147666|593433905|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
164290093|NCT01147666|593433906|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
164290094|NCT01147666|593433907|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
164290095|NCT01147666|593433908|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
164290096|NCT01147666|593433909|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
164290097|NCT01147666|593433910|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
164290098|NCT01147666|593433911|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
164290099|NCT01147666|593433912|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
164290100|NCT01147666|593433913|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
164290101|NCT01147666|593433899|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
164290102|NCT01147666|593433900|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
164290103|NCT01147666|593433901|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
164290104|NCT01147666|593433902|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
164290105|NCT01147666|593433903|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
164290106|NCT01147666|593433904|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
164290107|NCT01147666|593433905|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
164290108|NCT01147666|593433906|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
164290109|NCT01147666|593433907|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
164290110|NCT01147666|593433908|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
164290111|NCT01147666|593433909|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
164290112|NCT01147666|593433910|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
164290113|NCT01147666|593433911|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
164345410|NCT02380677|593640962|FG002|Overall Study|Lack of Efficacy|2|||
164345411|NCT02380677|593640963|FG003|Overall Study|Lack of Efficacy|0|||
164345412|NCT02380677|593640964|FG004|Overall Study|Lack of Efficacy|4|||
164345413|NCT02380677|593640965|FG005|Overall Study|Lack of Efficacy|1|||
164345414|NCT02380677|593640966|FG006|Overall Study|Lack of Efficacy|1|||
164345415|NCT02380677|593640967|FG007|Overall Study|Lack of Efficacy|2|||
164345416|NCT02380677|593640968|FG008|Overall Study|Lack of Efficacy|2|||
164345417|NCT02380677|593640969|FG009|Overall Study|Lack of Efficacy|0|||
164345418|NCT02380677|593640970|FG010|Overall Study|Lack of Efficacy|2|||
164345419|NCT02380677|593640971|FG011|Overall Study|Lack of Efficacy|1|||
164345420|NCT02380677|593640960|FG000|Overall Study|Withdrawal by Subject|0|||
164345421|NCT02380677|593640961|FG001|Overall Study|Withdrawal by Subject|0|||
164345422|NCT02380677|593640962|FG002|Overall Study|Withdrawal by Subject|0|||
164345423|NCT02380677|593640963|FG003|Overall Study|Withdrawal by Subject|0|||
164345424|NCT02380677|593640964|FG004|Overall Study|Withdrawal by Subject|0|||
164345425|NCT02380677|593640965|FG005|Overall Study|Withdrawal by Subject|0|||
164345426|NCT02380677|593640966|FG006|Overall Study|Withdrawal by Subject|0|||
164345427|NCT02380677|593640967|FG007|Overall Study|Withdrawal by Subject|0|||
164345428|NCT02380677|593640968|FG008|Overall Study|Withdrawal by Subject|0|||
164345429|NCT02380677|593640969|FG009|Overall Study|Withdrawal by Subject|1|||
164345430|NCT02380677|593640970|FG010|Overall Study|Withdrawal by Subject|0|||
164290114|NCT01147666|593433912|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
164290115|NCT01147666|593433913|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
164290116|NCT01147666|593433899|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
164290117|NCT01147666|593433900|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
164290118|NCT01147666|593433901|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
164290119|NCT01147666|593433902|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
164290120|NCT01147666|593433903|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
164345431|NCT02380677|593640971|FG011|Overall Study|Withdrawal by Subject|3|||
164345432|NCT02380677|593640960|FG000|Overall Study|Other|0|||
164290121|NCT01147666|593433904|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
164290122|NCT01147666|593433905|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
164290123|NCT01147666|593433906|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
164290124|NCT01147666|593433907|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
164290125|NCT01147666|593433908|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
164290126|NCT01147666|593433909|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
164290127|NCT01147666|593433910|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
164290128|NCT01147666|593433911|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
164290129|NCT01147666|593433912|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
164290130|NCT01147666|593433913|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
164290131|NCT01147666|593433899|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
164290132|NCT01147666|593433900|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
164290133|NCT01147666|593433901|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
164290134|NCT01147666|593433902|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
164290135|NCT01147666|593433903|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
164290136|NCT01147666|593433904|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
164290137|NCT01147666|593433905|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
164290138|NCT01147666|593433906|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
164290139|NCT01147666|593433907|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
164290140|NCT01147666|593433908|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
164290141|NCT01147666|593433909|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
164290142|NCT01147666|593433910|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
164290143|NCT01147666|593433911|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
164290144|NCT01147666|593433912|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
164290145|NCT01147666|593433913|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
164290146|NCT01147666|593433899|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
164290147|NCT01147666|593433900|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
164290148|NCT01147666|593433901|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
164290149|NCT01147666|593433902|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
164290150|NCT01147666|593433903|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
164290151|NCT01147666|593433904|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
164290152|NCT01147666|593433905|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
164290153|NCT01147666|593433906|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
164290154|NCT01147666|593433907|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
164290155|NCT01147666|593433908|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
164290156|NCT01147666|593433909|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
164290157|NCT01147666|593433910|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
164290158|NCT01147666|593433911|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
164290159|NCT01147666|593433912|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
164290160|NCT01147666|593433913|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
164290161|NCT01147666|593433899|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290162|NCT01147666|593433900|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290163|NCT01147666|593433901|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290164|NCT01147666|593433902|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
164290165|NCT01147666|593433903|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290166|NCT01147666|593433904|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290167|NCT01147666|593433905|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290168|NCT01147666|593433906|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290169|NCT01147666|593433907|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290170|NCT01147666|593433908|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290171|NCT01147666|593433909|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
164290172|NCT01147666|593433910|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290173|NCT01147666|593433911|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290174|NCT01147666|593433912|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290175|NCT01147666|593433913|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290176|NCT01147666|593433899|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
164290177|NCT01147666|593433900|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
164290178|NCT01147666|593433901|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
164290179|NCT01147666|593433902|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
164290180|NCT01147666|593433903|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
164290181|NCT01147666|593433904|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
164290182|NCT01147666|593433905|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
164290183|NCT01147666|593433906|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
164290184|NCT01147666|593433907|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
164290185|NCT01147666|593433908|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
164290186|NCT01147666|593433909|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
164290187|NCT01147666|593433910|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
164290188|NCT01147666|593433911|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
164345433|NCT02380677|593640961|FG001|Overall Study|Other|0|||
164290189|NCT01147666|593433912|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
164290190|NCT01147666|593433913|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
164290191|NCT01147666|593433899|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
164290192|NCT01147666|593433900|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
164290193|NCT01147666|593433901|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
164290194|NCT01147666|593433902|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
164290195|NCT01147666|593433903|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
164290196|NCT01147666|593433904|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
164290197|NCT01147666|593433905|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
164290198|NCT01147666|593433906|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
164290199|NCT01147666|593433907|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
164290200|NCT01147666|593433908|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
164345434|NCT02380677|593640962|FG002|Overall Study|Other|0|||
164345435|NCT02380677|593640963|FG003|Overall Study|Other|1|||
164345436|NCT02380677|593640964|FG004|Overall Study|Other|1|||
164345437|NCT02380677|593640965|FG005|Overall Study|Other|1|||
164345438|NCT02380677|593640966|FG006|Overall Study|Other|0|||
164345439|NCT02380677|593640967|FG007|Overall Study|Other|0|||
164345440|NCT02380677|593640968|FG008|Overall Study|Other|0|||
164345441|NCT02380677|593640969|FG009|Overall Study|Other|0|||
164345442|NCT02380677|593640970|FG010|Overall Study|Other|0|||
164345443|NCT02380677|593640971|FG011|Overall Study|Other|0|||
164345444|NCT01342796|593640972|FG000|Overall Study|Withdrawal by Subject|2|||
164345445|NCT01342796|593640973|FG001|Overall Study|Withdrawal by Subject|0|||
164345446|NCT01342796|593640972|FG000|Overall Study|Lost to Follow-up|0|||
164345447|NCT01342796|593640973|FG001|Overall Study|Lost to Follow-up|3|||
164345448|NCT01342796|593640972|FG000|Overall Study|Inappropriate enrollment|1|||
164345449|NCT01342796|593640973|FG001|Overall Study|Inappropriate enrollment|0|||
164345450|NCT01751867|593640974|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
164345451|NCT01751867|593640975|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
164345452|NCT01751867|593640974|FG000|Overall Study|Diease Progression|4|||
164345453|NCT01751867|593640975|FG001|Overall Study|Diease Progression|18|||
164345454|NCT01751867|593640974|FG000|Overall Study|Adverse Event|8|||
164345455|NCT01751867|593640975|FG001|Overall Study|Adverse Event|15|||
164345456|NCT01751867|593640974|FG000|Overall Study|Poor Compliance|0|||
164345457|NCT01751867|593640975|FG001|Overall Study|Poor Compliance|5|||
164345458|NCT01751867|593640974|FG000|Overall Study|Withdrawal by Subject|3|||
164345459|NCT01751867|593640975|FG001|Overall Study|Withdrawal by Subject|1|||
164345460|NCT01751867|593640974|FG000|Overall Study|Physician Decision|4|||
164345461|NCT01751867|593640975|FG001|Overall Study|Physician Decision|7|||
164345462|NCT01751867|593640974|FG000|Overall Study|Protocol Violation|0|||
164345463|NCT01751867|593640975|FG001|Overall Study|Protocol Violation|2|||
164345464|NCT01751867|593640974|FG000|Overall Study|Death|0|||
164345465|NCT01751867|593640975|FG001|Overall Study|Death|5|||
164345466|NCT01751867|593640974|FG000|Overall Study|Other|11|||
164345467|NCT01751867|593640975|FG001|Overall Study|Other|37|||
164345468|NCT01751867|593640974|FG000|Overall Study|Randomized but not treated.|2|||
164345469|NCT01751867|593640975|FG001|Overall Study|Randomized but not treated.|1|||
164345470|NCT01396148|593640976|FG000|Overall Study|Patient Decision|1|||
164290201|NCT01147666|593433909|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
164290202|NCT01147666|593433910|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
164290203|NCT01147666|593433911|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
164290204|NCT01147666|593433912|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
164290205|NCT01147666|593433913|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
164290206|NCT01147666|593433899|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
164290207|NCT01147666|593433900|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
164290208|NCT01147666|593433901|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
164290209|NCT01147666|593433902|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
164290210|NCT01147666|593433903|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
164290211|NCT01147666|593433904|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
164290212|NCT01147666|593433905|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
164290213|NCT01147666|593433906|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
164290214|NCT01147666|593433907|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
164290215|NCT01147666|593433908|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
164290216|NCT01147666|593433909|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
164290217|NCT01147666|593433910|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
164290218|NCT01147666|593433911|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
164290219|NCT01147666|593433912|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
164290220|NCT01147666|593433913|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
164290221|NCT01147666|593433899|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290222|NCT01147666|593433900|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290223|NCT01147666|593433901|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290224|NCT01147666|593433902|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
164290225|NCT01147666|593433903|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290226|NCT01147666|593433904|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164345471|NCT00224042|593640985|FG000|Overall Study|Adverse Event|2|||
164345472|NCT00224042|593640986|FG001|Overall Study|Adverse Event|1|||
164345473|NCT00224042|593640985|FG000|Overall Study|Protocol Violation|0|||
164345474|NCT00224042|593640986|FG001|Overall Study|Protocol Violation|1|||
164345475|NCT00224042|593640985|FG000|Overall Study|Physician Decision|0|||
164345476|NCT00224042|593640986|FG001|Overall Study|Physician Decision|1|||
164345477|NCT00224042|593640985|FG000|Overall Study|Did not meet lab incusion criteria|2|||
164345478|NCT00224042|593640986|FG001|Overall Study|Did not meet lab incusion criteria|3|||
164345479|NCT00224042|593640985|FG000|Overall Study|Other|2|||
164345480|NCT00224042|593640986|FG001|Overall Study|Other|0|||
164345481|NCT00840450|593640987|FG000|Overall Study|Adverse Event|1|||
164586736|NCT01855789|594511911|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
164290227|NCT01147666|593433905|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290228|NCT01147666|593433906|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290229|NCT01147666|593433907|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290230|NCT01147666|593433908|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290231|NCT01147666|593433909|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290232|NCT01147666|593433910|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290233|NCT01147666|593433911|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290234|NCT01147666|593433912|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290235|NCT01147666|593433913|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290236|NCT01147666|593433899|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
164290237|NCT01147666|593433900|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
164290238|NCT01147666|593433901|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
164290239|NCT01147666|593433902|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
164290240|NCT01147666|593433903|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
164290241|NCT01147666|593433904|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
164290242|NCT01147666|593433905|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
164290243|NCT01147666|593433906|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
164290244|NCT01147666|593433907|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
164290245|NCT01147666|593433908|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
164290246|NCT01147666|593433909|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
164290247|NCT01147666|593433910|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
164290248|NCT01147666|593433911|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
164290249|NCT01147666|593433912|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
164290250|NCT01147666|593433913|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
164290251|NCT01147666|593433899|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164290252|NCT01147666|593433900|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164290253|NCT01147666|593433901|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164345482|NCT00840450|593640987|FG000|Overall Study|Lack of Efficacy|2|||
164345483|NCT03095066|593640988|FG000|Overall Study (Baseline to Week 12)|Adverse Event|3|||
164345484|NCT03095066|593640989|FG001|Overall Study (Baseline to Week 12)|Adverse Event|6|||
164345485|NCT03095066|593640990|FG002|Overall Study (Baseline to Week 12)|Adverse Event|0|||
164345486|NCT03095066|593640991|FG003|Overall Study (Baseline to Week 12)|Adverse Event|0|||
164345487|NCT03095066|593640992|FG004|Overall Study (Baseline to Week 12)|Adverse Event|0|||
164345488|NCT03095066|593640993|FG005|Overall Study (Baseline to Week 12)|Adverse Event|0|||
164345489|NCT03095066|593640994|FG006|Overall Study (Baseline to Week 12)|Adverse Event|0|||
164345490|NCT03095066|593640995|FG007|Overall Study (Baseline to Week 12)|Adverse Event|0|||
164345491|NCT03095066|593640988|FG000|Overall Study (Baseline to Week 12)|Lost to Follow-up|6|||
164345492|NCT03095066|593640989|FG001|Overall Study (Baseline to Week 12)|Lost to Follow-up|1|||
164345493|NCT03095066|593640990|FG002|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
164345494|NCT03095066|593640991|FG003|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
164345495|NCT03095066|593640992|FG004|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
164345496|NCT03095066|593640993|FG005|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
164345497|NCT03095066|593640994|FG006|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
164345498|NCT03095066|593640995|FG007|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
164345499|NCT03095066|593640988|FG000|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|2|||
164586737|NCT01855789|594511912|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
164586738|NCT01855789|594511913|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
164586739|NCT01855789|594511910|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
164586740|NCT01855789|594511911|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
164586741|NCT01855789|594511912|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
164586742|NCT01855789|594511913|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
164586743|NCT01855789|594511910|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
164586744|NCT01855789|594511911|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
164586745|NCT01855789|594511912|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
164586746|NCT01855789|594511913|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
164586747|NCT01855789|594511910|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
164586748|NCT01855789|594511911|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
164586749|NCT01855789|594511912|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
164586750|NCT01855789|594511913|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
164586751|NCT01855789|594511910|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
164586752|NCT01855789|594511911|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
164586753|NCT01855789|594511912|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
164586754|NCT01855789|594511913|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
164586755|NCT01855789|594511910|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
164290254|NCT01147666|593433902|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
164290255|NCT01147666|593433903|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164290256|NCT01147666|593433904|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164290257|NCT01147666|593433905|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164290258|NCT01147666|593433906|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164290259|NCT01147666|593433907|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164290260|NCT01147666|593433908|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164290261|NCT01147666|593433909|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
164290262|NCT01147666|593433910|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164290263|NCT01147666|593433911|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164290264|NCT01147666|593433912|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164290265|NCT01147666|593433913|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164290266|NCT01147666|593433899|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290267|NCT01147666|593433900|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290268|NCT01147666|593433901|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290269|NCT01147666|593433902|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290270|NCT01147666|593433903|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290271|NCT01147666|593433904|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290272|NCT01147666|593433905|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290273|NCT01147666|593433906|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290274|NCT01147666|593433907|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290275|NCT01147666|593433908|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290276|NCT01147666|593433909|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290277|NCT01147666|593433910|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290278|NCT01147666|593433911|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
164290279|NCT01147666|593433912|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290280|NCT01147666|593433913|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290281|NCT01147666|593433899|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290282|NCT01147666|593433900|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290283|NCT01147666|593433901|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290284|NCT01147666|593433902|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290285|NCT01147666|593433903|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290286|NCT01147666|593433904|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290287|NCT01147666|593433905|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290288|NCT01147666|593433906|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290289|NCT01147666|593433907|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290290|NCT01147666|593433908|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290291|NCT01147666|593433909|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290292|NCT01147666|593433910|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290293|NCT01147666|593433911|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
164290294|NCT01147666|593433912|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290295|NCT01147666|593433913|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
164290296|NCT02748863|593433914|FG000|Treatment Period 1|Adverse Event|0|||
164290297|NCT02748863|593433915|FG001|Treatment Period 1|Adverse Event|1|||
164290298|NCT02748863|593433916|FG002|Treatment Period 1|Adverse Event|0|||
164290299|NCT02748863|593433917|FG003|Treatment Period 1|Adverse Event|0|||
164290300|NCT02748863|593433918|FG004|Treatment Period 1|Adverse Event|0|||
164290301|NCT02748863|593433914|FG000|Treatment Period 1|Lack of Efficacy|0|||
164290302|NCT02748863|593433915|FG001|Treatment Period 1|Lack of Efficacy|0|||
164290303|NCT02748863|593433916|FG002|Treatment Period 1|Lack of Efficacy|1|||
164290304|NCT02748863|593433917|FG003|Treatment Period 1|Lack of Efficacy|0|||
164290305|NCT02748863|593433918|FG004|Treatment Period 1|Lack of Efficacy|0|||
164290306|NCT02748863|593433914|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164290307|NCT02748863|593433915|FG001|Treatment Period 1|Withdrawal by Subject|1|||
164290308|NCT02748863|593433916|FG002|Treatment Period 1|Withdrawal by Subject|1|||
164290309|NCT02748863|593433917|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164290310|NCT02748863|593433918|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164290311|NCT02748863|593433914|FG000|Treatment Period 2|Lost to Follow-up|2|||
164290312|NCT02748863|593433915|FG001|Treatment Period 2|Lost to Follow-up|0|||
164290313|NCT02748863|593433916|FG002|Treatment Period 2|Lost to Follow-up|0|||
164290314|NCT02748863|593433917|FG003|Treatment Period 2|Lost to Follow-up|0|||
164290315|NCT02748863|593433918|FG004|Treatment Period 2|Lost to Follow-up|0|||
164290316|NCT02748863|593433914|FG000|Treatment Period 2|Adverse Event|3|||
164290317|NCT02748863|593433915|FG001|Treatment Period 2|Adverse Event|2|||
164290318|NCT02748863|593433916|FG002|Treatment Period 2|Adverse Event|0|||
164290319|NCT02748863|593433917|FG003|Treatment Period 2|Adverse Event|2|||
164290320|NCT02748863|593433918|FG004|Treatment Period 2|Adverse Event|0|||
164290321|NCT02748863|593433914|FG000|Treatment Period 2|Lack of Efficacy|0|||
164290322|NCT02748863|593433915|FG001|Treatment Period 2|Lack of Efficacy|1|||
164290323|NCT02748863|593433916|FG002|Treatment Period 2|Lack of Efficacy|0|||
164290324|NCT02748863|593433917|FG003|Treatment Period 2|Lack of Efficacy|0|||
164290325|NCT02748863|593433918|FG004|Treatment Period 2|Lack of Efficacy|0|||
164290326|NCT02748863|593433914|FG000|Treatment Period 2|Pregnancy|0|||
164290327|NCT02748863|593433915|FG001|Treatment Period 2|Pregnancy|0|||
164290328|NCT02748863|593433916|FG002|Treatment Period 2|Pregnancy|0|||
164290329|NCT02748863|593433917|FG003|Treatment Period 2|Pregnancy|0|||
164290330|NCT02748863|593433918|FG004|Treatment Period 2|Pregnancy|1|||
164290331|NCT01135134|593433919|FG000|Overall Study|Adverse Event|1|||
164290332|NCT01135134|593433920|FG001|Overall Study|Adverse Event|1|||
164290333|NCT01135134|593433919|FG000|Overall Study|Did not meet protocol eligibility|1|||
164290334|NCT01135134|593433920|FG001|Overall Study|Did not meet protocol eligibility|0|||
164290335|NCT02576639|593433921|FG000|Overall Study|Withdrawal by Subject|1|||
164290336|NCT02576639|593433922|FG001|Overall Study|Withdrawal by Subject|2|||
164290337|NCT02576639|593433923|FG002|Overall Study|Withdrawal by Subject|1|||
164290338|NCT02576639|593433924|FG003|Overall Study|Withdrawal by Subject|0|||
164290339|NCT02576639|593433925|FG004|Overall Study|Withdrawal by Subject|1|||
164290340|NCT02576639|593433921|FG000|Overall Study|Adverse Event|1|||
164290341|NCT02576639|593433922|FG001|Overall Study|Adverse Event|0|||
164290342|NCT02576639|593433923|FG002|Overall Study|Adverse Event|1|||
164290343|NCT02576639|593433924|FG003|Overall Study|Adverse Event|1|||
164290344|NCT02576639|593433925|FG004|Overall Study|Adverse Event|2|||
164290345|NCT02576639|593433921|FG000|Overall Study|Physician Decision|0|||
164290346|NCT02576639|593433922|FG001|Overall Study|Physician Decision|0|||
164290347|NCT02576639|593433923|FG002|Overall Study|Physician Decision|0|||
164290348|NCT02576639|593433924|FG003|Overall Study|Physician Decision|0|||
164290349|NCT02576639|593433925|FG004|Overall Study|Physician Decision|1|||
164290350|NCT01329978|593433938|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
164290351|NCT01329978|593433939|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
164290352|NCT01329978|593433940|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
164290353|NCT01329978|593433941|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
164290354|NCT01329978|593433942|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
164290355|NCT01329978|593433938|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
164290356|NCT01329978|593433939|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
164290357|NCT01329978|593433940|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
164290358|NCT01329978|593433941|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
164290359|NCT01329978|593433942|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
164290360|NCT01329978|593433938|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
164290361|NCT01329978|593433939|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
164345500|NCT03095066|593640989|FG001|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|1|||
164345501|NCT03095066|593640990|FG002|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
164345502|NCT03095066|593640991|FG003|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
164345503|NCT03095066|593640992|FG004|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
164345504|NCT03095066|593640993|FG005|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
164345505|NCT03095066|593640994|FG006|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
164345506|NCT03095066|593640995|FG007|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
164345507|NCT03095066|593640988|FG000|Overall Study (Baseline to Week 12)|Physician Decision|0|||
164345508|NCT03095066|593640989|FG001|Overall Study (Baseline to Week 12)|Physician Decision|1|||
164345509|NCT03095066|593640990|FG002|Overall Study (Baseline to Week 12)|Physician Decision|0|||
164345510|NCT03095066|593640991|FG003|Overall Study (Baseline to Week 12)|Physician Decision|0|||
164345511|NCT03095066|593640992|FG004|Overall Study (Baseline to Week 12)|Physician Decision|0|||
164345512|NCT03095066|593640993|FG005|Overall Study (Baseline to Week 12)|Physician Decision|0|||
164345513|NCT03095066|593640994|FG006|Overall Study (Baseline to Week 12)|Physician Decision|0|||
164345514|NCT03095066|593640995|FG007|Overall Study (Baseline to Week 12)|Physician Decision|0|||
164345515|NCT03095066|593640988|FG000|Overall Study (Baseline to Week 12)|Protocol Deviation|1|||
164345516|NCT03095066|593640989|FG001|Overall Study (Baseline to Week 12)|Protocol Deviation|2|||
164345517|NCT03095066|593640990|FG002|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
164345518|NCT03095066|593640991|FG003|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
164345519|NCT03095066|593640992|FG004|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
164345520|NCT03095066|593640993|FG005|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
164345521|NCT03095066|593640994|FG006|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
164345522|NCT03095066|593640995|FG007|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
164345523|NCT03095066|593640988|FG000|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|1|||
164433346|NCT00335556|593957220|FG003|Overall Study|Physician Decision|1|||
164692751|NCT04126343|594897053|FG005|Overall Study|Withdrawal by Subject|0|||
164290362|NCT01329978|593433940|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
164290363|NCT01329978|593433941|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
164290364|NCT01329978|593433942|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
164290365|NCT01329978|593433938|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
164290366|NCT01329978|593433939|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
164290367|NCT01329978|593433940|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
164290368|NCT01329978|593433941|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
164290369|NCT01329978|593433942|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
164290370|NCT01329978|593433938|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
164290371|NCT01329978|593433939|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
164290372|NCT01329978|593433940|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
164290373|NCT01329978|593433941|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
164290374|NCT01329978|593433942|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
164290375|NCT01329978|593433938|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
164290376|NCT01329978|593433939|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
164290377|NCT01329978|593433940|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
164290378|NCT01329978|593433941|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
164290379|NCT01329978|593433942|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
164290380|NCT01329978|593433938|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
164290381|NCT01329978|593433939|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
164290382|NCT01329978|593433940|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
164290383|NCT01329978|593433941|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
164290384|NCT01329978|593433942|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
164290385|NCT01188772|593433944|FG000|Overall Study|Randomized but Not Treated|0|||
164290386|NCT01188772|593433945|FG001|Overall Study|Randomized but Not Treated|1|||
164290387|NCT01188772|593433946|FG002|Overall Study|Randomized but Not Treated|0|||
164290388|NCT01188772|593433947|FG003|Overall Study|Randomized but Not Treated|0|||
164290389|NCT01188772|593433944|FG000|Overall Study|Adverse Event|0|||
164290390|NCT01188772|593433945|FG001|Overall Study|Adverse Event|1|||
164290391|NCT01188772|593433946|FG002|Overall Study|Adverse Event|2|||
164290392|NCT01188772|593433947|FG003|Overall Study|Adverse Event|0|||
164290393|NCT01188772|593433944|FG000|Overall Study|Lost to Follow-up|4|||
164290394|NCT01188772|593433945|FG001|Overall Study|Lost to Follow-up|1|||
164290395|NCT01188772|593433946|FG002|Overall Study|Lost to Follow-up|1|||
164290396|NCT01188772|593433947|FG003|Overall Study|Lost to Follow-up|1|||
164290397|NCT01188772|593433944|FG000|Overall Study|Non-responder|0|||
164290398|NCT01188772|593433945|FG001|Overall Study|Non-responder|0|||
164290399|NCT01188772|593433946|FG002|Overall Study|Non-responder|3|||
164290400|NCT01188772|593433947|FG003|Overall Study|Non-responder|0|||
164290401|NCT01188772|593433944|FG000|Overall Study|Physician Decision|0|||
164290402|NCT01188772|593433945|FG001|Overall Study|Physician Decision|0|||
164290403|NCT01188772|593433946|FG002|Overall Study|Physician Decision|1|||
164290404|NCT01188772|593433947|FG003|Overall Study|Physician Decision|0|||
164290405|NCT01188772|593433944|FG000|Overall Study|Terminated by Sponsor|0|||
164290406|NCT01188772|593433945|FG001|Overall Study|Terminated by Sponsor|0|||
164290407|NCT01188772|593433946|FG002|Overall Study|Terminated by Sponsor|1|||
164290408|NCT01188772|593433947|FG003|Overall Study|Terminated by Sponsor|0|||
164290409|NCT01188772|593433944|FG000|Overall Study|Treatment Failure|0|||
164290410|NCT01188772|593433945|FG001|Overall Study|Treatment Failure|0|||
164290411|NCT01188772|593433946|FG002|Overall Study|Treatment Failure|1|||
164290412|NCT01188772|593433947|FG003|Overall Study|Treatment Failure|0|||
164290413|NCT01188772|593433944|FG000|Overall Study|Virologic Failure|1|||
164290414|NCT01188772|593433945|FG001|Overall Study|Virologic Failure|0|||
164290415|NCT01188772|593433946|FG002|Overall Study|Virologic Failure|0|||
164290416|NCT01188772|593433947|FG003|Overall Study|Virologic Failure|0|||
164290417|NCT01188772|593433944|FG000|Overall Study|Withdrawal by Subject|0|||
164290418|NCT01188772|593433945|FG001|Overall Study|Withdrawal by Subject|0|||
164290419|NCT01188772|593433946|FG002|Overall Study|Withdrawal by Subject|2|||
164290420|NCT01188772|593433947|FG003|Overall Study|Withdrawal by Subject|0|||
164290421|NCT03081884|593433951|FG000|Overall Study|deferred prostate cancer treatment|1|||
164290422|NCT03081884|593433951|FG000|Overall Study|metastasis managed with systemic therapy|3|||
164290423|NCT02294058|593433952|FG000|Overall Study|Adverse Event|16|||
164290424|NCT02294058|593433953|FG001|Overall Study|Adverse Event|7|||
164290425|NCT02294058|593433954|FG002|Overall Study|Adverse Event|13|||
164290426|NCT02294058|593433952|FG000|Overall Study|Lack of Efficacy|3|||
164290427|NCT02294058|593433953|FG001|Overall Study|Lack of Efficacy|3|||
164290428|NCT02294058|593433954|FG002|Overall Study|Lack of Efficacy|0|||
164290429|NCT02294058|593433952|FG000|Overall Study|Lost to Follow-up|1|||
164290430|NCT02294058|593433953|FG001|Overall Study|Lost to Follow-up|0|||
164290431|NCT02294058|593433954|FG002|Overall Study|Lost to Follow-up|2|||
164290432|NCT02294058|593433952|FG000|Overall Study|Withdrawal by Subject|10|||
164692752|NCT04126343|594897048|FG000|Overall Study|Related to COVID-19 pandemic|3|||
164345524|NCT03095066|593640989|FG001|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
164345525|NCT03095066|593640990|FG002|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
164692753|NCT04126343|594897049|FG001|Overall Study|Related to COVID-19 pandemic|4|||
164290433|NCT02294058|593433953|FG001|Overall Study|Withdrawal by Subject|14|||
164345526|NCT03095066|593640991|FG003|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
164433347|NCT00335556|593957221|FG004|Overall Study|Physician Decision|0|||
164290434|NCT02294058|593433954|FG002|Overall Study|Withdrawal by Subject|13|||
164290435|NCT02294058|593433952|FG000|Overall Study|Physician Decision|2|||
164290436|NCT02294058|593433953|FG001|Overall Study|Physician Decision|1|||
164290437|NCT02294058|593433954|FG002|Overall Study|Physician Decision|0|||
164290438|NCT02294058|593433952|FG000|Overall Study|Miscellaneous|4|||
164290439|NCT02294058|593433953|FG001|Overall Study|Miscellaneous|1|||
164290440|NCT02294058|593433954|FG002|Overall Study|Miscellaneous|1|||
164290441|NCT00510835|593433959|FG000|Overall Study|Withdrawal by Subject|6|||
164290442|NCT00510835|593433960|FG001|Overall Study|Withdrawal by Subject|2|||
164290443|NCT00510835|593433961|FG002|Overall Study|Withdrawal by Subject|2|||
164290444|NCT05470985|593433962|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
164290445|NCT05470985|593433963|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
164290446|NCT05470985|593433962|FG000|Double Blind Treatment Period|Physician Decision|0|||
164290447|NCT05470985|593433963|FG001|Double Blind Treatment Period|Physician Decision|1|||
164290448|NCT05470985|593433962|FG000|Long Term Extension|Adverse Event|0|||
164290449|NCT05470985|593433963|FG001|Long Term Extension|Adverse Event|1|||
164290450|NCT05470985|593433962|FG000|Long Term Extension|Study terminated by sponsor|2|||
164290451|NCT05470985|593433963|FG001|Long Term Extension|Study terminated by sponsor|0|||
164290452|NCT01917747|593433964|FG000|Overall Study|Withdrawal by Subject|1|||
164290453|NCT01917747|593433965|FG001|Overall Study|Withdrawal by Subject|2|||
164290454|NCT01917747|593433964|FG000|Overall Study|Lost to Follow-up|18|||
164290455|NCT01917747|593433965|FG001|Overall Study|Lost to Follow-up|9|||
164290456|NCT02741245|593433975|FG000|Overall Study|Adverse Event|0|||
164290457|NCT02741245|593433976|FG001|Overall Study|Adverse Event|0|||
164290458|NCT02741245|593433977|FG002|Overall Study|Adverse Event|0|||
164290459|NCT02741245|593433978|FG003|Overall Study|Adverse Event|2|||
164290460|NCT02741245|593433979|FG004|Overall Study|Adverse Event|2|||
164290461|NCT02741245|593433975|FG000|Overall Study|Protocol Violation|0|||
164290462|NCT02741245|593433976|FG001|Overall Study|Protocol Violation|1|||
164290463|NCT02741245|593433977|FG002|Overall Study|Protocol Violation|0|||
164290464|NCT02741245|593433978|FG003|Overall Study|Protocol Violation|1|||
164290465|NCT02741245|593433979|FG004|Overall Study|Protocol Violation|0|||
164290466|NCT02741245|593433975|FG000|Overall Study|Withdrawal by Subject|0|||
164290467|NCT02741245|593433976|FG001|Overall Study|Withdrawal by Subject|0|||
164290468|NCT02741245|593433977|FG002|Overall Study|Withdrawal by Subject|0|||
164290469|NCT02741245|593433978|FG003|Overall Study|Withdrawal by Subject|1|||
164290470|NCT02741245|593433979|FG004|Overall Study|Withdrawal by Subject|0|||
164290471|NCT00152503|593433987|FG000|Overall Study|Adverse Event|4|||
164290472|NCT00607087|593433988|FG000|Overall Study|Withdrawal by Subject|9|||
164290473|NCT00607087|593433989|FG001|Overall Study|Withdrawal by Subject|4|||
164290474|NCT00607087|593433990|FG002|Overall Study|Withdrawal by Subject|4|||
164290475|NCT00607087|593433988|FG000|Overall Study|Adverse Event|3|||
164290476|NCT00607087|593433989|FG001|Overall Study|Adverse Event|2|||
164290477|NCT00607087|593433990|FG002|Overall Study|Adverse Event|3|||
164290478|NCT00607087|593433988|FG000|Overall Study|Other reason|1|||
164290479|NCT00607087|593433989|FG001|Overall Study|Other reason|5|||
164290480|NCT00607087|593433990|FG002|Overall Study|Other reason|2|||
164290481|NCT00607087|593433988|FG000|Overall Study|Poor compliance to protocol|1|||
164290482|NCT00607087|593433989|FG001|Overall Study|Poor compliance to protocol|0|||
164290483|NCT00607087|593433990|FG002|Overall Study|Poor compliance to protocol|1|||
164290484|NCT00607087|593433988|FG000|Overall Study|Lost to Follow-up|1|||
164290485|NCT00607087|593433989|FG001|Overall Study|Lost to Follow-up|0|||
164290486|NCT00607087|593433990|FG002|Overall Study|Lost to Follow-up|0|||
164290487|NCT00607087|593433988|FG000|Period 1|Withdrawal by Subject|7|||
164290488|NCT00607087|593433989|FG001|Period 1|Withdrawal by Subject|2|||
164290489|NCT00607087|593433990|FG002|Period 1|Withdrawal by Subject|3|||
164290490|NCT00607087|593433988|FG000|Period 1|Adverse Event|3|||
164290491|NCT00607087|593433989|FG001|Period 1|Adverse Event|0|||
164290492|NCT00607087|593433990|FG002|Period 1|Adverse Event|0|||
164290493|NCT00607087|593433988|FG000|Period 1|Poor compliance to protocol|1|||
164290494|NCT00607087|593433989|FG001|Period 1|Poor compliance to protocol|0|||
164290495|NCT00607087|593433990|FG002|Period 1|Poor compliance to protocol|0|||
164692754|NCT04126343|594897050|FG002|Overall Study|Related to COVID-19 pandemic|3|||
164692755|NCT04126343|594897051|FG003|Overall Study|Related to COVID-19 pandemic|3|||
164433348|NCT00335556|593957222|FG005|Overall Study|Physician Decision|0|||
164433349|NCT00335556|593957217|FG000|Overall Study|Ineligible|2|||
164290496|NCT00607087|593433988|FG000|Period 1|Lost to Follow-up|1|||
164290497|NCT00607087|593433989|FG001|Period 1|Lost to Follow-up|0|||
164290498|NCT00607087|593433990|FG002|Period 1|Lost to Follow-up|0|||
164290499|NCT00607087|593433988|FG000|Period 1|Other reason|0|||
164290500|NCT00607087|593433989|FG001|Period 1|Other reason|4|||
164290501|NCT00607087|593433990|FG002|Period 1|Other reason|2|||
164290502|NCT00607087|593433988|FG000|Period 2|Withdrawal by Subject|0|||
164290503|NCT00607087|593433989|FG001|Period 2|Withdrawal by Subject|1|||
164290504|NCT00607087|593433990|FG002|Period 2|Withdrawal by Subject|1|||
164290505|NCT00607087|593433988|FG000|Period 2|Other reason|1|||
164290506|NCT00607087|593433989|FG001|Period 2|Other reason|1|||
164290507|NCT00607087|593433990|FG002|Period 2|Other reason|0|||
164433350|NCT00335556|593957218|FG001|Overall Study|Ineligible|0|||
164586756|NCT01855789|594511911|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
164586757|NCT01855789|594511912|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
164586758|NCT01855789|594511913|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
164586759|NCT01855789|594511910|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
164586760|NCT01855789|594511911|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
164586761|NCT01855789|594511912|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
164586762|NCT01855789|594511913|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
164586763|NCT01855789|594511910|FG000|2) Week 24 up to End of Study|Other|0|||
164586764|NCT01855789|594511911|FG001|2) Week 24 up to End of Study|Other|0|||
164586765|NCT01855789|594511912|FG002|2) Week 24 up to End of Study|Other|0|||
164290508|NCT00607087|593433988|FG000|Period 2|Adverse Event|0|||
164290509|NCT00607087|593433989|FG001|Period 2|Adverse Event|1|||
164290510|NCT00607087|593433990|FG002|Period 2|Adverse Event|3|||
164290511|NCT00607087|593433988|FG000|Period 2|Poor compliance to protocol|0|||
164290512|NCT00607087|593433989|FG001|Period 2|Poor compliance to protocol|0|||
164290513|NCT00607087|593433990|FG002|Period 2|Poor compliance to protocol|1|||
164290514|NCT00607087|593433988|FG000|Period 3|Withdrawal by Subject|2|||
164290515|NCT00607087|593433989|FG001|Period 3|Withdrawal by Subject|1|||
164290516|NCT00607087|593433990|FG002|Period 3|Withdrawal by Subject|0|||
164290517|NCT00607087|593433988|FG000|Period 3|Adverse Event|0|||
164290518|NCT00607087|593433989|FG001|Period 3|Adverse Event|1|||
164290519|NCT00607087|593433990|FG002|Period 3|Adverse Event|0|||
164290520|NCT01774799|593433993|FG000|Overall Study|Lost to Follow-up|1|||
164290521|NCT01774799|593433994|FG001|Overall Study|Lost to Follow-up|1|||
164345527|NCT03095066|593640992|FG004|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
164345528|NCT03095066|593640993|FG005|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
164345529|NCT03095066|593640994|FG006|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
164345530|NCT03095066|593640995|FG007|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
164345531|NCT03095066|593640988|FG000|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
164345532|NCT03095066|593640989|FG001|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
164345533|NCT03095066|593640990|FG002|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
164345534|NCT03095066|593640991|FG003|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
164345535|NCT03095066|593640992|FG004|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
164345536|NCT03095066|593640993|FG005|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
164345537|NCT03095066|593640994|FG006|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
164345538|NCT03095066|593640995|FG007|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
164345539|NCT03095066|593640988|FG000|Overall Study (Baseline to Week 12)|Reason not Specified|8|||
164345540|NCT03095066|593640989|FG001|Overall Study (Baseline to Week 12)|Reason not Specified|2|||
164345541|NCT03095066|593640990|FG002|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
164345542|NCT03095066|593640991|FG003|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
164345543|NCT03095066|593640992|FG004|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
164345544|NCT03095066|593640993|FG005|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
164345545|NCT03095066|593640994|FG006|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
164345546|NCT03095066|593640995|FG007|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
164345547|NCT03095066|593640988|FG000|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
164345548|NCT03095066|593640989|FG001|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
164345549|NCT03095066|593640990|FG002|Stage 1 (Baseline to Week 6)|Adverse Event|2|||
164345550|NCT03095066|593640991|FG003|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
164345551|NCT03095066|593640992|FG004|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
164345552|NCT03095066|593640993|FG005|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
164345553|NCT03095066|593640994|FG006|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
164345554|NCT03095066|593640995|FG007|Stage 1 (Baseline to Week 6)|Adverse Event|6|||
164345555|NCT03095066|593640988|FG000|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
164345556|NCT03095066|593640989|FG001|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
164345557|NCT03095066|593640990|FG002|Stage 1 (Baseline to Week 6)|Lost to Follow-up|3|||
164345558|NCT03095066|593640991|FG003|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
164345559|NCT03095066|593640992|FG004|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
164345560|NCT03095066|593640993|FG005|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
164345561|NCT03095066|593640994|FG006|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
164345562|NCT03095066|593640995|FG007|Stage 1 (Baseline to Week 6)|Lost to Follow-up|1|||
164345563|NCT03095066|593640988|FG000|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
164345564|NCT03095066|593640989|FG001|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
164586766|NCT01855789|594511913|FG003|2) Week 24 up to End of Study|Other|1|||
164586767|NCT01863758|594511914|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
164586768|NCT01863758|594511914|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
164586769|NCT02975349|594511915|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164290522|NCT01774799|593433995|FG002|Overall Study|Lost to Follow-up|0|||
164290523|NCT01774799|593433996|FG003|Overall Study|Lost to Follow-up|0|||
164290524|NCT04393493|593433999|FG000|First 4 Days of Intervention|Early improvement|5|||
164290525|NCT04393493|593434000|FG001|First 4 Days of Intervention|Early improvement|7|||
164290526|NCT02910466|593434001|FG000|Overall Study|Adverse Event|1|||
164290527|NCT02910466|593434001|FG000|Overall Study|Withdrawal by Subject|3|||
164290528|NCT02910466|593434001|FG000|Overall Study|Lost to Follow-up|5|||
164290529|NCT02910466|593434001|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
164290530|NCT02910466|593434001|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
164290531|NCT05051579|593434005|FG000|Overall Study|Withdrawal by Subject|3|||
164290532|NCT05051579|593434006|FG001|Overall Study|Withdrawal by Subject|5|||
164290533|NCT05051579|593434007|FG002|Overall Study|Withdrawal by Subject|2|||
164290534|NCT05051579|593434008|FG003|Overall Study|Withdrawal by Subject|1|||
164290535|NCT05051579|593434009|FG004|Overall Study|Withdrawal by Subject|4|||
164290536|NCT05051579|593434010|FG005|Overall Study|Withdrawal by Subject|0|||
164290537|NCT05051579|593434011|FG006|Overall Study|Withdrawal by Subject|4|||
164290538|NCT05051579|593434005|FG000|Overall Study|Lost to Follow-up|1|||
164290539|NCT05051579|593434006|FG001|Overall Study|Lost to Follow-up|0|||
164290540|NCT05051579|593434007|FG002|Overall Study|Lost to Follow-up|0|||
164290541|NCT05051579|593434008|FG003|Overall Study|Lost to Follow-up|0|||
164290542|NCT05051579|593434009|FG004|Overall Study|Lost to Follow-up|1|||
164290543|NCT05051579|593434010|FG005|Overall Study|Lost to Follow-up|0|||
164290544|NCT05051579|593434011|FG006|Overall Study|Lost to Follow-up|1|||
164290545|NCT05051579|593434005|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
164290546|NCT05051579|593434006|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
164290547|NCT05051579|593434007|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
164290548|NCT05051579|593434008|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
164290549|NCT05051579|593434009|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
164290550|NCT05051579|593434010|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
164290551|NCT05051579|593434011|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
164290552|NCT05051579|593434005|FG000|Overall Study|Adverse Event|2|||
164290553|NCT05051579|593434006|FG001|Overall Study|Adverse Event|1|||
164290554|NCT05051579|593434007|FG002|Overall Study|Adverse Event|0|||
164290555|NCT05051579|593434008|FG003|Overall Study|Adverse Event|4|||
164290556|NCT05051579|593434009|FG004|Overall Study|Adverse Event|1|||
164290557|NCT05051579|593434010|FG005|Overall Study|Adverse Event|2|||
164290558|NCT05051579|593434011|FG006|Overall Study|Adverse Event|0|||
164290559|NCT05051579|593434005|FG000|Overall Study|Inadvertent Enrollment|0|||
164290560|NCT05051579|593434006|FG001|Overall Study|Inadvertent Enrollment|0|||
164290561|NCT05051579|593434007|FG002|Overall Study|Inadvertent Enrollment|0|||
164290562|NCT05051579|593434008|FG003|Overall Study|Inadvertent Enrollment|0|||
164290563|NCT05051579|593434009|FG004|Overall Study|Inadvertent Enrollment|0|||
164290564|NCT05051579|593434010|FG005|Overall Study|Inadvertent Enrollment|0|||
164290565|NCT05051579|593434011|FG006|Overall Study|Inadvertent Enrollment|1|||
164290566|NCT05051579|593434005|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
164290567|NCT05051579|593434006|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
164290568|NCT05051579|593434007|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
164290569|NCT05051579|593434008|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
164290570|NCT05051579|593434009|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
164290571|NCT05051579|593434010|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
164290572|NCT05051579|593434011|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
164290573|NCT05051579|593434005|FG000|Overall Study|Sponsor Decision|0|||
164290574|NCT05051579|593434006|FG001|Overall Study|Sponsor Decision|0|||
164290575|NCT05051579|593434007|FG002|Overall Study|Sponsor Decision|0|||
164290576|NCT05051579|593434008|FG003|Overall Study|Sponsor Decision|0|||
164290577|NCT05051579|593434009|FG004|Overall Study|Sponsor Decision|1|||
164290578|NCT05051579|593434010|FG005|Overall Study|Sponsor Decision|0|||
164290579|NCT05051579|593434011|FG006|Overall Study|Sponsor Decision|0|||
164290580|NCT05051579|593434005|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
164290581|NCT05051579|593434006|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
164299945|NCT01652235|593472960|FG000|Overall Study|Withdrawal by Subject|2|||
164290582|NCT05051579|593434007|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
164290583|NCT05051579|593434008|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
164290584|NCT05051579|593434009|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
164290585|NCT05051579|593434010|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
164290586|NCT05051579|593434011|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
164290587|NCT00717249|593434012|FG000|Overall Study|Lens Discomfort|4|||
164290588|NCT00717249|593434013|FG001|Overall Study|Lens Discomfort|1|||
164290589|NCT00717249|593434012|FG000|Overall Study|Unsatisfactory visual Response|0|||
164290590|NCT00717249|593434013|FG001|Overall Study|Unsatisfactory visual Response|2|||
164290591|NCT00717249|593434012|FG000|Overall Study|Adverse Event|4|||
164290592|NCT00717249|593434013|FG001|Overall Study|Adverse Event|2|||
164290593|NCT00717249|593434012|FG000|Overall Study|Lost to Follow-up|2|||
164290594|NCT00717249|593434013|FG001|Overall Study|Lost to Follow-up|0|||
164290595|NCT00717249|593434012|FG000|Overall Study|Withdrawal by Subject|1|||
164290596|NCT00717249|593434013|FG001|Overall Study|Withdrawal by Subject|2|||
164290597|NCT00717249|593434012|FG000|Overall Study|Pregnancy|6|||
164290598|NCT00717249|593434013|FG001|Overall Study|Pregnancy|3|||
164290599|NCT00717249|593434012|FG000|Overall Study|Protocol Violation|0|||
164290600|NCT00717249|593434013|FG001|Overall Study|Protocol Violation|2|||
164290601|NCT00717249|593434012|FG000|Overall Study|Subject became Ineligible|1|||
164290602|NCT00717249|593434013|FG001|Overall Study|Subject became Ineligible|1|||
164290603|NCT00717249|593434012|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
164290604|NCT00717249|593434013|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
164290605|NCT00717249|593434012|FG000|Overall Study|Gastric Surgery|0|||
164290606|NCT00717249|593434013|FG001|Overall Study|Gastric Surgery|1|||
164290607|NCT00717249|593434012|FG000|Overall Study|Diagnosed with Diabetes|1|||
164290608|NCT00717249|593434013|FG001|Overall Study|Diagnosed with Diabetes|0|||
164290609|NCT00717249|593434012|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
164290610|NCT00717249|593434013|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
164290611|NCT00717249|593434012|FG000|Overall Study|Subject relocated|1|||
164290612|NCT00717249|593434013|FG001|Overall Study|Subject relocated|0|||
164290613|NCT00717249|593434012|FG000|Overall Study|Headaches|1|||
164290614|NCT00717249|593434013|FG001|Overall Study|Headaches|0|||
164290615|NCT03370718|593434017|FG000|Overall Study|Withdrawal by Subject|1|||
164290616|NCT06172348|593434018|FG000|Treatment Period 2|Adverse Event|0|||
164290617|NCT06172348|593434019|FG001|Treatment Period 2|Adverse Event|0|||
164290618|NCT06172348|593434020|FG002|Treatment Period 2|Adverse Event|1|||
164290619|NCT06172348|593434021|FG003|Treatment Period 2|Adverse Event|0|||
164290620|NCT06172348|593434022|FG004|Treatment Period 2|Adverse Event|0|||
164290621|NCT06172348|593434023|FG005|Treatment Period 2|Adverse Event|0|||
164290622|NCT01116648|593434024|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
164290623|NCT01116648|593434025|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
164290624|NCT01116648|593434026|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
164290625|NCT01116648|593434027|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
164290626|NCT01116648|593434028|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
164290627|NCT01116648|593434029|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
164290628|NCT01116648|593434030|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
164290629|NCT01116648|593434031|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
164290630|NCT01116648|593434032|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
164290631|NCT01116648|593434033|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
164290632|NCT01116648|593434034|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
164290633|NCT01116648|593434035|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
164290634|NCT01116648|593434036|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
164290635|NCT01116648|593434037|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
164290636|NCT01116648|593434038|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
164290637|NCT04539938|593434039|FG000|Overall Study|Death|30|||
164290638|NCT04539938|593434039|FG000|Overall Study|Withdrawal by Subject|4|||
164290639|NCT04037891|593434040|FG000|Open-label Period|Withdrawal by Subject|1|||
164345565|NCT03095066|593640990|FG002|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|2|||
164345566|NCT03095066|593640991|FG003|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
164345567|NCT03095066|593640992|FG004|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
164345568|NCT03095066|593640993|FG005|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
164345569|NCT03095066|593640994|FG006|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
164345570|NCT03095066|593640995|FG007|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|1|||
164586770|NCT02975349|594511916|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164290640|NCT04037891|593434041|FG001|Open-label Period|Withdrawal by Subject|0|||
164290641|NCT04037891|593434042|FG002|Open-label Period|Withdrawal by Subject|0|||
164345571|NCT03095066|593640988|FG000|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
164290642|NCT04037891|593434040|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
164290643|NCT04037891|593434041|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
164290644|NCT04037891|593434042|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
164290645|NCT00990106|593434043|FG000|Overall Study|"too busy to continue"|1|||
164290646|NCT00990106|593434044|FG001|Overall Study|"too busy to continue"|2|||
164290647|NCT00990106|593434043|FG000|Overall Study|Lost to Follow-up|1|||
164290648|NCT00990106|593434044|FG001|Overall Study|Lost to Follow-up|3|||
164290649|NCT00990106|593434043|FG000|Overall Study|Withdrawal by Subject|2|||
164290650|NCT00990106|593434044|FG001|Overall Study|Withdrawal by Subject|1|||
164290651|NCT00990106|593434043|FG000|Overall Study|opted for open label prazosin|1|||
164290652|NCT00990106|593434044|FG001|Overall Study|opted for open label prazosin|1|||
164345572|NCT03095066|593640989|FG001|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
164345573|NCT03095066|593640990|FG002|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|2|||
164345574|NCT03095066|593640991|FG003|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
164345575|NCT03095066|593640992|FG004|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
164345576|NCT03095066|593640993|FG005|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
164345577|NCT03095066|593640994|FG006|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
164345578|NCT03095066|593640995|FG007|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|3|||
164345579|NCT03095066|593640988|FG000|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
164345580|NCT03095066|593640989|FG001|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
164345581|NCT03095066|593640990|FG002|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|1|||
164345582|NCT03095066|593640991|FG003|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
164345583|NCT03095066|593640992|FG004|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
164345584|NCT03095066|593640993|FG005|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
164345585|NCT03095066|593640994|FG006|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
164345586|NCT03095066|593640995|FG007|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
164345587|NCT03095066|593640988|FG000|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
164345588|NCT03095066|593640989|FG001|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
164345589|NCT03095066|593640990|FG002|Stage 1 (Baseline to Week 6)|Reason Not Specified|5|||
164345590|NCT03095066|593640991|FG003|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
164345591|NCT03095066|593640992|FG004|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
164345592|NCT03095066|593640993|FG005|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
164290653|NCT00990106|593434043|FG000|Overall Study|relocation/deployment|4|||
164290654|NCT00990106|593434044|FG001|Overall Study|relocation/deployment|1|||
164290655|NCT00990106|593434043|FG000|Overall Study|started exclusionary medication|0|||
164290656|NCT00990106|593434044|FG001|Overall Study|started exclusionary medication|1|||
164290657|NCT00990106|593434043|FG000|Overall Study|planned major surgery|0|||
164290658|NCT00990106|593434044|FG001|Overall Study|planned major surgery|1|||
164290659|NCT00990106|593434043|FG000|Overall Study|scheduling conflicts|0|||
164290660|NCT00990106|593434044|FG001|Overall Study|scheduling conflicts|2|||
164290661|NCT04194944|593434045|FG000|Overall Study|Lost to Follow-up|3|||
164290662|NCT04194944|593434046|FG001|Overall Study|Lost to Follow-up|0|||
164290663|NCT04194944|593434045|FG000|Overall Study|Withdrawal by Subject|2|||
164290664|NCT04194944|593434046|FG001|Overall Study|Withdrawal by Subject|2|||
164290665|NCT04194944|593434045|FG000|Overall Study|On Treatment|93|||
164290666|NCT04194944|593434046|FG001|Overall Study|On Treatment|30|||
164290667|NCT03737123|593436069|FG000|Study Treatment|Adverse Event|2|||
164290668|NCT03737123|593436070|FG001|Study Treatment|Adverse Event|0|||
164290669|NCT03737123|593436069|FG000|Study Treatment|Disease Progression|2|||
164290670|NCT03737123|593436070|FG001|Study Treatment|Disease Progression|0|||
164290671|NCT03737123|593436069|FG000|Study Treatment|Withdrawal by Subject|2|||
164290672|NCT03737123|593436070|FG001|Study Treatment|Withdrawal by Subject|0|||
164290673|NCT03737123|593436069|FG000|Follow up|Death|1|||
164290674|NCT03737123|593436070|FG001|Follow up|Death|0|||
164290675|NCT03737123|593436069|FG000|Follow up|Withdrawal by Subject|1|||
164290676|NCT03737123|593436070|FG001|Follow up|Withdrawal by Subject|0|||
164290677|NCT03737123|593436069|FG000|Follow up|Termination of study|4|||
164290678|NCT03737123|593436070|FG001|Follow up|Termination of study|0|||
164290679|NCT01519323|593436071|FG000|Overall Study|Death|3|||
164290680|NCT01519323|593436072|FG001|Overall Study|Death|2|||
164290681|NCT01519323|593436071|FG000|Overall Study|Study terminated by sponsor|0|||
164290682|NCT01519323|593436072|FG001|Overall Study|Study terminated by sponsor|1|||
164290683|NCT00445549|593436073|FG000|Overall Study|progressive disease|12|||
164345593|NCT03095066|593640994|FG006|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
164345594|NCT03095066|593640995|FG007|Stage 1 (Baseline to Week 6)|Reason Not Specified|2|||
164345595|NCT03095066|593640988|FG000|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
164345596|NCT03095066|593640989|FG001|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
164290684|NCT03096834|593436081|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
164290685|NCT03096834|593436082|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
164290686|NCT03096834|593436083|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
164290687|NCT03096834|593436084|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
164290688|NCT03096834|593436081|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
164290689|NCT03096834|593436082|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
164345597|NCT03095066|593640990|FG002|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
164433351|NCT00335556|593957219|FG002|Overall Study|Ineligible|0|||
164290690|NCT03096834|593436083|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
164290691|NCT03096834|593436084|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
164290692|NCT03096834|593436081|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
164290693|NCT03096834|593436082|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
164290694|NCT03096834|593436083|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
164290695|NCT03096834|593436084|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
164290696|NCT03096834|593436081|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
164290697|NCT03096834|593436082|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
164290698|NCT03096834|593436083|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
164290699|NCT03096834|593436084|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
164290700|NCT03096834|593436081|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
164290701|NCT03096834|593436082|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
164290702|NCT03096834|593436083|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
164290703|NCT03096834|593436084|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
164290704|NCT03096834|593436081|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
164290705|NCT03096834|593436082|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
164290706|NCT03096834|593436083|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
164290707|NCT03096834|593436084|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
164290708|NCT03096834|593436081|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
164290709|NCT03096834|593436082|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
164290710|NCT03096834|593436083|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
164290711|NCT03096834|593436084|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
164290712|NCT03096834|593436081|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
164290713|NCT03096834|593436082|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
164290714|NCT03096834|593436083|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
164290715|NCT03096834|593436084|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
164290716|NCT03096834|593436081|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
164290717|NCT03096834|593436082|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
164290718|NCT03096834|593436083|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
164290719|NCT03096834|593436084|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
164290720|NCT03096834|593436081|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
164290721|NCT03096834|593436082|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
164290722|NCT03096834|593436083|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
164290723|NCT03096834|593436084|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
164290724|NCT03096834|593436081|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
164290725|NCT03096834|593436082|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
164290726|NCT03096834|593436083|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
164290727|NCT03096834|593436084|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
164290728|NCT03096834|593436081|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
164290729|NCT03096834|593436082|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
164290730|NCT03096834|593436083|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
164290731|NCT03096834|593436084|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
164290732|NCT01600326|593436087|FG000|Overall Study|Lost to Follow-up|1|||
164290733|NCT01600326|593436088|FG001|Overall Study|Lost to Follow-up|1|||
164290734|NCT01169103|593436094|FG000|Overall Study|Lost to Follow-up|3|||
164290735|NCT01169103|593436095|FG001|Overall Study|Lost to Follow-up|3|||
164290736|NCT01169103|593436094|FG000|Overall Study|Withdrawal by Subject|3|||
164290737|NCT01169103|593436095|FG001|Overall Study|Withdrawal by Subject|1|||
164290738|NCT06039579|593436096|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
164290739|NCT06039579|593436097|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
164290740|NCT06039579|593436098|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
164290741|NCT06039579|593436099|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
164290742|NCT06039579|593436100|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
164290743|NCT06039579|593436101|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
164290744|NCT06039579|593436102|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
164290745|NCT06039579|593436103|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
164290746|NCT02792231|593436104|FG000|Overall Study|Patient/guardian decision|32|||
164290747|NCT02792231|593436105|FG001|Overall Study|Patient/guardian decision|42|||
164290748|NCT02792231|593436104|FG000|Overall Study|Adverse Event|15|||
164290749|NCT02792231|593436105|FG001|Overall Study|Adverse Event|11|||
164290750|NCT02792231|593436104|FG000|Overall Study|Physician Decision|14|||
164290751|NCT02792231|593436105|FG001|Overall Study|Physician Decision|12|||
164290752|NCT02792231|593436104|FG000|Overall Study|Lack of Efficacy|7|||
164290753|NCT02792231|593436105|FG001|Overall Study|Lack of Efficacy|9|||
164290754|NCT02792231|593436104|FG000|Overall Study|Lost to Follow-up|9|||
164290755|NCT02792231|593436105|FG001|Overall Study|Lost to Follow-up|5|||
164290756|NCT02792231|593436104|FG000|Overall Study|Pregnancy|1|||
164290757|NCT02792231|593436105|FG001|Overall Study|Pregnancy|3|||
164290758|NCT02792231|593436104|FG000|Overall Study|Non-compliance with study treatment|2|||
164290759|NCT02792231|593436105|FG001|Overall Study|Non-compliance with study treatment|1|||
164290760|NCT02792231|593436104|FG000|Overall Study|Protocol deviation|2|||
164290761|NCT02792231|593436105|FG001|Overall Study|Protocol deviation|0|||
164290762|NCT02792231|593436104|FG000|Overall Study|Technical problems|0|||
164433352|NCT00335556|593957220|FG003|Overall Study|Ineligible|0|||
164586771|NCT02975349|594511917|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164290763|NCT02792231|593436105|FG001|Overall Study|Technical problems|1|||
164290764|NCT03309878|593436106|FG000|Overall Study|Adverse Event|1|||
164290765|NCT03309878|593436107|FG001|Overall Study|Adverse Event|0|||
164290766|NCT03309878|593436108|FG002|Overall Study|Adverse Event|0|||
164290767|NCT03309878|593436109|FG003|Overall Study|Adverse Event|0|||
164290768|NCT03309878|593436106|FG000|Overall Study|Did not maintain eligibility|2|||
164586772|NCT02975349|594511918|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
164586773|NCT02975349|594511919|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
164586774|NCT02975349|594511920|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164586775|NCT02975349|594511921|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164586776|NCT02975349|594511915|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
164586777|NCT02975349|594511916|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164586778|NCT02975349|594511917|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164586779|NCT02975349|594511918|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164586780|NCT02975349|594511919|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164586781|NCT02975349|594511920|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164586782|NCT02975349|594511921|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164586783|NCT02975349|594511915|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
164586784|NCT02975349|594511916|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
164586785|NCT02975349|594511917|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
164586786|NCT02975349|594511918|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
164586787|NCT02975349|594511919|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
164586788|NCT02975349|594511920|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
164586789|NCT02975349|594511921|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
164290769|NCT03309878|593436107|FG001|Overall Study|Did not maintain eligibility|1|||
164290770|NCT03309878|593436108|FG002|Overall Study|Did not maintain eligibility|0|||
164290771|NCT03309878|593436109|FG003|Overall Study|Did not maintain eligibility|0|||
164290772|NCT03309878|593436106|FG000|Overall Study|Withdrawal by Subject|0|||
164290773|NCT03309878|593436107|FG001|Overall Study|Withdrawal by Subject|1|||
164290774|NCT03309878|593436108|FG002|Overall Study|Withdrawal by Subject|0|||
164290775|NCT03309878|593436109|FG003|Overall Study|Withdrawal by Subject|0|||
164290776|NCT00657046|593436115|FG000|Overall Study|Adverse Event|1|||
164290777|NCT00657046|593436116|FG001|Overall Study|Adverse Event|1|||
164290778|NCT00657046|593436117|FG002|Overall Study|Adverse Event|0|||
164290779|NCT00657046|593436115|FG000|Overall Study|Protocol Violation|2|||
164290780|NCT00657046|593436116|FG001|Overall Study|Protocol Violation|2|||
164290781|NCT00657046|593436117|FG002|Overall Study|Protocol Violation|0|||
164290782|NCT00657046|593436115|FG000|Overall Study|Withdrawal by Subject|1|||
164290783|NCT00657046|593436116|FG001|Overall Study|Withdrawal by Subject|0|||
164290784|NCT00657046|593436117|FG002|Overall Study|Withdrawal by Subject|0|||
164290785|NCT00657046|593436115|FG000|Overall Study|Death|0|||
164290786|NCT00657046|593436116|FG001|Overall Study|Death|0|||
164345598|NCT03095066|593640991|FG003|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
164345599|NCT03095066|593640992|FG004|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
164345600|NCT03095066|593640993|FG005|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
164345601|NCT03095066|593640994|FG006|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
164345602|NCT03095066|593640995|FG007|Stage 1 (Baseline to Week 6)|Physician Decision|1|||
164345603|NCT03095066|593640988|FG000|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
164345604|NCT03095066|593640989|FG001|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
164345605|NCT03095066|593640990|FG002|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
164345606|NCT03095066|593640991|FG003|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
164345607|NCT03095066|593640992|FG004|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
164345608|NCT03095066|593640993|FG005|Stage 2 (Week 7 to Week 12)|Adverse Event|1|||
164345609|NCT03095066|593640994|FG006|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
164345610|NCT03095066|593640995|FG007|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
164345611|NCT03095066|593640988|FG000|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
164345612|NCT03095066|593640989|FG001|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
164345613|NCT03095066|593640990|FG002|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
164345614|NCT03095066|593640991|FG003|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
164345615|NCT03095066|593640992|FG004|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|1|||
164345616|NCT03095066|593640993|FG005|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
164345617|NCT03095066|593640994|FG006|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|2|||
164345618|NCT03095066|593640995|FG007|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
164345619|NCT03095066|593640988|FG000|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
164345620|NCT03095066|593640989|FG001|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
164290787|NCT00657046|593436117|FG002|Overall Study|Death|1|||
164290788|NCT00657046|593436115|FG000|Overall Study|Surgery|0|||
164290789|NCT00657046|593436116|FG001|Overall Study|Surgery|0|||
164290790|NCT00657046|593436117|FG002|Overall Study|Surgery|1|||
164290791|NCT03827655|593436128|FG000|Overall Study|Death|0|||
164290792|NCT03827655|593436129|FG001|Overall Study|Death|0|||
164290793|NCT03827655|593436130|FG002|Overall Study|Death|0|||
164290794|NCT03827655|593436131|FG003|Overall Study|Death|0|||
164290795|NCT03827655|593436132|FG004|Overall Study|Death|1|||
164290796|NCT03827655|593436128|FG000|Overall Study|Protocol Deviation|1|||
164290797|NCT03827655|593436129|FG001|Overall Study|Protocol Deviation|0|||
164290798|NCT03827655|593436130|FG002|Overall Study|Protocol Deviation|1|||
164290799|NCT03827655|593436131|FG003|Overall Study|Protocol Deviation|1|||
164290800|NCT03827655|593436132|FG004|Overall Study|Protocol Deviation|0|||
164290801|NCT03827655|593436128|FG000|Overall Study|Withdrawal by Subject|3|||
164290802|NCT03827655|593436129|FG001|Overall Study|Withdrawal by Subject|2|||
164290803|NCT03827655|593436130|FG002|Overall Study|Withdrawal by Subject|2|||
164290804|NCT03827655|593436131|FG003|Overall Study|Withdrawal by Subject|0|||
164290805|NCT03827655|593436132|FG004|Overall Study|Withdrawal by Subject|1|||
164290806|NCT03827655|593436128|FG000|Overall Study|Reason not Specified|3|||
164290807|NCT03827655|593436129|FG001|Overall Study|Reason not Specified|1|||
164290808|NCT03827655|593436130|FG002|Overall Study|Reason not Specified|1|||
164290809|NCT03827655|593436131|FG003|Overall Study|Reason not Specified|1|||
164290810|NCT03827655|593436132|FG004|Overall Study|Reason not Specified|1|||
164290811|NCT03935126|593436135|FG000|Overall Study|Study termination by sponsor|3|||
164290812|NCT01092728|593436136|FG000|Overall Study|Withdrawal by Subject|2|||
164290813|NCT01092728|593436137|FG001|Overall Study|Withdrawal by Subject|0|||
164290814|NCT01092728|593436136|FG000|Overall Study|Adverse Event|0|||
164290815|NCT01092728|593436137|FG001|Overall Study|Adverse Event|1|||
164290816|NCT01092728|593436136|FG000|Overall Study|Disease Progression|1|||
164290817|NCT01092728|593436137|FG001|Overall Study|Disease Progression|13|||
164290818|NCT01092728|593436136|FG000|Overall Study|Prohibited Concomitant Medications|1|||
164290819|NCT01092728|593436137|FG001|Overall Study|Prohibited Concomitant Medications|0|||
164290820|NCT02336607|593436138|FG000|Overall Study|Physician Decision|1|||
164290821|NCT02336607|593436139|FG001|Overall Study|Physician Decision|4|||
164290822|NCT02336607|593436140|FG002|Overall Study|Physician Decision|3|||
164290823|NCT02336607|593436141|FG003|Overall Study|Physician Decision|15|||
164290824|NCT02336607|593436138|FG000|Overall Study|Lack of Efficacy|1|||
164290825|NCT02336607|593436139|FG001|Overall Study|Lack of Efficacy|0|||
164290826|NCT02336607|593436140|FG002|Overall Study|Lack of Efficacy|0|||
164290827|NCT02336607|593436141|FG003|Overall Study|Lack of Efficacy|2|||
164290828|NCT02336607|593436138|FG000|Overall Study|Lost to Follow-up|2|||
164290829|NCT02336607|593436139|FG001|Overall Study|Lost to Follow-up|1|||
164290830|NCT02336607|593436140|FG002|Overall Study|Lost to Follow-up|0|||
164290831|NCT02336607|593436141|FG003|Overall Study|Lost to Follow-up|21|||
164290832|NCT02336607|593436138|FG000|Overall Study|Protocol Violation|0|||
164290833|NCT02336607|593436139|FG001|Overall Study|Protocol Violation|1|||
164290834|NCT02336607|593436140|FG002|Overall Study|Protocol Violation|1|||
164290835|NCT02336607|593436141|FG003|Overall Study|Protocol Violation|3|||
164290836|NCT02336607|593436138|FG000|Overall Study|Adverse Event|0|||
164290837|NCT02336607|593436139|FG001|Overall Study|Adverse Event|2|||
164290838|NCT02336607|593436140|FG002|Overall Study|Adverse Event|2|||
164290839|NCT02336607|593436141|FG003|Overall Study|Adverse Event|26|||
164290840|NCT02336607|593436138|FG000|Overall Study|Withdrawal by Subject|0|||
164290841|NCT02336607|593436139|FG001|Overall Study|Withdrawal by Subject|2|||
164290842|NCT02336607|593436140|FG002|Overall Study|Withdrawal by Subject|0|||
164290843|NCT02336607|593436141|FG003|Overall Study|Withdrawal by Subject|20|||
164290844|NCT01454596|593436147|FG000|Overall Study|Death|0|||
164290845|NCT01454596|593436148|FG001|Overall Study|Death|0|||
164290846|NCT01454596|593436149|FG002|Overall Study|Death|0|||
164290847|NCT01454596|593436150|FG003|Overall Study|Death|0|||
164290848|NCT01454596|593436151|FG004|Overall Study|Death|0|||
164290849|NCT01454596|593436152|FG005|Overall Study|Death|0|||
164290850|NCT01454596|593436153|FG006|Overall Study|Death|0|||
164290851|NCT01454596|593436154|FG007|Overall Study|Death|0|||
164290852|NCT01454596|593436155|FG008|Overall Study|Death|0|||
164290853|NCT01454596|593436156|FG009|Overall Study|Death|1|||
164290854|NCT01454596|593436157|FG010|Overall Study|Death|1|||
164290855|NCT01454596|593436158|FG011|Overall Study|Death|0|||
164290856|NCT03318549|593436170|FG000|Overall Study|Withdrawal by Subject|5|||
164586790|NCT02975349|594511915|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
164290857|NCT03318549|593436171|FG001|Overall Study|Withdrawal by Subject|19|||
164290858|NCT03318549|593436172|FG002|Overall Study|Withdrawal by Subject|2|||
164290859|NCT03318549|593436173|FG003|Overall Study|Withdrawal by Subject|0|||
164290860|NCT03318549|593436174|FG004|Overall Study|Withdrawal by Subject|0|||
164290861|NCT03318549|593436175|FG005|Overall Study|Withdrawal by Subject|0|||
164290862|NCT03318549|593436176|FG006|Overall Study|Withdrawal by Subject|0|||
164290863|NCT03318549|593436170|FG000|Overall Study|Physician Decision|0|||
164290864|NCT03318549|593436171|FG001|Overall Study|Physician Decision|4|||
164290865|NCT03318549|593436172|FG002|Overall Study|Physician Decision|1|||
164290866|NCT03318549|593436173|FG003|Overall Study|Physician Decision|0|||
164290867|NCT03318549|593436174|FG004|Overall Study|Physician Decision|0|||
164290868|NCT03318549|593436175|FG005|Overall Study|Physician Decision|0|||
164290869|NCT03318549|593436176|FG006|Overall Study|Physician Decision|0|||
164290870|NCT03318549|593436170|FG000|Overall Study|Lost to Follow-up|0|||
164290871|NCT03318549|593436171|FG001|Overall Study|Lost to Follow-up|3|||
164290872|NCT03318549|593436172|FG002|Overall Study|Lost to Follow-up|3|||
164290873|NCT03318549|593436173|FG003|Overall Study|Lost to Follow-up|0|||
164290874|NCT03318549|593436174|FG004|Overall Study|Lost to Follow-up|0|||
164290875|NCT03318549|593436175|FG005|Overall Study|Lost to Follow-up|0|||
164290876|NCT03318549|593436176|FG006|Overall Study|Lost to Follow-up|0|||
164290877|NCT00104650|593436177|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
164290878|NCT00104650|593436178|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
164290879|NCT00104650|593436179|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
164290880|NCT00104650|593436177|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
164290881|NCT00104650|593436178|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
164290882|NCT00104650|593436179|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
164290883|NCT00104650|593436177|FG000|Treatment Period (25 Weeks)|Death|7|||
164290884|NCT00104650|593436178|FG001|Treatment Period (25 Weeks)|Death|5|||
164290885|NCT00104650|593436179|FG002|Treatment Period (25 Weeks)|Death|6|||
164290886|NCT00104650|593436177|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
164290887|NCT00104650|593436178|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
164290888|NCT00104650|593436179|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
164290889|NCT00104650|593436177|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
164290890|NCT00104650|593436178|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
164290891|NCT00104650|593436179|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
164290892|NCT00104650|593436177|FG000|Treatment Period (25 Weeks)|Other|1|||
164290893|NCT00104650|593436178|FG001|Treatment Period (25 Weeks)|Other|0|||
164290894|NCT00104650|593436179|FG002|Treatment Period (25 Weeks)|Other|0|||
164290895|NCT00104650|593436177|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
164290896|NCT00104650|593436178|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
164290897|NCT00104650|593436179|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
164290898|NCT00104650|593436177|FG000|Follow-up Period|Physician Decision|1|||
164290899|NCT00104650|593436178|FG001|Follow-up Period|Physician Decision|1|||
164290900|NCT00104650|593436179|FG002|Follow-up Period|Physician Decision|0|||
164290901|NCT00104650|593436177|FG000|Follow-up Period|Adverse Event|1|||
164290902|NCT00104650|593436178|FG001|Follow-up Period|Adverse Event|0|||
164290903|NCT00104650|593436179|FG002|Follow-up Period|Adverse Event|1|||
164290904|NCT00104650|593436177|FG000|Follow-up Period|Withdrawal by Subject|0|||
164290905|NCT00104650|593436178|FG001|Follow-up Period|Withdrawal by Subject|3|||
164290906|NCT00104650|593436179|FG002|Follow-up Period|Withdrawal by Subject|3|||
164290907|NCT00104650|593436177|FG000|Follow-up Period|Death|6|||
164290908|NCT00104650|593436178|FG001|Follow-up Period|Death|6|||
164290909|NCT00104650|593436179|FG002|Follow-up Period|Death|4|||
164290910|NCT00104650|593436177|FG000|Follow-up Period|Disease progression|3|||
164290911|NCT00104650|593436178|FG001|Follow-up Period|Disease progression|1|||
164290912|NCT00104650|593436179|FG002|Follow-up Period|Disease progression|0|||
164290913|NCT00104650|593436177|FG000|Follow-up Period|Lost to Follow-up|0|||
164290914|NCT00104650|593436178|FG001|Follow-up Period|Lost to Follow-up|1|||
164290915|NCT00104650|593436179|FG002|Follow-up Period|Lost to Follow-up|2|||
164290916|NCT00104650|593436177|FG000|Follow-up Period|Other|0|||
164290917|NCT00104650|593436178|FG001|Follow-up Period|Other|1|||
164290918|NCT00104650|593436179|FG002|Follow-up Period|Other|0|||
164290919|NCT03515824|593436180|FG000|Overall Study|Death|3|||
164290920|NCT03515824|593436181|FG001|Overall Study|Death|2|||
164290921|NCT03515824|593436182|FG002|Overall Study|Death|6|||
164290922|NCT03515824|593436183|FG003|Overall Study|Death|0|||
164290923|NCT03515824|593436180|FG000|Overall Study|Lost to Follow-up|0|||
164290924|NCT03515824|593436181|FG001|Overall Study|Lost to Follow-up|1|||
164290925|NCT03515824|593436182|FG002|Overall Study|Lost to Follow-up|1|||
164290926|NCT03515824|593436183|FG003|Overall Study|Lost to Follow-up|0|||
164290927|NCT03515824|593436180|FG000|Overall Study|Study terminated by sponsor|0|||
164290928|NCT03515824|593436181|FG001|Overall Study|Study terminated by sponsor|1|||
164290929|NCT03515824|593436182|FG002|Overall Study|Study terminated by sponsor|6|||
164290930|NCT03515824|593436183|FG003|Overall Study|Study terminated by sponsor|0|||
164290931|NCT03515824|593436180|FG000|Overall Study|Status not recorded|0|||
164290932|NCT03515824|593436181|FG001|Overall Study|Status not recorded|0|||
164290933|NCT03515824|593436182|FG002|Overall Study|Status not recorded|2|||
164290934|NCT03515824|593436183|FG003|Overall Study|Status not recorded|0|||
164290935|NCT03084796|593436185|FG000|Overall Study|Adverse Event|4|||
164290936|NCT03084796|593436186|FG001|Overall Study|Adverse Event|5|||
164290937|NCT03084796|593436187|FG002|Overall Study|Adverse Event|6|||
164290938|NCT03084796|593436188|FG003|Overall Study|Adverse Event|2|||
164290939|NCT03084796|593436189|FG004|Overall Study|Adverse Event|3|||
164290940|NCT03084796|593436190|FG005|Overall Study|Adverse Event|5|||
164290941|NCT03084796|593436185|FG000|Overall Study|Withdrawal by Subject|3|||
164290942|NCT03084796|593436186|FG001|Overall Study|Withdrawal by Subject|5|||
164290943|NCT03084796|593436187|FG002|Overall Study|Withdrawal by Subject|2|||
164290944|NCT03084796|593436188|FG003|Overall Study|Withdrawal by Subject|1|||
164290945|NCT03084796|593436189|FG004|Overall Study|Withdrawal by Subject|3|||
164290946|NCT03084796|593436190|FG005|Overall Study|Withdrawal by Subject|0|||
164290947|NCT03084796|593436185|FG000|Overall Study|Protocol Violation|0|||
164290948|NCT03084796|593436186|FG001|Overall Study|Protocol Violation|0|||
164290949|NCT03084796|593436187|FG002|Overall Study|Protocol Violation|1|||
164290950|NCT03084796|593436188|FG003|Overall Study|Protocol Violation|0|||
164290951|NCT03084796|593436189|FG004|Overall Study|Protocol Violation|1|||
164290952|NCT03084796|593436190|FG005|Overall Study|Protocol Violation|1|||
164290953|NCT03084796|593436185|FG000|Overall Study|Lack of Efficacy|0|||
164290954|NCT03084796|593436186|FG001|Overall Study|Lack of Efficacy|0|||
164290955|NCT03084796|593436187|FG002|Overall Study|Lack of Efficacy|1|||
164290956|NCT03084796|593436188|FG003|Overall Study|Lack of Efficacy|0|||
164290957|NCT03084796|593436189|FG004|Overall Study|Lack of Efficacy|1|||
164290958|NCT03084796|593436190|FG005|Overall Study|Lack of Efficacy|0|||
164290959|NCT03084796|593436185|FG000|Overall Study|Lost to Follow-up|0|||
164290960|NCT03084796|593436186|FG001|Overall Study|Lost to Follow-up|0|||
164290961|NCT03084796|593436187|FG002|Overall Study|Lost to Follow-up|1|||
164290962|NCT03084796|593436188|FG003|Overall Study|Lost to Follow-up|1|||
164290963|NCT03084796|593436189|FG004|Overall Study|Lost to Follow-up|3|||
164290964|NCT03084796|593436190|FG005|Overall Study|Lost to Follow-up|1|||
164290965|NCT03084796|593436185|FG000|Overall Study|Randomization error|0|||
164290966|NCT03084796|593436186|FG001|Overall Study|Randomization error|0|||
164290967|NCT03084796|593436187|FG002|Overall Study|Randomization error|1|||
164290968|NCT03084796|593436188|FG003|Overall Study|Randomization error|0|||
164290969|NCT03084796|593436189|FG004|Overall Study|Randomization error|0|||
164290970|NCT03084796|593436190|FG005|Overall Study|Randomization error|0|||
164290971|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
164290972|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
164290973|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
164290974|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
164290975|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
164290976|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
164290977|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
164290978|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
164290979|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
164290980|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
164290981|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
164290982|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
164290983|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
164290984|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
164290985|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
164290986|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
164290987|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
164290988|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
164290989|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
164290990|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
164290991|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
164290992|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
164290993|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
164345621|NCT03095066|593640990|FG002|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
164290994|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
164290995|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
164290996|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
164290997|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
164290998|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
164290999|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
164291000|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
164291001|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
164291002|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
164291003|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
164291004|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
164291005|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
164291006|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
164291007|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
164291008|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
164291009|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
164291010|NCT02586623|593436191|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
164291011|NCT02586623|593436192|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
164291012|NCT02586623|593436193|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
164291013|NCT02586623|593436191|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
164291014|NCT02586623|593436192|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
164291015|NCT02586623|593436193|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
164291016|NCT02586623|593436191|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
164291017|NCT02586623|593436192|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
164291018|NCT02586623|593436193|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
164291019|NCT02586623|593436191|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
164291020|NCT02586623|593436192|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
164291021|NCT02586623|593436193|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
164291022|NCT02586623|593436191|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
164291023|NCT02586623|593436192|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
164291024|NCT02586623|593436193|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
164291025|NCT02586623|593436191|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
164433353|NCT00335556|593957221|FG004|Overall Study|Ineligible|0|||
164433354|NCT00335556|593957222|FG005|Overall Study|Ineligible|0|||
164433355|NCT00335556|593957217|FG000|Overall Study|Refusal of further protocol therapy|0|||
164433356|NCT00335556|593957218|FG001|Overall Study|Refusal of further protocol therapy|4|||
164433357|NCT00335556|593957219|FG002|Overall Study|Refusal of further protocol therapy|0|||
164433358|NCT00335556|593957220|FG003|Overall Study|Refusal of further protocol therapy|1|||
164433359|NCT00335556|593957221|FG004|Overall Study|Refusal of further protocol therapy|0|||
164433360|NCT00335556|593957222|FG005|Overall Study|Refusal of further protocol therapy|0|||
164433361|NCT01674569|593957223|FG000|Overall Study|Adverse Event|0|||
164433362|NCT01674569|593957224|FG001|Overall Study|Adverse Event|2|||
164433363|NCT01674569|593957225|FG002|Overall Study|Adverse Event|0|||
164433364|NCT01674569|593957226|FG003|Overall Study|Adverse Event|1|||
164433365|NCT01674569|593957227|FG004|Overall Study|Adverse Event|2|||
164433366|NCT01674569|593957228|FG005|Overall Study|Adverse Event|2|||
164433367|NCT01674569|593957223|FG000|Overall Study|Protocol Violation|0|||
164433368|NCT01674569|593957224|FG001|Overall Study|Protocol Violation|1|||
164433369|NCT01674569|593957225|FG002|Overall Study|Protocol Violation|1|||
164433370|NCT01674569|593957226|FG003|Overall Study|Protocol Violation|0|||
164433371|NCT01674569|593957227|FG004|Overall Study|Protocol Violation|0|||
164433372|NCT01674569|593957228|FG005|Overall Study|Protocol Violation|0|||
164433373|NCT01674569|593957223|FG000|Overall Study|Withdrawal by Subject|0|||
164433374|NCT01674569|593957224|FG001|Overall Study|Withdrawal by Subject|0|||
164433375|NCT01674569|593957225|FG002|Overall Study|Withdrawal by Subject|1|||
164433376|NCT01674569|593957226|FG003|Overall Study|Withdrawal by Subject|0|||
164433377|NCT01674569|593957227|FG004|Overall Study|Withdrawal by Subject|0|||
164433378|NCT01674569|593957228|FG005|Overall Study|Withdrawal by Subject|0|||
164433379|NCT02365298|593957236|FG000|Period 2|incorrect Rx dispensed|1|||
164433380|NCT02365298|593957237|FG001|Period 2|incorrect Rx dispensed|0|||
164433381|NCT02365298|593957236|FG000|Period 2|Discontinued at request of Sponsor|1|||
164433382|NCT02365298|593957237|FG001|Period 2|Discontinued at request of Sponsor|0|||
164433383|NCT02365298|593957236|FG000|Period 2|Test Article longer available|0|||
164433384|NCT02365298|593957237|FG001|Period 2|Test Article longer available|1|||
164433385|NCT02365298|593957236|FG000|Period 2|Protocol Violation|0|||
164433386|NCT02365298|593957237|FG001|Period 2|Protocol Violation|1|||
164433387|NCT02846415|593957238|FG000|Overall Study|Lost to Follow-up|2|||
164433388|NCT02846415|593957239|FG001|Overall Study|Lost to Follow-up|0|||
164433389|NCT02846415|593957238|FG000|Overall Study|Withdrawal by Subject|1|||
164433390|NCT02846415|593957239|FG001|Overall Study|Withdrawal by Subject|1|||
164433391|NCT03404843|593957240|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
164433392|NCT03404843|593957241|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
164433393|NCT00567164|593957242|FG000|Overall Study|Withdrawal by Subject|171|||
164433394|NCT00567164|593957243|FG001|Overall Study|Withdrawal by Subject|21|||
164433395|NCT00567164|593957244|FG002|Overall Study|Withdrawal by Subject|17|||
164433396|NCT00567164|593957242|FG000|Overall Study|Protocol Violation|23|||
164433397|NCT00567164|593957243|FG001|Overall Study|Protocol Violation|4|||
164433398|NCT00567164|593957244|FG002|Overall Study|Protocol Violation|2|||
164433399|NCT00567164|593957242|FG000|Overall Study|Adverse Event|92|||
164433400|NCT00567164|593957243|FG001|Overall Study|Adverse Event|13|||
164291026|NCT02586623|593436192|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
164291027|NCT02586623|593436193|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
164291028|NCT02586623|593436191|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
164291029|NCT02586623|593436192|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
164291030|NCT02586623|593436193|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
164291031|NCT02586623|593436191|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
164291032|NCT02586623|593436192|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
164291033|NCT02586623|593436193|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
164291034|NCT03799341|593436194|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
164291035|NCT03799341|593436195|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
164291036|NCT03799341|593436196|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
164291037|NCT03799341|593436194|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
164291038|NCT03799341|593436195|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
164291039|NCT03799341|593436196|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
164291040|NCT03799341|593436194|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
164291041|NCT03799341|593436195|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
164291042|NCT03799341|593436196|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
164291043|NCT03799341|593436194|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
164291044|NCT03799341|593436195|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
164291045|NCT03799341|593436196|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
164291046|NCT03799341|593436194|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
164291047|NCT03799341|593436195|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
164291048|NCT03799341|593436196|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
164291049|NCT03799341|593436194|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
164291050|NCT03799341|593436195|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
164291051|NCT03799341|593436196|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
164291052|NCT03064490|593436197|FG000|Overall Study|Physician Decision|5|||
164291053|NCT05579977|593436202|FG000|Treatment Phase|Other|0|||
164291054|NCT05579977|593436203|FG001|Treatment Phase|Other|0|||
164291055|NCT05579977|593436204|FG002|Treatment Phase|Other|0|||
164291056|NCT05579977|593436205|FG003|Treatment Phase|Other|2|||
164291057|NCT05579977|593436206|FG004|Treatment Phase|Other|1|||
164291058|NCT05579977|593436207|FG005|Treatment Phase|Other|2|||
164291059|NCT05579977|593436208|FG006|Treatment Phase|Other|1|||
164291060|NCT05579977|593436209|FG007|Treatment Phase|Other|2|||
164291061|NCT05579977|593436210|FG008|Treatment Phase|Other|2|||
164291062|NCT05579977|593436211|FG009|Treatment Phase|Other|1|||
164291063|NCT05579977|593436212|FG010|Treatment Phase|Other|0|||
164291064|NCT05579977|593436213|FG011|Treatment Phase|Other|0|||
164291065|NCT05579977|593436214|FG012|Treatment Phase|Other|3|||
164291066|NCT05579977|593436202|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
164291067|NCT05579977|593436203|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
164291068|NCT05579977|593436204|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
164291069|NCT05579977|593436205|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
164291070|NCT05579977|593436206|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
164291071|NCT05579977|593436207|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
164291072|NCT05579977|593436208|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
164291073|NCT05579977|593436209|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
164291074|NCT05579977|593436210|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
164291075|NCT05579977|593436211|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
164291076|NCT05579977|593436212|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
164291077|NCT05579977|593436213|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
164291078|NCT05579977|593436214|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
164291079|NCT05579977|593436202|FG000|Treatment Phase|Withdrawal by Subject|2|||
164291080|NCT05579977|593436203|FG001|Treatment Phase|Withdrawal by Subject|0|||
164291081|NCT05579977|593436204|FG002|Treatment Phase|Withdrawal by Subject|0|||
164291082|NCT05579977|593436205|FG003|Treatment Phase|Withdrawal by Subject|1|||
164291083|NCT05579977|593436206|FG004|Treatment Phase|Withdrawal by Subject|2|||
164291084|NCT05579977|593436207|FG005|Treatment Phase|Withdrawal by Subject|0|||
164291085|NCT05579977|593436208|FG006|Treatment Phase|Withdrawal by Subject|1|||
164291086|NCT05579977|593436209|FG007|Treatment Phase|Withdrawal by Subject|8|||
164291087|NCT05579977|593436210|FG008|Treatment Phase|Withdrawal by Subject|3|||
164345622|NCT03095066|593640991|FG003|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
164345623|NCT03095066|593640992|FG004|Stage 2 (Week 7 to Week 12)|Protocol Deviation|1|||
164345624|NCT03095066|593640993|FG005|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
164345625|NCT03095066|593640994|FG006|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
164345626|NCT03095066|593640995|FG007|Stage 2 (Week 7 to Week 12)|Protocol Deviation|2|||
164345627|NCT03095066|593640988|FG000|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
164345628|NCT03095066|593640989|FG001|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
164433401|NCT00567164|593957244|FG002|Overall Study|Adverse Event|9|||
164433402|NCT00567164|593957242|FG000|Overall Study|Death|0|||
164433403|NCT00567164|593957243|FG001|Overall Study|Death|0|||
164433404|NCT00567164|593957244|FG002|Overall Study|Death|1|||
164433405|NCT00567164|593957242|FG000|Overall Study|Lost to Follow-up|202|||
164433406|NCT00567164|593957243|FG001|Overall Study|Lost to Follow-up|23|||
164433407|NCT00567164|593957244|FG002|Overall Study|Lost to Follow-up|21|||
164433408|NCT00567164|593957242|FG000|Overall Study|Pregnancy|20|||
164433409|NCT00567164|593957243|FG001|Overall Study|Pregnancy|4|||
164433410|NCT00567164|593957244|FG002|Overall Study|Pregnancy|6|||
164433411|NCT00567164|593957242|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
164433412|NCT00567164|593957243|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
164433413|NCT00567164|593957244|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
164433414|NCT00567164|593957242|FG000|Overall Study|Missing|1|||
164433415|NCT00567164|593957243|FG001|Overall Study|Missing|0|||
164433416|NCT00567164|593957244|FG002|Overall Study|Missing|0|||
164433417|NCT02322216|593957253|FG000|Overall Study|Adverse Event|1|||
164433418|NCT02322216|593957254|FG001|Overall Study|Adverse Event|0|||
164433419|NCT02322216|593957253|FG000|Overall Study|Withdrawal by Subject|1|||
164433420|NCT02322216|593957254|FG001|Overall Study|Withdrawal by Subject|4|||
164433421|NCT00404079|593957259|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
164433422|NCT00404079|593957260|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
164433423|NCT00580801|593957265|FG000|Overall Study|Physician Decision|1|||
164433424|NCT00580801|593957266|FG001|Overall Study|Physician Decision|0|||
164433425|NCT00580801|593957267|FG002|Overall Study|Physician Decision|0|||
164433426|NCT00580801|593957265|FG000|Overall Study|Adverse Event|2|||
164433427|NCT00580801|593957266|FG001|Overall Study|Adverse Event|0|||
164433428|NCT00580801|593957267|FG002|Overall Study|Adverse Event|0|||
164433429|NCT00580801|593957265|FG000|Overall Study|Lost to Follow-up|2|||
164433430|NCT00580801|593957266|FG001|Overall Study|Lost to Follow-up|0|||
164433431|NCT00580801|593957267|FG002|Overall Study|Lost to Follow-up|0|||
164433432|NCT00580801|593957265|FG000|Overall Study|Reached a virologic endpoint|0|||
164433433|NCT00580801|593957266|FG001|Overall Study|Reached a virologic endpoint|1|||
164433434|NCT00580801|593957267|FG002|Overall Study|Reached a virologic endpoint|2|||
164433435|NCT00580801|593957265|FG000|Overall Study|Participant non-compliant|0|||
164433436|NCT00580801|593957266|FG001|Overall Study|Participant non-compliant|0|||
164433437|NCT00580801|593957267|FG002|Overall Study|Participant non-compliant|1|||
164433438|NCT00580801|593957265|FG000|Overall Study|Travel|1|||
164433439|NCT00580801|593957266|FG001|Overall Study|Travel|0|||
164433440|NCT00580801|593957267|FG002|Overall Study|Travel|0|||
164433441|NCT02595398|593957268|FG000|Overall Study|Non-compliance|1|||
164433442|NCT02595398|593957269|FG001|Overall Study|Non-compliance|0|||
164433443|NCT02595398|593957268|FG000|Overall Study|Withdrawal by Subject|2|||
164433444|NCT02595398|593957269|FG001|Overall Study|Withdrawal by Subject|1|||
164433445|NCT02595398|593957268|FG000|Overall Study|Lost to Follow-up|1|||
164433446|NCT02595398|593957269|FG001|Overall Study|Lost to Follow-up|0|||
164433447|NCT00502593|593957270|FG000|Overall Study|Withdrawn unspecified reason|1|||
164291088|NCT05579977|593436211|FG009|Treatment Phase|Withdrawal by Subject|3|||
164291089|NCT05579977|593436212|FG010|Treatment Phase|Withdrawal by Subject|5|||
164291090|NCT05579977|593436213|FG011|Treatment Phase|Withdrawal by Subject|1|||
164291091|NCT05579977|593436214|FG012|Treatment Phase|Withdrawal by Subject|3|||
164291092|NCT05579977|593436202|FG000|Treatment Phase|Study terminated by sponsor|70|||
164291093|NCT05579977|593436203|FG001|Treatment Phase|Study terminated by sponsor|70|||
164291094|NCT05579977|593436204|FG002|Treatment Phase|Study terminated by sponsor|61|||
164291095|NCT05579977|593436205|FG003|Treatment Phase|Study terminated by sponsor|59|||
164291096|NCT05579977|593436206|FG004|Treatment Phase|Study terminated by sponsor|63|||
164291097|NCT05579977|593436207|FG005|Treatment Phase|Study terminated by sponsor|53|||
164433448|NCT00502593|593957271|FG001|Overall Study|Withdrawn unspecified reason|1|||
164433449|NCT00502593|593957272|FG002|Overall Study|Withdrawn unspecified reason|3|||
164433450|NCT00502593|593957273|FG003|Overall Study|Withdrawn unspecified reason|1|||
164433451|NCT00502593|593957274|FG004|Overall Study|Withdrawn unspecified reason|2|||
164433452|NCT00502593|593957275|FG005|Overall Study|Withdrawn unspecified reason|0|||
164433453|NCT00502593|593957276|FG006|Overall Study|Withdrawn unspecified reason|2|||
164433454|NCT00502593|593957277|FG007|Overall Study|Withdrawn unspecified reason|0|||
164433455|NCT00502593|593957278|FG008|Overall Study|Withdrawn unspecified reason|0|||
164433456|NCT00502593|593957279|FG009|Overall Study|Withdrawn unspecified reason|0|||
164433457|NCT00502593|593957280|FG010|Overall Study|Withdrawn unspecified reason|0|||
164433458|NCT00502593|593957281|FG011|Overall Study|Withdrawn unspecified reason|0|||
164433459|NCT00502593|593957270|FG000|Overall Study|Withdrawal by Subject|0|||
164433460|NCT00502593|593957271|FG001|Overall Study|Withdrawal by Subject|0|||
164433461|NCT00502593|593957272|FG002|Overall Study|Withdrawal by Subject|6|||
164433462|NCT00502593|593957273|FG003|Overall Study|Withdrawal by Subject|2|||
164433463|NCT00502593|593957274|FG004|Overall Study|Withdrawal by Subject|2|||
164433464|NCT00502593|593957275|FG005|Overall Study|Withdrawal by Subject|0|||
164433465|NCT00502593|593957276|FG006|Overall Study|Withdrawal by Subject|3|||
164433466|NCT00502593|593957277|FG007|Overall Study|Withdrawal by Subject|0|||
164433467|NCT00502593|593957278|FG008|Overall Study|Withdrawal by Subject|3|||
164291098|NCT05579977|593436208|FG006|Treatment Phase|Study terminated by sponsor|66|||
164291099|NCT05579977|593436209|FG007|Treatment Phase|Study terminated by sponsor|48|||
164291100|NCT05579977|593436210|FG008|Treatment Phase|Study terminated by sponsor|47|||
164291101|NCT05579977|593436211|FG009|Treatment Phase|Study terminated by sponsor|37|||
164291102|NCT05579977|593436212|FG010|Treatment Phase|Study terminated by sponsor|44|||
164291103|NCT05579977|593436213|FG011|Treatment Phase|Study terminated by sponsor|36|||
164291104|NCT05579977|593436214|FG012|Treatment Phase|Study terminated by sponsor|32|||
164291105|NCT05579977|593436202|FG000|Treatment Phase|Pregnancy|0|||
164291106|NCT05579977|593436203|FG001|Treatment Phase|Pregnancy|0|||
164291107|NCT05579977|593436204|FG002|Treatment Phase|Pregnancy|0|||
164291108|NCT05579977|593436205|FG003|Treatment Phase|Pregnancy|0|||
164291109|NCT05579977|593436206|FG004|Treatment Phase|Pregnancy|0|||
164345629|NCT03095066|593640990|FG002|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
164345630|NCT03095066|593640991|FG003|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
164345631|NCT03095066|593640992|FG004|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|2|||
164345632|NCT03095066|593640993|FG005|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
164345633|NCT03095066|593640994|FG006|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
164345634|NCT03095066|593640995|FG007|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|1|||
164345635|NCT03095066|593640988|FG000|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
164345636|NCT03095066|593640989|FG001|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
164345637|NCT03095066|593640990|FG002|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
164345638|NCT03095066|593640991|FG003|Stage 2 (Week 7 to Week 12)|Reason Not Specified|2|||
164345639|NCT03095066|593640992|FG004|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
164345640|NCT03095066|593640993|FG005|Stage 2 (Week 7 to Week 12)|Reason Not Specified|1|||
164345641|NCT03095066|593640994|FG006|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
164345642|NCT03095066|593640995|FG007|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
164345643|NCT05988619|593640997|FG000|Overall Study|Lost to Follow-up|1|||
164345644|NCT05988619|593640998|FG001|Overall Study|Lost to Follow-up|4|||
164345645|NCT05988619|593640997|FG000|Overall Study|Withdrawal by Subject|2|||
164345646|NCT05988619|593640998|FG001|Overall Study|Withdrawal by Subject|9|||
164345647|NCT00726232|593641001|FG000|Initial Phase (Dose-finding)|Death|0|||
164345648|NCT00726232|593641002|FG001|Initial Phase (Dose-finding)|Death|0|||
164345649|NCT00726232|593641003|FG002|Initial Phase (Dose-finding)|Death|0|||
164345650|NCT00726232|593641004|FG003|Initial Phase (Dose-finding)|Death|0|||
164345651|NCT00726232|593641005|FG004|Initial Phase (Dose-finding)|Death|1|||
164345652|NCT00726232|593641006|FG005|Initial Phase (Dose-finding)|Death|0|||
164345653|NCT00726232|593641007|FG006|Initial Phase (Dose-finding)|Death|0|||
164345654|NCT00726232|593641008|FG007|Initial Phase (Dose-finding)|Death|0|||
164345655|NCT00726232|593641001|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
164345656|NCT00726232|593641002|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
164345657|NCT00726232|593641003|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
164345658|NCT00726232|593641004|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
164345659|NCT00726232|593641005|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
164345660|NCT00726232|593641006|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
164345661|NCT00726232|593641007|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
164345662|NCT00726232|593641008|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
164345663|NCT00726232|593641001|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
164345664|NCT00726232|593641002|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
164345665|NCT00726232|593641003|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
164345666|NCT00726232|593641004|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
164345667|NCT00726232|593641005|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
164345668|NCT00726232|593641006|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
164345669|NCT00726232|593641007|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
164345670|NCT00726232|593641008|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
164345671|NCT00726232|593641001|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
164345672|NCT00726232|593641002|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
164345673|NCT00726232|593641003|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
164345674|NCT00726232|593641004|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
164345675|NCT00726232|593641005|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
164345676|NCT00726232|593641006|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
164345677|NCT00726232|593641007|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
164345678|NCT00726232|593641008|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
164345679|NCT00726232|593641001|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
164291110|NCT05579977|593436207|FG005|Treatment Phase|Pregnancy|0|||
164291111|NCT05579977|593436208|FG006|Treatment Phase|Pregnancy|0|||
164345680|NCT00726232|593641002|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
164345681|NCT00726232|593641003|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
164345682|NCT00726232|593641004|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
164433468|NCT00502593|593957279|FG009|Overall Study|Withdrawal by Subject|0|||
164291112|NCT05579977|593436209|FG007|Treatment Phase|Pregnancy|0|||
164291113|NCT05579977|593436210|FG008|Treatment Phase|Pregnancy|0|||
164291114|NCT05579977|593436211|FG009|Treatment Phase|Pregnancy|1|||
164433469|NCT00502593|593957280|FG010|Overall Study|Withdrawal by Subject|1|||
164433470|NCT00502593|593957281|FG011|Overall Study|Withdrawal by Subject|0|||
164433471|NCT00502593|593957270|FG000|Overall Study|Lost to Follow-up|2|||
164433472|NCT00502593|593957271|FG001|Overall Study|Lost to Follow-up|1|||
164433473|NCT00502593|593957272|FG002|Overall Study|Lost to Follow-up|1|||
164433474|NCT00502593|593957273|FG003|Overall Study|Lost to Follow-up|1|||
164433475|NCT00502593|593957274|FG004|Overall Study|Lost to Follow-up|0|||
164433476|NCT00502593|593957275|FG005|Overall Study|Lost to Follow-up|0|||
164433477|NCT00502593|593957276|FG006|Overall Study|Lost to Follow-up|0|||
164433478|NCT00502593|593957277|FG007|Overall Study|Lost to Follow-up|0|||
164433479|NCT00502593|593957278|FG008|Overall Study|Lost to Follow-up|3|||
164433480|NCT00502593|593957279|FG009|Overall Study|Lost to Follow-up|0|||
164433481|NCT00502593|593957280|FG010|Overall Study|Lost to Follow-up|1|||
164433482|NCT00502593|593957281|FG011|Overall Study|Lost to Follow-up|0|||
164433483|NCT04154943|593957282|FG000|Overall Study|Study Ongoing|68|||
164433484|NCT04154943|593957282|FG000|Overall Study|Lost to Follow-up|1|||
164433485|NCT04154943|593957282|FG000|Overall Study|Decision by the Investigator|1|||
164433486|NCT04154943|593957282|FG000|Overall Study|Death|5|||
164433487|NCT04154943|593957282|FG000|Overall Study|Withdrawal by Subject|4|||
164433488|NCT00544440|593957284|FG000|Overall Study|Other|1|||
164433489|NCT00544440|593957284|FG000|Overall Study|Adverse Event|1|||
164433490|NCT00544440|593957284|FG000|Overall Study|Withdrawal by Subject|2|||
164433491|NCT00544440|593957284|FG000|Overall Study|Subject Non-compliance|1|||
164433492|NCT00544440|593957284|FG000|Overall Study|Progressive Disease|47|||
164433493|NCT00544440|593957284|FG000|Overall Study|Other|5|||
164433494|NCT03601507|593957285|FG000|Overall Study|Adverse Event|1|||
164433495|NCT01460342|593957288|FG000|Overall Study|Adverse Event|5|||
164433496|NCT01460342|593957289|FG001|Overall Study|Adverse Event|4|||
164433497|NCT01460342|593957288|FG000|Overall Study|Lost to Follow-up|1|||
164433498|NCT01460342|593957289|FG001|Overall Study|Lost to Follow-up|2|||
164433499|NCT01460342|593957288|FG000|Overall Study|Protocol Violation|0|||
164433500|NCT01460342|593957289|FG001|Overall Study|Protocol Violation|1|||
164433501|NCT01460342|593957288|FG000|Overall Study|Withdrawal by Subject|3|||
164433502|NCT01460342|593957289|FG001|Overall Study|Withdrawal by Subject|4|||
164433503|NCT01460342|593957288|FG000|Overall Study|Physician Decision|1|||
164433504|NCT01460342|593957289|FG001|Overall Study|Physician Decision|3|||
164433505|NCT01460342|593957288|FG000|Overall Study|Lack of Efficacy|1|||
164433506|NCT01460342|593957289|FG001|Overall Study|Lack of Efficacy|0|||
164433507|NCT02107014|593957290|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
164433508|NCT00591838|593957291|FG000|Overall Study|Withdrawal by Subject|0|||
164433509|NCT00591838|593957292|FG001|Overall Study|Withdrawal by Subject|0|||
164433510|NCT00591838|593957293|FG002|Overall Study|Withdrawal by Subject|0|||
164433511|NCT00591838|593957294|FG003|Overall Study|Withdrawal by Subject|1|||
164433512|NCT00591838|593957295|FG004|Overall Study|Withdrawal by Subject|0|||
164433513|NCT03761784|593957296|FG000|Overall Study|Adverse Event|4|||
164433514|NCT03761784|593957297|FG001|Overall Study|Adverse Event|0|||
164433515|NCT03761784|593957296|FG000|Overall Study|Lost to Follow-up|10|||
164433516|NCT03761784|593957297|FG001|Overall Study|Lost to Follow-up|7|||
164433517|NCT03761784|593957296|FG000|Overall Study|Pregnancy|1|||
164433518|NCT03761784|593957297|FG001|Overall Study|Pregnancy|0|||
164433519|NCT03761784|593957296|FG000|Overall Study|Protocol Violation|2|||
164433520|NCT03761784|593957297|FG001|Overall Study|Protocol Violation|0|||
164433521|NCT03761784|593957296|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
164433522|NCT03761784|593957297|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
164433523|NCT03761784|593957296|FG000|Overall Study|Withdrawal by Subject|9|||
164433524|NCT03761784|593957297|FG001|Overall Study|Withdrawal by Subject|4|||
164433525|NCT03761784|593957296|FG000|Overall Study|Physician Decision|1|||
164433526|NCT03761784|593957297|FG001|Overall Study|Physician Decision|0|||
164433527|NCT03761784|593957296|FG000|Overall Study|Other Than Specified|1|||
164433528|NCT03761784|593957297|FG001|Overall Study|Other Than Specified|0|||
164433529|NCT01549652|593957298|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
164433530|NCT01549652|593957299|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
164433531|NCT01549652|593957300|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
164433532|NCT01549652|593957301|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
164433533|NCT01549652|593957298|FG000|Overall Study|Study Drug Titration Failure|5|||
164433534|NCT01549652|593957299|FG001|Overall Study|Study Drug Titration Failure|6|||
164586791|NCT02975349|594511916|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
164586792|NCT02975349|594511917|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
164433535|NCT01549652|593957300|FG002|Overall Study|Study Drug Titration Failure|0|||
164433536|NCT01549652|593957301|FG003|Overall Study|Study Drug Titration Failure|0|||
164586793|NCT02975349|594511918|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
164433537|NCT01549652|593957298|FG000|Overall Study|Withdrawal Effect|0|||
164433538|NCT01549652|593957299|FG001|Overall Study|Withdrawal Effect|2|||
164433539|NCT01549652|593957300|FG002|Overall Study|Withdrawal Effect|0|||
164433540|NCT01549652|593957301|FG003|Overall Study|Withdrawal Effect|0|||
164433541|NCT01549652|593957298|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
164433542|NCT01549652|593957299|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
164345683|NCT00726232|593641005|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
164345684|NCT00726232|593641006|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
164345685|NCT00726232|593641007|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
164345686|NCT00726232|593641008|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
164345687|NCT00726232|593641001|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
164345688|NCT00726232|593641002|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
164291115|NCT05579977|593436212|FG010|Treatment Phase|Pregnancy|0|||
164291116|NCT05579977|593436213|FG011|Treatment Phase|Pregnancy|0|||
164291117|NCT05579977|593436214|FG012|Treatment Phase|Pregnancy|0|||
164291118|NCT05579977|593436202|FG000|Treatment Phase|Physician Decision|0|||
164291119|NCT05579977|593436203|FG001|Treatment Phase|Physician Decision|0|||
164291120|NCT05579977|593436204|FG002|Treatment Phase|Physician Decision|0|||
164291121|NCT05579977|593436205|FG003|Treatment Phase|Physician Decision|0|||
164291122|NCT05579977|593436206|FG004|Treatment Phase|Physician Decision|0|||
164291123|NCT05579977|593436207|FG005|Treatment Phase|Physician Decision|0|||
164291124|NCT05579977|593436208|FG006|Treatment Phase|Physician Decision|0|||
164291125|NCT05579977|593436209|FG007|Treatment Phase|Physician Decision|0|||
164291126|NCT05579977|593436210|FG008|Treatment Phase|Physician Decision|0|||
164291127|NCT05579977|593436211|FG009|Treatment Phase|Physician Decision|0|||
164291128|NCT05579977|593436212|FG010|Treatment Phase|Physician Decision|0|||
164291129|NCT05579977|593436213|FG011|Treatment Phase|Physician Decision|1|||
164291130|NCT05579977|593436214|FG012|Treatment Phase|Physician Decision|0|||
164291131|NCT05579977|593436202|FG000|Treatment Phase|Lost to Follow-up|0|||
164291132|NCT05579977|593436203|FG001|Treatment Phase|Lost to Follow-up|0|||
164291133|NCT05579977|593436204|FG002|Treatment Phase|Lost to Follow-up|0|||
164291134|NCT05579977|593436205|FG003|Treatment Phase|Lost to Follow-up|1|||
164291135|NCT05579977|593436206|FG004|Treatment Phase|Lost to Follow-up|1|||
164291136|NCT05579977|593436207|FG005|Treatment Phase|Lost to Follow-up|1|||
164291137|NCT05579977|593436208|FG006|Treatment Phase|Lost to Follow-up|0|||
164291138|NCT05579977|593436209|FG007|Treatment Phase|Lost to Follow-up|1|||
164291139|NCT05579977|593436210|FG008|Treatment Phase|Lost to Follow-up|2|||
164291140|NCT05579977|593436211|FG009|Treatment Phase|Lost to Follow-up|2|||
164291141|NCT05579977|593436212|FG010|Treatment Phase|Lost to Follow-up|1|||
164291142|NCT05579977|593436213|FG011|Treatment Phase|Lost to Follow-up|4|||
164291143|NCT05579977|593436214|FG012|Treatment Phase|Lost to Follow-up|3|||
164291144|NCT05579977|593436202|FG000|Treatment Phase|Death|1|||
164291145|NCT05579977|593436203|FG001|Treatment Phase|Death|0|||
164291146|NCT05579977|593436204|FG002|Treatment Phase|Death|0|||
164291147|NCT05579977|593436205|FG003|Treatment Phase|Death|0|||
164291148|NCT05579977|593436206|FG004|Treatment Phase|Death|0|||
164291149|NCT05579977|593436207|FG005|Treatment Phase|Death|0|||
164291150|NCT05579977|593436208|FG006|Treatment Phase|Death|0|||
164291151|NCT05579977|593436209|FG007|Treatment Phase|Death|0|||
164291152|NCT05579977|593436210|FG008|Treatment Phase|Death|0|||
164291153|NCT05579977|593436211|FG009|Treatment Phase|Death|0|||
164291154|NCT05579977|593436212|FG010|Treatment Phase|Death|0|||
164291155|NCT05579977|593436213|FG011|Treatment Phase|Death|0|||
164291156|NCT05579977|593436214|FG012|Treatment Phase|Death|0|||
164291157|NCT05579977|593436202|FG000|Treatment Phase|Adverse Event|0|||
164291158|NCT05579977|593436203|FG001|Treatment Phase|Adverse Event|3|||
164291159|NCT05579977|593436204|FG002|Treatment Phase|Adverse Event|11|||
164291160|NCT05579977|593436205|FG003|Treatment Phase|Adverse Event|10|||
164291161|NCT05579977|593436206|FG004|Treatment Phase|Adverse Event|5|||
164291162|NCT05579977|593436207|FG005|Treatment Phase|Adverse Event|17|||
164291163|NCT05579977|593436208|FG006|Treatment Phase|Adverse Event|5|||
164291164|NCT05579977|593436209|FG007|Treatment Phase|Adverse Event|5|||
164291165|NCT05579977|593436210|FG008|Treatment Phase|Adverse Event|12|||
164291166|NCT05579977|593436211|FG009|Treatment Phase|Adverse Event|20|||
164291167|NCT05579977|593436212|FG010|Treatment Phase|Adverse Event|15|||
164291168|NCT05579977|593436213|FG011|Treatment Phase|Adverse Event|24|||
164291169|NCT05579977|593436214|FG012|Treatment Phase|Adverse Event|23|||
164291170|NCT05579977|593436202|FG000|Treatment Phase|Randomized not treated|0|||
164291171|NCT05579977|593436203|FG001|Treatment Phase|Randomized not treated|0|||
164345689|NCT00726232|593641003|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
164586794|NCT02975349|594511919|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
164291172|NCT05579977|593436204|FG002|Treatment Phase|Randomized not treated|0|||
164291173|NCT05579977|593436205|FG003|Treatment Phase|Randomized not treated|0|||
164291174|NCT05579977|593436206|FG004|Treatment Phase|Randomized not treated|1|||
164291175|NCT05579977|593436207|FG005|Treatment Phase|Randomized not treated|0|||
164291176|NCT05579977|593436208|FG006|Treatment Phase|Randomized not treated|0|||
164291177|NCT05579977|593436209|FG007|Treatment Phase|Randomized not treated|0|||
164291178|NCT05579977|593436210|FG008|Treatment Phase|Randomized not treated|0|||
164291179|NCT05579977|593436211|FG009|Treatment Phase|Randomized not treated|0|||
164291180|NCT05579977|593436212|FG010|Treatment Phase|Randomized not treated|0|||
164291181|NCT05579977|593436213|FG011|Treatment Phase|Randomized not treated|0|||
164291182|NCT05579977|593436214|FG012|Treatment Phase|Randomized not treated|0|||
164291183|NCT05579977|593436202|FG000|Follow up|Death|1|||
164291184|NCT05579977|593436203|FG001|Follow up|Death|0|||
164291185|NCT05579977|593436204|FG002|Follow up|Death|0|||
164291186|NCT05579977|593436205|FG003|Follow up|Death|0|||
164291187|NCT05579977|593436206|FG004|Follow up|Death|0|||
164291188|NCT05579977|593436207|FG005|Follow up|Death|0|||
164291189|NCT05579977|593436208|FG006|Follow up|Death|0|||
164291190|NCT05579977|593436209|FG007|Follow up|Death|0|||
164291191|NCT05579977|593436210|FG008|Follow up|Death|0|||
164291192|NCT05579977|593436211|FG009|Follow up|Death|0|||
164291193|NCT05579977|593436212|FG010|Follow up|Death|0|||
164291194|NCT05579977|593436213|FG011|Follow up|Death|0|||
164291195|NCT05579977|593436214|FG012|Follow up|Death|0|||
164291196|NCT05579977|593436202|FG000|Follow up|Lost to Follow-up|0|||
164291197|NCT05579977|593436203|FG001|Follow up|Lost to Follow-up|0|||
164291198|NCT05579977|593436204|FG002|Follow up|Lost to Follow-up|0|||
164291199|NCT05579977|593436205|FG003|Follow up|Lost to Follow-up|1|||
164291200|NCT05579977|593436206|FG004|Follow up|Lost to Follow-up|1|||
164291201|NCT05579977|593436207|FG005|Follow up|Lost to Follow-up|2|||
164291202|NCT05579977|593436208|FG006|Follow up|Lost to Follow-up|1|||
164291203|NCT05579977|593436209|FG007|Follow up|Lost to Follow-up|1|||
164291204|NCT05579977|593436210|FG008|Follow up|Lost to Follow-up|3|||
164291205|NCT05579977|593436211|FG009|Follow up|Lost to Follow-up|2|||
164291206|NCT05579977|593436212|FG010|Follow up|Lost to Follow-up|2|||
164291207|NCT05579977|593436213|FG011|Follow up|Lost to Follow-up|4|||
164291208|NCT05579977|593436214|FG012|Follow up|Lost to Follow-up|4|||
164291209|NCT05579977|593436202|FG000|Follow up|Withdrawal by Subject|2|||
164291210|NCT05579977|593436203|FG001|Follow up|Withdrawal by Subject|0|||
164291211|NCT05579977|593436204|FG002|Follow up|Withdrawal by Subject|0|||
164291212|NCT05579977|593436205|FG003|Follow up|Withdrawal by Subject|0|||
164291213|NCT05579977|593436206|FG004|Follow up|Withdrawal by Subject|1|||
164291214|NCT05579977|593436207|FG005|Follow up|Withdrawal by Subject|0|||
164291215|NCT05579977|593436208|FG006|Follow up|Withdrawal by Subject|1|||
164291216|NCT05579977|593436209|FG007|Follow up|Withdrawal by Subject|4|||
164291217|NCT05579977|593436210|FG008|Follow up|Withdrawal by Subject|2|||
164291218|NCT05579977|593436211|FG009|Follow up|Withdrawal by Subject|3|||
164291219|NCT05579977|593436212|FG010|Follow up|Withdrawal by Subject|3|||
164291220|NCT05579977|593436213|FG011|Follow up|Withdrawal by Subject|1|||
164291221|NCT05579977|593436214|FG012|Follow up|Withdrawal by Subject|3|||
164291222|NCT00348673|593436215|FG000|Stage 1|Randomized but not Treated|0|||
164291223|NCT00348673|593436216|FG001|Stage 1|Randomized but not Treated|0|||
164291224|NCT00348673|593436217|FG002|Stage 1|Randomized but not Treated|1|||
164291225|NCT00348673|593436218|FG003|Stage 1|Randomized but not Treated|0|||
164291226|NCT00348673|593436219|FG004|Stage 1|Randomized but not Treated|0|||
164291227|NCT00348673|593436220|FG005|Stage 1|Randomized but not Treated|0|||
164291228|NCT00348673|593436221|FG006|Stage 1|Randomized but not Treated|0|||
164291229|NCT00348673|593436222|FG007|Stage 1|Randomized but not Treated|0|||
164291230|NCT00348673|593436223|FG008|Stage 1|Randomized but not Treated|0|||
164291231|NCT01928927|593436225|FG000|Overall Study|Lost to Follow-up|1|||
164291232|NCT01928927|593436226|FG001|Overall Study|Lost to Follow-up|0|||
164291233|NCT01928927|593436225|FG000|Overall Study|Withdrawal by Subject|1|||
164291234|NCT01928927|593436226|FG001|Overall Study|Withdrawal by Subject|1|||
164291235|NCT00350844|593436229|FG000|Overall Study|Lost to Follow-up|1|||
164291236|NCT01420926|593436230|FG000|Overall Study|Adverse Event|6|||
164291237|NCT01420926|593436231|FG001|Overall Study|Adverse Event|4|||
164291238|NCT01420926|593436230|FG000|Overall Study|Death|18|||
164291239|NCT01420926|593436231|FG001|Overall Study|Death|17|||
164291240|NCT01420926|593436230|FG000|Overall Study|Withdrawal by Subject|11|||
164291241|NCT01420926|593436231|FG001|Overall Study|Withdrawal by Subject|17|||
164291242|NCT01420926|593436230|FG000|Overall Study|Non-protocol treatment|17|||
164291243|NCT01420926|593436231|FG001|Overall Study|Non-protocol treatment|20|||
164291244|NCT01420926|593436230|FG000|Overall Study|Physician Decision|8|||
164291245|NCT01420926|593436231|FG001|Overall Study|Physician Decision|5|||
164291246|NCT04564846|593437997|FG000|Overall Study|Withdrawal by Subject|2|||
164291247|NCT04564846|593437998|FG001|Overall Study|Withdrawal by Subject|1|||
164291248|NCT04564846|593437997|FG000|Overall Study|Physician Decision|0|||
164291249|NCT04564846|593437998|FG001|Overall Study|Physician Decision|1|||
164291250|NCT04564846|593437997|FG000|Overall Study|Lost to Follow-up|0|||
164291251|NCT04564846|593437998|FG001|Overall Study|Lost to Follow-up|1|||
164291252|NCT04564846|593437997|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
164291253|NCT04564846|593437998|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
164291254|NCT04564846|593437997|FG000|Overall Study|Subject non-compliance|1|||
164291255|NCT04564846|593437998|FG001|Overall Study|Subject non-compliance|0|||
164291256|NCT03798717|593437999|FG000|Overall Study|Failed Screening|0|||
164291257|NCT03798717|593438000|FG001|Overall Study|Failed Screening|0|||
164291258|NCT03798717|593438001|FG002|Overall Study|Failed Screening|0|||
164291259|NCT03798717|593438002|FG003|Overall Study|Failed Screening|0|||
164291260|NCT03798717|593438003|FG004|Overall Study|Failed Screening|0|||
164291261|NCT03798717|593438004|FG005|Overall Study|Failed Screening|1|||
164433543|NCT01549652|593957300|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
164433544|NCT01549652|593957301|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
164433545|NCT01549652|593957298|FG000|Overall Study|Problem with Infusion|1|||
164433546|NCT01549652|593957299|FG001|Overall Study|Problem with Infusion|0|||
164433547|NCT01549652|593957300|FG002|Overall Study|Problem with Infusion|0|||
164433548|NCT01549652|593957301|FG003|Overall Study|Problem with Infusion|0|||
164433549|NCT01549652|593957298|FG000|Overall Study|Titration Non-Compliance|1|||
164433550|NCT01549652|593957299|FG001|Overall Study|Titration Non-Compliance|3|||
164433551|NCT01549652|593957300|FG002|Overall Study|Titration Non-Compliance|4|||
164433552|NCT01549652|593957301|FG003|Overall Study|Titration Non-Compliance|5|||
164433553|NCT01549652|593957298|FG000|Overall Study|Titration Side Effects|0|||
164433554|NCT01549652|593957299|FG001|Overall Study|Titration Side Effects|0|||
164433555|NCT01549652|593957300|FG002|Overall Study|Titration Side Effects|6|||
164433556|NCT01549652|593957301|FG003|Overall Study|Titration Side Effects|3|||
164433557|NCT01549652|593957298|FG000|Overall Study|Withdrawal by Subject|0|||
164433558|NCT01549652|593957299|FG001|Overall Study|Withdrawal by Subject|0|||
164433559|NCT01549652|593957300|FG002|Overall Study|Withdrawal by Subject|5|||
164433560|NCT01549652|593957301|FG003|Overall Study|Withdrawal by Subject|3|||
164433561|NCT00586339|593957302|FG000|Overall Study|Withdrawal by Subject|1|||
164433562|NCT00586339|593957303|FG001|Overall Study|Withdrawal by Subject|3|||
164291262|NCT03798717|593437999|FG000|Overall Study|Physician Decision|1|||
164291263|NCT03798717|593438000|FG001|Overall Study|Physician Decision|0|||
164291264|NCT03798717|593438001|FG002|Overall Study|Physician Decision|1|||
164291265|NCT03798717|593438002|FG003|Overall Study|Physician Decision|0|||
164291266|NCT03798717|593438003|FG004|Overall Study|Physician Decision|0|||
164291267|NCT03798717|593438004|FG005|Overall Study|Physician Decision|0|||
164291268|NCT03798717|593437999|FG000|Overall Study|Withdrawal by Subject|0|||
164291269|NCT03798717|593438000|FG001|Overall Study|Withdrawal by Subject|0|||
164291270|NCT03798717|593438001|FG002|Overall Study|Withdrawal by Subject|0|||
164291271|NCT03798717|593438002|FG003|Overall Study|Withdrawal by Subject|1|||
164291272|NCT03798717|593438003|FG004|Overall Study|Withdrawal by Subject|0|||
164291273|NCT03798717|593438004|FG005|Overall Study|Withdrawal by Subject|0|||
164291274|NCT03798717|593437999|FG000|Overall Study|Lost to Follow-up|1|||
164291275|NCT03798717|593438000|FG001|Overall Study|Lost to Follow-up|0|||
164291276|NCT03798717|593438001|FG002|Overall Study|Lost to Follow-up|0|||
164291277|NCT03798717|593438002|FG003|Overall Study|Lost to Follow-up|1|||
164291278|NCT03798717|593438003|FG004|Overall Study|Lost to Follow-up|0|||
164345690|NCT00726232|593641004|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
164345691|NCT00726232|593641005|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
164345692|NCT00726232|593641006|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
164345693|NCT00726232|593641007|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
164345694|NCT00726232|593641008|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
164345695|NCT00726232|593641001|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
164345696|NCT00726232|593641002|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
164345697|NCT00726232|593641003|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
164345698|NCT00726232|593641004|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
164345699|NCT00726232|593641005|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
164345700|NCT00726232|593641006|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
164345701|NCT00726232|593641007|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
164345702|NCT00726232|593641008|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
164345703|NCT00726232|593641001|FG000|Expansion Phase|Death|0|||
164345704|NCT00726232|593641002|FG001|Expansion Phase|Death|0|||
164345705|NCT00726232|593641003|FG002|Expansion Phase|Death|0|||
164345706|NCT00726232|593641004|FG003|Expansion Phase|Death|0|||
164345707|NCT00726232|593641005|FG004|Expansion Phase|Death|0|||
164345708|NCT00726232|593641006|FG005|Expansion Phase|Death|0|||
164345709|NCT00726232|593641007|FG006|Expansion Phase|Death|0|||
164345710|NCT00726232|593641008|FG007|Expansion Phase|Death|1|||
164345711|NCT00726232|593641001|FG000|Expansion Phase|Adverse Event|0|||
164345712|NCT00726232|593641002|FG001|Expansion Phase|Adverse Event|0|||
164345713|NCT00726232|593641003|FG002|Expansion Phase|Adverse Event|0|||
164345714|NCT00726232|593641004|FG003|Expansion Phase|Adverse Event|0|||
164345715|NCT00726232|593641005|FG004|Expansion Phase|Adverse Event|0|||
164345716|NCT00726232|593641006|FG005|Expansion Phase|Adverse Event|0|||
164291279|NCT03798717|593438004|FG005|Overall Study|Lost to Follow-up|0|||
164291280|NCT03798717|593437999|FG000|Overall Study|Adverse Event|0|||
164291281|NCT03798717|593438000|FG001|Overall Study|Adverse Event|1|||
164291282|NCT03798717|593438001|FG002|Overall Study|Adverse Event|0|||
164345717|NCT00726232|593641007|FG006|Expansion Phase|Adverse Event|6|||
164345718|NCT00726232|593641008|FG007|Expansion Phase|Adverse Event|11|||
164345719|NCT00726232|593641001|FG000|Expansion Phase|Withdrawal by Subject|0|||
164345720|NCT00726232|593641002|FG001|Expansion Phase|Withdrawal by Subject|0|||
164345721|NCT00726232|593641003|FG002|Expansion Phase|Withdrawal by Subject|0|||
164291283|NCT03798717|593438002|FG003|Overall Study|Adverse Event|0|||
164291284|NCT03798717|593438003|FG004|Overall Study|Adverse Event|0|||
164291285|NCT03798717|593438004|FG005|Overall Study|Adverse Event|0|||
164345722|NCT00726232|593641004|FG003|Expansion Phase|Withdrawal by Subject|0|||
164345723|NCT00726232|593641005|FG004|Expansion Phase|Withdrawal by Subject|0|||
164345724|NCT00726232|593641006|FG005|Expansion Phase|Withdrawal by Subject|0|||
164345725|NCT00726232|593641007|FG006|Expansion Phase|Withdrawal by Subject|2|||
164345726|NCT00726232|593641008|FG007|Expansion Phase|Withdrawal by Subject|3|||
164345727|NCT00726232|593641001|FG000|Expansion Phase|Disease progression|0|||
164345728|NCT00726232|593641002|FG001|Expansion Phase|Disease progression|0|||
164345729|NCT00726232|593641003|FG002|Expansion Phase|Disease progression|0|||
164345730|NCT00726232|593641004|FG003|Expansion Phase|Disease progression|0|||
164345731|NCT00726232|593641005|FG004|Expansion Phase|Disease progression|0|||
164345732|NCT00726232|593641006|FG005|Expansion Phase|Disease progression|0|||
164345733|NCT00726232|593641007|FG006|Expansion Phase|Disease progression|4|||
164345734|NCT00726232|593641008|FG007|Expansion Phase|Disease progression|0|||
164345735|NCT00726232|593641001|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
164345736|NCT00726232|593641002|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
164345737|NCT00726232|593641003|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
164345738|NCT00726232|593641004|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
164345739|NCT00726232|593641005|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
164345740|NCT00726232|593641006|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
164345741|NCT00726232|593641007|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
164345742|NCT00726232|593641008|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
164345743|NCT00726232|593641001|FG000|Expansion Phase|Per Investigator: lack of response|0|||
164345744|NCT00726232|593641002|FG001|Expansion Phase|Per Investigator: lack of response|0|||
164345745|NCT00726232|593641003|FG002|Expansion Phase|Per Investigator: lack of response|0|||
164345746|NCT00726232|593641004|FG003|Expansion Phase|Per Investigator: lack of response|0|||
164345747|NCT00726232|593641005|FG004|Expansion Phase|Per Investigator: lack of response|0|||
164345748|NCT00726232|593641006|FG005|Expansion Phase|Per Investigator: lack of response|0|||
164345749|NCT00726232|593641007|FG006|Expansion Phase|Per Investigator: lack of response|1|||
164345750|NCT00726232|593641008|FG007|Expansion Phase|Per Investigator: lack of response|7|||
164345751|NCT00726232|593641001|FG000|Expansion Phase|Unspecified reason|0|||
164345752|NCT00726232|593641002|FG001|Expansion Phase|Unspecified reason|0|||
164345753|NCT00726232|593641003|FG002|Expansion Phase|Unspecified reason|0|||
164345754|NCT00726232|593641004|FG003|Expansion Phase|Unspecified reason|0|||
164345755|NCT00726232|593641005|FG004|Expansion Phase|Unspecified reason|0|||
164345756|NCT00726232|593641006|FG005|Expansion Phase|Unspecified reason|0|||
164345757|NCT00726232|593641007|FG006|Expansion Phase|Unspecified reason|1|||
164345758|NCT00726232|593641008|FG007|Expansion Phase|Unspecified reason|0|||
164345759|NCT01203098|593641011|FG000|Overall Study|Adverse Event|3|||
164345760|NCT01203098|593641012|FG001|Overall Study|Adverse Event|1|||
164345761|NCT01203098|593641013|FG002|Overall Study|Adverse Event|7|||
164345762|NCT01203098|593641011|FG000|Overall Study|Lost to Follow-up|0|||
164345763|NCT01203098|593641012|FG001|Overall Study|Lost to Follow-up|0|||
164345764|NCT01203098|593641013|FG002|Overall Study|Lost to Follow-up|1|||
164345765|NCT01203098|593641011|FG000|Overall Study|Physician Decision|2|||
164345766|NCT01203098|593641012|FG001|Overall Study|Physician Decision|2|||
164345767|NCT01203098|593641013|FG002|Overall Study|Physician Decision|0|||
164345768|NCT01203098|593641011|FG000|Overall Study|Withdrawal by Subject|1|||
164345769|NCT01203098|593641012|FG001|Overall Study|Withdrawal by Subject|1|||
164345770|NCT01203098|593641013|FG002|Overall Study|Withdrawal by Subject|3|||
164345771|NCT03095612|593641018|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
164345772|NCT03095612|593641019|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
164345773|NCT03095612|593641020|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
164345774|NCT03095612|593641021|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
164345775|NCT03095612|593641022|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
164345776|NCT03095612|593641023|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
164345777|NCT03095612|593641024|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
164345778|NCT00621582|593641025|FG000|Overall Study|Adverse Event|7|||
164345779|NCT00621582|593641025|FG000|Overall Study|Protocol Violation|57|||
164345780|NCT00621582|593641025|FG000|Overall Study|Lost to Follow-up|24|||
164345781|NCT00621582|593641025|FG000|Overall Study|issues not identified by investigators|18|||
164345782|NCT01042678|593641026|FG000|Overall Study|Physician Decision|1|||
164345783|NCT01042678|593641027|FG001|Overall Study|Physician Decision|0|||
164345784|NCT01042678|593641028|FG002|Overall Study|Physician Decision|0|||
164345785|NCT01042678|593641029|FG003|Overall Study|Physician Decision|0|||
164345786|NCT01042678|593641030|FG004|Overall Study|Physician Decision|0|||
164345787|NCT01042678|593641031|FG005|Overall Study|Physician Decision|0|||
164345788|NCT01387932|593641032|FG000|Randomized and Treated|Physician Decision|3|||
164345789|NCT01387932|593641033|FG001|Randomized and Treated|Physician Decision|2|||
164433563|NCT00586339|593957304|FG002|Overall Study|Withdrawal by Subject|1|||
164433564|NCT00586339|593957302|FG000|Overall Study|Migrated/moved from study area|3|||
164433565|NCT00586339|593957303|FG001|Overall Study|Migrated/moved from study area|2|||
164433566|NCT00586339|593957304|FG002|Overall Study|Migrated/moved from study area|4|||
164433567|NCT00586339|593957302|FG000|Overall Study|Lost to Follow-up|3|||
164433568|NCT00586339|593957303|FG001|Overall Study|Lost to Follow-up|2|||
164291286|NCT03798717|593437999|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
164291287|NCT03798717|593438000|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
164291288|NCT03798717|593438001|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
164291289|NCT03798717|593438002|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
164291290|NCT03798717|593438003|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
164291291|NCT03798717|593438004|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
164291292|NCT00179621|593438005|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
164291293|NCT00179621|593438006|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
164291294|NCT00179621|593438007|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
164291295|NCT00179621|593438008|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
164291296|NCT00179621|593438005|FG000|Double-Blind Period|Adverse Event|2|||
164291297|NCT00179621|593438006|FG001|Double-Blind Period|Adverse Event|7|||
164291298|NCT00179621|593438007|FG002|Double-Blind Period|Adverse Event|4|||
164291299|NCT00179621|593438008|FG003|Double-Blind Period|Adverse Event|0|||
164291300|NCT00179621|593438005|FG000|Double-Blind Period|Withdrawal by Subject|2|||
164291301|NCT00179621|593438006|FG001|Double-Blind Period|Withdrawal by Subject|1|||
164291302|NCT00179621|593438007|FG002|Double-Blind Period|Withdrawal by Subject|3|||
164291303|NCT00179621|593438008|FG003|Double-Blind Period|Withdrawal by Subject|0|||
164291304|NCT00179621|593438005|FG000|Double-Blind Period|Death|0|||
164291305|NCT00179621|593438006|FG001|Double-Blind Period|Death|1|||
164291306|NCT00179621|593438007|FG002|Double-Blind Period|Death|2|||
164291307|NCT00179621|593438008|FG003|Double-Blind Period|Death|0|||
164291308|NCT00179621|593438005|FG000|Double-Blind Period|Protocol Violation|1|||
164291309|NCT00179621|593438006|FG001|Double-Blind Period|Protocol Violation|0|||
164291310|NCT00179621|593438007|FG002|Double-Blind Period|Protocol Violation|0|||
164291311|NCT00179621|593438008|FG003|Double-Blind Period|Protocol Violation|0|||
164291312|NCT00179621|593438005|FG000|Double-Blind Period|Other|0|||
164291313|NCT00179621|593438006|FG001|Double-Blind Period|Other|2|||
164291314|NCT00179621|593438007|FG002|Double-Blind Period|Other|2|||
164291315|NCT00179621|593438008|FG003|Double-Blind Period|Other|0|||
164291316|NCT00179621|593438005|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
164291317|NCT00179621|593438006|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
164291318|NCT00179621|593438007|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
164291319|NCT00179621|593438008|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
164291320|NCT00179621|593438005|FG000|Open-Label Period|Adverse Event|0|||
164291321|NCT00179621|593438006|FG001|Open-Label Period|Adverse Event|6|||
164291322|NCT00179621|593438007|FG002|Open-Label Period|Adverse Event|5|||
164291323|NCT00179621|593438008|FG003|Open-Label Period|Adverse Event|6|||
164291324|NCT00179621|593438005|FG000|Open-Label Period|Withdrawal by Subject|0|||
164291325|NCT00179621|593438006|FG001|Open-Label Period|Withdrawal by Subject|2|||
164291326|NCT00179621|593438007|FG002|Open-Label Period|Withdrawal by Subject|2|||
164291327|NCT00179621|593438008|FG003|Open-Label Period|Withdrawal by Subject|2|||
164291328|NCT00179621|593438005|FG000|Open-Label Period|Death|0|||
164291329|NCT00179621|593438006|FG001|Open-Label Period|Death|0|||
164291330|NCT00179621|593438007|FG002|Open-Label Period|Death|1|||
164291331|NCT00179621|593438008|FG003|Open-Label Period|Death|2|||
164291332|NCT00179621|593438005|FG000|Open-Label Period|Other|0|||
164291333|NCT00179621|593438006|FG001|Open-Label Period|Other|1|||
164291334|NCT00179621|593438007|FG002|Open-Label Period|Other|1|||
164291335|NCT00179621|593438008|FG003|Open-Label Period|Other|2|||
164291336|NCT00865345|593438009|FG000|Overall Study|Withdrawal by Subject|2|||
164291337|NCT00966654|593438014|FG000|Overall Study|Study was terminated,PI left institution|12|||
164291338|NCT00882440|593438017|FG000|Overall Study|Adverse Event|2|||
164291339|NCT00882440|593438018|FG001|Overall Study|Adverse Event|2|||
164291340|NCT00882440|593438019|FG002|Overall Study|Adverse Event|2|||
164433569|NCT00586339|593957304|FG002|Overall Study|Lost to Follow-up|1|||
164291341|NCT00882440|593438020|FG003|Overall Study|Adverse Event|1|||
164433570|NCT00559949|593957305|FG000|Overall Study|Progressive Disease during cycle 1|1|||
164291342|NCT00882440|593438021|FG004|Overall Study|Adverse Event|1|||
164291343|NCT00882440|593438022|FG005|Overall Study|Adverse Event|4|||
164291344|NCT00882440|593438023|FG006|Overall Study|Adverse Event|2|||
164291345|NCT00882440|593438017|FG000|Overall Study|Lack of Efficacy|3|||
164291346|NCT00882440|593438018|FG001|Overall Study|Lack of Efficacy|5|||
164291347|NCT00882440|593438019|FG002|Overall Study|Lack of Efficacy|2|||
164291348|NCT00882440|593438020|FG003|Overall Study|Lack of Efficacy|0|||
164291349|NCT00882440|593438021|FG004|Overall Study|Lack of Efficacy|0|||
164291350|NCT00882440|593438022|FG005|Overall Study|Lack of Efficacy|3|||
164433571|NCT00559949|593957305|FG000|Overall Study|Adverse Event|1|||
164291351|NCT00882440|593438023|FG006|Overall Study|Lack of Efficacy|0|||
164291352|NCT00882440|593438017|FG000|Overall Study|Lost to Follow-up|2|||
164291353|NCT00882440|593438018|FG001|Overall Study|Lost to Follow-up|0|||
164433572|NCT00559949|593957305|FG000|Overall Study|Withdrawal by Subject|4|||
164291354|NCT00882440|593438019|FG002|Overall Study|Lost to Follow-up|1|||
164291355|NCT00882440|593438020|FG003|Overall Study|Lost to Follow-up|1|||
164291356|NCT00882440|593438021|FG004|Overall Study|Lost to Follow-up|1|||
164291357|NCT00882440|593438022|FG005|Overall Study|Lost to Follow-up|0|||
164291358|NCT00882440|593438023|FG006|Overall Study|Lost to Follow-up|1|||
164291359|NCT00882440|593438017|FG000|Overall Study|Protocol Violation|0|||
164291360|NCT00882440|593438018|FG001|Overall Study|Protocol Violation|0|||
164291361|NCT00882440|593438019|FG002|Overall Study|Protocol Violation|1|||
164291362|NCT00882440|593438020|FG003|Overall Study|Protocol Violation|1|||
164291363|NCT00882440|593438021|FG004|Overall Study|Protocol Violation|1|||
164291364|NCT00882440|593438022|FG005|Overall Study|Protocol Violation|0|||
164345790|NCT01387932|593641032|FG000|Randomized and Treated|Withdrawal by Subject|4|||
164345791|NCT01387932|593641033|FG001|Randomized and Treated|Withdrawal by Subject|2|||
164345792|NCT01387932|593641032|FG000|Survival Follow-up|Liver Transplant|24|||
164345793|NCT01387932|593641033|FG001|Survival Follow-up|Liver Transplant|28|||
164345794|NCT01387932|593641032|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
164345795|NCT01387932|593641033|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
164345796|NCT01387932|593641032|FG000|Survival Follow-up|Withdrawal by Subject|2|||
164345797|NCT01387932|593641033|FG001|Survival Follow-up|Withdrawal by Subject|4|||
164345798|NCT01387932|593641032|FG000|Survival Follow-up|Lost to Follow-up|6|||
164345799|NCT01387932|593641033|FG001|Survival Follow-up|Lost to Follow-up|5|||
164345800|NCT02197520|593641036|FG000|Period 1|Withdrawal by Subject|1|||
164345801|NCT02197520|593641037|FG001|Period 1|Withdrawal by Subject|0|||
164345802|NCT02197520|593641036|FG000|Period 2|Adverse Event|0|||
164345803|NCT02197520|593641037|FG001|Period 2|Adverse Event|2|||
164345804|NCT02197520|593641036|FG000|Period 2|Withdrawal by Subject|1|||
164345805|NCT02197520|593641037|FG001|Period 2|Withdrawal by Subject|0|||
164345806|NCT03208244|593641038|FG000|Overall Study|Death|1|||
164345807|NCT04431453|593641043|FG000|Overall Study|Withdrew Consent|0|||
164345808|NCT04431453|593641044|FG001|Overall Study|Withdrew Consent|1|||
164345809|NCT04431453|593641045|FG002|Overall Study|Withdrew Consent|0|||
164345810|NCT04431453|593641046|FG003|Overall Study|Withdrew Consent|2|||
164345811|NCT04431453|593641047|FG004|Overall Study|Withdrew Consent|0|||
164345812|NCT04431453|593641048|FG005|Overall Study|Withdrew Consent|0|||
164345813|NCT04431453|593641049|FG006|Overall Study|Withdrew Consent|0|||
164345814|NCT04431453|593641050|FG007|Overall Study|Withdrew Consent|0|||
164345815|NCT04431453|593641043|FG000|Overall Study|Death|1|||
164345816|NCT04431453|593641044|FG001|Overall Study|Death|0|||
164345817|NCT04431453|593641045|FG002|Overall Study|Death|0|||
164345818|NCT04431453|593641046|FG003|Overall Study|Death|0|||
164345819|NCT04431453|593641047|FG004|Overall Study|Death|0|||
164345820|NCT04431453|593641048|FG005|Overall Study|Death|0|||
164345821|NCT04431453|593641049|FG006|Overall Study|Death|0|||
164345822|NCT04431453|593641050|FG007|Overall Study|Death|1|||
164345823|NCT04431453|593641043|FG000|Overall Study|Lost to Follow-up|0|||
164345824|NCT04431453|593641044|FG001|Overall Study|Lost to Follow-up|0|||
164345825|NCT04431453|593641045|FG002|Overall Study|Lost to Follow-up|1|||
164345826|NCT04431453|593641046|FG003|Overall Study|Lost to Follow-up|1|||
164345827|NCT04431453|593641047|FG004|Overall Study|Lost to Follow-up|0|||
164345828|NCT04431453|593641048|FG005|Overall Study|Lost to Follow-up|0|||
164345829|NCT04431453|593641049|FG006|Overall Study|Lost to Follow-up|0|||
164345830|NCT04431453|593641050|FG007|Overall Study|Lost to Follow-up|0|||
164345831|NCT04431453|593641043|FG000|Overall Study|Enrolled but Never Treated|0|||
164345832|NCT04431453|593641044|FG001|Overall Study|Enrolled but Never Treated|0|||
164345833|NCT04431453|593641045|FG002|Overall Study|Enrolled but Never Treated|0|||
164345834|NCT04431453|593641046|FG003|Overall Study|Enrolled but Never Treated|0|||
164345835|NCT04431453|593641047|FG004|Overall Study|Enrolled but Never Treated|1|||
164345836|NCT04431453|593641048|FG005|Overall Study|Enrolled but Never Treated|0|||
164345837|NCT04431453|593641049|FG006|Overall Study|Enrolled but Never Treated|0|||
164345838|NCT04431453|593641050|FG007|Overall Study|Enrolled but Never Treated|0|||
164345839|NCT03385564|593641051|FG000|Overall Study|Adverse Event|0|||
164345840|NCT03385564|593641052|FG001|Overall Study|Adverse Event|0|||
164345841|NCT03385564|593641053|FG002|Overall Study|Adverse Event|3|||
164345842|NCT03385564|593641054|FG003|Overall Study|Adverse Event|3|||
164291365|NCT00882440|593438023|FG006|Overall Study|Protocol Violation|0|||
164291366|NCT00882440|593438017|FG000|Overall Study|Withdrawal by Subject|2|||
164291367|NCT00882440|593438018|FG001|Overall Study|Withdrawal by Subject|1|||
164291368|NCT00882440|593438019|FG002|Overall Study|Withdrawal by Subject|1|||
164345843|NCT03385564|593641051|FG000|Overall Study|Other than listed|0|||
164345844|NCT03385564|593641052|FG001|Overall Study|Other than listed|0|||
164345845|NCT03385564|593641053|FG002|Overall Study|Other than listed|0|||
164345846|NCT03385564|593641054|FG003|Overall Study|Other than listed|5|||
164345847|NCT03385564|593641051|FG000|Overall Study|Withdrawal by Subject|0|||
164345848|NCT03385564|593641052|FG001|Overall Study|Withdrawal by Subject|1|||
164345849|NCT03385564|593641053|FG002|Overall Study|Withdrawal by Subject|1|||
164345850|NCT03385564|593641054|FG003|Overall Study|Withdrawal by Subject|0|||
164345851|NCT03385564|593641051|FG000|Overall Study|Lack of Efficacy|0|||
164345852|NCT03385564|593641052|FG001|Overall Study|Lack of Efficacy|0|||
164345853|NCT03385564|593641053|FG002|Overall Study|Lack of Efficacy|0|||
164433573|NCT00559949|593957305|FG000|Overall Study|No disease evaluation per protocol|1|||
164433574|NCT02512042|593957306|FG000|Overall Study|Adverse Event|0|||
164433575|NCT02512042|593957307|FG001|Overall Study|Adverse Event|4|||
164586795|NCT02975349|594511920|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
164586796|NCT02975349|594511921|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
164291369|NCT00882440|593438020|FG003|Overall Study|Withdrawal by Subject|0|||
164291370|NCT00882440|593438021|FG004|Overall Study|Withdrawal by Subject|6|||
164291371|NCT00882440|593438022|FG005|Overall Study|Withdrawal by Subject|0|||
164291372|NCT00882440|593438023|FG006|Overall Study|Withdrawal by Subject|1|||
164291373|NCT00882440|593438017|FG000|Overall Study|Patient Uncooperative|2|||
164291374|NCT00882440|593438018|FG001|Overall Study|Patient Uncooperative|0|||
164291375|NCT00882440|593438019|FG002|Overall Study|Patient Uncooperative|0|||
164291376|NCT00882440|593438020|FG003|Overall Study|Patient Uncooperative|0|||
164291377|NCT00882440|593438021|FG004|Overall Study|Patient Uncooperative|1|||
164291378|NCT00882440|593438022|FG005|Overall Study|Patient Uncooperative|0|||
164291379|NCT00882440|593438023|FG006|Overall Study|Patient Uncooperative|0|||
164291380|NCT05482308|593438027|FG000|Overall Study|Withdrawal by Subject|1|||
164291381|NCT05482308|593438028|FG001|Overall Study|Withdrawal by Subject|0|||
164291382|NCT05482308|593438027|FG000|Overall Study|No longer meets eligibility criteria|0|||
164291383|NCT05482308|593438028|FG001|Overall Study|No longer meets eligibility criteria|1|||
164291384|NCT01693029|593438037|FG000|Overall Study|Withdrawal by Subject|15|||
164291385|NCT01693029|593438038|FG001|Overall Study|Withdrawal by Subject|22|||
164291386|NCT01693029|593438037|FG000|Overall Study|Kidney transplantation|7|||
164291387|NCT01693029|593438038|FG001|Overall Study|Kidney transplantation|7|||
164291388|NCT01693029|593438037|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
164291389|NCT01693029|593438038|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
164291390|NCT01693029|593438037|FG000|Overall Study|Protocol Violation|6|||
164291391|NCT01693029|593438038|FG001|Overall Study|Protocol Violation|7|||
164291392|NCT01693029|593438037|FG000|Overall Study|Change in dialysis modality|2|||
164291393|NCT01693029|593438038|FG001|Overall Study|Change in dialysis modality|1|||
164291394|NCT01693029|593438037|FG000|Overall Study|Physician Decision|0|||
164291395|NCT01693029|593438038|FG001|Overall Study|Physician Decision|2|||
164291396|NCT01693029|593438037|FG000|Overall Study|Lost to Follow-up|0|||
164291397|NCT01693029|593438038|FG001|Overall Study|Lost to Follow-up|1|||
164291398|NCT01693029|593438037|FG000|Overall Study|Adverse Event|1|||
164291399|NCT01693029|593438038|FG001|Overall Study|Adverse Event|6|||
164291400|NCT01693029|593438037|FG000|Overall Study|Death|5|||
164291401|NCT01693029|593438038|FG001|Overall Study|Death|8|||
164291402|NCT01693029|593438037|FG000|Overall Study|Non-compliance|2|||
164291403|NCT01693029|593438038|FG001|Overall Study|Non-compliance|1|||
164291404|NCT01329263|593438039|FG000|Overall Study|Lost to Follow-up|4|||
164291405|NCT01329263|593438040|FG001|Overall Study|Lost to Follow-up|21|||
164291406|NCT01329263|593438039|FG000|Overall Study|Withdrawal by Subject|1|||
164291407|NCT01329263|593438040|FG001|Overall Study|Withdrawal by Subject|2|||
164291408|NCT01631435|593438042|FG000|Overall Study|Adverse Event|2|||
164291409|NCT01631435|593438042|FG000|Overall Study|Withdrawal by Subject|2|||
164291410|NCT01631435|593438042|FG000|Overall Study|incomplete study procedure|5|||
164291411|NCT01421017|593438043|FG000|Overall Study|Withdrawal by Subject|2|||
164291412|NCT01421017|593438044|FG001|Overall Study|Withdrawal by Subject|0|||
164291413|NCT01421017|593438045|FG002|Overall Study|Withdrawal by Subject|0|||
164291414|NCT01421017|593438043|FG000|Overall Study|POD|0|||
164291415|NCT01421017|593438044|FG001|Overall Study|POD|6|||
164291416|NCT01421017|593438045|FG002|Overall Study|POD|3|||
164291417|NCT02313766|593438046|FG000|Overall Study|surgery cancelled|1|||
164291418|NCT02313766|593438047|FG001|Overall Study|surgery cancelled|0|||
164291419|NCT02313766|593438048|FG002|Overall Study|surgery cancelled|0|||
164291420|NCT02313766|593438046|FG000|Overall Study|Lost to Follow-up|0|||
164291421|NCT02313766|593438047|FG001|Overall Study|Lost to Follow-up|2|||
164291422|NCT02313766|593438048|FG002|Overall Study|Lost to Follow-up|0|||
164291423|NCT02313766|593438046|FG000|Overall Study|Adverse Event|0|||
164291424|NCT02313766|593438047|FG001|Overall Study|Adverse Event|1|||
164291425|NCT02313766|593438048|FG002|Overall Study|Adverse Event|0|||
164291426|NCT01005251|593438051|FG000|Overall Study|Withdrawal by Subject|2|||
164291427|NCT01005251|593438052|FG001|Overall Study|Withdrawal by Subject|5|||
164586797|NCT02975349|594511915|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
164291428|NCT01005251|593438053|FG002|Overall Study|Withdrawal by Subject|3|||
164291429|NCT01005251|593438054|FG003|Overall Study|Withdrawal by Subject|4|||
164291430|NCT01005251|593438055|FG004|Overall Study|Withdrawal by Subject|9|||
164291431|NCT01005251|593438051|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
164291432|NCT01005251|593438052|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164291433|NCT01005251|593438053|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
164291434|NCT01005251|593438054|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
164291435|NCT01005251|593438055|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
164291436|NCT01005251|593438051|FG000|Overall Study|Adverse Event|2|||
164291437|NCT01005251|593438052|FG001|Overall Study|Adverse Event|6|||
164291438|NCT01005251|593438053|FG002|Overall Study|Adverse Event|8|||
164291439|NCT01005251|593438054|FG003|Overall Study|Adverse Event|5|||
164586798|NCT02975349|594511916|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
164291440|NCT01005251|593438055|FG004|Overall Study|Adverse Event|4|||
164291441|NCT01005251|593438051|FG000|Overall Study|Protocol Violation|1|||
164291442|NCT01005251|593438052|FG001|Overall Study|Protocol Violation|0|||
164291443|NCT01005251|593438053|FG002|Overall Study|Protocol Violation|0|||
164291444|NCT01005251|593438054|FG003|Overall Study|Protocol Violation|0|||
164291445|NCT01005251|593438055|FG004|Overall Study|Protocol Violation|2|||
164291446|NCT01005251|593438051|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
164345854|NCT03385564|593641054|FG003|Overall Study|Lack of Efficacy|1|||
164345855|NCT03385564|593641051|FG000|Overall Study|Death|0|||
164345856|NCT03385564|593641052|FG001|Overall Study|Death|0|||
164345857|NCT03385564|593641053|FG002|Overall Study|Death|1|||
164345858|NCT03385564|593641054|FG003|Overall Study|Death|0|||
164345859|NCT01702961|593641061|FG000|Overall Study|Additional treatment|3|||
164345860|NCT01702961|593641061|FG000|Overall Study|Progressive disease|5|||
164345861|NCT01702961|593641061|FG000|Overall Study|Relapse|20|||
164345862|NCT01702961|593641061|FG000|Overall Study|Death|6|||
164345863|NCT01702961|593641061|FG000|Overall Study|Lost to Follow-up|2|||
164345864|NCT01702961|593641061|FG000|Overall Study|Ongoing|11|||
164345865|NCT02405780|593641068|FG000|Period I|Adverse Event|8|||
164345866|NCT02405780|593641069|FG001|Period I|Adverse Event|0|||
164345867|NCT02405780|593641070|FG002|Period I|Adverse Event|3|||
164345868|NCT02405780|593641071|FG003|Period I|Adverse Event|7|||
164345869|NCT02405780|593641068|FG000|Period I|Medical reasons|1|||
164345870|NCT02405780|593641069|FG001|Period I|Medical reasons|1|||
164345871|NCT02405780|593641070|FG002|Period I|Medical reasons|0|||
164345872|NCT02405780|593641071|FG003|Period I|Medical reasons|1|||
164345873|NCT02405780|593641068|FG000|Period I|Screening Failure|1|||
164345874|NCT02405780|593641069|FG001|Period I|Screening Failure|0|||
164345875|NCT02405780|593641070|FG002|Period I|Screening Failure|1|||
164345876|NCT02405780|593641071|FG003|Period I|Screening Failure|0|||
164345877|NCT02405780|593641068|FG000|Period I|Withdrawal by Subject|9|||
164345878|NCT02405780|593641069|FG001|Period I|Withdrawal by Subject|1|||
164345879|NCT02405780|593641070|FG002|Period I|Withdrawal by Subject|3|||
164345880|NCT02405780|593641071|FG003|Period I|Withdrawal by Subject|4|||
164345881|NCT02405780|593641068|FG000|Period I|Non-compliance with study procedures|8|||
164345882|NCT02405780|593641069|FG001|Period I|Non-compliance with study procedures|6|||
164345883|NCT02405780|593641070|FG002|Period I|Non-compliance with study procedures|8|||
164345884|NCT02405780|593641071|FG003|Period I|Non-compliance with study procedures|11|||
164345885|NCT02405780|593641068|FG000|Period II|Adverse Event|3|||
164345886|NCT02405780|593641069|FG001|Period II|Adverse Event|5|||
164345887|NCT02405780|593641070|FG002|Period II|Adverse Event|4|||
164345888|NCT02405780|593641071|FG003|Period II|Adverse Event|11|||
164345889|NCT02405780|593641068|FG000|Period II|Medical reason|0|||
164345890|NCT02405780|593641069|FG001|Period II|Medical reason|1|||
164345891|NCT02405780|593641070|FG002|Period II|Medical reason|0|||
164345892|NCT02405780|593641071|FG003|Period II|Medical reason|0|||
164345893|NCT02405780|593641068|FG000|Period II|Pregnancy|0|||
164345894|NCT02405780|593641069|FG001|Period II|Pregnancy|0|||
164345895|NCT02405780|593641070|FG002|Period II|Pregnancy|1|||
164345896|NCT02405780|593641071|FG003|Period II|Pregnancy|0|||
164345897|NCT02405780|593641068|FG000|Period II|Withdrawal by Subject|7|||
164345898|NCT02405780|593641069|FG001|Period II|Withdrawal by Subject|4|||
164345899|NCT02405780|593641070|FG002|Period II|Withdrawal by Subject|0|||
164345900|NCT02405780|593641071|FG003|Period II|Withdrawal by Subject|3|||
164345901|NCT02405780|593641068|FG000|Period II|Non-compliance with study procedures|5|||
164345902|NCT02405780|593641069|FG001|Period II|Non-compliance with study procedures|2|||
164345903|NCT02405780|593641070|FG002|Period II|Non-compliance with study procedures|7|||
164345904|NCT02405780|593641071|FG003|Period II|Non-compliance with study procedures|4|||
164345905|NCT00668707|593641072|FG000|Overall Study|Cancer Recurrence|58|||
164345906|NCT00668707|593641073|FG001|Overall Study|Cancer Recurrence|58|||
164345907|NCT00668707|593641072|FG000|Overall Study|Withdrawal by Subject|117|||
164586799|NCT02975349|594511917|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
164586800|NCT02975349|594511918|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
164586801|NCT02975349|594511919|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
164291447|NCT01005251|593438052|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
164345908|NCT00668707|593641073|FG001|Overall Study|Withdrawal by Subject|100|||
164345909|NCT00668707|593641072|FG000|Overall Study|Lost to Follow-up|3|||
164345910|NCT00668707|593641073|FG001|Overall Study|Lost to Follow-up|6|||
164345911|NCT00668707|593641072|FG000|Overall Study|Protocol Violation|10|||
164345912|NCT00668707|593641073|FG001|Overall Study|Protocol Violation|12|||
164345913|NCT00668707|593641072|FG000|Overall Study|Death|11|||
164345914|NCT00668707|593641073|FG001|Overall Study|Death|4|||
164345915|NCT03724032|593641077|FG000|Overall Study|Physician Decision|1|||
164345916|NCT03724032|593641078|FG001|Overall Study|Physician Decision|0|||
164345917|NCT03724032|593641079|FG002|Overall Study|Physician Decision|0|||
164345918|NCT03724032|593641077|FG000|Overall Study|Protocol Violation|2|||
164345919|NCT03724032|593641078|FG001|Overall Study|Protocol Violation|2|||
164345920|NCT03724032|593641079|FG002|Overall Study|Protocol Violation|1|||
164586802|NCT02975349|594511920|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
164586803|NCT02975349|594511921|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
164586804|NCT02975349|594511915|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
164586805|NCT02975349|594511916|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
164586806|NCT02975349|594511917|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
164586807|NCT02975349|594511918|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
164586808|NCT02975349|594511919|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
164586809|NCT02975349|594511920|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
164586810|NCT02975349|594511921|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
164433576|NCT02512042|593957306|FG000|Overall Study|Withdrawal by Subject|6|||
164433577|NCT02512042|593957307|FG001|Overall Study|Withdrawal by Subject|6|||
164433578|NCT02512042|593957306|FG000|Overall Study|Non-compliance with study drug|1|||
164433579|NCT02512042|593957307|FG001|Overall Study|Non-compliance with study drug|2|||
164586811|NCT02975349|594511915|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
164586812|NCT02975349|594511916|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
164433580|NCT02512042|593957306|FG000|Overall Study|Lost to Follow-up|5|||
164433581|NCT02512042|593957307|FG001|Overall Study|Lost to Follow-up|2|||
164433582|NCT02512042|593957306|FG000|Overall Study|Other|11|||
164433583|NCT02512042|593957307|FG001|Overall Study|Other|11|||
164433584|NCT02059980|593957312|FG000|Overall Study|Lost to Follow-up|2|||
164433585|NCT02059980|593957313|FG001|Overall Study|Lost to Follow-up|1|||
164433586|NCT03381274|593957314|FG000|Overall Study|Death|2|||
164433587|NCT03381274|593957315|FG001|Overall Study|Death|9|||
164433588|NCT03381274|593957316|FG002|Overall Study|Death|3|||
164433589|NCT03381274|593957317|FG003|Overall Study|Death|2|||
164433590|NCT03381274|593957318|FG004|Overall Study|Death|3|||
164433591|NCT03381274|593957314|FG000|Overall Study|Lost to Follow-up|0|||
164433592|NCT03381274|593957315|FG001|Overall Study|Lost to Follow-up|0|||
164433593|NCT03381274|593957316|FG002|Overall Study|Lost to Follow-up|0|||
164433594|NCT03381274|593957317|FG003|Overall Study|Lost to Follow-up|1|||
164433595|NCT03381274|593957318|FG004|Overall Study|Lost to Follow-up|0|||
164433596|NCT03381274|593957314|FG000|Overall Study|Withdrawal by Subject|2|||
164433597|NCT03381274|593957315|FG001|Overall Study|Withdrawal by Subject|1|||
164433598|NCT03381274|593957316|FG002|Overall Study|Withdrawal by Subject|3|||
164433599|NCT03381274|593957317|FG003|Overall Study|Withdrawal by Subject|1|||
164433600|NCT03381274|593957318|FG004|Overall Study|Withdrawal by Subject|0|||
164433601|NCT03381274|593957314|FG000|Overall Study|Other|1|||
164433602|NCT03381274|593957315|FG001|Overall Study|Other|11|||
164433603|NCT03381274|593957316|FG002|Overall Study|Other|0|||
164433604|NCT03381274|593957317|FG003|Overall Study|Other|2|||
164433605|NCT03381274|593957318|FG004|Overall Study|Other|2|||
164433606|NCT04109118|593957319|FG000|Overall Study|Lost to Follow-up|3|||
164433607|NCT02824432|593957320|FG000|Overall Study|Major Protocol Deviation|1|||
164433608|NCT02824432|593957321|FG001|Overall Study|Major Protocol Deviation|0|||
164433609|NCT03598790|593958591|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
164433610|NCT03598790|593958592|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
164433611|NCT03598790|593958593|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
164433612|NCT03598790|593958594|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
164433613|NCT03598790|593958595|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
164433614|NCT03598790|593958596|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
164433615|NCT03598790|593958597|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
164433616|NCT03598790|593958598|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
164433617|NCT03598790|593958599|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
164433618|NCT03598790|593958591|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
164291448|NCT01005251|593438053|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
164291449|NCT01005251|593438054|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
164291450|NCT01005251|593438055|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
164291451|NCT01005251|593438051|FG000|Overall Study|Lost to Follow-up|1|||
164291452|NCT01005251|593438052|FG001|Overall Study|Lost to Follow-up|4|||
164291453|NCT01005251|593438053|FG002|Overall Study|Lost to Follow-up|2|||
164291454|NCT01005251|593438054|FG003|Overall Study|Lost to Follow-up|0|||
164291455|NCT01005251|593438055|FG004|Overall Study|Lost to Follow-up|0|||
164291456|NCT01005251|593438051|FG000|Overall Study|Physician Decision|0|||
164291457|NCT01005251|593438052|FG001|Overall Study|Physician Decision|0|||
164291458|NCT01005251|593438053|FG002|Overall Study|Physician Decision|0|||
164291459|NCT01005251|593438054|FG003|Overall Study|Physician Decision|0|||
164291460|NCT01005251|593438055|FG004|Overall Study|Physician Decision|2|||
164291461|NCT01005251|593438051|FG000|Overall Study|Patient moved|1|||
164291462|NCT01005251|593438052|FG001|Overall Study|Patient moved|0|||
164291463|NCT01005251|593438053|FG002|Overall Study|Patient moved|0|||
164433619|NCT03598790|593958592|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
164433620|NCT03598790|593958593|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
164433621|NCT03598790|593958594|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
164433622|NCT03598790|593958595|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
164433623|NCT03598790|593958596|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
164433624|NCT03598790|593958597|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
164433625|NCT03598790|593958598|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
164433626|NCT03598790|593958599|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
164433627|NCT03598790|593958591|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
164433628|NCT03598790|593958592|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
164433629|NCT03598790|593958593|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
164433630|NCT03598790|593958594|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
164433631|NCT03598790|593958595|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
164433632|NCT03598790|593958596|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
164433633|NCT03598790|593958597|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
164433634|NCT03598790|593958598|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
164433635|NCT03598790|593958599|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
164433636|NCT03598790|593958591|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
164433637|NCT03598790|593958592|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
164433638|NCT03598790|593958593|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
164433639|NCT03598790|593958594|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
164433640|NCT03598790|593958595|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
164433641|NCT03598790|593958596|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
164433642|NCT03598790|593958597|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
164433643|NCT03598790|593958598|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
164433644|NCT03598790|593958599|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
164433645|NCT03598790|593958591|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
164433646|NCT03598790|593958592|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
164433647|NCT03598790|593958593|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
164433648|NCT03598790|593958594|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
164433649|NCT03598790|593958595|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
164433650|NCT03598790|593958596|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
164433651|NCT03598790|593958597|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
164433652|NCT03598790|593958598|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
164433653|NCT03598790|593958599|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
164433654|NCT03598790|593958591|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
164433655|NCT03598790|593958592|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
164433656|NCT03598790|593958593|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
164433657|NCT03598790|593958594|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
164433658|NCT03598790|593958595|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
164433659|NCT03598790|593958596|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
164433660|NCT03598790|593958597|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
164433661|NCT03598790|593958598|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
164433662|NCT03598790|593958599|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
164433663|NCT03598790|593958591|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
164433664|NCT03598790|593958592|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
164433665|NCT03598790|593958593|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
164433666|NCT03598790|593958594|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
164433667|NCT03598790|593958595|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
164433668|NCT03598790|593958596|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
164433669|NCT03598790|593958597|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
164433670|NCT03598790|593958598|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
164433671|NCT03598790|593958599|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
164433672|NCT03598790|593958591|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
164433673|NCT03598790|593958592|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
164433674|NCT03598790|593958593|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
164433675|NCT03598790|593958594|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
164433676|NCT03598790|593958595|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
164433677|NCT03598790|593958596|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
164433678|NCT03598790|593958597|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
164433679|NCT03598790|593958598|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
164433680|NCT03598790|593958599|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
164433681|NCT03598790|593958591|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
164291464|NCT01005251|593438054|FG003|Overall Study|Patient moved|0|||
164291465|NCT01005251|593438055|FG004|Overall Study|Patient moved|0|||
164433682|NCT03598790|593958592|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
164433683|NCT03598790|593958593|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
164433684|NCT03598790|593958594|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
164433685|NCT03598790|593958595|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
164433686|NCT03598790|593958596|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
164433687|NCT03598790|593958597|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
164433688|NCT03598790|593958598|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
164433689|NCT03598790|593958599|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
164433690|NCT03598790|593958591|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
164433691|NCT03598790|593958592|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
164433692|NCT03598790|593958593|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
164433693|NCT03598790|593958594|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
164433694|NCT03598790|593958595|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
164433695|NCT03598790|593958596|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
164433696|NCT03598790|593958597|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
164433697|NCT03598790|593958598|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
164433698|NCT03598790|593958599|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
164433699|NCT03598790|593958591|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
164433700|NCT03598790|593958592|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
164433701|NCT03598790|593958593|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
164433702|NCT03598790|593958594|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
164433703|NCT03598790|593958595|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
164433704|NCT03598790|593958596|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
164433705|NCT03598790|593958597|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
164433706|NCT03598790|593958598|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
164433707|NCT03598790|593958599|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
164433708|NCT03598790|593958591|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
164433709|NCT03598790|593958592|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
164433710|NCT03598790|593958593|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
164433711|NCT03598790|593958594|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
164433712|NCT03598790|593958595|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
164433713|NCT03598790|593958596|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
164433714|NCT03598790|593958597|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
164433715|NCT03598790|593958598|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
164433716|NCT03598790|593958599|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
164433717|NCT03598790|593958591|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
164433718|NCT03598790|593958592|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
164433719|NCT03598790|593958593|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
164433720|NCT03598790|593958594|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
164433721|NCT03598790|593958595|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
164433722|NCT03598790|593958596|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
164433723|NCT03598790|593958597|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
164433724|NCT03598790|593958598|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
164433725|NCT03598790|593958599|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
164433726|NCT03598790|593958591|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
164433727|NCT03598790|593958592|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
164433728|NCT03598790|593958593|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
164433729|NCT03598790|593958594|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
164433730|NCT03598790|593958595|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
164433731|NCT03598790|593958596|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
164433732|NCT03598790|593958597|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
164433733|NCT03598790|593958598|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
164433734|NCT03598790|593958599|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
164433735|NCT03598790|593958591|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
164586813|NCT02975349|594511917|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
164586814|NCT02975349|594511918|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
164586815|NCT02975349|594511919|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
164586816|NCT02975349|594511920|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
164586817|NCT02975349|594511921|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
164586818|NCT02975349|594511915|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
164586819|NCT02975349|594511916|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
164291466|NCT01005251|593438051|FG000|Overall Study|Wrong drug dispensed|0|||
164291467|NCT01005251|593438052|FG001|Overall Study|Wrong drug dispensed|1|||
164291468|NCT01005251|593438053|FG002|Overall Study|Wrong drug dispensed|0|||
164291469|NCT01005251|593438054|FG003|Overall Study|Wrong drug dispensed|0|||
164291470|NCT01005251|593438055|FG004|Overall Study|Wrong drug dispensed|0|||
164291471|NCT01005251|593438051|FG000|Overall Study|Randomized in error|0|||
164291472|NCT01005251|593438052|FG001|Overall Study|Randomized in error|0|||
164291473|NCT01005251|593438053|FG002|Overall Study|Randomized in error|1|||
164291474|NCT01005251|593438054|FG003|Overall Study|Randomized in error|1|||
164291475|NCT01005251|593438055|FG004|Overall Study|Randomized in error|0|||
164291476|NCT01005251|593438051|FG000|Overall Study|Lack of Efficacy|0|||
164291477|NCT01005251|593438052|FG001|Overall Study|Lack of Efficacy|0|||
164291478|NCT01005251|593438053|FG002|Overall Study|Lack of Efficacy|1|||
164291479|NCT01005251|593438054|FG003|Overall Study|Lack of Efficacy|1|||
164291480|NCT01005251|593438055|FG004|Overall Study|Lack of Efficacy|0|||
164291481|NCT01702844|593438056|FG000|Overall Study|Adverse Event|9|||
164291482|NCT01702844|593438056|FG000|Overall Study|Death|1|||
164291483|NCT01702844|593438056|FG000|Overall Study|Withdrawal by Subject|3|||
164291484|NCT01702844|593438056|FG000|Overall Study|Physician Decision|6|||
164291485|NCT02123134|593438057|FG000|Overall Study|Withdrawal of consent|3|||
164291486|NCT02123134|593438058|FG001|Overall Study|Withdrawal of consent|2|||
164291487|NCT02123134|593438057|FG000|Overall Study|Administrative decision|0|||
164291488|NCT02123134|593438058|FG001|Overall Study|Administrative decision|1|||
164291489|NCT02995980|593438059|FG000|Overall Study|Lost to Follow-up|14|||
164291490|NCT00141453|593438061|FG000|Overall Study|Protocol Violation|6|||
164291491|NCT00141453|593438062|FG001|Overall Study|Protocol Violation|5|||
164291492|NCT01458639|593438063|FG000|Overall Study|Physician Decision|4|||
164291493|NCT01458639|593438063|FG000|Overall Study|Equipment issue|1|||
164291494|NCT01458639|593438063|FG000|Overall Study|Inability to obtain subject blood sample|1|||
164291495|NCT02656017|593438064|FG000|Overall Study|Study burden|3|||
164291496|NCT02656017|593438065|FG001|Overall Study|Study burden|3|||
164291497|NCT02656017|593438064|FG000|Overall Study|Adverse Event|2|||
164291498|NCT02656017|593438065|FG001|Overall Study|Adverse Event|1|||
164291499|NCT02656017|593438064|FG000|Overall Study|Unable/unwilling to take study medication|2|||
164291500|NCT02656017|593438065|FG001|Overall Study|Unable/unwilling to take study medication|1|||
164291501|NCT02656017|593438064|FG000|Overall Study|Began Tolvaptan|1|||
164291502|NCT02656017|593438065|FG001|Overall Study|Began Tolvaptan|1|||
164291503|NCT02656017|593438064|FG000|Overall Study|Withdrawal by Subject|1|||
164291504|NCT02656017|593438065|FG001|Overall Study|Withdrawal by Subject|0|||
164291505|NCT04245111|593438066|FG000|Overall Study|Lost to Follow-up|5|||
164291506|NCT04245111|593438067|FG001|Overall Study|Lost to Follow-up|1|||
164291507|NCT04245111|593438068|FG002|Overall Study|Lost to Follow-up|1|||
164291508|NCT01884077|593438069|FG000|Overall Study|screen fail|0|||
164291509|NCT01884077|593438070|FG001|Overall Study|screen fail|2|||
164291510|NCT01884077|593438069|FG000|Overall Study|canceled surgery|2|||
164291511|NCT01884077|593438070|FG001|Overall Study|canceled surgery|0|||
164291512|NCT01884077|593438069|FG000|Overall Study|Lost to Follow-up|0|||
164291513|NCT01884077|593438070|FG001|Overall Study|Lost to Follow-up|4|||
164291514|NCT01884077|593438069|FG000|Overall Study|study closed|6|||
164291515|NCT01884077|593438070|FG001|Overall Study|study closed|4|||
164291516|NCT00981149|593438071|FG000|Overall Study|Lost to Follow-up|1|||
164291517|NCT00981149|593438072|FG001|Overall Study|Lost to Follow-up|2|||
164291518|NCT00981149|593438071|FG000|Overall Study|Withdrawal by Subject|1|||
164291519|NCT00981149|593438072|FG001|Overall Study|Withdrawal by Subject|1|||
164291520|NCT01220167|593438073|FG000|Period 3|Urine positive for substance abuse|0|||
164291521|NCT01220167|593438074|FG001|Period 3|Urine positive for substance abuse|1|||
164291522|NCT01220167|593438075|FG002|Period 3|Urine positive for substance abuse|0|||
164291523|NCT01008943|593438076|FG000|Overall Study|Withdrawal by Subject|1|||
164291524|NCT00861705|593438077|FG000|Overall Study|Never Began Treatment|7|||
164291525|NCT00861705|593438078|FG001|Overall Study|Never Began Treatment|3|||
164291526|NCT00861705|593438079|FG002|Overall Study|Never Began Treatment|0|||
164345921|NCT00751933|593641080|FG000|Overall Study|Withdrawal by Subject|0|||
164345922|NCT00751933|593641081|FG001|Overall Study|Withdrawal by Subject|1|||
164291527|NCT00861705|593438080|FG003|Overall Study|Never Began Treatment|1|||
164291528|NCT02634333|593438081|FG000|Overall Study|Completed out of Window|3|||
164291529|NCT02634333|593438082|FG001|Overall Study|Completed out of Window|2|||
164291530|NCT02634333|593438081|FG000|Overall Study|Missed Visit|5|||
164291531|NCT02634333|593438082|FG001|Overall Study|Missed Visit|2|||
164291532|NCT02634333|593438081|FG000|Overall Study|Lost to Follow-up|12|||
164291533|NCT02634333|593438082|FG001|Overall Study|Lost to Follow-up|7|||
164291534|NCT02634333|593438081|FG000|Overall Study|Withdrawal by Subject|9|||
164291535|NCT02634333|593438082|FG001|Overall Study|Withdrawal by Subject|13|||
164291536|NCT02634333|593438081|FG000|Overall Study|Death|11|||
164291537|NCT02634333|593438082|FG001|Overall Study|Death|8|||
164291538|NCT00300755|593438087|FG000|Overall Study|Adverse Event|1|||
164291539|NCT00300755|593438088|FG001|Overall Study|Adverse Event|2|||
164291540|NCT00300755|593438089|FG002|Overall Study|Adverse Event|1|||
164291541|NCT00300755|593438087|FG000|Overall Study|Withdrawal by Subject|0|||
164433736|NCT03598790|593958592|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
164433737|NCT03598790|593958593|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
164433738|NCT03598790|593958594|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
164433739|NCT03598790|593958595|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
164433740|NCT03598790|593958596|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
164433741|NCT03598790|593958597|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
164433742|NCT03598790|593958598|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
164433743|NCT03598790|593958599|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
164433744|NCT03598790|593958591|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
164433745|NCT03598790|593958592|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
164433746|NCT03598790|593958593|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
164433747|NCT03598790|593958594|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
164433748|NCT03598790|593958595|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
164433749|NCT03598790|593958596|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
164433750|NCT03598790|593958597|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
164433751|NCT03598790|593958598|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
164433752|NCT03598790|593958599|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
164433753|NCT03598790|593958591|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
164433754|NCT03598790|593958592|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
164433755|NCT03598790|593958593|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
164433756|NCT03598790|593958594|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
164433757|NCT03598790|593958595|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
164433758|NCT03598790|593958596|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
164433759|NCT03598790|593958597|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
164433760|NCT03598790|593958598|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
164433761|NCT03598790|593958599|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
164291542|NCT00300755|593438088|FG001|Overall Study|Withdrawal by Subject|2|||
164291543|NCT00300755|593438089|FG002|Overall Study|Withdrawal by Subject|0|||
164291544|NCT00300755|593438087|FG000|Overall Study|Protocol Violation|0|||
164291545|NCT00300755|593438088|FG001|Overall Study|Protocol Violation|0|||
164291546|NCT00300755|593438089|FG002|Overall Study|Protocol Violation|1|||
164291547|NCT02694744|593438090|FG000|Overall Study|Adverse Event|2|||
164291548|NCT02694744|593438091|FG001|Overall Study|Adverse Event|1|||
164291549|NCT02694744|593438090|FG000|Overall Study|Withdrawal by Subject|2|||
164291550|NCT02694744|593438091|FG001|Overall Study|Withdrawal by Subject|1|||
164291551|NCT02694744|593438090|FG000|Overall Study|Physician Decision|1|||
164291552|NCT02694744|593438091|FG001|Overall Study|Physician Decision|2|||
164291553|NCT02694744|593438090|FG000|Overall Study|Lost to Follow-up|1|||
164291554|NCT02694744|593438091|FG001|Overall Study|Lost to Follow-up|0|||
164291555|NCT02694744|593438090|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
164291556|NCT02694744|593438091|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
164291557|NCT00883779|593438092|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
164291558|NCT00883779|593438093|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
164291559|NCT00883779|593438092|FG000|Primary Study Treatment Phase|Disease progression|75|||
164291560|NCT00883779|593438093|FG001|Primary Study Treatment Phase|Disease progression|59|||
164433762|NCT03598790|593958591|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
164433763|NCT03598790|593958592|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
164433764|NCT03598790|593958593|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
164433765|NCT03598790|593958594|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
164433766|NCT03598790|593958595|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
164433767|NCT03598790|593958596|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
164433768|NCT03598790|593958597|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
164291561|NCT00883779|593438092|FG000|Primary Study Treatment Phase|Adverse Event|16|||
164291562|NCT00883779|593438093|FG001|Primary Study Treatment Phase|Adverse Event|16|||
164433769|NCT03598790|593958598|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
164433770|NCT03598790|593958599|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
164291563|NCT00883779|593438092|FG000|Primary Study Treatment Phase|Death|2|||
164291564|NCT00883779|593438093|FG001|Primary Study Treatment Phase|Death|3|||
164291565|NCT00883779|593438092|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
164291566|NCT00883779|593438093|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
164291567|NCT00883779|593438092|FG000|Primary Study Treatment Phase|Other|3|||
164291568|NCT00883779|593438093|FG001|Primary Study Treatment Phase|Other|0|||
164291569|NCT00883779|593438092|FG000|Post-Study Treatment Phase|Adverse Event|2|||
164433771|NCT03598790|593958591|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
164433772|NCT03598790|593958592|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
164433773|NCT03598790|593958593|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
164433774|NCT03598790|593958594|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
164433775|NCT03598790|593958595|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
164433776|NCT03598790|593958596|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
164433777|NCT03598790|593958597|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
164433778|NCT03598790|593958598|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
164433779|NCT03598790|593958599|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
164433780|NCT03598790|593958591|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
164433781|NCT03598790|593958592|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
164433782|NCT03598790|593958593|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
164433783|NCT03598790|593958594|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
164433784|NCT03598790|593958595|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
164433785|NCT03598790|593958596|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
164433786|NCT03598790|593958597|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
164433787|NCT03598790|593958598|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
164433788|NCT03598790|593958599|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
164433789|NCT03598790|593958591|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
164433790|NCT03598790|593958592|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
164433791|NCT03598790|593958593|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
164433792|NCT03598790|593958594|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
164433793|NCT03598790|593958595|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
164433794|NCT03598790|593958596|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
164433795|NCT03598790|593958597|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
164433796|NCT03598790|593958598|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
164291570|NCT00883779|593438093|FG001|Post-Study Treatment Phase|Adverse Event|3|||
164433797|NCT03598790|593958599|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
164433798|NCT03598790|593958591|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
164433799|NCT03598790|593958592|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
164433800|NCT03598790|593958593|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
164433801|NCT03598790|593958594|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
164433802|NCT03598790|593958595|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
164433803|NCT03598790|593958596|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
164433804|NCT03598790|593958597|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
164433805|NCT03598790|593958598|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
164433806|NCT03598790|593958599|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
164433807|NCT03598790|593958591|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
164433808|NCT03598790|593958592|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
164433809|NCT03598790|593958593|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
164433810|NCT03598790|593958594|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
164433811|NCT03598790|593958595|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
164433812|NCT03598790|593958596|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
164433813|NCT03598790|593958597|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
164433814|NCT03598790|593958598|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
164433815|NCT03598790|593958599|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
164433816|NCT03598790|593958591|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
164433817|NCT03598790|593958592|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
164433818|NCT03598790|593958593|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
164433819|NCT03598790|593958594|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
164433820|NCT03598790|593958595|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
164433821|NCT03598790|593958596|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
164433822|NCT03598790|593958597|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
164433823|NCT03598790|593958598|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
164433824|NCT03598790|593958599|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
164433825|NCT03598790|593958591|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
164433826|NCT03598790|593958592|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
164433827|NCT03598790|593958593|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
164291571|NCT00883779|593438092|FG000|Post-Study Treatment Phase|Death|1|||
164291572|NCT00883779|593438093|FG001|Post-Study Treatment Phase|Death|3|||
164291573|NCT00883779|593438092|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
164291574|NCT00883779|593438093|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
164291575|NCT00883779|593438092|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
164291576|NCT00883779|593438093|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
164291577|NCT00883779|593438092|FG000|Post-Study Treatment Phase|Disease progression|103|||
164291578|NCT00883779|593438093|FG001|Post-Study Treatment Phase|Disease progression|122|||
164291579|NCT00883779|593438092|FG000|Post-Study Treatment Phase|Other|3|||
164291580|NCT00883779|593438093|FG001|Post-Study Treatment Phase|Other|0|||
164291581|NCT00883779|593438092|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
164291582|NCT00883779|593438093|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
164291583|NCT00883779|593438092|FG000|Off-study Phase|Death|185|||
164291584|NCT00883779|593438093|FG001|Off-study Phase|Death|174|||
164291585|NCT00883779|593438092|FG000|Off-study Phase|Refused treatment|1|||
164291586|NCT00883779|593438093|FG001|Off-study Phase|Refused treatment|1|||
164291587|NCT00883779|593438092|FG000|Off-study Phase|Failure to return|5|||
164291588|NCT00883779|593438093|FG001|Off-study Phase|Failure to return|6|||
164291589|NCT00883779|593438092|FG000|Off-study Phase|Other|18|||
164291590|NCT00883779|593438093|FG001|Off-study Phase|Other|21|||
164291591|NCT04575155|593438094|FG000|2 Month|Withdrawal by Subject|1|||
164291592|NCT04575155|593438095|FG001|2 Month|Withdrawal by Subject|1|||
164291593|NCT04575155|593438094|FG000|2 Month|Lost to Follow-up|5|||
164291594|NCT04575155|593438095|FG001|2 Month|Lost to Follow-up|3|||
164291595|NCT04575155|593438094|FG000|2 Month|Ineligible|1|||
164291596|NCT04575155|593438095|FG001|2 Month|Ineligible|0|||
164291597|NCT06237049|593438096|FG000|Overall Study|Death|0|||
164291598|NCT06237049|593438097|FG001|Overall Study|Death|0|||
164291599|NCT06237049|593438098|FG002|Overall Study|Death|0|||
164291600|NCT06237049|593438099|FG003|Overall Study|Death|1|||
164291601|NCT06237049|593438096|FG000|Overall Study|Lost to Follow-up|11|||
164291602|NCT06237049|593438097|FG001|Overall Study|Lost to Follow-up|5|||
164291603|NCT06237049|593438098|FG002|Overall Study|Lost to Follow-up|8|||
164291604|NCT06237049|593438099|FG003|Overall Study|Lost to Follow-up|8|||
164291605|NCT06237049|593438096|FG000|Overall Study|Protocol Violation|0|||
164291606|NCT06237049|593438097|FG001|Overall Study|Protocol Violation|1|||
164291607|NCT06237049|593438098|FG002|Overall Study|Protocol Violation|0|||
164291608|NCT06237049|593438099|FG003|Overall Study|Protocol Violation|1|||
164291609|NCT06237049|593438096|FG000|Overall Study|Withdrawal by Subject|4|||
164291610|NCT06237049|593438097|FG001|Overall Study|Withdrawal by Subject|2|||
164291611|NCT06237049|593438098|FG002|Overall Study|Withdrawal by Subject|1|||
164291612|NCT06237049|593438099|FG003|Overall Study|Withdrawal by Subject|0|||
164291613|NCT03748823|593438100|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
164291614|NCT03748823|593438101|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
164291615|NCT03748823|593438100|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
164291616|NCT03748823|593438101|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
164291617|NCT03748823|593438100|FG000|Extension Period|Withdrawal by Subject|9|||
164291618|NCT03748823|593438101|FG001|Extension Period|Withdrawal by Subject|12|||
164291619|NCT03748823|593438100|FG000|Extension Period|Death|2|||
164291620|NCT03748823|593438101|FG001|Extension Period|Death|2|||
164291621|NCT03748823|593438100|FG000|Extension Period|Other than Specified|0|||
164291622|NCT03748823|593438101|FG001|Extension Period|Other than Specified|1|||
164291623|NCT03748823|593438100|FG000|Extension Period|Protocol Violation|1|||
164291624|NCT03748823|593438101|FG001|Extension Period|Protocol Violation|0|||
164291625|NCT03748823|593438100|FG000|Extension Period|Lost to Follow-up|0|||
164291626|NCT03748823|593438101|FG001|Extension Period|Lost to Follow-up|1|||
164291627|NCT03748823|593438100|FG000|Extension Period|Lack of Efficacy|0|||
164291628|NCT03748823|593438101|FG001|Extension Period|Lack of Efficacy|1|||
164291629|NCT03748823|593438100|FG000|Extension Period|Physician Decision|1|||
164345923|NCT00751933|593641082|FG002|Overall Study|Withdrawal by Subject|0|||
164345924|NCT00751933|593641083|FG003|Overall Study|Withdrawal by Subject|0|||
164345925|NCT00751933|593641080|FG000|Overall Study|Physician Decision|0|||
164345926|NCT00751933|593641081|FG001|Overall Study|Physician Decision|0|||
164345927|NCT00751933|593641082|FG002|Overall Study|Physician Decision|1|||
164345928|NCT00751933|593641083|FG003|Overall Study|Physician Decision|1|||
164345929|NCT03846804|593641085|FG000|Overall Study|Refused blood draw|1|||
164291630|NCT03748823|593438101|FG001|Extension Period|Physician Decision|2|||
164291631|NCT04678115|593438102|FG000|Overall Study|Lost to Follow-up|1|||
164291632|NCT04678115|593438103|FG001|Overall Study|Lost to Follow-up|0|||
164291633|NCT01363700|593438104|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
164291634|NCT01363700|593438105|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
164291635|NCT01363700|593438106|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
164291636|NCT01363700|593438107|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
164345930|NCT03846804|593641085|FG000|Overall Study|Protocol Violation|1|||
164345931|NCT00361569|593641086|FG000|Overall Study|Protocol Violation|3|||
164433828|NCT03598790|593958594|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
164291637|NCT01363700|593438108|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
164291638|NCT03649217|593438109|FG000|Overall Study|subject had severe ataxia not initially found|1|||
164345932|NCT00361569|593641087|FG001|Overall Study|Protocol Violation|2|||
164433829|NCT03598790|593958595|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
164433830|NCT03598790|593958596|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
164433831|NCT03598790|593958597|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
164433832|NCT03598790|593958598|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
164433833|NCT03598790|593958599|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
164433834|NCT03598790|593958591|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
164433835|NCT03598790|593958592|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
164433836|NCT03598790|593958593|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
164433837|NCT03598790|593958594|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
164433838|NCT03598790|593958595|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
164291639|NCT03649217|593438109|FG000|Overall Study|subject had cognitive issues not initially found|1|||
164291640|NCT02552966|593438112|FG000|Overall Study|Lost to Follow-up|2|||
164291641|NCT02552966|593438112|FG000|Overall Study|Withdrawal by Subject|3|||
164291642|NCT01091675|593438114|FG000|Overall Study|Adverse Event|7|||
164291643|NCT01091675|593438114|FG000|Overall Study|Lack of Efficacy|27|||
164433839|NCT03598790|593958596|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
164433840|NCT03598790|593958597|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
164433841|NCT03598790|593958598|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
164291644|NCT02365649|593438122|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
164291645|NCT02365649|593438123|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
164291646|NCT02365649|593438124|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
164291647|NCT02365649|593438125|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
164291648|NCT02365649|593438126|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
164291649|NCT02365649|593438127|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
164291650|NCT02365649|593438128|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
164291651|NCT02365649|593438129|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
164291652|NCT02365649|593438130|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
164291653|NCT02365649|593438131|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
164291654|NCT02365649|593438122|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
164345933|NCT00361569|593641088|FG002|Overall Study|Protocol Violation|4|||
164345934|NCT00361569|593641089|FG003|Overall Study|Protocol Violation|2|||
164345935|NCT00361569|593641086|FG000|Overall Study|Withdrawal by Subject|2|||
164345936|NCT00361569|593641087|FG001|Overall Study|Withdrawal by Subject|1|||
164345937|NCT00361569|593641088|FG002|Overall Study|Withdrawal by Subject|9|||
164345938|NCT00361569|593641089|FG003|Overall Study|Withdrawal by Subject|14|||
164345939|NCT00361569|593641086|FG000|Overall Study|Adverse Event|3|||
164345940|NCT00361569|593641087|FG001|Overall Study|Adverse Event|5|||
164345941|NCT00361569|593641088|FG002|Overall Study|Adverse Event|2|||
164433842|NCT03598790|593958599|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
164433843|NCT04018066|593958600|FG000|Overall Study|participants started taking medications during the study period|3|||
164433844|NCT04018066|593958600|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
164433845|NCT03568318|593958601|FG000|Overall Study|Adverse Event|3|||
164433846|NCT03568318|593958602|FG001|Overall Study|Adverse Event|1|||
164433847|NCT03568318|593958603|FG002|Overall Study|Adverse Event|1|||
164433848|NCT03568318|593958604|FG003|Overall Study|Adverse Event|0|||
164433849|NCT03568318|593958605|FG004|Overall Study|Adverse Event|1|||
164433850|NCT03568318|593958606|FG005|Overall Study|Adverse Event|0|||
164433851|NCT03568318|593958601|FG000|Overall Study|Withdrawal by Subject|6|||
164433852|NCT03568318|593958602|FG001|Overall Study|Withdrawal by Subject|5|||
164433853|NCT03568318|593958603|FG002|Overall Study|Withdrawal by Subject|2|||
164433854|NCT03568318|593958604|FG003|Overall Study|Withdrawal by Subject|1|||
164433855|NCT03568318|593958605|FG004|Overall Study|Withdrawal by Subject|0|||
164433856|NCT03568318|593958606|FG005|Overall Study|Withdrawal by Subject|0|||
164433857|NCT03568318|593958601|FG000|Overall Study|Lost to Follow-up|3|||
164433858|NCT03568318|593958602|FG001|Overall Study|Lost to Follow-up|2|||
164345942|NCT00361569|593641089|FG003|Overall Study|Adverse Event|2|||
164345943|NCT00361569|593641086|FG000|Overall Study|Lost to Follow-up|2|||
164345944|NCT00361569|593641087|FG001|Overall Study|Lost to Follow-up|3|||
164345945|NCT00361569|593641088|FG002|Overall Study|Lost to Follow-up|3|||
164345946|NCT00361569|593641089|FG003|Overall Study|Lost to Follow-up|2|||
164433859|NCT03568318|593958603|FG002|Overall Study|Lost to Follow-up|2|||
164433860|NCT03568318|593958604|FG003|Overall Study|Lost to Follow-up|2|||
164433861|NCT03568318|593958605|FG004|Overall Study|Lost to Follow-up|1|||
164433862|NCT03568318|593958606|FG005|Overall Study|Lost to Follow-up|0|||
164433863|NCT03568318|593958601|FG000|Overall Study|Other|3|||
164433864|NCT03568318|593958602|FG001|Overall Study|Other|1|||
164433865|NCT03568318|593958603|FG002|Overall Study|Other|3|||
164433866|NCT03568318|593958604|FG003|Overall Study|Other|0|||
164345947|NCT00361569|593641086|FG000|Overall Study|Not specified by investigator|2|||
164345948|NCT00361569|593641087|FG001|Overall Study|Not specified by investigator|0|||
164291655|NCT02365649|593438123|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
164291656|NCT02365649|593438124|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
164291657|NCT02365649|593438125|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
164291658|NCT02365649|593438126|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
164291659|NCT02365649|593438127|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
164291660|NCT02365649|593438128|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
164291661|NCT02365649|593438129|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
164291662|NCT02365649|593438130|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
164291663|NCT02365649|593438131|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
164291664|NCT02365649|593438122|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
164291665|NCT02365649|593438123|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
164291666|NCT02365649|593438124|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
164291667|NCT02365649|593438125|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
164291668|NCT02365649|593438126|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
164291669|NCT02365649|593438127|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
164291670|NCT02365649|593438128|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
164291671|NCT02365649|593438129|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
164291672|NCT02365649|593438130|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
164291673|NCT02365649|593438131|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
164291674|NCT02365649|593438122|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
164291675|NCT02365649|593438123|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
164291676|NCT02365649|593438124|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
164291677|NCT02365649|593438125|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
164291678|NCT02365649|593438126|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
164291679|NCT02365649|593438127|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
164291680|NCT02365649|593438128|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
164291681|NCT02365649|593438129|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
164291682|NCT02365649|593438130|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
164291683|NCT02365649|593438131|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
164291684|NCT02365649|593438122|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
164291685|NCT02365649|593438123|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
164291686|NCT02365649|593438124|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
164291687|NCT02365649|593438125|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
164291688|NCT02365649|593438126|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
164291689|NCT02365649|593438127|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
164291690|NCT02365649|593438128|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
164291691|NCT02365649|593438129|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
164291692|NCT02365649|593438130|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
164291693|NCT02365649|593438131|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
164291694|NCT02365649|593438122|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
164291695|NCT02365649|593438123|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
164291696|NCT02365649|593438124|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
164291697|NCT02365649|593438125|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
164291698|NCT02365649|593438126|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
164291699|NCT02365649|593438127|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
164291700|NCT02365649|593438128|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
164291701|NCT02365649|593438129|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
164291702|NCT02365649|593438130|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
164291703|NCT02365649|593438131|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
164291704|NCT02365649|593438122|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
164291705|NCT02365649|593438123|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
164291706|NCT02365649|593438124|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
164291707|NCT02365649|593438125|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
164291708|NCT02365649|593438126|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
164291709|NCT02365649|593438127|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
164291710|NCT02365649|593438128|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
164291711|NCT02365649|593438129|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
164291712|NCT02365649|593438130|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
164291713|NCT02365649|593438131|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
164291714|NCT02365649|593438122|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
164291715|NCT02365649|593438123|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
164345949|NCT00361569|593641088|FG002|Overall Study|Not specified by investigator|0|||
164345950|NCT00361569|593641089|FG003|Overall Study|Not specified by investigator|1|||
164345951|NCT02605824|593641090|FG000|Overall Study|Physician Decision|1|||
164345952|NCT02605824|593641091|FG001|Overall Study|Physician Decision|0|||
164586820|NCT02975349|594511917|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
164586821|NCT02975349|594511918|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
164291716|NCT02365649|593438124|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
164291717|NCT02365649|593438125|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
164291718|NCT02365649|593438126|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
164291719|NCT02365649|593438127|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
164291720|NCT02365649|593438128|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
164291721|NCT02365649|593438129|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
164291722|NCT02365649|593438130|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
164291723|NCT02365649|593438131|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
164291724|NCT02365649|593438122|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
164291725|NCT02365649|593438123|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
164291726|NCT02365649|593438124|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
164291727|NCT02365649|593438125|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
164291728|NCT02365649|593438126|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
164291729|NCT02365649|593438127|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
164291730|NCT02365649|593438128|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
164291731|NCT02365649|593438129|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
164291732|NCT02365649|593438130|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
164291733|NCT02365649|593438131|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
164345953|NCT04875195|593641092|FG000|Overall Study|Death|9|||
164345954|NCT04875195|593641093|FG001|Overall Study|Death|3|||
164345955|NCT04875195|593641092|FG000|Overall Study|Withdrawal by Subject|2|||
164345956|NCT04875195|593641093|FG001|Overall Study|Withdrawal by Subject|1|||
164345957|NCT04875195|593641092|FG000|Overall Study|Ongoing in study|49|||
164345958|NCT04875195|593641093|FG001|Overall Study|Ongoing in study|2|||
164345959|NCT02339584|593641094|FG000|Overall Study|Adverse Event|11|||
164345960|NCT02339584|593641095|FG001|Overall Study|Adverse Event|7|||
164345961|NCT02339584|593641094|FG000|Overall Study|Lack of Efficacy|0|||
164345962|NCT02339584|593641095|FG001|Overall Study|Lack of Efficacy|1|||
164345963|NCT02339584|593641094|FG000|Overall Study|Physician Decision|1|||
164345964|NCT02339584|593641095|FG001|Overall Study|Physician Decision|2|||
164345965|NCT02339584|593641094|FG000|Overall Study|Protocol Violation|1|||
164345966|NCT02339584|593641095|FG001|Overall Study|Protocol Violation|1|||
164345967|NCT02339584|593641094|FG000|Overall Study|Withdrawal by Subject|2|||
164345968|NCT02339584|593641095|FG001|Overall Study|Withdrawal by Subject|4|||
164345969|NCT00826943|593641096|FG000|Overall Study|Withdrawal by Subject|0|||
164345970|NCT00826943|593641097|FG001|Overall Study|Withdrawal by Subject|0|||
164345971|NCT00826943|593641098|FG002|Overall Study|Withdrawal by Subject|0|||
164345972|NCT00826943|593641099|FG003|Overall Study|Withdrawal by Subject|0|||
164345973|NCT00826943|593641100|FG004|Overall Study|Withdrawal by Subject|1|||
164345974|NCT00826943|593641101|FG005|Overall Study|Withdrawal by Subject|0|||
164345975|NCT03715530|593641102|FG000|Overall Study|Lost to Follow-up|3|||
164345976|NCT03715530|593641103|FG001|Overall Study|Lost to Follow-up|1|||
164345977|NCT03715530|593641104|FG002|Overall Study|Lost to Follow-up|2|||
164345978|NCT01594762|593641105|FG000|Overall Study|Withdrawal by Subject|1|||
164345979|NCT01594762|593641106|FG001|Overall Study|Withdrawal by Subject|0|||
164345980|NCT01594762|593641105|FG000|Overall Study|Lost to Follow-up|10|||
164345981|NCT01594762|593641106|FG001|Overall Study|Lost to Follow-up|10|||
164345982|NCT03338998|593641110|FG000|Treatment Period|Withdrawal by Subject|1|||
164345983|NCT03338998|593641111|FG001|Treatment Period|Withdrawal by Subject|1|||
164345984|NCT03338998|593641110|FG000|Treatment Period|Adverse Event|0|||
164345985|NCT03338998|593641111|FG001|Treatment Period|Adverse Event|2|||
164345986|NCT03338998|593641110|FG000|Treatment Period|Protocol deviation|1|||
164345987|NCT03338998|593641111|FG001|Treatment Period|Protocol deviation|0|||
164345988|NCT03338998|593641110|FG000|Treatment Period|Physician Decision|2|||
164345989|NCT03338998|593641111|FG001|Treatment Period|Physician Decision|0|||
164345990|NCT03338998|593641110|FG000|Treatment Period|Subject failed swallow test|4|||
164345991|NCT03338998|593641111|FG001|Treatment Period|Subject failed swallow test|0|||
164345992|NCT03338998|593641110|FG000|Safety Follow-Up Period|Adverse Event|0|||
164345993|NCT03338998|593641111|FG001|Safety Follow-Up Period|Adverse Event|1|||
164291734|NCT02365649|593438122|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
164291735|NCT02365649|593438123|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
164291736|NCT02365649|593438124|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
164345994|NCT03338998|593641110|FG000|Safety Follow-Up Period|Protocol deviation|1|||
164345995|NCT03338998|593641111|FG001|Safety Follow-Up Period|Protocol deviation|0|||
164291737|NCT02365649|593438125|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
164345996|NCT03338998|593641110|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
164345997|NCT03338998|593641111|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
164345998|NCT04706091|593641114|FG000|Treatment 2|Withdrawal by Subject|1|||
164345999|NCT04706091|593641115|FG001|Treatment 2|Withdrawal by Subject|0|||
164346000|NCT03329573|593641116|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
164346001|NCT03329573|593641117|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
164291738|NCT02365649|593438126|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
164291739|NCT02365649|593438127|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
164291740|NCT02365649|593438128|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
164291741|NCT02365649|593438129|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
164291742|NCT02365649|593438130|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
164291743|NCT02365649|593438131|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
164291744|NCT02365649|593438122|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
164291745|NCT02365649|593438123|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
164291746|NCT02365649|593438124|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
164291747|NCT02365649|593438125|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
164291748|NCT02365649|593438126|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
164291749|NCT02365649|593438127|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
164291750|NCT02365649|593438128|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
164291751|NCT02365649|593438129|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
164291752|NCT02365649|593438130|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
164291753|NCT02365649|593438131|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
164346002|NCT03329573|593641118|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
164346003|NCT03329573|593641119|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
164346004|NCT03329573|593641116|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
164346005|NCT03329573|593641117|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
164346006|NCT03329573|593641118|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
164346007|NCT03329573|593641119|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
164346008|NCT03329573|593641116|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
164346009|NCT03329573|593641117|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
164346010|NCT03329573|593641118|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
164346011|NCT03329573|593641119|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
164346012|NCT03329573|593641116|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
164346013|NCT03329573|593641117|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
164346014|NCT03329573|593641118|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
164346015|NCT03329573|593641119|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
164346016|NCT02777333|593641122|FG000|Overall Study|Withdrawal by Subject|0|||
164346017|NCT02777333|593641123|FG001|Overall Study|Withdrawal by Subject|1|||
164346018|NCT02777333|593641122|FG000|Overall Study|Lost to Follow-up|0|||
164346019|NCT02777333|593641123|FG001|Overall Study|Lost to Follow-up|1|||
164346020|NCT05695209|593641131|FG000|3-months|Withdrawal by Subject|2|||
164346021|NCT05695209|593641132|FG001|3-months|Withdrawal by Subject|0|||
164346022|NCT05695209|593641131|FG000|3-months|Unable to contact for 3-month data collection|0|||
164346023|NCT05695209|593641132|FG001|3-months|Unable to contact for 3-month data collection|1|||
164346024|NCT05695209|593641131|FG000|6-months|Lost to Follow-up|1|||
164346025|NCT05695209|593641132|FG001|6-months|Lost to Follow-up|1|||
164346026|NCT03069378|593641135|FG000|Overall Study|Withdrawal by Subject|1|||
164346027|NCT02993146|593641136|FG000|Overall Study|Withdrawal by Subject|0|||
164346028|NCT02993146|593641137|FG001|Overall Study|Withdrawal by Subject|0|||
164346029|NCT02993146|593641138|FG002|Overall Study|Withdrawal by Subject|1|||
164346030|NCT02993146|593641139|FG003|Overall Study|Withdrawal by Subject|1|||
164346031|NCT01397708|593641140|FG000|Overall Study|Withdrawal by Subject|0|||
164346032|NCT01397708|593641141|FG001|Overall Study|Withdrawal by Subject|0|||
164346033|NCT01397708|593641142|FG002|Overall Study|Withdrawal by Subject|1|||
164346034|NCT01397708|593641143|FG003|Overall Study|Withdrawal by Subject|0|||
164346035|NCT01397708|593641144|FG004|Overall Study|Withdrawal by Subject|0|||
164346036|NCT01397708|593641145|FG005|Overall Study|Withdrawal by Subject|0|||
164346037|NCT01397708|593641146|FG006|Overall Study|Withdrawal by Subject|0|||
164346038|NCT01397708|593641147|FG007|Overall Study|Withdrawal by Subject|1|||
164346039|NCT01397708|593641140|FG000|Overall Study|Death|0|||
164346040|NCT01397708|593641141|FG001|Overall Study|Death|0|||
164346041|NCT01397708|593641142|FG002|Overall Study|Death|1|||
164346042|NCT01397708|593641143|FG003|Overall Study|Death|1|||
164346043|NCT01397708|593641144|FG004|Overall Study|Death|0|||
164346044|NCT01397708|593641145|FG005|Overall Study|Death|0|||
164346045|NCT01397708|593641146|FG006|Overall Study|Death|0|||
164346046|NCT01397708|593641147|FG007|Overall Study|Death|0|||
164346047|NCT01397708|593641140|FG000|Overall Study|Lost to Follow-up|0|||
164346048|NCT01397708|593641141|FG001|Overall Study|Lost to Follow-up|0|||
164346049|NCT01397708|593641142|FG002|Overall Study|Lost to Follow-up|0|||
164346050|NCT01397708|593641143|FG003|Overall Study|Lost to Follow-up|0|||
164346051|NCT01397708|593641144|FG004|Overall Study|Lost to Follow-up|1|||
164346052|NCT01397708|593641145|FG005|Overall Study|Lost to Follow-up|0|||
164346053|NCT01397708|593641146|FG006|Overall Study|Lost to Follow-up|0|||
164346054|NCT01397708|593641147|FG007|Overall Study|Lost to Follow-up|0|||
164346055|NCT01397708|593641140|FG000|Overall Study|Other|0|||
164346056|NCT01397708|593641141|FG001|Overall Study|Other|0|||
164346057|NCT01397708|593641142|FG002|Overall Study|Other|0|||
164433867|NCT03568318|593958605|FG004|Overall Study|Other|0|||
164433868|NCT03568318|593958606|FG005|Overall Study|Other|0|||
164433869|NCT03568318|593958601|FG000|Overall Study|Ongoing at Time of Analysis|5|||
164433870|NCT03568318|593958602|FG001|Overall Study|Ongoing at Time of Analysis|3|||
164433871|NCT03568318|593958603|FG002|Overall Study|Ongoing at Time of Analysis|2|||
164433872|NCT03568318|593958604|FG003|Overall Study|Ongoing at Time of Analysis|1|||
164433873|NCT03568318|593958605|FG004|Overall Study|Ongoing at Time of Analysis|0|||
164433874|NCT03568318|593958606|FG005|Overall Study|Ongoing at Time of Analysis|0|||
164433875|NCT03518112|593958610|FG000|Overall Study|Withdrawal by Subject|1|||
164433876|NCT05197049|593958615|FG000|Overall Study|Death|0|||
164433877|NCT05197049|593958616|FG001|Overall Study|Death|1|||
164433878|NCT05197049|593958617|FG002|Overall Study|Death|0|||
164433879|NCT05197049|593958615|FG000|Overall Study|Lost to Follow-up|3|||
164433880|NCT05197049|593958616|FG001|Overall Study|Lost to Follow-up|1|||
164433881|NCT05197049|593958617|FG002|Overall Study|Lost to Follow-up|0|||
164433882|NCT05197049|593958615|FG000|Overall Study|Withdrawal by Subject|15|||
164586822|NCT02975349|594511919|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
164586823|NCT02975349|594511920|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
164586824|NCT02975349|594511921|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
164291754|NCT02365649|593438122|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
164291755|NCT02365649|593438123|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
164291756|NCT02365649|593438124|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
164291757|NCT02365649|593438125|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
164291758|NCT02365649|593438126|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
164291759|NCT02365649|593438127|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
164291760|NCT02365649|593438128|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
164291761|NCT02365649|593438129|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
164291762|NCT02365649|593438130|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
164291763|NCT02365649|593438131|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
164291764|NCT01506271|593438132|FG000|Overall Study|Progressive disease|0|||
164291765|NCT01506271|593438133|FG001|Overall Study|Progressive disease|1|||
164291766|NCT01506271|593438134|FG002|Overall Study|Progressive disease|0|||
164291767|NCT01506271|593438132|FG000|Overall Study|Protocol Violation|3|||
164291768|NCT01506271|593438133|FG001|Overall Study|Protocol Violation|1|||
164291769|NCT01506271|593438134|FG002|Overall Study|Protocol Violation|0|||
164291770|NCT01506271|593438132|FG000|Overall Study|Death|0|||
164291771|NCT01506271|593438133|FG001|Overall Study|Death|1|||
164291772|NCT01506271|593438134|FG002|Overall Study|Death|0|||
164291773|NCT01506271|593438132|FG000|Overall Study|Adverse Event|0|||
164291774|NCT01506271|593438133|FG001|Overall Study|Adverse Event|2|||
164291775|NCT01506271|593438134|FG002|Overall Study|Adverse Event|0|||
164291776|NCT01506271|593438132|FG000|Overall Study|Insufficient supply of study drug|1|||
164291777|NCT01506271|593438133|FG001|Overall Study|Insufficient supply of study drug|0|||
164291778|NCT01506271|593438134|FG002|Overall Study|Insufficient supply of study drug|0|||
164291779|NCT01506271|593438132|FG000|Overall Study|Withdrawal by Subject|0|||
164291780|NCT01506271|593438133|FG001|Overall Study|Withdrawal by Subject|1|||
164291781|NCT01506271|593438134|FG002|Overall Study|Withdrawal by Subject|1|||
164291782|NCT01506271|593438132|FG000|Overall Study|Lost to Follow-up|0|||
164291783|NCT01506271|593438133|FG001|Overall Study|Lost to Follow-up|1|||
164291784|NCT01506271|593438134|FG002|Overall Study|Lost to Follow-up|2|||
164291785|NCT01433172|593438136|FG000|Overall Study|Withdrawal by Subject|0|||
164291786|NCT01433172|593438137|FG001|Overall Study|Withdrawal by Subject|1|||
164291787|NCT01433172|593438138|FG002|Overall Study|Withdrawal by Subject|0|||
164291788|NCT01433172|593438136|FG000|Overall Study|Disease Progression|0|||
164291789|NCT01433172|593438137|FG001|Overall Study|Disease Progression|0|||
164291790|NCT01433172|593438138|FG002|Overall Study|Disease Progression|1|||
164291791|NCT01433172|593438136|FG000|Overall Study|Death|0|||
164291792|NCT01433172|593438137|FG001|Overall Study|Death|2|||
164291793|NCT01433172|593438138|FG002|Overall Study|Death|0|||
164291794|NCT01391663|593438139|FG000|Overall Study|Withdrawal by Subject|0|||
164291795|NCT01391663|593438140|FG001|Overall Study|Withdrawal by Subject|0|||
164291796|NCT01391663|593438141|FG002|Overall Study|Withdrawal by Subject|1|||
164291797|NCT01391663|593438142|FG003|Overall Study|Withdrawal by Subject|0|||
164291798|NCT00920855|593438143|FG000|Overall Study|Adverse Event|1|||
164291799|NCT00920855|593438144|FG001|Overall Study|Adverse Event|1|||
164291800|NCT00920855|593438145|FG002|Overall Study|Adverse Event|4|||
164291801|NCT00920855|593438143|FG000|Overall Study|Withdrawal by Subject|2|||
164291802|NCT00920855|593438144|FG001|Overall Study|Withdrawal by Subject|1|||
164433883|NCT05197049|593958616|FG001|Overall Study|Withdrawal by Subject|3|||
164433884|NCT05197049|593958617|FG002|Overall Study|Withdrawal by Subject|1|||
164433885|NCT05197049|593958615|FG000|Overall Study|GCP non-compliance|1|||
164433886|NCT05197049|593958616|FG001|Overall Study|GCP non-compliance|2|||
164589046|NCT02232516|594521371|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
164433887|NCT05197049|593958617|FG002|Overall Study|GCP non-compliance|0|||
164433888|NCT00015457|593958620|FG000|First Intervention|Adverse Event|0|||
164433889|NCT00015457|593958621|FG001|First Intervention|Adverse Event|2|||
164291803|NCT00920855|593438145|FG002|Overall Study|Withdrawal by Subject|6|||
164291804|NCT00920855|593438143|FG000|Overall Study|Disease progression|2|||
164291805|NCT00920855|593438144|FG001|Overall Study|Disease progression|1|||
164291806|NCT00920855|593438145|FG002|Overall Study|Disease progression|10|||
164586825|NCT02975349|594511915|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
164291807|NCT00920855|593438143|FG000|Overall Study|Noncompliance to study medication|0|||
164291808|NCT00920855|593438144|FG001|Overall Study|Noncompliance to study medication|0|||
164291809|NCT00920855|593438145|FG002|Overall Study|Noncompliance to study medication|1|||
164291810|NCT00920855|593438143|FG000|Overall Study|Response plateau; started maintenance|0|||
164291811|NCT00920855|593438144|FG001|Overall Study|Response plateau; started maintenance|0|||
164291812|NCT00920855|593438145|FG002|Overall Study|Response plateau; started maintenance|1|||
164291813|NCT00539994|593438146|FG000|Overall Study|Lost to Follow-up|2|||
164291814|NCT00539994|593438147|FG001|Overall Study|Lost to Follow-up|1|||
164291815|NCT00539994|593438148|FG002|Overall Study|Lost to Follow-up|0|||
164291816|NCT00539994|593438146|FG000|Overall Study|Withdrawal by Subject|1|||
164291817|NCT00539994|593438147|FG001|Overall Study|Withdrawal by Subject|0|||
164291818|NCT00539994|593438148|FG002|Overall Study|Withdrawal by Subject|1|||
164291819|NCT00539994|593438146|FG000|Overall Study|Physician Decision|0|||
164291820|NCT00539994|593438147|FG001|Overall Study|Physician Decision|0|||
164291821|NCT00539994|593438148|FG002|Overall Study|Physician Decision|1|||
164291822|NCT01611194|593438152|FG000|Overall Study|Lost to Follow-up|0|||
164291823|NCT01611194|593438153|FG001|Overall Study|Lost to Follow-up|1|||
164291824|NCT01611194|593438152|FG000|Overall Study|Withdrawal by Subject|0|||
164291825|NCT01611194|593438153|FG001|Overall Study|Withdrawal by Subject|1|||
164291826|NCT01611194|593438152|FG000|Overall Study|drug use|0|||
164291827|NCT01611194|593438153|FG001|Overall Study|drug use|1|||
164291828|NCT02464410|593438165|FG000|Overall Study|Death|3|||
164291829|NCT02464410|593438166|FG001|Overall Study|Death|4|||
164291830|NCT02464410|593438165|FG000|Overall Study|Lost to Follow-up|7|||
164291831|NCT02464410|593438166|FG001|Overall Study|Lost to Follow-up|9|||
164291832|NCT02464410|593438165|FG000|Overall Study|Withdrawal by Subject|12|||
164291833|NCT02464410|593438166|FG001|Overall Study|Withdrawal by Subject|3|||
164291834|NCT01871519|593438167|FG000|Overall Study|Death|26|||
164291835|NCT01871519|593438167|FG000|Overall Study|Lost to Follow-up|15|||
164291836|NCT01871519|593438167|FG000|Overall Study|Withdrawal by Subject|49|||
164291837|NCT01777776|593438168|FG000|Overall Study|Adverse Event|2|||
164291838|NCT01777776|593438169|FG001|Overall Study|Adverse Event|4|||
164291839|NCT01777776|593438170|FG002|Overall Study|Adverse Event|0|||
164291840|NCT01777776|593438171|FG003|Overall Study|Adverse Event|0|||
164291841|NCT01777776|593438168|FG000|Overall Study|Disease Progression|4|||
164291842|NCT01777776|593438169|FG001|Overall Study|Disease Progression|8|||
164291843|NCT01777776|593438170|FG002|Overall Study|Disease Progression|6|||
164291844|NCT01777776|593438171|FG003|Overall Study|Disease Progression|3|||
164291845|NCT01777776|593438168|FG000|Overall Study|Withdrawal by Subject|0|||
164291846|NCT01777776|593438169|FG001|Overall Study|Withdrawal by Subject|0|||
164291847|NCT01777776|593438170|FG002|Overall Study|Withdrawal by Subject|0|||
164291848|NCT01777776|593438171|FG003|Overall Study|Withdrawal by Subject|1|||
164291849|NCT02775916|593438172|FG000|Overall Study|Adverse Event|1|||
164291850|NCT02775916|593438173|FG001|Overall Study|Adverse Event|0|||
164291851|NCT02775916|593438172|FG000|Overall Study|Subject/Guardian Decision|2|||
164291852|NCT02775916|593438173|FG001|Overall Study|Subject/Guardian Decision|0|||
164291853|NCT02426580|593439517|FG000|Overall Study|Death|2|||
164291854|NCT02426580|593439518|FG001|Overall Study|Death|2|||
164291855|NCT02426580|593439517|FG000|Overall Study|Lost to Follow-up|0|||
164291856|NCT02426580|593439518|FG001|Overall Study|Lost to Follow-up|9|||
164291857|NCT02426580|593439517|FG000|Overall Study|transfer to hemodialysis|5|||
164291858|NCT02426580|593439518|FG001|Overall Study|transfer to hemodialysis|5|||
164291859|NCT02426580|593439517|FG000|Overall Study|Kidney transplant|3|||
164291860|NCT02426580|593439518|FG001|Overall Study|Kidney transplant|0|||
164291861|NCT02426580|593439517|FG000|Overall Study|Allergic to egg white|1|||
164433890|NCT00015457|593958620|FG000|First Intervention|Lack of Efficacy|0|||
164291862|NCT02426580|593439518|FG001|Overall Study|Allergic to egg white|0|||
164291863|NCT00762359|593439519|FG000|Overall Study|Adverse Event|20|||
164291864|NCT00762359|593439520|FG001|Overall Study|Adverse Event|23|||
164291865|NCT00762359|593439519|FG000|Overall Study|Protocol Violation|21|||
164291866|NCT00762359|593439520|FG001|Overall Study|Protocol Violation|13|||
164291867|NCT00762359|593439519|FG000|Overall Study|Withdrawal by Subject|13|||
164291868|NCT00762359|593439520|FG001|Overall Study|Withdrawal by Subject|10|||
164291869|NCT00762359|593439519|FG000|Overall Study|Lack of Efficacy|0|||
164291870|NCT00762359|593439520|FG001|Overall Study|Lack of Efficacy|4|||
164291871|NCT00762359|593439519|FG000|Overall Study|Institution closed|2|||
164291872|NCT00762359|593439520|FG001|Overall Study|Institution closed|3|||
164291873|NCT00762359|593439519|FG000|Overall Study|Physician Decision|2|||
164291874|NCT00762359|593439520|FG001|Overall Study|Physician Decision|3|||
164291875|NCT00762359|593439519|FG000|Overall Study|Removal|0|||
164291876|NCT00762359|593439520|FG001|Overall Study|Removal|1|||
164291877|NCT00762359|593439519|FG000|Overall Study|Withdrew consent|1|||
164291878|NCT00762359|593439520|FG001|Overall Study|Withdrew consent|0|||
164291879|NCT01535807|593439522|FG000|Overall Study|Withdrawal by Subject|1|||
164291880|NCT01535807|593439523|FG001|Overall Study|Withdrawal by Subject|1|||
164291881|NCT01535807|593439522|FG000|Overall Study|Data collection error|1|||
164291882|NCT01535807|593439523|FG001|Overall Study|Data collection error|1|||
164291883|NCT00833040|593439526|FG000|Overall Study|Adverse Event|0|||
164291884|NCT00833040|593439527|FG001|Overall Study|Adverse Event|0|||
164291885|NCT00833040|593439528|FG002|Overall Study|Adverse Event|0|||
164291886|NCT00833040|593439529|FG003|Overall Study|Adverse Event|0|||
164291887|NCT00833040|593439530|FG004|Overall Study|Adverse Event|0|||
164291888|NCT00833040|593439531|FG005|Overall Study|Adverse Event|1|||
164291889|NCT00416624|593439532|FG000|Overall Study|Withdrawal by Subject|1|||
164291890|NCT00416624|593439533|FG001|Overall Study|Withdrawal by Subject|6|||
164291891|NCT00416624|593439534|FG002|Overall Study|Withdrawal by Subject|4|||
164291892|NCT00416624|593439535|FG003|Overall Study|Withdrawal by Subject|9|||
164291893|NCT00416624|593439532|FG000|Overall Study|Death|4|||
164291894|NCT00416624|593439533|FG001|Overall Study|Death|7|||
164291895|NCT00416624|593439534|FG002|Overall Study|Death|7|||
164291896|NCT00416624|593439535|FG003|Overall Study|Death|1|||
164291897|NCT00416624|593439532|FG000|Overall Study|Adverse Event|8|||
164291898|NCT00416624|593439533|FG001|Overall Study|Adverse Event|3|||
164291899|NCT00416624|593439534|FG002|Overall Study|Adverse Event|2|||
164291900|NCT00416624|593439535|FG003|Overall Study|Adverse Event|2|||
164291901|NCT00416624|593439532|FG000|Overall Study|Other|8|||
164291902|NCT00416624|593439533|FG001|Overall Study|Other|11|||
164291903|NCT00416624|593439534|FG002|Overall Study|Other|5|||
164291904|NCT00416624|593439535|FG003|Overall Study|Other|5|||
164291905|NCT00416624|593439532|FG000|Overall Study|Cancel|1|||
164291906|NCT00416624|593439533|FG001|Overall Study|Cancel|0|||
164291907|NCT00416624|593439534|FG002|Overall Study|Cancel|0|||
164291908|NCT00416624|593439535|FG003|Overall Study|Cancel|0|||
164291909|NCT02193776|593439536|FG000|Overall Study|Consent withdrawn|1|||
164291910|NCT02193776|593439537|FG001|Overall Study|Consent withdrawn|0|||
164291911|NCT02193776|593439538|FG002|Overall Study|Consent withdrawn|0|||
164291912|NCT02193776|593439539|FG003|Overall Study|Consent withdrawn|0|||
164291913|NCT02193776|593439536|FG000|Overall Study|Failure to comply with protocol|0|||
164291914|NCT02193776|593439537|FG001|Overall Study|Failure to comply with protocol|1|||
164291915|NCT02193776|593439538|FG002|Overall Study|Failure to comply with protocol|0|||
164291916|NCT02193776|593439539|FG003|Overall Study|Failure to comply with protocol|0|||
164291917|NCT02193776|593439536|FG000|Overall Study|Investigator/Sponsor decision|1|||
164291918|NCT02193776|593439537|FG001|Overall Study|Investigator/Sponsor decision|1|||
164291919|NCT02193776|593439538|FG002|Overall Study|Investigator/Sponsor decision|0|||
164291920|NCT02193776|593439539|FG003|Overall Study|Investigator/Sponsor decision|0|||
164291921|NCT02193776|593439536|FG000|Overall Study|Death|1|||
164291922|NCT02193776|593439537|FG001|Overall Study|Death|0|||
164291923|NCT02193776|593439538|FG002|Overall Study|Death|0|||
164291924|NCT02193776|593439539|FG003|Overall Study|Death|0|||
164291925|NCT02193776|593439536|FG000|Overall Study|Adverse event/Specific toxicity|5|||
164291926|NCT02193776|593439537|FG001|Overall Study|Adverse event/Specific toxicity|5|||
164291927|NCT02193776|593439538|FG002|Overall Study|Adverse event/Specific toxicity|2|||
164291928|NCT02193776|593439539|FG003|Overall Study|Adverse event/Specific toxicity|2|||
164291929|NCT00657540|593439546|FG000|Overall Study|Lost to Follow-up|1|||
164291930|NCT00657540|593439547|FG001|Overall Study|Lost to Follow-up|4|||
164291931|NCT02043938|593439548|FG000|Overall Study|Withdrawal by Subject|7|||
164291932|NCT02043938|593439548|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
164291933|NCT02043938|593439548|FG000|Overall Study|No show by subject|1|||
164291934|NCT02043938|593439548|FG000|Overall Study|Investigator decision|1|||
164291935|NCT02611479|593439560|FG000|Baseline Enrollment|Exited study|13|||
164291936|NCT02611479|593439560|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
164291937|NCT02611479|593439560|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
164291938|NCT02611479|593439560|FG000|Data Cleaning|No baseline function or pain metrics|2|||
164291939|NCT02422498|593439565|FG000|Overall Study|Inevaluable|4|||
164291940|NCT02653326|593439566|FG000|Overall Study|Lost to Follow-up|10|||
164291941|NCT02653326|593439567|FG001|Overall Study|Lost to Follow-up|7|||
164291942|NCT01620060|593439568|FG000|Overall Study|Adverse Event|9|||
164291943|NCT01620060|593439568|FG000|Overall Study|Protocol Violation|1|||
164291944|NCT01620060|593439568|FG000|Overall Study|Withdrawal by Subject|1|||
164291945|NCT01620060|593439568|FG000|Overall Study|Did not comply with Study Produre|1|||
164291946|NCT01620060|593439568|FG000|Overall Study|Family emergency|1|||
164291947|NCT01620060|593439568|FG000|Overall Study|Per Sponsor Decision|2|||
164291948|NCT01960140|593439569|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
164291949|NCT03452540|593439570|FG000|Overall Study|Adverse Event|1|||
164291950|NCT03452540|593439570|FG000|Overall Study|Withdrawal by Subject|1|||
164291951|NCT03452540|593439570|FG000|Overall Study|Other SAE and AE|2|||
164291952|NCT04664153|593439573|FG000|Overall Study|Lack of Efficacy|0|||
164291953|NCT04664153|593439574|FG001|Overall Study|Lack of Efficacy|0|||
164291954|NCT04664153|593439575|FG002|Overall Study|Lack of Efficacy|1|||
164291955|NCT04664153|593439576|FG003|Overall Study|Lack of Efficacy|0|||
164291956|NCT04664153|593439573|FG000|Overall Study|Physician Decision|0|||
164291957|NCT04664153|593439574|FG001|Overall Study|Physician Decision|0|||
164291958|NCT04664153|593439575|FG002|Overall Study|Physician Decision|1|||
164291959|NCT04664153|593439576|FG003|Overall Study|Physician Decision|0|||
164291960|NCT04664153|593439573|FG000|Overall Study|Withdrawal by Subject|3|||
164291961|NCT04664153|593439574|FG001|Overall Study|Withdrawal by Subject|2|||
164291962|NCT04664153|593439575|FG002|Overall Study|Withdrawal by Subject|1|||
164291963|NCT04664153|593439576|FG003|Overall Study|Withdrawal by Subject|2|||
164291964|NCT04664153|593439573|FG000|Overall Study|Other|0|||
164291965|NCT04664153|593439574|FG001|Overall Study|Other|1|||
164291966|NCT04664153|593439575|FG002|Overall Study|Other|0|||
164291967|NCT04664153|593439576|FG003|Overall Study|Other|0|||
164291968|NCT04664153|593439573|FG000|Overall Study|Adverse Event|4|||
164291969|NCT04664153|593439574|FG001|Overall Study|Adverse Event|0|||
164291970|NCT04664153|593439575|FG002|Overall Study|Adverse Event|1|||
164291971|NCT04664153|593439576|FG003|Overall Study|Adverse Event|0|||
164291972|NCT00231777|593439578|FG000|Overall Study|Lost to Follow-up|3|||
164291973|NCT00231777|593439579|FG001|Overall Study|Lost to Follow-up|0|||
164291974|NCT00231777|593439578|FG000|Overall Study|Other|3|||
164291975|NCT00231777|593439579|FG001|Overall Study|Other|2|||
164291976|NCT00524485|593439580|FG000|Overall Study|Withdrawal by Subject|5|||
164291977|NCT01600885|593439581|FG000|First Period|Adverse Event|1|||
164291978|NCT01600885|593439582|FG001|First Period|Adverse Event|1|||
164291979|NCT01600885|593439581|FG000|First Period|moved out of area|1|||
164291980|NCT01600885|593439582|FG001|First Period|moved out of area|0|||
164291981|NCT00642356|593439596|FG000|Overall Study|Adverse Event|1|||
164291982|NCT00642356|593439597|FG001|Overall Study|Adverse Event|0|||
164291983|NCT00642356|593439596|FG000|Overall Study|Protocol Violation|0|||
164291984|NCT00642356|593439597|FG001|Overall Study|Protocol Violation|3|||
164291985|NCT00642356|593439596|FG000|Overall Study|Lack of Efficacy|1|||
164291986|NCT00642356|593439597|FG001|Overall Study|Lack of Efficacy|0|||
164291987|NCT01009060|593439600|FG000|Overall Study|Adverse Event|1|||
164291988|NCT01009060|593439601|FG001|Overall Study|Adverse Event|2|||
164291989|NCT01009060|593439600|FG000|Overall Study|Protocol Violation|0|||
164291990|NCT01009060|593439601|FG001|Overall Study|Protocol Violation|1|||
164291991|NCT01009060|593439600|FG000|Overall Study|Lost to Follow-up|1|||
164291992|NCT01009060|593439601|FG001|Overall Study|Lost to Follow-up|0|||
164291993|NCT01009060|593439600|FG000|Overall Study|Physician Decision|1|||
164291994|NCT01009060|593439601|FG001|Overall Study|Physician Decision|1|||
164291995|NCT01009060|593439600|FG000|Overall Study|Withdrawal by Subject|1|||
164291996|NCT01009060|593439601|FG001|Overall Study|Withdrawal by Subject|1|||
164291997|NCT00005906|593439602|FG000|Overall Study|Lack of Efficacy|3|||
164291998|NCT04551989|593439603|FG000|Overall Study|Adverse Event|4|||
164291999|NCT04551989|593439603|FG000|Overall Study|Protocol Violation|3|||
164292000|NCT04551989|593439603|FG000|Overall Study|Lost to Follow-up|1|||
164292001|NCT04551989|593439603|FG000|Overall Study|Physician Decision|3|||
164292002|NCT04201431|593439604|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
164292003|NCT04201431|593439605|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
164292004|NCT04201431|593439606|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
164292005|NCT00088530|593439611|FG000|Overall Study|Progressive/Relapsed Disease|28|||
164292006|NCT00088530|593439612|FG001|Overall Study|Progressive/Relapsed Disease|39|||
164292007|NCT00088530|593439611|FG000|Overall Study|Adverse Event|15|||
164292008|NCT00088530|593439612|FG001|Overall Study|Adverse Event|9|||
164292009|NCT00088530|593439611|FG000|Overall Study|Withdrawal by Subject|2|||
164292010|NCT00088530|593439612|FG001|Overall Study|Withdrawal by Subject|5|||
164292011|NCT00088530|593439611|FG000|Overall Study|Lost to Follow-up|2|||
164292012|NCT00088530|593439612|FG001|Overall Study|Lost to Follow-up|0|||
164292013|NCT00088530|593439611|FG000|Overall Study|Physician Decision|2|||
164292014|NCT00088530|593439612|FG001|Overall Study|Physician Decision|0|||
164292015|NCT00088530|593439611|FG000|Overall Study|Sponsor decision|0|||
164292016|NCT00088530|593439612|FG001|Overall Study|Sponsor decision|1|||
164292017|NCT00088530|593439611|FG000|Overall Study|Patient never treated|1|||
164292018|NCT00088530|593439612|FG001|Overall Study|Patient never treated|0|||
164292019|NCT04571944|593439613|FG000|Overall Study|Death|1|||
164292020|NCT04571944|593439614|FG001|Overall Study|Death|0|||
164292021|NCT04571944|593439613|FG000|Overall Study|Withdrawal by Subject|3|||
164292022|NCT04571944|593439614|FG001|Overall Study|Withdrawal by Subject|0|||
164292023|NCT04571944|593439613|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
164299946|NCT05138653|593472961|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
164299947|NCT05138653|593472962|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299948|NCT05138653|593472963|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299949|NCT05138653|593472964|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299950|NCT05138653|593472965|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299951|NCT05138653|593472966|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299952|NCT05138653|593472967|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299953|NCT05138653|593472968|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164433891|NCT00015457|593958621|FG001|First Intervention|Lack of Efficacy|1|||
164433892|NCT00015457|593958620|FG000|Second Intervention|Withdrawal by Subject|1|||
164433893|NCT00015457|593958621|FG001|Second Intervention|Withdrawal by Subject|0|||
164433894|NCT01456936|593958622|FG000|Overall Study|Other reason|41|||
164433895|NCT01456936|593958623|FG001|Overall Study|Other reason|30|||
164433896|NCT01456936|593958624|FG002|Overall Study|Other reason|36|||
164433897|NCT01456936|593958625|FG003|Overall Study|Other reason|33|||
164433898|NCT01456936|593958622|FG000|Overall Study|No longer meets eligibility criteria|4|||
164433899|NCT01456936|593958623|FG001|Overall Study|No longer meets eligibility criteria|8|||
164433900|NCT01456936|593958624|FG002|Overall Study|No longer meets eligibility criteria|6|||
164433901|NCT01456936|593958625|FG003|Overall Study|No longer meets eligibility criteria|5|||
164433902|NCT01456936|593958622|FG000|Overall Study|Protocol Violation|4|||
164433903|NCT01456936|593958623|FG001|Overall Study|Protocol Violation|2|||
164433904|NCT01456936|593958624|FG002|Overall Study|Protocol Violation|5|||
164433905|NCT01456936|593958625|FG003|Overall Study|Protocol Violation|5|||
164433906|NCT01456936|593958622|FG000|Overall Study|Pregnancy|1|||
164433907|NCT01456936|593958623|FG001|Overall Study|Pregnancy|0|||
164433908|NCT01456936|593958624|FG002|Overall Study|Pregnancy|0|||
164433909|NCT01456936|593958625|FG003|Overall Study|Pregnancy|1|||
164433910|NCT01456936|593958622|FG000|Overall Study|Insufficient clinical response|4|||
164433911|NCT01456936|593958623|FG001|Overall Study|Insufficient clinical response|4|||
164433912|NCT01456936|593958624|FG002|Overall Study|Insufficient clinical response|14|||
164433913|NCT01456936|593958625|FG003|Overall Study|Insufficient clinical response|13|||
164433914|NCT01456936|593958622|FG000|Overall Study|No longer willing to participate|195|||
164433915|NCT01456936|593958623|FG001|Overall Study|No longer willing to participate|218|||
164586826|NCT02975349|594511916|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
164586827|NCT02975349|594511917|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
164586828|NCT02975349|594511918|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
164586829|NCT02975349|594511919|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
164586830|NCT02975349|594511920|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
164586831|NCT02975349|594511921|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
164586832|NCT02975349|594511915|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
164586833|NCT02975349|594511916|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
164586834|NCT02975349|594511917|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
164586835|NCT02975349|594511918|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
164586836|NCT02975349|594511919|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
164586837|NCT02975349|594511920|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
164586838|NCT02975349|594511921|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
164586839|NCT02975349|594511915|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
164586840|NCT02975349|594511916|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
164586841|NCT02975349|594511917|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
164586842|NCT02975349|594511918|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
164586843|NCT02975349|594511919|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
164586844|NCT02975349|594511920|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
164586845|NCT02975349|594511921|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
164586846|NCT02975349|594511915|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
164586847|NCT02975349|594511916|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
164586848|NCT02975349|594511917|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
164586849|NCT02975349|594511918|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
164586850|NCT02975349|594511919|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
164586851|NCT02975349|594511920|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
164586852|NCT02975349|594511921|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
164586853|NCT02975349|594511915|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
164586854|NCT02975349|594511916|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
164586855|NCT02975349|594511917|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
164586856|NCT02975349|594511918|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
164586857|NCT02975349|594511919|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
164433916|NCT01456936|593958624|FG002|Overall Study|No longer willing to participate|224|||
164433917|NCT01456936|593958625|FG003|Overall Study|No longer willing to participate|248|||
164433918|NCT01456936|593958622|FG000|Overall Study|Lost to Follow-up|135|||
164586858|NCT02975349|594511920|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
164586859|NCT02975349|594511921|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
164586860|NCT02975349|594511915|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
164586861|NCT02975349|594511916|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
164433919|NCT01456936|593958623|FG001|Overall Study|Lost to Follow-up|126|||
164433920|NCT01456936|593958624|FG002|Overall Study|Lost to Follow-up|144|||
164433921|NCT01456936|593958625|FG003|Overall Study|Lost to Follow-up|127|||
164433922|NCT01456936|593958622|FG000|Overall Study|Medication error|0|||
164433923|NCT01456936|593958623|FG001|Overall Study|Medication error|1|||
164346058|NCT01397708|593641143|FG003|Overall Study|Other|0|||
164346059|NCT01397708|593641144|FG004|Overall Study|Other|0|||
164346060|NCT01397708|593641145|FG005|Overall Study|Other|0|||
164346061|NCT01397708|593641146|FG006|Overall Study|Other|1|||
164346062|NCT01397708|593641147|FG007|Overall Study|Other|0|||
164346063|NCT04997304|593641148|FG000|Overall Study|Lost to Follow-up|11|||
164346064|NCT04997304|593641148|FG000|Overall Study|Death|1|||
164346065|NCT04997304|593641148|FG000|Overall Study|Withdrawal by Subject|14|||
164346066|NCT01606800|593642758|FG000|Overall Study|Adverse Event|3|||
164346067|NCT01606800|593642759|FG001|Overall Study|Adverse Event|1|||
164346068|NCT01606800|593642758|FG000|Overall Study|Participant withdrew consent|0|||
164346069|NCT01606800|593642759|FG001|Overall Study|Participant withdrew consent|1|||
164346070|NCT01606800|593642758|FG000|Overall Study|Missing completion status|2|||
164346071|NCT01606800|593642759|FG001|Overall Study|Missing completion status|0|||
164346072|NCT00612690|593642765|FG000|Overall Study|Lost to Follow-up|72|||
164346073|NCT00612690|593642766|FG001|Overall Study|Lost to Follow-up|98|||
164346074|NCT00612690|593642765|FG000|Overall Study|Withdrawal by Subject|32|||
164346075|NCT00612690|593642766|FG001|Overall Study|Withdrawal by Subject|20|||
164346076|NCT00612690|593642765|FG000|Overall Study|Withdrawal by Site|11|||
164346077|NCT00612690|593642766|FG001|Overall Study|Withdrawal by Site|0|||
164346078|NCT02370160|593642769|FG000|Overall Study|Death|3|||
164346079|NCT02370160|593642770|FG001|Overall Study|Death|4|||
164346080|NCT02370160|593642771|FG002|Overall Study|Death|1|||
164346081|NCT04487730|593642772|FG000|Overall Study|Withdrawal by Subject|3|||
164346082|NCT04487730|593642773|FG001|Overall Study|Withdrawal by Subject|1|||
164346083|NCT04487730|593642772|FG000|Overall Study|Lost to Follow-up|0|||
164346084|NCT04487730|593642773|FG001|Overall Study|Lost to Follow-up|1|||
164346085|NCT04487730|593642772|FG000|Overall Study|Physician Decision|0|||
164346086|NCT04487730|593642773|FG001|Overall Study|Physician Decision|1|||
164346087|NCT00907777|593642774|FG000|Overall Study|Withdrawal by Subject|0|||
164346088|NCT00907777|593642775|FG001|Overall Study|Withdrawal by Subject|1|||
164346089|NCT03291808|593642776|FG000|Overall Study|Lost to Follow-up|6|||
164346090|NCT03291808|593642776|FG000|Overall Study|Research burden|4|||
164346091|NCT00638378|593642777|FG000|Overall Study|Death|2|||
164346092|NCT00638378|593642777|FG000|Overall Study|Adverse Event|1|||
164346093|NCT00638378|593642777|FG000|Overall Study|Disease progression|15|||
164346094|NCT00638378|593642777|FG000|Overall Study|Physician Decision|4|||
164346095|NCT03364023|593642778|FG000|Overall Study|Lost to Follow-up|3|||
164346096|NCT03364023|593642778|FG000|Overall Study|Death|14|||
164346097|NCT02891850|593642779|FG000|Overall Study|Adverse Event|3|||
164346098|NCT02891850|593642780|FG001|Overall Study|Adverse Event|0|||
164346099|NCT02891850|593642779|FG000|Overall Study|Death|0|||
164346100|NCT02891850|593642780|FG001|Overall Study|Death|4|||
164346101|NCT02891850|593642779|FG000|Overall Study|Physician Decision|1|||
164346102|NCT02891850|593642780|FG001|Overall Study|Physician Decision|0|||
164346103|NCT02891850|593642779|FG000|Overall Study|Pregnancy|1|||
164346104|NCT02891850|593642780|FG001|Overall Study|Pregnancy|0|||
164346105|NCT02891850|593642779|FG000|Overall Study|Withdrawal by Subject|2|||
164346106|NCT02891850|593642780|FG001|Overall Study|Withdrawal by Subject|3|||
164346107|NCT03797014|593642783|FG000|Overall Study|Withdrawal by Subject|1|||
164346108|NCT03797014|593642783|FG000|Overall Study|Lost to Follow-up|1|||
164346109|NCT03797014|593642783|FG000|Overall Study|Protocol Violation|1|||
164346110|NCT01970397|593642784|FG000|Overall Study|Adverse Event|0|||
164346111|NCT01970397|593642785|FG001|Overall Study|Adverse Event|1|||
164346112|NCT01970397|593642784|FG000|Overall Study|Lost to Follow-up|0|||
164346113|NCT01970397|593642785|FG001|Overall Study|Lost to Follow-up|1|||
164346114|NCT01970397|593642784|FG000|Overall Study|Personal Reasons|1|||
164346115|NCT01970397|593642785|FG001|Overall Study|Personal Reasons|2|||
164346116|NCT01970397|593642784|FG000|Overall Study|Protocol Violation|1|||
164346117|NCT01970397|593642785|FG001|Overall Study|Protocol Violation|1|||
164346118|NCT00105469|593642790|FG000|Overall Study|Adverse Event|9|||
164346119|NCT00105469|593642791|FG001|Overall Study|Adverse Event|8|||
164346120|NCT00105469|593642790|FG000|Overall Study|Protocol Violation|4|||
164346121|NCT00105469|593642791|FG001|Overall Study|Protocol Violation|0|||
164346122|NCT00105469|593642790|FG000|Overall Study|Withdrawal by Subject|2|||
164346123|NCT00105469|593642791|FG001|Overall Study|Withdrawal by Subject|3|||
164346124|NCT00105469|593642790|FG000|Overall Study|Lost to Follow-up|1|||
164346125|NCT00105469|593642791|FG001|Overall Study|Lost to Follow-up|0|||
164346126|NCT00105469|593642790|FG000|Overall Study|Lack of Efficacy|2|||
164346127|NCT00105469|593642791|FG001|Overall Study|Lack of Efficacy|0|||
164346128|NCT00105469|593642790|FG000|Overall Study|Other Reason|4|||
164346129|NCT00105469|593642791|FG001|Overall Study|Other Reason|0|||
164346130|NCT00056316|593642792|FG000|Overall Study|Withdrawal by Subject|2|||
164346131|NCT00056316|593642793|FG001|Overall Study|Withdrawal by Subject|2|||
164346132|NCT00056316|593642792|FG000|Overall Study|Death/NH placement of pt|1|||
164346133|NCT00056316|593642793|FG001|Overall Study|Death/NH placement of pt|1|||
164346134|NCT00573469|593642801|FG000|Overall Study|Adverse Event|1|||
164346135|NCT00573469|593642802|FG001|Overall Study|Adverse Event|1|||
164346136|NCT00573469|593642803|FG002|Overall Study|Adverse Event|1|||
164346137|NCT00573469|593642801|FG000|Overall Study|Withdrawal by Subject|0|||
164433924|NCT01456936|593958624|FG002|Overall Study|Medication error|0|||
164292024|NCT04571944|593439614|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
164292025|NCT00686777|593439618|FG000|Overall Study|Adverse Event|2|||
164292026|NCT00686777|593439618|FG000|Overall Study|Pregnancy|1|||
164292027|NCT00686777|593439618|FG000|Overall Study|Withdrawal by Subject|2|||
164292028|NCT00686777|593439618|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
164292029|NCT00686777|593439618|FG000|Overall Study|No Visit|1|||
164292030|NCT00499681|593439619|FG000|Overall Study|toxicity|0|||
164292031|NCT00499681|593439620|FG001|Overall Study|toxicity|1|||
164292032|NCT00499681|593439619|FG000|Overall Study|disease progression|0|||
164292033|NCT00499681|593439620|FG001|Overall Study|disease progression|1|||
164292034|NCT00890825|593439621|FG000|Overall Study|Withdrawal by Subject|1|||
164292035|NCT00890825|593439622|FG001|Overall Study|Withdrawal by Subject|0|||
164292036|NCT00890825|593439621|FG000|Overall Study|Alive at data cut off (DCO)|13|||
164292037|NCT00890825|593439622|FG001|Overall Study|Alive at data cut off (DCO)|14|||
164292038|NCT02920892|593439623|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
164292039|NCT02920892|593439624|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
164292040|NCT02920892|593439625|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
164292041|NCT02920892|593439623|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
164292042|NCT02920892|593439624|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
164346138|NCT00573469|593642802|FG001|Overall Study|Withdrawal by Subject|2|||
164346139|NCT00573469|593642803|FG002|Overall Study|Withdrawal by Subject|0|||
164346140|NCT00573469|593642801|FG000|Overall Study|Other|5|||
164346141|NCT00573469|593642802|FG001|Overall Study|Other|1|||
164346142|NCT00573469|593642803|FG002|Overall Study|Other|3|||
164346143|NCT02468414|593642804|FG000|Overall Study|Early Study Termination by Sponsor|1|||
164346144|NCT02468414|593642805|FG001|Overall Study|Early Study Termination by Sponsor|0|||
164346145|NCT02468414|593642804|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
164346146|NCT02468414|593642805|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
164346147|NCT02468414|593642804|FG000|Overall Study|Screen Failure|1|||
164346148|NCT02468414|593642805|FG001|Overall Study|Screen Failure|0|||
164346149|NCT00004978|593642806|FG000|Overall Study|Death|107|||
164346150|NCT00004978|593642807|FG001|Overall Study|Death|116|||
164346151|NCT00004978|593642806|FG000|Overall Study|Lost to Follow-up|101|||
164346152|NCT00004978|593642807|FG001|Overall Study|Lost to Follow-up|108|||
164346153|NCT00004978|593642806|FG000|Overall Study|Withdrawal by Subject|17|||
164346154|NCT00004978|593642807|FG001|Overall Study|Withdrawal by Subject|26|||
164346155|NCT00004978|593642806|FG000|Overall Study|site closure - not in analysis cohort|19|||
164346156|NCT00004978|593642807|FG001|Overall Study|site closure - not in analysis cohort|20|||
164346157|NCT02155608|593642812|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
164346158|NCT02155608|593642813|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
164346159|NCT02155608|593642812|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
164346160|NCT02155608|593642813|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
164346161|NCT03555591|593642814|FG000|Overall Study|Protocol Violation|77|||
164346162|NCT01532414|593642817|FG000|Overall Study|Lost to Follow-up|3|||
164346163|NCT01532414|593642818|FG001|Overall Study|Lost to Follow-up|0|||
164346164|NCT01532414|593642819|FG002|Overall Study|Lost to Follow-up|1|||
164346165|NCT01532414|593642817|FG000|Overall Study|Withdrawal by Subject|3|||
164346166|NCT01532414|593642818|FG001|Overall Study|Withdrawal by Subject|0|||
164346167|NCT01532414|593642819|FG002|Overall Study|Withdrawal by Subject|0|||
164346168|NCT01532414|593642817|FG000|Overall Study|No V6 semen sample|0|||
164346169|NCT01532414|593642818|FG001|Overall Study|No V6 semen sample|1|||
164346170|NCT01532414|593642819|FG002|Overall Study|No V6 semen sample|0|||
164346171|NCT01532414|593642817|FG000|Overall Study|Adverse Event|0|||
164346172|NCT01532414|593642818|FG001|Overall Study|Adverse Event|1|||
164346173|NCT01532414|593642819|FG002|Overall Study|Adverse Event|1|||
164346174|NCT01532414|593642817|FG000|Overall Study|Unable to complete 24 hour PK|0|||
164346175|NCT01532414|593642818|FG001|Overall Study|Unable to complete 24 hour PK|0|||
164346176|NCT01532414|593642819|FG002|Overall Study|Unable to complete 24 hour PK|1|||
164346177|NCT01532414|593642817|FG000|Overall Study|Withdrawn by sponsor|1|||
164346178|NCT01532414|593642818|FG001|Overall Study|Withdrawn by sponsor|0|||
164346179|NCT01532414|593642819|FG002|Overall Study|Withdrawn by sponsor|0|||
164346180|NCT05035550|593642827|FG000|Overall Study|Withdrawal by Subject|3|||
164433925|NCT01456936|593958625|FG003|Overall Study|Medication error|1|||
164292043|NCT02920892|593439625|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
164292044|NCT02920892|593439623|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
164292045|NCT02920892|593439624|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
164346181|NCT05035550|593642828|FG001|Overall Study|Withdrawal by Subject|0|||
164346182|NCT00160693|593642831|FG000|Overall Study|Adverse Event|97|||
164346183|NCT00160693|593642831|FG000|Overall Study|Lack of Efficacy|30|||
164346184|NCT00160693|593642831|FG000|Overall Study|Protocol Violation|24|||
164346185|NCT00160693|593642831|FG000|Overall Study|Lost to Follow-up|15|||
164346186|NCT00160693|593642831|FG000|Overall Study|Withdrawal by Subject|54|||
164346187|NCT00160693|593642831|FG000|Overall Study|Study terminated by sponsor|15|||
164346188|NCT00617123|593642832|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
164346189|NCT00617123|593642833|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
164292046|NCT02920892|593439625|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
164292047|NCT02920892|593439623|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
164292048|NCT02920892|593439624|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
164433926|NCT01456936|593958622|FG000|Overall Study|Adverse event (study drug)|25|||
164292049|NCT02920892|593439625|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
164292050|NCT02920892|593439623|FG000|Placebo-Controlled Period|Physician Decision|0|||
164292051|NCT02920892|593439624|FG001|Placebo-Controlled Period|Physician Decision|0|||
164292052|NCT02920892|593439625|FG002|Placebo-Controlled Period|Physician Decision|1|||
164292053|NCT02920892|593439623|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
164292054|NCT02920892|593439624|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
164292055|NCT02920892|593439625|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
164292056|NCT02920892|593439623|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
164292057|NCT02920892|593439624|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
164292058|NCT02920892|593439625|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
164292059|NCT02920892|593439623|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
164292060|NCT02920892|593439624|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
164292061|NCT02920892|593439625|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
164433927|NCT01456936|593958623|FG001|Overall Study|Adverse event (study drug)|21|||
164433928|NCT01456936|593958624|FG002|Overall Study|Adverse event (study drug)|26|||
164433929|NCT01456936|593958625|FG003|Overall Study|Adverse event (study drug)|17|||
164433930|NCT01456936|593958622|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
164433931|NCT01456936|593958623|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
164433932|NCT01456936|593958624|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
164433933|NCT01456936|593958625|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
164433934|NCT01456936|593958622|FG000|Overall Study|Death|0|||
164433935|NCT01456936|593958623|FG001|Overall Study|Death|3|||
164433936|NCT01456936|593958624|FG002|Overall Study|Death|1|||
164433937|NCT01456936|593958625|FG003|Overall Study|Death|3|||
164433938|NCT01456936|593958622|FG000|Overall Study|Randomized but not treated|21|||
164433939|NCT01456936|593958623|FG001|Overall Study|Randomized but not treated|28|||
164433940|NCT01456936|593958624|FG002|Overall Study|Randomized but not treated|16|||
164433941|NCT01456936|593958625|FG003|Overall Study|Randomized but not treated|21|||
164433942|NCT01744691|593958628|FG000|Overall Study|Progressive Disease|18|||
164433943|NCT01744691|593958628|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
164433944|NCT01744691|593958628|FG000|Overall Study|Withdrawal of consent for treatment|3|||
164433945|NCT01744691|593958628|FG000|Overall Study|Physician Decision|4|||
164433946|NCT02701361|593958629|FG000|Overall Study|Lost to Follow-up|5|||
164433947|NCT02701361|593958630|FG001|Overall Study|Lost to Follow-up|2|||
164433948|NCT02701361|593958631|FG002|Overall Study|Lost to Follow-up|1|||
164433949|NCT02701361|593958629|FG000|Overall Study|Withdrawal by Subject|4|||
164433950|NCT02701361|593958630|FG001|Overall Study|Withdrawal by Subject|0|||
164433951|NCT02701361|593958631|FG002|Overall Study|Withdrawal by Subject|0|||
164433952|NCT02701361|593958629|FG000|Overall Study|timed out in rehab center|0|||
164433953|NCT02701361|593958630|FG001|Overall Study|timed out in rehab center|1|||
164433954|NCT02701361|593958631|FG002|Overall Study|timed out in rehab center|0|||
164433955|NCT02701361|593958629|FG000|Overall Study|incarceration|0|||
164433956|NCT02701361|593958630|FG001|Overall Study|incarceration|0|||
164433957|NCT02701361|593958631|FG002|Overall Study|incarceration|1|||
164433958|NCT01321606|593958637|FG000|Overall Study|Lost to Follow-up|0|||
164433959|NCT01321606|593958638|FG001|Overall Study|Lost to Follow-up|0|||
164433960|NCT01321606|593958639|FG002|Overall Study|Lost to Follow-up|0|||
164433961|NCT01321606|593958640|FG003|Overall Study|Lost to Follow-up|1|||
164433962|NCT03235349|593958643|FG000|Overall Study|Adverse Event|1|||
164433963|NCT03235349|593958643|FG000|Overall Study|Other|1|||
164433964|NCT03394027|593958644|FG000|Overall Study|Ineligible|3|||
164433965|NCT03394027|593958645|FG001|Overall Study|Ineligible|1|||
164433966|NCT03394027|593958646|FG002|Overall Study|Ineligible|3|||
164433967|NCT03394027|593958644|FG000|Overall Study|Participant declined to participate before treatment started|0|||
164292062|NCT01721161|593439626|FG000|Overall Study|Adverse Event|2|||
164292063|NCT01721161|593439627|FG001|Overall Study|Adverse Event|3|||
164433968|NCT03394027|593958645|FG001|Overall Study|Participant declined to participate before treatment started|0|||
164433969|NCT03394027|593958646|FG002|Overall Study|Participant declined to participate before treatment started|1|||
164433970|NCT04181827|593958649|FG000|Overall Study|Ongoing|124|||
164292064|NCT01721161|593439626|FG000|Overall Study|Lost to Follow-up|1|||
164292065|NCT01721161|593439627|FG001|Overall Study|Lost to Follow-up|2|||
164292066|NCT01721161|593439626|FG000|Overall Study|Withdrawal by Subject|1|||
164433971|NCT04181827|593958650|FG001|Overall Study|Ongoing|157|||
164433972|NCT04181827|593958649|FG000|Overall Study|Death|82|||
164433973|NCT04181827|593958650|FG001|Overall Study|Death|50|||
164433974|NCT04181827|593958649|FG000|Overall Study|Lost to Follow-up|0|||
164433975|NCT04181827|593958650|FG001|Overall Study|Lost to Follow-up|1|||
164433976|NCT04181827|593958649|FG000|Overall Study|Withdrawal by Subject|5|||
164433977|NCT04181827|593958650|FG001|Overall Study|Withdrawal by Subject|0|||
164292067|NCT01721161|593439627|FG001|Overall Study|Withdrawal by Subject|1|||
164292068|NCT01721161|593439626|FG000|Overall Study|Other|0|||
164433978|NCT03887936|593958652|FG000|Overall Study|Relocation|2|||
164433979|NCT03887936|593958653|FG001|Overall Study|Relocation|2|||
164433980|NCT03887936|593958652|FG000|Overall Study|Physician Decision|0|||
164433981|NCT03887936|593958653|FG001|Overall Study|Physician Decision|1|||
164433982|NCT03887936|593958652|FG000|Overall Study|Withdrawal by Subject|0|||
164433983|NCT03887936|593958653|FG001|Overall Study|Withdrawal by Subject|1|||
164433984|NCT06269367|593958654|FG000|Phase I|Unable to perform study procedures|0|||
164433985|NCT06269367|593958655|FG001|Phase I|Unable to perform study procedures|1|||
164433986|NCT06269367|593958654|FG000|Phase I|Could not continue study for personal reasons.|1|||
164433987|NCT06269367|593958655|FG001|Phase I|Could not continue study for personal reasons.|0|||
164433988|NCT03331250|593958656|FG000|Overall Study|Withdrawal by Subject|1|||
164433989|NCT05824351|593958664|FG000|Overall Study|Adverse Event|6|||
164586862|NCT02975349|594511917|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
164586863|NCT02975349|594511918|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
164586864|NCT02975349|594511919|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
164586865|NCT02975349|594511920|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
164292069|NCT01721161|593439627|FG001|Overall Study|Other|1|||
164292070|NCT01216202|593439628|FG000|Overall Study|Withdrawal by Subject|8|||
164292071|NCT01216202|593439629|FG001|Overall Study|Withdrawal by Subject|0|||
164292072|NCT01216202|593439628|FG000|Overall Study|Death|0|||
164292073|NCT01216202|593439629|FG001|Overall Study|Death|2|||
164292074|NCT01216202|593439628|FG000|Overall Study|Lost to Follow-up|14|||
164292075|NCT01216202|593439629|FG001|Overall Study|Lost to Follow-up|0|||
164292076|NCT00614380|593439632|FG000|Overall Study|Adverse Event|14|||
164292077|NCT00614380|593439633|FG001|Overall Study|Adverse Event|4|||
164292078|NCT00614380|593439634|FG002|Overall Study|Adverse Event|0|||
164292079|NCT00614380|593439635|FG003|Overall Study|Adverse Event|0|||
164292080|NCT00614380|593439632|FG000|Overall Study|Lost to Follow-up|6|||
164292081|NCT00614380|593439633|FG001|Overall Study|Lost to Follow-up|1|||
164292082|NCT00614380|593439634|FG002|Overall Study|Lost to Follow-up|0|||
164292083|NCT00614380|593439635|FG003|Overall Study|Lost to Follow-up|0|||
164292084|NCT00614380|593439632|FG000|Overall Study|Non compliant with the protocol|12|||
164292085|NCT00614380|593439633|FG001|Overall Study|Non compliant with the protocol|2|||
164292086|NCT00614380|593439634|FG002|Overall Study|Non compliant with the protocol|1|||
164292087|NCT00614380|593439635|FG003|Overall Study|Non compliant with the protocol|2|||
164292088|NCT00614380|593439632|FG000|Overall Study|Consent withdrawn|3|||
164292089|NCT00614380|593439633|FG001|Overall Study|Consent withdrawn|1|||
164292090|NCT00614380|593439634|FG002|Overall Study|Consent withdrawn|0|||
164292091|NCT00614380|593439635|FG003|Overall Study|Consent withdrawn|0|||
164292092|NCT00689390|593439638|FG000|Overall Study|Adverse Event|19|||
164292093|NCT00689390|593439639|FG001|Overall Study|Adverse Event|0|||
164292094|NCT00689390|593439638|FG000|Overall Study|Lost to Follow-up|179|||
164292095|NCT00689390|593439639|FG001|Overall Study|Lost to Follow-up|7|||
164292096|NCT00689390|593439638|FG000|Overall Study|Withdrawal by Subject|117|||
164292097|NCT00689390|593439639|FG001|Overall Study|Withdrawal by Subject|3|||
164292098|NCT00689390|593439638|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
164292099|NCT00689390|593439639|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
164292100|NCT00689390|593439638|FG000|Overall Study|Non-Compliance With Protocol|21|||
164292101|NCT00689390|593439639|FG001|Overall Study|Non-Compliance With Protocol|0|||
164292102|NCT00689390|593439638|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
164292103|NCT00689390|593439639|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
164292104|NCT00689390|593439638|FG000|Overall Study|Administrative|37|||
164292105|NCT00689390|593439639|FG001|Overall Study|Administrative|0|||
164292106|NCT04908397|593439642|FG000|Overall Study|Withdrawal by Subject|2|||
164292107|NCT00462306|593439643|FG000|Overall Study|insufficient data|0|||
164292108|NCT00462306|593439644|FG001|Overall Study|insufficient data|13|||
164292109|NCT00191334|593439650|FG000|Overall Study|Adverse Event|4|||
164292110|NCT00191334|593439650|FG000|Overall Study|Disease Progression or Relapse|8|||
164292111|NCT00191334|593439650|FG000|Overall Study|Physician Decision|1|||
164292112|NCT00191334|593439650|FG000|Overall Study|Withdrawal by Subject|4|||
164292113|NCT00452790|593439651|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
164292114|NCT00452790|593439652|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
164292115|NCT00452790|593439651|FG000|Infant Series|Parent/legal guardian request|8|||
164292116|NCT00452790|593439652|FG001|Infant Series|Parent/legal guardian request|6|||
164433990|NCT02912260|593958665|FG000|Main Study|Lost to Follow-up|5|||
164433991|NCT02912260|593958666|FG001|Main Study|Lost to Follow-up|4|||
164586866|NCT02975349|594511921|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
164586867|NCT02975349|594511915|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
164586868|NCT02975349|594511916|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
164586869|NCT02975349|594511917|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
164292117|NCT00452790|593439651|FG000|Infant Series|Failed to return|4|||
164433992|NCT02912260|593958665|FG000|Main Study|Withdrawal by Subject|2|||
164292118|NCT00452790|593439652|FG001|Infant Series|Failed to return|1|||
164433993|NCT02912260|593958666|FG001|Main Study|Withdrawal by Subject|2|||
164433994|NCT02912260|593958665|FG000|Main Study|Adverse Event|3|||
164433995|NCT02912260|593958666|FG001|Main Study|Adverse Event|0|||
164433996|NCT02912260|593958665|FG000|Main Study|Physician Decision|0|||
164433997|NCT02912260|593958666|FG001|Main Study|Physician Decision|1|||
164433998|NCT02912260|593958665|FG000|Extension Study|Withdrawal by Subject|1|||
164433999|NCT02912260|593958666|FG001|Extension Study|Withdrawal by Subject|1|||
164434000|NCT00124982|593958668|FG000|Short-term Period|Death|1|||
164434001|NCT00124982|593958669|FG001|Short-term Period|Death|1|||
164434002|NCT00124982|593958670|FG002|Short-term Period|Death|0|||
164434003|NCT00124982|593958668|FG000|Short-term Period|Adverse Event|17|||
164434004|NCT00124982|593958669|FG001|Short-term Period|Adverse Event|22|||
164434005|NCT00124982|593958670|FG002|Short-term Period|Adverse Event|0|||
164434006|NCT00124982|593958668|FG000|Short-term Period|Lack of Efficacy|32|||
164434007|NCT00124982|593958669|FG001|Short-term Period|Lack of Efficacy|73|||
164434008|NCT00124982|593958670|FG002|Short-term Period|Lack of Efficacy|0|||
164434009|NCT00124982|593958668|FG000|Short-term Period|Lost to Follow-up|8|||
164434010|NCT00124982|593958669|FG001|Short-term Period|Lost to Follow-up|5|||
164434011|NCT00124982|593958670|FG002|Short-term Period|Lost to Follow-up|0|||
164434012|NCT00124982|593958668|FG000|Short-term Period|Withdrawal of Consent|7|||
164434013|NCT00124982|593958669|FG001|Short-term Period|Withdrawal of Consent|9|||
164434014|NCT00124982|593958670|FG002|Short-term Period|Withdrawal of Consent|0|||
164434015|NCT00124982|593958668|FG000|Short-term Period|Poor/Non-compliance|3|||
164434016|NCT00124982|593958669|FG001|Short-term Period|Poor/Non-compliance|1|||
164434017|NCT00124982|593958670|FG002|Short-term Period|Poor/Non-compliance|0|||
164434018|NCT00124982|593958668|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
164434019|NCT00124982|593958669|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
164434020|NCT00124982|593958670|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
164434021|NCT00124982|593958668|FG000|Short-term Period|Participant Decision|1|||
164434022|NCT00124982|593958669|FG001|Short-term Period|Participant Decision|0|||
164434023|NCT00124982|593958670|FG002|Short-term Period|Participant Decision|0|||
164434024|NCT00124982|593958668|FG000|Short-term Period|Participant Chose Own Doctor|0|||
164434025|NCT00124982|593958669|FG001|Short-term Period|Participant Chose Own Doctor|1|||
164434026|NCT00124982|593958670|FG002|Short-term Period|Participant Chose Own Doctor|0|||
164434027|NCT00124982|593958668|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
164434028|NCT00124982|593958669|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
164434029|NCT00124982|593958670|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
164434030|NCT00124982|593958668|FG000|Short-term Period|Participant Had Lymphopenia|1|||
164434031|NCT00124982|593958669|FG001|Short-term Period|Participant Had Lymphopenia|0|||
164434032|NCT00124982|593958670|FG002|Short-term Period|Participant Had Lymphopenia|0|||
164434033|NCT00124982|593958668|FG000|Long-term Period|Death|0|||
164434034|NCT00124982|593958669|FG001|Long-term Period|Death|0|||
164434035|NCT00124982|593958670|FG002|Long-term Period|Death|1|||
164434036|NCT00124982|593958668|FG000|Long-term Period|Adverse Event|0|||
164434037|NCT00124982|593958669|FG001|Long-term Period|Adverse Event|0|||
164434038|NCT00124982|593958670|FG002|Long-term Period|Adverse Event|17|||
164434039|NCT00124982|593958668|FG000|Long-term Period|Lack of Efficacy|0|||
164434040|NCT00124982|593958669|FG001|Long-term Period|Lack of Efficacy|0|||
164434041|NCT00124982|593958670|FG002|Long-term Period|Lack of Efficacy|46|||
164434042|NCT00124982|593958668|FG000|Long-term Period|Lost to Follow-up|0|||
164434043|NCT00124982|593958669|FG001|Long-term Period|Lost to Follow-up|0|||
164434044|NCT00124982|593958670|FG002|Long-term Period|Lost to Follow-up|4|||
164434045|NCT00124982|593958668|FG000|Long-term Period|Withdrawal by Subject|0|||
164434046|NCT00124982|593958669|FG001|Long-term Period|Withdrawal by Subject|0|||
164434047|NCT00124982|593958670|FG002|Long-term Period|Withdrawal by Subject|16|||
164434048|NCT00124982|593958668|FG000|Long-term Period|Pregnancy|0|||
164292119|NCT00452790|593439651|FG000|Infant Series|Protocol Violation|1|||
164292120|NCT00452790|593439652|FG001|Infant Series|Protocol Violation|3|||
164292121|NCT00452790|593439651|FG000|Infant Series|Lost to Follow-up|2|||
164292122|NCT00452790|593439652|FG001|Infant Series|Lost to Follow-up|2|||
164434049|NCT00124982|593958669|FG001|Long-term Period|Pregnancy|0|||
164434050|NCT00124982|593958670|FG002|Long-term Period|Pregnancy|1|||
164434051|NCT00124982|593958668|FG000|Long-term Period|Poor/Non-compliance|0|||
164434052|NCT00124982|593958669|FG001|Long-term Period|Poor/Non-compliance|0|||
164434053|NCT00124982|593958670|FG002|Long-term Period|Poor/Non-compliance|2|||
164434054|NCT00124982|593958668|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
164434055|NCT00124982|593958669|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
164434056|NCT00124982|593958670|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
164434057|NCT00124982|593958668|FG000|Long-term Period|Neurologist Recommendation|0|||
164434058|NCT00124982|593958669|FG001|Long-term Period|Neurologist Recommendation|0|||
164434059|NCT00124982|593958670|FG002|Long-term Period|Neurologist Recommendation|1|||
164434060|NCT01311713|593958671|FG000|Overall Study|Death|0|||
164434061|NCT01311713|593958672|FG001|Overall Study|Death|0|||
164292123|NCT00452790|593439651|FG000|Infant Series|Adverse Event|1|||
164434062|NCT01311713|593958673|FG002|Overall Study|Death|1|||
164434063|NCT01311713|593958674|FG003|Overall Study|Death|1|||
164434064|NCT01311713|593958675|FG004|Overall Study|Death|0|||
164692756|NCT04126343|594897052|FG004|Overall Study|Related to COVID-19 pandemic|3|||
164692757|NCT04126343|594897053|FG005|Overall Study|Related to COVID-19 pandemic|3|||
164692758|NCT01235442|594897054|FG000|Overall Study|Lost to Follow-up|12|||
164692759|NCT01235442|594897055|FG001|Overall Study|Lost to Follow-up|10|||
164692760|NCT01235442|594897054|FG000|Overall Study|Death|0|||
164692761|NCT01235442|594897055|FG001|Overall Study|Death|2|||
164692762|NCT01235442|594897054|FG000|Overall Study|Pregnancy|1|||
164292124|NCT00452790|593439652|FG001|Infant Series|Adverse Event|2|||
164292125|NCT00452790|593439651|FG000|Infant Series|Other reasons|1|||
164292126|NCT00452790|593439652|FG001|Infant Series|Other reasons|2|||
164292127|NCT00452790|593439651|FG000|Infant Series|Investigator request|0|||
164292128|NCT00452790|593439652|FG001|Infant Series|Investigator request|1|||
164292129|NCT00452790|593439651|FG000|Infant Series|Death|0|||
164292130|NCT00452790|593439652|FG001|Infant Series|Death|1|||
164292131|NCT00452790|593439651|FG000|After Infant Series|Investigator request|10|||
164292132|NCT00452790|593439652|FG001|After Infant Series|Investigator request|10|||
164292133|NCT00452790|593439651|FG000|After Infant Series|Adverse Event|4|||
164292134|NCT00452790|593439652|FG001|After Infant Series|Adverse Event|1|||
164292135|NCT00452790|593439651|FG000|After Infant Series|Parent/legal guardian request|1|||
164292136|NCT00452790|593439652|FG001|After Infant Series|Parent/legal guardian request|3|||
164292137|NCT00452790|593439651|FG000|After Infant Series|Lost to Follow-up|4|||
164292138|NCT00452790|593439652|FG001|After Infant Series|Lost to Follow-up|0|||
164292139|NCT00452790|593439651|FG000|After Infant Series|Failed to return|1|||
164292140|NCT00452790|593439652|FG001|After Infant Series|Failed to return|0|||
164292141|NCT00452790|593439651|FG000|After Infant Series|Other reasons|1|||
164292142|NCT00452790|593439652|FG001|After Infant Series|Other reasons|0|||
164292143|NCT00452790|593439651|FG000|Toddler Dose|Failed to return|0|||
164292144|NCT00452790|593439652|FG001|Toddler Dose|Failed to return|1|||
164292145|NCT00452790|593439651|FG000|Toddler Dose|Parent/legal guardian request|0|||
164292146|NCT00452790|593439652|FG001|Toddler Dose|Parent/legal guardian request|1|||
164292147|NCT02926638|593439657|FG000|Overall Study|Progression|2|||
164292148|NCT02926638|593439658|FG001|Overall Study|Progression|5|||
164292149|NCT02926638|593439657|FG000|Overall Study|Ineligible|1|||
164292150|NCT02926638|593439658|FG001|Overall Study|Ineligible|0|||
164292151|NCT02926638|593439657|FG000|Overall Study|Not protocol specified|1|||
164292152|NCT02926638|593439658|FG001|Overall Study|Not protocol specified|0|||
164292153|NCT02360228|593439659|FG000|Overall Study|Withdrawal by Subject|1|||
164292154|NCT02360228|593439660|FG001|Overall Study|Withdrawal by Subject|0|||
164292155|NCT02360228|593439661|FG002|Overall Study|Withdrawal by Subject|0|||
164292156|NCT02360228|593439659|FG000|Overall Study|Self-discontinued medication|0|||
164292157|NCT02360228|593439660|FG001|Overall Study|Self-discontinued medication|1|||
164292158|NCT02360228|593439661|FG002|Overall Study|Self-discontinued medication|0|||
164292159|NCT02360228|593439659|FG000|Overall Study|Unstable symptoms during screening|0|||
164292160|NCT02360228|593439660|FG001|Overall Study|Unstable symptoms during screening|0|||
164292161|NCT02360228|593439661|FG002|Overall Study|Unstable symptoms during screening|1|||
164292162|NCT01063153|593439666|FG000|Overall Study|Found Ineligible During Screening|2|||
164292163|NCT01063153|593439667|FG001|Overall Study|Found Ineligible During Screening|0|||
164292164|NCT01063153|593439666|FG000|Overall Study|Lost to Follow-up|0|||
164292165|NCT01063153|593439667|FG001|Overall Study|Lost to Follow-up|7|||
164292166|NCT01063153|593439666|FG000|Overall Study|Withdrawal by Subject|0|||
164292167|NCT01063153|593439667|FG001|Overall Study|Withdrawal by Subject|1|||
164292168|NCT01063153|593439666|FG000|Overall Study|Physician Decision|0|||
164292169|NCT01063153|593439667|FG001|Overall Study|Physician Decision|4|||
164292170|NCT01908426|593441045|FG000|Overall Study|Adverse Event|98|||
164292171|NCT01908426|593441046|FG001|Overall Study|Adverse Event|11|||
164292172|NCT01908426|593441045|FG000|Overall Study|Clinical Deterioration|72|||
164292173|NCT01908426|593441046|FG001|Overall Study|Clinical Deterioration|38|||
164292174|NCT01908426|593441045|FG000|Overall Study|Lack of Efficacy|3|||
164292175|NCT01908426|593441046|FG001|Overall Study|Lack of Efficacy|0|||
164292176|NCT01908426|593441045|FG000|Overall Study|Lost to Follow-up|0|||
164292177|NCT01908426|593441046|FG001|Overall Study|Lost to Follow-up|1|||
164292178|NCT01908426|593441045|FG000|Overall Study|Physician Decision|3|||
164292179|NCT01908426|593441046|FG001|Overall Study|Physician Decision|3|||
164292180|NCT01908426|593441045|FG000|Overall Study|Withdrawal by Subject|11|||
164292181|NCT01908426|593441046|FG001|Overall Study|Withdrawal by Subject|6|||
164292182|NCT01908426|593441045|FG000|Overall Study|Progressive Disease|206|||
164292183|NCT01908426|593441046|FG001|Overall Study|Progressive Disease|152|||
164292184|NCT01908426|593441045|FG000|Overall Study|Protocol Violation|1|||
164292185|NCT01908426|593441046|FG001|Overall Study|Protocol Violation|0|||
164292186|NCT01908426|593441045|FG000|Overall Study|No Study Treatment Given|3|||
164292187|NCT01908426|593441046|FG001|Overall Study|No Study Treatment Given|0|||
164292188|NCT02973100|593441052|FG000|Overall Study|Adverse Event|1|||
164292189|NCT02973100|593441053|FG001|Overall Study|Adverse Event|2|||
164292190|NCT02973100|593441054|FG002|Overall Study|Adverse Event|1|||
164292191|NCT02973100|593441055|FG003|Overall Study|Adverse Event|2|||
164692763|NCT01235442|594897055|FG001|Overall Study|Pregnancy|1|||
164692764|NCT01235442|594897054|FG000|Overall Study|Ineligibility determined|5|||
164586870|NCT02975349|594511918|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
164292192|NCT02973100|593441052|FG000|Overall Study|Lost to Follow-up|3|||
164292193|NCT02973100|593441053|FG001|Overall Study|Lost to Follow-up|1|||
164292194|NCT02973100|593441054|FG002|Overall Study|Lost to Follow-up|1|||
164292195|NCT02973100|593441055|FG003|Overall Study|Lost to Follow-up|0|||
164292196|NCT02973100|593441052|FG000|Overall Study|Withdrawal by Subject|3|||
164292197|NCT02973100|593441053|FG001|Overall Study|Withdrawal by Subject|5|||
164292198|NCT02973100|593441054|FG002|Overall Study|Withdrawal by Subject|1|||
164292199|NCT02973100|593441055|FG003|Overall Study|Withdrawal by Subject|4|||
164292200|NCT02973100|593441052|FG000|Overall Study|Notification of change in address|0|||
164292201|NCT02973100|593441053|FG001|Overall Study|Notification of change in address|0|||
164292202|NCT02973100|593441054|FG002|Overall Study|Notification of change in address|0|||
164292203|NCT02973100|593441055|FG003|Overall Study|Notification of change in address|1|||
164292204|NCT02973100|593441052|FG000|Overall Study|Failed to attend Safety followup period|0|||
164292205|NCT02973100|593441053|FG001|Overall Study|Failed to attend Safety followup period|0|||
164292206|NCT02973100|593441054|FG002|Overall Study|Failed to attend Safety followup period|1|||
164292207|NCT02973100|593441055|FG003|Overall Study|Failed to attend Safety followup period|0|||
164292208|NCT00383552|593441056|FG000|Overall Study|Adverse Event|7|||
164292209|NCT00383552|593441057|FG001|Overall Study|Adverse Event|6|||
164292210|NCT00383552|593441058|FG002|Overall Study|Adverse Event|9|||
164292211|NCT00383552|593441059|FG003|Overall Study|Adverse Event|6|||
164292212|NCT00383552|593441056|FG000|Overall Study|Lack of Efficacy|4|||
164292213|NCT00383552|593441057|FG001|Overall Study|Lack of Efficacy|13|||
164292214|NCT00383552|593441058|FG002|Overall Study|Lack of Efficacy|29|||
164292215|NCT00383552|593441059|FG003|Overall Study|Lack of Efficacy|42|||
164292216|NCT00383552|593441056|FG000|Overall Study|Lost to Follow-up|0|||
164292217|NCT00383552|593441057|FG001|Overall Study|Lost to Follow-up|1|||
164292218|NCT00383552|593441058|FG002|Overall Study|Lost to Follow-up|5|||
164292219|NCT00383552|593441059|FG003|Overall Study|Lost to Follow-up|1|||
164292220|NCT00383552|593441056|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
164292221|NCT00383552|593441057|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
164292222|NCT00383552|593441058|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
164292223|NCT00383552|593441059|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
164292224|NCT00383552|593441056|FG000|Overall Study|Did not wish to continue (related)|1|||
164292225|NCT00383552|593441057|FG001|Overall Study|Did not wish to continue (related)|0|||
164292226|NCT00383552|593441058|FG002|Overall Study|Did not wish to continue (related)|2|||
164292227|NCT00383552|593441059|FG003|Overall Study|Did not wish to continue (related)|3|||
164292228|NCT00383552|593441056|FG000|Overall Study|Noncompliance with the protocol|11|||
164292229|NCT00383552|593441057|FG001|Overall Study|Noncompliance with the protocol|6|||
164292230|NCT00383552|593441058|FG002|Overall Study|Noncompliance with the protocol|8|||
164292231|NCT00383552|593441059|FG003|Overall Study|Noncompliance with the protocol|10|||
164292232|NCT00383552|593441056|FG000|Overall Study|Did not meet protocol eligibility|8|||
164292233|NCT00383552|593441057|FG001|Overall Study|Did not meet protocol eligibility|6|||
164292234|NCT00383552|593441058|FG002|Overall Study|Did not meet protocol eligibility|2|||
164292235|NCT00383552|593441059|FG003|Overall Study|Did not meet protocol eligibility|3|||
164292236|NCT00383552|593441056|FG000|Overall Study|Administrative|1|||
164292237|NCT00383552|593441057|FG001|Overall Study|Administrative|0|||
164292238|NCT00383552|593441058|FG002|Overall Study|Administrative|1|||
164292239|NCT00383552|593441059|FG003|Overall Study|Administrative|1|||
164292240|NCT01419236|593441066|FG000|Overall Study|Adverse Event|1|||
164292241|NCT01419236|593441067|FG001|Overall Study|Adverse Event|0|||
164292242|NCT01419236|593441066|FG000|Overall Study|Lack of Efficacy|0|||
164292243|NCT01419236|593441067|FG001|Overall Study|Lack of Efficacy|1|||
164292244|NCT01419236|593441066|FG000|Overall Study|Lost to Follow-up|1|||
164292245|NCT01419236|593441067|FG001|Overall Study|Lost to Follow-up|0|||
164292246|NCT01419236|593441066|FG000|Overall Study|Physician Decision|1|||
164292247|NCT01419236|593441067|FG001|Overall Study|Physician Decision|0|||
164292248|NCT01419236|593441066|FG000|Overall Study|Withdrawal by Subject|1|||
164292249|NCT01419236|593441067|FG001|Overall Study|Withdrawal by Subject|4|||
164292250|NCT01419236|593441066|FG000|Overall Study|Entry Criteria Not Met|1|||
164292251|NCT01419236|593441067|FG001|Overall Study|Entry Criteria Not Met|0|||
164292252|NCT04456504|593441068|FG000|Overall Study|Lost to Follow-up|2|||
164292253|NCT01342913|593441071|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
164292254|NCT01342913|593441072|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
164292255|NCT01342913|593441073|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
164292256|NCT01342913|593441071|FG000|2-week Run-in Period|Physician Decision|6|||
164292257|NCT01342913|593441072|FG001|2-week Run-in Period|Physician Decision|0|||
164292258|NCT01342913|593441073|FG002|2-week Run-in Period|Physician Decision|0|||
164292259|NCT01342913|593441071|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
164292260|NCT01342913|593441072|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
164292261|NCT01342913|593441073|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
164292262|NCT01342913|593441071|FG000|2-week Run-in Period|Adverse Event|2|||
164586871|NCT02975349|594511919|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
164586872|NCT02975349|594511920|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
164292263|NCT01342913|593441072|FG001|2-week Run-in Period|Adverse Event|0|||
164692765|NCT01235442|594897055|FG001|Overall Study|Ineligibility determined|4|||
164692766|NCT01235442|594897054|FG000|Overall Study|Protocol Violation|3|||
164692767|NCT01235442|594897055|FG001|Overall Study|Protocol Violation|3|||
164692768|NCT01235442|594897054|FG000|Overall Study|Adverse Event|4|||
164692769|NCT01235442|594897055|FG001|Overall Study|Adverse Event|6|||
164692770|NCT01235442|594897054|FG000|Overall Study|Withdrawal by Subject|15|||
164692771|NCT01235442|594897055|FG001|Overall Study|Withdrawal by Subject|9|||
164692772|NCT01235442|594897054|FG000|Overall Study|Lack of Efficacy|1|||
164292264|NCT01342913|593441073|FG002|2-week Run-in Period|Adverse Event|0|||
164292265|NCT01342913|593441071|FG000|2-week Run-in Period|Protocol Violation|5|||
164292266|NCT01342913|593441072|FG001|2-week Run-in Period|Protocol Violation|0|||
164292267|NCT01342913|593441073|FG002|2-week Run-in Period|Protocol Violation|0|||
164292268|NCT01342913|593441071|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
164292269|NCT01342913|593441072|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
164292270|NCT01342913|593441073|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
164292271|NCT01342913|593441071|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164292272|NCT01342913|593441072|FG001|Double-Blind Treatment Period|Adverse Event|3|||
164292273|NCT01342913|593441073|FG002|Double-Blind Treatment Period|Adverse Event|6|||
164292274|NCT01342913|593441071|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
164292275|NCT01342913|593441072|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
164292276|NCT01342913|593441073|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
164292277|NCT01342913|593441071|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
164292278|NCT01342913|593441072|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
164292279|NCT01342913|593441073|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
164292280|NCT01342913|593441071|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
164292281|NCT01342913|593441072|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
164292282|NCT01342913|593441073|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
164292283|NCT01342913|593441071|FG000|Double-Blind Treatment Period|Physician Decision|0|||
164292284|NCT01342913|593441072|FG001|Double-Blind Treatment Period|Physician Decision|2|||
164292285|NCT01342913|593441073|FG002|Double-Blind Treatment Period|Physician Decision|0|||
164292286|NCT01342913|593441071|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164292287|NCT01342913|593441072|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
164292288|NCT01342913|593441073|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
164292289|NCT03287791|593441078|FG000|Overall Study|Insufficient Therapeutic Response|0|||
164292290|NCT03287791|593441079|FG001|Overall Study|Insufficient Therapeutic Response|0|||
164292291|NCT03287791|593441080|FG002|Overall Study|Insufficient Therapeutic Response|1|||
164292292|NCT03287791|593441078|FG000|Overall Study|Adverse Event|0|||
164292293|NCT03287791|593441079|FG001|Overall Study|Adverse Event|4|||
164292294|NCT03287791|593441080|FG002|Overall Study|Adverse Event|3|||
164292295|NCT03287791|593441078|FG000|Overall Study|Withdrawal by Subject|12|||
164292296|NCT03287791|593441079|FG001|Overall Study|Withdrawal by Subject|12|||
164292297|NCT03287791|593441080|FG002|Overall Study|Withdrawal by Subject|17|||
164292298|NCT03287791|593441078|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
164292299|NCT03287791|593441079|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
164292300|NCT03287791|593441080|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
164292301|NCT03287791|593441078|FG000|Overall Study|Lost to Follow-up|8|||
164292302|NCT03287791|593441079|FG001|Overall Study|Lost to Follow-up|14|||
164292303|NCT03287791|593441080|FG002|Overall Study|Lost to Follow-up|11|||
164292304|NCT03287791|593441078|FG000|Overall Study|Protocol Violation|7|||
164292305|NCT03287791|593441079|FG001|Overall Study|Protocol Violation|2|||
164292306|NCT03287791|593441080|FG002|Overall Study|Protocol Violation|1|||
164292307|NCT03287791|593441078|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
164292308|NCT03287791|593441079|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
164292309|NCT03287791|593441080|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
164292310|NCT03287791|593441078|FG000|Overall Study|Too much time between 2 visits|0|||
164292311|NCT03287791|593441079|FG001|Overall Study|Too much time between 2 visits|1|||
164292312|NCT03287791|593441080|FG002|Overall Study|Too much time between 2 visits|0|||
164292313|NCT03287791|593441078|FG000|Overall Study|Non-compliance|0|||
164292314|NCT03287791|593441079|FG001|Overall Study|Non-compliance|1|||
164292315|NCT03287791|593441080|FG002|Overall Study|Non-compliance|0|||
164292316|NCT03287791|593441078|FG000|Overall Study|Did not meet inclusion criteria|1|||
164346190|NCT00617123|593642832|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
164346191|NCT00617123|593642833|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
164346192|NCT00617123|593642832|FG000|Referral Screening Period|Adverse Event|0|||
164292317|NCT03287791|593441079|FG001|Overall Study|Did not meet inclusion criteria|0|||
164292318|NCT03287791|593441080|FG002|Overall Study|Did not meet inclusion criteria|0|||
164292319|NCT01381016|593441081|FG000|Overall Study|Lost to Follow-up|1|||
164292320|NCT01381016|593441082|FG001|Overall Study|Lost to Follow-up|1|||
164346193|NCT00617123|593642833|FG001|Referral Screening Period|Adverse Event|1|||
164692773|NCT01235442|594897055|FG001|Overall Study|Lack of Efficacy|3|||
164692774|NCT01235442|594897054|FG000|Overall Study|Noncompliance|1|||
164586873|NCT02975349|594511921|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
164586874|NCT01663740|594511922|FG000|Overall Study|Lost to Follow-up|1|||
164586875|NCT01663740|594511923|FG001|Overall Study|Lost to Follow-up|4|||
164292321|NCT01381016|593441081|FG000|Overall Study|Screen Failure|2|||
164292322|NCT01381016|593441082|FG001|Overall Study|Screen Failure|2|||
164292323|NCT01381016|593441081|FG000|Overall Study|Withdrawal by Subject|0|||
164292324|NCT01381016|593441082|FG001|Overall Study|Withdrawal by Subject|1|||
164292325|NCT01381016|593441081|FG000|Overall Study|Physician Decision|0|||
164292326|NCT01381016|593441082|FG001|Overall Study|Physician Decision|2|||
164292327|NCT03598036|593441088|FG000|Overall Study|Withdrawal by Subject|1|||
164292328|NCT03598036|593441089|FG001|Overall Study|Withdrawal by Subject|0|||
164292329|NCT02891174|593441090|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
164292330|NCT02891174|593441091|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
164292331|NCT02891174|593441090|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
164292332|NCT02891174|593441091|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
164292333|NCT02891174|593441090|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
164292334|NCT02891174|593441091|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
164292335|NCT02891174|593441090|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
164292336|NCT02891174|593441091|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
164292337|NCT02891174|593441090|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
164292338|NCT02891174|593441091|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
164292339|NCT02891174|593441090|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
164292340|NCT02891174|593441091|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
164292341|NCT02891174|593441090|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
164292342|NCT02891174|593441091|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
164292343|NCT04319198|593441092|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
164292344|NCT04319198|593441093|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
164292345|NCT04319198|593441094|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
164292346|NCT04319198|593441092|FG000|Overall Study|Death|0|||
164292347|NCT04319198|593441093|FG001|Overall Study|Death|3|||
164292348|NCT04319198|593441094|FG002|Overall Study|Death|3|||
164292349|NCT04319198|593441092|FG000|Overall Study|Reason Not Specified|0|||
164292350|NCT04319198|593441093|FG001|Overall Study|Reason Not Specified|2|||
164292351|NCT04319198|593441094|FG002|Overall Study|Reason Not Specified|4|||
164292352|NCT04319198|593441092|FG000|Overall Study|Withdrawal of Consent|0|||
164292353|NCT04319198|593441093|FG001|Overall Study|Withdrawal of Consent|0|||
164292354|NCT04319198|593441094|FG002|Overall Study|Withdrawal of Consent|5|||
164292355|NCT04319198|593441092|FG000|Overall Study|Site Terminated by Sponsor|0|||
164292356|NCT04319198|593441093|FG001|Overall Study|Site Terminated by Sponsor|1|||
164292357|NCT04319198|593441094|FG002|Overall Study|Site Terminated by Sponsor|0|||
164292358|NCT02250326|593441098|FG000|Treatment|Death|1|||
164292359|NCT02250326|593441099|FG001|Treatment|Death|13|||
164292360|NCT02250326|593441100|FG002|Treatment|Death|2|||
164292361|NCT02250326|593441098|FG000|Treatment|Adverse Event|8|||
164292362|NCT02250326|593441099|FG001|Treatment|Adverse Event|8|||
164292363|NCT02250326|593441100|FG002|Treatment|Adverse Event|9|||
164292364|NCT02250326|593441098|FG000|Treatment|Progressive Disease|42|||
164292365|NCT02250326|593441099|FG001|Treatment|Progressive Disease|40|||
164292366|NCT02250326|593441100|FG002|Treatment|Progressive Disease|47|||
164292367|NCT02250326|593441098|FG000|Treatment|Symptomatic Deterioration|9|||
164292368|NCT02250326|593441099|FG001|Treatment|Symptomatic Deterioration|4|||
164586876|NCT01663740|594511922|FG000|Overall Study|Other|9|||
164586877|NCT01663740|594511923|FG001|Overall Study|Other|2|||
164586878|NCT01663740|594511922|FG000|Overall Study|Inclusion/Exclusion not met|1|||
164586879|NCT01663740|594511923|FG001|Overall Study|Inclusion/Exclusion not met|0|||
164586880|NCT01663740|594511922|FG000|Overall Study|Death|0|||
164586881|NCT01663740|594511923|FG001|Overall Study|Death|1|||
164586882|NCT01663740|594511922|FG000|Overall Study|Withdrawal by Subject|2|||
164586883|NCT01663740|594511923|FG001|Overall Study|Withdrawal by Subject|1|||
164586884|NCT01663740|594511922|FG000|Overall Study|No end of study status|3|||
164586885|NCT01663740|594511923|FG001|Overall Study|No end of study status|0|||
164586886|NCT02658656|594511924|FG000|Screening|Failed eligibility criteria|0|||
164586887|NCT02658656|594511925|FG001|Screening|Failed eligibility criteria|0|||
164586888|NCT02658656|594511926|FG002|Screening|Failed eligibility criteria|263|||
164586889|NCT02658656|594511924|FG000|Randomization|Withdrawal by Subject|8|||
164586890|NCT02658656|594511925|FG001|Randomization|Withdrawal by Subject|7|||
164586891|NCT02658656|594511926|FG002|Randomization|Withdrawal by Subject|0|||
164586892|NCT02658656|594511924|FG000|Randomization|Lost to Follow-up|1|||
164692775|NCT01235442|594897055|FG001|Overall Study|Noncompliance|2|||
164292369|NCT02250326|593441100|FG002|Treatment|Symptomatic Deterioration|10|||
164292370|NCT02250326|593441098|FG000|Treatment|Withdrawal by Subject|11|||
164292371|NCT02250326|593441099|FG001|Treatment|Withdrawal by Subject|6|||
164586893|NCT02658656|594511925|FG001|Randomization|Lost to Follow-up|3|||
164586894|NCT02658656|594511926|FG002|Randomization|Lost to Follow-up|0|||
164692776|NCT01235442|594897054|FG000|Overall Study|Administrative decision|1|||
164292372|NCT02250326|593441100|FG002|Treatment|Withdrawal by Subject|4|||
164292373|NCT02250326|593441098|FG000|Treatment|Other reasons|8|||
164292374|NCT02250326|593441099|FG001|Treatment|Other reasons|7|||
164292375|NCT02250326|593441100|FG002|Treatment|Other reasons|7|||
164292376|NCT02250326|593441098|FG000|Extension Period|Progressive Disease|0|||
164292377|NCT02250326|593441099|FG001|Extension Period|Progressive Disease|2|||
164292378|NCT02250326|593441100|FG002|Extension Period|Progressive Disease|0|||
164292379|NCT02250326|593441098|FG000|Extension Period|Withdrawal by Subject|0|||
164292380|NCT02250326|593441099|FG001|Extension Period|Withdrawal by Subject|1|||
164292381|NCT02250326|593441100|FG002|Extension Period|Withdrawal by Subject|0|||
164292382|NCT02250326|593441098|FG000|Extension Period|Withdrawal by investigator|0|||
164292383|NCT02250326|593441099|FG001|Extension Period|Withdrawal by investigator|1|||
164292384|NCT02250326|593441100|FG002|Extension Period|Withdrawal by investigator|0|||
164292385|NCT05801991|593441101|FG000|Overall Study|Lost to Follow-up|1|||
164292386|NCT05801991|593441102|FG001|Overall Study|Lost to Follow-up|0|||
164292387|NCT01838694|593441103|FG000|Overall Study|Adverse Event|0|||
164292388|NCT01838694|593441104|FG001|Overall Study|Adverse Event|1|||
164292389|NCT04235140|593441105|FG000|Overall Study|Adverse Event|2|||
164292390|NCT04235140|593441105|FG000|Overall Study|Lost to Follow-up|1|||
164292391|NCT04235140|593441105|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
164292392|NCT04235140|593441105|FG000|Overall Study|Commercial drug is available for participants|7|||
164292393|NCT03016312|593441106|FG000|Overall Study|discontinued before the treatment started|0|||
164292394|NCT03016312|593441107|FG001|Overall Study|discontinued before the treatment started|1|||
164292395|NCT03016312|593441106|FG000|Overall Study|Withdrawal by Subject|37|||
164292396|NCT03016312|593441107|FG001|Overall Study|Withdrawal by Subject|44|||
164292397|NCT03016312|593441106|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
164292398|NCT03016312|593441107|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
164292399|NCT03016312|593441106|FG000|Overall Study|Physician Decision|1|||
164292400|NCT03016312|593441107|FG001|Overall Study|Physician Decision|3|||
164292401|NCT03016312|593441106|FG000|Overall Study|Lost to Follow-up|12|||
164292402|NCT03016312|593441107|FG001|Overall Study|Lost to Follow-up|12|||
164292403|NCT03016312|593441106|FG000|Overall Study|Death|210|||
164292404|NCT03016312|593441107|FG001|Overall Study|Death|184|||
164346194|NCT00617123|593642832|FG000|Study Treatment Period|Withdrawal by Subject|8|||
164346195|NCT00617123|593642833|FG001|Study Treatment Period|Withdrawal by Subject|12|||
164346196|NCT00617123|593642832|FG000|Study Treatment Period|Adverse Event|7|||
164692777|NCT01235442|594897055|FG001|Overall Study|Administrative decision|2|||
164692778|NCT01235442|594897054|FG000|Overall Study|Other unspecified|1|||
164692779|NCT01235442|594897055|FG001|Overall Study|Other unspecified|2|||
164692780|NCT01857973|594897060|FG000|Overall Study|Subject did not meet required BG range|3|||
164692781|NCT01857973|594897060|FG000|Overall Study|drop out after 3 failed attempts|1|||
164346197|NCT00617123|593642833|FG001|Study Treatment Period|Adverse Event|3|||
164346198|NCT00617123|593642832|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
164346199|NCT00617123|593642833|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
164346200|NCT00617123|593642832|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
164346201|NCT00617123|593642833|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
164346202|NCT03052725|593642834|FG000|Overall Study|Adverse Event|2|||
164346203|NCT03052725|593642835|FG001|Overall Study|Adverse Event|0|||
164346204|NCT03052725|593642834|FG000|Overall Study|Withdrawal by Subject|3|||
164346205|NCT03052725|593642835|FG001|Overall Study|Withdrawal by Subject|4|||
164346206|NCT03052725|593642834|FG000|Overall Study|Pregnancy|0|||
164346207|NCT03052725|593642835|FG001|Overall Study|Pregnancy|1|||
164346208|NCT03052725|593642834|FG000|Overall Study|Site closure|0|||
164346209|NCT03052725|593642835|FG001|Overall Study|Site closure|1|||
164346210|NCT03052725|593642834|FG000|Overall Study|Study terminated by sponsor|143|||
164346211|NCT03052725|593642835|FG001|Overall Study|Study terminated by sponsor|144|||
164346212|NCT00777608|593642837|FG000|Overall Study|Lost to Follow-up|1|||
164346213|NCT00777608|593642838|FG001|Overall Study|Lost to Follow-up|1|||
164346214|NCT00777608|593642837|FG000|Overall Study|Withdrawal by Subject|1|||
164346215|NCT00777608|593642838|FG001|Overall Study|Withdrawal by Subject|3|||
164346216|NCT00777608|593642837|FG000|Overall Study|Protocol Violation|1|||
164346217|NCT00777608|593642838|FG001|Overall Study|Protocol Violation|0|||
164692782|NCT01857973|594897060|FG000|Overall Study|Physician Decision|1|||
164692783|NCT01701973|594897063|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
164292405|NCT03016312|593441106|FG000|Overall Study|loss to contact|1|||
164346218|NCT00777608|593642837|FG000|Overall Study|Investigator Decision|1|||
164292406|NCT03016312|593441107|FG001|Overall Study|loss to contact|0|||
164346219|NCT00777608|593642838|FG001|Overall Study|Investigator Decision|2|||
164346220|NCT04213079|593642839|FG000|Overall Study|Lost to Follow-up|0|||
164692784|NCT01701973|594897064|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
164292407|NCT03016312|593441106|FG000|Overall Study|started a new cancer therapy|1|||
164292408|NCT03016312|593441107|FG001|Overall Study|started a new cancer therapy|0|||
164292409|NCT01755234|593441111|FG000|Overall Study|Lost to Follow-up|11|||
164292410|NCT01755234|593441112|FG001|Overall Study|Lost to Follow-up|6|||
164292411|NCT01755234|593441111|FG000|Overall Study|Change in surgical case|2|||
164292412|NCT01755234|593441112|FG001|Overall Study|Change in surgical case|1|||
164292413|NCT01755234|593441111|FG000|Overall Study|case cancelled|1|||
164292414|NCT01755234|593441112|FG001|Overall Study|case cancelled|0|||
164292415|NCT01755234|593441111|FG000|Overall Study|Withdrawal by Subject|0|||
164292416|NCT01755234|593441112|FG001|Overall Study|Withdrawal by Subject|1|||
164292417|NCT01755234|593441111|FG000|Overall Study|unblinded|1|||
164292418|NCT01755234|593441112|FG001|Overall Study|unblinded|0|||
164292419|NCT02836652|593441113|FG000|Overall Study|Death|3|||
164292420|NCT02836652|593441114|FG001|Overall Study|Death|3|||
164292421|NCT02836652|593441113|FG000|Overall Study|Transplant/Explant|3|||
164292422|NCT02836652|593441114|FG001|Overall Study|Transplant/Explant|4|||
164292423|NCT02836652|593441113|FG000|Overall Study|Withdrawn|9|||
164292424|NCT02836652|593441114|FG001|Overall Study|Withdrawn|9|||
164292425|NCT02836652|593441113|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
164292426|NCT02836652|593441114|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
164292427|NCT03812380|593441115|FG000|Overall Study|Protocol Violation|3|||
164292428|NCT03812380|593441116|FG001|Overall Study|Protocol Violation|3|||
164292429|NCT03812380|593441115|FG000|Overall Study|Withdrawal by Subject|5|||
164292430|NCT03812380|593441116|FG001|Overall Study|Withdrawal by Subject|4|||
164292431|NCT03812380|593441115|FG000|Overall Study|Early termination of study|14|||
164292432|NCT03812380|593441116|FG001|Overall Study|Early termination of study|14|||
164292433|NCT02349633|593441118|FG000|Overall Study|Death|0|||
164292434|NCT02349633|593441119|FG001|Overall Study|Death|1|||
164292435|NCT02349633|593441120|FG002|Overall Study|Death|0|||
164292436|NCT02349633|593441121|FG003|Overall Study|Death|0|||
164292437|NCT02349633|593441122|FG004|Overall Study|Death|0|||
164292438|NCT02349633|593441123|FG005|Overall Study|Death|1|||
164292439|NCT02349633|593441124|FG006|Overall Study|Death|1|||
164292440|NCT02349633|593441125|FG007|Overall Study|Death|1|||
164292441|NCT02349633|593441126|FG008|Overall Study|Death|0|||
164292442|NCT02349633|593441127|FG009|Overall Study|Death|1|||
164292443|NCT02349633|593441128|FG010|Overall Study|Death|0|||
164292444|NCT02349633|593441129|FG011|Overall Study|Death|0|||
164292445|NCT02349633|593441130|FG012|Overall Study|Death|0|||
164292446|NCT02349633|593441131|FG013|Overall Study|Death|0|||
164292447|NCT02349633|593441118|FG000|Overall Study|Withdrawal by Subject|0|||
164292448|NCT02349633|593441119|FG001|Overall Study|Withdrawal by Subject|0|||
164292449|NCT02349633|593441120|FG002|Overall Study|Withdrawal by Subject|0|||
164292450|NCT02349633|593441121|FG003|Overall Study|Withdrawal by Subject|1|||
164292451|NCT02349633|593441122|FG004|Overall Study|Withdrawal by Subject|0|||
164292452|NCT02349633|593441123|FG005|Overall Study|Withdrawal by Subject|0|||
164292453|NCT02349633|593441124|FG006|Overall Study|Withdrawal by Subject|0|||
164292454|NCT02349633|593441125|FG007|Overall Study|Withdrawal by Subject|2|||
164292455|NCT02349633|593441126|FG008|Overall Study|Withdrawal by Subject|2|||
164292456|NCT02349633|593441127|FG009|Overall Study|Withdrawal by Subject|1|||
164292457|NCT02349633|593441128|FG010|Overall Study|Withdrawal by Subject|0|||
164292458|NCT02349633|593441129|FG011|Overall Study|Withdrawal by Subject|0|||
164292459|NCT02349633|593441130|FG012|Overall Study|Withdrawal by Subject|0|||
164292460|NCT02349633|593441131|FG013|Overall Study|Withdrawal by Subject|0|||
164292461|NCT02349633|593441118|FG000|Overall Study|Withdrawal of informed consent|0|||
164292462|NCT02349633|593441119|FG001|Overall Study|Withdrawal of informed consent|0|||
164292463|NCT02349633|593441120|FG002|Overall Study|Withdrawal of informed consent|0|||
164292464|NCT02349633|593441121|FG003|Overall Study|Withdrawal of informed consent|1|||
164292465|NCT02349633|593441122|FG004|Overall Study|Withdrawal of informed consent|1|||
164292466|NCT02349633|593441123|FG005|Overall Study|Withdrawal of informed consent|0|||
164292467|NCT02349633|593441124|FG006|Overall Study|Withdrawal of informed consent|0|||
164292468|NCT02349633|593441125|FG007|Overall Study|Withdrawal of informed consent|3|||
164292469|NCT02349633|593441126|FG008|Overall Study|Withdrawal of informed consent|0|||
164292470|NCT02349633|593441127|FG009|Overall Study|Withdrawal of informed consent|0|||
164292471|NCT02349633|593441128|FG010|Overall Study|Withdrawal of informed consent|0|||
164292472|NCT02349633|593441129|FG011|Overall Study|Withdrawal of informed consent|0|||
164292473|NCT02349633|593441130|FG012|Overall Study|Withdrawal of informed consent|0|||
164292474|NCT02349633|593441131|FG013|Overall Study|Withdrawal of informed consent|0|||
164292475|NCT02349633|593441118|FG000|Overall Study|Transition to compassionate use|0|||
164292476|NCT02349633|593441119|FG001|Overall Study|Transition to compassionate use|0|||
164292477|NCT02349633|593441120|FG002|Overall Study|Transition to compassionate use|0|||
164346221|NCT04213079|593642840|FG001|Overall Study|Lost to Follow-up|2|||
164346222|NCT00520936|593642841|FG000|Overall Study|Physician Decision|0|||
164346223|NCT00520936|593642842|FG001|Overall Study|Physician Decision|2|||
164346224|NCT00520936|593642843|FG002|Overall Study|Physician Decision|1|||
164292478|NCT02349633|593441121|FG003|Overall Study|Transition to compassionate use|0|||
164292479|NCT02349633|593441122|FG004|Overall Study|Transition to compassionate use|1|||
164292480|NCT02349633|593441123|FG005|Overall Study|Transition to compassionate use|0|||
164292481|NCT02349633|593441124|FG006|Overall Study|Transition to compassionate use|0|||
164292482|NCT02349633|593441125|FG007|Overall Study|Transition to compassionate use|3|||
164292483|NCT02349633|593441126|FG008|Overall Study|Transition to compassionate use|0|||
164346225|NCT00520936|593642844|FG003|Overall Study|Physician Decision|0|||
164346226|NCT00520936|593642845|FG004|Overall Study|Physician Decision|0|||
164292484|NCT02349633|593441127|FG009|Overall Study|Transition to compassionate use|1|||
164292485|NCT02349633|593441128|FG010|Overall Study|Transition to compassionate use|0|||
164292486|NCT02349633|593441129|FG011|Overall Study|Transition to compassionate use|0|||
164292487|NCT02349633|593441130|FG012|Overall Study|Transition to compassionate use|0|||
164292488|NCT02349633|593441131|FG013|Overall Study|Transition to compassionate use|0|||
164292489|NCT02349633|593441118|FG000|Overall Study|Early termination of survival follow-up|0|||
164292490|NCT02349633|593441119|FG001|Overall Study|Early termination of survival follow-up|0|||
164292491|NCT02349633|593441120|FG002|Overall Study|Early termination of survival follow-up|0|||
164292492|NCT02349633|593441121|FG003|Overall Study|Early termination of survival follow-up|0|||
164292493|NCT02349633|593441122|FG004|Overall Study|Early termination of survival follow-up|0|||
164292494|NCT02349633|593441123|FG005|Overall Study|Early termination of survival follow-up|0|||
164292495|NCT02349633|593441124|FG006|Overall Study|Early termination of survival follow-up|0|||
164292496|NCT02349633|593441125|FG007|Overall Study|Early termination of survival follow-up|4|||
164292497|NCT02349633|593441126|FG008|Overall Study|Early termination of survival follow-up|0|||
164292498|NCT02349633|593441127|FG009|Overall Study|Early termination of survival follow-up|0|||
164292499|NCT02349633|593441128|FG010|Overall Study|Early termination of survival follow-up|0|||
164292500|NCT02349633|593441129|FG011|Overall Study|Early termination of survival follow-up|0|||
164292501|NCT02349633|593441130|FG012|Overall Study|Early termination of survival follow-up|0|||
164292502|NCT02349633|593441131|FG013|Overall Study|Early termination of survival follow-up|0|||
164292503|NCT02349633|593441118|FG000|Overall Study|Termination by sponsor|0|||
164292504|NCT02349633|593441119|FG001|Overall Study|Termination by sponsor|0|||
164292505|NCT02349633|593441120|FG002|Overall Study|Termination by sponsor|0|||
164292506|NCT02349633|593441121|FG003|Overall Study|Termination by sponsor|0|||
164292507|NCT02349633|593441122|FG004|Overall Study|Termination by sponsor|0|||
164346227|NCT00520936|593642846|FG005|Overall Study|Physician Decision|0|||
164346228|NCT00520936|593642847|FG006|Overall Study|Physician Decision|0|||
164346229|NCT00520936|593642848|FG007|Overall Study|Physician Decision|0|||
164346230|NCT00520936|593642841|FG000|Overall Study|Withdrawal by Subject|0|||
164346231|NCT00520936|593642842|FG001|Overall Study|Withdrawal by Subject|0|||
164346232|NCT00520936|593642843|FG002|Overall Study|Withdrawal by Subject|0|||
164346233|NCT00520936|593642844|FG003|Overall Study|Withdrawal by Subject|0|||
164346234|NCT00520936|593642845|FG004|Overall Study|Withdrawal by Subject|0|||
164346235|NCT00520936|593642846|FG005|Overall Study|Withdrawal by Subject|0|||
164346236|NCT00520936|593642847|FG006|Overall Study|Withdrawal by Subject|0|||
164346237|NCT00520936|593642848|FG007|Overall Study|Withdrawal by Subject|1|||
164346238|NCT00520936|593642841|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
164346239|NCT00520936|593642842|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
164346240|NCT00520936|593642843|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
164346241|NCT00520936|593642844|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
164346242|NCT00520936|593642845|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
164346243|NCT00520936|593642846|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
164346244|NCT00520936|593642847|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
164346245|NCT00520936|593642848|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
164346246|NCT00520936|593642841|FG000|Overall Study|Death|0|||
164346247|NCT00520936|593642842|FG001|Overall Study|Death|0|||
164346248|NCT00520936|593642843|FG002|Overall Study|Death|0|||
164346249|NCT00520936|593642844|FG003|Overall Study|Death|0|||
164346250|NCT00520936|593642845|FG004|Overall Study|Death|0|||
164346251|NCT00520936|593642846|FG005|Overall Study|Death|0|||
164346252|NCT00520936|593642847|FG006|Overall Study|Death|1|||
164346253|NCT00520936|593642848|FG007|Overall Study|Death|0|||
164346254|NCT00520936|593642841|FG000|Overall Study|Protocol Violation|0|||
164346255|NCT00520936|593642842|FG001|Overall Study|Protocol Violation|1|||
164346256|NCT00520936|593642843|FG002|Overall Study|Protocol Violation|1|||
164346257|NCT00520936|593642844|FG003|Overall Study|Protocol Violation|0|||
164346258|NCT00520936|593642845|FG004|Overall Study|Protocol Violation|1|||
164346259|NCT00520936|593642846|FG005|Overall Study|Protocol Violation|0|||
164346260|NCT00520936|593642847|FG006|Overall Study|Protocol Violation|1|||
164346261|NCT00520936|593642848|FG007|Overall Study|Protocol Violation|0|||
164346262|NCT00587054|593642852|FG000|Overall Study|Patient not treated|9|||
164346263|NCT03858309|593642853|FG000|Overall Study|Withdrawal by Subject|2|||
164346264|NCT03858309|593642854|FG001|Overall Study|Withdrawal by Subject|3|||
164346265|NCT01812174|593642855|FG000|Overall Study|Death|1|||
164346266|NCT01812174|593642856|FG001|Overall Study|Death|0|||
164346267|NCT01812174|593642855|FG000|Overall Study|Protocol Violation|2|||
164346268|NCT01812174|593642856|FG001|Overall Study|Protocol Violation|0|||
164346269|NCT00553644|593642857|FG000|Overall Study|Adverse Event|17|||
164346270|NCT00553644|593642857|FG000|Overall Study|Withdrawal by Subject|4|||
164346271|NCT00553644|593642857|FG000|Overall Study|Physician Decision|1|||
164346272|NCT00553644|593642857|FG000|Overall Study|Alternative therapy|6|||
164346273|NCT01336764|593642860|FG000|Overall Study|Withdrawal by Subject|5|||
164292508|NCT02349633|593441123|FG005|Overall Study|Termination by sponsor|0|||
164292509|NCT02349633|593441124|FG006|Overall Study|Termination by sponsor|0|||
164346274|NCT01336764|593642861|FG001|Overall Study|Withdrawal by Subject|5|||
164434065|NCT01311713|593958676|FG005|Overall Study|Death|1|||
164434066|NCT01311713|593958677|FG006|Overall Study|Death|0|||
164434067|NCT01311713|593958671|FG000|Overall Study|Adverse Event|0|||
164434068|NCT01311713|593958672|FG001|Overall Study|Adverse Event|1|||
164434069|NCT01311713|593958673|FG002|Overall Study|Adverse Event|0|||
164434070|NCT01311713|593958674|FG003|Overall Study|Adverse Event|2|||
164434071|NCT01311713|593958675|FG004|Overall Study|Adverse Event|0|||
164434072|NCT01311713|593958676|FG005|Overall Study|Adverse Event|0|||
164434073|NCT01311713|593958677|FG006|Overall Study|Adverse Event|2|||
164434074|NCT01311713|593958671|FG000|Overall Study|Withdrawal by Subject|0|||
164434075|NCT01311713|593958672|FG001|Overall Study|Withdrawal by Subject|1|||
164434076|NCT01311713|593958673|FG002|Overall Study|Withdrawal by Subject|1|||
164434077|NCT01311713|593958674|FG003|Overall Study|Withdrawal by Subject|0|||
164434078|NCT01311713|593958675|FG004|Overall Study|Withdrawal by Subject|0|||
164434079|NCT01311713|593958676|FG005|Overall Study|Withdrawal by Subject|1|||
164434080|NCT01311713|593958677|FG006|Overall Study|Withdrawal by Subject|2|||
164434081|NCT01311713|593958671|FG000|Overall Study|Disease progression|3|||
164434082|NCT01311713|593958672|FG001|Overall Study|Disease progression|4|||
164434083|NCT01311713|593958673|FG002|Overall Study|Disease progression|3|||
164434084|NCT01311713|593958674|FG003|Overall Study|Disease progression|2|||
164434085|NCT01311713|593958675|FG004|Overall Study|Disease progression|4|||
164434086|NCT01311713|593958676|FG005|Overall Study|Disease progression|4|||
164434087|NCT01311713|593958677|FG006|Overall Study|Disease progression|5|||
164434088|NCT01311713|593958671|FG000|Overall Study|Lost to Follow-up|0|||
164434089|NCT01311713|593958672|FG001|Overall Study|Lost to Follow-up|0|||
164434090|NCT01311713|593958673|FG002|Overall Study|Lost to Follow-up|1|||
164434091|NCT01311713|593958674|FG003|Overall Study|Lost to Follow-up|0|||
164434092|NCT01311713|593958675|FG004|Overall Study|Lost to Follow-up|0|||
164434093|NCT01311713|593958676|FG005|Overall Study|Lost to Follow-up|0|||
164434094|NCT01311713|593958677|FG006|Overall Study|Lost to Follow-up|0|||
164434095|NCT01311713|593958671|FG000|Overall Study|Stopped taking study medication|0|||
164434096|NCT01311713|593958672|FG001|Overall Study|Stopped taking study medication|0|||
164434097|NCT01311713|593958673|FG002|Overall Study|Stopped taking study medication|0|||
164434098|NCT01311713|593958674|FG003|Overall Study|Stopped taking study medication|1|||
164434099|NCT01311713|593958675|FG004|Overall Study|Stopped taking study medication|1|||
164434100|NCT01311713|593958676|FG005|Overall Study|Stopped taking study medication|0|||
164434101|NCT01311713|593958677|FG006|Overall Study|Stopped taking study medication|0|||
164434102|NCT01311713|593958671|FG000|Overall Study|Enrolled but not treated|0|||
164434103|NCT01311713|593958672|FG001|Overall Study|Enrolled but not treated|0|||
164434104|NCT01311713|593958673|FG002|Overall Study|Enrolled but not treated|1|||
164434105|NCT01311713|593958674|FG003|Overall Study|Enrolled but not treated|0|||
164434106|NCT01311713|593958675|FG004|Overall Study|Enrolled but not treated|0|||
164292510|NCT02349633|593441125|FG007|Overall Study|Termination by sponsor|1|||
164292511|NCT02349633|593441126|FG008|Overall Study|Termination by sponsor|0|||
164292512|NCT02349633|593441127|FG009|Overall Study|Termination by sponsor|2|||
164292513|NCT02349633|593441128|FG010|Overall Study|Termination by sponsor|0|||
164292514|NCT02349633|593441129|FG011|Overall Study|Termination by sponsor|0|||
164292515|NCT02349633|593441130|FG012|Overall Study|Termination by sponsor|0|||
164292516|NCT02349633|593441131|FG013|Overall Study|Termination by sponsor|0|||
164292517|NCT02349633|593441118|FG000|Overall Study|Other|0|||
164292518|NCT02349633|593441119|FG001|Overall Study|Other|0|||
164292519|NCT02349633|593441120|FG002|Overall Study|Other|0|||
164292520|NCT02349633|593441121|FG003|Overall Study|Other|0|||
164292521|NCT02349633|593441122|FG004|Overall Study|Other|0|||
164292522|NCT02349633|593441123|FG005|Overall Study|Other|0|||
164292523|NCT02349633|593441124|FG006|Overall Study|Other|0|||
164292524|NCT02349633|593441125|FG007|Overall Study|Other|2|||
164292525|NCT02349633|593441126|FG008|Overall Study|Other|0|||
164292526|NCT02349633|593441127|FG009|Overall Study|Other|0|||
164292527|NCT02349633|593441128|FG010|Overall Study|Other|0|||
164434107|NCT01311713|593958676|FG005|Overall Study|Enrolled but not treated|0|||
164434108|NCT01311713|593958677|FG006|Overall Study|Enrolled but not treated|0|||
164434109|NCT01311713|593958671|FG000|Overall Study|Other than specified|0|||
164434110|NCT01311713|593958672|FG001|Overall Study|Other than specified|1|||
164434111|NCT01311713|593958673|FG002|Overall Study|Other than specified|2|||
164434112|NCT01311713|593958674|FG003|Overall Study|Other than specified|0|||
164434113|NCT01311713|593958675|FG004|Overall Study|Other than specified|0|||
164434114|NCT01311713|593958676|FG005|Overall Study|Other than specified|0|||
164434115|NCT01311713|593958677|FG006|Overall Study|Other than specified|0|||
164434116|NCT00980538|593958680|FG000|Overall Study|Lost to Follow-up|20|||
164586895|NCT02658656|594511924|FG000|Randomization|Adverse Event|4|||
164586896|NCT02658656|594511925|FG001|Randomization|Adverse Event|0|||
164586897|NCT02658656|594511926|FG002|Randomization|Adverse Event|0|||
164586898|NCT02658656|594511924|FG000|Randomization|Administrative Termination|3|||
164586899|NCT02658656|594511925|FG001|Randomization|Administrative Termination|1|||
164586900|NCT02658656|594511926|FG002|Randomization|Administrative Termination|0|||
164586901|NCT02658656|594511924|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
164292528|NCT02349633|593441129|FG011|Overall Study|Other|0|||
164292529|NCT02349633|593441130|FG012|Overall Study|Other|0|||
164292530|NCT02349633|593441131|FG013|Overall Study|Other|0|||
164292531|NCT00667628|593441132|FG000|Overall Study|Lost to Follow-up|1|||
164292532|NCT00667628|593441133|FG001|Overall Study|Lost to Follow-up|0|||
164292533|NCT00667628|593441132|FG000|Overall Study|Death|6|||
164292534|NCT00667628|593441133|FG001|Overall Study|Death|6|||
164292535|NCT00667628|593441132|FG000|Overall Study|Investigator Considers in Best Interest|1|||
164292536|NCT00667628|593441133|FG001|Overall Study|Investigator Considers in Best Interest|0|||
164292537|NCT00667628|593441132|FG000|Overall Study|Sponsor Terminated Study|17|||
164292538|NCT00667628|593441133|FG001|Overall Study|Sponsor Terminated Study|21|||
164292539|NCT05789745|593441134|FG000|Overall Study|Withdrawal by Subject|0|||
164292540|NCT05789745|593441135|FG001|Overall Study|Withdrawal by Subject|0|||
164292541|NCT05789745|593441136|FG002|Overall Study|Withdrawal by Subject|0|||
164292542|NCT05789745|593441137|FG003|Overall Study|Withdrawal by Subject|0|||
164292543|NCT05789745|593441138|FG004|Overall Study|Withdrawal by Subject|1|||
164292544|NCT04663321|593441139|FG000|Overall Study|Study terminated by Sponsor|2|||
164292545|NCT04663321|593441140|FG001|Overall Study|Study terminated by Sponsor|1|||
164292546|NCT04663321|593441141|FG002|Overall Study|Study terminated by Sponsor|2|||
164292547|NCT04663321|593441139|FG000|Overall Study|Withdrawal by Subject|10|||
164292548|NCT04663321|593441140|FG001|Overall Study|Withdrawal by Subject|3|||
164292549|NCT04663321|593441141|FG002|Overall Study|Withdrawal by Subject|2|||
164292550|NCT04663321|593441139|FG000|Overall Study|Not provided|0|||
164292551|NCT04663321|593441140|FG001|Overall Study|Not provided|0|||
164292552|NCT04663321|593441141|FG002|Overall Study|Not provided|1|||
164292553|NCT00622505|593441144|FG000|Overall Study|Adverse Event|9|||
164292554|NCT00622505|593441145|FG001|Overall Study|Adverse Event|7|||
164292555|NCT00622505|593441144|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
164292556|NCT00622505|593441145|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
164346275|NCT01051323|593642862|FG000|Overall Study|Discontinuation of treatment|103|||
164346276|NCT01051323|593642862|FG000|Overall Study|Transplantation|28|||
164346277|NCT01051323|593642862|FG000|Overall Study|Dialysis dependency|22|||
164346278|NCT01051323|593642862|FG000|Overall Study|Withdrawal by Subject|13|||
164346279|NCT01051323|593642862|FG000|Overall Study|Lost to Follow-up|31|||
164346280|NCT01051323|593642862|FG000|Overall Study|Death|129|||
164346281|NCT01051323|593642862|FG000|Overall Study|Hospitalization|28|||
164346282|NCT01051323|593642862|FG000|Overall Study|Other|148|||
164346283|NCT01051323|593642862|FG000|Overall Study|Missing|37|||
164346284|NCT01626391|593642863|FG000|Overall Study|Physician Decision|1|||
164346285|NCT01626391|593642864|FG001|Overall Study|Physician Decision|0|||
164346286|NCT01626391|593642863|FG000|Overall Study|Withdrawal by Subject|1|||
164346287|NCT01626391|593642864|FG001|Overall Study|Withdrawal by Subject|0|||
164346288|NCT00370032|593642865|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
164346289|NCT00370032|593642866|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
164346290|NCT00370032|593642865|FG000|Washout Period|Withdrawal by Subject|0|||
164346291|NCT00370032|593642866|FG001|Washout Period|Withdrawal by Subject|1|||
164346292|NCT00370032|593642865|FG000|Washout Period|Lost to Follow-up|0|||
164346293|NCT00370032|593642866|FG001|Washout Period|Lost to Follow-up|1|||
164346294|NCT00370032|593642865|FG000|Washout Period|Adverse Event|1|||
164346295|NCT00370032|593642866|FG001|Washout Period|Adverse Event|0|||
164346296|NCT00370032|593642865|FG000|Follow-up Period|Withdrawal by Subject|1|||
164346297|NCT00370032|593642866|FG001|Follow-up Period|Withdrawal by Subject|0|||
164346298|NCT05683249|593642867|FG000|Overall Study|Adverse Event|3|||
164346299|NCT05683249|593642868|FG001|Overall Study|Adverse Event|1|||
164346300|NCT05683249|593642867|FG000|Overall Study|Lack of Efficacy|0|||
164346301|NCT05683249|593642868|FG001|Overall Study|Lack of Efficacy|2|||
164346302|NCT05683249|593642867|FG000|Overall Study|Lost to Follow-up|6|||
164292557|NCT00622505|593441144|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
164346303|NCT05683249|593642868|FG001|Overall Study|Lost to Follow-up|5|||
164346304|NCT05683249|593642867|FG000|Overall Study|Non-compliance with Study Drug|2|||
164346305|NCT05683249|593642868|FG001|Overall Study|Non-compliance with Study Drug|0|||
164346306|NCT05683249|593642867|FG000|Overall Study|Protocol Violation|6|||
164346307|NCT05683249|593642868|FG001|Overall Study|Protocol Violation|3|||
164346308|NCT05683249|593642867|FG000|Overall Study|Withdrawal by Subject|9|||
164346309|NCT05683249|593642868|FG001|Overall Study|Withdrawal by Subject|8|||
164346310|NCT05683249|593642867|FG000|Overall Study|Other|0|||
164292558|NCT00622505|593441145|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
164292559|NCT00622505|593441144|FG000|Overall Study|Withdrawal by Subject|12|||
164292560|NCT00622505|593441145|FG001|Overall Study|Withdrawal by Subject|5|||
164292561|NCT00622505|593441144|FG000|Overall Study|Administrative Problems|2|||
164292562|NCT00622505|593441145|FG001|Overall Study|Administrative Problems|4|||
164292563|NCT00622505|593441144|FG000|Overall Study|Death|2|||
164292564|NCT00622505|593441145|FG001|Overall Study|Death|2|||
164346311|NCT05683249|593642868|FG001|Overall Study|Other|2|||
164346312|NCT05469178|593642869|FG000|Overall Study|Death|1|||
164346313|NCT05469178|593642870|FG001|Overall Study|Death|1|||
164346314|NCT05469178|593642871|FG002|Overall Study|Death|3|||
164346315|NCT05469178|593642872|FG003|Overall Study|Death|6|||
164292565|NCT00619515|593441146|FG000|Overall Study|Study Termination by IRB|73|||
164292566|NCT03294590|593441149|FG000|Overall Study|Lost to Follow-up|105|||
164292567|NCT03294590|593441150|FG001|Overall Study|Lost to Follow-up|107|||
164292568|NCT01962441|593441153|FG000|Randomized Period|Randomized but Never Treated|4|||
164292569|NCT01962441|593441154|FG001|Randomized Period|Randomized but Never Treated|2|||
164292570|NCT01962441|593441155|FG002|Randomized Period|Randomized but Never Treated|3|||
164292571|NCT01962441|593441153|FG000|Randomized Period|Lost to Follow-up|2|||
164292572|NCT01962441|593441154|FG001|Randomized Period|Lost to Follow-up|4|||
164292573|NCT01962441|593441155|FG002|Randomized Period|Lost to Follow-up|4|||
164292574|NCT01962441|593441153|FG000|Randomized Period|Withdrew Consent|3|||
164292575|NCT01962441|593441154|FG001|Randomized Period|Withdrew Consent|3|||
164292576|NCT01962441|593441155|FG002|Randomized Period|Withdrew Consent|2|||
164292577|NCT01962441|593441153|FG000|Randomized Period|Adverse Event|1|||
164292578|NCT01962441|593441154|FG001|Randomized Period|Adverse Event|1|||
164292579|NCT01962441|593441155|FG002|Randomized Period|Adverse Event|0|||
164292580|NCT01962441|593441153|FG000|Randomized Period|Death|0|||
164292581|NCT01962441|593441154|FG001|Randomized Period|Death|0|||
164292582|NCT01962441|593441155|FG002|Randomized Period|Death|2|||
164292583|NCT01962441|593441153|FG000|Randomized Period|Protocol Violation|0|||
164292584|NCT01962441|593441154|FG001|Randomized Period|Protocol Violation|1|||
164292585|NCT01962441|593441155|FG002|Randomized Period|Protocol Violation|0|||
164292586|NCT01962441|593441153|FG000|Retreatment Substudy|Lack of Efficacy|1|||
164292587|NCT01962441|593441154|FG001|Retreatment Substudy|Lack of Efficacy|0|||
164292588|NCT01962441|593441155|FG002|Retreatment Substudy|Lack of Efficacy|0|||
164292589|NCT01962441|593441153|FG000|Retreatment Substudy|Lost to Follow-up|1|||
164292590|NCT01962441|593441154|FG001|Retreatment Substudy|Lost to Follow-up|0|||
164292591|NCT01962441|593441155|FG002|Retreatment Substudy|Lost to Follow-up|0|||
164346316|NCT05469178|593642869|FG000|Overall Study|Lack of Efficacy|2|||
164346317|NCT05469178|593642870|FG001|Overall Study|Lack of Efficacy|2|||
164346318|NCT05469178|593642871|FG002|Overall Study|Lack of Efficacy|1|||
164346319|NCT05469178|593642872|FG003|Overall Study|Lack of Efficacy|10|||
164346320|NCT00968513|593642873|FG000|Overall Study|Death|4|||
164346321|NCT00968513|593642874|FG001|Overall Study|Death|10|||
164346322|NCT00968513|593642875|FG002|Overall Study|Death|15|||
164346323|NCT05466682|593642884|FG000|Overall Study|Withdrawal by Subject|0|||
164346324|NCT05466682|593642885|FG001|Overall Study|Withdrawal by Subject|2|||
164346325|NCT05466682|593642884|FG000|Overall Study|Lost to Follow-up|2|||
164346326|NCT05466682|593642885|FG001|Overall Study|Lost to Follow-up|1|||
164346327|NCT02801396|593642886|FG000|Period 1|Withdrawal by Subject|0|||
164346328|NCT02801396|593642887|FG001|Period 1|Withdrawal by Subject|0|||
164346329|NCT02801396|593642888|FG002|Period 1|Withdrawal by Subject|0|||
164346330|NCT02801396|593642889|FG003|Period 1|Withdrawal by Subject|0|||
164346331|NCT02801396|593642890|FG004|Period 1|Withdrawal by Subject|1|||
164346332|NCT02801396|593642891|FG005|Period 1|Withdrawal by Subject|0|||
164346333|NCT03087643|593642898|FG000|Overall Study|Withdrawal by Subject|2|||
164346334|NCT03087643|593642899|FG001|Overall Study|Withdrawal by Subject|4|||
164346335|NCT03087643|593642898|FG000|Overall Study|Death|2|||
164346336|NCT03087643|593642899|FG001|Overall Study|Death|2|||
164346337|NCT02083783|593642900|FG000|Overall Study|Withdrawal by Subject|1|||
164346338|NCT02083783|593642901|FG001|Overall Study|Withdrawal by Subject|0|||
164346339|NCT02256631|593642902|FG000|Overall Study|Lost to Follow-up|1|||
164346340|NCT02256631|593642903|FG001|Overall Study|Lost to Follow-up|1|||
164346341|NCT02256631|593642904|FG002|Overall Study|Lost to Follow-up|0|||
164346342|NCT02256631|593642905|FG003|Overall Study|Lost to Follow-up|2|||
164346343|NCT02256631|593642906|FG004|Overall Study|Lost to Follow-up|0|||
164346344|NCT02256631|593642907|FG005|Overall Study|Lost to Follow-up|4|||
164346345|NCT02256631|593642908|FG006|Overall Study|Lost to Follow-up|1|||
164346346|NCT02256631|593642902|FG000|Overall Study|Withdrawal by Subject|0|||
164346347|NCT02256631|593642903|FG001|Overall Study|Withdrawal by Subject|0|||
164346348|NCT02256631|593642904|FG002|Overall Study|Withdrawal by Subject|0|||
164346349|NCT02256631|593642905|FG003|Overall Study|Withdrawal by Subject|1|||
164346350|NCT02256631|593642906|FG004|Overall Study|Withdrawal by Subject|1|||
164346351|NCT02256631|593642907|FG005|Overall Study|Withdrawal by Subject|0|||
164346352|NCT02256631|593642908|FG006|Overall Study|Withdrawal by Subject|1|||
164346353|NCT02256631|593642902|FG000|Overall Study|Unable to get to clinic|0|||
164692785|NCT01701973|594897065|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
164346354|NCT02256631|593642903|FG001|Overall Study|Unable to get to clinic|2|||
164346355|NCT02256631|593642904|FG002|Overall Study|Unable to get to clinic|0|||
164346356|NCT02256631|593642905|FG003|Overall Study|Unable to get to clinic|1|||
164346357|NCT02256631|593642906|FG004|Overall Study|Unable to get to clinic|0|||
164346358|NCT02256631|593642907|FG005|Overall Study|Unable to get to clinic|1|||
164346359|NCT02256631|593642908|FG006|Overall Study|Unable to get to clinic|2|||
164692786|NCT01701973|594897066|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
164292592|NCT04862065|593441156|FG000|Screening|Protocol Violation|54|||
164346360|NCT04528732|593642909|FG000|Overall Study|Death|1|||
164292593|NCT04862065|593441157|FG001|Screening|Protocol Violation|0|||
164292594|NCT04862065|593441158|FG002|Screening|Protocol Violation|0|||
164292595|NCT04862065|593441156|FG000|Screening|Insufficient Sample|1|||
164292596|NCT04862065|593441157|FG001|Screening|Insufficient Sample|0|||
164586902|NCT02658656|594511925|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
164292597|NCT04862065|593441158|FG002|Screening|Insufficient Sample|0|||
164292598|NCT04862065|593441156|FG000|Follow-Up|Lost to Follow-up|3|||
164292599|NCT04862065|593441157|FG001|Follow-Up|Lost to Follow-up|0|||
164292600|NCT04862065|593441158|FG002|Follow-Up|Lost to Follow-up|0|||
164292601|NCT02055898|593441159|FG000|First Intervention (5 Days)|Physician Decision|2|||
164292602|NCT02055898|593441160|FG001|First Intervention (5 Days)|Physician Decision|0|||
164292603|NCT02055898|593441159|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
164292604|NCT02055898|593441160|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
164292605|NCT01453140|593441161|FG000|Overall Study|Adverse Event|3|||
164292606|NCT00743249|593441163|FG000|Overall Study|Adverse Event|0|||
164292607|NCT00743249|593441164|FG001|Overall Study|Adverse Event|4|||
164292608|NCT00743249|593441163|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
164292609|NCT00743249|593441164|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
164292610|NCT00743249|593441163|FG000|Overall Study|Unsuccessful insertion of stent|2|||
164292611|NCT00743249|593441164|FG001|Overall Study|Unsuccessful insertion of stent|1|||
164292612|NCT00718510|593441165|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
164292613|NCT00718510|593441166|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
164292614|NCT00718510|593441165|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
164292615|NCT00718510|593441166|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
164292616|NCT02201524|593441167|FG000|Overall Study|Adverse Event|0|||
164292617|NCT02201524|593441168|FG001|Overall Study|Adverse Event|2|||
164292618|NCT02201524|593441169|FG002|Overall Study|Adverse Event|1|||
164292619|NCT02201524|593441170|FG003|Overall Study|Adverse Event|0|||
164292620|NCT02201524|593441167|FG000|Overall Study|Insufficient clinical response|1|||
164292621|NCT02201524|593441168|FG001|Overall Study|Insufficient clinical response|0|||
164292622|NCT02201524|593441169|FG002|Overall Study|Insufficient clinical response|0|||
164292623|NCT02201524|593441170|FG003|Overall Study|Insufficient clinical response|0|||
164292624|NCT02201524|593441167|FG000|Overall Study|Lost to Follow-up|0|||
164292625|NCT02201524|593441168|FG001|Overall Study|Lost to Follow-up|0|||
164292626|NCT02201524|593441169|FG002|Overall Study|Lost to Follow-up|2|||
164292627|NCT02201524|593441170|FG003|Overall Study|Lost to Follow-up|0|||
164292628|NCT02201524|593441167|FG000|Overall Study|No longer meets eligibility criteria|0|||
164292629|NCT02201524|593441168|FG001|Overall Study|No longer meets eligibility criteria|0|||
164292630|NCT02201524|593441169|FG002|Overall Study|No longer meets eligibility criteria|0|||
164292631|NCT02201524|593441170|FG003|Overall Study|No longer meets eligibility criteria|2|||
164292632|NCT02201524|593441167|FG000|Overall Study|Protocol Violation|0|||
164292633|NCT02201524|593441168|FG001|Overall Study|Protocol Violation|0|||
164292634|NCT02201524|593441169|FG002|Overall Study|Protocol Violation|0|||
164292635|NCT02201524|593441170|FG003|Overall Study|Protocol Violation|1|||
164292636|NCT02201524|593441167|FG000|Overall Study|Withdrawal by Subject|0|||
164292637|NCT02201524|593441168|FG001|Overall Study|Withdrawal by Subject|0|||
164292638|NCT02201524|593441169|FG002|Overall Study|Withdrawal by Subject|1|||
164292639|NCT02201524|593441170|FG003|Overall Study|Withdrawal by Subject|1|||
164292640|NCT02201524|593441167|FG000|Overall Study|Other|1|||
164292641|NCT02201524|593441168|FG001|Overall Study|Other|1|||
164292642|NCT02201524|593441169|FG002|Overall Study|Other|0|||
164292643|NCT02201524|593441170|FG003|Overall Study|Other|0|||
164346361|NCT04528732|593642910|FG001|Overall Study|Death|0|||
164346362|NCT04528732|593642911|FG002|Overall Study|Death|1|||
164346363|NCT04528732|593642909|FG000|Overall Study|Lost to Follow-up|0|||
164346364|NCT04528732|593642910|FG001|Overall Study|Lost to Follow-up|1|||
164346365|NCT04528732|593642911|FG002|Overall Study|Lost to Follow-up|2|||
164346366|NCT01654536|593642915|FG000|Overall Study|Lost to Follow-up|5|||
164346367|NCT01654536|593642916|FG001|Overall Study|Lost to Follow-up|5|||
164346368|NCT01654536|593642915|FG000|Overall Study|Physician Decision|12|||
164346369|NCT01654536|593642916|FG001|Overall Study|Physician Decision|8|||
164346370|NCT01654536|593642915|FG000|Overall Study|Withdrawal by Subject|27|||
164346371|NCT01654536|593642916|FG001|Overall Study|Withdrawal by Subject|25|||
164346372|NCT04698187|593642921|FG000|Overall Study|Withdrawal by Subject|7|||
164346373|NCT04698187|593642921|FG000|Overall Study|Death|21|||
164292644|NCT00423657|593441172|FG000|Overall Study|Withdrew consent|10|||
164346374|NCT04698187|593642921|FG000|Overall Study|Sponsor Decision|15|||
164346375|NCT04698187|593642921|FG000|Overall Study|In-transit Disease|1|||
164346376|NCT04362072|593642922|FG000|Treatment|Adverse Event|1|||
164292645|NCT00423657|593441173|FG001|Overall Study|Withdrew consent|8|||
164292646|NCT00423657|593441172|FG000|Overall Study|Non-compliance|0|||
164292647|NCT00423657|593441173|FG001|Overall Study|Non-compliance|1|||
164292648|NCT00423657|593441172|FG000|Overall Study|Other|15|||
164292649|NCT00423657|593441173|FG001|Overall Study|Other|16|||
164292650|NCT00423657|593441172|FG000|Overall Study|Request of sponsor/investigator|1|||
164292651|NCT00423657|593441173|FG001|Overall Study|Request of sponsor/investigator|0|||
164346377|NCT04362072|593642922|FG000|Treatment|Death|9|||
164346378|NCT04362072|593642922|FG000|Treatment|Physician Decision|2|||
164346379|NCT04362072|593642922|FG000|Treatment|Progressive disease|27|||
164586903|NCT02658656|594511926|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
164586904|NCT02658656|594511924|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
164346380|NCT04362072|593642922|FG000|Treatment|Withdrawal by Subject|4|||
164346381|NCT04362072|593642922|FG000|Treatment|Global deterioration of health status|1|||
164346382|NCT04362072|593642922|FG000|Treatment|Switched to commercial Lorlatinib|13|||
164346383|NCT04362072|593642922|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
164346384|NCT04362072|593642922|FG000|Treatment|Other|3|||
164346385|NCT04362072|593642922|FG000|Follow up|Death|2|||
164346386|NCT04362072|593642922|FG000|Follow up|Other|2|||
164346387|NCT04524689|593642923|FG000|Overall Study|Withdrawal by Subject|1|||
164346388|NCT04524689|593642924|FG001|Overall Study|Withdrawal by Subject|1|||
164346389|NCT04524689|593642925|FG002|Overall Study|Withdrawal by Subject|0|||
164346390|NCT04524689|593642926|FG003|Overall Study|Withdrawal by Subject|0|||
164346391|NCT04524689|593642927|FG004|Overall Study|Withdrawal by Subject|2|||
164346392|NCT04524689|593642928|FG005|Overall Study|Withdrawal by Subject|0|||
164346393|NCT04524689|593642923|FG000|Overall Study|Study terminated by Sponsor|6|||
164346394|NCT04524689|593642924|FG001|Overall Study|Study terminated by Sponsor|0|||
164346395|NCT04524689|593642925|FG002|Overall Study|Study terminated by Sponsor|1|||
164346396|NCT04524689|593642926|FG003|Overall Study|Study terminated by Sponsor|0|||
164346397|NCT04524689|593642927|FG004|Overall Study|Study terminated by Sponsor|4|||
164346398|NCT04524689|593642928|FG005|Overall Study|Study terminated by Sponsor|0|||
164346399|NCT04524689|593642923|FG000|Overall Study|Not related to Coronavirus disease 2019|9|||
164346400|NCT04524689|593642924|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
164346401|NCT04524689|593642925|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
164346402|NCT04524689|593642926|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
164346403|NCT04524689|593642927|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
164346404|NCT04524689|593642928|FG005|Overall Study|Not related to Coronavirus disease 2019|1|||
164346405|NCT01133522|593642929|FG000|Overall Study|Withdrawal by Subject|0|||
164346406|NCT01133522|593642930|FG001|Overall Study|Withdrawal by Subject|1|||
164346407|NCT01133522|593642931|FG002|Overall Study|Withdrawal by Subject|0|||
164346408|NCT01133522|593642932|FG003|Overall Study|Withdrawal by Subject|1|||
164346409|NCT01133522|593642933|FG004|Overall Study|Withdrawal by Subject|0|||
164346410|NCT01133522|593642934|FG005|Overall Study|Withdrawal by Subject|0|||
164346411|NCT01133522|593642935|FG006|Overall Study|Withdrawal by Subject|0|||
164346412|NCT01133522|593642936|FG007|Overall Study|Withdrawal by Subject|0|||
164346413|NCT01133522|593642937|FG008|Overall Study|Withdrawal by Subject|0|||
164346414|NCT01133522|593642938|FG009|Overall Study|Withdrawal by Subject|0|||
164346415|NCT01133522|593642929|FG000|Overall Study|Physician Decision|0|||
164346416|NCT01133522|593642930|FG001|Overall Study|Physician Decision|0|||
164346417|NCT01133522|593642931|FG002|Overall Study|Physician Decision|0|||
164346418|NCT01133522|593642932|FG003|Overall Study|Physician Decision|0|||
164346419|NCT01133522|593642933|FG004|Overall Study|Physician Decision|1|||
164346420|NCT01133522|593642934|FG005|Overall Study|Physician Decision|0|||
164346421|NCT01133522|593642935|FG006|Overall Study|Physician Decision|0|||
164346422|NCT01133522|593642936|FG007|Overall Study|Physician Decision|0|||
164346423|NCT01133522|593642937|FG008|Overall Study|Physician Decision|0|||
164346424|NCT01133522|593642938|FG009|Overall Study|Physician Decision|0|||
164346425|NCT01664533|593644997|FG000|Overall Study|Death|42|||
164346426|NCT01664533|593644997|FG000|Overall Study|Lost to Follow-up|3|||
164346427|NCT01664533|593644997|FG000|Overall Study|Study termination|9|||
164346428|NCT01664533|593644997|FG000|Overall Study|Protocol Violation|3|||
164346429|NCT00844831|593644999|FG000|Overall Study|Withdrawal by Subject|4|||
164346430|NCT00844831|593644999|FG000|Overall Study|Adverse Event|1|||
164346431|NCT00844831|593644999|FG000|Overall Study|Physician Decision|1|||
164346432|NCT05255068|593645000|FG000|Overall Study|Lost to Follow-up|0|||
164346433|NCT05255068|593645001|FG001|Overall Study|Lost to Follow-up|1|||
164346434|NCT03156543|593645003|FG000|Overall Study|Withdrawal by Subject|1|||
164346435|NCT03156543|593645004|FG001|Overall Study|Withdrawal by Subject|0|||
164346436|NCT02397278|593645007|FG000|Overall Study|Withdrawal by Subject|0|||
164346437|NCT02397278|593645008|FG001|Overall Study|Withdrawal by Subject|2|||
164346438|NCT02397278|593645007|FG000|Overall Study|Deemed ineligible following surgery|1|||
164346439|NCT02397278|593645008|FG001|Overall Study|Deemed ineligible following surgery|1|||
164346440|NCT02601469|593645010|FG000|Overall Study|Enrolled in Error|1|||
164346441|NCT02601469|593645011|FG001|Overall Study|Enrolled in Error|0|||
164346442|NCT02161731|593645012|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
164586905|NCT02658656|594511925|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
164586906|NCT02658656|594511926|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
164586907|NCT02658656|594511924|FG000|Randomization|Not eligible for Randomization|1|||
164586908|NCT02658656|594511925|FG001|Randomization|Not eligible for Randomization|0|||
164586909|NCT02658656|594511926|FG002|Randomization|Not eligible for Randomization|0|||
164346443|NCT02161731|593645013|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
164346444|NCT02161731|593645012|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
164346445|NCT02161731|593645013|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
164346446|NCT01315678|593645014|FG000|Overall Study|Withdrawal by Subject|7|||
164292652|NCT02314052|593441174|FG000|Cycle One|Adverse Event|0|||
164292653|NCT02314052|593441175|FG001|Cycle One|Adverse Event|0|||
164292654|NCT02314052|593441176|FG002|Cycle One|Adverse Event|0|||
164292655|NCT02314052|593441177|FG003|Cycle One|Adverse Event|1|||
164292656|NCT02314052|593441178|FG004|Cycle One|Adverse Event|0|||
164292657|NCT02314052|593441179|FG005|Cycle One|Adverse Event|0|||
164292658|NCT00474955|593441180|FG000|Overall Study|Adverse Event|2|||
164292659|NCT00474955|593441180|FG000|Overall Study|Drug unavailability|1|||
164292660|NCT00474955|593441180|FG000|Overall Study|Personal reasons|5|||
164292661|NCT02269124|593441182|FG000|Overall Study|Lost to Follow-up|1|||
164292662|NCT02269124|593441183|FG001|Overall Study|Lost to Follow-up|0|||
164292663|NCT02269124|593441182|FG000|Overall Study|Withdrawal by Subject|0|||
164292664|NCT02269124|593441183|FG001|Overall Study|Withdrawal by Subject|2|||
164292665|NCT00667888|593441186|FG000|Overall Study|Death|1|||
164292666|NCT00667888|593441187|FG001|Overall Study|Death|1|||
164292667|NCT00667888|593441186|FG000|Overall Study|Withdrawal by Subject|6|||
164292668|NCT00667888|593441187|FG001|Overall Study|Withdrawal by Subject|3|||
164292669|NCT00667888|593441186|FG000|Overall Study|Proceed with other treatment|3|||
164292670|NCT00667888|593441187|FG001|Overall Study|Proceed with other treatment|3|||
164292671|NCT00667888|593441186|FG000|Overall Study|Ineligible after SIM|0|||
164292672|NCT00667888|593441187|FG001|Overall Study|Ineligible after SIM|2|||
164292673|NCT01945021|593441188|FG000|Overall Study|Adverse Event|1|||
164292674|NCT01945021|593441188|FG000|Overall Study|Withdrawal of consent|12|||
164292675|NCT01945021|593441188|FG000|Overall Study|Lost to Follow-up|5|||
164292676|NCT01945021|593441188|FG000|Overall Study|Death|65|||
164292677|NCT00739401|593441189|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
164292678|NCT00739401|593441189|FG000|Overall Study|Death|3|||
164292679|NCT00739401|593441189|FG000|Overall Study|Withdrawal by Subject|4|||
164292680|NCT01239381|593441191|FG000|Overall Study|Protocol Violation|1|||
164292681|NCT01239381|593441191|FG000|Overall Study|Withdrawal by Subject|1|||
164292682|NCT03409796|593442953|FG000|Overall Study|Adverse Event|2|||
164292683|NCT03409796|593442954|FG001|Overall Study|Adverse Event|0|||
164292684|NCT03409796|593442953|FG000|Overall Study|Other|0|||
164292685|NCT03409796|593442954|FG001|Overall Study|Other|1|||
164292686|NCT00770653|593442955|FG000|Overall Study|Adverse Event|13|||
164292687|NCT00770653|593442956|FG001|Overall Study|Adverse Event|5|||
164292688|NCT00770653|593442955|FG000|Overall Study|Protocol Violation|8|||
164292689|NCT00770653|593442956|FG001|Overall Study|Protocol Violation|6|||
164292690|NCT00770653|593442955|FG000|Overall Study|Withdrawal by Subject|4|||
164292691|NCT00770653|593442956|FG001|Overall Study|Withdrawal by Subject|7|||
164292692|NCT00770653|593442955|FG000|Overall Study|Lack of Compliance|1|||
164292693|NCT00770653|593442956|FG001|Overall Study|Lack of Compliance|4|||
164292694|NCT00770653|593442955|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
164292695|NCT00770653|593442956|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
164292696|NCT00770653|593442955|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
164292697|NCT00770653|593442956|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
164292698|NCT00770653|593442955|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
164292699|NCT00770653|593442956|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
164292700|NCT00770653|593442955|FG000|Overall Study|Lost to Follow-up|1|||
164292701|NCT00770653|593442956|FG001|Overall Study|Lost to Follow-up|2|||
164292702|NCT00770653|593442955|FG000|Overall Study|Physician Decision|1|||
164292703|NCT00770653|593442956|FG001|Overall Study|Physician Decision|0|||
164292704|NCT00683878|593442958|FG000|Overall Study|Lack of Efficacy|3|||
164292705|NCT00683878|593442959|FG001|Overall Study|Lack of Efficacy|0|||
164292706|NCT00683878|593442960|FG002|Overall Study|Lack of Efficacy|1|||
164292707|NCT00683878|593442958|FG000|Overall Study|Adverse Event|4|||
164292708|NCT00683878|593442959|FG001|Overall Study|Adverse Event|3|||
164292709|NCT00683878|593442960|FG002|Overall Study|Adverse Event|3|||
164292710|NCT00683878|593442958|FG000|Overall Study|Withdrawal by Subject|9|||
164292711|NCT00683878|593442959|FG001|Overall Study|Withdrawal by Subject|8|||
164292712|NCT00683878|593442960|FG002|Overall Study|Withdrawal by Subject|6|||
164292713|NCT00683878|593442958|FG000|Overall Study|Death|0|||
164292714|NCT00683878|593442959|FG001|Overall Study|Death|1|||
164292715|NCT00683878|593442960|FG002|Overall Study|Death|0|||
164292716|NCT00683878|593442958|FG000|Overall Study|Lost to Follow-up|4|||
164292717|NCT00683878|593442959|FG001|Overall Study|Lost to Follow-up|2|||
164292718|NCT00683878|593442960|FG002|Overall Study|Lost to Follow-up|4|||
164292719|NCT00683878|593442958|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
164292720|NCT00683878|593442959|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
164292721|NCT00683878|593442960|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
164292722|NCT02869633|593442961|FG000|Overall Study|Death|2|||
164292723|NCT02869633|593442962|FG001|Overall Study|Death|1|||
164292724|NCT02869633|593442961|FG000|Overall Study|Patient refused follow-up|1|||
164292725|NCT02869633|593442962|FG001|Overall Study|Patient refused follow-up|0|||
164292726|NCT02869633|593442961|FG000|Overall Study|Provider discretion|1|||
164292727|NCT02869633|593442962|FG001|Overall Study|Provider discretion|0|||
164292728|NCT02869633|593442961|FG000|Overall Study|Investigator decision|1|||
164292729|NCT02869633|593442962|FG001|Overall Study|Investigator decision|0|||
164292730|NCT02869633|593442961|FG000|Overall Study|Lost to Follow-up|0|||
164292731|NCT02869633|593442962|FG001|Overall Study|Lost to Follow-up|1|||
164292732|NCT02869633|593442961|FG000|Overall Study|Not eligible|6|||
164292733|NCT02869633|593442962|FG001|Overall Study|Not eligible|1|||
164292734|NCT02869633|593442961|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
164292735|NCT02869633|593442962|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
164292736|NCT02869633|593442961|FG000|Overall Study|Withdrawal by Subject|0|||
164292737|NCT02869633|593442962|FG001|Overall Study|Withdrawal by Subject|1|||
164292738|NCT04607668|593442971|FG000|Overall Study|Death|49|||
164292739|NCT04607668|593442972|FG001|Overall Study|Death|26|||
164292740|NCT04607668|593442971|FG000|Overall Study|Lost to Follow-up|3|||
164292741|NCT04607668|593442972|FG001|Overall Study|Lost to Follow-up|4|||
164292742|NCT04607668|593442971|FG000|Overall Study|Study terminated by Sponsor|92|||
164292743|NCT04607668|593442972|FG001|Overall Study|Study terminated by Sponsor|114|||
164292744|NCT04607668|593442971|FG000|Overall Study|Withdrawal by Subject|12|||
164292745|NCT04607668|593442972|FG001|Overall Study|Withdrawal by Subject|11|||
164292746|NCT04607668|593442971|FG000|Overall Study|Other, unspecified|8|||
164292747|NCT04607668|593442972|FG001|Overall Study|Other, unspecified|7|||
164292748|NCT01451723|593442973|FG000|Overall Study|study halted|6|||
164292749|NCT01451723|593442974|FG001|Overall Study|study halted|5|||
164292750|NCT02210000|593442975|FG000|Overall Study|Study Terminated|11|||
164292751|NCT02210000|593442976|FG001|Overall Study|Study Terminated|12|||
164292752|NCT02210000|593442975|FG000|Overall Study|Withdrawal by Subject|7|||
164292753|NCT02210000|593442976|FG001|Overall Study|Withdrawal by Subject|1|||
164292754|NCT02210000|593442975|FG000|Overall Study|Adverse Event|1|||
164292755|NCT02210000|593442976|FG001|Overall Study|Adverse Event|5|||
164292756|NCT02210000|593442975|FG000|Overall Study|Lost to Follow-up|0|||
164292757|NCT02210000|593442976|FG001|Overall Study|Lost to Follow-up|2|||
164292758|NCT02210000|593442975|FG000|Overall Study|Physician Decision|0|||
164292759|NCT02210000|593442976|FG001|Overall Study|Physician Decision|1|||
164292760|NCT00308139|593442977|FG000|Overall Study|Adverse Event|20|||
164292761|NCT00308139|593442978|FG001|Overall Study|Adverse Event|14|||
164292762|NCT00308139|593442977|FG000|Overall Study|Lost to Follow-up|13|||
164292763|NCT00308139|593442978|FG001|Overall Study|Lost to Follow-up|8|||
164292764|NCT00308139|593442977|FG000|Overall Study|Protocol Violation|3|||
164292765|NCT00308139|593442978|FG001|Overall Study|Protocol Violation|2|||
164292766|NCT00308139|593442977|FG000|Overall Study|Withdrawal of Consent|40|||
164292767|NCT00308139|593442978|FG001|Overall Study|Withdrawal of Consent|42|||
164292768|NCT00308139|593442977|FG000|Overall Study|Investigator Decision|11|||
164292769|NCT00308139|593442978|FG001|Overall Study|Investigator Decision|10|||
164292770|NCT00308139|593442977|FG000|Overall Study|Loss of Glucose Control|5|||
164292771|NCT00308139|593442978|FG001|Overall Study|Loss of Glucose Control|7|||
164292772|NCT00308139|593442977|FG000|Overall Study|Administrative|1|||
164292773|NCT00308139|593442978|FG001|Overall Study|Administrative|4|||
164292774|NCT00308139|593442977|FG000|Overall Study|Other|1|||
164292775|NCT00308139|593442978|FG001|Overall Study|Other|0|||
164292776|NCT00962208|593442987|FG000|Overall Study|Could not achieve good vision|9|||
164292777|NCT00962208|593442988|FG001|Overall Study|Could not achieve good vision|0|||
164292778|NCT00962208|593442987|FG000|Overall Study|Contraindicated to continue study|5|||
164292779|NCT00962208|593442988|FG001|Overall Study|Contraindicated to continue study|1|||
164292780|NCT00962208|593442987|FG000|Overall Study|Lost to Follow-up|0|||
164292781|NCT00962208|593442988|FG001|Overall Study|Lost to Follow-up|9|||
164292782|NCT00791388|593442989|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
164292783|NCT00791388|593442990|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
164292784|NCT00791388|593442991|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
164292785|NCT00791388|593442992|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
164292786|NCT00791388|593442993|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
164292787|NCT00791388|593442989|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
164292788|NCT00791388|593442990|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
164292789|NCT00791388|593442991|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
164292790|NCT00791388|593442992|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
164292791|NCT00791388|593442993|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
164292792|NCT00791388|593442989|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
164292793|NCT00791388|593442990|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
164292794|NCT00791388|593442991|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
164292795|NCT00791388|593442992|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
164292796|NCT00791388|593442993|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
164292797|NCT01731912|593443000|FG000|Overall Study|noncompliance|2|||
164292798|NCT03010527|593443002|FG000|Overall Study|Death|0|||
164292799|NCT03010527|593443003|FG001|Overall Study|Death|0|||
164292800|NCT03010527|593443004|FG002|Overall Study|Death|1|||
164292801|NCT03010527|593443002|FG000|Overall Study|Adverse Event|0|||
164292802|NCT03010527|593443003|FG001|Overall Study|Adverse Event|4|||
164292803|NCT03010527|593443004|FG002|Overall Study|Adverse Event|2|||
164292804|NCT03010527|593443002|FG000|Overall Study|Protocol Violation|0|||
164292805|NCT03010527|593443003|FG001|Overall Study|Protocol Violation|1|||
164586910|NCT02658656|594511924|FG000|Randomization|Protocol Violation|1|||
164292806|NCT03010527|593443004|FG002|Overall Study|Protocol Violation|0|||
164292807|NCT03010527|593443002|FG000|Overall Study|Lost to Follow-up|0|||
164292808|NCT03010527|593443003|FG001|Overall Study|Lost to Follow-up|2|||
164292809|NCT03010527|593443004|FG002|Overall Study|Lost to Follow-up|1|||
164292810|NCT03010527|593443002|FG000|Overall Study|Withdrawal by Subject|0|||
164292811|NCT03010527|593443003|FG001|Overall Study|Withdrawal by Subject|3|||
164292812|NCT03010527|593443004|FG002|Overall Study|Withdrawal by Subject|4|||
164292813|NCT03010527|593443002|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
164292814|NCT03010527|593443003|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
164292815|NCT03010527|593443004|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
164292816|NCT03010527|593443002|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
164292817|NCT03010527|593443003|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
164292818|NCT03010527|593443004|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
164292819|NCT03010527|593443002|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
164292820|NCT03010527|593443003|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
164292821|NCT03010527|593443004|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
164292822|NCT00443040|593443005|FG000|Overall Study|Withdrawal by Subject|1|||
164292823|NCT00443040|593443006|FG001|Overall Study|Withdrawal by Subject|0|||
164292824|NCT00443040|593443007|FG002|Overall Study|Withdrawal by Subject|0|||
164292825|NCT00443040|593443005|FG000|Overall Study|Converted to an open laparotomy|3|||
164292826|NCT00443040|593443006|FG001|Overall Study|Converted to an open laparotomy|0|||
164292827|NCT00443040|593443007|FG002|Overall Study|Converted to an open laparotomy|1|||
164292828|NCT04750824|593443008|FG000|Overall Study|Toxicity/intolerability|3|||
164292829|NCT04750824|593443009|FG001|Overall Study|Toxicity/intolerability|1|||
164292830|NCT04750824|593443008|FG000|Overall Study|Death|1|||
164292831|NCT04750824|593443009|FG001|Overall Study|Death|3|||
164292832|NCT04750824|593443008|FG000|Overall Study|Scheduled duration of therapy complete|1|||
164292833|NCT04750824|593443009|FG001|Overall Study|Scheduled duration of therapy complete|9|||
164292834|NCT04750824|593443008|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
164292835|NCT04750824|593443009|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
164292836|NCT02469623|593443010|FG000|Overall Study|Not consented for long-term follow-up|4|||
164292837|NCT02469623|593443010|FG000|Overall Study|Lost to Follow-up|4|||
164292838|NCT02469623|593443010|FG000|Overall Study|Withdrawal by Subject|2|||
164292839|NCT02469623|593443010|FG000|Overall Study|Death|3|||
164292840|NCT04073186|593443011|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
164292841|NCT04073186|593443011|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
164292842|NCT04073186|593443011|FG000|First Wearing Cycle|Protocol Violation|1|||
164292843|NCT04073186|593443011|FG000|First Wearing Cycle|Lens Discomfort|2|||
164292844|NCT04073186|593443011|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
164292845|NCT04073186|593443011|FG000|Second Wearing Cycle|Adverse Event|1|||
164292846|NCT01096316|593443012|FG000|Overall Study|Lost to Follow-up|15|||
164292847|NCT01096316|593443013|FG001|Overall Study|Lost to Follow-up|9|||
164292848|NCT02763644|593443014|FG000|Overall Study|Patient/guardian decision|1|||
164292849|NCT02763644|593443015|FG001|Overall Study|Patient/guardian decision|0|||
164292850|NCT02763644|593443014|FG000|Overall Study|Death|1|||
164292851|NCT02763644|593443015|FG001|Overall Study|Death|1|||
164292852|NCT02763644|593443014|FG000|Overall Study|Adverse Event|1|||
164292853|NCT02763644|593443015|FG001|Overall Study|Adverse Event|1|||
164292854|NCT00473434|593443016|FG000|Overall Study|Physician Decision|3|||
164292855|NCT00473434|593443016|FG000|Overall Study|Withdrawal by Subject|9|||
164292856|NCT00473434|593443016|FG000|Overall Study|Compliance|3|||
164292857|NCT00473434|593443016|FG000|Overall Study|Lack of Efficacy|3|||
164292858|NCT00473434|593443016|FG000|Overall Study|Adverse Event|3|||
164292859|NCT00473434|593443016|FG000|Overall Study|Patient was selling medication to others|1|||
164292860|NCT00473434|593443016|FG000|Overall Study|Safety evaluation|1|||
164292861|NCT00473434|593443016|FG000|Overall Study|Reason not specified|6|||
164292862|NCT00473434|593443016|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
164292863|NCT00473434|593443016|FG000|Overall Study|Switching to trial medication|1|||
164292864|NCT00473434|593443016|FG000|Overall Study|No longer required|1|||
164292865|NCT02356159|593443018|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
164292866|NCT02356159|593443019|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
164292867|NCT02356159|593443020|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
164292868|NCT02356159|593443021|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
164586911|NCT02658656|594511925|FG001|Randomization|Protocol Violation|0|||
164586912|NCT02658656|594511926|FG002|Randomization|Protocol Violation|0|||
164292869|NCT02356159|593443022|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
164292870|NCT02356159|593443023|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
164292871|NCT06418152|593443024|FG000|Overall Study|Frequent DBS setting changes|1|||
164292872|NCT06418152|593443024|FG000|Overall Study|Withdrawal by Subject|2|||
164292873|NCT02529852|593443029|FG000|Overall Study|Withdrawal by Subject|2|||
164292874|NCT00117637|593443030|FG000|First Intervention (Period 1)|Adverse Event|11|||
164586913|NCT02112448|594511927|FG000|Overall Study|lab values precluding use of ketorolac|2|||
164586914|NCT02112448|594511928|FG001|Overall Study|lab values precluding use of ketorolac|2|||
164292875|NCT00117637|593443031|FG001|First Intervention (Period 1)|Adverse Event|16|||
164292876|NCT00117637|593443030|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
164292877|NCT00117637|593443031|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
164292878|NCT00117637|593443030|FG000|First Intervention (Period 1)|Protocol Violation|1|||
164292879|NCT00117637|593443031|FG001|First Intervention (Period 1)|Protocol Violation|0|||
164292880|NCT00117637|593443030|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
164292881|NCT00117637|593443031|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
164292882|NCT00117637|593443030|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
164292883|NCT00117637|593443031|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
164292884|NCT00117637|593443030|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
164292885|NCT00117637|593443031|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
164292886|NCT00117637|593443030|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
164292887|NCT00117637|593443031|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
164292888|NCT00117637|593443030|FG000|First Intervention (Period 1)|reason not reported|0|||
164292889|NCT00117637|593443031|FG001|First Intervention (Period 1)|reason not reported|1|||
164292890|NCT00117637|593443030|FG000|Second Intervention (Period 2)|Adverse Event|0|||
164292891|NCT00117637|593443031|FG001|Second Intervention (Period 2)|Adverse Event|9|||
164292892|NCT00117637|593443030|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
164292893|NCT00117637|593443031|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
164292894|NCT00117637|593443030|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
164292895|NCT00117637|593443031|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
164292896|NCT00117637|593443030|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
164292897|NCT00117637|593443031|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
164292898|NCT00117637|593443030|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
164292899|NCT00117637|593443031|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
164292900|NCT00117637|593443030|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
164292901|NCT00117637|593443031|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
164292902|NCT00117637|593443030|FG000|Second Intervention (Period 2)|reason not reported|1|||
164292903|NCT00117637|593443031|FG001|Second Intervention (Period 2)|reason not reported|0|||
164292904|NCT03206216|593443037|FG000|Overall Study|Withdrawal by Subject|0|||
164292905|NCT03206216|593443038|FG001|Overall Study|Withdrawal by Subject|1|||
164292906|NCT01582061|593443041|FG000|Overall Study|Lack of Efficacy|3|||
164292907|NCT01582061|593443042|FG001|Overall Study|Lack of Efficacy|23|||
164292908|NCT01582061|593443041|FG000|Overall Study|Adverse Event|12|||
164292909|NCT01582061|593443042|FG001|Overall Study|Adverse Event|8|||
164292910|NCT01582061|593443041|FG000|Overall Study|Withdrawal by Subject|10|||
164292911|NCT01582061|593443042|FG001|Overall Study|Withdrawal by Subject|4|||
164292912|NCT01582061|593443041|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164292913|NCT01582061|593443042|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164292914|NCT01582061|593443041|FG000|Overall Study|Death|0|||
164292915|NCT01582061|593443042|FG001|Overall Study|Death|1|||
164292916|NCT01582061|593443041|FG000|Overall Study|condition no longer requires study drug|1|||
164292917|NCT01582061|593443042|FG001|Overall Study|condition no longer requires study drug|0|||
164292918|NCT01582061|593443041|FG000|Overall Study|Lost to Follow-up|1|||
164292919|NCT01582061|593443042|FG001|Overall Study|Lost to Follow-up|0|||
164292920|NCT00097500|593443043|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
164292921|NCT00097500|593443044|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
164292922|NCT00097500|593443043|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
164292923|NCT00097500|593443044|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
164292924|NCT00097500|593443043|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
164292925|NCT00097500|593443044|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
164292926|NCT00097500|593443043|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
164292927|NCT00097500|593443044|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
164292928|NCT00097500|593443043|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
164292929|NCT00097500|593443044|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
164292930|NCT00097500|593443043|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
164292931|NCT00097500|593443044|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
164586915|NCT02112448|594511927|FG000|Overall Study|Protocol Violation|1|||
164586916|NCT02112448|594511928|FG001|Overall Study|Protocol Violation|2|||
164586917|NCT02112448|594511927|FG000|Overall Study|Physician Decision|4|||
164586918|NCT02112448|594511928|FG001|Overall Study|Physician Decision|6|||
164586919|NCT02112448|594511927|FG000|Overall Study|required heparin so could not use ketoro|1|||
164586920|NCT02112448|594511928|FG001|Overall Study|required heparin so could not use ketoro|0|||
164586921|NCT03625986|594513680|FG000|Randomization Period|Lost to Follow-up|7|||
164586922|NCT03625986|594513681|FG001|Randomization Period|Lost to Follow-up|12|||
164586923|NCT03625986|594513680|FG000|Randomization Period|Withdrawal by Subject|10|||
164292932|NCT00097500|593443043|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
164292933|NCT00097500|593443044|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
164586924|NCT03625986|594513681|FG001|Randomization Period|Withdrawal by Subject|6|||
164292934|NCT03119259|593443051|FG000|Overall Study|Withdrawn as no longer eligible|1|||
164292935|NCT03119259|593443052|FG001|Overall Study|Withdrawn as no longer eligible|0|||
164292936|NCT03119259|593443051|FG000|Overall Study|Withdrawal by Subject|4|||
164292937|NCT03119259|593443052|FG001|Overall Study|Withdrawal by Subject|2|||
164292938|NCT03119259|593443051|FG000|Overall Study|Lost to Follow-up|0|||
164292939|NCT03119259|593443052|FG001|Overall Study|Lost to Follow-up|1|||
164292940|NCT00647296|593443060|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
164292941|NCT00647296|593443061|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
164292942|NCT00647296|593443062|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
164292943|NCT00647296|593443063|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
164292944|NCT00647296|593443060|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
164292945|NCT00647296|593443061|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
164292946|NCT00647296|593443062|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
164292947|NCT00647296|593443063|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
164292948|NCT00647296|593443060|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
164292949|NCT00647296|593443061|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
164292950|NCT00647296|593443062|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
164292951|NCT00647296|593443063|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
164292952|NCT00647296|593443060|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
164292953|NCT00647296|593443061|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
164292954|NCT00647296|593443062|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
164292955|NCT00647296|593443063|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
164292956|NCT00647296|593443060|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
164292957|NCT00647296|593443061|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
164292958|NCT00647296|593443062|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
164292959|NCT00647296|593443063|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
164292960|NCT00647296|593443060|FG000|Part 2: 4-week Placebo Washout|Death|3|||
164292961|NCT00647296|593443061|FG001|Part 2: 4-week Placebo Washout|Death|0|||
164292962|NCT00647296|593443062|FG002|Part 2: 4-week Placebo Washout|Death|0|||
164292963|NCT00647296|593443063|FG003|Part 2: 4-week Placebo Washout|Death|0|||
164292964|NCT00647296|593443060|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
164292965|NCT00647296|593443061|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
164292966|NCT00647296|593443062|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
164292967|NCT00647296|593443063|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
164292968|NCT00647296|593443060|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
164292969|NCT00647296|593443061|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
164292970|NCT00647296|593443062|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
164292971|NCT00647296|593443063|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
164292972|NCT00647296|593443060|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
164292973|NCT00647296|593443061|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
164292974|NCT00647296|593443062|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
164292975|NCT00647296|593443063|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
164292976|NCT00647296|593443060|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
164292977|NCT00647296|593443061|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
164292978|NCT00647296|593443062|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
164292979|NCT00647296|593443063|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
164292980|NCT00647296|593443060|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
164292981|NCT00647296|593443061|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
164292982|NCT00647296|593443062|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
164292983|NCT00647296|593443063|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
164292984|NCT01300234|593443064|FG000|Overall Study|Adverse Event|1|||
164292985|NCT01300234|593443065|FG001|Overall Study|Adverse Event|1|||
164292986|NCT01300234|593443064|FG000|Overall Study|Protocol Violation|2|||
164292987|NCT01300234|593443065|FG001|Overall Study|Protocol Violation|3|||
164292988|NCT01300234|593443064|FG000|Overall Study|Withdrawal by Subject|5|||
164292989|NCT01300234|593443065|FG001|Overall Study|Withdrawal by Subject|9|||
164292990|NCT01300234|593443064|FG000|Overall Study|Lost to Follow-up|14|||
164292991|NCT01300234|593443065|FG001|Overall Study|Lost to Follow-up|12|||
164292992|NCT01300234|593443064|FG000|Overall Study|Pregnancy|2|||
164292993|NCT01300234|593443065|FG001|Overall Study|Pregnancy|1|||
164292994|NCT01300234|593443064|FG000|Overall Study|Participant reached stopping critera|2|||
164292995|NCT01300234|593443065|FG001|Overall Study|Participant reached stopping critera|0|||
164292996|NCT01300234|593443064|FG000|Overall Study|Participant stopped medication|1|||
164292997|NCT01300234|593443065|FG001|Overall Study|Participant stopped medication|1|||
164292998|NCT01300234|593443064|FG000|Overall Study|Participant refused return to hospital|1|||
164292999|NCT01300234|593443065|FG001|Overall Study|Participant refused return to hospital|0|||
164293000|NCT03253679|593443066|FG000|Overall Study|Screen Failure|1|||
164434117|NCT00980538|593958680|FG000|Overall Study|Sponsor's Decision|4|||
164586925|NCT03009539|594513689|FG000|Overall Study|Lost to Follow-up|132|||
164293001|NCT04816214|593443067|FG000|Overall Study|Progressive Disease|4|||
164293002|NCT04816214|593443068|FG001|Overall Study|Progressive Disease|0|||
164293003|NCT04816214|593443069|FG002|Overall Study|Progressive Disease|0|||
164293004|NCT04816214|593443067|FG000|Overall Study|Death|1|||
164293005|NCT04816214|593443068|FG001|Overall Study|Death|0|||
164293006|NCT04816214|593443069|FG002|Overall Study|Death|0|||
164293007|NCT04816214|593443067|FG000|Overall Study|Study Terminated by Sponsor|1|||
164293008|NCT04816214|593443068|FG001|Overall Study|Study Terminated by Sponsor|0|||
164293009|NCT04816214|593443069|FG002|Overall Study|Study Terminated by Sponsor|0|||
164293010|NCT04879628|593443070|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
164293011|NCT04879628|593443071|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
164293012|NCT04879628|593443072|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
164293013|NCT04879628|593443073|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
164293014|NCT04879628|593443070|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
164293015|NCT04879628|593443071|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
164293016|NCT04879628|593443072|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
164293017|NCT04879628|593443073|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
164293018|NCT04879628|593443070|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
164293019|NCT04879628|593443071|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
164293020|NCT04879628|593443072|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
164293021|NCT04879628|593443073|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
164293022|NCT04879628|593443070|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
164293023|NCT04879628|593443071|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
164293024|NCT04879628|593443072|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
164293025|NCT04879628|593443073|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
164293026|NCT00360412|593443079|FG000|Overall Study|Adverse Event|37|||
164293027|NCT00360412|593443080|FG001|Overall Study|Adverse Event|65|||
164293028|NCT00360412|593443079|FG000|Overall Study|Protocol Violation|2|||
164293029|NCT00360412|593443080|FG001|Overall Study|Protocol Violation|5|||
164293030|NCT00360412|593443079|FG000|Overall Study|Patient withdrew consent|27|||
164293031|NCT00360412|593443080|FG001|Overall Study|Patient withdrew consent|52|||
164293032|NCT00360412|593443079|FG000|Overall Study|Lack of therapeutic efficacy|46|||
164293033|NCT00360412|593443080|FG001|Overall Study|Lack of therapeutic efficacy|61|||
164293034|NCT00360412|593443079|FG000|Overall Study|Physician Decision|2|||
164293035|NCT00360412|593443080|FG001|Overall Study|Physician Decision|4|||
164293036|NCT00360412|593443079|FG000|Overall Study|Other|5|||
164293037|NCT00360412|593443080|FG001|Overall Study|Other|6|||
164293038|NCT00360412|593443079|FG000|Overall Study|Study termination by Sponsor|214|||
164293039|NCT00360412|593443080|FG001|Overall Study|Study termination by Sponsor|469|||
164293040|NCT00871871|593443081|FG000|Part I|Adverse Event|0|||
164293041|NCT00871871|593443082|FG001|Part I|Adverse Event|2|||
164293042|NCT00871871|593443083|FG002|Part I|Adverse Event|0|||
164293043|NCT00871871|593443084|FG003|Part I|Adverse Event|0|||
164293044|NCT00871871|593443081|FG000|Part I|Withdrawal by Subject|3|||
164293045|NCT00871871|593443082|FG001|Part I|Withdrawal by Subject|0|||
164293046|NCT00871871|593443083|FG002|Part I|Withdrawal by Subject|0|||
164293047|NCT00871871|593443084|FG003|Part I|Withdrawal by Subject|0|||
164293048|NCT00871871|593443081|FG000|Part I|Laboratory abnormality|0|||
164293049|NCT00871871|593443082|FG001|Part I|Laboratory abnormality|1|||
164293050|NCT00871871|593443083|FG002|Part I|Laboratory abnormality|0|||
164293051|NCT00871871|593443084|FG003|Part I|Laboratory abnormality|0|||
164293052|NCT00871871|593443081|FG000|Part II|Lack of Efficacy|0|||
164293053|NCT00871871|593443082|FG001|Part II|Lack of Efficacy|0|||
164586926|NCT03009539|594513690|FG001|Overall Study|Lost to Follow-up|113|||
164293054|NCT00871871|593443083|FG002|Part II|Lack of Efficacy|1|||
164293055|NCT00871871|593443084|FG003|Part II|Lack of Efficacy|0|||
164293056|NCT00871871|593443081|FG000|Part II|Withdrawal by Subject|0|||
164293057|NCT00871871|593443082|FG001|Part II|Withdrawal by Subject|0|||
164293058|NCT00871871|593443083|FG002|Part II|Withdrawal by Subject|2|||
164293059|NCT00871871|593443084|FG003|Part II|Withdrawal by Subject|1|||
164293060|NCT00871871|593443081|FG000|Part II|Adverse Event|0|||
164293061|NCT00871871|593443082|FG001|Part II|Adverse Event|0|||
164293062|NCT00871871|593443083|FG002|Part II|Adverse Event|1|||
164293063|NCT00871871|593443084|FG003|Part II|Adverse Event|2|||
164293064|NCT00871871|593443081|FG000|Part II|Protocol Violation|0|||
164293065|NCT00871871|593443082|FG001|Part II|Protocol Violation|0|||
164293066|NCT00871871|593443083|FG002|Part II|Protocol Violation|0|||
164293067|NCT00871871|593443084|FG003|Part II|Protocol Violation|1|||
164293068|NCT04612725|593443085|FG000|Overall Study|Adverse Event|1|||
164293069|NCT04612725|593443086|FG001|Overall Study|Adverse Event|3|||
164293070|NCT04612725|593443087|FG002|Overall Study|Adverse Event|1|||
164293071|NCT04612725|593443088|FG003|Overall Study|Adverse Event|0|||
164293072|NCT04612725|593443089|FG004|Overall Study|Adverse Event|1|||
164293073|NCT04612725|593443085|FG000|Overall Study|Lost to Follow-up|0|||
164293074|NCT04612725|593443086|FG001|Overall Study|Lost to Follow-up|1|||
164293075|NCT04612725|593443087|FG002|Overall Study|Lost to Follow-up|0|||
164293076|NCT04612725|593443088|FG003|Overall Study|Lost to Follow-up|0|||
164293077|NCT04612725|593443089|FG004|Overall Study|Lost to Follow-up|0|||
164293078|NCT04612725|593443085|FG000|Overall Study|Physician Decision|2|||
164293079|NCT04612725|593443086|FG001|Overall Study|Physician Decision|0|||
164293080|NCT04612725|593443087|FG002|Overall Study|Physician Decision|0|||
164293081|NCT04612725|593443088|FG003|Overall Study|Physician Decision|0|||
164293082|NCT04612725|593443089|FG004|Overall Study|Physician Decision|0|||
164293083|NCT04612725|593443085|FG000|Overall Study|Study terminated by sponsor|3|||
164293084|NCT04612725|593443086|FG001|Overall Study|Study terminated by sponsor|1|||
164293085|NCT04612725|593443087|FG002|Overall Study|Study terminated by sponsor|2|||
164293086|NCT04612725|593443088|FG003|Overall Study|Study terminated by sponsor|4|||
164293087|NCT04612725|593443089|FG004|Overall Study|Study terminated by sponsor|5|||
164293088|NCT04612725|593443085|FG000|Overall Study|Withdrawal by Subject|8|||
164293089|NCT04612725|593443086|FG001|Overall Study|Withdrawal by Subject|3|||
164293090|NCT04612725|593443087|FG002|Overall Study|Withdrawal by Subject|5|||
164293091|NCT04612725|593443088|FG003|Overall Study|Withdrawal by Subject|1|||
164293092|NCT04612725|593443089|FG004|Overall Study|Withdrawal by Subject|9|||
164293093|NCT04612725|593443085|FG000|Overall Study|Other|0|||
164293094|NCT04612725|593443086|FG001|Overall Study|Other|0|||
164293095|NCT04612725|593443087|FG002|Overall Study|Other|0|||
164293096|NCT04612725|593443088|FG003|Overall Study|Other|0|||
164293097|NCT04612725|593443089|FG004|Overall Study|Other|1|||
164293098|NCT03863509|593443090|FG000|Overall Study|COVID-19 shutdown period|0|||
164293099|NCT03863509|593443091|FG001|Overall Study|COVID-19 shutdown period|4|||
164293100|NCT03863509|593443092|FG002|Overall Study|COVID-19 shutdown period|0|||
164293101|NCT03863509|593443090|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
164293102|NCT03863509|593443091|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
164293103|NCT03863509|593443092|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
164293104|NCT03863509|593443090|FG000|Overall Study|Lost to Follow-up|8|||
164293105|NCT03863509|593443091|FG001|Overall Study|Lost to Follow-up|0|||
164293106|NCT03863509|593443092|FG002|Overall Study|Lost to Follow-up|2|||
164293107|NCT03863509|593443090|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
164293108|NCT03863509|593443091|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
164293109|NCT03863509|593443092|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
164293110|NCT03863509|593443090|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
164293111|NCT03863509|593443091|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
164293112|NCT03863509|593443092|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
164293113|NCT03861273|593443093|FG000|Screening Phase (3 Weeks)|Other|1|||
164293114|NCT03861273|593443093|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
164293115|NCT03861273|593443093|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
164293116|NCT03861273|593443093|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
164293117|NCT03861273|593443093|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
164293118|NCT00948064|593445130|FG000|Phase I|No treatment received|1|||
164293119|NCT00948064|593445131|FG001|Phase I|No treatment received|0|||
164293120|NCT00948064|593445132|FG002|Phase I|No treatment received|0|||
164586927|NCT03009539|594513691|FG002|Overall Study|Lost to Follow-up|132|||
164586928|NCT03009539|594513692|FG003|Overall Study|Lost to Follow-up|113|||
164586929|NCT04543955|594513693|FG000|Overall Study|Company cancelled study|1|||
164586930|NCT04543955|594513694|FG001|Overall Study|Company cancelled study|0|||
164586931|NCT03918642|594513695|FG000|Overall Study|Lost to Follow-up|12|||
164586932|NCT03918642|594513696|FG001|Overall Study|Lost to Follow-up|10|||
164586933|NCT01277289|594513706|FG000|Overall Study|fragile vein|1|||
164586934|NCT01277289|594513707|FG001|Overall Study|fragile vein|0|||
164586935|NCT01277289|594513706|FG000|Overall Study|Physician Decision|1|||
164586936|NCT01277289|594513707|FG001|Overall Study|Physician Decision|0|||
164586937|NCT01277289|594513706|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
164586938|NCT01277289|594513707|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
164586939|NCT01277289|594513706|FG000|Overall Study|Protocol Violation|1|||
164586940|NCT01277289|594513707|FG001|Overall Study|Protocol Violation|1|||
164586941|NCT01277289|594513706|FG000|Overall Study|Adverse Event|2|||
164586942|NCT01277289|594513707|FG001|Overall Study|Adverse Event|1|||
164586943|NCT01277289|594513706|FG000|Overall Study|consent withdrawn|1|||
164586944|NCT01277289|594513707|FG001|Overall Study|consent withdrawn|1|||
164586945|NCT01277289|594513706|FG000|Overall Study|premature closure of the study|4|||
164586946|NCT01277289|594513707|FG001|Overall Study|premature closure of the study|2|||
164586947|NCT04760314|594513710|FG000|Induction Period|Withdrawal by Subject|0|||
164586948|NCT04760314|594513711|FG001|Induction Period|Withdrawal by Subject|1|||
164586949|NCT04760314|594513712|FG002|Induction Period|Withdrawal by Subject|1|||
164586950|NCT04760314|594513713|FG003|Induction Period|Withdrawal by Subject|0|||
164586951|NCT04760314|594513714|FG004|Induction Period|Withdrawal by Subject|0|||
164586952|NCT04760314|594513715|FG005|Induction Period|Withdrawal by Subject|0|||
164293121|NCT00948064|593445130|FG000|Phase II|Physician Decision|0|||
164293122|NCT00948064|593445131|FG001|Phase II|Physician Decision|0|||
164293123|NCT00948064|593445132|FG002|Phase II|Physician Decision|1|||
164293124|NCT00948064|593445130|FG000|Phase II|Withdrawal by Subject|0|||
164293125|NCT00948064|593445131|FG001|Phase II|Withdrawal by Subject|1|||
164293126|NCT00948064|593445132|FG002|Phase II|Withdrawal by Subject|0|||
164293127|NCT00740220|593445133|FG000|Overall Study|screen failures (non-COPD patients)|9|||
164293128|NCT00633477|593445134|FG000|Overall Study|Death|1|||
164293129|NCT00633477|593445135|FG001|Overall Study|Death|0|||
164293130|NCT00633477|593445134|FG000|Overall Study|Randomized but not treated|1|||
164293131|NCT00633477|593445135|FG001|Overall Study|Randomized but not treated|0|||
164293132|NCT04906499|593445144|FG000|Overall Study|Lack of time|1|||
164293133|NCT03346434|593445146|FG000|Overall Study|Randomized in Error|0|||
164293134|NCT03346434|593445147|FG001|Overall Study|Randomized in Error|0|||
164293135|NCT03346434|593445148|FG002|Overall Study|Randomized in Error|0|||
164293136|NCT03346434|593445149|FG003|Overall Study|Randomized in Error|0|||
164293137|NCT03346434|593445150|FG004|Overall Study|Randomized in Error|1|||
164293138|NCT03346434|593445151|FG005|Overall Study|Randomized in Error|0|||
164293139|NCT03346434|593445146|FG000|Overall Study|Withdrawal by Subject|0|||
164293140|NCT03346434|593445147|FG001|Overall Study|Withdrawal by Subject|0|||
164293141|NCT03346434|593445148|FG002|Overall Study|Withdrawal by Subject|1|||
164293142|NCT03346434|593445149|FG003|Overall Study|Withdrawal by Subject|0|||
164293143|NCT03346434|593445150|FG004|Overall Study|Withdrawal by Subject|1|||
164293144|NCT03346434|593445151|FG005|Overall Study|Withdrawal by Subject|0|||
164293145|NCT03346434|593445146|FG000|Overall Study|Lost to Follow-up|0|||
164293146|NCT03346434|593445147|FG001|Overall Study|Lost to Follow-up|0|||
164692787|NCT01701973|594897067|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
164692788|NCT01701973|594897068|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
164692789|NCT01701973|594897069|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
164692790|NCT01701973|594897070|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
164692791|NCT02663882|594897071|FG000|Overall Study|Lost to Follow-up|4|||
164692792|NCT02663882|594897072|FG001|Overall Study|Lost to Follow-up|2|||
164692793|NCT03712124|594897073|FG000|Overall Study|Protocol Violation|1|||
164692794|NCT03712124|594897074|FG001|Overall Study|Protocol Violation|0|||
164692795|NCT00388037|594897078|FG000|Overall Study|Protocol Violation|1|||
164692796|NCT00602537|594897079|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
164692797|NCT00602537|594897080|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
164293147|NCT03346434|593445148|FG002|Overall Study|Lost to Follow-up|0|||
164293148|NCT03346434|593445149|FG003|Overall Study|Lost to Follow-up|0|||
164293149|NCT03346434|593445150|FG004|Overall Study|Lost to Follow-up|1|||
164293150|NCT03346434|593445151|FG005|Overall Study|Lost to Follow-up|1|||
164293151|NCT03346434|593445146|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
164293152|NCT03346434|593445147|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
164293153|NCT03346434|593445148|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
164293154|NCT03346434|593445149|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
164293155|NCT03346434|593445150|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
164293156|NCT03346434|593445151|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
164293157|NCT02081677|593445154|FG000|Overall Study|Adverse Event|0|||
164293158|NCT02081677|593445155|FG001|Overall Study|Adverse Event|0|||
164293159|NCT02081677|593445156|FG002|Overall Study|Adverse Event|1|||
164293160|NCT02081677|593445157|FG003|Overall Study|Adverse Event|0|||
164293161|NCT02081677|593445154|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
164293162|NCT02081677|593445155|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
164692798|NCT00602537|594897079|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
164692799|NCT00602537|594897080|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
164692800|NCT00602537|594897079|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
164293163|NCT02081677|593445156|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
164293164|NCT02081677|593445157|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
164293165|NCT02081677|593445154|FG000|Overall Study|Not comfortable with lens care system|1|||
164293166|NCT02081677|593445155|FG001|Overall Study|Not comfortable with lens care system|0|||
164293167|NCT02081677|593445156|FG002|Overall Study|Not comfortable with lens care system|0|||
164293168|NCT02081677|593445157|FG003|Overall Study|Not comfortable with lens care system|0|||
164293169|NCT02081677|593445154|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
164293170|NCT02081677|593445155|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
164293171|NCT02081677|593445156|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
164293172|NCT02081677|593445157|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
164293173|NCT04416204|593445170|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
164293174|NCT04416204|593445171|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
164293175|NCT04416204|593445172|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
164293176|NCT04416204|593445173|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
164293177|NCT01959503|593445174|FG000|Overall Study|Death|2|||
164293178|NCT01959503|593445175|FG001|Overall Study|Death|1|||
164293179|NCT01959503|593445174|FG000|Overall Study|Randomized but not treated|1|||
164293180|NCT01959503|593445175|FG001|Overall Study|Randomized but not treated|1|||
164293181|NCT01393158|593445177|FG000|Overall Study|Adverse Event|1|||
164293182|NCT01393158|593445178|FG001|Overall Study|Adverse Event|0|||
164293183|NCT04233801|593445180|FG000|Overall Study|Other than listed|0|||
164293184|NCT04233801|593445181|FG001|Overall Study|Other than listed|0|||
164293185|NCT04233801|593445182|FG002|Overall Study|Other than listed|1|||
164293186|NCT04233801|593445180|FG000|Overall Study|Withdrawal by Subject|0|||
164293187|NCT04233801|593445181|FG001|Overall Study|Withdrawal by Subject|2|||
164293188|NCT04233801|593445182|FG002|Overall Study|Withdrawal by Subject|3|||
164293189|NCT02173769|593445183|FG000|Overall Study|Protocol Violation|4|||
164293190|NCT04024891|593445196|FG000|Overall Study|Pregnancy|0|||
164293191|NCT04024891|593445197|FG001|Overall Study|Pregnancy|1|||
164293192|NCT03095651|593445205|FG000|Overall Study|Lost to Follow-up|1|||
164293193|NCT03095651|593445206|FG001|Overall Study|Lost to Follow-up|1|||
164293194|NCT03095651|593445207|FG002|Overall Study|Lost to Follow-up|0|||
164293195|NCT03095651|593445208|FG003|Overall Study|Lost to Follow-up|1|||
164293196|NCT03095651|593445209|FG004|Overall Study|Lost to Follow-up|0|||
164293197|NCT03095651|593445210|FG005|Overall Study|Lost to Follow-up|0|||
164293198|NCT03095651|593445211|FG006|Overall Study|Lost to Follow-up|0|||
164293199|NCT03095651|593445212|FG007|Overall Study|Lost to Follow-up|0|||
164293200|NCT03095651|593445205|FG000|Overall Study|Withdrawal by Subject|0|||
164293201|NCT03095651|593445206|FG001|Overall Study|Withdrawal by Subject|0|||
164293202|NCT03095651|593445207|FG002|Overall Study|Withdrawal by Subject|0|||
164293203|NCT03095651|593445208|FG003|Overall Study|Withdrawal by Subject|0|||
164293204|NCT03095651|593445209|FG004|Overall Study|Withdrawal by Subject|0|||
164293205|NCT03095651|593445210|FG005|Overall Study|Withdrawal by Subject|1|||
164293206|NCT03095651|593445211|FG006|Overall Study|Withdrawal by Subject|0|||
164293207|NCT03095651|593445212|FG007|Overall Study|Withdrawal by Subject|0|||
164293208|NCT04124939|593445216|FG000|Overall Study|Lost to Follow-up|1|||
164293209|NCT04124939|593445217|FG001|Overall Study|Lost to Follow-up|3|||
164293210|NCT01751061|593445218|FG000|Overall Study|Death|1|||
164293211|NCT01751061|593445219|FG001|Overall Study|Death|0|||
164293212|NCT01751061|593445218|FG000|Overall Study|patient death|5|||
164293213|NCT01751061|593445219|FG001|Overall Study|patient death|0|||
164293214|NCT01751061|593445218|FG000|Overall Study|Lost to Follow-up|40|||
164293215|NCT01751061|593445219|FG001|Overall Study|Lost to Follow-up|25|||
164293216|NCT01751061|593445218|FG000|Overall Study|patient regained decisional capacity|4|||
164293217|NCT01751061|593445219|FG001|Overall Study|patient regained decisional capacity|8|||
164293218|NCT01751061|593445218|FG000|Overall Study|Withdrawal by Subject|4|||
164293219|NCT01751061|593445219|FG001|Overall Study|Withdrawal by Subject|1|||
164293220|NCT01751061|593445218|FG000|Overall Study|Physician Decision|2|||
164293221|NCT01751061|593445219|FG001|Overall Study|Physician Decision|0|||
164293222|NCT02412306|593445220|FG000|Overall Study|Lost to Follow-up|0|||
164293223|NCT02412306|593445221|FG001|Overall Study|Lost to Follow-up|1|||
164293224|NCT02412306|593445222|FG002|Overall Study|Lost to Follow-up|0|||
164293225|NCT02412306|593445223|FG003|Overall Study|Lost to Follow-up|0|||
164293226|NCT02412306|593445224|FG004|Overall Study|Lost to Follow-up|0|||
164293227|NCT02412306|593445220|FG000|Overall Study|Withdrawal by Subject|0|||
164346447|NCT01315678|593645015|FG001|Overall Study|Withdrawal by Subject|3|||
164346448|NCT01315678|593645014|FG000|Overall Study|Adverse Event|3|||
164346449|NCT01315678|593645015|FG001|Overall Study|Adverse Event|1|||
164346450|NCT01315678|593645014|FG000|Overall Study|Lost to Follow-up|1|||
164346451|NCT01315678|593645015|FG001|Overall Study|Lost to Follow-up|0|||
164346452|NCT01315678|593645014|FG000|Overall Study|similar reason to those listed above|3|||
164346453|NCT01315678|593645015|FG001|Overall Study|similar reason to those listed above|2|||
164346454|NCT00790023|593645016|FG000|Overall Study|Adverse Event|2|||
164346455|NCT00790023|593645017|FG001|Overall Study|Adverse Event|1|||
164346456|NCT00790023|593645018|FG002|Overall Study|Adverse Event|4|||
164346457|NCT00790023|593645016|FG000|Overall Study|Protocol Violation|2|||
164346458|NCT00790023|593645017|FG001|Overall Study|Protocol Violation|4|||
164346459|NCT00790023|593645018|FG002|Overall Study|Protocol Violation|2|||
164346460|NCT00790023|593645016|FG000|Overall Study|Withdrawal by Subject|2|||
164586953|NCT04760314|594513716|FG006|Induction Period|Withdrawal by Subject|0|||
164586954|NCT04760314|594513717|FG007|Induction Period|Withdrawal by Subject|0|||
164586955|NCT04760314|594513718|FG008|Induction Period|Withdrawal by Subject|0|||
164586956|NCT04760314|594513719|FG009|Induction Period|Withdrawal by Subject|0|||
164293228|NCT02412306|593445221|FG001|Overall Study|Withdrawal by Subject|0|||
164586957|NCT04760314|594513720|FG010|Induction Period|Withdrawal by Subject|0|||
164293229|NCT02412306|593445222|FG002|Overall Study|Withdrawal by Subject|1|||
164293230|NCT02412306|593445223|FG003|Overall Study|Withdrawal by Subject|0|||
164586958|NCT04760314|594513710|FG000|Induction Period|Adverse Event|0|||
164586959|NCT04760314|594513711|FG001|Induction Period|Adverse Event|0|||
164293231|NCT02412306|593445224|FG004|Overall Study|Withdrawal by Subject|0|||
164293232|NCT02412306|593445220|FG000|Overall Study|Death|5|||
164293233|NCT02412306|593445221|FG001|Overall Study|Death|7|||
164293234|NCT02412306|593445222|FG002|Overall Study|Death|15|||
164346461|NCT00790023|593645017|FG001|Overall Study|Withdrawal by Subject|0|||
164346462|NCT00790023|593645018|FG002|Overall Study|Withdrawal by Subject|6|||
164586960|NCT04760314|594513712|FG002|Induction Period|Adverse Event|2|||
164586961|NCT04760314|594513713|FG003|Induction Period|Adverse Event|0|||
164586962|NCT04760314|594513714|FG004|Induction Period|Adverse Event|0|||
164586963|NCT04760314|594513715|FG005|Induction Period|Adverse Event|0|||
164434118|NCT00980538|593958680|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
164434119|NCT00980538|593958680|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
164586964|NCT04760314|594513716|FG006|Induction Period|Adverse Event|0|||
164293235|NCT02412306|593445223|FG003|Overall Study|Death|0|||
164293236|NCT02412306|593445224|FG004|Overall Study|Death|2|||
164293237|NCT00435409|593445225|FG000|Overall Study|Protocol Violation|1|||
164293238|NCT00435409|593445226|FG001|Overall Study|Protocol Violation|2|||
164293239|NCT00435409|593445227|FG002|Overall Study|Protocol Violation|0|||
164293240|NCT00435409|593445225|FG000|Overall Study|Lost to Follow-up|1|||
164293241|NCT00435409|593445226|FG001|Overall Study|Lost to Follow-up|2|||
164293242|NCT00435409|593445227|FG002|Overall Study|Lost to Follow-up|0|||
164293243|NCT00435409|593445225|FG000|Overall Study|Death|8|||
164293244|NCT00435409|593445226|FG001|Overall Study|Death|6|||
164293245|NCT00435409|593445227|FG002|Overall Study|Death|6|||
164293246|NCT00435409|593445225|FG000|Overall Study|Objective progression or relapse|158|||
164293247|NCT00435409|593445226|FG001|Overall Study|Objective progression or relapse|93|||
164293248|NCT00435409|593445227|FG002|Overall Study|Objective progression or relapse|58|||
164293249|NCT00435409|593445225|FG000|Overall Study|Global deterioration of health status|0|||
164293250|NCT00435409|593445226|FG001|Overall Study|Global deterioration of health status|0|||
164293251|NCT00435409|593445227|FG002|Overall Study|Global deterioration of health status|4|||
164293252|NCT00435409|593445225|FG000|Overall Study|Withdrawal by Subject|8|||
164293253|NCT00435409|593445226|FG001|Overall Study|Withdrawal by Subject|7|||
164293254|NCT00435409|593445227|FG002|Overall Study|Withdrawal by Subject|1|||
164293255|NCT00435409|593445225|FG000|Overall Study|Other|45|||
164293256|NCT00435409|593445226|FG001|Overall Study|Other|30|||
164293257|NCT00435409|593445227|FG002|Overall Study|Other|1|||
164293258|NCT00435409|593445225|FG000|Overall Study|Adverse Event|0|||
164293259|NCT00435409|593445226|FG001|Overall Study|Adverse Event|0|||
164293260|NCT00435409|593445227|FG002|Overall Study|Adverse Event|8|||
164293261|NCT00435409|593445225|FG000|Overall Study|Sponsor decision|0|||
164293262|NCT00435409|593445226|FG001|Overall Study|Sponsor decision|3|||
164293263|NCT00435409|593445227|FG002|Overall Study|Sponsor decision|0|||
164293264|NCT05196828|593445228|FG000|Overall Study|Withdrawal by Subject|2|||
164293265|NCT05196828|593445229|FG001|Overall Study|Withdrawal by Subject|0|||
164293266|NCT05196828|593445228|FG000|Overall Study|Lost to Follow-up|0|||
164293267|NCT05196828|593445229|FG001|Overall Study|Lost to Follow-up|4|||
164293268|NCT05196828|593445228|FG000|Overall Study|Adverse Event|1|||
164293269|NCT05196828|593445229|FG001|Overall Study|Adverse Event|0|||
164293270|NCT03192176|593445230|FG000|Overall Study|Adverse Event|1|||
164293271|NCT03192176|593445231|FG001|Overall Study|Adverse Event|0|||
164293272|NCT03192176|593445232|FG002|Overall Study|Adverse Event|4|||
164293273|NCT03192176|593445233|FG003|Overall Study|Adverse Event|5|||
164293274|NCT03192176|593445234|FG004|Overall Study|Adverse Event|3|||
164293275|NCT03192176|593445235|FG005|Overall Study|Adverse Event|2|||
164293276|NCT03192176|593445236|FG006|Overall Study|Adverse Event|3|||
164293277|NCT03192176|593445237|FG007|Overall Study|Adverse Event|3|||
164293278|NCT03192176|593445230|FG000|Overall Study|Lost to Follow-up|0|||
164293279|NCT03192176|593445231|FG001|Overall Study|Lost to Follow-up|0|||
164293280|NCT03192176|593445232|FG002|Overall Study|Lost to Follow-up|1|||
164293281|NCT03192176|593445233|FG003|Overall Study|Lost to Follow-up|2|||
164293282|NCT03192176|593445234|FG004|Overall Study|Lost to Follow-up|3|||
164293283|NCT03192176|593445235|FG005|Overall Study|Lost to Follow-up|1|||
164293284|NCT03192176|593445236|FG006|Overall Study|Lost to Follow-up|1|||
164293285|NCT03192176|593445237|FG007|Overall Study|Lost to Follow-up|1|||
164293286|NCT03192176|593445230|FG000|Overall Study|Physician Decision|1|||
164293287|NCT03192176|593445231|FG001|Overall Study|Physician Decision|0|||
164293288|NCT03192176|593445232|FG002|Overall Study|Physician Decision|0|||
164293289|NCT03192176|593445233|FG003|Overall Study|Physician Decision|0|||
164293290|NCT03192176|593445234|FG004|Overall Study|Physician Decision|0|||
164293291|NCT03192176|593445235|FG005|Overall Study|Physician Decision|2|||
164293292|NCT03192176|593445236|FG006|Overall Study|Physician Decision|1|||
164293293|NCT03192176|593445237|FG007|Overall Study|Physician Decision|0|||
164293294|NCT03192176|593445230|FG000|Overall Study|Protocol Deviation|1|||
164293295|NCT03192176|593445231|FG001|Overall Study|Protocol Deviation|1|||
164293296|NCT03192176|593445232|FG002|Overall Study|Protocol Deviation|0|||
164293297|NCT03192176|593445233|FG003|Overall Study|Protocol Deviation|0|||
164293298|NCT03192176|593445234|FG004|Overall Study|Protocol Deviation|2|||
164293299|NCT03192176|593445235|FG005|Overall Study|Protocol Deviation|0|||
164293300|NCT03192176|593445236|FG006|Overall Study|Protocol Deviation|0|||
164293301|NCT03192176|593445237|FG007|Overall Study|Protocol Deviation|0|||
164293302|NCT03192176|593445230|FG000|Overall Study|Withdrawal by Subject|3|||
164293303|NCT03192176|593445231|FG001|Overall Study|Withdrawal by Subject|4|||
164293304|NCT03192176|593445232|FG002|Overall Study|Withdrawal by Subject|0|||
164293305|NCT03192176|593445233|FG003|Overall Study|Withdrawal by Subject|4|||
164293306|NCT03192176|593445234|FG004|Overall Study|Withdrawal by Subject|3|||
164293307|NCT03192176|593445235|FG005|Overall Study|Withdrawal by Subject|4|||
164586965|NCT04760314|594513717|FG007|Induction Period|Adverse Event|0|||
164586966|NCT04760314|594513718|FG008|Induction Period|Adverse Event|0|||
164586967|NCT04760314|594513719|FG009|Induction Period|Adverse Event|0|||
164293308|NCT03192176|593445236|FG006|Overall Study|Withdrawal by Subject|4|||
164293309|NCT03192176|593445237|FG007|Overall Study|Withdrawal by Subject|2|||
164293310|NCT03192176|593445230|FG000|Overall Study|Miscellaneous|1|||
164293311|NCT03192176|593445231|FG001|Overall Study|Miscellaneous|0|||
164293312|NCT03192176|593445232|FG002|Overall Study|Miscellaneous|1|||
164293313|NCT03192176|593445233|FG003|Overall Study|Miscellaneous|1|||
164293314|NCT03192176|593445234|FG004|Overall Study|Miscellaneous|1|||
164293315|NCT03192176|593445235|FG005|Overall Study|Miscellaneous|2|||
164293316|NCT03192176|593445236|FG006|Overall Study|Miscellaneous|0|||
164293317|NCT03192176|593445237|FG007|Overall Study|Miscellaneous|1|||
164293318|NCT00836589|593445240|FG000|Overall Study|Lost to Follow-up|246|||
164293319|NCT00836589|593445240|FG000|Overall Study|Death|429|||
164293320|NCT00836589|593445240|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
164293321|NCT02914639|593445242|FG000|Overall Study|Withdrawal by Subject|0|||
164293322|NCT02914639|593445243|FG001|Overall Study|Withdrawal by Subject|2|||
164293323|NCT01045460|593445247|FG000|Overall Study|Physician Decision|3|||
164293324|NCT01045460|593445248|FG001|Overall Study|Physician Decision|2|||
164434120|NCT00980538|593958680|FG000|Overall Study|Switch to Commercially Available Medication|25|||
164434121|NCT00980538|593958680|FG000|Overall Study|Participant Non-Compliant|9|||
164293325|NCT01045460|593445247|FG000|Overall Study|Lost to Follow-up|0|||
164293326|NCT01045460|593445248|FG001|Overall Study|Lost to Follow-up|1|||
164293327|NCT01045460|593445247|FG000|Overall Study|Lack of Efficacy|3|||
164293328|NCT01045460|593445248|FG001|Overall Study|Lack of Efficacy|0|||
164293329|NCT00436332|593445249|FG000|Overall Study|Adverse Event|9|||
164293330|NCT00436332|593445249|FG000|Overall Study|Withdrawal by Subject|2|||
164293331|NCT00436332|593445249|FG000|Overall Study|Progression|59|||
164293332|NCT00436332|593445249|FG000|Overall Study|Death|2|||
164293333|NCT00436332|593445249|FG000|Overall Study|Not Protocol Specified|6|||
164293334|NCT00436332|593445249|FG000|Overall Study|Ineligible|2|||
164293335|NCT00436332|593445249|FG000|Overall Study|Never Received Treatment|3|||
164293336|NCT00472108|593445250|FG000|Overall Study|Lost to Follow-up|0|||
164293337|NCT00472108|593445251|FG001|Overall Study|Lost to Follow-up|1|||
164293338|NCT00062439|593445252|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
164293339|NCT00062439|593445252|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
164293340|NCT00062439|593445252|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
164293341|NCT00062439|593445252|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
164293342|NCT00062439|593445252|FG000|Post Chemoradiation Assessment|Death|1|||
164293343|NCT00062439|593445252|FG000|Post Chemoradiation Assessment|Disease progression|2|||
164293344|NCT00062439|593445252|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
164293345|NCT00062439|593445252|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
164293346|NCT00062439|593445252|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
164293347|NCT00062439|593445252|FG000|Surgery|Physician Decision|4|||
164293348|NCT00062439|593445252|FG000|Surgery|Death|1|||
164293349|NCT00062439|593445252|FG000|Surgery|Adverse Event|2|||
164293350|NCT00062439|593445252|FG000|Consolidation Chemotherapy|Adverse Event|2|||
164293351|NCT01924845|593445253|FG000|Overall Study|Adverse Event|3|||
164293352|NCT01924845|593445253|FG000|Overall Study|Withdrawal by Subject|2|||
164293353|NCT01924845|593445253|FG000|Overall Study|Protocol Violation|1|||
164293354|NCT03780452|593445254|FG000|Overall Study|Screening failure|2|||
164293355|NCT02388269|593445255|FG000|Overall Study|Adverse Event|2|||
164293356|NCT02388269|593445256|FG001|Overall Study|Adverse Event|0|||
164293357|NCT02388269|593445257|FG002|Overall Study|Adverse Event|0|||
164293358|NCT02388269|593445255|FG000|Overall Study|Withdrawal by Subject|1|||
164293359|NCT02388269|593445256|FG001|Overall Study|Withdrawal by Subject|2|||
164293360|NCT02388269|593445257|FG002|Overall Study|Withdrawal by Subject|0|||
164293361|NCT02388269|593445255|FG000|Overall Study|less than 50% stimulations|1|||
164434122|NCT00980538|593958680|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
164434123|NCT00980538|593958680|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
164434124|NCT00980538|593958680|FG000|Overall Study|Other|60|||
164434125|NCT00980538|593958680|FG000|Overall Study|Other|1|||
164434126|NCT03878446|593958681|FG000|Overall Study|Withdrawn by parent or guardian|1|||
164293362|NCT02388269|593445256|FG001|Overall Study|less than 50% stimulations|0|||
164293363|NCT02388269|593445257|FG002|Overall Study|less than 50% stimulations|0|||
164293364|NCT02388269|593445255|FG000|Overall Study|no diary data|3|||
164293365|NCT02388269|593445256|FG001|Overall Study|no diary data|0|||
164293366|NCT02388269|593445257|FG002|Overall Study|no diary data|0|||
164293367|NCT02388269|593445255|FG000|Overall Study|Protocol Violation|2|||
164293368|NCT02388269|593445256|FG001|Overall Study|Protocol Violation|0|||
164293369|NCT02388269|593445257|FG002|Overall Study|Protocol Violation|0|||
164293370|NCT02388269|593445255|FG000|Overall Study|Screen Failure|0|||
164293371|NCT02388269|593445256|FG001|Overall Study|Screen Failure|0|||
164293372|NCT02388269|593445257|FG002|Overall Study|Screen Failure|10|||
164434127|NCT03878446|593958682|FG001|Overall Study|Withdrawn by parent or guardian|0|||
164293373|NCT00265564|593445260|FG000|Overall Study|Lost to Follow-up|5|||
164293374|NCT00265564|593445261|FG001|Overall Study|Lost to Follow-up|7|||
164293375|NCT00265564|593445260|FG000|Overall Study|met exclusion criteria|5|||
164293376|NCT00265564|593445261|FG001|Overall Study|met exclusion criteria|2|||
164293377|NCT01553084|593445262|FG000|Overall Study|Withdrawal by Subject|15|||
164293378|NCT01553084|593445263|FG001|Overall Study|Withdrawal by Subject|13|||
164293379|NCT01553084|593445264|FG002|Overall Study|Withdrawal by Subject|35|||
164293380|NCT04698343|593445265|FG000|Overall Study|Withdrawal by Subject|6|||
164293381|NCT04698343|593445265|FG000|Overall Study|Physician Decision|2|||
164293382|NCT04698343|593445265|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
164293383|NCT04698343|593445265|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
164293384|NCT04698343|593445265|FG000|Overall Study|Personal reasons|3|||
164293385|NCT04698343|593445265|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
164293386|NCT03882021|593445267|FG000|Enrollment|Procedure aborted/cancelled|2|||
164293387|NCT03882021|593445267|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
164293388|NCT03882021|593445267|FG000|Enrollment to 3-Month|Death|1|||
164293389|NCT03882021|593445267|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
164293390|NCT03882021|593445267|FG000|Enrollment to 3-Month|Missed Visit|4|||
164293391|NCT03882021|593445267|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
164293392|NCT03882021|593445267|FG000|6-Month to 12-Month Visit|Death|1|||
164293393|NCT03882021|593445267|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
164293394|NCT03582215|593445268|FG000|Overall Study|Adverse Event|1|||
164293395|NCT03582215|593445269|FG001|Overall Study|Adverse Event|0|||
164293396|NCT03582215|593445270|FG002|Overall Study|Adverse Event|0|||
164293397|NCT03582215|593445271|FG003|Overall Study|Adverse Event|0|||
164293398|NCT03582215|593445272|FG004|Overall Study|Adverse Event|0|||
164293399|NCT03582215|593445273|FG005|Overall Study|Adverse Event|0|||
164293400|NCT03582215|593445274|FG006|Overall Study|Adverse Event|2|||
164293401|NCT03582215|593445275|FG007|Overall Study|Adverse Event|2|||
164293402|NCT02174731|593445276|FG000|Overall Study|Participant decision|67|||
164293403|NCT02174731|593445277|FG001|Overall Study|Participant decision|64|||
164293404|NCT02174731|593445276|FG000|Overall Study|Incorrect enrolment before randomization|0|||
164293405|NCT02174731|593445277|FG001|Overall Study|Incorrect enrolment before randomization|1|||
164293406|NCT02174731|593445276|FG000|Overall Study|Missing|2|||
164293407|NCT02174731|593445277|FG001|Overall Study|Missing|0|||
164293408|NCT00325897|593445281|FG000|Overall Study|Lost to Follow-up|12|||
164293409|NCT00325897|593445282|FG001|Overall Study|Lost to Follow-up|13|||
164293410|NCT03915717|593445285|FG000|Overall Study|EchoMark Not Implanted|6|||
164293411|NCT02903160|593445288|FG000|Overall Study|Adverse Event|2|||
164293412|NCT02903160|593445288|FG000|Overall Study|Death|1|||
164293413|NCT02903160|593445288|FG000|Overall Study|Lost to Follow-up|2|||
164293414|NCT02903160|593445288|FG000|Overall Study|Withdrawal by Subject|1|||
164293415|NCT02903160|593445288|FG000|Overall Study|Medical Insurance Barriers|1|||
164293416|NCT01664910|593445291|FG000|Overall Study|Adverse Event|0|||
164293417|NCT01664910|593445292|FG001|Overall Study|Adverse Event|0|||
164293418|NCT01664910|593445293|FG002|Overall Study|Adverse Event|1|||
164293419|NCT02525471|593445294|FG000|Overall Study|Screen Failure|6|||
164293420|NCT02525471|593445294|FG000|Overall Study|Withdrawal by Subject|4|||
164293421|NCT02525471|593445294|FG000|Overall Study|Death|1|||
164293422|NCT02240485|593445295|FG000|3 Months Post-admission|Lost to Follow-up|1|||
164293423|NCT02240485|593445296|FG001|3 Months Post-admission|Lost to Follow-up|5|||
164293424|NCT02240485|593445295|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
164293425|NCT02240485|593445296|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
164293426|NCT02240485|593445295|FG000|9 Months Post-admission|Lost to Follow-up|3|||
164434128|NCT03878446|593958683|FG002|Overall Study|Withdrawn by parent or guardian|0|||
164434129|NCT03878446|593958684|FG003|Overall Study|Withdrawn by parent or guardian|0|||
164434130|NCT03878446|593958685|FG004|Overall Study|Withdrawn by parent or guardian|0|||
164434131|NCT05663866|593958686|FG000|Overall Study|Adverse Event|0|||
164692801|NCT00602537|594897080|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
164293427|NCT02240485|593445296|FG001|9 Months Post-admission|Lost to Follow-up|1|||
164293428|NCT02240485|593445295|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
164293429|NCT02240485|593445296|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
164293430|NCT02240485|593445295|FG000|18 Months Post-admission|Lost to Follow-up|1|||
164293431|NCT02240485|593445296|FG001|18 Months Post-admission|Lost to Follow-up|1|||
164434132|NCT05663866|593958687|FG001|Overall Study|Adverse Event|0|||
164434133|NCT05663866|593958688|FG002|Overall Study|Adverse Event|1|||
164692802|NCT00602537|594897079|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
164293432|NCT02240485|593445295|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
164293433|NCT02240485|593445296|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
164293434|NCT00844376|593445300|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
164293435|NCT00844376|593445301|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
164293436|NCT00539981|593445304|FG000|Overall Study|Adverse events (AE)|3|||
164293437|NCT00539981|593445305|FG001|Overall Study|Adverse events (AE)|3|||
164293438|NCT00539981|593445304|FG000|Overall Study|Lost to Follow-up|260|||
164293439|NCT00539981|593445305|FG001|Overall Study|Lost to Follow-up|251|||
164293440|NCT00539981|593445304|FG000|Overall Study|Withdrew consent|22|||
164434134|NCT05663866|593958689|FG003|Overall Study|Adverse Event|0|||
164434135|NCT05663866|593958686|FG000|Overall Study|Physician Decision|0|||
164692803|NCT00602537|594897080|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
164293441|NCT00539981|593445305|FG001|Overall Study|Withdrew consent|14|||
164293442|NCT00539981|593445304|FG000|Overall Study|Death|1|||
164293443|NCT00539981|593445305|FG001|Overall Study|Death|1|||
164293444|NCT00539981|593445304|FG000|Overall Study|Other reason-unspecified|9|||
164293445|NCT00539981|593445305|FG001|Overall Study|Other reason-unspecified|13|||
164293446|NCT01759420|593445306|FG000|Overall Study|Screen failure|5|||
164293447|NCT01759420|593445306|FG000|Overall Study|Inaccurate EKG machine readings|1|||
164293448|NCT01129622|593445307|FG000|Overall Study|Withdrawal by Subject|2|||
164293449|NCT03069352|593445311|FG000|Overall Study|Ongoing|12|||
164293450|NCT03069352|593445312|FG001|Overall Study|Ongoing|40|||
164293451|NCT02621424|593445313|FG000|Overall Study|Withdrawal by Subject|1|||
164293452|NCT02621424|593445314|FG001|Overall Study|Withdrawal by Subject|2|||
164293453|NCT01690052|593447694|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
164293454|NCT01690052|593447695|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
164293455|NCT05635461|593447696|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
164293456|NCT05635461|593447697|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
164293457|NCT05635461|593447698|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
164293458|NCT05635461|593447699|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
164293459|NCT05635461|593447700|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
164293460|NCT05635461|593447701|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
164293461|NCT05635461|593447696|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
164293462|NCT05635461|593447697|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
164293463|NCT05635461|593447698|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
164293464|NCT05635461|593447699|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
164293465|NCT05635461|593447700|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
164293466|NCT05635461|593447701|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
164293467|NCT05635461|593447696|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
164293468|NCT05635461|593447697|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
164293469|NCT05635461|593447698|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
164293470|NCT05635461|593447699|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
164293471|NCT05635461|593447700|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
164293472|NCT05635461|593447701|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
164293473|NCT02648204|593447705|FG000|Overall Study|Withdrawal by Subject|12|||
164293474|NCT02648204|593447706|FG001|Overall Study|Withdrawal by Subject|8|||
164293475|NCT02648204|593447707|FG002|Overall Study|Withdrawal by Subject|2|||
164293476|NCT02648204|593447708|FG003|Overall Study|Withdrawal by Subject|6|||
164293477|NCT02648204|593447705|FG000|Overall Study|Lost to Follow-up|5|||
164293478|NCT02648204|593447706|FG001|Overall Study|Lost to Follow-up|8|||
164293479|NCT02648204|593447707|FG002|Overall Study|Lost to Follow-up|4|||
164293480|NCT02648204|593447708|FG003|Overall Study|Lost to Follow-up|6|||
164293481|NCT02648204|593447705|FG000|Overall Study|Missing follow-up information|4|||
164293482|NCT02648204|593447706|FG001|Overall Study|Missing follow-up information|4|||
164293483|NCT02648204|593447707|FG002|Overall Study|Missing follow-up information|4|||
164293484|NCT02648204|593447708|FG003|Overall Study|Missing follow-up information|2|||
164293485|NCT02648204|593447705|FG000|Overall Study|Death|1|||
164293486|NCT02648204|593447706|FG001|Overall Study|Death|1|||
164293487|NCT02648204|593447707|FG002|Overall Study|Death|2|||
164293488|NCT02648204|593447708|FG003|Overall Study|Death|2|||
164293489|NCT02648204|593447705|FG000|Overall Study|Adverse Event|0|||
164293490|NCT02648204|593447706|FG001|Overall Study|Adverse Event|0|||
164293491|NCT02648204|593447707|FG002|Overall Study|Adverse Event|1|||
164293492|NCT02648204|593447708|FG003|Overall Study|Adverse Event|0|||
164293493|NCT04349891|593447709|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
164293494|NCT04349891|593447710|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
164293495|NCT04349891|593447709|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
164293496|NCT04349891|593447710|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
164293497|NCT04349891|593447709|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
164293498|NCT04349891|593447710|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
164293499|NCT04349891|593447709|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
164293500|NCT04349891|593447710|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
164346463|NCT00790023|593645016|FG000|Overall Study|Lost to Follow-up|0|||
164346464|NCT00790023|593645017|FG001|Overall Study|Lost to Follow-up|0|||
164692804|NCT00602537|594897079|FG000|Follow Up Study Comparison|Adverse Event|1|||
164692805|NCT00602537|594897080|FG001|Follow Up Study Comparison|Adverse Event|0|||
164692806|NCT00602537|594897079|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
164692807|NCT00602537|594897080|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
164692808|NCT00602537|594897079|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
164692809|NCT00602537|594897080|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
164692810|NCT02941523|594897081|FG000|Monotherapy|Withdrawal by Subject|0|||
164692811|NCT02941523|594897082|FG001|Monotherapy|Withdrawal by Subject|1|||
164692812|NCT02941523|594897081|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
164692813|NCT02941523|594897082|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
164346465|NCT00790023|593645018|FG002|Overall Study|Lost to Follow-up|1|||
164346466|NCT00790023|593645016|FG000|Overall Study|Other|5|||
164293501|NCT00614575|593447711|FG000|Overall Study|Adverse Event|106|||
164293502|NCT00614575|593447711|FG000|Overall Study|Lost to Follow-up|55|||
164293503|NCT00614575|593447711|FG000|Overall Study|Lack of Efficacy|14|||
164293504|NCT00614575|593447711|FG000|Overall Study|Withdrawal by Subject|6|||
164293505|NCT00614575|593447711|FG000|Overall Study|Death|3|||
164293506|NCT00614575|593447711|FG000|Overall Study|Physician Decision|2|||
164293507|NCT00614575|593447711|FG000|Overall Study|No data were collected.|18|||
164293508|NCT00614575|593447711|FG000|Overall Study|Irregularly enrolled patients|23|||
164293509|NCT00614575|593447711|FG000|Overall Study|No treatment|1|||
164293510|NCT00189540|593447714|FG000|Overall Study|Withdrawal by Subject|3|||
164293511|NCT00189540|593447715|FG001|Overall Study|Withdrawal by Subject|0|||
164293512|NCT00189540|593447714|FG000|Overall Study|Death|4|||
164293513|NCT00189540|593447715|FG001|Overall Study|Death|1|||
164293514|NCT00286442|593447716|FG000|Overall Study|Hyperglycemic Rescue|19|||
164293515|NCT00286442|593447717|FG001|Overall Study|Hyperglycemic Rescue|17|||
164293516|NCT00286442|593447718|FG002|Overall Study|Hyperglycemic Rescue|25|||
164293517|NCT00286442|593447716|FG000|Overall Study|Adverse Event|7|||
164293518|NCT00286442|593447717|FG001|Overall Study|Adverse Event|6|||
164293519|NCT00286442|593447718|FG002|Overall Study|Adverse Event|1|||
164293520|NCT00286442|593447716|FG000|Overall Study|Protocol Violation|2|||
164293521|NCT00286442|593447717|FG001|Overall Study|Protocol Violation|4|||
164293522|NCT00286442|593447718|FG002|Overall Study|Protocol Violation|2|||
164293523|NCT00286442|593447716|FG000|Overall Study|Lost to Follow-up|5|||
164293524|NCT00286442|593447717|FG001|Overall Study|Lost to Follow-up|2|||
164293525|NCT00286442|593447718|FG002|Overall Study|Lost to Follow-up|1|||
164293526|NCT00286442|593447716|FG000|Overall Study|Physician Decision|1|||
164293527|NCT00286442|593447717|FG001|Overall Study|Physician Decision|1|||
164293528|NCT00286442|593447718|FG002|Overall Study|Physician Decision|1|||
164293529|NCT00286442|593447716|FG000|Overall Study|Administrative Error|1|||
164293530|NCT00286442|593447717|FG001|Overall Study|Administrative Error|1|||
164293531|NCT00286442|593447718|FG002|Overall Study|Administrative Error|0|||
164293532|NCT00286442|593447716|FG000|Overall Study|Withdrawal by Subject|2|||
164293533|NCT00286442|593447717|FG001|Overall Study|Withdrawal by Subject|14|||
164293534|NCT00286442|593447718|FG002|Overall Study|Withdrawal by Subject|2|||
164293535|NCT02163902|593447721|FG000|Overall Study|Subject's Request|3|||
164293536|NCT02163902|593447722|FG001|Overall Study|Subject's Request|4|||
164293537|NCT02163902|593447721|FG000|Overall Study|Lost to Follow-up|6|||
164293538|NCT02163902|593447722|FG001|Overall Study|Lost to Follow-up|7|||
164293539|NCT02163902|593447721|FG000|Overall Study|Administrative Decision|2|||
164293540|NCT02163902|593447722|FG001|Overall Study|Administrative Decision|2|||
164293541|NCT00079040|593447723|FG000|Overall Study|Withdrew before treatment|1|||
164293542|NCT00079040|593447723|FG000|Overall Study|Ineligible|1|||
164293543|NCT04079296|593447724|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
164293544|NCT04079296|593447725|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
164293545|NCT04079296|593447726|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
164293546|NCT04079296|593447727|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
164293547|NCT04079296|593447728|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
164293548|NCT04079296|593447724|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
164293549|NCT04079296|593447725|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
164293550|NCT04079296|593447726|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
164293551|NCT04079296|593447727|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
164293552|NCT04079296|593447728|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
164293553|NCT04079296|593447724|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
164586968|NCT04760314|594513720|FG010|Induction Period|Adverse Event|0|||
164586969|NCT04760314|594513710|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
164586970|NCT04760314|594513711|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
164586971|NCT04760314|594513712|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
164586972|NCT04760314|594513713|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
164586973|NCT04760314|594513714|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
164586974|NCT04760314|594513715|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
164586975|NCT04760314|594513716|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
164586976|NCT04760314|594513717|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
164586977|NCT04760314|594513718|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
164586978|NCT04760314|594513719|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
164586979|NCT04760314|594513720|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
164293554|NCT04079296|593447725|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
164293555|NCT04079296|593447726|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
164293556|NCT04079296|593447727|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
164293557|NCT04079296|593447728|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
164293558|NCT04079296|593447724|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
164293559|NCT04079296|593447725|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
164293560|NCT04079296|593447726|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
164586980|NCT04760314|594513710|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
164586981|NCT04760314|594513711|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
164293561|NCT04079296|593447727|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
164293562|NCT04079296|593447728|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
164293563|NCT04079296|593447724|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
164293564|NCT04079296|593447725|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
164293565|NCT04079296|593447726|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
164293566|NCT04079296|593447727|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
164293567|NCT04079296|593447728|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
164293568|NCT04079296|593447724|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
164293569|NCT04079296|593447725|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
164293570|NCT04079296|593447726|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
164293571|NCT04079296|593447727|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
164293572|NCT04079296|593447728|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
164293573|NCT04079296|593447724|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
164293574|NCT04079296|593447725|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
164293575|NCT04079296|593447726|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
164293576|NCT04079296|593447727|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
164293577|NCT04079296|593447728|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
164293578|NCT04079296|593447724|FG000|Dose Expansion Phase (168 Days)|Death|0|||
164293579|NCT04079296|593447725|FG001|Dose Expansion Phase (168 Days)|Death|0|||
164293580|NCT04079296|593447726|FG002|Dose Expansion Phase (168 Days)|Death|0|||
164293581|NCT04079296|593447727|FG003|Dose Expansion Phase (168 Days)|Death|1|||
164293582|NCT04079296|593447728|FG004|Dose Expansion Phase (168 Days)|Death|0|||
164293583|NCT00467740|593447741|FG000|Overall Study|Adverse Event|0|||
164293584|NCT00467740|593447742|FG001|Overall Study|Adverse Event|0|||
164293585|NCT00467740|593447743|FG002|Overall Study|Adverse Event|1|||
164293586|NCT00467740|593447744|FG003|Overall Study|Adverse Event|0|||
164293587|NCT00467740|593447745|FG004|Overall Study|Adverse Event|0|||
164293588|NCT00467740|593447741|FG000|Overall Study|Protocol Violation|0|||
164293589|NCT00467740|593447742|FG001|Overall Study|Protocol Violation|0|||
164293590|NCT00467740|593447743|FG002|Overall Study|Protocol Violation|1|||
164293591|NCT00467740|593447744|FG003|Overall Study|Protocol Violation|0|||
164293592|NCT00467740|593447745|FG004|Overall Study|Protocol Violation|0|||
164293593|NCT00467740|593447741|FG000|Overall Study|Lost to Follow-up|0|||
164293594|NCT00467740|593447742|FG001|Overall Study|Lost to Follow-up|1|||
164293595|NCT00467740|593447743|FG002|Overall Study|Lost to Follow-up|0|||
164293596|NCT00467740|593447744|FG003|Overall Study|Lost to Follow-up|0|||
164293597|NCT00467740|593447745|FG004|Overall Study|Lost to Follow-up|0|||
164293598|NCT00467740|593447741|FG000|Overall Study|Withdrawal by Subject|1|||
164293599|NCT00467740|593447742|FG001|Overall Study|Withdrawal by Subject|1|||
164293600|NCT00467740|593447743|FG002|Overall Study|Withdrawal by Subject|0|||
164293601|NCT00467740|593447744|FG003|Overall Study|Withdrawal by Subject|1|||
164293602|NCT00467740|593447745|FG004|Overall Study|Withdrawal by Subject|0|||
164293603|NCT00467740|593447741|FG000|Overall Study|Lack of Efficacy|0|||
164293604|NCT00467740|593447742|FG001|Overall Study|Lack of Efficacy|1|||
164293605|NCT00467740|593447743|FG002|Overall Study|Lack of Efficacy|0|||
164293606|NCT00467740|593447744|FG003|Overall Study|Lack of Efficacy|0|||
164293607|NCT00467740|593447745|FG004|Overall Study|Lack of Efficacy|0|||
164293608|NCT00867165|593447746|FG000|Overall Study|Adverse Event|3|||
164293609|NCT00867165|593447747|FG001|Overall Study|Adverse Event|0|||
164293610|NCT00867165|593447746|FG000|Overall Study|Withdrawal by Subject|1|||
164293611|NCT00867165|593447747|FG001|Overall Study|Withdrawal by Subject|0|||
164293612|NCT03275740|593447748|FG000|Overall Study|Adverse Event|0|||
164346467|NCT00790023|593645017|FG001|Overall Study|Other|5|||
164346468|NCT00790023|593645018|FG002|Overall Study|Other|8|||
164346469|NCT01338792|593645019|FG000|Overall Study|Adverse Event|2|||
164346470|NCT01338792|593645019|FG000|Overall Study|Death|1|||
164293613|NCT03275740|593447749|FG001|Overall Study|Adverse Event|0|||
164346471|NCT01338792|593645019|FG000|Overall Study|Withdrawal by Subject|1|||
164346472|NCT00062374|593645020|FG000|Overall Study|Not treated|12|||
164346473|NCT03633695|593645023|FG000|Overall Study|Lost to Follow-up|4|||
164346474|NCT03633695|593645024|FG001|Overall Study|Lost to Follow-up|5|||
164346475|NCT03633695|593645023|FG000|Overall Study|Discontinued|8|||
164346476|NCT03633695|593645024|FG001|Overall Study|Discontinued|4|||
164346477|NCT00684593|593645025|FG000|Overall Study|Adverse Event|0|||
164346478|NCT00684593|593645026|FG001|Overall Study|Adverse Event|2|||
164293614|NCT03275740|593447750|FG002|Overall Study|Adverse Event|0|||
164293615|NCT03275740|593447751|FG003|Overall Study|Adverse Event|0|||
164293616|NCT03275740|593447752|FG004|Overall Study|Adverse Event|1|||
164293617|NCT03275740|593447753|FG005|Overall Study|Adverse Event|0|||
164293618|NCT03275740|593447754|FG006|Overall Study|Adverse Event|0|||
164293619|NCT03275740|593447755|FG007|Overall Study|Adverse Event|0|||
164293620|NCT03275740|593447756|FG008|Overall Study|Adverse Event|0|||
164346479|NCT02599129|593645032|FG000|Overall Study|Lack of Efficacy|2|||
164346480|NCT02599129|593645033|FG001|Overall Study|Lack of Efficacy|2|||
164346481|NCT02599129|593645032|FG000|Overall Study|Lost to Follow-up|1|||
164346482|NCT02599129|593645033|FG001|Overall Study|Lost to Follow-up|0|||
164346483|NCT02599129|593645032|FG000|Overall Study|Withdrawal by Subject|2|||
164293621|NCT03275740|593447757|FG009|Overall Study|Adverse Event|0|||
164293622|NCT03275740|593447758|FG010|Overall Study|Adverse Event|0|||
164293623|NCT03275740|593447759|FG011|Overall Study|Adverse Event|0|||
164293624|NCT03275740|593447748|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
164293625|NCT03275740|593447749|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
164293626|NCT03275740|593447750|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
164293627|NCT03275740|593447751|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
164293628|NCT03275740|593447752|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
164293629|NCT03275740|593447753|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
164293630|NCT03275740|593447754|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
164293631|NCT03275740|593447755|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
164293632|NCT03275740|593447756|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
164293633|NCT03275740|593447757|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
164293634|NCT03275740|593447758|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
164293635|NCT03275740|593447759|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
164293636|NCT03275740|593447748|FG000|Overall Study|Withdrawal by Subject|0|||
164293637|NCT03275740|593447749|FG001|Overall Study|Withdrawal by Subject|0|||
164293638|NCT03275740|593447750|FG002|Overall Study|Withdrawal by Subject|0|||
164293639|NCT03275740|593447751|FG003|Overall Study|Withdrawal by Subject|0|||
164293640|NCT03275740|593447752|FG004|Overall Study|Withdrawal by Subject|0|||
164293641|NCT03275740|593447753|FG005|Overall Study|Withdrawal by Subject|0|||
164293642|NCT03275740|593447754|FG006|Overall Study|Withdrawal by Subject|0|||
164293643|NCT03275740|593447755|FG007|Overall Study|Withdrawal by Subject|0|||
164293644|NCT03275740|593447756|FG008|Overall Study|Withdrawal by Subject|1|||
164293645|NCT03275740|593447757|FG009|Overall Study|Withdrawal by Subject|1|||
164293646|NCT03275740|593447758|FG010|Overall Study|Withdrawal by Subject|0|||
164293647|NCT03275740|593447759|FG011|Overall Study|Withdrawal by Subject|0|||
164293648|NCT00988884|593447761|FG000|Overall Study|Adverse Event|0|||
164293649|NCT00988884|593447762|FG001|Overall Study|Adverse Event|1|||
164293650|NCT00988884|593447761|FG000|Overall Study|Lost to Follow-up|20|||
164293651|NCT00988884|593447762|FG001|Overall Study|Lost to Follow-up|16|||
164293652|NCT00988884|593447761|FG000|Overall Study|Protocol Violation|0|||
164293653|NCT00988884|593447762|FG001|Overall Study|Protocol Violation|1|||
164293654|NCT00988884|593447761|FG000|Overall Study|Withdrawal by Subject|15|||
164293655|NCT00988884|593447762|FG001|Overall Study|Withdrawal by Subject|18|||
164293656|NCT04621448|593447764|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
164293657|NCT04621448|593447765|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
164293658|NCT04621448|593447766|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
164293659|NCT04621448|593447767|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
164293660|NCT04621448|593447764|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
164293661|NCT04621448|593447765|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
164293662|NCT04621448|593447766|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
164293663|NCT04621448|593447767|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
164293664|NCT04621448|593447764|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
164293665|NCT04621448|593447765|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
164293666|NCT04621448|593447766|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
164293667|NCT04621448|593447767|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
164293668|NCT04621448|593447764|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
164293669|NCT04621448|593447765|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
164293670|NCT04621448|593447766|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
164293671|NCT04621448|593447767|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
164293672|NCT00549640|593447768|FG000|Overall Study|Withdrawal by Subject|6|||
164293673|NCT00549640|593447769|FG001|Overall Study|Withdrawal by Subject|12|||
164293674|NCT00549640|593447768|FG000|Overall Study|Adverse Event|5|||
164293675|NCT00549640|593447769|FG001|Overall Study|Adverse Event|0|||
164293676|NCT00549640|593447768|FG000|Overall Study|Lost to Follow-up|7|||
164293677|NCT00549640|593447769|FG001|Overall Study|Lost to Follow-up|4|||
164293678|NCT03550378|593447770|FG000|Overall Study|Death|0|||
164293679|NCT03550378|593447771|FG001|Overall Study|Death|1|||
164293680|NCT04486235|593447772|FG000|Overall Study|Pregnancy|1|||
164293681|NCT04486235|593447773|FG001|Overall Study|Pregnancy|0|||
164293682|NCT04486235|593447772|FG000|Overall Study|Lost to Follow-up|1|||
164293683|NCT04486235|593447773|FG001|Overall Study|Lost to Follow-up|0|||
164293684|NCT00626275|593447774|FG000|Part A - Treatment Period 1|Adverse Event|1|||
164293685|NCT00626275|593447775|FG001|Part A - Treatment Period 1|Adverse Event|0|||
164293686|NCT00626275|593447776|FG002|Part A - Treatment Period 1|Adverse Event|0|||
164293687|NCT00626275|593447777|FG003|Part A - Treatment Period 1|Adverse Event|0|||
164293688|NCT00626275|593447778|FG004|Part A - Treatment Period 1|Adverse Event|0|||
164293689|NCT00626275|593447779|FG005|Part A - Treatment Period 1|Adverse Event|0|||
164293690|NCT00626275|593447780|FG006|Part A - Treatment Period 1|Adverse Event|0|||
164293691|NCT00626275|593447781|FG007|Part A - Treatment Period 1|Adverse Event|0|||
164293692|NCT00626275|593447774|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
164293693|NCT00626275|593447775|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
164346484|NCT02599129|593645033|FG001|Overall Study|Withdrawal by Subject|1|||
164346485|NCT00617773|593645034|FG000|Overall Study|Physician Decision|1|||
164346486|NCT00617773|593645034|FG000|Overall Study|Lack of compliance with the protocol|1|||
164346487|NCT00617773|593645034|FG000|Overall Study|Withdrawal by Subject|1|||
164346488|NCT00617773|593645034|FG000|Overall Study|Death|1|||
164346489|NCT00617773|593645034|FG000|Overall Study|Progressive disease|19|||
164346490|NCT00617773|593645034|FG000|Overall Study|Protocol Violation|1|||
164346491|NCT01029795|593645035|FG000|Overall Study|Entry Criteria Not Met|2|||
164293694|NCT00626275|593447776|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
164293695|NCT00626275|593447777|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
164293696|NCT00626275|593447778|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
164293697|NCT00626275|593447779|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
164293698|NCT00626275|593447780|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
164293699|NCT00626275|593447781|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
164293700|NCT00626275|593447774|FG000|Part B|Lost to Follow-up|0|||
164293701|NCT00626275|593447775|FG001|Part B|Lost to Follow-up|0|||
164293702|NCT00626275|593447776|FG002|Part B|Lost to Follow-up|0|||
164293703|NCT00626275|593447777|FG003|Part B|Lost to Follow-up|0|||
164293704|NCT00626275|593447778|FG004|Part B|Lost to Follow-up|0|||
164346492|NCT01029795|593645036|FG001|Overall Study|Entry Criteria Not Met|1|||
164293705|NCT00626275|593447779|FG005|Part B|Lost to Follow-up|0|||
164293706|NCT00626275|593447780|FG006|Part B|Lost to Follow-up|1|||
164293707|NCT00626275|593447781|FG007|Part B|Lost to Follow-up|0|||
164293708|NCT00626275|593447774|FG000|Part B|Withdrawal by Subject|0|||
164293709|NCT00626275|593447775|FG001|Part B|Withdrawal by Subject|0|||
164293710|NCT00626275|593447776|FG002|Part B|Withdrawal by Subject|0|||
164293711|NCT00626275|593447777|FG003|Part B|Withdrawal by Subject|0|||
164293712|NCT00626275|593447778|FG004|Part B|Withdrawal by Subject|0|||
164293713|NCT00626275|593447779|FG005|Part B|Withdrawal by Subject|0|||
164293714|NCT00626275|593447780|FG006|Part B|Withdrawal by Subject|0|||
164293715|NCT00626275|593447781|FG007|Part B|Withdrawal by Subject|1|||
164293716|NCT04999839|593447782|FG000|Overall Study|Adverse Event|1|||
164293717|NCT04999839|593447783|FG001|Overall Study|Adverse Event|1|||
164346493|NCT01029795|593645035|FG000|Overall Study|Physician Decision|2|||
164346494|NCT01029795|593645036|FG001|Overall Study|Physician Decision|1|||
164346495|NCT01029795|593645035|FG000|Overall Study|Sponsor Decision|11|||
164346496|NCT01029795|593645036|FG001|Overall Study|Sponsor Decision|17|||
164346497|NCT01029795|593645035|FG000|Overall Study|Withdrawal by Subject|1|||
164346498|NCT01029795|593645036|FG001|Overall Study|Withdrawal by Subject|3|||
164346499|NCT03217175|593645037|FG000|Overall Study|Physician Decision|4|||
164346500|NCT03217175|593645038|FG001|Overall Study|Physician Decision|1|||
164434136|NCT05663866|593958687|FG001|Overall Study|Physician Decision|0|||
164586982|NCT04760314|594513712|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
164586983|NCT04760314|594513713|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
164586984|NCT04760314|594513714|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
164434137|NCT05663866|593958688|FG002|Overall Study|Physician Decision|0|||
164434138|NCT05663866|593958689|FG003|Overall Study|Physician Decision|1|||
164293718|NCT04999839|593447784|FG002|Overall Study|Adverse Event|1|||
164293719|NCT04999839|593447785|FG003|Overall Study|Adverse Event|1|||
164293720|NCT04999839|593447786|FG004|Overall Study|Adverse Event|1|||
164293721|NCT04999839|593447782|FG000|Overall Study|Lost to Follow-up|2|||
164293722|NCT04999839|593447783|FG001|Overall Study|Lost to Follow-up|0|||
164293723|NCT04999839|593447784|FG002|Overall Study|Lost to Follow-up|2|||
164293724|NCT04999839|593447785|FG003|Overall Study|Lost to Follow-up|4|||
164293725|NCT04999839|593447786|FG004|Overall Study|Lost to Follow-up|1|||
164293726|NCT04999839|593447782|FG000|Overall Study|Withdrawal by Subject|6|||
164293727|NCT04999839|593447783|FG001|Overall Study|Withdrawal by Subject|5|||
164293728|NCT04999839|593447784|FG002|Overall Study|Withdrawal by Subject|3|||
164434139|NCT05663866|593958686|FG000|Overall Study|Withdrawal by Subject|0|||
164434140|NCT05663866|593958687|FG001|Overall Study|Withdrawal by Subject|2|||
164434141|NCT05663866|593958688|FG002|Overall Study|Withdrawal by Subject|1|||
164586985|NCT04760314|594513715|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
164293729|NCT04999839|593447785|FG003|Overall Study|Withdrawal by Subject|2|||
164346501|NCT00429273|593645049|FG000|Overall Study|Lost to Follow-up|1|||
164346502|NCT00429273|593645050|FG001|Overall Study|Lost to Follow-up|2|||
164346503|NCT00429273|593645051|FG002|Overall Study|Lost to Follow-up|2|||
164346504|NCT00429273|593645049|FG000|Overall Study|Physician Decision|6|||
164346505|NCT00429273|593645050|FG001|Overall Study|Physician Decision|5|||
164586986|NCT04760314|594513716|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
164293730|NCT04999839|593447786|FG004|Overall Study|Withdrawal by Subject|2|||
164293731|NCT04999839|593447782|FG000|Overall Study|Lack of Efficacy|0|||
164293732|NCT04999839|593447783|FG001|Overall Study|Lack of Efficacy|1|||
164293733|NCT04999839|593447784|FG002|Overall Study|Lack of Efficacy|0|||
164293734|NCT04999839|593447785|FG003|Overall Study|Lack of Efficacy|0|||
164293735|NCT04999839|593447786|FG004|Overall Study|Lack of Efficacy|0|||
164293736|NCT04999839|593447782|FG000|Overall Study|Physician Decision|0|||
164293737|NCT04999839|593447783|FG001|Overall Study|Physician Decision|0|||
164293738|NCT04999839|593447784|FG002|Overall Study|Physician Decision|0|||
164434142|NCT05663866|593958689|FG003|Overall Study|Withdrawal by Subject|2|||
164293739|NCT04999839|593447785|FG003|Overall Study|Physician Decision|0|||
164293740|NCT04999839|593447786|FG004|Overall Study|Physician Decision|1|||
164293741|NCT04999839|593447782|FG000|Overall Study|Sponsor request|0|||
164293742|NCT04999839|593447783|FG001|Overall Study|Sponsor request|1|||
164293743|NCT04999839|593447784|FG002|Overall Study|Sponsor request|0|||
164293744|NCT04999839|593447785|FG003|Overall Study|Sponsor request|0|||
164293745|NCT04999839|593447786|FG004|Overall Study|Sponsor request|0|||
164293746|NCT04999839|593447782|FG000|Overall Study|Other|0|||
164293747|NCT04999839|593447783|FG001|Overall Study|Other|0|||
164293748|NCT04999839|593447784|FG002|Overall Study|Other|1|||
164293749|NCT04999839|593447785|FG003|Overall Study|Other|0|||
164293750|NCT04999839|593447786|FG004|Overall Study|Other|0|||
164293751|NCT01362348|593447787|FG000|Overall Study|Protocol-defined stopping criteria|9|||
164293752|NCT01362348|593447787|FG000|Overall Study|Study closed/terminated|5|||
164293753|NCT00399516|593447788|FG000|Overall Study|Lost to Follow-up|2|||
164293754|NCT01046565|593447789|FG000|Overall Study|Adverse Event|2|||
164293755|NCT01046565|593447789|FG000|Overall Study|Withdrawal by Subject|7|||
164293756|NCT00377520|593447790|FG000|Overall Study|Ineligible (Prior radiation)|1|||
164293757|NCT00292942|593447791|FG000|Overall Study|Withdrawal by Subject|0|||
164293758|NCT00292942|593447792|FG001|Overall Study|Withdrawal by Subject|0|||
164293759|NCT00292942|593447793|FG002|Overall Study|Withdrawal by Subject|1|||
164293760|NCT00292942|593447794|FG003|Overall Study|Withdrawal by Subject|0|||
164293761|NCT00292942|593447791|FG000|Overall Study|Adverse Event|0|||
164293762|NCT00292942|593447792|FG001|Overall Study|Adverse Event|0|||
164293763|NCT00292942|593447793|FG002|Overall Study|Adverse Event|0|||
164293764|NCT00292942|593447794|FG003|Overall Study|Adverse Event|1|||
164293765|NCT00644358|593447795|FG000|Overall Study|Adverse Event|124|||
164293766|NCT00644358|593447795|FG000|Overall Study|Lost to Follow-up|105|||
164293767|NCT00644358|593447795|FG000|Overall Study|Consent Withdrawal|64|||
164293768|NCT00644358|593447795|FG000|Overall Study|Lack of Effectiveness|39|||
164293769|NCT00644358|593447795|FG000|Overall Study|Protocol Violation|5|||
164293770|NCT00644358|593447795|FG000|Overall Study|Noncompliance|14|||
164293771|NCT00644358|593447795|FG000|Overall Study|Other Unspecified|11|||
164293772|NCT00651924|593447800|FG000|Overall Study|Withdrawal by PI|0|||
164293773|NCT00651924|593447801|FG001|Overall Study|Withdrawal by PI|2|||
164293774|NCT00651924|593447800|FG000|Overall Study|Withdrawal by Subject|0|||
164293775|NCT00651924|593447801|FG001|Overall Study|Withdrawal by Subject|5|||
164293776|NCT00758771|593447802|FG000|Overall Study|Withdrawal by Subject|1|||
164586987|NCT04760314|594513717|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
164293777|NCT00758771|593447803|FG001|Overall Study|Withdrawal by Subject|1|||
164346506|NCT00429273|593645051|FG002|Overall Study|Physician Decision|5|||
164586988|NCT04760314|594513718|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
164586989|NCT04760314|594513719|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
164586990|NCT04760314|594513720|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
164586991|NCT04760314|594513710|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
164586992|NCT04760314|594513711|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
164586993|NCT04760314|594513712|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
164586994|NCT04760314|594513713|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
164586995|NCT04760314|594513714|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
164586996|NCT04760314|594513715|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
164586997|NCT04760314|594513716|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
164692814|NCT02941523|594897081|FG000|Carboplatin Combination Therapy|Death|1|||
164692815|NCT02941523|594897082|FG001|Carboplatin Combination Therapy|Death|2|||
164692816|NCT02941523|594897081|FG000|Carboplatin Combination Therapy|Disease progression|2|||
164692817|NCT02941523|594897082|FG001|Carboplatin Combination Therapy|Disease progression|0|||
164692818|NCT02941523|594897081|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
164692819|NCT02941523|594897082|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
164692820|NCT04330157|594897083|FG000|Overall Study|Protocol Violation|4|||
164692821|NCT04330157|594897083|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
164692822|NCT00869440|594897084|FG000|Overall Study|Withdrawal by Subject|1|||
164692823|NCT00869440|594897085|FG001|Overall Study|Withdrawal by Subject|0|||
164692824|NCT00869440|594897086|FG002|Overall Study|Withdrawal by Subject|0|||
164692825|NCT00869440|594897087|FG003|Overall Study|Withdrawal by Subject|0|||
164692826|NCT00869440|594897084|FG000|Overall Study|Physician Decision|1|||
164692827|NCT00869440|594897085|FG001|Overall Study|Physician Decision|1|||
164692828|NCT00869440|594897086|FG002|Overall Study|Physician Decision|0|||
164293778|NCT00758771|593447802|FG000|Overall Study|Did not meet eligibility criteria|2|||
164293779|NCT00758771|593447803|FG001|Overall Study|Did not meet eligibility criteria|4|||
164293780|NCT00960063|593447804|FG000|Overall Study|Adverse Event|1|||
164293781|NCT00960063|593447805|FG001|Overall Study|Adverse Event|0|||
164293782|NCT00960063|593447806|FG002|Overall Study|Adverse Event|0|||
164692829|NCT00869440|594897087|FG003|Overall Study|Physician Decision|0|||
164293783|NCT00960063|593447804|FG000|Overall Study|Progression of Disease|0|||
164293784|NCT00960063|593447805|FG001|Overall Study|Progression of Disease|0|||
164293785|NCT00960063|593447806|FG002|Overall Study|Progression of Disease|3|||
164293786|NCT00625131|593447807|FG000|Overall Study|Lost to Follow-up|3|||
164293787|NCT00625131|593447808|FG001|Overall Study|Lost to Follow-up|2|||
164293788|NCT00625131|593447809|FG002|Overall Study|Lost to Follow-up|0|||
164293789|NCT00625131|593447807|FG000|Overall Study|Withdrawal by Subject|1|||
164293790|NCT00625131|593447808|FG001|Overall Study|Withdrawal by Subject|0|||
164293791|NCT00625131|593447809|FG002|Overall Study|Withdrawal by Subject|5|||
164293792|NCT05083351|593447815|FG000|Overall Study|Adverse Event|3|||
164293793|NCT05083351|593447815|FG000|Overall Study|Did not meet data inclusion criteria|8|||
164293794|NCT05083351|593447815|FG000|Overall Study|Did not meet eligibility criteria|19|||
164293795|NCT05083351|593447815|FG000|Overall Study|Study Staff Decision|19|||
164293796|NCT02051764|593447823|FG000|Overall Study|Study terminated by sponsor|0|||
164293797|NCT02051764|593447824|FG001|Overall Study|Study terminated by sponsor|7|||
164293798|NCT00591006|593447825|FG000|Overall Study|Withdrawal by Subject|0|||
164293799|NCT00591006|593447826|FG001|Overall Study|Withdrawal by Subject|0|||
164293800|NCT00591006|593447827|FG002|Overall Study|Withdrawal by Subject|0|||
164293801|NCT00591006|593447828|FG003|Overall Study|Withdrawal by Subject|0|||
164293802|NCT00591006|593447829|FG004|Overall Study|Withdrawal by Subject|0|||
164293803|NCT00591006|593447830|FG005|Overall Study|Withdrawal by Subject|0|||
164293804|NCT00591006|593447831|FG006|Overall Study|Withdrawal by Subject|0|||
164293805|NCT00591006|593447832|FG007|Overall Study|Withdrawal by Subject|0|||
164293806|NCT00591006|593447833|FG008|Overall Study|Withdrawal by Subject|0|||
164293807|NCT00591006|593447834|FG009|Overall Study|Withdrawal by Subject|0|||
164293808|NCT00591006|593447835|FG010|Overall Study|Withdrawal by Subject|0|||
164293809|NCT00591006|593447836|FG011|Overall Study|Withdrawal by Subject|0|||
164293810|NCT00591006|593447837|FG012|Overall Study|Withdrawal by Subject|0|||
164293811|NCT00591006|593447838|FG013|Overall Study|Withdrawal by Subject|0|||
164293812|NCT00591006|593447839|FG014|Overall Study|Withdrawal by Subject|0|||
164293813|NCT00591006|593447840|FG015|Overall Study|Withdrawal by Subject|1|||
164293814|NCT00591006|593447841|FG016|Overall Study|Withdrawal by Subject|0|||
164346507|NCT00429273|593645049|FG000|Overall Study|Adverse Event|1|||
164346508|NCT00429273|593645050|FG001|Overall Study|Adverse Event|1|||
164346509|NCT00429273|593645051|FG002|Overall Study|Adverse Event|2|||
164346510|NCT01218204|593645056|FG000|Part B Washout|Adverse Event|0|||
164346511|NCT01218204|593645057|FG001|Part B Washout|Adverse Event|1|||
164346512|NCT01218204|593645058|FG002|Part B Washout|Adverse Event|0|||
164346513|NCT01218204|593645059|FG003|Part B Washout|Adverse Event|0|||
164586998|NCT04760314|594513717|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
164586999|NCT04760314|594513718|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
164587000|NCT04760314|594513719|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
164293815|NCT00591006|593447842|FG017|Overall Study|Withdrawal by Subject|0|||
164293816|NCT00591006|593447843|FG018|Overall Study|Withdrawal by Subject|0|||
164293817|NCT00591006|593447844|FG019|Overall Study|Withdrawal by Subject|0|||
164587001|NCT04760314|594513720|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
164587002|NCT04760314|594513710|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
164587003|NCT04760314|594513711|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
164587004|NCT04760314|594513712|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
164587005|NCT04760314|594513713|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
164587006|NCT04760314|594513714|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
164587007|NCT04760314|594513715|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
164587008|NCT04760314|594513716|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
164587009|NCT04760314|594513717|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
164587010|NCT04760314|594513718|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
164587011|NCT04760314|594513719|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
164587012|NCT04760314|594513720|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
164587013|NCT04760314|594513710|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164587014|NCT04760314|594513711|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164587015|NCT04760314|594513712|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164587016|NCT04760314|594513713|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164587017|NCT04760314|594513714|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164587018|NCT04760314|594513715|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164587019|NCT04760314|594513716|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164587020|NCT04760314|594513717|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
164587021|NCT04760314|594513718|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164293818|NCT00591006|593447845|FG020|Overall Study|Withdrawal by Subject|0|||
164293819|NCT00591006|593447846|FG021|Overall Study|Withdrawal by Subject|0|||
164293820|NCT00591006|593447847|FG022|Overall Study|Withdrawal by Subject|0|||
164293821|NCT00591006|593447848|FG023|Overall Study|Withdrawal by Subject|1|||
164346514|NCT01218204|593645056|FG000|Part B Washout|Lost to Follow-up|0|||
164346515|NCT01218204|593645057|FG001|Part B Washout|Lost to Follow-up|2|||
164346516|NCT01218204|593645058|FG002|Part B Washout|Lost to Follow-up|0|||
164587022|NCT04760314|594513719|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
164587023|NCT04760314|594513720|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
164587024|NCT04760314|594513710|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164587025|NCT04760314|594513711|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164293822|NCT00591006|593447825|FG000|Overall Study|Adverse Event|0|||
164293823|NCT00591006|593447826|FG001|Overall Study|Adverse Event|0|||
164293824|NCT00591006|593447827|FG002|Overall Study|Adverse Event|0|||
164587026|NCT04760314|594513712|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164587027|NCT04760314|594513713|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164692830|NCT04314843|594897088|FG000|Overall Study|Death|2|||
164587028|NCT04760314|594513714|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164587029|NCT04760314|594513715|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164587030|NCT04760314|594513716|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164587031|NCT04760314|594513717|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
164587032|NCT04760314|594513718|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
164587033|NCT04760314|594513719|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
164587034|NCT04760314|594513720|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164587035|NCT04760314|594513710|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164587036|NCT04760314|594513711|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164587037|NCT04760314|594513712|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164587038|NCT04760314|594513713|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164587039|NCT04760314|594513714|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164587040|NCT04760314|594513715|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164587041|NCT04760314|594513716|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164587042|NCT04760314|594513717|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
164587043|NCT04760314|594513718|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164692831|NCT04314843|594897089|FG001|Overall Study|Death|2|||
164692832|NCT04314843|594897088|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
164692833|NCT04314843|594897089|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
164692834|NCT01899326|594897091|FG000|Overall Study|Withdrawal by Subject|1|||
164692835|NCT01899326|594897091|FG000|Overall Study|Adverse Event|2|||
164692836|NCT01899326|594897091|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
164692837|NCT00104247|594897092|FG000|Overall Study|Withdrawal by Subject|1|||
164692838|NCT00104247|594897093|FG001|Overall Study|Withdrawal by Subject|0|||
164692839|NCT00104247|594897092|FG000|Overall Study|Noncompliant with dosing|0|||
164692840|NCT00104247|594897093|FG001|Overall Study|Noncompliant with dosing|1|||
164692841|NCT01378962|594897094|FG000|Overall Study|Death|14|||
164692842|NCT01378962|594897094|FG000|Overall Study|Lost to Follow-up|1|||
164692843|NCT01378962|594897094|FG000|Overall Study|Other|2|||
164692844|NCT01588548|594897095|FG000|Overall Study|Withdrawal by Subject|0|||
164692845|NCT01588548|594897096|FG001|Overall Study|Withdrawal by Subject|1|||
164293825|NCT00591006|593447828|FG003|Overall Study|Adverse Event|0|||
164293826|NCT00591006|593447829|FG004|Overall Study|Adverse Event|0|||
164293827|NCT00591006|593447830|FG005|Overall Study|Adverse Event|0|||
164293828|NCT00591006|593447831|FG006|Overall Study|Adverse Event|0|||
164293829|NCT00591006|593447832|FG007|Overall Study|Adverse Event|0|||
164293830|NCT00591006|593447833|FG008|Overall Study|Adverse Event|0|||
164293831|NCT00591006|593447834|FG009|Overall Study|Adverse Event|0|||
164346517|NCT01218204|593645059|FG003|Part B Washout|Lost to Follow-up|0|||
164346518|NCT01218204|593645056|FG000|Part B Washout|Physician Decision|0|||
164346519|NCT01218204|593645057|FG001|Part B Washout|Physician Decision|14|||
164346520|NCT01218204|593645058|FG002|Part B Washout|Physician Decision|0|||
164346521|NCT01218204|593645059|FG003|Part B Washout|Physician Decision|0|||
164346522|NCT01218204|593645056|FG000|Part B Washout|Withdrawal by Subject|0|||
164346523|NCT01218204|593645057|FG001|Part B Washout|Withdrawal by Subject|14|||
164346524|NCT01218204|593645058|FG002|Part B Washout|Withdrawal by Subject|0|||
164346525|NCT01218204|593645059|FG003|Part B Washout|Withdrawal by Subject|0|||
164346526|NCT01218204|593645056|FG000|Part B Washout|Reached defined stopping criteria|0|||
164346527|NCT01218204|593645057|FG001|Part B Washout|Reached defined stopping criteria|2|||
164346528|NCT01218204|593645058|FG002|Part B Washout|Reached defined stopping criteria|0|||
164346529|NCT01218204|593645059|FG003|Part B Washout|Reached defined stopping criteria|0|||
164346530|NCT01218204|593645056|FG000|Part B Washout|Did not meet continuation criteria|0|||
164346531|NCT01218204|593645057|FG001|Part B Washout|Did not meet continuation criteria|112|||
164346532|NCT01218204|593645058|FG002|Part B Washout|Did not meet continuation criteria|0|||
164346533|NCT01218204|593645059|FG003|Part B Washout|Did not meet continuation criteria|0|||
164346534|NCT01218204|593645056|FG000|Part B Run-in|Adverse Event|0|||
164346535|NCT01218204|593645057|FG001|Part B Run-in|Adverse Event|0|||
164346536|NCT01218204|593645058|FG002|Part B Run-in|Adverse Event|1|||
164346537|NCT01218204|593645059|FG003|Part B Run-in|Adverse Event|0|||
164346538|NCT01218204|593645056|FG000|Part B Run-in|Protocol Violation|0|||
164692846|NCT01588548|594897097|FG002|Overall Study|Withdrawal by Subject|1|||
164293832|NCT00591006|593447835|FG010|Overall Study|Adverse Event|0|||
164293833|NCT00591006|593447836|FG011|Overall Study|Adverse Event|0|||
164346539|NCT01218204|593645057|FG001|Part B Run-in|Protocol Violation|0|||
164346540|NCT01218204|593645058|FG002|Part B Run-in|Protocol Violation|2|||
164434143|NCT05663866|593958686|FG000|Overall Study|Progressive disease|4|||
164587044|NCT04760314|594513719|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164293834|NCT00591006|593447837|FG012|Overall Study|Adverse Event|0|||
164293835|NCT00591006|593447838|FG013|Overall Study|Adverse Event|0|||
164293836|NCT00591006|593447839|FG014|Overall Study|Adverse Event|0|||
164293837|NCT00591006|593447840|FG015|Overall Study|Adverse Event|0|||
164293838|NCT00591006|593447841|FG016|Overall Study|Adverse Event|0|||
164293839|NCT00591006|593447842|FG017|Overall Study|Adverse Event|0|||
164293840|NCT00591006|593447843|FG018|Overall Study|Adverse Event|0|||
164293841|NCT00591006|593447844|FG019|Overall Study|Adverse Event|0|||
164293842|NCT00591006|593447845|FG020|Overall Study|Adverse Event|0|||
164293843|NCT00591006|593447846|FG021|Overall Study|Adverse Event|0|||
164293844|NCT00591006|593447847|FG022|Overall Study|Adverse Event|1|||
164293845|NCT00591006|593447848|FG023|Overall Study|Adverse Event|0|||
164293846|NCT02898454|593447849|FG000|Overall Study|Adverse Event|4|||
164293847|NCT02898454|593447850|FG001|Overall Study|Adverse Event|1|||
164293848|NCT02898454|593447851|FG002|Overall Study|Adverse Event|2|||
164293849|NCT02898454|593447849|FG000|Overall Study|Protocol Violation|1|||
164293850|NCT02898454|593447850|FG001|Overall Study|Protocol Violation|0|||
164293851|NCT02898454|593447851|FG002|Overall Study|Protocol Violation|1|||
164293852|NCT02898454|593447849|FG000|Overall Study|Lack of Efficacy|4|||
164293853|NCT02898454|593447850|FG001|Overall Study|Lack of Efficacy|1|||
164293854|NCT02898454|593447851|FG002|Overall Study|Lack of Efficacy|0|||
164293855|NCT02898454|593447849|FG000|Overall Study|Withdrawal by Subject|6|||
164293856|NCT02898454|593447850|FG001|Overall Study|Withdrawal by Subject|3|||
164293857|NCT02898454|593447851|FG002|Overall Study|Withdrawal by Subject|3|||
164293858|NCT02898454|593447849|FG000|Overall Study|Lost to Follow-up|1|||
164293859|NCT02898454|593447850|FG001|Overall Study|Lost to Follow-up|0|||
164293860|NCT02898454|593447851|FG002|Overall Study|Lost to Follow-up|0|||
164293861|NCT02898454|593447849|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
164293862|NCT02898454|593447850|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
164293863|NCT02898454|593447851|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
164293864|NCT03040141|593447852|FG000|Overall Study|Death|1|||
164293865|NCT03040141|593447853|FG001|Overall Study|Death|2|||
164293866|NCT03040141|593447854|FG002|Overall Study|Death|3|||
164293867|NCT03040141|593447852|FG000|Overall Study|Withdrawal by Subject|3|||
164293868|NCT03040141|593447853|FG001|Overall Study|Withdrawal by Subject|1|||
164293869|NCT03040141|593447854|FG002|Overall Study|Withdrawal by Subject|1|||
164293870|NCT03040141|593447852|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
164293871|NCT03040141|593447853|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
164293872|NCT03040141|593447854|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
164293873|NCT03040141|593447852|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
164293874|NCT03040141|593447853|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
164293875|NCT03040141|593447854|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
164293876|NCT01384734|593447856|FG000|Overall Study|Adverse Event|0|||
164293877|NCT01384734|593447857|FG001|Overall Study|Adverse Event|3|||
164293878|NCT01384734|593447858|FG002|Overall Study|Adverse Event|0|||
164293879|NCT01384734|593447859|FG003|Overall Study|Adverse Event|2|||
164293880|NCT01384734|593447860|FG004|Overall Study|Adverse Event|7|||
164293881|NCT01384734|593447856|FG000|Overall Study|Death|1|||
164293882|NCT01384734|593447857|FG001|Overall Study|Death|0|||
164293883|NCT01384734|593447858|FG002|Overall Study|Death|1|||
164293884|NCT01384734|593447859|FG003|Overall Study|Death|0|||
164293885|NCT01384734|593447860|FG004|Overall Study|Death|0|||
164293886|NCT01384734|593447856|FG000|Overall Study|Continuation criteria not met|0|||
164293887|NCT01384734|593447857|FG001|Overall Study|Continuation criteria not met|0|||
164293888|NCT01384734|593447858|FG002|Overall Study|Continuation criteria not met|1|||
164293889|NCT01384734|593447859|FG003|Overall Study|Continuation criteria not met|1|||
164293890|NCT01384734|593447860|FG004|Overall Study|Continuation criteria not met|0|||
164293891|NCT01384734|593447856|FG000|Overall Study|Lack of Efficacy|3|||
164293892|NCT01384734|593447857|FG001|Overall Study|Lack of Efficacy|7|||
164293893|NCT01384734|593447858|FG002|Overall Study|Lack of Efficacy|4|||
164293894|NCT01384734|593447859|FG003|Overall Study|Lack of Efficacy|4|||
164293895|NCT01384734|593447860|FG004|Overall Study|Lack of Efficacy|2|||
164293896|NCT01384734|593447856|FG000|Overall Study|Lost to Follow-up|5|||
164293897|NCT01384734|593447857|FG001|Overall Study|Lost to Follow-up|3|||
164293898|NCT01384734|593447858|FG002|Overall Study|Lost to Follow-up|3|||
164293899|NCT01384734|593447859|FG003|Overall Study|Lost to Follow-up|8|||
164293900|NCT01384734|593447860|FG004|Overall Study|Lost to Follow-up|5|||
164293901|NCT01384734|593447856|FG000|Overall Study|Non-compliance with study drug|1|||
164587045|NCT04760314|594513720|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164587046|NCT04760314|594513710|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
164587047|NCT04760314|594513711|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
164293902|NCT01384734|593447857|FG001|Overall Study|Non-compliance with study drug|2|||
164346541|NCT01218204|593645059|FG003|Part B Run-in|Protocol Violation|0|||
164293903|NCT01384734|593447858|FG002|Overall Study|Non-compliance with study drug|6|||
164293904|NCT01384734|593447859|FG003|Overall Study|Non-compliance with study drug|0|||
164293905|NCT01384734|593447860|FG004|Overall Study|Non-compliance with study drug|2|||
164293906|NCT01384734|593447856|FG000|Overall Study|Pregnancy|0|||
164293907|NCT01384734|593447857|FG001|Overall Study|Pregnancy|1|||
164293908|NCT01384734|593447858|FG002|Overall Study|Pregnancy|0|||
164293909|NCT01384734|593447859|FG003|Overall Study|Pregnancy|0|||
164293910|NCT01384734|593447860|FG004|Overall Study|Pregnancy|1|||
164293911|NCT01384734|593447856|FG000|Overall Study|Sponsor terminated|0|||
164293912|NCT01384734|593447857|FG001|Overall Study|Sponsor terminated|0|||
164293913|NCT01384734|593447858|FG002|Overall Study|Sponsor terminated|0|||
164293914|NCT01384734|593447859|FG003|Overall Study|Sponsor terminated|0|||
164293915|NCT01384734|593447860|FG004|Overall Study|Sponsor terminated|1|||
164293916|NCT01384734|593447856|FG000|Overall Study|Withdrawal by Subject|5|||
164293917|NCT01384734|593447857|FG001|Overall Study|Withdrawal by Subject|5|||
164293918|NCT01384734|593447858|FG002|Overall Study|Withdrawal by Subject|6|||
164293919|NCT01384734|593447859|FG003|Overall Study|Withdrawal by Subject|7|||
164293920|NCT01384734|593447860|FG004|Overall Study|Withdrawal by Subject|9|||
164293921|NCT01384734|593447856|FG000|Overall Study|Investigator relocating|0|||
164293922|NCT01384734|593447857|FG001|Overall Study|Investigator relocating|2|||
164293923|NCT01384734|593447858|FG002|Overall Study|Investigator relocating|0|||
164293924|NCT01384734|593447859|FG003|Overall Study|Investigator relocating|3|||
164293925|NCT01384734|593447860|FG004|Overall Study|Investigator relocating|1|||
164293926|NCT01384734|593447856|FG000|Overall Study|Unable to come back for visit|1|||
164434144|NCT05663866|593958687|FG001|Overall Study|Progressive disease|8|||
164434145|NCT05663866|593958688|FG002|Overall Study|Progressive disease|5|||
164434146|NCT05663866|593958689|FG003|Overall Study|Progressive disease|2|||
164587048|NCT04760314|594513712|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
164587049|NCT04760314|594513713|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
164587050|NCT04760314|594513714|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
164587051|NCT04760314|594513715|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
164587052|NCT04760314|594513716|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
164293927|NCT01384734|593447857|FG001|Overall Study|Unable to come back for visit|0|||
164293928|NCT01384734|593447858|FG002|Overall Study|Unable to come back for visit|1|||
164293929|NCT01384734|593447859|FG003|Overall Study|Unable to come back for visit|1|||
164293930|NCT01384734|593447860|FG004|Overall Study|Unable to come back for visit|0|||
164587053|NCT04760314|594513717|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
164587054|NCT04760314|594513718|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
164587055|NCT04760314|594513719|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
164587056|NCT04760314|594513720|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
164587057|NCT03515538|594513730|FG000|Overall Study|Lack of Efficacy|2|||
164587058|NCT03515538|594513731|FG001|Overall Study|Lack of Efficacy|0|||
164587059|NCT03515538|594513732|FG002|Overall Study|Lack of Efficacy|2|||
164587060|NCT03515538|594513733|FG003|Overall Study|Lack of Efficacy|0|||
164587061|NCT03515538|594513730|FG000|Overall Study|Death|0|||
164587062|NCT03515538|594513731|FG001|Overall Study|Death|0|||
164587063|NCT03515538|594513732|FG002|Overall Study|Death|1|||
164587064|NCT03515538|594513733|FG003|Overall Study|Death|0|||
164293931|NCT01384734|593447856|FG000|Overall Study|Prison|0|||
164293932|NCT01384734|593447857|FG001|Overall Study|Prison|0|||
164293933|NCT01384734|593447858|FG002|Overall Study|Prison|1|||
164293934|NCT01384734|593447859|FG003|Overall Study|Prison|0|||
164293935|NCT01384734|593447860|FG004|Overall Study|Prison|0|||
164293936|NCT01384734|593447856|FG000|Overall Study|As per Exclusion criteria|0|||
164293937|NCT01384734|593447857|FG001|Overall Study|As per Exclusion criteria|1|||
164293938|NCT01384734|593447858|FG002|Overall Study|As per Exclusion criteria|0|||
164293939|NCT01384734|593447859|FG003|Overall Study|As per Exclusion criteria|0|||
164293940|NCT01384734|593447860|FG004|Overall Study|As per Exclusion criteria|0|||
164293941|NCT01384734|593447856|FG000|Overall Study|Missed End of treatment visit|0|||
164293942|NCT01384734|593447857|FG001|Overall Study|Missed End of treatment visit|0|||
164293943|NCT01384734|593447858|FG002|Overall Study|Missed End of treatment visit|0|||
164293944|NCT01384734|593447859|FG003|Overall Study|Missed End of treatment visit|1|||
164293945|NCT01384734|593447860|FG004|Overall Study|Missed End of treatment visit|0|||
164293946|NCT01384734|593447856|FG000|Overall Study|Adhesion problem|0|||
164293947|NCT01384734|593447857|FG001|Overall Study|Adhesion problem|0|||
164293948|NCT01384734|593447858|FG002|Overall Study|Adhesion problem|0|||
164293949|NCT01384734|593447859|FG003|Overall Study|Adhesion problem|1|||
164293950|NCT01384734|593447860|FG004|Overall Study|Adhesion problem|0|||
164293951|NCT01384734|593447856|FG000|Overall Study|Early termination|0|||
164293952|NCT01384734|593447857|FG001|Overall Study|Early termination|0|||
164293953|NCT01384734|593447858|FG002|Overall Study|Early termination|0|||
164293954|NCT01384734|593447859|FG003|Overall Study|Early termination|0|||
164293955|NCT01384734|593447860|FG004|Overall Study|Early termination|1|||
164293956|NCT01384734|593447856|FG000|Overall Study|Physician Decision|1|||
164293957|NCT01384734|593447857|FG001|Overall Study|Physician Decision|0|||
164434147|NCT05663866|593958686|FG000|Overall Study|Other|1|||
164587065|NCT03515538|594513730|FG000|Overall Study|Protocol Violation|0|||
164587066|NCT03515538|594513731|FG001|Overall Study|Protocol Violation|0|||
164293958|NCT01384734|593447858|FG002|Overall Study|Physician Decision|0|||
164293959|NCT01384734|593447859|FG003|Overall Study|Physician Decision|0|||
164293960|NCT01384734|593447860|FG004|Overall Study|Physician Decision|0|||
164293961|NCT01290523|593447861|FG000|Overall Study|Death|3|||
164293962|NCT03071263|593447862|FG000|Overall Study|Adverse Event|1|||
164293963|NCT03071263|593447863|FG001|Overall Study|Adverse Event|3|||
164293964|NCT03071263|593447862|FG000|Overall Study|Withdrawal by Subject|1|||
164293965|NCT03071263|593447863|FG001|Overall Study|Withdrawal by Subject|3|||
164293966|NCT03071263|593447862|FG000|Overall Study|Physician Decision|1|||
164293967|NCT03071263|593447863|FG001|Overall Study|Physician Decision|0|||
164346542|NCT01218204|593645056|FG000|Part B Run-in|Withdrawal by Subject|0|||
164293968|NCT03071263|593447862|FG000|Overall Study|Participant moved to another city|0|||
164293969|NCT03071263|593447863|FG001|Overall Study|Participant moved to another city|1|||
164293970|NCT02922725|593447865|FG000|Overall Study|Withdrawal by Subject|1|||
164434148|NCT05663866|593958687|FG001|Overall Study|Other|0|||
164434149|NCT05663866|593958688|FG002|Overall Study|Other|0|||
164434150|NCT05663866|593958689|FG003|Overall Study|Other|0|||
164434151|NCT05663866|593958686|FG000|Overall Study|Ongoing|1|||
164434152|NCT05663866|593958687|FG001|Overall Study|Ongoing|27|||
164434153|NCT05663866|593958688|FG002|Overall Study|Ongoing|6|||
164434154|NCT05663866|593958689|FG003|Overall Study|Ongoing|1|||
164434155|NCT05803720|593958690|FG000|Overall Study|Lost to Follow-up|3|||
164434156|NCT05803720|593958691|FG001|Overall Study|Lost to Follow-up|4|||
164434157|NCT05803720|593958690|FG000|Overall Study|Family leave/emergency|1|||
164434158|NCT05803720|593958691|FG001|Overall Study|Family leave/emergency|1|||
164434159|NCT03370133|593958692|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
164434160|NCT03370133|593958693|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
164434161|NCT03370133|593958694|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
164434162|NCT03370133|593958695|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
164434163|NCT03370133|593958696|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
164434164|NCT03370133|593958697|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
164434165|NCT03370133|593958692|FG000|Initial Treatment Period (WK 16)|Death|1|||
164434166|NCT03370133|593958693|FG001|Initial Treatment Period (WK 16)|Death|1|||
164434167|NCT03370133|593958694|FG002|Initial Treatment Period (WK 16)|Death|1|||
164434168|NCT03370133|593958695|FG003|Initial Treatment Period (WK 16)|Death|0|||
164434169|NCT03370133|593958696|FG004|Initial Treatment Period (WK 16)|Death|0|||
164434170|NCT03370133|593958697|FG005|Initial Treatment Period (WK 16)|Death|0|||
164434171|NCT03370133|593958692|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
164434172|NCT03370133|593958693|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
164434173|NCT03370133|593958694|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
164434174|NCT03370133|593958695|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
164434175|NCT03370133|593958696|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
164434176|NCT03370133|593958697|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
164434177|NCT03370133|593958692|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
164434178|NCT03370133|593958693|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
164434179|NCT03370133|593958694|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
164434180|NCT03370133|593958695|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
164434181|NCT03370133|593958696|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
164434182|NCT03370133|593958697|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
164434183|NCT03370133|593958692|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
164434184|NCT03370133|593958693|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
164434185|NCT03370133|593958694|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
164434186|NCT03370133|593958695|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
164434187|NCT03370133|593958696|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
164434188|NCT03370133|593958697|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
164434189|NCT03370133|593958692|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
164434190|NCT03370133|593958693|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
164434191|NCT03370133|593958694|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
164434192|NCT03370133|593958695|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
164434193|NCT03370133|593958696|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
164434194|NCT03370133|593958697|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
164434195|NCT03370133|593958692|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
164434196|NCT03370133|593958693|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
164434197|NCT03370133|593958694|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
164434198|NCT03370133|593958695|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
164434199|NCT03370133|593958696|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
164434200|NCT03370133|593958697|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
164434201|NCT03370133|593958692|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
164434202|NCT03370133|593958693|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
164434203|NCT03370133|593958694|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
164434204|NCT03370133|593958695|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
164434205|NCT03370133|593958696|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
164434206|NCT03370133|593958697|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
164434207|NCT03370133|593958692|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
164434208|NCT03370133|593958693|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
164434209|NCT03370133|593958694|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
164434210|NCT03370133|593958695|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
164434211|NCT03370133|593958696|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
164434212|NCT03370133|593958697|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
164434213|NCT03370133|593958692|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
164587067|NCT03515538|594513732|FG002|Overall Study|Protocol Violation|0|||
164434214|NCT03370133|593958693|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
164587068|NCT03515538|594513733|FG003|Overall Study|Protocol Violation|1|||
164587069|NCT03515538|594513730|FG000|Overall Study|Screen failure (baseline dropout)|0|||
164587070|NCT03515538|594513731|FG001|Overall Study|Screen failure (baseline dropout)|1|||
164293971|NCT02922725|593447866|FG001|Overall Study|Withdrawal by Subject|0|||
164293972|NCT02922725|593447867|FG002|Overall Study|Withdrawal by Subject|0|||
164293973|NCT05148234|593447871|FG000|Phase I|Ineligible|0|||
164293974|NCT05148234|593447872|FG001|Phase I|Ineligible|0|||
164293975|NCT05148234|593447873|FG002|Phase I|Ineligible|0|||
164293976|NCT05148234|593447874|FG003|Phase I|Ineligible|0|||
164293977|NCT05148234|593447875|FG004|Phase I|Ineligible|0|||
164293978|NCT05148234|593447876|FG005|Phase I|Ineligible|0|||
164293979|NCT05148234|593447877|FG006|Phase I|Ineligible|0|||
164293980|NCT05148234|593447878|FG007|Phase I|Ineligible|1|||
164293981|NCT05148234|593447871|FG000|Phase I|Company closed the trial.|0|||
164293982|NCT05148234|593447872|FG001|Phase I|Company closed the trial.|1|||
164434215|NCT03370133|593958694|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
164434216|NCT03370133|593958695|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
164434217|NCT03370133|593958696|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
164434218|NCT03370133|593958697|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
164434219|NCT03370133|593958692|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
164434220|NCT03370133|593958693|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
164434221|NCT03370133|593958694|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
164434222|NCT03370133|593958695|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
164434223|NCT03370133|593958696|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
164434224|NCT03370133|593958697|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
164434225|NCT03370133|593958692|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
164434226|NCT03370133|593958693|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
164434227|NCT03370133|593958694|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
164434228|NCT03370133|593958695|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
164434229|NCT03370133|593958696|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
164434230|NCT03370133|593958697|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
164434231|NCT03370133|593958692|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
164434232|NCT03370133|593958693|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
164434233|NCT03370133|593958694|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
164434234|NCT03370133|593958695|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
164434235|NCT03370133|593958696|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
164434236|NCT03370133|593958697|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
164434237|NCT03370133|593958692|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
164434238|NCT03370133|593958693|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
164434239|NCT03370133|593958694|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
164434240|NCT03370133|593958695|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
164434241|NCT03370133|593958696|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
164434242|NCT03370133|593958697|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
164434243|NCT03370133|593958692|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
164434244|NCT03370133|593958693|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
164434245|NCT03370133|593958694|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
164434246|NCT03370133|593958695|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
164434247|NCT03370133|593958696|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
164434248|NCT03370133|593958697|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
164434249|NCT06688370|593958698|FG000|Overall Study|Discontinued the treatment|1|||
164434250|NCT06688370|593958698|FG000|Overall Study|Prohibited treatment taken|4|||
164434251|NCT02501811|593958699|FG000|Overall Study|Death|1|||
164434252|NCT02501811|593958700|FG001|Overall Study|Death|3|||
164434253|NCT02501811|593958701|FG002|Overall Study|Death|2|||
164434254|NCT02501811|593958702|FG003|Overall Study|Death|3|||
164434255|NCT02501811|593958699|FG000|Overall Study|Withdrawal by Subject|3|||
164434256|NCT02501811|593958700|FG001|Overall Study|Withdrawal by Subject|3|||
164434257|NCT02501811|593958701|FG002|Overall Study|Withdrawal by Subject|2|||
164434258|NCT02501811|593958702|FG003|Overall Study|Withdrawal by Subject|3|||
164434259|NCT02501811|593958699|FG000|Overall Study|Lost to Follow-up|0|||
164434260|NCT02501811|593958700|FG001|Overall Study|Lost to Follow-up|0|||
164434261|NCT02501811|593958701|FG002|Overall Study|Lost to Follow-up|2|||
164434262|NCT02501811|593958702|FG003|Overall Study|Lost to Follow-up|1|||
164434263|NCT04804605|593960695|FG000|Overall Study|Withdrawal by Subject|46|||
164587071|NCT03515538|594513732|FG002|Overall Study|Screen failure (baseline dropout)|0|||
164587072|NCT03515538|594513733|FG003|Overall Study|Screen failure (baseline dropout)|0|||
164587073|NCT03515538|594513730|FG000|Overall Study|Withdrawal by Subject|2|||
164587074|NCT03515538|594513731|FG001|Overall Study|Withdrawal by Subject|2|||
164587075|NCT03515538|594513732|FG002|Overall Study|Withdrawal by Subject|1|||
164587076|NCT03515538|594513733|FG003|Overall Study|Withdrawal by Subject|3|||
164587077|NCT03515538|594513730|FG000|Overall Study|Physician Decision|1|||
164587078|NCT03515538|594513731|FG001|Overall Study|Physician Decision|0|||
164587079|NCT03515538|594513732|FG002|Overall Study|Physician Decision|0|||
164587080|NCT03515538|594513733|FG003|Overall Study|Physician Decision|1|||
164434264|NCT04804605|593960696|FG001|Overall Study|Withdrawal by Subject|26|||
164434265|NCT04804605|593960697|FG002|Overall Study|Withdrawal by Subject|37|||
164434266|NCT04804605|593960698|FG003|Overall Study|Withdrawal by Subject|21|||
164434267|NCT04804605|593960695|FG000|Overall Study|Lost to Follow-up|47|||
164434268|NCT04804605|593960696|FG001|Overall Study|Lost to Follow-up|21|||
164434269|NCT04804605|593960697|FG002|Overall Study|Lost to Follow-up|30|||
164434270|NCT04804605|593960698|FG003|Overall Study|Lost to Follow-up|17|||
164434271|NCT04804605|593960695|FG000|Overall Study|Lack of Efficacy|28|||
164434272|NCT04804605|593960696|FG001|Overall Study|Lack of Efficacy|11|||
164434273|NCT04804605|593960697|FG002|Overall Study|Lack of Efficacy|37|||
164434274|NCT04804605|593960698|FG003|Overall Study|Lack of Efficacy|8|||
164434275|NCT04804605|593960695|FG000|Overall Study|Adverse Event|10|||
164434276|NCT04804605|593960696|FG001|Overall Study|Adverse Event|10|||
164434277|NCT04804605|593960697|FG002|Overall Study|Adverse Event|10|||
164434278|NCT04804605|593960698|FG003|Overall Study|Adverse Event|7|||
164434279|NCT04804605|593960695|FG000|Overall Study|Non-compliance|8|||
164434280|NCT04804605|593960696|FG001|Overall Study|Non-compliance|3|||
164434281|NCT04804605|593960697|FG002|Overall Study|Non-compliance|5|||
164434282|NCT04804605|593960698|FG003|Overall Study|Non-compliance|1|||
164434283|NCT04804605|593960695|FG000|Overall Study|Physician Decision|3|||
164434284|NCT04804605|593960696|FG001|Overall Study|Physician Decision|0|||
164434285|NCT04804605|593960697|FG002|Overall Study|Physician Decision|5|||
164434286|NCT04804605|593960698|FG003|Overall Study|Physician Decision|0|||
164434287|NCT04804605|593960695|FG000|Overall Study|Protocol Violation|1|||
164434288|NCT04804605|593960696|FG001|Overall Study|Protocol Violation|0|||
164434289|NCT04804605|593960697|FG002|Overall Study|Protocol Violation|0|||
164434290|NCT04804605|593960698|FG003|Overall Study|Protocol Violation|1|||
164434291|NCT04804605|593960695|FG000|Overall Study|Miscellaneous|7|||
164434292|NCT04804605|593960696|FG001|Overall Study|Miscellaneous|3|||
164434293|NCT04804605|593960697|FG002|Overall Study|Miscellaneous|4|||
164434294|NCT04804605|593960698|FG003|Overall Study|Miscellaneous|2|||
164434295|NCT00567879|593960701|FG000|Overall Study|Adverse Event|2|||
164434296|NCT00567879|593960702|FG001|Overall Study|Adverse Event|0|||
164434297|NCT00567879|593960703|FG002|Overall Study|Adverse Event|1|||
164434298|NCT00567879|593960704|FG003|Overall Study|Adverse Event|0|||
164434299|NCT00567879|593960705|FG004|Overall Study|Adverse Event|1|||
164434300|NCT00567879|593960706|FG005|Overall Study|Adverse Event|0|||
164434301|NCT00567879|593960701|FG000|Overall Study|Abnormal test procedure(s)|0|||
164434302|NCT00567879|593960702|FG001|Overall Study|Abnormal test procedure(s)|0|||
164434303|NCT00567879|593960703|FG002|Overall Study|Abnormal test procedure(s)|1|||
164434304|NCT00567879|593960704|FG003|Overall Study|Abnormal test procedure(s)|0|||
164434305|NCT00567879|593960705|FG004|Overall Study|Abnormal test procedure(s)|0|||
164434306|NCT00567879|593960706|FG005|Overall Study|Abnormal test procedure(s)|0|||
164434307|NCT00567879|593960701|FG000|Overall Study|Withdrawal by Subject|0|||
164434308|NCT00567879|593960702|FG001|Overall Study|Withdrawal by Subject|0|||
164434309|NCT00567879|593960703|FG002|Overall Study|Withdrawal by Subject|3|||
164434310|NCT00567879|593960704|FG003|Overall Study|Withdrawal by Subject|1|||
164434311|NCT00567879|593960705|FG004|Overall Study|Withdrawal by Subject|0|||
164434312|NCT00567879|593960706|FG005|Overall Study|Withdrawal by Subject|0|||
164434313|NCT00567879|593960701|FG000|Overall Study|New cancer therapy|0|||
164434314|NCT00567879|593960702|FG001|Overall Study|New cancer therapy|0|||
164434315|NCT00567879|593960703|FG002|Overall Study|New cancer therapy|1|||
164434316|NCT00567879|593960704|FG003|Overall Study|New cancer therapy|0|||
164434317|NCT00567879|593960705|FG004|Overall Study|New cancer therapy|0|||
164434318|NCT00567879|593960706|FG005|Overall Study|New cancer therapy|0|||
164434319|NCT00567879|593960701|FG000|Overall Study|Disease progression|5|||
164434320|NCT00567879|593960702|FG001|Overall Study|Disease progression|7|||
164434321|NCT00567879|593960703|FG002|Overall Study|Disease progression|15|||
164434322|NCT00567879|593960704|FG003|Overall Study|Disease progression|5|||
164434323|NCT00567879|593960705|FG004|Overall Study|Disease progression|11|||
164434324|NCT00567879|593960706|FG005|Overall Study|Disease progression|3|||
164434325|NCT01249092|593960708|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
164434326|NCT01249092|593960708|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
164434327|NCT00151996|593960711|FG000|Overall Study|Adverse Event|3|||
164434328|NCT00151996|593960712|FG001|Overall Study|Adverse Event|2|||
164434329|NCT00151996|593960711|FG000|Overall Study|Withdrawal by Subject|1|||
164434330|NCT00151996|593960712|FG001|Overall Study|Withdrawal by Subject|1|||
164434331|NCT00151996|593960711|FG000|Overall Study|Protocol Violation|1|||
164434332|NCT00151996|593960712|FG001|Overall Study|Protocol Violation|2|||
164434333|NCT00151996|593960711|FG000|Overall Study|Sponsor's decision|0|||
164434334|NCT00151996|593960712|FG001|Overall Study|Sponsor's decision|2|||
164434335|NCT01546155|593960713|FG000|Overall Study|could not tolerate long scan duration|3|||
164434336|NCT01649791|593960716|FG000|Overall Study|Disease Progression|2|||
164434337|NCT01649791|593960716|FG000|Overall Study|Adverse Event|1|||
164434338|NCT02987543|593960717|FG000|Overall Study|Ongoing study at data cut off|49|||
164434339|NCT02987543|593960718|FG001|Overall Study|Ongoing study at data cut off|21|||
164434340|NCT02987543|593960719|FG002|Overall Study|Ongoing study at data cut off|19|||
164434341|NCT02987543|593960720|FG003|Overall Study|Ongoing study at data cut off|12|||
164434342|NCT02987543|593960717|FG000|Overall Study|Death|88|||
164293983|NCT05148234|593447873|FG002|Phase I|Company closed the trial.|0|||
164293984|NCT05148234|593447874|FG003|Phase I|Company closed the trial.|0|||
164293985|NCT05148234|593447875|FG004|Phase I|Company closed the trial.|0|||
164293986|NCT05148234|593447876|FG005|Phase I|Company closed the trial.|0|||
164293987|NCT05148234|593447877|FG006|Phase I|Company closed the trial.|0|||
164434343|NCT02987543|593960718|FG001|Overall Study|Death|54|||
164434344|NCT02987543|593960719|FG002|Overall Study|Death|67|||
164434345|NCT02987543|593960720|FG003|Overall Study|Death|28|||
164434346|NCT02987543|593960717|FG000|Overall Study|Lost to Follow-up|3|||
164434347|NCT02987543|593960718|FG001|Overall Study|Lost to Follow-up|0|||
164434348|NCT02987543|593960719|FG002|Overall Study|Lost to Follow-up|1|||
164434349|NCT02987543|593960720|FG003|Overall Study|Lost to Follow-up|0|||
164434350|NCT02987543|593960717|FG000|Overall Study|Screen failure|0|||
164434351|NCT02987543|593960718|FG001|Overall Study|Screen failure|0|||
164434352|NCT02987543|593960719|FG002|Overall Study|Screen failure|0|||
164434353|NCT02987543|593960720|FG003|Overall Study|Screen failure|1|||
164434354|NCT02987543|593960717|FG000|Overall Study|Withdrawal by Subject|21|||
164434355|NCT02987543|593960718|FG001|Overall Study|Withdrawal by Subject|7|||
164434356|NCT02987543|593960719|FG002|Overall Study|Withdrawal by Subject|7|||
164434357|NCT02987543|593960720|FG003|Overall Study|Withdrawal by Subject|6|||
164434358|NCT02987543|593960717|FG000|Overall Study|Study terminated by sponsor|1|||
164434359|NCT02987543|593960718|FG001|Overall Study|Study terminated by sponsor|0|||
164434360|NCT02987543|593960719|FG002|Overall Study|Study terminated by sponsor|0|||
164434361|NCT02987543|593960720|FG003|Overall Study|Study terminated by sponsor|0|||
164434362|NCT02987543|593960717|FG000|Overall Study|Investigator decision|0|||
164434363|NCT02987543|593960718|FG001|Overall Study|Investigator decision|1|||
164434364|NCT02987543|593960719|FG002|Overall Study|Investigator decision|0|||
164434365|NCT02987543|593960720|FG003|Overall Study|Investigator decision|0|||
164434366|NCT02987543|593960717|FG000|Overall Study|Disease progression|0|||
164434367|NCT02987543|593960718|FG001|Overall Study|Disease progression|0|||
164434368|NCT02987543|593960719|FG002|Overall Study|Disease progression|0|||
164434369|NCT02987543|593960720|FG003|Overall Study|Disease progression|1|||
164434370|NCT03646669|593960721|FG000|Overall Study|Withdrawal by Subject|5|||
164434371|NCT03646669|593960722|FG001|Overall Study|Withdrawal by Subject|0|||
164434372|NCT01227278|593960724|FG000|Overall Study|Withdrawal by Subject|4|||
164434373|NCT01227278|593960725|FG001|Overall Study|Withdrawal by Subject|4|||
164434374|NCT01227278|593960724|FG000|Overall Study|Death|0|||
164434375|NCT01227278|593960725|FG001|Overall Study|Death|2|||
164434376|NCT01227278|593960724|FG000|Overall Study|Other|1|||
164434377|NCT01227278|593960725|FG001|Overall Study|Other|2|||
164434378|NCT00420316|593960728|FG000|Overall Study|Withdrawal by Subject|0|||
164434379|NCT00420316|593960729|FG001|Overall Study|Withdrawal by Subject|1|||
164434380|NCT00420316|593960728|FG000|Overall Study|Lost to Follow-up|12|||
164434381|NCT00420316|593960729|FG001|Overall Study|Lost to Follow-up|8|||
164434382|NCT04033432|593960736|FG000|Overall Study|Progressive Disease|8|||
164434383|NCT04033432|593960736|FG000|Overall Study|Adverse Event|4|||
164434384|NCT04033432|593960736|FG000|Overall Study|Death|1|||
164434385|NCT04936035|593960741|FG000|6-Month Placebo-controlled DB Period|Adverse Event|0|||
164434386|NCT04936035|593960742|FG001|6-Month Placebo-controlled DB Period|Adverse Event|1|||
164434387|NCT04936035|593960743|FG002|6-Month Placebo-controlled DB Period|Adverse Event|0|||
164434388|NCT04936035|593960744|FG003|6-Month Placebo-controlled DB Period|Adverse Event|0|||
164434389|NCT04936035|593960745|FG004|6-Month Placebo-controlled DB Period|Adverse Event|0|||
164434390|NCT04936035|593960746|FG005|6-Month Placebo-controlled DB Period|Adverse Event|0|||
164434391|NCT04936035|593960747|FG006|6-Month Placebo-controlled DB Period|Adverse Event|0|||
164434392|NCT04936035|593960748|FG007|6-Month Placebo-controlled DB Period|Adverse Event|0|||
164434393|NCT04936035|593960749|FG008|6-Month Placebo-controlled DB Period|Adverse Event|0|||
164293988|NCT05148234|593447878|FG007|Phase I|Company closed the trial.|0|||
164293989|NCT01400698|593447880|FG000|Overall Study|Lost to Follow-up|2|||
164293990|NCT01400698|593447881|FG001|Overall Study|Lost to Follow-up|5|||
164293991|NCT01400698|593447882|FG002|Overall Study|Lost to Follow-up|2|||
164293992|NCT01400698|593447883|FG003|Overall Study|Lost to Follow-up|1|||
164293993|NCT01400698|593447884|FG004|Overall Study|Lost to Follow-up|4|||
164293994|NCT01400698|593447885|FG005|Overall Study|Lost to Follow-up|3|||
164293995|NCT01400698|593447880|FG000|Overall Study|Withdrawal by Subject|8|||
164293996|NCT01400698|593447881|FG001|Overall Study|Withdrawal by Subject|2|||
164293997|NCT01400698|593447882|FG002|Overall Study|Withdrawal by Subject|0|||
164293998|NCT01400698|593447883|FG003|Overall Study|Withdrawal by Subject|4|||
164346543|NCT01218204|593645057|FG001|Part B Run-in|Withdrawal by Subject|0|||
164346544|NCT01218204|593645058|FG002|Part B Run-in|Withdrawal by Subject|3|||
164346545|NCT01218204|593645059|FG003|Part B Run-in|Withdrawal by Subject|0|||
164346546|NCT01218204|593645056|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
164346547|NCT01218204|593645057|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
164346548|NCT01218204|593645058|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
164346549|NCT01218204|593645059|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
164346550|NCT01218204|593645056|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
164346551|NCT01218204|593645057|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
164346552|NCT01218204|593645058|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
164346553|NCT01218204|593645059|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
164346554|NCT01061177|593645064|FG000|Overall Study|Adverse Event|117|||
164346555|NCT01061177|593645064|FG000|Overall Study|Withdrawal by Subject|27|||
164346556|NCT01061177|593645064|FG000|Overall Study|Disease progression|17|||
164346557|NCT01061177|593645064|FG000|Overall Study|Protocol Violation|11|||
164346558|NCT01061177|593645064|FG000|Overall Study|Lost to Follow-up|9|||
164346559|NCT01061177|593645064|FG000|Overall Study|New cancer therapy|9|||
164346560|NCT01061177|593645064|FG000|Overall Study|Abnormal laboratory values|6|||
164346561|NCT01061177|593645064|FG000|Overall Study|Abnormal test procedure results|4|||
164346562|NCT01061177|593645064|FG000|Overall Study|Administratie problems|4|||
164346563|NCT01061177|593645064|FG000|Overall Study|Death|4|||
164346564|NCT03616600|593645065|FG000|Overall Study|Withdrawal by Subject|1|||
164346565|NCT03616600|593645066|FG001|Overall Study|Withdrawal by Subject|0|||
164346566|NCT03984994|593645067|FG000|Overall Study|Withdrawal by Subject|2|||
164346567|NCT03984994|593645068|FG001|Overall Study|Withdrawal by Subject|1|||
164346568|NCT03010176|593645070|FG000|Overall Study|Death|21|||
164346569|NCT03010176|593645071|FG001|Overall Study|Death|35|||
164346570|NCT03010176|593645072|FG002|Overall Study|Death|19|||
164346571|NCT03010176|593645073|FG003|Overall Study|Death|19|||
164434394|NCT04936035|593960750|FG009|6-Month Placebo-controlled DB Period|Adverse Event|0|||
164434395|NCT04936035|593960751|FG010|6-Month Placebo-controlled DB Period|Adverse Event|0|||
164434396|NCT04936035|593960752|FG011|6-Month Placebo-controlled DB Period|Adverse Event|0|||
164434397|NCT04936035|593960753|FG012|6-Month Placebo-controlled DB Period|Adverse Event|0|||
164587081|NCT03088605|594513736|FG000|Overall Study|Withdrawal by Subject|1|||
164587082|NCT03088605|594513737|FG001|Overall Study|Withdrawal by Subject|0|||
164692847|NCT01588548|594897098|FG003|Overall Study|Withdrawal by Subject|1|||
164692848|NCT01588548|594897099|FG004|Overall Study|Withdrawal by Subject|2|||
164692849|NCT01588548|594897100|FG005|Overall Study|Withdrawal by Subject|3|||
164293999|NCT01400698|593447884|FG004|Overall Study|Withdrawal by Subject|1|||
164587083|NCT02345161|594513738|FG000|Overall Study|Withdrawal by Subject|25|||
164587084|NCT02345161|594513739|FG001|Overall Study|Withdrawal by Subject|33|||
164587085|NCT02345161|594513738|FG000|Overall Study|Adverse Event|16|||
164587086|NCT02345161|594513739|FG001|Overall Study|Adverse Event|19|||
164587087|NCT02345161|594513738|FG000|Overall Study|Physician Decision|4|||
164587088|NCT02345161|594513739|FG001|Overall Study|Physician Decision|4|||
164587089|NCT02345161|594513738|FG000|Overall Study|Lost to Follow-up|0|||
164587090|NCT02345161|594513739|FG001|Overall Study|Lost to Follow-up|1|||
164587091|NCT02225223|594513741|FG000|Overall Study|Death|10|||
164587092|NCT02225223|594513742|FG001|Overall Study|Death|1|||
164587093|NCT02225223|594513741|FG000|Overall Study|Lost to Follow-up|5|||
164587094|NCT02225223|594513742|FG001|Overall Study|Lost to Follow-up|0|||
164587095|NCT02225223|594513741|FG000|Overall Study|Other|1|||
164587096|NCT02225223|594513742|FG001|Overall Study|Other|2|||
164587097|NCT02225223|594513741|FG000|Overall Study|Physician Decision|1|||
164587098|NCT02225223|594513742|FG001|Overall Study|Physician Decision|0|||
164587099|NCT02225223|594513741|FG000|Overall Study|Withdrawal by Subject|2|||
164587100|NCT02225223|594513742|FG001|Overall Study|Withdrawal by Subject|2|||
164587101|NCT03666143|594513743|FG000|Overall Study|Death|158|||
164294000|NCT01400698|593447885|FG005|Overall Study|Withdrawal by Subject|3|||
164587102|NCT03666143|594513743|FG000|Overall Study|Sponsor Decision|31|||
164346572|NCT03010176|593645074|FG004|Overall Study|Death|14|||
164346573|NCT03010176|593645075|FG005|Overall Study|Death|0|||
164346574|NCT03010176|593645070|FG000|Overall Study|Lost to Follow-up|0|||
164346575|NCT03010176|593645071|FG001|Overall Study|Lost to Follow-up|0|||
164346576|NCT03010176|593645072|FG002|Overall Study|Lost to Follow-up|0|||
164346577|NCT03010176|593645073|FG003|Overall Study|Lost to Follow-up|0|||
164346578|NCT03010176|593645074|FG004|Overall Study|Lost to Follow-up|1|||
164434398|NCT04936035|593960741|FG000|6-Month Placebo-controlled DB Period|Death|0|||
164434399|NCT04936035|593960742|FG001|6-Month Placebo-controlled DB Period|Death|0|||
164434400|NCT04936035|593960743|FG002|6-Month Placebo-controlled DB Period|Death|0|||
164434401|NCT04936035|593960744|FG003|6-Month Placebo-controlled DB Period|Death|1|||
164434402|NCT04936035|593960745|FG004|6-Month Placebo-controlled DB Period|Death|0|||
164434403|NCT04936035|593960746|FG005|6-Month Placebo-controlled DB Period|Death|0|||
164434404|NCT04936035|593960747|FG006|6-Month Placebo-controlled DB Period|Death|0|||
164434405|NCT04936035|593960748|FG007|6-Month Placebo-controlled DB Period|Death|0|||
164434406|NCT04936035|593960749|FG008|6-Month Placebo-controlled DB Period|Death|0|||
164434407|NCT04936035|593960750|FG009|6-Month Placebo-controlled DB Period|Death|0|||
164434408|NCT04936035|593960751|FG010|6-Month Placebo-controlled DB Period|Death|0|||
164434409|NCT04936035|593960752|FG011|6-Month Placebo-controlled DB Period|Death|0|||
164434410|NCT04936035|593960753|FG012|6-Month Placebo-controlled DB Period|Death|0|||
164434411|NCT04936035|593960741|FG000|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
164434412|NCT04936035|593960742|FG001|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
164434413|NCT04936035|593960743|FG002|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
164434414|NCT04936035|593960744|FG003|6-Month Placebo-controlled DB Period|Lost to Follow-up|2|||
164434415|NCT04936035|593960745|FG004|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
164434416|NCT04936035|593960746|FG005|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
164434417|NCT04936035|593960747|FG006|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
164434418|NCT04936035|593960748|FG007|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
164434419|NCT04936035|593960749|FG008|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
164434420|NCT04936035|593960750|FG009|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
164434421|NCT04936035|593960751|FG010|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
164434422|NCT04936035|593960752|FG011|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
164434423|NCT04936035|593960753|FG012|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
164434424|NCT04936035|593960741|FG000|6-Month Placebo-controlled DB Period|Physician Decision|0|||
164434425|NCT04936035|593960742|FG001|6-Month Placebo-controlled DB Period|Physician Decision|1|||
164434426|NCT04936035|593960743|FG002|6-Month Placebo-controlled DB Period|Physician Decision|0|||
164434427|NCT04936035|593960744|FG003|6-Month Placebo-controlled DB Period|Physician Decision|0|||
164434428|NCT04936035|593960745|FG004|6-Month Placebo-controlled DB Period|Physician Decision|0|||
164434429|NCT04936035|593960746|FG005|6-Month Placebo-controlled DB Period|Physician Decision|0|||
164434430|NCT04936035|593960747|FG006|6-Month Placebo-controlled DB Period|Physician Decision|0|||
164434431|NCT04936035|593960748|FG007|6-Month Placebo-controlled DB Period|Physician Decision|0|||
164434432|NCT04936035|593960749|FG008|6-Month Placebo-controlled DB Period|Physician Decision|0|||
164434433|NCT04936035|593960750|FG009|6-Month Placebo-controlled DB Period|Physician Decision|0|||
164434434|NCT04936035|593960751|FG010|6-Month Placebo-controlled DB Period|Physician Decision|0|||
164434435|NCT04936035|593960752|FG011|6-Month Placebo-controlled DB Period|Physician Decision|0|||
164434436|NCT04936035|593960753|FG012|6-Month Placebo-controlled DB Period|Physician Decision|0|||
164434437|NCT04936035|593960741|FG000|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
164434438|NCT04936035|593960742|FG001|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
164434439|NCT04936035|593960743|FG002|6-Month Placebo-controlled DB Period|Protocol Deviation|1|||
164434440|NCT04936035|593960744|FG003|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
164434441|NCT04936035|593960745|FG004|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
164434442|NCT04936035|593960746|FG005|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
164434443|NCT04936035|593960747|FG006|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
164434444|NCT04936035|593960748|FG007|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
164434445|NCT04936035|593960749|FG008|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
164434446|NCT04936035|593960750|FG009|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
164434447|NCT04936035|593960751|FG010|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
164587103|NCT03666143|594513743|FG000|Overall Study|Withdrawal by Subject|11|||
164587104|NCT03666143|594513743|FG000|Overall Study|Lost to Follow-up|5|||
164587105|NCT03666143|594513743|FG000|Overall Study|Physician Decision|1|||
164587106|NCT03666143|594513743|FG000|Overall Study|Rolled into extension study|9|||
164587107|NCT03666143|594513743|FG000|Overall Study|Progressive Disease|1|||
164587108|NCT02639182|594513749|FG000|Overall Study|Disease Progression|50|||
164587109|NCT02639182|594513750|FG001|Overall Study|Disease Progression|49|||
164587110|NCT02639182|594513749|FG000|Overall Study|Adverse Event|7|||
164587111|NCT02639182|594513750|FG001|Overall Study|Adverse Event|5|||
164587112|NCT02639182|594513749|FG000|Overall Study|Physician Decision|3|||
164587113|NCT02639182|594513750|FG001|Overall Study|Physician Decision|3|||
164587114|NCT02639182|594513749|FG000|Overall Study|Withdrew Consent|5|||
164587115|NCT02639182|594513750|FG001|Overall Study|Withdrew Consent|4|||
164587116|NCT02639182|594513749|FG000|Overall Study|Lost to Follow-up|0|||
164587117|NCT02639182|594513750|FG001|Overall Study|Lost to Follow-up|1|||
164587118|NCT02639182|594513749|FG000|Overall Study|Study Closure|1|||
164587119|NCT02639182|594513750|FG001|Overall Study|Study Closure|2|||
164587120|NCT02639182|594513749|FG000|Overall Study|Sponsor Ended Study|0|||
164587121|NCT02639182|594513750|FG001|Overall Study|Sponsor Ended Study|1|||
164294001|NCT01400698|593447880|FG000|Overall Study|Protocol Violation|0|||
164294002|NCT01400698|593447881|FG001|Overall Study|Protocol Violation|1|||
164294003|NCT01400698|593447882|FG002|Overall Study|Protocol Violation|0|||
164294004|NCT01400698|593447883|FG003|Overall Study|Protocol Violation|0|||
164294005|NCT01400698|593447884|FG004|Overall Study|Protocol Violation|1|||
164294006|NCT01400698|593447885|FG005|Overall Study|Protocol Violation|0|||
164294007|NCT01400698|593447880|FG000|Overall Study|Non-compliance|0|||
164294008|NCT01400698|593447881|FG001|Overall Study|Non-compliance|1|||
164294009|NCT01400698|593447882|FG002|Overall Study|Non-compliance|0|||
164294010|NCT01400698|593447883|FG003|Overall Study|Non-compliance|1|||
164294011|NCT01400698|593447884|FG004|Overall Study|Non-compliance|0|||
164294012|NCT01400698|593447885|FG005|Overall Study|Non-compliance|0|||
164294013|NCT01400698|593447880|FG000|Overall Study|Adverse Event|1|||
164294014|NCT01400698|593447881|FG001|Overall Study|Adverse Event|0|||
164294015|NCT01400698|593447882|FG002|Overall Study|Adverse Event|0|||
164294016|NCT01400698|593447883|FG003|Overall Study|Adverse Event|0|||
164294017|NCT01400698|593447884|FG004|Overall Study|Adverse Event|0|||
164294018|NCT01400698|593447885|FG005|Overall Study|Adverse Event|0|||
164294019|NCT01400698|593447880|FG000|Overall Study|Other|4|||
164294020|NCT01400698|593447881|FG001|Overall Study|Other|2|||
164294021|NCT01400698|593447882|FG002|Overall Study|Other|0|||
164294022|NCT01400698|593447883|FG003|Overall Study|Other|2|||
164294023|NCT01400698|593447884|FG004|Overall Study|Other|1|||
164294024|NCT01400698|593447885|FG005|Overall Study|Other|0|||
164294025|NCT04750642|593447886|FG000|Overall Study|Adverse Event|1|||
164294026|NCT04750642|593447887|FG001|Overall Study|Adverse Event|0|||
164294027|NCT04750642|593447886|FG000|Overall Study|Withdrawal by Subject|0|||
164294028|NCT04750642|593447887|FG001|Overall Study|Withdrawal by Subject|1|||
164294029|NCT04750642|593447886|FG000|Overall Study|Protocol Violation|0|||
164294030|NCT04750642|593447887|FG001|Overall Study|Protocol Violation|1|||
164294031|NCT01650194|593447888|FG000|Overall Study|Progressive Disease (PD)|35|||
164294032|NCT01650194|593447888|FG000|Overall Study|Withdrawal by Subject|2|||
164294033|NCT01650194|593447888|FG000|Overall Study|Miscellaneous|10|||
164294034|NCT01602224|593449987|FG000|Overall Study|Adverse Event|0|||
164294035|NCT01602224|593449988|FG001|Overall Study|Adverse Event|1|||
164294036|NCT01602224|593449989|FG002|Overall Study|Adverse Event|0|||
164294037|NCT01602224|593449987|FG000|Overall Study|Investigator Decison|1|||
164294038|NCT01602224|593449988|FG001|Overall Study|Investigator Decison|0|||
164294039|NCT01602224|593449989|FG002|Overall Study|Investigator Decison|0|||
164294040|NCT01602224|593449987|FG000|Overall Study|Lost to Follow-up|0|||
164294041|NCT01602224|593449988|FG001|Overall Study|Lost to Follow-up|0|||
164294042|NCT01602224|593449989|FG002|Overall Study|Lost to Follow-up|1|||
164294043|NCT01602224|593449987|FG000|Overall Study|Protocol Violation|0|||
164294044|NCT01602224|593449988|FG001|Overall Study|Protocol Violation|1|||
164294045|NCT01602224|593449989|FG002|Overall Study|Protocol Violation|0|||
164294046|NCT01602224|593449987|FG000|Overall Study|Sponsor Decision|2|||
164294047|NCT01602224|593449988|FG001|Overall Study|Sponsor Decision|3|||
164294048|NCT01602224|593449989|FG002|Overall Study|Sponsor Decision|2|||
164294049|NCT01602224|593449987|FG000|Overall Study|Withdrawal by Subject|5|||
164294050|NCT01602224|593449988|FG001|Overall Study|Withdrawal by Subject|3|||
164294051|NCT01602224|593449989|FG002|Overall Study|Withdrawal by Subject|3|||
164294052|NCT01352117|593449990|FG000|Overall Study|Death|15|||
164294053|NCT01352117|593449991|FG001|Overall Study|Death|16|||
164294054|NCT01352117|593449990|FG000|Overall Study|Withdrawal by Subject|1|||
164346579|NCT03010176|593645075|FG005|Overall Study|Lost to Follow-up|0|||
164294055|NCT01352117|593449991|FG001|Overall Study|Withdrawal by Subject|0|||
164294056|NCT01352117|593449990|FG000|Overall Study|Lost to Follow-up|2|||
164294057|NCT01352117|593449991|FG001|Overall Study|Lost to Follow-up|7|||
164294058|NCT01352117|593449990|FG000|Overall Study|Non-adherent to study requirements|1|||
164294059|NCT01352117|593449991|FG001|Overall Study|Non-adherent to study requirements|1|||
164294060|NCT01352117|593449990|FG000|Overall Study|Did not initiate study treatment|1|||
164294061|NCT01352117|593449991|FG001|Overall Study|Did not initiate study treatment|0|||
164346580|NCT03010176|593645070|FG000|Overall Study|Physician Decision|0|||
164346581|NCT03010176|593645071|FG001|Overall Study|Physician Decision|4|||
164294062|NCT01352117|593449990|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
164294063|NCT01352117|593449991|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
164294064|NCT00644423|593449992|FG000|Overall Study|Lost to Follow-up|1|||
164294065|NCT00644423|593449993|FG001|Overall Study|Lost to Follow-up|1|||
164294066|NCT03525444|593449994|FG000|Overall Study|Adverse Event|0|||
164692850|NCT01588548|594897095|FG000|Overall Study|Adverse Event|0|||
164692851|NCT01588548|594897096|FG001|Overall Study|Adverse Event|0|||
164692852|NCT01588548|594897097|FG002|Overall Study|Adverse Event|1|||
164692853|NCT01588548|594897098|FG003|Overall Study|Adverse Event|2|||
164692854|NCT01588548|594897099|FG004|Overall Study|Adverse Event|1|||
164692855|NCT01588548|594897100|FG005|Overall Study|Adverse Event|0|||
164692856|NCT01588548|594897095|FG000|Overall Study|Condition Under Investigation Worsened|3|||
164692857|NCT01588548|594897096|FG001|Overall Study|Condition Under Investigation Worsened|6|||
164692858|NCT01588548|594897097|FG002|Overall Study|Condition Under Investigation Worsened|4|||
164692859|NCT01588548|594897098|FG003|Overall Study|Condition Under Investigation Worsened|4|||
164692860|NCT01588548|594897099|FG004|Overall Study|Condition Under Investigation Worsened|3|||
164692861|NCT01588548|594897100|FG005|Overall Study|Condition Under Investigation Worsened|3|||
164692862|NCT03257254|594897101|FG000|Overall Study|Withdrawal by Subject|7|||
164692863|NCT03257254|594897101|FG000|Overall Study|Lost to Follow-up|9|||
164692864|NCT03257254|594897101|FG000|Overall Study|Study discontinued by sponsor|5|||
164692865|NCT04149535|594897105|FG000|Overall Study|Death|11|||
164692866|NCT04149535|594897106|FG001|Overall Study|Death|7|||
164692867|NCT04149535|594897105|FG000|Overall Study|Physician Decision|10|||
164692868|NCT04149535|594897106|FG001|Overall Study|Physician Decision|4|||
164692869|NCT04149535|594897105|FG000|Overall Study|Withdrawal by Subject|6|||
164692870|NCT04149535|594897106|FG001|Overall Study|Withdrawal by Subject|7|||
164692871|NCT04149535|594897105|FG000|Overall Study|Not described|2|||
164692872|NCT04149535|594897106|FG001|Overall Study|Not described|0|||
164692873|NCT00109837|594899274|FG000|Overall Study|Adverse Event|2|||
164692874|NCT00109837|594899274|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
164692875|NCT00109837|594899274|FG000|Overall Study|Death|1|||
164692876|NCT00109837|594899274|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
164692877|NCT00109837|594899274|FG000|Overall Study|Not treated|1|||
164692878|NCT00109837|594899274|FG000|Overall Study|Ineligible|1|||
164692879|NCT01989676|594899275|FG000|Overall Study|Death|52|||
164692880|NCT01989676|594899276|FG001|Overall Study|Death|60|||
164692881|NCT01989676|594899275|FG000|Overall Study|Protocol Violation|2|||
164692882|NCT01989676|594899276|FG001|Overall Study|Protocol Violation|1|||
164692883|NCT01989676|594899275|FG000|Overall Study|Lost to Follow-up|8|||
164692884|NCT01989676|594899276|FG001|Overall Study|Lost to Follow-up|18|||
164692885|NCT01989676|594899275|FG000|Overall Study|No longer willing to participate in study|26|||
164692886|NCT01989676|594899276|FG001|Overall Study|No longer willing to participate in study|26|||
164692887|NCT01989676|594899275|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
164692888|NCT01989676|594899276|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
164692889|NCT01989676|594899275|FG000|Overall Study|Other|4|||
164692890|NCT01989676|594899276|FG001|Overall Study|Other|3|||
164692891|NCT01619579|594899277|FG000|Overall Study|Withdrawal by Subject|0|||
164692892|NCT01619579|594899278|FG001|Overall Study|Withdrawal by Subject|3|||
164692893|NCT02688387|594899280|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164294067|NCT03525444|593449995|FG001|Overall Study|Adverse Event|1|||
164294068|NCT03525444|593449994|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
164294069|NCT03525444|593449995|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
164294070|NCT03525444|593449994|FG000|Overall Study|Other|0|||
164294071|NCT03525444|593449995|FG001|Overall Study|Other|1|||
164294072|NCT00262860|593449997|FG000|Overall Study|Adverse Event|2|||
164294073|NCT02741128|593449998|FG000|Overall Study|Protocol Violation|4|||
164294074|NCT02741128|593449999|FG001|Overall Study|Protocol Violation|1|||
164294075|NCT02741128|593449998|FG000|Overall Study|Withdrawal by Subject|2|||
164294076|NCT02741128|593449999|FG001|Overall Study|Withdrawal by Subject|0|||
164294077|NCT02741128|593449998|FG000|Overall Study|Lost to Follow-up|1|||
164346582|NCT03010176|593645072|FG002|Overall Study|Physician Decision|0|||
164692894|NCT02688387|594899281|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164692895|NCT02688387|594899282|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
164692896|NCT02688387|594899283|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164692897|NCT02688387|594899284|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164692898|NCT02688387|594899285|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164692899|NCT02688387|594899286|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164294078|NCT02741128|593449999|FG001|Overall Study|Lost to Follow-up|0|||
164692900|NCT02688387|594899287|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164294079|NCT01419769|593450000|FG000|Overall Study|Did not receive the AXIOS stent|3|||
164346583|NCT03010176|593645073|FG003|Overall Study|Physician Decision|1|||
164294080|NCT01419769|593450000|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
164294081|NCT00878501|593450001|FG000|Overall Study|Adverse Event|11|||
164294082|NCT00878501|593450002|FG001|Overall Study|Adverse Event|3|||
164294083|NCT00878501|593450003|FG002|Overall Study|Adverse Event|3|||
164294084|NCT00878501|593450001|FG000|Overall Study|Lack of Efficacy|2|||
164294085|NCT00878501|593450002|FG001|Overall Study|Lack of Efficacy|1|||
164294086|NCT00878501|593450003|FG002|Overall Study|Lack of Efficacy|0|||
164294087|NCT00878501|593450001|FG000|Overall Study|Withdrawal by Subject|2|||
164294088|NCT00878501|593450002|FG001|Overall Study|Withdrawal by Subject|1|||
164346584|NCT03010176|593645074|FG004|Overall Study|Physician Decision|0|||
164346585|NCT03010176|593645075|FG005|Overall Study|Physician Decision|0|||
164346586|NCT03010176|593645070|FG000|Overall Study|Sponsor Decision|0|||
164346587|NCT03010176|593645071|FG001|Overall Study|Sponsor Decision|4|||
164346588|NCT03010176|593645072|FG002|Overall Study|Sponsor Decision|4|||
164346589|NCT03010176|593645073|FG003|Overall Study|Sponsor Decision|1|||
164346590|NCT03010176|593645074|FG004|Overall Study|Sponsor Decision|6|||
164346591|NCT03010176|593645075|FG005|Overall Study|Sponsor Decision|0|||
164346592|NCT03010176|593645070|FG000|Overall Study|Withdrawal by Subject|11|||
164346593|NCT03010176|593645071|FG001|Overall Study|Withdrawal by Subject|9|||
164346594|NCT03010176|593645072|FG002|Overall Study|Withdrawal by Subject|3|||
164346595|NCT03010176|593645073|FG003|Overall Study|Withdrawal by Subject|0|||
164346596|NCT03010176|593645074|FG004|Overall Study|Withdrawal by Subject|4|||
164346597|NCT03010176|593645075|FG005|Overall Study|Withdrawal by Subject|0|||
164346598|NCT04220866|593645076|FG000|Overall Study|Death|4|||
164346599|NCT04220866|593645077|FG001|Overall Study|Death|5|||
164346600|NCT04220866|593645076|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
164346601|NCT04220866|593645077|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
164346602|NCT04220866|593645076|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
164346603|NCT04220866|593645077|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
164346604|NCT04220866|593645076|FG000|Overall Study|Withdrawal by Subject|0|||
164346605|NCT04220866|593645077|FG001|Overall Study|Withdrawal by Subject|1|||
164346606|NCT00709761|593645082|FG000|Overall Study|Withdrawal by Subject|8|||
164346607|NCT00709761|593645082|FG000|Overall Study|study closed/terminated|17|||
164346608|NCT00709761|593645082|FG000|Overall Study|Lost to Follow-up|2|||
164346609|NCT03478930|593645086|FG000|Overall Study|Adverse Event|0|||
164346610|NCT03478930|593645087|FG001|Overall Study|Adverse Event|1|||
164346611|NCT03478930|593645086|FG000|Overall Study|Lack of Efficacy|3|||
164346612|NCT03478930|593645087|FG001|Overall Study|Lack of Efficacy|3|||
164346613|NCT03478930|593645086|FG000|Overall Study|Withdrawal by Subject|6|||
164346614|NCT03478930|593645087|FG001|Overall Study|Withdrawal by Subject|5|||
164346615|NCT00555971|593645090|FG000|Overall Study|Adverse Event|1|||
164346616|NCT00555971|593645091|FG001|Overall Study|Adverse Event|1|||
164346617|NCT02573311|593645092|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
164346618|NCT02573311|593645093|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
164346619|NCT02573311|593645092|FG000|Disposition for Part 2|Physician Decision|25|||
164346620|NCT02573311|593645093|FG001|Disposition for Part 2|Physician Decision|7|||
164346621|NCT02573311|593645092|FG000|Disposition for Part 2|Adverse Event|36|||
164346622|NCT02573311|593645093|FG001|Disposition for Part 2|Adverse Event|5|||
164346623|NCT02573311|593645092|FG000|Disposition for Part 2|Lost to Follow-up|76|||
164346624|NCT02573311|593645093|FG001|Disposition for Part 2|Lost to Follow-up|7|||
164346625|NCT02573311|593645092|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
164346626|NCT02573311|593645093|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
164346627|NCT02573311|593645092|FG000|Disposition for Part 2|Investigator decision|0|||
164346628|NCT02573311|593645093|FG001|Disposition for Part 2|Investigator decision|1|||
164346629|NCT02573311|593645092|FG000|Disposition for Part 2|Other than specified above|13|||
164346630|NCT02573311|593645093|FG001|Disposition for Part 2|Other than specified above|3|||
164346631|NCT01328431|593645094|FG000|Baseline|Protocol Violation|0|||
164346632|NCT01328431|593645095|FG001|Baseline|Protocol Violation|2|||
164346633|NCT01328431|593645094|FG000|1 Month (1M)|Lost to Follow-up|55|||
164346634|NCT01328431|593645095|FG001|1 Month (1M)|Lost to Follow-up|58|||
164346635|NCT01328431|593645094|FG000|3 Month (3M)|Death|2|||
164346636|NCT01328431|593645095|FG001|3 Month (3M)|Death|2|||
164346637|NCT01328431|593645094|FG000|3 Month (3M)|Lost to Follow-up|75|||
164346638|NCT01328431|593645095|FG001|3 Month (3M)|Lost to Follow-up|70|||
164346639|NCT01328431|593645094|FG000|12 Month (12M)|Death|2|||
164346640|NCT01328431|593645095|FG001|12 Month (12M)|Death|6|||
164346641|NCT01328431|593645094|FG000|12 Month (12M)|Lost to Follow-up|82|||
164346642|NCT01328431|593645095|FG001|12 Month (12M)|Lost to Follow-up|91|||
164346643|NCT01427972|593645098|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
164346644|NCT01427972|593645099|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
164346645|NCT01427972|593645100|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
164346646|NCT01427972|593645101|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
164346647|NCT01427972|593645102|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
164346648|NCT01427972|593645103|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
164346649|NCT01427972|593645104|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
164346650|NCT01427972|593645105|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
164346651|NCT01427972|593645106|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
164346652|NCT01427972|593645107|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
164346653|NCT01427972|593645108|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
164346654|NCT01427972|593645109|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
164346655|NCT01427972|593645098|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
164434448|NCT04936035|593960752|FG011|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
164434449|NCT04936035|593960753|FG012|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
164434450|NCT04936035|593960741|FG000|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
164434451|NCT04936035|593960742|FG001|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
164434452|NCT04936035|593960743|FG002|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|1|||
164434453|NCT04936035|593960744|FG003|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|2|||
164434454|NCT04936035|593960745|FG004|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|3|||
164346656|NCT01427972|593645099|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
164346657|NCT01427972|593645100|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
164434455|NCT04936035|593960746|FG005|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
164434456|NCT04936035|593960747|FG006|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
164434457|NCT04936035|593960748|FG007|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
164434458|NCT04936035|593960749|FG008|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
164434459|NCT04936035|593960750|FG009|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
164434460|NCT04936035|593960751|FG010|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
164434461|NCT04936035|593960752|FG011|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
164434462|NCT04936035|593960753|FG012|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
164434463|NCT04936035|593960741|FG000|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
164434464|NCT04936035|593960742|FG001|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
164434465|NCT04936035|593960743|FG002|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
164434466|NCT04936035|593960744|FG003|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
164434467|NCT04936035|593960745|FG004|6-Month Placebo-controlled DB Period|Reason Unknown|1|||
164434468|NCT04936035|593960746|FG005|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
164434469|NCT04936035|593960747|FG006|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
164434470|NCT04936035|593960748|FG007|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
164434471|NCT04936035|593960749|FG008|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
164434472|NCT04936035|593960750|FG009|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
164434473|NCT04936035|593960751|FG010|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
164434474|NCT04936035|593960752|FG011|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
164434475|NCT04936035|593960753|FG012|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
164434476|NCT04936035|593960741|FG000|6-Month Placebo-controlled DB Period|Withdrawal by Subject|1|||
164434477|NCT04936035|593960742|FG001|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
164434478|NCT04936035|593960743|FG002|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
164434479|NCT04936035|593960744|FG003|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
164434480|NCT04936035|593960745|FG004|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
164434481|NCT04936035|593960746|FG005|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
164434482|NCT04936035|593960747|FG006|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
164434483|NCT04936035|593960748|FG007|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
164434484|NCT04936035|593960749|FG008|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
164434485|NCT04936035|593960750|FG009|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
164434486|NCT04936035|593960751|FG010|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
164434487|NCT04936035|593960752|FG011|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
164434488|NCT04936035|593960753|FG012|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
164434489|NCT04936035|593960741|FG000|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
164434490|NCT04936035|593960742|FG001|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
164434491|NCT04936035|593960743|FG002|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
164434492|NCT04936035|593960744|FG003|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
164434493|NCT04936035|593960745|FG004|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
164434494|NCT04936035|593960746|FG005|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
164434495|NCT04936035|593960747|FG006|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|1|||
164434496|NCT04936035|593960748|FG007|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
164434497|NCT04936035|593960749|FG008|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
164434498|NCT04936035|593960750|FG009|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
164434499|NCT04936035|593960751|FG010|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|7|||
164434500|NCT04936035|593960752|FG011|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|5|||
164434501|NCT04936035|593960753|FG012|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|3|||
164434502|NCT04936035|593960741|FG000|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
164434503|NCT04936035|593960742|FG001|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
164434504|NCT04936035|593960743|FG002|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
164434505|NCT04936035|593960744|FG003|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
164434506|NCT04936035|593960745|FG004|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
164434507|NCT04936035|593960746|FG005|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
164434508|NCT04936035|593960747|FG006|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
164434509|NCT04936035|593960748|FG007|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
164434510|NCT04936035|593960749|FG008|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
164434511|NCT04936035|593960750|FG009|Post-6-Month DB Period (30months)|Lost to Follow-up|3|||
164434512|NCT04936035|593960751|FG010|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
164434513|NCT04936035|593960752|FG011|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
164434514|NCT04936035|593960753|FG012|Post-6-Month DB Period (30months)|Lost to Follow-up|4|||
164294089|NCT00878501|593450003|FG002|Overall Study|Withdrawal by Subject|2|||
164294090|NCT00878501|593450001|FG000|Overall Study|Protocol Violation|0|||
164294091|NCT00878501|593450002|FG001|Overall Study|Protocol Violation|0|||
164346658|NCT01427972|593645101|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
164346659|NCT01427972|593645102|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
164346660|NCT01427972|593645103|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
164346661|NCT01427972|593645104|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
164346662|NCT01427972|593645105|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
164346663|NCT01427972|593645106|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
164346664|NCT01427972|593645107|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
164346665|NCT01427972|593645108|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
164346666|NCT01427972|593645109|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
164346667|NCT01427972|593645098|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
164346668|NCT01427972|593645099|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
164346669|NCT01427972|593645100|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
164346670|NCT01427972|593645101|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
164346671|NCT01427972|593645102|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
164346672|NCT01427972|593645103|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
164346673|NCT01427972|593645104|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
164346674|NCT01427972|593645105|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
164346675|NCT01427972|593645106|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
164346676|NCT01427972|593645107|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
164346677|NCT01427972|593645108|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
164346678|NCT01427972|593645109|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
164346679|NCT02094677|593645110|FG000|Overall Study|Screening|3|||
164346680|NCT02094677|593645111|FG001|Overall Study|Screening|1|||
164346681|NCT04967443|593645117|FG000|Open Label Treatment|Death|1|||
164346682|NCT04967443|593645118|FG001|Open Label Treatment|Death|0|||
164346683|NCT04967443|593645119|FG002|Open Label Treatment|Death|0|||
164346684|NCT04967443|593645120|FG003|Open Label Treatment|Death|0|||
164346685|NCT04967443|593645121|FG004|Open Label Treatment|Death|0|||
164346686|NCT04967443|593645122|FG005|Open Label Treatment|Death|0|||
164346687|NCT04967443|593645123|FG006|Open Label Treatment|Death|0|||
164346688|NCT04967443|593645124|FG007|Open Label Treatment|Death|0|||
164346689|NCT04967443|593645117|FG000|Open Label Treatment|Lost to Follow-up|0|||
164346690|NCT04967443|593645118|FG001|Open Label Treatment|Lost to Follow-up|0|||
164346691|NCT04967443|593645119|FG002|Open Label Treatment|Lost to Follow-up|1|||
164346692|NCT04967443|593645120|FG003|Open Label Treatment|Lost to Follow-up|0|||
164346693|NCT04967443|593645121|FG004|Open Label Treatment|Lost to Follow-up|0|||
164346694|NCT04967443|593645122|FG005|Open Label Treatment|Lost to Follow-up|0|||
164346695|NCT04967443|593645123|FG006|Open Label Treatment|Lost to Follow-up|0|||
164346696|NCT04967443|593645124|FG007|Open Label Treatment|Lost to Follow-up|0|||
164346697|NCT04967443|593645117|FG000|Open Label Treatment|Withdrawal by Subject|0|||
164346698|NCT04967443|593645118|FG001|Open Label Treatment|Withdrawal by Subject|1|||
164346699|NCT04967443|593645119|FG002|Open Label Treatment|Withdrawal by Subject|0|||
164346700|NCT04967443|593645120|FG003|Open Label Treatment|Withdrawal by Subject|1|||
164346701|NCT04967443|593645121|FG004|Open Label Treatment|Withdrawal by Subject|0|||
164346702|NCT04967443|593645122|FG005|Open Label Treatment|Withdrawal by Subject|1|||
164346703|NCT04967443|593645123|FG006|Open Label Treatment|Withdrawal by Subject|2|||
164346704|NCT04967443|593645124|FG007|Open Label Treatment|Withdrawal by Subject|3|||
164346705|NCT04967443|593645117|FG000|Follow-Up|Death|1|||
164346706|NCT04967443|593645118|FG001|Follow-Up|Death|0|||
164346707|NCT04967443|593645119|FG002|Follow-Up|Death|0|||
164346708|NCT04967443|593645120|FG003|Follow-Up|Death|0|||
164346709|NCT04967443|593645121|FG004|Follow-Up|Death|0|||
164346710|NCT04967443|593645122|FG005|Follow-Up|Death|0|||
164346711|NCT04967443|593645123|FG006|Follow-Up|Death|0|||
164346712|NCT04967443|593645124|FG007|Follow-Up|Death|0|||
164346713|NCT04967443|593645117|FG000|Follow-Up|Lost to Follow-up|0|||
164346714|NCT04967443|593645118|FG001|Follow-Up|Lost to Follow-up|0|||
164346715|NCT04967443|593645119|FG002|Follow-Up|Lost to Follow-up|1|||
164346716|NCT04967443|593645120|FG003|Follow-Up|Lost to Follow-up|1|||
164346717|NCT04967443|593645121|FG004|Follow-Up|Lost to Follow-up|0|||
164346718|NCT04967443|593645122|FG005|Follow-Up|Lost to Follow-up|0|||
164346719|NCT04967443|593645123|FG006|Follow-Up|Lost to Follow-up|0|||
164434515|NCT04936035|593960741|FG000|Post-6-Month DB Period (30months)|Physician Decision|0|||
164434516|NCT04936035|593960742|FG001|Post-6-Month DB Period (30months)|Physician Decision|0|||
164346720|NCT04967443|593645124|FG007|Follow-Up|Lost to Follow-up|0|||
164346721|NCT04967443|593645117|FG000|Follow-Up|Withdrawal by Subject|0|||
164346722|NCT04967443|593645118|FG001|Follow-Up|Withdrawal by Subject|1|||
164346723|NCT04967443|593645119|FG002|Follow-Up|Withdrawal by Subject|0|||
164346724|NCT04967443|593645120|FG003|Follow-Up|Withdrawal by Subject|1|||
164346725|NCT04967443|593645121|FG004|Follow-Up|Withdrawal by Subject|0|||
164346726|NCT04967443|593645122|FG005|Follow-Up|Withdrawal by Subject|1|||
164346727|NCT04967443|593645123|FG006|Follow-Up|Withdrawal by Subject|2|||
164346728|NCT04967443|593645124|FG007|Follow-Up|Withdrawal by Subject|3|||
164346729|NCT04502693|593645125|FG000|Overall Study|Adverse Event|7|||
164346730|NCT04502693|593645126|FG001|Overall Study|Adverse Event|6|||
164346731|NCT04502693|593645127|FG002|Overall Study|Adverse Event|11|||
164434517|NCT04936035|593960743|FG002|Post-6-Month DB Period (30months)|Physician Decision|0|||
164434518|NCT04936035|593960744|FG003|Post-6-Month DB Period (30months)|Physician Decision|0|||
164434519|NCT04936035|593960745|FG004|Post-6-Month DB Period (30months)|Physician Decision|0|||
164434520|NCT04936035|593960746|FG005|Post-6-Month DB Period (30months)|Physician Decision|0|||
164434521|NCT04936035|593960747|FG006|Post-6-Month DB Period (30months)|Physician Decision|0|||
164434522|NCT04936035|593960748|FG007|Post-6-Month DB Period (30months)|Physician Decision|0|||
164434523|NCT04936035|593960749|FG008|Post-6-Month DB Period (30months)|Physician Decision|0|||
164434524|NCT04936035|593960750|FG009|Post-6-Month DB Period (30months)|Physician Decision|2|||
164434525|NCT04936035|593960751|FG010|Post-6-Month DB Period (30months)|Physician Decision|0|||
164434526|NCT04936035|593960752|FG011|Post-6-Month DB Period (30months)|Physician Decision|1|||
164434527|NCT04936035|593960753|FG012|Post-6-Month DB Period (30months)|Physician Decision|0|||
164434528|NCT04936035|593960741|FG000|Post-6-Month DB Period (30months)|Adverse Event|0|||
164434529|NCT04936035|593960742|FG001|Post-6-Month DB Period (30months)|Adverse Event|0|||
164434530|NCT04936035|593960743|FG002|Post-6-Month DB Period (30months)|Adverse Event|0|||
164434531|NCT04936035|593960744|FG003|Post-6-Month DB Period (30months)|Adverse Event|0|||
164434532|NCT04936035|593960745|FG004|Post-6-Month DB Period (30months)|Adverse Event|0|||
164434533|NCT04936035|593960746|FG005|Post-6-Month DB Period (30months)|Adverse Event|1|||
164434534|NCT04936035|593960747|FG006|Post-6-Month DB Period (30months)|Adverse Event|0|||
164434535|NCT04936035|593960748|FG007|Post-6-Month DB Period (30months)|Adverse Event|1|||
164434536|NCT04936035|593960749|FG008|Post-6-Month DB Period (30months)|Adverse Event|0|||
164434537|NCT04936035|593960750|FG009|Post-6-Month DB Period (30months)|Adverse Event|0|||
164434538|NCT04936035|593960751|FG010|Post-6-Month DB Period (30months)|Adverse Event|0|||
164434539|NCT04936035|593960752|FG011|Post-6-Month DB Period (30months)|Adverse Event|0|||
164434540|NCT04936035|593960753|FG012|Post-6-Month DB Period (30months)|Adverse Event|0|||
164434541|NCT04936035|593960741|FG000|Post-6-Month DB Period (30months)|Death|0|||
164434542|NCT04936035|593960742|FG001|Post-6-Month DB Period (30months)|Death|0|||
164434543|NCT04936035|593960743|FG002|Post-6-Month DB Period (30months)|Death|0|||
164434544|NCT04936035|593960744|FG003|Post-6-Month DB Period (30months)|Death|0|||
164434545|NCT04936035|593960745|FG004|Post-6-Month DB Period (30months)|Death|0|||
164434546|NCT04936035|593960746|FG005|Post-6-Month DB Period (30months)|Death|0|||
164434547|NCT04936035|593960747|FG006|Post-6-Month DB Period (30months)|Death|0|||
164434548|NCT04936035|593960748|FG007|Post-6-Month DB Period (30months)|Death|0|||
164434549|NCT04936035|593960749|FG008|Post-6-Month DB Period (30months)|Death|0|||
164587122|NCT02639182|594513749|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
164587123|NCT02639182|594513750|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
164587124|NCT02546856|594513751|FG000|4 Months Evaluation|Death|2|||
164587125|NCT02546856|594513752|FG001|4 Months Evaluation|Death|3|||
164434550|NCT04936035|593960750|FG009|Post-6-Month DB Period (30months)|Death|1|||
164434551|NCT04936035|593960751|FG010|Post-6-Month DB Period (30months)|Death|0|||
164294092|NCT00878501|593450003|FG002|Overall Study|Protocol Violation|1|||
164294093|NCT00878501|593450001|FG000|Overall Study|Incorrect enrolment|1|||
164434552|NCT04936035|593960752|FG011|Post-6-Month DB Period (30months)|Death|0|||
164587126|NCT02546856|594513751|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
164587127|NCT02546856|594513752|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
164587128|NCT02546856|594513751|FG000|4 Months Evaluation|Lost to Follow-up|3|||
164587129|NCT02546856|594513752|FG001|4 Months Evaluation|Lost to Follow-up|3|||
164587130|NCT02546856|594513751|FG000|4 Months Evaluation|Physician Decision|3|||
164587131|NCT02546856|594513752|FG001|4 Months Evaluation|Physician Decision|0|||
164587132|NCT02546856|594513751|FG000|4 Months Evaluation|Working or living abroad|5|||
164587133|NCT02546856|594513752|FG001|4 Months Evaluation|Working or living abroad|1|||
164587134|NCT02546856|594513751|FG000|4 Months Evaluation|reasons not due to titration|4|||
164587135|NCT02546856|594513752|FG001|4 Months Evaluation|reasons not due to titration|1|||
164587136|NCT02546856|594513751|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
164587137|NCT02546856|594513752|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
164587138|NCT02546856|594513751|FG000|6 Months Evaluation|Death|1|||
164587139|NCT02546856|594513752|FG001|6 Months Evaluation|Death|1|||
164587140|NCT02546856|594513751|FG000|6 Months Evaluation|Lost to Follow-up|1|||
164587141|NCT02546856|594513752|FG001|6 Months Evaluation|Lost to Follow-up|1|||
164587142|NCT02546856|594513751|FG000|6 Months Evaluation|Working or living abroad|6|||
164587143|NCT02546856|594513752|FG001|6 Months Evaluation|Working or living abroad|4|||
164587144|NCT02546856|594513751|FG000|6 Months Evaluation|reasons not due to titration|0|||
164587145|NCT02546856|594513752|FG001|6 Months Evaluation|reasons not due to titration|1|||
164587146|NCT00130208|594513755|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
164587147|NCT00130208|594513756|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
164587148|NCT00130208|594513755|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
164587149|NCT00130208|594513756|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
164587150|NCT00130208|594513755|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
164587151|NCT00130208|594513756|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
164587152|NCT00130208|594513755|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
164587153|NCT00130208|594513756|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
164587154|NCT00130208|594513755|FG000|Maintenance Period (26 Weeks)|Other|1|||
164587155|NCT00130208|594513756|FG001|Maintenance Period (26 Weeks)|Other|1|||
164587156|NCT00130208|594513755|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
164587157|NCT00130208|594513756|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
164587158|NCT00130208|594513755|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
164587159|NCT00130208|594513756|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
164587160|NCT00130208|594513755|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
164587161|NCT00130208|594513756|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
164587162|NCT00130208|594513755|FG000|Washout Period (8 Weeks)|Other|1|||
164587163|NCT00130208|594513756|FG001|Washout Period (8 Weeks)|Other|1|||
164587164|NCT04655586|594513757|FG000|Overall Study|Physician Decision|1|||
164587165|NCT04655586|594513758|FG001|Overall Study|Physician Decision|3|||
164587166|NCT04655586|594513759|FG002|Overall Study|Physician Decision|4|||
164587167|NCT04655586|594513757|FG000|Overall Study|Withdrawal by Subject|1|||
164587168|NCT04655586|594513758|FG001|Overall Study|Withdrawal by Subject|3|||
164587169|NCT04655586|594513759|FG002|Overall Study|Withdrawal by Subject|1|||
164587170|NCT03268746|594513760|FG000|Overall Study|Withdrawal by Subject|1|||
164587171|NCT00986258|594513761|FG000|Observation Period|Not eligible to be dosed|11|||
164587172|NCT00986258|594513761|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
164587173|NCT00986258|594513761|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
164587174|NCT00986258|594513761|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
164587175|NCT00986258|594513761|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
164587176|NCT00986258|594513761|FG000|Titration and Optimal Dose Period|Other|1|||
164587177|NCT00986258|594513761|FG000|Maintenance Period|Adverse Event|5|||
164587178|NCT00986258|594513761|FG000|Maintenance Period|Lack of Efficacy|2|||
164587179|NCT00986258|594513761|FG000|Maintenance Period|Withdrawal by Subject|2|||
164587180|NCT01372878|594513762|FG000|Overall Study|Withdrawal by Subject|63|||
164587181|NCT01372878|594513762|FG000|Overall Study|Protocol Violation|17|||
164587182|NCT01372878|594513762|FG000|Overall Study|incomplete study procedure|104|||
164587183|NCT01035606|594513765|FG000|Overall Study|change in health, job demands,family|3|||
164587184|NCT01035606|594513766|FG001|Overall Study|change in health, job demands,family|3|||
164587185|NCT01035606|594513767|FG002|Overall Study|change in health, job demands,family|4|||
164587186|NCT01070303|594513768|FG000|Overall Study|Adverse Event|39|||
164587187|NCT01070303|594513768|FG000|Overall Study|Withdrawal by Subject|20|||
164587188|NCT01070303|594513768|FG000|Overall Study|Lost to Follow-up|9|||
164587189|NCT01070303|594513768|FG000|Overall Study|Protocol Violation|0|||
164587190|NCT01070303|594513768|FG000|Overall Study|Lack of Efficacy|2|||
164587191|NCT01070303|594513768|FG000|Overall Study|Administrative Reason|1|||
164587192|NCT01070303|594513768|FG000|Overall Study|Other|18|||
164587193|NCT02145156|594513769|FG000|Overall Study|No match to vaccination records|60|||
164587194|NCT02145156|594513770|FG001|Overall Study|No match to vaccination records|52|||
164587195|NCT02145156|594513771|FG002|Overall Study|No match to vaccination records|41|||
164587196|NCT02064439|594513773|FG000|Overall Study|Adverse Event|51|||
164587197|NCT02064439|594513774|FG001|Overall Study|Adverse Event|47|||
164587198|NCT02064439|594513775|FG002|Overall Study|Adverse Event|46|||
164294094|NCT00878501|593450002|FG001|Overall Study|Incorrect enrolment|2|||
164294095|NCT00878501|593450003|FG002|Overall Study|Incorrect enrolment|0|||
164294096|NCT00878501|593450001|FG000|Overall Study|Intake of prohibited concom. medication|0|||
164294097|NCT00878501|593450002|FG001|Overall Study|Intake of prohibited concom. medication|0|||
164294098|NCT00878501|593450003|FG002|Overall Study|Intake of prohibited concom. medication|1|||
164587199|NCT02064439|594513773|FG000|Overall Study|Death|0|||
164294099|NCT00878501|593450001|FG000|Overall Study|Mis-randomisation of patient|1|||
164692901|NCT02688387|594899288|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164692902|NCT02688387|594899289|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164692903|NCT02688387|594899290|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164692904|NCT02688387|594899291|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164692905|NCT02688387|594899292|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164692906|NCT02688387|594899293|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164692907|NCT02688387|594899294|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164692908|NCT02688387|594899295|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164692909|NCT02688387|594899296|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164692910|NCT02688387|594899297|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164692911|NCT02688387|594899298|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164692912|NCT02688387|594899299|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164692913|NCT02688387|594899300|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164692914|NCT02688387|594899301|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164692915|NCT02688387|594899280|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164692916|NCT02688387|594899281|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164692917|NCT02688387|594899282|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164692918|NCT02688387|594899283|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
164692919|NCT02688387|594899284|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164692920|NCT02688387|594899285|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164692921|NCT02688387|594899286|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164692922|NCT02688387|594899287|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164692923|NCT02688387|594899288|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164692924|NCT02688387|594899289|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164692925|NCT02688387|594899290|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164692926|NCT02688387|594899291|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164692927|NCT02688387|594899292|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164692928|NCT02688387|594899293|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164692929|NCT02688387|594899294|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164692930|NCT02688387|594899295|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164692931|NCT02688387|594899296|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164692932|NCT02688387|594899297|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164692933|NCT02688387|594899298|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164692934|NCT02688387|594899299|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164692935|NCT02688387|594899300|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164692936|NCT02688387|594899301|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164692937|NCT02688387|594899280|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164692938|NCT02688387|594899281|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
164692939|NCT02688387|594899282|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164692940|NCT02688387|594899283|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164692941|NCT02688387|594899284|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164692942|NCT02688387|594899285|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164692943|NCT02688387|594899286|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164692944|NCT02688387|594899287|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164692945|NCT02688387|594899288|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164692946|NCT02688387|594899289|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164692947|NCT02688387|594899290|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164692948|NCT02688387|594899291|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164692949|NCT02688387|594899292|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164692950|NCT02688387|594899293|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164692951|NCT02688387|594899294|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164692952|NCT02688387|594899295|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164692953|NCT02688387|594899296|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164692954|NCT02688387|594899297|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164692955|NCT02688387|594899298|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164692956|NCT02688387|594899299|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164692957|NCT02688387|594899300|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164692958|NCT02688387|594899301|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164692959|NCT02688387|594899280|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164692960|NCT02688387|594899281|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164692961|NCT02688387|594899282|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
164294100|NCT00878501|593450002|FG001|Overall Study|Mis-randomisation of patient|0|||
164692962|NCT02688387|594899283|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164692963|NCT02688387|594899284|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
164692964|NCT02688387|594899285|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164692965|NCT02688387|594899286|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164692966|NCT02688387|594899287|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164692967|NCT02688387|594899288|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164692968|NCT02688387|594899289|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164692969|NCT02688387|594899290|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164692970|NCT02688387|594899291|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164692971|NCT02688387|594899292|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164692972|NCT02688387|594899293|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164692973|NCT02688387|594899294|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164692974|NCT02688387|594899295|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164692975|NCT02688387|594899296|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164692976|NCT02688387|594899297|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164692977|NCT02688387|594899298|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164692978|NCT02688387|594899299|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164692979|NCT02688387|594899300|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164692980|NCT02688387|594899301|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164692981|NCT02688387|594899280|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
164692982|NCT02688387|594899281|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164692983|NCT02688387|594899282|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164692984|NCT02688387|594899283|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164692985|NCT02688387|594899284|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164692986|NCT02688387|594899285|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164692987|NCT02688387|594899286|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164692988|NCT02688387|594899287|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164692989|NCT02688387|594899288|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164692990|NCT02688387|594899289|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164692991|NCT02688387|594899290|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164692992|NCT02688387|594899291|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164692993|NCT02688387|594899292|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164692994|NCT02688387|594899293|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164692995|NCT02688387|594899294|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164692996|NCT02688387|594899295|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164692997|NCT02688387|594899296|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164692998|NCT02688387|594899297|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164692999|NCT02688387|594899298|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164693000|NCT02688387|594899299|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164693001|NCT02688387|594899300|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164693002|NCT02688387|594899301|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164693003|NCT02688387|594899280|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164693004|NCT02688387|594899281|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164693005|NCT02688387|594899282|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164693006|NCT02688387|594899283|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164693007|NCT02688387|594899284|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164693008|NCT02688387|594899285|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164693009|NCT02688387|594899286|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164693010|NCT02688387|594899287|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164693011|NCT02688387|594899288|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164693012|NCT02688387|594899289|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164693013|NCT02688387|594899290|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
164693014|NCT02688387|594899291|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164693015|NCT02688387|594899292|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164693016|NCT02688387|594899293|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164693017|NCT02688387|594899294|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164693018|NCT02688387|594899295|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164693019|NCT02688387|594899296|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164693020|NCT02688387|594899297|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164693021|NCT02688387|594899298|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164693022|NCT02688387|594899299|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164693023|NCT02688387|594899300|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164693024|NCT02688387|594899301|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164434553|NCT04936035|593960753|FG012|Post-6-Month DB Period (30months)|Death|0|||
164434554|NCT04936035|593960741|FG000|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
164434555|NCT04936035|593960742|FG001|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
164434556|NCT04936035|593960743|FG002|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
164434557|NCT04936035|593960744|FG003|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
164434558|NCT04936035|593960745|FG004|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
164434559|NCT04936035|593960746|FG005|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
164434560|NCT04936035|593960747|FG006|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
164434561|NCT04936035|593960748|FG007|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
164434562|NCT04936035|593960749|FG008|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
164434563|NCT04936035|593960750|FG009|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
164434564|NCT04936035|593960751|FG010|Post-6-Month DB Period (30months)|Reason Not Specified|2|||
164434565|NCT04936035|593960752|FG011|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
164434566|NCT04936035|593960753|FG012|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
164434567|NCT05827926|593960758|FG000|Overall Study|Lost to Follow-up|1|||
164434568|NCT05827926|593960759|FG001|Overall Study|Lost to Follow-up|0|||
164434569|NCT05827926|593960760|FG002|Overall Study|Lost to Follow-up|0|||
164434570|NCT05827926|593960761|FG003|Overall Study|Lost to Follow-up|0|||
164434571|NCT05827926|593960762|FG004|Overall Study|Lost to Follow-up|0|||
164434572|NCT05827926|593960763|FG005|Overall Study|Lost to Follow-up|1|||
164434573|NCT05827926|593960764|FG006|Overall Study|Lost to Follow-up|0|||
164434574|NCT05827926|593960765|FG007|Overall Study|Lost to Follow-up|0|||
164434575|NCT05827926|593960766|FG008|Overall Study|Lost to Follow-up|0|||
164434576|NCT05827926|593960767|FG009|Overall Study|Lost to Follow-up|0|||
164434577|NCT05827926|593960768|FG010|Overall Study|Lost to Follow-up|0|||
164434578|NCT05827926|593960769|FG011|Overall Study|Lost to Follow-up|0|||
164434579|NCT05827926|593960770|FG012|Overall Study|Lost to Follow-up|1|||
164434580|NCT05827926|593960771|FG013|Overall Study|Lost to Follow-up|1|||
164434581|NCT05827926|593960772|FG014|Overall Study|Lost to Follow-up|0|||
164434582|NCT05827926|593960773|FG015|Overall Study|Lost to Follow-up|1|||
164434583|NCT05827926|593960774|FG016|Overall Study|Lost to Follow-up|2|||
164434584|NCT05827926|593960775|FG017|Overall Study|Lost to Follow-up|0|||
164434585|NCT05827926|593960776|FG018|Overall Study|Lost to Follow-up|0|||
164434586|NCT05827926|593960777|FG019|Overall Study|Lost to Follow-up|0|||
164434587|NCT05827926|593960778|FG020|Overall Study|Lost to Follow-up|1|||
164434588|NCT05827926|593960779|FG021|Overall Study|Lost to Follow-up|2|||
164434589|NCT05827926|593960780|FG022|Overall Study|Lost to Follow-up|1|||
164434590|NCT05827926|593960781|FG023|Overall Study|Lost to Follow-up|1|||
164434591|NCT05827926|593960782|FG024|Overall Study|Lost to Follow-up|2|||
164434592|NCT05827926|593960783|FG025|Overall Study|Lost to Follow-up|1|||
164434593|NCT05827926|593960784|FG026|Overall Study|Lost to Follow-up|4|||
164434594|NCT05827926|593960785|FG027|Overall Study|Lost to Follow-up|1|||
164294101|NCT00878501|593450003|FG002|Overall Study|Mis-randomisation of patient|0|||
164294102|NCT00878501|593450001|FG000|Overall Study|Administrative|0|||
164434595|NCT05827926|593960786|FG028|Overall Study|Lost to Follow-up|2|||
164587200|NCT02064439|594513774|FG001|Overall Study|Death|2|||
164587201|NCT02064439|594513775|FG002|Overall Study|Death|3|||
164587202|NCT02064439|594513773|FG000|Overall Study|Withdrawal by Subject|29|||
164587203|NCT02064439|594513774|FG001|Overall Study|Withdrawal by Subject|18|||
164587204|NCT02064439|594513775|FG002|Overall Study|Withdrawal by Subject|26|||
164587205|NCT02064439|594513773|FG000|Overall Study|Protocol Violation|3|||
164587206|NCT02064439|594513774|FG001|Overall Study|Protocol Violation|5|||
164587207|NCT02064439|594513775|FG002|Overall Study|Protocol Violation|3|||
164587208|NCT02064439|594513773|FG000|Overall Study|Lost to Follow-up|1|||
164587209|NCT02064439|594513774|FG001|Overall Study|Lost to Follow-up|3|||
164587210|NCT02064439|594513775|FG002|Overall Study|Lost to Follow-up|4|||
164587211|NCT02064439|594513773|FG000|Overall Study|Non-compliance with study medication|21|||
164587212|NCT02064439|594513774|FG001|Overall Study|Non-compliance with study medication|19|||
164587213|NCT02064439|594513775|FG002|Overall Study|Non-compliance with study medication|23|||
164587214|NCT02064439|594513773|FG000|Overall Study|Physician Decision|0|||
164587215|NCT02064439|594513774|FG001|Overall Study|Physician Decision|1|||
164587216|NCT02064439|594513775|FG002|Overall Study|Physician Decision|1|||
164587217|NCT02064439|594513773|FG000|Overall Study|Logistical difficulties|6|||
164587218|NCT02064439|594513774|FG001|Overall Study|Logistical difficulties|5|||
164587219|NCT02064439|594513775|FG002|Overall Study|Logistical difficulties|2|||
164587220|NCT02064439|594513773|FG000|Overall Study|Efficacy outcome reached|18|||
164587221|NCT02064439|594513774|FG001|Overall Study|Efficacy outcome reached|16|||
164587222|NCT02064439|594513775|FG002|Overall Study|Efficacy outcome reached|57|||
164587223|NCT02064439|594513773|FG000|Overall Study|Safety outcome reached|12|||
164434596|NCT05827926|593960787|FG029|Overall Study|Lost to Follow-up|1|||
164434597|NCT05827926|593960788|FG030|Overall Study|Lost to Follow-up|5|||
164434598|NCT05827926|593960789|FG031|Overall Study|Lost to Follow-up|0|||
164434599|NCT05827926|593960790|FG032|Overall Study|Lost to Follow-up|3|||
164434600|NCT05827926|593960791|FG033|Overall Study|Lost to Follow-up|2|||
164587224|NCT02064439|594513774|FG001|Overall Study|Safety outcome reached|20|||
164587225|NCT02064439|594513775|FG002|Overall Study|Safety outcome reached|10|||
164434601|NCT05827926|593960792|FG034|Overall Study|Lost to Follow-up|1|||
164294103|NCT00878501|593450002|FG001|Overall Study|Administrative|0|||
164434602|NCT05827926|593960793|FG035|Overall Study|Lost to Follow-up|3|||
164587226|NCT02064439|594513773|FG000|Overall Study|Other|2|||
164587227|NCT02064439|594513774|FG001|Overall Study|Other|2|||
164294104|NCT00878501|593450003|FG002|Overall Study|Administrative|1|||
164294105|NCT01194830|593450013|FG000|Overall Study|Adverse Event|3|||
164294106|NCT01194830|593450014|FG001|Overall Study|Adverse Event|2|||
164294107|NCT01194830|593450013|FG000|Overall Study|Protocol Violation|5|||
164294108|NCT01194830|593450014|FG001|Overall Study|Protocol Violation|4|||
164294109|NCT01194830|593450013|FG000|Overall Study|Lost to Follow-up|9|||
164434603|NCT05827926|593960794|FG036|Overall Study|Lost to Follow-up|4|||
164434604|NCT05827926|593960758|FG000|Overall Study|Withdrawal by Subject|1|||
164294110|NCT01194830|593450014|FG001|Overall Study|Lost to Follow-up|7|||
164294111|NCT01194830|593450013|FG000|Overall Study|Withdrawal by Subject|2|||
164294112|NCT01194830|593450014|FG001|Overall Study|Withdrawal by Subject|1|||
164294113|NCT01194830|593450013|FG000|Overall Study|Lack of Efficacy|1|||
164294114|NCT01194830|593450014|FG001|Overall Study|Lack of Efficacy|1|||
164294115|NCT01194830|593450013|FG000|Overall Study|Non-compliance issues|4|||
164294116|NCT01194830|593450014|FG001|Overall Study|Non-compliance issues|4|||
164294117|NCT01194830|593450013|FG000|Overall Study|Other Reason|12|||
164294118|NCT01194830|593450014|FG001|Overall Study|Other Reason|8|||
164294119|NCT00866177|593450017|FG000|Overall Study|Withdrawal by Subject|1|||
164294120|NCT00866177|593450017|FG000|Overall Study|Not Treated|151|||
164294121|NCT03661723|593450029|FG000|Overall Study|Disease Progression|4|||
164294122|NCT03661723|593450030|FG001|Overall Study|Disease Progression|24|||
164294123|NCT03661723|593450031|FG002|Overall Study|Disease Progression|4|||
164294124|NCT03661723|593450032|FG003|Overall Study|Disease Progression|19|||
164294125|NCT03661723|593450029|FG000|Overall Study|Withdrawal by Subject|1|||
164294126|NCT03661723|593450030|FG001|Overall Study|Withdrawal by Subject|0|||
164294127|NCT03661723|593450031|FG002|Overall Study|Withdrawal by Subject|2|||
164294128|NCT03661723|593450032|FG003|Overall Study|Withdrawal by Subject|4|||
164294129|NCT03661723|593450029|FG000|Overall Study|Physician Decision|1|||
164294130|NCT03661723|593450030|FG001|Overall Study|Physician Decision|0|||
164294131|NCT03661723|593450031|FG002|Overall Study|Physician Decision|0|||
164294132|NCT03661723|593450032|FG003|Overall Study|Physician Decision|0|||
164294133|NCT03661723|593450029|FG000|Overall Study|Clinical Deterioration|0|||
164294134|NCT03661723|593450030|FG001|Overall Study|Clinical Deterioration|0|||
164294135|NCT03661723|593450031|FG002|Overall Study|Clinical Deterioration|0|||
164294136|NCT03661723|593450032|FG003|Overall Study|Clinical Deterioration|1|||
164294137|NCT03760029|593450033|FG000|Overall Study|Death|1|||
164294138|NCT03760029|593450034|FG001|Overall Study|Death|0|||
164294139|NCT03760029|593450035|FG002|Overall Study|Death|0|||
164294140|NCT03760029|593450033|FG000|Overall Study|Lost to Follow-up|0|||
164294141|NCT03760029|593450034|FG001|Overall Study|Lost to Follow-up|2|||
164294142|NCT03760029|593450035|FG002|Overall Study|Lost to Follow-up|1|||
164294143|NCT03760029|593450033|FG000|Overall Study|Withdrawal by Subject|1|||
164294144|NCT03760029|593450034|FG001|Overall Study|Withdrawal by Subject|4|||
164294145|NCT03760029|593450035|FG002|Overall Study|Withdrawal by Subject|1|||
164294146|NCT03760029|593450033|FG000|Overall Study|Withdrawal by parent/guardian|4|||
164294147|NCT03760029|593450034|FG001|Overall Study|Withdrawal by parent/guardian|4|||
164294148|NCT03760029|593450035|FG002|Overall Study|Withdrawal by parent/guardian|1|||
164294149|NCT03760029|593450033|FG000|Overall Study|Other|2|||
164294150|NCT03760029|593450034|FG001|Overall Study|Other|1|||
164294151|NCT03760029|593450035|FG002|Overall Study|Other|0|||
164294152|NCT04890652|593450043|FG000|Overall Study|Withdrawal by Subject|2|||
164294153|NCT00807911|593450049|FG000|Overall Study|Withdrawal by Subject|12|||
164294154|NCT00807911|593450050|FG001|Overall Study|Withdrawal by Subject|10|||
164294155|NCT00807911|593450049|FG000|Overall Study|Ineligible|0|||
164294156|NCT00807911|593450050|FG001|Overall Study|Ineligible|4|||
164294157|NCT02399215|593450070|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
164294158|NCT02399215|593450070|FG000|Overall Study|Withdrawal by Subject|1|||
164294159|NCT00772538|593450071|FG000|Overall Study|Adverse Event|6|||
164294160|NCT00772538|593450072|FG001|Overall Study|Adverse Event|6|||
164294161|NCT00772538|593450071|FG000|Overall Study|Protocol Violation|3|||
164294162|NCT00772538|593450072|FG001|Overall Study|Protocol Violation|3|||
164294163|NCT00772538|593450071|FG000|Overall Study|Lost to Follow-up|1|||
164294164|NCT00772538|593450072|FG001|Overall Study|Lost to Follow-up|1|||
164294165|NCT00772538|593450071|FG000|Overall Study|Withdrawal by Subject|3|||
164294166|NCT00772538|593450072|FG001|Overall Study|Withdrawal by Subject|8|||
164587228|NCT02064439|594513775|FG002|Overall Study|Other|7|||
164294167|NCT00772538|593450071|FG000|Overall Study|Lack of Efficacy|0|||
164294168|NCT00772538|593450072|FG001|Overall Study|Lack of Efficacy|1|||
164294169|NCT00772538|593450071|FG000|Overall Study|Other|7|||
164294170|NCT00772538|593450072|FG001|Overall Study|Other|7|||
164294171|NCT04602390|593450079|FG000|Overall Study|Withdrawal by Subject|0|||
164294172|NCT04602390|593450080|FG001|Overall Study|Withdrawal by Subject|0|||
164294173|NCT04602390|593450081|FG002|Overall Study|Withdrawal by Subject|0|||
164294174|NCT04602390|593450082|FG003|Overall Study|Withdrawal by Subject|0|||
164693025|NCT02688387|594899280|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164693026|NCT02688387|594899281|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164693027|NCT02688387|594899282|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164693028|NCT02688387|594899283|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164693029|NCT02688387|594899284|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164693030|NCT02688387|594899285|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164693031|NCT02688387|594899286|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164693032|NCT02688387|594899287|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164693033|NCT02688387|594899288|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164693034|NCT02688387|594899289|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164693035|NCT02688387|594899290|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164693036|NCT02688387|594899291|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164693037|NCT02688387|594899292|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164693038|NCT02688387|594899293|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164693039|NCT02688387|594899294|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
164693040|NCT02688387|594899295|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164693041|NCT02688387|594899296|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164693042|NCT02688387|594899297|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164693043|NCT02688387|594899298|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164693044|NCT02688387|594899299|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164693045|NCT02688387|594899300|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164693046|NCT02688387|594899301|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164693047|NCT02688387|594899280|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164693048|NCT02688387|594899281|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164693049|NCT02688387|594899282|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164693050|NCT02688387|594899283|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164693051|NCT02688387|594899284|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164693052|NCT02688387|594899285|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164693053|NCT02688387|594899286|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164693054|NCT02688387|594899287|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164693055|NCT02688387|594899288|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164693056|NCT02688387|594899289|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164693057|NCT02688387|594899290|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164693058|NCT02688387|594899291|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164693059|NCT02688387|594899292|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164693060|NCT02688387|594899293|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164693061|NCT02688387|594899294|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164693062|NCT02688387|594899295|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164693063|NCT02688387|594899296|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164693064|NCT02688387|594899297|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164693065|NCT02688387|594899298|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164693066|NCT02688387|594899299|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164693067|NCT02688387|594899300|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
164693068|NCT02688387|594899301|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164693069|NCT02688387|594899280|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164693070|NCT02688387|594899281|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164693071|NCT02688387|594899282|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164693072|NCT02688387|594899283|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164693073|NCT02688387|594899284|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164693074|NCT02688387|594899285|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164693075|NCT02688387|594899286|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164693076|NCT02688387|594899287|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164693077|NCT02688387|594899288|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164693078|NCT02688387|594899289|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164294175|NCT04602390|593450083|FG004|Overall Study|Withdrawal by Subject|1|||
164294176|NCT04602390|593450084|FG005|Overall Study|Withdrawal by Subject|0|||
164294177|NCT04602390|593450079|FG000|Overall Study|Adverse Event|0|||
164294178|NCT04602390|593450080|FG001|Overall Study|Adverse Event|0|||
164294179|NCT04602390|593450081|FG002|Overall Study|Adverse Event|0|||
164294180|NCT04602390|593450082|FG003|Overall Study|Adverse Event|0|||
164434605|NCT05827926|593960759|FG001|Overall Study|Withdrawal by Subject|0|||
164693079|NCT02688387|594899290|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164693080|NCT02688387|594899291|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164693081|NCT02688387|594899292|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164294181|NCT04602390|593450083|FG004|Overall Study|Adverse Event|0|||
164294182|NCT04602390|593450084|FG005|Overall Study|Adverse Event|1|||
164294183|NCT01791244|593450087|FG000|Overall Study|Adverse Event|5|||
164294184|NCT01791244|593450088|FG001|Overall Study|Adverse Event|7|||
164294185|NCT01791244|593450087|FG000|Overall Study|Insufficient clinical response|10|||
164294186|NCT01791244|593450088|FG001|Overall Study|Insufficient clinical response|10|||
164294187|NCT01791244|593450087|FG000|Overall Study|Laboratory Abnormality|0|||
164294188|NCT01791244|593450088|FG001|Overall Study|Laboratory Abnormality|1|||
164294189|NCT00703014|593450089|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
164294190|NCT00703014|593450090|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
164294191|NCT00703014|593450091|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
164294192|NCT00703014|593450092|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
164294193|NCT00703014|593450089|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
164294194|NCT00703014|593450090|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
164294195|NCT00703014|593450091|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
164299954|NCT05138653|593472969|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299955|NCT05138653|593472970|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299956|NCT05138653|593472971|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299957|NCT05138653|593472972|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299958|NCT05138653|593472973|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299959|NCT05138653|593472974|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299960|NCT05138653|593472975|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299961|NCT05138653|593472976|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299962|NCT05138653|593472961|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299963|NCT05138653|593472962|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
164299964|NCT05138653|593472963|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299965|NCT05138653|593472964|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299966|NCT05138653|593472965|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299967|NCT05138653|593472966|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299968|NCT05138653|593472967|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299969|NCT05138653|593472968|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299970|NCT05138653|593472969|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
164299971|NCT05138653|593472970|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299972|NCT05138653|593472971|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299973|NCT05138653|593472972|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299974|NCT05138653|593472973|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299975|NCT05138653|593472974|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299976|NCT05138653|593472975|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299977|NCT05138653|593472976|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299978|NCT05138653|593472961|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299979|NCT05138653|593472962|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
164299980|NCT05138653|593472963|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299981|NCT05138653|593472964|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299982|NCT05138653|593472965|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
164299983|NCT05138653|593472966|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299984|NCT05138653|593472967|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299985|NCT05138653|593472968|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299986|NCT05138653|593472969|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299987|NCT05138653|593472970|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299988|NCT05138653|593472971|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299989|NCT05138653|593472972|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299990|NCT05138653|593472973|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299991|NCT05138653|593472974|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299992|NCT05138653|593472975|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299993|NCT05138653|593472976|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299994|NCT05138653|593472961|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164299995|NCT05138653|593472962|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164299996|NCT05138653|593472963|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164346732|NCT04502693|593645128|FG003|Overall Study|Adverse Event|1|||
164346733|NCT04502693|593645125|FG000|Overall Study|Lost to Follow-up|32|||
164294196|NCT00703014|593450092|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
164294197|NCT04949191|593450093|FG000|Overall Study|Non-compliance with Study Drug|1|||
164294198|NCT04949191|593450094|FG001|Overall Study|Non-compliance with Study Drug|0|||
164294199|NCT04949191|593450095|FG002|Overall Study|Non-compliance with Study Drug|0|||
164294200|NCT04949191|593450096|FG003|Overall Study|Non-compliance with Study Drug|0|||
164294201|NCT04949191|593450093|FG000|Overall Study|Progressive Disease|0|||
164294202|NCT04949191|593450094|FG001|Overall Study|Progressive Disease|1|||
164294203|NCT04949191|593450095|FG002|Overall Study|Progressive Disease|0|||
164294204|NCT04949191|593450096|FG003|Overall Study|Progressive Disease|0|||
164294205|NCT04949191|593450093|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
164294206|NCT04949191|593450094|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
164294207|NCT04949191|593450095|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
164294208|NCT04949191|593450096|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
164294209|NCT04949191|593450093|FG000|Overall Study|Sponsor Terminated Study|0|||
164294210|NCT04949191|593450094|FG001|Overall Study|Sponsor Terminated Study|0|||
164294211|NCT04949191|593450095|FG002|Overall Study|Sponsor Terminated Study|1|||
164346734|NCT04502693|593645126|FG001|Overall Study|Lost to Follow-up|36|||
164346735|NCT04502693|593645127|FG002|Overall Study|Lost to Follow-up|69|||
164346736|NCT04502693|593645128|FG003|Overall Study|Lost to Follow-up|4|||
164346737|NCT04502693|593645125|FG000|Overall Study|Protocol Violation|8|||
164346738|NCT04502693|593645126|FG001|Overall Study|Protocol Violation|8|||
164346739|NCT04502693|593645127|FG002|Overall Study|Protocol Violation|16|||
164346740|NCT04502693|593645128|FG003|Overall Study|Protocol Violation|1|||
164346741|NCT04502693|593645125|FG000|Overall Study|Withdrawal by Subject|46|||
164346742|NCT04502693|593645126|FG001|Overall Study|Withdrawal by Subject|38|||
164346743|NCT04502693|593645127|FG002|Overall Study|Withdrawal by Subject|54|||
164346744|NCT04502693|593645128|FG003|Overall Study|Withdrawal by Subject|7|||
164346745|NCT04502693|593645125|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
164346746|NCT04502693|593645126|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
164346747|NCT04502693|593645127|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
164294212|NCT04949191|593450096|FG003|Overall Study|Sponsor Terminated Study|1|||
164294213|NCT04590014|593450103|FG000|Overall Study|Withdrawal by Subject|1|||
164294214|NCT04590014|593450104|FG001|Overall Study|Withdrawal by Subject|0|||
164294215|NCT00468299|593450105|FG000|Overall Study|Withdrawal by Subject|0|||
164294216|NCT00468299|593450106|FG001|Overall Study|Withdrawal by Subject|1|||
164294217|NCT03546621|593450107|FG000|Overall Study|Withdrawal by Subject|0|||
164294218|NCT03546621|593450108|FG001|Overall Study|Withdrawal by Subject|1|||
164294219|NCT03546621|593450109|FG002|Overall Study|Withdrawal by Subject|2|||
164294220|NCT03546621|593450110|FG003|Overall Study|Withdrawal by Subject|1|||
164294221|NCT03546621|593450107|FG000|Overall Study|Lost to Follow-up|0|||
164294222|NCT03546621|593450108|FG001|Overall Study|Lost to Follow-up|1|||
164294223|NCT03546621|593450109|FG002|Overall Study|Lost to Follow-up|0|||
164294224|NCT03546621|593450110|FG003|Overall Study|Lost to Follow-up|0|||
164294225|NCT03546621|593450107|FG000|Overall Study|Adverse Event|0|||
164294226|NCT03546621|593450108|FG001|Overall Study|Adverse Event|1|||
164294227|NCT03546621|593450109|FG002|Overall Study|Adverse Event|0|||
164294228|NCT03546621|593450110|FG003|Overall Study|Adverse Event|1|||
164294229|NCT03546621|593450107|FG000|Overall Study|Progressive disease|0|||
164294230|NCT03546621|593450108|FG001|Overall Study|Progressive disease|0|||
164294231|NCT03546621|593450109|FG002|Overall Study|Progressive disease|0|||
164294232|NCT03546621|593450110|FG003|Overall Study|Progressive disease|1|||
164294233|NCT00660192|593450111|FG000|Overall Study|Lost to Follow-up|2|||
164294234|NCT00660192|593450112|FG001|Overall Study|Lost to Follow-up|3|||
164294235|NCT00982735|593450113|FG000|Overall Study|Lost to Follow-up|6|||
164294236|NCT00982735|593450113|FG000|Overall Study|Patient ineligible for trial|224|||
164294237|NCT03740048|593450114|FG000|Overall Study|Withdrawal by Subject|1|||
164294238|NCT03740048|593450115|FG001|Overall Study|Withdrawal by Subject|1|||
164294239|NCT03740048|593450114|FG000|Overall Study|Death|1|||
164346748|NCT04502693|593645128|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164346749|NCT04502693|593645125|FG000|Overall Study|Other|1|||
164346750|NCT04502693|593645126|FG001|Overall Study|Other|0|||
164693082|NCT02688387|594899293|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164346751|NCT04502693|593645127|FG002|Overall Study|Other|1|||
164693083|NCT02688387|594899294|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164294240|NCT03740048|593450115|FG001|Overall Study|Death|6|||
164294241|NCT03740048|593450114|FG000|Overall Study|Switched to thrice-weekly HD|2|||
164294242|NCT03740048|593450115|FG001|Overall Study|Switched to thrice-weekly HD|0|||
164294243|NCT03740048|593450114|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
164346752|NCT04502693|593645128|FG003|Overall Study|Other|1|||
164434606|NCT05827926|593960760|FG002|Overall Study|Withdrawal by Subject|1|||
164294244|NCT03740048|593450115|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
164346753|NCT02784431|593645129|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
164346754|NCT02784431|593645129|FG000|Overall Study|Early Study Termination|19|||
164346755|NCT00279305|593645130|FG000|Overall Study|Pregnancy|1|||
164294245|NCT03740048|593450114|FG000|Overall Study|Lost to Follow-up|0|||
164294246|NCT03740048|593450115|FG001|Overall Study|Lost to Follow-up|1|||
164294247|NCT03740048|593450114|FG000|Overall Study|Non-compliance with HD|0|||
164294248|NCT03740048|593450115|FG001|Overall Study|Non-compliance with HD|1|||
164294249|NCT03261336|593450116|FG000|Overall Study|Adverse Event|1|||
164294250|NCT01069484|593450117|FG000|Overall Study|Death-in-near-family|1|||
164294251|NCT01069484|593450118|FG001|Overall Study|Death-in-near-family|0|||
164294252|NCT01069484|593450117|FG000|Overall Study|No specific reason|8|||
164294253|NCT01069484|593450118|FG001|Overall Study|No specific reason|2|||
164294254|NCT01069484|593450117|FG000|Overall Study|Illness mother or child|3|||
164294255|NCT01069484|593450118|FG001|Overall Study|Illness mother or child|1|||
164294256|NCT02343263|593450122|FG000|Overall Study|Physician Decision|5|||
164294257|NCT02343263|593450123|FG001|Overall Study|Physician Decision|3|||
164294258|NCT02343263|593450124|FG002|Overall Study|Physician Decision|1|||
164294259|NCT00849940|593450127|FG000|Overall Study|Physician Decision|4|||
164294260|NCT03353675|593450131|FG000|Overall Study|Adverse Event|4|||
164294261|NCT00402168|593450132|FG000|Randomized|Lost to Follow-up|1|||
164294262|NCT00402168|593450133|FG001|Randomized|Lost to Follow-up|0|||
164294263|NCT00402168|593450132|FG000|Randomized|Withdrawal by Subject|0|||
164294264|NCT00402168|593450133|FG001|Randomized|Withdrawal by Subject|1|||
164294265|NCT00402168|593450132|FG000|Treatment (up to 12 Months)|Death|0|||
164294266|NCT00402168|593450133|FG001|Treatment (up to 12 Months)|Death|1|||
164294267|NCT00402168|593450132|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
164294268|NCT00402168|593450133|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
164294269|NCT00402168|593450132|FG000|Treatment (up to 12 Months)|non-specified|0|||
164294270|NCT00402168|593450133|FG001|Treatment (up to 12 Months)|non-specified|1|||
164294271|NCT00402168|593450132|FG000|Long Term (LT)|Adverse Event|1|||
164294272|NCT00402168|593450133|FG001|Long Term (LT)|Adverse Event|5|||
164294273|NCT00402168|593450132|FG000|Long Term (LT)|Withdrawal by Subject|4|||
164294274|NCT00402168|593450133|FG001|Long Term (LT)|Withdrawal by Subject|7|||
164294275|NCT00402168|593450132|FG000|Long Term (LT)|Pregnancy|0|||
164294276|NCT00402168|593450133|FG001|Long Term (LT)|Pregnancy|1|||
164294277|NCT00402168|593450132|FG000|Long Term (LT)|Lost to Follow-up|1|||
164294278|NCT00402168|593450133|FG001|Long Term (LT)|Lost to Follow-up|0|||
164294279|NCT00402168|593450132|FG000|Long Term (LT)|Death|4|||
164294280|NCT00402168|593450133|FG001|Long Term (LT)|Death|0|||
164294281|NCT00402168|593450132|FG000|Long Term (LT)|Lack of Efficacy|0|||
164294282|NCT00402168|593450133|FG001|Long Term (LT)|Lack of Efficacy|2|||
164294283|NCT00402168|593450132|FG000|Long Term (LT)|non-specified|1|||
164294284|NCT00402168|593450133|FG001|Long Term (LT)|non-specified|2|||
164294285|NCT00402168|593450132|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
164294286|NCT00402168|593450133|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
164294287|NCT00402168|593450132|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
164294288|NCT00402168|593450133|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
164294289|NCT00550407|593450136|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
164294290|NCT00550407|593450137|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
164294291|NCT00550407|593450138|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
164294292|NCT00550407|593450136|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
164294293|NCT00550407|593450137|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
164294294|NCT00550407|593450138|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
164294295|NCT00550407|593450136|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
164294296|NCT00550407|593450137|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
164294297|NCT00550407|593450138|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
164294298|NCT00550407|593450136|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
164294299|NCT00550407|593450137|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
164294300|NCT00550407|593450138|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
164294301|NCT00550407|593450136|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
164294302|NCT00550407|593450137|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
164294303|NCT00550407|593450138|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
164294304|NCT00550407|593450136|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
164294305|NCT00550407|593450137|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
164294306|NCT00550407|593450138|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
164294307|NCT00550407|593450136|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
164294308|NCT00550407|593450137|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
164294309|NCT00550407|593450138|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
164294310|NCT00550407|593450136|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
164294311|NCT00550407|593450137|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
164294312|NCT00550407|593450138|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
164294313|NCT00550407|593450136|FG000|26-Week Randomized Phase|Adverse Event|0|||
164294314|NCT00550407|593450137|FG001|26-Week Randomized Phase|Adverse Event|5|||
164294315|NCT00550407|593450138|FG002|26-Week Randomized Phase|Adverse Event|2|||
164294316|NCT00550407|593450136|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
164294317|NCT00550407|593450137|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
164294318|NCT00550407|593450138|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
164294319|NCT00550407|593450136|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
164294320|NCT00550407|593450137|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
164294321|NCT00550407|593450138|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
164294322|NCT00550407|593450136|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
164294323|NCT00550407|593450137|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
164294324|NCT00550407|593450138|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
164294325|NCT00584415|593450139|FG000|Overall Study|Adverse Event|7|||
164294326|NCT02370420|593450140|FG000|Overall Study|Physician Decision|3|||
164294327|NCT02370420|593450141|FG001|Overall Study|Physician Decision|3|||
164294328|NCT02370420|593450140|FG000|Overall Study|Lost to Follow-up|11|||
164294329|NCT02370420|593450141|FG001|Overall Study|Lost to Follow-up|9|||
164294330|NCT00556894|593450142|FG000|Overall Study|Adverse Event|2|||
164294331|NCT00556894|593450143|FG001|Overall Study|Adverse Event|3|||
164294332|NCT00556894|593450144|FG002|Overall Study|Adverse Event|3|||
164294333|NCT00556894|593450142|FG000|Overall Study|Death|1|||
164294334|NCT00556894|593450143|FG001|Overall Study|Death|0|||
164294335|NCT00556894|593450144|FG002|Overall Study|Death|0|||
164294336|NCT00556894|593450142|FG000|Overall Study|regulatory decision in Bulgaria|10|||
164294337|NCT00556894|593450143|FG001|Overall Study|regulatory decision in Bulgaria|14|||
164294338|NCT00556894|593450144|FG002|Overall Study|regulatory decision in Bulgaria|13|||
164294339|NCT00556894|593450142|FG000|Overall Study|Change in therapy|2|||
164294340|NCT00556894|593450143|FG001|Overall Study|Change in therapy|1|||
164294341|NCT00556894|593450144|FG002|Overall Study|Change in therapy|2|||
164294342|NCT00556894|593450142|FG000|Overall Study|Withdrawal by Subject|1|||
164294343|NCT00556894|593450143|FG001|Overall Study|Withdrawal by Subject|1|||
164294344|NCT00556894|593450144|FG002|Overall Study|Withdrawal by Subject|1|||
164294345|NCT03883581|593450145|FG000|Overall Study|Withdrawal by Subject|4|||
164294346|NCT03224130|593452093|FG000|Overall Study|consent issue|0|||
164294347|NCT03224130|593452094|FG001|Overall Study|consent issue|1|||
164294348|NCT01453049|593452095|FG000|Overall Study|Protocol Violation|2|||
164294349|NCT01453049|593452096|FG001|Overall Study|Protocol Violation|5|||
164294350|NCT01453049|593452095|FG000|Overall Study|Lost to Follow-up|2|||
164294351|NCT01453049|593452096|FG001|Overall Study|Lost to Follow-up|1|||
164294352|NCT01453049|593452095|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
164294353|NCT01453049|593452096|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
164294354|NCT01453049|593452095|FG000|Overall Study|Withdrawal by Subject|1|||
164294355|NCT01453049|593452096|FG001|Overall Study|Withdrawal by Subject|0|||
164294356|NCT01453049|593452095|FG000|Overall Study|Randomized in Error|1|||
164294357|NCT01453049|593452096|FG001|Overall Study|Randomized in Error|0|||
164294358|NCT01317472|593452101|FG000|Overall Study|Withdrawal by Subject|1|||
164294359|NCT01317472|593452102|FG001|Overall Study|Withdrawal by Subject|0|||
164294360|NCT01317472|593452101|FG000|Overall Study|Unrelated hospitalization|1|||
164294361|NCT01317472|593452102|FG001|Overall Study|Unrelated hospitalization|0|||
164693084|NCT02688387|594899295|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164693085|NCT02688387|594899296|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164693086|NCT02688387|594899297|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164693087|NCT02688387|594899298|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
164693088|NCT02688387|594899299|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164693089|NCT02688387|594899300|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
164693090|NCT02688387|594899301|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164693091|NCT02688387|594899280|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164693092|NCT02688387|594899281|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164693093|NCT02688387|594899282|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164693094|NCT02688387|594899283|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164693095|NCT02688387|594899284|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164693096|NCT02688387|594899285|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164693097|NCT02688387|594899286|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164693098|NCT02688387|594899287|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164294362|NCT01815918|593452103|FG000|Overall Study|Patient samples not analyzable|3|||
164294363|NCT01815918|593452104|FG001|Overall Study|Patient samples not analyzable|4|||
164294364|NCT01815918|593452103|FG000|Overall Study|Lack of Efficacy|15|||
164294365|NCT01815918|593452104|FG001|Overall Study|Lack of Efficacy|15|||
164294366|NCT03532542|593452112|FG000|Overall Study|Death|1|||
164294367|NCT03532542|593452113|FG001|Overall Study|Death|0|||
164294368|NCT03532542|593452112|FG000|Overall Study|Study Terminated by Sponsor|41|||
164294369|NCT03532542|593452113|FG001|Overall Study|Study Terminated by Sponsor|65|||
164294370|NCT03532542|593452112|FG000|Overall Study|Withdrawal by Subject|6|||
164294371|NCT03532542|593452113|FG001|Overall Study|Withdrawal by Subject|5|||
164294372|NCT01018030|593452114|FG000|Overall Study|Adverse Event|10|||
164294373|NCT01018030|593452115|FG001|Overall Study|Adverse Event|5|||
164294374|NCT01018030|593452116|FG002|Overall Study|Adverse Event|5|||
164693099|NCT02688387|594899288|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164693100|NCT02688387|594899289|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164693101|NCT02688387|594899290|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164693102|NCT02688387|594899291|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164693103|NCT02688387|594899292|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164693104|NCT02688387|594899293|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164693105|NCT02688387|594899294|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164693106|NCT02688387|594899295|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164693107|NCT02688387|594899296|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164693108|NCT02688387|594899297|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164693109|NCT02688387|594899298|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164693110|NCT02688387|594899299|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
164693111|NCT02688387|594899300|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164294375|NCT01018030|593452114|FG000|Overall Study|Withdrawal by Subject|2|||
164294376|NCT01018030|593452115|FG001|Overall Study|Withdrawal by Subject|2|||
164294377|NCT01018030|593452116|FG002|Overall Study|Withdrawal by Subject|4|||
164294378|NCT01018030|593452114|FG000|Overall Study|Lost to Follow-up|2|||
164693112|NCT02688387|594899301|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164693113|NCT02190279|594899302|FG000|Overall Study|Withdrawal consent|1|||
164294379|NCT01018030|593452115|FG001|Overall Study|Lost to Follow-up|0|||
164294380|NCT01018030|593452116|FG002|Overall Study|Lost to Follow-up|3|||
164294381|NCT01018030|593452114|FG000|Overall Study|Protocol Violation|2|||
164294382|NCT01018030|593452115|FG001|Overall Study|Protocol Violation|1|||
164294383|NCT01018030|593452116|FG002|Overall Study|Protocol Violation|0|||
164294384|NCT01018030|593452114|FG000|Overall Study|Physician Decision|1|||
164294385|NCT01018030|593452115|FG001|Overall Study|Physician Decision|0|||
164294386|NCT01018030|593452116|FG002|Overall Study|Physician Decision|1|||
164294387|NCT01018030|593452114|FG000|Overall Study|Lack of Efficacy|1|||
164294388|NCT01018030|593452115|FG001|Overall Study|Lack of Efficacy|0|||
164294389|NCT01018030|593452116|FG002|Overall Study|Lack of Efficacy|0|||
164294390|NCT01018030|593452114|FG000|Overall Study|Did Not Receive Study Drug|1|||
164294391|NCT01018030|593452115|FG001|Overall Study|Did Not Receive Study Drug|3|||
164294392|NCT01018030|593452116|FG002|Overall Study|Did Not Receive Study Drug|0|||
164294393|NCT01089504|593452117|FG000|Overall Study|Lost to Follow-up|1|||
164294394|NCT01089504|593452118|FG001|Overall Study|Lost to Follow-up|1|||
164294395|NCT01089504|593452117|FG000|Overall Study|Withdrawal by Subject|2|||
164294396|NCT01089504|593452118|FG001|Overall Study|Withdrawal by Subject|0|||
164294397|NCT00001832|593452119|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
164294398|NCT00001832|593452120|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
164294399|NCT00001832|593452121|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
164294400|NCT00001832|593452122|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
164294401|NCT00001832|593452123|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
164294402|NCT00001832|593452124|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
164294403|NCT00001832|593452125|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
164294404|NCT00001832|593452126|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
164294405|NCT00001832|593452127|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
164693114|NCT02190279|594899303|FG001|Overall Study|Withdrawal consent|0|||
164693115|NCT02190279|594899304|FG002|Overall Study|Withdrawal consent|1|||
164693116|NCT02190279|594899302|FG000|Overall Study|Lost to Follow-up|2|||
164693117|NCT02190279|594899303|FG001|Overall Study|Lost to Follow-up|0|||
164434607|NCT05827926|593960761|FG003|Overall Study|Withdrawal by Subject|1|||
164434608|NCT05827926|593960762|FG004|Overall Study|Withdrawal by Subject|0|||
164434609|NCT05827926|593960763|FG005|Overall Study|Withdrawal by Subject|0|||
164434610|NCT05827926|593960764|FG006|Overall Study|Withdrawal by Subject|0|||
164434611|NCT05827926|593960765|FG007|Overall Study|Withdrawal by Subject|0|||
164434612|NCT05827926|593960766|FG008|Overall Study|Withdrawal by Subject|0|||
164434613|NCT05827926|593960767|FG009|Overall Study|Withdrawal by Subject|0|||
164434614|NCT05827926|593960768|FG010|Overall Study|Withdrawal by Subject|0|||
164434615|NCT05827926|593960769|FG011|Overall Study|Withdrawal by Subject|0|||
164434616|NCT05827926|593960770|FG012|Overall Study|Withdrawal by Subject|1|||
164434617|NCT05827926|593960771|FG013|Overall Study|Withdrawal by Subject|1|||
164434618|NCT05827926|593960772|FG014|Overall Study|Withdrawal by Subject|1|||
164434619|NCT05827926|593960773|FG015|Overall Study|Withdrawal by Subject|2|||
164434620|NCT05827926|593960774|FG016|Overall Study|Withdrawal by Subject|1|||
164434621|NCT05827926|593960775|FG017|Overall Study|Withdrawal by Subject|1|||
164434622|NCT05827926|593960776|FG018|Overall Study|Withdrawal by Subject|0|||
164434623|NCT05827926|593960777|FG019|Overall Study|Withdrawal by Subject|0|||
164434624|NCT05827926|593960778|FG020|Overall Study|Withdrawal by Subject|1|||
164434625|NCT05827926|593960779|FG021|Overall Study|Withdrawal by Subject|0|||
164434626|NCT05827926|593960780|FG022|Overall Study|Withdrawal by Subject|0|||
164434627|NCT05827926|593960781|FG023|Overall Study|Withdrawal by Subject|2|||
164434628|NCT05827926|593960782|FG024|Overall Study|Withdrawal by Subject|1|||
164434629|NCT05827926|593960783|FG025|Overall Study|Withdrawal by Subject|0|||
164434630|NCT05827926|593960784|FG026|Overall Study|Withdrawal by Subject|0|||
164434631|NCT05827926|593960785|FG027|Overall Study|Withdrawal by Subject|1|||
164434632|NCT05827926|593960786|FG028|Overall Study|Withdrawal by Subject|0|||
164434633|NCT05827926|593960787|FG029|Overall Study|Withdrawal by Subject|0|||
164434634|NCT05827926|593960788|FG030|Overall Study|Withdrawal by Subject|0|||
164434635|NCT05827926|593960789|FG031|Overall Study|Withdrawal by Subject|2|||
164434636|NCT05827926|593960790|FG032|Overall Study|Withdrawal by Subject|0|||
164434637|NCT05827926|593960791|FG033|Overall Study|Withdrawal by Subject|0|||
164434638|NCT05827926|593960792|FG034|Overall Study|Withdrawal by Subject|0|||
164434639|NCT05827926|593960793|FG035|Overall Study|Withdrawal by Subject|0|||
164434640|NCT05827926|593960794|FG036|Overall Study|Withdrawal by Subject|1|||
164434641|NCT05827926|593960758|FG000|Overall Study|Other Than Specified|0|||
164434642|NCT05827926|593960759|FG001|Overall Study|Other Than Specified|0|||
164434643|NCT05827926|593960760|FG002|Overall Study|Other Than Specified|0|||
164434644|NCT05827926|593960761|FG003|Overall Study|Other Than Specified|1|||
164434645|NCT05827926|593960762|FG004|Overall Study|Other Than Specified|0|||
164434646|NCT05827926|593960763|FG005|Overall Study|Other Than Specified|0|||
164434647|NCT05827926|593960764|FG006|Overall Study|Other Than Specified|1|||
164434648|NCT05827926|593960765|FG007|Overall Study|Other Than Specified|0|||
164434649|NCT05827926|593960766|FG008|Overall Study|Other Than Specified|0|||
164434650|NCT05827926|593960767|FG009|Overall Study|Other Than Specified|0|||
164434651|NCT05827926|593960768|FG010|Overall Study|Other Than Specified|0|||
164434652|NCT05827926|593960769|FG011|Overall Study|Other Than Specified|0|||
164434653|NCT05827926|593960770|FG012|Overall Study|Other Than Specified|0|||
164434654|NCT05827926|593960771|FG013|Overall Study|Other Than Specified|1|||
164434655|NCT05827926|593960772|FG014|Overall Study|Other Than Specified|0|||
164434656|NCT05827926|593960773|FG015|Overall Study|Other Than Specified|1|||
164434657|NCT05827926|593960774|FG016|Overall Study|Other Than Specified|0|||
164434658|NCT05827926|593960775|FG017|Overall Study|Other Than Specified|0|||
164434659|NCT05827926|593960776|FG018|Overall Study|Other Than Specified|0|||
164434660|NCT05827926|593960777|FG019|Overall Study|Other Than Specified|0|||
164434661|NCT05827926|593960778|FG020|Overall Study|Other Than Specified|0|||
164434662|NCT05827926|593960779|FG021|Overall Study|Other Than Specified|1|||
164434663|NCT05827926|593960780|FG022|Overall Study|Other Than Specified|1|||
164434664|NCT05827926|593960781|FG023|Overall Study|Other Than Specified|0|||
164434665|NCT05827926|593960782|FG024|Overall Study|Other Than Specified|0|||
164434666|NCT05827926|593960783|FG025|Overall Study|Other Than Specified|1|||
164434667|NCT05827926|593960784|FG026|Overall Study|Other Than Specified|0|||
164434668|NCT05827926|593960785|FG027|Overall Study|Other Than Specified|0|||
164434669|NCT05827926|593960786|FG028|Overall Study|Other Than Specified|0|||
164434670|NCT05827926|593960787|FG029|Overall Study|Other Than Specified|0|||
164434671|NCT05827926|593960788|FG030|Overall Study|Other Than Specified|0|||
164434672|NCT05827926|593960789|FG031|Overall Study|Other Than Specified|1|||
164693118|NCT02190279|594899304|FG002|Overall Study|Lost to Follow-up|0|||
164693119|NCT02190279|594899302|FG000|Overall Study|Refused further treatment|0|||
164434673|NCT05827926|593960790|FG032|Overall Study|Other Than Specified|0|||
164434674|NCT05827926|593960791|FG033|Overall Study|Other Than Specified|0|||
164434675|NCT05827926|593960792|FG034|Overall Study|Other Than Specified|0|||
164434676|NCT05827926|593960793|FG035|Overall Study|Other Than Specified|0|||
164434677|NCT05827926|593960794|FG036|Overall Study|Other Than Specified|0|||
164434678|NCT05827926|593960758|FG000|Overall Study|Physician Decision|0|||
164434679|NCT05827926|593960759|FG001|Overall Study|Physician Decision|0|||
164434680|NCT05827926|593960760|FG002|Overall Study|Physician Decision|0|||
164434681|NCT05827926|593960761|FG003|Overall Study|Physician Decision|0|||
164434682|NCT05827926|593960762|FG004|Overall Study|Physician Decision|0|||
164434683|NCT05827926|593960763|FG005|Overall Study|Physician Decision|0|||
164434684|NCT05827926|593960764|FG006|Overall Study|Physician Decision|0|||
164294406|NCT00001832|593452128|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
164294407|NCT00001832|593452129|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
164294408|NCT00001832|593452130|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
164294409|NCT00001832|593452131|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
164294410|NCT00001832|593452132|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
164294411|NCT00001832|593452133|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
164294412|NCT00001832|593452119|FG000|Treatment Period|Death during treatment|0|||
164294413|NCT00001832|593452120|FG001|Treatment Period|Death during treatment|0|||
164294414|NCT00001832|593452121|FG002|Treatment Period|Death during treatment|0|||
164294415|NCT00001832|593452122|FG003|Treatment Period|Death during treatment|0|||
164294416|NCT00001832|593452123|FG004|Treatment Period|Death during treatment|0|||
164294417|NCT00001832|593452124|FG005|Treatment Period|Death during treatment|1|||
164294418|NCT00001832|593452125|FG006|Treatment Period|Death during treatment|0|||
164294419|NCT00001832|593452126|FG007|Treatment Period|Death during treatment|0|||
164294420|NCT00001832|593452127|FG008|Treatment Period|Death during treatment|0|||
164294421|NCT00001832|593452128|FG009|Treatment Period|Death during treatment|0|||
164294422|NCT00001832|593452129|FG010|Treatment Period|Death during treatment|0|||
164294423|NCT00001832|593452130|FG011|Treatment Period|Death during treatment|0|||
164294424|NCT00001832|593452131|FG012|Treatment Period|Death during treatment|0|||
164346756|NCT00279305|593645131|FG001|Overall Study|Pregnancy|0|||
164346757|NCT00279305|593645130|FG000|Overall Study|Withdrawal by Subject|2|||
164346758|NCT00279305|593645131|FG001|Overall Study|Withdrawal by Subject|0|||
164346759|NCT00279305|593645130|FG000|Overall Study|Dificulting establishing IV|1|||
164346760|NCT00279305|593645131|FG001|Overall Study|Dificulting establishing IV|0|||
164346761|NCT00279305|593645130|FG000|Overall Study|FDA Safety Alert|4|||
164346762|NCT00279305|593645131|FG001|Overall Study|FDA Safety Alert|1|||
164346763|NCT04404361|593645132|FG000|Overall Study|Death|12|||
164346764|NCT04404361|593645133|FG001|Overall Study|Death|12|||
164346765|NCT04404361|593645132|FG000|Overall Study|Withdrawal by Subject|13|||
164346766|NCT04404361|593645133|FG001|Overall Study|Withdrawal by Subject|5|||
164346767|NCT04404361|593645132|FG000|Overall Study|Lost to Follow-up|6|||
164346768|NCT04404361|593645133|FG001|Overall Study|Lost to Follow-up|3|||
164346769|NCT04404361|593645132|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
164346770|NCT04404361|593645133|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
164346771|NCT01063868|593645138|FG000|Overall Study|Adverse Event|9|||
164346772|NCT01063868|593645139|FG001|Overall Study|Adverse Event|7|||
164346773|NCT01063868|593645138|FG000|Overall Study|Withdrawal by Subject|3|||
164346774|NCT01063868|593645139|FG001|Overall Study|Withdrawal by Subject|1|||
164346775|NCT01063868|593645138|FG000|Overall Study|Study Terminated By Sponsor|23|||
164346776|NCT01063868|593645139|FG001|Overall Study|Study Terminated By Sponsor|4|||
164346777|NCT01949506|593645140|FG000|Overall Study|Physician Decision|1|||
164434685|NCT05827926|593960765|FG007|Overall Study|Physician Decision|0|||
164434686|NCT05827926|593960766|FG008|Overall Study|Physician Decision|0|||
164294425|NCT00001832|593452132|FG013|Treatment Period|Death during treatment|0|||
164346778|NCT01446289|593645141|FG000|Overall Study|Withdrawal by Subject|1|||
164346779|NCT01446289|593645142|FG001|Overall Study|Withdrawal by Subject|0|||
164346780|NCT01446289|593645143|FG002|Overall Study|Withdrawal by Subject|1|||
164346781|NCT01446289|593645144|FG003|Overall Study|Withdrawal by Subject|0|||
164346782|NCT03307967|593645145|FG000|Overall Study|Lost to Follow-up|4|||
164346783|NCT02915016|593645146|FG000|Overall Study|Lost to Follow-up|4|||
164346784|NCT02915016|593645147|FG001|Overall Study|Lost to Follow-up|2|||
164346785|NCT02915016|593645148|FG002|Overall Study|Lost to Follow-up|5|||
164346786|NCT02915016|593645149|FG003|Overall Study|Lost to Follow-up|3|||
164346787|NCT02915016|593645150|FG004|Overall Study|Lost to Follow-up|5|||
164346788|NCT02915016|593645151|FG005|Overall Study|Lost to Follow-up|2|||
164346789|NCT02915016|593645152|FG006|Overall Study|Lost to Follow-up|8|||
164346790|NCT02915016|593645153|FG007|Overall Study|Lost to Follow-up|2|||
164346791|NCT02915016|593645146|FG000|Overall Study|Physician Decision|0|||
164346792|NCT02915016|593645147|FG001|Overall Study|Physician Decision|0|||
164346793|NCT02915016|593645148|FG002|Overall Study|Physician Decision|1|||
164346794|NCT02915016|593645149|FG003|Overall Study|Physician Decision|0|||
164346795|NCT02915016|593645150|FG004|Overall Study|Physician Decision|0|||
164346796|NCT02915016|593645151|FG005|Overall Study|Physician Decision|1|||
164346797|NCT02915016|593645152|FG006|Overall Study|Physician Decision|2|||
164346798|NCT02915016|593645153|FG007|Overall Study|Physician Decision|0|||
164346799|NCT02915016|593645146|FG000|Overall Study|Withdrawal by Subject|2|||
164346800|NCT02915016|593645147|FG001|Overall Study|Withdrawal by Subject|0|||
164346801|NCT02915016|593645148|FG002|Overall Study|Withdrawal by Subject|1|||
164346802|NCT02915016|593645149|FG003|Overall Study|Withdrawal by Subject|0|||
164346803|NCT02915016|593645150|FG004|Overall Study|Withdrawal by Subject|1|||
164346804|NCT02915016|593645151|FG005|Overall Study|Withdrawal by Subject|3|||
164346805|NCT02915016|593645152|FG006|Overall Study|Withdrawal by Subject|1|||
164346806|NCT02915016|593645153|FG007|Overall Study|Withdrawal by Subject|1|||
164346807|NCT02915016|593645146|FG000|Overall Study|Elected not to continue|0|||
164346808|NCT02915016|593645147|FG001|Overall Study|Elected not to continue|0|||
164346809|NCT02915016|593645148|FG002|Overall Study|Elected not to continue|0|||
164346810|NCT02915016|593645149|FG003|Overall Study|Elected not to continue|1|||
164346811|NCT02915016|593645150|FG004|Overall Study|Elected not to continue|0|||
164346812|NCT02915016|593645151|FG005|Overall Study|Elected not to continue|0|||
164346813|NCT02915016|593645152|FG006|Overall Study|Elected not to continue|1|||
164346814|NCT02915016|593645153|FG007|Overall Study|Elected not to continue|0|||
164346815|NCT02915016|593645146|FG000|Overall Study|HIV infection|1|||
164346816|NCT02915016|593645147|FG001|Overall Study|HIV infection|1|||
164346817|NCT02915016|593645148|FG002|Overall Study|HIV infection|1|||
164346818|NCT02915016|593645149|FG003|Overall Study|HIV infection|0|||
164346819|NCT02915016|593645150|FG004|Overall Study|HIV infection|1|||
164346820|NCT02915016|593645151|FG005|Overall Study|HIV infection|0|||
164346821|NCT02915016|593645152|FG006|Overall Study|HIV infection|0|||
164346822|NCT02915016|593645153|FG007|Overall Study|HIV infection|0|||
164346823|NCT02915016|593645146|FG000|Overall Study|Participant unable to adhere|0|||
164346824|NCT02915016|593645147|FG001|Overall Study|Participant unable to adhere|0|||
164346825|NCT02915016|593645148|FG002|Overall Study|Participant unable to adhere|0|||
164346826|NCT02915016|593645149|FG003|Overall Study|Participant unable to adhere|0|||
164346827|NCT02915016|593645150|FG004|Overall Study|Participant unable to adhere|0|||
164346828|NCT02915016|593645151|FG005|Overall Study|Participant unable to adhere|0|||
164346829|NCT02915016|593645152|FG006|Overall Study|Participant unable to adhere|0|||
164346830|NCT02915016|593645153|FG007|Overall Study|Participant unable to adhere|1|||
164346831|NCT02578316|593645154|FG000|Extension Phase|Progression of disease|6|||
164346832|NCT02166905|593645155|FG000|Overall Study|Withdrawal by Subject|1|||
164346833|NCT02166905|593645156|FG001|Overall Study|Withdrawal by Subject|0|||
164346834|NCT02166905|593645157|FG002|Overall Study|Withdrawal by Subject|0|||
164346835|NCT02166905|593645158|FG003|Overall Study|Withdrawal by Subject|0|||
164346836|NCT02617628|593645159|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
164346837|NCT02617628|593645160|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
164346838|NCT03278873|593645165|FG000|Overall Study|Withdrawal by Subject|0|||
164346839|NCT03278873|593645166|FG001|Overall Study|Withdrawal by Subject|1|||
164346840|NCT03278873|593645167|FG002|Overall Study|Withdrawal by Subject|0|||
164346841|NCT03278873|593645168|FG003|Overall Study|Withdrawal by Subject|0|||
164346842|NCT03278873|593645165|FG000|Overall Study|Sponsor's decision|0|||
164346843|NCT03278873|593645166|FG001|Overall Study|Sponsor's decision|1|||
164346844|NCT03278873|593645167|FG002|Overall Study|Sponsor's decision|0|||
164346845|NCT03278873|593645168|FG003|Overall Study|Sponsor's decision|0|||
164346846|NCT03278873|593645165|FG000|Overall Study|Early Termination|2|||
164346847|NCT03278873|593645166|FG001|Overall Study|Early Termination|6|||
164587229|NCT02433288|594513776|FG000|Overall Study|Severe non-compliance to protocol|13|||
164346848|NCT03278873|593645167|FG002|Overall Study|Early Termination|0|||
164346849|NCT03278873|593645168|FG003|Overall Study|Early Termination|4|||
164346850|NCT03278873|593645165|FG000|Overall Study|Lost to Follow-up|0|||
164346851|NCT03278873|593645166|FG001|Overall Study|Lost to Follow-up|0|||
164346852|NCT03278873|593645167|FG002|Overall Study|Lost to Follow-up|2|||
164346853|NCT03278873|593645168|FG003|Overall Study|Lost to Follow-up|0|||
164346854|NCT03278873|593645165|FG000|Overall Study|The patient decided to withdraw via email|1|||
164346855|NCT03278873|593645166|FG001|Overall Study|The patient decided to withdraw via email|0|||
164346856|NCT03278873|593645167|FG002|Overall Study|The patient decided to withdraw via email|0|||
164346857|NCT03278873|593645168|FG003|Overall Study|The patient decided to withdraw via email|0|||
164346858|NCT03278873|593645165|FG000|Overall Study|The patient was unresponsive to contact|0|||
164294426|NCT00001832|593452133|FG014|Treatment Period|Death during treatment|0|||
164294427|NCT00001832|593452119|FG000|Treatment Period|Not treated|0|||
164294428|NCT00001832|593452120|FG001|Treatment Period|Not treated|0|||
164294429|NCT00001832|593452121|FG002|Treatment Period|Not treated|0|||
164294430|NCT00001832|593452122|FG003|Treatment Period|Not treated|0|||
164294431|NCT00001832|593452123|FG004|Treatment Period|Not treated|0|||
164294432|NCT00001832|593452124|FG005|Treatment Period|Not treated|0|||
164294433|NCT00001832|593452125|FG006|Treatment Period|Not treated|0|||
164294434|NCT00001832|593452126|FG007|Treatment Period|Not treated|1|||
164294435|NCT00001832|593452127|FG008|Treatment Period|Not treated|0|||
164294436|NCT00001832|593452128|FG009|Treatment Period|Not treated|0|||
164294437|NCT00001832|593452129|FG010|Treatment Period|Not treated|0|||
164294438|NCT00001832|593452130|FG011|Treatment Period|Not treated|0|||
164294439|NCT00001832|593452131|FG012|Treatment Period|Not treated|0|||
164294440|NCT00001832|593452132|FG013|Treatment Period|Not treated|0|||
164294441|NCT00001832|593452133|FG014|Treatment Period|Not treated|0|||
164294442|NCT00713609|593452134|FG000|Overall Study|Adverse Event|2|||
164294443|NCT00713609|593452135|FG001|Overall Study|Adverse Event|0|||
164294444|NCT00713609|593452136|FG002|Overall Study|Adverse Event|2|||
164294445|NCT00713609|593452137|FG003|Overall Study|Adverse Event|2|||
164294446|NCT00713609|593452138|FG004|Overall Study|Adverse Event|3|||
164294447|NCT00713609|593452139|FG005|Overall Study|Adverse Event|1|||
164294448|NCT00713609|593452134|FG000|Overall Study|Lost to Follow-up|5|||
164294449|NCT00713609|593452135|FG001|Overall Study|Lost to Follow-up|7|||
164294450|NCT00713609|593452136|FG002|Overall Study|Lost to Follow-up|5|||
164294451|NCT00713609|593452137|FG003|Overall Study|Lost to Follow-up|5|||
164294452|NCT00713609|593452138|FG004|Overall Study|Lost to Follow-up|7|||
164294453|NCT00713609|593452139|FG005|Overall Study|Lost to Follow-up|0|||
164294454|NCT00713609|593452134|FG000|Overall Study|Lack of Efficacy|1|||
164294455|NCT00713609|593452135|FG001|Overall Study|Lack of Efficacy|3|||
164294456|NCT00713609|593452136|FG002|Overall Study|Lack of Efficacy|0|||
164294457|NCT00713609|593452137|FG003|Overall Study|Lack of Efficacy|0|||
164294458|NCT00713609|593452138|FG004|Overall Study|Lack of Efficacy|1|||
164294459|NCT00713609|593452139|FG005|Overall Study|Lack of Efficacy|0|||
164294460|NCT00713609|593452134|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
164294461|NCT00713609|593452135|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
164294462|NCT00713609|593452136|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
164294463|NCT00713609|593452137|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
164294464|NCT00713609|593452138|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
164294465|NCT00713609|593452139|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
164294466|NCT00713609|593452134|FG000|Overall Study|Withdrawal by Subject|6|||
164294467|NCT00713609|593452135|FG001|Overall Study|Withdrawal by Subject|1|||
164294468|NCT00713609|593452136|FG002|Overall Study|Withdrawal by Subject|5|||
164294469|NCT00713609|593452137|FG003|Overall Study|Withdrawal by Subject|1|||
164294470|NCT00713609|593452138|FG004|Overall Study|Withdrawal by Subject|5|||
164294471|NCT00713609|593452139|FG005|Overall Study|Withdrawal by Subject|7|||
164294472|NCT00713609|593452134|FG000|Overall Study|Protocol Violation|6|||
164294473|NCT00713609|593452135|FG001|Overall Study|Protocol Violation|3|||
164294474|NCT00713609|593452136|FG002|Overall Study|Protocol Violation|1|||
164294475|NCT00713609|593452137|FG003|Overall Study|Protocol Violation|1|||
164294476|NCT00713609|593452138|FG004|Overall Study|Protocol Violation|2|||
164294477|NCT00713609|593452139|FG005|Overall Study|Protocol Violation|0|||
164294478|NCT04529083|593452140|FG000|Overall Study|Withdrawal by Subject|3|||
164294479|NCT04196686|593452145|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
164294480|NCT04196686|593452146|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
164294481|NCT00914849|593452152|FG000|Overall Study|Withdrawal by Subject|1|||
164294482|NCT00914849|593452153|FG001|Overall Study|Withdrawal by Subject|0|||
164294483|NCT00914849|593452152|FG000|Overall Study|Not eligible|0|||
164346859|NCT03278873|593645166|FG001|Overall Study|The patient was unresponsive to contact|0|||
164346860|NCT03278873|593645167|FG002|Overall Study|The patient was unresponsive to contact|0|||
164346861|NCT03278873|593645168|FG003|Overall Study|The patient was unresponsive to contact|4|||
164346862|NCT03278873|593645165|FG000|Overall Study|The patient wished to participate no longer|0|||
164346863|NCT03278873|593645166|FG001|Overall Study|The patient wished to participate no longer|1|||
164346864|NCT03278873|593645167|FG002|Overall Study|The patient wished to participate no longer|0|||
164346865|NCT03278873|593645168|FG003|Overall Study|The patient wished to participate no longer|0|||
164346866|NCT03278873|593645165|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
164346867|NCT03278873|593645166|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
164355672|NCT03720470|593678630|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
164294484|NCT00914849|593452153|FG001|Overall Study|Not eligible|1|||
164294485|NCT01001221|593452154|FG000|Overall Study|Adverse Event|1|||
164294486|NCT01001221|593452155|FG001|Overall Study|Adverse Event|2|||
164294487|NCT01001221|593452156|FG002|Overall Study|Adverse Event|0|||
164294488|NCT01001221|593452157|FG003|Overall Study|Adverse Event|2|||
164294489|NCT01001221|593452158|FG004|Overall Study|Adverse Event|0|||
164294490|NCT01001221|593452154|FG000|Overall Study|Disease progression|3|||
164294491|NCT01001221|593452155|FG001|Overall Study|Disease progression|2|||
164346868|NCT03278873|593645167|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
164346869|NCT03278873|593645168|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
164587230|NCT02433288|594513777|FG001|Overall Study|Severe non-compliance to protocol|7|||
164587231|NCT02433288|594513776|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
164587232|NCT02433288|594513777|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
164294492|NCT01001221|593452156|FG002|Overall Study|Disease progression|2|||
164294493|NCT01001221|593452157|FG003|Overall Study|Disease progression|4|||
164294494|NCT01001221|593452158|FG004|Overall Study|Disease progression|0|||
164294495|NCT01001221|593452154|FG000|Overall Study|Other|1|||
164294496|NCT01001221|593452155|FG001|Overall Study|Other|1|||
164294497|NCT01001221|593452156|FG002|Overall Study|Other|0|||
164294498|NCT01001221|593452157|FG003|Overall Study|Other|0|||
164294499|NCT01001221|593452158|FG004|Overall Study|Other|0|||
164294500|NCT01001221|593452154|FG000|Overall Study|Not treated; protocol exclusion|0|||
164294501|NCT01001221|593452155|FG001|Overall Study|Not treated; protocol exclusion|0|||
164294502|NCT01001221|593452156|FG002|Overall Study|Not treated; protocol exclusion|1|||
164587233|NCT02433288|594513776|FG000|Overall Study|Withdrawal by Subject|101|||
164587234|NCT02433288|594513777|FG001|Overall Study|Withdrawal by Subject|99|||
164587235|NCT02433288|594513776|FG000|Overall Study|Lost to Follow-up|2|||
164587236|NCT02433288|594513777|FG001|Overall Study|Lost to Follow-up|14|||
164587237|NCT02433288|594513776|FG000|Overall Study|Death|0|||
164587238|NCT02433288|594513777|FG001|Overall Study|Death|3|||
164587239|NCT00858702|594513778|FG000|Overall Study|Lack of Efficacy|1|||
164587240|NCT00858702|594513779|FG001|Overall Study|Lack of Efficacy|0|||
164587241|NCT00858702|594513778|FG000|Overall Study|Protocol Violation|1|||
164587242|NCT00858702|594513779|FG001|Overall Study|Protocol Violation|1|||
164587243|NCT00858702|594513778|FG000|Overall Study|Other|2|||
164587244|NCT00858702|594513779|FG001|Overall Study|Other|1|||
164587245|NCT00858702|594513778|FG000|Overall Study|Withdrawal by Subject|1|||
164587246|NCT00858702|594513779|FG001|Overall Study|Withdrawal by Subject|0|||
164587247|NCT01063751|594513782|FG000|Overall Study|Censored from analyses|42|||
164587248|NCT01063751|594513782|FG000|Overall Study|Withdrawal by Subject|34|||
164587249|NCT01063751|594513782|FG000|Overall Study|Lost to Follow-up|30|||
164587250|NCT01063751|594513782|FG000|Overall Study|Death|13|||
164587251|NCT01063751|594513782|FG000|Overall Study|Sponsored Terminated Study|60|||
164587252|NCT01063751|594513782|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
164587253|NCT01063751|594513782|FG000|Overall Study|Investigator site closed|10|||
164587254|NCT01063751|594513782|FG000|Overall Study|Revision|6|||
164587255|NCT01063751|594513782|FG000|Overall Study|Physician Decision|4|||
164587256|NCT02805907|594513783|FG000|Overall Study|Lost to Follow-up|3|||
164587257|NCT02805907|594513784|FG001|Overall Study|Lost to Follow-up|3|||
164587258|NCT01264965|594513793|FG000|Overall Study|Withdrawal by Subject|10|||
164587259|NCT02075255|594513796|FG000|Overall Study|Study specific withdrawal criteria|0|||
164587260|NCT02075255|594513797|FG001|Overall Study|Study specific withdrawal criteria|1|||
164587261|NCT02075255|594513798|FG002|Overall Study|Study specific withdrawal criteria|1|||
164587262|NCT02075255|594513796|FG000|Overall Study|Withdrawal by Subject|4|||
164587263|NCT02075255|594513797|FG001|Overall Study|Withdrawal by Subject|1|||
164346870|NCT05243641|593645169|FG000|Overall Study|Adverse Event|3|||
164346871|NCT05243641|593645170|FG001|Overall Study|Adverse Event|0|||
164346872|NCT05243641|593645171|FG002|Overall Study|Adverse Event|0|||
164346873|NCT05243641|593645172|FG003|Overall Study|Adverse Event|1|||
164587264|NCT02075255|594513798|FG002|Overall Study|Withdrawal by Subject|0|||
164693120|NCT02190279|594899303|FG001|Overall Study|Refused further treatment|0|||
164346874|NCT05243641|593645173|FG004|Overall Study|Adverse Event|0|||
164346875|NCT05243641|593645174|FG005|Overall Study|Adverse Event|0|||
164346876|NCT05243641|593645169|FG000|Overall Study|Disease progression|4|||
164346877|NCT05243641|593645170|FG001|Overall Study|Disease progression|0|||
164346878|NCT05243641|593645171|FG002|Overall Study|Disease progression|0|||
164346879|NCT05243641|593645172|FG003|Overall Study|Disease progression|2|||
164346880|NCT05243641|593645173|FG004|Overall Study|Disease progression|0|||
164346881|NCT05243641|593645174|FG005|Overall Study|Disease progression|0|||
164587265|NCT02075255|594513796|FG000|Overall Study|Lost to Follow-up|0|||
164587266|NCT02075255|594513797|FG001|Overall Study|Lost to Follow-up|0|||
164693121|NCT02190279|594899304|FG002|Overall Study|Refused further treatment|1|||
164587267|NCT02075255|594513798|FG002|Overall Study|Lost to Follow-up|1|||
164693122|NCT02190279|594899302|FG000|Overall Study|Screening failure|0|||
164294503|NCT01001221|593452157|FG003|Overall Study|Not treated; protocol exclusion|0|||
164294504|NCT01001221|593452158|FG004|Overall Study|Not treated; protocol exclusion|0|||
164346882|NCT05372419|593645186|FG000|Overall Study|Protocol Deviation|1|||
164346883|NCT05372419|593645186|FG000|Overall Study|Withdrawal by Subject|5|||
164346884|NCT05372419|593645186|FG000|Overall Study|Lost to Follow-up|7|||
164346885|NCT02801331|593645187|FG000|Overall Study|Transferred to another hospital|8|||
164587268|NCT02075255|594513796|FG000|Overall Study|Adverse Event|0|||
164587269|NCT02075255|594513797|FG001|Overall Study|Adverse Event|0|||
164587270|NCT02075255|594513798|FG002|Overall Study|Adverse Event|1|||
164587271|NCT02075255|594513796|FG000|Overall Study|Death|0|||
164587272|NCT02075255|594513797|FG001|Overall Study|Death|2|||
164294505|NCT05106959|593452159|FG000|Overall Study|Lost to Follow-up|1|||
164294506|NCT03448406|593452160|FG000|Overall Study|Noncompliance of scheduled visits|1|||
164294507|NCT03448406|593452161|FG001|Overall Study|Noncompliance of scheduled visits|2|||
164294508|NCT03448406|593452160|FG000|Overall Study|Withdrawal by Subject|1|||
164294509|NCT03448406|593452161|FG001|Overall Study|Withdrawal by Subject|2|||
164294510|NCT03448406|593452160|FG000|Overall Study|Protocol Violation|1|||
164294511|NCT03448406|593452161|FG001|Overall Study|Protocol Violation|0|||
164294512|NCT03448406|593452160|FG000|Overall Study|Adverse Event|8|||
164294513|NCT03448406|593452161|FG001|Overall Study|Adverse Event|9|||
164294514|NCT00087152|593452162|FG000|Overall Study|Ineligible|6|||
164294515|NCT01292486|593452163|FG000|Overall Study|Protocol Violation|2|||
164294516|NCT01292486|593452163|FG000|Overall Study|Did not meet screening criteria|2|||
164294517|NCT01292486|593452163|FG000|Overall Study|Adverse Event|1|||
164294518|NCT01292486|593452163|FG000|Overall Study|Physician Decision|1|||
164294519|NCT02542865|593452166|FG000|Overall Study|Identified as screen failure|1|||
164294520|NCT02542865|593452167|FG001|Overall Study|Identified as screen failure|0|||
164294521|NCT02542865|593452166|FG000|Overall Study|Withdrawal by Subject|16|||
164434687|NCT05827926|593960767|FG009|Overall Study|Physician Decision|0|||
164693123|NCT02190279|594899303|FG001|Overall Study|Screening failure|0|||
164693124|NCT02190279|594899304|FG002|Overall Study|Screening failure|1|||
164693125|NCT02938442|594899305|FG000|Overall Study|Death|0|||
164693126|NCT02938442|594899306|FG001|Overall Study|Death|1|||
164693127|NCT02938442|594899305|FG000|Overall Study|Lost to Follow-up|0|||
164693128|NCT02938442|594899306|FG001|Overall Study|Lost to Follow-up|1|||
164693129|NCT02938442|594899305|FG000|Overall Study|Physician Decision|0|||
164693130|NCT02938442|594899306|FG001|Overall Study|Physician Decision|1|||
164693131|NCT02938442|594899305|FG000|Overall Study|Withdrawal by Subject|2|||
164693132|NCT02938442|594899306|FG001|Overall Study|Withdrawal by Subject|0|||
164693133|NCT00480324|594899307|FG000|Overall Study|Adverse Event|1|||
164693134|NCT00480324|594899308|FG001|Overall Study|Adverse Event|1|||
164693135|NCT00480324|594899307|FG000|Overall Study|Protocol Violation|0|||
164693136|NCT00480324|594899308|FG001|Overall Study|Protocol Violation|1|||
164693137|NCT00480324|594899307|FG000|Overall Study|Withdrawal by Subject|14|||
164693138|NCT00480324|594899308|FG001|Overall Study|Withdrawal by Subject|5|||
164693139|NCT00480324|594899307|FG000|Overall Study|Lost to Follow-up|17|||
164693140|NCT00480324|594899308|FG001|Overall Study|Lost to Follow-up|8|||
164693141|NCT00480324|594899307|FG000|Overall Study|Subject's mother pregnant|0|||
164693142|NCT00480324|594899308|FG001|Overall Study|Subject's mother pregnant|1|||
164693143|NCT00966381|594899309|FG000|Overall Study|Withdrawal by Subject|2|||
164693144|NCT00966381|594899310|FG001|Overall Study|Withdrawal by Subject|2|||
164693145|NCT01915940|594899311|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
164693146|NCT01915940|594899312|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
164693147|NCT01915940|594899313|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
164693148|NCT01915940|594899311|FG000|Treatment Period|Decision of Participant|0|||
164693149|NCT01915940|594899312|FG001|Treatment Period|Decision of Participant|1|||
164693150|NCT01915940|594899313|FG002|Treatment Period|Decision of Participant|3|||
164693151|NCT01915940|594899311|FG000|Treatment Period|Adverse Event|0|||
164693152|NCT01915940|594899312|FG001|Treatment Period|Adverse Event|9|||
164693153|NCT01915940|594899313|FG002|Treatment Period|Adverse Event|1|||
164693154|NCT01915940|594899311|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
164693155|NCT01915940|594899312|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
164693156|NCT01915940|594899313|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
164693157|NCT03686150|594899314|FG000|Overall Study|Withdrawal by Subject|1|||
164693158|NCT03686150|594899315|FG001|Overall Study|Withdrawal by Subject|1|||
164693159|NCT03686150|594899316|FG002|Overall Study|Withdrawal by Subject|1|||
164693160|NCT03686150|594899317|FG003|Overall Study|Withdrawal by Subject|0|||
164693161|NCT03686150|594899318|FG004|Overall Study|Withdrawal by Subject|1|||
164693162|NCT03686150|594899319|FG005|Overall Study|Withdrawal by Subject|2|||
164693163|NCT03686150|594899314|FG000|Overall Study|Physician Decision|1|||
164693164|NCT03686150|594899315|FG001|Overall Study|Physician Decision|0|||
164693165|NCT03686150|594899316|FG002|Overall Study|Physician Decision|0|||
164693166|NCT03686150|594899317|FG003|Overall Study|Physician Decision|0|||
164693167|NCT03686150|594899318|FG004|Overall Study|Physician Decision|0|||
164693168|NCT03686150|594899319|FG005|Overall Study|Physician Decision|1|||
164693169|NCT03686150|594899314|FG000|Overall Study|Lost to Follow-up|0|||
164693170|NCT03686150|594899315|FG001|Overall Study|Lost to Follow-up|1|||
164693171|NCT03686150|594899316|FG002|Overall Study|Lost to Follow-up|0|||
164693172|NCT03686150|594899317|FG003|Overall Study|Lost to Follow-up|0|||
164693173|NCT03686150|594899318|FG004|Overall Study|Lost to Follow-up|0|||
164693174|NCT03686150|594899319|FG005|Overall Study|Lost to Follow-up|0|||
164294522|NCT02542865|593452167|FG001|Overall Study|Withdrawal by Subject|0|||
164294523|NCT01277744|593452170|FG000|Overall Study|Physician Decision|2|||
164294524|NCT02358473|593452172|FG000|Overall Study|Disease Progession|6|||
164294525|NCT02358473|593452172|FG000|Overall Study|Adverse Event|3|||
164294526|NCT02358473|593452172|FG000|Overall Study|Withdrawal by Subject|2|||
164693175|NCT02443324|594899320|FG000|Overall Study|Death|4|||
164294527|NCT02358473|593452172|FG000|Overall Study|Physician Decision|2|||
164294528|NCT00730158|593452175|FG000|Overall Study|Withdrawal by Subject|1|||
164294529|NCT00730158|593452176|FG001|Overall Study|Withdrawal by Subject|1|||
164294530|NCT03535974|593452178|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
164294531|NCT03535974|593452179|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
164294532|NCT03535974|593452180|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
164294533|NCT03535974|593452178|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
164294534|NCT03535974|593452179|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
164294535|NCT03535974|593452180|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
164294536|NCT04059549|593452181|FG000|Overall Study|Withdrawal by Subject|2|||
164294537|NCT04059549|593452182|FG001|Overall Study|Withdrawal by Subject|0|||
164294538|NCT02678351|593452183|FG000|Overall Study|Withdrawal by Subject|1|||
164294539|NCT03259230|593452184|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
164693176|NCT02443324|594899321|FG001|Overall Study|Death|1|||
164693177|NCT02443324|594899322|FG002|Overall Study|Death|0|||
164693178|NCT02443324|594899323|FG003|Overall Study|Death|3|||
164693179|NCT02443324|594899324|FG004|Overall Study|Death|1|||
164693180|NCT02443324|594899325|FG005|Overall Study|Death|3|||
164693181|NCT02443324|594899326|FG006|Overall Study|Death|2|||
164693182|NCT02443324|594899320|FG000|Overall Study|Lost to Follow-up|0|||
164693183|NCT02443324|594899321|FG001|Overall Study|Lost to Follow-up|0|||
164693184|NCT02443324|594899322|FG002|Overall Study|Lost to Follow-up|0|||
164693185|NCT02443324|594899323|FG003|Overall Study|Lost to Follow-up|1|||
164693186|NCT02443324|594899324|FG004|Overall Study|Lost to Follow-up|0|||
164693187|NCT02443324|594899325|FG005|Overall Study|Lost to Follow-up|1|||
164693188|NCT02443324|594899326|FG006|Overall Study|Lost to Follow-up|0|||
164693189|NCT02443324|594899320|FG000|Overall Study|Physician Decision|0|||
164693190|NCT02443324|594899321|FG001|Overall Study|Physician Decision|3|||
164693191|NCT02443324|594899322|FG002|Overall Study|Physician Decision|5|||
164693192|NCT02443324|594899323|FG003|Overall Study|Physician Decision|1|||
164693193|NCT02443324|594899324|FG004|Overall Study|Physician Decision|1|||
164693194|NCT02443324|594899325|FG005|Overall Study|Physician Decision|0|||
164693195|NCT02443324|594899326|FG006|Overall Study|Physician Decision|2|||
164693196|NCT02443324|594899320|FG000|Overall Study|Progressive Disease|20|||
164693197|NCT02443324|594899321|FG001|Overall Study|Progressive Disease|20|||
164693198|NCT02443324|594899322|FG002|Overall Study|Progressive Disease|13|||
164693199|NCT02443324|594899323|FG003|Overall Study|Progressive Disease|10|||
164693200|NCT02443324|594899324|FG004|Overall Study|Progressive Disease|13|||
164693201|NCT02443324|594899325|FG005|Overall Study|Progressive Disease|17|||
164693202|NCT02443324|594899326|FG006|Overall Study|Progressive Disease|10|||
164693203|NCT02443324|594899320|FG000|Overall Study|Withdrawal by Subject|0|||
164693204|NCT02443324|594899321|FG001|Overall Study|Withdrawal by Subject|0|||
164693205|NCT02443324|594899322|FG002|Overall Study|Withdrawal by Subject|3|||
164693206|NCT02443324|594899323|FG003|Overall Study|Withdrawal by Subject|1|||
164294540|NCT03259230|593452185|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
164294541|NCT02913482|593452186|FG000|Overall Study|Death|0|||
164294542|NCT02913482|593452187|FG001|Overall Study|Death|2|||
164294543|NCT02913482|593452188|FG002|Overall Study|Death|2|||
164294544|NCT02913482|593452186|FG000|Overall Study|Progressive Disease|1|||
164294545|NCT02913482|593452187|FG001|Overall Study|Progressive Disease|1|||
164294546|NCT02913482|593452188|FG002|Overall Study|Progressive Disease|1|||
164294547|NCT02913482|593452186|FG000|Overall Study|Reason not specified|0|||
164294548|NCT02913482|593452187|FG001|Overall Study|Reason not specified|0|||
164294549|NCT02913482|593452188|FG002|Overall Study|Reason not specified|1|||
164294550|NCT02913482|593452186|FG000|Overall Study|Withdrawal by Subject|0|||
164294551|NCT02913482|593452187|FG001|Overall Study|Withdrawal by Subject|1|||
164294552|NCT02913482|593452188|FG002|Overall Study|Withdrawal by Subject|1|||
164294553|NCT01919229|593452189|FG000|Overall Study|Subject/guardian decision|0|||
164294554|NCT01919229|593452190|FG001|Overall Study|Subject/guardian decision|0|||
164294555|NCT01919229|593452191|FG002|Overall Study|Subject/guardian decision|1|||
164693207|NCT02443324|594899324|FG004|Overall Study|Withdrawal by Subject|1|||
164693208|NCT02443324|594899325|FG005|Overall Study|Withdrawal by Subject|0|||
164693209|NCT02443324|594899326|FG006|Overall Study|Withdrawal by Subject|1|||
164294556|NCT01011673|593452192|FG000|Randomized|Secondary headache|2|||
164294557|NCT01011673|593452193|FG001|Randomized|Secondary headache|1|||
164294558|NCT01011673|593452192|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
164294559|NCT01011673|593452193|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
164294560|NCT05468814|593452194|FG000|Overall Study|Lost to Follow-up|5|||
164294561|NCT05468814|593452195|FG001|Overall Study|Lost to Follow-up|6|||
164294562|NCT04716426|593452200|FG000|Overall Study|Vaccination|1|||
164693210|NCT02443324|594899320|FG000|Overall Study|Adverse Event|0|||
164693211|NCT02443324|594899321|FG001|Overall Study|Adverse Event|1|||
164693212|NCT02443324|594899322|FG002|Overall Study|Adverse Event|3|||
164693213|NCT02443324|594899323|FG003|Overall Study|Adverse Event|0|||
164693214|NCT02443324|594899324|FG004|Overall Study|Adverse Event|4|||
164693215|NCT02443324|594899325|FG005|Overall Study|Adverse Event|3|||
164693216|NCT02443324|594899326|FG006|Overall Study|Adverse Event|3|||
164693217|NCT02443324|594899320|FG000|Overall Study|Enrolled but Never Treated|0|||
164294563|NCT04716426|593452201|FG001|Overall Study|Vaccination|1|||
164294564|NCT04716426|593452200|FG000|Overall Study|Contamination|1|||
164294565|NCT04716426|593452201|FG001|Overall Study|Contamination|0|||
164434688|NCT05827926|593960768|FG010|Overall Study|Physician Decision|0|||
164587273|NCT02075255|594513798|FG002|Overall Study|Death|0|||
164587274|NCT01469013|594513799|FG000|Part A (Treatment Period)|Adverse Event|1|||
164434689|NCT05827926|593960769|FG011|Overall Study|Physician Decision|0|||
164587275|NCT01469013|594513800|FG001|Part A (Treatment Period)|Adverse Event|0|||
164587276|NCT01469013|594513801|FG002|Part A (Treatment Period)|Adverse Event|0|||
164587277|NCT01469013|594513802|FG003|Part A (Treatment Period)|Adverse Event|0|||
164587278|NCT01469013|594513803|FG004|Part A (Treatment Period)|Adverse Event|1|||
164587279|NCT01469013|594513804|FG005|Part A (Treatment Period)|Adverse Event|0|||
164587280|NCT01469013|594513805|FG006|Part A (Treatment Period)|Adverse Event|0|||
164587281|NCT01469013|594513806|FG007|Part A (Treatment Period)|Adverse Event|0|||
164587282|NCT01469013|594513807|FG008|Part A (Treatment Period)|Adverse Event|0|||
164587283|NCT01469013|594513808|FG009|Part A (Treatment Period)|Adverse Event|0|||
164587284|NCT01469013|594513809|FG010|Part A (Treatment Period)|Adverse Event|0|||
164587285|NCT01469013|594513810|FG011|Part A (Treatment Period)|Adverse Event|0|||
164587286|NCT01469013|594513811|FG012|Part A (Treatment Period)|Adverse Event|0|||
164587287|NCT01469013|594513799|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
164587288|NCT01469013|594513800|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
164587289|NCT01469013|594513801|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
164587290|NCT01469013|594513802|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
164587291|NCT01469013|594513803|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
164587292|NCT01469013|594513804|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
164587293|NCT01469013|594513805|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
164587294|NCT01469013|594513806|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
164587295|NCT01469013|594513807|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
164587296|NCT01469013|594513808|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
164587297|NCT01469013|594513809|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
164587298|NCT01469013|594513810|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
164587299|NCT01469013|594513811|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
164587300|NCT01469013|594513799|FG000|Part B (Extension Period)|Adverse Event|0|||
164587301|NCT01469013|594513800|FG001|Part B (Extension Period)|Adverse Event|0|||
164587302|NCT01469013|594513801|FG002|Part B (Extension Period)|Adverse Event|0|||
164587303|NCT01469013|594513802|FG003|Part B (Extension Period)|Adverse Event|0|||
164587304|NCT01469013|594513803|FG004|Part B (Extension Period)|Adverse Event|0|||
164587305|NCT01469013|594513804|FG005|Part B (Extension Period)|Adverse Event|2|||
164587306|NCT01469013|594513805|FG006|Part B (Extension Period)|Adverse Event|5|||
164587307|NCT01469013|594513806|FG007|Part B (Extension Period)|Adverse Event|5|||
164587308|NCT01469013|594513807|FG008|Part B (Extension Period)|Adverse Event|3|||
164587309|NCT01469013|594513808|FG009|Part B (Extension Period)|Adverse Event|3|||
164587310|NCT01469013|594513809|FG010|Part B (Extension Period)|Adverse Event|1|||
164587311|NCT01469013|594513810|FG011|Part B (Extension Period)|Adverse Event|6|||
164587312|NCT01469013|594513811|FG012|Part B (Extension Period)|Adverse Event|3|||
164587313|NCT01469013|594513799|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
164587314|NCT01469013|594513800|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
164587315|NCT01469013|594513801|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
164587316|NCT01469013|594513802|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
164587317|NCT01469013|594513803|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
164587318|NCT01469013|594513804|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
164587319|NCT01469013|594513805|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
164587320|NCT01469013|594513806|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
164587321|NCT01469013|594513807|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
164587322|NCT01469013|594513808|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
164587323|NCT01469013|594513809|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
164587324|NCT01469013|594513810|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
164587325|NCT01469013|594513811|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
164587326|NCT05232097|594513812|FG000|Overall Study|Physician Decision|1|||
164587327|NCT00425438|594513813|FG000|Overall Study|Termination by Sponsor|25|||
164587328|NCT00425438|594513814|FG001|Overall Study|Termination by Sponsor|27|||
164587329|NCT01172288|594513815|FG000|Overall Study|Adverse Event|1|||
164587330|NCT01172288|594513816|FG001|Overall Study|Adverse Event|0|||
164587331|NCT01172288|594513815|FG000|Overall Study|Protocol Violation|0|||
164587332|NCT01172288|594513816|FG001|Overall Study|Protocol Violation|1|||
164587333|NCT01327339|594513817|FG000|Overall Study|Protocol Violation|8|||
164587334|NCT03303339|594513820|FG000|Overall Study|Death|2|||
164587335|NCT03303339|594513821|FG001|Overall Study|Death|2|||
164587336|NCT03303339|594513822|FG002|Overall Study|Death|2|||
164587337|NCT03303339|594513823|FG003|Overall Study|Death|1|||
164587338|NCT03303339|594513824|FG004|Overall Study|Death|4|||
164587339|NCT03303339|594513825|FG005|Overall Study|Death|2|||
164294566|NCT01650558|593452204|FG000|Overall Study|Migration out of study area|61|||
164587340|NCT03303339|594513826|FG006|Overall Study|Death|2|||
164587341|NCT03303339|594513827|FG007|Overall Study|Death|2|||
164587342|NCT03303339|594513828|FG008|Overall Study|Death|3|||
164294567|NCT01650558|593452205|FG001|Overall Study|Migration out of study area|71|||
164294568|NCT01650558|593452206|FG002|Overall Study|Migration out of study area|56|||
164294569|NCT01650558|593452204|FG000|Overall Study|Lost to Follow-up|10|||
164294570|NCT01650558|593452205|FG001|Overall Study|Lost to Follow-up|13|||
164294571|NCT01650558|593452206|FG002|Overall Study|Lost to Follow-up|6|||
164294572|NCT01650558|593452204|FG000|Overall Study|Death|10|||
164294573|NCT01650558|593452205|FG001|Overall Study|Death|6|||
164294574|NCT01650558|593452206|FG002|Overall Study|Death|8|||
164294575|NCT01650558|593452204|FG000|Overall Study|Withdrawal by Subject|1|||
164294576|NCT01650558|593452205|FG001|Overall Study|Withdrawal by Subject|1|||
164294577|NCT01650558|593452206|FG002|Overall Study|Withdrawal by Subject|3|||
164294578|NCT01650558|593452204|FG000|Overall Study|Non-compliant participant|1|||
164294579|NCT01650558|593452205|FG001|Overall Study|Non-compliant participant|0|||
164294580|NCT01650558|593452206|FG002|Overall Study|Non-compliant participant|2|||
164294581|NCT01650558|593452204|FG000|Overall Study|Physician Decision|0|||
164294582|NCT01650558|593452205|FG001|Overall Study|Physician Decision|1|||
164294583|NCT01650558|593452206|FG002|Overall Study|Physician Decision|0|||
164294584|NCT02960217|593452207|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
164294585|NCT02960217|593452208|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
164294586|NCT02960217|593452207|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
164294587|NCT02960217|593452208|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
164294588|NCT02960217|593452207|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
164294589|NCT02960217|593452208|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
164294590|NCT02960217|593452207|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
164294591|NCT02960217|593452208|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
164294592|NCT02960217|593452207|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
164434690|NCT05827926|593960770|FG012|Overall Study|Physician Decision|0|||
164434691|NCT05827926|593960771|FG013|Overall Study|Physician Decision|0|||
164434692|NCT05827926|593960772|FG014|Overall Study|Physician Decision|0|||
164434693|NCT05827926|593960773|FG015|Overall Study|Physician Decision|0|||
164434694|NCT05827926|593960774|FG016|Overall Study|Physician Decision|0|||
164434695|NCT05827926|593960775|FG017|Overall Study|Physician Decision|0|||
164434696|NCT05827926|593960776|FG018|Overall Study|Physician Decision|1|||
164434697|NCT05827926|593960777|FG019|Overall Study|Physician Decision|0|||
164434698|NCT05827926|593960778|FG020|Overall Study|Physician Decision|0|||
164434699|NCT05827926|593960779|FG021|Overall Study|Physician Decision|0|||
164434700|NCT05827926|593960780|FG022|Overall Study|Physician Decision|0|||
164434701|NCT05827926|593960781|FG023|Overall Study|Physician Decision|0|||
164434702|NCT05827926|593960782|FG024|Overall Study|Physician Decision|0|||
164434703|NCT05827926|593960783|FG025|Overall Study|Physician Decision|0|||
164434704|NCT05827926|593960784|FG026|Overall Study|Physician Decision|0|||
164434705|NCT05827926|593960785|FG027|Overall Study|Physician Decision|0|||
164294593|NCT02960217|593452208|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
164294594|NCT02960217|593452207|FG000|Open-Label Extension Phase|Adverse Event|1|||
164294595|NCT02960217|593452208|FG001|Open-Label Extension Phase|Adverse Event|0|||
164294596|NCT02960217|593452207|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
164294597|NCT02960217|593452208|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
164294598|NCT02960217|593452207|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
164434706|NCT05827926|593960786|FG028|Overall Study|Physician Decision|0|||
164294599|NCT02960217|593452208|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
164294600|NCT02960217|593452207|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
164294601|NCT02960217|593452208|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
164294602|NCT02734693|593452209|FG000|Overall Study|Adverse Event|1|||
164294603|NCT02734693|593452210|FG001|Overall Study|Adverse Event|3|||
164294604|NCT02734693|593452211|FG002|Overall Study|Adverse Event|3|||
164434707|NCT05827926|593960787|FG029|Overall Study|Physician Decision|0|||
164434708|NCT05827926|593960788|FG030|Overall Study|Physician Decision|0|||
164434709|NCT05827926|593960789|FG031|Overall Study|Physician Decision|0|||
164434710|NCT05827926|593960790|FG032|Overall Study|Physician Decision|0|||
164434711|NCT05827926|593960791|FG033|Overall Study|Physician Decision|0|||
164434712|NCT05827926|593960792|FG034|Overall Study|Physician Decision|0|||
164434713|NCT05827926|593960793|FG035|Overall Study|Physician Decision|0|||
164434714|NCT05827926|593960794|FG036|Overall Study|Physician Decision|0|||
164434715|NCT04588480|593960802|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
164434716|NCT04588480|593960803|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
164434717|NCT04588480|593960804|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
164434718|NCT04588480|593960802|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
164434719|NCT04588480|593960803|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
164434720|NCT04588480|593960804|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
164434721|NCT01242085|593960805|FG000|Overall Study|Withdrawal by Subject|4|||
164434722|NCT01242085|593960806|FG001|Overall Study|Withdrawal by Subject|2|||
164434723|NCT01242085|593960807|FG002|Overall Study|Withdrawal by Subject|0|||
164434724|NCT01242085|593960805|FG000|Overall Study|medically unable to have surgery|4|||
164434725|NCT01242085|593960806|FG001|Overall Study|medically unable to have surgery|5|||
164434726|NCT01242085|593960807|FG002|Overall Study|medically unable to have surgery|0|||
164434727|NCT02430532|593960809|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
164434728|NCT02430532|593960810|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
164434729|NCT02430532|593960809|FG000|Overall Study|Consent Withdrawn|0|||
164434730|NCT02430532|593960810|FG001|Overall Study|Consent Withdrawn|2|||
164434731|NCT02430532|593960809|FG000|Overall Study|Adverse Event|0|||
164434732|NCT02430532|593960810|FG001|Overall Study|Adverse Event|1|||
164434733|NCT01190150|593960811|FG000|First Treatment|Withdrawal by Subject|1|||
164434734|NCT01190150|593960812|FG001|First Treatment|Withdrawal by Subject|0|||
164434735|NCT01190150|593960811|FG000|Washout|Withdrawal by Subject|0|||
164434736|NCT01190150|593960812|FG001|Washout|Withdrawal by Subject|1|||
164434737|NCT01190150|593960811|FG000|Washout|Difficulty in adherence|0|||
164434738|NCT01190150|593960812|FG001|Washout|Difficulty in adherence|1|||
164434739|NCT04511650|593960813|FG000|Overall Study|Lost to Follow-up|1|||
164434740|NCT04511650|593960814|FG001|Overall Study|Lost to Follow-up|0|||
164434741|NCT04511650|593960815|FG002|Overall Study|Lost to Follow-up|0|||
164434742|NCT04511650|593960813|FG000|Overall Study|Withdrawal by Subject|1|||
164434743|NCT04511650|593960814|FG001|Overall Study|Withdrawal by Subject|0|||
164434744|NCT04511650|593960815|FG002|Overall Study|Withdrawal by Subject|0|||
164434745|NCT04511650|593960813|FG000|Overall Study|reason not provided|0|||
164434746|NCT04511650|593960814|FG001|Overall Study|reason not provided|0|||
164434747|NCT04511650|593960815|FG002|Overall Study|reason not provided|1|||
164434748|NCT04511650|593960813|FG000|Overall Study|Death|1|||
164434749|NCT04511650|593960814|FG001|Overall Study|Death|1|||
164434750|NCT04511650|593960815|FG002|Overall Study|Death|1|||
164434751|NCT05650333|593960816|FG000|Treatment Period (7 Days)|Adverse Event|1|||
164434752|NCT02873754|593960817|FG000|Overall Study|Lost to Follow-up|5|||
164434753|NCT02873754|593960817|FG000|Overall Study|Couldn't complete study procedures|1|||
164434754|NCT01981850|593960818|FG000|Main Phase Stage 1|Death|2|||
164434755|NCT01981850|593960819|FG001|Main Phase Stage 1|Death|0|||
164434756|NCT01981850|593960820|FG002|Main Phase Stage 1|Death|0|||
164434757|NCT01981850|593960821|FG003|Main Phase Stage 1|Death|0|||
164434758|NCT01981850|593960822|FG004|Main Phase Stage 1|Death|0|||
164434759|NCT01981850|593960823|FG005|Main Phase Stage 1|Death|0|||
164434760|NCT01981850|593960824|FG006|Main Phase Stage 1|Death|0|||
164434761|NCT01981850|593960825|FG007|Main Phase Stage 1|Death|0|||
164434762|NCT01981850|593960826|FG008|Main Phase Stage 1|Death|0|||
164294605|NCT02734693|593452209|FG000|Overall Study|Lack of Efficacy|1|||
164434763|NCT01981850|593960827|FG009|Main Phase Stage 1|Death|0|||
164434764|NCT01981850|593960818|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
164434765|NCT01981850|593960819|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
164294606|NCT02734693|593452210|FG001|Overall Study|Lack of Efficacy|0|||
164294607|NCT02734693|593452211|FG002|Overall Study|Lack of Efficacy|0|||
164294608|NCT02734693|593452209|FG000|Overall Study|Lost to Follow-up|2|||
164294609|NCT02734693|593452210|FG001|Overall Study|Lost to Follow-up|0|||
164434766|NCT01981850|593960820|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
164434767|NCT01981850|593960821|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
164434768|NCT01981850|593960822|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
164434769|NCT01981850|593960823|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
164434770|NCT01981850|593960824|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
164434771|NCT01981850|593960825|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
164434772|NCT01981850|593960826|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
164294610|NCT02734693|593452211|FG002|Overall Study|Lost to Follow-up|0|||
164294611|NCT02734693|593452209|FG000|Overall Study|Protocol Violation|1|||
164294612|NCT02734693|593452210|FG001|Overall Study|Protocol Violation|0|||
164294613|NCT02734693|593452211|FG002|Overall Study|Protocol Violation|0|||
164294614|NCT02734693|593452209|FG000|Overall Study|Withdrawal by Subject|1|||
164294615|NCT02734693|593452210|FG001|Overall Study|Withdrawal by Subject|0|||
164294616|NCT02734693|593452211|FG002|Overall Study|Withdrawal by Subject|0|||
164294617|NCT02675907|593452215|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
164294618|NCT02675907|593452216|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
164294619|NCT02675907|593452215|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
164294620|NCT02675907|593452216|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
164294621|NCT02675907|593452215|FG000|Study Overall|Lack of Efficacy|1|||
164294622|NCT02675907|593452216|FG001|Study Overall|Lack of Efficacy|0|||
164294623|NCT02675907|593452215|FG000|Study Overall|Withdrawal by Subject|2|||
164294624|NCT02675907|593452216|FG001|Study Overall|Withdrawal by Subject|2|||
164294625|NCT02675907|593452215|FG000|Study Overall|Lost to Follow-up|0|||
164294626|NCT02675907|593452216|FG001|Study Overall|Lost to Follow-up|2|||
164294627|NCT01611792|593452217|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
164294628|NCT01611792|593452218|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
164294629|NCT01611792|593452217|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
164294630|NCT01611792|593452218|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
164294631|NCT03416868|593452219|FG000|Overall Study|Withdrawal by Subject|2|||
164294632|NCT03416868|593452219|FG000|Overall Study|Lost to Follow-up|1|||
164294633|NCT00960375|593452222|FG000|Overall Study|Lost to Follow-up|20|||
164294634|NCT00960375|593452223|FG001|Overall Study|Lost to Follow-up|22|||
164294635|NCT03624881|593452224|FG000|Overall Study|Screen Failure|14|||
164294636|NCT03624881|593452225|FG001|Overall Study|Screen Failure|0|||
164294637|NCT03624881|593452224|FG000|Overall Study|No Catheter Inserted|6|||
164294638|NCT03624881|593452225|FG001|Overall Study|No Catheter Inserted|1|||
164294639|NCT03624881|593452224|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
164294640|NCT03624881|593452225|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
164294641|NCT03624881|593452224|FG000|Overall Study|Death|2|||
164294642|NCT03624881|593452225|FG001|Overall Study|Death|0|||
164294643|NCT03624881|593452224|FG000|Overall Study|Lost to Follow-up|10|||
164294644|NCT03624881|593452225|FG001|Overall Study|Lost to Follow-up|4|||
164294645|NCT03624881|593452224|FG000|Overall Study|Withdrawal by Subject|12|||
164294646|NCT03624881|593452225|FG001|Overall Study|Withdrawal by Subject|1|||
164294647|NCT03473236|593452227|FG000|Overall Study|Withdrawal by Subject|0|||
164294648|NCT03473236|593452228|FG001|Overall Study|Withdrawal by Subject|0|||
164294649|NCT03473236|593452229|FG002|Overall Study|Withdrawal by Subject|0|||
164294650|NCT03473236|593452230|FG003|Overall Study|Withdrawal by Subject|0|||
164294651|NCT03473236|593452231|FG004|Overall Study|Withdrawal by Subject|0|||
164294652|NCT03473236|593452232|FG005|Overall Study|Withdrawal by Subject|1|||
164294653|NCT03473236|593452233|FG006|Overall Study|Withdrawal by Subject|0|||
164294654|NCT03473236|593452234|FG007|Overall Study|Withdrawal by Subject|0|||
164294655|NCT03473236|593452235|FG008|Overall Study|Withdrawal by Subject|1|||
164294656|NCT03473236|593452236|FG009|Overall Study|Withdrawal by Subject|0|||
164294657|NCT04264442|593452237|FG000|Overall Study|Lack of Efficacy|6|||
164294658|NCT04264442|593452237|FG000|Overall Study|Lost to Follow-up|2|||
164294659|NCT04264442|593452237|FG000|Overall Study|Sponsor Decision|23|||
164294660|NCT04264442|593452237|FG000|Overall Study|Withdrawal by Subject|11|||
164294661|NCT04264442|593452237|FG000|Overall Study|Study Termination|5|||
164294662|NCT03309020|593452238|FG000|Overall Study|Death|1|||
164434773|NCT01981850|593960827|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
164434774|NCT01981850|593960818|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
164294663|NCT03309020|593452239|FG001|Overall Study|Death|0|||
164294664|NCT03309020|593452238|FG000|Overall Study|Did not undergo surgery|2|||
164294665|NCT03309020|593452239|FG001|Overall Study|Did not undergo surgery|1|||
164294666|NCT02362724|593452246|FG000|Overall Study|Withdrawal by Subject|3|||
164294667|NCT02362724|593452247|FG001|Overall Study|Withdrawal by Subject|1|||
164294668|NCT02362724|593452246|FG000|Overall Study|Adverse Event|3|||
164294669|NCT02362724|593452247|FG001|Overall Study|Adverse Event|0|||
164294670|NCT05190120|593452250|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
164294671|NCT05190120|593452251|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
164294672|NCT05190120|593452252|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
164294673|NCT05190120|593452253|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
164294674|NCT05190120|593452250|FG000|Overall Study|Lost to Follow-up|5|||
164294675|NCT05190120|593452251|FG001|Overall Study|Lost to Follow-up|0|||
164294676|NCT05190120|593452252|FG002|Overall Study|Lost to Follow-up|2|||
164294677|NCT05190120|593452253|FG003|Overall Study|Lost to Follow-up|3|||
164294678|NCT03062358|593452254|FG000|Overall Study|Death|269|||
164294679|NCT03062358|593452255|FG001|Overall Study|Death|145|||
164294680|NCT03062358|593452254|FG000|Overall Study|Withdrawal by Subject|2|||
164587343|NCT03303339|594513829|FG009|Overall Study|Death|3|||
164587344|NCT03303339|594513830|FG010|Overall Study|Death|4|||
164587345|NCT03303339|594513831|FG011|Overall Study|Death|24|||
164587346|NCT03303339|594513820|FG000|Overall Study|Study Terminated by Sponsor|0|||
164587347|NCT03303339|594513821|FG001|Overall Study|Study Terminated by Sponsor|0|||
164294681|NCT03062358|593452255|FG001|Overall Study|Withdrawal by Subject|1|||
164346886|NCT02801331|593645188|FG001|Overall Study|Transferred to another hospital|7|||
164434775|NCT01981850|593960819|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
164434776|NCT01981850|593960820|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
164434777|NCT01981850|593960821|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
164434778|NCT01981850|593960822|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
164434779|NCT01981850|593960823|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
164434780|NCT01981850|593960824|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
164434781|NCT01981850|593960825|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
164434782|NCT01981850|593960826|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
164434783|NCT01981850|593960827|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
164434784|NCT01981850|593960818|FG000|Main Phase Stage 1|Various reasons|0|||
164434785|NCT01981850|593960819|FG001|Main Phase Stage 1|Various reasons|0|||
164434786|NCT01981850|593960820|FG002|Main Phase Stage 1|Various reasons|2|||
164434787|NCT01981850|593960821|FG003|Main Phase Stage 1|Various reasons|0|||
164434788|NCT01981850|593960822|FG004|Main Phase Stage 1|Various reasons|0|||
164587348|NCT03303339|594513822|FG002|Overall Study|Study Terminated by Sponsor|0|||
164587349|NCT03303339|594513823|FG003|Overall Study|Study Terminated by Sponsor|0|||
164294682|NCT03062358|593452254|FG000|Overall Study|Sponsor Decision|29|||
164294683|NCT03062358|593452255|FG001|Overall Study|Sponsor Decision|7|||
164294684|NCT05893862|593452256|FG000|Overall Study|Physician Decision|0|||
164294685|NCT05893862|593452257|FG001|Overall Study|Physician Decision|1|||
164294686|NCT05893862|593452258|FG002|Overall Study|Physician Decision|0|||
164294687|NCT05893862|593452259|FG003|Overall Study|Physician Decision|0|||
164294688|NCT05893862|593452260|FG004|Overall Study|Physician Decision|1|||
164294689|NCT05893862|593452261|FG005|Overall Study|Physician Decision|0|||
164294690|NCT05893862|593452256|FG000|Overall Study|Withdrawal by Subject|1|||
164294691|NCT05893862|593452257|FG001|Overall Study|Withdrawal by Subject|7|||
164294692|NCT05893862|593452258|FG002|Overall Study|Withdrawal by Subject|1|||
164294693|NCT05893862|593452259|FG003|Overall Study|Withdrawal by Subject|3|||
164294694|NCT05893862|593452260|FG004|Overall Study|Withdrawal by Subject|3|||
164294695|NCT05893862|593452261|FG005|Overall Study|Withdrawal by Subject|2|||
164294696|NCT05893862|593452256|FG000|Overall Study|Adverse Event|1|||
164294697|NCT05893862|593452257|FG001|Overall Study|Adverse Event|4|||
164294698|NCT05893862|593452258|FG002|Overall Study|Adverse Event|2|||
164294699|NCT05893862|593452259|FG003|Overall Study|Adverse Event|2|||
164294700|NCT05893862|593452260|FG004|Overall Study|Adverse Event|1|||
164346887|NCT02801331|593645187|FG000|Overall Study|Withdrawal by Subject|0|||
164346888|NCT02801331|593645188|FG001|Overall Study|Withdrawal by Subject|4|||
164346889|NCT02801331|593645187|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
164346890|NCT02801331|593645188|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
164346891|NCT02443987|593645189|FG000|Overall Study|Bladder injury|1|||
164346892|NCT02443987|593645190|FG001|Overall Study|Bladder injury|1|||
164346893|NCT02443987|593645189|FG000|Overall Study|Other|0|||
164346894|NCT02443987|593645190|FG001|Overall Study|Other|1|||
164346895|NCT00407797|593646738|FG000|Overall Study|Lost to Follow-up|2|||
164346896|NCT00407797|593646738|FG000|Overall Study|Adverse Event|6|||
164346897|NCT00407797|593646738|FG000|Overall Study|Other|7|||
164346898|NCT00407797|593646738|FG000|Overall Study|Withdrawal by Subject|3|||
164346899|NCT01402492|593646742|FG000|Overall Study|Withdrawal by Subject|17|||
164346900|NCT01402492|593646743|FG001|Overall Study|Withdrawal by Subject|11|||
164346901|NCT01402492|593646744|FG002|Overall Study|Withdrawal by Subject|11|||
164346902|NCT01402492|593646742|FG000|Overall Study|Adverse Event|2|||
164346903|NCT01402492|593646743|FG001|Overall Study|Adverse Event|3|||
164346904|NCT01402492|593646744|FG002|Overall Study|Adverse Event|4|||
164434789|NCT01981850|593960823|FG005|Main Phase Stage 1|Various reasons|0|||
164294701|NCT05893862|593452261|FG005|Overall Study|Adverse Event|0|||
164294702|NCT04158583|593452262|FG000|Overall Study|Withdrawal by Subject|1|||
164346905|NCT01402492|593646742|FG000|Overall Study|Physician Decision|0|||
164346906|NCT01402492|593646743|FG001|Overall Study|Physician Decision|3|||
164294703|NCT04158583|593452263|FG001|Overall Study|Withdrawal by Subject|1|||
164294704|NCT04158583|593452264|FG002|Overall Study|Withdrawal by Subject|0|||
164294705|NCT04158583|593452265|FG003|Overall Study|Withdrawal by Subject|0|||
164294706|NCT04158583|593452266|FG004|Overall Study|Withdrawal by Subject|1|||
164294707|NCT04158583|593452267|FG005|Overall Study|Withdrawal by Subject|0|||
164294708|NCT04158583|593452268|FG006|Overall Study|Withdrawal by Subject|0|||
164294709|NCT04158583|593452269|FG007|Overall Study|Withdrawal by Subject|0|||
164346907|NCT01402492|593646744|FG002|Overall Study|Physician Decision|0|||
164346908|NCT01402492|593646742|FG000|Overall Study|Incarcerated (N=3)|2|||
164346909|NCT01402492|593646743|FG001|Overall Study|Incarcerated (N=3)|0|||
164434790|NCT01981850|593960824|FG006|Main Phase Stage 1|Various reasons|0|||
164587350|NCT03303339|594513824|FG004|Overall Study|Study Terminated by Sponsor|0|||
164294710|NCT04158583|593452270|FG008|Overall Study|Withdrawal by Subject|2|||
164294711|NCT04158583|593452271|FG009|Overall Study|Withdrawal by Subject|0|||
164294712|NCT04158583|593452262|FG000|Overall Study|Study Terminated by Sponsor|0|||
164294713|NCT04158583|593452263|FG001|Overall Study|Study Terminated by Sponsor|0|||
164294714|NCT04158583|593452264|FG002|Overall Study|Study Terminated by Sponsor|0|||
164294715|NCT04158583|593452265|FG003|Overall Study|Study Terminated by Sponsor|1|||
164294716|NCT04158583|593452266|FG004|Overall Study|Study Terminated by Sponsor|0|||
164294717|NCT04158583|593452267|FG005|Overall Study|Study Terminated by Sponsor|0|||
164294718|NCT04158583|593452268|FG006|Overall Study|Study Terminated by Sponsor|0|||
164294719|NCT04158583|593452269|FG007|Overall Study|Study Terminated by Sponsor|0|||
164294720|NCT04158583|593452270|FG008|Overall Study|Study Terminated by Sponsor|0|||
164294721|NCT04158583|593452271|FG009|Overall Study|Study Terminated by Sponsor|0|||
164294722|NCT04158583|593452262|FG000|Overall Study|Progressive Disease|1|||
164294723|NCT04158583|593452263|FG001|Overall Study|Progressive Disease|0|||
164294724|NCT04158583|593452264|FG002|Overall Study|Progressive Disease|3|||
164294725|NCT04158583|593452265|FG003|Overall Study|Progressive Disease|5|||
164294726|NCT04158583|593452266|FG004|Overall Study|Progressive Disease|0|||
164294727|NCT04158583|593452267|FG005|Overall Study|Progressive Disease|1|||
164294728|NCT04158583|593452268|FG006|Overall Study|Progressive Disease|6|||
164294729|NCT04158583|593452269|FG007|Overall Study|Progressive Disease|2|||
164294730|NCT04158583|593452270|FG008|Overall Study|Progressive Disease|1|||
164294731|NCT04158583|593452271|FG009|Overall Study|Progressive Disease|2|||
164294732|NCT04158583|593452262|FG000|Overall Study|Lost to Follow-up|0|||
164294733|NCT04158583|593452263|FG001|Overall Study|Lost to Follow-up|0|||
164294734|NCT04158583|593452264|FG002|Overall Study|Lost to Follow-up|1|||
164294735|NCT04158583|593452265|FG003|Overall Study|Lost to Follow-up|1|||
164294736|NCT04158583|593452266|FG004|Overall Study|Lost to Follow-up|1|||
164294737|NCT04158583|593452267|FG005|Overall Study|Lost to Follow-up|0|||
164294738|NCT04158583|593452268|FG006|Overall Study|Lost to Follow-up|0|||
164294739|NCT04158583|593452269|FG007|Overall Study|Lost to Follow-up|0|||
164294740|NCT04158583|593452270|FG008|Overall Study|Lost to Follow-up|0|||
164294741|NCT04158583|593452271|FG009|Overall Study|Lost to Follow-up|0|||
164294742|NCT04158583|593452262|FG000|Overall Study|Due To Patient Status|0|||
164346910|NCT01402492|593646744|FG002|Overall Study|Incarcerated (N=3)|1|||
164346911|NCT00601458|593646758|FG000|Overall Study|Dosing Error|1|||
164346912|NCT00601458|593646759|FG001|Overall Study|Dosing Error|0|||
164346913|NCT00601458|593646760|FG002|Overall Study|Dosing Error|0|||
164294743|NCT04158583|593452263|FG001|Overall Study|Due To Patient Status|0|||
164346914|NCT00601458|593646758|FG000|Overall Study|Incomplete Data|0|||
164346915|NCT00601458|593646759|FG001|Overall Study|Incomplete Data|2|||
164294744|NCT04158583|593452264|FG002|Overall Study|Due To Patient Status|0|||
164294745|NCT04158583|593452265|FG003|Overall Study|Due To Patient Status|0|||
164294746|NCT04158583|593452266|FG004|Overall Study|Due To Patient Status|0|||
164294747|NCT04158583|593452267|FG005|Overall Study|Due To Patient Status|0|||
164294748|NCT04158583|593452268|FG006|Overall Study|Due To Patient Status|0|||
164294749|NCT04158583|593452269|FG007|Overall Study|Due To Patient Status|0|||
164294750|NCT04158583|593452270|FG008|Overall Study|Due To Patient Status|1|||
164346916|NCT00601458|593646760|FG002|Overall Study|Incomplete Data|0|||
164346917|NCT00601458|593646758|FG000|Overall Study|Protocol Violation|3|||
164346918|NCT00601458|593646759|FG001|Overall Study|Protocol Violation|2|||
164346919|NCT00601458|593646760|FG002|Overall Study|Protocol Violation|1|||
164346920|NCT00601458|593646758|FG000|Overall Study|Early Termination|0|||
164346921|NCT00601458|593646759|FG001|Overall Study|Early Termination|1|||
164346922|NCT00601458|593646760|FG002|Overall Study|Early Termination|1|||
164346923|NCT00518986|593646761|FG000|Overall Study|Adverse Event|12|||
164587351|NCT03303339|594513825|FG005|Overall Study|Study Terminated by Sponsor|0|||
164346924|NCT00518986|593646762|FG001|Overall Study|Adverse Event|7|||
164346925|NCT00518986|593646761|FG000|Overall Study|Lack of Efficacy|0|||
164346926|NCT00518986|593646762|FG001|Overall Study|Lack of Efficacy|2|||
164346927|NCT00518986|593646761|FG000|Overall Study|Lost to Follow-up|3|||
164346928|NCT00518986|593646762|FG001|Overall Study|Lost to Follow-up|2|||
164346929|NCT00518986|593646761|FG000|Overall Study|Physician Decision|0|||
164346930|NCT00518986|593646762|FG001|Overall Study|Physician Decision|3|||
164346931|NCT00518986|593646761|FG000|Overall Study|Protocol Violation|5|||
164346932|NCT00518986|593646762|FG001|Overall Study|Protocol Violation|7|||
164346933|NCT00518986|593646761|FG000|Overall Study|Withdrawal by Subject|4|||
164346934|NCT00518986|593646762|FG001|Overall Study|Withdrawal by Subject|4|||
164346935|NCT00518986|593646761|FG000|Overall Study|Non-Specific|2|||
164346936|NCT00518986|593646762|FG001|Overall Study|Non-Specific|1|||
164346937|NCT04862585|593646766|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
164346938|NCT04862585|593646767|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
164346939|NCT04862585|593646766|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
164346940|NCT04862585|593646767|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
164346941|NCT04862585|593646766|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
164346942|NCT04862585|593646767|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
164346943|NCT04862585|593646766|FG000|Overall Study|one withdrew without providing a reason|0|||
164346944|NCT04862585|593646767|FG001|Overall Study|one withdrew without providing a reason|1|||
164346945|NCT05288062|593646768|FG000|Overall Study|Ineligible|0|||
164346946|NCT05288062|593646769|FG001|Overall Study|Ineligible|0|||
164346947|NCT05288062|593646770|FG002|Overall Study|Ineligible|1|||
164346948|NCT05288062|593646771|FG003|Overall Study|Ineligible|0|||
164346949|NCT05288062|593646768|FG000|Overall Study|Withdrawal by Subject|0|||
164346950|NCT05288062|593646769|FG001|Overall Study|Withdrawal by Subject|0|||
164346951|NCT05288062|593646770|FG002|Overall Study|Withdrawal by Subject|1|||
164346952|NCT05288062|593646771|FG003|Overall Study|Withdrawal by Subject|0|||
164346953|NCT02099708|593646773|FG000|Overall Study|Data Not Available|30|||
164346954|NCT02099708|593646773|FG000|Overall Study|Lost to Follow-up|141|||
164346955|NCT02099708|593646773|FG000|Overall Study|Other|29|||
164346956|NCT01874054|593646774|FG000|Overall Study|Withdrawal by Subject|3|||
164346957|NCT01874054|593646774|FG000|Overall Study|Study Termination by Sponsor|42|||
164346958|NCT01874054|593646774|FG000|Overall Study|Lost to Follow-up|5|||
164346959|NCT01874054|593646774|FG000|Overall Study|Death|5|||
164346960|NCT00702923|593646775|FG000|Overall Study|Adverse Event|1|||
164346961|NCT02002091|593646776|FG000|Screening|Lost to Follow-up|10|||
164346962|NCT02002091|593646777|FG001|Screening|Lost to Follow-up|12|||
164346963|NCT02002091|593646776|FG000|Screening|Death|3|||
164346964|NCT02002091|593646777|FG001|Screening|Death|2|||
164346965|NCT03953820|593646778|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
164346966|NCT03953820|593646779|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
164346967|NCT03953820|593646780|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
164346968|NCT03953820|593646778|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
164346969|NCT03953820|593646779|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
164346970|NCT03953820|593646780|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
164294751|NCT04158583|593452271|FG009|Overall Study|Due To Patient Status|0|||
164294752|NCT04158583|593452262|FG000|Overall Study|Death|3|||
164294753|NCT04158583|593452263|FG001|Overall Study|Death|4|||
164294754|NCT04158583|593452264|FG002|Overall Study|Death|2|||
164294755|NCT04158583|593452265|FG003|Overall Study|Death|2|||
164294756|NCT04158583|593452266|FG004|Overall Study|Death|4|||
164294757|NCT04158583|593452267|FG005|Overall Study|Death|3|||
164294758|NCT04158583|593452268|FG006|Overall Study|Death|5|||
164294759|NCT04158583|593452269|FG007|Overall Study|Death|2|||
164294760|NCT04158583|593452270|FG008|Overall Study|Death|0|||
164294761|NCT04158583|593452271|FG009|Overall Study|Death|1|||
164294762|NCT04158583|593452262|FG000|Overall Study|Clinical Progression Disease|0|||
164294763|NCT04158583|593452263|FG001|Overall Study|Clinical Progression Disease|0|||
164294764|NCT04158583|593452264|FG002|Overall Study|Clinical Progression Disease|0|||
164294765|NCT04158583|593452265|FG003|Overall Study|Clinical Progression Disease|1|||
164294766|NCT04158583|593452266|FG004|Overall Study|Clinical Progression Disease|0|||
164294767|NCT04158583|593452267|FG005|Overall Study|Clinical Progression Disease|0|||
164294768|NCT04158583|593452268|FG006|Overall Study|Clinical Progression Disease|0|||
164346971|NCT01233258|593646783|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
164346972|NCT01233258|593646784|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
164346973|NCT01233258|593646785|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
164346974|NCT01233258|593646786|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
164346975|NCT01233258|593646787|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
164346976|NCT01233258|593646788|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
164346977|NCT01233258|593646783|FG000|First Intervention (6 Months)|Protocol Violation|0|||
164346978|NCT01233258|593646784|FG001|First Intervention (6 Months)|Protocol Violation|0|||
164294769|NCT04158583|593452269|FG007|Overall Study|Clinical Progression Disease|0|||
164693218|NCT02443324|594899321|FG001|Overall Study|Enrolled but Never Treated|0|||
164693219|NCT02443324|594899322|FG002|Overall Study|Enrolled but Never Treated|1|||
164693220|NCT02443324|594899323|FG003|Overall Study|Enrolled but Never Treated|0|||
164693221|NCT02443324|594899324|FG004|Overall Study|Enrolled but Never Treated|1|||
164693222|NCT02443324|594899325|FG005|Overall Study|Enrolled but Never Treated|0|||
164693223|NCT02443324|594899326|FG006|Overall Study|Enrolled but Never Treated|1|||
164693224|NCT03346070|594899329|FG000|Overall Study|Death|0|||
164693225|NCT03346070|594899330|FG001|Overall Study|Death|0|||
164693226|NCT03346070|594899331|FG002|Overall Study|Death|0|||
164693227|NCT03346070|594899332|FG003|Overall Study|Death|0|||
164693228|NCT03346070|594899333|FG004|Overall Study|Death|1|||
164693229|NCT03346070|594899329|FG000|Overall Study|Lost to Follow-up|0|||
164693230|NCT03346070|594899330|FG001|Overall Study|Lost to Follow-up|1|||
164693231|NCT03346070|594899331|FG002|Overall Study|Lost to Follow-up|2|||
164693232|NCT03346070|594899332|FG003|Overall Study|Lost to Follow-up|0|||
164693233|NCT03346070|594899333|FG004|Overall Study|Lost to Follow-up|0|||
164693234|NCT03346070|594899329|FG000|Overall Study|Physician Decision|0|||
164693235|NCT03346070|594899330|FG001|Overall Study|Physician Decision|0|||
164693236|NCT03346070|594899331|FG002|Overall Study|Physician Decision|0|||
164693237|NCT03346070|594899332|FG003|Overall Study|Physician Decision|1|||
164693238|NCT03346070|594899333|FG004|Overall Study|Physician Decision|1|||
164693239|NCT03346070|594899329|FG000|Overall Study|Withdrawal by Subject|1|||
164693240|NCT03346070|594899330|FG001|Overall Study|Withdrawal by Subject|0|||
164693241|NCT03346070|594899331|FG002|Overall Study|Withdrawal by Subject|0|||
164693242|NCT03346070|594899332|FG003|Overall Study|Withdrawal by Subject|1|||
164693243|NCT03346070|594899333|FG004|Overall Study|Withdrawal by Subject|0|||
164693244|NCT03346070|594899329|FG000|Overall Study|Study medication not received as planned|2|||
164693245|NCT03346070|594899330|FG001|Overall Study|Study medication not received as planned|3|||
164693246|NCT03346070|594899331|FG002|Overall Study|Study medication not received as planned|2|||
164693247|NCT03346070|594899332|FG003|Overall Study|Study medication not received as planned|3|||
164693248|NCT03346070|594899333|FG004|Overall Study|Study medication not received as planned|2|||
164693249|NCT03346070|594899329|FG000|Overall Study|Screen Failure|0|||
164693250|NCT03346070|594899330|FG001|Overall Study|Screen Failure|0|||
164693251|NCT03346070|594899331|FG002|Overall Study|Screen Failure|0|||
164693252|NCT03346070|594899332|FG003|Overall Study|Screen Failure|1|||
164346979|NCT01233258|593646785|FG002|First Intervention (6 Months)|Protocol Violation|1|||
164346980|NCT01233258|593646786|FG003|First Intervention (6 Months)|Protocol Violation|0|||
164346981|NCT01233258|593646787|FG004|First Intervention (6 Months)|Protocol Violation|0|||
164346982|NCT01233258|593646788|FG005|First Intervention (6 Months)|Protocol Violation|0|||
164346983|NCT01233258|593646783|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
164346984|NCT01233258|593646784|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
164346985|NCT01233258|593646785|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
164346986|NCT01233258|593646786|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
164346987|NCT01233258|593646787|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
164346988|NCT01233258|593646788|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
164346989|NCT00530946|593646792|FG000|Overall Study|Adverse Event|1|||
164346990|NCT00530946|593646793|FG001|Overall Study|Adverse Event|2|||
164346991|NCT00530946|593646794|FG002|Overall Study|Adverse Event|1|||
164346992|NCT00530946|593646795|FG003|Overall Study|Adverse Event|1|||
164346993|NCT00530946|593646792|FG000|Overall Study|Protocol Violation|0|||
164346994|NCT00530946|593646793|FG001|Overall Study|Protocol Violation|0|||
164346995|NCT00530946|593646794|FG002|Overall Study|Protocol Violation|0|||
164346996|NCT00530946|593646795|FG003|Overall Study|Protocol Violation|1|||
164346997|NCT00530946|593646792|FG000|Overall Study|Noncompliance|1|||
164346998|NCT00530946|593646793|FG001|Overall Study|Noncompliance|0|||
164346999|NCT00530946|593646794|FG002|Overall Study|Noncompliance|0|||
164347000|NCT00530946|593646795|FG003|Overall Study|Noncompliance|0|||
164347001|NCT01534962|593646796|FG000|Overall Study|Randomized but did not start treatment|2|||
164347002|NCT01534962|593646797|FG001|Overall Study|Randomized but did not start treatment|0|||
164347003|NCT01534962|593646798|FG002|Overall Study|Randomized but did not start treatment|0|||
164347004|NCT01534962|593646799|FG003|Overall Study|Randomized but did not start treatment|1|||
164347005|NCT01534962|593646796|FG000|Overall Study|Discontinued at AF recurrence|35|||
164693253|NCT03346070|594899333|FG004|Overall Study|Screen Failure|1|||
164693254|NCT00988208|594899337|FG000|Overall Study|Adverse Event|71|||
164693255|NCT00988208|594899338|FG001|Overall Study|Adverse Event|122|||
164693256|NCT00988208|594899337|FG000|Overall Study|Disease Progression|103|||
164693257|NCT00988208|594899338|FG001|Overall Study|Disease Progression|89|||
164693258|NCT00988208|594899337|FG000|Overall Study|Withdrawal by Subject|50|||
164693259|NCT00988208|594899338|FG001|Overall Study|Withdrawal by Subject|57|||
164693260|NCT00988208|594899337|FG000|Overall Study|Death|9|||
164693261|NCT00988208|594899338|FG001|Overall Study|Death|15|||
164347006|NCT01534962|593646797|FG001|Overall Study|Discontinued at AF recurrence|26|||
164417817|NCT01757665|593899523|FG000|Overall Study|Lost to Follow-up|1|||
164693262|NCT00988208|594899337|FG000|Overall Study|Lost to Follow-up|2|||
164693263|NCT00988208|594899338|FG001|Overall Study|Lost to Follow-up|3|||
164347007|NCT01534962|593646798|FG002|Overall Study|Discontinued at AF recurrence|24|||
164693264|NCT00988208|594899337|FG000|Overall Study|Protocol Violation|9|||
164693265|NCT00988208|594899338|FG001|Overall Study|Protocol Violation|2|||
164693266|NCT00988208|594899337|FG000|Overall Study|Sponsor Decision|102|||
164693267|NCT00988208|594899338|FG001|Overall Study|Sponsor Decision|78|||
164693268|NCT00988208|594899337|FG000|Overall Study|Clinical Progression|17|||
164693269|NCT00988208|594899338|FG001|Overall Study|Clinical Progression|16|||
164693270|NCT00988208|594899337|FG000|Overall Study|Biochemical Progression|21|||
164693271|NCT00988208|594899338|FG001|Overall Study|Biochemical Progression|7|||
164693272|NCT00988208|594899337|FG000|Overall Study|Clinical Deterioration|7|||
164693273|NCT00988208|594899338|FG001|Overall Study|Clinical Deterioration|14|||
164693274|NCT00988208|594899337|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
164693275|NCT00988208|594899338|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
164693276|NCT00988208|594899337|FG000|Overall Study|Other|8|||
164693277|NCT00988208|594899338|FG001|Overall Study|Other|3|||
164693278|NCT01613378|594899345|FG000|Overall Study|Lack of Efficacy|13|||
164693279|NCT01613378|594899345|FG000|Overall Study|Adverse Event|11|||
164693280|NCT01613378|594899345|FG000|Overall Study|Withdrawal by Subject|8|||
164693281|NCT01613378|594899345|FG000|Overall Study|Death|2|||
164693282|NCT01613378|594899345|FG000|Overall Study|Lost to Follow-up|1|||
164693283|NCT01613378|594899345|FG000|Overall Study|Other Reason|4|||
164693284|NCT00317642|594899346|FG000|Overall Study|Not Received Either Study Drug|1|||
164693285|NCT00317642|594899347|FG001|Overall Study|Not Received Either Study Drug|3|||
164693286|NCT00317642|594899346|FG000|Overall Study|Physician Decision|15|||
164693287|NCT00317642|594899347|FG001|Overall Study|Physician Decision|7|||
164693288|NCT00317642|594899346|FG000|Overall Study|Participant declined treatment|14|||
164693289|NCT00317642|594899347|FG001|Overall Study|Participant declined treatment|3|||
164693290|NCT00317642|594899346|FG000|Overall Study|Adverse Event|17|||
164693291|NCT00317642|594899347|FG001|Overall Study|Adverse Event|5|||
164693292|NCT00317642|594899346|FG000|Overall Study|Treatment Failure|56|||
164693293|NCT00317642|594899347|FG001|Overall Study|Treatment Failure|102|||
164693294|NCT00317642|594899346|FG000|Overall Study|Disease Recurrence|1|||
164693295|NCT00317642|594899347|FG001|Overall Study|Disease Recurrence|2|||
164693296|NCT00317642|594899346|FG000|Overall Study|Death|14|||
164693297|NCT00317642|594899347|FG001|Overall Study|Death|7|||
164693298|NCT00317642|594899346|FG000|Overall Study|Not Continue to Consolidation|2|||
164693299|NCT00317642|594899347|FG001|Overall Study|Not Continue to Consolidation|0|||
164693300|NCT00317642|594899346|FG000|Overall Study|Withdrawal by Subject|0|||
164693301|NCT00317642|594899347|FG001|Overall Study|Withdrawal by Subject|1|||
164693302|NCT00317642|594899346|FG000|Overall Study|Referred For Transplantation|1|||
164693303|NCT00317642|594899347|FG001|Overall Study|Referred For Transplantation|0|||
164693304|NCT00317642|594899346|FG000|Overall Study|AML Not Centrally Confirmed|1|||
164693305|NCT00317642|594899347|FG001|Overall Study|AML Not Centrally Confirmed|5|||
164693306|NCT00880087|594899348|FG000|Overall Study|Lost to Follow-up|0|||
164693307|NCT00880087|594899349|FG001|Overall Study|Lost to Follow-up|2|||
164693308|NCT01239472|594899352|FG000|Overall Study|Withdrawal by Subject|5|||
164693309|NCT01239472|594899353|FG001|Overall Study|Withdrawal by Subject|1|||
164693310|NCT01239472|594899352|FG000|Overall Study|Adverse Event|0|||
164693311|NCT01239472|594899353|FG001|Overall Study|Adverse Event|1|||
164693312|NCT01239472|594899352|FG000|Overall Study|Lack of Efficacy|0|||
164693313|NCT01239472|594899353|FG001|Overall Study|Lack of Efficacy|1|||
164693314|NCT00418522|594899357|FG000|Overall Study|Adverse Event|7|||
164693315|NCT00418522|594899358|FG001|Overall Study|Adverse Event|1|||
164693316|NCT00418522|594899357|FG000|Overall Study|Lack of Efficacy|1|||
164693317|NCT00418522|594899358|FG001|Overall Study|Lack of Efficacy|3|||
164693318|NCT00418522|594899357|FG000|Overall Study|Lost to Follow-up|10|||
164693319|NCT00418522|594899358|FG001|Overall Study|Lost to Follow-up|4|||
164693320|NCT00418522|594899357|FG000|Overall Study|Withdrawal by Subject|31|||
164693321|NCT00418522|594899358|FG001|Overall Study|Withdrawal by Subject|7|||
164693322|NCT00418522|594899357|FG000|Overall Study|Other|27|||
164693323|NCT00418522|594899358|FG001|Overall Study|Other|23|||
164693324|NCT00418522|594899357|FG000|Overall Study|Randomized but did not receive treatment|7|||
164693325|NCT00418522|594899358|FG001|Overall Study|Randomized but did not receive treatment|4|||
164693326|NCT01005329|594899359|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
164693327|NCT01206439|594899362|FG000|Overall Study|subject did not meet inclusion criteria|1|||
164693328|NCT01466036|594899367|FG000|Overall Study|Death|1|||
164693329|NCT01466036|594899368|FG001|Overall Study|Death|1|||
164693330|NCT01466036|594899367|FG000|Overall Study|Physician Decision|0|||
164693331|NCT01466036|594899368|FG001|Overall Study|Physician Decision|4|||
164693332|NCT01466036|594899367|FG000|Overall Study|Adverse Event|2|||
164693333|NCT01466036|594899368|FG001|Overall Study|Adverse Event|6|||
164693334|NCT01466036|594899367|FG000|Overall Study|Withdrawal by Subject|2|||
164693335|NCT01466036|594899368|FG001|Overall Study|Withdrawal by Subject|8|||
164693336|NCT01466036|594899367|FG000|Overall Study|progression/relapse|14|||
164693337|NCT01466036|594899368|FG001|Overall Study|progression/relapse|21|||
164693338|NCT01466036|594899367|FG000|Overall Study|prolonged treatment delay|1|||
164347008|NCT01534962|593646799|FG003|Overall Study|Discontinued at AF recurrence|31|||
164347009|NCT00880009|593646804|FG000|Overall Study|Study terminated by sponsor|14|||
164693339|NCT01466036|594899368|FG001|Overall Study|prolonged treatment delay|1|||
164693340|NCT01808248|594899375|FG000|Overall Study|Lack of Efficacy|3|||
164693341|NCT01808248|594899375|FG000|Overall Study|Withdrawal by Subject|1|||
164693342|NCT01808248|594899375|FG000|Overall Study|Lost to Follow-up|1|||
164693343|NCT03635983|594899383|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
164693344|NCT03635983|594899384|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
164693345|NCT03635983|594899383|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
164693346|NCT03635983|594899384|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164693347|NCT03635983|594899383|FG000|Pre-Treatment Period|Other reasons|0|||
164693348|NCT03635983|594899384|FG001|Pre-Treatment Period|Other reasons|1|||
164693349|NCT03635983|594899383|FG000|Pre-Treatment Period|Disease Progression|0|||
164693350|NCT03635983|594899384|FG001|Pre-Treatment Period|Disease Progression|1|||
164693351|NCT03635983|594899383|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
164693352|NCT03635983|594899384|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
164693353|NCT03635983|594899383|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
164693354|NCT03635983|594899384|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
164693355|NCT03635983|594899383|FG000|Treatment Period|Withdrawal by Subject|3|||
164693356|NCT03635983|594899384|FG001|Treatment Period|Withdrawal by Subject|5|||
164693357|NCT03635983|594899383|FG000|Treatment Period|Death|3|||
164693358|NCT03635983|594899384|FG001|Treatment Period|Death|5|||
164693359|NCT03635983|594899383|FG000|Treatment Period|Poor/Non-compliance|2|||
164693360|NCT03635983|594899384|FG001|Treatment Period|Poor/Non-compliance|1|||
164693361|NCT03635983|594899383|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
164693362|NCT03635983|594899384|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
164693363|NCT03635983|594899383|FG000|Treatment Period|Other reasons|7|||
164693364|NCT03635983|594899384|FG001|Treatment Period|Other reasons|4|||
164693365|NCT03635983|594899383|FG000|Treatment Period|Disease progression|230|||
164693366|NCT03635983|594899384|FG001|Treatment Period|Disease progression|201|||
164417818|NCT01757665|593899524|FG001|Overall Study|Lost to Follow-up|1|||
164434791|NCT01981850|593960825|FG007|Main Phase Stage 1|Various reasons|0|||
164434792|NCT01981850|593960826|FG008|Main Phase Stage 1|Various reasons|0|||
164434793|NCT01981850|593960827|FG009|Main Phase Stage 1|Various reasons|0|||
164434794|NCT01981850|593960818|FG000|Main Phase Stage 2|Adverse Event|0|||
164434795|NCT01981850|593960819|FG001|Main Phase Stage 2|Adverse Event|0|||
164434796|NCT01981850|593960820|FG002|Main Phase Stage 2|Adverse Event|0|||
164434797|NCT01981850|593960821|FG003|Main Phase Stage 2|Adverse Event|0|||
164434798|NCT01981850|593960822|FG004|Main Phase Stage 2|Adverse Event|6|||
164434799|NCT01981850|593960823|FG005|Main Phase Stage 2|Adverse Event|5|||
164434800|NCT01981850|593960824|FG006|Main Phase Stage 2|Adverse Event|7|||
164434801|NCT01981850|593960825|FG007|Main Phase Stage 2|Adverse Event|0|||
164434802|NCT01981850|593960826|FG008|Main Phase Stage 2|Adverse Event|0|||
164434803|NCT01981850|593960827|FG009|Main Phase Stage 2|Adverse Event|0|||
164434804|NCT01981850|593960818|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
164434805|NCT01981850|593960819|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
164434806|NCT01981850|593960820|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
164434807|NCT01981850|593960821|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
164434808|NCT01981850|593960822|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
164434809|NCT01981850|593960823|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
164434810|NCT01981850|593960824|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
164434811|NCT01981850|593960825|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
164434812|NCT01981850|593960826|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
164434813|NCT01981850|593960827|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
164434814|NCT01981850|593960818|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
164434815|NCT01981850|593960819|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
164434816|NCT01981850|593960820|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
164434817|NCT01981850|593960821|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
164434818|NCT01981850|593960822|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
164434819|NCT01981850|593960823|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
164434820|NCT01981850|593960824|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
164434821|NCT01981850|593960825|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
164434822|NCT01981850|593960826|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
164434823|NCT01981850|593960827|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
164434824|NCT01981850|593960818|FG000|Main Phase Stage 2|Various reasons|0|||
164434825|NCT01981850|593960819|FG001|Main Phase Stage 2|Various reasons|0|||
164434826|NCT01981850|593960820|FG002|Main Phase Stage 2|Various reasons|0|||
164434827|NCT01981850|593960821|FG003|Main Phase Stage 2|Various reasons|0|||
164434828|NCT01981850|593960822|FG004|Main Phase Stage 2|Various reasons|2|||
164434829|NCT01981850|593960823|FG005|Main Phase Stage 2|Various reasons|0|||
164434830|NCT01981850|593960824|FG006|Main Phase Stage 2|Various reasons|1|||
164434831|NCT01981850|593960825|FG007|Main Phase Stage 2|Various reasons|0|||
164434832|NCT01981850|593960826|FG008|Main Phase Stage 2|Various reasons|0|||
164434833|NCT01981850|593960827|FG009|Main Phase Stage 2|Various reasons|0|||
164434834|NCT01981850|593960818|FG000|Main Phase Stage 2|Progressive Disease|0|||
164434835|NCT01981850|593960819|FG001|Main Phase Stage 2|Progressive Disease|0|||
164434836|NCT01981850|593960820|FG002|Main Phase Stage 2|Progressive Disease|0|||
164434837|NCT01981850|593960821|FG003|Main Phase Stage 2|Progressive Disease|0|||
164434838|NCT01981850|593960822|FG004|Main Phase Stage 2|Progressive Disease|0|||
164434839|NCT01981850|593960823|FG005|Main Phase Stage 2|Progressive Disease|6|||
164434840|NCT01981850|593960824|FG006|Main Phase Stage 2|Progressive Disease|6|||
164434841|NCT01981850|593960825|FG007|Main Phase Stage 2|Progressive Disease|0|||
164434842|NCT01981850|593960826|FG008|Main Phase Stage 2|Progressive Disease|0|||
164434843|NCT01981850|593960827|FG009|Main Phase Stage 2|Progressive Disease|0|||
164434844|NCT01981850|593960818|FG000|Open Label Extension (OLE)|Adverse Event|0|||
164434845|NCT01981850|593960819|FG001|Open Label Extension (OLE)|Adverse Event|0|||
164434846|NCT01981850|593960820|FG002|Open Label Extension (OLE)|Adverse Event|0|||
164434847|NCT01981850|593960821|FG003|Open Label Extension (OLE)|Adverse Event|0|||
164434848|NCT01981850|593960822|FG004|Open Label Extension (OLE)|Adverse Event|0|||
164434849|NCT01981850|593960823|FG005|Open Label Extension (OLE)|Adverse Event|0|||
164434850|NCT01981850|593960824|FG006|Open Label Extension (OLE)|Adverse Event|0|||
164434851|NCT01981850|593960825|FG007|Open Label Extension (OLE)|Adverse Event|2|||
164434852|NCT01981850|593960826|FG008|Open Label Extension (OLE)|Adverse Event|1|||
164434853|NCT01981850|593960827|FG009|Open Label Extension (OLE)|Adverse Event|8|||
164434854|NCT01981850|593960818|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
164434855|NCT01981850|593960819|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
164434856|NCT01981850|593960820|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
164434857|NCT01981850|593960821|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
164294770|NCT04158583|593452270|FG008|Overall Study|Clinical Progression Disease|0|||
164294771|NCT04158583|593452271|FG009|Overall Study|Clinical Progression Disease|0|||
164434858|NCT01981850|593960822|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
164587352|NCT03303339|594513826|FG006|Overall Study|Study Terminated by Sponsor|0|||
164434859|NCT01981850|593960823|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
164434860|NCT01981850|593960824|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
164434861|NCT01981850|593960825|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
164347010|NCT00880009|593646804|FG000|Overall Study|Withdrawal by Subject|1|||
164347011|NCT00880009|593646804|FG000|Overall Study|Protocol Violation|1|||
164347012|NCT03322631|593646807|FG000|Overall Study|Withdrawal by Subject|0|||
164347013|NCT03322631|593646808|FG001|Overall Study|Withdrawal by Subject|1|||
164347014|NCT03322631|593646809|FG002|Overall Study|Withdrawal by Subject|0|||
164347015|NCT03322631|593646810|FG003|Overall Study|Withdrawal by Subject|0|||
164347016|NCT03322631|593646807|FG000|Overall Study|Adverse Event|0|||
164347017|NCT03322631|593646808|FG001|Overall Study|Adverse Event|0|||
164347018|NCT03322631|593646809|FG002|Overall Study|Adverse Event|1|||
164347019|NCT03322631|593646810|FG003|Overall Study|Adverse Event|0|||
164347020|NCT01300650|593646812|FG000|Overall Study|Adverse Event|1|||
164347021|NCT00602797|593646813|FG000|Overall Study|Adverse Event|1|||
164347022|NCT03943147|593646814|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
164347023|NCT03943147|593646815|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
164347024|NCT03943147|593646814|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
164347025|NCT03943147|593646815|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
164347026|NCT03943147|593646814|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
164347027|NCT03943147|593646815|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
164347028|NCT03943147|593646814|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
164347029|NCT03943147|593646815|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
164347030|NCT03943147|593646814|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
164347031|NCT03943147|593646815|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
164347032|NCT03943147|593646814|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
164347033|NCT03943147|593646815|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
164347034|NCT01318993|593646816|FG000|Overall Study|Adverse Event|53|||
164347035|NCT01318993|593646816|FG000|Overall Study|Lack of Efficacy|121|||
164347036|NCT01318993|593646816|FG000|Overall Study|Protocol Violation|3|||
164347037|NCT01318993|593646816|FG000|Overall Study|Protocol based stopping criteria|6|||
164347038|NCT01318993|593646816|FG000|Overall Study|Study closed or terminated|174|||
164347039|NCT01318993|593646816|FG000|Overall Study|Lost to Follow-up|4|||
164347040|NCT01318993|593646816|FG000|Overall Study|Physician Decision|13|||
164347041|NCT01318993|593646816|FG000|Overall Study|Withdrawal by Subject|24|||
164347042|NCT03736447|593646820|FG000|Overall Study|Adverse Event|5|||
164347043|NCT03736447|593646821|FG001|Overall Study|Adverse Event|1|||
164587353|NCT03303339|594513827|FG007|Overall Study|Study Terminated by Sponsor|0|||
164587354|NCT03303339|594513828|FG008|Overall Study|Study Terminated by Sponsor|1|||
164347044|NCT03736447|593646820|FG000|Overall Study|Withdrawal by Subject|5|||
164347045|NCT03736447|593646821|FG001|Overall Study|Withdrawal by Subject|1|||
164587355|NCT03303339|594513829|FG009|Overall Study|Study Terminated by Sponsor|0|||
164347046|NCT03736447|593646820|FG000|Overall Study|Lost to Follow-up|1|||
164347047|NCT03736447|593646821|FG001|Overall Study|Lost to Follow-up|0|||
164347048|NCT03736447|593646820|FG000|Overall Study|Physician Decision|1|||
164347049|NCT03736447|593646821|FG001|Overall Study|Physician Decision|0|||
164347050|NCT03736447|593646820|FG000|Overall Study|Continued commitment to study treatment|3|||
164347051|NCT03736447|593646821|FG001|Overall Study|Continued commitment to study treatment|0|||
164347052|NCT03736447|593646820|FG000|Overall Study|Taste aversion to study product|0|||
164347053|NCT03736447|593646821|FG001|Overall Study|Taste aversion to study product|1|||
164347054|NCT02619175|593646822|FG000|Overall Study|Withdrawal by Subject|1|||
164347055|NCT02619175|593646823|FG001|Overall Study|Withdrawal by Subject|0|||
164347056|NCT02619175|593646822|FG000|Overall Study|foot pain|1|||
164347057|NCT02619175|593646823|FG001|Overall Study|foot pain|0|||
164347058|NCT02795832|593646827|FG000|Overall Study|Adverse Event|0|||
164347059|NCT02795832|593646828|FG001|Overall Study|Adverse Event|0|||
164347060|NCT02795832|593646829|FG002|Overall Study|Adverse Event|0|||
164347061|NCT02795832|593646830|FG003|Overall Study|Adverse Event|0|||
164347062|NCT02795832|593646831|FG004|Overall Study|Adverse Event|0|||
164347063|NCT02795832|593646832|FG005|Overall Study|Adverse Event|3|||
164347064|NCT02695329|593646835|FG000|Overall Study|Adverse Event|1|||
164347065|NCT02695329|593646836|FG001|Overall Study|Adverse Event|0|||
164347066|NCT02695329|593646835|FG000|Overall Study|Poor X-ray quality for measurement|4|||
164347067|NCT02695329|593646836|FG001|Overall Study|Poor X-ray quality for measurement|5|||
164347068|NCT01382212|593646837|FG000|Overall Study|Kidney transplant|1|||
164347069|NCT01382212|593646837|FG000|Overall Study|Withdrew consent|1|||
164347070|NCT01273597|593646838|FG000|Overall Study|Adverse Event|5|||
164347071|NCT01273597|593646838|FG000|Overall Study|Underwent Kidney Transplantation|2|||
164347072|NCT01273597|593646838|FG000|Overall Study|Reason Not Reported|1|||
164347073|NCT00393029|593646839|FG000|Overall Study|Not treated|0|||
164347074|NCT00393029|593646840|FG001|Overall Study|Not treated|1|||
164347075|NCT03547583|593646842|FG000|Overall Study|Adverse Event|16|||
164347076|NCT03547583|593646843|FG001|Overall Study|Adverse Event|11|||
164347077|NCT03547583|593646844|FG002|Overall Study|Adverse Event|10|||
164347078|NCT03547583|593646842|FG000|Overall Study|Death|11|||
164347079|NCT03547583|593646843|FG001|Overall Study|Death|7|||
164347080|NCT03547583|593646844|FG002|Overall Study|Death|4|||
164347081|NCT03547583|593646842|FG000|Overall Study|Lost to Follow-up|1|||
164347082|NCT03547583|593646843|FG001|Overall Study|Lost to Follow-up|0|||
164347083|NCT03547583|593646844|FG002|Overall Study|Lost to Follow-up|0|||
164347084|NCT03547583|593646842|FG000|Overall Study|Non-compliance with study drug|0|||
164347085|NCT03547583|593646843|FG001|Overall Study|Non-compliance with study drug|0|||
164347086|NCT03547583|593646844|FG002|Overall Study|Non-compliance with study drug|1|||
164347087|NCT03547583|593646842|FG000|Overall Study|Physician Decision|1|||
164347088|NCT03547583|593646843|FG001|Overall Study|Physician Decision|0|||
164347089|NCT03547583|593646844|FG002|Overall Study|Physician Decision|3|||
164347090|NCT03547583|593646842|FG000|Overall Study|Protocol Violation|2|||
164347091|NCT03547583|593646843|FG001|Overall Study|Protocol Violation|1|||
164347092|NCT03547583|593646844|FG002|Overall Study|Protocol Violation|1|||
164347093|NCT03547583|593646842|FG000|Overall Study|Withdrawal by Subject|12|||
164347094|NCT03547583|593646843|FG001|Overall Study|Withdrawal by Subject|19|||
164347095|NCT03547583|593646844|FG002|Overall Study|Withdrawal by Subject|10|||
164347096|NCT03547583|593646842|FG000|Overall Study|Other|2|||
164347097|NCT03547583|593646843|FG001|Overall Study|Other|2|||
164347098|NCT03547583|593646844|FG002|Overall Study|Other|3|||
164347099|NCT01846416|593646845|FG000|Treatment Phase|Death|2|||
164347100|NCT01846416|593646846|FG001|Treatment Phase|Death|9|||
164347101|NCT01846416|593646847|FG002|Treatment Phase|Death|1|||
164347102|NCT01846416|593646845|FG000|Treatment Phase|Withdrawal by Subject|2|||
164347103|NCT01846416|593646846|FG001|Treatment Phase|Withdrawal by Subject|4|||
164347104|NCT01846416|593646847|FG002|Treatment Phase|Withdrawal by Subject|2|||
164347105|NCT01846416|593646845|FG000|Treatment Phase|Other|1|||
164347106|NCT01846416|593646846|FG001|Treatment Phase|Other|5|||
164347107|NCT01846416|593646847|FG002|Treatment Phase|Other|1|||
164347108|NCT01846416|593646845|FG000|Treatment Phase|Physician Decision|1|||
164434862|NCT01981850|593960826|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
164434863|NCT01981850|593960827|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
164434864|NCT01981850|593960818|FG000|Open Label Extension (OLE)|Various reasons|0|||
164434865|NCT01981850|593960819|FG001|Open Label Extension (OLE)|Various reasons|0|||
164434866|NCT01981850|593960820|FG002|Open Label Extension (OLE)|Various reasons|0|||
164434867|NCT01981850|593960821|FG003|Open Label Extension (OLE)|Various reasons|0|||
164434868|NCT01981850|593960822|FG004|Open Label Extension (OLE)|Various reasons|0|||
164434869|NCT01981850|593960823|FG005|Open Label Extension (OLE)|Various reasons|0|||
164434870|NCT01981850|593960824|FG006|Open Label Extension (OLE)|Various reasons|0|||
164434871|NCT01981850|593960825|FG007|Open Label Extension (OLE)|Various reasons|3|||
164434872|NCT01981850|593960826|FG008|Open Label Extension (OLE)|Various reasons|1|||
164434873|NCT01981850|593960827|FG009|Open Label Extension (OLE)|Various reasons|3|||
164434874|NCT01981850|593960818|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
164434875|NCT01981850|593960819|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
164434876|NCT01981850|593960820|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
164434877|NCT01981850|593960821|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
164434878|NCT01981850|593960822|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
164434879|NCT01981850|593960823|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
164434880|NCT01981850|593960824|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
164434881|NCT01981850|593960825|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
164434882|NCT01981850|593960826|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
164434883|NCT01981850|593960827|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
164434884|NCT01981850|593960818|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
164434885|NCT01981850|593960819|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
164434886|NCT01981850|593960820|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
164693367|NCT03635983|594899383|FG000|Treatment Period|Study drug toxicity|35|||
164434887|NCT01981850|593960821|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
164434888|NCT01981850|593960822|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
164434889|NCT01981850|593960823|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
164434890|NCT01981850|593960824|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
164434891|NCT01981850|593960825|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
164434892|NCT01981850|593960826|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
164434893|NCT01981850|593960827|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
164434894|NCT01981850|593960818|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
164434895|NCT01981850|593960819|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
164434896|NCT01981850|593960820|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
164434897|NCT01981850|593960821|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
164434898|NCT01981850|593960822|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
164434899|NCT01981850|593960823|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
164434900|NCT01981850|593960824|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
164434901|NCT01981850|593960825|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
164693368|NCT03635983|594899384|FG001|Treatment Period|Study drug toxicity|36|||
164693369|NCT03635983|594899383|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
164693370|NCT03635983|594899384|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
164693371|NCT03635983|594899383|FG000|Treatment Period|Maximum clinical benefit|3|||
164693372|NCT03635983|594899384|FG001|Treatment Period|Maximum clinical benefit|5|||
164693373|NCT03635983|594899383|FG000|Treatment Period|Administrative reason by the sponsor|1|||
164693374|NCT03635983|594899384|FG001|Treatment Period|Administrative reason by the sponsor|2|||
164693375|NCT03635983|594899383|FG000|Treatment Period|Lost to Follow-up|0|||
164693376|NCT03635983|594899384|FG001|Treatment Period|Lost to Follow-up|1|||
164693377|NCT00330460|594899389|FG000|Overall Study|Physician Decision|1|||
164693378|NCT00330460|594899390|FG001|Overall Study|Physician Decision|0|||
164693379|NCT00330460|594899389|FG000|Overall Study|Adverse Event|10|||
164693380|NCT00330460|594899390|FG001|Overall Study|Adverse Event|8|||
164693381|NCT00330460|594899389|FG000|Overall Study|Withdrawal by Subject|18|||
164693382|NCT00330460|594899390|FG001|Overall Study|Withdrawal by Subject|17|||
164693383|NCT00330460|594899389|FG000|Overall Study|Death|1|||
164693384|NCT00330460|594899390|FG001|Overall Study|Death|1|||
164693385|NCT00330460|594899389|FG000|Overall Study|Ineligibility determined|1|||
164693386|NCT00330460|594899390|FG001|Overall Study|Ineligibility determined|3|||
164693387|NCT00330460|594899389|FG000|Overall Study|Lost to Follow-up|8|||
164693388|NCT00330460|594899390|FG001|Overall Study|Lost to Follow-up|3|||
164693389|NCT00330460|594899389|FG000|Overall Study|Noncompliance|2|||
164693390|NCT00330460|594899390|FG001|Overall Study|Noncompliance|1|||
164693391|NCT00330460|594899389|FG000|Overall Study|Other|1|||
164693392|NCT00330460|594899390|FG001|Overall Study|Other|0|||
164693393|NCT02808819|594899393|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
164434902|NCT01981850|593960826|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
164434903|NCT01981850|593960827|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
164693394|NCT02808819|594899394|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
164693395|NCT02808819|594899393|FG000|Overall Study|Withdrawal by Subject|10|||
164294772|NCT04158583|593452262|FG000|Overall Study|Clinical Progression|0|||
164294773|NCT04158583|593452263|FG001|Overall Study|Clinical Progression|0|||
164294774|NCT04158583|593452264|FG002|Overall Study|Clinical Progression|0|||
164294775|NCT04158583|593452265|FG003|Overall Study|Clinical Progression|0|||
164294776|NCT04158583|593452266|FG004|Overall Study|Clinical Progression|1|||
164294777|NCT04158583|593452267|FG005|Overall Study|Clinical Progression|0|||
164294778|NCT04158583|593452268|FG006|Overall Study|Clinical Progression|2|||
164294779|NCT04158583|593452269|FG007|Overall Study|Clinical Progression|0|||
164294780|NCT04158583|593452270|FG008|Overall Study|Clinical Progression|0|||
164294781|NCT04158583|593452271|FG009|Overall Study|Clinical Progression|0|||
164294782|NCT04158583|593452262|FG000|Overall Study|Clinical Deterioration|0|||
164294783|NCT04158583|593452263|FG001|Overall Study|Clinical Deterioration|0|||
164294784|NCT04158583|593452264|FG002|Overall Study|Clinical Deterioration|0|||
164294785|NCT04158583|593452265|FG003|Overall Study|Clinical Deterioration|1|||
164294786|NCT04158583|593452266|FG004|Overall Study|Clinical Deterioration|0|||
164294787|NCT04158583|593452267|FG005|Overall Study|Clinical Deterioration|0|||
164294788|NCT04158583|593452268|FG006|Overall Study|Clinical Deterioration|0|||
164294789|NCT04158583|593452269|FG007|Overall Study|Clinical Deterioration|0|||
164294790|NCT04158583|593452270|FG008|Overall Study|Clinical Deterioration|0|||
164294791|NCT04158583|593452271|FG009|Overall Study|Clinical Deterioration|1|||
164294792|NCT01766050|593454176|FG000|Overall Study|Adverse Event|1|||
164294793|NCT01766050|593454176|FG000|Overall Study|Lost to Follow-up|1|||
164294794|NCT01766050|593454176|FG000|Overall Study|Withdrawal by Subject|2|||
164294795|NCT01097668|593454177|FG000|Overall Study|Withdrawal by Subject|1|||
164294796|NCT01097668|593454178|FG001|Overall Study|Withdrawal by Subject|2|||
164294797|NCT01097668|593454177|FG000|Overall Study|Lost to Follow-up|1|||
164294798|NCT01097668|593454178|FG001|Overall Study|Lost to Follow-up|0|||
164294799|NCT00812708|593454179|FG000|Overall Study|Device could not be implanted|2|||
164294800|NCT00812708|593454179|FG000|Overall Study|Lack of medical insurance|1|||
164294801|NCT00812708|593454179|FG000|Overall Study|Switched to another study|1|||
164294802|NCT00812708|593454179|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
164347109|NCT01846416|593646846|FG001|Treatment Phase|Physician Decision|2|||
164347110|NCT01846416|593646847|FG002|Treatment Phase|Physician Decision|0|||
164347111|NCT01846416|593646845|FG000|Treatment Phase|Adverse Event|3|||
164347112|NCT01846416|593646846|FG001|Treatment Phase|Adverse Event|4|||
164347113|NCT01846416|593646847|FG002|Treatment Phase|Adverse Event|0|||
164347114|NCT01846416|593646845|FG000|Treatment Phase|Non-compliance|0|||
164347115|NCT01846416|593646846|FG001|Treatment Phase|Non-compliance|2|||
164347116|NCT01846416|593646847|FG002|Treatment Phase|Non-compliance|0|||
164347117|NCT01846416|593646845|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
164347118|NCT01846416|593646846|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
164347119|NCT01846416|593646847|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
164347120|NCT01846416|593646845|FG000|Treatment Phase|Progressive Disease|21|||
164347121|NCT01846416|593646846|FG001|Treatment Phase|Progressive Disease|63|||
164347122|NCT01846416|593646847|FG002|Treatment Phase|Progressive Disease|9|||
164347123|NCT01846416|593646845|FG000|Survival Follow-up|Death|21|||
164347124|NCT01846416|593646846|FG001|Survival Follow-up|Death|62|||
164434904|NCT03412747|593960829|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
164434905|NCT03412747|593960830|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
164693396|NCT02808819|594899394|FG001|Overall Study|Withdrawal by Subject|13|||
164693397|NCT02808819|594899393|FG000|Overall Study|Site terminated by sponsor|2|||
164294803|NCT00812708|593454179|FG000|Overall Study|Signed consent but later withdrew|3|||
164294804|NCT02421172|593454180|FG000|Period 1|Adverse Event|1|||
164294805|NCT02421172|593454181|FG001|Period 1|Adverse Event|0|||
164294806|NCT02421172|593454182|FG002|Period 1|Adverse Event|0|||
164294807|NCT02421172|593454183|FG003|Period 1|Adverse Event|0|||
164294808|NCT02421172|593454184|FG004|Period 1|Adverse Event|0|||
164294809|NCT02421172|593454180|FG000|Period 1|Lost to Follow-up|3|||
164294810|NCT02421172|593454181|FG001|Period 1|Lost to Follow-up|1|||
164294811|NCT02421172|593454182|FG002|Period 1|Lost to Follow-up|0|||
164294812|NCT02421172|593454183|FG003|Period 1|Lost to Follow-up|0|||
164294813|NCT02421172|593454184|FG004|Period 1|Lost to Follow-up|0|||
164693398|NCT02808819|594899394|FG001|Overall Study|Site terminated by sponsor|0|||
164693399|NCT02808819|594899393|FG000|Overall Study|Pregnancy|1|||
164294814|NCT02421172|593454180|FG000|Period 1|Patient/guardian decision|0|||
164294815|NCT02421172|593454181|FG001|Period 1|Patient/guardian decision|1|||
164294816|NCT02421172|593454182|FG002|Period 1|Patient/guardian decision|0|||
164434906|NCT03412747|593960831|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
164294817|NCT02421172|593454183|FG003|Period 1|Patient/guardian decision|0|||
164294818|NCT02421172|593454184|FG004|Period 1|Patient/guardian decision|0|||
164294819|NCT02421172|593454180|FG000|Period 2|Adverse Event|0|||
164294820|NCT02421172|593454181|FG001|Period 2|Adverse Event|0|||
164294821|NCT02421172|593454182|FG002|Period 2|Adverse Event|4|||
164294822|NCT02421172|593454183|FG003|Period 2|Adverse Event|0|||
164294823|NCT02421172|593454184|FG004|Period 2|Adverse Event|0|||
164347125|NCT01846416|593646847|FG002|Survival Follow-up|Death|9|||
164693400|NCT02808819|594899394|FG001|Overall Study|Pregnancy|0|||
164294824|NCT02421172|593454180|FG000|Period 2|Lost to Follow-up|0|||
164294825|NCT02421172|593454181|FG001|Period 2|Lost to Follow-up|0|||
164294826|NCT02421172|593454182|FG002|Period 2|Lost to Follow-up|0|||
164294827|NCT02421172|593454183|FG003|Period 2|Lost to Follow-up|1|||
164294828|NCT02421172|593454184|FG004|Period 2|Lost to Follow-up|0|||
164294829|NCT02421172|593454180|FG000|Period 2|Patient/guardian decision|0|||
164294830|NCT02421172|593454181|FG001|Period 2|Patient/guardian decision|0|||
164294831|NCT02421172|593454182|FG002|Period 2|Patient/guardian decision|3|||
164294832|NCT02421172|593454183|FG003|Period 2|Patient/guardian decision|2|||
164294833|NCT02421172|593454184|FG004|Period 2|Patient/guardian decision|1|||
164294834|NCT00928486|593454185|FG000|Overall Study|Adverse Event|2|||
164294835|NCT00928486|593454185|FG000|Overall Study|Disease Progression|7|||
164294836|NCT00928486|593454185|FG000|Overall Study|Withdrawal by Subject|1|||
164294837|NCT01021020|593454186|FG000|Period I|Protocol Violation|1|||
164294838|NCT01021020|593454186|FG000|Period I|Withdrawal by Subject|1|||
164294839|NCT01021020|593454186|FG000|14 Day Washout Period A|Physician Decision|1|||
164294840|NCT00755183|593454187|FG000|Overall Study|Adverse Event|5|||
164294841|NCT00755183|593454188|FG001|Overall Study|Adverse Event|2|||
164294842|NCT00755183|593454187|FG000|Overall Study|Protocol Violation|0|||
164294843|NCT00755183|593454188|FG001|Overall Study|Protocol Violation|1|||
164294844|NCT00755183|593454187|FG000|Overall Study|Withdrawal by Subject|0|||
164294845|NCT00755183|593454188|FG001|Overall Study|Withdrawal by Subject|2|||
164294846|NCT00755183|593454187|FG000|Overall Study|Administrative|2|||
164294847|NCT00755183|593454188|FG001|Overall Study|Administrative|1|||
164294848|NCT02587520|593454191|FG000|Overall Study|Protocol Violation|2|||
164294849|NCT02587520|593454192|FG001|Overall Study|Protocol Violation|0|||
164434907|NCT03412747|593960829|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
164434908|NCT03412747|593960830|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
164434909|NCT03412747|593960831|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
164434910|NCT03412747|593960829|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
164434911|NCT03412747|593960830|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
164587356|NCT03303339|594513830|FG010|Overall Study|Study Terminated by Sponsor|1|||
164587357|NCT03303339|594513831|FG011|Overall Study|Study Terminated by Sponsor|1|||
164587358|NCT03303339|594513820|FG000|Overall Study|Withdrawal by Subject|1|||
164587359|NCT03303339|594513821|FG001|Overall Study|Withdrawal by Subject|0|||
164587360|NCT03303339|594513822|FG002|Overall Study|Withdrawal by Subject|0|||
164587361|NCT03303339|594513823|FG003|Overall Study|Withdrawal by Subject|0|||
164587362|NCT03303339|594513824|FG004|Overall Study|Withdrawal by Subject|0|||
164587363|NCT03303339|594513825|FG005|Overall Study|Withdrawal by Subject|1|||
164587364|NCT03303339|594513826|FG006|Overall Study|Withdrawal by Subject|1|||
164587365|NCT03303339|594513827|FG007|Overall Study|Withdrawal by Subject|0|||
164587366|NCT03303339|594513828|FG008|Overall Study|Withdrawal by Subject|0|||
164587367|NCT03303339|594513829|FG009|Overall Study|Withdrawal by Subject|0|||
164587368|NCT03303339|594513830|FG010|Overall Study|Withdrawal by Subject|0|||
164587369|NCT03303339|594513831|FG011|Overall Study|Withdrawal by Subject|2|||
164587370|NCT03303339|594513820|FG000|Overall Study|Physician Decision|0|||
164587371|NCT03303339|594513821|FG001|Overall Study|Physician Decision|0|||
164587372|NCT03303339|594513822|FG002|Overall Study|Physician Decision|0|||
164587373|NCT03303339|594513823|FG003|Overall Study|Physician Decision|0|||
164587374|NCT03303339|594513824|FG004|Overall Study|Physician Decision|1|||
164587375|NCT03303339|594513825|FG005|Overall Study|Physician Decision|0|||
164587376|NCT03303339|594513826|FG006|Overall Study|Physician Decision|0|||
164587377|NCT03303339|594513827|FG007|Overall Study|Physician Decision|0|||
164587378|NCT03303339|594513828|FG008|Overall Study|Physician Decision|0|||
164587379|NCT03303339|594513829|FG009|Overall Study|Physician Decision|0|||
164587380|NCT03303339|594513830|FG010|Overall Study|Physician Decision|0|||
164587381|NCT03303339|594513831|FG011|Overall Study|Physician Decision|0|||
164587382|NCT03303339|594513820|FG000|Overall Study|Safety/Non-compliance|0|||
164587383|NCT03303339|594513821|FG001|Overall Study|Safety/Non-compliance|0|||
164587384|NCT03303339|594513822|FG002|Overall Study|Safety/Non-compliance|0|||
164587385|NCT03303339|594513823|FG003|Overall Study|Safety/Non-compliance|0|||
164587386|NCT03303339|594513824|FG004|Overall Study|Safety/Non-compliance|0|||
164587387|NCT03303339|594513825|FG005|Overall Study|Safety/Non-compliance|0|||
164587388|NCT03303339|594513826|FG006|Overall Study|Safety/Non-compliance|0|||
164587389|NCT03303339|594513827|FG007|Overall Study|Safety/Non-compliance|0|||
164587390|NCT03303339|594513828|FG008|Overall Study|Safety/Non-compliance|0|||
164587391|NCT03303339|594513829|FG009|Overall Study|Safety/Non-compliance|0|||
164587392|NCT03303339|594513830|FG010|Overall Study|Safety/Non-compliance|0|||
164693401|NCT02808819|594899393|FG000|Overall Study|Lost to Follow-up|1|||
164294850|NCT02587520|593454193|FG002|Overall Study|Protocol Violation|0|||
164294851|NCT02587520|593454194|FG003|Overall Study|Protocol Violation|2|||
164294852|NCT02587520|593454195|FG004|Overall Study|Protocol Violation|0|||
164294853|NCT02587520|593454196|FG005|Overall Study|Protocol Violation|1|||
164294854|NCT02587520|593454197|FG006|Overall Study|Protocol Violation|1|||
164294855|NCT02587520|593454198|FG007|Overall Study|Protocol Violation|1|||
164294856|NCT02587520|593454199|FG008|Overall Study|Protocol Violation|3|||
164294857|NCT02587520|593454200|FG009|Overall Study|Protocol Violation|3|||
164294858|NCT02587520|593454201|FG010|Overall Study|Protocol Violation|1|||
164294859|NCT02587520|593454202|FG011|Overall Study|Protocol Violation|2|||
164294860|NCT02587520|593454203|FG012|Overall Study|Protocol Violation|0|||
164294861|NCT02587520|593454204|FG013|Overall Study|Protocol Violation|0|||
164294862|NCT02587520|593454205|FG014|Overall Study|Protocol Violation|0|||
164294863|NCT02587520|593454206|FG015|Overall Study|Protocol Violation|0|||
164294864|NCT02587520|593454207|FG016|Overall Study|Protocol Violation|0|||
164294865|NCT02587520|593454208|FG017|Overall Study|Protocol Violation|0|||
164294866|NCT02587520|593454191|FG000|Overall Study|Adverse Event|0|||
164294867|NCT02587520|593454192|FG001|Overall Study|Adverse Event|0|||
164294868|NCT02587520|593454193|FG002|Overall Study|Adverse Event|0|||
164294869|NCT02587520|593454194|FG003|Overall Study|Adverse Event|0|||
164294870|NCT02587520|593454195|FG004|Overall Study|Adverse Event|0|||
164294871|NCT02587520|593454196|FG005|Overall Study|Adverse Event|0|||
164294872|NCT02587520|593454197|FG006|Overall Study|Adverse Event|0|||
164294873|NCT02587520|593454198|FG007|Overall Study|Adverse Event|0|||
164294874|NCT02587520|593454199|FG008|Overall Study|Adverse Event|0|||
164294875|NCT02587520|593454200|FG009|Overall Study|Adverse Event|0|||
164294876|NCT02587520|593454201|FG010|Overall Study|Adverse Event|0|||
164294877|NCT02587520|593454202|FG011|Overall Study|Adverse Event|1|||
164294878|NCT02587520|593454203|FG012|Overall Study|Adverse Event|0|||
164294879|NCT02587520|593454204|FG013|Overall Study|Adverse Event|0|||
164294880|NCT02587520|593454205|FG014|Overall Study|Adverse Event|0|||
164294881|NCT02587520|593454206|FG015|Overall Study|Adverse Event|0|||
164294882|NCT02587520|593454207|FG016|Overall Study|Adverse Event|0|||
164294883|NCT02587520|593454208|FG017|Overall Study|Adverse Event|0|||
164294884|NCT02587520|593454191|FG000|Overall Study|Withdrawal by Subject|0|||
164294885|NCT02587520|593454192|FG001|Overall Study|Withdrawal by Subject|0|||
164294886|NCT02587520|593454193|FG002|Overall Study|Withdrawal by Subject|1|||
164294887|NCT02587520|593454194|FG003|Overall Study|Withdrawal by Subject|1|||
164294888|NCT02587520|593454195|FG004|Overall Study|Withdrawal by Subject|0|||
164294889|NCT02587520|593454196|FG005|Overall Study|Withdrawal by Subject|1|||
164294890|NCT02587520|593454197|FG006|Overall Study|Withdrawal by Subject|1|||
164294891|NCT02587520|593454198|FG007|Overall Study|Withdrawal by Subject|0|||
164294892|NCT02587520|593454199|FG008|Overall Study|Withdrawal by Subject|0|||
164294893|NCT02587520|593454200|FG009|Overall Study|Withdrawal by Subject|0|||
164294894|NCT02587520|593454201|FG010|Overall Study|Withdrawal by Subject|0|||
164294895|NCT02587520|593454202|FG011|Overall Study|Withdrawal by Subject|0|||
164294896|NCT02587520|593454203|FG012|Overall Study|Withdrawal by Subject|0|||
164294897|NCT02587520|593454204|FG013|Overall Study|Withdrawal by Subject|1|||
164294898|NCT02587520|593454205|FG014|Overall Study|Withdrawal by Subject|0|||
164294899|NCT02587520|593454206|FG015|Overall Study|Withdrawal by Subject|0|||
164294900|NCT02587520|593454207|FG016|Overall Study|Withdrawal by Subject|0|||
164294901|NCT02587520|593454208|FG017|Overall Study|Withdrawal by Subject|0|||
164294902|NCT02587520|593454191|FG000|Overall Study|Lost to Follow-up|0|||
164294903|NCT02587520|593454192|FG001|Overall Study|Lost to Follow-up|2|||
164294904|NCT02587520|593454193|FG002|Overall Study|Lost to Follow-up|0|||
164294905|NCT02587520|593454194|FG003|Overall Study|Lost to Follow-up|2|||
164294906|NCT02587520|593454195|FG004|Overall Study|Lost to Follow-up|0|||
164294907|NCT02587520|593454196|FG005|Overall Study|Lost to Follow-up|1|||
164294908|NCT02587520|593454197|FG006|Overall Study|Lost to Follow-up|1|||
164294909|NCT02587520|593454198|FG007|Overall Study|Lost to Follow-up|1|||
164294910|NCT02587520|593454199|FG008|Overall Study|Lost to Follow-up|0|||
164294911|NCT02587520|593454200|FG009|Overall Study|Lost to Follow-up|2|||
164294912|NCT02587520|593454201|FG010|Overall Study|Lost to Follow-up|2|||
164294913|NCT02587520|593454202|FG011|Overall Study|Lost to Follow-up|1|||
164294914|NCT02587520|593454203|FG012|Overall Study|Lost to Follow-up|0|||
164294915|NCT02587520|593454204|FG013|Overall Study|Lost to Follow-up|0|||
164294916|NCT02587520|593454205|FG014|Overall Study|Lost to Follow-up|0|||
164294917|NCT02587520|593454206|FG015|Overall Study|Lost to Follow-up|0|||
164294918|NCT02587520|593454207|FG016|Overall Study|Lost to Follow-up|0|||
164294919|NCT02587520|593454208|FG017|Overall Study|Lost to Follow-up|0|||
164294920|NCT00672555|593454209|FG000|Overall Study|Lost to Follow-up|4|||
164294921|NCT00672555|593454209|FG000|Overall Study|Did not want to answer questionnaire|2|||
164294922|NCT04516746|593454212|FG000|Overall Study|Randomized but not Treated|51|||
164294923|NCT04516746|593454213|FG001|Overall Study|Randomized but not Treated|19|||
164294924|NCT04516746|593454212|FG000|Overall Study|Adverse Event|0|||
164294925|NCT04516746|593454213|FG001|Overall Study|Adverse Event|1|||
164294926|NCT04516746|593454212|FG000|Overall Study|Death|62|||
164294927|NCT04516746|593454213|FG001|Overall Study|Death|32|||
164294928|NCT04516746|593454212|FG000|Overall Study|Lost to Follow-up|3431|||
164294929|NCT04516746|593454213|FG001|Overall Study|Lost to Follow-up|1831|||
164294930|NCT04516746|593454212|FG000|Overall Study|Withdrawal by Subject|1946|||
164294931|NCT04516746|593454213|FG001|Overall Study|Withdrawal by Subject|1696|||
164294932|NCT04516746|593454212|FG000|Overall Study|Physician Decision|10|||
164294933|NCT04516746|593454213|FG001|Overall Study|Physician Decision|8|||
164294934|NCT04516746|593454212|FG000|Overall Study|Other|35|||
164294935|NCT04516746|593454213|FG001|Overall Study|Other|16|||
164294936|NCT03489863|593454214|FG000|Overall Study|Withdrawal by Subject|0|||
164294937|NCT03489863|593454215|FG001|Overall Study|Withdrawal by Subject|1|||
164294938|NCT00768989|593454217|FG000|Prior to Week 24|Withdrawal by Subject|1|||
164294939|NCT00768989|593454218|FG001|Prior to Week 24|Withdrawal by Subject|0|||
164294940|NCT00768989|593454217|FG000|Prior to Week 24|Adverse Event|3|||
164294941|NCT00768989|593454218|FG001|Prior to Week 24|Adverse Event|0|||
164294942|NCT00768989|593454217|FG000|Prior to Week 24|Lost to Follow-up|0|||
164294943|NCT00768989|593454218|FG001|Prior to Week 24|Lost to Follow-up|1|||
164294944|NCT00768989|593454217|FG000|Prior to Week 24|Protocol Violation|0|||
164294945|NCT00768989|593454218|FG001|Prior to Week 24|Protocol Violation|2|||
164294946|NCT00768989|593454217|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
164294947|NCT00768989|593454218|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
164294948|NCT00768989|593454217|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
164294949|NCT00768989|593454218|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
164294950|NCT00768989|593454217|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
164294951|NCT00768989|593454218|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
164294952|NCT00768989|593454217|FG000|On or After Week 36|Lack of Efficacy|1|||
164294953|NCT00768989|593454218|FG001|On or After Week 36|Lack of Efficacy|0|||
164294954|NCT00768989|593454217|FG000|On or After Week 36|Adverse Event|0|||
164294955|NCT00768989|593454218|FG001|On or After Week 36|Adverse Event|1|||
164294956|NCT00768989|593454217|FG000|On or After Week 36|Lost to Follow-up|1|||
164294957|NCT00768989|593454218|FG001|On or After Week 36|Lost to Follow-up|0|||
164294958|NCT00768989|593454217|FG000|On or After Week 36|Poor Compliance|1|||
164294959|NCT00768989|593454218|FG001|On or After Week 36|Poor Compliance|0|||
164294960|NCT00768989|593454217|FG000|On or After Week 36|Protocol Violation|1|||
164294961|NCT00768989|593454218|FG001|On or After Week 36|Protocol Violation|0|||
164294962|NCT00768989|593454217|FG000|On or After Week 36|Did not attend termination visit|2|||
164294963|NCT00768989|593454218|FG001|On or After Week 36|Did not attend termination visit|0|||
164294964|NCT00768989|593454217|FG000|On or After Week 36|Sponsor Termination|45|||
164294965|NCT00768989|593454218|FG001|On or After Week 36|Sponsor Termination|26|||
164294966|NCT02153086|593454219|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
164294967|NCT02153086|593454219|FG000|Overall Study|Other|2|||
164693402|NCT02808819|594899394|FG001|Overall Study|Lost to Follow-up|6|||
164693403|NCT02808819|594899393|FG000|Overall Study|Protocol Violation|0|||
164693404|NCT02808819|594899394|FG001|Overall Study|Protocol Violation|1|||
164693405|NCT02808819|594899393|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
164693406|NCT02808819|594899394|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
164693407|NCT02808819|594899393|FG000|Overall Study|Death|1|||
164693408|NCT02808819|594899394|FG001|Overall Study|Death|0|||
164693409|NCT02808819|594899393|FG000|Overall Study|Adverse Event|3|||
164693410|NCT02808819|594899394|FG001|Overall Study|Adverse Event|4|||
164693411|NCT03297294|594899395|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
164693412|NCT03297294|594899396|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
164693413|NCT03297294|594899397|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
164693414|NCT03297294|594899398|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
164693415|NCT03297294|594899399|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
164693416|NCT03297294|594899395|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
164693417|NCT03297294|594899396|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
164693418|NCT03297294|594899397|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
164693419|NCT03297294|594899398|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
164693420|NCT03297294|594899399|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
164693421|NCT03297294|594899395|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
164693422|NCT03297294|594899396|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
164693423|NCT03297294|594899397|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
164693424|NCT03297294|594899398|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
164693425|NCT03297294|594899399|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
164693426|NCT03297294|594899395|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
164693427|NCT03297294|594899396|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
164693428|NCT03297294|594899397|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
164693429|NCT03297294|594899398|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
164693430|NCT03297294|594899399|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
164693431|NCT03297294|594899395|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
164693432|NCT03297294|594899396|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
164693433|NCT03297294|594899397|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
164693434|NCT03297294|594899398|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
164693435|NCT03297294|594899399|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
164294968|NCT00446849|593454220|FG000|Acute Phase|Lack of Efficacy|64|||
164294969|NCT00446849|593454220|FG000|Acute Phase|Protocol Violation|10|||
164294970|NCT00446849|593454220|FG000|Acute Phase|Consent withdrawn|4|||
164294971|NCT00446849|593454220|FG000|Acute Phase|Lost to Follow-up|2|||
164294972|NCT00446849|593454220|FG000|Acute Phase|Physician Decision|1|||
164294973|NCT00446849|593454220|FG000|Acute Phase|noncompliance|1|||
164294974|NCT00446849|593454220|FG000|Maintenance Phase|Lack of Efficacy|40|||
164294975|NCT00446849|593454220|FG000|Maintenance Phase|Protocol Violation|7|||
164294976|NCT00446849|593454220|FG000|Maintenance Phase|Adverse Event|6|||
164294977|NCT00446849|593454220|FG000|Maintenance Phase|Consent withdrawn|5|||
164294978|NCT00446849|593454220|FG000|Maintenance Phase|Lost to Follow-up|3|||
164294979|NCT00446849|593454220|FG000|Maintenance Phase|Pregnancy|1|||
164294980|NCT00446849|593454220|FG000|Maintenance Phase|noncompliance|2|||
164294981|NCT00446849|593454220|FG000|Maintenance Phase|prohibited medication use|2|||
164294982|NCT00446849|593454220|FG000|Maintenance Phase|antibiotic use|1|||
164294983|NCT00446849|593454220|FG000|Maintenance Phase|study closure|1|||
164294984|NCT00446849|593454220|FG000|Maintenance Phase|hydrocodone use|1|||
164294985|NCT00446849|593454220|FG000|Maintenance Phase|concomitant medication use|1|||
164294986|NCT03115359|593454221|FG000|Overall Study|Withdrawal by Subject|29|||
164294987|NCT03115359|593454222|FG001|Overall Study|Withdrawal by Subject|39|||
164294988|NCT03115359|593454221|FG000|Overall Study|Scheduling conflict|25|||
164294989|NCT03115359|593454222|FG001|Overall Study|Scheduling conflict|23|||
164294990|NCT03115359|593454221|FG000|Overall Study|Personal reasons including health|12|||
164294991|NCT03115359|593454222|FG001|Overall Study|Personal reasons including health|9|||
164294992|NCT03115359|593454221|FG000|Overall Study|Transportation barriers|3|||
164294993|NCT03115359|593454222|FG001|Overall Study|Transportation barriers|0|||
164294994|NCT03115359|593454221|FG000|Overall Study|No longer interested|5|||
164294995|NCT03115359|593454222|FG001|Overall Study|No longer interested|4|||
164294996|NCT03115359|593454221|FG000|Overall Study|No reason provided|45|||
164294997|NCT03115359|593454222|FG001|Overall Study|No reason provided|47|||
164294998|NCT05546476|593454224|FG000|Period 1: Part A|Adverse Event|2|||
164294999|NCT05546476|593454225|FG001|Period 1: Part A|Adverse Event|0|||
164295000|NCT05546476|593454226|FG002|Period 1: Part A|Adverse Event|0|||
164295001|NCT05546476|593454227|FG003|Period 1: Part A|Adverse Event|1|||
164295002|NCT05546476|593454224|FG000|Period 1: Part A|Death|4|||
164295003|NCT05546476|593454225|FG001|Period 1: Part A|Death|4|||
164295004|NCT05546476|593454226|FG002|Period 1: Part A|Death|5|||
164295005|NCT05546476|593454227|FG003|Period 1: Part A|Death|6|||
164295006|NCT05546476|593454224|FG000|Period 1: Part A|Lack of Efficacy|0|||
164295007|NCT05546476|593454225|FG001|Period 1: Part A|Lack of Efficacy|0|||
164295008|NCT05546476|593454226|FG002|Period 1: Part A|Lack of Efficacy|0|||
164295009|NCT05546476|593454227|FG003|Period 1: Part A|Lack of Efficacy|1|||
164295010|NCT05546476|593454224|FG000|Period 1: Part A|Lost to Follow-up|0|||
164295011|NCT05546476|593454225|FG001|Period 1: Part A|Lost to Follow-up|0|||
164295012|NCT05546476|593454226|FG002|Period 1: Part A|Lost to Follow-up|0|||
164295013|NCT05546476|593454227|FG003|Period 1: Part A|Lost to Follow-up|1|||
164295014|NCT05546476|593454224|FG000|Period 1: Part A|Physician Decision|1|||
164295015|NCT05546476|593454225|FG001|Period 1: Part A|Physician Decision|0|||
164295016|NCT05546476|593454226|FG002|Period 1: Part A|Physician Decision|0|||
164295017|NCT05546476|593454227|FG003|Period 1: Part A|Physician Decision|0|||
164295018|NCT05546476|593454224|FG000|Period 1: Part A|Progressive disease|3|||
164295019|NCT05546476|593454225|FG001|Period 1: Part A|Progressive disease|5|||
164295020|NCT05546476|593454226|FG002|Period 1: Part A|Progressive disease|0|||
164295021|NCT05546476|593454227|FG003|Period 1: Part A|Progressive disease|1|||
164295022|NCT05546476|593454224|FG000|Period 1: Part A|Withdrawal by Subject|1|||
164295023|NCT05546476|593454225|FG001|Period 1: Part A|Withdrawal by Subject|1|||
164295024|NCT05546476|593454226|FG002|Period 1: Part A|Withdrawal by Subject|1|||
164295025|NCT05546476|593454227|FG003|Period 1: Part A|Withdrawal by Subject|2|||
164295026|NCT05546476|593454224|FG000|Period 1: Part A|Global deterioration of health status|2|||
164295027|NCT05546476|593454225|FG001|Period 1: Part A|Global deterioration of health status|2|||
164295028|NCT05546476|593454226|FG002|Period 1: Part A|Global deterioration of health status|1|||
164295029|NCT05546476|593454227|FG003|Period 1: Part A|Global deterioration of health status|4|||
164295030|NCT05546476|593454224|FG000|Period 1: Part A|Other: Unspecified|0|||
164295031|NCT05546476|593454225|FG001|Period 1: Part A|Other: Unspecified|2|||
164295032|NCT05546476|593454226|FG002|Period 1: Part A|Other: Unspecified|0|||
164295033|NCT05546476|593454227|FG003|Period 1: Part A|Other: Unspecified|0|||
164295034|NCT05546476|593454224|FG000|Period 2: Part B|Ongoing|26|||
164295035|NCT05546476|593454225|FG001|Period 2: Part B|Ongoing|27|||
164295036|NCT05546476|593454226|FG002|Period 2: Part B|Ongoing|35|||
164295037|NCT05546476|593454227|FG003|Period 2: Part B|Ongoing|29|||
164295038|NCT03585660|593454228|FG000|Overall Study|operator error|1|||
164693436|NCT01435031|594899400|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
164693437|NCT01435031|594899400|FG000|ITT at 1 Month|Death|1|||
164693438|NCT01435031|594899400|FG000|ITT at 1 Month|Lost to Follow-up|4|||
164693439|NCT01435031|594899400|FG000|ITT at 6 Months|Death|2|||
164693440|NCT01435031|594899400|FG000|ITT at 6 Months|Lost to Follow-up|3|||
164693441|NCT01435031|594899400|FG000|ITT at 1 Year|Death|1|||
164693442|NCT01435031|594899400|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
164693443|NCT01435031|594899400|FG000|ITT at 1 Year|Lost to Follow-up|6|||
164693444|NCT01435031|594899400|FG000|ITT at 2 Years|Death|7|||
164693445|NCT01435031|594899400|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
164295039|NCT03585660|593454228|FG000|Overall Study|technical error|2|||
164295040|NCT03585660|593454228|FG000|Overall Study|hip prosthesis|2|||
164693446|NCT01435031|594899400|FG000|ITT at 2 Years|Lost to Follow-up|4|||
164295041|NCT03585660|593454228|FG000|Overall Study|did not undergo biopsy|8|||
164295042|NCT03585660|593454228|FG000|Overall Study|scanner problem|2|||
164295043|NCT05316597|593454230|FG000|First Session|Withdrawal by Subject|0|||
164295044|NCT05316597|593454231|FG001|First Session|Withdrawal by Subject|1|||
164295045|NCT05316597|593454230|FG000|Washout Period|Lost to Follow-up|1|||
164295046|NCT05316597|593454231|FG001|Washout Period|Lost to Follow-up|2|||
164295047|NCT05316597|593454230|FG000|Washout Period|Physician Decision|1|||
164295048|NCT05316597|593454231|FG001|Washout Period|Physician Decision|1|||
164295049|NCT05316597|593454230|FG000|Washout Period|Excluded before second session|1|||
164295050|NCT05316597|593454231|FG001|Washout Period|Excluded before second session|1|||
164295051|NCT05316597|593454230|FG000|Washout Period|Withdrawal by Subject|0|||
164295052|NCT05316597|593454231|FG001|Washout Period|Withdrawal by Subject|4|||
164295053|NCT01706458|593454232|FG000|Overall Study|Physician Decision|3|||
164295054|NCT01706458|593454233|FG001|Overall Study|Physician Decision|4|||
164295055|NCT03547518|593454234|FG000|Overall Study|Lost to Follow-up|2|||
164295056|NCT03547518|593454235|FG001|Overall Study|Lost to Follow-up|0|||
164295057|NCT02766023|593454240|FG000|Overall Study|Lost to Follow-up|23|||
164295058|NCT02766023|593454241|FG001|Overall Study|Lost to Follow-up|11|||
164295059|NCT02766023|593454240|FG000|Overall Study|Pregnancy|1|||
164295060|NCT02766023|593454241|FG001|Overall Study|Pregnancy|0|||
164295061|NCT02766023|593454240|FG000|Overall Study|Adverse Event|1|||
164295062|NCT02766023|593454241|FG001|Overall Study|Adverse Event|0|||
164295063|NCT02766023|593454240|FG000|Overall Study|Withdrawal by Subject|4|||
164295064|NCT02766023|593454241|FG001|Overall Study|Withdrawal by Subject|5|||
164295065|NCT02766023|593454240|FG000|Overall Study|Physician Decision|1|||
164295066|NCT02766023|593454241|FG001|Overall Study|Physician Decision|0|||
164295067|NCT02766023|593454240|FG000|Overall Study|Not Eligible at Enrollment|0|||
164295068|NCT02766023|593454241|FG001|Overall Study|Not Eligible at Enrollment|1|||
164295069|NCT00286468|593454242|FG000|Overall Study|Hyperglycemic Rescue|28|||
164295070|NCT00286468|593454243|FG001|Overall Study|Hyperglycemic Rescue|30|||
164295071|NCT00286468|593454244|FG002|Overall Study|Hyperglycemic Rescue|31|||
164295072|NCT00286468|593454242|FG000|Overall Study|Adverse Event|2|||
164693447|NCT01435031|594899400|FG000|ITT at 3 Years|Death|5|||
164693448|NCT01435031|594899400|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
164693449|NCT01435031|594899400|FG000|ITT at 3 Years|Lost to Follow-up|4|||
164693450|NCT01435031|594899400|FG000|ITT at 4 Years|Death|4|||
164693451|NCT01435031|594899400|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
164693452|NCT01435031|594899400|FG000|ITT at 4 Years|Lost to Follow-up|1|||
164693453|NCT03718117|594899404|FG000|Overall Study|Death|12|||
164693454|NCT03718117|594899405|FG001|Overall Study|Death|11|||
164693455|NCT03718117|594899406|FG002|Overall Study|Death|0|||
164693456|NCT03718117|594899404|FG000|Overall Study|Other|0|||
164693457|NCT03718117|594899405|FG001|Overall Study|Other|1|||
164693458|NCT03718117|594899406|FG002|Overall Study|Other|0|||
164693459|NCT03718117|594899404|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
164693460|NCT03718117|594899405|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
164693461|NCT03718117|594899406|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
164693462|NCT03718117|594899404|FG000|Overall Study|Participant not met eligibility criteria|0|||
164693463|NCT03718117|594899405|FG001|Overall Study|Participant not met eligibility criteria|0|||
164693464|NCT03718117|594899406|FG002|Overall Study|Participant not met eligibility criteria|2|||
164693465|NCT01917968|594899407|FG000|Overall Study|Death|3|||
164693466|NCT01917968|594899408|FG001|Overall Study|Death|2|||
164693467|NCT01917968|594899407|FG000|Overall Study|Lost to Follow-up|21|||
164693468|NCT01917968|594899408|FG001|Overall Study|Lost to Follow-up|39|||
164693469|NCT01917968|594899407|FG000|Overall Study|Physician Decision|1|||
164693470|NCT01917968|594899408|FG001|Overall Study|Physician Decision|2|||
164693471|NCT01917968|594899407|FG000|Overall Study|Withdrawal by Subject|20|||
164693472|NCT01917968|594899408|FG001|Overall Study|Withdrawal by Subject|35|||
164693473|NCT01917968|594899407|FG000|Overall Study|Subject Relocation|5|||
164693474|NCT01917968|594899408|FG001|Overall Study|Subject Relocation|1|||
164693475|NCT01917968|594899407|FG000|Overall Study|36M Missed Visit|3|||
164693476|NCT01917968|594899408|FG001|Overall Study|36M Missed Visit|2|||
164295073|NCT00286468|593454243|FG001|Overall Study|Adverse Event|6|||
164295074|NCT00286468|593454244|FG002|Overall Study|Adverse Event|4|||
164295075|NCT00286468|593454242|FG000|Overall Study|Protocol Violation|0|||
164295076|NCT00286468|593454243|FG001|Overall Study|Protocol Violation|3|||
164295077|NCT00286468|593454244|FG002|Overall Study|Protocol Violation|1|||
164295078|NCT00286468|593454242|FG000|Overall Study|Lost to Follow-up|1|||
164693477|NCT01917968|594899407|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
164693478|NCT01917968|594899408|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
164693479|NCT01917968|594899407|FG000|Overall Study|Change in Family Circumstances|0|||
164693480|NCT01917968|594899408|FG001|Overall Study|Change in Family Circumstances|1|||
164295079|NCT00286468|593454243|FG001|Overall Study|Lost to Follow-up|1|||
164693481|NCT01917968|594899407|FG000|Overall Study|No Data Available|0|||
164693482|NCT01917968|594899408|FG001|Overall Study|No Data Available|2|||
164693483|NCT02030535|594899410|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
164295080|NCT00286468|593454244|FG002|Overall Study|Lost to Follow-up|2|||
164693484|NCT01435928|594899411|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
164295081|NCT00286468|593454242|FG000|Overall Study|Withdrawal by Subject|3|||
164295082|NCT00286468|593454243|FG001|Overall Study|Withdrawal by Subject|8|||
164295083|NCT00286468|593454244|FG002|Overall Study|Withdrawal by Subject|11|||
164295084|NCT00286468|593454242|FG000|Overall Study|Physician Decision|3|||
164295085|NCT00286468|593454243|FG001|Overall Study|Physician Decision|2|||
164295086|NCT00286468|593454244|FG002|Overall Study|Physician Decision|1|||
164295087|NCT03103542|593454245|FG000|Overall Study|Physician Decision|2|||
164295088|NCT03103542|593454245|FG000|Overall Study|Adverse Event|2|||
164295089|NCT03103542|593454245|FG000|Overall Study|Other|2|||
164295090|NCT03103542|593454245|FG000|Overall Study|Withdrawal by Subject|1|||
164295091|NCT02953652|593454246|FG000|Overall Study|Adverse Event|18|||
164295092|NCT02953652|593454246|FG000|Overall Study|Withdrawal by Subject|6|||
164295093|NCT02953652|593454246|FG000|Overall Study|Protocol Violation|1|||
164295094|NCT02953652|593454246|FG000|Overall Study|Disease Progression|27|||
164295095|NCT02384551|593454250|FG000|Overall Study|Lost to Follow-up|13|||
164295096|NCT02384551|593454251|FG001|Overall Study|Lost to Follow-up|14|||
164295097|NCT02384551|593454252|FG002|Overall Study|Lost to Follow-up|14|||
164295098|NCT02384551|593454253|FG003|Overall Study|Lost to Follow-up|14|||
164295099|NCT03035032|593454259|FG000|Overall Study|Adverse Event|2|||
164295100|NCT03035032|593454259|FG000|Overall Study|Death|9|||
164295101|NCT03035032|593454259|FG000|Overall Study|Lost to Follow-up|1|||
164295102|NCT03035032|593454259|FG000|Overall Study|Progressive Disease|22|||
164295103|NCT03035032|593454259|FG000|Overall Study|Protocol Violation|2|||
164295104|NCT03035032|593454259|FG000|Overall Study|Withdrawal by Subject|2|||
164295105|NCT03035032|593454259|FG000|Overall Study|Physician Decision|5|||
164295106|NCT03406780|593454260|FG000|Overall Study|Withdrawal by Subject|1|||
164295107|NCT03406780|593454261|FG001|Overall Study|Withdrawal by Subject|1|||
164295108|NCT03406780|593454260|FG000|Overall Study|Other|0|||
164295109|NCT03406780|593454261|FG001|Overall Study|Other|2|||
164295110|NCT01903356|593454273|FG000|Overall Study|Lost to Follow-up|7|||
164295111|NCT01903356|593454273|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
164295112|NCT01903356|593454273|FG000|Overall Study|Violated the dosage and administration|3|||
164295113|NCT03305666|593454274|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
164295114|NCT03305666|593454275|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
164295115|NCT02546609|593454278|FG000|Overall Study|Withdrawal by Subject|0|||
164295116|NCT02546609|593454279|FG001|Overall Study|Withdrawal by Subject|1|||
164295117|NCT02546609|593454280|FG002|Overall Study|Withdrawal by Subject|2|||
164295118|NCT02546609|593454278|FG000|Overall Study|Adverse Event|0|||
164295119|NCT02546609|593454279|FG001|Overall Study|Adverse Event|6|||
164295120|NCT02546609|593454280|FG002|Overall Study|Adverse Event|1|||
164295121|NCT02546609|593454278|FG000|Overall Study|Protocol Violation|0|||
164295122|NCT02546609|593454279|FG001|Overall Study|Protocol Violation|1|||
164295123|NCT02546609|593454280|FG002|Overall Study|Protocol Violation|1|||
164295124|NCT02546609|593454278|FG000|Overall Study|Lost to Follow-up|2|||
164295125|NCT02546609|593454279|FG001|Overall Study|Lost to Follow-up|3|||
164295126|NCT02546609|593454280|FG002|Overall Study|Lost to Follow-up|1|||
164295127|NCT02546609|593454278|FG000|Overall Study|travel or work schedule restriction|0|||
164295128|NCT02546609|593454279|FG001|Overall Study|travel or work schedule restriction|0|||
164295129|NCT02546609|593454280|FG002|Overall Study|travel or work schedule restriction|2|||
164295130|NCT02756338|593454282|FG000|Overall Study|Withdrawn by Investigator|1|||
164295131|NCT02756338|593454282|FG000|Overall Study|Device Replaced with Pacemaker|4|||
164295132|NCT01546857|593454284|FG000|Overall Study|Withdrawal by Subject|2|||
164295133|NCT01546857|593454285|FG001|Overall Study|Withdrawal by Subject|3|||
164295134|NCT01339689|593454286|FG000|Overall Study|Adverse Event|1|||
164295135|NCT01339689|593454287|FG001|Overall Study|Adverse Event|2|||
164295136|NCT01339689|593454286|FG000|Overall Study|Lost to Follow-up|9|||
164587393|NCT03303339|594513831|FG011|Overall Study|Safety/Non-compliance|1|||
164587394|NCT01748760|594513833|FG000|Overall Study|Withdrawal by Subject|1|||
164587395|NCT01748760|594513834|FG001|Overall Study|Withdrawal by Subject|1|||
164295137|NCT01339689|593454287|FG001|Overall Study|Lost to Follow-up|3|||
164295138|NCT01339689|593454286|FG000|Overall Study|Withdrawal by Subject|3|||
164295139|NCT01339689|593454287|FG001|Overall Study|Withdrawal by Subject|0|||
164295140|NCT01339689|593454286|FG000|Overall Study|Noncompliance|1|||
164295141|NCT01339689|593454287|FG001|Overall Study|Noncompliance|0|||
164295142|NCT01339689|593454286|FG000|Overall Study|Relocated out of area|0|||
164295143|NCT01339689|593454287|FG001|Overall Study|Relocated out of area|1|||
164295144|NCT01339689|593454286|FG000|Overall Study|Other|2|||
164587396|NCT01748760|594513833|FG000|Overall Study|Lost to Follow-up|5|||
164587397|NCT01748760|594513834|FG001|Overall Study|Lost to Follow-up|1|||
164587398|NCT00510692|594513835|FG000|Overall Study|Adverse Event|1|||
164295145|NCT01339689|593454287|FG001|Overall Study|Other|2|||
164295146|NCT01339689|593454286|FG000|Overall Study|multiple reasons|1|||
164295147|NCT01339689|593454287|FG001|Overall Study|multiple reasons|1|||
164295148|NCT01176032|593454288|FG000|Overall Study|Adverse Event|1|||
164295149|NCT01176032|593454289|FG001|Overall Study|Adverse Event|0|||
164295150|NCT01176032|593454288|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164295151|NCT01176032|593454289|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
164295152|NCT01176032|593454288|FG000|Overall Study|Protocol Violation|1|||
164295153|NCT01176032|593454289|FG001|Overall Study|Protocol Violation|0|||
164295154|NCT01176032|593454288|FG000|Overall Study|Informed consent withdrawn|3|||
164295155|NCT01176032|593454289|FG001|Overall Study|Informed consent withdrawn|0|||
164295156|NCT01176032|593454288|FG000|Overall Study|Other|1|||
164295157|NCT01176032|593454289|FG001|Overall Study|Other|0|||
164295158|NCT01469221|593454290|FG000|Double Blind Phase|Protocol Violation|1|||
164295159|NCT01469221|593454291|FG001|Double Blind Phase|Protocol Violation|0|||
164295160|NCT01469221|593454292|FG002|Double Blind Phase|Protocol Violation|0|||
164295161|NCT01469221|593454290|FG000|Double Blind Phase|Physician Decision|1|||
164295162|NCT01469221|593454291|FG001|Double Blind Phase|Physician Decision|1|||
164295163|NCT01469221|593454292|FG002|Double Blind Phase|Physician Decision|0|||
164295164|NCT01469221|593454290|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
164295165|NCT01469221|593454291|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
164295166|NCT01469221|593454292|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
164295167|NCT00659061|593454294|FG000|Overall Study|Migration due to political unrest|21|||
164295168|NCT00659061|593454295|FG001|Overall Study|Migration due to political unrest|15|||
164295169|NCT05121766|593454302|FG000|Overall Study|Covid reinfection|3|||
164295170|NCT05121766|593454303|FG001|Overall Study|Covid reinfection|0|||
164295171|NCT05121766|593454302|FG000|Overall Study|Withdrawal by Subject|3|||
164295172|NCT05121766|593454303|FG001|Overall Study|Withdrawal by Subject|1|||
164295173|NCT05121766|593454302|FG000|Overall Study|Adverse Event|2|||
164295174|NCT05121766|593454303|FG001|Overall Study|Adverse Event|4|||
164295175|NCT05121766|593454302|FG000|Overall Study|Lost to Follow-up|0|||
164295176|NCT05121766|593454303|FG001|Overall Study|Lost to Follow-up|1|||
164295177|NCT01632020|593454304|FG000|Overall Study|Withdrawal by Subject|1|||
164295178|NCT01632020|593454305|FG001|Overall Study|Withdrawal by Subject|0|||
164295179|NCT01632020|593454304|FG000|Overall Study|Adverse Event|1|||
164295180|NCT01632020|593454305|FG001|Overall Study|Adverse Event|0|||
164295181|NCT00528957|593454309|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
164295182|NCT00528957|593454310|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
164295183|NCT00528957|593454309|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
164295184|NCT00528957|593454310|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
164295185|NCT00528957|593454309|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
164295186|NCT00528957|593454310|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
164295187|NCT00528957|593454309|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
164295188|NCT00528957|593454310|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
164295189|NCT00528957|593454309|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
164295190|NCT00528957|593454310|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
164295191|NCT00528957|593454309|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
164295192|NCT00528957|593454310|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
164295193|NCT00528957|593454309|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
164295194|NCT00528957|593454310|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
164295195|NCT00528957|593454309|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
164295196|NCT00528957|593454310|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
164295197|NCT00528957|593454309|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
164295198|NCT00528957|593454310|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
164295199|NCT00528957|593454309|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
164295200|NCT00528957|593454310|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
164295201|NCT00528957|593454309|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
164347126|NCT01846416|593646845|FG000|Survival Follow-up|Lost to Follow-up|0|||
164347127|NCT01846416|593646846|FG001|Survival Follow-up|Lost to Follow-up|2|||
164347128|NCT01846416|593646847|FG002|Survival Follow-up|Lost to Follow-up|2|||
164295202|NCT00528957|593454310|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
164295203|NCT00528957|593454309|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
164347129|NCT01846416|593646845|FG000|Survival Follow-up|Withdrawal by Subject|2|||
164347130|NCT01846416|593646846|FG001|Survival Follow-up|Withdrawal by Subject|7|||
164295204|NCT00528957|593454310|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
164295205|NCT00528957|593454309|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
164295206|NCT00528957|593454310|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
164295207|NCT00528957|593454309|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
164295208|NCT00528957|593454310|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
164295209|NCT00528957|593454309|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
164295210|NCT00528957|593454310|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
164295211|NCT00528957|593454309|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
164295212|NCT00528957|593454310|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
164347131|NCT01846416|593646847|FG002|Survival Follow-up|Withdrawal by Subject|0|||
164347132|NCT01846416|593646845|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
164347133|NCT01846416|593646846|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
164347134|NCT01846416|593646847|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
164347135|NCT01846416|593646845|FG000|Survival Follow-up|Other|3|||
164347136|NCT01846416|593646846|FG001|Survival Follow-up|Other|1|||
164347137|NCT01846416|593646847|FG002|Survival Follow-up|Other|1|||
164347138|NCT00382252|593646848|FG000|Overall Study|Death|4|||
164295213|NCT00083889|593454315|FG000|Overall Study|Adverse Event|76|||
164295214|NCT00083889|593454316|FG001|Overall Study|Adverse Event|86|||
164295215|NCT00083889|593454315|FG000|Overall Study|Protocol Violation|2|||
164295216|NCT00083889|593454316|FG001|Overall Study|Protocol Violation|2|||
164295217|NCT00083889|593454315|FG000|Overall Study|Withdrawal by Subject|22|||
164295218|NCT00083889|593454316|FG001|Overall Study|Withdrawal by Subject|24|||
164295219|NCT00083889|593454315|FG000|Overall Study|Lack of Efficacy|240|||
164295220|NCT00083889|593454316|FG001|Overall Study|Lack of Efficacy|219|||
164295221|NCT00083889|593454315|FG000|Overall Study|Decision of sponsor|32|||
164295222|NCT00083889|593454316|FG001|Overall Study|Decision of sponsor|4|||
164295223|NCT00083889|593454315|FG000|Overall Study|Randomized: did not take study drug|0|||
164295224|NCT00083889|593454316|FG001|Overall Study|Randomized: did not take study drug|15|||
164295225|NCT00083889|593454315|FG000|Overall Study|Completed on marketed sunitinub|3|||
164295226|NCT00083889|593454316|FG001|Overall Study|Completed on marketed sunitinub|0|||
164295227|NCT00083889|593454315|FG000|Overall Study|Crossover to SU011248|0|||
164295228|NCT00083889|593454316|FG001|Overall Study|Crossover to SU011248|25|||
164295229|NCT00168844|593454317|FG000|Overall Study|Adverse Event|31|||
164295230|NCT00168844|593454318|FG001|Overall Study|Adverse Event|32|||
164295231|NCT00168844|593454319|FG002|Overall Study|Adverse Event|48|||
164295232|NCT00168844|593454317|FG000|Overall Study|Lost to Follow-up|4|||
164295233|NCT00168844|593454318|FG001|Overall Study|Lost to Follow-up|5|||
164295234|NCT00168844|593454319|FG002|Overall Study|Lost to Follow-up|11|||
164295235|NCT00168844|593454317|FG000|Overall Study|Withdrawal by Subject|12|||
164295236|NCT00168844|593454318|FG001|Overall Study|Withdrawal by Subject|9|||
164295237|NCT00168844|593454319|FG002|Overall Study|Withdrawal by Subject|19|||
164295238|NCT00168844|593454317|FG000|Overall Study|Protocol Violation|2|||
164295239|NCT00168844|593454318|FG001|Overall Study|Protocol Violation|2|||
164295240|NCT00168844|593454319|FG002|Overall Study|Protocol Violation|4|||
164295241|NCT00168844|593454317|FG000|Overall Study|Other|6|||
164295242|NCT00168844|593454318|FG001|Overall Study|Other|7|||
164295243|NCT00168844|593454319|FG002|Overall Study|Other|9|||
164295244|NCT02994108|593455799|FG000|Intervention Messages|Withdrawal by Subject|2|||
164295245|NCT02994108|593455800|FG001|Intervention Messages|Withdrawal by Subject|0|||
164295246|NCT02994108|593455799|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
164295247|NCT02994108|593455800|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
164295248|NCT02994108|593455799|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
164295249|NCT02994108|593455800|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
164295250|NCT02994108|593455799|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
164295251|NCT02994108|593455800|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
164295252|NCT00089297|593455801|FG000|Overall Study|Adverse Event|9|||
164295253|NCT00089297|593455801|FG000|Overall Study|Death|1|||
164295254|NCT00089297|593455801|FG000|Overall Study|Withdrawal by Subject|12|||
164295255|NCT00089297|593455801|FG000|Overall Study|Disease progression|2|||
164295256|NCT00089297|593455801|FG000|Overall Study|Ineligible|11|||
164295257|NCT00089297|593455801|FG000|Overall Study|Secondary malignancy|1|||
164347139|NCT00382252|593646848|FG000|Overall Study|Protocol Violation|8|||
164347140|NCT00382252|593646848|FG000|Overall Study|Not treated by RFA|1|||
164347141|NCT00833794|593646849|FG000|Open-label Phase|Adverse Event|225|||
164347142|NCT00833794|593646850|FG001|Open-label Phase|Adverse Event|0|||
164347143|NCT00833794|593646849|FG000|Open-label Phase|Lack of Efficacy|28|||
164295258|NCT00089297|593455801|FG000|Overall Study|IRB approval not ready|1|||
164295259|NCT00089297|593455801|FG000|Overall Study|Non-compliance|1|||
164295260|NCT00904969|593455802|FG000|Overall Study|Lost to Follow-up|4|||
164295261|NCT00904969|593455802|FG000|Overall Study|Withdrawal by Subject|3|||
164295262|NCT00904969|593455802|FG000|Overall Study|Additional Treatments|11|||
164295263|NCT00904969|593455802|FG000|Overall Study|Case Aborted; Subject Exited|1|||
164295264|NCT04515771|593455815|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
164295265|NCT04515771|593455816|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
164295266|NCT04515771|593455815|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
164295267|NCT04515771|593455816|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
164295268|NCT04515771|593455815|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
164295269|NCT04515771|593455816|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
164295270|NCT02927301|593455824|FG000|Overall Study|Death|39|||
164295271|NCT02927301|593455824|FG000|Overall Study|Lost to Follow-up|8|||
164347144|NCT00833794|593646850|FG001|Open-label Phase|Lack of Efficacy|0|||
164295272|NCT02927301|593455824|FG000|Overall Study|Physician Decision|2|||
164295273|NCT02927301|593455824|FG000|Overall Study|Withdrawal by Subject|12|||
164347145|NCT00833794|593646849|FG000|Open-label Phase|Withdrawal by Subject|48|||
164347146|NCT00833794|593646850|FG001|Open-label Phase|Withdrawal by Subject|0|||
164347147|NCT00833794|593646849|FG000|Open-label Phase|Physician Decision|20|||
164295274|NCT02927301|593455824|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
164295275|NCT04742556|593455825|FG000|Overall Study|Withdrawal by Subject|0|||
164295276|NCT04742556|593455826|FG001|Overall Study|Withdrawal by Subject|1|||
164295277|NCT04742556|593455827|FG002|Overall Study|Withdrawal by Subject|0|||
164295278|NCT04742556|593455825|FG000|Overall Study|Adverse Event|0|||
164295279|NCT04742556|593455826|FG001|Overall Study|Adverse Event|0|||
164295280|NCT04742556|593455827|FG002|Overall Study|Adverse Event|2|||
164295281|NCT04742556|593455825|FG000|Overall Study|Clinical disease progression|0|||
164295282|NCT04742556|593455826|FG001|Overall Study|Clinical disease progression|1|||
164295283|NCT04742556|593455827|FG002|Overall Study|Clinical disease progression|2|||
164295284|NCT04742556|593455825|FG000|Overall Study|Objective disease progression|3|||
164295285|NCT04742556|593455826|FG001|Overall Study|Objective disease progression|2|||
164295286|NCT04742556|593455827|FG002|Overall Study|Objective disease progression|4|||
164295287|NCT02903771|593455828|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
164295288|NCT02903771|593455829|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
164295289|NCT02903771|593455830|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
164295290|NCT02903771|593455831|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
164295291|NCT02903771|593455832|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
164295292|NCT02903771|593455833|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
164295293|NCT02903771|593455834|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
164295294|NCT02903771|593455828|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
164295295|NCT02903771|593455829|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
164295296|NCT02903771|593455830|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
164295297|NCT02903771|593455831|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
164295298|NCT02903771|593455832|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
164295299|NCT02903771|593455833|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
164295300|NCT02903771|593455834|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
164295301|NCT02903771|593455828|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
164295302|NCT02903771|593455829|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
164295303|NCT02903771|593455830|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
164295304|NCT02903771|593455831|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
164295305|NCT02903771|593455832|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
164295306|NCT02903771|593455833|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
164295307|NCT02903771|593455834|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
164295308|NCT02903771|593455828|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
164295309|NCT02903771|593455829|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
164295310|NCT02903771|593455830|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
164295311|NCT02903771|593455831|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
164295312|NCT02903771|593455832|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
164295313|NCT02903771|593455833|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
164295314|NCT02903771|593455834|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
164295315|NCT02903771|593455828|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
164295316|NCT02903771|593455829|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
164295317|NCT02903771|593455830|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
164295318|NCT02903771|593455831|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
164295319|NCT02903771|593455832|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
164295320|NCT02903771|593455833|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
164295321|NCT02903771|593455834|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
164295322|NCT02903771|593455828|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
164295323|NCT02903771|593455829|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
164295324|NCT02903771|593455830|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
164295325|NCT02903771|593455831|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
164295326|NCT02903771|593455832|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
164295327|NCT02903771|593455833|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
164295328|NCT02903771|593455834|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
164295329|NCT02903771|593455828|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
164295330|NCT02903771|593455829|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
164295331|NCT02903771|593455830|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
164295332|NCT02903771|593455831|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
164295333|NCT02903771|593455832|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
164295334|NCT02903771|593455833|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
164295335|NCT02903771|593455834|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
164418051|NCT01032044|593899616|FG001|Overall Study|Adverse Event|1|||
164295336|NCT02903771|593455828|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
164295337|NCT02903771|593455829|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
164295338|NCT02903771|593455830|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
164295339|NCT02903771|593455831|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
164295340|NCT02903771|593455832|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
164295341|NCT02903771|593455833|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
164295342|NCT02903771|593455834|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
164295343|NCT02903771|593455828|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
164295344|NCT02903771|593455829|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
164295345|NCT02903771|593455830|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
164295346|NCT02903771|593455831|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
164295347|NCT02903771|593455832|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
164295348|NCT02903771|593455833|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
164295349|NCT02903771|593455834|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
164295350|NCT02903771|593455828|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
164295351|NCT02903771|593455829|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
164295352|NCT02903771|593455830|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
164295353|NCT02903771|593455831|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
164295354|NCT02903771|593455832|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
164295355|NCT02903771|593455833|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
164295356|NCT02903771|593455834|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
164295357|NCT02903771|593455828|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
164295358|NCT02903771|593455829|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
164295359|NCT02903771|593455830|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
164295360|NCT02903771|593455831|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
164295361|NCT02903771|593455832|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
164295362|NCT02903771|593455833|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
164295363|NCT02903771|593455834|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
164295364|NCT04247347|593455835|FG000|Overall Study|Withdrawal by Subject|2|||
164295365|NCT04247347|593455836|FG001|Overall Study|Withdrawal by Subject|3|||
164295366|NCT04247347|593455837|FG002|Overall Study|Withdrawal by Subject|3|||
164295367|NCT04247347|593455835|FG000|Overall Study|Lost to Follow-up|1|||
164295368|NCT04247347|593455836|FG001|Overall Study|Lost to Follow-up|1|||
164295369|NCT04247347|593455837|FG002|Overall Study|Lost to Follow-up|1|||
164295370|NCT03562195|593455838|FG000|Overall Study|Adverse Event|0|||
164295371|NCT03562195|593455839|FG001|Overall Study|Adverse Event|6|||
164295372|NCT03562195|593455838|FG000|Overall Study|Lack of Efficacy|0|||
164347148|NCT00833794|593646850|FG001|Open-label Phase|Physician Decision|0|||
164347149|NCT00833794|593646849|FG000|Open-label Phase|Administrative reason|1|||
164347150|NCT00833794|593646850|FG001|Open-label Phase|Administrative reason|0|||
164347151|NCT00833794|593646849|FG000|Open-label Phase|Protocol Violation|47|||
164347152|NCT00833794|593646850|FG001|Open-label Phase|Protocol Violation|0|||
164347153|NCT00833794|593646849|FG000|Open-label Phase|Did not complete wash-out period|12|||
164347154|NCT00833794|593646850|FG001|Open-label Phase|Did not complete wash-out period|0|||
164347155|NCT00833794|593646849|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
164347156|NCT00833794|593646850|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
164347157|NCT00833794|593646849|FG000|Double-blind Phase|Adverse Event|44|||
164347158|NCT00833794|593646850|FG001|Double-blind Phase|Adverse Event|11|||
164347159|NCT00833794|593646849|FG000|Double-blind Phase|Lack of Efficacy|34|||
164347160|NCT00833794|593646850|FG001|Double-blind Phase|Lack of Efficacy|22|||
164347161|NCT00833794|593646849|FG000|Double-blind Phase|Withdrawal by Subject|23|||
164347162|NCT00833794|593646850|FG001|Double-blind Phase|Withdrawal by Subject|6|||
164347163|NCT00833794|593646849|FG000|Double-blind Phase|Physician Decision|4|||
164347164|NCT00833794|593646850|FG001|Double-blind Phase|Physician Decision|7|||
164347165|NCT00833794|593646849|FG000|Double-blind Phase|Administrative reason|1|||
164347166|NCT00833794|593646850|FG001|Double-blind Phase|Administrative reason|3|||
164347167|NCT00039130|593646853|FG000|Overall Study|Adverse Event|11|||
164347168|NCT00039130|593646853|FG000|Overall Study|Death|9|||
164347169|NCT00039130|593646853|FG000|Overall Study|Withdrawal by Subject|3|||
164347170|NCT00039130|593646853|FG000|Overall Study|Progression|2|||
164347171|NCT00039130|593646853|FG000|Overall Study|Subsequent treatment|2|||
164347172|NCT00039130|593646853|FG000|Overall Study|Physician Decision|3|||
164347173|NCT01269463|593646854|FG000|First Intervention|Withdrawal by Subject|1|||
164347174|NCT01269463|593646855|FG001|First Intervention|Withdrawal by Subject|0|||
164347175|NCT01269463|593646854|FG000|First Intervention|Adverse Event|1|||
164347176|NCT01269463|593646855|FG001|First Intervention|Adverse Event|0|||
164434912|NCT03412747|593960831|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
164434913|NCT03412747|593960829|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
164434914|NCT03412747|593960830|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
164434915|NCT03412747|593960831|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
164434916|NCT03412747|593960829|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
164434917|NCT03412747|593960830|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
164295373|NCT03562195|593455839|FG001|Overall Study|Lack of Efficacy|5|||
164295374|NCT03562195|593455838|FG000|Overall Study|Protocol Violation|0|||
164347177|NCT01269463|593646854|FG000|First Intervention|Lack of Efficacy|0|||
164347178|NCT01269463|593646855|FG001|First Intervention|Lack of Efficacy|1|||
164347179|NCT01269463|593646854|FG000|First Intervention|Physician Decision|0|||
164295375|NCT03562195|593455839|FG001|Overall Study|Protocol Violation|1|||
164295376|NCT03562195|593455838|FG000|Overall Study|Lost to Follow-up|0|||
164295377|NCT03562195|593455839|FG001|Overall Study|Lost to Follow-up|1|||
164295378|NCT03562195|593455838|FG000|Overall Study|Physician Decision|1|||
164295379|NCT03562195|593455839|FG001|Overall Study|Physician Decision|0|||
164295380|NCT03562195|593455838|FG000|Overall Study|Withdrawal by Subject|3|||
164295381|NCT03562195|593455839|FG001|Overall Study|Withdrawal by Subject|0|||
164295382|NCT02218372|593455840|FG000|Overall Study|Adverse Event|1|||
164295383|NCT02218372|593455841|FG001|Overall Study|Adverse Event|1|||
164295384|NCT02218372|593455840|FG000|Overall Study|Miscellaneous|2|||
164295385|NCT02218372|593455841|FG001|Overall Study|Miscellaneous|1|||
164295386|NCT02218372|593455840|FG000|Overall Study|Randomized but did not receive treatment|2|||
164295387|NCT02218372|593455841|FG001|Overall Study|Randomized but did not receive treatment|3|||
164295388|NCT02218372|593455840|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164347180|NCT01269463|593646855|FG001|First Intervention|Physician Decision|1|||
164347181|NCT02612727|593646859|FG000|Overall Study|Parent request|4|||
164587399|NCT00510692|594513836|FG001|Overall Study|Adverse Event|3|||
164347182|NCT02612727|593646860|FG001|Overall Study|Parent request|1|||
164347183|NCT02612727|593646859|FG000|Overall Study|Needed treatment incompatible with PT|1|||
164347184|NCT02612727|593646860|FG001|Overall Study|Needed treatment incompatible with PT|1|||
164347185|NCT02612727|593646859|FG000|Overall Study|Direct hyperbilirubinemia|0|||
164347186|NCT02612727|593646860|FG001|Overall Study|Direct hyperbilirubinemia|2|||
164347187|NCT04518306|593646863|FG000|Double-Blind Period|Run in failure|0|||
164347188|NCT04518306|593646864|FG001|Double-Blind Period|Run in failure|0|||
164347189|NCT04518306|593646865|FG002|Double-Blind Period|Run in failure|1|||
164347190|NCT04518306|593646863|FG000|Double-Blind Period|Adverse Event|0|||
164347191|NCT04518306|593646864|FG001|Double-Blind Period|Adverse Event|2|||
164347192|NCT04518306|593646865|FG002|Double-Blind Period|Adverse Event|2|||
164347193|NCT04518306|593646863|FG000|Double-Blind Period|Lost to Follow-up|1|||
164347194|NCT04518306|593646864|FG001|Double-Blind Period|Lost to Follow-up|2|||
164347195|NCT04518306|593646865|FG002|Double-Blind Period|Lost to Follow-up|2|||
164347196|NCT04518306|593646863|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
164347197|NCT04518306|593646864|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
164347198|NCT04518306|593646865|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
164347199|NCT04518306|593646863|FG000|Double-Blind Period|Other|0|||
164347200|NCT04518306|593646864|FG001|Double-Blind Period|Other|2|||
164347201|NCT04518306|593646865|FG002|Double-Blind Period|Other|0|||
164347202|NCT04518306|593646863|FG000|Double-Blind Period|Missing|0|||
164347203|NCT04518306|593646864|FG001|Double-Blind Period|Missing|1|||
164347204|NCT04518306|593646865|FG002|Double-Blind Period|Missing|0|||
164347205|NCT03268954|593646866|FG000|Overall Study|Withdrawal by Subject|27|||
164347206|NCT03268954|593646867|FG001|Overall Study|Withdrawal by Subject|17|||
164347207|NCT03268954|593646866|FG000|Overall Study|Lost to Follow-up|2|||
164347208|NCT03268954|593646867|FG001|Overall Study|Lost to Follow-up|3|||
164347209|NCT03268954|593646866|FG000|Overall Study|Reason Not Specified|3|||
164347210|NCT03268954|593646867|FG001|Overall Study|Reason Not Specified|8|||
164347211|NCT05358444|593646868|FG000|Overall Study|Withdrawal by Subject|0|||
164347212|NCT05358444|593646869|FG001|Overall Study|Withdrawal by Subject|1|||
164347213|NCT05358444|593646868|FG000|Overall Study|Lost to Follow-up|0|||
164347214|NCT05358444|593646869|FG001|Overall Study|Lost to Follow-up|3|||
164347215|NCT03820986|593646873|FG000|Overall Study|Death|201|||
164347216|NCT03820986|593646874|FG001|Overall Study|Death|175|||
164347217|NCT03820986|593646873|FG000|Overall Study|Lost to Follow-up|1|||
164347218|NCT03820986|593646874|FG001|Overall Study|Lost to Follow-up|1|||
164347219|NCT03820986|593646873|FG000|Overall Study|Physician Decision|1|||
164347220|NCT03820986|593646874|FG001|Overall Study|Physician Decision|0|||
164347221|NCT03820986|593646873|FG000|Overall Study|Sponsor Decision|122|||
164347222|NCT03820986|593646874|FG001|Overall Study|Sponsor Decision|160|||
164347223|NCT03820986|593646873|FG000|Overall Study|Withdrawal by Subject|9|||
164347224|NCT03820986|593646874|FG001|Overall Study|Withdrawal by Subject|4|||
164347225|NCT01638546|593646885|FG000|Overall Study|Adverse Event|1|||
164347226|NCT01638546|593646886|FG001|Overall Study|Adverse Event|3|||
164347227|NCT02513394|593646887|FG000|Overall Study|Withdrawal by Subject|11|||
164347228|NCT02513394|593646888|FG001|Overall Study|Withdrawal by Subject|23|||
164347229|NCT02513394|593646887|FG000|Overall Study|Ineligible|1|||
164347230|NCT02513394|593646888|FG001|Overall Study|Ineligible|0|||
164587400|NCT00510692|594513835|FG000|Overall Study|Withdrawal by Subject|1|||
164587401|NCT00510692|594513836|FG001|Overall Study|Withdrawal by Subject|0|||
164347231|NCT00540514|593648717|FG000|Overall Study|Still on treatment|3|||
164295389|NCT02218372|593455841|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
164295390|NCT02923726|593455842|FG000|Overall Study|Death|196|||
164295391|NCT02923726|593455843|FG001|Overall Study|Death|175|||
164347232|NCT00540514|593648718|FG001|Overall Study|Still on treatment|0|||
164347233|NCT00540514|593648717|FG000|Overall Study|Unacceptable Toxicity|61|||
164347234|NCT00540514|593648718|FG001|Overall Study|Unacceptable Toxicity|62|||
164347235|NCT00540514|593648717|FG000|Overall Study|Adverse Event|20|||
164347236|NCT00540514|593648718|FG001|Overall Study|Adverse Event|24|||
164295392|NCT02923726|593455842|FG000|Overall Study|Withdrawal by Subject|337|||
164295393|NCT02923726|593455843|FG001|Overall Study|Withdrawal by Subject|307|||
164295394|NCT03988400|593455848|FG000|Overall Study|Adverse Event|1|||
164295395|NCT03988400|593455849|FG001|Overall Study|Adverse Event|0|||
164295396|NCT03988400|593455848|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
164295397|NCT03988400|593455849|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
164295398|NCT03988400|593455848|FG000|Overall Study|Lost to Follow-up|0|||
164295399|NCT03988400|593455849|FG001|Overall Study|Lost to Follow-up|1|||
164295400|NCT04913610|593455850|FG000|Randomized Participants|Did Not Receive Treatment|0|||
164295401|NCT04913610|593455851|FG001|Randomized Participants|Did Not Receive Treatment|0|||
164295402|NCT04913610|593455852|FG002|Randomized Participants|Did Not Receive Treatment|1|||
164295403|NCT04913610|593455853|FG003|Randomized Participants|Did Not Receive Treatment|1|||
164295404|NCT04913610|593455854|FG004|Randomized Participants|Did Not Receive Treatment|0|||
164295405|NCT04913610|593455850|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
164295406|NCT04913610|593455851|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
164295407|NCT04913610|593455852|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
164295408|NCT04913610|593455853|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
164295409|NCT04913610|593455854|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
164295410|NCT03186209|593455855|FG000|Overall Study|Withdrawal by Subject|11|||
164295411|NCT03186209|593455856|FG001|Overall Study|Withdrawal by Subject|22|||
164295412|NCT03186209|593455855|FG000|Overall Study|Pregnancy|1|||
164295413|NCT03186209|593455856|FG001|Overall Study|Pregnancy|0|||
164295414|NCT03186209|593455855|FG000|Overall Study|Adverse Event|4|||
164295415|NCT03186209|593455856|FG001|Overall Study|Adverse Event|0|||
164295416|NCT03186209|593455855|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
164295417|NCT03186209|593455856|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
164295418|NCT03186209|593455855|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
164295419|NCT03186209|593455856|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
164295420|NCT03186209|593455855|FG000|Overall Study|Fail to meet randomization criteria|0|||
164295421|NCT03186209|593455856|FG001|Overall Study|Fail to meet randomization criteria|1|||
164295422|NCT03186209|593455855|FG000|Overall Study|Lost to Follow-up|0|||
164295423|NCT03186209|593455856|FG001|Overall Study|Lost to Follow-up|1|||
164295424|NCT00953667|593455864|FG000|Overall Study|Lost to Follow-up|11|||
164295425|NCT00953667|593455864|FG000|Overall Study|Physician Decision|35|||
164295426|NCT00953667|593455864|FG000|Overall Study|Withdrawal by Subject|63|||
164295427|NCT00953667|593455864|FG000|Overall Study|Adverse Event|10|||
164295428|NCT00953667|593455864|FG000|Overall Study|poor venous access,unable to draw blood|4|||
164295429|NCT04038359|593455865|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
164295430|NCT04038359|593455866|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
164295431|NCT04038359|593455865|FG000|Overall Study|Death|8|||
164295432|NCT04038359|593455866|FG001|Overall Study|Death|7|||
164295433|NCT04038359|593455865|FG000|Overall Study|Lost to Follow-up|3|||
164295434|NCT04038359|593455866|FG001|Overall Study|Lost to Follow-up|0|||
164295435|NCT04038359|593455865|FG000|Overall Study|Participant Moved|1|||
164295436|NCT04038359|593455866|FG001|Overall Study|Participant Moved|0|||
164295437|NCT04038359|593455865|FG000|Overall Study|Withdrawal by Subject|4|||
164295438|NCT04038359|593455866|FG001|Overall Study|Withdrawal by Subject|3|||
164295439|NCT04038359|593455865|FG000|Overall Study|Physician Decision|3|||
164295440|NCT04038359|593455866|FG001|Overall Study|Physician Decision|2|||
164295441|NCT04038359|593455865|FG000|Overall Study|Adverse Event|0|||
164295442|NCT04038359|593455866|FG001|Overall Study|Adverse Event|2|||
164347237|NCT00540514|593648717|FG000|Overall Study|Physician Decision|86|||
164347238|NCT00540514|593648718|FG001|Overall Study|Physician Decision|99|||
164347239|NCT00540514|593648717|FG000|Overall Study|Protocol Deviation|3|||
164347240|NCT00540514|593648718|FG001|Overall Study|Protocol Deviation|4|||
164347241|NCT00540514|593648717|FG000|Overall Study|Lost to Follow-up|1|||
164347242|NCT00540514|593648718|FG001|Overall Study|Lost to Follow-up|1|||
164347243|NCT00540514|593648717|FG000|Overall Study|Withdrawal by Subject|65|||
164295443|NCT04038359|593455865|FG000|Overall Study|Progressive Disease|0|||
164295444|NCT04038359|593455866|FG001|Overall Study|Progressive Disease|1|||
164295445|NCT00475670|593455867|FG000|Overall Study|Death|0|||
164295446|NCT00475670|593455868|FG001|Overall Study|Death|1|||
164347244|NCT00540514|593648718|FG001|Overall Study|Withdrawal by Subject|67|||
164347245|NCT00540514|593648717|FG000|Overall Study|Excluded prior to treatment|7|||
164347246|NCT00540514|593648718|FG001|Overall Study|Excluded prior to treatment|7|||
164295447|NCT00475670|593455867|FG000|Overall Study|Lack of Efficacy|3|||
164295448|NCT00475670|593455868|FG001|Overall Study|Lack of Efficacy|34|||
164295449|NCT00475670|593455867|FG000|Overall Study|Refused treatment|0|||
164295450|NCT00475670|593455868|FG001|Overall Study|Refused treatment|2|||
164295451|NCT00475670|593455867|FG000|Overall Study|Failure to Return|0|||
164295452|NCT00475670|593455868|FG001|Overall Study|Failure to Return|1|||
164295453|NCT00475670|593455867|FG000|Overall Study|Other|0|||
164295454|NCT00475670|593455868|FG001|Overall Study|Other|3|||
164295455|NCT02004236|593455871|FG000|Overall Study|Lack of Efficacy|0|||
164295456|NCT02004236|593455872|FG001|Overall Study|Lack of Efficacy|0|||
164295457|NCT02004236|593455873|FG002|Overall Study|Lack of Efficacy|16|||
164295458|NCT00551759|593455875|FG000|Overall Study|Adverse Event|7|||
164295459|NCT00551759|593455875|FG000|Overall Study|Death|5|||
164295460|NCT00551759|593455875|FG000|Overall Study|Ineligible|1|||
164295461|NCT00918385|593455876|FG000|Monotherapy|Adverse Event|1|||
164295462|NCT00918385|593455877|FG001|Monotherapy|Adverse Event|6|||
164295463|NCT00918385|593455876|FG000|Monotherapy|Complicating illness|1|||
164295464|NCT00918385|593455877|FG001|Monotherapy|Complicating illness|0|||
164295465|NCT00918385|593455876|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
164295466|NCT00918385|593455877|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
164295467|NCT00918385|593455876|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
164295468|NCT00918385|593455877|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
164295469|NCT00918385|593455876|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
164295470|NCT00918385|593455877|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
164295471|NCT00918385|593455876|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
164295472|NCT00918385|593455877|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
164295473|NCT00322881|593455880|FG000|Overall Study|Death|2|||
164295474|NCT00322881|593455880|FG000|Overall Study|Adverse Event|1|||
164295475|NCT00322881|593455880|FG000|Overall Study|Disease Progression|2|||
164295476|NCT01476722|593455881|FG000|Overall Study|Adverse Event|1|||
164295477|NCT00918281|593455889|FG000|Overall Study|Physician Decision|29|||
164295478|NCT02978417|593455890|FG000|Overall Study|Lost to Follow-up|2|||
164295479|NCT02978417|593455891|FG001|Overall Study|Lost to Follow-up|2|||
164295480|NCT01323582|593455892|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
164295481|NCT01323582|593455893|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
164295482|NCT01323582|593455892|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
164295483|NCT01323582|593455893|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
164295484|NCT01323582|593455892|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
164295485|NCT01323582|593455893|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
164295486|NCT03557970|593455898|FG000|Overall Study|Study closure|1|||
164295487|NCT03557970|593455899|FG001|Overall Study|Study closure|0|||
164295488|NCT03557970|593455898|FG000|Overall Study|Physician Decision|0|||
164295489|NCT03557970|593455899|FG001|Overall Study|Physician Decision|1|||
164295490|NCT03557970|593455898|FG000|Overall Study|Death|0|||
164295491|NCT03557970|593455899|FG001|Overall Study|Death|1|||
164295492|NCT00112736|593455900|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
164295493|NCT00112736|593455901|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
164295494|NCT00525512|593455912|FG000|Double-Blind Phase|Adverse Event|48|||
164295495|NCT00525512|593455913|FG001|Double-Blind Phase|Adverse Event|28|||
164295496|NCT00525512|593455914|FG002|Double-Blind Phase|Adverse Event|0|||
164295497|NCT00525512|593455915|FG003|Double-Blind Phase|Adverse Event|0|||
164295498|NCT00525512|593455912|FG000|Double-Blind Phase|Protocol Violation|3|||
164295499|NCT00525512|593455913|FG001|Double-Blind Phase|Protocol Violation|1|||
164295500|NCT00525512|593455914|FG002|Double-Blind Phase|Protocol Violation|0|||
164295501|NCT00525512|593455915|FG003|Double-Blind Phase|Protocol Violation|0|||
164295502|NCT00525512|593455912|FG000|Double-Blind Phase|Lost to Follow-up|3|||
164295503|NCT00525512|593455913|FG001|Double-Blind Phase|Lost to Follow-up|7|||
164295504|NCT00525512|593455914|FG002|Double-Blind Phase|Lost to Follow-up|0|||
164295505|NCT00525512|593455915|FG003|Double-Blind Phase|Lost to Follow-up|0|||
164295506|NCT00525512|593455912|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
164587402|NCT02116972|594513837|FG000|Overall Study|Adverse Event|4|||
164587403|NCT02116972|594513838|FG001|Overall Study|Adverse Event|4|||
164587404|NCT02116972|594513839|FG002|Overall Study|Adverse Event|1|||
164587405|NCT02116972|594513837|FG000|Overall Study|Withdrawal by Subject|1|||
164587406|NCT02116972|594513838|FG001|Overall Study|Withdrawal by Subject|1|||
164587407|NCT02116972|594513839|FG002|Overall Study|Withdrawal by Subject|5|||
164295507|NCT00525512|593455913|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
164295508|NCT00525512|593455914|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
164295509|NCT00525512|593455915|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
164295510|NCT00525512|593455912|FG000|Double-Blind Phase|Lack of Efficacy|13|||
164295511|NCT00525512|593455913|FG001|Double-Blind Phase|Lack of Efficacy|5|||
164295512|NCT00525512|593455914|FG002|Double-Blind Phase|Lack of Efficacy|0|||
164295513|NCT00525512|593455915|FG003|Double-Blind Phase|Lack of Efficacy|0|||
164587408|NCT02116972|594513837|FG000|Overall Study|Protocol Violation|1|||
164587409|NCT02116972|594513838|FG001|Overall Study|Protocol Violation|0|||
164295514|NCT00525512|593455912|FG000|Double-Blind Phase|Other reason (not specified)|12|||
164295515|NCT00525512|593455913|FG001|Double-Blind Phase|Other reason (not specified)|13|||
164295516|NCT00525512|593455914|FG002|Double-Blind Phase|Other reason (not specified)|0|||
164295517|NCT00525512|593455915|FG003|Double-Blind Phase|Other reason (not specified)|0|||
164295518|NCT00525512|593455912|FG000|Open-Label Phase|Adverse Event|0|||
164295519|NCT00525512|593455913|FG001|Open-Label Phase|Adverse Event|0|||
164295520|NCT00525512|593455914|FG002|Open-Label Phase|Adverse Event|1|||
164295521|NCT00525512|593455915|FG003|Open-Label Phase|Adverse Event|0|||
164295522|NCT00525512|593455912|FG000|Open-Label Phase|Lost to Follow-up|0|||
164295523|NCT00525512|593455913|FG001|Open-Label Phase|Lost to Follow-up|0|||
164295524|NCT00525512|593455914|FG002|Open-Label Phase|Lost to Follow-up|1|||
164295525|NCT00525512|593455915|FG003|Open-Label Phase|Lost to Follow-up|0|||
164295526|NCT00525512|593455912|FG000|Open-Label Phase|Other reason (not specified)|0|||
164295527|NCT00525512|593455913|FG001|Open-Label Phase|Other reason (not specified)|0|||
164295528|NCT00525512|593455914|FG002|Open-Label Phase|Other reason (not specified)|4|||
164295529|NCT00525512|593455915|FG003|Open-Label Phase|Other reason (not specified)|5|||
164295530|NCT01601535|593455916|FG000|Phase 1|Adverse Event|1|||
164295531|NCT01601535|593455917|FG001|Phase 1|Adverse Event|0|||
164295532|NCT01601535|593455918|FG002|Phase 1|Adverse Event|2|||
164295533|NCT01601535|593455919|FG003|Phase 1|Adverse Event|1|||
164295534|NCT01601535|593455920|FG004|Phase 1|Adverse Event|0|||
164295535|NCT01601535|593455921|FG005|Phase 1|Adverse Event|0|||
164295536|NCT01601535|593455916|FG000|Phase 1|Withdrawal by Subject|2|||
164295537|NCT01601535|593455917|FG001|Phase 1|Withdrawal by Subject|1|||
164295538|NCT01601535|593455918|FG002|Phase 1|Withdrawal by Subject|1|||
164295539|NCT01601535|593455919|FG003|Phase 1|Withdrawal by Subject|2|||
164295540|NCT01601535|593455920|FG004|Phase 1|Withdrawal by Subject|0|||
164295541|NCT01601535|593455921|FG005|Phase 1|Withdrawal by Subject|0|||
164295542|NCT01601535|593455916|FG000|Phase 1|Progressive Disease|2|||
164295543|NCT01601535|593455917|FG001|Phase 1|Progressive Disease|3|||
164295544|NCT01601535|593455918|FG002|Phase 1|Progressive Disease|2|||
164295545|NCT01601535|593455919|FG003|Phase 1|Progressive Disease|1|||
164295546|NCT01601535|593455920|FG004|Phase 1|Progressive Disease|0|||
164295547|NCT01601535|593455921|FG005|Phase 1|Progressive Disease|0|||
164295548|NCT01601535|593455916|FG000|Phase 1|Started Another Treatment|1|||
164295549|NCT01601535|593455917|FG001|Phase 1|Started Another Treatment|2|||
164295550|NCT01601535|593455918|FG002|Phase 1|Started Another Treatment|0|||
164295551|NCT01601535|593455919|FG003|Phase 1|Started Another Treatment|0|||
164295552|NCT01601535|593455920|FG004|Phase 1|Started Another Treatment|0|||
164295553|NCT01601535|593455921|FG005|Phase 1|Started Another Treatment|0|||
164295554|NCT01601535|593455916|FG000|Phase 2|Adverse Event|0|||
164295555|NCT01601535|593455917|FG001|Phase 2|Adverse Event|0|||
164295556|NCT01601535|593455918|FG002|Phase 2|Adverse Event|0|||
164295557|NCT01601535|593455919|FG003|Phase 2|Adverse Event|0|||
164295558|NCT01601535|593455920|FG004|Phase 2|Adverse Event|5|||
164295559|NCT01601535|593455921|FG005|Phase 2|Adverse Event|1|||
164295560|NCT01601535|593455916|FG000|Phase 2|Withdrawal by Subject|0|||
164295561|NCT01601535|593455917|FG001|Phase 2|Withdrawal by Subject|0|||
164295562|NCT01601535|593455918|FG002|Phase 2|Withdrawal by Subject|0|||
164295563|NCT01601535|593455919|FG003|Phase 2|Withdrawal by Subject|0|||
164295564|NCT01601535|593455920|FG004|Phase 2|Withdrawal by Subject|8|||
164295565|NCT01601535|593455921|FG005|Phase 2|Withdrawal by Subject|2|||
164295566|NCT01601535|593455916|FG000|Phase 2|Progressive Disease|0|||
164295567|NCT01601535|593455917|FG001|Phase 2|Progressive Disease|0|||
164295568|NCT01601535|593455918|FG002|Phase 2|Progressive Disease|0|||
164693485|NCT01435928|594899412|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
164693486|NCT01435928|594899413|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
164693487|NCT01435928|594899411|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
164693488|NCT01435928|594899412|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
164693489|NCT01435928|594899413|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
164693490|NCT01435928|594899411|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
164693491|NCT01435928|594899412|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
164693492|NCT01435928|594899413|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
164295569|NCT01601535|593455919|FG003|Phase 2|Progressive Disease|0|||
164295570|NCT01601535|593455920|FG004|Phase 2|Progressive Disease|5|||
164295571|NCT01601535|593455921|FG005|Phase 2|Progressive Disease|7|||
164295572|NCT01601535|593455916|FG000|Phase 2|Started Another Treatment|0|||
164295573|NCT01601535|593455917|FG001|Phase 2|Started Another Treatment|0|||
164295574|NCT01601535|593455918|FG002|Phase 2|Started Another Treatment|0|||
164295575|NCT01601535|593455919|FG003|Phase 2|Started Another Treatment|0|||
164295576|NCT01601535|593455920|FG004|Phase 2|Started Another Treatment|1|||
164347247|NCT00540514|593648717|FG000|Overall Study|Paclitaxel not available|0|||
164693493|NCT01435928|594899411|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
164693494|NCT01435928|594899412|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
164693495|NCT01435928|594899413|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
164295577|NCT01601535|593455921|FG005|Phase 2|Started Another Treatment|2|||
164295578|NCT03600909|593455924|FG000|Overall Study|Not treated|0|||
164295579|NCT03600909|593455925|FG001|Overall Study|Not treated|3|||
164295580|NCT03600909|593455926|FG002|Overall Study|Not treated|0|||
164295581|NCT04576988|593455927|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
164295582|NCT04576988|593455928|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
164295583|NCT04576988|593455927|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
164295584|NCT04576988|593455928|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
164295585|NCT04576988|593455927|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
164295586|NCT04576988|593455928|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
164295587|NCT04576988|593455927|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
164434918|NCT03412747|593960831|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
164434919|NCT03412747|593960829|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
164295588|NCT04576988|593455928|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
164295589|NCT04576988|593455927|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
164295590|NCT04576988|593455928|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
164295591|NCT04576988|593455927|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
164295592|NCT04576988|593455928|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
164295593|NCT04576988|593455927|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
164295594|NCT04576988|593455928|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
164295595|NCT04576988|593455927|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
164295596|NCT04576988|593455928|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
164295597|NCT04576988|593455927|FG000|Long Term Double Blind (LTDB)|Death|2|||
164295598|NCT04576988|593455928|FG001|Long Term Double Blind (LTDB)|Death|1|||
164295599|NCT04576988|593455927|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
164295600|NCT04576988|593455928|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
164295601|NCT02919761|593455939|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
164295602|NCT02919761|593455940|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
164295603|NCT02919761|593455941|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
164295604|NCT02919761|593455939|FG000|Part 1: Open Label|Adverse Event|1|||
164295605|NCT02919761|593455940|FG001|Part 1: Open Label|Adverse Event|0|||
164295606|NCT02919761|593455941|FG002|Part 1: Open Label|Adverse Event|0|||
164295607|NCT02919761|593455939|FG000|Part 1: Open Label|Lost to Follow-up|1|||
164295608|NCT02919761|593455940|FG001|Part 1: Open Label|Lost to Follow-up|0|||
164295609|NCT02919761|593455941|FG002|Part 1: Open Label|Lost to Follow-up|0|||
164295610|NCT02919761|593455939|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
164295611|NCT02919761|593455940|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
164295612|NCT02919761|593455941|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
164295613|NCT02919761|593455939|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
164295614|NCT02919761|593455940|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
164295615|NCT02919761|593455941|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
164295616|NCT02919761|593455939|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
164295617|NCT02919761|593455940|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
164295618|NCT02919761|593455941|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
164295619|NCT02919761|593455939|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
164295620|NCT02919761|593455940|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
164295621|NCT02919761|593455941|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
164295622|NCT02919761|593455939|FG000|Part 1: Open Label|Termination by Sponsor|1|||
164347248|NCT00540514|593648718|FG001|Overall Study|Paclitaxel not available|2|||
164347249|NCT01892293|593648725|FG000|Overall Study|Apheresed but not treated|4|||
164347250|NCT03602482|593648730|FG000|Overall Study|Withdrawal by Subject|6|||
164347251|NCT03602482|593648731|FG001|Overall Study|Withdrawal by Subject|7|||
164347252|NCT03602482|593648732|FG002|Overall Study|Withdrawal by Subject|0|||
164347253|NCT03602482|593648733|FG003|Overall Study|Withdrawal by Subject|0|||
164347254|NCT00618072|593648753|FG000|Overall Study|Lost to Follow-up|2|||
164347255|NCT00618072|593648754|FG001|Overall Study|Lost to Follow-up|0|||
164347256|NCT00618072|593648755|FG002|Overall Study|Lost to Follow-up|3|||
164347257|NCT00618072|593648753|FG000|Overall Study|Physician Decision|0|||
164347258|NCT00618072|593648754|FG001|Overall Study|Physician Decision|1|||
164347259|NCT00618072|593648755|FG002|Overall Study|Physician Decision|1|||
164347260|NCT00684307|593648756|FG000|Overall Study|Adverse Event|11|||
164347261|NCT00684307|593648757|FG001|Overall Study|Adverse Event|6|||
164347262|NCT00684307|593648758|FG002|Overall Study|Adverse Event|15|||
164347263|NCT00684307|593648759|FG003|Overall Study|Adverse Event|16|||
164347264|NCT00684307|593648760|FG004|Overall Study|Adverse Event|8|||
164587410|NCT02116972|594513839|FG002|Overall Study|Protocol Violation|1|||
164295623|NCT02919761|593455940|FG001|Part 1: Open Label|Termination by Sponsor|0|||
164295624|NCT02919761|593455941|FG002|Part 1: Open Label|Termination by Sponsor|0|||
164347265|NCT00684307|593648756|FG000|Overall Study|Development of increasing Liver Function|0|||
164347266|NCT00684307|593648757|FG001|Overall Study|Development of increasing Liver Function|2|||
164587411|NCT02116972|594513837|FG000|Overall Study|Lost to Follow-up|4|||
164295625|NCT02919761|593455939|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
164347267|NCT00684307|593648758|FG002|Overall Study|Development of increasing Liver Function|0|||
164347268|NCT00684307|593648759|FG003|Overall Study|Development of increasing Liver Function|1|||
164587412|NCT02116972|594513838|FG001|Overall Study|Lost to Follow-up|3|||
164587413|NCT02116972|594513839|FG002|Overall Study|Lost to Follow-up|1|||
164295626|NCT02919761|593455940|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
164295627|NCT02919761|593455941|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
164295628|NCT02919761|593455939|FG000|Part 2: Double-blind|Adverse Event|0|||
164295629|NCT02919761|593455940|FG001|Part 2: Double-blind|Adverse Event|1|||
164295630|NCT02919761|593455941|FG002|Part 2: Double-blind|Adverse Event|0|||
164295631|NCT02919761|593455939|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
164295632|NCT02919761|593455940|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
164295633|NCT02919761|593455941|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
164347269|NCT00684307|593648760|FG004|Overall Study|Development of increasing Liver Function|0|||
164347270|NCT00684307|593648756|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
164347271|NCT00684307|593648757|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
164347272|NCT00684307|593648758|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
164347273|NCT00684307|593648759|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
164347274|NCT00684307|593648760|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
164347275|NCT00684307|593648756|FG000|Overall Study|Incorrect enrolment or randomization|4|||
164434920|NCT03412747|593960830|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
164693496|NCT01435928|594899411|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
164693497|NCT01435928|594899412|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
164693498|NCT01435928|594899413|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
164693499|NCT01435928|594899411|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
164693500|NCT01435928|594899412|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
164693501|NCT01435928|594899413|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
164693502|NCT01435928|594899411|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
164693503|NCT01435928|594899412|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
164693504|NCT01435928|594899413|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
164693505|NCT01435928|594899411|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
164693506|NCT01435928|594899412|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
164693507|NCT01435928|594899413|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
164693508|NCT01435928|594899411|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
164693509|NCT01435928|594899412|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
164693510|NCT01435928|594899413|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
164693511|NCT01435928|594899411|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
164693512|NCT01435928|594899412|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
164693513|NCT01435928|594899413|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
164693514|NCT01435928|594899411|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
164693515|NCT01435928|594899412|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
164693516|NCT01435928|594899413|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
164693517|NCT01435928|594899411|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
164693518|NCT01435928|594899412|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
164693519|NCT01435928|594899413|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
164693520|NCT01435928|594899411|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
164693521|NCT01435928|594899412|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
164693522|NCT01435928|594899413|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
164693523|NCT01435928|594899411|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
164693524|NCT01435928|594899412|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
164693525|NCT01435928|594899413|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
164693526|NCT01435928|594899411|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
164693527|NCT01435928|594899412|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
164693528|NCT01435928|594899413|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
164693529|NCT01435928|594899411|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
164693530|NCT01435928|594899412|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
164693531|NCT01435928|594899413|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
164693532|NCT01634854|594899414|FG000|Overall Study|Cesarean delivery|2|||
164693533|NCT01634854|594899415|FG001|Overall Study|Cesarean delivery|7|||
164693534|NCT03365791|594899416|FG000|Overall Study|Adverse Event|5|||
164693535|NCT03365791|594899416|FG000|Overall Study|Death|1|||
164693536|NCT03365791|594899416|FG000|Overall Study|Lost to Follow-up|1|||
164693537|NCT03365791|594899416|FG000|Overall Study|Physician Decision|9|||
164693538|NCT03365791|594899416|FG000|Overall Study|Progressive disease|51|||
164693539|NCT03365791|594899416|FG000|Overall Study|Subject/guardian decision|5|||
164295634|NCT02919761|593455939|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
164295635|NCT02919761|593455940|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
164295636|NCT02919761|593455941|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
164295637|NCT02919761|593455939|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
164693540|NCT00739973|594899417|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
164693541|NCT00739973|594899418|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
164693542|NCT00739973|594899419|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
164295638|NCT02919761|593455940|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
164295639|NCT02919761|593455941|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
164434921|NCT03412747|593960831|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
164434922|NCT03412747|593960829|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
164295640|NCT02919761|593455939|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
164295641|NCT02919761|593455940|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
164295642|NCT02919761|593455941|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
164295643|NCT02919761|593455939|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
164295644|NCT02919761|593455940|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
164295645|NCT02919761|593455941|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
164295646|NCT02919761|593455939|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
164295647|NCT02919761|593455940|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
164295648|NCT02919761|593455941|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
164295649|NCT03724942|593455942|FG000|Overall Study|Adverse Event|20|||
164295650|NCT03724942|593455943|FG001|Overall Study|Adverse Event|14|||
164295651|NCT03724942|593455942|FG000|Overall Study|Lack of Efficacy|0|||
164295652|NCT03724942|593455943|FG001|Overall Study|Lack of Efficacy|1|||
164295653|NCT03724942|593455942|FG000|Overall Study|Physician Decision|5|||
164295654|NCT03724942|593455943|FG001|Overall Study|Physician Decision|2|||
164295655|NCT03724942|593455942|FG000|Overall Study|Protocol Violation|1|||
164295656|NCT03724942|593455943|FG001|Overall Study|Protocol Violation|0|||
164295657|NCT03724942|593455942|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
164295658|NCT03724942|593455943|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
164295659|NCT03724942|593455942|FG000|Overall Study|Withdrawal by Legal Representative|3|||
164295660|NCT03724942|593455943|FG001|Overall Study|Withdrawal by Legal Representative|0|||
164295661|NCT00410956|593455944|FG000|Overall Study|Adverse Event|1|||
164295662|NCT00410956|593455944|FG000|Overall Study|Death|2|||
164295663|NCT00410956|593455944|FG000|Overall Study|Lack of Efficacy|10|||
164295664|NCT00410956|593455944|FG000|Overall Study|Physician Decision|6|||
164295665|NCT00880698|593455945|FG000|Overall Study|Death|0|||
164295666|NCT00880698|593455946|FG001|Overall Study|Death|0|||
164295667|NCT00880698|593455947|FG002|Overall Study|Death|1|||
164295668|NCT00880698|593455948|FG003|Overall Study|Death|2|||
164295669|NCT00880698|593455945|FG000|Overall Study|Lost to Follow-up|1|||
164295670|NCT00880698|593455946|FG001|Overall Study|Lost to Follow-up|3|||
164295671|NCT00880698|593455947|FG002|Overall Study|Lost to Follow-up|0|||
164295672|NCT00880698|593455948|FG003|Overall Study|Lost to Follow-up|1|||
164295673|NCT01295814|593458041|FG000|Overall Study|Lack of Efficacy|0|||
164295674|NCT01295814|593458042|FG001|Overall Study|Lack of Efficacy|2|||
164295675|NCT01295814|593458041|FG000|Overall Study|Withdrawal by Subject|2|||
164295676|NCT01295814|593458042|FG001|Overall Study|Withdrawal by Subject|0|||
164295677|NCT03414983|593458043|FG000|Pre-Treatment|Other reasons|1|||
164295678|NCT03414983|593458044|FG001|Pre-Treatment|Other reasons|0|||
164295679|NCT03414983|593458043|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
164295680|NCT03414983|593458044|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
164295681|NCT03414983|593458043|FG000|Pre-Treatment|Participant withdrew consent|1|||
164295682|NCT03414983|593458044|FG001|Pre-Treatment|Participant withdrew consent|3|||
164295683|NCT03414983|593458043|FG000|Treatment|Participant withdrew consent|4|||
164295684|NCT03414983|593458044|FG001|Treatment|Participant withdrew consent|3|||
164295685|NCT03414983|593458043|FG000|Treatment|Participant request to discontinue study treatment|8|||
164295686|NCT03414983|593458044|FG001|Treatment|Participant request to discontinue study treatment|10|||
164295687|NCT03414983|593458043|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
164295688|NCT03414983|593458044|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
164693543|NCT00739973|594899420|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
164295689|NCT03414983|593458043|FG000|Treatment|Death|0|||
164295690|NCT03414983|593458044|FG001|Treatment|Death|1|||
164295691|NCT03414983|593458043|FG000|Treatment|Study Drug Toxicity|10|||
164295692|NCT03414983|593458044|FG001|Treatment|Study Drug Toxicity|5|||
164295693|NCT03414983|593458043|FG000|Treatment|Disease Progression|75|||
164295694|NCT03414983|593458044|FG001|Treatment|Disease Progression|29|||
164295695|NCT03414983|593458043|FG000|Treatment|Not reported|1|||
164295696|NCT03414983|593458044|FG001|Treatment|Not reported|0|||
164295697|NCT03414983|593458043|FG000|Treatment|Other reasons|3|||
164295698|NCT03414983|593458044|FG001|Treatment|Other reasons|2|||
164295699|NCT03414983|593458043|FG000|Treatment|Poor/non-compliance|2|||
164295700|NCT03414983|593458044|FG001|Treatment|Poor/non-compliance|0|||
164295701|NCT03414983|593458043|FG000|Treatment|Maximum clinical benefit|5|||
164693544|NCT00739973|594899421|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
164295702|NCT03414983|593458044|FG001|Treatment|Maximum clinical benefit|9|||
164295703|NCT03414983|593458043|FG000|Treatment|Lost to Follow-up|0|||
164295704|NCT03414983|593458044|FG001|Treatment|Lost to Follow-up|1|||
164295705|NCT03414983|593458043|FG000|Treatment|Administrative reasons by sponsor|1|||
164295706|NCT03414983|593458044|FG001|Treatment|Administrative reasons by sponsor|0|||
164295707|NCT00948246|593458045|FG000|Overall Study|Lost to Follow-up|11|||
164295708|NCT00948246|593458045|FG000|Overall Study|Adverse Event|11|||
164295709|NCT00948246|593458045|FG000|Overall Study|Death|1|||
164295710|NCT00948246|593458045|FG000|Overall Study|Withdrawal by Subject|1|||
164295711|NCT00148317|593458046|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
164295712|NCT00148317|593458046|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
164295713|NCT00148317|593458046|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
164295714|NCT02326155|593458047|FG000|Overall Study|Adverse Event|21|||
164295715|NCT02326155|593458048|FG001|Overall Study|Adverse Event|5|||
164295716|NCT02326155|593458047|FG000|Overall Study|Death|3|||
164295717|NCT02326155|593458048|FG001|Overall Study|Death|0|||
164295718|NCT02326155|593458047|FG000|Overall Study|Lack of Efficacy|49|||
164295719|NCT02326155|593458048|FG001|Overall Study|Lack of Efficacy|5|||
164295720|NCT02326155|593458047|FG000|Overall Study|Lost to Follow-up|14|||
164295721|NCT02326155|593458048|FG001|Overall Study|Lost to Follow-up|3|||
164295722|NCT02326155|593458047|FG000|Overall Study|Protocol Violation|2|||
164295723|NCT02326155|593458048|FG001|Overall Study|Protocol Violation|0|||
164295724|NCT02326155|593458047|FG000|Overall Study|Withdrawal by Subject|34|||
164295725|NCT02326155|593458048|FG001|Overall Study|Withdrawal by Subject|11|||
164295726|NCT02326155|593458047|FG000|Overall Study|Disease progression|37|||
164295727|NCT02326155|593458048|FG001|Overall Study|Disease progression|4|||
164295728|NCT02326155|593458047|FG000|Overall Study|Study close|188|||
164347276|NCT00684307|593648757|FG001|Overall Study|Incorrect enrolment or randomization|0|||
164347277|NCT00684307|593648758|FG002|Overall Study|Incorrect enrolment or randomization|0|||
164347278|NCT00684307|593648759|FG003|Overall Study|Incorrect enrolment or randomization|0|||
164347279|NCT00684307|593648760|FG004|Overall Study|Incorrect enrolment or randomization|0|||
164347280|NCT00684307|593648756|FG000|Overall Study|Interupted IP for more than 7 days|0|||
164347281|NCT00684307|593648757|FG001|Overall Study|Interupted IP for more than 7 days|4|||
164347282|NCT00684307|593648758|FG002|Overall Study|Interupted IP for more than 7 days|1|||
164347283|NCT00684307|593648759|FG003|Overall Study|Interupted IP for more than 7 days|3|||
164347284|NCT00684307|593648760|FG004|Overall Study|Interupted IP for more than 7 days|3|||
164347285|NCT00684307|593648756|FG000|Overall Study|Severe non compliance to protocol|1|||
164347286|NCT00684307|593648757|FG001|Overall Study|Severe non compliance to protocol|0|||
164347287|NCT00684307|593648758|FG002|Overall Study|Severe non compliance to protocol|0|||
164347288|NCT00684307|593648759|FG003|Overall Study|Severe non compliance to protocol|1|||
164347289|NCT00684307|593648760|FG004|Overall Study|Severe non compliance to protocol|2|||
164347290|NCT00684307|593648756|FG000|Overall Study|Participant not willing to continue|7|||
164347291|NCT00684307|593648757|FG001|Overall Study|Participant not willing to continue|10|||
164347292|NCT00684307|593648758|FG002|Overall Study|Participant not willing to continue|11|||
164347293|NCT00684307|593648759|FG003|Overall Study|Participant not willing to continue|5|||
164347294|NCT00684307|593648760|FG004|Overall Study|Participant not willing to continue|8|||
164347295|NCT00684307|593648756|FG000|Overall Study|Criteria from the CSR|0|||
164347296|NCT00684307|593648757|FG001|Overall Study|Criteria from the CSR|0|||
164347297|NCT00684307|593648758|FG002|Overall Study|Criteria from the CSR|1|||
164347298|NCT00684307|593648759|FG003|Overall Study|Criteria from the CSR|3|||
164347299|NCT00684307|593648760|FG004|Overall Study|Criteria from the CSR|3|||
164347300|NCT02170298|593648761|FG000|Overall Study|Withdrawal by Subject|0|||
164347301|NCT02170298|593648762|FG001|Overall Study|Withdrawal by Subject|1|||
164347302|NCT02170298|593648761|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
164347303|NCT02170298|593648762|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
164347304|NCT05048784|593648763|FG000|Period 1|Adverse Event|3|||
164347305|NCT05048784|593648764|FG001|Period 1|Adverse Event|1|||
164347306|NCT05048784|593648765|FG002|Period 1|Adverse Event|0|||
164347307|NCT05048784|593648766|FG003|Period 1|Adverse Event|0|||
164347308|NCT05048784|593648763|FG000|Period 2|Lost to Follow-up|0|||
164347309|NCT05048784|593648764|FG001|Period 2|Lost to Follow-up|1|||
164347310|NCT05048784|593648765|FG002|Period 2|Lost to Follow-up|0|||
164347311|NCT05048784|593648766|FG003|Period 2|Lost to Follow-up|0|||
164347312|NCT02853604|593648769|FG000|Overall Study|Withdrawal by Subject|12|||
164347313|NCT02853604|593648770|FG001|Overall Study|Withdrawal by Subject|35|||
164347314|NCT02853604|593648769|FG000|Overall Study|Lost to Follow-up|4|||
164347315|NCT02853604|593648770|FG001|Overall Study|Lost to Follow-up|8|||
164347316|NCT02853604|593648769|FG000|Overall Study|Death|1|||
164347317|NCT02853604|593648770|FG001|Overall Study|Death|5|||
164347318|NCT02853604|593648769|FG000|Overall Study|Miscellaneous|11|||
164347319|NCT02853604|593648770|FG001|Overall Study|Miscellaneous|2|||
164347320|NCT02853604|593648769|FG000|Overall Study|Progressive Disease|0|||
164347321|NCT02853604|593648770|FG001|Overall Study|Progressive Disease|2|||
164347322|NCT00727025|593648771|FG000|Overall Study|Physician Decision|23|||
164347323|NCT02269241|593648772|FG000|Overall Study|Lost to Follow-up|269|||
164347324|NCT02269241|593648772|FG000|Overall Study|Withdrawal by Subject|155|||
164347325|NCT02269241|593648772|FG000|Overall Study|Protocol Violation|1|||
164347326|NCT02269241|593648772|FG000|Overall Study|Physician Decision|7|||
164434923|NCT03412747|593960830|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
164347327|NCT02269241|593648772|FG000|Overall Study|Pregnancy|15|||
164434924|NCT03412747|593960831|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
164295729|NCT02326155|593458048|FG001|Overall Study|Study close|21|||
164295730|NCT02326155|593458047|FG000|Overall Study|except for study close|46|||
164295731|NCT02326155|593458048|FG001|Overall Study|except for study close|13|||
164295732|NCT04199351|593458049|FG000|Overall Study|Decision by sponsor|0|||
164295733|NCT04199351|593458050|FG001|Overall Study|Decision by sponsor|0|||
164295734|NCT04199351|593458051|FG002|Overall Study|Decision by sponsor|0|||
164295735|NCT04199351|593458052|FG003|Overall Study|Decision by sponsor|2|||
164295736|NCT04199351|593458053|FG004|Overall Study|Decision by sponsor|0|||
164295737|NCT04199351|593458054|FG005|Overall Study|Decision by sponsor|0|||
164295738|NCT04199351|593458055|FG006|Overall Study|Decision by sponsor|0|||
164295739|NCT04199351|593458056|FG007|Overall Study|Decision by sponsor|0|||
164295740|NCT04199351|593458057|FG008|Overall Study|Decision by sponsor|0|||
164295741|NCT04199351|593458058|FG009|Overall Study|Decision by sponsor|6|||
164295742|NCT04199351|593458049|FG000|Overall Study|Lost to Follow-up|0|||
164295743|NCT04199351|593458050|FG001|Overall Study|Lost to Follow-up|0|||
164295744|NCT04199351|593458051|FG002|Overall Study|Lost to Follow-up|1|||
164295745|NCT04199351|593458052|FG003|Overall Study|Lost to Follow-up|0|||
164295746|NCT04199351|593458053|FG004|Overall Study|Lost to Follow-up|0|||
164295747|NCT04199351|593458054|FG005|Overall Study|Lost to Follow-up|1|||
164295748|NCT04199351|593458055|FG006|Overall Study|Lost to Follow-up|0|||
164295749|NCT04199351|593458056|FG007|Overall Study|Lost to Follow-up|0|||
164295750|NCT04199351|593458057|FG008|Overall Study|Lost to Follow-up|0|||
164295751|NCT04199351|593458058|FG009|Overall Study|Lost to Follow-up|0|||
164295752|NCT04199351|593458049|FG000|Overall Study|Withdrawal by Subject|0|||
164295753|NCT04199351|593458050|FG001|Overall Study|Withdrawal by Subject|1|||
164295754|NCT04199351|593458051|FG002|Overall Study|Withdrawal by Subject|0|||
164295755|NCT04199351|593458052|FG003|Overall Study|Withdrawal by Subject|0|||
164295756|NCT04199351|593458053|FG004|Overall Study|Withdrawal by Subject|1|||
164295757|NCT04199351|593458054|FG005|Overall Study|Withdrawal by Subject|4|||
164295758|NCT04199351|593458055|FG006|Overall Study|Withdrawal by Subject|2|||
164295759|NCT04199351|593458056|FG007|Overall Study|Withdrawal by Subject|0|||
164295760|NCT04199351|593458057|FG008|Overall Study|Withdrawal by Subject|3|||
164295761|NCT04199351|593458058|FG009|Overall Study|Withdrawal by Subject|0|||
164295762|NCT03623243|593458059|FG000|Overall Study|Adverse Event|15|||
164295763|NCT03623243|593458059|FG000|Overall Study|Guardian Decision|1|||
164295764|NCT03623243|593458059|FG000|Overall Study|New Therapy for Study Indication|1|||
164295765|NCT03623243|593458059|FG000|Overall Study|Protocol Deviation|3|||
164295766|NCT03623243|593458059|FG000|Overall Study|Physician Decision|4|||
164295767|NCT03623243|593458059|FG000|Overall Study|Patient Decision|15|||
164295768|NCT00979901|593458063|FG000|Overall Study|Adverse Event|1|||
164295769|NCT00979901|593458064|FG001|Overall Study|Adverse Event|3|||
164295770|NCT00979901|593458065|FG002|Overall Study|Adverse Event|9|||
164295771|NCT00979901|593458066|FG003|Overall Study|Adverse Event|2|||
164295772|NCT00979901|593458063|FG000|Overall Study|Lack of Efficacy|8|||
164295773|NCT00979901|593458064|FG001|Overall Study|Lack of Efficacy|4|||
164295774|NCT00979901|593458065|FG002|Overall Study|Lack of Efficacy|9|||
164295775|NCT00979901|593458066|FG003|Overall Study|Lack of Efficacy|0|||
164295776|NCT00979901|593458063|FG000|Overall Study|Lost to Follow-up|1|||
164295777|NCT00979901|593458064|FG001|Overall Study|Lost to Follow-up|1|||
164295778|NCT00979901|593458065|FG002|Overall Study|Lost to Follow-up|2|||
164295779|NCT00979901|593458066|FG003|Overall Study|Lost to Follow-up|0|||
164295780|NCT00979901|593458063|FG000|Overall Study|Protocol Violation|2|||
164295781|NCT00979901|593458064|FG001|Overall Study|Protocol Violation|2|||
164295782|NCT00979901|593458065|FG002|Overall Study|Protocol Violation|7|||
164295783|NCT00979901|593458066|FG003|Overall Study|Protocol Violation|1|||
164295784|NCT00979901|593458063|FG000|Overall Study|Withdrawal by Subject|2|||
164295785|NCT00979901|593458064|FG001|Overall Study|Withdrawal by Subject|1|||
164295786|NCT00979901|593458065|FG002|Overall Study|Withdrawal by Subject|1|||
164295787|NCT00979901|593458066|FG003|Overall Study|Withdrawal by Subject|1|||
164295788|NCT00979901|593458063|FG000|Overall Study|Noncompliance|1|||
164295789|NCT00979901|593458064|FG001|Overall Study|Noncompliance|0|||
164347328|NCT02269241|593648772|FG000|Overall Study|Wish for pregnancy|5|||
164347329|NCT02269241|593648772|FG000|Overall Study|Development of an exclusion criteria|16|||
164347330|NCT02269241|593648772|FG000|Overall Study|Adverse Event|113|||
164418052|NCT01032044|593899615|FG000|Overall Study|Lost to Follow-up|11|||
164295790|NCT00979901|593458065|FG002|Overall Study|Noncompliance|0|||
164295791|NCT00979901|593458066|FG003|Overall Study|Noncompliance|0|||
164295792|NCT00979901|593458063|FG000|Overall Study|out-of-state|1|||
164295793|NCT00979901|593458064|FG001|Overall Study|out-of-state|0|||
164295794|NCT00979901|593458065|FG002|Overall Study|out-of-state|0|||
164295795|NCT00979901|593458066|FG003|Overall Study|out-of-state|0|||
164295796|NCT00979901|593458063|FG000|Overall Study|vacation|1|||
164295797|NCT00979901|593458064|FG001|Overall Study|vacation|0|||
164295798|NCT00979901|593458065|FG002|Overall Study|vacation|0|||
164295799|NCT00979901|593458066|FG003|Overall Study|vacation|0|||
164295800|NCT00979901|593458063|FG000|Overall Study|elevated lab values pre-randomization|1|||
164295801|NCT00979901|593458064|FG001|Overall Study|elevated lab values pre-randomization|0|||
164295802|NCT00979901|593458065|FG002|Overall Study|elevated lab values pre-randomization|0|||
164295803|NCT00979901|593458066|FG003|Overall Study|elevated lab values pre-randomization|0|||
164295804|NCT00979901|593458063|FG000|Overall Study|Discontinued in Error|0|||
164295805|NCT00979901|593458064|FG001|Overall Study|Discontinued in Error|1|||
164295806|NCT00979901|593458065|FG002|Overall Study|Discontinued in Error|0|||
164587414|NCT02116972|594513837|FG000|Overall Study|Lack of Efficacy|6|||
164587415|NCT02116972|594513838|FG001|Overall Study|Lack of Efficacy|6|||
164295807|NCT00979901|593458066|FG003|Overall Study|Discontinued in Error|0|||
164295808|NCT00979901|593458063|FG000|Overall Study|Left Country|0|||
164295809|NCT00979901|593458064|FG001|Overall Study|Left Country|0|||
164295810|NCT00979901|593458065|FG002|Overall Study|Left Country|1|||
164295811|NCT00979901|593458066|FG003|Overall Study|Left Country|0|||
164295812|NCT00979901|593458063|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
164295813|NCT00979901|593458064|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
164295814|NCT00979901|593458065|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
164295815|NCT00979901|593458066|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
164295816|NCT03924622|593458067|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
164295817|NCT03924622|593458068|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
164295818|NCT03924622|593458069|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
164295819|NCT03924622|593458070|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
164295820|NCT03924622|593458071|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
164295821|NCT03924622|593458072|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
164295822|NCT03085095|593458074|FG000|Overall Study|Adverse Event|23|||
164295823|NCT03085095|593458075|FG001|Overall Study|Adverse Event|8|||
164295824|NCT03085095|593458074|FG000|Overall Study|Protocol Violation|0|||
164295825|NCT03085095|593458075|FG001|Overall Study|Protocol Violation|1|||
164295826|NCT03085095|593458074|FG000|Overall Study|Lost to Follow-up|2|||
164295827|NCT03085095|593458075|FG001|Overall Study|Lost to Follow-up|1|||
164295828|NCT03085095|593458074|FG000|Overall Study|Withdrawal by Subject|17|||
164295829|NCT03085095|593458075|FG001|Overall Study|Withdrawal by Subject|6|||
164295830|NCT03085095|593458074|FG000|Overall Study|Physician Decision|9|||
164295831|NCT03085095|593458075|FG001|Overall Study|Physician Decision|3|||
164295832|NCT03085095|593458074|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
164295833|NCT03085095|593458075|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
164295834|NCT03085095|593458074|FG000|Overall Study|Did not Receive Study Drug|2|||
164295835|NCT03085095|593458075|FG001|Overall Study|Did not Receive Study Drug|2|||
164295836|NCT03085095|593458074|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
164295837|NCT03085095|593458075|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
164295838|NCT02814916|593458077|FG000|Overall Study|Withdrawal of consent|0|||
164295839|NCT02814916|593458078|FG001|Overall Study|Withdrawal of consent|2|||
164295840|NCT02814916|593458079|FG002|Overall Study|Withdrawal of consent|0|||
164295841|NCT02814916|593458077|FG000|Overall Study|Lost to Follow-up|0|||
164295842|NCT02814916|593458078|FG001|Overall Study|Lost to Follow-up|1|||
164295843|NCT02814916|593458079|FG002|Overall Study|Lost to Follow-up|0|||
164295844|NCT02814916|593458077|FG000|Overall Study|Other, not specified|0|||
164295845|NCT02814916|593458078|FG001|Overall Study|Other, not specified|1|||
164295846|NCT02814916|593458079|FG002|Overall Study|Other, not specified|0|||
164295847|NCT05543265|593458081|FG000|Overall Study|Lost to Follow-up|3|||
164295848|NCT05543265|593458082|FG001|Overall Study|Lost to Follow-up|3|||
164295849|NCT05543265|593458081|FG000|Overall Study|Withdrawal by Subject|0|||
164295850|NCT05543265|593458082|FG001|Overall Study|Withdrawal by Subject|1|||
164295851|NCT02182895|593458083|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
164295852|NCT02182895|593458084|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
164295853|NCT01488045|593458094|FG000|Overall Study|Withdrawal by Subject|6|||
164295854|NCT01488045|593458095|FG001|Overall Study|Withdrawal by Subject|11|||
164295855|NCT01488045|593458094|FG000|Overall Study|Failure to present for colonoscopy|3|||
164295856|NCT01488045|593458095|FG001|Overall Study|Failure to present for colonoscopy|6|||
164295857|NCT01488045|593458094|FG000|Overall Study|Failure to report exclusion criteria|0|||
164295858|NCT01488045|593458095|FG001|Overall Study|Failure to report exclusion criteria|1|||
164295859|NCT00671658|593458097|FG000|Overall Study|Physician Decision|5|||
164295860|NCT03617172|593458100|FG000|Overall Study|Lost to Follow-up|1|||
164295861|NCT03617172|593458101|FG001|Overall Study|Lost to Follow-up|0|||
164295862|NCT01680341|593458102|FG000|Overall Study|Adverse Event|3|||
164295863|NCT01680341|593458103|FG001|Overall Study|Adverse Event|2|||
164295864|NCT01680341|593458102|FG000|Overall Study|Unclassified|18|||
164295865|NCT01680341|593458103|FG001|Overall Study|Unclassified|15|||
164295866|NCT02587221|593458105|FG000|Overall Study|Adverse Event|3|||
164295867|NCT02587221|593458106|FG001|Overall Study|Adverse Event|3|||
164295868|NCT02587221|593458105|FG000|Overall Study|Death|33|||
164295869|NCT02587221|593458106|FG001|Overall Study|Death|34|||
164295870|NCT02587221|593458105|FG000|Overall Study|Withdrawal by Subject|66|||
164347331|NCT02269241|593648772|FG000|Overall Study|At the specific request of the sponsor|20|||
164295871|NCT02587221|593458106|FG001|Overall Study|Withdrawal by Subject|61|||
164295872|NCT02587221|593458105|FG000|Overall Study|Lost to Follow-up|21|||
164347332|NCT02269241|593648772|FG000|Overall Study|Several reasons not classified|53|||
164347333|NCT02269241|593648772|FG000|Overall Study|Screening failures|546|||
164347334|NCT03020160|593648773|FG000|Overall Study|Withdrawal by Subject|1|||
164587416|NCT02116972|594513839|FG002|Overall Study|Lack of Efficacy|5|||
164693545|NCT00739973|594899422|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
164693546|NCT00739973|594899423|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
164295873|NCT02587221|593458106|FG001|Overall Study|Lost to Follow-up|19|||
164295874|NCT02587221|593458105|FG000|Overall Study|Protocol Violation|6|||
164295875|NCT02587221|593458106|FG001|Overall Study|Protocol Violation|5|||
164295876|NCT02587221|593458105|FG000|Overall Study|Other Reason or Unspecified|2|||
164295877|NCT02587221|593458106|FG001|Overall Study|Other Reason or Unspecified|1|||
164295878|NCT01499940|593458107|FG000|Overall Study|Study was withdrawn before completion.|9|||
164295879|NCT04739982|593458108|FG000|Overall Study|Lost to Follow-up|176|||
164295880|NCT04739982|593458109|FG001|Overall Study|Lost to Follow-up|65|||
164295881|NCT04739982|593458108|FG000|Overall Study|Withdrawal by Subject|19|||
164295882|NCT04739982|593458109|FG001|Overall Study|Withdrawal by Subject|0|||
164295883|NCT04739982|593458108|FG000|Overall Study|Protocol Violation|0|||
164295884|NCT04739982|593458109|FG001|Overall Study|Protocol Violation|5|||
164295885|NCT04914364|593458111|FG000|Overall Study|No longer eligible for study|1|||
164295886|NCT04914364|593458111|FG000|Overall Study|Lost to Follow-up|2|||
164295887|NCT01168349|593458112|FG000|Overall Study|Death|157|||
164295888|NCT01168349|593458112|FG000|Overall Study|Lost to Follow-up|34|||
164295889|NCT01168349|593458112|FG000|Overall Study|Withdrawal by Subject|9|||
164295890|NCT01168349|593458112|FG000|Overall Study|Kidney transplantation|3|||
164295891|NCT01168349|593458112|FG000|Overall Study|Other|22|||
164295892|NCT01168349|593458112|FG000|Overall Study|Protocol Violation|76|||
164295893|NCT01033240|593458113|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
164295894|NCT01033240|593458114|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
164295895|NCT01033240|593458115|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
164295896|NCT01033240|593458113|FG000|Overall Study|Death|2|||
164295897|NCT01033240|593458114|FG001|Overall Study|Death|0|||
164295898|NCT01033240|593458115|FG002|Overall Study|Death|0|||
164295899|NCT01033240|593458113|FG000|Overall Study|Withdrew Consent|2|||
164295900|NCT01033240|593458114|FG001|Overall Study|Withdrew Consent|9|||
164295901|NCT01033240|593458115|FG002|Overall Study|Withdrew Consent|2|||
164295902|NCT01033240|593458113|FG000|Overall Study|Disease Progression|35|||
164295903|NCT01033240|593458114|FG001|Overall Study|Disease Progression|32|||
164295904|NCT01033240|593458115|FG002|Overall Study|Disease Progression|41|||
164295905|NCT01033240|593458113|FG000|Overall Study|Investigator Discretion|0|||
164295906|NCT01033240|593458114|FG001|Overall Study|Investigator Discretion|0|||
164295907|NCT01033240|593458115|FG002|Overall Study|Investigator Discretion|2|||
164295908|NCT01033240|593458113|FG000|Overall Study|Other|0|||
164295909|NCT01033240|593458114|FG001|Overall Study|Other|1|||
164295910|NCT01033240|593458115|FG002|Overall Study|Other|2|||
164295911|NCT03521570|593458116|FG000|Overall Study|Not eligible|11|||
164295912|NCT02138890|593458121|FG000|Overall Study|Adverse Event|1|||
164295913|NCT02138890|593458122|FG001|Overall Study|Adverse Event|0|||
164295914|NCT05435339|593458123|FG000|Overall Study|Death|1|||
164295915|NCT05435339|593458124|FG001|Overall Study|Death|0|||
164295916|NCT05435339|593458125|FG002|Overall Study|Death|3|||
164295917|NCT05435339|593458126|FG003|Overall Study|Death|1|||
164295918|NCT05435339|593458127|FG004|Overall Study|Death|3|||
164295919|NCT05435339|593458128|FG005|Overall Study|Death|2|||
164295920|NCT05435339|593458129|FG006|Overall Study|Death|4|||
164295921|NCT05435339|593458130|FG007|Overall Study|Death|6|||
164295922|NCT05435339|593458123|FG000|Overall Study|Sponsor Decision|0|||
164295923|NCT05435339|593458124|FG001|Overall Study|Sponsor Decision|1|||
164295924|NCT05435339|593458125|FG002|Overall Study|Sponsor Decision|0|||
164295925|NCT05435339|593458126|FG003|Overall Study|Sponsor Decision|0|||
164295926|NCT05435339|593458127|FG004|Overall Study|Sponsor Decision|2|||
164295927|NCT05435339|593458128|FG005|Overall Study|Sponsor Decision|1|||
164295928|NCT05435339|593458129|FG006|Overall Study|Sponsor Decision|2|||
164295929|NCT05435339|593458130|FG007|Overall Study|Sponsor Decision|2|||
164295930|NCT05435339|593458123|FG000|Overall Study|Withdrawal by Subject|0|||
164295931|NCT05435339|593458124|FG001|Overall Study|Withdrawal by Subject|0|||
164347335|NCT03020160|593648774|FG001|Overall Study|Withdrawal by Subject|0|||
164347336|NCT02270957|593648775|FG000|Overall Study|Lack of Efficacy|2|||
164295932|NCT05435339|593458125|FG002|Overall Study|Withdrawal by Subject|0|||
164295933|NCT05435339|593458126|FG003|Overall Study|Withdrawal by Subject|0|||
164347337|NCT02270957|593648776|FG001|Overall Study|Lack of Efficacy|4|||
164347338|NCT02270957|593648775|FG000|Overall Study|Adverse Event|2|||
164347339|NCT02270957|593648776|FG001|Overall Study|Adverse Event|0|||
164347340|NCT01539538|593648784|FG000|Overall Study|Adverse Event|13|||
164347341|NCT01539538|593648785|FG001|Overall Study|Adverse Event|18|||
164693547|NCT00739973|594899424|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
164295934|NCT05435339|593458127|FG004|Overall Study|Withdrawal by Subject|1|||
164295935|NCT05435339|593458128|FG005|Overall Study|Withdrawal by Subject|0|||
164347342|NCT01539538|593648784|FG000|Overall Study|Lack of Efficacy|13|||
164347343|NCT01539538|593648785|FG001|Overall Study|Lack of Efficacy|16|||
164295936|NCT05435339|593458129|FG006|Overall Study|Withdrawal by Subject|1|||
164347344|NCT01539538|593648784|FG000|Overall Study|Withdrawal by Subject|2|||
164347345|NCT01539538|593648785|FG001|Overall Study|Withdrawal by Subject|3|||
164295937|NCT05435339|593458130|FG007|Overall Study|Withdrawal by Subject|1|||
164693548|NCT00739973|594899425|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
164693549|NCT00739973|594899417|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
164693550|NCT00739973|594899418|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
164693551|NCT00739973|594899419|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
164693552|NCT00739973|594899420|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
164693553|NCT00739973|594899421|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
164693554|NCT00739973|594899422|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
164693555|NCT00739973|594899423|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
164693556|NCT00739973|594899424|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
164693557|NCT00739973|594899425|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
164693558|NCT00739973|594899417|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
164693559|NCT00739973|594899418|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
164693560|NCT00739973|594899419|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
164693561|NCT00739973|594899420|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
164693562|NCT00739973|594899421|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
164693563|NCT00739973|594899422|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
164693564|NCT00739973|594899423|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
164693565|NCT00739973|594899424|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
164693566|NCT00739973|594899425|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
164693567|NCT00739973|594899417|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
164693568|NCT00739973|594899418|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
164693569|NCT00739973|594899419|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
164693570|NCT00739973|594899420|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
164693571|NCT00739973|594899421|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
164693572|NCT00739973|594899422|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
164693573|NCT00739973|594899423|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
164693574|NCT00739973|594899424|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
164693575|NCT00739973|594899425|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
164693576|NCT00739973|594899417|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
164693577|NCT00739973|594899418|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
164693578|NCT00739973|594899419|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
164693579|NCT00739973|594899420|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
164693580|NCT00739973|594899421|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
164693581|NCT00739973|594899422|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
164693582|NCT00739973|594899423|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
164295938|NCT01446159|593458131|FG000|Overall Study|Withdrawal by Subject|1|||
164295939|NCT01446159|593458132|FG001|Overall Study|Withdrawal by Subject|0|||
164295940|NCT01446159|593458133|FG002|Overall Study|Withdrawal by Subject|14|||
164295941|NCT01446159|593458134|FG003|Overall Study|Withdrawal by Subject|11|||
164295942|NCT01446159|593458131|FG000|Overall Study|Lost to Follow-up|0|||
164295943|NCT01446159|593458132|FG001|Overall Study|Lost to Follow-up|0|||
164295944|NCT01446159|593458133|FG002|Overall Study|Lost to Follow-up|1|||
164295945|NCT01446159|593458134|FG003|Overall Study|Lost to Follow-up|2|||
164295946|NCT01446159|593458131|FG000|Overall Study|Death|2|||
164295947|NCT01446159|593458132|FG001|Overall Study|Death|3|||
164295948|NCT01446159|593458133|FG002|Overall Study|Death|43|||
164295949|NCT01446159|593458134|FG003|Overall Study|Death|36|||
164295950|NCT01446159|593458131|FG000|Overall Study|Other|0|||
164295951|NCT01446159|593458132|FG001|Overall Study|Other|0|||
164295952|NCT01446159|593458133|FG002|Overall Study|Other|13|||
164295953|NCT01446159|593458134|FG003|Overall Study|Other|13|||
164295954|NCT05135871|593458143|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
164295955|NCT05135871|593458144|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
164295956|NCT05135871|593458145|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
164295957|NCT05135871|593458146|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
164295958|NCT04258423|593458147|FG000|Overall Study|Study Closure|2|||
164295959|NCT04258423|593458148|FG001|Overall Study|Study Closure|2|||
164295960|NCT03980730|593458151|FG000|Overall Study|Study Terminated by Sponsor|0|||
164295961|NCT03980730|593458152|FG001|Overall Study|Study Terminated by Sponsor|3|||
164295962|NCT03980730|593458151|FG000|Overall Study|Adverse Event|2|||
164295963|NCT03980730|593458152|FG001|Overall Study|Adverse Event|0|||
164295964|NCT03980730|593458151|FG000|Overall Study|Sponsor Request|0|||
164295965|NCT03980730|593458152|FG001|Overall Study|Sponsor Request|1|||
164295966|NCT01247324|593458153|FG000|Overall Study|Death|6|||
164295967|NCT01247324|593458154|FG001|Overall Study|Death|10|||
164434925|NCT03412747|593960829|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
164434926|NCT03412747|593960830|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
164434927|NCT03412747|593960831|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
164434928|NCT03412747|593960829|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
164434929|NCT03412747|593960830|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
164434930|NCT03412747|593960831|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
164434931|NCT03412747|593960829|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
164434932|NCT03412747|593960830|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
164434933|NCT03412747|593960831|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
164434934|NCT03412747|593960829|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
164434935|NCT03412747|593960830|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
164434936|NCT03412747|593960831|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
164434937|NCT03412747|593960829|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
164434938|NCT03412747|593960830|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
164434939|NCT03412747|593960831|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
164434940|NCT03412747|593960829|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
164434941|NCT03412747|593960830|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
164434942|NCT03412747|593960831|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
164434943|NCT03412747|593960829|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
164434944|NCT03412747|593960830|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
164434945|NCT03412747|593960831|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
164434946|NCT03412747|593960829|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
164434947|NCT03412747|593960830|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
164434948|NCT03412747|593960831|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
164434949|NCT03412747|593960829|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
164434950|NCT03412747|593960830|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
164434951|NCT03412747|593960831|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
164434952|NCT04075266|593960832|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
164434953|NCT04075266|593960833|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
164434954|NCT04075266|593960832|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
164434955|NCT04075266|593960833|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
164434956|NCT01582945|593960834|FG000|Overall Study|Intolerable side-effects|1|||
164434957|NCT01582945|593960834|FG000|Overall Study|Scheduling conflicts|1|||
164434958|NCT01726023|593960835|FG000|Overall Study|Death|1|||
164434959|NCT01726023|593960836|FG001|Overall Study|Death|1|||
164434960|NCT01726023|593960835|FG000|Overall Study|Lost to Follow-up|5|||
164434961|NCT01726023|593960836|FG001|Overall Study|Lost to Follow-up|10|||
164434962|NCT01726023|593960835|FG000|Overall Study|Other Eligibility criteria|7|||
164434963|NCT01726023|593960836|FG001|Overall Study|Other Eligibility criteria|7|||
164434964|NCT01726023|593960835|FG000|Overall Study|Withdrawal by Subject|16|||
164434965|NCT01726023|593960836|FG001|Overall Study|Withdrawal by Subject|8|||
164434966|NCT04982575|593960843|FG000|Overall Study|Withdrawal by Subject|2|||
164434967|NCT04982575|593960844|FG001|Overall Study|Withdrawal by Subject|0|||
164434968|NCT04982575|593960845|FG002|Overall Study|Withdrawal by Subject|2|||
164434969|NCT03038022|593960848|FG000|Overall Study|Withdrawal by Subject|2|||
164434970|NCT03038022|593960849|FG001|Overall Study|Withdrawal by Subject|0|||
164434971|NCT03038022|593960848|FG000|Overall Study|Adverse Event|4|||
164434972|NCT03038022|593960849|FG001|Overall Study|Adverse Event|2|||
164434973|NCT01467427|593960852|FG000|Overall Study|Withdrawal by Subject|1|||
164434974|NCT01467427|593960853|FG001|Overall Study|Withdrawal by Subject|0|||
164434975|NCT01467427|593960852|FG000|Overall Study|Not continuing in extension phase|0|||
164434976|NCT01467427|593960853|FG001|Overall Study|Not continuing in extension phase|2|||
164295968|NCT01247324|593458153|FG000|Overall Study|Physician Decision|2|||
164295969|NCT01247324|593458154|FG001|Overall Study|Physician Decision|3|||
164295970|NCT01247324|593458153|FG000|Overall Study|Non-compliance with study drug|3|||
164295971|NCT01247324|593458154|FG001|Overall Study|Non-compliance with study drug|0|||
164295972|NCT01247324|593458153|FG000|Overall Study|Lack of Efficacy|24|||
164434977|NCT01467427|593960852|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
164434978|NCT01467427|593960853|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
164295973|NCT01247324|593458154|FG001|Overall Study|Lack of Efficacy|14|||
164295974|NCT01247324|593458153|FG000|Overall Study|Non-compliance|3|||
164434979|NCT01467427|593960852|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
164434980|NCT01467427|593960853|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
164434981|NCT01467427|593960852|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
164434982|NCT01467427|593960853|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
164434983|NCT01467427|593960852|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
164434984|NCT01467427|593960853|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
164434985|NCT04925752|593960854|FG000|Overall Study|Still on Study|1826|||
164587417|NCT02116972|594513837|FG000|Overall Study|scheduling conflicts and relocation|3|||
164295975|NCT01247324|593458154|FG001|Overall Study|Non-compliance|2|||
164295976|NCT01247324|593458153|FG000|Overall Study|Pregnancy|5|||
164295977|NCT01247324|593458154|FG001|Overall Study|Pregnancy|10|||
164587418|NCT02116972|594513838|FG001|Overall Study|scheduling conflicts and relocation|3|||
164587419|NCT02116972|594513839|FG002|Overall Study|scheduling conflicts and relocation|6|||
164295978|NCT01247324|593458153|FG000|Overall Study|Protocol Violation|1|||
164587420|NCT00784784|594513840|FG000|Overall Study|Withdrawal by Subject|2|||
164587421|NCT00784784|594513841|FG001|Overall Study|Withdrawal by Subject|2|||
164295979|NCT01247324|593458154|FG001|Overall Study|Protocol Violation|1|||
164295980|NCT01247324|593458153|FG000|Overall Study|Reason not specified|42|||
164295981|NCT01247324|593458154|FG001|Overall Study|Reason not specified|32|||
164295982|NCT01247324|593458153|FG000|Overall Study|Consent withdrawn by participant|41|||
164295983|NCT01247324|593458154|FG001|Overall Study|Consent withdrawn by participant|56|||
164295984|NCT01247324|593458153|FG000|Overall Study|Adverse Event|49|||
164295985|NCT01247324|593458154|FG001|Overall Study|Adverse Event|35|||
164295986|NCT01247324|593458153|FG000|Overall Study|Lost to Follow-up|3|||
164295987|NCT01247324|593458154|FG001|Overall Study|Lost to Follow-up|6|||
164295988|NCT01247324|593458153|FG000|Overall Study|Study Terminated by Sponsor|4|||
164295989|NCT01247324|593458154|FG001|Overall Study|Study Terminated by Sponsor|1|||
164295990|NCT01247324|593458153|FG000|Overall Study|Missing|2|||
164295991|NCT01247324|593458154|FG001|Overall Study|Missing|1|||
164295992|NCT00880620|593458162|FG000|Overall Study|Adverse Event|4|||
164295993|NCT00880620|593458163|FG001|Overall Study|Adverse Event|5|||
164295994|NCT00880620|593458164|FG002|Overall Study|Adverse Event|15|||
164295995|NCT00880620|593458165|FG003|Overall Study|Adverse Event|15|||
164295996|NCT00880620|593458162|FG000|Overall Study|Death|0|||
164295997|NCT00880620|593458163|FG001|Overall Study|Death|0|||
164295998|NCT00880620|593458164|FG002|Overall Study|Death|1|||
164295999|NCT00880620|593458165|FG003|Overall Study|Death|0|||
164296000|NCT00880620|593458162|FG000|Overall Study|Lack of Efficacy|12|||
164296001|NCT00880620|593458163|FG001|Overall Study|Lack of Efficacy|4|||
164296002|NCT00880620|593458164|FG002|Overall Study|Lack of Efficacy|0|||
164296003|NCT00880620|593458165|FG003|Overall Study|Lack of Efficacy|1|||
164296004|NCT00880620|593458162|FG000|Overall Study|Lost to Follow-up|0|||
164296005|NCT00880620|593458163|FG001|Overall Study|Lost to Follow-up|1|||
164296006|NCT00880620|593458164|FG002|Overall Study|Lost to Follow-up|1|||
164296007|NCT00880620|593458165|FG003|Overall Study|Lost to Follow-up|0|||
164296008|NCT00880620|593458162|FG000|Overall Study|Protocol Violation|0|||
164296009|NCT00880620|593458163|FG001|Overall Study|Protocol Violation|1|||
164296010|NCT00880620|593458164|FG002|Overall Study|Protocol Violation|0|||
164296011|NCT00880620|593458165|FG003|Overall Study|Protocol Violation|2|||
164296012|NCT00880620|593458162|FG000|Overall Study|Withdrawal by Subject|4|||
164296013|NCT00880620|593458163|FG001|Overall Study|Withdrawal by Subject|3|||
164296014|NCT00880620|593458164|FG002|Overall Study|Withdrawal by Subject|1|||
164296015|NCT00880620|593458165|FG003|Overall Study|Withdrawal by Subject|3|||
164296016|NCT00880620|593458162|FG000|Overall Study|Noncompliance|0|||
164296017|NCT00880620|593458163|FG001|Overall Study|Noncompliance|0|||
164296018|NCT00880620|593458164|FG002|Overall Study|Noncompliance|1|||
164296019|NCT00880620|593458165|FG003|Overall Study|Noncompliance|1|||
164296020|NCT00880620|593458162|FG000|Overall Study|Other|1|||
164296021|NCT00880620|593458163|FG001|Overall Study|Other|1|||
164296022|NCT00880620|593458164|FG002|Overall Study|Other|2|||
164347346|NCT01539538|593648784|FG000|Overall Study|PCA no longer required or PCA problem|3|||
164347347|NCT01539538|593648785|FG001|Overall Study|PCA no longer required or PCA problem|7|||
164347348|NCT03897465|593648786|FG000|Overall Study|Lost to Follow-up|2|||
164347349|NCT03897465|593648787|FG001|Overall Study|Lost to Follow-up|1|||
164347350|NCT03897465|593648786|FG000|Overall Study|Adverse Event|2|||
164347351|NCT03897465|593648787|FG001|Overall Study|Adverse Event|0|||
164347352|NCT03897465|593648786|FG000|Overall Study|complete healing by V2|1|||
164347353|NCT03897465|593648787|FG001|Overall Study|complete healing by V2|0|||
164347354|NCT03897465|593648786|FG000|Overall Study|occurence of exclusion criterion|1|||
164347355|NCT03897465|593648787|FG001|Overall Study|occurence of exclusion criterion|1|||
164347356|NCT03897465|593648786|FG000|Overall Study|Other|1|||
164347357|NCT03897465|593648787|FG001|Overall Study|Other|0|||
164347358|NCT00847379|593648788|FG000|Overall Study|Study terminated by Sponsor|59|||
164347359|NCT00847379|593648789|FG001|Overall Study|Study terminated by Sponsor|57|||
164347360|NCT00847379|593648790|FG002|Overall Study|Study terminated by Sponsor|57|||
164347361|NCT00521014|593648791|FG000|Overall Study|Inevaluable, not treated|1|||
164347362|NCT04390191|593648792|FG000|Overall Study|Withdrawal by Subject|1|||
164347363|NCT04390191|593648793|FG001|Overall Study|Withdrawal by Subject|0|||
164347364|NCT03978832|593648796|FG000|Overall Study|Adverse Event|1|||
164347365|NCT03978832|593648796|FG000|Overall Study|Lost to Follow-up|1|||
164347366|NCT03978832|593648796|FG000|Overall Study|Withdrawal by Subject|6|||
164347367|NCT03978832|593648796|FG000|Overall Study|Physician Decision|2|||
164347368|NCT03978832|593648796|FG000|Overall Study|did not pass screening criteria|44|||
164296023|NCT00880620|593458165|FG003|Overall Study|Other|2|||
164296024|NCT03474588|593458169|FG000|Overall Study|Withdrawal by Subject|4|||
164296025|NCT03474588|593458170|FG001|Overall Study|Withdrawal by Subject|3|||
164347369|NCT00003499|593648797|FG000|Overall Study|Not evaluable|8|||
164347370|NCT02042183|593648802|FG000|Overall Study|Physician Decision|7|||
164347371|NCT02042183|593648803|FG001|Overall Study|Physician Decision|2|||
164347372|NCT02042183|593648802|FG000|Overall Study|Lack of Efficacy|4|||
164347373|NCT02042183|593648803|FG001|Overall Study|Lack of Efficacy|3|||
164347374|NCT02042183|593648802|FG000|Overall Study|Non-compliance with Study Drug|2|||
164347375|NCT02042183|593648803|FG001|Overall Study|Non-compliance with Study Drug|3|||
164347376|NCT02042183|593648802|FG000|Overall Study|Adverse Event|17|||
164347377|NCT02042183|593648803|FG001|Overall Study|Adverse Event|6|||
164347378|NCT02042183|593648802|FG000|Overall Study|Other|3|||
164347379|NCT02042183|593648803|FG001|Overall Study|Other|3|||
164347380|NCT02042183|593648802|FG000|Overall Study|Withdrawal by Subject|21|||
164347381|NCT02042183|593648803|FG001|Overall Study|Withdrawal by Subject|16|||
164347382|NCT02042183|593648802|FG000|Overall Study|Site Terminated by Sponsor|2|||
164347383|NCT02042183|593648803|FG001|Overall Study|Site Terminated by Sponsor|1|||
164347384|NCT02042183|593648802|FG000|Overall Study|Lost to Follow-up|9|||
164347385|NCT02042183|593648803|FG001|Overall Study|Lost to Follow-up|2|||
164347386|NCT01256008|593648804|FG000|Overall Study|Lost to Follow-up|6|||
164347387|NCT01256008|593648805|FG001|Overall Study|Lost to Follow-up|4|||
164347388|NCT01256008|593648806|FG002|Overall Study|Lost to Follow-up|11|||
164347389|NCT01256008|593648804|FG000|Overall Study|Withdrawal by Subject|2|||
164347390|NCT01256008|593648805|FG001|Overall Study|Withdrawal by Subject|3|||
164347391|NCT01256008|593648806|FG002|Overall Study|Withdrawal by Subject|10|||
164347392|NCT02244606|593648807|FG000|Overall Study|Adverse Event|0|||
164347393|NCT02244606|593648808|FG001|Overall Study|Adverse Event|1|||
164347394|NCT02244606|593648809|FG002|Overall Study|Adverse Event|1|||
164347395|NCT02244606|593648810|FG003|Overall Study|Adverse Event|0|||
164347396|NCT02244606|593648807|FG000|Overall Study|Lost to Follow-up|2|||
164347397|NCT02244606|593648808|FG001|Overall Study|Lost to Follow-up|2|||
164347398|NCT02244606|593648809|FG002|Overall Study|Lost to Follow-up|1|||
164347399|NCT02244606|593648810|FG003|Overall Study|Lost to Follow-up|0|||
164347400|NCT02244606|593648807|FG000|Overall Study|Protocol Violation|0|||
164347401|NCT02244606|593648808|FG001|Overall Study|Protocol Violation|0|||
164347402|NCT02244606|593648809|FG002|Overall Study|Protocol Violation|0|||
164347403|NCT02244606|593648810|FG003|Overall Study|Protocol Violation|1|||
164347404|NCT02244606|593648807|FG000|Overall Study|Withdrawal by Subject|1|||
164347405|NCT02244606|593648808|FG001|Overall Study|Withdrawal by Subject|1|||
164347406|NCT02244606|593648809|FG002|Overall Study|Withdrawal by Subject|0|||
164347407|NCT02244606|593648810|FG003|Overall Study|Withdrawal by Subject|0|||
164347408|NCT02244606|593648807|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
164347409|NCT02244606|593648808|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
164347410|NCT02244606|593648809|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
164347411|NCT02244606|593648810|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
164347412|NCT00378378|593648813|FG000|Overall Study|Withdrawal by Subject|0|||
164347413|NCT00378378|593648814|FG001|Overall Study|Withdrawal by Subject|1|||
164347414|NCT00378378|593648815|FG002|Overall Study|Withdrawal by Subject|0|||
164347415|NCT00378378|593648813|FG000|Overall Study|Treatment Failure|0|||
164347416|NCT00378378|593648814|FG001|Overall Study|Treatment Failure|0|||
164347417|NCT00378378|593648815|FG002|Overall Study|Treatment Failure|1|||
164347418|NCT00378378|593648813|FG000|Overall Study|Non-compliance with protocol|0|||
164347419|NCT00378378|593648814|FG001|Overall Study|Non-compliance with protocol|0|||
164347420|NCT00378378|593648815|FG002|Overall Study|Non-compliance with protocol|1|||
164347421|NCT02321800|593648821|FG000|Overall Study|Withdrawal by Subject|3|||
164347422|NCT02321800|593648822|FG001|Overall Study|Withdrawal by Subject|3|||
164347423|NCT02321800|593648821|FG000|Overall Study|Death|1|||
164347424|NCT02321800|593648822|FG001|Overall Study|Death|0|||
164347425|NCT02321800|593648821|FG000|Overall Study|Protocol Violation|1|||
164347426|NCT02321800|593648822|FG001|Overall Study|Protocol Violation|0|||
164347427|NCT02321800|593648821|FG000|Overall Study|Lost to Follow-up|10|||
164347428|NCT02321800|593648822|FG001|Overall Study|Lost to Follow-up|4|||
164347429|NCT02321800|593648821|FG000|Overall Study|Adverse Event|2|||
164347430|NCT02321800|593648822|FG001|Overall Study|Adverse Event|3|||
164347431|NCT02321800|593648821|FG000|Overall Study|Other, Miscellaneous|3|||
164347432|NCT02321800|593648822|FG001|Overall Study|Other, Miscellaneous|1|||
164347433|NCT01854710|593648823|FG000|Overall Study|Withdrawal by Subject|2|||
164347434|NCT01854710|593648824|FG001|Overall Study|Withdrawal by Subject|1|||
164347435|NCT01854710|593648825|FG002|Overall Study|Withdrawal by Subject|0|||
164347436|NCT01854710|593648826|FG003|Overall Study|Withdrawal by Subject|0|||
164347437|NCT01854710|593648827|FG004|Overall Study|Withdrawal by Subject|0|||
164347438|NCT01854710|593648828|FG005|Overall Study|Withdrawal by Subject|0|||
164347439|NCT01854710|593648823|FG000|Overall Study|CRI procedural error|2|||
164347440|NCT01854710|593648824|FG001|Overall Study|CRI procedural error|2|||
164347441|NCT01854710|593648825|FG002|Overall Study|CRI procedural error|2|||
164347442|NCT01854710|593648826|FG003|Overall Study|CRI procedural error|2|||
164347443|NCT01854710|593648827|FG004|Overall Study|CRI procedural error|2|||
164434986|NCT04925752|593960855|FG001|Overall Study|Still on Study|926|||
164434987|NCT04925752|593960854|FG000|Overall Study|Withdrew Consent|128|||
164434988|NCT04925752|593960855|FG001|Overall Study|Withdrew Consent|59|||
164434989|NCT04925752|593960854|FG000|Overall Study|Lost to Follow-up|73|||
164434990|NCT04925752|593960855|FG001|Overall Study|Lost to Follow-up|47|||
164434991|NCT04925752|593960854|FG000|Overall Study|Randomized but Never Treated|12|||
164434992|NCT04925752|593960855|FG001|Overall Study|Randomized but Never Treated|9|||
164347444|NCT01854710|593648828|FG005|Overall Study|CRI procedural error|2|||
164434993|NCT04925752|593960854|FG000|Overall Study|Hiv-1 Infection|6|||
164434994|NCT04925752|593960855|FG001|Overall Study|Hiv-1 Infection|7|||
164434995|NCT04925752|593960854|FG000|Overall Study|Investigator's discretion|8|||
164434996|NCT04925752|593960855|FG001|Overall Study|Investigator's discretion|5|||
164434997|NCT04925752|593960854|FG000|Overall Study|Non-compliance with Study Drug|8|||
164434998|NCT04925752|593960855|FG001|Overall Study|Non-compliance with Study Drug|5|||
164434999|NCT04925752|593960854|FG000|Overall Study|Adverse Event|5|||
164435000|NCT04925752|593960855|FG001|Overall Study|Adverse Event|2|||
164435001|NCT04925752|593960854|FG000|Overall Study|Death|4|||
164435002|NCT04925752|593960855|FG001|Overall Study|Death|2|||
164435003|NCT04925752|593960854|FG000|Overall Study|Protocol Violation|1|||
164435004|NCT04925752|593960855|FG001|Overall Study|Protocol Violation|3|||
164435005|NCT04925752|593960854|FG000|Overall Study|Withdrew Assent|1|||
164435006|NCT04925752|593960855|FG001|Overall Study|Withdrew Assent|0|||
164435007|NCT04269200|593960856|FG000|Global Cohort|Death|72|||
164435008|NCT04269200|593960857|FG001|Global Cohort|Death|54|||
164435009|NCT04269200|593960858|FG002|Global Cohort|Death|49|||
164435010|NCT04269200|593960856|FG000|Global Cohort|Lost to Follow-up|0|||
164435011|NCT04269200|593960857|FG001|Global Cohort|Lost to Follow-up|0|||
164347445|NCT03132220|593648833|FG000|Overall Study|Lost to Follow-up|17|||
164347446|NCT03132220|593648834|FG001|Overall Study|Lost to Follow-up|8|||
164347447|NCT03132220|593648833|FG000|Overall Study|Withdrawal by Subject|1|||
164347448|NCT03132220|593648834|FG001|Overall Study|Withdrawal by Subject|4|||
164347449|NCT00642460|593648838|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
164347450|NCT00642460|593648839|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
164347451|NCT00642460|593648840|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
164347452|NCT00642460|593648841|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
164347453|NCT00642460|593648842|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
164347454|NCT00642460|593648843|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
164347455|NCT00642460|593648838|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
164347456|NCT00642460|593648839|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
164347457|NCT00642460|593648840|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
164347458|NCT00642460|593648841|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
164347459|NCT00642460|593648842|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
164347460|NCT00642460|593648843|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
164347461|NCT00642460|593648838|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
164347462|NCT00642460|593648839|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
164347463|NCT00642460|593648840|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
164347464|NCT00642460|593648841|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
164347465|NCT00642460|593648842|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
164347466|NCT00642460|593648843|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
164347467|NCT00642460|593648838|FG000|Part II: Open-Label Up to Week 92|Death|0|||
164347468|NCT00642460|593648839|FG001|Part II: Open-Label Up to Week 92|Death|1|||
164347469|NCT00642460|593648840|FG002|Part II: Open-Label Up to Week 92|Death|0|||
164347470|NCT00642460|593648841|FG003|Part II: Open-Label Up to Week 92|Death|2|||
164347471|NCT00642460|593648842|FG004|Part II: Open-Label Up to Week 92|Death|0|||
164347472|NCT00642460|593648843|FG005|Part II: Open-Label Up to Week 92|Death|0|||
164347473|NCT00642460|593648838|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
164347474|NCT00642460|593648839|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
164347475|NCT00642460|593648840|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
164347476|NCT00642460|593648841|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
164347477|NCT00642460|593648842|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
164435012|NCT04269200|593960858|FG002|Global Cohort|Lost to Follow-up|2|||
164347478|NCT00642460|593648843|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
164435013|NCT04269200|593960856|FG000|Global Cohort|Withdrawal by Subject|22|||
164435014|NCT04269200|593960857|FG001|Global Cohort|Withdrawal by Subject|25|||
164435015|NCT04269200|593960858|FG002|Global Cohort|Withdrawal by Subject|18|||
164435016|NCT04269200|593960856|FG000|China Cohort|Death|12|||
164435017|NCT04269200|593960857|FG001|China Cohort|Death|11|||
164347479|NCT00642460|593648838|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
164435018|NCT04269200|593960858|FG002|China Cohort|Death|13|||
164435019|NCT04269200|593960856|FG000|China Cohort|Lost to Follow-up|0|||
164435020|NCT04269200|593960857|FG001|China Cohort|Lost to Follow-up|1|||
164435021|NCT04269200|593960858|FG002|China Cohort|Lost to Follow-up|1|||
164435022|NCT04269200|593960856|FG000|China Cohort|Withdrawal by Subject|2|||
164435023|NCT04269200|593960857|FG001|China Cohort|Withdrawal by Subject|2|||
164296026|NCT03474588|593458169|FG000|Overall Study|Death|0|||
164435024|NCT04269200|593960858|FG002|China Cohort|Withdrawal by Subject|4|||
164435025|NCT01155869|593960860|FG000|Overall Study|Lost to Follow-up|3|||
164435026|NCT01155869|593960861|FG001|Overall Study|Lost to Follow-up|1|||
164435027|NCT00117988|593960863|FG000|Overall Study|Death|3|||
164435028|NCT00117988|593960863|FG000|Overall Study|Adverse Event|1|||
164435029|NCT02137850|593960864|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
164435030|NCT02137850|593960865|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
164435031|NCT02137850|593960866|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
164435032|NCT02137850|593960864|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
164435033|NCT02137850|593960865|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
164435034|NCT02137850|593960866|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
164435035|NCT02137850|593960864|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
164435036|NCT02137850|593960865|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
164435037|NCT02137850|593960866|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
164435038|NCT02137850|593960864|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
164435039|NCT02137850|593960865|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
164435040|NCT02137850|593960866|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
164435041|NCT02137850|593960864|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
164435042|NCT02137850|593960865|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
164435043|NCT02137850|593960866|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
164435044|NCT02137850|593960864|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
164435045|NCT02137850|593960865|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
164435046|NCT02137850|593960866|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
164435047|NCT02137850|593960864|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
164435048|NCT02137850|593960865|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
164435049|NCT02137850|593960866|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
164435050|NCT02137850|593960864|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
164435051|NCT02137850|593960865|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
164435052|NCT02137850|593960866|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
164435053|NCT02137850|593960864|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
164435054|NCT02137850|593960865|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
164435055|NCT02137850|593960866|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
164435056|NCT02137850|593960864|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
164435057|NCT02137850|593960865|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
164435058|NCT02137850|593960866|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
164435059|NCT02137850|593960864|FG000|Main Phase: Prophylaxis|Other|0|||
164435060|NCT02137850|593960865|FG001|Main Phase: Prophylaxis|Other|1|||
164435061|NCT02137850|593960866|FG002|Main Phase: Prophylaxis|Other|0|||
164435062|NCT02137850|593960864|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
164435063|NCT02137850|593960865|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
164435064|NCT02137850|593960866|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
164435065|NCT02137850|593960864|FG000|Main Phase: Prophylaxis|Early site closure|0|||
164435066|NCT02137850|593960865|FG001|Main Phase: Prophylaxis|Early site closure|2|||
164435067|NCT02137850|593960866|FG002|Main Phase: Prophylaxis|Early site closure|0|||
164435068|NCT02137850|593960864|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
164435069|NCT02137850|593960865|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
164435070|NCT02137850|593960866|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
164435071|NCT02137850|593960864|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
164435072|NCT02137850|593960865|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
164435073|NCT02137850|593960866|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
164435074|NCT02137850|593960864|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
164435075|NCT02137850|593960865|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
164435076|NCT02137850|593960866|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
164435077|NCT02137850|593960864|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
164435078|NCT02137850|593960865|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
164296027|NCT03474588|593458170|FG001|Overall Study|Death|1|||
164296028|NCT01607957|593458172|FG000|Overall Study|Not treated|1|||
164435079|NCT02137850|593960866|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
164435080|NCT02137850|593960864|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
164435081|NCT02137850|593960865|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
164435082|NCT02137850|593960866|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
164693583|NCT00739973|594899424|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
164693584|NCT00739973|594899425|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
164693585|NCT00739973|594899417|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
164435083|NCT02137850|593960864|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
164435084|NCT02137850|593960865|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
164435085|NCT02137850|593960866|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
164435086|NCT02137850|593960864|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
164435087|NCT02137850|593960865|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
164435088|NCT02137850|593960866|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
164296029|NCT01607957|593458173|FG001|Overall Study|Not treated|1|||
164296030|NCT01607957|593458172|FG000|Overall Study|Death|367|||
164296031|NCT01607957|593458173|FG001|Overall Study|Death|211|||
164296032|NCT01607957|593458172|FG000|Overall Study|Lost to Follow-up|3|||
164296033|NCT01607957|593458173|FG001|Overall Study|Lost to Follow-up|3|||
164296034|NCT01607957|593458172|FG000|Overall Study|Participant refusal|1|||
164296035|NCT01607957|593458173|FG001|Overall Study|Participant refusal|0|||
164296036|NCT01691794|593458176|FG000|Overall Study|Poor/Non-Compliance|1|||
164296037|NCT01691794|593458177|FG001|Overall Study|Poor/Non-Compliance|4|||
164296038|NCT01691794|593458178|FG002|Overall Study|Poor/Non-Compliance|1|||
164296039|NCT01691794|593458176|FG000|Overall Study|Death|0|||
164296040|NCT01691794|593458177|FG001|Overall Study|Death|0|||
164296041|NCT01691794|593458178|FG002|Overall Study|Death|1|||
164296042|NCT01691794|593458176|FG000|Overall Study|Lack of Efficacy|0|||
164296043|NCT01691794|593458177|FG001|Overall Study|Lack of Efficacy|7|||
164296044|NCT01691794|593458178|FG002|Overall Study|Lack of Efficacy|1|||
164296045|NCT01691794|593458176|FG000|Overall Study|Participant request to discontinue|0|||
164296046|NCT01691794|593458177|FG001|Overall Study|Participant request to discontinue|1|||
164296047|NCT01691794|593458178|FG002|Overall Study|Participant request to discontinue|0|||
164296048|NCT01691794|593458176|FG000|Overall Study|Adverse Event|0|||
164296049|NCT01691794|593458177|FG001|Overall Study|Adverse Event|1|||
164296050|NCT01691794|593458178|FG002|Overall Study|Adverse Event|1|||
164296051|NCT01691794|593458176|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
164296052|NCT01691794|593458177|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
164296053|NCT01691794|593458178|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
164296054|NCT01691794|593458176|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
164296055|NCT01691794|593458177|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
164296056|NCT01691794|593458178|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
164296057|NCT04972786|593458179|FG000|First Intervention (1 Day)|Adverse Event|1|||
164296058|NCT04972786|593458180|FG001|First Intervention (1 Day)|Adverse Event|0|||
164296059|NCT02016781|593458181|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
164296060|NCT02016781|593458182|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
164296061|NCT02016781|593458181|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
164296062|NCT02016781|593458182|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
164296063|NCT02016781|593458181|FG000|Final Database Lock|Withdrawal by Subject|2|||
164296064|NCT02016781|593458182|FG001|Final Database Lock|Withdrawal by Subject|1|||
164296065|NCT02016781|593458181|FG000|Final Database Lock|Lost to Follow-up|11|||
164296066|NCT02016781|593458182|FG001|Final Database Lock|Lost to Follow-up|4|||
164296067|NCT02016781|593458181|FG000|Final Database Lock|Missing data|0|||
164296068|NCT02016781|593458182|FG001|Final Database Lock|Missing data|3|||
164296069|NCT04886154|593458183|FG000|Overall Study|Adverse Event|0|||
164296070|NCT04886154|593458184|FG001|Overall Study|Adverse Event|0|||
164296071|NCT04886154|593458185|FG002|Overall Study|Adverse Event|0|||
164296072|NCT04886154|593458186|FG003|Overall Study|Adverse Event|0|||
164296073|NCT04886154|593458187|FG004|Overall Study|Adverse Event|1|||
164296074|NCT04886154|593458188|FG005|Overall Study|Adverse Event|0|||
164296075|NCT04886154|593458189|FG006|Overall Study|Adverse Event|0|||
164296076|NCT04886154|593458190|FG007|Overall Study|Adverse Event|1|||
164296077|NCT04886154|593458191|FG008|Overall Study|Adverse Event|1|||
164296078|NCT04886154|593458192|FG009|Overall Study|Adverse Event|0|||
164296079|NCT04886154|593458193|FG010|Overall Study|Adverse Event|0|||
164296080|NCT04886154|593458194|FG011|Overall Study|Adverse Event|1|||
164296081|NCT04886154|593458195|FG012|Overall Study|Adverse Event|0|||
164296082|NCT04886154|593458196|FG013|Overall Study|Adverse Event|0|||
164296083|NCT04886154|593458197|FG014|Overall Study|Adverse Event|3|||
164296084|NCT04886154|593458183|FG000|Overall Study|Lost to Follow-up|1|||
164296085|NCT04886154|593458184|FG001|Overall Study|Lost to Follow-up|0|||
164296086|NCT04886154|593458185|FG002|Overall Study|Lost to Follow-up|2|||
164296087|NCT04886154|593458186|FG003|Overall Study|Lost to Follow-up|0|||
164296088|NCT04886154|593458187|FG004|Overall Study|Lost to Follow-up|17|||
164296089|NCT04886154|593458188|FG005|Overall Study|Lost to Follow-up|7|||
164296090|NCT04886154|593458189|FG006|Overall Study|Lost to Follow-up|8|||
164296091|NCT04886154|593458190|FG007|Overall Study|Lost to Follow-up|7|||
164296092|NCT04886154|593458191|FG008|Overall Study|Lost to Follow-up|8|||
164296093|NCT04886154|593458192|FG009|Overall Study|Lost to Follow-up|0|||
164296094|NCT04886154|593458193|FG010|Overall Study|Lost to Follow-up|2|||
164296095|NCT04886154|593458194|FG011|Overall Study|Lost to Follow-up|0|||
164296096|NCT04886154|593458195|FG012|Overall Study|Lost to Follow-up|0|||
164296097|NCT04886154|593458196|FG013|Overall Study|Lost to Follow-up|0|||
164296098|NCT04886154|593458197|FG014|Overall Study|Lost to Follow-up|0|||
164418053|NCT01032044|593899616|FG001|Overall Study|Lost to Follow-up|11|||
164435089|NCT02137850|593960864|FG000|Extension Phase: Prophylaxis|Other|0|||
164435090|NCT02137850|593960865|FG001|Extension Phase: Prophylaxis|Other|1|||
164435091|NCT02137850|593960866|FG002|Extension Phase: Prophylaxis|Other|0|||
164435092|NCT02137850|593960864|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
164435093|NCT02137850|593960865|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
164435094|NCT02137850|593960866|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
164435095|NCT03536884|593960867|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
164435096|NCT03536884|593960868|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
164435097|NCT03536884|593960869|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
164435098|NCT03536884|593960870|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
164435099|NCT03536884|593960871|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
164435100|NCT03536884|593960872|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
164435101|NCT03536884|593960873|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
164435102|NCT03536884|593960874|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
164693586|NCT00739973|594899418|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
164296099|NCT04886154|593458183|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296100|NCT04886154|593458184|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296101|NCT04886154|593458185|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296102|NCT04886154|593458186|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296103|NCT04886154|593458187|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296104|NCT04886154|593458188|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296105|NCT04886154|593458189|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
164296106|NCT04886154|593458190|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164693587|NCT00739973|594899419|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
164693588|NCT00739973|594899420|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
164693589|NCT00739973|594899421|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
164296107|NCT04886154|593458191|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296108|NCT04886154|593458192|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296109|NCT04886154|593458193|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296110|NCT04886154|593458194|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296111|NCT04886154|593458195|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296112|NCT04886154|593458196|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296113|NCT04886154|593458197|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296114|NCT04886154|593458183|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164296115|NCT04886154|593458184|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164296116|NCT04886154|593458185|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164296117|NCT04886154|593458186|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164296118|NCT04886154|593458187|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164296119|NCT04886154|593458188|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164296120|NCT04886154|593458189|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
164347480|NCT00642460|593648839|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
164347481|NCT00642460|593648840|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
164347482|NCT00642460|593648841|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
164347483|NCT00642460|593648842|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
164347484|NCT00642460|593648843|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
164347485|NCT00642460|593648838|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
164347486|NCT00642460|593648839|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
164347487|NCT00642460|593648840|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
164347488|NCT00642460|593648841|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
164347489|NCT00642460|593648842|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
164347490|NCT00642460|593648843|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
164347491|NCT00642460|593648838|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
164347492|NCT00642460|593648839|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
164347493|NCT00642460|593648840|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
164347494|NCT00642460|593648841|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
164693590|NCT00739973|594899422|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
164693591|NCT00739973|594899423|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
164693592|NCT00739973|594899424|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
164347495|NCT00642460|593648842|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
164347496|NCT00642460|593648843|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
164347497|NCT00642460|593648838|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
164435103|NCT03536884|593960875|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
164296121|NCT04886154|593458190|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164435104|NCT03536884|593960876|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
164435105|NCT03536884|593960877|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
164296122|NCT04886154|593458191|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164296123|NCT04886154|593458192|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164296124|NCT04886154|593458193|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164296125|NCT04886154|593458194|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164296126|NCT04886154|593458195|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164296127|NCT04886154|593458196|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164296128|NCT04886154|593458197|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164296129|NCT04886154|593458183|FG000|Overall Study|Other, Not Specified|0|||
164296130|NCT04886154|593458184|FG001|Overall Study|Other, Not Specified|0|||
164296131|NCT04886154|593458185|FG002|Overall Study|Other, Not Specified|0|||
164296132|NCT04886154|593458186|FG003|Overall Study|Other, Not Specified|0|||
164296133|NCT04886154|593458187|FG004|Overall Study|Other, Not Specified|11|||
164296134|NCT04886154|593458188|FG005|Overall Study|Other, Not Specified|8|||
164296135|NCT04886154|593458189|FG006|Overall Study|Other, Not Specified|9|||
164296136|NCT04886154|593458190|FG007|Overall Study|Other, Not Specified|10|||
164296137|NCT04886154|593458191|FG008|Overall Study|Other, Not Specified|6|||
164296138|NCT04886154|593458192|FG009|Overall Study|Other, Not Specified|1|||
164296139|NCT04886154|593458193|FG010|Overall Study|Other, Not Specified|1|||
164296140|NCT04886154|593458194|FG011|Overall Study|Other, Not Specified|2|||
164296141|NCT04886154|593458195|FG012|Overall Study|Other, Not Specified|1|||
164296142|NCT04886154|593458196|FG013|Overall Study|Other, Not Specified|2|||
164296143|NCT04886154|593458197|FG014|Overall Study|Other, Not Specified|3|||
164296144|NCT03919773|593458198|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
164296145|NCT03919773|593458199|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
164296146|NCT03919773|593458198|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
164296147|NCT03919773|593458199|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
164296148|NCT02702492|593458200|FG000|Overall Study|Disease progression|3|||
164296149|NCT02702492|593458201|FG001|Overall Study|Disease progression|3|||
164296150|NCT02702492|593458202|FG002|Overall Study|Disease progression|2|||
164296151|NCT02702492|593458203|FG003|Overall Study|Disease progression|4|||
164296152|NCT02702492|593458204|FG004|Overall Study|Disease progression|4|||
164296153|NCT02702492|593458205|FG005|Overall Study|Disease progression|1|||
164296154|NCT02702492|593458206|FG006|Overall Study|Disease progression|2|||
164296155|NCT02702492|593458207|FG007|Overall Study|Disease progression|8|||
164296156|NCT02702492|593458208|FG008|Overall Study|Disease progression|5|||
164296157|NCT02702492|593458209|FG009|Overall Study|Disease progression|1|||
164296158|NCT02702492|593458210|FG010|Overall Study|Disease progression|0|||
164296159|NCT02702492|593458211|FG011|Overall Study|Disease progression|3|||
164296160|NCT02702492|593458212|FG012|Overall Study|Disease progression|2|||
164296161|NCT02702492|593458200|FG000|Overall Study|Clinical progression|0|||
164296162|NCT02702492|593458201|FG001|Overall Study|Clinical progression|0|||
164296163|NCT02702492|593458202|FG002|Overall Study|Clinical progression|2|||
164296164|NCT02702492|593458203|FG003|Overall Study|Clinical progression|1|||
164296165|NCT02702492|593458204|FG004|Overall Study|Clinical progression|0|||
164296166|NCT02702492|593458205|FG005|Overall Study|Clinical progression|2|||
164296167|NCT02702492|593458206|FG006|Overall Study|Clinical progression|1|||
164296168|NCT02702492|593458207|FG007|Overall Study|Clinical progression|4|||
164296169|NCT02702492|593458208|FG008|Overall Study|Clinical progression|0|||
164296170|NCT02702492|593458209|FG009|Overall Study|Clinical progression|0|||
164296171|NCT02702492|593458210|FG010|Overall Study|Clinical progression|1|||
164296172|NCT02702492|593458211|FG011|Overall Study|Clinical progression|2|||
164296173|NCT02702492|593458212|FG012|Overall Study|Clinical progression|0|||
164296174|NCT02702492|593458200|FG000|Overall Study|Adverse Event|0|||
164296175|NCT02702492|593458201|FG001|Overall Study|Adverse Event|0|||
164296176|NCT02702492|593458202|FG002|Overall Study|Adverse Event|1|||
164296177|NCT02702492|593458203|FG003|Overall Study|Adverse Event|2|||
164296178|NCT02702492|593458204|FG004|Overall Study|Adverse Event|1|||
164296179|NCT02702492|593458205|FG005|Overall Study|Adverse Event|0|||
164296180|NCT02702492|593458206|FG006|Overall Study|Adverse Event|1|||
164296181|NCT02702492|593458207|FG007|Overall Study|Adverse Event|0|||
164435106|NCT03536884|593960878|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
164435107|NCT03536884|593960867|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
164435108|NCT03536884|593960868|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
164435109|NCT03536884|593960869|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
164296182|NCT02702492|593458208|FG008|Overall Study|Adverse Event|2|||
164587422|NCT00872898|594513843|FG000|Part Two - Double Blind|Adverse Event|4|||
164296183|NCT02702492|593458209|FG009|Overall Study|Adverse Event|0|||
164296184|NCT02702492|593458210|FG010|Overall Study|Adverse Event|0|||
164296185|NCT02702492|593458211|FG011|Overall Study|Adverse Event|0|||
164296186|NCT02702492|593458212|FG012|Overall Study|Adverse Event|1|||
164296187|NCT02702492|593458200|FG000|Overall Study|Other|0|||
164296188|NCT02702492|593458201|FG001|Overall Study|Other|0|||
164296189|NCT02702492|593458202|FG002|Overall Study|Other|0|||
164296190|NCT02702492|593458203|FG003|Overall Study|Other|0|||
164296191|NCT02702492|593458204|FG004|Overall Study|Other|0|||
164296192|NCT02702492|593458205|FG005|Overall Study|Other|0|||
164296193|NCT02702492|593458206|FG006|Overall Study|Other|0|||
164296194|NCT02702492|593458207|FG007|Overall Study|Other|0|||
164296195|NCT02702492|593458208|FG008|Overall Study|Other|0|||
164296196|NCT02702492|593458209|FG009|Overall Study|Other|0|||
164296197|NCT02702492|593458210|FG010|Overall Study|Other|0|||
164296198|NCT02702492|593458211|FG011|Overall Study|Other|0|||
164296199|NCT02702492|593458212|FG012|Overall Study|Other|1|||
164296200|NCT01775501|593460087|FG000|Overall Study|Discontinued prior to treatment|1|||
164296201|NCT03037385|593460088|FG000|Overall Study|Adverse Event|0|||
164296202|NCT03037385|593460089|FG001|Overall Study|Adverse Event|0|||
164296203|NCT03037385|593460090|FG002|Overall Study|Adverse Event|1|||
164296204|NCT03037385|593460091|FG003|Overall Study|Adverse Event|0|||
164296205|NCT03037385|593460092|FG004|Overall Study|Adverse Event|0|||
164296206|NCT03037385|593460093|FG005|Overall Study|Adverse Event|0|||
164296207|NCT03037385|593460094|FG006|Overall Study|Adverse Event|0|||
164296208|NCT03037385|593460095|FG007|Overall Study|Adverse Event|0|||
164296209|NCT03037385|593460096|FG008|Overall Study|Adverse Event|0|||
164296210|NCT03037385|593460097|FG009|Overall Study|Adverse Event|6|||
164296211|NCT03037385|593460088|FG000|Overall Study|Death|1|||
164296212|NCT03037385|593460089|FG001|Overall Study|Death|4|||
164296213|NCT03037385|593460090|FG002|Overall Study|Death|2|||
164296214|NCT03037385|593460091|FG003|Overall Study|Death|2|||
164296215|NCT03037385|593460092|FG004|Overall Study|Death|5|||
164296216|NCT03037385|593460093|FG005|Overall Study|Death|2|||
164296217|NCT03037385|593460094|FG006|Overall Study|Death|1|||
164296218|NCT03037385|593460095|FG007|Overall Study|Death|4|||
164296219|NCT03037385|593460096|FG008|Overall Study|Death|3|||
164347498|NCT00642460|593648839|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
164347499|NCT00642460|593648840|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
164347500|NCT00642460|593648841|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
164347501|NCT00642460|593648842|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
164347502|NCT00642460|593648843|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
164347503|NCT00642460|593648838|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
164347504|NCT00642460|593648839|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
164347505|NCT00642460|593648840|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
164347506|NCT00642460|593648841|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
164347507|NCT00642460|593648842|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
164347508|NCT00642460|593648843|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
164347509|NCT00642460|593648838|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
164347510|NCT00642460|593648839|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
164347511|NCT00642460|593648840|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
164347512|NCT00642460|593648841|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
164347513|NCT00642460|593648842|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
164347514|NCT00642460|593648843|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
164347515|NCT00642460|593648838|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
164347516|NCT00642460|593648839|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
164347517|NCT00642460|593648840|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
164347518|NCT00642460|593648841|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
164347519|NCT00642460|593648842|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
164347520|NCT00642460|593648843|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
164347521|NCT00642460|593648838|FG000|Part III: Open-Label Up to Week 260|Other|0|||
164347522|NCT00642460|593648839|FG001|Part III: Open-Label Up to Week 260|Other|0|||
164347523|NCT00642460|593648840|FG002|Part III: Open-Label Up to Week 260|Other|0|||
164347524|NCT00642460|593648841|FG003|Part III: Open-Label Up to Week 260|Other|0|||
164347525|NCT00642460|593648842|FG004|Part III: Open-Label Up to Week 260|Other|2|||
164347526|NCT00642460|593648843|FG005|Part III: Open-Label Up to Week 260|Other|2|||
164347527|NCT00642460|593648838|FG000|Part III: Open-Label Up to Week 260|Death|0|||
164347528|NCT00642460|593648839|FG001|Part III: Open-Label Up to Week 260|Death|0|||
164347529|NCT00642460|593648840|FG002|Part III: Open-Label Up to Week 260|Death|0|||
164347530|NCT00642460|593648841|FG003|Part III: Open-Label Up to Week 260|Death|0|||
164347531|NCT00642460|593648842|FG004|Part III: Open-Label Up to Week 260|Death|0|||
164347532|NCT00642460|593648843|FG005|Part III: Open-Label Up to Week 260|Death|3|||
164296220|NCT03037385|593460097|FG009|Overall Study|Death|240|||
164296221|NCT03037385|593460088|FG000|Overall Study|Initiation of Another Therapy|1|||
164296222|NCT03037385|593460089|FG001|Overall Study|Initiation of Another Therapy|0|||
164296223|NCT03037385|593460090|FG002|Overall Study|Initiation of Another Therapy|0|||
164296224|NCT03037385|593460091|FG003|Overall Study|Initiation of Another Therapy|0|||
164347533|NCT00642460|593648838|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
164347534|NCT00642460|593648839|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
164296225|NCT03037385|593460092|FG004|Overall Study|Initiation of Another Therapy|0|||
164296226|NCT03037385|593460093|FG005|Overall Study|Initiation of Another Therapy|0|||
164296227|NCT03037385|593460094|FG006|Overall Study|Initiation of Another Therapy|0|||
164296228|NCT03037385|593460095|FG007|Overall Study|Initiation of Another Therapy|1|||
164296229|NCT03037385|593460096|FG008|Overall Study|Initiation of Another Therapy|0|||
164296230|NCT03037385|593460097|FG009|Overall Study|Initiation of Another Therapy|2|||
164296231|NCT03037385|593460088|FG000|Overall Study|Lost to Follow-up|0|||
164296232|NCT03037385|593460089|FG001|Overall Study|Lost to Follow-up|0|||
164296233|NCT03037385|593460090|FG002|Overall Study|Lost to Follow-up|0|||
164296234|NCT03037385|593460091|FG003|Overall Study|Lost to Follow-up|0|||
164296235|NCT03037385|593460092|FG004|Overall Study|Lost to Follow-up|0|||
164296236|NCT03037385|593460093|FG005|Overall Study|Lost to Follow-up|1|||
164296237|NCT03037385|593460094|FG006|Overall Study|Lost to Follow-up|0|||
164296238|NCT03037385|593460095|FG007|Overall Study|Lost to Follow-up|0|||
164296239|NCT03037385|593460096|FG008|Overall Study|Lost to Follow-up|0|||
164296240|NCT03037385|593460097|FG009|Overall Study|Lost to Follow-up|16|||
164296241|NCT03037385|593460088|FG000|Overall Study|Physician Decision|0|||
164296242|NCT03037385|593460089|FG001|Overall Study|Physician Decision|0|||
164296243|NCT03037385|593460090|FG002|Overall Study|Physician Decision|0|||
164296244|NCT03037385|593460091|FG003|Overall Study|Physician Decision|0|||
164296245|NCT03037385|593460092|FG004|Overall Study|Physician Decision|0|||
164296246|NCT03037385|593460093|FG005|Overall Study|Physician Decision|0|||
164296247|NCT03037385|593460094|FG006|Overall Study|Physician Decision|0|||
164296248|NCT03037385|593460095|FG007|Overall Study|Physician Decision|0|||
164296249|NCT03037385|593460096|FG008|Overall Study|Physician Decision|0|||
164296250|NCT03037385|593460097|FG009|Overall Study|Physician Decision|1|||
164296251|NCT03037385|593460088|FG000|Overall Study|Progressive Disease|0|||
164296252|NCT03037385|593460089|FG001|Overall Study|Progressive Disease|1|||
164296253|NCT03037385|593460090|FG002|Overall Study|Progressive Disease|1|||
164296254|NCT03037385|593460091|FG003|Overall Study|Progressive Disease|5|||
164296255|NCT03037385|593460092|FG004|Overall Study|Progressive Disease|2|||
164296256|NCT03037385|593460093|FG005|Overall Study|Progressive Disease|0|||
164296257|NCT03037385|593460094|FG006|Overall Study|Progressive Disease|1|||
164296258|NCT03037385|593460095|FG007|Overall Study|Progressive Disease|0|||
164296259|NCT03037385|593460096|FG008|Overall Study|Progressive Disease|0|||
164296260|NCT03037385|593460097|FG009|Overall Study|Progressive Disease|30|||
164296261|NCT03037385|593460088|FG000|Overall Study|Withdrawal by Subject|0|||
164296262|NCT03037385|593460089|FG001|Overall Study|Withdrawal by Subject|0|||
164296263|NCT03037385|593460090|FG002|Overall Study|Withdrawal by Subject|1|||
164296264|NCT03037385|593460091|FG003|Overall Study|Withdrawal by Subject|2|||
164296265|NCT03037385|593460092|FG004|Overall Study|Withdrawal by Subject|1|||
164296266|NCT03037385|593460093|FG005|Overall Study|Withdrawal by Subject|3|||
164296267|NCT03037385|593460094|FG006|Overall Study|Withdrawal by Subject|0|||
164296268|NCT03037385|593460095|FG007|Overall Study|Withdrawal by Subject|0|||
164296269|NCT03037385|593460096|FG008|Overall Study|Withdrawal by Subject|0|||
164296270|NCT03037385|593460097|FG009|Overall Study|Withdrawal by Subject|52|||
164296271|NCT03037385|593460088|FG000|Overall Study|Reason Not Specified|0|||
164296272|NCT03037385|593460089|FG001|Overall Study|Reason Not Specified|1|||
164296273|NCT03037385|593460090|FG002|Overall Study|Reason Not Specified|0|||
164296274|NCT03037385|593460091|FG003|Overall Study|Reason Not Specified|4|||
164296275|NCT03037385|593460092|FG004|Overall Study|Reason Not Specified|3|||
164296276|NCT03037385|593460093|FG005|Overall Study|Reason Not Specified|6|||
164296277|NCT03037385|593460094|FG006|Overall Study|Reason Not Specified|2|||
164296278|NCT03037385|593460095|FG007|Overall Study|Reason Not Specified|0|||
164296279|NCT03037385|593460096|FG008|Overall Study|Reason Not Specified|1|||
164296280|NCT03037385|593460097|FG009|Overall Study|Reason Not Specified|181|||
164296281|NCT02318706|593460098|FG000|Double-blind Phase|Adverse Event|7|||
164296282|NCT02318706|593460099|FG001|Double-blind Phase|Adverse Event|4|||
164296283|NCT02318706|593460100|FG002|Double-blind Phase|Adverse Event|3|||
164296284|NCT02318706|593460101|FG003|Double-blind Phase|Adverse Event|10|||
164296285|NCT02318706|593460102|FG004|Double-blind Phase|Adverse Event|0|||
164296286|NCT02318706|593460098|FG000|Double-blind Phase|Lost to Follow-up|1|||
164296287|NCT02318706|593460099|FG001|Double-blind Phase|Lost to Follow-up|0|||
164296288|NCT02318706|593460100|FG002|Double-blind Phase|Lost to Follow-up|0|||
164296289|NCT02318706|593460101|FG003|Double-blind Phase|Lost to Follow-up|0|||
164296290|NCT02318706|593460102|FG004|Double-blind Phase|Lost to Follow-up|0|||
164296291|NCT02318706|593460098|FG000|Double-blind Phase|Protocol Violation|4|||
164296292|NCT02318706|593460099|FG001|Double-blind Phase|Protocol Violation|2|||
164296293|NCT02318706|593460100|FG002|Double-blind Phase|Protocol Violation|4|||
164296294|NCT02318706|593460101|FG003|Double-blind Phase|Protocol Violation|3|||
164296295|NCT02318706|593460102|FG004|Double-blind Phase|Protocol Violation|0|||
164296296|NCT02318706|593460098|FG000|Double-blind Phase|Withdrawal by Subject|9|||
164296297|NCT02318706|593460099|FG001|Double-blind Phase|Withdrawal by Subject|5|||
164693593|NCT00739973|594899425|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
164296298|NCT02318706|593460100|FG002|Double-blind Phase|Withdrawal by Subject|7|||
164296299|NCT02318706|593460101|FG003|Double-blind Phase|Withdrawal by Subject|10|||
164296300|NCT02318706|593460102|FG004|Double-blind Phase|Withdrawal by Subject|0|||
164296301|NCT02318706|593460098|FG000|Double-blind Phase|Other|4|||
164296302|NCT02318706|593460099|FG001|Double-blind Phase|Other|1|||
164296303|NCT02318706|593460100|FG002|Double-blind Phase|Other|2|||
164296304|NCT02318706|593460101|FG003|Double-blind Phase|Other|1|||
164296305|NCT02318706|593460102|FG004|Double-blind Phase|Other|0|||
164296306|NCT02318706|593460098|FG000|Double-blind Phase|Death|0|||
164296307|NCT02318706|593460099|FG001|Double-blind Phase|Death|0|||
164296308|NCT02318706|593460100|FG002|Double-blind Phase|Death|2|||
164296309|NCT02318706|593460101|FG003|Double-blind Phase|Death|0|||
164296310|NCT02318706|593460102|FG004|Double-blind Phase|Death|0|||
164296311|NCT02318706|593460098|FG000|Open-label Extension Phase|Adverse Event|0|||
164296312|NCT02318706|593460099|FG001|Open-label Extension Phase|Adverse Event|0|||
164296313|NCT02318706|593460100|FG002|Open-label Extension Phase|Adverse Event|0|||
164296314|NCT02318706|593460101|FG003|Open-label Extension Phase|Adverse Event|0|||
164296315|NCT02318706|593460102|FG004|Open-label Extension Phase|Adverse Event|21|||
164296316|NCT02318706|593460098|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
164296317|NCT02318706|593460099|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
164296318|NCT02318706|593460100|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
164296319|NCT02318706|593460101|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
164296320|NCT02318706|593460102|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
164296321|NCT02318706|593460098|FG000|Open-label Extension Phase|Death|0|||
164296322|NCT02318706|593460099|FG001|Open-label Extension Phase|Death|0|||
164296323|NCT02318706|593460100|FG002|Open-label Extension Phase|Death|0|||
164296324|NCT02318706|593460101|FG003|Open-label Extension Phase|Death|0|||
164296325|NCT02318706|593460102|FG004|Open-label Extension Phase|Death|1|||
164296326|NCT02318706|593460098|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
164296327|NCT02318706|593460099|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
164296328|NCT02318706|593460100|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
164296329|NCT02318706|593460101|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
164296330|NCT02318706|593460102|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
164296331|NCT04328077|593460103|FG000|Overall Study|Lost to Follow-up|0|||
164296332|NCT04328077|593460104|FG001|Overall Study|Lost to Follow-up|1|||
164296333|NCT04328077|593460105|FG002|Overall Study|Lost to Follow-up|0|||
164296334|NCT04328077|593460106|FG003|Overall Study|Lost to Follow-up|0|||
164296335|NCT04328077|593460103|FG000|Overall Study|Withdrawal by Subject|0|||
164296336|NCT04328077|593460104|FG001|Overall Study|Withdrawal by Subject|1|||
164296337|NCT04328077|593460105|FG002|Overall Study|Withdrawal by Subject|1|||
164296338|NCT04328077|593460106|FG003|Overall Study|Withdrawal by Subject|3|||
164296339|NCT01456039|593460107|FG000|Phase 1 (First Step)|Disease Progression|1|||
164296340|NCT01456039|593460108|FG001|Phase 1 (First Step)|Disease Progression|1|||
164296341|NCT01456039|593460109|FG002|Phase 1 (First Step)|Disease Progression|0|||
164296342|NCT01456039|593460107|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
164296343|NCT01456039|593460108|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
164296344|NCT01456039|593460109|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
164296345|NCT01456039|593460107|FG000|Phase 1 (First Step)|Adverse Event|0|||
164296346|NCT01456039|593460108|FG001|Phase 1 (First Step)|Adverse Event|3|||
164296347|NCT01456039|593460109|FG002|Phase 1 (First Step)|Adverse Event|0|||
164296348|NCT01456039|593460107|FG000|Phase 1 (First Step)|Other|0|||
164296349|NCT01456039|593460108|FG001|Phase 1 (First Step)|Other|1|||
164296350|NCT01456039|593460109|FG002|Phase 1 (First Step)|Other|0|||
164296351|NCT01456039|593460107|FG000|Phase 2 (Second Step)|Disease Progression|0|||
164296352|NCT01456039|593460108|FG001|Phase 2 (Second Step)|Disease Progression|0|||
164296353|NCT01456039|593460109|FG002|Phase 2 (Second Step)|Disease Progression|17|||
164296354|NCT01456039|593460107|FG000|Phase 2 (Second Step)|Adverse Event|0|||
164296355|NCT01456039|593460108|FG001|Phase 2 (Second Step)|Adverse Event|0|||
164296356|NCT01456039|593460109|FG002|Phase 2 (Second Step)|Adverse Event|10|||
164296357|NCT01456039|593460107|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
164296358|NCT01456039|593460108|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
164296359|NCT01456039|593460109|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
164296360|NCT01456039|593460107|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
164296361|NCT01456039|593460108|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
164296362|NCT01456039|593460109|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
164296363|NCT01456039|593460107|FG000|Phase 2 (Second Step)|Other|0|||
164296364|NCT01456039|593460108|FG001|Phase 2 (Second Step)|Other|0|||
164296365|NCT01456039|593460109|FG002|Phase 2 (Second Step)|Other|1|||
164296366|NCT01702311|593460113|FG000|Overall Study|Withdrawal by Subject|3|||
164296367|NCT01702311|593460114|FG001|Overall Study|Withdrawal by Subject|2|||
164296368|NCT01702311|593460113|FG000|Overall Study|Discharge less than 24 hours|10|||
164296369|NCT01702311|593460114|FG001|Overall Study|Discharge less than 24 hours|7|||
164296370|NCT01702311|593460113|FG000|Overall Study|Physician Decision|3|||
164296371|NCT01702311|593460114|FG001|Overall Study|Physician Decision|4|||
164296372|NCT04106557|593460121|FG000|Overall Study|Physician Decision|0|||
164296373|NCT04106557|593460122|FG001|Overall Study|Physician Decision|1|||
164296374|NCT04106557|593460123|FG002|Overall Study|Physician Decision|0|||
164296375|NCT04106557|593460121|FG000|Overall Study|Protocol Violation|0|||
164296376|NCT04106557|593460122|FG001|Overall Study|Protocol Violation|1|||
164296377|NCT04106557|593460123|FG002|Overall Study|Protocol Violation|0|||
164296378|NCT00313014|593460124|FG000|Overall Study|Withdrawal by Subject|11|||
164296379|NCT00313014|593460125|FG001|Overall Study|Withdrawal by Subject|7|||
164296380|NCT00313014|593460126|FG002|Overall Study|Withdrawal by Subject|5|||
164296381|NCT00313014|593460124|FG000|Overall Study|Adverse Event|14|||
164296382|NCT00313014|593460125|FG001|Overall Study|Adverse Event|29|||
164296383|NCT00313014|593460126|FG002|Overall Study|Adverse Event|16|||
164296384|NCT00313014|593460124|FG000|Overall Study|Lost to Follow-up|7|||
164296385|NCT00313014|593460125|FG001|Overall Study|Lost to Follow-up|6|||
164296386|NCT00313014|593460126|FG002|Overall Study|Lost to Follow-up|10|||
164296387|NCT00313014|593460124|FG000|Overall Study|Administrative|9|||
164296388|NCT00313014|593460125|FG001|Overall Study|Administrative|6|||
164296389|NCT00313014|593460126|FG002|Overall Study|Administrative|14|||
164296390|NCT00313014|593460124|FG000|Overall Study|Lack of Efficacy|52|||
164296391|NCT00313014|593460125|FG001|Overall Study|Lack of Efficacy|25|||
164296392|NCT00313014|593460126|FG002|Overall Study|Lack of Efficacy|16|||
164296393|NCT03714672|593460129|FG000|Overall Study|Adverse Event|0|||
164296394|NCT03714672|593460130|FG001|Overall Study|Adverse Event|0|||
164296395|NCT03714672|593460131|FG002|Overall Study|Adverse Event|3|||
164296396|NCT03714672|593460132|FG003|Overall Study|Adverse Event|0|||
164296397|NCT03714672|593460129|FG000|Overall Study|Physician Decision|0|||
164296398|NCT03714672|593460130|FG001|Overall Study|Physician Decision|1|||
164296399|NCT03714672|593460131|FG002|Overall Study|Physician Decision|0|||
164296400|NCT03714672|593460132|FG003|Overall Study|Physician Decision|0|||
164296401|NCT03714672|593460129|FG000|Overall Study|Other Reason|1|||
164296402|NCT03714672|593460130|FG001|Overall Study|Other Reason|2|||
164296403|NCT03714672|593460131|FG002|Overall Study|Other Reason|1|||
164296404|NCT03714672|593460132|FG003|Overall Study|Other Reason|1|||
164296405|NCT03714672|593460129|FG000|Overall Study|Lost to Follow-up|1|||
164296406|NCT03714672|593460130|FG001|Overall Study|Lost to Follow-up|1|||
164296407|NCT03714672|593460131|FG002|Overall Study|Lost to Follow-up|0|||
164296408|NCT03714672|593460132|FG003|Overall Study|Lost to Follow-up|0|||
164296409|NCT03007966|593460139|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
164296410|NCT03007966|593460140|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
164296411|NCT00474487|593460141|FG000|Overall Study|Withdrawal by Subject|6|||
164296412|NCT00474487|593460142|FG001|Overall Study|Withdrawal by Subject|0|||
164296413|NCT00474487|593460143|FG002|Overall Study|Withdrawal by Subject|0|||
164296414|NCT00474487|593460144|FG003|Overall Study|Withdrawal by Subject|0|||
164296415|NCT00474487|593460141|FG000|Overall Study|Lost to Follow-up|20|||
164296416|NCT00474487|593460142|FG001|Overall Study|Lost to Follow-up|1|||
164296417|NCT00474487|593460143|FG002|Overall Study|Lost to Follow-up|7|||
164296418|NCT00474487|593460144|FG003|Overall Study|Lost to Follow-up|0|||
164296419|NCT00474487|593460141|FG000|Overall Study|Inappropriate enrollment|4|||
164296420|NCT00474487|593460142|FG001|Overall Study|Inappropriate enrollment|0|||
164296421|NCT00474487|593460143|FG002|Overall Study|Inappropriate enrollment|7|||
164296422|NCT00474487|593460144|FG003|Overall Study|Inappropriate enrollment|0|||
164296423|NCT00474487|593460141|FG000|Overall Study|Death|0|||
164296424|NCT00474487|593460142|FG001|Overall Study|Death|1|||
164296425|NCT00474487|593460143|FG002|Overall Study|Death|0|||
164296426|NCT00474487|593460144|FG003|Overall Study|Death|0|||
164296427|NCT00419393|593460145|FG000|Overall Study|Adverse Event|5|||
164296428|NCT00419393|593460145|FG000|Overall Study|Protocol Violation|5|||
164296429|NCT00419393|593460145|FG000|Overall Study|Withdrawal by Subject|7|||
164296430|NCT00419393|593460145|FG000|Overall Study|Other: Sponsor request|3|||
164296431|NCT00419393|593460145|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
164296432|NCT00419393|593460145|FG000|Overall Study|Other: Site closure|1|||
164296433|NCT00419393|593460145|FG000|Overall Study|Other: Other health problems|1|||
164296434|NCT00419393|593460145|FG000|Overall Study|Other: Investigator decision|1|||
164296435|NCT00248625|593460148|FG000|Overall Study|Withdrawal by Subject|0|||
164296436|NCT00248625|593460149|FG001|Overall Study|Withdrawal by Subject|2|||
164296437|NCT03284710|593460152|FG000|Overall Study|Withdrawal by Subject|1|||
164296438|NCT03284710|593460153|FG001|Overall Study|Withdrawal by Subject|0|||
164296439|NCT03284710|593460154|FG002|Overall Study|Withdrawal by Subject|1|||
164296440|NCT03284710|593460155|FG003|Overall Study|Withdrawal by Subject|6|||
164296441|NCT03284710|593460152|FG000|Overall Study|Lost to Follow-up|3|||
164296442|NCT03284710|593460153|FG001|Overall Study|Lost to Follow-up|3|||
164296443|NCT03284710|593460154|FG002|Overall Study|Lost to Follow-up|1|||
164296444|NCT03284710|593460155|FG003|Overall Study|Lost to Follow-up|0|||
164296445|NCT03284710|593460152|FG000|Overall Study|Physician Decision|1|||
164296446|NCT03284710|593460153|FG001|Overall Study|Physician Decision|0|||
164296447|NCT03284710|593460154|FG002|Overall Study|Physician Decision|0|||
164296448|NCT03284710|593460155|FG003|Overall Study|Physician Decision|0|||
164296449|NCT03284710|593460152|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
164296450|NCT03284710|593460153|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
164296451|NCT03284710|593460154|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
164296452|NCT03284710|593460155|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
164296453|NCT03284710|593460152|FG000|Overall Study|HIV Infection|0|||
164435110|NCT03536884|593960870|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
164296454|NCT03284710|593460153|FG001|Overall Study|HIV Infection|2|||
164296455|NCT03284710|593460154|FG002|Overall Study|HIV Infection|2|||
164296456|NCT03284710|593460155|FG003|Overall Study|HIV Infection|1|||
164296457|NCT05176314|593460158|FG000|Overall Study|Lost to Follow-up|2|||
164296458|NCT05176314|593460158|FG000|Overall Study|Physician Decision|1|||
164296459|NCT05176314|593460158|FG000|Overall Study|Adverse Event|1|||
164296460|NCT02118584|593460160|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
164296461|NCT02118584|593460161|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
164296462|NCT02118584|593460162|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
164296463|NCT02118584|593460160|FG000|Part 1: Open Label Extension Period|Death|9|||
164296464|NCT02118584|593460161|FG001|Part 1: Open Label Extension Period|Death|0|||
164296465|NCT02118584|593460162|FG002|Part 1: Open Label Extension Period|Death|0|||
164296466|NCT02118584|593460160|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
164296467|NCT02118584|593460161|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
164296468|NCT02118584|593460162|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
164296469|NCT02118584|593460160|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
164296470|NCT02118584|593460161|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
164296471|NCT02118584|593460162|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
164296472|NCT02118584|593460160|FG000|Part 1: Open Label Extension Period|Other|135|||
164296473|NCT02118584|593460161|FG001|Part 1: Open Label Extension Period|Other|0|||
164296474|NCT02118584|593460162|FG002|Part 1: Open Label Extension Period|Other|0|||
164296475|NCT02118584|593460160|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
164296476|NCT02118584|593460161|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
164296477|NCT02118584|593460162|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
164296478|NCT02118584|593460160|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
164296479|NCT02118584|593460161|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
164296480|NCT02118584|593460162|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
164296481|NCT02118584|593460160|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
164296482|NCT02118584|593460161|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
164296483|NCT02118584|593460162|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
164296484|NCT02118584|593460160|FG000|Part 1: Open Label Extension Period|Other|3|||
164296485|NCT02118584|593460161|FG001|Part 1: Open Label Extension Period|Other|0|||
164296486|NCT02118584|593460162|FG002|Part 1: Open Label Extension Period|Other|0|||
164296487|NCT02118584|593460160|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
164296488|NCT02118584|593460161|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
164296489|NCT02118584|593460162|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
164296490|NCT02118584|593460160|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
164296491|NCT02118584|593460161|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
164296492|NCT02118584|593460162|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
164296493|NCT02118584|593460160|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
164296494|NCT02118584|593460161|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
164296495|NCT02118584|593460162|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
164296496|NCT02118584|593460160|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
164296497|NCT02118584|593460161|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
164296498|NCT02118584|593460162|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
164296499|NCT02118584|593460160|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
164296500|NCT02118584|593460161|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
164296501|NCT02118584|593460162|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
164296502|NCT02118584|593460160|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
164296503|NCT02118584|593460161|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
164296504|NCT02118584|593460162|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
164296505|NCT02118584|593460160|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
164296506|NCT02118584|593460161|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
164296507|NCT02118584|593460162|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
164296508|NCT02118584|593460160|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
164296509|NCT02118584|593460161|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
164296510|NCT02118584|593460162|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
164296511|NCT02118584|593460160|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
164296512|NCT02118584|593460161|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
164296513|NCT02118584|593460162|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
164296514|NCT01231984|593460163|FG000|Study Period 1|Withdrawal by Subject|0|||
164296515|NCT01231984|593460164|FG001|Study Period 1|Withdrawal by Subject|0|||
164296516|NCT01231984|593460165|FG002|Study Period 1|Withdrawal by Subject|0|||
164296517|NCT01231984|593460166|FG003|Study Period 1|Withdrawal by Subject|1|||
164296518|NCT01231984|593460163|FG000|Study Period 1|Lost to Follow-up|1|||
164296519|NCT01231984|593460164|FG001|Study Period 1|Lost to Follow-up|1|||
164296520|NCT01231984|593460165|FG002|Study Period 1|Lost to Follow-up|1|||
164296521|NCT01231984|593460166|FG003|Study Period 1|Lost to Follow-up|0|||
164296522|NCT01231984|593460163|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
164296523|NCT01231984|593460164|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
164296524|NCT01231984|593460165|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
164296525|NCT01231984|593460166|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
164296526|NCT01231984|593460163|FG000|Study Period 1|Screen Failure|0|||
164296527|NCT01231984|593460164|FG001|Study Period 1|Screen Failure|0|||
164296528|NCT01231984|593460165|FG002|Study Period 1|Screen Failure|0|||
164296529|NCT01231984|593460166|FG003|Study Period 1|Screen Failure|1|||
164296530|NCT01231984|593460163|FG000|Study Period 1|Non-compliance with study requirements|5|||
164296531|NCT01231984|593460164|FG001|Study Period 1|Non-compliance with study requirements|0|||
164296532|NCT01231984|593460165|FG002|Study Period 1|Non-compliance with study requirements|2|||
164296533|NCT01231984|593460166|FG003|Study Period 1|Non-compliance with study requirements|1|||
164296534|NCT01231984|593460163|FG000|Study Period 1|Protocol Violation|3|||
164296535|NCT01231984|593460164|FG001|Study Period 1|Protocol Violation|4|||
164296536|NCT01231984|593460165|FG002|Study Period 1|Protocol Violation|2|||
164296537|NCT01231984|593460166|FG003|Study Period 1|Protocol Violation|3|||
164296538|NCT01231984|593460163|FG000|Study Period 1|Adverse Event|1|||
164296539|NCT01231984|593460164|FG001|Study Period 1|Adverse Event|0|||
164296540|NCT01231984|593460165|FG002|Study Period 1|Adverse Event|0|||
164296541|NCT01231984|593460166|FG003|Study Period 1|Adverse Event|0|||
164296542|NCT01231984|593460163|FG000|Study Period 1|Other|0|||
164296543|NCT01231984|593460164|FG001|Study Period 1|Other|0|||
164296544|NCT01231984|593460165|FG002|Study Period 1|Other|0|||
164296545|NCT01231984|593460166|FG003|Study Period 1|Other|1|||
164296546|NCT01231984|593460163|FG000|Study Period 2|Withdrawal by Subject|1|||
164296547|NCT01231984|593460164|FG001|Study Period 2|Withdrawal by Subject|1|||
164296548|NCT01231984|593460165|FG002|Study Period 2|Withdrawal by Subject|0|||
164296549|NCT01231984|593460166|FG003|Study Period 2|Withdrawal by Subject|0|||
164296550|NCT01231984|593460163|FG000|Study Period 2|Lost to Follow-up|1|||
164296551|NCT01231984|593460164|FG001|Study Period 2|Lost to Follow-up|0|||
164296552|NCT01231984|593460165|FG002|Study Period 2|Lost to Follow-up|0|||
164296553|NCT01231984|593460166|FG003|Study Period 2|Lost to Follow-up|3|||
164296554|NCT01231984|593460163|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
164296555|NCT01231984|593460164|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
164296556|NCT01231984|593460165|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
164296557|NCT01231984|593460166|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
164296558|NCT00537394|593460172|FG000|First Year of Follow-up|Death|7|||
164296559|NCT00537394|593460173|FG001|First Year of Follow-up|Death|0|||
164296560|NCT00537394|593460174|FG002|First Year of Follow-up|Death|0|||
164296561|NCT00537394|593460172|FG000|First Year of Follow-up|Severe debilitation|1|||
164296562|NCT00537394|593460173|FG001|First Year of Follow-up|Severe debilitation|0|||
164296563|NCT00537394|593460174|FG002|First Year of Follow-up|Severe debilitation|1|||
164296564|NCT00537394|593460172|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
164296565|NCT00537394|593460173|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
164296566|NCT00537394|593460174|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
164296567|NCT00537394|593460172|FG000|First Year of Follow-up|Lost to Follow-up|1|||
164296568|NCT00537394|593460173|FG001|First Year of Follow-up|Lost to Follow-up|5|||
164296569|NCT00537394|593460174|FG002|First Year of Follow-up|Lost to Follow-up|1|||
164296570|NCT00537394|593460172|FG000|2nd Year of Follow-up|Death|4|||
164296571|NCT00537394|593460173|FG001|2nd Year of Follow-up|Death|1|||
164296572|NCT00537394|593460174|FG002|2nd Year of Follow-up|Death|2|||
164296573|NCT00537394|593460172|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
164296574|NCT00537394|593460173|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
164347535|NCT00642460|593648840|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
164347536|NCT00642460|593648841|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
164347537|NCT00642460|593648842|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
164347538|NCT00642460|593648843|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
164347539|NCT00642460|593648838|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
164347540|NCT00642460|593648839|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
164296575|NCT00537394|593460174|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
164296576|NCT00537394|593460172|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
164296577|NCT00537394|593460173|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
164296578|NCT00537394|593460174|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
164296579|NCT00537394|593460172|FG000|2nd Year of Follow-up|Clinic site closure|1|||
164296580|NCT00537394|593460173|FG001|2nd Year of Follow-up|Clinic site closure|0|||
164296581|NCT00537394|593460174|FG002|2nd Year of Follow-up|Clinic site closure|0|||
164296582|NCT01283139|593460175|FG000|Overall Study|Lost to Follow-up|5|||
164296583|NCT01283139|593460176|FG001|Overall Study|Lost to Follow-up|2|||
164296584|NCT01283139|593460177|FG002|Overall Study|Lost to Follow-up|3|||
164296585|NCT01283139|593460178|FG003|Overall Study|Lost to Follow-up|1|||
164296586|NCT01283139|593460175|FG000|Overall Study|Withdrawal by Subject|8|||
164296587|NCT01283139|593460176|FG001|Overall Study|Withdrawal by Subject|8|||
164296588|NCT01283139|593460177|FG002|Overall Study|Withdrawal by Subject|6|||
164296589|NCT01283139|593460178|FG003|Overall Study|Withdrawal by Subject|8|||
164296590|NCT01283139|593460175|FG000|Overall Study|Death|2|||
164296591|NCT01283139|593460176|FG001|Overall Study|Death|0|||
164296592|NCT01283139|593460177|FG002|Overall Study|Death|2|||
164296593|NCT01283139|593460178|FG003|Overall Study|Death|2|||
164296594|NCT01283139|593460175|FG000|Overall Study|Lack of Efficacy|1|||
164296595|NCT01283139|593460176|FG001|Overall Study|Lack of Efficacy|2|||
164296596|NCT01283139|593460177|FG002|Overall Study|Lack of Efficacy|2|||
164296597|NCT01283139|593460178|FG003|Overall Study|Lack of Efficacy|1|||
164296598|NCT01283139|593460175|FG000|Overall Study|Early termination due to AE/SAE|1|||
164296599|NCT01283139|593460176|FG001|Overall Study|Early termination due to AE/SAE|1|||
164296600|NCT01283139|593460177|FG002|Overall Study|Early termination due to AE/SAE|0|||
164296601|NCT01283139|593460178|FG003|Overall Study|Early termination due to AE/SAE|0|||
164296602|NCT01283139|593460175|FG000|Overall Study|Participant's refusal to continue|0|||
164296603|NCT01283139|593460176|FG001|Overall Study|Participant's refusal to continue|3|||
164296604|NCT01283139|593460177|FG002|Overall Study|Participant's refusal to continue|1|||
164296605|NCT01283139|593460178|FG003|Overall Study|Participant's refusal to continue|1|||
164296606|NCT01283139|593460175|FG000|Overall Study|Pregnancy|0|||
164296607|NCT01283139|593460176|FG001|Overall Study|Pregnancy|1|||
164296608|NCT01283139|593460177|FG002|Overall Study|Pregnancy|1|||
164296609|NCT01283139|593460178|FG003|Overall Study|Pregnancy|0|||
164296610|NCT01283139|593460175|FG000|Overall Study|Missed follow-up visit|0|||
164296611|NCT01283139|593460176|FG001|Overall Study|Missed follow-up visit|1|||
164296612|NCT01283139|593460177|FG002|Overall Study|Missed follow-up visit|2|||
164296613|NCT01283139|593460178|FG003|Overall Study|Missed follow-up visit|2|||
164296614|NCT01283139|593460175|FG000|Overall Study|Participant randomized in error|0|||
164296615|NCT01283139|593460176|FG001|Overall Study|Participant randomized in error|0|||
164296616|NCT01283139|593460177|FG002|Overall Study|Participant randomized in error|1|||
164296617|NCT01283139|593460178|FG003|Overall Study|Participant randomized in error|0|||
164296618|NCT00004563|593460183|FG000|Overall Study|Withdrawal by Subject|20|||
164296619|NCT00004563|593460184|FG001|Overall Study|Withdrawal by Subject|16|||
164296620|NCT00004563|593460183|FG000|Overall Study|Lack of Efficacy|3|||
164296621|NCT00004563|593460184|FG001|Overall Study|Lack of Efficacy|5|||
164296622|NCT00004563|593460183|FG000|Overall Study|Death|2|||
164296623|NCT00004563|593460184|FG001|Overall Study|Death|3|||
164296624|NCT01056822|593460185|FG000|Overall Study|Adverse Event|0|||
164296625|NCT01056822|593460186|FG001|Overall Study|Adverse Event|1|||
164296626|NCT01056822|593460185|FG000|Overall Study|Protocol Violation|6|||
164296627|NCT01056822|593460186|FG001|Overall Study|Protocol Violation|5|||
164296628|NCT01056822|593460185|FG000|Overall Study|Withdrawal by Subject|1|||
164296629|NCT01056822|593460186|FG001|Overall Study|Withdrawal by Subject|1|||
164347541|NCT00642460|593648840|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
164347542|NCT00642460|593648841|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
164347543|NCT00642460|593648842|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
164347544|NCT00642460|593648843|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
164347545|NCT04171531|593648847|FG000|Overall Study|Lost to Follow-up|4|||
164296630|NCT01056822|593460185|FG000|Overall Study|Lost to Follow-up|1|||
164296631|NCT01056822|593460186|FG001|Overall Study|Lost to Follow-up|0|||
164296632|NCT00784563|593460187|FG000|Years 1 & 2|Withdrawal by Subject|3|||
164347546|NCT04171531|593648848|FG001|Overall Study|Lost to Follow-up|5|||
164296633|NCT00784563|593460188|FG001|Years 1 & 2|Withdrawal by Subject|2|||
164296634|NCT00784563|593460189|FG002|Years 1 & 2|Withdrawal by Subject|0|||
164296635|NCT00784563|593460187|FG000|Years 1 & 2|Adverse Event|0|||
164296636|NCT00784563|593460188|FG001|Years 1 & 2|Adverse Event|3|||
164296637|NCT00784563|593460189|FG002|Years 1 & 2|Adverse Event|0|||
164296638|NCT00784563|593460187|FG000|Year 3|Withdrawal by Subject|0|||
164296639|NCT00784563|593460188|FG001|Year 3|Withdrawal by Subject|0|||
164296640|NCT00784563|593460189|FG002|Year 3|Withdrawal by Subject|2|||
164296641|NCT00784563|593460187|FG000|Year 3|Adverse Event|0|||
164587423|NCT00872898|594513844|FG001|Part Two - Double Blind|Adverse Event|3|||
164587424|NCT00872898|594513843|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
164587425|NCT00872898|594513844|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
164587426|NCT00872898|594513843|FG000|Part Two - Double Blind|Protocol Violation|1|||
164587427|NCT00872898|594513844|FG001|Part Two - Double Blind|Protocol Violation|0|||
164587428|NCT00872898|594513843|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
164587429|NCT00872898|594513844|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
164587430|NCT00872898|594513843|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
164587431|NCT00872898|594513844|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
164587432|NCT00872898|594513843|FG000|Part Two - Double Blind|Other reasons|2|||
164587433|NCT00872898|594513844|FG001|Part Two - Double Blind|Other reasons|0|||
164587434|NCT03176966|594513845|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
164587435|NCT03176966|594513846|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
164587436|NCT03176966|594513845|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
164587437|NCT03176966|594513846|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
164587438|NCT03176966|594513845|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
164587439|NCT03176966|594513846|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
164587440|NCT03176966|594513845|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
164587441|NCT03176966|594513846|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
164587442|NCT03176966|594513845|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
164587443|NCT03176966|594513846|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
164587444|NCT03176966|594513845|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
164587445|NCT03176966|594513846|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
164587446|NCT03176966|594513845|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
164587447|NCT03176966|594513846|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
164587448|NCT00404768|594513850|FG000|Part A and B|Withdrawn due to labor progression|1|||
164587449|NCT00404768|594513851|FG001|Part A and B|Withdrawn due to labor progression|0|||
164587450|NCT00404768|594513852|FG002|Part A and B|Withdrawn due to labor progression|0|||
164587451|NCT00404768|594513853|FG003|Part A and B|Withdrawn due to labor progression|0|||
164587452|NCT00404768|594513850|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
164587453|NCT00404768|594513851|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
164587454|NCT00404768|594513852|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
164587455|NCT00404768|594513853|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
164587456|NCT00404768|594513850|FG000|Part C|Adverse Event|0|||
164587457|NCT00404768|594513851|FG001|Part C|Adverse Event|0|||
164587458|NCT00404768|594513852|FG002|Part C|Adverse Event|0|||
164587459|NCT00404768|594513853|FG003|Part C|Adverse Event|3|||
164587460|NCT00404768|594513850|FG000|Part C|Lost to Follow-up|0|||
164587461|NCT00404768|594513851|FG001|Part C|Lost to Follow-up|0|||
164587462|NCT00404768|594513852|FG002|Part C|Lost to Follow-up|3|||
164587463|NCT00404768|594513853|FG003|Part C|Lost to Follow-up|1|||
164587464|NCT00404768|594513850|FG000|Part C|Withdrawal by Subject|0|||
164587465|NCT00404768|594513851|FG001|Part C|Withdrawal by Subject|0|||
164587466|NCT00404768|594513852|FG002|Part C|Withdrawal by Subject|2|||
164587467|NCT00404768|594513853|FG003|Part C|Withdrawal by Subject|1|||
164587468|NCT00404768|594513850|FG000|Part C|Early withdrawal from study medication|0|||
164587469|NCT00404768|594513851|FG001|Part C|Early withdrawal from study medication|0|||
164587470|NCT00404768|594513852|FG002|Part C|Early withdrawal from study medication|1|||
164587471|NCT00404768|594513853|FG003|Part C|Early withdrawal from study medication|0|||
164587472|NCT00404768|594513850|FG000|Part C|Participant did not respond to therapy|0|||
164587473|NCT00404768|594513851|FG001|Part C|Participant did not respond to therapy|0|||
164587474|NCT00404768|594513852|FG002|Part C|Participant did not respond to therapy|1|||
164587475|NCT00404768|594513853|FG003|Part C|Participant did not respond to therapy|1|||
164587476|NCT00404768|594513850|FG000|Part C|Physician withdrew the study medication|0|||
164587477|NCT00404768|594513851|FG001|Part C|Physician withdrew the study medication|0|||
164587478|NCT00404768|594513852|FG002|Part C|Physician withdrew the study medication|1|||
164587479|NCT00404768|594513853|FG003|Part C|Physician withdrew the study medication|0|||
164587480|NCT00404768|594513850|FG000|Part C|Participant delivered baby|0|||
164587481|NCT00404768|594513851|FG001|Part C|Participant delivered baby|0|||
164587482|NCT00404768|594513852|FG002|Part C|Participant delivered baby|0|||
164587483|NCT00404768|594513853|FG003|Part C|Participant delivered baby|1|||
164587484|NCT00404768|594513850|FG000|Part C|Unsatisfactory uterine response to IP|0|||
164587485|NCT00404768|594513851|FG001|Part C|Unsatisfactory uterine response to IP|0|||
164587486|NCT00404768|594513852|FG002|Part C|Unsatisfactory uterine response to IP|0|||
164693594|NCT00739973|594899417|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
164693595|NCT00739973|594899418|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
164693596|NCT00739973|594899419|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
164587487|NCT00404768|594513853|FG003|Part C|Unsatisfactory uterine response to IP|1|||
164587488|NCT00404768|594513850|FG000|Part C|Active labor|0|||
164587489|NCT00404768|594513851|FG001|Part C|Active labor|0|||
164587490|NCT00404768|594513852|FG002|Part C|Active labor|0|||
164587491|NCT00404768|594513853|FG003|Part C|Active labor|1|||
164587492|NCT00404768|594513850|FG000|Part C|Lack of Efficacy|0|||
164587493|NCT00404768|594513851|FG001|Part C|Lack of Efficacy|0|||
164587494|NCT00404768|594513852|FG002|Part C|Lack of Efficacy|0|||
164587495|NCT00404768|594513853|FG003|Part C|Lack of Efficacy|2|||
164587496|NCT00404768|594513850|FG000|Part C|Treatment failure|0|||
164587497|NCT00404768|594513851|FG001|Part C|Treatment failure|0|||
164587498|NCT00404768|594513852|FG002|Part C|Treatment failure|0|||
164587499|NCT00404768|594513853|FG003|Part C|Treatment failure|1|||
164296642|NCT00784563|593460188|FG001|Year 3|Adverse Event|0|||
164296643|NCT00784563|593460189|FG002|Year 3|Adverse Event|1|||
164296644|NCT00762164|593460190|FG000|Overall Study|Lost to Follow-up|1|||
164296645|NCT00762164|593460191|FG001|Overall Study|Lost to Follow-up|1|||
164296646|NCT00762164|593460190|FG000|Overall Study|Discontinued medication|2|||
164296647|NCT00762164|593460191|FG001|Overall Study|Discontinued medication|0|||
164296648|NCT00762164|593460190|FG000|Overall Study|Withdrawal by Subject|0|||
164296649|NCT00762164|593460191|FG001|Overall Study|Withdrawal by Subject|1|||
164296650|NCT01844765|593460194|FG000|Overall Study|Adverse Event|6|||
164296651|NCT01844765|593460195|FG001|Overall Study|Adverse Event|8|||
164296652|NCT01844765|593460194|FG000|Overall Study|Withdrawal by Subject|2|||
164296653|NCT01844765|593460195|FG001|Overall Study|Withdrawal by Subject|3|||
164296654|NCT01844765|593460194|FG000|Overall Study|Disease progression|1|||
164296655|NCT01844765|593460195|FG001|Overall Study|Disease progression|0|||
164296656|NCT01844765|593460194|FG000|Overall Study|Administrative problems|3|||
164296657|NCT01844765|593460195|FG001|Overall Study|Administrative problems|4|||
164296658|NCT01844765|593460194|FG000|Overall Study|Protocol deviation|2|||
164296659|NCT01844765|593460195|FG001|Overall Study|Protocol deviation|0|||
164296660|NCT01844765|593460194|FG000|Overall Study|Untreated|1|||
164296661|NCT01844765|593460195|FG001|Overall Study|Untreated|0|||
164296662|NCT02025179|593460196|FG000|Overall Study|Lost to Follow-up|0|||
164296663|NCT02025179|593460197|FG001|Overall Study|Lost to Follow-up|0|||
164296664|NCT02025179|593460198|FG002|Overall Study|Lost to Follow-up|1|||
164296665|NCT00556075|593460199|FG000|Overall Study|Lost to Follow-up|3|||
164296666|NCT00556075|593460200|FG001|Overall Study|Lost to Follow-up|0|||
164296667|NCT00556075|593460201|FG002|Overall Study|Lost to Follow-up|3|||
164296668|NCT00556075|593460199|FG000|Overall Study|Withdrawal by Subject|3|||
164296669|NCT00556075|593460200|FG001|Overall Study|Withdrawal by Subject|3|||
164296670|NCT00556075|593460201|FG002|Overall Study|Withdrawal by Subject|0|||
164296671|NCT00556075|593460199|FG000|Overall Study|Protocol Violation|1|||
164296672|NCT00556075|593460200|FG001|Overall Study|Protocol Violation|1|||
164296673|NCT00556075|593460201|FG002|Overall Study|Protocol Violation|3|||
164296674|NCT00556075|593460199|FG000|Overall Study|Not eligible|1|||
164296675|NCT00556075|593460200|FG001|Overall Study|Not eligible|1|||
164296676|NCT00556075|593460201|FG002|Overall Study|Not eligible|2|||
164296677|NCT00556075|593460199|FG000|Overall Study|Adverse Event|1|||
164296678|NCT00556075|593460200|FG001|Overall Study|Adverse Event|2|||
164296679|NCT00556075|593460201|FG002|Overall Study|Adverse Event|0|||
164296680|NCT00556075|593460199|FG000|Overall Study|Personal issues|4|||
164296681|NCT00556075|593460200|FG001|Overall Study|Personal issues|1|||
164296682|NCT00556075|593460201|FG002|Overall Study|Personal issues|0|||
164296683|NCT00556075|593460199|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
164296684|NCT00556075|593460200|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
164296685|NCT00556075|593460201|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
164296686|NCT00601835|593460202|FG000|Overall Study|Withdrawal by Subject|9|||
164296687|NCT00601835|593460203|FG001|Overall Study|Withdrawal by Subject|6|||
164296688|NCT00601835|593460202|FG000|Overall Study|Physician Decision|1|||
164296689|NCT00601835|593460203|FG001|Overall Study|Physician Decision|0|||
164296690|NCT00601835|593460202|FG000|Overall Study|Lost to Follow-up|37|||
164296691|NCT00601835|593460203|FG001|Overall Study|Lost to Follow-up|5|||
164296692|NCT00601835|593460202|FG000|Overall Study|Adverse Event|1|||
164296693|NCT00601835|593460203|FG001|Overall Study|Adverse Event|1|||
164296694|NCT00601835|593460202|FG000|Overall Study|Relocate|12|||
164296695|NCT00601835|593460203|FG001|Overall Study|Relocate|2|||
164296696|NCT01927497|593460204|FG000|Overall Study|Death|0|||
164587500|NCT00404768|594513850|FG000|Part C|Investigator discretion|0|||
164296697|NCT01927497|593460205|FG001|Overall Study|Death|1|||
164296698|NCT01927497|593460204|FG000|Overall Study|Protocol Violation|2|||
164296699|NCT01927497|593460205|FG001|Overall Study|Protocol Violation|0|||
164296700|NCT00395746|593460206|FG000|Overall Study|Adverse Event|5|||
164296701|NCT00395746|593460207|FG001|Overall Study|Adverse Event|2|||
164296702|NCT00395746|593460208|FG002|Overall Study|Adverse Event|2|||
164296703|NCT00395746|593460206|FG000|Overall Study|Protocol Violation|0|||
164296704|NCT00395746|593460207|FG001|Overall Study|Protocol Violation|1|||
164296705|NCT00395746|593460208|FG002|Overall Study|Protocol Violation|0|||
164296706|NCT00395746|593460206|FG000|Overall Study|Lack of Efficacy|2|||
164296707|NCT00395746|593460207|FG001|Overall Study|Lack of Efficacy|0|||
164296708|NCT00395746|593460208|FG002|Overall Study|Lack of Efficacy|17|||
164296709|NCT00395746|593460206|FG000|Overall Study|Hypoglycaemia|2|||
164296710|NCT00395746|593460207|FG001|Overall Study|Hypoglycaemia|1|||
164296711|NCT00395746|593460208|FG002|Overall Study|Hypoglycaemia|0|||
164296712|NCT00395746|593460206|FG000|Overall Study|Subject decision|0|||
164587501|NCT00404768|594513851|FG001|Part C|Investigator discretion|0|||
164587502|NCT00404768|594513852|FG002|Part C|Investigator discretion|0|||
164587503|NCT00404768|594513853|FG003|Part C|Investigator discretion|1|||
164296713|NCT00395746|593460207|FG001|Overall Study|Subject decision|0|||
164296714|NCT00395746|593460208|FG002|Overall Study|Subject decision|1|||
164296715|NCT00395746|593460206|FG000|Overall Study|Withdrawal of consent|0|||
164296716|NCT00395746|593460207|FG001|Overall Study|Withdrawal of consent|0|||
164296717|NCT00395746|593460208|FG002|Overall Study|Withdrawal of consent|1|||
164296718|NCT00395746|593460206|FG000|Overall Study|Difficultulty in use of device|0|||
164296719|NCT00395746|593460207|FG001|Overall Study|Difficultulty in use of device|0|||
164296720|NCT00395746|593460208|FG002|Overall Study|Difficultulty in use of device|1|||
164296721|NCT00395746|593460206|FG000|Overall Study|Unable to visit site on schedule|1|||
164296722|NCT00395746|593460207|FG001|Overall Study|Unable to visit site on schedule|0|||
164296723|NCT00395746|593460208|FG002|Overall Study|Unable to visit site on schedule|0|||
164296724|NCT04528641|593460209|FG000|Overall Study|Withdrawal by Subject|0|||
164296725|NCT04528641|593460210|FG001|Overall Study|Withdrawal by Subject|0|||
164296726|NCT04528641|593460211|FG002|Overall Study|Withdrawal by Subject|0|||
164296727|NCT04528641|593460212|FG003|Overall Study|Withdrawal by Subject|1|||
164296728|NCT04528641|593460213|FG004|Overall Study|Withdrawal by Subject|0|||
164296729|NCT04528641|593460214|FG005|Overall Study|Withdrawal by Subject|1|||
164296730|NCT03914417|593460215|FG000|Overall Study|Withdrawal by Subject|2|||
164296731|NCT00517296|593460220|FG000|Overall Study|Withdrawal by Subject|1|||
164296732|NCT00517296|593460221|FG001|Overall Study|Withdrawal by Subject|0|||
164296733|NCT04764162|593460224|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
164296734|NCT04764162|593460225|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
164296735|NCT00791934|593460226|FG000|Overall Study|Withdrawal by Subject|2|||
164296736|NCT00791934|593460226|FG000|Overall Study|Did not consent for extended follow-up|13|||
164296737|NCT01300728|593460227|FG000|Overall Study|Withdrawal by Subject|1|||
164296738|NCT01300728|593460228|FG001|Overall Study|Withdrawal by Subject|1|||
164296739|NCT01300728|593460227|FG000|Overall Study|Physician Decision|1|||
164296740|NCT01300728|593460228|FG001|Overall Study|Physician Decision|0|||
164296741|NCT00506350|593460229|FG000|Overall Study|Serious Adverse Event|1|||
164296742|NCT00506350|593460230|FG001|Overall Study|Serious Adverse Event|0|||
164296743|NCT00506350|593460231|FG002|Overall Study|Serious Adverse Event|0|||
164296744|NCT00506350|593460232|FG003|Overall Study|Serious Adverse Event|0|||
164296745|NCT00506350|593460233|FG004|Overall Study|Serious Adverse Event|0|||
164296746|NCT00506350|593460234|FG005|Overall Study|Serious Adverse Event|0|||
164296747|NCT00506350|593460235|FG006|Overall Study|Serious Adverse Event|0|||
164296748|NCT00506350|593460236|FG007|Overall Study|Serious Adverse Event|0|||
164296749|NCT00506350|593460237|FG008|Overall Study|Serious Adverse Event|0|||
164296750|NCT00506350|593460229|FG000|Overall Study|Adverse Event|0|||
164296751|NCT00506350|593460230|FG001|Overall Study|Adverse Event|0|||
164296752|NCT00506350|593460231|FG002|Overall Study|Adverse Event|0|||
164296753|NCT00506350|593460232|FG003|Overall Study|Adverse Event|0|||
164296754|NCT00506350|593460233|FG004|Overall Study|Adverse Event|0|||
164296755|NCT00506350|593460234|FG005|Overall Study|Adverse Event|0|||
164296756|NCT00506350|593460235|FG006|Overall Study|Adverse Event|0|||
164296757|NCT00506350|593460236|FG007|Overall Study|Adverse Event|1|||
164296758|NCT00506350|593460237|FG008|Overall Study|Adverse Event|1|||
164296759|NCT00506350|593460229|FG000|Overall Study|Protocol Violation|0|||
164296760|NCT00506350|593460230|FG001|Overall Study|Protocol Violation|0|||
164296761|NCT00506350|593460231|FG002|Overall Study|Protocol Violation|1|||
164296762|NCT00506350|593460232|FG003|Overall Study|Protocol Violation|0|||
164296763|NCT00506350|593460233|FG004|Overall Study|Protocol Violation|0|||
164296764|NCT00506350|593460234|FG005|Overall Study|Protocol Violation|0|||
164296765|NCT00506350|593460235|FG006|Overall Study|Protocol Violation|1|||
164296766|NCT00506350|593460236|FG007|Overall Study|Protocol Violation|0|||
164296767|NCT00506350|593460237|FG008|Overall Study|Protocol Violation|0|||
164296768|NCT00506350|593460229|FG000|Overall Study|Withdrawal by Subject|0|||
164296769|NCT00506350|593460230|FG001|Overall Study|Withdrawal by Subject|1|||
164296770|NCT00506350|593460231|FG002|Overall Study|Withdrawal by Subject|1|||
164296771|NCT00506350|593460232|FG003|Overall Study|Withdrawal by Subject|1|||
164296772|NCT00506350|593460233|FG004|Overall Study|Withdrawal by Subject|4|||
164296773|NCT00506350|593460234|FG005|Overall Study|Withdrawal by Subject|1|||
164296774|NCT00506350|593460235|FG006|Overall Study|Withdrawal by Subject|1|||
164296775|NCT00506350|593460236|FG007|Overall Study|Withdrawal by Subject|2|||
164296776|NCT00506350|593460237|FG008|Overall Study|Withdrawal by Subject|0|||
164296777|NCT00506350|593460229|FG000|Overall Study|Lost to Follow-up|1|||
164296778|NCT00506350|593460230|FG001|Overall Study|Lost to Follow-up|1|||
164296779|NCT00506350|593460231|FG002|Overall Study|Lost to Follow-up|1|||
164296780|NCT00506350|593460232|FG003|Overall Study|Lost to Follow-up|1|||
164296781|NCT00506350|593460233|FG004|Overall Study|Lost to Follow-up|2|||
164296782|NCT00506350|593460234|FG005|Overall Study|Lost to Follow-up|1|||
164296783|NCT00506350|593460235|FG006|Overall Study|Lost to Follow-up|0|||
164296784|NCT00506350|593460236|FG007|Overall Study|Lost to Follow-up|0|||
164296785|NCT00506350|593460237|FG008|Overall Study|Lost to Follow-up|2|||
164296786|NCT00506350|593460229|FG000|Overall Study|Medical Reason|0|||
164296787|NCT00506350|593460230|FG001|Overall Study|Medical Reason|0|||
164693597|NCT00739973|594899420|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
164296788|NCT00506350|593460231|FG002|Overall Study|Medical Reason|0|||
164296789|NCT00506350|593460232|FG003|Overall Study|Medical Reason|0|||
164296790|NCT00506350|593460233|FG004|Overall Study|Medical Reason|1|||
164296791|NCT00506350|593460234|FG005|Overall Study|Medical Reason|0|||
164296792|NCT00506350|593460235|FG006|Overall Study|Medical Reason|0|||
164296793|NCT00506350|593460236|FG007|Overall Study|Medical Reason|0|||
164296794|NCT00506350|593460237|FG008|Overall Study|Medical Reason|0|||
164296795|NCT00506350|593460229|FG000|Overall Study|Other|1|||
164296796|NCT00506350|593460230|FG001|Overall Study|Other|1|||
164296797|NCT00506350|593460231|FG002|Overall Study|Other|3|||
164296798|NCT00506350|593460232|FG003|Overall Study|Other|0|||
164296799|NCT00506350|593460233|FG004|Overall Study|Other|3|||
164296800|NCT00506350|593460234|FG005|Overall Study|Other|0|||
164296801|NCT00506350|593460235|FG006|Overall Study|Other|0|||
164296802|NCT00506350|593460236|FG007|Overall Study|Other|2|||
164296803|NCT00506350|593460237|FG008|Overall Study|Other|2|||
164296804|NCT00945009|593460238|FG000|Overall Study|Lack of Efficacy|10|||
164296805|NCT00945009|593460239|FG001|Overall Study|Lack of Efficacy|0|||
164296806|NCT00945009|593460240|FG002|Overall Study|Lack of Efficacy|0|||
164296807|NCT00945009|593460238|FG000|Overall Study|Physician Decision|21|||
164296808|NCT00945009|593460239|FG001|Overall Study|Physician Decision|4|||
164296809|NCT00945009|593460240|FG002|Overall Study|Physician Decision|3|||
164296810|NCT00945009|593460238|FG000|Overall Study|Protocol Violation|6|||
164296811|NCT00945009|593460239|FG001|Overall Study|Protocol Violation|1|||
164296812|NCT00945009|593460240|FG002|Overall Study|Protocol Violation|0|||
164296813|NCT00945009|593460238|FG000|Overall Study|Withdrawal by Subject|1|||
164296814|NCT00945009|593460239|FG001|Overall Study|Withdrawal by Subject|0|||
164296815|NCT00945009|593460240|FG002|Overall Study|Withdrawal by Subject|0|||
164296816|NCT00945009|593460238|FG000|Overall Study|Ineligible|6|||
164296817|NCT00945009|593460239|FG001|Overall Study|Ineligible|1|||
164296818|NCT00945009|593460240|FG002|Overall Study|Ineligible|0|||
164296819|NCT00945009|593460238|FG000|Overall Study|Inevaluable|0|||
164296820|NCT00945009|593460239|FG001|Overall Study|Inevaluable|1|||
164296821|NCT00945009|593460240|FG002|Overall Study|Inevaluable|0|||
164296822|NCT00945009|593460238|FG000|Overall Study|Refusal of further protocol|1|||
164296823|NCT00945009|593460239|FG001|Overall Study|Refusal of further protocol|0|||
164296824|NCT00945009|593460240|FG002|Overall Study|Refusal of further protocol|0|||
164296825|NCT04972162|593460243|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
164296826|NCT04972162|593460244|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
164296827|NCT00781768|593461884|FG000|Overall Study|Not transplanted.|0|||
164296828|NCT00781768|593461885|FG001|Overall Study|Not transplanted.|2|||
164296829|NCT02458313|593461886|FG000|Overall Study|Withdrawal by Subject|6|||
164296830|NCT02458313|593461887|FG001|Overall Study|Withdrawal by Subject|8|||
164296831|NCT02458313|593461886|FG000|Overall Study|Excluded for motion during MRI|1|||
164296832|NCT02458313|593461887|FG001|Overall Study|Excluded for motion during MRI|2|||
164296833|NCT00199381|593461891|FG000|Overall Study|Withdrawal by Subject|38|||
164296834|NCT00199381|593461891|FG000|Overall Study|Adverse Event|73|||
164296835|NCT00199381|593461891|FG000|Overall Study|Protocol Violation|6|||
164296836|NCT00199381|593461891|FG000|Overall Study|Lack of Efficacy|27|||
164296837|NCT00199381|593461891|FG000|Overall Study|Not including due to early termination|37|||
164296838|NCT00199381|593461891|FG000|Overall Study|Study termination by Sponsor|323|||
164296839|NCT00385671|593461893|FG000|Overall Study|Adverse Event|14|||
164296840|NCT00385671|593461894|FG001|Overall Study|Adverse Event|27|||
164296841|NCT00385671|593461895|FG002|Overall Study|Adverse Event|18|||
164296842|NCT00385671|593461893|FG000|Overall Study|Lack of Efficacy|5|||
164296843|NCT00385671|593461894|FG001|Overall Study|Lack of Efficacy|9|||
164296844|NCT00385671|593461895|FG002|Overall Study|Lack of Efficacy|5|||
164296845|NCT00385671|593461893|FG000|Overall Study|Lost to Follow-up|6|||
164693598|NCT00739973|594899421|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
164296846|NCT00385671|593461894|FG001|Overall Study|Lost to Follow-up|6|||
164347547|NCT04171531|593648847|FG000|Overall Study|Consent only through 6 months|1|||
164347548|NCT04171531|593648848|FG001|Overall Study|Consent only through 6 months|1|||
164347549|NCT04171531|593648847|FG000|Overall Study|Insurance did not cover procedure|0|||
164347550|NCT04171531|593648848|FG001|Overall Study|Insurance did not cover procedure|1|||
164347551|NCT04171531|593648847|FG000|Overall Study|Physician Decision|0|||
164693599|NCT00739973|594899422|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
164693600|NCT00739973|594899423|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
164296847|NCT00385671|593461895|FG002|Overall Study|Lost to Follow-up|5|||
164296848|NCT00385671|593461893|FG000|Overall Study|Physician Decision|2|||
164296849|NCT00385671|593461894|FG001|Overall Study|Physician Decision|1|||
164296850|NCT00385671|593461895|FG002|Overall Study|Physician Decision|2|||
164296851|NCT00385671|593461893|FG000|Overall Study|Protocol Violation|5|||
164296852|NCT00385671|593461894|FG001|Overall Study|Protocol Violation|2|||
164296853|NCT00385671|593461895|FG002|Overall Study|Protocol Violation|1|||
164347552|NCT04171531|593648848|FG001|Overall Study|Physician Decision|3|||
164296854|NCT00385671|593461893|FG000|Overall Study|Sponsor Decision|2|||
164296855|NCT00385671|593461894|FG001|Overall Study|Sponsor Decision|2|||
164296856|NCT00385671|593461895|FG002|Overall Study|Sponsor Decision|1|||
164587504|NCT00404768|594513850|FG000|Part C|Researcher suspended study medication|0|||
164587505|NCT00404768|594513851|FG001|Part C|Researcher suspended study medication|0|||
164296857|NCT00385671|593461893|FG000|Overall Study|Withdrawal by Subject|4|||
164296858|NCT00385671|593461894|FG001|Overall Study|Withdrawal by Subject|4|||
164296859|NCT00385671|593461895|FG002|Overall Study|Withdrawal by Subject|4|||
164296860|NCT02608684|593461896|FG000|Overall Study|Physician Decision|2|||
164296861|NCT02608684|593461896|FG000|Overall Study|Withdrawal by Subject|1|||
164296862|NCT00751296|593461897|FG000|Overall Study|Adverse Event|2|||
164296863|NCT01972217|593461898|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
164296864|NCT01972217|593461899|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
164296865|NCT01972217|593461900|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
164296866|NCT01972217|593461901|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
164296867|NCT01972217|593461898|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
164296868|NCT01972217|593461899|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
164296869|NCT01972217|593461900|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
164296870|NCT01972217|593461901|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
164296871|NCT01972217|593461898|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
164296872|NCT01972217|593461899|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
164296873|NCT01972217|593461900|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
164296874|NCT01972217|593461901|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
164296875|NCT01972217|593461898|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
164296876|NCT01972217|593461899|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
164296877|NCT01972217|593461900|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
164296878|NCT01972217|593461901|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
164296879|NCT01972217|593461898|FG000|Part B Double-blind, Randomised Period|Death|0|||
164296880|NCT01972217|593461899|FG001|Part B Double-blind, Randomised Period|Death|0|||
164296881|NCT01972217|593461900|FG002|Part B Double-blind, Randomised Period|Death|43|||
164296882|NCT01972217|593461901|FG003|Part B Double-blind, Randomised Period|Death|44|||
164296883|NCT01972217|593461898|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
164296884|NCT01972217|593461899|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
164296885|NCT01972217|593461900|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
164296886|NCT01972217|593461901|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
164296887|NCT01972217|593461898|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
164296888|NCT01972217|593461899|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
164296889|NCT01972217|593461900|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
164296890|NCT01972217|593461901|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
164296891|NCT01972217|593461898|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
164296892|NCT01972217|593461899|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
164296893|NCT01972217|593461900|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
164296894|NCT01972217|593461901|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
164296895|NCT01972217|593461898|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
164296896|NCT01972217|593461899|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
164296897|NCT01972217|593461900|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
164296898|NCT01972217|593461901|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
164296899|NCT03453164|593461904|FG000|Overall Study|Lack of Efficacy|16|||
164296900|NCT03453164|593461904|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
164296901|NCT01428258|593461905|FG000|Intervention 1|Withdrawal by Subject|2|||
164296902|NCT01428258|593461906|FG001|Intervention 1|Withdrawal by Subject|0|||
164296903|NCT03566511|593461907|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
164296904|NCT03566511|593461908|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
164296905|NCT02939287|593461913|FG000|Overall Study|met exclusion criteria|1|||
164296906|NCT02939287|593461914|FG001|Overall Study|met exclusion criteria|1|||
164296907|NCT02939287|593461915|FG002|Overall Study|met exclusion criteria|1|||
164296908|NCT02939287|593461913|FG000|Overall Study|Did not complete survey|2|||
164296909|NCT02939287|593461914|FG001|Overall Study|Did not complete survey|2|||
164296910|NCT02939287|593461915|FG002|Overall Study|Did not complete survey|0|||
164296911|NCT02939287|593461913|FG000|Overall Study|Withdrawal by Subject|1|||
164296912|NCT02939287|593461914|FG001|Overall Study|Withdrawal by Subject|1|||
164296913|NCT02939287|593461915|FG002|Overall Study|Withdrawal by Subject|0|||
164296914|NCT04026113|593461916|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
164296915|NCT04026113|593461917|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
164296916|NCT04026113|593461918|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
164347553|NCT04171531|593648847|FG000|Overall Study|Withdrawal by Subject|1|||
164587506|NCT00404768|594513852|FG002|Part C|Researcher suspended study medication|0|||
164587507|NCT00404768|594513853|FG003|Part C|Researcher suspended study medication|1|||
164587508|NCT04359823|594515837|FG000|Overall Study|Lost to Follow-up|0|||
164587509|NCT04359823|594515838|FG001|Overall Study|Lost to Follow-up|1|||
164347554|NCT04171531|593648848|FG001|Overall Study|Withdrawal by Subject|5|||
164347555|NCT05537883|593648851|FG000|Overall Study|revisional surgery|4|||
164347556|NCT05537883|593648852|FG001|Overall Study|revisional surgery|2|||
164347557|NCT05537883|593648851|FG000|Overall Study|surgeries were cancelled|0|||
164347558|NCT05537883|593648852|FG001|Overall Study|surgeries were cancelled|2|||
164347559|NCT05537883|593648851|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
164347560|NCT05537883|593648852|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
164347561|NCT02296320|593648854|FG000|Overall Study|Withdrawal by Subject|4|||
164347562|NCT02296320|593648855|FG001|Overall Study|Withdrawal by Subject|0|||
164347563|NCT02296320|593648856|FG002|Overall Study|Withdrawal by Subject|2|||
164347564|NCT02296320|593648854|FG000|Overall Study|Death|24|||
164347565|NCT02296320|593648855|FG001|Overall Study|Death|3|||
164347566|NCT02296320|593648856|FG002|Overall Study|Death|27|||
164347567|NCT02296320|593648854|FG000|Overall Study|Lost to Follow-up|5|||
164347568|NCT02296320|593648855|FG001|Overall Study|Lost to Follow-up|2|||
164347569|NCT02296320|593648856|FG002|Overall Study|Lost to Follow-up|7|||
164347570|NCT02296320|593648854|FG000|Overall Study|Not treated|2|||
164347571|NCT02296320|593648855|FG001|Overall Study|Not treated|0|||
164347572|NCT02296320|593648856|FG002|Overall Study|Not treated|0|||
164347573|NCT02296320|593648854|FG000|Overall Study|Not - specified|0|||
164347574|NCT02296320|593648855|FG001|Overall Study|Not - specified|0|||
164435111|NCT03536884|593960871|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
164435112|NCT03536884|593960872|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
164435113|NCT03536884|593960873|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
164435114|NCT03536884|593960874|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
164435115|NCT03536884|593960875|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
164435116|NCT03536884|593960876|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
164435117|NCT03536884|593960877|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
164435118|NCT03536884|593960878|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
164435119|NCT03536884|593960867|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
164435120|NCT03536884|593960868|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
164435121|NCT03536884|593960869|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
164435122|NCT03536884|593960870|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
164435123|NCT03536884|593960871|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
164435124|NCT03536884|593960872|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
164435125|NCT03536884|593960873|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
164435126|NCT03536884|593960874|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
164435127|NCT03536884|593960875|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
164435128|NCT03536884|593960876|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
164435129|NCT03536884|593960877|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
164435130|NCT03536884|593960878|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
164435131|NCT03536884|593960867|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
164435132|NCT03536884|593960868|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
164435133|NCT03536884|593960869|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
164435134|NCT03536884|593960870|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
164435135|NCT03536884|593960871|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
164435136|NCT03536884|593960872|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
164435137|NCT03536884|593960873|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
164435138|NCT03536884|593960874|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
164435139|NCT03536884|593960875|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
164435140|NCT03536884|593960876|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
164435141|NCT03536884|593960877|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
164435142|NCT03536884|593960878|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
164435143|NCT03536884|593960867|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
164693601|NCT00739973|594899424|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
164693602|NCT00739973|594899425|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
164347575|NCT02296320|593648856|FG002|Overall Study|Not - specified|1|||
164347576|NCT05229406|593648857|FG000|Overall Study|Withdrawal by Subject|1|||
164347577|NCT05229406|593648858|FG001|Overall Study|Withdrawal by Subject|2|||
164347578|NCT01697566|593648861|FG000|Overall Study|Withdrawal by Subject|0|||
164347579|NCT01697566|593648862|FG001|Overall Study|Withdrawal by Subject|0|||
164347580|NCT01697566|593648863|FG002|Overall Study|Withdrawal by Subject|1|||
164347581|NCT01697566|593648864|FG003|Overall Study|Withdrawal by Subject|1|||
164347582|NCT01697566|593648861|FG000|Overall Study|Final biopsy not obtained|0|||
164347583|NCT01697566|593648862|FG001|Overall Study|Final biopsy not obtained|0|||
164347584|NCT01697566|593648863|FG002|Overall Study|Final biopsy not obtained|1|||
164347585|NCT01697566|593648864|FG003|Overall Study|Final biopsy not obtained|0|||
164347586|NCT01930123|593648865|FG000|Overall Study|Adverse Event|1|||
164296917|NCT04026113|593461919|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
164296918|NCT04026113|593461916|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
164296919|NCT04026113|593461917|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
164587510|NCT04359823|594515837|FG000|Overall Study|Withdrawal by Subject|0|||
164587511|NCT04359823|594515838|FG001|Overall Study|Withdrawal by Subject|1|||
164587512|NCT01850563|594515839|FG000|Overall Study|Not eligible|3|||
164587513|NCT01850563|594515840|FG001|Overall Study|Not eligible|0|||
164587514|NCT03132805|594515844|FG000|Overall Study|Lost to Follow-up|142|||
164587515|NCT03132805|594515845|FG001|Overall Study|Lost to Follow-up|141|||
164435144|NCT03536884|593960868|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
164435145|NCT03536884|593960869|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
164435146|NCT03536884|593960870|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
164435147|NCT03536884|593960871|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
164296920|NCT04026113|593461918|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
164296921|NCT04026113|593461919|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
164296922|NCT04026113|593461916|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
164296923|NCT04026113|593461917|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164296924|NCT04026113|593461918|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
164296925|NCT04026113|593461919|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164296926|NCT04026113|593461916|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
164296927|NCT04026113|593461917|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
164296928|NCT04026113|593461918|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
164296929|NCT04026113|593461919|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
164296930|NCT04026113|593461916|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
164296931|NCT04026113|593461917|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
164296932|NCT04026113|593461918|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
164296933|NCT04026113|593461919|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
164296934|NCT04026113|593461916|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
164296935|NCT04026113|593461917|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
164435148|NCT03536884|593960872|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
164435149|NCT03536884|593960873|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
164435150|NCT03536884|593960874|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
164435151|NCT03536884|593960875|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
164435152|NCT03536884|593960876|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
164435153|NCT03536884|593960877|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
164435154|NCT03536884|593960878|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
164435155|NCT03536884|593960867|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
164435156|NCT03536884|593960868|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
164435157|NCT03536884|593960869|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
164435158|NCT03536884|593960870|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
164435159|NCT03536884|593960871|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
164435160|NCT03536884|593960872|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
164435161|NCT03536884|593960873|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
164435162|NCT03536884|593960874|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
164435163|NCT03536884|593960875|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
164587516|NCT03132805|594515846|FG002|Overall Study|Lost to Follow-up|113|||
164587517|NCT03151148|594515847|FG000|Overall Study|Lost to Follow-up|1|||
164587518|NCT03151148|594515848|FG001|Overall Study|Lost to Follow-up|0|||
164296936|NCT04026113|593461918|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
164296937|NCT04026113|593461919|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
164587519|NCT03151148|594515847|FG000|Overall Study|Withdrawal by Subject|1|||
164587520|NCT03151148|594515848|FG001|Overall Study|Withdrawal by Subject|0|||
164587521|NCT01228071|594515849|FG000|Overall Study|Protocol Violation|1|||
164296938|NCT04026113|593461916|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
164296939|NCT04026113|593461917|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
164296940|NCT04026113|593461918|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
164296941|NCT04026113|593461919|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
164296942|NCT04026113|593461916|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
164296943|NCT04026113|593461917|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
164296944|NCT04026113|593461918|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
164296945|NCT04026113|593461919|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
164296946|NCT04026113|593461916|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
164296947|NCT04026113|593461917|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
164296948|NCT04026113|593461918|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
164296949|NCT04026113|593461919|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
164296950|NCT01709721|593461920|FG000|Open Label Phase|Withdrawal by Subject|0|||
164296951|NCT01709721|593461921|FG001|Open Label Phase|Withdrawal by Subject|0|||
164296952|NCT01709721|593461922|FG002|Open Label Phase|Withdrawal by Subject|5|||
164296953|NCT01709721|593461920|FG000|Open Label Phase|Adverse Event|0|||
164296954|NCT01709721|593461921|FG001|Open Label Phase|Adverse Event|0|||
164296955|NCT01709721|593461922|FG002|Open Label Phase|Adverse Event|8|||
164296956|NCT01709721|593461920|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
164296957|NCT01709721|593461921|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
164296958|NCT01709721|593461922|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
164296959|NCT01709721|593461920|FG000|Open Label Phase|Investigator Decision|0|||
164296960|NCT01709721|593461921|FG001|Open Label Phase|Investigator Decision|0|||
164296961|NCT01709721|593461922|FG002|Open Label Phase|Investigator Decision|1|||
164296962|NCT01709721|593461920|FG000|Open Label Phase|Sponsor Decision|0|||
164296963|NCT01709721|593461921|FG001|Open Label Phase|Sponsor Decision|0|||
164296964|NCT01709721|593461922|FG002|Open Label Phase|Sponsor Decision|2|||
164296965|NCT01709721|593461920|FG000|Open Label Phase|Protocol Violation|0|||
164296966|NCT01709721|593461921|FG001|Open Label Phase|Protocol Violation|0|||
164296967|NCT01709721|593461922|FG002|Open Label Phase|Protocol Violation|1|||
164296968|NCT01709721|593461920|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
164296969|NCT01709721|593461921|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
164296970|NCT01709721|593461922|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
164296971|NCT01709721|593461920|FG000|Open Label Phase|Inadequate Pain Control|0|||
164296972|NCT01709721|593461921|FG001|Open Label Phase|Inadequate Pain Control|0|||
164296973|NCT01709721|593461922|FG002|Open Label Phase|Inadequate Pain Control|37|||
164296974|NCT01709721|593461920|FG000|Open Label Phase|Other, Specify in text field in database|0|||
164296975|NCT01709721|593461921|FG001|Open Label Phase|Other, Specify in text field in database|0|||
164296976|NCT01709721|593461922|FG002|Open Label Phase|Other, Specify in text field in database|14|||
164296977|NCT01709721|593461920|FG000|Randomized Phase|Adverse Event|0|||
164296978|NCT01709721|593461921|FG001|Randomized Phase|Adverse Event|1|||
164296979|NCT01709721|593461922|FG002|Randomized Phase|Adverse Event|0|||
164296980|NCT01709721|593461920|FG000|Randomized Phase|Lost to Follow-up|1|||
164296981|NCT01709721|593461921|FG001|Randomized Phase|Lost to Follow-up|0|||
164296982|NCT01709721|593461922|FG002|Randomized Phase|Lost to Follow-up|0|||
164347587|NCT01930123|593648866|FG001|Overall Study|Adverse Event|0|||
164347588|NCT01930123|593648865|FG000|Overall Study|Physician Decision|21|||
164347589|NCT01930123|593648866|FG001|Overall Study|Physician Decision|8|||
164347590|NCT01930123|593648865|FG000|Overall Study|Withdrawal by Subject|1|||
164347591|NCT01930123|593648866|FG001|Overall Study|Withdrawal by Subject|0|||
164347592|NCT01447433|593648867|FG000|Overall Study|Lost to Follow-up|0|||
164347593|NCT01447433|593648868|FG001|Overall Study|Lost to Follow-up|2|||
164347594|NCT01447433|593648867|FG000|Overall Study|Withdrawal by Subject|3|||
164296983|NCT01709721|593461920|FG000|Randomized Phase|Inadequate Pain Control|1|||
164296984|NCT01709721|593461921|FG001|Randomized Phase|Inadequate Pain Control|2|||
164296985|NCT01709721|593461922|FG002|Randomized Phase|Inadequate Pain Control|0|||
164296986|NCT01709721|593461920|FG000|Randomized Phase|Other, Specify text field in database|1|||
164296987|NCT01709721|593461921|FG001|Randomized Phase|Other, Specify text field in database|3|||
164296988|NCT01709721|593461922|FG002|Randomized Phase|Other, Specify text field in database|0|||
164296989|NCT02558894|593461925|FG000|Overall Study|Death; any cause, entire study duration|28|||
164296990|NCT02558894|593461926|FG001|Overall Study|Death; any cause, entire study duration|31|||
164296991|NCT02558894|593461925|FG000|Overall Study|Withdrawal by Subject|2|||
164296992|NCT02558894|593461926|FG001|Overall Study|Withdrawal by Subject|1|||
164296993|NCT02558894|593461925|FG000|Overall Study|Closure of Part A|2|||
164296994|NCT02558894|593461926|FG001|Overall Study|Closure of Part A|1|||
164296995|NCT05236270|593461930|FG000|Overall Study|Lost to Follow-up|3|||
164296996|NCT05236270|593461931|FG001|Overall Study|Lost to Follow-up|2|||
164296997|NCT05236270|593461932|FG002|Overall Study|Lost to Follow-up|0|||
164296998|NCT05236270|593461933|FG003|Overall Study|Lost to Follow-up|0|||
164296999|NCT05236270|593461934|FG004|Overall Study|Lost to Follow-up|2|||
164297000|NCT05236270|593461935|FG005|Overall Study|Lost to Follow-up|0|||
164297001|NCT05236270|593461936|FG006|Overall Study|Lost to Follow-up|1|||
164347595|NCT01447433|593648868|FG001|Overall Study|Withdrawal by Subject|3|||
164347596|NCT01447433|593648867|FG000|Overall Study|Protocol Violation|1|||
164347597|NCT01447433|593648868|FG001|Overall Study|Protocol Violation|1|||
164347598|NCT00729651|593648871|FG000|Overall Study|Withdrawal by Subject|5|||
164347599|NCT00729651|593648872|FG001|Overall Study|Withdrawal by Subject|6|||
164347600|NCT00729651|593648871|FG000|Overall Study|Lost to Follow-up|5|||
164347601|NCT00729651|593648872|FG001|Overall Study|Lost to Follow-up|4|||
164347602|NCT00729651|593648871|FG000|Overall Study|Protocol Violation|0|||
164347603|NCT00729651|593648872|FG001|Overall Study|Protocol Violation|1|||
164347604|NCT00729651|593648871|FG000|Overall Study|Adverse Event|7|||
164347605|NCT00729651|593648872|FG001|Overall Study|Adverse Event|3|||
164347606|NCT00729651|593648871|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
164347607|NCT00729651|593648872|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
164347608|NCT00729651|593648871|FG000|Overall Study|Subject's private reason|2|||
164347609|NCT00729651|593648872|FG001|Overall Study|Subject's private reason|0|||
164347610|NCT03310021|593648873|FG000|Overall Study|Withdrawal by Subject|0|||
164347611|NCT03310021|593648874|FG001|Overall Study|Withdrawal by Subject|0|||
164347612|NCT03310021|593648875|FG002|Overall Study|Withdrawal by Subject|0|||
164347613|NCT03310021|593648876|FG003|Overall Study|Withdrawal by Subject|0|||
164347614|NCT03310021|593648877|FG004|Overall Study|Withdrawal by Subject|0|||
164347615|NCT03310021|593648878|FG005|Overall Study|Withdrawal by Subject|0|||
164347616|NCT03310021|593648879|FG006|Overall Study|Withdrawal by Subject|1|||
164347617|NCT03310021|593648880|FG007|Overall Study|Withdrawal by Subject|0|||
164347618|NCT03310021|593648881|FG008|Overall Study|Withdrawal by Subject|0|||
164347619|NCT03310021|593648882|FG009|Overall Study|Withdrawal by Subject|0|||
164347620|NCT03310021|593648883|FG010|Overall Study|Withdrawal by Subject|0|||
164347621|NCT03310021|593648884|FG011|Overall Study|Withdrawal by Subject|0|||
164347622|NCT03310021|593648885|FG012|Overall Study|Withdrawal by Subject|0|||
164347623|NCT03310021|593648886|FG013|Overall Study|Withdrawal by Subject|0|||
164347624|NCT03310021|593648887|FG014|Overall Study|Withdrawal by Subject|0|||
164347625|NCT03310021|593648888|FG015|Overall Study|Withdrawal by Subject|0|||
164347626|NCT03310021|593648889|FG016|Overall Study|Withdrawal by Subject|0|||
164347627|NCT03310021|593648890|FG017|Overall Study|Withdrawal by Subject|0|||
164347628|NCT03310021|593648891|FG018|Overall Study|Withdrawal by Subject|0|||
164347629|NCT03310021|593648892|FG019|Overall Study|Withdrawal by Subject|0|||
164347630|NCT03310021|593648873|FG000|Overall Study|Lost to Follow-up|0|||
164347631|NCT03310021|593648874|FG001|Overall Study|Lost to Follow-up|0|||
164347632|NCT03310021|593648875|FG002|Overall Study|Lost to Follow-up|0|||
164347633|NCT03310021|593648876|FG003|Overall Study|Lost to Follow-up|0|||
164347634|NCT03310021|593648877|FG004|Overall Study|Lost to Follow-up|0|||
164347635|NCT03310021|593648878|FG005|Overall Study|Lost to Follow-up|0|||
164347636|NCT03310021|593648879|FG006|Overall Study|Lost to Follow-up|0|||
164347637|NCT03310021|593648880|FG007|Overall Study|Lost to Follow-up|0|||
164347638|NCT03310021|593648881|FG008|Overall Study|Lost to Follow-up|0|||
164347639|NCT03310021|593648882|FG009|Overall Study|Lost to Follow-up|0|||
164347640|NCT03310021|593648883|FG010|Overall Study|Lost to Follow-up|1|||
164347641|NCT03310021|593648884|FG011|Overall Study|Lost to Follow-up|0|||
164347642|NCT03310021|593648885|FG012|Overall Study|Lost to Follow-up|0|||
164347643|NCT03310021|593648886|FG013|Overall Study|Lost to Follow-up|0|||
164347644|NCT03310021|593648887|FG014|Overall Study|Lost to Follow-up|0|||
164297002|NCT05236270|593461937|FG007|Overall Study|Lost to Follow-up|3|||
164297003|NCT02476617|593461938|FG000|Overall Study|Adverse Event|1|||
164297004|NCT02476617|593461938|FG000|Overall Study|Lost to Follow-up|1|||
164297005|NCT01383928|593461939|FG000|Overall Study|Initiation of ASCT|2|||
164297006|NCT01383928|593461940|FG001|Overall Study|Initiation of ASCT|1|||
164347645|NCT03310021|593648888|FG015|Overall Study|Lost to Follow-up|0|||
164347646|NCT03310021|593648889|FG016|Overall Study|Lost to Follow-up|0|||
164347647|NCT03310021|593648890|FG017|Overall Study|Lost to Follow-up|0|||
164347648|NCT03310021|593648891|FG018|Overall Study|Lost to Follow-up|0|||
164297007|NCT01383928|593461941|FG002|Overall Study|Initiation of ASCT|18|||
164297008|NCT01383928|593461939|FG000|Overall Study|Adverse Event|1|||
164297009|NCT01383928|593461940|FG001|Overall Study|Adverse Event|2|||
164297010|NCT01383928|593461941|FG002|Overall Study|Adverse Event|8|||
164297011|NCT01383928|593461939|FG000|Overall Study|Other|1|||
164297012|NCT01383928|593461940|FG001|Overall Study|Other|3|||
164297013|NCT01383928|593461941|FG002|Overall Study|Other|4|||
164297014|NCT01383928|593461939|FG000|Overall Study|Progressive Disease|1|||
164297015|NCT01383928|593461940|FG001|Overall Study|Progressive Disease|1|||
164297016|NCT01383928|593461941|FG002|Overall Study|Progressive Disease|5|||
164297017|NCT01383928|593461939|FG000|Overall Study|Withdrawal by Subject|0|||
164297018|NCT01383928|593461940|FG001|Overall Study|Withdrawal by Subject|0|||
164297019|NCT01383928|593461941|FG002|Overall Study|Withdrawal by Subject|4|||
164297020|NCT01383928|593461939|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
164297021|NCT01383928|593461940|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
164297022|NCT01383928|593461941|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
164297023|NCT03486912|593461942|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
164297024|NCT03486912|593461943|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
164297025|NCT03486912|593461944|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
164297026|NCT03486912|593461945|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
164297027|NCT03486912|593461942|FG000|Treatment Period|Withdrawal by Subject|3|||
164297028|NCT03486912|593461943|FG001|Treatment Period|Withdrawal by Subject|3|||
164297029|NCT03486912|593461944|FG002|Treatment Period|Withdrawal by Subject|3|||
164297030|NCT03486912|593461945|FG003|Treatment Period|Withdrawal by Subject|2|||
164297031|NCT03486912|593461942|FG000|Treatment Period|Other Reasons|0|||
164297032|NCT03486912|593461943|FG001|Treatment Period|Other Reasons|2|||
164297033|NCT03486912|593461944|FG002|Treatment Period|Other Reasons|1|||
164297034|NCT03486912|593461945|FG003|Treatment Period|Other Reasons|1|||
164297035|NCT03486912|593461942|FG000|Treatment Period|Adverse Event|0|||
164297036|NCT03486912|593461943|FG001|Treatment Period|Adverse Event|1|||
164297037|NCT03486912|593461944|FG002|Treatment Period|Adverse Event|1|||
164297038|NCT03486912|593461945|FG003|Treatment Period|Adverse Event|0|||
164297039|NCT03486912|593461942|FG000|Treatment Period|Lost to Follow-up|1|||
164297040|NCT03486912|593461943|FG001|Treatment Period|Lost to Follow-up|0|||
164297041|NCT03486912|593461944|FG002|Treatment Period|Lost to Follow-up|0|||
164297042|NCT03486912|593461945|FG003|Treatment Period|Lost to Follow-up|2|||
164297043|NCT02491684|593461946|FG000|Treatment Phase|Adverse Event|2|||
164297044|NCT02491684|593461947|FG001|Treatment Phase|Adverse Event|2|||
164297045|NCT02491684|593461946|FG000|Treatment Phase|Incorrect randomisation|1|||
164297046|NCT02491684|593461947|FG001|Treatment Phase|Incorrect randomisation|0|||
164297047|NCT02491684|593461946|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
164297048|NCT02491684|593461947|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
164297049|NCT01149096|593461948|FG000|Overall Study|Lost to Follow-up|0|||
164297050|NCT01149096|593461949|FG001|Overall Study|Lost to Follow-up|1|||
164297051|NCT01263769|593461950|FG000|Overall Study|Non-Compliant with treatment|1|||
164297052|NCT03267277|593461951|FG000|Overall Study|Withdrawal by Subject|1|||
164297053|NCT01451606|593461952|FG000|Overall Study|Withdrawal by Subject|4|||
164297054|NCT01451606|593461953|FG001|Overall Study|Withdrawal by Subject|3|||
164297055|NCT00468169|593461954|FG000|Overall Study|Withdrawal by Subject|1|||
164297056|NCT00468169|593461955|FG001|Overall Study|Withdrawal by Subject|0|||
164297057|NCT01126749|593461960|FG000|Phase 1b|Other|0|||
164297058|NCT01126749|593461961|FG001|Phase 1b|Other|1|||
164297059|NCT01126749|593461962|FG002|Phase 1b|Other|0|||
164297060|NCT01126749|593461963|FG003|Phase 1b|Other|0|||
164297061|NCT01126749|593461960|FG000|Phase 1b|Withdrawal by Subject|0|||
164297062|NCT01126749|593461961|FG001|Phase 1b|Withdrawal by Subject|1|||
164297063|NCT01126749|593461962|FG002|Phase 1b|Withdrawal by Subject|0|||
164297064|NCT01126749|593461963|FG003|Phase 1b|Withdrawal by Subject|0|||
164297065|NCT01126749|593461960|FG000|Phase 1b|Death|3|||
164297066|NCT01126749|593461961|FG001|Phase 1b|Death|4|||
164297067|NCT01126749|593461962|FG002|Phase 1b|Death|0|||
164297068|NCT01126749|593461963|FG003|Phase 1b|Death|0|||
164297069|NCT01126749|593461960|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
164297070|NCT01126749|593461961|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
164297071|NCT01126749|593461962|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
164587522|NCT01228071|594515849|FG000|Overall Study|Withdrawal by Subject|1|||
164297072|NCT01126749|593461963|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
164587523|NCT04439838|594515850|FG000|Overall Study|Withdrawal by Subject|0|||
164297073|NCT01126749|593461960|FG000|Phase 2|Study Termination by Sponsor|0|||
164587524|NCT04439838|594515851|FG001|Overall Study|Withdrawal by Subject|0|||
164297074|NCT01126749|593461961|FG001|Phase 2|Study Termination by Sponsor|0|||
164297075|NCT01126749|593461962|FG002|Phase 2|Study Termination by Sponsor|12|||
164297076|NCT01126749|593461963|FG003|Phase 2|Study Termination by Sponsor|6|||
164297077|NCT01126749|593461960|FG000|Phase 2|Other|0|||
164297078|NCT01126749|593461961|FG001|Phase 2|Other|0|||
164297079|NCT01126749|593461962|FG002|Phase 2|Other|4|||
164297080|NCT01126749|593461963|FG003|Phase 2|Other|2|||
164297081|NCT01126749|593461960|FG000|Phase 2|Withdrawal by Subject|0|||
164297082|NCT01126749|593461961|FG001|Phase 2|Withdrawal by Subject|0|||
164297083|NCT01126749|593461962|FG002|Phase 2|Withdrawal by Subject|0|||
164297084|NCT01126749|593461963|FG003|Phase 2|Withdrawal by Subject|2|||
164297085|NCT01126749|593461960|FG000|Phase 2|Lost to Follow-up|0|||
164297086|NCT01126749|593461961|FG001|Phase 2|Lost to Follow-up|0|||
164297087|NCT01126749|593461962|FG002|Phase 2|Lost to Follow-up|0|||
164297088|NCT01126749|593461963|FG003|Phase 2|Lost to Follow-up|1|||
164297089|NCT01126749|593461960|FG000|Phase 2|Death|0|||
164297090|NCT01126749|593461961|FG001|Phase 2|Death|0|||
164297091|NCT01126749|593461962|FG002|Phase 2|Death|22|||
164297092|NCT01126749|593461963|FG003|Phase 2|Death|22|||
164297093|NCT01126749|593461960|FG000|Phase 2|Adverse Event|0|||
164297094|NCT01126749|593461961|FG001|Phase 2|Adverse Event|0|||
164297095|NCT01126749|593461962|FG002|Phase 2|Adverse Event|0|||
164297096|NCT01126749|593461963|FG003|Phase 2|Adverse Event|1|||
164297097|NCT03668873|593461964|FG000|Overall Study|Lost to Follow-up|6|||
164297098|NCT03668873|593461965|FG001|Overall Study|Lost to Follow-up|3|||
164297099|NCT02183675|593461966|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
164297100|NCT02183675|593461967|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
164297101|NCT02183675|593461968|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
164297102|NCT02183675|593461969|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
164297103|NCT02183675|593461970|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
164297104|NCT02183675|593461971|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
164297105|NCT01521117|593461972|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
164297106|NCT01521117|593461973|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
164297107|NCT01521117|593461972|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
164297108|NCT01521117|593461973|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
164297109|NCT01521117|593461972|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
164297110|NCT01521117|593461973|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
164297111|NCT02657889|593461983|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
164297112|NCT02657889|593461984|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
164297113|NCT02657889|593461985|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
164297114|NCT02657889|593461986|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
164297115|NCT02657889|593461983|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
164297116|NCT02657889|593461984|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
164297117|NCT02657889|593461985|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
164297118|NCT02657889|593461986|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
164297119|NCT02657889|593461983|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
164297120|NCT02657889|593461984|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
164297121|NCT02657889|593461985|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
164297122|NCT02657889|593461986|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
164297123|NCT02657889|593461983|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
164297124|NCT02657889|593461984|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
164297125|NCT02657889|593461985|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
164297126|NCT02657889|593461986|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
164297127|NCT02657889|593461983|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
164297128|NCT02657889|593461984|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
164297129|NCT02657889|593461985|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
164297130|NCT02657889|593461986|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
164297131|NCT02657889|593461983|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
164297132|NCT02657889|593461984|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
164297133|NCT02657889|593461985|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
164297134|NCT02657889|593461986|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
164297135|NCT02657889|593461983|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
164347649|NCT03310021|593648892|FG019|Overall Study|Lost to Follow-up|0|||
164347650|NCT01128842|593648893|FG000|Overall Study|Adverse Event|1|||
164347651|NCT01128842|593648893|FG000|Overall Study|Disease Progression|6|||
164693603|NCT00739973|594899417|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
164693604|NCT00739973|594899418|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
164693605|NCT00739973|594899419|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
164693606|NCT00739973|594899420|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
164693607|NCT00739973|594899421|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
164693608|NCT00739973|594899422|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
164693609|NCT00739973|594899423|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
164693610|NCT00739973|594899424|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
164297136|NCT02657889|593461984|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
164297137|NCT02657889|593461985|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
164297138|NCT02657889|593461986|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
164297139|NCT02657889|593461983|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
164297140|NCT02657889|593461984|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
164297141|NCT02657889|593461985|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
164297142|NCT02657889|593461986|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
164297143|NCT02657889|593461983|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
164297144|NCT02657889|593461984|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
164297145|NCT02657889|593461985|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
164297146|NCT02657889|593461986|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
164297147|NCT02657889|593461983|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
164297148|NCT02657889|593461984|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
164297149|NCT02657889|593461985|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
164297150|NCT02657889|593461986|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
164297151|NCT02657889|593461983|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
164297152|NCT02657889|593461984|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
164297153|NCT02657889|593461985|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
164297154|NCT02657889|593461986|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
164297155|NCT02657889|593461983|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
164297156|NCT02657889|593461984|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
164297157|NCT02657889|593461985|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
164297158|NCT02657889|593461986|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
164297159|NCT03050801|593461995|FG000|Experiment 1|Lost to Follow-up|0|||
164297160|NCT03050801|593461996|FG001|Experiment 1|Lost to Follow-up|1|||
164297161|NCT03050801|593461997|FG002|Experiment 1|Lost to Follow-up|0|||
164297162|NCT03050801|593461998|FG003|Experiment 1|Lost to Follow-up|0|||
164297163|NCT03050801|593461999|FG004|Experiment 1|Lost to Follow-up|0|||
164347652|NCT02378961|593648894|FG000|Overall Study|Lack of Efficacy|4|||
164347653|NCT02378961|593648895|FG001|Overall Study|Lack of Efficacy|2|||
164347654|NCT02378961|593648896|FG002|Overall Study|Lack of Efficacy|0|||
164347655|NCT02378961|593648897|FG003|Overall Study|Lack of Efficacy|1|||
164347656|NCT02378961|593648894|FG000|Overall Study|Death|0|||
164347657|NCT02378961|593648895|FG001|Overall Study|Death|0|||
164347658|NCT02378961|593648896|FG002|Overall Study|Death|1|||
164347659|NCT02378961|593648897|FG003|Overall Study|Death|0|||
164347660|NCT00390468|593648898|FG000|Overall Study|Protocol Violation|2|||
164347661|NCT00390468|593648898|FG000|Overall Study|Lack of Efficacy|1|||
164347662|NCT01049308|593648899|FG000|Pill Counts|Withdrawal by Subject|83|||
164347663|NCT01348165|593648901|FG000|Overall Study|Adverse Event|0|||
164435164|NCT03536884|593960876|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
164435165|NCT03536884|593960877|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
164435166|NCT03536884|593960878|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
164435167|NCT03536884|593960867|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
164435168|NCT03536884|593960868|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
164297164|NCT03050801|593462000|FG005|Experiment 1|Lost to Follow-up|0|||
164297165|NCT03050801|593461995|FG000|Experiment 1|Physician Decision|0|||
164297166|NCT03050801|593461996|FG001|Experiment 1|Physician Decision|3|||
164297167|NCT03050801|593461997|FG002|Experiment 1|Physician Decision|0|||
164297168|NCT03050801|593461998|FG003|Experiment 1|Physician Decision|0|||
164435169|NCT03536884|593960869|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
164435170|NCT03536884|593960870|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
164435171|NCT03536884|593960871|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
164435172|NCT03536884|593960872|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
164435173|NCT03536884|593960873|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
164435174|NCT03536884|593960874|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
164435175|NCT03536884|593960875|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
164435176|NCT03536884|593960876|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
164435177|NCT03536884|593960877|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
164435178|NCT03536884|593960878|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
164435179|NCT03536884|593960867|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
164435180|NCT03536884|593960868|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
164435181|NCT03536884|593960869|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
164435182|NCT03536884|593960870|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
164435183|NCT03536884|593960871|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
164435184|NCT03536884|593960872|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
164435185|NCT03536884|593960873|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
164435186|NCT03536884|593960874|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
164435187|NCT03536884|593960875|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
164435188|NCT03536884|593960876|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
164435189|NCT03536884|593960877|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
164435190|NCT03536884|593960878|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
164435191|NCT03536884|593960867|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
164435192|NCT03536884|593960868|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
164435193|NCT03536884|593960869|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
164435194|NCT03536884|593960870|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
164435195|NCT03536884|593960871|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
164435196|NCT03536884|593960872|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
164435197|NCT03536884|593960873|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
164435198|NCT03536884|593960874|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
164435199|NCT03536884|593960875|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
164435200|NCT03536884|593960876|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
164435201|NCT03536884|593960877|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
164435202|NCT03536884|593960878|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
164435203|NCT03536884|593960867|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
164435204|NCT03536884|593960868|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
164435205|NCT03536884|593960869|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
164435206|NCT03536884|593960870|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
164435207|NCT03536884|593960871|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
164435208|NCT03536884|593960872|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
164435209|NCT03536884|593960873|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
164435210|NCT03536884|593960874|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
164297169|NCT03050801|593461999|FG004|Experiment 1|Physician Decision|0|||
164297170|NCT03050801|593462000|FG005|Experiment 1|Physician Decision|0|||
164297171|NCT03050801|593461995|FG000|Experiment 1|Change of experimental design|0|||
164297172|NCT03050801|593461996|FG001|Experiment 1|Change of experimental design|3|||
164297173|NCT03050801|593461997|FG002|Experiment 1|Change of experimental design|0|||
164435211|NCT03536884|593960875|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
164435212|NCT03536884|593960876|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
164435213|NCT03536884|593960877|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
164693611|NCT00739973|594899425|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
164435214|NCT03536884|593960878|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
164435215|NCT03536884|593960867|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
164435216|NCT03536884|593960868|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
164435217|NCT03536884|593960869|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
164435218|NCT03536884|593960870|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
164297174|NCT03050801|593461998|FG003|Experiment 1|Change of experimental design|0|||
164297175|NCT03050801|593461999|FG004|Experiment 1|Change of experimental design|0|||
164297176|NCT03050801|593462000|FG005|Experiment 1|Change of experimental design|0|||
164297177|NCT03050801|593461995|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
164297178|NCT03050801|593461996|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
164297179|NCT03050801|593461997|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
164297180|NCT03050801|593461998|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
164297181|NCT03050801|593461999|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
164297182|NCT03050801|593462000|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
164297183|NCT03050801|593461995|FG000|Experiment 2|Lost to Follow-up|0|||
164297184|NCT03050801|593461996|FG001|Experiment 2|Lost to Follow-up|0|||
164297185|NCT03050801|593461997|FG002|Experiment 2|Lost to Follow-up|0|||
164297186|NCT03050801|593461998|FG003|Experiment 2|Lost to Follow-up|1|||
164297187|NCT03050801|593461999|FG004|Experiment 2|Lost to Follow-up|1|||
164297188|NCT03050801|593462000|FG005|Experiment 2|Lost to Follow-up|0|||
164297189|NCT03050801|593461995|FG000|Experiment 2|Physician Decision|0|||
164297190|NCT03050801|593461996|FG001|Experiment 2|Physician Decision|0|||
164297191|NCT03050801|593461997|FG002|Experiment 2|Physician Decision|0|||
164297192|NCT03050801|593461998|FG003|Experiment 2|Physician Decision|0|||
164297193|NCT03050801|593461999|FG004|Experiment 2|Physician Decision|1|||
164297194|NCT03050801|593462000|FG005|Experiment 2|Physician Decision|0|||
164297195|NCT03050801|593461995|FG000|Experiment 2|Pregnancy|0|||
164297196|NCT03050801|593461996|FG001|Experiment 2|Pregnancy|0|||
164297197|NCT03050801|593461997|FG002|Experiment 2|Pregnancy|0|||
164297198|NCT03050801|593461998|FG003|Experiment 2|Pregnancy|0|||
164297199|NCT03050801|593461999|FG004|Experiment 2|Pregnancy|1|||
164297200|NCT03050801|593462000|FG005|Experiment 2|Pregnancy|0|||
164297201|NCT03050801|593461995|FG000|Experiment 2|Withdrawal by Subject|0|||
164297202|NCT03050801|593461996|FG001|Experiment 2|Withdrawal by Subject|0|||
164297203|NCT03050801|593461997|FG002|Experiment 2|Withdrawal by Subject|0|||
164297204|NCT03050801|593461998|FG003|Experiment 2|Withdrawal by Subject|1|||
164297205|NCT03050801|593461999|FG004|Experiment 2|Withdrawal by Subject|0|||
164297206|NCT03050801|593462000|FG005|Experiment 2|Withdrawal by Subject|0|||
164297207|NCT03050801|593461995|FG000|Experiment 2|Poor data quality|0|||
164297208|NCT03050801|593461996|FG001|Experiment 2|Poor data quality|0|||
164297209|NCT03050801|593461997|FG002|Experiment 2|Poor data quality|0|||
164297210|NCT03050801|593461998|FG003|Experiment 2|Poor data quality|4|||
164297211|NCT03050801|593461999|FG004|Experiment 2|Poor data quality|1|||
164297212|NCT03050801|593462000|FG005|Experiment 2|Poor data quality|0|||
164297213|NCT03050801|593461995|FG000|Experiment 2|Discomfort during stimulation|0|||
164297214|NCT03050801|593461996|FG001|Experiment 2|Discomfort during stimulation|0|||
164297215|NCT03050801|593461997|FG002|Experiment 2|Discomfort during stimulation|0|||
164297216|NCT03050801|593461998|FG003|Experiment 2|Discomfort during stimulation|0|||
164297217|NCT03050801|593461999|FG004|Experiment 2|Discomfort during stimulation|0|||
164297218|NCT03050801|593462000|FG005|Experiment 2|Discomfort during stimulation|2|||
164297219|NCT01576341|593462001|FG000|Overall Study|Withdrawal by Subject|24|||
164297220|NCT01576341|593462001|FG000|Overall Study|Adverse Event|10|||
164297221|NCT01576341|593462001|FG000|Overall Study|Death|21|||
164297222|NCT01576341|593462001|FG000|Overall Study|Physician Decision|2|||
164297223|NCT01576341|593462001|FG000|Overall Study|Lost to Follow-up|2|||
164297224|NCT01576341|593462001|FG000|Overall Study|Kidney transplantation|10|||
164297225|NCT01576341|593462001|FG000|Overall Study|Protocol Violation|12|||
164297226|NCT01576341|593462001|FG000|Overall Study|Other|12|||
164297227|NCT03836625|593462002|FG000|Overall Study|Lost to Follow-up|9|||
164297228|NCT03836625|593462003|FG001|Overall Study|Lost to Follow-up|9|||
164297229|NCT03836625|593462002|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
164297230|NCT03836625|593462003|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
164297231|NCT03836625|593462002|FG000|Overall Study|Death|0|||
164297232|NCT03836625|593462003|FG001|Overall Study|Death|1|||
164297233|NCT03836625|593462002|FG000|Overall Study|Refused follow-up|0|||
164297234|NCT03836625|593462003|FG001|Overall Study|Refused follow-up|1|||
164297235|NCT03361137|593462004|FG000|Overall Study|Reason not specified|1|||
164297236|NCT03361137|593462005|FG001|Overall Study|Reason not specified|0|||
164297237|NCT03361137|593462006|FG002|Overall Study|Reason not specified|0|||
164297238|NCT03361137|593462007|FG003|Overall Study|Reason not specified|0|||
164347664|NCT01348165|593648902|FG001|Overall Study|Adverse Event|0|||
164297239|NCT03361137|593462008|FG004|Overall Study|Reason not specified|0|||
164297240|NCT03413891|593462010|FG000|Overall Study|Lost to Follow-up|2|||
164297241|NCT03413891|593462011|FG001|Overall Study|Lost to Follow-up|1|||
164297242|NCT03413891|593462010|FG000|Overall Study|Protocol Violation|0|||
164297243|NCT03413891|593462011|FG001|Overall Study|Protocol Violation|1|||
164297244|NCT03077542|593462016|FG000|Overall Study|Death|4|||
164297245|NCT03077542|593462017|FG001|Overall Study|Death|0|||
164297246|NCT03077542|593462016|FG000|Overall Study|Physician Decision|6|||
164297247|NCT03077542|593462017|FG001|Overall Study|Physician Decision|1|||
164297248|NCT03077542|593462016|FG000|Overall Study|Withdrawal by Subject|0|||
164297249|NCT03077542|593462017|FG001|Overall Study|Withdrawal by Subject|1|||
164297250|NCT00795704|593462018|FG000|Overall Study|Withdrawal by Subject|3|||
164297251|NCT00795704|593462019|FG001|Overall Study|Withdrawal by Subject|2|||
164297252|NCT00795704|593462018|FG000|Overall Study|Adverse Event|1|||
164297253|NCT00795704|593462019|FG001|Overall Study|Adverse Event|1|||
164297254|NCT00301808|593462020|FG000|Overall Study|Adverse Event|5|||
164297255|NCT00301808|593462020|FG000|Overall Study|Death|3|||
164297256|NCT00301808|593462020|FG000|Overall Study|Lack of Efficacy|4|||
164297257|NCT00844844|593462021|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
164297258|NCT00844844|593462021|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
164297259|NCT00844844|593462021|FG000|Extension Treatment Period|Adverse Event|2|||
164297260|NCT00844844|593462021|FG000|Post Treatment Period|Withdrawal by Subject|1|||
164297261|NCT03905096|593462022|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
164297262|NCT03905096|593462023|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
164297263|NCT04659044|593462037|FG000|Induction|Physician Decision|1|||
164297264|NCT04659044|593462037|FG000|Induction|Adverse Event|2|||
164297265|NCT04966013|593462039|FG000|Overall Study|Withdrawal by Subject|0|||
164297266|NCT04966013|593462040|FG001|Overall Study|Withdrawal by Subject|2|||
164297267|NCT04966013|593462041|FG002|Overall Study|Withdrawal by Subject|1|||
164297268|NCT04966013|593462039|FG000|Overall Study|Adverse Event|2|||
164297269|NCT04966013|593462040|FG001|Overall Study|Adverse Event|1|||
164297270|NCT04966013|593462041|FG002|Overall Study|Adverse Event|1|||
164297271|NCT04875975|593462045|FG000|Overall Study|Adverse Event|1|||
164297272|NCT04875975|593462046|FG001|Overall Study|Adverse Event|2|||
164297273|NCT04875975|593462045|FG000|Overall Study|Lack of Efficacy|2|||
164297274|NCT04875975|593462046|FG001|Overall Study|Lack of Efficacy|2|||
164297275|NCT04875975|593462045|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
164297276|NCT04875975|593462046|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
164297277|NCT04875975|593462045|FG000|Overall Study|Relapse With Insults|0|||
164297278|NCT04875975|593462046|FG001|Overall Study|Relapse With Insults|1|||
164297279|NCT04875975|593462045|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
164297280|NCT04875975|593462046|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
164297281|NCT01910298|593462047|FG000|Overall Study|Adverse Event|1|||
164297282|NCT01910298|593462048|FG001|Overall Study|Adverse Event|0|||
164297283|NCT01910298|593462047|FG000|Overall Study|Withdrawal by Subject|2|||
164297284|NCT01910298|593462048|FG001|Overall Study|Withdrawal by Subject|7|||
164297285|NCT01910298|593462047|FG000|Overall Study|Protocol Deviation|0|||
164297286|NCT01910298|593462048|FG001|Overall Study|Protocol Deviation|5|||
164297287|NCT01910298|593462047|FG000|Overall Study|Lost to Follow-up|1|||
164297288|NCT01910298|593462048|FG001|Overall Study|Lost to Follow-up|1|||
164297289|NCT01910298|593462047|FG000|Overall Study|Study Terminated by Sponsor|1|||
164297290|NCT01910298|593462048|FG001|Overall Study|Study Terminated by Sponsor|17|||
164297291|NCT01910298|593462047|FG000|Overall Study|Other Miscellaneous Reasons|0|||
164297292|NCT01910298|593462048|FG001|Overall Study|Other Miscellaneous Reasons|2|||
164297293|NCT02429830|593462051|FG000|Overall Study|Lost to Follow-up|1|||
164297294|NCT02429830|593462051|FG000|Overall Study|Device Explant|2|||
164297295|NCT04944992|593463803|FG000|Overall Study|Lost to Follow-up|1|||
164297296|NCT04944992|593463804|FG001|Overall Study|Lost to Follow-up|1|||
164297297|NCT04944992|593463803|FG000|Overall Study|Physician Decision|1|||
164297298|NCT04944992|593463804|FG001|Overall Study|Physician Decision|0|||
164297299|NCT04944992|593463803|FG000|Overall Study|Withdrawal by Subject|6|||
164297300|NCT04944992|593463804|FG001|Overall Study|Withdrawal by Subject|1|||
164297301|NCT05024032|593463808|FG000|Overall Study|Withdrawal by Subject|0|||
164297302|NCT05024032|593463809|FG001|Overall Study|Withdrawal by Subject|3|||
164297303|NCT05024032|593463810|FG002|Overall Study|Withdrawal by Subject|4|||
164297304|NCT05024032|593463808|FG000|Overall Study|Adverse Event|0|||
164297305|NCT05024032|593463809|FG001|Overall Study|Adverse Event|1|||
164297306|NCT05024032|593463810|FG002|Overall Study|Adverse Event|0|||
164297307|NCT05024032|593463808|FG000|Overall Study|Protocol Deviation|1|||
164297308|NCT05024032|593463809|FG001|Overall Study|Protocol Deviation|0|||
164297309|NCT05024032|593463810|FG002|Overall Study|Protocol Deviation|0|||
164297310|NCT00939393|593463811|FG000|Overall Study|Withdrawal by Subject|1|||
164297311|NCT00939393|593463812|FG001|Overall Study|Withdrawal by Subject|0|||
164297312|NCT00939393|593463811|FG000|Overall Study|Lost to Follow-up|3|||
164297313|NCT00939393|593463812|FG001|Overall Study|Lost to Follow-up|0|||
164297314|NCT00744497|593463817|FG000|Overall Study|Withdrawal by Subject|21|||
164297315|NCT00744497|593463818|FG001|Overall Study|Withdrawal by Subject|18|||
164297316|NCT00744497|593463817|FG000|Overall Study|Death|11|||
164297317|NCT00744497|593463818|FG001|Overall Study|Death|9|||
164297318|NCT00744497|593463817|FG000|Overall Study|Lost to Follow-up|4|||
164297319|NCT00744497|593463818|FG001|Overall Study|Lost to Follow-up|2|||
164297320|NCT00744497|593463817|FG000|Overall Study|Poor compliance/noncompliance|9|||
164297321|NCT00744497|593463818|FG001|Overall Study|Poor compliance/noncompliance|5|||
164297322|NCT00744497|593463817|FG000|Overall Study|No longer meets study criteria|7|||
164297323|NCT00744497|593463818|FG001|Overall Study|No longer meets study criteria|3|||
164297324|NCT00744497|593463817|FG000|Overall Study|Administrative Reason By Sponsor|25|||
164297325|NCT00744497|593463818|FG001|Overall Study|Administrative Reason By Sponsor|8|||
164297326|NCT00744497|593463817|FG000|Overall Study|Disease progression|312|||
164297327|NCT00744497|593463818|FG001|Overall Study|Disease progression|219|||
164297328|NCT00744497|593463817|FG000|Overall Study|Study drug toxicity|68|||
164297329|NCT00744497|593463818|FG001|Overall Study|Study drug toxicity|141|||
164435219|NCT03536884|593960871|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
164435220|NCT03536884|593960872|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
164297330|NCT00744497|593463817|FG000|Overall Study|Adverse event unrelated to study drug|78|||
164297331|NCT00744497|593463818|FG001|Overall Study|Adverse event unrelated to study drug|122|||
164297332|NCT00744497|593463817|FG000|Overall Study|Patient requested to stop study drug|65|||
164297333|NCT00744497|593463818|FG001|Overall Study|Patient requested to stop study drug|80|||
164297334|NCT00744497|593463817|FG000|Overall Study|Maximum clinical benefit|141|||
164297335|NCT00744497|593463818|FG001|Overall Study|Maximum clinical benefit|142|||
164297336|NCT00744497|593463817|FG000|Overall Study|Not defined|19|||
164297337|NCT00744497|593463818|FG001|Overall Study|Not defined|13|||
164297338|NCT01074502|593463820|FG000|Overall Study|Withdrawal by Subject|1|||
164297339|NCT03459079|593463821|FG000|Overall Study|Adverse Event|4|||
164297340|NCT03459079|593463822|FG001|Overall Study|Adverse Event|2|||
164297341|NCT03459079|593463823|FG002|Overall Study|Adverse Event|0|||
164297342|NCT03459079|593463821|FG000|Overall Study|Withdrawal by Subject|2|||
164297343|NCT03459079|593463822|FG001|Overall Study|Withdrawal by Subject|2|||
164297344|NCT03459079|593463823|FG002|Overall Study|Withdrawal by Subject|0|||
164297345|NCT00674817|593463831|FG000|Period 1|Withdrawal by Subject|2|||
164297346|NCT00674817|593463831|FG000|Period 1|Protocol Violation|1|||
164297347|NCT00674817|593463831|FG000|Period 3|Adverse Event|1|||
164297348|NCT00674817|593463831|FG000|Period 3|Protocol Violation|1|||
164297349|NCT00674817|593463831|FG000|Period 4|Adverse Event|1|||
164297350|NCT04945733|593463835|FG000|Overall Study|Physician Decision|1|||
164297351|NCT04945733|593463836|FG001|Overall Study|Physician Decision|3|||
164297352|NCT04945733|593463837|FG002|Overall Study|Physician Decision|0|||
164297353|NCT04945733|593463835|FG000|Overall Study|Withdrawal by Subject|3|||
164297354|NCT04945733|593463836|FG001|Overall Study|Withdrawal by Subject|3|||
164297355|NCT04945733|593463837|FG002|Overall Study|Withdrawal by Subject|0|||
164297356|NCT05660577|593463838|FG000|Overall Study|Discontinued|9|||
164297357|NCT03363841|593463843|FG000|Overall Study|Adverse Event|1|||
164297358|NCT03363841|593463843|FG000|Overall Study|Withdrawal by Subject|1|||
164297359|NCT03363841|593463843|FG000|Overall Study|Death|7|||
164297360|NCT03363841|593463843|FG000|Overall Study|Physician Decision|1|||
164297361|NCT02156076|593463848|FG000|Treatment Period|no longer meets study criteria|0|||
164297362|NCT02156076|593463849|FG001|Treatment Period|no longer meets study criteria|0|||
164297363|NCT02156076|593463850|FG002|Treatment Period|no longer meets study criteria|1|||
164297364|NCT02156076|593463851|FG003|Treatment Period|no longer meets study criteria|0|||
164297365|NCT02156076|593463848|FG000|Treatment Period|Poor/non-compliance|0|||
164297366|NCT02156076|593463849|FG001|Treatment Period|Poor/non-compliance|1|||
164297367|NCT02156076|593463850|FG002|Treatment Period|Poor/non-compliance|0|||
164297368|NCT02156076|593463851|FG003|Treatment Period|Poor/non-compliance|0|||
164297369|NCT02156076|593463848|FG000|Treatment Period|Lost to Follow-up|0|||
164297370|NCT02156076|593463849|FG001|Treatment Period|Lost to Follow-up|0|||
164435221|NCT03536884|593960873|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
164435222|NCT03536884|593960874|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
164435223|NCT03536884|593960875|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
164435224|NCT03536884|593960876|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
164435225|NCT03536884|593960877|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
164435226|NCT03536884|593960878|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
164435227|NCT03536884|593960867|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
164435228|NCT03536884|593960868|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
164693612|NCT00739973|594899417|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
164693613|NCT00739973|594899418|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
164693614|NCT00739973|594899419|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
164693615|NCT00739973|594899420|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
164297371|NCT02156076|593463850|FG002|Treatment Period|Lost to Follow-up|0|||
164297372|NCT02156076|593463851|FG003|Treatment Period|Lost to Follow-up|1|||
164297373|NCT02156076|593463848|FG000|Treatment Period|Withdrawal by Subject|0|||
164297374|NCT02156076|593463849|FG001|Treatment Period|Withdrawal by Subject|0|||
164297375|NCT02156076|593463850|FG002|Treatment Period|Withdrawal by Subject|1|||
164297376|NCT02156076|593463851|FG003|Treatment Period|Withdrawal by Subject|0|||
164297377|NCT02156076|593463848|FG000|Treatment Period|Subject request to discontinue treatment|0|||
164693616|NCT00739973|594899421|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
164693617|NCT00739973|594899422|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
164297378|NCT02156076|593463849|FG001|Treatment Period|Subject request to discontinue treatment|1|||
164297379|NCT02156076|593463850|FG002|Treatment Period|Subject request to discontinue treatment|0|||
164297380|NCT02156076|593463851|FG003|Treatment Period|Subject request to discontinue treatment|0|||
164297381|NCT02156076|593463848|FG000|Treatment Period|Adverse Event|0|||
164297382|NCT02156076|593463849|FG001|Treatment Period|Adverse Event|0|||
164297383|NCT02156076|593463850|FG002|Treatment Period|Adverse Event|0|||
164435229|NCT03536884|593960869|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
164435230|NCT03536884|593960870|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
164297384|NCT02156076|593463851|FG003|Treatment Period|Adverse Event|1|||
164297385|NCT02156076|593463848|FG000|Follow-up Period|Withdrawal by Subject|1|||
164297386|NCT02156076|593463849|FG001|Follow-up Period|Withdrawal by Subject|0|||
164297387|NCT02156076|593463850|FG002|Follow-up Period|Withdrawal by Subject|0|||
164297388|NCT02156076|593463851|FG003|Follow-up Period|Withdrawal by Subject|0|||
164297389|NCT00981656|593463856|FG000|Overall Study|Protocol Violation|1|||
164297390|NCT00981656|593463856|FG000|Overall Study|Did not start protocol treatment|2|||
164297391|NCT00687596|593463857|FG000|Overall Study|Adverse Event (AE)|10|||
164297392|NCT00687596|593463858|FG001|Overall Study|Adverse Event (AE)|3|||
164297393|NCT00687596|593463857|FG000|Overall Study|Radiological Disease Progression|6|||
164297394|NCT00687596|593463858|FG001|Overall Study|Radiological Disease Progression|2|||
164297395|NCT00687596|593463857|FG000|Overall Study|Clinical Disease Progression|1|||
164297396|NCT00687596|593463858|FG001|Overall Study|Clinical Disease Progression|3|||
164297397|NCT00687596|593463857|FG000|Overall Study|Investigator Discretion|3|||
164297398|NCT00687596|593463858|FG001|Overall Study|Investigator Discretion|1|||
164297399|NCT00687596|593463857|FG000|Overall Study|Sponsor Terminated Study|6|||
164297400|NCT00687596|593463858|FG001|Overall Study|Sponsor Terminated Study|17|||
164297401|NCT01527149|593463859|FG000|Overall Study|Death|2|||
164297402|NCT02230410|593463862|FG000|Overall Study|Screen Failure|3|||
164297403|NCT02992288|593463866|FG000|Overall Study|Adverse Event|8|||
164297404|NCT02992288|593463867|FG001|Overall Study|Adverse Event|2|||
164297405|NCT02992288|593463868|FG002|Overall Study|Adverse Event|2|||
164297406|NCT02992288|593463869|FG003|Overall Study|Adverse Event|2|||
164297407|NCT02992288|593463870|FG004|Overall Study|Adverse Event|2|||
164297408|NCT02992288|593463871|FG005|Overall Study|Adverse Event|7|||
164297409|NCT02992288|593463866|FG000|Overall Study|Non-compliance with study drug|0|||
164297410|NCT02992288|593463867|FG001|Overall Study|Non-compliance with study drug|1|||
164297411|NCT02992288|593463868|FG002|Overall Study|Non-compliance with study drug|1|||
164297412|NCT02992288|593463869|FG003|Overall Study|Non-compliance with study drug|0|||
164297413|NCT02992288|593463870|FG004|Overall Study|Non-compliance with study drug|1|||
164297414|NCT02992288|593463871|FG005|Overall Study|Non-compliance with study drug|0|||
164297415|NCT02992288|593463866|FG000|Overall Study|Physician Decision|3|||
164297416|NCT02992288|593463867|FG001|Overall Study|Physician Decision|0|||
164297417|NCT02992288|593463868|FG002|Overall Study|Physician Decision|1|||
164297418|NCT02992288|593463869|FG003|Overall Study|Physician Decision|0|||
164297419|NCT02992288|593463870|FG004|Overall Study|Physician Decision|0|||
164297420|NCT02992288|593463871|FG005|Overall Study|Physician Decision|1|||
164297421|NCT02992288|593463866|FG000|Overall Study|Death|2|||
164297422|NCT02992288|593463867|FG001|Overall Study|Death|0|||
164297423|NCT02992288|593463868|FG002|Overall Study|Death|2|||
164297424|NCT02992288|593463869|FG003|Overall Study|Death|1|||
164297425|NCT02992288|593463870|FG004|Overall Study|Death|2|||
164297426|NCT02992288|593463871|FG005|Overall Study|Death|0|||
164297427|NCT02992288|593463866|FG000|Overall Study|Lost to Follow-up|0|||
164297428|NCT02992288|593463867|FG001|Overall Study|Lost to Follow-up|0|||
164297429|NCT02992288|593463868|FG002|Overall Study|Lost to Follow-up|0|||
164297430|NCT02992288|593463869|FG003|Overall Study|Lost to Follow-up|1|||
164297431|NCT02992288|593463870|FG004|Overall Study|Lost to Follow-up|0|||
164297432|NCT02992288|593463871|FG005|Overall Study|Lost to Follow-up|0|||
164297433|NCT02992288|593463866|FG000|Overall Study|Protocol Violation|0|||
164297434|NCT02992288|593463867|FG001|Overall Study|Protocol Violation|0|||
164297435|NCT02992288|593463868|FG002|Overall Study|Protocol Violation|0|||
164297436|NCT02992288|593463869|FG003|Overall Study|Protocol Violation|0|||
164297437|NCT02992288|593463870|FG004|Overall Study|Protocol Violation|0|||
164297438|NCT02992288|593463871|FG005|Overall Study|Protocol Violation|1|||
164297439|NCT02992288|593463866|FG000|Overall Study|Withdrawal by Subject|4|||
164297440|NCT02992288|593463867|FG001|Overall Study|Withdrawal by Subject|2|||
164347665|NCT01348165|593648903|FG002|Overall Study|Adverse Event|0|||
164347666|NCT01348165|593648904|FG003|Overall Study|Adverse Event|0|||
164347667|NCT01348165|593648905|FG004|Overall Study|Adverse Event|0|||
164347668|NCT01348165|593648906|FG005|Overall Study|Adverse Event|0|||
164347669|NCT01348165|593648907|FG006|Overall Study|Adverse Event|1|||
164347670|NCT05766423|593648913|FG000|Overall Study|Withdrawal by Subject|1|||
164347671|NCT05766423|593648914|FG001|Overall Study|Withdrawal by Subject|0|||
164347672|NCT05766423|593648913|FG000|Overall Study|Consented, not scheduled|3|||
164347673|NCT05766423|593648914|FG001|Overall Study|Consented, not scheduled|5|||
164347674|NCT00996216|593650838|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
164297441|NCT02992288|593463868|FG002|Overall Study|Withdrawal by Subject|1|||
164297442|NCT02992288|593463869|FG003|Overall Study|Withdrawal by Subject|5|||
164297443|NCT02992288|593463870|FG004|Overall Study|Withdrawal by Subject|3|||
164297444|NCT02992288|593463871|FG005|Overall Study|Withdrawal by Subject|4|||
164297445|NCT00499486|593463872|FG000|Overall Study|Withdrawal by Subject|16|||
164347675|NCT00996216|593650838|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
164347676|NCT00996216|593650838|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
164347677|NCT01411774|593650844|FG000|Overall Study|Withdrawal by Subject|0|||
164297446|NCT00656513|593463873|FG000|Overall Study|Protocol Violation|1|||
164297447|NCT00656513|593463874|FG001|Overall Study|Protocol Violation|0|||
164297448|NCT00656513|593463875|FG002|Overall Study|Protocol Violation|2|||
164587525|NCT04439838|594515852|FG002|Overall Study|Withdrawal by Subject|0|||
164587526|NCT04439838|594515853|FG003|Overall Study|Withdrawal by Subject|0|||
164297449|NCT00656513|593463873|FG000|Overall Study|Withdrawal by Subject|0|||
164297450|NCT00656513|593463874|FG001|Overall Study|Withdrawal by Subject|11|||
164297451|NCT00656513|593463875|FG002|Overall Study|Withdrawal by Subject|4|||
164297452|NCT00656513|593463873|FG000|Overall Study|Death|0|||
164297453|NCT00656513|593463874|FG001|Overall Study|Death|0|||
164297454|NCT00656513|593463875|FG002|Overall Study|Death|1|||
164297455|NCT00656513|593463873|FG000|Overall Study|Missing data|0|||
164297456|NCT00656513|593463874|FG001|Overall Study|Missing data|11|||
164297457|NCT00656513|593463875|FG002|Overall Study|Missing data|9|||
164297458|NCT00656513|593463873|FG000|Overall Study|Incomplete treatment|3|||
164297459|NCT00656513|593463874|FG001|Overall Study|Incomplete treatment|0|||
164297460|NCT00656513|593463875|FG002|Overall Study|Incomplete treatment|0|||
164297461|NCT00656513|593463873|FG000|Overall Study|Treatment completed outside of timeframe|0|||
164297462|NCT00656513|593463874|FG001|Overall Study|Treatment completed outside of timeframe|3|||
164297463|NCT00656513|593463875|FG002|Overall Study|Treatment completed outside of timeframe|1|||
164297464|NCT00656513|593463873|FG000|Overall Study|Missing baseline form|0|||
164297465|NCT00656513|593463874|FG001|Overall Study|Missing baseline form|5|||
164297466|NCT00656513|593463875|FG002|Overall Study|Missing baseline form|5|||
164297467|NCT03796728|593463877|FG000|Overall Study|Lost to Follow-up|8|||
164297468|NCT03796728|593463877|FG000|Overall Study|Reason not Specified|16|||
164297469|NCT00333775|593463878|FG000|Overall Study|Death|144|||
164297470|NCT00333775|593463879|FG001|Overall Study|Death|149|||
164297471|NCT00333775|593463880|FG002|Overall Study|Death|143|||
164297472|NCT00333775|593463878|FG000|Overall Study|In Follow-up When Study Stopped|87|||
164297473|NCT00333775|593463879|FG001|Overall Study|In Follow-up When Study Stopped|92|||
164297474|NCT00333775|593463880|FG002|Overall Study|In Follow-up When Study Stopped|96|||
164297475|NCT00333775|593463878|FG000|Overall Study|Lost to Follow-up|10|||
164297476|NCT00333775|593463879|FG001|Overall Study|Lost to Follow-up|7|||
164297477|NCT00333775|593463880|FG002|Overall Study|Lost to Follow-up|8|||
164297478|NCT00412984|593463885|FG000|Overall Study|Death|331|||
164297479|NCT00412984|593463886|FG001|Overall Study|Death|349|||
164297480|NCT00412984|593463885|FG000|Overall Study|Adverse Event|679|||
164297481|NCT00412984|593463886|FG001|Overall Study|Adverse Event|738|||
164297482|NCT00412984|593463885|FG000|Overall Study|Withdrawal by Subject|921|||
164297483|NCT00412984|593463886|FG001|Overall Study|Withdrawal by Subject|989|||
164297484|NCT00412984|593463885|FG000|Overall Study|Lost to Follow-up|51|||
164297485|NCT00412984|593463886|FG001|Overall Study|Lost to Follow-up|39|||
164297486|NCT00412984|593463885|FG000|Overall Study|Poor/Noncompliance|57|||
164297487|NCT00412984|593463886|FG001|Overall Study|Poor/Noncompliance|77|||
164297488|NCT00412984|593463885|FG000|Overall Study|Pregnancy|1|||
164297489|NCT00412984|593463886|FG001|Overall Study|Pregnancy|0|||
164297490|NCT00412984|593463885|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
164297491|NCT00412984|593463886|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
164297492|NCT00412984|593463885|FG000|Overall Study|Administrative Reason by Sponsor|11|||
164297493|NCT00412984|593463886|FG001|Overall Study|Administrative Reason by Sponsor|8|||
164297494|NCT00412984|593463885|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
164297495|NCT00412984|593463886|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
164297496|NCT00412984|593463885|FG000|Overall Study|Other Reason|80|||
164297497|NCT00412984|593463886|FG001|Overall Study|Other Reason|92|||
164297498|NCT00412984|593463885|FG000|Overall Study|Not Reported|11|||
164297499|NCT00412984|593463886|FG001|Overall Study|Not Reported|12|||
164297500|NCT03651765|593463888|FG000|Overall Study|Adverse Event|6|||
164297501|NCT03651765|593463888|FG000|Overall Study|Lack of Efficacy|18|||
164297502|NCT03651765|593463888|FG000|Overall Study|Lost to Follow-up|5|||
164297503|NCT03651765|593463888|FG000|Overall Study|Non-Compliance with Study Drug|4|||
164587527|NCT04439838|594515854|FG004|Overall Study|Withdrawal by Subject|0|||
164587528|NCT04439838|594515855|FG005|Overall Study|Withdrawal by Subject|0|||
164587529|NCT04439838|594515856|FG006|Overall Study|Withdrawal by Subject|0|||
164297504|NCT03651765|593463888|FG000|Overall Study|Physician Decision|6|||
164297505|NCT03651765|593463888|FG000|Overall Study|Pregnancy|1|||
164297506|NCT03651765|593463888|FG000|Overall Study|Discontinued by Sponsor|40|||
164297507|NCT03651765|593463888|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
164297508|NCT03651765|593463888|FG000|Overall Study|Withdrawal by Subject|24|||
164297509|NCT03651765|593463888|FG000|Overall Study|Miscellaneous|6|||
164297510|NCT04218240|593463889|FG000|Overall Study|Withdrawal by Subject|6|||
164297511|NCT04218240|593463890|FG001|Overall Study|Withdrawal by Subject|0|||
164297512|NCT04218240|593463889|FG000|Overall Study|Lack of Efficacy|24|||
164297513|NCT04218240|593463890|FG001|Overall Study|Lack of Efficacy|19|||
164297514|NCT04218240|593463889|FG000|Overall Study|Physician Decision|0|||
164587530|NCT04439838|594515857|FG007|Overall Study|Withdrawal by Subject|0|||
164297515|NCT04218240|593463890|FG001|Overall Study|Physician Decision|1|||
164297516|NCT04218240|593463889|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
164587531|NCT04439838|594515858|FG008|Overall Study|Withdrawal by Subject|1|||
164297517|NCT04218240|593463890|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
164297518|NCT04097678|593463893|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
164693618|NCT00739973|594899423|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
164693619|NCT00739973|594899424|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
164347678|NCT01411774|593650845|FG001|Overall Study|Withdrawal by Subject|3|||
164347679|NCT03808545|593650846|FG000|Overall Study|Withdrawal by Subject|1|||
164347680|NCT03808545|593650847|FG001|Overall Study|Withdrawal by Subject|1|||
164347681|NCT03292588|593650851|FG000|Overall Study|Death|1|||
164297519|NCT04097678|593463894|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
164297520|NCT03694678|593463895|FG000|Overall Study|Withdrawal by Subject|2|||
164297521|NCT03694678|593463896|FG001|Overall Study|Withdrawal by Subject|0|||
164297522|NCT03694678|593463895|FG000|Overall Study|Lost to Follow-up|2|||
164297523|NCT03694678|593463896|FG001|Overall Study|Lost to Follow-up|3|||
164297524|NCT02435212|593463897|FG000|Core Phase|Adverse Event|8|||
164297525|NCT02435212|593463898|FG001|Core Phase|Adverse Event|5|||
164297526|NCT02435212|593463897|FG000|Core Phase|Withdrawal by Subject|3|||
164297527|NCT02435212|593463898|FG001|Core Phase|Withdrawal by Subject|0|||
164297528|NCT02435212|593463897|FG000|Core Phase|Withdrawal by parent/guardian|9|||
164297529|NCT02435212|593463898|FG001|Core Phase|Withdrawal by parent/guardian|4|||
164297530|NCT02435212|593463897|FG000|Core Phase|Protocol Violation|1|||
164297531|NCT02435212|593463898|FG001|Core Phase|Protocol Violation|2|||
164297532|NCT02435212|593463897|FG000|Core Phase|Physician Decision|3|||
164297533|NCT02435212|593463898|FG001|Core Phase|Physician Decision|0|||
164297534|NCT02435212|593463897|FG000|Core Phase|Lost to Follow-up|0|||
164297535|NCT02435212|593463898|FG001|Core Phase|Lost to Follow-up|1|||
164297536|NCT02435212|593463897|FG000|Core Phase|Lack of Efficacy|0|||
164297537|NCT02435212|593463898|FG001|Core Phase|Lack of Efficacy|1|||
164297538|NCT02435212|593463897|FG000|Core Phase|Recovery|1|||
164297539|NCT02435212|593463898|FG001|Core Phase|Recovery|0|||
164297540|NCT02435212|593463897|FG000|Optional Extension Phase|Adverse Event|3|||
164297541|NCT02435212|593463898|FG001|Optional Extension Phase|Adverse Event|9|||
164297542|NCT02435212|593463897|FG000|Optional Extension Phase|Physician Decision|6|||
164297543|NCT02435212|593463898|FG001|Optional Extension Phase|Physician Decision|8|||
164297544|NCT02435212|593463897|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
164297545|NCT02435212|593463898|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
164297546|NCT02435212|593463897|FG000|Optional Extension Phase|Lack of Efficacy|2|||
164297547|NCT02435212|593463898|FG001|Optional Extension Phase|Lack of Efficacy|3|||
164297548|NCT02435212|593463897|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
164347682|NCT03292588|593650852|FG001|Overall Study|Death|0|||
164347683|NCT03292588|593650851|FG000|Overall Study|Lost to Follow-up|12|||
164347684|NCT03292588|593650852|FG001|Overall Study|Lost to Follow-up|16|||
164347685|NCT03292588|593650851|FG000|Overall Study|Physician Decision|0|||
164347686|NCT03292588|593650852|FG001|Overall Study|Physician Decision|1|||
164347687|NCT03292588|593650851|FG000|Overall Study|Withdrawal by Subject|4|||
164347688|NCT03292588|593650852|FG001|Overall Study|Withdrawal by Subject|4|||
164347689|NCT03292588|593650851|FG000|Overall Study|Move out of town|1|||
164347690|NCT03292588|593650852|FG001|Overall Study|Move out of town|0|||
164347691|NCT03292588|593650851|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
164347692|NCT03292588|593650852|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
164347693|NCT05526716|593650858|FG000|Overall Study|Death|1|||
164347694|NCT05526716|593650859|FG001|Overall Study|Death|2|||
164347695|NCT05526716|593650858|FG000|Overall Study|Lost to Follow-up|17|||
164347696|NCT05526716|593650859|FG001|Overall Study|Lost to Follow-up|15|||
164347697|NCT05526716|593650858|FG000|Overall Study|Physician Decision|0|||
164347698|NCT05526716|593650859|FG001|Overall Study|Physician Decision|1|||
164347699|NCT05526716|593650858|FG000|Overall Study|Randomized by mistake without study treatment|0|||
164347700|NCT05526716|593650859|FG001|Overall Study|Randomized by mistake without study treatment|1|||
164347701|NCT05526716|593650858|FG000|Overall Study|Withdrawal by Subject|12|||
164347702|NCT05526716|593650859|FG001|Overall Study|Withdrawal by Subject|12|||
164347703|NCT05526716|593650858|FG000|Overall Study|Not reported|0|||
164347704|NCT05526716|593650859|FG001|Overall Study|Not reported|2|||
164347705|NCT03489720|593650860|FG000|Overall Study|Withdrawal by Subject|2|||
164347706|NCT03489720|593650861|FG001|Overall Study|Withdrawal by Subject|0|||
164347707|NCT01806545|593650864|FG000|Overall Study|Adverse Event|2|||
164347708|NCT01806545|593650865|FG001|Overall Study|Adverse Event|3|||
164347709|NCT01806545|593650864|FG000|Overall Study|Lost to Follow-up|1|||
164347710|NCT01806545|593650865|FG001|Overall Study|Lost to Follow-up|0|||
164297549|NCT02435212|593463898|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
164297550|NCT02435212|593463897|FG000|Optional Extension Phase|Protocol Violation|0|||
164297551|NCT02435212|593463898|FG001|Optional Extension Phase|Protocol Violation|1|||
164297552|NCT02435212|593463897|FG000|Optional Extension Phase|Recovery|1|||
164347711|NCT01806545|593650864|FG000|Overall Study|Withdrawal by Subject|3|||
164347712|NCT01806545|593650865|FG001|Overall Study|Withdrawal by Subject|2|||
164347713|NCT04932096|593650866|FG000|Overall Study|Withdrawal by Subject|1|||
164297553|NCT02435212|593463898|FG001|Optional Extension Phase|Recovery|1|||
164297554|NCT02435212|593463897|FG000|Optional Extension Phase|Death|1|||
164297555|NCT02435212|593463898|FG001|Optional Extension Phase|Death|0|||
164297556|NCT02435212|593463897|FG000|Optional Extension Phase|Technical problems|2|||
164297557|NCT02435212|593463898|FG001|Optional Extension Phase|Technical problems|0|||
164297558|NCT04711850|593463902|FG000|Overall Study|Graft loss|2|||
164297559|NCT04711850|593463903|FG001|Overall Study|Graft loss|1|||
164297560|NCT04711850|593463902|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
164297561|NCT04711850|593463903|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
164297562|NCT04711850|593463902|FG000|Overall Study|Study terminated by sponsor|5|||
164347714|NCT04932096|593650867|FG001|Overall Study|Withdrawal by Subject|1|||
164347715|NCT04932096|593650866|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
164347716|NCT04932096|593650867|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
164297563|NCT04711850|593463903|FG001|Overall Study|Study terminated by sponsor|3|||
164297564|NCT04711850|593463902|FG000|Overall Study|Sponsor decision|0|||
164347717|NCT01438957|593650868|FG000|Overall Study|Physician Decision|1|||
164297565|NCT04711850|593463903|FG001|Overall Study|Sponsor decision|2|||
164297566|NCT01346358|593463904|FG000|Overall Study|Withdrawal by Subject|1|||
164297567|NCT01346358|593463905|FG001|Overall Study|Withdrawal by Subject|0|||
164297568|NCT01346358|593463906|FG002|Overall Study|Withdrawal by Subject|1|||
164297569|NCT01346358|593463907|FG003|Overall Study|Withdrawal by Subject|1|||
164297570|NCT01346358|593463908|FG004|Overall Study|Withdrawal by Subject|0|||
164297571|NCT01346358|593463909|FG005|Overall Study|Withdrawal by Subject|2|||
164297572|NCT01346358|593463910|FG006|Overall Study|Withdrawal by Subject|1|||
164297573|NCT01346358|593463911|FG007|Overall Study|Withdrawal by Subject|1|||
164297574|NCT01346358|593463912|FG008|Overall Study|Withdrawal by Subject|1|||
164297575|NCT01346358|593463904|FG000|Overall Study|Adverse Event|1|||
164297576|NCT01346358|593463905|FG001|Overall Study|Adverse Event|0|||
164297577|NCT01346358|593463906|FG002|Overall Study|Adverse Event|0|||
164297578|NCT01346358|593463907|FG003|Overall Study|Adverse Event|0|||
164297579|NCT01346358|593463908|FG004|Overall Study|Adverse Event|1|||
164297580|NCT01346358|593463909|FG005|Overall Study|Adverse Event|0|||
164297581|NCT01346358|593463910|FG006|Overall Study|Adverse Event|0|||
164297582|NCT01346358|593463911|FG007|Overall Study|Adverse Event|0|||
164297583|NCT01346358|593463912|FG008|Overall Study|Adverse Event|1|||
164297584|NCT01346358|593463904|FG000|Overall Study|Non-Compliance|0|||
164297585|NCT01346358|593463905|FG001|Overall Study|Non-Compliance|0|||
164297586|NCT01346358|593463906|FG002|Overall Study|Non-Compliance|0|||
164297587|NCT01346358|593463907|FG003|Overall Study|Non-Compliance|0|||
164297588|NCT01346358|593463908|FG004|Overall Study|Non-Compliance|0|||
164297589|NCT01346358|593463909|FG005|Overall Study|Non-Compliance|0|||
164297590|NCT01346358|593463910|FG006|Overall Study|Non-Compliance|0|||
164297591|NCT01346358|593463911|FG007|Overall Study|Non-Compliance|2|||
164297592|NCT01346358|593463912|FG008|Overall Study|Non-Compliance|0|||
164297593|NCT01346358|593463904|FG000|Overall Study|Physician Decision|0|||
164297594|NCT01346358|593463905|FG001|Overall Study|Physician Decision|1|||
164297595|NCT01346358|593463906|FG002|Overall Study|Physician Decision|0|||
164297596|NCT01346358|593463907|FG003|Overall Study|Physician Decision|0|||
164297597|NCT01346358|593463908|FG004|Overall Study|Physician Decision|0|||
164297598|NCT01346358|593463909|FG005|Overall Study|Physician Decision|0|||
164297599|NCT01346358|593463910|FG006|Overall Study|Physician Decision|0|||
164297600|NCT01346358|593463911|FG007|Overall Study|Physician Decision|1|||
164297601|NCT01346358|593463912|FG008|Overall Study|Physician Decision|1|||
164297602|NCT04819945|593463915|FG000|Overall Study|Lost to Follow-up|1|||
164297603|NCT04531176|593463932|FG000|Overall Study|Study was stopped early|24|||
164297604|NCT04531176|593463933|FG001|Overall Study|Study was stopped early|26|||
164297605|NCT04531176|593463934|FG002|Overall Study|Study was stopped early|24|||
164347718|NCT01438957|593650869|FG001|Overall Study|Physician Decision|1|||
164347719|NCT01438957|593650870|FG002|Overall Study|Physician Decision|0|||
164347720|NCT01438957|593650871|FG003|Overall Study|Physician Decision|1|||
164693620|NCT00739973|594899425|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
164693621|NCT00739973|594899417|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
164693622|NCT00739973|594899418|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
164693623|NCT00739973|594899419|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
164693624|NCT00739973|594899420|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
164693625|NCT00739973|594899421|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
164693626|NCT00739973|594899422|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
164693627|NCT00739973|594899423|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
164693628|NCT00739973|594899424|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
164693629|NCT00739973|594899425|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
164693630|NCT00739973|594899417|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
164693631|NCT00739973|594899418|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
164693632|NCT00739973|594899419|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
164693633|NCT00739973|594899420|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
164693634|NCT00739973|594899421|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
164693635|NCT00739973|594899422|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
164694671|NCT01546142|594905312|FG000|Overall Study|Subject Noncompliance|1|||
164297606|NCT00561652|593463939|FG000|Overall Study|Withdrawal by Subject|0|||
164297607|NCT00561652|593463940|FG001|Overall Study|Withdrawal by Subject|1|||
164297608|NCT04484961|593463943|FG000|Overall Study|Lost to Follow-up|9|||
164297609|NCT04484961|593463944|FG001|Overall Study|Lost to Follow-up|9|||
164297610|NCT00685165|593463945|FG000|Washout Period of 14 Days|Adverse Event|1|||
164297611|NCT00685165|593463946|FG001|Washout Period of 14 Days|Adverse Event|0|||
164297612|NCT03155724|593463947|FG000|Overall Study|Death|3|||
164297613|NCT03155724|593463947|FG000|Overall Study|Physician Decision|1|||
164297614|NCT03155724|593463947|FG000|Overall Study|Study closure|7|||
164297615|NCT02485691|593463949|FG000|Overall Study|Adverse Event|25|||
164347721|NCT01438957|593650872|FG004|Overall Study|Physician Decision|0|||
164297616|NCT02485691|593463950|FG001|Overall Study|Adverse Event|11|||
164347722|NCT00884312|593650874|FG000|Overall Study|Non-fatal Progressive Disease|0|||
164435231|NCT03536884|593960871|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
164435232|NCT03536884|593960872|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
164435233|NCT03536884|593960873|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
164435234|NCT03536884|593960874|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
164435235|NCT03536884|593960875|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
164435236|NCT03536884|593960876|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
164435237|NCT03536884|593960877|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
164435238|NCT03536884|593960878|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
164435239|NCT03536884|593960867|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
164435240|NCT03536884|593960868|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
164435241|NCT03536884|593960869|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
164435242|NCT03536884|593960870|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
164435243|NCT03536884|593960871|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
164435244|NCT03536884|593960872|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
164435245|NCT03536884|593960873|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
164435246|NCT03536884|593960874|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
164435247|NCT03536884|593960875|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
164435248|NCT03536884|593960876|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
164435249|NCT03536884|593960877|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
164435250|NCT03536884|593960878|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
164435251|NCT03536884|593960867|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
164435252|NCT03536884|593960868|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
164435253|NCT03536884|593960869|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
164435254|NCT03536884|593960870|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
164435255|NCT03536884|593960871|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
164435256|NCT03536884|593960872|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
164435257|NCT03536884|593960873|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
164435258|NCT03536884|593960874|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
164435259|NCT03536884|593960875|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
164435260|NCT03536884|593960876|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
164435261|NCT03536884|593960877|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
164435262|NCT03536884|593960878|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
164435263|NCT03536884|593960867|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
164435264|NCT03536884|593960868|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
164435265|NCT03536884|593960869|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
164435266|NCT03536884|593960870|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
164435267|NCT03536884|593960871|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
164435268|NCT03536884|593960872|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
164435269|NCT03536884|593960873|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
164435270|NCT03536884|593960874|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
164435271|NCT03536884|593960875|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
164435272|NCT03536884|593960876|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
164435273|NCT03536884|593960877|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
164435274|NCT03536884|593960878|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
164435275|NCT03536884|593960867|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
164435276|NCT03536884|593960868|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
164435277|NCT03536884|593960869|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
164435278|NCT03536884|593960870|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
164435279|NCT03536884|593960871|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
164435280|NCT03536884|593960872|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
164435281|NCT03536884|593960873|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
164435282|NCT03536884|593960874|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
164435283|NCT03536884|593960875|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
164435284|NCT03536884|593960876|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
164435285|NCT03536884|593960877|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
164435286|NCT03536884|593960878|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
164435287|NCT03536884|593960867|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
164435288|NCT03536884|593960868|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
164435289|NCT03536884|593960869|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
164435290|NCT03536884|593960870|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
164435291|NCT03536884|593960871|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
164587532|NCT00960440|594515861|FG000|Overall Study|Death|0|||
164435292|NCT03536884|593960872|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
164435293|NCT03536884|593960873|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
164587533|NCT00960440|594515862|FG001|Overall Study|Death|0|||
164587534|NCT00960440|594515863|FG002|Overall Study|Death|0|||
164435294|NCT03536884|593960874|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
164435295|NCT03536884|593960875|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
164435296|NCT03536884|593960876|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
164435297|NCT03536884|593960877|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
164435298|NCT03536884|593960878|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
164435299|NCT03536884|593960867|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
164435300|NCT03536884|593960868|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
164435301|NCT03536884|593960869|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
164435302|NCT03536884|593960870|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
164435303|NCT03536884|593960871|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
164435304|NCT03536884|593960872|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
164435305|NCT03536884|593960873|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
164435306|NCT03536884|593960874|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
164435307|NCT03536884|593960875|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
164435308|NCT03536884|593960876|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
164435309|NCT03536884|593960877|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
164435310|NCT03536884|593960878|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
164435311|NCT03536884|593960867|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
164435312|NCT03536884|593960868|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
164435313|NCT03536884|593960869|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
164435314|NCT03536884|593960870|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
164435315|NCT03536884|593960871|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
164435316|NCT03536884|593960872|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
164435317|NCT03536884|593960873|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
164435318|NCT03536884|593960874|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
164435319|NCT03536884|593960875|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
164435320|NCT03536884|593960876|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
164435321|NCT03536884|593960877|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
164435322|NCT03536884|593960878|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
164435323|NCT03536884|593960867|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
164435324|NCT03536884|593960868|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
164435325|NCT03536884|593960869|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
164435326|NCT03536884|593960870|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
164435327|NCT03536884|593960871|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
164435328|NCT03536884|593960872|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
164435329|NCT03536884|593960873|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
164435330|NCT03536884|593960874|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
164435331|NCT03536884|593960875|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
164435332|NCT03536884|593960876|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
164435333|NCT03536884|593960877|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
164435334|NCT03536884|593960878|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
164435335|NCT03536884|593960867|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
164435336|NCT03536884|593960868|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
164435337|NCT03536884|593960869|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
164435338|NCT03536884|593960870|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
164435339|NCT03536884|593960871|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
164435340|NCT03536884|593960872|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
164435341|NCT03536884|593960873|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
164435342|NCT03536884|593960874|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
164435343|NCT03536884|593960875|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
164435344|NCT03536884|593960876|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
164435345|NCT03536884|593960877|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
164435346|NCT03536884|593960878|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
164435347|NCT03536884|593960867|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
164435348|NCT03536884|593960868|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
164435349|NCT03536884|593960869|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
164435350|NCT03536884|593960870|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
164435351|NCT03536884|593960871|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
164435352|NCT03536884|593960872|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
164435353|NCT03536884|593960873|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
164435354|NCT03536884|593960874|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
164435355|NCT03536884|593960875|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
164435356|NCT03536884|593960876|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
164435357|NCT03536884|593960877|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
164435358|NCT03536884|593960878|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
164435359|NCT03536884|593960867|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
164587535|NCT00960440|594515864|FG003|Overall Study|Death|1|||
164587536|NCT00960440|594515861|FG000|Overall Study|Adverse Event|12|||
164587537|NCT00960440|594515862|FG001|Overall Study|Adverse Event|12|||
164587538|NCT00960440|594515863|FG002|Overall Study|Adverse Event|4|||
164587539|NCT00960440|594515864|FG003|Overall Study|Adverse Event|4|||
164435360|NCT03536884|593960868|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
164435361|NCT03536884|593960869|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
164435362|NCT03536884|593960870|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
164435363|NCT03536884|593960871|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
164435364|NCT03536884|593960872|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
164435365|NCT03536884|593960873|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
164435366|NCT03536884|593960874|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
164435367|NCT03536884|593960875|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
164435368|NCT03536884|593960876|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
164435369|NCT03536884|593960877|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
164435370|NCT03536884|593960878|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
164435371|NCT03536884|593960867|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
164435372|NCT03536884|593960868|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
164435373|NCT03536884|593960869|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
164435374|NCT03536884|593960870|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
164435375|NCT03536884|593960871|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
164297617|NCT02485691|593463949|FG000|Overall Study|Poor compliance to protocol|0|||
164297618|NCT02485691|593463950|FG001|Overall Study|Poor compliance to protocol|1|||
164297619|NCT02485691|593463949|FG000|Overall Study|Disease progression|57|||
164297620|NCT02485691|593463950|FG001|Overall Study|Disease progression|92|||
164435376|NCT03536884|593960872|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
164435377|NCT03536884|593960873|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
164297621|NCT02485691|593463949|FG000|Overall Study|Investigator's decision|23|||
164297622|NCT02485691|593463950|FG001|Overall Study|Investigator's decision|5|||
164435378|NCT03536884|593960874|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
164435379|NCT03536884|593960875|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
164435380|NCT03536884|593960876|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
164435381|NCT03536884|593960877|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
164435382|NCT03536884|593960878|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
164435383|NCT03536884|593960867|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
164435384|NCT03536884|593960868|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
164435385|NCT03536884|593960869|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
164435386|NCT03536884|593960870|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
164435387|NCT03536884|593960871|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
164435388|NCT03536884|593960872|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
164435389|NCT03536884|593960873|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
164435390|NCT03536884|593960874|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
164435391|NCT03536884|593960875|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
164435392|NCT03536884|593960876|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
164435393|NCT03536884|593960877|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
164435394|NCT03536884|593960878|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
164435395|NCT03536884|593960867|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
164435396|NCT03536884|593960868|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
164435397|NCT03536884|593960869|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
164435398|NCT03536884|593960870|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
164435399|NCT03536884|593960871|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
164435400|NCT03536884|593960872|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
164435401|NCT03536884|593960873|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
164435402|NCT03536884|593960874|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
164435403|NCT03536884|593960875|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
164435404|NCT03536884|593960876|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
164435405|NCT03536884|593960877|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
164435406|NCT03536884|593960878|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
164435407|NCT03722446|593960879|FG000|Overall Study|Protocol Violation|15|||
164435408|NCT03722446|593960880|FG001|Overall Study|Protocol Violation|2|||
164435409|NCT01137292|593960885|FG000|Overall Study|Death|30|||
164435410|NCT01137292|593960885|FG000|Overall Study|Adverse Event|3|||
164435411|NCT01137292|593960885|FG000|Overall Study|Lack of Efficacy|13|||
164435412|NCT01137292|593960885|FG000|Overall Study|Lost to Follow-up|1|||
164435413|NCT01137292|593960885|FG000|Overall Study|Other|7|||
164297623|NCT02485691|593463949|FG000|Overall Study|Participant's request|13|||
164297624|NCT02485691|593463950|FG001|Overall Study|Participant's request|6|||
164297625|NCT02485691|593463949|FG000|Overall Study|Other reason|8|||
164297626|NCT02485691|593463950|FG001|Overall Study|Other reason|9|||
164297627|NCT02485691|593463949|FG000|Overall Study|Randomized and not treated|3|||
164297628|NCT02485691|593463950|FG001|Overall Study|Randomized and not treated|2|||
164297629|NCT03518086|593463953|FG000|Overall Study|Adverse Event|23|||
164297630|NCT03518086|593463954|FG001|Overall Study|Adverse Event|15|||
164297631|NCT03518086|593463955|FG002|Overall Study|Adverse Event|3|||
164297632|NCT03518086|593463956|FG003|Overall Study|Adverse Event|2|||
164297633|NCT03518086|593463953|FG000|Overall Study|Withdrawal by Subject|8|||
164297634|NCT03518086|593463954|FG001|Overall Study|Withdrawal by Subject|5|||
164297635|NCT03518086|593463955|FG002|Overall Study|Withdrawal by Subject|1|||
164297636|NCT03518086|593463956|FG003|Overall Study|Withdrawal by Subject|0|||
164297637|NCT03518086|593463953|FG000|Overall Study|Lack of Efficacy|5|||
164297638|NCT03518086|593463954|FG001|Overall Study|Lack of Efficacy|5|||
164297639|NCT03518086|593463955|FG002|Overall Study|Lack of Efficacy|0|||
164297640|NCT03518086|593463956|FG003|Overall Study|Lack of Efficacy|2|||
164297641|NCT03518086|593463953|FG000|Overall Study|Protocol Violation|1|||
164297642|NCT03518086|593463954|FG001|Overall Study|Protocol Violation|5|||
164297643|NCT03518086|593463955|FG002|Overall Study|Protocol Violation|1|||
164297644|NCT03518086|593463956|FG003|Overall Study|Protocol Violation|3|||
164297645|NCT03518086|593463953|FG000|Overall Study|Lost to Follow-up|0|||
164297646|NCT03518086|593463954|FG001|Overall Study|Lost to Follow-up|3|||
164297647|NCT03518086|593463955|FG002|Overall Study|Lost to Follow-up|0|||
164297648|NCT03518086|593463956|FG003|Overall Study|Lost to Follow-up|0|||
164297649|NCT03518086|593463953|FG000|Overall Study|Insufficient Diary Data|0|||
164297650|NCT03518086|593463954|FG001|Overall Study|Insufficient Diary Data|2|||
164297651|NCT03518086|593463955|FG002|Overall Study|Insufficient Diary Data|0|||
164297652|NCT03518086|593463956|FG003|Overall Study|Insufficient Diary Data|0|||
164297653|NCT03518086|593463953|FG000|Overall Study|Non- compliance to Protocol|0|||
164297654|NCT03518086|593463954|FG001|Overall Study|Non- compliance to Protocol|1|||
164297655|NCT03518086|593463955|FG002|Overall Study|Non- compliance to Protocol|0|||
164297656|NCT03518086|593463956|FG003|Overall Study|Non- compliance to Protocol|0|||
164297657|NCT03518086|593463953|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
164297658|NCT03518086|593463954|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
164297659|NCT03518086|593463955|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
164297660|NCT03518086|593463956|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
164297661|NCT03518086|593463953|FG000|Overall Study|Site Terminated by Sponsor|0|||
164297662|NCT03518086|593463954|FG001|Overall Study|Site Terminated by Sponsor|1|||
164297663|NCT03518086|593463955|FG002|Overall Study|Site Terminated by Sponsor|0|||
164297664|NCT03518086|593463956|FG003|Overall Study|Site Terminated by Sponsor|0|||
164297665|NCT03518086|593463953|FG000|Overall Study|Pregnancy|0|||
164297666|NCT03518086|593463954|FG001|Overall Study|Pregnancy|0|||
164297667|NCT03518086|593463955|FG002|Overall Study|Pregnancy|0|||
164297668|NCT03518086|593463956|FG003|Overall Study|Pregnancy|2|||
164297669|NCT02336282|593463957|FG000|Overall Study|Unrelated illness|1|||
164297670|NCT02336282|593463957|FG000|Overall Study|Uncomfortable with technology|1|||
164297671|NCT02336282|593463957|FG000|Overall Study|Lost to Follow-up|1|||
164297672|NCT02336282|593463957|FG000|Overall Study|Not enough time to complete sessions|2|||
164297673|NCT04163341|593463958|FG000|Overall Study|Withdrawal by Subject|2|||
164297674|NCT04163341|593463959|FG001|Overall Study|Withdrawal by Subject|0|||
164297675|NCT04163341|593463958|FG000|Overall Study|Lost to Follow-up|3|||
164297676|NCT04163341|593463959|FG001|Overall Study|Lost to Follow-up|4|||
164297677|NCT00079417|593465953|FG000|Overall Study|Physician Decision|2|||
164297678|NCT00079417|593465953|FG000|Overall Study|Ineligible|7|||
164297679|NCT01615939|593465954|FG000|Overall Study|Lost to Follow-up|5|||
164297680|NCT01615939|593465955|FG001|Overall Study|Lost to Follow-up|0|||
164297681|NCT01586364|593465956|FG000|Overall Study|Withdrawal by Subject|40|||
164297682|NCT01586364|593465956|FG000|Overall Study|Adverse Event|37|||
164297683|NCT01586364|593465956|FG000|Overall Study|Lost to Follow-up|17|||
164297684|NCT01586364|593465956|FG000|Overall Study|Protocol Violation|16|||
164297685|NCT01586364|593465956|FG000|Overall Study|Lack of Efficacy|1|||
164297686|NCT01586364|593465956|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
164297687|NCT01586364|593465956|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
164297688|NCT01586364|593465956|FG000|Overall Study|Other-Site closure due to PI illness|1|||
164587540|NCT00960440|594515861|FG000|Overall Study|Lack of Efficacy|2|||
164587541|NCT00960440|594515862|FG001|Overall Study|Lack of Efficacy|5|||
164297689|NCT01586364|593465956|FG000|Overall Study|Other-PI discretion, site closing|2|||
164297690|NCT01586364|593465956|FG000|Overall Study|Other-Not specified|1|||
164297691|NCT02121535|593465957|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
164297692|NCT02121535|593465958|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
164297693|NCT02121535|593465957|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
164297694|NCT02121535|593465958|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
164587542|NCT00960440|594515863|FG002|Overall Study|Lack of Efficacy|3|||
164297695|NCT05366738|593465959|FG000|Overall Study|Adverse Event|0|||
164297696|NCT05366738|593465960|FG001|Overall Study|Adverse Event|1|||
164297697|NCT05366738|593465961|FG002|Overall Study|Adverse Event|0|||
164297698|NCT01054885|593465968|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
164297699|NCT01054885|593465969|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164297700|NCT01054885|593465970|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164297701|NCT01054885|593465971|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164297702|NCT01054885|593465972|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164297703|NCT01054885|593465973|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164297704|NCT01054885|593465974|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164297705|NCT01054885|593465968|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
164297706|NCT01054885|593465969|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
164297707|NCT01054885|593465970|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
164297708|NCT01054885|593465971|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
164297709|NCT01054885|593465972|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
164297710|NCT01054885|593465973|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
164297711|NCT01054885|593465974|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
164297712|NCT01054885|593465968|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
164297713|NCT01054885|593465969|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164297714|NCT01054885|593465970|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164297715|NCT01054885|593465971|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164297716|NCT01054885|593465972|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164297717|NCT01054885|593465973|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164297718|NCT01054885|593465974|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164297719|NCT01054885|593465968|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
164297720|NCT01054885|593465969|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164297721|NCT01054885|593465970|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164297722|NCT01054885|593465971|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164297723|NCT01054885|593465972|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164297724|NCT01054885|593465973|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164297725|NCT01054885|593465974|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164297726|NCT01054885|593465968|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
164297727|NCT01054885|593465969|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
164297728|NCT01054885|593465970|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
164297729|NCT01054885|593465971|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
164297730|NCT01054885|593465972|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
164297731|NCT01054885|593465973|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
164297732|NCT01054885|593465974|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
164297733|NCT01054885|593465968|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
164297734|NCT01054885|593465969|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
164297735|NCT01054885|593465970|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
164297736|NCT01054885|593465971|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
164297737|NCT01054885|593465972|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
164297738|NCT01054885|593465973|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
164297739|NCT01054885|593465974|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
164297740|NCT01054885|593465968|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
164297741|NCT01054885|593465969|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
164297742|NCT01054885|593465970|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
164297743|NCT01054885|593465971|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
164297744|NCT01054885|593465972|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
164297745|NCT01054885|593465973|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
164297746|NCT01054885|593465974|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
164297747|NCT01054885|593465968|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
164297748|NCT01054885|593465969|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
164297749|NCT01054885|593465970|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
164297750|NCT01054885|593465971|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
164297751|NCT01054885|593465972|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
164297752|NCT01054885|593465973|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
164297753|NCT01054885|593465974|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
164297754|NCT01054885|593465968|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
164297755|NCT01054885|593465969|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
164297756|NCT01054885|593465970|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
164297757|NCT01054885|593465971|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
164299997|NCT05138653|593472964|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164299998|NCT05138653|593472965|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164297758|NCT01054885|593465972|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
164297759|NCT01054885|593465973|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
164297760|NCT01054885|593465974|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
164297761|NCT01054885|593465968|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
164297762|NCT01054885|593465969|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
164297763|NCT01054885|593465970|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
164297764|NCT01054885|593465971|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
164297765|NCT01054885|593465972|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
164297766|NCT01054885|593465973|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
164297767|NCT01054885|593465974|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
164297768|NCT01054885|593465968|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
164297769|NCT01054885|593465969|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
164297770|NCT01054885|593465970|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
164297771|NCT01054885|593465971|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
164297772|NCT01054885|593465972|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
164297773|NCT01054885|593465973|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
164297774|NCT01054885|593465974|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
164297775|NCT01054885|593465968|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
164297776|NCT01054885|593465969|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
164297777|NCT01054885|593465970|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
164435414|NCT04540835|593960886|FG000|Week 1|Lost to Follow-up|1|||
164435415|NCT04540835|593960886|FG000|Week 6|Pregnancy|1|||
164435416|NCT04540835|593960886|FG000|Week 6|Lack of Efficacy|1|||
164435417|NCT01838200|593960887|FG000|Overall Study|Adverse Event|0|||
164435418|NCT01838200|593960888|FG001|Overall Study|Adverse Event|2|||
164297778|NCT01054885|593465971|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
164297779|NCT01054885|593465972|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
164297780|NCT01054885|593465973|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
164297781|NCT01054885|593465974|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
164297782|NCT01054885|593465968|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164435419|NCT01838200|593960887|FG000|Overall Study|Progressive disease|3|||
164435420|NCT01838200|593960888|FG001|Overall Study|Progressive disease|0|||
164435421|NCT03105336|593960889|FG000|Overall Study|Rollover to Longterm Follow-up Study Criteria|61|||
164435422|NCT03105336|593960890|FG001|Overall Study|Rollover to Longterm Follow-up Study Criteria|15|||
164435423|NCT03105336|593960889|FG000|Overall Study|Death|40|||
164435424|NCT03105336|593960890|FG001|Overall Study|Death|8|||
164435425|NCT03105336|593960889|FG000|Overall Study|Lost to Follow-up|13|||
164435426|NCT03105336|593960890|FG001|Overall Study|Lost to Follow-up|2|||
164435427|NCT03105336|593960889|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|7|||
164435428|NCT03105336|593960890|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
164435429|NCT03105336|593960889|FG000|Overall Study|Reason Not Specified|3|||
164435430|NCT03105336|593960890|FG001|Overall Study|Reason Not Specified|3|||
164435431|NCT03105336|593960889|FG000|Overall Study|Investigator Decision|3|||
164435432|NCT03105336|593960890|FG001|Overall Study|Investigator Decision|0|||
164435433|NCT03451851|593960891|FG000|PCP: Week 0 -16|Adverse Event|1|||
164693636|NCT00739973|594899423|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
164297783|NCT01054885|593465969|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
164297784|NCT01054885|593465970|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
164297785|NCT01054885|593465971|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164297786|NCT01054885|593465972|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164297787|NCT01054885|593465973|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
164297788|NCT01054885|593465974|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
164297789|NCT01054885|593465968|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
164297790|NCT01054885|593465969|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
164297791|NCT01054885|593465970|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
164297792|NCT01054885|593465971|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
164297793|NCT01054885|593465972|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
164435434|NCT03451851|593960892|FG001|PCP: Week 0 -16|Adverse Event|0|||
164435435|NCT03451851|593960893|FG002|PCP: Week 0 -16|Adverse Event|0|||
164435436|NCT03451851|593960894|FG003|PCP: Week 0 -16|Adverse Event|0|||
164435437|NCT03451851|593960895|FG004|PCP: Week 0 -16|Adverse Event|0|||
164435438|NCT03451851|593960896|FG005|PCP: Week 0 -16|Adverse Event|0|||
164435439|NCT03451851|593960897|FG006|PCP: Week 0 -16|Adverse Event|1|||
164435440|NCT03451851|593960898|FG007|PCP: Week 0 -16|Adverse Event|0|||
164435441|NCT03451851|593960891|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
164435442|NCT03451851|593960892|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
164435443|NCT03451851|593960893|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
164693637|NCT00739973|594899424|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
164297794|NCT01054885|593465973|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
164297795|NCT01054885|593465974|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
164297796|NCT01054885|593465968|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
164297797|NCT01054885|593465969|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
164297798|NCT01054885|593465970|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
164297799|NCT01054885|593465971|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
164297800|NCT01054885|593465972|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
164297801|NCT01054885|593465973|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
164297802|NCT01054885|593465974|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
164297803|NCT00804908|593465975|FG000|Overall Study|Other|115|||
164297804|NCT00804908|593465976|FG001|Overall Study|Other|116|||
164297805|NCT00804908|593465977|FG002|Overall Study|Other|114|||
164297806|NCT01280903|593465978|FG000|Overall Study|Lost to Follow-up|23|||
164297807|NCT01280903|593465979|FG001|Overall Study|Lost to Follow-up|16|||
164297808|NCT03829228|593465982|FG000|Overall Study|Protocol Violation|1|||
164297809|NCT02177695|593465983|FG000|ITT Analysis|Ineligible|5|||
164297810|NCT02177695|593465984|FG001|ITT Analysis|Ineligible|5|||
164297811|NCT02177695|593465983|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
164297812|NCT02177695|593465984|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
164297813|NCT02177695|593465983|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
164297814|NCT02177695|593465984|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
164297815|NCT02177695|593465983|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
164297816|NCT02177695|593465984|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
164297817|NCT02443688|593465987|FG000|Overall Study|Adverse Event|2|||
164297818|NCT02443688|593465988|FG001|Overall Study|Adverse Event|3|||
164297819|NCT02443688|593465989|FG002|Overall Study|Adverse Event|2|||
164297820|NCT02443688|593465987|FG000|Overall Study|Lost to Follow-up|1|||
164297821|NCT02443688|593465988|FG001|Overall Study|Lost to Follow-up|0|||
164297822|NCT02443688|593465989|FG002|Overall Study|Lost to Follow-up|0|||
164297823|NCT02443688|593465987|FG000|Overall Study|Physician Decision|3|||
164297824|NCT02443688|593465988|FG001|Overall Study|Physician Decision|0|||
164297825|NCT02443688|593465989|FG002|Overall Study|Physician Decision|1|||
164297826|NCT02443688|593465987|FG000|Overall Study|Pregnancy|0|||
164297827|NCT02443688|593465988|FG001|Overall Study|Pregnancy|0|||
164297828|NCT02443688|593465989|FG002|Overall Study|Pregnancy|1|||
164297829|NCT02443688|593465987|FG000|Overall Study|Withdrawal by Subject|3|||
164297830|NCT02443688|593465988|FG001|Overall Study|Withdrawal by Subject|3|||
164297831|NCT02443688|593465989|FG002|Overall Study|Withdrawal by Subject|4|||
164297832|NCT02443688|593465987|FG000|Overall Study|Non-compliance with study drug|1|||
164297833|NCT02443688|593465988|FG001|Overall Study|Non-compliance with study drug|2|||
164297834|NCT02443688|593465989|FG002|Overall Study|Non-compliance with study drug|4|||
164297835|NCT02443688|593465987|FG000|Overall Study|Sponsor Request|2|||
164297836|NCT02443688|593465988|FG001|Overall Study|Sponsor Request|1|||
164297837|NCT02443688|593465989|FG002|Overall Study|Sponsor Request|0|||
164297838|NCT03182374|593465990|FG000|Overall Study|Lost to Follow-up|3|||
164297839|NCT03182374|593465991|FG001|Overall Study|Lost to Follow-up|2|||
164297840|NCT03182374|593465990|FG000|Overall Study|Lack of Efficacy|8|||
164297841|NCT03182374|593465991|FG001|Overall Study|Lack of Efficacy|14|||
164297842|NCT03182374|593465990|FG000|Overall Study|Withdrawal by Subject|1|||
164297843|NCT03182374|593465991|FG001|Overall Study|Withdrawal by Subject|1|||
164297844|NCT03182374|593465990|FG000|Overall Study|exit for non-compliance|1|||
164297845|NCT03182374|593465991|FG001|Overall Study|exit for non-compliance|1|||
164297846|NCT03182374|593465990|FG000|Overall Study|one subject was randomized but not treated|1|||
164297847|NCT03182374|593465991|FG001|Overall Study|one subject was randomized but not treated|0|||
164297848|NCT03182374|593465990|FG000|Overall Study|Other reasons|0|||
164297849|NCT03182374|593465991|FG001|Overall Study|Other reasons|3|||
164297850|NCT01462370|593465992|FG000|Overall Study|Lack of Qualifying Event|1|||
164297851|NCT01462370|593465993|FG001|Overall Study|Lack of Qualifying Event|1|||
164297852|NCT01462370|593465992|FG000|Overall Study|Physician Decision|0|||
164297853|NCT01462370|593465993|FG001|Overall Study|Physician Decision|1|||
164297854|NCT01462370|593465992|FG000|Overall Study|Withdrawal by Subject|0|||
164297855|NCT01462370|593465993|FG001|Overall Study|Withdrawal by Subject|3|||
164347723|NCT00884312|593650875|FG001|Overall Study|Non-fatal Progressive Disease|8|||
164347724|NCT00884312|593650874|FG000|Overall Study|Fatal Progressive Disease|0|||
164347725|NCT00884312|593650875|FG001|Overall Study|Fatal Progressive Disease|1|||
164347726|NCT00884312|593650874|FG000|Overall Study|Non-fatal Adverse Event|1|||
164297856|NCT00473564|593465996|FG000|Overall Study|robot surgery aborted in OR|23|||
164297857|NCT00914316|593465999|FG000|Phase 1|Physician Decision|4|||
164347727|NCT00884312|593650875|FG001|Overall Study|Non-fatal Adverse Event|0|||
164347728|NCT00884312|593650874|FG000|Overall Study|Fatal Adverse Event|1|||
164347729|NCT00884312|593650875|FG001|Overall Study|Fatal Adverse Event|4|||
164347730|NCT00884312|593650874|FG000|Overall Study|Withdrawal by Subject|0|||
164297858|NCT00914316|593466000|FG001|Phase 1|Physician Decision|0|||
164297859|NCT00914316|593466001|FG002|Phase 1|Physician Decision|1|||
164297860|NCT00914316|593466002|FG003|Phase 1|Physician Decision|2|||
164347731|NCT00884312|593650875|FG001|Overall Study|Withdrawal by Subject|6|||
164347732|NCT00884312|593650874|FG000|Overall Study|Physician Decision|0|||
164347733|NCT00884312|593650875|FG001|Overall Study|Physician Decision|1|||
164347734|NCT00884312|593650874|FG000|Overall Study|Other|0|||
164347735|NCT00884312|593650875|FG001|Overall Study|Other|4|||
164347736|NCT00884312|593650874|FG000|Overall Study|Did Not Receive Study Drug|0|||
164347737|NCT00884312|593650875|FG001|Overall Study|Did Not Receive Study Drug|1|||
164347738|NCT03902574|593650877|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
164347739|NCT03902574|593650878|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
164347740|NCT03902574|593650879|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
164347741|NCT00133952|593650880|FG000|Overall Study|Adverse Event|1|||
164347742|NCT00133952|593650881|FG001|Overall Study|Adverse Event|2|||
164347743|NCT00133952|593650880|FG000|Overall Study|Death|3|||
164347744|NCT00133952|593650881|FG001|Overall Study|Death|2|||
164347745|NCT00133952|593650880|FG000|Overall Study|Lost to Follow-up|9|||
164347746|NCT00133952|593650881|FG001|Overall Study|Lost to Follow-up|14|||
164347747|NCT00133952|593650880|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
164347748|NCT00133952|593650881|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
164347749|NCT00133952|593650880|FG000|Overall Study|Protocol Violation|1|||
164347750|NCT00133952|593650881|FG001|Overall Study|Protocol Violation|1|||
164347751|NCT00133952|593650880|FG000|Overall Study|Withdrawal by Subject|20|||
164347752|NCT00133952|593650881|FG001|Overall Study|Withdrawal by Subject|4|||
164347753|NCT00133952|593650880|FG000|Overall Study|Physician Decision|4|||
164347754|NCT00133952|593650881|FG001|Overall Study|Physician Decision|3|||
164347755|NCT00133952|593650880|FG000|Overall Study|Sponsor Decision|0|||
164347756|NCT00133952|593650881|FG001|Overall Study|Sponsor Decision|1|||
164347757|NCT02101060|593650893|FG000|Overall Study|Adverse Event|1|||
164347758|NCT02101060|593650894|FG001|Overall Study|Adverse Event|0|||
164347759|NCT02101060|593650893|FG000|Overall Study|Withdrawal by Subject|1|||
164347760|NCT02101060|593650894|FG001|Overall Study|Withdrawal by Subject|1|||
164347761|NCT02101060|593650893|FG000|Overall Study|Lost to Follow-up|3|||
164347762|NCT02101060|593650894|FG001|Overall Study|Lost to Follow-up|3|||
164347763|NCT00545168|593650901|FG000|Overall Study|Lost to Follow-up|5|||
164347764|NCT00545168|593650902|FG001|Overall Study|Lost to Follow-up|5|||
164347765|NCT00545168|593650903|FG002|Overall Study|Lost to Follow-up|5|||
164347766|NCT00545168|593650901|FG000|Overall Study|Withdrawal by Subject|9|||
164347767|NCT00545168|593650902|FG001|Overall Study|Withdrawal by Subject|0|||
164347768|NCT00545168|593650903|FG002|Overall Study|Withdrawal by Subject|13|||
164347769|NCT00545168|593650901|FG000|Overall Study|Protocol Violation|1|||
164347770|NCT00545168|593650902|FG001|Overall Study|Protocol Violation|0|||
164347771|NCT00545168|593650903|FG002|Overall Study|Protocol Violation|1|||
164347772|NCT00545168|593650901|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
164347773|NCT00545168|593650902|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
164347774|NCT00545168|593650903|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
164347775|NCT01833520|593650908|FG000|Overall Study|Lack of Efficacy|3|||
164347776|NCT01833520|593650909|FG001|Overall Study|Lack of Efficacy|3|||
164347777|NCT01833520|593650910|FG002|Overall Study|Lack of Efficacy|8|||
164347778|NCT01833520|593650911|FG003|Overall Study|Lack of Efficacy|3|||
164347779|NCT00489541|593650912|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
164347780|NCT00489541|593650913|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
164347781|NCT00489541|593650912|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
164347782|NCT00489541|593650913|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
164347783|NCT00489541|593650912|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
164347784|NCT00489541|593650913|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
164347785|NCT00489541|593650912|FG000|12-Month Clinical Follow-up|Death|3|||
164347786|NCT00489541|593650913|FG001|12-Month Clinical Follow-up|Death|2|||
164347787|NCT00489541|593650912|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
164347788|NCT00489541|593650913|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
164347789|NCT00489541|593650912|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
164347790|NCT00489541|593650913|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
164347791|NCT00003479|593650917|FG000|Overall Study|Not evaluable|3|||
164347792|NCT01484197|593650918|FG000|Treatment Period 1|Adverse Event|1|||
164347793|NCT01484197|593650919|FG001|Treatment Period 1|Adverse Event|0|||
164347794|NCT01484197|593650920|FG002|Treatment Period 1|Adverse Event|0|||
164347795|NCT01484197|593650921|FG003|Treatment Period 1|Adverse Event|0|||
164347796|NCT01484197|593650918|FG000|Treatment Period 2|Subject withdrew consent|0|||
164347797|NCT01484197|593650919|FG001|Treatment Period 2|Subject withdrew consent|0|||
164347798|NCT01484197|593650920|FG002|Treatment Period 2|Subject withdrew consent|0|||
164347799|NCT01484197|593650921|FG003|Treatment Period 2|Subject withdrew consent|1|||
164347800|NCT01727297|593650922|FG000|Overall Study|Death|13|||
164347801|NCT01727297|593650923|FG001|Overall Study|Death|0|||
164347802|NCT01727297|593650922|FG000|Overall Study|Protocol Violation|1|||
164347803|NCT01727297|593650923|FG001|Overall Study|Protocol Violation|10|||
164347804|NCT01727297|593650922|FG000|Overall Study|Adverse Event|3|||
164347805|NCT01727297|593650923|FG001|Overall Study|Adverse Event|1|||
164347806|NCT01727297|593650922|FG000|Overall Study|Lost to Follow-up|11|||
164435444|NCT03451851|593960894|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
164435445|NCT03451851|593960895|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
164435446|NCT03451851|593960896|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
164435447|NCT03451851|593960897|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
164435448|NCT03451851|593960898|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
164435449|NCT03451851|593960891|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
164435450|NCT03451851|593960892|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
164435451|NCT03451851|593960893|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
164435452|NCT03451851|593960894|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
164435453|NCT03451851|593960895|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
164435454|NCT03451851|593960896|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
164435455|NCT03451851|593960897|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
164435456|NCT03451851|593960898|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
164435457|NCT03451851|593960891|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
164435458|NCT03451851|593960892|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
164435459|NCT03451851|593960893|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
164435460|NCT03451851|593960894|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
164435461|NCT03451851|593960895|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
164435462|NCT03451851|593960896|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
164435463|NCT03451851|593960897|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
164435464|NCT03451851|593960898|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
164435465|NCT03451851|593960891|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
164435466|NCT03451851|593960892|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
164435467|NCT03451851|593960893|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
164435468|NCT03451851|593960894|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
164435469|NCT03451851|593960895|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
164435470|NCT03451851|593960896|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
164435471|NCT03451851|593960897|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
164435472|NCT03451851|593960898|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
164435473|NCT03451851|593960891|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
164435474|NCT03451851|593960892|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
164435475|NCT03451851|593960893|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
164435476|NCT03451851|593960894|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
164435477|NCT03451851|593960895|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
164435478|NCT03451851|593960896|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
164435479|NCT03451851|593960897|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
164435480|NCT03451851|593960898|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
164435481|NCT03944512|593960899|FG000|Overall Study|Death|0|||
164435482|NCT03944512|593960900|FG001|Overall Study|Death|0|||
164435483|NCT03944512|593960901|FG002|Overall Study|Death|1|||
164435484|NCT03944512|593960902|FG003|Overall Study|Death|2|||
164435485|NCT03944512|593960899|FG000|Overall Study|Lost to Follow-up|0|||
164435486|NCT03944512|593960900|FG001|Overall Study|Lost to Follow-up|0|||
164435487|NCT03944512|593960901|FG002|Overall Study|Lost to Follow-up|4|||
164435488|NCT03944512|593960902|FG003|Overall Study|Lost to Follow-up|4|||
164435489|NCT03944512|593960899|FG000|Overall Study|refused follow-up|0|||
164435490|NCT03944512|593960900|FG001|Overall Study|refused follow-up|0|||
164435491|NCT03944512|593960901|FG002|Overall Study|refused follow-up|2|||
164435492|NCT03944512|593960902|FG003|Overall Study|refused follow-up|2|||
164435493|NCT01090024|593962024|FG000|Period 1|Met exclusion criteria|0|||
164435494|NCT01090024|593962025|FG001|Period 1|Met exclusion criteria|0|||
164435495|NCT01090024|593962026|FG002|Period 1|Met exclusion criteria|0|||
164435496|NCT01090024|593962027|FG003|Period 1|Met exclusion criteria|0|||
164435497|NCT01090024|593962028|FG004|Period 1|Met exclusion criteria|0|||
164435498|NCT01090024|593962029|FG005|Period 1|Met exclusion criteria|0|||
164435499|NCT01090024|593962030|FG006|Period 1|Met exclusion criteria|0|||
164435500|NCT01090024|593962031|FG007|Period 1|Met exclusion criteria|0|||
164435501|NCT01090024|593962032|FG008|Period 1|Met exclusion criteria|0|||
164435502|NCT01090024|593962033|FG009|Period 1|Met exclusion criteria|0|||
164435503|NCT01090024|593962034|FG010|Period 1|Met exclusion criteria|0|||
164435504|NCT01090024|593962035|FG011|Period 1|Met exclusion criteria|0|||
164435505|NCT01090024|593962036|FG012|Period 1|Met exclusion criteria|0|||
164435506|NCT01090024|593962037|FG013|Period 1|Met exclusion criteria|0|||
164435507|NCT01090024|593962038|FG014|Period 1|Met exclusion criteria|1|||
164435508|NCT01090024|593962039|FG015|Period 1|Met exclusion criteria|0|||
164435509|NCT01090024|593962040|FG016|Period 1|Met exclusion criteria|0|||
164435510|NCT01090024|593962041|FG017|Period 1|Met exclusion criteria|0|||
164435511|NCT01090024|593962024|FG000|Period 1|Adverse Event|0|||
164435512|NCT01090024|593962025|FG001|Period 1|Adverse Event|0|||
164435513|NCT01090024|593962026|FG002|Period 1|Adverse Event|0|||
164435514|NCT01090024|593962027|FG003|Period 1|Adverse Event|0|||
164435515|NCT01090024|593962028|FG004|Period 1|Adverse Event|0|||
164435516|NCT01090024|593962029|FG005|Period 1|Adverse Event|0|||
164435517|NCT01090024|593962030|FG006|Period 1|Adverse Event|0|||
164435518|NCT01090024|593962031|FG007|Period 1|Adverse Event|0|||
164435519|NCT01090024|593962032|FG008|Period 1|Adverse Event|0|||
164435520|NCT01090024|593962033|FG009|Period 1|Adverse Event|1|||
164435521|NCT01090024|593962034|FG010|Period 1|Adverse Event|0|||
164435522|NCT01090024|593962035|FG011|Period 1|Adverse Event|1|||
164435523|NCT01090024|593962036|FG012|Period 1|Adverse Event|0|||
164435524|NCT01090024|593962037|FG013|Period 1|Adverse Event|0|||
164435525|NCT01090024|593962038|FG014|Period 1|Adverse Event|0|||
164435526|NCT01090024|593962039|FG015|Period 1|Adverse Event|0|||
164435527|NCT01090024|593962040|FG016|Period 1|Adverse Event|0|||
164435528|NCT01090024|593962041|FG017|Period 1|Adverse Event|1|||
164435529|NCT01090024|593962024|FG000|Period 1|Withdrawal by Subject|0|||
164435530|NCT01090024|593962025|FG001|Period 1|Withdrawal by Subject|0|||
164435531|NCT01090024|593962026|FG002|Period 1|Withdrawal by Subject|0|||
164435532|NCT01090024|593962027|FG003|Period 1|Withdrawal by Subject|1|||
164435533|NCT01090024|593962028|FG004|Period 1|Withdrawal by Subject|0|||
164435534|NCT01090024|593962029|FG005|Period 1|Withdrawal by Subject|0|||
164435535|NCT01090024|593962030|FG006|Period 1|Withdrawal by Subject|0|||
164587543|NCT00960440|594515864|FG003|Overall Study|Lack of Efficacy|8|||
164587544|NCT00960440|594515861|FG000|Overall Study|Protocol Violation|2|||
164587545|NCT00960440|594515862|FG001|Overall Study|Protocol Violation|8|||
164587546|NCT00960440|594515863|FG002|Overall Study|Protocol Violation|3|||
164297861|NCT00914316|593465999|FG000|Phase 1|Withdrawal by Subject|0|||
164297862|NCT00914316|593466000|FG001|Phase 1|Withdrawal by Subject|2|||
164297863|NCT00914316|593466001|FG002|Phase 1|Withdrawal by Subject|4|||
164297864|NCT00914316|593466002|FG003|Phase 1|Withdrawal by Subject|0|||
164297865|NCT00914316|593465999|FG000|Phase 1|Adverse Event|1|||
164297866|NCT00914316|593466000|FG001|Phase 1|Adverse Event|0|||
164297867|NCT00914316|593466001|FG002|Phase 1|Adverse Event|0|||
164297868|NCT00914316|593466002|FG003|Phase 1|Adverse Event|0|||
164297869|NCT00914316|593465999|FG000|Phase 2|Withdrawal by Subject|1|||
164297870|NCT00914316|593466000|FG001|Phase 2|Withdrawal by Subject|0|||
164297871|NCT00914316|593466001|FG002|Phase 2|Withdrawal by Subject|1|||
164297872|NCT00914316|593466002|FG003|Phase 2|Withdrawal by Subject|0|||
164297873|NCT01391546|593466004|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
164297874|NCT01391546|593466005|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
164297875|NCT00726063|593466006|FG000|Overall Study|Adverse Event|9|||
164297876|NCT00726063|593466007|FG001|Overall Study|Adverse Event|7|||
164297877|NCT02007096|593466008|FG000|Overall Study|medication not available|2|||
164297878|NCT02007096|593466009|FG001|Overall Study|medication not available|0|||
164297879|NCT02007096|593466008|FG000|Overall Study|did not inject saline|0|||
164297880|NCT02007096|593466009|FG001|Overall Study|did not inject saline|3|||
164297881|NCT02007096|593466008|FG000|Overall Study|did not follow postoperative protocol|8|||
164297882|NCT02007096|593466009|FG001|Overall Study|did not follow postoperative protocol|11|||
164297883|NCT02007096|593466008|FG000|Overall Study|converted to open surgery|1|||
164297884|NCT02007096|593466009|FG001|Overall Study|converted to open surgery|1|||
164297885|NCT02007096|593466008|FG000|Overall Study|no mesh placed|0|||
164297886|NCT02007096|593466009|FG001|Overall Study|no mesh placed|1|||
164297887|NCT06271993|593466010|FG000|Overall Study|Not reactive to histamine|5|||
164297888|NCT06271993|593466011|FG001|Overall Study|Not reactive to histamine|5|||
164297889|NCT06271993|593466012|FG002|Overall Study|Not reactive to histamine|5|||
164297890|NCT00837434|593466018|FG000|Overall Study|Physician Decision|3|||
164297891|NCT00837434|593466019|FG001|Overall Study|Physician Decision|0|||
164297892|NCT00837434|593466018|FG000|Overall Study|Lost to Follow-up|1|||
164435536|NCT01090024|593962031|FG007|Period 1|Withdrawal by Subject|0|||
164587547|NCT00960440|594515864|FG003|Overall Study|Protocol Violation|4|||
164297893|NCT00837434|593466019|FG001|Overall Study|Lost to Follow-up|1|||
164297894|NCT00837434|593466018|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
164297895|NCT00837434|593466019|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
164297896|NCT00837434|593466018|FG000|Overall Study|Noncompliant|2|||
164297897|NCT00837434|593466019|FG001|Overall Study|Noncompliant|0|||
164435537|NCT01090024|593962032|FG008|Period 1|Withdrawal by Subject|0|||
164435538|NCT01090024|593962033|FG009|Period 1|Withdrawal by Subject|0|||
164435539|NCT01090024|593962034|FG010|Period 1|Withdrawal by Subject|0|||
164297898|NCT00837434|593466018|FG000|Overall Study|Baseline assessments not done in time|1|||
164297899|NCT00837434|593466019|FG001|Overall Study|Baseline assessments not done in time|0|||
164587548|NCT00960440|594515861|FG000|Overall Study|Withdrawal by Subject|9|||
164297900|NCT00837434|593466018|FG000|Overall Study|Unable to obtain study drug|1|||
164297901|NCT00837434|593466019|FG001|Overall Study|Unable to obtain study drug|0|||
164297902|NCT01980017|593466020|FG000|Overall Study|Lost to Follow-up|30|||
164297903|NCT01980017|593466021|FG001|Overall Study|Lost to Follow-up|21|||
164297904|NCT01980017|593466020|FG000|Overall Study|Death|0|||
164297905|NCT01980017|593466021|FG001|Overall Study|Death|1|||
164297906|NCT03044106|593466022|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
164435540|NCT01090024|593962035|FG011|Period 1|Withdrawal by Subject|0|||
164435541|NCT01090024|593962036|FG012|Period 1|Withdrawal by Subject|0|||
164435542|NCT01090024|593962037|FG013|Period 1|Withdrawal by Subject|0|||
164435543|NCT01090024|593962038|FG014|Period 1|Withdrawal by Subject|0|||
164297907|NCT03044106|593466023|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
164297908|NCT01207414|593466024|FG000|Overall Study|Adverse Event|25|||
164297909|NCT01207414|593466025|FG001|Overall Study|Adverse Event|39|||
164297910|NCT01207414|593466024|FG000|Overall Study|Abnormal test procedure results|0|||
164297911|NCT01207414|593466025|FG001|Overall Study|Abnormal test procedure results|1|||
164297912|NCT01207414|593466024|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
164297913|NCT01207414|593466025|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
164297914|NCT01207414|593466024|FG000|Overall Study|Patient withdrew consent|14|||
164297915|NCT01207414|593466025|FG001|Overall Study|Patient withdrew consent|11|||
164297916|NCT01207414|593466024|FG000|Overall Study|Lost to Follow-up|15|||
164297917|NCT01207414|593466025|FG001|Overall Study|Lost to Follow-up|17|||
164297918|NCT01207414|593466024|FG000|Overall Study|Administrative problems|1|||
164297919|NCT01207414|593466025|FG001|Overall Study|Administrative problems|1|||
164297920|NCT01207414|593466024|FG000|Overall Study|Protocol deviation|12|||
164297921|NCT01207414|593466025|FG001|Overall Study|Protocol deviation|9|||
164297922|NCT01207414|593466024|FG000|Overall Study|Randomized in error|1|||
164297923|NCT01207414|593466025|FG001|Overall Study|Randomized in error|0|||
164297924|NCT01748292|593466026|FG000|Overall Study|Adverse Event|2|||
164297925|NCT01748292|593466027|FG001|Overall Study|Adverse Event|4|||
164297926|NCT01748292|593466026|FG000|Overall Study|Lost to Follow-up|0|||
164297927|NCT01748292|593466027|FG001|Overall Study|Lost to Follow-up|3|||
164297928|NCT01748292|593466026|FG000|Overall Study|Death|0|||
164297929|NCT01748292|593466027|FG001|Overall Study|Death|3|||
164297930|NCT01748292|593466026|FG000|Overall Study|Withdrawal by Subject|0|||
164297931|NCT01748292|593466027|FG001|Overall Study|Withdrawal by Subject|2|||
164297932|NCT02057250|593466028|FG000|AID Assessment Phase|Adverse Event|3|||
164297933|NCT02057250|593466029|FG001|AID Assessment Phase|Adverse Event|2|||
164297934|NCT02057250|593466030|FG002|AID Assessment Phase|Adverse Event|6|||
164297935|NCT02057250|593466031|FG003|AID Assessment Phase|Adverse Event|1|||
164297936|NCT02057250|593466032|FG004|AID Assessment Phase|Adverse Event|0|||
164297937|NCT02057250|593466028|FG000|AID Assessment Phase|Other than specified above|1|||
164297938|NCT02057250|593466029|FG001|AID Assessment Phase|Other than specified above|1|||
164297939|NCT02057250|593466030|FG002|AID Assessment Phase|Other than specified above|1|||
164297940|NCT02057250|593466031|FG003|AID Assessment Phase|Other than specified above|1|||
164297941|NCT02057250|593466032|FG004|AID Assessment Phase|Other than specified above|0|||
164297942|NCT02057250|593466028|FG000|Extension Phase|Adverse Event|0|||
164297943|NCT02057250|593466029|FG001|Extension Phase|Adverse Event|0|||
164297944|NCT02057250|593466030|FG002|Extension Phase|Adverse Event|0|||
164297945|NCT02057250|593466031|FG003|Extension Phase|Adverse Event|0|||
164297946|NCT02057250|593466032|FG004|Extension Phase|Adverse Event|15|||
164297947|NCT02057250|593466028|FG000|Extension Phase|Lack of Efficacy|0|||
164297948|NCT02057250|593466029|FG001|Extension Phase|Lack of Efficacy|0|||
164297949|NCT02057250|593466030|FG002|Extension Phase|Lack of Efficacy|0|||
164297950|NCT02057250|593466031|FG003|Extension Phase|Lack of Efficacy|0|||
164297951|NCT02057250|593466032|FG004|Extension Phase|Lack of Efficacy|10|||
164297952|NCT02057250|593466028|FG000|Extension Phase|Entered in this period but not treated|0|||
164297953|NCT02057250|593466029|FG001|Extension Phase|Entered in this period but not treated|0|||
164297954|NCT02057250|593466030|FG002|Extension Phase|Entered in this period but not treated|0|||
164297955|NCT02057250|593466031|FG003|Extension Phase|Entered in this period but not treated|0|||
164297956|NCT02057250|593466032|FG004|Extension Phase|Entered in this period but not treated|4|||
164297957|NCT02057250|593466028|FG000|Extension Phase|Other than specified above|0|||
164297958|NCT02057250|593466029|FG001|Extension Phase|Other than specified above|0|||
164297959|NCT02057250|593466030|FG002|Extension Phase|Other than specified above|0|||
164297960|NCT02057250|593466031|FG003|Extension Phase|Other than specified above|0|||
164297961|NCT02057250|593466032|FG004|Extension Phase|Other than specified above|7|||
164297962|NCT03199976|593466034|FG000|Overall Study|Lack of Efficacy|3|||
164347807|NCT01727297|593650923|FG001|Overall Study|Lost to Follow-up|0|||
164347808|NCT01727297|593650922|FG000|Overall Study|Withdrawal by Subject|26|||
164347809|NCT01727297|593650923|FG001|Overall Study|Withdrawal by Subject|27|||
164347810|NCT01727297|593650922|FG000|Overall Study|Physician Decision|19|||
164347811|NCT01727297|593650923|FG001|Overall Study|Physician Decision|5|||
164347812|NCT01727297|593650922|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
164347813|NCT01727297|593650923|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
164347814|NCT01192516|593650924|FG000|Overall Study|Lost to Follow-up|7|||
164347815|NCT01192516|593650925|FG001|Overall Study|Lost to Follow-up|10|||
164347816|NCT01192516|593650926|FG002|Overall Study|Lost to Follow-up|7|||
164347817|NCT01192516|593650924|FG000|Overall Study|Withdrawal by Subject|4|||
164347818|NCT01192516|593650925|FG001|Overall Study|Withdrawal by Subject|4|||
164347819|NCT01192516|593650926|FG002|Overall Study|Withdrawal by Subject|1|||
164347820|NCT01192516|593650924|FG000|Overall Study|started new treatment|5|||
164347821|NCT01192516|593650925|FG001|Overall Study|started new treatment|1|||
164347822|NCT01192516|593650926|FG002|Overall Study|started new treatment|0|||
164347823|NCT01192516|593650924|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
164347824|NCT01192516|593650925|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
164347825|NCT01192516|593650926|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
164297963|NCT03199976|593466035|FG001|Overall Study|Lack of Efficacy|6|||
164297964|NCT03199976|593466036|FG002|Overall Study|Lack of Efficacy|13|||
164297965|NCT03199976|593466034|FG000|Overall Study|Withdrawal by Subject|1|||
164297966|NCT03199976|593466035|FG001|Overall Study|Withdrawal by Subject|0|||
164297967|NCT03199976|593466036|FG002|Overall Study|Withdrawal by Subject|0|||
164297968|NCT03199976|593466034|FG000|Overall Study|Lost to Follow-up|0|||
164297969|NCT03199976|593466035|FG001|Overall Study|Lost to Follow-up|1|||
164297970|NCT03199976|593466036|FG002|Overall Study|Lost to Follow-up|1|||
164297971|NCT03367793|593466037|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
164297972|NCT03367793|593466038|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
164297973|NCT03367793|593466039|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
164297974|NCT03367793|593466040|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
164297975|NCT03367793|593466041|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
164297976|NCT03367793|593466042|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
164297977|NCT03962491|593466043|FG000|Overall Study|Lost to Follow-up|4|||
164297978|NCT03962491|593466044|FG001|Overall Study|Lost to Follow-up|5|||
164297979|NCT05058365|593466047|FG000|Overall Study|Migration|1|||
164297980|NCT05058365|593466048|FG001|Overall Study|Migration|1|||
164297981|NCT00702702|593466049|FG000|Overall Study|Study prematurely terminated|56|||
164297982|NCT02738801|593466058|FG000|Overall Study|Adverse Event|1|||
164297983|NCT02738801|593466059|FG001|Overall Study|Adverse Event|1|||
164297984|NCT02738801|593466058|FG000|Overall Study|Withdrawal by Subject|0|||
164297985|NCT02738801|593466059|FG001|Overall Study|Withdrawal by Subject|1|||
164297986|NCT03279081|593466060|FG000|Overall Study|Withdrawal by Subject|12|||
164297987|NCT03279081|593466061|FG001|Overall Study|Withdrawal by Subject|20|||
164297988|NCT03279081|593466060|FG000|Overall Study|Physician Decision|4|||
164297989|NCT03279081|593466061|FG001|Overall Study|Physician Decision|1|||
164297990|NCT03279081|593466060|FG000|Overall Study|Lost to Follow-up|8|||
164297991|NCT03279081|593466061|FG001|Overall Study|Lost to Follow-up|8|||
164297992|NCT03279081|593466060|FG000|Overall Study|Death|0|||
164297993|NCT03279081|593466061|FG001|Overall Study|Death|1|||
164347826|NCT00982878|593650930|FG000|Overall Study|Physician Decision|1|||
164347827|NCT04605484|593650931|FG000|Overall Study|Lost to Follow-up|0|||
164347828|NCT04605484|593650932|FG001|Overall Study|Lost to Follow-up|1|||
164347829|NCT04605484|593650933|FG002|Overall Study|Lost to Follow-up|1|||
164347830|NCT04605484|593650931|FG000|Overall Study|Other|0|||
164347831|NCT04605484|593650932|FG001|Overall Study|Other|1|||
164347832|NCT04605484|593650933|FG002|Overall Study|Other|0|||
164347833|NCT03366337|593650936|FG000|Overall Study|Lost to Follow-up|1|||
164347834|NCT03366337|593650937|FG001|Overall Study|Lost to Follow-up|0|||
164347835|NCT03366337|593650938|FG002|Overall Study|Lost to Follow-up|1|||
164347836|NCT03366337|593650939|FG003|Overall Study|Lost to Follow-up|0|||
164347837|NCT03366337|593650936|FG000|Overall Study|Withdrawal by Subject|2|||
164347838|NCT03366337|593650937|FG001|Overall Study|Withdrawal by Subject|0|||
164347839|NCT03366337|593650938|FG002|Overall Study|Withdrawal by Subject|1|||
164347840|NCT03366337|593650939|FG003|Overall Study|Withdrawal by Subject|1|||
164347841|NCT01578187|593650946|FG000|Usability Phase|Withdrawal by Subject|1|||
164347842|NCT02516163|593650951|FG000|Overall Study|Withdrawal by Subject|1|||
164347843|NCT02516163|593650951|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
164347844|NCT02516163|593650951|FG000|Overall Study|Unfit/delay in surgery|3|||
164347845|NCT02516163|593650951|FG000|Overall Study|Use of incorrect measurement technique|5|||
164347846|NCT02516163|593650951|FG000|Overall Study|Data not recorded|2|||
164347847|NCT02516163|593650951|FG000|Overall Study|MRI contraindication exclusion|6|||
164347848|NCT01217814|593650952|FG000|Overall Study|Adverse Event|1|||
164347849|NCT01217814|593650953|FG001|Overall Study|Adverse Event|1|||
164347850|NCT01217814|593650954|FG002|Overall Study|Adverse Event|0|||
164347851|NCT01217814|593650952|FG000|Overall Study|Lack of Efficacy|0|||
164347852|NCT01217814|593650953|FG001|Overall Study|Lack of Efficacy|0|||
164347853|NCT01217814|593650954|FG002|Overall Study|Lack of Efficacy|1|||
164347854|NCT01658072|593650957|FG000|Overall Study|Protocol Violation|4|||
164347855|NCT01658072|593650958|FG001|Overall Study|Protocol Violation|2|||
164347856|NCT00040664|593650959|FG000|Overall Study|Adverse Event|12|||
164347857|NCT00040664|593650960|FG001|Overall Study|Adverse Event|3|||
164347858|NCT00040664|593650961|FG002|Overall Study|Adverse Event|2|||
164347859|NCT00040664|593650962|FG003|Overall Study|Adverse Event|7|||
164347860|NCT00040664|593650959|FG000|Overall Study|Lack of Efficacy|9|||
164347861|NCT00040664|593650960|FG001|Overall Study|Lack of Efficacy|2|||
164347862|NCT00040664|593650961|FG002|Overall Study|Lack of Efficacy|3|||
164347863|NCT00040664|593650962|FG003|Overall Study|Lack of Efficacy|4|||
164297994|NCT03279081|593466060|FG000|Overall Study|Adverse Event|1|||
164297995|NCT03279081|593466061|FG001|Overall Study|Adverse Event|0|||
164297996|NCT03279081|593466060|FG000|Overall Study|Reason not Specified|14|||
164297997|NCT03279081|593466061|FG001|Overall Study|Reason not Specified|4|||
164347864|NCT00040664|593650959|FG000|Overall Study|Insufficient CD4 response|1|||
164297998|NCT00771914|593466062|FG000|Overall Study|Physician Decision|0|||
164297999|NCT00771914|593466063|FG001|Overall Study|Physician Decision|0|||
164347865|NCT00040664|593650960|FG001|Overall Study|Insufficient CD4 response|0|||
164298000|NCT00771914|593466064|FG002|Overall Study|Physician Decision|0|||
164298001|NCT00771914|593466065|FG003|Overall Study|Physician Decision|1|||
164298002|NCT00771914|593466062|FG000|Overall Study|Lost to Follow-up|0|||
164298003|NCT00771914|593466063|FG001|Overall Study|Lost to Follow-up|0|||
164298004|NCT00771914|593466064|FG002|Overall Study|Lost to Follow-up|0|||
164298005|NCT00771914|593466065|FG003|Overall Study|Lost to Follow-up|1|||
164298006|NCT00388349|593466074|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
164298007|NCT00388349|593466075|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
164298008|NCT01667900|593466080|FG000|Part B|Death|0|||
164298009|NCT01667900|593466081|FG001|Part B|Death|0|||
164298010|NCT01667900|593466082|FG002|Part B|Death|0|||
164298011|NCT01667900|593466083|FG003|Part B|Death|0|||
164298012|NCT01667900|593466084|FG004|Part B|Death|0|||
164298013|NCT01667900|593466085|FG005|Part B|Death|0|||
164298014|NCT01667900|593466086|FG006|Part B|Death|0|||
164298015|NCT01667900|593466087|FG007|Part B|Death|0|||
164298016|NCT01667900|593466088|FG008|Part B|Death|0|||
164298017|NCT01667900|593466089|FG009|Part B|Death|0|||
164298018|NCT01667900|593466090|FG010|Part B|Death|0|||
164298019|NCT01667900|593466091|FG011|Part B|Death|0|||
164298020|NCT01667900|593466092|FG012|Part B|Death|0|||
164298021|NCT01667900|593466093|FG013|Part B|Death|0|||
164298022|NCT01667900|593466094|FG014|Part B|Death|0|||
164435544|NCT01090024|593962039|FG015|Period 1|Withdrawal by Subject|0|||
164435545|NCT01090024|593962040|FG016|Period 1|Withdrawal by Subject|0|||
164435546|NCT01090024|593962041|FG017|Period 1|Withdrawal by Subject|0|||
164435547|NCT01090024|593962024|FG000|Period 1|Lost to Follow-up|0|||
164435548|NCT01090024|593962025|FG001|Period 1|Lost to Follow-up|1|||
164435549|NCT01090024|593962026|FG002|Period 1|Lost to Follow-up|0|||
164435550|NCT01090024|593962027|FG003|Period 1|Lost to Follow-up|0|||
164435551|NCT01090024|593962028|FG004|Period 1|Lost to Follow-up|0|||
164435552|NCT01090024|593962029|FG005|Period 1|Lost to Follow-up|0|||
164435553|NCT01090024|593962030|FG006|Period 1|Lost to Follow-up|0|||
164435554|NCT01090024|593962031|FG007|Period 1|Lost to Follow-up|0|||
164435555|NCT01090024|593962032|FG008|Period 1|Lost to Follow-up|0|||
164435556|NCT01090024|593962033|FG009|Period 1|Lost to Follow-up|0|||
164298023|NCT01667900|593466095|FG015|Part B|Death|0|||
164298024|NCT01667900|593466096|FG016|Part B|Death|1|||
164298025|NCT01667900|593466097|FG017|Part B|Death|0|||
164298026|NCT01667900|593466098|FG018|Part B|Death|0|||
164298027|NCT01667900|593466099|FG019|Part B|Death|0|||
164298028|NCT00231816|593466102|FG000|Overall Study|Adverse Event|1|||
164298029|NCT00231816|593466103|FG001|Overall Study|Adverse Event|0|||
164298030|NCT00231816|593466102|FG000|Overall Study|Lost to Follow-up|8|||
164298031|NCT00231816|593466103|FG001|Overall Study|Lost to Follow-up|5|||
164298032|NCT00231816|593466102|FG000|Overall Study|Protocol Violation|2|||
164298033|NCT00231816|593466103|FG001|Overall Study|Protocol Violation|3|||
164298034|NCT00231816|593466102|FG000|Overall Study|Withdrawal by Subject|3|||
164298035|NCT00231816|593466103|FG001|Overall Study|Withdrawal by Subject|3|||
164347866|NCT00040664|593650961|FG002|Overall Study|Insufficient CD4 response|1|||
164347867|NCT00040664|593650962|FG003|Overall Study|Insufficient CD4 response|0|||
164347868|NCT00040664|593650959|FG000|Overall Study|Lost to Follow-up|4|||
164347869|NCT00040664|593650960|FG001|Overall Study|Lost to Follow-up|2|||
164347870|NCT00040664|593650961|FG002|Overall Study|Lost to Follow-up|0|||
164347871|NCT00040664|593650962|FG003|Overall Study|Lost to Follow-up|2|||
164347872|NCT00040664|593650959|FG000|Overall Study|Protocol Violation|2|||
164347873|NCT00040664|593650960|FG001|Overall Study|Protocol Violation|1|||
164347874|NCT00040664|593650961|FG002|Overall Study|Protocol Violation|0|||
164347875|NCT00040664|593650962|FG003|Overall Study|Protocol Violation|1|||
164347876|NCT00040664|593650959|FG000|Overall Study|Withdrawal by Subject|7|||
164347877|NCT00040664|593650960|FG001|Overall Study|Withdrawal by Subject|0|||
164347878|NCT00040664|593650961|FG002|Overall Study|Withdrawal by Subject|3|||
164347879|NCT00040664|593650962|FG003|Overall Study|Withdrawal by Subject|4|||
164347880|NCT00040664|593650959|FG000|Overall Study|Pregnancy|3|||
164347881|NCT00040664|593650960|FG001|Overall Study|Pregnancy|0|||
164347882|NCT00040664|593650961|FG002|Overall Study|Pregnancy|0|||
164347883|NCT00040664|593650962|FG003|Overall Study|Pregnancy|3|||
164347884|NCT00040664|593650959|FG000|Overall Study|Medication adherence/compliance problems|8|||
164347885|NCT00040664|593650960|FG001|Overall Study|Medication adherence/compliance problems|2|||
164347886|NCT00040664|593650961|FG002|Overall Study|Medication adherence/compliance problems|1|||
164347887|NCT00040664|593650962|FG003|Overall Study|Medication adherence/compliance problems|5|||
164347888|NCT00040664|593650959|FG000|Overall Study|Poor taste|2|||
164347889|NCT00040664|593650960|FG001|Overall Study|Poor taste|0|||
164347890|NCT00040664|593650961|FG002|Overall Study|Poor taste|2|||
164347891|NCT00040664|593650962|FG003|Overall Study|Poor taste|0|||
164347892|NCT00040664|593650959|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
164435557|NCT01090024|593962034|FG010|Period 1|Lost to Follow-up|0|||
164435558|NCT01090024|593962035|FG011|Period 1|Lost to Follow-up|0|||
164435559|NCT01090024|593962036|FG012|Period 1|Lost to Follow-up|0|||
164435560|NCT01090024|593962037|FG013|Period 1|Lost to Follow-up|0|||
164435561|NCT01090024|593962038|FG014|Period 1|Lost to Follow-up|0|||
164347893|NCT00040664|593650960|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
164347894|NCT00040664|593650961|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
164347895|NCT00040664|593650962|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
164347896|NCT00040664|593650959|FG000|Overall Study|Change of formulation|2|||
164298036|NCT00231816|593466102|FG000|Overall Study|Other|2|||
164298037|NCT00231816|593466103|FG001|Overall Study|Other|1|||
164435562|NCT01090024|593962039|FG015|Period 1|Lost to Follow-up|0|||
164298038|NCT00774046|593466104|FG000|Screening|Not eligible|56|||
164435563|NCT01090024|593962040|FG016|Period 1|Lost to Follow-up|0|||
164298039|NCT00774046|593466104|FG000|Enrollment|Desired other therapy/refused|28|||
164298040|NCT00774046|593466104|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
164298041|NCT00976274|593466105|FG000|Overall Study|Lost to Follow-up|5|||
164347897|NCT00040664|593650960|FG001|Overall Study|Change of formulation|2|||
164435564|NCT01090024|593962041|FG017|Period 1|Lost to Follow-up|0|||
164435565|NCT01090024|593962024|FG000|Period 2|Lost to Follow-up|0|||
164435566|NCT01090024|593962025|FG001|Period 2|Lost to Follow-up|0|||
164435567|NCT01090024|593962026|FG002|Period 2|Lost to Follow-up|0|||
164435568|NCT01090024|593962027|FG003|Period 2|Lost to Follow-up|1|||
164435569|NCT01090024|593962028|FG004|Period 2|Lost to Follow-up|0|||
164298042|NCT00976274|593466106|FG001|Overall Study|Lost to Follow-up|5|||
164298043|NCT00976274|593466105|FG000|Overall Study|Withdrawal by Subject|1|||
164298044|NCT00976274|593466106|FG001|Overall Study|Withdrawal by Subject|1|||
164298045|NCT00976274|593466105|FG000|Overall Study|Physician Decision|1|||
164298046|NCT00976274|593466106|FG001|Overall Study|Physician Decision|2|||
164298047|NCT01614249|593466108|FG000|Overall Study|Lost to Follow-up|11|||
164298048|NCT01614249|593466109|FG001|Overall Study|Lost to Follow-up|23|||
164298049|NCT02954536|593466110|FG000|Overall Study|Adverse Event|2|||
164298050|NCT02954536|593466110|FG000|Overall Study|Death|12|||
164298051|NCT05498649|593466111|FG000|Overall Study|Lost to Follow-up|1|||
164298052|NCT02946580|593466112|FG000|Overall Study|Withdrawal by Subject|1|||
164298053|NCT02946580|593466113|FG001|Overall Study|Withdrawal by Subject|2|||
164298054|NCT02946580|593466112|FG000|Overall Study|Adverse Event|0|||
164298055|NCT02946580|593466113|FG001|Overall Study|Adverse Event|2|||
164298056|NCT02946580|593466112|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
164298057|NCT02946580|593466113|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
164298058|NCT03094416|593466114|FG000|Run-in|Screening failure|8|||
164298059|NCT03094416|593466114|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
164298060|NCT03094416|593466114|FG000|Run-in|Withdrawal by Subject|3|||
164298061|NCT03094416|593466114|FG000|Treatment Period|Withdrawal by Subject|2|||
164298062|NCT00321789|593466117|FG000|Overall Study|Lost to Follow-up|4|||
164298063|NCT00321789|593466118|FG001|Overall Study|Lost to Follow-up|7|||
164435570|NCT01090024|593962029|FG005|Period 2|Lost to Follow-up|0|||
164435571|NCT01090024|593962030|FG006|Period 2|Lost to Follow-up|0|||
164435572|NCT01090024|593962031|FG007|Period 2|Lost to Follow-up|0|||
164435573|NCT01090024|593962032|FG008|Period 2|Lost to Follow-up|0|||
164435574|NCT01090024|593962033|FG009|Period 2|Lost to Follow-up|0|||
164435575|NCT01090024|593962034|FG010|Period 2|Lost to Follow-up|0|||
164435576|NCT01090024|593962035|FG011|Period 2|Lost to Follow-up|0|||
164435577|NCT01090024|593962036|FG012|Period 2|Lost to Follow-up|0|||
164435578|NCT01090024|593962037|FG013|Period 2|Lost to Follow-up|0|||
164435579|NCT01090024|593962038|FG014|Period 2|Lost to Follow-up|0|||
164435580|NCT01090024|593962039|FG015|Period 2|Lost to Follow-up|0|||
164435581|NCT01090024|593962040|FG016|Period 2|Lost to Follow-up|0|||
164435582|NCT01090024|593962041|FG017|Period 2|Lost to Follow-up|0|||
164435583|NCT01090024|593962024|FG000|Period 2|Adverse Event|1|||
164435584|NCT01090024|593962025|FG001|Period 2|Adverse Event|0|||
164435585|NCT01090024|593962026|FG002|Period 2|Adverse Event|0|||
164435586|NCT01090024|593962027|FG003|Period 2|Adverse Event|0|||
164435587|NCT01090024|593962028|FG004|Period 2|Adverse Event|0|||
164435588|NCT01090024|593962029|FG005|Period 2|Adverse Event|0|||
164435589|NCT01090024|593962030|FG006|Period 2|Adverse Event|0|||
164435590|NCT01090024|593962031|FG007|Period 2|Adverse Event|0|||
164435591|NCT01090024|593962032|FG008|Period 2|Adverse Event|0|||
164435592|NCT01090024|593962033|FG009|Period 2|Adverse Event|0|||
164298064|NCT00321789|593466117|FG000|Overall Study|Withdrawal by Subject|6|||
164298065|NCT00321789|593466118|FG001|Overall Study|Withdrawal by Subject|6|||
164298066|NCT00321789|593466117|FG000|Overall Study|Protocol Violation|5|||
164298067|NCT00321789|593466118|FG001|Overall Study|Protocol Violation|3|||
164299999|NCT05138653|593472966|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164300000|NCT05138653|593472967|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
164300001|NCT05138653|593472968|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164300002|NCT05138653|593472969|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164300003|NCT05138653|593472970|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164300004|NCT05138653|593472971|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164300005|NCT05138653|593472972|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164300006|NCT05138653|593472973|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164300007|NCT05138653|593472974|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164300008|NCT05138653|593472975|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164300009|NCT05138653|593472976|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164300010|NCT05138653|593472961|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164300011|NCT05138653|593472962|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164300012|NCT05138653|593472963|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164300013|NCT05138653|593472964|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164300014|NCT05138653|593472965|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164300015|NCT05138653|593472966|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164300016|NCT05138653|593472967|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164300017|NCT05138653|593472968|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164300018|NCT05138653|593472969|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164300019|NCT05138653|593472970|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164587549|NCT00960440|594515862|FG001|Overall Study|Withdrawal by Subject|5|||
164587550|NCT00960440|594515863|FG002|Overall Study|Withdrawal by Subject|2|||
164587551|NCT00960440|594515864|FG003|Overall Study|Withdrawal by Subject|1|||
164435593|NCT01090024|593962034|FG010|Period 2|Adverse Event|0|||
164435594|NCT01090024|593962035|FG011|Period 2|Adverse Event|0|||
164435595|NCT01090024|593962036|FG012|Period 2|Adverse Event|0|||
164298068|NCT00005780|593466119|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
164298069|NCT00374140|593466120|FG000|Overall Study|Lost to Follow-up|1|||
164298070|NCT00374140|593466120|FG000|Overall Study|Protocol Violation|1|||
164298071|NCT02651675|593466121|FG000|Overall Study|Death|0|||
164298072|NCT02651675|593466122|FG001|Overall Study|Death|0|||
164298073|NCT02651675|593466123|FG002|Overall Study|Death|1|||
164298074|NCT02246530|593466124|FG000|Overall Study|Lost to Follow-up|4|||
164298075|NCT02246530|593466125|FG001|Overall Study|Lost to Follow-up|0|||
164298076|NCT05712460|593466126|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
164298077|NCT05712460|593466127|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
164298078|NCT05712460|593466128|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
164298079|NCT05712460|593466129|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
164298080|NCT05712460|593466130|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
164298081|NCT05712460|593466131|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
164298082|NCT05712460|593466132|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
164298083|NCT05712460|593466133|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
164298084|NCT05712460|593466134|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
164298085|NCT05712460|593466135|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
164298086|NCT05712460|593466136|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
164298087|NCT05712460|593466137|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
164298088|NCT04292535|593466139|FG000|Overall Study|Withdrawal by Subject|0|||
164298089|NCT04292535|593466140|FG001|Overall Study|Withdrawal by Subject|0|||
164298090|NCT04292535|593466141|FG002|Overall Study|Withdrawal by Subject|0|||
164298091|NCT04292535|593466142|FG003|Overall Study|Withdrawal by Subject|0|||
164298092|NCT04292535|593466143|FG004|Overall Study|Withdrawal by Subject|0|||
164298093|NCT04292535|593466144|FG005|Overall Study|Withdrawal by Subject|0|||
164298094|NCT04292535|593466145|FG006|Overall Study|Withdrawal by Subject|0|||
164298095|NCT04292535|593466146|FG007|Overall Study|Withdrawal by Subject|1|||
164298096|NCT04292535|593466147|FG008|Overall Study|Withdrawal by Subject|0|||
164298097|NCT04292535|593466148|FG009|Overall Study|Withdrawal by Subject|0|||
164298098|NCT04292535|593466149|FG010|Overall Study|Withdrawal by Subject|0|||
164298099|NCT04292535|593466150|FG011|Overall Study|Withdrawal by Subject|0|||
164298100|NCT04292535|593466151|FG012|Overall Study|Withdrawal by Subject|0|||
164298101|NCT04292535|593466152|FG013|Overall Study|Withdrawal by Subject|0|||
164298102|NCT04292535|593466139|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
164298103|NCT04292535|593466140|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
164298104|NCT04292535|593466141|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
164298105|NCT04292535|593466142|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
164298106|NCT04292535|593466143|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
164298107|NCT04292535|593466144|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
164298108|NCT04292535|593466145|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
164298109|NCT04292535|593466146|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
164298110|NCT04292535|593466147|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
164298111|NCT04292535|593466148|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
164298112|NCT04292535|593466149|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
164298113|NCT04292535|593466150|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
164298114|NCT04292535|593466151|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
164435596|NCT01090024|593962037|FG013|Period 2|Adverse Event|0|||
164435597|NCT01090024|593962038|FG014|Period 2|Adverse Event|0|||
164435598|NCT01090024|593962039|FG015|Period 2|Adverse Event|0|||
164435599|NCT01090024|593962040|FG016|Period 2|Adverse Event|0|||
164435600|NCT01090024|593962041|FG017|Period 2|Adverse Event|0|||
164435601|NCT01090024|593962024|FG000|Period 3|Withdrawal by Subject|0|||
164435602|NCT01090024|593962025|FG001|Period 3|Withdrawal by Subject|0|||
164435603|NCT01090024|593962026|FG002|Period 3|Withdrawal by Subject|0|||
164435604|NCT01090024|593962027|FG003|Period 3|Withdrawal by Subject|0|||
164435605|NCT01090024|593962028|FG004|Period 3|Withdrawal by Subject|0|||
164435606|NCT01090024|593962029|FG005|Period 3|Withdrawal by Subject|0|||
164435607|NCT01090024|593962030|FG006|Period 3|Withdrawal by Subject|0|||
164587552|NCT00960440|594515861|FG000|Overall Study|Other|1|||
164587553|NCT00960440|594515862|FG001|Overall Study|Other|1|||
164587554|NCT00960440|594515863|FG002|Overall Study|Other|1|||
164435608|NCT01090024|593962031|FG007|Period 3|Withdrawal by Subject|0|||
164435609|NCT01090024|593962032|FG008|Period 3|Withdrawal by Subject|0|||
164587555|NCT00960440|594515864|FG003|Overall Study|Other|0|||
164435610|NCT01090024|593962033|FG009|Period 3|Withdrawal by Subject|0|||
164435611|NCT01090024|593962034|FG010|Period 3|Withdrawal by Subject|0|||
164298115|NCT04292535|593466152|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
164298116|NCT04292535|593466139|FG000|Overall Study|Report of Dizziness|0|||
164298117|NCT04292535|593466140|FG001|Overall Study|Report of Dizziness|0|||
164298118|NCT04292535|593466141|FG002|Overall Study|Report of Dizziness|0|||
164298119|NCT04292535|593466142|FG003|Overall Study|Report of Dizziness|0|||
164298120|NCT04292535|593466143|FG004|Overall Study|Report of Dizziness|0|||
164298121|NCT04292535|593466144|FG005|Overall Study|Report of Dizziness|0|||
164298122|NCT04292535|593466145|FG006|Overall Study|Report of Dizziness|0|||
164298123|NCT04292535|593466146|FG007|Overall Study|Report of Dizziness|0|||
164298124|NCT04292535|593466147|FG008|Overall Study|Report of Dizziness|0|||
164298125|NCT04292535|593466148|FG009|Overall Study|Report of Dizziness|0|||
164298126|NCT04292535|593466149|FG010|Overall Study|Report of Dizziness|0|||
164298127|NCT04292535|593466150|FG011|Overall Study|Report of Dizziness|0|||
164298128|NCT04292535|593466151|FG012|Overall Study|Report of Dizziness|0|||
164298129|NCT04292535|593466152|FG013|Overall Study|Report of Dizziness|1|||
164298130|NCT04292535|593466139|FG000|Overall Study|Equipment Failure|0|||
164298131|NCT04292535|593466140|FG001|Overall Study|Equipment Failure|0|||
164587556|NCT03332667|594515867|FG000|Overall Study|Adverse Event|0|||
164587557|NCT03332667|594515868|FG001|Overall Study|Adverse Event|0|||
164587558|NCT03332667|594515869|FG002|Overall Study|Adverse Event|2|||
164587559|NCT03332667|594515870|FG003|Overall Study|Adverse Event|1|||
164587560|NCT03332667|594515867|FG000|Overall Study|Withdrawal by Subject|2|||
164587561|NCT03332667|594515868|FG001|Overall Study|Withdrawal by Subject|1|||
164587562|NCT03332667|594515869|FG002|Overall Study|Withdrawal by Subject|5|||
164587563|NCT03332667|594515870|FG003|Overall Study|Withdrawal by Subject|1|||
164587564|NCT03332667|594515867|FG000|Overall Study|Disease Progression or Relapse|2|||
164587565|NCT03332667|594515868|FG001|Overall Study|Disease Progression or Relapse|1|||
164587566|NCT03332667|594515869|FG002|Overall Study|Disease Progression or Relapse|3|||
164587567|NCT03332667|594515870|FG003|Overall Study|Disease Progression or Relapse|0|||
164587568|NCT03332667|594515867|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
164587569|NCT03332667|594515868|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
164587570|NCT03332667|594515869|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
164298132|NCT04292535|593466141|FG002|Overall Study|Equipment Failure|0|||
164587571|NCT03332667|594515870|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
164587572|NCT03332667|594515867|FG000|Overall Study|No Treatment Received|0|||
164587573|NCT03332667|594515868|FG001|Overall Study|No Treatment Received|0|||
164587574|NCT03332667|594515869|FG002|Overall Study|No Treatment Received|1|||
164587575|NCT03332667|594515870|FG003|Overall Study|No Treatment Received|0|||
164587576|NCT00546351|594515871|FG000|Overall Study|Adverse Event|76|||
164298133|NCT04292535|593466142|FG003|Overall Study|Equipment Failure|0|||
164298134|NCT04292535|593466143|FG004|Overall Study|Equipment Failure|0|||
164298135|NCT04292535|593466144|FG005|Overall Study|Equipment Failure|0|||
164298136|NCT04292535|593466145|FG006|Overall Study|Equipment Failure|0|||
164298137|NCT04292535|593466146|FG007|Overall Study|Equipment Failure|0|||
164298138|NCT04292535|593466147|FG008|Overall Study|Equipment Failure|0|||
164298139|NCT04292535|593466148|FG009|Overall Study|Equipment Failure|0|||
164298140|NCT04292535|593466149|FG010|Overall Study|Equipment Failure|0|||
164298141|NCT04292535|593466150|FG011|Overall Study|Equipment Failure|1|||
164298142|NCT04292535|593466151|FG012|Overall Study|Equipment Failure|0|||
164298143|NCT04292535|593466152|FG013|Overall Study|Equipment Failure|0|||
164298144|NCT01420861|593466153|FG000|Overall Study|Adverse Event|2|||
164298145|NCT01420861|593466153|FG000|Overall Study|Study terminated by Sponsor|7|||
164298146|NCT01420861|593466153|FG000|Overall Study|Screen failure|7|||
164298147|NCT01420861|593466153|FG000|Overall Study|Randomized not Treated|2|||
164298148|NCT00303069|593467994|FG000|Overall Study|Lost to Follow-up|1|||
164298149|NCT00303069|593467995|FG001|Overall Study|Lost to Follow-up|0|||
164298150|NCT00303069|593467996|FG002|Overall Study|Lost to Follow-up|0|||
164298151|NCT00303069|593467997|FG003|Overall Study|Lost to Follow-up|2|||
164587577|NCT00546351|594515871|FG000|Overall Study|Lack of Efficacy|15|||
164587578|NCT00546351|594515871|FG000|Overall Study|Withdrawal by Subject|109|||
164587579|NCT00546351|594515871|FG000|Overall Study|Lost to Follow-up|9|||
164587580|NCT00546351|594515871|FG000|Overall Study|Protocol Deviation|1|||
164587581|NCT00546351|594515871|FG000|Overall Study|Unsatisfactory compliance|9|||
164587582|NCT00546351|594515871|FG000|Overall Study|Other reasons for premature termination|17|||
164587583|NCT04734873|594515872|FG000|Overall Study|Lost to Follow-up|1|||
164298152|NCT00303069|593467994|FG000|Overall Study|subject moved|1|||
164298153|NCT00303069|593467995|FG001|Overall Study|subject moved|0|||
164298154|NCT00303069|593467996|FG002|Overall Study|subject moved|0|||
164298155|NCT00303069|593467997|FG003|Overall Study|subject moved|0|||
164298156|NCT00303069|593467994|FG000|Overall Study|Recruitment into Army Reserves|0|||
164298157|NCT00303069|593467995|FG001|Overall Study|Recruitment into Army Reserves|0|||
164298158|NCT00303069|593467996|FG002|Overall Study|Recruitment into Army Reserves|1|||
164298159|NCT00303069|593467997|FG003|Overall Study|Recruitment into Army Reserves|0|||
164298160|NCT00092417|593467998|FG000|Overall Study|Lost to Follow-up|2|||
164298161|NCT00092417|593467999|FG001|Overall Study|Lost to Follow-up|0|||
164435612|NCT01090024|593962035|FG011|Period 3|Withdrawal by Subject|0|||
164435613|NCT01090024|593962036|FG012|Period 3|Withdrawal by Subject|0|||
164298162|NCT00092417|593467998|FG000|Overall Study|Withdrawal by Subject|2|||
164298163|NCT00092417|593467999|FG001|Overall Study|Withdrawal by Subject|1|||
164298164|NCT00092417|593467998|FG000|Overall Study|Other|1|||
164298165|NCT00092417|593467999|FG001|Overall Study|Other|0|||
164298166|NCT00425269|593468000|FG000|Overall Study|Pregnancy|5|||
164298167|NCT00425269|593468001|FG001|Overall Study|Pregnancy|7|||
164298168|NCT00425269|593468000|FG000|Overall Study|Lost to Follow-up|9|||
164298169|NCT00425269|593468001|FG001|Overall Study|Lost to Follow-up|9|||
164298170|NCT00425269|593468000|FG000|Overall Study|moved or medical reason|5|||
164298171|NCT00425269|593468001|FG001|Overall Study|moved or medical reason|4|||
164298172|NCT01084655|593468004|FG000|Overall Study|Radiographic disease progression|3|||
164298173|NCT01084655|593468005|FG001|Overall Study|Radiographic disease progression|2|||
164298174|NCT01084655|593468006|FG002|Overall Study|Radiographic disease progression|8|||
164298175|NCT01084655|593468004|FG000|Overall Study|Withdrawal by Subject|1|||
164298176|NCT01084655|593468005|FG001|Overall Study|Withdrawal by Subject|0|||
164298177|NCT01084655|593468006|FG002|Overall Study|Withdrawal by Subject|4|||
164298178|NCT01084655|593468004|FG000|Overall Study|Adverse Event|2|||
164298179|NCT01084655|593468005|FG001|Overall Study|Adverse Event|1|||
164435614|NCT01090024|593962037|FG013|Period 3|Withdrawal by Subject|0|||
164435615|NCT01090024|593962038|FG014|Period 3|Withdrawal by Subject|0|||
164435616|NCT01090024|593962039|FG015|Period 3|Withdrawal by Subject|1|||
164435617|NCT01090024|593962040|FG016|Period 3|Withdrawal by Subject|0|||
164435618|NCT01090024|593962041|FG017|Period 3|Withdrawal by Subject|0|||
164435619|NCT01090024|593962024|FG000|Period 3|Protocol Violation|0|||
164435620|NCT01090024|593962025|FG001|Period 3|Protocol Violation|0|||
164435621|NCT01090024|593962026|FG002|Period 3|Protocol Violation|0|||
164435622|NCT01090024|593962027|FG003|Period 3|Protocol Violation|0|||
164298180|NCT01084655|593468006|FG002|Overall Study|Adverse Event|2|||
164435623|NCT01090024|593962028|FG004|Period 3|Protocol Violation|0|||
164435624|NCT01090024|593962029|FG005|Period 3|Protocol Violation|0|||
164435625|NCT01090024|593962030|FG006|Period 3|Protocol Violation|0|||
164435626|NCT01090024|593962031|FG007|Period 3|Protocol Violation|0|||
164435627|NCT01090024|593962032|FG008|Period 3|Protocol Violation|1|||
164435628|NCT01090024|593962033|FG009|Period 3|Protocol Violation|0|||
164435629|NCT01090024|593962034|FG010|Period 3|Protocol Violation|0|||
164435630|NCT01090024|593962035|FG011|Period 3|Protocol Violation|0|||
164435631|NCT01090024|593962036|FG012|Period 3|Protocol Violation|0|||
164435632|NCT01090024|593962037|FG013|Period 3|Protocol Violation|0|||
164435633|NCT01090024|593962038|FG014|Period 3|Protocol Violation|0|||
164435634|NCT01090024|593962039|FG015|Period 3|Protocol Violation|0|||
164435635|NCT01090024|593962040|FG016|Period 3|Protocol Violation|0|||
164435636|NCT01090024|593962041|FG017|Period 3|Protocol Violation|0|||
164435637|NCT01090024|593962024|FG000|Period 3|Adverse Event|0|||
164435638|NCT01090024|593962025|FG001|Period 3|Adverse Event|0|||
164435639|NCT01090024|593962026|FG002|Period 3|Adverse Event|0|||
164435640|NCT01090024|593962027|FG003|Period 3|Adverse Event|0|||
164435641|NCT01090024|593962028|FG004|Period 3|Adverse Event|0|||
164435642|NCT01090024|593962029|FG005|Period 3|Adverse Event|1|||
164435643|NCT01090024|593962030|FG006|Period 3|Adverse Event|0|||
164298181|NCT01084655|593468004|FG000|Overall Study|Other|0|||
164298182|NCT01084655|593468005|FG001|Overall Study|Other|3|||
164298183|NCT01084655|593468006|FG002|Overall Study|Other|2|||
164298184|NCT01084655|593468004|FG000|Overall Study|Symptomatic deterioration|0|||
164435644|NCT01090024|593962031|FG007|Period 3|Adverse Event|0|||
164435645|NCT01090024|593962032|FG008|Period 3|Adverse Event|0|||
164435646|NCT01090024|593962033|FG009|Period 3|Adverse Event|0|||
164435647|NCT01090024|593962034|FG010|Period 3|Adverse Event|0|||
164435648|NCT01090024|593962035|FG011|Period 3|Adverse Event|0|||
164435649|NCT01090024|593962036|FG012|Period 3|Adverse Event|0|||
164435650|NCT01090024|593962037|FG013|Period 3|Adverse Event|0|||
164435651|NCT01090024|593962038|FG014|Period 3|Adverse Event|0|||
164435652|NCT01090024|593962039|FG015|Period 3|Adverse Event|0|||
164435653|NCT01090024|593962040|FG016|Period 3|Adverse Event|0|||
164298185|NCT01084655|593468005|FG001|Overall Study|Symptomatic deterioration|0|||
164298186|NCT01084655|593468006|FG002|Overall Study|Symptomatic deterioration|2|||
164298187|NCT01084655|593468004|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
164301046|NCT02435992|593478415|FG004|Overall Study|Adverse Event|0|||
164301047|NCT02435992|593478411|FG000|Overall Study|Lack of Efficacy|4|||
164301048|NCT02435992|593478412|FG001|Overall Study|Lack of Efficacy|10|||
164301049|NCT02435992|593478413|FG002|Overall Study|Lack of Efficacy|9|||
164301050|NCT02435992|593478414|FG003|Overall Study|Lack of Efficacy|0|||
164301051|NCT02435992|593478415|FG004|Overall Study|Lack of Efficacy|0|||
164301052|NCT02435992|593478411|FG000|Overall Study|Withdrawal by Subject|10|||
164301053|NCT02435992|593478412|FG001|Overall Study|Withdrawal by Subject|8|||
164301054|NCT02435992|593478413|FG002|Overall Study|Withdrawal by Subject|20|||
164301055|NCT02435992|593478414|FG003|Overall Study|Withdrawal by Subject|0|||
164301056|NCT02435992|593478415|FG004|Overall Study|Withdrawal by Subject|0|||
164301057|NCT02435992|593478411|FG000|Overall Study|Other Reason|1|||
164301058|NCT02435992|593478412|FG001|Overall Study|Other Reason|0|||
164298188|NCT01084655|593468005|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
164298189|NCT01084655|593468006|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
164298190|NCT00335777|593468007|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
164298191|NCT00335777|593468007|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
164298192|NCT00335777|593468007|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
164298193|NCT00335777|593468007|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
164298194|NCT00335777|593468007|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
164298195|NCT00992108|593468008|FG000|Overall Study|Lost to Follow-up|0|||
164298196|NCT00992108|593468009|FG001|Overall Study|Lost to Follow-up|1|||
164298197|NCT04639245|593468010|FG000|Overall Study|Death|1|||
164298198|NCT01112917|593468013|FG000|Overall Study|Death|2|||
164298199|NCT01112917|593468014|FG001|Overall Study|Death|11|||
164298200|NCT01112917|593468013|FG000|Overall Study|Lost to Follow-up|1|||
164298201|NCT01112917|593468014|FG001|Overall Study|Lost to Follow-up|1|||
164298202|NCT01112917|593468013|FG000|Overall Study|Withdrawal by Subject|1|||
164298203|NCT01112917|593468014|FG001|Overall Study|Withdrawal by Subject|3|||
164298204|NCT01112917|593468013|FG000|Overall Study|Unable to Convert Filter|3|||
164298205|NCT01112917|593468014|FG001|Overall Study|Unable to Convert Filter|0|||
164298206|NCT05101122|593468015|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
164298207|NCT05101122|593468015|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
164298208|NCT05101122|593468015|FG000|AD313 80/5|Withdrawal by Subject|1|||
164298209|NCT05101122|593468015|FG000|AD313 80/10|Physician Decision|1|||
164298210|NCT03131219|593468016|FG000|Initial Evaluation Period|Adverse Event|2|||
164298211|NCT03131219|593468017|FG001|Initial Evaluation Period|Adverse Event|0|||
164298212|NCT03131219|593468016|FG000|Initial Evaluation Period|Protocol Violation|1|||
164298213|NCT03131219|593468017|FG001|Initial Evaluation Period|Protocol Violation|0|||
164298214|NCT03131219|593468016|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
164298215|NCT03131219|593468017|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
164298216|NCT03131219|593468016|FG000|Initial Evaluation Period|Physician Decision|1|||
164298217|NCT03131219|593468017|FG001|Initial Evaluation Period|Physician Decision|0|||
164298218|NCT03131219|593468016|FG000|Extension Period|Physician Decision|1|||
164298219|NCT03131219|593468017|FG001|Extension Period|Physician Decision|0|||
164298220|NCT00616759|593468019|FG000|Overall Study|Physician Decision|2|||
164298221|NCT00616759|593468020|FG001|Overall Study|Physician Decision|0|||
164298222|NCT00616759|593468019|FG000|Overall Study|Withdrawal by Subject|1|||
164298223|NCT00616759|593468020|FG001|Overall Study|Withdrawal by Subject|2|||
164298224|NCT02399163|593468023|FG000|Overall Study|Adverse Event|2|||
164298225|NCT02399163|593468023|FG000|Overall Study|Protocol Deviation|2|||
164298226|NCT02399163|593468023|FG000|Overall Study|Withdrawal by Participant|5|||
164298227|NCT02177123|593468028|FG000|Overall Study|Lost to Follow-up|6|||
164298228|NCT02177123|593468028|FG000|Overall Study|Withdrawal by Subject|4|||
164298229|NCT02177123|593468028|FG000|Overall Study|Adverse Event|4|||
164298230|NCT02177123|593468028|FG000|Overall Study|Physician Decision|3|||
164298231|NCT02177123|593468028|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
164298232|NCT02177123|593468028|FG000|Overall Study|Excluded for medical reasons|2|||
164298233|NCT02177123|593468028|FG000|Overall Study|Death|1|||
164298234|NCT02177123|593468028|FG000|Overall Study|Other|1|||
164298235|NCT02177123|593468028|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
164693638|NCT00739973|594899425|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
164298236|NCT04613362|593468029|FG000|3 Month Follow-up|Lost to Follow-up|1|||
164298237|NCT04613362|593468030|FG001|3 Month Follow-up|Lost to Follow-up|2|||
164298238|NCT04613362|593468029|FG000|6 Month Follow-up|Lost to Follow-up|0|||
164298239|NCT04613362|593468030|FG001|6 Month Follow-up|Lost to Follow-up|1|||
164298240|NCT00074711|593468031|FG000|Overall Study|Withdrawal by Subject|1|||
164298241|NCT00074711|593468032|FG001|Overall Study|Withdrawal by Subject|1|||
164298242|NCT00074711|593468031|FG000|Overall Study|Lost to Follow-up|10|||
164298243|NCT00074711|593468032|FG001|Overall Study|Lost to Follow-up|8|||
164298244|NCT00074711|593468031|FG000|Overall Study|Participant stopped study drug|4|||
164298245|NCT00074711|593468032|FG001|Overall Study|Participant stopped study drug|6|||
164298246|NCT03466658|593468033|FG000|Overall Study|Withdrawal by Subject|3|||
164298247|NCT00886379|593468034|FG000|Overall Study|Transferred Schools|0|||
164298248|NCT00886379|593468035|FG001|Overall Study|Transferred Schools|0|||
164298249|NCT00886379|593468036|FG002|Overall Study|Transferred Schools|2|||
164298250|NCT00886379|593468037|FG003|Overall Study|Transferred Schools|1|||
164298251|NCT00886379|593468038|FG004|Overall Study|Transferred Schools|1|||
164298252|NCT00886379|593468034|FG000|Overall Study|Final blood draw not obtained|3|||
164298253|NCT00886379|593468035|FG001|Overall Study|Final blood draw not obtained|3|||
164298254|NCT00886379|593468036|FG002|Overall Study|Final blood draw not obtained|4|||
164298255|NCT00886379|593468037|FG003|Overall Study|Final blood draw not obtained|2|||
164298256|NCT00886379|593468038|FG004|Overall Study|Final blood draw not obtained|2|||
164298257|NCT01435382|593468045|FG000|Overall Study|Lost to Follow-up|1|||
164298258|NCT01435382|593468046|FG001|Overall Study|Lost to Follow-up|0|||
164298259|NCT01435382|593468047|FG002|Overall Study|Lost to Follow-up|1|||
164298260|NCT01435382|593468048|FG003|Overall Study|Lost to Follow-up|0|||
164298261|NCT01435382|593468045|FG000|Overall Study|Withdrawal by Subject|0|||
164298262|NCT01435382|593468046|FG001|Overall Study|Withdrawal by Subject|2|||
164435654|NCT01090024|593962041|FG017|Period 3|Adverse Event|0|||
164435655|NCT02380742|593962043|FG000|Overall Study|Withdrawal by Subject|1|||
164298263|NCT01435382|593468047|FG002|Overall Study|Withdrawal by Subject|0|||
164298264|NCT01435382|593468048|FG003|Overall Study|Withdrawal by Subject|1|||
164298265|NCT00910650|593468049|FG000|Overall Study|Death|2|||
164298266|NCT00260533|593468052|FG000|Overall Study|Other|3|||
164298267|NCT00260533|593468053|FG001|Overall Study|Other|3|||
164298268|NCT01761877|593468054|FG000|Overall Study|Adverse Event|7|||
164298269|NCT01761877|593468055|FG001|Overall Study|Adverse Event|0|||
164298270|NCT01761877|593468054|FG000|Overall Study|Withdrawal by Subject|6|||
164298271|NCT01761877|593468055|FG001|Overall Study|Withdrawal by Subject|4|||
164298272|NCT01761877|593468054|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
164298273|NCT01761877|593468055|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
164298274|NCT01761877|593468054|FG000|Overall Study|Death|0|||
164298275|NCT01761877|593468055|FG001|Overall Study|Death|1|||
164298276|NCT01761877|593468054|FG000|Overall Study|MRI intolerant|1|||
164298277|NCT01761877|593468055|FG001|Overall Study|MRI intolerant|6|||
164298278|NCT01310777|593468057|FG000|Overall Study|Adverse Event|23|||
164435656|NCT02380742|593962044|FG001|Overall Study|Withdrawal by Subject|0|||
164435657|NCT02689349|593962045|FG000|Overall Study|Not implanted|4|||
164435658|NCT02689349|593962046|FG001|Overall Study|Not implanted|0|||
164435659|NCT02689349|593962045|FG000|Overall Study|Withdrawal by Subject|9|||
164435660|NCT02689349|593962046|FG001|Overall Study|Withdrawal by Subject|0|||
164693639|NCT00739973|594899417|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
164298279|NCT01310777|593468058|FG001|Overall Study|Adverse Event|1|||
164298280|NCT01310777|593468059|FG002|Overall Study|Adverse Event|15|||
164298281|NCT01310777|593468057|FG000|Overall Study|Lost to Follow-up|0|||
164298282|NCT01310777|593468058|FG001|Overall Study|Lost to Follow-up|4|||
164298283|NCT01310777|593468059|FG002|Overall Study|Lost to Follow-up|1|||
164298284|NCT01310777|593468057|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
164298285|NCT01310777|593468058|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
164298286|NCT01310777|593468059|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
164298287|NCT01310777|593468057|FG000|Overall Study|Inadequate Control of IOP|5|||
164298288|NCT01310777|593468058|FG001|Overall Study|Inadequate Control of IOP|7|||
164298289|NCT01310777|593468059|FG002|Overall Study|Inadequate Control of IOP|10|||
164298290|NCT01310777|593468057|FG000|Overall Study|Other|4|||
164298291|NCT01310777|593468058|FG001|Overall Study|Other|1|||
164298292|NCT01310777|593468059|FG002|Overall Study|Other|2|||
164298293|NCT01780506|593468060|FG000|Double-Blind Phase|Randomized but not Treated|3|||
164298294|NCT01780506|593468061|FG001|Double-Blind Phase|Randomized but not Treated|2|||
164298295|NCT01780506|593468060|FG000|Double-Blind Phase|Adverse Event|4|||
164298296|NCT01780506|593468061|FG001|Double-Blind Phase|Adverse Event|14|||
164298297|NCT01780506|593468060|FG000|Double-Blind Phase|Death|1|||
164298298|NCT01780506|593468061|FG001|Double-Blind Phase|Death|2|||
164298299|NCT01780506|593468060|FG000|Double-Blind Phase|Pregnancy|2|||
164298300|NCT01780506|593468061|FG001|Double-Blind Phase|Pregnancy|1|||
164298301|NCT01780506|593468060|FG000|Double-Blind Phase|Lack of Efficacy|1|||
164298302|NCT01780506|593468061|FG001|Double-Blind Phase|Lack of Efficacy|1|||
164298303|NCT01780506|593468060|FG000|Double-Blind Phase|Investigator's Discretion|5|||
164298304|NCT01780506|593468061|FG001|Double-Blind Phase|Investigator's Discretion|2|||
164298305|NCT01780506|593468060|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
164298306|NCT01780506|593468061|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
164298307|NCT01780506|593468060|FG000|Double-Blind Phase|Protocol Violation|4|||
164298308|NCT01780506|593468061|FG001|Double-Blind Phase|Protocol Violation|3|||
164298309|NCT01780506|593468060|FG000|Double-Blind Phase|Withdrew Consent|23|||
164298310|NCT01780506|593468061|FG001|Double-Blind Phase|Withdrew Consent|24|||
164298311|NCT01780506|593468060|FG000|Double-Blind Phase|Lost to Follow-up|23|||
164298312|NCT01780506|593468061|FG001|Double-Blind Phase|Lost to Follow-up|26|||
164298313|NCT01780506|593468060|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
164298314|NCT01780506|593468061|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
164298315|NCT01867671|593468064|FG000|Overall Study|Adverse Event|5|||
164298316|NCT01867671|593468065|FG001|Overall Study|Adverse Event|3|||
164298317|NCT01867671|593468064|FG000|Overall Study|Anaphylaxis|0|||
164298318|NCT01867671|593468065|FG001|Overall Study|Anaphylaxis|1|||
164298319|NCT01867671|593468064|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
164298320|NCT01867671|593468065|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
164298321|NCT01867671|593468064|FG000|Overall Study|Lost to Follow-up|0|||
164435661|NCT03546907|593962048|FG000|Overall Study|Lack of Efficacy|1|||
164435662|NCT03546907|593962049|FG001|Overall Study|Lack of Efficacy|1|||
164435663|NCT03546907|593962048|FG000|Overall Study|Withdrawal by Subject|8|||
164298322|NCT01867671|593468065|FG001|Overall Study|Lost to Follow-up|1|||
164298323|NCT01867671|593468064|FG000|Overall Study|Non-compliance with Study Drug|1|||
164298324|NCT01867671|593468065|FG001|Overall Study|Non-compliance with Study Drug|2|||
164298325|NCT01867671|593468064|FG000|Overall Study|Withdrawal by Subject|21|||
164298326|NCT01867671|593468065|FG001|Overall Study|Withdrawal by Subject|21|||
164298327|NCT04852302|593468066|FG000|Overall Study|Withdrawal by Subject|2|||
164298328|NCT04852302|593468066|FG000|Overall Study|Did not complete CALM therapy.|2|||
164298329|NCT05249582|593468067|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
164298330|NCT05249582|593468068|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
164298331|NCT05249582|593468067|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
164298332|NCT05249582|593468068|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
164298333|NCT05249582|593468067|FG000|Overall Study|Declined to use virtual reality headset|1|||
164298334|NCT05249582|593468068|FG001|Overall Study|Declined to use virtual reality headset|0|||
164298335|NCT01743469|593468069|FG000|Active Treatment Phase|Adverse Event|10|||
164298336|NCT01743469|593468070|FG001|Active Treatment Phase|Adverse Event|5|||
164298337|NCT01743469|593468071|FG002|Active Treatment Phase|Adverse Event|8|||
164298338|NCT01743469|593468072|FG003|Active Treatment Phase|Adverse Event|1|||
164298339|NCT01743469|593468069|FG000|Active Treatment Phase|Disease Progression|40|||
164298340|NCT01743469|593468070|FG001|Active Treatment Phase|Disease Progression|47|||
164298341|NCT01743469|593468071|FG002|Active Treatment Phase|Disease Progression|30|||
164298342|NCT01743469|593468072|FG003|Active Treatment Phase|Disease Progression|20|||
164298343|NCT01743469|593468069|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
164298344|NCT01743469|593468070|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
164298345|NCT01743469|593468071|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
164298346|NCT01743469|593468072|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
164298347|NCT01743469|593468069|FG000|Active Treatment Phase|Missing|1|||
164298348|NCT01743469|593468070|FG001|Active Treatment Phase|Missing|0|||
164298349|NCT01743469|593468071|FG002|Active Treatment Phase|Missing|0|||
164298350|NCT01743469|593468072|FG003|Active Treatment Phase|Missing|0|||
164587584|NCT04734873|594515873|FG001|Overall Study|Lost to Follow-up|3|||
164587585|NCT04734873|594515874|FG002|Overall Study|Lost to Follow-up|2|||
164587586|NCT04734873|594515872|FG000|Overall Study|Randomized but not dosed|1|||
164587587|NCT04734873|594515873|FG001|Overall Study|Randomized but not dosed|0|||
164587588|NCT04734873|594515874|FG002|Overall Study|Randomized but not dosed|1|||
164587589|NCT00609609|594515875|FG000|Overall Study|Withdrawal by Subject|2|||
164587590|NCT00609609|594515876|FG001|Overall Study|Withdrawal by Subject|0|||
164587591|NCT00609609|594515875|FG000|Overall Study|Progression|4|||
164587592|NCT00609609|594515876|FG001|Overall Study|Progression|2|||
164587593|NCT03065530|594515877|FG000|Overall Study|Lack of Efficacy|1|||
164587594|NCT03065530|594515878|FG001|Overall Study|Lack of Efficacy|1|||
164587595|NCT03065530|594515879|FG002|Overall Study|Lack of Efficacy|0|||
164587596|NCT03065530|594515880|FG003|Overall Study|Lack of Efficacy|1|||
164587597|NCT03065530|594515877|FG000|Overall Study|Protocol Violation|1|||
164587598|NCT03065530|594515878|FG001|Overall Study|Protocol Violation|0|||
164587599|NCT03065530|594515879|FG002|Overall Study|Protocol Violation|1|||
164587600|NCT03065530|594515880|FG003|Overall Study|Protocol Violation|1|||
164587601|NCT02385123|594515883|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
164587602|NCT04498910|594515884|FG000|Overall Study|Lost to Follow-up|0|||
164587603|NCT04498910|594515885|FG001|Overall Study|Lost to Follow-up|1|||
164587604|NCT04498910|594515884|FG000|Overall Study|Withdrawal by Subject|2|||
164587605|NCT04498910|594515885|FG001|Overall Study|Withdrawal by Subject|1|||
164587606|NCT04498910|594515884|FG000|Overall Study|Adverse Event|1|||
164587607|NCT04498910|594515885|FG001|Overall Study|Adverse Event|0|||
164347898|NCT00040664|593650961|FG002|Overall Study|Change of formulation|0|||
164347899|NCT00040664|593650962|FG003|Overall Study|Change of formulation|0|||
164347900|NCT00040664|593650959|FG000|Overall Study|Non-viability of oral suspension|1|||
164347901|NCT00040664|593650960|FG001|Overall Study|Non-viability of oral suspension|0|||
164347902|NCT00040664|593650961|FG002|Overall Study|Non-viability of oral suspension|1|||
164347903|NCT00040664|593650962|FG003|Overall Study|Non-viability of oral suspension|0|||
164347904|NCT01709162|593650963|FG000|Overall Study|Disease progression|3|||
164347905|NCT01709162|593650964|FG001|Overall Study|Disease progression|3|||
164347906|NCT01709162|593650963|FG000|Overall Study|Study drug toxicity|2|||
164347907|NCT01709162|593650964|FG001|Overall Study|Study drug toxicity|0|||
164347908|NCT01709162|593650963|FG000|Overall Study|Administrative reason by sponsor|0|||
164347909|NCT01709162|593650964|FG001|Overall Study|Administrative reason by sponsor|1|||
164347910|NCT01709162|593650963|FG000|Overall Study|Other|1|||
164347911|NCT01709162|593650964|FG001|Overall Study|Other|0|||
164347912|NCT01709162|593650963|FG000|Overall Study|Withdrawal by Subject|0|||
164347913|NCT01709162|593650964|FG001|Overall Study|Withdrawal by Subject|1|||
164347914|NCT01637272|593650976|FG000|Overall Study|Adverse Event|6|||
164347915|NCT01637272|593650976|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164347916|NCT01637272|593650976|FG000|Overall Study|Withdrawal by Subject|3|||
164347917|NCT01637272|593650976|FG000|Overall Study|Lost to Follow-up|2|||
164347918|NCT01637272|593650976|FG000|Overall Study|completed core, did not enter ext. phase|4|||
164347919|NCT01637272|593650976|FG000|Overall Study|Administrative problems|1|||
164347920|NCT01637272|593650976|FG000|Overall Study|Protocol Violation|2|||
164347921|NCT01844518|593650977|FG000|Overall Study|Adverse Event|7|||
164347922|NCT01844518|593650978|FG001|Overall Study|Adverse Event|1|||
164347923|NCT01844518|593650977|FG000|Overall Study|Lack of Efficacy|17|||
164347924|NCT01844518|593650978|FG001|Overall Study|Lack of Efficacy|5|||
164347925|NCT01844518|593650977|FG000|Overall Study|Participant's request to discontinue|4|||
164347926|NCT01844518|593650978|FG001|Overall Study|Participant's request to discontinue|1|||
164347927|NCT01844518|593650977|FG000|Overall Study|Poor/Non-compliance|1|||
164347928|NCT01844518|593650978|FG001|Overall Study|Poor/Non-compliance|0|||
164347929|NCT01844518|593650977|FG000|Overall Study|No Longer Met Study Criteria|2|||
164347930|NCT01844518|593650978|FG001|Overall Study|No Longer Met Study Criteria|0|||
164347931|NCT01844518|593650977|FG000|Overall Study|Withdrawal by Subject|9|||
164347932|NCT01844518|593650978|FG001|Overall Study|Withdrawal by Subject|0|||
164347933|NCT01844518|593650977|FG000|Overall Study|Pregnancy|1|||
164347934|NCT01844518|593650978|FG001|Overall Study|Pregnancy|0|||
164347935|NCT05399641|593650979|FG000|Overall Study|Adverse Event|0|||
164347936|NCT05399641|593650980|FG001|Overall Study|Adverse Event|1|||
164347937|NCT05399641|593650981|FG002|Overall Study|Adverse Event|1|||
164347938|NCT05399641|593650979|FG000|Overall Study|Lost to Follow-up|1|||
164347939|NCT05399641|593650980|FG001|Overall Study|Lost to Follow-up|2|||
164347940|NCT05399641|593650981|FG002|Overall Study|Lost to Follow-up|2|||
164347941|NCT05399641|593650979|FG000|Overall Study|Physician Decision|1|||
164347942|NCT05399641|593650980|FG001|Overall Study|Physician Decision|3|||
164347943|NCT05399641|593650981|FG002|Overall Study|Physician Decision|3|||
164587608|NCT01809262|594515886|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
164587609|NCT01809262|594515887|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
164347944|NCT05399641|593650979|FG000|Overall Study|Withdrawal by Subject|4|||
164347945|NCT05399641|593650980|FG001|Overall Study|Withdrawal by Subject|11|||
164347946|NCT05399641|593650981|FG002|Overall Study|Withdrawal by Subject|7|||
164347947|NCT05399641|593650979|FG000|Overall Study|Reason not defined|3|||
164347948|NCT05399641|593650980|FG001|Overall Study|Reason not defined|5|||
164298351|NCT01743469|593468069|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
164298352|NCT01743469|593468070|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
164298353|NCT01743469|593468071|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
164298354|NCT01743469|593468072|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
164298355|NCT01743469|593468069|FG000|Follow-up Period - Post-Treatment|Death|43|||
164298356|NCT01743469|593468070|FG001|Follow-up Period - Post-Treatment|Death|47|||
164298357|NCT01743469|593468071|FG002|Follow-up Period - Post-Treatment|Death|22|||
164298358|NCT01743469|593468072|FG003|Follow-up Period - Post-Treatment|Death|16|||
164298359|NCT01743469|593468069|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
164298360|NCT01743469|593468070|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
164298361|NCT01743469|593468071|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
164298362|NCT01743469|593468072|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
164298363|NCT00317473|593468073|FG000|Overall Study|Withdrawal by Subject|2|||
164298364|NCT00317473|593468074|FG001|Overall Study|Withdrawal by Subject|1|||
164298365|NCT00317473|593468075|FG002|Overall Study|Withdrawal by Subject|2|||
164298366|NCT00317473|593468076|FG003|Overall Study|Withdrawal by Subject|1|||
164298367|NCT00317473|593468077|FG004|Overall Study|Withdrawal by Subject|3|||
164298368|NCT00317473|593468078|FG005|Overall Study|Withdrawal by Subject|1|||
164298369|NCT00317473|593468073|FG000|Overall Study|Relocation|1|||
164298370|NCT00317473|593468074|FG001|Overall Study|Relocation|0|||
164298371|NCT00317473|593468075|FG002|Overall Study|Relocation|1|||
164298372|NCT00317473|593468076|FG003|Overall Study|Relocation|1|||
164298373|NCT00317473|593468077|FG004|Overall Study|Relocation|5|||
164298374|NCT00317473|593468078|FG005|Overall Study|Relocation|2|||
164298375|NCT00317473|593468073|FG000|Overall Study|Death|1|||
164298376|NCT00317473|593468074|FG001|Overall Study|Death|0|||
164298377|NCT00317473|593468075|FG002|Overall Study|Death|0|||
164298378|NCT00317473|593468076|FG003|Overall Study|Death|0|||
164298379|NCT00317473|593468077|FG004|Overall Study|Death|0|||
164298380|NCT00317473|593468078|FG005|Overall Study|Death|0|||
164298381|NCT00317473|593468073|FG000|Overall Study|Other|0|||
164298382|NCT00317473|593468074|FG001|Overall Study|Other|2|||
164298383|NCT00317473|593468075|FG002|Overall Study|Other|0|||
164298384|NCT00317473|593468076|FG003|Overall Study|Other|0|||
164298385|NCT00317473|593468077|FG004|Overall Study|Other|0|||
164298386|NCT00317473|593468078|FG005|Overall Study|Other|0|||
164298387|NCT02285855|593468079|FG000|Overall Study|Withdrawal by Subject|2|||
164298388|NCT02285855|593468080|FG001|Overall Study|Withdrawal by Subject|1|||
164298389|NCT03253796|593468081|FG000|Period 1: Run-In|Adverse Event|4|||
164298390|NCT03253796|593468082|FG001|Period 1: Run-In|Adverse Event|0|||
164298391|NCT03253796|593468083|FG002|Period 1: Run-In|Adverse Event|0|||
164298392|NCT03253796|593468084|FG003|Period 1: Run-In|Adverse Event|0|||
164298393|NCT03253796|593468085|FG004|Period 1: Run-In|Adverse Event|0|||
164298394|NCT03253796|593468081|FG000|Period 1: Run-In|Lack of Efficacy|1|||
164298395|NCT03253796|593468082|FG001|Period 1: Run-In|Lack of Efficacy|0|||
164298396|NCT03253796|593468083|FG002|Period 1: Run-In|Lack of Efficacy|0|||
164298397|NCT03253796|593468084|FG003|Period 1: Run-In|Lack of Efficacy|0|||
164298398|NCT03253796|593468085|FG004|Period 1: Run-In|Lack of Efficacy|0|||
164298399|NCT03253796|593468081|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
164298400|NCT03253796|593468082|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
164298401|NCT03253796|593468083|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
164298402|NCT03253796|593468084|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
164298403|NCT03253796|593468085|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
164298404|NCT03253796|593468081|FG000|Period 1: Run-In|Protocol Violation|5|||
164298405|NCT03253796|593468082|FG001|Period 1: Run-In|Protocol Violation|0|||
164298406|NCT03253796|593468083|FG002|Period 1: Run-In|Protocol Violation|0|||
164298407|NCT03253796|593468084|FG003|Period 1: Run-In|Protocol Violation|0|||
164298408|NCT03253796|593468085|FG004|Period 1: Run-In|Protocol Violation|0|||
164298409|NCT03253796|593468081|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
164298410|NCT03253796|593468082|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
164298411|NCT03253796|593468083|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
164298412|NCT03253796|593468084|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
164298413|NCT03253796|593468085|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
164298414|NCT03253796|593468081|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
164298415|NCT03253796|593468082|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
164298416|NCT03253796|593468083|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
164298417|NCT03253796|593468084|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
164298418|NCT03253796|593468085|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
164298419|NCT03253796|593468081|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
164298420|NCT03253796|593468082|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
164298421|NCT03253796|593468083|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
164301059|NCT02435992|593478413|FG002|Overall Study|Other Reason|0|||
164301060|NCT02435992|593478414|FG003|Overall Study|Other Reason|0|||
164301061|NCT02435992|593478415|FG004|Overall Study|Other Reason|0|||
164301062|NCT02435992|593478411|FG000|Overall Study|Physician Decision|0|||
164301063|NCT02435992|593478412|FG001|Overall Study|Physician Decision|0|||
164298422|NCT03253796|593468084|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
164298423|NCT03253796|593468085|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
164298424|NCT03253796|593468081|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
164298425|NCT03253796|593468082|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
164298426|NCT03253796|593468083|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
164298427|NCT03253796|593468084|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
164298428|NCT03253796|593468085|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
164298429|NCT03253796|593468081|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
164298430|NCT03253796|593468082|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
164298431|NCT03253796|593468083|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
164298432|NCT03253796|593468084|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
164298433|NCT03253796|593468085|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
164298434|NCT03253796|593468081|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
164298435|NCT03253796|593468082|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
164298436|NCT03253796|593468083|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
164298437|NCT03253796|593468084|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
164298438|NCT03253796|593468085|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
164298439|NCT03253796|593468081|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
164298440|NCT03253796|593468082|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
164298441|NCT03253796|593468083|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
164298442|NCT03253796|593468084|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
164298443|NCT03253796|593468085|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
164298444|NCT00528112|593468086|FG000|Treatment up to 3 Years|Adverse Event|313|||
164298445|NCT00528112|593468087|FG001|Treatment up to 3 Years|Adverse Event|278|||
164298446|NCT00528112|593468086|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
164298447|NCT00528112|593468087|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
164298448|NCT00528112|593468086|FG000|Treatment up to 3 Years|Protocol Violation|16|||
164298449|NCT00528112|593468087|FG001|Treatment up to 3 Years|Protocol Violation|16|||
164298450|NCT00528112|593468086|FG000|Treatment up to 3 Years|Death|0|||
164298451|NCT00528112|593468087|FG001|Treatment up to 3 Years|Death|1|||
164298452|NCT00528112|593468086|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
164298453|NCT00528112|593468087|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
164298454|NCT00528112|593468086|FG000|Treatment up to 3 Years|Pregnancy|9|||
164298455|NCT00528112|593468087|FG001|Treatment up to 3 Years|Pregnancy|10|||
164298456|NCT00528112|593468086|FG000|Treatment up to 3 Years|Other reasons|186|||
164298457|NCT00528112|593468087|FG001|Treatment up to 3 Years|Other reasons|186|||
164298458|NCT00528112|593468086|FG000|Extension Phase|Withdrawal by Subject|0|||
164298459|NCT00528112|593468087|FG001|Extension Phase|Withdrawal by Subject|3|||
164298460|NCT00528112|593468086|FG000|Extension Phase|Other reasons|0|||
164298461|NCT00528112|593468087|FG001|Extension Phase|Other reasons|100|||
164298462|NCT00528112|593468086|FG000|Extension Phase|Pregnancy|0|||
164298463|NCT00528112|593468087|FG001|Extension Phase|Pregnancy|3|||
164298464|NCT00528112|593468086|FG000|Extension Phase|Lost to Follow-up|0|||
164298465|NCT00528112|593468087|FG001|Extension Phase|Lost to Follow-up|12|||
164298466|NCT00528112|593468086|FG000|Extension Phase|Death|0|||
164298467|NCT00528112|593468087|FG001|Extension Phase|Death|1|||
164298468|NCT00528112|593468086|FG000|Extension Phase|Adverse Event|0|||
164298469|NCT00528112|593468087|FG001|Extension Phase|Adverse Event|36|||
164298470|NCT00528112|593468086|FG000|Extension Phase|Protocol Violation|0|||
164298471|NCT00528112|593468087|FG001|Extension Phase|Protocol Violation|2|||
164298472|NCT02718898|593468090|FG000|Blinded Treatment Period|Adverse Event|5|||
164298473|NCT02718898|593468091|FG001|Blinded Treatment Period|Adverse Event|1|||
164298474|NCT02718898|593468092|FG002|Blinded Treatment Period|Adverse Event|0|||
164298475|NCT02718898|593468093|FG003|Blinded Treatment Period|Adverse Event|0|||
164298476|NCT02718898|593468094|FG004|Blinded Treatment Period|Adverse Event|0|||
164298477|NCT02718898|593468095|FG005|Blinded Treatment Period|Adverse Event|0|||
164347949|NCT05399641|593650981|FG002|Overall Study|Reason not defined|6|||
164347950|NCT04523220|593650989|FG000|Main Treatment Period|Physician Decision|1|||
164347951|NCT04523220|593650990|FG001|Main Treatment Period|Physician Decision|1|||
164587610|NCT01809262|594515888|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
164435664|NCT03546907|593962049|FG001|Overall Study|Withdrawal by Subject|9|||
164435665|NCT03546907|593962048|FG000|Overall Study|Adverse events (AEs)|7|||
164435666|NCT03546907|593962049|FG001|Overall Study|Adverse events (AEs)|10|||
164435667|NCT03546907|593962048|FG000|Overall Study|Other-unspecified|1|||
164435668|NCT03546907|593962049|FG001|Overall Study|Other-unspecified|1|||
164435669|NCT03720210|593962050|FG000|Overall Study|Lost to Follow-up|1|||
164435670|NCT02274493|593962056|FG000|Overall Study|Withdrawal by Subject|1|||
164435671|NCT00798096|593962059|FG000|Overall Study|Ongoing|2|||
164435672|NCT01178762|593962060|FG000|Overall Study|Lost to Follow-up|15|||
164435673|NCT02155829|593962061|FG000|Overall Study|Adverse Event|1|||
164587611|NCT01809262|594515889|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
164435674|NCT02155829|593962062|FG001|Overall Study|Adverse Event|0|||
164435675|NCT02155829|593962061|FG000|Overall Study|Withdrawal by Subject|3|||
164435676|NCT02155829|593962062|FG001|Overall Study|Withdrawal by Subject|3|||
164435677|NCT02155829|593962061|FG000|Overall Study|Protocol Violation|2|||
164435678|NCT02155829|593962062|FG001|Overall Study|Protocol Violation|0|||
164435679|NCT01585038|593962063|FG000|Overall Study|Adverse Event|2|||
164435680|NCT01585038|593962064|FG001|Overall Study|Adverse Event|2|||
164435681|NCT00678795|593962065|FG000|Overall Study|Adverse Event|7|||
164587612|NCT01809262|594515890|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
164587613|NCT01809262|594515891|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
164587614|NCT01809262|594515892|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
164587615|NCT01809262|594515893|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
164587616|NCT01809262|594515894|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
164435682|NCT00678795|593962066|FG001|Overall Study|Adverse Event|3|||
164435683|NCT00678795|593962065|FG000|Overall Study|Withdrawal by Subject|3|||
164435684|NCT00678795|593962066|FG001|Overall Study|Withdrawal by Subject|0|||
164435685|NCT00678795|593962065|FG000|Overall Study|Protocol Violation|0|||
164435686|NCT00678795|593962066|FG001|Overall Study|Protocol Violation|1|||
164435687|NCT00678795|593962065|FG000|Overall Study|Lost to Follow-up|0|||
164435688|NCT00678795|593962066|FG001|Overall Study|Lost to Follow-up|1|||
164435689|NCT00678795|593962065|FG000|Overall Study|Lack of Efficacy|1|||
164435690|NCT00678795|593962066|FG001|Overall Study|Lack of Efficacy|1|||
164587617|NCT01809262|594515895|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
164587618|NCT01809262|594515886|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
164587619|NCT01809262|594515887|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
164693640|NCT00739973|594899418|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
164693641|NCT00739973|594899419|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
164693642|NCT00739973|594899420|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
164693643|NCT00739973|594899421|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
164693644|NCT00739973|594899422|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
164693645|NCT00739973|594899423|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
164693646|NCT00739973|594899424|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
164693647|NCT00739973|594899425|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
164693648|NCT00739973|594899417|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
164693649|NCT00739973|594899418|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
164693650|NCT00739973|594899419|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
164693651|NCT00739973|594899420|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
164693652|NCT00739973|594899421|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
164693653|NCT00739973|594899422|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
164693654|NCT00739973|594899423|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
164693655|NCT00739973|594899424|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
164298478|NCT02718898|593468096|FG006|Blinded Treatment Period|Adverse Event|0|||
164298479|NCT02718898|593468090|FG000|Blinded Treatment Period|Physician Decision|1|||
164298480|NCT02718898|593468091|FG001|Blinded Treatment Period|Physician Decision|0|||
164298481|NCT02718898|593468092|FG002|Blinded Treatment Period|Physician Decision|0|||
164435691|NCT02982213|593962067|FG000|Overall Study|Did not complete follow up questionnaire|5|||
164587620|NCT01809262|594515888|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
164693656|NCT00739973|594899425|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
164693657|NCT00739973|594899417|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
164693658|NCT00739973|594899418|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
164693659|NCT00739973|594899419|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
164435692|NCT02982213|593962068|FG001|Overall Study|Did not complete follow up questionnaire|1|||
164435693|NCT02596035|593962070|FG000|Overall Study|Disease Progression|64|||
164435694|NCT02596035|593962071|FG001|Overall Study|Disease Progression|32|||
164435695|NCT02596035|593962072|FG002|Overall Study|Disease Progression|1|||
164435696|NCT02596035|593962070|FG000|Overall Study|study drug toxicity|12|||
164435697|NCT02596035|593962071|FG001|Overall Study|study drug toxicity|3|||
164435698|NCT02596035|593962072|FG002|Overall Study|study drug toxicity|0|||
164435699|NCT02596035|593962070|FG000|Overall Study|AE unrelated to study drug|5|||
164435700|NCT02596035|593962071|FG001|Overall Study|AE unrelated to study drug|2|||
164435701|NCT02596035|593962072|FG002|Overall Study|AE unrelated to study drug|0|||
164435702|NCT02596035|593962070|FG000|Overall Study|participant request to discontinue study treatment|2|||
164435703|NCT02596035|593962071|FG001|Overall Study|participant request to discontinue study treatment|0|||
164435704|NCT02596035|593962072|FG002|Overall Study|participant request to discontinue study treatment|0|||
164435705|NCT02596035|593962070|FG000|Overall Study|participant withdrew consent|2|||
164435706|NCT02596035|593962071|FG001|Overall Study|participant withdrew consent|2|||
164435707|NCT02596035|593962072|FG002|Overall Study|participant withdrew consent|0|||
164435708|NCT02596035|593962070|FG000|Overall Study|Poor/Non Comlpiance|0|||
164693660|NCT00739973|594899420|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
164693661|NCT00739973|594899421|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
164693662|NCT00739973|594899422|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
164693663|NCT00739973|594899423|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
164693664|NCT00739973|594899424|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
164693665|NCT00739973|594899425|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
164693666|NCT00739973|594899417|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
164693667|NCT00739973|594899418|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
164693668|NCT00739973|594899419|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
164693669|NCT00739973|594899420|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
164693670|NCT00739973|594899421|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
164693671|NCT00739973|594899422|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
164693672|NCT00739973|594899423|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
164435709|NCT02596035|593962071|FG001|Overall Study|Poor/Non Comlpiance|1|||
164693673|NCT00739973|594899424|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
164693674|NCT00739973|594899425|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
164693675|NCT00739973|594899417|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
164693676|NCT00739973|594899418|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
164435710|NCT02596035|593962072|FG002|Overall Study|Poor/Non Comlpiance|0|||
164693677|NCT00739973|594899419|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
164693678|NCT00739973|594899420|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
164693679|NCT00739973|594899421|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
164693680|NCT00739973|594899422|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
164693681|NCT00739973|594899423|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
164693682|NCT00739973|594899424|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
164693683|NCT00739973|594899425|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
164693684|NCT00739973|594899417|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
164693685|NCT00739973|594899418|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
164693686|NCT00739973|594899419|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
164693687|NCT00739973|594899420|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
164693688|NCT00739973|594899421|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
164693689|NCT00739973|594899422|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
164693690|NCT00739973|594899423|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
164693691|NCT00739973|594899424|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
164693692|NCT00739973|594899425|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
164693693|NCT02219308|594899426|FG000|Overall Study|Withdrawal by Subject|1|||
164693694|NCT02219308|594899427|FG001|Overall Study|Withdrawal by Subject|2|||
164693695|NCT02175368|594899428|FG000|Overall Study|Lost to Follow-up|1|||
164693696|NCT02875028|594899429|FG000|Washout Period|Withdrawal by Subject|0|||
164693697|NCT02875028|594899430|FG001|Washout Period|Withdrawal by Subject|1|||
164693698|NCT05068284|594899431|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
164693699|NCT05068284|594899432|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
164693700|NCT05068284|594899433|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
164693701|NCT05068284|594899434|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
164693702|NCT05068284|594899435|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
164693703|NCT05068284|594899436|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
164693704|NCT05068284|594899437|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
164693705|NCT05068284|594899438|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
164693706|NCT05068284|594899431|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
164693707|NCT05068284|594899432|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
164693708|NCT05068284|594899433|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
164693709|NCT05068284|594899434|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
164693710|NCT05068284|594899435|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
164693711|NCT05068284|594899436|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
164693712|NCT05068284|594899437|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
164693713|NCT05068284|594899438|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
164298482|NCT02718898|593468093|FG003|Blinded Treatment Period|Physician Decision|0|||
164298483|NCT02718898|593468094|FG004|Blinded Treatment Period|Physician Decision|0|||
164298484|NCT02718898|593468095|FG005|Blinded Treatment Period|Physician Decision|0|||
164298485|NCT02718898|593468096|FG006|Blinded Treatment Period|Physician Decision|0|||
164298486|NCT02718898|593468090|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
164298487|NCT02718898|593468091|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
164298488|NCT02718898|593468092|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
164298489|NCT02718898|593468093|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
164298490|NCT02718898|593468094|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
164298491|NCT02718898|593468095|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
164298492|NCT02718898|593468096|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
164298493|NCT02718898|593468090|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
164298494|NCT02718898|593468091|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
164298495|NCT02718898|593468092|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
164298496|NCT02718898|593468093|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
164298497|NCT02718898|593468094|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
164298498|NCT02718898|593468095|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
164298499|NCT02718898|593468096|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
164298500|NCT02718898|593468090|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
164298501|NCT02718898|593468091|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
164298502|NCT02718898|593468092|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
164298503|NCT02718898|593468093|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
164298504|NCT02718898|593468094|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
164298505|NCT02718898|593468095|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
164298506|NCT02718898|593468096|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
164298507|NCT02718898|593468090|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
164298508|NCT02718898|593468091|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
164298509|NCT02718898|593468092|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
164298510|NCT02718898|593468093|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
164298511|NCT02718898|593468094|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
164298512|NCT02718898|593468095|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
164298513|NCT02718898|593468096|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
164298514|NCT02718898|593468090|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
164298515|NCT02718898|593468091|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
164298516|NCT02718898|593468092|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
164298517|NCT02718898|593468093|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
164298518|NCT02718898|593468094|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
164298519|NCT02718898|593468095|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
164298520|NCT02718898|593468096|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
164298521|NCT02718898|593468090|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
164298522|NCT02718898|593468091|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
164298523|NCT02718898|593468092|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
164298524|NCT02718898|593468093|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
164298525|NCT02718898|593468094|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
164298526|NCT02718898|593468095|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
164298527|NCT02718898|593468096|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
164298528|NCT02718898|593468090|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
164298529|NCT02718898|593468091|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
164298530|NCT02718898|593468092|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
164298531|NCT02718898|593468093|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
164298532|NCT02718898|593468094|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
164298533|NCT02718898|593468095|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
164298534|NCT02718898|593468096|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
164298535|NCT02718898|593468090|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
164298536|NCT02718898|593468091|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
164298537|NCT02718898|593468092|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
164298538|NCT02718898|593468093|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
164298539|NCT02718898|593468094|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
164298540|NCT02718898|593468095|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
164298541|NCT02718898|593468096|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
164298542|NCT02718898|593468090|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
164298543|NCT02718898|593468091|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
164298544|NCT02718898|593468092|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
164298545|NCT02718898|593468093|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
164298546|NCT02718898|593468094|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
164298547|NCT02718898|593468095|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
164298548|NCT02718898|593468096|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
164298549|NCT02718898|593468090|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
164298550|NCT02718898|593468091|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
164298551|NCT02718898|593468092|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
164298552|NCT02718898|593468093|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
164298553|NCT02718898|593468094|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
164347952|NCT04523220|593650991|FG002|Main Treatment Period|Physician Decision|0|||
164347953|NCT04523220|593650989|FG000|Main Treatment Period|Other|5|||
164347954|NCT04523220|593650990|FG001|Main Treatment Period|Other|2|||
164347955|NCT04523220|593650991|FG002|Main Treatment Period|Other|4|||
164347956|NCT04523220|593650989|FG000|Main Treatment Period|Subject Decision|5|||
164347957|NCT04523220|593650990|FG001|Main Treatment Period|Subject Decision|7|||
164347958|NCT04523220|593650991|FG002|Main Treatment Period|Subject Decision|3|||
164347959|NCT04523220|593650989|FG000|Main Treatment Period|Death|5|||
164347960|NCT04523220|593650990|FG001|Main Treatment Period|Death|11|||
164347961|NCT04523220|593650991|FG002|Main Treatment Period|Death|4|||
164347962|NCT04523220|593650989|FG000|Main Treatment Period|Adverse Event|11|||
164347963|NCT04523220|593650990|FG001|Main Treatment Period|Adverse Event|9|||
164347964|NCT04523220|593650991|FG002|Main Treatment Period|Adverse Event|9|||
164347965|NCT04523220|593650989|FG000|Main Treatment Period|Withdrawal by Subject|3|||
164347966|NCT04523220|593650990|FG001|Main Treatment Period|Withdrawal by Subject|3|||
164347967|NCT04523220|593650991|FG002|Main Treatment Period|Withdrawal by Subject|4|||
164347968|NCT04523220|593650989|FG000|Main Treatment Period|Study drug never adminstered|10|||
164347969|NCT04523220|593650990|FG001|Main Treatment Period|Study drug never adminstered|3|||
164347970|NCT04523220|593650991|FG002|Main Treatment Period|Study drug never adminstered|5|||
164435711|NCT02596035|593962070|FG000|Overall Study|participant no longer meets study criteria|1|||
164435712|NCT02596035|593962071|FG001|Overall Study|participant no longer meets study criteria|0|||
164347971|NCT04523220|593650989|FG000|Extension Treatment Period|Physician Decision|1|||
164693714|NCT05068284|594899431|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
164693715|NCT05068284|594899432|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
164298554|NCT02718898|593468095|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
164298555|NCT02718898|593468096|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
164298556|NCT02718898|593468090|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
164298557|NCT02718898|593468091|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
164298558|NCT02718898|593468092|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
164298559|NCT02718898|593468093|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
164298560|NCT02718898|593468094|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
164298561|NCT02718898|593468095|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
164298562|NCT02718898|593468096|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
164298563|NCT02163538|593468097|FG000|Overall Study|Protocol Violation|1|||
164298564|NCT02163538|593468098|FG001|Overall Study|Protocol Violation|0|||
164298565|NCT02163538|593468097|FG000|Overall Study|Physician Decision|0|||
164298566|NCT02163538|593468098|FG001|Overall Study|Physician Decision|1|||
164298567|NCT01345240|593468099|FG000|Overall Study|Adverse Event|3|||
164298568|NCT01345240|593468100|FG001|Overall Study|Adverse Event|5|||
164298569|NCT01345240|593468101|FG002|Overall Study|Adverse Event|4|||
164298570|NCT01345240|593468102|FG003|Overall Study|Adverse Event|2|||
164298571|NCT01345240|593468103|FG004|Overall Study|Adverse Event|1|||
164298572|NCT01345240|593468099|FG000|Overall Study|Lost to Follow-up|8|||
164298573|NCT01345240|593468100|FG001|Overall Study|Lost to Follow-up|9|||
164298574|NCT01345240|593468101|FG002|Overall Study|Lost to Follow-up|14|||
164298575|NCT01345240|593468102|FG003|Overall Study|Lost to Follow-up|7|||
164298576|NCT01345240|593468103|FG004|Overall Study|Lost to Follow-up|9|||
164298577|NCT02158442|593468107|FG000|Overall Study|Withdrawal by Subject|1|||
164298578|NCT02158442|593468108|FG001|Overall Study|Withdrawal by Subject|0|||
164298579|NCT02158442|593468107|FG000|Overall Study|Perfusion staff not available|1|||
164298580|NCT02158442|593468108|FG001|Overall Study|Perfusion staff not available|0|||
164298581|NCT00617734|593468110|FG000|Overall Study|Withdrew Consent|2|||
164298582|NCT00617734|593468111|FG001|Overall Study|Withdrew Consent|0|||
164298583|NCT00617734|593468110|FG000|Overall Study|Adverse Event|4|||
164298584|NCT00617734|593468111|FG001|Overall Study|Adverse Event|1|||
164298585|NCT00617734|593468110|FG000|Overall Study|Protocol Violation|1|||
164298586|NCT00617734|593468111|FG001|Overall Study|Protocol Violation|0|||
164298587|NCT00617734|593468110|FG000|Overall Study|Found Ineligible After Randomization|1|||
164298588|NCT00617734|593468111|FG001|Overall Study|Found Ineligible After Randomization|4|||
164298589|NCT00617734|593468110|FG000|Overall Study|Lost to Follow-up|0|||
164298590|NCT00617734|593468111|FG001|Overall Study|Lost to Follow-up|1|||
164298591|NCT05135767|593468114|FG000|Baseline|Lost to Follow-up|1|||
164298592|NCT05135767|593468115|FG001|Baseline|Lost to Follow-up|1|||
164298593|NCT05135767|593468114|FG000|Baseline|Withdrawal by Subject|0|||
164298594|NCT05135767|593468115|FG001|Baseline|Withdrawal by Subject|2|||
164298595|NCT05135767|593468114|FG000|Active Study Phase|Lost to Follow-up|2|||
164298596|NCT05135767|593468115|FG001|Active Study Phase|Lost to Follow-up|0|||
164298597|NCT02694185|593468116|FG000|Overall Study|Withdrawal by Subject|45|||
164298598|NCT02694185|593468117|FG001|Overall Study|Withdrawal by Subject|0|||
164298599|NCT05082857|593468118|FG000|Overall Study|participants relocated and could not continue|2|||
164298600|NCT05082857|593468119|FG001|Overall Study|participants relocated and could not continue|1|||
164298601|NCT05082857|593468118|FG000|Overall Study|Lost to Follow-up|1|||
164298602|NCT05082857|593468119|FG001|Overall Study|Lost to Follow-up|3|||
164298603|NCT04366349|593468120|FG000|Overall Study|Withdrawal by Subject|1|||
164298604|NCT04366349|593468121|FG001|Overall Study|Withdrawal by Subject|0|||
164298605|NCT04366349|593468122|FG002|Overall Study|Withdrawal by Subject|0|||
164298606|NCT04366349|593468123|FG003|Overall Study|Withdrawal by Subject|0|||
164298607|NCT04366349|593468124|FG004|Overall Study|Withdrawal by Subject|0|||
164298608|NCT04366349|593468125|FG005|Overall Study|Withdrawal by Subject|0|||
164298609|NCT03341299|593468126|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
164298610|NCT03341299|593468127|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
164347972|NCT04523220|593650990|FG001|Extension Treatment Period|Physician Decision|0|||
164347973|NCT04523220|593650991|FG002|Extension Treatment Period|Physician Decision|3|||
164347974|NCT04523220|593650989|FG000|Extension Treatment Period|Other|2|||
164347975|NCT04523220|593650990|FG001|Extension Treatment Period|Other|6|||
164347976|NCT04523220|593650991|FG002|Extension Treatment Period|Other|6|||
164347977|NCT04523220|593650989|FG000|Extension Treatment Period|Subject Decision|5|||
164347978|NCT04523220|593650990|FG001|Extension Treatment Period|Subject Decision|2|||
164347979|NCT04523220|593650991|FG002|Extension Treatment Period|Subject Decision|4|||
164347980|NCT04523220|593650989|FG000|Extension Treatment Period|Death|6|||
164298611|NCT03341299|593468128|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
164298612|NCT03341299|593468129|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
164347981|NCT04523220|593650990|FG001|Extension Treatment Period|Death|4|||
164347982|NCT04523220|593650991|FG002|Extension Treatment Period|Death|7|||
164298613|NCT04905134|593468134|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
164347983|NCT04523220|593650989|FG000|Extension Treatment Period|Adverse Event|6|||
164347984|NCT04523220|593650990|FG001|Extension Treatment Period|Adverse Event|7|||
164298614|NCT04905134|593468134|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
164347985|NCT04523220|593650991|FG002|Extension Treatment Period|Adverse Event|9|||
164347986|NCT04523220|593650989|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
164347987|NCT04523220|593650990|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
164347988|NCT04523220|593650991|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
164347989|NCT04523220|593650989|FG000|Extension Treatment Period|Study drug never administered|0|||
164347990|NCT04523220|593650990|FG001|Extension Treatment Period|Study drug never administered|1|||
164347991|NCT04523220|593650991|FG002|Extension Treatment Period|Study drug never administered|0|||
164347992|NCT00256750|593650993|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
164347993|NCT00256750|593650994|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
164347994|NCT00256750|593650995|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
164347995|NCT00256750|593650993|FG000|Transplanted Pre-Treatment|Other|2|||
164347996|NCT00256750|593650994|FG001|Transplanted Pre-Treatment|Other|0|||
164347997|NCT00256750|593650995|FG002|Transplanted Pre-Treatment|Other|0|||
164347998|NCT00256750|593650993|FG000|Transplanted Pre-Treatment|Death|1|||
164347999|NCT00256750|593650994|FG001|Transplanted Pre-Treatment|Death|0|||
164348000|NCT00256750|593650995|FG002|Transplanted Pre-Treatment|Death|0|||
164348001|NCT00256750|593650993|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
164348002|NCT00256750|593650994|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
164348003|NCT00256750|593650995|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
164348004|NCT00256750|593650993|FG000|Post-Transplant Treated (12 Months)|Death|3|||
164348005|NCT00256750|593650994|FG001|Post-Transplant Treated (12 Months)|Death|2|||
164348006|NCT00256750|593650995|FG002|Post-Transplant Treated (12 Months)|Death|4|||
164348007|NCT00256750|593650993|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
164348008|NCT00256750|593650994|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
164348009|NCT00256750|593650995|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
164348010|NCT00256750|593650993|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
164348011|NCT00256750|593650994|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
164348012|NCT00256750|593650995|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
164348013|NCT00256750|593650993|FG000|Post-Transplant Treated (12 Months)|Other|5|||
164348014|NCT00256750|593650994|FG001|Post-Transplant Treated (12 Months)|Other|4|||
164348015|NCT00256750|593650995|FG002|Post-Transplant Treated (12 Months)|Other|2|||
164348016|NCT00256750|593650993|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
164348017|NCT00256750|593650994|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
164348018|NCT00256750|593650995|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
164348019|NCT00256750|593650993|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
164348020|NCT00256750|593650994|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
164348021|NCT00256750|593650995|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
164348022|NCT00256750|593650993|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
164348023|NCT00256750|593650994|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
164348024|NCT00256750|593650995|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
164348025|NCT00256750|593650993|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
164348026|NCT00256750|593650994|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
164348027|NCT00256750|593650995|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
164348028|NCT00256750|593650993|FG000|Post-Transplant Treated (24 Months)|Death|3|||
164348029|NCT00256750|593650994|FG001|Post-Transplant Treated (24 Months)|Death|0|||
164348030|NCT00256750|593650995|FG002|Post-Transplant Treated (24 Months)|Death|0|||
164348031|NCT00256750|593650993|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
164348032|NCT00256750|593650994|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
164348033|NCT00256750|593650995|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
164348034|NCT00256750|593650993|FG000|Post-Transplant Treated (24 Months)|Other|2|||
164348035|NCT00256750|593650994|FG001|Post-Transplant Treated (24 Months)|Other|0|||
164348036|NCT00256750|593650995|FG002|Post-Transplant Treated (24 Months)|Other|1|||
164348037|NCT00256750|593650993|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
164348038|NCT00256750|593650994|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
164348039|NCT00256750|593650995|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
164348040|NCT00256750|593650993|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
164348041|NCT00256750|593650994|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
164348042|NCT00256750|593650995|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
164348043|NCT00256750|593650993|FG000|Post-Transplant Treated (36 Months)|Death|0|||
164348044|NCT00256750|593650994|FG001|Post-Transplant Treated (36 Months)|Death|2|||
164348045|NCT00256750|593650995|FG002|Post-Transplant Treated (36 Months)|Death|1|||
164348046|NCT00256750|593650993|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
164348047|NCT00256750|593650994|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
164348048|NCT00256750|593650995|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
164348049|NCT00256750|593650993|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
164348050|NCT00256750|593650994|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
164348051|NCT00256750|593650995|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
164348052|NCT00256750|593650993|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
164348053|NCT00256750|593650994|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
164693716|NCT05068284|594899433|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
164693717|NCT05068284|594899434|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
164693718|NCT05068284|594899435|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
164693719|NCT05068284|594899436|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
164693720|NCT05068284|594899437|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
164693721|NCT05068284|594899438|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
164693722|NCT05068284|594899431|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
164693723|NCT05068284|594899432|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
164435713|NCT02596035|593962072|FG002|Overall Study|participant no longer meets study criteria|0|||
164435714|NCT02596035|593962070|FG000|Overall Study|other reasons|11|||
164435715|NCT02596035|593962071|FG001|Overall Study|other reasons|4|||
164435716|NCT02596035|593962072|FG002|Overall Study|other reasons|0|||
164435717|NCT03523962|593962074|FG000|Closed Fractures|Death|86|||
164435718|NCT03523962|593962075|FG001|Closed Fractures|Death|71|||
164435719|NCT03523962|593962076|FG002|Closed Fractures|Death|0|||
164435720|NCT03523962|593962077|FG003|Closed Fractures|Death|0|||
164435721|NCT03523962|593962074|FG000|Closed Fractures|Lost to Follow-up|62|||
164435722|NCT03523962|593962075|FG001|Closed Fractures|Lost to Follow-up|36|||
164435723|NCT03523962|593962076|FG002|Closed Fractures|Lost to Follow-up|0|||
164435724|NCT03523962|593962077|FG003|Closed Fractures|Lost to Follow-up|0|||
164435725|NCT03523962|593962074|FG000|Closed Fractures|Withdrawal by Subject|19|||
164435726|NCT03523962|593962075|FG001|Closed Fractures|Withdrawal by Subject|29|||
164435727|NCT03523962|593962076|FG002|Closed Fractures|Withdrawal by Subject|0|||
164435728|NCT03523962|593962077|FG003|Closed Fractures|Withdrawal by Subject|0|||
164435729|NCT03523962|593962074|FG000|Closed Fractures|Incarceration|1|||
164435730|NCT03523962|593962075|FG001|Closed Fractures|Incarceration|4|||
164435731|NCT03523962|593962076|FG002|Closed Fractures|Incarceration|0|||
164435732|NCT03523962|593962077|FG003|Closed Fractures|Incarceration|0|||
164435733|NCT03523962|593962074|FG000|Open Fractures|Death|0|||
164435734|NCT03523962|593962075|FG001|Open Fractures|Death|0|||
164435735|NCT03523962|593962076|FG002|Open Fractures|Death|11|||
164435736|NCT03523962|593962077|FG003|Open Fractures|Death|6|||
164435737|NCT03523962|593962074|FG000|Open Fractures|Lost to Follow-up|0|||
164435738|NCT03523962|593962075|FG001|Open Fractures|Lost to Follow-up|0|||
164435739|NCT03523962|593962076|FG002|Open Fractures|Lost to Follow-up|15|||
164435740|NCT03523962|593962077|FG003|Open Fractures|Lost to Follow-up|8|||
164435741|NCT03523962|593962074|FG000|Open Fractures|Withdrawal by Subject|0|||
164435742|NCT03523962|593962075|FG001|Open Fractures|Withdrawal by Subject|0|||
164435743|NCT03523962|593962076|FG002|Open Fractures|Withdrawal by Subject|6|||
164435744|NCT03523962|593962077|FG003|Open Fractures|Withdrawal by Subject|2|||
164435745|NCT03523962|593962074|FG000|Open Fractures|Incarceration|0|||
164435746|NCT03523962|593962075|FG001|Open Fractures|Incarceration|0|||
164435747|NCT03523962|593962076|FG002|Open Fractures|Incarceration|1|||
164435748|NCT03523962|593962077|FG003|Open Fractures|Incarceration|0|||
164435749|NCT00835380|593962078|FG000|Overall Study|Withdrawal by Subject|2|||
164435750|NCT03247543|593962079|FG000|Overall Study|Adverse Event|3|||
164435751|NCT03247543|593962080|FG001|Overall Study|Adverse Event|6|||
164435752|NCT03247543|593962081|FG002|Overall Study|Adverse Event|4|||
164435753|NCT03247543|593962079|FG000|Overall Study|Lost to Follow-up|10|||
164435754|NCT03247543|593962080|FG001|Overall Study|Lost to Follow-up|7|||
164435755|NCT03247543|593962081|FG002|Overall Study|Lost to Follow-up|8|||
164435756|NCT03247543|593962079|FG000|Overall Study|Consent withdrawn by caregiver|2|||
164435757|NCT03247543|593962080|FG001|Overall Study|Consent withdrawn by caregiver|2|||
164435758|NCT03247543|593962081|FG002|Overall Study|Consent withdrawn by caregiver|9|||
164435759|NCT03247543|593962079|FG000|Overall Study|Withdrawal by Subject|0|||
164435760|NCT03247543|593962080|FG001|Overall Study|Withdrawal by Subject|0|||
164435761|NCT03247543|593962081|FG002|Overall Study|Withdrawal by Subject|1|||
164435762|NCT03247543|593962079|FG000|Overall Study|Failure to Follow study procedures|1|||
164693724|NCT05068284|594899433|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
164435763|NCT03247543|593962080|FG001|Overall Study|Failure to Follow study procedures|3|||
164435764|NCT03247543|593962081|FG002|Overall Study|Failure to Follow study procedures|1|||
164435765|NCT03247543|593962079|FG000|Overall Study|Lack of Efficacy|1|||
164435766|NCT03247543|593962080|FG001|Overall Study|Lack of Efficacy|0|||
164435767|NCT03247543|593962081|FG002|Overall Study|Lack of Efficacy|0|||
164435768|NCT03247543|593962079|FG000|Overall Study|Non-compliance with study visits|0|||
164435769|NCT03247543|593962080|FG001|Overall Study|Non-compliance with study visits|1|||
164435770|NCT03247543|593962081|FG002|Overall Study|Non-compliance with study visits|0|||
164435771|NCT01081145|593962084|FG000|Open-Label Phase|Lack of Efficacy|56|||
164435772|NCT01081145|593962085|FG001|Open-Label Phase|Lack of Efficacy|0|||
164435773|NCT01081145|593962084|FG000|Open-Label Phase|Response criteria not met|46|||
164435774|NCT01081145|593962085|FG001|Open-Label Phase|Response criteria not met|0|||
164435775|NCT01081145|593962084|FG000|Open-Label Phase|Adverse Event|42|||
164435776|NCT01081145|593962085|FG001|Open-Label Phase|Adverse Event|0|||
164435777|NCT01081145|593962084|FG000|Open-Label Phase|Withdrawal by Subject|41|||
164587621|NCT01809262|594515889|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
164587622|NCT01809262|594515890|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
164587623|NCT01809262|594515891|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
164587624|NCT01809262|594515892|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
164693725|NCT05068284|594899434|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
164587625|NCT01809262|594515893|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
164587626|NCT01809262|594515894|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
164587627|NCT01809262|594515895|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
164587628|NCT02345434|594515898|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
164587629|NCT02345434|594515899|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
164587630|NCT00859898|594515901|FG000|Overall Study|Lack of Efficacy|0|||
164587631|NCT00859898|594515902|FG001|Overall Study|Lack of Efficacy|1|||
164587632|NCT00859898|594515903|FG002|Overall Study|Lack of Efficacy|1|||
164587633|NCT00859898|594515901|FG000|Overall Study|Adverse Event|4|||
164587634|NCT00859898|594515902|FG001|Overall Study|Adverse Event|9|||
164587635|NCT00859898|594515903|FG002|Overall Study|Adverse Event|8|||
164587636|NCT00859898|594515901|FG000|Overall Study|Withdrawal by Subject|11|||
164587637|NCT00859898|594515902|FG001|Overall Study|Withdrawal by Subject|8|||
164587638|NCT00859898|594515903|FG002|Overall Study|Withdrawal by Subject|11|||
164587639|NCT00859898|594515901|FG000|Overall Study|Death|0|||
164587640|NCT00859898|594515902|FG001|Overall Study|Death|0|||
164587641|NCT00859898|594515903|FG002|Overall Study|Death|1|||
164587642|NCT00859898|594515901|FG000|Overall Study|Lost to Follow-up|10|||
164587643|NCT00859898|594515902|FG001|Overall Study|Lost to Follow-up|11|||
164587644|NCT00859898|594515903|FG002|Overall Study|Lost to Follow-up|5|||
164587645|NCT00859898|594515901|FG000|Overall Study|poor/non-compliance|2|||
164693726|NCT05068284|594899435|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
164693727|NCT05068284|594899436|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
164693728|NCT05068284|594899437|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
164693729|NCT05068284|594899438|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
164693730|NCT05068284|594899431|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
164693731|NCT05068284|594899432|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
164693732|NCT05068284|594899433|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
164693733|NCT05068284|594899434|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
164693734|NCT05068284|594899435|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
164693735|NCT05068284|594899436|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
164693736|NCT05068284|594899437|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
164693737|NCT05068284|594899438|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
164693738|NCT05068284|594899431|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
164693739|NCT05068284|594899432|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
164693740|NCT05068284|594899433|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
164693741|NCT05068284|594899434|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
164693742|NCT05068284|594899435|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
164693743|NCT05068284|594899436|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
164693744|NCT05068284|594899437|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
164693745|NCT05068284|594899438|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
164693746|NCT05068284|594899431|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
164693747|NCT05068284|594899432|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
164693748|NCT05068284|594899433|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
164348054|NCT00256750|593650995|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
164348055|NCT00256750|593650993|FG000|Post-Transplant Treated (36 Months)|Other|0|||
164348056|NCT00256750|593650994|FG001|Post-Transplant Treated (36 Months)|Other|1|||
164348057|NCT00256750|593650995|FG002|Post-Transplant Treated (36 Months)|Other|1|||
164348058|NCT00256750|593650993|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
164348059|NCT00256750|593650994|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
164348060|NCT00256750|593650995|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
164348061|NCT00256750|593650993|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
164348062|NCT00256750|593650994|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
164348063|NCT00256750|593650995|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
164435778|NCT01081145|593962085|FG001|Open-Label Phase|Withdrawal by Subject|0|||
164587646|NCT00859898|594515902|FG001|Overall Study|poor/non-compliance|0|||
164587647|NCT00859898|594515903|FG002|Overall Study|poor/non-compliance|0|||
164587648|NCT00859898|594515901|FG000|Overall Study|No longer meets criteria|0|||
164348064|NCT00256750|593650993|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
164348065|NCT00256750|593650994|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
164348066|NCT00256750|593650995|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
164435779|NCT01081145|593962084|FG000|Open-Label Phase|Other|12|||
164587649|NCT00859898|594515902|FG001|Overall Study|No longer meets criteria|1|||
164587650|NCT00859898|594515903|FG002|Overall Study|No longer meets criteria|0|||
164587651|NCT00859898|594515901|FG000|Overall Study|non-specified|1|||
164587652|NCT00859898|594515902|FG001|Overall Study|non-specified|1|||
164587653|NCT00859898|594515903|FG002|Overall Study|non-specified|1|||
164587654|NCT03215264|594515905|FG000|Dose Level 2|Adverse Event|0|||
164587655|NCT03215264|594515906|FG001|Dose Level 2|Adverse Event|1|||
164587656|NCT03215264|594515907|FG002|Dose Level 2|Adverse Event|0|||
164587657|NCT03215264|594515905|FG000|Dose Level 3|Withdrawal by Subject|0|||
164587658|NCT03215264|594515906|FG001|Dose Level 3|Withdrawal by Subject|0|||
164587659|NCT03215264|594515907|FG002|Dose Level 3|Withdrawal by Subject|1|||
164587660|NCT01740440|594515910|FG000|Overall Study|Lost to Follow-up|3|||
164587661|NCT00367640|594515911|FG000|Overall Study|Adverse Event|3|||
164587662|NCT00367640|594515912|FG001|Overall Study|Adverse Event|6|||
164693749|NCT05068284|594899434|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
164693750|NCT05068284|594899435|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
164348067|NCT00256750|593650993|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
164693751|NCT05068284|594899436|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
164348068|NCT00256750|593650994|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
164348069|NCT00256750|593650995|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
164348070|NCT00256750|593650993|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
164348071|NCT00256750|593650994|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
164348072|NCT00256750|593650995|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
164348073|NCT00256750|593650993|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
164348074|NCT00256750|593650994|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
164348075|NCT00256750|593650995|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
164348076|NCT00256750|593650993|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
164348077|NCT00256750|593650994|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
164348078|NCT00256750|593650995|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
164348079|NCT00256750|593650993|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
164348080|NCT00256750|593650994|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
164348081|NCT00256750|593650995|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
164348082|NCT00256750|593650993|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
164348083|NCT00256750|593650994|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
164348084|NCT00256750|593650995|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
164348085|NCT04659161|593651000|FG000|Overall Study|Adverse Event|10|||
164348086|NCT04659161|593651001|FG001|Overall Study|Adverse Event|6|||
164348087|NCT04659161|593651000|FG000|Overall Study|Withdrawal by Subject|13|||
164348088|NCT04659161|593651001|FG001|Overall Study|Withdrawal by Subject|12|||
164348089|NCT04659161|593651000|FG000|Overall Study|Other|9|||
164348090|NCT04659161|593651001|FG001|Overall Study|Other|8|||
164348091|NCT01929343|593651002|FG000|Overall Study|Physician Decision|0|||
164348092|NCT01929343|593651003|FG001|Overall Study|Physician Decision|2|||
164348093|NCT01929343|593651004|FG002|Overall Study|Physician Decision|0|||
164348094|NCT01929343|593651002|FG000|Overall Study|Withdrawal by Subject|1|||
164348095|NCT01929343|593651003|FG001|Overall Study|Withdrawal by Subject|0|||
164348096|NCT01929343|593651004|FG002|Overall Study|Withdrawal by Subject|0|||
164348097|NCT02197130|593651007|FG000|Overall Study|Adverse Event|13|||
164348098|NCT02197130|593651008|FG001|Overall Study|Adverse Event|4|||
164348099|NCT02197130|593651009|FG002|Overall Study|Adverse Event|23|||
164348100|NCT02197130|593651007|FG000|Overall Study|Death|0|||
164348101|NCT02197130|593651008|FG001|Overall Study|Death|1|||
164348102|NCT02197130|593651009|FG002|Overall Study|Death|0|||
164348103|NCT02197130|593651007|FG000|Overall Study|Lost to Follow-up|2|||
164348104|NCT02197130|593651008|FG001|Overall Study|Lost to Follow-up|0|||
164348105|NCT02197130|593651009|FG002|Overall Study|Lost to Follow-up|1|||
164348106|NCT02197130|593651007|FG000|Overall Study|Does not meet entrance criteria|0|||
164348107|NCT02197130|593651008|FG001|Overall Study|Does not meet entrance criteria|0|||
164348108|NCT02197130|593651009|FG002|Overall Study|Does not meet entrance criteria|1|||
164348109|NCT02197130|593651007|FG000|Overall Study|Withdrawal by Subject|0|||
164348110|NCT02197130|593651008|FG001|Overall Study|Withdrawal by Subject|3|||
164348111|NCT02197130|593651009|FG002|Overall Study|Withdrawal by Subject|4|||
164348112|NCT02197130|593651007|FG000|Overall Study|Other|1|||
164348113|NCT02197130|593651008|FG001|Overall Study|Other|0|||
164587663|NCT00367640|594515913|FG002|Overall Study|Adverse Event|8|||
164693752|NCT05068284|594899437|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
164693753|NCT05068284|594899438|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
164348114|NCT02197130|593651009|FG002|Overall Study|Other|3|||
164348115|NCT02615145|593651010|FG000|Overall Study|Did Not Start Treatment|0|||
164348116|NCT02615145|593651011|FG001|Overall Study|Did Not Start Treatment|0|||
164348117|NCT02615145|593651012|FG002|Overall Study|Did Not Start Treatment|1|||
164348118|NCT02615145|593651013|FG003|Overall Study|Did Not Start Treatment|1|||
164587664|NCT00367640|594515914|FG003|Overall Study|Adverse Event|0|||
164348119|NCT02615145|593651010|FG000|Overall Study|Failure to Return|20|||
164348120|NCT02615145|593651011|FG001|Overall Study|Failure to Return|10|||
164348121|NCT02615145|593651012|FG002|Overall Study|Failure to Return|7|||
164587665|NCT00367640|594515911|FG000|Overall Study|Withdrawal by Subject|8|||
164348122|NCT02615145|593651013|FG003|Overall Study|Failure to Return|0|||
164348123|NCT02615145|593651010|FG000|Overall Study|Death|2|||
164348124|NCT02615145|593651011|FG001|Overall Study|Death|3|||
164348125|NCT02615145|593651012|FG002|Overall Study|Death|0|||
164348126|NCT02615145|593651013|FG003|Overall Study|Death|0|||
164348127|NCT02615145|593651010|FG000|Overall Study|Other, Not Specified|5|||
164348128|NCT02615145|593651011|FG001|Overall Study|Other, Not Specified|2|||
164348129|NCT02615145|593651012|FG002|Overall Study|Other, Not Specified|0|||
164348130|NCT02615145|593651013|FG003|Overall Study|Other, Not Specified|0|||
164348131|NCT00006237|593651018|FG000|Overall Study|Adverse Event|39|||
164348132|NCT00006237|593651019|FG001|Overall Study|Adverse Event|29|||
164348133|NCT00006237|593651018|FG000|Overall Study|Death|1|||
164348134|NCT00006237|593651019|FG001|Overall Study|Death|0|||
164348135|NCT00006237|593651018|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
164348136|NCT00006237|593651019|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
164348137|NCT00006237|593651018|FG000|Overall Study|Progression/relapse|54|||
164348138|NCT00006237|593651019|FG001|Overall Study|Progression/relapse|2|||
164348139|NCT00006237|593651018|FG000|Overall Study|Not eligible|9|||
164348140|NCT00006237|593651019|FG001|Overall Study|Not eligible|20|||
164348141|NCT00006237|593651018|FG000|Overall Study|Withdrawal by Subject|0|||
164348142|NCT00006237|593651019|FG001|Overall Study|Withdrawal by Subject|1|||
164348143|NCT00006237|593651018|FG000|Overall Study|Not protocol specified|14|||
164348144|NCT00006237|593651019|FG001|Overall Study|Not protocol specified|5|||
164348145|NCT03648983|593651024|FG000|Overall Study|Study was terminated due to PI departure|95|||
164348146|NCT01943292|593652552|FG000|Overall Study|Withdrawal by Subject|1|||
164348147|NCT01943292|593652553|FG001|Overall Study|Withdrawal by Subject|0|||
164348148|NCT01943292|593652554|FG002|Overall Study|Withdrawal by Subject|0|||
164348149|NCT00911820|593652555|FG000|Overall Study|RECIST progression|12|||
164348150|NCT00911820|593652556|FG001|Overall Study|RECIST progression|8|||
164348151|NCT00911820|593652555|FG000|Overall Study|Adverse Event|8|||
164348152|NCT00911820|593652556|FG001|Overall Study|Adverse Event|8|||
164348153|NCT00911820|593652555|FG000|Overall Study|Clinical Progression|7|||
164348154|NCT00911820|593652556|FG001|Overall Study|Clinical Progression|5|||
164348155|NCT00911820|593652555|FG000|Overall Study|Physician Decision|5|||
164348156|NCT00911820|593652556|FG001|Overall Study|Physician Decision|9|||
164348157|NCT00911820|593652555|FG000|Overall Study|Decline in Performance Status|4|||
164348158|NCT00911820|593652556|FG001|Overall Study|Decline in Performance Status|2|||
164348159|NCT00911820|593652555|FG000|Overall Study|Withdrawal by Subject|3|||
164348160|NCT00911820|593652556|FG001|Overall Study|Withdrawal by Subject|4|||
164348161|NCT00911820|593652555|FG000|Overall Study|Death|1|||
164348162|NCT00911820|593652556|FG001|Overall Study|Death|2|||
164348163|NCT00911820|593652555|FG000|Overall Study|Pursue surgery|1|||
164348164|NCT00911820|593652556|FG001|Overall Study|Pursue surgery|1|||
164348165|NCT00911820|593652555|FG000|Overall Study|Pursue Radiation|1|||
164348166|NCT00911820|593652556|FG001|Overall Study|Pursue Radiation|0|||
164348167|NCT00911820|593652555|FG000|Overall Study|Still on Therapy|2|||
164348168|NCT00911820|593652556|FG001|Overall Study|Still on Therapy|2|||
164348169|NCT00911820|593652555|FG000|Overall Study|Pathology Not Confirmed|1|||
164348170|NCT00911820|593652556|FG001|Overall Study|Pathology Not Confirmed|0|||
164348171|NCT00911820|593652555|FG000|Overall Study|Withdraw before Receive Treatment|0|||
164348172|NCT00911820|593652556|FG001|Overall Study|Withdraw before Receive Treatment|2|||
164348173|NCT02674529|593652559|FG000|Overall Study|Lost to Follow-up|1|||
164348174|NCT02674529|593652560|FG001|Overall Study|Lost to Follow-up|2|||
164348175|NCT02674529|593652559|FG000|Overall Study|Withdrawal by Subject|2|||
164348176|NCT02674529|593652560|FG001|Overall Study|Withdrawal by Subject|1|||
164348177|NCT02674529|593652559|FG000|Overall Study|Physician Decision|0|||
164587666|NCT00367640|594515912|FG001|Overall Study|Withdrawal by Subject|11|||
164587667|NCT00367640|594515913|FG002|Overall Study|Withdrawal by Subject|8|||
164587668|NCT00367640|594515914|FG003|Overall Study|Withdrawal by Subject|6|||
164587669|NCT00367640|594515911|FG000|Overall Study|Any other reason not above-mentioned|7|||
164587670|NCT00367640|594515912|FG001|Overall Study|Any other reason not above-mentioned|5|||
164587671|NCT00367640|594515913|FG002|Overall Study|Any other reason not above-mentioned|3|||
164587672|NCT00367640|594515914|FG003|Overall Study|Any other reason not above-mentioned|4|||
164348178|NCT02674529|593652560|FG001|Overall Study|Physician Decision|1|||
164348179|NCT02674529|593652559|FG000|Overall Study|Protocol Violation|0|||
164348180|NCT02674529|593652560|FG001|Overall Study|Protocol Violation|1|||
164694672|NCT01546142|594905313|FG001|Overall Study|Subject Noncompliance|1|||
164348181|NCT02141282|593652562|FG000|Overall Study|Adverse event, not related to progression|8|||
164587673|NCT02417233|594515915|FG000|Overall Study|Death|4|||
164348182|NCT02141282|593652563|FG001|Overall Study|Adverse event, not related to progression|1|||
164348183|NCT02141282|593652564|FG002|Overall Study|Adverse event, not related to progression|3|||
164348184|NCT02141282|593652565|FG003|Overall Study|Adverse event, not related to progression|1|||
164348185|NCT02141282|593652562|FG000|Overall Study|Adverse event, related to progression|1|||
164348186|NCT02141282|593652563|FG001|Overall Study|Adverse event, related to progression|0|||
164348187|NCT02141282|593652564|FG002|Overall Study|Adverse event, related to progression|2|||
164348188|NCT02141282|593652565|FG003|Overall Study|Adverse event, related to progression|0|||
164693754|NCT05068284|594899431|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
164693755|NCT05068284|594899432|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
164693756|NCT05068284|594899433|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
164693757|NCT05068284|594899434|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
164693758|NCT05068284|594899435|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
164693759|NCT05068284|594899436|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
164693760|NCT05068284|594899437|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
164693761|NCT05068284|594899438|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
164693762|NCT05068284|594899431|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
164693763|NCT05068284|594899432|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
164693764|NCT05068284|594899433|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
164693765|NCT05068284|594899434|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
164693766|NCT05068284|594899435|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
164693767|NCT05068284|594899436|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
164693768|NCT05068284|594899437|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
164693769|NCT05068284|594899438|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
164693770|NCT05068284|594899431|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
164693771|NCT05068284|594899432|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
164693772|NCT05068284|594899433|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
164693773|NCT05068284|594899434|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
164693774|NCT05068284|594899435|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
164693775|NCT05068284|594899436|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
164693776|NCT05068284|594899437|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
164693777|NCT05068284|594899438|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
164694673|NCT01546142|594905312|FG000|Overall Study|Adverse Event|6|||
164348189|NCT02141282|593652562|FG000|Overall Study|COVID-19 infection|1|||
164348190|NCT02141282|593652563|FG001|Overall Study|COVID-19 infection|0|||
164348191|NCT02141282|593652564|FG002|Overall Study|COVID-19 infection|0|||
164348192|NCT02141282|593652565|FG003|Overall Study|COVID-19 infection|0|||
164348193|NCT02141282|593652562|FG000|Overall Study|Lost to Follow-up|0|||
164348194|NCT02141282|593652563|FG001|Overall Study|Lost to Follow-up|0|||
164348195|NCT02141282|593652564|FG002|Overall Study|Lost to Follow-up|4|||
164348196|NCT02141282|593652565|FG003|Overall Study|Lost to Follow-up|2|||
164348197|NCT02141282|593652562|FG000|Overall Study|Other, not specified|14|||
164348198|NCT02141282|593652563|FG001|Overall Study|Other, not specified|11|||
164348199|NCT02141282|593652564|FG002|Overall Study|Other, not specified|23|||
164348200|NCT02141282|593652565|FG003|Overall Study|Other, not specified|9|||
164348201|NCT02141282|593652562|FG000|Overall Study|Progressive disease, Richter's|4|||
164348202|NCT02141282|593652563|FG001|Overall Study|Progressive disease, Richter's|1|||
164348203|NCT02141282|593652564|FG002|Overall Study|Progressive disease, Richter's|1|||
164348204|NCT02141282|593652565|FG003|Overall Study|Progressive disease, Richter's|1|||
164348205|NCT02141282|593652562|FG000|Overall Study|Progressive disease per protocol|12|||
164348206|NCT02141282|593652563|FG001|Overall Study|Progressive disease per protocol|7|||
164348207|NCT02141282|593652564|FG002|Overall Study|Progressive disease per protocol|9|||
164348208|NCT02141282|593652565|FG003|Overall Study|Progressive disease per protocol|2|||
164348209|NCT02141282|593652562|FG000|Overall Study|Stem cell transplant|1|||
164348210|NCT02141282|593652563|FG001|Overall Study|Stem cell transplant|0|||
164348211|NCT02141282|593652564|FG002|Overall Study|Stem cell transplant|1|||
164348212|NCT02141282|593652565|FG003|Overall Study|Stem cell transplant|0|||
164348213|NCT02141282|593652562|FG000|Overall Study|Study terminated by Sponsor|0|||
164348214|NCT02141282|593652563|FG001|Overall Study|Study terminated by Sponsor|1|||
164348215|NCT02141282|593652564|FG002|Overall Study|Study terminated by Sponsor|0|||
164348216|NCT02141282|593652565|FG003|Overall Study|Study terminated by Sponsor|0|||
164348217|NCT02141282|593652562|FG000|Overall Study|Subject non-compliance|0|||
164348218|NCT02141282|593652563|FG001|Overall Study|Subject non-compliance|0|||
164348219|NCT02141282|593652564|FG002|Overall Study|Subject non-compliance|1|||
164348220|NCT02141282|593652565|FG003|Overall Study|Subject non-compliance|0|||
164348221|NCT02141282|593652562|FG000|Overall Study|Withdrew consent|2|||
164348222|NCT02141282|593652563|FG001|Overall Study|Withdrew consent|0|||
164348223|NCT02141282|593652564|FG002|Overall Study|Withdrew consent|4|||
164348224|NCT02141282|593652565|FG003|Overall Study|Withdrew consent|0|||
164348225|NCT00963547|593652568|FG000|Overall Study|Adverse Event|0|||
164348226|NCT00963547|593652569|FG001|Overall Study|Adverse Event|1|||
164348227|NCT00963547|593652570|FG002|Overall Study|Adverse Event|0|||
164348228|NCT00963547|593652571|FG003|Overall Study|Adverse Event|1|||
164348229|NCT00963547|593652572|FG004|Overall Study|Adverse Event|0|||
164587674|NCT02417233|594515916|FG001|Overall Study|Death|10|||
164348230|NCT00963547|593652573|FG005|Overall Study|Adverse Event|0|||
164348231|NCT00963547|593652574|FG006|Overall Study|Adverse Event|0|||
164348232|NCT00963547|593652568|FG000|Overall Study|Physician Decision|1|||
164348233|NCT00963547|593652569|FG001|Overall Study|Physician Decision|1|||
164348234|NCT00963547|593652570|FG002|Overall Study|Physician Decision|0|||
164348235|NCT00963547|593652571|FG003|Overall Study|Physician Decision|0|||
164348236|NCT00963547|593652572|FG004|Overall Study|Physician Decision|0|||
164348237|NCT00963547|593652573|FG005|Overall Study|Physician Decision|0|||
164348238|NCT00963547|593652574|FG006|Overall Study|Physician Decision|0|||
164348239|NCT00963547|593652568|FG000|Overall Study|Progressive Disease|3|||
164348240|NCT00963547|593652569|FG001|Overall Study|Progressive Disease|8|||
164348241|NCT00963547|593652570|FG002|Overall Study|Progressive Disease|9|||
164348242|NCT00963547|593652571|FG003|Overall Study|Progressive Disease|5|||
164348243|NCT00963547|593652572|FG004|Overall Study|Progressive Disease|0|||
164348244|NCT00963547|593652573|FG005|Overall Study|Progressive Disease|0|||
164348245|NCT00963547|593652574|FG006|Overall Study|Progressive Disease|0|||
164348246|NCT00963547|593652568|FG000|Overall Study|Withdrawal by Subject|0|||
164348247|NCT00963547|593652569|FG001|Overall Study|Withdrawal by Subject|0|||
164348248|NCT00963547|593652570|FG002|Overall Study|Withdrawal by Subject|3|||
164348249|NCT00963547|593652571|FG003|Overall Study|Withdrawal by Subject|0|||
164348250|NCT00963547|593652572|FG004|Overall Study|Withdrawal by Subject|0|||
164348251|NCT00963547|593652573|FG005|Overall Study|Withdrawal by Subject|0|||
164348252|NCT00963547|593652574|FG006|Overall Study|Withdrawal by Subject|0|||
164348253|NCT00963547|593652568|FG000|Overall Study|Reason Unknown|0|||
164348254|NCT00963547|593652569|FG001|Overall Study|Reason Unknown|1|||
164348255|NCT00963547|593652570|FG002|Overall Study|Reason Unknown|0|||
164348256|NCT00963547|593652571|FG003|Overall Study|Reason Unknown|0|||
164348257|NCT00963547|593652572|FG004|Overall Study|Reason Unknown|0|||
164348258|NCT00963547|593652573|FG005|Overall Study|Reason Unknown|0|||
164348259|NCT00963547|593652574|FG006|Overall Study|Reason Unknown|0|||
164348260|NCT00331682|593652575|FG000|Overall Study|Adverse Event|1|||
164348261|NCT03761277|593652576|FG000|Enrollment to Implant|Screen Failure|17|||
164348262|NCT03761277|593652576|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
164348263|NCT03761277|593652576|FG000|Enrollment to Implant|Physician Decision|2|||
164348264|NCT03761277|593652576|FG000|Enrollment to Implant|Site Closure|3|||
164348265|NCT03761277|593652576|FG000|Enrollment to Implant|Sponsor Request|2|||
164348266|NCT03761277|593652576|FG000|Post-Implant to 6 Months|Adverse Event|2|||
164348267|NCT03761277|593652576|FG000|Post-Implant to 6 Months|Death|1|||
164348268|NCT03761277|593652576|FG000|Post-Implant to 6 Months|Site Closure|2|||
164348269|NCT03761277|593652576|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
164348270|NCT03761277|593652576|FG000|6 Months to 12 Months|Physician Decision|2|||
164348271|NCT03761277|593652576|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
164348272|NCT00187486|593652577|FG000|Overall Study|Protocol Violation|1|||
164348273|NCT00759031|593652578|FG000|First Intervention (1 Day)|Physician Decision|1|||
164348274|NCT00759031|593652579|FG001|First Intervention (1 Day)|Physician Decision|0|||
164348275|NCT00759031|593652578|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
164348276|NCT00759031|593652579|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
164348277|NCT00759031|593652578|FG000|First Intervention (1 Day)|Screening failure|1|||
164435780|NCT01081145|593962085|FG001|Open-Label Phase|Other|0|||
164435781|NCT01081145|593962084|FG000|Open-Label Phase|Lost to Follow-up|11|||
164435782|NCT01081145|593962085|FG001|Open-Label Phase|Lost to Follow-up|0|||
164435783|NCT01081145|593962084|FG000|Open-Label Phase|Protocol Violation|4|||
164435784|NCT01081145|593962085|FG001|Open-Label Phase|Protocol Violation|0|||
164435785|NCT01081145|593962084|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
164435786|NCT01081145|593962085|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
164435787|NCT01081145|593962084|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
164435788|NCT01081145|593962085|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
164435789|NCT01081145|593962084|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
164587675|NCT02417233|594515917|FG002|Overall Study|Death|14|||
164587676|NCT02417233|594515915|FG000|Overall Study|Lost to Follow-up|27|||
164587677|NCT02417233|594515916|FG001|Overall Study|Lost to Follow-up|39|||
164587678|NCT02417233|594515917|FG002|Overall Study|Lost to Follow-up|34|||
164587679|NCT02417233|594515915|FG000|Overall Study|Protocol Violation|2|||
164587680|NCT02417233|594515916|FG001|Overall Study|Protocol Violation|0|||
164587681|NCT02417233|594515917|FG002|Overall Study|Protocol Violation|2|||
164348278|NCT00759031|593652579|FG001|First Intervention (1 Day)|Screening failure|0|||
164587682|NCT02417233|594515915|FG000|Overall Study|Withdrawal by Subject|2|||
164587683|NCT02417233|594515916|FG001|Overall Study|Withdrawal by Subject|1|||
164348279|NCT00543140|593652580|FG000|Overall Study|Lost to Follow-up|33|||
164587684|NCT02417233|594515917|FG002|Overall Study|Withdrawal by Subject|8|||
164435790|NCT01081145|593962085|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
164587685|NCT02417233|594515915|FG000|Overall Study|Relocation out of study area|1|||
164587686|NCT02417233|594515916|FG001|Overall Study|Relocation out of study area|0|||
164348280|NCT00543140|593652580|FG000|Overall Study|Withdrawal by Subject|13|||
164348281|NCT00543140|593652580|FG000|Overall Study|Protocol Violation|10|||
164693778|NCT05068284|594899431|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
164693779|NCT05068284|594899432|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
164694674|NCT01546142|594905313|FG001|Overall Study|Adverse Event|3|||
164298615|NCT03009058|593468135|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
164298616|NCT05556265|593468136|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
164298617|NCT05556265|593468137|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
164298618|NCT05556265|593468138|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
164298619|NCT05556265|593468139|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
164298620|NCT05556265|593468140|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
164298621|NCT05556265|593468136|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
164298622|NCT05556265|593468137|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
164298623|NCT05556265|593468138|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
164298624|NCT05556265|593468139|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
164298625|NCT05556265|593468140|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
164298626|NCT05556265|593468136|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
164298627|NCT05556265|593468137|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
164298628|NCT05556265|593468138|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
164298629|NCT05556265|593468139|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
164298630|NCT05556265|593468140|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
164298631|NCT05556265|593468136|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
164298632|NCT05556265|593468137|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
164298633|NCT05556265|593468138|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
164298634|NCT05556265|593468139|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
164298635|NCT05556265|593468140|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
164298636|NCT05556265|593468136|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
164298637|NCT05556265|593468137|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
164298638|NCT05556265|593468138|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
164298639|NCT05556265|593468139|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
164298640|NCT05556265|593468140|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
164298641|NCT05556265|593468136|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
164298642|NCT05556265|593468137|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
164298643|NCT05556265|593468138|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
164298644|NCT05556265|593468139|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
164298645|NCT05556265|593468140|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
164298646|NCT05556265|593468136|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
164298647|NCT05556265|593468137|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
164298648|NCT05556265|593468138|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
164298649|NCT05556265|593468139|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
164298650|NCT05556265|593468140|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
164298651|NCT05556265|593468136|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
164298652|NCT05556265|593468137|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
164298653|NCT05556265|593468138|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
164298654|NCT05556265|593468139|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
164298655|NCT05556265|593468140|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
164298656|NCT05556265|593468136|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
164298657|NCT05556265|593468137|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
164298658|NCT05556265|593468138|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
164298659|NCT05556265|593468139|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
164298660|NCT05556265|593468140|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
164298661|NCT03137992|593468141|FG000|Washout Period 1|Adverse Event|1|||
164298662|NCT03137992|593468142|FG001|Washout Period 1|Adverse Event|1|||
164298663|NCT03137992|593468143|FG002|Washout Period 1|Adverse Event|0|||
164298664|NCT03137992|593468144|FG003|Washout Period 1|Adverse Event|0|||
164298665|NCT03137992|593468145|FG004|Washout Period 1|Adverse Event|0|||
164298666|NCT03137992|593468146|FG005|Washout Period 1|Adverse Event|1|||
164298667|NCT03137992|593468141|FG000|Washout Period 1|Withdrawal by Subject|0|||
164298668|NCT03137992|593468142|FG001|Washout Period 1|Withdrawal by Subject|1|||
164298669|NCT03137992|593468143|FG002|Washout Period 1|Withdrawal by Subject|1|||
164298670|NCT03137992|593468144|FG003|Washout Period 1|Withdrawal by Subject|0|||
164298671|NCT03137992|593468145|FG004|Washout Period 1|Withdrawal by Subject|0|||
164298672|NCT03137992|593468146|FG005|Washout Period 1|Withdrawal by Subject|0|||
164298673|NCT03137992|593468141|FG000|Washout Period 1|Principal Investigator Discretion|0|||
164298674|NCT03137992|593468142|FG001|Washout Period 1|Principal Investigator Discretion|1|||
164301064|NCT02435992|593478413|FG002|Overall Study|Physician Decision|1|||
164348282|NCT00543140|593652580|FG000|Overall Study|Insufficient weight loss|10|||
164348283|NCT00543140|593652580|FG000|Overall Study|SAE leading to explant of SAGB|3|||
164348284|NCT00543140|593652580|FG000|Overall Study|Death|1|||
164348285|NCT00543140|593652580|FG000|Overall Study|Subject moved|1|||
164348286|NCT00543140|593652580|FG000|Overall Study|Conversion to different procedure|1|||
164348287|NCT04532164|593652581|FG000|Overall Study|Adverse Event|1|||
164348288|NCT04532164|593652581|FG000|Overall Study|Protocol Violation|5|||
164348289|NCT04532164|593652581|FG000|Overall Study|Lost to Follow-up|1|||
164348290|NCT04532164|593652581|FG000|Overall Study|Found to be Ineligible|3|||
164348291|NCT04532164|593652581|FG000|Overall Study|Withdrawal by Subject|14|||
164348292|NCT02483520|593652582|FG000|Overall Study|Lost to Follow-up|3|||
164348293|NCT02483520|593652583|FG001|Overall Study|Lost to Follow-up|4|||
164348294|NCT02483520|593652582|FG000|Overall Study|Withdrawal by Subject|4|||
164348295|NCT02483520|593652583|FG001|Overall Study|Withdrawal by Subject|14|||
164348296|NCT02483520|593652582|FG000|Overall Study|Hospitalized|2|||
164348297|NCT02483520|593652583|FG001|Overall Study|Hospitalized|3|||
164348298|NCT02483520|593652582|FG000|Overall Study|Moved to LTC|2|||
164348299|NCT02483520|593652583|FG001|Overall Study|Moved to LTC|3|||
164348300|NCT01104493|593652586|FG000|Overall Study|Lost to Follow-up|0|||
164348301|NCT01104493|593652587|FG001|Overall Study|Lost to Follow-up|2|||
164348302|NCT03521934|593652598|FG000|Overall Study|Death|65|||
164348303|NCT03521934|593652599|FG001|Overall Study|Death|73|||
164348304|NCT03521934|593652598|FG000|Overall Study|Withdrawal by Subject|18|||
164348305|NCT03521934|593652599|FG001|Overall Study|Withdrawal by Subject|23|||
164348306|NCT03521934|593652598|FG000|Overall Study|Site Terminated by Sponsor|39|||
164348307|NCT03521934|593652599|FG001|Overall Study|Site Terminated by Sponsor|35|||
164348308|NCT03521934|593652598|FG000|Overall Study|Study Terminated by Sponsor|483|||
164348309|NCT03521934|593652599|FG001|Overall Study|Study Terminated by Sponsor|477|||
164348310|NCT03521934|593652598|FG000|Overall Study|Reason not Specified|3|||
164348311|NCT03521934|593652599|FG001|Overall Study|Reason not Specified|6|||
164348312|NCT00284050|593652600|FG000|Overall Study|Adverse Event|1|||
164348313|NCT00284050|593652601|FG001|Overall Study|Adverse Event|1|||
164348314|NCT00284050|593652602|FG002|Overall Study|Adverse Event|1|||
164348315|NCT00284050|593652600|FG000|Overall Study|Lack of Efficacy|0|||
164348316|NCT00284050|593652601|FG001|Overall Study|Lack of Efficacy|1|||
164348317|NCT00284050|593652602|FG002|Overall Study|Lack of Efficacy|3|||
164348318|NCT00284050|593652600|FG000|Overall Study|Protocol Violation|0|||
164348319|NCT00284050|593652601|FG001|Overall Study|Protocol Violation|1|||
164348320|NCT00284050|593652602|FG002|Overall Study|Protocol Violation|2|||
164348321|NCT00284050|593652600|FG000|Overall Study|Withdrawal by Subject|2|||
164348322|NCT00284050|593652601|FG001|Overall Study|Withdrawal by Subject|2|||
164348323|NCT00284050|593652602|FG002|Overall Study|Withdrawal by Subject|2|||
164348324|NCT00284050|593652600|FG000|Overall Study|Lost to Follow-up|1|||
164348325|NCT00284050|593652601|FG001|Overall Study|Lost to Follow-up|0|||
164348326|NCT00284050|593652602|FG002|Overall Study|Lost to Follow-up|1|||
164348327|NCT00284050|593652600|FG000|Overall Study|Death|1|||
164348328|NCT00284050|593652601|FG001|Overall Study|Death|0|||
164348329|NCT00284050|593652602|FG002|Overall Study|Death|0|||
164348330|NCT04182763|593652614|FG000|Double-Blind Period, initial 6 months|Physician Decision|0|||
164435791|NCT01081145|593962084|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
164435792|NCT01081145|593962085|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
164435793|NCT01081145|593962084|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
164435794|NCT01081145|593962085|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
164435795|NCT01081145|593962084|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
164435796|NCT01081145|593962085|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
164435797|NCT01081145|593962084|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
164435798|NCT01081145|593962085|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
164693780|NCT05068284|594899433|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
164693781|NCT05068284|594899434|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
164693782|NCT05068284|594899435|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
164693783|NCT05068284|594899436|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
164693784|NCT05068284|594899437|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
164693785|NCT05068284|594899438|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
164348331|NCT04182763|593652615|FG001|Double-Blind Period, initial 6 months|Physician Decision|0|||
164693786|NCT05068284|594899431|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
164694675|NCT01546142|594905312|FG000|Overall Study|Lost to Follow-up|20|||
164348332|NCT04182763|593652616|FG002|Double-Blind Period, initial 6 months|Physician Decision|0|||
164348333|NCT04182763|593652617|FG003|Double-Blind Period, initial 6 months|Physician Decision|1|||
164348334|NCT04182763|593652618|FG004|Double-Blind Period, initial 6 months|Physician Decision|0|||
164348335|NCT04182763|593652614|FG000|Double-Blind Period, initial 6 months|Death|0|||
164348336|NCT04182763|593652615|FG001|Double-Blind Period, initial 6 months|Death|1|||
164348337|NCT04182763|593652616|FG002|Double-Blind Period, initial 6 months|Death|0|||
164435799|NCT01253226|593962086|FG000|Overall Study|Adverse Event|0|||
164348338|NCT04182763|593652617|FG003|Double-Blind Period, initial 6 months|Death|0|||
164348339|NCT04182763|593652618|FG004|Double-Blind Period, initial 6 months|Death|0|||
164348340|NCT04182763|593652614|FG000|Open-Label Period, subsequent 18 months|Death|3|||
164348341|NCT04182763|593652615|FG001|Open-Label Period, subsequent 18 months|Death|2|||
164348342|NCT04182763|593652616|FG002|Open-Label Period, subsequent 18 months|Death|2|||
164348343|NCT04182763|593652617|FG003|Open-Label Period, subsequent 18 months|Death|0|||
164348344|NCT04182763|593652618|FG004|Open-Label Period, subsequent 18 months|Death|1|||
164348345|NCT04182763|593652614|FG000|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
164348346|NCT04182763|593652615|FG001|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
164348347|NCT04182763|593652616|FG002|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
164348348|NCT04182763|593652617|FG003|Open-Label Period, subsequent 18 months|Withdrawal by Subject|0|||
164348349|NCT04182763|593652618|FG004|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
164348350|NCT04182763|593652614|FG000|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
164348351|NCT04182763|593652615|FG001|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|4|||
164348352|NCT04182763|593652616|FG002|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
164348353|NCT04182763|593652617|FG003|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
164348354|NCT04182763|593652618|FG004|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|0|||
164348355|NCT02551731|593652620|FG000|Overall Study|Withdrawal by Subject|2|||
164348356|NCT05228132|593652637|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
164348357|NCT05228132|593652637|FG000|Overall Study|Adverse Event|3|||
164348358|NCT05228132|593652637|FG000|Overall Study|Lost to Follow-up|1|||
164348359|NCT05228132|593652637|FG000|Overall Study|Arteriovenous-fistula mature|1|||
164348360|NCT02627144|593652638|FG000|Overall Study|Serious adverse event|32|||
164348361|NCT02627144|593652638|FG000|Overall Study|Cancer progression|171|||
164348362|NCT02627144|593652638|FG000|Overall Study|Death from cancer|20|||
164348363|NCT02627144|593652638|FG000|Overall Study|Death from other cause|8|||
164348364|NCT02627144|593652638|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
164348365|NCT02627144|593652638|FG000|Overall Study|Administrative reasons|65|||
164348366|NCT02627144|593652638|FG000|Overall Study|Lost to Follow-up|8|||
164348367|NCT02627144|593652638|FG000|Overall Study|Enrolled, not treated|6|||
164348368|NCT02627144|593652638|FG000|Overall Study|Other|17|||
164348369|NCT04545385|593652643|FG000|Overall Study|Withdrawal by Subject|2|||
164348370|NCT04545385|593652644|FG001|Overall Study|Withdrawal by Subject|0|||
164348371|NCT04545385|593652643|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
164348372|NCT04545385|593652644|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
164348373|NCT04545385|593652643|FG000|Overall Study|Study termination|10|||
164348374|NCT04545385|593652644|FG001|Overall Study|Study termination|10|||
164348375|NCT04545385|593652643|FG000|Overall Study|Sponsor decision|2|||
164348376|NCT04545385|593652644|FG001|Overall Study|Sponsor decision|2|||
164348377|NCT04545385|593652643|FG000|Overall Study|Other than specified|1|||
164348378|NCT04545385|593652644|FG001|Overall Study|Other than specified|0|||
164348379|NCT01217801|593652649|FG000|Period 1|Protocol Violation|1|||
164348380|NCT01217801|593652650|FG001|Period 1|Protocol Violation|1|||
164348381|NCT01217801|593652649|FG000|Period 1|Withdrawal by Subject|0|||
164348382|NCT01217801|593652650|FG001|Period 1|Withdrawal by Subject|1|||
164348383|NCT00291577|593652652|FG000|Overall Study|Adverse Event|1|||
164348384|NCT00291577|593652652|FG000|Overall Study|Other|4|||
164348385|NCT00291577|593652652|FG000|Overall Study|Withdrawal by Subject|2|||
164587687|NCT02417233|594515917|FG002|Overall Study|Relocation out of study area|1|||
164587688|NCT02417233|594515915|FG000|Overall Study|Mentally unstable|0|||
164587689|NCT02417233|594515916|FG001|Overall Study|Mentally unstable|1|||
164587690|NCT02417233|594515917|FG002|Overall Study|Mentally unstable|0|||
164587691|NCT03408873|594515927|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
164587692|NCT03408873|594515927|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
164587693|NCT03408873|594515927|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
164587694|NCT03408873|594515927|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
164587695|NCT03408873|594515927|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
164587696|NCT03408873|594515927|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
164587697|NCT03799718|594515928|FG000|Overall Study|Adverse Event|2|||
164587698|NCT01188798|594515929|FG000|Overall Study|Death|0|||
164587699|NCT01188798|594515930|FG001|Overall Study|Death|1|||
164587700|NCT01188798|594515929|FG000|Overall Study|Required additional transplant|1|||
164587701|NCT01188798|594515930|FG001|Overall Study|Required additional transplant|1|||
164587702|NCT01188798|594515929|FG000|Overall Study|Protocol closure|1|||
164587703|NCT01188798|594515930|FG001|Overall Study|Protocol closure|1|||
164694676|NCT01546142|594905313|FG001|Overall Study|Lost to Follow-up|15|||
164348386|NCT00291577|593652652|FG000|Overall Study|Lack of Efficacy|14|||
164348387|NCT04584645|593652653|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
164348388|NCT04584645|593652654|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
164348389|NCT03845985|593652661|FG000|Overall Study|Lost to Follow-up|2|||
164435800|NCT01253226|593962087|FG001|Overall Study|Adverse Event|0|||
164435801|NCT01253226|593962088|FG002|Overall Study|Adverse Event|1|||
164435802|NCT01253226|593962089|FG003|Overall Study|Adverse Event|0|||
164435803|NCT01253226|593962090|FG004|Overall Study|Adverse Event|0|||
164435804|NCT01253226|593962086|FG000|Overall Study|Death|0|||
164435805|NCT01253226|593962087|FG001|Overall Study|Death|1|||
164435806|NCT01253226|593962088|FG002|Overall Study|Death|0|||
164435807|NCT01253226|593962089|FG003|Overall Study|Death|0|||
164348390|NCT03845985|593652662|FG001|Overall Study|Lost to Follow-up|1|||
164348391|NCT03845985|593652661|FG000|Overall Study|Physician Decision|1|||
164348392|NCT03845985|593652662|FG001|Overall Study|Physician Decision|0|||
164348393|NCT03845985|593652661|FG000|Overall Study|Withdrawal by Subject|4|||
164348394|NCT03845985|593652662|FG001|Overall Study|Withdrawal by Subject|1|||
164348395|NCT02756013|593652663|FG000|Overall Study|Adverse Event|1|||
164348396|NCT02756013|593652663|FG000|Overall Study|Hypersensitivity|1|||
164348397|NCT03926169|593652664|FG000|Period A|Adverse Event|2|||
164348398|NCT03926169|593652665|FG001|Period A|Adverse Event|2|||
164348399|NCT03926169|593652666|FG002|Period A|Adverse Event|1|||
164348400|NCT03926169|593652664|FG000|Period A|Withdrawal by Subject|2|||
164435808|NCT01253226|593962090|FG004|Overall Study|Death|0|||
164435809|NCT01253226|593962086|FG000|Overall Study|Physician Decision|0|||
164435810|NCT01253226|593962087|FG001|Overall Study|Physician Decision|0|||
164435811|NCT01253226|593962088|FG002|Overall Study|Physician Decision|0|||
164587704|NCT03662334|594515932|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
164348401|NCT03926169|593652665|FG001|Period A|Withdrawal by Subject|2|||
164348402|NCT03926169|593652666|FG002|Period A|Withdrawal by Subject|2|||
164348403|NCT03926169|593652664|FG000|Period A|Lost to Follow-up|3|||
164348404|NCT03926169|593652665|FG001|Period A|Lost to Follow-up|1|||
164348405|NCT03926169|593652666|FG002|Period A|Lost to Follow-up|0|||
164348406|NCT03926169|593652664|FG000|Period A|Lack of Efficacy|0|||
164348407|NCT03926169|593652665|FG001|Period A|Lack of Efficacy|2|||
164348408|NCT03926169|593652666|FG002|Period A|Lack of Efficacy|2|||
164348409|NCT03926169|593652664|FG000|Period A|COVID-19 Infection|0|||
164348410|NCT03926169|593652665|FG001|Period A|COVID-19 Infection|1|||
164348411|NCT03926169|593652666|FG002|Period A|COVID-19 Infection|0|||
164348412|NCT03926169|593652664|FG000|Period A|COVID-19 Logistical Restrictions|0|||
164348413|NCT03926169|593652665|FG001|Period A|COVID-19 Logistical Restrictions|2|||
164348414|NCT03926169|593652666|FG002|Period A|COVID-19 Logistical Restrictions|1|||
164348415|NCT03926169|593652664|FG000|Period A|Other, Not Specified|1|||
164348416|NCT03926169|593652665|FG001|Period A|Other, Not Specified|0|||
164348417|NCT03926169|593652666|FG002|Period A|Other, Not Specified|0|||
164348418|NCT03926169|593652664|FG000|Period B|Adverse Event|3|||
164348419|NCT03926169|593652665|FG001|Period B|Adverse Event|1|||
164348420|NCT03926169|593652666|FG002|Period B|Adverse Event|1|||
164348421|NCT03926169|593652664|FG000|Period B|Withdrawal by Subject|1|||
164348422|NCT03926169|593652665|FG001|Period B|Withdrawal by Subject|3|||
164348423|NCT03926169|593652666|FG002|Period B|Withdrawal by Subject|0|||
164298675|NCT03137992|593468143|FG002|Washout Period 1|Principal Investigator Discretion|0|||
164298676|NCT03137992|593468144|FG003|Washout Period 1|Principal Investigator Discretion|0|||
164298677|NCT03137992|593468145|FG004|Washout Period 1|Principal Investigator Discretion|0|||
164298678|NCT03137992|593468146|FG005|Washout Period 1|Principal Investigator Discretion|0|||
164348424|NCT03926169|593652664|FG000|Period B|Lack of Efficacy|3|||
164348425|NCT03926169|593652665|FG001|Period B|Lack of Efficacy|1|||
164348426|NCT03926169|593652666|FG002|Period B|Lack of Efficacy|1|||
164348427|NCT03926169|593652664|FG000|Period B|Lost to Follow-up|1|||
164348428|NCT03926169|593652665|FG001|Period B|Lost to Follow-up|1|||
164298679|NCT03137992|593468141|FG000|Washout Period 1|COPD Exacerbation|1|||
164298680|NCT03137992|593468142|FG001|Washout Period 1|COPD Exacerbation|1|||
164298681|NCT03137992|593468143|FG002|Washout Period 1|COPD Exacerbation|1|||
164298682|NCT03137992|593468144|FG003|Washout Period 1|COPD Exacerbation|0|||
164298683|NCT03137992|593468145|FG004|Washout Period 1|COPD Exacerbation|1|||
164298684|NCT03137992|593468146|FG005|Washout Period 1|COPD Exacerbation|1|||
164298685|NCT03137992|593468141|FG000|Washout Period 1|Subject Noncompliance|1|||
164298686|NCT03137992|593468142|FG001|Washout Period 1|Subject Noncompliance|0|||
164298687|NCT03137992|593468143|FG002|Washout Period 1|Subject Noncompliance|0|||
164298688|NCT03137992|593468144|FG003|Washout Period 1|Subject Noncompliance|0|||
164298689|NCT03137992|593468145|FG004|Washout Period 1|Subject Noncompliance|1|||
164298690|NCT03137992|593468146|FG005|Washout Period 1|Subject Noncompliance|0|||
164298691|NCT03137992|593468141|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
164435812|NCT01253226|593962089|FG003|Overall Study|Physician Decision|0|||
164298692|NCT03137992|593468142|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
164298693|NCT03137992|593468143|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
164435813|NCT01253226|593962090|FG004|Overall Study|Physician Decision|2|||
164435814|NCT01253226|593962086|FG000|Overall Study|Withdrawal by Subject|0|||
164298694|NCT03137992|593468144|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
164348429|NCT03926169|593652666|FG002|Period B|Lost to Follow-up|4|||
164348430|NCT03926169|593652664|FG000|Period B|Other, Not Specified|62|||
164348431|NCT03926169|593652665|FG001|Period B|Other, Not Specified|57|||
164348432|NCT03926169|593652666|FG002|Period B|Other, Not Specified|65|||
164348433|NCT03334539|593652667|FG000|Overall Study|Adverse Event|3|||
164348434|NCT03334539|593652668|FG001|Overall Study|Adverse Event|5|||
164348435|NCT03334539|593652669|FG002|Overall Study|Adverse Event|0|||
164348436|NCT03334539|593652667|FG000|Overall Study|Withdrawal by Subject|0|||
164348437|NCT03334539|593652668|FG001|Overall Study|Withdrawal by Subject|1|||
164348438|NCT03334539|593652669|FG002|Overall Study|Withdrawal by Subject|1|||
164348439|NCT03334539|593652667|FG000|Overall Study|Administrative Reasons|1|||
164348440|NCT03334539|593652668|FG001|Overall Study|Administrative Reasons|0|||
164348441|NCT03334539|593652669|FG002|Overall Study|Administrative Reasons|0|||
164348442|NCT03334539|593652667|FG000|Overall Study|Hypertension Not Controlled|0|||
164348443|NCT03334539|593652668|FG001|Overall Study|Hypertension Not Controlled|1|||
164348444|NCT03334539|593652669|FG002|Overall Study|Hypertension Not Controlled|0|||
164348445|NCT00968201|593652670|FG000|Base Study - (Period II)|Adverse Event|8|||
164348446|NCT00968201|593652671|FG001|Base Study - (Period II)|Adverse Event|0|||
164348447|NCT00968201|593652672|FG002|Base Study - (Period II)|Adverse Event|16|||
164348448|NCT00968201|593652670|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
164348449|NCT00968201|593652671|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
164348450|NCT00968201|593652672|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
164348451|NCT00968201|593652670|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
164348452|NCT00968201|593652671|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
164348453|NCT00968201|593652672|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
164348454|NCT00968201|593652670|FG000|Base Study - (Period II)|Protocol Violation|12|||
164348455|NCT00968201|593652671|FG001|Base Study - (Period II)|Protocol Violation|0|||
164348456|NCT00968201|593652672|FG002|Base Study - (Period II)|Protocol Violation|12|||
164348457|NCT00968201|593652670|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
164348458|NCT00968201|593652671|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
164348459|NCT00968201|593652672|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
164348460|NCT00968201|593652670|FG000|Base Study - (Period II)|Site Error|0|||
164348461|NCT00968201|593652671|FG001|Base Study - (Period II)|Site Error|0|||
164348462|NCT00968201|593652672|FG002|Base Study - (Period II)|Site Error|1|||
164348463|NCT00968201|593652670|FG000|Extension Study - (Period III)|Adverse Event|0|||
164348464|NCT00968201|593652671|FG001|Extension Study - (Period III)|Adverse Event|5|||
164348465|NCT00968201|593652672|FG002|Extension Study - (Period III)|Adverse Event|22|||
164348466|NCT00968201|593652670|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
164348467|NCT00968201|593652671|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
164348468|NCT00968201|593652672|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
164348469|NCT00968201|593652670|FG000|Extension Study - (Period III)|Protocol Violation|0|||
164348470|NCT00968201|593652671|FG001|Extension Study - (Period III)|Protocol Violation|17|||
164348471|NCT00968201|593652672|FG002|Extension Study - (Period III)|Protocol Violation|14|||
164348472|NCT00968201|593652670|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
164348473|NCT00968201|593652671|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
164348474|NCT00968201|593652672|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
164348475|NCT00968201|593652670|FG000|Extension Study - (Period III)|Patient Relocated|0|||
164348476|NCT00968201|593652671|FG001|Extension Study - (Period III)|Patient Relocated|1|||
164348477|NCT00968201|593652672|FG002|Extension Study - (Period III)|Patient Relocated|1|||
164348478|NCT00968201|593652670|FG000|Extension Study - (Period III)|Noncompliance|0|||
164348479|NCT00968201|593652671|FG001|Extension Study - (Period III)|Noncompliance|0|||
164348480|NCT00968201|593652672|FG002|Extension Study - (Period III)|Noncompliance|3|||
164348481|NCT00968201|593652670|FG000|Extension Study - (Period III)|Other|0|||
164348482|NCT00968201|593652671|FG001|Extension Study - (Period III)|Other|0|||
164348483|NCT00968201|593652672|FG002|Extension Study - (Period III)|Other|2|||
164348484|NCT00968201|593652670|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
164348485|NCT00968201|593652671|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
164348486|NCT00968201|593652672|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
164348487|NCT04974697|593652673|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
164348488|NCT04974697|593652673|FG000|Overall Study|Lens discomfort|1|||
164348489|NCT03706456|593652674|FG000|Overall Study|Adverse Event|1|||
164348490|NCT03706456|593652674|FG000|Overall Study|Lack of Efficacy|2|||
164348491|NCT03302234|593652676|FG000|Overall Study|Death|191|||
164348492|NCT03302234|593652677|FG001|Overall Study|Death|192|||
164348493|NCT03302234|593652676|FG000|Overall Study|Withdrawal by Subject|2|||
164348494|NCT03302234|593652677|FG001|Overall Study|Withdrawal by Subject|2|||
164348495|NCT03302234|593652676|FG000|Overall Study|Sponsor Decision|90|||
164348496|NCT03302234|593652677|FG001|Overall Study|Sponsor Decision|89|||
164348497|NCT03302234|593652676|FG000|Overall Study|Laryngeal carcinoma|0|||
164348498|NCT03302234|593652677|FG001|Overall Study|Laryngeal carcinoma|1|||
164348499|NCT03302234|593652676|FG000|Overall Study|Not Reported|1|||
164348500|NCT03302234|593652677|FG001|Overall Study|Not Reported|0|||
164348501|NCT04112784|593652678|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
164348502|NCT04112784|593652678|FG000|Overall Study|Screen Failures|4|||
164348503|NCT00221403|593652679|FG000|Overall Study|Protocol Violation|1|||
164348504|NCT00221403|593652680|FG001|Overall Study|Protocol Violation|0|||
164348505|NCT00221403|593652681|FG002|Overall Study|Protocol Violation|0|||
164348506|NCT00221403|593652679|FG000|Overall Study|Physician Decision|1|||
164348507|NCT00221403|593652680|FG001|Overall Study|Physician Decision|0|||
164348508|NCT00221403|593652681|FG002|Overall Study|Physician Decision|0|||
164348509|NCT00221403|593652679|FG000|Overall Study|Withdrawal by Subject|0|||
164348510|NCT00221403|593652680|FG001|Overall Study|Withdrawal by Subject|3|||
164348511|NCT00221403|593652681|FG002|Overall Study|Withdrawal by Subject|0|||
164348512|NCT00221403|593652679|FG000|Overall Study|Lack of Efficacy|0|||
164348513|NCT00221403|593652680|FG001|Overall Study|Lack of Efficacy|1|||
164348514|NCT00221403|593652681|FG002|Overall Study|Lack of Efficacy|0|||
164348515|NCT00221403|593652679|FG000|Overall Study|Adverse Event|0|||
164348516|NCT00221403|593652680|FG001|Overall Study|Adverse Event|1|||
164348517|NCT00221403|593652681|FG002|Overall Study|Adverse Event|0|||
164348518|NCT02439138|593652682|FG000|Overall Study|Adverse Event|1|||
164348519|NCT02439138|593652682|FG000|Overall Study|PI decision to terminate the study|2|||
164348520|NCT02216591|593652685|FG000|Overall Study|Lost to Follow-up|0|||
164348521|NCT02216591|593652686|FG001|Overall Study|Lost to Follow-up|1|||
164348522|NCT01950741|593652688|FG000|Overall Study|Lost to Follow-up|1|||
164348523|NCT01950741|593652688|FG000|Overall Study|Death|1|||
164348524|NCT01950741|593652688|FG000|Overall Study|Withdrawal by Subject|1|||
164348525|NCT00558558|593652691|FG000|Overall Study|Unable to swallow|1|||
164348526|NCT00558558|593652691|FG000|Overall Study|Withdrawal by Subject|1|||
164348527|NCT00558558|593652691|FG000|Overall Study|Lack of Efficacy|4|||
164348528|NCT02549937|593652693|FG000|Overall Study|Death|0|||
164348529|NCT02549937|593652694|FG001|Overall Study|Death|1|||
164348530|NCT02549937|593652695|FG002|Overall Study|Death|0|||
164348531|NCT02549937|593652696|FG003|Overall Study|Death|1|||
164348532|NCT02549937|593652697|FG004|Overall Study|Death|0|||
164348533|NCT02549937|593652698|FG005|Overall Study|Death|8|||
164348534|NCT02549937|593652699|FG006|Overall Study|Death|0|||
164348535|NCT02549937|593652700|FG007|Overall Study|Death|0|||
164348536|NCT02549937|593652701|FG008|Overall Study|Death|19|||
164348537|NCT02549937|593652693|FG000|Overall Study|No follow up required|3|||
164348538|NCT02549937|593652694|FG001|Overall Study|No follow up required|6|||
164348539|NCT02549937|593652695|FG002|Overall Study|No follow up required|3|||
164348540|NCT02549937|593652696|FG003|Overall Study|No follow up required|8|||
164348541|NCT02549937|593652697|FG004|Overall Study|No follow up required|12|||
164348542|NCT02549937|593652698|FG005|Overall Study|No follow up required|21|||
164348543|NCT02549937|593652699|FG006|Overall Study|No follow up required|9|||
164348544|NCT02549937|593652700|FG007|Overall Study|No follow up required|11|||
164348545|NCT02549937|593652701|FG008|Overall Study|No follow up required|0|||
164348546|NCT02549937|593652693|FG000|Overall Study|Other|0|||
164348547|NCT02549937|593652694|FG001|Overall Study|Other|0|||
164348548|NCT02549937|593652695|FG002|Overall Study|Other|0|||
164348549|NCT02549937|593652696|FG003|Overall Study|Other|0|||
164348550|NCT02549937|593652697|FG004|Overall Study|Other|1|||
164348551|NCT02549937|593652698|FG005|Overall Study|Other|0|||
164348552|NCT02549937|593652699|FG006|Overall Study|Other|3|||
164348553|NCT02549937|593652700|FG007|Overall Study|Other|2|||
164348554|NCT02549937|593652701|FG008|Overall Study|Other|3|||
164348555|NCT02549937|593652693|FG000|Overall Study|Lost to Follow-up|0|||
164348556|NCT02549937|593652694|FG001|Overall Study|Lost to Follow-up|0|||
164348557|NCT02549937|593652695|FG002|Overall Study|Lost to Follow-up|0|||
164348558|NCT02549937|593652696|FG003|Overall Study|Lost to Follow-up|0|||
164348559|NCT02549937|593652697|FG004|Overall Study|Lost to Follow-up|0|||
164348560|NCT02549937|593652698|FG005|Overall Study|Lost to Follow-up|0|||
164348561|NCT02549937|593652699|FG006|Overall Study|Lost to Follow-up|0|||
164348562|NCT02549937|593652700|FG007|Overall Study|Lost to Follow-up|0|||
164348563|NCT02549937|593652701|FG008|Overall Study|Lost to Follow-up|3|||
164348564|NCT02549937|593652693|FG000|Overall Study|Withdrawal by Subject|0|||
164348565|NCT02549937|593652694|FG001|Overall Study|Withdrawal by Subject|0|||
164348566|NCT02549937|593652695|FG002|Overall Study|Withdrawal by Subject|0|||
164348567|NCT02549937|593652696|FG003|Overall Study|Withdrawal by Subject|0|||
164348568|NCT02549937|593652697|FG004|Overall Study|Withdrawal by Subject|0|||
164348569|NCT02549937|593652698|FG005|Overall Study|Withdrawal by Subject|1|||
164348570|NCT02549937|593652699|FG006|Overall Study|Withdrawal by Subject|4|||
164435815|NCT01253226|593962087|FG001|Overall Study|Withdrawal by Subject|0|||
164348571|NCT02549937|593652700|FG007|Overall Study|Withdrawal by Subject|3|||
164348572|NCT02549937|593652701|FG008|Overall Study|Withdrawal by Subject|2|||
164348573|NCT02549937|593652693|FG000|Overall Study|Sponsor Decision|0|||
164348574|NCT02549937|593652694|FG001|Overall Study|Sponsor Decision|0|||
164348575|NCT02549937|593652695|FG002|Overall Study|Sponsor Decision|0|||
164348576|NCT02549937|593652696|FG003|Overall Study|Sponsor Decision|0|||
164348577|NCT02549937|593652697|FG004|Overall Study|Sponsor Decision|0|||
164348578|NCT02549937|593652698|FG005|Overall Study|Sponsor Decision|0|||
164348579|NCT02549937|593652699|FG006|Overall Study|Sponsor Decision|0|||
164348580|NCT02549937|593652700|FG007|Overall Study|Sponsor Decision|0|||
164348581|NCT02549937|593652701|FG008|Overall Study|Sponsor Decision|6|||
164348582|NCT02144012|593652704|FG000|Overall Study|Adverse Event|1|||
164348583|NCT02144012|593652705|FG001|Overall Study|Adverse Event|0|||
164348584|NCT02144012|593652704|FG000|Overall Study|Death|1|||
164298695|NCT03137992|593468145|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
164298696|NCT03137992|593468146|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
164348585|NCT02144012|593652705|FG001|Overall Study|Death|0|||
164348586|NCT02144012|593652704|FG000|Overall Study|Withdrawal by Subject|11|||
164348587|NCT02144012|593652705|FG001|Overall Study|Withdrawal by Subject|3|||
164348588|NCT02144012|593652704|FG000|Overall Study|Study Terminated by Sponsor|18|||
164348589|NCT02144012|593652705|FG001|Overall Study|Study Terminated by Sponsor|12|||
164348590|NCT02144012|593652704|FG000|Overall Study|Other|3|||
164348591|NCT02144012|593652705|FG001|Overall Study|Other|0|||
164348592|NCT00317356|593652706|FG000|Overall Study|Adverse Event|0|||
164348593|NCT00317356|593652707|FG001|Overall Study|Adverse Event|0|||
164348594|NCT00317356|593652708|FG002|Overall Study|Adverse Event|1|||
164348595|NCT00317356|593652709|FG003|Overall Study|Adverse Event|0|||
164348596|NCT00317356|593652706|FG000|Overall Study|Lack of Efficacy|1|||
164348597|NCT00317356|593652707|FG001|Overall Study|Lack of Efficacy|1|||
164348598|NCT00317356|593652708|FG002|Overall Study|Lack of Efficacy|0|||
164348599|NCT00317356|593652709|FG003|Overall Study|Lack of Efficacy|3|||
164348600|NCT00317356|593652706|FG000|Overall Study|Physician Decision|0|||
164348601|NCT00317356|593652707|FG001|Overall Study|Physician Decision|1|||
164348602|NCT00317356|593652708|FG002|Overall Study|Physician Decision|0|||
164348603|NCT00317356|593652709|FG003|Overall Study|Physician Decision|0|||
164348604|NCT04342897|593652710|FG000|Overall Study|Death|7|||
164348605|NCT04342897|593652711|FG001|Overall Study|Death|4|||
164348606|NCT04342897|593652710|FG000|Overall Study|Lost to Follow-up|6|||
164348607|NCT04342897|593652711|FG001|Overall Study|Lost to Follow-up|6|||
164348608|NCT04342897|593652710|FG000|Overall Study|Withdrawal by Subject|1|||
164348609|NCT04342897|593652711|FG001|Overall Study|Withdrawal by Subject|2|||
164348610|NCT00903695|593655266|FG000|Overall Study|medical exclusion after 1st testing|1|||
164348611|NCT00903695|593655267|FG001|Overall Study|medical exclusion after 1st testing|0|||
164348612|NCT00903695|593655266|FG000|Overall Study|lung cancer|1|||
164348613|NCT00903695|593655267|FG001|Overall Study|lung cancer|0|||
164298697|NCT03137992|593468141|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
164298698|NCT03137992|593468142|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
164298699|NCT03137992|593468143|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
164298700|NCT03137992|593468144|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
164298701|NCT03137992|593468145|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
164298702|NCT03137992|593468146|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
164298703|NCT03137992|593468141|FG000|Period 2 (Visit 3)|Adverse Event|0|||
164298704|NCT03137992|593468142|FG001|Period 2 (Visit 3)|Adverse Event|1|||
164298705|NCT03137992|593468143|FG002|Period 2 (Visit 3)|Adverse Event|0|||
164298706|NCT03137992|593468144|FG003|Period 2 (Visit 3)|Adverse Event|0|||
164298707|NCT03137992|593468145|FG004|Period 2 (Visit 3)|Adverse Event|0|||
164298708|NCT03137992|593468146|FG005|Period 2 (Visit 3)|Adverse Event|0|||
164298709|NCT03137992|593468141|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
164298710|NCT03137992|593468142|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
164298711|NCT03137992|593468143|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
164298712|NCT03137992|593468144|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
164298713|NCT03137992|593468145|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
164298714|NCT03137992|593468146|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
164298715|NCT03137992|593468141|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
164298716|NCT03137992|593468142|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
164298717|NCT03137992|593468143|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
164298718|NCT03137992|593468144|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
164298719|NCT03137992|593468145|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
164298720|NCT03137992|593468146|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
164298721|NCT03137992|593468141|FG000|Washout Period 2|COPD Exacerbation|1|||
164298722|NCT03137992|593468142|FG001|Washout Period 2|COPD Exacerbation|1|||
164298723|NCT03137992|593468143|FG002|Washout Period 2|COPD Exacerbation|0|||
164298724|NCT03137992|593468144|FG003|Washout Period 2|COPD Exacerbation|0|||
164298725|NCT03137992|593468145|FG004|Washout Period 2|COPD Exacerbation|1|||
164298726|NCT03137992|593468146|FG005|Washout Period 2|COPD Exacerbation|0|||
164298727|NCT03137992|593468141|FG000|Washout Period 2|Subject Non-compliance|0|||
164298728|NCT03137992|593468142|FG001|Washout Period 2|Subject Non-compliance|1|||
164298729|NCT03137992|593468143|FG002|Washout Period 2|Subject Non-compliance|0|||
164298730|NCT03137992|593468144|FG003|Washout Period 2|Subject Non-compliance|0|||
164298731|NCT03137992|593468145|FG004|Washout Period 2|Subject Non-compliance|0|||
164298732|NCT03137992|593468146|FG005|Washout Period 2|Subject Non-compliance|0|||
164298733|NCT03137992|593468141|FG000|Washout Period 2|Adverse Event|0|||
164298734|NCT03137992|593468142|FG001|Washout Period 2|Adverse Event|0|||
164298735|NCT03137992|593468143|FG002|Washout Period 2|Adverse Event|0|||
164298736|NCT03137992|593468144|FG003|Washout Period 2|Adverse Event|1|||
164348614|NCT01599234|593655268|FG000|Overall Study|Adverse Event|9|||
164348615|NCT01599234|593655269|FG001|Overall Study|Adverse Event|5|||
164348616|NCT01599234|593655268|FG000|Overall Study|Withdrawal by Subject|2|||
164348617|NCT01599234|593655269|FG001|Overall Study|Withdrawal by Subject|1|||
164348618|NCT01599234|593655268|FG000|Overall Study|Lost to Follow-up|1|||
164348619|NCT01599234|593655269|FG001|Overall Study|Lost to Follow-up|2|||
164587705|NCT03662334|594515933|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
164587706|NCT01024465|594515934|FG000|Overall Study|Adverse Event|2|||
164587707|NCT01024465|594515934|FG000|Overall Study|Physician Decision|1|||
164587708|NCT03078608|594515936|FG000|Overall Study|Death|1|||
164587709|NCT03078608|594515937|FG001|Overall Study|Death|2|||
164587710|NCT03078608|594515938|FG002|Overall Study|Death|0|||
164587711|NCT03078608|594515939|FG003|Overall Study|Death|0|||
164587712|NCT03078608|594515936|FG000|Overall Study|Withdrawal by Subject|8|||
164587713|NCT03078608|594515937|FG001|Overall Study|Withdrawal by Subject|1|||
164587714|NCT03078608|594515938|FG002|Overall Study|Withdrawal by Subject|0|||
164587715|NCT03078608|594515939|FG003|Overall Study|Withdrawal by Subject|0|||
164587716|NCT03078608|594515936|FG000|Overall Study|Lost to Follow-up|5|||
164587717|NCT03078608|594515937|FG001|Overall Study|Lost to Follow-up|8|||
164587718|NCT03078608|594515938|FG002|Overall Study|Lost to Follow-up|4|||
164587719|NCT03078608|594515939|FG003|Overall Study|Lost to Follow-up|1|||
164587720|NCT00723840|594515940|FG000|Overall Study|Lost to Follow-up|2|||
164587721|NCT00723840|594515940|FG000|Overall Study|Failure to return|18|||
164587722|NCT00723840|594515940|FG000|Overall Study|Withdrawal by Subject|55|||
164587723|NCT00723840|594515940|FG000|Overall Study|Serious Adverse Events|3|||
164587724|NCT00723840|594515940|FG000|Overall Study|Other Medical Event|2|||
164587725|NCT00723840|594515940|FG000|Overall Study|Unspecified reason|2|||
164587726|NCT01921270|594515951|FG000|Overall Study|Withdrawal by Subject|1|||
164587727|NCT00863928|594515954|FG000|Overall Study|Protocol Violation|26|||
164587728|NCT00863928|594515955|FG001|Overall Study|Protocol Violation|0|||
164587729|NCT00863928|594515954|FG000|Overall Study|Withdrawal by Subject|3|||
164587730|NCT00863928|594515955|FG001|Overall Study|Withdrawal by Subject|0|||
164587731|NCT00863928|594515954|FG000|Overall Study|surgery cancellation|4|||
164435816|NCT01253226|593962088|FG002|Overall Study|Withdrawal by Subject|0|||
164435817|NCT01253226|593962089|FG003|Overall Study|Withdrawal by Subject|1|||
164435818|NCT01253226|593962090|FG004|Overall Study|Withdrawal by Subject|0|||
164435819|NCT03593070|593962091|FG000|Overall Study|administrative withdrawal|1|||
164435820|NCT03593070|593962092|FG001|Overall Study|administrative withdrawal|1|||
164435821|NCT03643211|593962094|FG000|Overall Study|Contract violation/deficiency|12|||
164435822|NCT03643211|593962094|FG000|Overall Study|Invalid registration|3|||
164435823|NCT03643211|593962094|FG000|Overall Study|No treatment information|2|||
164435824|NCT03643211|593962094|FG000|Overall Study|No adverse event information - No revisit|4|||
164435825|NCT04858425|593962095|FG000|Overall Study|Adverse Event|2|||
164587732|NCT00863928|594515955|FG001|Overall Study|surgery cancellation|0|||
164587733|NCT00863928|594515954|FG000|Overall Study|medication allergy|3|||
164587734|NCT00863928|594515955|FG001|Overall Study|medication allergy|0|||
164587735|NCT03290300|594515956|FG000|Overall Study|Lost to Follow-up|3|||
164587736|NCT00864227|594515957|FG000|Overall Study|Withdrawal by Subject|1|||
164587737|NCT00864227|594515957|FG000|Overall Study|Disease Relapse/Progression|3|||
164587738|NCT02124798|594515958|FG000|Overall Study|Adverse Event|3|||
164587739|NCT02124798|594515958|FG000|Overall Study|Lost to Follow-up|1|||
164587740|NCT02792777|594515959|FG000|Overall Study|Withdrawal by Subject|2|||
164587741|NCT02792777|594515960|FG001|Overall Study|Withdrawal by Subject|0|||
164587742|NCT02792777|594515959|FG000|Overall Study|Recording malfunction|2|||
164587743|NCT02792777|594515960|FG001|Overall Study|Recording malfunction|0|||
164587744|NCT02792777|594515959|FG000|Overall Study|Later determined to be ineligible|2|||
164348620|NCT01599234|593655268|FG000|Overall Study|Lack of Efficacy|2|||
164348621|NCT01599234|593655269|FG001|Overall Study|Lack of Efficacy|4|||
164348622|NCT01599234|593655268|FG000|Overall Study|Unable to operate spray|1|||
164348623|NCT01599234|593655269|FG001|Overall Study|Unable to operate spray|0|||
164348624|NCT01599234|593655268|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
164348625|NCT01599234|593655269|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
164348626|NCT01599234|593655268|FG000|Overall Study|Death|1|||
164348627|NCT01599234|593655269|FG001|Overall Study|Death|0|||
164348628|NCT01599234|593655268|FG000|Overall Study|Patient would not stop driving|1|||
164435826|NCT04858425|593962096|FG001|Overall Study|Adverse Event|2|||
164435827|NCT04858425|593962095|FG000|Overall Study|Withdrawal by Subject|3|||
164435828|NCT04858425|593962096|FG001|Overall Study|Withdrawal by Subject|1|||
164587745|NCT02792777|594515960|FG001|Overall Study|Later determined to be ineligible|0|||
164587746|NCT02792777|594515959|FG000|Overall Study|Participant interviewed twice|1|||
164587747|NCT02792777|594515960|FG001|Overall Study|Participant interviewed twice|0|||
164587748|NCT02795156|594515961|FG000|Overall Study|Progressive Disease|22|||
164587749|NCT02795156|594515962|FG001|Overall Study|Progressive Disease|7|||
164435829|NCT04858425|593962095|FG000|Overall Study|Lost to Follow-up|4|||
164587750|NCT02795156|594515963|FG002|Overall Study|Progressive Disease|34|||
164587751|NCT02795156|594515964|FG003|Overall Study|Progressive Disease|7|||
164587752|NCT02795156|594515961|FG000|Overall Study|Adverse Event|13|||
164435830|NCT04858425|593962096|FG001|Overall Study|Lost to Follow-up|2|||
164587753|NCT02795156|594515962|FG001|Overall Study|Adverse Event|2|||
164348629|NCT01599234|593655269|FG001|Overall Study|Patient would not stop driving|0|||
164587754|NCT02795156|594515963|FG002|Overall Study|Adverse Event|3|||
164587755|NCT02795156|594515964|FG003|Overall Study|Adverse Event|2|||
164348630|NCT01599234|593655268|FG000|Overall Study|Contra-indication discovered|0|||
164348631|NCT01599234|593655269|FG001|Overall Study|Contra-indication discovered|1|||
164348632|NCT01599234|593655268|FG000|Overall Study|Pregnancy|0|||
164348633|NCT01599234|593655269|FG001|Overall Study|Pregnancy|1|||
164348634|NCT02511184|593655271|FG000|Overall Study|Death|1|||
164348635|NCT02511184|593655272|FG001|Overall Study|Death|0|||
164348636|NCT02511184|593655271|FG000|Overall Study|Lost to Follow-up|0|||
164348637|NCT02511184|593655272|FG001|Overall Study|Lost to Follow-up|1|||
164348638|NCT02511184|593655271|FG000|Overall Study|Study terminated by sponsor|1|||
164348639|NCT02511184|593655272|FG001|Overall Study|Study terminated by sponsor|5|||
164348640|NCT02511184|593655271|FG000|Overall Study|Withdrawal by Subject|0|||
164348641|NCT02511184|593655272|FG001|Overall Study|Withdrawal by Subject|1|||
164348642|NCT01513473|593655279|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
164348643|NCT01513473|593655280|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
164348644|NCT01513473|593655279|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
164348645|NCT01513473|593655280|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
164348646|NCT01513473|593655279|FG000|Main Trial (26 Weeks)|Unclassified|0|||
164348647|NCT01513473|593655280|FG001|Main Trial (26 Weeks)|Unclassified|2|||
164348648|NCT01513473|593655279|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
164348649|NCT01513473|593655280|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
164348650|NCT01513473|593655279|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
164348651|NCT01513473|593655280|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
164348652|NCT04016285|593655281|FG000|Overall Study|Did not progress to surgery|2|||
164348653|NCT04016285|593655282|FG001|Overall Study|Did not progress to surgery|5|||
164348654|NCT04016285|593655281|FG000|Overall Study|Failed to collect outcome data|5|||
164348655|NCT04016285|593655282|FG001|Overall Study|Failed to collect outcome data|3|||
164348656|NCT03462082|593655283|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
164348657|NCT03462082|593655284|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
164348658|NCT03462082|593655285|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
164348659|NCT03462082|593655286|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
164348660|NCT03462082|593655287|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
164348661|NCT03462082|593655288|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
164348662|NCT03462082|593655289|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
164348663|NCT03462082|593655290|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
164348664|NCT00743340|593655293|FG000|Overall Study|Study medication non-compliance|1|||
164348665|NCT00743340|593655293|FG000|Overall Study|Lost to Follow-up|1|||
164348666|NCT00743340|593655293|FG000|Overall Study|Withdrawal from the Study|5|||
164348667|NCT00743340|593655293|FG000|Overall Study|Protocol Violation|1|||
164348668|NCT00743340|593655293|FG000|Overall Study|Virologic failure|8|||
164348669|NCT00743340|593655293|FG000|Overall Study|Pregnancy|1|||
164348670|NCT00743340|593655293|FG000|Overall Study|Rolled over to other Gilead Study|23|||
164348671|NCT00743340|593655293|FG000|Overall Study|Participant Relocated|1|||
164348672|NCT00127660|593655294|FG000|Overall Study|Protocol Violation|3|||
164348673|NCT00127660|593655295|FG001|Overall Study|Protocol Violation|3|||
164348674|NCT00127660|593655296|FG002|Overall Study|Protocol Violation|5|||
164348675|NCT00127660|593655297|FG003|Overall Study|Protocol Violation|0|||
164348676|NCT01425281|593655298|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
164348677|NCT01425281|593655299|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
164348678|NCT01425281|593655298|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
164348679|NCT01425281|593655299|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
164348680|NCT01425281|593655298|FG000|At 180-day Clinical Follow-up|Death|0|||
164348681|NCT01425281|593655299|FG001|At 180-day Clinical Follow-up|Death|1|||
164348682|NCT01425281|593655298|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
164348683|NCT01425281|593655299|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
164348684|NCT01425281|593655298|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
164348685|NCT01425281|593655299|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
164348686|NCT01425281|593655298|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
164348687|NCT01425281|593655299|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
164348688|NCT01425281|593655298|FG000|At 2-year Clinical Follow-up|Death|2|||
164348689|NCT01425281|593655299|FG001|At 2-year Clinical Follow-up|Death|0|||
164348690|NCT01425281|593655298|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
164348691|NCT01425281|593655299|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
164348692|NCT01425281|593655298|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
164348693|NCT01425281|593655299|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
164348694|NCT01425281|593655298|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
164348695|NCT01425281|593655299|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
164435831|NCT04858425|593962095|FG000|Overall Study|Lost to Follow-up|1|||
164348696|NCT01425281|593655298|FG000|At 3-year Clinical Follow-up|Death|2|||
164348697|NCT01425281|593655299|FG001|At 3-year Clinical Follow-up|Death|3|||
164348698|NCT01425281|593655298|FG000|At 4-year Clinical Follow-up|Death|7|||
164348699|NCT01425281|593655299|FG001|At 4-year Clinical Follow-up|Death|3|||
164587756|NCT02795156|594515961|FG000|Overall Study|Death|1|||
164587757|NCT02795156|594515962|FG001|Overall Study|Death|1|||
164587758|NCT02795156|594515963|FG002|Overall Study|Death|1|||
164298737|NCT03137992|593468145|FG004|Washout Period 2|Adverse Event|1|||
164298738|NCT03137992|593468146|FG005|Washout Period 2|Adverse Event|0|||
164298739|NCT03137992|593468141|FG000|Washout Period 2|Withdrawal by Subject|1|||
164298740|NCT03137992|593468142|FG001|Washout Period 2|Withdrawal by Subject|0|||
164298741|NCT03137992|593468143|FG002|Washout Period 2|Withdrawal by Subject|0|||
164298742|NCT03137992|593468144|FG003|Washout Period 2|Withdrawal by Subject|0|||
164298743|NCT03137992|593468145|FG004|Washout Period 2|Withdrawal by Subject|1|||
164298744|NCT03137992|593468146|FG005|Washout Period 2|Withdrawal by Subject|0|||
164298745|NCT03137992|593468141|FG000|Washout Period 2|Sponsor Decision|0|||
164298746|NCT03137992|593468142|FG001|Washout Period 2|Sponsor Decision|0|||
164298747|NCT03137992|593468143|FG002|Washout Period 2|Sponsor Decision|0|||
164298748|NCT03137992|593468144|FG003|Washout Period 2|Sponsor Decision|0|||
164298749|NCT03137992|593468145|FG004|Washout Period 2|Sponsor Decision|0|||
164298750|NCT03137992|593468146|FG005|Washout Period 2|Sponsor Decision|1|||
164298751|NCT03137992|593468141|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
164298752|NCT03137992|593468142|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
164298753|NCT03137992|593468143|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
164298754|NCT03137992|593468144|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
164298755|NCT03137992|593468145|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
164298756|NCT03137992|593468146|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
164298757|NCT03137992|593468141|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
164298758|NCT03137992|593468142|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
164298759|NCT03137992|593468143|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
164298760|NCT03137992|593468144|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
164298761|NCT03137992|593468145|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
164298762|NCT03137992|593468146|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
164298763|NCT03137992|593468141|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
164298764|NCT03137992|593468142|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
164298765|NCT03137992|593468143|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
164298766|NCT03137992|593468144|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
164298767|NCT03137992|593468145|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
164298768|NCT03137992|593468146|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
164298769|NCT03137992|593468141|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
164298770|NCT03137992|593468142|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
164298771|NCT03137992|593468143|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
164298772|NCT03137992|593468144|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
164298773|NCT03137992|593468145|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
164298774|NCT03137992|593468146|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
164298775|NCT03137992|593468141|FG000|Part 2 (Open-label Extension)|Per study team|1|||
164298776|NCT03137992|593468142|FG001|Part 2 (Open-label Extension)|Per study team|0|||
164298777|NCT03137992|593468143|FG002|Part 2 (Open-label Extension)|Per study team|0|||
164298778|NCT03137992|593468144|FG003|Part 2 (Open-label Extension)|Per study team|0|||
164298779|NCT03137992|593468145|FG004|Part 2 (Open-label Extension)|Per study team|0|||
164298780|NCT03137992|593468146|FG005|Part 2 (Open-label Extension)|Per study team|0|||
164298781|NCT03137992|593468141|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
164298782|NCT03137992|593468142|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
164298783|NCT03137992|593468143|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
164298784|NCT03137992|593468144|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
164298785|NCT03137992|593468145|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
164298786|NCT03137992|593468146|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
164298787|NCT03221556|593468149|FG000|Allocation|post-randomization exclusion|0|||
164298788|NCT03221556|593468150|FG001|Allocation|post-randomization exclusion|1|||
164298789|NCT03221556|593468149|FG000|Follow-Up|Withdrawal by Subject|0|||
164298790|NCT03221556|593468150|FG001|Follow-Up|Withdrawal by Subject|1|||
164298791|NCT01486966|593468157|FG000|Overall Study|Adverse Event|0|||
164298792|NCT01486966|593468158|FG001|Overall Study|Adverse Event|1|||
164298793|NCT01486966|593468157|FG000|Overall Study|Withdrawal by Subject|0|||
164298794|NCT01486966|593468158|FG001|Overall Study|Withdrawal by Subject|1|||
164298795|NCT02331134|593468159|FG000|Overall Study|Withdrawal by Subject|1|||
164298796|NCT04825574|593468163|FG000|Overall Study|Commercial treatment became available|1|||
164298797|NCT04825574|593468163|FG000|Overall Study|Disease progression|1|||
164298798|NCT05967260|593468164|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
164298799|NCT05967260|593468165|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
164298800|NCT05565742|593468166|FG000|Overall Study|Withdrawal by Subject|0|||
164298801|NCT05565742|593468167|FG001|Overall Study|Withdrawal by Subject|0|||
164298802|NCT05565742|593468168|FG002|Overall Study|Withdrawal by Subject|2|||
164298803|NCT05565742|593468169|FG003|Overall Study|Withdrawal by Subject|2|||
164298804|NCT05565742|593468170|FG004|Overall Study|Withdrawal by Subject|2|||
164587759|NCT02795156|594515964|FG003|Overall Study|Death|0|||
164587760|NCT02795156|594515961|FG000|Overall Study|Physician Decision|1|||
164587761|NCT02795156|594515962|FG001|Overall Study|Physician Decision|0|||
164587762|NCT02795156|594515963|FG002|Overall Study|Physician Decision|1|||
164587763|NCT02795156|594515964|FG003|Overall Study|Physician Decision|0|||
164587764|NCT02795156|594515961|FG000|Overall Study|Withdrawal by Subject|2|||
164587765|NCT02795156|594515962|FG001|Overall Study|Withdrawal by Subject|0|||
164587766|NCT02795156|594515963|FG002|Overall Study|Withdrawal by Subject|3|||
164587767|NCT02795156|594515964|FG003|Overall Study|Withdrawal by Subject|0|||
164587768|NCT00501852|594515967|FG000|Overall Study|Adverse Event|3|||
164587769|NCT00501852|594515967|FG000|Overall Study|Withdrawal by Subject|2|||
164587770|NCT01171521|594515968|FG000|Overall Study|Lost to Follow-up|5|||
164587771|NCT01171521|594515968|FG000|Overall Study|screen failure|1|||
164587772|NCT00399802|594515969|FG000|Overall Study|Adverse Event|0|||
164587773|NCT00399802|594515970|FG001|Overall Study|Adverse Event|2|||
164587774|NCT00399802|594515969|FG000|Overall Study|Participant discontinued by mistake|0|||
164587775|NCT00399802|594515970|FG001|Overall Study|Participant discontinued by mistake|1|||
164587776|NCT00492921|594515971|FG000|Overall Study|Death|1|||
164587777|NCT00492921|594515972|FG001|Overall Study|Death|0|||
164587778|NCT00492921|594515973|FG002|Overall Study|Death|1|||
164587779|NCT00652093|594515974|FG000|Overall Study|Withdrawal by Subject|0|||
164587780|NCT00652093|594515975|FG001|Overall Study|Withdrawal by Subject|0|||
164587781|NCT00652093|594515976|FG002|Overall Study|Withdrawal by Subject|1|||
164587782|NCT00652093|594515977|FG003|Overall Study|Withdrawal by Subject|0|||
164587783|NCT00652093|594515978|FG004|Overall Study|Withdrawal by Subject|1|||
164587784|NCT00652093|594515979|FG005|Overall Study|Withdrawal by Subject|0|||
164587785|NCT00652093|594515974|FG000|Overall Study|Physician Decision|0|||
164587786|NCT00652093|594515975|FG001|Overall Study|Physician Decision|0|||
164587787|NCT00652093|594515976|FG002|Overall Study|Physician Decision|0|||
164587788|NCT00652093|594515977|FG003|Overall Study|Physician Decision|0|||
164587789|NCT00652093|594515978|FG004|Overall Study|Physician Decision|1|||
164587790|NCT00652093|594515979|FG005|Overall Study|Physician Decision|0|||
164587791|NCT01520922|594515982|FG000|Treatment Phase|Physician Decision|2|||
164587792|NCT01520922|594515983|FG001|Treatment Phase|Physician Decision|1|||
164587793|NCT01520922|594515982|FG000|Treatment Phase|Progression|0|||
164587794|NCT01520922|594515983|FG001|Treatment Phase|Progression|2|||
164587795|NCT01520922|594515982|FG000|Treatment Phase|Adverse Event|3|||
164587796|NCT01520922|594515983|FG001|Treatment Phase|Adverse Event|5|||
164587797|NCT01520922|594515982|FG000|Follow up|Lost to Follow-up|0|||
164587798|NCT01520922|594515983|FG001|Follow up|Lost to Follow-up|1|||
164587799|NCT01520922|594515982|FG000|Survival Follow-up|Withdrawal by Subject|1|||
164587800|NCT01520922|594515983|FG001|Survival Follow-up|Withdrawal by Subject|0|||
164587801|NCT01422304|594515984|FG000|Overall Study|Adverse Event|0|||
164587802|NCT01422304|594515985|FG001|Overall Study|Adverse Event|1|||
164587803|NCT01422304|594515984|FG000|Overall Study|Lost to Follow-up|14|||
164587804|NCT01422304|594515985|FG001|Overall Study|Lost to Follow-up|20|||
164587805|NCT01422304|594515984|FG000|Overall Study|Never Entered Follow-up|2|||
164587806|NCT01422304|594515985|FG001|Overall Study|Never Entered Follow-up|1|||
164587807|NCT01422304|594515984|FG000|Overall Study|Protocol Violation|1|||
164587808|NCT01422304|594515985|FG001|Overall Study|Protocol Violation|0|||
164587809|NCT01422304|594515984|FG000|Overall Study|Withdrawal by Subject|4|||
164587810|NCT01422304|594515985|FG001|Overall Study|Withdrawal by Subject|2|||
164587811|NCT01422304|594515984|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
164587812|NCT01422304|594515985|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
164587813|NCT01422304|594515984|FG000|Overall Study|Not Treated|3|||
164587814|NCT01422304|594515985|FG001|Overall Study|Not Treated|11|||
164587815|NCT03461289|594515989|FG000|Overall Study|Death|1|||
164435832|NCT04858425|593962096|FG001|Overall Study|Lost to Follow-up|0|||
164435833|NCT03473743|593962097|FG000|Overall Study|Withdrawal by Subject|0|||
164435834|NCT03473743|593962098|FG001|Overall Study|Withdrawal by Subject|0|||
164435835|NCT03473743|593962099|FG002|Overall Study|Withdrawal by Subject|0|||
164435836|NCT03473743|593962100|FG003|Overall Study|Withdrawal by Subject|0|||
164435837|NCT03473743|593962101|FG004|Overall Study|Withdrawal by Subject|0|||
164435838|NCT03473743|593962102|FG005|Overall Study|Withdrawal by Subject|0|||
164435839|NCT03473743|593962103|FG006|Overall Study|Withdrawal by Subject|0|||
164435840|NCT03473743|593962104|FG007|Overall Study|Withdrawal by Subject|3|||
164587816|NCT00564629|594515990|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
164587817|NCT00564629|594515991|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
164587818|NCT03241173|594515992|FG000|Overall Study|Death|3|||
164587819|NCT03241173|594515993|FG001|Overall Study|Death|2|||
164435841|NCT03473743|593962097|FG000|Overall Study|Other|0|||
164587820|NCT03241173|594515994|FG002|Overall Study|Death|4|||
164587821|NCT03241173|594515995|FG003|Overall Study|Death|4|||
164587822|NCT03241173|594515996|FG004|Overall Study|Death|2|||
164587823|NCT03241173|594515997|FG005|Overall Study|Death|2|||
164587824|NCT03241173|594515998|FG006|Overall Study|Death|3|||
164587825|NCT03241173|594515999|FG007|Overall Study|Death|1|||
164587826|NCT03241173|594516000|FG008|Overall Study|Death|0|||
164298805|NCT05565742|593468166|FG000|Overall Study|Death|1|||
164298806|NCT05565742|593468167|FG001|Overall Study|Death|0|||
164298807|NCT05565742|593468168|FG002|Overall Study|Death|0|||
164298808|NCT05565742|593468169|FG003|Overall Study|Death|0|||
164298809|NCT05565742|593468170|FG004|Overall Study|Death|0|||
164298810|NCT05565742|593468166|FG000|Overall Study|Participant Travelled Abroad|0|||
164298811|NCT05565742|593468167|FG001|Overall Study|Participant Travelled Abroad|0|||
164298812|NCT05565742|593468168|FG002|Overall Study|Participant Travelled Abroad|0|||
164298813|NCT05565742|593468169|FG003|Overall Study|Participant Travelled Abroad|0|||
164298814|NCT05565742|593468170|FG004|Overall Study|Participant Travelled Abroad|1|||
164298815|NCT00668148|593468171|FG000|Overall Study|Adverse Event|5|||
164298816|NCT00668148|593468171|FG000|Overall Study|Subject Non-compliance|1|||
164298817|NCT00668148|593468171|FG000|Overall Study|Progressive Disease Before Treatment|2|||
164298818|NCT00668148|593468171|FG000|Overall Study|Withdrawal of Consent|2|||
164298819|NCT05472090|593468173|FG000|Overall Study|Adverse Event|2|||
164298820|NCT05472090|593468174|FG001|Overall Study|Adverse Event|3|||
164298821|NCT05472090|593468173|FG000|Overall Study|Lack of Efficacy|1|||
164298822|NCT05472090|593468174|FG001|Overall Study|Lack of Efficacy|0|||
164298823|NCT05472090|593468173|FG000|Overall Study|Physician Decision|1|||
164298824|NCT05472090|593468174|FG001|Overall Study|Physician Decision|0|||
164298825|NCT05472090|593468173|FG000|Overall Study|Withdrawal by Subject|2|||
164298826|NCT05472090|593468174|FG001|Overall Study|Withdrawal by Subject|0|||
164298827|NCT05472090|593468173|FG000|Overall Study|Lost to Follow-up|0|||
164298828|NCT05472090|593468174|FG001|Overall Study|Lost to Follow-up|3|||
164298829|NCT02419001|593471157|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
164298830|NCT02419001|593471158|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
164298831|NCT01209689|593471162|FG000|Overall Study|Insufficient Therapeutic Response|7|||
164298832|NCT01209689|593471163|FG001|Overall Study|Insufficient Therapeutic Response|2|||
164298833|NCT01209689|593471162|FG000|Overall Study|Refused Treatment|8|||
164298834|NCT01209689|593471163|FG001|Overall Study|Refused Treatment|3|||
164298835|NCT01209689|593471162|FG000|Overall Study|Adverse Event|4|||
164298836|NCT01209689|593471163|FG001|Overall Study|Adverse Event|0|||
164298837|NCT01209689|593471162|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
164298838|NCT01209689|593471163|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
164298839|NCT01209689|593471162|FG000|Overall Study|Failure to Return|3|||
164298840|NCT01209689|593471163|FG001|Overall Study|Failure to Return|0|||
164298841|NCT01209689|593471162|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
164298842|NCT01209689|593471163|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
164298843|NCT03780244|593471166|FG000|Overall Study|Lost to Follow-up|1|||
164298844|NCT03780244|593471167|FG001|Overall Study|Lost to Follow-up|0|||
164298845|NCT01083771|593471168|FG000|Overall Study|non-compliant|2|||
164298846|NCT01083771|593471168|FG000|Overall Study|Withdrawal by Subject|3|||
164298847|NCT03175367|593471169|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
164298848|NCT03175367|593471170|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
164298849|NCT03175367|593471171|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
164298850|NCT03175367|593471172|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
164298851|NCT03175367|593471173|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
164298852|NCT03175367|593471174|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
164298853|NCT03175367|593471175|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
164298854|NCT03175367|593471169|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
164298855|NCT03175367|593471170|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
164298856|NCT03175367|593471171|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
164298857|NCT03175367|593471172|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
164298858|NCT03175367|593471173|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
164298859|NCT03175367|593471174|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
164298860|NCT03175367|593471175|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
164298861|NCT03175367|593471169|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
164301065|NCT02435992|593478414|FG003|Overall Study|Physician Decision|0|||
164301066|NCT02435992|593478415|FG004|Overall Study|Physician Decision|0|||
164301067|NCT03879772|593478416|FG000|Overall Study|Adverse Event|2|||
164301068|NCT03879772|593478417|FG001|Overall Study|Adverse Event|2|||
164301069|NCT03879772|593478418|FG002|Overall Study|Adverse Event|3|||
164301070|NCT03879772|593478419|FG003|Overall Study|Adverse Event|4|||
164301071|NCT03879772|593478420|FG004|Overall Study|Adverse Event|3|||
164301072|NCT03879772|593478416|FG000|Overall Study|Treatment Failure|1|||
164301073|NCT03879772|593478417|FG001|Overall Study|Treatment Failure|0|||
164301074|NCT03879772|593478418|FG002|Overall Study|Treatment Failure|0|||
164301075|NCT03879772|593478419|FG003|Overall Study|Treatment Failure|2|||
164301076|NCT03879772|593478420|FG004|Overall Study|Treatment Failure|1|||
164301077|NCT03879772|593478416|FG000|Overall Study|Lost to Follow-up|0|||
164301078|NCT03879772|593478417|FG001|Overall Study|Lost to Follow-up|0|||
164301079|NCT03879772|593478418|FG002|Overall Study|Lost to Follow-up|0|||
164301080|NCT03879772|593478419|FG003|Overall Study|Lost to Follow-up|0|||
164301081|NCT03879772|593478420|FG004|Overall Study|Lost to Follow-up|1|||
164348700|NCT01425281|593655298|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
164348701|NCT01425281|593655299|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
164348702|NCT01425281|593655298|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
164348703|NCT01425281|593655299|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
164348704|NCT01425281|593655298|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
164348705|NCT01425281|593655299|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
164348706|NCT01425281|593655298|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
164348707|NCT01425281|593655299|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
164348708|NCT01425281|593655298|FG000|At 5-year Clinical Follow-up|Death|2|||
164348709|NCT01425281|593655299|FG001|At 5-year Clinical Follow-up|Death|0|||
164348710|NCT01425281|593655298|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
164348711|NCT01425281|593655299|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
164348712|NCT01425281|593655298|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
164348713|NCT01425281|593655299|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
164348714|NCT01425281|593655298|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
164348715|NCT01425281|593655299|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
164348716|NCT01987505|593655300|FG000|Overall Study|Other|9|||
164348717|NCT01987505|593655300|FG000|Overall Study|Withdrawal by Subject|2|||
164348718|NCT01987505|593655300|FG000|Overall Study|Other Reason|2|||
164348719|NCT01987505|593655300|FG000|Overall Study|Lost to Follow-up|15|||
164348720|NCT01987505|593655300|FG000|Overall Study|Investigator Decision|2|||
164348721|NCT01987505|593655300|FG000|Overall Study|Death|4|||
164348722|NCT01749514|593655301|FG000|Overall Study|Lost to Follow-up|0|||
164348723|NCT01749514|593655302|FG001|Overall Study|Lost to Follow-up|0|||
164348724|NCT01749514|593655303|FG002|Overall Study|Lost to Follow-up|0|||
164348725|NCT01749514|593655304|FG003|Overall Study|Lost to Follow-up|0|||
164348726|NCT01749514|593655305|FG004|Overall Study|Lost to Follow-up|0|||
164348727|NCT01749514|593655306|FG005|Overall Study|Lost to Follow-up|0|||
164348728|NCT01749514|593655307|FG006|Overall Study|Lost to Follow-up|0|||
164348729|NCT01749514|593655308|FG007|Overall Study|Lost to Follow-up|1|||
164348730|NCT01749514|593655301|FG000|Overall Study|Withdrawal by Subject|0|||
164348731|NCT01749514|593655302|FG001|Overall Study|Withdrawal by Subject|0|||
164348732|NCT01749514|593655303|FG002|Overall Study|Withdrawal by Subject|0|||
164348733|NCT01749514|593655304|FG003|Overall Study|Withdrawal by Subject|0|||
164348734|NCT01749514|593655305|FG004|Overall Study|Withdrawal by Subject|0|||
164348735|NCT01749514|593655306|FG005|Overall Study|Withdrawal by Subject|1|||
164348736|NCT01749514|593655307|FG006|Overall Study|Withdrawal by Subject|0|||
164348737|NCT01749514|593655308|FG007|Overall Study|Withdrawal by Subject|1|||
164348738|NCT01749514|593655301|FG000|Overall Study|Not Reported|0|||
164348739|NCT01749514|593655302|FG001|Overall Study|Not Reported|0|||
164348740|NCT01749514|593655303|FG002|Overall Study|Not Reported|0|||
164348741|NCT01749514|593655304|FG003|Overall Study|Not Reported|0|||
164348742|NCT01749514|593655305|FG004|Overall Study|Not Reported|0|||
164348743|NCT01749514|593655306|FG005|Overall Study|Not Reported|0|||
164348744|NCT01749514|593655307|FG006|Overall Study|Not Reported|0|||
164348745|NCT01749514|593655308|FG007|Overall Study|Not Reported|5|||
164348746|NCT02509156|593655309|FG000|Randomized Phase|Death|1|||
164348747|NCT02509156|593655310|FG001|Randomized Phase|Death|0|||
164348748|NCT02509156|593655309|FG000|Randomized Phase|Withdrawal by Subject|1|||
164348749|NCT02509156|593655310|FG001|Randomized Phase|Withdrawal by Subject|1|||
164348750|NCT05131646|593655311|FG000|Overall Study|Withdrawal by Subject|1|||
164348751|NCT05131646|593655312|FG001|Overall Study|Withdrawal by Subject|0|||
164348752|NCT05131646|593655313|FG002|Overall Study|Withdrawal by Subject|0|||
164348753|NCT02128113|593655314|FG000|Overall Study|Withdrawal by Subject|3|||
164348754|NCT02128113|593655315|FG001|Overall Study|Withdrawal by Subject|1|||
164348755|NCT02128113|593655316|FG002|Overall Study|Withdrawal by Subject|0|||
164348756|NCT02128113|593655314|FG000|Overall Study|Protocol Violation|0|||
164348757|NCT02128113|593655315|FG001|Overall Study|Protocol Violation|1|||
164348758|NCT02128113|593655316|FG002|Overall Study|Protocol Violation|0|||
164348759|NCT02128113|593655314|FG000|Overall Study|Surgery cancelled|0|||
164348760|NCT02128113|593655315|FG001|Overall Study|Surgery cancelled|1|||
164348761|NCT02128113|593655316|FG002|Overall Study|Surgery cancelled|0|||
164348762|NCT02128113|593655314|FG000|Overall Study|Adverse Event|0|||
164348763|NCT02128113|593655315|FG001|Overall Study|Adverse Event|0|||
164348764|NCT02128113|593655316|FG002|Overall Study|Adverse Event|1|||
164348765|NCT01750242|593655317|FG000|Overall Study|Unreadable Images|3|||
164348766|NCT03765918|593655318|FG000|Overall Study|Death|109|||
164348767|NCT03765918|593655319|FG001|Overall Study|Death|127|||
164348768|NCT03765918|593655318|FG000|Overall Study|Lost to Follow-up|2|||
164348769|NCT03765918|593655319|FG001|Overall Study|Lost to Follow-up|3|||
164348770|NCT03765918|593655318|FG000|Overall Study|Withdrawal by Subject|12|||
164348771|NCT03765918|593655319|FG001|Overall Study|Withdrawal by Subject|16|||
164348772|NCT03765918|593655318|FG000|Overall Study|Participants Ongoing|240|||
164348773|NCT03765918|593655319|FG001|Overall Study|Participants Ongoing|205|||
164348774|NCT04202965|593655320|FG000|Overall Study|Adverse Event|3|||
164435842|NCT03473743|593962098|FG001|Overall Study|Other|0|||
164348775|NCT04202965|593655320|FG000|Overall Study|Did not meet inclusion criteria|1|||
164348776|NCT02969369|593655321|FG000|Study|Adverse Event|1|||
164348777|NCT02969369|593655322|FG001|Study|Adverse Event|6|||
164348778|NCT02969369|593655321|FG000|Study|Lack of Efficacy|0|||
164348779|NCT02969369|593655322|FG001|Study|Lack of Efficacy|1|||
164348780|NCT02969369|593655321|FG000|Study|Lost to Follow-up|0|||
164348781|NCT02969369|593655322|FG001|Study|Lost to Follow-up|1|||
164348782|NCT02969369|593655321|FG000|Study|Withdrawal by Subject|3|||
164348783|NCT02969369|593655322|FG001|Study|Withdrawal by Subject|5|||
164348784|NCT02969369|593655321|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
164348785|NCT02969369|593655322|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
164348786|NCT02969369|593655321|FG000|Double-blind Period|Adverse Event|1|||
164348787|NCT02969369|593655322|FG001|Double-blind Period|Adverse Event|5|||
164348788|NCT02969369|593655321|FG000|Double-blind Period|Lost to Follow-up|0|||
164348789|NCT02969369|593655322|FG001|Double-blind Period|Lost to Follow-up|1|||
164348790|NCT02969369|593655321|FG000|Double-blind Period|Withdrawal by Subject|2|||
164348791|NCT02969369|593655322|FG001|Double-blind Period|Withdrawal by Subject|3|||
164348792|NCT02969369|593655321|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
164348793|NCT02969369|593655322|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
164348794|NCT02969369|593655321|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
164348795|NCT02969369|593655322|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
164348796|NCT02969369|593655321|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
164348797|NCT02969369|593655322|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
164348798|NCT02969369|593655321|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
164348799|NCT02969369|593655322|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
164348800|NCT01980992|593655325|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
164348801|NCT01980992|593655326|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
164348802|NCT01980992|593655325|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
164348803|NCT01980992|593655326|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
164348804|NCT01980992|593655325|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
164348805|NCT01980992|593655326|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
164348806|NCT01980992|593655325|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
164348807|NCT01980992|593655326|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
164348808|NCT01980992|593655325|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
164348809|NCT01980992|593655326|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
164348810|NCT01980992|593655325|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
164348811|NCT01980992|593655326|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
164348812|NCT00299975|593655327|FG000|Overall Study|Adverse Event|1|||
164348813|NCT00299975|593655328|FG001|Overall Study|Adverse Event|0|||
164348814|NCT00299975|593655329|FG002|Overall Study|Adverse Event|2|||
164348815|NCT00299975|593655327|FG000|Overall Study|Pregnancy|0|||
164348816|NCT00299975|593655328|FG001|Overall Study|Pregnancy|0|||
164348817|NCT00299975|593655329|FG002|Overall Study|Pregnancy|1|||
164348818|NCT00299975|593655327|FG000|Overall Study|Lack of Efficacy|1|||
164348819|NCT00299975|593655328|FG001|Overall Study|Lack of Efficacy|0|||
164348820|NCT00299975|593655329|FG002|Overall Study|Lack of Efficacy|1|||
164348821|NCT00299975|593655327|FG000|Overall Study|Lost to Follow-up|1|||
164348822|NCT00299975|593655328|FG001|Overall Study|Lost to Follow-up|0|||
164348823|NCT00299975|593655329|FG002|Overall Study|Lost to Follow-up|0|||
164348824|NCT00299975|593655327|FG000|Overall Study|Withdrawal by Subject|0|||
164348825|NCT00299975|593655328|FG001|Overall Study|Withdrawal by Subject|1|||
164348826|NCT00299975|593655329|FG002|Overall Study|Withdrawal by Subject|3|||
164348827|NCT00299975|593655327|FG000|Overall Study|Physician Decision|0|||
164348828|NCT00299975|593655328|FG001|Overall Study|Physician Decision|0|||
164348829|NCT00299975|593655329|FG002|Overall Study|Physician Decision|1|||
164348830|NCT01169493|593655333|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
164348831|NCT01169493|593655334|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
164348832|NCT01169493|593655335|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
164435843|NCT03473743|593962099|FG002|Overall Study|Other|0|||
164435844|NCT03473743|593962100|FG003|Overall Study|Other|1|||
164435845|NCT03473743|593962101|FG004|Overall Study|Other|0|||
164435846|NCT03473743|593962102|FG005|Overall Study|Other|0|||
164435847|NCT03473743|593962103|FG006|Overall Study|Other|0|||
164435848|NCT03473743|593962104|FG007|Overall Study|Other|0|||
164435849|NCT03473743|593962097|FG000|Overall Study|Ongoing|0|||
164435850|NCT03473743|593962098|FG001|Overall Study|Ongoing|0|||
164348833|NCT01169493|593655336|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
164348834|NCT01169493|593655337|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
164348835|NCT01169493|593655338|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
164348836|NCT01169493|593655333|FG000|Period 3 (6 Months)|Adverse Event|0|||
164348837|NCT01169493|593655334|FG001|Period 3 (6 Months)|Adverse Event|1|||
164348838|NCT01169493|593655335|FG002|Period 3 (6 Months)|Adverse Event|0|||
164435851|NCT03473743|593962099|FG002|Overall Study|Ongoing|6|||
164587827|NCT03241173|594516001|FG009|Overall Study|Death|5|||
164587828|NCT03241173|594516002|FG010|Overall Study|Death|4|||
164587829|NCT03241173|594516003|FG011|Overall Study|Death|3|||
164587830|NCT03241173|594516004|FG012|Overall Study|Death|0|||
164587831|NCT03241173|594516005|FG013|Overall Study|Death|0|||
164587832|NCT03241173|594516006|FG014|Overall Study|Death|0|||
164587833|NCT03241173|594515992|FG000|Overall Study|Withdrawal by Subject|0|||
164587834|NCT03241173|594515993|FG001|Overall Study|Withdrawal by Subject|0|||
164587835|NCT03241173|594515994|FG002|Overall Study|Withdrawal by Subject|1|||
164587836|NCT03241173|594515995|FG003|Overall Study|Withdrawal by Subject|0|||
164587837|NCT03241173|594515996|FG004|Overall Study|Withdrawal by Subject|0|||
164298862|NCT03175367|593471170|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
164298863|NCT03175367|593471171|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
164348839|NCT01169493|593655336|FG003|Period 3 (6 Months)|Adverse Event|0|||
164348840|NCT01169493|593655337|FG004|Period 3 (6 Months)|Adverse Event|0|||
164348841|NCT01169493|593655338|FG005|Period 3 (6 Months)|Adverse Event|0|||
164348842|NCT01169493|593655333|FG000|Period 3 (6 Months)|Physician Decision|0|||
164348843|NCT01169493|593655334|FG001|Period 3 (6 Months)|Physician Decision|1|||
164348844|NCT01169493|593655335|FG002|Period 3 (6 Months)|Physician Decision|1|||
164348845|NCT01169493|593655336|FG003|Period 3 (6 Months)|Physician Decision|0|||
164348846|NCT01169493|593655337|FG004|Period 3 (6 Months)|Physician Decision|0|||
164348847|NCT01169493|593655338|FG005|Period 3 (6 Months)|Physician Decision|0|||
164348848|NCT03018704|593655343|FG000|Overall Study|Lost to Follow-up|1|||
164348849|NCT03018704|593655344|FG001|Overall Study|Lost to Follow-up|1|||
164348850|NCT00320411|593655345|FG000|Overall Study|No investigational product admin.|4|||
164348851|NCT04448171|593655348|FG000|Overall Study|Procedure Cancelled|1|||
164348852|NCT04448171|593655349|FG001|Overall Study|Procedure Cancelled|0|||
164348853|NCT04448171|593655348|FG000|Overall Study|Protocol Violation|1|||
164348854|NCT04448171|593655349|FG001|Overall Study|Protocol Violation|0|||
164348855|NCT02088047|593655350|FG000|Overall Study|Withdrawal by Subject|1|||
164348856|NCT02088047|593655351|FG001|Overall Study|Withdrawal by Subject|0|||
164348857|NCT00211809|593655354|FG000|Overall Study|Lack of Efficacy|1|||
164348858|NCT00211809|593655354|FG000|Overall Study|Lost to Follow-up|2|||
164435852|NCT03473743|593962100|FG003|Overall Study|Ongoing|8|||
164435853|NCT03473743|593962101|FG004|Overall Study|Ongoing|1|||
164435854|NCT03473743|593962102|FG005|Overall Study|Ongoing|1|||
164435855|NCT03473743|593962103|FG006|Overall Study|Ongoing|22|||
164435856|NCT03473743|593962104|FG007|Overall Study|Ongoing|24|||
164435857|NCT03473743|593962097|FG000|Overall Study|Randomized but not treated|0|||
164435858|NCT03473743|593962098|FG001|Overall Study|Randomized but not treated|0|||
164435859|NCT03473743|593962099|FG002|Overall Study|Randomized but not treated|0|||
164587838|NCT03241173|594515997|FG005|Overall Study|Withdrawal by Subject|1|||
164587839|NCT03241173|594515998|FG006|Overall Study|Withdrawal by Subject|0|||
164348859|NCT00211809|593655354|FG000|Overall Study|Pregnancy|1|||
164348860|NCT00211809|593655354|FG000|Overall Study|side effects|2|||
164348861|NCT01417234|593655355|FG000|Overall Study|Subject non-compliant|3|||
164348862|NCT00023764|593655356|FG000|Overall Study|Other|1|||
164348863|NCT00023764|593655356|FG000|Overall Study|Adverse Event|4|||
164348864|NCT00023764|593655356|FG000|Overall Study|Withdrawal by Subject|1|||
164348865|NCT00023764|593655356|FG000|Overall Study|Progression of disease|6|||
164348866|NCT00023764|593655356|FG000|Overall Study|patient received other treatment|1|||
164348867|NCT00023764|593655356|FG000|Overall Study|delay in obtaining staging images|1|||
164348868|NCT01537393|593655357|FG000|Overall Study|Exclude prior to study|32|||
164348869|NCT01537393|593655358|FG001|Overall Study|Exclude prior to study|44|||
164348870|NCT01537393|593655357|FG000|Overall Study|Death|20|||
164348871|NCT01537393|593655358|FG001|Overall Study|Death|32|||
164348872|NCT01537393|593655357|FG000|Overall Study|Withdrawal by Subject|18|||
164348873|NCT01537393|593655358|FG001|Overall Study|Withdrawal by Subject|17|||
164348874|NCT01537393|593655357|FG000|Overall Study|Lost to Follow-up|53|||
164348875|NCT01537393|593655358|FG001|Overall Study|Lost to Follow-up|48|||
164348876|NCT01537393|593655357|FG000|Overall Study|Failure - Regrafted|28|||
164298864|NCT03175367|593471172|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
164348877|NCT01537393|593655358|FG001|Overall Study|Failure - Regrafted|43|||
164435860|NCT03473743|593962100|FG003|Overall Study|Randomized but not treated|0|||
164587840|NCT03241173|594515999|FG007|Overall Study|Withdrawal by Subject|0|||
164587841|NCT03241173|594516000|FG008|Overall Study|Withdrawal by Subject|0|||
164298865|NCT03175367|593471173|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
164298866|NCT03175367|593471174|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
164298867|NCT03175367|593471175|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
164298868|NCT03175367|593471169|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
164298869|NCT03175367|593471170|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
164298870|NCT03175367|593471171|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
164348878|NCT01537393|593655357|FG000|Overall Study|Failure - Not regrafted|2|||
164348879|NCT01537393|593655358|FG001|Overall Study|Failure - Not regrafted|6|||
164348880|NCT01537393|593655357|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
164435861|NCT03473743|593962101|FG004|Overall Study|Randomized but not treated|0|||
164348881|NCT01537393|593655358|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
164348882|NCT00459953|593655360|FG000|Overall Study|not analyzed-household member in study|1|||
164348883|NCT00459953|593655361|FG001|Overall Study|not analyzed-household member in study|1|||
164348884|NCT00036270|593655364|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
164348885|NCT00036270|593655365|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
164348886|NCT00036270|593655364|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
164348887|NCT00036270|593655365|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
164348888|NCT00036270|593655364|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
164348889|NCT00036270|593655365|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
164348890|NCT00036270|593655364|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
164348891|NCT00036270|593655365|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
164348892|NCT00036270|593655364|FG000|Study Treatment to 5 Year Report|Other|277|||
164348893|NCT00036270|593655365|FG001|Study Treatment to 5 Year Report|Other|288|||
164348894|NCT00036270|593655364|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
164348895|NCT00036270|593655365|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
164348896|NCT00036270|593655364|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
164348897|NCT00036270|593655365|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
164348898|NCT00036270|593655364|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
164348899|NCT00036270|593655365|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
164348900|NCT00036270|593655364|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
164348901|NCT00036270|593655365|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
164348902|NCT00036270|593655364|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
164348903|NCT00036270|593655365|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
164348904|NCT00036270|593655364|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
164348905|NCT00036270|593655365|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
164348906|NCT00496470|593655366|FG000|Overall Study|Adverse Event|8|||
164348907|NCT00496470|593655367|FG001|Overall Study|Adverse Event|10|||
164348908|NCT00496470|593655366|FG000|Overall Study|Withdrawal by Subject|5|||
164348909|NCT00496470|593655367|FG001|Overall Study|Withdrawal by Subject|12|||
164348910|NCT00496470|593655366|FG000|Overall Study|Incorrectly enrolled|13|||
164348911|NCT00496470|593655367|FG001|Overall Study|Incorrectly enrolled|5|||
164348912|NCT00496470|593655366|FG000|Overall Study|Other reason|0|||
164348913|NCT00496470|593655367|FG001|Overall Study|Other reason|2|||
164348914|NCT01370356|593655368|FG000|Overall Study|Death|1|||
164348915|NCT01370356|593655369|FG001|Overall Study|Death|0|||
164348916|NCT01370356|593655368|FG000|Overall Study|Lack of Efficacy|6|||
164348917|NCT01370356|593655369|FG001|Overall Study|Lack of Efficacy|28|||
164348918|NCT01370356|593655368|FG000|Overall Study|Lost to Follow-up|76|||
164348919|NCT01370356|593655369|FG001|Overall Study|Lost to Follow-up|81|||
164348920|NCT01370356|593655368|FG000|Overall Study|Withdrawal by Subject|54|||
164348921|NCT01370356|593655369|FG001|Overall Study|Withdrawal by Subject|59|||
164348922|NCT01370356|593655368|FG000|Overall Study|Reason not specified|39|||
164348923|NCT01370356|593655369|FG001|Overall Study|Reason not specified|43|||
164348924|NCT01370356|593655368|FG000|Overall Study|Protocol Violation|3|||
164348925|NCT01370356|593655369|FG001|Overall Study|Protocol Violation|3|||
164348926|NCT01370356|593655368|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
164348927|NCT01370356|593655369|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
164348928|NCT01370356|593655368|FG000|Overall Study|AE Not Related to Study Drug|1|||
164348929|NCT01370356|593655369|FG001|Overall Study|AE Not Related to Study Drug|4|||
164348930|NCT00799422|593655377|FG000|First Week of Wear|Lost to Follow-up|0|||
164348931|NCT00799422|593655378|FG001|First Week of Wear|Lost to Follow-up|0|||
164348932|NCT00799422|593655379|FG002|First Week of Wear|Lost to Follow-up|1|||
164348933|NCT00799422|593655380|FG003|First Week of Wear|Lost to Follow-up|0|||
164348934|NCT00799422|593655381|FG004|First Week of Wear|Lost to Follow-up|0|||
164348935|NCT00799422|593655382|FG005|First Week of Wear|Lost to Follow-up|0|||
164348936|NCT00799422|593655377|FG000|First Week of Wear|Adverse Event|0|||
164348937|NCT00799422|593655378|FG001|First Week of Wear|Adverse Event|0|||
164435862|NCT03473743|593962102|FG005|Overall Study|Randomized but not treated|0|||
164435863|NCT03473743|593962103|FG006|Overall Study|Randomized but not treated|1|||
164435864|NCT03473743|593962104|FG007|Overall Study|Randomized but not treated|1|||
164348938|NCT00799422|593655379|FG002|First Week of Wear|Adverse Event|0|||
164348939|NCT00799422|593655380|FG003|First Week of Wear|Adverse Event|1|||
164348940|NCT00799422|593655381|FG004|First Week of Wear|Adverse Event|0|||
164348941|NCT00799422|593655382|FG005|First Week of Wear|Adverse Event|0|||
164348942|NCT01496612|593655383|FG000|1st Intervention|Adverse Event|1|||
164435865|NCT02864992|593962105|FG000|Overall Study|still on treatment|15|||
164348943|NCT01496612|593655384|FG001|1st Intervention|Adverse Event|0|||
164348944|NCT01496612|593655383|FG000|1st Intervention|Withdrawal by Subject|1|||
164435866|NCT02864992|593962106|FG001|Overall Study|still on treatment|1|||
164348945|NCT01496612|593655384|FG001|1st Intervention|Withdrawal by Subject|0|||
164348946|NCT03129100|593655386|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
164348947|NCT03129100|593655387|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
164435867|NCT02864992|593962107|FG002|Overall Study|still on treatment|33|||
164348948|NCT03129100|593655388|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
164348949|NCT03129100|593655389|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
164348950|NCT03129100|593655390|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
164348951|NCT03129100|593655391|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
164348952|NCT03129100|593655392|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
164348953|NCT03129100|593655393|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
164348954|NCT03129100|593655394|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
164348955|NCT03129100|593655395|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
164348956|NCT03129100|593655396|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
164348957|NCT03129100|593655397|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
164348958|NCT03129100|593655398|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
164348959|NCT03129100|593655399|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
164435868|NCT04536077|593962109|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
164435869|NCT04536077|593962110|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
164435870|NCT04536077|593962109|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
164435871|NCT04536077|593962110|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
164435872|NCT04948333|593962111|FG000|Overall Study|Adverse Event|6|||
164435873|NCT04948333|593962112|FG001|Overall Study|Adverse Event|4|||
164435874|NCT04948333|593962113|FG002|Overall Study|Adverse Event|0|||
164435875|NCT04948333|593962114|FG003|Overall Study|Adverse Event|2|||
164435876|NCT04948333|593962111|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
164435877|NCT04948333|593962112|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
164435878|NCT04948333|593962113|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
164435879|NCT04948333|593962114|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
164435880|NCT04948333|593962111|FG000|Overall Study|Progressive Disease|1|||
164435881|NCT04948333|593962112|FG001|Overall Study|Progressive Disease|5|||
164435882|NCT04948333|593962113|FG002|Overall Study|Progressive Disease|0|||
164435883|NCT04948333|593962114|FG003|Overall Study|Progressive Disease|0|||
164435884|NCT04948333|593962111|FG000|Overall Study|Physician Decision|2|||
164435885|NCT04948333|593962112|FG001|Overall Study|Physician Decision|2|||
164435886|NCT04948333|593962113|FG002|Overall Study|Physician Decision|0|||
164435887|NCT04948333|593962114|FG003|Overall Study|Physician Decision|0|||
164435888|NCT04948333|593962111|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
164435889|NCT04948333|593962112|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
164435890|NCT04948333|593962113|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
164435891|NCT04948333|593962114|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
164435892|NCT04948333|593962111|FG000|Overall Study|Withdrawal by Subject|2|||
164435893|NCT04948333|593962112|FG001|Overall Study|Withdrawal by Subject|0|||
164435894|NCT04948333|593962113|FG002|Overall Study|Withdrawal by Subject|0|||
164435895|NCT04948333|593962114|FG003|Overall Study|Withdrawal by Subject|1|||
164435896|NCT04948333|593962111|FG000|Overall Study|Protocol Violation|0|||
164435897|NCT04948333|593962112|FG001|Overall Study|Protocol Violation|1|||
164435898|NCT04948333|593962113|FG002|Overall Study|Protocol Violation|0|||
164435899|NCT04948333|593962114|FG003|Overall Study|Protocol Violation|0|||
164435900|NCT04948333|593962111|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
164348960|NCT03129100|593655400|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
164348961|NCT03129100|593655401|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
164348962|NCT03129100|593655402|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
164348963|NCT03129100|593655403|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
164435901|NCT04948333|593962112|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
164435902|NCT04948333|593962113|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
164435903|NCT04948333|593962114|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
164435904|NCT03805295|593962116|FG000|Overall Study|Lost to Follow-up|17|||
164435905|NCT03805295|593962117|FG001|Overall Study|Lost to Follow-up|43|||
164435906|NCT00539591|593962118|FG000|Overall Study|Toxicity|3|||
164435907|NCT00539591|593962119|FG001|Overall Study|Toxicity|0|||
164435908|NCT00539591|593962120|FG002|Overall Study|Toxicity|0|||
164435909|NCT00539591|593962118|FG000|Overall Study|Disease progression|2|||
164435910|NCT00539591|593962119|FG001|Overall Study|Disease progression|2|||
164435911|NCT00539591|593962120|FG002|Overall Study|Disease progression|3|||
164435912|NCT04305912|593962122|FG000|First Intervention|COVID-19 Suspension|2|||
164435913|NCT04305912|593962123|FG001|First Intervention|COVID-19 Suspension|0|||
164435914|NCT04305912|593962122|FG000|First Intervention|Withdrawal by Subject|0|||
164435915|NCT04305912|593962123|FG001|First Intervention|Withdrawal by Subject|1|||
164435916|NCT04305912|593962122|FG000|Second Intervention|Adverse Event|0|||
164435917|NCT04305912|593962123|FG001|Second Intervention|Adverse Event|1|||
164348964|NCT03129100|593655404|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
164348965|NCT03129100|593655405|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
164348966|NCT03129100|593655406|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
164435918|NCT04538664|593962127|FG000|Overall Study|Withdrawal by Subject|5|||
164348967|NCT03129100|593655407|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
164348968|NCT03129100|593655408|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
164435919|NCT04538664|593962128|FG001|Overall Study|Withdrawal by Subject|9|||
164435920|NCT04538664|593962127|FG000|Overall Study|Lost to Follow-up|2|||
164587842|NCT03241173|594516001|FG009|Overall Study|Withdrawal by Subject|0|||
164587843|NCT03241173|594516002|FG010|Overall Study|Withdrawal by Subject|0|||
164587844|NCT03241173|594516003|FG011|Overall Study|Withdrawal by Subject|0|||
164587845|NCT03241173|594516004|FG012|Overall Study|Withdrawal by Subject|0|||
164587846|NCT03241173|594516005|FG013|Overall Study|Withdrawal by Subject|0|||
164587847|NCT03241173|594516006|FG014|Overall Study|Withdrawal by Subject|0|||
164587848|NCT03241173|594515992|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
164587849|NCT03241173|594515993|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
164587850|NCT03241173|594515994|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
164587851|NCT03241173|594515995|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
164587852|NCT03241173|594515996|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
164587853|NCT03241173|594515997|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
164587854|NCT03241173|594515998|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
164587855|NCT03241173|594515999|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
164587856|NCT03241173|594516000|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
164587857|NCT03241173|594516001|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
164587858|NCT03241173|594516002|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
164587859|NCT03241173|594516003|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
164587860|NCT03241173|594516004|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
164587861|NCT03241173|594516005|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
164587862|NCT03241173|594516006|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
164587863|NCT03241173|594515992|FG000|Overall Study|Lost to Follow-up|0|||
164587864|NCT03241173|594515993|FG001|Overall Study|Lost to Follow-up|0|||
164587865|NCT03241173|594515994|FG002|Overall Study|Lost to Follow-up|0|||
164587866|NCT03241173|594515995|FG003|Overall Study|Lost to Follow-up|0|||
164587867|NCT03241173|594515996|FG004|Overall Study|Lost to Follow-up|1|||
164587868|NCT03241173|594515997|FG005|Overall Study|Lost to Follow-up|0|||
164587869|NCT03241173|594515998|FG006|Overall Study|Lost to Follow-up|0|||
164587870|NCT03241173|594515999|FG007|Overall Study|Lost to Follow-up|0|||
164298871|NCT03175367|593471172|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
164587871|NCT03241173|594516000|FG008|Overall Study|Lost to Follow-up|0|||
164587872|NCT03241173|594516001|FG009|Overall Study|Lost to Follow-up|1|||
164587873|NCT03241173|594516002|FG010|Overall Study|Lost to Follow-up|0|||
164587874|NCT03241173|594516003|FG011|Overall Study|Lost to Follow-up|0|||
164587875|NCT03241173|594516004|FG012|Overall Study|Lost to Follow-up|0|||
164587876|NCT03241173|594516005|FG013|Overall Study|Lost to Follow-up|0|||
164587877|NCT03241173|594516006|FG014|Overall Study|Lost to Follow-up|0|||
164587878|NCT00515463|594516011|FG000|Overall Study|Physician Decision|4|||
164587879|NCT00515463|594516012|FG001|Overall Study|Physician Decision|2|||
164298872|NCT03175367|593471173|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
164298873|NCT03175367|593471174|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
164298874|NCT03175367|593471175|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
164298875|NCT03175367|593471169|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
164298876|NCT03175367|593471170|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
164298877|NCT03175367|593471171|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
164298878|NCT03175367|593471172|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
164298879|NCT03175367|593471173|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
164298880|NCT03175367|593471174|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
164298881|NCT03175367|593471175|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
164298882|NCT03175367|593471169|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
164298883|NCT03175367|593471170|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
164298884|NCT03175367|593471171|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
164298885|NCT03175367|593471172|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
164298886|NCT03175367|593471173|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
164298887|NCT03175367|593471174|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
164298888|NCT03175367|593471175|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
164298889|NCT03175367|593471169|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
164298890|NCT03175367|593471170|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
164298891|NCT03175367|593471171|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
164298892|NCT03175367|593471172|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
164298893|NCT03175367|593471173|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
164298894|NCT03175367|593471174|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
164298895|NCT03175367|593471175|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
164298896|NCT02851615|593471176|FG000|Overall Study|Cognitive Issue|1|||
164298897|NCT02851615|593471177|FG001|Overall Study|Cognitive Issue|0|||
164298898|NCT02851615|593471176|FG000|Overall Study|Lost to Follow-up|0|||
164298899|NCT02851615|593471177|FG001|Overall Study|Lost to Follow-up|4|||
164298900|NCT02345070|593471179|FG000|Overall Study|Adverse Event|12|||
164298901|NCT02345070|593471180|FG001|Overall Study|Adverse Event|8|||
164298902|NCT02345070|593471181|FG002|Overall Study|Adverse Event|16|||
164693787|NCT05068284|594899432|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
164693788|NCT05068284|594899433|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
164693789|NCT05068284|594899434|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
164693790|NCT05068284|594899435|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
164693791|NCT05068284|594899436|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
164693792|NCT05068284|594899437|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
164693793|NCT05068284|594899438|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
164693794|NCT05068284|594899431|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
164693795|NCT05068284|594899432|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
164693796|NCT05068284|594899433|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
164348969|NCT03129100|593655409|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
164348970|NCT03129100|593655410|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
164348971|NCT03129100|593655411|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
164348972|NCT03129100|593655386|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
164348973|NCT03129100|593655387|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348974|NCT03129100|593655388|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348975|NCT03129100|593655389|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348976|NCT03129100|593655390|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348977|NCT03129100|593655391|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348978|NCT03129100|593655392|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348979|NCT03129100|593655393|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348980|NCT03129100|593655394|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348981|NCT03129100|593655395|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348982|NCT03129100|593655396|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348983|NCT03129100|593655397|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348984|NCT03129100|593655398|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348985|NCT03129100|593655399|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348986|NCT03129100|593655400|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348987|NCT03129100|593655401|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348988|NCT03129100|593655402|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348989|NCT03129100|593655403|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348990|NCT03129100|593655404|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348991|NCT03129100|593655405|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164298903|NCT02345070|593471179|FG000|Overall Study|Poor compliance to protocol|2|||
164298904|NCT02345070|593471180|FG001|Overall Study|Poor compliance to protocol|0|||
164298905|NCT02345070|593471181|FG002|Overall Study|Poor compliance to protocol|0|||
164298906|NCT02345070|593471179|FG000|Overall Study|Other than specified above|6|||
164298907|NCT02345070|593471180|FG001|Overall Study|Other than specified above|3|||
164298908|NCT02345070|593471181|FG002|Overall Study|Other than specified above|7|||
164298909|NCT02151058|593471182|FG000|Overall Study|Withdrawal by Subject|1|||
164298910|NCT02151058|593471183|FG001|Overall Study|Withdrawal by Subject|1|||
164298911|NCT02151058|593471184|FG002|Overall Study|Withdrawal by Subject|3|||
164298912|NCT02151058|593471182|FG000|Overall Study|Lost to Follow-up|1|||
164298913|NCT02151058|593471183|FG001|Overall Study|Lost to Follow-up|0|||
164298914|NCT02151058|593471184|FG002|Overall Study|Lost to Follow-up|2|||
164298915|NCT00321620|593471186|FG000|Overall Study|Death|269|||
164298916|NCT00321620|593471187|FG001|Overall Study|Death|294|||
164298917|NCT00321620|593471186|FG000|Overall Study|Withdrawal by Subject|164|||
164298918|NCT00321620|593471187|FG001|Overall Study|Withdrawal by Subject|147|||
164298919|NCT00321620|593471186|FG000|Overall Study|Disease progression|113|||
164298920|NCT00321620|593471187|FG001|Overall Study|Disease progression|117|||
164298921|NCT00321620|593471186|FG000|Overall Study|Adverse Event|43|||
164298922|NCT00321620|593471187|FG001|Overall Study|Adverse Event|56|||
164298923|NCT00321620|593471186|FG000|Overall Study|Lost to Follow-up|13|||
164298924|NCT00321620|593471187|FG001|Overall Study|Lost to Follow-up|9|||
164298925|NCT00321620|593471186|FG000|Overall Study|Physician Decision|4|||
164298926|NCT00321620|593471187|FG001|Overall Study|Physician Decision|1|||
164298927|NCT00321620|593471186|FG000|Overall Study|Noncompliance|14|||
164298928|NCT00321620|593471187|FG001|Overall Study|Noncompliance|7|||
164298929|NCT00321620|593471186|FG000|Overall Study|Protocol deviation|4|||
164298930|NCT00321620|593471187|FG001|Overall Study|Protocol deviation|3|||
164298931|NCT00321620|593471186|FG000|Overall Study|Ineligibility determined|2|||
164298932|NCT00321620|593471187|FG001|Overall Study|Ineligibility determined|3|||
164298933|NCT00321620|593471186|FG000|Overall Study|Participant request|75|||
164298934|NCT00321620|593471187|FG001|Overall Study|Participant request|52|||
164298935|NCT00321620|593471186|FG000|Overall Study|Other|42|||
164298936|NCT00321620|593471187|FG001|Overall Study|Other|33|||
164298937|NCT03337477|593471188|FG000|Overall Study|not categorized into the listed ones|11|||
164435921|NCT04538664|593962128|FG001|Overall Study|Lost to Follow-up|1|||
164435922|NCT04538664|593962127|FG000|Overall Study|Ongoing|106|||
164435923|NCT04538664|593962128|FG001|Overall Study|Ongoing|115|||
164435924|NCT03681678|593962131|FG000|Overall Study|Lost to Follow-up|20|||
164435925|NCT00828945|593962134|FG000|Overall Study|Death|4|||
164435926|NCT00828945|593962134|FG000|Overall Study|Participant was missing|1|||
164435927|NCT00828945|593962134|FG000|Overall Study|Other|36|||
164435928|NCT03431350|593962135|FG000|Overall Study|ONGOING|0|||
164435929|NCT03431350|593962136|FG001|Overall Study|ONGOING|0|||
164435930|NCT03431350|593962137|FG002|Overall Study|ONGOING|2|||
164435931|NCT03431350|593962138|FG003|Overall Study|ONGOING|0|||
164435932|NCT03431350|593962139|FG004|Overall Study|ONGOING|1|||
164435933|NCT03431350|593962140|FG005|Overall Study|ONGOING|3|||
164435934|NCT03431350|593962141|FG006|Overall Study|ONGOING|0|||
164435935|NCT03431350|593962142|FG007|Overall Study|ONGOING|1|||
164435936|NCT03431350|593962143|FG008|Overall Study|ONGOING|3|||
164435937|NCT03431350|593962144|FG009|Overall Study|ONGOING|4|||
164435938|NCT03431350|593962145|FG010|Overall Study|ONGOING|2|||
164435939|NCT03431350|593962146|FG011|Overall Study|ONGOING|1|||
164435940|NCT03431350|593962135|FG000|Overall Study|Death|6|||
164435941|NCT03431350|593962136|FG001|Overall Study|Death|5|||
164435942|NCT03431350|593962137|FG002|Overall Study|Death|18|||
164435943|NCT03431350|593962138|FG003|Overall Study|Death|7|||
164435944|NCT03431350|593962139|FG004|Overall Study|Death|4|||
164435945|NCT03431350|593962140|FG005|Overall Study|Death|3|||
164435946|NCT03431350|593962141|FG006|Overall Study|Death|2|||
164435947|NCT03431350|593962142|FG007|Overall Study|Death|0|||
164435948|NCT03431350|593962143|FG008|Overall Study|Death|0|||
164435949|NCT03431350|593962144|FG009|Overall Study|Death|0|||
164435950|NCT03431350|593962145|FG010|Overall Study|Death|4|||
164435951|NCT03431350|593962146|FG011|Overall Study|Death|0|||
164435952|NCT03431350|593962135|FG000|Overall Study|Lost to Follow-up|0|||
164435953|NCT03431350|593962136|FG001|Overall Study|Lost to Follow-up|1|||
164435954|NCT03431350|593962137|FG002|Overall Study|Lost to Follow-up|0|||
164435955|NCT03431350|593962138|FG003|Overall Study|Lost to Follow-up|0|||
164435956|NCT03431350|593962139|FG004|Overall Study|Lost to Follow-up|0|||
164435957|NCT03431350|593962140|FG005|Overall Study|Lost to Follow-up|0|||
164435958|NCT03431350|593962141|FG006|Overall Study|Lost to Follow-up|0|||
164435959|NCT03431350|593962142|FG007|Overall Study|Lost to Follow-up|0|||
164435960|NCT03431350|593962143|FG008|Overall Study|Lost to Follow-up|0|||
164435961|NCT03431350|593962144|FG009|Overall Study|Lost to Follow-up|0|||
164435962|NCT03431350|593962145|FG010|Overall Study|Lost to Follow-up|0|||
164435963|NCT03431350|593962146|FG011|Overall Study|Lost to Follow-up|0|||
164435964|NCT03431350|593962135|FG000|Overall Study|Withdrawal by Subject|0|||
164435965|NCT03431350|593962136|FG001|Overall Study|Withdrawal by Subject|0|||
164435966|NCT03431350|593962137|FG002|Overall Study|Withdrawal by Subject|0|||
164435967|NCT03431350|593962138|FG003|Overall Study|Withdrawal by Subject|1|||
164435968|NCT03431350|593962139|FG004|Overall Study|Withdrawal by Subject|1|||
164435969|NCT03431350|593962140|FG005|Overall Study|Withdrawal by Subject|1|||
164435970|NCT03431350|593962141|FG006|Overall Study|Withdrawal by Subject|0|||
164435971|NCT03431350|593962142|FG007|Overall Study|Withdrawal by Subject|0|||
164435972|NCT03431350|593962143|FG008|Overall Study|Withdrawal by Subject|0|||
164587880|NCT00515463|594516011|FG000|Overall Study|Adverse Event|1|||
164587881|NCT00515463|594516012|FG001|Overall Study|Adverse Event|2|||
164587882|NCT00515463|594516011|FG000|Overall Study|Withdrawal by Subject|3|||
164587883|NCT00515463|594516012|FG001|Overall Study|Withdrawal by Subject|4|||
164587884|NCT00515463|594516011|FG000|Overall Study|Lost to Follow-up|6|||
164587885|NCT00515463|594516012|FG001|Overall Study|Lost to Follow-up|5|||
164587886|NCT00515463|594516011|FG000|Overall Study|Other|0|||
164587887|NCT00515463|594516012|FG001|Overall Study|Other|1|||
164587888|NCT01903434|594516013|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
164587889|NCT01903434|594516014|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
164587890|NCT01903434|594516013|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
164587891|NCT01903434|594516014|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
164587892|NCT01118143|594516017|FG000|Overall Study|Withdrawal by Subject|2|||
164587893|NCT01118143|594516018|FG001|Overall Study|Withdrawal by Subject|5|||
164435973|NCT03431350|593962144|FG009|Overall Study|Withdrawal by Subject|2|||
164435974|NCT03431350|593962145|FG010|Overall Study|Withdrawal by Subject|0|||
164435975|NCT03431350|593962146|FG011|Overall Study|Withdrawal by Subject|1|||
164435976|NCT03431350|593962135|FG000|Overall Study|Other|0|||
164435977|NCT03431350|593962136|FG001|Overall Study|Other|0|||
164435978|NCT03431350|593962137|FG002|Overall Study|Other|1|||
164435979|NCT03431350|593962138|FG003|Overall Study|Other|3|||
164435980|NCT03431350|593962139|FG004|Overall Study|Other|2|||
164435981|NCT03431350|593962140|FG005|Overall Study|Other|2|||
164435982|NCT03431350|593962141|FG006|Overall Study|Other|4|||
164435983|NCT03431350|593962142|FG007|Overall Study|Other|0|||
164435984|NCT03431350|593962143|FG008|Overall Study|Other|14|||
164435985|NCT03431350|593962144|FG009|Overall Study|Other|11|||
164587894|NCT01158534|594517431|FG000|Overall Study|Withdrawal by Subject|1|||
164587895|NCT01158534|594517431|FG000|Overall Study|Death|1|||
164435986|NCT03431350|593962145|FG010|Overall Study|Other|11|||
164435987|NCT03431350|593962146|FG011|Overall Study|Other|15|||
164435988|NCT02141074|593962149|FG000|Pre-prophylaxis|Adverse Event|3|||
164435989|NCT02141074|593962150|FG001|Pre-prophylaxis|Adverse Event|0|||
164435990|NCT02141074|593962149|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
164435991|NCT02141074|593962150|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
164693797|NCT05068284|594899434|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
164693798|NCT05068284|594899435|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
164693799|NCT05068284|594899436|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
164435992|NCT02141074|593962149|FG000|Prophylaxis|Adverse Event|0|||
164435993|NCT02141074|593962150|FG001|Prophylaxis|Adverse Event|4|||
164435994|NCT02141074|593962149|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
164435995|NCT02141074|593962150|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
164693800|NCT05068284|594899437|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
164693801|NCT05068284|594899438|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
164693802|NCT05068284|594899431|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
164693803|NCT05068284|594899432|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
164693804|NCT05068284|594899433|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
164693805|NCT05068284|594899434|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
164693806|NCT05068284|594899435|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
164693807|NCT05068284|594899436|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
164435996|NCT02141074|593962149|FG000|Prophylaxis|Withdrawal by Subject|0|||
164435997|NCT02141074|593962150|FG001|Prophylaxis|Withdrawal by Subject|1|||
164435998|NCT03563053|593962151|FG000|Overall Study|Withdrawal by Subject|17|||
164435999|NCT03563053|593962151|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
164436000|NCT03563053|593962151|FG000|Overall Study|Adverse Event|3|||
164436001|NCT03563053|593962151|FG000|Overall Study|Physician Decision|1|||
164436002|NCT03563053|593962151|FG000|Overall Study|study terminated by sponsor|71|||
164436003|NCT04487080|593962155|FG000|Overall Study|Withdrawal by Subject|19|||
164436004|NCT04487080|593962156|FG001|Overall Study|Withdrawal by Subject|18|||
164436005|NCT04487080|593962157|FG002|Overall Study|Withdrawal by Subject|13|||
164436006|NCT04487080|593962155|FG000|Overall Study|Lost to Follow-up|3|||
164436007|NCT04487080|593962156|FG001|Overall Study|Lost to Follow-up|1|||
164436008|NCT04487080|593962157|FG002|Overall Study|Lost to Follow-up|0|||
164436009|NCT04487080|593962155|FG000|Overall Study|Ongoing|313|||
164436010|NCT04487080|593962156|FG001|Overall Study|Ongoing|297|||
164693808|NCT05068284|594899437|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
164693809|NCT05068284|594899438|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
164693810|NCT01546922|594901180|FG000|First Period of 10 Weeks|Protocol Violation|3|||
164693811|NCT01546922|594901181|FG001|First Period of 10 Weeks|Protocol Violation|1|||
164693812|NCT01546922|594901180|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
164693813|NCT01546922|594901181|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
164693814|NCT01546922|594901180|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
164348992|NCT03129100|593655406|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348993|NCT03129100|593655407|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348994|NCT03129100|593655408|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348995|NCT03129100|593655409|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348996|NCT03129100|593655410|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348997|NCT03129100|593655411|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348998|NCT03129100|593655386|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
164348999|NCT03129100|593655387|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
164349000|NCT03129100|593655388|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349001|NCT03129100|593655389|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349002|NCT03129100|593655390|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349003|NCT03129100|593655391|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349004|NCT03129100|593655392|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164436011|NCT04487080|593962157|FG002|Overall Study|Ongoing|149|||
164436012|NCT00470626|593963206|FG000|Overall Study|Lost to Follow-up|10|||
164436013|NCT00470626|593963206|FG000|Overall Study|Withdrawal by Subject|7|||
164436014|NCT00777556|593963207|FG000|Overall Study|Inappropriate self-selection|34|||
164436015|NCT00777556|593963207|FG000|Overall Study|Dispensed but did not use product|12|||
164436016|NCT00777556|593963207|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
164436017|NCT02930343|593963208|FG000|Overall Study|Lost to Follow-up|9|||
164693815|NCT01546922|594901181|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
164436018|NCT02930343|593963209|FG001|Overall Study|Lost to Follow-up|7|||
164436019|NCT00486759|593963210|FG000|Treatment|Adverse event/intercurrent illness|86|||
164436020|NCT00486759|593963211|FG001|Treatment|Adverse event/intercurrent illness|39|||
164436021|NCT00486759|593963210|FG000|Treatment|Insufficient therapeutic response|37|||
164436022|NCT00486759|593963211|FG001|Treatment|Insufficient therapeutic response|39|||
164436023|NCT00486759|593963210|FG000|Treatment|Death|17|||
164436024|NCT00486759|593963211|FG001|Treatment|Death|10|||
164436025|NCT00486759|593963210|FG000|Treatment|Withdrew consent|15|||
164436026|NCT00486759|593963211|FG001|Treatment|Withdrew consent|12|||
164436027|NCT00486759|593963210|FG000|Treatment|Administrative/reason not specified|17|||
164349005|NCT03129100|593655393|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349006|NCT03129100|593655394|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349007|NCT03129100|593655395|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349008|NCT03129100|593655396|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349009|NCT03129100|593655397|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349010|NCT03129100|593655398|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349011|NCT03129100|593655399|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349012|NCT03129100|593655400|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349013|NCT03129100|593655401|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349014|NCT03129100|593655402|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349015|NCT03129100|593655403|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349016|NCT03129100|593655404|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349017|NCT03129100|593655405|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349018|NCT03129100|593655406|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349019|NCT03129100|593655407|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349020|NCT03129100|593655408|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349021|NCT03129100|593655409|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349022|NCT03129100|593655410|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349023|NCT03129100|593655411|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349024|NCT03129100|593655386|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
164349025|NCT03129100|593655387|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
164349026|NCT03129100|593655388|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349027|NCT03129100|593655389|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349028|NCT03129100|593655390|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349029|NCT03129100|593655391|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349030|NCT03129100|593655392|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349031|NCT03129100|593655393|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349032|NCT03129100|593655394|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349033|NCT03129100|593655395|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349034|NCT03129100|593655396|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349035|NCT03129100|593655397|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349036|NCT03129100|593655398|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349037|NCT03129100|593655399|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349038|NCT03129100|593655400|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349039|NCT03129100|593655401|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349040|NCT03129100|593655402|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349041|NCT03129100|593655403|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349042|NCT03129100|593655404|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349043|NCT03129100|593655405|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349044|NCT03129100|593655406|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349045|NCT03129100|593655407|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349046|NCT03129100|593655408|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349047|NCT03129100|593655409|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349048|NCT03129100|593655410|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349049|NCT03129100|593655411|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349050|NCT03129100|593655386|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349051|NCT03129100|593655387|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
164349052|NCT03129100|593655388|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349053|NCT03129100|593655389|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349054|NCT03129100|593655390|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349055|NCT03129100|593655391|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349056|NCT03129100|593655392|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349057|NCT03129100|593655393|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349058|NCT03129100|593655394|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349059|NCT03129100|593655395|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349060|NCT03129100|593655396|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349061|NCT03129100|593655397|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349062|NCT03129100|593655398|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349063|NCT03129100|593655399|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349064|NCT03129100|593655400|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349065|NCT03129100|593655401|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349066|NCT03129100|593655402|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
164436028|NCT00486759|593963211|FG001|Treatment|Administrative/reason not specified|21|||
164436029|NCT00486759|593963210|FG000|Treatment|Refused treatment|10|||
164436030|NCT00486759|593963211|FG001|Treatment|Refused treatment|7|||
164436031|NCT00486759|593963210|FG000|Treatment|Violation of selection criteria at entry|3|||
164587896|NCT01158534|594517431|FG000|Overall Study|Other|1|||
164587897|NCT01115569|594517432|FG000|Conversion/Titration Phase|Adverse Event|59|||
164587898|NCT01115569|594517433|FG001|Conversion/Titration Phase|Adverse Event|0|||
164587899|NCT01115569|594517432|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
164587900|NCT01115569|594517433|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
164587901|NCT01115569|594517432|FG000|Conversion/Titration Phase|Physician Decision|5|||
164587902|NCT01115569|594517433|FG001|Conversion/Titration Phase|Physician Decision|0|||
164587903|NCT01115569|594517432|FG000|Conversion/Titration Phase|Protocol Violation|68|||
164587904|NCT01115569|594517433|FG001|Conversion/Titration Phase|Protocol Violation|0|||
164587905|NCT01115569|594517432|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
164587906|NCT01115569|594517433|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
164587907|NCT01115569|594517432|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
164587908|NCT01115569|594517433|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
164587909|NCT01115569|594517432|FG000|Maintenance Phase|Adverse Event|0|||
164587910|NCT01115569|594517433|FG001|Maintenance Phase|Adverse Event|43|||
164587911|NCT01115569|594517432|FG000|Maintenance Phase|Lost to Follow-up|0|||
164587912|NCT01115569|594517433|FG001|Maintenance Phase|Lost to Follow-up|8|||
164587913|NCT01115569|594517432|FG000|Maintenance Phase|Physician Decision|0|||
164587914|NCT01115569|594517433|FG001|Maintenance Phase|Physician Decision|3|||
164587915|NCT01115569|594517432|FG000|Maintenance Phase|Protocol Violation|0|||
164587916|NCT01115569|594517433|FG001|Maintenance Phase|Protocol Violation|9|||
164349067|NCT03129100|593655403|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349068|NCT03129100|593655404|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349069|NCT03129100|593655405|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349070|NCT03129100|593655406|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349071|NCT03129100|593655407|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349072|NCT03129100|593655408|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349073|NCT03129100|593655409|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349074|NCT03129100|593655410|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349075|NCT03129100|593655411|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349076|NCT03129100|593655386|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349077|NCT03129100|593655387|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349078|NCT03129100|593655388|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
164349079|NCT03129100|593655389|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
164349080|NCT03129100|593655390|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349081|NCT03129100|593655391|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
164349082|NCT03129100|593655392|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349083|NCT03129100|593655393|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349084|NCT03129100|593655394|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349085|NCT03129100|593655395|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349086|NCT03129100|593655396|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349087|NCT03129100|593655397|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349088|NCT03129100|593655398|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349089|NCT03129100|593655399|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349090|NCT03129100|593655400|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349091|NCT03129100|593655401|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349092|NCT03129100|593655402|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349093|NCT03129100|593655403|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349094|NCT03129100|593655404|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349095|NCT03129100|593655405|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349096|NCT03129100|593655406|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349097|NCT03129100|593655407|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349098|NCT03129100|593655408|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349099|NCT03129100|593655409|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349100|NCT03129100|593655410|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349101|NCT03129100|593655411|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349102|NCT03129100|593655386|FG000|Period2 Extension Period (Group A and B)|Death|0|||
164349103|NCT03129100|593655387|FG001|Period2 Extension Period (Group A and B)|Death|0|||
164349104|NCT03129100|593655388|FG002|Period2 Extension Period (Group A and B)|Death|1|||
164349105|NCT03129100|593655389|FG003|Period2 Extension Period (Group A and B)|Death|0|||
164349106|NCT03129100|593655390|FG004|Period2 Extension Period (Group A and B)|Death|0|||
164349107|NCT03129100|593655391|FG005|Period2 Extension Period (Group A and B)|Death|0|||
164349108|NCT03129100|593655392|FG006|Period2 Extension Period (Group A and B)|Death|0|||
164587917|NCT01115569|594517432|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164587918|NCT01115569|594517433|FG001|Maintenance Phase|Withdrawal by Subject|27|||
164587919|NCT01115569|594517432|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
164587920|NCT01115569|594517433|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
164587921|NCT01115569|594517432|FG000|Maintenance Phase|Administrative|0|||
164587922|NCT01115569|594517433|FG001|Maintenance Phase|Administrative|1|||
164436032|NCT00486759|593963211|FG001|Treatment|Violation of selection criteria at entry|3|||
164436033|NCT00486759|593963210|FG000|Treatment|Other protocol violation|1|||
164349109|NCT03129100|593655393|FG007|Period2 Extension Period (Group A and B)|Death|0|||
164349110|NCT03129100|593655394|FG008|Period2 Extension Period (Group A and B)|Death|0|||
164349111|NCT03129100|593655395|FG009|Period2 Extension Period (Group A and B)|Death|0|||
164349112|NCT03129100|593655396|FG010|Period2 Extension Period (Group A and B)|Death|0|||
164349113|NCT03129100|593655397|FG011|Period2 Extension Period (Group A and B)|Death|0|||
164349114|NCT03129100|593655398|FG012|Period2 Extension Period (Group A and B)|Death|0|||
164349115|NCT03129100|593655399|FG013|Period2 Extension Period (Group A and B)|Death|0|||
164349116|NCT03129100|593655400|FG014|Period2 Extension Period (Group A and B)|Death|0|||
164349117|NCT03129100|593655401|FG015|Period2 Extension Period (Group A and B)|Death|0|||
164349118|NCT03129100|593655402|FG016|Period2 Extension Period (Group A and B)|Death|0|||
164349119|NCT03129100|593655403|FG017|Period2 Extension Period (Group A and B)|Death|0|||
164349120|NCT03129100|593655404|FG018|Period2 Extension Period (Group A and B)|Death|0|||
164349121|NCT03129100|593655405|FG019|Period2 Extension Period (Group A and B)|Death|0|||
164349122|NCT03129100|593655406|FG020|Period2 Extension Period (Group A and B)|Death|0|||
164349123|NCT03129100|593655407|FG021|Period2 Extension Period (Group A and B)|Death|0|||
164349124|NCT03129100|593655408|FG022|Period2 Extension Period (Group A and B)|Death|0|||
164349125|NCT03129100|593655409|FG023|Period2 Extension Period (Group A and B)|Death|0|||
164349126|NCT03129100|593655410|FG024|Period2 Extension Period (Group A and B)|Death|0|||
164349127|NCT03129100|593655411|FG025|Period2 Extension Period (Group A and B)|Death|0|||
164349128|NCT03129100|593655386|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349129|NCT03129100|593655387|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349130|NCT03129100|593655388|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
164349131|NCT03129100|593655389|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
164349132|NCT03129100|593655390|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
164349133|NCT03129100|593655391|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
164349134|NCT03129100|593655392|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
164349135|NCT03129100|593655393|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349136|NCT03129100|593655394|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349137|NCT03129100|593655395|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349138|NCT03129100|593655396|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349139|NCT03129100|593655397|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349140|NCT03129100|593655398|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349141|NCT03129100|593655399|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349142|NCT03129100|593655400|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349143|NCT03129100|593655401|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349144|NCT03129100|593655402|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349145|NCT03129100|593655403|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349146|NCT03129100|593655404|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349147|NCT03129100|593655405|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349148|NCT03129100|593655406|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349149|NCT03129100|593655407|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349150|NCT03129100|593655408|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349151|NCT03129100|593655409|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349152|NCT03129100|593655410|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349153|NCT03129100|593655411|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349154|NCT03129100|593655386|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349155|NCT03129100|593655387|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349156|NCT03129100|593655388|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
164349157|NCT03129100|593655389|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349158|NCT03129100|593655390|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349159|NCT03129100|593655391|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349160|NCT03129100|593655392|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349161|NCT03129100|593655393|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349162|NCT03129100|593655394|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164436034|NCT00486759|593963211|FG001|Treatment|Other protocol violation|5|||
164436035|NCT00486759|593963210|FG000|Treatment|Failure to return|1|||
164436036|NCT00486759|593963211|FG001|Treatment|Failure to return|1|||
164436037|NCT00486759|593963210|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
164587923|NCT01614769|594517434|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
164587924|NCT01614769|594517435|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
164587925|NCT01614769|594517436|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
164587926|NCT01614769|594517437|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
164349163|NCT03129100|593655395|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349164|NCT03129100|593655396|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349165|NCT03129100|593655397|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349166|NCT03129100|593655398|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349167|NCT03129100|593655399|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349168|NCT03129100|593655400|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349169|NCT03129100|593655401|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349170|NCT03129100|593655402|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349171|NCT03129100|593655403|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349172|NCT03129100|593655404|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349173|NCT03129100|593655405|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349174|NCT03129100|593655406|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349175|NCT03129100|593655407|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349176|NCT03129100|593655408|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349177|NCT03129100|593655409|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349178|NCT03129100|593655410|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349179|NCT03129100|593655411|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349180|NCT03129100|593655386|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349181|NCT03129100|593655387|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349182|NCT03129100|593655388|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
164349183|NCT03129100|593655389|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349184|NCT03129100|593655390|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349185|NCT03129100|593655391|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349186|NCT03129100|593655392|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349187|NCT03129100|593655393|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349188|NCT03129100|593655394|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349189|NCT03129100|593655395|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349190|NCT03129100|593655396|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349191|NCT03129100|593655397|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349192|NCT03129100|593655398|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349193|NCT03129100|593655399|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349194|NCT03129100|593655400|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349195|NCT03129100|593655401|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349196|NCT03129100|593655402|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349197|NCT03129100|593655403|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349198|NCT03129100|593655404|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349199|NCT03129100|593655405|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349200|NCT03129100|593655406|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349201|NCT03129100|593655407|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349202|NCT03129100|593655408|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349203|NCT03129100|593655409|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349204|NCT03129100|593655410|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349205|NCT03129100|593655411|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349206|NCT03129100|593655386|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349207|NCT03129100|593655387|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349208|NCT03129100|593655388|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
164349209|NCT03129100|593655389|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349210|NCT03129100|593655390|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349211|NCT03129100|593655391|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349212|NCT03129100|593655392|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349213|NCT03129100|593655393|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349214|NCT03129100|593655394|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349215|NCT03129100|593655395|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349216|NCT03129100|593655396|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349217|NCT03129100|593655397|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349218|NCT03129100|593655398|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349219|NCT03129100|593655399|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349220|NCT03129100|593655400|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349221|NCT03129100|593655401|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349222|NCT03129100|593655402|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349223|NCT03129100|593655403|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349224|NCT03129100|593655404|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349225|NCT03129100|593655405|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349226|NCT03129100|593655406|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349227|NCT03129100|593655407|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349228|NCT03129100|593655408|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349229|NCT03129100|593655409|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349230|NCT03129100|593655410|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349231|NCT03129100|593655411|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349232|NCT03129100|593655386|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349233|NCT03129100|593655387|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164436038|NCT00486759|593963211|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
164349234|NCT03129100|593655388|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349235|NCT03129100|593655389|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349236|NCT03129100|593655390|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
164349237|NCT03129100|593655391|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
164349238|NCT03129100|593655392|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
164349239|NCT03129100|593655393|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349240|NCT03129100|593655394|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349241|NCT03129100|593655395|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349242|NCT03129100|593655396|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349243|NCT03129100|593655397|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349244|NCT03129100|593655398|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349245|NCT03129100|593655399|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349246|NCT03129100|593655400|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349247|NCT03129100|593655401|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349248|NCT03129100|593655402|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349249|NCT03129100|593655403|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349250|NCT03129100|593655404|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349251|NCT03129100|593655405|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349252|NCT03129100|593655406|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349253|NCT03129100|593655407|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349254|NCT03129100|593655408|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164436039|NCT00486759|593963210|FG000|Safety Follow-up|Death|40|||
164436040|NCT00486759|593963211|FG001|Safety Follow-up|Death|29|||
164436041|NCT00486759|593963210|FG000|Safety Follow-up|Withdrew consent|32|||
164436042|NCT00486759|593963211|FG001|Safety Follow-up|Withdrew consent|23|||
164436043|NCT00486759|593963210|FG000|Safety Follow-up|Failure to return|9|||
164436044|NCT00486759|593963211|FG001|Safety Follow-up|Failure to return|6|||
164436045|NCT00486759|593963210|FG000|Safety Follow-up|Administrative/not specified|8|||
164436046|NCT00486759|593963211|FG001|Safety Follow-up|Administrative/not specified|6|||
164436047|NCT00486759|593963210|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
164436048|NCT00486759|593963211|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
164436049|NCT00486759|593963210|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
164436050|NCT00486759|593963211|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
164298938|NCT03337477|593471189|FG001|Overall Study|not categorized into the listed ones|9|||
164298939|NCT03337477|593471188|FG000|Overall Study|Withdrawal by Subject|0|||
164298940|NCT03337477|593471189|FG001|Overall Study|Withdrawal by Subject|1|||
164298941|NCT03337477|593471188|FG000|Overall Study|Death|0|||
164298942|NCT03337477|593471189|FG001|Overall Study|Death|1|||
164298943|NCT03337477|593471188|FG000|Overall Study|Lost to Follow-up|0|||
164298944|NCT03337477|593471189|FG001|Overall Study|Lost to Follow-up|2|||
164298945|NCT01747876|593471191|FG000|Overall Study|Adverse Event|1|||
164298946|NCT01747876|593471192|FG001|Overall Study|Adverse Event|0|||
164298947|NCT01747876|593471193|FG002|Overall Study|Adverse Event|2|||
164298948|NCT01747876|593471191|FG000|Overall Study|Withdrawal by Subject|0|||
164298949|NCT01747876|593471192|FG001|Overall Study|Withdrawal by Subject|1|||
164298950|NCT01747876|593471193|FG002|Overall Study|Withdrawal by Subject|1|||
164298951|NCT01747876|593471191|FG000|Overall Study|Disease progression|4|||
164298952|NCT01747876|593471192|FG001|Overall Study|Disease progression|13|||
164298953|NCT01747876|593471193|FG002|Overall Study|Disease progression|8|||
164298954|NCT01747876|593471191|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
164298955|NCT01747876|593471192|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
164298956|NCT01747876|593471193|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
164298957|NCT03198715|593471194|FG000|Overall Study|Death|0|||
164298958|NCT03198715|593471195|FG001|Overall Study|Death|0|||
164298959|NCT03198715|593471196|FG002|Overall Study|Death|1|||
164298960|NCT03198715|593471197|FG003|Overall Study|Death|0|||
164298961|NCT03198715|593471198|FG004|Overall Study|Death|2|||
164298962|NCT03198715|593471194|FG000|Overall Study|Other|0|||
164298963|NCT03198715|593471195|FG001|Overall Study|Other|1|||
164298964|NCT03198715|593471196|FG002|Overall Study|Other|1|||
164298965|NCT03198715|593471197|FG003|Overall Study|Other|0|||
164298966|NCT03198715|593471198|FG004|Overall Study|Other|0|||
164298967|NCT00853307|593471199|FG000|Overall Study|Adverse Event|1|||
164298968|NCT00853307|593471200|FG001|Overall Study|Adverse Event|2|||
164298969|NCT00853307|593471199|FG000|Overall Study|Withdrawal by Subject|1|||
164298970|NCT00853307|593471200|FG001|Overall Study|Withdrawal by Subject|2|||
164298971|NCT00853307|593471199|FG000|Overall Study|Reason Not Specified|0|||
164298972|NCT00853307|593471200|FG001|Overall Study|Reason Not Specified|1|||
164298973|NCT04225897|593471207|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
164298974|NCT04225897|593471208|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
164298975|NCT04225897|593471209|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
164298976|NCT04225897|593471210|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
164298977|NCT04225897|593471211|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
164298978|NCT04225897|593471212|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
164298979|NCT04225897|593471213|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
164298980|NCT04225897|593471214|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
164298981|NCT04225897|593471215|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
164298982|NCT04225897|593471216|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
164298983|NCT04225897|593471217|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
164298984|NCT04225897|593471218|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
164298985|NCT04225897|593471207|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
164298986|NCT04225897|593471208|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
164298987|NCT04225897|593471209|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
164298988|NCT04225897|593471210|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
164298989|NCT04225897|593471211|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
164301313|NCT05462756|593480132|FG001|Treatment Period|Death|1|||
164301314|NCT05462756|593480131|FG000|Treatment Period|Lost to Follow-up|2|||
164301315|NCT05462756|593480132|FG001|Treatment Period|Lost to Follow-up|1|||
164301316|NCT05462756|593480131|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
164301317|NCT05462756|593480132|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
164301318|NCT05462756|593480131|FG000|Treatment Period|Physician Decision|2|||
164301319|NCT05462756|593480132|FG001|Treatment Period|Physician Decision|0|||
164301320|NCT05462756|593480131|FG000|Treatment Period|Protocol Violation|0|||
164301321|NCT05462756|593480132|FG001|Treatment Period|Protocol Violation|1|||
164301322|NCT05462756|593480131|FG000|Treatment Period|Withdrawal by Subject|5|||
164301323|NCT05462756|593480132|FG001|Treatment Period|Withdrawal by Subject|12|||
164301324|NCT05462756|593480131|FG000|Follow-Up Period|Adverse Event|1|||
164301325|NCT05462756|593480132|FG001|Follow-Up Period|Adverse Event|0|||
164301326|NCT05462756|593480131|FG000|Follow-Up Period|Death|1|||
164301327|NCT05462756|593480132|FG001|Follow-Up Period|Death|0|||
164301328|NCT05462756|593480131|FG000|Follow-Up Period|Lost to Follow-up|3|||
164301329|NCT05462756|593480132|FG001|Follow-Up Period|Lost to Follow-up|1|||
164301330|NCT05462756|593480131|FG000|Follow-Up Period|Withdrawal by Subject|0|||
164301331|NCT05462756|593480132|FG001|Follow-Up Period|Withdrawal by Subject|4|||
164301332|NCT03591406|593480133|FG000|Overall Study|Adverse Event|5|||
164301333|NCT03591406|593480134|FG001|Overall Study|Adverse Event|3|||
164301334|NCT03591406|593480133|FG000|Overall Study|Protocol Violation|2|||
164301335|NCT03591406|593480134|FG001|Overall Study|Protocol Violation|1|||
164301336|NCT03591406|593480133|FG000|Overall Study|Withdrawal by Subject|0|||
164301337|NCT03591406|593480134|FG001|Overall Study|Withdrawal by Subject|5|||
164301338|NCT01389596|593480135|FG000|Overall Study|Protocol Violation|3|||
164301339|NCT01389596|593480136|FG001|Overall Study|Protocol Violation|4|||
164301340|NCT01389596|593480137|FG002|Overall Study|Protocol Violation|3|||
164301341|NCT01389596|593480135|FG000|Overall Study|Withdrawal by Subject|1|||
164301342|NCT01389596|593480136|FG001|Overall Study|Withdrawal by Subject|2|||
164301343|NCT01389596|593480137|FG002|Overall Study|Withdrawal by Subject|2|||
164301344|NCT01389596|593480135|FG000|Overall Study|Insufficient Clinical Response|3|||
164301345|NCT01389596|593480136|FG001|Overall Study|Insufficient Clinical Response|4|||
164301346|NCT01389596|593480137|FG002|Overall Study|Insufficient Clinical Response|5|||
164301347|NCT01389596|593480135|FG000|Overall Study|Adverse Event|1|||
164301348|NCT01389596|593480136|FG001|Overall Study|Adverse Event|4|||
164301349|NCT01389596|593480137|FG002|Overall Study|Adverse Event|0|||
164301350|NCT01389596|593480135|FG000|Overall Study|Death|0|||
164301351|NCT01389596|593480136|FG001|Overall Study|Death|1|||
164301352|NCT01389596|593480137|FG002|Overall Study|Death|0|||
164301353|NCT01389596|593480135|FG000|Overall Study|Other Unspecified|2|||
164301354|NCT01389596|593480136|FG001|Overall Study|Other Unspecified|1|||
164301355|NCT01389596|593480137|FG002|Overall Study|Other Unspecified|0|||
164301356|NCT01709084|593480138|FG000|Overall Study|Lost to Follow-up|4|||
164301357|NCT01709084|593480139|FG001|Overall Study|Lost to Follow-up|7|||
164301358|NCT01709084|593480138|FG000|Overall Study|Withdrawal by Subject|2|||
164301359|NCT01709084|593480139|FG001|Overall Study|Withdrawal by Subject|2|||
164301360|NCT01709084|593480138|FG000|Overall Study|Adverse Event|5|||
164693816|NCT01546922|594901180|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
164693817|NCT01546922|594901181|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
164349255|NCT03129100|593655409|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349256|NCT03129100|593655410|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349257|NCT03129100|593655411|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349258|NCT03129100|593655386|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349259|NCT03129100|593655387|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349260|NCT03129100|593655388|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349261|NCT03129100|593655389|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349262|NCT03129100|593655390|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349263|NCT03129100|593655391|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349264|NCT03129100|593655392|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349265|NCT03129100|593655393|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349266|NCT03129100|593655394|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349267|NCT03129100|593655395|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
164349268|NCT03129100|593655396|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349269|NCT03129100|593655397|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349270|NCT03129100|593655398|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349271|NCT03129100|593655399|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349272|NCT03129100|593655400|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349273|NCT03129100|593655401|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349274|NCT03129100|593655402|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349275|NCT03129100|593655403|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349276|NCT03129100|593655404|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349277|NCT03129100|593655405|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349278|NCT03129100|593655406|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349279|NCT03129100|593655407|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349280|NCT03129100|593655408|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349281|NCT03129100|593655409|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349282|NCT03129100|593655410|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349283|NCT03129100|593655411|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349284|NCT03129100|593655386|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349285|NCT03129100|593655387|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349286|NCT03129100|593655388|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349287|NCT03129100|593655389|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349288|NCT03129100|593655390|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349289|NCT03129100|593655391|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349290|NCT03129100|593655392|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349291|NCT03129100|593655393|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349292|NCT03129100|593655394|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349293|NCT03129100|593655395|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349294|NCT03129100|593655396|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349295|NCT03129100|593655397|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
164349296|NCT03129100|593655398|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349297|NCT03129100|593655399|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349298|NCT03129100|593655400|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349299|NCT03129100|593655401|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349300|NCT03129100|593655402|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349301|NCT03129100|593655403|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349302|NCT03129100|593655404|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349303|NCT03129100|593655405|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349304|NCT03129100|593655406|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349305|NCT03129100|593655407|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349306|NCT03129100|593655408|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349307|NCT03129100|593655409|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349308|NCT03129100|593655410|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349309|NCT03129100|593655411|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349310|NCT03129100|593655386|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349311|NCT03129100|593655387|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164693818|NCT01546922|594901180|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
164693819|NCT01546922|594901181|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
164693820|NCT02000531|594901187|FG000|Overall Study|Lost to Follow-up|1|||
164693821|NCT02000531|594901188|FG001|Overall Study|Lost to Follow-up|0|||
164693822|NCT02000531|594901187|FG000|Overall Study|Discontinued due to data cut-off|3|||
164436051|NCT01185522|593963212|FG000|Overall Study|Lack of Efficacy|28|||
164436052|NCT01185522|593963212|FG000|Overall Study|Lost to Follow-up|19|||
164436053|NCT01185522|593963212|FG000|Overall Study|Withdrawal by Subject|10|||
164436054|NCT01185522|593963212|FG000|Overall Study|Poor tolerance|39|||
164436055|NCT01185522|593963212|FG000|Overall Study|Other reasons|12|||
164436056|NCT01729819|593963213|FG000|Overall Study|Adverse Event|2|||
164436057|NCT01729819|593963214|FG001|Overall Study|Adverse Event|4|||
164436058|NCT01729819|593963213|FG000|Overall Study|Lack of Efficacy|1|||
164436059|NCT01729819|593963214|FG001|Overall Study|Lack of Efficacy|0|||
164436060|NCT01729819|593963213|FG000|Overall Study|Lost to Follow-up|2|||
164436061|NCT01729819|593963214|FG001|Overall Study|Lost to Follow-up|0|||
164436062|NCT01729819|593963213|FG000|Overall Study|Other reason|1|||
164436063|NCT01729819|593963214|FG001|Overall Study|Other reason|0|||
164436064|NCT01729819|593963213|FG000|Overall Study|Protocol Violation|0|||
164436065|NCT01729819|593963214|FG001|Overall Study|Protocol Violation|1|||
164436066|NCT01729819|593963213|FG000|Overall Study|Withdrawal by Subject|0|||
164436067|NCT01729819|593963214|FG001|Overall Study|Withdrawal by Subject|2|||
164436068|NCT01025843|593963215|FG000|Washout 4|Withdrawal by Subject|0|||
164436069|NCT01025843|593963216|FG001|Washout 4|Withdrawal by Subject|0|||
164436070|NCT01025843|593963217|FG002|Washout 4|Withdrawal by Subject|1|||
164436071|NCT01025843|593963218|FG003|Washout 4|Withdrawal by Subject|1|||
164436072|NCT01025843|593963219|FG004|Washout 4|Withdrawal by Subject|0|||
164436073|NCT01025843|593963220|FG005|Washout 4|Withdrawal by Subject|0|||
164436074|NCT01025843|593963221|FG006|Washout 4|Withdrawal by Subject|0|||
164436075|NCT01025843|593963222|FG007|Washout 4|Withdrawal by Subject|0|||
164436076|NCT01025843|593963223|FG008|Washout 4|Withdrawal by Subject|0|||
164436077|NCT01025843|593963224|FG009|Washout 4|Withdrawal by Subject|0|||
164436078|NCT02814643|593963227|FG000|Overall Study|Lost to Follow-up|0|||
164436079|NCT02814643|593963228|FG001|Overall Study|Lost to Follow-up|1|||
164436080|NCT02814643|593963227|FG000|Overall Study|Withdrawal by Subject|1|||
164436081|NCT02814643|593963228|FG001|Overall Study|Withdrawal by Subject|2|||
164436082|NCT01281813|593963234|FG000|Overall Study|Adverse Event|0|||
164436083|NCT01281813|593963235|FG001|Overall Study|Adverse Event|0|||
164436084|NCT01281813|593963236|FG002|Overall Study|Adverse Event|10|||
164436085|NCT01281813|593963234|FG000|Overall Study|Lost to Follow-up|0|||
164436086|NCT01281813|593963235|FG001|Overall Study|Lost to Follow-up|0|||
164436087|NCT01281813|593963236|FG002|Overall Study|Lost to Follow-up|31|||
164436088|NCT01281813|593963234|FG000|Overall Study|Withdrawal by Subject|0|||
164436089|NCT01281813|593963235|FG001|Overall Study|Withdrawal by Subject|0|||
164436090|NCT01281813|593963236|FG002|Overall Study|Withdrawal by Subject|13|||
164436091|NCT01281813|593963234|FG000|Overall Study|Subject Non-Compliant|0|||
164436092|NCT01281813|593963235|FG001|Overall Study|Subject Non-Compliant|0|||
164436093|NCT01281813|593963236|FG002|Overall Study|Subject Non-Compliant|6|||
164436094|NCT01281813|593963234|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
164436095|NCT01281813|593963235|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
164436096|NCT01281813|593963236|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
164436097|NCT01281813|593963234|FG000|Overall Study|Sponsor's Decision|4|||
164436098|NCT01281813|593963235|FG001|Overall Study|Sponsor's Decision|3|||
164436099|NCT01281813|593963236|FG002|Overall Study|Sponsor's Decision|7|||
164436100|NCT01281813|593963234|FG000|Overall Study|Switched to Commercially Available Medication|0|||
164436101|NCT01281813|593963235|FG001|Overall Study|Switched to Commercially Available Medication|0|||
164436102|NCT01281813|593963236|FG002|Overall Study|Switched to Commercially Available Medication|26|||
164436103|NCT01281813|593963234|FG000|Overall Study|Other|0|||
164436104|NCT01281813|593963235|FG001|Overall Study|Other|1|||
164436105|NCT01281813|593963236|FG002|Overall Study|Other|39|||
164436106|NCT00549848|593963237|FG000|Overall Study|Death|1|||
164436107|NCT00549848|593963238|FG001|Overall Study|Death|4|||
164436108|NCT00549848|593963239|FG002|Overall Study|Death|13|||
164436109|NCT00549848|593963237|FG000|Overall Study|Physician Decision|0|||
164436110|NCT00549848|593963238|FG001|Overall Study|Physician Decision|0|||
164436111|NCT00549848|593963239|FG002|Overall Study|Physician Decision|4|||
164587927|NCT01614769|594517438|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
164436112|NCT00549848|593963237|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
164436113|NCT00549848|593963238|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
164436114|NCT00549848|593963239|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
164436115|NCT00549848|593963237|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
164436116|NCT00549848|593963238|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
164436117|NCT00549848|593963239|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
164436118|NCT00549848|593963237|FG000|Overall Study|Participant/Family Withdraw|2|||
164436119|NCT00549848|593963238|FG001|Overall Study|Participant/Family Withdraw|3|||
164436120|NCT00549848|593963239|FG002|Overall Study|Participant/Family Withdraw|5|||
164436121|NCT00549848|593963237|FG000|Overall Study|Second Malignancy|1|||
164436122|NCT00549848|593963238|FG001|Overall Study|Second Malignancy|0|||
164436123|NCT00549848|593963239|FG002|Overall Study|Second Malignancy|0|||
164436124|NCT00549848|593963237|FG000|Overall Study|Transplant|3|||
164436125|NCT00549848|593963238|FG001|Overall Study|Transplant|3|||
164436126|NCT00549848|593963239|FG002|Overall Study|Transplant|18|||
164349312|NCT03129100|593655388|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349313|NCT03129100|593655389|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349314|NCT03129100|593655390|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349315|NCT03129100|593655391|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349316|NCT03129100|593655392|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349317|NCT03129100|593655393|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349318|NCT03129100|593655394|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349319|NCT03129100|593655395|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349320|NCT03129100|593655396|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349321|NCT03129100|593655397|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
164349322|NCT03129100|593655398|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
164349323|NCT03129100|593655399|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
164349324|NCT03129100|593655400|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
164349325|NCT03129100|593655401|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349326|NCT03129100|593655402|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349327|NCT03129100|593655403|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349328|NCT03129100|593655404|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349329|NCT03129100|593655405|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349330|NCT03129100|593655406|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349331|NCT03129100|593655407|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349332|NCT03129100|593655408|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349333|NCT03129100|593655409|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349334|NCT03129100|593655410|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349335|NCT03129100|593655411|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349336|NCT03129100|593655386|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349337|NCT03129100|593655387|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349338|NCT03129100|593655388|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349339|NCT03129100|593655389|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349340|NCT03129100|593655390|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349341|NCT03129100|593655391|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349342|NCT03129100|593655392|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349343|NCT03129100|593655393|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349344|NCT03129100|593655394|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349345|NCT03129100|593655395|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349346|NCT03129100|593655396|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349347|NCT03129100|593655397|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
164349348|NCT03129100|593655398|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349349|NCT03129100|593655399|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
164349350|NCT03129100|593655400|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
164349351|NCT03129100|593655401|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349352|NCT03129100|593655402|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349353|NCT03129100|593655403|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349354|NCT03129100|593655404|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349355|NCT03129100|593655405|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349356|NCT03129100|593655406|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349357|NCT03129100|593655407|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349358|NCT03129100|593655408|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349359|NCT03129100|593655409|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349360|NCT03129100|593655410|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349361|NCT03129100|593655411|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349362|NCT03129100|593655386|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349363|NCT03129100|593655387|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349364|NCT03129100|593655388|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349365|NCT03129100|593655389|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349366|NCT03129100|593655390|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349367|NCT03129100|593655391|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349368|NCT03129100|593655392|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349369|NCT03129100|593655393|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349370|NCT03129100|593655394|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349371|NCT03129100|593655395|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349372|NCT03129100|593655396|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349373|NCT03129100|593655397|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349374|NCT03129100|593655398|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349375|NCT03129100|593655399|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349376|NCT03129100|593655400|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349377|NCT03129100|593655401|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
164349378|NCT03129100|593655402|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349379|NCT03129100|593655403|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349380|NCT03129100|593655404|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349381|NCT03129100|593655405|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349382|NCT03129100|593655406|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349383|NCT03129100|593655407|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349384|NCT03129100|593655408|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349385|NCT03129100|593655409|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349386|NCT03129100|593655410|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349387|NCT03129100|593655411|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349388|NCT03129100|593655386|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349389|NCT03129100|593655387|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349390|NCT03129100|593655388|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349391|NCT03129100|593655389|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349392|NCT03129100|593655390|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349393|NCT03129100|593655391|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349394|NCT03129100|593655392|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349395|NCT03129100|593655393|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349396|NCT03129100|593655394|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349397|NCT03129100|593655395|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349398|NCT03129100|593655396|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349399|NCT03129100|593655397|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349400|NCT03129100|593655398|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
164349401|NCT03129100|593655399|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349402|NCT03129100|593655400|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
164349403|NCT03129100|593655401|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
164349404|NCT03129100|593655402|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349405|NCT03129100|593655403|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349406|NCT03129100|593655404|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349407|NCT03129100|593655405|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349408|NCT03129100|593655406|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349409|NCT03129100|593655407|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349410|NCT03129100|593655408|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349411|NCT03129100|593655409|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349412|NCT03129100|593655410|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349413|NCT03129100|593655411|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349414|NCT03129100|593655386|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349415|NCT03129100|593655387|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349416|NCT03129100|593655388|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349417|NCT03129100|593655389|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349418|NCT03129100|593655390|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349419|NCT03129100|593655391|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349420|NCT03129100|593655392|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349421|NCT03129100|593655393|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349422|NCT03129100|593655394|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349423|NCT03129100|593655395|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349424|NCT03129100|593655396|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349425|NCT03129100|593655397|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349426|NCT03129100|593655398|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349427|NCT03129100|593655399|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349428|NCT03129100|593655400|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349429|NCT03129100|593655401|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349430|NCT03129100|593655402|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349431|NCT03129100|593655403|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
164349432|NCT03129100|593655404|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349433|NCT03129100|593655405|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
164349434|NCT03129100|593655406|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349435|NCT03129100|593655407|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349436|NCT03129100|593655408|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349437|NCT03129100|593655409|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349438|NCT03129100|593655410|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349439|NCT03129100|593655411|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349440|NCT03129100|593655386|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349441|NCT03129100|593655387|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349442|NCT03129100|593655388|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349443|NCT03129100|593655389|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349444|NCT03129100|593655390|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349445|NCT03129100|593655391|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349446|NCT03129100|593655392|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349447|NCT03129100|593655393|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349448|NCT03129100|593655394|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349449|NCT03129100|593655395|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349450|NCT03129100|593655396|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349451|NCT03129100|593655397|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349452|NCT03129100|593655398|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349453|NCT03129100|593655399|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349454|NCT03129100|593655400|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349455|NCT03129100|593655401|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349456|NCT03129100|593655402|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349457|NCT03129100|593655403|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349458|NCT03129100|593655404|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349459|NCT03129100|593655405|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349460|NCT03129100|593655406|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
164349461|NCT03129100|593655407|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349462|NCT03129100|593655408|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349463|NCT03129100|593655409|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349464|NCT03129100|593655410|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349465|NCT03129100|593655411|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349466|NCT03129100|593655386|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
164349467|NCT03129100|593655387|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
164349468|NCT03129100|593655388|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
164349469|NCT03129100|593655389|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
164349470|NCT03129100|593655390|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
164349471|NCT03129100|593655391|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
164349472|NCT03129100|593655392|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
164349473|NCT03129100|593655393|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
164349474|NCT03129100|593655394|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
164349475|NCT03129100|593655395|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
164349476|NCT03129100|593655396|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
164349477|NCT03129100|593655397|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
164349478|NCT03129100|593655398|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
164349479|NCT03129100|593655399|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
164349480|NCT03129100|593655400|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
164349481|NCT03129100|593655401|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
164349482|NCT03129100|593655402|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
164349483|NCT03129100|593655403|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
164349484|NCT03129100|593655404|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
164349485|NCT03129100|593655405|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
164349486|NCT03129100|593655406|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
164349487|NCT03129100|593655407|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
164349488|NCT03129100|593655408|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
164349489|NCT03129100|593655409|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
164349490|NCT03129100|593655410|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
164349491|NCT03129100|593655411|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
164349492|NCT03129100|593655386|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349493|NCT03129100|593655387|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349494|NCT03129100|593655388|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349495|NCT03129100|593655389|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349496|NCT03129100|593655390|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349497|NCT03129100|593655391|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349498|NCT03129100|593655392|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349499|NCT03129100|593655393|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349500|NCT03129100|593655394|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349501|NCT03129100|593655395|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349502|NCT03129100|593655396|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349503|NCT03129100|593655397|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164436127|NCT00549848|593963237|FG000|Overall Study|Unacceptable Toxicity|1|||
164436128|NCT00549848|593963238|FG001|Overall Study|Unacceptable Toxicity|6|||
164349504|NCT03129100|593655398|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349505|NCT03129100|593655399|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349506|NCT03129100|593655400|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164436129|NCT00549848|593963239|FG002|Overall Study|Unacceptable Toxicity|6|||
164349507|NCT03129100|593655401|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349508|NCT03129100|593655402|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349509|NCT03129100|593655403|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349510|NCT03129100|593655404|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349511|NCT03129100|593655405|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349512|NCT03129100|593655406|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
164349513|NCT03129100|593655407|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349514|NCT03129100|593655408|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349515|NCT03129100|593655409|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349516|NCT03129100|593655410|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349517|NCT03129100|593655411|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349518|NCT03129100|593655386|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
164349519|NCT03129100|593655387|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
164349520|NCT03129100|593655388|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
164349521|NCT03129100|593655389|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
164349522|NCT03129100|593655390|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
164349523|NCT03129100|593655391|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
164349524|NCT03129100|593655392|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
164349525|NCT03129100|593655393|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
164349526|NCT03129100|593655394|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
164349527|NCT03129100|593655395|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
164349528|NCT03129100|593655396|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
164349529|NCT03129100|593655397|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
164349530|NCT03129100|593655398|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
164349531|NCT03129100|593655399|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
164349532|NCT03129100|593655400|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
164349533|NCT03129100|593655401|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
164349534|NCT03129100|593655402|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
164349535|NCT03129100|593655403|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
164349536|NCT03129100|593655404|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
164349537|NCT03129100|593655405|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
164349538|NCT03129100|593655406|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
164349539|NCT03129100|593655407|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
164349540|NCT03129100|593655408|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
164349541|NCT03129100|593655409|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
164349542|NCT03129100|593655410|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
164349543|NCT03129100|593655411|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
164349544|NCT03129100|593655386|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349545|NCT03129100|593655387|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349546|NCT03129100|593655388|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349547|NCT03129100|593655389|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349548|NCT03129100|593655390|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349549|NCT03129100|593655391|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349550|NCT03129100|593655392|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349551|NCT03129100|593655393|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349552|NCT03129100|593655394|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349553|NCT03129100|593655395|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349554|NCT03129100|593655396|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349555|NCT03129100|593655397|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349556|NCT03129100|593655398|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349557|NCT03129100|593655399|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349558|NCT03129100|593655400|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349559|NCT03129100|593655401|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349560|NCT03129100|593655402|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349561|NCT03129100|593655403|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349562|NCT03129100|593655404|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349563|NCT03129100|593655405|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349564|NCT03129100|593655406|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349565|NCT03129100|593655407|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349566|NCT03129100|593655408|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349567|NCT03129100|593655409|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349568|NCT03129100|593655410|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
164349569|NCT03129100|593655411|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
164349570|NCT03129100|593655386|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349571|NCT03129100|593655387|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349572|NCT03129100|593655388|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349573|NCT03129100|593655389|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349574|NCT03129100|593655390|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349575|NCT03129100|593655391|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164587928|NCT01614769|594517439|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
164587929|NCT01614769|594517434|FG000|Period 1|Protocol Violation|0|||
164587930|NCT01614769|594517435|FG001|Period 1|Protocol Violation|0|||
164587931|NCT01614769|594517436|FG002|Period 1|Protocol Violation|0|||
164587932|NCT01614769|594517437|FG003|Period 1|Protocol Violation|1|||
164587933|NCT01614769|594517438|FG004|Period 1|Protocol Violation|0|||
164587934|NCT01614769|594517439|FG005|Period 1|Protocol Violation|0|||
164587935|NCT01614769|594517434|FG000|Period 1|Withdrawal by Subject|1|||
164349576|NCT03129100|593655392|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164436130|NCT00558363|593963240|FG000|Overall Study|Physician Decision|18|||
164436131|NCT00558363|593963241|FG001|Overall Study|Physician Decision|4|||
164436132|NCT00558363|593963240|FG000|Overall Study|Withdrawal by Subject|11|||
164436133|NCT00558363|593963241|FG001|Overall Study|Withdrawal by Subject|4|||
164436134|NCT00558363|593963240|FG000|Overall Study|Adverse Event|5|||
164436135|NCT00558363|593963241|FG001|Overall Study|Adverse Event|5|||
164436136|NCT00558363|593963240|FG000|Overall Study|Lack of Efficacy|2|||
164436137|NCT00558363|593963241|FG001|Overall Study|Lack of Efficacy|2|||
164436138|NCT00558363|593963240|FG000|Overall Study|Protocol Violation|2|||
164436139|NCT00558363|593963241|FG001|Overall Study|Protocol Violation|1|||
164436140|NCT00558363|593963240|FG000|Overall Study|Lost to Follow-up|0|||
164436141|NCT00558363|593963241|FG001|Overall Study|Lost to Follow-up|1|||
164349577|NCT03129100|593655393|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349578|NCT03129100|593655394|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349579|NCT03129100|593655395|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349580|NCT03129100|593655396|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349581|NCT03129100|593655397|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349582|NCT03129100|593655398|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349583|NCT03129100|593655399|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349584|NCT03129100|593655400|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349585|NCT03129100|593655401|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349586|NCT03129100|593655402|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349587|NCT03129100|593655403|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349588|NCT03129100|593655404|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349589|NCT03129100|593655405|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349590|NCT03129100|593655406|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349591|NCT03129100|593655407|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349592|NCT03129100|593655408|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349593|NCT03129100|593655409|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
164349594|NCT03129100|593655410|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
164349595|NCT03129100|593655411|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
164349596|NCT03129100|593655386|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349597|NCT03129100|593655387|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349598|NCT03129100|593655388|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164436142|NCT00558363|593963240|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
164436143|NCT00558363|593963241|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
164436144|NCT00558363|593963240|FG000|Overall Study|Randomized in Error|1|||
164436145|NCT00558363|593963241|FG001|Overall Study|Randomized in Error|2|||
164436146|NCT00558363|593963240|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
164436147|NCT00558363|593963241|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
164436148|NCT00868192|593963242|FG000|Overall Study|Ineligible|4|||
164436149|NCT03673124|593963243|FG000|Overall Study|Eligible with no protocol therapy|2|||
164349599|NCT03129100|593655389|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349600|NCT03129100|593655390|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349601|NCT03129100|593655391|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349602|NCT03129100|593655392|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349603|NCT03129100|593655393|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349604|NCT03129100|593655394|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349605|NCT03129100|593655395|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349606|NCT03129100|593655396|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349607|NCT03129100|593655397|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349608|NCT03129100|593655398|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164436150|NCT02174562|593963244|FG000|Overall Study|Withdrawal by Subject|7|||
164436151|NCT02174562|593963245|FG001|Overall Study|Withdrawal by Subject|2|||
164436152|NCT02174562|593963244|FG000|Overall Study|Death|2|||
164436153|NCT02174562|593963245|FG001|Overall Study|Death|0|||
164436154|NCT02174562|593963244|FG000|Overall Study|Lost to Follow-up|0|||
164436155|NCT02174562|593963245|FG001|Overall Study|Lost to Follow-up|3|||
164587936|NCT01614769|594517435|FG001|Period 1|Withdrawal by Subject|0|||
164436156|NCT01651949|593963251|FG000|Overall Study|Unknown status|4|||
164436157|NCT01651949|593963252|FG001|Overall Study|Unknown status|4|||
164587937|NCT01614769|594517436|FG002|Period 1|Withdrawal by Subject|0|||
164587938|NCT01614769|594517437|FG003|Period 1|Withdrawal by Subject|0|||
164693823|NCT02000531|594901188|FG001|Overall Study|Discontinued due to data cut-off|8|||
164349609|NCT03129100|593655399|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349610|NCT03129100|593655400|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349611|NCT03129100|593655401|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349612|NCT03129100|593655402|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349613|NCT03129100|593655403|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349614|NCT03129100|593655404|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349615|NCT03129100|593655405|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349616|NCT03129100|593655406|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349617|NCT03129100|593655407|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349618|NCT03129100|593655408|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349619|NCT03129100|593655409|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349620|NCT03129100|593655410|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
164349621|NCT03129100|593655411|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349622|NCT03129100|593655386|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349623|NCT03129100|593655387|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349624|NCT03129100|593655388|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349625|NCT03129100|593655389|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349626|NCT03129100|593655390|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349627|NCT03129100|593655391|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349628|NCT03129100|593655392|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349629|NCT03129100|593655393|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349630|NCT03129100|593655394|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349631|NCT03129100|593655395|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349632|NCT03129100|593655396|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349633|NCT03129100|593655397|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349634|NCT03129100|593655398|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349635|NCT03129100|593655399|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349636|NCT03129100|593655400|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349637|NCT03129100|593655401|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349638|NCT03129100|593655402|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349639|NCT03129100|593655403|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349640|NCT03129100|593655404|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349641|NCT03129100|593655405|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349642|NCT03129100|593655406|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349643|NCT03129100|593655407|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349644|NCT03129100|593655408|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349645|NCT03129100|593655409|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349646|NCT03129100|593655410|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349647|NCT03129100|593655411|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
164349648|NCT03129100|593655386|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
164349649|NCT03129100|593655387|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
164349650|NCT03129100|593655388|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
164349651|NCT03129100|593655389|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
164349652|NCT03129100|593655390|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
164349653|NCT03129100|593655391|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
164349654|NCT03129100|593655392|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
164349655|NCT03129100|593655393|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
164349656|NCT03129100|593655394|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
164349657|NCT03129100|593655395|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
164349658|NCT03129100|593655396|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
164349659|NCT03129100|593655397|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
164349660|NCT03129100|593655398|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
164349661|NCT03129100|593655399|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
164349662|NCT03129100|593655400|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
164349663|NCT03129100|593655401|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
164349664|NCT03129100|593655402|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
164349665|NCT03129100|593655403|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
164349666|NCT03129100|593655404|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
164349667|NCT03129100|593655405|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
164349668|NCT03129100|593655406|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
164349669|NCT03129100|593655407|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
164349670|NCT03129100|593655408|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
164349671|NCT03129100|593655409|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
164349672|NCT03129100|593655410|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
164349673|NCT03129100|593655411|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
164349674|NCT03708328|593655414|FG000|Overall Study|Death|3|||
164349675|NCT03708328|593655415|FG001|Overall Study|Death|3|||
164349676|NCT03708328|593655416|FG002|Overall Study|Death|4|||
164349677|NCT03708328|593655417|FG003|Overall Study|Death|2|||
164436158|NCT01651949|593963253|FG002|Overall Study|Unknown status|0|||
164436159|NCT01651949|593963251|FG000|Overall Study|Lost to Follow-up|30|||
164436160|NCT01651949|593963252|FG001|Overall Study|Lost to Follow-up|56|||
164436161|NCT01651949|593963253|FG002|Overall Study|Lost to Follow-up|20|||
164436162|NCT01651949|593963251|FG000|Overall Study|Protocol Violation|0|||
164436163|NCT01651949|593963252|FG001|Overall Study|Protocol Violation|2|||
164436164|NCT01651949|593963253|FG002|Overall Study|Protocol Violation|1|||
164436165|NCT01651949|593963251|FG000|Overall Study|Physician Decision|0|||
164298990|NCT04225897|593471212|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
164298991|NCT04225897|593471213|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
164298992|NCT04225897|593471214|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
164298993|NCT04225897|593471215|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
164298994|NCT04225897|593471216|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
164298995|NCT04225897|593471217|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
164298996|NCT04225897|593471218|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
164298997|NCT04225897|593471207|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
164298998|NCT04225897|593471208|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
164298999|NCT04225897|593471209|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
164299000|NCT04225897|593471210|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
164299001|NCT04225897|593471211|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
164299002|NCT04225897|593471212|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
164299003|NCT04225897|593471213|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
164299004|NCT04225897|593471214|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
164299005|NCT04225897|593471215|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
164299006|NCT04225897|593471216|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
164299007|NCT04225897|593471217|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
164299008|NCT04225897|593471218|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
164299009|NCT04225897|593471207|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
164299010|NCT04225897|593471208|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
164299011|NCT04225897|593471209|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
164299012|NCT04225897|593471210|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
164299013|NCT04225897|593471211|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
164299014|NCT04225897|593471212|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
164299015|NCT04225897|593471213|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
164299016|NCT04225897|593471214|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
164299017|NCT04225897|593471215|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
164299018|NCT04225897|593471216|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
164299019|NCT04225897|593471217|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
164299020|NCT04225897|593471218|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
164299021|NCT02703597|593471226|FG000|Assignment to Baseline|Lost to Follow-up|17|||
164299022|NCT02703597|593471227|FG001|Assignment to Baseline|Lost to Follow-up|16|||
164299023|NCT02703597|593471226|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
164299024|NCT02703597|593471227|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
164299025|NCT02703597|593471226|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
164299026|NCT02703597|593471227|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
164299027|NCT02703597|593471226|FG000|First Post-test to First Follow-up|Site drop out|0|||
164299028|NCT02703597|593471227|FG001|First Post-test to First Follow-up|Site drop out|58|||
164299029|NCT02703597|593471226|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
164299030|NCT02703597|593471227|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
164299031|NCT02703597|593471226|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
164299032|NCT02703597|593471227|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
164299033|NCT02703597|593471226|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
164299034|NCT02703597|593471227|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
164299035|NCT00481832|593471228|FG000|Enrollment|Physician Decision|8|||
164299036|NCT00481832|593471228|FG000|Enrollment|Unable to collect enough stem cells|2|||
164299037|NCT00481832|593471228|FG000|Inter-transplant Period|Adverse Event|4|||
164299038|NCT00481832|593471228|FG000|Inter-transplant Period|Death|3|||
164299039|NCT00481832|593471228|FG000|Inter-transplant Period|Physician Decision|4|||
164299040|NCT00481832|593471228|FG000|Inter-transplant Period|Disease relapse|11|||
164299041|NCT00481832|593471228|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
164299042|NCT00456846|593471229|FG000|Overall Study|Adverse Event|2|||
164299043|NCT00456846|593471230|FG001|Overall Study|Adverse Event|15|||
164299044|NCT00456846|593471229|FG000|Overall Study|Physician Decision|11|||
164299045|NCT00456846|593471230|FG001|Overall Study|Physician Decision|6|||
164299046|NCT00456846|593471229|FG000|Overall Study|Protocol Deviation|2|||
164299047|NCT00456846|593471230|FG001|Overall Study|Protocol Deviation|0|||
164436166|NCT01651949|593963252|FG001|Overall Study|Physician Decision|2|||
164349678|NCT03708328|593655418|FG004|Overall Study|Death|2|||
164349679|NCT03708328|593655419|FG005|Overall Study|Death|13|||
164349680|NCT03708328|593655420|FG006|Overall Study|Death|26|||
164349681|NCT03708328|593655421|FG007|Overall Study|Death|18|||
164349682|NCT03708328|593655422|FG008|Overall Study|Death|13|||
164349683|NCT03708328|593655423|FG009|Overall Study|Death|8|||
164349684|NCT03708328|593655414|FG000|Overall Study|Lost to Follow-up|0|||
164349685|NCT03708328|593655415|FG001|Overall Study|Lost to Follow-up|1|||
164349686|NCT03708328|593655416|FG002|Overall Study|Lost to Follow-up|0|||
164349687|NCT03708328|593655417|FG003|Overall Study|Lost to Follow-up|1|||
164349688|NCT03708328|593655418|FG004|Overall Study|Lost to Follow-up|0|||
164349689|NCT03708328|593655419|FG005|Overall Study|Lost to Follow-up|3|||
164349690|NCT03708328|593655420|FG006|Overall Study|Lost to Follow-up|3|||
164349691|NCT03708328|593655421|FG007|Overall Study|Lost to Follow-up|0|||
164349692|NCT03708328|593655422|FG008|Overall Study|Lost to Follow-up|0|||
164349693|NCT03708328|593655423|FG009|Overall Study|Lost to Follow-up|1|||
164349694|NCT03708328|593655414|FG000|Overall Study|Physician Decision|0|||
164349695|NCT03708328|593655415|FG001|Overall Study|Physician Decision|0|||
164349696|NCT03708328|593655416|FG002|Overall Study|Physician Decision|0|||
164349697|NCT03708328|593655417|FG003|Overall Study|Physician Decision|0|||
164349698|NCT03708328|593655418|FG004|Overall Study|Physician Decision|0|||
164349699|NCT03708328|593655419|FG005|Overall Study|Physician Decision|1|||
164349700|NCT03708328|593655420|FG006|Overall Study|Physician Decision|0|||
164349701|NCT03708328|593655421|FG007|Overall Study|Physician Decision|0|||
164349702|NCT03708328|593655422|FG008|Overall Study|Physician Decision|0|||
164349703|NCT03708328|593655423|FG009|Overall Study|Physician Decision|0|||
164349704|NCT03708328|593655414|FG000|Overall Study|Withdrawal by Subject|0|||
164349705|NCT03708328|593655415|FG001|Overall Study|Withdrawal by Subject|0|||
164349706|NCT03708328|593655416|FG002|Overall Study|Withdrawal by Subject|0|||
164349707|NCT03708328|593655417|FG003|Overall Study|Withdrawal by Subject|0|||
164349708|NCT03708328|593655418|FG004|Overall Study|Withdrawal by Subject|1|||
164349709|NCT03708328|593655419|FG005|Overall Study|Withdrawal by Subject|0|||
164349710|NCT03708328|593655420|FG006|Overall Study|Withdrawal by Subject|2|||
164349711|NCT03708328|593655421|FG007|Overall Study|Withdrawal by Subject|4|||
164349712|NCT03708328|593655422|FG008|Overall Study|Withdrawal by Subject|1|||
164349713|NCT03708328|593655423|FG009|Overall Study|Withdrawal by Subject|5|||
164349714|NCT03708328|593655414|FG000|Overall Study|Study Closed Locally|0|||
164349715|NCT03708328|593655415|FG001|Overall Study|Study Closed Locally|0|||
164349716|NCT03708328|593655416|FG002|Overall Study|Study Closed Locally|0|||
164349717|NCT03708328|593655417|FG003|Overall Study|Study Closed Locally|0|||
164349718|NCT03708328|593655418|FG004|Overall Study|Study Closed Locally|0|||
164349719|NCT03708328|593655419|FG005|Overall Study|Study Closed Locally|0|||
164349720|NCT03708328|593655420|FG006|Overall Study|Study Closed Locally|0|||
164349721|NCT03708328|593655421|FG007|Overall Study|Study Closed Locally|1|||
164349722|NCT03708328|593655422|FG008|Overall Study|Study Closed Locally|0|||
164349723|NCT03708328|593655423|FG009|Overall Study|Study Closed Locally|0|||
164349724|NCT03708328|593655414|FG000|Overall Study|Study Ended By Sponsor|0|||
164349725|NCT03708328|593655415|FG001|Overall Study|Study Ended By Sponsor|0|||
164349726|NCT03708328|593655416|FG002|Overall Study|Study Ended By Sponsor|0|||
164349727|NCT03708328|593655417|FG003|Overall Study|Study Ended By Sponsor|0|||
164349728|NCT03708328|593655418|FG004|Overall Study|Study Ended By Sponsor|0|||
164349729|NCT03708328|593655419|FG005|Overall Study|Study Ended By Sponsor|1|||
164349730|NCT03708328|593655420|FG006|Overall Study|Study Ended By Sponsor|0|||
164349731|NCT03708328|593655421|FG007|Overall Study|Study Ended By Sponsor|1|||
164349732|NCT03708328|593655422|FG008|Overall Study|Study Ended By Sponsor|0|||
164349733|NCT03708328|593655423|FG009|Overall Study|Study Ended By Sponsor|0|||
164349734|NCT03708328|593655414|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
164436167|NCT01651949|593963253|FG002|Overall Study|Physician Decision|0|||
164436168|NCT01651949|593963251|FG000|Overall Study|Adverse Event|0|||
164436169|NCT01651949|593963252|FG001|Overall Study|Adverse Event|2|||
164436170|NCT01651949|593963253|FG002|Overall Study|Adverse Event|1|||
164349735|NCT03708328|593655415|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
164349736|NCT03708328|593655416|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
164349737|NCT03708328|593655417|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
164349738|NCT03708328|593655418|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
164349739|NCT03708328|593655419|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
164349740|NCT03708328|593655420|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
164349741|NCT03708328|593655421|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
164349742|NCT03708328|593655422|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
164349743|NCT03708328|593655423|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
164436171|NCT01651949|593963251|FG000|Overall Study|Screen failure|2|||
164349744|NCT00571948|593655424|FG000|Overall Study|Lost to Follow-up|2|||
164349745|NCT00571948|593655425|FG001|Overall Study|Lost to Follow-up|0|||
164349746|NCT00571948|593655424|FG000|Overall Study|Withdrawal by Subject|1|||
164436172|NCT01651949|593963252|FG001|Overall Study|Screen failure|2|||
164436173|NCT01651949|593963253|FG002|Overall Study|Screen failure|0|||
164349747|NCT00571948|593655425|FG001|Overall Study|Withdrawal by Subject|2|||
164349748|NCT00571948|593655424|FG000|Overall Study|Protocol Violation|3|||
164349749|NCT00571948|593655425|FG001|Overall Study|Protocol Violation|3|||
164349750|NCT00571948|593655424|FG000|Overall Study|infant refused study meal|3|||
164349751|NCT00571948|593655425|FG001|Overall Study|infant refused study meal|4|||
164349752|NCT00571948|593655424|FG000|Overall Study|Parent were afraid of blood colection|2|||
164349753|NCT00571948|593655425|FG001|Overall Study|Parent were afraid of blood colection|5|||
164349754|NCT01845831|593655427|FG000|Inpatient Phase|Withdrawal by Subject|1|||
164349755|NCT01845831|593655428|FG001|Inpatient Phase|Withdrawal by Subject|1|||
164349756|NCT01845831|593655429|FG002|Inpatient Phase|Withdrawal by Subject|0|||
164349757|NCT01845831|593655430|FG003|Inpatient Phase|Withdrawal by Subject|0|||
164349758|NCT01845831|593655431|FG004|Inpatient Phase|Withdrawal by Subject|0|||
164349759|NCT02010775|593655432|FG000|Overall Study|Adverse Event|0|||
164349760|NCT02010775|593655433|FG001|Overall Study|Adverse Event|0|||
164349761|NCT02010775|593655434|FG002|Overall Study|Adverse Event|0|||
164349762|NCT02010775|593655435|FG003|Overall Study|Adverse Event|0|||
164349763|NCT02010775|593655436|FG004|Overall Study|Adverse Event|1|||
164349764|NCT02010775|593655432|FG000|Overall Study|Pregnancy|0|||
164349765|NCT02010775|593655433|FG001|Overall Study|Pregnancy|0|||
164349766|NCT02010775|593655434|FG002|Overall Study|Pregnancy|2|||
164349767|NCT02010775|593655435|FG003|Overall Study|Pregnancy|0|||
164349768|NCT02010775|593655436|FG004|Overall Study|Pregnancy|0|||
164349769|NCT02010775|593655432|FG000|Overall Study|Lost to Follow-up|2|||
164349770|NCT02010775|593655433|FG001|Overall Study|Lost to Follow-up|0|||
164349771|NCT02010775|593655434|FG002|Overall Study|Lost to Follow-up|0|||
164349772|NCT02010775|593655435|FG003|Overall Study|Lost to Follow-up|1|||
164349773|NCT02010775|593655436|FG004|Overall Study|Lost to Follow-up|1|||
164349774|NCT02010775|593655432|FG000|Overall Study|Personal Reasons|3|||
164349775|NCT02010775|593655433|FG001|Overall Study|Personal Reasons|3|||
164349776|NCT02010775|593655434|FG002|Overall Study|Personal Reasons|1|||
164349777|NCT02010775|593655435|FG003|Overall Study|Personal Reasons|2|||
164349778|NCT02010775|593655436|FG004|Overall Study|Personal Reasons|4|||
164349779|NCT02030041|593655438|FG000|Overall Study|Withdrawal by Subject|2|||
164349780|NCT02030041|593655439|FG001|Overall Study|Withdrawal by Subject|2|||
164349781|NCT02030041|593655440|FG002|Overall Study|Withdrawal by Subject|1|||
164349782|NCT02006719|593655441|FG000|Overall Study|Withdrawal by Subject|10|||
164349783|NCT02006719|593655442|FG001|Overall Study|Withdrawal by Subject|2|||
164349784|NCT02006719|593655441|FG000|Overall Study|Lost to Follow-up|5|||
164349785|NCT02006719|593655442|FG001|Overall Study|Lost to Follow-up|1|||
164349786|NCT02006719|593655441|FG000|Overall Study|Protocol Violation|2|||
164349787|NCT02006719|593655442|FG001|Overall Study|Protocol Violation|0|||
164349788|NCT02006719|593655441|FG000|Overall Study|Adverse Event|1|||
164349789|NCT02006719|593655442|FG001|Overall Study|Adverse Event|1|||
164349790|NCT02006719|593655441|FG000|Overall Study|Other/Unknown|0|||
164349791|NCT02006719|593655442|FG001|Overall Study|Other/Unknown|1|||
164349792|NCT00496054|593655448|FG000|Overall Study|Adverse Event|1|||
164349793|NCT00496054|593655448|FG000|Overall Study|Lost to Follow-up|7|||
164349794|NCT01737697|593655449|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
164349795|NCT01737697|593655450|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
164349796|NCT01737697|593655451|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
164349797|NCT01737697|593655452|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
164349798|NCT01737697|593655453|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
164349799|NCT01737697|593655454|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
164349800|NCT01737697|593655455|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
164349801|NCT01737697|593655456|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
164349802|NCT01737697|593655457|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
164349803|NCT01737697|593655458|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
164349804|NCT01737697|593655459|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
164349805|NCT01737697|593655460|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
164349806|NCT01737697|593655461|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
164349807|NCT01737697|593655462|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
164349808|NCT01737697|593655463|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
164349809|NCT01737697|593655449|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
164349810|NCT01737697|593655450|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
164349811|NCT01737697|593655451|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
164349812|NCT01737697|593655452|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
164349813|NCT01737697|593655453|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
164349814|NCT01737697|593655454|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
164349815|NCT01737697|593655455|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
164349816|NCT01737697|593655456|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
164349817|NCT01737697|593655457|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
164349818|NCT01737697|593655458|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
164349819|NCT01737697|593655459|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
164349820|NCT01737697|593655460|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
164349821|NCT01737697|593655461|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
164587939|NCT01614769|594517438|FG004|Period 1|Withdrawal by Subject|0|||
164349822|NCT01737697|593655462|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
164349823|NCT01737697|593655463|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
164349824|NCT01737697|593655449|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349825|NCT01737697|593655450|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349826|NCT01737697|593655451|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349827|NCT01737697|593655452|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
164349828|NCT01737697|593655453|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349829|NCT01737697|593655454|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349830|NCT01737697|593655455|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349831|NCT01737697|593655456|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349832|NCT01737697|593655457|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349833|NCT01737697|593655458|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349834|NCT01737697|593655459|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349835|NCT01737697|593655460|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349836|NCT01737697|593655461|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349837|NCT01737697|593655462|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349838|NCT01737697|593655463|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349839|NCT01737697|593655449|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349840|NCT01737697|593655450|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
164349841|NCT01737697|593655451|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349842|NCT01737697|593655452|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349843|NCT01737697|593655453|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349844|NCT01737697|593655454|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349845|NCT01737697|593655455|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349846|NCT01737697|593655456|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349847|NCT01737697|593655457|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349848|NCT01737697|593655458|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349849|NCT01737697|593655459|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349850|NCT01737697|593655460|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349851|NCT01737697|593655461|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349852|NCT01737697|593655462|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349853|NCT01737697|593655463|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349854|NCT01737697|593655449|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349855|NCT01737697|593655450|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349856|NCT01737697|593655451|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349857|NCT01737697|593655452|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349858|NCT01737697|593655453|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
164349859|NCT01737697|593655454|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349860|NCT01737697|593655455|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349861|NCT01737697|593655456|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349862|NCT01737697|593655457|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349863|NCT01737697|593655458|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349864|NCT01737697|593655459|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349865|NCT01737697|593655460|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349866|NCT01737697|593655461|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349867|NCT01737697|593655462|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349868|NCT01737697|593655463|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349869|NCT01737697|593655449|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
164349870|NCT01737697|593655450|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
164349871|NCT01737697|593655451|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
164349872|NCT01737697|593655452|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
164349873|NCT01737697|593655453|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
164349874|NCT01737697|593655454|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
164349875|NCT01737697|593655455|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
164349876|NCT01737697|593655456|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
164349877|NCT01737697|593655457|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
164349878|NCT01737697|593655458|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
164349879|NCT01737697|593655459|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
164349880|NCT01737697|593655460|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
164349881|NCT01737697|593655461|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
164693824|NCT02695719|594901189|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
164693825|NCT02695719|594901190|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
164693826|NCT02695719|594901189|FG000|Overall Study|Significant Protocol Deviation|0|||
164349882|NCT01737697|593655462|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
164349883|NCT01737697|593655463|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
164349884|NCT01737697|593655449|FG000|Subacute Phase|Adverse Event|0|||
164349885|NCT01737697|593655450|FG001|Subacute Phase|Adverse Event|0|||
164349886|NCT01737697|593655451|FG002|Subacute Phase|Adverse Event|0|||
164349887|NCT01737697|593655452|FG003|Subacute Phase|Adverse Event|0|||
164349888|NCT01737697|593655453|FG004|Subacute Phase|Adverse Event|0|||
164349889|NCT01737697|593655454|FG005|Subacute Phase|Adverse Event|1|||
164349890|NCT01737697|593655455|FG006|Subacute Phase|Adverse Event|1|||
164349891|NCT01737697|593655456|FG007|Subacute Phase|Adverse Event|1|||
164349892|NCT01737697|593655457|FG008|Subacute Phase|Adverse Event|1|||
164349893|NCT01737697|593655458|FG009|Subacute Phase|Adverse Event|1|||
164349894|NCT01737697|593655459|FG010|Subacute Phase|Adverse Event|4|||
164349895|NCT01737697|593655460|FG011|Subacute Phase|Adverse Event|1|||
164349896|NCT01737697|593655461|FG012|Subacute Phase|Adverse Event|1|||
164349897|NCT01737697|593655462|FG013|Subacute Phase|Adverse Event|0|||
164349898|NCT01737697|593655463|FG014|Subacute Phase|Adverse Event|0|||
164349899|NCT01737697|593655449|FG000|Subacute Phase|Withdrawal by Subject|0|||
164349900|NCT01737697|593655450|FG001|Subacute Phase|Withdrawal by Subject|0|||
164349901|NCT01737697|593655451|FG002|Subacute Phase|Withdrawal by Subject|0|||
164349902|NCT01737697|593655452|FG003|Subacute Phase|Withdrawal by Subject|0|||
164349903|NCT01737697|593655453|FG004|Subacute Phase|Withdrawal by Subject|0|||
164349904|NCT01737697|593655454|FG005|Subacute Phase|Withdrawal by Subject|1|||
164349905|NCT01737697|593655455|FG006|Subacute Phase|Withdrawal by Subject|0|||
164349906|NCT01737697|593655456|FG007|Subacute Phase|Withdrawal by Subject|2|||
164349907|NCT01737697|593655457|FG008|Subacute Phase|Withdrawal by Subject|0|||
164349908|NCT01737697|593655458|FG009|Subacute Phase|Withdrawal by Subject|1|||
164349909|NCT01737697|593655459|FG010|Subacute Phase|Withdrawal by Subject|0|||
164349910|NCT01737697|593655460|FG011|Subacute Phase|Withdrawal by Subject|1|||
164349911|NCT01737697|593655461|FG012|Subacute Phase|Withdrawal by Subject|1|||
164349912|NCT01737697|593655462|FG013|Subacute Phase|Withdrawal by Subject|1|||
164349913|NCT01737697|593655463|FG014|Subacute Phase|Withdrawal by Subject|0|||
164349914|NCT01737697|593655449|FG000|Subacute Phase|Lost to Follow-up|0|||
164349915|NCT01737697|593655450|FG001|Subacute Phase|Lost to Follow-up|0|||
164349916|NCT01737697|593655451|FG002|Subacute Phase|Lost to Follow-up|0|||
164349917|NCT01737697|593655452|FG003|Subacute Phase|Lost to Follow-up|0|||
164349918|NCT01737697|593655453|FG004|Subacute Phase|Lost to Follow-up|0|||
164349919|NCT01737697|593655454|FG005|Subacute Phase|Lost to Follow-up|0|||
164349920|NCT01737697|593655455|FG006|Subacute Phase|Lost to Follow-up|0|||
164349921|NCT01737697|593655456|FG007|Subacute Phase|Lost to Follow-up|0|||
164349922|NCT01737697|593655457|FG008|Subacute Phase|Lost to Follow-up|0|||
164349923|NCT01737697|593655458|FG009|Subacute Phase|Lost to Follow-up|0|||
164349924|NCT01737697|593655459|FG010|Subacute Phase|Lost to Follow-up|0|||
164349925|NCT01737697|593655460|FG011|Subacute Phase|Lost to Follow-up|0|||
164349926|NCT01737697|593655461|FG012|Subacute Phase|Lost to Follow-up|0|||
164349927|NCT01737697|593655462|FG013|Subacute Phase|Lost to Follow-up|0|||
164349928|NCT01737697|593655463|FG014|Subacute Phase|Lost to Follow-up|1|||
164349929|NCT01737697|593655449|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
164349930|NCT01737697|593655450|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
164349931|NCT01737697|593655451|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
164349932|NCT01737697|593655452|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
164349933|NCT01737697|593655453|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
164349934|NCT01737697|593655454|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
164349935|NCT01737697|593655455|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
164349936|NCT01737697|593655456|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
164349937|NCT01737697|593655457|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
164349938|NCT01737697|593655458|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
164349939|NCT01737697|593655459|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
164349940|NCT01737697|593655460|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
164349941|NCT01737697|593655461|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
164349942|NCT01737697|593655462|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
164349943|NCT01737697|593655463|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
164349944|NCT01737697|593655449|FG000|Subacute Phase|Protocol Violation|0|||
164349945|NCT01737697|593655450|FG001|Subacute Phase|Protocol Violation|0|||
164349946|NCT01737697|593655451|FG002|Subacute Phase|Protocol Violation|0|||
164349947|NCT01737697|593655452|FG003|Subacute Phase|Protocol Violation|0|||
164349948|NCT01737697|593655453|FG004|Subacute Phase|Protocol Violation|0|||
164349949|NCT01737697|593655454|FG005|Subacute Phase|Protocol Violation|1|||
164349950|NCT01737697|593655455|FG006|Subacute Phase|Protocol Violation|0|||
164349951|NCT01737697|593655456|FG007|Subacute Phase|Protocol Violation|0|||
164349952|NCT01737697|593655457|FG008|Subacute Phase|Protocol Violation|0|||
164349953|NCT01737697|593655458|FG009|Subacute Phase|Protocol Violation|0|||
164349954|NCT01737697|593655459|FG010|Subacute Phase|Protocol Violation|1|||
164349955|NCT01737697|593655460|FG011|Subacute Phase|Protocol Violation|0|||
164349956|NCT01737697|593655461|FG012|Subacute Phase|Protocol Violation|0|||
164349957|NCT01737697|593655462|FG013|Subacute Phase|Protocol Violation|0|||
164349958|NCT01737697|593655463|FG014|Subacute Phase|Protocol Violation|0|||
164349959|NCT01737697|593655449|FG000|Subacute Phase|Physician Decision|0|||
164349960|NCT01737697|593655450|FG001|Subacute Phase|Physician Decision|0|||
164349961|NCT01737697|593655451|FG002|Subacute Phase|Physician Decision|0|||
164349962|NCT01737697|593655452|FG003|Subacute Phase|Physician Decision|0|||
164349963|NCT01737697|593655453|FG004|Subacute Phase|Physician Decision|0|||
164349964|NCT01737697|593655454|FG005|Subacute Phase|Physician Decision|0|||
164349965|NCT01737697|593655455|FG006|Subacute Phase|Physician Decision|0|||
164349966|NCT01737697|593655456|FG007|Subacute Phase|Physician Decision|0|||
164349967|NCT01737697|593655457|FG008|Subacute Phase|Physician Decision|1|||
164349968|NCT01737697|593655458|FG009|Subacute Phase|Physician Decision|0|||
164349969|NCT01737697|593655459|FG010|Subacute Phase|Physician Decision|0|||
164349970|NCT01737697|593655460|FG011|Subacute Phase|Physician Decision|0|||
164349971|NCT01737697|593655461|FG012|Subacute Phase|Physician Decision|0|||
164349972|NCT01737697|593655462|FG013|Subacute Phase|Physician Decision|0|||
164349973|NCT01737697|593655463|FG014|Subacute Phase|Physician Decision|0|||
164349974|NCT01737697|593655449|FG000|Subacute Phase|Death|0|||
164349975|NCT01737697|593655450|FG001|Subacute Phase|Death|0|||
164349976|NCT01737697|593655451|FG002|Subacute Phase|Death|0|||
164349977|NCT01737697|593655452|FG003|Subacute Phase|Death|0|||
164349978|NCT01737697|593655453|FG004|Subacute Phase|Death|0|||
164349979|NCT01737697|593655454|FG005|Subacute Phase|Death|0|||
164349980|NCT01737697|593655455|FG006|Subacute Phase|Death|0|||
164349981|NCT01737697|593655456|FG007|Subacute Phase|Death|0|||
164349982|NCT01737697|593655457|FG008|Subacute Phase|Death|0|||
164349983|NCT01737697|593655458|FG009|Subacute Phase|Death|0|||
164349984|NCT01737697|593655459|FG010|Subacute Phase|Death|1|||
164349985|NCT01737697|593655460|FG011|Subacute Phase|Death|0|||
164349986|NCT01737697|593655461|FG012|Subacute Phase|Death|0|||
164349987|NCT01737697|593655462|FG013|Subacute Phase|Death|0|||
164349988|NCT01737697|593655463|FG014|Subacute Phase|Death|0|||
164349989|NCT02207244|593655464|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
164349990|NCT02207244|593655465|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
164349991|NCT02207244|593655466|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
164349992|NCT02207244|593655467|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
164349993|NCT02207244|593655468|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
164349994|NCT02207244|593655469|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
164349995|NCT02207244|593655470|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
164349996|NCT02207244|593655471|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
164349997|NCT02207244|593655472|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
164349998|NCT02207244|593655473|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
164349999|NCT02207244|593655474|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
164350000|NCT02207244|593655464|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
164350001|NCT02207244|593655465|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
164350002|NCT02207244|593655466|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
164350003|NCT02207244|593655467|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
164350004|NCT02207244|593655468|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
164350005|NCT02207244|593655469|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
164350006|NCT02207244|593655470|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
164350007|NCT02207244|593655471|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
164350008|NCT02207244|593655472|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
164350009|NCT02207244|593655473|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
164350010|NCT02207244|593655474|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
164350011|NCT02207244|593655464|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
164350012|NCT02207244|593655465|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
164350013|NCT02207244|593655466|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
164350014|NCT02207244|593655467|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
164350015|NCT02207244|593655468|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
164350016|NCT02207244|593655469|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
164350017|NCT02207244|593655470|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
164350018|NCT02207244|593655471|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
164350019|NCT02207244|593655472|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
164350020|NCT02207244|593655473|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
164350021|NCT02207244|593655474|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
164350022|NCT02207244|593655464|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
164350023|NCT02207244|593655465|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
164350024|NCT02207244|593655466|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
164350025|NCT02207244|593655467|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
164350026|NCT02207244|593655468|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
164350027|NCT02207244|593655469|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
164587940|NCT01614769|594517439|FG005|Period 1|Withdrawal by Subject|0|||
164587941|NCT01614769|594517434|FG000|Period 3|Withdrawal by Subject|0|||
164587942|NCT01614769|594517435|FG001|Period 3|Withdrawal by Subject|0|||
164587943|NCT01614769|594517436|FG002|Period 3|Withdrawal by Subject|1|||
164350028|NCT02207244|593655470|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
164350029|NCT02207244|593655471|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
164350030|NCT02207244|593655472|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
164350031|NCT02207244|593655473|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
164350032|NCT02207244|593655474|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
164350033|NCT02207244|593655464|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
164587944|NCT01614769|594517437|FG003|Period 3|Withdrawal by Subject|0|||
164350034|NCT02207244|593655465|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
164350035|NCT02207244|593655466|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
164350036|NCT02207244|593655467|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
164350037|NCT02207244|593655468|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
164350038|NCT02207244|593655469|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
164350039|NCT02207244|593655470|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
164350040|NCT02207244|593655471|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
164350041|NCT02207244|593655472|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
164350042|NCT02207244|593655473|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
164350043|NCT02207244|593655474|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
164350044|NCT02207244|593655464|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
164350045|NCT02207244|593655465|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
164350046|NCT02207244|593655466|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
164350047|NCT02207244|593655467|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
164350048|NCT02207244|593655468|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
164350049|NCT02207244|593655469|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
164350050|NCT02207244|593655470|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
164350051|NCT02207244|593655471|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
164350052|NCT02207244|593655472|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
164350053|NCT02207244|593655473|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
164350054|NCT02207244|593655474|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
164350055|NCT02207244|593655464|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
164350056|NCT02207244|593655465|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
164350057|NCT02207244|593655466|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
164350058|NCT02207244|593655467|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
164350059|NCT02207244|593655468|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
164350060|NCT02207244|593655469|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
164350061|NCT02207244|593655470|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
164350062|NCT02207244|593655471|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
164350063|NCT02207244|593655472|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
164350064|NCT02207244|593655473|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
164350065|NCT02207244|593655474|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
164350066|NCT02207244|593655464|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
164350067|NCT02207244|593655465|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
164350068|NCT02207244|593655466|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
164350069|NCT02207244|593655467|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
164350070|NCT02207244|593655468|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
164350071|NCT02207244|593655469|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
164350072|NCT02207244|593655470|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
164350073|NCT02207244|593655471|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
164350074|NCT02207244|593655472|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
164350075|NCT02207244|593655473|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
164350076|NCT02207244|593655474|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
164350077|NCT02207244|593655464|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
164350078|NCT02207244|593655465|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
164350079|NCT02207244|593655466|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
164350080|NCT02207244|593655467|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
164350081|NCT02207244|593655468|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
164350082|NCT02207244|593655469|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
164350083|NCT02207244|593655470|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
164350084|NCT02207244|593655471|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
164350085|NCT02207244|593655472|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
164350086|NCT02207244|593655473|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
164350087|NCT02207244|593655474|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
164350088|NCT02207244|593655464|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
164436174|NCT01651949|593963251|FG000|Overall Study|Withdrawal by Subject|17|||
164350089|NCT02207244|593655465|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
164436175|NCT01651949|593963252|FG001|Overall Study|Withdrawal by Subject|18|||
164350090|NCT02207244|593655466|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
164350091|NCT02207244|593655467|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
164350092|NCT02207244|593655468|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
164350093|NCT02207244|593655469|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
164350094|NCT02207244|593655470|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
164350095|NCT02207244|593655471|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
164350096|NCT02207244|593655472|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
164587945|NCT01614769|594517438|FG004|Period 3|Withdrawal by Subject|0|||
164587946|NCT01614769|594517439|FG005|Period 3|Withdrawal by Subject|0|||
164350097|NCT02207244|593655473|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
164350098|NCT02207244|593655474|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
164350099|NCT02207244|593655464|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
164350100|NCT02207244|593655465|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
164350101|NCT02207244|593655466|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
164350102|NCT02207244|593655467|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
164350103|NCT02207244|593655468|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
164350104|NCT02207244|593655469|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
164350105|NCT02207244|593655470|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
164350106|NCT02207244|593655471|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
164350107|NCT02207244|593655472|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
164350108|NCT02207244|593655473|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
164350109|NCT02207244|593655474|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
164350110|NCT02207244|593655464|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
164350111|NCT02207244|593655465|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
164350112|NCT02207244|593655466|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
164350113|NCT02207244|593655467|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
164350114|NCT02207244|593655468|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
164350115|NCT02207244|593655469|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
164350116|NCT02207244|593655470|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
164350117|NCT02207244|593655471|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
164350118|NCT02207244|593655472|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
164350119|NCT02207244|593655473|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
164350120|NCT02207244|593655474|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
164350121|NCT02207244|593655464|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
164350122|NCT02207244|593655465|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
164350123|NCT02207244|593655466|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
164350124|NCT02207244|593655467|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
164350125|NCT02207244|593655468|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
164350126|NCT02207244|593655469|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
164350127|NCT02207244|593655470|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
164350128|NCT02207244|593655471|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
164350129|NCT02207244|593655472|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
164350130|NCT02207244|593655473|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
164350131|NCT02207244|593655474|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
164350132|NCT02207244|593655464|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
164350133|NCT02207244|593655465|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
164350134|NCT02207244|593655466|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
164350135|NCT02207244|593655467|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
164350136|NCT02207244|593655468|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
164350137|NCT02207244|593655469|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
164350138|NCT02207244|593655470|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
164350139|NCT02207244|593655471|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
164350140|NCT02207244|593655472|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
164350141|NCT02207244|593655473|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
164350142|NCT02207244|593655474|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
164350143|NCT02207244|593655464|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
164350144|NCT02207244|593655465|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
164350145|NCT02207244|593655466|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
164350146|NCT02207244|593655467|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
164350147|NCT02207244|593655468|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
164350148|NCT02207244|593655469|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
164350149|NCT02207244|593655470|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
164350150|NCT02207244|593655471|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
164350151|NCT02207244|593655472|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
164350152|NCT02207244|593655473|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
164350153|NCT02207244|593655474|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
164350154|NCT02207244|593655464|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
164350155|NCT02207244|593655465|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
164350156|NCT02207244|593655466|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
164350157|NCT02207244|593655467|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
164350158|NCT02207244|593655468|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
164350159|NCT02207244|593655469|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
164350160|NCT02207244|593655470|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
164350161|NCT02207244|593655471|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
164350162|NCT02207244|593655472|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
164350163|NCT02207244|593655473|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
164350164|NCT02207244|593655474|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
164350165|NCT02207244|593655464|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
164350166|NCT02207244|593655465|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
164350167|NCT02207244|593655466|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
164350168|NCT02207244|593655467|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
164350169|NCT02207244|593655468|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
164350170|NCT02207244|593655469|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
164350171|NCT02207244|593655470|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
164350172|NCT02207244|593655471|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
164350173|NCT02207244|593655472|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
164350174|NCT02207244|593655473|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
164350175|NCT02207244|593655474|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
164350176|NCT02207244|593655464|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
164350177|NCT02207244|593655465|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
164350178|NCT02207244|593655466|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
164350179|NCT02207244|593655467|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
164350180|NCT02207244|593655468|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
164350181|NCT02207244|593655469|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
164350182|NCT02207244|593655470|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
164350183|NCT02207244|593655471|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
164350184|NCT02207244|593655472|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
164350185|NCT02207244|593655473|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
164350186|NCT02207244|593655474|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
164350187|NCT02207244|593655464|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
164350188|NCT02207244|593655465|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
164350189|NCT02207244|593655466|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
164350190|NCT02207244|593655467|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
164350191|NCT02207244|593655468|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
164350192|NCT02207244|593655469|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
164350193|NCT02207244|593655470|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
164350194|NCT02207244|593655471|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
164350195|NCT02207244|593655472|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
164350196|NCT02207244|593655473|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
164350197|NCT02207244|593655474|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
164350198|NCT02207244|593655464|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
164350199|NCT02207244|593655465|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
164350200|NCT02207244|593655466|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
164350201|NCT02207244|593655467|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
164350202|NCT02207244|593655468|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
164350203|NCT02207244|593655469|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
164350204|NCT02207244|593655470|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
164350205|NCT02207244|593655471|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
164350206|NCT02207244|593655472|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
164350207|NCT02207244|593655473|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
164350208|NCT02207244|593655474|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
164350209|NCT02207244|593655464|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
164350210|NCT02207244|593655465|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
164350211|NCT02207244|593655466|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
164350212|NCT02207244|593655467|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
164350213|NCT02207244|593655468|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
164350214|NCT02207244|593655469|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
164350215|NCT02207244|593655470|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
164350216|NCT02207244|593655471|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
164350217|NCT02207244|593655472|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
164350218|NCT02207244|593655473|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
164350219|NCT02207244|593655474|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
164350220|NCT02207244|593655464|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
164350221|NCT02207244|593655465|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
164350222|NCT02207244|593655466|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
164350223|NCT02207244|593655467|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
164350224|NCT02207244|593655468|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
164350225|NCT02207244|593655469|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
164350226|NCT02207244|593655470|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
164350227|NCT02207244|593655471|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
164350228|NCT02207244|593655472|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
164350229|NCT02207244|593655473|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
164350230|NCT02207244|593655474|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
164350231|NCT02207244|593655464|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
164350232|NCT02207244|593655465|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
164350233|NCT02207244|593655466|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
164350234|NCT02207244|593655467|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
164350235|NCT02207244|593655468|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
164350236|NCT02207244|593655469|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
164350237|NCT02207244|593655470|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
164350238|NCT02207244|593655471|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
164350239|NCT02207244|593655472|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
164350240|NCT02207244|593655473|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
164350241|NCT02207244|593655474|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
164350242|NCT02207244|593655464|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
164350243|NCT02207244|593655465|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
164350244|NCT02207244|593655466|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
164587947|NCT02115815|594517440|FG000|Overall Study|Withdrawal by Subject|2|||
164587948|NCT02115815|594517441|FG001|Overall Study|Withdrawal by Subject|0|||
164350245|NCT02207244|593655467|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
164350246|NCT02207244|593655468|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
164350247|NCT02207244|593655469|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
164350248|NCT02207244|593655470|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
164350249|NCT02207244|593655471|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
164350250|NCT02207244|593655472|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
164350251|NCT02207244|593655473|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
164350252|NCT02207244|593655474|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
164350253|NCT02207244|593655464|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
164350254|NCT02207244|593655465|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
164350255|NCT02207244|593655466|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
164350256|NCT02207244|593655467|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
164350257|NCT02207244|593655468|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
164350258|NCT02207244|593655469|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
164350259|NCT02207244|593655470|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
164350260|NCT02207244|593655471|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
164350261|NCT02207244|593655472|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
164350262|NCT02207244|593655473|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
164350263|NCT02207244|593655474|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
164350264|NCT02207244|593655464|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
164350265|NCT02207244|593655465|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
164350266|NCT02207244|593655466|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
164350267|NCT02207244|593655467|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
164350268|NCT02207244|593655468|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
164350269|NCT02207244|593655469|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
164350270|NCT02207244|593655470|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
164350271|NCT02207244|593655471|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
164350272|NCT02207244|593655472|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
164350273|NCT02207244|593655473|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
164350274|NCT02207244|593655474|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
164350275|NCT02207244|593655464|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
164350276|NCT02207244|593655465|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
164350277|NCT02207244|593655466|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
164350278|NCT02207244|593655467|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
164587949|NCT02115815|594517442|FG002|Overall Study|Withdrawal by Subject|0|||
164350279|NCT02207244|593655468|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
164350280|NCT02207244|593655469|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
164350281|NCT02207244|593655470|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
164350282|NCT02207244|593655471|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
164350283|NCT02207244|593655472|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
164350284|NCT02207244|593655473|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
164350285|NCT02207244|593655474|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
164587950|NCT02115815|594517443|FG003|Overall Study|Withdrawal by Subject|0|||
164350286|NCT02207244|593655464|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
164350287|NCT02207244|593655465|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
164350288|NCT02207244|593655466|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
164350289|NCT02207244|593655467|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
164350290|NCT02207244|593655468|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
164350291|NCT02207244|593655469|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
164350292|NCT02207244|593655470|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
164350293|NCT02207244|593655471|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
164350294|NCT02207244|593655472|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
164350295|NCT02207244|593655473|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
164350296|NCT02207244|593655474|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
164350297|NCT02207244|593655464|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
164350298|NCT02207244|593655465|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
164350299|NCT02207244|593655466|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
164350300|NCT02207244|593655467|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
164350301|NCT02207244|593655468|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
164350302|NCT02207244|593655469|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
164350303|NCT02207244|593655470|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
164350304|NCT02207244|593655471|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
164350305|NCT02207244|593655472|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
164350306|NCT02207244|593655473|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
164350307|NCT02207244|593655474|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
164350308|NCT01866930|593655477|FG000|Treatment Period|Other|1|||
164350309|NCT01866930|593655478|FG001|Treatment Period|Other|0|||
164350310|NCT01866930|593655477|FG000|Treatment Period|Death|0|||
164350311|NCT01866930|593655478|FG001|Treatment Period|Death|2|||
164350312|NCT01866930|593655477|FG000|Treatment Period|Poor/non compliance|0|||
164350313|NCT01866930|593655478|FG001|Treatment Period|Poor/non compliance|2|||
164350314|NCT01866930|593655477|FG000|Treatment Period|No longer meets study criteria|0|||
164350315|NCT01866930|593655478|FG001|Treatment Period|No longer meets study criteria|1|||
164350316|NCT01866930|593655477|FG000|Treatment Period|Withdrawal by Subject|2|||
164350317|NCT01866930|593655478|FG001|Treatment Period|Withdrawal by Subject|8|||
164350318|NCT01866930|593655477|FG000|Treatment Period|Lack of Efficacy|1|||
164350319|NCT01866930|593655478|FG001|Treatment Period|Lack of Efficacy|9|||
164350320|NCT01866930|593655477|FG000|Treatment Period|Adverse Event|4|||
164350321|NCT01866930|593655478|FG001|Treatment Period|Adverse Event|12|||
164350322|NCT01866930|593655477|FG000|Treatment Period|Lost to Follow-up|1|||
164350323|NCT01866930|593655478|FG001|Treatment Period|Lost to Follow-up|1|||
164350324|NCT01866930|593655477|FG000|Follow-up Period|Lost to Follow-up|1|||
164350325|NCT01866930|593655478|FG001|Follow-up Period|Lost to Follow-up|1|||
164350326|NCT01866930|593655477|FG000|Follow-up Period|Other|1|||
164350327|NCT01866930|593655478|FG001|Follow-up Period|Other|5|||
164350328|NCT01866930|593655477|FG000|Follow-up Period|No longer required per protocol|1|||
164350329|NCT01866930|593655478|FG001|Follow-up Period|No longer required per protocol|0|||
164350330|NCT01866930|593655477|FG000|Follow-up Period|Withdrawal by Subject|3|||
164350331|NCT01866930|593655478|FG001|Follow-up Period|Withdrawal by Subject|3|||
164350332|NCT00471328|593655483|FG000|Core Phase|Adverse Event|18|||
164350333|NCT00471328|593655484|FG001|Core Phase|Adverse Event|6|||
164350334|NCT00471328|593655483|FG000|Core Phase|Death|8|||
164350335|NCT00471328|593655484|FG001|Core Phase|Death|4|||
164350336|NCT00471328|593655483|FG000|Core Phase|Withdrawal by Subject|2|||
164350337|NCT00471328|593655484|FG001|Core Phase|Withdrawal by Subject|2|||
164350338|NCT00471328|593655483|FG000|Core Phase|Abnormal laboratory value|1|||
164350339|NCT00471328|593655484|FG001|Core Phase|Abnormal laboratory value|0|||
164350340|NCT00471328|593655483|FG000|Core Phase|Disease Progression|78|||
164350341|NCT00471328|593655484|FG001|Core Phase|Disease Progression|53|||
164350342|NCT00471328|593655483|FG000|Core Phase|Administrative Problem|0|||
164587951|NCT02115815|594517444|FG004|Overall Study|Withdrawal by Subject|0|||
164587952|NCT02115815|594517445|FG005|Overall Study|Withdrawal by Subject|0|||
164587953|NCT02115815|594517446|FG006|Overall Study|Withdrawal by Subject|0|||
164587954|NCT02115815|594517440|FG000|Overall Study|Not enough drug to dose participant|0|||
164587955|NCT02115815|594517441|FG001|Overall Study|Not enough drug to dose participant|0|||
164587956|NCT02115815|594517442|FG002|Overall Study|Not enough drug to dose participant|0|||
164587957|NCT02115815|594517443|FG003|Overall Study|Not enough drug to dose participant|0|||
164587958|NCT02115815|594517444|FG004|Overall Study|Not enough drug to dose participant|0|||
164587959|NCT02115815|594517445|FG005|Overall Study|Not enough drug to dose participant|1|||
164587960|NCT02115815|594517446|FG006|Overall Study|Not enough drug to dose participant|0|||
164587961|NCT02115815|594517440|FG000|Overall Study|Missed appointment, randomized in error|0|||
164587962|NCT02115815|594517441|FG001|Overall Study|Missed appointment, randomized in error|0|||
164587963|NCT02115815|594517442|FG002|Overall Study|Missed appointment, randomized in error|0|||
164587964|NCT02115815|594517443|FG003|Overall Study|Missed appointment, randomized in error|0|||
164587965|NCT02115815|594517444|FG004|Overall Study|Missed appointment, randomized in error|0|||
164587966|NCT02115815|594517445|FG005|Overall Study|Missed appointment, randomized in error|1|||
164350343|NCT00471328|593655484|FG001|Core Phase|Administrative Problem|1|||
164350344|NCT00471328|593655483|FG000|Core Phase|Protocol Deviation|0|||
164350345|NCT00471328|593655484|FG001|Core Phase|Protocol Deviation|1|||
164350346|NCT00471328|593655483|FG000|Extension Phase|Adverse Event|3|||
164350347|NCT00471328|593655484|FG001|Extension Phase|Adverse Event|12|||
164350348|NCT00471328|593655483|FG000|Extension Phase|Withdrawal by Subject|0|||
164350349|NCT00471328|593655484|FG001|Extension Phase|Withdrawal by Subject|2|||
164350350|NCT00471328|593655483|FG000|Extension Phase|Death|1|||
164350351|NCT00471328|593655484|FG001|Extension Phase|Death|7|||
164350352|NCT00471328|593655483|FG000|Extension Phase|Protocol Deviation|3|||
164350353|NCT00471328|593655484|FG001|Extension Phase|Protocol Deviation|1|||
164350354|NCT00471328|593655483|FG000|Extension Phase|Treatment duration as per protocol|0|||
164350355|NCT00471328|593655484|FG001|Extension Phase|Treatment duration as per protocol|1|||
164350356|NCT00471328|593655483|FG000|Extension Phase|Disease Progression|32|||
164350357|NCT00471328|593655484|FG001|Extension Phase|Disease Progression|44|||
164350358|NCT00471328|593655483|FG000|Extension Phase|New cancer Therapy|1|||
164350359|NCT00471328|593655484|FG001|Extension Phase|New cancer Therapy|0|||
164350360|NCT00471328|593655483|FG000|Extension Phase|Administrative Problem|1|||
164350361|NCT00471328|593655484|FG001|Extension Phase|Administrative Problem|0|||
164350362|NCT02854631|593655485|FG000|Overall Study|Adverse Event|1|||
164350363|NCT02854631|593655486|FG001|Overall Study|Adverse Event|2|||
164350364|NCT02854631|593655485|FG000|Overall Study|Withdrew Consent|3|||
164350365|NCT02854631|593655486|FG001|Overall Study|Withdrew Consent|2|||
164350366|NCT02854631|593655485|FG000|Overall Study|Investigator's Discretion|2|||
164350367|NCT02854631|593655486|FG001|Overall Study|Investigator's Discretion|0|||
164350368|NCT02854631|593655485|FG000|Overall Study|Death|12|||
164350369|NCT02854631|593655486|FG001|Overall Study|Death|8|||
164350370|NCT02854631|593655485|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
164350371|NCT02854631|593655486|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
164350372|NCT02854631|593655485|FG000|Overall Study|Protocol Violation|0|||
164350373|NCT02854631|593655486|FG001|Overall Study|Protocol Violation|1|||
164350374|NCT02854631|593655485|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
164350375|NCT02854631|593655486|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
164350376|NCT02854631|593655485|FG000|Overall Study|Lost to Follow-up|4|||
164350377|NCT02854631|593655486|FG001|Overall Study|Lost to Follow-up|2|||
164350378|NCT03930797|593655487|FG000|Overall Study|Lost to Follow-up|3|||
164350379|NCT03930797|593655488|FG001|Overall Study|Lost to Follow-up|10|||
164350380|NCT03727347|593655493|FG000|Overall Study|Withdrawal by Subject|2|||
164350381|NCT03727347|593655493|FG000|Overall Study|Lost to Follow-up|1|||
164350382|NCT04292743|593655494|FG000|Overall Study|Physician Decision|1|||
164350383|NCT04292743|593655495|FG001|Overall Study|Physician Decision|3|||
164350384|NCT04292743|593655496|FG002|Overall Study|Physician Decision|0|||
164350385|NCT04292743|593655497|FG003|Overall Study|Physician Decision|0|||
164350386|NCT04292743|593655494|FG000|Overall Study|Withdrawal by Subject|0|||
164350387|NCT04292743|593655495|FG001|Overall Study|Withdrawal by Subject|5|||
164350388|NCT04292743|593655496|FG002|Overall Study|Withdrawal by Subject|0|||
164350389|NCT04292743|593655497|FG003|Overall Study|Withdrawal by Subject|0|||
164350390|NCT04292743|593655494|FG000|Overall Study|Death|0|||
164350391|NCT04292743|593655495|FG001|Overall Study|Death|1|||
164350392|NCT04292743|593655496|FG002|Overall Study|Death|0|||
164350393|NCT04292743|593655497|FG003|Overall Study|Death|0|||
164350394|NCT04292743|593655494|FG000|Overall Study|Progression of Disease|2|||
164350395|NCT04292743|593655495|FG001|Overall Study|Progression of Disease|5|||
164350396|NCT04292743|593655496|FG002|Overall Study|Progression of Disease|0|||
164350397|NCT04292743|593655497|FG003|Overall Study|Progression of Disease|0|||
164350398|NCT04292743|593655494|FG000|Overall Study|No Treatment per protocol|0|||
164350399|NCT04292743|593655495|FG001|Overall Study|No Treatment per protocol|2|||
164350400|NCT04292743|593655496|FG002|Overall Study|No Treatment per protocol|0|||
164350401|NCT04292743|593655497|FG003|Overall Study|No Treatment per protocol|0|||
164350402|NCT05330702|593655498|FG000|Overall Study|Study terminated before all 6-month visit data could be collected|9|||
164350403|NCT05330702|593655499|FG001|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
164693827|NCT02695719|594901190|FG001|Overall Study|Significant Protocol Deviation|1|||
164693828|NCT02695719|594901189|FG000|Overall Study|Voluntary Withdrawal|1|||
164693829|NCT02695719|594901190|FG001|Overall Study|Voluntary Withdrawal|0|||
164693830|NCT00892281|594901193|FG000|Overall Study|Adverse Event|65|||
164693831|NCT00892281|594901194|FG001|Overall Study|Adverse Event|8|||
164350404|NCT05330702|593655500|FG002|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
164350405|NCT02881554|593655501|FG000|Overall Study|Withdrawal by Subject|2|||
164350406|NCT02881554|593655502|FG001|Overall Study|Withdrawal by Subject|0|||
164350407|NCT01852110|593657486|FG000|Overall Study|Adverse Event|12|||
164350408|NCT01852110|593657487|FG001|Overall Study|Adverse Event|5|||
164350409|NCT01852110|593657488|FG002|Overall Study|Adverse Event|0|||
164350410|NCT01852110|593657489|FG003|Overall Study|Adverse Event|0|||
164350411|NCT01852110|593657490|FG004|Overall Study|Adverse Event|0|||
164350412|NCT01852110|593657491|FG005|Overall Study|Adverse Event|0|||
164350413|NCT01852110|593657486|FG000|Overall Study|Lost to Follow-up|1|||
164350414|NCT01852110|593657487|FG001|Overall Study|Lost to Follow-up|3|||
164350415|NCT01852110|593657488|FG002|Overall Study|Lost to Follow-up|0|||
164350416|NCT01852110|593657489|FG003|Overall Study|Lost to Follow-up|0|||
164350417|NCT01852110|593657490|FG004|Overall Study|Lost to Follow-up|0|||
164350418|NCT01852110|593657491|FG005|Overall Study|Lost to Follow-up|0|||
164587967|NCT02115815|594517446|FG006|Overall Study|Missed appointment, randomized in error|0|||
164350419|NCT01852110|593657486|FG000|Overall Study|Non-compliance with Study Drug|2|||
164350420|NCT01852110|593657487|FG001|Overall Study|Non-compliance with Study Drug|1|||
164350421|NCT01852110|593657488|FG002|Overall Study|Non-compliance with Study Drug|0|||
164350422|NCT01852110|593657489|FG003|Overall Study|Non-compliance with Study Drug|0|||
164350423|NCT01852110|593657490|FG004|Overall Study|Non-compliance with Study Drug|0|||
164350424|NCT01852110|593657491|FG005|Overall Study|Non-compliance with Study Drug|0|||
164350425|NCT01852110|593657486|FG000|Overall Study|Physician Decision|1|||
164350426|NCT01852110|593657487|FG001|Overall Study|Physician Decision|0|||
164350427|NCT01852110|593657488|FG002|Overall Study|Physician Decision|0|||
164350428|NCT01852110|593657489|FG003|Overall Study|Physician Decision|0|||
164350429|NCT01852110|593657490|FG004|Overall Study|Physician Decision|0|||
164350430|NCT01852110|593657491|FG005|Overall Study|Physician Decision|0|||
164350431|NCT01852110|593657486|FG000|Overall Study|Protocol Violation|0|||
164350432|NCT01852110|593657487|FG001|Overall Study|Protocol Violation|1|||
164350433|NCT01852110|593657488|FG002|Overall Study|Protocol Violation|0|||
164350434|NCT01852110|593657489|FG003|Overall Study|Protocol Violation|0|||
164350435|NCT01852110|593657490|FG004|Overall Study|Protocol Violation|0|||
164350436|NCT01852110|593657491|FG005|Overall Study|Protocol Violation|0|||
164350437|NCT01852110|593657486|FG000|Overall Study|Study Terminated by Sponsor|30|||
164350438|NCT01852110|593657487|FG001|Overall Study|Study Terminated by Sponsor|32|||
164350439|NCT01852110|593657488|FG002|Overall Study|Study Terminated by Sponsor|0|||
164350440|NCT01852110|593657489|FG003|Overall Study|Study Terminated by Sponsor|0|||
164350441|NCT01852110|593657490|FG004|Overall Study|Study Terminated by Sponsor|0|||
164350442|NCT01852110|593657491|FG005|Overall Study|Study Terminated by Sponsor|0|||
164350443|NCT01852110|593657486|FG000|Overall Study|Withdrawal by Subject|4|||
164350444|NCT01852110|593657487|FG001|Overall Study|Withdrawal by Subject|4|||
164350445|NCT01852110|593657488|FG002|Overall Study|Withdrawal by Subject|0|||
164350446|NCT01852110|593657489|FG003|Overall Study|Withdrawal by Subject|0|||
164350447|NCT01852110|593657490|FG004|Overall Study|Withdrawal by Subject|0|||
164350448|NCT01852110|593657491|FG005|Overall Study|Withdrawal by Subject|0|||
164350449|NCT01549860|593657497|FG000|Overall Study|Withdrawal by Subject|1|||
164350450|NCT01549860|593657498|FG001|Overall Study|Withdrawal by Subject|0|||
164350451|NCT01549860|593657497|FG000|Overall Study|Physician Decision|1|||
164350452|NCT01549860|593657498|FG001|Overall Study|Physician Decision|1|||
164350453|NCT01366521|593657500|FG000|Overall Study|Adverse Event|1|||
164350454|NCT01366521|593657501|FG001|Overall Study|Adverse Event|0|||
164350455|NCT01366521|593657502|FG002|Overall Study|Adverse Event|0|||
164350456|NCT01366521|593657503|FG003|Overall Study|Adverse Event|0|||
164350457|NCT01366521|593657500|FG000|Overall Study|Protocol Violation|0|||
164350458|NCT01366521|593657501|FG001|Overall Study|Protocol Violation|0|||
164350459|NCT01366521|593657502|FG002|Overall Study|Protocol Violation|1|||
164350460|NCT01366521|593657503|FG003|Overall Study|Protocol Violation|0|||
164350461|NCT01366521|593657500|FG000|Overall Study|Physician Decision|0|||
164350462|NCT01366521|593657501|FG001|Overall Study|Physician Decision|0|||
164350463|NCT01366521|593657502|FG002|Overall Study|Physician Decision|1|||
164350464|NCT01366521|593657503|FG003|Overall Study|Physician Decision|0|||
164350465|NCT01366521|593657500|FG000|Overall Study|Withdrawal by Subject|0|||
164350466|NCT01366521|593657501|FG001|Overall Study|Withdrawal by Subject|1|||
164350467|NCT01366521|593657502|FG002|Overall Study|Withdrawal by Subject|0|||
164350468|NCT01366521|593657503|FG003|Overall Study|Withdrawal by Subject|0|||
164350469|NCT02430311|593657504|FG000|Part A|Adverse Event|0|||
164350470|NCT02430311|593657505|FG001|Part A|Adverse Event|1|||
164350471|NCT02430311|593657504|FG000|Part A|Withdrawal by Subject|1|||
164350472|NCT02430311|593657505|FG001|Part A|Withdrawal by Subject|0|||
164350473|NCT02430311|593657504|FG000|Part B|Meet study-specific withdrawal criteria|6|||
164350474|NCT02430311|593657505|FG001|Part B|Meet study-specific withdrawal criteria|6|||
164350475|NCT02430311|593657504|FG000|Part B|Withdrawal by Subject|2|||
164350476|NCT02430311|593657505|FG001|Part B|Withdrawal by Subject|2|||
164350477|NCT02430311|593657504|FG000|Part B|Adverse Event|1|||
164350478|NCT02430311|593657505|FG001|Part B|Adverse Event|0|||
164350479|NCT02430311|593657504|FG000|Part B|Death|1|||
164350480|NCT02430311|593657505|FG001|Part B|Death|0|||
164350481|NCT00578812|593657506|FG000|Overall Study|Not treated|6|||
164350482|NCT00578812|593657507|FG001|Overall Study|Not treated|7|||
164350483|NCT00166114|593657522|FG000|Overall Study|Protocol Violation|2|||
164350484|NCT00166114|593657523|FG001|Overall Study|Protocol Violation|1|||
164350485|NCT00166114|593657522|FG000|Overall Study|Withdrawal by Subject|10|||
164350486|NCT00166114|593657523|FG001|Overall Study|Withdrawal by Subject|4|||
164350487|NCT00166114|593657522|FG000|Overall Study|Adverse Event|2|||
164350488|NCT00166114|593657523|FG001|Overall Study|Adverse Event|1|||
164350489|NCT02708121|593657530|FG000|Overall Study|Withdrawn by Study Team|1|||
164350490|NCT02708121|593657531|FG001|Overall Study|Withdrawn by Study Team|1|||
164350491|NCT02708121|593657530|FG000|Overall Study|Withdrawal by Subject|0|||
164350492|NCT02708121|593657531|FG001|Overall Study|Withdrawal by Subject|4|||
164693832|NCT00892281|594901193|FG000|Overall Study|Lost to Follow-up|81|||
164350493|NCT03266107|593657532|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
164350494|NCT03266107|593657532|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
164587968|NCT02819310|594517447|FG000|Overall Study|Withdrawal by Subject|37|||
164587969|NCT02819310|594517447|FG000|Overall Study|Lost to Follow-up|16|||
164587970|NCT02819310|594517447|FG000|Overall Study|Adverse Event|13|||
164587971|NCT02819310|594517447|FG000|Overall Study|Lack of Efficacy|5|||
164587972|NCT02819310|594517447|FG000|Overall Study|Physician Decision|8|||
164587973|NCT02819310|594517447|FG000|Overall Study|Protocol Violation|30|||
164587974|NCT01254604|594517452|FG000|Overall Study|Lost to Follow-up|1|||
164587975|NCT01254604|594517453|FG001|Overall Study|Lost to Follow-up|1|||
164587976|NCT01254604|594517452|FG000|Overall Study|Protocol Violation|2|||
164587977|NCT01254604|594517453|FG001|Overall Study|Protocol Violation|2|||
164587978|NCT01254604|594517452|FG000|Overall Study|Withdrawal by Subject|2|||
164587979|NCT01254604|594517453|FG001|Overall Study|Withdrawal by Subject|4|||
164587980|NCT01254604|594517452|FG000|Overall Study|Adverse Event|3|||
164587981|NCT01254604|594517453|FG001|Overall Study|Adverse Event|2|||
164587982|NCT03074162|594517454|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
164587983|NCT03074162|594517455|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
164587984|NCT03074162|594517456|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
164587985|NCT03074162|594517457|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
164587986|NCT03074162|594517458|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
164587987|NCT03074162|594517459|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
164587988|NCT03074162|594517454|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
164587989|NCT03074162|594517455|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
164587990|NCT03074162|594517456|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
164587991|NCT03074162|594517457|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
164587992|NCT03074162|594517458|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
164587993|NCT03074162|594517459|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
164587994|NCT03074162|594517454|FG000|Period 3|Withdrawal by Subject|1|||
164587995|NCT03074162|594517455|FG001|Period 3|Withdrawal by Subject|0|||
164587996|NCT03074162|594517456|FG002|Period 3|Withdrawal by Subject|0|||
164587997|NCT03074162|594517457|FG003|Period 3|Withdrawal by Subject|0|||
164587998|NCT03074162|594517458|FG004|Period 3|Withdrawal by Subject|1|||
164587999|NCT03074162|594517459|FG005|Period 3|Withdrawal by Subject|0|||
164588000|NCT02778867|594517460|FG000|Phase 1|Withdrawal by Subject|2|||
164588001|NCT02778867|594517461|FG001|Phase 1|Withdrawal by Subject|3|||
164588002|NCT02778867|594517462|FG002|Phase 1|Withdrawal by Subject|0|||
164588003|NCT02778867|594517463|FG003|Phase 1|Withdrawal by Subject|0|||
164588004|NCT02778867|594517460|FG000|Phase 2|Withdrawal by Subject|0|||
164588005|NCT02778867|594517461|FG001|Phase 2|Withdrawal by Subject|0|||
164588006|NCT02778867|594517462|FG002|Phase 2|Withdrawal by Subject|1|||
164588007|NCT02778867|594517463|FG003|Phase 2|Withdrawal by Subject|0|||
164588008|NCT02778867|594517460|FG000|Phase 2|Physician Decision|0|||
164588009|NCT02778867|594517461|FG001|Phase 2|Physician Decision|0|||
164588010|NCT02778867|594517462|FG002|Phase 2|Physician Decision|0|||
164588011|NCT02778867|594517463|FG003|Phase 2|Physician Decision|1|||
164588012|NCT02778867|594517460|FG000|Phase 2|Adverse Event|0|||
164588013|NCT02778867|594517461|FG001|Phase 2|Adverse Event|0|||
164588014|NCT02778867|594517462|FG002|Phase 2|Adverse Event|0|||
164588015|NCT02778867|594517463|FG003|Phase 2|Adverse Event|1|||
164588016|NCT02948777|594517464|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
164588017|NCT02311478|594517465|FG000|Overall Study|Withdrawal by Subject|1|||
164588018|NCT02311478|594517465|FG000|Overall Study|Lost to Follow-up|5|||
164350495|NCT03266107|593657532|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
164350496|NCT03266107|593657532|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
164350497|NCT02548650|593657535|FG000|Triple Therapy|Adverse Event|1|||
164350498|NCT02548650|593657536|FG001|Triple Therapy|Adverse Event|0|||
164350499|NCT02548650|593657535|FG000|Triple Therapy|Withdrawal by Subject|0|||
164350500|NCT02548650|593657536|FG001|Triple Therapy|Withdrawal by Subject|4|||
164350501|NCT02548650|593657535|FG000|Double Therapy|Adverse Event|1|||
164350502|NCT02548650|593657536|FG001|Double Therapy|Adverse Event|1|||
164350503|NCT02548650|593657535|FG000|Double Therapy|Withdrawal by Subject|0|||
164350504|NCT02548650|593657536|FG001|Double Therapy|Withdrawal by Subject|1|||
164350505|NCT01191801|593657537|FG000|Overall Study|Death|36|||
164588019|NCT02311478|594517465|FG000|Overall Study|Failed IUD Insertion|1|||
164350506|NCT01191801|593657538|FG001|Overall Study|Death|12|||
164588020|NCT03242928|594517467|FG000|Overall Study|Adverse Event|2|||
164588021|NCT03242928|594517468|FG001|Overall Study|Adverse Event|1|||
164588022|NCT03242928|594517467|FG000|Overall Study|Lost to Follow-up|2|||
164350507|NCT01191801|593657537|FG000|Overall Study|Lack of Efficacy|176|||
164350508|NCT01191801|593657538|FG001|Overall Study|Lack of Efficacy|258|||
164588023|NCT03242928|594517468|FG001|Overall Study|Lost to Follow-up|0|||
164588024|NCT03242928|594517467|FG000|Overall Study|Physician Decision|0|||
164588025|NCT03242928|594517468|FG001|Overall Study|Physician Decision|1|||
164588026|NCT03242928|594517467|FG000|Overall Study|Withdrawal by Subject|5|||
164693833|NCT00892281|594901194|FG001|Overall Study|Lost to Follow-up|8|||
164693834|NCT00892281|594901193|FG000|Overall Study|Pregnancy|1|||
164350509|NCT01191801|593657537|FG000|Overall Study|Adverse Event|9|||
164350510|NCT01191801|593657538|FG001|Overall Study|Adverse Event|8|||
164350511|NCT01191801|593657537|FG000|Overall Study|Protocol Violation|2|||
164350512|NCT01191801|593657538|FG001|Overall Study|Protocol Violation|4|||
164350513|NCT01191801|593657537|FG000|Overall Study|Physician Decision|47|||
164350514|NCT01191801|593657538|FG001|Overall Study|Physician Decision|24|||
164350515|NCT01191801|593657537|FG000|Overall Study|Withdrawal by Subject|1|||
164350516|NCT01191801|593657538|FG001|Overall Study|Withdrawal by Subject|4|||
164350517|NCT01191801|593657537|FG000|Overall Study|Not Provided|45|||
164350518|NCT01191801|593657538|FG001|Overall Study|Not Provided|27|||
164350519|NCT00299104|593657539|FG000|Treatment Period|Adverse Event|14|||
164350520|NCT00299104|593657540|FG001|Treatment Period|Adverse Event|9|||
164350521|NCT00299104|593657541|FG002|Treatment Period|Adverse Event|7|||
164350522|NCT00299104|593657539|FG000|Treatment Period|Death|1|||
164350523|NCT00299104|593657540|FG001|Treatment Period|Death|1|||
164350524|NCT00299104|593657541|FG002|Treatment Period|Death|1|||
164350525|NCT00299104|593657539|FG000|Treatment Period|Insufficient therapeutic response|34|||
164350526|NCT00299104|593657540|FG001|Treatment Period|Insufficient therapeutic response|13|||
164350527|NCT00299104|593657541|FG002|Treatment Period|Insufficient therapeutic response|8|||
164350528|NCT00299104|593657539|FG000|Treatment Period|Failure to return|9|||
164350529|NCT00299104|593657540|FG001|Treatment Period|Failure to return|8|||
164350530|NCT00299104|593657541|FG002|Treatment Period|Failure to return|8|||
164350531|NCT00299104|593657539|FG000|Treatment Period|Violation of selection criteria|1|||
164350532|NCT00299104|593657540|FG001|Treatment Period|Violation of selection criteria|2|||
164350533|NCT00299104|593657541|FG002|Treatment Period|Violation of selection criteria|0|||
164350534|NCT00299104|593657539|FG000|Treatment Period|Protocol Violation|1|||
164350535|NCT00299104|593657540|FG001|Treatment Period|Protocol Violation|1|||
164350536|NCT00299104|593657541|FG002|Treatment Period|Protocol Violation|0|||
164350537|NCT00299104|593657539|FG000|Treatment Period|Refused treatment|9|||
164350538|NCT00299104|593657540|FG001|Treatment Period|Refused treatment|2|||
164350539|NCT00299104|593657541|FG002|Treatment Period|Refused treatment|2|||
164350540|NCT00299104|593657539|FG000|Treatment Period|Withdrew consent|14|||
164350541|NCT00299104|593657540|FG001|Treatment Period|Withdrew consent|19|||
164350542|NCT00299104|593657541|FG002|Treatment Period|Withdrew consent|9|||
164350543|NCT00299104|593657539|FG000|Treatment Period|Administrative reasons|106|||
164350544|NCT00299104|593657540|FG001|Treatment Period|Administrative reasons|120|||
164350545|NCT00299104|593657541|FG002|Treatment Period|Administrative reasons|137|||
164350546|NCT00299104|593657539|FG000|Safety Follow-Up (SFU) Period|Death|3|||
164350547|NCT00299104|593657540|FG001|Safety Follow-Up (SFU) Period|Death|2|||
164350548|NCT00299104|593657541|FG002|Safety Follow-Up (SFU) Period|Death|1|||
164350549|NCT00299104|593657539|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
164350550|NCT00299104|593657540|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
164350551|NCT00299104|593657541|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
164350552|NCT00299104|593657539|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
164350553|NCT00299104|593657540|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
164350554|NCT00299104|593657541|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
164350555|NCT00299104|593657539|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
164350556|NCT00299104|593657540|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
164350557|NCT00299104|593657541|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
164350558|NCT00299104|593657539|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
164350559|NCT00299104|593657540|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
164350560|NCT00299104|593657541|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
164350561|NCT00299104|593657539|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
164350562|NCT00299104|593657540|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
164350563|NCT00299104|593657541|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
164350564|NCT00299104|593657539|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
164350565|NCT00299104|593657540|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
164350566|NCT00299104|593657541|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
164350567|NCT00299104|593657539|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
164350568|NCT00299104|593657540|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
164350569|NCT00299104|593657541|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
164350570|NCT03167411|593657545|FG000|Overall Study|Adverse Event|0|||
164350571|NCT03167411|593657546|FG001|Overall Study|Adverse Event|1|||
164350572|NCT02651922|593657547|FG000|Overall Study|due to exclusion criteria|2|||
164350573|NCT01366209|593657548|FG000|Overall Study|Adverse Event|6|||
164350574|NCT01366209|593657549|FG001|Overall Study|Adverse Event|7|||
164350575|NCT01366209|593657548|FG000|Overall Study|Withdrawal by Subject|4|||
164350576|NCT01366209|593657549|FG001|Overall Study|Withdrawal by Subject|4|||
164350577|NCT01366209|593657548|FG000|Overall Study|Death|12|||
164350578|NCT01366209|593657549|FG001|Overall Study|Death|19|||
164350579|NCT01366209|593657548|FG000|Overall Study|Lung transplantation|6|||
164350580|NCT01366209|593657549|FG001|Overall Study|Lung transplantation|1|||
164350581|NCT01366209|593657548|FG000|Overall Study|Lost to Follow-up|2|||
164350582|NCT01366209|593657549|FG001|Overall Study|Lost to Follow-up|1|||
164436176|NCT01651949|593963253|FG002|Overall Study|Withdrawal by Subject|9|||
164436177|NCT01806714|593963256|FG000|Overall Study|No functioning phone number|200|||
164436178|NCT01806714|593963257|FG001|Overall Study|No functioning phone number|170|||
164436179|NCT02750709|593963260|FG000|Treatment Period 1|Adverse Event|0|||
164436180|NCT02750709|593963261|FG001|Treatment Period 1|Adverse Event|0|||
164436181|NCT02750709|593963262|FG002|Treatment Period 1|Adverse Event|0|||
164436182|NCT02750709|593963263|FG003|Treatment Period 1|Adverse Event|0|||
164350583|NCT01366209|593657548|FG000|Overall Study|Physician Decision|1|||
164350584|NCT01366209|593657549|FG001|Overall Study|Physician Decision|0|||
164350585|NCT01366209|593657548|FG000|Overall Study|Sponsors decision|0|||
164350586|NCT01366209|593657549|FG001|Overall Study|Sponsors decision|1|||
164350587|NCT01366209|593657548|FG000|Overall Study|Withdrew consent|4|||
164350588|NCT01366209|593657549|FG001|Overall Study|Withdrew consent|3|||
164350589|NCT00420927|593657550|FG000|Period 1|Adverse Event|19|||
164350590|NCT00420927|593657551|FG001|Period 1|Adverse Event|15|||
164350591|NCT00420927|593657552|FG002|Period 1|Adverse Event|0|||
164350592|NCT00420927|593657553|FG003|Period 1|Adverse Event|0|||
164350593|NCT00420927|593657554|FG004|Period 1|Adverse Event|0|||
164436183|NCT02750709|593963264|FG004|Treatment Period 1|Adverse Event|0|||
164436184|NCT02750709|593963265|FG005|Treatment Period 1|Adverse Event|1|||
164436185|NCT01120275|593963267|FG000|Overall Study|Adverse Event|3|||
164436186|NCT01120275|593963267|FG000|Overall Study|Progression|27|||
164350594|NCT00420927|593657555|FG005|Period 1|Adverse Event|0|||
164350595|NCT00420927|593657556|FG006|Period 1|Adverse Event|0|||
164350596|NCT00420927|593657550|FG000|Period 1|Withdrawal by Subject|7|||
164350597|NCT00420927|593657551|FG001|Period 1|Withdrawal by Subject|12|||
164350598|NCT00420927|593657552|FG002|Period 1|Withdrawal by Subject|0|||
164350599|NCT00420927|593657553|FG003|Period 1|Withdrawal by Subject|0|||
164350600|NCT00420927|593657554|FG004|Period 1|Withdrawal by Subject|0|||
164350601|NCT00420927|593657555|FG005|Period 1|Withdrawal by Subject|0|||
164350602|NCT00420927|593657556|FG006|Period 1|Withdrawal by Subject|0|||
164350603|NCT00420927|593657550|FG000|Period 1|Lost to Follow-up|8|||
164350604|NCT00420927|593657551|FG001|Period 1|Lost to Follow-up|6|||
164350605|NCT00420927|593657552|FG002|Period 1|Lost to Follow-up|0|||
164350606|NCT00420927|593657553|FG003|Period 1|Lost to Follow-up|0|||
164350607|NCT00420927|593657554|FG004|Period 1|Lost to Follow-up|0|||
164436187|NCT01120275|593963267|FG000|Overall Study|Ineligible|3|||
164436188|NCT01120275|593963267|FG000|Overall Study|Withdrawal by Subject|1|||
164436189|NCT01120275|593963267|FG000|Overall Study|Refusal|1|||
164436190|NCT01120275|593963267|FG000|Overall Study|Not specific|1|||
164436191|NCT00771849|593963268|FG000|Overall Study|Lost to Follow-up|1|||
164436192|NCT00771849|593963269|FG001|Overall Study|Lost to Follow-up|2|||
164436193|NCT00771849|593963268|FG000|Overall Study|Withdrawal by Subject|1|||
164436194|NCT00771849|593963269|FG001|Overall Study|Withdrawal by Subject|1|||
164436195|NCT00771849|593963268|FG000|Overall Study|Not vaccinated|0|||
164436196|NCT00771849|593963269|FG001|Overall Study|Not vaccinated|1|||
164436197|NCT00290732|593963270|FG000|Overall Study|Inability to instill drug intraductally.|0|||
164436198|NCT00290732|593963271|FG001|Overall Study|Inability to instill drug intraductally.|1|||
164436199|NCT00290732|593963272|FG002|Overall Study|Inability to instill drug intraductally.|1|||
164436200|NCT00290732|593963273|FG003|Overall Study|Inability to instill drug intraductally.|0|||
164436201|NCT00290732|593963274|FG004|Overall Study|Inability to instill drug intraductally.|0|||
164436202|NCT02736799|593963278|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
164436203|NCT02736799|593963279|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
164436204|NCT02736799|593963280|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
164436205|NCT02736799|593963281|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
164436206|NCT00843193|593963282|FG000|Overall Study|Adverse Event|2|||
164693835|NCT00892281|594901194|FG001|Overall Study|Pregnancy|0|||
164693836|NCT00892281|594901193|FG000|Overall Study|Protocol Violation|7|||
164693837|NCT00892281|594901194|FG001|Overall Study|Protocol Violation|2|||
164693838|NCT00892281|594901193|FG000|Overall Study|Withdrawal by Subject|86|||
164693839|NCT00892281|594901194|FG001|Overall Study|Withdrawal by Subject|14|||
164350608|NCT00420927|593657555|FG005|Period 1|Lost to Follow-up|0|||
164350609|NCT00420927|593657556|FG006|Period 1|Lost to Follow-up|0|||
164350610|NCT00420927|593657550|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
164350611|NCT00420927|593657551|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
164350612|NCT00420927|593657552|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
164436207|NCT00843193|593963283|FG001|Overall Study|Adverse Event|4|||
164436208|NCT00843193|593963282|FG000|Overall Study|Lack of Efficacy|1|||
164436209|NCT00843193|593963283|FG001|Overall Study|Lack of Efficacy|1|||
164436210|NCT00843193|593963282|FG000|Overall Study|Protocol Violation|1|||
164693840|NCT00892281|594901193|FG000|Overall Study|Subject failed to return for final visit|2|||
164350613|NCT00420927|593657553|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
164350614|NCT00420927|593657554|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
164350615|NCT00420927|593657555|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
164350616|NCT00420927|593657556|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
164350617|NCT00420927|593657550|FG000|Period 1|Death|2|||
164350618|NCT00420927|593657551|FG001|Period 1|Death|0|||
164350619|NCT00420927|593657552|FG002|Period 1|Death|0|||
164350620|NCT00420927|593657553|FG003|Period 1|Death|0|||
164350621|NCT00420927|593657554|FG004|Period 1|Death|0|||
164350622|NCT00420927|593657555|FG005|Period 1|Death|0|||
164350623|NCT00420927|593657556|FG006|Period 1|Death|0|||
164350624|NCT00420927|593657550|FG000|Period 1|Subject moved/relocated|0|||
164350625|NCT00420927|593657551|FG001|Period 1|Subject moved/relocated|2|||
164350626|NCT00420927|593657552|FG002|Period 1|Subject moved/relocated|0|||
164350627|NCT00420927|593657553|FG003|Period 1|Subject moved/relocated|0|||
164350628|NCT00420927|593657554|FG004|Period 1|Subject moved/relocated|0|||
164350629|NCT00420927|593657555|FG005|Period 1|Subject moved/relocated|0|||
164350630|NCT00420927|593657556|FG006|Period 1|Subject moved/relocated|0|||
164350631|NCT00420927|593657550|FG000|Period 1|Noncompliant with study drug|1|||
164350632|NCT00420927|593657551|FG001|Period 1|Noncompliant with study drug|1|||
164350633|NCT00420927|593657552|FG002|Period 1|Noncompliant with study drug|0|||
164350634|NCT00420927|593657553|FG003|Period 1|Noncompliant with study drug|0|||
164350635|NCT00420927|593657554|FG004|Period 1|Noncompliant with study drug|0|||
164350636|NCT00420927|593657555|FG005|Period 1|Noncompliant with study drug|0|||
164350637|NCT00420927|593657556|FG006|Period 1|Noncompliant with study drug|0|||
164350638|NCT00420927|593657550|FG000|Period 1|Randomization error|1|||
164350639|NCT00420927|593657551|FG001|Period 1|Randomization error|0|||
164436211|NCT00843193|593963283|FG001|Overall Study|Protocol Violation|2|||
164436212|NCT00843193|593963282|FG000|Overall Study|Lost to Follow-up|1|||
164436213|NCT00843193|593963283|FG001|Overall Study|Lost to Follow-up|0|||
164350640|NCT00420927|593657552|FG002|Period 1|Randomization error|0|||
164350641|NCT00420927|593657553|FG003|Period 1|Randomization error|0|||
164350642|NCT00420927|593657554|FG004|Period 1|Randomization error|0|||
164350643|NCT00420927|593657555|FG005|Period 1|Randomization error|0|||
164350644|NCT00420927|593657556|FG006|Period 1|Randomization error|0|||
164350645|NCT00420927|593657550|FG000|Period 1|Suspected tuberculosis/positive test|1|||
164350646|NCT00420927|593657551|FG001|Period 1|Suspected tuberculosis/positive test|1|||
164350647|NCT00420927|593657552|FG002|Period 1|Suspected tuberculosis/positive test|0|||
164350648|NCT00420927|593657553|FG003|Period 1|Suspected tuberculosis/positive test|0|||
164350649|NCT00420927|593657554|FG004|Period 1|Suspected tuberculosis/positive test|0|||
164350650|NCT00420927|593657555|FG005|Period 1|Suspected tuberculosis/positive test|0|||
164350651|NCT00420927|593657556|FG006|Period 1|Suspected tuberculosis/positive test|0|||
164350652|NCT00420927|593657550|FG000|Period 1|Study site closure|0|||
164350653|NCT00420927|593657551|FG001|Period 1|Study site closure|1|||
164350654|NCT00420927|593657552|FG002|Period 1|Study site closure|0|||
164350655|NCT00420927|593657553|FG003|Period 1|Study site closure|0|||
164350656|NCT00420927|593657554|FG004|Period 1|Study site closure|0|||
164350657|NCT00420927|593657555|FG005|Period 1|Study site closure|0|||
164350658|NCT00420927|593657556|FG006|Period 1|Study site closure|0|||
164350659|NCT00420927|593657550|FG000|Period 1|Subject received new diagnosis|0|||
164350660|NCT00420927|593657551|FG001|Period 1|Subject received new diagnosis|2|||
164350661|NCT00420927|593657552|FG002|Period 1|Subject received new diagnosis|0|||
164350662|NCT00420927|593657553|FG003|Period 1|Subject received new diagnosis|0|||
164350663|NCT00420927|593657554|FG004|Period 1|Subject received new diagnosis|0|||
164350664|NCT00420927|593657555|FG005|Period 1|Subject received new diagnosis|0|||
164350665|NCT00420927|593657556|FG006|Period 1|Subject received new diagnosis|0|||
164350666|NCT00420927|593657550|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
164350667|NCT00420927|593657551|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
164350668|NCT00420927|593657552|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
164350669|NCT00420927|593657553|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
164350670|NCT00420927|593657554|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
164350671|NCT00420927|593657555|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
164350672|NCT00420927|593657556|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
164350673|NCT00420927|593657550|FG000|Period 1|Failed to meet entry criteria|8|||
164350674|NCT00420927|593657551|FG001|Period 1|Failed to meet entry criteria|7|||
164350675|NCT00420927|593657552|FG002|Period 1|Failed to meet entry criteria|0|||
164350676|NCT00420927|593657553|FG003|Period 1|Failed to meet entry criteria|0|||
164436214|NCT00843193|593963282|FG000|Overall Study|Physician Decision|0|||
164436215|NCT00843193|593963283|FG001|Overall Study|Physician Decision|1|||
164436216|NCT00843193|593963282|FG000|Overall Study|Withdrawal by Subject|3|||
164436217|NCT00843193|593963283|FG001|Overall Study|Withdrawal by Subject|3|||
164436218|NCT00197015|593963284|FG000|Overall Study|Adverse Event|3|||
164350677|NCT00420927|593657554|FG004|Period 1|Failed to meet entry criteria|0|||
164350678|NCT00420927|593657555|FG005|Period 1|Failed to meet entry criteria|0|||
164350679|NCT00420927|593657556|FG006|Period 1|Failed to meet entry criteria|0|||
164350680|NCT00420927|593657550|FG000|Period 1|Took prohibited medication|1|||
164350681|NCT00420927|593657551|FG001|Period 1|Took prohibited medication|3|||
164436219|NCT00197015|593963285|FG001|Overall Study|Adverse Event|0|||
164350682|NCT00420927|593657552|FG002|Period 1|Took prohibited medication|0|||
164350683|NCT00420927|593657553|FG003|Period 1|Took prohibited medication|0|||
164350684|NCT00420927|593657554|FG004|Period 1|Took prohibited medication|0|||
164350685|NCT00420927|593657555|FG005|Period 1|Took prohibited medication|0|||
164436220|NCT00197015|593963286|FG002|Overall Study|Adverse Event|1|||
164350686|NCT00420927|593657556|FG006|Period 1|Took prohibited medication|0|||
164350687|NCT00420927|593657550|FG000|Period 2|Adverse Event|0|||
164350688|NCT00420927|593657551|FG001|Period 2|Adverse Event|0|||
164350689|NCT00420927|593657552|FG002|Period 2|Adverse Event|7|||
164350690|NCT00420927|593657553|FG003|Period 2|Adverse Event|3|||
164350691|NCT00420927|593657554|FG004|Period 2|Adverse Event|17|||
164350692|NCT00420927|593657555|FG005|Period 2|Adverse Event|6|||
164350693|NCT00420927|593657556|FG006|Period 2|Adverse Event|20|||
164350694|NCT00420927|593657550|FG000|Period 2|Withdrawal by Subject|0|||
164350695|NCT00420927|593657551|FG001|Period 2|Withdrawal by Subject|0|||
164350696|NCT00420927|593657552|FG002|Period 2|Withdrawal by Subject|1|||
164350697|NCT00420927|593657553|FG003|Period 2|Withdrawal by Subject|3|||
164350698|NCT00420927|593657554|FG004|Period 2|Withdrawal by Subject|11|||
164350699|NCT00420927|593657555|FG005|Period 2|Withdrawal by Subject|2|||
164350700|NCT00420927|593657556|FG006|Period 2|Withdrawal by Subject|12|||
164350701|NCT00420927|593657550|FG000|Period 2|Lost to Follow-up|0|||
164350702|NCT00420927|593657551|FG001|Period 2|Lost to Follow-up|0|||
164350703|NCT00420927|593657552|FG002|Period 2|Lost to Follow-up|2|||
164350704|NCT00420927|593657553|FG003|Period 2|Lost to Follow-up|2|||
164350705|NCT00420927|593657554|FG004|Period 2|Lost to Follow-up|6|||
164350706|NCT00420927|593657555|FG005|Period 2|Lost to Follow-up|3|||
164350707|NCT00420927|593657556|FG006|Period 2|Lost to Follow-up|9|||
164350708|NCT00420927|593657550|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
164350709|NCT00420927|593657551|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
164350710|NCT00420927|593657552|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
164350711|NCT00420927|593657553|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
164350712|NCT00420927|593657554|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
164350713|NCT00420927|593657555|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
164350714|NCT00420927|593657556|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
164350715|NCT00420927|593657550|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
164350716|NCT00420927|593657551|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
164350717|NCT00420927|593657552|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
164350718|NCT00420927|593657553|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
164350719|NCT00420927|593657554|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
164350720|NCT00420927|593657555|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
164350721|NCT00420927|593657556|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
164350722|NCT00420927|593657550|FG000|Period 2|Subject unable to find transportation|0|||
164350723|NCT00420927|593657551|FG001|Period 2|Subject unable to find transportation|0|||
164350724|NCT00420927|593657552|FG002|Period 2|Subject unable to find transportation|0|||
164350725|NCT00420927|593657553|FG003|Period 2|Subject unable to find transportation|0|||
164350726|NCT00420927|593657554|FG004|Period 2|Subject unable to find transportation|0|||
164350727|NCT00420927|593657555|FG005|Period 2|Subject unable to find transportation|0|||
164350728|NCT00420927|593657556|FG006|Period 2|Subject unable to find transportation|1|||
164350729|NCT00420927|593657550|FG000|Period 2|Physician Decision|0|||
164350730|NCT00420927|593657551|FG001|Period 2|Physician Decision|0|||
164350731|NCT00420927|593657552|FG002|Period 2|Physician Decision|0|||
164350732|NCT00420927|593657553|FG003|Period 2|Physician Decision|0|||
164350733|NCT00420927|593657554|FG004|Period 2|Physician Decision|1|||
164350734|NCT00420927|593657555|FG005|Period 2|Physician Decision|1|||
164350735|NCT00420927|593657556|FG006|Period 2|Physician Decision|0|||
164350736|NCT00420927|593657550|FG000|Period 2|Sponsor decision|0|||
164350737|NCT00420927|593657551|FG001|Period 2|Sponsor decision|0|||
164350738|NCT00420927|593657552|FG002|Period 2|Sponsor decision|1|||
164350739|NCT00420927|593657553|FG003|Period 2|Sponsor decision|0|||
164350740|NCT00420927|593657554|FG004|Period 2|Sponsor decision|0|||
164350741|NCT00420927|593657555|FG005|Period 2|Sponsor decision|0|||
164693841|NCT00892281|594901194|FG001|Overall Study|Subject failed to return for final visit|0|||
164693842|NCT00892281|594901193|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
164693843|NCT00892281|594901194|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
164693844|NCT00892281|594901193|FG000|Overall Study|Final visit completed 4 weeks late|0|||
164693845|NCT00892281|594901194|FG001|Overall Study|Final visit completed 4 weeks late|1|||
164693846|NCT00892281|594901193|FG000|Overall Study|Subject completed day after study closed|1|||
164693847|NCT00892281|594901194|FG001|Overall Study|Subject completed day after study closed|0|||
164693848|NCT00892281|594901193|FG000|Overall Study|Family emergency|1|||
164693849|NCT00892281|594901194|FG001|Overall Study|Family emergency|0|||
164693850|NCT00892281|594901193|FG000|Overall Study|Last visit not done - death in family|1|||
164350742|NCT00420927|593657556|FG006|Period 2|Sponsor decision|1|||
164350743|NCT00420927|593657550|FG000|Period 2|Randomization error|0|||
164350744|NCT00420927|593657551|FG001|Period 2|Randomization error|0|||
164350745|NCT00420927|593657552|FG002|Period 2|Randomization error|0|||
164350746|NCT00420927|593657553|FG003|Period 2|Randomization error|0|||
164350747|NCT00420927|593657554|FG004|Period 2|Randomization error|1|||
164350748|NCT00420927|593657555|FG005|Period 2|Randomization error|1|||
164350749|NCT00420927|593657556|FG006|Period 2|Randomization error|0|||
164693851|NCT00892281|594901194|FG001|Overall Study|Last visit not done - death in family|0|||
164350750|NCT00420927|593657550|FG000|Period 2|Noncompliant with study drug|0|||
164588027|NCT03242928|594517468|FG001|Overall Study|Withdrawal by Subject|3|||
164588028|NCT03276936|594517469|FG000|Overall Study|Adverse Event|4|||
164588029|NCT03276936|594517470|FG001|Overall Study|Adverse Event|2|||
164588030|NCT03276936|594517469|FG000|Overall Study|Lost to Follow-up|16|||
164588031|NCT03276936|594517470|FG001|Overall Study|Lost to Follow-up|13|||
164588032|NCT03276936|594517469|FG000|Overall Study|Withdrawal by Subject|30|||
164588033|NCT03276936|594517470|FG001|Overall Study|Withdrawal by Subject|20|||
164588034|NCT03276936|594517469|FG000|Overall Study|Not mentioned|6|||
164588035|NCT03276936|594517470|FG001|Overall Study|Not mentioned|3|||
164588036|NCT00943319|594517471|FG000|Overall Study|Death|1|||
164588037|NCT02043301|594517472|FG000|Overall Study|Discontinued|0|||
164588038|NCT02043301|594517473|FG001|Overall Study|Discontinued|1|||
164588039|NCT02043301|594517474|FG002|Overall Study|Discontinued|0|||
164588040|NCT03703375|594517478|FG000|Randomization Period|Withdrawal by Subject|0|||
164588041|NCT03703375|594517479|FG001|Randomization Period|Withdrawal by Subject|0|||
164588042|NCT03703375|594517480|FG002|Randomization Period|Withdrawal by Subject|0|||
164588043|NCT03703375|594517481|FG003|Randomization Period|Withdrawal by Subject|1|||
164588044|NCT03703375|594517478|FG000|Randomization Period|Completed safety run-in treatment|7|||
164299048|NCT00456846|593471229|FG000|Overall Study|Participant Discretion|1|||
164299049|NCT00456846|593471230|FG001|Overall Study|Participant Discretion|5|||
164299050|NCT00456846|593471229|FG000|Overall Study|Other|0|||
164299051|NCT00456846|593471230|FG001|Overall Study|Other|2|||
164299052|NCT00581308|593471231|FG000|Pre Discharge|Lost to Follow-up|1|||
164299053|NCT00581308|593471231|FG000|Pre Discharge|Device Removed|1|||
164299054|NCT00581308|593471231|FG000|Month 1|Lost to Follow-up|3|||
164299055|NCT00581308|593471231|FG000|Month 1|Withdrawal by Subject|2|||
164350751|NCT00420927|593657551|FG001|Period 2|Noncompliant with study drug|0|||
164350752|NCT00420927|593657552|FG002|Period 2|Noncompliant with study drug|0|||
164350753|NCT00420927|593657553|FG003|Period 2|Noncompliant with study drug|1|||
164350754|NCT00420927|593657554|FG004|Period 2|Noncompliant with study drug|0|||
164350755|NCT00420927|593657555|FG005|Period 2|Noncompliant with study drug|0|||
164350756|NCT00420927|593657556|FG006|Period 2|Noncompliant with study drug|2|||
164350757|NCT00420927|593657550|FG000|Period 2|Methotrexate intolerance|0|||
164350758|NCT00420927|593657551|FG001|Period 2|Methotrexate intolerance|0|||
164350759|NCT00420927|593657552|FG002|Period 2|Methotrexate intolerance|0|||
164350760|NCT00420927|593657553|FG003|Period 2|Methotrexate intolerance|0|||
164350761|NCT00420927|593657554|FG004|Period 2|Methotrexate intolerance|0|||
164350762|NCT00420927|593657555|FG005|Period 2|Methotrexate intolerance|0|||
164350763|NCT00420927|593657556|FG006|Period 2|Methotrexate intolerance|1|||
164350764|NCT00420927|593657550|FG000|Period 2|Took prohibited medication|0|||
164350765|NCT00420927|593657551|FG001|Period 2|Took prohibited medication|0|||
164350766|NCT00420927|593657552|FG002|Period 2|Took prohibited medication|0|||
164350767|NCT00420927|593657553|FG003|Period 2|Took prohibited medication|0|||
164350768|NCT00420927|593657554|FG004|Period 2|Took prohibited medication|1|||
164350769|NCT00420927|593657555|FG005|Period 2|Took prohibited medication|0|||
164350770|NCT00420927|593657556|FG006|Period 2|Took prohibited medication|0|||
164350771|NCT01218243|593657557|FG000|Overall Study|Lack of Efficacy|1|||
164350772|NCT01218243|593657558|FG001|Overall Study|Lack of Efficacy|1|||
164350773|NCT01218243|593657557|FG000|Overall Study|Lost to Follow-up|3|||
164350774|NCT01218243|593657558|FG001|Overall Study|Lost to Follow-up|3|||
164350775|NCT01218243|593657557|FG000|Overall Study|Protocol Violation|5|||
164350776|NCT01218243|593657558|FG001|Overall Study|Protocol Violation|10|||
164350777|NCT01032837|593657561|FG000|Overall Study|Adverse event/internal illness|0|||
164350778|NCT01032837|593657562|FG001|Overall Study|Adverse event/internal illness|1|||
164350779|NCT01032837|593657563|FG002|Overall Study|Adverse event/internal illness|0|||
164350780|NCT01032837|593657564|FG003|Overall Study|Adverse event/internal illness|1|||
164350781|NCT01032837|593657561|FG000|Overall Study|Withdrew consent|0|||
164350782|NCT01032837|593657562|FG001|Overall Study|Withdrew consent|2|||
164350783|NCT01032837|593657563|FG002|Overall Study|Withdrew consent|0|||
164350784|NCT01032837|593657564|FG003|Overall Study|Withdrew consent|1|||
164350785|NCT01032837|593657561|FG000|Overall Study|Failed to return|0|||
164350786|NCT01032837|593657562|FG001|Overall Study|Failed to return|0|||
164350787|NCT01032837|593657563|FG002|Overall Study|Failed to return|1|||
164350788|NCT01032837|593657564|FG003|Overall Study|Failed to return|0|||
164350789|NCT01032837|593657561|FG000|Overall Study|Refused treatment|0|||
164299056|NCT00581308|593471231|FG000|Month 1|Device Removed|2|||
164299057|NCT00581308|593471231|FG000|Month 1|Uknown|1|||
164350790|NCT01032837|593657562|FG001|Overall Study|Refused treatment|0|||
164350791|NCT01032837|593657563|FG002|Overall Study|Refused treatment|0|||
164350792|NCT01032837|593657564|FG003|Overall Study|Refused treatment|1|||
164350793|NCT01197560|593657565|FG000|Overall Study|Adverse Event|6|||
164588045|NCT03703375|594517479|FG001|Randomization Period|Completed safety run-in treatment|0|||
164350794|NCT01197560|593657566|FG001|Overall Study|Adverse Event|8|||
164350795|NCT01197560|593657565|FG000|Overall Study|Death|3|||
164350796|NCT01197560|593657566|FG001|Overall Study|Death|5|||
164350797|NCT01197560|593657565|FG000|Overall Study|Withdrawal by Subject|1|||
164299058|NCT00581308|593471231|FG000|Month 6|Lost to Follow-up|1|||
164436221|NCT00197015|593963284|FG000|Overall Study|Protocol Violation|0|||
164436222|NCT00197015|593963285|FG001|Overall Study|Protocol Violation|3|||
164436223|NCT00197015|593963286|FG002|Overall Study|Protocol Violation|3|||
164436224|NCT00197015|593963284|FG000|Overall Study|Withdrawal by Subject|17|||
164436225|NCT00197015|593963285|FG001|Overall Study|Withdrawal by Subject|37|||
164436226|NCT00197015|593963286|FG002|Overall Study|Withdrawal by Subject|34|||
164436227|NCT00197015|593963284|FG000|Overall Study|Lost to Follow-up|28|||
164436228|NCT00197015|593963285|FG001|Overall Study|Lost to Follow-up|46|||
164436229|NCT00197015|593963286|FG002|Overall Study|Lost to Follow-up|37|||
164436230|NCT00197015|593963284|FG000|Overall Study|Other|2|||
164436231|NCT00197015|593963285|FG001|Overall Study|Other|3|||
164436232|NCT00197015|593963286|FG002|Overall Study|Other|2|||
164436233|NCT00608907|593963291|FG000|Overall Study|Adverse Event|6|||
164436234|NCT00608907|593963292|FG001|Overall Study|Adverse Event|0|||
164436235|NCT00608907|593963293|FG002|Overall Study|Adverse Event|1|||
164436236|NCT00608907|593963291|FG000|Overall Study|Death|1|||
164436237|NCT00608907|593963292|FG001|Overall Study|Death|0|||
164436238|NCT00608907|593963293|FG002|Overall Study|Death|0|||
164436239|NCT00608907|593963291|FG000|Overall Study|Withdrawal by Subject|4|||
164436240|NCT00608907|593963292|FG001|Overall Study|Withdrawal by Subject|0|||
164436241|NCT00608907|593963293|FG002|Overall Study|Withdrawal by Subject|0|||
164436242|NCT00608907|593963291|FG000|Overall Study|Progressive Disease|1|||
164436243|NCT00608907|593963292|FG001|Overall Study|Progressive Disease|0|||
164436244|NCT00608907|593963293|FG002|Overall Study|Progressive Disease|0|||
164436245|NCT00881335|593963300|FG000|Overall Study|Lost to Follow-up|3|||
164436246|NCT00881335|593963301|FG001|Overall Study|Lost to Follow-up|2|||
164436247|NCT00554801|593963302|FG000|Overall Study|left area before completion|5|||
164350798|NCT01197560|593657566|FG001|Overall Study|Withdrawal by Subject|1|||
164350799|NCT01197560|593657565|FG000|Overall Study|Disease progression|40|||
164350800|NCT01197560|593657566|FG001|Overall Study|Disease progression|35|||
164350801|NCT01197560|593657565|FG000|Overall Study|Miscellaneous|4|||
164350802|NCT01197560|593657566|FG001|Overall Study|Miscellaneous|3|||
164350803|NCT01197560|593657565|FG000|Overall Study|Missing|0|||
164350804|NCT01197560|593657566|FG001|Overall Study|Missing|1|||
164350805|NCT00211510|593657569|FG000|Overall Study|Physician Decision|3|||
164350806|NCT00211510|593657570|FG001|Overall Study|Physician Decision|1|||
164350807|NCT00211510|593657569|FG000|Overall Study|Withdrawal by Subject|3|||
164350808|NCT00211510|593657570|FG001|Overall Study|Withdrawal by Subject|1|||
164350809|NCT01487200|593657571|FG000|Overall Study|Withdrawal by Subject|0|||
164350810|NCT01487200|593657572|FG001|Overall Study|Withdrawal by Subject|1|||
164350811|NCT01487200|593657573|FG002|Overall Study|Withdrawal by Subject|0|||
164350812|NCT01487200|593657574|FG003|Overall Study|Withdrawal by Subject|0|||
164350813|NCT02521870|593657580|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
164350814|NCT02521870|593657581|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
164350815|NCT02521870|593657582|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
164350816|NCT02521870|593657583|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
164350817|NCT02521870|593657584|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
164350818|NCT02521870|593657585|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
164350819|NCT02521870|593657586|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
164350820|NCT02521870|593657587|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
164350821|NCT02521870|593657588|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
164350822|NCT02521870|593657589|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
164350823|NCT02521870|593657590|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
164350824|NCT02521870|593657591|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
164350825|NCT02521870|593657580|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
164350826|NCT02521870|593657581|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
164350827|NCT02521870|593657582|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
164350828|NCT02521870|593657583|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
164350829|NCT02521870|593657584|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
164350830|NCT02521870|593657585|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
164350831|NCT02521870|593657586|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
164350832|NCT02521870|593657587|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
164350833|NCT02521870|593657588|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
164350834|NCT02521870|593657589|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
164350835|NCT02521870|593657590|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
164350836|NCT02521870|593657591|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
164350837|NCT02521870|593657580|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
164350838|NCT02521870|593657581|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
164350839|NCT02521870|593657582|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
164350840|NCT02521870|593657583|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
164436248|NCT00554801|593963303|FG001|Overall Study|left area before completion|0|||
164436249|NCT00554801|593963302|FG000|Overall Study|Withdrawal by Subject|14|||
164436250|NCT00554801|593963303|FG001|Overall Study|Withdrawal by Subject|0|||
164436251|NCT04845620|593963310|FG000|Overall Study|Withdrawal by Subject|11|||
164436252|NCT04845620|593963311|FG001|Overall Study|Withdrawal by Subject|10|||
164436253|NCT04845620|593963310|FG000|Overall Study|Adverse Event|5|||
164436254|NCT04845620|593963311|FG001|Overall Study|Adverse Event|4|||
164436255|NCT04845620|593963310|FG000|Overall Study|Lost to Follow-up|5|||
164350841|NCT02521870|593657584|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
164350842|NCT02521870|593657585|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
164350843|NCT02521870|593657586|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
164350844|NCT02521870|593657587|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
164350845|NCT02521870|593657588|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
164350846|NCT02521870|593657589|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
164350847|NCT02521870|593657590|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
164350848|NCT02521870|593657591|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
164350849|NCT02521870|593657580|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
164350850|NCT02521870|593657581|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
164350851|NCT02521870|593657582|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
164350852|NCT02521870|593657583|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
164350853|NCT02521870|593657584|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
164350854|NCT02521870|593657585|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
164350855|NCT02521870|593657586|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
164350856|NCT02521870|593657587|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
164350857|NCT02521870|593657588|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
164350858|NCT02521870|593657589|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
164350859|NCT02521870|593657590|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
164350860|NCT02521870|593657591|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
164350861|NCT02521870|593657580|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
164350862|NCT02521870|593657581|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
164350863|NCT02521870|593657582|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
164350864|NCT02521870|593657583|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
164350865|NCT02521870|593657584|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
164350866|NCT02521870|593657585|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
164350867|NCT02521870|593657586|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
164350868|NCT02521870|593657587|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
164350869|NCT02521870|593657588|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
164350870|NCT02521870|593657589|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
164350871|NCT02521870|593657590|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
164350872|NCT02521870|593657591|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
164350873|NCT02521870|593657580|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
164350874|NCT02521870|593657581|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
164350875|NCT02521870|593657582|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
164350876|NCT02521870|593657583|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
164350877|NCT02521870|593657584|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
164350878|NCT02521870|593657585|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
164350879|NCT02521870|593657586|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
164350880|NCT02521870|593657587|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
164350881|NCT02521870|593657588|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
164350882|NCT02521870|593657589|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
164350883|NCT02521870|593657590|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
164350884|NCT02521870|593657591|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
164350885|NCT02521870|593657580|FG000|Phase 2: Dose Expansion|Death|0|||
164350886|NCT02521870|593657581|FG001|Phase 2: Dose Expansion|Death|0|||
164350887|NCT02521870|593657582|FG002|Phase 2: Dose Expansion|Death|0|||
164350888|NCT02521870|593657583|FG003|Phase 2: Dose Expansion|Death|0|||
164350889|NCT02521870|593657584|FG004|Phase 2: Dose Expansion|Death|1|||
164350890|NCT02521870|593657585|FG005|Phase 2: Dose Expansion|Death|1|||
164350891|NCT02521870|593657586|FG006|Phase 2: Dose Expansion|Death|3|||
164350892|NCT02521870|593657587|FG007|Phase 2: Dose Expansion|Death|1|||
164350893|NCT02521870|593657588|FG008|Phase 2: Dose Expansion|Death|1|||
164350894|NCT02521870|593657589|FG009|Phase 2: Dose Expansion|Death|5|||
164350895|NCT02521870|593657590|FG010|Phase 2: Dose Expansion|Death|2|||
164350896|NCT02521870|593657591|FG011|Phase 2: Dose Expansion|Death|2|||
164350897|NCT02521870|593657580|FG000|Phase 2: Dose Expansion|Other|0|||
164350898|NCT02521870|593657581|FG001|Phase 2: Dose Expansion|Other|0|||
164350899|NCT02521870|593657582|FG002|Phase 2: Dose Expansion|Other|0|||
164350900|NCT02521870|593657583|FG003|Phase 2: Dose Expansion|Other|0|||
164350901|NCT02521870|593657584|FG004|Phase 2: Dose Expansion|Other|10|||
164350902|NCT02521870|593657585|FG005|Phase 2: Dose Expansion|Other|3|||
164350903|NCT02521870|593657586|FG006|Phase 2: Dose Expansion|Other|2|||
164350904|NCT02521870|593657587|FG007|Phase 2: Dose Expansion|Other|0|||
164350905|NCT02521870|593657588|FG008|Phase 2: Dose Expansion|Other|10|||
164350906|NCT02521870|593657589|FG009|Phase 2: Dose Expansion|Other|5|||
164350907|NCT02521870|593657590|FG010|Phase 2: Dose Expansion|Other|1|||
164350908|NCT02521870|593657591|FG011|Phase 2: Dose Expansion|Other|7|||
164350909|NCT02521870|593657580|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164350910|NCT02521870|593657581|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164350911|NCT02521870|593657582|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164350912|NCT02521870|593657583|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164350913|NCT02521870|593657584|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
164350914|NCT02521870|593657585|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164350915|NCT02521870|593657586|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164350916|NCT02521870|593657587|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164350917|NCT02521870|593657588|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164350918|NCT02521870|593657589|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164350919|NCT02521870|593657590|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164350920|NCT02521870|593657591|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164350921|NCT02521870|593657580|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
164350922|NCT02521870|593657581|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
164350923|NCT02521870|593657582|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
164350924|NCT02521870|593657583|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
164350925|NCT02521870|593657584|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
164350926|NCT02521870|593657585|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
164350927|NCT02521870|593657586|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
164350928|NCT02521870|593657587|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
164350929|NCT02521870|593657588|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
164350930|NCT02521870|593657589|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
164350931|NCT02521870|593657590|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
164350932|NCT02521870|593657591|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
164350933|NCT00519831|593657592|FG000|Overall Study|Adverse Event|3|||
164350934|NCT04051008|593657593|FG000|Overall Study|Withdrawal by Subject|2|||
164350935|NCT04051008|593657594|FG001|Overall Study|Withdrawal by Subject|0|||
164350936|NCT04051008|593657595|FG002|Overall Study|Withdrawal by Subject|1|||
164350937|NCT02862171|593657596|FG000|Overall Study|Death|1|||
164350938|NCT02862171|593657596|FG000|Overall Study|Lost to Follow-up|13|||
164350939|NCT02862171|593657596|FG000|Overall Study|Withdrawal by Subject|57|||
164350940|NCT02862171|593657596|FG000|Overall Study|Non-compliance|4|||
164350941|NCT02862171|593657596|FG000|Overall Study|HIV-1 seroconversion|18|||
164350942|NCT01962896|593657597|FG000|Overall Study|Lack of Efficacy|4|||
164350943|NCT00662012|593657598|FG000|Overall Study|Lost to Follow-up|85|||
164350944|NCT00662012|593657598|FG000|Overall Study|Death|1|||
164350945|NCT00662012|593657598|FG000|Overall Study|Withdrawal by Subject|1|||
164299059|NCT00581308|593471231|FG000|Month 6|Withdrawal by Subject|2|||
164299060|NCT00581308|593471231|FG000|Month 12|Death|1|||
164299061|NCT00581308|593471231|FG000|Month 12|Lost to Follow-up|14|||
164350946|NCT00844896|593657599|FG000|Overall Study|Lost to Follow-up|12|||
164350947|NCT00844896|593657600|FG001|Overall Study|Lost to Follow-up|16|||
164350948|NCT00844896|593657599|FG000|Overall Study|Parents did not have time to complete|0|||
164350949|NCT00844896|593657600|FG001|Overall Study|Parents did not have time to complete|1|||
164350950|NCT00458211|593657601|FG000|Overall Study|Lack of Efficacy|12|||
164350951|NCT00458211|593657601|FG000|Overall Study|Withdrawal by Subject|2|||
164436256|NCT04845620|593963311|FG001|Overall Study|Lost to Follow-up|4|||
164588046|NCT03703375|594517480|FG002|Randomization Period|Completed safety run-in treatment|0|||
164588047|NCT03703375|594517481|FG003|Randomization Period|Completed safety run-in treatment|0|||
164299062|NCT00581308|593471231|FG000|Month 12|Withdrawal by Subject|3|||
164299063|NCT00581308|593471231|FG000|Month 12|Device Removed|1|||
164299064|NCT00581308|593471231|FG000|Month 12|Other|1|||
164299065|NCT02006472|593471235|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
164299066|NCT02006472|593471236|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
164299067|NCT02006472|593471237|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
164299068|NCT02006472|593471238|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
164299069|NCT02006472|593471239|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
164299070|NCT02006472|593471235|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
164299071|NCT02006472|593471236|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
164299072|NCT02006472|593471237|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
164299073|NCT02006472|593471238|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
164299074|NCT02006472|593471239|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
164299075|NCT02006472|593471235|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
164299076|NCT02006472|593471236|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
164299077|NCT02006472|593471237|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
164299078|NCT02006472|593471238|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
164299079|NCT02006472|593471239|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
164299080|NCT02006472|593471235|FG000|Period 1 (Through Week 26)|Other|1|||
164299081|NCT02006472|593471236|FG001|Period 1 (Through Week 26)|Other|5|||
164299082|NCT02006472|593471237|FG002|Period 1 (Through Week 26)|Other|0|||
164299083|NCT02006472|593471238|FG003|Period 1 (Through Week 26)|Other|2|||
164299084|NCT02006472|593471239|FG004|Period 1 (Through Week 26)|Other|3|||
164588048|NCT03703375|594517478|FG000|Treatment Period|Other Reasons|0|||
164299085|NCT02006472|593471235|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
164299086|NCT02006472|593471236|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
164299087|NCT02006472|593471237|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
164299088|NCT02006472|593471238|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
164350952|NCT00458211|593657601|FG000|Overall Study|Protocol Violation|2|||
164350953|NCT00753415|593657606|FG000|Part A|Disease progression|1|||
164350954|NCT00753415|593657607|FG001|Part A|Disease progression|0|||
164350955|NCT00753415|593657608|FG002|Part A|Disease progression|1|||
164350956|NCT00753415|593657609|FG003|Part A|Disease progression|2|||
164350957|NCT00753415|593657610|FG004|Part A|Disease progression|0|||
164350958|NCT00753415|593657611|FG005|Part A|Disease progression|0|||
164350959|NCT00753415|593657612|FG006|Part A|Disease progression|0|||
164350960|NCT00753415|593657613|FG007|Part A|Disease progression|0|||
164350961|NCT00753415|593657614|FG008|Part A|Disease progression|0|||
164350962|NCT00753415|593657615|FG009|Part A|Disease progression|0|||
164350963|NCT00753415|593657606|FG000|Part A|Withdrawal by Subject|0|||
164350964|NCT00753415|593657607|FG001|Part A|Withdrawal by Subject|0|||
164350965|NCT00753415|593657608|FG002|Part A|Withdrawal by Subject|1|||
164350966|NCT00753415|593657609|FG003|Part A|Withdrawal by Subject|0|||
164350967|NCT00753415|593657610|FG004|Part A|Withdrawal by Subject|0|||
164350968|NCT00753415|593657611|FG005|Part A|Withdrawal by Subject|0|||
164350969|NCT00753415|593657612|FG006|Part A|Withdrawal by Subject|0|||
164350970|NCT00753415|593657613|FG007|Part A|Withdrawal by Subject|0|||
164350971|NCT00753415|593657614|FG008|Part A|Withdrawal by Subject|0|||
164350972|NCT00753415|593657615|FG009|Part A|Withdrawal by Subject|0|||
164350973|NCT00753415|593657606|FG000|Part B|Lost to Follow-up|0|||
164350974|NCT00753415|593657607|FG001|Part B|Lost to Follow-up|0|||
164350975|NCT00753415|593657608|FG002|Part B|Lost to Follow-up|0|||
164350976|NCT00753415|593657609|FG003|Part B|Lost to Follow-up|0|||
164350977|NCT00753415|593657610|FG004|Part B|Lost to Follow-up|0|||
164350978|NCT00753415|593657611|FG005|Part B|Lost to Follow-up|0|||
164350979|NCT00753415|593657612|FG006|Part B|Lost to Follow-up|0|||
164350980|NCT00753415|593657613|FG007|Part B|Lost to Follow-up|1|||
164350981|NCT00753415|593657614|FG008|Part B|Lost to Follow-up|1|||
164350982|NCT00753415|593657615|FG009|Part B|Lost to Follow-up|0|||
164350983|NCT00753415|593657606|FG000|Part B|Disease progression|0|||
164350984|NCT00753415|593657607|FG001|Part B|Disease progression|0|||
164350985|NCT00753415|593657608|FG002|Part B|Disease progression|0|||
164350986|NCT00753415|593657609|FG003|Part B|Disease progression|0|||
164350987|NCT00753415|593657610|FG004|Part B|Disease progression|0|||
164350988|NCT00753415|593657611|FG005|Part B|Disease progression|0|||
164350989|NCT00753415|593657612|FG006|Part B|Disease progression|0|||
164350990|NCT00753415|593657613|FG007|Part B|Disease progression|0|||
164350991|NCT00753415|593657614|FG008|Part B|Disease progression|2|||
164350992|NCT00753415|593657615|FG009|Part B|Disease progression|1|||
164350993|NCT00621153|593657616|FG000|Overall Study|Safety Reason|8|||
164350994|NCT00621153|593657617|FG001|Overall Study|Safety Reason|7|||
164350995|NCT00621153|593657616|FG000|Overall Study|Adverse Event|3|||
164350996|NCT00621153|593657617|FG001|Overall Study|Adverse Event|2|||
164350997|NCT00621153|593657616|FG000|Overall Study|Lost to Follow-up|5|||
164350998|NCT00621153|593657617|FG001|Overall Study|Lost to Follow-up|1|||
164350999|NCT00621153|593657616|FG000|Overall Study|Withdrawal by Subject|4|||
164351000|NCT00621153|593657617|FG001|Overall Study|Withdrawal by Subject|5|||
164351001|NCT04212650|593657618|FG000|Overall Study|Withdrawal by Subject|1|||
164351002|NCT04212650|593657619|FG001|Overall Study|Withdrawal by Subject|0|||
164351003|NCT00838578|593657620|FG000|Overall Study|Protocol Violation|2|||
164351004|NCT00598832|593657621|FG000|Overall Study|Lack of Efficacy|3|||
164351005|NCT00598832|593657622|FG001|Overall Study|Lack of Efficacy|7|||
164351006|NCT00598832|593657621|FG000|Overall Study|Adverse Event|6|||
164351007|NCT00598832|593657622|FG001|Overall Study|Adverse Event|2|||
164351008|NCT00598832|593657621|FG000|Overall Study|Withdrawal by Subject|25|||
164351009|NCT00598832|593657622|FG001|Overall Study|Withdrawal by Subject|36|||
164351010|NCT00598832|593657621|FG000|Overall Study|Protocol Violation|0|||
164351011|NCT00598832|593657622|FG001|Overall Study|Protocol Violation|2|||
164351012|NCT00598832|593657621|FG000|Overall Study|Lost to Follow-up|24|||
164351013|NCT00598832|593657622|FG001|Overall Study|Lost to Follow-up|29|||
164351014|NCT00598832|593657621|FG000|Overall Study|Pregnancy|2|||
164351015|NCT00598832|593657622|FG001|Overall Study|Pregnancy|2|||
164351016|NCT00598832|593657621|FG000|Overall Study|Physician Decision|1|||
164351017|NCT00598832|593657622|FG001|Overall Study|Physician Decision|4|||
164351018|NCT00598832|593657621|FG000|Overall Study|Non compliance|1|||
164351019|NCT00598832|593657622|FG001|Overall Study|Non compliance|0|||
164351020|NCT00357968|593657623|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
164351021|NCT00357968|593657624|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
164351022|NCT00357968|593657623|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
164351023|NCT00357968|593657624|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
164351024|NCT03919799|593657629|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
164351025|NCT03919799|593657630|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
164351026|NCT03919799|593657631|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
164351027|NCT03919799|593657632|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
164351028|NCT03919799|593657633|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
164351029|NCT03919799|593657629|FG000|DB Period (28 Weeks)|Adverse Event|1|||
164351030|NCT03919799|593657630|FG001|DB Period (28 Weeks)|Adverse Event|1|||
164351031|NCT03919799|593657631|FG002|DB Period (28 Weeks)|Adverse Event|1|||
164351032|NCT03919799|593657632|FG003|DB Period (28 Weeks)|Adverse Event|0|||
164351033|NCT03919799|593657633|FG004|DB Period (28 Weeks)|Adverse Event|0|||
164351034|NCT03919799|593657629|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
164351035|NCT03919799|593657630|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
164351036|NCT03919799|593657631|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
164351037|NCT03919799|593657632|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
164351038|NCT03919799|593657633|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
164351039|NCT03919799|593657629|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
164351040|NCT03919799|593657630|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
164351041|NCT03919799|593657631|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
164351042|NCT03919799|593657632|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
164351043|NCT03919799|593657633|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
164351044|NCT03919799|593657629|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
164351045|NCT03919799|593657630|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
164351046|NCT03919799|593657631|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
164351047|NCT03919799|593657632|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
164351048|NCT03919799|593657633|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
164351049|NCT02142959|593657635|FG000|Overall Study|Adverse Event|1|||
164351050|NCT02142959|593657636|FG001|Overall Study|Adverse Event|0|||
164351051|NCT02142959|593657637|FG002|Overall Study|Adverse Event|0|||
164351052|NCT02142959|593657635|FG000|Overall Study|Death|0|||
164351053|NCT02142959|593657636|FG001|Overall Study|Death|1|||
164351054|NCT02142959|593657637|FG002|Overall Study|Death|0|||
164351055|NCT02142959|593657635|FG000|Overall Study|Withdrawal by Subject|3|||
164351056|NCT02142959|593657636|FG001|Overall Study|Withdrawal by Subject|1|||
164351057|NCT02142959|593657637|FG002|Overall Study|Withdrawal by Subject|3|||
164351058|NCT02142959|593657635|FG000|Overall Study|Administrative Reasons|1|||
164351059|NCT02142959|593657636|FG001|Overall Study|Administrative Reasons|0|||
164351060|NCT02142959|593657637|FG002|Overall Study|Administrative Reasons|1|||
164351061|NCT02142959|593657635|FG000|Overall Study|Missing|0|||
164351062|NCT02142959|593657636|FG001|Overall Study|Missing|1|||
164351063|NCT02142959|593657637|FG002|Overall Study|Missing|0|||
164351064|NCT02142959|593657635|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
164351065|NCT02142959|593657636|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
164351066|NCT02142959|593657637|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
164351067|NCT02142959|593657635|FG000|Overall Study|Patient didn't complete end of study visit|0|||
164351068|NCT02142959|593657636|FG001|Overall Study|Patient didn't complete end of study visit|0|||
164351069|NCT02142959|593657637|FG002|Overall Study|Patient didn't complete end of study visit|1|||
164351070|NCT00679302|593657639|FG000|Overall Study|Lost to Follow-up|8|||
164351071|NCT00679302|593657640|FG001|Overall Study|Lost to Follow-up|4|||
164351072|NCT03547687|593657641|FG000|Overall Study|Withdrawal by Subject|1|||
164351073|NCT03547687|593657641|FG000|Overall Study|Death|1|||
164351074|NCT00646776|593657642|FG000|Overall Study|Adverse Event|1|||
164351075|NCT00646776|593657643|FG001|Overall Study|Adverse Event|9|||
164351076|NCT00646776|593657642|FG000|Overall Study|Investigator discretion|0|||
164351077|NCT00646776|593657643|FG001|Overall Study|Investigator discretion|4|||
164351078|NCT04656691|593657644|FG000|Overall Study|Adverse Event|1|||
164351079|NCT01753856|593657649|FG000|Overall Study|Adverse Event|1|||
164351080|NCT01753856|593657650|FG001|Overall Study|Adverse Event|0|||
164351081|NCT01753856|593657649|FG000|Overall Study|Withdrawal by Subject|0|||
164351082|NCT01753856|593657650|FG001|Overall Study|Withdrawal by Subject|2|||
164351083|NCT01753856|593657649|FG000|Overall Study|Sponsor Decision|2|||
164351084|NCT01753856|593657650|FG001|Overall Study|Sponsor Decision|0|||
164351085|NCT00887978|593657651|FG000|Overall Study|Adverse Event|18|||
164351086|NCT00887978|593657652|FG001|Overall Study|Adverse Event|5|||
164351087|NCT00887978|593657651|FG000|Overall Study|Clinical Worsening|4|||
164351088|NCT00887978|593657652|FG001|Overall Study|Clinical Worsening|4|||
164351089|NCT00887978|593657651|FG000|Overall Study|Death|2|||
164351090|NCT00887978|593657652|FG001|Overall Study|Death|3|||
164351091|NCT00887978|593657651|FG000|Overall Study|Withdrawal by Subject|1|||
164351092|NCT00887978|593657652|FG001|Overall Study|Withdrawal by Subject|2|||
164351093|NCT00887978|593657651|FG000|Overall Study|Lost to Follow-up|0|||
164351094|NCT00887978|593657652|FG001|Overall Study|Lost to Follow-up|1|||
164351095|NCT05980182|593657653|FG000|Overall Study|Lost to Follow-up|10|||
164351096|NCT04419714|593657661|FG000|Overall Study|Technical Fault|5|||
164351097|NCT04419714|593657661|FG000|Overall Study|Protocol Deviation|2|||
164351098|NCT04419714|593657661|FG000|Overall Study|Withdrawal by Subject|1|||
164351099|NCT02700815|593659003|FG000|Overall Study|Adverse Event|0|||
164351100|NCT02700815|593659004|FG001|Overall Study|Adverse Event|6|||
164351101|NCT02700815|593659005|FG002|Overall Study|Adverse Event|2|||
164351102|NCT02700815|593659006|FG003|Overall Study|Adverse Event|3|||
164351103|NCT02700815|593659003|FG000|Overall Study|Lack of Efficacy|0|||
164351104|NCT02700815|593659004|FG001|Overall Study|Lack of Efficacy|0|||
164351105|NCT02700815|593659005|FG002|Overall Study|Lack of Efficacy|1|||
164588049|NCT03703375|594517479|FG001|Treatment Period|Other Reasons|1|||
164351106|NCT02700815|593659006|FG003|Overall Study|Lack of Efficacy|2|||
164351107|NCT02700815|593659003|FG000|Overall Study|Lost to Follow-up|1|||
164351108|NCT02700815|593659004|FG001|Overall Study|Lost to Follow-up|0|||
164351109|NCT02700815|593659005|FG002|Overall Study|Lost to Follow-up|0|||
164351110|NCT02700815|593659006|FG003|Overall Study|Lost to Follow-up|1|||
164351111|NCT02700815|593659003|FG000|Overall Study|Refusal to continue medication|0|||
164351112|NCT02700815|593659004|FG001|Overall Study|Refusal to continue medication|1|||
164351113|NCT02700815|593659005|FG002|Overall Study|Refusal to continue medication|0|||
164351114|NCT02700815|593659006|FG003|Overall Study|Refusal to continue medication|1|||
164351115|NCT02700815|593659003|FG000|Overall Study|Withdrawal by Subject|0|||
164351116|NCT02700815|593659004|FG001|Overall Study|Withdrawal by Subject|0|||
164351117|NCT02700815|593659005|FG002|Overall Study|Withdrawal by Subject|1|||
164351118|NCT02700815|593659006|FG003|Overall Study|Withdrawal by Subject|0|||
164351119|NCT04023526|593659007|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
164351120|NCT04023526|593659008|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
164351121|NCT04023526|593659007|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
164351122|NCT04023526|593659008|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
164351123|NCT01955733|593659012|FG000|Period 1|Lost to Follow-up|1|||
164351124|NCT01955733|593659013|FG001|Period 1|Lost to Follow-up|0|||
164351125|NCT01955733|593659014|FG002|Period 1|Lost to Follow-up|0|||
164351126|NCT01955733|593659012|FG000|Period 2|Adverse Event|1|||
164351127|NCT01955733|593659013|FG001|Period 2|Adverse Event|0|||
164351128|NCT01955733|593659014|FG002|Period 2|Adverse Event|0|||
164351129|NCT01955733|593659012|FG000|Period 2|Physician Decision|0|||
164351130|NCT01955733|593659013|FG001|Period 2|Physician Decision|0|||
164351131|NCT01955733|593659014|FG002|Period 2|Physician Decision|1|||
164351132|NCT01955733|593659012|FG000|Period 2|Withdrawal by Subject|1|||
164351133|NCT01955733|593659013|FG001|Period 2|Withdrawal by Subject|3|||
164351134|NCT01955733|593659014|FG002|Period 2|Withdrawal by Subject|2|||
164351135|NCT01955733|593659012|FG000|Period 2|Study terminated by sponsor|8|||
164351136|NCT01955733|593659013|FG001|Period 2|Study terminated by sponsor|14|||
164351137|NCT01955733|593659014|FG002|Period 2|Study terminated by sponsor|16|||
164351138|NCT01955733|593659012|FG000|Period 2|Lost to Follow-up|2|||
164351139|NCT01955733|593659013|FG001|Period 2|Lost to Follow-up|0|||
164351140|NCT01955733|593659014|FG002|Period 2|Lost to Follow-up|0|||
164351141|NCT01955733|593659012|FG000|Period 2|Other not defined above|0|||
164351142|NCT01955733|593659013|FG001|Period 2|Other not defined above|2|||
164351143|NCT01955733|593659014|FG002|Period 2|Other not defined above|2|||
164351144|NCT02239978|593659017|FG000|Overall Study|Withdrawal by Subject|2|||
164351145|NCT02239978|593659018|FG001|Overall Study|Withdrawal by Subject|0|||
164351146|NCT02324569|593659026|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
164351147|NCT02324569|593659027|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
164351148|NCT02324569|593659026|FG000|Overall Study|Voluntary Withdrawal|3|||
164351149|NCT02324569|593659027|FG001|Overall Study|Voluntary Withdrawal|6|||
164351150|NCT02324569|593659026|FG000|Overall Study|Lack of Efficacy|2|||
164351151|NCT02324569|593659027|FG001|Overall Study|Lack of Efficacy|3|||
164351152|NCT02324569|593659026|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
164351153|NCT02324569|593659027|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
164351154|NCT02324569|593659026|FG000|Overall Study|Inconvenient Schedule|2|||
164351155|NCT02324569|593659027|FG001|Overall Study|Inconvenient Schedule|0|||
164351156|NCT00793403|593659036|FG000|Overall Study|Other|73|||
164351157|NCT02961751|593659045|FG000|Overall Study|Lost to Follow-up|11|||
164351158|NCT02961751|593659045|FG000|Overall Study|Physician Decision|2|||
164351159|NCT02961751|593659045|FG000|Overall Study|Not Eligible at Enrollment|1|||
164351160|NCT02961751|593659045|FG000|Overall Study|Protocol Violation|1|||
164351161|NCT00842712|593659046|FG000|Safety Run-in Part|Adverse Event|0|||
164351162|NCT00842712|593659047|FG001|Safety Run-in Part|Adverse Event|1|||
164351163|NCT00842712|593659048|FG002|Safety Run-in Part|Adverse Event|0|||
164351164|NCT00842712|593659049|FG003|Safety Run-in Part|Adverse Event|0|||
164351165|NCT00842712|593659050|FG004|Safety Run-in Part|Adverse Event|0|||
164351166|NCT00842712|593659051|FG005|Safety Run-in Part|Adverse Event|0|||
164351167|NCT00842712|593659052|FG006|Safety Run-in Part|Adverse Event|0|||
164351168|NCT00842712|593659046|FG000|Safety Run-in Part|Progressive disease|3|||
164351169|NCT00842712|593659047|FG001|Safety Run-in Part|Progressive disease|1|||
164351170|NCT00842712|593659048|FG002|Safety Run-in Part|Progressive disease|0|||
164351171|NCT00842712|593659049|FG003|Safety Run-in Part|Progressive disease|1|||
164436257|NCT04845620|593963310|FG000|Overall Study|Lack of Efficacy|4|||
164436258|NCT04845620|593963311|FG001|Overall Study|Lack of Efficacy|4|||
164436259|NCT04845620|593963310|FG000|Overall Study|Physician Decision|2|||
164436260|NCT04845620|593963311|FG001|Overall Study|Physician Decision|1|||
164436261|NCT00708097|593963312|FG000|Period 1|Protocol Violation|0|||
164436262|NCT00708097|593963313|FG001|Period 1|Protocol Violation|1|||
164436263|NCT00708097|593963314|FG002|Period 1|Protocol Violation|0|||
164436264|NCT00708097|593963315|FG003|Period 1|Protocol Violation|2|||
164436265|NCT00708097|593963316|FG004|Period 1|Protocol Violation|0|||
164436266|NCT00708097|593963312|FG000|Period 1|Other Reason|0|||
164351172|NCT00842712|593659050|FG004|Safety Run-in Part|Progressive disease|0|||
164436267|NCT00708097|593963313|FG001|Period 1|Other Reason|0|||
164351173|NCT00842712|593659051|FG005|Safety Run-in Part|Progressive disease|0|||
164436268|NCT00708097|593963314|FG002|Period 1|Other Reason|0|||
164436269|NCT00708097|593963315|FG003|Period 1|Other Reason|0|||
164436270|NCT00708097|593963316|FG004|Period 1|Other Reason|1|||
164436271|NCT00708097|593963312|FG000|Period 2|Protocol Violation|0|||
164436272|NCT00708097|593963313|FG001|Period 2|Protocol Violation|1|||
164351174|NCT00842712|593659052|FG006|Safety Run-in Part|Progressive disease|0|||
164351175|NCT00842712|593659046|FG000|Randomized Part|Randomized but not treated|0|||
164351176|NCT00842712|593659047|FG001|Randomized Part|Randomized but not treated|0|||
164351177|NCT00842712|593659048|FG002|Randomized Part|Randomized but not treated|0|||
164351178|NCT00842712|593659049|FG003|Randomized Part|Randomized but not treated|0|||
164351179|NCT00842712|593659050|FG004|Randomized Part|Randomized but not treated|0|||
164351180|NCT00842712|593659051|FG005|Randomized Part|Randomized but not treated|1|||
164351181|NCT00842712|593659052|FG006|Randomized Part|Randomized but not treated|4|||
164351182|NCT00842712|593659046|FG000|Randomized Part|Ongoing at cut-off date|0|||
164351183|NCT00842712|593659047|FG001|Randomized Part|Ongoing at cut-off date|0|||
164351184|NCT00842712|593659048|FG002|Randomized Part|Ongoing at cut-off date|0|||
164351185|NCT00842712|593659049|FG003|Randomized Part|Ongoing at cut-off date|0|||
164351186|NCT00842712|593659050|FG004|Randomized Part|Ongoing at cut-off date|0|||
164351187|NCT00842712|593659051|FG005|Randomized Part|Ongoing at cut-off date|0|||
164351188|NCT00842712|593659052|FG006|Randomized Part|Ongoing at cut-off date|2|||
164351189|NCT03909295|593659056|FG000|Overall Study|Adverse Event|2|||
164351190|NCT03909295|593659056|FG000|Overall Study|Study terminated by sponsor|50|||
164351191|NCT03312933|593659060|FG000|Overall Study|Protocol Violation|15|||
164351192|NCT03312933|593659060|FG000|Overall Study|Lost to Follow-up|36|||
164351193|NCT03312933|593659060|FG000|Overall Study|Withdrawal by Subject|3|||
164351194|NCT00848081|593659062|FG000|Overall Study|Adverse Event|6|||
164351195|NCT00848081|593659063|FG001|Overall Study|Adverse Event|7|||
164351196|NCT00848081|593659062|FG000|Overall Study|Protocol Violation|8|||
164351197|NCT00848081|593659063|FG001|Overall Study|Protocol Violation|5|||
164351198|NCT00848081|593659062|FG000|Overall Study|Lost to Follow-up|1|||
164351199|NCT00848081|593659063|FG001|Overall Study|Lost to Follow-up|0|||
164351200|NCT00848081|593659062|FG000|Overall Study|Physician Decision|0|||
164351201|NCT00848081|593659063|FG001|Overall Study|Physician Decision|3|||
164351202|NCT00848081|593659062|FG000|Overall Study|Withdrawal by Subject|5|||
164351203|NCT00848081|593659063|FG001|Overall Study|Withdrawal by Subject|3|||
164351204|NCT01752907|593659064|FG000|Overall Study|Withdrawal by Subject|4|||
164351205|NCT01752907|593659065|FG001|Overall Study|Withdrawal by Subject|10|||
164351206|NCT01752907|593659064|FG000|Overall Study|Lost to Follow-up|2|||
164351207|NCT01752907|593659065|FG001|Overall Study|Lost to Follow-up|1|||
164351208|NCT01752907|593659064|FG000|Overall Study|Decision by Sponsor|6|||
164351209|NCT01752907|593659065|FG001|Overall Study|Decision by Sponsor|9|||
164351210|NCT03098550|593659066|FG000|Overall Study|Disease Progression|30|||
164351211|NCT03098550|593659067|FG001|Overall Study|Disease Progression|19|||
164351212|NCT03098550|593659068|FG002|Overall Study|Disease Progression|41|||
164351213|NCT03098550|593659066|FG000|Overall Study|Study Drug Toxicity|2|||
164351214|NCT03098550|593659067|FG001|Overall Study|Study Drug Toxicity|1|||
164351215|NCT03098550|593659068|FG002|Overall Study|Study Drug Toxicity|0|||
164351216|NCT03098550|593659066|FG000|Overall Study|Death|1|||
164351217|NCT03098550|593659067|FG001|Overall Study|Death|0|||
164351218|NCT03098550|593659068|FG002|Overall Study|Death|0|||
164351219|NCT03098550|593659066|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
164351220|NCT03098550|593659067|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
164351221|NCT03098550|593659068|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
164351222|NCT03098550|593659066|FG000|Overall Study|Administrative reason by sponsor|0|||
164351223|NCT03098550|593659067|FG001|Overall Study|Administrative reason by sponsor|0|||
164351224|NCT03098550|593659068|FG002|Overall Study|Administrative reason by sponsor|1|||
164351225|NCT03098550|593659066|FG000|Overall Study|Other reasons|2|||
164351226|NCT03098550|593659067|FG001|Overall Study|Other reasons|0|||
164351227|NCT03098550|593659068|FG002|Overall Study|Other reasons|0|||
164351228|NCT01384760|593659075|FG000|Overall Study|Lost to Follow-up|0|||
164351229|NCT01384760|593659076|FG001|Overall Study|Lost to Follow-up|6|||
164351230|NCT01384760|593659075|FG000|Overall Study|Protocol Violation|16|||
164351231|NCT01384760|593659076|FG001|Overall Study|Protocol Violation|0|||
164351232|NCT00309387|593659087|FG000|Overall Study|Death|72|||
164351233|NCT00309387|593659088|FG001|Overall Study|Death|73|||
164351234|NCT00309387|593659087|FG000|Overall Study|Lost to Follow-up|70|||
164351235|NCT00309387|593659088|FG001|Overall Study|Lost to Follow-up|86|||
164436273|NCT00708097|593963314|FG002|Period 2|Protocol Violation|1|||
164436274|NCT00708097|593963315|FG003|Period 2|Protocol Violation|1|||
164693852|NCT00892281|594901193|FG000|Overall Study|Did not meet incl/excl criteria|1|||
164351236|NCT02899988|593659091|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
164351237|NCT02899988|593659092|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
164351238|NCT02899988|593659093|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164351239|NCT02899988|593659094|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164351240|NCT02899988|593659095|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164351241|NCT02899988|593659096|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164693853|NCT00892281|594901194|FG001|Overall Study|Did not meet incl/excl criteria|0|||
164436275|NCT00708097|593963316|FG004|Period 2|Protocol Violation|0|||
164351242|NCT02899988|593659097|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164351243|NCT02899988|593659098|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164351244|NCT02899988|593659099|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164351245|NCT02899988|593659100|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164351246|NCT02899988|593659101|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164351247|NCT02899988|593659091|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
164351248|NCT02899988|593659092|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
164351249|NCT02899988|593659093|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
164351250|NCT02899988|593659094|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
164351251|NCT02899988|593659095|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
164351252|NCT02899988|593659096|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
164351253|NCT02899988|593659097|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
164351254|NCT02899988|593659098|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
164351255|NCT02899988|593659099|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
164351256|NCT02899988|593659100|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
164351257|NCT02899988|593659101|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
164351258|NCT02899988|593659091|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
164351259|NCT02899988|593659092|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
164351260|NCT02899988|593659093|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
164351261|NCT02899988|593659094|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
164351262|NCT02899988|593659095|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
164351263|NCT02899988|593659096|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
164351264|NCT02899988|593659097|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
164351265|NCT02899988|593659098|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
164351266|NCT02899988|593659099|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
164351267|NCT02899988|593659100|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
164351268|NCT02899988|593659101|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
164351269|NCT02899988|593659091|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
164351270|NCT02899988|593659092|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
164351271|NCT02899988|593659093|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
164351272|NCT02899988|593659094|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
164351273|NCT02899988|593659095|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
164351274|NCT02899988|593659096|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
164351275|NCT02899988|593659097|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
164351276|NCT02899988|593659098|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
164351277|NCT02899988|593659099|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
164351278|NCT02899988|593659100|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
164351279|NCT02899988|593659101|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
164351280|NCT02899988|593659091|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
164351281|NCT02899988|593659092|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
164351282|NCT02899988|593659093|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
164351283|NCT02899988|593659094|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
164351284|NCT02899988|593659095|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
164351285|NCT02899988|593659096|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
164351286|NCT02899988|593659097|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
164351287|NCT02899988|593659098|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
164351288|NCT02899988|593659099|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
164351289|NCT02899988|593659100|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
164351290|NCT02899988|593659101|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
164351291|NCT02899988|593659091|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
164351292|NCT02899988|593659092|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
164351293|NCT02899988|593659093|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
164351294|NCT02899988|593659094|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
164351295|NCT02899988|593659095|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
164351296|NCT02899988|593659096|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
164351297|NCT02899988|593659097|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
164588050|NCT03703375|594517480|FG002|Treatment Period|Other Reasons|0|||
164588051|NCT03703375|594517481|FG003|Treatment Period|Other Reasons|3|||
164588052|NCT03703375|594517478|FG000|Treatment Period|Consent Withdrawal|0|||
164351298|NCT02899988|593659098|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
164351299|NCT02899988|593659099|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
164351300|NCT02899988|593659100|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
164351301|NCT02899988|593659101|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
164351302|NCT02041286|593659102|FG000|Overall Study|Adverse Event|1|||
164351303|NCT00085631|593659106|FG000|Overall Study|Missing Data|4|||
164588053|NCT03703375|594517479|FG001|Treatment Period|Consent Withdrawal|0|||
164588054|NCT03703375|594517480|FG002|Treatment Period|Consent Withdrawal|0|||
164588055|NCT03703375|594517481|FG003|Treatment Period|Consent Withdrawal|1|||
164588056|NCT03703375|594517478|FG000|Treatment Period|Death|1|||
164351304|NCT00085631|593659107|FG001|Overall Study|Missing Data|11|||
164351305|NCT00085631|593659108|FG002|Overall Study|Missing Data|7|||
164351306|NCT00411645|593659109|FG000|Overall Study|Consent Withdrawn|13|||
164351307|NCT00411645|593659110|FG001|Overall Study|Consent Withdrawn|22|||
164351308|NCT00411645|593659109|FG000|Overall Study|Death|56|||
164351309|NCT00411645|593659110|FG001|Overall Study|Death|135|||
164351310|NCT00411645|593659109|FG000|Overall Study|Investigator/Sponsor Decision|10|||
164351311|NCT00411645|593659110|FG001|Overall Study|Investigator/Sponsor Decision|7|||
164351312|NCT00411645|593659109|FG000|Overall Study|Lost to Follow-up|2|||
164351313|NCT00411645|593659110|FG001|Overall Study|Lost to Follow-up|0|||
164351314|NCT01349790|593659111|FG000|Overall Study|Investigator Judgement|3|||
164351315|NCT01349790|593659111|FG000|Overall Study|Death|2|||
164351316|NCT01349790|593659111|FG000|Overall Study|Withdrawal by Patient|2|||
164351317|NCT01349790|593659111|FG000|Overall Study|Adverse Event|1|||
164351318|NCT01349790|593659111|FG000|Overall Study|Lost to Follow-up|1|||
164351319|NCT02289690|593659112|FG000|Overall Study|Adverse Event Related to Progression|0|||
164351320|NCT02289690|593659113|FG001|Overall Study|Adverse Event Related to Progression|1|||
164351321|NCT02289690|593659114|FG002|Overall Study|Adverse Event Related to Progression|1|||
164351322|NCT02289690|593659115|FG003|Overall Study|Adverse Event Related to Progression|0|||
164351323|NCT02289690|593659116|FG004|Overall Study|Adverse Event Related to Progression|1|||
164351324|NCT02289690|593659117|FG005|Overall Study|Adverse Event Related to Progression|0|||
164351325|NCT02289690|593659118|FG006|Overall Study|Adverse Event Related to Progression|1|||
164351326|NCT02289690|593659119|FG007|Overall Study|Adverse Event Related to Progression|0|||
164351327|NCT02289690|593659120|FG008|Overall Study|Adverse Event Related to Progression|0|||
164351328|NCT02289690|593659121|FG009|Overall Study|Adverse Event Related to Progression|0|||
164351329|NCT02289690|593659112|FG000|Overall Study|Withdrawal by Subject|1|||
164351330|NCT02289690|593659113|FG001|Overall Study|Withdrawal by Subject|0|||
164351331|NCT02289690|593659114|FG002|Overall Study|Withdrawal by Subject|0|||
164351332|NCT02289690|593659115|FG003|Overall Study|Withdrawal by Subject|0|||
164351333|NCT02289690|593659116|FG004|Overall Study|Withdrawal by Subject|1|||
164351334|NCT02289690|593659117|FG005|Overall Study|Withdrawal by Subject|1|||
164351335|NCT02289690|593659118|FG006|Overall Study|Withdrawal by Subject|0|||
164351336|NCT02289690|593659119|FG007|Overall Study|Withdrawal by Subject|0|||
164351337|NCT02289690|593659120|FG008|Overall Study|Withdrawal by Subject|4|||
164351338|NCT02289690|593659121|FG009|Overall Study|Withdrawal by Subject|2|||
164351339|NCT02289690|593659112|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
164351340|NCT02289690|593659113|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
164351341|NCT02289690|593659114|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
164351342|NCT02289690|593659115|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
164351343|NCT02289690|593659116|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
164351344|NCT02289690|593659117|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
164351345|NCT02289690|593659118|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
164351346|NCT02289690|593659119|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
164351347|NCT02289690|593659120|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
164351348|NCT02289690|593659121|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
164351349|NCT02289690|593659112|FG000|Overall Study|Lost to Follow-up|0|||
164351350|NCT02289690|593659113|FG001|Overall Study|Lost to Follow-up|0|||
164351351|NCT02289690|593659114|FG002|Overall Study|Lost to Follow-up|0|||
164351352|NCT02289690|593659115|FG003|Overall Study|Lost to Follow-up|0|||
164351353|NCT02289690|593659116|FG004|Overall Study|Lost to Follow-up|0|||
164351354|NCT02289690|593659117|FG005|Overall Study|Lost to Follow-up|0|||
164351355|NCT02289690|593659118|FG006|Overall Study|Lost to Follow-up|0|||
164351356|NCT02289690|593659119|FG007|Overall Study|Lost to Follow-up|1|||
164351357|NCT02289690|593659120|FG008|Overall Study|Lost to Follow-up|0|||
164351358|NCT02289690|593659121|FG009|Overall Study|Lost to Follow-up|2|||
164351359|NCT02289690|593659112|FG000|Overall Study|Death|0|||
164351360|NCT02289690|593659113|FG001|Overall Study|Death|0|||
164351361|NCT02289690|593659114|FG002|Overall Study|Death|0|||
164351362|NCT02289690|593659115|FG003|Overall Study|Death|0|||
164351363|NCT02289690|593659116|FG004|Overall Study|Death|0|||
164351364|NCT02289690|593659117|FG005|Overall Study|Death|0|||
164351365|NCT02289690|593659118|FG006|Overall Study|Death|0|||
164351366|NCT02289690|593659119|FG007|Overall Study|Death|49|||
164351367|NCT02289690|593659120|FG008|Overall Study|Death|45|||
164351368|NCT02289690|593659121|FG009|Overall Study|Death|41|||
164351369|NCT02289690|593659112|FG000|Overall Study|Sponsor Discontinued Study|0|||
164351370|NCT02289690|593659113|FG001|Overall Study|Sponsor Discontinued Study|0|||
164351371|NCT02289690|593659114|FG002|Overall Study|Sponsor Discontinued Study|0|||
164351372|NCT02289690|593659115|FG003|Overall Study|Sponsor Discontinued Study|0|||
164351373|NCT02289690|593659116|FG004|Overall Study|Sponsor Discontinued Study|0|||
164351374|NCT02289690|593659117|FG005|Overall Study|Sponsor Discontinued Study|0|||
164351375|NCT02289690|593659118|FG006|Overall Study|Sponsor Discontinued Study|0|||
164351376|NCT02289690|593659119|FG007|Overall Study|Sponsor Discontinued Study|9|||
164351377|NCT02289690|593659120|FG008|Overall Study|Sponsor Discontinued Study|7|||
164436276|NCT04133363|593963317|FG000|Overall Study|Lost to Follow-up|2|||
164351378|NCT02289690|593659121|FG009|Overall Study|Sponsor Discontinued Study|15|||
164351379|NCT02289690|593659112|FG000|Overall Study|Other|0|||
164351380|NCT02289690|593659113|FG001|Overall Study|Other|0|||
164351381|NCT02289690|593659114|FG002|Overall Study|Other|0|||
164351382|NCT02289690|593659115|FG003|Overall Study|Other|1|||
164351383|NCT02289690|593659116|FG004|Overall Study|Other|1|||
164351384|NCT02289690|593659117|FG005|Overall Study|Other|0|||
164351385|NCT02289690|593659118|FG006|Overall Study|Other|1|||
164351386|NCT02289690|593659119|FG007|Overall Study|Other|2|||
164351387|NCT02289690|593659120|FG008|Overall Study|Other|3|||
164351388|NCT02289690|593659121|FG009|Overall Study|Other|1|||
164351389|NCT04166435|593659124|FG000|Overall Study|2 patients ineligible for response|2|||
164351390|NCT00814164|593659128|FG000|Overall Study|Progression|7|||
164351391|NCT00814164|593659128|FG000|Overall Study|not stated|7|||
164351392|NCT00814164|593659128|FG000|Overall Study|Death|5|||
164351393|NCT01053221|593659129|FG000|Overall Study|The study was closed prematurely|5|||
164351394|NCT01053221|593659130|FG001|Overall Study|The study was closed prematurely|9|||
164351395|NCT01025752|593659131|FG000|Overall Study|Lost to Follow-up|7|||
164351396|NCT01025752|593659132|FG001|Overall Study|Lost to Follow-up|10|||
164351397|NCT01025752|593659131|FG000|Overall Study|Physician Decision|1|||
164351398|NCT01025752|593659132|FG001|Overall Study|Physician Decision|3|||
164351399|NCT00855920|593659133|FG000|Overall Study|Protocol Violation|0|||
164351400|NCT00855920|593659134|FG001|Overall Study|Protocol Violation|0|||
164351401|NCT00855920|593659135|FG002|Overall Study|Protocol Violation|2|||
164351402|NCT00855920|593659133|FG000|Overall Study|Adverse Event|2|||
164351403|NCT00855920|593659134|FG001|Overall Study|Adverse Event|1|||
164351404|NCT00855920|593659135|FG002|Overall Study|Adverse Event|1|||
164351405|NCT00855920|593659133|FG000|Overall Study|Lack of Efficacy|2|||
164351406|NCT00855920|593659134|FG001|Overall Study|Lack of Efficacy|2|||
164351407|NCT00855920|593659135|FG002|Overall Study|Lack of Efficacy|2|||
164351408|NCT00855920|593659133|FG000|Overall Study|Withdrawal by Subject|2|||
164351409|NCT00855920|593659134|FG001|Overall Study|Withdrawal by Subject|3|||
164351410|NCT00855920|593659135|FG002|Overall Study|Withdrawal by Subject|2|||
164351411|NCT00855920|593659133|FG000|Overall Study|Lost to Follow-up|1|||
164351412|NCT00855920|593659134|FG001|Overall Study|Lost to Follow-up|0|||
164351413|NCT00855920|593659135|FG002|Overall Study|Lost to Follow-up|2|||
164351414|NCT00855920|593659133|FG000|Overall Study|Death|0|||
164351415|NCT00855920|593659134|FG001|Overall Study|Death|1|||
164351416|NCT00855920|593659135|FG002|Overall Study|Death|0|||
164351417|NCT00855920|593659133|FG000|Overall Study|Decision by the sponsor|0|||
164351418|NCT00855920|593659134|FG001|Overall Study|Decision by the sponsor|1|||
164351419|NCT00855920|593659135|FG002|Overall Study|Decision by the sponsor|1|||
164351420|NCT00855920|593659133|FG000|Overall Study|Other than specified above|1|||
164351421|NCT00855920|593659134|FG001|Overall Study|Other than specified above|1|||
164351422|NCT00855920|593659135|FG002|Overall Study|Other than specified above|1|||
164351423|NCT00843024|593659136|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
164351424|NCT00843024|593659137|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
164351425|NCT00843024|593659138|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
164351426|NCT00843024|593659139|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
164351427|NCT00843024|593659140|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
164351428|NCT00843024|593659141|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
164351429|NCT00843024|593659136|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
164351430|NCT00843024|593659137|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
164351431|NCT00843024|593659138|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
164351432|NCT00843024|593659139|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
164351433|NCT00843024|593659140|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
164351434|NCT00843024|593659141|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
164351435|NCT00843024|593659136|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
164351436|NCT00843024|593659137|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
164351437|NCT00843024|593659138|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
164351438|NCT00843024|593659139|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
164351439|NCT00843024|593659140|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
164588057|NCT03703375|594517479|FG001|Treatment Period|Death|0|||
164588058|NCT03703375|594517480|FG002|Treatment Period|Death|1|||
164588059|NCT03703375|594517481|FG003|Treatment Period|Death|2|||
164351440|NCT00843024|593659141|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
164351441|NCT00843024|593659136|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
164351442|NCT00843024|593659137|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
164351443|NCT00843024|593659138|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
164351444|NCT00843024|593659139|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
164351445|NCT00843024|593659140|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
164588060|NCT03703375|594517478|FG000|Treatment Period|Toxicity of Study Treatment|2|||
164351446|NCT00843024|593659141|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
164351447|NCT00843024|593659136|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
164351448|NCT00843024|593659137|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
164351449|NCT00843024|593659138|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
164588061|NCT03703375|594517479|FG001|Treatment Period|Toxicity of Study Treatment|0|||
164351450|NCT00843024|593659139|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
164351451|NCT00843024|593659140|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
164351452|NCT00843024|593659141|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
164351453|NCT00843024|593659136|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
164351454|NCT00843024|593659137|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
164351455|NCT00843024|593659138|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
164351456|NCT00843024|593659139|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
164351457|NCT00843024|593659140|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
164351458|NCT00843024|593659141|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
164351459|NCT00843024|593659136|FG000|Single-blind Placebo Run-In Phase|Other|0|||
164351460|NCT00843024|593659137|FG001|Single-blind Placebo Run-In Phase|Other|1|||
164351461|NCT00843024|593659138|FG002|Single-blind Placebo Run-In Phase|Other|0|||
164351462|NCT00843024|593659139|FG003|Single-blind Placebo Run-In Phase|Other|0|||
164351463|NCT00843024|593659140|FG004|Single-blind Placebo Run-In Phase|Other|0|||
164351464|NCT00843024|593659141|FG005|Single-blind Placebo Run-In Phase|Other|0|||
164351465|NCT00843024|593659136|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
164351466|NCT00843024|593659137|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
164351467|NCT00843024|593659138|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
164351468|NCT00843024|593659139|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
164351469|NCT00843024|593659140|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
164351470|NCT00843024|593659141|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
164351471|NCT00843024|593659136|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
164351472|NCT00843024|593659137|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
164351473|NCT00843024|593659138|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
164351474|NCT00843024|593659139|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
164351475|NCT00843024|593659140|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
164351476|NCT00843024|593659141|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
164351477|NCT00843024|593659136|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
164351478|NCT00843024|593659137|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
164351479|NCT00843024|593659138|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
164351480|NCT00843024|593659139|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
164351481|NCT00843024|593659140|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
164351482|NCT00843024|593659141|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
164351483|NCT00843024|593659136|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
164351484|NCT00843024|593659137|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
164351485|NCT00843024|593659138|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
164351486|NCT00843024|593659139|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
164351487|NCT00843024|593659140|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
164351488|NCT00843024|593659141|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
164351489|NCT00843024|593659136|FG000|Double-blind Treatment Phase|Physician Decision|0|||
164351490|NCT00843024|593659137|FG001|Double-blind Treatment Phase|Physician Decision|0|||
164351491|NCT00843024|593659138|FG002|Double-blind Treatment Phase|Physician Decision|0|||
164351492|NCT00843024|593659139|FG003|Double-blind Treatment Phase|Physician Decision|3|||
164351493|NCT00843024|593659140|FG004|Double-blind Treatment Phase|Physician Decision|1|||
164351494|NCT00843024|593659141|FG005|Double-blind Treatment Phase|Physician Decision|1|||
164351495|NCT00843024|593659136|FG000|Double-blind Treatment Phase|Adverse Event|0|||
164351496|NCT00843024|593659137|FG001|Double-blind Treatment Phase|Adverse Event|0|||
164351497|NCT00843024|593659138|FG002|Double-blind Treatment Phase|Adverse Event|0|||
164351498|NCT00843024|593659139|FG003|Double-blind Treatment Phase|Adverse Event|0|||
164351499|NCT00843024|593659140|FG004|Double-blind Treatment Phase|Adverse Event|1|||
164351500|NCT00843024|593659141|FG005|Double-blind Treatment Phase|Adverse Event|1|||
164351501|NCT00843024|593659136|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
164351502|NCT00843024|593659137|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
164351503|NCT00843024|593659138|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
164351504|NCT00843024|593659139|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
164351505|NCT00843024|593659140|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
164351506|NCT00843024|593659141|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
164351507|NCT05201703|593659142|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
164351508|NCT05201703|593659143|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
164351509|NCT05201703|593659142|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
164351510|NCT05201703|593659143|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
164351511|NCT02132130|593659144|FG000|Overall Study|Lost to Follow-up|0|||
164351512|NCT02132130|593659145|FG001|Overall Study|Lost to Follow-up|2|||
164351513|NCT02132130|593659146|FG002|Overall Study|Lost to Follow-up|0|||
164351514|NCT02132130|593659147|FG003|Overall Study|Lost to Follow-up|0|||
164351515|NCT02132130|593659144|FG000|Overall Study|Withdrawal by Subject|0|||
164351516|NCT02132130|593659145|FG001|Overall Study|Withdrawal by Subject|0|||
164351517|NCT02132130|593659146|FG002|Overall Study|Withdrawal by Subject|0|||
164351518|NCT02132130|593659147|FG003|Overall Study|Withdrawal by Subject|1|||
164351519|NCT04600921|593659148|FG000|Overall Study|Withdrawal by Subject|3|||
164351520|NCT04600921|593659149|FG001|Overall Study|Withdrawal by Subject|5|||
164351521|NCT04600921|593659148|FG000|Overall Study|Death|0|||
164351522|NCT04600921|593659149|FG001|Overall Study|Death|1|||
164351523|NCT05425745|593659153|FG000|Overall Study|Withdrawal of Consent|3|||
164351524|NCT05425745|593659154|FG001|Overall Study|Withdrawal of Consent|3|||
164351525|NCT05425745|593659153|FG000|Overall Study|Death|2|||
164351526|NCT05425745|593659154|FG001|Overall Study|Death|3|||
164351527|NCT05425745|593659153|FG000|Overall Study|Lost to Follow-up|1|||
164351528|NCT05425745|593659154|FG001|Overall Study|Lost to Follow-up|2|||
164351529|NCT05425745|593659153|FG000|Overall Study|Adverse Event|0|||
164351530|NCT05425745|593659154|FG001|Overall Study|Adverse Event|1|||
164351531|NCT05425745|593659153|FG000|Overall Study|Did not return for end of study visit|0|||
164351532|NCT05425745|593659154|FG001|Overall Study|Did not return for end of study visit|1|||
164351533|NCT05425745|593659153|FG000|Overall Study|End of study visit completed by phone|1|||
164351534|NCT05425745|593659154|FG001|Overall Study|End of study visit completed by phone|0|||
164351535|NCT05425745|593659153|FG000|Overall Study|Subject decision|1|||
164351536|NCT05425745|593659154|FG001|Overall Study|Subject decision|0|||
164351537|NCT04221009|593660807|FG000|Overall Study|Withdrawal by Subject|4|||
164351538|NCT00793598|593660808|FG000|Overall Study|Patient Request|0|||
164351539|NCT00793598|593660809|FG001|Overall Study|Patient Request|1|||
164351540|NCT00793598|593660810|FG002|Overall Study|Patient Request|0|||
164351541|NCT00793598|593660811|FG003|Overall Study|Patient Request|0|||
164351542|NCT00793598|593660812|FG004|Overall Study|Patient Request|0|||
164351543|NCT00793598|593660813|FG005|Overall Study|Patient Request|0|||
164351544|NCT00793598|593660814|FG006|Overall Study|Patient Request|0|||
164351545|NCT00793598|593660815|FG007|Overall Study|Patient Request|0|||
164351546|NCT00793598|593660808|FG000|Overall Study|Protocol Violation|0|||
164351547|NCT00793598|593660809|FG001|Overall Study|Protocol Violation|0|||
164351548|NCT00793598|593660810|FG002|Overall Study|Protocol Violation|0|||
164351549|NCT00793598|593660811|FG003|Overall Study|Protocol Violation|0|||
164351550|NCT00793598|593660812|FG004|Overall Study|Protocol Violation|0|||
164351551|NCT00793598|593660813|FG005|Overall Study|Protocol Violation|0|||
164351552|NCT00793598|593660814|FG006|Overall Study|Protocol Violation|0|||
164351553|NCT00793598|593660815|FG007|Overall Study|Protocol Violation|1|||
164351554|NCT00793598|593660808|FG000|Overall Study|Subject not dosed|0|||
164351555|NCT00793598|593660809|FG001|Overall Study|Subject not dosed|0|||
164351556|NCT00793598|593660810|FG002|Overall Study|Subject not dosed|0|||
164351557|NCT00793598|593660811|FG003|Overall Study|Subject not dosed|0|||
164351558|NCT00793598|593660812|FG004|Overall Study|Subject not dosed|0|||
164351559|NCT00793598|593660813|FG005|Overall Study|Subject not dosed|1|||
164351560|NCT00793598|593660814|FG006|Overall Study|Subject not dosed|0|||
164351561|NCT00793598|593660815|FG007|Overall Study|Subject not dosed|0|||
164351562|NCT02762266|593660816|FG000|Overall Study|Physician Decision|2|||
164351563|NCT02762266|593660817|FG001|Overall Study|Physician Decision|0|||
164351564|NCT00630396|593660823|FG000|Overall Study|Death|4|||
164351565|NCT00630396|593660823|FG000|Overall Study|Lost to Follow-up|3|||
164351566|NCT02990910|593660827|FG000|Overall Study|Lack of Efficacy|6|||
164351567|NCT02990910|593660828|FG001|Overall Study|Lack of Efficacy|10|||
164351568|NCT02064868|593660830|FG000|Overall Study|Lost to Follow-up|14|||
164351569|NCT02064868|593660831|FG001|Overall Study|Lost to Follow-up|8|||
164351570|NCT02064868|593660830|FG000|Overall Study|Physician Decision|1|||
164351571|NCT02064868|593660831|FG001|Overall Study|Physician Decision|0|||
164436277|NCT04133363|593963318|FG001|Overall Study|Lost to Follow-up|1|||
164436278|NCT04133363|593963319|FG002|Overall Study|Lost to Follow-up|4|||
164351572|NCT02064868|593660830|FG000|Overall Study|Withdrawal by Subject|14|||
164351573|NCT02064868|593660831|FG001|Overall Study|Withdrawal by Subject|3|||
164351574|NCT02064868|593660830|FG000|Overall Study|Technical Problems or Missing|5|||
164351575|NCT02064868|593660831|FG001|Overall Study|Technical Problems or Missing|2|||
164351576|NCT00482612|593660832|FG000|In-treatment Period|No study medication administered|0|||
164351577|NCT00482612|593660833|FG001|In-treatment Period|No study medication administered|0|||
164351578|NCT00482612|593660834|FG002|In-treatment Period|No study medication administered|1|||
164351579|NCT00482612|593660835|FG003|In-treatment Period|No study medication administered|0|||
164351580|NCT00482612|593660832|FG000|Follow-up Period|Other|4|||
164351581|NCT00482612|593660833|FG001|Follow-up Period|Other|2|||
164351582|NCT00482612|593660834|FG002|Follow-up Period|Other|1|||
164436279|NCT03354390|593963320|FG000|Level 1|Death|2|||
164351583|NCT00482612|593660835|FG003|Follow-up Period|Other|2|||
164351584|NCT00482612|593660832|FG000|Follow-up Period|Lack of compliance|0|||
164351585|NCT00482612|593660833|FG001|Follow-up Period|Lack of compliance|0|||
164351586|NCT00482612|593660834|FG002|Follow-up Period|Lack of compliance|1|||
164351587|NCT00482612|593660835|FG003|Follow-up Period|Lack of compliance|0|||
164351588|NCT00482612|593660832|FG000|Follow-up Period|Lost to Follow-up|0|||
164351589|NCT00482612|593660833|FG001|Follow-up Period|Lost to Follow-up|4|||
164351590|NCT00482612|593660834|FG002|Follow-up Period|Lost to Follow-up|2|||
164351591|NCT00482612|593660835|FG003|Follow-up Period|Lost to Follow-up|1|||
164351592|NCT00482612|593660832|FG000|Follow-up Period|Adverse Event|4|||
164436280|NCT03354390|593963321|FG001|Level 1|Death|0|||
164351593|NCT00482612|593660833|FG001|Follow-up Period|Adverse Event|7|||
164351594|NCT00482612|593660834|FG002|Follow-up Period|Adverse Event|9|||
164351595|NCT00482612|593660835|FG003|Follow-up Period|Adverse Event|0|||
164351596|NCT00482612|593660832|FG000|Follow-up Period|Lack of Efficacy|2|||
164351597|NCT00482612|593660833|FG001|Follow-up Period|Lack of Efficacy|0|||
164351598|NCT00482612|593660834|FG002|Follow-up Period|Lack of Efficacy|1|||
164351599|NCT00482612|593660835|FG003|Follow-up Period|Lack of Efficacy|0|||
164351600|NCT00482612|593660832|FG000|Follow-up Period|Withdrawal by Subject|3|||
164351601|NCT00482612|593660833|FG001|Follow-up Period|Withdrawal by Subject|5|||
164351602|NCT00482612|593660834|FG002|Follow-up Period|Withdrawal by Subject|7|||
164351603|NCT00482612|593660835|FG003|Follow-up Period|Withdrawal by Subject|2|||
164351604|NCT00482612|593660832|FG000|Follow-up Period|Reasons not related to trial|1|||
164351605|NCT00482612|593660833|FG001|Follow-up Period|Reasons not related to trial|0|||
164351606|NCT00482612|593660834|FG002|Follow-up Period|Reasons not related to trial|1|||
164351607|NCT00482612|593660835|FG003|Follow-up Period|Reasons not related to trial|3|||
164351608|NCT00660023|593660836|FG000|Overall Study|Adverse Event|2|||
164351609|NCT00660023|593660836|FG000|Overall Study|Death|8|||
164351610|NCT00660023|593660836|FG000|Overall Study|Blood Transfusion|5|||
164351611|NCT00660023|593660836|FG000|Overall Study|Renal Transplantation|3|||
164351612|NCT00660023|593660836|FG000|Overall Study|Withdrawal by Subject|1|||
164351613|NCT00660023|593660836|FG000|Overall Study|Missed Pregnancy Test|1|||
164351614|NCT00660023|593660836|FG000|Overall Study|Other Screening Failure|9|||
164351615|NCT04180488|593660838|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
164351616|NCT04180488|593660839|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
164351617|NCT04180488|593660840|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
164351618|NCT04180488|593660841|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
164351619|NCT04180488|593660842|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
164351620|NCT04180488|593660843|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
164351621|NCT04180488|593660838|FG000|Overall Study|Withdrawal by Subject|8|||
164351622|NCT04180488|593660839|FG001|Overall Study|Withdrawal by Subject|4|||
164351623|NCT04180488|593660840|FG002|Overall Study|Withdrawal by Subject|5|||
164351624|NCT04180488|593660841|FG003|Overall Study|Withdrawal by Subject|2|||
164351625|NCT04180488|593660842|FG004|Overall Study|Withdrawal by Subject|8|||
164351626|NCT04180488|593660843|FG005|Overall Study|Withdrawal by Subject|6|||
164351627|NCT04180488|593660838|FG000|Overall Study|Adverse Event|3|||
164351628|NCT04180488|593660839|FG001|Overall Study|Adverse Event|2|||
164351629|NCT04180488|593660840|FG002|Overall Study|Adverse Event|0|||
164351630|NCT04180488|593660841|FG003|Overall Study|Adverse Event|0|||
164351631|NCT04180488|593660842|FG004|Overall Study|Adverse Event|0|||
164351632|NCT04180488|593660843|FG005|Overall Study|Adverse Event|0|||
164351633|NCT04180488|593660838|FG000|Overall Study|Poor compliance to protocol|0|||
164351634|NCT04180488|593660839|FG001|Overall Study|Poor compliance to protocol|0|||
164351635|NCT04180488|593660840|FG002|Overall Study|Poor compliance to protocol|1|||
164351636|NCT04180488|593660841|FG003|Overall Study|Poor compliance to protocol|0|||
164351637|NCT04180488|593660842|FG004|Overall Study|Poor compliance to protocol|0|||
164351638|NCT04180488|593660843|FG005|Overall Study|Poor compliance to protocol|0|||
164351639|NCT03506815|593660844|FG000|Overall Study|Adverse Event|8|||
164351640|NCT03506815|593660845|FG001|Overall Study|Adverse Event|0|||
164351641|NCT03506815|593660844|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
164351642|NCT03506815|593660845|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
164351643|NCT03506815|593660844|FG000|Overall Study|Protocol Violation|1|||
164351644|NCT03506815|593660845|FG001|Overall Study|Protocol Violation|0|||
164351645|NCT03506815|593660844|FG000|Overall Study|Elective Surgery|1|||
164351646|NCT03506815|593660845|FG001|Overall Study|Elective Surgery|0|||
164351647|NCT00381095|593660851|FG000|Overall Study|Death|3|||
164351648|NCT00381095|593660852|FG001|Overall Study|Death|4|||
164351649|NCT00381095|593660851|FG000|Overall Study|Lack of Efficacy|2|||
164351650|NCT00381095|593660852|FG001|Overall Study|Lack of Efficacy|4|||
164351651|NCT00381095|593660851|FG000|Overall Study|Other|2|||
164351652|NCT00381095|593660852|FG001|Overall Study|Other|2|||
164351653|NCT00381095|593660851|FG000|Overall Study|Protocol Violation|1|||
164351654|NCT00381095|593660852|FG001|Overall Study|Protocol Violation|1|||
164351655|NCT00381095|593660851|FG000|Overall Study|Withdrawal by Subject|3|||
164351656|NCT00381095|593660852|FG001|Overall Study|Withdrawal by Subject|3|||
164351657|NCT00381095|593660851|FG000|Overall Study|Adverse Event|2|||
164351658|NCT00381095|593660852|FG001|Overall Study|Adverse Event|7|||
164351659|NCT02057406|593660853|FG000|Overall Study|Physician Decision|0|||
164351660|NCT02057406|593660854|FG001|Overall Study|Physician Decision|0|||
164351661|NCT02057406|593660855|FG002|Overall Study|Physician Decision|2|||
164351662|NCT02057406|593660853|FG000|Overall Study|Withdrawal by Subject|0|||
164351663|NCT02057406|593660854|FG001|Overall Study|Withdrawal by Subject|2|||
164351664|NCT02057406|593660855|FG002|Overall Study|Withdrawal by Subject|0|||
164351665|NCT02057406|593660853|FG000|Overall Study|Lost to Follow-up|0|||
164351666|NCT02057406|593660854|FG001|Overall Study|Lost to Follow-up|0|||
164351667|NCT02057406|593660855|FG002|Overall Study|Lost to Follow-up|1|||
164351668|NCT02057406|593660853|FG000|Overall Study|Death|1|||
164351669|NCT02057406|593660854|FG001|Overall Study|Death|0|||
164351670|NCT02057406|593660855|FG002|Overall Study|Death|0|||
164351671|NCT02057406|593660853|FG000|Overall Study|Protocol Violation|0|||
164351672|NCT02057406|593660854|FG001|Overall Study|Protocol Violation|1|||
164351673|NCT02057406|593660855|FG002|Overall Study|Protocol Violation|0|||
164351674|NCT02057406|593660853|FG000|Overall Study|Patient transportation issues|0|||
164351675|NCT02057406|593660854|FG001|Overall Study|Patient transportation issues|0|||
164351676|NCT02057406|593660855|FG002|Overall Study|Patient transportation issues|1|||
164351677|NCT03562481|593660856|FG000|First Intervention|Lost to Follow-up|1|||
164351678|NCT03562481|593660857|FG001|First Intervention|Lost to Follow-up|0|||
164351679|NCT01401283|593660859|FG000|Overall Study|surgery cancelled|5|||
164351680|NCT01401283|593660860|FG001|Overall Study|surgery cancelled|8|||
164351681|NCT01401283|593660859|FG000|Overall Study|preoperative arrhythmia|5|||
164351682|NCT01401283|593660860|FG001|Overall Study|preoperative arrhythmia|0|||
164351683|NCT01401283|593660859|FG000|Overall Study|no central venous access|0|||
164351684|NCT01401283|593660860|FG001|Overall Study|no central venous access|1|||
164351685|NCT01401283|593660859|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
164351686|NCT01401283|593660860|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
164351687|NCT02433483|593660861|FG000|Overall Study|Unacceptable toxicity|1|||
164351688|NCT02433483|593660861|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
164351689|NCT00856284|593660866|FG000|Overall Study|Hyperglycemic rescue|231|||
164351690|NCT00856284|593660867|FG001|Overall Study|Hyperglycemic rescue|201|||
164351691|NCT00856284|593660868|FG002|Overall Study|Hyperglycemic rescue|235|||
164351692|NCT00856284|593660866|FG000|Overall Study|Adverse Event|60|||
164351693|NCT00856284|593660867|FG001|Overall Study|Adverse Event|74|||
164351694|NCT00856284|593660868|FG002|Overall Study|Adverse Event|82|||
164351695|NCT00856284|593660866|FG000|Overall Study|Major protocol deviation|24|||
164351696|NCT00856284|593660867|FG001|Overall Study|Major protocol deviation|16|||
164351697|NCT00856284|593660868|FG002|Overall Study|Major protocol deviation|15|||
164351698|NCT00856284|593660866|FG000|Overall Study|Lost to Follow-up|20|||
164351699|NCT00856284|593660867|FG001|Overall Study|Lost to Follow-up|22|||
164351700|NCT00856284|593660868|FG002|Overall Study|Lost to Follow-up|28|||
164351701|NCT00856284|593660866|FG000|Overall Study|Voluntary withdrawal|48|||
164351702|NCT00856284|593660867|FG001|Overall Study|Voluntary withdrawal|52|||
164351703|NCT00856284|593660868|FG002|Overall Study|Voluntary withdrawal|62|||
164351704|NCT00856284|593660866|FG000|Overall Study|Pregnancy|1|||
164351705|NCT00856284|593660867|FG001|Overall Study|Pregnancy|2|||
164351706|NCT00856284|593660868|FG002|Overall Study|Pregnancy|0|||
164351707|NCT00856284|593660866|FG000|Overall Study|Investigator discretion|9|||
164351708|NCT00856284|593660867|FG001|Overall Study|Investigator discretion|8|||
164351709|NCT00856284|593660868|FG002|Overall Study|Investigator discretion|10|||
164351710|NCT00856284|593660866|FG000|Overall Study|Other|15|||
164351711|NCT00856284|593660867|FG001|Overall Study|Other|17|||
164351712|NCT00856284|593660868|FG002|Overall Study|Other|14|||
164351713|NCT00856284|593660866|FG000|Overall Study|Randomized in error|0|||
164351714|NCT00856284|593660867|FG001|Overall Study|Randomized in error|0|||
164351715|NCT00856284|593660868|FG002|Overall Study|Randomized in error|1|||
164351716|NCT01327885|593660873|FG000|Overall Study|Disease progression-according to RECIST|173|||
164351717|NCT01327885|593660874|FG001|Overall Study|Disease progression-according to RECIST|165|||
164351718|NCT01327885|593660873|FG000|Overall Study|Clinical progression|24|||
164351719|NCT01327885|593660874|FG001|Overall Study|Clinical progression|27|||
164351720|NCT01327885|593660873|FG000|Overall Study|Adverse Event|14|||
164351721|NCT01327885|593660874|FG001|Overall Study|Adverse Event|10|||
164351722|NCT01327885|593660873|FG000|Overall Study|Subject choice|5|||
164436281|NCT03354390|593963322|FG002|Level 1|Death|0|||
164436282|NCT03354390|593963323|FG003|Level 1|Death|0|||
164436283|NCT03354390|593963320|FG000|Level 1|Physician Decision|1|||
164588062|NCT03703375|594517480|FG002|Treatment Period|Toxicity of Study Treatment|4|||
164588063|NCT03703375|594517481|FG003|Treatment Period|Toxicity of Study Treatment|1|||
164588064|NCT03703375|594517478|FG000|Treatment Period|Progression|32|||
164588065|NCT03703375|594517479|FG001|Treatment Period|Progression|1|||
164436284|NCT03354390|593963321|FG001|Level 1|Physician Decision|0|||
164351723|NCT01327885|593660874|FG001|Overall Study|Subject choice|10|||
164351724|NCT01327885|593660873|FG000|Overall Study|Other|8|||
164351725|NCT01327885|593660874|FG001|Overall Study|Other|6|||
164351726|NCT01327885|593660873|FG000|Overall Study|Withdrawal of consent from study|3|||
164351727|NCT01327885|593660874|FG001|Overall Study|Withdrawal of consent from study|4|||
164351728|NCT01327885|593660873|FG000|Overall Study|Not treated|1|||
164351729|NCT01327885|593660874|FG001|Overall Study|Not treated|1|||
164351730|NCT01327885|593660873|FG000|Overall Study|Administrative decision|0|||
164351731|NCT01327885|593660874|FG001|Overall Study|Administrative decision|1|||
164351732|NCT03824912|593660880|FG000|Overall Study|Lost to Follow-up|18|||
164351733|NCT03824912|593660881|FG001|Overall Study|Lost to Follow-up|15|||
164351734|NCT03824912|593660882|FG002|Overall Study|Lost to Follow-up|8|||
164351735|NCT03824912|593660880|FG000|Overall Study|Negative Baseline Culture Result|118|||
164436285|NCT03354390|593963322|FG002|Level 1|Physician Decision|0|||
164351736|NCT03824912|593660881|FG001|Overall Study|Negative Baseline Culture Result|112|||
164351737|NCT03824912|593660882|FG002|Overall Study|Negative Baseline Culture Result|57|||
164351738|NCT03824912|593660880|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164351739|NCT03824912|593660881|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164351740|NCT03824912|593660882|FG002|Overall Study|Non-Compliance with Study Drug|1|||
164351741|NCT03824912|593660880|FG000|Overall Study|Protocol Violation|1|||
164351742|NCT03824912|593660881|FG001|Overall Study|Protocol Violation|4|||
164351743|NCT03824912|593660882|FG002|Overall Study|Protocol Violation|1|||
164351744|NCT03824912|593660880|FG000|Overall Study|Withdrawal by Subject|3|||
164351745|NCT03824912|593660881|FG001|Overall Study|Withdrawal by Subject|2|||
164351746|NCT03824912|593660882|FG002|Overall Study|Withdrawal by Subject|1|||
164351747|NCT03824912|593660880|FG000|Overall Study|Participation in another study|0|||
164351748|NCT03824912|593660881|FG001|Overall Study|Participation in another study|1|||
164351749|NCT03824912|593660882|FG002|Overall Study|Participation in another study|0|||
164351750|NCT04271605|593660883|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
164351751|NCT02485301|593660884|FG000|Overall Study|Serious Adverse Events|2|||
164351752|NCT02485301|593660885|FG001|Overall Study|Serious Adverse Events|1|||
164351753|NCT02485301|593660884|FG000|Overall Study|Protocol Violation|0|||
164351754|NCT02485301|593660885|FG001|Overall Study|Protocol Violation|1|||
164351755|NCT02485301|593660884|FG000|Overall Study|Withdrawal by Subject|6|||
164351756|NCT02485301|593660885|FG001|Overall Study|Withdrawal by Subject|7|||
164351757|NCT02485301|593660884|FG000|Overall Study|Migrated/moved from study area|10|||
164351758|NCT02485301|593660885|FG001|Overall Study|Migrated/moved from study area|19|||
164351759|NCT02485301|593660884|FG000|Overall Study|Lost to Follow-up|17|||
164351760|NCT02485301|593660885|FG001|Overall Study|Lost to Follow-up|17|||
164351761|NCT02485301|593660884|FG000|Overall Study|Other|3|||
164351762|NCT02485301|593660885|FG001|Overall Study|Other|4|||
164351763|NCT01059825|593660889|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
164351764|NCT01059825|593660890|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
164351765|NCT01059825|593660891|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
164351766|NCT01059825|593660892|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
164351767|NCT01059825|593660893|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
164693854|NCT00892281|594901193|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
164693855|NCT00892281|594901194|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
164693856|NCT00892281|594901193|FG000|Overall Study|Unable to redeem the drug voucher|1|||
164351768|NCT01059825|593660894|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
164351769|NCT01059825|593660895|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
164351770|NCT01059825|593660889|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
164351771|NCT01059825|593660890|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
164351772|NCT01059825|593660891|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
164351773|NCT01059825|593660892|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
164351774|NCT01059825|593660893|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
164351775|NCT01059825|593660894|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
164351776|NCT01059825|593660895|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
164351777|NCT01059825|593660889|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
164351778|NCT01059825|593660890|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
164351779|NCT01059825|593660891|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
164351780|NCT01059825|593660892|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
164351781|NCT01059825|593660893|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
164351782|NCT01059825|593660894|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
164351783|NCT01059825|593660895|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
164351784|NCT01059825|593660889|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
164351785|NCT01059825|593660890|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
164351786|NCT01059825|593660891|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
164351787|NCT01059825|593660892|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
164351788|NCT01059825|593660893|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
164351789|NCT01059825|593660894|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
164351790|NCT01059825|593660895|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
164351791|NCT01059825|593660889|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
164351792|NCT01059825|593660890|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
164351793|NCT01059825|593660891|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
164351794|NCT01059825|593660892|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
164351795|NCT01059825|593660893|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
164351796|NCT01059825|593660894|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
164351797|NCT01059825|593660895|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
164351798|NCT01059825|593660889|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
164351799|NCT01059825|593660890|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
164351800|NCT01059825|593660891|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
164351801|NCT01059825|593660892|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
164351802|NCT01059825|593660893|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
164351803|NCT01059825|593660894|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
164351804|NCT01059825|593660895|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
164351805|NCT01059825|593660889|FG000|Treatment Period|Lost to Follow-up|2|||
164351806|NCT01059825|593660890|FG001|Treatment Period|Lost to Follow-up|1|||
164351807|NCT01059825|593660891|FG002|Treatment Period|Lost to Follow-up|0|||
164351808|NCT01059825|593660892|FG003|Treatment Period|Lost to Follow-up|1|||
164351809|NCT01059825|593660893|FG004|Treatment Period|Lost to Follow-up|2|||
164351810|NCT01059825|593660894|FG005|Treatment Period|Lost to Follow-up|0|||
164351811|NCT01059825|593660895|FG006|Treatment Period|Lost to Follow-up|0|||
164351812|NCT01059825|593660889|FG000|Treatment Period|Withdrawal by Subject|3|||
164351813|NCT01059825|593660890|FG001|Treatment Period|Withdrawal by Subject|0|||
164351814|NCT01059825|593660891|FG002|Treatment Period|Withdrawal by Subject|1|||
164351815|NCT01059825|593660892|FG003|Treatment Period|Withdrawal by Subject|5|||
164351816|NCT01059825|593660893|FG004|Treatment Period|Withdrawal by Subject|4|||
164351817|NCT01059825|593660894|FG005|Treatment Period|Withdrawal by Subject|1|||
164351818|NCT01059825|593660895|FG006|Treatment Period|Withdrawal by Subject|0|||
164351819|NCT01059825|593660889|FG000|Treatment Period|Other reason not specified|1|||
164351820|NCT01059825|593660890|FG001|Treatment Period|Other reason not specified|2|||
164351821|NCT01059825|593660891|FG002|Treatment Period|Other reason not specified|1|||
164351822|NCT01059825|593660892|FG003|Treatment Period|Other reason not specified|2|||
164351823|NCT01059825|593660893|FG004|Treatment Period|Other reason not specified|0|||
164351824|NCT01059825|593660894|FG005|Treatment Period|Other reason not specified|0|||
164351825|NCT01059825|593660895|FG006|Treatment Period|Other reason not specified|0|||
164351826|NCT01059825|593660889|FG000|Treatment Period|Protocol Violation|0|||
164351827|NCT01059825|593660890|FG001|Treatment Period|Protocol Violation|0|||
164351828|NCT01059825|593660891|FG002|Treatment Period|Protocol Violation|1|||
164351829|NCT01059825|593660892|FG003|Treatment Period|Protocol Violation|1|||
164351830|NCT01059825|593660893|FG004|Treatment Period|Protocol Violation|1|||
164351831|NCT01059825|593660894|FG005|Treatment Period|Protocol Violation|1|||
164351832|NCT01059825|593660895|FG006|Treatment Period|Protocol Violation|0|||
164351833|NCT01059825|593660889|FG000|Treatment Period|Adverse event related to study drug|1|||
164351834|NCT01059825|593660890|FG001|Treatment Period|Adverse event related to study drug|0|||
164351835|NCT01059825|593660891|FG002|Treatment Period|Adverse event related to study drug|1|||
164351836|NCT01059825|593660892|FG003|Treatment Period|Adverse event related to study drug|1|||
164351837|NCT01059825|593660893|FG004|Treatment Period|Adverse event related to study drug|0|||
164351838|NCT01059825|593660894|FG005|Treatment Period|Adverse event related to study drug|0|||
164351839|NCT01059825|593660895|FG006|Treatment Period|Adverse event related to study drug|0|||
164351840|NCT01059825|593660889|FG000|Treatment Period|Insufficient clinical response|3|||
164351841|NCT01059825|593660890|FG001|Treatment Period|Insufficient clinical response|0|||
164351842|NCT01059825|593660891|FG002|Treatment Period|Insufficient clinical response|0|||
164351843|NCT01059825|593660892|FG003|Treatment Period|Insufficient clinical response|0|||
164351844|NCT01059825|593660893|FG004|Treatment Period|Insufficient clinical response|0|||
164351845|NCT01059825|593660894|FG005|Treatment Period|Insufficient clinical response|0|||
164351846|NCT01059825|593660895|FG006|Treatment Period|Insufficient clinical response|0|||
164351847|NCT01059825|593660889|FG000|Treatment Period|Adverse event not related to study drug|0|||
164351848|NCT01059825|593660890|FG001|Treatment Period|Adverse event not related to study drug|1|||
164351849|NCT01059825|593660891|FG002|Treatment Period|Adverse event not related to study drug|2|||
164351850|NCT01059825|593660892|FG003|Treatment Period|Adverse event not related to study drug|1|||
164351851|NCT01059825|593660893|FG004|Treatment Period|Adverse event not related to study drug|1|||
164351852|NCT01059825|593660894|FG005|Treatment Period|Adverse event not related to study drug|1|||
164351853|NCT01059825|593660895|FG006|Treatment Period|Adverse event not related to study drug|0|||
164351854|NCT03342690|593660904|FG000|Overall Study|Missing Information|9|||
164351855|NCT03342690|593660904|FG000|Overall Study|Protocol Violation|16|||
164351856|NCT03138889|593660905|FG000|Overall Study|Withdrawal by Subject|5|||
164351857|NCT03138889|593660906|FG001|Overall Study|Withdrawal by Subject|5|||
164351858|NCT03138889|593660907|FG002|Overall Study|Withdrawal by Subject|0|||
164351859|NCT03138889|593660908|FG003|Overall Study|Withdrawal by Subject|2|||
164351860|NCT03138889|593660909|FG004|Overall Study|Withdrawal by Subject|1|||
164351861|NCT03138889|593660910|FG005|Overall Study|Withdrawal by Subject|3|||
164351862|NCT03138889|593660911|FG006|Overall Study|Withdrawal by Subject|0|||
164351863|NCT03138889|593660912|FG007|Overall Study|Withdrawal by Subject|1|||
164351864|NCT00549302|593660921|FG000|Double-Blind|Death|2|||
164351865|NCT00549302|593660922|FG001|Double-Blind|Death|9|||
164693857|NCT00892281|594901194|FG001|Overall Study|Unable to redeem the drug voucher|0|||
164351866|NCT00549302|593660923|FG002|Double-Blind|Death|0|||
164351867|NCT00549302|593660921|FG000|Double-Blind|Adverse Event|3|||
164693858|NCT00892281|594901193|FG000|Overall Study|Subject not good candidate for study|1|||
164693859|NCT00892281|594901194|FG001|Overall Study|Subject not good candidate for study|0|||
164351868|NCT00549302|593660922|FG001|Double-Blind|Adverse Event|16|||
164351869|NCT00549302|593660923|FG002|Double-Blind|Adverse Event|0|||
164351870|NCT00549302|593660921|FG000|Double-Blind|Withdrawal by Subject|3|||
164351871|NCT00549302|593660922|FG001|Double-Blind|Withdrawal by Subject|8|||
164351872|NCT00549302|593660923|FG002|Double-Blind|Withdrawal by Subject|0|||
164351873|NCT00549302|593660921|FG000|Double-Blind|Investigator Decision|1|||
164351874|NCT00549302|593660922|FG001|Double-Blind|Investigator Decision|5|||
164351875|NCT00549302|593660923|FG002|Double-Blind|Investigator Decision|0|||
164351876|NCT00549302|593660921|FG000|Double-Blind|Sponsor Decision|0|||
164351877|NCT00549302|593660922|FG001|Double-Blind|Sponsor Decision|1|||
164351878|NCT00549302|593660923|FG002|Double-Blind|Sponsor Decision|0|||
164351879|NCT00549302|593660921|FG000|Double-Blind|Lost to Follow-up|1|||
164351880|NCT00549302|593660922|FG001|Double-Blind|Lost to Follow-up|2|||
164351881|NCT00549302|593660923|FG002|Double-Blind|Lost to Follow-up|0|||
164351882|NCT00549302|593660921|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
164351883|NCT00549302|593660922|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
164351884|NCT00549302|593660923|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
164351885|NCT00549302|593660921|FG000|Double-Blind|New condition or starts new therapy|0|||
164351886|NCT00549302|593660922|FG001|Double-Blind|New condition or starts new therapy|2|||
164351887|NCT00549302|593660923|FG002|Double-Blind|New condition or starts new therapy|0|||
164351888|NCT00549302|593660921|FG000|Open-Label|Adverse Event|0|||
164351889|NCT00549302|593660922|FG001|Open-Label|Adverse Event|0|||
164351890|NCT00549302|593660923|FG002|Open-Label|Adverse Event|11|||
164351891|NCT00549302|593660921|FG000|Open-Label|Death|0|||
164351892|NCT00549302|593660922|FG001|Open-Label|Death|0|||
164351893|NCT00549302|593660923|FG002|Open-Label|Death|40|||
164351894|NCT00549302|593660921|FG000|Open-Label|Investigator Decision|0|||
164351895|NCT00549302|593660922|FG001|Open-Label|Investigator Decision|0|||
164351896|NCT00549302|593660923|FG002|Open-Label|Investigator Decision|5|||
164351897|NCT00549302|593660921|FG000|Open-Label|Lost to Follow-up|0|||
164351898|NCT00549302|593660922|FG001|Open-Label|Lost to Follow-up|0|||
164351899|NCT00549302|593660923|FG002|Open-Label|Lost to Follow-up|2|||
164351900|NCT00549302|593660921|FG000|Open-Label|Other|0|||
164351901|NCT00549302|593660922|FG001|Open-Label|Other|0|||
164351902|NCT00549302|593660923|FG002|Open-Label|Other|3|||
164351903|NCT00549302|593660921|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
164351904|NCT00549302|593660922|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
164351905|NCT00549302|593660923|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
164351906|NCT00549302|593660921|FG000|Open-Label|Withdrawal by Subject|0|||
164351907|NCT00549302|593660922|FG001|Open-Label|Withdrawal by Subject|0|||
164351908|NCT00549302|593660923|FG002|Open-Label|Withdrawal by Subject|6|||
164351909|NCT01414114|593660924|FG000|Overall Study|Adverse Event|2|||
164351910|NCT01414114|593660924|FG000|Overall Study|Withdrawal by Subject|1|||
164351911|NCT01414114|593660924|FG000|Overall Study|Other|2|||
164351912|NCT00105482|593660929|FG000|Overall Study|Adverse Event|1|||
164351913|NCT00105482|593660930|FG001|Overall Study|Adverse Event|1|||
164351914|NCT00105482|593660929|FG000|Overall Study|Lost to Follow-up|26|||
164351915|NCT00105482|593660930|FG001|Overall Study|Lost to Follow-up|17|||
164351916|NCT00105482|593660929|FG000|Overall Study|Withdrawal by Subject|0|||
164351917|NCT00105482|593660930|FG001|Overall Study|Withdrawal by Subject|1|||
164351918|NCT00105482|593660929|FG000|Overall Study|Lost Interest|29|||
164351919|NCT00105482|593660930|FG001|Overall Study|Lost Interest|32|||
164351920|NCT00105482|593660929|FG000|Overall Study|Scheduling Conflict|2|||
164351921|NCT00105482|593660930|FG001|Overall Study|Scheduling Conflict|3|||
164351922|NCT00105482|593660929|FG000|Overall Study|Withdrawn by PI|1|||
164351923|NCT00105482|593660930|FG001|Overall Study|Withdrawn by PI|1|||
164351924|NCT02495168|593660936|FG000|Overall Study|Other than Specified|18|||
164351925|NCT02495168|593660937|FG001|Overall Study|Other than Specified|22|||
164351926|NCT02495168|593660938|FG002|Overall Study|Other than Specified|5|||
164351927|NCT02495168|593660936|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
164588066|NCT03703375|594517480|FG002|Treatment Period|Progression|7|||
164351928|NCT02495168|593660937|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
164351929|NCT02495168|593660938|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
164351930|NCT02495168|593660936|FG000|Overall Study|Physician Decision|1|||
164351931|NCT02495168|593660937|FG001|Overall Study|Physician Decision|1|||
164351932|NCT02495168|593660938|FG002|Overall Study|Physician Decision|0|||
164351933|NCT02495168|593660936|FG000|Overall Study|Lost to Follow-up|10|||
164351934|NCT02495168|593660937|FG001|Overall Study|Lost to Follow-up|6|||
164351935|NCT02495168|593660938|FG002|Overall Study|Lost to Follow-up|1|||
164351936|NCT02495168|593660936|FG000|Overall Study|Withdrawal by Subject|1|||
164351937|NCT02495168|593660937|FG001|Overall Study|Withdrawal by Subject|4|||
164351938|NCT02495168|593660938|FG002|Overall Study|Withdrawal by Subject|2|||
164351939|NCT02495168|593660936|FG000|Overall Study|Protocol Violation|0|||
164351940|NCT02495168|593660937|FG001|Overall Study|Protocol Violation|10|||
164351941|NCT02495168|593660938|FG002|Overall Study|Protocol Violation|1|||
164351942|NCT02495168|593660936|FG000|Overall Study|Adverse Event|4|||
164351943|NCT02495168|593660937|FG001|Overall Study|Adverse Event|8|||
164351944|NCT02495168|593660938|FG002|Overall Study|Adverse Event|3|||
164351945|NCT02495168|593660936|FG000|Overall Study|Lack of Efficacy|0|||
164351946|NCT02495168|593660937|FG001|Overall Study|Lack of Efficacy|0|||
164351947|NCT02495168|593660938|FG002|Overall Study|Lack of Efficacy|3|||
164351948|NCT00644995|593660939|FG000|Overall Study|Lost to Follow-up|1|||
164351949|NCT00644995|593660940|FG001|Overall Study|Lost to Follow-up|4|||
164351950|NCT00644995|593660939|FG000|Overall Study|Refused|1|||
164351951|NCT00644995|593660940|FG001|Overall Study|Refused|0|||
164351952|NCT00865124|593660941|FG000|Overall Study|Physician Decision|2|||
164351953|NCT00865124|593660942|FG001|Overall Study|Physician Decision|1|||
164351954|NCT00865124|593660943|FG002|Overall Study|Physician Decision|0|||
164351955|NCT00865124|593660941|FG000|Overall Study|Withdrawn consent|2|||
164351956|NCT00865124|593660942|FG001|Overall Study|Withdrawn consent|0|||
164351957|NCT00865124|593660943|FG002|Overall Study|Withdrawn consent|0|||
164351958|NCT02743520|593660944|FG000|Overall Study|Withdrawal by Subject|1|||
164351959|NCT03247530|593660945|FG000|Overall Study|Withdrawal by caregiver|19|||
164351960|NCT03247530|593660946|FG001|Overall Study|Withdrawal by caregiver|8|||
164351961|NCT03247530|593660947|FG002|Overall Study|Withdrawal by caregiver|10|||
164351962|NCT03247530|593660945|FG000|Overall Study|Lost to Follow-up|3|||
164351963|NCT03247530|593660946|FG001|Overall Study|Lost to Follow-up|9|||
164351964|NCT03247530|593660947|FG002|Overall Study|Lost to Follow-up|6|||
164351965|NCT03247530|593660945|FG000|Overall Study|Adverse Event|2|||
164351966|NCT03247530|593660946|FG001|Overall Study|Adverse Event|5|||
164351967|NCT03247530|593660947|FG002|Overall Study|Adverse Event|2|||
164351968|NCT03247530|593660945|FG000|Overall Study|Failure to follow procedure|1|||
164351969|NCT03247530|593660946|FG001|Overall Study|Failure to follow procedure|1|||
164351970|NCT03247530|593660947|FG002|Overall Study|Failure to follow procedure|1|||
164351971|NCT03247530|593660945|FG000|Overall Study|Withdrawal by Subject|1|||
164351972|NCT03247530|593660946|FG001|Overall Study|Withdrawal by Subject|1|||
164351973|NCT03247530|593660947|FG002|Overall Study|Withdrawal by Subject|0|||
164351974|NCT03247530|593660945|FG000|Overall Study|Study medication misuse|0|||
164351975|NCT03247530|593660946|FG001|Overall Study|Study medication misuse|1|||
164351976|NCT03247530|593660947|FG002|Overall Study|Study medication misuse|0|||
164351977|NCT03247530|593660945|FG000|Overall Study|Other, multiple categories|1|||
164351978|NCT03247530|593660946|FG001|Overall Study|Other, multiple categories|3|||
164351979|NCT03247530|593660947|FG002|Overall Study|Other, multiple categories|1|||
164351980|NCT03042533|593660948|FG000|Overall Study|MD left program|1|||
164351981|NCT03042533|593660949|FG001|Overall Study|MD left program|4|||
164351982|NCT03042533|593660950|FG002|Overall Study|MD left program|1|||
164351983|NCT01587001|593660951|FG000|Overall Study|Lost to Follow-up|2|||
164351984|NCT01587001|593660952|FG001|Overall Study|Lost to Follow-up|0|||
164351985|NCT01587001|593660951|FG000|Overall Study|Insufficient samples to complete testing|4|||
164351986|NCT01587001|593660952|FG001|Overall Study|Insufficient samples to complete testing|1|||
164351987|NCT04786990|593660953|FG000|Overall Study|Withdrawal by Subject|1|||
164351988|NCT04786990|593660953|FG000|Overall Study|Adverse Event|1|||
164351989|NCT04786990|593660953|FG000|Overall Study|Lost to Follow-up|1|||
164351990|NCT04786990|593660953|FG000|Overall Study|Noncompliance|1|||
164351991|NCT04786990|593660953|FG000|Overall Study|Unable to complete site visits|1|||
164351992|NCT04786990|593660953|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
164351993|NCT02233647|593660954|FG000|Overall Study|Adverse Event|1|||
164351994|NCT00439244|593660960|FG000|Overall Study|Adverse Event|5|||
164351995|NCT00439244|593660961|FG001|Overall Study|Adverse Event|2|||
164351996|NCT00439244|593660962|FG002|Overall Study|Adverse Event|3|||
164351997|NCT00439244|593660960|FG000|Overall Study|Withdrawal by Subject|3|||
164351998|NCT00439244|593660961|FG001|Overall Study|Withdrawal by Subject|1|||
164351999|NCT00439244|593660962|FG002|Overall Study|Withdrawal by Subject|2|||
164352000|NCT00439244|593660960|FG000|Overall Study|Lost to Follow-up|2|||
164352001|NCT00439244|593660961|FG001|Overall Study|Lost to Follow-up|1|||
164352002|NCT00439244|593660962|FG002|Overall Study|Lost to Follow-up|2|||
164352003|NCT00439244|593660960|FG000|Overall Study|Death|0|||
164352004|NCT00439244|593660961|FG001|Overall Study|Death|1|||
164693860|NCT00892281|594901193|FG000|Overall Study|Subject did not return for any visits|1|||
164352005|NCT00439244|593660962|FG002|Overall Study|Death|0|||
164352006|NCT00439244|593660960|FG000|Overall Study|Protocol Violation|0|||
164352007|NCT00439244|593660961|FG001|Overall Study|Protocol Violation|1|||
164352008|NCT00439244|593660962|FG002|Overall Study|Protocol Violation|0|||
164352009|NCT00439244|593660960|FG000|Overall Study|Administrative problems|1|||
164352010|NCT00439244|593660961|FG001|Overall Study|Administrative problems|0|||
164352011|NCT00439244|593660962|FG002|Overall Study|Administrative problems|0|||
164352012|NCT02846779|593660963|FG000|Overall Study|Lost Enrollment|83|||
164352013|NCT02846779|593660964|FG001|Overall Study|Lost Enrollment|82|||
164352014|NCT02846779|593660965|FG002|Overall Study|Lost Enrollment|86|||
164352015|NCT02846779|593660963|FG000|Overall Study|Less than 31 days of follow-up|56|||
164352016|NCT02846779|593660964|FG001|Overall Study|Less than 31 days of follow-up|45|||
164352017|NCT02846779|593660965|FG002|Overall Study|Less than 31 days of follow-up|52|||
164352018|NCT05353985|593660970|FG000|Overall Study|Adverse Event|5|||
164352019|NCT05353985|593660971|FG001|Overall Study|Adverse Event|7|||
164352020|NCT05353985|593660970|FG000|Overall Study|Lost to Follow-up|1|||
164352021|NCT05353985|593660971|FG001|Overall Study|Lost to Follow-up|1|||
164352022|NCT05353985|593660970|FG000|Overall Study|Protocol Violation|1|||
164352023|NCT05353985|593660971|FG001|Overall Study|Protocol Violation|0|||
164352024|NCT05353985|593660970|FG000|Overall Study|Withdrawal by Subject|13|||
164352025|NCT05353985|593660971|FG001|Overall Study|Withdrawal by Subject|17|||
164352026|NCT05353985|593660970|FG000|Overall Study|Reason Not Specified|1|||
164352027|NCT05353985|593660971|FG001|Overall Study|Reason Not Specified|0|||
164352028|NCT05353985|593660970|FG000|Overall Study|Randomized in Error & Not Treated|0|||
164352029|NCT05353985|593660971|FG001|Overall Study|Randomized in Error & Not Treated|1|||
164352030|NCT00524368|593662566|FG000|Overall Study|Adverse Event|10|||
164352031|NCT00524368|593662567|FG001|Overall Study|Adverse Event|12|||
164352032|NCT00524368|593662566|FG000|Overall Study|Lost to Follow-up|9|||
164352033|NCT00524368|593662567|FG001|Overall Study|Lost to Follow-up|13|||
164352034|NCT00524368|593662566|FG000|Overall Study|Withdrawal by Subject|4|||
164352035|NCT00524368|593662567|FG001|Overall Study|Withdrawal by Subject|5|||
164352036|NCT00524368|593662566|FG000|Overall Study|Non-compliant|8|||
164352037|NCT00524368|593662567|FG001|Overall Study|Non-compliant|9|||
164352038|NCT00524368|593662566|FG000|Overall Study|Reached a Virologic Endpoint|3|||
164352039|NCT00524368|593662567|FG001|Overall Study|Reached a Virologic Endpoint|2|||
164352040|NCT00524368|593662566|FG000|Overall Study|Sponsor's Decision|2|||
164352041|NCT00524368|593662567|FG001|Overall Study|Sponsor's Decision|0|||
164352042|NCT00524368|593662566|FG000|Overall Study|Ineligible to Continue the study|2|||
164352043|NCT00524368|593662567|FG001|Overall Study|Ineligible to Continue the study|5|||
164352044|NCT00524368|593662566|FG000|Overall Study|Other|3|||
164352045|NCT00524368|593662567|FG001|Overall Study|Other|2|||
164352046|NCT01438424|593662570|FG000|Overall Study|Continuing treatment|29|||
164352047|NCT01438424|593662570|FG000|Overall Study|Minimal virologic response|95|||
164352048|NCT01438424|593662570|FG000|Overall Study|Not identified|55|||
164352049|NCT01438424|593662570|FG000|Overall Study|Withdrawal by Subject|104|||
164352050|NCT01438424|593662570|FG000|Overall Study|Progression of chronic hepatitis B|22|||
164352051|NCT01438424|593662570|FG000|Overall Study|Death|22|||
164352052|NCT01438424|593662570|FG000|Overall Study|Adverse Event|17|||
164352053|NCT01438424|593662570|FG000|Overall Study|Lost to Follow-up|17|||
164352054|NCT01438424|593662570|FG000|Overall Study|Abnormal laboratory test result|14|||
164352055|NCT01438424|593662570|FG000|Overall Study|Need for drug prohibited by protocol|14|||
164352056|NCT01438424|593662570|FG000|Overall Study|Pregnancy|7|||
164352057|NCT01438424|593662570|FG000|Overall Study|No longer met inclusion criteria|1|||
164352058|NCT01438424|593662570|FG000|Overall Study|Participant noncompliance|20|||
164352059|NCT02373202|593662574|FG000|Overall Study|Adverse Event|2|||
164352060|NCT02373202|593662575|FG001|Overall Study|Adverse Event|5|||
164352061|NCT02373202|593662576|FG002|Overall Study|Adverse Event|2|||
164352062|NCT02373202|593662577|FG003|Overall Study|Adverse Event|1|||
164352063|NCT02373202|593662574|FG000|Overall Study|Lack of Efficacy|0|||
164352064|NCT02373202|593662575|FG001|Overall Study|Lack of Efficacy|0|||
164352065|NCT02373202|593662576|FG002|Overall Study|Lack of Efficacy|1|||
164352066|NCT02373202|593662577|FG003|Overall Study|Lack of Efficacy|0|||
164352067|NCT02373202|593662574|FG000|Overall Study|Other|0|||
164352068|NCT02373202|593662575|FG001|Overall Study|Other|1|||
164352069|NCT02373202|593662576|FG002|Overall Study|Other|0|||
164352070|NCT02373202|593662577|FG003|Overall Study|Other|0|||
164352071|NCT00410046|593662578|FG000|Overall Study|Adverse Event|3|||
164352072|NCT00410046|593662578|FG000|Overall Study|Withdrawal by Subject|1|||
164352073|NCT00410046|593662578|FG000|Overall Study|Lost to Follow-up|1|||
164352074|NCT03010254|593662579|FG000|Overall Study|Adverse Event|0|||
164352075|NCT03010254|593662580|FG001|Overall Study|Adverse Event|1|||
164352076|NCT03010254|593662579|FG000|Overall Study|Lost to Follow-up|4|||
164352077|NCT03010254|593662580|FG001|Overall Study|Lost to Follow-up|0|||
164352078|NCT03010254|593662579|FG000|Overall Study|Withdrawal by Subject|1|||
164352079|NCT03010254|593662580|FG001|Overall Study|Withdrawal by Subject|1|||
164352080|NCT03010254|593662579|FG000|Overall Study|Other|2|||
164352081|NCT03010254|593662580|FG001|Overall Study|Other|3|||
164352082|NCT02927080|593662587|FG000|Overall Study|Withdrawal by Subject|0|||
164352083|NCT02927080|593662588|FG001|Overall Study|Withdrawal by Subject|0|||
164352084|NCT02927080|593662589|FG002|Overall Study|Withdrawal by Subject|0|||
164352085|NCT02927080|593662590|FG003|Overall Study|Withdrawal by Subject|0|||
164352086|NCT02927080|593662591|FG004|Overall Study|Withdrawal by Subject|1|||
164352087|NCT02927080|593662592|FG005|Overall Study|Withdrawal by Subject|0|||
164352088|NCT02927080|593662593|FG006|Overall Study|Withdrawal by Subject|1|||
164352089|NCT02927080|593662594|FG007|Overall Study|Withdrawal by Subject|1|||
164352090|NCT02927080|593662595|FG008|Overall Study|Withdrawal by Subject|0|||
164352091|NCT02927080|593662596|FG009|Overall Study|Withdrawal by Subject|2|||
164352092|NCT02927080|593662587|FG000|Overall Study|Willingness to comply with protocol|0|||
164352093|NCT02927080|593662588|FG001|Overall Study|Willingness to comply with protocol|0|||
164352094|NCT02927080|593662589|FG002|Overall Study|Willingness to comply with protocol|0|||
164352095|NCT02927080|593662590|FG003|Overall Study|Willingness to comply with protocol|0|||
164352096|NCT02927080|593662591|FG004|Overall Study|Willingness to comply with protocol|0|||
164352097|NCT02927080|593662592|FG005|Overall Study|Willingness to comply with protocol|0|||
164352098|NCT02927080|593662593|FG006|Overall Study|Willingness to comply with protocol|0|||
164352099|NCT02927080|593662594|FG007|Overall Study|Willingness to comply with protocol|0|||
164352100|NCT02927080|593662595|FG008|Overall Study|Willingness to comply with protocol|0|||
164352101|NCT02927080|593662596|FG009|Overall Study|Willingness to comply with protocol|1|||
164352102|NCT02927080|593662587|FG000|Overall Study|Study terminated by Sponsor|0|||
164352103|NCT02927080|593662588|FG001|Overall Study|Study terminated by Sponsor|0|||
164352104|NCT02927080|593662589|FG002|Overall Study|Study terminated by Sponsor|0|||
164352105|NCT02927080|593662590|FG003|Overall Study|Study terminated by Sponsor|0|||
164352106|NCT02927080|593662591|FG004|Overall Study|Study terminated by Sponsor|0|||
164352107|NCT02927080|593662592|FG005|Overall Study|Study terminated by Sponsor|0|||
164352108|NCT02927080|593662593|FG006|Overall Study|Study terminated by Sponsor|6|||
164352109|NCT02927080|593662594|FG007|Overall Study|Study terminated by Sponsor|7|||
164352110|NCT02927080|593662595|FG008|Overall Study|Study terminated by Sponsor|2|||
164352111|NCT02927080|593662596|FG009|Overall Study|Study terminated by Sponsor|3|||
164352112|NCT02927080|593662587|FG000|Overall Study|Adverse Event|0|||
164352113|NCT02927080|593662588|FG001|Overall Study|Adverse Event|1|||
164352114|NCT02927080|593662589|FG002|Overall Study|Adverse Event|0|||
164352115|NCT02927080|593662590|FG003|Overall Study|Adverse Event|0|||
164352116|NCT02927080|593662591|FG004|Overall Study|Adverse Event|0|||
164352117|NCT02927080|593662592|FG005|Overall Study|Adverse Event|0|||
164352118|NCT02927080|593662593|FG006|Overall Study|Adverse Event|0|||
164352119|NCT02927080|593662594|FG007|Overall Study|Adverse Event|1|||
164352120|NCT02927080|593662595|FG008|Overall Study|Adverse Event|0|||
164352121|NCT02927080|593662596|FG009|Overall Study|Adverse Event|1|||
164352122|NCT02927080|593662587|FG000|Overall Study|Other|0|||
164352123|NCT02927080|593662588|FG001|Overall Study|Other|0|||
164352124|NCT02927080|593662589|FG002|Overall Study|Other|0|||
164352125|NCT02927080|593662590|FG003|Overall Study|Other|0|||
164352126|NCT02927080|593662591|FG004|Overall Study|Other|0|||
164352127|NCT02927080|593662592|FG005|Overall Study|Other|0|||
164352128|NCT02927080|593662593|FG006|Overall Study|Other|1|||
164352129|NCT02927080|593662594|FG007|Overall Study|Other|0|||
164436286|NCT03354390|593963323|FG003|Level 1|Physician Decision|0|||
164436287|NCT03354390|593963320|FG000|Level 2|Physician Decision|0|||
164436288|NCT03354390|593963321|FG001|Level 2|Physician Decision|2|||
164436289|NCT03354390|593963322|FG002|Level 2|Physician Decision|0|||
164436290|NCT03354390|593963323|FG003|Level 2|Physician Decision|0|||
164436291|NCT03354390|593963320|FG000|Level 2|Lack of Efficacy|0|||
164436292|NCT03354390|593963321|FG001|Level 2|Lack of Efficacy|1|||
164436293|NCT03354390|593963322|FG002|Level 2|Lack of Efficacy|0|||
164436294|NCT03354390|593963323|FG003|Level 2|Lack of Efficacy|0|||
164436295|NCT03354390|593963320|FG000|Level 2|Lost to Follow-up|0|||
164436296|NCT03354390|593963321|FG001|Level 2|Lost to Follow-up|1|||
164436297|NCT03354390|593963322|FG002|Level 2|Lost to Follow-up|0|||
164436298|NCT03354390|593963323|FG003|Level 2|Lost to Follow-up|0|||
164436299|NCT03354390|593963320|FG000|Level 3|Death|0|||
164436300|NCT03354390|593963321|FG001|Level 3|Death|0|||
164436301|NCT03354390|593963322|FG002|Level 3|Death|1|||
164436302|NCT03354390|593963323|FG003|Level 3|Death|0|||
164436303|NCT03354390|593963320|FG000|Level 3|Physician Decision|0|||
164436304|NCT03354390|593963321|FG001|Level 3|Physician Decision|0|||
164352130|NCT02927080|593662595|FG008|Overall Study|Other|1|||
164352131|NCT02927080|593662596|FG009|Overall Study|Other|0|||
164352132|NCT01404325|593662597|FG000|Overall Study|Lost to Follow-up|1|||
164436305|NCT03354390|593963322|FG002|Level 3|Physician Decision|2|||
164436306|NCT03354390|593963323|FG003|Level 3|Physician Decision|0|||
164436307|NCT03354390|593963320|FG000|Level 4|Death|0|||
164693861|NCT00892281|594901194|FG001|Overall Study|Subject did not return for any visits|0|||
164352133|NCT01404325|593662598|FG001|Overall Study|Lost to Follow-up|0|||
164352134|NCT01404325|593662597|FG000|Overall Study|Death|2|||
164352135|NCT01404325|593662598|FG001|Overall Study|Death|0|||
164352136|NCT01404325|593662597|FG000|Overall Study|Graft loss/Retransplantation|1|||
164352137|NCT01404325|593662598|FG001|Overall Study|Graft loss/Retransplantation|0|||
164352138|NCT01404325|593662597|FG000|Overall Study|non-specified reason|0|||
164436308|NCT03354390|593963321|FG001|Level 4|Death|0|||
164436309|NCT03354390|593963322|FG002|Level 4|Death|0|||
164436310|NCT03354390|593963323|FG003|Level 4|Death|3|||
164352139|NCT01404325|593662598|FG001|Overall Study|non-specified reason|2|||
164436311|NCT00726596|593964863|FG000|Overall Study|Adverse Event|2|||
164352140|NCT01411228|593662601|FG000|Overall Study|Lost to Follow-up|0|||
164436312|NCT00726596|593964864|FG001|Overall Study|Adverse Event|1|||
164436313|NCT00726596|593964863|FG000|Overall Study|Withdrawal by Subject|3|||
164436314|NCT00726596|593964864|FG001|Overall Study|Withdrawal by Subject|3|||
164352141|NCT01411228|593662602|FG001|Overall Study|Lost to Follow-up|0|||
164352142|NCT01411228|593662603|FG002|Overall Study|Lost to Follow-up|1|||
164436315|NCT00377455|593964876|FG000|Overall Study|Withdrawal by Subject|1|||
164436316|NCT00309452|593964877|FG000|Overall Study|Withdrawal by Subject|3|||
164436317|NCT00309452|593964878|FG001|Overall Study|Withdrawal by Subject|0|||
164436318|NCT02962674|593964880|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
164436319|NCT00771667|593964881|FG000|Induction Phase|Adverse Event|5|||
164436320|NCT00771667|593964882|FG001|Induction Phase|Adverse Event|2|||
164352143|NCT01411228|593662601|FG000|Overall Study|Withdrawal by Subject|1|||
164352144|NCT01411228|593662602|FG001|Overall Study|Withdrawal by Subject|0|||
164352145|NCT01411228|593662603|FG002|Overall Study|Withdrawal by Subject|0|||
164352146|NCT00664742|593662605|FG000|Overall Study|Withdrawn due to adverse events|3|||
164352147|NCT00664742|593662605|FG000|Overall Study|Withdrawal by Subject|31|||
164352148|NCT00664742|593662605|FG000|Overall Study|Lost to Follow-up|92|||
164352149|NCT02310568|593662606|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
164352150|NCT02310568|593662607|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
164352151|NCT02310568|593662608|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
164352152|NCT02310568|593662609|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
164352153|NCT02310568|593662610|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
164352154|NCT02310568|593662606|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
164352155|NCT02310568|593662607|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
164352156|NCT02310568|593662608|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
164352157|NCT02310568|593662609|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
164352158|NCT02310568|593662610|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
164352159|NCT02310568|593662606|FG000|Stage 1 ( 4 Weeks)|Other|1|||
164352160|NCT02310568|593662607|FG001|Stage 1 ( 4 Weeks)|Other|1|||
164352161|NCT02310568|593662608|FG002|Stage 1 ( 4 Weeks)|Other|0|||
164352162|NCT02310568|593662609|FG003|Stage 1 ( 4 Weeks)|Other|0|||
164352163|NCT02310568|593662610|FG004|Stage 1 ( 4 Weeks)|Other|0|||
164352164|NCT02310568|593662606|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
164352165|NCT02310568|593662607|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
164352166|NCT02310568|593662608|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
164352167|NCT02310568|593662609|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
164352168|NCT02310568|593662610|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
164352169|NCT02310568|593662606|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
164352170|NCT02310568|593662607|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
164352171|NCT02310568|593662608|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
164352172|NCT02310568|593662609|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
164352173|NCT02310568|593662610|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
164352174|NCT02310568|593662606|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
164352175|NCT02310568|593662607|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
164352176|NCT02310568|593662608|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
164352177|NCT02310568|593662609|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
164352178|NCT02310568|593662610|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
164352179|NCT02310568|593662606|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
164352180|NCT02310568|593662607|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
164352181|NCT02310568|593662608|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
164352182|NCT02310568|593662609|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
164352183|NCT02310568|593662610|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
164352184|NCT02310568|593662606|FG000|Stage 2 (4 Weeks)|Other|0|||
164352185|NCT02310568|593662607|FG001|Stage 2 (4 Weeks)|Other|1|||
164352186|NCT02310568|593662608|FG002|Stage 2 (4 Weeks)|Other|1|||
164352187|NCT02310568|593662609|FG003|Stage 2 (4 Weeks)|Other|0|||
164352188|NCT02310568|593662610|FG004|Stage 2 (4 Weeks)|Other|0|||
164352189|NCT02310568|593662606|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
164352190|NCT02310568|593662607|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
164352191|NCT02310568|593662608|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
164352192|NCT02310568|593662609|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
164352193|NCT02310568|593662610|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
164352194|NCT02310568|593662606|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
164352195|NCT02310568|593662607|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
164352196|NCT02310568|593662608|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
164352197|NCT02310568|593662609|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
164352198|NCT02310568|593662610|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
164352199|NCT02310568|593662606|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
164352200|NCT02310568|593662607|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
164352201|NCT02310568|593662608|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
164352202|NCT02310568|593662609|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
164352203|NCT02310568|593662610|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
164352204|NCT02989194|593662615|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
164352205|NCT02989194|593662616|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
164352206|NCT02989194|593662617|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
164352207|NCT02989194|593662615|FG000|Overall Study|Lost to Follow-up|0|||
164352208|NCT02989194|593662616|FG001|Overall Study|Lost to Follow-up|1|||
164352209|NCT02989194|593662617|FG002|Overall Study|Lost to Follow-up|0|||
164352210|NCT02989194|593662615|FG000|Overall Study|Withdrawal by Subject|0|||
164352211|NCT02989194|593662616|FG001|Overall Study|Withdrawal by Subject|1|||
164352212|NCT02989194|593662617|FG002|Overall Study|Withdrawal by Subject|0|||
164352213|NCT02670083|593662618|FG000|Overall Study|Adverse Event|16|||
164352214|NCT02670083|593662619|FG001|Overall Study|Adverse Event|13|||
164352215|NCT02670083|593662618|FG000|Overall Study|Death|4|||
164352216|NCT02670083|593662619|FG001|Overall Study|Death|6|||
164352217|NCT02670083|593662618|FG000|Overall Study|Lost to Follow-up|2|||
164352218|NCT02670083|593662619|FG001|Overall Study|Lost to Follow-up|2|||
164436321|NCT00771667|593964883|FG002|Induction Phase|Adverse Event|4|||
164436322|NCT00771667|593964884|FG003|Induction Phase|Adverse Event|1|||
164436323|NCT00771667|593964885|FG004|Induction Phase|Adverse Event|0|||
164436324|NCT00771667|593964886|FG005|Induction Phase|Adverse Event|0|||
164436325|NCT00771667|593964887|FG006|Induction Phase|Adverse Event|0|||
164436326|NCT00771667|593964888|FG007|Induction Phase|Adverse Event|0|||
164436327|NCT00771667|593964889|FG008|Induction Phase|Adverse Event|0|||
164436328|NCT00771667|593964890|FG009|Induction Phase|Adverse Event|0|||
164436329|NCT00771667|593964881|FG000|Induction Phase|Lack of Efficacy|9|||
164436330|NCT00771667|593964882|FG001|Induction Phase|Lack of Efficacy|2|||
164436331|NCT00771667|593964883|FG002|Induction Phase|Lack of Efficacy|4|||
164436332|NCT00771667|593964884|FG003|Induction Phase|Lack of Efficacy|3|||
164436333|NCT00771667|593964885|FG004|Induction Phase|Lack of Efficacy|0|||
164436334|NCT00771667|593964886|FG005|Induction Phase|Lack of Efficacy|0|||
164436335|NCT00771667|593964887|FG006|Induction Phase|Lack of Efficacy|0|||
164436336|NCT00771667|593964888|FG007|Induction Phase|Lack of Efficacy|0|||
164436337|NCT00771667|593964889|FG008|Induction Phase|Lack of Efficacy|0|||
164436338|NCT00771667|593964890|FG009|Induction Phase|Lack of Efficacy|0|||
164436339|NCT00771667|593964881|FG000|Induction Phase|Lost to Follow-up|1|||
164436340|NCT00771667|593964882|FG001|Induction Phase|Lost to Follow-up|0|||
164436341|NCT00771667|593964883|FG002|Induction Phase|Lost to Follow-up|1|||
164436342|NCT00771667|593964884|FG003|Induction Phase|Lost to Follow-up|0|||
164436343|NCT00771667|593964885|FG004|Induction Phase|Lost to Follow-up|0|||
164436344|NCT00771667|593964886|FG005|Induction Phase|Lost to Follow-up|0|||
164436345|NCT00771667|593964887|FG006|Induction Phase|Lost to Follow-up|0|||
164436346|NCT00771667|593964888|FG007|Induction Phase|Lost to Follow-up|0|||
164436347|NCT00771667|593964889|FG008|Induction Phase|Lost to Follow-up|0|||
164436348|NCT00771667|593964890|FG009|Induction Phase|Lost to Follow-up|0|||
164436349|NCT00771667|593964881|FG000|Induction Phase|Other|4|||
164436350|NCT00771667|593964882|FG001|Induction Phase|Other|6|||
164436351|NCT00771667|593964883|FG002|Induction Phase|Other|3|||
164436352|NCT00771667|593964884|FG003|Induction Phase|Other|4|||
164436353|NCT00771667|593964885|FG004|Induction Phase|Other|0|||
164436354|NCT00771667|593964886|FG005|Induction Phase|Other|0|||
164436355|NCT00771667|593964887|FG006|Induction Phase|Other|0|||
164436356|NCT00771667|593964888|FG007|Induction Phase|Other|0|||
164436357|NCT00771667|593964889|FG008|Induction Phase|Other|0|||
164436358|NCT00771667|593964890|FG009|Induction Phase|Other|0|||
164436359|NCT00771667|593964881|FG000|Maintenance Phase|Adverse Event|0|||
164436360|NCT00771667|593964882|FG001|Maintenance Phase|Adverse Event|0|||
164436361|NCT00771667|593964883|FG002|Maintenance Phase|Adverse Event|0|||
164436362|NCT00771667|593964884|FG003|Maintenance Phase|Adverse Event|0|||
164436363|NCT00771667|593964885|FG004|Maintenance Phase|Adverse Event|1|||
164436364|NCT00771667|593964886|FG005|Maintenance Phase|Adverse Event|3|||
164436365|NCT00771667|593964887|FG006|Maintenance Phase|Adverse Event|5|||
164436366|NCT00771667|593964888|FG007|Maintenance Phase|Adverse Event|1|||
164436367|NCT00771667|593964889|FG008|Maintenance Phase|Adverse Event|8|||
164436368|NCT00771667|593964890|FG009|Maintenance Phase|Adverse Event|7|||
164436369|NCT00771667|593964881|FG000|Maintenance Phase|Lack of Efficacy|0|||
164436370|NCT00771667|593964882|FG001|Maintenance Phase|Lack of Efficacy|0|||
164436371|NCT00771667|593964883|FG002|Maintenance Phase|Lack of Efficacy|0|||
164436372|NCT00771667|593964884|FG003|Maintenance Phase|Lack of Efficacy|0|||
164436373|NCT00771667|593964885|FG004|Maintenance Phase|Lack of Efficacy|1|||
164436374|NCT00771667|593964886|FG005|Maintenance Phase|Lack of Efficacy|3|||
164436375|NCT00771667|593964887|FG006|Maintenance Phase|Lack of Efficacy|3|||
164436376|NCT00771667|593964888|FG007|Maintenance Phase|Lack of Efficacy|2|||
164436377|NCT00771667|593964889|FG008|Maintenance Phase|Lack of Efficacy|11|||
164436378|NCT00771667|593964890|FG009|Maintenance Phase|Lack of Efficacy|7|||
164436379|NCT00771667|593964881|FG000|Maintenance Phase|Other|0|||
164436380|NCT00771667|593964882|FG001|Maintenance Phase|Other|0|||
164436381|NCT00771667|593964883|FG002|Maintenance Phase|Other|0|||
164436382|NCT00771667|593964884|FG003|Maintenance Phase|Other|0|||
164436383|NCT00771667|593964885|FG004|Maintenance Phase|Other|0|||
164436384|NCT00771667|593964886|FG005|Maintenance Phase|Other|1|||
164436385|NCT00771667|593964887|FG006|Maintenance Phase|Other|2|||
164436386|NCT00771667|593964888|FG007|Maintenance Phase|Other|2|||
164436387|NCT00771667|593964889|FG008|Maintenance Phase|Other|3|||
164436388|NCT00771667|593964890|FG009|Maintenance Phase|Other|3|||
164436389|NCT01897233|593964891|FG000|Part B (24 Weeks)|Adverse Event|1|||
164436390|NCT01897233|593964891|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
164436391|NCT01897233|593964891|FG000|Part B (24 Weeks)|Physician Decision|1|||
164436392|NCT00628862|593964896|FG000|Overall Study|Adverse Event|6|||
164436393|NCT00628862|593964897|FG001|Overall Study|Adverse Event|8|||
164436394|NCT00628862|593964898|FG002|Overall Study|Adverse Event|10|||
164436395|NCT00628862|593964896|FG000|Overall Study|Withdrawal by Subject|4|||
164436396|NCT00628862|593964897|FG001|Overall Study|Withdrawal by Subject|6|||
164436397|NCT00628862|593964898|FG002|Overall Study|Withdrawal by Subject|11|||
164352219|NCT02670083|593662618|FG000|Overall Study|Multiple Reasons|9|||
164352220|NCT02670083|593662619|FG001|Overall Study|Multiple Reasons|9|||
164352221|NCT02670083|593662618|FG000|Overall Study|Physician Decision|0|||
164352222|NCT02670083|593662619|FG001|Overall Study|Physician Decision|2|||
164352223|NCT02670083|593662618|FG000|Overall Study|Study Terminated By Sponsor|257|||
164352224|NCT02670083|593662619|FG001|Overall Study|Study Terminated By Sponsor|254|||
164352225|NCT02670083|593662618|FG000|Overall Study|Symptomatic Deterioration|0|||
164352226|NCT02670083|593662619|FG001|Overall Study|Symptomatic Deterioration|2|||
164352227|NCT02670083|593662618|FG000|Overall Study|Withdrawal by Subject|32|||
164352228|NCT02670083|593662619|FG001|Overall Study|Withdrawal by Subject|31|||
164352229|NCT02670083|593662618|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164352230|NCT02670083|593662619|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164352231|NCT02825992|593662620|FG000|Overall Study|Withdrawal by Subject|4|||
164352232|NCT02825992|593662620|FG000|Overall Study|Lost to Follow-up|2|||
164352233|NCT02825992|593662620|FG000|Overall Study|Procedure terminated|2|||
164352234|NCT04160091|593662623|FG000|Overall Study|Terminated by Sponsor|7|||
164352235|NCT04160091|593662624|FG001|Overall Study|Terminated by Sponsor|3|||
164352236|NCT04160091|593662625|FG002|Overall Study|Terminated by Sponsor|5|||
164352237|NCT04160091|593662626|FG003|Overall Study|Terminated by Sponsor|2|||
164352238|NCT04160091|593662623|FG000|Overall Study|Noncompliance|0|||
164352239|NCT04160091|593662624|FG001|Overall Study|Noncompliance|0|||
164352240|NCT04160091|593662625|FG002|Overall Study|Noncompliance|0|||
164352241|NCT04160091|593662626|FG003|Overall Study|Noncompliance|1|||
164352242|NCT04160091|593662623|FG000|Overall Study|Withdrawal by Subject|0|||
164352243|NCT04160091|593662624|FG001|Overall Study|Withdrawal by Subject|0|||
164352244|NCT04160091|593662625|FG002|Overall Study|Withdrawal by Subject|0|||
164352245|NCT04160091|593662626|FG003|Overall Study|Withdrawal by Subject|1|||
164352246|NCT00609492|593662627|FG000|Overall Study|Withdrawal by Subject|0|||
164352247|NCT00609492|593662628|FG001|Overall Study|Withdrawal by Subject|2|||
164352248|NCT00609492|593662629|FG002|Overall Study|Withdrawal by Subject|3|||
164352249|NCT00609492|593662627|FG000|Overall Study|Lost to Follow-up|1|||
164352250|NCT00609492|593662628|FG001|Overall Study|Lost to Follow-up|1|||
164352251|NCT00609492|593662629|FG002|Overall Study|Lost to Follow-up|4|||
164352252|NCT01224431|593662630|FG000|Overall Study|not randomized|0|||
164352253|NCT01224431|593662631|FG001|Overall Study|not randomized|4|||
164352254|NCT01224431|593662630|FG000|Overall Study|no video record|0|||
164352255|NCT01224431|593662631|FG001|Overall Study|no video record|1|||
164352256|NCT04492618|593662632|FG000|Overall Study|Withdrawal by Subject|1|||
164352257|NCT05620563|593662633|FG000|Overall Study|Adverse Event|3|||
164352258|NCT05620563|593662634|FG001|Overall Study|Adverse Event|1|||
164352259|NCT05620563|593662633|FG000|Overall Study|Lost to Follow-up|0|||
164352260|NCT05620563|593662634|FG001|Overall Study|Lost to Follow-up|2|||
164352261|NCT05620563|593662633|FG000|Overall Study|Protocol Deviation|1|||
164352262|NCT05620563|593662634|FG001|Overall Study|Protocol Deviation|2|||
164352263|NCT05620563|593662633|FG000|Overall Study|Withdrawal by Subject|3|||
164352264|NCT05620563|593662634|FG001|Overall Study|Withdrawal by Subject|3|||
164352265|NCT05620563|593662633|FG000|Overall Study|Physician Decision|0|||
164352266|NCT05620563|593662634|FG001|Overall Study|Physician Decision|1|||
164352267|NCT00779467|593662635|FG000|Overall Study|Lack of Efficacy|11|||
164352268|NCT00779467|593662636|FG001|Overall Study|Lack of Efficacy|2|||
164352269|NCT00779467|593662637|FG002|Overall Study|Lack of Efficacy|6|||
164352270|NCT00779467|593662638|FG003|Overall Study|Lack of Efficacy|11|||
164352271|NCT00779467|593662635|FG000|Overall Study|failed inclusion criteria|3|||
164352272|NCT00779467|593662636|FG001|Overall Study|failed inclusion criteria|3|||
164352273|NCT00779467|593662637|FG002|Overall Study|failed inclusion criteria|1|||
164352274|NCT00779467|593662638|FG003|Overall Study|failed inclusion criteria|2|||
164352275|NCT00779467|593662635|FG000|Overall Study|missing data|1|||
164352276|NCT00779467|593662636|FG001|Overall Study|missing data|0|||
164352277|NCT00779467|593662637|FG002|Overall Study|missing data|1|||
164352278|NCT00779467|593662638|FG003|Overall Study|missing data|4|||
164352279|NCT00779467|593662635|FG000|Overall Study|technical issue|0|||
164352280|NCT00779467|593662636|FG001|Overall Study|technical issue|0|||
164352281|NCT00779467|593662637|FG002|Overall Study|technical issue|2|||
164352282|NCT00779467|593662638|FG003|Overall Study|technical issue|1|||
164352283|NCT00779467|593662635|FG000|Overall Study|unavailable research staff|0|||
164352284|NCT00779467|593662636|FG001|Overall Study|unavailable research staff|0|||
164352285|NCT00779467|593662637|FG002|Overall Study|unavailable research staff|0|||
164352286|NCT00779467|593662638|FG003|Overall Study|unavailable research staff|1|||
164352287|NCT00460408|593662645|FG000|Overall Study|Adverse Event|1|||
164352288|NCT00460408|593662646|FG001|Overall Study|Adverse Event|0|||
164352289|NCT00460408|593662647|FG002|Overall Study|Adverse Event|0|||
164352290|NCT00460408|593662648|FG003|Overall Study|Adverse Event|0|||
164352291|NCT00460408|593662645|FG000|Overall Study|Death|7|||
164352292|NCT00460408|593662646|FG001|Overall Study|Death|0|||
164352293|NCT00460408|593662647|FG002|Overall Study|Death|0|||
164352294|NCT00460408|593662648|FG003|Overall Study|Death|0|||
164352295|NCT00460408|593662645|FG000|Overall Study|Lost to Follow-up|11|||
164352296|NCT00460408|593662646|FG001|Overall Study|Lost to Follow-up|0|||
164352297|NCT00460408|593662647|FG002|Overall Study|Lost to Follow-up|1|||
164352298|NCT00460408|593662648|FG003|Overall Study|Lost to Follow-up|0|||
164352299|NCT00460408|593662645|FG000|Overall Study|Withdrawal by Subject|31|||
164352300|NCT00460408|593662646|FG001|Overall Study|Withdrawal by Subject|0|||
164352301|NCT00460408|593662647|FG002|Overall Study|Withdrawal by Subject|0|||
164352302|NCT00460408|593662648|FG003|Overall Study|Withdrawal by Subject|0|||
164352303|NCT00460408|593662645|FG000|Overall Study|Insufficient clinical response|5|||
164352304|NCT00460408|593662646|FG001|Overall Study|Insufficient clinical response|1|||
164352305|NCT00460408|593662647|FG002|Overall Study|Insufficient clinical response|5|||
164352306|NCT00460408|593662648|FG003|Overall Study|Insufficient clinical response|0|||
164352307|NCT00460408|593662645|FG000|Overall Study|Other|12|||
164352308|NCT00460408|593662646|FG001|Overall Study|Other|2|||
164352309|NCT00460408|593662647|FG002|Overall Study|Other|0|||
164352310|NCT00460408|593662648|FG003|Overall Study|Other|0|||
164352311|NCT02573350|593662649|FG000|Overall Study|Lost to Follow-up|2|||
164352312|NCT02573350|593662650|FG001|Overall Study|Lost to Follow-up|1|||
164352313|NCT02573350|593662649|FG000|Overall Study|Adverse Event|3|||
164352314|NCT02573350|593662650|FG001|Overall Study|Adverse Event|4|||
164352315|NCT02573350|593662649|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
164352316|NCT02573350|593662650|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
164352317|NCT02573350|593662649|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
164352318|NCT02573350|593662650|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
164352319|NCT02573350|593662649|FG000|Overall Study|Subject withdrew consent to participate|6|||
164352320|NCT02573350|593662650|FG001|Overall Study|Subject withdrew consent to participate|1|||
164352321|NCT02573350|593662649|FG000|Overall Study|Protocol Deviation|1|||
164352322|NCT02573350|593662650|FG001|Overall Study|Protocol Deviation|1|||
164352323|NCT01111149|593662657|FG000|Overall Study|Protocol Violation|1|||
164352324|NCT01111149|593662658|FG001|Overall Study|Protocol Violation|1|||
164352325|NCT01111149|593662659|FG002|Overall Study|Protocol Violation|2|||
164352326|NCT01111149|593662657|FG000|Overall Study|Withdrawal by Subject|1|||
164352327|NCT01111149|593662658|FG001|Overall Study|Withdrawal by Subject|0|||
164352328|NCT01111149|593662659|FG002|Overall Study|Withdrawal by Subject|2|||
164352329|NCT00006903|593662662|FG000|Overall Study|Still receiving treatment|0|||
164352330|NCT00006903|593662663|FG001|Overall Study|Still receiving treatment|0|||
164352331|NCT00006903|593662664|FG002|Overall Study|Still receiving treatment|1|||
164352332|NCT00006903|593662662|FG000|Overall Study|Refused further treatment|0|||
164352333|NCT00006903|593662663|FG001|Overall Study|Refused further treatment|2|||
164352334|NCT00006903|593662664|FG002|Overall Study|Refused further treatment|1|||
164352335|NCT00006903|593662662|FG000|Overall Study|Adverse Event|0|||
164352336|NCT00006903|593662663|FG001|Overall Study|Adverse Event|0|||
164352337|NCT00006903|593662664|FG002|Overall Study|Adverse Event|1|||
164352338|NCT00006903|593662662|FG000|Overall Study|Death|0|||
164352339|NCT00006903|593662663|FG001|Overall Study|Death|1|||
164352340|NCT00006903|593662664|FG002|Overall Study|Death|0|||
164352341|NCT00006903|593662662|FG000|Overall Study|Patient never treated|0|||
164352342|NCT00006903|593662663|FG001|Overall Study|Patient never treated|0|||
164352343|NCT00006903|593662664|FG002|Overall Study|Patient never treated|1|||
164352344|NCT00006903|593662662|FG000|Overall Study|Ineligible|10|||
164352345|NCT00006903|593662663|FG001|Overall Study|Ineligible|1|||
164352346|NCT00006903|593662664|FG002|Overall Study|Ineligible|2|||
164352347|NCT02794883|593662665|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
164352348|NCT02794883|593662666|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
164352349|NCT02794883|593662667|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
164352350|NCT02794883|593662665|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
164352351|NCT02794883|593662666|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
164352352|NCT02794883|593662667|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
164352353|NCT02794883|593662665|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
164352354|NCT02794883|593662666|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
164352355|NCT02794883|593662667|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
164352356|NCT02794883|593662665|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
164352357|NCT02794883|593662666|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
164352358|NCT02794883|593662667|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
164352359|NCT02794883|593662665|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
164352360|NCT02794883|593662666|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
164352361|NCT02794883|593662667|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
164352362|NCT02794883|593662665|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
164352363|NCT02794883|593662666|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
164352364|NCT02794883|593662667|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
164352365|NCT02794883|593662665|FG000|Follow-up Period (up to 2 Years)|Death|12|||
164352366|NCT02794883|593662666|FG001|Follow-up Period (up to 2 Years)|Death|10|||
164436398|NCT00628862|593964896|FG000|Overall Study|Lost to Follow-up|0|||
164436399|NCT00628862|593964897|FG001|Overall Study|Lost to Follow-up|2|||
164436400|NCT00628862|593964898|FG002|Overall Study|Lost to Follow-up|1|||
164436401|NCT00628862|593964896|FG000|Overall Study|Protocol Violation|1|||
164436402|NCT00628862|593964897|FG001|Overall Study|Protocol Violation|0|||
164436403|NCT00628862|593964898|FG002|Overall Study|Protocol Violation|0|||
164436404|NCT00628862|593964896|FG000|Overall Study|COPD Exacerbation|0|||
164436405|NCT00628862|593964897|FG001|Overall Study|COPD Exacerbation|1|||
164436406|NCT00628862|593964898|FG002|Overall Study|COPD Exacerbation|0|||
164436407|NCT01883492|593964901|FG000|Overall Study|Lost to Follow-up|3|||
164436408|NCT01883492|593964902|FG001|Overall Study|Lost to Follow-up|4|||
164436409|NCT01883492|593964901|FG000|Overall Study|Surgery on contra-lateral hip|0|||
164436410|NCT01883492|593964902|FG001|Overall Study|Surgery on contra-lateral hip|1|||
164436411|NCT01883492|593964901|FG000|Overall Study|Poor X-ray quality|7|||
164436412|NCT01883492|593964902|FG001|Overall Study|Poor X-ray quality|4|||
164436413|NCT01883492|593964901|FG000|Overall Study|Withdrawal by Subject|1|||
164436414|NCT01883492|593964902|FG001|Overall Study|Withdrawal by Subject|0|||
164436415|NCT01883492|593964901|FG000|Overall Study|inappropriate implant used|1|||
164436416|NCT01883492|593964902|FG001|Overall Study|inappropriate implant used|1|||
164436417|NCT01883492|593964901|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
164436418|NCT01883492|593964902|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
164436419|NCT02192606|593964913|FG000|Overall Study|surgery type was changed|1|||
164436420|NCT02192606|593964914|FG001|Overall Study|surgery type was changed|1|||
164436421|NCT02192606|593964913|FG000|Overall Study|Physician Decision|1|||
164436422|NCT02192606|593964914|FG001|Overall Study|Physician Decision|2|||
164436423|NCT02192606|593964913|FG000|Overall Study|3D equipment rep unable to join|0|||
164436424|NCT02192606|593964914|FG001|Overall Study|3D equipment rep unable to join|1|||
164436425|NCT05193318|593964915|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
164436426|NCT05193318|593964915|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
164436427|NCT03670602|593964916|FG000|Overall Study|Lost to Follow-up|1|||
164436428|NCT03670602|593964917|FG001|Overall Study|Lost to Follow-up|0|||
164436429|NCT03670602|593964916|FG000|Overall Study|Withdrawal by Subject|0|||
164436430|NCT03670602|593964917|FG001|Overall Study|Withdrawal by Subject|3|||
164436431|NCT00957658|593964918|FG000|Overall Study|Death|1|||
164436432|NCT00957658|593964918|FG000|Overall Study|Lost to Follow-up|4|||
164436433|NCT00957658|593964918|FG000|Overall Study|Withdrawal by Subject|12|||
164436434|NCT00957658|593964918|FG000|Overall Study|Revision|1|||
164436435|NCT00957658|593964918|FG000|Overall Study|Incomplete 2 yr data|28|||
164436436|NCT00957658|593964918|FG000|Overall Study|Site termination|10|||
164436437|NCT00957658|593964918|FG000|Overall Study|unwilling/unable to return|2|||
164436438|NCT00957658|593964918|FG000|Overall Study|surgery cancelled|2|||
164436439|NCT00957658|593964918|FG000|Overall Study|Protocol Violation|5|||
164436440|NCT03383887|593964919|FG000|Overall Study|Lost to Follow-up|0|||
164436441|NCT03383887|593964920|FG001|Overall Study|Lost to Follow-up|1|||
164436442|NCT00975806|593964927|FG000|Overall Study|Adverse Event|2|||
164436443|NCT00975806|593964928|FG001|Overall Study|Adverse Event|1|||
164436444|NCT00975806|593964929|FG002|Overall Study|Adverse Event|2|||
164436445|NCT00975806|593964927|FG000|Overall Study|Disease Progression|1|||
164436446|NCT00975806|593964928|FG001|Overall Study|Disease Progression|5|||
164436447|NCT00975806|593964929|FG002|Overall Study|Disease Progression|1|||
164436448|NCT00975806|593964927|FG000|Overall Study|Withdrawal by Subject|1|||
164436449|NCT00975806|593964928|FG001|Overall Study|Withdrawal by Subject|0|||
164436450|NCT00975806|593964929|FG002|Overall Study|Withdrawal by Subject|0|||
164436451|NCT00975806|593964927|FG000|Overall Study|Death|0|||
164436452|NCT00975806|593964928|FG001|Overall Study|Death|1|||
164436453|NCT00975806|593964929|FG002|Overall Study|Death|0|||
164436454|NCT00975806|593964927|FG000|Overall Study|Physician decision and disease related|1|||
164436455|NCT00975806|593964928|FG001|Overall Study|Physician decision and disease related|0|||
164436456|NCT00975806|593964929|FG002|Overall Study|Physician decision and disease related|1|||
164436457|NCT00246012|593964930|FG000|Overall Study|Adverse Event|0|||
164436458|NCT00246012|593964931|FG001|Overall Study|Adverse Event|0|||
164588067|NCT03703375|594517481|FG003|Treatment Period|Progression|11|||
164588068|NCT03703375|594517478|FG000|Treatment Period|Completed treatment|7|||
164588069|NCT03703375|594517479|FG001|Treatment Period|Completed treatment|2|||
164436459|NCT00246012|593964932|FG002|Overall Study|Adverse Event|0|||
164436460|NCT00246012|593964933|FG003|Overall Study|Adverse Event|0|||
164436461|NCT00246012|593964934|FG004|Overall Study|Adverse Event|0|||
164436462|NCT00246012|593964935|FG005|Overall Study|Adverse Event|1|||
164436463|NCT00246012|593964936|FG006|Overall Study|Adverse Event|0|||
164436464|NCT00246012|593964937|FG007|Overall Study|Adverse Event|0|||
164436465|NCT00246012|593964938|FG008|Overall Study|Adverse Event|2|||
164436466|NCT00246012|593964930|FG000|Overall Study|Withdrawal by Subject|0|||
164436467|NCT00246012|593964931|FG001|Overall Study|Withdrawal by Subject|0|||
164436468|NCT00246012|593964932|FG002|Overall Study|Withdrawal by Subject|0|||
164436469|NCT00246012|593964933|FG003|Overall Study|Withdrawal by Subject|0|||
164436470|NCT00246012|593964934|FG004|Overall Study|Withdrawal by Subject|0|||
164588070|NCT03703375|594517480|FG002|Treatment Period|Completed treatment|0|||
164352367|NCT02794883|593662667|FG002|Follow-up Period (up to 2 Years)|Death|10|||
164352368|NCT01906008|593662669|FG000|Overall Study|Lost to Follow-up|2|||
164352369|NCT01906008|593662670|FG001|Overall Study|Lost to Follow-up|0|||
164352370|NCT01906008|593662669|FG000|Overall Study|Oxaliplatin toxicity|2|||
164352371|NCT01906008|593662670|FG001|Overall Study|Oxaliplatin toxicity|0|||
164352372|NCT01906008|593662669|FG000|Overall Study|Protocol Violation|0|||
164352373|NCT01906008|593662670|FG001|Overall Study|Protocol Violation|1|||
164352374|NCT01906008|593662669|FG000|Overall Study|Withdrawal by Subject|1|||
164352375|NCT01906008|593662670|FG001|Overall Study|Withdrawal by Subject|5|||
164352376|NCT01906008|593662669|FG000|Overall Study|Did not start study med|3|||
164352377|NCT01906008|593662670|FG001|Overall Study|Did not start study med|4|||
164352378|NCT01906008|593662669|FG000|Overall Study|Oxaliplatin stops|10|||
164352379|NCT01906008|593662670|FG001|Overall Study|Oxaliplatin stops|8|||
164352380|NCT01906008|593662669|FG000|Overall Study|Hospice|1|||
164352381|NCT01906008|593662670|FG001|Overall Study|Hospice|0|||
164352382|NCT01906008|593662669|FG000|Overall Study|Physician Decision|3|||
164352383|NCT01906008|593662670|FG001|Overall Study|Physician Decision|3|||
164352384|NCT01906008|593662669|FG000|Overall Study|Lack of compliance of study med|5|||
164352385|NCT01906008|593662670|FG001|Overall Study|Lack of compliance of study med|3|||
164352386|NCT01906008|593662669|FG000|Overall Study|Adverse Event|0|||
164352387|NCT01906008|593662670|FG001|Overall Study|Adverse Event|3|||
164352388|NCT01574326|593662671|FG000|Overall Study|Randomized but not treated|0|||
164352389|NCT01574326|593662672|FG001|Overall Study|Randomized but not treated|1|||
164352390|NCT01574326|593662671|FG000|Overall Study|Withdrawal by Participant|2|||
164352391|NCT01574326|593662672|FG001|Overall Study|Withdrawal by Participant|4|||
164352392|NCT01574326|593662671|FG000|Overall Study|Physician Decision|5|||
164352393|NCT01574326|593662672|FG001|Overall Study|Physician Decision|3|||
164352394|NCT01574326|593662671|FG000|Overall Study|Adverse Event|1|||
164352395|NCT01574326|593662672|FG001|Overall Study|Adverse Event|3|||
164352396|NCT01574326|593662671|FG000|Overall Study|Other: Mainly kidney transplant|8|||
164352397|NCT01574326|593662672|FG001|Overall Study|Other: Mainly kidney transplant|8|||
164352398|NCT00137046|593662673|FG000|Overall Study|Death|2|||
164352399|NCT00137046|593662674|FG001|Overall Study|Death|1|||
164352400|NCT00137046|593662673|FG000|Overall Study|Adverse Event|16|||
164352401|NCT00137046|593662674|FG001|Overall Study|Adverse Event|5|||
164352402|NCT00137046|593662673|FG000|Overall Study|Laboratory Abnormality|2|||
164352403|NCT00137046|593662674|FG001|Overall Study|Laboratory Abnormality|0|||
164352404|NCT00137046|593662673|FG000|Overall Study|Lack of Efficacy|13|||
164352405|NCT00137046|593662674|FG001|Overall Study|Lack of Efficacy|1|||
164352406|NCT00137046|593662673|FG000|Overall Study|Lost to Follow-up|8|||
164352407|NCT00137046|593662674|FG001|Overall Study|Lost to Follow-up|24|||
164352408|NCT00137046|593662673|FG000|Overall Study|Other|23|||
164352409|NCT00137046|593662674|FG001|Overall Study|Other|19|||
164352410|NCT00137046|593662673|FG000|Overall Study|Withdrawal by Subject|33|||
164352411|NCT00137046|593662674|FG001|Overall Study|Withdrawal by Subject|42|||
164352412|NCT00137046|593662673|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
164352413|NCT00137046|593662674|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
164352414|NCT00137046|593662673|FG000|Overall Study|Withdrew prior to study treatment|1|||
164352415|NCT00137046|593662674|FG001|Overall Study|Withdrew prior to study treatment|1|||
164352416|NCT02268084|593662681|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
164352417|NCT02268084|593662682|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
164352418|NCT02268084|593662681|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
164352419|NCT02268084|593662682|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
164352420|NCT05227027|593662683|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
164352421|NCT05227027|593662684|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
164352422|NCT03552198|593662685|FG000|Overall Study|Lost to Follow-up|42|||
164352423|NCT03552198|593662686|FG001|Overall Study|Lost to Follow-up|48|||
164352424|NCT03552198|593662687|FG002|Overall Study|Lost to Follow-up|15|||
164352425|NCT03552198|593662688|FG003|Overall Study|Lost to Follow-up|19|||
164352426|NCT03552198|593662685|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
164352427|NCT03552198|593662686|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
164352428|NCT03552198|593662687|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
164352429|NCT03552198|593662688|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
164352430|NCT03552198|593662685|FG000|Overall Study|Did not receive air alerts|1|||
164352431|NCT03552198|593662686|FG001|Overall Study|Did not receive air alerts|0|||
164352432|NCT03552198|593662687|FG002|Overall Study|Did not receive air alerts|0|||
164352433|NCT03552198|593662688|FG003|Overall Study|Did not receive air alerts|1|||
164352434|NCT06149247|593662689|FG000|Overall Study|Adverse Event|0|||
164352435|NCT06149247|593662690|FG001|Overall Study|Adverse Event|1|||
164352436|NCT00371137|593662695|FG000|Overall Study|Adverse Event|20|||
164352437|NCT00371137|593662696|FG001|Overall Study|Adverse Event|35|||
164352438|NCT00371137|593662697|FG002|Overall Study|Adverse Event|42|||
164352439|NCT00371137|593662695|FG000|Overall Study|Withdrawal by Subject|11|||
164352440|NCT00371137|593662696|FG001|Overall Study|Withdrawal by Subject|10|||
164352441|NCT00371137|593662697|FG002|Overall Study|Withdrawal by Subject|15|||
164352442|NCT00371137|593662695|FG000|Overall Study|Lost to Follow-up|6|||
164352443|NCT00371137|593662696|FG001|Overall Study|Lost to Follow-up|3|||
164352444|NCT00371137|593662697|FG002|Overall Study|Lost to Follow-up|5|||
164352445|NCT00371137|593662695|FG000|Overall Study|Lack of Efficacy|30|||
164352446|NCT00371137|593662696|FG001|Overall Study|Lack of Efficacy|12|||
164352447|NCT00371137|593662697|FG002|Overall Study|Lack of Efficacy|13|||
164352448|NCT00371137|593662695|FG000|Overall Study|Sponsor Decision|2|||
164352449|NCT00371137|593662696|FG001|Overall Study|Sponsor Decision|1|||
164352450|NCT00371137|593662697|FG002|Overall Study|Sponsor Decision|2|||
164352451|NCT00371137|593662695|FG000|Overall Study|Physician Decision|1|||
164352452|NCT00371137|593662696|FG001|Overall Study|Physician Decision|1|||
164352453|NCT00371137|593662697|FG002|Overall Study|Physician Decision|1|||
164352454|NCT00371137|593662695|FG000|Overall Study|Protocol Violation|2|||
164352455|NCT00371137|593662696|FG001|Overall Study|Protocol Violation|1|||
164352456|NCT00371137|593662697|FG002|Overall Study|Protocol Violation|1|||
164352457|NCT01756898|593662700|FG000|Overall Study|Adverse Event|7|||
164352458|NCT01756898|593662701|FG001|Overall Study|Adverse Event|1|||
164352459|NCT01756898|593662702|FG002|Overall Study|Adverse Event|0|||
164352460|NCT01756898|593662703|FG003|Overall Study|Adverse Event|0|||
164352461|NCT01756898|593662700|FG000|Overall Study|Lack of Efficacy|4|||
164352462|NCT01756898|593662701|FG001|Overall Study|Lack of Efficacy|7|||
164352463|NCT01756898|593662702|FG002|Overall Study|Lack of Efficacy|6|||
164352464|NCT01756898|593662703|FG003|Overall Study|Lack of Efficacy|6|||
164352465|NCT01756898|593662700|FG000|Overall Study|Lost to Follow-up|2|||
164352466|NCT01756898|593662701|FG001|Overall Study|Lost to Follow-up|4|||
164352467|NCT01756898|593662702|FG002|Overall Study|Lost to Follow-up|2|||
164352468|NCT01756898|593662703|FG003|Overall Study|Lost to Follow-up|3|||
164352469|NCT01756898|593662700|FG000|Overall Study|Protocol Violation|1|||
164352470|NCT01756898|593662701|FG001|Overall Study|Protocol Violation|2|||
164352471|NCT01756898|593662702|FG002|Overall Study|Protocol Violation|2|||
164352472|NCT01756898|593662703|FG003|Overall Study|Protocol Violation|1|||
164352473|NCT01756898|593662700|FG000|Overall Study|Withdrew Consent|5|||
164352474|NCT01756898|593662701|FG001|Overall Study|Withdrew Consent|3|||
164352475|NCT01756898|593662702|FG002|Overall Study|Withdrew Consent|5|||
164352476|NCT01756898|593662703|FG003|Overall Study|Withdrew Consent|6|||
164352477|NCT01756898|593662700|FG000|Overall Study|Other|0|||
164352478|NCT01756898|593662701|FG001|Overall Study|Other|2|||
164352479|NCT01756898|593662702|FG002|Overall Study|Other|2|||
164352480|NCT01756898|593662703|FG003|Overall Study|Other|0|||
164352481|NCT01500694|593662704|FG000|Overall Study|Adverse Event|4|||
164352482|NCT01500694|593662705|FG001|Overall Study|Adverse Event|3|||
164352483|NCT01500694|593662704|FG000|Overall Study|Protocol Violation|0|||
164352484|NCT01500694|593662705|FG001|Overall Study|Protocol Violation|1|||
164352485|NCT01500694|593662704|FG000|Overall Study|Withdrawal by Subject|23|||
164352486|NCT01500694|593662705|FG001|Overall Study|Withdrawal by Subject|14|||
164352487|NCT01500694|593662704|FG000|Overall Study|Lost to Follow-up|2|||
164352488|NCT01500694|593662705|FG001|Overall Study|Lost to Follow-up|3|||
164352489|NCT01500694|593662704|FG000|Overall Study|Lack of Efficacy|14|||
164352490|NCT01500694|593662705|FG001|Overall Study|Lack of Efficacy|5|||
164352491|NCT01500694|593662704|FG000|Overall Study|Other|9|||
164352492|NCT01500694|593662705|FG001|Overall Study|Other|3|||
164352493|NCT02837783|593662706|FG000|Overall Study|Adverse Event|1|||
164352494|NCT02837783|593662707|FG001|Overall Study|Adverse Event|0|||
164352495|NCT02837783|593662706|FG000|Overall Study|Other, Not Specified|1|||
164352496|NCT02837783|593662707|FG001|Overall Study|Other, Not Specified|2|||
164352497|NCT02154490|593664379|FG000|Overall Study|No tissue submitted|23|||
164352498|NCT02154490|593664379|FG000|Overall Study|No biomarker results|167|||
164352499|NCT02154490|593664379|FG000|Overall Study|Not assigned to a sub-study|270|||
164352500|NCT02154490|593664379|FG000|Overall Study|Did not register to a sub-study|749|||
164693862|NCT00892281|594901193|FG000|Overall Study|Subject missed several visits/lost meds|1|||
164352501|NCT01442493|593664381|FG000|Overall Study|withdrawn from study|3|||
164352502|NCT01442493|593664382|FG001|Overall Study|withdrawn from study|2|||
164352503|NCT00938639|593664383|FG000|Overall Study|Moved away from study area|0|||
164352504|NCT00938639|593664384|FG001|Overall Study|Moved away from study area|1|||
164352505|NCT00938639|593664383|FG000|Overall Study|Lost to Follow-up|1|||
164352506|NCT00938639|593664384|FG001|Overall Study|Lost to Follow-up|2|||
164352507|NCT00938639|593664383|FG000|Overall Study|Family issues|1|||
164352508|NCT00938639|593664384|FG001|Overall Study|Family issues|1|||
164352509|NCT00938639|593664383|FG000|Overall Study|Participant noncompliance|1|||
164352510|NCT00938639|593664384|FG001|Overall Study|Participant noncompliance|0|||
164352511|NCT02547649|593664387|FG000|Overall Study|Lost to Follow-up|3|||
164352512|NCT02547649|593664388|FG001|Overall Study|Lost to Follow-up|1|||
164352513|NCT02547649|593664389|FG002|Overall Study|Lost to Follow-up|1|||
164352514|NCT02547649|593664387|FG000|Overall Study|Not vaccinated|0|||
164436471|NCT00246012|593964935|FG005|Overall Study|Withdrawal by Subject|1|||
164352515|NCT02547649|593664388|FG001|Overall Study|Not vaccinated|0|||
164352516|NCT02547649|593664389|FG002|Overall Study|Not vaccinated|1|||
164352517|NCT02547649|593664387|FG000|Overall Study|Withdrawal by Subject|0|||
164588071|NCT03703375|594517481|FG003|Treatment Period|Completed treatment|0|||
164352518|NCT02547649|593664388|FG001|Overall Study|Withdrawal by Subject|4|||
164352519|NCT02547649|593664389|FG002|Overall Study|Withdrawal by Subject|2|||
164352520|NCT04326231|593664391|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
164352521|NCT03303079|593664392|FG000|Overall Study|Adverse Event|0|||
164352522|NCT03303079|593664393|FG001|Overall Study|Adverse Event|1|||
164352523|NCT03303079|593664394|FG002|Overall Study|Adverse Event|3|||
164352524|NCT03303079|593664392|FG000|Overall Study|Protocol Violation|5|||
164352525|NCT03303079|593664393|FG001|Overall Study|Protocol Violation|4|||
164352526|NCT03303079|593664394|FG002|Overall Study|Protocol Violation|7|||
164352527|NCT03303079|593664392|FG000|Overall Study|Withdrawal by Subject|2|||
164352528|NCT03303079|593664393|FG001|Overall Study|Withdrawal by Subject|4|||
164352529|NCT03303079|593664394|FG002|Overall Study|Withdrawal by Subject|2|||
164352530|NCT03303079|593664392|FG000|Overall Study|Other than specified|0|||
164352531|NCT03303079|593664393|FG001|Overall Study|Other than specified|2|||
164352532|NCT03303079|593664394|FG002|Overall Study|Other than specified|0|||
164352533|NCT03454997|593664395|FG000|Overall Study|Staff Coach - Left Oranization|1|||
164352534|NCT03454997|593664396|FG001|Overall Study|Staff Coach - Left Oranization|1|||
164352535|NCT03454997|593664395|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
164352536|NCT03454997|593664396|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
164352537|NCT03454997|593664395|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
164352538|NCT03454997|593664396|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
164352539|NCT03454997|593664395|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
164352540|NCT03454997|593664396|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
164352541|NCT03454997|593664395|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
164352542|NCT03454997|593664396|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
164352543|NCT03454997|593664395|FG000|Overall Study|Client with SMI - Left organization|0|||
164352544|NCT03454997|593664396|FG001|Overall Study|Client with SMI - Left organization|1|||
164352545|NCT03454997|593664395|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
164352546|NCT03454997|593664396|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
164352547|NCT01909674|593664405|FG000|Overall Study|Withdrawal by Subject|5|||
164352548|NCT01909674|593664406|FG001|Overall Study|Withdrawal by Subject|2|||
164352549|NCT01678911|593664410|FG000|Second Intervention|Lost to Follow-up|2|||
164352550|NCT01678911|593664411|FG001|Second Intervention|Lost to Follow-up|0|||
164352551|NCT02706691|593664412|FG000|Overall Study|Adverse Event|1|||
164352552|NCT01830972|593664418|FG000|Part II|Withdrawal by Subject|2|||
164352553|NCT01830972|593664419|FG001|Part II|Withdrawal by Subject|2|||
164352554|NCT01830972|593664418|FG000|Part III|Withdrawal by Subject|1|||
164352555|NCT01830972|593664419|FG001|Part III|Withdrawal by Subject|0|||
164352556|NCT01830972|593664418|FG000|Part III|Noncompliance|1|||
164352557|NCT01830972|593664419|FG001|Part III|Noncompliance|0|||
164352558|NCT01830972|593664418|FG000|Part IV|Withdrawal by Subject|2|||
164352559|NCT01830972|593664419|FG001|Part IV|Withdrawal by Subject|1|||
164352560|NCT01830972|593664418|FG000|Part IV|Non-Compliance|1|||
164352561|NCT01830972|593664419|FG001|Part IV|Non-Compliance|0|||
164352562|NCT02117648|593664420|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
164352563|NCT02117648|593664420|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
164352564|NCT02117648|593664420|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
164352565|NCT02117648|593664420|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
164352566|NCT02117648|593664420|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
164352567|NCT02117648|593664420|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
164352568|NCT02117648|593664420|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
164352569|NCT02117648|593664420|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
164352570|NCT02117648|593664420|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
164352571|NCT02117648|593664420|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
164352572|NCT02117648|593664420|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
164352573|NCT00171730|593664422|FG000|Overall Study|Adverse Event|3|||
164352574|NCT00171730|593664422|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
164352575|NCT00171730|593664422|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
164352576|NCT00171730|593664422|FG000|Overall Study|Withdrawal by Subject|3|||
164352577|NCT05025241|593664423|FG000|Screening|Failed Screening|5|||
164352578|NCT05025241|593664423|FG000|Treatment and Follow Up|Adverse Event|3|||
164352579|NCT02670837|593664424|FG000|Overall Study|Death|2|||
164352580|NCT02670837|593664425|FG001|Overall Study|Death|0|||
164352581|NCT02670837|593664426|FG002|Overall Study|Death|0|||
164352582|NCT01829191|593664427|FG000|Overall Study|Relocation|0|||
164352583|NCT01829191|593664428|FG001|Overall Study|Relocation|1|||
164352584|NCT01829191|593664427|FG000|Overall Study|Lens discomfort|0|||
164352585|NCT01829191|593664428|FG001|Overall Study|Lens discomfort|3|||
164352586|NCT01829191|593664427|FG000|Overall Study|Lens handling difficulty|1|||
164352587|NCT01829191|593664428|FG001|Overall Study|Lens handling difficulty|4|||
164352588|NCT01829191|593664427|FG000|Overall Study|Protocol Violation|4|||
164352589|NCT01829191|593664428|FG001|Overall Study|Protocol Violation|1|||
164352590|NCT01829191|593664427|FG000|Overall Study|Withdrawal by Subject|2|||
164588072|NCT03504774|594517482|FG000|Overall Study|Adverse Event|2|||
164436472|NCT00246012|593964936|FG006|Overall Study|Withdrawal by Subject|0|||
164436473|NCT00246012|593964937|FG007|Overall Study|Withdrawal by Subject|0|||
164436474|NCT00246012|593964938|FG008|Overall Study|Withdrawal by Subject|0|||
164436475|NCT00246012|593964930|FG000|Overall Study|Disease progression|3|||
164436476|NCT00246012|593964931|FG001|Overall Study|Disease progression|1|||
164436477|NCT00246012|593964932|FG002|Overall Study|Disease progression|2|||
164352591|NCT01829191|593664428|FG001|Overall Study|Withdrawal by Subject|3|||
164352592|NCT01829191|593664427|FG000|Overall Study|Lost to Follow-up|0|||
164352593|NCT01829191|593664428|FG001|Overall Study|Lost to Follow-up|1|||
164352594|NCT01829191|593664427|FG000|Overall Study|Subject was fit for ortho - k|0|||
164352595|NCT01829191|593664428|FG001|Overall Study|Subject was fit for ortho - k|1|||
164352596|NCT02220205|593664429|FG000|Overall Study|Withdrawal by Subject|1|||
164352597|NCT02220205|593664430|FG001|Overall Study|Withdrawal by Subject|0|||
164352598|NCT01276353|593664433|FG000|Double-blind|Adverse Event|2|||
164352599|NCT01276353|593664434|FG001|Double-blind|Adverse Event|0|||
164352600|NCT01276353|593664433|FG000|Double-blind|Withdrawal by Subject|1|||
164352601|NCT01276353|593664434|FG001|Double-blind|Withdrawal by Subject|0|||
164352602|NCT01276353|593664433|FG000|Extension|Adverse Event|2|||
164352603|NCT01276353|593664434|FG001|Extension|Adverse Event|5|||
164352604|NCT01276353|593664433|FG000|Extension|Withdrawal by Subject|1|||
164352605|NCT01276353|593664434|FG001|Extension|Withdrawal by Subject|2|||
164352606|NCT01276353|593664433|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
164352607|NCT01276353|593664434|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
164436478|NCT00246012|593964933|FG003|Overall Study|Disease progression|3|||
164436479|NCT00246012|593964934|FG004|Overall Study|Disease progression|3|||
164436480|NCT00246012|593964935|FG005|Overall Study|Disease progression|25|||
164436481|NCT00246012|593964936|FG006|Overall Study|Disease progression|30|||
164436482|NCT00246012|593964937|FG007|Overall Study|Disease progression|27|||
164436483|NCT00246012|593964938|FG008|Overall Study|Disease progression|26|||
164436484|NCT00246012|593964930|FG000|Overall Study|Other|0|||
164436485|NCT00246012|593964931|FG001|Overall Study|Other|0|||
164436486|NCT00246012|593964932|FG002|Overall Study|Other|0|||
164436487|NCT00246012|593964933|FG003|Overall Study|Other|0|||
164436488|NCT00246012|593964934|FG004|Overall Study|Other|0|||
164436489|NCT00246012|593964935|FG005|Overall Study|Other|0|||
164436490|NCT00246012|593964936|FG006|Overall Study|Other|0|||
164436491|NCT00246012|593964937|FG007|Overall Study|Other|1|||
164436492|NCT00246012|593964938|FG008|Overall Study|Other|0|||
164436493|NCT00246012|593964930|FG000|Overall Study|Randomly assigned but not treated|0|||
164436494|NCT00246012|593964931|FG001|Overall Study|Randomly assigned but not treated|0|||
164436495|NCT00246012|593964932|FG002|Overall Study|Randomly assigned but not treated|0|||
164436496|NCT00246012|593964933|FG003|Overall Study|Randomly assigned but not treated|0|||
164436497|NCT00246012|593964934|FG004|Overall Study|Randomly assigned but not treated|0|||
164436498|NCT00246012|593964935|FG005|Overall Study|Randomly assigned but not treated|1|||
164436499|NCT00246012|593964936|FG006|Overall Study|Randomly assigned but not treated|1|||
164436500|NCT00246012|593964937|FG007|Overall Study|Randomly assigned but not treated|0|||
164436501|NCT00246012|593964938|FG008|Overall Study|Randomly assigned but not treated|0|||
164436502|NCT02377362|593964939|FG000|Part A Second Treatment|Protocol Violation|0|||
164436503|NCT02377362|593964940|FG001|Part A Second Treatment|Protocol Violation|0|||
164436504|NCT02377362|593964941|FG002|Part A Second Treatment|Protocol Violation|0|||
164436505|NCT02377362|593964942|FG003|Part A Second Treatment|Protocol Violation|0|||
164436506|NCT02377362|593964943|FG004|Part A Second Treatment|Protocol Violation|1|||
164352608|NCT01276353|593664433|FG000|Extension|Physician Decision|1|||
164436507|NCT02377362|593964944|FG005|Part A Second Treatment|Protocol Violation|0|||
164436508|NCT02377362|593964945|FG006|Part A Second Treatment|Protocol Violation|0|||
164436509|NCT02377362|593964946|FG007|Part A Second Treatment|Protocol Violation|0|||
164436510|NCT02377362|593964947|FG008|Part A Second Treatment|Protocol Violation|0|||
164436511|NCT02377362|593964948|FG009|Part A Second Treatment|Protocol Violation|0|||
164436512|NCT02377362|593964949|FG010|Part A Second Treatment|Protocol Violation|0|||
164436513|NCT02377362|593964950|FG011|Part A Second Treatment|Protocol Violation|0|||
164436514|NCT02377362|593964951|FG012|Part A Second Treatment|Protocol Violation|0|||
164436515|NCT02377362|593964939|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
164436516|NCT02377362|593964940|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
164436517|NCT02377362|593964941|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
164436518|NCT02377362|593964942|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
164436519|NCT02377362|593964943|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
164352609|NCT01276353|593664434|FG001|Extension|Physician Decision|0|||
164352610|NCT01276353|593664433|FG000|Extension|Prohibited concomitant medications|0|||
164352611|NCT01276353|593664434|FG001|Extension|Prohibited concomitant medications|1|||
164436520|NCT02377362|593964944|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
164436521|NCT02377362|593964945|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
164436522|NCT02377362|593964946|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
164436523|NCT02377362|593964947|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
164436524|NCT02377362|593964948|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
164436525|NCT02377362|593964949|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
164436526|NCT02377362|593964950|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
164352612|NCT02266225|593664437|FG000|Overall Study|Lost to Follow-up|2|||
164352613|NCT02266225|593664437|FG000|Overall Study|Death|1|||
164352614|NCT02266225|593664437|FG000|Overall Study|Withdrawal by Subject|13|||
164352615|NCT00553514|593664438|FG000|Overall Study|Protocol deviation|0|||
164436527|NCT02377362|593964951|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
164436528|NCT02377362|593964939|FG000|Part B Overall|Protocol Violation|0|||
164436529|NCT02377362|593964940|FG001|Part B Overall|Protocol Violation|0|||
164436530|NCT02377362|593964941|FG002|Part B Overall|Protocol Violation|0|||
164436531|NCT02377362|593964942|FG003|Part B Overall|Protocol Violation|0|||
164436532|NCT02377362|593964943|FG004|Part B Overall|Protocol Violation|0|||
164436533|NCT02377362|593964944|FG005|Part B Overall|Protocol Violation|0|||
164436534|NCT02377362|593964945|FG006|Part B Overall|Protocol Violation|0|||
164436535|NCT02377362|593964946|FG007|Part B Overall|Protocol Violation|0|||
164436536|NCT02377362|593964947|FG008|Part B Overall|Protocol Violation|0|||
164436537|NCT02377362|593964948|FG009|Part B Overall|Protocol Violation|1|||
164436538|NCT02377362|593964949|FG010|Part B Overall|Protocol Violation|0|||
164436539|NCT02377362|593964950|FG011|Part B Overall|Protocol Violation|0|||
164436540|NCT02377362|593964951|FG012|Part B Overall|Protocol Violation|0|||
164436541|NCT02377362|593964939|FG000|Part B Overall|Adverse Event|0|||
164436542|NCT02377362|593964940|FG001|Part B Overall|Adverse Event|0|||
164436543|NCT02377362|593964941|FG002|Part B Overall|Adverse Event|0|||
164436544|NCT02377362|593964942|FG003|Part B Overall|Adverse Event|0|||
164436545|NCT02377362|593964943|FG004|Part B Overall|Adverse Event|0|||
164436546|NCT02377362|593964944|FG005|Part B Overall|Adverse Event|0|||
164436547|NCT02377362|593964945|FG006|Part B Overall|Adverse Event|1|||
164436548|NCT02377362|593964946|FG007|Part B Overall|Adverse Event|1|||
164436549|NCT02377362|593964947|FG008|Part B Overall|Adverse Event|0|||
164352616|NCT00553514|593664439|FG001|Overall Study|Protocol deviation|0|||
164352617|NCT00553514|593664440|FG002|Overall Study|Protocol deviation|0|||
164352618|NCT00553514|593664441|FG003|Overall Study|Protocol deviation|1|||
164352619|NCT00553514|593664442|FG004|Overall Study|Protocol deviation|0|||
164352620|NCT00553514|593664438|FG000|Overall Study|Lack of ovarian response|4|||
164352621|NCT00553514|593664439|FG001|Overall Study|Lack of ovarian response|5|||
164352622|NCT00553514|593664440|FG002|Overall Study|Lack of ovarian response|5|||
164352623|NCT00553514|593664441|FG003|Overall Study|Lack of ovarian response|5|||
164352624|NCT00553514|593664442|FG004|Overall Study|Lack of ovarian response|6|||
164352625|NCT00553514|593664438|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
164352626|NCT00553514|593664439|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
164352627|NCT00553514|593664440|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
164352628|NCT00553514|593664441|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
164352629|NCT00553514|593664442|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
164352630|NCT00553514|593664438|FG000|Overall Study|Risk of multiple pregnancy|0|||
164352631|NCT00553514|593664439|FG001|Overall Study|Risk of multiple pregnancy|2|||
164352632|NCT00553514|593664440|FG002|Overall Study|Risk of multiple pregnancy|0|||
164352633|NCT00553514|593664441|FG003|Overall Study|Risk of multiple pregnancy|1|||
164352634|NCT00553514|593664442|FG004|Overall Study|Risk of multiple pregnancy|0|||
164352635|NCT00553514|593664438|FG000|Overall Study|Other|1|||
164352636|NCT00553514|593664439|FG001|Overall Study|Other|1|||
164352637|NCT00553514|593664440|FG002|Overall Study|Other|0|||
164352638|NCT00553514|593664441|FG003|Overall Study|Other|0|||
164352639|NCT00553514|593664442|FG004|Overall Study|Other|1|||
164352640|NCT00660309|593664446|FG000|Overall Study|Adverse Event|2|||
164352641|NCT00660309|593664447|FG001|Overall Study|Adverse Event|0|||
164436550|NCT02377362|593964948|FG009|Part B Overall|Adverse Event|0|||
164352642|NCT00660309|593664446|FG000|Overall Study|Withdrawal by Subject|0|||
164352643|NCT00660309|593664447|FG001|Overall Study|Withdrawal by Subject|3|||
164352644|NCT02532972|593664451|FG000|Overall Study|Withdrawal by Subject|1|||
164352645|NCT01018186|593664452|FG000|2-week Run-in Period|Protocol Violation|1|||
164352646|NCT01018186|593664453|FG001|2-week Run-in Period|Protocol Violation|0|||
164436551|NCT02377362|593964949|FG010|Part B Overall|Adverse Event|0|||
164436552|NCT02377362|593964950|FG011|Part B Overall|Adverse Event|0|||
164436553|NCT02377362|593964951|FG012|Part B Overall|Adverse Event|0|||
164436554|NCT02377362|593964939|FG000|Part B Overall|Withdrawal by Subject|0|||
164436555|NCT02377362|593964940|FG001|Part B Overall|Withdrawal by Subject|0|||
164352647|NCT01018186|593664454|FG002|2-week Run-in Period|Protocol Violation|0|||
164436556|NCT02377362|593964941|FG002|Part B Overall|Withdrawal by Subject|0|||
164352648|NCT01018186|593664455|FG003|2-week Run-in Period|Protocol Violation|0|||
164352649|NCT01018186|593664452|FG000|2-week Run-in Period|Lost to Follow-up|2|||
164352650|NCT01018186|593664453|FG001|2-week Run-in Period|Lost to Follow-up|0|||
164352651|NCT01018186|593664454|FG002|2-week Run-in Period|Lost to Follow-up|0|||
164436557|NCT02377362|593964942|FG003|Part B Overall|Withdrawal by Subject|0|||
164436558|NCT02377362|593964943|FG004|Part B Overall|Withdrawal by Subject|0|||
164436559|NCT02377362|593964944|FG005|Part B Overall|Withdrawal by Subject|0|||
164436560|NCT02377362|593964945|FG006|Part B Overall|Withdrawal by Subject|1|||
164588073|NCT03504774|594517483|FG001|Overall Study|Adverse Event|0|||
164352652|NCT01018186|593664455|FG003|2-week Run-in Period|Lost to Follow-up|0|||
164352653|NCT01018186|593664452|FG000|2-week Run-in Period|Physician Decision|3|||
164352654|NCT01018186|593664453|FG001|2-week Run-in Period|Physician Decision|0|||
164352655|NCT01018186|593664454|FG002|2-week Run-in Period|Physician Decision|0|||
164352656|NCT01018186|593664455|FG003|2-week Run-in Period|Physician Decision|0|||
164352657|NCT01018186|593664452|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
164352658|NCT01018186|593664453|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
164352659|NCT01018186|593664454|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
164352660|NCT01018186|593664455|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
164352661|NCT01018186|593664452|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
164352662|NCT01018186|593664453|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
164352663|NCT01018186|593664454|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
164352664|NCT01018186|593664455|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
164352665|NCT01018186|593664452|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
164352666|NCT01018186|593664453|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
164352667|NCT01018186|593664454|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
164352668|NCT01018186|593664455|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
164352669|NCT01018186|593664452|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
164352670|NCT01018186|593664453|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
164352671|NCT01018186|593664454|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
164352672|NCT01018186|593664455|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
164352673|NCT01018186|593664452|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
164352674|NCT01018186|593664453|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
164352675|NCT01018186|593664454|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
164352676|NCT01018186|593664455|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
164352677|NCT01018186|593664452|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
164352678|NCT01018186|593664453|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
164352679|NCT01018186|593664454|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
164352680|NCT01018186|593664455|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
164352681|NCT01018186|593664452|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
164352682|NCT01018186|593664453|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
164352683|NCT01018186|593664454|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
164352684|NCT01018186|593664455|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
164352685|NCT01018186|593664452|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
164352686|NCT01018186|593664453|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
164352687|NCT01018186|593664454|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
164352688|NCT01018186|593664455|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
164352689|NCT01018186|593664452|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
164352690|NCT01018186|593664453|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
164352691|NCT01018186|593664454|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
164352692|NCT01018186|593664455|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
164352693|NCT02603419|593664456|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
164352694|NCT02603419|593664457|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
164352695|NCT02603419|593664458|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
164352696|NCT02603419|593664459|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
164352697|NCT02603419|593664460|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
164352698|NCT02603419|593664461|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
164352699|NCT02603419|593664456|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
164352700|NCT02603419|593664457|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
164352701|NCT02603419|593664458|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
164352702|NCT02603419|593664459|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
164352703|NCT02603419|593664460|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
164352704|NCT02603419|593664461|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
164352705|NCT02603419|593664456|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
164352706|NCT02603419|593664457|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
164352707|NCT02603419|593664458|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
164352708|NCT02603419|593664459|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
164352709|NCT02603419|593664460|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
164352710|NCT02603419|593664461|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
164352711|NCT02603419|593664456|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
164352712|NCT02603419|593664457|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
164352713|NCT02603419|593664458|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
164352714|NCT02603419|593664459|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
164588074|NCT03504774|594517482|FG000|Overall Study|Lost to Follow-up|0|||
164588075|NCT03504774|594517483|FG001|Overall Study|Lost to Follow-up|1|||
164588076|NCT03504774|594517482|FG000|Overall Study|Protocol Violation|11|||
164352715|NCT02603419|593664460|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
164352716|NCT02603419|593664461|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
164352717|NCT02603419|593664456|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
164352718|NCT02603419|593664457|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
164352719|NCT02603419|593664458|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
164352720|NCT02603419|593664459|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
164352721|NCT02603419|593664460|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
164352722|NCT02603419|593664461|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
164352723|NCT02603419|593664456|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
164352724|NCT02603419|593664457|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
164352725|NCT02603419|593664458|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
164352726|NCT02603419|593664459|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
164352727|NCT02603419|593664460|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
164352728|NCT02603419|593664461|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
164352729|NCT02603419|593664456|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
164352730|NCT02603419|593664457|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
164352731|NCT02603419|593664458|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
164352732|NCT02603419|593664459|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
164352733|NCT02603419|593664460|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
164352734|NCT02603419|593664461|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
164352735|NCT02603419|593664456|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
164352736|NCT02603419|593664457|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
164352737|NCT02603419|593664458|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
164352738|NCT02603419|593664459|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
164352739|NCT02603419|593664460|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
164352740|NCT02603419|593664461|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
164352741|NCT02603419|593664456|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
164352742|NCT02603419|593664457|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
164352743|NCT02603419|593664458|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
164352744|NCT02603419|593664459|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
164352745|NCT02603419|593664460|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
164352746|NCT02603419|593664461|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
164352747|NCT02603419|593664456|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
164352748|NCT02603419|593664457|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
164352749|NCT02603419|593664458|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
164352750|NCT02603419|593664459|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
164352751|NCT02603419|593664460|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
164352752|NCT02603419|593664461|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
164352753|NCT02925494|593664462|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
164352754|NCT02925494|593664463|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
164352755|NCT02925494|593664464|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
164352756|NCT02925494|593664465|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
164352757|NCT02925494|593664462|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
164352758|NCT02925494|593664463|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
164352759|NCT02925494|593664464|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
164352760|NCT02925494|593664465|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
164352761|NCT02925494|593664462|FG000|Post-Treatment Follow-Up Period|Other|1|||
164352762|NCT02925494|593664463|FG001|Post-Treatment Follow-Up Period|Other|4|||
164352763|NCT02925494|593664464|FG002|Post-Treatment Follow-Up Period|Other|3|||
164352764|NCT02925494|593664465|FG003|Post-Treatment Follow-Up Period|Other|6|||
164352765|NCT02925494|593664462|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
164352766|NCT02925494|593664463|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
164352767|NCT02925494|593664464|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
164352768|NCT02925494|593664465|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
164352769|NCT02925494|593664462|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
164352770|NCT02925494|593664463|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
164352771|NCT02925494|593664464|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
164352772|NCT02925494|593664465|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
164352773|NCT02925494|593664462|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
164352774|NCT02925494|593664463|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
164352775|NCT02925494|593664464|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
164352776|NCT02925494|593664465|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
164352777|NCT02925494|593664462|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
164352778|NCT02925494|593664463|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
164436561|NCT02377362|593964946|FG007|Part B Overall|Withdrawal by Subject|0|||
164352779|NCT02925494|593664464|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
164352780|NCT02925494|593664465|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
164352781|NCT01666782|593664471|FG000|Overall Study|Received 2 doses of vaccine|0|||
164352782|NCT01666782|593664472|FG001|Overall Study|Received 2 doses of vaccine|1|||
164352783|NCT01666782|593664471|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
164352784|NCT01666782|593664472|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
164352785|NCT02007109|593664475|FG000|Overall Study|Diary not returned or excluded|102|||
164352786|NCT02007109|593664475|FG000|Overall Study|Excluded - Age<7yo|9|||
164352787|NCT01858389|593664476|FG000|Overall Study|Death|1|||
164352788|NCT01858389|593664477|FG001|Overall Study|Death|3|||
164352789|NCT01858389|593664476|FG000|Overall Study|Study terminated by sponsor|0|||
164352790|NCT01858389|593664477|FG001|Overall Study|Study terminated by sponsor|2|||
164352791|NCT01858389|593664476|FG000|Overall Study|Withdrawal by Subject|0|||
164352792|NCT01858389|593664477|FG001|Overall Study|Withdrawal by Subject|1|||
164352793|NCT01858389|593664476|FG000|Overall Study|Progressive disease|10|||
164352794|NCT01858389|593664477|FG001|Overall Study|Progressive disease|11|||
164352795|NCT01858389|593664476|FG000|Overall Study|Other|2|||
164352796|NCT01858389|593664477|FG001|Overall Study|Other|4|||
164352797|NCT01858389|593664476|FG000|Overall Study|Adverse Event|3|||
164352798|NCT01858389|593664477|FG001|Overall Study|Adverse Event|1|||
164352799|NCT01858389|593664476|FG000|Overall Study|Did not receive treatment|0|||
164352800|NCT01858389|593664477|FG001|Overall Study|Did not receive treatment|3|||
164352801|NCT03572062|593664478|FG000|Overall Study|Adverse Event|0|||
164352802|NCT03572062|593664479|FG001|Overall Study|Adverse Event|0|||
164352803|NCT03572062|593664480|FG002|Overall Study|Adverse Event|0|||
164352804|NCT03572062|593664481|FG003|Overall Study|Adverse Event|0|||
164352805|NCT03572062|593664482|FG004|Overall Study|Adverse Event|0|||
164352806|NCT03572062|593664483|FG005|Overall Study|Adverse Event|0|||
164352807|NCT03572062|593664484|FG006|Overall Study|Adverse Event|0|||
164352808|NCT03572062|593664485|FG007|Overall Study|Adverse Event|0|||
164352809|NCT03572062|593664486|FG008|Overall Study|Adverse Event|1|||
164352810|NCT03572062|593664487|FG009|Overall Study|Adverse Event|3|||
164352811|NCT03572062|593664478|FG000|Overall Study|Death|0|||
164352812|NCT03572062|593664479|FG001|Overall Study|Death|0|||
164352813|NCT03572062|593664480|FG002|Overall Study|Death|0|||
164352814|NCT03572062|593664481|FG003|Overall Study|Death|0|||
164352815|NCT03572062|593664482|FG004|Overall Study|Death|0|||
164352816|NCT03572062|593664483|FG005|Overall Study|Death|1|||
164352817|NCT03572062|593664484|FG006|Overall Study|Death|0|||
164352818|NCT03572062|593664485|FG007|Overall Study|Death|0|||
164352819|NCT03572062|593664486|FG008|Overall Study|Death|0|||
164352820|NCT03572062|593664487|FG009|Overall Study|Death|0|||
164352821|NCT03572062|593664478|FG000|Overall Study|Lost to Follow-up|0|||
164352822|NCT03572062|593664479|FG001|Overall Study|Lost to Follow-up|0|||
164352823|NCT03572062|593664480|FG002|Overall Study|Lost to Follow-up|0|||
164352824|NCT03572062|593664481|FG003|Overall Study|Lost to Follow-up|0|||
164352825|NCT03572062|593664482|FG004|Overall Study|Lost to Follow-up|0|||
164352826|NCT03572062|593664483|FG005|Overall Study|Lost to Follow-up|1|||
164352827|NCT03572062|593664484|FG006|Overall Study|Lost to Follow-up|1|||
164352828|NCT03572062|593664485|FG007|Overall Study|Lost to Follow-up|0|||
164352829|NCT03572062|593664486|FG008|Overall Study|Lost to Follow-up|0|||
164352830|NCT03572062|593664487|FG009|Overall Study|Lost to Follow-up|0|||
164352831|NCT03572062|593664478|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
164352832|NCT03572062|593664479|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
164352833|NCT03572062|593664480|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
164352834|NCT03572062|593664481|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
164352835|NCT03572062|593664482|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
164352836|NCT03572062|593664483|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
164352837|NCT03572062|593664484|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
164352838|NCT03572062|593664485|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
164352839|NCT03572062|593664486|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
164352840|NCT03572062|593664487|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
164352841|NCT03572062|593664478|FG000|Overall Study|Study Terminated By Sponsor|0|||
164352842|NCT03572062|593664479|FG001|Overall Study|Study Terminated By Sponsor|0|||
164352843|NCT03572062|593664480|FG002|Overall Study|Study Terminated By Sponsor|0|||
164352844|NCT03572062|593664481|FG003|Overall Study|Study Terminated By Sponsor|0|||
164352845|NCT03572062|593664482|FG004|Overall Study|Study Terminated By Sponsor|0|||
164352846|NCT03572062|593664483|FG005|Overall Study|Study Terminated By Sponsor|0|||
164352847|NCT03572062|593664484|FG006|Overall Study|Study Terminated By Sponsor|0|||
164352848|NCT03572062|593664485|FG007|Overall Study|Study Terminated By Sponsor|0|||
164352849|NCT03572062|593664486|FG008|Overall Study|Study Terminated By Sponsor|29|||
164352850|NCT03572062|593664487|FG009|Overall Study|Study Terminated By Sponsor|27|||
164352851|NCT03572062|593664478|FG000|Overall Study|Physician Decision|0|||
164352852|NCT03572062|593664479|FG001|Overall Study|Physician Decision|0|||
164352853|NCT03572062|593664480|FG002|Overall Study|Physician Decision|0|||
164352854|NCT03572062|593664481|FG003|Overall Study|Physician Decision|0|||
164352855|NCT03572062|593664482|FG004|Overall Study|Physician Decision|0|||
164352856|NCT03572062|593664483|FG005|Overall Study|Physician Decision|0|||
164352857|NCT03572062|593664484|FG006|Overall Study|Physician Decision|0|||
164352858|NCT03572062|593664485|FG007|Overall Study|Physician Decision|0|||
164352859|NCT03572062|593664486|FG008|Overall Study|Physician Decision|1|||
164352860|NCT03572062|593664487|FG009|Overall Study|Physician Decision|0|||
164352861|NCT03572062|593664478|FG000|Overall Study|Withdrawal by Subject|0|||
164352862|NCT03572062|593664479|FG001|Overall Study|Withdrawal by Subject|0|||
164352863|NCT03572062|593664480|FG002|Overall Study|Withdrawal by Subject|0|||
164352864|NCT03572062|593664481|FG003|Overall Study|Withdrawal by Subject|0|||
164352865|NCT03572062|593664482|FG004|Overall Study|Withdrawal by Subject|0|||
164352866|NCT03572062|593664483|FG005|Overall Study|Withdrawal by Subject|0|||
164352867|NCT03572062|593664484|FG006|Overall Study|Withdrawal by Subject|0|||
164352868|NCT03572062|593664485|FG007|Overall Study|Withdrawal by Subject|0|||
164352869|NCT03572062|593664486|FG008|Overall Study|Withdrawal by Subject|0|||
164352870|NCT03572062|593664487|FG009|Overall Study|Withdrawal by Subject|1|||
164352871|NCT03572062|593664478|FG000|Overall Study|Randomized But Not Treated|0|||
164352872|NCT03572062|593664479|FG001|Overall Study|Randomized But Not Treated|0|||
164352873|NCT03572062|593664480|FG002|Overall Study|Randomized But Not Treated|0|||
164352874|NCT03572062|593664481|FG003|Overall Study|Randomized But Not Treated|0|||
164352875|NCT03572062|593664482|FG004|Overall Study|Randomized But Not Treated|1|||
164352876|NCT03572062|593664483|FG005|Overall Study|Randomized But Not Treated|2|||
164352877|NCT03572062|593664484|FG006|Overall Study|Randomized But Not Treated|0|||
164352878|NCT03572062|593664485|FG007|Overall Study|Randomized But Not Treated|1|||
164352879|NCT03572062|593664486|FG008|Overall Study|Randomized But Not Treated|0|||
164352880|NCT03572062|593664487|FG009|Overall Study|Randomized But Not Treated|0|||
164352881|NCT01691781|593664488|FG000|Overall Study|Withdrawal by Subject|4|||
164352882|NCT01691781|593664489|FG001|Overall Study|Withdrawal by Subject|3|||
164352883|NCT01691781|593664488|FG000|Overall Study|Physician Decision|1|||
164352884|NCT01691781|593664489|FG001|Overall Study|Physician Decision|1|||
164352885|NCT01691781|593664488|FG000|Overall Study|Protocol Violation|2|||
164352886|NCT01691781|593664489|FG001|Overall Study|Protocol Violation|2|||
164352887|NCT01691781|593664488|FG000|Overall Study|Adverse Event|0|||
164352888|NCT01691781|593664489|FG001|Overall Study|Adverse Event|1|||
164352889|NCT03978520|593664490|FG000|Overall Study|Adverse Event|2|||
164352890|NCT03978520|593664491|FG001|Overall Study|Adverse Event|5|||
164352891|NCT03978520|593664492|FG002|Overall Study|Adverse Event|3|||
164352892|NCT03978520|593664493|FG003|Overall Study|Adverse Event|5|||
164352893|NCT03978520|593664494|FG004|Overall Study|Adverse Event|6|||
164352894|NCT03978520|593664490|FG000|Overall Study|Withdrawal by Subject|10|||
164352895|NCT03978520|593664491|FG001|Overall Study|Withdrawal by Subject|4|||
164352896|NCT03978520|593664492|FG002|Overall Study|Withdrawal by Subject|5|||
164352897|NCT03978520|593664493|FG003|Overall Study|Withdrawal by Subject|6|||
164352898|NCT03978520|593664494|FG004|Overall Study|Withdrawal by Subject|5|||
164352899|NCT03978520|593664490|FG000|Overall Study|Lost to Follow-up|2|||
164352900|NCT03978520|593664491|FG001|Overall Study|Lost to Follow-up|2|||
164352901|NCT03978520|593664492|FG002|Overall Study|Lost to Follow-up|2|||
164436562|NCT02377362|593964947|FG008|Part B Overall|Withdrawal by Subject|0|||
164436563|NCT02377362|593964948|FG009|Part B Overall|Withdrawal by Subject|0|||
164436564|NCT02377362|593964949|FG010|Part B Overall|Withdrawal by Subject|0|||
164436565|NCT02377362|593964950|FG011|Part B Overall|Withdrawal by Subject|1|||
164436566|NCT02377362|593964951|FG012|Part B Overall|Withdrawal by Subject|0|||
164436567|NCT04889664|593964952|FG000|Screen|Lost to Follow-up|1|||
164436568|NCT04889664|593964952|FG000|Screen|Failed to meet screening criteria|1|||
164436569|NCT04889664|593964952|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
164436570|NCT02469064|593964958|FG000|Overall Study|Request not to receive intervention.|1|||
164436571|NCT02469064|593964959|FG001|Overall Study|Request not to receive intervention.|3|||
164436572|NCT00964366|593964960|FG000|Overall Study|Did not qualify at Day 1|1|||
164436573|NCT00964366|593964961|FG001|Overall Study|Did not qualify at Day 1|0|||
164436574|NCT00964366|593964960|FG000|Overall Study|Withdrawal by Subject|0|||
164436575|NCT00964366|593964961|FG001|Overall Study|Withdrawal by Subject|1|||
164436576|NCT02957539|593964962|FG000|Baseline to Week 16|Lost to Follow-up|8|||
164436577|NCT02957539|593964963|FG001|Baseline to Week 16|Lost to Follow-up|10|||
164436578|NCT02957539|593964964|FG002|Baseline to Week 16|Lost to Follow-up|16|||
164436579|NCT02957539|593964962|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
164588077|NCT03504774|594517483|FG001|Overall Study|Protocol Violation|3|||
164352902|NCT03978520|593664493|FG003|Overall Study|Lost to Follow-up|0|||
164352903|NCT03978520|593664494|FG004|Overall Study|Lost to Follow-up|1|||
164352904|NCT03978520|593664490|FG000|Overall Study|COVID-19 infection|0|||
164352905|NCT03978520|593664491|FG001|Overall Study|COVID-19 infection|1|||
164352906|NCT03978520|593664492|FG002|Overall Study|COVID-19 infection|0|||
164352907|NCT03978520|593664493|FG003|Overall Study|COVID-19 infection|0|||
164352908|NCT03978520|593664494|FG004|Overall Study|COVID-19 infection|0|||
164352909|NCT03978520|593664490|FG000|Overall Study|Other, not specified|9|||
164352910|NCT03978520|593664491|FG001|Overall Study|Other, not specified|4|||
164436580|NCT02957539|593964963|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
164436581|NCT02957539|593964964|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
164352911|NCT03978520|593664492|FG002|Overall Study|Other, not specified|1|||
164352912|NCT03978520|593664493|FG003|Overall Study|Other, not specified|1|||
164436582|NCT02957539|593964962|FG000|Week 16 to 32|Withdrawal by Subject|3|||
164436583|NCT02957539|593964963|FG001|Week 16 to 32|Withdrawal by Subject|3|||
164436584|NCT02957539|593964964|FG002|Week 16 to 32|Withdrawal by Subject|1|||
164436585|NCT02957539|593964962|FG000|Week 16 to 32|Lost to Follow-up|8|||
164436586|NCT02957539|593964963|FG001|Week 16 to 32|Lost to Follow-up|7|||
164436587|NCT02957539|593964964|FG002|Week 16 to 32|Lost to Follow-up|5|||
164299089|NCT02006472|593471239|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
164299090|NCT02006472|593471235|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
164299091|NCT02006472|593471236|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
164299092|NCT02006472|593471237|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
164299093|NCT02006472|593471238|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
164299094|NCT02006472|593471239|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
164299095|NCT02006472|593471235|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
164299096|NCT02006472|593471236|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
164299097|NCT02006472|593471237|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
164299098|NCT02006472|593471238|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
164299099|NCT02006472|593471239|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
164299100|NCT02006472|593471235|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
164299101|NCT02006472|593471236|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
164299102|NCT02006472|593471237|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
164299103|NCT02006472|593471238|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
164299104|NCT02006472|593471239|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
164299105|NCT02006472|593471235|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
164299106|NCT02006472|593471236|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
164299107|NCT02006472|593471237|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
164299108|NCT02006472|593471238|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
164299109|NCT02006472|593471239|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
164299110|NCT02006472|593471235|FG000|Period 2 (Through Week 52)|Other|0|||
164299111|NCT02006472|593471236|FG001|Period 2 (Through Week 52)|Other|1|||
164299112|NCT02006472|593471237|FG002|Period 2 (Through Week 52)|Other|0|||
164299113|NCT02006472|593471238|FG003|Period 2 (Through Week 52)|Other|1|||
164299114|NCT02006472|593471239|FG004|Period 2 (Through Week 52)|Other|0|||
164299115|NCT02006472|593471235|FG000|Period 2 (Through Week 52)|Not treated|0|||
164299116|NCT02006472|593471236|FG001|Period 2 (Through Week 52)|Not treated|0|||
164299117|NCT02006472|593471237|FG002|Period 2 (Through Week 52)|Not treated|2|||
164299118|NCT02006472|593471238|FG003|Period 2 (Through Week 52)|Not treated|0|||
164299119|NCT02006472|593471239|FG004|Period 2 (Through Week 52)|Not treated|0|||
164299120|NCT02006472|593471235|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
164299121|NCT02006472|593471236|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
164299122|NCT02006472|593471237|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
164299123|NCT02006472|593471238|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
164299124|NCT02006472|593471239|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
164299125|NCT02006472|593471235|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
164299126|NCT02006472|593471236|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
164299127|NCT02006472|593471237|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
164299128|NCT02006472|593471238|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
164299129|NCT02006472|593471239|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
164299130|NCT03219723|593471240|FG000|Overall Study|Case Report Forms Uncollected|6|||
164299131|NCT03219723|593471240|FG000|Overall Study|Protocol Deviation|4|||
164299132|NCT04558125|593471241|FG000|Overall Study|Death|1|||
164299133|NCT03137381|593471242|FG000|Overall Study|Adverse Event|3|||
164299134|NCT03137381|593471243|FG001|Overall Study|Adverse Event|0|||
164299135|NCT03137381|593471244|FG002|Overall Study|Adverse Event|2|||
164299136|NCT03137381|593471245|FG003|Overall Study|Adverse Event|0|||
164299137|NCT03137381|593471242|FG000|Overall Study|Lost to Follow-up|2|||
164299138|NCT03137381|593471243|FG001|Overall Study|Lost to Follow-up|1|||
164299139|NCT03137381|593471244|FG002|Overall Study|Lost to Follow-up|1|||
164299140|NCT03137381|593471245|FG003|Overall Study|Lost to Follow-up|0|||
164299141|NCT03137381|593471242|FG000|Overall Study|Protocol deviation|1|||
164299142|NCT03137381|593471243|FG001|Overall Study|Protocol deviation|1|||
164299143|NCT03137381|593471244|FG002|Overall Study|Protocol deviation|0|||
164299144|NCT03137381|593471245|FG003|Overall Study|Protocol deviation|1|||
164299145|NCT03137381|593471242|FG000|Overall Study|Withdrawal by Investigator|0|||
164299146|NCT03137381|593471243|FG001|Overall Study|Withdrawal by Investigator|1|||
164299147|NCT03137381|593471244|FG002|Overall Study|Withdrawal by Investigator|1|||
164299148|NCT03137381|593471245|FG003|Overall Study|Withdrawal by Investigator|0|||
164299149|NCT03137381|593471242|FG000|Overall Study|Withdrawal by Subject|3|||
164299150|NCT03137381|593471243|FG001|Overall Study|Withdrawal by Subject|4|||
164299151|NCT03137381|593471244|FG002|Overall Study|Withdrawal by Subject|3|||
164299152|NCT03137381|593471245|FG003|Overall Study|Withdrawal by Subject|0|||
164299153|NCT03137381|593471242|FG000|Overall Study|Pregnancy|0|||
164299154|NCT03137381|593471243|FG001|Overall Study|Pregnancy|0|||
164299155|NCT03137381|593471244|FG002|Overall Study|Pregnancy|1|||
164299156|NCT03137381|593471245|FG003|Overall Study|Pregnancy|0|||
164299157|NCT00459316|593471246|FG000|Steps 1 & 2|Other eligibility failure|1|||
164299158|NCT00459316|593471247|FG001|Steps 1 & 2|Other eligibility failure|1|||
164352913|NCT03978520|593664494|FG004|Overall Study|Other, not specified|2|||
164352914|NCT03978520|593664490|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
164352915|NCT03978520|593664491|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
164352916|NCT03978520|593664492|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
164352917|NCT03978520|593664493|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
164352918|NCT03978520|593664494|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
164352919|NCT02760069|593664495|FG000|Overall Study|Withdrawal by Subject|0|||
164352920|NCT02760069|593664496|FG001|Overall Study|Withdrawal by Subject|1|||
164352921|NCT02760069|593664497|FG002|Overall Study|Withdrawal by Subject|1|||
164352922|NCT00600483|593664500|FG000|Overall Study|Lost to Follow-up|26|||
164352923|NCT00600483|593664501|FG001|Overall Study|Lost to Follow-up|47|||
164352924|NCT00600483|593664500|FG000|Overall Study|Randomized but not treated|10|||
164352925|NCT00600483|593664501|FG001|Overall Study|Randomized but not treated|0|||
164352926|NCT03031678|593664507|FG000|Overall Study|Study closed prior to completion|1|||
164352927|NCT03694821|593664508|FG000|Overall Study|Study terminated|4|||
164352928|NCT03694821|593664509|FG001|Overall Study|Study terminated|8|||
164352929|NCT03694821|593664510|FG002|Overall Study|Study terminated|4|||
164352930|NCT05109442|593664515|FG000|Overall Study|Withdrawal by Subject|0|||
164352931|NCT05109442|593664516|FG001|Overall Study|Withdrawal by Subject|0|||
164352932|NCT05109442|593664517|FG002|Overall Study|Withdrawal by Subject|1|||
164352933|NCT05109442|593664518|FG003|Overall Study|Withdrawal by Subject|0|||
164352934|NCT05109442|593664519|FG004|Overall Study|Withdrawal by Subject|0|||
164352935|NCT05109442|593664520|FG005|Overall Study|Withdrawal by Subject|0|||
164352936|NCT05109442|593664515|FG000|Overall Study|Adverse Event|0|||
164352937|NCT05109442|593664516|FG001|Overall Study|Adverse Event|1|||
164352938|NCT05109442|593664517|FG002|Overall Study|Adverse Event|5|||
164352939|NCT05109442|593664518|FG003|Overall Study|Adverse Event|0|||
164352940|NCT05109442|593664519|FG004|Overall Study|Adverse Event|0|||
164352941|NCT05109442|593664520|FG005|Overall Study|Adverse Event|2|||
164352942|NCT05109442|593664515|FG000|Overall Study|Death|0|||
164352943|NCT05109442|593664516|FG001|Overall Study|Death|0|||
164352944|NCT05109442|593664517|FG002|Overall Study|Death|4|||
164352945|NCT05109442|593664518|FG003|Overall Study|Death|0|||
164352946|NCT05109442|593664519|FG004|Overall Study|Death|0|||
164352947|NCT05109442|593664520|FG005|Overall Study|Death|1|||
164352948|NCT05109442|593664515|FG000|Overall Study|Physician Decision|1|||
164352949|NCT05109442|593664516|FG001|Overall Study|Physician Decision|0|||
164352950|NCT05109442|593664517|FG002|Overall Study|Physician Decision|1|||
164352951|NCT05109442|593664518|FG003|Overall Study|Physician Decision|0|||
164352952|NCT05109442|593664519|FG004|Overall Study|Physician Decision|0|||
164352953|NCT05109442|593664520|FG005|Overall Study|Physician Decision|2|||
164352954|NCT05109442|593664515|FG000|Overall Study|Other than listed|0|||
164352955|NCT05109442|593664516|FG001|Overall Study|Other than listed|0|||
164352956|NCT05109442|593664517|FG002|Overall Study|Other than listed|9|||
164352957|NCT05109442|593664518|FG003|Overall Study|Other than listed|2|||
164352958|NCT05109442|593664519|FG004|Overall Study|Other than listed|0|||
164352959|NCT05109442|593664520|FG005|Overall Study|Other than listed|8|||
164352960|NCT05109442|593664515|FG000|Overall Study|Lack of Efficacy|3|||
164352961|NCT05109442|593664516|FG001|Overall Study|Lack of Efficacy|5|||
164352962|NCT05109442|593664517|FG002|Overall Study|Lack of Efficacy|29|||
164352963|NCT05109442|593664518|FG003|Overall Study|Lack of Efficacy|10|||
164352964|NCT05109442|593664519|FG004|Overall Study|Lack of Efficacy|11|||
164352965|NCT05109442|593664520|FG005|Overall Study|Lack of Efficacy|17|||
164352966|NCT03278613|593664526|FG000|Overall Study|Lost to Follow-up|3|||
164352967|NCT03278613|593664527|FG001|Overall Study|Lost to Follow-up|1|||
164352968|NCT01405456|593664528|FG000|Overall Study|Lost to Follow-up|2|||
164352969|NCT01405456|593664529|FG001|Overall Study|Lost to Follow-up|1|||
164352970|NCT01405456|593664528|FG000|Overall Study|Physician Decision|1|||
164352971|NCT01405456|593664529|FG001|Overall Study|Physician Decision|0|||
164352972|NCT05475236|593664531|FG000|Overall Study|Withdrawal by Subject|0|||
164352973|NCT05475236|593664532|FG001|Overall Study|Withdrawal by Subject|1|||
164352974|NCT05355805|593664535|FG000|Overall Study|Lost to Follow-up|6|||
164352975|NCT05355805|593664536|FG001|Overall Study|Lost to Follow-up|11|||
164352976|NCT05355805|593664537|FG002|Overall Study|Lost to Follow-up|10|||
164352977|NCT05355805|593664538|FG003|Overall Study|Lost to Follow-up|6|||
164352978|NCT05355805|593664535|FG000|Overall Study|Decision by Sponsor|0|||
164352979|NCT05355805|593664536|FG001|Overall Study|Decision by Sponsor|0|||
164352980|NCT05355805|593664537|FG002|Overall Study|Decision by Sponsor|1|||
164352981|NCT05355805|593664538|FG003|Overall Study|Decision by Sponsor|0|||
164352982|NCT05355805|593664535|FG000|Overall Study|Withdrawal by Subject|7|||
164352983|NCT05355805|593664536|FG001|Overall Study|Withdrawal by Subject|14|||
164352984|NCT05355805|593664537|FG002|Overall Study|Withdrawal by Subject|15|||
164352985|NCT05355805|593664538|FG003|Overall Study|Withdrawal by Subject|13|||
164352986|NCT02692716|593666565|FG000|Overall Study|Lost to Follow-up|2|||
164352987|NCT02692716|593666566|FG001|Overall Study|Lost to Follow-up|5|||
164352988|NCT02692716|593666565|FG000|Overall Study|Withdrawal by Subject|3|||
164352989|NCT02692716|593666566|FG001|Overall Study|Withdrawal by Subject|1|||
164352990|NCT02904512|593666576|FG000|Overall Study|Withdrawal by Subject|1|||
164352991|NCT02904512|593666577|FG001|Overall Study|Withdrawal by Subject|0|||
164352992|NCT02904512|593666576|FG000|Overall Study|Transferred to ICU|1|||
164352993|NCT02904512|593666577|FG001|Overall Study|Transferred to ICU|0|||
164352994|NCT02904512|593666576|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
164352995|NCT02904512|593666577|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
164352996|NCT01963403|593666584|FG000|Overall Study|Lost to Follow-up|2|||
164352997|NCT01963403|593666585|FG001|Overall Study|Lost to Follow-up|3|||
164352998|NCT01963403|593666584|FG000|Overall Study|Implant removal|0|||
164352999|NCT01963403|593666585|FG001|Overall Study|Implant removal|1|||
164353000|NCT03585504|593666586|FG000|Overall Study|Lost to Follow-up|26|||
164353001|NCT03585504|593666587|FG001|Overall Study|Lost to Follow-up|29|||
164353002|NCT02564042|593666588|FG000|Overall Study|Adverse Event|4|||
164353003|NCT02564042|593666589|FG001|Overall Study|Adverse Event|4|||
164353004|NCT02564042|593666590|FG002|Overall Study|Adverse Event|3|||
164353005|NCT02564042|593666591|FG003|Overall Study|Adverse Event|0|||
164353006|NCT02564042|593666592|FG004|Overall Study|Adverse Event|0|||
164353007|NCT02564042|593666593|FG005|Overall Study|Adverse Event|1|||
164353008|NCT02564042|593666588|FG000|Overall Study|Lost to Follow-up|1|||
164353009|NCT02564042|593666589|FG001|Overall Study|Lost to Follow-up|1|||
164353010|NCT02564042|593666590|FG002|Overall Study|Lost to Follow-up|1|||
164353011|NCT02564042|593666591|FG003|Overall Study|Lost to Follow-up|0|||
164353012|NCT02564042|593666592|FG004|Overall Study|Lost to Follow-up|1|||
164353013|NCT02564042|593666593|FG005|Overall Study|Lost to Follow-up|1|||
164353014|NCT02564042|593666588|FG000|Overall Study|Physician Decision|1|||
164353015|NCT02564042|593666589|FG001|Overall Study|Physician Decision|0|||
164353016|NCT02564042|593666590|FG002|Overall Study|Physician Decision|0|||
164353017|NCT02564042|593666591|FG003|Overall Study|Physician Decision|1|||
164353018|NCT02564042|593666592|FG004|Overall Study|Physician Decision|0|||
164353019|NCT02564042|593666593|FG005|Overall Study|Physician Decision|0|||
164353020|NCT02564042|593666588|FG000|Overall Study|Withdrawal by Subject|5|||
164353021|NCT02564042|593666589|FG001|Overall Study|Withdrawal by Subject|3|||
164353022|NCT02564042|593666590|FG002|Overall Study|Withdrawal by Subject|2|||
164353023|NCT02564042|593666591|FG003|Overall Study|Withdrawal by Subject|2|||
164353024|NCT02564042|593666592|FG004|Overall Study|Withdrawal by Subject|10|||
164353025|NCT02564042|593666593|FG005|Overall Study|Withdrawal by Subject|12|||
164353026|NCT01356966|593666594|FG000|Overall Study|Withdrawal by Subject|1|||
164353027|NCT01356966|593666595|FG001|Overall Study|Withdrawal by Subject|2|||
164353028|NCT01356966|593666594|FG000|Overall Study|Physician Decision|1|||
164353029|NCT01356966|593666595|FG001|Overall Study|Physician Decision|0|||
164353030|NCT02743806|593666596|FG000|Overall Study|Adverse Event|9|||
164353031|NCT02743806|593666596|FG000|Overall Study|Lost to Follow-up|8|||
164353032|NCT02743806|593666596|FG000|Overall Study|Voluntary Withdrawal|54|||
164353033|NCT02743806|593666596|FG000|Overall Study|Study Termination|65|||
164353034|NCT02743806|593666596|FG000|Overall Study|Pregnancy|6|||
164353035|NCT02743806|593666596|FG000|Overall Study|No Longer Clinically Benefiting|27|||
164353036|NCT02743806|593666596|FG000|Overall Study|Reason Not Specified|12|||
164353037|NCT00849381|593666598|FG000|Overall Study|Adverse Event|1|||
164353038|NCT00849381|593666598|FG000|Overall Study|Lost to Follow-up|129|||
164353039|NCT00849381|593666598|FG000|Overall Study|Protocol Violation|5|||
164353040|NCT00849381|593666598|FG000|Overall Study|Withdrawal by Subject|6|||
164353041|NCT00849381|593666598|FG000|Overall Study|Other|4|||
164353042|NCT04429061|593666604|FG000|Overall Study|Lost to Follow-up|62|||
164353043|NCT04429061|593666605|FG001|Overall Study|Lost to Follow-up|87|||
164353044|NCT04429061|593666604|FG000|Overall Study|Withdrawal by Subject|3|||
164353045|NCT04429061|593666605|FG001|Overall Study|Withdrawal by Subject|4|||
164353046|NCT02085785|593666606|FG000|Overall Study|Withdrawal by Subject|2|||
164353047|NCT02085785|593666607|FG001|Overall Study|Withdrawal by Subject|1|||
164353048|NCT02085785|593666606|FG000|Overall Study|Lost to Follow-up|0|||
164353049|NCT02085785|593666607|FG001|Overall Study|Lost to Follow-up|1|||
164353050|NCT03590041|593666608|FG000|Overall Study|Protocol Violation|4|||
164353051|NCT03590041|593666609|FG001|Overall Study|Protocol Violation|3|||
164353052|NCT03590041|593666608|FG000|Overall Study|No session data recorded|14|||
164353053|NCT03590041|593666609|FG001|Overall Study|No session data recorded|2|||
164353054|NCT02692703|593666610|FG000|Overall Study|Lost to Follow-up|1|||
164353055|NCT02692703|593666610|FG000|Overall Study|Other|1|||
164353056|NCT04118166|593666611|FG000|Overall Study|Adverse Event|1|||
164353057|NCT03519932|593666612|FG000|First Intervention|Adverse Event|1|||
164353058|NCT03519932|593666613|FG001|First Intervention|Adverse Event|3|||
164353059|NCT02254486|593666614|FG000|Overall Study|Adverse Event|1|||
164588078|NCT03504774|594517482|FG000|Overall Study|failed wk 52 DBPCFC|1|||
164588079|NCT03504774|594517483|FG001|Overall Study|failed wk 52 DBPCFC|0|||
164588080|NCT00625365|594517486|FG000|Overall Study|Withdrawal by Subject|1|||
164588081|NCT00625365|594517486|FG000|Overall Study|No IV access|5|||
164588082|NCT00625365|594517486|FG000|Overall Study|VSD|1|||
164588083|NCT01781429|594517487|FG000|Overall Study|Death|0|||
164588084|NCT01781429|594517488|FG001|Overall Study|Death|0|||
164588085|NCT01781429|594517489|FG002|Overall Study|Death|0|||
164588086|NCT01781429|594517490|FG003|Overall Study|Death|0|||
164588087|NCT01781429|594517491|FG004|Overall Study|Death|0|||
164588088|NCT01781429|594517492|FG005|Overall Study|Death|0|||
164588089|NCT01781429|594517493|FG006|Overall Study|Death|0|||
164588090|NCT01781429|594517494|FG007|Overall Study|Death|0|||
164588091|NCT01781429|594517495|FG008|Overall Study|Death|0|||
164588092|NCT01781429|594517496|FG009|Overall Study|Death|1|||
164588093|NCT01781429|594517497|FG010|Overall Study|Death|0|||
164588094|NCT01781429|594517498|FG011|Overall Study|Death|0|||
164588095|NCT01781429|594517499|FG012|Overall Study|Death|1|||
164588096|NCT01781429|594517500|FG013|Overall Study|Death|0|||
164588097|NCT01781429|594517501|FG014|Overall Study|Death|1|||
164588098|NCT01781429|594517502|FG015|Overall Study|Death|0|||
164588099|NCT01781429|594517487|FG000|Overall Study|Withdrawal by Subject|0|||
164588100|NCT01781429|594517488|FG001|Overall Study|Withdrawal by Subject|0|||
164588101|NCT01781429|594517489|FG002|Overall Study|Withdrawal by Subject|0|||
164588102|NCT01781429|594517490|FG003|Overall Study|Withdrawal by Subject|0|||
164588103|NCT01781429|594517491|FG004|Overall Study|Withdrawal by Subject|0|||
164588104|NCT01781429|594517492|FG005|Overall Study|Withdrawal by Subject|0|||
164588105|NCT01781429|594517493|FG006|Overall Study|Withdrawal by Subject|0|||
164588106|NCT01781429|594517494|FG007|Overall Study|Withdrawal by Subject|0|||
164588107|NCT01781429|594517495|FG008|Overall Study|Withdrawal by Subject|1|||
164588108|NCT01781429|594517496|FG009|Overall Study|Withdrawal by Subject|3|||
164588109|NCT01781429|594517497|FG010|Overall Study|Withdrawal by Subject|1|||
164588110|NCT01781429|594517498|FG011|Overall Study|Withdrawal by Subject|1|||
164588111|NCT01781429|594517499|FG012|Overall Study|Withdrawal by Subject|5|||
164588112|NCT01781429|594517500|FG013|Overall Study|Withdrawal by Subject|2|||
164588113|NCT01781429|594517501|FG014|Overall Study|Withdrawal by Subject|3|||
164353060|NCT02254486|593666615|FG001|Overall Study|Adverse Event|1|||
164353061|NCT02254486|593666614|FG000|Overall Study|Lack of Efficacy|1|||
164353062|NCT02254486|593666615|FG001|Overall Study|Lack of Efficacy|0|||
164353063|NCT02254486|593666614|FG000|Overall Study|Lost to Follow-up|2|||
164353064|NCT02254486|593666615|FG001|Overall Study|Lost to Follow-up|4|||
164353065|NCT02254486|593666614|FG000|Overall Study|Protocol Violation|1|||
164353066|NCT02254486|593666615|FG001|Overall Study|Protocol Violation|2|||
164353067|NCT02254486|593666614|FG000|Overall Study|Withdrawal by Subject|17|||
164353068|NCT02254486|593666615|FG001|Overall Study|Withdrawal by Subject|15|||
164353069|NCT02254486|593666614|FG000|Overall Study|GFR<60mL/min|16|||
164353070|NCT02254486|593666615|FG001|Overall Study|GFR<60mL/min|21|||
164353071|NCT02254486|593666614|FG000|Overall Study|Various|12|||
164353072|NCT02254486|593666615|FG001|Overall Study|Various|12|||
164353073|NCT01350414|593666616|FG000|Overall Study|Lost to Follow-up|13|||
164353074|NCT01350414|593666616|FG000|Overall Study|Withdrawal by Subject|4|||
164353075|NCT01350414|593666616|FG000|Overall Study|Physician Decision|2|||
164353076|NCT00267046|593666622|FG000|Overall Study|Disease progression|4|||
164353077|NCT00267046|593666623|FG001|Overall Study|Disease progression|2|||
164353078|NCT00267046|593666622|FG000|Overall Study|Chemotoxicity|2|||
164353079|NCT00267046|593666623|FG001|Overall Study|Chemotoxicity|0|||
164353080|NCT00267046|593666622|FG000|Overall Study|Open-label palifermin|2|||
164353081|NCT00267046|593666623|FG001|Overall Study|Open-label palifermin|7|||
164353082|NCT00267046|593666622|FG000|Overall Study|Surgery|3|||
164353083|NCT00267046|593666623|FG001|Overall Study|Surgery|1|||
164353084|NCT00267046|593666622|FG000|Overall Study|Withdrawal by Subject|1|||
164353085|NCT00267046|593666623|FG001|Overall Study|Withdrawal by Subject|0|||
164353086|NCT00267046|593666622|FG000|Overall Study|Radiation|0|||
164353087|NCT00267046|593666623|FG001|Overall Study|Radiation|1|||
164353088|NCT00103142|593666624|FG000|Overall Study|Adverse Event|1|||
164353089|NCT00103142|593666625|FG001|Overall Study|Adverse Event|0|||
164588114|NCT01781429|594517502|FG015|Overall Study|Withdrawal by Subject|0|||
164588115|NCT01781429|594517487|FG000|Overall Study|Disease Progression|1|||
164588116|NCT01781429|594517488|FG001|Overall Study|Disease Progression|0|||
164588117|NCT01781429|594517489|FG002|Overall Study|Disease Progression|1|||
164588118|NCT01781429|594517490|FG003|Overall Study|Disease Progression|1|||
164693863|NCT00892281|594901194|FG001|Overall Study|Subject missed several visits/lost meds|0|||
164353090|NCT00103142|593666624|FG000|Overall Study|Progression of disease|2|||
164588119|NCT01781429|594517491|FG004|Overall Study|Disease Progression|1|||
164588120|NCT01781429|594517492|FG005|Overall Study|Disease Progression|4|||
164588121|NCT01781429|594517493|FG006|Overall Study|Disease Progression|7|||
164588122|NCT01781429|594517494|FG007|Overall Study|Disease Progression|4|||
164353091|NCT00103142|593666625|FG001|Overall Study|Progression of disease|1|||
164588123|NCT01781429|594517495|FG008|Overall Study|Disease Progression|6|||
164588124|NCT01781429|594517496|FG009|Overall Study|Disease Progression|15|||
164588125|NCT01781429|594517497|FG010|Overall Study|Disease Progression|15|||
164353092|NCT02772081|593666626|FG000|Overall Study|Physician Decision|1|||
164353093|NCT02772081|593666627|FG001|Overall Study|Physician Decision|1|||
164353094|NCT02772081|593666626|FG000|Overall Study|Death|1|||
164353095|NCT02772081|593666627|FG001|Overall Study|Death|1|||
164353096|NCT01979016|593666637|FG000|Overall Study|Withdrawal by Subject|2|||
164353097|NCT01979016|593666638|FG001|Overall Study|Withdrawal by Subject|0|||
164353098|NCT01979016|593666637|FG000|Overall Study|Adverse Event|0|||
164353099|NCT01979016|593666638|FG001|Overall Study|Adverse Event|1|||
164353100|NCT01985867|593666639|FG000|Overall Study|Lost to Follow-up|3|||
164353101|NCT01985867|593666640|FG001|Overall Study|Lost to Follow-up|4|||
164353102|NCT01985867|593666639|FG000|Overall Study|Adverse Event|3|||
164353103|NCT01985867|593666640|FG001|Overall Study|Adverse Event|2|||
164353104|NCT01985867|593666639|FG000|Overall Study|Lack of Efficacy|1|||
164353105|NCT01985867|593666640|FG001|Overall Study|Lack of Efficacy|0|||
164436588|NCT02957539|593964962|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
164436589|NCT02957539|593964963|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
164436590|NCT02957539|593964964|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
164436591|NCT02957539|593964962|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
164436592|NCT02957539|593964963|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
164436593|NCT02957539|593964964|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
164436594|NCT01833832|593964965|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
164436595|NCT01156116|593964966|FG000|Overall Study|Withdrawal by Subject|3|||
164436596|NCT01156116|593964967|FG001|Overall Study|Withdrawal by Subject|1|||
164436597|NCT01156116|593964966|FG000|Overall Study|CPAP intolerance|2|||
164436598|NCT01156116|593964967|FG001|Overall Study|CPAP intolerance|0|||
164436599|NCT02057718|593964968|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
164436600|NCT02057718|593964969|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
164436601|NCT02057718|593964968|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
164436602|NCT02057718|593964969|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
164436603|NCT02057718|593964968|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
164436604|NCT02057718|593964969|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
164436605|NCT02057718|593964968|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
164436606|NCT02057718|593964969|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
164436607|NCT02057718|593964968|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
164693864|NCT00892281|594901193|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
164693865|NCT00892281|594901194|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
164693866|NCT00892281|594901193|FG000|Overall Study|Scheduled for knee replacement|0|||
164299159|NCT00459316|593471248|FG002|Steps 1 & 2|Other eligibility failure|0|||
164299160|NCT00459316|593471246|FG000|Steps 1 & 2|Death|1|||
164299161|NCT00459316|593471247|FG001|Steps 1 & 2|Death|1|||
164299162|NCT00459316|593471248|FG002|Steps 1 & 2|Death|0|||
164299163|NCT00459316|593471246|FG000|Steps 1 & 2|Not able to get to clinic|7|||
164299164|NCT00459316|593471247|FG001|Steps 1 & 2|Not able to get to clinic|4|||
164299165|NCT00459316|593471248|FG002|Steps 1 & 2|Not able to get to clinic|0|||
164299166|NCT00459316|593471246|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
164299167|NCT00459316|593471247|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
164299168|NCT00459316|593471248|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
164299169|NCT00459316|593471246|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
164299170|NCT00459316|593471247|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
164299171|NCT00459316|593471248|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
164299172|NCT00459316|593471246|FG000|Steps 1 & 2|Lost to Follow-up|5|||
164299173|NCT00459316|593471247|FG001|Steps 1 & 2|Lost to Follow-up|0|||
164299174|NCT00459316|593471248|FG002|Steps 1 & 2|Lost to Follow-up|2|||
164299175|NCT00459316|593471246|FG000|Step 3|Withdrawal by Subject|3|||
164299176|NCT00459316|593471247|FG001|Step 3|Withdrawal by Subject|0|||
164299177|NCT00459316|593471248|FG002|Step 3|Withdrawal by Subject|1|||
164299178|NCT01614886|593471249|FG000|Overall Study|Adverse Event|15|||
164299179|NCT01614886|593471250|FG001|Overall Study|Adverse Event|20|||
164299180|NCT01614886|593471249|FG000|Overall Study|Withdrawal by Subject|4|||
164299181|NCT01614886|593471250|FG001|Overall Study|Withdrawal by Subject|4|||
164299182|NCT01614886|593471249|FG000|Overall Study|Death|1|||
164299183|NCT01614886|593471250|FG001|Overall Study|Death|0|||
164299184|NCT01614886|593471249|FG000|Overall Study|Protocol deviation|0|||
164299185|NCT01614886|593471250|FG001|Overall Study|Protocol deviation|2|||
164299186|NCT03379818|593471253|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
164299187|NCT03379818|593471254|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
164299188|NCT03379818|593471253|FG000|Overall Study|Withdrawal by Subject|2|||
164299189|NCT03379818|593471254|FG001|Overall Study|Withdrawal by Subject|3|||
164299190|NCT03379818|593471253|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
164299191|NCT03379818|593471254|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
164299192|NCT00423579|593471255|FG000|Overall Study|Lost to Follow-up|3|||
164299193|NCT00423579|593471256|FG001|Overall Study|Lost to Follow-up|0|||
164299194|NCT00423579|593471255|FG000|Overall Study|Protocol Violation|1|||
164299195|NCT00423579|593471256|FG001|Overall Study|Protocol Violation|3|||
164353106|NCT01465997|593666641|FG000|Overall Study|Adverse Event|12|||
164353107|NCT01465997|593666642|FG001|Overall Study|Adverse Event|22|||
164353108|NCT01465997|593666641|FG000|Overall Study|Lack of Efficacy|13|||
164436608|NCT02057718|593964969|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
164436609|NCT02057718|593964968|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
164353109|NCT01465997|593666642|FG001|Overall Study|Lack of Efficacy|1|||
164353110|NCT01465997|593666641|FG000|Overall Study|Protocol Violation|1|||
164353111|NCT01465997|593666642|FG001|Overall Study|Protocol Violation|4|||
164353112|NCT01465997|593666641|FG000|Overall Study|Lost to Follow-up|6|||
164353113|NCT01465997|593666642|FG001|Overall Study|Lost to Follow-up|9|||
164353114|NCT01465997|593666641|FG000|Overall Study|Withdrawal by Subject|32|||
164353115|NCT01465997|593666642|FG001|Overall Study|Withdrawal by Subject|35|||
164353116|NCT01465997|593666641|FG000|Overall Study|investigator's decision|1|||
164353117|NCT01465997|593666642|FG001|Overall Study|investigator's decision|1|||
164353118|NCT01465997|593666641|FG000|Overall Study|Death|0|||
164353119|NCT01465997|593666642|FG001|Overall Study|Death|1|||
164353120|NCT01465997|593666641|FG000|Overall Study|sponsor's decision|1|||
164353121|NCT01465997|593666642|FG001|Overall Study|sponsor's decision|1|||
164353122|NCT01465997|593666641|FG000|Overall Study|subject withdrew consent|1|||
164353123|NCT01465997|593666642|FG001|Overall Study|subject withdrew consent|0|||
164353124|NCT01465997|593666641|FG000|Overall Study|local lab unblinded site|1|||
164353125|NCT01465997|593666642|FG001|Overall Study|local lab unblinded site|0|||
164353126|NCT01465997|593666641|FG000|Overall Study|withdrew before follow-up|0|||
164353127|NCT01465997|593666642|FG001|Overall Study|withdrew before follow-up|13|||
164353128|NCT01465997|593666641|FG000|Overall Study|decision by site staff|0|||
164436610|NCT02057718|593964969|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
164436611|NCT02057718|593964968|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
164436612|NCT02057718|593964969|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
164436613|NCT02057718|593964968|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
164436614|NCT02057718|593964969|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
164436615|NCT02057718|593964968|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
164436616|NCT02057718|593964969|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
164436617|NCT02057718|593964968|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
164436618|NCT02057718|593964969|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
164436619|NCT02057718|593964968|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
164353129|NCT01465997|593666642|FG001|Overall Study|decision by site staff|1|||
164353130|NCT01465997|593666641|FG000|Overall Study|subject left participation SP0993|0|||
164353131|NCT01465997|593666642|FG001|Overall Study|subject left participation SP0993|1|||
164353132|NCT02205814|593666643|FG000|Overall Study|Lost to Follow-up|0|||
164353133|NCT02205814|593666644|FG001|Overall Study|Lost to Follow-up|0|||
164353134|NCT02205814|593666645|FG002|Overall Study|Lost to Follow-up|0|||
164436620|NCT02057718|593964969|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
164436621|NCT00217672|593964970|FG000|Allocation|Ineligible|2|||
164436622|NCT00217672|593964971|FG001|Allocation|Ineligible|0|||
164436623|NCT00217672|593964970|FG000|Treatment|disease progression|33|||
164436624|NCT00217672|593964971|FG001|Treatment|disease progression|4|||
164436625|NCT00217672|593964970|FG000|Treatment|Adverse Event|18|||
164436626|NCT00217672|593964971|FG001|Treatment|Adverse Event|2|||
164436627|NCT00217672|593964970|FG000|Treatment|reqd treatment not permitted by protocol|6|||
164436628|NCT00217672|593964971|FG001|Treatment|reqd treatment not permitted by protocol|0|||
164436629|NCT00217672|593964970|FG000|Treatment|Physician Decision|6|||
164436630|NCT00217672|593964971|FG001|Treatment|Physician Decision|0|||
164436631|NCT00217672|593964970|FG000|Treatment|insurance issues|1|||
164436632|NCT00217672|593964971|FG001|Treatment|insurance issues|1|||
164353135|NCT02205814|593666646|FG003|Overall Study|Lost to Follow-up|1|||
164353136|NCT02205814|593666643|FG000|Overall Study|Lack of Efficacy|1|||
164353137|NCT02205814|593666644|FG001|Overall Study|Lack of Efficacy|0|||
164353138|NCT02205814|593666645|FG002|Overall Study|Lack of Efficacy|1|||
164353139|NCT02205814|593666646|FG003|Overall Study|Lack of Efficacy|1|||
164353140|NCT02205814|593666643|FG000|Overall Study|Physician Decision|0|||
164353141|NCT02205814|593666644|FG001|Overall Study|Physician Decision|0|||
164353142|NCT02205814|593666645|FG002|Overall Study|Physician Decision|1|||
164353143|NCT02205814|593666646|FG003|Overall Study|Physician Decision|0|||
164353144|NCT02205814|593666643|FG000|Overall Study|Protocol Violation|1|||
164353145|NCT02205814|593666644|FG001|Overall Study|Protocol Violation|0|||
164353146|NCT02205814|593666645|FG002|Overall Study|Protocol Violation|0|||
164353147|NCT02205814|593666646|FG003|Overall Study|Protocol Violation|1|||
164353148|NCT02205814|593666643|FG000|Overall Study|Withdrawal by Subject|0|||
164353149|NCT02205814|593666644|FG001|Overall Study|Withdrawal by Subject|1|||
164353150|NCT02205814|593666645|FG002|Overall Study|Withdrawal by Subject|2|||
164353151|NCT02205814|593666646|FG003|Overall Study|Withdrawal by Subject|1|||
164436633|NCT00217672|593964970|FG000|Treatment|Death|2|||
164436634|NCT00217672|593964971|FG001|Treatment|Death|0|||
164436635|NCT00217672|593964970|FG000|Treatment|secondary malignancy|1|||
164353152|NCT02205814|593666643|FG000|Overall Study|not compliant with study procedures|0|||
164353153|NCT02205814|593666644|FG001|Overall Study|not compliant with study procedures|0|||
164588126|NCT01781429|594517498|FG011|Overall Study|Disease Progression|15|||
164588127|NCT01781429|594517499|FG012|Overall Study|Disease Progression|15|||
164588128|NCT01781429|594517500|FG013|Overall Study|Disease Progression|4|||
164588129|NCT01781429|594517501|FG014|Overall Study|Disease Progression|11|||
164588130|NCT01781429|594517502|FG015|Overall Study|Disease Progression|0|||
164353154|NCT02205814|593666645|FG002|Overall Study|not compliant with study procedures|1|||
164353155|NCT02205814|593666646|FG003|Overall Study|not compliant with study procedures|0|||
164353156|NCT01426373|593666647|FG000|Overall Study|Adverse Event|6|||
164353157|NCT01426373|593666647|FG000|Overall Study|Lost to Follow-up|14|||
164353158|NCT01426373|593666647|FG000|Overall Study|Participant Convenience|10|||
164353159|NCT01426373|593666647|FG000|Overall Study|Miscellaneous Reasons|4|||
164353160|NCT00726661|593666650|FG000|Overall Study|Lost to Follow-up|36|||
164353161|NCT00726661|593666651|FG001|Overall Study|Lost to Follow-up|11|||
164588131|NCT01781429|594517487|FG000|Overall Study|Unacceptable Toxicity|0|||
164588132|NCT01781429|594517488|FG001|Overall Study|Unacceptable Toxicity|0|||
164588133|NCT01781429|594517489|FG002|Overall Study|Unacceptable Toxicity|0|||
164588134|NCT01781429|594517490|FG003|Overall Study|Unacceptable Toxicity|0|||
164588135|NCT01781429|594517491|FG004|Overall Study|Unacceptable Toxicity|0|||
164588136|NCT01781429|594517492|FG005|Overall Study|Unacceptable Toxicity|0|||
164588137|NCT01781429|594517493|FG006|Overall Study|Unacceptable Toxicity|0|||
164588138|NCT01781429|594517494|FG007|Overall Study|Unacceptable Toxicity|0|||
164588139|NCT01781429|594517495|FG008|Overall Study|Unacceptable Toxicity|0|||
164588140|NCT01781429|594517496|FG009|Overall Study|Unacceptable Toxicity|0|||
164588141|NCT01781429|594517497|FG010|Overall Study|Unacceptable Toxicity|0|||
164588142|NCT01781429|594517498|FG011|Overall Study|Unacceptable Toxicity|2|||
164588143|NCT01781429|594517499|FG012|Overall Study|Unacceptable Toxicity|0|||
164588144|NCT01781429|594517500|FG013|Overall Study|Unacceptable Toxicity|0|||
164588145|NCT01781429|594517501|FG014|Overall Study|Unacceptable Toxicity|0|||
164588146|NCT01781429|594517502|FG015|Overall Study|Unacceptable Toxicity|0|||
164588147|NCT01781429|594517487|FG000|Overall Study|Patient Condition Changed|0|||
164588148|NCT01781429|594517488|FG001|Overall Study|Patient Condition Changed|0|||
164588149|NCT01781429|594517489|FG002|Overall Study|Patient Condition Changed|0|||
164588150|NCT01781429|594517490|FG003|Overall Study|Patient Condition Changed|0|||
164353162|NCT00726661|593666650|FG000|Overall Study|Withdrawal by Subject|17|||
164353163|NCT00726661|593666651|FG001|Overall Study|Withdrawal by Subject|13|||
164588151|NCT01781429|594517491|FG004|Overall Study|Patient Condition Changed|0|||
164588152|NCT01781429|594517492|FG005|Overall Study|Patient Condition Changed|0|||
164588153|NCT01781429|594517493|FG006|Overall Study|Patient Condition Changed|0|||
164588154|NCT01781429|594517494|FG007|Overall Study|Patient Condition Changed|0|||
164353164|NCT00726661|593666650|FG000|Overall Study|Trial terminated by sponsor|214|||
164353165|NCT00726661|593666651|FG001|Overall Study|Trial terminated by sponsor|187|||
164353166|NCT00726661|593666650|FG000|Overall Study|Death|475|||
164353167|NCT00726661|593666651|FG001|Overall Study|Death|159|||
164353168|NCT00726661|593666650|FG000|Overall Study|Physician Decision|25|||
164353169|NCT00726661|593666651|FG001|Overall Study|Physician Decision|13|||
164353170|NCT00726661|593666650|FG000|Overall Study|Other|47|||
164353171|NCT00726661|593666651|FG001|Overall Study|Other|35|||
164353172|NCT02557646|593666654|FG000|Overall Study|Adverse Event|40|||
164353173|NCT02557646|593666654|FG000|Overall Study|Death|1|||
164353174|NCT02557646|593666654|FG000|Overall Study|Lack of Efficacy|186|||
164353175|NCT02557646|593666654|FG000|Overall Study|Withdrawal by Subject|18|||
164353176|NCT02557646|593666654|FG000|Overall Study|Lost to Follow-up|17|||
164353177|NCT02557646|593666654|FG000|Overall Study|Other|14|||
164353178|NCT00005937|593666660|FG000|Overall Study|Lack of Efficacy|5|||
164353179|NCT00160251|593666661|FG000|Prior to Amendment 2|Adverse Event|2|||
164353180|NCT00160251|593666662|FG001|Prior to Amendment 2|Adverse Event|1|||
164353181|NCT00160251|593666663|FG002|Prior to Amendment 2|Adverse Event|3|||
164353182|NCT00160251|593666664|FG003|Prior to Amendment 2|Adverse Event|1|||
164353183|NCT00160251|593666665|FG004|Prior to Amendment 2|Adverse Event|1|||
164353184|NCT00160251|593666666|FG005|Prior to Amendment 2|Adverse Event|1|||
164353185|NCT00160251|593666667|FG006|Prior to Amendment 2|Adverse Event|1|||
164353186|NCT00160251|593666668|FG007|Prior to Amendment 2|Adverse Event|0|||
164353187|NCT00160251|593666661|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
164353188|NCT00160251|593666662|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
164353189|NCT00160251|593666663|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
164353190|NCT00160251|593666664|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
164353191|NCT00160251|593666665|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
164353192|NCT00160251|593666666|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
164353193|NCT00160251|593666667|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
164588155|NCT01781429|594517495|FG008|Overall Study|Patient Condition Changed|0|||
164588156|NCT01781429|594517496|FG009|Overall Study|Patient Condition Changed|4|||
164588157|NCT01781429|594517497|FG010|Overall Study|Patient Condition Changed|0|||
164588158|NCT01781429|594517498|FG011|Overall Study|Patient Condition Changed|1|||
164588159|NCT01781429|594517499|FG012|Overall Study|Patient Condition Changed|0|||
164588160|NCT01781429|594517500|FG013|Overall Study|Patient Condition Changed|1|||
164588161|NCT01781429|594517501|FG014|Overall Study|Patient Condition Changed|0|||
164353194|NCT00160251|593666668|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
164588162|NCT01781429|594517502|FG015|Overall Study|Patient Condition Changed|0|||
164588163|NCT01781429|594517487|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
164588164|NCT01781429|594517488|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
164588165|NCT01781429|594517489|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
164588166|NCT01781429|594517490|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
164588167|NCT01781429|594517491|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
164588168|NCT01781429|594517492|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
164588169|NCT01781429|594517493|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
164588170|NCT01781429|594517494|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
164588171|NCT01781429|594517495|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
164588172|NCT01781429|594517496|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
164588173|NCT01781429|594517497|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
164588174|NCT01781429|594517498|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
164588175|NCT01781429|594517499|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
164588176|NCT01781429|594517500|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
164588177|NCT01781429|594517501|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
164588178|NCT01781429|594517502|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
164353195|NCT00160251|593666661|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
164353196|NCT00160251|593666662|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
164353197|NCT00160251|593666663|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
164353198|NCT00160251|593666664|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
164353199|NCT00160251|593666665|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
164353200|NCT00160251|593666666|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
164353201|NCT00160251|593666667|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
164353202|NCT00160251|593666668|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
164353203|NCT00160251|593666661|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
164353204|NCT00160251|593666662|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
164353205|NCT00160251|593666663|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
164353206|NCT00160251|593666664|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
164353207|NCT00160251|593666665|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
164353208|NCT00160251|593666666|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
164353209|NCT00160251|593666667|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
164353210|NCT00160251|593666668|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
164353211|NCT00160251|593666661|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
164353212|NCT00160251|593666662|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
164353213|NCT00160251|593666663|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
164353214|NCT00160251|593666664|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
164353215|NCT00160251|593666665|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
164353216|NCT00160251|593666666|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
164353217|NCT00160251|593666667|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
164353218|NCT00160251|593666668|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
164353219|NCT00160251|593666661|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
164353220|NCT00160251|593666662|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
164353221|NCT00160251|593666663|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
164353222|NCT00160251|593666664|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
164353223|NCT00160251|593666665|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
164353224|NCT00160251|593666666|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
164353225|NCT00160251|593666667|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
164353226|NCT00160251|593666668|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
164353227|NCT00160251|593666661|FG000|Post-amendment 2|Adverse Event|0|||
164353228|NCT00160251|593666662|FG001|Post-amendment 2|Adverse Event|0|||
164353229|NCT00160251|593666663|FG002|Post-amendment 2|Adverse Event|0|||
164353230|NCT00160251|593666664|FG003|Post-amendment 2|Adverse Event|0|||
164353231|NCT00160251|593666665|FG004|Post-amendment 2|Adverse Event|0|||
164353232|NCT00160251|593666666|FG005|Post-amendment 2|Adverse Event|0|||
164353233|NCT00160251|593666667|FG006|Post-amendment 2|Adverse Event|0|||
164353234|NCT00160251|593666668|FG007|Post-amendment 2|Adverse Event|20|||
164353235|NCT00160251|593666661|FG000|Post-amendment 2|Lack of Efficacy|0|||
164353236|NCT00160251|593666662|FG001|Post-amendment 2|Lack of Efficacy|0|||
164353237|NCT00160251|593666663|FG002|Post-amendment 2|Lack of Efficacy|0|||
164353238|NCT00160251|593666664|FG003|Post-amendment 2|Lack of Efficacy|0|||
164353239|NCT00160251|593666665|FG004|Post-amendment 2|Lack of Efficacy|0|||
164353240|NCT00160251|593666666|FG005|Post-amendment 2|Lack of Efficacy|0|||
164353241|NCT00160251|593666667|FG006|Post-amendment 2|Lack of Efficacy|0|||
164353242|NCT00160251|593666668|FG007|Post-amendment 2|Lack of Efficacy|24|||
164353243|NCT00160251|593666661|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
164588179|NCT01781429|594517487|FG000|Overall Study|Enrolled, but not treated|0|||
164588180|NCT01781429|594517488|FG001|Overall Study|Enrolled, but not treated|0|||
164588181|NCT01781429|594517489|FG002|Overall Study|Enrolled, but not treated|0|||
164353244|NCT00160251|593666662|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
164353245|NCT00160251|593666663|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
164353246|NCT00160251|593666664|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
164353247|NCT00160251|593666665|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
164353248|NCT00160251|593666666|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
164353249|NCT00160251|593666667|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
164353250|NCT00160251|593666668|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
164353251|NCT01288469|593666669|FG000|Overall Study|Adverse Event|4|||
164353252|NCT01288469|593666670|FG001|Overall Study|Adverse Event|1|||
164353253|NCT01288469|593666671|FG002|Overall Study|Adverse Event|1|||
164353254|NCT01288469|593666669|FG000|Overall Study|Poor compliance to protocol|0|||
164353255|NCT01288469|593666670|FG001|Overall Study|Poor compliance to protocol|1|||
164353256|NCT01288469|593666671|FG002|Overall Study|Poor compliance to protocol|0|||
164353257|NCT01288469|593666669|FG000|Overall Study|Participant Moved|1|||
164353258|NCT01288469|593666670|FG001|Overall Study|Participant Moved|0|||
164353259|NCT01288469|593666671|FG002|Overall Study|Participant Moved|0|||
164353260|NCT01288469|593666669|FG000|Overall Study|Consent withdrawn by subject|1|||
164353261|NCT01288469|593666670|FG001|Overall Study|Consent withdrawn by subject|1|||
164353262|NCT01288469|593666671|FG002|Overall Study|Consent withdrawn by subject|1|||
164353263|NCT01288469|593666669|FG000|Overall Study|Exclusion criteria finally met|1|||
164353264|NCT01288469|593666670|FG001|Overall Study|Exclusion criteria finally met|0|||
164353265|NCT01288469|593666671|FG002|Overall Study|Exclusion criteria finally met|0|||
164353266|NCT01574612|593666672|FG000|Overall Study|Adverse Event|3|||
164353267|NCT01574612|593666672|FG000|Overall Study|non compliant with drug|2|||
164353268|NCT01574612|593666672|FG000|Overall Study|Withdrawal by Subject|1|||
164353269|NCT01574612|593666672|FG000|Overall Study|Lost to Follow-up|2|||
164353270|NCT00582166|593666673|FG000|Overall Study|Death|1|||
164353271|NCT00582166|593666673|FG000|Overall Study|Ineligible pathology|1|||
164353272|NCT01606436|593666676|FG000|Overall Study|Withdrawal by Subject|0|||
164353273|NCT01606436|593666677|FG001|Overall Study|Withdrawal by Subject|0|||
164353274|NCT01606436|593666678|FG002|Overall Study|Withdrawal by Subject|1|||
164353275|NCT01606436|593666679|FG003|Overall Study|Withdrawal by Subject|1|||
164353276|NCT01606436|593666680|FG004|Overall Study|Withdrawal by Subject|1|||
164353277|NCT01606436|593666681|FG005|Overall Study|Withdrawal by Subject|0|||
164353278|NCT01606436|593666676|FG000|Overall Study|Adverse Event|0|||
164353279|NCT01606436|593666677|FG001|Overall Study|Adverse Event|0|||
164353280|NCT01606436|593666678|FG002|Overall Study|Adverse Event|1|||
164353281|NCT01606436|593666679|FG003|Overall Study|Adverse Event|0|||
164353282|NCT01606436|593666680|FG004|Overall Study|Adverse Event|0|||
164353283|NCT01606436|593666681|FG005|Overall Study|Adverse Event|0|||
164353284|NCT01606436|593666676|FG000|Overall Study|Sponsor Decision|0|||
164353285|NCT01606436|593666677|FG001|Overall Study|Sponsor Decision|0|||
164353286|NCT01606436|593666678|FG002|Overall Study|Sponsor Decision|0|||
164353287|NCT01606436|593666679|FG003|Overall Study|Sponsor Decision|1|||
164353288|NCT01606436|593666680|FG004|Overall Study|Sponsor Decision|0|||
164353289|NCT01606436|593666681|FG005|Overall Study|Sponsor Decision|0|||
164353290|NCT02859454|593666682|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
164353291|NCT00110149|593666683|FG000|Overall Study|Physician Decision|3|||
164353292|NCT02452398|593666688|FG000|Overall Study|Adverse Event|1|||
164353293|NCT02452398|593666688|FG000|Overall Study|Lost to Follow-up|28|||
164353294|NCT02452398|593666688|FG000|Overall Study|Physician Decision|2|||
164353295|NCT02452398|593666688|FG000|Overall Study|Withdrawal by Subject|6|||
164353296|NCT02452398|593666688|FG000|Overall Study|Moved away|4|||
164353297|NCT00748033|593666689|FG000|Overall Study|Adverse Event|0|||
164353298|NCT00748033|593666690|FG001|Overall Study|Adverse Event|1|||
164353299|NCT03334448|593666691|FG000|Washout|Personal Reason|0|||
164353300|NCT03334448|593666692|FG001|Washout|Personal Reason|1|||
164353301|NCT03334448|593666693|FG002|Washout|Personal Reason|0|||
164353302|NCT03334448|593666694|FG003|Washout|Personal Reason|0|||
164353303|NCT03334448|593666691|FG000|Washout|Protocol Violation|0|||
164353304|NCT03334448|593666692|FG001|Washout|Protocol Violation|0|||
164353305|NCT03334448|593666693|FG002|Washout|Protocol Violation|0|||
164353306|NCT03334448|593666694|FG003|Washout|Protocol Violation|1|||
164353307|NCT02326025|593666695|FG000|Overall Study|Adverse Event|3|||
164353308|NCT02326025|593666696|FG001|Overall Study|Adverse Event|0|||
164353309|NCT02326025|593666695|FG000|Overall Study|Physician Decision|1|||
164353310|NCT02326025|593666696|FG001|Overall Study|Physician Decision|2|||
164353311|NCT02326025|593666695|FG000|Overall Study|Physician and Participant Decision|1|||
164353312|NCT02326025|593666696|FG001|Overall Study|Physician and Participant Decision|0|||
164353313|NCT02326025|593666695|FG000|Overall Study|Withdrawal by Subject|0|||
164353314|NCT02326025|593666696|FG001|Overall Study|Withdrawal by Subject|2|||
164353315|NCT02326025|593666695|FG000|Overall Study|Protocol Violation|0|||
164353316|NCT02326025|593666696|FG001|Overall Study|Protocol Violation|1|||
164353317|NCT01365910|593666697|FG000|Overall Study|Withdrawal by Subject|7|||
164353318|NCT01365910|593666697|FG000|Overall Study|disease progression|18|||
164353319|NCT01365910|593666697|FG000|Overall Study|Adverse Event|3|||
164353320|NCT01365910|593666697|FG000|Overall Study|other complicating disease|1|||
164353321|NCT01365910|593666697|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
164588182|NCT01781429|594517490|FG003|Overall Study|Enrolled, but not treated|0|||
164588183|NCT01781429|594517491|FG004|Overall Study|Enrolled, but not treated|0|||
164588184|NCT01781429|594517492|FG005|Overall Study|Enrolled, but not treated|0|||
164588185|NCT01781429|594517493|FG006|Overall Study|Enrolled, but not treated|0|||
164588186|NCT01781429|594517494|FG007|Overall Study|Enrolled, but not treated|0|||
164588187|NCT01781429|594517495|FG008|Overall Study|Enrolled, but not treated|0|||
164588188|NCT01781429|594517496|FG009|Overall Study|Enrolled, but not treated|0|||
164588189|NCT01781429|594517497|FG010|Overall Study|Enrolled, but not treated|1|||
164588190|NCT01781429|594517498|FG011|Overall Study|Enrolled, but not treated|0|||
164588191|NCT01781429|594517499|FG012|Overall Study|Enrolled, but not treated|0|||
164588192|NCT01781429|594517500|FG013|Overall Study|Enrolled, but not treated|0|||
164588193|NCT01781429|594517501|FG014|Overall Study|Enrolled, but not treated|0|||
164588194|NCT01781429|594517502|FG015|Overall Study|Enrolled, but not treated|0|||
164588195|NCT03238248|594517503|FG000|Overall Study|Death|5|||
164353322|NCT02013791|593666698|FG000|Period 1|Lost to Follow-up|0|||
164353323|NCT02013791|593666699|FG001|Period 1|Lost to Follow-up|0|||
164353324|NCT02013791|593666700|FG002|Period 1|Lost to Follow-up|0|||
164353325|NCT02013791|593666701|FG003|Period 1|Lost to Follow-up|1|||
164588196|NCT03238248|594517503|FG000|Overall Study|Withdrawal by Subject|7|||
164588197|NCT03238248|594517503|FG000|Overall Study|Participant proceeding to transplant|10|||
164588198|NCT03238248|594517503|FG000|Overall Study|Lack of Efficacy|4|||
164353326|NCT02013791|593666702|FG004|Period 1|Lost to Follow-up|0|||
164353327|NCT02013791|593666703|FG005|Period 1|Lost to Follow-up|0|||
164353328|NCT02013791|593666704|FG006|Period 1|Lost to Follow-up|1|||
164353329|NCT02013791|593666705|FG007|Period 1|Lost to Follow-up|1|||
164353330|NCT02013791|593666706|FG008|Period 1|Lost to Follow-up|0|||
164353331|NCT02013791|593666698|FG000|Period 1|Other Miscellaneous Reasons|0|||
164353332|NCT02013791|593666699|FG001|Period 1|Other Miscellaneous Reasons|2|||
164353333|NCT02013791|593666700|FG002|Period 1|Other Miscellaneous Reasons|0|||
164588199|NCT03238248|594517503|FG000|Overall Study|Physician Decision|3|||
164353334|NCT02013791|593666701|FG003|Period 1|Other Miscellaneous Reasons|0|||
164353335|NCT02013791|593666702|FG004|Period 1|Other Miscellaneous Reasons|0|||
164353336|NCT02013791|593666703|FG005|Period 1|Other Miscellaneous Reasons|0|||
164353337|NCT02013791|593666704|FG006|Period 1|Other Miscellaneous Reasons|0|||
164353338|NCT02013791|593666705|FG007|Period 1|Other Miscellaneous Reasons|0|||
164353339|NCT02013791|593666706|FG008|Period 1|Other Miscellaneous Reasons|0|||
164353340|NCT03798483|593666707|FG000|Overall Study|Lost to Follow-up|2|||
164353341|NCT02643082|593666708|FG000|Period 1|Adverse Event|1|||
164353342|NCT02643082|593666709|FG001|Period 1|Adverse Event|0|||
164353343|NCT02289417|593666710|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
164353344|NCT02289417|593666711|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
164353345|NCT02289417|593666712|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
164353346|NCT02289417|593666713|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
164353347|NCT02289417|593666714|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
164353348|NCT02289417|593666715|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
164353349|NCT02289417|593666716|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
164353350|NCT02289417|593666717|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
164353351|NCT02289417|593666718|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
164353352|NCT02289417|593666710|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
164353353|NCT02289417|593666711|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
164353354|NCT02289417|593666712|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
164353355|NCT02289417|593666713|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
164353356|NCT02289417|593666714|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
164353357|NCT02289417|593666715|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
164353358|NCT02289417|593666716|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
164353359|NCT02289417|593666717|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
164353360|NCT02289417|593666718|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
164353361|NCT02289417|593666710|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
164353362|NCT02289417|593666711|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
164353363|NCT02289417|593666712|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
164353364|NCT02289417|593666713|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
164353365|NCT02289417|593666714|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
164353366|NCT02289417|593666715|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
164588200|NCT03238248|594517503|FG000|Overall Study|Transitioning to another study|1|||
164588201|NCT03238248|594517503|FG000|Overall Study|No longer benefiting|1|||
164588202|NCT03238248|594517503|FG000|Overall Study|Other complicating disease|1|||
164353367|NCT02289417|593666716|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
164353368|NCT02289417|593666717|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
164353369|NCT02289417|593666718|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
164588203|NCT03238248|594517503|FG000|Overall Study|Adverse Event|5|||
164588204|NCT03238248|594517503|FG000|Overall Study|Disease progression|26|||
164588205|NCT03238248|594517503|FG000|Overall Study|N/A participant is still on treatment|1|||
164588206|NCT03238248|594517503|FG000|Overall Study|Decline in condition|1|||
164353370|NCT02289417|593666710|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
164353371|NCT02289417|593666711|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
164353372|NCT02289417|593666712|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
164353373|NCT02289417|593666713|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
164353374|NCT02289417|593666714|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
164353375|NCT02289417|593666715|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
164353376|NCT02289417|593666716|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
164353377|NCT02289417|593666717|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
164353378|NCT02289417|593666718|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
164353379|NCT02289417|593666710|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
164353380|NCT02289417|593666711|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
164353381|NCT02289417|593666712|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
164353382|NCT02289417|593666713|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
164353383|NCT02289417|593666714|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
164353384|NCT02289417|593666715|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
164353385|NCT02289417|593666716|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
164353386|NCT02289417|593666717|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
164353387|NCT02289417|593666718|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
164353388|NCT02289417|593666710|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
164353389|NCT02289417|593666711|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
164353390|NCT02289417|593666712|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
164353391|NCT02289417|593666713|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
164353392|NCT02289417|593666714|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
164353393|NCT02289417|593666715|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
164353394|NCT02289417|593666716|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
164353395|NCT02289417|593666717|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
164353396|NCT02289417|593666718|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
164353397|NCT02289417|593666710|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
164353398|NCT02289417|593666711|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
164353399|NCT02289417|593666712|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
164353400|NCT02289417|593666713|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
164353401|NCT02289417|593666714|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
164353402|NCT02289417|593666715|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
164353403|NCT02289417|593666716|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
164353404|NCT02289417|593666717|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
164353405|NCT02289417|593666718|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
164353406|NCT02289417|593666710|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
164353407|NCT02289417|593666711|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
164353408|NCT02289417|593666712|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
164353409|NCT02289417|593666713|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
164353410|NCT02289417|593666714|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
164353411|NCT02289417|593666715|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
164353412|NCT02289417|593666716|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
164353413|NCT02289417|593666717|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
164353414|NCT02289417|593666718|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
164353415|NCT02289417|593666710|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
164353416|NCT02289417|593666711|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
164353417|NCT02289417|593666712|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
164353418|NCT02289417|593666713|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
164353419|NCT02289417|593666714|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
164353420|NCT02289417|593666715|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
164353421|NCT02289417|593666716|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
164353422|NCT02289417|593666717|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
164353423|NCT02289417|593666718|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
164353424|NCT02289417|593666710|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
164353425|NCT02289417|593666711|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
164353426|NCT02289417|593666712|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
164353427|NCT02289417|593666713|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
164353428|NCT02289417|593666714|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
164353429|NCT02289417|593666715|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
164353430|NCT02289417|593666716|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
164353431|NCT02289417|593666717|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
164353432|NCT02289417|593666718|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
164353433|NCT02289417|593666710|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
164436636|NCT00217672|593964971|FG001|Treatment|secondary malignancy|0|||
164353434|NCT02289417|593666711|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
164353435|NCT02289417|593666712|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
164353436|NCT02289417|593666713|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
164299196|NCT00423579|593471255|FG000|Overall Study|Diagnosis of diabetes|0|||
164299197|NCT00423579|593471256|FG001|Overall Study|Diagnosis of diabetes|1|||
164299198|NCT04004988|593471258|FG000|Period 1|Physician Decision|2|||
164299199|NCT04004988|593471259|FG001|Period 1|Physician Decision|0|||
164299200|NCT04004988|593471258|FG000|Period 1|Withdrawal by Subject|0|||
164299201|NCT04004988|593471259|FG001|Period 1|Withdrawal by Subject|1|||
164299202|NCT04004988|593471258|FG000|Period 1|Adverse Event|1|||
164299203|NCT04004988|593471259|FG001|Period 1|Adverse Event|2|||
164299204|NCT03873116|593471260|FG000|Part 1|Study drug discontinuation due to rash|0|||
164299205|NCT03873116|593471261|FG001|Part 1|Study drug discontinuation due to rash|0|||
164299206|NCT03873116|593471262|FG002|Part 1|Study drug discontinuation due to rash|0|||
164299207|NCT03873116|593471263|FG003|Part 1|Study drug discontinuation due to rash|0|||
164299208|NCT03873116|593471264|FG004|Part 1|Study drug discontinuation due to rash|0|||
164299209|NCT03873116|593471265|FG005|Part 1|Study drug discontinuation due to rash|1|||
164299210|NCT03873116|593471260|FG000|Part 2|Withdrawal by Subject|0|||
164299211|NCT03873116|593471261|FG001|Part 2|Withdrawal by Subject|0|||
164299212|NCT03873116|593471262|FG002|Part 2|Withdrawal by Subject|1|||
164299213|NCT03873116|593471263|FG003|Part 2|Withdrawal by Subject|0|||
164299214|NCT03873116|593471264|FG004|Part 2|Withdrawal by Subject|0|||
164299215|NCT03873116|593471265|FG005|Part 2|Withdrawal by Subject|0|||
164299216|NCT03873116|593471260|FG000|Part 2|Lab abnormality or AE|0|||
164299217|NCT03873116|593471261|FG001|Part 2|Lab abnormality or AE|0|||
164299218|NCT03873116|593471262|FG002|Part 2|Lab abnormality or AE|0|||
164299219|NCT03873116|593471263|FG003|Part 2|Lab abnormality or AE|0|||
164299220|NCT03873116|593471264|FG004|Part 2|Lab abnormality or AE|1|||
164299221|NCT03873116|593471265|FG005|Part 2|Lab abnormality or AE|0|||
164299222|NCT03873116|593471260|FG000|Part 3|Withdrawal by Subject|0|||
164299223|NCT03873116|593471261|FG001|Part 3|Withdrawal by Subject|0|||
164299224|NCT03873116|593471262|FG002|Part 3|Withdrawal by Subject|0|||
164299225|NCT03873116|593471263|FG003|Part 3|Withdrawal by Subject|0|||
164299226|NCT03873116|593471264|FG004|Part 3|Withdrawal by Subject|1|||
164299227|NCT03873116|593471265|FG005|Part 3|Withdrawal by Subject|0|||
164299228|NCT00003475|593471266|FG000|Overall Study|Not evaluable|13|||
164353437|NCT02289417|593666714|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
164353438|NCT02289417|593666715|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
164353439|NCT02289417|593666716|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
164353440|NCT02289417|593666717|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
164353441|NCT02289417|593666718|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
164353442|NCT02289417|593666710|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
164353443|NCT02289417|593666711|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
164353444|NCT02289417|593666712|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
164353445|NCT02289417|593666713|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
164353446|NCT02289417|593666714|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
164353447|NCT02289417|593666715|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
164353448|NCT02289417|593666716|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
164353449|NCT02289417|593666717|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
164353450|NCT02289417|593666718|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
164353451|NCT02289417|593666710|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
164353452|NCT02289417|593666711|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
164353453|NCT02289417|593666712|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
164353454|NCT02289417|593666713|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
164353455|NCT02289417|593666714|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
164353456|NCT02289417|593666715|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
164353457|NCT02289417|593666716|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
164353458|NCT02289417|593666717|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
164353459|NCT02289417|593666718|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
164353460|NCT02289417|593666710|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
164353461|NCT02289417|593666711|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
164353462|NCT02289417|593666712|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
164353463|NCT02289417|593666713|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
164353464|NCT02289417|593666714|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
164353465|NCT02289417|593666715|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
164353466|NCT02289417|593666716|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
164353467|NCT02289417|593666717|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
164353468|NCT02289417|593666718|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
164353469|NCT02725710|593666719|FG000|Overall Study|Lost to Follow-up|1|||
164353470|NCT02725710|593666720|FG001|Overall Study|Lost to Follow-up|0|||
164353471|NCT02505867|593666721|FG000|Overall Study|Lack of Efficacy|6|||
164353472|NCT02505867|593666722|FG001|Overall Study|Lack of Efficacy|6|||
164353473|NCT01782222|593666723|FG000|Overall Study|Adverse Event|4|||
164353474|NCT01782222|593666724|FG001|Overall Study|Adverse Event|5|||
164353475|NCT01782222|593666725|FG002|Overall Study|Adverse Event|3|||
164353476|NCT01782222|593666723|FG000|Overall Study|Lack of Efficacy|2|||
164353477|NCT01782222|593666724|FG001|Overall Study|Lack of Efficacy|1|||
164353478|NCT01782222|593666725|FG002|Overall Study|Lack of Efficacy|0|||
164353479|NCT01782222|593666723|FG000|Overall Study|Protocol Violation|1|||
164353480|NCT01782222|593666724|FG001|Overall Study|Protocol Violation|0|||
164353481|NCT01782222|593666725|FG002|Overall Study|Protocol Violation|0|||
164353482|NCT01782222|593666723|FG000|Overall Study|Withdrawal by Subject|1|||
164353483|NCT01782222|593666724|FG001|Overall Study|Withdrawal by Subject|4|||
164353484|NCT01782222|593666725|FG002|Overall Study|Withdrawal by Subject|1|||
164353485|NCT01782222|593666723|FG000|Overall Study|Moved to other state|0|||
164436637|NCT00217672|593964970|FG000|Follow-up|Withdrawal by Subject|4|||
164436638|NCT00217672|593964971|FG001|Follow-up|Withdrawal by Subject|0|||
164436639|NCT00217672|593964970|FG000|Follow-up|Lost to Follow-up|1|||
164436640|NCT00217672|593964971|FG001|Follow-up|Lost to Follow-up|0|||
164436641|NCT03781336|593964975|FG000|Overall Study|Withdrawal by Subject|2|||
164436642|NCT03781336|593964976|FG001|Overall Study|Withdrawal by Subject|2|||
164436643|NCT01972152|593964977|FG000|First Treatment Visit|Lost to Follow-up|0|||
164436644|NCT01972152|593964978|FG001|First Treatment Visit|Lost to Follow-up|1|||
164436645|NCT01972152|593964979|FG002|First Treatment Visit|Lost to Follow-up|0|||
164436646|NCT01972152|593964980|FG003|First Treatment Visit|Lost to Follow-up|0|||
164436647|NCT01972152|593964981|FG004|First Treatment Visit|Lost to Follow-up|0|||
164436648|NCT01972152|593964982|FG005|First Treatment Visit|Lost to Follow-up|0|||
164436649|NCT01972152|593964977|FG000|Second Treatment Visit|Protocol Violation|0|||
164353486|NCT01782222|593666724|FG001|Overall Study|Moved to other state|1|||
164353487|NCT01782222|593666725|FG002|Overall Study|Moved to other state|0|||
164353488|NCT03200860|593666726|FG000|Overall Study|Withdrawal by Subject|1|||
164353489|NCT03200860|593666727|FG001|Overall Study|Withdrawal by Subject|0|||
164436650|NCT01972152|593964978|FG001|Second Treatment Visit|Protocol Violation|1|||
164353490|NCT01605877|593666728|FG000|Overall Study|Withdrawal by Subject|1|||
164353491|NCT01918085|593666733|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
164353492|NCT01918085|593666734|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
164353493|NCT02634320|593666738|FG000|Overall Study|Adverse Event|2|||
164353494|NCT02634320|593666738|FG000|Overall Study|Lost to Follow-up|3|||
164353495|NCT02634320|593666738|FG000|Overall Study|Moved out of area|2|||
164353496|NCT02634320|593666738|FG000|Overall Study|Out of window for study visits|1|||
164353497|NCT02634320|593666738|FG000|Overall Study|Protocol Violation|1|||
164353498|NCT02634320|593666738|FG000|Overall Study|Withdrawal by Subject|5|||
164353499|NCT02634320|593666738|FG000|Overall Study|Lack of Efficacy|2|||
164353500|NCT00687323|593666739|FG000|Overall Study|Death|25|||
164353501|NCT00687323|593666739|FG000|Overall Study|Withdrawal by Subject|1|||
164353502|NCT00687323|593666739|FG000|Overall Study|Excluded from efficacy evaluations|6|||
164353503|NCT00687323|593666739|FG000|Overall Study|Screen failure|148|||
164353504|NCT03655691|593666747|FG000|Overall Study|Adverse Event|0|||
164353505|NCT03655691|593666748|FG001|Overall Study|Adverse Event|0|||
164353506|NCT03655691|593666749|FG002|Overall Study|Adverse Event|1|||
164353507|NCT03655691|593666747|FG000|Overall Study|Lost to Follow-up|1|||
164353508|NCT03655691|593666748|FG001|Overall Study|Lost to Follow-up|1|||
164353509|NCT03655691|593666749|FG002|Overall Study|Lost to Follow-up|2|||
164353510|NCT03655691|593666747|FG000|Overall Study|Protocol Violation|0|||
164353511|NCT03655691|593666748|FG001|Overall Study|Protocol Violation|1|||
164353512|NCT03655691|593666749|FG002|Overall Study|Protocol Violation|0|||
164353513|NCT03655691|593666747|FG000|Overall Study|Withdrawal by Subject|1|||
164353514|NCT03655691|593666748|FG001|Overall Study|Withdrawal by Subject|1|||
164353515|NCT03655691|593666749|FG002|Overall Study|Withdrawal by Subject|0|||
164353516|NCT04557371|593666750|FG000|Overall Study|Covid-19-related|0|||
164353517|NCT04557371|593666751|FG001|Overall Study|Covid-19-related|1|||
164353518|NCT04557371|593666752|FG002|Overall Study|Covid-19-related|0|||
164353519|NCT04557371|593666750|FG000|Overall Study|Withdrawal by Subject|0|||
164353520|NCT04557371|593666751|FG001|Overall Study|Withdrawal by Subject|1|||
164353521|NCT04557371|593666752|FG002|Overall Study|Withdrawal by Subject|0|||
164353522|NCT04557371|593666750|FG000|Overall Study|Adverse Event|1|||
164353523|NCT04557371|593666751|FG001|Overall Study|Adverse Event|0|||
164353524|NCT04557371|593666752|FG002|Overall Study|Adverse Event|0|||
164353525|NCT01428453|593666755|FG000|Overall Study|Adverse Event|2|||
164353526|NCT01428453|593666756|FG001|Overall Study|Adverse Event|7|||
164436651|NCT01972152|593964979|FG002|Second Treatment Visit|Protocol Violation|0|||
164436652|NCT01972152|593964980|FG003|Second Treatment Visit|Protocol Violation|0|||
164588207|NCT03238248|594517503|FG000|Overall Study|Alternative therapy|2|||
164353527|NCT01428453|593666755|FG000|Overall Study|Protocol Violation|1|||
164353528|NCT01428453|593666756|FG001|Overall Study|Protocol Violation|0|||
164353529|NCT01428453|593666755|FG000|Overall Study|Lost to Follow-up|0|||
164353530|NCT01428453|593666756|FG001|Overall Study|Lost to Follow-up|1|||
164353531|NCT01428453|593666755|FG000|Overall Study|Withdrawal by Subject|3|||
164353532|NCT01428453|593666756|FG001|Overall Study|Withdrawal by Subject|1|||
164436653|NCT01972152|593964981|FG004|Second Treatment Visit|Protocol Violation|0|||
164588208|NCT06094296|594517514|FG000|Overall Study|Progressive Disease|1|||
164436654|NCT01972152|593964982|FG005|Second Treatment Visit|Protocol Violation|0|||
164588209|NCT06094296|594517515|FG001|Overall Study|Progressive Disease|0|||
164353533|NCT01996709|593666757|FG000|Overall Study|Withdrawal by Subject|1|||
164353534|NCT01996709|593666758|FG001|Overall Study|Withdrawal by Subject|0|||
164353535|NCT01996709|593666757|FG000|Overall Study|Lost to Follow-up|3|||
164588210|NCT06094296|594517516|FG002|Overall Study|Progressive Disease|0|||
164588211|NCT06094296|594517517|FG003|Overall Study|Progressive Disease|0|||
164588212|NCT04964063|594517518|FG000|Overall Study|Adverse Event|4|||
164588213|NCT04964063|594517518|FG000|Overall Study|Lost to Follow-up|47|||
164588214|NCT04964063|594517518|FG000|Overall Study|Withdrawal by Subject|5|||
164588215|NCT04964063|594517518|FG000|Overall Study|Baseline Tasks Expired|41|||
164588216|NCT04964063|594517518|FG000|Overall Study|Participant withdrawn in error|1|||
164588217|NCT03350750|594517519|FG000|Overall Study|Death|1|||
164588218|NCT03350750|594517520|FG001|Overall Study|Death|1|||
164588219|NCT00700752|594517521|FG000|First Intervention|Withdrawal by Subject|0|||
164588220|NCT00700752|594517522|FG001|First Intervention|Withdrawal by Subject|2|||
164588221|NCT03964415|594517523|FG000|Overall Study|Sponsor's decision|1563|||
164588222|NCT03964415|594517524|FG001|Overall Study|Sponsor's decision|1528|||
164588223|NCT03964415|594517523|FG000|Overall Study|Lost to Follow-up|139|||
164588224|NCT03964415|594517524|FG001|Overall Study|Lost to Follow-up|146|||
164588225|NCT03964415|594517523|FG000|Overall Study|Withdrawal by Subject|68|||
164588226|NCT03964415|594517524|FG001|Overall Study|Withdrawal by Subject|72|||
164588227|NCT03964415|594517523|FG000|Overall Study|Physician Decision|34|||
164588228|NCT03964415|594517524|FG001|Overall Study|Physician Decision|48|||
164588229|NCT03964415|594517523|FG000|Overall Study|Adverse Event|3|||
164588230|NCT03964415|594517524|FG001|Overall Study|Adverse Event|0|||
164588231|NCT03964415|594517523|FG000|Overall Study|Death|4|||
164588232|NCT03964415|594517524|FG001|Overall Study|Death|6|||
164588233|NCT03964415|594517523|FG000|Overall Study|Protocol Violation|1|||
164588234|NCT03964415|594517524|FG001|Overall Study|Protocol Violation|4|||
164588235|NCT03964415|594517523|FG000|Overall Study|Other|35|||
164588236|NCT03964415|594517524|FG001|Overall Study|Other|38|||
164588237|NCT03964415|594517523|FG000|Overall Study|Randomized but not treated|6|||
164588238|NCT03964415|594517524|FG001|Overall Study|Randomized but not treated|7|||
164588239|NCT01097330|594517526|FG000|Overall Study|Study terminated early|7|||
164588240|NCT01097330|594517527|FG001|Overall Study|Study terminated early|5|||
164588241|NCT01426386|594517533|FG000|Overall Study|Adverse Event|0|||
164588242|NCT01426386|594517534|FG001|Overall Study|Adverse Event|1|||
164588243|NCT01426386|594517535|FG002|Overall Study|Adverse Event|0|||
164588244|NCT01426386|594517536|FG003|Overall Study|Adverse Event|0|||
164588245|NCT01426386|594517537|FG004|Overall Study|Adverse Event|0|||
164588246|NCT01426386|594517538|FG005|Overall Study|Adverse Event|0|||
164588247|NCT01426386|594517533|FG000|Overall Study|Did not attend scheduled visit|1|||
164588248|NCT01426386|594517534|FG001|Overall Study|Did not attend scheduled visit|4|||
164588249|NCT01426386|594517535|FG002|Overall Study|Did not attend scheduled visit|0|||
164588250|NCT01426386|594517536|FG003|Overall Study|Did not attend scheduled visit|0|||
164353536|NCT01996709|593666758|FG001|Overall Study|Lost to Follow-up|0|||
164353537|NCT01996709|593666757|FG000|Overall Study|Subject Non-Compliant|1|||
164353538|NCT01996709|593666758|FG001|Overall Study|Subject Non-Compliant|0|||
164353539|NCT01996709|593666757|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
164353540|NCT01996709|593666758|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
164353541|NCT03918447|593666759|FG000|Overall Study|Death|1|||
164353542|NCT03918447|593666760|FG001|Overall Study|Death|0|||
164353543|NCT03918447|593666759|FG000|Overall Study|Lost to Follow-up|13|||
164353544|NCT03918447|593666760|FG001|Overall Study|Lost to Follow-up|6|||
164353545|NCT03918447|593666759|FG000|Overall Study|Withdrawal by Subject|19|||
164353546|NCT03918447|593666760|FG001|Overall Study|Withdrawal by Subject|17|||
164353547|NCT03918447|593666759|FG000|Overall Study|Study Terminated by Sponsor|195|||
164353548|NCT03918447|593666760|FG001|Overall Study|Study Terminated by Sponsor|197|||
164353549|NCT03918447|593666759|FG000|Overall Study|Reason not Specified|0|||
164353550|NCT03918447|593666760|FG001|Overall Study|Reason not Specified|1|||
164353551|NCT00477971|593666761|FG000|Overall Study|Disease progression|6|||
164353552|NCT00477971|593666762|FG001|Overall Study|Disease progression|0|||
164353553|NCT00477971|593666761|FG000|Overall Study|Withdrawal by Subject|3|||
164353554|NCT00477971|593666762|FG001|Overall Study|Withdrawal by Subject|1|||
164353555|NCT00477971|593666761|FG000|Overall Study|Adverse Event|3|||
164353556|NCT00477971|593666762|FG001|Overall Study|Adverse Event|0|||
164353557|NCT00477971|593666761|FG000|Overall Study|Death|2|||
164353558|NCT00477971|593666762|FG001|Overall Study|Death|4|||
164353559|NCT00477971|593666761|FG000|Overall Study|Alternative treatment|3|||
164353560|NCT00477971|593666762|FG001|Overall Study|Alternative treatment|1|||
164353561|NCT01774968|593666763|FG000|Overall Study|Adverse Event|4|||
164588251|NCT01426386|594517537|FG004|Overall Study|Did not attend scheduled visit|2|||
164588252|NCT01426386|594517538|FG005|Overall Study|Did not attend scheduled visit|1|||
164588253|NCT01426386|594517533|FG000|Overall Study|Poor response|2|||
164588254|NCT01426386|594517534|FG001|Overall Study|Poor response|1|||
164588255|NCT01426386|594517535|FG002|Overall Study|Poor response|2|||
164588256|NCT01426386|594517536|FG003|Overall Study|Poor response|0|||
164588257|NCT01426386|594517537|FG004|Overall Study|Poor response|1|||
164588258|NCT01426386|594517538|FG005|Overall Study|Poor response|0|||
164588259|NCT01426386|594517533|FG000|Overall Study|Personal reasons|0|||
164588260|NCT01426386|594517534|FG001|Overall Study|Personal reasons|0|||
164588261|NCT01426386|594517535|FG002|Overall Study|Personal reasons|0|||
164588262|NCT01426386|594517536|FG003|Overall Study|Personal reasons|0|||
164588263|NCT01426386|594517537|FG004|Overall Study|Personal reasons|1|||
164588264|NCT01426386|594517538|FG005|Overall Study|Personal reasons|0|||
164588265|NCT02760407|594517539|FG000|Overall Study|Death|2|||
164588266|NCT02760407|594517540|FG001|Overall Study|Death|3|||
164588267|NCT02760407|594517541|FG002|Overall Study|Death|1|||
164588268|NCT02760407|594517542|FG003|Overall Study|Death|1|||
164588269|NCT02760407|594517539|FG000|Overall Study|Lost to Follow-up|1|||
164588270|NCT02760407|594517540|FG001|Overall Study|Lost to Follow-up|7|||
164588271|NCT02760407|594517541|FG002|Overall Study|Lost to Follow-up|4|||
164588272|NCT02760407|594517542|FG003|Overall Study|Lost to Follow-up|6|||
164588273|NCT02760407|594517539|FG000|Overall Study|Withdrawal by Subject|25|||
164588274|NCT02760407|594517540|FG001|Overall Study|Withdrawal by Subject|31|||
164588275|NCT02760407|594517541|FG002|Overall Study|Withdrawal by Subject|37|||
164588276|NCT02760407|594517542|FG003|Overall Study|Withdrawal by Subject|25|||
164588277|NCT02760407|594517539|FG000|Overall Study|Violation of Eligibility criteria|0|||
164588278|NCT02760407|594517540|FG001|Overall Study|Violation of Eligibility criteria|0|||
164588279|NCT02760407|594517541|FG002|Overall Study|Violation of Eligibility criteria|1|||
164588280|NCT02760407|594517542|FG003|Overall Study|Violation of Eligibility criteria|1|||
164588281|NCT02760407|594517539|FG000|Overall Study|Personal reasons|0|||
164588282|NCT02760407|594517540|FG001|Overall Study|Personal reasons|0|||
164588283|NCT02760407|594517541|FG002|Overall Study|Personal reasons|0|||
164588284|NCT02760407|594517542|FG003|Overall Study|Personal reasons|1|||
164588285|NCT02760407|594517539|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
164588286|NCT02760407|594517540|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
164588287|NCT02760407|594517541|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
164588288|NCT02760407|594517542|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
164588289|NCT02760407|594517539|FG000|Overall Study|Use of prohibited Medication|0|||
164588290|NCT02760407|594517540|FG001|Overall Study|Use of prohibited Medication|0|||
164588291|NCT02760407|594517541|FG002|Overall Study|Use of prohibited Medication|1|||
164588292|NCT02760407|594517542|FG003|Overall Study|Use of prohibited Medication|0|||
164588293|NCT02760407|594517539|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
164588294|NCT02760407|594517540|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
164588295|NCT02760407|594517541|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
164588296|NCT02760407|594517542|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
164588297|NCT02760407|594517539|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
164588298|NCT02760407|594517540|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
164588299|NCT02760407|594517541|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
164588300|NCT02760407|594517542|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
164588301|NCT02760407|594517539|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
164588302|NCT02760407|594517540|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
164588303|NCT02760407|594517541|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
164588304|NCT02760407|594517542|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
164588305|NCT02760407|594517539|FG000|Overall Study|Inadequately Enrolled|0|||
164588306|NCT02760407|594517540|FG001|Overall Study|Inadequately Enrolled|0|||
164588307|NCT02760407|594517541|FG002|Overall Study|Inadequately Enrolled|0|||
164588308|NCT02760407|594517542|FG003|Overall Study|Inadequately Enrolled|1|||
164588309|NCT02760407|594517539|FG000|Overall Study|Withdrawal By PI's Decision|0|||
164588310|NCT02760407|594517540|FG001|Overall Study|Withdrawal By PI's Decision|1|||
164588311|NCT02760407|594517541|FG002|Overall Study|Withdrawal By PI's Decision|0|||
164588312|NCT02760407|594517542|FG003|Overall Study|Withdrawal By PI's Decision|0|||
164588313|NCT02760407|594517539|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
164588314|NCT02760407|594517540|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
164588315|NCT02760407|594517541|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
164588316|NCT02760407|594517542|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
164588317|NCT02760407|594517539|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
164589047|NCT02232516|594521371|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
164589048|NCT02232516|594521371|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
164589049|NCT02232516|594521371|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
164589050|NCT02232516|594521371|FG000|Survival Follow-up|Death|15|||
164589051|NCT02232516|594521371|FG000|Survival Follow-up|Withdrawal by Subject|3|||
164589052|NCT02232516|594521371|FG000|Survival Follow-up|Lost to Follow-up|1|||
164436655|NCT04379713|593964985|FG000|Overall Study|Adverse Event|2|||
164436656|NCT04379713|593964986|FG001|Overall Study|Adverse Event|0|||
164436657|NCT04379713|593964985|FG000|Overall Study|Physician Decision|2|||
164436658|NCT04379713|593964986|FG001|Overall Study|Physician Decision|1|||
164436659|NCT04379713|593964985|FG000|Overall Study|Protocol Violation|11|||
164436660|NCT04379713|593964986|FG001|Overall Study|Protocol Violation|6|||
164436661|NCT04379713|593964985|FG000|Overall Study|No longer met eligibility criteria|14|||
164436662|NCT04379713|593964986|FG001|Overall Study|No longer met eligibility criteria|11|||
164436663|NCT04379713|593964985|FG000|Overall Study|Withdrawal by parent/guardian|36|||
164436664|NCT04379713|593964986|FG001|Overall Study|Withdrawal by parent/guardian|15|||
164436665|NCT04379713|593964985|FG000|Overall Study|Lost to Follow-up|31|||
164436666|NCT04379713|593964986|FG001|Overall Study|Lost to Follow-up|21|||
164436667|NCT04567888|593964987|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
164436668|NCT04567888|593964988|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
164436669|NCT04567888|593964987|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
164436670|NCT04567888|593964988|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
164436671|NCT04567888|593964987|FG000|Overall Study|Reported Unusual Birth Year|2|||
164436672|NCT04567888|593964988|FG001|Overall Study|Reported Unusual Birth Year|3|||
164436673|NCT04567888|593964987|FG000|Overall Study|Duplicate Responses|0|||
164436674|NCT04567888|593964988|FG001|Overall Study|Duplicate Responses|1|||
164436675|NCT00972504|593964990|FG000|Overall Study|Adverse Event|2|||
164436676|NCT00972504|593964990|FG000|Overall Study|Investigator discretion|1|||
164436677|NCT00319436|593964991|FG000|Overall Study|Withdrawal by Subject|6|||
164436678|NCT00319436|593964992|FG001|Overall Study|Withdrawal by Subject|7|||
164436679|NCT04771273|593964995|FG000|Dose Escalation Period|Not treated with trial medication|0|||
164436680|NCT04771273|593964996|FG001|Dose Escalation Period|Not treated with trial medication|1|||
164436681|NCT04771273|593964997|FG002|Dose Escalation Period|Not treated with trial medication|1|||
164436682|NCT04771273|593964998|FG003|Dose Escalation Period|Not treated with trial medication|0|||
164436683|NCT04771273|593964995|FG000|Dose Escalation Period|Other reasons than listed|2|||
164436684|NCT04771273|593964996|FG001|Dose Escalation Period|Other reasons than listed|0|||
164436685|NCT04771273|593964997|FG002|Dose Escalation Period|Other reasons than listed|2|||
164436686|NCT04771273|593964998|FG003|Dose Escalation Period|Other reasons than listed|1|||
164436687|NCT04771273|593964995|FG000|Dose Escalation Period|Protocol Violation|0|||
164436688|NCT04771273|593964996|FG001|Dose Escalation Period|Protocol Violation|0|||
164436689|NCT04771273|593964997|FG002|Dose Escalation Period|Protocol Violation|3|||
164436690|NCT04771273|593964998|FG003|Dose Escalation Period|Protocol Violation|1|||
164436691|NCT04771273|593964995|FG000|Dose Escalation Period|Burden of study procedures|1|||
164436692|NCT04771273|593964996|FG001|Dose Escalation Period|Burden of study procedures|0|||
164436693|NCT04771273|593964997|FG002|Dose Escalation Period|Burden of study procedures|0|||
164436694|NCT04771273|593964998|FG003|Dose Escalation Period|Burden of study procedures|0|||
164436695|NCT04771273|593964995|FG000|Dose Escalation Period|Change of residence|0|||
164436696|NCT04771273|593964996|FG001|Dose Escalation Period|Change of residence|0|||
164436697|NCT04771273|593964997|FG002|Dose Escalation Period|Change of residence|0|||
164436698|NCT04771273|593964998|FG003|Dose Escalation Period|Change of residence|1|||
164436699|NCT04771273|593964995|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
164436700|NCT04771273|593964996|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
164436701|NCT04771273|593964997|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
164436702|NCT04771273|593964998|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
164436703|NCT04771273|593964995|FG000|Dose Escalation Period|Adverse Event|8|||
164436704|NCT04771273|593964996|FG001|Dose Escalation Period|Adverse Event|9|||
164436705|NCT04771273|593964997|FG002|Dose Escalation Period|Adverse Event|12|||
164436706|NCT04771273|593964998|FG003|Dose Escalation Period|Adverse Event|2|||
164436707|NCT04771273|593964995|FG000|Maintenance Period|Other than listed|4|||
164436708|NCT04771273|593964996|FG001|Maintenance Period|Other than listed|2|||
164436709|NCT04771273|593964997|FG002|Maintenance Period|Other than listed|0|||
164436710|NCT04771273|593964998|FG003|Maintenance Period|Other than listed|3|||
164436711|NCT04771273|593964995|FG000|Maintenance Period|Burden of study procedures|1|||
164436712|NCT04771273|593964996|FG001|Maintenance Period|Burden of study procedures|0|||
164436713|NCT04771273|593964997|FG002|Maintenance Period|Burden of study procedures|0|||
164436714|NCT04771273|593964998|FG003|Maintenance Period|Burden of study procedures|0|||
164436715|NCT04771273|593964995|FG000|Maintenance Period|Change of residence|0|||
164436716|NCT04771273|593964996|FG001|Maintenance Period|Change of residence|1|||
164436717|NCT04771273|593964997|FG002|Maintenance Period|Change of residence|3|||
164436718|NCT04771273|593964998|FG003|Maintenance Period|Change of residence|0|||
164436719|NCT04771273|593964995|FG000|Maintenance Period|Perceived lack of efficacy|0|||
164436720|NCT04771273|593964996|FG001|Maintenance Period|Perceived lack of efficacy|0|||
164436721|NCT04771273|593964997|FG002|Maintenance Period|Perceived lack of efficacy|0|||
164436722|NCT04771273|593964998|FG003|Maintenance Period|Perceived lack of efficacy|1|||
164436723|NCT04771273|593964995|FG000|Maintenance Period|Adverse Event|4|||
164436724|NCT04771273|593964996|FG001|Maintenance Period|Adverse Event|5|||
164436725|NCT04771273|593964997|FG002|Maintenance Period|Adverse Event|5|||
164436726|NCT04771273|593964998|FG003|Maintenance Period|Adverse Event|0|||
164436727|NCT05196737|593964999|FG000|Non-intervention Week|Lost to Follow-up|2|||
164693867|NCT00892281|594901194|FG001|Overall Study|Scheduled for knee replacement|1|||
164693868|NCT00892281|594901193|FG000|Overall Study|PI complained of inadequate compensation|3|||
164693869|NCT00892281|594901194|FG001|Overall Study|PI complained of inadequate compensation|0|||
164353562|NCT01774968|593666764|FG001|Overall Study|Adverse Event|4|||
164353563|NCT01774968|593666763|FG000|Overall Study|Death|0|||
164353564|NCT01774968|593666764|FG001|Overall Study|Death|1|||
164353565|NCT01774968|593666763|FG000|Overall Study|Lost to Follow-up|1|||
164353566|NCT01774968|593666764|FG001|Overall Study|Lost to Follow-up|3|||
164353567|NCT01774968|593666763|FG000|Overall Study|Physician Decision|5|||
164353568|NCT01774968|593666764|FG001|Overall Study|Physician Decision|1|||
164353569|NCT01774968|593666763|FG000|Overall Study|Protocol Violation|14|||
164353570|NCT01774968|593666764|FG001|Overall Study|Protocol Violation|13|||
164353571|NCT01774968|593666763|FG000|Overall Study|Sponsor Decision|0|||
164353572|NCT01774968|593666764|FG001|Overall Study|Sponsor Decision|2|||
164353573|NCT01774968|593666763|FG000|Overall Study|Withdrawal by Subject|6|||
164353574|NCT01774968|593666764|FG001|Overall Study|Withdrawal by Subject|11|||
164353575|NCT01986855|593668317|FG000|Overall Study|Adverse Event|1|||
164353576|NCT01986855|593668318|FG001|Overall Study|Adverse Event|0|||
164353577|NCT01986855|593668319|FG002|Overall Study|Adverse Event|0|||
164353578|NCT01986855|593668317|FG000|Overall Study|Death|3|||
164353579|NCT01986855|593668318|FG001|Overall Study|Death|4|||
164353580|NCT01986855|593668319|FG002|Overall Study|Death|4|||
164353581|NCT01986855|593668317|FG000|Overall Study|Lost to Follow-up|2|||
164353582|NCT01986855|593668318|FG001|Overall Study|Lost to Follow-up|1|||
164353583|NCT01986855|593668319|FG002|Overall Study|Lost to Follow-up|0|||
164353584|NCT01986855|593668317|FG000|Overall Study|Screen Failure|0|||
164353585|NCT01986855|593668318|FG001|Overall Study|Screen Failure|1|||
164353586|NCT01986855|593668319|FG002|Overall Study|Screen Failure|0|||
164353587|NCT01986855|593668317|FG000|Overall Study|Participant Moved|0|||
164353588|NCT01986855|593668318|FG001|Overall Study|Participant Moved|0|||
164353589|NCT01986855|593668319|FG002|Overall Study|Participant Moved|2|||
164353590|NCT01986855|593668317|FG000|Overall Study|Withdrawal by Subject|7|||
164353591|NCT01986855|593668318|FG001|Overall Study|Withdrawal by Subject|8|||
164353592|NCT01986855|593668319|FG002|Overall Study|Withdrawal by Subject|5|||
164353593|NCT04317066|593668320|FG000|Overall Study|Sponsor decision|5|||
164353594|NCT04317066|593668320|FG000|Overall Study|Death|2|||
164353595|NCT02014597|593668324|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
164353596|NCT02014597|593668325|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
164353597|NCT02279173|593668327|FG000|Overall Study|Protocol-specified Criteria|67|||
164353598|NCT02279173|593668327|FG000|Overall Study|Withdrawal by Subject|20|||
164353599|NCT02279173|593668327|FG000|Overall Study|Decision by Sponsor|4|||
164353600|NCT02279173|593668327|FG000|Overall Study|Lost to Follow-up|3|||
164353601|NCT00754624|593668329|FG000|Overall Study|Adverse Event|16|||
164353602|NCT00754624|593668329|FG000|Overall Study|Death|1|||
164353603|NCT00754624|593668329|FG000|Overall Study|Physician Decision|8|||
164353604|NCT00754624|593668329|FG000|Overall Study|Protocol Violation|1|||
164353605|NCT00754624|593668329|FG000|Overall Study|Withdrawal by Subject|28|||
164353606|NCT00754624|593668329|FG000|Overall Study|Various|12|||
164353607|NCT00754624|593668329|FG000|Overall Study|Lost to Follow-up|3|||
164353608|NCT00022633|593668337|FG000|Overall Study|Adverse Event|11|||
164353609|NCT00022633|593668338|FG001|Overall Study|Adverse Event|1|||
164353610|NCT00022633|593668337|FG000|Overall Study|Refusal unrelated to adverse event|1|||
164353611|NCT00022633|593668338|FG001|Overall Study|Refusal unrelated to adverse event|0|||
164353612|NCT00022633|593668337|FG000|Overall Study|Progression/relapse|9|||
164353613|NCT00022633|593668338|FG001|Overall Study|Progression/relapse|2|||
164353614|NCT00022633|593668337|FG000|Overall Study|Death|4|||
164353615|NCT00022633|593668338|FG001|Overall Study|Death|0|||
164353616|NCT00022633|593668337|FG000|Overall Study|Other - not protocol specified|3|||
164353617|NCT00022633|593668338|FG001|Overall Study|Other - not protocol specified|2|||
164353618|NCT00022633|593668337|FG000|Overall Study|Ineligible|4|||
164693870|NCT00892281|594901193|FG000|Overall Study|Subject lost interest in program|0|||
164693871|NCT00892281|594901194|FG001|Overall Study|Subject lost interest in program|1|||
164693872|NCT00892281|594901193|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
164693873|NCT00892281|594901194|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
164353619|NCT00022633|593668338|FG001|Overall Study|Ineligible|0|||
164353620|NCT01741701|593668341|FG000|Overall Study|Adverse Event|5|||
164353621|NCT01741701|593668342|FG001|Overall Study|Adverse Event|1|||
164353622|NCT01741701|593668341|FG000|Overall Study|Withdrawal by Subject|0|||
164353623|NCT01741701|593668342|FG001|Overall Study|Withdrawal by Subject|1|||
164353624|NCT00372112|593668354|FG000|Overall Study|Adverse Event|0|||
164353625|NCT00372112|593668355|FG001|Overall Study|Adverse Event|1|||
164353626|NCT00372112|593668356|FG002|Overall Study|Adverse Event|1|||
164353627|NCT00372112|593668357|FG003|Overall Study|Adverse Event|1|||
164353628|NCT00372112|593668354|FG000|Overall Study|Withdrawal by Subject|0|||
164353629|NCT00372112|593668355|FG001|Overall Study|Withdrawal by Subject|0|||
164353630|NCT00372112|593668356|FG002|Overall Study|Withdrawal by Subject|2|||
164353631|NCT00372112|593668357|FG003|Overall Study|Withdrawal by Subject|1|||
164353632|NCT00372112|593668354|FG000|Overall Study|Exacerbation|0|||
164436728|NCT05196737|593964999|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
164436729|NCT02357784|593965000|FG000|Overall Study|Withdrawal by Subject|1|||
164436730|NCT00462943|593965001|FG000|Overall Study|Failure to achieve a response|5|||
164436731|NCT00462943|593965002|FG001|Overall Study|Failure to achieve a response|5|||
164436732|NCT00462943|593965003|FG002|Overall Study|Failure to achieve a response|1|||
164436733|NCT00462943|593965001|FG000|Overall Study|Adverse Event|6|||
164436734|NCT00462943|593965002|FG001|Overall Study|Adverse Event|4|||
164436735|NCT00462943|593965003|FG002|Overall Study|Adverse Event|1|||
164436736|NCT00462943|593965001|FG000|Overall Study|Protocol Violation|1|||
164436737|NCT00462943|593965002|FG001|Overall Study|Protocol Violation|0|||
164436738|NCT00462943|593965003|FG002|Overall Study|Protocol Violation|0|||
164436739|NCT00462943|593965001|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
164436740|NCT00462943|593965002|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
164436741|NCT00462943|593965003|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
164436742|NCT00462943|593965001|FG000|Overall Study|Disease Progression|15|||
164436743|NCT00462943|593965002|FG001|Overall Study|Disease Progression|15|||
164436744|NCT00462943|593965003|FG002|Overall Study|Disease Progression|9|||
164353633|NCT00372112|593668355|FG001|Overall Study|Exacerbation|0|||
164353634|NCT00372112|593668356|FG002|Overall Study|Exacerbation|0|||
164353635|NCT00372112|593668357|FG003|Overall Study|Exacerbation|1|||
164353636|NCT00372112|593668354|FG000|Overall Study|PR >240 at Visit 3|0|||
164436745|NCT00462943|593965001|FG000|Overall Study|Death|5|||
164353637|NCT00372112|593668355|FG001|Overall Study|PR >240 at Visit 3|0|||
164353638|NCT00372112|593668356|FG002|Overall Study|PR >240 at Visit 3|0|||
164353639|NCT00372112|593668357|FG003|Overall Study|PR >240 at Visit 3|1|||
164353640|NCT00372112|593668354|FG000|Overall Study|Hepatitis B|1|||
164353641|NCT00372112|593668355|FG001|Overall Study|Hepatitis B|0|||
164353642|NCT00372112|593668356|FG002|Overall Study|Hepatitis B|0|||
164353643|NCT00372112|593668357|FG003|Overall Study|Hepatitis B|0|||
164353644|NCT00372112|593668354|FG000|Overall Study|Other-protocol violation|0|||
164353645|NCT00372112|593668355|FG001|Overall Study|Other-protocol violation|0|||
164353646|NCT00372112|593668356|FG002|Overall Study|Other-protocol violation|1|||
164353647|NCT00372112|593668357|FG003|Overall Study|Other-protocol violation|0|||
164436746|NCT00462943|593965002|FG001|Overall Study|Death|2|||
164436747|NCT00462943|593965003|FG002|Overall Study|Death|7|||
164436748|NCT00462943|593965001|FG000|Overall Study|Stem Cell Transplant|1|||
164436749|NCT00462943|593965002|FG001|Overall Study|Stem Cell Transplant|1|||
164436750|NCT00462943|593965003|FG002|Overall Study|Stem Cell Transplant|0|||
164436751|NCT00462943|593965001|FG000|Overall Study|Bone Marrow Transplant|1|||
164436752|NCT00462943|593965002|FG001|Overall Study|Bone Marrow Transplant|0|||
164436753|NCT00462943|593965003|FG002|Overall Study|Bone Marrow Transplant|0|||
164436754|NCT00462943|593965001|FG000|Overall Study|Required Lymphocyte Infusion|1|||
164436755|NCT00462943|593965002|FG001|Overall Study|Required Lymphocyte Infusion|0|||
164436756|NCT00462943|593965003|FG002|Overall Study|Required Lymphocyte Infusion|0|||
164436757|NCT00462943|593965001|FG000|Overall Study|Transplant - not specified|1|||
164436758|NCT00462943|593965002|FG001|Overall Study|Transplant - not specified|0|||
164436759|NCT00462943|593965003|FG002|Overall Study|Transplant - not specified|1|||
164436760|NCT00462943|593965001|FG000|Overall Study|Physician Decision|1|||
164436761|NCT00462943|593965002|FG001|Overall Study|Physician Decision|0|||
164436762|NCT00462943|593965003|FG002|Overall Study|Physician Decision|0|||
164436763|NCT00462943|593965001|FG000|Overall Study|Withdrawal by Subject|0|||
164436764|NCT00462943|593965002|FG001|Overall Study|Withdrawal by Subject|1|||
164436765|NCT00462943|593965003|FG002|Overall Study|Withdrawal by Subject|0|||
164436766|NCT01144182|593965006|FG000|Overall Study|Death|5|||
164436767|NCT01144182|593965007|FG001|Overall Study|Death|6|||
164436768|NCT01144182|593965006|FG000|Overall Study|Withdrawal by Subject|3|||
164436769|NCT01144182|593965007|FG001|Overall Study|Withdrawal by Subject|6|||
164436770|NCT01144182|593965006|FG000|Overall Study|Lost to Follow-up|9|||
164436771|NCT01144182|593965007|FG001|Overall Study|Lost to Follow-up|9|||
164436772|NCT03395353|593965015|FG000|Overall Study|Adverse Event|20|||
164588318|NCT02760407|594517540|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
164588319|NCT02760407|594517541|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
164353648|NCT04649060|593668358|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
164353649|NCT04649060|593668359|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
164353650|NCT04649060|593668358|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
164353651|NCT04649060|593668359|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
164353652|NCT04649060|593668358|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
164436773|NCT03395353|593965015|FG000|Overall Study|Protocol Violation|1|||
164436774|NCT03395353|593965015|FG000|Overall Study|Lack of Efficacy|3|||
164436775|NCT03395353|593965015|FG000|Overall Study|Withdrawal by Subject|24|||
164436776|NCT03395353|593965015|FG000|Overall Study|Discontinued visit|1|||
164436777|NCT03395353|593965015|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
164436778|NCT03395353|593965015|FG000|Overall Study|Physician Decision|4|||
164436779|NCT03395353|593965015|FG000|Overall Study|Early termination of overall study|33|||
164353653|NCT04649060|593668359|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
164353654|NCT04649060|593668358|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
164353655|NCT04649060|593668359|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
164353656|NCT04649060|593668358|FG000|Arm A/Arm B Treatment|Patient Request|1|||
164353657|NCT04649060|593668359|FG001|Arm A/Arm B Treatment|Patient Request|0|||
164353658|NCT04649060|593668358|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
164353659|NCT04649060|593668359|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
164353660|NCT04649060|593668358|FG000|Arm A/Arm B Treatment|Other|1|||
164353661|NCT04649060|593668359|FG001|Arm A/Arm B Treatment|Other|0|||
164693874|NCT00892281|594901193|FG000|Overall Study|Death in family|1|||
164693875|NCT00892281|594901194|FG001|Overall Study|Death in family|0|||
164693876|NCT00892281|594901193|FG000|Overall Study|Lack of efficacy of study product|2|||
164353662|NCT04649060|593668358|FG000|Crossover (Arm B)|Adverse Event|0|||
164353663|NCT04649060|593668359|FG001|Crossover (Arm B)|Adverse Event|1|||
164353664|NCT04649060|593668358|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
164353665|NCT04649060|593668359|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
164353666|NCT03033394|593668360|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
164353667|NCT03033394|593668360|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
164353668|NCT03033394|593668360|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
164353669|NCT03033394|593668360|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
164353670|NCT03033394|593668360|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
164353671|NCT02927431|593668361|FG000|Overall Study|Withdrawal by Subject|0|||
164353672|NCT02927431|593668362|FG001|Overall Study|Withdrawal by Subject|0|||
164353673|NCT02927431|593668363|FG002|Overall Study|Withdrawal by Subject|1|||
164353674|NCT02246660|593668364|FG000|Overall Study|Withdrawal by Subject|0|||
164353675|NCT02246660|593668365|FG001|Overall Study|Withdrawal by Subject|1|||
164353676|NCT02246660|593668366|FG002|Overall Study|Withdrawal by Subject|0|||
164353677|NCT02246660|593668364|FG000|Overall Study|Death|0|||
164353678|NCT02246660|593668365|FG001|Overall Study|Death|0|||
164353679|NCT02246660|593668366|FG002|Overall Study|Death|1|||
164353680|NCT04952402|593668367|FG000|Overall Study|Lost to Follow-up|1|||
164353681|NCT04952402|593668368|FG001|Overall Study|Lost to Follow-up|3|||
164353682|NCT04952402|593668367|FG000|Overall Study|Lack Of Venous Access|0|||
164353683|NCT04952402|593668368|FG001|Overall Study|Lack Of Venous Access|1|||
164353684|NCT00143403|593668369|FG000|Overall Study|Adverse Event|3|||
164353685|NCT00143403|593668370|FG001|Overall Study|Adverse Event|8|||
164353686|NCT00143403|593668369|FG000|Overall Study|Death|1|||
164353687|NCT00143403|593668370|FG001|Overall Study|Death|0|||
164353688|NCT00143403|593668369|FG000|Overall Study|Withdrawal by Subject|3|||
164353689|NCT00143403|593668370|FG001|Overall Study|Withdrawal by Subject|12|||
164353690|NCT00143403|593668369|FG000|Overall Study|Relapse|15|||
164353691|NCT00143403|593668370|FG001|Overall Study|Relapse|7|||
164353692|NCT00143403|593668369|FG000|Overall Study|Protocol Violation|2|||
164353693|NCT00143403|593668370|FG001|Overall Study|Protocol Violation|2|||
164353694|NCT00143403|593668369|FG000|Overall Study|specified by site|4|||
164353695|NCT00143403|593668370|FG001|Overall Study|specified by site|9|||
164353696|NCT00143403|593668369|FG000|Overall Study|Randomized Not Treated|7|||
164353697|NCT00143403|593668370|FG001|Overall Study|Randomized Not Treated|8|||
164353698|NCT00587639|593668371|FG000|Overall Study|Withdrawal by Subject|1|||
164353699|NCT00533845|593668374|FG000|Overall Study|Physician Decision|1|||
164353700|NCT00533845|593668375|FG001|Overall Study|Physician Decision|0|||
164353701|NCT01442675|593668376|FG000|Overall Study|Protocol Violation|6|||
164353702|NCT01442675|593668376|FG000|Overall Study|Lost to Follow-up|2|||
164353703|NCT01442675|593668376|FG000|Overall Study|Withdrawal by Subject|4|||
164353704|NCT00667368|593668385|FG000|Overall Study|Lost to Follow-up|176|||
164353705|NCT00667368|593668386|FG001|Overall Study|Lost to Follow-up|155|||
164353706|NCT00667368|593668385|FG000|Overall Study|Discontinued early|24|||
164353707|NCT00667368|593668386|FG001|Overall Study|Discontinued early|17|||
164353708|NCT03944954|593668387|FG000|Overall Study|Withdrawal by Subject|22|||
164353709|NCT03944954|593668388|FG001|Overall Study|Withdrawal by Subject|4|||
164353710|NCT03944954|593668387|FG000|Overall Study|Lost to Follow-up|18|||
164353711|NCT03944954|593668388|FG001|Overall Study|Lost to Follow-up|0|||
164353712|NCT03944954|593668387|FG000|Overall Study|Failed Medical Screening|7|||
164353713|NCT03944954|593668388|FG001|Overall Study|Failed Medical Screening|0|||
164353714|NCT03235154|593668392|FG000|Overall Study|Withdrawal by Subject|1|||
164353715|NCT03235154|593668392|FG000|Overall Study|Adverse Event|1|||
164353716|NCT03235154|593668392|FG000|Overall Study|Lost to Follow-up|2|||
164353717|NCT02850965|593668393|FG000|Overall Study|Other than listed|3|||
164436780|NCT03301220|593965016|FG000|Overall Study|Death|26|||
164353718|NCT02850965|593668394|FG001|Overall Study|Other than listed|4|||
164353719|NCT02850965|593668393|FG000|Overall Study|Protocol Violation|0|||
164353720|NCT02850965|593668394|FG001|Overall Study|Protocol Violation|2|||
164353721|NCT02850965|593668393|FG000|Overall Study|Lost to Follow-up|5|||
164353722|NCT02850965|593668394|FG001|Overall Study|Lost to Follow-up|3|||
164353723|NCT02850965|593668393|FG000|Overall Study|Lack of Efficacy|4|||
164353724|NCT02850965|593668394|FG001|Overall Study|Lack of Efficacy|8|||
164436781|NCT03301220|593965017|FG001|Overall Study|Death|15|||
164436782|NCT03301220|593965016|FG000|Overall Study|Withdrawal by Subject|23|||
164436783|NCT03301220|593965017|FG001|Overall Study|Withdrawal by Subject|12|||
164436784|NCT03301220|593965016|FG000|Overall Study|Lost to Follow-up|1|||
164436785|NCT03301220|593965017|FG001|Overall Study|Lost to Follow-up|1|||
164436786|NCT03301220|593965016|FG000|Overall Study|Randomized in error|1|||
164436787|NCT03301220|593965017|FG001|Overall Study|Randomized in error|1|||
164436788|NCT03301220|593965016|FG000|Overall Study|Randomized but not treated|0|||
164436789|NCT03301220|593965017|FG001|Overall Study|Randomized but not treated|1|||
164436790|NCT03301220|593965016|FG000|Overall Study|Ongoing followup|145|||
164436791|NCT03301220|593965017|FG001|Overall Study|Ongoing followup|163|||
164436792|NCT03301220|593965016|FG000|Overall Study|Principal Investigator and participant decision|0|||
164436793|NCT03301220|593965017|FG001|Overall Study|Principal Investigator and participant decision|1|||
164436794|NCT03425643|593965020|FG000|Overall Study|Withdrawal by Subject|10|||
164436795|NCT03425643|593965021|FG001|Overall Study|Withdrawal by Subject|12|||
164436796|NCT03425643|593965020|FG000|Overall Study|Lost to Follow-up|2|||
164436797|NCT03425643|593965021|FG001|Overall Study|Lost to Follow-up|0|||
164436798|NCT03425643|593965020|FG000|Overall Study|Death|109|||
164436799|NCT03425643|593965021|FG001|Overall Study|Death|141|||
164436800|NCT03425643|593965020|FG000|Overall Study|Ongoing in study|276|||
164436801|NCT03425643|593965021|FG001|Overall Study|Ongoing in study|247|||
164436802|NCT07214922|593965024|FG000|Overall Study|Adverse Event|0|||
164436803|NCT07214922|593965025|FG001|Overall Study|Adverse Event|0|||
164436804|NCT07214922|593965026|FG002|Overall Study|Adverse Event|1|||
164436805|NCT07214922|593965027|FG003|Overall Study|Adverse Event|0|||
164436806|NCT07214922|593965024|FG000|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
164436807|NCT07214922|593965025|FG001|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|1|||
164436808|NCT07214922|593965026|FG002|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
164436809|NCT07214922|593965027|FG003|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
164436810|NCT00589667|593966370|FG000|Overall Study|Adverse Event|2|||
164436811|NCT00589667|593966370|FG000|Overall Study|Withdrawal by Subject|1|||
164436812|NCT00482729|593966373|FG000|Overall Study|Adverse Event|29|||
164436813|NCT00482729|593966374|FG001|Overall Study|Adverse Event|33|||
164436814|NCT00482729|593966373|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
164436815|NCT00482729|593966374|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
164436816|NCT00482729|593966373|FG000|Overall Study|Hyperglycemia Criteria|7|||
164436817|NCT00482729|593966374|FG001|Overall Study|Hyperglycemia Criteria|5|||
164436818|NCT00482729|593966373|FG000|Overall Study|Lack of Efficacy|4|||
164588320|NCT02760407|594517542|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
164588321|NCT02760407|594517539|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
164588322|NCT02760407|594517540|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
164436819|NCT00482729|593966374|FG001|Overall Study|Lack of Efficacy|16|||
164436820|NCT00482729|593966373|FG000|Overall Study|Lost to Follow-up|86|||
164588323|NCT02760407|594517541|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
164588324|NCT02760407|594517542|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
164436821|NCT00482729|593966374|FG001|Overall Study|Lost to Follow-up|66|||
164436822|NCT00482729|593966373|FG000|Overall Study|Physician Decision|10|||
164436823|NCT00482729|593966374|FG001|Overall Study|Physician Decision|7|||
164436824|NCT00482729|593966373|FG000|Overall Study|Pregnancy|4|||
164436825|NCT00482729|593966374|FG001|Overall Study|Pregnancy|2|||
164436826|NCT00482729|593966373|FG000|Overall Study|Protocol Violation|10|||
164436827|NCT00482729|593966374|FG001|Overall Study|Protocol Violation|18|||
164436828|NCT00482729|593966373|FG000|Overall Study|Withdrawal by Subject|67|||
164436829|NCT00482729|593966374|FG001|Overall Study|Withdrawal by Subject|69|||
164436830|NCT00954707|593966376|FG000|Overall Study|Death|34|||
164436831|NCT00954707|593966376|FG000|Overall Study|Withdrawal by Subject|100|||
164436832|NCT00954707|593966376|FG000|Overall Study|Lost to Follow-up|33|||
164436833|NCT03265210|593966377|FG000|Overall Study|Withdrawal by Subject|7|||
164436834|NCT03265210|593966378|FG001|Overall Study|Withdrawal by Subject|9|||
164436835|NCT03265210|593966377|FG000|Overall Study|Lost to Follow-up|2|||
164436836|NCT03265210|593966378|FG001|Overall Study|Lost to Follow-up|0|||
164436837|NCT03265210|593966377|FG000|Overall Study|Physician Decision|2|||
164436838|NCT03265210|593966378|FG001|Overall Study|Physician Decision|0|||
164436839|NCT03265210|593966377|FG000|Overall Study|Adverse Event|1|||
164436840|NCT03265210|593966378|FG001|Overall Study|Adverse Event|0|||
164436841|NCT02488980|593966380|FG000|Overall Study|Protocol Violation|2|||
164436842|NCT02488980|593966381|FG001|Overall Study|Protocol Violation|2|||
164588325|NCT02760407|594517539|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
164436843|NCT02488980|593966382|FG002|Overall Study|Protocol Violation|2|||
164436844|NCT02614560|593966386|FG000|Overall Study|Death|6|||
164436845|NCT02614560|593966387|FG001|Overall Study|Death|2|||
164436846|NCT00738699|593966388|FG000|Overall Study|Withdrawal by Subject|5|||
164436847|NCT00738699|593966389|FG001|Overall Study|Withdrawal by Subject|0|||
164436848|NCT00738699|593966388|FG000|Overall Study|Lost to Follow-up|1|||
164436849|NCT00738699|593966389|FG001|Overall Study|Lost to Follow-up|0|||
164299229|NCT04682366|593471267|FG000|Overall Study|Lost to Follow-up|1|||
164436850|NCT00738699|593966388|FG000|Overall Study|Death|144|||
164436851|NCT00738699|593966389|FG001|Overall Study|Death|68|||
164436852|NCT00738699|593966388|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
164436853|NCT00738699|593966389|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
164436854|NCT00738699|593966388|FG000|Overall Study|Other|2|||
164436855|NCT00738699|593966389|FG001|Overall Study|Other|0|||
164436856|NCT03201809|593966390|FG000|Overall Study|Lost to Follow-up|2|||
164436857|NCT03201809|593966391|FG001|Overall Study|Lost to Follow-up|0|||
164436858|NCT04107805|593966392|FG000|Overall Study|Adverse Event|0|||
164436859|NCT04107805|593966393|FG001|Overall Study|Adverse Event|0|||
164588326|NCT02760407|594517540|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
164588327|NCT02760407|594517541|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
164588328|NCT02760407|594517542|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
164588329|NCT02760407|594517539|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
164588330|NCT02760407|594517540|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
164588331|NCT02760407|594517541|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
164588332|NCT02760407|594517542|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
164588333|NCT02760407|594517539|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
164588334|NCT02760407|594517540|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
164588335|NCT02760407|594517541|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
164588336|NCT02760407|594517542|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
164588337|NCT02760407|594517539|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
164588338|NCT02760407|594517540|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
164588339|NCT02760407|594517541|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
164588340|NCT02760407|594517542|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
164588341|NCT02760407|594517539|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
164588342|NCT02760407|594517540|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
164588343|NCT02760407|594517541|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
164588344|NCT02760407|594517542|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
164588345|NCT02760407|594517539|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
164299230|NCT04682366|593471268|FG001|Overall Study|Lost to Follow-up|1|||
164299231|NCT03697252|593471275|FG000|Overall Study|Adverse Event|3|||
164299232|NCT03697252|593471276|FG001|Overall Study|Adverse Event|2|||
164299233|NCT03697252|593471275|FG000|Overall Study|Withdrawal by Subject|14|||
164299234|NCT03697252|593471276|FG001|Overall Study|Withdrawal by Subject|14|||
164299235|NCT03697252|593471275|FG000|Overall Study|Lost to Follow-up|0|||
164299236|NCT03697252|593471276|FG001|Overall Study|Lost to Follow-up|1|||
164299237|NCT03697252|593471275|FG000|Overall Study|Physician Decision|1|||
164299238|NCT03697252|593471276|FG001|Overall Study|Physician Decision|1|||
164299239|NCT03697252|593471275|FG000|Overall Study|Other|0|||
164299240|NCT03697252|593471276|FG001|Overall Study|Other|1|||
164299241|NCT03125395|593471277|FG000|Overall Study|Adverse Event|2|||
164299242|NCT03125395|593471277|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
164299243|NCT03125395|593471277|FG000|Overall Study|Physician Decision|2|||
164299244|NCT03125395|593471277|FG000|Overall Study|Commercial drug is available|5|||
164299245|NCT02531802|593471278|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
164299246|NCT02531802|593471279|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
164299247|NCT02531802|593471280|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
164299248|NCT02531802|593471281|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
164299249|NCT02531802|593471282|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
164299250|NCT02531802|593471283|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
164299251|NCT02531802|593471284|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
164299252|NCT02531802|593471285|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
164299253|NCT02531802|593471286|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
164299254|NCT02531802|593471287|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
164299255|NCT02531802|593471288|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
164299256|NCT02531802|593471289|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
164299257|NCT02531802|593471290|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
164299258|NCT02531802|593471291|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
164299259|NCT02531802|593471292|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
164299260|NCT02531802|593471293|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
164299261|NCT02531802|593471294|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
164299262|NCT02531802|593471295|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
164299263|NCT02531802|593471296|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
164299264|NCT02531802|593471297|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
164353725|NCT02850965|593668393|FG000|Overall Study|Adverse Event|3|||
164353726|NCT02850965|593668394|FG001|Overall Study|Adverse Event|2|||
164353727|NCT02850965|593668393|FG000|Overall Study|Withdrawal by Subject|3|||
164353728|NCT02850965|593668394|FG001|Overall Study|Withdrawal by Subject|4|||
164353729|NCT02850965|593668393|FG000|Overall Study|Physician Decision|0|||
164353730|NCT02850965|593668394|FG001|Overall Study|Physician Decision|1|||
164353731|NCT02850965|593668393|FG000|Overall Study|Randomized but not treated|0|||
164353732|NCT02850965|593668394|FG001|Overall Study|Randomized but not treated|1|||
164353733|NCT00536198|593668395|FG000|Overall Study|Lost to Follow-up|15|||
164353734|NCT00536198|593668396|FG001|Overall Study|Lost to Follow-up|14|||
164353735|NCT00536198|593668395|FG000|Overall Study|Withdrawal by Subject|16|||
164353736|NCT00536198|593668396|FG001|Overall Study|Withdrawal by Subject|12|||
164353737|NCT00536198|593668395|FG000|Overall Study|Adverse Event|2|||
164353738|NCT00536198|593668396|FG001|Overall Study|Adverse Event|2|||
164353739|NCT00536198|593668395|FG000|Overall Study|Rescue|3|||
164353740|NCT00536198|593668396|FG001|Overall Study|Rescue|9|||
164353741|NCT00536198|593668395|FG000|Overall Study|Pregnancy|1|||
164353742|NCT00536198|593668396|FG001|Overall Study|Pregnancy|1|||
164353743|NCT00536198|593668395|FG000|Overall Study|Protocol Violation|0|||
164353744|NCT00536198|593668396|FG001|Overall Study|Protocol Violation|1|||
164353745|NCT00881712|593668397|FG000|Overall Study|Death|1|||
164353746|NCT00881712|593668398|FG001|Overall Study|Death|0|||
164353747|NCT00881712|593668399|FG002|Overall Study|Death|0|||
164353748|NCT00881712|593668397|FG000|Overall Study|Withdrawal by Subject|1|||
164353749|NCT00881712|593668398|FG001|Overall Study|Withdrawal by Subject|0|||
164353750|NCT00881712|593668399|FG002|Overall Study|Withdrawal by Subject|0|||
164353751|NCT00276744|593668400|FG000|PART A|Reason unknown|98|||
164353752|NCT00230607|593668421|FG000|Overall Study|Other|3|||
164353753|NCT03672747|593668422|FG000|Overall Study|Lost to Follow-up|1|||
164353754|NCT03672747|593668423|FG001|Overall Study|Lost to Follow-up|1|||
164353755|NCT03672747|593668424|FG002|Overall Study|Lost to Follow-up|2|||
164353756|NCT03672747|593668425|FG003|Overall Study|Lost to Follow-up|2|||
164353757|NCT03672747|593668426|FG004|Overall Study|Lost to Follow-up|2|||
164353758|NCT03672747|593668427|FG005|Overall Study|Lost to Follow-up|1|||
164353759|NCT00965718|593668430|FG000|Overall Study|Withdrawal by Subject|4|||
164353760|NCT03667924|593668431|FG000|Baseline Completed|Lost to Follow-up|0|||
164353761|NCT03667924|593668432|FG001|Baseline Completed|Lost to Follow-up|2|||
164353762|NCT03667924|593668433|FG002|Baseline Completed|Lost to Follow-up|0|||
164353763|NCT03667924|593668431|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
164353764|NCT03667924|593668432|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
164353765|NCT03667924|593668433|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
164353766|NCT03667924|593668431|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
164353767|NCT03667924|593668432|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
164353768|NCT03667924|593668433|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
164353769|NCT03667924|593668431|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
164353770|NCT03667924|593668432|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
164353771|NCT03667924|593668433|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
164353772|NCT03667924|593668431|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
164693877|NCT00892281|594901194|FG001|Overall Study|Lack of efficacy of study product|0|||
164693878|NCT00892281|594901193|FG000|Overall Study|Subject not seen by PI at final visit|1|||
164693879|NCT00892281|594901194|FG001|Overall Study|Subject not seen by PI at final visit|0|||
164693880|NCT00892281|594901193|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
164693881|NCT00892281|594901194|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
164693882|NCT00892281|594901193|FG000|Overall Study|Missed multiple visits|1|||
164693883|NCT00892281|594901194|FG001|Overall Study|Missed multiple visits|0|||
164693884|NCT00892281|594901193|FG000|Overall Study|Missed visits rescheduled out of window|1|||
164693885|NCT00892281|594901194|FG001|Overall Study|Missed visits rescheduled out of window|0|||
164693886|NCT00892281|594901193|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
164693887|NCT00892281|594901194|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
164693888|NCT00892281|594901193|FG000|Overall Study|Subject had history of drug abuse|1|||
164693889|NCT00892281|594901194|FG001|Overall Study|Subject had history of drug abuse|0|||
164693890|NCT00892281|594901193|FG000|Overall Study|Rash on hand|1|||
164693891|NCT00892281|594901194|FG001|Overall Study|Rash on hand|0|||
164353773|NCT03667924|593668432|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
164353774|NCT03667924|593668433|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
164353775|NCT03667924|593668431|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
164353776|NCT03667924|593668432|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
164353777|NCT03667924|593668433|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
164353778|NCT03667924|593668431|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
164353779|NCT03667924|593668432|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
164353780|NCT03667924|593668433|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
164693892|NCT00892281|594901193|FG000|Overall Study|Visit 4 date out of window|1|||
164693893|NCT00892281|594901194|FG001|Overall Study|Visit 4 date out of window|0|||
164693894|NCT01280617|594901195|FG000|Overall Study|Adverse Event|0|||
164693895|NCT01280617|594901196|FG001|Overall Study|Adverse Event|1|||
164693896|NCT00986570|594901197|FG000|Overall Study|Lost to Follow-up|6|||
164693897|NCT00986570|594901197|FG000|Overall Study|Potential bias for objective assessment|1|||
164693898|NCT02225665|594901198|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
164693899|NCT02225665|594901199|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
164693900|NCT02225665|594901198|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
164693901|NCT02225665|594901199|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
164693902|NCT01311557|594901200|FG000|Overall Study|Serious adverse event|0|||
164693903|NCT01311557|594901201|FG001|Overall Study|Serious adverse event|1|||
164693904|NCT01311557|594901200|FG000|Overall Study|Protocol Violation|4|||
164693905|NCT01311557|594901201|FG001|Overall Study|Protocol Violation|2|||
164693906|NCT01311557|594901200|FG000|Overall Study|Lost to Follow-up|0|||
164693907|NCT01311557|594901201|FG001|Overall Study|Lost to Follow-up|1|||
164693908|NCT01311557|594901200|FG000|Overall Study|Withdrawal by Subject|1|||
164693909|NCT01311557|594901201|FG001|Overall Study|Withdrawal by Subject|2|||
164693910|NCT00608517|594901202|FG000|Overall Study|Death|1|||
164693911|NCT00608517|594901203|FG001|Overall Study|Death|0|||
164693912|NCT00608517|594901204|FG002|Overall Study|Death|0|||
164693913|NCT00572039|594901205|FG000|Overall Study|Withdrawal by Subject|9|||
164693914|NCT00572039|594901206|FG001|Overall Study|Withdrawal by Subject|6|||
164693915|NCT00572039|594901205|FG000|Overall Study|Death|2|||
164693916|NCT00572039|594901206|FG001|Overall Study|Death|3|||
164693917|NCT00572039|594901205|FG000|Overall Study|Ill|5|||
164693918|NCT00572039|594901206|FG001|Overall Study|Ill|1|||
164693919|NCT01098110|594901212|FG000|Overall Study|Withdrawal by Subject|14|||
164693920|NCT01098110|594901213|FG001|Overall Study|Withdrawal by Subject|24|||
164693921|NCT01098110|594901214|FG002|Overall Study|Withdrawal by Subject|19|||
164353781|NCT00126568|593668434|FG000|Overall Study|Death|2|||
164353782|NCT01244425|593668435|FG000|Overall Study|Withdrawal by Subject|2|||
164353783|NCT01244425|593668436|FG001|Overall Study|Withdrawal by Subject|2|||
164353784|NCT01244425|593668435|FG000|Overall Study|Adverse Event|1|||
164353785|NCT01244425|593668436|FG001|Overall Study|Adverse Event|1|||
164353786|NCT02547454|593668437|FG000|Overall Study|Due to hemodialysis|53|||
164353787|NCT02547454|593668437|FG000|Overall Study|Due to transplantation|1|||
164353788|NCT02547454|593668437|FG000|Overall Study|Due to no further need to treat|4|||
164353789|NCT02547454|593668437|FG000|Overall Study|Death|38|||
164353790|NCT02547454|593668437|FG000|Overall Study|Lost to Follow-up|26|||
164353791|NCT02547454|593668437|FG000|Overall Study|Other|39|||
164353792|NCT02547454|593668437|FG000|Overall Study|No data|11|||
164353793|NCT00733408|593669767|FG000|Overall Study|Adverse Event|4|||
164353794|NCT01134783|593669769|FG000|Overall Study|Pregnancy|16|||
164353795|NCT01134783|593669770|FG001|Overall Study|Pregnancy|8|||
164353796|NCT01134783|593669769|FG000|Overall Study|Withdrawal by Subject|15|||
164353797|NCT01134783|593669770|FG001|Overall Study|Withdrawal by Subject|9|||
164353798|NCT01134783|593669769|FG000|Overall Study|Lost to Follow-up|5|||
164353799|NCT01134783|593669770|FG001|Overall Study|Lost to Follow-up|20|||
164353800|NCT00531232|593669772|FG000|Overall Study|Investigator decision|0|||
164353801|NCT00531232|593669773|FG001|Overall Study|Investigator decision|0|||
164353802|NCT00531232|593669774|FG002|Overall Study|Investigator decision|4|||
164353803|NCT00531232|593669772|FG000|Overall Study|Participants refused further treatment|0|||
164353804|NCT00531232|593669773|FG001|Overall Study|Participants refused further treatment|1|||
164353805|NCT00531232|593669774|FG002|Overall Study|Participants refused further treatment|2|||
164353806|NCT00531232|593669772|FG000|Overall Study|Adverse events (AEs)|1|||
164353807|NCT00531232|593669773|FG001|Overall Study|Adverse events (AEs)|2|||
164353808|NCT00531232|593669774|FG002|Overall Study|Adverse events (AEs)|2|||
164353809|NCT00531232|593669772|FG000|Overall Study|Treatment failure|1|||
164353810|NCT00531232|593669773|FG001|Overall Study|Treatment failure|3|||
164353811|NCT00531232|593669774|FG002|Overall Study|Treatment failure|7|||
164353812|NCT00531232|593669772|FG000|Overall Study|Disease recurrence|0|||
164353813|NCT00531232|593669773|FG001|Overall Study|Disease recurrence|0|||
164353814|NCT00531232|593669774|FG002|Overall Study|Disease recurrence|1|||
164353815|NCT00531232|593669772|FG000|Overall Study|Deceased|2|||
164353816|NCT00531232|593669773|FG001|Overall Study|Deceased|2|||
164353817|NCT00531232|593669774|FG002|Overall Study|Deceased|2|||
164353818|NCT00531232|593669772|FG000|Overall Study|Withdrawal by Subject|0|||
164353819|NCT00531232|593669773|FG001|Overall Study|Withdrawal by Subject|1|||
164436860|NCT04107805|593966394|FG002|Overall Study|Adverse Event|0|||
164693922|NCT01098110|594901212|FG000|Overall Study|Adverse Event|30|||
164693923|NCT01098110|594901213|FG001|Overall Study|Adverse Event|32|||
164353820|NCT00531232|593669774|FG002|Overall Study|Withdrawal by Subject|2|||
164353821|NCT00531232|593669772|FG000|Overall Study|Other|0|||
164353822|NCT00531232|593669773|FG001|Overall Study|Other|0|||
164353823|NCT00531232|593669774|FG002|Overall Study|Other|5|||
164353824|NCT04232124|593669775|FG000|Overall Study|Lost to Follow-up|3|||
164693924|NCT01098110|594901214|FG002|Overall Study|Adverse Event|43|||
164436861|NCT04107805|593966395|FG003|Overall Study|Adverse Event|1|||
164436862|NCT04107805|593966396|FG004|Overall Study|Adverse Event|0|||
164436863|NCT04107805|593966397|FG005|Overall Study|Adverse Event|1|||
164436864|NCT04107805|593966398|FG006|Overall Study|Adverse Event|0|||
164436865|NCT04107805|593966399|FG007|Overall Study|Adverse Event|0|||
164436866|NCT04107805|593966400|FG008|Overall Study|Adverse Event|1|||
164436867|NCT01191086|593966405|FG000|Overall Study|Adverse Event|20|||
164436868|NCT01191086|593966405|FG000|Overall Study|Lack of Efficacy|10|||
164436869|NCT01191086|593966405|FG000|Overall Study|Lost to Follow-up|4|||
164436870|NCT01191086|593966405|FG000|Overall Study|Physician Decision|2|||
164436871|NCT01191086|593966405|FG000|Overall Study|Withdrawal by Subject|24|||
164436872|NCT01191086|593966405|FG000|Overall Study|Discontinuation criterion met|1|||
164436873|NCT01191086|593966405|FG000|Overall Study|Other|1|||
164436874|NCT00906035|593966417|FG000|Overall Study|Withdrawal by Subject|2|||
164436875|NCT00906035|593966418|FG001|Overall Study|Withdrawal by Subject|3|||
164436876|NCT00906035|593966419|FG002|Overall Study|Withdrawal by Subject|0|||
164436877|NCT00130637|593966424|FG000|Overall Study|Adverse Event|2|||
164436878|NCT00130637|593966424|FG000|Overall Study|Withdrawal by Subject|1|||
164436879|NCT00139737|593966425|FG000|Overall Study|Withdrawal by Subject|190|||
164436880|NCT00139737|593966425|FG000|Overall Study|Adverse Event|58|||
164436881|NCT00139737|593966425|FG000|Overall Study|Lack of Efficacy|40|||
164436882|NCT00139737|593966425|FG000|Overall Study|Lost to Follow-up|8|||
164436883|NCT00139737|593966425|FG000|Overall Study|Death|3|||
164588346|NCT02760407|594517540|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
164588347|NCT02760407|594517541|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
164588348|NCT02760407|594517542|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
164588349|NCT02062151|594517543|FG000|Overall Study|screen failure|1|||
164588350|NCT02522377|594517544|FG000|Overall Study|Withdrawal by Subject|1|||
164588351|NCT02522377|594517545|FG001|Overall Study|Withdrawal by Subject|0|||
164588352|NCT02522377|594517544|FG000|Overall Study|Remission Achieved|3|||
164588353|NCT02522377|594517545|FG001|Overall Study|Remission Achieved|0|||
164588354|NCT00945191|594517546|FG000|Overall Study|Did not achieve a complete response|18|||
164588355|NCT00945191|594517546|FG000|Overall Study|Participant relocated to another state|1|||
164588356|NCT00945191|594517546|FG000|Overall Study|Disease progression|3|||
164588357|NCT00945191|594517546|FG000|Overall Study|Serious adverse event or adverse event|1|||
164588358|NCT00945191|594517546|FG000|Overall Study|Investigator's discretion|1|||
164588359|NCT02137772|594517549|FG000|Overall Study|Adverse Event|6|||
164588360|NCT02137772|594517550|FG001|Overall Study|Adverse Event|3|||
164588361|NCT02137772|594517549|FG000|Overall Study|Death|71|||
164588362|NCT02137772|594517550|FG001|Overall Study|Death|44|||
164588363|NCT02137772|594517549|FG000|Overall Study|Lost to Follow-up|8|||
164588364|NCT02137772|594517550|FG001|Overall Study|Lost to Follow-up|4|||
164588365|NCT02137772|594517549|FG000|Overall Study|Physician Decision|15|||
164588366|NCT02137772|594517550|FG001|Overall Study|Physician Decision|5|||
164588367|NCT02137772|594517549|FG000|Overall Study|Withdrawal by Subject|28|||
164588368|NCT02137772|594517550|FG001|Overall Study|Withdrawal by Subject|17|||
164588369|NCT02137772|594517549|FG000|Overall Study|Non-compliance with study drug|1|||
164588370|NCT02137772|594517550|FG001|Overall Study|Non-compliance with study drug|0|||
164588371|NCT02137772|594517549|FG000|Overall Study|Not treated|3|||
164588372|NCT02137772|594517550|FG001|Overall Study|Not treated|2|||
164588373|NCT01844700|594517551|FG000|Overall Study|Lack of Efficacy|1|||
164588374|NCT01844700|594517552|FG001|Overall Study|Lack of Efficacy|0|||
164588375|NCT01844700|594517551|FG000|Overall Study|refused medication switch|1|||
164588376|NCT01844700|594517552|FG001|Overall Study|refused medication switch|0|||
164588377|NCT01844700|594517551|FG000|Overall Study|Withdrawal by Subject|1|||
164588378|NCT01844700|594517552|FG001|Overall Study|Withdrawal by Subject|0|||
164588379|NCT01844700|594517551|FG000|Overall Study|stopped taking meds|0|||
164588380|NCT01844700|594517552|FG001|Overall Study|stopped taking meds|1|||
164588381|NCT01797432|594517553|FG000|Overall Study|Lost to Follow-up|1|||
164588382|NCT01797432|594517553|FG000|Overall Study|Adverse Event|1|||
164588383|NCT01797432|594517553|FG000|Overall Study|Withdrawal by Subject|1|||
164588384|NCT01797432|594517553|FG000|Overall Study|lived too far from study site|1|||
164588385|NCT01137435|594517557|FG000|Overall Study|Lost to Follow-up|24|||
164588386|NCT01137435|594517557|FG000|Overall Study|Off label usage|4|||
164588387|NCT00487279|594517562|FG000|Overall Study|Death|1|||
164588388|NCT00487279|594517563|FG001|Overall Study|Death|0|||
164588389|NCT00487279|594517562|FG000|Overall Study|Withdrawal by Subject|0|||
164588390|NCT00487279|594517563|FG001|Overall Study|Withdrawal by Subject|2|||
164588391|NCT01416610|594517564|FG000|Overall Study|Adverse Event|4|||
164588392|NCT01416610|594517564|FG000|Overall Study|Adverse Event -Patient decision|3|||
164588393|NCT01416610|594517564|FG000|Overall Study|Lack of Efficacy|4|||
164588394|NCT01416610|594517564|FG000|Overall Study|No reason given|5|||
164588395|NCT01416610|594517564|FG000|Overall Study|Withdrawal by Subject|13|||
164588396|NCT01416610|594517564|FG000|Overall Study|Lost to Follow-up|7|||
164588397|NCT01416610|594517564|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
164588398|NCT04172831|594517566|FG000|Overall Study|Adverse Event|21|||
164588399|NCT04172831|594517567|FG001|Overall Study|Adverse Event|9|||
164588400|NCT04172831|594517566|FG000|Overall Study|Lack of Efficacy|2|||
164353825|NCT00463346|593669778|FG000|Overall Study|Withdrawal by Subject|3|||
164353826|NCT00463346|593669779|FG001|Overall Study|Withdrawal by Subject|3|||
164353827|NCT03641651|593669780|FG000|Overall Study|organizational issues at one study site|1|||
164353828|NCT01991067|593669782|FG000|Overall Study|Lost to Follow-up|6|||
164353829|NCT01991067|593669783|FG001|Overall Study|Lost to Follow-up|5|||
164588401|NCT04172831|594517567|FG001|Overall Study|Lack of Efficacy|8|||
164588402|NCT04172831|594517566|FG000|Overall Study|Physician Decision|0|||
164588403|NCT04172831|594517567|FG001|Overall Study|Physician Decision|1|||
164588404|NCT04172831|594517566|FG000|Overall Study|Withdrawal by Subject|12|||
164588405|NCT04172831|594517567|FG001|Overall Study|Withdrawal by Subject|11|||
164588406|NCT04172831|594517566|FG000|Overall Study|Lost to Follow-up|4|||
164588407|NCT04172831|594517567|FG001|Overall Study|Lost to Follow-up|9|||
164588408|NCT04172831|594517566|FG000|Overall Study|COVID-19 related crisis|3|||
164588409|NCT04172831|594517567|FG001|Overall Study|COVID-19 related crisis|3|||
164588410|NCT04172831|594517566|FG000|Overall Study|Subject non-compliance|1|||
164588411|NCT04172831|594517567|FG001|Overall Study|Subject non-compliance|1|||
164588412|NCT04172831|594517566|FG000|Overall Study|Family emergency|1|||
164588413|NCT04172831|594517567|FG001|Overall Study|Family emergency|0|||
164588414|NCT01696877|594517568|FG000|Overall Study|Adverse Event|0|||
164588415|NCT01696877|594517569|FG001|Overall Study|Adverse Event|1|||
164588416|NCT02119104|594517574|FG000|Overall Study|Protocol Violation|16|||
164588417|NCT00916721|594517577|FG000|Overall Study|Lost to Follow-up|0|||
164588418|NCT00916721|594517578|FG001|Overall Study|Lost to Follow-up|1|||
164588419|NCT00916721|594517577|FG000|Overall Study|Adverse Event|6|||
164588420|NCT00916721|594517578|FG001|Overall Study|Adverse Event|3|||
164588421|NCT00916721|594517577|FG000|Overall Study|Withdrawal by Subject|2|||
164588422|NCT00916721|594517578|FG001|Overall Study|Withdrawal by Subject|2|||
164588423|NCT00916721|594517577|FG000|Overall Study|Protocol Violation|2|||
164588424|NCT00916721|594517578|FG001|Overall Study|Protocol Violation|4|||
164353830|NCT00224055|593669785|FG000|Overall Study|Adverse Event|9|||
164353831|NCT00224055|593669786|FG001|Overall Study|Adverse Event|3|||
164353832|NCT00224055|593669785|FG000|Overall Study|Lost to Follow-up|1|||
164353833|NCT00224055|593669786|FG001|Overall Study|Lost to Follow-up|2|||
164353834|NCT00224055|593669785|FG000|Overall Study|Protocol Violation|1|||
164353835|NCT00224055|593669786|FG001|Overall Study|Protocol Violation|1|||
164353836|NCT00224055|593669785|FG000|Overall Study|Inclusion Violation|3|||
164353837|NCT00224055|593669786|FG001|Overall Study|Inclusion Violation|6|||
164353838|NCT00224055|593669785|FG000|Overall Study|Withdrawal by Subject|0|||
164353839|NCT00224055|593669786|FG001|Overall Study|Withdrawal by Subject|2|||
164353840|NCT00224055|593669785|FG000|Overall Study|Other|1|||
164353841|NCT00224055|593669786|FG001|Overall Study|Other|0|||
164353842|NCT00127712|593669789|FG000|Overall Study|Adverse Event|3|||
164353843|NCT00127712|593669790|FG001|Overall Study|Adverse Event|0|||
164353844|NCT00127712|593669789|FG000|Overall Study|Lack of GI access to continue|2|||
164353845|NCT00127712|593669790|FG001|Overall Study|Lack of GI access to continue|0|||
164353846|NCT00407563|593669791|FG000|Overall Study|Patient continues on treatment|1|||
164353847|NCT03055260|593669792|FG000|Overall Study|Withdrawal by Subject|1|||
164353848|NCT03055260|593669793|FG001|Overall Study|Withdrawal by Subject|0|||
164353849|NCT00464087|593669794|FG000|Overall Study|No PCI per inclusion criteria|0|||
164353850|NCT00464087|593669795|FG001|Overall Study|No PCI per inclusion criteria|0|||
164353851|NCT00464087|593669796|FG002|Overall Study|No PCI per inclusion criteria|29|||
164353852|NCT01164956|593669797|FG000|Overall Study|Side Effects|1|||
164353853|NCT01164956|593669798|FG001|Overall Study|Side Effects|0|||
164353854|NCT01164956|593669799|FG002|Overall Study|Side Effects|1|||
164353855|NCT00720434|593669800|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
164353856|NCT00720434|593669801|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
164693925|NCT01098110|594901212|FG000|Overall Study|Lack of Efficacy|13|||
164693926|NCT01098110|594901213|FG001|Overall Study|Lack of Efficacy|9|||
164693927|NCT01098110|594901214|FG002|Overall Study|Lack of Efficacy|27|||
164693928|NCT01098110|594901212|FG000|Overall Study|Other|4|||
164693929|NCT01098110|594901213|FG001|Overall Study|Other|7|||
164693930|NCT01098110|594901214|FG002|Overall Study|Other|5|||
164693931|NCT01098110|594901212|FG000|Overall Study|Untreated|1|||
164693932|NCT01098110|594901213|FG001|Overall Study|Untreated|1|||
164693933|NCT01098110|594901214|FG002|Overall Study|Untreated|0|||
164693934|NCT02147587|594901215|FG000|Overall Study|Adverse Event|9|||
164693935|NCT02147587|594901216|FG001|Overall Study|Adverse Event|4|||
164693936|NCT02147587|594901215|FG000|Overall Study|Lack of Efficacy|2|||
164693937|NCT02147587|594901216|FG001|Overall Study|Lack of Efficacy|1|||
164693938|NCT01355302|594901217|FG000|Phase 1b|Death|4|||
164693939|NCT01355302|594901218|FG001|Phase 1b|Death|0|||
164693940|NCT01355302|594901219|FG002|Phase 1b|Death|0|||
164693941|NCT01355302|594901217|FG000|Phase 1b|Study terminated by sponsor|2|||
164693942|NCT01355302|594901218|FG001|Phase 1b|Study terminated by sponsor|0|||
164693943|NCT01355302|594901219|FG002|Phase 1b|Study terminated by sponsor|0|||
164693944|NCT01315028|594901224|FG000|Overall Study|Lost to Follow-up|1|||
164693945|NCT01315028|594901225|FG001|Overall Study|Lost to Follow-up|0|||
164693946|NCT01315028|594901224|FG000|Overall Study|Death|0|||
164693947|NCT01315028|594901225|FG001|Overall Study|Death|1|||
164693948|NCT01714739|594901226|FG000|Overall Study|Disease progression|3|||
164693949|NCT01714739|594901227|FG001|Overall Study|Disease progression|5|||
164693950|NCT01714739|594901228|FG002|Overall Study|Disease progression|5|||
164693951|NCT01714739|594901229|FG003|Overall Study|Disease progression|204|||
164693952|NCT01714739|594901230|FG004|Overall Study|Disease progression|1|||
164693953|NCT01714739|594901231|FG005|Overall Study|Disease progression|3|||
164693954|NCT01714739|594901232|FG006|Overall Study|Disease progression|5|||
164693955|NCT01714739|594901226|FG000|Overall Study|Study drug toxicity|1|||
164693956|NCT01714739|594901227|FG001|Overall Study|Study drug toxicity|1|||
164299265|NCT02531802|593471298|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
164299266|NCT02531802|593471278|FG000|Received Vaccination 2|Physician Decision|0|||
164299267|NCT02531802|593471279|FG001|Received Vaccination 2|Physician Decision|0|||
164299268|NCT02531802|593471280|FG002|Received Vaccination 2|Physician Decision|0|||
164299269|NCT02531802|593471281|FG003|Received Vaccination 2|Physician Decision|0|||
164299270|NCT02531802|593471282|FG004|Received Vaccination 2|Physician Decision|0|||
164299271|NCT02531802|593471283|FG005|Received Vaccination 2|Physician Decision|1|||
164299272|NCT02531802|593471284|FG006|Received Vaccination 2|Physician Decision|0|||
164299273|NCT02531802|593471285|FG007|Received Vaccination 2|Physician Decision|0|||
164299274|NCT02531802|593471286|FG008|Received Vaccination 2|Physician Decision|0|||
164299275|NCT02531802|593471287|FG009|Received Vaccination 2|Physician Decision|2|||
164353857|NCT00720434|593669802|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
164353858|NCT00720434|593669803|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
164693957|NCT01714739|594901228|FG002|Overall Study|Study drug toxicity|1|||
164693958|NCT01714739|594901229|FG003|Overall Study|Study drug toxicity|15|||
164693959|NCT01714739|594901230|FG004|Overall Study|Study drug toxicity|0|||
164693960|NCT01714739|594901231|FG005|Overall Study|Study drug toxicity|0|||
164693961|NCT01714739|594901232|FG006|Overall Study|Study drug toxicity|5|||
164693962|NCT01714739|594901226|FG000|Overall Study|Death|0|||
164693963|NCT01714739|594901227|FG001|Overall Study|Death|0|||
164693964|NCT01714739|594901228|FG002|Overall Study|Death|0|||
164693965|NCT01714739|594901229|FG003|Overall Study|Death|1|||
164693966|NCT01714739|594901230|FG004|Overall Study|Death|0|||
164693967|NCT01714739|594901231|FG005|Overall Study|Death|0|||
164693968|NCT01714739|594901232|FG006|Overall Study|Death|0|||
164693969|NCT01714739|594901226|FG000|Overall Study|Adverse Event unrelated to drug|0|||
164693970|NCT01714739|594901227|FG001|Overall Study|Adverse Event unrelated to drug|0|||
164693971|NCT01714739|594901228|FG002|Overall Study|Adverse Event unrelated to drug|3|||
164693972|NCT01714739|594901229|FG003|Overall Study|Adverse Event unrelated to drug|21|||
164353859|NCT00720434|593669800|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
164353860|NCT00720434|593669801|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
164353861|NCT00720434|593669802|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
164353862|NCT00720434|593669803|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
164353863|NCT00720434|593669800|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
164353864|NCT00720434|593669801|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
164353865|NCT00720434|593669802|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
164353866|NCT00720434|593669803|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
164353867|NCT00720434|593669800|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
164353868|NCT00720434|593669801|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
164353869|NCT00720434|593669802|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
164353870|NCT00720434|593669803|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
164353871|NCT00720434|593669800|FG000|Open-Label Period (Week 5-72)|Other|4|||
164353872|NCT00720434|593669801|FG001|Open-Label Period (Week 5-72)|Other|3|||
164353873|NCT00720434|593669802|FG002|Open-Label Period (Week 5-72)|Other|3|||
164353874|NCT00720434|593669803|FG003|Open-Label Period (Week 5-72)|Other|2|||
164353875|NCT00418314|593669804|FG000|Overall Study|Withdrawal by Subject|1|||
164353876|NCT00418314|593669805|FG001|Overall Study|Withdrawal by Subject|2|||
164353877|NCT00967798|593669806|FG000|Overall Study|Withdrawal by Subject|5|||
164353878|NCT00967798|593669807|FG001|Overall Study|Withdrawal by Subject|2|||
164353879|NCT00967798|593669806|FG000|Overall Study|Lost to Follow-up|4|||
164353880|NCT00967798|593669807|FG001|Overall Study|Lost to Follow-up|1|||
164353881|NCT02425046|593669808|FG000|Overall Study|Lost to Follow-up|52|||
164353882|NCT02425046|593669809|FG001|Overall Study|Lost to Follow-up|50|||
164353883|NCT02425046|593669810|FG002|Overall Study|Lost to Follow-up|56|||
164353884|NCT02425046|593669808|FG000|Overall Study|Withdrawal by Subject|16|||
164353885|NCT02425046|593669809|FG001|Overall Study|Withdrawal by Subject|12|||
164353886|NCT02425046|593669810|FG002|Overall Study|Withdrawal by Subject|0|||
164353887|NCT01409564|593669811|FG000|Overall Study|low medication compliance|4|||
164353888|NCT01409564|593669812|FG001|Overall Study|low medication compliance|3|||
164353889|NCT01409564|593669811|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
164353890|NCT01409564|593669812|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
164353891|NCT02782780|593669813|FG000|Overall Study|dropped out after randomization.|7|||
164353892|NCT02782780|593669814|FG001|Overall Study|dropped out after randomization.|5|||
164353893|NCT02782780|593669813|FG000|Overall Study|Protocol Violation|0|||
164353894|NCT02782780|593669814|FG001|Overall Study|Protocol Violation|2|||
164353895|NCT01413191|593669815|FG000|Overall Study|Lost to Follow-up|5|||
164353896|NCT01413191|593669815|FG000|Overall Study|Disease Progression|5|||
164353897|NCT01413191|593669815|FG000|Overall Study|Death|1|||
164353898|NCT05040386|593669816|FG000|Overall Study|Withdrawal by Subject|1|||
164693973|NCT01714739|594901230|FG004|Overall Study|Adverse Event unrelated to drug|0|||
164693974|NCT01714739|594901231|FG005|Overall Study|Adverse Event unrelated to drug|0|||
164693975|NCT01714739|594901232|FG006|Overall Study|Adverse Event unrelated to drug|0|||
164693976|NCT01714739|594901226|FG000|Overall Study|Participant request to stop therapy|0|||
164693977|NCT01714739|594901227|FG001|Overall Study|Participant request to stop therapy|1|||
164693978|NCT01714739|594901228|FG002|Overall Study|Participant request to stop therapy|0|||
164693979|NCT01714739|594901229|FG003|Overall Study|Participant request to stop therapy|6|||
164693980|NCT01714739|594901230|FG004|Overall Study|Participant request to stop therapy|0|||
164693981|NCT01714739|594901231|FG005|Overall Study|Participant request to stop therapy|0|||
164693982|NCT01714739|594901232|FG006|Overall Study|Participant request to stop therapy|0|||
164693983|NCT01714739|594901226|FG000|Overall Study|Participant withdrew consent|0|||
164693984|NCT01714739|594901227|FG001|Overall Study|Participant withdrew consent|1|||
164693985|NCT01714739|594901228|FG002|Overall Study|Participant withdrew consent|0|||
164693986|NCT01714739|594901229|FG003|Overall Study|Participant withdrew consent|8|||
164693987|NCT01714739|594901230|FG004|Overall Study|Participant withdrew consent|0|||
164693988|NCT01714739|594901231|FG005|Overall Study|Participant withdrew consent|0|||
164693989|NCT01714739|594901232|FG006|Overall Study|Participant withdrew consent|0|||
164693990|NCT01714739|594901226|FG000|Overall Study|Lost to Follow-up|0|||
164693991|NCT01714739|594901227|FG001|Overall Study|Lost to Follow-up|0|||
164353899|NCT05040386|593669817|FG001|Overall Study|Withdrawal by Subject|0|||
164353900|NCT05040386|593669818|FG002|Overall Study|Withdrawal by Subject|1|||
164353901|NCT05040386|593669819|FG003|Overall Study|Withdrawal by Subject|0|||
164693992|NCT01714739|594901228|FG002|Overall Study|Lost to Follow-up|0|||
164693993|NCT01714739|594901229|FG003|Overall Study|Lost to Follow-up|1|||
164353902|NCT05040386|593669816|FG000|Overall Study|Lost to Follow-up|0|||
164353903|NCT05040386|593669817|FG001|Overall Study|Lost to Follow-up|0|||
164353904|NCT05040386|593669818|FG002|Overall Study|Lost to Follow-up|1|||
164693994|NCT01714739|594901230|FG004|Overall Study|Lost to Follow-up|0|||
164693995|NCT01714739|594901231|FG005|Overall Study|Lost to Follow-up|0|||
164693996|NCT01714739|594901232|FG006|Overall Study|Lost to Follow-up|0|||
164693997|NCT01714739|594901226|FG000|Overall Study|Maximum clinical benefit|0|||
164693998|NCT01714739|594901227|FG001|Overall Study|Maximum clinical benefit|1|||
164693999|NCT01714739|594901228|FG002|Overall Study|Maximum clinical benefit|1|||
164694000|NCT01714739|594901229|FG003|Overall Study|Maximum clinical benefit|3|||
164694001|NCT01714739|594901230|FG004|Overall Study|Maximum clinical benefit|0|||
164694002|NCT01714739|594901231|FG005|Overall Study|Maximum clinical benefit|0|||
164694003|NCT01714739|594901232|FG006|Overall Study|Maximum clinical benefit|0|||
164694004|NCT01714739|594901226|FG000|Overall Study|Poor/non-comliance|0|||
164694005|NCT01714739|594901227|FG001|Overall Study|Poor/non-comliance|1|||
164694006|NCT01714739|594901228|FG002|Overall Study|Poor/non-comliance|0|||
164694007|NCT01714739|594901229|FG003|Overall Study|Poor/non-comliance|1|||
164694008|NCT01714739|594901230|FG004|Overall Study|Poor/non-comliance|0|||
164694009|NCT01714739|594901231|FG005|Overall Study|Poor/non-comliance|0|||
164694010|NCT01714739|594901232|FG006|Overall Study|Poor/non-comliance|0|||
164694011|NCT01714739|594901226|FG000|Overall Study|No longer meets study criteria|0|||
164694012|NCT01714739|594901227|FG001|Overall Study|No longer meets study criteria|0|||
164694013|NCT01714739|594901228|FG002|Overall Study|No longer meets study criteria|0|||
164694014|NCT01714739|594901229|FG003|Overall Study|No longer meets study criteria|1|||
164694015|NCT01714739|594901230|FG004|Overall Study|No longer meets study criteria|0|||
164694016|NCT01714739|594901231|FG005|Overall Study|No longer meets study criteria|0|||
164694017|NCT01714739|594901232|FG006|Overall Study|No longer meets study criteria|0|||
164694018|NCT01714739|594901226|FG000|Overall Study|Other reason|0|||
164694019|NCT01714739|594901227|FG001|Overall Study|Other reason|0|||
164694020|NCT01714739|594901228|FG002|Overall Study|Other reason|0|||
164694021|NCT01714739|594901229|FG003|Overall Study|Other reason|3|||
164694022|NCT01714739|594901230|FG004|Overall Study|Other reason|1|||
164694023|NCT01714739|594901231|FG005|Overall Study|Other reason|0|||
164694024|NCT01714739|594901232|FG006|Overall Study|Other reason|0|||
164694025|NCT02531594|594901233|FG000|Overall Study|Withdrawal by Subject|7|||
164694026|NCT02531594|594901234|FG001|Overall Study|Withdrawal by Subject|8|||
164694027|NCT03649412|594901245|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
164694028|NCT03649412|594901246|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
164694029|NCT03649412|594901245|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
164694030|NCT03649412|594901246|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
164694031|NCT03649412|594901245|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
164694032|NCT03649412|594901246|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
164694033|NCT03649412|594901245|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
164694034|NCT03649412|594901246|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
164694035|NCT03649412|594901245|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
164694036|NCT03649412|594901246|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
164694037|NCT03649412|594901245|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
164694038|NCT03649412|594901246|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
164694039|NCT00865514|594901247|FG000|Overall Study|Infusion cost exceeded funding|2|||
164694040|NCT02865395|594901248|FG000|Overall Study|Physician Decision|6|||
164694041|NCT02865395|594901249|FG001|Overall Study|Physician Decision|10|||
164694042|NCT02865395|594901250|FG002|Overall Study|Physician Decision|7|||
164694043|NCT04364763|594901251|FG000|Overall Study|Death|1|||
164694044|NCT04364763|594901252|FG001|Overall Study|Death|2|||
164436884|NCT00139737|593966425|FG000|Overall Study|Laboratory Abnormality|2|||
164694045|NCT04364763|594901251|FG000|Overall Study|Lost to Follow-up|1|||
164694046|NCT04364763|594901252|FG001|Overall Study|Lost to Follow-up|0|||
164694047|NCT02250651|594901255|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
164694048|NCT02250651|594901256|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
164694049|NCT02250651|594901257|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
164694050|NCT02250651|594901255|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
164694051|NCT02250651|594901256|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
164694052|NCT02250651|594901257|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
164694053|NCT02250651|594901255|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
164694054|NCT02250651|594901256|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
164694055|NCT02250651|594901257|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
164694056|NCT02250651|594901255|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
164694057|NCT02250651|594901256|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
164694058|NCT02250651|594901257|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
164694059|NCT02250651|594901255|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
164694060|NCT02250651|594901256|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
164694061|NCT02250651|594901257|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
164694062|NCT02250651|594901255|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
164694063|NCT02250651|594901256|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
164694064|NCT02250651|594901257|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
164694065|NCT02250651|594901255|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
164694066|NCT02250651|594901256|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
164694067|NCT02250651|594901257|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
164694068|NCT02250651|594901255|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
164353905|NCT05040386|593669819|FG003|Overall Study|Lost to Follow-up|0|||
164353906|NCT03654651|593669820|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
164353907|NCT03654651|593669821|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
164353908|NCT03045328|593669822|FG000|Overall Study|Withdrawal by Subject|2|||
164353909|NCT00592839|593669825|FG000|Overall Study|Withdrawal by Subject|1|||
164353910|NCT00592839|593669826|FG001|Overall Study|Withdrawal by Subject|1|||
164353911|NCT00592839|593669827|FG002|Overall Study|Withdrawal by Subject|3|||
164353912|NCT00592839|593669825|FG000|Overall Study|Protocol Violation|1|||
164353913|NCT00592839|593669826|FG001|Overall Study|Protocol Violation|1|||
164353914|NCT00592839|593669827|FG002|Overall Study|Protocol Violation|2|||
164353915|NCT00592839|593669825|FG000|Overall Study|Adverse Event|0|||
164353916|NCT00592839|593669826|FG001|Overall Study|Adverse Event|1|||
164353917|NCT00592839|593669827|FG002|Overall Study|Adverse Event|0|||
164353918|NCT00592839|593669825|FG000|Overall Study|Lost to Follow-up|0|||
164353919|NCT00592839|593669826|FG001|Overall Study|Lost to Follow-up|1|||
164353920|NCT00592839|593669827|FG002|Overall Study|Lost to Follow-up|1|||
164353921|NCT00589914|593669830|FG000|Overall Study|Adverse Event|19|||
164353922|NCT00589914|593669831|FG001|Overall Study|Adverse Event|10|||
164353923|NCT00589914|593669830|FG000|Overall Study|Death|2|||
164353924|NCT00589914|593669831|FG001|Overall Study|Death|0|||
164353925|NCT00589914|593669830|FG000|Overall Study|Lack of Efficacy|40|||
164353926|NCT00589914|593669831|FG001|Overall Study|Lack of Efficacy|43|||
164353927|NCT00589914|593669830|FG000|Overall Study|Lost to Follow-up|11|||
164353928|NCT00589914|593669831|FG001|Overall Study|Lost to Follow-up|18|||
164353929|NCT00589914|593669830|FG000|Overall Study|Pregnancy|1|||
164353930|NCT00589914|593669831|FG001|Overall Study|Pregnancy|0|||
164353931|NCT00589914|593669830|FG000|Overall Study|Withdrawal by Subject|55|||
164353932|NCT00589914|593669831|FG001|Overall Study|Withdrawal by Subject|49|||
164353933|NCT00589914|593669830|FG000|Overall Study|Other|22|||
164353934|NCT00589914|593669831|FG001|Overall Study|Other|17|||
164353935|NCT00799487|593669833|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
164353936|NCT00799487|593669834|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
164353937|NCT00799487|593669835|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
164353938|NCT00799487|593669833|FG000|Dose Adjustment Period|Adverse Event|2|||
164694069|NCT02250651|594901256|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
164588425|NCT01519427|594517579|FG000|Overall Study|disease progression|2|||
164588426|NCT00798967|594517589|FG000|Overall Study|Adverse Event|2|||
164588427|NCT00798967|594517590|FG001|Overall Study|Adverse Event|3|||
164588428|NCT00798967|594517589|FG000|Overall Study|Withdrawal by Subject|0|||
164588429|NCT00798967|594517590|FG001|Overall Study|Withdrawal by Subject|1|||
164588430|NCT00798967|594517589|FG000|Overall Study|Physician Decision|1|||
164588431|NCT00798967|594517590|FG001|Overall Study|Physician Decision|0|||
164588432|NCT00798967|594517589|FG000|Overall Study|Randomized in error by site|1|||
164588433|NCT00798967|594517590|FG001|Overall Study|Randomized in error by site|0|||
164588434|NCT00633139|594517593|FG000|Overall Study|Non compliance|0|||
164588435|NCT00633139|594517594|FG001|Overall Study|Non compliance|0|||
164588436|NCT00633139|594517595|FG002|Overall Study|Non compliance|1|||
164588437|NCT00633139|594517593|FG000|Overall Study|Withdrawal by Subject|0|||
164588438|NCT00633139|594517594|FG001|Overall Study|Withdrawal by Subject|1|||
164588439|NCT00633139|594517595|FG002|Overall Study|Withdrawal by Subject|0|||
164588440|NCT02269319|594517597|FG000|Overall Study|Lost to Follow-up|4|||
164588441|NCT02269319|594517598|FG001|Overall Study|Lost to Follow-up|3|||
164588442|NCT02269319|594517597|FG000|Overall Study|Adverse Event|0|||
164588443|NCT02269319|594517598|FG001|Overall Study|Adverse Event|1|||
164588444|NCT02269319|594517597|FG000|Overall Study|Instructions not followed|1|||
164588445|NCT02269319|594517598|FG001|Overall Study|Instructions not followed|0|||
164588446|NCT01507246|594517599|FG000|Overall Study|Required different surgical procedures|2|||
164588447|NCT01507246|594517600|FG001|Overall Study|Required different surgical procedures|1|||
164588448|NCT04083222|594517601|FG000|Overall Study|Voluntary Withdrawal|0|||
164588449|NCT04083222|594517602|FG001|Overall Study|Voluntary Withdrawal|1|||
164588450|NCT04083222|594517601|FG000|Overall Study|Reason not Specified|0|||
164588451|NCT04083222|594517602|FG001|Overall Study|Reason not Specified|1|||
164588452|NCT03575468|594517605|FG000|Overall Study|Withdrawal by Subject|3|||
164588453|NCT03575468|594517606|FG001|Overall Study|Withdrawal by Subject|0|||
164588454|NCT03575468|594517605|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
164694070|NCT02250651|594901257|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
164694071|NCT02250651|594901255|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
164694072|NCT02250651|594901256|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
164694073|NCT02250651|594901257|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
164694074|NCT02250651|594901255|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
164694075|NCT02250651|594901256|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
164694076|NCT02250651|594901257|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
164694077|NCT02250651|594901255|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
164694078|NCT02250651|594901256|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
164694079|NCT02250651|594901257|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
164694080|NCT02250651|594901255|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
164694081|NCT02250651|594901256|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
164694082|NCT02250651|594901257|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
164694083|NCT02250651|594901255|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
164694084|NCT02250651|594901256|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
164694085|NCT02250651|594901257|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
164694086|NCT02250651|594901255|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
164694087|NCT02250651|594901256|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
164694088|NCT02250651|594901257|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
164694089|NCT02250651|594901255|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
164694090|NCT02250651|594901256|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
164694091|NCT02250651|594901257|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
164694092|NCT01264835|594901258|FG000|Overall Study|Lost to Follow-up|1|||
164436885|NCT00139737|593966425|FG000|Overall Study|Protocol Violation|18|||
164588455|NCT03575468|594517606|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
164588456|NCT03575468|594517605|FG000|Overall Study|Lost to Follow-up|13|||
164588457|NCT03575468|594517606|FG001|Overall Study|Lost to Follow-up|17|||
164588458|NCT01522651|594517607|FG000|Overall Study|Adverse Event|3|||
164588459|NCT01522651|594517608|FG001|Overall Study|Adverse Event|4|||
164588460|NCT01522651|594517609|FG002|Overall Study|Adverse Event|4|||
164588461|NCT01522651|594517610|FG003|Overall Study|Adverse Event|5|||
164588462|NCT01522651|594517611|FG004|Overall Study|Adverse Event|4|||
164588463|NCT01522651|594517607|FG000|Overall Study|Cardioversion|1|||
164588464|NCT01522651|594517608|FG001|Overall Study|Cardioversion|0|||
164588465|NCT01522651|594517609|FG002|Overall Study|Cardioversion|0|||
164588466|NCT01522651|594517610|FG003|Overall Study|Cardioversion|0|||
164588467|NCT01522651|594517611|FG004|Overall Study|Cardioversion|0|||
164588468|NCT01522651|594517607|FG000|Overall Study|Device Malfunction|0|||
164588469|NCT01522651|594517608|FG001|Overall Study|Device Malfunction|1|||
164588470|NCT01522651|594517609|FG002|Overall Study|Device Malfunction|0|||
164588471|NCT01522651|594517610|FG003|Overall Study|Device Malfunction|0|||
164694093|NCT01256060|594901259|FG000|Overall Study|Lost to Follow-up|0|||
164694094|NCT01256060|594901260|FG001|Overall Study|Lost to Follow-up|1|||
164694095|NCT01256060|594901261|FG002|Overall Study|Lost to Follow-up|0|||
164694096|NCT01256060|594901262|FG003|Overall Study|Lost to Follow-up|0|||
164694097|NCT01557920|594901269|FG000|Overall Study|Withdrawal by Subject|2|||
164694098|NCT01557920|594901270|FG001|Overall Study|Withdrawal by Subject|3|||
164694099|NCT01557920|594901269|FG000|Overall Study|Lack of Efficacy|1|||
164694100|NCT01557920|594901270|FG001|Overall Study|Lack of Efficacy|0|||
164694101|NCT00436917|594901271|FG000|Overall Study|Withdrawal by Subject|13|||
164694102|NCT00436917|594901271|FG000|Overall Study|Adverse Event|2|||
164694103|NCT00436917|594901271|FG000|Overall Study|Physician Decision|1|||
164694104|NCT00436917|594901271|FG000|Overall Study|Death|1|||
164694105|NCT00436917|594901271|FG000|Overall Study|Lost to Follow-up|1|||
164694106|NCT00436917|594901271|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
164694107|NCT00436917|594901271|FG000|Overall Study|Increased creatinine|1|||
164694108|NCT00436917|594901271|FG000|Overall Study|Personal conflicts of patient|1|||
164694109|NCT03170869|594901272|FG000|Overall Study|Protocol Violation|5|||
164694110|NCT03170869|594901272|FG000|Overall Study|Early study termination|3|||
164694111|NCT01175473|594901275|FG000|Overall Study|Adverse Event|2|||
164299276|NCT02531802|593471288|FG010|Received Vaccination 2|Physician Decision|0|||
164299277|NCT02531802|593471289|FG011|Received Vaccination 2|Physician Decision|0|||
164299278|NCT02531802|593471290|FG012|Received Vaccination 2|Physician Decision|0|||
164299279|NCT02531802|593471291|FG013|Received Vaccination 2|Physician Decision|1|||
164299280|NCT02531802|593471292|FG014|Received Vaccination 2|Physician Decision|0|||
164299281|NCT02531802|593471293|FG015|Received Vaccination 2|Physician Decision|0|||
164299282|NCT02531802|593471294|FG016|Received Vaccination 2|Physician Decision|0|||
164299283|NCT02531802|593471295|FG017|Received Vaccination 2|Physician Decision|1|||
164299284|NCT02531802|593471296|FG018|Received Vaccination 2|Physician Decision|0|||
164299285|NCT02531802|593471297|FG019|Received Vaccination 2|Physician Decision|0|||
164299286|NCT02531802|593471298|FG020|Received Vaccination 2|Physician Decision|0|||
164299287|NCT02531802|593471278|FG000|Received Vaccination 2|Adverse Event|0|||
164299288|NCT02531802|593471279|FG001|Received Vaccination 2|Adverse Event|0|||
164299289|NCT02531802|593471280|FG002|Received Vaccination 2|Adverse Event|0|||
164299290|NCT02531802|593471281|FG003|Received Vaccination 2|Adverse Event|0|||
164299291|NCT02531802|593471282|FG004|Received Vaccination 2|Adverse Event|0|||
164299292|NCT02531802|593471283|FG005|Received Vaccination 2|Adverse Event|2|||
164299293|NCT02531802|593471284|FG006|Received Vaccination 2|Adverse Event|0|||
164299294|NCT02531802|593471285|FG007|Received Vaccination 2|Adverse Event|0|||
164299295|NCT02531802|593471286|FG008|Received Vaccination 2|Adverse Event|0|||
164299296|NCT02531802|593471287|FG009|Received Vaccination 2|Adverse Event|0|||
164299297|NCT02531802|593471288|FG010|Received Vaccination 2|Adverse Event|0|||
164299298|NCT02531802|593471289|FG011|Received Vaccination 2|Adverse Event|0|||
164299299|NCT02531802|593471290|FG012|Received Vaccination 2|Adverse Event|0|||
164299300|NCT02531802|593471291|FG013|Received Vaccination 2|Adverse Event|0|||
164299301|NCT02531802|593471292|FG014|Received Vaccination 2|Adverse Event|0|||
164299302|NCT02531802|593471293|FG015|Received Vaccination 2|Adverse Event|0|||
164299303|NCT02531802|593471294|FG016|Received Vaccination 2|Adverse Event|0|||
164299304|NCT02531802|593471295|FG017|Received Vaccination 2|Adverse Event|2|||
164299305|NCT02531802|593471296|FG018|Received Vaccination 2|Adverse Event|1|||
164299306|NCT02531802|593471297|FG019|Received Vaccination 2|Adverse Event|0|||
164299307|NCT02531802|593471298|FG020|Received Vaccination 2|Adverse Event|1|||
164299308|NCT02531802|593471278|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
164299309|NCT02531802|593471279|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
164299310|NCT02531802|593471280|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
164299311|NCT02531802|593471281|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
164299312|NCT02531802|593471282|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
164299313|NCT02531802|593471283|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
164299314|NCT02531802|593471284|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
164299315|NCT02531802|593471285|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
164299316|NCT02531802|593471286|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
164299317|NCT02531802|593471287|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
164299318|NCT02531802|593471288|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
164299319|NCT02531802|593471289|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
164299320|NCT02531802|593471290|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
164299321|NCT02531802|593471291|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
164299322|NCT02531802|593471292|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
164299323|NCT02531802|593471293|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
164299324|NCT02531802|593471294|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
164299325|NCT02531802|593471295|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
164299326|NCT02531802|593471296|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
164299327|NCT02531802|593471297|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
164694112|NCT01175473|594901276|FG001|Overall Study|Adverse Event|2|||
164694113|NCT00983528|594901277|FG000|Overall Study|Death|4|||
164694114|NCT00983528|594901277|FG000|Overall Study|Lost to Follow-up|1|||
164694115|NCT00983528|594901277|FG000|Overall Study|Study Terminated|1|||
164588472|NCT01522651|594517611|FG004|Overall Study|Device Malfunction|0|||
164588473|NCT01522651|594517607|FG000|Overall Study|Investigator's Discretion|0|||
164588474|NCT01522651|594517608|FG001|Overall Study|Investigator's Discretion|1|||
164588475|NCT01522651|594517609|FG002|Overall Study|Investigator's Discretion|0|||
164588476|NCT01522651|594517610|FG003|Overall Study|Investigator's Discretion|0|||
164588477|NCT01522651|594517611|FG004|Overall Study|Investigator's Discretion|0|||
164588478|NCT01522651|594517607|FG000|Overall Study|Protocol Violation|3|||
164588479|NCT01522651|594517608|FG001|Overall Study|Protocol Violation|0|||
164588480|NCT01522651|594517609|FG002|Overall Study|Protocol Violation|0|||
164588481|NCT01522651|594517610|FG003|Overall Study|Protocol Violation|0|||
164588482|NCT01522651|594517611|FG004|Overall Study|Protocol Violation|0|||
164588483|NCT01522651|594517607|FG000|Overall Study|Reason Not Specified|0|||
164588484|NCT01522651|594517608|FG001|Overall Study|Reason Not Specified|0|||
164588485|NCT01522651|594517609|FG002|Overall Study|Reason Not Specified|0|||
164588486|NCT01522651|594517610|FG003|Overall Study|Reason Not Specified|1|||
164588487|NCT01522651|594517611|FG004|Overall Study|Reason Not Specified|0|||
164588488|NCT01522651|594517607|FG000|Overall Study|Participant Non-Compliance|1|||
164588489|NCT01522651|594517608|FG001|Overall Study|Participant Non-Compliance|0|||
164588490|NCT01522651|594517609|FG002|Overall Study|Participant Non-Compliance|0|||
164588491|NCT01522651|594517610|FG003|Overall Study|Participant Non-Compliance|0|||
164588492|NCT01522651|594517611|FG004|Overall Study|Participant Non-Compliance|0|||
164588493|NCT01522651|594517607|FG000|Overall Study|Withdrew Consent|1|||
164588494|NCT01522651|594517608|FG001|Overall Study|Withdrew Consent|1|||
164588495|NCT01522651|594517609|FG002|Overall Study|Withdrew Consent|0|||
164588496|NCT01522651|594517610|FG003|Overall Study|Withdrew Consent|1|||
164588497|NCT01522651|594517611|FG004|Overall Study|Withdrew Consent|1|||
164588498|NCT01522651|594517607|FG000|Overall Study|Randomized but Never Treated|0|||
164588499|NCT01522651|594517608|FG001|Overall Study|Randomized but Never Treated|1|||
164588500|NCT01522651|594517609|FG002|Overall Study|Randomized but Never Treated|0|||
164588501|NCT01522651|594517610|FG003|Overall Study|Randomized but Never Treated|1|||
164588502|NCT01522651|594517611|FG004|Overall Study|Randomized but Never Treated|1|||
164588503|NCT01989546|594519127|FG000|Overall Study|Clinical Progression|1|||
164588504|NCT01989546|594519127|FG000|Overall Study|Disease progression on study|8|||
164588505|NCT01793051|594519134|FG000|Overall Study|Withdrawal by Subject|6|||
164588506|NCT01793051|594519135|FG001|Overall Study|Withdrawal by Subject|4|||
164588507|NCT01793051|594519134|FG000|Overall Study|Adverse Event|0|||
164588508|NCT01793051|594519135|FG001|Overall Study|Adverse Event|2|||
164588509|NCT01793051|594519134|FG000|Overall Study|Too ill to continue|1|||
164588510|NCT01793051|594519135|FG001|Overall Study|Too ill to continue|0|||
164588511|NCT01793051|594519134|FG000|Overall Study|Switched chemo|1|||
164588512|NCT01793051|594519135|FG001|Overall Study|Switched chemo|1|||
164588513|NCT01793051|594519134|FG000|Overall Study|Lack of compliance|1|||
164588514|NCT01793051|594519135|FG001|Overall Study|Lack of compliance|0|||
164588515|NCT01793051|594519134|FG000|Overall Study|Requested to be removed from the study|1|||
164588516|NCT01793051|594519135|FG001|Overall Study|Requested to be removed from the study|1|||
164694116|NCT00373425|594901279|FG000|Overall Study|Relapse of NSCLC|116|||
164694117|NCT00373425|594901280|FG001|Overall Study|Relapse of NSCLC|104|||
164694118|NCT00373425|594901281|FG002|Overall Study|Relapse of NSCLC|19|||
164694119|NCT00373425|594901282|FG003|Overall Study|Relapse of NSCLC|2|||
164694120|NCT00373425|594901283|FG004|Overall Study|Relapse of NSCLC|26|||
164694121|NCT00373425|594901279|FG000|Overall Study|Adverse Event|191|||
164694122|NCT00373425|594901280|FG001|Overall Study|Adverse Event|22|||
164353939|NCT00799487|593669834|FG001|Dose Adjustment Period|Adverse Event|0|||
164353940|NCT00799487|593669835|FG002|Dose Adjustment Period|Adverse Event|0|||
164353941|NCT00799487|593669833|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
164353942|NCT00799487|593669834|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
164353943|NCT00799487|593669835|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
164353944|NCT00799487|593669833|FG000|Dose Adjustment Period|Investigator Discretion|2|||
164353945|NCT00799487|593669834|FG001|Dose Adjustment Period|Investigator Discretion|0|||
164353946|NCT00799487|593669835|FG002|Dose Adjustment Period|Investigator Discretion|0|||
164353947|NCT00799487|593669833|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
164353948|NCT00799487|593669834|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
164588517|NCT00059215|594519137|FG000|Overall Study|Adverse Event|5|||
164588518|NCT00059215|594519138|FG001|Overall Study|Adverse Event|5|||
164353949|NCT00799487|593669835|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
164588519|NCT00059215|594519139|FG002|Overall Study|Adverse Event|9|||
164588520|NCT00059215|594519140|FG003|Overall Study|Adverse Event|9|||
164588521|NCT00059215|594519137|FG000|Overall Study|Death|0|||
164588522|NCT00059215|594519138|FG001|Overall Study|Death|0|||
164588523|NCT00059215|594519139|FG002|Overall Study|Death|3|||
164588524|NCT00059215|594519140|FG003|Overall Study|Death|0|||
164588525|NCT00059215|594519137|FG000|Overall Study|Lost to Follow-up|1|||
164588526|NCT00059215|594519138|FG001|Overall Study|Lost to Follow-up|2|||
164588527|NCT00059215|594519139|FG002|Overall Study|Lost to Follow-up|0|||
164588528|NCT00059215|594519140|FG003|Overall Study|Lost to Follow-up|0|||
164588529|NCT00059215|594519137|FG000|Overall Study|Withdrawal by Subject|4|||
164694123|NCT00373425|594901281|FG002|Overall Study|Adverse Event|59|||
164353950|NCT00799487|593669833|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
164353951|NCT00799487|593669834|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
164353952|NCT00799487|593669835|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
164353953|NCT00799487|593669833|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
164353954|NCT00799487|593669834|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
164353955|NCT00799487|593669835|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
164353956|NCT00799487|593669833|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
164588530|NCT00059215|594519138|FG001|Overall Study|Withdrawal by Subject|4|||
164588531|NCT00059215|594519139|FG002|Overall Study|Withdrawal by Subject|1|||
164588532|NCT00059215|594519140|FG003|Overall Study|Withdrawal by Subject|3|||
164588533|NCT00059215|594519137|FG000|Overall Study|Protocol Violation|1|||
164588534|NCT00059215|594519138|FG001|Overall Study|Protocol Violation|0|||
164588535|NCT00059215|594519139|FG002|Overall Study|Protocol Violation|1|||
164588536|NCT00059215|594519140|FG003|Overall Study|Protocol Violation|0|||
164588537|NCT00059215|594519137|FG000|Overall Study|Protocol entry criteria not met|1|||
164588538|NCT00059215|594519138|FG001|Overall Study|Protocol entry criteria not met|1|||
164588539|NCT00059215|594519139|FG002|Overall Study|Protocol entry criteria not met|0|||
164588540|NCT00059215|594519140|FG003|Overall Study|Protocol entry criteria not met|2|||
164588541|NCT00059215|594519137|FG000|Overall Study|Physician Decision|1|||
164588542|NCT00059215|594519138|FG001|Overall Study|Physician Decision|2|||
164588543|NCT00059215|594519139|FG002|Overall Study|Physician Decision|1|||
164588544|NCT00059215|594519140|FG003|Overall Study|Physician Decision|1|||
164588545|NCT04494633|594519141|FG000|Overall Study|Lost to Follow-up|5|||
164588546|NCT04494633|594519142|FG001|Overall Study|Lost to Follow-up|3|||
164588547|NCT04494633|594519141|FG000|Overall Study|Protocol Violation|1|||
164588548|NCT04494633|594519142|FG001|Overall Study|Protocol Violation|1|||
164588549|NCT01958671|594519143|FG000|Overall Study|Adverse Event|1|||
164588550|NCT01958671|594519144|FG001|Overall Study|Adverse Event|1|||
164588551|NCT01958671|594519145|FG002|Overall Study|Adverse Event|5|||
164588552|NCT01958671|594519143|FG000|Overall Study|Death|1|||
164588553|NCT01958671|594519144|FG001|Overall Study|Death|0|||
164588554|NCT01958671|594519145|FG002|Overall Study|Death|0|||
164588555|NCT01958671|594519143|FG000|Overall Study|Excluded medication|0|||
164588556|NCT01958671|594519144|FG001|Overall Study|Excluded medication|0|||
164588557|NCT01958671|594519145|FG002|Overall Study|Excluded medication|1|||
164588558|NCT01958671|594519143|FG000|Overall Study|Hyperglycemia|0|||
164588559|NCT01958671|594519144|FG001|Overall Study|Hyperglycemia|0|||
164588560|NCT01958671|594519145|FG002|Overall Study|Hyperglycemia|2|||
164588561|NCT01958671|594519143|FG000|Overall Study|Lost to Follow-up|7|||
164588562|NCT01958671|594519144|FG001|Overall Study|Lost to Follow-up|11|||
164588563|NCT01958671|594519145|FG002|Overall Study|Lost to Follow-up|7|||
164588564|NCT01958671|594519143|FG000|Overall Study|Non-compliance with study drug|1|||
164588565|NCT01958671|594519144|FG001|Overall Study|Non-compliance with study drug|1|||
164588566|NCT01958671|594519145|FG002|Overall Study|Non-compliance with study drug|1|||
164588567|NCT01958671|594519143|FG000|Overall Study|Pregnancy|0|||
164588568|NCT01958671|594519144|FG001|Overall Study|Pregnancy|0|||
164588569|NCT01958671|594519145|FG002|Overall Study|Pregnancy|1|||
164588570|NCT01958671|594519143|FG000|Overall Study|Protocol Violation|0|||
164588571|NCT01958671|594519144|FG001|Overall Study|Protocol Violation|1|||
164588572|NCT01958671|594519145|FG002|Overall Study|Protocol Violation|0|||
164588573|NCT01958671|594519143|FG000|Overall Study|Study site terminated by sponsor|1|||
164588574|NCT01958671|594519144|FG001|Overall Study|Study site terminated by sponsor|0|||
164588575|NCT01958671|594519145|FG002|Overall Study|Study site terminated by sponsor|1|||
164588576|NCT01958671|594519143|FG000|Overall Study|Participant moved|0|||
164588577|NCT01958671|594519144|FG001|Overall Study|Participant moved|0|||
164588578|NCT01958671|594519145|FG002|Overall Study|Participant moved|1|||
164588579|NCT01958671|594519143|FG000|Overall Study|Withdrawal by Subject|8|||
164588580|NCT01958671|594519144|FG001|Overall Study|Withdrawal by Subject|10|||
164588581|NCT01958671|594519145|FG002|Overall Study|Withdrawal by Subject|13|||
164588582|NCT02207530|594519148|FG000|Overall Study|Worsening condition under investigation|78|||
164588583|NCT02207530|594519148|FG000|Overall Study|Patient decision to stop study treatment|5|||
164588584|NCT02207530|594519148|FG000|Overall Study|Adverse Event|8|||
164588585|NCT03952468|594519151|FG000|Overall Study|Death|0|||
164588586|NCT03952468|594519152|FG001|Overall Study|Death|1|||
164588587|NCT03952468|594519151|FG000|Overall Study|Adverse Event|0|||
164588588|NCT03952468|594519152|FG001|Overall Study|Adverse Event|1|||
164588589|NCT03952468|594519151|FG000|Overall Study|Physician Decision|1|||
164588590|NCT03952468|594519152|FG001|Overall Study|Physician Decision|0|||
164588591|NCT03952468|594519151|FG000|Overall Study|Lost to Follow-up|3|||
164588592|NCT03952468|594519152|FG001|Overall Study|Lost to Follow-up|4|||
164588593|NCT03952468|594519151|FG000|Overall Study|Withdrawal by Subject|2|||
164588594|NCT03952468|594519152|FG001|Overall Study|Withdrawal by Subject|1|||
164588595|NCT01849848|594519153|FG000|Overall Study|Physician Decision|1|||
164588596|NCT01849848|594519153|FG000|Overall Study|Progression of the primary disease|3|||
164588597|NCT01702363|594519155|FG000|Overall Study|Adverse Event|14|||
164588598|NCT01702363|594519155|FG000|Overall Study|Lack of Efficacy|4|||
164588599|NCT01702363|594519155|FG000|Overall Study|Withdrawal by Subject|2|||
164588600|NCT00406315|594519157|FG000|Overall Study|Death|1|||
164588601|NCT00406315|594519157|FG000|Overall Study|Adverse Event|39|||
164588602|NCT00406315|594519157|FG000|Overall Study|Laboratory Abnormality|4|||
164588603|NCT00406315|594519157|FG000|Overall Study|Lack of Efficacy|13|||
164588604|NCT00406315|594519157|FG000|Overall Study|Other|33|||
164588605|NCT00406315|594519157|FG000|Overall Study|Lost to Follow-up|21|||
164299328|NCT02531802|593471298|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
164299329|NCT00106704|593471299|FG000|Overall Study|Adverse Event|10|||
164299330|NCT00106704|593471300|FG001|Overall Study|Adverse Event|7|||
164299331|NCT00106704|593471299|FG000|Overall Study|Death|2|||
164588606|NCT00406315|594519157|FG000|Overall Study|Withdrawal by Subject|30|||
164588607|NCT02202031|594519158|FG000|Overall Study|Lost to Follow-up|1|||
164588608|NCT02202031|594519159|FG001|Overall Study|Lost to Follow-up|0|||
164588609|NCT02202031|594519158|FG000|Overall Study|Too Busy|1|||
164588610|NCT02202031|594519159|FG001|Overall Study|Too Busy|3|||
164588611|NCT02202031|594519158|FG000|Overall Study|Illness/Medical Reason|0|||
164588612|NCT02202031|594519159|FG001|Overall Study|Illness/Medical Reason|2|||
164588613|NCT02202031|594519158|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
164588614|NCT02202031|594519159|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
164588615|NCT00321984|594519161|FG000|Overall Study|Adverse Event|9|||
164588616|NCT00321984|594519162|FG001|Overall Study|Adverse Event|6|||
164588617|NCT00321984|594519163|FG002|Overall Study|Adverse Event|8|||
164588618|NCT00321984|594519161|FG000|Overall Study|Protocol Violation|0|||
164588619|NCT00321984|594519162|FG001|Overall Study|Protocol Violation|1|||
164588620|NCT00321984|594519163|FG002|Overall Study|Protocol Violation|1|||
164588621|NCT00321984|594519161|FG000|Overall Study|Lost to Follow-up|2|||
164588622|NCT00321984|594519162|FG001|Overall Study|Lost to Follow-up|4|||
164588623|NCT00321984|594519163|FG002|Overall Study|Lost to Follow-up|2|||
164588624|NCT00321984|594519161|FG000|Overall Study|Withdrawal by Subject|8|||
164588625|NCT00321984|594519162|FG001|Overall Study|Withdrawal by Subject|6|||
164588626|NCT00321984|594519163|FG002|Overall Study|Withdrawal by Subject|5|||
164588627|NCT00321984|594519161|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
164588628|NCT00321984|594519162|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
164588629|NCT00321984|594519163|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
164588630|NCT00321984|594519161|FG000|Overall Study|Lack of Efficacy|3|||
164588631|NCT00321984|594519162|FG001|Overall Study|Lack of Efficacy|1|||
164588632|NCT00321984|594519163|FG002|Overall Study|Lack of Efficacy|3|||
164588633|NCT00321984|594519161|FG000|Overall Study|Noncompliant|0|||
164588634|NCT00321984|594519162|FG001|Overall Study|Noncompliant|0|||
164588635|NCT00321984|594519163|FG002|Overall Study|Noncompliant|2|||
164588636|NCT00321984|594519161|FG000|Overall Study|Pregnancy|0|||
164588637|NCT00321984|594519162|FG001|Overall Study|Pregnancy|1|||
164588638|NCT00321984|594519163|FG002|Overall Study|Pregnancy|0|||
164588639|NCT00321984|594519161|FG000|Overall Study|Per Subject Request|1|||
164588640|NCT00321984|594519162|FG001|Overall Study|Per Subject Request|0|||
164588641|NCT00321984|594519163|FG002|Overall Study|Per Subject Request|0|||
164588642|NCT00321984|594519161|FG000|Overall Study|Per Investigator Request|1|||
164588643|NCT00321984|594519162|FG001|Overall Study|Per Investigator Request|0|||
164588644|NCT00321984|594519163|FG002|Overall Study|Per Investigator Request|0|||
164588645|NCT00321984|594519161|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
164588646|NCT00321984|594519162|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
164588647|NCT00321984|594519163|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
164588648|NCT02214186|594519164|FG000|Overall Study|Lost to Follow-up|1|||
164588649|NCT02214186|594519165|FG001|Overall Study|Lost to Follow-up|1|||
164588650|NCT02214186|594519164|FG000|Overall Study|Protocol Violation|1|||
164299332|NCT00106704|593471300|FG001|Overall Study|Death|1|||
164436886|NCT00139737|593966425|FG000|Overall Study|Withdrew During Screening Phase|8|||
164436887|NCT00139737|593966425|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
164436888|NCT00139737|593966425|FG000|Overall Study|Screened, Not Treated|13|||
164436889|NCT00158054|593966426|FG000|Overall Study|Refused to continue|3|||
164436890|NCT00158054|593966427|FG001|Overall Study|Refused to continue|0|||
164436891|NCT00158054|593966426|FG000|Overall Study|Unavailable for follow up|7|||
164436892|NCT00158054|593966427|FG001|Overall Study|Unavailable for follow up|3|||
164436893|NCT01157182|593966428|FG000|Washout of 28 Days|Adverse Event|2|||
164436894|NCT01157182|593966429|FG001|Washout of 28 Days|Adverse Event|0|||
164436895|NCT00878722|593966430|FG000|Overall Study|Progressive disease|3|||
164436896|NCT00878722|593966431|FG001|Overall Study|Progressive disease|3|||
164436897|NCT00878722|593966432|FG002|Overall Study|Progressive disease|3|||
164436898|NCT00878722|593966433|FG003|Overall Study|Progressive disease|7|||
164436899|NCT00878722|593966434|FG004|Overall Study|Progressive disease|7|||
164436900|NCT00878722|593966435|FG005|Overall Study|Progressive disease|1|||
164436901|NCT00878722|593966436|FG006|Overall Study|Progressive disease|4|||
164436902|NCT00878722|593966437|FG007|Overall Study|Progressive disease|3|||
164436903|NCT00878722|593966430|FG000|Overall Study|Death|0|||
164436904|NCT00878722|593966431|FG001|Overall Study|Death|0|||
164436905|NCT00878722|593966432|FG002|Overall Study|Death|0|||
164436906|NCT00878722|593966433|FG003|Overall Study|Death|1|||
164436907|NCT00878722|593966434|FG004|Overall Study|Death|0|||
164436908|NCT00878722|593966435|FG005|Overall Study|Death|1|||
164436909|NCT00878722|593966436|FG006|Overall Study|Death|0|||
164436910|NCT00878722|593966437|FG007|Overall Study|Death|2|||
164436911|NCT00878722|593966430|FG000|Overall Study|Adverse Event|0|||
164436912|NCT00878722|593966431|FG001|Overall Study|Adverse Event|0|||
164436913|NCT00878722|593966432|FG002|Overall Study|Adverse Event|0|||
164436914|NCT00878722|593966433|FG003|Overall Study|Adverse Event|0|||
164436915|NCT00878722|593966434|FG004|Overall Study|Adverse Event|0|||
164588651|NCT02214186|594519165|FG001|Overall Study|Protocol Violation|1|||
164588652|NCT01525849|594519169|FG000|Overall Study|Lost to Follow-up|3|||
164588653|NCT01525849|594519170|FG001|Overall Study|Lost to Follow-up|2|||
164588654|NCT01525849|594519169|FG000|Overall Study|Withdrawal by Subject|1|||
164588655|NCT01525849|594519170|FG001|Overall Study|Withdrawal by Subject|9|||
164588656|NCT01525849|594519169|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
164588657|NCT01525849|594519170|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
164588658|NCT01525849|594519169|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
164588659|NCT01525849|594519170|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
164588660|NCT00339183|594519171|FG000|Overall Study|Adverse Event|5|||
164588661|NCT00339183|594519172|FG001|Overall Study|Adverse Event|3|||
164588662|NCT00339183|594519171|FG000|Overall Study|Withdrawal by Subject|16|||
164588663|NCT00339183|594519172|FG001|Overall Study|Withdrawal by Subject|19|||
164588664|NCT00339183|594519171|FG000|Overall Study|Physician Decision|2|||
164588665|NCT00339183|594519172|FG001|Overall Study|Physician Decision|4|||
164588666|NCT00339183|594519171|FG000|Overall Study|Lost to Follow-up|17|||
164588667|NCT00339183|594519172|FG001|Overall Study|Lost to Follow-up|17|||
164588668|NCT00339183|594519171|FG000|Overall Study|Protocol-specified criteria|12|||
164588669|NCT00339183|594519172|FG001|Overall Study|Protocol-specified criteria|8|||
164588670|NCT00339183|594519171|FG000|Overall Study|Missing reason|3|||
164588671|NCT00339183|594519172|FG001|Overall Study|Missing reason|1|||
164588672|NCT00339183|594519171|FG000|Overall Study|Other|46|||
164588673|NCT00339183|594519172|FG001|Overall Study|Other|40|||
164588674|NCT00339183|594519171|FG000|Overall Study|Ongoing|20|||
164588675|NCT00339183|594519172|FG001|Overall Study|Ongoing|13|||
164588676|NCT00793819|594519173|FG000|Overall Study|Adverse Event|8|||
164588677|NCT00793819|594519174|FG001|Overall Study|Adverse Event|4|||
164588678|NCT00793819|594519173|FG000|Overall Study|Lack of Efficacy|1|||
164588679|NCT00793819|594519174|FG001|Overall Study|Lack of Efficacy|1|||
164588680|NCT00793819|594519173|FG000|Overall Study|Withdrawal by Subject|4|||
164588681|NCT00793819|594519174|FG001|Overall Study|Withdrawal by Subject|3|||
164588682|NCT00793819|594519173|FG000|Overall Study|Lost to Follow-up|1|||
164588683|NCT00793819|594519174|FG001|Overall Study|Lost to Follow-up|1|||
164588684|NCT00002663|594519175|FG000|Overall Study|Death|4|||
164588685|NCT00002663|594519176|FG001|Overall Study|Death|1|||
164588686|NCT00002663|594519177|FG002|Overall Study|Death|1|||
164588687|NCT00002663|594519178|FG003|Overall Study|Death|0|||
164588688|NCT00002663|594519179|FG004|Overall Study|Death|0|||
164588689|NCT00002663|594519180|FG005|Overall Study|Death|13|||
164588690|NCT00002663|594519181|FG006|Overall Study|Death|0|||
164588691|NCT00002663|594519182|FG007|Overall Study|Death|1|||
164588692|NCT00002663|594519183|FG008|Overall Study|Death|1|||
164588693|NCT00002663|594519184|FG009|Overall Study|Death|1|||
164588694|NCT00002663|594519175|FG000|Overall Study|Lost to Follow-up|3|||
164436916|NCT00878722|593966435|FG005|Overall Study|Adverse Event|0|||
164436917|NCT00878722|593966436|FG006|Overall Study|Adverse Event|2|||
164588695|NCT00002663|594519176|FG001|Overall Study|Lost to Follow-up|0|||
164588696|NCT00002663|594519177|FG002|Overall Study|Lost to Follow-up|0|||
164353957|NCT00799487|593669834|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
164353958|NCT00799487|593669835|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
164353959|NCT00799487|593669833|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
164694124|NCT00373425|594901282|FG003|Overall Study|Adverse Event|0|||
164694125|NCT00373425|594901283|FG004|Overall Study|Adverse Event|34|||
164694126|NCT00373425|594901279|FG000|Overall Study|Patient request|35|||
164353960|NCT00799487|593669834|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
164353961|NCT00799487|593669835|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
164353962|NCT00799487|593669833|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
164353963|NCT00799487|593669834|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
164353964|NCT00799487|593669835|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
164353965|NCT00799487|593669833|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
164353966|NCT00799487|593669834|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
164353967|NCT00799487|593669835|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
164353968|NCT00799487|593669833|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
164353969|NCT00799487|593669834|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
164353970|NCT00799487|593669835|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
164353971|NCT02618434|593669840|FG000|Overall Study|Withdrawal by Subject|0|||
164353972|NCT02618434|593669841|FG001|Overall Study|Withdrawal by Subject|2|||
164299333|NCT00106704|593471299|FG000|Overall Study|Lack of Efficacy|67|||
164299334|NCT00106704|593471300|FG001|Overall Study|Lack of Efficacy|69|||
164299335|NCT00106704|593471299|FG000|Overall Study|Lost to Follow-up|7|||
164299336|NCT00106704|593471300|FG001|Overall Study|Lost to Follow-up|3|||
164299337|NCT00106704|593471299|FG000|Overall Study|Pregnancy|1|||
164299338|NCT00106704|593471300|FG001|Overall Study|Pregnancy|0|||
164299339|NCT00106704|593471299|FG000|Overall Study|Protocol Violation|4|||
164299340|NCT00106704|593471300|FG001|Overall Study|Protocol Violation|7|||
164299341|NCT00106704|593471299|FG000|Overall Study|Withdrawal by Subject|14|||
164299342|NCT00106704|593471300|FG001|Overall Study|Withdrawal by Subject|21|||
164299343|NCT00106704|593471299|FG000|Overall Study|Patient moved|1|||
164299344|NCT00106704|593471300|FG001|Overall Study|Patient moved|0|||
164299345|NCT00106704|593471299|FG000|Overall Study|Site terminated|0|||
164299346|NCT00106704|593471300|FG001|Overall Study|Site terminated|1|||
164299347|NCT00106704|593471299|FG000|Overall Study|Planned major surgery|1|||
164299348|NCT00106704|593471300|FG001|Overall Study|Planned major surgery|0|||
164299349|NCT00106704|593471299|FG000|Overall Study|Patient Received Glycemic Medication|22|||
164299350|NCT00106704|593471300|FG001|Overall Study|Patient Received Glycemic Medication|41|||
164299351|NCT00106704|593471299|FG000|Overall Study|Unable to re-enter US|1|||
164299352|NCT00106704|593471300|FG001|Overall Study|Unable to re-enter US|0|||
164299353|NCT00106704|593471299|FG000|Overall Study|Laboratory test|1|||
164299354|NCT00106704|593471300|FG001|Overall Study|Laboratory test|1|||
164299355|NCT00482053|593471302|FG000|Inter-treatment Period|Disease progression|1|||
164299356|NCT04842747|593471306|FG000|Overall Study|Withdrawal by Subject|6|||
164299357|NCT04842747|593471307|FG001|Overall Study|Withdrawal by Subject|2|||
164299358|NCT04842747|593471306|FG000|Overall Study|Lost to Follow-up|1|||
164299359|NCT04842747|593471307|FG001|Overall Study|Lost to Follow-up|2|||
164299360|NCT04842747|593471306|FG000|Overall Study|Physician Decision|1|||
164299361|NCT04842747|593471307|FG001|Overall Study|Physician Decision|0|||
164299362|NCT04842747|593471306|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
164299363|NCT04842747|593471307|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
164299364|NCT02559622|593471309|FG000|Overall Study|Progressive disease|0|||
164299365|NCT02559622|593471310|FG001|Overall Study|Progressive disease|1|||
164299366|NCT02559622|593471311|FG002|Overall Study|Progressive disease|0|||
164299367|NCT02559622|593471312|FG003|Overall Study|Progressive disease|0|||
164299368|NCT02559622|593471309|FG000|Overall Study|Adverse Event|0|||
164299369|NCT02559622|593471310|FG001|Overall Study|Adverse Event|2|||
164299370|NCT02559622|593471311|FG002|Overall Study|Adverse Event|2|||
164299371|NCT02559622|593471312|FG003|Overall Study|Adverse Event|2|||
164299372|NCT02559622|593471309|FG000|Overall Study|Patient/guardian decision|1|||
164299373|NCT02559622|593471310|FG001|Overall Study|Patient/guardian decision|2|||
164299374|NCT02559622|593471311|FG002|Overall Study|Patient/guardian decision|0|||
164299375|NCT02559622|593471312|FG003|Overall Study|Patient/guardian decision|1|||
164299376|NCT01710345|593471313|FG000|Overall Study|Adverse Event|0|||
164299377|NCT01710345|593471314|FG001|Overall Study|Adverse Event|2|||
164299378|NCT01710345|593471315|FG002|Overall Study|Adverse Event|0|||
164299379|NCT01710345|593471313|FG000|Overall Study|Lack of Efficacy|2|||
164299380|NCT01710345|593471314|FG001|Overall Study|Lack of Efficacy|3|||
164299381|NCT01710345|593471315|FG002|Overall Study|Lack of Efficacy|1|||
164299382|NCT01710345|593471313|FG000|Overall Study|Drug Dosing Error|1|||
164299383|NCT01710345|593471314|FG001|Overall Study|Drug Dosing Error|0|||
164299384|NCT01710345|593471315|FG002|Overall Study|Drug Dosing Error|0|||
164299385|NCT04011540|593471317|FG000|Overall Study|Lost to Follow-up|9|||
164299386|NCT04011540|593471318|FG001|Overall Study|Lost to Follow-up|6|||
164299387|NCT01033019|593471319|FG000|Overall Study|Withdrawal by Subject|1|||
164694127|NCT00373425|594901280|FG001|Overall Study|Patient request|18|||
164694128|NCT00373425|594901281|FG002|Overall Study|Patient request|43|||
164694129|NCT00373425|594901282|FG003|Overall Study|Patient request|6|||
164694130|NCT00373425|594901283|FG004|Overall Study|Patient request|7|||
164694131|NCT00373425|594901279|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
164694132|NCT00373425|594901280|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
164694133|NCT00373425|594901281|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
164694134|NCT00373425|594901282|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
164694135|NCT00373425|594901283|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
164694136|NCT00373425|594901279|FG000|Overall Study|Death|7|||
164694137|NCT00373425|594901280|FG001|Overall Study|Death|0|||
164694138|NCT00373425|594901281|FG002|Overall Study|Death|3|||
164694139|NCT00373425|594901282|FG003|Overall Study|Death|1|||
164694140|NCT00373425|594901283|FG004|Overall Study|Death|0|||
164694141|NCT00551616|594901286|FG000|Overall Study|Lost to Follow-up|48|||
164694142|NCT00551616|594901287|FG001|Overall Study|Lost to Follow-up|40|||
164694143|NCT02692482|594901288|FG000|Overall Study|Death|2|||
164694144|NCT02692482|594901289|FG001|Overall Study|Death|2|||
164694145|NCT02692482|594901288|FG000|Overall Study|Withdrawal by Subject|1|||
164694146|NCT02692482|594901289|FG001|Overall Study|Withdrawal by Subject|2|||
164694147|NCT00105157|594901292|FG000|Double-Blind (DB)|Never Treated|1|||
164694148|NCT00105157|594901293|FG001|Double-Blind (DB)|Never Treated|0|||
164694149|NCT00105157|594901294|FG002|Double-Blind (DB)|Never Treated|0|||
164694150|NCT00105157|594901295|FG003|Double-Blind (DB)|Never Treated|0|||
164694151|NCT00105157|594901292|FG000|Double-Blind (DB)|Adverse Event|2|||
164694152|NCT00105157|594901293|FG001|Double-Blind (DB)|Adverse Event|0|||
164694153|NCT00105157|594901294|FG002|Double-Blind (DB)|Adverse Event|1|||
164694154|NCT00105157|594901295|FG003|Double-Blind (DB)|Adverse Event|1|||
164694155|NCT00105157|594901292|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
164694156|NCT00105157|594901293|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
164694157|NCT00105157|594901294|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
164694158|NCT00105157|594901295|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
164694159|NCT00105157|594901292|FG000|Open-Label Continuation of DB|Adverse Event|3|||
164694160|NCT00105157|594901293|FG001|Open-Label Continuation of DB|Adverse Event|1|||
164694161|NCT00105157|594901294|FG002|Open-Label Continuation of DB|Adverse Event|0|||
164694162|NCT00105157|594901295|FG003|Open-Label Continuation of DB|Adverse Event|0|||
164694163|NCT00105157|594901292|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
164694164|NCT00105157|594901293|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
164694165|NCT00105157|594901294|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
164694166|NCT00105157|594901295|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
164694167|NCT00105157|594901292|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
164694168|NCT00105157|594901293|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
164694169|NCT00105157|594901294|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
164694170|NCT00105157|594901295|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
164694171|NCT00105157|594901292|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
164694172|NCT00105157|594901293|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
164694173|NCT00105157|594901294|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
164694174|NCT00105157|594901295|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
164694175|NCT00105157|594901292|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
164694176|NCT00105157|594901293|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
164694177|NCT00105157|594901294|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
164694178|NCT00105157|594901295|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
164694179|NCT00105157|594901292|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
164694180|NCT00105157|594901293|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
164694181|NCT00105157|594901294|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
164694182|NCT00105157|594901295|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
164694183|NCT00105157|594901292|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
164353973|NCT02618434|593669842|FG002|Overall Study|Withdrawal by Subject|3|||
164353974|NCT02618434|593669840|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
164353975|NCT02618434|593669841|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
164694184|NCT00105157|594901293|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
164694185|NCT00105157|594901294|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
164694186|NCT00105157|594901295|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
164353976|NCT02618434|593669842|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
164353977|NCT02618434|593669840|FG000|Overall Study|Lost to Follow-up|3|||
164694187|NCT00105157|594901292|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
164353978|NCT02618434|593669841|FG001|Overall Study|Lost to Follow-up|1|||
164694188|NCT00105157|594901293|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
164694189|NCT00105157|594901294|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
164694190|NCT00105157|594901295|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
164694191|NCT00105157|594901292|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
164353979|NCT02618434|593669842|FG002|Overall Study|Lost to Follow-up|3|||
164353980|NCT02618434|593669840|FG000|Overall Study|Adverse Event|1|||
164353981|NCT02618434|593669841|FG001|Overall Study|Adverse Event|0|||
164353982|NCT02618434|593669842|FG002|Overall Study|Adverse Event|12|||
164353983|NCT02618434|593669840|FG000|Overall Study|Physician Decision|0|||
164353984|NCT02618434|593669841|FG001|Overall Study|Physician Decision|1|||
164353985|NCT02618434|593669842|FG002|Overall Study|Physician Decision|0|||
164436918|NCT00878722|593966437|FG007|Overall Study|Adverse Event|0|||
164588697|NCT00002663|594519178|FG003|Overall Study|Lost to Follow-up|1|||
164588698|NCT00002663|594519179|FG004|Overall Study|Lost to Follow-up|0|||
164588699|NCT00002663|594519180|FG005|Overall Study|Lost to Follow-up|1|||
164588700|NCT00002663|594519181|FG006|Overall Study|Lost to Follow-up|0|||
164588701|NCT00002663|594519182|FG007|Overall Study|Lost to Follow-up|0|||
164588702|NCT00002663|594519183|FG008|Overall Study|Lost to Follow-up|0|||
164588703|NCT00002663|594519184|FG009|Overall Study|Lost to Follow-up|0|||
164588704|NCT00002663|594519175|FG000|Overall Study|Other|0|||
164588705|NCT00002663|594519176|FG001|Overall Study|Other|1|||
164588706|NCT00002663|594519177|FG002|Overall Study|Other|0|||
164588707|NCT00002663|594519178|FG003|Overall Study|Other|0|||
164588708|NCT00002663|594519179|FG004|Overall Study|Other|0|||
164588709|NCT00002663|594519180|FG005|Overall Study|Other|1|||
164588710|NCT00002663|594519181|FG006|Overall Study|Other|1|||
164588711|NCT00002663|594519182|FG007|Overall Study|Other|0|||
164588712|NCT00002663|594519183|FG008|Overall Study|Other|0|||
164588713|NCT00002663|594519184|FG009|Overall Study|Other|0|||
164588714|NCT00002663|594519175|FG000|Overall Study|Physician Decision|0|||
164588715|NCT00002663|594519176|FG001|Overall Study|Physician Decision|0|||
164588716|NCT00002663|594519177|FG002|Overall Study|Physician Decision|0|||
164588717|NCT00002663|594519178|FG003|Overall Study|Physician Decision|0|||
164588718|NCT00002663|594519179|FG004|Overall Study|Physician Decision|1|||
164588719|NCT00002663|594519180|FG005|Overall Study|Physician Decision|0|||
164588720|NCT00002663|594519181|FG006|Overall Study|Physician Decision|0|||
164588721|NCT00002663|594519182|FG007|Overall Study|Physician Decision|0|||
164588722|NCT00002663|594519183|FG008|Overall Study|Physician Decision|1|||
164588723|NCT00002663|594519184|FG009|Overall Study|Physician Decision|1|||
164588724|NCT00002663|594519175|FG000|Overall Study|Adverse Event|0|||
164588725|NCT00002663|594519176|FG001|Overall Study|Adverse Event|0|||
164588726|NCT00002663|594519177|FG002|Overall Study|Adverse Event|0|||
164588727|NCT00002663|594519178|FG003|Overall Study|Adverse Event|1|||
164588728|NCT00002663|594519179|FG004|Overall Study|Adverse Event|0|||
164588729|NCT00002663|594519180|FG005|Overall Study|Adverse Event|0|||
164588730|NCT00002663|594519181|FG006|Overall Study|Adverse Event|0|||
164588731|NCT00002663|594519182|FG007|Overall Study|Adverse Event|1|||
164588732|NCT00002663|594519183|FG008|Overall Study|Adverse Event|0|||
164588733|NCT00002663|594519184|FG009|Overall Study|Adverse Event|0|||
164588734|NCT00446446|594519186|FG000|Overall Study|Death|10|||
164588735|NCT00446446|594519186|FG000|Overall Study|Withdrawal by Subject|6|||
164588736|NCT00446446|594519186|FG000|Overall Study|Other|4|||
164588737|NCT00446446|594519186|FG000|Overall Study|Disease Progession|2|||
164588738|NCT00446446|594519186|FG000|Overall Study|Adverse Event|1|||
164588739|NCT00446446|594519186|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
164588740|NCT02142894|594519187|FG000|Overall Study|Protocol Violation|8|||
164588741|NCT00611130|594519193|FG000|Overall Study|Lost to Follow-up|25|||
164588742|NCT00611130|594519194|FG001|Overall Study|Lost to Follow-up|29|||
164588743|NCT00611130|594519193|FG000|Overall Study|Protocol noncompliance|7|||
164588744|NCT00611130|594519194|FG001|Overall Study|Protocol noncompliance|6|||
164588745|NCT00611130|594519193|FG000|Overall Study|Withdrawal by Subject|6|||
164588746|NCT00611130|594519194|FG001|Overall Study|Withdrawal by Subject|5|||
164588747|NCT00611130|594519193|FG000|Overall Study|Other|5|||
164588748|NCT00611130|594519194|FG001|Overall Study|Other|4|||
164588749|NCT00611130|594519193|FG000|Overall Study|Incarceration|3|||
164588750|NCT00611130|594519194|FG001|Overall Study|Incarceration|2|||
164588751|NCT00611130|594519193|FG000|Overall Study|Administrative|1|||
164588752|NCT00611130|594519194|FG001|Overall Study|Administrative|1|||
164588753|NCT00611130|594519193|FG000|Overall Study|Adverse Event|1|||
164588754|NCT00611130|594519194|FG001|Overall Study|Adverse Event|0|||
164588755|NCT00611130|594519193|FG000|Overall Study|Death|1|||
164353986|NCT02618434|593669840|FG000|Overall Study|Protocol Violation|0|||
164588756|NCT00611130|594519194|FG001|Overall Study|Death|0|||
164588757|NCT01302769|594519203|FG000|Overall Study|Lost to Follow-up|1|||
164588758|NCT01302769|594519204|FG001|Overall Study|Lost to Follow-up|1|||
164588759|NCT01734993|594519212|FG000|Overall Study|Adverse Event|1|||
164588760|NCT01734993|594519212|FG000|Overall Study|Lack of Efficacy|1|||
164588761|NCT00525148|594519215|FG000|Overall Study|Other Adverse Event|3|||
164588762|NCT00525148|594519216|FG001|Overall Study|Other Adverse Event|5|||
164353987|NCT02618434|593669841|FG001|Overall Study|Protocol Violation|0|||
164588763|NCT00525148|594519217|FG002|Overall Study|Other Adverse Event|1|||
164588764|NCT00525148|594519218|FG003|Overall Study|Other Adverse Event|8|||
164588765|NCT00525148|594519215|FG000|Overall Study|Progressive disease|18|||
164588766|NCT00525148|594519216|FG001|Overall Study|Progressive disease|30|||
164588767|NCT00525148|594519217|FG002|Overall Study|Progressive disease|6|||
164588768|NCT00525148|594519218|FG003|Overall Study|Progressive disease|49|||
164694192|NCT00105157|594901293|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
164694193|NCT00105157|594901294|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
164694194|NCT00105157|594901295|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
164694195|NCT00105157|594901292|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
164694196|NCT00105157|594901293|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
164694197|NCT00105157|594901294|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
164694198|NCT00105157|594901295|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
164694199|NCT00105157|594901292|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
164694200|NCT00105157|594901293|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
164694201|NCT00105157|594901294|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
164694202|NCT00105157|594901295|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
164694203|NCT03314662|594901296|FG000|Overall Study|Withdrawal by Subject|1|||
164694204|NCT03314662|594901297|FG001|Overall Study|Withdrawal by Subject|1|||
164694205|NCT03314662|594901298|FG002|Overall Study|Withdrawal by Subject|1|||
164694206|NCT03314662|594901296|FG000|Overall Study|Lost to Follow-up|5|||
164694207|NCT03314662|594901297|FG001|Overall Study|Lost to Follow-up|4|||
164694208|NCT03314662|594901298|FG002|Overall Study|Lost to Follow-up|4|||
164694209|NCT03314662|594901296|FG000|Overall Study|Death|2|||
164694210|NCT03314662|594901297|FG001|Overall Study|Death|0|||
164694211|NCT03314662|594901298|FG002|Overall Study|Death|0|||
164694212|NCT01117766|594901303|FG000|First Intervention|Adverse Event|0|||
164694213|NCT01117766|594901304|FG001|First Intervention|Adverse Event|1|||
164694214|NCT01117766|594901303|FG000|First Intervention|Protocol Violation|1|||
164694215|NCT01117766|594901304|FG001|First Intervention|Protocol Violation|0|||
164694216|NCT01117766|594901303|FG000|Washout Period|Protocol Violation|0|||
164694217|NCT01117766|594901304|FG001|Washout Period|Protocol Violation|2|||
164694218|NCT01117766|594901303|FG000|Second Intervention|Lost to Follow-up|1|||
164694219|NCT01117766|594901304|FG001|Second Intervention|Lost to Follow-up|0|||
164694220|NCT01117766|594901303|FG000|Second Intervention|Other|1|||
164694221|NCT01117766|594901304|FG001|Second Intervention|Other|2|||
164694222|NCT01117766|594901303|FG000|Second Intervention|Adverse Event|0|||
164694223|NCT01117766|594901304|FG001|Second Intervention|Adverse Event|2|||
164694224|NCT01117766|594901303|FG000|Second Intervention|Withdrawal by Subject|0|||
164694225|NCT01117766|594901304|FG001|Second Intervention|Withdrawal by Subject|1|||
164694226|NCT04405739|594901305|FG000|Overall Study|Adverse Event|0|||
164694227|NCT04405739|594901306|FG001|Overall Study|Adverse Event|1|||
164694228|NCT04405739|594901307|FG002|Overall Study|Adverse Event|0|||
164694229|NCT04405739|594901308|FG003|Overall Study|Adverse Event|0|||
164694230|NCT04405739|594901305|FG000|Overall Study|Lost to Follow-up|0|||
164694231|NCT04405739|594901306|FG001|Overall Study|Lost to Follow-up|2|||
164694232|NCT04405739|594901307|FG002|Overall Study|Lost to Follow-up|1|||
164694233|NCT04405739|594901308|FG003|Overall Study|Lost to Follow-up|3|||
164694234|NCT04405739|594901305|FG000|Overall Study|Withdrawal by Subject|0|||
164694235|NCT04405739|594901306|FG001|Overall Study|Withdrawal by Subject|2|||
164694236|NCT04405739|594901307|FG002|Overall Study|Withdrawal by Subject|1|||
164694237|NCT04405739|594901308|FG003|Overall Study|Withdrawal by Subject|1|||
164694238|NCT04405739|594901305|FG000|Overall Study|Death|0|||
164694239|NCT04405739|594901306|FG001|Overall Study|Death|0|||
164694240|NCT04405739|594901307|FG002|Overall Study|Death|1|||
164694241|NCT04405739|594901308|FG003|Overall Study|Death|0|||
164694242|NCT04405739|594901305|FG000|Overall Study|Transferred to rehab|0|||
164694243|NCT04405739|594901306|FG001|Overall Study|Transferred to rehab|0|||
164694244|NCT04405739|594901307|FG002|Overall Study|Transferred to rehab|0|||
164694245|NCT04405739|594901308|FG003|Overall Study|Transferred to rehab|1|||
164694246|NCT04405739|594901305|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
164694247|NCT04405739|594901306|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
164694248|NCT04405739|594901307|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
164694249|NCT04405739|594901308|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
164694250|NCT00438659|594901309|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
164694251|NCT00438659|594901310|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
164694252|NCT00438659|594901309|FG000|Overall Study|Cancel|5|||
164353988|NCT02618434|593669842|FG002|Overall Study|Protocol Violation|1|||
164694253|NCT00438659|594901310|FG001|Overall Study|Cancel|2|||
164694254|NCT05766787|594901311|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
164694255|NCT05766787|594901312|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
164694256|NCT05766787|594901311|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
164694257|NCT05766787|594901312|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
164694258|NCT05766787|594901311|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
164694259|NCT05766787|594901312|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
164694260|NCT01867606|594901313|FG000|Overall Study|Withdrawal by Subject|10|||
164694261|NCT01867606|594901314|FG001|Overall Study|Withdrawal by Subject|14|||
164694262|NCT01867606|594901313|FG000|Overall Study|Protocol Violation|0|||
164353989|NCT02618434|593669840|FG000|Overall Study|Other, Multiple categories|1|||
164353990|NCT02618434|593669841|FG001|Overall Study|Other, Multiple categories|1|||
164353991|NCT02618434|593669842|FG002|Overall Study|Other, Multiple categories|1|||
164353992|NCT02289898|593669848|FG000|Overall Study|Death|5|||
164353993|NCT02289898|593669849|FG001|Overall Study|Death|4|||
164353994|NCT02289898|593669850|FG002|Overall Study|Death|3|||
164353995|NCT02289898|593669848|FG000|Overall Study|Physician Decision|2|||
164694263|NCT01867606|594901314|FG001|Overall Study|Protocol Violation|1|||
164694264|NCT00206102|594901315|FG000|Overall Study|Adverse Event|119|||
164694265|NCT00206102|594901316|FG001|Overall Study|Adverse Event|82|||
164694266|NCT00206102|594901315|FG000|Overall Study|Protocol Violation|0|||
164694267|NCT00206102|594901316|FG001|Overall Study|Protocol Violation|2|||
164694268|NCT00206102|594901315|FG000|Overall Study|Lack of therapeutic response|16|||
164694269|NCT00206102|594901316|FG001|Overall Study|Lack of therapeutic response|11|||
164694270|NCT00206102|594901315|FG000|Overall Study|Lost to Follow-up|95|||
164694271|NCT00206102|594901316|FG001|Overall Study|Lost to Follow-up|66|||
164694272|NCT00206102|594901315|FG000|Overall Study|Withdrawal by Subject|118|||
164694273|NCT00206102|594901316|FG001|Overall Study|Withdrawal by Subject|101|||
164694274|NCT00206102|594901315|FG000|Overall Study|Study-specific discontinuation criteria|18|||
164694275|NCT00206102|594901316|FG001|Overall Study|Study-specific discontinuation criteria|17|||
164694276|NCT00206102|594901315|FG000|Overall Study|None of those categories|42|||
164694277|NCT00206102|594901316|FG001|Overall Study|None of those categories|36|||
164694278|NCT01835548|594901322|FG000|Dose Optimization Period|Adverse Event|0|||
164694279|NCT01835548|594901323|FG001|Dose Optimization Period|Adverse Event|0|||
164694280|NCT01835548|594901324|FG002|Dose Optimization Period|Adverse Event|1|||
164694281|NCT01835548|594901322|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
164694282|NCT01835548|594901323|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
164694283|NCT01835548|594901324|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
164694284|NCT01835548|594901322|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164694285|NCT01835548|594901323|FG001|Double-Blind Treatment Period|Adverse Event|1|||
164694286|NCT01835548|594901324|FG002|Double-Blind Treatment Period|Adverse Event|0|||
164694287|NCT01835548|594901322|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164694288|NCT01835548|594901323|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
164694289|NCT01835548|594901324|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164694290|NCT02490800|594901325|FG000|Overall Study|Adverse Event|0|||
164694291|NCT02490800|594901326|FG001|Overall Study|Adverse Event|0|||
164694292|NCT02490800|594901327|FG002|Overall Study|Adverse Event|0|||
164694293|NCT02490800|594901328|FG003|Overall Study|Adverse Event|2|||
164694294|NCT02490800|594901329|FG004|Overall Study|Adverse Event|3|||
164694295|NCT02490800|594901330|FG005|Overall Study|Adverse Event|2|||
164694296|NCT02490800|594901331|FG006|Overall Study|Adverse Event|0|||
164694297|NCT02490800|594901332|FG007|Overall Study|Adverse Event|0|||
164694298|NCT02490800|594901333|FG008|Overall Study|Adverse Event|0|||
164694299|NCT02490800|594901334|FG009|Overall Study|Adverse Event|0|||
164694300|NCT02490800|594901335|FG010|Overall Study|Adverse Event|0|||
164694301|NCT02490800|594901336|FG011|Overall Study|Adverse Event|2|||
164694302|NCT02490800|594901337|FG012|Overall Study|Adverse Event|2|||
164694303|NCT02490800|594901325|FG000|Overall Study|Withdrawal by Subject|0|||
164694304|NCT02490800|594901326|FG001|Overall Study|Withdrawal by Subject|0|||
164694305|NCT02490800|594901327|FG002|Overall Study|Withdrawal by Subject|0|||
164694306|NCT02490800|594901328|FG003|Overall Study|Withdrawal by Subject|1|||
164694307|NCT02490800|594901329|FG004|Overall Study|Withdrawal by Subject|0|||
164694308|NCT02490800|594901330|FG005|Overall Study|Withdrawal by Subject|0|||
164694309|NCT02490800|594901331|FG006|Overall Study|Withdrawal by Subject|0|||
164694310|NCT02490800|594901332|FG007|Overall Study|Withdrawal by Subject|0|||
164694311|NCT02490800|594901333|FG008|Overall Study|Withdrawal by Subject|1|||
164694312|NCT02490800|594901334|FG009|Overall Study|Withdrawal by Subject|0|||
164694313|NCT02490800|594901335|FG010|Overall Study|Withdrawal by Subject|0|||
164694314|NCT02490800|594901336|FG011|Overall Study|Withdrawal by Subject|0|||
164694315|NCT02490800|594901337|FG012|Overall Study|Withdrawal by Subject|0|||
164694316|NCT02490800|594901325|FG000|Overall Study|Progressive disease|3|||
164353996|NCT02289898|593669849|FG001|Overall Study|Physician Decision|5|||
164353997|NCT02289898|593669850|FG002|Overall Study|Physician Decision|2|||
164694317|NCT02490800|594901326|FG001|Overall Study|Progressive disease|3|||
164353998|NCT02289898|593669848|FG000|Overall Study|Withdrawal by Subject|0|||
164353999|NCT02289898|593669849|FG001|Overall Study|Withdrawal by Subject|4|||
164694318|NCT02490800|594901327|FG002|Overall Study|Progressive disease|3|||
164694319|NCT02490800|594901328|FG003|Overall Study|Progressive disease|4|||
164694320|NCT02490800|594901329|FG004|Overall Study|Progressive disease|4|||
164694321|NCT02490800|594901330|FG005|Overall Study|Progressive disease|1|||
164694322|NCT02490800|594901331|FG006|Overall Study|Progressive disease|4|||
164694323|NCT02490800|594901332|FG007|Overall Study|Progressive disease|3|||
164694324|NCT02490800|594901333|FG008|Overall Study|Progressive disease|6|||
164694325|NCT02490800|594901334|FG009|Overall Study|Progressive disease|2|||
164694326|NCT02490800|594901335|FG010|Overall Study|Progressive disease|7|||
164694327|NCT02490800|594901336|FG011|Overall Study|Progressive disease|1|||
164694328|NCT02490800|594901337|FG012|Overall Study|Progressive disease|10|||
164354000|NCT02289898|593669850|FG002|Overall Study|Withdrawal by Subject|1|||
164354001|NCT02289898|593669848|FG000|Overall Study|Adverse Event|3|||
164299388|NCT01033019|593471320|FG001|Overall Study|Withdrawal by Subject|0|||
164299389|NCT01339832|593471321|FG000|Overall Study|Lost to Follow-up|3|||
164299390|NCT01339832|593471321|FG000|Overall Study|Death|11|||
164299391|NCT01668784|593471335|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
164299392|NCT01668784|593471336|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
164299393|NCT01668784|593471335|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
164299394|NCT01668784|593471336|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
164299395|NCT01668784|593471335|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
164299396|NCT01668784|593471336|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
164299397|NCT01668784|593471335|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
164299398|NCT01668784|593471336|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
164299399|NCT01668784|593471335|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
164299400|NCT01668784|593471336|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
164299401|NCT01668784|593471335|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
164299402|NCT01668784|593471336|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
164299403|NCT01668784|593471335|FG000|Treatment Period|Disease Progression|316|||
164299404|NCT01668784|593471336|FG001|Treatment Period|Disease Progression|293|||
164299405|NCT01668784|593471335|FG000|Treatment Period|Study Drug Toxicity|46|||
164299406|NCT01668784|593471336|FG001|Treatment Period|Study Drug Toxicity|53|||
164299407|NCT01668784|593471335|FG000|Treatment Period|Death|1|||
164299408|NCT01668784|593471336|FG001|Treatment Period|Death|1|||
164299409|NCT01668784|593471335|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
164354002|NCT02289898|593669849|FG001|Overall Study|Adverse Event|5|||
164354003|NCT02289898|593669850|FG002|Overall Study|Adverse Event|5|||
164354004|NCT02289898|593669848|FG000|Overall Study|Disease progression|34|||
164588769|NCT00525148|594519215|FG000|Overall Study|Refused continuation of study medication|0|||
164588770|NCT00525148|594519216|FG001|Overall Study|Refused continuation of study medication|2|||
164588771|NCT00525148|594519217|FG002|Overall Study|Refused continuation of study medication|0|||
164299410|NCT01668784|593471336|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
164299411|NCT01668784|593471335|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
164299412|NCT01668784|593471336|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
164299413|NCT01668784|593471335|FG000|Treatment Period|Withdrawal by Subject|5|||
164299414|NCT01668784|593471336|FG001|Treatment Period|Withdrawal by Subject|3|||
164299415|NCT01668784|593471335|FG000|Treatment Period|Maximal Clinical Benefit|3|||
164299416|NCT01668784|593471336|FG001|Treatment Period|Maximal Clinical Benefit|3|||
164299417|NCT01668784|593471335|FG000|Treatment Period|Other|2|||
164299418|NCT01668784|593471336|FG001|Treatment Period|Other|8|||
164299419|NCT01668784|593471335|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
164299420|NCT01668784|593471336|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
164299421|NCT02761330|593471337|FG000|Treatment Week 1|Withdrawal by Subject|0|||
164299422|NCT02761330|593471338|FG001|Treatment Week 1|Withdrawal by Subject|0|||
164299423|NCT02761330|593471339|FG002|Treatment Week 1|Withdrawal by Subject|0|||
164299424|NCT02761330|593471340|FG003|Treatment Week 1|Withdrawal by Subject|1|||
164299425|NCT02761330|593471341|FG004|Treatment Week 1|Withdrawal by Subject|0|||
164299426|NCT02761330|593471342|FG005|Treatment Week 1|Withdrawal by Subject|1|||
164354005|NCT02289898|593669849|FG001|Overall Study|Disease progression|28|||
164588772|NCT00525148|594519218|FG003|Overall Study|Refused continuation of study medication|1|||
164588773|NCT00525148|594519215|FG000|Overall Study|Other than stated|2|||
164588774|NCT00525148|594519216|FG001|Overall Study|Other than stated|1|||
164588775|NCT00525148|594519217|FG002|Overall Study|Other than stated|0|||
164588776|NCT00525148|594519218|FG003|Overall Study|Other than stated|3|||
164588777|NCT05100199|594519219|FG000|Overall Study|Lost to Follow-up|5|||
164588778|NCT05100199|594519220|FG001|Overall Study|Lost to Follow-up|8|||
164588779|NCT05100199|594519221|FG002|Overall Study|Lost to Follow-up|3|||
164588780|NCT05100199|594519222|FG003|Overall Study|Lost to Follow-up|6|||
164588781|NCT05100199|594519219|FG000|Overall Study|Withdrawal by Subject|3|||
164588782|NCT05100199|594519220|FG001|Overall Study|Withdrawal by Subject|3|||
164588783|NCT05100199|594519221|FG002|Overall Study|Withdrawal by Subject|9|||
164588784|NCT05100199|594519222|FG003|Overall Study|Withdrawal by Subject|7|||
164588785|NCT05100199|594519219|FG000|Overall Study|Other|0|||
164588786|NCT05100199|594519220|FG001|Overall Study|Other|0|||
164588787|NCT05100199|594519221|FG002|Overall Study|Other|1|||
164588788|NCT05100199|594519222|FG003|Overall Study|Other|1|||
164588789|NCT01455428|594519223|FG000|Overall Study|Protocol Violation|2|||
164588790|NCT01455428|594519224|FG001|Overall Study|Protocol Violation|1|||
164588791|NCT01455428|594519223|FG000|Overall Study|Adverse Event|6|||
164588792|NCT01455428|594519224|FG001|Overall Study|Adverse Event|2|||
164588793|NCT01455428|594519223|FG000|Overall Study|Lost to Follow-up|1|||
164588794|NCT01455428|594519224|FG001|Overall Study|Lost to Follow-up|1|||
164588795|NCT01455428|594519223|FG000|Overall Study|Withdrawal by Subject|2|||
164588796|NCT01455428|594519224|FG001|Overall Study|Withdrawal by Subject|5|||
164588797|NCT01455428|594519223|FG000|Overall Study|Did not meet entrance criteria|0|||
164588798|NCT01455428|594519224|FG001|Overall Study|Did not meet entrance criteria|2|||
164694329|NCT02490800|594901325|FG000|Overall Study|Patient enrolled in post-trial access|0|||
164694330|NCT02490800|594901326|FG001|Overall Study|Patient enrolled in post-trial access|0|||
164354006|NCT02289898|593669850|FG002|Overall Study|Disease progression|34|||
164354007|NCT02289898|593669848|FG000|Overall Study|Use of another anticancer therapy|0|||
164354008|NCT02289898|593669849|FG001|Overall Study|Use of another anticancer therapy|0|||
164354009|NCT02289898|593669850|FG002|Overall Study|Use of another anticancer therapy|1|||
164694331|NCT02490800|594901327|FG002|Overall Study|Patient enrolled in post-trial access|0|||
164694332|NCT02490800|594901328|FG003|Overall Study|Patient enrolled in post-trial access|0|||
164694333|NCT02490800|594901329|FG004|Overall Study|Patient enrolled in post-trial access|0|||
164694334|NCT02490800|594901330|FG005|Overall Study|Patient enrolled in post-trial access|0|||
164694335|NCT02490800|594901331|FG006|Overall Study|Patient enrolled in post-trial access|0|||
164694336|NCT02490800|594901332|FG007|Overall Study|Patient enrolled in post-trial access|0|||
164694337|NCT02490800|594901333|FG008|Overall Study|Patient enrolled in post-trial access|0|||
164694338|NCT02490800|594901334|FG009|Overall Study|Patient enrolled in post-trial access|1|||
164694339|NCT02490800|594901335|FG010|Overall Study|Patient enrolled in post-trial access|1|||
164694340|NCT02490800|594901336|FG011|Overall Study|Patient enrolled in post-trial access|0|||
164694341|NCT02490800|594901337|FG012|Overall Study|Patient enrolled in post-trial access|6|||
164694342|NCT00576303|594901338|FG000|Dose Titration Period|Early withdrawal|17|||
164694343|NCT00576303|594901338|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
164694344|NCT00576303|594901338|FG000|Long Term Safety Period|Early withdrawal|16|||
164694345|NCT02843659|594901341|FG000|Overall Study|Subject Withdrew Consent|0|||
164694346|NCT02843659|594901342|FG001|Overall Study|Subject Withdrew Consent|0|||
164694347|NCT02843659|594901343|FG002|Overall Study|Subject Withdrew Consent|1|||
164694348|NCT02843659|594901341|FG000|Overall Study|Administrative Reason by Sponsor|4|||
164694349|NCT02843659|594901342|FG001|Overall Study|Administrative Reason by Sponsor|5|||
164694350|NCT02843659|594901343|FG002|Overall Study|Administrative Reason by Sponsor|4|||
164694351|NCT02843659|594901341|FG000|Overall Study|Adverse Event|0|||
164694352|NCT02843659|594901342|FG001|Overall Study|Adverse Event|1|||
164694353|NCT02843659|594901343|FG002|Overall Study|Adverse Event|0|||
164694354|NCT03203642|594901344|FG000|Overall Study|Adverse Event|3|||
164694355|NCT03203642|594901345|FG001|Overall Study|Adverse Event|1|||
164694356|NCT03203642|594901344|FG000|Overall Study|Withdrawal by Subject|6|||
164694357|NCT03203642|594901345|FG001|Overall Study|Withdrawal by Subject|6|||
164694358|NCT03203642|594901344|FG000|Overall Study|Lost to Follow-up|2|||
164694359|NCT03203642|594901345|FG001|Overall Study|Lost to Follow-up|1|||
164694360|NCT03203642|594901344|FG000|Overall Study|Termination of the study by sponsor|1|||
164694361|NCT03203642|594901345|FG001|Overall Study|Termination of the study by sponsor|1|||
164694362|NCT03203642|594901344|FG000|Overall Study|Participant moved|0|||
164354010|NCT02289898|593669848|FG000|Overall Study|Other|8|||
164354011|NCT02289898|593669849|FG001|Overall Study|Other|7|||
164354012|NCT02289898|593669850|FG002|Overall Study|Other|10|||
164354013|NCT04626297|593669851|FG000|Overall Study|Adverse Event|5|||
164354014|NCT04626297|593669852|FG001|Overall Study|Adverse Event|3|||
164354015|NCT04626297|593669851|FG000|Overall Study|Lost to Follow-up|7|||
164354016|NCT04626297|593669852|FG001|Overall Study|Lost to Follow-up|3|||
164354017|NCT04626297|593669851|FG000|Overall Study|Protocol Violation|5|||
164354018|NCT04626297|593669852|FG001|Overall Study|Protocol Violation|1|||
164354019|NCT04626297|593669851|FG000|Overall Study|Withdrawal by Subject|20|||
164354020|NCT04626297|593669852|FG001|Overall Study|Withdrawal by Subject|6|||
164354021|NCT04626297|593669851|FG000|Overall Study|Sponsor decision|2|||
164354022|NCT04626297|593669852|FG001|Overall Study|Sponsor decision|1|||
164354023|NCT00885105|593669855|FG000|Overall Study|Withdrawal by Subject|0|||
164354024|NCT00885105|593669856|FG001|Overall Study|Withdrawal by Subject|8|||
164354025|NCT00885105|593669855|FG000|Overall Study|Adverse Event|1|||
164354026|NCT00885105|593669856|FG001|Overall Study|Adverse Event|0|||
164354027|NCT00885105|593669855|FG000|Overall Study|Protocol Violation|0|||
164354028|NCT00885105|593669856|FG001|Overall Study|Protocol Violation|2|||
164354029|NCT02066233|593669857|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
164354030|NCT02066233|593669858|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
164354031|NCT02598076|593669859|FG000|Overall Study|Lost to Follow-up|2|||
164354032|NCT02598076|593669860|FG001|Overall Study|Lost to Follow-up|3|||
164354033|NCT02005445|593669861|FG000|Overall Study|Dual study enrollment|0|||
164354034|NCT02005445|593669862|FG001|Overall Study|Dual study enrollment|1|||
164694363|NCT03203642|594901345|FG001|Overall Study|Participant moved|1|||
164694364|NCT03203642|594901344|FG000|Overall Study|Investigator's decision|3|||
164694365|NCT03203642|594901345|FG001|Overall Study|Investigator's decision|0|||
164694366|NCT03203642|594901344|FG000|Overall Study|Other than above specified|0|||
164694367|NCT03203642|594901345|FG001|Overall Study|Other than above specified|1|||
164694368|NCT00977548|594902969|FG000|Overall Study|Ineligible|4|||
164694369|NCT00977548|594902969|FG000|Overall Study|Adverse Event|8|||
164694370|NCT00977548|594902969|FG000|Overall Study|Withdrawal by Subject|1|||
164354035|NCT00759954|593669863|FG000|Overall Study|Personal reason|1|||
164354036|NCT00759954|593669864|FG001|Overall Study|Personal reason|0|||
164354037|NCT00759954|593669863|FG000|Overall Study|Adverse Event|1|||
164354038|NCT00759954|593669864|FG001|Overall Study|Adverse Event|2|||
164588799|NCT01455428|594519223|FG000|Overall Study|Insufficient clinical response|0|||
164588800|NCT01455428|594519224|FG001|Overall Study|Insufficient clinical response|2|||
164588801|NCT01455428|594519223|FG000|Overall Study|Did not receive treatment|1|||
164588802|NCT01455428|594519224|FG001|Overall Study|Did not receive treatment|1|||
164588803|NCT01455428|594519223|FG000|Overall Study|Other|2|||
164588804|NCT01455428|594519224|FG001|Overall Study|Other|4|||
164588805|NCT03694522|594519227|FG000|Overall Study|Withdrawal by Subject|8|||
164588806|NCT03694522|594519228|FG001|Overall Study|Withdrawal by Subject|10|||
164588807|NCT03694522|594519227|FG000|Overall Study|Physician Decision|53|||
164588808|NCT03694522|594519228|FG001|Overall Study|Physician Decision|54|||
164588809|NCT03694522|594519227|FG000|Overall Study|Other|1|||
164588810|NCT03694522|594519228|FG001|Overall Study|Other|1|||
164588811|NCT03694522|594519227|FG000|Overall Study|Lost to Follow-up|0|||
164588812|NCT03694522|594519228|FG001|Overall Study|Lost to Follow-up|1|||
164588813|NCT00257192|594519230|FG000|Overall Study|Adverse Event|21|||
164588814|NCT00257192|594519231|FG001|Overall Study|Adverse Event|10|||
164588815|NCT00257192|594519230|FG000|Overall Study|Laboratory abnormality|1|||
164588816|NCT00257192|594519231|FG001|Overall Study|Laboratory abnormality|1|||
164588817|NCT00257192|594519230|FG000|Overall Study|Lost to Follow-up|3|||
164588818|NCT00257192|594519231|FG001|Overall Study|Lost to Follow-up|3|||
164354039|NCT00010374|593669865|FG000|Overall Study|False positive phrenic nerve test|1|||
164354040|NCT02407704|593669870|FG000|Overall Study|Lost to Follow-up|0|||
164354041|NCT02407704|593669871|FG001|Overall Study|Lost to Follow-up|0|||
164354042|NCT02407704|593669872|FG002|Overall Study|Lost to Follow-up|0|||
164354043|NCT02407704|593669873|FG003|Overall Study|Lost to Follow-up|2|||
164354044|NCT02407704|593669870|FG000|Overall Study|Protocol Violation|0|||
164354045|NCT02407704|593669871|FG001|Overall Study|Protocol Violation|0|||
164354046|NCT02407704|593669872|FG002|Overall Study|Protocol Violation|0|||
164354047|NCT02407704|593669873|FG003|Overall Study|Protocol Violation|1|||
164354048|NCT02407704|593669870|FG000|Overall Study|Withdrawal by Subject|0|||
164354049|NCT02407704|593669871|FG001|Overall Study|Withdrawal by Subject|0|||
164354050|NCT02407704|593669872|FG002|Overall Study|Withdrawal by Subject|1|||
164354051|NCT02407704|593669873|FG003|Overall Study|Withdrawal by Subject|0|||
164354052|NCT01683383|593669874|FG000|Overall Study|Infant was not transported|1|||
164354053|NCT01683383|593669875|FG001|Overall Study|Infant was not transported|0|||
164354054|NCT02496611|593669876|FG000|Overall Study|Lost to Follow-up|2|||
164354055|NCT02496611|593669877|FG001|Overall Study|Lost to Follow-up|1|||
164354056|NCT02496611|593669876|FG000|Overall Study|Withdrawal by Subject|5|||
164354057|NCT02496611|593669877|FG001|Overall Study|Withdrawal by Subject|2|||
164588819|NCT00257192|594519230|FG000|Overall Study|Insufficient clinical response|18|||
164588820|NCT00257192|594519231|FG001|Overall Study|Insufficient clinical response|18|||
164588821|NCT00257192|594519230|FG000|Overall Study|Withdrawal by Subject|14|||
164588822|NCT00257192|594519231|FG001|Overall Study|Withdrawal by Subject|2|||
164588823|NCT00257192|594519230|FG000|Overall Study|Randomized but not treated|0|||
164588824|NCT00257192|594519231|FG001|Overall Study|Randomized but not treated|1|||
164588825|NCT00257192|594519230|FG000|Overall Study|Study terminated by sponsor|1|||
164354058|NCT03228537|593669884|FG000|Neoadjuvant|Adverse Event|2|||
164354059|NCT03228537|593669884|FG000|Neoadjuvant|Progression/Relapse|4|||
164354060|NCT03228537|593669884|FG000|Neoadjuvant|Death|1|||
164354061|NCT03228537|593669884|FG000|Surgery|Death|1|||
164354062|NCT03228537|593669884|FG000|Surgery|Other - Not Protocol Specified|2|||
164354063|NCT03228537|593669884|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
164354064|NCT03228537|593669884|FG000|Maintenance|Progression/Relapse|10|||
164354065|NCT00580606|593669888|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
164354066|NCT00580606|593669889|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
164354067|NCT00580606|593669888|FG000|Open Label (OL)|Withdrawal by Subject|4|||
164354068|NCT00580606|593669889|FG001|Open Label (OL)|Withdrawal by Subject|6|||
164354069|NCT00580606|593669888|FG000|Open Label (OL)|Dosing Symptoms|0|||
164354070|NCT00580606|593669889|FG001|Open Label (OL)|Dosing Symptoms|1|||
164354071|NCT00580606|593669888|FG000|Open Label (OL)|Lost to Follow-up|0|||
164354072|NCT00580606|593669889|FG001|Open Label (OL)|Lost to Follow-up|1|||
164354073|NCT00580606|593669888|FG000|Open Label (OL)|Pregnancy|0|||
164354074|NCT00580606|593669889|FG001|Open Label (OL)|Pregnancy|1|||
164436919|NCT00878722|593966430|FG000|Overall Study|Withdrawal by Subject|0|||
164354075|NCT00580606|593669888|FG000|Open Label (OL)|Non-compliance|2|||
164436920|NCT00878722|593966431|FG001|Overall Study|Withdrawal by Subject|0|||
164354076|NCT00580606|593669889|FG001|Open Label (OL)|Non-compliance|0|||
164694371|NCT01844531|594902970|FG000|Overall Study|Withdrawal by Subject|0|||
164354077|NCT00580606|593669888|FG000|Open Label (OL)|Physician Decision|1|||
164354078|NCT00580606|593669889|FG001|Open Label (OL)|Physician Decision|1|||
164354079|NCT00580606|593669888|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
164354080|NCT00580606|593669889|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
164354081|NCT03358290|593669891|FG000|Overall Study|Study discontinued by Sponsor|0|||
164694372|NCT01844531|594902971|FG001|Overall Study|Withdrawal by Subject|1|||
164354082|NCT03358290|593669892|FG001|Overall Study|Study discontinued by Sponsor|1|||
164354083|NCT03358290|593669893|FG002|Overall Study|Study discontinued by Sponsor|1|||
164354084|NCT03358290|593669894|FG003|Overall Study|Study discontinued by Sponsor|0|||
164354085|NCT03358290|593669895|FG004|Overall Study|Study discontinued by Sponsor|0|||
164354086|NCT03358290|593669891|FG000|Overall Study|Adverse Event|0|||
164354087|NCT03358290|593669892|FG001|Overall Study|Adverse Event|0|||
164354088|NCT03358290|593669893|FG002|Overall Study|Adverse Event|1|||
164354089|NCT03358290|593669894|FG003|Overall Study|Adverse Event|2|||
164354090|NCT03358290|593669895|FG004|Overall Study|Adverse Event|0|||
164354091|NCT03358290|593669891|FG000|Overall Study|Withdrawal by Subject|0|||
164354092|NCT03358290|593669892|FG001|Overall Study|Withdrawal by Subject|0|||
164354093|NCT03358290|593669893|FG002|Overall Study|Withdrawal by Subject|0|||
164354094|NCT03358290|593669894|FG003|Overall Study|Withdrawal by Subject|0|||
164354095|NCT03358290|593669895|FG004|Overall Study|Withdrawal by Subject|1|||
164354096|NCT01482884|593669896|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
164354097|NCT01482884|593669897|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
164354098|NCT01482884|593669896|FG000|Overall Study|Protocol Violation|1|||
164354099|NCT01482884|593669897|FG001|Overall Study|Protocol Violation|0|||
164354100|NCT01482884|593669896|FG000|Overall Study|Lost to Follow-up|2|||
164354101|NCT01482884|593669897|FG001|Overall Study|Lost to Follow-up|2|||
164354102|NCT01482884|593669896|FG000|Overall Study|Lack of Efficacy|0|||
164354103|NCT01482884|593669897|FG001|Overall Study|Lack of Efficacy|1|||
164354104|NCT01482884|593669896|FG000|Overall Study|Adverse Event|2|||
164694373|NCT01844531|594902972|FG002|Overall Study|Withdrawal by Subject|0|||
164694374|NCT01844531|594902973|FG003|Overall Study|Withdrawal by Subject|0|||
164694375|NCT00794417|594902974|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
164694376|NCT00794417|594902975|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
164694377|NCT00794417|594902976|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
164694378|NCT00794417|594902977|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
164694379|NCT00794417|594902974|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
164694380|NCT00794417|594902975|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
164694381|NCT00794417|594902976|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
164694382|NCT00794417|594902977|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
164694383|NCT00794417|594902974|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
164694384|NCT00794417|594902975|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
164354105|NCT01482884|593669897|FG001|Overall Study|Adverse Event|1|||
164354106|NCT01482884|593669896|FG000|Overall Study|Withdrawal by Subject|8|||
164354107|NCT01482884|593669897|FG001|Overall Study|Withdrawal by Subject|13|||
164354108|NCT04102020|593669898|FG000|Overall Study|Adverse Event|1|||
164354109|NCT04102020|593669899|FG001|Overall Study|Adverse Event|0|||
164354110|NCT04102020|593669900|FG002|Overall Study|Adverse Event|0|||
164354111|NCT04102020|593669901|FG003|Overall Study|Adverse Event|1|||
164354112|NCT04102020|593669902|FG004|Overall Study|Adverse Event|0|||
164354113|NCT04102020|593669898|FG000|Overall Study|Withdrawal by Subject|0|||
164354114|NCT04102020|593669899|FG001|Overall Study|Withdrawal by Subject|1|||
164354115|NCT04102020|593669900|FG002|Overall Study|Withdrawal by Subject|1|||
164354116|NCT04102020|593669901|FG003|Overall Study|Withdrawal by Subject|1|||
164694385|NCT00794417|594902976|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
164354117|NCT04102020|593669902|FG004|Overall Study|Withdrawal by Subject|1|||
164354118|NCT04102020|593669898|FG000|Overall Study|Death|1|||
164354119|NCT04102020|593669899|FG001|Overall Study|Death|4|||
164354120|NCT04102020|593669900|FG002|Overall Study|Death|1|||
164354121|NCT04102020|593669901|FG003|Overall Study|Death|1|||
164354122|NCT04102020|593669902|FG004|Overall Study|Death|0|||
164354123|NCT04102020|593669898|FG000|Overall Study|Physician Decision|1|||
164354124|NCT04102020|593669899|FG001|Overall Study|Physician Decision|2|||
164694386|NCT00794417|594902977|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
164694387|NCT00794417|594902974|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
164694388|NCT00794417|594902975|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
164354125|NCT04102020|593669900|FG002|Overall Study|Physician Decision|2|||
164354126|NCT04102020|593669901|FG003|Overall Study|Physician Decision|0|||
164354127|NCT04102020|593669902|FG004|Overall Study|Physician Decision|1|||
164354128|NCT04102020|593669898|FG000|Overall Study|COVID-19 Infection|1|||
164354129|NCT04102020|593669899|FG001|Overall Study|COVID-19 Infection|0|||
164354130|NCT04102020|593669900|FG002|Overall Study|COVID-19 Infection|0|||
164354131|NCT04102020|593669901|FG003|Overall Study|COVID-19 Infection|0|||
164354132|NCT04102020|593669902|FG004|Overall Study|COVID-19 Infection|0|||
164588826|NCT00257192|594519231|FG001|Overall Study|Study terminated by sponsor|0|||
164588827|NCT00257192|594519230|FG000|Overall Study|Miscellaneous|0|||
164588828|NCT00257192|594519231|FG001|Overall Study|Miscellaneous|4|||
164588829|NCT01158950|594519234|FG000|1st Intervention (1 Day)|Physician Decision|1|||
164588830|NCT01158950|594519235|FG001|1st Intervention (1 Day)|Physician Decision|2|||
164588831|NCT01905397|594519236|FG000|Overall Study|Death|0|||
164588832|NCT01905397|594519237|FG001|Overall Study|Death|1|||
164588833|NCT01905397|594519236|FG000|Overall Study|Withdrawal by Subject|2|||
164588834|NCT01905397|594519237|FG001|Overall Study|Withdrawal by Subject|0|||
164588835|NCT01905397|594519236|FG000|Overall Study|Surgery canceled/aborted|9|||
164588836|NCT01905397|594519237|FG001|Overall Study|Surgery canceled/aborted|5|||
164588837|NCT01905397|594519236|FG000|Overall Study|Incision < 7 cm|2|||
164588838|NCT01905397|594519237|FG001|Overall Study|Incision < 7 cm|0|||
164588839|NCT01905397|594519236|FG000|Overall Study|Wrong treatment|1|||
164588840|NCT01905397|594519237|FG001|Overall Study|Wrong treatment|1|||
164588841|NCT01905397|594519236|FG000|Overall Study|Device not applied|3|||
164588842|NCT01905397|594519237|FG001|Overall Study|Device not applied|0|||
164588843|NCT01905397|594519236|FG000|Overall Study|Dressing not applied in operating room|1|||
164588844|NCT01905397|594519237|FG001|Overall Study|Dressing not applied in operating room|0|||
164588845|NCT01905397|594519236|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
164588846|NCT01905397|594519237|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
164588847|NCT00638846|594519240|FG000|Overall Study|Adverse Event|0|||
164588848|NCT00638846|594519241|FG001|Overall Study|Adverse Event|1|||
164588849|NCT00638846|594519240|FG000|Overall Study|Lost to Follow-up|3|||
164588850|NCT00638846|594519241|FG001|Overall Study|Lost to Follow-up|2|||
164588851|NCT00638846|594519240|FG000|Overall Study|lens issue|1|||
164588852|NCT00638846|594519241|FG001|Overall Study|lens issue|3|||
164588853|NCT02746679|594519245|FG000|Overall Study|Lost to Follow-up|4|||
164588854|NCT02746679|594519246|FG001|Overall Study|Lost to Follow-up|6|||
164588855|NCT01927562|594519249|FG000|Overall Study|Lost to Follow-up|30|||
164588856|NCT01927562|594519249|FG000|Overall Study|Withdrawal by Subject|3|||
164588857|NCT01927562|594519249|FG000|Overall Study|Physician Decision|5|||
164588858|NCT00642616|594519250|FG000|Overall Study|Adverse Event|2|||
164588859|NCT00642616|594519251|FG001|Overall Study|Adverse Event|0|||
164588860|NCT00642616|594519252|FG002|Overall Study|Adverse Event|1|||
164588861|NCT00642616|594519253|FG003|Overall Study|Adverse Event|0|||
164588862|NCT00642616|594519250|FG000|Overall Study|Study Terminated by Sponsor|7|||
164588863|NCT00642616|594519251|FG001|Overall Study|Study Terminated by Sponsor|6|||
164588864|NCT00642616|594519252|FG002|Overall Study|Study Terminated by Sponsor|4|||
164588865|NCT00642616|594519253|FG003|Overall Study|Study Terminated by Sponsor|5|||
164588866|NCT00642616|594519250|FG000|Overall Study|Withdrawal by Subject|0|||
164588867|NCT00642616|594519251|FG001|Overall Study|Withdrawal by Subject|1|||
164588868|NCT00642616|594519252|FG002|Overall Study|Withdrawal by Subject|1|||
164588869|NCT00642616|594519253|FG003|Overall Study|Withdrawal by Subject|1|||
164588870|NCT00642616|594519250|FG000|Overall Study|Protocol Violation|0|||
164588871|NCT00642616|594519251|FG001|Overall Study|Protocol Violation|0|||
164588872|NCT00642616|594519252|FG002|Overall Study|Protocol Violation|2|||
164588873|NCT00642616|594519253|FG003|Overall Study|Protocol Violation|0|||
164588874|NCT00642616|594519250|FG000|Overall Study|Physician Decision|0|||
164588875|NCT00642616|594519251|FG001|Overall Study|Physician Decision|0|||
164588876|NCT00642616|594519252|FG002|Overall Study|Physician Decision|1|||
164588877|NCT00642616|594519253|FG003|Overall Study|Physician Decision|1|||
164588878|NCT02955186|594519257|FG000|Overall Study|Withdrawal by Subject|6|||
164588879|NCT02955186|594519258|FG001|Overall Study|Withdrawal by Subject|2|||
164588880|NCT02955186|594519257|FG000|Overall Study|Protocol Violation|1|||
164588881|NCT02955186|594519258|FG001|Overall Study|Protocol Violation|0|||
164588882|NCT01276847|594519262|FG000|Overall Study|Withdrawal by Subject|1|||
164588883|NCT01276847|594519263|FG001|Overall Study|Withdrawal by Subject|0|||
164588884|NCT01276847|594519264|FG002|Overall Study|Withdrawal by Subject|0|||
164588885|NCT00469014|594519265|FG000|Initial Phase Randomization|Disease Progression|0|||
164588886|NCT00469014|594519266|FG001|Initial Phase Randomization|Disease Progression|1|||
164588887|NCT00469014|594519267|FG002|Initial Phase Randomization|Disease Progression|1|||
164588888|NCT00469014|594519268|FG003|Initial Phase Randomization|Disease Progression|0|||
164588889|NCT00469014|594519265|FG000|Initial Phase Randomization|No Response|1|||
164588890|NCT00469014|594519266|FG001|Initial Phase Randomization|No Response|0|||
164588891|NCT00469014|594519267|FG002|Initial Phase Randomization|No Response|0|||
164354133|NCT04102020|593669898|FG000|Overall Study|Not disclosed|5|||
164694389|NCT00794417|594902976|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
164694390|NCT00794417|594902977|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
164694391|NCT00794417|594902974|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
164694392|NCT00794417|594902975|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
164694393|NCT00794417|594902976|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
164694394|NCT00794417|594902977|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
164694395|NCT00794417|594902974|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
164694396|NCT00794417|594902975|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
164694397|NCT00794417|594902976|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
164694398|NCT00794417|594902977|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
164694399|NCT00255151|594902981|FG000|Overall Study|Adverse Event|10|||
164694400|NCT00255151|594902982|FG001|Overall Study|Adverse Event|6|||
164694401|NCT00255151|594902983|FG002|Overall Study|Adverse Event|9|||
164694402|NCT00255151|594902981|FG000|Overall Study|Lost to Follow-up|4|||
164694403|NCT00255151|594902982|FG001|Overall Study|Lost to Follow-up|3|||
164694404|NCT00255151|594902983|FG002|Overall Study|Lost to Follow-up|4|||
164694405|NCT00255151|594902981|FG000|Overall Study|Withdrawal by Subject|18|||
164694406|NCT00255151|594902982|FG001|Overall Study|Withdrawal by Subject|17|||
164694407|NCT00255151|594902983|FG002|Overall Study|Withdrawal by Subject|8|||
164694408|NCT00255151|594902981|FG000|Overall Study|Noncompliance|0|||
164694409|NCT00255151|594902982|FG001|Overall Study|Noncompliance|1|||
164694410|NCT00255151|594902983|FG002|Overall Study|Noncompliance|2|||
164694411|NCT00255151|594902981|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
164694412|NCT00255151|594902982|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
164694413|NCT00255151|594902983|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
164694414|NCT00255151|594902981|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
164694415|NCT00255151|594902982|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
164694416|NCT00255151|594902983|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
164694417|NCT00255151|594902981|FG000|Overall Study|Possible Barrett's Esophagus|1|||
164694418|NCT00255151|594902982|FG001|Overall Study|Possible Barrett's Esophagus|3|||
164694419|NCT00255151|594902983|FG002|Overall Study|Possible Barrett's Esophagus|8|||
164694420|NCT00255151|594902981|FG000|Overall Study|Esophageal Stricture|0|||
164694421|NCT00255151|594902982|FG001|Overall Study|Esophageal Stricture|0|||
164694422|NCT00255151|594902983|FG002|Overall Study|Esophageal Stricture|1|||
164694423|NCT00255151|594902981|FG000|Overall Study|Therapeutic Failure|11|||
164694424|NCT00255151|594902982|FG001|Overall Study|Therapeutic Failure|2|||
164694425|NCT00255151|594902983|FG002|Overall Study|Therapeutic Failure|3|||
164694426|NCT00792623|594902984|FG000|Overall Study|Adverse Event|2|||
164354134|NCT04102020|593669899|FG001|Overall Study|Not disclosed|3|||
164354135|NCT04102020|593669900|FG002|Overall Study|Not disclosed|8|||
164354136|NCT04102020|593669901|FG003|Overall Study|Not disclosed|0|||
164354137|NCT04102020|593669902|FG004|Overall Study|Not disclosed|1|||
164354138|NCT04102020|593669898|FG000|Overall Study|MIssing|1|||
164354139|NCT04102020|593669899|FG001|Overall Study|MIssing|0|||
164354140|NCT04102020|593669900|FG002|Overall Study|MIssing|1|||
164354141|NCT04102020|593669901|FG003|Overall Study|MIssing|1|||
164354142|NCT04102020|593669902|FG004|Overall Study|MIssing|1|||
164354143|NCT04102020|593669898|FG000|Overall Study|Continuing in ongoing study|13|||
164354144|NCT04102020|593669899|FG001|Overall Study|Continuing in ongoing study|13|||
164354145|NCT04102020|593669900|FG002|Overall Study|Continuing in ongoing study|7|||
164354146|NCT04102020|593669901|FG003|Overall Study|Continuing in ongoing study|26|||
164354147|NCT04102020|593669902|FG004|Overall Study|Continuing in ongoing study|12|||
164354148|NCT04853225|593669903|FG000|Overall Study|Withdrawal by Subject|81|||
164354149|NCT04853225|593669904|FG001|Overall Study|Withdrawal by Subject|4|||
164354150|NCT04853225|593669905|FG002|Overall Study|Withdrawal by Subject|1|||
164354151|NCT04853225|593669903|FG000|Overall Study|Physician Decision|12|||
164354152|NCT04853225|593669904|FG001|Overall Study|Physician Decision|4|||
164354153|NCT04853225|593669905|FG002|Overall Study|Physician Decision|1|||
164354154|NCT04853225|593669903|FG000|Overall Study|Lost to Follow-up|50|||
164436921|NCT00878722|593966432|FG002|Overall Study|Withdrawal by Subject|0|||
164436922|NCT00878722|593966433|FG003|Overall Study|Withdrawal by Subject|0|||
164436923|NCT00878722|593966434|FG004|Overall Study|Withdrawal by Subject|0|||
164694427|NCT00792623|594902984|FG000|Overall Study|Withdrawal by Subject|5|||
164354155|NCT04853225|593669904|FG001|Overall Study|Lost to Follow-up|0|||
164354156|NCT04853225|593669905|FG002|Overall Study|Lost to Follow-up|0|||
164354157|NCT04853225|593669903|FG000|Overall Study|Other|102|||
164436924|NCT00878722|593966435|FG005|Overall Study|Withdrawal by Subject|0|||
164694428|NCT00743509|594902993|FG000|Overall Study|Withdrawal by Subject|2|||
164694429|NCT01534078|594902996|FG000|Overall Study|Death|1|||
164694430|NCT01534078|594902996|FG000|Overall Study|Withdrawal by Subject|1|||
164694431|NCT01470417|594903000|FG000|Overall Study|Disease progression|0|||
164694432|NCT01470417|594903001|FG001|Overall Study|Disease progression|2|||
164694433|NCT02973321|594903004|FG000|Overall Study|Other than specified|0|||
164694434|NCT02973321|594903005|FG001|Overall Study|Other than specified|5|||
164694435|NCT02973321|594903006|FG002|Overall Study|Other than specified|3|||
164354158|NCT04853225|593669904|FG001|Overall Study|Other|11|||
164354159|NCT04853225|593669905|FG002|Overall Study|Other|5|||
164354160|NCT04853225|593669903|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
164354161|NCT04853225|593669904|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
164354162|NCT04853225|593669905|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
164354163|NCT04853225|593669903|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
164354164|NCT04853225|593669904|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
164354165|NCT04853225|593669905|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
164354166|NCT03789318|593669906|FG000|Overall Study|Adverse Event|0|||
164354167|NCT03789318|593669907|FG001|Overall Study|Adverse Event|0|||
164354168|NCT03789318|593669908|FG002|Overall Study|Adverse Event|1|||
164354169|NCT03789318|593669909|FG003|Overall Study|Adverse Event|1|||
164354170|NCT03789318|593669910|FG004|Overall Study|Adverse Event|0|||
164354171|NCT03789318|593669906|FG000|Overall Study|Lost to Follow-up|0|||
164354172|NCT03789318|593669907|FG001|Overall Study|Lost to Follow-up|0|||
164354173|NCT03789318|593669908|FG002|Overall Study|Lost to Follow-up|1|||
164354174|NCT03789318|593669909|FG003|Overall Study|Lost to Follow-up|0|||
164354175|NCT03789318|593669910|FG004|Overall Study|Lost to Follow-up|0|||
164354176|NCT03789318|593669906|FG000|Overall Study|Withdrawal by Subject|0|||
164354177|NCT03789318|593669907|FG001|Overall Study|Withdrawal by Subject|0|||
164354178|NCT03789318|593669908|FG002|Overall Study|Withdrawal by Subject|1|||
164354179|NCT03789318|593669909|FG003|Overall Study|Withdrawal by Subject|0|||
164354180|NCT03789318|593669910|FG004|Overall Study|Withdrawal by Subject|0|||
164354181|NCT01463878|593672278|FG000|Overall Study|no longer met criteria for tube feed|2|||
164354182|NCT01463878|593672279|FG001|Overall Study|no longer met criteria for tube feed|2|||
164354183|NCT02051608|593672282|FG000|Part 1: Double Blind Treatment|Death|3|||
164354184|NCT02051608|593672283|FG001|Part 1: Double Blind Treatment|Death|3|||
164354185|NCT02051608|593672284|FG002|Part 1: Double Blind Treatment|Death|0|||
164354186|NCT02051608|593672285|FG003|Part 1: Double Blind Treatment|Death|0|||
164354187|NCT02051608|593672282|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
164354188|NCT02051608|593672283|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
164354189|NCT02051608|593672284|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
164354190|NCT02051608|593672285|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
164354191|NCT02051608|593672282|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
164354192|NCT02051608|593672283|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
164354193|NCT02051608|593672284|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
164354194|NCT02051608|593672285|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
164354195|NCT02051608|593672282|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
164354196|NCT02051608|593672283|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
164354197|NCT02051608|593672284|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
164354198|NCT02051608|593672285|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
164354199|NCT02051608|593672282|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
164354200|NCT02051608|593672283|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
164354201|NCT02051608|593672284|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
164354202|NCT02051608|593672285|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
164354203|NCT02051608|593672282|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
164354204|NCT02051608|593672283|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
164354205|NCT02051608|593672284|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
164354206|NCT02051608|593672285|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
164694436|NCT02973321|594903007|FG003|Overall Study|Other than specified|3|||
164694437|NCT02973321|594903008|FG004|Overall Study|Other than specified|1|||
164694438|NCT02973321|594903004|FG000|Overall Study|Lack of Efficacy|0|||
164694439|NCT02973321|594903005|FG001|Overall Study|Lack of Efficacy|0|||
164694440|NCT02973321|594903006|FG002|Overall Study|Lack of Efficacy|0|||
164694441|NCT02973321|594903007|FG003|Overall Study|Lack of Efficacy|0|||
164694442|NCT02973321|594903008|FG004|Overall Study|Lack of Efficacy|1|||
164694443|NCT02973321|594903004|FG000|Overall Study|Adverse Event|1|||
164694444|NCT02973321|594903005|FG001|Overall Study|Adverse Event|10|||
164694445|NCT02973321|594903006|FG002|Overall Study|Adverse Event|11|||
164354207|NCT02051608|593672282|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
164354208|NCT02051608|593672283|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
164354209|NCT02051608|593672284|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
164354210|NCT02051608|593672285|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
164354211|NCT02051608|593672282|FG000|Part 1: Double Blind Treatment|Other|6|||
164354212|NCT02051608|593672283|FG001|Part 1: Double Blind Treatment|Other|3|||
164354213|NCT02051608|593672284|FG002|Part 1: Double Blind Treatment|Other|0|||
164694446|NCT02973321|594903007|FG003|Overall Study|Adverse Event|13|||
164694447|NCT02973321|594903008|FG004|Overall Study|Adverse Event|3|||
164354214|NCT02051608|593672285|FG003|Part 1: Double Blind Treatment|Other|0|||
164354215|NCT02051608|593672282|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
164694448|NCT00493454|594903009|FG000|Overall Study|Withdrawal by Subject|1|||
164694449|NCT02274948|594903012|FG000|Overall Study|Lost to Follow-up|28|||
164694450|NCT02274948|594903013|FG001|Overall Study|Lost to Follow-up|25|||
164354216|NCT02051608|593672283|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
164354217|NCT02051608|593672284|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
164354218|NCT02051608|593672285|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
164354219|NCT02051608|593672282|FG000|Part 2: Open-label Extension|Adverse Event|0|||
164354220|NCT02051608|593672283|FG001|Part 2: Open-label Extension|Adverse Event|0|||
164354221|NCT02051608|593672284|FG002|Part 2: Open-label Extension|Adverse Event|6|||
164354222|NCT02051608|593672285|FG003|Part 2: Open-label Extension|Adverse Event|8|||
164354223|NCT02051608|593672282|FG000|Part 2: Open-label Extension|Death|0|||
164354224|NCT02051608|593672283|FG001|Part 2: Open-label Extension|Death|0|||
164354225|NCT02051608|593672284|FG002|Part 2: Open-label Extension|Death|7|||
164354226|NCT02051608|593672285|FG003|Part 2: Open-label Extension|Death|4|||
164354227|NCT02051608|593672282|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
164354228|NCT02051608|593672283|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
164354229|NCT02051608|593672284|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
164354230|NCT02051608|593672285|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
164354231|NCT02051608|593672282|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
164354232|NCT02051608|593672283|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
164354233|NCT02051608|593672284|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
164354234|NCT02051608|593672285|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
164354235|NCT02051608|593672282|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
164354236|NCT02051608|593672283|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
164354237|NCT02051608|593672284|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
164354238|NCT02051608|593672285|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
164354239|NCT02051608|593672282|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
164354240|NCT02051608|593672283|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
164354241|NCT02051608|593672284|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
164354242|NCT02051608|593672285|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
164354243|NCT02051608|593672282|FG000|Part 2: Open-label Extension|Physician Decision|0|||
164354244|NCT02051608|593672283|FG001|Part 2: Open-label Extension|Physician Decision|0|||
164354245|NCT02051608|593672284|FG002|Part 2: Open-label Extension|Physician Decision|8|||
164354246|NCT02051608|593672285|FG003|Part 2: Open-label Extension|Physician Decision|5|||
164354247|NCT02051608|593672282|FG000|Part 2: Open-label Extension|Other|0|||
164354248|NCT02051608|593672283|FG001|Part 2: Open-label Extension|Other|0|||
164354249|NCT02051608|593672284|FG002|Part 2: Open-label Extension|Other|9|||
164354250|NCT02051608|593672285|FG003|Part 2: Open-label Extension|Other|9|||
164354251|NCT00142584|593672286|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
164354252|NCT00142584|593672287|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
164354253|NCT00142584|593672286|FG000|Overall Study|Withdrawal by Subject|30|||
164354254|NCT00142584|593672287|FG001|Overall Study|Withdrawal by Subject|16|||
164354255|NCT00142584|593672286|FG000|Overall Study|Lost to Follow-up|22|||
164354256|NCT00142584|593672287|FG001|Overall Study|Lost to Follow-up|12|||
164354257|NCT00142584|593672286|FG000|Overall Study|Adverse Event|14|||
164354258|NCT00142584|593672287|FG001|Overall Study|Adverse Event|5|||
164354259|NCT00142584|593672286|FG000|Overall Study|Protocol Violation|4|||
164354260|NCT00142584|593672287|FG001|Overall Study|Protocol Violation|7|||
164354261|NCT00142584|593672286|FG000|Overall Study|Treatment Failure|2|||
164354262|NCT00142584|593672287|FG001|Overall Study|Treatment Failure|0|||
164354263|NCT01083576|593672288|FG000|Overall Study|Treatment Failure|6|||
164354264|NCT01083576|593672289|FG001|Overall Study|Treatment Failure|1|||
164354265|NCT01986985|593672290|FG000|Overall Study|Withdrawal by Subject|4|||
164354266|NCT01986985|593672290|FG000|Overall Study|Scan not completed due to malfunction|3|||
164354267|NCT00449540|593672291|FG000|Pretreatment Phase|No migraine experienced|66|||
164354268|NCT00449540|593672292|FG001|Pretreatment Phase|No migraine experienced|0|||
164354269|NCT00449540|593672293|FG002|Pretreatment Phase|No migraine experienced|0|||
164354270|NCT00449540|593672291|FG000|Treatment Phase|did not experience or treat migraine|0|||
164354271|NCT00449540|593672292|FG001|Treatment Phase|did not experience or treat migraine|20|||
164354272|NCT00449540|593672293|FG002|Treatment Phase|did not experience or treat migraine|17|||
164354273|NCT04577118|593672294|FG000|Overall Study|Withdrawal by Subject|4|||
164354274|NCT02036294|593672295|FG000|Overall Study|Death|7|||
164354275|NCT02036294|593672296|FG001|Overall Study|Death|8|||
164354276|NCT02036294|593672295|FG000|Overall Study|Withdrawal by Subject|2|||
164354277|NCT02036294|593672296|FG001|Overall Study|Withdrawal by Subject|3|||
164354278|NCT00356369|593672297|FG000|Active Phase|Withdrawal by Subject|2|||
164354279|NCT00356369|593672298|FG001|Active Phase|Withdrawal by Subject|1|||
164354280|NCT00673465|593672301|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
164354281|NCT00673465|593672302|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
164354282|NCT00673465|593672303|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
164354283|NCT00673465|593672304|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
164354284|NCT00673465|593672305|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
164354285|NCT00673465|593672306|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
164354286|NCT00673465|593672307|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
164436925|NCT00878722|593966436|FG006|Overall Study|Withdrawal by Subject|0|||
164436926|NCT00878722|593966437|FG007|Overall Study|Withdrawal by Subject|2|||
164436927|NCT00878722|593966430|FG000|Overall Study|Relapse|0|||
164436928|NCT00878722|593966431|FG001|Overall Study|Relapse|0|||
164436929|NCT00878722|593966432|FG002|Overall Study|Relapse|0|||
164436930|NCT00878722|593966433|FG003|Overall Study|Relapse|1|||
164436931|NCT00878722|593966434|FG004|Overall Study|Relapse|0|||
164436932|NCT00878722|593966435|FG005|Overall Study|Relapse|0|||
164436933|NCT00878722|593966436|FG006|Overall Study|Relapse|0|||
164436934|NCT00878722|593966437|FG007|Overall Study|Relapse|0|||
164436935|NCT00383188|593966438|FG000|Overall Study|Adverse Event|4|||
164436936|NCT00383188|593966439|FG001|Overall Study|Adverse Event|7|||
164436937|NCT00383188|593966440|FG002|Overall Study|Adverse Event|9|||
164436938|NCT00383188|593966441|FG003|Overall Study|Adverse Event|8|||
164436939|NCT00383188|593966442|FG004|Overall Study|Adverse Event|8|||
164694451|NCT02274948|594903012|FG000|Overall Study|Withdrawal by Subject|64|||
164694452|NCT02274948|594903013|FG001|Overall Study|Withdrawal by Subject|58|||
164694453|NCT02274948|594903012|FG000|Overall Study|Stopped on family Practitioner advice|2|||
164694454|NCT02274948|594903013|FG001|Overall Study|Stopped on family Practitioner advice|5|||
164694455|NCT02274948|594903012|FG000|Overall Study|Left the area|4|||
164694456|NCT02274948|594903013|FG001|Overall Study|Left the area|3|||
164354287|NCT00673465|593672308|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
164354288|NCT00673465|593672309|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
164354289|NCT00673465|593672310|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
164354290|NCT00673465|593672311|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
164354291|NCT00673465|593672312|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
164354292|NCT00673465|593672301|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
164354293|NCT00673465|593672302|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
164354294|NCT00673465|593672303|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
164354295|NCT00673465|593672304|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
164354296|NCT00673465|593672305|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
164354297|NCT00673465|593672306|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
164354298|NCT00673465|593672307|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
164354299|NCT00673465|593672308|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
164354300|NCT00673465|593672309|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
164354301|NCT00673465|593672310|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
164354302|NCT00673465|593672311|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
164354303|NCT00673465|593672312|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
164354304|NCT01285310|593672313|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
164354305|NCT01285310|593672314|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
164354306|NCT01285310|593672315|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
164354307|NCT01285310|593672316|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
164354308|NCT01285310|593672317|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
164354309|NCT01285310|593672313|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
164354310|NCT01285310|593672314|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
164354311|NCT01285310|593672315|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
164354312|NCT01285310|593672316|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
164354313|NCT01285310|593672317|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
164354314|NCT01285310|593672313|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
164354315|NCT01285310|593672314|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
164354316|NCT01285310|593672315|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
164354317|NCT01285310|593672316|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
164354318|NCT01285310|593672317|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
164354319|NCT01285310|593672313|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
164354320|NCT01285310|593672314|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
164354321|NCT01285310|593672315|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
164354322|NCT01285310|593672316|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
164354323|NCT01285310|593672317|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
164354324|NCT01285310|593672313|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
164436940|NCT00383188|593966438|FG000|Overall Study|Lack of Efficacy|9|||
164436941|NCT00383188|593966439|FG001|Overall Study|Lack of Efficacy|3|||
164436942|NCT00383188|593966440|FG002|Overall Study|Lack of Efficacy|3|||
164436943|NCT00383188|593966441|FG003|Overall Study|Lack of Efficacy|2|||
164436944|NCT00383188|593966442|FG004|Overall Study|Lack of Efficacy|6|||
164436945|NCT00383188|593966438|FG000|Overall Study|Other|3|||
164354325|NCT01285310|593672314|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
164436946|NCT00383188|593966439|FG001|Overall Study|Other|1|||
164354326|NCT01285310|593672315|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
164436947|NCT00383188|593966440|FG002|Overall Study|Other|0|||
164436948|NCT00383188|593966441|FG003|Overall Study|Other|2|||
164694457|NCT00707434|594903014|FG000|Overall Study|Adverse Event|1|||
164354327|NCT01285310|593672316|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
164354328|NCT01285310|593672317|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
164354329|NCT01285310|593672313|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
164354330|NCT01285310|593672314|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
164354331|NCT01285310|593672315|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
164354332|NCT01285310|593672316|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
164354333|NCT01285310|593672317|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
164354334|NCT01285310|593672313|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
164354335|NCT01285310|593672314|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
164354336|NCT01285310|593672315|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
164354337|NCT01285310|593672316|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
164354338|NCT01285310|593672317|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
164354339|NCT01285310|593672313|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
164354340|NCT01285310|593672314|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
164354341|NCT01285310|593672315|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
164354342|NCT01285310|593672316|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
164354343|NCT01285310|593672317|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
164354344|NCT01285310|593672313|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
164354345|NCT01285310|593672314|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
164354346|NCT01285310|593672315|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
164354347|NCT01285310|593672316|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
164354348|NCT01285310|593672317|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
164354349|NCT01285310|593672313|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
164354350|NCT01285310|593672314|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
164354351|NCT01285310|593672315|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
164354352|NCT01285310|593672316|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
164354353|NCT01285310|593672317|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
164354354|NCT01285310|593672313|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
164354355|NCT01285310|593672314|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
164354356|NCT01285310|593672315|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
164354357|NCT01285310|593672316|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
164354358|NCT01285310|593672317|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
164354359|NCT01285310|593672313|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
164354360|NCT01285310|593672314|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
164354361|NCT01285310|593672315|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
164354362|NCT01285310|593672316|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
164354363|NCT01285310|593672317|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
164354364|NCT00514540|593672318|FG000|First-Line Chemo|Withdrawal by Subject|1|||
164354365|NCT00514540|593672318|FG000|First-Line Chemo|Protocol Violation|7|||
164354366|NCT00514540|593672318|FG000|Second-Line|Physician/Patient Decision|31|||
164354367|NCT01996982|593672321|FG000|Overall Study|PI/team left institution|7|||
164354368|NCT01195415|593672340|FG000|Overall Study|No repeat biopsy due to progression|2|||
164354369|NCT01919723|593672341|FG000|Overall Study|Blood Samples Hemolyzed|2|||
164354370|NCT01919723|593672342|FG001|Overall Study|Blood Samples Hemolyzed|2|||
164354371|NCT00555321|593672343|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
164354372|NCT00555321|593672344|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
164354373|NCT00555321|593672345|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
164354374|NCT00555321|593672346|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
164354375|NCT00555321|593672347|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
164354376|NCT00555321|593672343|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
164354377|NCT00555321|593672344|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
164354378|NCT00555321|593672345|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
164354379|NCT00555321|593672346|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
164354380|NCT00555321|593672347|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
164354381|NCT00555321|593672343|FG000|Treatment Phase up to 12-months|Death|2|||
164354382|NCT00555321|593672344|FG001|Treatment Phase up to 12-months|Death|1|||
164354383|NCT00555321|593672345|FG002|Treatment Phase up to 12-months|Death|4|||
164354384|NCT00555321|593672346|FG003|Treatment Phase up to 12-months|Death|0|||
164354385|NCT00555321|593672347|FG004|Treatment Phase up to 12-months|Death|0|||
164354386|NCT00555321|593672343|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
164354387|NCT00555321|593672344|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
164354388|NCT00555321|593672345|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
164354389|NCT00555321|593672346|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
164354390|NCT00555321|593672347|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
164354391|NCT00555321|593672343|FG000|Treatment Phase up to 12-months|Other Reason|1|||
164354392|NCT00555321|593672344|FG001|Treatment Phase up to 12-months|Other Reason|3|||
164354393|NCT00555321|593672345|FG002|Treatment Phase up to 12-months|Other Reason|2|||
164354394|NCT00555321|593672346|FG003|Treatment Phase up to 12-months|Other Reason|0|||
164354395|NCT00555321|593672347|FG004|Treatment Phase up to 12-months|Other Reason|0|||
164354396|NCT00555321|593672343|FG000|Treatment Phase up to 12-months|Never treated|2|||
164354397|NCT00555321|593672344|FG001|Treatment Phase up to 12-months|Never treated|3|||
164694458|NCT02502734|594903015|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
164694459|NCT02502734|594903016|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
164694460|NCT02502734|594903015|FG000|Washout Period|Adverse Event|1|||
164694461|NCT02502734|594903016|FG001|Washout Period|Adverse Event|0|||
164694462|NCT00985231|594903019|FG000|Overall Study|ineligible|1|||
164694463|NCT00985231|594903020|FG001|Overall Study|ineligible|0|||
164354398|NCT00555321|593672345|FG002|Treatment Phase up to 12-months|Never treated|1|||
164354399|NCT00555321|593672346|FG003|Treatment Phase up to 12-months|Never treated|0|||
164354400|NCT00555321|593672347|FG004|Treatment Phase up to 12-months|Never treated|4|||
164354401|NCT00555321|593672343|FG000|Long-term Extension Phase|Adverse Event|2|||
164354402|NCT00555321|593672344|FG001|Long-term Extension Phase|Adverse Event|5|||
164354403|NCT00555321|593672345|FG002|Long-term Extension Phase|Adverse Event|2|||
164354404|NCT00555321|593672346|FG003|Long-term Extension Phase|Adverse Event|1|||
164354405|NCT00555321|593672347|FG004|Long-term Extension Phase|Adverse Event|0|||
164354406|NCT00555321|593672343|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
164354407|NCT00555321|593672344|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
164354408|NCT00555321|593672345|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
164354409|NCT00555321|593672346|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
164354410|NCT00555321|593672347|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
164354411|NCT00555321|593672343|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
164354412|NCT00555321|593672344|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
164354413|NCT00555321|593672345|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
164354414|NCT00555321|593672346|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
164354415|NCT00555321|593672347|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
164354416|NCT00555321|593672343|FG000|Long-term Extension Phase|Death|2|||
164354417|NCT00555321|593672344|FG001|Long-term Extension Phase|Death|0|||
164354418|NCT00555321|593672345|FG002|Long-term Extension Phase|Death|0|||
164354419|NCT00555321|593672346|FG003|Long-term Extension Phase|Death|3|||
164354420|NCT00555321|593672347|FG004|Long-term Extension Phase|Death|0|||
164354421|NCT00555321|593672343|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
164354422|NCT00555321|593672344|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
164354423|NCT00555321|593672345|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
164354424|NCT00555321|593672346|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
164354425|NCT00555321|593672347|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
164354426|NCT00555321|593672343|FG000|Long-term Extension Phase|Other Reason|1|||
164354427|NCT00555321|593672344|FG001|Long-term Extension Phase|Other Reason|0|||
164354428|NCT00555321|593672345|FG002|Long-term Extension Phase|Other Reason|2|||
164436949|NCT00383188|593966442|FG004|Overall Study|Other|6|||
164436950|NCT00383188|593966438|FG000|Overall Study|No longer willing to participate|1|||
164436951|NCT00383188|593966439|FG001|Overall Study|No longer willing to participate|0|||
164436952|NCT00383188|593966440|FG002|Overall Study|No longer willing to participate|1|||
164436953|NCT00383188|593966441|FG003|Overall Study|No longer willing to participate|0|||
164436954|NCT00383188|593966442|FG004|Overall Study|No longer willing to participate|2|||
164436955|NCT00383188|593966438|FG000|Overall Study|Lost to Follow-up|0|||
164436956|NCT00383188|593966439|FG001|Overall Study|Lost to Follow-up|0|||
164694464|NCT00985231|594903019|FG000|Overall Study|Protocol Violation|1|||
164694465|NCT00985231|594903020|FG001|Overall Study|Protocol Violation|0|||
164694466|NCT00985231|594903019|FG000|Overall Study|Withdrawal by Subject|1|||
164694467|NCT00985231|594903020|FG001|Overall Study|Withdrawal by Subject|0|||
164694468|NCT00985231|594903019|FG000|Overall Study|Lost to Follow-up|0|||
164694469|NCT00985231|594903020|FG001|Overall Study|Lost to Follow-up|1|||
164354429|NCT00555321|593672346|FG003|Long-term Extension Phase|Other Reason|0|||
164354430|NCT00555321|593672347|FG004|Long-term Extension Phase|Other Reason|0|||
164354431|NCT04294472|593672348|FG000|Overall Study|Adverse Event|0|||
164354432|NCT04294472|593672349|FG001|Overall Study|Adverse Event|1|||
164354433|NCT04294472|593672350|FG002|Overall Study|Adverse Event|1|||
164354434|NCT04294472|593672348|FG000|Overall Study|Randomized but not treated|0|||
164354435|NCT04294472|593672349|FG001|Overall Study|Randomized but not treated|1|||
164354436|NCT04294472|593672350|FG002|Overall Study|Randomized but not treated|1|||
164354437|NCT00563381|593672351|FG000|Overall Study|Adverse Event|264|||
164354438|NCT00563381|593672352|FG001|Overall Study|Adverse Event|292|||
164354439|NCT00563381|593672351|FG000|Overall Study|Protocol Violation|66|||
164694470|NCT00985231|594903019|FG000|Overall Study|Study related symptoms & complaints|0|||
164694471|NCT00985231|594903020|FG001|Overall Study|Study related symptoms & complaints|2|||
164354440|NCT00563381|593672352|FG001|Overall Study|Protocol Violation|74|||
164354441|NCT00563381|593672351|FG000|Overall Study|Lost to Follow-up|7|||
164354442|NCT00563381|593672352|FG001|Overall Study|Lost to Follow-up|15|||
164436957|NCT00383188|593966440|FG002|Overall Study|Lost to Follow-up|0|||
164694472|NCT00089076|594903021|FG000|Overall Study|Alternate Therapy|1|||
164694473|NCT00089076|594903021|FG000|Overall Study|Withdrawal by Subject|2|||
164588892|NCT00469014|594519268|FG003|Initial Phase Randomization|No Response|1|||
164588893|NCT00469014|594519265|FG000|Adaptive Randomization|Not Evaluable|1|||
164588894|NCT00469014|594519266|FG001|Adaptive Randomization|Not Evaluable|0|||
164588895|NCT00469014|594519267|FG002|Adaptive Randomization|Not Evaluable|0|||
164588896|NCT00469014|594519268|FG003|Adaptive Randomization|Not Evaluable|1|||
164588897|NCT00469014|594519265|FG000|Adaptive Randomization|No Response|0|||
164588898|NCT00469014|594519266|FG001|Adaptive Randomization|No Response|1|||
164588899|NCT00469014|594519267|FG002|Adaptive Randomization|No Response|0|||
164588900|NCT00469014|594519268|FG003|Adaptive Randomization|No Response|0|||
164588901|NCT00469014|594519265|FG000|Adaptive Randomization|Death|0|||
164588902|NCT00469014|594519266|FG001|Adaptive Randomization|Death|0|||
164588903|NCT00469014|594519267|FG002|Adaptive Randomization|Death|1|||
164588904|NCT00469014|594519268|FG003|Adaptive Randomization|Death|0|||
164588905|NCT04770155|594519269|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
164588906|NCT04770155|594519270|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
164588907|NCT04770155|594519271|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
164588908|NCT04770155|594519272|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
164588909|NCT04770155|594519273|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
164588910|NCT04770155|594519274|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
164588911|NCT04770155|594519275|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
164588912|NCT04770155|594519276|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
164588913|NCT02021812|594519279|FG000|Overall Study|Death|8|||
164588914|NCT02021812|594519279|FG000|Overall Study|Withdrawal by Subject|3|||
164588915|NCT02021812|594519279|FG000|Overall Study|Lost to Follow-up|2|||
164588916|NCT02021812|594519279|FG000|Overall Study|Refuse to return, COVD 19|2|||
164588917|NCT00081289|594519280|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
164588918|NCT00081289|594519281|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
164588919|NCT00081289|594519280|FG000|Overall Study|Ineligible / no protocol treatment|3|||
164588920|NCT00081289|594519281|FG001|Overall Study|Ineligible / no protocol treatment|4|||
164588921|NCT02239094|594519284|FG000|Overall Study|Withdrawal by Subject|1|||
164588922|NCT02239094|594519284|FG000|Overall Study|Remitted before started|1|||
164588923|NCT01469052|594519287|FG000|Overall Study|Adverse Event|2|||
164588924|NCT01469052|594519288|FG001|Overall Study|Adverse Event|3|||
164588925|NCT01469052|594519289|FG002|Overall Study|Adverse Event|0|||
164588926|NCT01469052|594519290|FG003|Overall Study|Adverse Event|2|||
164588927|NCT01469052|594519291|FG004|Overall Study|Adverse Event|0|||
164588928|NCT01469052|594519292|FG005|Overall Study|Adverse Event|1|||
164588929|NCT01469052|594519287|FG000|Overall Study|Progressive disease|3|||
164588930|NCT01469052|594519288|FG001|Overall Study|Progressive disease|0|||
164588931|NCT01469052|594519289|FG002|Overall Study|Progressive disease|5|||
164299427|NCT05386329|593471343|FG000|Overall Study|Lost to Follow-up|3|||
164588932|NCT01469052|594519290|FG003|Overall Study|Progressive disease|3|||
164299428|NCT03043313|593471346|FG000|Overall Study|Withdrawal by Subject|5|||
164299429|NCT03043313|593471347|FG001|Overall Study|Withdrawal by Subject|1|||
164299430|NCT03043313|593471348|FG002|Overall Study|Withdrawal by Subject|1|||
164299431|NCT03043313|593471346|FG000|Overall Study|Lost to Follow-up|1|||
164299432|NCT03043313|593471347|FG001|Overall Study|Lost to Follow-up|1|||
164299433|NCT03043313|593471348|FG002|Overall Study|Lost to Follow-up|0|||
164299434|NCT03043313|593471346|FG000|Overall Study|Death|28|||
164299435|NCT03043313|593471347|FG001|Overall Study|Death|26|||
164299436|NCT03043313|593471348|FG002|Overall Study|Death|17|||
164299437|NCT03043313|593471346|FG000|Overall Study|Participation terminated by sponsor|11|||
164299438|NCT03043313|593471347|FG001|Overall Study|Participation terminated by sponsor|13|||
164299439|NCT03043313|593471348|FG002|Overall Study|Participation terminated by sponsor|13|||
164299440|NCT04973449|593471351|FG000|Overall Study|Withdrawal by Subject|3|||
164299441|NCT04973449|593471352|FG001|Overall Study|Withdrawal by Subject|3|||
164299442|NCT04973449|593471353|FG002|Overall Study|Withdrawal by Subject|2|||
164299443|NCT04973449|593471354|FG003|Overall Study|Withdrawal by Subject|5|||
164299444|NCT04973449|593471355|FG004|Overall Study|Withdrawal by Subject|5|||
164299445|NCT04973449|593471356|FG005|Overall Study|Withdrawal by Subject|4|||
164299446|NCT04973449|593471357|FG006|Overall Study|Withdrawal by Subject|7|||
164299447|NCT04973449|593471358|FG007|Overall Study|Withdrawal by Subject|5|||
164299448|NCT04973449|593471351|FG000|Overall Study|Lost to Follow-up|15|||
164299449|NCT04973449|593471352|FG001|Overall Study|Lost to Follow-up|16|||
164299450|NCT04973449|593471353|FG002|Overall Study|Lost to Follow-up|16|||
164299451|NCT04973449|593471354|FG003|Overall Study|Lost to Follow-up|13|||
164299452|NCT04973449|593471355|FG004|Overall Study|Lost to Follow-up|5|||
164354443|NCT00563381|593672351|FG000|Overall Study|Withdrawal by Subject|192|||
164354444|NCT00563381|593672352|FG001|Overall Study|Withdrawal by Subject|209|||
164354445|NCT00563381|593672351|FG000|Overall Study|Lack of Efficacy|32|||
164354446|NCT00563381|593672352|FG001|Overall Study|Lack of Efficacy|24|||
164354447|NCT00563381|593672351|FG000|Overall Study|Individual different reasons|24|||
164354448|NCT00563381|593672352|FG001|Overall Study|Individual different reasons|34|||
164354449|NCT01957644|593672353|FG000|Overall Study|Adverse Event|4|||
164354450|NCT01957644|593672354|FG001|Overall Study|Adverse Event|2|||
164354451|NCT01957644|593672355|FG002|Overall Study|Adverse Event|0|||
164354452|NCT01957644|593672356|FG003|Overall Study|Adverse Event|0|||
164354453|NCT01957644|593672357|FG004|Overall Study|Adverse Event|1|||
164354454|NCT01957644|593672353|FG000|Overall Study|Progressive disease / relapse|0|||
164354455|NCT01957644|593672354|FG001|Overall Study|Progressive disease / relapse|1|||
164354456|NCT01957644|593672355|FG002|Overall Study|Progressive disease / relapse|0|||
164354457|NCT01957644|593672356|FG003|Overall Study|Progressive disease / relapse|1|||
164354458|NCT01957644|593672357|FG004|Overall Study|Progressive disease / relapse|0|||
164354459|NCT01957644|593672353|FG000|Overall Study|Other reason|1|||
164354460|NCT01957644|593672354|FG001|Overall Study|Other reason|2|||
164354461|NCT01957644|593672355|FG002|Overall Study|Other reason|1|||
164354462|NCT01957644|593672356|FG003|Overall Study|Other reason|1|||
164354463|NCT01957644|593672357|FG004|Overall Study|Other reason|0|||
164354464|NCT01957644|593672353|FG000|Overall Study|Withdrawal by Subject|1|||
164354465|NCT01957644|593672354|FG001|Overall Study|Withdrawal by Subject|0|||
164354466|NCT01957644|593672355|FG002|Overall Study|Withdrawal by Subject|0|||
164354467|NCT01957644|593672356|FG003|Overall Study|Withdrawal by Subject|0|||
164354468|NCT01957644|593672357|FG004|Overall Study|Withdrawal by Subject|0|||
164354469|NCT01957644|593672353|FG000|Overall Study|Protocol Violation|0|||
164354470|NCT01957644|593672354|FG001|Overall Study|Protocol Violation|1|||
164354471|NCT01957644|593672355|FG002|Overall Study|Protocol Violation|0|||
164354472|NCT01957644|593672356|FG003|Overall Study|Protocol Violation|0|||
164354473|NCT01957644|593672357|FG004|Overall Study|Protocol Violation|0|||
164354474|NCT04044716|593672358|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
164354475|NCT04044716|593672359|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
164354476|NCT04044716|593672360|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
164354477|NCT04044716|593672358|FG000|Overall Study|Lost to Follow-up|2|||
164354478|NCT04044716|593672359|FG001|Overall Study|Lost to Follow-up|3|||
164354479|NCT04044716|593672360|FG002|Overall Study|Lost to Follow-up|0|||
164354480|NCT01957553|593672361|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
164354481|NCT01957553|593672362|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
164354482|NCT01957553|593672361|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
164354483|NCT01957553|593672362|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
164354484|NCT01957553|593672361|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
164354485|NCT01957553|593672362|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
164354486|NCT01957553|593672361|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
164354487|NCT01957553|593672362|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
164354488|NCT01957553|593672361|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
164354489|NCT01957553|593672362|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
164354490|NCT01957553|593672361|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
164354491|NCT01957553|593672362|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
164354492|NCT01957553|593672361|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
164354493|NCT01957553|593672362|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
164354494|NCT01957553|593672361|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
164354495|NCT01957553|593672362|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
164354496|NCT01957553|593672361|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
164354497|NCT01957553|593672362|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
164354498|NCT01348347|593672363|FG000|Overall Study|Withdrawal by Subject|1|||
164354499|NCT01348347|593672364|FG001|Overall Study|Withdrawal by Subject|1|||
164354500|NCT01348347|593672365|FG002|Overall Study|Withdrawal by Subject|1|||
164354501|NCT01348347|593672363|FG000|Overall Study|Progressive disease|2|||
164354502|NCT01348347|593672364|FG001|Overall Study|Progressive disease|5|||
164354503|NCT01348347|593672365|FG002|Overall Study|Progressive disease|5|||
164354504|NCT00996307|593672375|FG000|Overall Study|Adverse Event|0|||
164354505|NCT00996307|593672376|FG001|Overall Study|Adverse Event|1|||
164354506|NCT00996307|593672377|FG002|Overall Study|Adverse Event|0|||
164354507|NCT00996307|593672378|FG003|Overall Study|Adverse Event|0|||
164354508|NCT00996307|593672375|FG000|Overall Study|Withdrawal by Subject|3|||
164354509|NCT00996307|593672376|FG001|Overall Study|Withdrawal by Subject|2|||
164354510|NCT00996307|593672377|FG002|Overall Study|Withdrawal by Subject|5|||
164354511|NCT00996307|593672378|FG003|Overall Study|Withdrawal by Subject|5|||
164354512|NCT00996307|593672375|FG000|Overall Study|Lost to Follow-up|13|||
164354513|NCT00996307|593672376|FG001|Overall Study|Lost to Follow-up|13|||
164436958|NCT00383188|593966441|FG003|Overall Study|Lost to Follow-up|0|||
164436959|NCT00383188|593966442|FG004|Overall Study|Lost to Follow-up|1|||
164694474|NCT00089076|594903021|FG000|Overall Study|Progression|7|||
164694475|NCT00808509|594903022|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
164694476|NCT00808509|594903023|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
164694477|NCT00808509|594903022|FG000|Randomized Phase|Reduced methotrexate dose|1|||
164694478|NCT00808509|594903023|FG001|Randomized Phase|Reduced methotrexate dose|2|||
164694479|NCT00808509|594903022|FG000|Randomized Phase|Patient refused rescue therapy|0|||
164694480|NCT00808509|594903023|FG001|Randomized Phase|Patient refused rescue therapy|3|||
164694481|NCT00931463|594903024|FG000|Overall Study|Death|8|||
164694482|NCT00931463|594903025|FG001|Overall Study|Death|4|||
164694483|NCT00931463|594903024|FG000|Overall Study|Withdrawal by Subject|5|||
164694484|NCT00931463|594903025|FG001|Overall Study|Withdrawal by Subject|0|||
164694485|NCT00931463|594903024|FG000|Overall Study|Lost to Follow-up|4|||
164694486|NCT00931463|594903025|FG001|Overall Study|Lost to Follow-up|1|||
164694487|NCT02169791|594903028|FG000|Overall Study|Death|6|||
164694488|NCT02169791|594903028|FG000|Overall Study|patient withdrew consent|1|||
164694489|NCT01501110|594903031|FG000|Overall Study|Death|0|||
164694490|NCT01501110|594903032|FG001|Overall Study|Death|1|||
164694491|NCT00575380|594903039|FG000|Overall Study|Withdrawal by Subject|1|||
164694492|NCT00575380|594903040|FG001|Overall Study|Withdrawal by Subject|0|||
164694493|NCT00575380|594903039|FG000|Overall Study|Adverse Event|0|||
164694494|NCT00575380|594903040|FG001|Overall Study|Adverse Event|1|||
164694495|NCT00575380|594903039|FG000|Overall Study|Various|0|||
164694496|NCT00575380|594903040|FG001|Overall Study|Various|2|||
164694497|NCT00003531|594903043|FG000|Overall Study|Not evaluable|10|||
164694498|NCT00346164|594903044|FG000|Overall Study|Adverse Event|0|||
164694499|NCT00346164|594903045|FG001|Overall Study|Adverse Event|0|||
164694500|NCT00346164|594903046|FG002|Overall Study|Adverse Event|0|||
164694501|NCT00346164|594903047|FG003|Overall Study|Adverse Event|1|||
164694502|NCT00346164|594903044|FG000|Overall Study|Lack of Efficacy|0|||
164694503|NCT00346164|594903045|FG001|Overall Study|Lack of Efficacy|1|||
164694504|NCT00346164|594903046|FG002|Overall Study|Lack of Efficacy|7|||
164694505|NCT00346164|594903047|FG003|Overall Study|Lack of Efficacy|25|||
164694506|NCT00346164|594903044|FG000|Overall Study|Physician Decision|0|||
164694507|NCT00346164|594903045|FG001|Overall Study|Physician Decision|1|||
164694508|NCT00346164|594903046|FG002|Overall Study|Physician Decision|2|||
164694509|NCT00346164|594903047|FG003|Overall Study|Physician Decision|27|||
164694510|NCT00346164|594903044|FG000|Overall Study|Protocol Violation|6|||
164694511|NCT00346164|594903045|FG001|Overall Study|Protocol Violation|2|||
164694512|NCT00346164|594903046|FG002|Overall Study|Protocol Violation|10|||
164694513|NCT00346164|594903047|FG003|Overall Study|Protocol Violation|4|||
164694514|NCT00346164|594903044|FG000|Overall Study|Withdrawal by Subject|0|||
164694515|NCT00346164|594903045|FG001|Overall Study|Withdrawal by Subject|0|||
164694516|NCT00346164|594903046|FG002|Overall Study|Withdrawal by Subject|2|||
164694517|NCT00346164|594903047|FG003|Overall Study|Withdrawal by Subject|0|||
164694518|NCT00346164|594903044|FG000|Overall Study|Ineligible|11|||
164694519|NCT00346164|594903045|FG001|Overall Study|Ineligible|2|||
164694520|NCT00346164|594903046|FG002|Overall Study|Ineligible|2|||
164694521|NCT00346164|594903047|FG003|Overall Study|Ineligible|23|||
164354514|NCT00996307|593672377|FG002|Overall Study|Lost to Follow-up|7|||
164354515|NCT00996307|593672378|FG003|Overall Study|Lost to Follow-up|15|||
164354516|NCT00996307|593672375|FG000|Overall Study|Administrative reason|0|||
164354517|NCT00996307|593672376|FG001|Overall Study|Administrative reason|1|||
164354518|NCT00996307|593672377|FG002|Overall Study|Administrative reason|0|||
164354519|NCT00996307|593672378|FG003|Overall Study|Administrative reason|0|||
164354520|NCT00996307|593672375|FG000|Overall Study|Unable to classify|4|||
164354521|NCT00996307|593672376|FG001|Overall Study|Unable to classify|0|||
164354522|NCT00996307|593672377|FG002|Overall Study|Unable to classify|2|||
164354523|NCT00996307|593672378|FG003|Overall Study|Unable to classify|1|||
164354524|NCT02788357|593672379|FG000|Overall Study|Lost to Follow-up|3|||
164354525|NCT02788357|593672380|FG001|Overall Study|Lost to Follow-up|0|||
164354526|NCT00640601|593672381|FG000|Overall Study|Adverse Event|43|||
164354527|NCT00640601|593672381|FG000|Overall Study|Withdrawal by Subject|20|||
164354528|NCT00640601|593672381|FG000|Overall Study|Protocol Violation|6|||
164354529|NCT00640601|593672381|FG000|Overall Study|Lack of Efficacy|16|||
164694522|NCT00346164|594903044|FG000|Overall Study|Refusal of further protocol therapy|0|||
164694523|NCT00346164|594903045|FG001|Overall Study|Refusal of further protocol therapy|1|||
164694524|NCT00346164|594903046|FG002|Overall Study|Refusal of further protocol therapy|3|||
164354530|NCT00640601|593672381|FG000|Overall Study|Lost to Follow-up|9|||
164354531|NCT00640601|593672381|FG000|Overall Study|Physician Decision|8|||
164354532|NCT00640601|593672381|FG000|Overall Study|treatment naive, combination therapy|10|||
164354533|NCT03198234|593672382|FG000|Overall Study|Relapse of primary disease|0|||
164354534|NCT03198234|593672383|FG001|Overall Study|Relapse of primary disease|1|||
164694525|NCT00346164|594903047|FG003|Overall Study|Refusal of further protocol therapy|15|||
164694526|NCT00346164|594903044|FG000|Overall Study|Inability to start week 16 tx on time|0|||
164694527|NCT00346164|594903045|FG001|Overall Study|Inability to start week 16 tx on time|0|||
164694528|NCT00346164|594903046|FG002|Overall Study|Inability to start week 16 tx on time|0|||
164694529|NCT00346164|594903047|FG003|Overall Study|Inability to start week 16 tx on time|11|||
164694530|NCT02927834|594903048|FG000|Overall Study|Lost to Follow-up|1|||
164694531|NCT02927834|594903049|FG001|Overall Study|Lost to Follow-up|2|||
164354535|NCT03198234|593672384|FG002|Overall Study|Relapse of primary disease|0|||
164354536|NCT00165776|593672386|FG000|Overall Study|Lack of Efficacy|0|||
164354537|NCT00165776|593672387|FG001|Overall Study|Lack of Efficacy|0|||
164354538|NCT00165776|593672388|FG002|Overall Study|Lack of Efficacy|0|||
164354539|NCT00165776|593672389|FG003|Overall Study|Lack of Efficacy|1|||
164354540|NCT00165776|593672386|FG000|Overall Study|Withdrawal by Subject|4|||
164354541|NCT00165776|593672387|FG001|Overall Study|Withdrawal by Subject|1|||
164354542|NCT00165776|593672388|FG002|Overall Study|Withdrawal by Subject|2|||
164354543|NCT00165776|593672389|FG003|Overall Study|Withdrawal by Subject|0|||
164354544|NCT00165776|593672386|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
164354545|NCT00165776|593672387|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
164354546|NCT00165776|593672388|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
164354547|NCT00165776|593672389|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
164354548|NCT04285879|593672390|FG000|Overall Study|Lost to Follow-up|1|||
164354549|NCT04285879|593672391|FG001|Overall Study|Lost to Follow-up|8|||
164354550|NCT04285879|593672390|FG000|Overall Study|medical/surgical exclusion|16|||
164354551|NCT04285879|593672391|FG001|Overall Study|medical/surgical exclusion|0|||
164354552|NCT01835587|593672394|FG000|Overall Study|Disease Recurrence or Relapse|0|||
164354553|NCT01835587|593672395|FG001|Overall Study|Disease Recurrence or Relapse|3|||
164354554|NCT01835587|593672396|FG002|Overall Study|Disease Recurrence or Relapse|0|||
164354555|NCT01835587|593672397|FG003|Overall Study|Disease Recurrence or Relapse|3|||
164354556|NCT01835587|593672394|FG000|Overall Study|Withdrawal by Subject|2|||
164354557|NCT01835587|593672395|FG001|Overall Study|Withdrawal by Subject|0|||
164354558|NCT01835587|593672396|FG002|Overall Study|Withdrawal by Subject|0|||
164354559|NCT01835587|593672397|FG003|Overall Study|Withdrawal by Subject|3|||
164354560|NCT01835587|593672394|FG000|Overall Study|Adverse Event|0|||
164354561|NCT01835587|593672395|FG001|Overall Study|Adverse Event|0|||
164354562|NCT01835587|593672396|FG002|Overall Study|Adverse Event|2|||
164354563|NCT01835587|593672397|FG003|Overall Study|Adverse Event|2|||
164354564|NCT01835587|593672394|FG000|Overall Study|Death|0|||
164354565|NCT01835587|593672395|FG001|Overall Study|Death|0|||
164354566|NCT01835587|593672396|FG002|Overall Study|Death|0|||
164354567|NCT01835587|593672397|FG003|Overall Study|Death|1|||
164354568|NCT01835587|593672394|FG000|Overall Study|Miscellaneous|0|||
164354569|NCT01835587|593672395|FG001|Overall Study|Miscellaneous|1|||
164354570|NCT01835587|593672396|FG002|Overall Study|Miscellaneous|0|||
164354571|NCT01835587|593672397|FG003|Overall Study|Miscellaneous|0|||
164354572|NCT03310775|593672404|FG000|Overall Study|Lost to Follow-up|2|||
164354573|NCT03310775|593672405|FG001|Overall Study|Lost to Follow-up|3|||
164354574|NCT03310775|593672404|FG000|Overall Study|aggravation of depression|0|||
164354575|NCT03310775|593672405|FG001|Overall Study|aggravation of depression|1|||
164354576|NCT01648205|593672408|FG000|Placebo|Pregnancy|1|||
164354577|NCT01648205|593672408|FG000|Placebo|Withdrawal by Subject|1|||
164354578|NCT01648205|593672408|FG000|Placebo|Protocol Violation|2|||
164354579|NCT01648205|593672408|FG000|Ranolazine|Death|1|||
164354580|NCT01648205|593672408|FG000|Ranolazine|Withdrawal by Subject|1|||
164354581|NCT01648205|593672408|FG000|Ranolazine|Protocol Violation|3|||
164354582|NCT02622321|593672409|FG000|Overall Study|Withdrawal by Subject|2|||
164354583|NCT02622321|593672410|FG001|Overall Study|Withdrawal by Subject|0|||
164354584|NCT02622321|593672411|FG002|Overall Study|Withdrawal by Subject|0|||
164354585|NCT02622321|593672412|FG003|Overall Study|Withdrawal by Subject|0|||
164354586|NCT02622321|593672409|FG000|Overall Study|Death|0|||
164354587|NCT02622321|593672410|FG001|Overall Study|Death|0|||
164354588|NCT02622321|593672411|FG002|Overall Study|Death|1|||
164354589|NCT02622321|593672412|FG003|Overall Study|Death|0|||
164354590|NCT02622321|593672409|FG000|Overall Study|Physician Decision|1|||
164354591|NCT02622321|593672410|FG001|Overall Study|Physician Decision|0|||
164354592|NCT02622321|593672411|FG002|Overall Study|Physician Decision|0|||
164354593|NCT02622321|593672412|FG003|Overall Study|Physician Decision|0|||
164354594|NCT01958008|593672414|FG000|Overall Study|Worsening of disease under study|0|||
164354595|NCT01958008|593672415|FG001|Overall Study|Worsening of disease under study|0|||
164354596|NCT01958008|593672416|FG002|Overall Study|Worsening of disease under study|1|||
164354597|NCT01958008|593672417|FG003|Overall Study|Worsening of disease under study|0|||
164354598|NCT01958008|593672414|FG000|Overall Study|Other adverse event|1|||
164354599|NCT01958008|593672415|FG001|Overall Study|Other adverse event|0|||
164354600|NCT01958008|593672416|FG002|Overall Study|Other adverse event|0|||
164588933|NCT01469052|594519291|FG004|Overall Study|Progressive disease|7|||
164354601|NCT01958008|593672417|FG003|Overall Study|Other adverse event|0|||
164354602|NCT00241280|593672418|FG000|Overall Study|Adverse Event|2|||
164354603|NCT00241280|593672419|FG001|Overall Study|Adverse Event|6|||
164354604|NCT00241280|593672418|FG000|Overall Study|Discomfort|11|||
164354605|NCT00241280|593672419|FG001|Overall Study|Discomfort|16|||
164354606|NCT00241280|593672418|FG000|Overall Study|Pregnancy|1|||
164354607|NCT00241280|593672419|FG001|Overall Study|Pregnancy|5|||
164354608|NCT00241280|593672418|FG000|Overall Study|Lost to Follow-up|5|||
164354609|NCT00241280|593672419|FG001|Overall Study|Lost to Follow-up|8|||
164354610|NCT00241280|593672418|FG000|Overall Study|Withdrawal by Subject|7|||
164354611|NCT00241280|593672419|FG001|Overall Study|Withdrawal by Subject|4|||
164354612|NCT00241280|593672418|FG000|Overall Study|Protocol Violation|4|||
164354613|NCT00241280|593672419|FG001|Overall Study|Protocol Violation|10|||
164354614|NCT00241280|593672418|FG000|Overall Study|Relocation|4|||
164354615|NCT00241280|593672419|FG001|Overall Study|Relocation|4|||
164354616|NCT00241280|593672418|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
164354617|NCT00241280|593672419|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
164354618|NCT00241280|593672418|FG000|Overall Study|Unsatisfactory Visual Response|1|||
164354619|NCT00241280|593672419|FG001|Overall Study|Unsatisfactory Visual Response|1|||
164354620|NCT00241280|593672418|FG000|Overall Study|Diabetic|1|||
164354621|NCT00241280|593672419|FG001|Overall Study|Diabetic|0|||
164354622|NCT00241280|593672418|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
164354623|NCT00241280|593672419|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
164354624|NCT00241280|593672418|FG000|Overall Study|Dispensed incorrect test article|1|||
164354625|NCT00241280|593672419|FG001|Overall Study|Dispensed incorrect test article|2|||
164354626|NCT00241280|593672418|FG000|Overall Study|Unacceptable Fit|0|||
164354627|NCT00241280|593672419|FG001|Overall Study|Unacceptable Fit|1|||
164354628|NCT00241280|593672418|FG000|Overall Study|Scheduling Conflict|0|||
164354629|NCT00241280|593672419|FG001|Overall Study|Scheduling Conflict|2|||
164354630|NCT00241280|593672418|FG000|Overall Study|History of Ocular Surgery|0|||
164354631|NCT00241280|593672419|FG001|Overall Study|History of Ocular Surgery|1|||
164354632|NCT00241280|593672418|FG000|Overall Study|Coating on Lens|1|||
164354633|NCT00241280|593672419|FG001|Overall Study|Coating on Lens|0|||
164354634|NCT00241280|593672418|FG000|Overall Study|Excessive Dryness|0|||
164354635|NCT00241280|593672419|FG001|Overall Study|Excessive Dryness|1|||
164354636|NCT02260921|593672426|FG000|Overall Study|Adverse Event|1|||
164354637|NCT02260921|593672427|FG001|Overall Study|Adverse Event|0|||
164354638|NCT02260921|593672426|FG000|Overall Study|Lost to Follow-up|4|||
164354639|NCT02260921|593672427|FG001|Overall Study|Lost to Follow-up|3|||
164354640|NCT02260921|593672426|FG000|Overall Study|Withdraw Consent|4|||
164354641|NCT02260921|593672427|FG001|Overall Study|Withdraw Consent|1|||
164354642|NCT02260921|593672426|FG000|Overall Study|Death|1|||
164354643|NCT02260921|593672427|FG001|Overall Study|Death|0|||
164354644|NCT02260921|593672426|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
164354645|NCT02260921|593672427|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
164354646|NCT02999854|593672437|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
164354647|NCT02999854|593672438|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
164354648|NCT02999854|593672437|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
164354649|NCT02999854|593672438|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
164354650|NCT02999854|593672437|FG000|Active Study Phase (up to 18 Months)|Death|7|||
164354651|NCT02999854|593672438|FG001|Active Study Phase (up to 18 Months)|Death|5|||
164354652|NCT02999854|593672437|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
164354653|NCT02999854|593672438|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
164354654|NCT02999854|593672437|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
164354655|NCT02999854|593672438|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
164354656|NCT02999854|593672437|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
164354657|NCT02999854|593672438|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
164354658|NCT02999854|593672437|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
164354659|NCT02999854|593672438|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
164354660|NCT02999854|593672437|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
164354661|NCT02999854|593672438|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
164354662|NCT00203996|593672439|FG000|Overall Study|Lost to Follow-up|0|||
164354663|NCT00203996|593672440|FG001|Overall Study|Lost to Follow-up|0|||
164354664|NCT00203996|593672441|FG002|Overall Study|Lost to Follow-up|0|||
164354665|NCT00203996|593672442|FG003|Overall Study|Lost to Follow-up|1|||
164354666|NCT00203996|593672443|FG004|Overall Study|Lost to Follow-up|0|||
164354667|NCT00203996|593672444|FG005|Overall Study|Lost to Follow-up|0|||
164354668|NCT00203996|593672445|FG006|Overall Study|Lost to Follow-up|0|||
164354669|NCT00203996|593672446|FG007|Overall Study|Lost to Follow-up|0|||
164354670|NCT00203996|593672447|FG008|Overall Study|Lost to Follow-up|0|||
164354671|NCT00203996|593672448|FG009|Overall Study|Lost to Follow-up|0|||
164354672|NCT00203996|593672439|FG000|Overall Study|Protocol Violation|0|||
164354673|NCT00203996|593672440|FG001|Overall Study|Protocol Violation|0|||
164354674|NCT00203996|593672441|FG002|Overall Study|Protocol Violation|0|||
164354675|NCT00203996|593672442|FG003|Overall Study|Protocol Violation|6|||
164354676|NCT00203996|593672443|FG004|Overall Study|Protocol Violation|1|||
164354677|NCT00203996|593672444|FG005|Overall Study|Protocol Violation|0|||
164354678|NCT00203996|593672445|FG006|Overall Study|Protocol Violation|0|||
164354679|NCT00203996|593672446|FG007|Overall Study|Protocol Violation|0|||
164354680|NCT00203996|593672447|FG008|Overall Study|Protocol Violation|0|||
164354681|NCT00203996|593672448|FG009|Overall Study|Protocol Violation|0|||
164354682|NCT00203996|593672439|FG000|Overall Study|Physician Decision|0|||
164354683|NCT00203996|593672440|FG001|Overall Study|Physician Decision|0|||
164354684|NCT00203996|593672441|FG002|Overall Study|Physician Decision|0|||
164354685|NCT00203996|593672442|FG003|Overall Study|Physician Decision|2|||
164354686|NCT00203996|593672443|FG004|Overall Study|Physician Decision|0|||
164354687|NCT00203996|593672444|FG005|Overall Study|Physician Decision|0|||
164694532|NCT02927834|594903050|FG002|Overall Study|Lost to Follow-up|2|||
164694533|NCT03812991|594903052|FG000|Overall Study|Lost to Follow-up|3|||
164694534|NCT03812991|594903053|FG001|Overall Study|Lost to Follow-up|1|||
164694535|NCT00127166|594903054|FG000|Period I|Protocol Violation|0|||
164694536|NCT00127166|594903055|FG001|Period I|Protocol Violation|2|||
164694537|NCT00127166|594903054|FG000|Period I|Withdrawal by Subject|2|||
164694538|NCT00127166|594903055|FG001|Period I|Withdrawal by Subject|0|||
164694539|NCT00127166|594903054|FG000|Period I|Patient did not meet inclusion criteria|1|||
164694540|NCT00127166|594903055|FG001|Period I|Patient did not meet inclusion criteria|0|||
164694541|NCT00127166|594903054|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
164694542|NCT00127166|594903055|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
164694543|NCT00127166|594903054|FG000|Period II|Withdrawal by Subject|2|||
164694544|NCT00127166|594903055|FG001|Period II|Withdrawal by Subject|0|||
164694545|NCT00127166|594903054|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
164694546|NCT00127166|594903055|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
164694547|NCT01396421|594903056|FG000|Overall Study|Lost to Follow-up|0|||
164694548|NCT01396421|594903057|FG001|Overall Study|Lost to Follow-up|0|||
164694549|NCT01396421|594903058|FG002|Overall Study|Lost to Follow-up|0|||
164694550|NCT01396421|594903059|FG003|Overall Study|Lost to Follow-up|1|||
164694551|NCT01396421|594903056|FG000|Overall Study|Adverse Event|17|||
164694552|NCT01396421|594903057|FG001|Overall Study|Adverse Event|15|||
164694553|NCT01396421|594903058|FG002|Overall Study|Adverse Event|12|||
164694554|NCT01396421|594903059|FG003|Overall Study|Adverse Event|32|||
164694555|NCT01396421|594903056|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
164694556|NCT01396421|594903057|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
164694557|NCT01396421|594903058|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
164694558|NCT01396421|594903059|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
164354688|NCT00203996|593672445|FG006|Overall Study|Physician Decision|0|||
164354689|NCT00203996|593672446|FG007|Overall Study|Physician Decision|0|||
164354690|NCT00203996|593672447|FG008|Overall Study|Physician Decision|0|||
164354691|NCT00203996|593672448|FG009|Overall Study|Physician Decision|1|||
164354692|NCT00203996|593672439|FG000|Overall Study|CPAP machine malfunction|0|||
164354693|NCT00203996|593672440|FG001|Overall Study|CPAP machine malfunction|0|||
164354694|NCT00203996|593672441|FG002|Overall Study|CPAP machine malfunction|0|||
164354695|NCT00203996|593672442|FG003|Overall Study|CPAP machine malfunction|1|||
164354696|NCT00203996|593672443|FG004|Overall Study|CPAP machine malfunction|0|||
164354697|NCT00203996|593672444|FG005|Overall Study|CPAP machine malfunction|0|||
164354698|NCT00203996|593672445|FG006|Overall Study|CPAP machine malfunction|0|||
164354699|NCT00203996|593672446|FG007|Overall Study|CPAP machine malfunction|0|||
164354700|NCT00203996|593672447|FG008|Overall Study|CPAP machine malfunction|0|||
164354701|NCT00203996|593672448|FG009|Overall Study|CPAP machine malfunction|0|||
164354702|NCT00203996|593672439|FG000|Overall Study|Scheduling issue|0|||
164354703|NCT00203996|593672440|FG001|Overall Study|Scheduling issue|0|||
164354704|NCT00203996|593672441|FG002|Overall Study|Scheduling issue|0|||
164354705|NCT00203996|593672442|FG003|Overall Study|Scheduling issue|0|||
164354706|NCT00203996|593672443|FG004|Overall Study|Scheduling issue|0|||
164354707|NCT00203996|593672444|FG005|Overall Study|Scheduling issue|0|||
164354708|NCT00203996|593672445|FG006|Overall Study|Scheduling issue|0|||
164354709|NCT00203996|593672446|FG007|Overall Study|Scheduling issue|2|||
164354710|NCT00203996|593672447|FG008|Overall Study|Scheduling issue|0|||
164354711|NCT00203996|593672448|FG009|Overall Study|Scheduling issue|0|||
164354712|NCT03064451|593672449|FG000|Overall Study|Lost to Follow-up|1|||
164354713|NCT03064451|593672449|FG000|Overall Study|Mapping Failure|4|||
164354714|NCT03064451|593672449|FG000|Overall Study|Exited prior to procedure|8|||
164354715|NCT03064451|593672449|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
164354716|NCT00897104|593672450|FG000|Overall Study|Lost to Follow-up|12|||
164354717|NCT00897104|593672451|FG001|Overall Study|Lost to Follow-up|17|||
164354718|NCT00897104|593672452|FG002|Overall Study|Lost to Follow-up|2|||
164354719|NCT00897104|593672450|FG000|Overall Study|Pregnancy|0|||
164354720|NCT00897104|593672451|FG001|Overall Study|Pregnancy|1|||
164354721|NCT00897104|593672452|FG002|Overall Study|Pregnancy|0|||
164354722|NCT00897104|593672450|FG000|Overall Study|Protocol Violation|0|||
164354723|NCT00897104|593672451|FG001|Overall Study|Protocol Violation|1|||
164354724|NCT00897104|593672452|FG002|Overall Study|Protocol Violation|0|||
164354725|NCT00897104|593672450|FG000|Overall Study|Withdrawal by Subject|23|||
164354726|NCT00897104|593672451|FG001|Overall Study|Withdrawal by Subject|27|||
164354727|NCT00897104|593672452|FG002|Overall Study|Withdrawal by Subject|3|||
164354728|NCT00897104|593672450|FG000|Overall Study|Abnormal Prestudy Labs|2|||
164694559|NCT01396421|594903056|FG000|Overall Study|Physician Decision|1|||
164354729|NCT00897104|593672451|FG001|Overall Study|Abnormal Prestudy Labs|0|||
164354730|NCT00897104|593672452|FG002|Overall Study|Abnormal Prestudy Labs|0|||
164354731|NCT00897104|593672450|FG000|Overall Study|Abnormal Baseline ECG|2|||
164354732|NCT00897104|593672451|FG001|Overall Study|Abnormal Baseline ECG|2|||
164694560|NCT01396421|594903057|FG001|Overall Study|Physician Decision|1|||
164694561|NCT01396421|594903058|FG002|Overall Study|Physician Decision|0|||
164694562|NCT01396421|594903059|FG003|Overall Study|Physician Decision|3|||
164694563|NCT01396421|594903056|FG000|Overall Study|Withdrawal by Subject|31|||
164694564|NCT01396421|594903057|FG001|Overall Study|Withdrawal by Subject|24|||
164354733|NCT00897104|593672452|FG002|Overall Study|Abnormal Baseline ECG|0|||
164354734|NCT00897104|593672450|FG000|Overall Study|Need for Concom. Med.|0|||
164354735|NCT00897104|593672451|FG001|Overall Study|Need for Concom. Med.|1|||
164354736|NCT00897104|593672452|FG002|Overall Study|Need for Concom. Med.|1|||
164354737|NCT00897104|593672450|FG000|Overall Study|Lack of Migraine Attack|20|||
164354738|NCT00897104|593672451|FG001|Overall Study|Lack of Migraine Attack|22|||
164694565|NCT01396421|594903058|FG002|Overall Study|Withdrawal by Subject|13|||
164694566|NCT01396421|594903059|FG003|Overall Study|Withdrawal by Subject|21|||
164694567|NCT01396421|594903056|FG000|Overall Study|Protocol Deviation|2|||
164694568|NCT01396421|594903057|FG001|Overall Study|Protocol Deviation|1|||
164694569|NCT01396421|594903058|FG002|Overall Study|Protocol Deviation|1|||
164354739|NCT00897104|593672452|FG002|Overall Study|Lack of Migraine Attack|1|||
164354740|NCT00897104|593672450|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
164354741|NCT00897104|593672451|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
164354742|NCT00897104|593672452|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
164354743|NCT00897104|593672450|FG000|Overall Study|Other|3|||
164354744|NCT00897104|593672451|FG001|Overall Study|Other|0|||
164354745|NCT00897104|593672452|FG002|Overall Study|Other|0|||
164354746|NCT00897104|593672450|FG000|Overall Study|Protocol Violation|1|||
164354747|NCT00897104|593672451|FG001|Overall Study|Protocol Violation|0|||
164354748|NCT00897104|593672452|FG002|Overall Study|Protocol Violation|0|||
164354749|NCT00897104|593672450|FG000|Overall Study|Withdrawal by Subject|0|||
164354750|NCT00897104|593672451|FG001|Overall Study|Withdrawal by Subject|0|||
164354751|NCT00897104|593672452|FG002|Overall Study|Withdrawal by Subject|1|||
164354752|NCT00750204|593672453|FG000|Overall Study|study halted prematurely|1|||
164354753|NCT00750204|593672454|FG001|Overall Study|study halted prematurely|1|||
164354754|NCT00434330|593672457|FG000|Overall Study|Adverse Event|0|||
164354755|NCT00434330|593672458|FG001|Overall Study|Adverse Event|0|||
164354756|NCT00434330|593672459|FG002|Overall Study|Adverse Event|1|||
164354757|NCT00434330|593672460|FG003|Overall Study|Adverse Event|0|||
164354758|NCT00434330|593672461|FG004|Overall Study|Adverse Event|0|||
164354759|NCT00434330|593672462|FG005|Overall Study|Adverse Event|0|||
164354760|NCT00434330|593672457|FG000|Overall Study|Death|1|||
164354761|NCT00434330|593672458|FG001|Overall Study|Death|0|||
164354762|NCT00434330|593672459|FG002|Overall Study|Death|0|||
164354763|NCT00434330|593672460|FG003|Overall Study|Death|0|||
164354764|NCT00434330|593672461|FG004|Overall Study|Death|1|||
164354765|NCT00434330|593672462|FG005|Overall Study|Death|1|||
164354766|NCT00434330|593672457|FG000|Overall Study|Withdrawal by Subject|0|||
164354767|NCT00434330|593672458|FG001|Overall Study|Withdrawal by Subject|0|||
164354768|NCT00434330|593672459|FG002|Overall Study|Withdrawal by Subject|1|||
164354769|NCT00434330|593672460|FG003|Overall Study|Withdrawal by Subject|1|||
164354770|NCT00434330|593672461|FG004|Overall Study|Withdrawal by Subject|0|||
164354771|NCT00434330|593672462|FG005|Overall Study|Withdrawal by Subject|0|||
164354772|NCT00434330|593672457|FG000|Overall Study|Renal transplant|0|||
164354773|NCT00434330|593672458|FG001|Overall Study|Renal transplant|0|||
164354774|NCT00434330|593672459|FG002|Overall Study|Renal transplant|0|||
164354775|NCT00434330|593672460|FG003|Overall Study|Renal transplant|1|||
164354776|NCT00434330|593672461|FG004|Overall Study|Renal transplant|0|||
164354777|NCT00434330|593672462|FG005|Overall Study|Renal transplant|0|||
164354778|NCT00434330|593672457|FG000|Overall Study|Subject Not Compliant With Study|0|||
164354779|NCT00434330|593672458|FG001|Overall Study|Subject Not Compliant With Study|0|||
164354780|NCT00434330|593672459|FG002|Overall Study|Subject Not Compliant With Study|1|||
164354781|NCT00434330|593672460|FG003|Overall Study|Subject Not Compliant With Study|0|||
164354782|NCT00434330|593672461|FG004|Overall Study|Subject Not Compliant With Study|0|||
164354783|NCT00434330|593672462|FG005|Overall Study|Subject Not Compliant With Study|0|||
164354784|NCT00850564|593672463|FG000|Overall Study|Withdrawal by Subject|2|||
164354785|NCT03032705|593672464|FG000|Overall Study|Lost to Follow-up|16|||
164354786|NCT03032705|593672465|FG001|Overall Study|Lost to Follow-up|17|||
164354787|NCT03032705|593672464|FG000|Overall Study|did not quality|6|||
164354788|NCT03032705|593672465|FG001|Overall Study|did not quality|6|||
164354789|NCT02167893|593672468|FG000|Overall Study|Investigator transferred|85|||
164354790|NCT02167893|593672468|FG000|Overall Study|Investigator health reasons|10|||
164354791|NCT02167893|593672468|FG000|Overall Study|Case report forms not collected|68|||
164354792|NCT04818840|593672469|FG000|Overall Study|Lost to Follow-up|0|||
164354793|NCT04818840|593672470|FG001|Overall Study|Lost to Follow-up|5|||
164354794|NCT04818840|593672469|FG000|Overall Study|Physician Decision|1|||
164354795|NCT04818840|593672470|FG001|Overall Study|Physician Decision|0|||
164354796|NCT04818840|593672469|FG000|Overall Study|Site Terminated by Sponsor|0|||
164694570|NCT01396421|594903059|FG003|Overall Study|Protocol Deviation|0|||
164354797|NCT04818840|593672470|FG001|Overall Study|Site Terminated by Sponsor|3|||
164354798|NCT04818840|593672469|FG000|Overall Study|Study Terminated by Sponsor|43|||
164354799|NCT04818840|593672470|FG001|Overall Study|Study Terminated by Sponsor|7|||
164354800|NCT04818840|593672469|FG000|Overall Study|Withdrawal by Subject|0|||
164354801|NCT04818840|593672470|FG001|Overall Study|Withdrawal by Subject|1|||
164354802|NCT04847557|593672475|FG000|Overall Study|Adverse Event|1|||
164354803|NCT04847557|593672476|FG001|Overall Study|Adverse Event|0|||
164694571|NCT01396421|594903056|FG000|Overall Study|Lack of Efficacy|7|||
164354804|NCT04847557|593672475|FG000|Overall Study|Death|19|||
164354805|NCT04847557|593672476|FG001|Overall Study|Death|15|||
164354806|NCT04847557|593672475|FG000|Overall Study|Lost to Follow-up|3|||
164354807|NCT04847557|593672476|FG001|Overall Study|Lost to Follow-up|6|||
164354808|NCT04847557|593672475|FG000|Overall Study|Physician Decision|1|||
164354809|NCT04847557|593672476|FG001|Overall Study|Physician Decision|0|||
164354810|NCT04847557|593672475|FG000|Overall Study|Protocol Violation|0|||
164354811|NCT04847557|593672476|FG001|Overall Study|Protocol Violation|1|||
164354812|NCT04847557|593672475|FG000|Overall Study|Withdrawal by Subject|8|||
164354813|NCT04847557|593672476|FG001|Overall Study|Withdrawal by Subject|14|||
164354814|NCT01325584|593672477|FG000|Overall Study|Death|1|||
164354815|NCT01853826|593674326|FG000|Overall Study|Patients who switched to commercial drug|11|||
164354816|NCT01853826|593674326|FG000|Overall Study|Patient refused to continue medication|21|||
164354817|NCT01853826|593674326|FG000|Overall Study|Lost to Follow-up|2|||
164354818|NCT01853826|593674326|FG000|Overall Study|Non-compliant with protocol|4|||
164354819|NCT01853826|593674326|FG000|Overall Study|Other adverse events (AE)|62|||
164354820|NCT01853826|593674326|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
164354821|NCT01853826|593674326|FG000|Overall Study|Progressive disease|342|||
164354822|NCT01853826|593674326|FG000|Overall Study|Other than listed|13|||
164354823|NCT01853826|593674326|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
164354824|NCT00397982|593674327|FG000|Overall Study|Withdrawal by Subject|1|||
164354825|NCT00397982|593674327|FG000|Overall Study|Adverse Event|1|||
164354826|NCT00397982|593674327|FG000|Overall Study|noncompliance|1|||
164354827|NCT00397982|593674327|FG000|Overall Study|Unrelated health issues|1|||
164354828|NCT02329730|593674333|FG000|Overall Study|Protocol Violation|0|||
164354829|NCT02329730|593674334|FG001|Overall Study|Protocol Violation|0|||
164354830|NCT02329730|593674335|FG002|Overall Study|Protocol Violation|0|||
164354831|NCT02329730|593674336|FG003|Overall Study|Protocol Violation|0|||
164354832|NCT02329730|593674337|FG004|Overall Study|Protocol Violation|2|||
164354833|NCT02329730|593674338|FG005|Overall Study|Protocol Violation|2|||
164354834|NCT02329730|593674339|FG006|Overall Study|Protocol Violation|0|||
164354835|NCT02329730|593674340|FG007|Overall Study|Protocol Violation|0|||
164354836|NCT02329730|593674341|FG008|Overall Study|Protocol Violation|0|||
164354837|NCT02329730|593674342|FG009|Overall Study|Protocol Violation|0|||
164354838|NCT02329730|593674343|FG010|Overall Study|Protocol Violation|0|||
164354839|NCT02329730|593674344|FG011|Overall Study|Protocol Violation|0|||
164354840|NCT02329730|593674333|FG000|Overall Study|Withdrawal by Subject|0|||
164354841|NCT02329730|593674334|FG001|Overall Study|Withdrawal by Subject|0|||
164354842|NCT02329730|593674335|FG002|Overall Study|Withdrawal by Subject|0|||
164354843|NCT02329730|593674336|FG003|Overall Study|Withdrawal by Subject|0|||
164354844|NCT02329730|593674337|FG004|Overall Study|Withdrawal by Subject|1|||
164354845|NCT02329730|593674338|FG005|Overall Study|Withdrawal by Subject|0|||
164354846|NCT02329730|593674339|FG006|Overall Study|Withdrawal by Subject|1|||
164354847|NCT02329730|593674340|FG007|Overall Study|Withdrawal by Subject|1|||
164354848|NCT02329730|593674341|FG008|Overall Study|Withdrawal by Subject|1|||
164354849|NCT02329730|593674342|FG009|Overall Study|Withdrawal by Subject|1|||
164354850|NCT02329730|593674343|FG010|Overall Study|Withdrawal by Subject|0|||
164354851|NCT02329730|593674344|FG011|Overall Study|Withdrawal by Subject|0|||
164354852|NCT02345850|593674348|FG000|Overall Study|Not transplanted|10|||
164354853|NCT02345850|593674349|FG001|Overall Study|Not transplanted|5|||
164354854|NCT02345850|593674350|FG002|Overall Study|Not transplanted|4|||
164354855|NCT02345850|593674348|FG000|Overall Study|Lost to Follow-up|2|||
164354856|NCT02345850|593674349|FG001|Overall Study|Lost to Follow-up|3|||
164354857|NCT02345850|593674350|FG002|Overall Study|Lost to Follow-up|2|||
164354858|NCT02345850|593674348|FG000|Overall Study|Withdrawal by Subject|1|||
164354859|NCT02345850|593674349|FG001|Overall Study|Withdrawal by Subject|0|||
164354860|NCT02345850|593674350|FG002|Overall Study|Withdrawal by Subject|0|||
164354861|NCT02392247|593674354|FG000|Overall Study|Withdrawal by Subject|1|||
164354862|NCT02392247|593674354|FG000|Overall Study|Surgery cancelled; no data|1|||
164354863|NCT04779489|593674355|FG000|Overall Study|Physician Decision|1|||
164354864|NCT00951665|593674356|FG000|Phase 1b|Adverse Event|2|||
164354865|NCT00951665|593674357|FG001|Phase 1b|Adverse Event|1|||
164354866|NCT00951665|593674358|FG002|Phase 1b|Adverse Event|0|||
164354867|NCT00951665|593674359|FG003|Phase 1b|Adverse Event|1|||
164354868|NCT00951665|593674360|FG004|Phase 1b|Adverse Event|0|||
164354869|NCT00951665|593674361|FG005|Phase 1b|Adverse Event|0|||
164354870|NCT00951665|593674356|FG000|Phase 1b|Death|1|||
164354871|NCT00951665|593674357|FG001|Phase 1b|Death|0|||
164354872|NCT00951665|593674358|FG002|Phase 1b|Death|2|||
164436960|NCT00410124|593966443|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
164354873|NCT00951665|593674359|FG003|Phase 1b|Death|0|||
164354874|NCT00951665|593674360|FG004|Phase 1b|Death|0|||
164354875|NCT00951665|593674361|FG005|Phase 1b|Death|0|||
164354876|NCT00951665|593674356|FG000|Phase 1b|Physician Decision|4|||
164354877|NCT00951665|593674357|FG001|Phase 1b|Physician Decision|0|||
164354878|NCT00951665|593674358|FG002|Phase 1b|Physician Decision|1|||
164354879|NCT00951665|593674359|FG003|Phase 1b|Physician Decision|0|||
164354880|NCT00951665|593674360|FG004|Phase 1b|Physician Decision|0|||
164354881|NCT00951665|593674361|FG005|Phase 1b|Physician Decision|0|||
164354882|NCT00951665|593674356|FG000|Phase 1b|Withdrawal by Subject|0|||
164694572|NCT01396421|594903057|FG001|Overall Study|Lack of Efficacy|17|||
164694573|NCT01396421|594903058|FG002|Overall Study|Lack of Efficacy|7|||
164694574|NCT01396421|594903059|FG003|Overall Study|Lack of Efficacy|18|||
164694575|NCT01148225|594903060|FG000|Overall Study|Other|185|||
164694576|NCT04798482|594903065|FG000|Overall Study|Physician Decision|1|||
164694577|NCT04798482|594903065|FG000|Overall Study|Lost eligibility|1|||
164694578|NCT01506908|594903066|FG000|Overall Study|Adverse Event|1|||
164694579|NCT01506908|594903067|FG001|Overall Study|Adverse Event|0|||
164694580|NCT01610063|594903068|FG000|Overall Study|Lost to Follow-up|42|||
164694581|NCT01610063|594903069|FG001|Overall Study|Lost to Follow-up|20|||
164694582|NCT01169038|594903078|FG000|Overall Study|Death|1|||
164694583|NCT01169038|594903078|FG000|Overall Study|Adverse Event|5|||
164694584|NCT01169038|594903078|FG000|Overall Study|Required antibiotic administration|1|||
164694585|NCT04232540|594903079|FG000|Overall Study|Lost to Follow-up|1|||
164299453|NCT04973449|593471356|FG005|Overall Study|Lost to Follow-up|6|||
164299454|NCT04973449|593471357|FG006|Overall Study|Lost to Follow-up|10|||
164299455|NCT04973449|593471358|FG007|Overall Study|Lost to Follow-up|6|||
164299456|NCT04973449|593471351|FG000|Overall Study|Death|1|||
164299457|NCT04973449|593471352|FG001|Overall Study|Death|0|||
164299458|NCT04973449|593471353|FG002|Overall Study|Death|0|||
164299459|NCT04973449|593471354|FG003|Overall Study|Death|0|||
164299460|NCT04973449|593471355|FG004|Overall Study|Death|0|||
164299461|NCT04973449|593471356|FG005|Overall Study|Death|1|||
164299462|NCT04973449|593471357|FG006|Overall Study|Death|0|||
164299463|NCT04973449|593471358|FG007|Overall Study|Death|0|||
164299464|NCT04973449|593471351|FG000|Overall Study|Other|1|||
164299465|NCT04973449|593471352|FG001|Overall Study|Other|1|||
164299466|NCT04973449|593471353|FG002|Overall Study|Other|2|||
164299467|NCT04973449|593471354|FG003|Overall Study|Other|1|||
164299468|NCT04973449|593471355|FG004|Overall Study|Other|4|||
164299469|NCT04973449|593471356|FG005|Overall Study|Other|0|||
164299470|NCT04973449|593471357|FG006|Overall Study|Other|2|||
164299471|NCT04973449|593471358|FG007|Overall Study|Other|2|||
164299472|NCT01506596|593471359|FG000|Overall Study|ineligible pathology|1|||
164299473|NCT04408989|593471361|FG000|Overall Study|Lost to Follow-up|0|||
164299474|NCT04408989|593471362|FG001|Overall Study|Lost to Follow-up|0|||
164299475|NCT04408989|593471363|FG002|Overall Study|Lost to Follow-up|1|||
164299476|NCT04408989|593471361|FG000|Overall Study|Withdrawal by Subject|0|||
164299477|NCT04408989|593471362|FG001|Overall Study|Withdrawal by Subject|0|||
164299478|NCT04408989|593471363|FG002|Overall Study|Withdrawal by Subject|2|||
164299479|NCT02260934|593471378|FG000|Overall Study|Lost to Follow-up|2|||
164299480|NCT02260934|593471379|FG001|Overall Study|Lost to Follow-up|1|||
164299481|NCT02260934|593471378|FG000|Overall Study|Withdrawal by Subject|0|||
164299482|NCT02260934|593471379|FG001|Overall Study|Withdrawal by Subject|2|||
164299483|NCT02260934|593471378|FG000|Overall Study|Participant Relocated|1|||
164299484|NCT02260934|593471379|FG001|Overall Study|Participant Relocated|0|||
164299485|NCT02260934|593471378|FG000|Overall Study|Site error|0|||
164299486|NCT02260934|593471379|FG001|Overall Study|Site error|1|||
164299487|NCT04609319|593471382|FG000|Overall Study|Death|64|||
164299488|NCT04609319|593471383|FG001|Overall Study|Death|49|||
164299489|NCT04609319|593471384|FG002|Overall Study|Death|1|||
164299490|NCT04609319|593471382|FG000|Overall Study|Withdrawal of consent|15|||
164299491|NCT04609319|593471383|FG001|Overall Study|Withdrawal of consent|3|||
164299492|NCT04609319|593471384|FG002|Overall Study|Withdrawal of consent|0|||
164299493|NCT04609319|593471382|FG000|Overall Study|Lost to Follow-up|20|||
164299494|NCT04609319|593471383|FG001|Overall Study|Lost to Follow-up|33|||
164299495|NCT04609319|593471384|FG002|Overall Study|Lost to Follow-up|0|||
164299496|NCT04609319|593471382|FG000|Overall Study|Alive until end of follow-up|60|||
164299497|NCT04609319|593471383|FG001|Overall Study|Alive until end of follow-up|53|||
164299498|NCT04609319|593471384|FG002|Overall Study|Alive until end of follow-up|1|||
164299499|NCT04272242|593471387|FG000|Overall Study|Withdrawal by Subject|3|||
164299500|NCT04272242|593471387|FG000|Overall Study|Lost to Follow-up|1|||
164299501|NCT04272242|593471387|FG000|Overall Study|Adverse Event|1|||
164299502|NCT01520506|593472823|FG000|Overall Study|Missed Visit|4|||
164299503|NCT01520506|593472823|FG000|Overall Study|Lost to Follow-up|1|||
164299504|NCT01520506|593472823|FG000|Overall Study|Withdrawal by Subject|1|||
164299505|NCT00906204|593472824|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
164299506|NCT00906204|593472825|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
164299507|NCT00906204|593472824|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
164299508|NCT00906204|593472825|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
164299509|NCT00906204|593472824|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
164299510|NCT00906204|593472825|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
164299511|NCT00906204|593472824|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
164299512|NCT00906204|593472825|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
164301361|NCT01709084|593480139|FG001|Overall Study|Adverse Event|0|||
164301362|NCT01709084|593480138|FG000|Overall Study|Other|5|||
164301363|NCT01709084|593480139|FG001|Overall Study|Other|3|||
164301364|NCT01709084|593480138|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
164301365|NCT01709084|593480139|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
164354883|NCT00951665|593674357|FG001|Phase 1b|Withdrawal by Subject|1|||
164354884|NCT00951665|593674358|FG002|Phase 1b|Withdrawal by Subject|0|||
164354885|NCT00951665|593674359|FG003|Phase 1b|Withdrawal by Subject|0|||
164354886|NCT00951665|593674360|FG004|Phase 1b|Withdrawal by Subject|0|||
164354887|NCT00951665|593674361|FG005|Phase 1b|Withdrawal by Subject|0|||
164354888|NCT00951665|593674356|FG000|Phase 1b|Disease Progression|13|||
164354889|NCT00951665|593674357|FG001|Phase 1b|Disease Progression|2|||
164354890|NCT00951665|593674358|FG002|Phase 1b|Disease Progression|14|||
164354891|NCT00951665|593674359|FG003|Phase 1b|Disease Progression|0|||
164354892|NCT00951665|593674360|FG004|Phase 1b|Disease Progression|0|||
164354893|NCT00951665|593674361|FG005|Phase 1b|Disease Progression|0|||
164354894|NCT00951665|593674356|FG000|Phase 1b|Protocol Violation|2|||
164354895|NCT00951665|593674357|FG001|Phase 1b|Protocol Violation|0|||
164354896|NCT00951665|593674358|FG002|Phase 1b|Protocol Violation|0|||
164354897|NCT00951665|593674359|FG003|Phase 1b|Protocol Violation|0|||
164354898|NCT00951665|593674360|FG004|Phase 1b|Protocol Violation|0|||
164354899|NCT00951665|593674361|FG005|Phase 1b|Protocol Violation|0|||
164354900|NCT00951665|593674356|FG000|Phase 2a|Adverse Event|0|||
164354901|NCT00951665|593674357|FG001|Phase 2a|Adverse Event|0|||
164354902|NCT00951665|593674358|FG002|Phase 2a|Adverse Event|0|||
164354903|NCT00951665|593674359|FG003|Phase 2a|Adverse Event|0|||
164354904|NCT00951665|593674360|FG004|Phase 2a|Adverse Event|2|||
164354905|NCT00951665|593674361|FG005|Phase 2a|Adverse Event|0|||
164354906|NCT00951665|593674356|FG000|Phase 2a|Death|0|||
164354907|NCT00951665|593674357|FG001|Phase 2a|Death|0|||
164354908|NCT00951665|593674358|FG002|Phase 2a|Death|0|||
164354909|NCT00951665|593674359|FG003|Phase 2a|Death|0|||
164354910|NCT00951665|593674360|FG004|Phase 2a|Death|1|||
164354911|NCT00951665|593674361|FG005|Phase 2a|Death|1|||
164354912|NCT00951665|593674356|FG000|Phase 2a|Lost to Follow-up|0|||
164354913|NCT00951665|593674357|FG001|Phase 2a|Lost to Follow-up|0|||
164354914|NCT00951665|593674358|FG002|Phase 2a|Lost to Follow-up|0|||
164354915|NCT00951665|593674359|FG003|Phase 2a|Lost to Follow-up|0|||
164354916|NCT00951665|593674360|FG004|Phase 2a|Lost to Follow-up|1|||
164354917|NCT00951665|593674361|FG005|Phase 2a|Lost to Follow-up|0|||
164354918|NCT00951665|593674356|FG000|Phase 2a|Physician Decision|0|||
164354919|NCT00951665|593674357|FG001|Phase 2a|Physician Decision|0|||
164354920|NCT00951665|593674358|FG002|Phase 2a|Physician Decision|0|||
164354921|NCT00951665|593674359|FG003|Phase 2a|Physician Decision|0|||
164354922|NCT00951665|593674360|FG004|Phase 2a|Physician Decision|0|||
164354923|NCT00951665|593674361|FG005|Phase 2a|Physician Decision|1|||
164354924|NCT00951665|593674356|FG000|Phase 2a|Withdrawal by Subject|0|||
164354925|NCT00951665|593674357|FG001|Phase 2a|Withdrawal by Subject|0|||
164354926|NCT00951665|593674358|FG002|Phase 2a|Withdrawal by Subject|0|||
164354927|NCT00951665|593674359|FG003|Phase 2a|Withdrawal by Subject|0|||
164354928|NCT00951665|593674360|FG004|Phase 2a|Withdrawal by Subject|2|||
164354929|NCT00951665|593674361|FG005|Phase 2a|Withdrawal by Subject|0|||
164354930|NCT00951665|593674356|FG000|Phase 2a|Disease Progression|0|||
164354931|NCT00951665|593674357|FG001|Phase 2a|Disease Progression|0|||
164354932|NCT00951665|593674358|FG002|Phase 2a|Disease Progression|0|||
164354933|NCT00951665|593674359|FG003|Phase 2a|Disease Progression|0|||
164436961|NCT00410124|593966444|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
164354934|NCT00951665|593674360|FG004|Phase 2a|Disease Progression|6|||
164354935|NCT00951665|593674361|FG005|Phase 2a|Disease Progression|5|||
164354936|NCT02450903|593674364|FG000|Overall Study|Adverse Event|3|||
164354937|NCT02450903|593674364|FG000|Overall Study|Progressive disease|15|||
164588934|NCT01469052|594519292|FG005|Overall Study|Progressive disease|2|||
164354938|NCT02450903|593674364|FG000|Overall Study|Switched to commercial drug|1|||
164354939|NCT02450903|593674364|FG000|Overall Study|Subject/guardian decision|1|||
164354940|NCT05126901|593674365|FG000|Overall Study|Withdrawal by Subject|1|||
164354941|NCT05126901|593674366|FG001|Overall Study|Withdrawal by Subject|1|||
164354942|NCT05126901|593674367|FG002|Overall Study|Withdrawal by Subject|4|||
164354943|NCT05126901|593674365|FG000|Overall Study|Adverse Event|0|||
164354944|NCT05126901|593674366|FG001|Overall Study|Adverse Event|0|||
164354945|NCT05126901|593674367|FG002|Overall Study|Adverse Event|1|||
164354946|NCT05126901|593674365|FG000|Overall Study|Lost to Follow-up|0|||
164588935|NCT01469052|594519287|FG000|Overall Study|Lack of Efficacy|0|||
164588936|NCT01469052|594519288|FG001|Overall Study|Lack of Efficacy|0|||
164588937|NCT01469052|594519289|FG002|Overall Study|Lack of Efficacy|0|||
164588938|NCT01469052|594519290|FG003|Overall Study|Lack of Efficacy|0|||
164588939|NCT01469052|594519291|FG004|Overall Study|Lack of Efficacy|0|||
164588940|NCT01469052|594519292|FG005|Overall Study|Lack of Efficacy|2|||
164588941|NCT01469052|594519287|FG000|Overall Study|Moved to rollover protocol|1|||
164588942|NCT01469052|594519288|FG001|Overall Study|Moved to rollover protocol|0|||
164588943|NCT01469052|594519289|FG002|Overall Study|Moved to rollover protocol|1|||
164588944|NCT01469052|594519290|FG003|Overall Study|Moved to rollover protocol|0|||
164588945|NCT01469052|594519291|FG004|Overall Study|Moved to rollover protocol|0|||
164588946|NCT01469052|594519292|FG005|Overall Study|Moved to rollover protocol|1|||
164588947|NCT01469052|594519287|FG000|Overall Study|Other|0|||
164588948|NCT01469052|594519288|FG001|Overall Study|Other|1|||
164588949|NCT01469052|594519289|FG002|Overall Study|Other|0|||
164694586|NCT04232540|594903080|FG001|Overall Study|Lost to Follow-up|0|||
164694587|NCT00537017|594903081|FG000|Treatment Phase|Adverse Event|19|||
164694588|NCT00537017|594903081|FG000|Treatment Phase|Withdrawal by Subject|13|||
164694589|NCT00537017|594903081|FG000|Treatment Phase|Protocol Violation|2|||
164694590|NCT00537017|594903081|FG000|Follow-up Phase|Withdrawal by Subject|9|||
164694591|NCT01662362|594903083|FG000|Overall Study|Lost to Follow-up|38|||
164694592|NCT02339090|594903084|FG000|Overall Study|Adverse Event|1|||
164694593|NCT02339090|594903085|FG001|Overall Study|Adverse Event|0|||
164354947|NCT05126901|593674366|FG001|Overall Study|Lost to Follow-up|2|||
164354948|NCT05126901|593674367|FG002|Overall Study|Lost to Follow-up|0|||
164354949|NCT00254540|593674368|FG000|Overall Study|Adverse Event|6|||
164354950|NCT00254540|593674369|FG001|Overall Study|Adverse Event|7|||
164354951|NCT00254540|593674368|FG000|Overall Study|Lack of Efficacy|13|||
164354952|NCT00254540|593674369|FG001|Overall Study|Lack of Efficacy|13|||
164354953|NCT00254540|593674368|FG000|Overall Study|Death|0|||
164354954|NCT00254540|593674369|FG001|Overall Study|Death|1|||
164354955|NCT00254540|593674368|FG000|Overall Study|Laboratory Test Abnormality|0|||
164354956|NCT00254540|593674369|FG001|Overall Study|Laboratory Test Abnormality|1|||
164354957|NCT00710710|593674370|FG000|Overall Study|Consent withdrawn|2|||
164354958|NCT00710710|593674371|FG001|Overall Study|Consent withdrawn|2|||
164354959|NCT00710710|593674370|FG000|Overall Study|Protocol Violation|0|||
164354960|NCT00710710|593674371|FG001|Overall Study|Protocol Violation|1|||
164354961|NCT00710710|593674370|FG000|Overall Study|Adverse Event|3|||
164354962|NCT00710710|593674371|FG001|Overall Study|Adverse Event|3|||
164354963|NCT00710710|593674370|FG000|Overall Study|Progressive disease|40|||
164354964|NCT00710710|593674371|FG001|Overall Study|Progressive disease|38|||
164354965|NCT00715078|593674372|FG000|Overall Study|Death|29|||
164354966|NCT00715078|593674373|FG001|Overall Study|Death|36|||
164354967|NCT00715078|593674374|FG002|Overall Study|Death|36|||
164354968|NCT00715078|593674372|FG000|Overall Study|Withdrawal by Subject|1|||
164354969|NCT00715078|593674373|FG001|Overall Study|Withdrawal by Subject|0|||
164354970|NCT00715078|593674374|FG002|Overall Study|Withdrawal by Subject|1|||
164354971|NCT00715078|593674372|FG000|Overall Study|Unable to start due to disease prog.|0|||
164354972|NCT00715078|593674373|FG001|Overall Study|Unable to start due to disease prog.|0|||
164354973|NCT00715078|593674374|FG002|Overall Study|Unable to start due to disease prog.|1|||
164354974|NCT01313767|593674375|FG000|Overall Study|Adverse Event|1|||
164354975|NCT01313767|593674376|FG001|Overall Study|Adverse Event|0|||
164354976|NCT01313767|593674375|FG000|Overall Study|Lost to Follow-up|1|||
164354977|NCT01313767|593674376|FG001|Overall Study|Lost to Follow-up|0|||
164354978|NCT01313767|593674375|FG000|Overall Study|Withdrawal by Subject|2|||
164354979|NCT01313767|593674376|FG001|Overall Study|Withdrawal by Subject|1|||
164354980|NCT01313767|593674375|FG000|Overall Study|Protocol Violation|3|||
164694594|NCT02339090|594903084|FG000|Overall Study|Lost to Follow-up|0|||
164694595|NCT02339090|594903085|FG001|Overall Study|Lost to Follow-up|1|||
164694596|NCT02339090|594903084|FG000|Overall Study|Non-compliance With Study Drug|0|||
164694597|NCT02339090|594903085|FG001|Overall Study|Non-compliance With Study Drug|1|||
164694598|NCT02339090|594903084|FG000|Overall Study|Withdrawal by Subject|2|||
164694599|NCT02339090|594903085|FG001|Overall Study|Withdrawal by Subject|1|||
164694600|NCT02339090|594903084|FG000|Overall Study|Poor Growth|3|||
164694601|NCT02339090|594903085|FG001|Overall Study|Poor Growth|0|||
164354981|NCT01313767|593674376|FG001|Overall Study|Protocol Violation|1|||
164354982|NCT01529346|593674377|FG000|Overall Study|Lost to Follow-up|2|||
164354983|NCT01529346|593674378|FG001|Overall Study|Lost to Follow-up|0|||
164354984|NCT01529346|593674379|FG002|Overall Study|Lost to Follow-up|1|||
164354985|NCT01529346|593674380|FG003|Overall Study|Lost to Follow-up|0|||
164354986|NCT01529346|593674381|FG004|Overall Study|Lost to Follow-up|0|||
164354987|NCT01529346|593674377|FG000|Overall Study|Other|0|||
164354988|NCT01529346|593674378|FG001|Overall Study|Other|1|||
164354989|NCT01529346|593674379|FG002|Overall Study|Other|1|||
164354990|NCT01529346|593674380|FG003|Overall Study|Other|0|||
164354991|NCT01529346|593674381|FG004|Overall Study|Other|0|||
164354992|NCT02282020|593674388|FG000|Overall Study|Objective Disease Progression|128|||
164354993|NCT02282020|593674389|FG001|Overall Study|Objective Disease Progression|30|||
164354994|NCT02282020|593674388|FG000|Overall Study|Adverse Event|18|||
164354995|NCT02282020|593674389|FG001|Overall Study|Adverse Event|15|||
164354996|NCT02282020|593674388|FG000|Overall Study|Withdrawal by Subject|7|||
164354997|NCT02282020|593674389|FG001|Overall Study|Withdrawal by Subject|10|||
164354998|NCT02282020|593674388|FG000|Overall Study|Miscellaneous|5|||
164354999|NCT02282020|593674389|FG001|Overall Study|Miscellaneous|19|||
164355000|NCT02282020|593674388|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
164694602|NCT02339090|594903084|FG000|Overall Study|Randomized but not treated|0|||
164694603|NCT02339090|594903085|FG001|Overall Study|Randomized but not treated|2|||
164694604|NCT00442546|594903086|FG000|Overall Study|Adverse Event|11|||
164355001|NCT02282020|593674389|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
164355002|NCT02282020|593674388|FG000|Overall Study|Developed Discontinuation Criteria|0|||
164355003|NCT02282020|593674389|FG001|Overall Study|Developed Discontinuation Criteria|2|||
164355004|NCT02282020|593674388|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
164355005|NCT02282020|593674389|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
164355006|NCT00588848|593674390|FG000|Overall Study|Physician Decision|0|||
164355007|NCT00588848|593674391|FG001|Overall Study|Physician Decision|3|||
164355008|NCT00249444|593674392|FG000|Overall Study|Lost to Follow-up|2|||
164355009|NCT00249444|593674393|FG001|Overall Study|Lost to Follow-up|2|||
164355010|NCT00249444|593674392|FG000|Overall Study|non-compliant|9|||
164355011|NCT00249444|593674393|FG001|Overall Study|non-compliant|11|||
164355012|NCT00249444|593674392|FG000|Overall Study|Adverse Event|1|||
164355013|NCT00249444|593674393|FG001|Overall Study|Adverse Event|1|||
164355014|NCT00249444|593674392|FG000|Overall Study|life event|0|||
164355015|NCT00249444|593674393|FG001|Overall Study|life event|1|||
164355016|NCT01499667|593674394|FG000|Overall Study|administrative problems|4|||
164355017|NCT01499667|593674395|FG001|Overall Study|administrative problems|5|||
164355018|NCT01499667|593674396|FG002|Overall Study|administrative problems|5|||
164355019|NCT01499667|593674394|FG000|Overall Study|Protocol Violation|1|||
164355020|NCT01499667|593674395|FG001|Overall Study|Protocol Violation|3|||
164355021|NCT01499667|593674396|FG002|Overall Study|Protocol Violation|2|||
164355022|NCT01499667|593674394|FG000|Overall Study|Adverse Event|0|||
164355023|NCT01499667|593674395|FG001|Overall Study|Adverse Event|2|||
164355024|NCT01499667|593674396|FG002|Overall Study|Adverse Event|2|||
164355025|NCT01499667|593674394|FG000|Overall Study|Withdrawal by Subject|2|||
164355026|NCT01499667|593674395|FG001|Overall Study|Withdrawal by Subject|1|||
164355027|NCT01499667|593674396|FG002|Overall Study|Withdrawal by Subject|1|||
164355028|NCT01499667|593674394|FG000|Overall Study|Lack of Efficacy|2|||
164355029|NCT01499667|593674395|FG001|Overall Study|Lack of Efficacy|0|||
164355030|NCT01499667|593674396|FG002|Overall Study|Lack of Efficacy|0|||
164355031|NCT02673489|593674397|FG000|Treatment Period|Lost to Follow-up|3|||
164355032|NCT02673489|593674398|FG001|Treatment Period|Lost to Follow-up|0|||
164355033|NCT02673489|593674397|FG000|Treatment Period|Participant request to discontinue|1|||
164355034|NCT02673489|593674398|FG001|Treatment Period|Participant request to discontinue|1|||
164355035|NCT02673489|593674397|FG000|Treatment Period|Participant moved to another province|1|||
164355036|NCT02673489|593674398|FG001|Treatment Period|Participant moved to another province|0|||
164355037|NCT02673489|593674397|FG000|Treatment Period|Participant was incarcerated|0|||
164355038|NCT02673489|593674398|FG001|Treatment Period|Participant was incarcerated|1|||
164355039|NCT02673489|593674397|FG000|Treatment Period|Adverse Event|0|||
164355040|NCT02673489|593674398|FG001|Treatment Period|Adverse Event|1|||
164355041|NCT02673489|593674397|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
164355042|NCT02673489|593674398|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
164355043|NCT02673489|593674397|FG000|Follow Up Period|Unable to return for follow-up|0|||
164355044|NCT02673489|593674398|FG001|Follow Up Period|Unable to return for follow-up|1|||
164355045|NCT00232817|593674399|FG000|Overall Study|Protocol Violation|2|||
164355046|NCT00232817|593674400|FG001|Overall Study|Protocol Violation|1|||
164355047|NCT01084174|593674404|FG000|Overall Study|gastrointestinal symptoms|1|||
164355048|NCT01084174|593674405|FG001|Overall Study|gastrointestinal symptoms|1|||
164355049|NCT01084174|593674404|FG000|Overall Study|Eosinophilic esophagitis|0|||
164355050|NCT01084174|593674405|FG001|Overall Study|Eosinophilic esophagitis|1|||
164355051|NCT01084174|593674404|FG000|Overall Study|Anaphylaxis|0|||
164355052|NCT01084174|593674405|FG001|Overall Study|Anaphylaxis|1|||
164355053|NCT01084174|593674404|FG000|Overall Study|Participant noncompliance|0|||
164355054|NCT01084174|593674405|FG001|Overall Study|Participant noncompliance|1|||
164355055|NCT04273217|593674406|FG000|Overall Study|Lost to Follow-up|0|||
164355056|NCT04273217|593674407|FG001|Overall Study|Lost to Follow-up|0|||
164355057|NCT04273217|593674408|FG002|Overall Study|Lost to Follow-up|0|||
164355058|NCT04273217|593674409|FG003|Overall Study|Lost to Follow-up|0|||
164355059|NCT04273217|593674410|FG004|Overall Study|Lost to Follow-up|0|||
164355060|NCT04273217|593674411|FG005|Overall Study|Lost to Follow-up|1|||
164355061|NCT04273217|593674406|FG000|Overall Study|Participant non-compliance|0|||
164355062|NCT04273217|593674407|FG001|Overall Study|Participant non-compliance|0|||
164355063|NCT04273217|593674408|FG002|Overall Study|Participant non-compliance|0|||
164355064|NCT04273217|593674409|FG003|Overall Study|Participant non-compliance|0|||
164355065|NCT04273217|593674410|FG004|Overall Study|Participant non-compliance|1|||
164355066|NCT04273217|593674411|FG005|Overall Study|Participant non-compliance|0|||
164355067|NCT04273217|593674406|FG000|Overall Study|Positive urine drug screen|1|||
164355068|NCT04273217|593674407|FG001|Overall Study|Positive urine drug screen|0|||
164355069|NCT04273217|593674408|FG002|Overall Study|Positive urine drug screen|1|||
164355070|NCT04273217|593674409|FG003|Overall Study|Positive urine drug screen|0|||
164355071|NCT04273217|593674410|FG004|Overall Study|Positive urine drug screen|0|||
164355072|NCT04273217|593674411|FG005|Overall Study|Positive urine drug screen|1|||
164355073|NCT04532099|593674412|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
164355074|NCT04532099|593674413|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
164355075|NCT04532099|593674414|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
164355076|NCT05492942|593674415|FG000|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|10|||
164355077|NCT05492942|593674416|FG001|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|7|||
164355078|NCT05492942|593674417|FG002|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|8|||
164355079|NCT05492942|593674418|FG003|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|13|||
164694605|NCT00442546|594903087|FG001|Overall Study|Adverse Event|17|||
164355080|NCT02506153|593674419|FG000|Overall Study|Adverse Event|359|||
164355081|NCT02506153|593674420|FG001|Overall Study|Adverse Event|114|||
164355082|NCT02506153|593674419|FG000|Overall Study|Refused unrelated to adverse event|127|||
164694606|NCT00442546|594903088|FG002|Overall Study|Adverse Event|13|||
164355083|NCT02506153|593674420|FG001|Overall Study|Refused unrelated to adverse event|18|||
164355084|NCT02506153|593674419|FG000|Overall Study|Progression/relapse|91|||
164355085|NCT02506153|593674420|FG001|Overall Study|Progression/relapse|136|||
164355086|NCT02506153|593674419|FG000|Overall Study|Death|2|||
164355087|NCT02506153|593674420|FG001|Overall Study|Death|1|||
164355088|NCT02506153|593674419|FG000|Overall Study|Other - not protocol specified|23|||
164355089|NCT02506153|593674420|FG001|Overall Study|Other - not protocol specified|12|||
164355090|NCT03103919|593674421|FG000|Overall Study|Adverse Event|2|||
164355091|NCT03103919|593674422|FG001|Overall Study|Adverse Event|2|||
164355092|NCT01124422|593674423|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
164355093|NCT01124422|593674424|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
164355094|NCT01124422|593674425|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
164355095|NCT01124422|593674423|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
164355096|NCT01124422|593674424|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
164355097|NCT01124422|593674425|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
164355098|NCT01124422|593674423|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
164355099|NCT01124422|593674424|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
164355100|NCT01124422|593674425|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
164355101|NCT01124422|593674423|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
164355102|NCT01124422|593674424|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
164355103|NCT01124422|593674425|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
164355104|NCT01124422|593674423|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
164355105|NCT01124422|593674424|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
164355106|NCT01124422|593674425|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
164355107|NCT01124422|593674423|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
164355108|NCT01124422|593674424|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
164355109|NCT01124422|593674425|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
164355110|NCT01124422|593674423|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
164355111|NCT01124422|593674424|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
164355112|NCT01124422|593674425|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
164355113|NCT01124422|593674423|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
164355114|NCT01124422|593674424|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
164355115|NCT01124422|593674425|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
164355116|NCT01124422|593674423|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
164355117|NCT01124422|593674424|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
164355118|NCT01124422|593674425|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
164355119|NCT01124422|593674423|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
164355120|NCT01124422|593674424|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
164355121|NCT01124422|593674425|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
164355122|NCT01828281|593674426|FG000|Overall Study|Withdrawal by Subject|1|||
164355123|NCT01828281|593674427|FG001|Overall Study|Withdrawal by Subject|0|||
164355124|NCT03454893|593674430|FG000|Overall Study|Study Terminated by the Sponsor|5|||
164355125|NCT03454893|593674430|FG000|Overall Study|Did not pass screening|4|||
164355126|NCT04876274|593674431|FG000|Overall Study|Lost to Follow-up|9|||
164355127|NCT04876274|593674432|FG001|Overall Study|Lost to Follow-up|12|||
164355128|NCT03070782|593674435|FG000|Overall Study|Adverse Event|3|||
164355129|NCT03070782|593674436|FG001|Overall Study|Adverse Event|0|||
164355130|NCT03070782|593674437|FG002|Overall Study|Adverse Event|3|||
164355131|NCT03070782|593674438|FG003|Overall Study|Adverse Event|1|||
164355132|NCT03070782|593674439|FG004|Overall Study|Adverse Event|6|||
164355133|NCT03070782|593674440|FG005|Overall Study|Adverse Event|2|||
164355134|NCT03070782|593674435|FG000|Overall Study|Withdrawal by Subject|2|||
164355135|NCT03070782|593674436|FG001|Overall Study|Withdrawal by Subject|1|||
164355136|NCT03070782|593674437|FG002|Overall Study|Withdrawal by Subject|1|||
164355137|NCT03070782|593674438|FG003|Overall Study|Withdrawal by Subject|0|||
164355138|NCT03070782|593674439|FG004|Overall Study|Withdrawal by Subject|4|||
164355139|NCT03070782|593674440|FG005|Overall Study|Withdrawal by Subject|3|||
164355140|NCT03070782|593674435|FG000|Overall Study|Reason Not Specified|2|||
164355141|NCT03070782|593674436|FG001|Overall Study|Reason Not Specified|0|||
164355142|NCT03070782|593674437|FG002|Overall Study|Reason Not Specified|0|||
164694607|NCT00442546|594903086|FG000|Overall Study|Lost to Follow-up|1|||
164694608|NCT00442546|594903087|FG001|Overall Study|Lost to Follow-up|2|||
164694609|NCT00442546|594903088|FG002|Overall Study|Lost to Follow-up|1|||
164355143|NCT03070782|593674438|FG003|Overall Study|Reason Not Specified|1|||
164355144|NCT03070782|593674439|FG004|Overall Study|Reason Not Specified|2|||
164355145|NCT03070782|593674440|FG005|Overall Study|Reason Not Specified|1|||
164355146|NCT03070782|593674435|FG000|Overall Study|Ineligibility|0|||
164355147|NCT03070782|593674436|FG001|Overall Study|Ineligibility|0|||
164355148|NCT03070782|593674437|FG002|Overall Study|Ineligibility|0|||
164355149|NCT03070782|593674438|FG003|Overall Study|Ineligibility|1|||
164588950|NCT01469052|594519290|FG003|Overall Study|Other|0|||
164355150|NCT03070782|593674439|FG004|Overall Study|Ineligibility|0|||
164355151|NCT03070782|593674440|FG005|Overall Study|Ineligibility|1|||
164355152|NCT03070782|593674435|FG000|Overall Study|Pregnancy|0|||
164355153|NCT03070782|593674436|FG001|Overall Study|Pregnancy|0|||
164355154|NCT03070782|593674437|FG002|Overall Study|Pregnancy|0|||
164355155|NCT03070782|593674438|FG003|Overall Study|Pregnancy|1|||
164355156|NCT03070782|593674439|FG004|Overall Study|Pregnancy|0|||
164355157|NCT03070782|593674440|FG005|Overall Study|Pregnancy|0|||
164355158|NCT03070782|593674435|FG000|Overall Study|Investigator Judgement|0|||
164355159|NCT03070782|593674436|FG001|Overall Study|Investigator Judgement|0|||
164355160|NCT03070782|593674437|FG002|Overall Study|Investigator Judgement|0|||
164355161|NCT03070782|593674438|FG003|Overall Study|Investigator Judgement|1|||
164355162|NCT03070782|593674439|FG004|Overall Study|Investigator Judgement|0|||
164355163|NCT03070782|593674440|FG005|Overall Study|Investigator Judgement|0|||
164355164|NCT03527966|593674443|FG000|Overall Study|Lost to Follow-up|3|||
164355165|NCT03527966|593674444|FG001|Overall Study|Lost to Follow-up|0|||
164355166|NCT01948050|593674445|FG000|Overall Study|Withdrawal by Subject|0|||
164588951|NCT01469052|594519291|FG004|Overall Study|Other|1|||
164299513|NCT00906204|593472824|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
164355167|NCT01948050|593674446|FG001|Overall Study|Withdrawal by Subject|1|||
164355168|NCT02288559|593674447|FG000|Overall Study|Adverse Event|1|||
164355169|NCT02288559|593674448|FG001|Overall Study|Adverse Event|1|||
164355170|NCT02288559|593674449|FG002|Overall Study|Adverse Event|5|||
164355171|NCT02288559|593674450|FG003|Overall Study|Adverse Event|0|||
164355172|NCT02288559|593674447|FG000|Overall Study|Death|0|||
164355173|NCT02288559|593674448|FG001|Overall Study|Death|0|||
164355174|NCT02288559|593674449|FG002|Overall Study|Death|1|||
164355175|NCT02288559|593674450|FG003|Overall Study|Death|0|||
164355176|NCT02288559|593674447|FG000|Overall Study|Lost to Follow-up|0|||
164355177|NCT02288559|593674448|FG001|Overall Study|Lost to Follow-up|0|||
164355178|NCT02288559|593674449|FG002|Overall Study|Lost to Follow-up|0|||
164355179|NCT02288559|593674450|FG003|Overall Study|Lost to Follow-up|1|||
164436962|NCT00410124|593966443|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
164299514|NCT00906204|593472825|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
164299515|NCT00696072|593472826|FG000|Overall Study|continuing active treatment|10|||
164299516|NCT00696072|593472827|FG001|Overall Study|continuing active treatment|13|||
164299517|NCT00696072|593472826|FG000|Overall Study|Adverse Event|10|||
164299518|NCT00696072|593472827|FG001|Overall Study|Adverse Event|6|||
164299519|NCT00696072|593472826|FG000|Overall Study|Patient Request|3|||
164299520|NCT00696072|593472827|FG001|Overall Study|Patient Request|7|||
164299521|NCT00696072|593472826|FG000|Overall Study|Investigator Request|1|||
164299522|NCT00696072|593472827|FG001|Overall Study|Investigator Request|4|||
164299523|NCT00696072|593472826|FG000|Overall Study|Sponsor Request|0|||
164299524|NCT00696072|593472827|FG001|Overall Study|Sponsor Request|1|||
164299525|NCT00696072|593472826|FG000|Overall Study|Disease Progression|32|||
164299526|NCT00696072|593472827|FG001|Overall Study|Disease Progression|30|||
164299527|NCT00696072|593472826|FG000|Overall Study|Non-specified|1|||
164299528|NCT00696072|593472827|FG001|Overall Study|Non-specified|2|||
164299529|NCT00535496|593472828|FG000|Overall Study|Lost to Follow-up|0|||
164299530|NCT00535496|593472829|FG001|Overall Study|Lost to Follow-up|1|||
164299531|NCT00535496|593472830|FG002|Overall Study|Lost to Follow-up|0|||
164299532|NCT00535496|593472831|FG003|Overall Study|Lost to Follow-up|0|||
164299533|NCT00535496|593472828|FG000|Overall Study|Not treated with sugammadex|0|||
164299534|NCT00535496|593472829|FG001|Overall Study|Not treated with sugammadex|1|||
164299535|NCT00535496|593472830|FG002|Overall Study|Not treated with sugammadex|0|||
164299536|NCT00535496|593472831|FG003|Overall Study|Not treated with sugammadex|0|||
164299537|NCT00371150|593472832|FG000|Overall Study|Lost to Follow-up|3|||
164299538|NCT00371150|593472833|FG001|Overall Study|Lost to Follow-up|2|||
164299539|NCT00124943|593472834|FG000|Phase II|Adverse Event|0|||
164299540|NCT00124943|593472835|FG001|Phase II|Adverse Event|2|||
164299541|NCT00124943|593472836|FG002|Phase II|Adverse Event|0|||
164299542|NCT00124943|593472837|FG003|Phase II|Adverse Event|1|||
164299543|NCT00124943|593472834|FG000|Phase II|Protocol Violation|0|||
164299544|NCT00124943|593472835|FG001|Phase II|Protocol Violation|0|||
164299545|NCT00124943|593472836|FG002|Phase II|Protocol Violation|0|||
164299546|NCT00124943|593472837|FG003|Phase II|Protocol Violation|1|||
164299547|NCT00124943|593472834|FG000|Phase II|Lost to Follow-up|0|||
164355180|NCT02288559|593674447|FG000|Overall Study|Withdrawal by Subject|0|||
164355181|NCT02288559|593674448|FG001|Overall Study|Withdrawal by Subject|0|||
164355182|NCT02288559|593674449|FG002|Overall Study|Withdrawal by Subject|2|||
164355183|NCT02288559|593674450|FG003|Overall Study|Withdrawal by Subject|1|||
164355184|NCT02288559|593674447|FG000|Overall Study|Reason Not Specified|0|||
164355185|NCT02288559|593674448|FG001|Overall Study|Reason Not Specified|0|||
164299548|NCT00124943|593472835|FG001|Phase II|Lost to Follow-up|0|||
164299549|NCT00124943|593472836|FG002|Phase II|Lost to Follow-up|0|||
164299550|NCT00124943|593472837|FG003|Phase II|Lost to Follow-up|1|||
164299551|NCT00124943|593472834|FG000|Phase II|Withdrawal by Subject|0|||
164299552|NCT00124943|593472835|FG001|Phase II|Withdrawal by Subject|0|||
164299553|NCT00124943|593472836|FG002|Phase II|Withdrawal by Subject|0|||
164299554|NCT00124943|593472837|FG003|Phase II|Withdrawal by Subject|2|||
164436963|NCT00410124|593966444|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
164436964|NCT00410124|593966443|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
164436965|NCT00410124|593966444|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
164436966|NCT00410124|593966443|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
164436967|NCT00410124|593966444|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
164436968|NCT00410124|593966443|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
164436969|NCT00410124|593966444|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
164436970|NCT00410124|593966443|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
164436971|NCT00410124|593966444|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
164436972|NCT00410124|593966443|FG000|Core Phase Double Blind (15 Months)|Death|7|||
164436973|NCT00410124|593966444|FG001|Core Phase Double Blind (15 Months)|Death|4|||
164436974|NCT00410124|593966443|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
164436975|NCT00410124|593966444|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
164436976|NCT00410124|593966443|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
164436977|NCT00410124|593966444|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
164436978|NCT00410124|593966443|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
164436979|NCT00410124|593966444|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
164355186|NCT02288559|593674449|FG002|Overall Study|Reason Not Specified|3|||
164355187|NCT02288559|593674450|FG003|Overall Study|Reason Not Specified|0|||
164355188|NCT02709785|593674453|FG000|Overall Study|Withdrawal by Subject|1|||
164355189|NCT02709785|593674454|FG001|Overall Study|Withdrawal by Subject|2|||
164355190|NCT02709785|593674455|FG002|Overall Study|Withdrawal by Subject|1|||
164355191|NCT01961323|593674458|FG000|Overall Study|Withdrawal by Subject|7|||
164355192|NCT01961323|593674458|FG000|Overall Study|Lost to Follow-up|8|||
164355193|NCT01961323|593674458|FG000|Overall Study|screen failure|34|||
164355194|NCT00810407|593674459|FG000|Overall Study|Protocol Violation|3|||
164355195|NCT00810407|593674459|FG000|Overall Study|No Visit After First Day of Treatment|3|||
164355196|NCT02320149|593674463|FG000|Overall Study|Adverse Event|3|||
164355197|NCT02320149|593674464|FG001|Overall Study|Adverse Event|7|||
164355198|NCT02320149|593674463|FG000|Overall Study|Withdrawal of Consent|28|||
164355199|NCT02320149|593674464|FG001|Overall Study|Withdrawal of Consent|32|||
164355200|NCT02320149|593674463|FG000|Overall Study|Lost to Follow-up|21|||
164355201|NCT02320149|593674464|FG001|Overall Study|Lost to Follow-up|34|||
164355202|NCT02320149|593674463|FG000|Overall Study|Protocol Violation|2|||
164355203|NCT02320149|593674464|FG001|Overall Study|Protocol Violation|1|||
164355204|NCT02320149|593674463|FG000|Overall Study|Noncompliance with Study Treatment|7|||
164355205|NCT02320149|593674464|FG001|Overall Study|Noncompliance with Study Treatment|2|||
164355206|NCT02320149|593674463|FG000|Overall Study|Lack of Efficacy|0|||
164355207|NCT02320149|593674464|FG001|Overall Study|Lack of Efficacy|1|||
164355208|NCT02320149|593674463|FG000|Overall Study|Other Miscellaneous Reasons|2|||
164355209|NCT02320149|593674464|FG001|Overall Study|Other Miscellaneous Reasons|3|||
164355210|NCT00276159|593674465|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
164355211|NCT00333866|593674468|FG000|Overall Study|Adverse Event|23|||
164355212|NCT00333866|593674469|FG001|Overall Study|Adverse Event|37|||
164355213|NCT00333866|593674470|FG002|Overall Study|Adverse Event|38|||
164355214|NCT00333866|593674471|FG003|Overall Study|Adverse Event|47|||
164355215|NCT00333866|593674468|FG000|Overall Study|Other|3|||
164355216|NCT00333866|593674469|FG001|Overall Study|Other|2|||
164355217|NCT00333866|593674470|FG002|Overall Study|Other|2|||
164355218|NCT00333866|593674471|FG003|Overall Study|Other|2|||
164355219|NCT00333866|593674468|FG000|Overall Study|Lack of Efficacy|8|||
164355220|NCT00333866|593674469|FG001|Overall Study|Lack of Efficacy|6|||
164355221|NCT00333866|593674470|FG002|Overall Study|Lack of Efficacy|3|||
164355222|NCT00333866|593674471|FG003|Overall Study|Lack of Efficacy|5|||
164355223|NCT00333866|593674468|FG000|Overall Study|Lost to Follow-up|1|||
164355224|NCT00333866|593674469|FG001|Overall Study|Lost to Follow-up|2|||
164355225|NCT00333866|593674470|FG002|Overall Study|Lost to Follow-up|2|||
164355226|NCT00333866|593674471|FG003|Overall Study|Lost to Follow-up|2|||
164436980|NCT00410124|593966443|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
164355227|NCT00333866|593674468|FG000|Overall Study|Withdrawal by Subject|8|||
164355228|NCT00333866|593674469|FG001|Overall Study|Withdrawal by Subject|14|||
164355229|NCT00333866|593674470|FG002|Overall Study|Withdrawal by Subject|4|||
164355230|NCT00333866|593674471|FG003|Overall Study|Withdrawal by Subject|9|||
164355231|NCT00333866|593674468|FG000|Overall Study|Randomized but not Treated|5|||
164436981|NCT00410124|593966444|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
164355232|NCT00333866|593674469|FG001|Overall Study|Randomized but not Treated|3|||
164355233|NCT00333866|593674470|FG002|Overall Study|Randomized but not Treated|2|||
164355234|NCT00333866|593674471|FG003|Overall Study|Randomized but not Treated|1|||
164355235|NCT06073119|593674472|FG000|Overall Study|Adverse Event|1|||
164355236|NCT06073119|593674473|FG001|Overall Study|Adverse Event|3|||
164355237|NCT06073119|593674474|FG002|Overall Study|Adverse Event|0|||
164355238|NCT06073119|593674475|FG003|Overall Study|Adverse Event|0|||
164355239|NCT06073119|593674476|FG004|Overall Study|Adverse Event|1|||
164355240|NCT06073119|593674477|FG005|Overall Study|Adverse Event|0|||
164355241|NCT06073119|593674472|FG000|Overall Study|Non-compliance with study schedule|1|||
164355242|NCT06073119|593674473|FG001|Overall Study|Non-compliance with study schedule|0|||
164355243|NCT06073119|593674474|FG002|Overall Study|Non-compliance with study schedule|0|||
164355244|NCT06073119|593674475|FG003|Overall Study|Non-compliance with study schedule|0|||
164355245|NCT06073119|593674476|FG004|Overall Study|Non-compliance with study schedule|1|||
164355246|NCT06073119|593674477|FG005|Overall Study|Non-compliance with study schedule|0|||
164355247|NCT06073119|593674472|FG000|Overall Study|Withdrawal by Subject|4|||
164355248|NCT06073119|593674473|FG001|Overall Study|Withdrawal by Subject|4|||
164355249|NCT06073119|593674474|FG002|Overall Study|Withdrawal by Subject|3|||
164355250|NCT06073119|593674475|FG003|Overall Study|Withdrawal by Subject|5|||
164355251|NCT06073119|593674476|FG004|Overall Study|Withdrawal by Subject|3|||
164355252|NCT06073119|593674477|FG005|Overall Study|Withdrawal by Subject|1|||
164355253|NCT06073119|593674472|FG000|Overall Study|Other|2|||
164355254|NCT06073119|593674473|FG001|Overall Study|Other|4|||
164355255|NCT06073119|593674474|FG002|Overall Study|Other|1|||
164355256|NCT06073119|593674475|FG003|Overall Study|Other|0|||
164355257|NCT06073119|593674476|FG004|Overall Study|Other|1|||
164355258|NCT06073119|593674477|FG005|Overall Study|Other|0|||
164588952|NCT01469052|594519292|FG005|Overall Study|Other|0|||
164355259|NCT01359449|593674480|FG000|Overall Study|Lost to Follow-up|1|||
164355260|NCT01359449|593674481|FG001|Overall Study|Lost to Follow-up|0|||
164355261|NCT01359449|593674480|FG000|Overall Study|Protocol Violation|0|||
164355262|NCT01359449|593674481|FG001|Overall Study|Protocol Violation|2|||
164355263|NCT01359449|593674480|FG000|Overall Study|Withdrawal by Subject|3|||
164355264|NCT01359449|593674481|FG001|Overall Study|Withdrawal by Subject|2|||
164355265|NCT01907815|593674485|FG000|Overall Study|Withdrawal by Subject|1|||
164355266|NCT01907815|593674486|FG001|Overall Study|Withdrawal by Subject|0|||
164355267|NCT00191789|593674487|FG000|Overall Study|Adverse Event|5|||
164355268|NCT00191789|593674487|FG000|Overall Study|Patient: Satisfactory Response|5|||
164355269|NCT00191789|593674487|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
164355270|NCT00191789|593674487|FG000|Overall Study|Withdrawal by Subject|4|||
164355271|NCT00191789|593674487|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
164355272|NCT00191789|593674487|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
164355273|NCT00191789|593674487|FG000|Overall Study|Death - Not Study-Drug Related|1|||
164355274|NCT01414855|593674488|FG000|Overall Study|Death|17|||
164355275|NCT01414855|593674488|FG000|Overall Study|Lost to Follow-up|5|||
164355276|NCT01414855|593674488|FG000|Overall Study|Withdrawal by Subject|7|||
164355277|NCT01937559|593674491|FG000|Overall Study|Physician Decision|3|||
164355278|NCT01937559|593674492|FG001|Overall Study|Physician Decision|3|||
164355279|NCT01937559|593674493|FG002|Overall Study|Physician Decision|0|||
164355280|NCT01937559|593674491|FG000|Overall Study|Withdrawal by Subject|6|||
164355281|NCT01937559|593674492|FG001|Overall Study|Withdrawal by Subject|4|||
164355282|NCT01937559|593674493|FG002|Overall Study|Withdrawal by Subject|0|||
164355283|NCT01937559|593674491|FG000|Overall Study|screen fail|2|||
164355284|NCT01937559|593674492|FG001|Overall Study|screen fail|4|||
164355285|NCT01937559|593674493|FG002|Overall Study|screen fail|0|||
164588953|NCT02508701|594519293|FG000|Overall Study|Lost to Follow-up|9|||
164588954|NCT02508701|594519294|FG001|Overall Study|Lost to Follow-up|5|||
164299555|NCT03181932|593472838|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
164299556|NCT03181932|593472839|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
164299557|NCT03181932|593472838|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
164299558|NCT03181932|593472839|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
164299559|NCT03181932|593472838|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
164299560|NCT03181932|593472839|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
164299561|NCT03181932|593472838|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
164299562|NCT03181932|593472839|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
164299563|NCT03181932|593472838|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
164299564|NCT03181932|593472839|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
164299565|NCT03181932|593472838|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
164299566|NCT03181932|593472839|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
164299567|NCT03181932|593472838|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
164299568|NCT03181932|593472839|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
164299569|NCT03181932|593472838|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
164299570|NCT03181932|593472839|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
164299571|NCT03181932|593472838|FG000|Period 2 (Open-label Period)|Reason missing|2|||
164299572|NCT03181932|593472839|FG001|Period 2 (Open-label Period)|Reason missing|0|||
164299573|NCT03304626|593472840|FG000|Overall Study|Adverse Event|1|||
164299574|NCT03304626|593472841|FG001|Overall Study|Adverse Event|0|||
164299575|NCT03304626|593472840|FG000|Overall Study|Lack of Efficacy|1|||
164299576|NCT03304626|593472841|FG001|Overall Study|Lack of Efficacy|1|||
164299577|NCT00408317|593472848|FG000|First Intervention Period|Adverse Event|0|||
164299578|NCT00408317|593472849|FG001|First Intervention Period|Adverse Event|1|||
164299579|NCT00408317|593472848|FG000|Second Intervention Period|Adverse Event|2|||
164299580|NCT00408317|593472849|FG001|Second Intervention Period|Adverse Event|0|||
164299581|NCT00408317|593472848|FG000|Second Intervention Period|Protocol Violation|0|||
164299582|NCT00408317|593472849|FG001|Second Intervention Period|Protocol Violation|1|||
164299583|NCT00408317|593472848|FG000|Second Intervention Period|Withdrawal of consent|0|||
164299584|NCT00408317|593472849|FG001|Second Intervention Period|Withdrawal of consent|1|||
164299585|NCT02379728|593472852|FG000|Overall Study|Lost to Follow-up|1|||
164299586|NCT02379728|593472853|FG001|Overall Study|Lost to Follow-up|0|||
164299587|NCT02379728|593472854|FG002|Overall Study|Lost to Follow-up|3|||
164299588|NCT02379728|593472855|FG003|Overall Study|Lost to Follow-up|0|||
164299589|NCT02379728|593472852|FG000|Overall Study|Withdrawal by Subject|5|||
164299590|NCT02379728|593472853|FG001|Overall Study|Withdrawal by Subject|0|||
164299591|NCT02379728|593472854|FG002|Overall Study|Withdrawal by Subject|5|||
164299592|NCT02379728|593472855|FG003|Overall Study|Withdrawal by Subject|3|||
164299593|NCT02379728|593472852|FG000|Overall Study|Protocol Violation|0|||
164299594|NCT02379728|593472853|FG001|Overall Study|Protocol Violation|0|||
164299595|NCT02379728|593472854|FG002|Overall Study|Protocol Violation|2|||
164299596|NCT02379728|593472855|FG003|Overall Study|Protocol Violation|0|||
164299597|NCT01921205|593472856|FG000|Overall Study|Adverse Event|12|||
164299598|NCT01921205|593472857|FG001|Overall Study|Adverse Event|7|||
164299599|NCT01921205|593472856|FG000|Overall Study|Lack of Efficacy|1|||
164299600|NCT01921205|593472857|FG001|Overall Study|Lack of Efficacy|0|||
164299601|NCT01921205|593472856|FG000|Overall Study|Protocol Violation|1|||
164299602|NCT01921205|593472857|FG001|Overall Study|Protocol Violation|3|||
164299603|NCT01921205|593472856|FG000|Overall Study|Lost to Follow-up|1|||
164299604|NCT01921205|593472857|FG001|Overall Study|Lost to Follow-up|1|||
164299605|NCT01921205|593472856|FG000|Overall Study|Withdrawal by Subject|6|||
164299606|NCT01921205|593472857|FG001|Overall Study|Withdrawal by Subject|5|||
164299607|NCT01921205|593472856|FG000|Overall Study|Use Of Prohibited Medication|0|||
164299608|NCT01921205|593472857|FG001|Overall Study|Use Of Prohibited Medication|1|||
164299609|NCT01921205|593472856|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
164299610|NCT01921205|593472857|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
164299611|NCT01921205|593472856|FG000|Overall Study|Non Compliance Of The Parent|0|||
164299612|NCT01921205|593472857|FG001|Overall Study|Non Compliance Of The Parent|1|||
164299613|NCT01921205|593472856|FG000|Overall Study|Non Compliance Of Child|0|||
164299614|NCT01921205|593472857|FG001|Overall Study|Non Compliance Of Child|1|||
164299615|NCT03331315|593472858|FG000|Overall Study|Physician Decision|18|||
164299616|NCT03331315|593472859|FG001|Overall Study|Physician Decision|14|||
164299617|NCT00360230|593472860|FG000|Overall Study|Withdrawal by Subject|1|||
164299618|NCT00360230|593472861|FG001|Overall Study|Withdrawal by Subject|1|||
164299619|NCT00360230|593472862|FG002|Overall Study|Withdrawal by Subject|0|||
164299620|NCT00360230|593472863|FG003|Overall Study|Withdrawal by Subject|1|||
164436982|NCT00410124|593966443|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
164588955|NCT02508701|594519295|FG002|Overall Study|Lost to Follow-up|5|||
164299621|NCT00360230|593472864|FG004|Overall Study|Withdrawal by Subject|1|||
164299622|NCT00360230|593472865|FG005|Overall Study|Withdrawal by Subject|1|||
164299623|NCT00360230|593472866|FG006|Overall Study|Withdrawal by Subject|0|||
164299624|NCT00360230|593472860|FG000|Overall Study|Migrated|4|||
164355286|NCT03653637|593676318|FG000|Overall Study|Death|1|||
164355287|NCT03653637|593676319|FG001|Overall Study|Death|3|||
164355288|NCT03653637|593676318|FG000|Overall Study|Lost to Follow-up|29|||
164355289|NCT03653637|593676319|FG001|Overall Study|Lost to Follow-up|30|||
164355290|NCT03653637|593676318|FG000|Overall Study|Physician Decision|1|||
164355291|NCT03653637|593676319|FG001|Overall Study|Physician Decision|1|||
164355292|NCT03653637|593676318|FG000|Overall Study|Withdrawal by Subject|7|||
164355293|NCT03653637|593676319|FG001|Overall Study|Withdrawal by Subject|4|||
164355294|NCT02068443|593676322|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
164355295|NCT02068443|593676323|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
164355296|NCT02068443|593676324|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
164355297|NCT02068443|593676322|FG000|Overall Study|Voluntary Withdrawal|4|||
164355298|NCT02068443|593676323|FG001|Overall Study|Voluntary Withdrawal|0|||
164355299|NCT02068443|593676324|FG002|Overall Study|Voluntary Withdrawal|1|||
164355300|NCT02068443|593676322|FG000|Overall Study|Lack of Efficacy|2|||
164355301|NCT02068443|593676323|FG001|Overall Study|Lack of Efficacy|1|||
164355302|NCT02068443|593676324|FG002|Overall Study|Lack of Efficacy|0|||
164355303|NCT02068443|593676322|FG000|Overall Study|Other Reason Not Specified|1|||
164355304|NCT02068443|593676323|FG001|Overall Study|Other Reason Not Specified|0|||
164355305|NCT02068443|593676324|FG002|Overall Study|Other Reason Not Specified|0|||
164355306|NCT02723084|593676326|FG000|Overall Study|Withdrawal by Subject|1|||
164355307|NCT02723084|593676327|FG001|Overall Study|Withdrawal by Subject|1|||
164355308|NCT02723084|593676326|FG000|Overall Study|Lost to Follow-up|3|||
164355309|NCT02723084|593676327|FG001|Overall Study|Lost to Follow-up|0|||
164355310|NCT04067544|593676330|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
164355311|NCT01320085|593676331|FG000|Overall Study|Disease Progression|26|||
164355312|NCT01320085|593676332|FG001|Overall Study|Disease Progression|93|||
164355313|NCT01320085|593676333|FG002|Overall Study|Disease Progression|17|||
164355314|NCT01320085|593676331|FG000|Overall Study|Adverse Event|12|||
164355315|NCT01320085|593676332|FG001|Overall Study|Adverse Event|20|||
164355316|NCT01320085|593676333|FG002|Overall Study|Adverse Event|5|||
164355317|NCT01320085|593676331|FG000|Overall Study|Withdrawal by Subject|2|||
164355318|NCT01320085|593676332|FG001|Overall Study|Withdrawal by Subject|4|||
164355319|NCT01320085|593676333|FG002|Overall Study|Withdrawal by Subject|1|||
164355320|NCT01320085|593676331|FG000|Overall Study|Protocol Deviation|1|||
164355321|NCT01320085|593676332|FG001|Overall Study|Protocol Deviation|0|||
164355322|NCT01320085|593676333|FG002|Overall Study|Protocol Deviation|1|||
164355323|NCT01320085|593676331|FG000|Overall Study|Administrative problems|0|||
164355324|NCT01320085|593676332|FG001|Overall Study|Administrative problems|0|||
164355325|NCT01320085|593676333|FG002|Overall Study|Administrative problems|1|||
164355326|NCT00225251|593676336|FG000|Overall Study|Withdrawal by Subject|1|||
164355327|NCT00225251|593676337|FG001|Overall Study|Withdrawal by Subject|1|||
164355328|NCT01702454|593676338|FG000|Overall Study|Consent withdrawal|0|||
164355329|NCT01702454|593676339|FG001|Overall Study|Consent withdrawal|1|||
164355330|NCT01702454|593676338|FG000|Overall Study|Migrated/moved from study area|0|||
164355331|NCT01702454|593676339|FG001|Overall Study|Migrated/moved from study area|1|||
164355332|NCT01702454|593676338|FG000|Overall Study|Lost to Follow-up|3|||
164355333|NCT01702454|593676339|FG001|Overall Study|Lost to Follow-up|6|||
164355334|NCT00082355|593676340|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
164355335|NCT00082355|593676340|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
164355336|NCT00082355|593676340|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
164355337|NCT02233309|593676343|FG000|Overall Study|Physician Decision|5|||
164355338|NCT00475176|593676348|FG000|Overall Study|Adverse Event|2|||
164355339|NCT00475176|593676348|FG000|Overall Study|Withdrawal by Subject|1|||
164355340|NCT00475176|593676348|FG000|Overall Study|Protocol Violation|1|||
164355341|NCT01484873|593676349|FG000|Overall Study|Withdrawal by Subject|2|||
164355342|NCT01549392|593676350|FG000|Overall Study|Withdrawal by Subject|1|||
164355343|NCT01549392|593676351|FG001|Overall Study|Withdrawal by Subject|0|||
164355344|NCT00227903|593676352|FG000|Overall Study|Withdrawal by Subject|2|||
164355345|NCT00227903|593676353|FG001|Overall Study|Withdrawal by Subject|5|||
164355346|NCT00227903|593676352|FG000|Overall Study|Subject moved out of area|1|||
164355347|NCT00227903|593676353|FG001|Overall Study|Subject moved out of area|2|||
164355348|NCT00227903|593676352|FG000|Overall Study|Lost to Follow-up|1|||
164355349|NCT00227903|593676353|FG001|Overall Study|Lost to Follow-up|3|||
164355350|NCT00227903|593676352|FG000|Overall Study|Miscarriage|1|||
164355351|NCT00227903|593676353|FG001|Overall Study|Miscarriage|0|||
164355352|NCT01475331|593676354|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
164355353|NCT01475331|593676355|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
164355354|NCT01475331|593676354|FG000|Overall Study|excessive main duct communication|1|||
164355355|NCT01475331|593676355|FG001|Overall Study|excessive main duct communication|1|||
164355356|NCT01475331|593676354|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
164355357|NCT01475331|593676355|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
164355358|NCT01475331|593676354|FG000|Overall Study|Sign of malignancy during the procedure|2|||
164355359|NCT01475331|593676355|FG001|Overall Study|Sign of malignancy during the procedure|0|||
164436983|NCT00410124|593966444|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
164436984|NCT00410124|593966443|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
164436985|NCT00410124|593966444|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
164436986|NCT00410124|593966443|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
164436987|NCT00410124|593966444|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
164436988|NCT00410124|593966443|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
164436989|NCT00410124|593966444|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
164436990|NCT00410124|593966443|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
164436991|NCT00410124|593966444|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
164436992|NCT00880048|593966449|FG000|Overall Study|Adverse Event|2|||
164436993|NCT00880048|593966450|FG001|Overall Study|Adverse Event|3|||
164436994|NCT00880048|593966451|FG002|Overall Study|Adverse Event|5|||
164436995|NCT00880048|593966449|FG000|Overall Study|Lack of Efficacy|1|||
164436996|NCT00880048|593966450|FG001|Overall Study|Lack of Efficacy|2|||
164436997|NCT00880048|593966451|FG002|Overall Study|Lack of Efficacy|2|||
164436998|NCT00880048|593966449|FG000|Overall Study|Protocol Violation|4|||
164436999|NCT00880048|593966450|FG001|Overall Study|Protocol Violation|6|||
164437000|NCT00880048|593966451|FG002|Overall Study|Protocol Violation|5|||
164437001|NCT00880048|593966449|FG000|Overall Study|Lost to Follow-up|6|||
164437002|NCT00880048|593966450|FG001|Overall Study|Lost to Follow-up|6|||
164437003|NCT00880048|593966451|FG002|Overall Study|Lost to Follow-up|5|||
164437004|NCT00880048|593966449|FG000|Overall Study|Physician Decision|1|||
164437005|NCT00880048|593966450|FG001|Overall Study|Physician Decision|1|||
164355360|NCT01475331|593676354|FG000|Overall Study|cyst found to be prohibitively small|0|||
164355361|NCT01475331|593676355|FG001|Overall Study|cyst found to be prohibitively small|1|||
164355362|NCT00462761|593676356|FG000|Overall Study|Adverse Event|6|||
164355363|NCT00462761|593676356|FG000|Overall Study|Withdrawal by Subject|9|||
164355364|NCT00462761|593676356|FG000|Overall Study|Physician Decision|5|||
164355365|NCT00462761|593676356|FG000|Overall Study|Disease progression|43|||
164355366|NCT00462761|593676356|FG000|Overall Study|Death|12|||
164355367|NCT00462761|593676356|FG000|Overall Study|Other|1|||
164355368|NCT02877082|593676357|FG000|Overall Study|Trial was closed early|5|||
164355369|NCT00311623|593676360|FG000|Overall Study|Physician Decision|0|||
164355370|NCT00311623|593676361|FG001|Overall Study|Physician Decision|0|||
164355371|NCT00311623|593676362|FG002|Overall Study|Physician Decision|2|||
164355372|NCT03998189|593676363|FG000|Overall Study|Lack of Efficacy|0|||
164355373|NCT03998189|593676364|FG001|Overall Study|Lack of Efficacy|1|||
164355374|NCT04983264|593676365|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
164355375|NCT04983264|593676366|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
164437006|NCT00880048|593966451|FG002|Overall Study|Physician Decision|7|||
164437007|NCT00880048|593966449|FG000|Overall Study|Withdrawal by Subject|5|||
164437008|NCT00880048|593966450|FG001|Overall Study|Withdrawal by Subject|8|||
164437009|NCT00880048|593966451|FG002|Overall Study|Withdrawal by Subject|5|||
164437010|NCT00880048|593966449|FG000|Overall Study|Study closed/terminated|9|||
164437011|NCT00880048|593966450|FG001|Overall Study|Study closed/terminated|7|||
164437012|NCT00880048|593966451|FG002|Overall Study|Study closed/terminated|6|||
164437013|NCT00639002|593966452|FG000|Overall Study|Death|1|||
164437014|NCT00639002|593966452|FG000|Overall Study|Adverse Event|1|||
164437015|NCT00639002|593966452|FG000|Overall Study|Protocol Violation|1|||
164437016|NCT00639002|593966452|FG000|Overall Study|Disease progression|3|||
164437017|NCT00639002|593966452|FG000|Overall Study|Physician Decision|6|||
164437018|NCT00639002|593966452|FG000|Overall Study|Lack of Efficacy|1|||
164437019|NCT01839877|593966456|FG000|Overall Study|Protocol Violation|1|||
164437020|NCT00597519|593966463|FG000|Overall Study|Death|1|||
164437021|NCT02781584|593966469|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
164437022|NCT02781584|593966470|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
164437023|NCT02781584|593966471|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
164437024|NCT02781584|593966472|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
164437025|NCT02781584|593966473|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
164437026|NCT02781584|593966474|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
164437027|NCT02781584|593966475|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
164437028|NCT02781584|593966476|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
164588956|NCT02508701|594519296|FG003|Overall Study|Lost to Follow-up|3|||
164588957|NCT03894904|594519297|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
164694610|NCT00442546|594903086|FG000|Overall Study|Other|4|||
164355376|NCT04983264|593676367|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
164355377|NCT04983264|593676365|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
164355378|NCT04983264|593676366|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
164355379|NCT04983264|593676367|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
164355380|NCT00558025|593676370|FG000|Overall Study|Adverse Event|1|||
164437029|NCT02781584|593966477|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
164437030|NCT02781584|593966478|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
164437031|NCT02781584|593966479|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
164437032|NCT02781584|593966480|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
164437033|NCT02781584|593966481|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
164437034|NCT02781584|593966469|FG000|Pre-treatment Phase|Adverse Event|0|||
164437035|NCT02781584|593966470|FG001|Pre-treatment Phase|Adverse Event|0|||
164437036|NCT02781584|593966471|FG002|Pre-treatment Phase|Adverse Event|0|||
164437037|NCT02781584|593966472|FG003|Pre-treatment Phase|Adverse Event|0|||
164437038|NCT02781584|593966473|FG004|Pre-treatment Phase|Adverse Event|0|||
164437039|NCT02781584|593966474|FG005|Pre-treatment Phase|Adverse Event|0|||
164437040|NCT02781584|593966475|FG006|Pre-treatment Phase|Adverse Event|0|||
164437041|NCT02781584|593966476|FG007|Pre-treatment Phase|Adverse Event|0|||
164437042|NCT02781584|593966477|FG008|Pre-treatment Phase|Adverse Event|0|||
164437043|NCT02781584|593966478|FG009|Pre-treatment Phase|Adverse Event|0|||
164437044|NCT02781584|593966479|FG010|Pre-treatment Phase|Adverse Event|0|||
164437045|NCT02781584|593966480|FG011|Pre-treatment Phase|Adverse Event|1|||
164437046|NCT02781584|593966481|FG012|Pre-treatment Phase|Adverse Event|0|||
164437047|NCT02781584|593966469|FG000|Treatment Phase|Withdrew Consent|0|||
164437048|NCT02781584|593966470|FG001|Treatment Phase|Withdrew Consent|0|||
164437049|NCT02781584|593966471|FG002|Treatment Phase|Withdrew Consent|0|||
164437050|NCT02781584|593966472|FG003|Treatment Phase|Withdrew Consent|0|||
164437051|NCT02781584|593966473|FG004|Treatment Phase|Withdrew Consent|0|||
164437052|NCT02781584|593966474|FG005|Treatment Phase|Withdrew Consent|1|||
164437053|NCT02781584|593966475|FG006|Treatment Phase|Withdrew Consent|0|||
164437054|NCT02781584|593966476|FG007|Treatment Phase|Withdrew Consent|0|||
164437055|NCT02781584|593966477|FG008|Treatment Phase|Withdrew Consent|0|||
164437056|NCT02781584|593966478|FG009|Treatment Phase|Withdrew Consent|0|||
164437057|NCT02781584|593966479|FG010|Treatment Phase|Withdrew Consent|1|||
164437058|NCT02781584|593966480|FG011|Treatment Phase|Withdrew Consent|2|||
164437059|NCT02781584|593966481|FG012|Treatment Phase|Withdrew Consent|0|||
164437060|NCT02781584|593966469|FG000|Treatment Phase|Adverse Event|0|||
164437061|NCT02781584|593966470|FG001|Treatment Phase|Adverse Event|0|||
164437062|NCT02781584|593966471|FG002|Treatment Phase|Adverse Event|0|||
164437063|NCT02781584|593966472|FG003|Treatment Phase|Adverse Event|0|||
164437064|NCT02781584|593966473|FG004|Treatment Phase|Adverse Event|0|||
164437065|NCT02781584|593966474|FG005|Treatment Phase|Adverse Event|0|||
164437066|NCT02781584|593966475|FG006|Treatment Phase|Adverse Event|0|||
164437067|NCT02781584|593966476|FG007|Treatment Phase|Adverse Event|1|||
164437068|NCT02781584|593966477|FG008|Treatment Phase|Adverse Event|0|||
164437069|NCT02781584|593966478|FG009|Treatment Phase|Adverse Event|0|||
164437070|NCT02781584|593966479|FG010|Treatment Phase|Adverse Event|0|||
164437071|NCT02781584|593966480|FG011|Treatment Phase|Adverse Event|0|||
164437072|NCT02781584|593966481|FG012|Treatment Phase|Adverse Event|0|||
164437073|NCT00768651|593966482|FG000|Overall Study|Withdrawal by Subject|1|||
164437074|NCT02104765|593966483|FG000|Overall Study|Lost to Follow-up|0|||
164437075|NCT02104765|593966484|FG001|Overall Study|Lost to Follow-up|0|||
164437076|NCT02104765|593966485|FG002|Overall Study|Lost to Follow-up|1|||
164437077|NCT02104765|593966486|FG003|Overall Study|Lost to Follow-up|0|||
164437078|NCT02104765|593966487|FG004|Overall Study|Lost to Follow-up|0|||
164437079|NCT02104765|593966488|FG005|Overall Study|Lost to Follow-up|0|||
164437080|NCT02104765|593966489|FG006|Overall Study|Lost to Follow-up|0|||
164437081|NCT02104765|593966483|FG000|Overall Study|Withdrawal by Subject|0|||
164437082|NCT02104765|593966484|FG001|Overall Study|Withdrawal by Subject|0|||
164437083|NCT02104765|593966485|FG002|Overall Study|Withdrawal by Subject|0|||
164437084|NCT02104765|593966486|FG003|Overall Study|Withdrawal by Subject|1|||
164437085|NCT02104765|593966487|FG004|Overall Study|Withdrawal by Subject|1|||
164437086|NCT02104765|593966488|FG005|Overall Study|Withdrawal by Subject|0|||
164437087|NCT02104765|593966489|FG006|Overall Study|Withdrawal by Subject|1|||
164437088|NCT02698241|593966491|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
164355381|NCT00558025|593676371|FG001|Overall Study|Adverse Event|1|||
164355382|NCT00558025|593676370|FG000|Overall Study|Withdrawal by Subject|2|||
164355383|NCT00558025|593676371|FG001|Overall Study|Withdrawal by Subject|2|||
164355384|NCT00558025|593676370|FG000|Overall Study|Protocol Violation|1|||
164355385|NCT00558025|593676371|FG001|Overall Study|Protocol Violation|0|||
164355386|NCT01506479|593676372|FG000|Overall Study|Lost to Follow-up|1|||
164355387|NCT01506479|593676373|FG001|Overall Study|Lost to Follow-up|2|||
164355388|NCT01506479|593676374|FG002|Overall Study|Lost to Follow-up|2|||
164355389|NCT01506479|593676372|FG000|Overall Study|Withdrawal by Subject|1|||
164437089|NCT02698241|593966491|FG000|Overall Study|Screening not met|7|||
164437090|NCT02698241|593966491|FG000|Overall Study|Withdrawal by Subject|7|||
164437091|NCT02698241|593966491|FG000|Overall Study|Physician Decision|2|||
164589053|NCT02232516|594521371|FG000|Survival Follow-up|Still in follow-up|5|||
164355390|NCT01506479|593676373|FG001|Overall Study|Withdrawal by Subject|2|||
164437092|NCT02698241|593966491|FG000|Overall Study|Subject underwent system modification|2|||
164437093|NCT02698241|593966491|FG000|Overall Study|Lost to Follow-up|3|||
164355391|NCT01506479|593676374|FG002|Overall Study|Withdrawal by Subject|1|||
164437094|NCT02698241|593966491|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
164437095|NCT02698241|593966491|FG000|Overall Study|geographic and licensing issue|1|||
164437096|NCT02698241|593966491|FG000|Overall Study|Death|2|||
164437097|NCT01543685|593966492|FG000|Overall Study|Lack of Efficacy|1|||
164437098|NCT01543685|593966493|FG001|Overall Study|Lack of Efficacy|2|||
164437099|NCT01543685|593966494|FG002|Overall Study|Lack of Efficacy|2|||
164437100|NCT01543685|593966495|FG003|Overall Study|Lack of Efficacy|0|||
164437101|NCT01543685|593966496|FG004|Overall Study|Lack of Efficacy|2|||
164437102|NCT01543685|593966492|FG000|Overall Study|Adverse Event|2|||
164437103|NCT01543685|593966493|FG001|Overall Study|Adverse Event|1|||
164437104|NCT01543685|593966494|FG002|Overall Study|Adverse Event|0|||
164437105|NCT01543685|593966495|FG003|Overall Study|Adverse Event|0|||
164437106|NCT01543685|593966496|FG004|Overall Study|Adverse Event|2|||
164437107|NCT04776213|593966497|FG000|Overall Study|Other|1|||
164437108|NCT04776213|593966497|FG000|Overall Study|Withdrawal by Subject|7|||
164437109|NCT04776213|593966497|FG000|Overall Study|Protocol Violation|1|||
164437110|NCT04776213|593966497|FG000|Overall Study|Lost to Follow-up|2|||
164437111|NCT00906282|593966501|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
164437112|NCT00906282|593966501|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
164437113|NCT00906282|593966501|FG000|Preoperative Chemotherapy|Progressive disease|6|||
164437114|NCT00906282|593966501|FG000|Preoperative Chemotherapy|Toxicity|1|||
164437115|NCT01751724|593966502|FG000|Overall Study|extubated bef.start assigned treatment|1|||
164437116|NCT01751724|593966503|FG001|Overall Study|extubated bef.start assigned treatment|0|||
164437117|NCT01751724|593966502|FG000|Overall Study|withdrawn by parent|0|||
164437118|NCT01751724|593966503|FG001|Overall Study|withdrawn by parent|2|||
164437119|NCT02685033|593966506|FG000|Overall Study|Withdrawal of Consent|0|||
164437120|NCT02685033|593966507|FG001|Overall Study|Withdrawal of Consent|1|||
164437121|NCT02685033|593966506|FG000|Overall Study|Lost to Follow-up|2|||
164437122|NCT02685033|593966507|FG001|Overall Study|Lost to Follow-up|1|||
164437123|NCT02685033|593966506|FG000|Overall Study|Adverse Event|1|||
164437124|NCT02685033|593966507|FG001|Overall Study|Adverse Event|0|||
164437125|NCT00603447|593966508|FG000|Overall Study|Adverse Event|0|||
164437126|NCT00603447|593966509|FG001|Overall Study|Adverse Event|1|||
164437127|NCT00603447|593966510|FG002|Overall Study|Adverse Event|1|||
164437128|NCT00603447|593966511|FG003|Overall Study|Adverse Event|2|||
164437129|NCT00603447|593966512|FG004|Overall Study|Adverse Event|1|||
164437130|NCT00603447|593966513|FG005|Overall Study|Adverse Event|2|||
164437131|NCT00603447|593966514|FG006|Overall Study|Adverse Event|10|||
164355392|NCT01506479|593676372|FG000|Overall Study|Missing assessment|1|||
164355393|NCT01506479|593676373|FG001|Overall Study|Missing assessment|0|||
164355394|NCT01506479|593676374|FG002|Overall Study|Missing assessment|0|||
164355395|NCT01506479|593676372|FG000|Overall Study|Adverse Event|0|||
164355396|NCT01506479|593676373|FG001|Overall Study|Adverse Event|1|||
164355397|NCT01506479|593676374|FG002|Overall Study|Adverse Event|0|||
164355398|NCT05247866|593676376|FG000|Overall Study|Adverse Event|2|||
164355399|NCT05247866|593676376|FG000|Overall Study|Lack of Efficacy|1|||
164355400|NCT05247866|593676376|FG000|Overall Study|Protocol Violation|1|||
164355401|NCT05247866|593676376|FG000|Overall Study|Withdrawal by Subject|3|||
164355402|NCT03315208|593676379|FG000|Overall Study|Lost to Follow-up|11|||
164355403|NCT03315208|593676380|FG001|Overall Study|Lost to Follow-up|6|||
164355404|NCT03315208|593676379|FG000|Overall Study|Withdrawal by Subject|2|||
164355405|NCT03315208|593676380|FG001|Overall Study|Withdrawal by Subject|0|||
164355406|NCT02746874|593676381|FG000|Overall Study|Withdrawal by Subject|0|||
164355407|NCT02746874|593676382|FG001|Overall Study|Withdrawal by Subject|1|||
164355408|NCT02746874|593676381|FG000|Overall Study|Surgery Date Changed|0|||
164355409|NCT02746874|593676382|FG001|Overall Study|Surgery Date Changed|2|||
164355410|NCT01156311|593676386|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
164355411|NCT01156311|593676387|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
164355412|NCT01156311|593676388|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
164355413|NCT01156311|593676389|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
164355414|NCT01156311|593676386|FG000|2-Month Monotherapy Period|Physician Decision|0|||
164355415|NCT01156311|593676387|FG001|2-Month Monotherapy Period|Physician Decision|1|||
164355416|NCT01156311|593676388|FG002|2-Month Monotherapy Period|Physician Decision|0|||
164355417|NCT01156311|593676389|FG003|2-Month Monotherapy Period|Physician Decision|0|||
164437132|NCT00603447|593966508|FG000|Overall Study|Other|0|||
164355418|NCT01156311|593676386|FG000|2-Month Monotherapy Period|Other|1|||
164355419|NCT01156311|593676387|FG001|2-Month Monotherapy Period|Other|0|||
164355420|NCT01156311|593676388|FG002|2-Month Monotherapy Period|Other|0|||
164355421|NCT01156311|593676389|FG003|2-Month Monotherapy Period|Other|0|||
164355422|NCT01156311|593676386|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
164694611|NCT00442546|594903087|FG001|Overall Study|Other|9|||
164355423|NCT01156311|593676387|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
164355424|NCT01156311|593676388|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
164355425|NCT01156311|593676389|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
164355426|NCT01156311|593676386|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
164355427|NCT01156311|593676387|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
164355428|NCT01156311|593676388|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
164355429|NCT01156311|593676389|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
164355430|NCT01156311|593676386|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
164355431|NCT01156311|593676387|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
164355432|NCT01156311|593676388|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
164355433|NCT01156311|593676389|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
164355434|NCT01156311|593676386|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
164355435|NCT01156311|593676387|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
164355436|NCT01156311|593676388|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
164355437|NCT01156311|593676389|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
164355438|NCT01156311|593676386|FG000|6-month Add-on Therapy Period|Other|0|||
164355439|NCT01156311|593676387|FG001|6-month Add-on Therapy Period|Other|0|||
164355440|NCT01156311|593676388|FG002|6-month Add-on Therapy Period|Other|1|||
164355441|NCT01156311|593676389|FG003|6-month Add-on Therapy Period|Other|2|||
164355442|NCT06133348|593676392|FG000|Overall Study|Death|3|||
164355443|NCT06133348|593676392|FG000|Overall Study|Lost to Follow-up|1|||
164355444|NCT06133348|593676392|FG000|Overall Study|Physician Decision|1|||
164355445|NCT06133348|593676392|FG000|Overall Study|Withdrawal by Subject|5|||
164355446|NCT02393547|593676395|FG000|Overall Study|Adverse Event|2|||
164355447|NCT02393547|593676395|FG000|Overall Study|Withdrawal by Subject|3|||
164355448|NCT02393547|593676395|FG000|Overall Study|Lost to Follow-up|1|||
164355449|NCT00429104|593676397|FG000|Overall Study|Protocol Violation|1|||
164355450|NCT04997161|593676414|FG000|Overall Study|Study terminated by sponsor|3|||
164355451|NCT00752232|593676415|FG000|Overall Study|Protocol Violation|0|||
164355452|NCT00752232|593676416|FG001|Overall Study|Protocol Violation|0|||
164355453|NCT00752232|593676417|FG002|Overall Study|Protocol Violation|0|||
164355454|NCT00752232|593676418|FG003|Overall Study|Protocol Violation|0|||
164355455|NCT00752232|593676419|FG004|Overall Study|Protocol Violation|0|||
164355456|NCT00752232|593676420|FG005|Overall Study|Protocol Violation|1|||
164355457|NCT00752232|593676421|FG006|Overall Study|Protocol Violation|0|||
164355458|NCT00752232|593676415|FG000|Overall Study|Caregiver request|2|||
164355459|NCT00752232|593676416|FG001|Overall Study|Caregiver request|0|||
164355460|NCT00752232|593676417|FG002|Overall Study|Caregiver request|0|||
164355461|NCT00752232|593676418|FG003|Overall Study|Caregiver request|0|||
164355462|NCT00752232|593676419|FG004|Overall Study|Caregiver request|1|||
164355463|NCT00752232|593676420|FG005|Overall Study|Caregiver request|0|||
164355464|NCT00752232|593676421|FG006|Overall Study|Caregiver request|0|||
164355465|NCT00752232|593676415|FG000|Overall Study|Investigator request|0|||
164355466|NCT00752232|593676416|FG001|Overall Study|Investigator request|0|||
164355467|NCT00752232|593676417|FG002|Overall Study|Investigator request|0|||
164355468|NCT00752232|593676418|FG003|Overall Study|Investigator request|0|||
164355469|NCT00752232|593676419|FG004|Overall Study|Investigator request|1|||
164355470|NCT00752232|593676420|FG005|Overall Study|Investigator request|0|||
164355471|NCT00752232|593676421|FG006|Overall Study|Investigator request|0|||
164355472|NCT00752232|593676415|FG000|Overall Study|Subject request|0|||
164355473|NCT00752232|593676416|FG001|Overall Study|Subject request|0|||
164355474|NCT00752232|593676417|FG002|Overall Study|Subject request|1|||
164355475|NCT00752232|593676418|FG003|Overall Study|Subject request|0|||
164355476|NCT00752232|593676419|FG004|Overall Study|Subject request|0|||
164355477|NCT00752232|593676420|FG005|Overall Study|Subject request|0|||
164355478|NCT00752232|593676421|FG006|Overall Study|Subject request|0|||
164355479|NCT00752232|593676415|FG000|Overall Study|Group home admission|0|||
164355480|NCT00752232|593676416|FG001|Overall Study|Group home admission|0|||
164355481|NCT00752232|593676417|FG002|Overall Study|Group home admission|0|||
164355482|NCT00752232|593676418|FG003|Overall Study|Group home admission|1|||
164355483|NCT00752232|593676419|FG004|Overall Study|Group home admission|0|||
164355484|NCT00752232|593676420|FG005|Overall Study|Group home admission|0|||
164355485|NCT00752232|593676421|FG006|Overall Study|Group home admission|0|||
164355486|NCT00752232|593676415|FG000|Overall Study|Caregiver could not attend the subject|0|||
164355487|NCT00752232|593676416|FG001|Overall Study|Caregiver could not attend the subject|0|||
164355488|NCT00752232|593676417|FG002|Overall Study|Caregiver could not attend the subject|0|||
164355489|NCT00752232|593676418|FG003|Overall Study|Caregiver could not attend the subject|0|||
164355490|NCT00752232|593676419|FG004|Overall Study|Caregiver could not attend the subject|1|||
164355491|NCT00752232|593676420|FG005|Overall Study|Caregiver could not attend the subject|0|||
164355492|NCT00752232|593676421|FG006|Overall Study|Caregiver could not attend the subject|0|||
164355493|NCT04502589|593676422|FG000|Overall Study|Physician Decision|1|||
164355494|NCT04502589|593676423|FG001|Overall Study|Physician Decision|0|||
164355495|NCT02730455|593676425|FG000|Overall Study|Death|5|||
164355496|NCT02730455|593676426|FG001|Overall Study|Death|6|||
164355497|NCT02730455|593676427|FG002|Overall Study|Death|4|||
164437133|NCT00603447|593966509|FG001|Overall Study|Other|0|||
164437134|NCT00603447|593966510|FG002|Overall Study|Other|1|||
164437135|NCT00603447|593966511|FG003|Overall Study|Other|0|||
164437136|NCT00603447|593966512|FG004|Overall Study|Other|3|||
164437137|NCT00603447|593966513|FG005|Overall Study|Other|0|||
164437138|NCT00603447|593966514|FG006|Overall Study|Other|13|||
164437139|NCT00603447|593966508|FG000|Overall Study|Withdrew Consent|0|||
164437140|NCT00603447|593966509|FG001|Overall Study|Withdrew Consent|2|||
164437141|NCT00603447|593966510|FG002|Overall Study|Withdrew Consent|0|||
164437142|NCT00603447|593966511|FG003|Overall Study|Withdrew Consent|0|||
164437143|NCT00603447|593966512|FG004|Overall Study|Withdrew Consent|1|||
164437144|NCT00603447|593966513|FG005|Overall Study|Withdrew Consent|0|||
164437145|NCT00603447|593966514|FG006|Overall Study|Withdrew Consent|1|||
164437146|NCT00798265|593966515|FG000|Overall Study|Lost to Follow-up|1|||
164437147|NCT00798265|593966516|FG001|Overall Study|Lost to Follow-up|10|||
164437148|NCT00798265|593966515|FG000|Overall Study|Study closing|7|||
164437149|NCT00798265|593966516|FG001|Overall Study|Study closing|6|||
164437150|NCT00798265|593966515|FG000|Overall Study|Withdrawal by Subject|0|||
164437151|NCT00798265|593966516|FG001|Overall Study|Withdrawal by Subject|1|||
164437152|NCT00798265|593966515|FG000|Overall Study|Screen failure|0|||
164437153|NCT00798265|593966516|FG001|Overall Study|Screen failure|1|||
164437154|NCT01066923|593966517|FG000|Overall Study|Withdrawal by Subject|3|||
164437155|NCT01066923|593966518|FG001|Overall Study|Withdrawal by Subject|3|||
164437156|NCT01066923|593966519|FG002|Overall Study|Withdrawal by Subject|8|||
164437157|NCT01066923|593966520|FG003|Overall Study|Withdrawal by Subject|8|||
164437158|NCT03538041|593968090|FG000|12-Week Treatment Period|Adverse Event|1|||
164437159|NCT03538041|593968091|FG001|12-Week Treatment Period|Adverse Event|1|||
164437160|NCT03538041|593968090|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
164437161|NCT03538041|593968091|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
164437162|NCT03538041|593968090|FG000|Treatment Extension Period|Adverse Event|4|||
164437163|NCT03538041|593968091|FG001|Treatment Extension Period|Adverse Event|1|||
164437164|NCT03538041|593968090|FG000|Treatment Extension Period|Physician Decision|1|||
164437165|NCT03538041|593968091|FG001|Treatment Extension Period|Physician Decision|1|||
164437166|NCT03538041|593968090|FG000|Treatment Extension Period|Lack of Efficacy|1|||
164437167|NCT03538041|593968091|FG001|Treatment Extension Period|Lack of Efficacy|4|||
164437168|NCT03538041|593968090|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
164437169|NCT03538041|593968091|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
164437170|NCT03538041|593968090|FG000|Treatment Extension Period|Death|0|||
164437171|NCT03538041|593968091|FG001|Treatment Extension Period|Death|1|||
164437172|NCT00094809|593968092|FG000|Overall Study|Protocol deviation|2|||
164437173|NCT00094809|593968093|FG001|Overall Study|Protocol deviation|2|||
164437174|NCT00094809|593968092|FG000|Overall Study|Noncompliance|1|||
164437175|NCT00094809|593968093|FG001|Overall Study|Noncompliance|0|||
164437176|NCT00094809|593968092|FG000|Overall Study|Adverse Event|3|||
164437177|NCT00094809|593968093|FG001|Overall Study|Adverse Event|1|||
164437178|NCT00094809|593968092|FG000|Overall Study|Withdrawal by Subject|8|||
164437179|NCT00094809|593968093|FG001|Overall Study|Withdrawal by Subject|9|||
164437180|NCT00094809|593968092|FG000|Overall Study|Disease progression|3|||
164437181|NCT00094809|593968093|FG001|Overall Study|Disease progression|3|||
164437182|NCT00094809|593968092|FG000|Overall Study|Physician Decision|3|||
164437183|NCT00094809|593968093|FG001|Overall Study|Physician Decision|5|||
164437184|NCT00094809|593968092|FG000|Overall Study|Lost to Follow-up|6|||
164437185|NCT00094809|593968093|FG001|Overall Study|Lost to Follow-up|6|||
164437186|NCT00094809|593968092|FG000|Overall Study|Death|19|||
164437187|NCT00094809|593968093|FG001|Overall Study|Death|25|||
164437188|NCT00094809|593968092|FG000|Overall Study|Protocol-specified criteria|1|||
164437189|NCT00094809|593968093|FG001|Overall Study|Protocol-specified criteria|1|||
164437190|NCT00094809|593968092|FG000|Overall Study|Other|2|||
164437191|NCT00094809|593968093|FG001|Overall Study|Other|4|||
164589054|NCT01070550|594521372|FG000|Overall Study|Adverse Event|43|||
164437192|NCT00094809|593968092|FG000|Overall Study|Informed consent signed after treatment|1|||
164437193|NCT00094809|593968093|FG001|Overall Study|Informed consent signed after treatment|0|||
164437194|NCT00094809|593968092|FG000|Overall Study|Study drug not received|2|||
164437195|NCT00094809|593968093|FG001|Overall Study|Study drug not received|8|||
164437196|NCT00094809|593968092|FG000|Overall Study|Other|1|||
164437197|NCT00094809|593968093|FG001|Overall Study|Other|1|||
164437198|NCT02046616|593968104|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
164437199|NCT02046616|593968104|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
164437200|NCT02046616|593968104|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
164437201|NCT02046616|593968104|FG000|24-Week Treatment Period|Physician Decision|3|||
164588958|NCT03894904|594519298|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
164437202|NCT02046616|593968104|FG000|24-Week Treatment Period|Other|1|||
164437203|NCT02046616|593968104|FG000|8-Week FU Period|Lost to Follow-up|1|||
164437204|NCT01563354|593968107|FG000|Core Phase|Adverse Event|5|||
164437205|NCT01563354|593968108|FG001|Core Phase|Adverse Event|15|||
164437206|NCT01563354|593968109|FG002|Core Phase|Adverse Event|13|||
164437207|NCT01563354|593968107|FG000|Core Phase|Withdrawal by Subject|1|||
164437208|NCT01563354|593968108|FG001|Core Phase|Withdrawal by Subject|0|||
164437209|NCT01563354|593968109|FG002|Core Phase|Withdrawal by Subject|3|||
164437210|NCT01563354|593968107|FG000|Core Phase|Lost to Follow-up|1|||
164437211|NCT01563354|593968108|FG001|Core Phase|Lost to Follow-up|0|||
164437212|NCT01563354|593968109|FG002|Core Phase|Lost to Follow-up|0|||
164437213|NCT01563354|593968107|FG000|Core Phase|Death|1|||
164437214|NCT01563354|593968108|FG001|Core Phase|Death|5|||
164437215|NCT01563354|593968109|FG002|Core Phase|Death|2|||
164437216|NCT01563354|593968107|FG000|Core Phase|Diseasse progression|18|||
164437217|NCT01563354|593968108|FG001|Core Phase|Diseasse progression|7|||
164437218|NCT01563354|593968109|FG002|Core Phase|Diseasse progression|8|||
164437219|NCT01563354|593968107|FG000|Core Phase|Protocol deviation|2|||
164437220|NCT01563354|593968108|FG001|Core Phase|Protocol deviation|0|||
164437221|NCT01563354|593968109|FG002|Core Phase|Protocol deviation|0|||
164437222|NCT01563354|593968107|FG000|Core Phase|PI decision - did not enter extension|0|||
164437223|NCT01563354|593968108|FG001|Core Phase|PI decision - did not enter extension|1|||
164437224|NCT01563354|593968109|FG002|Core Phase|PI decision - did not enter extension|0|||
164437225|NCT01563354|593968107|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
164437226|NCT01563354|593968108|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
164437227|NCT01563354|593968109|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
164437228|NCT01563354|593968107|FG000|Extension Phase|Adverse Event|0|||
164437229|NCT01563354|593968108|FG001|Extension Phase|Adverse Event|3|||
164437230|NCT01563354|593968109|FG002|Extension Phase|Adverse Event|2|||
164437231|NCT01563354|593968107|FG000|Extension Phase|Withdrawal by Subject|0|||
164437232|NCT01563354|593968108|FG001|Extension Phase|Withdrawal by Subject|1|||
164437233|NCT01563354|593968109|FG002|Extension Phase|Withdrawal by Subject|0|||
164437234|NCT01563354|593968107|FG000|Extension Phase|Administration problems|3|||
164437235|NCT01563354|593968108|FG001|Extension Phase|Administration problems|2|||
164437236|NCT01563354|593968109|FG002|Extension Phase|Administration problems|3|||
164437237|NCT01563354|593968107|FG000|Extension Phase|Disease progression|9|||
164437238|NCT01563354|593968108|FG001|Extension Phase|Disease progression|8|||
164437239|NCT01563354|593968109|FG002|Extension Phase|Disease progression|10|||
164437240|NCT01988233|593968115|FG000|Overall Study|Lost to Follow-up|64|||
164437241|NCT01988233|593968116|FG001|Overall Study|Lost to Follow-up|51|||
164437242|NCT01689519|593968117|FG000|Intent to Treat|Death|157|||
164437243|NCT01689519|593968118|FG001|Intent to Treat|Death|167|||
164437244|NCT01689519|593968117|FG000|Intent to Treat|Lost to Follow-up|4|||
164437245|NCT01689519|593968118|FG001|Intent to Treat|Lost to Follow-up|8|||
164437246|NCT01689519|593968117|FG000|Intent to Treat|Other|2|||
164437247|NCT01689519|593968118|FG001|Intent to Treat|Other|4|||
164437248|NCT01689519|593968117|FG000|Intent to Treat|Physician Decision|4|||
164437249|NCT01689519|593968118|FG001|Intent to Treat|Physician Decision|1|||
164437250|NCT01689519|593968117|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
164437251|NCT01689519|593968118|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
164437252|NCT01689519|593968117|FG000|Intent to Treat|Withdrawal by Subject|21|||
164437253|NCT01689519|593968118|FG001|Intent to Treat|Withdrawal by Subject|20|||
164437254|NCT01689519|593968117|FG000|Safety Population|Death|158|||
164437255|NCT01689519|593968118|FG001|Safety Population|Death|165|||
164437256|NCT01689519|593968117|FG000|Safety Population|Lost to Follow-up|4|||
164437257|NCT01689519|593968118|FG001|Safety Population|Lost to Follow-up|8|||
164437258|NCT01689519|593968117|FG000|Safety Population|Other|2|||
164437259|NCT01689519|593968118|FG001|Safety Population|Other|4|||
164437260|NCT01689519|593968117|FG000|Safety Population|Physician Decision|4|||
164437261|NCT01689519|593968118|FG001|Safety Population|Physician Decision|1|||
164437262|NCT01689519|593968117|FG000|Safety Population|Study Terminated By Sponsor|60|||
164437263|NCT01689519|593968118|FG001|Safety Population|Study Terminated By Sponsor|47|||
164437264|NCT01689519|593968117|FG000|Safety Population|Withdrawal by Subject|20|||
164437265|NCT01689519|593968118|FG001|Safety Population|Withdrawal by Subject|20|||
164437266|NCT01050569|593968120|FG000|Overall Study|Lost to Follow-up|20|||
164437267|NCT01050569|593968121|FG001|Overall Study|Lost to Follow-up|14|||
164437268|NCT01050569|593968122|FG002|Overall Study|Lost to Follow-up|16|||
164437269|NCT01050569|593968120|FG000|Overall Study|Withdrawal by Subject|9|||
164437270|NCT01050569|593968121|FG001|Overall Study|Withdrawal by Subject|3|||
164437271|NCT01050569|593968122|FG002|Overall Study|Withdrawal by Subject|11|||
164437272|NCT01050569|593968120|FG000|Overall Study|Lack of Efficacy|5|||
164437273|NCT01050569|593968121|FG001|Overall Study|Lack of Efficacy|4|||
164437274|NCT01050569|593968122|FG002|Overall Study|Lack of Efficacy|3|||
164437275|NCT01050569|593968120|FG000|Overall Study|Adverse Event|1|||
164437276|NCT01050569|593968121|FG001|Overall Study|Adverse Event|0|||
164437277|NCT01050569|593968122|FG002|Overall Study|Adverse Event|0|||
164437278|NCT01050569|593968120|FG000|Overall Study|Physician Decision|3|||
164437279|NCT01050569|593968121|FG001|Overall Study|Physician Decision|3|||
164437280|NCT01050569|593968122|FG002|Overall Study|Physician Decision|3|||
164437281|NCT03525119|593968123|FG000|Overall Study|Adverse Event|0|||
164437282|NCT03525119|593968124|FG001|Overall Study|Adverse Event|1|||
164299625|NCT00360230|593472861|FG001|Overall Study|Migrated|1|||
164437283|NCT03525119|593968125|FG002|Overall Study|Adverse Event|0|||
164437284|NCT03525119|593968123|FG000|Overall Study|Lost to Follow-up|32|||
164437285|NCT03525119|593968124|FG001|Overall Study|Lost to Follow-up|33|||
164437286|NCT03525119|593968125|FG002|Overall Study|Lost to Follow-up|37|||
164437287|NCT03525119|593968123|FG000|Overall Study|Withdrawal by Subject|5|||
164437288|NCT03525119|593968124|FG001|Overall Study|Withdrawal by Subject|4|||
164437289|NCT03525119|593968125|FG002|Overall Study|Withdrawal by Subject|2|||
164437290|NCT03525119|593968123|FG000|Overall Study|Reason not Specified|2|||
164437291|NCT03525119|593968124|FG001|Overall Study|Reason not Specified|1|||
164437292|NCT03525119|593968125|FG002|Overall Study|Reason not Specified|2|||
164437293|NCT03525119|593968123|FG000|Overall Study|Randomized but not Vaccinated|1|||
164437294|NCT03525119|593968124|FG001|Overall Study|Randomized but not Vaccinated|0|||
164437295|NCT03525119|593968125|FG002|Overall Study|Randomized but not Vaccinated|2|||
164437296|NCT05046132|593968126|FG000|Overall Study|Adverse Event|4|||
164437297|NCT05046132|593968127|FG001|Overall Study|Adverse Event|0|||
164694612|NCT00442546|594903088|FG002|Overall Study|Other|6|||
164437298|NCT05046132|593968128|FG002|Overall Study|Adverse Event|0|||
164437299|NCT05046132|593968126|FG000|Overall Study|Withdrawal by Subject|3|||
164437300|NCT05046132|593968127|FG001|Overall Study|Withdrawal by Subject|0|||
164437301|NCT05046132|593968128|FG002|Overall Study|Withdrawal by Subject|0|||
164437302|NCT05046132|593968126|FG000|Overall Study|Positive Covid19 Result.|0|||
164437303|NCT05046132|593968127|FG001|Overall Study|Positive Covid19 Result.|1|||
164437304|NCT05046132|593968128|FG002|Overall Study|Positive Covid19 Result.|0|||
164437305|NCT01959412|593968129|FG000|Overall Study|Protocol deviation|1|||
164437306|NCT01959412|593968130|FG001|Overall Study|Protocol deviation|1|||
164437307|NCT01959412|593968131|FG002|Overall Study|Protocol deviation|0|||
164437308|NCT01959412|593968132|FG003|Overall Study|Protocol deviation|1|||
164437309|NCT01959412|593968133|FG004|Overall Study|Protocol deviation|3|||
164437310|NCT01959412|593968134|FG005|Overall Study|Protocol deviation|0|||
164437311|NCT01959412|593968129|FG000|Overall Study|Adverse Event|0|||
164437312|NCT01959412|593968130|FG001|Overall Study|Adverse Event|0|||
164437313|NCT01959412|593968131|FG002|Overall Study|Adverse Event|0|||
164437314|NCT01959412|593968132|FG003|Overall Study|Adverse Event|1|||
164437315|NCT01959412|593968133|FG004|Overall Study|Adverse Event|0|||
164437316|NCT01959412|593968134|FG005|Overall Study|Adverse Event|0|||
164437317|NCT01186848|593968135|FG000|Overall Study|Lost to Follow-up|4|||
164437318|NCT01186848|593968135|FG000|Overall Study|Withdrawal by Subject|2|||
164437319|NCT01186848|593968135|FG000|Overall Study|Adverse Event|2|||
164437320|NCT00770965|593968150|FG000|Safety Set|Withdrawal by Subject|0|||
164437321|NCT00770965|593968151|FG001|Safety Set|Withdrawal by Subject|0|||
164437322|NCT00770965|593968152|FG002|Safety Set|Withdrawal by Subject|0|||
164437323|NCT00770965|593968153|FG003|Safety Set|Withdrawal by Subject|1|||
164437324|NCT00770965|593968150|FG000|Safety Set|Protocol deviation|0|||
164437325|NCT00770965|593968151|FG001|Safety Set|Protocol deviation|0|||
164437326|NCT00770965|593968152|FG002|Safety Set|Protocol deviation|1|||
164437327|NCT00770965|593968153|FG003|Safety Set|Protocol deviation|0|||
164437328|NCT00770965|593968150|FG000|Excluded Set|Administrative problems|14|||
164437329|NCT00770965|593968151|FG001|Excluded Set|Administrative problems|12|||
164437330|NCT00770965|593968152|FG002|Excluded Set|Administrative problems|12|||
164437331|NCT00770965|593968153|FG003|Excluded Set|Administrative problems|10|||
164437332|NCT00770965|593968150|FG000|Excluded Set|Withdrawal by Subject|1|||
164437333|NCT00770965|593968151|FG001|Excluded Set|Withdrawal by Subject|1|||
164437334|NCT00770965|593968152|FG002|Excluded Set|Withdrawal by Subject|2|||
164437335|NCT00770965|593968153|FG003|Excluded Set|Withdrawal by Subject|3|||
164437336|NCT00509769|593968154|FG000|Overall Study|Progressive disease|77|||
164437337|NCT00509769|593968154|FG000|Overall Study|Adverse Event|4|||
164437338|NCT00509769|593968154|FG000|Overall Study|Patient's decision|1|||
164437339|NCT00509769|593968154|FG000|Overall Study|Physician Decision|8|||
164437340|NCT00509769|593968154|FG000|Overall Study|Use of prohibited therapies during study|1|||
164437341|NCT00414648|593968155|FG000|Overall Study|Adverse Event|5|||
164437342|NCT00414648|593968156|FG001|Overall Study|Adverse Event|5|||
164437343|NCT00414648|593968155|FG000|Overall Study|Death|0|||
164437344|NCT00414648|593968156|FG001|Overall Study|Death|1|||
164437345|NCT00414648|593968155|FG000|Overall Study|Lack of Efficacy|0|||
164437346|NCT00414648|593968156|FG001|Overall Study|Lack of Efficacy|2|||
164437347|NCT00414648|593968155|FG000|Overall Study|Withdrawal by Subject|0|||
164437348|NCT00414648|593968156|FG001|Overall Study|Withdrawal by Subject|1|||
164437349|NCT02371746|593968157|FG000|Overall Study|Consent withdrawn|0|||
164437350|NCT02371746|593968158|FG001|Overall Study|Consent withdrawn|0|||
164437351|NCT02371746|593968159|FG002|Overall Study|Consent withdrawn|0|||
164437352|NCT02371746|593968160|FG003|Overall Study|Consent withdrawn|0|||
164437353|NCT02371746|593968161|FG004|Overall Study|Consent withdrawn|0|||
164437354|NCT02371746|593968162|FG005|Overall Study|Consent withdrawn|0|||
164437355|NCT02371746|593968163|FG006|Overall Study|Consent withdrawn|1|||
164437356|NCT00754936|593968164|FG000|Overall Study|Lost to Follow-up|3|||
164437357|NCT00754936|593968164|FG000|Overall Study|Physician Decision|1|||
164437358|NCT00754936|593968164|FG000|Overall Study|Withdrawal by Subject|2|||
164437359|NCT00754936|593968164|FG000|Overall Study|Side Effects|3|||
164437360|NCT00754936|593968164|FG000|Overall Study|Inter-current medical events|3|||
164437361|NCT00436644|593968165|FG000|Overall Study|Adverse Event|2|||
164437362|NCT00436644|593968165|FG000|Overall Study|Death|1|||
164437363|NCT04364269|593968170|FG000|Overall Study|Adverse Event|1|||
164694613|NCT00442546|594903086|FG000|Overall Study|Withdrawal by Subject|5|||
164694614|NCT00442546|594903087|FG001|Overall Study|Withdrawal by Subject|5|||
164437364|NCT04364269|593968171|FG001|Overall Study|Adverse Event|0|||
164437365|NCT04364269|593968172|FG002|Overall Study|Adverse Event|0|||
164437366|NCT04364269|593968170|FG000|Overall Study|Withdrawal by Subject|0|||
164437367|NCT04364269|593968171|FG001|Overall Study|Withdrawal by Subject|1|||
164355498|NCT02730455|593676425|FG000|Overall Study|Consent withdrawn|2|||
164355499|NCT02730455|593676426|FG001|Overall Study|Consent withdrawn|4|||
164355500|NCT02730455|593676427|FG002|Overall Study|Consent withdrawn|1|||
164355501|NCT02730455|593676425|FG000|Overall Study|Lost to Follow-up|3|||
164355502|NCT02730455|593676426|FG001|Overall Study|Lost to Follow-up|1|||
164355503|NCT02730455|593676427|FG002|Overall Study|Lost to Follow-up|4|||
164355504|NCT02730455|593676425|FG000|Overall Study|Other|1|||
164355505|NCT02730455|593676426|FG001|Overall Study|Other|1|||
164355506|NCT02730455|593676427|FG002|Overall Study|Other|2|||
164355507|NCT02730455|593676425|FG000|Overall Study|Other|2|||
164355508|NCT02730455|593676426|FG001|Overall Study|Other|2|||
164355509|NCT02730455|593676427|FG002|Overall Study|Other|0|||
164355510|NCT02733367|593676428|FG000|Overall Study|Withdrawal by Subject|6|||
164355511|NCT01922089|593676431|FG000|Overall Study|Adverse Event|18|||
164355512|NCT01922089|593676432|FG001|Overall Study|Adverse Event|13|||
164355513|NCT01922089|593676431|FG000|Overall Study|Protocol Deviation|10|||
164355514|NCT01922089|593676432|FG001|Overall Study|Protocol Deviation|7|||
164355515|NCT01922089|593676431|FG000|Overall Study|Withdrawal by Subject|3|||
164355516|NCT01922089|593676432|FG001|Overall Study|Withdrawal by Subject|4|||
164355517|NCT01922089|593676431|FG000|Overall Study|administrative problems|4|||
164355518|NCT01922089|593676432|FG001|Overall Study|administrative problems|1|||
164355519|NCT01922089|593676431|FG000|Overall Study|Physician Decision|2|||
164355520|NCT01922089|593676432|FG001|Overall Study|Physician Decision|3|||
164355521|NCT01922089|593676431|FG000|Overall Study|Death|2|||
164355522|NCT01922089|593676432|FG001|Overall Study|Death|1|||
164355523|NCT01922089|593676431|FG000|Overall Study|Lost to Follow-up|0|||
164355524|NCT01922089|593676432|FG001|Overall Study|Lost to Follow-up|1|||
164355525|NCT05582889|593676434|FG000|Overall Study|Health event|3|||
164355526|NCT05582889|593676435|FG001|Overall Study|Health event|2|||
164355527|NCT05582889|593676434|FG000|Overall Study|Lost to Follow-up|2|||
164355528|NCT05582889|593676435|FG001|Overall Study|Lost to Follow-up|4|||
164355529|NCT00001723|593676436|FG000|Overall Study|Lack of Efficacy|6|||
164355530|NCT00001723|593676437|FG001|Overall Study|Lack of Efficacy|7|||
164355531|NCT00001723|593676436|FG000|Overall Study|Lack of family interest|4|||
164355532|NCT00001723|593676437|FG001|Overall Study|Lack of family interest|5|||
164355533|NCT00001723|593676436|FG000|Overall Study|Lost to Follow-up|2|||
164355534|NCT00001723|593676437|FG001|Overall Study|Lost to Follow-up|2|||
164355535|NCT00001723|593676436|FG000|Overall Study|medication intolerance|1|||
164355536|NCT00001723|593676437|FG001|Overall Study|medication intolerance|2|||
164355537|NCT02170051|593676438|FG000|Overall Study|Withdrawal by Subject|10|||
164355538|NCT02170051|593676439|FG001|Overall Study|Withdrawal by Subject|10|||
164355539|NCT02170051|593676438|FG000|Overall Study|Lost to Follow-up|1|||
164355540|NCT02170051|593676439|FG001|Overall Study|Lost to Follow-up|3|||
164355541|NCT04551092|593676440|FG000|Overall Study|Lost to Follow-up|7|||
164355542|NCT04551092|593676440|FG000|Overall Study|Withdrawal by Subject|4|||
164355543|NCT01324999|593676441|FG000|Overall Study|Adverse Event|3|||
164355544|NCT01324999|593676441|FG000|Overall Study|Withdrawal by Subject|2|||
164355545|NCT01712490|593676442|FG000|Overall Study|Ongoing|601|||
164355546|NCT01712490|593676443|FG001|Overall Study|Ongoing|586|||
164355547|NCT01712490|593676442|FG000|Overall Study|Other|11|||
164355548|NCT01712490|593676443|FG001|Overall Study|Other|11|||
164355549|NCT01712490|593676442|FG000|Overall Study|Withdrawal by Subject|36|||
164355550|NCT01712490|593676443|FG001|Overall Study|Withdrawal by Subject|44|||
164355551|NCT01712490|593676442|FG000|Overall Study|Lost to Follow-up|16|||
164355552|NCT01712490|593676443|FG001|Overall Study|Lost to Follow-up|29|||
164355553|NCT01714635|593676456|FG000|Overall Study|Discontinued|1|||
164355554|NCT01714635|593676457|FG001|Overall Study|Discontinued|0|||
164355555|NCT01714635|593676458|FG002|Overall Study|Discontinued|2|||
164355556|NCT01714635|593676456|FG000|Overall Study|Missed 6-month exam|1|||
164355557|NCT01714635|593676457|FG001|Overall Study|Missed 6-month exam|0|||
164355558|NCT01714635|593676458|FG002|Overall Study|Missed 6-month exam|0|||
164355559|NCT02860169|593676459|FG000|Part A|Withdrawal by Subject|1|||
164355560|NCT02860169|593676459|FG000|Part A|Other (Screening failure)|6|||
164355561|NCT02860169|593676459|FG000|Part A|Other (Survey not completed)|3|||
164355562|NCT02860169|593676459|FG000|Part A|Other (did not completed consent)|1|||
164355563|NCT02860169|593676459|FG000|Part B|Other (Screening failure)|10|||
164355564|NCT02860169|593676459|FG000|Part B|Withdrawal by Subject|1|||
164355565|NCT02860169|593676459|FG000|Part C|Other (Screening failure)|1|||
164355566|NCT01782495|593676460|FG000|Overall Study|Adverse Event|0|||
164355567|NCT01782495|593676461|FG001|Overall Study|Adverse Event|0|||
164355568|NCT01782495|593676462|FG002|Overall Study|Adverse Event|0|||
164355569|NCT01782495|593676463|FG003|Overall Study|Adverse Event|0|||
164355570|NCT01782495|593676464|FG004|Overall Study|Adverse Event|0|||
164355571|NCT01782495|593676465|FG005|Overall Study|Adverse Event|0|||
164355572|NCT01782495|593676466|FG006|Overall Study|Adverse Event|0|||
164355573|NCT01782495|593676467|FG007|Overall Study|Adverse Event|2|||
164355574|NCT01782495|593676468|FG008|Overall Study|Adverse Event|0|||
164355575|NCT01782495|593676469|FG009|Overall Study|Adverse Event|0|||
164437368|NCT04364269|593968172|FG002|Overall Study|Withdrawal by Subject|0|||
164437369|NCT04173572|593968173|FG000|Overall Study|Withdrawal by Subject|1|||
164437370|NCT04173572|593968174|FG001|Overall Study|Withdrawal by Subject|5|||
164437371|NCT04173572|593968173|FG000|Overall Study|Lost to Follow-up|3|||
164437372|NCT04173572|593968174|FG001|Overall Study|Lost to Follow-up|1|||
164437373|NCT01490580|593968175|FG000|Overall Study|Parents withdrew consent|0|||
164437374|NCT01490580|593968176|FG001|Overall Study|Parents withdrew consent|2|||
164437375|NCT03478696|593968179|FG000|Overall Study|Adverse Event|1|||
164437376|NCT03478696|593968180|FG001|Overall Study|Adverse Event|5|||
164437377|NCT03478696|593968179|FG000|Overall Study|Lost to Follow-up|1|||
164437378|NCT03478696|593968180|FG001|Overall Study|Lost to Follow-up|0|||
164437379|NCT03478696|593968179|FG000|Overall Study|Physician Decision|6|||
164437380|NCT03478696|593968180|FG001|Overall Study|Physician Decision|3|||
164437381|NCT03478696|593968179|FG000|Overall Study|Withdrawal by Subject|9|||
164437382|NCT03478696|593968180|FG001|Overall Study|Withdrawal by Subject|4|||
164437383|NCT01104415|593968181|FG000|Core Phase|Consent withdrawn by subjects|1|||
164437384|NCT01104415|593968182|FG001|Core Phase|Consent withdrawn by subjects|0|||
164437385|NCT01104415|593968181|FG000|Extension Period|Progressive disease|0|||
164437386|NCT01104415|593968182|FG001|Extension Period|Progressive disease|4|||
164437387|NCT01104415|593968181|FG000|Extension Period|Death|0|||
164437388|NCT01104415|593968182|FG001|Extension Period|Death|1|||
164437389|NCT01104415|593968181|FG000|Extension Period|Physician Decision|0|||
164437390|NCT01104415|593968182|FG001|Extension Period|Physician Decision|1|||
164437391|NCT01104415|593968181|FG000|Extension Period|Transition to Study LX1606.302|0|||
164437392|NCT01104415|593968182|FG001|Extension Period|Transition to Study LX1606.302|4|||
164437393|NCT01104415|593968181|FG000|Extension Period|Heart surgery/feeling miserable|0|||
164437394|NCT01104415|593968182|FG001|Extension Period|Heart surgery/feeling miserable|1|||
164437395|NCT02914522|593968183|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
164437396|NCT02914522|593968184|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
164437397|NCT02914522|593968185|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
164437398|NCT02914522|593968186|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
164437399|NCT02914522|593968187|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
164437400|NCT02914522|593968188|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
164437401|NCT02914522|593968189|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
164437402|NCT02914522|593968190|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
164437403|NCT02914522|593968191|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
164299626|NCT00360230|593472862|FG002|Overall Study|Migrated|3|||
164437404|NCT02914522|593968192|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
164437405|NCT02914522|593968193|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
164437406|NCT02914522|593968183|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
164437407|NCT02914522|593968184|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
164437408|NCT02914522|593968185|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
164437409|NCT02914522|593968186|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
164588959|NCT03894904|594519297|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
164437410|NCT02914522|593968187|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
164437411|NCT02914522|593968188|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
164299627|NCT00360230|593472863|FG003|Overall Study|Migrated|1|||
164299628|NCT00360230|593472864|FG004|Overall Study|Migrated|4|||
164299629|NCT00360230|593472865|FG005|Overall Study|Migrated|1|||
164299630|NCT00360230|593472866|FG006|Overall Study|Migrated|1|||
164437412|NCT02914522|593968189|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
164437413|NCT02914522|593968190|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
164437414|NCT02914522|593968191|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
164437415|NCT02914522|593968192|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
164437416|NCT02914522|593968193|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
164437417|NCT02914522|593968183|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
164437418|NCT02914522|593968184|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
164437419|NCT02914522|593968185|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
164437420|NCT02914522|593968186|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
164299631|NCT00360230|593472860|FG000|Overall Study|Other|1|||
164299632|NCT00360230|593472861|FG001|Overall Study|Other|0|||
164355576|NCT01782495|593676470|FG010|Overall Study|Adverse Event|0|||
164355577|NCT01782495|593676460|FG000|Overall Study|Withdrew Consent|0|||
164355578|NCT01782495|593676461|FG001|Overall Study|Withdrew Consent|1|||
164355579|NCT01782495|593676462|FG002|Overall Study|Withdrew Consent|0|||
164355580|NCT01782495|593676463|FG003|Overall Study|Withdrew Consent|0|||
164355581|NCT01782495|593676464|FG004|Overall Study|Withdrew Consent|0|||
164355582|NCT01782495|593676465|FG005|Overall Study|Withdrew Consent|0|||
164355583|NCT01782495|593676466|FG006|Overall Study|Withdrew Consent|0|||
164355584|NCT01782495|593676467|FG007|Overall Study|Withdrew Consent|1|||
164355585|NCT01782495|593676468|FG008|Overall Study|Withdrew Consent|0|||
164355586|NCT01782495|593676469|FG009|Overall Study|Withdrew Consent|0|||
164355587|NCT01782495|593676470|FG010|Overall Study|Withdrew Consent|0|||
164355588|NCT00396591|593676475|FG000|Overall Study|Disease Progression|13|||
164355589|NCT00396591|593676475|FG000|Overall Study|Adverse Event|2|||
164355590|NCT00396591|593676475|FG000|Overall Study|Participant request|1|||
164355591|NCT01962207|593676476|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
164355592|NCT01962207|593676477|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
164355593|NCT01962207|593676478|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
164355594|NCT01962207|593676479|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
164355595|NCT01962207|593676476|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
164355596|NCT01962207|593676477|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
164355597|NCT01962207|593676478|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
164355598|NCT01962207|593676479|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
164355599|NCT01962207|593676476|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
164355600|NCT01962207|593676477|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
164437421|NCT02914522|593968187|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
164299633|NCT00360230|593472862|FG002|Overall Study|Other|0|||
164299634|NCT00360230|593472863|FG003|Overall Study|Other|0|||
164299635|NCT00360230|593472864|FG004|Overall Study|Other|0|||
164299636|NCT00360230|593472865|FG005|Overall Study|Other|0|||
164299637|NCT00360230|593472866|FG006|Overall Study|Other|0|||
164299638|NCT00360230|593472860|FG000|Overall Study|Protocol Violation|0|||
164299639|NCT00360230|593472861|FG001|Overall Study|Protocol Violation|0|||
164299640|NCT00360230|593472862|FG002|Overall Study|Protocol Violation|0|||
164299641|NCT00360230|593472863|FG003|Overall Study|Protocol Violation|0|||
164299642|NCT00360230|593472864|FG004|Overall Study|Protocol Violation|0|||
164299643|NCT00360230|593472865|FG005|Overall Study|Protocol Violation|1|||
164299644|NCT00360230|593472866|FG006|Overall Study|Protocol Violation|0|||
164299645|NCT00360230|593472860|FG000|Overall Study|Death|0|||
164299646|NCT00360230|593472861|FG001|Overall Study|Death|1|||
164299647|NCT00360230|593472862|FG002|Overall Study|Death|0|||
164299648|NCT00360230|593472863|FG003|Overall Study|Death|0|||
164299649|NCT00360230|593472864|FG004|Overall Study|Death|0|||
164299650|NCT00360230|593472865|FG005|Overall Study|Death|1|||
164299651|NCT00360230|593472866|FG006|Overall Study|Death|1|||
164299652|NCT01052493|593472873|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
164299653|NCT01052493|593472874|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
164299654|NCT01052493|593472875|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
164437422|NCT02914522|593968188|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
164299655|NCT01075243|593472884|FG000|Overall Study|Lost to Follow-up|5|||
164299656|NCT01075243|593472885|FG001|Overall Study|Lost to Follow-up|2|||
164299657|NCT01075243|593472886|FG002|Overall Study|Lost to Follow-up|0|||
164299658|NCT01075243|593472884|FG000|Overall Study|Withdrawal by Subject|1|||
164299659|NCT01075243|593472885|FG001|Overall Study|Withdrawal by Subject|1|||
164437468|NCT02914522|593968190|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
164589204|NCT01070550|594521372|FG000|Overall Study|Withdrawal by Subject|35|||
164589205|NCT01070550|594521373|FG001|Overall Study|Withdrawal by Subject|0|||
164589206|NCT01070550|594521374|FG002|Overall Study|Withdrawal by Subject|3|||
164589207|NCT01070550|594521375|FG003|Overall Study|Withdrawal by Subject|0|||
164589208|NCT01070550|594521376|FG004|Overall Study|Withdrawal by Subject|0|||
164589209|NCT01070550|594521377|FG005|Overall Study|Withdrawal by Subject|0|||
164589210|NCT01585961|594521379|FG000|Overall Study|Death|6|||
164589211|NCT01585961|594521379|FG000|Overall Study|Physician Decision|1|||
164589212|NCT01585961|594521379|FG000|Overall Study|Decision to use non-study catheter|1|||
164589213|NCT01585961|594521379|FG000|Overall Study|Withdrawal by Subject|1|||
164589214|NCT01585961|594521379|FG000|Overall Study|Lost to Follow-up|23|||
164437469|NCT02914522|593968191|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
164589215|NCT01585961|594521379|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
164355673|NCT03720470|593678625|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
164355674|NCT03720470|593678626|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
164355675|NCT03720470|593678627|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
164589216|NCT01258348|594521380|FG000|Overall Study|Adverse Event|1|||
164355676|NCT03720470|593678628|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
164355677|NCT03720470|593678629|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
164355678|NCT03720470|593678630|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
164355679|NCT03720470|593678625|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
164355680|NCT03720470|593678626|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
164355681|NCT03720470|593678627|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
164355682|NCT03720470|593678628|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
164355683|NCT03720470|593678629|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
164355684|NCT03720470|593678630|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
164355685|NCT03720470|593678625|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
164355686|NCT03720470|593678626|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
164355687|NCT03720470|593678627|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
164355688|NCT03720470|593678628|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
164437470|NCT02914522|593968192|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
164437471|NCT02914522|593968193|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
164437472|NCT02914522|593968183|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
164437473|NCT02914522|593968184|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
164437474|NCT02914522|593968185|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
164437475|NCT02914522|593968186|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
164437476|NCT02914522|593968187|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
164437477|NCT02914522|593968188|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
164437478|NCT02914522|593968189|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
164437479|NCT02914522|593968190|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
164437480|NCT02914522|593968191|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
164437481|NCT02914522|593968192|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
164437482|NCT02914522|593968193|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
164437483|NCT02914522|593968183|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
164437484|NCT02914522|593968184|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
164437485|NCT02914522|593968185|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
164437486|NCT02914522|593968186|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
164437487|NCT02914522|593968187|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
164437488|NCT02914522|593968188|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
164437489|NCT02914522|593968189|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
164437490|NCT02914522|593968190|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
164437491|NCT02914522|593968191|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
164437492|NCT02914522|593968192|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
164437493|NCT02914522|593968193|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
164437494|NCT02914522|593968183|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
164694677|NCT01546142|594905312|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
164694678|NCT01546142|594905313|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
164694679|NCT01546142|594905312|FG000|Overall Study|Subject Randomized but Not Treated|1|||
164694680|NCT01546142|594905313|FG001|Overall Study|Subject Randomized but Not Treated|0|||
164694681|NCT01213836|594905314|FG000|Period 1, First Intervention|Adverse Event|2|||
164694682|NCT01213836|594905315|FG001|Period 1, First Intervention|Adverse Event|1|||
164694683|NCT01213836|594905314|FG000|Period 1, First Intervention|Protocol Violation|0|||
164694684|NCT01213836|594905315|FG001|Period 1, First Intervention|Protocol Violation|1|||
164694685|NCT01213836|594905314|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
164694686|NCT01213836|594905315|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
164694687|NCT00706095|594905316|FG000|Overall Study|Progressive Disease|4|||
164694688|NCT00706095|594905317|FG001|Overall Study|Progressive Disease|5|||
164694689|NCT00706095|594905318|FG002|Overall Study|Progressive Disease|3|||
164694690|NCT00706095|594905316|FG000|Overall Study|Clinical Progression|1|||
164694691|NCT00706095|594905317|FG001|Overall Study|Clinical Progression|2|||
164694692|NCT00706095|594905318|FG002|Overall Study|Clinical Progression|2|||
164437495|NCT02914522|593968184|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
164437496|NCT02914522|593968185|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
164437497|NCT02914522|593968186|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
164437498|NCT02914522|593968187|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
164437499|NCT02914522|593968188|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
164437500|NCT02914522|593968189|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
164437501|NCT02914522|593968190|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
164437502|NCT02914522|593968191|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
164437503|NCT02914522|593968192|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
164437504|NCT02914522|593968193|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
164355689|NCT03720470|593678629|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
164355690|NCT03720470|593678630|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
164355691|NCT03720470|593678625|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
164355692|NCT03720470|593678626|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
164355693|NCT03720470|593678627|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
164355694|NCT03720470|593678628|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
164355695|NCT03720470|593678629|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
164355696|NCT03720470|593678630|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
164355697|NCT03720470|593678625|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
164355698|NCT03720470|593678626|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
164355699|NCT03720470|593678627|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
164355700|NCT03720470|593678628|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
164355701|NCT03720470|593678629|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
164355702|NCT03720470|593678630|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
164355703|NCT03720470|593678625|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
164355704|NCT03720470|593678626|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
164355705|NCT03720470|593678627|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
164355706|NCT03720470|593678628|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
164355707|NCT03720470|593678629|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
164355708|NCT03720470|593678630|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
164355709|NCT03720470|593678625|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
164355710|NCT03720470|593678626|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
164355711|NCT03720470|593678627|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
164355712|NCT03720470|593678628|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
164355713|NCT03720470|593678629|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
164355714|NCT03720470|593678630|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
164355715|NCT03720470|593678625|FG000|Treatment Period: Final 4 Weeks|Other|0|||
164355716|NCT03720470|593678626|FG001|Treatment Period: Final 4 Weeks|Other|1|||
164355717|NCT03720470|593678627|FG002|Treatment Period: Final 4 Weeks|Other|0|||
164355718|NCT03720470|593678628|FG003|Treatment Period: Final 4 Weeks|Other|2|||
164355719|NCT03720470|593678629|FG004|Treatment Period: Final 4 Weeks|Other|1|||
164355720|NCT03720470|593678630|FG005|Treatment Period: Final 4 Weeks|Other|0|||
164355721|NCT01988103|593678631|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
164355722|NCT01988103|593678632|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
164355723|NCT01988103|593678633|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
164355724|NCT01988103|593678634|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
164355725|NCT01988103|593678635|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
164355726|NCT01988103|593678631|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
164355727|NCT01988103|593678632|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
164355728|NCT01988103|593678633|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
164355729|NCT01988103|593678634|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
164355730|NCT01988103|593678635|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
164355731|NCT01988103|593678631|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
164355732|NCT01988103|593678632|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
164355733|NCT01988103|593678633|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
164355734|NCT01988103|593678634|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
164355735|NCT01988103|593678635|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
164437505|NCT02914522|593968183|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
164437506|NCT02914522|593968184|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
164589217|NCT01258348|594521381|FG001|Overall Study|Adverse Event|1|||
164589218|NCT01258348|594521382|FG002|Overall Study|Adverse Event|3|||
164589219|NCT01258348|594521383|FG003|Overall Study|Adverse Event|2|||
164589220|NCT01258348|594521384|FG004|Overall Study|Adverse Event|4|||
164589221|NCT01258348|594521380|FG000|Overall Study|Progressive Disease|0|||
164589222|NCT01258348|594521381|FG001|Overall Study|Progressive Disease|3|||
164589223|NCT01258348|594521382|FG002|Overall Study|Progressive Disease|0|||
164589224|NCT01258348|594521383|FG003|Overall Study|Progressive Disease|2|||
164589225|NCT01258348|594521384|FG004|Overall Study|Progressive Disease|2|||
164589226|NCT01258348|594521380|FG000|Overall Study|Physician Decision|0|||
164589227|NCT01258348|594521381|FG001|Overall Study|Physician Decision|0|||
164589228|NCT01258348|594521382|FG002|Overall Study|Physician Decision|0|||
164589229|NCT01258348|594521383|FG003|Overall Study|Physician Decision|2|||
164589230|NCT01258348|594521384|FG004|Overall Study|Physician Decision|0|||
164589231|NCT01258348|594521380|FG000|Overall Study|Withdrawal by Subject|0|||
164437507|NCT02914522|593968185|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
164437508|NCT02914522|593968186|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
164437509|NCT02914522|593968187|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
164437510|NCT02914522|593968188|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
164437511|NCT02914522|593968189|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
164437512|NCT02914522|593968190|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
164589232|NCT01258348|594521381|FG001|Overall Study|Withdrawal by Subject|1|||
164589233|NCT01258348|594521382|FG002|Overall Study|Withdrawal by Subject|0|||
164589234|NCT01258348|594521383|FG003|Overall Study|Withdrawal by Subject|0|||
164589235|NCT01258348|594521384|FG004|Overall Study|Withdrawal by Subject|0|||
164589236|NCT01505491|594521388|FG000|Overall Study|Other reason not listed|1|||
164589237|NCT01505491|594521389|FG001|Overall Study|Other reason not listed|0|||
164589238|NCT01505491|594521390|FG002|Overall Study|Other reason not listed|0|||
164589239|NCT01505491|594521388|FG000|Overall Study|Withdrawal by Subject|1|||
164589240|NCT01505491|594521389|FG001|Overall Study|Withdrawal by Subject|1|||
164589241|NCT01505491|594521390|FG002|Overall Study|Withdrawal by Subject|4|||
164589242|NCT01505491|594521388|FG000|Overall Study|Lost to Follow-up|0|||
164589243|NCT01505491|594521389|FG001|Overall Study|Lost to Follow-up|0|||
164589244|NCT01505491|594521390|FG002|Overall Study|Lost to Follow-up|1|||
164589245|NCT01120093|594521399|FG000|Treatment Period 1|Adverse Event|0|||
164589246|NCT01120093|594521400|FG001|Treatment Period 1|Adverse Event|0|||
164589247|NCT01120093|594521401|FG002|Treatment Period 1|Adverse Event|1|||
164589248|NCT01120093|594521402|FG003|Treatment Period 1|Adverse Event|0|||
164589249|NCT01120093|594521403|FG004|Treatment Period 1|Adverse Event|1|||
164589250|NCT01120093|594521399|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164589251|NCT01120093|594521400|FG001|Treatment Period 1|Withdrawal by Subject|1|||
164589252|NCT01120093|594521401|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164589253|NCT01120093|594521402|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164589254|NCT01120093|594521403|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164589255|NCT01120093|594521399|FG000|Treatment Period 2|Adverse Event|0|||
164589256|NCT01120093|594521400|FG001|Treatment Period 2|Adverse Event|0|||
164589257|NCT01120093|594521401|FG002|Treatment Period 2|Adverse Event|0|||
164589258|NCT01120093|594521402|FG003|Treatment Period 2|Adverse Event|1|||
164589259|NCT01120093|594521403|FG004|Treatment Period 2|Adverse Event|0|||
164589260|NCT01120093|594521399|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164589261|NCT01120093|594521400|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164589262|NCT01120093|594521401|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164589263|NCT01120093|594521402|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164589264|NCT01120093|594521403|FG004|Treatment Period 2|Withdrawal by Subject|1|||
164589265|NCT01120093|594521399|FG000|Treatment Period 3|Lack of Efficacy|0|||
164589266|NCT01120093|594521400|FG001|Treatment Period 3|Lack of Efficacy|0|||
164589267|NCT01120093|594521401|FG002|Treatment Period 3|Lack of Efficacy|0|||
164589268|NCT01120093|594521402|FG003|Treatment Period 3|Lack of Efficacy|1|||
164589269|NCT01120093|594521403|FG004|Treatment Period 3|Lack of Efficacy|0|||
164589270|NCT01120093|594521399|FG000|Treatment Period 3|Adverse Event|0|||
164589271|NCT01120093|594521400|FG001|Treatment Period 3|Adverse Event|0|||
164589272|NCT01120093|594521401|FG002|Treatment Period 3|Adverse Event|0|||
164589273|NCT01120093|594521402|FG003|Treatment Period 3|Adverse Event|0|||
164589274|NCT01120093|594521403|FG004|Treatment Period 3|Adverse Event|1|||
164589275|NCT01120093|594521399|FG000|Treatment Period 3|Withdrawal by Subject|0|||
164355736|NCT01988103|593678631|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
164355737|NCT01988103|593678632|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
164355738|NCT01988103|593678633|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
164355739|NCT01988103|593678634|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
164355740|NCT01988103|593678635|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
164355741|NCT01988103|593678631|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
164355742|NCT01988103|593678632|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
164355743|NCT01988103|593678633|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
164355744|NCT01988103|593678634|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
164355745|NCT01988103|593678635|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
164355746|NCT01988103|593678631|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
164355747|NCT01988103|593678632|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
164355748|NCT01988103|593678633|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
164355749|NCT01988103|593678634|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
164355750|NCT01988103|593678635|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
164437513|NCT02914522|593968191|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
164589276|NCT01120093|594521400|FG001|Treatment Period 3|Withdrawal by Subject|0|||
164589277|NCT01120093|594521401|FG002|Treatment Period 3|Withdrawal by Subject|1|||
164589278|NCT01120093|594521402|FG003|Treatment Period 3|Withdrawal by Subject|0|||
164589279|NCT01120093|594521403|FG004|Treatment Period 3|Withdrawal by Subject|0|||
164589280|NCT01120093|594521399|FG000|Treatment Period 4|Adverse Event|1|||
164589281|NCT01120093|594521400|FG001|Treatment Period 4|Adverse Event|0|||
164589282|NCT01120093|594521401|FG002|Treatment Period 4|Adverse Event|0|||
164589283|NCT01120093|594521402|FG003|Treatment Period 4|Adverse Event|0|||
164589284|NCT01120093|594521403|FG004|Treatment Period 4|Adverse Event|0|||
164589285|NCT01120093|594521399|FG000|Treatment Period 5|Adverse Event|0|||
164589286|NCT01120093|594521400|FG001|Treatment Period 5|Adverse Event|1|||
164589287|NCT01120093|594521401|FG002|Treatment Period 5|Adverse Event|0|||
164589288|NCT01120093|594521402|FG003|Treatment Period 5|Adverse Event|1|||
164589289|NCT01120093|594521403|FG004|Treatment Period 5|Adverse Event|0|||
164589290|NCT03649321|594521408|FG000|Overall Study|Withdrawal by Subject|1|||
164589291|NCT03649321|594521409|FG001|Overall Study|Withdrawal by Subject|0|||
164589292|NCT03649321|594521408|FG000|Overall Study|Death|1|||
164589293|NCT03649321|594521409|FG001|Overall Study|Death|0|||
164589294|NCT01312428|594521410|FG000|Overall Study|Study Termination|3|||
164589295|NCT01312428|594521411|FG001|Overall Study|Study Termination|4|||
164589296|NCT01797783|594521414|FG000|Overall Study|Adverse Event|1|||
164589297|NCT01797783|594521415|FG001|Overall Study|Adverse Event|1|||
164589298|NCT01797783|594521414|FG000|Overall Study|Withdrawal by Subject|1|||
164589299|NCT01797783|594521415|FG001|Overall Study|Withdrawal by Subject|0|||
164589300|NCT02092389|594521422|FG000|Overall Study|Adverse Event|1|||
164589301|NCT02092389|594521422|FG000|Overall Study|Other|5|||
164589302|NCT01242020|594521423|FG000|Overall Study|Withdrawal by Subject|2|||
164589303|NCT01242020|594521424|FG001|Overall Study|Withdrawal by Subject|0|||
164589304|NCT01242020|594521423|FG000|Overall Study|Failed screening|1|||
164589305|NCT01242020|594521424|FG001|Overall Study|Failed screening|0|||
164589306|NCT01618656|594521425|FG000|Overall Study|Withdrawal by Subject|7|||
164589307|NCT01618656|594521426|FG001|Overall Study|Withdrawal by Subject|3|||
164694693|NCT00706095|594905316|FG000|Overall Study|Withdrawal by Subject|1|||
164694694|NCT00706095|594905317|FG001|Overall Study|Withdrawal by Subject|0|||
164694695|NCT00706095|594905318|FG002|Overall Study|Withdrawal by Subject|0|||
164694696|NCT00263887|594905320|FG000|Overall Study|Withdrawal by Subject|1|||
164694697|NCT00263887|594905321|FG001|Overall Study|Withdrawal by Subject|1|||
164694698|NCT00263887|594905320|FG000|Overall Study|Lung transplantation|1|||
164694699|NCT00263887|594905321|FG001|Overall Study|Lung transplantation|2|||
164694700|NCT00263887|594905320|FG000|Overall Study|Too ill to attend visit|1|||
164694701|NCT00263887|594905321|FG001|Overall Study|Too ill to attend visit|0|||
164694702|NCT00263887|594905320|FG000|Overall Study|Adverse Event|0|||
164694703|NCT00263887|594905321|FG001|Overall Study|Adverse Event|2|||
164694704|NCT00263887|594905320|FG000|Overall Study|Disease progression|0|||
164355751|NCT01988103|593678631|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
164355752|NCT01988103|593678632|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
164694705|NCT00263887|594905321|FG001|Overall Study|Disease progression|1|||
164694706|NCT00263887|594905320|FG000|Overall Study|Lack of Efficacy|0|||
164694707|NCT00263887|594905321|FG001|Overall Study|Lack of Efficacy|1|||
164694708|NCT01011556|594905322|FG000|Overall Study|Adverse Event|1|||
164694709|NCT01011556|594905323|FG001|Overall Study|Adverse Event|3|||
164694710|NCT01011556|594905324|FG002|Overall Study|Adverse Event|2|||
164694711|NCT01011556|594905325|FG003|Overall Study|Adverse Event|1|||
164694712|NCT01011556|594905322|FG000|Overall Study|Lost to Follow-up|1|||
164694713|NCT01011556|594905323|FG001|Overall Study|Lost to Follow-up|0|||
164694714|NCT01011556|594905324|FG002|Overall Study|Lost to Follow-up|0|||
164694715|NCT01011556|594905325|FG003|Overall Study|Lost to Follow-up|0|||
164694716|NCT01011556|594905322|FG000|Overall Study|Physician Decision|1|||
164694717|NCT01011556|594905323|FG001|Overall Study|Physician Decision|0|||
164694718|NCT01011556|594905324|FG002|Overall Study|Physician Decision|0|||
164694719|NCT01011556|594905325|FG003|Overall Study|Physician Decision|1|||
164694720|NCT01011556|594905322|FG000|Overall Study|Protocol Violation|0|||
164694721|NCT01011556|594905323|FG001|Overall Study|Protocol Violation|1|||
164694722|NCT01011556|594905324|FG002|Overall Study|Protocol Violation|0|||
164694723|NCT01011556|594905325|FG003|Overall Study|Protocol Violation|0|||
164694724|NCT01011556|594905322|FG000|Overall Study|Withdrawal by Subject|1|||
164694725|NCT01011556|594905323|FG001|Overall Study|Withdrawal by Subject|2|||
164589308|NCT01618656|594521425|FG000|Overall Study|Physician Decision|1|||
164589309|NCT01618656|594521426|FG001|Overall Study|Physician Decision|1|||
164589310|NCT01899144|594521427|FG000|Treatment Period 2|Other|1|||
164589311|NCT01899144|594521427|FG000|Treatment Period 3|Other|2|||
164589312|NCT01899144|594521427|FG000|Treatment Period 5|Other|1|||
164589313|NCT00751881|594521428|FG000|Core Treatment Period|Not treated|1|||
164589314|NCT00751881|594521429|FG001|Core Treatment Period|Not treated|1|||
164589315|NCT00751881|594521430|FG002|Core Treatment Period|Not treated|2|||
164589316|NCT00751881|594521428|FG000|Core Treatment Period|Adverse Event|26|||
164589317|NCT00751881|594521429|FG001|Core Treatment Period|Adverse Event|54|||
164589318|NCT00751881|594521430|FG002|Core Treatment Period|Adverse Event|58|||
164589319|NCT00751881|594521428|FG000|Core Treatment Period|Lack of Efficacy|37|||
164694726|NCT01011556|594905324|FG002|Overall Study|Withdrawal by Subject|4|||
164694727|NCT01011556|594905325|FG003|Overall Study|Withdrawal by Subject|4|||
164694728|NCT01011556|594905322|FG000|Overall Study|Sponsor decision|0|||
164694729|NCT01011556|594905323|FG001|Overall Study|Sponsor decision|1|||
164589320|NCT00751881|594521429|FG001|Core Treatment Period|Lack of Efficacy|30|||
164589321|NCT00751881|594521430|FG002|Core Treatment Period|Lack of Efficacy|20|||
164589322|NCT00751881|594521428|FG000|Core Treatment Period|Poor compliance to protocol|15|||
164694730|NCT01011556|594905324|FG002|Overall Study|Sponsor decision|1|||
164694731|NCT01011556|594905325|FG003|Overall Study|Sponsor decision|2|||
164694732|NCT01011556|594905322|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
164694733|NCT01011556|594905323|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
164694734|NCT01011556|594905324|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
164437514|NCT02914522|593968192|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
164437515|NCT02914522|593968193|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
164437516|NCT02914522|593968183|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
164437517|NCT02914522|593968184|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
164437518|NCT02914522|593968185|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
164437519|NCT02914522|593968186|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
164437520|NCT02914522|593968187|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
164589323|NCT00751881|594521429|FG001|Core Treatment Period|Poor compliance to protocol|3|||
164589324|NCT00751881|594521430|FG002|Core Treatment Period|Poor compliance to protocol|4|||
164589325|NCT00751881|594521428|FG000|Core Treatment Period|Lost to Follow-up|6|||
164589326|NCT00751881|594521429|FG001|Core Treatment Period|Lost to Follow-up|4|||
164589327|NCT00751881|594521430|FG002|Core Treatment Period|Lost to Follow-up|3|||
164589328|NCT00751881|594521428|FG000|Core Treatment Period|Other: protocol deviation|3|||
164589329|NCT00751881|594521429|FG001|Core Treatment Period|Other: protocol deviation|3|||
164589330|NCT00751881|594521430|FG002|Core Treatment Period|Other: protocol deviation|7|||
164589331|NCT00751881|594521428|FG000|Core Treatment Period|Other: wish to parent|5|||
164589332|NCT00751881|594521429|FG001|Core Treatment Period|Other: wish to parent|7|||
164589333|NCT00751881|594521430|FG002|Core Treatment Period|Other: wish to parent|4|||
164589334|NCT00751881|594521428|FG000|Core Treatment Period|Other: personal/family constraints|6|||
164589335|NCT00751881|594521429|FG001|Core Treatment Period|Other: personal/family constraints|7|||
164589336|NCT00751881|594521430|FG002|Core Treatment Period|Other: personal/family constraints|10|||
164589337|NCT00751881|594521428|FG000|Core Treatment Period|Other: MS treatment change|6|||
164589338|NCT00751881|594521429|FG001|Core Treatment Period|Other: MS treatment change|4|||
164589339|NCT00751881|594521430|FG002|Core Treatment Period|Other: MS treatment change|4|||
164589340|NCT00751881|594521428|FG000|Core Treatment Period|Other: tolerability complaints|2|||
164589341|NCT00751881|594521429|FG001|Core Treatment Period|Other: tolerability complaints|0|||
164589342|NCT00751881|594521430|FG002|Core Treatment Period|Other: tolerability complaints|0|||
164589343|NCT00751881|594521428|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
164589344|NCT00751881|594521429|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
164589345|NCT00751881|594521430|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
164589346|NCT00751881|594521428|FG000|Extension Study Period|Adverse Event|18|||
164589347|NCT00751881|594521429|FG001|Extension Study Period|Adverse Event|20|||
164589348|NCT00751881|594521430|FG002|Extension Study Period|Adverse Event|21|||
164589349|NCT00751881|594521428|FG000|Extension Study Period|Lack of Efficacy|14|||
164589350|NCT00751881|594521429|FG001|Extension Study Period|Lack of Efficacy|10|||
164589351|NCT00751881|594521430|FG002|Extension Study Period|Lack of Efficacy|20|||
164589352|NCT00751881|594521428|FG000|Extension Study Period|Lost to Follow-up|4|||
164589353|NCT00751881|594521429|FG001|Extension Study Period|Lost to Follow-up|9|||
164589354|NCT00751881|594521430|FG002|Extension Study Period|Lost to Follow-up|6|||
164589355|NCT00751881|594521428|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
164589356|NCT00751881|594521429|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
164589357|NCT00751881|594521430|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
164589358|NCT00751881|594521428|FG000|Extension Study Period|Other than specified above|26|||
164589359|NCT00751881|594521429|FG001|Extension Study Period|Other than specified above|30|||
164589360|NCT00751881|594521430|FG002|Extension Study Period|Other than specified above|18|||
164589361|NCT03648996|594521432|FG000|Overall Study|Withdrawal by Subject|0|||
164589362|NCT03648996|594521433|FG001|Overall Study|Withdrawal by Subject|2|||
164589363|NCT03648996|594521434|FG002|Overall Study|Withdrawal by Subject|2|||
164589364|NCT03648996|594521432|FG000|Overall Study|Physician Decision|2|||
164589365|NCT03648996|594521433|FG001|Overall Study|Physician Decision|0|||
164589366|NCT03648996|594521434|FG002|Overall Study|Physician Decision|0|||
164589367|NCT00530712|594521440|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
164589368|NCT00530712|594521440|FG000|30 Day Follow-up Visit|Missed Visit|5|||
164589369|NCT00530712|594521440|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
164589370|NCT00530712|594521440|FG000|6 Month Follow-up Visit|Missed Visit|3|||
164589371|NCT00530712|594521440|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
164589372|NCT00530712|594521440|FG000|6 Month Follow-up Visit|Death|2|||
164589373|NCT00530712|594521440|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
164589374|NCT00530712|594521440|FG000|12 Month Follow-up Visit|Missed Visit|3|||
164589375|NCT00530712|594521440|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
164589376|NCT00530712|594521440|FG000|12 Month Follow-up Visit|Death|9|||
164589377|NCT02749370|594521441|FG000|Overall Study|Withdrawal by Subject|11|||
164589378|NCT02749370|594521441|FG000|Overall Study|Lost to Follow-up|3|||
164589379|NCT03242759|594521445|FG000|Overall Study|Adverse Event|5|||
164589380|NCT03242759|594521446|FG001|Overall Study|Adverse Event|1|||
164589381|NCT03242759|594521445|FG000|Overall Study|Withdrawal by Subject|4|||
164589382|NCT03242759|594521446|FG001|Overall Study|Withdrawal by Subject|3|||
164589383|NCT03242759|594521445|FG000|Overall Study|Lost to Follow-up|3|||
164589384|NCT03242759|594521446|FG001|Overall Study|Lost to Follow-up|1|||
164589385|NCT03242759|594521445|FG000|Overall Study|Administrative problems|1|||
164694735|NCT01011556|594905325|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
164694736|NCT05212883|594905326|FG000|Overall Study|Invalid test result|125|||
164694737|NCT00614822|594905327|FG000|Overall Study|Adverse Event|3|||
164694738|NCT03095118|594905328|FG000|Overall Study|Adverse Event|1|||
164694739|NCT03095118|594905328|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
164694740|NCT00530348|594905329|FG000|Overall Study|Adverse Event|5|||
164694741|NCT00530348|594905330|FG001|Overall Study|Adverse Event|1|||
164694742|NCT00530348|594905329|FG000|Overall Study|Death|0|||
164694743|NCT00530348|594905330|FG001|Overall Study|Death|1|||
164694744|NCT00530348|594905329|FG000|Overall Study|Lack of Efficacy|2|||
164694745|NCT00530348|594905330|FG001|Overall Study|Lack of Efficacy|0|||
164694746|NCT00530348|594905329|FG000|Overall Study|Lost to Follow-up|0|||
164694747|NCT00530348|594905330|FG001|Overall Study|Lost to Follow-up|2|||
164694748|NCT00530348|594905329|FG000|Overall Study|Physician Decision|1|||
164694749|NCT00530348|594905330|FG001|Overall Study|Physician Decision|2|||
164694750|NCT00530348|594905329|FG000|Overall Study|Pregnancy|1|||
164694751|NCT00530348|594905330|FG001|Overall Study|Pregnancy|0|||
164694752|NCT00530348|594905329|FG000|Overall Study|Withdrawal by Subject|12|||
164694753|NCT00530348|594905330|FG001|Overall Study|Withdrawal by Subject|12|||
164694754|NCT00530348|594905329|FG000|Overall Study|Randomised in error|1|||
164694755|NCT00530348|594905330|FG001|Overall Study|Randomised in error|0|||
164694756|NCT00530348|594905329|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
164694757|NCT00530348|594905330|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
164694758|NCT03920280|594905332|FG000|Overall Study|Adverse Event|2|||
164694759|NCT03920280|594905333|FG001|Overall Study|Adverse Event|3|||
164694760|NCT03920280|594905332|FG000|Overall Study|Lost to Follow-up|0|||
164694761|NCT03920280|594905333|FG001|Overall Study|Lost to Follow-up|1|||
164694762|NCT03920280|594905332|FG000|Overall Study|Withdrawal by Subject|1|||
164694763|NCT03920280|594905333|FG001|Overall Study|Withdrawal by Subject|1|||
164694764|NCT03920280|594905332|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
164694765|NCT03920280|594905333|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
164694766|NCT01009515|594905334|FG000|Overall Study|Withdrawal by Subject|3|||
164694767|NCT02075606|594905336|FG000|Overall Study|Adverse Event|5|||
164694768|NCT02075606|594905336|FG000|Overall Study|Withdrawal by Subject|1|||
164694769|NCT02075606|594905336|FG000|Overall Study|Death|1|||
164694770|NCT02075606|594905336|FG000|Overall Study|Investigator's decision|1|||
164694771|NCT02075606|594905336|FG000|Overall Study|Symptom management|1|||
164694772|NCT02075606|594905336|FG000|Overall Study|Increasing Symptoms|1|||
164694773|NCT00983476|594905340|FG000|Overall Study|Did not receive intervention|17|||
164694774|NCT00983476|594905341|FG001|Overall Study|Did not receive intervention|22|||
164694775|NCT00983476|594905342|FG002|Overall Study|Did not receive intervention|0|||
164694776|NCT01439724|594905344|FG000|Overall Study|missing consultation|9|||
164694777|NCT01439724|594905345|FG001|Overall Study|missing consultation|8|||
164694778|NCT01857206|594905347|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
164694779|NCT01857206|594905348|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
164694780|NCT01857206|594905347|FG000|Overall Study|Lost to Follow-up|9|||
164694781|NCT01857206|594905348|FG001|Overall Study|Lost to Follow-up|6|||
164694782|NCT01857206|594905347|FG000|Overall Study|Unclassified|3|||
164694783|NCT01857206|594905348|FG001|Overall Study|Unclassified|3|||
164694784|NCT01857206|594905347|FG000|Overall Study|Withdrawal by Subject|1|||
164694785|NCT01857206|594905348|FG001|Overall Study|Withdrawal by Subject|0|||
164694786|NCT01483625|594905349|FG000|Overall Study|Adverse Event|1|||
164694787|NCT01483625|594905350|FG001|Overall Study|Adverse Event|1|||
164694788|NCT01483625|594905349|FG000|Overall Study|Refused to continue medication|2|||
164694789|NCT01483625|594905350|FG001|Overall Study|Refused to continue medication|1|||
164694790|NCT01483625|594905349|FG000|Overall Study|Due to other reason|1|||
164694791|NCT01483625|594905350|FG001|Overall Study|Due to other reason|0|||
164694792|NCT00084799|594905351|FG000|Overall Study|Disease Progression|1|||
164694793|NCT00084799|594905352|FG001|Overall Study|Disease Progression|0|||
164694794|NCT04019054|594905353|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
164694795|NCT04019054|594905354|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
164694796|NCT04019054|594905353|FG000|Overall Study|Withdrawal by Subject|3|||
164694797|NCT04019054|594905354|FG001|Overall Study|Withdrawal by Subject|1|||
164694798|NCT01261624|594905359|FG000|Week 0 to Week 12|Disease Progression|1|||
164694799|NCT01261624|594905360|FG001|Week 0 to Week 12|Disease Progression|1|||
164694800|NCT01261624|594905359|FG000|Week 0 to Week 12|Insufficient Response|0|||
164694801|NCT01261624|594905360|FG001|Week 0 to Week 12|Insufficient Response|2|||
164694802|NCT01261624|594905359|FG000|Week 13 to Week 24|Insufficient Response|0|||
164694803|NCT01261624|594905360|FG001|Week 13 to Week 24|Insufficient Response|1|||
164694804|NCT01040793|594905361|FG000|Overall Study|Adverse Event|5|||
164694805|NCT01040793|594905362|FG001|Overall Study|Adverse Event|3|||
164694806|NCT01040793|594905363|FG002|Overall Study|Adverse Event|0|||
164694807|NCT01040793|594905364|FG003|Overall Study|Adverse Event|2|||
164694808|NCT01040793|594905365|FG004|Overall Study|Adverse Event|2|||
164694809|NCT01040793|594905366|FG005|Overall Study|Adverse Event|1|||
164355753|NCT01988103|593678633|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
164355754|NCT01988103|593678634|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
164355755|NCT01988103|593678635|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
164355756|NCT01946425|593678637|FG000|Overall Study|Protocol Violation|1|||
164355757|NCT01946425|593678638|FG001|Overall Study|Protocol Violation|0|||
164355758|NCT01946425|593678637|FG000|Overall Study|Withdrawal by Subject|1|||
164355759|NCT01946425|593678638|FG001|Overall Study|Withdrawal by Subject|0|||
164355760|NCT05682326|593678642|FG000|Overall Study|Withdrawal by Subject|1|||
164355761|NCT05682326|593678643|FG001|Overall Study|Withdrawal by Subject|0|||
164355762|NCT01402544|593678644|FG000|Overall Study|Withdrawal by Subject|6|||
164355763|NCT01113801|593678645|FG000|Overall Study|Adverse Event|4|||
164355764|NCT01113801|593678646|FG001|Overall Study|Adverse Event|0|||
164355765|NCT01113801|593678647|FG002|Overall Study|Adverse Event|2|||
164355766|NCT01113801|593678648|FG003|Overall Study|Adverse Event|6|||
164355767|NCT01113801|593678645|FG000|Overall Study|Death|4|||
164355768|NCT01113801|593678646|FG001|Overall Study|Death|5|||
164355769|NCT01113801|593678647|FG002|Overall Study|Death|3|||
164355770|NCT01113801|593678648|FG003|Overall Study|Death|4|||
164355771|NCT01113801|593678645|FG000|Overall Study|Protocol Violation|0|||
164355772|NCT01113801|593678646|FG001|Overall Study|Protocol Violation|1|||
164355773|NCT01113801|593678647|FG002|Overall Study|Protocol Violation|0|||
164355774|NCT01113801|593678648|FG003|Overall Study|Protocol Violation|0|||
164355775|NCT01113801|593678645|FG000|Overall Study|Withdrawal by Subject|9|||
164355776|NCT01113801|593678646|FG001|Overall Study|Withdrawal by Subject|7|||
164355777|NCT01113801|593678647|FG002|Overall Study|Withdrawal by Subject|7|||
164355778|NCT01113801|593678648|FG003|Overall Study|Withdrawal by Subject|8|||
164355779|NCT01113801|593678645|FG000|Overall Study|Physician Decision|2|||
164589386|NCT03242759|594521446|FG001|Overall Study|Administrative problems|1|||
164589387|NCT03242759|594521445|FG000|Overall Study|Death|22|||
164589388|NCT03242759|594521446|FG001|Overall Study|Death|0|||
164589389|NCT03242759|594521445|FG000|Overall Study|Change visit schedule|0|||
164589390|NCT03242759|594521446|FG001|Overall Study|Change visit schedule|1|||
164589391|NCT00504166|594521452|FG000|Overall Study|Adverse Event|1|||
164589392|NCT00504166|594521453|FG001|Overall Study|Adverse Event|4|||
164589393|NCT00504166|594521452|FG000|Overall Study|Withdrawal by Subject|3|||
164589394|NCT00504166|594521453|FG001|Overall Study|Withdrawal by Subject|6|||
164589395|NCT00504166|594521452|FG000|Overall Study|Physician Decision|1|||
164589396|NCT00504166|594521453|FG001|Overall Study|Physician Decision|1|||
164589397|NCT00504166|594521452|FG000|Overall Study|Lost to Follow-up|1|||
164589398|NCT00504166|594521453|FG001|Overall Study|Lost to Follow-up|3|||
164589399|NCT00839098|594521456|FG000|Overall Study|Withdrawal by Subject|2|||
164589400|NCT00839098|594521457|FG001|Overall Study|Withdrawal by Subject|1|||
164589401|NCT00839098|594521458|FG002|Overall Study|Withdrawal by Subject|7|||
164589402|NCT01345786|594521459|FG000|Overall Study|Adverse Event|0|||
164589403|NCT01345786|594521460|FG001|Overall Study|Adverse Event|1|||
164589404|NCT01345786|594521461|FG002|Overall Study|Adverse Event|3|||
164589405|NCT01345786|594521462|FG003|Overall Study|Adverse Event|1|||
164589406|NCT01345786|594521459|FG000|Overall Study|Subject withdrew consent|2|||
164589407|NCT01345786|594521460|FG001|Overall Study|Subject withdrew consent|2|||
164589408|NCT01345786|594521461|FG002|Overall Study|Subject withdrew consent|1|||
164589409|NCT01345786|594521462|FG003|Overall Study|Subject withdrew consent|0|||
164589410|NCT01345786|594521459|FG000|Overall Study|Noncompliance with protocol|1|||
164589411|NCT01345786|594521460|FG001|Overall Study|Noncompliance with protocol|0|||
164589412|NCT01345786|594521461|FG002|Overall Study|Noncompliance with protocol|1|||
164589413|NCT01345786|594521462|FG003|Overall Study|Noncompliance with protocol|0|||
164589414|NCT01345786|594521459|FG000|Overall Study|Administrative|3|||
164589415|NCT01345786|594521460|FG001|Overall Study|Administrative|5|||
164589416|NCT01345786|594521461|FG002|Overall Study|Administrative|0|||
164589417|NCT01345786|594521462|FG003|Overall Study|Administrative|0|||
164589418|NCT01345786|594521459|FG000|Overall Study|Lost to Follow-up|0|||
164589419|NCT01345786|594521460|FG001|Overall Study|Lost to Follow-up|0|||
164589420|NCT01345786|594521461|FG002|Overall Study|Lost to Follow-up|0|||
164589421|NCT01345786|594521462|FG003|Overall Study|Lost to Follow-up|2|||
164589422|NCT02190435|594521463|FG000|Overall Study|First 12 patients were lead-ins|12|||
164589423|NCT02190435|594521464|FG001|Overall Study|First 12 patients were lead-ins|0|||
164589424|NCT02190435|594521463|FG000|Overall Study|3 consented screen fails|3|||
164589425|NCT02190435|594521464|FG001|Overall Study|3 consented screen fails|0|||
164589426|NCT02399475|594521473|FG000|Overall Study|Physician Decision|1|||
164589427|NCT02399475|594521474|FG001|Overall Study|Physician Decision|0|||
164355780|NCT01113801|593678646|FG001|Overall Study|Physician Decision|2|||
164355781|NCT01113801|593678647|FG002|Overall Study|Physician Decision|3|||
164355782|NCT01113801|593678648|FG003|Overall Study|Physician Decision|3|||
164355783|NCT01113801|593678645|FG000|Overall Study|Sponsor Decision|15|||
164355784|NCT01113801|593678646|FG001|Overall Study|Sponsor Decision|21|||
164355785|NCT01113801|593678647|FG002|Overall Study|Sponsor Decision|20|||
164355786|NCT01113801|593678648|FG003|Overall Study|Sponsor Decision|15|||
164355787|NCT01113801|593678645|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
164589428|NCT02260193|594521475|FG000|Overall Study|Lack of Efficacy|0|||
164694810|NCT01040793|594905361|FG000|Overall Study|Protocol Violation|1|||
164694811|NCT01040793|594905362|FG001|Overall Study|Protocol Violation|1|||
164694812|NCT01040793|594905363|FG002|Overall Study|Protocol Violation|1|||
164355788|NCT01113801|593678646|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
164355789|NCT01113801|593678647|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
164589429|NCT02260193|594521476|FG001|Overall Study|Lack of Efficacy|1|||
164589430|NCT02260193|594521477|FG002|Overall Study|Lack of Efficacy|6|||
164589431|NCT02260193|594521475|FG000|Overall Study|Adverse Event|3|||
164694813|NCT01040793|594905364|FG003|Overall Study|Protocol Violation|0|||
164694814|NCT01040793|594905365|FG004|Overall Study|Protocol Violation|1|||
164694815|NCT01040793|594905366|FG005|Overall Study|Protocol Violation|0|||
164694816|NCT01040793|594905361|FG000|Overall Study|Lost to Follow-up|0|||
164694817|NCT01040793|594905362|FG001|Overall Study|Lost to Follow-up|1|||
164694818|NCT01040793|594905363|FG002|Overall Study|Lost to Follow-up|1|||
164694819|NCT01040793|594905364|FG003|Overall Study|Lost to Follow-up|0|||
164694820|NCT01040793|594905365|FG004|Overall Study|Lost to Follow-up|0|||
164694821|NCT01040793|594905366|FG005|Overall Study|Lost to Follow-up|0|||
164694822|NCT01040793|594905361|FG000|Overall Study|Withdrawal by Subject|0|||
164694823|NCT01040793|594905362|FG001|Overall Study|Withdrawal by Subject|0|||
164694824|NCT01040793|594905363|FG002|Overall Study|Withdrawal by Subject|0|||
164694825|NCT01040793|594905364|FG003|Overall Study|Withdrawal by Subject|2|||
164694826|NCT01040793|594905365|FG004|Overall Study|Withdrawal by Subject|0|||
164694827|NCT01040793|594905366|FG005|Overall Study|Withdrawal by Subject|0|||
164694828|NCT01040793|594905361|FG000|Overall Study|Other reasons not listed above|0|||
164694829|NCT01040793|594905362|FG001|Overall Study|Other reasons not listed above|0|||
164694830|NCT01040793|594905363|FG002|Overall Study|Other reasons not listed above|1|||
164694831|NCT01040793|594905364|FG003|Overall Study|Other reasons not listed above|0|||
164694832|NCT01040793|594905365|FG004|Overall Study|Other reasons not listed above|1|||
164694833|NCT01040793|594905366|FG005|Overall Study|Other reasons not listed above|0|||
164694834|NCT02094261|594905367|FG000|Overall Study|Death|24|||
164694835|NCT02094261|594905367|FG000|Overall Study|Lost to Follow-up|1|||
164694836|NCT02094261|594905367|FG000|Overall Study|Withdrawal by Subject|4|||
164694837|NCT02094261|594905367|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
164694838|NCT02412722|594905370|FG000|Overall Study|Adverse Event|0|||
164694839|NCT02412722|594905371|FG001|Overall Study|Adverse Event|2|||
164694840|NCT02412722|594905372|FG002|Overall Study|Adverse Event|0|||
164694841|NCT02412722|594905373|FG003|Overall Study|Adverse Event|3|||
164694842|NCT02412722|594905374|FG004|Overall Study|Adverse Event|0|||
164694843|NCT02412722|594905375|FG005|Overall Study|Adverse Event|3|||
164694844|NCT02412722|594905370|FG000|Overall Study|Progressive Disease|6|||
164694845|NCT02412722|594905371|FG001|Overall Study|Progressive Disease|4|||
164694846|NCT02412722|594905372|FG002|Overall Study|Progressive Disease|4|||
164694847|NCT02412722|594905373|FG003|Overall Study|Progressive Disease|9|||
164694848|NCT02412722|594905374|FG004|Overall Study|Progressive Disease|3|||
164694849|NCT02412722|594905375|FG005|Overall Study|Progressive Disease|3|||
164694850|NCT02412722|594905370|FG000|Overall Study|Withdrawal by Subject|2|||
164694851|NCT02412722|594905371|FG001|Overall Study|Withdrawal by Subject|0|||
164694852|NCT02412722|594905372|FG002|Overall Study|Withdrawal by Subject|1|||
164694853|NCT02412722|594905373|FG003|Overall Study|Withdrawal by Subject|2|||
164694854|NCT02412722|594905374|FG004|Overall Study|Withdrawal by Subject|1|||
164589432|NCT02260193|594521476|FG001|Overall Study|Adverse Event|4|||
164589433|NCT02260193|594521477|FG002|Overall Study|Adverse Event|1|||
164589434|NCT02260193|594521475|FG000|Overall Study|Protocol Violation|0|||
164589435|NCT02260193|594521476|FG001|Overall Study|Protocol Violation|4|||
164589436|NCT02260193|594521477|FG002|Overall Study|Protocol Violation|0|||
164589437|NCT02260193|594521475|FG000|Overall Study|Withdrawal by Subject|3|||
164589438|NCT02260193|594521476|FG001|Overall Study|Withdrawal by Subject|0|||
164589439|NCT02260193|594521477|FG002|Overall Study|Withdrawal by Subject|2|||
164589440|NCT02260193|594521475|FG000|Overall Study|Kidney Transplantation|0|||
164589441|NCT02260193|594521476|FG001|Overall Study|Kidney Transplantation|0|||
164589442|NCT02260193|594521477|FG002|Overall Study|Kidney Transplantation|1|||
164589443|NCT01963117|594521478|FG000|Overall Study|Death|1|||
164589444|NCT01070784|594521479|FG000|Overall Study|Withdrawal by Subject|6|||
164589445|NCT01070784|594521480|FG001|Overall Study|Withdrawal by Subject|9|||
164589446|NCT01070784|594521479|FG000|Overall Study|Adverse Event|14|||
164589447|NCT01070784|594521480|FG001|Overall Study|Adverse Event|9|||
164589448|NCT01780389|594521481|FG000|Overall Study|Adverse Event|1|||
164589449|NCT00935220|594521482|FG000|Overall Study|Adverse Event|1|||
164589450|NCT00935220|594521482|FG000|Overall Study|Other reason (not specified)|1|||
164589451|NCT01095250|594521483|FG000|Overall Study|administrative reasons|8|||
164589452|NCT01095250|594521484|FG001|Overall Study|administrative reasons|10|||
164694855|NCT02412722|594905375|FG005|Overall Study|Withdrawal by Subject|1|||
164355790|NCT01113801|593678648|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
164589453|NCT01095250|594521485|FG002|Overall Study|administrative reasons|7|||
164694856|NCT02412722|594905370|FG000|Overall Study|Lost to Follow-up|0|||
164694857|NCT02412722|594905371|FG001|Overall Study|Lost to Follow-up|0|||
164694858|NCT02412722|594905372|FG002|Overall Study|Lost to Follow-up|0|||
164694859|NCT02412722|594905373|FG003|Overall Study|Lost to Follow-up|0|||
164589454|NCT01095250|594521486|FG003|Overall Study|administrative reasons|5|||
164589455|NCT01095250|594521483|FG000|Overall Study|Withdrawal by Subject|0|||
164589456|NCT01095250|594521484|FG001|Overall Study|Withdrawal by Subject|0|||
164589457|NCT01095250|594521485|FG002|Overall Study|Withdrawal by Subject|1|||
164589458|NCT01095250|594521486|FG003|Overall Study|Withdrawal by Subject|0|||
164589459|NCT01000064|594521487|FG000|Overall Study|Withdrawal by Subject|1|||
164589460|NCT01000064|594521488|FG001|Overall Study|Withdrawal by Subject|1|||
164589461|NCT02518620|594521489|FG000|Overall Study|Adverse Event|23|||
164589462|NCT02518620|594521490|FG001|Overall Study|Adverse Event|11|||
164589463|NCT02518620|594521489|FG000|Overall Study|Lack of Efficacy|2|||
164589464|NCT02518620|594521490|FG001|Overall Study|Lack of Efficacy|0|||
164589465|NCT02518620|594521489|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164589466|NCT02518620|594521490|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164589467|NCT02518620|594521489|FG000|Overall Study|Physician Decision|1|||
164589468|NCT02518620|594521490|FG001|Overall Study|Physician Decision|1|||
164589469|NCT02518620|594521489|FG000|Overall Study|Sponsor's Decision|0|||
164589470|NCT02518620|594521490|FG001|Overall Study|Sponsor's Decision|3|||
164589471|NCT02518620|594521489|FG000|Overall Study|Lost to Follow-up|1|||
164589472|NCT02518620|594521490|FG001|Overall Study|Lost to Follow-up|1|||
164589473|NCT02518620|594521489|FG000|Overall Study|Withdrawal by Subject|17|||
164589474|NCT02518620|594521490|FG001|Overall Study|Withdrawal by Subject|9|||
164589475|NCT02518620|594521489|FG000|Overall Study|Death|1|||
164589476|NCT02518620|594521490|FG001|Overall Study|Death|0|||
164589477|NCT02518620|594521489|FG000|Overall Study|Pregnancy Wish|3|||
164589478|NCT02518620|594521490|FG001|Overall Study|Pregnancy Wish|0|||
164589479|NCT02518620|594521489|FG000|Overall Study|Pregnancy|1|||
164589480|NCT02518620|594521490|FG001|Overall Study|Pregnancy|0|||
164589481|NCT02518620|594521489|FG000|Overall Study|Relocation|2|||
164589482|NCT02518620|594521490|FG001|Overall Study|Relocation|1|||
164589483|NCT01415440|594521492|FG000|Overall Study|Lost to Follow-up|0|||
164589484|NCT01415440|594521493|FG001|Overall Study|Lost to Follow-up|1|||
164589485|NCT01415440|594521494|FG002|Overall Study|Lost to Follow-up|2|||
164589486|NCT01415440|594521492|FG000|Overall Study|Physician Decision|3|||
164589487|NCT01415440|594521493|FG001|Overall Study|Physician Decision|0|||
164589488|NCT01415440|594521494|FG002|Overall Study|Physician Decision|0|||
164589489|NCT01415440|594521492|FG000|Overall Study|Withdrawal by Subject|1|||
164589490|NCT01415440|594521493|FG001|Overall Study|Withdrawal by Subject|0|||
164589491|NCT01415440|594521494|FG002|Overall Study|Withdrawal by Subject|0|||
164589492|NCT02522481|594521498|FG000|Overall Study|discontinued|1|||
164589493|NCT02522481|594521498|FG000|Overall Study|Not dosed|2|||
164589494|NCT03123939|594521499|FG000|Overall Study|Lack of Efficacy|6|||
164589495|NCT03123939|594521499|FG000|Overall Study|Death|5|||
164589496|NCT03123939|594521499|FG000|Overall Study|Physician Decision|2|||
164589497|NCT03123939|594521499|FG000|Overall Study|Subject/guardian decision|2|||
164589498|NCT03123939|594521499|FG000|Overall Study|Lost to Follow-up|1|||
164589499|NCT03123939|594521499|FG000|Overall Study|New therapy for study indication|1|||
164589500|NCT03123939|594521499|FG000|Overall Study|Protocol deviation|1|||
164589501|NCT03123939|594521499|FG000|Overall Study|Progressive disease|18|||
164589502|NCT03123939|594521499|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
164589503|NCT03123939|594521499|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
164589504|NCT02322892|594522988|FG000|Overall Study|Surgery cancelled|1|||
164589505|NCT02322892|594522989|FG001|Overall Study|Surgery cancelled|2|||
164589506|NCT02322892|594522988|FG000|Overall Study|Met exclusion criteria|0|||
164589507|NCT02322892|594522989|FG001|Overall Study|Met exclusion criteria|1|||
164589508|NCT02322892|594522988|FG000|Overall Study|Protocol Violation|1|||
164589509|NCT02322892|594522989|FG001|Overall Study|Protocol Violation|0|||
164589510|NCT02817555|594522990|FG000|Overall Study|Death|1|||
164589511|NCT02817555|594522991|FG001|Overall Study|Death|3|||
164437521|NCT02914522|593968188|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
164589512|NCT02817555|594522990|FG000|Overall Study|moved away|1|||
164589513|NCT02817555|594522991|FG001|Overall Study|moved away|0|||
164589514|NCT02817555|594522990|FG000|Overall Study|transplant|1|||
164589515|NCT02817555|594522991|FG001|Overall Study|transplant|1|||
164589516|NCT02817555|594522990|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
164589517|NCT02817555|594522991|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
164589518|NCT02125331|594522992|FG000|Overall Study|Protocol Violation|1|||
164589519|NCT02125331|594522993|FG001|Overall Study|Protocol Violation|0|||
164589520|NCT02125331|594522992|FG000|Overall Study|technical problem|2|||
164589521|NCT02125331|594522993|FG001|Overall Study|technical problem|0|||
164589522|NCT02125331|594522992|FG000|Overall Study|screen failure|2|||
164589523|NCT02125331|594522993|FG001|Overall Study|screen failure|0|||
164589524|NCT01432262|594522994|FG000|Overall Study|Withdrawal by Subject|2|||
164589525|NCT01432262|594522995|FG001|Overall Study|Withdrawal by Subject|1|||
164589526|NCT04657016|594522996|FG000|Overall Study|Adverse Event|2|||
164589527|NCT04657016|594522997|FG001|Overall Study|Adverse Event|4|||
164589528|NCT04657016|594522996|FG000|Overall Study|Death|1|||
164589529|NCT04657016|594522997|FG001|Overall Study|Death|1|||
164589530|NCT04657016|594522996|FG000|Overall Study|Lost to Follow-up|24|||
164589531|NCT04657016|594522997|FG001|Overall Study|Lost to Follow-up|12|||
164694860|NCT02412722|594905374|FG004|Overall Study|Lost to Follow-up|1|||
164694861|NCT02412722|594905375|FG005|Overall Study|Lost to Follow-up|0|||
164355791|NCT01949051|593678652|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
164355792|NCT01949051|593678653|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
164355793|NCT01949051|593678654|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
164355794|NCT01949051|593678655|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
164355795|NCT01949051|593678656|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
164355796|NCT01949051|593678657|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
164355797|NCT01949051|593678652|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
164355798|NCT01949051|593678653|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
164355799|NCT01949051|593678654|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
164355800|NCT01949051|593678655|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
164355801|NCT01949051|593678656|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
164694862|NCT02412722|594905370|FG000|Overall Study|Received drug in run-in and discontinued|0|||
164694863|NCT02412722|594905371|FG001|Overall Study|Received drug in run-in and discontinued|2|||
164694864|NCT02412722|594905372|FG002|Overall Study|Received drug in run-in and discontinued|0|||
164694865|NCT02412722|594905373|FG003|Overall Study|Received drug in run-in and discontinued|0|||
164694866|NCT02412722|594905374|FG004|Overall Study|Received drug in run-in and discontinued|0|||
164694867|NCT02412722|594905375|FG005|Overall Study|Received drug in run-in and discontinued|0|||
164694868|NCT02412722|594905370|FG000|Overall Study|Reason not Specified|3|||
164694869|NCT02412722|594905371|FG001|Overall Study|Reason not Specified|0|||
164694870|NCT02412722|594905372|FG002|Overall Study|Reason not Specified|2|||
164694871|NCT02412722|594905373|FG003|Overall Study|Reason not Specified|1|||
164694872|NCT02412722|594905374|FG004|Overall Study|Reason not Specified|2|||
164694873|NCT02412722|594905375|FG005|Overall Study|Reason not Specified|6|||
164694874|NCT01083680|594905376|FG000|Overall Study|Lost to Follow-up|2758|||
164694875|NCT01083680|594905376|FG000|Overall Study|Withdrawal by Subject|1086|||
164694876|NCT03877926|594905377|FG000|Overall Study|Adverse Event|1|||
164694877|NCT03877926|594905378|FG001|Overall Study|Adverse Event|0|||
164694878|NCT03877926|594905379|FG002|Overall Study|Adverse Event|0|||
164694879|NCT03877926|594905380|FG003|Overall Study|Adverse Event|0|||
164694880|NCT03877926|594905377|FG000|Overall Study|Death|2|||
164694881|NCT03877926|594905378|FG001|Overall Study|Death|2|||
164694882|NCT03877926|594905379|FG002|Overall Study|Death|2|||
164694883|NCT03877926|594905380|FG003|Overall Study|Death|0|||
164694884|NCT03877926|594905377|FG000|Overall Study|Lost to Follow-up|41|||
164694885|NCT03877926|594905378|FG001|Overall Study|Lost to Follow-up|52|||
164694886|NCT03877926|594905379|FG002|Overall Study|Lost to Follow-up|45|||
164694887|NCT03877926|594905380|FG003|Overall Study|Lost to Follow-up|17|||
164694888|NCT03877926|594905377|FG000|Overall Study|Physician Decision|2|||
164694889|NCT03877926|594905378|FG001|Overall Study|Physician Decision|0|||
164355802|NCT01949051|593678657|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
164437522|NCT02914522|593968189|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
164589532|NCT04657016|594522996|FG000|Overall Study|Physician Decision|1|||
164589533|NCT04657016|594522997|FG001|Overall Study|Physician Decision|2|||
164589534|NCT04657016|594522996|FG000|Overall Study|Pregnancy|2|||
164589535|NCT04657016|594522997|FG001|Overall Study|Pregnancy|2|||
164589536|NCT04657016|594522996|FG000|Overall Study|Protocol Deviation|1|||
164589537|NCT04657016|594522997|FG001|Overall Study|Protocol Deviation|0|||
164589538|NCT04657016|594522996|FG000|Overall Study|Withdrawal by Subject|28|||
164589539|NCT04657016|594522997|FG001|Overall Study|Withdrawal by Subject|14|||
164589540|NCT04657016|594522996|FG000|Overall Study|Other - as reported by the investigator|6|||
164589541|NCT04657016|594522997|FG001|Overall Study|Other - as reported by the investigator|0|||
164589542|NCT00701727|594522998|FG000|First Treatment Period|Adverse Event|0|||
164589543|NCT00701727|594522999|FG001|First Treatment Period|Adverse Event|0|||
164589544|NCT00701727|594522998|FG000|First Treatment Period|Withdrawal by Subject|1|||
164589545|NCT00701727|594522999|FG001|First Treatment Period|Withdrawal by Subject|0|||
164589546|NCT00701727|594522998|FG000|First Treatment Period|sponsor decision|0|||
164589547|NCT00701727|594522999|FG001|First Treatment Period|sponsor decision|1|||
164589548|NCT00701727|594522998|FG000|First Treatment Period|Lost to Follow-up|0|||
164589549|NCT00701727|594522999|FG001|First Treatment Period|Lost to Follow-up|1|||
164589550|NCT00701727|594522998|FG000|Second Treatment Period|Withdrawal by Subject|2|||
164589551|NCT00701727|594522999|FG001|Second Treatment Period|Withdrawal by Subject|0|||
164589552|NCT02601001|594523006|FG000|Dosing Period 2|Adverse Event|0|||
164589553|NCT02601001|594523007|FG001|Dosing Period 2|Adverse Event|0|||
164589554|NCT02601001|594523008|FG002|Dosing Period 2|Adverse Event|0|||
164589555|NCT02601001|594523009|FG003|Dosing Period 2|Adverse Event|0|||
164589556|NCT02601001|594523010|FG004|Dosing Period 2|Adverse Event|0|||
164589557|NCT02601001|594523011|FG005|Dosing Period 2|Adverse Event|0|||
164589558|NCT02601001|594523012|FG006|Dosing Period 2|Adverse Event|1|||
164589559|NCT01356602|594523015|FG000|Overall Study|Protocol Deviation|0|||
164694890|NCT03877926|594905379|FG002|Overall Study|Physician Decision|2|||
164694891|NCT03877926|594905380|FG003|Overall Study|Physician Decision|0|||
164694892|NCT03877926|594905377|FG000|Overall Study|Withdrawal by Subject|18|||
164694893|NCT03877926|594905378|FG001|Overall Study|Withdrawal by Subject|21|||
164694894|NCT03877926|594905379|FG002|Overall Study|Withdrawal by Subject|12|||
164589560|NCT01356602|594523016|FG001|Overall Study|Protocol Deviation|1|||
164589561|NCT01356602|594523017|FG002|Overall Study|Protocol Deviation|1|||
164589562|NCT01356602|594523015|FG000|Overall Study|Administrative Problems|1|||
164589563|NCT01356602|594523016|FG001|Overall Study|Administrative Problems|4|||
164589564|NCT01356602|594523017|FG002|Overall Study|Administrative Problems|5|||
164589565|NCT01356602|594523015|FG000|Overall Study|Lost to Follow-up|4|||
164589566|NCT01356602|594523016|FG001|Overall Study|Lost to Follow-up|5|||
164589567|NCT01356602|594523017|FG002|Overall Study|Lost to Follow-up|6|||
164589568|NCT01356602|594523015|FG000|Overall Study|Withdrawal by Subject|4|||
164589569|NCT01356602|594523016|FG001|Overall Study|Withdrawal by Subject|3|||
164589570|NCT01356602|594523017|FG002|Overall Study|Withdrawal by Subject|7|||
164589571|NCT01356602|594523015|FG000|Overall Study|Lack of Efficacy|0|||
164589572|NCT01356602|594523016|FG001|Overall Study|Lack of Efficacy|1|||
164589573|NCT01356602|594523017|FG002|Overall Study|Lack of Efficacy|4|||
164589574|NCT01356602|594523015|FG000|Overall Study|Adverse Event|0|||
164589575|NCT01356602|594523016|FG001|Overall Study|Adverse Event|1|||
164589576|NCT01356602|594523017|FG002|Overall Study|Adverse Event|1|||
164589577|NCT01931462|594523018|FG000|Overall Study|Withdrawal by Subject|1|||
164589578|NCT01701583|594523019|FG000|Overall Study|Withdrawal by Subject|2|||
164589579|NCT01701583|594523020|FG001|Overall Study|Withdrawal by Subject|0|||
164589580|NCT05070429|594523021|FG000|Overall Study|Death|0|||
164589581|NCT05070429|594523022|FG001|Overall Study|Death|4|||
164589582|NCT05070429|594523021|FG000|Overall Study|Withdrawal by Subject|2|||
164589583|NCT05070429|594523022|FG001|Overall Study|Withdrawal by Subject|1|||
164589584|NCT05070429|594523021|FG000|Overall Study|Other|15|||
164589585|NCT05070429|594523022|FG001|Overall Study|Other|5|||
164589586|NCT00615290|594523023|FG000|Overall Study|Adverse Event|2|||
164589587|NCT00615290|594523023|FG000|Overall Study|Lost to Follow-up|3|||
164589588|NCT00615290|594523023|FG000|Overall Study|Withdrawal by Subject|1|||
164589589|NCT00615290|594523023|FG000|Overall Study|Other|2|||
164589590|NCT02849990|594523024|FG000|Overall Study|Adverse Event|1|||
164589591|NCT02849990|594523024|FG000|Overall Study|Withdrawal by Subject|1|||
164589592|NCT01252134|594523025|FG000|Period 1, 8 Hours|Personal Reasons|0|||
164589593|NCT01252134|594523026|FG001|Period 1, 8 Hours|Personal Reasons|1|||
164589594|NCT01252134|594523027|FG002|Period 1, 8 Hours|Personal Reasons|1|||
164589595|NCT01252134|594523028|FG003|Period 1, 8 Hours|Personal Reasons|0|||
164589596|NCT01252134|594523029|FG004|Period 1, 8 Hours|Personal Reasons|0|||
164589597|NCT01252134|594523030|FG005|Period 1, 8 Hours|Personal Reasons|0|||
164589598|NCT02678741|594523031|FG000|Overall Study|Death|4|||
164589599|NCT02678741|594523031|FG000|Overall Study|Withdrawal by Subject|1|||
164589600|NCT02678741|594523031|FG000|Overall Study|ineligible|3|||
164589601|NCT02678741|594523031|FG000|Overall Study|Not RECIST Measurable|2|||
164589602|NCT02678741|594523031|FG000|Overall Study|Lack of Efficacy|10|||
164589603|NCT02531373|594523040|FG000|Overall Study|Lack of Efficacy|0|||
164589604|NCT02531373|594523041|FG001|Overall Study|Lack of Efficacy|0|||
164589605|NCT02531373|594523042|FG002|Overall Study|Lack of Efficacy|0|||
164589606|NCT02531373|594523043|FG003|Overall Study|Lack of Efficacy|0|||
164589607|NCT02531373|594523044|FG004|Overall Study|Lack of Efficacy|3|||
164589608|NCT02531373|594523045|FG005|Overall Study|Lack of Efficacy|2|||
164589609|NCT02531373|594523046|FG006|Overall Study|Lack of Efficacy|4|||
164589610|NCT02531373|594523047|FG007|Overall Study|Lack of Efficacy|8|||
164589611|NCT02531373|594523048|FG008|Overall Study|Lack of Efficacy|5|||
164589612|NCT02531373|594523040|FG000|Overall Study|Lost to Follow-up|0|||
164589613|NCT02531373|594523041|FG001|Overall Study|Lost to Follow-up|0|||
164589614|NCT02531373|594523042|FG002|Overall Study|Lost to Follow-up|0|||
164589615|NCT02531373|594523043|FG003|Overall Study|Lost to Follow-up|0|||
164589616|NCT02531373|594523044|FG004|Overall Study|Lost to Follow-up|0|||
164589617|NCT02531373|594523045|FG005|Overall Study|Lost to Follow-up|2|||
164589618|NCT02531373|594523046|FG006|Overall Study|Lost to Follow-up|2|||
164589619|NCT02531373|594523047|FG007|Overall Study|Lost to Follow-up|0|||
164589620|NCT02531373|594523048|FG008|Overall Study|Lost to Follow-up|0|||
164589621|NCT02531373|594523040|FG000|Overall Study|Physician Decision|0|||
164589622|NCT02531373|594523041|FG001|Overall Study|Physician Decision|0|||
164589623|NCT02531373|594523042|FG002|Overall Study|Physician Decision|0|||
164589624|NCT02531373|594523043|FG003|Overall Study|Physician Decision|0|||
164589625|NCT02531373|594523044|FG004|Overall Study|Physician Decision|2|||
164589626|NCT02531373|594523045|FG005|Overall Study|Physician Decision|1|||
164589627|NCT02531373|594523046|FG006|Overall Study|Physician Decision|0|||
164589628|NCT02531373|594523047|FG007|Overall Study|Physician Decision|0|||
164589629|NCT02531373|594523048|FG008|Overall Study|Physician Decision|0|||
164589630|NCT02531373|594523040|FG000|Overall Study|Protocol Violation|0|||
164589631|NCT02531373|594523041|FG001|Overall Study|Protocol Violation|0|||
164589632|NCT02531373|594523042|FG002|Overall Study|Protocol Violation|0|||
164589633|NCT02531373|594523043|FG003|Overall Study|Protocol Violation|0|||
164589634|NCT02531373|594523044|FG004|Overall Study|Protocol Violation|0|||
164589635|NCT02531373|594523045|FG005|Overall Study|Protocol Violation|1|||
164589636|NCT02531373|594523046|FG006|Overall Study|Protocol Violation|1|||
164589637|NCT02531373|594523047|FG007|Overall Study|Protocol Violation|0|||
164589638|NCT02531373|594523048|FG008|Overall Study|Protocol Violation|1|||
164589639|NCT02531373|594523040|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164355803|NCT01949051|593678652|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
164355804|NCT01949051|593678653|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
164355805|NCT01949051|593678654|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
164355806|NCT01949051|593678655|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
164355807|NCT01949051|593678656|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
164355808|NCT01949051|593678657|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
164694895|NCT03877926|594905380|FG003|Overall Study|Withdrawal by Subject|4|||
164694896|NCT03877926|594905377|FG000|Overall Study|Other - Various|4|||
164694897|NCT03877926|594905378|FG001|Overall Study|Other - Various|1|||
164694898|NCT03877926|594905379|FG002|Overall Study|Other - Various|1|||
164694899|NCT03877926|594905380|FG003|Overall Study|Other - Various|0|||
164694900|NCT03877926|594905377|FG000|Overall Study|Not Treated|3|||
164694901|NCT03877926|594905378|FG001|Overall Study|Not Treated|1|||
164694902|NCT03877926|594905379|FG002|Overall Study|Not Treated|1|||
164694903|NCT03877926|594905380|FG003|Overall Study|Not Treated|0|||
164694904|NCT03554317|594905382|FG000|Overall Study|Withdrawal by Subject|1|||
164694905|NCT03554317|594905382|FG000|Overall Study|PSA Progression|3|||
164694906|NCT03554317|594905382|FG000|Overall Study|Radiographic Progression|4|||
164694907|NCT03546647|594905383|FG000|Overall Study|Adverse Event|1|||
164694908|NCT03546647|594905384|FG001|Overall Study|Adverse Event|0|||
164694909|NCT02400476|594905387|FG000|Overall Study|Adverse Event|57|||
164694910|NCT02400476|594905388|FG001|Overall Study|Adverse Event|10|||
164694911|NCT02400476|594905389|FG002|Overall Study|Adverse Event|22|||
164694912|NCT02400476|594905390|FG003|Overall Study|Adverse Event|19|||
164694913|NCT02400476|594905391|FG004|Overall Study|Adverse Event|5|||
164694914|NCT02400476|594905392|FG005|Overall Study|Adverse Event|8|||
164694915|NCT02400476|594905387|FG000|Overall Study|Withdrawal by Subject|4|||
164694916|NCT02400476|594905388|FG001|Overall Study|Withdrawal by Subject|1|||
164694917|NCT02400476|594905389|FG002|Overall Study|Withdrawal by Subject|12|||
164694918|NCT02400476|594905390|FG003|Overall Study|Withdrawal by Subject|7|||
164694919|NCT02400476|594905391|FG004|Overall Study|Withdrawal by Subject|5|||
164694920|NCT02400476|594905392|FG005|Overall Study|Withdrawal by Subject|5|||
164694921|NCT02400476|594905387|FG000|Overall Study|Lost to Follow-up|0|||
164694922|NCT02400476|594905388|FG001|Overall Study|Lost to Follow-up|0|||
164694923|NCT02400476|594905389|FG002|Overall Study|Lost to Follow-up|0|||
164694924|NCT02400476|594905390|FG003|Overall Study|Lost to Follow-up|1|||
164694925|NCT02400476|594905391|FG004|Overall Study|Lost to Follow-up|3|||
164694926|NCT02400476|594905392|FG005|Overall Study|Lost to Follow-up|1|||
164694927|NCT02400476|594905387|FG000|Overall Study|Physician Decision|0|||
164694928|NCT02400476|594905388|FG001|Overall Study|Physician Decision|0|||
164694929|NCT02400476|594905389|FG002|Overall Study|Physician Decision|1|||
164694930|NCT02400476|594905390|FG003|Overall Study|Physician Decision|1|||
164694931|NCT02400476|594905391|FG004|Overall Study|Physician Decision|0|||
164694932|NCT02400476|594905392|FG005|Overall Study|Physician Decision|1|||
164694933|NCT02400476|594905387|FG000|Overall Study|Other, Disease Progression|0|||
164694934|NCT02400476|594905388|FG001|Overall Study|Other, Disease Progression|1|||
164694935|NCT02400476|594905389|FG002|Overall Study|Other, Disease Progression|2|||
164694936|NCT02400476|594905390|FG003|Overall Study|Other, Disease Progression|1|||
164694937|NCT02400476|594905391|FG004|Overall Study|Other, Disease Progression|2|||
164694938|NCT02400476|594905392|FG005|Overall Study|Other, Disease Progression|1|||
164694939|NCT02400476|594905387|FG000|Overall Study|Other, Decreased Quality of Life|0|||
164694940|NCT02400476|594905388|FG001|Overall Study|Other, Decreased Quality of Life|0|||
164694941|NCT02400476|594905389|FG002|Overall Study|Other, Decreased Quality of Life|2|||
164694942|NCT02400476|594905390|FG003|Overall Study|Other, Decreased Quality of Life|0|||
164694943|NCT02400476|594905391|FG004|Overall Study|Other, Decreased Quality of Life|0|||
164694944|NCT02400476|594905392|FG005|Overall Study|Other, Decreased Quality of Life|0|||
164694945|NCT02400476|594905387|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
164694946|NCT02400476|594905388|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
164694947|NCT02400476|594905389|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
164694948|NCT02400476|594905390|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
164694949|NCT02400476|594905391|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
164694950|NCT02400476|594905392|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
164694951|NCT00124462|594905393|FG000|Overall Study|Lost to Follow-up|3|||
164694952|NCT00124462|594905394|FG001|Overall Study|Lost to Follow-up|3|||
164694953|NCT00124462|594905393|FG000|Overall Study|Physician Decision|3|||
164694954|NCT00124462|594905394|FG001|Overall Study|Physician Decision|4|||
164694955|NCT00124462|594905393|FG000|Overall Study|Withdrawal by Subject|4|||
164694956|NCT00124462|594905394|FG001|Overall Study|Withdrawal by Subject|5|||
164355809|NCT01949051|593678652|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
164694957|NCT00124462|594905393|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
164694958|NCT00124462|594905394|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
164694959|NCT02487082|594905395|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
164694960|NCT02487082|594905396|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
164694961|NCT02487082|594905395|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
164694962|NCT02487082|594905396|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
164355810|NCT01949051|593678653|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
164355811|NCT01949051|593678654|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
164355812|NCT01949051|593678655|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
164355813|NCT01949051|593678656|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
164355814|NCT01949051|593678657|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
164355815|NCT01949051|593678652|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
164355816|NCT01949051|593678653|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
164355817|NCT01949051|593678654|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
164355818|NCT01949051|593678655|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
164355819|NCT01949051|593678656|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
164355820|NCT01949051|593678657|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
164355821|NCT04545866|593678659|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|1|||
164355822|NCT04545866|593678660|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
164355823|NCT04545866|593678659|FG000|Overall Study|Withdrawal by Physician|1|||
164355824|NCT04545866|593678660|FG001|Overall Study|Withdrawal by Physician|0|||
164355825|NCT04463719|593678663|FG000|Overall Study|Exclusion criteria identified during clinical visit|2|||
164355826|NCT04463719|593678664|FG001|Overall Study|Exclusion criteria identified during clinical visit|2|||
164437523|NCT02914522|593968190|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
164437524|NCT02914522|593968191|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
164437525|NCT02914522|593968192|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
164437526|NCT02914522|593968193|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
164437527|NCT02914522|593968183|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
164437528|NCT02914522|593968184|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
164437529|NCT02914522|593968185|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
164437530|NCT02914522|593968186|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
164437531|NCT02914522|593968187|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
164437532|NCT02914522|593968188|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
164437533|NCT02914522|593968189|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
164355827|NCT04463719|593678665|FG002|Overall Study|Exclusion criteria identified during clinical visit|0|||
164355828|NCT02436356|593678666|FG000|Overall Study|Excluded by MRI Screening|0|||
164437534|NCT02914522|593968190|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
164437535|NCT02914522|593968191|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
164437536|NCT02914522|593968192|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
164437537|NCT02914522|593968193|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
164437538|NCT02914522|593968183|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
164437539|NCT02914522|593968184|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
164437540|NCT02914522|593968185|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
164437541|NCT02914522|593968186|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
164437542|NCT02914522|593968187|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
164437543|NCT02914522|593968188|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
164437544|NCT02914522|593968189|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
164437545|NCT02914522|593968190|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
164437546|NCT02914522|593968191|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
164437547|NCT02914522|593968192|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
164437548|NCT02914522|593968193|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
164437549|NCT02914522|593968183|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
164437550|NCT02914522|593968184|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
164437551|NCT02914522|593968185|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
164437552|NCT02914522|593968186|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
164437553|NCT02914522|593968187|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
164437554|NCT02914522|593968188|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
164437555|NCT02914522|593968189|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
164437556|NCT02914522|593968190|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
164437557|NCT02914522|593968191|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
164437558|NCT02914522|593968192|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
164437559|NCT02914522|593968193|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
164437560|NCT02914522|593968183|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
164532191|NCT00150969|594320500|FG001|24 Month Main Study|Adverse Event|4|||
164532192|NCT00150969|594320499|FG000|24 Month Main Study|Death|1|||
164532193|NCT00150969|594320500|FG001|24 Month Main Study|Death|1|||
164532194|NCT00150969|594320499|FG000|24 Month Main Study|Lack of Efficacy|1|||
164532195|NCT00150969|594320500|FG001|24 Month Main Study|Lack of Efficacy|8|||
164532196|NCT00150969|594320499|FG000|24 Month Main Study|Lost to Follow-up|3|||
164532197|NCT00150969|594320500|FG001|24 Month Main Study|Lost to Follow-up|2|||
164355829|NCT02436356|593678667|FG001|Overall Study|Excluded by MRI Screening|0|||
164532198|NCT00150969|594320499|FG000|24 Month Main Study|Protocol Violation|4|||
164532199|NCT00150969|594320500|FG001|24 Month Main Study|Protocol Violation|2|||
164532200|NCT00150969|594320499|FG000|24 Month Main Study|Withdrawal by Subject|7|||
164355830|NCT02436356|593678668|FG002|Overall Study|Excluded by MRI Screening|2|||
164355831|NCT02436356|593678666|FG000|Overall Study|Lost to Follow-up|0|||
164355832|NCT02436356|593678667|FG001|Overall Study|Lost to Follow-up|1|||
164355833|NCT02436356|593678668|FG002|Overall Study|Lost to Follow-up|0|||
164355834|NCT02436356|593678666|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
164355835|NCT02436356|593678667|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
164355836|NCT02436356|593678668|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
164355837|NCT02436356|593678666|FG000|Overall Study|Excluded due to other medical conditions|3|||
164355838|NCT02436356|593678667|FG001|Overall Study|Excluded due to other medical conditions|0|||
164355839|NCT02436356|593678668|FG002|Overall Study|Excluded due to other medical conditions|0|||
164355840|NCT02436356|593678666|FG000|Overall Study|Withdrawal by Subject|1|||
164355841|NCT02436356|593678667|FG001|Overall Study|Withdrawal by Subject|0|||
164355842|NCT02436356|593678668|FG002|Overall Study|Withdrawal by Subject|0|||
164437561|NCT02914522|593968184|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
164437562|NCT02914522|593968185|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
164437563|NCT02914522|593968186|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
164437564|NCT02914522|593968187|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
164437565|NCT02914522|593968188|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
164437566|NCT02914522|593968189|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
164437567|NCT02914522|593968190|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
164437568|NCT02914522|593968191|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
164437569|NCT02914522|593968192|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
164437570|NCT02914522|593968193|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
164437571|NCT03098030|593968194|FG000|Overall Study|Death|10|||
164437572|NCT03098030|593968195|FG001|Overall Study|Death|156|||
164437573|NCT03098030|593968196|FG002|Overall Study|Death|156|||
164437574|NCT03098030|593968197|FG003|Overall Study|Death|82|||
164437575|NCT03098030|593968194|FG000|Overall Study|Withdrawal by Subject|0|||
164437576|NCT03098030|593968195|FG001|Overall Study|Withdrawal by Subject|7|||
164437577|NCT03098030|593968196|FG002|Overall Study|Withdrawal by Subject|8|||
164589640|NCT02531373|594523041|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164589641|NCT02531373|594523042|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
164589642|NCT02531373|594523043|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
164589643|NCT02531373|594523044|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
164589644|NCT02531373|594523045|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
164589645|NCT02531373|594523046|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
164589646|NCT02531373|594523047|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
164589647|NCT02531373|594523048|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
164589648|NCT02531373|594523040|FG000|Overall Study|Withdrawal by Subject|0|||
164589649|NCT02531373|594523041|FG001|Overall Study|Withdrawal by Subject|0|||
164589650|NCT02531373|594523042|FG002|Overall Study|Withdrawal by Subject|0|||
164589651|NCT02531373|594523043|FG003|Overall Study|Withdrawal by Subject|0|||
164589652|NCT02531373|594523044|FG004|Overall Study|Withdrawal by Subject|3|||
164589653|NCT02531373|594523045|FG005|Overall Study|Withdrawal by Subject|0|||
164589654|NCT02531373|594523046|FG006|Overall Study|Withdrawal by Subject|0|||
164589655|NCT02531373|594523047|FG007|Overall Study|Withdrawal by Subject|0|||
164589656|NCT02531373|594523048|FG008|Overall Study|Withdrawal by Subject|0|||
164589657|NCT00390780|594523049|FG000|Overall Study|Not completed|10|||
164589658|NCT00390780|594523050|FG001|Overall Study|Not completed|4|||
164589659|NCT00390780|594523049|FG000|Overall Study|Protocol Violation|6|||
164589660|NCT00390780|594523050|FG001|Overall Study|Protocol Violation|4|||
164589661|NCT00390780|594523049|FG000|Overall Study|Lost to Follow-up|3|||
164589662|NCT00390780|594523050|FG001|Overall Study|Lost to Follow-up|6|||
164589663|NCT00390780|594523049|FG000|Overall Study|Adverse Event|2|||
164589664|NCT00390780|594523050|FG001|Overall Study|Adverse Event|3|||
164589665|NCT00390780|594523049|FG000|Overall Study|Death|1|||
164589666|NCT00390780|594523050|FG001|Overall Study|Death|3|||
164589667|NCT00390780|594523049|FG000|Overall Study|Withdrawal by Subject|1|||
164589668|NCT00390780|594523050|FG001|Overall Study|Withdrawal by Subject|2|||
164589669|NCT00390780|594523049|FG000|Overall Study|Inclusion criteria not satisfied|0|||
164589670|NCT00390780|594523050|FG001|Overall Study|Inclusion criteria not satisfied|2|||
164589671|NCT00390780|594523049|FG000|Overall Study|Lost to follow up and other reasons|0|||
164589672|NCT00390780|594523050|FG001|Overall Study|Lost to follow up and other reasons|1|||
164589673|NCT00390780|594523049|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
164589674|NCT00390780|594523050|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
164589675|NCT00390780|594523049|FG000|Overall Study|SAE, death|0|||
164437578|NCT03098030|593968197|FG003|Overall Study|Withdrawal by Subject|2|||
164589676|NCT00390780|594523050|FG001|Overall Study|SAE, death|1|||
164589677|NCT00305006|594523051|FG000|Overall Study|Withdrawal by Subject|1|||
164589678|NCT00305006|594523052|FG001|Overall Study|Withdrawal by Subject|0|||
164589679|NCT00305006|594523051|FG000|Overall Study|Failure to complete pretest|0|||
164355843|NCT02875860|593678669|FG000|Overall Study|Withdrawal by Subject|0|||
164355844|NCT02875860|593678670|FG001|Overall Study|Withdrawal by Subject|1|||
164355845|NCT03287804|593678671|FG000|Overall Study|Death|1|||
164355846|NCT03287804|593678671|FG000|Overall Study|Physician Decision|2|||
164355847|NCT03287804|593678671|FG000|Overall Study|Progressive disease|8|||
164355848|NCT01881776|593678672|FG000|Overall Study|Lost to Follow-up|1|||
164355849|NCT01881776|593678673|FG001|Overall Study|Lost to Follow-up|2|||
164355850|NCT01881776|593678674|FG002|Overall Study|Lost to Follow-up|1|||
164355851|NCT01881776|593678672|FG000|Overall Study|Protocol Violation|0|||
164355852|NCT01881776|593678673|FG001|Overall Study|Protocol Violation|2|||
164355853|NCT01881776|593678674|FG002|Overall Study|Protocol Violation|1|||
164355854|NCT00487747|593678675|FG000|Overall Study|Adverse Event|1|||
164355855|NCT00487747|593678675|FG000|Overall Study|Lost to Follow-up|9|||
164355856|NCT00487747|593678675|FG000|Overall Study|Lack of Efficacy|1|||
164355857|NCT04483011|593678676|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
164355858|NCT04483011|593678677|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
164437579|NCT03098030|593968194|FG000|Overall Study|Lost to Follow-up|0|||
164694963|NCT00588731|594905397|FG000|Overall Study|Withdrawal by Subject|3|||
164694964|NCT00588731|594905398|FG001|Overall Study|Withdrawal by Subject|2|||
164694965|NCT00268892|594905403|FG000|Overall Study|Adverse Event|14|||
164694966|NCT00268892|594905404|FG001|Overall Study|Adverse Event|17|||
164694967|NCT00268892|594905405|FG002|Overall Study|Adverse Event|20|||
164694968|NCT00268892|594905403|FG000|Overall Study|Lack of Efficacy|1|||
164694969|NCT00268892|594905404|FG001|Overall Study|Lack of Efficacy|3|||
164694970|NCT00268892|594905405|FG002|Overall Study|Lack of Efficacy|0|||
164694971|NCT00268892|594905403|FG000|Overall Study|Withdrawal by Subject|14|||
164694972|NCT00268892|594905404|FG001|Overall Study|Withdrawal by Subject|15|||
164694973|NCT00268892|594905405|FG002|Overall Study|Withdrawal by Subject|13|||
164694974|NCT00268892|594905403|FG000|Overall Study|Physician Decision|0|||
164694975|NCT00268892|594905404|FG001|Overall Study|Physician Decision|1|||
164694976|NCT00268892|594905405|FG002|Overall Study|Physician Decision|0|||
164694977|NCT00268892|594905403|FG000|Overall Study|Lost to Follow-up|5|||
164694978|NCT00268892|594905404|FG001|Overall Study|Lost to Follow-up|2|||
164694979|NCT00268892|594905405|FG002|Overall Study|Lost to Follow-up|4|||
164694980|NCT00268892|594905403|FG000|Overall Study|Protocol Violation|0|||
164694981|NCT00268892|594905404|FG001|Overall Study|Protocol Violation|1|||
164694982|NCT00268892|594905405|FG002|Overall Study|Protocol Violation|0|||
164694983|NCT00268892|594905403|FG000|Overall Study|Disease Progression|1|||
164694984|NCT00268892|594905404|FG001|Overall Study|Disease Progression|1|||
164694985|NCT00268892|594905405|FG002|Overall Study|Disease Progression|0|||
164694986|NCT00268892|594905403|FG000|Overall Study|Trial Site Closed|4|||
164694987|NCT00268892|594905404|FG001|Overall Study|Trial Site Closed|2|||
164694988|NCT00268892|594905405|FG002|Overall Study|Trial Site Closed|2|||
164694989|NCT00680186|594905406|FG000|Overall Study|Adverse Event|47|||
164694990|NCT00680186|594905407|FG001|Overall Study|Adverse Event|44|||
164694991|NCT00680186|594905406|FG000|Overall Study|Protocol Violation|31|||
164694992|NCT00680186|594905407|FG001|Overall Study|Protocol Violation|26|||
164694993|NCT00680186|594905406|FG000|Overall Study|Lost to Follow-up|11|||
164694994|NCT00680186|594905407|FG001|Overall Study|Lost to Follow-up|6|||
164694995|NCT00680186|594905406|FG000|Overall Study|Withdrawal by Subject|32|||
164694996|NCT00680186|594905407|FG001|Overall Study|Withdrawal by Subject|39|||
164694997|NCT00680186|594905406|FG000|Overall Study|Other|4|||
164694998|NCT00680186|594905407|FG001|Overall Study|Other|1|||
164694999|NCT01684878|594905410|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
164695000|NCT01684878|594905411|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
164695001|NCT01684878|594905412|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
164695002|NCT01684878|594905413|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
164695003|NCT01684878|594905410|FG000|Part 1: Safety Run in Phase|Death|15|||
164695004|NCT01684878|594905411|FG001|Part 1: Safety Run in Phase|Death|20|||
164695005|NCT01684878|594905412|FG002|Part 1: Safety Run in Phase|Death|0|||
164695006|NCT01684878|594905413|FG003|Part 1: Safety Run in Phase|Death|0|||
164695007|NCT01684878|594905410|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
164695008|NCT01684878|594905411|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
164695009|NCT01684878|594905412|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
164695010|NCT01684878|594905413|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
164695011|NCT01684878|594905410|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
164355859|NCT02979522|593678700|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
164355860|NCT02979522|593678701|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
164695012|NCT01684878|594905411|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
164695013|NCT01684878|594905412|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
164355861|NCT02979522|593678700|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
164355862|NCT02979522|593678701|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
164695014|NCT01684878|594905413|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
164695015|NCT01684878|594905410|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
164695016|NCT01684878|594905411|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
164695017|NCT01684878|594905412|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
164355863|NCT01896531|593678704|FG000|Overall Study|Death|57|||
164355864|NCT01896531|593678705|FG001|Overall Study|Death|59|||
164355865|NCT01896531|593678704|FG000|Overall Study|Lost to Follow-up|3|||
164355866|NCT01896531|593678705|FG001|Overall Study|Lost to Follow-up|0|||
164355867|NCT01896531|593678704|FG000|Overall Study|Non-compliance|0|||
164355868|NCT01896531|593678705|FG001|Overall Study|Non-compliance|1|||
164355869|NCT01896531|593678704|FG000|Overall Study|Study Ended by Sponsor|7|||
164355870|NCT01896531|593678705|FG001|Overall Study|Study Ended by Sponsor|20|||
164355871|NCT01896531|593678704|FG000|Overall Study|Withdrawal by Subject|3|||
164355872|NCT01896531|593678705|FG001|Overall Study|Withdrawal by Subject|2|||
164355873|NCT01896531|593678704|FG000|Overall Study|Death Prior to Treatment|1|||
164355874|NCT01896531|593678705|FG001|Overall Study|Death Prior to Treatment|0|||
164355875|NCT05185089|593678706|FG000|First Intervention (4 weeks)|Adverse Event|0|||
164437580|NCT03098030|593968195|FG001|Overall Study|Lost to Follow-up|0|||
164695018|NCT01684878|594905413|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
164695019|NCT01684878|594905410|FG000|Part 2: Randomized Phase|Death|0|||
164695020|NCT01684878|594905411|FG001|Part 2: Randomized Phase|Death|0|||
164695021|NCT01684878|594905412|FG002|Part 2: Randomized Phase|Death|62|||
164695022|NCT01684878|594905413|FG003|Part 2: Randomized Phase|Death|68|||
164695023|NCT01684878|594905410|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
164695024|NCT01684878|594905411|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
164695025|NCT01684878|594905412|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
164695026|NCT01684878|594905413|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
164695027|NCT01684878|594905410|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
164695028|NCT01684878|594905411|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
164695029|NCT01684878|594905412|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
164695030|NCT01684878|594905413|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
164695031|NCT04647383|594905417|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
164695032|NCT04647383|594905418|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
164695033|NCT04647383|594905419|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
164695034|NCT04647383|594905420|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
164695035|NCT02087176|594905421|FG000|Overall Study|Withdrawal by Subject|1|||
164695036|NCT02087176|594905421|FG000|Overall Study|Death|10|||
164695037|NCT02087176|594905421|FG000|Overall Study|Censored|19|||
164695038|NCT02087176|594905421|FG000|Overall Study|Study Terminated by Sponsor|2|||
164695039|NCT00479388|594905426|FG000|Overall Study|Adverse Event|90|||
164695040|NCT00479388|594905427|FG001|Overall Study|Adverse Event|45|||
164695041|NCT00479388|594905426|FG000|Overall Study|Lost to Follow-up|0|||
164695042|NCT00479388|594905427|FG001|Overall Study|Lost to Follow-up|2|||
164695043|NCT00479388|594905426|FG000|Overall Study|Protocol Violation|10|||
164695044|NCT00479388|594905427|FG001|Overall Study|Protocol Violation|9|||
164695045|NCT00479388|594905426|FG000|Overall Study|Withdrawal by Subject|32|||
164695046|NCT00479388|594905427|FG001|Overall Study|Withdrawal by Subject|17|||
164695047|NCT03942211|594905428|FG000|Overall Study|Death|1|||
164695048|NCT03942211|594905429|FG001|Overall Study|Death|0|||
164695049|NCT03942211|594905428|FG000|Overall Study|Study terminated by sponsor|5|||
164695050|NCT03942211|594905429|FG001|Overall Study|Study terminated by sponsor|3|||
164695051|NCT03942211|594905428|FG000|Overall Study|Adverse Event|0|||
164695052|NCT03942211|594905429|FG001|Overall Study|Adverse Event|1|||
164695053|NCT01876368|594905435|FG000|Overall Study|Adverse Event|2|||
164695054|NCT01876368|594905436|FG001|Overall Study|Adverse Event|5|||
164695055|NCT01876368|594905435|FG000|Overall Study|Lack of Efficacy|1|||
164695056|NCT01876368|594905436|FG001|Overall Study|Lack of Efficacy|0|||
164695057|NCT01876368|594905435|FG000|Overall Study|Lost to Follow-up|0|||
164695058|NCT01876368|594905436|FG001|Overall Study|Lost to Follow-up|1|||
164695059|NCT01876368|594905435|FG000|Overall Study|Non-compliance with study treatment|0|||
164695060|NCT01876368|594905436|FG001|Overall Study|Non-compliance with study treatment|1|||
164695061|NCT01876368|594905435|FG000|Overall Study|Physician Decision|0|||
164695062|NCT01876368|594905436|FG001|Overall Study|Physician Decision|2|||
164695063|NCT01876368|594905435|FG000|Overall Study|Protocol deviation|3|||
164695064|NCT01876368|594905436|FG001|Overall Study|Protocol deviation|3|||
164695065|NCT01876368|594905435|FG000|Overall Study|Subject/guardian decision|3|||
164695066|NCT01876368|594905436|FG001|Overall Study|Subject/guardian decision|1|||
164695067|NCT01955044|594905437|FG000|Overall Study|Death|1|||
164695068|NCT01955044|594905438|FG001|Overall Study|Death|1|||
164695069|NCT01955044|594905439|FG002|Overall Study|Death|0|||
164695070|NCT00605917|594905442|FG000|Overall Study|Protocol Violation|79|||
164695071|NCT03043560|594905443|FG000|Overall Study|Discontinued Intervention|1|||
164695072|NCT03043560|594905444|FG001|Overall Study|Discontinued Intervention|2|||
164695073|NCT03043560|594905443|FG000|Overall Study|Lost to Follow-up|0|||
164695074|NCT03043560|594905444|FG001|Overall Study|Lost to Follow-up|1|||
164695075|NCT00292227|594905445|FG000|Patch Period|Adverse Event|1|||
164695076|NCT00292227|594905446|FG001|Patch Period|Adverse Event|0|||
164355876|NCT05185089|593678707|FG001|First Intervention (4 weeks)|Adverse Event|0|||
164695077|NCT00292227|594905447|FG002|Patch Period|Adverse Event|2|||
164695078|NCT00292227|594905445|FG000|Patch Period|Withdrawal by Subject|0|||
164695079|NCT00292227|594905446|FG001|Patch Period|Withdrawal by Subject|0|||
164355877|NCT05185089|593678708|FG002|First Intervention (4 weeks)|Adverse Event|0|||
164437581|NCT03098030|593968196|FG002|Overall Study|Lost to Follow-up|2|||
164437582|NCT03098030|593968197|FG003|Overall Study|Lost to Follow-up|1|||
164437583|NCT03368001|593968199|FG000|Allocation|Lost to Pretest|16|||
164437584|NCT03368001|593968200|FG001|Allocation|Lost to Pretest|25|||
164437585|NCT03368001|593968199|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
164437586|NCT03368001|593968200|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
164437587|NCT03368001|593968199|FG000|Posttest|Lost to Posttest|7|||
164437588|NCT03368001|593968200|FG001|Posttest|Lost to Posttest|11|||
164437589|NCT03368001|593968199|FG000|Posttest|Discontinued Intervention|6|||
164589680|NCT00305006|594523052|FG001|Overall Study|Failure to complete pretest|1|||
164695080|NCT00292227|594905447|FG002|Patch Period|Withdrawal by Subject|1|||
164695081|NCT02329431|594905450|FG000|Overall Study|Lost to Follow-up|20|||
164695082|NCT02329431|594905451|FG001|Overall Study|Lost to Follow-up|13|||
164695083|NCT02105701|594905452|FG000|Overall Study|Lost to Follow-up|1|||
164695084|NCT02105701|594905453|FG001|Overall Study|Lost to Follow-up|0|||
164695085|NCT02105701|594905454|FG002|Overall Study|Lost to Follow-up|2|||
164695086|NCT02105701|594905455|FG003|Overall Study|Lost to Follow-up|1|||
164695087|NCT02105701|594905452|FG000|Overall Study|Protocol Violation|0|||
164695088|NCT02105701|594905453|FG001|Overall Study|Protocol Violation|0|||
164695089|NCT02105701|594905454|FG002|Overall Study|Protocol Violation|1|||
164695090|NCT02105701|594905455|FG003|Overall Study|Protocol Violation|0|||
164695091|NCT02105701|594905452|FG000|Overall Study|Withdrawal by Subject|2|||
164695092|NCT02105701|594905453|FG001|Overall Study|Withdrawal by Subject|1|||
164695093|NCT02105701|594905454|FG002|Overall Study|Withdrawal by Subject|0|||
164695094|NCT02105701|594905455|FG003|Overall Study|Withdrawal by Subject|1|||
164695095|NCT02105701|594905452|FG000|Overall Study|Death|1|||
164695096|NCT02105701|594905453|FG001|Overall Study|Death|0|||
164695097|NCT02105701|594905454|FG002|Overall Study|Death|0|||
164695098|NCT02105701|594905455|FG003|Overall Study|Death|0|||
164695099|NCT00248170|594905457|FG000|Overall Study|Withdrawal by Subject|71|||
164695100|NCT00248170|594905458|FG001|Overall Study|Withdrawal by Subject|79|||
164695101|NCT00248170|594905457|FG000|Overall Study|Protocol Violation|35|||
164695102|NCT00248170|594905458|FG001|Overall Study|Protocol Violation|30|||
164695103|NCT00248170|594905457|FG000|Overall Study|Lost to Follow-up|28|||
164695104|NCT00248170|594905458|FG001|Overall Study|Lost to Follow-up|35|||
164695105|NCT00248170|594905457|FG000|Overall Study|Disease progression|196|||
164695106|NCT00248170|594905458|FG001|Overall Study|Disease progression|216|||
164695107|NCT00248170|594905457|FG000|Overall Study|Death|28|||
164695108|NCT00248170|594905458|FG001|Overall Study|Death|47|||
164695109|NCT00248170|594905457|FG000|Overall Study|Adverse Event|311|||
164695110|NCT00248170|594905458|FG001|Overall Study|Adverse Event|296|||
164695111|NCT00248170|594905457|FG000|Overall Study|Administrative problems|22|||
164695112|NCT00248170|594905458|FG001|Overall Study|Administrative problems|25|||
164695113|NCT00248170|594905457|FG000|Overall Study|Abnormal test procedure(s) result|49|||
164695114|NCT00248170|594905458|FG001|Overall Study|Abnormal test procedure(s) result|61|||
164695115|NCT00248170|594905457|FG000|Overall Study|Abnormal laboratory values|4|||
164695116|NCT00248170|594905458|FG001|Overall Study|Abnormal laboratory values|0|||
164695117|NCT00248170|594905457|FG000|Overall Study|Protocol deviation|17|||
164695118|NCT00248170|594905458|FG001|Overall Study|Protocol deviation|19|||
164695119|NCT02953678|594905482|FG000|Overall Study|Adverse Event|20|||
164695120|NCT02953678|594905482|FG000|Overall Study|Death|7|||
164695121|NCT02953678|594905482|FG000|Overall Study|Physician Decision|23|||
164695122|NCT02953678|594905482|FG000|Overall Study|Progressive Disease of GVHD|7|||
164695123|NCT02953678|594905482|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
164695124|NCT02953678|594905482|FG000|Overall Study|Withdrawal by participant|3|||
164695125|NCT02953678|594905482|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
164695126|NCT02953678|594905482|FG000|Overall Study|Participants were transferred to commercial product.|3|||
164695127|NCT04034355|594905485|FG000|Overall Study|Study terminated by Sponsor|10|||
164437590|NCT03368001|593968200|FG001|Posttest|Discontinued Intervention|19|||
164437591|NCT03368001|593968199|FG000|Follow-up|Lost to Follow-up|6|||
164437592|NCT03368001|593968200|FG001|Follow-up|Lost to Follow-up|3|||
164437593|NCT03612804|593968201|FG000|Overall Study|Death|0|||
164589681|NCT02606045|594523053|FG000|Overall Study|Study closed before treament could begin|1|||
164589682|NCT02606045|594523054|FG001|Overall Study|Study closed before treament could begin|2|||
164589683|NCT01671085|594523056|FG000|Overall Study|Withdrawal by Subject|1|||
164589684|NCT01671085|594523057|FG001|Overall Study|Withdrawal by Subject|0|||
164589685|NCT00365716|594523058|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
164589686|NCT00365716|594523059|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
164589687|NCT00365716|594523060|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
164589688|NCT00365716|594523061|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
164589689|NCT00365716|594523062|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
164589690|NCT00365716|594523063|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
164589691|NCT00365716|594523064|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
164589692|NCT00365716|594523058|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
164695128|NCT04034355|594905486|FG001|Overall Study|Study terminated by Sponsor|17|||
164355878|NCT05185089|593678709|FG003|First Intervention (4 weeks)|Adverse Event|1|||
164355879|NCT05185089|593678706|FG000|Second Intervention (4 weeks)|Death|0|||
164355880|NCT05185089|593678707|FG001|Second Intervention (4 weeks)|Death|1|||
164355881|NCT05185089|593678708|FG002|Second Intervention (4 weeks)|Death|0|||
164355882|NCT05185089|593678709|FG003|Second Intervention (4 weeks)|Death|0|||
164355883|NCT05185089|593678706|FG000|Second Intervention (4 weeks)|Adverse Event|1|||
164355884|NCT05185089|593678707|FG001|Second Intervention (4 weeks)|Adverse Event|0|||
164355885|NCT05185089|593678708|FG002|Second Intervention (4 weeks)|Adverse Event|0|||
164355886|NCT05185089|593678709|FG003|Second Intervention (4 weeks)|Adverse Event|0|||
164355887|NCT00770289|593678710|FG000|Overall Study|Other|6|||
164355888|NCT02733991|593678711|FG000|Overall Study|Adverse Event|1|||
164355889|NCT02733991|593678712|FG001|Overall Study|Adverse Event|0|||
164355890|NCT02733991|593678711|FG000|Overall Study|Withdrawal by Subject|0|||
164355891|NCT02733991|593678712|FG001|Overall Study|Withdrawal by Subject|5|||
164355892|NCT02956486|593678715|FG000|Core Phase|Adverse Event|51|||
164355893|NCT02956486|593678716|FG001|Core Phase|Adverse Event|88|||
164355894|NCT02956486|593678717|FG002|Core Phase|Adverse Event|0|||
164355895|NCT02956486|593678715|FG000|Core Phase|Lost to Follow-up|8|||
164355896|NCT02956486|593678716|FG001|Core Phase|Lost to Follow-up|6|||
164355897|NCT02956486|593678717|FG002|Core Phase|Lost to Follow-up|0|||
164355898|NCT02956486|593678715|FG000|Core Phase|Inadequate therapeutic effect|4|||
164355899|NCT02956486|593678716|FG001|Core Phase|Inadequate therapeutic effect|5|||
164355900|NCT02956486|593678717|FG002|Core Phase|Inadequate therapeutic effect|0|||
164355901|NCT02956486|593678715|FG000|Core Phase|Withdrawal by Subject|101|||
164589693|NCT00365716|594523059|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
164589694|NCT00365716|594523060|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
164589695|NCT00365716|594523061|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
164589696|NCT00365716|594523062|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
164589697|NCT00365716|594523063|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
164589698|NCT00365716|594523064|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
164589699|NCT00365716|594523058|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
164589700|NCT00365716|594523059|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
164589701|NCT00365716|594523060|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
164589702|NCT00365716|594523061|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
164589703|NCT00365716|594523062|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
164589704|NCT00365716|594523063|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
164589705|NCT00365716|594523064|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
164589706|NCT00365716|594523058|FG000|Base Study (Day 1 to Month 7)|Other|0|||
164589707|NCT00365716|594523059|FG001|Base Study (Day 1 to Month 7)|Other|1|||
164589708|NCT00365716|594523060|FG002|Base Study (Day 1 to Month 7)|Other|0|||
164589709|NCT00365716|594523061|FG003|Base Study (Day 1 to Month 7)|Other|0|||
164589710|NCT00365716|594523062|FG004|Base Study (Day 1 to Month 7)|Other|0|||
164589711|NCT00365716|594523063|FG005|Base Study (Day 1 to Month 7)|Other|0|||
164589712|NCT00365716|594523064|FG006|Base Study (Day 1 to Month 7)|Other|0|||
164589713|NCT00365716|594523058|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
164589714|NCT00365716|594523059|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
164589715|NCT00365716|594523060|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
164589716|NCT00365716|594523061|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
164589717|NCT00365716|594523062|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
164589718|NCT00365716|594523063|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
164589719|NCT00365716|594523064|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
164589720|NCT00365716|594523058|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
164589721|NCT00365716|594523059|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
164589722|NCT00365716|594523060|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
164589723|NCT00365716|594523061|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
164589724|NCT00365716|594523062|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
164589725|NCT00365716|594523063|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
164355902|NCT02956486|593678716|FG001|Core Phase|Withdrawal by Subject|104|||
164355903|NCT02956486|593678717|FG002|Core Phase|Withdrawal by Subject|0|||
164695129|NCT04034355|594905485|FG000|Overall Study|Withdrawal by Subject|12|||
164695130|NCT04034355|594905486|FG001|Overall Study|Withdrawal by Subject|11|||
164695131|NCT04034355|594905485|FG000|Overall Study|Site terminated by Sponsor|4|||
164695132|NCT04034355|594905486|FG001|Overall Study|Site terminated by Sponsor|5|||
164695133|NCT04034355|594905485|FG000|Overall Study|Adverse Event|2|||
164695134|NCT04034355|594905486|FG001|Overall Study|Adverse Event|0|||
164695135|NCT04034355|594905485|FG000|Overall Study|Death|1|||
164695136|NCT04034355|594905486|FG001|Overall Study|Death|1|||
164695137|NCT04034355|594905485|FG000|Overall Study|Not reported|2|||
164695138|NCT04034355|594905486|FG001|Overall Study|Not reported|0|||
164695139|NCT04034355|594905485|FG000|Overall Study|Lost to Follow-up|1|||
164695140|NCT04034355|594905486|FG001|Overall Study|Lost to Follow-up|0|||
164695141|NCT04034355|594905485|FG000|Overall Study|Physician Decision|1|||
164695142|NCT04034355|594905486|FG001|Overall Study|Physician Decision|0|||
164695143|NCT04034355|594905485|FG000|Overall Study|Protocol Violation|0|||
164695144|NCT04034355|594905486|FG001|Overall Study|Protocol Violation|1|||
164695145|NCT04034355|594905485|FG000|Overall Study|Progressive disease|1|||
164695146|NCT04034355|594905486|FG001|Overall Study|Progressive disease|0|||
164695147|NCT03064438|594907635|FG000|Overall Study|Lost to Follow-up|1|||
164695148|NCT03064438|594907636|FG001|Overall Study|Lost to Follow-up|0|||
164695149|NCT03064438|594907635|FG000|Overall Study|Withdrawal by Subject|0|||
164695150|NCT03064438|594907636|FG001|Overall Study|Withdrawal by Subject|1|||
164695151|NCT01937351|594907637|FG000|Overall Study|Withdrawal by Subject|4|||
164695152|NCT01937351|594907638|FG001|Overall Study|Withdrawal by Subject|2|||
164695153|NCT01937351|594907637|FG000|Overall Study|Death|1|||
164695154|NCT01937351|594907638|FG001|Overall Study|Death|0|||
164695155|NCT01937351|594907637|FG000|Overall Study|Not treated w device, per protocol fail|4|||
164695156|NCT01937351|594907638|FG001|Overall Study|Not treated w device, per protocol fail|0|||
164695157|NCT04373551|594907639|FG000|Overall Study|Lost to Follow-up|15|||
164695158|NCT04373551|594907639|FG000|Overall Study|Did not collect 12-month data on participants enrolled in 2024 (at Site 2)|4|||
164695159|NCT02070757|594907640|FG000|Overall Study|Adverse Event|107|||
164695160|NCT02070757|594907641|FG001|Overall Study|Adverse Event|99|||
164695161|NCT02070757|594907640|FG000|Overall Study|Lost to Follow-up|7|||
164695162|NCT02070757|594907641|FG001|Overall Study|Lost to Follow-up|4|||
164695163|NCT02070757|594907640|FG000|Overall Study|Protocol Violation|0|||
164695164|NCT02070757|594907641|FG001|Overall Study|Protocol Violation|4|||
164695165|NCT02070757|594907640|FG000|Overall Study|Withdrawal by Subject|1|||
164695166|NCT02070757|594907641|FG001|Overall Study|Withdrawal by Subject|3|||
164695167|NCT02070757|594907640|FG000|Overall Study|Investigator Decision|0|||
164695168|NCT02070757|594907641|FG001|Overall Study|Investigator Decision|2|||
164695169|NCT02070757|594907640|FG000|Overall Study|Discharged from Study Hospital|2|||
164695170|NCT02070757|594907641|FG001|Overall Study|Discharged from Study Hospital|2|||
164695171|NCT04086641|594907642|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
164695172|NCT04086641|594907643|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
164695173|NCT00126126|594907653|FG000|Overall Study|Lost to Follow-up|0|||
164695174|NCT00126126|594907654|FG001|Overall Study|Lost to Follow-up|2|||
164695175|NCT01048502|594907655|FG000|Overall Study|Lost to Follow-up|2|||
164695176|NCT01048502|594907656|FG001|Overall Study|Lost to Follow-up|0|||
164695177|NCT01048502|594907657|FG002|Overall Study|Lost to Follow-up|0|||
164695178|NCT01048502|594907658|FG003|Overall Study|Lost to Follow-up|0|||
164695179|NCT01048502|594907655|FG000|Overall Study|Adverse Event|1|||
164695180|NCT01048502|594907656|FG001|Overall Study|Adverse Event|0|||
164695181|NCT01048502|594907657|FG002|Overall Study|Adverse Event|0|||
164695182|NCT01048502|594907658|FG003|Overall Study|Adverse Event|0|||
164695183|NCT01048502|594907655|FG000|Overall Study|Withdrawal by Subject|1|||
164695184|NCT01048502|594907656|FG001|Overall Study|Withdrawal by Subject|4|||
164695185|NCT01048502|594907657|FG002|Overall Study|Withdrawal by Subject|5|||
164695186|NCT01048502|594907658|FG003|Overall Study|Withdrawal by Subject|3|||
164695187|NCT01048502|594907655|FG000|Overall Study|Physician Decision|0|||
164695188|NCT01048502|594907656|FG001|Overall Study|Physician Decision|3|||
164695189|NCT01048502|594907657|FG002|Overall Study|Physician Decision|0|||
164695190|NCT01048502|594907658|FG003|Overall Study|Physician Decision|1|||
164695191|NCT01333072|594907660|FG000|Overall Study|Lost to Follow-up|3|||
164695192|NCT01333072|594907661|FG001|Overall Study|Lost to Follow-up|0|||
164695193|NCT01333072|594907660|FG000|Overall Study|Adverse Event|2|||
164695194|NCT01333072|594907661|FG001|Overall Study|Adverse Event|4|||
164695195|NCT01333072|594907660|FG000|Overall Study|Physician Decision|1|||
164695196|NCT01333072|594907661|FG001|Overall Study|Physician Decision|0|||
164355904|NCT02956486|593678715|FG000|Core Phase|Study terminated by sponsor|888|||
164355905|NCT02956486|593678716|FG001|Core Phase|Study terminated by sponsor|848|||
164355906|NCT02956486|593678717|FG002|Core Phase|Study terminated by sponsor|0|||
164355907|NCT02956486|593678715|FG000|Core Phase|Other|27|||
164695197|NCT02457611|594907662|FG000|Overall Study|Lost to Follow-up|3|||
164695198|NCT01463982|594907663|FG000|Overall Study|Withdrawal by Subject|0|||
164695199|NCT01463982|594907664|FG001|Overall Study|Withdrawal by Subject|1|||
164355908|NCT02956486|593678716|FG001|Core Phase|Other|18|||
164695200|NCT01463982|594907665|FG002|Overall Study|Withdrawal by Subject|1|||
164437594|NCT03612804|593968202|FG001|Overall Study|Death|7|||
164437595|NCT03612804|593968203|FG002|Overall Study|Death|0|||
164437596|NCT03612804|593968204|FG003|Overall Study|Death|8|||
164437597|NCT03612804|593968201|FG000|Overall Study|Medication copay coverage issues|0|||
164437598|NCT03612804|593968202|FG001|Overall Study|Medication copay coverage issues|0|||
164437599|NCT03612804|593968203|FG002|Overall Study|Medication copay coverage issues|0|||
164589726|NCT00365716|594523064|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
164589727|NCT00365716|594523058|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
164589728|NCT00365716|594523059|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
164589729|NCT00365716|594523060|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
164589730|NCT00365716|594523061|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
164589731|NCT00365716|594523062|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
164589732|NCT00365716|594523063|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
164589733|NCT00365716|594523064|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
164589734|NCT00365716|594523058|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
164589735|NCT00365716|594523059|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
164589736|NCT00365716|594523060|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
164589737|NCT00365716|594523061|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
164589738|NCT00365716|594523062|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
164589739|NCT00365716|594523063|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
164589740|NCT00365716|594523064|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
164589741|NCT00365716|594523058|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
164589742|NCT00365716|594523059|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
164589743|NCT00365716|594523060|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
164589744|NCT00365716|594523061|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
164589745|NCT00365716|594523062|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
164589746|NCT00365716|594523063|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
164589747|NCT00365716|594523064|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
164589748|NCT00365716|594523058|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
164589749|NCT00365716|594523059|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
164589750|NCT00365716|594523060|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
164589751|NCT00365716|594523061|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
164589752|NCT00365716|594523062|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
164589753|NCT00365716|594523063|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
164589754|NCT00365716|594523064|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
164589755|NCT00365716|594523058|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
164589756|NCT00365716|594523059|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
164589757|NCT00365716|594523060|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
164589758|NCT00365716|594523061|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
164589759|NCT00365716|594523062|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
164589760|NCT00365716|594523063|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
164589761|NCT00365716|594523064|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
164589762|NCT00365716|594523058|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
164589763|NCT00365716|594523059|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
164589764|NCT00365716|594523060|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
164589765|NCT00365716|594523061|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
164589766|NCT00365716|594523062|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
164589767|NCT00365716|594523063|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
164589768|NCT00365716|594523064|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
164589769|NCT00365716|594523058|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
164589770|NCT00365716|594523059|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
164589771|NCT00365716|594523060|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
164589772|NCT00365716|594523061|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
164589773|NCT00365716|594523062|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
164589774|NCT00365716|594523063|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
164589775|NCT00365716|594523064|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
164589776|NCT00365716|594523058|FG000|Extension 1|Lost to Follow-up|0|||
164589777|NCT00365716|594523059|FG001|Extension 1|Lost to Follow-up|0|||
164589778|NCT00365716|594523060|FG002|Extension 1|Lost to Follow-up|0|||
164589779|NCT00365716|594523061|FG003|Extension 1|Lost to Follow-up|0|||
164589780|NCT00365716|594523062|FG004|Extension 1|Lost to Follow-up|0|||
164589781|NCT00365716|594523063|FG005|Extension 1|Lost to Follow-up|1|||
164589782|NCT00365716|594523064|FG006|Extension 1|Lost to Follow-up|0|||
164589783|NCT00365716|594523058|FG000|Extension 1|Other|0|||
164589784|NCT00365716|594523059|FG001|Extension 1|Other|0|||
164589785|NCT00365716|594523060|FG002|Extension 1|Other|0|||
164589786|NCT00365716|594523061|FG003|Extension 1|Other|0|||
164437600|NCT03612804|593968204|FG003|Overall Study|Medication copay coverage issues|17|||
164437601|NCT03612804|593968201|FG000|Overall Study|Not current smoker at time of screening|0|||
164437602|NCT03612804|593968202|FG001|Overall Study|Not current smoker at time of screening|1|||
164437603|NCT03612804|593968203|FG002|Overall Study|Not current smoker at time of screening|0|||
164437604|NCT03612804|593968204|FG003|Overall Study|Not current smoker at time of screening|3|||
164437605|NCT03612804|593968201|FG000|Overall Study|Non-veteran status|0|||
164437606|NCT03612804|593968202|FG001|Overall Study|Non-veteran status|1|||
164437607|NCT03612804|593968203|FG002|Overall Study|Non-veteran status|0|||
164437608|NCT03612804|593968204|FG003|Overall Study|Non-veteran status|0|||
164437609|NCT03612804|593968201|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
164437610|NCT03612804|593968202|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
164437611|NCT03612804|593968203|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
164437612|NCT03612804|593968204|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
164437613|NCT03612804|593968201|FG000|Overall Study|Provider retired from VA|0|||
164437614|NCT03612804|593968202|FG001|Overall Study|Provider retired from VA|0|||
164437615|NCT03612804|593968203|FG002|Overall Study|Provider retired from VA|2|||
164437616|NCT03612804|593968204|FG003|Overall Study|Provider retired from VA|0|||
164437617|NCT03612804|593968201|FG000|Overall Study|Withdrawal by Subject|0|||
164437618|NCT03612804|593968202|FG001|Overall Study|Withdrawal by Subject|0|||
164437619|NCT03612804|593968203|FG002|Overall Study|Withdrawal by Subject|7|||
164437620|NCT03612804|593968204|FG003|Overall Study|Withdrawal by Subject|0|||
164437621|NCT03612804|593968201|FG000|Overall Study|Provider involved with study activities|1|||
164437622|NCT03612804|593968202|FG001|Overall Study|Provider involved with study activities|0|||
164437623|NCT03612804|593968203|FG002|Overall Study|Provider involved with study activities|0|||
164437624|NCT03612804|593968204|FG003|Overall Study|Provider involved with study activities|0|||
164437625|NCT05484726|593968205|FG000|Overall Study|Protocol Violation|3|||
164437626|NCT05484726|593968206|FG001|Overall Study|Protocol Violation|3|||
164437627|NCT05484726|593968205|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
164437628|NCT05484726|593968206|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
164437629|NCT05484726|593968205|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
164437630|NCT05484726|593968206|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
164437631|NCT05484726|593968205|FG000|Overall Study|continued need of mechanical ventilation|2|||
164437632|NCT05484726|593968206|FG001|Overall Study|continued need of mechanical ventilation|3|||
164437633|NCT05484726|593968205|FG000|Overall Study|Withdrawal by Subject|2|||
164437634|NCT05484726|593968206|FG001|Overall Study|Withdrawal by Subject|3|||
164437635|NCT05484726|593968205|FG000|Overall Study|IVH (G III & IV)|2|||
164437636|NCT05484726|593968206|FG001|Overall Study|IVH (G III & IV)|1|||
164437637|NCT05484726|593968205|FG000|Overall Study|NEC (stage II & III)|2|||
164437638|NCT05484726|593968206|FG001|Overall Study|NEC (stage II & III)|3|||
164437639|NCT04550039|593968207|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
164437640|NCT04550039|593968208|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
164437641|NCT04550039|593968207|FG000|Overall Study|patient self-withdrew from study|0|||
164437642|NCT04550039|593968208|FG001|Overall Study|patient self-withdrew from study|1|||
164437643|NCT04391309|593968209|FG000|Overall Study|Death|1|||
164437644|NCT04391309|593968210|FG001|Overall Study|Death|1|||
164437645|NCT04391309|593968209|FG000|Overall Study|Lost to Follow-up|3|||
164437646|NCT04391309|593968210|FG001|Overall Study|Lost to Follow-up|2|||
164437647|NCT04391309|593968209|FG000|Overall Study|Withdrawal by Subject|2|||
164437648|NCT04391309|593968210|FG001|Overall Study|Withdrawal by Subject|2|||
164437649|NCT00995709|593968215|FG000|Overall Study|Adverse Event|4|||
164437650|NCT00995709|593968216|FG001|Overall Study|Adverse Event|2|||
164437651|NCT00995709|593968217|FG002|Overall Study|Adverse Event|0|||
164437652|NCT00995709|593968215|FG000|Overall Study|Lack of Efficacy|0|||
164437653|NCT00995709|593968216|FG001|Overall Study|Lack of Efficacy|1|||
164437654|NCT00995709|593968217|FG002|Overall Study|Lack of Efficacy|4|||
164437655|NCT00995709|593968215|FG000|Overall Study|Withdrawal by Subject|0|||
164437656|NCT00995709|593968216|FG001|Overall Study|Withdrawal by Subject|4|||
164437657|NCT00995709|593968217|FG002|Overall Study|Withdrawal by Subject|1|||
164437658|NCT00995709|593968215|FG000|Overall Study|Lost to Follow-up|1|||
164437659|NCT00995709|593968216|FG001|Overall Study|Lost to Follow-up|0|||
164437660|NCT00995709|593968217|FG002|Overall Study|Lost to Follow-up|0|||
164437661|NCT00995709|593968215|FG000|Overall Study|Death|0|||
164437662|NCT00995709|593968216|FG001|Overall Study|Death|1|||
164437663|NCT00995709|593968217|FG002|Overall Study|Death|0|||
164437664|NCT00995709|593968215|FG000|Overall Study|Protocol Violation|2|||
164437665|NCT00995709|593968216|FG001|Overall Study|Protocol Violation|1|||
164437666|NCT00995709|593968217|FG002|Overall Study|Protocol Violation|0|||
164437667|NCT00604721|593968220|FG000|Overall Study|Physician Decision|1|||
164437668|NCT00604721|593968220|FG000|Overall Study|Withdrawal by Subject|1|||
164437669|NCT01838551|593968221|FG000|Overall Study|Adverse Event|16|||
164437670|NCT01838551|593968221|FG000|Overall Study|Death|1|||
164437671|NCT01838551|593968221|FG000|Overall Study|Lack of Efficacy|10|||
164437672|NCT01838551|593968221|FG000|Overall Study|Physician Decision|4|||
164437673|NCT01838551|593968221|FG000|Overall Study|Withdrawal by Subject|10|||
164437674|NCT01838551|593968221|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
164437675|NCT00038103|593968222|FG000|Overall Study|Adverse Event|5|||
164437676|NCT00038103|593968223|FG001|Overall Study|Adverse Event|6|||
164437677|NCT00038103|593968222|FG000|Overall Study|Lack of Efficacy|48|||
164437678|NCT00038103|593968223|FG001|Overall Study|Lack of Efficacy|41|||
164437679|NCT00038103|593968222|FG000|Overall Study|Withdrawal by Subject|0|||
164437680|NCT00038103|593968223|FG001|Overall Study|Withdrawal by Subject|3|||
164437681|NCT00038103|593968222|FG000|Overall Study|Lost to Follow-up|0|||
164437682|NCT00038103|593968223|FG001|Overall Study|Lost to Follow-up|3|||
164437683|NCT00038103|593968222|FG000|Overall Study|Protocol Violation|0|||
164437684|NCT00038103|593968223|FG001|Overall Study|Protocol Violation|2|||
164695201|NCT01463982|594907666|FG003|Overall Study|Withdrawal by Subject|0|||
164695202|NCT01463982|594907663|FG000|Overall Study|Treatment delay over 5 week|0|||
164695203|NCT01463982|594907664|FG001|Overall Study|Treatment delay over 5 week|0|||
164695204|NCT01463982|594907665|FG002|Overall Study|Treatment delay over 5 week|1|||
164695205|NCT01463982|594907666|FG003|Overall Study|Treatment delay over 5 week|0|||
164695206|NCT04220775|594907673|FG000|Overall Study|Adverse Event|1|||
164695207|NCT04220775|594907674|FG001|Overall Study|Adverse Event|0|||
164695208|NCT04220775|594907673|FG000|Overall Study|Disease Progression|1|||
164695209|NCT04220775|594907674|FG001|Overall Study|Disease Progression|0|||
164695210|NCT00271024|594907677|FG000|Overall Study|Lost Interest|3|||
164695211|NCT00271024|594907678|FG001|Overall Study|Lost Interest|4|||
164695212|NCT00271024|594907679|FG002|Overall Study|Lost Interest|2|||
164695213|NCT00271024|594907680|FG003|Overall Study|Lost Interest|3|||
164695214|NCT00271024|594907677|FG000|Overall Study|Unknown/Unspecified|11|||
164695215|NCT00271024|594907678|FG001|Overall Study|Unknown/Unspecified|11|||
164695216|NCT00271024|594907679|FG002|Overall Study|Unknown/Unspecified|8|||
164695217|NCT00271024|594907680|FG003|Overall Study|Unknown/Unspecified|4|||
164695218|NCT00271024|594907677|FG000|Overall Study|Protocol Violation|1|||
164695219|NCT00271024|594907678|FG001|Overall Study|Protocol Violation|6|||
164695220|NCT00271024|594907679|FG002|Overall Study|Protocol Violation|5|||
164695221|NCT00271024|594907680|FG003|Overall Study|Protocol Violation|11|||
164695222|NCT00271024|594907677|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
164695223|NCT00271024|594907678|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
164695224|NCT00271024|594907679|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
164695225|NCT00271024|594907680|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
164695226|NCT00271024|594907677|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
164695227|NCT00271024|594907678|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
164695228|NCT00271024|594907679|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
164695229|NCT00271024|594907680|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
164695230|NCT04668274|594907684|FG000|Part 1 Study Period 1|Adverse Event|3|||
164695231|NCT04668274|594907685|FG001|Part 1 Study Period 1|Adverse Event|0|||
164695232|NCT04668274|594907686|FG002|Part 1 Study Period 1|Adverse Event|0|||
164695233|NCT04668274|594907687|FG003|Part 1 Study Period 1|Adverse Event|0|||
164695234|NCT04668274|594907684|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
164695235|NCT04668274|594907685|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
164695236|NCT04668274|594907686|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
164695237|NCT04668274|594907687|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
164695238|NCT04668274|594907684|FG000|Part 1 Study Period 2|Other|0|||
164695239|NCT04668274|594907685|FG001|Part 1 Study Period 2|Other|1|||
164695240|NCT04668274|594907686|FG002|Part 1 Study Period 2|Other|0|||
164695241|NCT04668274|594907687|FG003|Part 1 Study Period 2|Other|0|||
164695242|NCT04668274|594907684|FG000|Part 1 Study Period 3|Adverse Event|0|||
164695243|NCT04668274|594907685|FG001|Part 1 Study Period 3|Adverse Event|0|||
164695244|NCT04668274|594907686|FG002|Part 1 Study Period 3|Adverse Event|1|||
164695245|NCT04668274|594907687|FG003|Part 1 Study Period 3|Adverse Event|0|||
164695246|NCT04668274|594907684|FG000|Part 1 Study Period 3|Other|0|||
164695247|NCT04668274|594907685|FG001|Part 1 Study Period 3|Other|0|||
164695248|NCT04668274|594907686|FG002|Part 1 Study Period 3|Other|2|||
164437685|NCT00038103|593968222|FG000|Overall Study|Sponsor Decision|0|||
164437686|NCT00038103|593968223|FG001|Overall Study|Sponsor Decision|1|||
164437687|NCT00038103|593968222|FG000|Overall Study|Randomized/never treated|2|||
164437688|NCT00038103|593968223|FG001|Overall Study|Randomized/never treated|0|||
164695249|NCT04668274|594907687|FG003|Part 1 Study Period 3|Other|0|||
164695250|NCT04668274|594907684|FG000|Part 2 Study Period 4|Other|0|||
164695251|NCT04668274|594907685|FG001|Part 2 Study Period 4|Other|0|||
164695252|NCT04668274|594907686|FG002|Part 2 Study Period 4|Other|0|||
164695253|NCT04668274|594907687|FG003|Part 2 Study Period 4|Other|1|||
164695254|NCT04449341|594907690|FG000|Overall Study|Protocol Violation|1|||
164437689|NCT02163915|593968232|FG000|Overall Study|Withdrawal by Subject|2|||
164437690|NCT02163915|593968233|FG001|Overall Study|Withdrawal by Subject|0|||
164437691|NCT02163915|593968234|FG002|Overall Study|Withdrawal by Subject|2|||
164437692|NCT02163915|593968235|FG003|Overall Study|Withdrawal by Subject|2|||
164437693|NCT02163915|593968236|FG004|Overall Study|Withdrawal by Subject|2|||
164437694|NCT02163915|593968232|FG000|Overall Study|Study termination|1|||
164695255|NCT04449341|594907691|FG001|Overall Study|Protocol Violation|0|||
164437695|NCT02163915|593968233|FG001|Overall Study|Study termination|0|||
164437696|NCT02163915|593968234|FG002|Overall Study|Study termination|0|||
164437697|NCT02163915|593968235|FG003|Overall Study|Study termination|0|||
164437698|NCT02163915|593968236|FG004|Overall Study|Study termination|2|||
164437699|NCT02163915|593968232|FG000|Overall Study|Physician Decision|0|||
164437700|NCT02163915|593968233|FG001|Overall Study|Physician Decision|0|||
164437701|NCT02163915|593968234|FG002|Overall Study|Physician Decision|0|||
164437702|NCT02163915|593968235|FG003|Overall Study|Physician Decision|1|||
164437703|NCT02163915|593968236|FG004|Overall Study|Physician Decision|0|||
164437704|NCT02299336|593968241|FG000|Overall Study|Withdrawal by Subject|11|||
164437705|NCT02299336|593968241|FG000|Overall Study|Adverse Event|1|||
164437706|NCT02299336|593968241|FG000|Overall Study|Death|1|||
164437707|NCT02299336|593968241|FG000|Overall Study|Lost to Follow-up|1|||
164437708|NCT02013037|593968245|FG000|Overall Study|Death|6|||
164437709|NCT02013037|593968245|FG000|Overall Study|Withdrawal by Subject|1|||
164437710|NCT02013037|593968245|FG000|Overall Study|Awaiting Transplantation|7|||
164437711|NCT02013037|593968245|FG000|Overall Study|Transplanted without DSA|2|||
164437712|NCT01867580|593968246|FG000|Overall Study|Withdrawal by Subject|2|||
164437713|NCT01867580|593968247|FG001|Overall Study|Withdrawal by Subject|3|||
164437714|NCT01867580|593968246|FG000|Overall Study|Physician Decision|17|||
164437715|NCT01867580|593968247|FG001|Overall Study|Physician Decision|12|||
164437716|NCT01867580|593968246|FG000|Overall Study|Lost to Follow-up|3|||
164589787|NCT00365716|594523062|FG004|Extension 1|Other|0|||
164589788|NCT00365716|594523063|FG005|Extension 1|Other|9|||
164589789|NCT00365716|594523064|FG006|Extension 1|Other|0|||
164695256|NCT04499482|594907692|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
164695257|NCT02363439|594907693|FG000|Overall Study|Lack of Efficacy|4|||
164695258|NCT03573817|594907698|FG000|Overall Study|Adverse Event|0|||
164695259|NCT03573817|594907699|FG001|Overall Study|Adverse Event|2|||
164695260|NCT03573817|594907698|FG000|Overall Study|Protocol Violation|0|||
164695261|NCT03573817|594907699|FG001|Overall Study|Protocol Violation|1|||
164695262|NCT03573817|594907698|FG000|Overall Study|Withdrawal by Subject|1|||
164589790|NCT00365716|594523058|FG000|Extension 1|Moved|0|||
164589791|NCT00365716|594523059|FG001|Extension 1|Moved|0|||
164589792|NCT00365716|594523060|FG002|Extension 1|Moved|0|||
164589793|NCT00365716|594523061|FG003|Extension 1|Moved|0|||
164589794|NCT00365716|594523062|FG004|Extension 1|Moved|0|||
164589795|NCT00365716|594523063|FG005|Extension 1|Moved|4|||
164589796|NCT00365716|594523064|FG006|Extension 1|Moved|0|||
164589797|NCT00365716|594523058|FG000|Extension 1|Withdrawal by Subject|0|||
164589798|NCT00365716|594523059|FG001|Extension 1|Withdrawal by Subject|0|||
164589799|NCT00365716|594523060|FG002|Extension 1|Withdrawal by Subject|0|||
164589800|NCT00365716|594523061|FG003|Extension 1|Withdrawal by Subject|0|||
164589801|NCT00365716|594523062|FG004|Extension 1|Withdrawal by Subject|0|||
164589802|NCT00365716|594523063|FG005|Extension 1|Withdrawal by Subject|3|||
164589803|NCT00365716|594523064|FG006|Extension 1|Withdrawal by Subject|0|||
164589804|NCT00365716|594523058|FG000|Extension 1|Pregnancy|0|||
164589805|NCT00365716|594523059|FG001|Extension 1|Pregnancy|0|||
164589806|NCT00365716|594523060|FG002|Extension 1|Pregnancy|0|||
164589807|NCT00365716|594523061|FG003|Extension 1|Pregnancy|0|||
164589808|NCT00365716|594523062|FG004|Extension 1|Pregnancy|0|||
164589809|NCT00365716|594523063|FG005|Extension 1|Pregnancy|4|||
164589810|NCT00365716|594523064|FG006|Extension 1|Pregnancy|0|||
164589811|NCT00365716|594523058|FG000|Extension 1|Protocol Violation|0|||
164589812|NCT00365716|594523059|FG001|Extension 1|Protocol Violation|0|||
164695263|NCT03573817|594907699|FG001|Overall Study|Withdrawal by Subject|1|||
164695264|NCT02010255|594907700|FG000|Overall Study|Death|0|||
164695265|NCT02010255|594907701|FG001|Overall Study|Death|1|||
164695266|NCT02010255|594907702|FG002|Overall Study|Death|4|||
164695267|NCT02010255|594907703|FG003|Overall Study|Death|4|||
164695268|NCT02010255|594907704|FG004|Overall Study|Death|2|||
164695269|NCT02010255|594907705|FG005|Overall Study|Death|0|||
164695270|NCT02010255|594907706|FG006|Overall Study|Death|1|||
164695271|NCT02010255|594907707|FG007|Overall Study|Death|1|||
164695272|NCT02010255|594907708|FG008|Overall Study|Death|1|||
164695273|NCT02010255|594907709|FG009|Overall Study|Death|0|||
164437717|NCT01867580|593968247|FG001|Overall Study|Lost to Follow-up|5|||
164437718|NCT01867580|593968246|FG000|Overall Study|Sponsor terminated study|1|||
164437719|NCT01867580|593968247|FG001|Overall Study|Sponsor terminated study|0|||
164437720|NCT01867580|593968246|FG000|Overall Study|Missed follow-up assessment|2|||
164437721|NCT01867580|593968247|FG001|Overall Study|Missed follow-up assessment|1|||
164589813|NCT00365716|594523060|FG002|Extension 1|Protocol Violation|0|||
164589814|NCT00365716|594523061|FG003|Extension 1|Protocol Violation|0|||
164695274|NCT02010255|594907710|FG010|Overall Study|Death|1|||
164437722|NCT01867580|593968246|FG000|Overall Study|Interruption to therapy|3|||
164589815|NCT00365716|594523062|FG004|Extension 1|Protocol Violation|0|||
164589816|NCT00365716|594523063|FG005|Extension 1|Protocol Violation|1|||
164589817|NCT00365716|594523064|FG006|Extension 1|Protocol Violation|0|||
164589818|NCT00365716|594523058|FG000|Extension 2|Lost to Follow-up|0|||
164589819|NCT00365716|594523059|FG001|Extension 2|Lost to Follow-up|0|||
164589820|NCT00365716|594523060|FG002|Extension 2|Lost to Follow-up|0|||
164589821|NCT00365716|594523061|FG003|Extension 2|Lost to Follow-up|0|||
164695275|NCT02010255|594907711|FG011|Overall Study|Death|1|||
164695276|NCT02010255|594907712|FG012|Overall Study|Death|0|||
164695277|NCT02010255|594907713|FG013|Overall Study|Death|0|||
164695278|NCT02010255|594907700|FG000|Overall Study|Lack of Efficacy|4|||
164695279|NCT02010255|594907701|FG001|Overall Study|Lack of Efficacy|1|||
164695280|NCT02010255|594907702|FG002|Overall Study|Lack of Efficacy|2|||
164695281|NCT02010255|594907703|FG003|Overall Study|Lack of Efficacy|1|||
164695282|NCT02010255|594907704|FG004|Overall Study|Lack of Efficacy|1|||
164695283|NCT02010255|594907705|FG005|Overall Study|Lack of Efficacy|0|||
164695284|NCT02010255|594907706|FG006|Overall Study|Lack of Efficacy|0|||
164695285|NCT02010255|594907707|FG007|Overall Study|Lack of Efficacy|0|||
164695286|NCT02010255|594907708|FG008|Overall Study|Lack of Efficacy|0|||
164695287|NCT02010255|594907709|FG009|Overall Study|Lack of Efficacy|0|||
164695288|NCT02010255|594907710|FG010|Overall Study|Lack of Efficacy|1|||
164695289|NCT02010255|594907711|FG011|Overall Study|Lack of Efficacy|0|||
164695290|NCT02010255|594907712|FG012|Overall Study|Lack of Efficacy|0|||
164695291|NCT02010255|594907713|FG013|Overall Study|Lack of Efficacy|0|||
164695292|NCT02010255|594907700|FG000|Overall Study|Withdrew Consent|1|||
164695293|NCT02010255|594907701|FG001|Overall Study|Withdrew Consent|0|||
164695294|NCT02010255|594907702|FG002|Overall Study|Withdrew Consent|0|||
164695295|NCT02010255|594907703|FG003|Overall Study|Withdrew Consent|1|||
164695296|NCT02010255|594907704|FG004|Overall Study|Withdrew Consent|0|||
164695297|NCT02010255|594907705|FG005|Overall Study|Withdrew Consent|0|||
164695298|NCT02010255|594907706|FG006|Overall Study|Withdrew Consent|0|||
164695299|NCT02010255|594907707|FG007|Overall Study|Withdrew Consent|0|||
164695300|NCT02010255|594907708|FG008|Overall Study|Withdrew Consent|0|||
164695301|NCT02010255|594907709|FG009|Overall Study|Withdrew Consent|0|||
164695302|NCT02010255|594907710|FG010|Overall Study|Withdrew Consent|0|||
164695303|NCT02010255|594907711|FG011|Overall Study|Withdrew Consent|0|||
164695304|NCT02010255|594907712|FG012|Overall Study|Withdrew Consent|0|||
164695305|NCT02010255|594907713|FG013|Overall Study|Withdrew Consent|0|||
164695306|NCT02010255|594907700|FG000|Overall Study|Adverse Event|1|||
164695307|NCT02010255|594907701|FG001|Overall Study|Adverse Event|0|||
164695308|NCT02010255|594907702|FG002|Overall Study|Adverse Event|0|||
164695309|NCT02010255|594907703|FG003|Overall Study|Adverse Event|0|||
164695310|NCT02010255|594907704|FG004|Overall Study|Adverse Event|0|||
164695311|NCT02010255|594907705|FG005|Overall Study|Adverse Event|0|||
164695312|NCT02010255|594907706|FG006|Overall Study|Adverse Event|0|||
164695313|NCT02010255|594907707|FG007|Overall Study|Adverse Event|0|||
164695314|NCT02010255|594907708|FG008|Overall Study|Adverse Event|0|||
164695315|NCT02010255|594907709|FG009|Overall Study|Adverse Event|0|||
164695316|NCT02010255|594907710|FG010|Overall Study|Adverse Event|0|||
164695317|NCT02010255|594907711|FG011|Overall Study|Adverse Event|0|||
164695318|NCT02010255|594907712|FG012|Overall Study|Adverse Event|0|||
164695319|NCT02010255|594907713|FG013|Overall Study|Adverse Event|0|||
164695320|NCT02010255|594907700|FG000|Overall Study|Lost to Follow-up|0|||
164695321|NCT02010255|594907701|FG001|Overall Study|Lost to Follow-up|0|||
164695322|NCT02010255|594907702|FG002|Overall Study|Lost to Follow-up|1|||
164695323|NCT02010255|594907703|FG003|Overall Study|Lost to Follow-up|0|||
164695324|NCT02010255|594907704|FG004|Overall Study|Lost to Follow-up|1|||
164695325|NCT02010255|594907705|FG005|Overall Study|Lost to Follow-up|0|||
164695326|NCT02010255|594907706|FG006|Overall Study|Lost to Follow-up|0|||
164437723|NCT01867580|593968247|FG001|Overall Study|Interruption to therapy|0|||
164695327|NCT02010255|594907707|FG007|Overall Study|Lost to Follow-up|0|||
164695328|NCT02010255|594907708|FG008|Overall Study|Lost to Follow-up|0|||
164695329|NCT02010255|594907709|FG009|Overall Study|Lost to Follow-up|0|||
164695330|NCT02010255|594907710|FG010|Overall Study|Lost to Follow-up|0|||
164695331|NCT02010255|594907711|FG011|Overall Study|Lost to Follow-up|0|||
164695332|NCT02010255|594907712|FG012|Overall Study|Lost to Follow-up|0|||
164695333|NCT02010255|594907713|FG013|Overall Study|Lost to Follow-up|0|||
164695334|NCT02010255|594907700|FG000|Overall Study|Randomized but Not Treated|0|||
164437724|NCT01867580|593968246|FG000|Overall Study|Osteomyelitis|0|||
164695335|NCT02010255|594907701|FG001|Overall Study|Randomized but Not Treated|0|||
164695336|NCT02010255|594907702|FG002|Overall Study|Randomized but Not Treated|0|||
164695337|NCT02010255|594907703|FG003|Overall Study|Randomized but Not Treated|0|||
164695338|NCT02010255|594907704|FG004|Overall Study|Randomized but Not Treated|0|||
164695339|NCT02010255|594907705|FG005|Overall Study|Randomized but Not Treated|0|||
164695340|NCT02010255|594907706|FG006|Overall Study|Randomized but Not Treated|0|||
164695341|NCT02010255|594907707|FG007|Overall Study|Randomized but Not Treated|0|||
164695342|NCT02010255|594907708|FG008|Overall Study|Randomized but Not Treated|0|||
164695343|NCT02010255|594907709|FG009|Overall Study|Randomized but Not Treated|0|||
164695344|NCT02010255|594907710|FG010|Overall Study|Randomized but Not Treated|0|||
164695345|NCT02010255|594907711|FG011|Overall Study|Randomized but Not Treated|0|||
164695346|NCT02010255|594907712|FG012|Overall Study|Randomized but Not Treated|0|||
164695347|NCT02010255|594907713|FG013|Overall Study|Randomized but Not Treated|1|||
164695348|NCT00508027|594907722|FG000|Dose Level 1|Lost to Follow-up|4|||
164695349|NCT00508027|594907722|FG000|Dose Level 1|Withdrawal by Subject|2|||
164695350|NCT00508027|594907722|FG000|Dose Level 1|Physician Decision|2|||
164695351|NCT00508027|594907722|FG000|Dose Level 2|Lost to Follow-up|2|||
164695352|NCT00508027|594907722|FG000|Dose Level 2|Withdrawal by Subject|2|||
164695353|NCT00537199|594907727|FG000|Overall Study|Study Terminated|1|||
164695354|NCT00467831|594907728|FG000|Overall Study|Death|2|||
164695355|NCT00467831|594907728|FG000|Overall Study|Withdrawal by Subject|1|||
164695356|NCT00612677|594907729|FG000|Overall Study|study closed before treatment started|1|||
164695357|NCT03139240|594907730|FG000|Overall Study|Lost to Follow-up|0|||
164695358|NCT03139240|594907731|FG001|Overall Study|Lost to Follow-up|1|||
164695359|NCT03139240|594907732|FG002|Overall Study|Lost to Follow-up|1|||
164695360|NCT03139240|594907733|FG003|Overall Study|Lost to Follow-up|0|||
164695361|NCT00860743|594907735|FG000|Overall Study|Withdrawal by Subject|3|||
164695362|NCT00860743|594907736|FG001|Overall Study|Withdrawal by Subject|0|||
164695363|NCT00823199|594907740|FG000|Overall Study|Withdrawal by Subject|2|||
164695364|NCT02776553|594907741|FG000|Overall Study|Lost to Follow-up|1|||
164695365|NCT02776553|594907742|FG001|Overall Study|Lost to Follow-up|0|||
164695366|NCT02776553|594907741|FG000|Overall Study|got liver transplant|1|||
164695367|NCT02776553|594907742|FG001|Overall Study|got liver transplant|2|||
164695368|NCT02776553|594907741|FG000|Overall Study|had other surgery|1|||
164695369|NCT02776553|594907742|FG001|Overall Study|had other surgery|0|||
164695370|NCT02776553|594907741|FG000|Overall Study|Protocol Violation|0|||
164695371|NCT02776553|594907742|FG001|Overall Study|Protocol Violation|1|||
164695372|NCT00941720|594907743|FG000|Overall Study|Withdrawal by Subject|1|||
164695373|NCT00941720|594907743|FG000|Overall Study|Insurance denied participation|11|||
164695374|NCT00941720|594907743|FG000|Overall Study|ineligible|2|||
164695375|NCT00171340|594907744|FG000|Overall Study|Adverse Event|46|||
164695376|NCT00171340|594907745|FG001|Overall Study|Adverse Event|42|||
164695377|NCT00171340|594907744|FG000|Overall Study|Lack of Efficacy|29|||
164695378|NCT00171340|594907745|FG001|Overall Study|Lack of Efficacy|41|||
164695379|NCT00171340|594907744|FG000|Overall Study|Protocol Violation|7|||
164695380|NCT00171340|594907745|FG001|Overall Study|Protocol Violation|8|||
164695381|NCT00171340|594907744|FG000|Overall Study|Withdrawal by Subject|22|||
164695382|NCT00171340|594907745|FG001|Overall Study|Withdrawal by Subject|19|||
164695383|NCT00171340|594907744|FG000|Overall Study|Lost to Follow-up|0|||
164695384|NCT00171340|594907745|FG001|Overall Study|Lost to Follow-up|5|||
164695385|NCT00171340|594907744|FG000|Overall Study|Abnormal Laboratory Results|2|||
164695386|NCT00171340|594907745|FG001|Overall Study|Abnormal Laboratory Results|0|||
164695387|NCT00171340|594907744|FG000|Overall Study|Abnormal Test Procedure Results|6|||
164695388|NCT00171340|594907745|FG001|Overall Study|Abnormal Test Procedure Results|11|||
164695389|NCT00171340|594907744|FG000|Overall Study|No Longer Required Study Drug|1|||
164695390|NCT00171340|594907745|FG001|Overall Study|No Longer Required Study Drug|1|||
164695391|NCT00171340|594907744|FG000|Overall Study|Administrative Problems|5|||
164695392|NCT00171340|594907745|FG001|Overall Study|Administrative Problems|2|||
164695393|NCT00171340|594907744|FG000|Overall Study|Death|6|||
164695394|NCT00171340|594907745|FG001|Overall Study|Death|6|||
164695395|NCT03827018|594907746|FG000|Overall Study|Adverse Event|1|||
164695396|NCT03827018|594907747|FG001|Overall Study|Adverse Event|0|||
164695397|NCT03827018|594907746|FG000|Overall Study|Withdrawal by Subject|2|||
164695398|NCT03827018|594907747|FG001|Overall Study|Withdrawal by Subject|2|||
164695399|NCT03827018|594907746|FG000|Overall Study|Lack of Efficacy|0|||
164695400|NCT03827018|594907747|FG001|Overall Study|Lack of Efficacy|1|||
164695401|NCT01998243|594907748|FG000|Overall Study|Pregnancy|0|||
164695402|NCT01998243|594907749|FG001|Overall Study|Pregnancy|1|||
164695403|NCT01998243|594907748|FG000|Overall Study|Protocol Violation|5|||
164437725|NCT01867580|593968247|FG001|Overall Study|Osteomyelitis|1|||
164437726|NCT01867580|593968246|FG000|Overall Study|Continuation of therapy|0|||
164437727|NCT01867580|593968247|FG001|Overall Study|Continuation of therapy|1|||
164437728|NCT01867580|593968246|FG000|Overall Study|Wound recurrence|0|||
164437729|NCT01867580|593968247|FG001|Overall Study|Wound recurrence|1|||
164437730|NCT02465359|593968248|FG000|Overall Study|Lack of Efficacy|1|||
164695404|NCT01998243|594907749|FG001|Overall Study|Protocol Violation|2|||
164695405|NCT01998243|594907748|FG000|Overall Study|Withdrawal by Subject|3|||
164695406|NCT01998243|594907749|FG001|Overall Study|Withdrawal by Subject|4|||
164695407|NCT04569786|594907763|FG000|Overall Study|Lost to Follow-up|1|||
164695408|NCT04569786|594907764|FG001|Overall Study|Lost to Follow-up|0|||
164695409|NCT04569786|594907765|FG002|Overall Study|Lost to Follow-up|4|||
164695410|NCT04569786|594907766|FG003|Overall Study|Lost to Follow-up|1|||
164695411|NCT04569786|594907767|FG004|Overall Study|Lost to Follow-up|0|||
164695412|NCT04569786|594907763|FG000|Overall Study|Withdrawal by Subject|0|||
164695413|NCT04569786|594907764|FG001|Overall Study|Withdrawal by Subject|0|||
164695414|NCT04569786|594907765|FG002|Overall Study|Withdrawal by Subject|0|||
164695415|NCT04569786|594907766|FG003|Overall Study|Withdrawal by Subject|5|||
164695416|NCT04569786|594907767|FG004|Overall Study|Withdrawal by Subject|1|||
164695417|NCT04569786|594907763|FG000|Overall Study|Physician Decision|0|||
164695418|NCT04569786|594907764|FG001|Overall Study|Physician Decision|0|||
164695419|NCT04569786|594907765|FG002|Overall Study|Physician Decision|0|||
164695420|NCT04569786|594907766|FG003|Overall Study|Physician Decision|1|||
164695421|NCT04569786|594907767|FG004|Overall Study|Physician Decision|0|||
164695422|NCT01640184|594907768|FG000|Overall Study|Death|1|||
164695423|NCT01640184|594907769|FG001|Overall Study|Death|0|||
164695424|NCT01640184|594907770|FG002|Overall Study|Death|0|||
164589822|NCT00365716|594523062|FG004|Extension 2|Lost to Follow-up|0|||
164589823|NCT00365716|594523063|FG005|Extension 2|Lost to Follow-up|0|||
164589824|NCT00365716|594523064|FG006|Extension 2|Lost to Follow-up|2|||
164589825|NCT00365716|594523058|FG000|Extension 2|Other|0|||
164589826|NCT00365716|594523059|FG001|Extension 2|Other|0|||
164695425|NCT01640184|594907768|FG000|Overall Study|Lost to Follow-up|4|||
164695426|NCT01640184|594907769|FG001|Overall Study|Lost to Follow-up|1|||
164695427|NCT01640184|594907770|FG002|Overall Study|Lost to Follow-up|0|||
164695428|NCT01640184|594907768|FG000|Overall Study|Physician Decision|3|||
164695429|NCT01640184|594907769|FG001|Overall Study|Physician Decision|0|||
164695430|NCT01640184|594907770|FG002|Overall Study|Physician Decision|0|||
164695431|NCT01640184|594907768|FG000|Overall Study|Withdrawal by Subject|0|||
164695432|NCT01640184|594907769|FG001|Overall Study|Withdrawal by Subject|1|||
164695433|NCT01640184|594907770|FG002|Overall Study|Withdrawal by Subject|1|||
164695434|NCT01640184|594907768|FG000|Overall Study|Protocol Violation|0|||
164437731|NCT02465359|593968248|FG000|Overall Study|Withdrawal by Subject|1|||
164589827|NCT00365716|594523060|FG002|Extension 2|Other|0|||
164589828|NCT00365716|594523061|FG003|Extension 2|Other|0|||
164589829|NCT00365716|594523062|FG004|Extension 2|Other|0|||
164589830|NCT00365716|594523063|FG005|Extension 2|Other|0|||
164589831|NCT00365716|594523064|FG006|Extension 2|Other|3|||
164589832|NCT00365716|594523058|FG000|Extension 2|Withdrawal by Subject|0|||
164589833|NCT00365716|594523059|FG001|Extension 2|Withdrawal by Subject|0|||
164589834|NCT00365716|594523060|FG002|Extension 2|Withdrawal by Subject|0|||
164589835|NCT00365716|594523061|FG003|Extension 2|Withdrawal by Subject|0|||
164589836|NCT00365716|594523062|FG004|Extension 2|Withdrawal by Subject|0|||
164589837|NCT00365716|594523063|FG005|Extension 2|Withdrawal by Subject|0|||
164589838|NCT00365716|594523064|FG006|Extension 2|Withdrawal by Subject|5|||
164589839|NCT02184143|594523066|FG000|Overall Study|Withdrawal by Subject|4|||
164589840|NCT02184143|594523067|FG001|Overall Study|Withdrawal by Subject|4|||
164589841|NCT02184143|594523066|FG000|Overall Study|Lost to Follow-up|5|||
164589842|NCT02184143|594523067|FG001|Overall Study|Lost to Follow-up|3|||
164695435|NCT01640184|594907769|FG001|Overall Study|Protocol Violation|0|||
164695436|NCT01640184|594907770|FG002|Overall Study|Protocol Violation|1|||
164437732|NCT02465359|593968248|FG000|Overall Study|Adverse Event|1|||
164437733|NCT01304147|593968249|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
164437734|NCT01304147|593968250|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
164437735|NCT01212757|593968251|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
164437736|NCT01212757|593968252|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
164437737|NCT01212757|593968253|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
164437738|NCT01212757|593968254|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
164437739|NCT01212757|593968255|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
164437740|NCT01212757|593968256|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
164437741|NCT01212757|593968257|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
164437742|NCT01212757|593968258|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
164437743|NCT01212757|593968259|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
164437744|NCT01212757|593968251|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
164437745|NCT01212757|593968252|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
164437746|NCT01212757|593968253|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
164437747|NCT01212757|593968254|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
164437748|NCT01212757|593968255|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
164437749|NCT01212757|593968256|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
164437750|NCT01212757|593968257|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
164437751|NCT01212757|593968258|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
164437752|NCT01212757|593968259|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
164437753|NCT01212757|593968251|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
164437754|NCT01212757|593968252|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
164437755|NCT01212757|593968253|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
164437756|NCT01212757|593968254|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
164589843|NCT02184143|594523066|FG000|Overall Study|Death|1|||
164589844|NCT02184143|594523067|FG001|Overall Study|Death|0|||
164589845|NCT00431847|594523068|FG000|Overall Study|completion of less than two study visits|6|||
164589846|NCT00431847|594523069|FG001|Overall Study|completion of less than two study visits|3|||
164589847|NCT00431847|594523070|FG002|Overall Study|completion of less than two study visits|4|||
164695437|NCT01351350|594907771|FG000|Overall Study|Disease Progression|5|||
164695438|NCT01351350|594907772|FG001|Overall Study|Disease Progression|13|||
164695439|NCT01351350|594907773|FG002|Overall Study|Disease Progression|6|||
164695440|NCT01351350|594907774|FG003|Overall Study|Disease Progression|8|||
164695441|NCT01351350|594907775|FG004|Overall Study|Disease Progression|5|||
164695442|NCT01351350|594907771|FG000|Overall Study|Adverse Event|1|||
164695443|NCT01351350|594907772|FG001|Overall Study|Adverse Event|10|||
164695444|NCT01351350|594907773|FG002|Overall Study|Adverse Event|1|||
164695445|NCT01351350|594907774|FG003|Overall Study|Adverse Event|2|||
164695446|NCT01351350|594907775|FG004|Overall Study|Adverse Event|0|||
164695447|NCT01351350|594907771|FG000|Overall Study|Participant Decision|2|||
164695448|NCT01351350|594907772|FG001|Overall Study|Participant Decision|6|||
164589848|NCT00431847|594523071|FG003|Overall Study|completion of less than two study visits|14|||
164589849|NCT00431847|594523072|FG004|Overall Study|completion of less than two study visits|0|||
164589850|NCT00431847|594523068|FG000|Overall Study|Protocol Violation|0|||
164589851|NCT00431847|594523069|FG001|Overall Study|Protocol Violation|0|||
164589852|NCT00431847|594523070|FG002|Overall Study|Protocol Violation|0|||
164589853|NCT00431847|594523071|FG003|Overall Study|Protocol Violation|0|||
164589854|NCT00431847|594523072|FG004|Overall Study|Protocol Violation|1|||
164589855|NCT02853331|594523075|FG000|Overall Study|Death|59|||
164589856|NCT02853331|594523076|FG001|Overall Study|Death|95|||
164589857|NCT02853331|594523075|FG000|Overall Study|Withdrawal by Subject|5|||
164589858|NCT02853331|594523076|FG001|Overall Study|Withdrawal by Subject|9|||
164695449|NCT01351350|594907773|FG002|Overall Study|Participant Decision|3|||
164695450|NCT01351350|594907774|FG003|Overall Study|Participant Decision|3|||
164695451|NCT01351350|594907775|FG004|Overall Study|Participant Decision|2|||
164695452|NCT01351350|594907771|FG000|Overall Study|Enrolled but not Treated|0|||
164695453|NCT01351350|594907772|FG001|Overall Study|Enrolled but not Treated|0|||
164695454|NCT01351350|594907773|FG002|Overall Study|Enrolled but not Treated|1|||
164695455|NCT01351350|594907774|FG003|Overall Study|Enrolled but not Treated|0|||
164695456|NCT01351350|594907775|FG004|Overall Study|Enrolled but not Treated|0|||
164695457|NCT02260258|594907779|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
164695458|NCT02260258|594907780|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
164695459|NCT01644149|594907781|FG000|Overall Study|Withdrawal by Subject|1|||
164695460|NCT01644149|594907782|FG001|Overall Study|Withdrawal by Subject|0|||
164695461|NCT01644149|594907781|FG000|Overall Study|Lost to Follow-up|3|||
164695462|NCT01644149|594907782|FG001|Overall Study|Lost to Follow-up|1|||
164695463|NCT00690482|594907783|FG000|Overall Study|Adverse Event|2|||
164695464|NCT00690482|594907784|FG001|Overall Study|Adverse Event|1|||
164695465|NCT00690482|594907783|FG000|Overall Study|Incorrect enrolment|0|||
164695466|NCT00690482|594907784|FG001|Overall Study|Incorrect enrolment|1|||
164695467|NCT00690482|594907783|FG000|Overall Study|Study-specific discontinuation criteria|1|||
164695468|NCT00690482|594907784|FG001|Overall Study|Study-specific discontinuation criteria|0|||
164695469|NCT00690482|594907783|FG000|Overall Study|Intake of prohibited medicine|1|||
164589859|NCT02853331|594523075|FG000|Overall Study|Ongoing in study|368|||
164589860|NCT02853331|594523076|FG001|Overall Study|Ongoing in study|325|||
164589861|NCT00751101|594523077|FG000|Overall Study|Withdrawal by Subject|1|||
164589862|NCT00751101|594523078|FG001|Overall Study|Withdrawal by Subject|0|||
164589863|NCT00751101|594523077|FG000|Overall Study|No HFS / Never Started Patch/|0|||
164589864|NCT00751101|594523078|FG001|Overall Study|No HFS / Never Started Patch/|4|||
164589865|NCT00751101|594523077|FG000|Overall Study|Never began capecitabine|1|||
164589866|NCT00751101|594523078|FG001|Overall Study|Never began capecitabine|0|||
164589867|NCT00751101|594523077|FG000|Overall Study|Physician Decision|0|||
164589868|NCT00751101|594523078|FG001|Overall Study|Physician Decision|1|||
164589869|NCT00844428|594523082|FG000|Screening Period|Screen Failure|3|||
164589870|NCT00844428|594523082|FG000|Extension Treatment Period|Death|1|||
164589871|NCT00844428|594523082|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
164589872|NCT00789477|594523083|FG000|Overall Study|Withdrawal by Subject|2|||
164695470|NCT00690482|594907784|FG001|Overall Study|Intake of prohibited medicine|0|||
164695471|NCT00690482|594907783|FG000|Overall Study|withdrew consent at rand.day|0|||
164695472|NCT00690482|594907784|FG001|Overall Study|withdrew consent at rand.day|1|||
164355909|NCT02956486|593678717|FG002|Core Phase|Other|0|||
164355910|NCT02956486|593678715|FG000|Core Phase|Not treated|0|||
164355911|NCT02956486|593678716|FG001|Core Phase|Not treated|3|||
164355912|NCT02956486|593678717|FG002|Core Phase|Not treated|0|||
164355913|NCT02956486|593678715|FG000|Extension Phase|Adverse Event|0|||
164355914|NCT02956486|593678716|FG001|Extension Phase|Adverse Event|0|||
164355915|NCT02956486|593678717|FG002|Extension Phase|Adverse Event|2|||
164589873|NCT00789477|594523084|FG001|Overall Study|Withdrawal by Subject|1|||
164589874|NCT00789477|594523085|FG002|Overall Study|Withdrawal by Subject|3|||
164589875|NCT00789477|594523086|FG003|Overall Study|Withdrawal by Subject|2|||
164695473|NCT01930175|594907785|FG000|Core Study|Lost to Follow-up|0|||
164695474|NCT01930175|594907786|FG001|Core Study|Lost to Follow-up|1|||
164695475|NCT01930175|594907787|FG002|Core Study|Lost to Follow-up|0|||
164355916|NCT02956486|593678715|FG000|Extension Phase|Study terminated by sponsor|0|||
164589876|NCT00789477|594523087|FG004|Overall Study|Withdrawal by Subject|3|||
164589877|NCT00789477|594523083|FG000|Overall Study|Protocol Violation|1|||
164589878|NCT00789477|594523084|FG001|Overall Study|Protocol Violation|0|||
164589879|NCT00789477|594523085|FG002|Overall Study|Protocol Violation|0|||
164695476|NCT01930175|594907785|FG000|Core Study|Adverse Event|0|||
164695477|NCT01930175|594907786|FG001|Core Study|Adverse Event|0|||
164355917|NCT02956486|593678716|FG001|Extension Phase|Study terminated by sponsor|0|||
164355918|NCT02956486|593678717|FG002|Extension Phase|Study terminated by sponsor|16|||
164695478|NCT01930175|594907787|FG002|Core Study|Adverse Event|1|||
164695479|NCT02820740|594907788|FG000|Overall Study|Did not have procedure|2|||
164695480|NCT00890552|594907789|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
164695481|NCT00890552|594907789|FG000|On-treatment|Early prog disease/ death|10|||
164695482|NCT04965389|594907790|FG000|Overall Study|Other reasons|1|||
164695483|NCT04965389|594907791|FG001|Overall Study|Other reasons|0|||
164695484|NCT04965389|594907792|FG002|Overall Study|Other reasons|0|||
164695485|NCT04965389|594907793|FG003|Overall Study|Other reasons|0|||
164695486|NCT04965389|594907790|FG000|Overall Study|Participant withdrew consent|0|||
164695487|NCT04965389|594907791|FG001|Overall Study|Participant withdrew consent|1|||
164695488|NCT04965389|594907792|FG002|Overall Study|Participant withdrew consent|0|||
164695489|NCT04965389|594907793|FG003|Overall Study|Participant withdrew consent|0|||
164695490|NCT04965389|594907790|FG000|Overall Study|Poor/Non-compliance|0|||
164695491|NCT04965389|594907791|FG001|Overall Study|Poor/Non-compliance|1|||
164695492|NCT04965389|594907792|FG002|Overall Study|Poor/Non-compliance|0|||
164695493|NCT04965389|594907793|FG003|Overall Study|Poor/Non-compliance|0|||
164695494|NCT00925301|594907794|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
164695495|NCT00925301|594907795|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
164695496|NCT00925301|594907796|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
164695497|NCT00925301|594907797|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
164695498|NCT00925301|594907794|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
164695499|NCT00925301|594907795|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
164695500|NCT00925301|594907796|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
164695501|NCT00925301|594907797|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
164695502|NCT00925301|594907794|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
164695503|NCT00925301|594907795|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
164695504|NCT00925301|594907796|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
164695505|NCT00925301|594907797|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
164695506|NCT00925301|594907794|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
164695507|NCT00925301|594907795|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
164695508|NCT00925301|594907796|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
164695509|NCT00925301|594907797|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
164695510|NCT00925301|594907794|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
164695511|NCT00925301|594907795|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
164695512|NCT00925301|594907796|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
164695513|NCT00925301|594907797|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
164695514|NCT00925301|594907794|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
164695515|NCT00925301|594907795|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
164695516|NCT00925301|594907796|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
164695517|NCT00925301|594907797|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
164695518|NCT00925301|594907794|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
164695519|NCT00925301|594907795|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
164695520|NCT00925301|594907796|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
164695521|NCT00925301|594907797|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
164695522|NCT01436643|594907798|FG000|2-week Pre-treatment|Abnormal test result|0|||
164695523|NCT01436643|594907799|FG001|2-week Pre-treatment|Abnormal test result|0|||
164695524|NCT01436643|594907800|FG002|2-week Pre-treatment|Abnormal test result|0|||
164695525|NCT01436643|594907801|FG003|2-week Pre-treatment|Abnormal test result|1|||
164695526|NCT01436643|594907798|FG000|2-week Pre-treatment|Adverse Event|0|||
164695527|NCT01436643|594907799|FG001|2-week Pre-treatment|Adverse Event|0|||
164695528|NCT01436643|594907800|FG002|2-week Pre-treatment|Adverse Event|0|||
164695529|NCT01436643|594907801|FG003|2-week Pre-treatment|Adverse Event|5|||
164695530|NCT01436643|594907798|FG000|2-week Pre-treatment|Protocol Violation|0|||
164695531|NCT01436643|594907799|FG001|2-week Pre-treatment|Protocol Violation|0|||
164695532|NCT01436643|594907800|FG002|2-week Pre-treatment|Protocol Violation|0|||
164695533|NCT01436643|594907801|FG003|2-week Pre-treatment|Protocol Violation|4|||
164695534|NCT01436643|594907798|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
164695535|NCT01436643|594907799|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
164695536|NCT01436643|594907800|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
164695537|NCT01436643|594907801|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
164695538|NCT01436643|594907798|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
164695539|NCT01436643|594907799|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
164695540|NCT01436643|594907800|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
164355919|NCT02956486|593678715|FG000|Extension Phase|Not Treated|0|||
164695541|NCT01436643|594907801|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
164695542|NCT01436643|594907798|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
164695543|NCT01436643|594907799|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
164695544|NCT01436643|594907800|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
164355920|NCT02956486|593678716|FG001|Extension Phase|Not Treated|0|||
164355921|NCT02956486|593678717|FG002|Extension Phase|Not Treated|1|||
164355922|NCT02485574|593678724|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
164355923|NCT00255047|593678726|FG000|Overall Study|Serious Adverse Events|2|||
164355924|NCT00255047|593678727|FG001|Overall Study|Serious Adverse Events|1|||
164355925|NCT00255047|593678728|FG002|Overall Study|Serious Adverse Events|2|||
164355926|NCT00255047|593678729|FG003|Overall Study|Serious Adverse Events|1|||
164355927|NCT00255047|593678726|FG000|Overall Study|Adverse Event|0|||
164355928|NCT00255047|593678727|FG001|Overall Study|Adverse Event|3|||
164355929|NCT00255047|593678728|FG002|Overall Study|Adverse Event|2|||
164355930|NCT00255047|593678729|FG003|Overall Study|Adverse Event|1|||
164355931|NCT00255047|593678726|FG000|Overall Study|Protocol Violation|13|||
164355932|NCT00255047|593678727|FG001|Overall Study|Protocol Violation|13|||
164355933|NCT00255047|593678728|FG002|Overall Study|Protocol Violation|16|||
164355934|NCT00255047|593678729|FG003|Overall Study|Protocol Violation|20|||
164355935|NCT00255047|593678726|FG000|Overall Study|Lost to Follow-up|9|||
164355936|NCT00255047|593678727|FG001|Overall Study|Lost to Follow-up|8|||
164355937|NCT00255047|593678728|FG002|Overall Study|Lost to Follow-up|5|||
164355938|NCT00255047|593678729|FG003|Overall Study|Lost to Follow-up|6|||
164355939|NCT00255047|593678726|FG000|Overall Study|Withdrawal by Subject|24|||
164355940|NCT00255047|593678727|FG001|Overall Study|Withdrawal by Subject|23|||
164355941|NCT00255047|593678728|FG002|Overall Study|Withdrawal by Subject|25|||
164355942|NCT00255047|593678729|FG003|Overall Study|Withdrawal by Subject|18|||
164355943|NCT01585194|593678736|FG000|Overall Study|Withdrawal by Subject|1|||
164355944|NCT01585194|593678736|FG000|Overall Study|Physician Decision|2|||
164355945|NCT01585194|593678736|FG000|Overall Study|Lack of insurance|1|||
164355946|NCT00993291|593678737|FG000|Overall Study|Withdrawal by Subject|1|||
164355947|NCT00003492|593678738|FG000|Overall Study|Not evaluable|6|||
164355948|NCT04446377|593678739|FG000|Overall Study|Withdrawal by Subject|6|||
164355949|NCT04446377|593678740|FG001|Overall Study|Withdrawal by Subject|1|||
164355950|NCT04446377|593678739|FG000|Overall Study|Physician Decision|1|||
164355951|NCT04446377|593678740|FG001|Overall Study|Physician Decision|1|||
164355952|NCT04446377|593678739|FG000|Overall Study|Lost to Follow-up|0|||
164355953|NCT04446377|593678740|FG001|Overall Study|Lost to Follow-up|2|||
164355954|NCT04446377|593678739|FG000|Overall Study|Not eligible|0|||
164355955|NCT04446377|593678740|FG001|Overall Study|Not eligible|1|||
164355956|NCT03049280|593678746|FG000|Overall Study|Physician Decision|1|||
164355957|NCT01867021|593678747|FG000|Overall Study|Adverse Event|0|||
164355958|NCT01867021|593678748|FG001|Overall Study|Adverse Event|1|||
164355959|NCT01867021|593678747|FG000|Overall Study|Not Eligible|0|||
164355960|NCT01867021|593678748|FG001|Overall Study|Not Eligible|1|||
164355961|NCT01867021|593678747|FG000|Overall Study|Death|1|||
164355962|NCT01867021|593678748|FG001|Overall Study|Death|0|||
164355963|NCT01867021|593678747|FG000|Overall Study|Lost to Follow-up|0|||
164355964|NCT01867021|593678748|FG001|Overall Study|Lost to Follow-up|2|||
164355965|NCT01867021|593678747|FG000|Overall Study|Withdrawal by Subject|1|||
164355966|NCT01867021|593678748|FG001|Overall Study|Withdrawal by Subject|6|||
164355967|NCT01129960|593678752|FG000|Overall Study|Withdrawal by Subject|3|||
164355968|NCT01129960|593678753|FG001|Overall Study|Withdrawal by Subject|0|||
164355969|NCT01129960|593678754|FG002|Overall Study|Withdrawal by Subject|3|||
164437757|NCT01212757|593968255|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
164589880|NCT00789477|594523086|FG003|Overall Study|Protocol Violation|1|||
164589881|NCT00789477|594523087|FG004|Overall Study|Protocol Violation|0|||
164589882|NCT00789477|594523083|FG000|Overall Study|Adverse Event|3|||
164589883|NCT00789477|594523084|FG001|Overall Study|Adverse Event|3|||
164589884|NCT00789477|594523085|FG002|Overall Study|Adverse Event|1|||
164589885|NCT00789477|594523086|FG003|Overall Study|Adverse Event|0|||
164589886|NCT00789477|594523087|FG004|Overall Study|Adverse Event|0|||
164589887|NCT00789477|594523083|FG000|Overall Study|Death|1|||
164589888|NCT00789477|594523084|FG001|Overall Study|Death|1|||
164589889|NCT00789477|594523085|FG002|Overall Study|Death|2|||
164589890|NCT00789477|594523086|FG003|Overall Study|Death|2|||
164589891|NCT00789477|594523087|FG004|Overall Study|Death|0|||
164589892|NCT00789477|594523083|FG000|Overall Study|Lost to Follow-up|0|||
164589893|NCT00789477|594523084|FG001|Overall Study|Lost to Follow-up|1|||
164589894|NCT00789477|594523085|FG002|Overall Study|Lost to Follow-up|4|||
164589895|NCT00789477|594523086|FG003|Overall Study|Lost to Follow-up|2|||
164355970|NCT01129960|593678755|FG003|Overall Study|Withdrawal by Subject|2|||
164355971|NCT01129960|593678752|FG000|Overall Study|Lack of Efficacy|1|||
164355972|NCT01129960|593678753|FG001|Overall Study|Lack of Efficacy|1|||
164355973|NCT01129960|593678754|FG002|Overall Study|Lack of Efficacy|1|||
164589896|NCT00789477|594523087|FG004|Overall Study|Lost to Follow-up|4|||
164355974|NCT01129960|593678755|FG003|Overall Study|Lack of Efficacy|1|||
164355975|NCT01129960|593678752|FG000|Overall Study|Adverse Event|23|||
164355976|NCT01129960|593678753|FG001|Overall Study|Adverse Event|16|||
164355977|NCT01129960|593678754|FG002|Overall Study|Adverse Event|16|||
164355978|NCT01129960|593678755|FG003|Overall Study|Adverse Event|7|||
164355979|NCT01129960|593678752|FG000|Overall Study|Protocol Violation|1|||
164355980|NCT01129960|593678753|FG001|Overall Study|Protocol Violation|2|||
164355981|NCT01129960|593678754|FG002|Overall Study|Protocol Violation|3|||
164355982|NCT01129960|593678755|FG003|Overall Study|Protocol Violation|0|||
164355983|NCT01129960|593678752|FG000|Overall Study|Lost to Follow-up|0|||
164355984|NCT01129960|593678753|FG001|Overall Study|Lost to Follow-up|2|||
164355985|NCT01129960|593678754|FG002|Overall Study|Lost to Follow-up|3|||
164355986|NCT01129960|593678755|FG003|Overall Study|Lost to Follow-up|3|||
164355987|NCT01129960|593678752|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
164355988|NCT01129960|593678753|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
164355989|NCT01129960|593678754|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
164355990|NCT01129960|593678755|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
164355991|NCT01129960|593678752|FG000|Overall Study|Physician Decision|1|||
164355992|NCT01129960|593678753|FG001|Overall Study|Physician Decision|0|||
164355993|NCT01129960|593678754|FG002|Overall Study|Physician Decision|0|||
164355994|NCT01129960|593678755|FG003|Overall Study|Physician Decision|0|||
164355995|NCT01129960|593678752|FG000|Overall Study|Pregnancy|1|||
164355996|NCT01129960|593678753|FG001|Overall Study|Pregnancy|0|||
164355997|NCT01129960|593678754|FG002|Overall Study|Pregnancy|0|||
164355998|NCT01129960|593678755|FG003|Overall Study|Pregnancy|0|||
164355999|NCT02056340|593678757|FG000|Overall Study|Lost to Follow-up|5|||
164356000|NCT02056340|593678758|FG001|Overall Study|Lost to Follow-up|5|||
164356001|NCT02056340|593678757|FG000|Overall Study|Withdrawal by Subject|2|||
164356002|NCT02056340|593678758|FG001|Overall Study|Withdrawal by Subject|6|||
164356003|NCT01927367|593678761|FG000|Overall Study|Withdrawal by Subject|7|||
164356004|NCT01927367|593678762|FG001|Overall Study|Withdrawal by Subject|4|||
164356005|NCT01927367|593678761|FG000|Overall Study|No baseline data|0|||
164356006|NCT01927367|593678762|FG001|Overall Study|No baseline data|1|||
164356007|NCT00071513|593678763|FG000|Intervention Component|Withdrawal by Subject|2|||
164356008|NCT00071513|593678764|FG001|Intervention Component|Withdrawal by Subject|3|||
164356009|NCT00071513|593678763|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
164356010|NCT00071513|593678764|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
164356011|NCT01634360|593678765|FG000|Overall Study|Adverse Event|10|||
164356012|NCT01634360|593678766|FG001|Overall Study|Adverse Event|34|||
164356013|NCT01634360|593678765|FG000|Overall Study|subject withdrew consent|13|||
164356014|NCT01634360|593678766|FG001|Overall Study|subject withdrew consent|23|||
164356015|NCT01634360|593678765|FG000|Overall Study|Protocol Violation|1|||
164356016|NCT01634360|593678766|FG001|Overall Study|Protocol Violation|1|||
164356017|NCT01634360|593678765|FG000|Overall Study|Lack of Efficacy|4|||
164356018|NCT01634360|593678766|FG001|Overall Study|Lack of Efficacy|14|||
164356019|NCT01634360|593678765|FG000|Overall Study|Other|3|||
164356020|NCT01634360|593678766|FG001|Overall Study|Other|20|||
164356021|NCT01634360|593678765|FG000|Overall Study|Study termination by sponsor|18|||
164356022|NCT01634360|593678766|FG001|Overall Study|Study termination by sponsor|44|||
164356023|NCT02743871|593678767|FG000|Overall Study|Lost to Follow-up|0|||
164356024|NCT02743871|593678768|FG001|Overall Study|Lost to Follow-up|0|||
164356025|NCT02743871|593678769|FG002|Overall Study|Lost to Follow-up|0|||
164356026|NCT02743871|593678770|FG003|Overall Study|Lost to Follow-up|1|||
164356027|NCT02743871|593678771|FG004|Overall Study|Lost to Follow-up|0|||
164356028|NCT02743871|593678772|FG005|Overall Study|Lost to Follow-up|0|||
164356029|NCT02743871|593678773|FG006|Overall Study|Lost to Follow-up|1|||
164356030|NCT02743871|593678774|FG007|Overall Study|Lost to Follow-up|0|||
164356031|NCT02743871|593678775|FG008|Overall Study|Lost to Follow-up|0|||
164356032|NCT02743871|593678776|FG009|Overall Study|Lost to Follow-up|0|||
164356033|NCT02743871|593678777|FG010|Overall Study|Lost to Follow-up|0|||
164695545|NCT01436643|594907801|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
164695546|NCT03234608|594907803|FG000|Overall Study|Lost to Follow-up|23|||
164695547|NCT03234608|594907804|FG001|Overall Study|Lost to Follow-up|21|||
164695548|NCT03693950|594907805|FG000|Overall Study|Withdrawal by Subject|1|||
164695549|NCT03693950|594907806|FG001|Overall Study|Withdrawal by Subject|0|||
164695550|NCT01362296|594907807|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
164695551|NCT01362296|594907808|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
164695552|NCT01362296|594907809|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
164695553|NCT01362296|594907810|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
164695554|NCT01362296|594907807|FG000|Randomized Phase (RP)|Physician Decision|1|||
164695555|NCT01362296|594907808|FG001|Randomized Phase (RP)|Physician Decision|9|||
164695556|NCT01362296|594907809|FG002|Randomized Phase (RP)|Physician Decision|0|||
164695557|NCT01362296|594907810|FG003|Randomized Phase (RP)|Physician Decision|0|||
164695558|NCT01362296|594907807|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
164695559|NCT01362296|594907808|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
164695560|NCT01362296|594907809|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
164695561|NCT01362296|594907810|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
164695562|NCT01362296|594907807|FG000|Randomized Phase (RP)|Adverse Event|20|||
164695563|NCT01362296|594907808|FG001|Randomized Phase (RP)|Adverse Event|4|||
164695564|NCT01362296|594907809|FG002|Randomized Phase (RP)|Adverse Event|0|||
164695565|NCT01362296|594907810|FG003|Randomized Phase (RP)|Adverse Event|0|||
164695566|NCT01362296|594907807|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
164695567|NCT01362296|594907808|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
164695568|NCT01362296|594907809|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
164695569|NCT01362296|594907810|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
164695570|NCT01362296|594907807|FG000|Crossover Phase|PD including Death due to PD|0|||
164695571|NCT01362296|594907808|FG001|Crossover Phase|PD including Death due to PD|0|||
164695572|NCT01362296|594907809|FG002|Crossover Phase|PD including Death due to PD|16|||
164695573|NCT01362296|594907810|FG003|Crossover Phase|PD including Death due to PD|1|||
164695574|NCT01362296|594907807|FG000|Crossover Phase|Withdrawal by Subject|0|||
164695575|NCT01362296|594907808|FG001|Crossover Phase|Withdrawal by Subject|0|||
164695576|NCT01362296|594907809|FG002|Crossover Phase|Withdrawal by Subject|2|||
164695577|NCT01362296|594907810|FG003|Crossover Phase|Withdrawal by Subject|1|||
164695578|NCT01362296|594907807|FG000|Crossover Phase|Adverse Event|0|||
164695579|NCT01362296|594907808|FG001|Crossover Phase|Adverse Event|0|||
164695580|NCT01362296|594907809|FG002|Crossover Phase|Adverse Event|4|||
164695581|NCT01362296|594907810|FG003|Crossover Phase|Adverse Event|0|||
164695582|NCT01362296|594907807|FG000|Crossover Phase|Study Closed/Terminated|0|||
164695583|NCT01362296|594907808|FG001|Crossover Phase|Study Closed/Terminated|0|||
164695584|NCT01362296|594907809|FG002|Crossover Phase|Study Closed/Terminated|1|||
164695585|NCT01362296|594907810|FG003|Crossover Phase|Study Closed/Terminated|0|||
164695586|NCT04230876|594907811|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
164695587|NCT04230876|594907812|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
164695588|NCT01181531|594907813|FG000|Overall Study|Other|17|||
164695589|NCT01181531|594907814|FG001|Overall Study|Other|12|||
164695590|NCT01181531|594907813|FG000|Overall Study|Partial consent by subject withdrawn|0|||
164695591|NCT01181531|594907814|FG001|Overall Study|Partial consent by subject withdrawn|1|||
164356034|NCT02743871|593678778|FG011|Overall Study|Lost to Follow-up|2|||
164356035|NCT02743871|593678779|FG012|Overall Study|Lost to Follow-up|0|||
164356036|NCT02743871|593678780|FG013|Overall Study|Lost to Follow-up|0|||
164356037|NCT02743871|593678767|FG000|Overall Study|Withdrawal by Subject|0|||
164356038|NCT02743871|593678768|FG001|Overall Study|Withdrawal by Subject|0|||
164356039|NCT02743871|593678769|FG002|Overall Study|Withdrawal by Subject|0|||
164356040|NCT02743871|593678770|FG003|Overall Study|Withdrawal by Subject|0|||
164356041|NCT02743871|593678771|FG004|Overall Study|Withdrawal by Subject|0|||
164356042|NCT02743871|593678772|FG005|Overall Study|Withdrawal by Subject|0|||
164356043|NCT02743871|593678773|FG006|Overall Study|Withdrawal by Subject|0|||
164356044|NCT02743871|593678774|FG007|Overall Study|Withdrawal by Subject|0|||
164695592|NCT01181531|594907813|FG000|Overall Study|Physician Decision|3|||
164695593|NCT01181531|594907814|FG001|Overall Study|Physician Decision|1|||
164695594|NCT01181531|594907813|FG000|Overall Study|Noncompliance|2|||
164695595|NCT01181531|594907814|FG001|Overall Study|Noncompliance|2|||
164695596|NCT01181531|594907813|FG000|Overall Study|Ineligibility determined|1|||
164695597|NCT01181531|594907814|FG001|Overall Study|Ineligibility determined|2|||
164356045|NCT02743871|593678775|FG008|Overall Study|Withdrawal by Subject|0|||
164356046|NCT02743871|593678776|FG009|Overall Study|Withdrawal by Subject|0|||
164356047|NCT02743871|593678777|FG010|Overall Study|Withdrawal by Subject|1|||
164356048|NCT02743871|593678778|FG011|Overall Study|Withdrawal by Subject|0|||
164356049|NCT02743871|593678779|FG012|Overall Study|Withdrawal by Subject|12|||
164356050|NCT02743871|593678780|FG013|Overall Study|Withdrawal by Subject|6|||
164356051|NCT02743871|593678767|FG000|Overall Study|Adverse Event|1|||
164356052|NCT02743871|593678768|FG001|Overall Study|Adverse Event|0|||
164356053|NCT02743871|593678769|FG002|Overall Study|Adverse Event|0|||
164356054|NCT02743871|593678770|FG003|Overall Study|Adverse Event|0|||
164356055|NCT02743871|593678771|FG004|Overall Study|Adverse Event|0|||
164356056|NCT02743871|593678772|FG005|Overall Study|Adverse Event|0|||
164356057|NCT02743871|593678773|FG006|Overall Study|Adverse Event|0|||
164356058|NCT02743871|593678774|FG007|Overall Study|Adverse Event|0|||
164356059|NCT02743871|593678775|FG008|Overall Study|Adverse Event|0|||
164356060|NCT02743871|593678776|FG009|Overall Study|Adverse Event|0|||
164356061|NCT02743871|593678777|FG010|Overall Study|Adverse Event|0|||
164356062|NCT02743871|593678778|FG011|Overall Study|Adverse Event|0|||
164356063|NCT02743871|593678779|FG012|Overall Study|Adverse Event|0|||
164356064|NCT02743871|593678780|FG013|Overall Study|Adverse Event|0|||
164356065|NCT02743871|593678767|FG000|Overall Study|Other|0|||
164356066|NCT02743871|593678768|FG001|Overall Study|Other|0|||
164356067|NCT02743871|593678769|FG002|Overall Study|Other|0|||
164356068|NCT02743871|593678770|FG003|Overall Study|Other|0|||
164356069|NCT02743871|593678771|FG004|Overall Study|Other|0|||
164356070|NCT02743871|593678772|FG005|Overall Study|Other|0|||
164356071|NCT02743871|593678773|FG006|Overall Study|Other|0|||
164356072|NCT02743871|593678774|FG007|Overall Study|Other|0|||
164356073|NCT02743871|593678775|FG008|Overall Study|Other|0|||
164356074|NCT02743871|593678776|FG009|Overall Study|Other|0|||
164356075|NCT02743871|593678777|FG010|Overall Study|Other|0|||
164356076|NCT02743871|593678778|FG011|Overall Study|Other|1|||
164356077|NCT02743871|593678779|FG012|Overall Study|Other|1|||
164356078|NCT02743871|593678780|FG013|Overall Study|Other|1|||
164356079|NCT02743871|593678767|FG000|Overall Study|Protocol Violation|0|||
164356080|NCT02743871|593678768|FG001|Overall Study|Protocol Violation|0|||
164356081|NCT02743871|593678769|FG002|Overall Study|Protocol Violation|0|||
164356082|NCT02743871|593678770|FG003|Overall Study|Protocol Violation|0|||
164589897|NCT00789477|594523083|FG000|Overall Study|Lack of Efficacy|2|||
164356083|NCT02743871|593678771|FG004|Overall Study|Protocol Violation|0|||
164356084|NCT02743871|593678772|FG005|Overall Study|Protocol Violation|0|||
164356085|NCT02743871|593678773|FG006|Overall Study|Protocol Violation|0|||
164356086|NCT02743871|593678774|FG007|Overall Study|Protocol Violation|0|||
164356087|NCT02743871|593678775|FG008|Overall Study|Protocol Violation|0|||
164356088|NCT02743871|593678776|FG009|Overall Study|Protocol Violation|0|||
164356089|NCT02743871|593678777|FG010|Overall Study|Protocol Violation|0|||
164356090|NCT02743871|593678778|FG011|Overall Study|Protocol Violation|0|||
164356091|NCT02743871|593678779|FG012|Overall Study|Protocol Violation|2|||
164356092|NCT02743871|593678780|FG013|Overall Study|Protocol Violation|0|||
164589898|NCT00789477|594523084|FG001|Overall Study|Lack of Efficacy|0|||
164589899|NCT00789477|594523085|FG002|Overall Study|Lack of Efficacy|0|||
164589900|NCT00789477|594523086|FG003|Overall Study|Lack of Efficacy|0|||
164589901|NCT00789477|594523087|FG004|Overall Study|Lack of Efficacy|0|||
164589902|NCT00789477|594523083|FG000|Overall Study|Other|2|||
164589903|NCT00789477|594523084|FG001|Overall Study|Other|0|||
164589904|NCT00789477|594523085|FG002|Overall Study|Other|1|||
164589905|NCT00789477|594523086|FG003|Overall Study|Other|3|||
164589906|NCT00789477|594523087|FG004|Overall Study|Other|0|||
164589907|NCT00455858|594523088|FG000|Overall Study|Lost to Follow-up|2|||
164589908|NCT00455858|594523088|FG000|Overall Study|Protocol Violation|1|||
164589909|NCT00455858|594523088|FG000|Overall Study|Lack of Efficacy|1|||
164589910|NCT00455858|594523088|FG000|Overall Study|Well controlled FPG without insulin|1|||
164589911|NCT00455858|594523088|FG000|Overall Study|Withdrawal|1|||
164589912|NCT02375698|594523089|FG000|Overall Study|Withdrawal by Subject|0|||
164589913|NCT02375698|594523090|FG001|Overall Study|Withdrawal by Subject|2|||
164589914|NCT02375698|594523089|FG000|Overall Study|Physician Decision|2|||
164589915|NCT02375698|594523090|FG001|Overall Study|Physician Decision|0|||
164589916|NCT02680847|594523091|FG000|Overall Study|Other|2|||
164589917|NCT02680847|594523092|FG001|Overall Study|Other|0|||
164589918|NCT02680847|594523093|FG002|Overall Study|Other|0|||
164589919|NCT02680847|594523091|FG000|Overall Study|No longer met eligibility criteria|2|||
164589920|NCT02680847|594523092|FG001|Overall Study|No longer met eligibility criteria|2|||
164589921|NCT02680847|594523093|FG002|Overall Study|No longer met eligibility criteria|0|||
164589922|NCT02680847|594523091|FG000|Overall Study|Unwilling to participate in study|1|||
164589923|NCT02680847|594523092|FG001|Overall Study|Unwilling to participate in study|1|||
164589924|NCT02680847|594523093|FG002|Overall Study|Unwilling to participate in study|0|||
164589925|NCT02680847|594523091|FG000|Overall Study|Lack of Efficacy|0|||
164589926|NCT02680847|594523092|FG001|Overall Study|Lack of Efficacy|0|||
164589927|NCT02680847|594523093|FG002|Overall Study|Lack of Efficacy|2|||
164589928|NCT02680847|594523091|FG000|Overall Study|Adverse Event|0|||
164695598|NCT01181531|594907813|FG000|Overall Study|Protocol Specified Criteria|15|||
164695599|NCT01181531|594907814|FG001|Overall Study|Protocol Specified Criteria|8|||
164695600|NCT01181531|594907813|FG000|Overall Study|Pregnancy|0|||
164695601|NCT01181531|594907814|FG001|Overall Study|Pregnancy|1|||
164695602|NCT01181531|594907813|FG000|Overall Study|Withdrawal by Subject|8|||
164695603|NCT01181531|594907814|FG001|Overall Study|Withdrawal by Subject|7|||
164695604|NCT01181531|594907813|FG000|Overall Study|Protocol Violation|6|||
164695605|NCT01181531|594907814|FG001|Overall Study|Protocol Violation|6|||
164695606|NCT01181531|594907813|FG000|Overall Study|Death|9|||
164695607|NCT01181531|594907814|FG001|Overall Study|Death|12|||
164695608|NCT01181531|594907813|FG000|Overall Study|Adverse Event|0|||
164695609|NCT01181531|594907814|FG001|Overall Study|Adverse Event|1|||
164695610|NCT00545688|594907816|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
164695611|NCT00545688|594907817|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
164695612|NCT00545688|594907818|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
164695613|NCT00545688|594907819|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
164695614|NCT00545688|594907816|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
164695615|NCT00545688|594907817|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
164695616|NCT00545688|594907818|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
164695617|NCT00545688|594907819|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
164695618|NCT00545688|594907816|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
164695619|NCT00545688|594907817|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
164695620|NCT00545688|594907818|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
164695621|NCT00545688|594907819|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
164695622|NCT00545688|594907816|FG000|Neo-Adjuvant Treatment Period|Death|0|||
164695623|NCT00545688|594907817|FG001|Neo-Adjuvant Treatment Period|Death|1|||
164695624|NCT00545688|594907818|FG002|Neo-Adjuvant Treatment Period|Death|0|||
164695625|NCT00545688|594907819|FG003|Neo-Adjuvant Treatment Period|Death|0|||
164695626|NCT00545688|594907816|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
164695627|NCT00545688|594907817|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
164695628|NCT00545688|594907818|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
164695629|NCT00545688|594907819|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
164695630|NCT00545688|594907816|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
164695631|NCT00545688|594907817|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
164695632|NCT00545688|594907818|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
164695633|NCT00545688|594907819|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
164695634|NCT00545688|594907816|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
164695635|NCT00545688|594907817|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
164695636|NCT00545688|594907818|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
164695637|NCT00545688|594907819|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
164695638|NCT00545688|594907816|FG000|Adjuvant Treatment Period|Disease Progression|3|||
164695639|NCT00545688|594907817|FG001|Adjuvant Treatment Period|Disease Progression|3|||
164695640|NCT00545688|594907818|FG002|Adjuvant Treatment Period|Disease Progression|0|||
164695641|NCT00545688|594907819|FG003|Adjuvant Treatment Period|Disease Progression|7|||
164695642|NCT00545688|594907816|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
164695643|NCT00545688|594907817|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
164695644|NCT00545688|594907818|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
164695645|NCT00545688|594907819|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
164695646|NCT00545688|594907816|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
164695647|NCT00545688|594907817|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
164695648|NCT00545688|594907818|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
164695649|NCT00545688|594907819|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
164695650|NCT00545688|594907816|FG000|Adjuvant Treatment Period|Adverse Event|0|||
164695651|NCT00545688|594907817|FG001|Adjuvant Treatment Period|Adverse Event|3|||
164695652|NCT00545688|594907818|FG002|Adjuvant Treatment Period|Adverse Event|2|||
164356093|NCT03171415|593678782|FG000|Overall Study|Lost to Follow-up|0|||
164356094|NCT03171415|593678783|FG001|Overall Study|Lost to Follow-up|0|||
164356095|NCT03171415|593678784|FG002|Overall Study|Lost to Follow-up|0|||
164356096|NCT03171415|593678785|FG003|Overall Study|Lost to Follow-up|0|||
164356097|NCT03171415|593678786|FG004|Overall Study|Lost to Follow-up|2|||
164356098|NCT02848651|593678787|FG000|Overall Study|Death|85|||
164356099|NCT02848651|593678787|FG000|Overall Study|Lost to Follow-up|1|||
164356100|NCT02848651|593678787|FG000|Overall Study|Non-Compliance|1|||
164695653|NCT00545688|594907819|FG003|Adjuvant Treatment Period|Adverse Event|2|||
164695654|NCT00545688|594907816|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
164695655|NCT00545688|594907817|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
164695656|NCT00545688|594907818|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
164695657|NCT00545688|594907819|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
164695658|NCT00545688|594907816|FG000|Follow-Up Period|Death|4|||
164695659|NCT00545688|594907817|FG001|Follow-Up Period|Death|2|||
164695660|NCT00545688|594907818|FG002|Follow-Up Period|Death|2|||
164695661|NCT00545688|594907819|FG003|Follow-Up Period|Death|6|||
164695662|NCT00545688|594907816|FG000|Follow-Up Period|Disease Progression|6|||
164695663|NCT00545688|594907817|FG001|Follow-Up Period|Disease Progression|5|||
164695664|NCT00545688|594907818|FG002|Follow-Up Period|Disease Progression|9|||
164695665|NCT00545688|594907819|FG003|Follow-Up Period|Disease Progression|9|||
164695666|NCT00545688|594907816|FG000|Follow-Up Period|Refused Treatment|6|||
164695667|NCT00545688|594907817|FG001|Follow-Up Period|Refused Treatment|2|||
164695668|NCT00545688|594907818|FG002|Follow-Up Period|Refused Treatment|0|||
164695669|NCT00545688|594907819|FG003|Follow-Up Period|Refused Treatment|2|||
164695670|NCT00545688|594907816|FG000|Follow-Up Period|Lost to Follow-up|3|||
164695671|NCT00545688|594907817|FG001|Follow-Up Period|Lost to Follow-up|3|||
164695672|NCT00545688|594907818|FG002|Follow-Up Period|Lost to Follow-up|3|||
164695673|NCT00545688|594907819|FG003|Follow-Up Period|Lost to Follow-up|1|||
164695674|NCT00545688|594907816|FG000|Follow-Up Period|Unspecified Reason|2|||
164695675|NCT00545688|594907817|FG001|Follow-Up Period|Unspecified Reason|5|||
164695676|NCT00545688|594907818|FG002|Follow-Up Period|Unspecified Reason|6|||
164695677|NCT00545688|594907819|FG003|Follow-Up Period|Unspecified Reason|8|||
164695678|NCT00545688|594907816|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
164695679|NCT00545688|594907817|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
164695680|NCT00545688|594907818|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
164695681|NCT00545688|594907819|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
164695682|NCT02737592|594907822|FG000|Overall Study|Withdrawal by Subject|1|||
164695683|NCT02792218|594907824|FG000|Overall Study|Patient/guardian decision|15|||
164695684|NCT02792218|594907825|FG001|Overall Study|Patient/guardian decision|42|||
164695685|NCT02792218|594907824|FG000|Overall Study|Adverse Event|15|||
164695686|NCT02792218|594907825|FG001|Overall Study|Adverse Event|14|||
164695687|NCT02792218|594907824|FG000|Overall Study|Lost to Follow-up|10|||
164695688|NCT02792218|594907825|FG001|Overall Study|Lost to Follow-up|5|||
164695689|NCT02792218|594907824|FG000|Overall Study|Lack of Efficacy|1|||
164695690|NCT02792218|594907825|FG001|Overall Study|Lack of Efficacy|12|||
164695691|NCT02792218|594907824|FG000|Overall Study|Physician Decision|4|||
164695692|NCT02792218|594907825|FG001|Overall Study|Physician Decision|4|||
164695693|NCT02792218|594907824|FG000|Overall Study|Protocol deviation|3|||
164695694|NCT02792218|594907825|FG001|Overall Study|Protocol deviation|2|||
164695695|NCT02792218|594907824|FG000|Overall Study|New therapy for study indication|0|||
164695696|NCT02792218|594907825|FG001|Overall Study|New therapy for study indication|1|||
164695697|NCT02792218|594907824|FG000|Overall Study|Non-compliance with study treatment|0|||
164695698|NCT02792218|594907825|FG001|Overall Study|Non-compliance with study treatment|1|||
164695699|NCT02792218|594907824|FG000|Overall Study|Pregnancy|1|||
164695700|NCT02792218|594907825|FG001|Overall Study|Pregnancy|0|||
164695701|NCT03123783|594907826|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
164695702|NCT03123783|594907827|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
164695703|NCT03123783|594907828|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
164695704|NCT03123783|594907829|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
164695705|NCT03123783|594907830|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
164695706|NCT03123783|594907831|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
164695707|NCT03123783|594907832|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
164695708|NCT03123783|594907826|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
164695709|NCT03123783|594907827|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
164695710|NCT03123783|594907828|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
164695711|NCT03123783|594907829|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
164695712|NCT03123783|594907830|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
164695713|NCT03123783|594907831|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
164695714|NCT03123783|594907832|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
164695715|NCT03123783|594907826|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
164695716|NCT03123783|594907827|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
164695717|NCT03123783|594907828|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
164695718|NCT03123783|594907829|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
164695719|NCT03123783|594907830|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
164695720|NCT03123783|594907831|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
164695721|NCT03123783|594907832|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
164695722|NCT03123783|594907826|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
164695723|NCT03123783|594907827|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
164695724|NCT03123783|594907828|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
164695725|NCT03123783|594907829|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
164695726|NCT03123783|594907830|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
164695727|NCT03123783|594907831|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
164695728|NCT03123783|594907832|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
164695729|NCT01557582|594907833|FG000|Overall Study|Protocol Violation|4|||
164695730|NCT01557582|594907833|FG000|Overall Study|Operator error|2|||
164695731|NCT00749411|594907840|FG000|Overall Study|Adverse Event|0|||
164695732|NCT00749411|594907841|FG001|Overall Study|Adverse Event|2|||
164695733|NCT00749411|594907840|FG000|Overall Study|Lack of Efficacy|0|||
164695734|NCT00749411|594907841|FG001|Overall Study|Lack of Efficacy|1|||
164695735|NCT00749411|594907840|FG000|Overall Study|Protocol Violation|1|||
164695736|NCT00749411|594907841|FG001|Overall Study|Protocol Violation|1|||
164695737|NCT00749411|594907840|FG000|Overall Study|Protocol-defined stopping criteria|0|||
164695738|NCT00749411|594907841|FG001|Overall Study|Protocol-defined stopping criteria|1|||
164695739|NCT00614926|594908944|FG000|Overall Study|Burden of travel|1|||
164695740|NCT00614926|594908945|FG001|Overall Study|Burden of travel|0|||
164695741|NCT00614926|594908944|FG000|Overall Study|Adverse Event|3|||
164695742|NCT00614926|594908945|FG001|Overall Study|Adverse Event|0|||
164695743|NCT01432574|594908952|FG000|Overall Study|Moved|2|||
164695744|NCT01432574|594908952|FG000|Overall Study|Not interested|1|||
164695745|NCT03135899|594908953|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
164695746|NCT03135899|594908954|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
164695747|NCT03135899|594908955|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
164695748|NCT03135899|594908956|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
164356101|NCT02848651|593678787|FG000|Overall Study|Symptomatic Deterioration|1|||
164356102|NCT02848651|593678787|FG000|Overall Study|Physician Decision|4|||
164356103|NCT02848651|593678787|FG000|Overall Study|Withdrawal by Subject|14|||
164356104|NCT00883116|593678788|FG000|Overall Study|Adverse event unrelated to study drug|5|||
164695749|NCT03135899|594908957|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
164695750|NCT03135899|594908958|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
164356105|NCT00883116|593678789|FG001|Overall Study|Adverse event unrelated to study drug|10|||
164356106|NCT00883116|593678788|FG000|Overall Study|Death|6|||
164356107|NCT00883116|593678789|FG001|Overall Study|Death|2|||
164356108|NCT00883116|593678788|FG000|Overall Study|Disease progression|130|||
164356109|NCT00883116|593678789|FG001|Overall Study|Disease progression|128|||
164356110|NCT00883116|593678788|FG000|Overall Study|Lost to Follow-up|0|||
164356111|NCT00883116|593678789|FG001|Overall Study|Lost to Follow-up|1|||
164356112|NCT00883116|593678788|FG000|Overall Study|Maximum clinical benefit|13|||
164356113|NCT00883116|593678789|FG001|Overall Study|Maximum clinical benefit|46|||
164356114|NCT00883116|593678788|FG000|Overall Study|Not identified|3|||
164356115|NCT00883116|593678789|FG001|Overall Study|Not identified|6|||
164356116|NCT00883116|593678788|FG000|Overall Study|Study drug toxicity|36|||
164356117|NCT00883116|593678789|FG001|Overall Study|Study drug toxicity|16|||
164356118|NCT00883116|593678788|FG000|Overall Study|Withdrawal by Subject|14|||
164356119|NCT00883116|593678789|FG001|Overall Study|Withdrawal by Subject|8|||
164356120|NCT00883116|593678788|FG000|Overall Study|No longer meets study criteria|2|||
164356121|NCT00883116|593678789|FG001|Overall Study|No longer meets study criteria|2|||
164356122|NCT04140292|593678790|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
164356123|NCT04140292|593678791|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
164356124|NCT00680043|593678795|FG000|Overall Study|Withdrawal by Subject|1|||
164356125|NCT00680043|593678796|FG001|Overall Study|Withdrawal by Subject|0|||
164356126|NCT00680043|593678797|FG002|Overall Study|Withdrawal by Subject|0|||
164356127|NCT00680043|593678795|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
164356128|NCT00680043|593678796|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
164356129|NCT00680043|593678797|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
164356130|NCT00680043|593678795|FG000|Overall Study|Renal Transplant|1|||
164356131|NCT00680043|593678796|FG001|Overall Study|Renal Transplant|0|||
164356132|NCT00680043|593678797|FG002|Overall Study|Renal Transplant|4|||
164356133|NCT02484729|593678798|FG000|Overall Study|Failure of IntelliCap Error|0|||
164356134|NCT02484729|593678799|FG001|Overall Study|Failure of IntelliCap Error|0|||
164356135|NCT02484729|593678800|FG002|Overall Study|Failure of IntelliCap Error|0|||
164356136|NCT02484729|593678801|FG003|Overall Study|Failure of IntelliCap Error|0|||
164356137|NCT02484729|593678802|FG004|Overall Study|Failure of IntelliCap Error|0|||
164356138|NCT02484729|593678803|FG005|Overall Study|Failure of IntelliCap Error|0|||
164356139|NCT02484729|593678804|FG006|Overall Study|Failure of IntelliCap Error|0|||
164356140|NCT02484729|593678805|FG007|Overall Study|Failure of IntelliCap Error|0|||
164356141|NCT02484729|593678806|FG008|Overall Study|Failure of IntelliCap Error|0|||
164356142|NCT02484729|593678807|FG009|Overall Study|Failure of IntelliCap Error|1|||
164356143|NCT02480114|593678808|FG000|Overall Study|Not completing surveys|3|||
164356144|NCT02480114|593678809|FG001|Overall Study|Not completing surveys|2|||
164356145|NCT02480114|593678808|FG000|Overall Study|Withdrawal by Subject|2|||
164356146|NCT02480114|593678809|FG001|Overall Study|Withdrawal by Subject|4|||
164356147|NCT02480114|593678808|FG000|Overall Study|Disease progression|3|||
164356148|NCT02480114|593678809|FG001|Overall Study|Disease progression|0|||
164356149|NCT02480114|593678808|FG000|Overall Study|Improper completion of survey|1|||
164356150|NCT02480114|593678809|FG001|Overall Study|Improper completion of survey|1|||
164356151|NCT02480114|593678808|FG000|Overall Study|Not eligible|0|||
164356152|NCT02480114|593678809|FG001|Overall Study|Not eligible|1|||
164356153|NCT01031069|593678810|FG000|Overall Study|Serious Adverse Event|0|||
164356154|NCT01031069|593678811|FG001|Overall Study|Serious Adverse Event|1|||
164356155|NCT01031069|593678812|FG002|Overall Study|Serious Adverse Event|0|||
164356156|NCT01031069|593678813|FG003|Overall Study|Serious Adverse Event|0|||
164356157|NCT01031069|593678810|FG000|Overall Study|Withdrawal by Subject|2|||
164356158|NCT01031069|593678811|FG001|Overall Study|Withdrawal by Subject|3|||
164356159|NCT01031069|593678812|FG002|Overall Study|Withdrawal by Subject|18|||
164356160|NCT01031069|593678813|FG003|Overall Study|Withdrawal by Subject|18|||
164356161|NCT01031069|593678810|FG000|Overall Study|Migrated/moved from study area|1|||
164356162|NCT01031069|593678811|FG001|Overall Study|Migrated/moved from study area|2|||
164356163|NCT01031069|593678812|FG002|Overall Study|Migrated/moved from study area|1|||
164356164|NCT01031069|593678813|FG003|Overall Study|Migrated/moved from study area|1|||
164437758|NCT01212757|593968256|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
164356165|NCT01031069|593678810|FG000|Overall Study|Lost to Follow-up|9|||
164356166|NCT01031069|593678811|FG001|Overall Study|Lost to Follow-up|5|||
164356167|NCT01031069|593678812|FG002|Overall Study|Lost to Follow-up|21|||
164356168|NCT01031069|593678813|FG003|Overall Study|Lost to Follow-up|15|||
164356169|NCT01031069|593678810|FG000|Overall Study|Other|0|||
164356170|NCT01031069|593678811|FG001|Overall Study|Other|0|||
164356171|NCT01031069|593678812|FG002|Overall Study|Other|1|||
164356172|NCT01031069|593678813|FG003|Overall Study|Other|0|||
164356173|NCT01317160|593678814|FG000|Overall Study|Incorrect inclusion|1|||
164695751|NCT03135899|594908959|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
164695752|NCT03135899|594908960|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
164695753|NCT03135899|594908953|FG000|Overall Study|Withdrawal by Subject|0|||
164695754|NCT03135899|594908954|FG001|Overall Study|Withdrawal by Subject|0|||
164695755|NCT03135899|594908955|FG002|Overall Study|Withdrawal by Subject|0|||
164695756|NCT03135899|594908956|FG003|Overall Study|Withdrawal by Subject|0|||
164695757|NCT03135899|594908957|FG004|Overall Study|Withdrawal by Subject|0|||
164695758|NCT03135899|594908958|FG005|Overall Study|Withdrawal by Subject|2|||
164695759|NCT03135899|594908959|FG006|Overall Study|Withdrawal by Subject|0|||
164695760|NCT03135899|594908960|FG007|Overall Study|Withdrawal by Subject|0|||
164695761|NCT01042535|594908961|FG000|Overall Study|disease progression prior to treatment|3|||
164695762|NCT01042535|594908961|FG000|Overall Study|disease progression during treatment|3|||
164695763|NCT01042535|594908961|FG000|Overall Study|complications from other disease|2|||
164695764|NCT02129647|594908967|FG000|Overall Study|Adverse Event|2|||
164695765|NCT02129647|594908967|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
164695766|NCT00918463|594908968|FG000|Overall Study|Death|1|||
164695767|NCT00918463|594908968|FG000|Overall Study|Lack of Efficacy|1|||
164695768|NCT01045993|594908970|FG000|Overall Study|Treated-later found eligibility not met|0|||
164695769|NCT01045993|594908971|FG001|Overall Study|Treated-later found eligibility not met|1|||
164695770|NCT01045993|594908972|FG002|Overall Study|Treated-later found eligibility not met|0|||
164695771|NCT01045993|594908973|FG003|Overall Study|Treated-later found eligibility not met|0|||
164695772|NCT01659736|594908974|FG000|Treatment Period|Adverse Event|1|||
164695773|NCT01659736|594908975|FG001|Treatment Period|Adverse Event|1|||
164695774|NCT01659736|594908974|FG000|Treatment Period|Protocol Violation|3|||
164695775|NCT01659736|594908975|FG001|Treatment Period|Protocol Violation|1|||
164695776|NCT01659736|594908974|FG000|Treatment Period|Withdrawal by Subject|1|||
164695777|NCT01659736|594908975|FG001|Treatment Period|Withdrawal by Subject|0|||
164695778|NCT01659736|594908974|FG000|3-month Follow-up|Lost to Follow-up|0|||
164695779|NCT01659736|594908975|FG001|3-month Follow-up|Lost to Follow-up|1|||
164695780|NCT01570283|594908981|FG000|Cohort 1: Dose Level 1|Death|0|||
164695781|NCT01570283|594908982|FG001|Cohort 1: Dose Level 1|Death|1|||
164695782|NCT01570283|594908983|FG002|Cohort 1: Dose Level 1|Death|0|||
164695783|NCT01570283|594908984|FG003|Cohort 1: Dose Level 1|Death|0|||
164695784|NCT01570283|594908985|FG004|Cohort 1: Dose Level 1|Death|0|||
164695785|NCT01570283|594908986|FG005|Cohort 1: Dose Level 1|Death|0|||
164695786|NCT01570283|594908981|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
164695787|NCT01570283|594908982|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
164695788|NCT01570283|594908983|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
164695789|NCT01570283|594908984|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
164695790|NCT01570283|594908985|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
164695791|NCT01570283|594908986|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
164695792|NCT01570283|594908981|FG000|Cohort 2: Dose Level 2|Death|0|||
164695793|NCT01570283|594908982|FG001|Cohort 2: Dose Level 2|Death|0|||
164695794|NCT01570283|594908983|FG002|Cohort 2: Dose Level 2|Death|1|||
164695795|NCT01570283|594908984|FG003|Cohort 2: Dose Level 2|Death|0|||
164695796|NCT01570283|594908985|FG004|Cohort 2: Dose Level 2|Death|0|||
164695797|NCT01570283|594908986|FG005|Cohort 2: Dose Level 2|Death|0|||
164695798|NCT01570283|594908981|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
164695799|NCT01570283|594908982|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
164695800|NCT01570283|594908983|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
164695801|NCT01570283|594908984|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
164695802|NCT01570283|594908985|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
164695803|NCT01570283|594908986|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
164695804|NCT01570283|594908981|FG000|Cohort 3: Dose Level 3|Death|0|||
164695805|NCT01570283|594908982|FG001|Cohort 3: Dose Level 3|Death|0|||
164695806|NCT01570283|594908983|FG002|Cohort 3: Dose Level 3|Death|0|||
164695807|NCT01570283|594908984|FG003|Cohort 3: Dose Level 3|Death|0|||
164695808|NCT01570283|594908985|FG004|Cohort 3: Dose Level 3|Death|0|||
164695809|NCT01570283|594908986|FG005|Cohort 3: Dose Level 3|Death|1|||
164695810|NCT01570283|594908981|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
164695811|NCT01570283|594908982|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
164695812|NCT01570283|594908983|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
164695813|NCT01570283|594908984|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
164695814|NCT01570283|594908985|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
164695815|NCT01570283|594908986|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
164695816|NCT01833533|594908987|FG000|Overall Study|Adverse Event|0|||
164695817|NCT01833533|594908988|FG001|Overall Study|Adverse Event|1|||
164695818|NCT01833533|594908987|FG000|Overall Study|Lost to Follow-up|4|||
164695819|NCT01833533|594908988|FG001|Overall Study|Lost to Follow-up|9|||
164695820|NCT01833533|594908987|FG000|Overall Study|To Enter an Extension Study|0|||
164695821|NCT01833533|594908988|FG001|Overall Study|To Enter an Extension Study|4|||
164356174|NCT01317160|593678815|FG001|Overall Study|Incorrect inclusion|1|||
164356175|NCT01317160|593678814|FG000|Overall Study|Lost to Follow-up|3|||
164356176|NCT01317160|593678815|FG001|Overall Study|Lost to Follow-up|3|||
164356177|NCT01317160|593678814|FG000|Overall Study|Withdrawal by Subject|0|||
164356178|NCT01317160|593678815|FG001|Overall Study|Withdrawal by Subject|2|||
164356179|NCT03578367|593678817|FG000|Overall Study|Adverse Event|0|||
164356180|NCT03578367|593678818|FG001|Overall Study|Adverse Event|3|||
164356181|NCT03578367|593678819|FG002|Overall Study|Adverse Event|0|||
164356182|NCT03578367|593678820|FG003|Overall Study|Adverse Event|5|||
164356183|NCT03578367|593678817|FG000|Overall Study|Withdrawal by Subject|2|||
164356184|NCT03578367|593678818|FG001|Overall Study|Withdrawal by Subject|2|||
164356185|NCT03578367|593678819|FG002|Overall Study|Withdrawal by Subject|1|||
164356186|NCT03578367|593678820|FG003|Overall Study|Withdrawal by Subject|3|||
164356187|NCT03578367|593678817|FG000|Overall Study|Physician Decision|0|||
164356188|NCT03578367|593678818|FG001|Overall Study|Physician Decision|0|||
164356189|NCT03578367|593678819|FG002|Overall Study|Physician Decision|14|||
164356190|NCT03578367|593678820|FG003|Overall Study|Physician Decision|0|||
164356191|NCT03578367|593678817|FG000|Overall Study|Death|1|||
164356192|NCT03578367|593678818|FG001|Overall Study|Death|0|||
164356193|NCT03578367|593678819|FG002|Overall Study|Death|0|||
164356194|NCT03578367|593678820|FG003|Overall Study|Death|0|||
164356195|NCT03578367|593678817|FG000|Overall Study|Not treated|0|||
164356196|NCT03578367|593678818|FG001|Overall Study|Not treated|0|||
164356197|NCT03578367|593678819|FG002|Overall Study|Not treated|1|||
164356198|NCT03578367|593678820|FG003|Overall Study|Not treated|0|||
164356199|NCT00670800|593680906|FG000|Overall Study|2 controls were insulin resistant|0|||
164356200|NCT00670800|593680907|FG001|Overall Study|2 controls were insulin resistant|2|||
164356201|NCT00587561|593680908|FG000|Overall Study|Lost to Follow-up|6|||
164356202|NCT00587561|593680909|FG001|Overall Study|Lost to Follow-up|4|||
164356203|NCT05661942|593680910|FG000|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|2|||
164356204|NCT05661942|593680911|FG001|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|7|||
164356205|NCT02081690|593680915|FG000|Overall Study|Death|3|||
164356206|NCT02081690|593680915|FG000|Overall Study|Physician Decision|3|||
164356207|NCT02081690|593680915|FG000|Overall Study|Withdrawal by Subject|1|||
164356208|NCT00982488|593680917|FG000|Overall Study|Administrative reason by sponsor|81|||
164356209|NCT00982488|593680918|FG001|Overall Study|Administrative reason by sponsor|3|||
164356210|NCT00982488|593680919|FG002|Overall Study|Administrative reason by sponsor|11|||
164356211|NCT00982488|593680920|FG003|Overall Study|Administrative reason by sponsor|0|||
164356212|NCT00982488|593680921|FG004|Overall Study|Administrative reason by sponsor|0|||
164356213|NCT00982488|593680917|FG000|Overall Study|Adverse event unrelated to study drug|5|||
164356214|NCT00982488|593680918|FG001|Overall Study|Adverse event unrelated to study drug|1|||
164356215|NCT00982488|593680919|FG002|Overall Study|Adverse event unrelated to study drug|0|||
164356216|NCT00982488|593680920|FG003|Overall Study|Adverse event unrelated to study drug|0|||
164356217|NCT00982488|593680921|FG004|Overall Study|Adverse event unrelated to study drug|0|||
164356218|NCT00982488|593680917|FG000|Overall Study|Death|11|||
164356219|NCT00982488|593680918|FG001|Overall Study|Death|0|||
164356220|NCT00982488|593680919|FG002|Overall Study|Death|2|||
164356221|NCT00982488|593680920|FG003|Overall Study|Death|0|||
164356222|NCT00982488|593680921|FG004|Overall Study|Death|0|||
164356223|NCT00982488|593680917|FG000|Overall Study|Disease progression|30|||
164356224|NCT00982488|593680918|FG001|Overall Study|Disease progression|5|||
164356225|NCT00982488|593680919|FG002|Overall Study|Disease progression|10|||
164356226|NCT00982488|593680920|FG003|Overall Study|Disease progression|1|||
164356227|NCT00982488|593680921|FG004|Overall Study|Disease progression|1|||
164356228|NCT00982488|593680917|FG000|Overall Study|Lost to Follow-up|1|||
164356229|NCT00982488|593680918|FG001|Overall Study|Lost to Follow-up|0|||
164356230|NCT00982488|593680919|FG002|Overall Study|Lost to Follow-up|0|||
164356231|NCT00982488|593680920|FG003|Overall Study|Lost to Follow-up|0|||
164356232|NCT00982488|593680921|FG004|Overall Study|Lost to Follow-up|0|||
164356233|NCT00982488|593680917|FG000|Overall Study|Maximum clinical benefit|1|||
164356234|NCT00982488|593680918|FG001|Overall Study|Maximum clinical benefit|1|||
164356235|NCT00982488|593680919|FG002|Overall Study|Maximum clinical benefit|1|||
164356236|NCT00982488|593680920|FG003|Overall Study|Maximum clinical benefit|0|||
164356237|NCT00982488|593680921|FG004|Overall Study|Maximum clinical benefit|0|||
164356238|NCT00982488|593680917|FG000|Overall Study|Other|15|||
164356239|NCT00982488|593680918|FG001|Overall Study|Other|1|||
164356240|NCT00982488|593680919|FG002|Overall Study|Other|3|||
164356241|NCT00982488|593680920|FG003|Overall Study|Other|1|||
164356242|NCT00982488|593680921|FG004|Overall Study|Other|0|||
164356243|NCT00982488|593680917|FG000|Overall Study|Poor compliance/noncompliance|0|||
164356244|NCT00982488|593680918|FG001|Overall Study|Poor compliance/noncompliance|1|||
164356245|NCT00982488|593680919|FG002|Overall Study|Poor compliance/noncompliance|0|||
164437759|NCT01212757|593968257|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
164356246|NCT00982488|593680920|FG003|Overall Study|Poor compliance/noncompliance|0|||
164356247|NCT00982488|593680921|FG004|Overall Study|Poor compliance/noncompliance|0|||
164356248|NCT00982488|593680917|FG000|Overall Study|Stem cell transplant|2|||
164356249|NCT00982488|593680918|FG001|Overall Study|Stem cell transplant|0|||
164695822|NCT01833533|594908987|FG000|Overall Study|Other|2|||
164695823|NCT01833533|594908988|FG001|Overall Study|Other|7|||
164695824|NCT02017860|594908989|FG000|Overall Study|Adverse Event|1|||
164695825|NCT02017860|594908989|FG000|Overall Study|Withdrawal by Subject|1|||
164695826|NCT02772562|594908990|FG000|Overall Study|Withdrawal by Subject|1|||
164695827|NCT02772562|594908990|FG000|Overall Study|Protocol Violation|1|||
164695828|NCT00754442|594908995|FG000|Overall Study|Withdrawal by Subject|5|||
164695829|NCT00754442|594908996|FG001|Overall Study|Withdrawal by Subject|3|||
164695830|NCT00384293|594908997|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
164695831|NCT00384293|594908998|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
164695832|NCT00384293|594908999|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
164695833|NCT00384293|594908997|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
164695834|NCT00384293|594908998|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
164695835|NCT00384293|594908999|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
164695836|NCT00384293|594908997|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
164695837|NCT00384293|594908998|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
164695838|NCT00384293|594908999|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
164695839|NCT00384293|594908997|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
164695840|NCT00384293|594908998|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
164695841|NCT00384293|594908999|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
164695842|NCT00384293|594908997|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
164695843|NCT00384293|594908998|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
164695844|NCT00384293|594908999|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
164695845|NCT00384293|594908997|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
164695846|NCT00384293|594908998|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
164695847|NCT00384293|594908999|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
164695848|NCT00384293|594908997|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
164695849|NCT00384293|594908998|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
164356250|NCT00982488|593680919|FG002|Overall Study|Stem cell transplant|0|||
164356251|NCT00982488|593680920|FG003|Overall Study|Stem cell transplant|1|||
164356252|NCT00982488|593680921|FG004|Overall Study|Stem cell transplant|0|||
164356253|NCT00982488|593680917|FG000|Overall Study|Study drug toxicity|34|||
164695850|NCT00384293|594908999|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
164356254|NCT00982488|593680918|FG001|Overall Study|Study drug toxicity|1|||
164356255|NCT00982488|593680919|FG002|Overall Study|Study drug toxicity|6|||
164695851|NCT00384293|594908997|FG000|Post-randomization Period|Adverse Event|0|||
164695852|NCT00384293|594908998|FG001|Post-randomization Period|Adverse Event|23|||
164695853|NCT00384293|594908999|FG002|Post-randomization Period|Adverse Event|7|||
164695854|NCT00384293|594908997|FG000|Post-randomization Period|Lost to Follow-up|0|||
164695855|NCT00384293|594908998|FG001|Post-randomization Period|Lost to Follow-up|2|||
164695856|NCT00384293|594908999|FG002|Post-randomization Period|Lost to Follow-up|1|||
164695857|NCT00384293|594908997|FG000|Post-randomization Period|Protocol Violation|0|||
164695858|NCT00384293|594908998|FG001|Post-randomization Period|Protocol Violation|1|||
164695859|NCT00384293|594908999|FG002|Post-randomization Period|Protocol Violation|0|||
164695860|NCT00384293|594908997|FG000|Post-randomization Period|Withdrawal by Subject|0|||
164695861|NCT00384293|594908998|FG001|Post-randomization Period|Withdrawal by Subject|8|||
164695862|NCT00384293|594908999|FG002|Post-randomization Period|Withdrawal by Subject|6|||
164695863|NCT00384293|594908997|FG000|Post-randomization Period|Trial Termination|0|||
164695864|NCT00384293|594908998|FG001|Post-randomization Period|Trial Termination|180|||
164695865|NCT00384293|594908999|FG002|Post-randomization Period|Trial Termination|204|||
164695866|NCT00384293|594908997|FG000|Post-randomization Period|Patient Randomized in Error|0|||
164695867|NCT00384293|594908998|FG001|Post-randomization Period|Patient Randomized in Error|0|||
164695868|NCT00384293|594908999|FG002|Post-randomization Period|Patient Randomized in Error|1|||
164695869|NCT01020526|594909005|FG000|Overall Study|Withdrawal by Subject|5|||
164356256|NCT00982488|593680920|FG003|Overall Study|Study drug toxicity|0|||
164356257|NCT00982488|593680921|FG004|Overall Study|Study drug toxicity|0|||
164356258|NCT00982488|593680917|FG000|Overall Study|Withdrawal by Subject|5|||
164356259|NCT00982488|593680918|FG001|Overall Study|Withdrawal by Subject|1|||
164356260|NCT00982488|593680919|FG002|Overall Study|Withdrawal by Subject|1|||
164356261|NCT00982488|593680920|FG003|Overall Study|Withdrawal by Subject|0|||
164356262|NCT00982488|593680921|FG004|Overall Study|Withdrawal by Subject|0|||
164356263|NCT03204981|593680922|FG000|Overall Study|Physician Decision|2|||
164356264|NCT03204981|593680922|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
164695870|NCT01020526|594909005|FG000|Overall Study|Other reasons|3|||
164695871|NCT01020526|594909005|FG000|Overall Study|Insufficient clinical response|3|||
164695872|NCT01020526|594909005|FG000|Overall Study|Lost to Follow-up|1|||
164695873|NCT01020526|594909005|FG000|Overall Study|Adverse Event|2|||
164356265|NCT04203238|593680923|FG000|Overall Study|Withdrawal by Subject|1|||
164356266|NCT04203238|593680924|FG001|Overall Study|Withdrawal by Subject|1|||
164589929|NCT02680847|594523092|FG001|Overall Study|Adverse Event|0|||
164589930|NCT02680847|594523093|FG002|Overall Study|Adverse Event|1|||
164589931|NCT01595646|594523096|FG000|Overall Study|Withdrawal by Subject|1|||
164589932|NCT01595646|594523097|FG001|Overall Study|Withdrawal by Subject|0|||
164589933|NCT01595646|594523098|FG002|Overall Study|Withdrawal by Subject|0|||
164589934|NCT01161524|594523101|FG000|Core Study (23 Weeks)|Adverse Event|3|||
164589935|NCT01161524|594523102|FG001|Core Study (23 Weeks)|Adverse Event|0|||
164589936|NCT01161524|594523103|FG002|Core Study (23 Weeks)|Adverse Event|0|||
164589937|NCT01161524|594523101|FG000|Core Study (23 Weeks)|Other|1|||
164589938|NCT01161524|594523102|FG001|Core Study (23 Weeks)|Other|0|||
164589939|NCT01161524|594523103|FG002|Core Study (23 Weeks)|Other|0|||
164589940|NCT01161524|594523101|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
164589941|NCT01161524|594523102|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
164589942|NCT01161524|594523103|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
164589943|NCT01161524|594523101|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
164589944|NCT01161524|594523102|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
164589945|NCT01161524|594523103|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
164589946|NCT01161524|594523101|FG000|Core Study (23 Weeks)|Subject Choice|3|||
164589947|NCT01161524|594523102|FG001|Core Study (23 Weeks)|Subject Choice|2|||
164589948|NCT01161524|594523103|FG002|Core Study (23 Weeks)|Subject Choice|0|||
164589949|NCT01161524|594523101|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
164589950|NCT01161524|594523102|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
164589951|NCT01161524|594523103|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
164589952|NCT01161524|594523101|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
164589953|NCT01161524|594523102|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
164589954|NCT01161524|594523103|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
164589955|NCT01161524|594523101|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
164589956|NCT01161524|594523102|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
164589957|NCT01161524|594523103|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
164589958|NCT01161524|594523101|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
164589959|NCT01161524|594523102|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
164589960|NCT01161524|594523103|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
164356267|NCT04203238|593680923|FG000|Overall Study|Covid-19|3|||
164356268|NCT04203238|593680924|FG001|Overall Study|Covid-19|0|||
164356269|NCT04244786|593680927|FG000|Overall Study|Adverse Event|0|||
164356270|NCT04244786|593680928|FG001|Overall Study|Adverse Event|0|||
164356271|NCT04244786|593680929|FG002|Overall Study|Adverse Event|2|||
164356272|NCT04244786|593680927|FG000|Overall Study|Withdrawal by Subject|0|||
164356273|NCT04244786|593680928|FG001|Overall Study|Withdrawal by Subject|0|||
164356274|NCT04244786|593680929|FG002|Overall Study|Withdrawal by Subject|5|||
164356275|NCT03274687|593680930|FG000|Overall Study|Protocol Violation|1|||
164356276|NCT03274687|593680931|FG001|Overall Study|Protocol Violation|1|||
164356277|NCT01572909|593680934|FG000|Overall Study|Adverse Event|7|||
164356278|NCT01572909|593680935|FG001|Overall Study|Adverse Event|2|||
164356279|NCT01572909|593680934|FG000|Overall Study|Death|3|||
164356280|NCT01572909|593680935|FG001|Overall Study|Death|1|||
164356281|NCT01572909|593680934|FG000|Overall Study|Lost to Follow-up|8|||
164356282|NCT01572909|593680935|FG001|Overall Study|Lost to Follow-up|7|||
164356283|NCT01572909|593680934|FG000|Overall Study|Physician Decision|1|||
164356284|NCT01572909|593680935|FG001|Overall Study|Physician Decision|1|||
164356285|NCT01572909|593680934|FG000|Overall Study|Technical Issues|1|||
164356286|NCT01572909|593680935|FG001|Overall Study|Technical Issues|0|||
164356287|NCT01572909|593680934|FG000|Overall Study|Withdrawal by Subject|12|||
164356288|NCT01572909|593680935|FG001|Overall Study|Withdrawal by Subject|11|||
164356289|NCT01572909|593680934|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
164356290|NCT01572909|593680935|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
164356291|NCT01199289|593680936|FG000|Overall Study|Ineligibility determined|2|||
164356292|NCT01199289|593680937|FG001|Overall Study|Ineligibility determined|1|||
164356293|NCT01199289|593680938|FG002|Overall Study|Ineligibility determined|0|||
164356294|NCT01199289|593680939|FG003|Overall Study|Ineligibility determined|0|||
164356295|NCT01199289|593680936|FG000|Overall Study|Protocol Violation|1|||
164356296|NCT01199289|593680937|FG001|Overall Study|Protocol Violation|0|||
164356297|NCT01199289|593680938|FG002|Overall Study|Protocol Violation|0|||
164356298|NCT01199289|593680939|FG003|Overall Study|Protocol Violation|1|||
164356299|NCT01199289|593680936|FG000|Overall Study|Noncompliance|1|||
164356300|NCT01199289|593680937|FG001|Overall Study|Noncompliance|0|||
164356301|NCT01199289|593680938|FG002|Overall Study|Noncompliance|2|||
164356302|NCT01199289|593680939|FG003|Overall Study|Noncompliance|0|||
164356303|NCT01199289|593680936|FG000|Overall Study|Adverse Event|0|||
164589961|NCT01161524|594523101|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
164356304|NCT01199289|593680937|FG001|Overall Study|Adverse Event|3|||
164356305|NCT01199289|593680938|FG002|Overall Study|Adverse Event|1|||
164356306|NCT01199289|593680939|FG003|Overall Study|Adverse Event|4|||
164356307|NCT01199289|593680936|FG000|Overall Study|Full consent withdrawn|2|||
164356308|NCT01199289|593680937|FG001|Overall Study|Full consent withdrawn|2|||
164356309|NCT01199289|593680938|FG002|Overall Study|Full consent withdrawn|2|||
164356310|NCT01199289|593680939|FG003|Overall Study|Full consent withdrawn|3|||
164695874|NCT01719562|594909006|FG000|Overall Study|Lost to Follow-up|1|||
164695875|NCT01719562|594909007|FG001|Overall Study|Lost to Follow-up|0|||
164695876|NCT01719562|594909006|FG000|Overall Study|Death|1|||
164695877|NCT01719562|594909007|FG001|Overall Study|Death|0|||
164695878|NCT01719562|594909006|FG000|Overall Study|New cancer diagnosis|1|||
164695879|NCT01719562|594909007|FG001|Overall Study|New cancer diagnosis|0|||
164695880|NCT02013531|594909008|FG000|Overall Study|Lost to Follow-up|3|||
164695881|NCT02013531|594909008|FG000|Overall Study|Met Withdrawal Criteria|1|||
164695882|NCT02013531|594909008|FG000|Overall Study|Withdrawal by Subject|1|||
164695883|NCT01832402|594909011|FG000|Overall Study|Lost to Follow-up|2|||
164695884|NCT01832402|594909012|FG001|Overall Study|Lost to Follow-up|0|||
164695885|NCT01832402|594909011|FG000|Overall Study|Withdrawal by Subject|3|||
164695886|NCT01832402|594909012|FG001|Overall Study|Withdrawal by Subject|3|||
164695887|NCT01832402|594909011|FG000|Overall Study|Declining Performance status|2|||
164695888|NCT01832402|594909012|FG001|Overall Study|Declining Performance status|1|||
164695889|NCT01198873|594909013|FG000|Overall Study|Adverse Event|4|||
164695890|NCT01198873|594909014|FG001|Overall Study|Adverse Event|7|||
164695891|NCT01198873|594909013|FG000|Overall Study|Study closure|29|||
164695892|NCT01198873|594909014|FG001|Overall Study|Study closure|23|||
164695893|NCT01198873|594909013|FG000|Overall Study|Other than above|4|||
164695894|NCT01198873|594909014|FG001|Overall Study|Other than above|2|||
164695895|NCT00613730|594909022|FG000|Overall Study|Disease progression|2|||
164695896|NCT00613730|594909022|FG000|Overall Study|Administrative decision|1|||
164695897|NCT00895037|594909023|FG000|Overall Study|Death|0|||
164695898|NCT00895037|594909024|FG001|Overall Study|Death|2|||
164695899|NCT00895037|594909025|FG002|Overall Study|Death|1|||
164695900|NCT03903159|594909038|FG000|Overall Study|Discharged with Staff Approval|2|||
164695901|NCT03903159|594909038|FG000|Overall Study|Discharged at Staff Request|2|||
164695902|NCT03903159|594909038|FG000|Overall Study|Discharged Against Staff Advice|1|||
164695903|NCT01382251|594909041|FG000|Overall Study|Surgeries cancelled or delayed|16|||
164695904|NCT01382251|594909042|FG001|Overall Study|Surgeries cancelled or delayed|16|||
164695905|NCT01382251|594909041|FG000|Overall Study|Lost to Follow-up|4|||
164695906|NCT01382251|594909042|FG001|Overall Study|Lost to Follow-up|4|||
164695907|NCT01382251|594909041|FG000|Overall Study|Contacted after study closed|1|||
164695908|NCT01382251|594909042|FG001|Overall Study|Contacted after study closed|1|||
164695909|NCT01117987|594909043|FG000|Overall Study|Protocol deviation|0|||
164356311|NCT01199289|593680936|FG000|Overall Study|Administrative decision|0|||
164356312|NCT01199289|593680937|FG001|Overall Study|Administrative decision|0|||
164356313|NCT01199289|593680938|FG002|Overall Study|Administrative decision|0|||
164356314|NCT01199289|593680939|FG003|Overall Study|Administrative decision|1|||
164356315|NCT01199289|593680936|FG000|Overall Study|Lost to Follow-up|0|||
164356316|NCT01199289|593680937|FG001|Overall Study|Lost to Follow-up|0|||
164356317|NCT01199289|593680938|FG002|Overall Study|Lost to Follow-up|0|||
164356318|NCT01199289|593680939|FG003|Overall Study|Lost to Follow-up|1|||
164356319|NCT01199289|593680936|FG000|Overall Study|Protocol-specified criteria|3|||
164356320|NCT01199289|593680937|FG001|Overall Study|Protocol-specified criteria|0|||
164356321|NCT01199289|593680938|FG002|Overall Study|Protocol-specified criteria|0|||
164356322|NCT01199289|593680939|FG003|Overall Study|Protocol-specified criteria|1|||
164356323|NCT01199289|593680936|FG000|Overall Study|Pregnancy|0|||
164356324|NCT01199289|593680937|FG001|Overall Study|Pregnancy|1|||
164356325|NCT01199289|593680938|FG002|Overall Study|Pregnancy|0|||
164356326|NCT01199289|593680939|FG003|Overall Study|Pregnancy|1|||
164356327|NCT02636868|593680940|FG000|Overall Study|Death|0|||
164356328|NCT02636868|593680941|FG001|Overall Study|Death|1|||
164356329|NCT02636868|593680942|FG002|Overall Study|Death|2|||
164356330|NCT00415909|593680946|FG000|Overall Study|Withdrawal by Subject|2|||
164356331|NCT00415909|593680946|FG000|Overall Study|Death|1|||
164356332|NCT05024058|593680947|FG000|Treatment|Study terminated by sponsor|5|||
164356333|NCT05024058|593680948|FG001|Treatment|Study terminated by sponsor|6|||
164356334|NCT05024058|593680949|FG002|Treatment|Study terminated by sponsor|4|||
164356335|NCT05024058|593680950|FG003|Treatment|Study terminated by sponsor|2|||
164356336|NCT05024058|593680951|FG004|Treatment|Study terminated by sponsor|3|||
164356337|NCT05024058|593680952|FG005|Treatment|Study terminated by sponsor|3|||
164356338|NCT05024058|593680953|FG006|Treatment|Study terminated by sponsor|1|||
164356339|NCT05024058|593680954|FG007|Treatment|Study terminated by sponsor|3|||
164356340|NCT05024058|593680955|FG008|Treatment|Study terminated by sponsor|6|||
164695910|NCT01117987|594909044|FG001|Overall Study|Protocol deviation|1|||
164356341|NCT05024058|593680956|FG009|Treatment|Study terminated by sponsor|6|||
164356342|NCT05024058|593680947|FG000|Follow-up|Withdrawal by Subject|1|||
164695911|NCT01117987|594909043|FG000|Overall Study|Subject no longer requires study drug|1|||
164695912|NCT01117987|594909044|FG001|Overall Study|Subject no longer requires study drug|0|||
164695913|NCT01117987|594909043|FG000|Overall Study|Lost to Follow-up|1|||
164356343|NCT05024058|593680948|FG001|Follow-up|Withdrawal by Subject|0|||
164356344|NCT05024058|593680949|FG002|Follow-up|Withdrawal by Subject|1|||
164356345|NCT05024058|593680950|FG003|Follow-up|Withdrawal by Subject|0|||
164356346|NCT05024058|593680951|FG004|Follow-up|Withdrawal by Subject|0|||
164356347|NCT05024058|593680952|FG005|Follow-up|Withdrawal by Subject|0|||
164356348|NCT05024058|593680953|FG006|Follow-up|Withdrawal by Subject|0|||
164356349|NCT05024058|593680954|FG007|Follow-up|Withdrawal by Subject|1|||
164356350|NCT05024058|593680955|FG008|Follow-up|Withdrawal by Subject|0|||
164356351|NCT05024058|593680956|FG009|Follow-up|Withdrawal by Subject|1|||
164356352|NCT02734810|593680958|FG000|Overall Study|Adverse Event|1|||
164356353|NCT02734810|593680959|FG001|Overall Study|Adverse Event|0|||
164356354|NCT02734810|593680958|FG000|Overall Study|Lack of Efficacy|1|||
164356355|NCT02734810|593680959|FG001|Overall Study|Lack of Efficacy|0|||
164356356|NCT02507505|593680963|FG000|Overall Study|Withdrawal by Subject|13|||
164356357|NCT02507505|593680964|FG001|Overall Study|Withdrawal by Subject|11|||
164356358|NCT02507505|593680963|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
164356359|NCT02507505|593680964|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
164356360|NCT02507505|593680963|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
164356361|NCT02507505|593680964|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
164356362|NCT02507505|593680963|FG000|Overall Study|Death before receipt of anesthesia|0|||
164356363|NCT02507505|593680964|FG001|Overall Study|Death before receipt of anesthesia|1|||
164356364|NCT00931762|593680965|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
164356365|NCT00931762|593680965|FG000|Overall Study|Administrative Problems|5|||
164356366|NCT00931762|593680965|FG000|Overall Study|Death|1|||
164356367|NCT00931762|593680965|FG000|Overall Study|Disease Progression|3|||
164356368|NCT00931762|593680965|FG000|Overall Study|Adverse Event (s)|11|||
164356369|NCT00931762|593680965|FG000|Overall Study|Subject withdrew consent|13|||
164356370|NCT03182829|593680966|FG000|Overall Study|Protocol Violation|12|||
164356371|NCT03182829|593680967|FG001|Overall Study|Protocol Violation|12|||
164356372|NCT03182829|593680966|FG000|Overall Study|Other|4|||
164356373|NCT03182829|593680967|FG001|Overall Study|Other|3|||
164356374|NCT03316131|593680968|FG000|Treatment Period 2|Protocol deviation|1|||
164589962|NCT01161524|594523102|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
164589963|NCT01161524|594523103|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
164589964|NCT00866294|594523105|FG000|Overall Study|Adverse Event|12|||
164589965|NCT00866294|594523106|FG001|Overall Study|Adverse Event|13|||
164589966|NCT00866294|594523107|FG002|Overall Study|Adverse Event|9|||
164589967|NCT00866294|594523105|FG000|Overall Study|Lack of Efficacy|7|||
164589968|NCT00866294|594523106|FG001|Overall Study|Lack of Efficacy|1|||
164589969|NCT00866294|594523107|FG002|Overall Study|Lack of Efficacy|0|||
164589970|NCT00866294|594523105|FG000|Overall Study|Protocol Violation|2|||
164589971|NCT00866294|594523106|FG001|Overall Study|Protocol Violation|0|||
164589972|NCT00866294|594523107|FG002|Overall Study|Protocol Violation|0|||
164589973|NCT00866294|594523105|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
164589974|NCT00866294|594523106|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
164589975|NCT00866294|594523107|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
164589976|NCT00866294|594523105|FG000|Overall Study|Lost to Follow-up|1|||
164589977|NCT00866294|594523106|FG001|Overall Study|Lost to Follow-up|3|||
164695914|NCT01117987|594909044|FG001|Overall Study|Lost to Follow-up|1|||
164695915|NCT01117987|594909043|FG000|Overall Study|Abnormal test procedure result|2|||
164437760|NCT01212757|593968258|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
164437761|NCT01212757|593968259|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
164437762|NCT01212757|593968251|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
164437763|NCT01212757|593968252|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
164437764|NCT01212757|593968253|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
164437765|NCT01212757|593968254|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
164437766|NCT01212757|593968255|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
164437767|NCT01212757|593968256|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
164437768|NCT01212757|593968257|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
164437769|NCT01212757|593968258|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
164437770|NCT01212757|593968259|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
164437771|NCT01212757|593968251|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
164437772|NCT01212757|593968252|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
164437773|NCT01212757|593968253|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
164437774|NCT01212757|593968254|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
164437775|NCT01212757|593968255|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
164437776|NCT01212757|593968256|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
164437777|NCT01212757|593968257|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
164437778|NCT01212757|593968258|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
164437779|NCT01212757|593968259|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
164437780|NCT01212757|593968251|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
164589978|NCT00866294|594523107|FG002|Overall Study|Lost to Follow-up|0|||
164589979|NCT00866294|594523105|FG000|Overall Study|Physician Decision|6|||
164589980|NCT00866294|594523106|FG001|Overall Study|Physician Decision|2|||
164695916|NCT01117987|594909044|FG001|Overall Study|Abnormal test procedure result|0|||
164695917|NCT01117987|594909043|FG000|Overall Study|Lack of Efficacy|3|||
164695918|NCT01117987|594909044|FG001|Overall Study|Lack of Efficacy|4|||
164695919|NCT01117987|594909043|FG000|Overall Study|Death|5|||
164695920|NCT01117987|594909044|FG001|Overall Study|Death|10|||
164695921|NCT01117987|594909043|FG000|Overall Study|Withdrawal by Subject|5|||
164695922|NCT01117987|594909044|FG001|Overall Study|Withdrawal by Subject|10|||
164695923|NCT01117987|594909043|FG000|Overall Study|Adverse Event|19|||
164695924|NCT01117987|594909044|FG001|Overall Study|Adverse Event|26|||
164695925|NCT01117987|594909043|FG000|Overall Study|Administrative problems|25|||
164695926|NCT01117987|594909044|FG001|Overall Study|Administrative problems|22|||
164695927|NCT00702208|594909050|FG000|Overall Study|Lost to Follow-up|28|||
164695928|NCT00702208|594909050|FG000|Overall Study|Did not self-lavage|1|||
164695929|NCT00702208|594909050|FG000|Overall Study|Unsatisfactory colposcopy|2|||
164695930|NCT00562120|594909051|FG000|First Intervention Period|Adverse Event|1|||
164695931|NCT00562120|594909052|FG001|First Intervention Period|Adverse Event|0|||
164695932|NCT00562120|594909053|FG002|First Intervention Period|Adverse Event|0|||
164695933|NCT00562120|594909054|FG003|First Intervention Period|Adverse Event|0|||
164695934|NCT00562120|594909051|FG000|First Intervention Period|Randomized but not Treated|1|||
164695935|NCT00562120|594909052|FG001|First Intervention Period|Randomized but not Treated|0|||
164695936|NCT00562120|594909053|FG002|First Intervention Period|Randomized but not Treated|0|||
164695937|NCT00562120|594909054|FG003|First Intervention Period|Randomized but not Treated|0|||
164695938|NCT02148445|594909055|FG000|Overall Study|Death|1|||
164695939|NCT02148445|594909056|FG001|Overall Study|Death|3|||
164695940|NCT03450629|594909057|FG000|Overall Study|Adverse Event|15|||
164695941|NCT03450629|594909058|FG001|Overall Study|Adverse Event|14|||
164695942|NCT03450629|594909057|FG000|Overall Study|Physician Decision|2|||
164695943|NCT03450629|594909058|FG001|Overall Study|Physician Decision|2|||
164695944|NCT03450629|594909057|FG000|Overall Study|Lack of Efficacy|2|||
164695945|NCT03450629|594909058|FG001|Overall Study|Lack of Efficacy|0|||
164695946|NCT03450629|594909057|FG000|Overall Study|Lost to Follow-up|4|||
164695947|NCT03450629|594909058|FG001|Overall Study|Lost to Follow-up|2|||
164695948|NCT03450629|594909057|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
164695949|NCT03450629|594909058|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
164695950|NCT03450629|594909057|FG000|Overall Study|Non-Compliance With Study Drug|2|||
164695951|NCT03450629|594909058|FG001|Overall Study|Non-Compliance With Study Drug|1|||
164695952|NCT03450629|594909057|FG000|Overall Study|Protocol Violation|11|||
164695953|NCT03450629|594909058|FG001|Overall Study|Protocol Violation|8|||
164695954|NCT03450629|594909057|FG000|Overall Study|Withdrawal by Subject|12|||
164695955|NCT03450629|594909058|FG001|Overall Study|Withdrawal by Subject|6|||
164695956|NCT03366194|594909059|FG000|Overall Study|Lost to Follow-up|2|||
164695957|NCT02093923|594909060|FG000|Overall Study|Lost to Follow-up|0|||
164695958|NCT02093923|594909061|FG001|Overall Study|Lost to Follow-up|0|||
164356375|NCT03316131|593680969|FG001|Treatment Period 2|Protocol deviation|0|||
164356376|NCT02664441|593680970|FG000|Randomization|Withdrawal by Subject|0|||
164356377|NCT02664441|593680971|FG001|Randomization|Withdrawal by Subject|1|||
164356378|NCT02664441|593680970|FG000|36-week Randomized Trial|Adverse Event|2|||
164356379|NCT02664441|593680971|FG001|36-week Randomized Trial|Adverse Event|0|||
164356380|NCT02664441|593680970|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
164356381|NCT02664441|593680971|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
164356382|NCT02664441|593680970|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
164356383|NCT02664441|593680971|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
164356384|NCT02664441|593680970|FG000|18-week Open Label Extension|Adverse Event|1|||
164356385|NCT02664441|593680971|FG001|18-week Open Label Extension|Adverse Event|0|||
164356386|NCT02664441|593680970|FG000|18-week Open Label Extension|Physician Decision|1|||
164356387|NCT02664441|593680971|FG001|18-week Open Label Extension|Physician Decision|0|||
164356388|NCT02664441|593680970|FG000|18-week Open Label Extension|Death|1|||
164356389|NCT02664441|593680971|FG001|18-week Open Label Extension|Death|0|||
164356390|NCT02664441|593680970|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
164356391|NCT02664441|593680971|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
164695959|NCT02093923|594909062|FG002|Overall Study|Lost to Follow-up|0|||
164695960|NCT02093923|594909063|FG003|Overall Study|Lost to Follow-up|1|||
164695961|NCT02093923|594909064|FG004|Overall Study|Lost to Follow-up|0|||
164695962|NCT02093923|594909060|FG000|Overall Study|Screen failure after randomization|0|||
164356392|NCT03510884|593680972|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
164356393|NCT03510884|593680973|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
164356394|NCT03510884|593680974|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
164356395|NCT03510884|593680975|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
164695963|NCT02093923|594909061|FG001|Overall Study|Screen failure after randomization|0|||
164695964|NCT02093923|594909062|FG002|Overall Study|Screen failure after randomization|0|||
164695965|NCT02093923|594909063|FG003|Overall Study|Screen failure after randomization|1|||
164695966|NCT02093923|594909064|FG004|Overall Study|Screen failure after randomization|0|||
164695967|NCT03438006|594909065|FG000|Overall Study|Adverse Event|1|||
164695968|NCT03438006|594909065|FG000|Overall Study|Lost to Follow-up|67|||
164695969|NCT03438006|594909065|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
164356396|NCT03510884|593680972|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
164356397|NCT03510884|593680973|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
164356398|NCT03510884|593680974|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
164356399|NCT03510884|593680975|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
164356400|NCT03510884|593680972|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
164356401|NCT03510884|593680973|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
164356402|NCT03510884|593680974|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
164356403|NCT03510884|593680975|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
164417406|NCT01474512|593899492|FG003|Long-Term Extension Period|Physician Decision|0|||
164589981|NCT00866294|594523107|FG002|Overall Study|Physician Decision|1|||
164589982|NCT01651260|594523110|FG000|Overall Study|unable to apply product|3|||
164417407|NCT01474512|593899493|FG004|Long-Term Extension Period|Physician Decision|0|||
164589983|NCT01952015|594523111|FG000|Induction|Protocol Violation|1|||
164417408|NCT01474512|593899494|FG005|Long-Term Extension Period|Physician Decision|0|||
164417409|NCT01474512|593899495|FG006|Long-Term Extension Period|Physician Decision|0|||
164589984|NCT01952015|594523111|FG000|Maintenance|Adverse Event|2|||
164589985|NCT01952015|594523111|FG000|Treatment Period 3|Physician Decision|9|||
164589986|NCT01096550|594523115|FG000|Overall Study|discontinued site|10|||
164589987|NCT01096550|594523116|FG001|Overall Study|discontinued site|11|||
164589988|NCT01096550|594523115|FG000|Overall Study|non-regular treatment track at clinic|1|||
164589989|NCT01096550|594523116|FG001|Overall Study|non-regular treatment track at clinic|1|||
164589990|NCT01096550|594523115|FG000|Overall Study|clinic readmission|1|||
164589991|NCT01096550|594523116|FG001|Overall Study|clinic readmission|1|||
164589992|NCT01096550|594523115|FG000|Overall Study|Withdrawal by Subject|0|||
164589993|NCT01096550|594523116|FG001|Overall Study|Withdrawal by Subject|1|||
164589994|NCT01096550|594523115|FG000|Overall Study|non-African American participant|13|||
164589995|NCT01096550|594523116|FG001|Overall Study|non-African American participant|6|||
164589996|NCT01096550|594523115|FG000|Overall Study|Lost to Follow-up|12|||
164589997|NCT01096550|594523116|FG001|Overall Study|Lost to Follow-up|9|||
164589998|NCT00651118|594523117|FG000|Overall Study|Adverse Event|4|||
164589999|NCT00651118|594523118|FG001|Overall Study|Adverse Event|0|||
164590000|NCT00651118|594523119|FG002|Overall Study|Adverse Event|1|||
164590001|NCT00651118|594523120|FG003|Overall Study|Adverse Event|1|||
164590002|NCT00651118|594523117|FG000|Overall Study|Protocol Violation|2|||
164590003|NCT00651118|594523118|FG001|Overall Study|Protocol Violation|2|||
164590004|NCT00651118|594523119|FG002|Overall Study|Protocol Violation|6|||
164590005|NCT00651118|594523120|FG003|Overall Study|Protocol Violation|2|||
164590006|NCT00651118|594523117|FG000|Overall Study|Lost to Follow-up|2|||
164590007|NCT00651118|594523118|FG001|Overall Study|Lost to Follow-up|0|||
164590008|NCT00651118|594523119|FG002|Overall Study|Lost to Follow-up|1|||
164590009|NCT00651118|594523120|FG003|Overall Study|Lost to Follow-up|2|||
164590010|NCT00651118|594523117|FG000|Overall Study|administrative|1|||
164590011|NCT00651118|594523118|FG001|Overall Study|administrative|4|||
164590012|NCT00651118|594523119|FG002|Overall Study|administrative|2|||
164590013|NCT00651118|594523120|FG003|Overall Study|administrative|1|||
164590014|NCT00651118|594523117|FG000|Overall Study|Withdrawal by Subject|0|||
164590015|NCT00651118|594523118|FG001|Overall Study|Withdrawal by Subject|1|||
164590016|NCT00651118|594523119|FG002|Overall Study|Withdrawal by Subject|1|||
164590017|NCT00651118|594523120|FG003|Overall Study|Withdrawal by Subject|1|||
164590018|NCT03117049|594523121|FG000|Overall Study|Continued the follow-up period|109|||
164590019|NCT03117049|594523122|FG001|Overall Study|Continued the follow-up period|129|||
164590020|NCT03117049|594523121|FG000|Overall Study|Died|82|||
164590021|NCT03117049|594523122|FG001|Overall Study|Died|93|||
164590022|NCT03117049|594523121|FG000|Overall Study|Consent withdrawal|7|||
164590023|NCT03117049|594523122|FG001|Overall Study|Consent withdrawal|6|||
164590024|NCT03117049|594523121|FG000|Overall Study|Missing contact|3|||
164590025|NCT03117049|594523122|FG001|Overall Study|Missing contact|3|||
164590026|NCT01555463|594523125|FG000|Treatment|Adverse Event|6|||
164590027|NCT01555463|594523126|FG001|Treatment|Adverse Event|12|||
164590028|NCT01555463|594523125|FG000|Treatment|Withdrawal by Subject|24|||
164590029|NCT01555463|594523126|FG001|Treatment|Withdrawal by Subject|36|||
164590030|NCT01555463|594523125|FG000|Treatment|Lost to Follow-up|28|||
164590031|NCT01555463|594523126|FG001|Treatment|Lost to Follow-up|23|||
164590032|NCT01555463|594523125|FG000|Treatment|Protocol Violation|4|||
164590033|NCT01555463|594523126|FG001|Treatment|Protocol Violation|5|||
164590034|NCT01555463|594523125|FG000|Treatment|Other reason|2|||
164590035|NCT01555463|594523126|FG001|Treatment|Other reason|3|||
164590036|NCT01555463|594523125|FG000|Follow up|Adverse Event|2|||
164590037|NCT01555463|594523126|FG001|Follow up|Adverse Event|5|||
164590038|NCT01555463|594523125|FG000|Follow up|Death|0|||
164590039|NCT01555463|594523126|FG001|Follow up|Death|1|||
164590040|NCT01555463|594523125|FG000|Follow up|Withdrawal by Subject|22|||
164590041|NCT01555463|594523126|FG001|Follow up|Withdrawal by Subject|22|||
164590042|NCT01555463|594523125|FG000|Follow up|Lost to Follow-up|9|||
164356404|NCT03510884|593680972|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
164356405|NCT03510884|593680973|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
164356406|NCT03510884|593680974|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
164356407|NCT03510884|593680975|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
164356408|NCT03510884|593680972|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
164356409|NCT03510884|593680973|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
164356410|NCT03510884|593680974|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
164356411|NCT03510884|593680975|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
164356412|NCT03510884|593680972|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
164356413|NCT03510884|593680973|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
164356414|NCT03510884|593680974|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
164356415|NCT03510884|593680975|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
164356416|NCT03510884|593680972|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
164356417|NCT03510884|593680973|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
164356418|NCT03510884|593680974|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
164356419|NCT03510884|593680975|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
164356420|NCT03510884|593680972|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
164437781|NCT01212757|593968252|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
164437782|NCT01212757|593968253|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
164437783|NCT01212757|593968254|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
164437784|NCT01212757|593968255|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
164437785|NCT01212757|593968256|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
164437786|NCT01212757|593968257|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
164437787|NCT01212757|593968258|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
164437788|NCT01212757|593968259|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
164437789|NCT01212757|593968251|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
164437790|NCT01212757|593968252|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
164437791|NCT01212757|593968253|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
164437792|NCT01212757|593968254|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
164437793|NCT01212757|593968255|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
164437794|NCT01212757|593968256|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
164437795|NCT01212757|593968257|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
164437796|NCT01212757|593968258|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
164437797|NCT01212757|593968259|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
164437798|NCT01212757|593968251|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
164437799|NCT01212757|593968252|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
164437800|NCT01212757|593968253|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
164437801|NCT01212757|593968254|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
164437802|NCT01212757|593968255|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
164437803|NCT01212757|593968256|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
164437804|NCT01212757|593968257|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
164437805|NCT01212757|593968258|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
164437806|NCT01212757|593968259|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
164437807|NCT01212757|593968251|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
164437808|NCT01212757|593968252|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
164437809|NCT01212757|593968253|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
164437810|NCT01212757|593968254|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
164437811|NCT01212757|593968255|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
164437812|NCT01212757|593968256|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
164437813|NCT01212757|593968257|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
164437814|NCT01212757|593968258|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
164437815|NCT01212757|593968259|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
164437816|NCT01212757|593968251|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
164437817|NCT01212757|593968252|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
164437818|NCT01212757|593968253|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
164437819|NCT01212757|593968254|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
164437820|NCT01212757|593968255|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
164437821|NCT01212757|593968256|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
164356421|NCT03510884|593680973|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
164356422|NCT03510884|593680974|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
164356423|NCT03510884|593680975|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
164437822|NCT01212757|593968257|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
164437823|NCT01212757|593968258|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
164590043|NCT01555463|594523126|FG001|Follow up|Lost to Follow-up|10|||
164356424|NCT03510884|593680972|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
164356425|NCT03510884|593680973|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
164356426|NCT03510884|593680974|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
164356427|NCT03510884|593680975|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
164356428|NCT03510884|593680972|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
164356429|NCT03510884|593680973|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
164356430|NCT03510884|593680974|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
164356431|NCT03510884|593680975|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
164356432|NCT05608005|593680976|FG000|Overall Study|Adverse Event|2|||
164356433|NCT05608005|593680977|FG001|Overall Study|Adverse Event|1|||
164356434|NCT05608005|593680978|FG002|Overall Study|Adverse Event|3|||
164356435|NCT05608005|593680976|FG000|Overall Study|Protocol Violation|2|||
164356436|NCT05608005|593680977|FG001|Overall Study|Protocol Violation|3|||
164356437|NCT05608005|593680978|FG002|Overall Study|Protocol Violation|0|||
164356438|NCT05608005|593680976|FG000|Overall Study|Withdrawal by Subject|10|||
164356439|NCT05608005|593680977|FG001|Overall Study|Withdrawal by Subject|12|||
164356440|NCT05608005|593680978|FG002|Overall Study|Withdrawal by Subject|4|||
164356441|NCT05608005|593680976|FG000|Overall Study|Lost to Follow-up|25|||
164695970|NCT03438006|594909065|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
164695971|NCT00955721|594909066|FG000|Overall Study|Physician Decision|1|||
164695972|NCT00955721|594909067|FG001|Overall Study|Physician Decision|0|||
164695973|NCT00955721|594909066|FG000|Overall Study|Death|1|||
164695974|NCT00955721|594909067|FG001|Overall Study|Death|0|||
164695975|NCT00955721|594909066|FG000|Overall Study|Withdrawal by Subject|1|||
164695976|NCT00955721|594909067|FG001|Overall Study|Withdrawal by Subject|0|||
164695977|NCT04678817|594910509|FG000|Overall Study|Lost to Follow-up|28|||
164695978|NCT04678817|594910510|FG001|Overall Study|Lost to Follow-up|0|||
164695979|NCT04678817|594910511|FG002|Overall Study|Lost to Follow-up|0|||
164695980|NCT01961687|594910514|FG000|Overall Study|Lost to Follow-up|19|||
164695981|NCT01961687|594910514|FG000|Overall Study|Re-operation|17|||
164695982|NCT01961687|594910514|FG000|Overall Study|Death|7|||
164695983|NCT01961687|594910514|FG000|Overall Study|Withdrawal by Subject|6|||
164695984|NCT01961687|594910514|FG000|Overall Study|Adverse Event|6|||
164695985|NCT01961687|594910514|FG000|Overall Study|Moved to area without study site|2|||
164695986|NCT01961687|594910514|FG000|Overall Study|Sponsor decision|2|||
164695987|NCT01961687|594910514|FG000|Overall Study|Physician Decision|1|||
164695988|NCT01961687|594910514|FG000|Overall Study|Unable to meet follow-up requirements|1|||
164356442|NCT05608005|593680977|FG001|Overall Study|Lost to Follow-up|27|||
164356443|NCT05608005|593680978|FG002|Overall Study|Lost to Follow-up|15|||
164356444|NCT05608005|593680976|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
164695989|NCT01552369|594910516|FG000|Overall Study|Did not consent to extended follow up|8|||
164695990|NCT01552369|594910517|FG001|Overall Study|Did not consent to extended follow up|9|||
164417410|NCT01474512|593899496|FG007|Long-Term Extension Period|Physician Decision|0|||
164695991|NCT02999984|594910524|FG000|Overall Study|Treatment Failure|1|||
164695992|NCT00754013|594910528|FG000|Overall Study|Lost to Follow-up|1|||
164695993|NCT00754013|594910529|FG001|Overall Study|Lost to Follow-up|1|||
164695994|NCT00754013|594910528|FG000|Overall Study|didn't return after study termed|3|||
164356445|NCT05608005|593680977|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
164356446|NCT05608005|593680978|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
164356447|NCT00157950|593680979|FG000|Overall Study|Death|1|||
164356448|NCT00157950|593680980|FG001|Overall Study|Death|0|||
164356449|NCT01287897|593680984|FG000|Overall Study|Adverse Event|5|||
164356450|NCT01287897|593680985|FG001|Overall Study|Adverse Event|3|||
164356451|NCT01287897|593680986|FG002|Overall Study|Adverse Event|6|||
164356452|NCT01287897|593680987|FG003|Overall Study|Adverse Event|4|||
164356453|NCT01287897|593680984|FG000|Overall Study|Lack of Efficacy|2|||
164356454|NCT01287897|593680985|FG001|Overall Study|Lack of Efficacy|0|||
164356455|NCT01287897|593680986|FG002|Overall Study|Lack of Efficacy|0|||
164356456|NCT01287897|593680987|FG003|Overall Study|Lack of Efficacy|0|||
164356457|NCT01287897|593680984|FG000|Overall Study|Protocol Violation|1|||
164356458|NCT01287897|593680985|FG001|Overall Study|Protocol Violation|1|||
164356459|NCT01287897|593680986|FG002|Overall Study|Protocol Violation|0|||
164356460|NCT01287897|593680987|FG003|Overall Study|Protocol Violation|1|||
164356461|NCT01287897|593680984|FG000|Overall Study|Lost to Follow-up|0|||
164356462|NCT01287897|593680985|FG001|Overall Study|Lost to Follow-up|0|||
164356463|NCT01287897|593680986|FG002|Overall Study|Lost to Follow-up|2|||
164356464|NCT01287897|593680987|FG003|Overall Study|Lost to Follow-up|0|||
164356465|NCT01287897|593680984|FG000|Overall Study|Withdrawal by Subject|1|||
164356466|NCT01287897|593680985|FG001|Overall Study|Withdrawal by Subject|5|||
164356467|NCT01287897|593680986|FG002|Overall Study|Withdrawal by Subject|3|||
164356468|NCT01287897|593680987|FG003|Overall Study|Withdrawal by Subject|2|||
164356469|NCT01287897|593680984|FG000|Overall Study|Not consented properly|0|||
164356470|NCT01287897|593680985|FG001|Overall Study|Not consented properly|1|||
164356471|NCT01287897|593680986|FG002|Overall Study|Not consented properly|0|||
164356472|NCT01287897|593680987|FG003|Overall Study|Not consented properly|0|||
164356473|NCT01287897|593680984|FG000|Overall Study|Not meeting entrance criteria|1|||
164356474|NCT01287897|593680985|FG001|Overall Study|Not meeting entrance criteria|1|||
164356475|NCT01287897|593680986|FG002|Overall Study|Not meeting entrance criteria|0|||
164356476|NCT01287897|593680987|FG003|Overall Study|Not meeting entrance criteria|0|||
164356477|NCT01287897|593680984|FG000|Overall Study|Other|1|||
164356478|NCT01287897|593680985|FG001|Overall Study|Other|0|||
164356479|NCT01287897|593680986|FG002|Overall Study|Other|1|||
164356480|NCT01287897|593680987|FG003|Overall Study|Other|0|||
164356481|NCT02892760|593680988|FG000|Overall Study|Withdrawal by Subject|3|||
164356482|NCT00386776|593680989|FG000|Overall Study|Withdrawal by Subject|8|||
164356483|NCT01500629|593680994|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
164356484|NCT01500629|593680995|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
164356485|NCT02902965|593680996|FG000|Overall Study|Withdrawal by Subject|10|||
164356486|NCT00293254|593680997|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
164356487|NCT00293254|593680998|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
164356488|NCT00293254|593680997|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
164356489|NCT00293254|593680998|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
164356490|NCT00293254|593680997|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
164356491|NCT00293254|593680998|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
164356492|NCT00293254|593680997|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
164356493|NCT00293254|593680998|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
164356494|NCT00293254|593680997|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
164356495|NCT00293254|593680998|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
164356496|NCT00293254|593680997|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
164356497|NCT00293254|593680998|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
164356498|NCT00293254|593680997|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
164356499|NCT00293254|593680998|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
164356500|NCT00293254|593680997|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
164356501|NCT00293254|593680998|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
164356502|NCT00293254|593680997|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
164356503|NCT00293254|593680998|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
164356504|NCT00293254|593680997|FG000|Extension - Double-Blind Week 49-156|Death|4|||
164356505|NCT00293254|593680998|FG001|Extension - Double-Blind Week 49-156|Death|1|||
164356506|NCT00293254|593680997|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
164356507|NCT00293254|593680998|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
164356508|NCT00293254|593680997|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
164356509|NCT00293254|593680998|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
164590044|NCT01555463|594523125|FG000|Follow up|Protocol Violation|2|||
164590045|NCT01555463|594523126|FG001|Follow up|Protocol Violation|4|||
164590046|NCT01555463|594523125|FG000|Follow up|Other reason|3|||
164590047|NCT01555463|594523126|FG001|Follow up|Other reason|3|||
164590048|NCT03844633|594523131|FG000|1 Week FU|Lost to Follow-up|0|||
164590049|NCT03844633|594523132|FG001|1 Week FU|Lost to Follow-up|1|||
164590050|NCT03844633|594523133|FG002|1 Week FU|Lost to Follow-up|4|||
164590051|NCT03844633|594523131|FG000|12-month Follow-up|Lost to Follow-up|7|||
164356510|NCT00293254|593680997|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
164356511|NCT00293254|593680998|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
164356512|NCT00293254|593680997|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
164356513|NCT00293254|593680998|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
164356514|NCT00293254|593680997|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
164356515|NCT00293254|593680998|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
164356516|NCT00293254|593680997|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
164356517|NCT00293254|593680998|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
164356518|NCT00293254|593680997|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
164356519|NCT00293254|593680998|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
164356520|NCT00293254|593680997|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
164356521|NCT00293254|593680998|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
164356522|NCT00293254|593680997|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
164356523|NCT00293254|593680998|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
164356524|NCT00293254|593680997|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
164590052|NCT03844633|594523132|FG001|12-month Follow-up|Lost to Follow-up|5|||
164590053|NCT03844633|594523133|FG002|12-month Follow-up|Lost to Follow-up|8|||
164590054|NCT02588248|594523138|FG000|Overall Study|Physician Decision|4|||
164590055|NCT02588248|594523139|FG001|Overall Study|Physician Decision|3|||
164356525|NCT00293254|593680998|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
164356526|NCT00293254|593680997|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
164356527|NCT00293254|593680998|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
164356528|NCT00293254|593680997|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
164356529|NCT00293254|593680998|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
164356530|NCT00293254|593680997|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
164356531|NCT00293254|593680998|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
164356532|NCT00293254|593680997|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
164356533|NCT00293254|593680998|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
164356534|NCT00293254|593680997|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
164356535|NCT00293254|593680998|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
164356536|NCT00293254|593680997|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
164356537|NCT00293254|593680998|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
164356538|NCT00293254|593680997|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
164356539|NCT00293254|593680998|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
164356540|NCT02259582|593680999|FG000|Overall Study|Physician Decision|0|||
164356541|NCT02259582|593681000|FG001|Overall Study|Physician Decision|1|||
164356542|NCT02259582|593681001|FG002|Overall Study|Physician Decision|0|||
164356543|NCT02259582|593680999|FG000|Overall Study|Death|0|||
164356544|NCT02259582|593681000|FG001|Overall Study|Death|0|||
164356545|NCT02259582|593681001|FG002|Overall Study|Death|1|||
164356546|NCT02259582|593680999|FG000|Overall Study|Adverse Event|1|||
164356547|NCT02259582|593681000|FG001|Overall Study|Adverse Event|0|||
164356548|NCT02259582|593681001|FG002|Overall Study|Adverse Event|1|||
164356549|NCT02259582|593680999|FG000|Overall Study|Withdrawal by Subject|0|||
164356550|NCT02259582|593681000|FG001|Overall Study|Withdrawal by Subject|0|||
164356551|NCT02259582|593681001|FG002|Overall Study|Withdrawal by Subject|1|||
164356552|NCT02259582|593680999|FG000|Overall Study|Disease progression|14|||
164356553|NCT02259582|593681000|FG001|Overall Study|Disease progression|15|||
164356554|NCT02259582|593681001|FG002|Overall Study|Disease progression|17|||
164356555|NCT02259582|593680999|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
164356556|NCT02259582|593681000|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
164356557|NCT02259582|593681001|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
164356558|NCT02335489|593681002|FG000|Overall Study|Sponsor terminated study|4|||
164356559|NCT02335489|593681002|FG000|Overall Study|Lost to Follow-up|1|||
164356560|NCT02335489|593681002|FG000|Overall Study|Withdrawal by Subject|2|||
164356561|NCT02335489|593681002|FG000|Overall Study|Physician Decision|2|||
164356562|NCT02335489|593681002|FG000|Overall Study|Lack of Efficacy|1|||
164356563|NCT00759863|593681005|FG000|Overall Study|Death, moved, or lost contact|20|||
164356564|NCT00759863|593681006|FG001|Overall Study|Death, moved, or lost contact|18|||
164356565|NCT00503308|593681010|FG000|Overall Study|Protocol Violation|2|||
164356566|NCT00503308|593681011|FG001|Overall Study|Protocol Violation|1|||
164356567|NCT00531050|593681013|FG000|Part 1: Period 1|Adverse Event|0|||
164356568|NCT00531050|593681014|FG001|Part 1: Period 1|Adverse Event|1|||
164356569|NCT00531050|593681015|FG002|Part 1: Period 1|Adverse Event|0|||
164356570|NCT00531050|593681016|FG003|Part 1: Period 1|Adverse Event|0|||
164356571|NCT00531050|593681017|FG004|Part 1: Period 1|Adverse Event|0|||
164356572|NCT00531050|593681018|FG005|Part 1: Period 1|Adverse Event|0|||
164356573|NCT00531050|593681013|FG000|Part 1: Period 1|Protocol Deviation|0|||
164356574|NCT00531050|593681014|FG001|Part 1: Period 1|Protocol Deviation|0|||
164356575|NCT00531050|593681015|FG002|Part 1: Period 1|Protocol Deviation|0|||
164356576|NCT00531050|593681016|FG003|Part 1: Period 1|Protocol Deviation|1|||
164590056|NCT01355068|594523140|FG000|First Intervention Period|Adverse Event|0|||
164695995|NCT00754013|594910529|FG001|Overall Study|didn't return after study termed|4|||
164695996|NCT01197417|594910533|FG000|Overall Study|Physician Decision|3|||
164695997|NCT01197417|594910534|FG001|Overall Study|Physician Decision|2|||
164695998|NCT01197417|594910533|FG000|Overall Study|Withdrawal by Subject|2|||
164695999|NCT01197417|594910534|FG001|Overall Study|Withdrawal by Subject|4|||
164696000|NCT01197417|594910533|FG000|Overall Study|Site miscommunication|0|||
164696001|NCT01197417|594910534|FG001|Overall Study|Site miscommunication|1|||
164356577|NCT00531050|593681017|FG004|Part 1: Period 1|Protocol Deviation|0|||
164356578|NCT00531050|593681018|FG005|Part 1: Period 1|Protocol Deviation|0|||
164356579|NCT00531050|593681013|FG000|Part 1: Period 3|Adverse Event|1|||
164356580|NCT00531050|593681014|FG001|Part 1: Period 3|Adverse Event|0|||
164356581|NCT00531050|593681015|FG002|Part 1: Period 3|Adverse Event|0|||
164356582|NCT00531050|593681016|FG003|Part 1: Period 3|Adverse Event|0|||
164356583|NCT00531050|593681017|FG004|Part 1: Period 3|Adverse Event|0|||
164356584|NCT00531050|593681018|FG005|Part 1: Period 3|Adverse Event|0|||
164356585|NCT00531050|593681013|FG000|Part 2: Period 1|Adverse Event|0|||
164356586|NCT00531050|593681014|FG001|Part 2: Period 1|Adverse Event|0|||
164356587|NCT00531050|593681015|FG002|Part 2: Period 1|Adverse Event|0|||
164356588|NCT00531050|593681016|FG003|Part 2: Period 1|Adverse Event|0|||
164356589|NCT00531050|593681017|FG004|Part 2: Period 1|Adverse Event|0|||
164356590|NCT00531050|593681018|FG005|Part 2: Period 1|Adverse Event|1|||
164356591|NCT00531050|593681013|FG000|Part 2: Period 3|Abnormal test procedure|1|||
164356592|NCT00531050|593681014|FG001|Part 2: Period 3|Abnormal test procedure|0|||
164356593|NCT00531050|593681015|FG002|Part 2: Period 3|Abnormal test procedure|0|||
164356594|NCT00531050|593681016|FG003|Part 2: Period 3|Abnormal test procedure|0|||
164356595|NCT00531050|593681017|FG004|Part 2: Period 3|Abnormal test procedure|0|||
164356596|NCT00531050|593681018|FG005|Part 2: Period 3|Abnormal test procedure|1|||
164356597|NCT03263442|593681019|FG000|Inpatient Phase|Death|1|||
164356598|NCT03263442|593681020|FG001|Inpatient Phase|Death|0|||
164356599|NCT03263442|593681019|FG000|Inpatient Phase|Withdrawal by Subject|1|||
164356600|NCT03263442|593681020|FG001|Inpatient Phase|Withdrawal by Subject|0|||
164356601|NCT03263442|593681019|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
164356602|NCT03263442|593681020|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
164356603|NCT03263442|593681019|FG000|1-month Follow-Up|Lost to Follow-up|1|||
164356604|NCT03263442|593681020|FG001|1-month Follow-Up|Lost to Follow-up|0|||
164356605|NCT03263442|593681019|FG000|3-month Follow-Up|Lost to Follow-up|1|||
164356606|NCT03263442|593681020|FG001|3-month Follow-Up|Lost to Follow-up|3|||
164356607|NCT03263442|593681019|FG000|6-month Follow-Up|Lost to Follow-up|2|||
164356608|NCT03263442|593681020|FG001|6-month Follow-Up|Lost to Follow-up|2|||
164356609|NCT01594125|593681021|FG000|Overall Study|Withdrawal by Subject|1|||
164356610|NCT01594125|593681022|FG001|Overall Study|Withdrawal by Subject|0|||
164356611|NCT01594125|593681023|FG002|Overall Study|Withdrawal by Subject|0|||
164356612|NCT01594125|593681024|FG003|Overall Study|Withdrawal by Subject|1|||
164356613|NCT01594125|593681025|FG004|Overall Study|Withdrawal by Subject|0|||
164356614|NCT01594125|593681021|FG000|Overall Study|Progressive Disease|3|||
164356615|NCT01594125|593681022|FG001|Overall Study|Progressive Disease|12|||
164356616|NCT01594125|593681023|FG002|Overall Study|Progressive Disease|3|||
164356617|NCT01594125|593681024|FG003|Overall Study|Progressive Disease|3|||
164356618|NCT01594125|593681025|FG004|Overall Study|Progressive Disease|7|||
164356619|NCT00708643|593681026|FG000|Overall Study|Adverse Event|0|||
164356620|NCT00708643|593681027|FG001|Overall Study|Adverse Event|1|||
164356621|NCT03635957|593681030|FG000|Run-In Period|Lost to Follow-up|1|||
164356622|NCT03635957|593681030|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
164356623|NCT01710033|593681031|FG000|Stage 2|Adverse Event|0|||
164356624|NCT01710033|593681032|FG001|Stage 2|Adverse Event|0|||
164356625|NCT01710033|593681033|FG002|Stage 2|Adverse Event|0|||
164696002|NCT01197417|594910533|FG000|Overall Study|Subject transferred to intensive care|0|||
164696003|NCT01197417|594910534|FG001|Overall Study|Subject transferred to intensive care|1|||
164696004|NCT01197417|594910533|FG000|Overall Study|Not consented in time to receive drug|0|||
164696005|NCT01197417|594910534|FG001|Overall Study|Not consented in time to receive drug|1|||
164356626|NCT01710033|593681034|FG003|Stage 2|Adverse Event|0|||
164356627|NCT01710033|593681035|FG004|Stage 2|Adverse Event|1|||
164356628|NCT01525550|593681037|FG000|Overall Study|Lost to Follow-up|8|||
164356629|NCT01525550|593681038|FG001|Overall Study|Lost to Follow-up|2|||
164437824|NCT01212757|593968259|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
164437825|NCT01212757|593968251|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
164356630|NCT01525550|593681037|FG000|Overall Study|Death|19|||
164356631|NCT01525550|593681038|FG001|Overall Study|Death|28|||
164356632|NCT01525550|593681037|FG000|Overall Study|Other|0|||
164356633|NCT01525550|593681038|FG001|Overall Study|Other|4|||
164356634|NCT01525550|593681037|FG000|Overall Study|Sponsor's Decision|30|||
164356635|NCT01525550|593681038|FG001|Overall Study|Sponsor's Decision|11|||
164356636|NCT01525550|593681037|FG000|Overall Study|Withdrawal by Subject|4|||
164356637|NCT01525550|593681038|FG001|Overall Study|Withdrawal by Subject|0|||
164437826|NCT01212757|593968252|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
164356638|NCT00460031|593681041|FG000|Overall Study|Adverse Event|5|||
164356639|NCT00460031|593681041|FG000|Overall Study|Withdrawal by Subject|5|||
164356640|NCT00460031|593681041|FG000|Overall Study|Death|1|||
164356641|NCT03045887|593681050|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
164356642|NCT03045887|593681051|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
164356643|NCT03045887|593681052|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
164356644|NCT03045887|593681053|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
164356645|NCT03045887|593681054|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
164696006|NCT01197417|594910533|FG000|Overall Study|Hypotension|1|||
164696007|NCT01197417|594910534|FG001|Overall Study|Hypotension|2|||
164696008|NCT01197417|594910533|FG000|Overall Study|Found to be ineligible|2|||
164696009|NCT01197417|594910534|FG001|Overall Study|Found to be ineligible|5|||
164696010|NCT01197417|594910533|FG000|Overall Study|No 25-hour magnesium level|0|||
164696011|NCT01197417|594910534|FG001|Overall Study|No 25-hour magnesium level|2|||
164696012|NCT02813421|594910541|FG000|Overall Study|Withdrawal by Subject|1|||
164696013|NCT02813421|594910542|FG001|Overall Study|Withdrawal by Subject|2|||
164696014|NCT02813421|594910541|FG000|Overall Study|Lost to Follow-up|1|||
164696015|NCT02813421|594910542|FG001|Overall Study|Lost to Follow-up|1|||
164696016|NCT02914236|594910543|FG000|Overall Study|Lost to Follow-up|1|||
164696017|NCT01221090|594910550|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
164696018|NCT01221090|594910551|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
164696019|NCT01221090|594910552|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
164696020|NCT01221090|594910553|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
164696021|NCT01221090|594910550|FG000|Overall Study|Withdrawal by Subject|0|||
164696022|NCT01221090|594910551|FG001|Overall Study|Withdrawal by Subject|22|||
164696023|NCT01221090|594910552|FG002|Overall Study|Withdrawal by Subject|27|||
164696024|NCT01221090|594910553|FG003|Overall Study|Withdrawal by Subject|2|||
164696025|NCT03438539|594910554|FG000|Overall Study|Lost to Follow-up|8|||
164696026|NCT03438539|594910555|FG001|Overall Study|Lost to Follow-up|4|||
164696027|NCT03438539|594910556|FG002|Overall Study|Lost to Follow-up|10|||
164696028|NCT03438539|594910557|FG003|Overall Study|Lost to Follow-up|9|||
164696029|NCT03438539|594910558|FG004|Overall Study|Lost to Follow-up|3|||
164696030|NCT03438539|594910559|FG005|Overall Study|Lost to Follow-up|8|||
164696031|NCT00440466|594910561|FG000|Overall Study|Death|3|||
164696032|NCT00440466|594910562|FG001|Overall Study|Death|2|||
164696033|NCT00440466|594910563|FG002|Overall Study|Death|9|||
164696034|NCT00440466|594910561|FG000|Overall Study|Adverse Event|3|||
164696035|NCT00440466|594910562|FG001|Overall Study|Adverse Event|4|||
164696036|NCT00440466|594910563|FG002|Overall Study|Adverse Event|11|||
164696037|NCT00440466|594910561|FG000|Overall Study|Lost to Follow-up|1|||
164696038|NCT00440466|594910562|FG001|Overall Study|Lost to Follow-up|0|||
164696039|NCT00440466|594910563|FG002|Overall Study|Lost to Follow-up|2|||
164356646|NCT03045887|593681055|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
164356647|NCT03045887|593681056|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
164356648|NCT03045887|593681057|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
164356649|NCT03045887|593681058|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
164356650|NCT03045887|593681059|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
164356651|NCT03045887|593681050|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
164356652|NCT03045887|593681051|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
164356653|NCT03045887|593681052|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
164356654|NCT03045887|593681053|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
164356655|NCT03045887|593681054|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
164356656|NCT03045887|593681055|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
164356657|NCT03045887|593681056|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
164356658|NCT03045887|593681057|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
164356659|NCT03045887|593681058|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
164356660|NCT03045887|593681059|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
164356661|NCT03045887|593681050|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
164356662|NCT03045887|593681051|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
164356663|NCT03045887|593681052|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
164356664|NCT03045887|593681053|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
164356665|NCT03045887|593681054|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
164356666|NCT03045887|593681055|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
164356667|NCT03045887|593681056|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
164696040|NCT00440466|594910561|FG000|Overall Study|Physician Decision|2|||
164696041|NCT00440466|594910562|FG001|Overall Study|Physician Decision|0|||
164696042|NCT00440466|594910563|FG002|Overall Study|Physician Decision|1|||
164696043|NCT00440466|594910561|FG000|Overall Study|Protocol Violation|2|||
164696044|NCT00440466|594910562|FG001|Overall Study|Protocol Violation|0|||
164696045|NCT00440466|594910563|FG002|Overall Study|Protocol Violation|4|||
164696046|NCT00440466|594910561|FG000|Overall Study|Withdrawal by Subject|2|||
164356668|NCT03045887|593681057|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
164356669|NCT03045887|593681058|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
164356670|NCT03045887|593681059|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
164356671|NCT03045887|593681050|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
164356672|NCT03045887|593681051|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
164356673|NCT03045887|593681052|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
164356674|NCT03045887|593681053|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
164356675|NCT03045887|593681054|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
164356676|NCT03045887|593681055|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
164356677|NCT03045887|593681056|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
164356678|NCT03045887|593681057|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
164356679|NCT03045887|593681058|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
164356680|NCT03045887|593681059|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
164356681|NCT03045887|593681050|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164356682|NCT03045887|593681051|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164356683|NCT03045887|593681052|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164356684|NCT03045887|593681053|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
164356685|NCT03045887|593681054|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164356686|NCT03045887|593681055|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164356687|NCT03045887|593681056|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164696047|NCT00440466|594910562|FG001|Overall Study|Withdrawal by Subject|5|||
164696048|NCT00440466|594910563|FG002|Overall Study|Withdrawal by Subject|9|||
164696049|NCT00440466|594910561|FG000|Overall Study|Began Dialysis|0|||
164696050|NCT00440466|594910562|FG001|Overall Study|Began Dialysis|0|||
164696051|NCT00440466|594910563|FG002|Overall Study|Began Dialysis|1|||
164696052|NCT00440466|594910561|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
164696053|NCT00440466|594910562|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
164696054|NCT00440466|594910563|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
164696055|NCT00655850|594910566|FG000|Overall Study|Death|2|||
164696056|NCT00655850|594910566|FG000|Overall Study|Withdrawal by Subject|1|||
164696057|NCT01223235|594910567|FG000|Overall Study|Withdrawal by Subject|1|||
164696058|NCT01715896|594910570|FG000|Overall Study|Lost to Follow-up|0|||
164696059|NCT01715896|594910571|FG001|Overall Study|Lost to Follow-up|2|||
164696060|NCT01715896|594910570|FG000|Overall Study|Withdrawal by Subject|1|||
164696061|NCT01715896|594910571|FG001|Overall Study|Withdrawal by Subject|4|||
164696062|NCT01715896|594910570|FG000|Overall Study|Other|2|||
164696063|NCT01715896|594910571|FG001|Overall Study|Other|5|||
164696064|NCT03756883|594910572|FG000|Overall Study|Adverse Event|2|||
164696065|NCT03756883|594910573|FG001|Overall Study|Adverse Event|2|||
164696066|NCT03756883|594910574|FG002|Overall Study|Adverse Event|2|||
164696067|NCT03756883|594910572|FG000|Overall Study|Lack of Efficacy|0|||
164696068|NCT03756883|594910573|FG001|Overall Study|Lack of Efficacy|1|||
164696069|NCT03756883|594910574|FG002|Overall Study|Lack of Efficacy|2|||
164696070|NCT03756883|594910572|FG000|Overall Study|Lost to Follow-up|3|||
164696071|NCT03756883|594910573|FG001|Overall Study|Lost to Follow-up|3|||
164696072|NCT03756883|594910574|FG002|Overall Study|Lost to Follow-up|0|||
164696073|NCT03756883|594910572|FG000|Overall Study|Protocol Violation|2|||
164696074|NCT03756883|594910573|FG001|Overall Study|Protocol Violation|0|||
164696075|NCT03756883|594910574|FG002|Overall Study|Protocol Violation|1|||
164696076|NCT03756883|594910572|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
164696077|NCT03756883|594910573|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
164696078|NCT03756883|594910574|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
164696079|NCT03756883|594910572|FG000|Overall Study|Withdrawal by Subject|4|||
164696080|NCT03756883|594910573|FG001|Overall Study|Withdrawal by Subject|1|||
164696081|NCT03756883|594910574|FG002|Overall Study|Withdrawal by Subject|0|||
164696082|NCT03756883|594910572|FG000|Overall Study|Other Reasons|2|||
164356688|NCT03045887|593681057|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164356689|NCT03045887|593681058|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164356690|NCT03045887|593681059|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164356691|NCT03414424|593681060|FG000|Overall Study|Screened out after consent|0|||
164356692|NCT03414424|593681061|FG001|Overall Study|Screened out after consent|2|||
164356693|NCT03414424|593681060|FG000|Overall Study|Lost to Follow-up|0|||
164356694|NCT03414424|593681061|FG001|Overall Study|Lost to Follow-up|1|||
164437827|NCT01212757|593968253|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
164437828|NCT01212757|593968254|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
164696083|NCT03756883|594910573|FG001|Overall Study|Other Reasons|4|||
164696084|NCT03756883|594910574|FG002|Overall Study|Other Reasons|0|||
164696085|NCT00685802|594910575|FG000|Washout Period of 7 Days|Protocol Violation|2|||
164696086|NCT00685802|594910576|FG001|Washout Period of 7 Days|Protocol Violation|0|||
164696087|NCT00685802|594910575|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
164696088|NCT00685802|594910576|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
164696089|NCT03336242|594910577|FG000|Overall Study|Adverse Event|0|||
164356695|NCT01846507|593681062|FG000|Overall Study|Lost to Follow-up|4|||
164356696|NCT01846507|593681062|FG000|Overall Study|Protocol Violation|1|||
164356697|NCT01846507|593681062|FG000|Overall Study|Missing data|2|||
164356698|NCT01314443|593681063|FG000|Overall Study|Withdrawal by Subject|2|||
164356699|NCT01314443|593681064|FG001|Overall Study|Withdrawal by Subject|1|||
164696090|NCT03336242|594910578|FG001|Overall Study|Adverse Event|1|||
164696091|NCT00103038|594910583|FG000|Overall Study|Withdrawal by Subject|8|||
164696092|NCT00103038|594910583|FG000|Overall Study|Screen failure|3|||
164696093|NCT00103038|594910583|FG000|Overall Study|Death|1|||
164696094|NCT00103038|594910583|FG000|Overall Study|Physician Decision|1|||
164696095|NCT05445843|594910586|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
164696096|NCT05445843|594910587|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
164696097|NCT05445843|594910586|FG000|Overall Study|Progressive disease|17|||
164696098|NCT05445843|594910587|FG001|Overall Study|Progressive disease|9|||
164696099|NCT05445843|594910586|FG000|Overall Study|Physician Decision|16|||
164696100|NCT05445843|594910587|FG001|Overall Study|Physician Decision|4|||
164696101|NCT05445843|594910586|FG000|Overall Study|Death|6|||
164696102|NCT05445843|594910587|FG001|Overall Study|Death|3|||
164696103|NCT05445843|594910586|FG000|Overall Study|Subject decision|6|||
164696104|NCT05445843|594910587|FG001|Overall Study|Subject decision|2|||
164696105|NCT05445843|594910586|FG000|Overall Study|Adverse Event|2|||
164696106|NCT05445843|594910587|FG001|Overall Study|Adverse Event|0|||
164696107|NCT05307679|594910592|FG000|Overall Study|Study terminated by sponsor or physician decision|2|||
164696108|NCT05307679|594910593|FG001|Overall Study|Study terminated by sponsor or physician decision|5|||
164696109|NCT01740791|594910596|FG000|Overall Study|Randomized but never treated|5|||
164696110|NCT01740791|594910597|FG001|Overall Study|Randomized but never treated|3|||
164696111|NCT01740791|594910598|FG002|Overall Study|Randomized but never treated|2|||
164696112|NCT01740791|594910599|FG003|Overall Study|Randomized but never treated|2|||
164696113|NCT01740791|594910600|FG004|Overall Study|Randomized but never treated|1|||
164696114|NCT01740791|594910601|FG005|Overall Study|Randomized but never treated|3|||
164696115|NCT01740791|594910596|FG000|Overall Study|Lost to Follow-up|2|||
164696116|NCT01740791|594910597|FG001|Overall Study|Lost to Follow-up|0|||
164696117|NCT01740791|594910598|FG002|Overall Study|Lost to Follow-up|2|||
164696118|NCT01740791|594910599|FG003|Overall Study|Lost to Follow-up|3|||
164696119|NCT01740791|594910600|FG004|Overall Study|Lost to Follow-up|2|||
164696120|NCT01740791|594910601|FG005|Overall Study|Lost to Follow-up|3|||
164696121|NCT01740791|594910596|FG000|Overall Study|Withdrew Consent|4|||
164696122|NCT01740791|594910597|FG001|Overall Study|Withdrew Consent|0|||
164696123|NCT01740791|594910598|FG002|Overall Study|Withdrew Consent|1|||
164696124|NCT01740791|594910599|FG003|Overall Study|Withdrew Consent|2|||
164696125|NCT01740791|594910600|FG004|Overall Study|Withdrew Consent|0|||
164696126|NCT01740791|594910601|FG005|Overall Study|Withdrew Consent|3|||
164696127|NCT01740791|594910596|FG000|Overall Study|Investigator's discretion|1|||
164696128|NCT01740791|594910597|FG001|Overall Study|Investigator's discretion|0|||
164696129|NCT01740791|594910598|FG002|Overall Study|Investigator's discretion|1|||
164696130|NCT01740791|594910599|FG003|Overall Study|Investigator's discretion|0|||
164696131|NCT01740791|594910600|FG004|Overall Study|Investigator's discretion|0|||
164696132|NCT01740791|594910601|FG005|Overall Study|Investigator's discretion|1|||
164696133|NCT01740791|594910596|FG000|Overall Study|Adverse Event|0|||
164696134|NCT01740791|594910597|FG001|Overall Study|Adverse Event|0|||
164696135|NCT01740791|594910598|FG002|Overall Study|Adverse Event|0|||
164696136|NCT01740791|594910599|FG003|Overall Study|Adverse Event|0|||
164696137|NCT01740791|594910600|FG004|Overall Study|Adverse Event|0|||
164696138|NCT01740791|594910601|FG005|Overall Study|Adverse Event|1|||
164696139|NCT02674386|594910602|FG000|Overall Study|Lost to Follow-up|0|||
164696140|NCT02674386|594910603|FG001|Overall Study|Lost to Follow-up|1|||
164696141|NCT02674386|594910604|FG002|Overall Study|Lost to Follow-up|1|||
164696142|NCT02674386|594910602|FG000|Overall Study|Withdrawal by Subject|0|||
164696143|NCT02674386|594910603|FG001|Overall Study|Withdrawal by Subject|4|||
164696144|NCT02674386|594910604|FG002|Overall Study|Withdrawal by Subject|0|||
164696145|NCT02674386|594910602|FG000|Overall Study|Other|0|||
164696146|NCT02674386|594910603|FG001|Overall Study|Other|1|||
164696147|NCT02674386|594910604|FG002|Overall Study|Other|0|||
164696148|NCT02674386|594910602|FG000|Overall Study|Enrolled but not evaluated|0|||
164696149|NCT02674386|594910603|FG001|Overall Study|Enrolled but not evaluated|4|||
164696150|NCT02674386|594910604|FG002|Overall Study|Enrolled but not evaluated|0|||
164356700|NCT01314443|593681065|FG002|Overall Study|Withdrawal by Subject|1|||
164356701|NCT01314443|593681066|FG003|Overall Study|Withdrawal by Subject|1|||
164696151|NCT02462486|594910605|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
164696152|NCT02462486|594910606|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
164696153|NCT02462486|594910607|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
164696154|NCT02462486|594910605|FG000|Overall Study|Adverse Event|53|||
164696155|NCT02462486|594910606|FG001|Overall Study|Adverse Event|48|||
164696156|NCT02462486|594910607|FG002|Overall Study|Adverse Event|21|||
164696157|NCT02462486|594910605|FG000|Overall Study|Lack of Efficacy|6|||
164356702|NCT01314443|593681063|FG000|Overall Study|Protocol Violation|2|||
164356703|NCT01314443|593681064|FG001|Overall Study|Protocol Violation|2|||
164356704|NCT01314443|593681065|FG002|Overall Study|Protocol Violation|1|||
164356705|NCT01314443|593681066|FG003|Overall Study|Protocol Violation|1|||
164356706|NCT01782859|593681067|FG000|Overall Study|Protocol Violation|6|||
164356707|NCT01782859|593681068|FG001|Overall Study|Protocol Violation|6|||
164356708|NCT01782859|593681067|FG000|Overall Study|Withdrawal by Subject|0|||
164356709|NCT01782859|593681068|FG001|Overall Study|Withdrawal by Subject|1|||
164356710|NCT00680745|593681072|FG000|Overall Study|Withdrawal by Subject|8|||
164356711|NCT00680745|593681073|FG001|Overall Study|Withdrawal by Subject|3|||
164356712|NCT00680745|593681074|FG002|Overall Study|Withdrawal by Subject|2|||
164356713|NCT00680745|593681075|FG003|Overall Study|Withdrawal by Subject|8|||
164356714|NCT00680745|593681072|FG000|Overall Study|Lost to Follow-up|0|||
164356715|NCT00680745|593681073|FG001|Overall Study|Lost to Follow-up|1|||
164356716|NCT00680745|593681074|FG002|Overall Study|Lost to Follow-up|1|||
164356717|NCT00680745|593681075|FG003|Overall Study|Lost to Follow-up|0|||
164356718|NCT00680745|593681072|FG000|Overall Study|Death|1|||
164356719|NCT00680745|593681073|FG001|Overall Study|Death|0|||
164356720|NCT00680745|593681074|FG002|Overall Study|Death|1|||
164356721|NCT00680745|593681075|FG003|Overall Study|Death|0|||
164356722|NCT00680745|593681072|FG000|Overall Study|Adverse Event|5|||
164356723|NCT00680745|593681073|FG001|Overall Study|Adverse Event|3|||
164356724|NCT00680745|593681074|FG002|Overall Study|Adverse Event|3|||
164356725|NCT00680745|593681075|FG003|Overall Study|Adverse Event|3|||
164356726|NCT00680745|593681072|FG000|Overall Study|Poor/Non-compliance|0|||
164356727|NCT00680745|593681073|FG001|Overall Study|Poor/Non-compliance|3|||
164356728|NCT00680745|593681074|FG002|Overall Study|Poor/Non-compliance|0|||
164356729|NCT00680745|593681075|FG003|Overall Study|Poor/Non-compliance|0|||
164356730|NCT00680745|593681072|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
164356731|NCT00680745|593681073|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
164356732|NCT00680745|593681074|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
164356733|NCT00680745|593681075|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
164356734|NCT00680745|593681072|FG000|Overall Study|False Treatment|0|||
164356735|NCT00680745|593681073|FG001|Overall Study|False Treatment|1|||
164356736|NCT00680745|593681074|FG002|Overall Study|False Treatment|3|||
164356737|NCT00680745|593681075|FG003|Overall Study|False Treatment|0|||
164356738|NCT01408914|593681076|FG000|Overall Study|Could not complete tx in protocol period|5|||
164356739|NCT01408914|593681077|FG001|Overall Study|Could not complete tx in protocol period|5|||
164356740|NCT01408914|593681078|FG002|Overall Study|Could not complete tx in protocol period|6|||
164356741|NCT01408914|593681076|FG000|Overall Study|Lost to Follow-up|4|||
164356742|NCT01408914|593681077|FG001|Overall Study|Lost to Follow-up|1|||
164356743|NCT01408914|593681078|FG002|Overall Study|Lost to Follow-up|2|||
164356744|NCT01408914|593681076|FG000|Overall Study|Physician Decision|1|||
164356745|NCT01408914|593681077|FG001|Overall Study|Physician Decision|1|||
164356746|NCT01408914|593681078|FG002|Overall Study|Physician Decision|0|||
164356747|NCT01408914|593681076|FG000|Overall Study|Withdrawal by Subject|1|||
164356748|NCT01408914|593681077|FG001|Overall Study|Withdrawal by Subject|0|||
164356749|NCT01408914|593681078|FG002|Overall Study|Withdrawal by Subject|1|||
164356750|NCT01408914|593681076|FG000|Overall Study|Moved out of study jurisdiction|1|||
164356751|NCT01408914|593681077|FG001|Overall Study|Moved out of study jurisdiction|1|||
164356752|NCT01408914|593681078|FG002|Overall Study|Moved out of study jurisdiction|0|||
164356753|NCT01408914|593681076|FG000|Overall Study|Late exclusion|0|||
164356754|NCT01408914|593681077|FG001|Overall Study|Late exclusion|3|||
164356755|NCT01408914|593681078|FG002|Overall Study|Late exclusion|3|||
164356756|NCT01408914|593681076|FG000|Overall Study|Change in local TB/HIV norms|0|||
164356757|NCT01408914|593681077|FG001|Overall Study|Change in local TB/HIV norms|1|||
164356758|NCT01408914|593681078|FG002|Overall Study|Change in local TB/HIV norms|1|||
164356759|NCT04903626|593681082|FG000|Overall Study|Lost to Follow-up|6|||
164356760|NCT04903626|593681082|FG000|Overall Study|Withdrawal by Subject|1|||
164356761|NCT04903626|593681082|FG000|Overall Study|Other, Not Specified|1|||
164356762|NCT06112756|593681085|FG000|Overall Study|Withdrawal by Subject|0|||
164356763|NCT06112756|593681086|FG001|Overall Study|Withdrawal by Subject|2|||
164356764|NCT06112756|593681085|FG000|Overall Study|Subject took an out of state job and had to early terminate|1|||
164356765|NCT06112756|593681086|FG001|Overall Study|Subject took an out of state job and had to early terminate|0|||
164356766|NCT06112756|593681085|FG000|Overall Study|Adverse Event|2|||
164437829|NCT01212757|593968255|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
164437830|NCT01212757|593968256|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
164356767|NCT06112756|593681086|FG001|Overall Study|Adverse Event|2|||
164356768|NCT03060629|593681087|FG000|Overall Study|Death|4|||
164356769|NCT03060629|593681088|FG001|Overall Study|Death|5|||
164356770|NCT03060629|593681087|FG000|Overall Study|Withdrawal by Subject|50|||
164356771|NCT03060629|593681088|FG001|Overall Study|Withdrawal by Subject|35|||
164356772|NCT03060629|593681087|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
164356773|NCT03060629|593681088|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
164356774|NCT03060629|593681087|FG000|Overall Study|Participant Relocate|15|||
164356775|NCT03060629|593681088|FG001|Overall Study|Participant Relocate|15|||
164696158|NCT02462486|594910606|FG001|Overall Study|Lack of Efficacy|12|||
164356776|NCT03060629|593681087|FG000|Overall Study|Unable to Contact Participant|34|||
164356777|NCT03060629|593681088|FG001|Overall Study|Unable to Contact Participant|23|||
164356778|NCT03060629|593681087|FG000|Overall Study|Investigator Decision|7|||
164356779|NCT03060629|593681088|FG001|Overall Study|Investigator Decision|7|||
164356780|NCT03060629|593681087|FG000|Overall Study|Study Terminated by Sponsor|1100|||
164356781|NCT03060629|593681088|FG001|Overall Study|Study Terminated by Sponsor|1123|||
164356782|NCT03060629|593681087|FG000|Overall Study|Other|4|||
164356783|NCT03060629|593681088|FG001|Overall Study|Other|4|||
164356784|NCT01862874|593681089|FG000|Overall Study|Randomized not treated|1|||
164356785|NCT01862874|593681090|FG001|Overall Study|Randomized not treated|0|||
164356786|NCT01862874|593681089|FG000|Overall Study|Adverse Event|0|||
164356787|NCT01862874|593681090|FG001|Overall Study|Adverse Event|3|||
164356788|NCT01862874|593681089|FG000|Overall Study|Lost to Follow-up|26|||
164356789|NCT01862874|593681090|FG001|Overall Study|Lost to Follow-up|29|||
164356790|NCT01862874|593681089|FG000|Overall Study|Physician Decision|5|||
164356791|NCT01862874|593681090|FG001|Overall Study|Physician Decision|3|||
164356792|NCT01862874|593681089|FG000|Overall Study|Withdrawn by parent/guardian|1|||
164356793|NCT01862874|593681090|FG001|Overall Study|Withdrawn by parent/guardian|1|||
164356794|NCT01862874|593681089|FG000|Overall Study|Withdrawal by Subject|46|||
164356795|NCT01862874|593681090|FG001|Overall Study|Withdrawal by Subject|40|||
164356796|NCT01862874|593681089|FG000|Overall Study|Death|0|||
164356797|NCT01862874|593681090|FG001|Overall Study|Death|1|||
164356798|NCT03681405|593681091|FG000|Overall Study|Found to be ineligible after randomized|1|||
164356799|NCT03681405|593681092|FG001|Overall Study|Found to be ineligible after randomized|0|||
164356800|NCT00412854|593682649|FG000|Overall Study|Withdrawn due to adverse events|1|||
164356801|NCT00412854|593682650|FG001|Overall Study|Withdrawn due to adverse events|5|||
164356802|NCT00412854|593682649|FG000|Overall Study|Withdrawn for other reasons|13|||
164356803|NCT00412854|593682650|FG001|Overall Study|Withdrawn for other reasons|11|||
164356804|NCT03518073|593682651|FG000|Overall Study|Adverse Event|2|||
164356805|NCT03518073|593682652|FG001|Overall Study|Adverse Event|4|||
164356806|NCT03518073|593682653|FG002|Overall Study|Adverse Event|2|||
164356807|NCT03518073|593682651|FG000|Overall Study|Death|2|||
164356808|NCT03518073|593682652|FG001|Overall Study|Death|1|||
164356809|NCT03518073|593682653|FG002|Overall Study|Death|3|||
164356810|NCT03518073|593682651|FG000|Overall Study|Lost to Follow-up|1|||
164356811|NCT03518073|593682652|FG001|Overall Study|Lost to Follow-up|0|||
164356812|NCT03518073|593682653|FG002|Overall Study|Lost to Follow-up|1|||
164356813|NCT03518073|593682651|FG000|Overall Study|Physician Decision|5|||
164356814|NCT03518073|593682652|FG001|Overall Study|Physician Decision|0|||
164356815|NCT03518073|593682653|FG002|Overall Study|Physician Decision|2|||
164356816|NCT03518073|593682651|FG000|Overall Study|Progressive disease|1|||
164356817|NCT03518073|593682652|FG001|Overall Study|Progressive disease|1|||
164356818|NCT03518073|593682653|FG002|Overall Study|Progressive disease|1|||
164356819|NCT03518073|593682651|FG000|Overall Study|Protocol Violation|1|||
164356820|NCT03518073|593682652|FG001|Overall Study|Protocol Violation|0|||
164356821|NCT03518073|593682653|FG002|Overall Study|Protocol Violation|0|||
164356822|NCT03518073|593682651|FG000|Overall Study|Withdrawal by Subject|30|||
164356823|NCT03518073|593682652|FG001|Overall Study|Withdrawal by Subject|34|||
164356824|NCT03518073|593682653|FG002|Overall Study|Withdrawal by Subject|29|||
164356825|NCT03518073|593682651|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
164437831|NCT01212757|593968257|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
164437832|NCT01212757|593968258|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
164437833|NCT01212757|593968259|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
164437834|NCT01212757|593968251|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
164437835|NCT01212757|593968252|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
164437836|NCT01212757|593968253|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
164696159|NCT02462486|594910607|FG002|Overall Study|Lack of Efficacy|3|||
164696160|NCT02462486|594910605|FG000|Overall Study|Lost to Follow-up|3|||
164437837|NCT01212757|593968254|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
164437838|NCT01212757|593968255|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
164437839|NCT01212757|593968256|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
164696161|NCT02462486|594910606|FG001|Overall Study|Lost to Follow-up|4|||
164696162|NCT02462486|594910607|FG002|Overall Study|Lost to Follow-up|2|||
164696163|NCT02462486|594910605|FG000|Overall Study|Withdrawal by Subject|25|||
164356826|NCT03518073|593682652|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
164356827|NCT03518073|593682653|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
164356828|NCT03518073|593682651|FG000|Overall Study|Covid-19|1|||
164356829|NCT03518073|593682652|FG001|Overall Study|Covid-19|2|||
164356830|NCT03518073|593682653|FG002|Overall Study|Covid-19|1|||
164356831|NCT03045081|593682654|FG000|Overall Study|Withdrawal by Subject|6|||
164356832|NCT03045081|593682655|FG001|Overall Study|Withdrawal by Subject|11|||
164356833|NCT03804879|593682656|FG000|Overall Study|Adverse Event|3|||
164356834|NCT03804879|593682657|FG001|Overall Study|Adverse Event|0|||
164356835|NCT03804879|593682656|FG000|Overall Study|Study Terminated By Sponsor|10|||
164356836|NCT03804879|593682657|FG001|Overall Study|Study Terminated By Sponsor|12|||
164356837|NCT03804879|593682656|FG000|Overall Study|Withdrawal by Subject|3|||
164356838|NCT03804879|593682657|FG001|Overall Study|Withdrawal by Subject|1|||
164356839|NCT02436889|593682658|FG000|Overall Study|No improvement in symptoms|1|||
164356840|NCT02436889|593682659|FG001|Overall Study|No improvement in symptoms|0|||
164356841|NCT02436889|593682658|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
164356842|NCT02436889|593682659|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
164356843|NCT01034462|593682660|FG000|Overall Study|Adverse Event|7|||
164356844|NCT01034462|593682661|FG001|Overall Study|Adverse Event|17|||
164356845|NCT01034462|593682660|FG000|Overall Study|Lack of Efficacy|4|||
164356846|NCT01034462|593682661|FG001|Overall Study|Lack of Efficacy|4|||
164356847|NCT01034462|593682660|FG000|Overall Study|Protocol Violation|10|||
164356848|NCT01034462|593682661|FG001|Overall Study|Protocol Violation|7|||
164356849|NCT01034462|593682660|FG000|Overall Study|Withdrawal by Subject|9|||
164356850|NCT01034462|593682661|FG001|Overall Study|Withdrawal by Subject|8|||
164356851|NCT01034462|593682660|FG000|Overall Study|Lost to Follow-up|14|||
164356852|NCT01034462|593682661|FG001|Overall Study|Lost to Follow-up|16|||
164356853|NCT01034462|593682660|FG000|Overall Study|Other reasons|1|||
164356854|NCT01034462|593682661|FG001|Overall Study|Other reasons|2|||
164356855|NCT02169739|593682663|FG000|Overall Study|Lost to Follow-up|0|||
164356856|NCT02169739|593682664|FG001|Overall Study|Lost to Follow-up|4|||
164356857|NCT03480750|593682665|FG000|Overall Study|Withdrawal by Subject|0|||
164356858|NCT03480750|593682666|FG001|Overall Study|Withdrawal by Subject|1|||
164356859|NCT03480750|593682667|FG002|Overall Study|Withdrawal by Subject|0|||
164356860|NCT03480750|593682668|FG003|Overall Study|Withdrawal by Subject|0|||
164356861|NCT03480750|593682669|FG004|Overall Study|Withdrawal by Subject|0|||
164356862|NCT03480750|593682670|FG005|Overall Study|Withdrawal by Subject|0|||
164356863|NCT03480750|593682665|FG000|Overall Study|The interruption in Trientine shippment|0|||
164356864|NCT03480750|593682666|FG001|Overall Study|The interruption in Trientine shippment|0|||
164356865|NCT03480750|593682667|FG002|Overall Study|The interruption in Trientine shippment|0|||
164356866|NCT03480750|593682668|FG003|Overall Study|The interruption in Trientine shippment|0|||
164356867|NCT03480750|593682669|FG004|Overall Study|The interruption in Trientine shippment|0|||
164356868|NCT03480750|593682670|FG005|Overall Study|The interruption in Trientine shippment|1|||
164356869|NCT03683758|593682675|FG000|Overall Study|Non-study commitment conflict|1|||
164356870|NCT03683758|593682676|FG001|Overall Study|Non-study commitment conflict|3|||
164356871|NCT03683758|593682675|FG000|Overall Study|Illness preventing participation|1|||
164356872|NCT03683758|593682676|FG001|Overall Study|Illness preventing participation|0|||
164356873|NCT03683758|593682675|FG000|Overall Study|Adverse Event|1|||
164356874|NCT03683758|593682676|FG001|Overall Study|Adverse Event|0|||
164356875|NCT00723892|593682677|FG000|Overall Study|Participant not tracked|33|||
164356876|NCT00723892|593682678|FG001|Overall Study|Participant not tracked|35|||
164356877|NCT00723892|593682677|FG000|Overall Study|Virological criterion|24|||
164356878|NCT00723892|593682678|FG001|Overall Study|Virological criterion|9|||
164356879|NCT00723892|593682677|FG000|Overall Study|Withdrawal by Subject|6|||
164356880|NCT00723892|593682678|FG001|Overall Study|Withdrawal by Subject|9|||
164356881|NCT00723892|593682677|FG000|Overall Study|End planned|11|||
164356882|NCT00723892|593682678|FG001|Overall Study|End planned|7|||
164356883|NCT00723892|593682677|FG000|Overall Study|Bad tolerance|5|||
164356884|NCT00723892|593682678|FG001|Overall Study|Bad tolerance|5|||
164437840|NCT01212757|593968257|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
164437841|NCT01212757|593968258|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
164590057|NCT01355068|594523141|FG001|First Intervention Period|Adverse Event|1|||
164590058|NCT01355068|594523140|FG000|First Intervention Period|Withdrawal by Subject|0|||
164590059|NCT01355068|594523141|FG001|First Intervention Period|Withdrawal by Subject|1|||
164590060|NCT00336492|594523144|FG000|Overall Study|Adverse Event|4|||
164590061|NCT00336492|594523145|FG001|Overall Study|Adverse Event|3|||
164590062|NCT00336492|594523146|FG002|Overall Study|Adverse Event|6|||
164590063|NCT00336492|594523144|FG000|Overall Study|Lack of Efficacy|6|||
164590064|NCT00336492|594523145|FG001|Overall Study|Lack of Efficacy|1|||
164590065|NCT00336492|594523146|FG002|Overall Study|Lack of Efficacy|4|||
164590066|NCT00336492|594523144|FG000|Overall Study|Other|5|||
164590067|NCT00336492|594523145|FG001|Overall Study|Other|0|||
164590068|NCT00336492|594523146|FG002|Overall Study|Other|1|||
164590069|NCT04229446|594523147|FG000|Overall Study|Death|12|||
164590070|NCT04229446|594523148|FG001|Overall Study|Death|10|||
164590071|NCT04229446|594523147|FG000|Overall Study|Lost to Follow-up|5|||
164590072|NCT04229446|594523148|FG001|Overall Study|Lost to Follow-up|8|||
164590073|NCT01781026|594523149|FG000|Overall Study|Lack of Efficacy|2|||
164356885|NCT00723892|593682677|FG000|Overall Study|Multiple reasons|17|||
164356886|NCT00723892|593682678|FG001|Overall Study|Multiple reasons|12|||
164356887|NCT00723892|593682677|FG000|Overall Study|Other|6|||
164356888|NCT00723892|593682678|FG001|Overall Study|Other|3|||
164356889|NCT00723892|593682677|FG000|Overall Study|Study end|1|||
164356890|NCT00723892|593682678|FG001|Overall Study|Study end|3|||
164356891|NCT00723892|593682677|FG000|Overall Study|Weight loss|1|||
164356892|NCT00723892|593682678|FG001|Overall Study|Weight loss|3|||
164590074|NCT03141307|594523150|FG000|In-Hospital|Withdrawal by Subject|0|||
164590075|NCT03141307|594523151|FG001|In-Hospital|Withdrawal by Subject|2|||
164356893|NCT00723892|593682677|FG000|Overall Study|Alcohol abuse|0|||
164356894|NCT00723892|593682678|FG001|Overall Study|Alcohol abuse|1|||
164356895|NCT00723892|593682677|FG000|Overall Study|Intercurrent infection|2|||
164356896|NCT00723892|593682678|FG001|Overall Study|Intercurrent infection|0|||
164356897|NCT00723892|593682677|FG000|Overall Study|Drug addiction|1|||
164356898|NCT00723892|593682678|FG001|Overall Study|Drug addiction|0|||
164356899|NCT02411292|593682679|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
164356900|NCT02411292|593682679|FG000|Overall Study|Death|2|||
164356901|NCT02411292|593682679|FG000|Overall Study|Lost to Follow-up|3|||
164356902|NCT00453921|593682680|FG000|Overall Study|Withdrawal by Subject|1|||
164356903|NCT00453921|593682681|FG001|Overall Study|Withdrawal by Subject|1|||
164356904|NCT00453921|593682682|FG002|Overall Study|Withdrawal by Subject|1|||
164356905|NCT00453921|593682683|FG003|Overall Study|Withdrawal by Subject|1|||
164356906|NCT00453921|593682680|FG000|Overall Study|Lost to Follow-up|0|||
164356907|NCT00453921|593682681|FG001|Overall Study|Lost to Follow-up|0|||
164356908|NCT00453921|593682682|FG002|Overall Study|Lost to Follow-up|1|||
164356909|NCT00453921|593682683|FG003|Overall Study|Lost to Follow-up|0|||
164356910|NCT00303498|593682684|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
164356911|NCT00303498|593682685|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
164356912|NCT00303498|593682684|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
164356913|NCT00303498|593682685|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
164356914|NCT00303498|593682684|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
164356915|NCT00303498|593682685|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
164356916|NCT00303498|593682684|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
164356917|NCT00303498|593682685|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
164356918|NCT00303498|593682684|FG000|Run-In-Phase (10 Weeks)|Other|4|||
164356919|NCT00303498|593682685|FG001|Run-In-Phase (10 Weeks)|Other|1|||
164356920|NCT00303498|593682684|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
164356921|NCT00303498|593682685|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
164356922|NCT00303498|593682684|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
164356923|NCT00303498|593682685|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
164356924|NCT00303498|593682684|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
164356925|NCT00303498|593682685|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
164356926|NCT00303498|593682684|FG000|Maintenance Phase (24 Weeks)|Death|1|||
164356927|NCT00303498|593682685|FG001|Maintenance Phase (24 Weeks)|Death|0|||
164356928|NCT00303498|593682684|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
164356929|NCT00303498|593682685|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
164356930|NCT00303498|593682684|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
164356931|NCT00303498|593682685|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
164356932|NCT00303498|593682684|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
164356933|NCT00303498|593682685|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
164356934|NCT00303498|593682684|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
164356935|NCT00303498|593682685|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
164356936|NCT00303498|593682684|FG000|Maintenance Phase (24 Weeks)|Other|1|||
164356937|NCT00303498|593682685|FG001|Maintenance Phase (24 Weeks)|Other|0|||
164356938|NCT00303498|593682684|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
164590076|NCT03141307|594523150|FG000|In-Hospital|Protocol Violation|4|||
164356939|NCT00303498|593682685|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
164437842|NCT01212757|593968259|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
164437843|NCT01212757|593968251|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
164437844|NCT01212757|593968252|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
164437845|NCT01212757|593968253|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
164437846|NCT01212757|593968254|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
164437847|NCT01212757|593968255|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
164437848|NCT01212757|593968256|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
164437849|NCT01212757|593968257|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
164437850|NCT01212757|593968258|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
164437851|NCT01212757|593968259|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
164437852|NCT01212757|593968251|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
164437853|NCT01212757|593968252|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
164437854|NCT01212757|593968253|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
164437855|NCT01212757|593968254|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
164437856|NCT01212757|593968255|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
164437857|NCT01212757|593968256|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
164437858|NCT01212757|593968257|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
164437859|NCT01212757|593968258|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
164356940|NCT00303498|593682684|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
164356941|NCT00303498|593682685|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
164356942|NCT00174915|593682686|FG000|Overall Study|Lost to Follow-up|19|||
164356943|NCT00174915|593682687|FG001|Overall Study|Lost to Follow-up|17|||
164356944|NCT00174915|593682688|FG002|Overall Study|Lost to Follow-up|9|||
164356945|NCT00174915|593682689|FG003|Overall Study|Lost to Follow-up|17|||
164356946|NCT00174915|593682690|FG004|Overall Study|Lost to Follow-up|10|||
164356947|NCT00174915|593682686|FG000|Overall Study|Adverse Event|18|||
164356948|NCT00174915|593682687|FG001|Overall Study|Adverse Event|16|||
164356949|NCT00174915|593682688|FG002|Overall Study|Adverse Event|11|||
164356950|NCT00174915|593682689|FG003|Overall Study|Adverse Event|18|||
164356951|NCT00174915|593682690|FG004|Overall Study|Adverse Event|5|||
164356952|NCT00174915|593682686|FG000|Overall Study|Personal Reason(s)|16|||
164356953|NCT00174915|593682687|FG001|Overall Study|Personal Reason(s)|16|||
164356954|NCT00174915|593682688|FG002|Overall Study|Personal Reason(s)|9|||
164356955|NCT00174915|593682689|FG003|Overall Study|Personal Reason(s)|9|||
164356956|NCT00174915|593682690|FG004|Overall Study|Personal Reason(s)|9|||
164356957|NCT00174915|593682686|FG000|Overall Study|Other|15|||
164356958|NCT00174915|593682687|FG001|Overall Study|Other|8|||
164356959|NCT00174915|593682688|FG002|Overall Study|Other|6|||
164356960|NCT00174915|593682689|FG003|Overall Study|Other|5|||
164356961|NCT00174915|593682690|FG004|Overall Study|Other|3|||
164356962|NCT00174915|593682686|FG000|Overall Study|Gout Flare|13|||
164437860|NCT01212757|593968259|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
164437861|NCT01212757|593968251|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
164437862|NCT01212757|593968252|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
164437863|NCT01212757|593968253|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
164437864|NCT01212757|593968254|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
164437865|NCT01212757|593968255|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
164437866|NCT01212757|593968256|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
164437867|NCT01212757|593968257|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
164437868|NCT01212757|593968258|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
164437869|NCT01212757|593968259|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
164437870|NCT01212757|593968251|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
164437871|NCT01212757|593968252|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
164437872|NCT01212757|593968253|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
164437873|NCT01212757|593968254|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
164437874|NCT01212757|593968255|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
164437875|NCT01212757|593968256|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
164437876|NCT01212757|593968257|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
164437877|NCT01212757|593968258|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
164437878|NCT01212757|593968259|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
164437879|NCT01212757|593968251|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
164437880|NCT01212757|593968252|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
164437881|NCT01212757|593968253|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
164356963|NCT00174915|593682687|FG001|Overall Study|Gout Flare|6|||
164356964|NCT00174915|593682688|FG002|Overall Study|Gout Flare|8|||
164356965|NCT00174915|593682689|FG003|Overall Study|Gout Flare|1|||
164356966|NCT00174915|593682690|FG004|Overall Study|Gout Flare|0|||
164356967|NCT00174915|593682686|FG000|Overall Study|Protocol Violation|6|||
164356968|NCT00174915|593682687|FG001|Overall Study|Protocol Violation|3|||
164356969|NCT00174915|593682688|FG002|Overall Study|Protocol Violation|3|||
164356970|NCT00174915|593682689|FG003|Overall Study|Protocol Violation|6|||
164356971|NCT00174915|593682690|FG004|Overall Study|Protocol Violation|3|||
164356972|NCT00174915|593682686|FG000|Overall Study|Therapeutic Failure|6|||
164356973|NCT00174915|593682687|FG001|Overall Study|Therapeutic Failure|3|||
164356974|NCT00174915|593682688|FG002|Overall Study|Therapeutic Failure|2|||
164356975|NCT00174915|593682689|FG003|Overall Study|Therapeutic Failure|1|||
164356976|NCT00174915|593682690|FG004|Overall Study|Therapeutic Failure|3|||
164356977|NCT02232425|593682691|FG000|Overall Study|Lost to Follow-up|6|||
164356978|NCT02232425|593682692|FG001|Overall Study|Lost to Follow-up|2|||
164356979|NCT02232425|593682691|FG000|Overall Study|Adverse Event|2|||
164356980|NCT02232425|593682692|FG001|Overall Study|Adverse Event|0|||
164356981|NCT02232425|593682691|FG000|Overall Study|Withdrawal by Subject|5|||
164356982|NCT02232425|593682692|FG001|Overall Study|Withdrawal by Subject|6|||
164356983|NCT02232425|593682691|FG000|Overall Study|Lack of Efficacy|1|||
164356984|NCT02232425|593682692|FG001|Overall Study|Lack of Efficacy|0|||
164356985|NCT03060447|593682693|FG000|Overall Study|Withdrawal by Subject|2|||
164356986|NCT03060447|593682694|FG001|Overall Study|Withdrawal by Subject|0|||
164356987|NCT01601626|593682697|FG000|Overall Study|Death|1|||
164356988|NCT01601626|593682698|FG001|Overall Study|Death|1|||
164356989|NCT01601626|593682699|FG002|Overall Study|Death|1|||
164356990|NCT01601626|593682697|FG000|Overall Study|Lost to Follow-up|1|||
164356991|NCT01601626|593682698|FG001|Overall Study|Lost to Follow-up|2|||
164356992|NCT01601626|593682699|FG002|Overall Study|Lost to Follow-up|0|||
164356993|NCT01601626|593682697|FG000|Overall Study|Unable to Get to Clinic|0|||
164356994|NCT01601626|593682698|FG001|Overall Study|Unable to Get to Clinic|1|||
164356995|NCT01601626|593682699|FG002|Overall Study|Unable to Get to Clinic|0|||
164356996|NCT01601626|593682697|FG000|Overall Study|Withdrawal by Subject|0|||
164356997|NCT01601626|593682698|FG001|Overall Study|Withdrawal by Subject|1|||
164356998|NCT01601626|593682699|FG002|Overall Study|Withdrawal by Subject|1|||
164356999|NCT01601626|593682697|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
164357000|NCT01601626|593682698|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
164357001|NCT01601626|593682699|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
164357002|NCT00498602|593682700|FG000|Overall Study|Death|0|||
164357003|NCT00498602|593682701|FG001|Overall Study|Death|0|||
164357004|NCT00498602|593682702|FG002|Overall Study|Death|0|||
164357005|NCT00498602|593682703|FG003|Overall Study|Death|0|||
164357006|NCT00498602|593682704|FG004|Overall Study|Death|0|||
164357007|NCT00498602|593682705|FG005|Overall Study|Death|1|||
164357008|NCT00498602|593682706|FG006|Overall Study|Death|0|||
164357009|NCT00498602|593682700|FG000|Overall Study|Lack of Efficacy|1|||
164357010|NCT00498602|593682701|FG001|Overall Study|Lack of Efficacy|0|||
164357011|NCT00498602|593682702|FG002|Overall Study|Lack of Efficacy|0|||
164357012|NCT00498602|593682703|FG003|Overall Study|Lack of Efficacy|0|||
164357013|NCT00498602|593682704|FG004|Overall Study|Lack of Efficacy|0|||
164357014|NCT00498602|593682705|FG005|Overall Study|Lack of Efficacy|0|||
164357015|NCT00498602|593682706|FG006|Overall Study|Lack of Efficacy|0|||
164357016|NCT00498602|593682700|FG000|Overall Study|Lost to Follow-up|0|||
164357017|NCT00498602|593682701|FG001|Overall Study|Lost to Follow-up|2|||
164357018|NCT00498602|593682702|FG002|Overall Study|Lost to Follow-up|0|||
164357019|NCT00498602|593682703|FG003|Overall Study|Lost to Follow-up|2|||
164357020|NCT00498602|593682704|FG004|Overall Study|Lost to Follow-up|0|||
164357021|NCT00498602|593682705|FG005|Overall Study|Lost to Follow-up|0|||
164357022|NCT00498602|593682706|FG006|Overall Study|Lost to Follow-up|0|||
164357023|NCT00498602|593682700|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
164357024|NCT00498602|593682701|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
164357025|NCT00498602|593682702|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
164357026|NCT00498602|593682703|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
164357027|NCT00498602|593682704|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
164357028|NCT00498602|593682705|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
164357029|NCT00498602|593682706|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
164357030|NCT00498602|593682700|FG000|Overall Study|AE not related to Study Drug|1|||
164357031|NCT00498602|593682701|FG001|Overall Study|AE not related to Study Drug|3|||
164357032|NCT00498602|593682702|FG002|Overall Study|AE not related to Study Drug|0|||
164357033|NCT00498602|593682703|FG003|Overall Study|AE not related to Study Drug|0|||
164357034|NCT00498602|593682704|FG004|Overall Study|AE not related to Study Drug|2|||
164357035|NCT00498602|593682705|FG005|Overall Study|AE not related to Study Drug|2|||
164357036|NCT00498602|593682706|FG006|Overall Study|AE not related to Study Drug|1|||
164357037|NCT00498602|593682700|FG000|Overall Study|Caregiver Request|2|||
164357038|NCT00498602|593682701|FG001|Overall Study|Caregiver Request|2|||
164357039|NCT00498602|593682702|FG002|Overall Study|Caregiver Request|2|||
164357040|NCT00498602|593682703|FG003|Overall Study|Caregiver Request|0|||
164357041|NCT00498602|593682704|FG004|Overall Study|Caregiver Request|1|||
164357042|NCT00498602|593682705|FG005|Overall Study|Caregiver Request|2|||
164357043|NCT00498602|593682706|FG006|Overall Study|Caregiver Request|0|||
164357044|NCT00498602|593682700|FG000|Overall Study|Investigator Request|0|||
164357045|NCT00498602|593682701|FG001|Overall Study|Investigator Request|0|||
164357046|NCT00498602|593682702|FG002|Overall Study|Investigator Request|1|||
164357047|NCT00498602|593682703|FG003|Overall Study|Investigator Request|0|||
164357048|NCT00498602|593682704|FG004|Overall Study|Investigator Request|0|||
164357049|NCT00498602|593682705|FG005|Overall Study|Investigator Request|0|||
164357050|NCT00498602|593682706|FG006|Overall Study|Investigator Request|0|||
164357051|NCT00498602|593682700|FG000|Overall Study|Subject Request|3|||
164357052|NCT00498602|593682701|FG001|Overall Study|Subject Request|0|||
164357053|NCT00498602|593682702|FG002|Overall Study|Subject Request|1|||
164357054|NCT00498602|593682703|FG003|Overall Study|Subject Request|1|||
164357055|NCT00498602|593682704|FG004|Overall Study|Subject Request|1|||
164357056|NCT00498602|593682705|FG005|Overall Study|Subject Request|4|||
164357057|NCT00498602|593682706|FG006|Overall Study|Subject Request|1|||
164357058|NCT00498602|593682700|FG000|Overall Study|Other|2|||
164357059|NCT00498602|593682701|FG001|Overall Study|Other|3|||
164357060|NCT00498602|593682702|FG002|Overall Study|Other|1|||
164357061|NCT00498602|593682703|FG003|Overall Study|Other|0|||
164357062|NCT00498602|593682704|FG004|Overall Study|Other|0|||
164357063|NCT00498602|593682705|FG005|Overall Study|Other|3|||
164357064|NCT00498602|593682706|FG006|Overall Study|Other|0|||
164357065|NCT00546637|593682707|FG000|Overall Study|Adverse Event|46|||
164357066|NCT00546637|593682708|FG001|Overall Study|Adverse Event|20|||
164357067|NCT00546637|593682707|FG000|Overall Study|Lack of Efficacy|5|||
164357068|NCT00546637|593682708|FG001|Overall Study|Lack of Efficacy|5|||
164357069|NCT00546637|593682707|FG000|Overall Study|Lost to Follow-up|2|||
164357070|NCT00546637|593682708|FG001|Overall Study|Lost to Follow-up|2|||
164357071|NCT00546637|593682707|FG000|Overall Study|Other|10|||
164357072|NCT00546637|593682708|FG001|Overall Study|Other|12|||
164357073|NCT00546637|593682707|FG000|Overall Study|Withdrawal by Subject|7|||
164357074|NCT00546637|593682708|FG001|Overall Study|Withdrawal by Subject|9|||
164357075|NCT00546637|593682707|FG000|Overall Study|Randomized, but not treated|3|||
164357076|NCT00546637|593682708|FG001|Overall Study|Randomized, but not treated|1|||
164357077|NCT04984993|593682715|FG000|Overall Study|Withdrawal by Subject|8|||
164357078|NCT04984993|593682716|FG001|Overall Study|Withdrawal by Subject|2|||
164357079|NCT04984993|593682715|FG000|Overall Study|Lost to Follow-up|2|||
164357080|NCT04984993|593682716|FG001|Overall Study|Lost to Follow-up|2|||
164357081|NCT04984993|593682715|FG000|Overall Study|Both patients moved to another country|4|||
164357082|NCT04984993|593682716|FG001|Overall Study|Both patients moved to another country|0|||
164357083|NCT01110707|593682717|FG000|Overall Study|Protocol Violation|0|||
164357084|NCT01110707|593682718|FG001|Overall Study|Protocol Violation|3|||
164357085|NCT03108027|593682731|FG000|Period 1|Subject/Guardian Decision|0|||
164357086|NCT03108027|593682732|FG001|Period 1|Subject/Guardian Decision|0|||
164357087|NCT03108027|593682733|FG002|Period 1|Subject/Guardian Decision|0|||
164357088|NCT03108027|593682734|FG003|Period 1|Subject/Guardian Decision|2|||
164357089|NCT03108027|593682735|FG004|Period 1|Subject/Guardian Decision|0|||
164357090|NCT03108027|593682736|FG005|Period 1|Subject/Guardian Decision|0|||
164357091|NCT03108027|593682731|FG000|Period 3|Adverse Event|0|||
164357092|NCT03108027|593682732|FG001|Period 3|Adverse Event|1|||
164357093|NCT03108027|593682733|FG002|Period 3|Adverse Event|0|||
164357094|NCT03108027|593682734|FG003|Period 3|Adverse Event|0|||
164357095|NCT03108027|593682735|FG004|Period 3|Adverse Event|0|||
164357096|NCT03108027|593682736|FG005|Period 3|Adverse Event|0|||
164357097|NCT02426892|593682737|FG000|Overall Study|Adverse Event|2|||
164357098|NCT02426892|593682737|FG000|Overall Study|Lack of Efficacy|17|||
164357099|NCT02426892|593682737|FG000|Overall Study|Withdrawal by Subject|1|||
164357100|NCT03178773|593682738|FG000|Overall Study|Death|0|||
164357101|NCT03178773|593682739|FG001|Overall Study|Death|1|||
164357102|NCT03178773|593682738|FG000|Overall Study|Lost to Follow-up|29|||
164357103|NCT03178773|593682739|FG001|Overall Study|Lost to Follow-up|25|||
164357104|NCT03178773|593682738|FG000|Overall Study|Withdrawal by Subject|10|||
164357105|NCT03178773|593682739|FG001|Overall Study|Withdrawal by Subject|14|||
164357106|NCT01382446|593682740|FG000|Overall Study|Withdrawal by Subject|0|||
164357107|NCT01382446|593682741|FG001|Overall Study|Withdrawal by Subject|1|||
164357108|NCT01382446|593682740|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
164357109|NCT01382446|593682741|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
164357110|NCT00003901|593682742|FG000|Overall Study|Adverse Event|1|||
164357111|NCT00003901|593682742|FG000|Overall Study|Withdrawal by Subject|1|||
164357112|NCT00003901|593682742|FG000|Overall Study|Ineligible|6|||
164357113|NCT00003901|593682742|FG000|Overall Study|CT Scan not within protocol requirement|2|||
164357114|NCT00003901|593682742|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
164357115|NCT00003901|593682742|FG000|Overall Study|Medical problems|6|||
164357116|NCT00268996|593682745|FG000|Overall Study|Adverse Event|11|||
164357117|NCT00268996|593682746|FG001|Overall Study|Adverse Event|7|||
164357118|NCT00268996|593682745|FG000|Overall Study|Lost to Follow-up|3|||
164357119|NCT00268996|593682746|FG001|Overall Study|Lost to Follow-up|1|||
164357120|NCT00268996|593682745|FG000|Overall Study|Withdrawal by Subject|5|||
164437882|NCT01212757|593968254|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
164357121|NCT00268996|593682746|FG001|Overall Study|Withdrawal by Subject|11|||
164357122|NCT00268996|593682745|FG000|Overall Study|Non-compliance|1|||
164357123|NCT00268996|593682746|FG001|Overall Study|Non-compliance|0|||
164357124|NCT00268996|593682745|FG000|Overall Study|Other|1|||
164357125|NCT00268996|593682746|FG001|Overall Study|Other|1|||
164357126|NCT03325075|593682749|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
164696164|NCT02462486|594910606|FG001|Overall Study|Withdrawal by Subject|22|||
164357127|NCT03325075|593682750|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
164357128|NCT03325075|593682751|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
164357129|NCT03325075|593682752|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
164357130|NCT03325075|593682749|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
164357131|NCT03325075|593682750|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
164357132|NCT03325075|593682751|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
164357133|NCT03325075|593682752|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
164357134|NCT03325075|593682749|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
164357135|NCT03325075|593682750|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
164357136|NCT03325075|593682751|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
164357137|NCT03325075|593682752|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
164357138|NCT00422591|593682753|FG000|Overall Study|Physician Decision|4|||
164437883|NCT01212757|593968255|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
164437884|NCT01212757|593968256|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
164437885|NCT01212757|593968257|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
164437886|NCT01212757|593968258|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
164437887|NCT01212757|593968259|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
164437888|NCT01212757|593968251|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
164437889|NCT01212757|593968252|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
164437890|NCT01212757|593968253|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
164437891|NCT01212757|593968254|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
164437892|NCT01212757|593968255|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
164437893|NCT01212757|593968256|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
164590077|NCT03141307|594523151|FG001|In-Hospital|Protocol Violation|0|||
164590078|NCT03141307|594523150|FG000|Follow-Up|Lost to Follow-up|97|||
164590079|NCT03141307|594523151|FG001|Follow-Up|Lost to Follow-up|54|||
164590080|NCT00227877|594523152|FG000|Pre-visit Assessment|Technical difficulties|7|||
164590081|NCT00227877|594523153|FG001|Pre-visit Assessment|Technical difficulties|3|||
164590082|NCT00227877|594523154|FG002|Pre-visit Assessment|Technical difficulties|0|||
164590083|NCT00227877|594523155|FG003|Pre-visit Assessment|Technical difficulties|0|||
164590084|NCT00227877|594523152|FG000|Post-visit Checklist|Lost to Follow-up|24|||
164590085|NCT00227877|594523153|FG001|Post-visit Checklist|Lost to Follow-up|13|||
164590086|NCT00227877|594523154|FG002|Post-visit Checklist|Lost to Follow-up|1|||
164590087|NCT00227877|594523155|FG003|Post-visit Checklist|Lost to Follow-up|0|||
164590088|NCT00227877|594523152|FG000|3-months Follow-up|Completed late|135|||
164590089|NCT00227877|594523153|FG001|3-months Follow-up|Completed late|128|||
164590090|NCT00227877|594523154|FG002|3-months Follow-up|Completed late|34|||
164590091|NCT00227877|594523155|FG003|3-months Follow-up|Completed late|8|||
164590092|NCT00227877|594523152|FG000|3-months Follow-up|Lost to Follow-up|178|||
164590093|NCT00227877|594523153|FG001|3-months Follow-up|Lost to Follow-up|139|||
164696165|NCT02462486|594910607|FG002|Overall Study|Withdrawal by Subject|19|||
164696166|NCT02462486|594910605|FG000|Overall Study|Protocol Violation|3|||
164696167|NCT02462486|594910606|FG001|Overall Study|Protocol Violation|1|||
164696168|NCT02462486|594910607|FG002|Overall Study|Protocol Violation|1|||
164696169|NCT02462486|594910605|FG000|Overall Study|Reason not Specified|3|||
164696170|NCT02462486|594910606|FG001|Overall Study|Reason not Specified|4|||
164696171|NCT02462486|594910607|FG002|Overall Study|Reason not Specified|3|||
164696172|NCT02039063|594910608|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
164696173|NCT02039063|594910609|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
164696174|NCT02039063|594910610|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
164696175|NCT02039063|594910611|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
164696176|NCT02039063|594910608|FG000|Treatment Phase|Progression of disease|0|||
164696177|NCT02039063|594910609|FG001|Treatment Phase|Progression of disease|0|||
164696178|NCT02039063|594910610|FG002|Treatment Phase|Progression of disease|1|||
164696179|NCT02039063|594910611|FG003|Treatment Phase|Progression of disease|1|||
164696180|NCT02039063|594910608|FG000|Extension Phase|Inadequate therapeutic effect|0|||
164696181|NCT02039063|594910609|FG001|Extension Phase|Inadequate therapeutic effect|1|||
164696182|NCT02039063|594910610|FG002|Extension Phase|Inadequate therapeutic effect|2|||
164696183|NCT02039063|594910611|FG003|Extension Phase|Inadequate therapeutic effect|0|||
164696184|NCT02039063|594910608|FG000|Extension Phase|Progression of disease|0|||
164696185|NCT02039063|594910609|FG001|Extension Phase|Progression of disease|0|||
164696186|NCT02039063|594910610|FG002|Extension Phase|Progression of disease|0|||
164696187|NCT02039063|594910611|FG003|Extension Phase|Progression of disease|1|||
164696188|NCT02039063|594910608|FG000|Extension Phase|Adverse Event|0|||
164696189|NCT02039063|594910609|FG001|Extension Phase|Adverse Event|0|||
164590094|NCT00227877|594523154|FG002|3-months Follow-up|Lost to Follow-up|18|||
164590095|NCT00227877|594523155|FG003|3-months Follow-up|Lost to Follow-up|13|||
164590096|NCT00227877|594523152|FG000|12-months Follow-up|Completed late|78|||
164590097|NCT00227877|594523153|FG001|12-months Follow-up|Completed late|74|||
164696190|NCT02039063|594910610|FG002|Extension Phase|Adverse Event|1|||
164590098|NCT00227877|594523154|FG002|12-months Follow-up|Completed late|1|||
164357139|NCT00422591|593682753|FG000|Overall Study|Withdrawal by Subject|2|||
164357140|NCT01414075|593682758|FG000|Overall Study|Adverse Event|1|||
164357141|NCT01414075|593682759|FG001|Overall Study|Adverse Event|0|||
164357142|NCT01414075|593682760|FG002|Overall Study|Adverse Event|1|||
164357143|NCT01414075|593682761|FG003|Overall Study|Adverse Event|0|||
164357144|NCT01414075|593682758|FG000|Overall Study|Death|1|||
164357145|NCT01414075|593682759|FG001|Overall Study|Death|0|||
164357146|NCT01414075|593682760|FG002|Overall Study|Death|0|||
164357147|NCT01414075|593682761|FG003|Overall Study|Death|1|||
164357148|NCT01414075|593682758|FG000|Overall Study|Withdrawal by Subject|0|||
164357149|NCT01414075|593682759|FG001|Overall Study|Withdrawal by Subject|0|||
164357150|NCT01414075|593682760|FG002|Overall Study|Withdrawal by Subject|0|||
164357151|NCT01414075|593682761|FG003|Overall Study|Withdrawal by Subject|1|||
164357152|NCT01414075|593682758|FG000|Overall Study|Other than specified|1|||
164357153|NCT01414075|593682759|FG001|Overall Study|Other than specified|0|||
164357154|NCT01414075|593682760|FG002|Overall Study|Other than specified|1|||
164357155|NCT01414075|593682761|FG003|Overall Study|Other than specified|0|||
164357156|NCT00573534|593682763|FG000|Overall Study|oppositional behavior|3|||
164357157|NCT04851314|593682768|FG000|Overall Study|Unable to complete research set-up procedures|0|||
164357158|NCT04851314|593682769|FG001|Overall Study|Unable to complete research set-up procedures|2|||
164357159|NCT04851314|593682768|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
164357160|NCT04851314|593682769|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
164357161|NCT00867009|593682770|FG000|Induction Period|Nonserious Adverse Event|5|||
164357162|NCT00867009|593682770|FG000|Induction Period|Serious Adverse Event|10|||
164357163|NCT00867009|593682770|FG000|Induction Period|Death due to serious adverse event|6|||
164357164|NCT00867009|593682770|FG000|Induction Period|Death due to Study Disease|4|||
164357165|NCT00867009|593682770|FG000|Induction Period|Protocol Violation|1|||
164357166|NCT00867009|593682770|FG000|Induction Period|Withdrawal by Subject|8|||
164357167|NCT00867009|593682770|FG000|Induction Period|Physician Decision|3|||
164357168|NCT00867009|593682770|FG000|Induction Period|Progressive Disease (PD)|25|||
164357169|NCT00867009|593682770|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
164357170|NCT03266094|593682773|FG000|Overall Study|Lost to Follow-up|1|||
164357171|NCT03266094|593682773|FG000|Overall Study|Withdrawal by Subject|1|||
164357172|NCT03241342|593682778|FG000|Overall Study|Adverse Event|5|||
164357173|NCT03241342|593682779|FG001|Overall Study|Adverse Event|8|||
164696191|NCT02039063|594910611|FG003|Extension Phase|Adverse Event|0|||
164696192|NCT00775528|594910616|FG000|Overall Study|Protocol Violation|1|||
164696193|NCT02492841|594910617|FG000|Overall Study|Lost to Follow-up|34|||
164696194|NCT02492841|594910618|FG001|Overall Study|Lost to Follow-up|31|||
164696195|NCT02492841|594910619|FG002|Overall Study|Lost to Follow-up|35|||
164696196|NCT01192399|594910621|FG000|Overall Study|Lack of Efficacy|2|||
164696197|NCT00384176|594910625|FG000|Overall Study|Death|239|||
164696198|NCT00384176|594910626|FG001|Overall Study|Death|247|||
164696199|NCT00384176|594910627|FG002|Overall Study|Death|105|||
164696200|NCT00384176|594910625|FG000|Overall Study|Withdrawal by Subject|52|||
164696201|NCT00384176|594910626|FG001|Overall Study|Withdrawal by Subject|48|||
164696202|NCT00384176|594910627|FG002|Overall Study|Withdrawal by Subject|22|||
164696203|NCT00384176|594910625|FG000|Overall Study|Lost to Follow-up|16|||
164696204|NCT00384176|594910626|FG001|Overall Study|Lost to Follow-up|18|||
164357174|NCT03241342|593682780|FG002|Overall Study|Adverse Event|4|||
164357175|NCT03241342|593682778|FG000|Overall Study|Lack of Efficacy|0|||
164357176|NCT03241342|593682779|FG001|Overall Study|Lack of Efficacy|0|||
164357177|NCT03241342|593682780|FG002|Overall Study|Lack of Efficacy|1|||
164357178|NCT03241342|593682778|FG000|Overall Study|noncompliance with study drug|2|||
164357179|NCT03241342|593682779|FG001|Overall Study|noncompliance with study drug|1|||
164357180|NCT03241342|593682780|FG002|Overall Study|noncompliance with study drug|1|||
164357181|NCT03241342|593682778|FG000|Overall Study|sponsor decision|0|||
164357182|NCT03241342|593682779|FG001|Overall Study|sponsor decision|1|||
164357183|NCT03241342|593682780|FG002|Overall Study|sponsor decision|2|||
164357184|NCT03241342|593682778|FG000|Overall Study|not reported|15|||
164357185|NCT03241342|593682779|FG001|Overall Study|not reported|21|||
164357186|NCT03241342|593682780|FG002|Overall Study|not reported|19|||
164357187|NCT03036072|593682784|FG000|Overall Study|Death|0|||
164357188|NCT03036072|593682785|FG001|Overall Study|Death|1|||
164357189|NCT03036072|593682784|FG000|Overall Study|Withdrawal by Subject|0|||
164357190|NCT03036072|593682785|FG001|Overall Study|Withdrawal by Subject|1|||
164357191|NCT03036072|593682784|FG000|Overall Study|Physician Decision|0|||
164357192|NCT03036072|593682785|FG001|Overall Study|Physician Decision|1|||
164357193|NCT03334903|593682786|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
164696205|NCT00384176|594910627|FG002|Overall Study|Lost to Follow-up|4|||
164696206|NCT00384176|594910625|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
164696207|NCT00384176|594910626|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
164696208|NCT00384176|594910627|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
164357194|NCT03334903|593682787|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
164357195|NCT03334903|593682786|FG000|Overall Study|Protocol Violation|1|||
164696209|NCT00384176|594910625|FG000|Overall Study|Longer QTC as Visit 1|1|||
164696210|NCT00384176|594910626|FG001|Overall Study|Longer QTC as Visit 1|0|||
164696211|NCT00384176|594910627|FG002|Overall Study|Longer QTC as Visit 1|0|||
164696212|NCT00384176|594910625|FG000|Overall Study|Toxicity of treatment|1|||
164696213|NCT00384176|594910626|FG001|Overall Study|Toxicity of treatment|0|||
164696214|NCT00384176|594910627|FG002|Overall Study|Toxicity of treatment|0|||
164696215|NCT00384176|594910625|FG000|Overall Study|Did not receive study treatment|0|||
164696216|NCT00384176|594910626|FG001|Overall Study|Did not receive study treatment|1|||
164696217|NCT00384176|594910627|FG002|Overall Study|Did not receive study treatment|1|||
164696218|NCT00384176|594910625|FG000|Overall Study|Physician Decision|0|||
164696219|NCT00384176|594910626|FG001|Overall Study|Physician Decision|2|||
164696220|NCT00384176|594910627|FG002|Overall Study|Physician Decision|0|||
164696221|NCT00384176|594910625|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
164696222|NCT00384176|594910626|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
164696223|NCT00384176|594910627|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
164696224|NCT01425528|594910628|FG000|Overall Study|Withdrawal by Subject|1|||
164696225|NCT01425528|594910629|FG001|Overall Study|Withdrawal by Subject|1|||
164696226|NCT02697773|594910630|FG000|Overall Study|Adverse Event|2|||
164696227|NCT02697773|594910631|FG001|Overall Study|Adverse Event|1|||
164696228|NCT02697773|594910632|FG002|Overall Study|Adverse Event|2|||
164696229|NCT02697773|594910630|FG000|Overall Study|Death|0|||
164696230|NCT02697773|594910631|FG001|Overall Study|Death|0|||
164696231|NCT02697773|594910632|FG002|Overall Study|Death|2|||
164696232|NCT02697773|594910630|FG000|Overall Study|Lack of Efficacy|4|||
164696233|NCT02697773|594910631|FG001|Overall Study|Lack of Efficacy|6|||
164696234|NCT02697773|594910632|FG002|Overall Study|Lack of Efficacy|6|||
164696235|NCT02697773|594910630|FG000|Overall Study|Lost to Follow-up|5|||
164696236|NCT02697773|594910631|FG001|Overall Study|Lost to Follow-up|5|||
164696237|NCT02697773|594910632|FG002|Overall Study|Lost to Follow-up|7|||
164696238|NCT02697773|594910630|FG000|Overall Study|Other|15|||
164696239|NCT02697773|594910631|FG001|Overall Study|Other|11|||
164696240|NCT02697773|594910632|FG002|Overall Study|Other|10|||
164696241|NCT02697773|594910630|FG000|Overall Study|Protocol Violation|1|||
164696242|NCT02697773|594910631|FG001|Overall Study|Protocol Violation|1|||
164696243|NCT02697773|594910632|FG002|Overall Study|Protocol Violation|0|||
164696244|NCT02697773|594910630|FG000|Overall Study|Withdrawal by Subject|10|||
164696245|NCT02697773|594910631|FG001|Overall Study|Withdrawal by Subject|13|||
164696246|NCT02697773|594910632|FG002|Overall Study|Withdrawal by Subject|13|||
164696247|NCT02697773|594910630|FG000|Overall Study|Randomized but not treated|1|||
164696248|NCT02697773|594910631|FG001|Overall Study|Randomized but not treated|1|||
164696249|NCT02697773|594910632|FG002|Overall Study|Randomized but not treated|0|||
164696250|NCT00613834|594910633|FG000|Overall Study|Withdrawal by Subject|0|||
164696251|NCT00613834|594910634|FG001|Overall Study|Withdrawal by Subject|3|||
164696252|NCT00842530|594910635|FG000|Overall Study|Serious adverse event|0|||
164696253|NCT00842530|594910636|FG001|Overall Study|Serious adverse event|6|||
164696254|NCT00842530|594910635|FG000|Overall Study|Other adverse event|6|||
164696255|NCT00842530|594910636|FG001|Overall Study|Other adverse event|1|||
164696256|NCT00842530|594910635|FG000|Overall Study|Protocol Violation|32|||
164696257|NCT00842530|594910636|FG001|Overall Study|Protocol Violation|14|||
164696258|NCT00842530|594910635|FG000|Overall Study|Lost to Follow-up|6|||
164696259|NCT00842530|594910636|FG001|Overall Study|Lost to Follow-up|8|||
164696260|NCT00842530|594910635|FG000|Overall Study|Withdrawal by Subject|73|||
164357196|NCT03334903|593682787|FG001|Overall Study|Protocol Violation|3|||
164357197|NCT03334903|593682786|FG000|Overall Study|Surgery postponed|1|||
164357198|NCT03334903|593682787|FG001|Overall Study|Surgery postponed|0|||
164357199|NCT03334903|593682786|FG000|Overall Study|Adverse Event|1|||
164357200|NCT03334903|593682787|FG001|Overall Study|Adverse Event|1|||
164357201|NCT03334903|593682786|FG000|Overall Study|Withdrawal by Subject|0|||
164357202|NCT03334903|593682787|FG001|Overall Study|Withdrawal by Subject|1|||
164357203|NCT00001596|593684258|FG000|Overall Study|Death|1|||
164696261|NCT00842530|594910636|FG001|Overall Study|Withdrawal by Subject|28|||
164696262|NCT02939950|594910637|FG000|Overall Study|Lost to Follow-up|13|||
164696263|NCT02939950|594910638|FG001|Overall Study|Lost to Follow-up|16|||
164696264|NCT02939950|594910637|FG000|Overall Study|Positive slit lamp findings|0|||
164696265|NCT02939950|594910638|FG001|Overall Study|Positive slit lamp findings|1|||
164696266|NCT02939950|594910637|FG000|Overall Study|Chalazion upper lid|0|||
164696267|NCT02939950|594910638|FG001|Overall Study|Chalazion upper lid|1|||
164696268|NCT02939950|594910637|FG000|Overall Study|Lack of motivation|0|||
164696269|NCT02939950|594910638|FG001|Overall Study|Lack of motivation|2|||
164696270|NCT02939950|594910637|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
164696271|NCT02939950|594910638|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
164696272|NCT02939950|594910637|FG000|Overall Study|Military orders|1|||
164357204|NCT00001596|593684259|FG001|Overall Study|Death|0|||
164696273|NCT02939950|594910638|FG001|Overall Study|Military orders|0|||
164696274|NCT02939950|594910637|FG000|Overall Study|Participant Relocated|5|||
164696275|NCT02939950|594910638|FG001|Overall Study|Participant Relocated|3|||
164357205|NCT00001596|593684258|FG000|Overall Study|Withdrawal by Subject|3|||
164357206|NCT00001596|593684259|FG001|Overall Study|Withdrawal by Subject|1|||
164357207|NCT00001596|593684258|FG000|Overall Study|Study Termination|12|||
164357208|NCT00001596|593684259|FG001|Overall Study|Study Termination|9|||
164357209|NCT00001596|593684258|FG000|Overall Study|Adverse Event|1|||
164357210|NCT00001596|593684259|FG001|Overall Study|Adverse Event|0|||
164357211|NCT00903617|593684265|FG000|Overall Study|Adverse Event|0|||
164357212|NCT00903617|593684266|FG001|Overall Study|Adverse Event|1|||
164357213|NCT00903617|593684267|FG002|Overall Study|Adverse Event|1|||
164357214|NCT00903617|593684268|FG003|Overall Study|Adverse Event|0|||
164357215|NCT00903617|593684265|FG000|Overall Study|Protocol-defined stopping criteria|0|||
164357216|NCT00903617|593684266|FG001|Overall Study|Protocol-defined stopping criteria|2|||
164357217|NCT00903617|593684267|FG002|Overall Study|Protocol-defined stopping criteria|0|||
164357218|NCT00903617|593684268|FG003|Overall Study|Protocol-defined stopping criteria|0|||
164357219|NCT00903617|593684265|FG000|Overall Study|Lost to Follow-up|2|||
164357220|NCT00903617|593684266|FG001|Overall Study|Lost to Follow-up|0|||
164357221|NCT00903617|593684267|FG002|Overall Study|Lost to Follow-up|1|||
164357222|NCT00903617|593684268|FG003|Overall Study|Lost to Follow-up|1|||
164357223|NCT00903617|593684265|FG000|Overall Study|Withdrawal by Subject|1|||
164357224|NCT00903617|593684266|FG001|Overall Study|Withdrawal by Subject|2|||
164357225|NCT00903617|593684267|FG002|Overall Study|Withdrawal by Subject|3|||
164357226|NCT00903617|593684268|FG003|Overall Study|Withdrawal by Subject|0|||
164357227|NCT01104636|593684269|FG000|Overall Study|Lack of Efficacy|43|||
164357228|NCT01104636|593684269|FG000|Overall Study|Lost to Follow-up|24|||
164357229|NCT01104636|593684269|FG000|Overall Study|Withdrawal by Subject|4|||
164357230|NCT01104636|593684269|FG000|Overall Study|Other|43|||
164357231|NCT01104636|593684269|FG000|Overall Study|Study terminated by sponsor|1|||
164357232|NCT01104636|593684269|FG000|Overall Study|Pregnancy|2|||
164357233|NCT01104636|593684269|FG000|Overall Study|Adverse Event|40|||
164357234|NCT01104636|593684269|FG000|Overall Study|Ongoing|21|||
164357235|NCT01706003|593684270|FG000|Overall Study|Withdrawal by Subject|2|||
164357236|NCT01706003|593684271|FG001|Overall Study|Withdrawal by Subject|0|||
164357237|NCT01706003|593684270|FG000|Overall Study|Not scheduled|3|||
164357238|NCT01706003|593684271|FG001|Overall Study|Not scheduled|0|||
164357239|NCT01706003|593684270|FG000|Overall Study|Lost to Follow-up|6|||
164357240|NCT01706003|593684271|FG001|Overall Study|Lost to Follow-up|4|||
164357241|NCT01244906|593684274|FG000|Overall Study|Death|2|||
164357242|NCT01244906|593684274|FG000|Overall Study|Progression of disease post treatment|6|||
164357243|NCT02865187|593684277|FG000|Overall Study|Lost to Follow-up|12|||
164357244|NCT02865187|593684278|FG001|Overall Study|Lost to Follow-up|7|||
164357245|NCT02865187|593684277|FG000|Overall Study|Adverse Event|1|||
164357246|NCT02865187|593684278|FG001|Overall Study|Adverse Event|0|||
164357247|NCT04267133|593684279|FG000|Overall Study|Withdrawal by Subject|1|||
164357248|NCT04267133|593684279|FG000|Overall Study|Adverse Event|4|||
164357249|NCT03318315|593684280|FG000|Overall Study|Lost to Follow-up|3|||
164357250|NCT03318315|593684281|FG001|Overall Study|Lost to Follow-up|2|||
164357251|NCT03318315|593684282|FG002|Overall Study|Lost to Follow-up|1|||
164357252|NCT03318315|593684280|FG000|Overall Study|Protocol Violation|1|||
164357253|NCT03318315|593684281|FG001|Overall Study|Protocol Violation|1|||
164357254|NCT03318315|593684282|FG002|Overall Study|Protocol Violation|1|||
164357255|NCT03318315|593684280|FG000|Overall Study|Withdrawal by Subject|0|||
164357256|NCT03318315|593684281|FG001|Overall Study|Withdrawal by Subject|0|||
164357257|NCT03318315|593684282|FG002|Overall Study|Withdrawal by Subject|2|||
164357258|NCT02968563|593684283|FG000|Overall Study|Adverse Event|0|||
164357259|NCT02968563|593684284|FG001|Overall Study|Adverse Event|6|||
164357260|NCT02968563|593684283|FG000|Overall Study|Death|1|||
164357261|NCT02968563|593684284|FG001|Overall Study|Death|1|||
164357262|NCT02968563|593684283|FG000|Overall Study|Lost to Follow-up|0|||
164357263|NCT02968563|593684284|FG001|Overall Study|Lost to Follow-up|1|||
164357264|NCT00674661|593684285|FG000|Overall Study|Other|5|||
164357265|NCT00674661|593684286|FG001|Overall Study|Other|7|||
164357266|NCT00674661|593684285|FG000|Overall Study|Lost to Follow-up|6|||
164357267|NCT00674661|593684286|FG001|Overall Study|Lost to Follow-up|3|||
164357268|NCT00674661|593684285|FG000|Overall Study|Withdrawal by Subject|0|||
164357269|NCT00674661|593684286|FG001|Overall Study|Withdrawal by Subject|5|||
164357270|NCT02617511|593684291|FG000|Overall Study|Withdrawal by Subject|1|||
164357271|NCT02617511|593684292|FG001|Overall Study|Withdrawal by Subject|0|||
164357272|NCT00811473|593684293|FG000|Overall Study|Adverse Event|3|||
164357273|NCT00811473|593684294|FG001|Overall Study|Adverse Event|12|||
164357274|NCT00811473|593684293|FG000|Overall Study|Lost to Follow-up|5|||
164357275|NCT00811473|593684294|FG001|Overall Study|Lost to Follow-up|1|||
164357276|NCT00811473|593684293|FG000|Overall Study|Withdrawal by Subject|2|||
164357277|NCT00811473|593684294|FG001|Overall Study|Withdrawal by Subject|4|||
164357278|NCT00811473|593684293|FG000|Overall Study|Severe non-compliance to protocol|2|||
164357279|NCT00811473|593684294|FG001|Overall Study|Severe non-compliance to protocol|4|||
164357280|NCT00811473|593684293|FG000|Overall Study|Lack of therapeutic response|4|||
164357281|NCT00811473|593684294|FG001|Overall Study|Lack of therapeutic response|1|||
164357282|NCT00811473|593684293|FG000|Overall Study|Condition under investigation worsened|1|||
164357283|NCT00811473|593684294|FG001|Overall Study|Condition under investigation worsened|3|||
164357284|NCT00811473|593684293|FG000|Overall Study|Other 2|4|||
164357285|NCT00811473|593684294|FG001|Overall Study|Other 2|1|||
164357286|NCT00811473|593684293|FG000|Overall Study|Incorrect Enrollment|1|||
164357287|NCT00811473|593684294|FG001|Overall Study|Incorrect Enrollment|0|||
164357288|NCT00811473|593684293|FG000|Overall Study|Safety Reasons|1|||
164357289|NCT00811473|593684294|FG001|Overall Study|Safety Reasons|0|||
164357290|NCT01119131|593684298|FG000|Overall Study|Adverse Event|1|||
164357291|NCT01119131|593684299|FG001|Overall Study|Adverse Event|1|||
164357292|NCT01119131|593684300|FG002|Overall Study|Adverse Event|1|||
164357293|NCT01119131|593684298|FG000|Overall Study|Non-Compliance|1|||
164357294|NCT01119131|593684299|FG001|Overall Study|Non-Compliance|0|||
164357295|NCT01119131|593684300|FG002|Overall Study|Non-Compliance|4|||
164357296|NCT01119131|593684298|FG000|Overall Study|Physician Decision|0|||
164357297|NCT01119131|593684299|FG001|Overall Study|Physician Decision|0|||
164357298|NCT01119131|593684300|FG002|Overall Study|Physician Decision|1|||
164357299|NCT01909479|593684301|FG000|From Baseline to Week 26|Adverse Event|3|||
164357300|NCT01909479|593684302|FG001|From Baseline to Week 26|Adverse Event|2|||
164357301|NCT01909479|593684301|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
164357302|NCT01909479|593684302|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
164357303|NCT01909479|593684301|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
164357304|NCT01909479|593684302|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
164357305|NCT01909479|593684301|FG000|26 - 52 Weeks|Adverse Event|0|||
164357306|NCT01909479|593684302|FG001|26 - 52 Weeks|Adverse Event|1|||
164357307|NCT01909479|593684301|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
164357308|NCT01909479|593684302|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
164357309|NCT01909479|593684301|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
164357310|NCT01909479|593684302|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
164357311|NCT01909479|593684301|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
164357312|NCT01909479|593684302|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
164357313|NCT01909479|593684301|FG000|52 Weeks to End of Study|Adverse Event|2|||
164357314|NCT01909479|593684302|FG001|52 Weeks to End of Study|Adverse Event|1|||
164357315|NCT01909479|593684301|FG000|52 Weeks to End of Study|Death|0|||
164357316|NCT01909479|593684302|FG001|52 Weeks to End of Study|Death|1|||
164357317|NCT01909479|593684301|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
164357318|NCT01909479|593684302|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
164357319|NCT01909479|593684301|FG000|52 Weeks to End of Study|Protocol Violation|1|||
164357320|NCT01909479|593684302|FG001|52 Weeks to End of Study|Protocol Violation|0|||
164357321|NCT01909479|593684301|FG000|52 Weeks to End of Study|Progressive disease|1|||
164357322|NCT01909479|593684302|FG001|52 Weeks to End of Study|Progressive disease|1|||
164357323|NCT01909479|593684301|FG000|52 Weeks to End of Study|Personal reasons|2|||
164357324|NCT01909479|593684302|FG001|52 Weeks to End of Study|Personal reasons|1|||
164357325|NCT01909479|593684301|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
164357326|NCT01909479|593684302|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
164357327|NCT01909479|593684301|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
164357328|NCT01909479|593684302|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
164357329|NCT01909479|593684301|FG000|52 Weeks to End of Study|Lack of contact|1|||
164357330|NCT01909479|593684302|FG001|52 Weeks to End of Study|Lack of contact|0|||
164357331|NCT01909479|593684301|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
164357332|NCT01909479|593684302|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
164357333|NCT01909479|593684301|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
164357334|NCT01909479|593684302|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
164357335|NCT01187043|593684304|FG000|Overall Study|Adverse Event|0|||
164357336|NCT01187043|593684305|FG001|Overall Study|Adverse Event|0|||
164357337|NCT01187043|593684306|FG002|Overall Study|Adverse Event|0|||
164357338|NCT01187043|593684307|FG003|Overall Study|Adverse Event|0|||
164357339|NCT01187043|593684308|FG004|Overall Study|Adverse Event|1|||
164357340|NCT01187043|593684304|FG000|Overall Study|Unable to make scheduled visits|1|||
164437894|NCT01212757|593968257|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
164437895|NCT01212757|593968258|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
164437896|NCT01212757|593968259|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
164437897|NCT01212757|593968251|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
164437898|NCT01212757|593968252|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
164437899|NCT01212757|593968253|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
164357341|NCT01187043|593684305|FG001|Overall Study|Unable to make scheduled visits|0|||
164357342|NCT01187043|593684306|FG002|Overall Study|Unable to make scheduled visits|4|||
164357343|NCT01187043|593684307|FG003|Overall Study|Unable to make scheduled visits|0|||
164437900|NCT01212757|593968254|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
164437901|NCT01212757|593968255|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
164357344|NCT01187043|593684308|FG004|Overall Study|Unable to make scheduled visits|1|||
164357345|NCT00927784|593684313|FG000|Overall Study|Death|1|||
164357346|NCT00927784|593684314|FG001|Overall Study|Death|0|||
164357347|NCT00927784|593684313|FG000|Overall Study|Withdrawal by Subject|1|||
164357348|NCT00927784|593684314|FG001|Overall Study|Withdrawal by Subject|0|||
164357349|NCT02457910|593684315|FG000|Overall Study|Withdrawal by Subject|0|||
164357350|NCT02457910|593684316|FG001|Overall Study|Withdrawal by Subject|0|||
164357351|NCT02457910|593684317|FG002|Overall Study|Withdrawal by Subject|0|||
164357352|NCT02457910|593684318|FG003|Overall Study|Withdrawal by Subject|0|||
164357353|NCT02457910|593684319|FG004|Overall Study|Withdrawal by Subject|0|||
164357354|NCT02457910|593684320|FG005|Overall Study|Withdrawal by Subject|1|||
164357355|NCT02457910|593684315|FG000|Overall Study|Adverse Event|0|||
164357356|NCT02457910|593684316|FG001|Overall Study|Adverse Event|2|||
164357357|NCT02457910|593684317|FG002|Overall Study|Adverse Event|1|||
164357358|NCT02457910|593684318|FG003|Overall Study|Adverse Event|1|||
164357359|NCT02457910|593684319|FG004|Overall Study|Adverse Event|1|||
164357360|NCT02457910|593684320|FG005|Overall Study|Adverse Event|3|||
164357361|NCT02457910|593684315|FG000|Overall Study|Disease progression|3|||
164357362|NCT02457910|593684316|FG001|Overall Study|Disease progression|3|||
164357363|NCT02457910|593684317|FG002|Overall Study|Disease progression|1|||
164357364|NCT02457910|593684318|FG003|Overall Study|Disease progression|1|||
164357365|NCT02457910|593684319|FG004|Overall Study|Disease progression|4|||
164357366|NCT02457910|593684320|FG005|Overall Study|Disease progression|6|||
164357367|NCT02457910|593684315|FG000|Overall Study|Other complicating illness|0|||
164357368|NCT02457910|593684316|FG001|Overall Study|Other complicating illness|0|||
164357369|NCT02457910|593684317|FG002|Overall Study|Other complicating illness|0|||
164357370|NCT02457910|593684318|FG003|Overall Study|Other complicating illness|0|||
164357371|NCT02457910|593684319|FG004|Overall Study|Other complicating illness|0|||
164357372|NCT02457910|593684320|FG005|Overall Study|Other complicating illness|1|||
164357373|NCT02457910|593684315|FG000|Overall Study|Death|0|||
164357374|NCT02457910|593684316|FG001|Overall Study|Death|0|||
164357375|NCT02457910|593684317|FG002|Overall Study|Death|1|||
164357376|NCT02457910|593684318|FG003|Overall Study|Death|0|||
164357377|NCT02457910|593684319|FG004|Overall Study|Death|0|||
164357378|NCT02457910|593684320|FG005|Overall Study|Death|0|||
164357379|NCT00467259|593684321|FG000|Overall Study|Adverse Event|24|||
164357380|NCT00467259|593684322|FG001|Overall Study|Adverse Event|90|||
164357381|NCT00467259|593684321|FG000|Overall Study|Protocol Violation|1|||
164357382|NCT00467259|593684322|FG001|Overall Study|Protocol Violation|7|||
164357383|NCT00467259|593684321|FG000|Overall Study|Withdrawal by Subject|34|||
164357384|NCT00467259|593684322|FG001|Overall Study|Withdrawal by Subject|108|||
164357385|NCT00467259|593684321|FG000|Overall Study|Physician Decision|0|||
164357386|NCT00467259|593684322|FG001|Overall Study|Physician Decision|2|||
164357387|NCT00467259|593684321|FG000|Overall Study|Lost to Follow-up|14|||
164357388|NCT00467259|593684322|FG001|Overall Study|Lost to Follow-up|34|||
164357389|NCT00467259|593684321|FG000|Overall Study|Site Closed|2|||
164357390|NCT00467259|593684322|FG001|Overall Study|Site Closed|1|||
164357391|NCT02196558|593684323|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
164357392|NCT02196558|593684324|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
164357393|NCT02196558|593684325|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
164357394|NCT02196558|593684323|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
164357395|NCT02196558|593684324|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
164357396|NCT02196558|593684325|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
164357397|NCT02196558|593684323|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
164357398|NCT02196558|593684324|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
164357399|NCT02196558|593684325|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
164357400|NCT02196558|593684323|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
164357401|NCT02196558|593684324|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
164357402|NCT02196558|593684325|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
164357403|NCT02196558|593684323|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
164357404|NCT02196558|593684324|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
164357405|NCT02196558|593684325|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
164357406|NCT01339429|593684329|FG000|Overall Study|Withdrawal by Subject|1|||
164357407|NCT01339429|593684329|FG000|Overall Study|Physician Decision|3|||
164437902|NCT01212757|593968256|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
164437903|NCT01212757|593968257|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
164696276|NCT02939950|594910637|FG000|Overall Study|Study related symptoms|8|||
164696277|NCT02939950|594910638|FG001|Overall Study|Study related symptoms|8|||
164696278|NCT02939950|594910637|FG000|Overall Study|Unacceptable lens movement|2|||
164696279|NCT02939950|594910638|FG001|Overall Study|Unacceptable lens movement|0|||
164696280|NCT02939950|594910637|FG000|Overall Study|Protocol Violation|6|||
164696281|NCT02939950|594910638|FG001|Overall Study|Protocol Violation|3|||
164357408|NCT00459667|593684330|FG000|Overall Study|Adverse Event|9|||
164357409|NCT00459667|593684331|FG001|Overall Study|Adverse Event|12|||
164357410|NCT00459667|593684332|FG002|Overall Study|Adverse Event|8|||
164357411|NCT00459667|593684330|FG000|Overall Study|Lost to Follow-up|5|||
164357412|NCT00459667|593684331|FG001|Overall Study|Lost to Follow-up|9|||
164357413|NCT00459667|593684332|FG002|Overall Study|Lost to Follow-up|3|||
164357414|NCT00459667|593684330|FG000|Overall Study|Pregnancy|1|||
164357415|NCT00459667|593684331|FG001|Overall Study|Pregnancy|1|||
164357416|NCT00459667|593684332|FG002|Overall Study|Pregnancy|1|||
164357417|NCT00459667|593684330|FG000|Overall Study|Protocol Violation|1|||
164696282|NCT02939950|594910637|FG000|Overall Study|Physician Decision|2|||
164696283|NCT02939950|594910638|FG001|Overall Study|Physician Decision|0|||
164357418|NCT00459667|593684331|FG001|Overall Study|Protocol Violation|0|||
164357419|NCT00459667|593684332|FG002|Overall Study|Protocol Violation|0|||
164357420|NCT00459667|593684330|FG000|Overall Study|Withdrawal by Subject|3|||
164357421|NCT00459667|593684331|FG001|Overall Study|Withdrawal by Subject|5|||
164357422|NCT00459667|593684332|FG002|Overall Study|Withdrawal by Subject|5|||
164357423|NCT00459667|593684330|FG000|Overall Study|Other disease modifying treatment|1|||
164357424|NCT00459667|593684331|FG001|Overall Study|Other disease modifying treatment|2|||
164357425|NCT00459667|593684332|FG002|Overall Study|Other disease modifying treatment|1|||
164357426|NCT00459667|593684330|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
164357427|NCT00459667|593684331|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
164357428|NCT00459667|593684332|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
164357429|NCT00459667|593684330|FG000|Overall Study|No treatment administered|6|||
164357430|NCT00459667|593684331|FG001|Overall Study|No treatment administered|3|||
164357431|NCT00459667|593684332|FG002|Overall Study|No treatment administered|1|||
164357432|NCT01013701|593684333|FG000|Overall Study|study prematurely terminated|7|||
164357433|NCT00556712|593684335|FG000|Overall Study|Adverse Event|7|||
164357434|NCT00556712|593684336|FG001|Overall Study|Adverse Event|19|||
164357435|NCT00556712|593684335|FG000|Overall Study|Death|5|||
164357436|NCT00556712|593684336|FG001|Overall Study|Death|10|||
164357437|NCT00556712|593684335|FG000|Overall Study|Progressive Disease|383|||
164357438|NCT00556712|593684336|FG001|Overall Study|Progressive Disease|320|||
164357439|NCT00556712|593684335|FG000|Overall Study|Protocol Violation|3|||
164357440|NCT00556712|593684336|FG001|Overall Study|Protocol Violation|2|||
164357441|NCT00556712|593684335|FG000|Overall Study|Refused Treatment|17|||
164357442|NCT00556712|593684336|FG001|Overall Study|Refused Treatment|16|||
164357443|NCT00556712|593684335|FG000|Overall Study|Failure to Return|2|||
164357444|NCT00556712|593684336|FG001|Overall Study|Failure to Return|3|||
164357445|NCT00556712|593684335|FG000|Overall Study|Other|2|||
164357446|NCT00556712|593684336|FG001|Overall Study|Other|2|||
164357447|NCT00556712|593684335|FG000|Overall Study|Ongoing at Data Cutoff|32|||
164357448|NCT00556712|593684336|FG001|Overall Study|Ongoing at Data Cutoff|66|||
164357449|NCT01059799|593684339|FG000|Overall Study|Adverse Event|2|||
164357450|NCT01059799|593684340|FG001|Overall Study|Adverse Event|3|||
164357451|NCT01059799|593684339|FG000|Overall Study|Lack of Efficacy|1|||
164357452|NCT01059799|593684340|FG001|Overall Study|Lack of Efficacy|0|||
164357453|NCT01059799|593684339|FG000|Overall Study|Protocol Violation|3|||
164357454|NCT01059799|593684340|FG001|Overall Study|Protocol Violation|2|||
164357455|NCT01059799|593684339|FG000|Overall Study|Withdrawal criteria|13|||
164357456|NCT01059799|593684340|FG001|Overall Study|Withdrawal criteria|2|||
164357457|NCT01059799|593684339|FG000|Overall Study|Other|12|||
164357458|NCT01059799|593684340|FG001|Overall Study|Other|3|||
164357459|NCT01361464|593684341|FG000|Overall Study|Death|1|||
164357460|NCT01361464|593684341|FG000|Overall Study|Withdrawal by Subject|2|||
164357461|NCT01722071|593684346|FG000|Overall Study|Protocol Violation|1|||
164357462|NCT01722071|593684347|FG001|Overall Study|Protocol Violation|0|||
164357463|NCT01106898|593684348|FG000|Overall Study|Adverse Event|6|||
164357464|NCT03021265|593684349|FG000|Overall Study|Adverse Event|29|||
164357465|NCT03021265|593684349|FG000|Overall Study|Lack of Efficacy|3|||
164357466|NCT03021265|593684349|FG000|Overall Study|Improved|17|||
164357467|NCT03021265|593684349|FG000|Overall Study|Lost to Follow-up|67|||
164357468|NCT03021265|593684349|FG000|Overall Study|No reason given|2|||
164357469|NCT03021265|593684349|FG000|Overall Study|No visit since the first visit|4|||
164357470|NCT00818662|593684350|FG000|Overall Study|Adverse Event|5|||
164357471|NCT00818662|593684351|FG001|Overall Study|Adverse Event|14|||
164357472|NCT00818662|593684352|FG002|Overall Study|Adverse Event|4|||
164357473|NCT00818662|593684353|FG003|Overall Study|Adverse Event|3|||
164357474|NCT00818662|593684350|FG000|Overall Study|Withdrawal by Subject|5|||
164357475|NCT00818662|593684351|FG001|Overall Study|Withdrawal by Subject|4|||
164357476|NCT00818662|593684352|FG002|Overall Study|Withdrawal by Subject|2|||
164437904|NCT01212757|593968258|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
164437905|NCT01212757|593968259|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
164696284|NCT02939950|594910637|FG000|Overall Study|Pregnancy|6|||
164696285|NCT02939950|594910638|FG001|Overall Study|Pregnancy|7|||
164696286|NCT02939950|594910637|FG000|Overall Study|Withdrawal by Subject|12|||
164357477|NCT00818662|593684353|FG003|Overall Study|Withdrawal by Subject|2|||
164357478|NCT00818662|593684350|FG000|Overall Study|Death|1|||
164357479|NCT00818662|593684351|FG001|Overall Study|Death|3|||
164357480|NCT00818662|593684352|FG002|Overall Study|Death|0|||
164357481|NCT00818662|593684353|FG003|Overall Study|Death|0|||
164357482|NCT00818662|593684350|FG000|Overall Study|Physician Decision|1|||
164437906|NCT01212757|593968251|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
164696287|NCT02939950|594910638|FG001|Overall Study|Withdrawal by Subject|28|||
164357483|NCT00818662|593684351|FG001|Overall Study|Physician Decision|0|||
164357484|NCT00818662|593684352|FG002|Overall Study|Physician Decision|0|||
164357485|NCT00818662|593684353|FG003|Overall Study|Physician Decision|0|||
164357486|NCT00818662|593684350|FG000|Overall Study|Lost to Follow-up|0|||
164357487|NCT00818662|593684351|FG001|Overall Study|Lost to Follow-up|0|||
164357488|NCT00818662|593684352|FG002|Overall Study|Lost to Follow-up|0|||
164357489|NCT00818662|593684353|FG003|Overall Study|Lost to Follow-up|1|||
164357490|NCT00818662|593684350|FG000|Overall Study|Unwilling or Unable to Participate|4|||
164357491|NCT00818662|593684351|FG001|Overall Study|Unwilling or Unable to Participate|6|||
164357492|NCT00818662|593684352|FG002|Overall Study|Unwilling or Unable to Participate|2|||
164357493|NCT00818662|593684353|FG003|Overall Study|Unwilling or Unable to Participate|4|||
164357494|NCT00818662|593684350|FG000|Overall Study|Protocol Violation|1|||
164357495|NCT00818662|593684351|FG001|Overall Study|Protocol Violation|1|||
164357496|NCT00818662|593684352|FG002|Overall Study|Protocol Violation|0|||
164357497|NCT00818662|593684353|FG003|Overall Study|Protocol Violation|0|||
164357498|NCT00818662|593684350|FG000|Overall Study|Requires a Prohibited Medication|1|||
164357499|NCT00818662|593684351|FG001|Overall Study|Requires a Prohibited Medication|0|||
164357500|NCT00818662|593684352|FG002|Overall Study|Requires a Prohibited Medication|0|||
164357501|NCT00818662|593684353|FG003|Overall Study|Requires a Prohibited Medication|0|||
164357502|NCT00818662|593684350|FG000|Overall Study|Safety Risk|1|||
164357503|NCT00818662|593684351|FG001|Overall Study|Safety Risk|1|||
164357504|NCT00818662|593684352|FG002|Overall Study|Safety Risk|0|||
164357505|NCT00818662|593684353|FG003|Overall Study|Safety Risk|1|||
164357506|NCT00818662|593684350|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
164357507|NCT00818662|593684351|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
164357508|NCT00818662|593684352|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
164357509|NCT00818662|593684353|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
164357510|NCT00818662|593684350|FG000|Overall Study|Participant's health declined|0|||
164357511|NCT00818662|593684351|FG001|Overall Study|Participant's health declined|0|||
164357512|NCT00818662|593684352|FG002|Overall Study|Participant's health declined|0|||
164357513|NCT00818662|593684353|FG003|Overall Study|Participant's health declined|1|||
164357514|NCT00818662|593684350|FG000|Overall Study|Caregiver to pursue other treatment|0|||
164357515|NCT00818662|593684351|FG001|Overall Study|Caregiver to pursue other treatment|1|||
164357516|NCT00818662|593684352|FG002|Overall Study|Caregiver to pursue other treatment|0|||
164357517|NCT00818662|593684353|FG003|Overall Study|Caregiver to pursue other treatment|0|||
164357518|NCT00818662|593684350|FG000|Overall Study|Moving out of state|0|||
164357519|NCT00818662|593684351|FG001|Overall Study|Moving out of state|0|||
164357520|NCT00818662|593684352|FG002|Overall Study|Moving out of state|0|||
164357521|NCT00818662|593684353|FG003|Overall Study|Moving out of state|1|||
164357522|NCT00818662|593684350|FG000|Overall Study|Declined move to another study site|1|||
164357523|NCT00818662|593684351|FG001|Overall Study|Declined move to another study site|0|||
164357524|NCT00818662|593684352|FG002|Overall Study|Declined move to another study site|0|||
164357525|NCT00818662|593684353|FG003|Overall Study|Declined move to another study site|0|||
164357526|NCT00818662|593684350|FG000|Overall Study|Change in living situation|0|||
164357527|NCT00818662|593684351|FG001|Overall Study|Change in living situation|0|||
164357528|NCT00818662|593684352|FG002|Overall Study|Change in living situation|0|||
164357529|NCT00818662|593684353|FG003|Overall Study|Change in living situation|1|||
164357530|NCT00818662|593684350|FG000|Overall Study|Study partner decision|0|||
164357531|NCT00818662|593684351|FG001|Overall Study|Study partner decision|0|||
164357532|NCT00818662|593684352|FG002|Overall Study|Study partner decision|0|||
164357533|NCT00818662|593684353|FG003|Overall Study|Study partner decision|1|||
164357534|NCT00818662|593684350|FG000|Overall Study|Admitted to long term nursing care|0|||
164357535|NCT00818662|593684351|FG001|Overall Study|Admitted to long term nursing care|1|||
164357536|NCT00818662|593684352|FG002|Overall Study|Admitted to long term nursing care|0|||
164357537|NCT00818662|593684353|FG003|Overall Study|Admitted to long term nursing care|0|||
164357538|NCT01338493|593684354|FG000|Enrolled|Withdrawal by Subject|1|||
164357539|NCT01338493|593684354|FG000|Enrolled|Patient not implanted|4|||
164357540|NCT01338493|593684354|FG000|Discharge|Death|1|||
164357541|NCT01338493|593684354|FG000|Discharge|Missed visit|1|||
164357542|NCT01338493|593684354|FG000|6 Months Follow up|Lost to Follow-up|11|||
164357543|NCT01338493|593684354|FG000|6 Months Follow up|Missed visit|8|||
164357544|NCT01338493|593684354|FG000|12 Months Follow up|Lost to Follow-up|9|||
164357545|NCT01846611|593684355|FG000|Overall Study|Lost to Follow-up|4|||
164357546|NCT01846611|593684356|FG001|Overall Study|Lost to Follow-up|6|||
164357547|NCT01846611|593684355|FG000|Overall Study|Withdrawal by Subject|15|||
164357548|NCT01846611|593684356|FG001|Overall Study|Withdrawal by Subject|19|||
164357549|NCT01846611|593684355|FG000|Overall Study|Other|19|||
164437907|NCT01212757|593968252|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
164696288|NCT02939950|594910637|FG000|Overall Study|Adverse Event|7|||
164437908|NCT01212757|593968253|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
164696289|NCT02939950|594910638|FG001|Overall Study|Adverse Event|3|||
164696290|NCT02939950|594910637|FG000|Overall Study|Randomized, not dispensed|1|||
164696291|NCT02939950|594910638|FG001|Overall Study|Randomized, not dispensed|0|||
164696292|NCT02939950|594910637|FG000|Overall Study|Ineligible at Baseline|2|||
164696293|NCT02939950|594910638|FG001|Overall Study|Ineligible at Baseline|8|||
164357550|NCT01846611|593684356|FG001|Overall Study|Other|18|||
164357551|NCT00541034|593684357|FG000|Overall Study|Non-Compliance|3|||
164357552|NCT01614067|593684358|FG000|Overall Study|Pregnancy|1|||
164357553|NCT01614067|593684359|FG001|Overall Study|Pregnancy|0|||
164357554|NCT01614067|593684358|FG000|Overall Study|Physician Decision|6|||
164437909|NCT01212757|593968254|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
164357555|NCT01614067|593684359|FG001|Overall Study|Physician Decision|5|||
164357556|NCT01614067|593684358|FG000|Overall Study|Withdrawal by Subject|0|||
164357557|NCT01614067|593684359|FG001|Overall Study|Withdrawal by Subject|1|||
164357558|NCT01614067|593684358|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
164357559|NCT01614067|593684359|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
164357560|NCT00847704|593684360|FG000|Overall Study|Withdrawal by Subject|1|||
164357561|NCT02289079|593684366|FG000|Overall Study|Physician Decision|2|||
164357562|NCT02289079|593684367|FG001|Overall Study|Physician Decision|0|||
164357563|NCT02289079|593684366|FG000|Overall Study|Lost to Follow-up|0|||
164357564|NCT02289079|593684367|FG001|Overall Study|Lost to Follow-up|1|||
164357565|NCT02671422|593684368|FG000|Overall Study|Lost to Follow-up|1|||
164357566|NCT02671422|593684368|FG000|Overall Study|Adverse Event|68|||
164357567|NCT02671422|593684368|FG000|Overall Study|Lack of Efficacy|1|||
164357568|NCT02671422|593684368|FG000|Overall Study|Lost to Follow-up|4|||
164357569|NCT02671422|593684368|FG000|Overall Study|Withdrawal by Subject|7|||
164357570|NCT02671422|593684368|FG000|Overall Study|Progressive Disease|156|||
164357571|NCT02671422|593684368|FG000|Overall Study|Worsening of Disease|4|||
164357572|NCT02671422|593684368|FG000|Overall Study|Sponsor decision|5|||
164357573|NCT02671422|593684368|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
164357574|NCT02671422|593684368|FG000|Overall Study|Not treated with Vargatef®|3|||
164357575|NCT02671422|593684368|FG000|Overall Study|Other not defined above|3|||
164357576|NCT02111850|593684369|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
164357577|NCT02111850|593684370|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
164357578|NCT02111850|593684371|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
164357579|NCT02111850|593684372|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
164357580|NCT02111850|593684373|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
164357581|NCT02111850|593684374|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
164357582|NCT02111850|593684375|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
164357583|NCT02111850|593684376|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
164357584|NCT02111850|593684377|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
164357585|NCT02111850|593684378|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
164357586|NCT02111850|593684379|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
164357587|NCT03061331|593684380|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
164357588|NCT03061331|593684381|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
164357589|NCT02625259|593684382|FG000|First Intervention (Day 1)|Other|0|||
164357590|NCT02625259|593684383|FG001|First Intervention (Day 1)|Other|0|||
164357591|NCT02625259|593684384|FG002|First Intervention (Day 1)|Other|1|||
164357592|NCT02625259|593684385|FG003|First Intervention (Day 1)|Other|0|||
164357593|NCT02625259|593684386|FG004|First Intervention (Day 1)|Other|0|||
164357594|NCT02625259|593684382|FG000|First Intervention (Day 1)|Adverse Event|2|||
164357595|NCT02625259|593684383|FG001|First Intervention (Day 1)|Adverse Event|1|||
164357596|NCT02625259|593684384|FG002|First Intervention (Day 1)|Adverse Event|0|||
164357597|NCT02625259|593684385|FG003|First Intervention (Day 1)|Adverse Event|0|||
164357598|NCT02625259|593684386|FG004|First Intervention (Day 1)|Adverse Event|0|||
164357599|NCT02625259|593684382|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
164357600|NCT02625259|593684383|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
164357601|NCT02625259|593684384|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
164357602|NCT02625259|593684385|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
164357603|NCT02625259|593684386|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
164357604|NCT00513474|593684387|FG000|Overall Study|Death|6|||
164357605|NCT00513474|593684388|FG001|Overall Study|Death|9|||
164357606|NCT00513474|593684387|FG000|Overall Study|Participant Withdrew Consent|1|||
164357607|NCT00513474|593684388|FG001|Overall Study|Participant Withdrew Consent|0|||
164437910|NCT01212757|593968255|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
164437911|NCT01212757|593968256|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
164437912|NCT01212757|593968257|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
164437913|NCT01212757|593968258|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
164437914|NCT01212757|593968259|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
164437915|NCT01212757|593968251|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
164437916|NCT01212757|593968252|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
164437917|NCT01212757|593968253|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
164437918|NCT01212757|593968254|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
164437919|NCT01212757|593968255|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
164590099|NCT00227877|594523155|FG003|12-months Follow-up|Completed late|0|||
164590100|NCT00227877|594523152|FG000|12-months Follow-up|Lost to Follow-up|232|||
164357608|NCT04772755|593684389|FG000|Overall Study|Withdrawal by Subject|1|||
164437920|NCT01212757|593968256|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
164590101|NCT00227877|594523153|FG001|12-months Follow-up|Lost to Follow-up|189|||
164590102|NCT00227877|594523154|FG002|12-months Follow-up|Lost to Follow-up|30|||
164696294|NCT02243293|594910639|FG000|Overall Study|Adverse Event|1|||
164357609|NCT04772755|593684390|FG001|Overall Study|Withdrawal by Subject|0|||
164357610|NCT04772755|593684389|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
164357611|NCT04772755|593684390|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
164357612|NCT00195676|593684392|FG000|Period O - Open-label Treatment|Adverse Event|82|||
164357613|NCT00195676|593684392|FG000|Period O - Open-label Treatment|Death|6|||
164357614|NCT00195676|593684392|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
164357615|NCT00195676|593684392|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
164357616|NCT00195676|593684392|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
164357617|NCT00195676|593684392|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
164357618|NCT00195676|593684392|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
164357619|NCT00195676|593684392|FG000|Period O - Open-label Treatment|Other reasons|68|||
164357620|NCT00195676|593684392|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
164357621|NCT00195676|593684392|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
164357622|NCT00195676|593684392|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
164357623|NCT00195676|593684392|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
164357624|NCT00195676|593684392|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
164357625|NCT00195676|593684392|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
164357626|NCT00195676|593684392|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
164357627|NCT00195676|593684392|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
164357628|NCT00195676|593684392|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
164357629|NCT00195676|593684392|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
164357630|NCT00195676|593684392|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
164357631|NCT00195676|593684392|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
164357632|NCT00195676|593684392|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
164357633|NCT01189812|593684393|FG000|Overall Study|Withdrawal by Subject|2|||
164357634|NCT01189812|593684394|FG001|Overall Study|Withdrawal by Subject|3|||
164357635|NCT01189812|593684393|FG000|Overall Study|Adverse Event|1|||
164357636|NCT01189812|593684394|FG001|Overall Study|Adverse Event|0|||
164357637|NCT01189812|593684393|FG000|Overall Study|Out of Window|4|||
164357638|NCT01189812|593684394|FG001|Overall Study|Out of Window|3|||
164357639|NCT01189812|593684393|FG000|Overall Study|Moved out of State|1|||
164357640|NCT01189812|593684394|FG001|Overall Study|Moved out of State|2|||
164357641|NCT03761147|593684395|FG000|Overall Study|Withdrawal by Subject|6|||
164357642|NCT03761147|593684396|FG001|Overall Study|Withdrawal by Subject|1|||
164357643|NCT03761147|593684395|FG000|Overall Study|Adverse Event|1|||
164357644|NCT03761147|593684396|FG001|Overall Study|Adverse Event|3|||
164357645|NCT04080297|593684397|FG000|Overall Study|Adverse Event|1|||
164357646|NCT04080297|593684398|FG001|Overall Study|Adverse Event|3|||
164357647|NCT04080297|593684397|FG000|Overall Study|concurrent illness|1|||
164357648|NCT04080297|593684398|FG001|Overall Study|concurrent illness|0|||
164357649|NCT02744391|593684399|FG000|Overall Study|Lost to Follow-up|9|||
164357650|NCT02744391|593684399|FG000|Overall Study|Physician Decision|2|||
164357651|NCT02744391|593684399|FG000|Overall Study|Withdrawal by Subject|3|||
164357652|NCT05838742|593684400|FG000|Overall Study|Adverse Event|2|||
164357653|NCT05838742|593684401|FG001|Overall Study|Adverse Event|0|||
164357654|NCT05838742|593684402|FG002|Overall Study|Adverse Event|1|||
164357655|NCT05838742|593684403|FG003|Overall Study|Adverse Event|0|||
164357656|NCT05838742|593684404|FG004|Overall Study|Adverse Event|1|||
164357657|NCT05838742|593684400|FG000|Overall Study|Lost to Follow-up|1|||
164357658|NCT05838742|593684401|FG001|Overall Study|Lost to Follow-up|1|||
164357659|NCT05838742|593684402|FG002|Overall Study|Lost to Follow-up|1|||
164357660|NCT05838742|593684403|FG003|Overall Study|Lost to Follow-up|0|||
164357661|NCT05838742|593684404|FG004|Overall Study|Lost to Follow-up|0|||
164357662|NCT05838742|593684400|FG000|Overall Study|Physician Decision|0|||
164357663|NCT05838742|593684401|FG001|Overall Study|Physician Decision|0|||
164357664|NCT05838742|593684402|FG002|Overall Study|Physician Decision|0|||
164357665|NCT05838742|593684403|FG003|Overall Study|Physician Decision|0|||
164357666|NCT05838742|593684404|FG004|Overall Study|Physician Decision|1|||
164357667|NCT05838742|593684400|FG000|Overall Study|Withdrawal by Subject|8|||
164357668|NCT05838742|593684401|FG001|Overall Study|Withdrawal by Subject|3|||
164357669|NCT05838742|593684402|FG002|Overall Study|Withdrawal by Subject|3|||
164357670|NCT05838742|593684403|FG003|Overall Study|Withdrawal by Subject|1|||
164357671|NCT05838742|593684404|FG004|Overall Study|Withdrawal by Subject|4|||
164357672|NCT05838742|593684400|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|68|||
164357673|NCT05838742|593684401|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
164357674|NCT05838742|593684402|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|33|||
164357675|NCT05838742|593684403|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
164357676|NCT05838742|593684404|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|32|||
164357677|NCT05838742|593684400|FG000|Overall Study|Lack of Efficacy|0|||
164357678|NCT05838742|593684401|FG001|Overall Study|Lack of Efficacy|0|||
164357679|NCT05838742|593684402|FG002|Overall Study|Lack of Efficacy|0|||
164357680|NCT05838742|593684403|FG003|Overall Study|Lack of Efficacy|1|||
164357681|NCT05838742|593684404|FG004|Overall Study|Lack of Efficacy|0|||
164357682|NCT05838742|593684400|FG000|Overall Study|Randomized, not treated|2|||
164357683|NCT05838742|593684401|FG001|Overall Study|Randomized, not treated|1|||
164357684|NCT05838742|593684402|FG002|Overall Study|Randomized, not treated|0|||
164357685|NCT05838742|593684403|FG003|Overall Study|Randomized, not treated|1|||
164357686|NCT05838742|593684404|FG004|Overall Study|Randomized, not treated|0|||
164357687|NCT02045797|593684405|FG000|Overall Study|Adverse Event|3|||
164357688|NCT02045797|593684406|FG001|Overall Study|Adverse Event|1|||
164357689|NCT02045797|593684407|FG002|Overall Study|Adverse Event|0|||
164357690|NCT02045797|593684405|FG000|Overall Study|Lack of Efficacy|1|||
164357691|NCT02045797|593684406|FG001|Overall Study|Lack of Efficacy|0|||
164357692|NCT02045797|593684407|FG002|Overall Study|Lack of Efficacy|0|||
164357693|NCT02045797|593684405|FG000|Overall Study|Lost to Follow-up|2|||
164357694|NCT02045797|593684406|FG001|Overall Study|Lost to Follow-up|3|||
164357695|NCT02045797|593684407|FG002|Overall Study|Lost to Follow-up|1|||
164357696|NCT02045797|593684405|FG000|Overall Study|Physician Decision|0|||
164357697|NCT02045797|593684406|FG001|Overall Study|Physician Decision|1|||
164357698|NCT02045797|593684407|FG002|Overall Study|Physician Decision|0|||
164357699|NCT02045797|593684405|FG000|Overall Study|Withdrawal by Subject|1|||
164357700|NCT02045797|593684406|FG001|Overall Study|Withdrawal by Subject|2|||
164357701|NCT02045797|593684407|FG002|Overall Study|Withdrawal by Subject|0|||
164357702|NCT03851302|593684408|FG000|Screening (1 Day)|Withdrawal by Subject|0|||
164357703|NCT03851302|593684409|FG001|Screening (1 Day)|Withdrawal by Subject|0|||
164357704|NCT03851302|593684410|FG002|Screening (1 Day)|Withdrawal by Subject|0|||
164357705|NCT03851302|593684411|FG003|Screening (1 Day)|Withdrawal by Subject|1|||
164357706|NCT03851302|593684412|FG004|Screening (1 Day)|Withdrawal by Subject|0|||
164357707|NCT03851302|593684413|FG005|Screening (1 Day)|Withdrawal by Subject|0|||
164357708|NCT03851302|593684408|FG000|Screening (1 Day)|Screened out|0|||
164357709|NCT03851302|593684409|FG001|Screening (1 Day)|Screened out|0|||
164357710|NCT03851302|593684410|FG002|Screening (1 Day)|Screened out|1|||
164357711|NCT03851302|593684411|FG003|Screening (1 Day)|Screened out|1|||
164357712|NCT03851302|593684412|FG004|Screening (1 Day)|Screened out|0|||
164357713|NCT03851302|593684413|FG005|Screening (1 Day)|Screened out|0|||
164357714|NCT03851302|593684408|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
164357715|NCT03851302|593684409|FG001|First Intervention (1 Day)|Withdrawal by Subject|0|||
164357716|NCT03851302|593684410|FG002|First Intervention (1 Day)|Withdrawal by Subject|0|||
164357717|NCT03851302|593684411|FG003|First Intervention (1 Day)|Withdrawal by Subject|0|||
164357718|NCT03851302|593684412|FG004|First Intervention (1 Day)|Withdrawal by Subject|0|||
164357719|NCT03851302|593684413|FG005|First Intervention (1 Day)|Withdrawal by Subject|0|||
164357720|NCT00501293|593686277|FG000|Optimization Period|Enrolled in error|1|||
164357721|NCT00501293|593686278|FG001|Optimization Period|Enrolled in error|0|||
164357722|NCT00501293|593686277|FG000|Maintenance Period|Withdrawal by Subject|14|||
164357723|NCT00501293|593686278|FG001|Maintenance Period|Withdrawal by Subject|13|||
164357724|NCT00501293|593686277|FG000|Maintenance Period|Lost to Follow-up|12|||
164357725|NCT00501293|593686278|FG001|Maintenance Period|Lost to Follow-up|7|||
164357726|NCT00501293|593686277|FG000|Maintenance Period|Adverse Event|6|||
164357727|NCT00501293|593686278|FG001|Maintenance Period|Adverse Event|6|||
164357728|NCT00501293|593686277|FG000|Maintenance Period|Protocol Violation|2|||
164357729|NCT00501293|593686278|FG001|Maintenance Period|Protocol Violation|1|||
164357730|NCT00501293|593686277|FG000|Maintenance Period|Lack of Efficacy|4|||
164357731|NCT00501293|593686278|FG001|Maintenance Period|Lack of Efficacy|1|||
164357732|NCT00501293|593686277|FG000|Maintenance Period|Noncompliant with study medication|5|||
164357733|NCT00501293|593686278|FG001|Maintenance Period|Noncompliant with study medication|0|||
164357734|NCT00501293|593686277|FG000|Maintenance Period|Went into rehabilitation|1|||
164357735|NCT00501293|593686278|FG001|Maintenance Period|Went into rehabilitation|0|||
164357736|NCT00501293|593686277|FG000|Maintenance Period|Would not wear patch|1|||
164357737|NCT00501293|593686278|FG001|Maintenance Period|Would not wear patch|0|||
164357738|NCT00501293|593686277|FG000|Maintenance Period|Application site reaction|1|||
164357739|NCT00501293|593686278|FG001|Maintenance Period|Application site reaction|0|||
164437921|NCT01212757|593968257|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
164437922|NCT01212757|593968258|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
164357740|NCT02355691|593686282|FG000|Overall Study|Loss of Research Personnel|7|||
164357741|NCT02355691|593686283|FG001|Overall Study|Loss of Research Personnel|9|||
164357742|NCT01042236|593686287|FG000|Treatment Period 1|Adverse Event|0|||
164357743|NCT01042236|593686288|FG001|Treatment Period 1|Adverse Event|1|||
164357744|NCT01042236|593686289|FG002|Treatment Period 1|Adverse Event|0|||
164590103|NCT00227877|594523155|FG003|12-months Follow-up|Lost to Follow-up|26|||
164590104|NCT01937130|594525148|FG000|Overall Study|Withdrawal by Subject|0|||
164357745|NCT01042236|593686290|FG003|Treatment Period 1|Adverse Event|0|||
164357746|NCT01042236|593686291|FG004|Treatment Period 1|Adverse Event|1|||
164357747|NCT01042236|593686292|FG005|Treatment Period 1|Adverse Event|0|||
164357748|NCT01042236|593686287|FG000|Treatment Period 3|Adverse Event|0|||
164357749|NCT01042236|593686288|FG001|Treatment Period 3|Adverse Event|0|||
164357750|NCT01042236|593686289|FG002|Treatment Period 3|Adverse Event|0|||
164357751|NCT01042236|593686290|FG003|Treatment Period 3|Adverse Event|1|||
164590105|NCT01937130|594525149|FG001|Overall Study|Withdrawal by Subject|0|||
164357752|NCT01042236|593686291|FG004|Treatment Period 3|Adverse Event|0|||
164357753|NCT01042236|593686292|FG005|Treatment Period 3|Adverse Event|0|||
164357754|NCT01042236|593686287|FG000|Treatment Period 3|Protocol Violation|0|||
164357755|NCT01042236|593686288|FG001|Treatment Period 3|Protocol Violation|0|||
164357756|NCT01042236|593686289|FG002|Treatment Period 3|Protocol Violation|0|||
164357757|NCT01042236|593686290|FG003|Treatment Period 3|Protocol Violation|1|||
164357758|NCT01042236|593686291|FG004|Treatment Period 3|Protocol Violation|0|||
164357759|NCT01042236|593686292|FG005|Treatment Period 3|Protocol Violation|0|||
164357760|NCT01172847|593686295|FG000|Overall Study|Withdrawal by Subject|3|||
164357761|NCT02132767|593686300|FG000|Overall Study|Death|3|||
164357762|NCT02132767|593686301|FG001|Overall Study|Death|2|||
164357763|NCT02132767|593686300|FG000|Overall Study|Withdrawal by Subject|10|||
164357764|NCT02132767|593686301|FG001|Overall Study|Withdrawal by Subject|9|||
164357765|NCT02132767|593686300|FG000|Overall Study|Lost to Follow-up|4|||
164357766|NCT02132767|593686301|FG001|Overall Study|Lost to Follow-up|4|||
164696295|NCT02243293|594910640|FG001|Overall Study|Adverse Event|0|||
164696296|NCT02243293|594910641|FG002|Overall Study|Adverse Event|0|||
164357767|NCT00390858|593686302|FG000|Overall Study|Adverse Event|6|||
164357768|NCT00390858|593686303|FG001|Overall Study|Adverse Event|2|||
164357769|NCT00390858|593686302|FG000|Overall Study|Lack of Efficacy|0|||
164357770|NCT00390858|593686303|FG001|Overall Study|Lack of Efficacy|1|||
164357771|NCT00390858|593686302|FG000|Overall Study|Withdrawal by Subject|3|||
164357772|NCT00390858|593686303|FG001|Overall Study|Withdrawal by Subject|4|||
164357773|NCT00937157|593686304|FG000|Overall Study|Pregnancy|1|||
164357774|NCT00937157|593686304|FG000|Overall Study|Lost to Follow-up|3|||
164357775|NCT02141997|593686305|FG000|Overall Study|Adverse Event|0|||
164357776|NCT02141997|593686306|FG001|Overall Study|Adverse Event|2|||
164357777|NCT02141997|593686307|FG002|Overall Study|Adverse Event|0|||
164357778|NCT02141997|593686308|FG003|Overall Study|Adverse Event|1|||
164357779|NCT02141997|593686305|FG000|Overall Study|Participant noncompliance|1|||
164357780|NCT02141997|593686306|FG001|Overall Study|Participant noncompliance|0|||
164357781|NCT02141997|593686307|FG002|Overall Study|Participant noncompliance|0|||
164357782|NCT02141997|593686308|FG003|Overall Study|Participant noncompliance|0|||
164357783|NCT02141997|593686305|FG000|Overall Study|Withdrew consent|1|||
164357784|NCT02141997|593686306|FG001|Overall Study|Withdrew consent|0|||
164357785|NCT02141997|593686307|FG002|Overall Study|Withdrew consent|3|||
164357786|NCT02141997|593686308|FG003|Overall Study|Withdrew consent|0|||
164357787|NCT02141997|593686305|FG000|Overall Study|Other|1|||
164357788|NCT02141997|593686306|FG001|Overall Study|Other|4|||
164357789|NCT02141997|593686307|FG002|Overall Study|Other|0|||
164357790|NCT02141997|593686308|FG003|Overall Study|Other|0|||
164357791|NCT00451321|593686309|FG000|Overall Study|Lost to Follow-up|3|||
164357792|NCT00451321|593686310|FG001|Overall Study|Lost to Follow-up|3|||
164357793|NCT00451321|593686311|FG002|Overall Study|Lost to Follow-up|1|||
164357794|NCT00451321|593686312|FG003|Overall Study|Lost to Follow-up|3|||
164357795|NCT00451321|593686313|FG004|Overall Study|Lost to Follow-up|0|||
164357796|NCT00451321|593686314|FG005|Overall Study|Lost to Follow-up|1|||
164357797|NCT00451321|593686315|FG006|Overall Study|Lost to Follow-up|0|||
164357798|NCT00451321|593686316|FG007|Overall Study|Lost to Follow-up|0|||
164357799|NCT00451321|593686309|FG000|Overall Study|Withdrawal by Subject|3|||
164357800|NCT00451321|593686310|FG001|Overall Study|Withdrawal by Subject|1|||
164357801|NCT00451321|593686311|FG002|Overall Study|Withdrawal by Subject|0|||
164357802|NCT00451321|593686312|FG003|Overall Study|Withdrawal by Subject|4|||
164357803|NCT00451321|593686313|FG004|Overall Study|Withdrawal by Subject|0|||
164357804|NCT00451321|593686314|FG005|Overall Study|Withdrawal by Subject|0|||
164357805|NCT00451321|593686315|FG006|Overall Study|Withdrawal by Subject|0|||
164357806|NCT00451321|593686316|FG007|Overall Study|Withdrawal by Subject|0|||
164357807|NCT00451321|593686309|FG000|Overall Study|Study closed/terminated|1|||
164357808|NCT00451321|593686310|FG001|Overall Study|Study closed/terminated|1|||
164357809|NCT00451321|593686311|FG002|Overall Study|Study closed/terminated|17|||
164357810|NCT00451321|593686312|FG003|Overall Study|Study closed/terminated|5|||
164357811|NCT00451321|593686313|FG004|Overall Study|Study closed/terminated|7|||
164357812|NCT00451321|593686314|FG005|Overall Study|Study closed/terminated|7|||
164357813|NCT00451321|593686315|FG006|Overall Study|Study closed/terminated|5|||
164357814|NCT00451321|593686316|FG007|Overall Study|Study closed/terminated|3|||
164696297|NCT02243293|594910642|FG003|Overall Study|Adverse Event|0|||
164696298|NCT02243293|594910643|FG004|Overall Study|Adverse Event|0|||
164696299|NCT02243293|594910644|FG005|Overall Study|Adverse Event|0|||
164696300|NCT02243293|594910645|FG006|Overall Study|Adverse Event|0|||
164357815|NCT00451321|593686309|FG000|Overall Study|Sponsor decision to amend protocol|0|||
164357816|NCT00451321|593686310|FG001|Overall Study|Sponsor decision to amend protocol|0|||
164357817|NCT00451321|593686311|FG002|Overall Study|Sponsor decision to amend protocol|0|||
164696301|NCT02243293|594910646|FG007|Overall Study|Adverse Event|0|||
164357818|NCT00451321|593686312|FG003|Overall Study|Sponsor decision to amend protocol|0|||
164357819|NCT00451321|593686313|FG004|Overall Study|Sponsor decision to amend protocol|0|||
164357820|NCT00451321|593686314|FG005|Overall Study|Sponsor decision to amend protocol|1|||
164357821|NCT00451321|593686315|FG006|Overall Study|Sponsor decision to amend protocol|1|||
164357822|NCT00451321|593686316|FG007|Overall Study|Sponsor decision to amend protocol|3|||
164357823|NCT00732615|593686319|FG000|Overall Study|Withdrawal by Subject|3|||
164357824|NCT00732615|593686320|FG001|Overall Study|Withdrawal by Subject|1|||
164696302|NCT02243293|594910647|FG008|Overall Study|Adverse Event|0|||
164357825|NCT00732615|593686319|FG000|Overall Study|Lost to Follow-up|0|||
164357826|NCT00732615|593686320|FG001|Overall Study|Lost to Follow-up|1|||
164357827|NCT00732615|593686319|FG000|Overall Study|Adverse Event|0|||
164696303|NCT02243293|594910648|FG009|Overall Study|Adverse Event|0|||
164357828|NCT00732615|593686320|FG001|Overall Study|Adverse Event|2|||
164357829|NCT00732615|593686319|FG000|Overall Study|Physician Decision|3|||
164357830|NCT00732615|593686320|FG001|Overall Study|Physician Decision|0|||
164357831|NCT00732615|593686319|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
164357832|NCT00732615|593686320|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
164357833|NCT00909389|593686323|FG000|Overall Study|Adverse Event|6|||
164357834|NCT00909389|593686323|FG000|Overall Study|Death|4|||
164357835|NCT00909389|593686323|FG000|Overall Study|Poor Compliance|16|||
164357836|NCT00909389|593686323|FG000|Overall Study|Lost to Follow-up|4|||
164357837|NCT00909389|593686323|FG000|Overall Study|No Information|103|||
164357838|NCT03566823|593686326|FG000|Overall Study|Lack of Efficacy|0|||
164357839|NCT03566823|593686327|FG001|Overall Study|Lack of Efficacy|1|||
164357840|NCT03566823|593686328|FG002|Overall Study|Lack of Efficacy|0|||
164357841|NCT03566823|593686326|FG000|Overall Study|Withdrawal by Subject|1|||
164357842|NCT03566823|593686327|FG001|Overall Study|Withdrawal by Subject|2|||
164357843|NCT03566823|593686328|FG002|Overall Study|Withdrawal by Subject|0|||
164357844|NCT03566823|593686326|FG000|Overall Study|Adverse Event|1|||
164357845|NCT03566823|593686327|FG001|Overall Study|Adverse Event|0|||
164357846|NCT03566823|593686328|FG002|Overall Study|Adverse Event|2|||
164357847|NCT01166763|593686329|FG000|Overall Study|Withdrawal by Subject|3|||
164357848|NCT03557151|593686330|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
164357849|NCT03557151|593686331|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
164357850|NCT03557151|593686330|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
164357851|NCT03557151|593686331|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
164357852|NCT03557151|593686330|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
164357853|NCT03557151|593686331|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
164357854|NCT02810392|593686332|FG000|Overall Study|Subject too ill to continue|1|||
164357855|NCT02810392|593686333|FG001|Overall Study|Subject too ill to continue|0|||
164357856|NCT02810392|593686332|FG000|Overall Study|COVID 19 research restrictions|0|||
164357857|NCT02810392|593686333|FG001|Overall Study|COVID 19 research restrictions|1|||
164357858|NCT03035409|593686335|FG000|Overall Study|Adverse Event|5|||
164357859|NCT03035409|593686335|FG000|Overall Study|Death|2|||
164357860|NCT03035409|593686335|FG000|Overall Study|Withdrawal by Subject|2|||
164357861|NCT03035409|593686335|FG000|Overall Study|Non compliance|4|||
164357862|NCT03035409|593686335|FG000|Overall Study|Patient was jittery|1|||
164357863|NCT03035409|593686335|FG000|Overall Study|Did not like Questionnaire|1|||
164357864|NCT03035409|593686335|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
164357865|NCT03035409|593686335|FG000|Overall Study|Did not like taking drugs|1|||
164357866|NCT06079320|593686336|FG000|Follow up Phase|Lost to Follow-up|1|||
164357867|NCT06079320|593686337|FG001|Follow up Phase|Lost to Follow-up|0|||
164357868|NCT03428360|593686338|FG000|Overall Study|Informed consent withdrawn|5|||
164357869|NCT03428360|593686338|FG000|Overall Study|Withdrawal by Subject|4|||
164357870|NCT03428360|593686338|FG000|Overall Study|Lost to Follow-up|5|||
164357871|NCT03428360|593686338|FG000|Overall Study|Physician Decision|2|||
164357872|NCT03428360|593686338|FG000|Overall Study|Informed consent withdrawn|5|||
164357873|NCT03428360|593686338|FG000|Overall Study|Study terminated by sponsor|10|||
164357874|NCT03428360|593686338|FG000|Overall Study|Non-compliant with study|1|||
164357875|NCT03428360|593686338|FG000|Overall Study|Non-compliant with study drug|3|||
164696304|NCT02243293|594910649|FG010|Overall Study|Adverse Event|0|||
164696305|NCT02243293|594910650|FG011|Overall Study|Adverse Event|0|||
164696306|NCT02243293|594910651|FG012|Overall Study|Adverse Event|0|||
164696307|NCT02243293|594910652|FG013|Overall Study|Adverse Event|0|||
164696308|NCT02243293|594910653|FG014|Overall Study|Adverse Event|0|||
164696309|NCT02243293|594910654|FG015|Overall Study|Adverse Event|1|||
164357876|NCT03428360|593686338|FG000|Overall Study|Death|3|||
164357877|NCT03428360|593686338|FG000|Overall Study|Adverse Event|1|||
164357878|NCT03428360|593686338|FG000|Overall Study|Not on antiepileptic drug|1|||
164696310|NCT02243293|594910655|FG016|Overall Study|Adverse Event|0|||
164696311|NCT02243293|594910656|FG017|Overall Study|Adverse Event|0|||
164696312|NCT02243293|594910657|FG018|Overall Study|Adverse Event|0|||
164696313|NCT02243293|594910658|FG019|Overall Study|Adverse Event|0|||
164696314|NCT02243293|594910659|FG020|Overall Study|Adverse Event|1|||
164696315|NCT02243293|594910660|FG021|Overall Study|Adverse Event|0|||
164696316|NCT02243293|594910639|FG000|Overall Study|Withdrawal by Subject|1|||
164696317|NCT02243293|594910640|FG001|Overall Study|Withdrawal by Subject|0|||
164696318|NCT02243293|594910641|FG002|Overall Study|Withdrawal by Subject|0|||
164357879|NCT02107482|593686344|FG000|Overall Study|inconveinence|2|||
164357880|NCT02107482|593686344|FG000|Overall Study|Lost to Follow-up|1|||
164357881|NCT02107482|593686344|FG000|Overall Study|Lack of Efficacy|1|||
164357882|NCT04868890|593686345|FG000|Overall Study|Death|2|||
164357883|NCT04868890|593686346|FG001|Overall Study|Death|1|||
164696319|NCT02243293|594910642|FG003|Overall Study|Withdrawal by Subject|0|||
164696320|NCT02243293|594910643|FG004|Overall Study|Withdrawal by Subject|0|||
164696321|NCT02243293|594910644|FG005|Overall Study|Withdrawal by Subject|0|||
164696322|NCT02243293|594910645|FG006|Overall Study|Withdrawal by Subject|0|||
164357884|NCT04868890|593686345|FG000|Overall Study|Withdrawal by Subject|1|||
164357885|NCT04868890|593686346|FG001|Overall Study|Withdrawal by Subject|5|||
164357886|NCT02669433|593686349|FG000|Overall Study|Protocol Violation|0|||
164357887|NCT02669433|593686350|FG001|Overall Study|Protocol Violation|4|||
164357888|NCT02669433|593686351|FG002|Overall Study|Protocol Violation|1|||
164357889|NCT02669433|593686349|FG000|Overall Study|Disease Progression|1|||
164357890|NCT02669433|593686350|FG001|Overall Study|Disease Progression|0|||
164357891|NCT02669433|593686351|FG002|Overall Study|Disease Progression|0|||
164357892|NCT02669433|593686349|FG000|Overall Study|Physician Decision|1|||
164357893|NCT02669433|593686350|FG001|Overall Study|Physician Decision|1|||
164357894|NCT02669433|593686351|FG002|Overall Study|Physician Decision|0|||
164357895|NCT02669433|593686349|FG000|Overall Study|Adverse Event|6|||
164357896|NCT02669433|593686350|FG001|Overall Study|Adverse Event|7|||
164357897|NCT02669433|593686351|FG002|Overall Study|Adverse Event|10|||
164357898|NCT02669433|593686349|FG000|Overall Study|Sponsor Termination|1|||
164357899|NCT02669433|593686350|FG001|Overall Study|Sponsor Termination|0|||
164357900|NCT02669433|593686351|FG002|Overall Study|Sponsor Termination|1|||
164357901|NCT02669433|593686349|FG000|Overall Study|Withdrawal by Subject|5|||
164357902|NCT02669433|593686350|FG001|Overall Study|Withdrawal by Subject|1|||
164357903|NCT02669433|593686351|FG002|Overall Study|Withdrawal by Subject|0|||
164357904|NCT02669433|593686349|FG000|Overall Study|Withdrawal by Caregiver|1|||
164357905|NCT02669433|593686350|FG001|Overall Study|Withdrawal by Caregiver|0|||
164357906|NCT02669433|593686351|FG002|Overall Study|Withdrawal by Caregiver|2|||
164357907|NCT02669433|593686349|FG000|Overall Study|Death|0|||
164357908|NCT02669433|593686350|FG001|Overall Study|Death|1|||
164357909|NCT02669433|593686351|FG002|Overall Study|Death|1|||
164357910|NCT00576927|593686352|FG000|Clinical Assessment|Lack of Efficacy|24|||
164357911|NCT00576927|593686352|FG000|Clinical Assessment|Death|1|||
164357912|NCT00576927|593686352|FG000|Clinical Assessment|Withdrawal by Subject|10|||
164357913|NCT00576927|593686352|FG000|Clinical Assessment|Physician Decision|1|||
164357914|NCT00576927|593686352|FG000|Baseline|Physician Decision|9|||
164357915|NCT00576927|593686352|FG000|Baseline|Medication Change by PCP of subject|1|||
164357916|NCT00576927|593686352|FG000|Baseline|Withdrawal by Subject|3|||
164357917|NCT00576927|593686352|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
164357918|NCT00576927|593686352|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
164357919|NCT00576927|593686352|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
164357920|NCT00576927|593686352|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
164357921|NCT00576927|593686352|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
164357922|NCT03128892|593686353|FG000|Overall Study|Withdrawal by Subject|2|||
164357923|NCT03128892|593686353|FG000|Overall Study|Physician Decision|1|||
164357924|NCT01850524|593686357|FG000|Overall Study|Lost to Follow-up|5|||
164357925|NCT01850524|593686358|FG001|Overall Study|Lost to Follow-up|10|||
164357926|NCT01850524|593686357|FG000|Overall Study|Withdrawal by Subject|24|||
164357927|NCT01850524|593686358|FG001|Overall Study|Withdrawal by Subject|22|||
164357928|NCT01850524|593686357|FG000|Overall Study|Reason not Specified|142|||
164357929|NCT01850524|593686358|FG001|Overall Study|Reason not Specified|141|||
164357930|NCT00368355|593686360|FG000|Overall Study|Adverse Event|1|||
164357931|NCT00368355|593686361|FG001|Overall Study|Adverse Event|0|||
164357932|NCT00368355|593686360|FG000|Overall Study|Death|2|||
164357933|NCT00368355|593686361|FG001|Overall Study|Death|4|||
164357934|NCT00368355|593686360|FG000|Overall Study|Relapse|6|||
164696323|NCT02243293|594910646|FG007|Overall Study|Withdrawal by Subject|0|||
164696324|NCT02243293|594910647|FG008|Overall Study|Withdrawal by Subject|0|||
164696325|NCT02243293|594910648|FG009|Overall Study|Withdrawal by Subject|1|||
164696326|NCT02243293|594910649|FG010|Overall Study|Withdrawal by Subject|0|||
164696327|NCT02243293|594910650|FG011|Overall Study|Withdrawal by Subject|1|||
164696328|NCT02243293|594910651|FG012|Overall Study|Withdrawal by Subject|0|||
164696329|NCT02243293|594910652|FG013|Overall Study|Withdrawal by Subject|0|||
164696330|NCT02243293|594910653|FG014|Overall Study|Withdrawal by Subject|0|||
164696331|NCT02243293|594910654|FG015|Overall Study|Withdrawal by Subject|0|||
164357935|NCT00368355|593686361|FG001|Overall Study|Relapse|10|||
164357936|NCT00368355|593686360|FG000|Overall Study|Subsequent transplant|0|||
164357937|NCT00368355|593686361|FG001|Overall Study|Subsequent transplant|3|||
164357938|NCT00368355|593686360|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
164357939|NCT00368355|593686361|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
164357940|NCT03473808|593686370|FG000|Overall Study|Withdrawal by Subject|1|||
164357941|NCT02157298|593686373|FG000|Overall Study|Adverse Event|1|||
164696332|NCT02243293|594910655|FG016|Overall Study|Withdrawal by Subject|0|||
164357942|NCT02157298|593686374|FG001|Overall Study|Adverse Event|0|||
164696333|NCT02243293|594910656|FG017|Overall Study|Withdrawal by Subject|0|||
164357943|NCT02157298|593686373|FG000|Overall Study|Subject no longer meets study criteria|1|||
164357944|NCT02157298|593686374|FG001|Overall Study|Subject no longer meets study criteria|2|||
164357945|NCT02157298|593686373|FG000|Overall Study|Poor/Non-compliance|1|||
164357946|NCT02157298|593686374|FG001|Overall Study|Poor/Non-compliance|0|||
164357947|NCT02157298|593686373|FG000|Overall Study|Withdrawal by Subject|1|||
164357948|NCT02157298|593686374|FG001|Overall Study|Withdrawal by Subject|0|||
164357949|NCT04059094|593686375|FG000|Overall Study|Adverse Event|0|||
164357950|NCT04059094|593686376|FG001|Overall Study|Adverse Event|0|||
164357951|NCT04059094|593686377|FG002|Overall Study|Adverse Event|0|||
164357952|NCT04059094|593686378|FG003|Overall Study|Adverse Event|0|||
164357953|NCT04059094|593686379|FG004|Overall Study|Adverse Event|1|||
164357954|NCT04059094|593686375|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
164357955|NCT04059094|593686376|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
164357956|NCT04059094|593686377|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
164357957|NCT04059094|593686378|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
164357958|NCT04059094|593686379|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
164357959|NCT01085591|593686380|FG000|Overall Study|Adverse Event|0|||
164357960|NCT01085591|593686381|FG001|Overall Study|Adverse Event|1|||
164357961|NCT01085591|593686382|FG002|Overall Study|Adverse Event|3|||
164357962|NCT01085591|593686380|FG000|Overall Study|Physician Decision|1|||
164357963|NCT01085591|593686381|FG001|Overall Study|Physician Decision|0|||
164357964|NCT01085591|593686382|FG002|Overall Study|Physician Decision|1|||
164357965|NCT01085591|593686380|FG000|Overall Study|Withdrawal by Subject|0|||
164357966|NCT01085591|593686381|FG001|Overall Study|Withdrawal by Subject|2|||
164357967|NCT01085591|593686382|FG002|Overall Study|Withdrawal by Subject|1|||
164357968|NCT01085591|593686380|FG000|Overall Study|Lost to Follow-up|0|||
164357969|NCT01085591|593686381|FG001|Overall Study|Lost to Follow-up|1|||
164357970|NCT01085591|593686382|FG002|Overall Study|Lost to Follow-up|1|||
164357971|NCT01085591|593686380|FG000|Overall Study|Protocol Violation|1|||
164357972|NCT01085591|593686381|FG001|Overall Study|Protocol Violation|1|||
164357973|NCT01085591|593686382|FG002|Overall Study|Protocol Violation|1|||
164357974|NCT01085591|593686380|FG000|Overall Study|Other|0|||
164357975|NCT01085591|593686381|FG001|Overall Study|Other|1|||
164357976|NCT01085591|593686382|FG002|Overall Study|Other|0|||
164357977|NCT01085591|593686380|FG000|Overall Study|Not Properly Consented|1|||
164357978|NCT01085591|593686381|FG001|Overall Study|Not Properly Consented|0|||
164357979|NCT01085591|593686382|FG002|Overall Study|Not Properly Consented|0|||
164357980|NCT03715764|593686383|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
164696334|NCT02243293|594910657|FG018|Overall Study|Withdrawal by Subject|0|||
164696335|NCT02243293|594910658|FG019|Overall Study|Withdrawal by Subject|0|||
164696336|NCT02243293|594910659|FG020|Overall Study|Withdrawal by Subject|0|||
164696337|NCT02243293|594910660|FG021|Overall Study|Withdrawal by Subject|1|||
164696338|NCT02243293|594910639|FG000|Overall Study|Lost to Follow-up|0|||
164696339|NCT02243293|594910640|FG001|Overall Study|Lost to Follow-up|1|||
164357981|NCT03715764|593686384|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
164357982|NCT03715764|593686383|FG000|3 Month Follow-up|Lost to Follow-up|2|||
164357983|NCT03715764|593686384|FG001|3 Month Follow-up|Lost to Follow-up|2|||
164357984|NCT03715764|593686383|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
164357985|NCT03715764|593686384|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
164357986|NCT03715764|593686383|FG000|6 Month Follow-up|Lost to Follow-up|3|||
164357987|NCT03715764|593686384|FG001|6 Month Follow-up|Lost to Follow-up|0|||
164357988|NCT03715764|593686383|FG000|12 Month Follow-up|Lost to Follow-up|2|||
164357989|NCT03715764|593686384|FG001|12 Month Follow-up|Lost to Follow-up|3|||
164357990|NCT03715764|593686383|FG000|12 Month Follow-up|Pregnancy|0|||
164357991|NCT03715764|593686384|FG001|12 Month Follow-up|Pregnancy|1|||
164357992|NCT03715764|593686383|FG000|12 Month Follow-up|Surgery|2|||
164357993|NCT03715764|593686384|FG001|12 Month Follow-up|Surgery|0|||
164357994|NCT03715764|593686383|FG000|12 Month Follow-up|Wrong address|1|||
164357995|NCT03715764|593686384|FG001|12 Month Follow-up|Wrong address|0|||
164357996|NCT03715764|593686383|FG000|12 Month Follow-up|No symptoms|1|||
164357997|NCT03715764|593686384|FG001|12 Month Follow-up|No symptoms|0|||
164357998|NCT03715764|593686383|FG000|12 Month Follow-up|Changed primary care centre|0|||
164357999|NCT03715764|593686384|FG001|12 Month Follow-up|Changed primary care centre|1|||
164358000|NCT01980875|593686386|FG000|Overall Study|Withdrew Consent|1|||
164358001|NCT01980875|593686387|FG001|Overall Study|Withdrew Consent|1|||
164358002|NCT01980875|593686388|FG002|Overall Study|Withdrew Consent|1|||
164358003|NCT01980875|593686386|FG000|Overall Study|Study Terminated by Sponsor|7|||
164358004|NCT01980875|593686387|FG001|Overall Study|Study Terminated by Sponsor|24|||
164358005|NCT01980875|593686388|FG002|Overall Study|Study Terminated by Sponsor|22|||
164358006|NCT01980875|593686386|FG000|Overall Study|Lost to Follow-up|0|||
164358007|NCT01980875|593686387|FG001|Overall Study|Lost to Follow-up|0|||
164358008|NCT01980875|593686388|FG002|Overall Study|Lost to Follow-up|1|||
164696340|NCT02243293|594910641|FG002|Overall Study|Lost to Follow-up|1|||
164358009|NCT00662363|593686389|FG000|Overall Study|Withdrawal by Subject|6|||
164358010|NCT00662363|593686390|FG001|Overall Study|Withdrawal by Subject|5|||
164358011|NCT00662363|593686389|FG000|Overall Study|Adverse Event|0|||
164358012|NCT00662363|593686390|FG001|Overall Study|Adverse Event|3|||
164358013|NCT00662363|593686389|FG000|Overall Study|Discharged early from rehab|4|||
164696341|NCT02243293|594910642|FG003|Overall Study|Lost to Follow-up|1|||
164696342|NCT02243293|594910643|FG004|Overall Study|Lost to Follow-up|0|||
164358014|NCT00662363|593686390|FG001|Overall Study|Discharged early from rehab|1|||
164358015|NCT00662363|593686389|FG000|Overall Study|Protocol Violation|1|||
164696343|NCT02243293|594910644|FG005|Overall Study|Lost to Follow-up|0|||
164696344|NCT02243293|594910645|FG006|Overall Study|Lost to Follow-up|3|||
164696345|NCT02243293|594910646|FG007|Overall Study|Lost to Follow-up|0|||
164358016|NCT00662363|593686390|FG001|Overall Study|Protocol Violation|1|||
164358017|NCT01905657|593686391|FG000|Overall Study|Adverse Event|23|||
164358018|NCT01905657|593686392|FG001|Overall Study|Adverse Event|17|||
164358019|NCT01905657|593686393|FG002|Overall Study|Adverse Event|18|||
164358020|NCT01905657|593686391|FG000|Overall Study|Clinical Progression|103|||
164358021|NCT01905657|593686392|FG001|Overall Study|Clinical Progression|78|||
164358022|NCT01905657|593686393|FG002|Overall Study|Clinical Progression|59|||
164358023|NCT01905657|593686391|FG000|Overall Study|Death|40|||
164358024|NCT01905657|593686392|FG001|Overall Study|Death|43|||
164358025|NCT01905657|593686393|FG002|Overall Study|Death|47|||
164358026|NCT01905657|593686391|FG000|Overall Study|Excluded Medication|13|||
164358027|NCT01905657|593686392|FG001|Overall Study|Excluded Medication|16|||
164358028|NCT01905657|593686393|FG002|Overall Study|Excluded Medication|9|||
164358029|NCT01905657|593686391|FG000|Overall Study|Lost to Follow-up|1|||
164358030|NCT01905657|593686392|FG001|Overall Study|Lost to Follow-up|2|||
164358031|NCT01905657|593686393|FG002|Overall Study|Lost to Follow-up|1|||
164358032|NCT01905657|593686391|FG000|Overall Study|Physician Decision|5|||
164358033|NCT01905657|593686392|FG001|Overall Study|Physician Decision|8|||
164358034|NCT01905657|593686393|FG002|Overall Study|Physician Decision|12|||
164358035|NCT01905657|593686391|FG000|Overall Study|Protocol Violation|2|||
164358036|NCT01905657|593686392|FG001|Overall Study|Protocol Violation|1|||
164358037|NCT01905657|593686393|FG002|Overall Study|Protocol Violation|1|||
164358038|NCT01905657|593686391|FG000|Overall Study|Screen Failure|0|||
164358039|NCT01905657|593686392|FG001|Overall Study|Screen Failure|1|||
164358040|NCT01905657|593686393|FG002|Overall Study|Screen Failure|0|||
164358041|NCT01905657|593686391|FG000|Overall Study|Withdrawal by Subject|15|||
164358042|NCT01905657|593686392|FG001|Overall Study|Withdrawal by Subject|21|||
164358043|NCT01905657|593686393|FG002|Overall Study|Withdrawal by Subject|53|||
164358044|NCT01905657|593686391|FG000|Overall Study|Sponsor Decision|1|||
164358045|NCT01905657|593686392|FG001|Overall Study|Sponsor Decision|0|||
164358046|NCT01905657|593686393|FG002|Overall Study|Sponsor Decision|0|||
164358047|NCT05119569|593686398|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
164358048|NCT05119569|593686399|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
164358049|NCT05119569|593686400|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
164358050|NCT05119569|593686401|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
164358051|NCT05119569|593686398|FG000|Double Blind Treatment Phase|Adverse Event|6|||
164358052|NCT05119569|593686399|FG001|Double Blind Treatment Phase|Adverse Event|0|||
164358053|NCT05119569|593686400|FG002|Double Blind Treatment Phase|Adverse Event|0|||
164358054|NCT05119569|593686401|FG003|Double Blind Treatment Phase|Adverse Event|0|||
164358055|NCT05119569|593686398|FG000|Open Label Extension Phase|Ongoing in the study|0|||
164358056|NCT05119569|593686399|FG001|Open Label Extension Phase|Ongoing in the study|0|||
164358057|NCT05119569|593686400|FG002|Open Label Extension Phase|Ongoing in the study|65|||
164358058|NCT05119569|593686401|FG003|Open Label Extension Phase|Ongoing in the study|34|||
164358059|NCT02623439|593686404|FG000|Overall Study|Withdrawal by Subject|1|||
164358060|NCT02623439|593686404|FG000|Overall Study|Screen Failure|1|||
164358061|NCT02200445|593686407|FG000|Overall Study|Lack of Efficacy|1|||
164358062|NCT02200445|593686408|FG001|Overall Study|Lack of Efficacy|2|||
164358063|NCT02200445|593686409|FG002|Overall Study|Lack of Efficacy|2|||
164358064|NCT02200445|593686407|FG000|Overall Study|Adverse Event|0|||
164358065|NCT02200445|593686408|FG001|Overall Study|Adverse Event|2|||
164358066|NCT02200445|593686409|FG002|Overall Study|Adverse Event|0|||
164358067|NCT04484142|593686410|FG000|Overall Study|Adverse Event|13|||
164358068|NCT04484142|593686410|FG000|Overall Study|Progressive Disease|87|||
164358069|NCT04484142|593686410|FG000|Overall Study|Clinical Progression|10|||
164437923|NCT01212757|593968259|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
164696346|NCT02243293|594910647|FG008|Overall Study|Lost to Follow-up|0|||
164696347|NCT02243293|594910648|FG009|Overall Study|Lost to Follow-up|0|||
164696348|NCT02243293|594910649|FG010|Overall Study|Lost to Follow-up|0|||
164696349|NCT02243293|594910650|FG011|Overall Study|Lost to Follow-up|2|||
164696350|NCT02243293|594910651|FG012|Overall Study|Lost to Follow-up|0|||
164696351|NCT02243293|594910652|FG013|Overall Study|Lost to Follow-up|0|||
164696352|NCT02243293|594910653|FG014|Overall Study|Lost to Follow-up|0|||
164696353|NCT02243293|594910654|FG015|Overall Study|Lost to Follow-up|0|||
164696354|NCT02243293|594910655|FG016|Overall Study|Lost to Follow-up|3|||
164358070|NCT04484142|593686410|FG000|Overall Study|Withdrawal by Subject|6|||
164358071|NCT04484142|593686410|FG000|Overall Study|Physician Decision|1|||
164358072|NCT03700671|593686411|FG000|Overall Study|Lack of Efficacy|1|||
164358073|NCT03700671|593686412|FG001|Overall Study|Lack of Efficacy|2|||
164358074|NCT05371509|593686413|FG000|Overall Study|Physician Decision|1|||
164358075|NCT05371509|593686414|FG001|Overall Study|Physician Decision|0|||
164358076|NCT04405037|593686421|FG000|Overall Study|Withdrawal by Subject|1|||
164358077|NCT04405037|593686422|FG001|Overall Study|Withdrawal by Subject|0|||
164358078|NCT04405037|593686421|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
164358079|NCT04405037|593686422|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
164696355|NCT02243293|594910656|FG017|Overall Study|Lost to Follow-up|1|||
164696356|NCT02243293|594910657|FG018|Overall Study|Lost to Follow-up|0|||
164696357|NCT02243293|594910658|FG019|Overall Study|Lost to Follow-up|0|||
164696358|NCT02243293|594910659|FG020|Overall Study|Lost to Follow-up|1|||
164696359|NCT02243293|594910660|FG021|Overall Study|Lost to Follow-up|2|||
164696360|NCT02243293|594910639|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
164696361|NCT02243293|594910640|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
164696362|NCT02243293|594910641|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
164696363|NCT02243293|594910642|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
164696364|NCT02243293|594910643|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
164696365|NCT02243293|594910644|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
164696366|NCT02243293|594910645|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
164696367|NCT02243293|594910646|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
164696368|NCT02243293|594910647|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
164696369|NCT02243293|594910648|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
164696370|NCT02243293|594910649|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
164696371|NCT02243293|594910650|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
164696372|NCT02243293|594910651|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
164696373|NCT02243293|594910652|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
164696374|NCT02243293|594910653|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
164358080|NCT04434092|593686423|FG000|Primary Treatment Period:Baseline-Week24|Physician Decision|2|||
164358081|NCT04434092|593686424|FG001|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
164358082|NCT04434092|593686425|FG002|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
164358083|NCT04434092|593686423|FG000|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|2|||
164358084|NCT04434092|593686424|FG001|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
164358085|NCT04434092|593686425|FG002|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
164358086|NCT04434092|593686423|FG000|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|1|||
164358087|NCT04434092|593686424|FG001|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
164358088|NCT04434092|593686425|FG002|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
164358089|NCT04434092|593686423|FG000|Primary Treatment Period:Baseline-Week24|Death|1|||
164358090|NCT04434092|593686424|FG001|Primary Treatment Period:Baseline-Week24|Death|1|||
164358091|NCT04434092|593686425|FG002|Primary Treatment Period:Baseline-Week24|Death|0|||
164358092|NCT04434092|593686423|FG000|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|127|||
164358093|NCT04434092|593686424|FG001|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|65|||
164358094|NCT04434092|593686425|FG002|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|6|||
164358095|NCT04434092|593686423|FG000|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
164358096|NCT04434092|593686424|FG001|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
164358097|NCT04434092|593686425|FG002|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|0|||
164358098|NCT04434092|593686423|FG000|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
164358099|NCT04434092|593686424|FG001|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|1|||
164358100|NCT04434092|593686425|FG002|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
164358101|NCT02554812|593686426|FG000|Overall Study|Adverse Event|2|||
164358102|NCT02554812|593686427|FG001|Overall Study|Adverse Event|5|||
164358103|NCT02554812|593686428|FG002|Overall Study|Adverse Event|3|||
164358104|NCT02554812|593686429|FG003|Overall Study|Adverse Event|0|||
164358105|NCT02554812|593686430|FG004|Overall Study|Adverse Event|5|||
164358106|NCT02554812|593686431|FG005|Overall Study|Adverse Event|0|||
164358107|NCT02554812|593686432|FG006|Overall Study|Adverse Event|1|||
164358108|NCT02554812|593686433|FG007|Overall Study|Adverse Event|6|||
164358109|NCT02554812|593686434|FG008|Overall Study|Adverse Event|2|||
164358110|NCT02554812|593686435|FG009|Overall Study|Adverse Event|2|||
164358111|NCT02554812|593686436|FG010|Overall Study|Adverse Event|1|||
164358112|NCT02554812|593686437|FG011|Overall Study|Adverse Event|2|||
164358113|NCT02554812|593686438|FG012|Overall Study|Adverse Event|0|||
164358114|NCT02554812|593686439|FG013|Overall Study|Adverse Event|3|||
164437924|NCT01212757|593968251|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
164437925|NCT01212757|593968252|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
164696375|NCT02243293|594910654|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
164696376|NCT02243293|594910655|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
164696377|NCT02243293|594910656|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
164696378|NCT02243293|594910657|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
164696379|NCT02243293|594910658|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
164696380|NCT02243293|594910659|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
164358115|NCT02554812|593686440|FG014|Overall Study|Adverse Event|2|||
164358116|NCT02554812|593686441|FG015|Overall Study|Adverse Event|1|||
164358117|NCT02554812|593686442|FG016|Overall Study|Adverse Event|0|||
164696381|NCT02243293|594910660|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
164358118|NCT02554812|593686443|FG017|Overall Study|Adverse Event|1|||
164358119|NCT02554812|593686444|FG018|Overall Study|Adverse Event|0|||
164358120|NCT02554812|593686445|FG019|Overall Study|Adverse Event|0|||
164358121|NCT02554812|593686446|FG020|Overall Study|Adverse Event|0|||
164358122|NCT02554812|593686447|FG021|Overall Study|Adverse Event|2|||
164358123|NCT02554812|593686448|FG022|Overall Study|Adverse Event|1|||
164358124|NCT02554812|593686449|FG023|Overall Study|Adverse Event|1|||
164358125|NCT02554812|593686450|FG024|Overall Study|Adverse Event|1|||
164696382|NCT02243293|594910639|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
164696383|NCT02243293|594910640|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
164358126|NCT02554812|593686451|FG025|Overall Study|Adverse Event|2|||
164358127|NCT02554812|593686452|FG026|Overall Study|Adverse Event|1|||
164358128|NCT02554812|593686426|FG000|Overall Study|Death|1|||
164358129|NCT02554812|593686427|FG001|Overall Study|Death|2|||
164358130|NCT02554812|593686428|FG002|Overall Study|Death|2|||
164358131|NCT02554812|593686429|FG003|Overall Study|Death|2|||
164358132|NCT02554812|593686430|FG004|Overall Study|Death|0|||
164358133|NCT02554812|593686431|FG005|Overall Study|Death|1|||
164358134|NCT02554812|593686432|FG006|Overall Study|Death|1|||
164358135|NCT02554812|593686433|FG007|Overall Study|Death|1|||
164358136|NCT02554812|593686434|FG008|Overall Study|Death|0|||
164358137|NCT02554812|593686435|FG009|Overall Study|Death|0|||
164358138|NCT02554812|593686436|FG010|Overall Study|Death|0|||
164358139|NCT02554812|593686437|FG011|Overall Study|Death|0|||
164358140|NCT02554812|593686438|FG012|Overall Study|Death|0|||
164358141|NCT02554812|593686439|FG013|Overall Study|Death|0|||
164358142|NCT02554812|593686440|FG014|Overall Study|Death|1|||
164358143|NCT02554812|593686441|FG015|Overall Study|Death|1|||
164358144|NCT02554812|593686442|FG016|Overall Study|Death|1|||
164358145|NCT02554812|593686443|FG017|Overall Study|Death|0|||
164358146|NCT02554812|593686444|FG018|Overall Study|Death|1|||
164358147|NCT02554812|593686445|FG019|Overall Study|Death|2|||
164358148|NCT02554812|593686446|FG020|Overall Study|Death|0|||
164358149|NCT02554812|593686447|FG021|Overall Study|Death|1|||
164358150|NCT02554812|593686448|FG022|Overall Study|Death|1|||
164358151|NCT02554812|593686449|FG023|Overall Study|Death|0|||
164358152|NCT02554812|593686450|FG024|Overall Study|Death|0|||
164358153|NCT02554812|593686451|FG025|Overall Study|Death|0|||
164358154|NCT02554812|593686452|FG026|Overall Study|Death|0|||
164358155|NCT02554812|593686426|FG000|Overall Study|Lost to Follow-up|0|||
164358156|NCT02554812|593686427|FG001|Overall Study|Lost to Follow-up|1|||
164358157|NCT02554812|593686428|FG002|Overall Study|Lost to Follow-up|0|||
164358158|NCT02554812|593686429|FG003|Overall Study|Lost to Follow-up|0|||
164358159|NCT02554812|593686430|FG004|Overall Study|Lost to Follow-up|0|||
164358160|NCT02554812|593686431|FG005|Overall Study|Lost to Follow-up|0|||
164358161|NCT02554812|593686432|FG006|Overall Study|Lost to Follow-up|0|||
164358162|NCT02554812|593686433|FG007|Overall Study|Lost to Follow-up|0|||
164358163|NCT02554812|593686434|FG008|Overall Study|Lost to Follow-up|0|||
164358164|NCT02554812|593686435|FG009|Overall Study|Lost to Follow-up|0|||
164358165|NCT02554812|593686436|FG010|Overall Study|Lost to Follow-up|0|||
164358166|NCT02554812|593686437|FG011|Overall Study|Lost to Follow-up|0|||
164358167|NCT02554812|593686438|FG012|Overall Study|Lost to Follow-up|0|||
164358168|NCT02554812|593686439|FG013|Overall Study|Lost to Follow-up|0|||
164358169|NCT02554812|593686440|FG014|Overall Study|Lost to Follow-up|0|||
164358170|NCT02554812|593686441|FG015|Overall Study|Lost to Follow-up|0|||
164358171|NCT02554812|593686442|FG016|Overall Study|Lost to Follow-up|0|||
164358172|NCT02554812|593686443|FG017|Overall Study|Lost to Follow-up|0|||
164358173|NCT02554812|593686444|FG018|Overall Study|Lost to Follow-up|0|||
164358174|NCT02554812|593686445|FG019|Overall Study|Lost to Follow-up|0|||
164358175|NCT02554812|593686446|FG020|Overall Study|Lost to Follow-up|0|||
164358176|NCT02554812|593686447|FG021|Overall Study|Lost to Follow-up|0|||
164358177|NCT02554812|593686448|FG022|Overall Study|Lost to Follow-up|0|||
164696384|NCT02243293|594910641|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
164696385|NCT02243293|594910642|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
164358178|NCT02554812|593686449|FG023|Overall Study|Lost to Follow-up|0|||
164358179|NCT02554812|593686450|FG024|Overall Study|Lost to Follow-up|0|||
164358180|NCT02554812|593686451|FG025|Overall Study|Lost to Follow-up|0|||
164358181|NCT02554812|593686452|FG026|Overall Study|Lost to Follow-up|0|||
164358182|NCT02554812|593686426|FG000|Overall Study|Global deterioration of health status|4|||
164358183|NCT02554812|593686427|FG001|Overall Study|Global deterioration of health status|3|||
164358184|NCT02554812|593686428|FG002|Overall Study|Global deterioration of health status|3|||
164358185|NCT02554812|593686429|FG003|Overall Study|Global deterioration of health status|2|||
164358186|NCT02554812|593686430|FG004|Overall Study|Global deterioration of health status|5|||
164358187|NCT02554812|593686431|FG005|Overall Study|Global deterioration of health status|0|||
164358188|NCT02554812|593686432|FG006|Overall Study|Global deterioration of health status|2|||
164358189|NCT02554812|593686433|FG007|Overall Study|Global deterioration of health status|1|||
164358190|NCT02554812|593686434|FG008|Overall Study|Global deterioration of health status|1|||
164358191|NCT02554812|593686435|FG009|Overall Study|Global deterioration of health status|1|||
164358192|NCT02554812|593686436|FG010|Overall Study|Global deterioration of health status|2|||
164358193|NCT02554812|593686437|FG011|Overall Study|Global deterioration of health status|1|||
164358194|NCT02554812|593686438|FG012|Overall Study|Global deterioration of health status|0|||
164358195|NCT02554812|593686439|FG013|Overall Study|Global deterioration of health status|0|||
164358196|NCT02554812|593686440|FG014|Overall Study|Global deterioration of health status|0|||
164358197|NCT02554812|593686441|FG015|Overall Study|Global deterioration of health status|1|||
164358198|NCT02554812|593686442|FG016|Overall Study|Global deterioration of health status|0|||
164358199|NCT02554812|593686443|FG017|Overall Study|Global deterioration of health status|0|||
164358200|NCT02554812|593686444|FG018|Overall Study|Global deterioration of health status|0|||
164358201|NCT02554812|593686445|FG019|Overall Study|Global deterioration of health status|0|||
164358202|NCT02554812|593686446|FG020|Overall Study|Global deterioration of health status|0|||
164358203|NCT02554812|593686447|FG021|Overall Study|Global deterioration of health status|0|||
164358204|NCT02554812|593686448|FG022|Overall Study|Global deterioration of health status|0|||
164358205|NCT02554812|593686449|FG023|Overall Study|Global deterioration of health status|0|||
164358206|NCT02554812|593686450|FG024|Overall Study|Global deterioration of health status|0|||
164358207|NCT02554812|593686451|FG025|Overall Study|Global deterioration of health status|0|||
164358208|NCT02554812|593686452|FG026|Overall Study|Global deterioration of health status|0|||
164358209|NCT02554812|593686426|FG000|Overall Study|Progressive disease|20|||
164358210|NCT02554812|593686427|FG001|Overall Study|Progressive disease|16|||
164358211|NCT02554812|593686428|FG002|Overall Study|Progressive disease|19|||
164358212|NCT02554812|593686429|FG003|Overall Study|Progressive disease|18|||
164358213|NCT02554812|593686430|FG004|Overall Study|Progressive disease|21|||
164358214|NCT02554812|593686431|FG005|Overall Study|Progressive disease|15|||
164358215|NCT02554812|593686432|FG006|Overall Study|Progressive disease|6|||
164358216|NCT02554812|593686433|FG007|Overall Study|Progressive disease|13|||
164358217|NCT02554812|593686434|FG008|Overall Study|Progressive disease|6|||
164358218|NCT02554812|593686435|FG009|Overall Study|Progressive disease|6|||
164358219|NCT02554812|593686436|FG010|Overall Study|Progressive disease|8|||
164358220|NCT02554812|593686437|FG011|Overall Study|Progressive disease|8|||
164358221|NCT02554812|593686438|FG012|Overall Study|Progressive disease|6|||
164358222|NCT02554812|593686439|FG013|Overall Study|Progressive disease|10|||
164358223|NCT02554812|593686440|FG014|Overall Study|Progressive disease|20|||
164358224|NCT02554812|593686441|FG015|Overall Study|Progressive disease|6|||
164358225|NCT02554812|593686442|FG016|Overall Study|Progressive disease|3|||
164358226|NCT02554812|593686443|FG017|Overall Study|Progressive disease|3|||
164358227|NCT02554812|593686444|FG018|Overall Study|Progressive disease|11|||
164358228|NCT02554812|593686445|FG019|Overall Study|Progressive disease|7|||
164358229|NCT02554812|593686446|FG020|Overall Study|Progressive disease|11|||
164358230|NCT02554812|593686447|FG021|Overall Study|Progressive disease|6|||
164358231|NCT02554812|593686448|FG022|Overall Study|Progressive disease|9|||
164358232|NCT02554812|593686449|FG023|Overall Study|Progressive disease|9|||
164358233|NCT02554812|593686450|FG024|Overall Study|Progressive disease|4|||
164358234|NCT02554812|593686451|FG025|Overall Study|Progressive disease|5|||
164358235|NCT02554812|593686452|FG026|Overall Study|Progressive disease|5|||
164358236|NCT02554812|593686426|FG000|Overall Study|Other|0|||
164358237|NCT02554812|593686427|FG001|Overall Study|Other|0|||
164358238|NCT02554812|593686428|FG002|Overall Study|Other|2|||
164358239|NCT02554812|593686429|FG003|Overall Study|Other|3|||
164358240|NCT02554812|593686430|FG004|Overall Study|Other|2|||
164358241|NCT02554812|593686431|FG005|Overall Study|Other|1|||
164358242|NCT02554812|593686432|FG006|Overall Study|Other|0|||
164358243|NCT02554812|593686433|FG007|Overall Study|Other|0|||
164437926|NCT01212757|593968253|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
164437927|NCT01212757|593968254|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
164437928|NCT01212757|593968255|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
164437929|NCT01212757|593968256|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
164696386|NCT02243293|594910643|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
164696387|NCT02243293|594910644|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
164696388|NCT02243293|594910645|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
164696389|NCT02243293|594910646|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
164696390|NCT02243293|594910647|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
164358244|NCT02554812|593686434|FG008|Overall Study|Other|1|||
164358245|NCT02554812|593686435|FG009|Overall Study|Other|1|||
164358246|NCT02554812|593686436|FG010|Overall Study|Other|0|||
164358247|NCT02554812|593686437|FG011|Overall Study|Other|0|||
164696391|NCT02243293|594910648|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
164358248|NCT02554812|593686438|FG012|Overall Study|Other|1|||
164358249|NCT02554812|593686439|FG013|Overall Study|Other|0|||
164358250|NCT02554812|593686440|FG014|Overall Study|Other|1|||
164358251|NCT02554812|593686441|FG015|Overall Study|Other|0|||
164358252|NCT02554812|593686442|FG016|Overall Study|Other|0|||
164358253|NCT02554812|593686443|FG017|Overall Study|Other|0|||
164358254|NCT02554812|593686444|FG018|Overall Study|Other|0|||
164358255|NCT02554812|593686445|FG019|Overall Study|Other|0|||
164358256|NCT02554812|593686446|FG020|Overall Study|Other|0|||
164358257|NCT02554812|593686447|FG021|Overall Study|Other|2|||
164358258|NCT02554812|593686448|FG022|Overall Study|Other|0|||
164696392|NCT02243293|594910649|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
164696393|NCT02243293|594910650|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
164696394|NCT02243293|594910651|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
164696395|NCT02243293|594910652|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
164696396|NCT02243293|594910653|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
164696397|NCT02243293|594910654|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
164696398|NCT02243293|594910655|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
164696399|NCT02243293|594910656|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
164696400|NCT02243293|594910657|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
164696401|NCT02243293|594910658|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
164696402|NCT02243293|594910659|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
164696403|NCT02243293|594910660|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
164696404|NCT02377063|594910661|FG000|Overall Study|Non-compliance|5|||
164696405|NCT02723773|594912563|FG000|Overall Study|Adverse Event|934|||
164696406|NCT02723773|594912564|FG001|Overall Study|Adverse Event|3|||
164696407|NCT02723773|594912565|FG002|Overall Study|Adverse Event|1|||
164696408|NCT02723773|594912566|FG003|Overall Study|Adverse Event|9|||
164696409|NCT02723773|594912563|FG000|Overall Study|Protocol Violation|1|||
164696410|NCT02723773|594912564|FG001|Overall Study|Protocol Violation|0|||
164696411|NCT02723773|594912565|FG002|Overall Study|Protocol Violation|0|||
164696412|NCT02723773|594912566|FG003|Overall Study|Protocol Violation|0|||
164696413|NCT02723773|594912563|FG000|Overall Study|Withdrawal by Subject|360|||
164696414|NCT02723773|594912564|FG001|Overall Study|Withdrawal by Subject|5|||
164696415|NCT02723773|594912565|FG002|Overall Study|Withdrawal by Subject|6|||
164696416|NCT02723773|594912566|FG003|Overall Study|Withdrawal by Subject|10|||
164696417|NCT02723773|594912563|FG000|Overall Study|Migrated/moved from study area|37|||
164696418|NCT02723773|594912564|FG001|Overall Study|Migrated/moved from study area|0|||
164696419|NCT02723773|594912565|FG002|Overall Study|Migrated/moved from study area|0|||
164696420|NCT02723773|594912566|FG003|Overall Study|Migrated/moved from study area|1|||
164696421|NCT02723773|594912563|FG000|Overall Study|Lost to Follow-up|198|||
164696422|NCT02723773|594912564|FG001|Overall Study|Lost to Follow-up|0|||
164696423|NCT02723773|594912565|FG002|Overall Study|Lost to Follow-up|0|||
164696424|NCT02723773|594912566|FG003|Overall Study|Lost to Follow-up|0|||
164696425|NCT02723773|594912563|FG000|Overall Study|Other|189|||
164696426|NCT02723773|594912564|FG001|Overall Study|Other|1|||
164696427|NCT02723773|594912565|FG002|Overall Study|Other|2|||
164696428|NCT02723773|594912566|FG003|Overall Study|Other|2|||
164696429|NCT05168774|594912567|FG000|Overall Study|Lack of Efficacy|1|||
164696430|NCT05168774|594912568|FG001|Overall Study|Lack of Efficacy|2|||
164696431|NCT05168774|594912567|FG000|Overall Study|Withdrawal by Subject|1|||
164696432|NCT05168774|594912568|FG001|Overall Study|Withdrawal by Subject|2|||
164696433|NCT05168774|594912567|FG000|Overall Study|Adverse Event|2|||
164696434|NCT05168774|594912568|FG001|Overall Study|Adverse Event|0|||
164696435|NCT02124902|594912570|FG000|Overall Study|Adverse Event|7|||
164696436|NCT02124902|594912571|FG001|Overall Study|Adverse Event|2|||
164696437|NCT02124902|594912570|FG000|Overall Study|Went to alternative treatment|4|||
164696438|NCT02124902|594912571|FG001|Overall Study|Went to alternative treatment|0|||
164696439|NCT02124902|594912570|FG000|Overall Study|Withdrawal by Subject|2|||
164696440|NCT02124902|594912571|FG001|Overall Study|Withdrawal by Subject|1|||
164696441|NCT02124902|594912570|FG000|Overall Study|Physician Decision|2|||
164696442|NCT02124902|594912571|FG001|Overall Study|Physician Decision|0|||
164696443|NCT02124902|594912570|FG000|Overall Study|Not eligible|1|||
164696444|NCT02124902|594912571|FG001|Overall Study|Not eligible|0|||
164696445|NCT02124902|594912570|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
164696446|NCT02124902|594912571|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
164696447|NCT01314118|594912572|FG000|Overall Study|Adverse Event|10|||
164358259|NCT02554812|593686449|FG023|Overall Study|Other|0|||
164358260|NCT02554812|593686450|FG024|Overall Study|Other|0|||
164358261|NCT02554812|593686451|FG025|Overall Study|Other|0|||
164358262|NCT02554812|593686452|FG026|Overall Study|Other|0|||
164358263|NCT02554812|593686426|FG000|Overall Study|Withdrawal by Subject|1|||
164696448|NCT01314118|594912572|FG000|Overall Study|Progressive disease|3|||
164696449|NCT01314118|594912572|FG000|Overall Study|Death|8|||
164696450|NCT01314118|594912572|FG000|Overall Study|Physician Decision|13|||
164696451|NCT01314118|594912572|FG000|Overall Study|Sponsor Decision|1|||
164696452|NCT01314118|594912572|FG000|Overall Study|Protocol Violation|2|||
164696453|NCT01314118|594912572|FG000|Overall Study|Withdrawal by Subject|26|||
164696454|NCT01314118|594912572|FG000|Overall Study|Other|21|||
164696455|NCT02658487|594912578|FG000|Overall Study|Death|2|||
164696456|NCT02658487|594912578|FG000|Overall Study|Disease progression|10|||
164696457|NCT02658487|594912578|FG000|Overall Study|Alternative therapy|1|||
164696458|NCT02658487|594912578|FG000|Overall Study|Adverse Event|1|||
164696459|NCT02658487|594912578|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
164358264|NCT02554812|593686427|FG001|Overall Study|Withdrawal by Subject|0|||
164696460|NCT02658487|594912578|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
164696461|NCT01467479|594912579|FG000|Overall Study|No Study Medication|1|||
164696462|NCT01467479|594912580|FG001|Overall Study|No Study Medication|0|||
164696463|NCT01467479|594912581|FG002|Overall Study|No Study Medication|2|||
164696464|NCT01467479|594912579|FG000|Overall Study|Adverse Event|1|||
164696465|NCT01467479|594912580|FG001|Overall Study|Adverse Event|2|||
164696466|NCT01467479|594912581|FG002|Overall Study|Adverse Event|0|||
164696467|NCT01467479|594912579|FG000|Overall Study|Death|0|||
164696468|NCT01467479|594912580|FG001|Overall Study|Death|0|||
164696469|NCT01467479|594912581|FG002|Overall Study|Death|1|||
164696470|NCT01467479|594912579|FG000|Overall Study|Lost to Follow-up|2|||
164696471|NCT01467479|594912580|FG001|Overall Study|Lost to Follow-up|5|||
164696472|NCT01467479|594912581|FG002|Overall Study|Lost to Follow-up|3|||
164696473|NCT01467479|594912579|FG000|Overall Study|Withdrawal of Consent|3|||
164696474|NCT01467479|594912580|FG001|Overall Study|Withdrawal of Consent|7|||
164696475|NCT01467479|594912581|FG002|Overall Study|Withdrawal of Consent|7|||
164696476|NCT01467479|594912579|FG000|Overall Study|Study Terminated by Sponsor|1|||
164696477|NCT01467479|594912580|FG001|Overall Study|Study Terminated by Sponsor|3|||
164696478|NCT01467479|594912581|FG002|Overall Study|Study Terminated by Sponsor|3|||
164696479|NCT01467479|594912579|FG000|Overall Study|Other|1|||
164696480|NCT01467479|594912580|FG001|Overall Study|Other|0|||
164696481|NCT01467479|594912581|FG002|Overall Study|Other|0|||
164696482|NCT02284347|594912591|FG000|Overall Study|Lost to Follow-up|2|||
164696483|NCT02284347|594912591|FG000|Overall Study|Withdrawn prior to treatment|1|||
164696484|NCT01730040|594912593|FG000|Overall Study|Randomized but not treated|0|||
164696485|NCT01730040|594912594|FG001|Overall Study|Randomized but not treated|0|||
164696486|NCT01730040|594912595|FG002|Overall Study|Randomized but not treated|0|||
164696487|NCT01730040|594912596|FG003|Overall Study|Randomized but not treated|0|||
164696488|NCT01730040|594912597|FG004|Overall Study|Randomized but not treated|0|||
164696489|NCT01730040|594912598|FG005|Overall Study|Randomized but not treated|1|||
164696490|NCT01730040|594912599|FG006|Overall Study|Randomized but not treated|0|||
164696491|NCT01730040|594912593|FG000|Overall Study|Subject moved|0|||
164696492|NCT01730040|594912594|FG001|Overall Study|Subject moved|0|||
164696493|NCT01730040|594912595|FG002|Overall Study|Subject moved|1|||
164696494|NCT01730040|594912596|FG003|Overall Study|Subject moved|0|||
164696495|NCT01730040|594912597|FG004|Overall Study|Subject moved|0|||
164696496|NCT01730040|594912598|FG005|Overall Study|Subject moved|0|||
164696497|NCT01730040|594912599|FG006|Overall Study|Subject moved|1|||
164696498|NCT01730040|594912593|FG000|Overall Study|Physician Decision|0|||
164696499|NCT01730040|594912594|FG001|Overall Study|Physician Decision|0|||
164696500|NCT01730040|594912595|FG002|Overall Study|Physician Decision|0|||
164696501|NCT01730040|594912596|FG003|Overall Study|Physician Decision|0|||
164696502|NCT01730040|594912597|FG004|Overall Study|Physician Decision|0|||
164696503|NCT01730040|594912598|FG005|Overall Study|Physician Decision|1|||
164696504|NCT01730040|594912599|FG006|Overall Study|Physician Decision|1|||
164696505|NCT01730040|594912593|FG000|Overall Study|Other than specified|7|||
164696506|NCT01730040|594912594|FG001|Overall Study|Other than specified|8|||
164696507|NCT01730040|594912595|FG002|Overall Study|Other than specified|5|||
164696508|NCT01730040|594912596|FG003|Overall Study|Other than specified|5|||
164696509|NCT01730040|594912597|FG004|Overall Study|Other than specified|5|||
164696510|NCT01730040|594912598|FG005|Overall Study|Other than specified|4|||
164696511|NCT01730040|594912599|FG006|Overall Study|Other than specified|4|||
164696512|NCT01730040|594912593|FG000|Overall Study|Adverse Event|4|||
164696513|NCT01730040|594912594|FG001|Overall Study|Adverse Event|3|||
164696514|NCT01730040|594912595|FG002|Overall Study|Adverse Event|5|||
164696515|NCT01730040|594912596|FG003|Overall Study|Adverse Event|3|||
164696516|NCT01730040|594912597|FG004|Overall Study|Adverse Event|1|||
164696517|NCT01730040|594912598|FG005|Overall Study|Adverse Event|1|||
164696518|NCT01730040|594912599|FG006|Overall Study|Adverse Event|2|||
164696519|NCT01730040|594912593|FG000|Overall Study|Poor compliance to protocol|2|||
164696520|NCT01730040|594912594|FG001|Overall Study|Poor compliance to protocol|4|||
164696521|NCT01730040|594912595|FG002|Overall Study|Poor compliance to protocol|0|||
164696522|NCT01730040|594912596|FG003|Overall Study|Poor compliance to protocol|0|||
164696523|NCT01730040|594912597|FG004|Overall Study|Poor compliance to protocol|0|||
164696524|NCT01730040|594912598|FG005|Overall Study|Poor compliance to protocol|0|||
164696525|NCT01730040|594912599|FG006|Overall Study|Poor compliance to protocol|1|||
164696526|NCT00544817|594912602|FG000|Combined Modality|Lack of Efficacy|2|||
164358265|NCT02554812|593686428|FG002|Overall Study|Withdrawal by Subject|0|||
164358266|NCT02554812|593686429|FG003|Overall Study|Withdrawal by Subject|2|||
164696527|NCT00544817|594912602|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
164696528|NCT00544817|594912602|FG000|Combined Modality|Adverse Event|2|||
164696529|NCT00544817|594912602|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
164696530|NCT00544817|594912602|FG000|No Treatment Interval|Lack of Efficacy|8|||
164696531|NCT00544817|594912602|FG000|No Treatment Interval|Physician Decision|3|||
164358267|NCT02554812|593686430|FG004|Overall Study|Withdrawal by Subject|2|||
164696532|NCT00544817|594912602|FG000|No Treatment Interval|Adverse Event|1|||
164696533|NCT00544817|594912602|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
164696534|NCT00544817|594912602|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
164696535|NCT00544817|594912602|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
164358268|NCT02554812|593686431|FG005|Overall Study|Withdrawal by Subject|3|||
164358269|NCT02554812|593686432|FG006|Overall Study|Withdrawal by Subject|0|||
164358270|NCT02554812|593686433|FG007|Overall Study|Withdrawal by Subject|0|||
164358271|NCT02554812|593686434|FG008|Overall Study|Withdrawal by Subject|1|||
164358272|NCT02554812|593686435|FG009|Overall Study|Withdrawal by Subject|1|||
164358273|NCT02554812|593686436|FG010|Overall Study|Withdrawal by Subject|0|||
164358274|NCT02554812|593686437|FG011|Overall Study|Withdrawal by Subject|1|||
164358275|NCT02554812|593686438|FG012|Overall Study|Withdrawal by Subject|1|||
164358276|NCT02554812|593686439|FG013|Overall Study|Withdrawal by Subject|1|||
164358277|NCT02554812|593686440|FG014|Overall Study|Withdrawal by Subject|1|||
164358278|NCT02554812|593686441|FG015|Overall Study|Withdrawal by Subject|1|||
164358279|NCT02554812|593686442|FG016|Overall Study|Withdrawal by Subject|3|||
164358280|NCT02554812|593686443|FG017|Overall Study|Withdrawal by Subject|1|||
164358281|NCT02554812|593686444|FG018|Overall Study|Withdrawal by Subject|0|||
164358282|NCT02554812|593686445|FG019|Overall Study|Withdrawal by Subject|2|||
164358283|NCT02554812|593686446|FG020|Overall Study|Withdrawal by Subject|0|||
164358284|NCT02554812|593686447|FG021|Overall Study|Withdrawal by Subject|1|||
164358285|NCT02554812|593686448|FG022|Overall Study|Withdrawal by Subject|0|||
164358286|NCT02554812|593686449|FG023|Overall Study|Withdrawal by Subject|1|||
164358287|NCT02554812|593686450|FG024|Overall Study|Withdrawal by Subject|0|||
164358288|NCT02554812|593686451|FG025|Overall Study|Withdrawal by Subject|0|||
164358289|NCT02554812|593686452|FG026|Overall Study|Withdrawal by Subject|1|||
164358290|NCT02554812|593686426|FG000|Overall Study|Physician Decision|1|||
164358291|NCT02554812|593686427|FG001|Overall Study|Physician Decision|0|||
164358292|NCT02554812|593686428|FG002|Overall Study|Physician Decision|0|||
164358293|NCT02554812|593686429|FG003|Overall Study|Physician Decision|1|||
164358294|NCT02554812|593686430|FG004|Overall Study|Physician Decision|0|||
164358295|NCT02554812|593686431|FG005|Overall Study|Physician Decision|1|||
164358296|NCT02554812|593686432|FG006|Overall Study|Physician Decision|0|||
164358297|NCT02554812|593686433|FG007|Overall Study|Physician Decision|0|||
164358298|NCT02554812|593686434|FG008|Overall Study|Physician Decision|0|||
164358299|NCT02554812|593686435|FG009|Overall Study|Physician Decision|0|||
164358300|NCT02554812|593686436|FG010|Overall Study|Physician Decision|1|||
164358301|NCT02554812|593686437|FG011|Overall Study|Physician Decision|0|||
164358302|NCT02554812|593686438|FG012|Overall Study|Physician Decision|0|||
164358303|NCT02554812|593686439|FG013|Overall Study|Physician Decision|0|||
164358304|NCT02554812|593686440|FG014|Overall Study|Physician Decision|0|||
164358305|NCT02554812|593686441|FG015|Overall Study|Physician Decision|0|||
164358306|NCT02554812|593686442|FG016|Overall Study|Physician Decision|1|||
164358307|NCT02554812|593686443|FG017|Overall Study|Physician Decision|1|||
164358308|NCT02554812|593686444|FG018|Overall Study|Physician Decision|0|||
164358309|NCT02554812|593686445|FG019|Overall Study|Physician Decision|1|||
164358310|NCT02554812|593686446|FG020|Overall Study|Physician Decision|1|||
164358311|NCT02554812|593686447|FG021|Overall Study|Physician Decision|0|||
164358312|NCT02554812|593686448|FG022|Overall Study|Physician Decision|1|||
164358313|NCT02554812|593686449|FG023|Overall Study|Physician Decision|0|||
164358314|NCT02554812|593686450|FG024|Overall Study|Physician Decision|0|||
164358315|NCT02554812|593686451|FG025|Overall Study|Physician Decision|0|||
164358316|NCT02554812|593686452|FG026|Overall Study|Physician Decision|0|||
164358317|NCT02554812|593686426|FG000|Overall Study|Study terminated by sponsor|0|||
164358318|NCT02554812|593686427|FG001|Overall Study|Study terminated by sponsor|0|||
164358319|NCT02554812|593686428|FG002|Overall Study|Study terminated by sponsor|0|||
164358320|NCT02554812|593686429|FG003|Overall Study|Study terminated by sponsor|0|||
164358321|NCT02554812|593686430|FG004|Overall Study|Study terminated by sponsor|0|||
164358322|NCT02554812|593686431|FG005|Overall Study|Study terminated by sponsor|0|||
164358323|NCT02554812|593686432|FG006|Overall Study|Study terminated by sponsor|0|||
164358324|NCT02554812|593686433|FG007|Overall Study|Study terminated by sponsor|0|||
164358325|NCT02554812|593686434|FG008|Overall Study|Study terminated by sponsor|0|||
164358326|NCT02554812|593686435|FG009|Overall Study|Study terminated by sponsor|0|||
164358327|NCT02554812|593686436|FG010|Overall Study|Study terminated by sponsor|0|||
164358328|NCT02554812|593686437|FG011|Overall Study|Study terminated by sponsor|0|||
164358329|NCT02554812|593686438|FG012|Overall Study|Study terminated by sponsor|0|||
164696536|NCT01885182|594912603|FG000|Overall Study|Adverse Event|11|||
164358330|NCT02554812|593686439|FG013|Overall Study|Study terminated by sponsor|0|||
164358331|NCT02554812|593686440|FG014|Overall Study|Study terminated by sponsor|0|||
164358332|NCT02554812|593686441|FG015|Overall Study|Study terminated by sponsor|0|||
164358333|NCT02554812|593686442|FG016|Overall Study|Study terminated by sponsor|0|||
164358334|NCT02554812|593686443|FG017|Overall Study|Study terminated by sponsor|0|||
164358335|NCT02554812|593686444|FG018|Overall Study|Study terminated by sponsor|0|||
164358336|NCT02554812|593686445|FG019|Overall Study|Study terminated by sponsor|0|||
164358337|NCT02554812|593686446|FG020|Overall Study|Study terminated by sponsor|0|||
164358338|NCT02554812|593686447|FG021|Overall Study|Study terminated by sponsor|0|||
164358339|NCT02554812|593686448|FG022|Overall Study|Study terminated by sponsor|0|||
164358340|NCT02554812|593686449|FG023|Overall Study|Study terminated by sponsor|0|||
164358341|NCT02554812|593686450|FG024|Overall Study|Study terminated by sponsor|1|||
164358342|NCT02554812|593686451|FG025|Overall Study|Study terminated by sponsor|0|||
164358343|NCT02554812|593686452|FG026|Overall Study|Study terminated by sponsor|0|||
164696537|NCT01885182|594912604|FG001|Overall Study|Adverse Event|13|||
164696538|NCT01885182|594912603|FG000|Overall Study|Withdrawal by Subject|13|||
164696539|NCT01885182|594912604|FG001|Overall Study|Withdrawal by Subject|6|||
164696540|NCT01885182|594912603|FG000|Overall Study|Lost to Follow-up|2|||
164696541|NCT01885182|594912604|FG001|Overall Study|Lost to Follow-up|2|||
164696542|NCT01885182|594912603|FG000|Overall Study|Lack of Efficacy|8|||
164696543|NCT01885182|594912604|FG001|Overall Study|Lack of Efficacy|1|||
164696544|NCT02310789|594912605|FG000|Overall Study|Adverse Event|1|||
164696545|NCT00380692|594912608|FG000|Study Period II - Double Blind|Adverse Event|1|||
164696546|NCT00380692|594912609|FG001|Study Period II - Double Blind|Adverse Event|0|||
164696547|NCT00380692|594912608|FG000|Study Period II - Double Blind|Protocol Violation|2|||
164696548|NCT00380692|594912609|FG001|Study Period II - Double Blind|Protocol Violation|2|||
164696549|NCT00380692|594912608|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
164696550|NCT00380692|594912609|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
164696551|NCT00380692|594912608|FG000|Study Period II - Double Blind|Physician Decision|0|||
164696552|NCT00380692|594912609|FG001|Study Period II - Double Blind|Physician Decision|1|||
164696553|NCT00380692|594912608|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
164696554|NCT00380692|594912609|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
164696555|NCT00380692|594912608|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
164696556|NCT00380692|594912609|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
164696557|NCT00380692|594912608|FG000|Study Period III - Open Label|Adverse Event|5|||
164696558|NCT00380692|594912609|FG001|Study Period III - Open Label|Adverse Event|3|||
164696559|NCT00380692|594912608|FG000|Study Period III - Open Label|Protocol Violation|0|||
164696560|NCT00380692|594912609|FG001|Study Period III - Open Label|Protocol Violation|0|||
164696561|NCT00380692|594912608|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
164696562|NCT00380692|594912609|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
164696563|NCT00380692|594912608|FG000|Study Period III - Open Label|Physician Decision|0|||
164696564|NCT00380692|594912609|FG001|Study Period III - Open Label|Physician Decision|3|||
164696565|NCT00380692|594912608|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
164696566|NCT00380692|594912609|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
164696567|NCT00380692|594912608|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
164696568|NCT00380692|594912609|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
164696569|NCT00708708|594912611|FG000|Overall Study|Another therapy instead of Enbrel|141|||
164696570|NCT00708708|594912611|FG000|Overall Study|Lost to Follow-up|52|||
164696571|NCT00708708|594912611|FG000|Overall Study|Withdrawal by Subject|51|||
164696572|NCT00708708|594912611|FG000|Overall Study|Intolerance|42|||
164696573|NCT00708708|594912611|FG000|Overall Study|Another therapy along with Enbrel|15|||
164696574|NCT00708708|594912611|FG000|Overall Study|Other unspecified|11|||
164696575|NCT00708708|594912611|FG000|Overall Study|Good effectiveness|9|||
164696576|NCT00708708|594912611|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
164696577|NCT00708708|594912611|FG000|Overall Study|Administrative reasons|7|||
164696578|NCT00708708|594912611|FG000|Overall Study|Lack of effectiveness|4|||
164696579|NCT00708708|594912611|FG000|Overall Study|Lack of compliance|3|||
164696580|NCT00708708|594912611|FG000|Overall Study|Pregnancy|3|||
164696581|NCT00708708|594912611|FG000|Overall Study|Adverse Event|3|||
164696582|NCT00708708|594912611|FG000|Overall Study|Missing values|392|||
164696583|NCT04213209|594912612|FG000|Overall Study|Protocol Violation|1|||
164358344|NCT02554812|593686426|FG000|Overall Study|No longer meets eligibility criteria|0|||
164358345|NCT02554812|593686427|FG001|Overall Study|No longer meets eligibility criteria|1|||
164590106|NCT01937130|594525150|FG002|Overall Study|Withdrawal by Subject|0|||
164590107|NCT01937130|594525151|FG003|Overall Study|Withdrawal by Subject|1|||
164590108|NCT01937130|594525148|FG000|Overall Study|Adverse Event|0|||
164590109|NCT01937130|594525149|FG001|Overall Study|Adverse Event|1|||
164590110|NCT01937130|594525150|FG002|Overall Study|Adverse Event|0|||
164590111|NCT01937130|594525151|FG003|Overall Study|Adverse Event|1|||
164590112|NCT01937130|594525148|FG000|Overall Study|Death|1|||
164590113|NCT01937130|594525149|FG001|Overall Study|Death|1|||
164590114|NCT01937130|594525150|FG002|Overall Study|Death|1|||
164590115|NCT01937130|594525151|FG003|Overall Study|Death|0|||
164590116|NCT01937130|594525148|FG000|Overall Study|Lost to Follow-up|2|||
164590117|NCT01937130|594525149|FG001|Overall Study|Lost to Follow-up|0|||
164590118|NCT01937130|594525150|FG002|Overall Study|Lost to Follow-up|2|||
164590119|NCT01937130|594525151|FG003|Overall Study|Lost to Follow-up|0|||
164590120|NCT01937130|594525148|FG000|Overall Study|Physician Decision|0|||
164590121|NCT01937130|594525149|FG001|Overall Study|Physician Decision|1|||
164590122|NCT01937130|594525150|FG002|Overall Study|Physician Decision|0|||
164590123|NCT01937130|594525151|FG003|Overall Study|Physician Decision|0|||
164590124|NCT01937130|594525148|FG000|Overall Study|Patients unable to swallow|0|||
164590125|NCT01937130|594525149|FG001|Overall Study|Patients unable to swallow|1|||
164696584|NCT04213209|594912613|FG001|Overall Study|Protocol Violation|0|||
164696585|NCT04213209|594912614|FG002|Overall Study|Protocol Violation|0|||
164696586|NCT04213209|594912615|FG003|Overall Study|Protocol Violation|0|||
164696587|NCT04213209|594912616|FG004|Overall Study|Protocol Violation|0|||
164696588|NCT04213209|594912617|FG005|Overall Study|Protocol Violation|0|||
164590126|NCT01937130|594525150|FG002|Overall Study|Patients unable to swallow|0|||
164696589|NCT02065713|594912620|FG000|Overall Study|Adverse Event|0|||
164696590|NCT02065713|594912621|FG001|Overall Study|Adverse Event|1|||
164696591|NCT02065713|594912620|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164696592|NCT02065713|594912621|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164696593|NCT00140413|594912624|FG000|Overall Study|Lost to Follow-up|1|||
164696594|NCT00140413|594912625|FG001|Overall Study|Lost to Follow-up|0|||
164696595|NCT00140413|594912624|FG000|Overall Study|Withdrawal by Subject|2|||
164696596|NCT00140413|594912625|FG001|Overall Study|Withdrawal by Subject|0|||
164696597|NCT02459665|594912626|FG000|Overall Study|Withdrawal by Subject|0|||
164696598|NCT02459665|594912627|FG001|Overall Study|Withdrawal by Subject|1|||
164696599|NCT02459665|594912628|FG002|Overall Study|Withdrawal by Subject|1|||
164696600|NCT02459665|594912629|FG003|Overall Study|Withdrawal by Subject|2|||
164696601|NCT03005067|594912632|FG000|Overall Study|Withdrawal by Subject|3|||
164696602|NCT03005067|594912633|FG001|Overall Study|Withdrawal by Subject|2|||
164696603|NCT03005067|594912632|FG000|Overall Study|Adverse Event|4|||
164696604|NCT03005067|594912633|FG001|Overall Study|Adverse Event|3|||
164696605|NCT03005067|594912632|FG000|Overall Study|Other (reason not specified)|3|||
164696606|NCT03005067|594912633|FG001|Overall Study|Other (reason not specified)|1|||
164696607|NCT03005067|594912632|FG000|Overall Study|Protocol Violation|0|||
164696608|NCT03005067|594912633|FG001|Overall Study|Protocol Violation|1|||
164696609|NCT00296491|594912636|FG000|Overall Study|Low Pollen Counts|18|||
164696610|NCT00296491|594912637|FG001|Overall Study|Low Pollen Counts|26|||
164696611|NCT00296491|594912638|FG002|Overall Study|Low Pollen Counts|25|||
164696612|NCT00296491|594912639|FG003|Overall Study|Low Pollen Counts|16|||
164696613|NCT00296491|594912636|FG000|Overall Study|Protocol Violation|4|||
164696614|NCT00296491|594912637|FG001|Overall Study|Protocol Violation|6|||
164696615|NCT00296491|594912638|FG002|Overall Study|Protocol Violation|2|||
164696616|NCT00296491|594912639|FG003|Overall Study|Protocol Violation|3|||
164696617|NCT00296491|594912636|FG000|Overall Study|Adverse Event|1|||
164696618|NCT00296491|594912637|FG001|Overall Study|Adverse Event|3|||
164696619|NCT00296491|594912638|FG002|Overall Study|Adverse Event|1|||
164696620|NCT00296491|594912639|FG003|Overall Study|Adverse Event|4|||
164696621|NCT00296491|594912636|FG000|Overall Study|Withdrawn due to Asthma|0|||
164696622|NCT00296491|594912637|FG001|Overall Study|Withdrawn due to Asthma|0|||
164696623|NCT00296491|594912638|FG002|Overall Study|Withdrawn due to Asthma|0|||
164696624|NCT00296491|594912639|FG003|Overall Study|Withdrawn due to Asthma|4|||
164696625|NCT00296491|594912636|FG000|Overall Study|Withdrawal by Subject|7|||
164696626|NCT00296491|594912637|FG001|Overall Study|Withdrawal by Subject|3|||
164696627|NCT00296491|594912638|FG002|Overall Study|Withdrawal by Subject|3|||
164696628|NCT00296491|594912639|FG003|Overall Study|Withdrawal by Subject|2|||
164696629|NCT00296491|594912636|FG000|Overall Study|Non-Compliance|12|||
164696630|NCT00296491|594912637|FG001|Overall Study|Non-Compliance|13|||
164696631|NCT00296491|594912638|FG002|Overall Study|Non-Compliance|10|||
164696632|NCT00296491|594912639|FG003|Overall Study|Non-Compliance|14|||
164696633|NCT00296491|594912636|FG000|Overall Study|Lost to Follow-up|0|||
164696634|NCT00296491|594912637|FG001|Overall Study|Lost to Follow-up|2|||
164696635|NCT00296491|594912638|FG002|Overall Study|Lost to Follow-up|2|||
164696636|NCT00296491|594912639|FG003|Overall Study|Lost to Follow-up|0|||
164696637|NCT01929395|594912644|FG000|Overall Study|Did not complete - non-related toxicity|1|||
164696638|NCT01929395|594912645|FG001|Overall Study|Did not complete - non-related toxicity|0|||
164696639|NCT01929395|594912646|FG002|Overall Study|Did not complete - non-related toxicity|0|||
164696640|NCT01929395|594912644|FG000|Overall Study|Withdrawal by Subject|0|||
164696641|NCT01929395|594912645|FG001|Overall Study|Withdrawal by Subject|1|||
164696642|NCT01929395|594912646|FG002|Overall Study|Withdrawal by Subject|0|||
164696643|NCT01929395|594912644|FG000|Overall Study|Screen Fail|0|||
164696644|NCT01929395|594912645|FG001|Overall Study|Screen Fail|0|||
164696645|NCT01929395|594912646|FG002|Overall Study|Screen Fail|1|||
164696646|NCT03604341|594912648|FG000|Overall Study|Withdrawal by Subject|1|||
164696647|NCT03604341|594912649|FG001|Overall Study|Withdrawal by Subject|1|||
164696648|NCT03604341|594912648|FG000|Overall Study|Adverse Event|1|||
164696649|NCT03604341|594912649|FG001|Overall Study|Adverse Event|0|||
164696650|NCT03604341|594912648|FG000|Overall Study|Protocol Violation|0|||
164696651|NCT03604341|594912649|FG001|Overall Study|Protocol Violation|1|||
164696652|NCT00355472|594912650|FG000|Overall Study|Physician Decision|1|||
164696653|NCT04706507|594912657|FG000|Overall Study|Death|45|||
164696654|NCT04706507|594912658|FG001|Overall Study|Death|22|||
164696655|NCT04706507|594912657|FG000|Overall Study|Unable to adhere|0|||
164696656|NCT04706507|594912658|FG001|Overall Study|Unable to adhere|2|||
164696657|NCT04706507|594912657|FG000|Overall Study|Lost to Follow-up|13|||
164696658|NCT04706507|594912658|FG001|Overall Study|Lost to Follow-up|12|||
164696659|NCT04706507|594912657|FG000|Overall Study|Withdrawal of consent|1|||
164696660|NCT04706507|594912658|FG001|Overall Study|Withdrawal of consent|1|||
164696661|NCT04706507|594912657|FG000|Overall Study|Patient or LAR refuses further participation|0|||
164696662|NCT04706507|594912658|FG001|Overall Study|Patient or LAR refuses further participation|3|||
164696663|NCT02310763|594912662|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
164696664|NCT02310763|594912663|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
164696665|NCT02310763|594912664|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
164696666|NCT02310763|594912662|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
164696667|NCT02310763|594912663|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
164696668|NCT02310763|594912664|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
164696669|NCT02310763|594912662|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
164696670|NCT02310763|594912663|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
164696671|NCT02310763|594912664|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
164696672|NCT02310763|594912662|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
164696673|NCT02310763|594912663|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
164696674|NCT02310763|594912664|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
164696675|NCT02310763|594912662|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
164696676|NCT02310763|594912663|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
164696677|NCT02310763|594912664|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
164696678|NCT01731886|594912666|FG000|Overall Study|Death|1|||
164696679|NCT01731886|594912667|FG001|Overall Study|Death|0|||
164696680|NCT01731886|594912666|FG000|Overall Study|Never started treatment|0|||
164696681|NCT01731886|594912667|FG001|Overall Study|Never started treatment|1|||
164696682|NCT01731886|594912666|FG000|Overall Study|Non-compliant|1|||
164696683|NCT01731886|594912667|FG001|Overall Study|Non-compliant|0|||
164696684|NCT02280187|594912668|FG000|Overall Study|Lost to Follow-up|218|||
164696685|NCT00939627|594912669|FG000|Overall Study|Disease Progression|16|||
164696686|NCT00939627|594912670|FG001|Overall Study|Disease Progression|12|||
164696687|NCT00939627|594912671|FG002|Overall Study|Disease Progression|0|||
164696688|NCT00939627|594912669|FG000|Overall Study|Adverse Event|6|||
164696689|NCT00939627|594912670|FG001|Overall Study|Adverse Event|7|||
164696690|NCT00939627|594912671|FG002|Overall Study|Adverse Event|0|||
164696691|NCT00939627|594912669|FG000|Overall Study|Death|0|||
164696692|NCT00939627|594912670|FG001|Overall Study|Death|2|||
164696693|NCT00939627|594912671|FG002|Overall Study|Death|0|||
164696694|NCT00939627|594912669|FG000|Overall Study|Withdrawal by Subject|2|||
164696695|NCT00939627|594912670|FG001|Overall Study|Withdrawal by Subject|4|||
164696696|NCT00939627|594912671|FG002|Overall Study|Withdrawal by Subject|0|||
164696697|NCT00939627|594912669|FG000|Overall Study|Other complicating disease|1|||
164696698|NCT00939627|594912670|FG001|Overall Study|Other complicating disease|1|||
164696699|NCT00939627|594912671|FG002|Overall Study|Other complicating disease|0|||
164696700|NCT00939627|594912669|FG000|Overall Study|Not compliant|2|||
164696701|NCT00939627|594912670|FG001|Overall Study|Not compliant|0|||
164696702|NCT00939627|594912671|FG002|Overall Study|Not compliant|0|||
164696703|NCT00939627|594912669|FG000|Overall Study|No off-tx reason given|0|||
164696704|NCT00939627|594912670|FG001|Overall Study|No off-tx reason given|2|||
164696705|NCT00939627|594912671|FG002|Overall Study|No off-tx reason given|0|||
164696706|NCT03417830|594912674|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
164696707|NCT03417830|594912675|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
164696708|NCT02563769|594912676|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
164696709|NCT02563769|594912677|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
164696710|NCT02563769|594912678|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
164696711|NCT00303667|594912690|FG000|Overall Study|Death|0|||
164696712|NCT00303667|594912691|FG001|Overall Study|Death|4|||
164696713|NCT01523587|594912692|FG000|Overall Study|Other than listed|5|||
164696714|NCT01523587|594912693|FG001|Overall Study|Other than listed|5|||
164696715|NCT01523587|594912692|FG000|Overall Study|Worsening of underlying cancer disease|19|||
164696716|NCT01523587|594912693|FG001|Overall Study|Worsening of underlying cancer disease|34|||
164696717|NCT01523587|594912692|FG000|Overall Study|Adverse Event|68|||
164696718|NCT01523587|594912693|FG001|Overall Study|Adverse Event|52|||
164696719|NCT01523587|594912692|FG000|Overall Study|Protocol Violation|5|||
164696720|NCT01523587|594912693|FG001|Overall Study|Protocol Violation|3|||
164696721|NCT01523587|594912692|FG000|Overall Study|Lost to Follow-up|2|||
164696722|NCT01523587|594912693|FG001|Overall Study|Lost to Follow-up|2|||
164696723|NCT01523587|594912692|FG000|Overall Study|Withdrawal by Subject|28|||
164696724|NCT01523587|594912693|FG001|Overall Study|Withdrawal by Subject|20|||
164696725|NCT01523587|594912692|FG000|Overall Study|Withdrew due to Progressive disease|265|||
164696726|NCT01523587|594912693|FG001|Overall Study|Withdrew due to Progressive disease|279|||
164696727|NCT01523587|594912692|FG000|Overall Study|Randomised but bot treated|6|||
164696728|NCT01523587|594912693|FG001|Overall Study|Randomised but bot treated|2|||
164696729|NCT00724373|594912694|FG000|Overall Study|Adverse Event|41|||
164696730|NCT00724373|594912694|FG000|Overall Study|Lack of Efficacy|82|||
164696731|NCT00724373|594912694|FG000|Overall Study|Lost to Follow-up|7|||
164696732|NCT00724373|594912694|FG000|Overall Study|Non-compliance|2|||
164696733|NCT00724373|594912694|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
164696734|NCT00724373|594912694|FG000|Overall Study|Participant moved away|1|||
164696735|NCT00724373|594912694|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
164696736|NCT00724373|594912694|FG000|Overall Study|Only to have 24 week regimen|1|||
164696737|NCT00724373|594912694|FG000|Overall Study|Viral Relapse|1|||
164696738|NCT00724373|594912694|FG000|Overall Study|Acute HCV infection|1|||
164696739|NCT00724373|594912694|FG000|Overall Study|Drug Relapse|1|||
164696740|NCT00724373|594912694|FG000|Overall Study|Tolerability|23|||
164696741|NCT02083926|594912697|FG000|Overall Study|Withdrawal by Subject|1|||
164696742|NCT02083926|594912698|FG001|Overall Study|Withdrawal by Subject|0|||
164696743|NCT03465436|594912701|FG000|Period 1|Protocol Violation|0|||
164696744|NCT03465436|594912702|FG001|Period 1|Protocol Violation|0|||
164696745|NCT03465436|594912703|FG002|Period 1|Protocol Violation|1|||
164696746|NCT03465436|594912704|FG003|Period 1|Protocol Violation|0|||
164696747|NCT03465436|594912701|FG000|Period 2|Protocol Violation|0|||
164696748|NCT03465436|594912702|FG001|Period 2|Protocol Violation|1|||
164696749|NCT03465436|594912703|FG002|Period 2|Protocol Violation|0|||
164696750|NCT03465436|594912704|FG003|Period 2|Protocol Violation|0|||
164696751|NCT03465436|594912701|FG000|Period 3|Protocol Violation|1|||
164696752|NCT03465436|594912702|FG001|Period 3|Protocol Violation|1|||
164696753|NCT03465436|594912703|FG002|Period 3|Protocol Violation|0|||
164358346|NCT02554812|593686428|FG002|Overall Study|No longer meets eligibility criteria|0|||
164358347|NCT02554812|593686429|FG003|Overall Study|No longer meets eligibility criteria|0|||
164358348|NCT02554812|593686430|FG004|Overall Study|No longer meets eligibility criteria|0|||
164358349|NCT02554812|593686431|FG005|Overall Study|No longer meets eligibility criteria|0|||
164358350|NCT02554812|593686432|FG006|Overall Study|No longer meets eligibility criteria|0|||
164358351|NCT02554812|593686433|FG007|Overall Study|No longer meets eligibility criteria|0|||
164358352|NCT02554812|593686434|FG008|Overall Study|No longer meets eligibility criteria|0|||
164358353|NCT02554812|593686435|FG009|Overall Study|No longer meets eligibility criteria|0|||
164358354|NCT02554812|593686436|FG010|Overall Study|No longer meets eligibility criteria|0|||
164358355|NCT02554812|593686437|FG011|Overall Study|No longer meets eligibility criteria|0|||
164358356|NCT02554812|593686438|FG012|Overall Study|No longer meets eligibility criteria|0|||
164358357|NCT02554812|593686439|FG013|Overall Study|No longer meets eligibility criteria|0|||
164358358|NCT02554812|593686440|FG014|Overall Study|No longer meets eligibility criteria|0|||
164590127|NCT01937130|594525151|FG003|Overall Study|Patients unable to swallow|0|||
164590128|NCT01937130|594525148|FG000|Overall Study|Patient lost to FU due to death|2|||
164590129|NCT01937130|594525149|FG001|Overall Study|Patient lost to FU due to death|0|||
164590130|NCT01937130|594525150|FG002|Overall Study|Patient lost to FU due to death|0|||
164590131|NCT01937130|594525151|FG003|Overall Study|Patient lost to FU due to death|0|||
164590132|NCT04191967|594525152|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
164590133|NCT04191967|594525152|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
164590134|NCT01431144|594525153|FG000|Overall Study|Implant mobility and removal|2|||
164590135|NCT01431144|594525154|FG001|Overall Study|Implant mobility and removal|0|||
164590136|NCT00747617|594525160|FG000|Overall Study|Lost to Follow-up|3|||
164590137|NCT00747617|594525161|FG001|Overall Study|Lost to Follow-up|1|||
164590138|NCT01746732|594525162|FG000|Lead-In Period|Withdrawal by Subject|1|||
164590139|NCT01746732|594525163|FG001|Lead-In Period|Withdrawal by Subject|0|||
164590140|NCT01746732|594525164|FG002|Lead-In Period|Withdrawal by Subject|0|||
164590141|NCT01746732|594525162|FG000|Period 1|Physician Decision|0|||
164590142|NCT01746732|594525163|FG001|Period 1|Physician Decision|1|||
164590143|NCT01746732|594525164|FG002|Period 1|Physician Decision|0|||
164590144|NCT01746732|594525162|FG000|Period 2|Withdrawal by Subject|0|||
164590145|NCT01746732|594525163|FG001|Period 2|Withdrawal by Subject|0|||
164590146|NCT01746732|594525164|FG002|Period 2|Withdrawal by Subject|2|||
164590147|NCT01746732|594525162|FG000|Period 2|Adverse Event|0|||
164590148|NCT01746732|594525163|FG001|Period 2|Adverse Event|0|||
164590149|NCT01746732|594525164|FG002|Period 2|Adverse Event|1|||
164590150|NCT01746732|594525162|FG000|Period 2|Lost to Follow-up|0|||
164590151|NCT01746732|594525163|FG001|Period 2|Lost to Follow-up|0|||
164590152|NCT01746732|594525164|FG002|Period 2|Lost to Follow-up|1|||
164590153|NCT00137436|594525165|FG000|Overall Study|Adverse Event|13|||
164590154|NCT00137436|594525165|FG000|Overall Study|Death|2|||
164590155|NCT00137436|594525165|FG000|Overall Study|Lack of Efficacy|17|||
164590156|NCT00137436|594525165|FG000|Overall Study|Withdrawal by Subject|6|||
164590157|NCT00137436|594525165|FG000|Overall Study|Other|5|||
164590158|NCT00165646|594525166|FG000|Overall Study|Adverse Event|1|||
164590159|NCT00165646|594525167|FG001|Overall Study|Adverse Event|1|||
164590160|NCT00165646|594525168|FG002|Overall Study|Adverse Event|1|||
164590161|NCT00165646|594525166|FG000|Overall Study|Lack of Efficacy|1|||
164590162|NCT00165646|594525167|FG001|Overall Study|Lack of Efficacy|2|||
164590163|NCT00165646|594525168|FG002|Overall Study|Lack of Efficacy|0|||
164590164|NCT00165646|594525166|FG000|Overall Study|Withdrawal by Subject|0|||
164590165|NCT00165646|594525167|FG001|Overall Study|Withdrawal by Subject|2|||
164590166|NCT00165646|594525168|FG002|Overall Study|Withdrawal by Subject|1|||
164590167|NCT00165646|594525166|FG000|Overall Study|Physician Decision|2|||
164696754|NCT03465436|594912704|FG003|Period 3|Protocol Violation|0|||
164358359|NCT02554812|593686441|FG015|Overall Study|No longer meets eligibility criteria|0|||
164590168|NCT00165646|594525167|FG001|Overall Study|Physician Decision|0|||
164590169|NCT00165646|594525168|FG002|Overall Study|Physician Decision|2|||
164696755|NCT03465436|594912701|FG000|Period 4|Protocol Violation|0|||
164437930|NCT01212757|593968257|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
164437931|NCT01212757|593968258|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
164437932|NCT01212757|593968259|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
164437933|NCT01212757|593968251|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
164437934|NCT01212757|593968252|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
164437935|NCT01212757|593968253|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
164437936|NCT01212757|593968254|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
164437937|NCT01212757|593968255|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
164437938|NCT01212757|593968256|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
164437939|NCT01212757|593968257|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
164437940|NCT01212757|593968258|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
164437941|NCT01212757|593968259|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
164437942|NCT01212757|593968251|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
164437943|NCT01212757|593968252|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
164437944|NCT01212757|593968253|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
164437945|NCT01212757|593968254|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
164437946|NCT01212757|593968255|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
164437947|NCT01212757|593968256|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
164437948|NCT01212757|593968257|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
164437949|NCT01212757|593968258|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
164437950|NCT01212757|593968259|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
164437951|NCT01212757|593968251|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
164437952|NCT01212757|593968252|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
164437953|NCT01212757|593968253|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
164437954|NCT01212757|593968254|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
164437955|NCT01212757|593968255|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
164437956|NCT01212757|593968256|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
164437957|NCT01212757|593968257|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
164437958|NCT01212757|593968258|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
164437959|NCT01212757|593968259|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
164437960|NCT01212757|593968251|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
164437961|NCT01212757|593968252|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
164437962|NCT01212757|593968253|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
164437963|NCT01212757|593968254|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
164437964|NCT01212757|593968255|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
164437965|NCT01212757|593968256|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
164437966|NCT01212757|593968257|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
164437967|NCT01212757|593968258|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
164437968|NCT01212757|593968259|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
164437969|NCT01212757|593968251|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
164437970|NCT01212757|593968252|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
164437971|NCT01212757|593968253|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
164437972|NCT01212757|593968254|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
164437973|NCT01212757|593968255|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
164437974|NCT01212757|593968256|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
164437975|NCT01212757|593968257|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
164437976|NCT01212757|593968258|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
164437977|NCT01212757|593968259|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
164437978|NCT01212757|593968251|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
164437979|NCT01212757|593968252|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
164437980|NCT01212757|593968253|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
164437981|NCT01212757|593968254|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
164437982|NCT01212757|593968255|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
164437983|NCT01212757|593968256|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
164437984|NCT01212757|593968257|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
164437985|NCT01212757|593968258|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
164437986|NCT01212757|593968259|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
164437987|NCT01212757|593968251|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
164437988|NCT01212757|593968252|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
164437989|NCT01212757|593968253|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
164437990|NCT01212757|593968254|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
164437991|NCT01212757|593968255|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
164437992|NCT01212757|593968256|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
164437993|NCT01212757|593968257|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
164437994|NCT01212757|593968258|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
164437995|NCT01212757|593968259|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
164437996|NCT01212757|593968251|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
164437997|NCT01212757|593968252|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
164437998|NCT01212757|593968253|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
164358360|NCT02554812|593686442|FG016|Overall Study|No longer meets eligibility criteria|0|||
164358361|NCT02554812|593686443|FG017|Overall Study|No longer meets eligibility criteria|0|||
164590170|NCT00165646|594525166|FG000|Overall Study|Protocol Violation|1|||
164590171|NCT00165646|594525167|FG001|Overall Study|Protocol Violation|0|||
164696756|NCT03465436|594912702|FG001|Period 4|Protocol Violation|0|||
164696757|NCT03465436|594912703|FG002|Period 4|Protocol Violation|1|||
164696758|NCT03465436|594912704|FG003|Period 4|Protocol Violation|0|||
164696759|NCT02244424|594912705|FG000|Overall Study|Lost to Follow-up|20|||
164696760|NCT02244424|594912706|FG001|Overall Study|Lost to Follow-up|10|||
164696761|NCT04117945|594912707|FG000|Overall Study|Death|1|||
164696762|NCT04117945|594912708|FG001|Overall Study|Death|0|||
164696763|NCT04117945|594912707|FG000|Overall Study|Withdrawal by Subject|3|||
164696764|NCT04117945|594912708|FG001|Overall Study|Withdrawal by Subject|1|||
164696765|NCT04117945|594912707|FG000|Overall Study|Disease Progression|0|||
164696766|NCT04117945|594912708|FG001|Overall Study|Disease Progression|2|||
164696767|NCT04117945|594912707|FG000|Overall Study|Ineligible|8|||
164696768|NCT04117945|594912708|FG001|Overall Study|Ineligible|7|||
164696769|NCT01524913|594912712|FG000|Overall Study|Lost to Follow-up|4|||
164696770|NCT01524913|594912713|FG001|Overall Study|Lost to Follow-up|0|||
164696771|NCT01524913|594912714|FG002|Overall Study|Lost to Follow-up|0|||
164590172|NCT00165646|594525168|FG002|Overall Study|Protocol Violation|0|||
164590173|NCT01104558|594525169|FG000|Overall Study|Protocol Violation|6|||
164590174|NCT01104558|594525169|FG000|Overall Study|Missing of primary efficacy assessment|10|||
164590175|NCT01104558|594525169|FG000|Overall Study|Missing of genetic analysis results|1|||
164590176|NCT00696657|594525170|FG000|Overall Study|Protocol Violation|0|||
164590177|NCT00696657|594525171|FG001|Overall Study|Protocol Violation|0|||
164590178|NCT00696657|594525172|FG002|Overall Study|Protocol Violation|0|||
164590179|NCT00696657|594525173|FG003|Overall Study|Protocol Violation|0|||
164590180|NCT00696657|594525174|FG004|Overall Study|Protocol Violation|0|||
164590181|NCT00696657|594525175|FG005|Overall Study|Protocol Violation|1|||
164590182|NCT00696657|594525176|FG006|Overall Study|Protocol Violation|0|||
164590183|NCT00696657|594525177|FG007|Overall Study|Protocol Violation|0|||
164590184|NCT00696657|594525178|FG008|Overall Study|Protocol Violation|1|||
164590185|NCT00696657|594525170|FG000|Overall Study|Lack of Efficacy|0|||
164590186|NCT00696657|594525171|FG001|Overall Study|Lack of Efficacy|1|||
164590187|NCT00696657|594525172|FG002|Overall Study|Lack of Efficacy|0|||
164590188|NCT00696657|594525173|FG003|Overall Study|Lack of Efficacy|0|||
164590189|NCT00696657|594525174|FG004|Overall Study|Lack of Efficacy|0|||
164590190|NCT00696657|594525175|FG005|Overall Study|Lack of Efficacy|0|||
164590191|NCT00696657|594525176|FG006|Overall Study|Lack of Efficacy|0|||
164590192|NCT00696657|594525177|FG007|Overall Study|Lack of Efficacy|0|||
164590193|NCT00696657|594525178|FG008|Overall Study|Lack of Efficacy|0|||
164590194|NCT00696657|594525170|FG000|Overall Study|Withdrawal criteria|1|||
164590195|NCT00696657|594525171|FG001|Overall Study|Withdrawal criteria|3|||
164590196|NCT00696657|594525172|FG002|Overall Study|Withdrawal criteria|2|||
164590197|NCT00696657|594525173|FG003|Overall Study|Withdrawal criteria|2|||
164590198|NCT00696657|594525174|FG004|Overall Study|Withdrawal criteria|0|||
164590199|NCT00696657|594525175|FG005|Overall Study|Withdrawal criteria|0|||
164590200|NCT00696657|594525176|FG006|Overall Study|Withdrawal criteria|1|||
164590201|NCT00696657|594525177|FG007|Overall Study|Withdrawal criteria|1|||
164590202|NCT00696657|594525178|FG008|Overall Study|Withdrawal criteria|2|||
164590203|NCT00696657|594525170|FG000|Overall Study|Unclassified|0|||
164590204|NCT00696657|594525171|FG001|Overall Study|Unclassified|1|||
164696772|NCT00402025|594912715|FG000|Overall Study|Adverse Event|0|||
164590205|NCT00696657|594525172|FG002|Overall Study|Unclassified|3|||
164590206|NCT00696657|594525173|FG003|Overall Study|Unclassified|2|||
164590207|NCT00696657|594525174|FG004|Overall Study|Unclassified|4|||
164358362|NCT02554812|593686444|FG018|Overall Study|No longer meets eligibility criteria|0|||
164696773|NCT00402025|594912716|FG001|Overall Study|Adverse Event|0|||
164696774|NCT00402025|594912717|FG002|Overall Study|Adverse Event|2|||
164696775|NCT00402025|594912715|FG000|Overall Study|Death|0|||
164696776|NCT00402025|594912716|FG001|Overall Study|Death|1|||
164696777|NCT00402025|594912717|FG002|Overall Study|Death|5|||
164696778|NCT00402025|594912715|FG000|Overall Study|Disease Progression|1|||
164696779|NCT00402025|594912716|FG001|Overall Study|Disease Progression|1|||
164696780|NCT00402025|594912717|FG002|Overall Study|Disease Progression|2|||
164358363|NCT02554812|593686445|FG019|Overall Study|No longer meets eligibility criteria|0|||
164358364|NCT02554812|593686446|FG020|Overall Study|No longer meets eligibility criteria|0|||
164358365|NCT02554812|593686447|FG021|Overall Study|No longer meets eligibility criteria|0|||
164358366|NCT02554812|593686448|FG022|Overall Study|No longer meets eligibility criteria|0|||
164358367|NCT02554812|593686449|FG023|Overall Study|No longer meets eligibility criteria|0|||
164358368|NCT02554812|593686450|FG024|Overall Study|No longer meets eligibility criteria|0|||
164358369|NCT02554812|593686451|FG025|Overall Study|No longer meets eligibility criteria|0|||
164358370|NCT02554812|593686452|FG026|Overall Study|No longer meets eligibility criteria|0|||
164358371|NCT02879305|593686453|FG000|Overall Study|Investigator Site Closed|55|||
164358372|NCT02879305|593686454|FG001|Overall Study|Investigator Site Closed|57|||
164358373|NCT02879305|593686453|FG000|Overall Study|Withdrawal by Subject|44|||
164358374|NCT02879305|593686454|FG001|Overall Study|Withdrawal by Subject|42|||
164358375|NCT02879305|593686453|FG000|Overall Study|Lost to Follow-up|17|||
164358376|NCT02879305|593686454|FG001|Overall Study|Lost to Follow-up|12|||
164358377|NCT02879305|593686453|FG000|Overall Study|Other|1|||
164358378|NCT02879305|593686454|FG001|Overall Study|Other|0|||
164358379|NCT01786629|593688141|FG000|Overall Study|Lack of Efficacy|0|||
164358380|NCT01786629|593688142|FG001|Overall Study|Lack of Efficacy|4|||
164358381|NCT01786629|593688141|FG000|Overall Study|Adverse Event|0|||
164358382|NCT01786629|593688142|FG001|Overall Study|Adverse Event|1|||
164358383|NCT00180414|593688143|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
164358384|NCT00180414|593688144|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
164358385|NCT00613938|593688145|FG000|Overall Study|Withdrawal by Subject|2|||
164358386|NCT00613938|593688146|FG001|Overall Study|Withdrawal by Subject|4|||
164358387|NCT00613938|593688147|FG002|Overall Study|Withdrawal by Subject|9|||
164358388|NCT00613938|593688148|FG003|Overall Study|Withdrawal by Subject|9|||
164358389|NCT00613938|593688145|FG000|Overall Study|Adverse Event|1|||
164358390|NCT00613938|593688146|FG001|Overall Study|Adverse Event|4|||
164358391|NCT00613938|593688147|FG002|Overall Study|Adverse Event|8|||
164358392|NCT00613938|593688148|FG003|Overall Study|Adverse Event|5|||
164358393|NCT00613938|593688145|FG000|Overall Study|Lack of Efficacy|16|||
164358394|NCT00613938|593688146|FG001|Overall Study|Lack of Efficacy|18|||
164358395|NCT00613938|593688147|FG002|Overall Study|Lack of Efficacy|5|||
164358396|NCT00613938|593688148|FG003|Overall Study|Lack of Efficacy|9|||
164358397|NCT00613938|593688145|FG000|Overall Study|Other|1|||
164358398|NCT00613938|593688146|FG001|Overall Study|Other|2|||
164358399|NCT00613938|593688147|FG002|Overall Study|Other|1|||
164358400|NCT00613938|593688148|FG003|Overall Study|Other|3|||
164358401|NCT00623727|593688149|FG000|Double Blind (DB)|Adverse Event|1|||
164358402|NCT00623727|593688150|FG001|Double Blind (DB)|Adverse Event|3|||
164358403|NCT00623727|593688149|FG000|Double Blind (DB)|Physician Decision|0|||
164358404|NCT00623727|593688150|FG001|Double Blind (DB)|Physician Decision|1|||
164358405|NCT00623727|593688149|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
164358406|NCT00623727|593688150|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
164358407|NCT00623727|593688149|FG000|Double Blind (DB)|Lack of Efficacy|2|||
164358408|NCT00623727|593688150|FG001|Double Blind (DB)|Lack of Efficacy|2|||
164358409|NCT00623727|593688149|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
164358410|NCT00623727|593688150|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
164358411|NCT00623727|593688149|FG000|Double Blind (DB)|Lost to Follow-up|1|||
164358412|NCT00623727|593688150|FG001|Double Blind (DB)|Lost to Follow-up|1|||
164696781|NCT00402025|594912715|FG000|Overall Study|Physician Decision|1|||
164696782|NCT00402025|594912716|FG001|Overall Study|Physician Decision|1|||
164358413|NCT00623727|593688149|FG000|Double Blind (DB)|Protocol Violation|2|||
164358414|NCT00623727|593688150|FG001|Double Blind (DB)|Protocol Violation|2|||
164358415|NCT00623727|593688149|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
164358416|NCT00623727|593688150|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
164358417|NCT00623727|593688149|FG000|Open Label Follow-up|Study termination|0|||
164696783|NCT00402025|594912717|FG002|Overall Study|Physician Decision|0|||
164696784|NCT00402025|594912715|FG000|Overall Study|Participant Decision|0|||
164358418|NCT00623727|593688150|FG001|Open Label Follow-up|Study termination|6|||
164358419|NCT00623727|593688149|FG000|Open Label Follow-up|Participant convenience|0|||
164358420|NCT00623727|593688150|FG001|Open Label Follow-up|Participant convenience|1|||
164358421|NCT01852942|593688151|FG000|Overall Study|Physician Decision|1|||
164358422|NCT01852942|593688152|FG001|Overall Study|Physician Decision|0|||
164358423|NCT01852942|593688151|FG000|Overall Study|Death|1|||
164696785|NCT00402025|594912716|FG001|Overall Study|Participant Decision|0|||
164437999|NCT01212757|593968254|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
164696786|NCT00402025|594912717|FG002|Overall Study|Participant Decision|1|||
164696787|NCT03940703|594914039|FG000|Overall Study|Still under treatment|31|||
164696788|NCT03940703|594914040|FG001|Overall Study|Still under treatment|0|||
164696789|NCT04079712|594914041|FG000|Overall Study|Disease progression before starting treatment|1|||
164696790|NCT01475253|594914042|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
164696791|NCT01475253|594914043|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
164696792|NCT01475253|594914044|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
164696793|NCT01475253|594914045|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
164696794|NCT01475253|594914042|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
164696795|NCT01475253|594914043|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
164696796|NCT01475253|594914044|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
164696797|NCT01475253|594914045|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
164696798|NCT02676284|594914047|FG000|Overall Study|Withdrawal by Subject|1|||
164696799|NCT04507126|594914049|FG000|Overall Study|Withdrawal by Subject|3|||
164696800|NCT04507126|594914049|FG000|Overall Study|Protocol Violation|4|||
164696801|NCT01567826|594914053|FG000|Overall Study|Lost to Follow-up|3|||
164696802|NCT01567826|594914054|FG001|Overall Study|Lost to Follow-up|2|||
164696803|NCT00865098|594914058|FG000|Overall Study|Progressive disease|1|||
164696804|NCT01014624|594914059|FG000|Overall Study|Adverse Event|0|||
164696805|NCT01014624|594914060|FG001|Overall Study|Adverse Event|1|||
164696806|NCT01014624|594914059|FG000|Overall Study|Protocol Violation|1|||
164696807|NCT01014624|594914060|FG001|Overall Study|Protocol Violation|0|||
164696808|NCT01014624|594914059|FG000|Overall Study|Withdrawal by Subject|1|||
164590208|NCT00696657|594525175|FG005|Overall Study|Unclassified|2|||
164590209|NCT00696657|594525176|FG006|Overall Study|Unclassified|0|||
164590210|NCT00696657|594525177|FG007|Overall Study|Unclassified|0|||
164590211|NCT00696657|594525178|FG008|Overall Study|Unclassified|1|||
164590212|NCT00696657|594525170|FG000|Overall Study|Adverse Event|0|||
164590213|NCT00696657|594525171|FG001|Overall Study|Adverse Event|0|||
164590214|NCT00696657|594525172|FG002|Overall Study|Adverse Event|3|||
164590215|NCT00696657|594525173|FG003|Overall Study|Adverse Event|7|||
164590216|NCT00696657|594525174|FG004|Overall Study|Adverse Event|6|||
164590217|NCT00696657|594525175|FG005|Overall Study|Adverse Event|9|||
164590218|NCT00696657|594525176|FG006|Overall Study|Adverse Event|14|||
164590219|NCT00696657|594525177|FG007|Overall Study|Adverse Event|2|||
164590220|NCT00696657|594525178|FG008|Overall Study|Adverse Event|5|||
164590221|NCT00523341|594525180|FG000|Overall Study|Withdrawal by Subject|399|||
164590222|NCT00523341|594525181|FG001|Overall Study|Withdrawal by Subject|427|||
164590223|NCT00523341|594525180|FG000|Overall Study|Other|181|||
164590224|NCT00523341|594525181|FG001|Overall Study|Other|198|||
164590225|NCT00523341|594525180|FG000|Overall Study|Adverse Event|122|||
164590226|NCT00523341|594525181|FG001|Overall Study|Adverse Event|155|||
164590227|NCT00523341|594525180|FG000|Overall Study|Death|101|||
164590228|NCT00523341|594525181|FG001|Overall Study|Death|110|||
164590229|NCT00523341|594525180|FG000|Overall Study|Lost to Follow-up|73|||
164590230|NCT00523341|594525181|FG001|Overall Study|Lost to Follow-up|61|||
164590231|NCT00523341|594525180|FG000|Overall Study|Non-compliance|20|||
164590232|NCT00523341|594525181|FG001|Overall Study|Non-compliance|13|||
164590233|NCT00523341|594525180|FG000|Overall Study|Physician Decision|14|||
164590234|NCT00523341|594525181|FG001|Overall Study|Physician Decision|13|||
164590235|NCT00523341|594525180|FG000|Overall Study|Requirement for Alternative Therapy|4|||
164590236|NCT00523341|594525181|FG001|Overall Study|Requirement for Alternative Therapy|14|||
164590237|NCT00523341|594525180|FG000|Overall Study|Protocol Deviation|6|||
164590238|NCT00523341|594525181|FG001|Overall Study|Protocol Deviation|5|||
164590239|NCT00523341|594525180|FG000|Overall Study|Ineligibility Determined|3|||
164590240|NCT00523341|594525181|FG001|Overall Study|Ineligibility Determined|4|||
164590241|NCT00523341|594525180|FG000|Overall Study|Disease Progression|1|||
164590242|NCT00523341|594525181|FG001|Overall Study|Disease Progression|0|||
164590243|NCT00912015|594525182|FG000|Overall Study|Lack of Efficacy|1|||
164590244|NCT00912015|594525183|FG001|Overall Study|Lack of Efficacy|0|||
164590245|NCT00912015|594525184|FG002|Overall Study|Lack of Efficacy|0|||
164590246|NCT00912015|594525185|FG003|Overall Study|Lack of Efficacy|0|||
164590247|NCT00912015|594525182|FG000|Overall Study|Withdrawal by Subject|8|||
164590248|NCT00912015|594525183|FG001|Overall Study|Withdrawal by Subject|8|||
164590249|NCT00912015|594525184|FG002|Overall Study|Withdrawal by Subject|3|||
164590250|NCT00912015|594525185|FG003|Overall Study|Withdrawal by Subject|0|||
164590251|NCT00912015|594525182|FG000|Overall Study|Protocol Violation|1|||
164590252|NCT00912015|594525183|FG001|Overall Study|Protocol Violation|0|||
164590253|NCT00912015|594525184|FG002|Overall Study|Protocol Violation|0|||
164590254|NCT00912015|594525185|FG003|Overall Study|Protocol Violation|1|||
164590255|NCT00912015|594525182|FG000|Overall Study|Adverse Event|6|||
164438000|NCT01212757|593968255|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
164438001|NCT01212757|593968256|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
164438002|NCT01212757|593968257|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
164438003|NCT01212757|593968258|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
164438004|NCT01212757|593968259|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
164438005|NCT01212757|593968251|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
164438006|NCT01212757|593968252|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
164438007|NCT01212757|593968253|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
164438008|NCT01212757|593968254|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
164438009|NCT01212757|593968255|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
164438010|NCT01212757|593968256|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
164438011|NCT01212757|593968257|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
164438012|NCT01212757|593968258|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
164438013|NCT01212757|593968259|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
164438014|NCT01212757|593968251|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
164438015|NCT01212757|593968252|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
164590256|NCT00912015|594525183|FG001|Overall Study|Adverse Event|0|||
164590257|NCT00912015|594525184|FG002|Overall Study|Adverse Event|0|||
164590258|NCT00912015|594525185|FG003|Overall Study|Adverse Event|1|||
164590259|NCT01790438|594525186|FG000|Overall Study|Adverse Event|3|||
164590260|NCT01790438|594525187|FG001|Overall Study|Adverse Event|2|||
164590261|NCT01790438|594525186|FG000|Overall Study|Death|4|||
164590262|NCT01790438|594525187|FG001|Overall Study|Death|0|||
164590263|NCT01790438|594525186|FG000|Overall Study|Lost to Follow-up|5|||
164590264|NCT01790438|594525187|FG001|Overall Study|Lost to Follow-up|2|||
164590265|NCT01790438|594525186|FG000|Overall Study|Withdrawal by Subject|13|||
164590266|NCT01790438|594525187|FG001|Overall Study|Withdrawal by Subject|2|||
164590267|NCT01790438|594525186|FG000|Overall Study|Physician Decision|3|||
164590268|NCT01790438|594525187|FG001|Overall Study|Physician Decision|1|||
164590269|NCT01790438|594525186|FG000|Overall Study|Sponsor Decision|0|||
164590270|NCT01790438|594525187|FG001|Overall Study|Sponsor Decision|3|||
164590271|NCT01790438|594525186|FG000|Overall Study|Protocol Required Discontinuation|7|||
164590272|NCT01790438|594525187|FG001|Overall Study|Protocol Required Discontinuation|1|||
164590273|NCT02090114|594525188|FG000|Overall Study|Withdrawal by Subject|3|||
164590274|NCT02090114|594525189|FG001|Overall Study|Withdrawal by Subject|6|||
164590275|NCT02090114|594525190|FG002|Overall Study|Withdrawal by Subject|2|||
164590276|NCT02090114|594525191|FG003|Overall Study|Withdrawal by Subject|1|||
164590277|NCT02090114|594525188|FG000|Overall Study|Physician Decision|5|||
164590278|NCT02090114|594525189|FG001|Overall Study|Physician Decision|0|||
164590279|NCT02090114|594525190|FG002|Overall Study|Physician Decision|1|||
164590280|NCT02090114|594525191|FG003|Overall Study|Physician Decision|1|||
164696809|NCT01014624|594914060|FG001|Overall Study|Withdrawal by Subject|0|||
164696810|NCT01557842|594914071|FG000|Overall Study|Lost to Follow-up|0|||
164696811|NCT01557842|594914072|FG001|Overall Study|Lost to Follow-up|1|||
164696812|NCT01557842|594914071|FG000|Overall Study|Death|1|||
164696813|NCT01557842|594914072|FG001|Overall Study|Death|0|||
164696814|NCT01557842|594914071|FG000|Overall Study|Lack of Efficacy|0|||
164696815|NCT01557842|594914072|FG001|Overall Study|Lack of Efficacy|1|||
164696816|NCT01557842|594914071|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
164696817|NCT01557842|594914072|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
164696818|NCT01557842|594914071|FG000|Overall Study|Study Terminated by Sponsor|3|||
164696819|NCT01557842|594914072|FG001|Overall Study|Study Terminated by Sponsor|4|||
164696820|NCT01557842|594914071|FG000|Overall Study|Not Ablated|2|||
164696821|NCT01557842|594914072|FG001|Overall Study|Not Ablated|0|||
164696822|NCT05611996|594914073|FG000|Overall Study|Ineligible|1|||
164696823|NCT05611996|594914073|FG000|Overall Study|Withdrawal by Subject|9|||
164696824|NCT04479475|594914081|FG000|Overall Study|Withdrawal by Subject|7|||
164696825|NCT05560763|594914084|FG000|Overall Study|Withdrawal by Subject|4|||
164696826|NCT00619359|594914087|FG000|Overall Study|Adverse Event|32|||
164696827|NCT00619359|594914088|FG001|Overall Study|Adverse Event|36|||
164696828|NCT00619359|594914087|FG000|Overall Study|Lost to Follow-up|12|||
164696829|NCT00619359|594914088|FG001|Overall Study|Lost to Follow-up|16|||
164696830|NCT00619359|594914087|FG000|Overall Study|Physician Decision|0|||
164696831|NCT00619359|594914088|FG001|Overall Study|Physician Decision|7|||
164696832|NCT00619359|594914087|FG000|Overall Study|Protocol Violation|1|||
164696833|NCT00619359|594914088|FG001|Overall Study|Protocol Violation|1|||
164696834|NCT00619359|594914087|FG000|Overall Study|Withdrawal by Subject|19|||
164696835|NCT00619359|594914088|FG001|Overall Study|Withdrawal by Subject|20|||
164696836|NCT00619359|594914087|FG000|Overall Study|Progressive Disease|3|||
164696837|NCT00619359|594914088|FG001|Overall Study|Progressive Disease|1|||
164696838|NCT06972251|594914089|FG000|Overall Study|Withdrawal by Subject|1|||
164696839|NCT06972251|594914090|FG001|Overall Study|Withdrawal by Subject|0|||
164696840|NCT06972251|594914089|FG000|Overall Study|Lost to Follow-up|10|||
164696841|NCT06972251|594914090|FG001|Overall Study|Lost to Follow-up|2|||
164696842|NCT05575063|594914091|FG000|Overall Study|Withdrawal by Subject|1|||
164696843|NCT00484419|594914092|FG000|Overall Study|Adverse Event|3|||
164696844|NCT00484419|594914093|FG001|Overall Study|Adverse Event|0|||
164696845|NCT00484419|594914094|FG002|Overall Study|Adverse Event|0|||
164696846|NCT00484419|594914092|FG000|Overall Study|Lost to Follow-up|1|||
164696847|NCT00484419|594914093|FG001|Overall Study|Lost to Follow-up|0|||
164696848|NCT00484419|594914094|FG002|Overall Study|Lost to Follow-up|2|||
164696849|NCT00484419|594914092|FG000|Overall Study|Withdrawal by Subject|3|||
164696850|NCT00484419|594914093|FG001|Overall Study|Withdrawal by Subject|1|||
164696851|NCT00484419|594914094|FG002|Overall Study|Withdrawal by Subject|1|||
164696852|NCT00484419|594914092|FG000|Overall Study|subject met discontinuation criteria|2|||
164696853|NCT00484419|594914093|FG001|Overall Study|subject met discontinuation criteria|2|||
164696854|NCT00484419|594914094|FG002|Overall Study|subject met discontinuation criteria|4|||
164696855|NCT00484419|594914092|FG000|Overall Study|required restricted medication|1|||
164358424|NCT01852942|593688152|FG001|Overall Study|Death|1|||
164358425|NCT01852942|593688151|FG000|Overall Study|Withdrawal by Subject|2|||
164358426|NCT01852942|593688152|FG001|Overall Study|Withdrawal by Subject|3|||
164358427|NCT01852942|593688151|FG000|Overall Study|Lost to Follow-up|1|||
164358428|NCT01852942|593688152|FG001|Overall Study|Lost to Follow-up|2|||
164358429|NCT03220217|593688154|FG000|Overall Study|Withdrawal by Subject|0|||
164358430|NCT03220217|593688155|FG001|Overall Study|Withdrawal by Subject|1|||
164358431|NCT03220217|593688156|FG002|Overall Study|Withdrawal by Subject|0|||
164358432|NCT03220217|593688154|FG000|Overall Study|Subject Missed Procedure|0|||
164358433|NCT03220217|593688155|FG001|Overall Study|Subject Missed Procedure|0|||
164358434|NCT03220217|593688156|FG002|Overall Study|Subject Missed Procedure|1|||
164358435|NCT03025542|593688157|FG000|Overall Study|Adverse Event|0|||
164358436|NCT03025542|593688158|FG001|Overall Study|Adverse Event|2|||
164358437|NCT03025542|593688157|FG000|Overall Study|Lost to Follow-up|1|||
164358438|NCT03025542|593688158|FG001|Overall Study|Lost to Follow-up|0|||
164358439|NCT03025542|593688157|FG000|Overall Study|Withdrawal by Subject|1|||
164358440|NCT03025542|593688158|FG001|Overall Study|Withdrawal by Subject|0|||
164696856|NCT00484419|594914093|FG001|Overall Study|required restricted medication|0|||
164696857|NCT00484419|594914094|FG002|Overall Study|required restricted medication|1|||
164358441|NCT00312494|593688161|FG000|Overall Study|Randomized; not treated with study drug|9|||
164358442|NCT00312494|593688162|FG001|Overall Study|Randomized; not treated with study drug|10|||
164696858|NCT00484419|594914092|FG000|Overall Study|Physician Decision|1|||
164696859|NCT00484419|594914093|FG001|Overall Study|Physician Decision|1|||
164696860|NCT00484419|594914094|FG002|Overall Study|Physician Decision|1|||
164696861|NCT00484419|594914092|FG000|Overall Study|subject unable to receive medication|1|||
164696862|NCT00484419|594914093|FG001|Overall Study|subject unable to receive medication|0|||
164358443|NCT00312494|593688163|FG002|Overall Study|Randomized; not treated with study drug|5|||
164438016|NCT01212757|593968253|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
164438017|NCT01212757|593968254|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
164438018|NCT01212757|593968255|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
164438019|NCT01212757|593968256|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
164438020|NCT01212757|593968257|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
164438021|NCT01212757|593968258|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
164438022|NCT01212757|593968259|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
164438023|NCT01212757|593968251|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
164590281|NCT02090114|594525188|FG000|Overall Study|Adverse Event|1|||
164590282|NCT02090114|594525189|FG001|Overall Study|Adverse Event|2|||
164590283|NCT02090114|594525190|FG002|Overall Study|Adverse Event|2|||
164590284|NCT02090114|594525191|FG003|Overall Study|Adverse Event|0|||
164696863|NCT00484419|594914094|FG002|Overall Study|subject unable to receive medication|0|||
164696864|NCT00484419|594914092|FG000|Overall Study|subject relocated|0|||
164696865|NCT00484419|594914093|FG001|Overall Study|subject relocated|1|||
164590285|NCT02090114|594525188|FG000|Overall Study|Progressive Disease|20|||
164590286|NCT02090114|594525189|FG001|Overall Study|Progressive Disease|21|||
164590287|NCT02090114|594525190|FG002|Overall Study|Progressive Disease|23|||
164590288|NCT02090114|594525191|FG003|Overall Study|Progressive Disease|6|||
164590289|NCT02090114|594525188|FG000|Overall Study|Death|1|||
164590290|NCT02090114|594525189|FG001|Overall Study|Death|0|||
164590291|NCT02090114|594525190|FG002|Overall Study|Death|1|||
164590292|NCT02090114|594525191|FG003|Overall Study|Death|0|||
164590293|NCT01605071|594525192|FG000|Overall Study|Withdrawal by Subject|3|||
164590294|NCT01605071|594525193|FG001|Overall Study|Withdrawal by Subject|2|||
164590295|NCT03123354|594525194|FG000|Overall Study|Physician Decision|6|||
164590296|NCT01345123|594525200|FG000|Overall Study|participants no longer with health plan|79|||
164590297|NCT01345123|594525201|FG001|Overall Study|participants no longer with health plan|85|||
164590298|NCT01345123|594525202|FG002|Overall Study|participants no longer with health plan|88|||
164590299|NCT01798134|594525203|FG000|Overall Study|Lost to Follow-up|1|||
164590300|NCT01798134|594525203|FG000|Overall Study|Withdrawal by Subject|3|||
164590301|NCT01798134|594525203|FG000|Overall Study|Death|2|||
164590302|NCT01798134|594525203|FG000|Overall Study|Adverse Event|3|||
164590303|NCT01798134|594525203|FG000|Overall Study|Physician Decision|3|||
164590304|NCT01798134|594525203|FG000|Overall Study|Liver transplant/surgery|4|||
164590305|NCT02653976|594525204|FG000|Overall Study|Withdrawal by Subject|5|||
164590306|NCT02653976|594525204|FG000|Overall Study|Death|4|||
164590307|NCT02436577|594525205|FG000|Overall Study|Protocol Deviation|0|||
164590308|NCT02436577|594525206|FG001|Overall Study|Protocol Deviation|1|||
164590309|NCT02436577|594525207|FG002|Overall Study|Protocol Deviation|0|||
164590310|NCT02436577|594525208|FG003|Overall Study|Protocol Deviation|0|||
164590311|NCT02436577|594525209|FG004|Overall Study|Protocol Deviation|0|||
164590312|NCT02436577|594525210|FG005|Overall Study|Protocol Deviation|0|||
164590313|NCT00366548|594525211|FG000|Infant Series|Adverse Event|1|||
164590314|NCT00366548|594525212|FG001|Infant Series|Adverse Event|3|||
164590315|NCT00366548|594525211|FG000|Infant Series|Protocol Violation|0|||
164590316|NCT00366548|594525212|FG001|Infant Series|Protocol Violation|1|||
164590317|NCT00366548|594525211|FG000|Infant Series|Withdrawal by Subject|3|||
164590318|NCT00366548|594525212|FG001|Infant Series|Withdrawal by Subject|1|||
164590319|NCT00366548|594525211|FG000|After Infant Series|Withdrawal by Subject|3|||
164590320|NCT00366548|594525212|FG001|After Infant Series|Withdrawal by Subject|1|||
164590321|NCT00366548|594525211|FG000|After Infant Series|Adverse Event|2|||
164590322|NCT00366548|594525212|FG001|After Infant Series|Adverse Event|0|||
164590323|NCT00366548|594525211|FG000|After Infant Series|Lost to Follow-up|1|||
164590324|NCT00366548|594525212|FG001|After Infant Series|Lost to Follow-up|0|||
164590325|NCT03650452|594525213|FG000|Overall Study|Physician Decision|1|||
164590326|NCT03650452|594525214|FG001|Overall Study|Physician Decision|0|||
164590327|NCT03650452|594525213|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
164590328|NCT03650452|594525214|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
164590329|NCT03650452|594525213|FG000|Overall Study|Adverse Event|3|||
164590330|NCT03650452|594525214|FG001|Overall Study|Adverse Event|4|||
164590331|NCT03650452|594525213|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
164590332|NCT03650452|594525214|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
164590333|NCT01795898|594525216|FG000|Overall Study|Adverse Event|27|||
164590334|NCT01795898|594525216|FG000|Overall Study|Lost to Follow-up|20|||
164590335|NCT01795898|594525216|FG000|Overall Study|Withdrawal of consent|6|||
164590336|NCT01795898|594525216|FG000|Overall Study|Diagnosed with metastasis|1|||
164590337|NCT01795898|594525216|FG000|Overall Study|No pain|1|||
164590338|NCT01795898|594525216|FG000|Overall Study|Death|1|||
164590339|NCT01795898|594525216|FG000|Overall Study|Withdrew consent & had adverse events|3|||
164590340|NCT01795898|594525216|FG000|Overall Study|Physician Decision|1|||
164590341|NCT02042404|594525217|FG000|Overall Study|Death|1|||
164590342|NCT02042404|594525218|FG001|Overall Study|Death|0|||
164590343|NCT02042404|594525217|FG000|Overall Study|Unrelated Adverse Event|3|||
164438024|NCT01212757|593968252|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
164590344|NCT02042404|594525218|FG001|Overall Study|Unrelated Adverse Event|0|||
164590345|NCT02042404|594525217|FG000|Overall Study|Inability to meet time requirements|1|||
164696866|NCT00484419|594914094|FG002|Overall Study|subject relocated|0|||
164696867|NCT00484419|594914092|FG000|Overall Study|sponsor decision, randomized in error|0|||
164696868|NCT00484419|594914093|FG001|Overall Study|sponsor decision, randomized in error|0|||
164696869|NCT00484419|594914094|FG002|Overall Study|sponsor decision, randomized in error|2|||
164696870|NCT01829113|594914095|FG000|Overall Study|Disease Progression|37|||
164696871|NCT01829113|594914096|FG001|Overall Study|Disease Progression|48|||
164696872|NCT01829113|594914095|FG000|Overall Study|Adverse Event|14|||
164696873|NCT01829113|594914096|FG001|Overall Study|Adverse Event|10|||
164696874|NCT01829113|594914095|FG000|Overall Study|Withdrawal by Subject|17|||
164696875|NCT01829113|594914096|FG001|Overall Study|Withdrawal by Subject|10|||
164696876|NCT01829113|594914095|FG000|Overall Study|Death|4|||
164696877|NCT01829113|594914096|FG001|Overall Study|Death|6|||
164696878|NCT01829113|594914095|FG000|Overall Study|Sponsor Decision|1|||
164696879|NCT01829113|594914096|FG001|Overall Study|Sponsor Decision|1|||
164696880|NCT01829113|594914095|FG000|Overall Study|No Study Treatment Received|3|||
164696881|NCT01829113|594914096|FG001|Overall Study|No Study Treatment Received|2|||
164696882|NCT01829113|594914095|FG000|Overall Study|Physician Decision|1|||
164696883|NCT01829113|594914096|FG001|Overall Study|Physician Decision|1|||
164696884|NCT00873119|594914098|FG000|Overall Study|Patient request|4|||
164696885|NCT00873119|594914099|FG001|Overall Study|Patient request|2|||
164696886|NCT00873119|594914098|FG000|Overall Study|Adverse Event|8|||
164696887|NCT00873119|594914099|FG001|Overall Study|Adverse Event|0|||
164696888|NCT00873119|594914098|FG000|Overall Study|Progressive disease|26|||
164696889|NCT00873119|594914099|FG001|Overall Study|Progressive disease|18|||
164696890|NCT00873119|594914098|FG000|Overall Study|Death|2|||
164696891|NCT00873119|594914099|FG001|Overall Study|Death|1|||
164696892|NCT00873119|594914098|FG000|Overall Study|Other|2|||
164696893|NCT00873119|594914099|FG001|Overall Study|Other|5|||
164358444|NCT00312494|593688161|FG000|Overall Study|Adverse Event|33|||
164358445|NCT00312494|593688162|FG001|Overall Study|Adverse Event|15|||
164358446|NCT00312494|593688163|FG002|Overall Study|Adverse Event|11|||
164358447|NCT00312494|593688161|FG000|Overall Study|Lack of Efficacy|4|||
164358448|NCT00312494|593688162|FG001|Overall Study|Lack of Efficacy|6|||
164358449|NCT00312494|593688163|FG002|Overall Study|Lack of Efficacy|8|||
164358450|NCT00312494|593688161|FG000|Overall Study|Laboratory abnormality|1|||
164358451|NCT00312494|593688162|FG001|Overall Study|Laboratory abnormality|0|||
164358452|NCT00312494|593688163|FG002|Overall Study|Laboratory abnormality|0|||
164358453|NCT00312494|593688161|FG000|Overall Study|Lost to Follow-up|8|||
164358454|NCT00312494|593688162|FG001|Overall Study|Lost to Follow-up|8|||
164358455|NCT00312494|593688163|FG002|Overall Study|Lost to Follow-up|8|||
164358456|NCT00312494|593688161|FG000|Overall Study|Withdrawal by Subject|6|||
164358457|NCT00312494|593688162|FG001|Overall Study|Withdrawal by Subject|9|||
164358458|NCT00312494|593688163|FG002|Overall Study|Withdrawal by Subject|10|||
164358459|NCT00312494|593688161|FG000|Overall Study|Other|10|||
164358460|NCT00312494|593688162|FG001|Overall Study|Other|10|||
164358461|NCT00312494|593688163|FG002|Overall Study|Other|1|||
164358462|NCT00488345|593688164|FG000|Overall Study|Adverse Event|0|||
164358463|NCT00488345|593688165|FG001|Overall Study|Adverse Event|1|||
164358464|NCT00488345|593688166|FG002|Overall Study|Adverse Event|1|||
164358465|NCT00488345|593688164|FG000|Overall Study|Unable to administer antibiotics at home|0|||
164358466|NCT00488345|593688165|FG001|Overall Study|Unable to administer antibiotics at home|1|||
164358467|NCT00488345|593688166|FG002|Overall Study|Unable to administer antibiotics at home|0|||
164358468|NCT00488345|593688164|FG000|Overall Study|Institutional Review Board review|0|||
164358469|NCT00488345|593688165|FG001|Overall Study|Institutional Review Board review|0|||
164358470|NCT00488345|593688166|FG002|Overall Study|Institutional Review Board review|1|||
164358471|NCT00488345|593688164|FG000|Overall Study|Surgical team recommendation|0|||
164358472|NCT00488345|593688165|FG001|Overall Study|Surgical team recommendation|1|||
164358473|NCT00488345|593688166|FG002|Overall Study|Surgical team recommendation|0|||
164358474|NCT00488345|593688164|FG000|Overall Study|Parent/legal guardian request|0|||
164358475|NCT00488345|593688165|FG001|Overall Study|Parent/legal guardian request|1|||
164358476|NCT00488345|593688166|FG002|Overall Study|Parent/legal guardian request|1|||
164696894|NCT00873119|594914098|FG000|Overall Study|Not treated|2|||
164696895|NCT00873119|594914099|FG001|Overall Study|Not treated|0|||
164696896|NCT03648879|594914100|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
164696897|NCT00285584|594914101|FG000|Month 3|Lost to Follow-up|3|||
164696898|NCT00285584|594914102|FG001|Month 3|Lost to Follow-up|3|||
164696899|NCT00285584|594914101|FG000|Month 3|Withdrawal by Subject|1|||
164358477|NCT00696696|593688169|FG000|Overall Study|Adverse Event|5|||
164358478|NCT00696696|593688169|FG000|Overall Study|Withdrawal by Subject|8|||
164358479|NCT00696696|593688169|FG000|Overall Study|Physician Decision|2|||
164358480|NCT00696696|593688169|FG000|Overall Study|Death|3|||
164358481|NCT02642614|593688170|FG000|Overall Study|Adverse Event|1|||
164358482|NCT02642614|593688171|FG001|Overall Study|Adverse Event|1|||
164358483|NCT02642614|593688172|FG002|Overall Study|Adverse Event|2|||
164358484|NCT02642614|593688173|FG003|Overall Study|Adverse Event|2|||
164696900|NCT00285584|594914102|FG001|Month 3|Withdrawal by Subject|0|||
164696901|NCT00285584|594914101|FG000|Month 6|Lost to Follow-up|0|||
164696902|NCT00285584|594914102|FG001|Month 6|Lost to Follow-up|1|||
164438025|NCT01212757|593968253|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
164438026|NCT01212757|593968254|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
164438027|NCT01212757|593968255|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
164438028|NCT01212757|593968256|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
164438029|NCT01212757|593968257|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
164438030|NCT01212757|593968258|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
164438031|NCT01212757|593968259|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
164438032|NCT01212757|593968251|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
164438033|NCT01212757|593968252|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
164438034|NCT01212757|593968253|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
164438035|NCT01212757|593968254|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
164438036|NCT01212757|593968255|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
164438037|NCT01212757|593968256|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
164438038|NCT01212757|593968257|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
164438039|NCT01212757|593968258|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
164438040|NCT01212757|593968259|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
164438041|NCT01212757|593968251|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
164438042|NCT01212757|593968252|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
164438043|NCT01212757|593968253|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
164438044|NCT01212757|593968254|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
164438045|NCT01212757|593968255|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
164438046|NCT01212757|593968256|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
164438047|NCT01212757|593968257|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
164438048|NCT01212757|593968258|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
164438049|NCT01212757|593968259|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
164438050|NCT01212757|593968251|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
164438051|NCT01212757|593968252|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
164438052|NCT01212757|593968253|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
164438053|NCT01212757|593968254|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
164438054|NCT01212757|593968255|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
164438055|NCT01212757|593968256|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
164438056|NCT01212757|593968257|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
164438057|NCT01212757|593968258|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
164438058|NCT01212757|593968259|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
164438059|NCT03141788|593968260|FG000|Overall Study|Lost to Follow-up|1|||
164438060|NCT03141788|593968260|FG000|Overall Study|Protocol Violation|3|||
164438061|NCT03141788|593968260|FG000|Overall Study|Withdrawal by Subject|4|||
164438062|NCT02812966|593968263|FG000|Overall Study|Death|1|||
164438063|NCT02812966|593968264|FG001|Overall Study|Death|0|||
164438064|NCT03284957|593970654|FG000|Overall Study|Adverse Event|0|||
164438065|NCT03284957|593970655|FG001|Overall Study|Adverse Event|0|||
164438066|NCT03284957|593970656|FG002|Overall Study|Adverse Event|0|||
164438067|NCT03284957|593970657|FG003|Overall Study|Adverse Event|0|||
164438068|NCT03284957|593970658|FG004|Overall Study|Adverse Event|0|||
164438069|NCT03284957|593970659|FG005|Overall Study|Adverse Event|1|||
164438070|NCT03284957|593970660|FG006|Overall Study|Adverse Event|1|||
164696903|NCT01884688|594914103|FG000|Overall Study|Screen Failure|2|||
164696904|NCT04099641|594914104|FG000|Overall Study|Death|46|||
164696905|NCT04099641|594914105|FG001|Overall Study|Death|12|||
164696906|NCT04099641|594914104|FG000|Overall Study|Lost to Follow-up|1|||
164696907|NCT04099641|594914105|FG001|Overall Study|Lost to Follow-up|0|||
164696908|NCT04099641|594914104|FG000|Overall Study|Withdrawal by Subject|2|||
164696909|NCT04099641|594914105|FG001|Overall Study|Withdrawal by Subject|0|||
164696910|NCT02470091|594914107|FG000|Overall Study|Withdrawal by Subject|1|||
164696911|NCT02470091|594914108|FG001|Overall Study|Withdrawal by Subject|0|||
164696912|NCT02470091|594914107|FG000|Overall Study|Ineligible|0|||
164438071|NCT03284957|593970661|FG007|Overall Study|Adverse Event|1|||
164438072|NCT03284957|593970662|FG008|Overall Study|Adverse Event|0|||
164438073|NCT03284957|593970663|FG009|Overall Study|Adverse Event|4|||
164438074|NCT03284957|593970664|FG010|Overall Study|Adverse Event|1|||
164438075|NCT03284957|593970665|FG011|Overall Study|Adverse Event|1|||
164438076|NCT03284957|593970666|FG012|Overall Study|Adverse Event|0|||
164438077|NCT03284957|593970667|FG013|Overall Study|Adverse Event|0|||
164438078|NCT03284957|593970668|FG014|Overall Study|Adverse Event|0|||
164438079|NCT03284957|593970669|FG015|Overall Study|Adverse Event|0|||
164438080|NCT03284957|593970654|FG000|Overall Study|Progressive Disease|3|||
164438081|NCT03284957|593970655|FG001|Overall Study|Progressive Disease|3|||
164696913|NCT02470091|594914108|FG001|Overall Study|Ineligible|2|||
164696914|NCT02709486|594914109|FG000|Overall Study|Adverse Event|2|||
164696915|NCT02709486|594914110|FG001|Overall Study|Adverse Event|5|||
164696916|NCT02709486|594914111|FG002|Overall Study|Adverse Event|3|||
164696917|NCT02709486|594914109|FG000|Overall Study|Death|0|||
164696918|NCT02709486|594914110|FG001|Overall Study|Death|0|||
164696919|NCT02709486|594914111|FG002|Overall Study|Death|2|||
164696920|NCT02709486|594914109|FG000|Overall Study|Insufficient clinical response|7|||
164696921|NCT02709486|594914110|FG001|Overall Study|Insufficient clinical response|3|||
164696922|NCT02709486|594914111|FG002|Overall Study|Insufficient clinical response|3|||
164696923|NCT02709486|594914109|FG000|Overall Study|Lost to Follow-up|3|||
164696924|NCT02709486|594914110|FG001|Overall Study|Lost to Follow-up|2|||
164696925|NCT02709486|594914111|FG002|Overall Study|Lost to Follow-up|2|||
164696926|NCT02709486|594914109|FG000|Overall Study|Other|0|||
164696927|NCT02709486|594914110|FG001|Overall Study|Other|2|||
164696928|NCT02709486|594914111|FG002|Overall Study|Other|3|||
164696929|NCT02709486|594914109|FG000|Overall Study|Withdrawal by Subject|32|||
164696930|NCT02709486|594914110|FG001|Overall Study|Withdrawal by Subject|22|||
164696931|NCT02709486|594914111|FG002|Overall Study|Withdrawal by Subject|32|||
164696932|NCT00536484|594914116|FG000|Overall Study|Adverse Event|21|||
164696933|NCT00536484|594914117|FG001|Overall Study|Adverse Event|34|||
164696934|NCT00536484|594914116|FG000|Overall Study|Withdrawal by Subject|11|||
164696935|NCT00536484|594914117|FG001|Overall Study|Withdrawal by Subject|11|||
164696936|NCT00536484|594914116|FG000|Overall Study|Lost to Follow-up|8|||
164696937|NCT00536484|594914117|FG001|Overall Study|Lost to Follow-up|6|||
164696938|NCT00536484|594914116|FG000|Overall Study|Lack of Efficacy|16|||
164696939|NCT00536484|594914117|FG001|Overall Study|Lack of Efficacy|5|||
164696940|NCT00536484|594914116|FG000|Overall Study|Other|4|||
164696941|NCT00536484|594914117|FG001|Overall Study|Other|0|||
164696942|NCT00706355|594914118|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
164696943|NCT00706355|594914119|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
164696944|NCT00706355|594914120|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
164696945|NCT00706355|594914121|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
164696946|NCT00706355|594914118|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
164696947|NCT00706355|594914119|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
164696948|NCT00706355|594914120|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
164696949|NCT00706355|594914121|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
164696950|NCT00706355|594914118|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
164696951|NCT00706355|594914119|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
164696952|NCT00706355|594914120|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
164696953|NCT00706355|594914121|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
164696954|NCT00706355|594914118|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
164696955|NCT00706355|594914119|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
164696956|NCT00706355|594914120|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
164696957|NCT00706355|594914121|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
164696958|NCT00706355|594914118|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
164696959|NCT00706355|594914119|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
164696960|NCT00706355|594914120|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
164696961|NCT00706355|594914121|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
164696962|NCT00706355|594914118|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
164696963|NCT00706355|594914119|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
164696964|NCT00706355|594914120|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
164696965|NCT00706355|594914121|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
164696966|NCT00706355|594914118|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
164696967|NCT00706355|594914119|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
164696968|NCT00706355|594914120|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
164696969|NCT00706355|594914121|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
164696970|NCT00706355|594914118|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
164696971|NCT00706355|594914119|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
164696972|NCT00706355|594914120|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
164696973|NCT00706355|594914121|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
164696974|NCT00706355|594914118|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
164696975|NCT00706355|594914119|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
164696976|NCT00706355|594914120|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
164696977|NCT00706355|594914121|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
164696978|NCT02549573|594914124|FG000|Overall Study|Withdrawal by Subject|0|||
164696979|NCT02549573|594914125|FG001|Overall Study|Withdrawal by Subject|2|||
164696980|NCT02549573|594914124|FG000|Overall Study|Protocol Violation|0|||
164696981|NCT02549573|594914125|FG001|Overall Study|Protocol Violation|1|||
164358485|NCT02642614|593688170|FG000|Overall Study|Lost to Follow-up|1|||
164358486|NCT02642614|593688171|FG001|Overall Study|Lost to Follow-up|0|||
164358487|NCT02642614|593688172|FG002|Overall Study|Lost to Follow-up|0|||
164358488|NCT02642614|593688173|FG003|Overall Study|Lost to Follow-up|0|||
164358489|NCT02642614|593688170|FG000|Overall Study|Withdrawal by Subject|1|||
164696982|NCT02610816|594914126|FG000|Phase 1|Withdrawal by Subject|2|||
164696983|NCT02610816|594914127|FG001|Phase 1|Withdrawal by Subject|6|||
164696984|NCT02610816|594914128|FG002|Phase 1|Withdrawal by Subject|0|||
164696985|NCT02610816|594914129|FG003|Phase 1|Withdrawal by Subject|0|||
164696986|NCT02610816|594914126|FG000|Phase 1|Lost to Follow-up|2|||
164696987|NCT02610816|594914127|FG001|Phase 1|Lost to Follow-up|1|||
164696988|NCT02610816|594914128|FG002|Phase 1|Lost to Follow-up|0|||
164696989|NCT02610816|594914129|FG003|Phase 1|Lost to Follow-up|0|||
164696990|NCT02610816|594914126|FG000|Phase 1|Physician Decision|0|||
164696991|NCT02610816|594914127|FG001|Phase 1|Physician Decision|1|||
164696992|NCT02610816|594914128|FG002|Phase 1|Physician Decision|0|||
164696993|NCT02610816|594914129|FG003|Phase 1|Physician Decision|0|||
164696994|NCT02610816|594914126|FG000|Phase 2|Withdrawal by Subject|0|||
164696995|NCT02610816|594914127|FG001|Phase 2|Withdrawal by Subject|0|||
164696996|NCT02610816|594914128|FG002|Phase 2|Withdrawal by Subject|9|||
164696997|NCT02610816|594914129|FG003|Phase 2|Withdrawal by Subject|3|||
164696998|NCT02610816|594914126|FG000|Phase 2|Lost to Follow-up|0|||
164696999|NCT02610816|594914127|FG001|Phase 2|Lost to Follow-up|0|||
164697000|NCT02610816|594914128|FG002|Phase 2|Lost to Follow-up|2|||
164697001|NCT02610816|594914129|FG003|Phase 2|Lost to Follow-up|0|||
164697002|NCT02610816|594914126|FG000|Phase 2|Physician Decision|0|||
164697003|NCT02610816|594914127|FG001|Phase 2|Physician Decision|0|||
164697004|NCT02610816|594914128|FG002|Phase 2|Physician Decision|0|||
164697005|NCT02610816|594914129|FG003|Phase 2|Physician Decision|2|||
164697006|NCT02610816|594914126|FG000|Phase 2|Pregnancy|0|||
164697007|NCT02610816|594914127|FG001|Phase 2|Pregnancy|0|||
164697008|NCT02610816|594914128|FG002|Phase 2|Pregnancy|0|||
164697009|NCT02610816|594914129|FG003|Phase 2|Pregnancy|1|||
164697010|NCT02691741|594914130|FG000|Overall Study|Adverse Event|0|||
164697011|NCT02691741|594914131|FG001|Overall Study|Adverse Event|2|||
164697012|NCT02691741|594914130|FG000|Overall Study|Lost to Follow-up|1|||
164697013|NCT02691741|594914131|FG001|Overall Study|Lost to Follow-up|0|||
164697014|NCT02691741|594914130|FG000|Overall Study|Physician Decision|0|||
164697015|NCT02691741|594914131|FG001|Overall Study|Physician Decision|1|||
164697016|NCT02691741|594914130|FG000|Overall Study|Withdrawal by Subject|0|||
164697017|NCT02691741|594914131|FG001|Overall Study|Withdrawal by Subject|4|||
164697018|NCT01172821|594914132|FG000|Overall Study|Adverse Event|5|||
164697019|NCT01172821|594914133|FG001|Overall Study|Adverse Event|2|||
164697020|NCT01172821|594914134|FG002|Overall Study|Adverse Event|2|||
164697021|NCT01172821|594914135|FG003|Overall Study|Adverse Event|7|||
164697022|NCT01172821|594914132|FG000|Overall Study|Protocol Violation|0|||
164697023|NCT01172821|594914133|FG001|Overall Study|Protocol Violation|2|||
164697024|NCT01172821|594914134|FG002|Overall Study|Protocol Violation|1|||
164697025|NCT01172821|594914135|FG003|Overall Study|Protocol Violation|2|||
164697026|NCT01172821|594914132|FG000|Overall Study|Lost to Follow-up|4|||
164697027|NCT01172821|594914133|FG001|Overall Study|Lost to Follow-up|1|||
164697028|NCT01172821|594914134|FG002|Overall Study|Lost to Follow-up|2|||
164697029|NCT01172821|594914135|FG003|Overall Study|Lost to Follow-up|2|||
164697030|NCT01172821|594914132|FG000|Overall Study|Withdrawal by Subject|2|||
164697031|NCT01172821|594914133|FG001|Overall Study|Withdrawal by Subject|3|||
164697032|NCT01172821|594914134|FG002|Overall Study|Withdrawal by Subject|3|||
164697033|NCT01172821|594914135|FG003|Overall Study|Withdrawal by Subject|3|||
164697034|NCT01172821|594914132|FG000|Overall Study|Other|3|||
164697035|NCT01172821|594914133|FG001|Overall Study|Other|4|||
164697036|NCT01172821|594914134|FG002|Overall Study|Other|5|||
164697037|NCT01172821|594914135|FG003|Overall Study|Other|3|||
164697038|NCT02756637|594914136|FG000|Overall Study|Not eligible for initial SWOG study|10|||
164697039|NCT02756637|594914137|FG001|Overall Study|Not eligible for initial SWOG study|10|||
164697040|NCT02756637|594914136|FG000|Overall Study|No available NLR value|44|||
164697041|NCT02756637|594914137|FG001|Overall Study|No available NLR value|44|||
164697042|NCT02756637|594914136|FG000|Overall Study|Did not complete curative therapy|33|||
164697043|NCT02756637|594914137|FG001|Overall Study|Did not complete curative therapy|0|||
164697044|NCT02985879|594914138|FG000|Overall Study|Adverse Event|7|||
164697045|NCT02985879|594914139|FG001|Overall Study|Adverse Event|9|||
164697046|NCT02985879|594914140|FG002|Overall Study|Adverse Event|7|||
164697047|NCT02985879|594914138|FG000|Overall Study|Withdrew consent|6|||
164697048|NCT02985879|594914139|FG001|Overall Study|Withdrew consent|8|||
164697049|NCT02985879|594914140|FG002|Overall Study|Withdrew consent|10|||
164697050|NCT02985879|594914138|FG000|Overall Study|Lost to Follow-up|1|||
164697051|NCT02985879|594914139|FG001|Overall Study|Lost to Follow-up|0|||
164697052|NCT02985879|594914140|FG002|Overall Study|Lost to Follow-up|2|||
164697053|NCT02985879|594914138|FG000|Overall Study|Other, not specified|62|||
164697054|NCT02985879|594914139|FG001|Overall Study|Other, not specified|58|||
164697055|NCT02985879|594914140|FG002|Overall Study|Other, not specified|58|||
164697056|NCT05626803|594915590|FG000|Overall Study|Lost to Follow-up|0|||
164697057|NCT05626803|594915591|FG001|Overall Study|Lost to Follow-up|1|||
164697058|NCT05626803|594915592|FG002|Overall Study|Lost to Follow-up|0|||
164697059|NCT05626803|594915593|FG003|Overall Study|Lost to Follow-up|0|||
164697060|NCT04974619|594915594|FG000|Overall Study|Lost to Follow-up|0|||
164697061|NCT04974619|594915595|FG001|Overall Study|Lost to Follow-up|0|||
164697062|NCT04974619|594915596|FG002|Overall Study|Lost to Follow-up|1|||
164438082|NCT03284957|593970656|FG002|Overall Study|Progressive Disease|4|||
164438083|NCT03284957|593970657|FG003|Overall Study|Progressive Disease|3|||
164438084|NCT03284957|593970658|FG004|Overall Study|Progressive Disease|3|||
164438085|NCT03284957|593970659|FG005|Overall Study|Progressive Disease|5|||
164438086|NCT03284957|593970660|FG006|Overall Study|Progressive Disease|45|||
164438087|NCT03284957|593970661|FG007|Overall Study|Progressive Disease|8|||
164438088|NCT03284957|593970662|FG008|Overall Study|Progressive Disease|5|||
164438089|NCT03284957|593970663|FG009|Overall Study|Progressive Disease|18|||
164438090|NCT03284957|593970664|FG010|Overall Study|Progressive Disease|7|||
164438091|NCT03284957|593970665|FG011|Overall Study|Progressive Disease|2|||
164438092|NCT03284957|593970666|FG012|Overall Study|Progressive Disease|3|||
164438093|NCT03284957|593970667|FG013|Overall Study|Progressive Disease|1|||
164438094|NCT03284957|593970668|FG014|Overall Study|Progressive Disease|1|||
164438095|NCT03284957|593970669|FG015|Overall Study|Progressive Disease|2|||
164438096|NCT03284957|593970654|FG000|Overall Study|Withdrawal by Subject|0|||
164590346|NCT02042404|594525218|FG001|Overall Study|Inability to meet time requirements|0|||
164590347|NCT01623531|594525223|FG000|Overall Study|Death|1|||
164590348|NCT01623531|594525224|FG001|Overall Study|Death|0|||
164590349|NCT01623531|594525223|FG000|Overall Study|Protocol Violation|2|||
164590350|NCT01623531|594525224|FG001|Overall Study|Protocol Violation|1|||
164438097|NCT03284957|593970655|FG001|Overall Study|Withdrawal by Subject|0|||
164438098|NCT03284957|593970656|FG002|Overall Study|Withdrawal by Subject|0|||
164438099|NCT03284957|593970657|FG003|Overall Study|Withdrawal by Subject|0|||
164438100|NCT03284957|593970658|FG004|Overall Study|Withdrawal by Subject|0|||
164438101|NCT03284957|593970659|FG005|Overall Study|Withdrawal by Subject|0|||
164438102|NCT03284957|593970660|FG006|Overall Study|Withdrawal by Subject|0|||
164590351|NCT01623531|594525223|FG000|Overall Study|Missing data at primary outcome time poi|1|||
164590352|NCT01623531|594525224|FG001|Overall Study|Missing data at primary outcome time poi|1|||
164590353|NCT04184622|594525225|FG000|Primary Treatment Period|Adverse Event|6|||
164590354|NCT04184622|594525226|FG001|Primary Treatment Period|Adverse Event|4|||
164590355|NCT04184622|594525227|FG002|Primary Treatment Period|Adverse Event|8|||
164590356|NCT04184622|594525228|FG003|Primary Treatment Period|Adverse Event|6|||
164590357|NCT04184622|594525225|FG000|Primary Treatment Period|Death|4|||
164590358|NCT04184622|594525226|FG001|Primary Treatment Period|Death|4|||
164590359|NCT04184622|594525227|FG002|Primary Treatment Period|Death|2|||
164590360|NCT04184622|594525228|FG003|Primary Treatment Period|Death|1|||
164590361|NCT04184622|594525225|FG000|Primary Treatment Period|Lost to Follow-up|41|||
164590362|NCT04184622|594525226|FG001|Primary Treatment Period|Lost to Follow-up|17|||
164590363|NCT04184622|594525227|FG002|Primary Treatment Period|Lost to Follow-up|15|||
164590364|NCT04184622|594525228|FG003|Primary Treatment Period|Lost to Follow-up|13|||
164590365|NCT04184622|594525225|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
164590366|NCT04184622|594525226|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
164590367|NCT04184622|594525227|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
164590368|NCT04184622|594525228|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
164590369|NCT04184622|594525225|FG000|Primary Treatment Period|Physician Decision|0|||
164590370|NCT04184622|594525226|FG001|Primary Treatment Period|Physician Decision|0|||
164590371|NCT04184622|594525227|FG002|Primary Treatment Period|Physician Decision|3|||
164590372|NCT04184622|594525228|FG003|Primary Treatment Period|Physician Decision|1|||
164590373|NCT04184622|594525225|FG000|Primary Treatment Period|Pregnancy|4|||
164590374|NCT04184622|594525226|FG001|Primary Treatment Period|Pregnancy|3|||
164590375|NCT04184622|594525227|FG002|Primary Treatment Period|Pregnancy|4|||
164590376|NCT04184622|594525228|FG003|Primary Treatment Period|Pregnancy|1|||
164590377|NCT04184622|594525225|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
164590378|NCT04184622|594525226|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
164590379|NCT04184622|594525227|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
164590380|NCT04184622|594525228|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
164590381|NCT04184622|594525225|FG000|Additional Treatment Period|Adverse Event|1|||
164590382|NCT04184622|594525226|FG001|Additional Treatment Period|Adverse Event|2|||
164590383|NCT04184622|594525227|FG002|Additional Treatment Period|Adverse Event|1|||
164590384|NCT04184622|594525228|FG003|Additional Treatment Period|Adverse Event|0|||
164590385|NCT04184622|594525225|FG000|Additional Treatment Period|Death|0|||
164590386|NCT04184622|594525226|FG001|Additional Treatment Period|Death|0|||
164590387|NCT04184622|594525227|FG002|Additional Treatment Period|Death|1|||
164590388|NCT04184622|594525228|FG003|Additional Treatment Period|Death|1|||
164590389|NCT04184622|594525225|FG000|Additional Treatment Period|Lost to Follow-up|6|||
164590390|NCT04184622|594525226|FG001|Additional Treatment Period|Lost to Follow-up|4|||
164590391|NCT04184622|594525227|FG002|Additional Treatment Period|Lost to Follow-up|8|||
164590392|NCT04184622|594525228|FG003|Additional Treatment Period|Lost to Follow-up|6|||
164438103|NCT03284957|593970661|FG007|Overall Study|Withdrawal by Subject|0|||
164438104|NCT03284957|593970662|FG008|Overall Study|Withdrawal by Subject|0|||
164438105|NCT03284957|593970663|FG009|Overall Study|Withdrawal by Subject|2|||
164590393|NCT04184622|594525225|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
164438106|NCT03284957|593970664|FG010|Overall Study|Withdrawal by Subject|0|||
164590394|NCT04184622|594525226|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
164438107|NCT03284957|593970665|FG011|Overall Study|Withdrawal by Subject|0|||
164438108|NCT03284957|593970666|FG012|Overall Study|Withdrawal by Subject|0|||
164438109|NCT03284957|593970667|FG013|Overall Study|Withdrawal by Subject|0|||
164438110|NCT03284957|593970668|FG014|Overall Study|Withdrawal by Subject|0|||
164438111|NCT03284957|593970669|FG015|Overall Study|Withdrawal by Subject|0|||
164438112|NCT03284957|593970654|FG000|Overall Study|Other|0|||
164438113|NCT03284957|593970655|FG001|Overall Study|Other|0|||
164438114|NCT03284957|593970656|FG002|Overall Study|Other|0|||
164438115|NCT03284957|593970657|FG003|Overall Study|Other|0|||
164438116|NCT03284957|593970658|FG004|Overall Study|Other|0|||
164438117|NCT03284957|593970659|FG005|Overall Study|Other|0|||
164438118|NCT03284957|593970660|FG006|Overall Study|Other|3|||
164438119|NCT03284957|593970661|FG007|Overall Study|Other|0|||
164438120|NCT03284957|593970662|FG008|Overall Study|Other|1|||
164438121|NCT03284957|593970663|FG009|Overall Study|Other|6|||
164438122|NCT03284957|593970664|FG010|Overall Study|Other|0|||
164438123|NCT03284957|593970665|FG011|Overall Study|Other|0|||
164438124|NCT03284957|593970666|FG012|Overall Study|Other|0|||
164438125|NCT03284957|593970667|FG013|Overall Study|Other|0|||
164438126|NCT03284957|593970668|FG014|Overall Study|Other|2|||
164438127|NCT03284957|593970669|FG015|Overall Study|Other|0|||
164438128|NCT01070888|593970672|FG000|First Intervention (14 Days)|Adverse Event|0|||
164438129|NCT01070888|593970673|FG001|First Intervention (14 Days)|Adverse Event|1|||
164438130|NCT01070888|593970672|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
164438131|NCT01070888|593970673|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
164438132|NCT01070888|593970672|FG000|Washout (14 Days)|Physician Decision|1|||
164438133|NCT01070888|593970673|FG001|Washout (14 Days)|Physician Decision|0|||
164438134|NCT02577523|593970676|FG000|Overall Study|Adverse Event|1|||
164438135|NCT02577523|593970677|FG001|Overall Study|Adverse Event|1|||
164438136|NCT02577523|593970676|FG000|Overall Study|Lack of Efficacy|1|||
164438137|NCT02577523|593970677|FG001|Overall Study|Lack of Efficacy|1|||
164438138|NCT02577523|593970676|FG000|Overall Study|Withdrawal by Subject|1|||
164438139|NCT02577523|593970677|FG001|Overall Study|Withdrawal by Subject|0|||
164438140|NCT02525796|593970679|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
164438141|NCT02525796|593970680|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
164590395|NCT04184622|594525227|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
164590396|NCT04184622|594525228|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
164590397|NCT04184622|594525225|FG000|Additional Treatment Period|Physician Decision|0|||
164358490|NCT02642614|593688171|FG001|Overall Study|Withdrawal by Subject|1|||
164358491|NCT02642614|593688172|FG002|Overall Study|Withdrawal by Subject|0|||
164358492|NCT02642614|593688173|FG003|Overall Study|Withdrawal by Subject|0|||
164358493|NCT01585428|593688174|FG000|Overall Study|Death during treatment|1|||
164358494|NCT01585428|593688175|FG001|Overall Study|Death during treatment|0|||
164358495|NCT02057198|593688178|FG000|Overall Study|Death|0|||
164358496|NCT02057198|593688179|FG001|Overall Study|Death|0|||
164358497|NCT02057198|593688180|FG002|Overall Study|Death|1|||
164358498|NCT02057198|593688178|FG000|Overall Study|Discharged early; lost to followup|0|||
164358499|NCT02057198|593688179|FG001|Overall Study|Discharged early; lost to followup|1|||
164358500|NCT02057198|593688180|FG002|Overall Study|Discharged early; lost to followup|0|||
164358501|NCT00065507|593688182|FG000|Overall Study|Death|16|||
164358502|NCT00065507|593688183|FG001|Overall Study|Death|17|||
164358503|NCT00065507|593688182|FG000|Overall Study|Adverse Event|4|||
164358504|NCT00065507|593688183|FG001|Overall Study|Adverse Event|3|||
164358505|NCT00065507|593688182|FG000|Overall Study|Lack of Efficacy|0|||
164358506|NCT00065507|593688183|FG001|Overall Study|Lack of Efficacy|6|||
164438142|NCT02525796|593970681|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
164438143|NCT02525796|593970679|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
164438144|NCT02525796|593970680|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
164590398|NCT04184622|594525226|FG001|Additional Treatment Period|Physician Decision|0|||
164590399|NCT04184622|594525227|FG002|Additional Treatment Period|Physician Decision|1|||
164590400|NCT04184622|594525228|FG003|Additional Treatment Period|Physician Decision|0|||
164590401|NCT04184622|594525225|FG000|Additional Treatment Period|Pregnancy|0|||
164590402|NCT04184622|594525226|FG001|Additional Treatment Period|Pregnancy|0|||
164590403|NCT04184622|594525227|FG002|Additional Treatment Period|Pregnancy|0|||
164590404|NCT04184622|594525228|FG003|Additional Treatment Period|Pregnancy|1|||
164590405|NCT04184622|594525225|FG000|Additional Treatment Period|Protocol deviation|0|||
164590406|NCT04184622|594525226|FG001|Additional Treatment Period|Protocol deviation|0|||
164590407|NCT04184622|594525227|FG002|Additional Treatment Period|Protocol deviation|1|||
164358507|NCT00065507|593688182|FG000|Overall Study|Poor/Non-compliance|3|||
164358508|NCT00065507|593688183|FG001|Overall Study|Poor/Non-compliance|2|||
164358509|NCT00065507|593688182|FG000|Overall Study|Lost to Follow-up|3|||
164358510|NCT00065507|593688183|FG001|Overall Study|Lost to Follow-up|0|||
164438145|NCT02525796|593970681|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
164438146|NCT02525796|593970679|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
164438147|NCT02525796|593970680|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
164438148|NCT02525796|593970681|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
164438149|NCT02525796|593970679|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
164438150|NCT02525796|593970680|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
164590408|NCT04184622|594525228|FG003|Additional Treatment Period|Protocol deviation|0|||
164590409|NCT04184622|594525225|FG000|Additional Treatment Period|Site closed|1|||
164590410|NCT04184622|594525226|FG001|Additional Treatment Period|Site closed|0|||
164590411|NCT04184622|594525227|FG002|Additional Treatment Period|Site closed|1|||
164590412|NCT04184622|594525228|FG003|Additional Treatment Period|Site closed|0|||
164590413|NCT04184622|594525225|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
164590414|NCT04184622|594525226|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
164590415|NCT04184622|594525227|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
164590416|NCT04184622|594525228|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
164590417|NCT04184622|594525225|FG000|Safety Follow-up Period|Adverse Event|6|||
164590418|NCT04184622|594525226|FG001|Safety Follow-up Period|Adverse Event|8|||
164590419|NCT04184622|594525227|FG002|Safety Follow-up Period|Adverse Event|9|||
164590420|NCT04184622|594525228|FG003|Safety Follow-up Period|Adverse Event|16|||
164590421|NCT04184622|594525225|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
164590422|NCT04184622|594525226|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
164590423|NCT04184622|594525227|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
164590424|NCT04184622|594525228|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
164590425|NCT04184622|594525225|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
164590426|NCT04184622|594525226|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
164590427|NCT04184622|594525227|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
164590428|NCT04184622|594525228|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
164590429|NCT04184622|594525225|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
164590430|NCT04184622|594525226|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
164590431|NCT04184622|594525227|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
164590432|NCT04184622|594525228|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
164590433|NCT04184622|594525225|FG000|Safety Follow-up Period|Physician Decision|1|||
164590434|NCT04184622|594525226|FG001|Safety Follow-up Period|Physician Decision|0|||
164590435|NCT04184622|594525227|FG002|Safety Follow-up Period|Physician Decision|0|||
164590436|NCT04184622|594525228|FG003|Safety Follow-up Period|Physician Decision|1|||
164590437|NCT04184622|594525225|FG000|Safety Follow-up Period|Pregnancy|1|||
164590438|NCT04184622|594525226|FG001|Safety Follow-up Period|Pregnancy|3|||
164590439|NCT04184622|594525227|FG002|Safety Follow-up Period|Pregnancy|0|||
164590440|NCT04184622|594525228|FG003|Safety Follow-up Period|Pregnancy|6|||
164590441|NCT04184622|594525225|FG000|Safety Follow-up Period|Protocol deviation|1|||
164590442|NCT04184622|594525226|FG001|Safety Follow-up Period|Protocol deviation|0|||
164590443|NCT04184622|594525227|FG002|Safety Follow-up Period|Protocol deviation|0|||
164590444|NCT04184622|594525228|FG003|Safety Follow-up Period|Protocol deviation|0|||
164590445|NCT04184622|594525225|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
164590446|NCT04184622|594525226|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
164590447|NCT04184622|594525227|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
164590448|NCT04184622|594525228|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
164590449|NCT02795988|594525233|FG000|Phase 1b|Withdrawal by Subject|0|||
164590450|NCT02795988|594525234|FG001|Phase 1b|Withdrawal by Subject|1|||
164590451|NCT02795988|594525235|FG002|Phase 1b|Withdrawal by Subject|0|||
164590452|NCT02795988|594525236|FG003|Phase 1b|Withdrawal by Subject|0|||
164590453|NCT02795988|594525237|FG004|Phase 1b|Withdrawal by Subject|0|||
164590454|NCT02795988|594525238|FG005|Phase 1b|Withdrawal by Subject|0|||
164590455|NCT02795988|594525239|FG006|Phase 1b|Withdrawal by Subject|0|||
164590456|NCT02795988|594525233|FG000|Phase 1b|Death|1|||
164590457|NCT02795988|594525234|FG001|Phase 1b|Death|2|||
164590458|NCT02795988|594525235|FG002|Phase 1b|Death|1|||
164697063|NCT04974619|594915594|FG000|Overall Study|Withdrawal by Subject|0|||
164697064|NCT04974619|594915595|FG001|Overall Study|Withdrawal by Subject|0|||
164697065|NCT04974619|594915596|FG002|Overall Study|Withdrawal by Subject|1|||
164697066|NCT04974619|594915594|FG000|Overall Study|Protocol Violation|0|||
164697067|NCT04974619|594915595|FG001|Overall Study|Protocol Violation|1|||
164697068|NCT04974619|594915596|FG002|Overall Study|Protocol Violation|0|||
164697069|NCT01688466|594915597|FG000|Overall Study|Withdrawal by Subject|2|||
164697070|NCT01688466|594915598|FG001|Overall Study|Withdrawal by Subject|1|||
164697071|NCT01688466|594915597|FG000|Overall Study|Death|0|||
164697072|NCT01688466|594915598|FG001|Overall Study|Death|1|||
164697073|NCT01688466|594915597|FG000|Overall Study|Adverse Event|0|||
164697074|NCT01688466|594915598|FG001|Overall Study|Adverse Event|4|||
164697075|NCT01688466|594915597|FG000|Overall Study|Not evaluable|0|||
164697076|NCT01688466|594915598|FG001|Overall Study|Not evaluable|1|||
164697077|NCT03310957|594915599|FG000|Overall Study|Withdrawal by Subject|1|||
164697078|NCT03310957|594915600|FG001|Overall Study|Withdrawal by Subject|1|||
164697079|NCT03310957|594915601|FG002|Overall Study|Withdrawal by Subject|1|||
164697080|NCT03310957|594915602|FG003|Overall Study|Withdrawal by Subject|5|||
164697081|NCT03310957|594915603|FG004|Overall Study|Withdrawal by Subject|0|||
164697082|NCT03310957|594915604|FG005|Overall Study|Withdrawal by Subject|4|||
164697083|NCT03310957|594915605|FG006|Overall Study|Withdrawal by Subject|3|||
164697084|NCT03310957|594915599|FG000|Overall Study|Site Terminated|0|||
164697085|NCT03310957|594915600|FG001|Overall Study|Site Terminated|1|||
164697086|NCT03310957|594915601|FG002|Overall Study|Site Terminated|1|||
164697087|NCT03310957|594915602|FG003|Overall Study|Site Terminated|1|||
164697088|NCT03310957|594915603|FG004|Overall Study|Site Terminated|0|||
164697089|NCT03310957|594915604|FG005|Overall Study|Site Terminated|2|||
164697090|NCT03310957|594915605|FG006|Overall Study|Site Terminated|8|||
164697091|NCT03310957|594915599|FG000|Overall Study|Lost to Follow-up|1|||
164697092|NCT03310957|594915600|FG001|Overall Study|Lost to Follow-up|1|||
164697093|NCT03310957|594915601|FG002|Overall Study|Lost to Follow-up|1|||
164697094|NCT03310957|594915602|FG003|Overall Study|Lost to Follow-up|4|||
164697095|NCT03310957|594915603|FG004|Overall Study|Lost to Follow-up|0|||
164697096|NCT03310957|594915604|FG005|Overall Study|Lost to Follow-up|4|||
164697097|NCT03310957|594915605|FG006|Overall Study|Lost to Follow-up|2|||
164697098|NCT03310957|594915599|FG000|Overall Study|Death|5|||
164697099|NCT03310957|594915600|FG001|Overall Study|Death|8|||
164697100|NCT03310957|594915601|FG002|Overall Study|Death|18|||
164697101|NCT03310957|594915602|FG003|Overall Study|Death|31|||
164697102|NCT03310957|594915603|FG004|Overall Study|Death|1|||
164697103|NCT03310957|594915604|FG005|Overall Study|Death|29|||
164697104|NCT03310957|594915605|FG006|Overall Study|Death|7|||
164697105|NCT03310957|594915599|FG000|Overall Study|Discontinuation per sponsor|0|||
164697106|NCT03310957|594915600|FG001|Overall Study|Discontinuation per sponsor|1|||
164697107|NCT03310957|594915601|FG002|Overall Study|Discontinuation per sponsor|2|||
164697108|NCT03310957|594915602|FG003|Overall Study|Discontinuation per sponsor|4|||
164697109|NCT03310957|594915603|FG004|Overall Study|Discontinuation per sponsor|1|||
164697110|NCT03310957|594915604|FG005|Overall Study|Discontinuation per sponsor|9|||
164697111|NCT03310957|594915605|FG006|Overall Study|Discontinuation per sponsor|12|||
164697112|NCT03310957|594915599|FG000|Overall Study|Discontinuation per protocol amendment 11|0|||
164697113|NCT03310957|594915600|FG001|Overall Study|Discontinuation per protocol amendment 11|0|||
164697114|NCT03310957|594915601|FG002|Overall Study|Discontinuation per protocol amendment 11|0|||
164697115|NCT03310957|594915602|FG003|Overall Study|Discontinuation per protocol amendment 11|1|||
164697116|NCT03310957|594915603|FG004|Overall Study|Discontinuation per protocol amendment 11|0|||
164697117|NCT03310957|594915604|FG005|Overall Study|Discontinuation per protocol amendment 11|3|||
164697118|NCT03310957|594915605|FG006|Overall Study|Discontinuation per protocol amendment 11|5|||
164697119|NCT03310957|594915599|FG000|Overall Study|Treatment landscape|0|||
164697120|NCT03310957|594915600|FG001|Overall Study|Treatment landscape|0|||
164697121|NCT03310957|594915601|FG002|Overall Study|Treatment landscape|1|||
164697122|NCT03310957|594915602|FG003|Overall Study|Treatment landscape|1|||
164697123|NCT03310957|594915603|FG004|Overall Study|Treatment landscape|0|||
164697124|NCT03310957|594915604|FG005|Overall Study|Treatment landscape|1|||
164697125|NCT03310957|594915605|FG006|Overall Study|Treatment landscape|0|||
164697126|NCT03310957|594915599|FG000|Overall Study|Alanine aminotransferase (ALT) increased|0|||
164697127|NCT03310957|594915600|FG001|Overall Study|Alanine aminotransferase (ALT) increased|0|||
164697128|NCT03310957|594915601|FG002|Overall Study|Alanine aminotransferase (ALT) increased|0|||
164697129|NCT03310957|594915602|FG003|Overall Study|Alanine aminotransferase (ALT) increased|0|||
164697130|NCT03310957|594915603|FG004|Overall Study|Alanine aminotransferase (ALT) increased|1|||
164697131|NCT03310957|594915604|FG005|Overall Study|Alanine aminotransferase (ALT) increased|0|||
164697132|NCT03310957|594915605|FG006|Overall Study|Alanine aminotransferase (ALT) increased|0|||
164697133|NCT03310957|594915599|FG000|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
164697134|NCT03310957|594915600|FG001|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
164697135|NCT03310957|594915601|FG002|Overall Study|Elevated Aspartate aminotransferase (AST)|1|||
164697136|NCT03310957|594915602|FG003|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
164697137|NCT03310957|594915603|FG004|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
164697138|NCT03310957|594915604|FG005|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
164697139|NCT03310957|594915605|FG006|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
164697140|NCT03310957|594915599|FG000|Overall Study|Hospice|0|||
164697141|NCT03310957|594915600|FG001|Overall Study|Hospice|0|||
164697142|NCT03310957|594915601|FG002|Overall Study|Hospice|0|||
164697143|NCT03310957|594915602|FG003|Overall Study|Hospice|0|||
164697144|NCT03310957|594915603|FG004|Overall Study|Hospice|0|||
164697145|NCT03310957|594915604|FG005|Overall Study|Hospice|1|||
164697146|NCT03310957|594915605|FG006|Overall Study|Hospice|0|||
164697147|NCT03310957|594915599|FG000|Overall Study|Progressive|0|||
164697148|NCT03310957|594915600|FG001|Overall Study|Progressive|0|||
164697149|NCT03310957|594915601|FG002|Overall Study|Progressive|1|||
164697150|NCT03310957|594915602|FG003|Overall Study|Progressive|0|||
164697151|NCT03310957|594915603|FG004|Overall Study|Progressive|0|||
164358511|NCT00065507|593688182|FG000|Overall Study|Subject Withdrew Consent|2|||
164358512|NCT00065507|593688183|FG001|Overall Study|Subject Withdrew Consent|1|||
164358513|NCT00065507|593688182|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
164358514|NCT00065507|593688183|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
164358515|NCT00350636|593688184|FG000|Overall Study|Adverse Event|19|||
164358516|NCT00350636|593688185|FG001|Overall Study|Adverse Event|13|||
164358517|NCT00350636|593688184|FG000|Overall Study|Protocol Violation|1|||
164358518|NCT00350636|593688185|FG001|Overall Study|Protocol Violation|3|||
164358519|NCT00350636|593688184|FG000|Overall Study|Withdrawal by Subject|13|||
164358520|NCT00350636|593688185|FG001|Overall Study|Withdrawal by Subject|17|||
164358521|NCT00350636|593688184|FG000|Overall Study|Lost to Follow-up|9|||
164358522|NCT00350636|593688185|FG001|Overall Study|Lost to Follow-up|8|||
164358523|NCT00350636|593688184|FG000|Overall Study|Physician Decision|0|||
164358524|NCT00350636|593688185|FG001|Overall Study|Physician Decision|2|||
164358525|NCT00350636|593688184|FG000|Overall Study|Other|1|||
164358526|NCT00350636|593688185|FG001|Overall Study|Other|2|||
164358527|NCT00100815|593688186|FG000|Overall Study|Progression|24|||
164358528|NCT00100815|593688186|FG000|Overall Study|Adverse Event|18|||
164358529|NCT00100815|593688186|FG000|Overall Study|Death|4|||
164358530|NCT00100815|593688186|FG000|Overall Study|Other|3|||
164358531|NCT01647282|593688189|FG000|Overall Study|Physician Decision|7|||
164358532|NCT01647282|593688190|FG001|Overall Study|Physician Decision|5|||
164358533|NCT00665353|593688191|FG000|Study Step 1|Adverse Event|1|||
164358534|NCT00665353|593688191|FG000|Study Step 1|Withdrawal by Subject|2|||
164358535|NCT00665353|593688191|FG000|Study Step 2|Lost to Follow-up|2|||
164358536|NCT00665353|593688191|FG000|Study Step 2|Lack of Efficacy|12|||
164438151|NCT02525796|593970681|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
164438152|NCT02525796|593970679|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
164358537|NCT01851720|593688192|FG000|Overall Study|Lost to Follow-up|0|||
164358538|NCT01851720|593688193|FG001|Overall Study|Lost to Follow-up|1|||
164358539|NCT01870583|593688198|FG000|Overall Study|Protocol Violation|0|||
164358540|NCT01870583|593688199|FG001|Overall Study|Protocol Violation|5|||
164358541|NCT01870583|593688200|FG002|Overall Study|Protocol Violation|3|||
164358542|NCT01870583|593688198|FG000|Overall Study|Lost to Follow-up|11|||
164358543|NCT01870583|593688199|FG001|Overall Study|Lost to Follow-up|13|||
164358544|NCT01870583|593688200|FG002|Overall Study|Lost to Follow-up|5|||
164358545|NCT02389998|593688201|FG000|Overall Study|car accident|1|||
164358546|NCT02389998|593688202|FG001|Overall Study|car accident|0|||
164358547|NCT02632552|593688204|FG000|Overall Study|Lost to Follow-up|14|||
164590459|NCT02795988|594525236|FG003|Phase 1b|Death|0|||
164590460|NCT02795988|594525237|FG004|Phase 1b|Death|0|||
164358548|NCT02632552|593688205|FG001|Overall Study|Lost to Follow-up|8|||
164358549|NCT02632552|593688204|FG000|Overall Study|Withdrawal by Subject|2|||
164358550|NCT02632552|593688205|FG001|Overall Study|Withdrawal by Subject|0|||
164358551|NCT02632552|593688204|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
164358552|NCT02632552|593688205|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
164358553|NCT00450450|593688212|FG000|Overall Study|Death|1|||
164358554|NCT00450450|593688213|FG001|Overall Study|Death|3|||
164358555|NCT00450450|593688212|FG000|Overall Study|Relapse|2|||
164358556|NCT00450450|593688213|FG001|Overall Study|Relapse|0|||
164358557|NCT00450450|593688212|FG000|Overall Study|Missing Data|2|||
164358558|NCT00450450|593688213|FG001|Overall Study|Missing Data|0|||
164358559|NCT02150954|593688216|FG000|Overall Study|Protocol Violation|1|||
164358560|NCT02150954|593688217|FG001|Overall Study|Protocol Violation|0|||
164358561|NCT02377466|593688227|FG000|Overall Study|Other: Randomized and not treated|0|||
164358562|NCT02377466|593688228|FG001|Overall Study|Other: Randomized and not treated|2|||
164358563|NCT04210310|593688229|FG000|Overall Study|Lost to Follow-up|32|||
164358564|NCT04210310|593688230|FG001|Overall Study|Lost to Follow-up|1|||
164358565|NCT00495170|593688231|FG000|Overall Study|Lost to Follow-up|9|||
164358566|NCT00495170|593688231|FG000|Overall Study|Withdrawal by Subject|3|||
164358567|NCT00495170|593688231|FG000|Overall Study|Inappropriate staging|8|||
164358568|NCT00330616|593688232|FG000|Overall Study|Adverse Event|13|||
164358569|NCT00330616|593688232|FG000|Overall Study|Lack of Efficacy|1|||
164358570|NCT00330616|593688232|FG000|Overall Study|Lost to Follow-up|2|||
164358571|NCT00330616|593688232|FG000|Overall Study|Withdrawal by Subject|4|||
164358572|NCT00330616|593688232|FG000|Overall Study|Other|1|||
164358573|NCT00597766|593688239|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
164358574|NCT00597766|593688240|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
164358575|NCT00597766|593688241|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
164358576|NCT00597766|593688239|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
164358577|NCT00597766|593688240|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
164358578|NCT00597766|593688241|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
164358579|NCT01333059|593688242|FG000|Overall Study|Physician Decision|3|||
164358580|NCT01333059|593688243|FG001|Overall Study|Physician Decision|3|||
164358581|NCT01333059|593688242|FG000|Overall Study|Protocol Violation|3|||
164358582|NCT01333059|593688243|FG001|Overall Study|Protocol Violation|0|||
164438153|NCT02525796|593970680|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
164438154|NCT02525796|593970681|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
164438155|NCT00708032|593970682|FG000|Overall Study|Adverse Event|0|||
164590461|NCT02795988|594525238|FG005|Phase 1b|Death|0|||
164590462|NCT02795988|594525239|FG006|Phase 1b|Death|0|||
164590463|NCT02795988|594525233|FG000|Phase 1b|Physician Decision|0|||
164590464|NCT02795988|594525234|FG001|Phase 1b|Physician Decision|0|||
164590465|NCT02795988|594525235|FG002|Phase 1b|Physician Decision|1|||
164590466|NCT02795988|594525236|FG003|Phase 1b|Physician Decision|0|||
164590467|NCT02795988|594525237|FG004|Phase 1b|Physician Decision|0|||
164590468|NCT02795988|594525238|FG005|Phase 1b|Physician Decision|0|||
164590469|NCT02795988|594525239|FG006|Phase 1b|Physician Decision|0|||
164590470|NCT02795988|594525233|FG000|Phase 1b|Progressive Disease|2|||
164590471|NCT02795988|594525234|FG001|Phase 1b|Progressive Disease|2|||
164590472|NCT02795988|594525235|FG002|Phase 1b|Progressive Disease|0|||
164590473|NCT02795988|594525236|FG003|Phase 1b|Progressive Disease|0|||
164590474|NCT02795988|594525237|FG004|Phase 1b|Progressive Disease|0|||
164590475|NCT02795988|594525238|FG005|Phase 1b|Progressive Disease|0|||
164590476|NCT02795988|594525239|FG006|Phase 1b|Progressive Disease|0|||
164590477|NCT02795988|594525233|FG000|Phase 2|Withdrawal by Subject|0|||
164590478|NCT02795988|594525234|FG001|Phase 2|Withdrawal by Subject|0|||
164590479|NCT02795988|594525235|FG002|Phase 2|Withdrawal by Subject|0|||
164590480|NCT02795988|594525236|FG003|Phase 2|Withdrawal by Subject|1|||
164590481|NCT02795988|594525237|FG004|Phase 2|Withdrawal by Subject|0|||
164590482|NCT02795988|594525238|FG005|Phase 2|Withdrawal by Subject|0|||
164590483|NCT02795988|594525239|FG006|Phase 2|Withdrawal by Subject|0|||
164590484|NCT02795988|594525233|FG000|Phase 2|Death|0|||
164590485|NCT02795988|594525234|FG001|Phase 2|Death|0|||
164590486|NCT02795988|594525235|FG002|Phase 2|Death|0|||
164590487|NCT02795988|594525236|FG003|Phase 2|Death|17|||
164590488|NCT02795988|594525237|FG004|Phase 2|Death|17|||
164590489|NCT02795988|594525238|FG005|Phase 2|Death|0|||
164590490|NCT02795988|594525239|FG006|Phase 2|Death|0|||
164590491|NCT02795988|594525233|FG000|Phase 2|Other|0|||
164590492|NCT02795988|594525234|FG001|Phase 2|Other|0|||
164590493|NCT02795988|594525235|FG002|Phase 2|Other|0|||
164590494|NCT02795988|594525236|FG003|Phase 2|Other|1|||
164590495|NCT02795988|594525237|FG004|Phase 2|Other|0|||
164590496|NCT02795988|594525238|FG005|Phase 2|Other|0|||
164590497|NCT02795988|594525239|FG006|Phase 2|Other|0|||
164590498|NCT02795988|594525233|FG000|Phase 2 Extension|Death|0|||
164590499|NCT02795988|594525234|FG001|Phase 2 Extension|Death|0|||
164590500|NCT02795988|594525235|FG002|Phase 2 Extension|Death|0|||
164590501|NCT02795988|594525236|FG003|Phase 2 Extension|Death|0|||
164590502|NCT02795988|594525237|FG004|Phase 2 Extension|Death|0|||
164590503|NCT02795988|594525238|FG005|Phase 2 Extension|Death|5|||
164590504|NCT02795988|594525239|FG006|Phase 2 Extension|Death|6|||
164590505|NCT02795988|594525233|FG000|Phase 2 Extension|Other reasons|0|||
164590506|NCT02795988|594525234|FG001|Phase 2 Extension|Other reasons|0|||
164590507|NCT02795988|594525235|FG002|Phase 2 Extension|Other reasons|0|||
164590508|NCT02795988|594525236|FG003|Phase 2 Extension|Other reasons|0|||
164590509|NCT02795988|594525237|FG004|Phase 2 Extension|Other reasons|0|||
164590510|NCT02795988|594525238|FG005|Phase 2 Extension|Other reasons|2|||
164590511|NCT02795988|594525239|FG006|Phase 2 Extension|Other reasons|1|||
164590512|NCT02834403|594525240|FG000|Overall Study|Physician Decision|2|||
164590513|NCT02834403|594525241|FG001|Overall Study|Physician Decision|1|||
164590514|NCT02834403|594525242|FG002|Overall Study|Physician Decision|2|||
164590515|NCT02834403|594525243|FG003|Overall Study|Physician Decision|1|||
164590516|NCT02834403|594525244|FG004|Overall Study|Physician Decision|1|||
164590517|NCT02834403|594525245|FG005|Overall Study|Physician Decision|2|||
164590518|NCT02834403|594525246|FG006|Overall Study|Physician Decision|12|||
164590519|NCT02834403|594525240|FG000|Overall Study|Adverse Event|0|||
164358583|NCT00737282|593688245|FG000|Overall Study|Study prematurely terminated|175|||
164358584|NCT02763189|593688246|FG000|Overall Study|Device failure|0|||
164358585|NCT02763189|593688247|FG001|Overall Study|Device failure|2|||
164358586|NCT02049957|593688252|FG000|Overall Study|Progressive Disease|5|||
164358587|NCT02049957|593688253|FG001|Overall Study|Progressive Disease|4|||
164358588|NCT02049957|593688254|FG002|Overall Study|Progressive Disease|2|||
164358589|NCT02049957|593688255|FG003|Overall Study|Progressive Disease|2|||
164358590|NCT02049957|593688256|FG004|Overall Study|Progressive Disease|6|||
164590520|NCT02834403|594525241|FG001|Overall Study|Adverse Event|0|||
164590521|NCT02834403|594525242|FG002|Overall Study|Adverse Event|0|||
164590522|NCT02834403|594525243|FG003|Overall Study|Adverse Event|0|||
164590523|NCT02834403|594525244|FG004|Overall Study|Adverse Event|1|||
164590524|NCT02834403|594525245|FG005|Overall Study|Adverse Event|1|||
164590525|NCT02834403|594525246|FG006|Overall Study|Adverse Event|3|||
164590526|NCT02834403|594525240|FG000|Overall Study|Withdrawal by Subject|0|||
164590527|NCT02834403|594525241|FG001|Overall Study|Withdrawal by Subject|1|||
164590528|NCT02834403|594525242|FG002|Overall Study|Withdrawal by Subject|0|||
164590529|NCT02834403|594525243|FG003|Overall Study|Withdrawal by Subject|0|||
164590530|NCT02834403|594525244|FG004|Overall Study|Withdrawal by Subject|1|||
164590531|NCT02834403|594525245|FG005|Overall Study|Withdrawal by Subject|0|||
164590532|NCT02834403|594525246|FG006|Overall Study|Withdrawal by Subject|0|||
164590533|NCT02834403|594525240|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
164590534|NCT02834403|594525241|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
164590535|NCT02834403|594525242|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
164590536|NCT02834403|594525243|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
164590537|NCT02834403|594525244|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
164590538|NCT02834403|594525245|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
164590539|NCT02834403|594525246|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
164590540|NCT02341014|594525247|FG000|Overall Study|Adverse Event|0|||
164590541|NCT02341014|594525248|FG001|Overall Study|Adverse Event|1|||
164590542|NCT02341014|594525249|FG002|Overall Study|Adverse Event|0|||
164590543|NCT02341014|594525250|FG003|Overall Study|Adverse Event|0|||
164590544|NCT02341014|594525251|FG004|Overall Study|Adverse Event|2|||
164590545|NCT00726323|594525252|FG000|Overall Study|Withdrawal by Subject|3|||
164590546|NCT00726323|594525253|FG001|Overall Study|Withdrawal by Subject|1|||
164590547|NCT00726323|594525252|FG000|Overall Study|Physician Decision|1|||
164590548|NCT00726323|594525253|FG001|Overall Study|Physician Decision|0|||
164590549|NCT00726323|594525252|FG000|Overall Study|Progressive disease|23|||
164590550|NCT00726323|594525253|FG001|Overall Study|Progressive disease|16|||
164590551|NCT00726323|594525252|FG000|Overall Study|Clinical progression|0|||
164590552|NCT00726323|594525253|FG001|Overall Study|Clinical progression|3|||
164590553|NCT00726323|594525252|FG000|Overall Study|Adverse Event|9|||
164590554|NCT00726323|594525253|FG001|Overall Study|Adverse Event|9|||
164590555|NCT00726323|594525252|FG000|Overall Study|Death|1|||
164590556|NCT00726323|594525253|FG001|Overall Study|Death|0|||
164590557|NCT00726323|594525252|FG000|Overall Study|Participant wished to discontinue|0|||
164590558|NCT00726323|594525253|FG001|Overall Study|Participant wished to discontinue|1|||
164697152|NCT03310957|594915604|FG005|Overall Study|Progressive|0|||
164697153|NCT03310957|594915605|FG006|Overall Study|Progressive|0|||
164697154|NCT04146363|594915612|FG000|Induction Period|Adverse Event|1|||
164358591|NCT02049957|593688257|FG005|Overall Study|Progressive Disease|35|||
164358592|NCT02049957|593688258|FG006|Overall Study|Progressive Disease|7|||
164358593|NCT02049957|593688259|FG007|Overall Study|Progressive Disease|26|||
164358594|NCT02049957|593688260|FG008|Overall Study|Progressive Disease|6|||
164358595|NCT02049957|593688252|FG000|Overall Study|Adverse Event|1|||
164358596|NCT02049957|593688253|FG001|Overall Study|Adverse Event|1|||
164358597|NCT02049957|593688254|FG002|Overall Study|Adverse Event|1|||
164358598|NCT02049957|593688255|FG003|Overall Study|Adverse Event|0|||
164358599|NCT02049957|593688256|FG004|Overall Study|Adverse Event|0|||
164697155|NCT04146363|594915613|FG001|Induction Period|Adverse Event|2|||
164590559|NCT00726323|594525252|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
164697156|NCT04146363|594915614|FG002|Induction Period|Adverse Event|0|||
164697157|NCT04146363|594915615|FG003|Induction Period|Adverse Event|0|||
164697158|NCT04146363|594915616|FG004|Induction Period|Adverse Event|0|||
164697159|NCT04146363|594915617|FG005|Induction Period|Adverse Event|0|||
164697160|NCT04146363|594915618|FG006|Induction Period|Adverse Event|0|||
164697161|NCT04146363|594915619|FG007|Induction Period|Adverse Event|0|||
164697162|NCT04146363|594915620|FG008|Induction Period|Adverse Event|0|||
164697163|NCT04146363|594915621|FG009|Induction Period|Adverse Event|0|||
164697164|NCT04146363|594915622|FG010|Induction Period|Adverse Event|0|||
164697165|NCT04146363|594915612|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
164697166|NCT04146363|594915613|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
164697167|NCT04146363|594915614|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
164697168|NCT04146363|594915615|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
164697169|NCT04146363|594915616|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
164697170|NCT04146363|594915617|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
164697171|NCT04146363|594915618|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
164697172|NCT04146363|594915619|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
164697173|NCT04146363|594915620|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
164697174|NCT04146363|594915621|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
164697175|NCT04146363|594915622|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
164697176|NCT04146363|594915612|FG000|Induction Period|Lack of Efficacy|7|||
164697177|NCT04146363|594915613|FG001|Induction Period|Lack of Efficacy|2|||
164697178|NCT04146363|594915614|FG002|Induction Period|Lack of Efficacy|0|||
164697179|NCT04146363|594915615|FG003|Induction Period|Lack of Efficacy|0|||
164697180|NCT04146363|594915616|FG004|Induction Period|Lack of Efficacy|0|||
164697181|NCT04146363|594915617|FG005|Induction Period|Lack of Efficacy|0|||
164697182|NCT04146363|594915618|FG006|Induction Period|Lack of Efficacy|0|||
164697183|NCT04146363|594915619|FG007|Induction Period|Lack of Efficacy|0|||
164697184|NCT04146363|594915620|FG008|Induction Period|Lack of Efficacy|0|||
164697185|NCT04146363|594915621|FG009|Induction Period|Lack of Efficacy|0|||
164697186|NCT04146363|594915622|FG010|Induction Period|Lack of Efficacy|0|||
164697187|NCT04146363|594915612|FG000|Induction Period|Lost to Follow-up|1|||
164697188|NCT04146363|594915613|FG001|Induction Period|Lost to Follow-up|4|||
164697189|NCT04146363|594915614|FG002|Induction Period|Lost to Follow-up|0|||
164697190|NCT04146363|594915615|FG003|Induction Period|Lost to Follow-up|0|||
164697191|NCT04146363|594915616|FG004|Induction Period|Lost to Follow-up|0|||
164697192|NCT04146363|594915617|FG005|Induction Period|Lost to Follow-up|0|||
164697193|NCT04146363|594915618|FG006|Induction Period|Lost to Follow-up|0|||
164697194|NCT04146363|594915619|FG007|Induction Period|Lost to Follow-up|0|||
164697195|NCT04146363|594915620|FG008|Induction Period|Lost to Follow-up|0|||
164697196|NCT04146363|594915621|FG009|Induction Period|Lost to Follow-up|0|||
164697197|NCT04146363|594915622|FG010|Induction Period|Lost to Follow-up|0|||
164697198|NCT04146363|594915612|FG000|Induction Period|Positive quantiferon test|0|||
164697199|NCT04146363|594915613|FG001|Induction Period|Positive quantiferon test|1|||
164697200|NCT04146363|594915614|FG002|Induction Period|Positive quantiferon test|0|||
164697201|NCT04146363|594915615|FG003|Induction Period|Positive quantiferon test|0|||
164697202|NCT04146363|594915616|FG004|Induction Period|Positive quantiferon test|0|||
164697203|NCT04146363|594915617|FG005|Induction Period|Positive quantiferon test|0|||
164697204|NCT04146363|594915618|FG006|Induction Period|Positive quantiferon test|0|||
164697205|NCT04146363|594915619|FG007|Induction Period|Positive quantiferon test|0|||
164697206|NCT04146363|594915620|FG008|Induction Period|Positive quantiferon test|0|||
164697207|NCT04146363|594915621|FG009|Induction Period|Positive quantiferon test|0|||
164697208|NCT04146363|594915622|FG010|Induction Period|Positive quantiferon test|0|||
164697209|NCT04146363|594915612|FG000|Induction Period|Protocol Deviation|5|||
164697210|NCT04146363|594915613|FG001|Induction Period|Protocol Deviation|6|||
164697211|NCT04146363|594915614|FG002|Induction Period|Protocol Deviation|0|||
164697212|NCT04146363|594915615|FG003|Induction Period|Protocol Deviation|0|||
164697213|NCT04146363|594915616|FG004|Induction Period|Protocol Deviation|0|||
164697214|NCT04146363|594915617|FG005|Induction Period|Protocol Deviation|0|||
164697215|NCT04146363|594915618|FG006|Induction Period|Protocol Deviation|0|||
164697216|NCT04146363|594915619|FG007|Induction Period|Protocol Deviation|0|||
164697217|NCT04146363|594915620|FG008|Induction Period|Protocol Deviation|0|||
164697218|NCT04146363|594915621|FG009|Induction Period|Protocol Deviation|0|||
164697219|NCT04146363|594915622|FG010|Induction Period|Protocol Deviation|0|||
164697220|NCT04146363|594915612|FG000|Induction Period|Withdrawal by Subject|6|||
164697221|NCT04146363|594915613|FG001|Induction Period|Withdrawal by Subject|3|||
164697222|NCT04146363|594915614|FG002|Induction Period|Withdrawal by Subject|0|||
164697223|NCT04146363|594915615|FG003|Induction Period|Withdrawal by Subject|0|||
164697224|NCT04146363|594915616|FG004|Induction Period|Withdrawal by Subject|0|||
164697225|NCT04146363|594915617|FG005|Induction Period|Withdrawal by Subject|0|||
164697226|NCT04146363|594915618|FG006|Induction Period|Withdrawal by Subject|0|||
164697227|NCT04146363|594915619|FG007|Induction Period|Withdrawal by Subject|0|||
164697228|NCT04146363|594915620|FG008|Induction Period|Withdrawal by Subject|0|||
164697229|NCT04146363|594915621|FG009|Induction Period|Withdrawal by Subject|0|||
164697230|NCT04146363|594915622|FG010|Induction Period|Withdrawal by Subject|0|||
164697231|NCT04146363|594915612|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
164438156|NCT00708032|593970683|FG001|Overall Study|Adverse Event|2|||
164438157|NCT00708032|593970682|FG000|Overall Study|Lost to Follow-up|1|||
164438158|NCT00708032|593970683|FG001|Overall Study|Lost to Follow-up|2|||
164438159|NCT00708032|593970682|FG000|Overall Study|Pregnancy|0|||
164438160|NCT00708032|593970683|FG001|Overall Study|Pregnancy|1|||
164438161|NCT00708032|593970682|FG000|Overall Study|Poor vision|0|||
164438162|NCT00708032|593970683|FG001|Overall Study|Poor vision|6|||
164438163|NCT00708032|593970682|FG000|Overall Study|Visit out of range at month 12|4|||
164438164|NCT00708032|593970683|FG001|Overall Study|Visit out of range at month 12|1|||
164438165|NCT00708032|593970682|FG000|Overall Study|Did not meet protocol criteria|1|||
164438166|NCT00708032|593970683|FG001|Overall Study|Did not meet protocol criteria|2|||
164438167|NCT00708032|593970682|FG000|Overall Study|Protocol Violation|4|||
164438168|NCT00708032|593970683|FG001|Overall Study|Protocol Violation|1|||
164438169|NCT00708032|593970682|FG000|Overall Study|Withdrawal by Subject|0|||
164438170|NCT00708032|593970683|FG001|Overall Study|Withdrawal by Subject|1|||
164438171|NCT01198275|593970684|FG000|Overall Study|Adverse Event|2|||
164438172|NCT01198275|593970685|FG001|Overall Study|Adverse Event|3|||
164438173|NCT01198275|593970684|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
164438174|NCT01198275|593970685|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
164438175|NCT00391846|593970686|FG000|Overall Study|Adverse Event|4|||
164438176|NCT00391846|593970687|FG001|Overall Study|Adverse Event|1|||
164438177|NCT00391846|593970686|FG000|Overall Study|Did not meet the required elig. crit|2|||
164438178|NCT00391846|593970687|FG001|Overall Study|Did not meet the required elig. crit|2|||
164438179|NCT00391846|593970686|FG000|Overall Study|Withdrawal by Subject|2|||
164438180|NCT00391846|593970687|FG001|Overall Study|Withdrawal by Subject|3|||
164438181|NCT00391846|593970686|FG000|Overall Study|Developed study specific DC criteria|0|||
164438182|NCT00391846|593970687|FG001|Overall Study|Developed study specific DC criteria|1|||
164438183|NCT00150176|593970688|FG000|Overall Study|Adverse Event|16|||
164590560|NCT00726323|594525253|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
164590561|NCT04705597|594525254|FG000|Overall Study|Death|16|||
164590562|NCT04705597|594525255|FG001|Overall Study|Death|9|||
164590563|NCT04705597|594525254|FG000|Overall Study|Lost to Follow-up|1|||
164590564|NCT04705597|594525255|FG001|Overall Study|Lost to Follow-up|0|||
164590565|NCT04705597|594525254|FG000|Overall Study|Withdrawal by Subject|1|||
164590566|NCT04705597|594525255|FG001|Overall Study|Withdrawal by Subject|2|||
164590567|NCT05058664|594525256|FG000|Overall Study|No follow-up data provided|4|||
164590568|NCT05058664|594525257|FG001|Overall Study|No follow-up data provided|0|||
164590569|NCT05058664|594525258|FG002|Overall Study|No follow-up data provided|2|||
164590570|NCT05058664|594525256|FG000|Overall Study|Withdrawal by Subject|0|||
164590571|NCT05058664|594525257|FG001|Overall Study|Withdrawal by Subject|0|||
164590572|NCT05058664|594525258|FG002|Overall Study|Withdrawal by Subject|1|||
164590573|NCT01617681|594525259|FG000|Period 1 Double Blind|Adverse Event|2|||
164590574|NCT01617681|594525260|FG001|Period 1 Double Blind|Adverse Event|0|||
164590575|NCT01617681|594525261|FG002|Period 1 Double Blind|Adverse Event|0|||
164590576|NCT01617681|594525262|FG003|Period 1 Double Blind|Adverse Event|2|||
164590577|NCT01617681|594525263|FG004|Period 1 Double Blind|Adverse Event|0|||
164590578|NCT01617681|594525259|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
164590579|NCT01617681|594525260|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
164590580|NCT01617681|594525261|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
164590581|NCT01617681|594525262|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
164590582|NCT01617681|594525263|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
164590583|NCT01617681|594525259|FG000|Period 2 Open Label|Adverse Event|0|||
164590584|NCT01617681|594525260|FG001|Period 2 Open Label|Adverse Event|0|||
164590585|NCT01617681|594525261|FG002|Period 2 Open Label|Adverse Event|0|||
164590586|NCT01617681|594525262|FG003|Period 2 Open Label|Adverse Event|0|||
164590587|NCT01617681|594525263|FG004|Period 2 Open Label|Adverse Event|3|||
164590588|NCT01617681|594525259|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
164590589|NCT01617681|594525260|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
164590590|NCT01617681|594525261|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
164590591|NCT01617681|594525262|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
164590592|NCT01617681|594525263|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
164590593|NCT00109733|594525270|FG000|Overall Study|Protocol Violation|0|||
164590594|NCT00109733|594525271|FG001|Overall Study|Protocol Violation|1|||
164590595|NCT00109733|594525270|FG000|Overall Study|Stopped taking study drug|1|||
164590596|NCT00109733|594525271|FG001|Overall Study|Stopped taking study drug|1|||
164590597|NCT00109733|594525270|FG000|Overall Study|Non-compliant|0|||
164590598|NCT00109733|594525271|FG001|Overall Study|Non-compliant|1|||
164590599|NCT00109733|594525270|FG000|Overall Study|Could not commit time for study|1|||
164590600|NCT00109733|594525271|FG001|Overall Study|Could not commit time for study|1|||
164590601|NCT05628181|594525277|FG000|Overall Study|Death|2|||
164590602|NCT05628181|594525278|FG001|Overall Study|Death|4|||
164590603|NCT05628181|594525279|FG002|Overall Study|Death|0|||
164590604|NCT01996319|594525280|FG000|Overall Study|Protocol Violation|1|||
164590605|NCT01996319|594525281|FG001|Overall Study|Protocol Violation|0|||
164590606|NCT01996319|594525280|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
164590607|NCT01996319|594525281|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
164697232|NCT04146363|594915613|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
164697233|NCT04146363|594915614|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
164697234|NCT04146363|594915615|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
164697235|NCT04146363|594915616|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
164697236|NCT04146363|594915617|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
164697237|NCT04146363|594915618|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
164697238|NCT04146363|594915619|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
164697239|NCT04146363|594915620|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
164697240|NCT04146363|594915621|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
164697241|NCT04146363|594915622|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
164697242|NCT04146363|594915612|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164697243|NCT04146363|594915613|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164697244|NCT04146363|594915614|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164697245|NCT04146363|594915615|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164697246|NCT04146363|594915616|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164697247|NCT04146363|594915617|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164697248|NCT04146363|594915618|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164697249|NCT04146363|594915619|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
164697250|NCT04146363|594915620|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164697251|NCT04146363|594915621|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164697252|NCT04146363|594915622|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164697253|NCT04146363|594915612|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164697254|NCT04146363|594915613|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164697255|NCT04146363|594915614|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164697256|NCT04146363|594915615|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164697257|NCT04146363|594915616|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164697258|NCT04146363|594915617|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164697259|NCT04146363|594915618|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
164697260|NCT04146363|594915619|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
164697261|NCT04146363|594915620|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164697262|NCT04146363|594915621|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164697263|NCT04146363|594915622|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164358600|NCT02049957|593688257|FG005|Overall Study|Adverse Event|5|||
164358601|NCT02049957|593688258|FG006|Overall Study|Adverse Event|0|||
164358602|NCT02049957|593688259|FG007|Overall Study|Adverse Event|6|||
164358603|NCT02049957|593688260|FG008|Overall Study|Adverse Event|1|||
164358604|NCT02049957|593688252|FG000|Overall Study|Study Terminated by Sponsor|0|||
164358605|NCT02049957|593688253|FG001|Overall Study|Study Terminated by Sponsor|1|||
164358606|NCT02049957|593688254|FG002|Overall Study|Study Terminated by Sponsor|0|||
164358607|NCT02049957|593688255|FG003|Overall Study|Study Terminated by Sponsor|0|||
164358608|NCT02049957|593688256|FG004|Overall Study|Study Terminated by Sponsor|0|||
164358609|NCT02049957|593688257|FG005|Overall Study|Study Terminated by Sponsor|0|||
164358610|NCT02049957|593688258|FG006|Overall Study|Study Terminated by Sponsor|1|||
164358611|NCT02049957|593688259|FG007|Overall Study|Study Terminated by Sponsor|0|||
164358612|NCT02049957|593688260|FG008|Overall Study|Study Terminated by Sponsor|0|||
164358613|NCT02049957|593688252|FG000|Overall Study|Withdrawal by Subject|0|||
164358614|NCT02049957|593688253|FG001|Overall Study|Withdrawal by Subject|0|||
164358615|NCT02049957|593688254|FG002|Overall Study|Withdrawal by Subject|0|||
164358616|NCT02049957|593688255|FG003|Overall Study|Withdrawal by Subject|1|||
164358617|NCT02049957|593688256|FG004|Overall Study|Withdrawal by Subject|0|||
164358618|NCT02049957|593688257|FG005|Overall Study|Withdrawal by Subject|2|||
164358619|NCT02049957|593688258|FG006|Overall Study|Withdrawal by Subject|0|||
164358620|NCT02049957|593688259|FG007|Overall Study|Withdrawal by Subject|3|||
164358621|NCT02049957|593688260|FG008|Overall Study|Withdrawal by Subject|1|||
164358622|NCT02049957|593688252|FG000|Overall Study|Physician Decision|0|||
164358623|NCT02049957|593688253|FG001|Overall Study|Physician Decision|0|||
164358624|NCT02049957|593688254|FG002|Overall Study|Physician Decision|0|||
164358625|NCT02049957|593688255|FG003|Overall Study|Physician Decision|0|||
164358626|NCT02049957|593688256|FG004|Overall Study|Physician Decision|0|||
164358627|NCT02049957|593688257|FG005|Overall Study|Physician Decision|1|||
164358628|NCT02049957|593688258|FG006|Overall Study|Physician Decision|0|||
164358629|NCT02049957|593688259|FG007|Overall Study|Physician Decision|0|||
164358630|NCT02049957|593688260|FG008|Overall Study|Physician Decision|0|||
164358631|NCT04447755|593688261|FG000|Overall Study|Death|9|||
164358632|NCT04447755|593688262|FG001|Overall Study|Death|16|||
164358633|NCT04447755|593688263|FG002|Overall Study|Death|8|||
164358634|NCT04447755|593688264|FG003|Overall Study|Death|9|||
164358635|NCT04447755|593688265|FG004|Overall Study|Death|8|||
164697264|NCT04146363|594915612|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
164358636|NCT04447755|593688266|FG005|Overall Study|Death|9|||
164358637|NCT04447755|593688267|FG006|Overall Study|Death|55|||
164358638|NCT04447755|593688261|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164358639|NCT04447755|593688262|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
164358640|NCT04447755|593688263|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
164358641|NCT04447755|593688264|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
164358642|NCT04447755|593688265|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
164358643|NCT04447755|593688266|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
164358644|NCT04447755|593688267|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
164358645|NCT04447755|593688261|FG000|Overall Study|Sponsor Decision|0|||
164358646|NCT04447755|593688262|FG001|Overall Study|Sponsor Decision|0|||
164358647|NCT04447755|593688263|FG002|Overall Study|Sponsor Decision|0|||
164358648|NCT04447755|593688264|FG003|Overall Study|Sponsor Decision|0|||
164358649|NCT04447755|593688265|FG004|Overall Study|Sponsor Decision|1|||
164358650|NCT04447755|593688266|FG005|Overall Study|Sponsor Decision|0|||
164358651|NCT04447755|593688267|FG006|Overall Study|Sponsor Decision|10|||
164358652|NCT04447755|593688261|FG000|Overall Study|Lost to Follow-up|0|||
164358653|NCT04447755|593688262|FG001|Overall Study|Lost to Follow-up|0|||
164358654|NCT04447755|593688263|FG002|Overall Study|Lost to Follow-up|0|||
164358655|NCT04447755|593688264|FG003|Overall Study|Lost to Follow-up|0|||
164358656|NCT04447755|593688265|FG004|Overall Study|Lost to Follow-up|0|||
164590608|NCT01996319|594525280|FG000|Overall Study|Adverse Event|2|||
164590609|NCT01996319|594525281|FG001|Overall Study|Adverse Event|2|||
164590610|NCT01234402|594525282|FG000|Overall Study|Lost to Follow-up|0|||
164590611|NCT01234402|594525283|FG001|Overall Study|Lost to Follow-up|1|||
164590612|NCT01234402|594525284|FG002|Overall Study|Lost to Follow-up|3|||
164590613|NCT01234402|594525282|FG000|Overall Study|Withdrawal by Subject|1|||
164590614|NCT01234402|594525283|FG001|Overall Study|Withdrawal by Subject|3|||
164590615|NCT01234402|594525284|FG002|Overall Study|Withdrawal by Subject|4|||
164590616|NCT01234402|594525282|FG000|Overall Study|Never treated: Death|0|||
164590617|NCT01234402|594525283|FG001|Overall Study|Never treated: Death|0|||
164590618|NCT01234402|594525284|FG002|Overall Study|Never treated: Death|1|||
164590619|NCT01234402|594525282|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
164590620|NCT01234402|594525283|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
164590621|NCT01234402|594525284|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
164590622|NCT01234402|594525282|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
164590623|NCT01234402|594525283|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
164590624|NCT01234402|594525284|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
164590625|NCT00637273|594525285|FG000|Overall Study|Adverse Event|11|||
164697265|NCT04146363|594915613|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
164697266|NCT04146363|594915614|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
164697267|NCT04146363|594915615|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
164697268|NCT04146363|594915616|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
164697269|NCT04146363|594915617|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
164697270|NCT04146363|594915618|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
164697271|NCT04146363|594915619|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
164697272|NCT04146363|594915620|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
164697273|NCT04146363|594915621|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
164697274|NCT04146363|594915622|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
164697275|NCT04146363|594915612|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
164697276|NCT04146363|594915613|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
164697277|NCT04146363|594915614|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
164697278|NCT04146363|594915615|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
164697279|NCT04146363|594915616|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
164697280|NCT04146363|594915617|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
164697281|NCT04146363|594915618|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
164697282|NCT04146363|594915619|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
164697283|NCT04146363|594915620|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
164697284|NCT04146363|594915621|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
164697285|NCT04146363|594915622|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
164697286|NCT04146363|594915612|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
164697287|NCT04146363|594915613|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
164697288|NCT04146363|594915614|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
164697289|NCT04146363|594915615|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
164697290|NCT04146363|594915616|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
164697291|NCT04146363|594915617|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
164697292|NCT04146363|594915618|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
164697293|NCT04146363|594915619|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
164697294|NCT04146363|594915620|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
164697295|NCT04146363|594915621|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
164358657|NCT04447755|593688266|FG005|Overall Study|Lost to Follow-up|0|||
164358658|NCT04447755|593688267|FG006|Overall Study|Lost to Follow-up|1|||
164358659|NCT00840294|593688268|FG000|Overall Study|Withdrawal by Subject|2|||
164358660|NCT00840294|593688269|FG001|Overall Study|Withdrawal by Subject|1|||
164358661|NCT00840294|593688268|FG000|Overall Study|Protocol Violation|1|||
164358662|NCT00840294|593688269|FG001|Overall Study|Protocol Violation|3|||
164358663|NCT00840294|593688268|FG000|Overall Study|Illness|0|||
164358664|NCT00840294|593688269|FG001|Overall Study|Illness|1|||
164358665|NCT03721276|593688271|FG000|Overall Study|Lost to Follow-up|5|||
164358666|NCT03721276|593688272|FG001|Overall Study|Lost to Follow-up|3|||
164358667|NCT03721276|593688271|FG000|Overall Study|Adverse Event|0|||
164358668|NCT03721276|593688272|FG001|Overall Study|Adverse Event|1|||
164358669|NCT01405742|593688275|FG000|Overall Study|Lost to Follow-up|1|||
164358670|NCT01405742|593688276|FG001|Overall Study|Lost to Follow-up|0|||
164358671|NCT01340898|593688277|FG000|Primary Phase|Serious Adverse Events|0|||
164358672|NCT01340898|593688278|FG001|Primary Phase|Serious Adverse Events|0|||
164358673|NCT01340898|593688279|FG002|Primary Phase|Serious Adverse Events|1|||
164358674|NCT01340898|593688277|FG000|Primary Phase|Withdrawal by Subject|8|||
164358675|NCT01340898|593688278|FG001|Primary Phase|Withdrawal by Subject|7|||
164358676|NCT01340898|593688279|FG002|Primary Phase|Withdrawal by Subject|5|||
164358677|NCT01340898|593688277|FG000|Primary Phase|Migrated/moved from study area|4|||
164358678|NCT01340898|593688278|FG001|Primary Phase|Migrated/moved from study area|1|||
164358679|NCT01340898|593688279|FG002|Primary Phase|Migrated/moved from study area|0|||
164358680|NCT01340898|593688277|FG000|Primary Phase|Lost to Follow-up|4|||
164358681|NCT01340898|593688278|FG001|Primary Phase|Lost to Follow-up|1|||
164358682|NCT01340898|593688279|FG002|Primary Phase|Lost to Follow-up|0|||
164358683|NCT01340898|593688277|FG000|Booster Phase|Withdrawal by Subject|3|||
164358684|NCT01340898|593688278|FG001|Booster Phase|Withdrawal by Subject|0|||
164358685|NCT01340898|593688279|FG002|Booster Phase|Withdrawal by Subject|4|||
164358686|NCT01340898|593688277|FG000|Booster Phase|Migrated/moved from study area|3|||
164358687|NCT01340898|593688278|FG001|Booster Phase|Migrated/moved from study area|0|||
164358688|NCT01340898|593688279|FG002|Booster Phase|Migrated/moved from study area|0|||
164358689|NCT01340898|593688277|FG000|Booster Phase|Lost to Follow-up|4|||
164358690|NCT01340898|593688278|FG001|Booster Phase|Lost to Follow-up|2|||
164358691|NCT01340898|593688279|FG002|Booster Phase|Lost to Follow-up|3|||
164358692|NCT04900220|593688280|FG000|Overall Study|Lost to Follow-up|1|||
164358693|NCT04900220|593688281|FG001|Overall Study|Lost to Follow-up|1|||
164358694|NCT02028065|593688282|FG000|Randomization Through Start Treatment|Not treated|1|||
164358695|NCT02028065|593688283|FG001|Randomization Through Start Treatment|Not treated|3|||
164358696|NCT02028065|593688284|FG002|Randomization Through Start Treatment|Not treated|3|||
164358697|NCT02028065|593688282|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
164358698|NCT02028065|593688283|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
164358699|NCT02028065|593688284|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
164358700|NCT02028065|593688282|FG000|Treatment Through Study Completion|Physician Decision|1|||
164358701|NCT02028065|593688283|FG001|Treatment Through Study Completion|Physician Decision|0|||
164358702|NCT02028065|593688284|FG002|Treatment Through Study Completion|Physician Decision|0|||
164358703|NCT02028065|593688282|FG000|Treatment Through Study Completion|Protocol Violation|1|||
164358704|NCT02028065|593688283|FG001|Treatment Through Study Completion|Protocol Violation|4|||
164358705|NCT02028065|593688284|FG002|Treatment Through Study Completion|Protocol Violation|0|||
164358706|NCT02028065|593688282|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
164358707|NCT02028065|593688283|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
164358708|NCT02028065|593688284|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
164358709|NCT02028065|593688282|FG000|Treatment Through Study Completion|Adverse Event|3|||
164358710|NCT02028065|593688283|FG001|Treatment Through Study Completion|Adverse Event|3|||
164358711|NCT02028065|593688284|FG002|Treatment Through Study Completion|Adverse Event|5|||
164358712|NCT01698801|593688289|FG000|Treatment Phase|Adverse Event|4|||
164358713|NCT01698801|593688289|FG000|Treatment Phase|Protocol Violation|1|||
164358714|NCT01698801|593688289|FG000|Treatment Phase|Other|4|||
164358715|NCT01698801|593688289|FG000|Treatment Phase|Withdrawal by Subject|1|||
164358716|NCT01698801|593688289|FG000|Treatment Phase|Disease progression|1|||
164358717|NCT01698801|593688289|FG000|Follow Up Phase|Withdrawal by Subject|1|||
164358718|NCT01698801|593688289|FG000|Follow Up Phase|Death|4|||
164358719|NCT00656474|593688290|FG000|Overall Study|Other Reason|1|||
164358720|NCT02062879|593688291|FG000|Overall Study|Withdrawal by Subject|4|||
164358721|NCT02062879|593688292|FG001|Overall Study|Withdrawal by Subject|1|||
164358722|NCT00665847|593688296|FG000|Overall Study|Adverse Event|8|||
164358723|NCT00665847|593688296|FG000|Overall Study|Withdrawal by Subject|2|||
164358724|NCT00665847|593688296|FG000|Overall Study|Subject non-compliant|8|||
164358725|NCT00665847|593688296|FG000|Overall Study|Subject reached a virologic endpoint|4|||
164358726|NCT00665847|593688296|FG000|Overall Study|Resistance to TMC125|1|||
164358727|NCT00665847|593688296|FG000|Overall Study|Subject ineligible to continue the trial|1|||
164358728|NCT00665847|593688296|FG000|Overall Study|Switch to Commercial Medication|1|||
164358729|NCT00410761|593689921|FG000|Randomized Treatment Period|Adverse Event|34|||
164358730|NCT00410761|593689922|FG001|Randomized Treatment Period|Adverse Event|3|||
164358731|NCT00410761|593689921|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
164358732|NCT00410761|593689922|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
164358733|NCT00410761|593689921|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
164358734|NCT00410761|593689922|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
164358735|NCT00410761|593689921|FG000|Randomized Treatment Period|Other|69|||
164358736|NCT00410761|593689922|FG001|Randomized Treatment Period|Other|21|||
164358737|NCT00410761|593689921|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
164358738|NCT00410761|593689922|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
164358739|NCT00410761|593689921|FG000|Open-Label Treatment Period|Adverse Event|13|||
164358740|NCT00410761|593689922|FG001|Open-Label Treatment Period|Adverse Event|15|||
164358741|NCT00410761|593689921|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
164358742|NCT00410761|593689922|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
164358743|NCT00410761|593689921|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
164358744|NCT00410761|593689922|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
164697296|NCT04146363|594915622|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
164697297|NCT04146363|594915612|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
164697298|NCT04146363|594915613|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
164697299|NCT04146363|594915614|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
164697300|NCT04146363|594915615|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
164697301|NCT04146363|594915616|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
164697302|NCT04146363|594915617|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
164697303|NCT04146363|594915618|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
164697304|NCT04146363|594915619|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
164697305|NCT04146363|594915620|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
164358745|NCT00410761|593689921|FG000|Open-Label Treatment Period|Other|18|||
164358746|NCT00410761|593689922|FG001|Open-Label Treatment Period|Other|9|||
164697306|NCT04146363|594915621|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
164697307|NCT04146363|594915622|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
164697308|NCT04146363|594915612|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164697309|NCT04146363|594915613|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164358747|NCT04708886|593689931|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
164358748|NCT04708886|593689931|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
164358749|NCT01729754|593689932|FG000|Part 1|Adverse Event|2|||
164358750|NCT01729754|593689933|FG001|Part 1|Adverse Event|0|||
164358751|NCT01729754|593689934|FG002|Part 1|Adverse Event|0|||
164358752|NCT01729754|593689935|FG003|Part 1|Adverse Event|1|||
164358753|NCT01729754|593689936|FG004|Part 1|Adverse Event|0|||
164358754|NCT01729754|593689937|FG005|Part 1|Adverse Event|0|||
164358755|NCT01729754|593689938|FG006|Part 1|Adverse Event|2|||
164358756|NCT01729754|593689939|FG007|Part 1|Adverse Event|0|||
164358757|NCT01729754|593689940|FG008|Part 1|Adverse Event|0|||
164358758|NCT01729754|593689941|FG009|Part 1|Adverse Event|5|||
164358759|NCT01729754|593689932|FG000|Part 1|Lack of Efficacy|1|||
164358760|NCT01729754|593689933|FG001|Part 1|Lack of Efficacy|0|||
164358761|NCT01729754|593689934|FG002|Part 1|Lack of Efficacy|0|||
164358762|NCT01729754|593689935|FG003|Part 1|Lack of Efficacy|0|||
164438184|NCT00150176|593970689|FG001|Overall Study|Adverse Event|53|||
164438185|NCT00150176|593970688|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
164438186|NCT00150176|593970689|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
164438187|NCT00150176|593970688|FG000|Overall Study|Withdrawal by Subject|19|||
164438188|NCT00150176|593970689|FG001|Overall Study|Withdrawal by Subject|12|||
164438189|NCT00150176|593970688|FG000|Overall Study|Lost to Follow-up|3|||
164438190|NCT00150176|593970689|FG001|Overall Study|Lost to Follow-up|3|||
164438191|NCT00150176|593970688|FG000|Overall Study|OTHER|11|||
164438192|NCT00150176|593970689|FG001|Overall Study|OTHER|13|||
164438193|NCT02477670|593970694|FG000|Stage 1|Adverse Event|2|||
164438194|NCT02477670|593970695|FG001|Stage 1|Adverse Event|7|||
164438195|NCT02477670|593970696|FG002|Stage 1|Adverse Event|0|||
164438196|NCT02477670|593970697|FG003|Stage 1|Adverse Event|0|||
164438197|NCT02477670|593970698|FG004|Stage 1|Adverse Event|0|||
164438198|NCT02477670|593970699|FG005|Stage 1|Adverse Event|0|||
164438199|NCT02477670|593970700|FG006|Stage 1|Adverse Event|0|||
164438200|NCT02477670|593970694|FG000|Stage 1|Lost to Follow-up|0|||
164438201|NCT02477670|593970695|FG001|Stage 1|Lost to Follow-up|2|||
164438202|NCT02477670|593970696|FG002|Stage 1|Lost to Follow-up|0|||
164438203|NCT02477670|593970697|FG003|Stage 1|Lost to Follow-up|0|||
164438204|NCT02477670|593970698|FG004|Stage 1|Lost to Follow-up|0|||
164438205|NCT02477670|593970699|FG005|Stage 1|Lost to Follow-up|0|||
164438206|NCT02477670|593970700|FG006|Stage 1|Lost to Follow-up|0|||
164438207|NCT02477670|593970694|FG000|Stage 1|Withdrawal by Subject|1|||
164438208|NCT02477670|593970695|FG001|Stage 1|Withdrawal by Subject|2|||
164438209|NCT02477670|593970696|FG002|Stage 1|Withdrawal by Subject|0|||
164438210|NCT02477670|593970697|FG003|Stage 1|Withdrawal by Subject|0|||
164438211|NCT02477670|593970698|FG004|Stage 1|Withdrawal by Subject|0|||
164438212|NCT02477670|593970699|FG005|Stage 1|Withdrawal by Subject|0|||
164438213|NCT02477670|593970700|FG006|Stage 1|Withdrawal by Subject|0|||
164438214|NCT02477670|593970694|FG000|Stage 1|Non-compliance with Study Drug|1|||
164438215|NCT02477670|593970695|FG001|Stage 1|Non-compliance with Study Drug|2|||
164438216|NCT02477670|593970696|FG002|Stage 1|Non-compliance with Study Drug|0|||
164438217|NCT02477670|593970697|FG003|Stage 1|Non-compliance with Study Drug|0|||
164438218|NCT02477670|593970698|FG004|Stage 1|Non-compliance with Study Drug|0|||
164438219|NCT02477670|593970699|FG005|Stage 1|Non-compliance with Study Drug|0|||
164438220|NCT02477670|593970700|FG006|Stage 1|Non-compliance with Study Drug|0|||
164438221|NCT02477670|593970694|FG000|Stage 2|Adverse Event|0|||
164438222|NCT02477670|593970695|FG001|Stage 2|Adverse Event|0|||
164438223|NCT02477670|593970696|FG002|Stage 2|Adverse Event|1|||
164438224|NCT02477670|593970697|FG003|Stage 2|Adverse Event|0|||
164438225|NCT02477670|593970698|FG004|Stage 2|Adverse Event|0|||
164438226|NCT02477670|593970699|FG005|Stage 2|Adverse Event|0|||
164438227|NCT02477670|593970700|FG006|Stage 2|Adverse Event|0|||
164438228|NCT02477670|593970694|FG000|Stage 2|Antipsychotic Medication Changed|0|||
164438229|NCT02477670|593970695|FG001|Stage 2|Antipsychotic Medication Changed|0|||
164438230|NCT02477670|593970696|FG002|Stage 2|Antipsychotic Medication Changed|1|||
164438231|NCT02477670|593970697|FG003|Stage 2|Antipsychotic Medication Changed|0|||
164438232|NCT02477670|593970698|FG004|Stage 2|Antipsychotic Medication Changed|0|||
164438233|NCT02477670|593970699|FG005|Stage 2|Antipsychotic Medication Changed|0|||
164438234|NCT02477670|593970700|FG006|Stage 2|Antipsychotic Medication Changed|0|||
164697310|NCT04146363|594915614|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164438235|NCT02477670|593970694|FG000|Stage 2|Withdrawal by Subject|0|||
164697311|NCT04146363|594915615|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164438236|NCT02477670|593970695|FG001|Stage 2|Withdrawal by Subject|0|||
164438237|NCT02477670|593970696|FG002|Stage 2|Withdrawal by Subject|0|||
164358763|NCT01729754|593689936|FG004|Part 1|Lack of Efficacy|0|||
164358764|NCT01729754|593689937|FG005|Part 1|Lack of Efficacy|0|||
164438238|NCT02477670|593970697|FG003|Stage 2|Withdrawal by Subject|1|||
164438239|NCT02477670|593970698|FG004|Stage 2|Withdrawal by Subject|0|||
164438240|NCT02477670|593970699|FG005|Stage 2|Withdrawal by Subject|0|||
164438241|NCT02477670|593970700|FG006|Stage 2|Withdrawal by Subject|0|||
164438242|NCT00970307|593970701|FG000|Overall Study|Serious Adverse Event|1|||
164358765|NCT01729754|593689938|FG006|Part 1|Lack of Efficacy|2|||
164438243|NCT00970307|593970702|FG001|Overall Study|Serious Adverse Event|0|||
164438244|NCT00970307|593970703|FG002|Overall Study|Serious Adverse Event|0|||
164358766|NCT01729754|593689939|FG007|Part 1|Lack of Efficacy|0|||
164438245|NCT00970307|593970701|FG000|Overall Study|Withdrawal by Subject|2|||
164438246|NCT00970307|593970702|FG001|Overall Study|Withdrawal by Subject|3|||
164438247|NCT00970307|593970703|FG002|Overall Study|Withdrawal by Subject|2|||
164438248|NCT02810080|593970704|FG000|Overall Study|Adverse Event|3|||
164438249|NCT02810080|593970705|FG001|Overall Study|Adverse Event|0|||
164358767|NCT01729754|593689940|FG008|Part 1|Lack of Efficacy|0|||
164358768|NCT01729754|593689941|FG009|Part 1|Lack of Efficacy|0|||
164358769|NCT01729754|593689932|FG000|Part 1|Lost to Follow-up|1|||
164358770|NCT01729754|593689933|FG001|Part 1|Lost to Follow-up|0|||
164358771|NCT01729754|593689934|FG002|Part 1|Lost to Follow-up|0|||
164358772|NCT01729754|593689935|FG003|Part 1|Lost to Follow-up|2|||
164358773|NCT01729754|593689936|FG004|Part 1|Lost to Follow-up|0|||
164358774|NCT01729754|593689937|FG005|Part 1|Lost to Follow-up|0|||
164358775|NCT01729754|593689938|FG006|Part 1|Lost to Follow-up|3|||
164358776|NCT01729754|593689939|FG007|Part 1|Lost to Follow-up|0|||
164358777|NCT01729754|593689940|FG008|Part 1|Lost to Follow-up|0|||
164358778|NCT01729754|593689941|FG009|Part 1|Lost to Follow-up|3|||
164358779|NCT01729754|593689932|FG000|Part 1|Non-compliance with Study Drug|1|||
164358780|NCT01729754|593689933|FG001|Part 1|Non-compliance with Study Drug|0|||
164358781|NCT01729754|593689934|FG002|Part 1|Non-compliance with Study Drug|0|||
164358782|NCT01729754|593689935|FG003|Part 1|Non-compliance with Study Drug|0|||
164358783|NCT01729754|593689936|FG004|Part 1|Non-compliance with Study Drug|0|||
164358784|NCT01729754|593689937|FG005|Part 1|Non-compliance with Study Drug|0|||
164358785|NCT01729754|593689938|FG006|Part 1|Non-compliance with Study Drug|0|||
164358786|NCT01729754|593689939|FG007|Part 1|Non-compliance with Study Drug|0|||
164358787|NCT01729754|593689940|FG008|Part 1|Non-compliance with Study Drug|0|||
164358788|NCT01729754|593689941|FG009|Part 1|Non-compliance with Study Drug|0|||
164358789|NCT01729754|593689932|FG000|Part 1|Physician Decision|0|||
164358790|NCT01729754|593689933|FG001|Part 1|Physician Decision|0|||
164358791|NCT01729754|593689934|FG002|Part 1|Physician Decision|0|||
164358792|NCT01729754|593689935|FG003|Part 1|Physician Decision|0|||
164358793|NCT01729754|593689936|FG004|Part 1|Physician Decision|0|||
164358794|NCT01729754|593689937|FG005|Part 1|Physician Decision|0|||
164358795|NCT01729754|593689938|FG006|Part 1|Physician Decision|0|||
164358796|NCT01729754|593689939|FG007|Part 1|Physician Decision|0|||
164358797|NCT01729754|593689940|FG008|Part 1|Physician Decision|0|||
164358798|NCT01729754|593689941|FG009|Part 1|Physician Decision|4|||
164358799|NCT01729754|593689932|FG000|Part 1|Pregnancy|0|||
164358800|NCT01729754|593689933|FG001|Part 1|Pregnancy|0|||
164358801|NCT01729754|593689934|FG002|Part 1|Pregnancy|0|||
164358802|NCT01729754|593689935|FG003|Part 1|Pregnancy|1|||
164358803|NCT01729754|593689936|FG004|Part 1|Pregnancy|0|||
164358804|NCT01729754|593689937|FG005|Part 1|Pregnancy|0|||
164358805|NCT01729754|593689938|FG006|Part 1|Pregnancy|0|||
164358806|NCT01729754|593689939|FG007|Part 1|Pregnancy|0|||
164358807|NCT01729754|593689940|FG008|Part 1|Pregnancy|0|||
164358808|NCT01729754|593689941|FG009|Part 1|Pregnancy|1|||
164358809|NCT01729754|593689932|FG000|Part 1|Progressive Disease|0|||
164358810|NCT01729754|593689933|FG001|Part 1|Progressive Disease|0|||
164358811|NCT01729754|593689934|FG002|Part 1|Progressive Disease|0|||
164358812|NCT01729754|593689935|FG003|Part 1|Progressive Disease|0|||
164358813|NCT01729754|593689936|FG004|Part 1|Progressive Disease|0|||
164358814|NCT01729754|593689937|FG005|Part 1|Progressive Disease|0|||
164358815|NCT01729754|593689938|FG006|Part 1|Progressive Disease|0|||
164358816|NCT01729754|593689939|FG007|Part 1|Progressive Disease|0|||
164358817|NCT01729754|593689940|FG008|Part 1|Progressive Disease|0|||
164358818|NCT01729754|593689941|FG009|Part 1|Progressive Disease|1|||
164358819|NCT01729754|593689932|FG000|Part 1|Protocol Violation|2|||
164358820|NCT01729754|593689933|FG001|Part 1|Protocol Violation|0|||
164358821|NCT01729754|593689934|FG002|Part 1|Protocol Violation|0|||
164358822|NCT01729754|593689935|FG003|Part 1|Protocol Violation|1|||
164358823|NCT01729754|593689936|FG004|Part 1|Protocol Violation|0|||
164358824|NCT01729754|593689937|FG005|Part 1|Protocol Violation|0|||
164358825|NCT01729754|593689938|FG006|Part 1|Protocol Violation|1|||
164358826|NCT01729754|593689939|FG007|Part 1|Protocol Violation|0|||
164358827|NCT01729754|593689940|FG008|Part 1|Protocol Violation|0|||
164358828|NCT01729754|593689941|FG009|Part 1|Protocol Violation|0|||
164358829|NCT01729754|593689932|FG000|Part 1|Withdrawal by Subject|5|||
164358830|NCT01729754|593689933|FG001|Part 1|Withdrawal by Subject|0|||
164358831|NCT01729754|593689934|FG002|Part 1|Withdrawal by Subject|0|||
164358832|NCT01729754|593689935|FG003|Part 1|Withdrawal by Subject|7|||
164358833|NCT01729754|593689936|FG004|Part 1|Withdrawal by Subject|0|||
164358834|NCT01729754|593689937|FG005|Part 1|Withdrawal by Subject|0|||
164358835|NCT01729754|593689938|FG006|Part 1|Withdrawal by Subject|5|||
164358836|NCT01729754|593689939|FG007|Part 1|Withdrawal by Subject|0|||
164358837|NCT01729754|593689940|FG008|Part 1|Withdrawal by Subject|0|||
164358838|NCT01729754|593689941|FG009|Part 1|Withdrawal by Subject|6|||
164358839|NCT01729754|593689932|FG000|Part 1|Other Protocol Specified Criteria|2|||
164358840|NCT01729754|593689933|FG001|Part 1|Other Protocol Specified Criteria|0|||
164358841|NCT01729754|593689934|FG002|Part 1|Other Protocol Specified Criteria|0|||
164358842|NCT01729754|593689935|FG003|Part 1|Other Protocol Specified Criteria|0|||
164358843|NCT01729754|593689936|FG004|Part 1|Other Protocol Specified Criteria|0|||
164358844|NCT01729754|593689937|FG005|Part 1|Other Protocol Specified Criteria|0|||
164358845|NCT01729754|593689938|FG006|Part 1|Other Protocol Specified Criteria|1|||
164358846|NCT01729754|593689939|FG007|Part 1|Other Protocol Specified Criteria|0|||
164358847|NCT01729754|593689940|FG008|Part 1|Other Protocol Specified Criteria|0|||
164358848|NCT01729754|593689941|FG009|Part 1|Other Protocol Specified Criteria|4|||
164358849|NCT01729754|593689932|FG000|Part 2|Adverse Event|2|||
164358850|NCT01729754|593689933|FG001|Part 2|Adverse Event|0|||
164358851|NCT01729754|593689934|FG002|Part 2|Adverse Event|0|||
164358852|NCT01729754|593689935|FG003|Part 2|Adverse Event|0|||
164358853|NCT01729754|593689936|FG004|Part 2|Adverse Event|0|||
164358854|NCT01729754|593689937|FG005|Part 2|Adverse Event|0|||
164358855|NCT01729754|593689938|FG006|Part 2|Adverse Event|0|||
164358856|NCT01729754|593689939|FG007|Part 2|Adverse Event|0|||
164358857|NCT01729754|593689940|FG008|Part 2|Adverse Event|1|||
164358858|NCT01729754|593689941|FG009|Part 2|Adverse Event|2|||
164358859|NCT01729754|593689932|FG000|Part 2|Lack of Efficacy|0|||
164358860|NCT01729754|593689933|FG001|Part 2|Lack of Efficacy|0|||
164358861|NCT01729754|593689934|FG002|Part 2|Lack of Efficacy|0|||
164358862|NCT01729754|593689935|FG003|Part 2|Lack of Efficacy|0|||
164358863|NCT01729754|593689936|FG004|Part 2|Lack of Efficacy|0|||
164358864|NCT01729754|593689937|FG005|Part 2|Lack of Efficacy|0|||
164358865|NCT01729754|593689938|FG006|Part 2|Lack of Efficacy|0|||
164358866|NCT01729754|593689939|FG007|Part 2|Lack of Efficacy|0|||
164358867|NCT01729754|593689940|FG008|Part 2|Lack of Efficacy|2|||
164358868|NCT01729754|593689941|FG009|Part 2|Lack of Efficacy|2|||
164358869|NCT01729754|593689932|FG000|Part 2|Lost to Follow-up|0|||
164358870|NCT01729754|593689933|FG001|Part 2|Lost to Follow-up|0|||
164358871|NCT01729754|593689934|FG002|Part 2|Lost to Follow-up|0|||
164358872|NCT01729754|593689935|FG003|Part 2|Lost to Follow-up|2|||
164358873|NCT01729754|593689936|FG004|Part 2|Lost to Follow-up|0|||
164358874|NCT01729754|593689937|FG005|Part 2|Lost to Follow-up|0|||
164358875|NCT01729754|593689938|FG006|Part 2|Lost to Follow-up|0|||
164358876|NCT01729754|593689939|FG007|Part 2|Lost to Follow-up|1|||
164358877|NCT01729754|593689940|FG008|Part 2|Lost to Follow-up|0|||
164358878|NCT01729754|593689941|FG009|Part 2|Lost to Follow-up|2|||
164358879|NCT01729754|593689932|FG000|Part 2|Non-Compliance with Study Drug|0|||
164358880|NCT01729754|593689933|FG001|Part 2|Non-Compliance with Study Drug|0|||
164358881|NCT01729754|593689934|FG002|Part 2|Non-Compliance with Study Drug|0|||
164358882|NCT01729754|593689935|FG003|Part 2|Non-Compliance with Study Drug|0|||
164358883|NCT01729754|593689936|FG004|Part 2|Non-Compliance with Study Drug|0|||
164358884|NCT01729754|593689937|FG005|Part 2|Non-Compliance with Study Drug|0|||
164358885|NCT01729754|593689938|FG006|Part 2|Non-Compliance with Study Drug|0|||
164358886|NCT01729754|593689939|FG007|Part 2|Non-Compliance with Study Drug|0|||
164358887|NCT01729754|593689940|FG008|Part 2|Non-Compliance with Study Drug|0|||
164358888|NCT01729754|593689941|FG009|Part 2|Non-Compliance with Study Drug|1|||
164358889|NCT01729754|593689932|FG000|Part 2|Pregnancy|0|||
164358890|NCT01729754|593689933|FG001|Part 2|Pregnancy|0|||
164358891|NCT01729754|593689934|FG002|Part 2|Pregnancy|0|||
164358892|NCT01729754|593689935|FG003|Part 2|Pregnancy|1|||
164358893|NCT01729754|593689936|FG004|Part 2|Pregnancy|0|||
164358894|NCT01729754|593689937|FG005|Part 2|Pregnancy|0|||
164358895|NCT01729754|593689938|FG006|Part 2|Pregnancy|0|||
164358896|NCT01729754|593689939|FG007|Part 2|Pregnancy|0|||
164358897|NCT01729754|593689940|FG008|Part 2|Pregnancy|0|||
164358898|NCT01729754|593689941|FG009|Part 2|Pregnancy|1|||
164358899|NCT01729754|593689932|FG000|Part 2|Withdrawal by Subject|3|||
164358900|NCT01729754|593689933|FG001|Part 2|Withdrawal by Subject|0|||
164358901|NCT01729754|593689934|FG002|Part 2|Withdrawal by Subject|0|||
164358902|NCT01729754|593689935|FG003|Part 2|Withdrawal by Subject|2|||
164358903|NCT01729754|593689936|FG004|Part 2|Withdrawal by Subject|0|||
164358904|NCT01729754|593689937|FG005|Part 2|Withdrawal by Subject|0|||
164358905|NCT01729754|593689938|FG006|Part 2|Withdrawal by Subject|0|||
164358906|NCT01729754|593689939|FG007|Part 2|Withdrawal by Subject|1|||
164358907|NCT01729754|593689940|FG008|Part 2|Withdrawal by Subject|1|||
164358908|NCT01729754|593689941|FG009|Part 2|Withdrawal by Subject|4|||
164358909|NCT01729754|593689932|FG000|Part 2|Other Protocol Specified Criteria|1|||
164358910|NCT01729754|593689933|FG001|Part 2|Other Protocol Specified Criteria|0|||
164358911|NCT01729754|593689934|FG002|Part 2|Other Protocol Specified Criteria|0|||
164358912|NCT01729754|593689935|FG003|Part 2|Other Protocol Specified Criteria|0|||
164358913|NCT01729754|593689936|FG004|Part 2|Other Protocol Specified Criteria|0|||
164358914|NCT01729754|593689937|FG005|Part 2|Other Protocol Specified Criteria|0|||
164358915|NCT01729754|593689938|FG006|Part 2|Other Protocol Specified Criteria|0|||
164358916|NCT01729754|593689939|FG007|Part 2|Other Protocol Specified Criteria|1|||
164358917|NCT01729754|593689940|FG008|Part 2|Other Protocol Specified Criteria|0|||
164358918|NCT01729754|593689941|FG009|Part 2|Other Protocol Specified Criteria|0|||
164358919|NCT01729754|593689932|FG000|Part 3|Adverse Event|0|||
164358920|NCT01729754|593689933|FG001|Part 3|Adverse Event|0|||
164358921|NCT01729754|593689934|FG002|Part 3|Adverse Event|1|||
164358922|NCT01729754|593689935|FG003|Part 3|Adverse Event|0|||
164358923|NCT01729754|593689936|FG004|Part 3|Adverse Event|0|||
164358924|NCT01729754|593689937|FG005|Part 3|Adverse Event|5|||
164358925|NCT01729754|593689938|FG006|Part 3|Adverse Event|0|||
164358926|NCT01729754|593689939|FG007|Part 3|Adverse Event|0|||
164358927|NCT01729754|593689940|FG008|Part 3|Adverse Event|0|||
164358928|NCT01729754|593689941|FG009|Part 3|Adverse Event|3|||
164358929|NCT01729754|593689932|FG000|Part 3|Death|0|||
164358930|NCT01729754|593689933|FG001|Part 3|Death|0|||
164358931|NCT01729754|593689934|FG002|Part 3|Death|0|||
164358932|NCT01729754|593689935|FG003|Part 3|Death|0|||
164358933|NCT01729754|593689936|FG004|Part 3|Death|0|||
164358934|NCT01729754|593689937|FG005|Part 3|Death|2|||
164358935|NCT01729754|593689938|FG006|Part 3|Death|0|||
164358936|NCT01729754|593689939|FG007|Part 3|Death|0|||
164358937|NCT01729754|593689940|FG008|Part 3|Death|0|||
164358938|NCT01729754|593689941|FG009|Part 3|Death|0|||
164358939|NCT01729754|593689932|FG000|Part 3|Lack of Efficacy|0|||
164358940|NCT01729754|593689933|FG001|Part 3|Lack of Efficacy|0|||
164358941|NCT01729754|593689934|FG002|Part 3|Lack of Efficacy|0|||
164358942|NCT01729754|593689935|FG003|Part 3|Lack of Efficacy|0|||
164358943|NCT01729754|593689936|FG004|Part 3|Lack of Efficacy|2|||
164358944|NCT01729754|593689937|FG005|Part 3|Lack of Efficacy|0|||
164358945|NCT01729754|593689938|FG006|Part 3|Lack of Efficacy|0|||
164358946|NCT01729754|593689939|FG007|Part 3|Lack of Efficacy|0|||
164358947|NCT01729754|593689940|FG008|Part 3|Lack of Efficacy|0|||
164358948|NCT01729754|593689941|FG009|Part 3|Lack of Efficacy|4|||
164358949|NCT01729754|593689932|FG000|Part 3|Lost to Follow-up|0|||
164358950|NCT01729754|593689933|FG001|Part 3|Lost to Follow-up|1|||
164358951|NCT01729754|593689934|FG002|Part 3|Lost to Follow-up|2|||
164358952|NCT01729754|593689935|FG003|Part 3|Lost to Follow-up|0|||
164358953|NCT01729754|593689936|FG004|Part 3|Lost to Follow-up|0|||
164358954|NCT01729754|593689937|FG005|Part 3|Lost to Follow-up|3|||
164358955|NCT01729754|593689938|FG006|Part 3|Lost to Follow-up|0|||
164358956|NCT01729754|593689939|FG007|Part 3|Lost to Follow-up|0|||
164358957|NCT01729754|593689940|FG008|Part 3|Lost to Follow-up|1|||
164358958|NCT01729754|593689941|FG009|Part 3|Lost to Follow-up|0|||
164358959|NCT01729754|593689932|FG000|Part 3|Physician Decision|0|||
164358960|NCT01729754|593689933|FG001|Part 3|Physician Decision|0|||
164358961|NCT01729754|593689934|FG002|Part 3|Physician Decision|1|||
164358962|NCT01729754|593689935|FG003|Part 3|Physician Decision|0|||
164358963|NCT01729754|593689936|FG004|Part 3|Physician Decision|0|||
164358964|NCT01729754|593689937|FG005|Part 3|Physician Decision|0|||
164358965|NCT01729754|593689938|FG006|Part 3|Physician Decision|0|||
164358966|NCT01729754|593689939|FG007|Part 3|Physician Decision|0|||
164358967|NCT01729754|593689940|FG008|Part 3|Physician Decision|0|||
164358968|NCT01729754|593689941|FG009|Part 3|Physician Decision|0|||
164358969|NCT01729754|593689932|FG000|Part 3|Withdrawal by Subject|0|||
164358970|NCT01729754|593689933|FG001|Part 3|Withdrawal by Subject|4|||
164358971|NCT01729754|593689934|FG002|Part 3|Withdrawal by Subject|1|||
164358972|NCT01729754|593689935|FG003|Part 3|Withdrawal by Subject|0|||
164358973|NCT01729754|593689936|FG004|Part 3|Withdrawal by Subject|2|||
164358974|NCT01729754|593689937|FG005|Part 3|Withdrawal by Subject|1|||
164358975|NCT01729754|593689938|FG006|Part 3|Withdrawal by Subject|0|||
164358976|NCT01729754|593689939|FG007|Part 3|Withdrawal by Subject|2|||
164358977|NCT01729754|593689940|FG008|Part 3|Withdrawal by Subject|0|||
164358978|NCT01729754|593689941|FG009|Part 3|Withdrawal by Subject|0|||
164358979|NCT01729754|593689932|FG000|Part 3|Other Protocol Specified Criteria|0|||
164358980|NCT01729754|593689933|FG001|Part 3|Other Protocol Specified Criteria|0|||
164358981|NCT01729754|593689934|FG002|Part 3|Other Protocol Specified Criteria|0|||
164358982|NCT01729754|593689935|FG003|Part 3|Other Protocol Specified Criteria|0|||
164358983|NCT01729754|593689936|FG004|Part 3|Other Protocol Specified Criteria|0|||
164358984|NCT01729754|593689937|FG005|Part 3|Other Protocol Specified Criteria|2|||
164358985|NCT01729754|593689938|FG006|Part 3|Other Protocol Specified Criteria|0|||
164358986|NCT01729754|593689939|FG007|Part 3|Other Protocol Specified Criteria|1|||
164358987|NCT01729754|593689940|FG008|Part 3|Other Protocol Specified Criteria|0|||
164358988|NCT01729754|593689941|FG009|Part 3|Other Protocol Specified Criteria|0|||
164697312|NCT04146363|594915616|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164358989|NCT00936910|593689942|FG000|Overall Study|Lack of Efficacy|3|||
164358990|NCT00773292|593689943|FG000|Treatment 48 Weeks|Adverse Event|1|||
164358991|NCT00773292|593689943|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
164358992|NCT01853046|593689944|FG000|Overall Study|Withdrawal by Subject|1|||
164358993|NCT01853046|593689945|FG001|Overall Study|Withdrawal by Subject|1|||
164358994|NCT01853046|593689944|FG000|Overall Study|Adverse Event|4|||
164358995|NCT01853046|593689945|FG001|Overall Study|Adverse Event|2|||
164358996|NCT01853046|593689944|FG000|Overall Study|Disease progression|13|||
164358997|NCT01853046|593689945|FG001|Overall Study|Disease progression|3|||
164358998|NCT03020407|593689947|FG000|Overall Study|Withdrawal by Subject|2|||
164358999|NCT03020407|593689948|FG001|Overall Study|Withdrawal by Subject|1|||
164359000|NCT03020407|593689947|FG000|Overall Study|Lost to Follow-up|2|||
164359001|NCT03020407|593689948|FG001|Overall Study|Lost to Follow-up|3|||
164359002|NCT03020407|593689947|FG000|Overall Study|Protocol Violation|0|||
164359003|NCT03020407|593689948|FG001|Overall Study|Protocol Violation|1|||
164359004|NCT00708162|593689949|FG000|Randomized Phase|Randomized but Not Treated|7|||
164359005|NCT00708162|593689950|FG001|Randomized Phase|Randomized but Not Treated|5|||
164359006|NCT00708162|593689949|FG000|Randomized Phase|Participant Noncompliance|40|||
164359007|NCT00708162|593689950|FG001|Randomized Phase|Participant Noncompliance|32|||
164359008|NCT00708162|593689949|FG000|Randomized Phase|Lost to Follow-up|34|||
164359009|NCT00708162|593689950|FG001|Randomized Phase|Lost to Follow-up|34|||
164359010|NCT00708162|593689949|FG000|Randomized Phase|Withdrew Consent|31|||
164359011|NCT00708162|593689950|FG001|Randomized Phase|Withdrew Consent|22|||
164359012|NCT00708162|593689949|FG000|Randomized Phase|Lack of Efficacy|14|||
164359013|NCT00708162|593689950|FG001|Randomized Phase|Lack of Efficacy|19|||
164359014|NCT00708162|593689949|FG000|Randomized Phase|Protocol Violation|10|||
164359015|NCT00708162|593689950|FG001|Randomized Phase|Protocol Violation|11|||
164359016|NCT00708162|593689949|FG000|Randomized Phase|Adverse Event|8|||
164438250|NCT02810080|593970704|FG000|Overall Study|Death|0|||
164438251|NCT02810080|593970705|FG001|Overall Study|Death|2|||
164438252|NCT02810080|593970704|FG000|Overall Study|Physician Decision|4|||
164438253|NCT02810080|593970705|FG001|Overall Study|Physician Decision|0|||
164438254|NCT02810080|593970704|FG000|Overall Study|Withdrawal by Subject|0|||
164438255|NCT02810080|593970705|FG001|Overall Study|Withdrawal by Subject|2|||
164438256|NCT01811706|593970715|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
164438257|NCT01811706|593970716|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
164438258|NCT05174013|593970718|FG000|Overall Study|Lost to Follow-up|0|||
164438259|NCT05174013|593970719|FG001|Overall Study|Lost to Follow-up|0|||
164438260|NCT05174013|593970720|FG002|Overall Study|Lost to Follow-up|0|||
164438261|NCT05174013|593970721|FG003|Overall Study|Lost to Follow-up|1|||
164438262|NCT05174013|593970722|FG004|Overall Study|Lost to Follow-up|0|||
164438263|NCT05174013|593970723|FG005|Overall Study|Lost to Follow-up|0|||
164438264|NCT05174013|593970718|FG000|Overall Study|Withdrawal by Subject|0|||
164438265|NCT05174013|593970719|FG001|Overall Study|Withdrawal by Subject|0|||
164438266|NCT05174013|593970720|FG002|Overall Study|Withdrawal by Subject|1|||
164438267|NCT05174013|593970721|FG003|Overall Study|Withdrawal by Subject|0|||
164438268|NCT05174013|593970722|FG004|Overall Study|Withdrawal by Subject|0|||
164438269|NCT05174013|593970723|FG005|Overall Study|Withdrawal by Subject|0|||
164359017|NCT00708162|593689950|FG001|Randomized Phase|Adverse Event|12|||
164359018|NCT00708162|593689949|FG000|Randomized Phase|Investigator's Discretion|7|||
164697313|NCT04146363|594915617|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164359019|NCT00708162|593689950|FG001|Randomized Phase|Investigator's Discretion|10|||
164359020|NCT00708162|593689949|FG000|Randomized Phase|Death|2|||
164359021|NCT00708162|593689950|FG001|Randomized Phase|Death|9|||
164359022|NCT00708162|593689949|FG000|Randomized Phase|Pregnancy|3|||
164359023|NCT00708162|593689950|FG001|Randomized Phase|Pregnancy|0|||
164359024|NCT00708162|593689949|FG000|Open-Label Phase|Lost to Follow-up|10|||
164359025|NCT00708162|593689950|FG001|Open-Label Phase|Lost to Follow-up|8|||
164359026|NCT00708162|593689949|FG000|Open-Label Phase|Withdrew Consent|12|||
164359027|NCT00708162|593689950|FG001|Open-Label Phase|Withdrew Consent|6|||
164359028|NCT00708162|593689949|FG000|Open-Label Phase|Participant Noncompliance|7|||
164359029|NCT00708162|593689950|FG001|Open-Label Phase|Participant Noncompliance|7|||
164359030|NCT00708162|593689949|FG000|Open-Label Phase|Lack of Efficacy|7|||
164359031|NCT00708162|593689950|FG001|Open-Label Phase|Lack of Efficacy|4|||
164359032|NCT00708162|593689949|FG000|Open-Label Phase|Investigator's Discretion|3|||
164359033|NCT00708162|593689950|FG001|Open-Label Phase|Investigator's Discretion|2|||
164359034|NCT00708162|593689949|FG000|Open-Label Phase|Death|3|||
164359035|NCT00708162|593689950|FG001|Open-Label Phase|Death|1|||
164359036|NCT00708162|593689949|FG000|Open-Label Phase|Adverse Event|1|||
164359037|NCT00708162|593689950|FG001|Open-Label Phase|Adverse Event|2|||
164359038|NCT00708162|593689949|FG000|Open-Label Phase|Other|1|||
164359039|NCT00708162|593689950|FG001|Open-Label Phase|Other|0|||
164359040|NCT02699554|593689951|FG000|Overall Study|Lost to Follow-up|9|||
164359041|NCT00788151|593689952|FG000|Overall Study|Other adverse event|0|||
164359042|NCT00788151|593689953|FG001|Overall Study|Other adverse event|2|||
164359043|NCT00788151|593689952|FG000|Overall Study|Protocol Violation|0|||
164359044|NCT00788151|593689953|FG001|Overall Study|Protocol Violation|1|||
164359045|NCT00788151|593689952|FG000|Overall Study|Withdrawal by Subject|13|||
164359046|NCT00788151|593689953|FG001|Overall Study|Withdrawal by Subject|6|||
164359047|NCT00788151|593689952|FG000|Overall Study|Enrolled but not treated|1|||
164438270|NCT00753012|593970727|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
164438271|NCT00753012|593970728|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
164438272|NCT00753012|593970727|FG000|Overall Study|Adverse Event|2|||
164438273|NCT00753012|593970728|FG001|Overall Study|Adverse Event|0|||
164438274|NCT00753012|593970727|FG000|Overall Study|Withdrawal by Subject|0|||
164359048|NCT00788151|593689953|FG001|Overall Study|Enrolled but not treated|1|||
164359049|NCT00503009|593689954|FG000|Overall Study|Protocol Violation|1|||
164359050|NCT00503009|593689955|FG001|Overall Study|Protocol Violation|0|||
164697314|NCT04146363|594915618|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164697315|NCT04146363|594915619|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164697316|NCT04146363|594915620|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
164697317|NCT04146363|594915621|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
164359051|NCT00503009|593689956|FG002|Overall Study|Protocol Violation|1|||
164359052|NCT00503009|593689954|FG000|Overall Study|Withdrawal by Subject|0|||
164359053|NCT00503009|593689955|FG001|Overall Study|Withdrawal by Subject|1|||
164359054|NCT00503009|593689956|FG002|Overall Study|Withdrawal by Subject|1|||
164359055|NCT00503009|593689954|FG000|Overall Study|Physician Decision|0|||
164359056|NCT00503009|593689955|FG001|Overall Study|Physician Decision|1|||
164359057|NCT00503009|593689956|FG002|Overall Study|Physician Decision|1|||
164438275|NCT00753012|593970728|FG001|Overall Study|Withdrawal by Subject|1|||
164438276|NCT00753012|593970727|FG000|Overall Study|Lost to Follow-up|4|||
164438277|NCT00753012|593970728|FG001|Overall Study|Lost to Follow-up|0|||
164438278|NCT00753012|593970727|FG000|Overall Study|Confounded endpoint data|1|||
164438279|NCT00753012|593970728|FG001|Overall Study|Confounded endpoint data|0|||
164438280|NCT01930045|593970729|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
164697318|NCT04146363|594915622|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
164697319|NCT04146363|594915612|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164697320|NCT04146363|594915613|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164697321|NCT04146363|594915614|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164697322|NCT04146363|594915615|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164359058|NCT01349803|593689958|FG000|Overall Study|Adverse Event|0|||
164359059|NCT01349803|593689959|FG001|Overall Study|Adverse Event|0|||
164359060|NCT01349803|593689960|FG002|Overall Study|Adverse Event|0|||
164359061|NCT01349803|593689961|FG003|Overall Study|Adverse Event|2|||
164359062|NCT01349803|593689958|FG000|Overall Study|Withdrawal by Subject|1|||
164359063|NCT01349803|593689959|FG001|Overall Study|Withdrawal by Subject|0|||
164359064|NCT01349803|593689960|FG002|Overall Study|Withdrawal by Subject|0|||
164359065|NCT01349803|593689961|FG003|Overall Study|Withdrawal by Subject|0|||
164359066|NCT01349803|593689958|FG000|Overall Study|Protocol-specified criteria|0|||
164359067|NCT01349803|593689959|FG001|Overall Study|Protocol-specified criteria|1|||
164359068|NCT01349803|593689960|FG002|Overall Study|Protocol-specified criteria|3|||
164359069|NCT01349803|593689961|FG003|Overall Study|Protocol-specified criteria|0|||
164359070|NCT02345811|593689962|FG000|First Intervention|Withdrawal by Subject|1|||
164359071|NCT02345811|593689963|FG001|First Intervention|Withdrawal by Subject|1|||
164359072|NCT02522286|593689964|FG000|Overall Study|Withdrawal by Subject|3|||
164359073|NCT02522286|593689965|FG001|Overall Study|Withdrawal by Subject|0|||
164359074|NCT02522286|593689966|FG002|Overall Study|Withdrawal by Subject|0|||
164359075|NCT02522286|593689967|FG003|Overall Study|Withdrawal by Subject|3|||
164359076|NCT00605813|593689969|FG000|Overall Study|Protocol Violation|25|||
164359077|NCT01163279|593689971|FG000|Overall Study|Withdrawal by Subject|2|||
164359078|NCT01163279|593689972|FG001|Overall Study|Withdrawal by Subject|0|||
164359079|NCT01394523|593689976|FG000|Overall Study|Unable to place block|1|||
164359080|NCT01394523|593689977|FG001|Overall Study|Unable to place block|0|||
164359081|NCT01394523|593689978|FG002|Overall Study|Unable to place block|0|||
164359082|NCT03525574|593689984|FG000|Overall Study|Adverse Event|15|||
164359083|NCT03525574|593689985|FG001|Overall Study|Adverse Event|0|||
164359084|NCT03525574|593689984|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
164359085|NCT03525574|593689985|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
164359086|NCT03525574|593689984|FG000|Overall Study|Lost to Follow-up|4|||
164359087|NCT03525574|593689985|FG001|Overall Study|Lost to Follow-up|0|||
164359088|NCT03525574|593689984|FG000|Overall Study|Commercial drug is Available for participant|48|||
164359089|NCT03525574|593689985|FG001|Overall Study|Commercial drug is Available for participant|0|||
164359090|NCT03525574|593689984|FG000|Overall Study|Death|1|||
164359091|NCT03525574|593689985|FG001|Overall Study|Death|0|||
164359092|NCT03525574|593689984|FG000|Overall Study|Other non-compliance|2|||
164359093|NCT03525574|593689985|FG001|Overall Study|Other non-compliance|0|||
164359094|NCT03525574|593689984|FG000|Overall Study|Physician Decision|6|||
164359095|NCT03525574|593689985|FG001|Overall Study|Physician Decision|0|||
164359096|NCT03525574|593689984|FG000|Overall Study|Other|58|||
164359097|NCT03525574|593689985|FG001|Overall Study|Other|0|||
164359098|NCT03525574|593689984|FG000|Overall Study|Enrolled but never dosed|1|||
164359099|NCT03525574|593689985|FG001|Overall Study|Enrolled but never dosed|0|||
164359100|NCT03525574|593689984|FG000|Overall Study|Not enrolled in 105 study|0|||
164359101|NCT03525574|593689985|FG001|Overall Study|Not enrolled in 105 study|3|||
164359102|NCT04741074|593689988|FG000|Overall Study|Withdrawal by Subject|1|||
164359103|NCT04741074|593689989|FG001|Overall Study|Withdrawal by Subject|1|||
164359104|NCT04741074|593689988|FG000|Overall Study|Study terminated prematurely|1|||
164359105|NCT04741074|593689989|FG001|Overall Study|Study terminated prematurely|0|||
164359106|NCT01770379|593689990|FG000|Overall Study|Technical issues|1|||
164359107|NCT01770379|593689991|FG001|Overall Study|Technical issues|0|||
164359108|NCT01770379|593689992|FG002|Overall Study|Technical issues|0|||
164359109|NCT01770379|593689990|FG000|Overall Study|Withdrawal by Subject|7|||
164359110|NCT01770379|593689991|FG001|Overall Study|Withdrawal by Subject|10|||
164359111|NCT01770379|593689992|FG002|Overall Study|Withdrawal by Subject|7|||
164359112|NCT01770379|593689990|FG000|Overall Study|study terminated by sponsor|22|||
164697323|NCT04146363|594915616|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164697324|NCT04146363|594915617|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164359113|NCT01770379|593689991|FG001|Overall Study|study terminated by sponsor|23|||
164359114|NCT01770379|593689992|FG002|Overall Study|study terminated by sponsor|22|||
164359115|NCT01770379|593689990|FG000|Overall Study|Protocol Violation|0|||
164359116|NCT01770379|593689991|FG001|Overall Study|Protocol Violation|1|||
164359117|NCT01770379|593689992|FG002|Overall Study|Protocol Violation|1|||
164359118|NCT01770379|593689990|FG000|Overall Study|Physician Decision|0|||
164359119|NCT01770379|593689991|FG001|Overall Study|Physician Decision|1|||
164359120|NCT01770379|593689992|FG002|Overall Study|Physician Decision|2|||
164359121|NCT01770379|593689990|FG000|Overall Study|Lost to Follow-up|0|||
164359122|NCT01770379|593689991|FG001|Overall Study|Lost to Follow-up|0|||
164359123|NCT01770379|593689992|FG002|Overall Study|Lost to Follow-up|2|||
164359124|NCT01770379|593689990|FG000|Overall Study|Lack of Efficacy|8|||
164359125|NCT01770379|593689991|FG001|Overall Study|Lack of Efficacy|6|||
164359126|NCT01770379|593689992|FG002|Overall Study|Lack of Efficacy|6|||
164359127|NCT01770379|593689990|FG000|Overall Study|Adverse Event|1|||
164359128|NCT01770379|593689991|FG001|Overall Study|Adverse Event|3|||
164359129|NCT01770379|593689992|FG002|Overall Study|Adverse Event|2|||
164359130|NCT00778700|593689993|FG000|Overall Study|Adverse Event|6|||
164359131|NCT00778700|593689994|FG001|Overall Study|Adverse Event|1|||
164359132|NCT00778700|593689995|FG002|Overall Study|Adverse Event|3|||
164359133|NCT00778700|593689996|FG003|Overall Study|Adverse Event|5|||
164359134|NCT00778700|593689993|FG000|Overall Study|Protocol Violation|1|||
164359135|NCT00778700|593689994|FG001|Overall Study|Protocol Violation|1|||
164359136|NCT00778700|593689995|FG002|Overall Study|Protocol Violation|0|||
164359137|NCT00778700|593689996|FG003|Overall Study|Protocol Violation|0|||
164359138|NCT00778700|593689993|FG000|Overall Study|Subject Withdrew Consent|6|||
164359139|NCT00778700|593689994|FG001|Overall Study|Subject Withdrew Consent|4|||
164359140|NCT00778700|593689995|FG002|Overall Study|Subject Withdrew Consent|1|||
164359141|NCT00778700|593689996|FG003|Overall Study|Subject Withdrew Consent|4|||
164359142|NCT00778700|593689993|FG000|Overall Study|Lost to Follow-up|3|||
164359143|NCT00778700|593689994|FG001|Overall Study|Lost to Follow-up|1|||
164359144|NCT00778700|593689995|FG002|Overall Study|Lost to Follow-up|0|||
164359145|NCT00778700|593689996|FG003|Overall Study|Lost to Follow-up|1|||
164359146|NCT00778700|593689993|FG000|Overall Study|Reason not Specified|2|||
164359147|NCT00778700|593689994|FG001|Overall Study|Reason not Specified|0|||
164359148|NCT00778700|593689995|FG002|Overall Study|Reason not Specified|1|||
164359149|NCT00778700|593689996|FG003|Overall Study|Reason not Specified|3|||
164359150|NCT00778700|593689993|FG000|Overall Study|Other|0|||
164359151|NCT00778700|593689994|FG001|Overall Study|Other|0|||
164359152|NCT00778700|593689995|FG002|Overall Study|Other|1|||
164359153|NCT00778700|593689996|FG003|Overall Study|Other|0|||
164359154|NCT03274440|593690002|FG000|Overall Study|Time commitment too great|1|||
164359155|NCT03274440|593690003|FG001|Overall Study|Time commitment too great|0|||
164359156|NCT03274440|593690004|FG002|Overall Study|Time commitment too great|0|||
164359157|NCT03274440|593690005|FG003|Overall Study|Time commitment too great|1|||
164359158|NCT03274440|593690006|FG004|Overall Study|Time commitment too great|0|||
164359159|NCT03274440|593690007|FG005|Overall Study|Time commitment too great|0|||
164359160|NCT02611778|593690008|FG000|Overall Study|Withdrawal by Subject|2|||
164359161|NCT02611778|593690009|FG001|Overall Study|Withdrawal by Subject|8|||
164359162|NCT02611778|593690008|FG000|Overall Study|Adverse Event|1|||
164359163|NCT02611778|593690009|FG001|Overall Study|Adverse Event|2|||
164359164|NCT02611778|593690008|FG000|Overall Study|Death|2|||
164359165|NCT02611778|593690009|FG001|Overall Study|Death|1|||
164359166|NCT02611778|593690008|FG000|Overall Study|Protocol Violation|1|||
164359167|NCT02611778|593690009|FG001|Overall Study|Protocol Violation|0|||
164359168|NCT02611778|593690008|FG000|Overall Study|Lost to Follow-up|3|||
164359169|NCT02611778|593690009|FG001|Overall Study|Lost to Follow-up|1|||
164359170|NCT02611778|593690008|FG000|Overall Study|Need for alternative treatment|1|||
164359171|NCT02611778|593690009|FG001|Overall Study|Need for alternative treatment|0|||
164359172|NCT02611778|593690008|FG000|Overall Study|Other Reason|2|||
164359173|NCT02611778|593690009|FG001|Overall Study|Other Reason|1|||
164359174|NCT04008030|593690011|FG000|Pre-Treatment|Withdrawal by Subject|0|||
164359175|NCT04008030|593690012|FG001|Pre-Treatment|Withdrawal by Subject|0|||
164359176|NCT04008030|593690013|FG002|Pre-Treatment|Withdrawal by Subject|9|||
164359177|NCT04008030|593690011|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
164359178|NCT04008030|593690012|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
164359179|NCT04008030|593690013|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
164359180|NCT04008030|593690011|FG000|Pre-Treatment|Other reasons|0|||
164359181|NCT04008030|593690012|FG001|Pre-Treatment|Other reasons|1|||
164359182|NCT04008030|593690013|FG002|Pre-Treatment|Other reasons|6|||
164359183|NCT04008030|593690011|FG000|Treatment|Withdrawal by Subject|1|||
164359184|NCT04008030|593690012|FG001|Treatment|Withdrawal by Subject|1|||
164359185|NCT04008030|593690013|FG002|Treatment|Withdrawal by Subject|1|||
164438281|NCT01930045|593970730|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
164438282|NCT01930045|593970731|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
164590626|NCT00637273|594525286|FG001|Overall Study|Adverse Event|5|||
164590627|NCT00637273|594525287|FG002|Overall Study|Adverse Event|7|||
164359186|NCT04008030|593690011|FG000|Treatment|Death|2|||
164359187|NCT04008030|593690012|FG001|Treatment|Death|4|||
164359188|NCT04008030|593690013|FG002|Treatment|Death|0|||
164359189|NCT04008030|593690011|FG000|Treatment|Pregnancy|0|||
164359190|NCT04008030|593690012|FG001|Treatment|Pregnancy|1|||
164359191|NCT04008030|593690013|FG002|Treatment|Pregnancy|0|||
164359192|NCT04008030|593690011|FG000|Treatment|Participant no longer meets study criteria|0|||
164359193|NCT04008030|593690012|FG001|Treatment|Participant no longer meets study criteria|1|||
164359194|NCT04008030|593690013|FG002|Treatment|Participant no longer meets study criteria|0|||
164359195|NCT04008030|593690011|FG000|Treatment|Other reasons|5|||
164438283|NCT01930045|593970732|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
164590628|NCT00637273|594525285|FG000|Overall Study|Lost to Follow-up|8|||
164590629|NCT00637273|594525286|FG001|Overall Study|Lost to Follow-up|9|||
164590630|NCT00637273|594525287|FG002|Overall Study|Lost to Follow-up|13|||
164590631|NCT00637273|594525285|FG000|Overall Study|Protocol Violation|2|||
164438284|NCT01930045|593970733|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
164438285|NCT01930045|593970734|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
164438286|NCT01930045|593970729|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
164438287|NCT01930045|593970730|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
164438288|NCT01930045|593970731|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
164438289|NCT01930045|593970732|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
164438290|NCT01930045|593970733|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
164438291|NCT01930045|593970734|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
164438292|NCT00241644|593970735|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
164438293|NCT00241644|593970736|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
164438294|NCT00241644|593970737|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
164438295|NCT00241644|593970738|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
164438296|NCT00241644|593970735|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
164438297|NCT00241644|593970736|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
164438298|NCT00241644|593970737|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
164438299|NCT00241644|593970738|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
164438300|NCT00241644|593970735|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
164438301|NCT00241644|593970736|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
164438302|NCT00241644|593970737|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
164438303|NCT00241644|593970738|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
164438304|NCT00241644|593970735|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
164438305|NCT00241644|593970736|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
164438306|NCT00241644|593970737|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
164438307|NCT00241644|593970738|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
164438308|NCT00241644|593970735|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
164438309|NCT00241644|593970736|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
164438310|NCT00241644|593970737|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
164438311|NCT00241644|593970738|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
164438312|NCT00241644|593970735|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
164438313|NCT00241644|593970736|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
164438314|NCT00241644|593970737|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
164438315|NCT00241644|593970738|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
164438316|NCT00241644|593970735|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
164438317|NCT00241644|593970736|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
164438318|NCT00241644|593970737|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
164359196|NCT04008030|593690012|FG001|Treatment|Other reasons|13|||
164359197|NCT04008030|593690013|FG002|Treatment|Other reasons|6|||
164359198|NCT04008030|593690011|FG000|Treatment|Disease Progression|137|||
164359199|NCT04008030|593690012|FG001|Treatment|Disease Progression|82|||
164359200|NCT04008030|593690013|FG002|Treatment|Disease Progression|85|||
164359201|NCT04008030|593690011|FG000|Treatment|Study drug toxicity|28|||
164359202|NCT04008030|593690012|FG001|Treatment|Study drug toxicity|48|||
164359203|NCT04008030|593690013|FG002|Treatment|Study drug toxicity|8|||
164359204|NCT04008030|593690011|FG000|Treatment|Adverse Event unrelated to study drug|28|||
164359205|NCT04008030|593690012|FG001|Treatment|Adverse Event unrelated to study drug|22|||
164359206|NCT04008030|593690013|FG002|Treatment|Adverse Event unrelated to study drug|6|||
164359207|NCT04008030|593690011|FG000|Treatment|Maximum Clinical Benefit|0|||
164359208|NCT04008030|593690012|FG001|Treatment|Maximum Clinical Benefit|1|||
164359209|NCT04008030|593690013|FG002|Treatment|Maximum Clinical Benefit|9|||
164359210|NCT04008030|593690011|FG000|Treatment|On-going treatment|13|||
164359211|NCT04008030|593690012|FG001|Treatment|On-going treatment|20|||
164359212|NCT04008030|593690013|FG002|Treatment|On-going treatment|0|||
164359213|NCT02574247|593690020|FG000|Overall Study|Withdrawal by Subject|1|||
164359214|NCT02574247|593690021|FG001|Overall Study|Withdrawal by Subject|0|||
164359215|NCT02574247|593690022|FG002|Overall Study|Withdrawal by Subject|0|||
164359216|NCT02574247|593690020|FG000|Overall Study|Did not meet inclusion criteria|4|||
164359217|NCT02574247|593690021|FG001|Overall Study|Did not meet inclusion criteria|3|||
164359218|NCT02574247|593690022|FG002|Overall Study|Did not meet inclusion criteria|5|||
164359219|NCT02268864|593690023|FG000|Overall Study|Withdrawal by Subject|2|||
164359220|NCT02268864|593690024|FG001|Overall Study|Withdrawal by Subject|0|||
164359221|NCT02268864|593690025|FG002|Overall Study|Withdrawal by Subject|0|||
164438319|NCT00241644|593970738|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
164438320|NCT00241644|593970735|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
164438321|NCT00241644|593970736|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
164590632|NCT00637273|594525286|FG001|Overall Study|Protocol Violation|4|||
164590633|NCT00637273|594525287|FG002|Overall Study|Protocol Violation|1|||
164359222|NCT02268864|593690023|FG000|Overall Study|Death|0|||
164359223|NCT02268864|593690024|FG001|Overall Study|Death|1|||
164359224|NCT02268864|593690025|FG002|Overall Study|Death|0|||
164359225|NCT01528254|593690030|FG000|Overall Study|Administrative problems|96|||
164359226|NCT01528254|593690031|FG001|Overall Study|Administrative problems|94|||
164359227|NCT01528254|593690030|FG000|Overall Study|Adverse Event|28|||
164697325|NCT04146363|594915618|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164697326|NCT04146363|594915619|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164697327|NCT04146363|594915620|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
164697328|NCT04146363|594915621|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
164697329|NCT04146363|594915622|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164697330|NCT04146363|594915612|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
164697331|NCT04146363|594915613|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
164697332|NCT04146363|594915614|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
164697333|NCT04146363|594915615|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
164697334|NCT04146363|594915616|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
164697335|NCT04146363|594915617|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
164697336|NCT04146363|594915618|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
164697337|NCT04146363|594915619|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
164697338|NCT04146363|594915620|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
164697339|NCT04146363|594915621|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
164697340|NCT04146363|594915622|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
164697341|NCT04146363|594915612|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164697342|NCT04146363|594915613|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164697343|NCT04146363|594915614|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164697344|NCT04146363|594915615|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164697345|NCT04146363|594915616|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164697346|NCT04146363|594915617|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164697347|NCT04146363|594915618|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164359228|NCT01528254|593690031|FG001|Overall Study|Adverse Event|44|||
164697348|NCT04146363|594915619|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164697349|NCT04146363|594915620|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
164697350|NCT04146363|594915621|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
164697351|NCT04146363|594915622|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
164697352|NCT04146363|594915612|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
164697353|NCT04146363|594915613|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
164697354|NCT04146363|594915614|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
164697355|NCT04146363|594915615|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
164697356|NCT04146363|594915616|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
164697357|NCT04146363|594915617|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
164697358|NCT04146363|594915618|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
164697359|NCT04146363|594915619|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
164697360|NCT04146363|594915620|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
164697361|NCT04146363|594915621|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
164697362|NCT04146363|594915622|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
164359229|NCT01528254|593690030|FG000|Overall Study|Lost to Follow-up|17|||
164359230|NCT01528254|593690031|FG001|Overall Study|Lost to Follow-up|24|||
164359231|NCT01528254|593690030|FG000|Overall Study|Death|13|||
164359232|NCT01528254|593690031|FG001|Overall Study|Death|9|||
164359233|NCT01528254|593690030|FG000|Overall Study|Protocol deviation|9|||
164359234|NCT01528254|593690031|FG001|Overall Study|Protocol deviation|19|||
164359235|NCT01528254|593690030|FG000|Overall Study|New therapy for study indication|8|||
164359236|NCT01528254|593690031|FG001|Overall Study|New therapy for study indication|6|||
164359237|NCT01528254|593690030|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
164697363|NCT04146363|594915612|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
164697364|NCT04146363|594915613|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
164697365|NCT04146363|594915614|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
164697366|NCT04146363|594915615|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
164697367|NCT04146363|594915616|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
164697368|NCT04146363|594915617|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
164697369|NCT04146363|594915618|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
164697370|NCT04146363|594915619|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
164697371|NCT04146363|594915620|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
164697372|NCT04146363|594915621|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
164697373|NCT04146363|594915622|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
164697374|NCT00107042|594915626|FG000|Overall Study|Lost to Follow-up|9|||
164697375|NCT00107042|594915627|FG001|Overall Study|Lost to Follow-up|7|||
164697376|NCT00107042|594915626|FG000|Overall Study|Withdrawal by Subject|6|||
164697377|NCT00107042|594915627|FG001|Overall Study|Withdrawal by Subject|1|||
164697378|NCT00107042|594915626|FG000|Overall Study|Moved out of area|5|||
164359238|NCT01528254|593690031|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
164359239|NCT01528254|593690030|FG000|Overall Study|Withdrawal by Subject|5|||
164359240|NCT01528254|593690031|FG001|Overall Study|Withdrawal by Subject|4|||
164438322|NCT00241644|593970737|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
164697379|NCT00107042|594915627|FG001|Overall Study|Moved out of area|3|||
164697380|NCT00107042|594915626|FG000|Overall Study|Pregnancy|1|||
164697381|NCT00107042|594915627|FG001|Overall Study|Pregnancy|1|||
164697382|NCT00107042|594915626|FG000|Overall Study|Inadvertent enrollment|0|||
164697383|NCT00107042|594915627|FG001|Overall Study|Inadvertent enrollment|1|||
164697384|NCT00107042|594915626|FG000|Overall Study|vaccinated outside window|1|||
164697385|NCT00107042|594915627|FG001|Overall Study|vaccinated outside window|1|||
164697386|NCT00107042|594915626|FG000|Overall Study|Disallowed medications|0|||
164697387|NCT00107042|594915627|FG001|Overall Study|Disallowed medications|2|||
164697388|NCT03919448|594915628|FG000|Overall Study|Withdrawal by Subject|1|||
164697389|NCT03919448|594915629|FG001|Overall Study|Withdrawal by Subject|0|||
164697390|NCT03919448|594915630|FG002|Overall Study|Withdrawal by Subject|0|||
164697391|NCT04776746|594915631|FG000|Overall Study|Study terminated by sponsor|61|||
164697392|NCT04776746|594915631|FG000|Overall Study|Adverse Event|5|||
164697393|NCT04776746|594915631|FG000|Overall Study|Death|4|||
164697394|NCT04776746|594915631|FG000|Overall Study|Lack of Efficacy|3|||
164697395|NCT04776746|594915631|FG000|Overall Study|Noncompliance with study drug|2|||
164697396|NCT04776746|594915631|FG000|Overall Study|Not related to COVID-19|2|||
164697397|NCT03265288|594915638|FG000|Overall Study|Adverse Event|0|||
164697398|NCT03265288|594915639|FG001|Overall Study|Adverse Event|1|||
164697399|NCT03265288|594915638|FG000|Overall Study|Withdrawal by Subject|13|||
164697400|NCT03265288|594915639|FG001|Overall Study|Withdrawal by Subject|5|||
164697401|NCT03265288|594915638|FG000|Overall Study|Drug Withdrawn|3|||
164697402|NCT03265288|594915639|FG001|Overall Study|Drug Withdrawn|3|||
164697403|NCT03265288|594915638|FG000|Overall Study|Any Other Reason|7|||
164697404|NCT03265288|594915639|FG001|Overall Study|Any Other Reason|3|||
164697405|NCT03575871|594915648|FG000|Overall Study|Adverse Event|5|||
164697406|NCT03575871|594915649|FG001|Overall Study|Adverse Event|5|||
164697407|NCT03575871|594915650|FG002|Overall Study|Adverse Event|8|||
164697408|NCT03575871|594915648|FG000|Overall Study|Death|1|||
164697409|NCT03575871|594915649|FG001|Overall Study|Death|0|||
164697410|NCT03575871|594915650|FG002|Overall Study|Death|0|||
164697411|NCT03575871|594915648|FG000|Overall Study|Lack of Efficacy|5|||
164697412|NCT03575871|594915649|FG001|Overall Study|Lack of Efficacy|4|||
164697413|NCT03575871|594915650|FG002|Overall Study|Lack of Efficacy|7|||
164697414|NCT03575871|594915648|FG000|Overall Study|Lost to Follow-up|1|||
164697415|NCT03575871|594915649|FG001|Overall Study|Lost to Follow-up|1|||
164697416|NCT03575871|594915650|FG002|Overall Study|Lost to Follow-up|1|||
164697417|NCT03575871|594915648|FG000|Overall Study|Protocol Deviation|1|||
164697418|NCT03575871|594915649|FG001|Overall Study|Protocol Deviation|1|||
164697419|NCT03575871|594915650|FG002|Overall Study|Protocol Deviation|1|||
164697420|NCT03575871|594915648|FG000|Overall Study|Withdrawal by Subject|6|||
164697421|NCT03575871|594915649|FG001|Overall Study|Withdrawal by Subject|1|||
164697422|NCT03575871|594915650|FG002|Overall Study|Withdrawal by Subject|9|||
164697423|NCT03575871|594915648|FG000|Overall Study|Other than specified|2|||
164697424|NCT03575871|594915649|FG001|Overall Study|Other than specified|2|||
164697425|NCT03575871|594915650|FG002|Overall Study|Other than specified|0|||
164697426|NCT05444556|594915651|FG000|Overall Study|Withdrawal by Subject|0|||
164697427|NCT05444556|594915652|FG001|Overall Study|Withdrawal by Subject|0|||
164697428|NCT05444556|594915653|FG002|Overall Study|Withdrawal by Subject|2|||
164697429|NCT05444556|594915654|FG003|Overall Study|Withdrawal by Subject|1|||
164697430|NCT02791893|594915655|FG000|Blinded Phase|Lost to Follow-up|2|||
164697431|NCT02791893|594915656|FG001|Blinded Phase|Lost to Follow-up|2|||
164697432|NCT02791893|594915655|FG000|Blinded Phase|Withdrawal by Subject|1|||
164697433|NCT02791893|594915656|FG001|Blinded Phase|Withdrawal by Subject|2|||
164697434|NCT02791893|594915655|FG000|Open Label Phase|Lost to Follow-up|3|||
164697435|NCT02791893|594915656|FG001|Open Label Phase|Lost to Follow-up|0|||
164697436|NCT02791893|594915655|FG000|Open Label Phase|Withdrawal by Subject|0|||
164697437|NCT02791893|594915656|FG001|Open Label Phase|Withdrawal by Subject|2|||
164438323|NCT00241644|593970738|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
164697438|NCT04319159|594915661|FG000|Overall Study|Screening failure|13|||
164697439|NCT04319159|594915661|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
164697440|NCT04319159|594915661|FG000|Overall Study|Withdrawal by Subject|1|||
164697441|NCT02100319|594915669|FG000|Overall Study|Case Report Forms Uncollected|11|||
164697442|NCT02100319|594915669|FG000|Overall Study|Protocol Deviation|5|||
164697443|NCT04976621|594915672|FG000|Overall Study|Lost to Follow-up|2|||
164697444|NCT04976621|594915673|FG001|Overall Study|Lost to Follow-up|2|||
164697445|NCT04976621|594915672|FG000|Overall Study|Withdrawal by Subject|1|||
164697446|NCT04976621|594915673|FG001|Overall Study|Withdrawal by Subject|1|||
164697447|NCT02589522|594915675|FG000|Overall Study|Physician Decision|1|||
164697448|NCT02589522|594915676|FG001|Overall Study|Physician Decision|2|||
164697449|NCT02589522|594915677|FG002|Overall Study|Physician Decision|0|||
164697450|NCT02589522|594915675|FG000|Overall Study|Did not start treatment|1|||
164697451|NCT02589522|594915676|FG001|Overall Study|Did not start treatment|0|||
164697452|NCT02589522|594915677|FG002|Overall Study|Did not start treatment|0|||
164697453|NCT01478828|594915678|FG000|Overall Study|Adverse Event|1|||
164697454|NCT00949988|594915681|FG000|Overall Study|Withdrawal by Subject|3|||
164697455|NCT03891329|594915685|FG000|Overall Study|Death|5|||
164697456|NCT03891329|594915685|FG000|Overall Study|Lost to Follow-up|4|||
164697457|NCT03891329|594915685|FG000|Overall Study|Physician Decision|4|||
164590634|NCT00637273|594525285|FG000|Overall Study|Withdrawal of Consent|18|||
164590635|NCT00637273|594525286|FG001|Overall Study|Withdrawal of Consent|6|||
164590636|NCT00637273|594525287|FG002|Overall Study|Withdrawal of Consent|18|||
164697458|NCT03891329|594915685|FG000|Overall Study|Device explanted|3|||
164697459|NCT03891329|594915685|FG000|Overall Study|No study device implanted|3|||
164697460|NCT03176784|594915686|FG000|Overall Study|Lost to Follow-up|77|||
164590637|NCT00637273|594525285|FG000|Overall Study|Investigator Decision|1|||
164590638|NCT00637273|594525286|FG001|Overall Study|Investigator Decision|3|||
164590639|NCT00637273|594525287|FG002|Overall Study|Investigator Decision|1|||
164590640|NCT00637273|594525285|FG000|Overall Study|Administrative|2|||
164590641|NCT00637273|594525286|FG001|Overall Study|Administrative|0|||
164590642|NCT00637273|594525287|FG002|Overall Study|Administrative|0|||
164590643|NCT00637273|594525285|FG000|Overall Study|Loss of Glucose Control|1|||
164590644|NCT00637273|594525286|FG001|Overall Study|Loss of Glucose Control|1|||
164590645|NCT00637273|594525287|FG002|Overall Study|Loss of Glucose Control|1|||
164590646|NCT02280291|594525289|FG000|Overall Study|Lost to Follow-up|2|||
164590647|NCT02280291|594525290|FG001|Overall Study|Lost to Follow-up|1|||
164590648|NCT02280291|594525291|FG002|Overall Study|Lost to Follow-up|3|||
164590649|NCT02280291|594525292|FG003|Overall Study|Lost to Follow-up|8|||
164590650|NCT02280291|594525289|FG000|Overall Study|Protocol Violation|1|||
164590651|NCT02280291|594525290|FG001|Overall Study|Protocol Violation|0|||
164590652|NCT02280291|594525291|FG002|Overall Study|Protocol Violation|0|||
164590653|NCT02280291|594525292|FG003|Overall Study|Protocol Violation|0|||
164590654|NCT02280291|594525289|FG000|Overall Study|Other|1|||
164590655|NCT02280291|594525290|FG001|Overall Study|Other|1|||
164590656|NCT02280291|594525291|FG002|Overall Study|Other|0|||
164590657|NCT02280291|594525292|FG003|Overall Study|Other|0|||
164590658|NCT00506077|594525294|FG000|Treatment Period 1|Adverse Event|2|||
164590659|NCT00506077|594525295|FG001|Treatment Period 1|Adverse Event|1|||
164590660|NCT00506077|594525294|FG000|Treatment Period 1|Lost to Follow-up|0|||
164590661|NCT00506077|594525295|FG001|Treatment Period 1|Lost to Follow-up|2|||
164590662|NCT00506077|594525294|FG000|Treatment Period 1|Withdrawal by Subject|2|||
164590663|NCT00506077|594525295|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164590664|NCT00506077|594525294|FG000|Treatment Period 2|Adverse Event|0|||
164590665|NCT00506077|594525295|FG001|Treatment Period 2|Adverse Event|1|||
164590666|NCT00506077|594525294|FG000|Treatment Period 2|Withdrawal by Subject|1|||
164590667|NCT00506077|594525295|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164590668|NCT00316303|594525296|FG000|Overall Study|Lost to Follow-up|11|||
164590669|NCT00316303|594525297|FG001|Overall Study|Lost to Follow-up|16|||
164590670|NCT01106534|594525300|FG000|Overall Study|Withdrawal by Subject|18|||
164590671|NCT01106534|594525300|FG000|Overall Study|Lost to Follow-up|2|||
164590672|NCT01106534|594525300|FG000|Overall Study|Death|16|||
164590673|NCT01106534|594525300|FG000|Overall Study|Physician Decision|1|||
164590674|NCT00570739|594525305|FG000|Overall Study|Adverse Event|8|||
164590675|NCT00570739|594525306|FG001|Overall Study|Adverse Event|6|||
164590676|NCT00570739|594525307|FG002|Overall Study|Adverse Event|2|||
164590677|NCT00570739|594525308|FG003|Overall Study|Adverse Event|2|||
164590678|NCT00570739|594525305|FG000|Overall Study|Lost to Follow-up|4|||
164590679|NCT00570739|594525306|FG001|Overall Study|Lost to Follow-up|5|||
164590680|NCT00570739|594525307|FG002|Overall Study|Lost to Follow-up|4|||
164590681|NCT00570739|594525308|FG003|Overall Study|Lost to Follow-up|1|||
164590682|NCT00570739|594525305|FG000|Overall Study|Physician Decision|1|||
164590683|NCT00570739|594525306|FG001|Overall Study|Physician Decision|1|||
164590684|NCT00570739|594525307|FG002|Overall Study|Physician Decision|0|||
164590685|NCT00570739|594525308|FG003|Overall Study|Physician Decision|0|||
164590686|NCT00570739|594525305|FG000|Overall Study|Withdrawal by Subject|7|||
164590687|NCT00570739|594525306|FG001|Overall Study|Withdrawal by Subject|7|||
164590688|NCT00570739|594525307|FG002|Overall Study|Withdrawal by Subject|3|||
164590689|NCT00570739|594525308|FG003|Overall Study|Withdrawal by Subject|5|||
164590690|NCT00570739|594525305|FG000|Overall Study|Required restricted medication|0|||
164590691|NCT00570739|594525306|FG001|Overall Study|Required restricted medication|0|||
164590692|NCT00570739|594525307|FG002|Overall Study|Required restricted medication|1|||
164590693|NCT00570739|594525308|FG003|Overall Study|Required restricted medication|0|||
164590694|NCT00570739|594525305|FG000|Overall Study|Met discontinuation criteria|1|||
164590695|NCT00570739|594525306|FG001|Overall Study|Met discontinuation criteria|0|||
164590696|NCT00570739|594525307|FG002|Overall Study|Met discontinuation criteria|1|||
164590697|NCT00570739|594525308|FG003|Overall Study|Met discontinuation criteria|1|||
164590698|NCT00570739|594525305|FG000|Overall Study|Other|0|||
164590699|NCT00570739|594525306|FG001|Overall Study|Other|2|||
164590700|NCT00570739|594525307|FG002|Overall Study|Other|5|||
164697461|NCT03176784|594915687|FG001|Overall Study|Lost to Follow-up|79|||
164697462|NCT03176784|594915688|FG002|Overall Study|Lost to Follow-up|79|||
164697463|NCT03176784|594915689|FG003|Overall Study|Lost to Follow-up|49|||
164697464|NCT03176784|594915686|FG000|Overall Study|Withdrawal by Subject|28|||
164697465|NCT03176784|594915687|FG001|Overall Study|Withdrawal by Subject|34|||
164697466|NCT03176784|594915688|FG002|Overall Study|Withdrawal by Subject|34|||
164697467|NCT03176784|594915689|FG003|Overall Study|Withdrawal by Subject|21|||
164697468|NCT02990806|594915690|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
164697469|NCT02990806|594915691|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
164697470|NCT02990806|594915692|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
164697471|NCT02990806|594915693|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
164697472|NCT02990806|594915690|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
164697473|NCT02990806|594915691|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
164697474|NCT02990806|594915692|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
164697475|NCT02990806|594915693|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
164697476|NCT02990806|594915690|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
164697477|NCT02990806|594915691|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
164697478|NCT02990806|594915692|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
164697479|NCT02990806|594915693|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
164697480|NCT02990806|594915690|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
164697481|NCT02990806|594915691|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
164697482|NCT02990806|594915692|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
164697483|NCT02990806|594915693|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
164697484|NCT02990806|594915690|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
164697485|NCT02990806|594915691|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
164697486|NCT02990806|594915692|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
164697487|NCT02990806|594915693|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
164697488|NCT02990806|594915690|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
164697489|NCT02990806|594915691|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
164697490|NCT02990806|594915692|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
164697491|NCT02990806|594915693|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
164697492|NCT02990806|594915690|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
164697493|NCT02990806|594915691|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
164697494|NCT02990806|594915692|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
164697495|NCT02990806|594915693|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
164697496|NCT02990806|594915690|FG000|Stage 1 (22 Weeks)|Death|0|||
164697497|NCT02990806|594915691|FG001|Stage 1 (22 Weeks)|Death|1|||
164697498|NCT02990806|594915692|FG002|Stage 1 (22 Weeks)|Death|0|||
164697499|NCT02990806|594915693|FG003|Stage 1 (22 Weeks)|Death|0|||
164697500|NCT02990806|594915690|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
164697501|NCT02990806|594915691|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
164697502|NCT02990806|594915692|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
164697503|NCT02990806|594915693|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
164697504|NCT02990806|594915690|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
164697505|NCT02990806|594915691|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
164697506|NCT02990806|594915692|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
164697507|NCT02990806|594915693|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
164697508|NCT02990806|594915690|FG000|Stage 1 (22 Weeks)|Other|1|||
164697509|NCT02990806|594915691|FG001|Stage 1 (22 Weeks)|Other|3|||
164697510|NCT02990806|594915692|FG002|Stage 1 (22 Weeks)|Other|0|||
164697511|NCT02990806|594915693|FG003|Stage 1 (22 Weeks)|Other|0|||
164697512|NCT02990806|594915690|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
164697513|NCT02990806|594915691|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
164697514|NCT02990806|594915692|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
164697515|NCT02990806|594915693|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
164590701|NCT00570739|594525308|FG003|Overall Study|Other|3|||
164590702|NCT01765764|594525310|FG000|Treatment Period|Adverse Event|1|||
164590703|NCT01765764|594525311|FG001|Treatment Period|Adverse Event|2|||
164590704|NCT01765764|594525312|FG002|Treatment Period|Adverse Event|1|||
164590705|NCT01765764|594525310|FG000|Treatment Period|Lost to Follow-up|0|||
164590706|NCT01765764|594525311|FG001|Treatment Period|Lost to Follow-up|3|||
164590707|NCT01765764|594525312|FG002|Treatment Period|Lost to Follow-up|2|||
164590708|NCT01765764|594525310|FG000|Treatment Period|Personal Reasons|1|||
164590709|NCT01765764|594525311|FG001|Treatment Period|Personal Reasons|2|||
164590710|NCT01765764|594525312|FG002|Treatment Period|Personal Reasons|1|||
164590711|NCT01765764|594525310|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
164590712|NCT01765764|594525311|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
164590713|NCT01765764|594525312|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
164590714|NCT01323673|594525317|FG000|Overall Study|Adverse Event|0|||
164590715|NCT01323673|594525318|FG001|Overall Study|Adverse Event|1|||
164590716|NCT01323673|594525317|FG000|Overall Study|Lost to Follow-up|0|||
164590717|NCT01323673|594525318|FG001|Overall Study|Lost to Follow-up|1|||
164590718|NCT01323673|594525317|FG000|Overall Study|Protocol Violation|1|||
164590719|NCT01323673|594525318|FG001|Overall Study|Protocol Violation|0|||
164590720|NCT01323673|594525317|FG000|Overall Study|Withdrawal by Subject|2|||
164590721|NCT01323673|594525318|FG001|Overall Study|Withdrawal by Subject|3|||
164697516|NCT02990806|594915690|FG000|Stage 2 (32 Weeks)|Death|1|||
164697517|NCT02990806|594915691|FG001|Stage 2 (32 Weeks)|Death|0|||
164697518|NCT02990806|594915692|FG002|Stage 2 (32 Weeks)|Death|0|||
164697519|NCT02990806|594915693|FG003|Stage 2 (32 Weeks)|Death|0|||
164697520|NCT02990806|594915690|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
164697521|NCT02990806|594915691|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
164697522|NCT02990806|594915692|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
164697523|NCT02990806|594915693|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
164697524|NCT02990806|594915690|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
164697525|NCT02990806|594915691|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
164697526|NCT02990806|594915692|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
164697527|NCT02990806|594915693|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
164697528|NCT02990806|594915690|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
164697529|NCT02990806|594915691|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
164697530|NCT02990806|594915692|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
164697531|NCT02990806|594915693|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
164697532|NCT02990806|594915690|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
164697533|NCT02990806|594915691|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
164697534|NCT02990806|594915692|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
164697535|NCT02990806|594915693|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
164697536|NCT02990806|594915690|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
164697537|NCT02990806|594915691|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
164697538|NCT02990806|594915692|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
164697539|NCT02990806|594915693|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
164697540|NCT02990806|594915690|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
164697541|NCT02990806|594915691|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
164697542|NCT02990806|594915692|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
164697543|NCT02990806|594915693|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
164697544|NCT02990806|594915690|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
164697545|NCT02990806|594915691|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
164697546|NCT02990806|594915692|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
164697547|NCT02990806|594915693|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
164697548|NCT02990806|594915690|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
164697549|NCT02990806|594915691|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
164697550|NCT02990806|594915692|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
164697551|NCT02990806|594915693|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
164697552|NCT02990806|594915690|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
164697553|NCT02990806|594915691|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
164697554|NCT02990806|594915692|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
164697555|NCT02990806|594915693|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
164697556|NCT02990806|594915690|FG000|Stage 2 (32 Weeks)|Other|3|||
164697557|NCT02990806|594915691|FG001|Stage 2 (32 Weeks)|Other|0|||
164697558|NCT02990806|594915692|FG002|Stage 2 (32 Weeks)|Other|4|||
164697559|NCT02990806|594915693|FG003|Stage 2 (32 Weeks)|Other|1|||
164697560|NCT02990806|594915690|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
164697561|NCT02990806|594915691|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
164697562|NCT02990806|594915692|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
164697563|NCT02990806|594915693|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
164697564|NCT02990806|594915690|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
164697565|NCT02990806|594915691|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
164697566|NCT02990806|594915692|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
164697567|NCT02990806|594915693|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
164697568|NCT02990806|594915690|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
164697569|NCT02990806|594915691|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
164697570|NCT02990806|594915692|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
164697571|NCT02990806|594915693|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
164697572|NCT02990806|594915690|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
164697573|NCT02990806|594915691|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
164697574|NCT02990806|594915692|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
164697575|NCT02990806|594915693|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
164697576|NCT02990806|594915690|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
164697577|NCT02990806|594915691|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
164697578|NCT02990806|594915692|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
164697579|NCT02990806|594915693|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
164697580|NCT02990806|594915690|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
164697581|NCT02990806|594915691|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
164697582|NCT02990806|594915692|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
164697583|NCT02990806|594915693|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
164697584|NCT02990806|594915690|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
164697585|NCT02990806|594915691|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
164697586|NCT02990806|594915692|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
164697587|NCT02990806|594915693|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
164697588|NCT02990806|594915690|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
164697589|NCT02990806|594915691|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
164697590|NCT02990806|594915692|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
164697591|NCT02990806|594915693|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
164697592|NCT02990806|594915690|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
164697593|NCT02990806|594915691|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
164697594|NCT02990806|594915692|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
164697595|NCT02990806|594915693|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
164697596|NCT02654587|594915696|FG000|Overall Study|patient alive at end of study|22|||
164697597|NCT02654587|594915697|FG001|Overall Study|patient alive at end of study|8|||
164697598|NCT02654587|594915696|FG000|Overall Study|Withdrawal by Subject|1|||
164697599|NCT02654587|594915697|FG001|Overall Study|Withdrawal by Subject|7|||
164697600|NCT00904748|594915700|FG000|Overall Study|Withdrawal by Subject|1|||
164697601|NCT00904748|594915701|FG001|Overall Study|Withdrawal by Subject|1|||
164697602|NCT00904748|594915702|FG002|Overall Study|Withdrawal by Subject|1|||
164697603|NCT00904748|594915703|FG003|Overall Study|Withdrawal by Subject|2|||
164697604|NCT00904748|594915704|FG004|Overall Study|Withdrawal by Subject|0|||
164697605|NCT00904748|594915705|FG005|Overall Study|Withdrawal by Subject|0|||
164697606|NCT00904748|594915700|FG000|Overall Study|Adverse Event|0|||
164697607|NCT00904748|594915701|FG001|Overall Study|Adverse Event|0|||
164697608|NCT00904748|594915702|FG002|Overall Study|Adverse Event|0|||
164697609|NCT00904748|594915703|FG003|Overall Study|Adverse Event|0|||
164697610|NCT00904748|594915704|FG004|Overall Study|Adverse Event|1|||
164697611|NCT00904748|594915705|FG005|Overall Study|Adverse Event|0|||
164697612|NCT01682148|594915706|FG000|Overall Study|Withdrawal by Subject|2|||
164697613|NCT01682148|594915707|FG001|Overall Study|Withdrawal by Subject|0|||
164697614|NCT01682148|594915706|FG000|Overall Study|Lost to Follow-up|1|||
164697615|NCT01682148|594915707|FG001|Overall Study|Lost to Follow-up|2|||
164697616|NCT01682148|594915706|FG000|Overall Study|Protocol Violation|1|||
164697617|NCT01682148|594915707|FG001|Overall Study|Protocol Violation|1|||
164697618|NCT00396331|594915708|FG000|Overall Study|Failed to mobilize - no transplant|8|||
164697619|NCT00396331|594915708|FG000|Overall Study|Did not go on to transplant|5|||
164697620|NCT00396331|594915708|FG000|Overall Study|Lost to Follow-up|3|||
164697621|NCT00396331|594915708|FG000|Overall Study|Death|16|||
164697622|NCT01029392|594915716|FG000|Overall Study|Withdrawal by Subject|18|||
164697623|NCT01029392|594915717|FG001|Overall Study|Withdrawal by Subject|11|||
164697624|NCT01029392|594915716|FG000|Overall Study|Physician Decision|2|||
164697625|NCT01029392|594915717|FG001|Overall Study|Physician Decision|0|||
164697626|NCT01103479|594915718|FG000|Overall Study|Up to date with CRC screening|1|||
164697627|NCT01103479|594915719|FG001|Overall Study|Up to date with CRC screening|9|||
164697628|NCT01103479|594915720|FG002|Overall Study|Up to date with CRC screening|12|||
164697629|NCT01103479|594915718|FG000|Overall Study|Family history of CRC|1|||
164697630|NCT01103479|594915719|FG001|Overall Study|Family history of CRC|0|||
164697631|NCT01103479|594915720|FG002|Overall Study|Family history of CRC|2|||
164697632|NCT01103479|594915718|FG000|Overall Study|Active cancer|1|||
164697633|NCT01103479|594915719|FG001|Overall Study|Active cancer|0|||
164697634|NCT01103479|594915720|FG002|Overall Study|Active cancer|0|||
164697635|NCT01103479|594915718|FG000|Overall Study|Saw non-study physician|2|||
164697636|NCT01103479|594915719|FG001|Overall Study|Saw non-study physician|0|||
164697637|NCT01103479|594915720|FG002|Overall Study|Saw non-study physician|0|||
164697638|NCT00834899|594915721|FG000|Overall Study|Withdrawal by Subject|1|||
164697639|NCT00834899|594915722|FG001|Overall Study|Withdrawal by Subject|1|||
164697640|NCT01298778|594915723|FG000|Overall Study|Lost to Follow-up|2|||
164697641|NCT01298778|594915724|FG001|Overall Study|Lost to Follow-up|3|||
164697642|NCT01298778|594915723|FG000|Overall Study|Incorrect use of VAS|1|||
164697643|NCT01298778|594915724|FG001|Overall Study|Incorrect use of VAS|0|||
164697644|NCT01298778|594915723|FG000|Overall Study|Withdrawal by Subject|0|||
164438324|NCT00241644|593970735|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
164438325|NCT00241644|593970736|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
164697645|NCT01298778|594915724|FG001|Overall Study|Withdrawal by Subject|1|||
164697646|NCT01298778|594915723|FG000|Overall Study|Protocol Violation|0|||
164697647|NCT01298778|594915724|FG001|Overall Study|Protocol Violation|1|||
164697648|NCT01298778|594915723|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
164697649|NCT01298778|594915724|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
164697650|NCT02377921|594915725|FG000|Overall Study|Subject non-compliance|1|||
164697651|NCT02377921|594915726|FG001|Overall Study|Subject non-compliance|1|||
164697652|NCT02443545|594915729|FG000|Overall Study|Adverse Event|1|||
164697653|NCT02443545|594915730|FG001|Overall Study|Adverse Event|1|||
164697654|NCT02443545|594915729|FG000|Overall Study|Lost to Follow-up|0|||
164438326|NCT00241644|593970737|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
164438327|NCT00241644|593970738|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
164438328|NCT00241644|593970735|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
164438329|NCT00241644|593970736|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
164438330|NCT00241644|593970737|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
164438331|NCT00241644|593970738|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
164438332|NCT00241644|593970735|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
164438333|NCT00241644|593970736|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
164438334|NCT00241644|593970737|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
164438335|NCT00241644|593970738|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
164438336|NCT00241644|593970735|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
164438337|NCT00241644|593970736|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
164438338|NCT00241644|593970737|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
164438339|NCT00241644|593970738|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
164438340|NCT00241644|593970735|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
164438341|NCT00241644|593970736|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
164590722|NCT04907539|594527103|FG000|Overall Study|Consent withdrawn|1|||
164697655|NCT02443545|594915730|FG001|Overall Study|Lost to Follow-up|2|||
164697656|NCT02443545|594915729|FG000|Overall Study|Physician Decision|3|||
164697657|NCT02443545|594915730|FG001|Overall Study|Physician Decision|0|||
164697658|NCT02443545|594915729|FG000|Overall Study|Protocol Violation|8|||
164697659|NCT02443545|594915730|FG001|Overall Study|Protocol Violation|1|||
164697660|NCT02443545|594915729|FG000|Overall Study|Pregnancy|1|||
164697661|NCT02443545|594915730|FG001|Overall Study|Pregnancy|1|||
164697662|NCT02443545|594915729|FG000|Overall Study|Withdrawal by Subject|6|||
164697663|NCT02443545|594915730|FG001|Overall Study|Withdrawal by Subject|3|||
164697664|NCT02443545|594915729|FG000|Overall Study|Termination of study|20|||
164697665|NCT02443545|594915730|FG001|Overall Study|Termination of study|11|||
164697666|NCT02139124|594915733|FG000|Overall Study|Adverse Event|2|||
164697667|NCT02139124|594915734|FG001|Overall Study|Adverse Event|0|||
164697668|NCT02139124|594915735|FG002|Overall Study|Adverse Event|1|||
164697669|NCT02139124|594915736|FG003|Overall Study|Adverse Event|2|||
164697670|NCT02139124|594915737|FG004|Overall Study|Adverse Event|5|||
164697671|NCT02139124|594915733|FG000|Overall Study|Withdrawal by Subject|2|||
164697672|NCT02139124|594915734|FG001|Overall Study|Withdrawal by Subject|2|||
164697673|NCT02139124|594915735|FG002|Overall Study|Withdrawal by Subject|2|||
164697674|NCT02139124|594915736|FG003|Overall Study|Withdrawal by Subject|2|||
164697675|NCT02139124|594915737|FG004|Overall Study|Withdrawal by Subject|3|||
164697676|NCT02139124|594915733|FG000|Overall Study|Protocol Violation|0|||
164697677|NCT02139124|594915734|FG001|Overall Study|Protocol Violation|0|||
164697678|NCT02139124|594915735|FG002|Overall Study|Protocol Violation|0|||
164697679|NCT02139124|594915736|FG003|Overall Study|Protocol Violation|1|||
164697680|NCT02139124|594915737|FG004|Overall Study|Protocol Violation|1|||
164697681|NCT02139124|594915733|FG000|Overall Study|non-compliant|1|||
164697682|NCT02139124|594915734|FG001|Overall Study|non-compliant|0|||
164697683|NCT02139124|594915735|FG002|Overall Study|non-compliant|0|||
164697684|NCT02139124|594915736|FG003|Overall Study|non-compliant|2|||
164697685|NCT02139124|594915737|FG004|Overall Study|non-compliant|0|||
164438342|NCT00241644|593970737|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
164438343|NCT00241644|593970738|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
164438344|NCT00864682|593970740|FG000|Overall Study|Protocol Violation|2|||
164438345|NCT00864682|593970741|FG001|Overall Study|Protocol Violation|1|||
164590723|NCT04907539|594527104|FG001|Overall Study|Consent withdrawn|0|||
164590724|NCT04907539|594527103|FG000|Overall Study|Death|14|||
164590725|NCT04907539|594527104|FG001|Overall Study|Death|3|||
164590726|NCT00051558|594527105|FG000|Overall Study|Adverse Event|30|||
164590727|NCT00051558|594527106|FG001|Overall Study|Adverse Event|18|||
164590728|NCT00051558|594527105|FG000|Overall Study|Withdrawal by Subject|29|||
164590729|NCT00051558|594527106|FG001|Overall Study|Withdrawal by Subject|42|||
164590730|NCT00051558|594527105|FG000|Overall Study|Death|9|||
164590731|NCT00051558|594527106|FG001|Overall Study|Death|15|||
164590732|NCT00051558|594527105|FG000|Overall Study|Lost to Follow-up|4|||
164590733|NCT00051558|594527106|FG001|Overall Study|Lost to Follow-up|13|||
164590734|NCT00051558|594527105|FG000|Overall Study|Protocol Violation|3|||
164590735|NCT00051558|594527106|FG001|Overall Study|Protocol Violation|4|||
164590736|NCT00051558|594527105|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
164590737|NCT00051558|594527106|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
164590738|NCT00051558|594527105|FG000|Overall Study|Sponsor Decision|6|||
164590739|NCT00051558|594527106|FG001|Overall Study|Sponsor Decision|1|||
164590740|NCT00051558|594527105|FG000|Overall Study|Other|2|||
164697686|NCT02139124|594915733|FG000|Overall Study|incarceration|0|||
164697687|NCT02139124|594915734|FG001|Overall Study|incarceration|0|||
164590741|NCT00051558|594527106|FG001|Overall Study|Other|1|||
164590742|NCT00051558|594527105|FG000|Overall Study|Significant Lab Value|2|||
164697688|NCT02139124|594915735|FG002|Overall Study|incarceration|1|||
164697689|NCT02139124|594915736|FG003|Overall Study|incarceration|0|||
164697690|NCT02139124|594915737|FG004|Overall Study|incarceration|0|||
164697691|NCT02139124|594915733|FG000|Overall Study|subject moved|1|||
164697692|NCT02139124|594915734|FG001|Overall Study|subject moved|0|||
164590743|NCT00051558|594527106|FG001|Overall Study|Significant Lab Value|0|||
164590744|NCT00051558|594527105|FG000|Overall Study|Physician Decision|5|||
164697693|NCT02139124|594915735|FG002|Overall Study|subject moved|0|||
164697694|NCT02139124|594915736|FG003|Overall Study|subject moved|0|||
164697695|NCT02139124|594915737|FG004|Overall Study|subject moved|0|||
164697696|NCT02139124|594915733|FG000|Overall Study|Lost to Follow-up|3|||
164697697|NCT02139124|594915734|FG001|Overall Study|Lost to Follow-up|2|||
164697698|NCT02139124|594915735|FG002|Overall Study|Lost to Follow-up|0|||
164697699|NCT02139124|594915736|FG003|Overall Study|Lost to Follow-up|5|||
164697700|NCT02139124|594915737|FG004|Overall Study|Lost to Follow-up|4|||
164697701|NCT03821272|594916852|FG000|Overall Study|Death|1|||
164697702|NCT03821272|594916853|FG001|Overall Study|Death|0|||
164697703|NCT03821272|594916852|FG000|Overall Study|Physician Decision|1|||
164697704|NCT03821272|594916853|FG001|Overall Study|Physician Decision|0|||
164697705|NCT03821272|594916852|FG000|Overall Study|Withdrawal by Subject|1|||
164697706|NCT03821272|594916853|FG001|Overall Study|Withdrawal by Subject|0|||
164697707|NCT05904769|594916854|FG000|Overall Study|Physician Decision|0|||
164697708|NCT05904769|594916855|FG001|Overall Study|Physician Decision|6|||
164697709|NCT02516410|594916861|FG000|Overall Study|Adverse Event|0|||
164697710|NCT02516410|594916862|FG001|Overall Study|Adverse Event|1|||
164697711|NCT02516410|594916861|FG000|Overall Study|Withdrawal by Subject|0|||
164697712|NCT02516410|594916862|FG001|Overall Study|Withdrawal by Subject|1|||
164697713|NCT01286558|594916863|FG000|Overall Study|Adverse Event|1|||
164697714|NCT01286558|594916864|FG001|Overall Study|Adverse Event|1|||
164697715|NCT01286558|594916863|FG000|Overall Study|Withdrawal by Subject|0|||
164697716|NCT01286558|594916864|FG001|Overall Study|Withdrawal by Subject|1|||
164697717|NCT01220297|594916865|FG000|Overall Study|Death|2|||
164697718|NCT01220297|594916865|FG000|Overall Study|Lost to Follow-up|1|||
164697719|NCT01287039|594916867|FG000|Overall Study|Noncompliance with study procedures|0|||
164697720|NCT01287039|594916868|FG001|Overall Study|Noncompliance with study procedures|1|||
164697721|NCT01287039|594916867|FG000|Overall Study|Change of location/residence|0|||
164697722|NCT01287039|594916868|FG001|Overall Study|Change of location/residence|3|||
164697723|NCT01287039|594916867|FG000|Overall Study|Elective surgery|0|||
164697724|NCT01287039|594916868|FG001|Overall Study|Elective surgery|1|||
164697725|NCT01287039|594916867|FG000|Overall Study|Protocol Violation|2|||
164697726|NCT01287039|594916868|FG001|Overall Study|Protocol Violation|3|||
164697727|NCT01287039|594916867|FG000|Overall Study|Excluded medication taken|1|||
164697728|NCT01287039|594916868|FG001|Overall Study|Excluded medication taken|0|||
164697729|NCT01287039|594916867|FG000|Overall Study|Noncompliance with study medication|0|||
164697730|NCT01287039|594916868|FG001|Overall Study|Noncompliance with study medication|1|||
164697731|NCT01287039|594916867|FG000|Overall Study|Problem with travel|0|||
164697732|NCT01287039|594916868|FG001|Overall Study|Problem with travel|1|||
164697733|NCT01287039|594916867|FG000|Overall Study|Death|1|||
164697734|NCT01287039|594916868|FG001|Overall Study|Death|0|||
164697735|NCT01287039|594916867|FG000|Overall Study|Change of residence|1|||
164697736|NCT01287039|594916868|FG001|Overall Study|Change of residence|0|||
164697737|NCT01287039|594916867|FG000|Overall Study|Adverse Event|7|||
164697738|NCT01287039|594916868|FG001|Overall Study|Adverse Event|4|||
164697739|NCT01287039|594916867|FG000|Overall Study|Withdrawal by Subject|14|||
164697740|NCT01287039|594916868|FG001|Overall Study|Withdrawal by Subject|11|||
164697741|NCT01287039|594916867|FG000|Overall Study|Lost to Follow-up|3|||
164697742|NCT01287039|594916868|FG001|Overall Study|Lost to Follow-up|2|||
164697743|NCT01117337|594916874|FG000|Overall Study|Lost to Follow-up|4|||
164697744|NCT01117337|594916875|FG001|Overall Study|Lost to Follow-up|0|||
164697745|NCT00584844|594916877|FG000|Overall Study|Withdrawal by Subject|59|||
164697746|NCT00584844|594916877|FG000|Overall Study|Screen Failure|20|||
164697747|NCT02370914|594916881|FG000|Overall Study|Protocol Violation|2|||
164697748|NCT03451006|594916882|FG000|Overall Study|Withdrawal by Subject|2|||
164697749|NCT03451006|594916883|FG001|Overall Study|Withdrawal by Subject|2|||
164697750|NCT05224544|594916884|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
164697751|NCT05224544|594916885|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
164697752|NCT03847194|594916886|FG000|Overall Study|Lost to Follow-up|2|||
164697753|NCT03847194|594916887|FG001|Overall Study|Lost to Follow-up|5|||
164697754|NCT03847194|594916886|FG000|Overall Study|Withdrawal by Subject|1|||
164697755|NCT03847194|594916887|FG001|Overall Study|Withdrawal by Subject|2|||
164697756|NCT03847194|594916886|FG000|Overall Study|Death|0|||
164697757|NCT03847194|594916887|FG001|Overall Study|Death|1|||
164697758|NCT01341587|594916888|FG000|Overall Study|Lost to Follow-up|2|||
164697759|NCT01341587|594916889|FG001|Overall Study|Lost to Follow-up|0|||
164438346|NCT00864682|593970742|FG002|Overall Study|Protocol Violation|2|||
164697760|NCT01341587|594916888|FG000|Overall Study|stopped using the meters|2|||
164697761|NCT01341587|594916889|FG001|Overall Study|stopped using the meters|10|||
164697762|NCT00351351|594916890|FG000|Overall Study|surgical access pbs; device issues|9|||
164697763|NCT00351351|594916891|FG001|Overall Study|surgical access pbs; device issues|4|||
164697764|NCT01825837|594916892|FG000|PART I|Withdrawal by Subject|0|||
164697765|NCT01825837|594916893|FG001|PART I|Withdrawal by Subject|0|||
164697766|NCT01825837|594916894|FG002|PART I|Withdrawal by Subject|0|||
164697767|NCT01825837|594916895|FG003|PART I|Withdrawal by Subject|6|||
164697768|NCT01825837|594916892|FG000|PART I|Patient non-compliance|0|||
164697769|NCT01825837|594916893|FG001|PART I|Patient non-compliance|0|||
164697770|NCT01825837|594916894|FG002|PART I|Patient non-compliance|0|||
164697771|NCT01825837|594916895|FG003|PART I|Patient non-compliance|1|||
164697772|NCT01825837|594916892|FG000|PART I|Treatment failure|0|||
164697773|NCT01825837|594916893|FG001|PART I|Treatment failure|0|||
164697774|NCT01825837|594916894|FG002|PART I|Treatment failure|0|||
164697775|NCT01825837|594916895|FG003|PART I|Treatment failure|7|||
164697776|NCT01825837|594916892|FG000|PART I|reason unspecified|0|||
164697777|NCT01825837|594916893|FG001|PART I|reason unspecified|0|||
164697778|NCT01825837|594916894|FG002|PART I|reason unspecified|0|||
164697779|NCT01825837|594916895|FG003|PART I|reason unspecified|3|||
164697780|NCT01825837|594916892|FG000|PART II|Withdrawal by Subject|3|||
164697781|NCT01825837|594916893|FG001|PART II|Withdrawal by Subject|3|||
164697782|NCT01825837|594916894|FG002|PART II|Withdrawal by Subject|7|||
164697783|NCT01825837|594916895|FG003|PART II|Withdrawal by Subject|0|||
164697784|NCT01825837|594916892|FG000|PART II|Patient non-compliance|5|||
164697785|NCT01825837|594916893|FG001|PART II|Patient non-compliance|2|||
164697786|NCT01825837|594916894|FG002|PART II|Patient non-compliance|4|||
164697787|NCT01825837|594916895|FG003|PART II|Patient non-compliance|0|||
164697788|NCT01825837|594916892|FG000|PART II|Adverse Event|3|||
164697789|NCT01825837|594916893|FG001|PART II|Adverse Event|3|||
164697790|NCT01825837|594916894|FG002|PART II|Adverse Event|1|||
164697791|NCT01825837|594916895|FG003|PART II|Adverse Event|0|||
164697792|NCT01825837|594916892|FG000|PART II|Treatment failure|6|||
164697793|NCT01825837|594916893|FG001|PART II|Treatment failure|4|||
164697794|NCT01825837|594916894|FG002|PART II|Treatment failure|5|||
164697795|NCT01825837|594916895|FG003|PART II|Treatment failure|0|||
164697796|NCT01825837|594916892|FG000|PART II|reason unspecified|2|||
164697797|NCT01825837|594916893|FG001|PART II|reason unspecified|2|||
164697798|NCT01825837|594916894|FG002|PART II|reason unspecified|2|||
164697799|NCT01825837|594916895|FG003|PART II|reason unspecified|0|||
164697800|NCT01202877|594916896|FG000|Overall Study|Disease Progression|0|||
164697801|NCT01202877|594916897|FG001|Overall Study|Disease Progression|1|||
164697802|NCT01202877|594916898|FG002|Overall Study|Disease Progression|2|||
164697803|NCT01202877|594916896|FG000|Overall Study|Adverse Event|0|||
164697804|NCT01202877|594916897|FG001|Overall Study|Adverse Event|0|||
164697805|NCT01202877|594916898|FG002|Overall Study|Adverse Event|2|||
164697806|NCT01202877|594916896|FG000|Overall Study|Withdrawal by Subject|0|||
164697807|NCT01202877|594916897|FG001|Overall Study|Withdrawal by Subject|0|||
164697808|NCT01202877|594916898|FG002|Overall Study|Withdrawal by Subject|1|||
164697809|NCT01202877|594916896|FG000|Overall Study|Death|0|||
164697810|NCT01202877|594916897|FG001|Overall Study|Death|0|||
164697811|NCT01202877|594916898|FG002|Overall Study|Death|1|||
164697812|NCT04403763|594916899|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
164697813|NCT04403763|594916900|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
164697814|NCT04403763|594916901|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
164697815|NCT04403763|594916902|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
164697816|NCT04403763|594916903|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
164697817|NCT04403763|594916904|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
164697818|NCT04403763|594916905|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
164697819|NCT04403763|594916899|FG000|Stage 1|Early termination due to PK tube failure|0|||
164697820|NCT04403763|594916900|FG001|Stage 1|Early termination due to PK tube failure|0|||
164697821|NCT04403763|594916901|FG002|Stage 1|Early termination due to PK tube failure|1|||
164697822|NCT04403763|594916902|FG003|Stage 1|Early termination due to PK tube failure|0|||
164697823|NCT04403763|594916903|FG004|Stage 1|Early termination due to PK tube failure|0|||
164697824|NCT04403763|594916904|FG005|Stage 1|Early termination due to PK tube failure|0|||
164697825|NCT04403763|594916905|FG006|Stage 1|Early termination due to PK tube failure|0|||
164697826|NCT04403763|594916899|FG000|Stage 2A|Adverse Event|0|||
164697827|NCT04403763|594916900|FG001|Stage 2A|Adverse Event|0|||
164697828|NCT04403763|594916901|FG002|Stage 2A|Adverse Event|0|||
164697829|NCT04403763|594916902|FG003|Stage 2A|Adverse Event|0|||
164697830|NCT04403763|594916903|FG004|Stage 2A|Adverse Event|0|||
164697831|NCT04403763|594916904|FG005|Stage 2A|Adverse Event|0|||
164697832|NCT04403763|594916905|FG006|Stage 2A|Adverse Event|1|||
164697833|NCT00350402|594916906|FG000|Overall Study|Lost to Follow-up|1|||
164697834|NCT00350402|594916907|FG001|Overall Study|Lost to Follow-up|1|||
164697835|NCT01376310|594916908|FG000|Overall Study|Study closed/terminated|1|||
164697836|NCT01376310|594916909|FG001|Overall Study|Study closed/terminated|2|||
164697837|NCT01376310|594916908|FG000|Overall Study|Withdrawal by Subject|8|||
164697838|NCT01376310|594916909|FG001|Overall Study|Withdrawal by Subject|2|||
164697839|NCT01376310|594916908|FG000|Overall Study|Physician Decision|26|||
164697840|NCT01376310|594916909|FG001|Overall Study|Physician Decision|7|||
164697841|NCT01376310|594916908|FG000|Overall Study|Lost to Follow-up|1|||
164697842|NCT01376310|594916909|FG001|Overall Study|Lost to Follow-up|0|||
164697843|NCT00645944|594916912|FG000|Randomized|Withdrawal by Subject|1|||
164697844|NCT00645944|594916913|FG001|Randomized|Withdrawal by Subject|2|||
164697845|NCT00645944|594916912|FG000|Received Medication|Adverse Event|2|||
164697846|NCT00645944|594916913|FG001|Received Medication|Adverse Event|1|||
164697847|NCT00645944|594916912|FG000|Received Medication|Withdrawal by Subject|1|||
164697848|NCT00645944|594916913|FG001|Received Medication|Withdrawal by Subject|1|||
164697849|NCT00645944|594916912|FG000|Received Medication|Lost to Follow-up|1|||
164359241|NCT01528254|593690030|FG000|Overall Study|Abnormal laboratory value(s)|3|||
164359242|NCT01528254|593690031|FG001|Overall Study|Abnormal laboratory value(s)|7|||
164359243|NCT01528254|593690030|FG000|Overall Study|Abnormal test procedure result(s)|1|||
164359244|NCT01528254|593690031|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164359245|NCT01528254|593690030|FG000|Overall Study|No longer requires study drug|1|||
164359246|NCT01528254|593690031|FG001|Overall Study|No longer requires study drug|1|||
164359247|NCT00383149|593690032|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
164359248|NCT00383149|593690032|FG000|Overall Study|Death|2|||
164359249|NCT00383149|593690032|FG000|Overall Study|Disease Progression|38|||
164359250|NCT00383149|593690032|FG000|Overall Study|Lost to Follow-up|1|||
164359251|NCT00383149|593690032|FG000|Overall Study|Other|1|||
164359252|NCT00383149|593690032|FG000|Overall Study|Study Drug Toxicity|4|||
164359253|NCT00383149|593690032|FG000|Overall Study|Request to Discontinue Treatment|4|||
164359254|NCT00383149|593690032|FG000|Overall Study|Participant Withdrew Consent|1|||
164359255|NCT00416078|593690039|FG000|Overall Study|Death|3|||
164359256|NCT00416078|593690040|FG001|Overall Study|Death|4|||
164359257|NCT00416078|593690039|FG000|Overall Study|Withdrawal by Subject|3|||
164359258|NCT00416078|593690040|FG001|Overall Study|Withdrawal by Subject|2|||
164359259|NCT00416078|593690039|FG000|Overall Study|Physician Decision|1|||
164359260|NCT00416078|593690040|FG001|Overall Study|Physician Decision|0|||
164359261|NCT00416078|593690039|FG000|Overall Study|Lost to Follow-up|4|||
164359262|NCT00416078|593690040|FG001|Overall Study|Lost to Follow-up|2|||
164359263|NCT02998840|593690049|FG000|Overall Study|Lost to Follow-up|1|||
164359264|NCT02998840|593690050|FG001|Overall Study|Lost to Follow-up|1|||
164359265|NCT02998840|593690051|FG002|Overall Study|Lost to Follow-up|2|||
164359266|NCT02998840|593690052|FG003|Overall Study|Lost to Follow-up|3|||
164359267|NCT02998840|593690049|FG000|Overall Study|Withdrawal by Subject|1|||
164359268|NCT02998840|593690050|FG001|Overall Study|Withdrawal by Subject|1|||
164359269|NCT02998840|593690051|FG002|Overall Study|Withdrawal by Subject|0|||
164359270|NCT02998840|593690052|FG003|Overall Study|Withdrawal by Subject|1|||
164359271|NCT02998840|593690049|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
164359272|NCT02998840|593690050|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
164359273|NCT02998840|593690051|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
164359274|NCT02998840|593690052|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
164359275|NCT01686633|593690053|FG000|Overall Study|Lack of Efficacy|33|||
164359276|NCT01686633|593690054|FG001|Overall Study|Lack of Efficacy|13|||
164359277|NCT01686633|593690055|FG002|Overall Study|Lack of Efficacy|11|||
164359278|NCT01686633|593690053|FG000|Overall Study|Withdrawal by Subject|8|||
164359279|NCT01686633|593690054|FG001|Overall Study|Withdrawal by Subject|8|||
164359280|NCT01686633|593690055|FG002|Overall Study|Withdrawal by Subject|5|||
164359281|NCT01686633|593690053|FG000|Overall Study|Physician Decision|3|||
164359282|NCT01686633|593690054|FG001|Overall Study|Physician Decision|4|||
164359283|NCT01686633|593690055|FG002|Overall Study|Physician Decision|4|||
164359284|NCT01686633|593690053|FG000|Overall Study|Adverse Event|4|||
164359285|NCT01686633|593690054|FG001|Overall Study|Adverse Event|3|||
164697850|NCT00645944|594916913|FG001|Received Medication|Lost to Follow-up|0|||
164697851|NCT00645944|594916912|FG000|Received Medication|Protocol Violation|2|||
164697852|NCT00645944|594916913|FG001|Received Medication|Protocol Violation|1|||
164697853|NCT01807117|594916915|FG000|Overall Study|Physician Decision|2|||
164697854|NCT01807117|594916915|FG000|Overall Study|Disease diagnosis not a study disease|1|||
164697855|NCT01534637|594916916|FG000|Overall Study|Physician Decision|3|||
164697856|NCT01534637|594916916|FG000|Overall Study|Lack of Efficacy|3|||
164697857|NCT01534637|594916916|FG000|Overall Study|Withdrawal by Subject|1|||
164697858|NCT01534637|594916916|FG000|Overall Study|Adverse Event|1|||
164697859|NCT01534637|594916916|FG000|Overall Study|Liver Mets before treatment|1|||
164697860|NCT00606502|594916922|FG000|Randomization|Randomized but not treated|3|||
164697861|NCT00606502|594916923|FG001|Randomization|Randomized but not treated|0|||
164697862|NCT00606502|594916922|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
164697863|NCT00606502|594916923|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
164697864|NCT02080832|594916933|FG000|Overall Study|Excluded from analysis by MRI|9|||
164697865|NCT02080832|594916934|FG001|Overall Study|Excluded from analysis by MRI|10|||
164697866|NCT02080832|594916935|FG002|Overall Study|Excluded from analysis by MRI|14|||
164697867|NCT02080832|594916933|FG000|Overall Study|Lost to Follow-up|0|||
164697868|NCT02080832|594916934|FG001|Overall Study|Lost to Follow-up|2|||
164697869|NCT02080832|594916935|FG002|Overall Study|Lost to Follow-up|2|||
164359286|NCT01686633|593690055|FG002|Overall Study|Adverse Event|3|||
164359287|NCT01686633|593690053|FG000|Overall Study|Protocol Violation|2|||
164359288|NCT01686633|593690054|FG001|Overall Study|Protocol Violation|3|||
164359289|NCT01686633|593690055|FG002|Overall Study|Protocol Violation|0|||
164697870|NCT01560507|594916936|FG000|Overall Study|Lost to Follow-up|3|||
164697871|NCT01560507|594916937|FG001|Overall Study|Lost to Follow-up|1|||
164359290|NCT01686633|593690053|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
164359291|NCT01686633|593690054|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
164359292|NCT01686633|593690055|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
164359293|NCT01686633|593690053|FG000|Overall Study|Lost to Follow-up|0|||
164359294|NCT01686633|593690054|FG001|Overall Study|Lost to Follow-up|1|||
164359295|NCT01686633|593690055|FG002|Overall Study|Lost to Follow-up|1|||
164359296|NCT00511667|593690060|FG000|Overall Study|Adverse Event|1|||
164359297|NCT00511667|593690061|FG001|Overall Study|Adverse Event|0|||
164359298|NCT00511667|593690060|FG000|Overall Study|Protocol Violation|1|||
164359299|NCT00511667|593690061|FG001|Overall Study|Protocol Violation|1|||
164359300|NCT00511667|593690060|FG000|Overall Study|Withdrawal by Subject|2|||
164359301|NCT00511667|593690061|FG001|Overall Study|Withdrawal by Subject|0|||
164359302|NCT00511667|593690060|FG000|Overall Study|Site terminated|6|||
164359303|NCT00511667|593690061|FG001|Overall Study|Site terminated|1|||
164359304|NCT00511667|593690060|FG000|Overall Study|Other|2|||
164697872|NCT01560507|594916938|FG002|Overall Study|Lost to Follow-up|2|||
164697873|NCT01560507|594916936|FG000|Overall Study|Withdrawal by Subject|1|||
164697874|NCT01560507|594916937|FG001|Overall Study|Withdrawal by Subject|1|||
164697875|NCT01560507|594916938|FG002|Overall Study|Withdrawal by Subject|0|||
164359305|NCT00511667|593690061|FG001|Overall Study|Other|1|||
164359306|NCT03564145|593690062|FG000|Overall Study|Adverse Event|4|||
164359307|NCT03564145|593690062|FG000|Overall Study|Lost to Follow-up|21|||
164359308|NCT03564145|593690062|FG000|Overall Study|Protocol Violation|2|||
164359309|NCT03564145|593690062|FG000|Overall Study|Withdrawal by Subject|48|||
164359310|NCT03564145|593690062|FG000|Overall Study|Study Terminated by Sponsor|146|||
164359311|NCT03564145|593690062|FG000|Overall Study|Physician Decision|1|||
164359312|NCT03564145|593690062|FG000|Overall Study|Other Than Specified|1|||
164359313|NCT03564145|593690062|FG000|Overall Study|Pregnancy|1|||
164359314|NCT04219891|593690065|FG000|Overall Study|Lost to Follow-up|3|||
164359315|NCT04219891|593690065|FG000|Overall Study|Withdrawal by Subject|2|||
164359316|NCT03724812|593691633|FG000|Overall Study|Missed Visit|1|||
164359317|NCT03724812|593691633|FG000|Overall Study|Death|2|||
164359318|NCT03724812|593691633|FG000|Overall Study|Withdrawal by Subject|1|||
164359319|NCT03227029|593691634|FG000|Overall Study|Child Wheezed (no treatment)|0|||
164359320|NCT03227029|593691635|FG001|Overall Study|Child Wheezed (no treatment)|1|||
164359321|NCT03227029|593691636|FG002|Overall Study|Child Wheezed (no treatment)|0|||
164359322|NCT03227029|593691634|FG000|Overall Study|No post RSV season visit due to COVID|3|||
164359323|NCT03227029|593691635|FG001|Overall Study|No post RSV season visit due to COVID|3|||
164359324|NCT03227029|593691636|FG002|Overall Study|No post RSV season visit due to COVID|2|||
164359325|NCT03227029|593691634|FG000|Overall Study|Not able to get to clinic|0|||
164359326|NCT03227029|593691635|FG001|Overall Study|Not able to get to clinic|0|||
164359327|NCT03227029|593691636|FG002|Overall Study|Not able to get to clinic|1|||
164359328|NCT03227029|593691634|FG000|Overall Study|Withdrawal by Subject|1|||
164359329|NCT03227029|593691635|FG001|Overall Study|Withdrawal by Subject|0|||
164359330|NCT03227029|593691636|FG002|Overall Study|Withdrawal by Subject|0|||
164359331|NCT03227029|593691634|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
164359332|NCT03227029|593691635|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
164359333|NCT03227029|593691636|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
164359334|NCT01291173|593691637|FG000|Overall Study|Adverse Event|0|||
164359335|NCT01291173|593691638|FG001|Overall Study|Adverse Event|3|||
164359336|NCT01291173|593691639|FG002|Overall Study|Adverse Event|1|||
164359337|NCT01291173|593691640|FG003|Overall Study|Adverse Event|3|||
164359338|NCT01291173|593691637|FG000|Overall Study|Protocol Violation|7|||
164359339|NCT01291173|593691638|FG001|Overall Study|Protocol Violation|2|||
164359340|NCT01291173|593691639|FG002|Overall Study|Protocol Violation|2|||
164359341|NCT01291173|593691640|FG003|Overall Study|Protocol Violation|5|||
164359342|NCT01291173|593691637|FG000|Overall Study|Withdrawal by Subject|6|||
164359343|NCT01291173|593691638|FG001|Overall Study|Withdrawal by Subject|4|||
164359344|NCT01291173|593691639|FG002|Overall Study|Withdrawal by Subject|4|||
164359345|NCT01291173|593691640|FG003|Overall Study|Withdrawal by Subject|2|||
164359346|NCT01291173|593691637|FG000|Overall Study|Lost to Follow-up|4|||
164359347|NCT01291173|593691638|FG001|Overall Study|Lost to Follow-up|6|||
164359348|NCT01291173|593691639|FG002|Overall Study|Lost to Follow-up|3|||
164359349|NCT01291173|593691640|FG003|Overall Study|Lost to Follow-up|2|||
164359350|NCT01291173|593691637|FG000|Overall Study|Unable to meet visit schedule|0|||
164359351|NCT01291173|593691638|FG001|Overall Study|Unable to meet visit schedule|0|||
164359352|NCT01291173|593691639|FG002|Overall Study|Unable to meet visit schedule|1|||
164359353|NCT01291173|593691640|FG003|Overall Study|Unable to meet visit schedule|0|||
164359354|NCT01291173|593691637|FG000|Overall Study|Lack of compliance|0|||
164359355|NCT01291173|593691638|FG001|Overall Study|Lack of compliance|0|||
164359356|NCT01291173|593691639|FG002|Overall Study|Lack of compliance|0|||
164359357|NCT01291173|593691640|FG003|Overall Study|Lack of compliance|1|||
164359358|NCT01291173|593691637|FG000|Overall Study|Subject was unblinded|0|||
164359359|NCT01291173|593691638|FG001|Overall Study|Subject was unblinded|0|||
164359360|NCT01291173|593691639|FG002|Overall Study|Subject was unblinded|1|||
164359361|NCT01291173|593691640|FG003|Overall Study|Subject was unblinded|0|||
164359362|NCT01291173|593691637|FG000|Overall Study|Excluded therapy|0|||
164359363|NCT01291173|593691638|FG001|Overall Study|Excluded therapy|0|||
164697876|NCT00560937|594916939|FG000|Overall Study|Withdrawal by Subject|0|||
164697877|NCT00560937|594916940|FG001|Overall Study|Withdrawal by Subject|1|||
164438347|NCT02506257|593970748|FG000|Overall Study|Adverse Event|0|||
164438348|NCT02506257|593970749|FG001|Overall Study|Adverse Event|2|||
164697878|NCT00560937|594916939|FG000|Overall Study|Physician Decision|1|||
164697879|NCT00560937|594916940|FG001|Overall Study|Physician Decision|1|||
164438349|NCT02506257|593970750|FG002|Overall Study|Adverse Event|3|||
164438350|NCT02506257|593970751|FG003|Overall Study|Adverse Event|0|||
164438351|NCT02506257|593970748|FG000|Overall Study|Protocol Violation|0|||
164438352|NCT02506257|593970749|FG001|Overall Study|Protocol Violation|0|||
164697880|NCT03069417|594916941|FG000|Overall Study|Lost to Follow-up|2|||
164697881|NCT03069417|594916942|FG001|Overall Study|Lost to Follow-up|0|||
164697882|NCT03069417|594916941|FG000|Overall Study|Reason Unknown|4|||
164359364|NCT01291173|593691639|FG002|Overall Study|Excluded therapy|1|||
164359365|NCT01291173|593691640|FG003|Overall Study|Excluded therapy|0|||
164359366|NCT01074450|593691646|FG000|First Intervention|Emesis in Dosing Interval|0|||
164359367|NCT01074450|593691647|FG001|First Intervention|Emesis in Dosing Interval|2|||
164359368|NCT01074450|593691646|FG000|Second Intervention|Protocol Violation|1|||
164359369|NCT01074450|593691647|FG001|Second Intervention|Protocol Violation|0|||
164359370|NCT01074450|593691646|FG000|Second Intervention|Physician Decision|0|||
164359371|NCT01074450|593691647|FG001|Second Intervention|Physician Decision|1|||
164359372|NCT02728895|593691648|FG000|Overall Study|Other|1|||
164359373|NCT02728895|593691649|FG001|Overall Study|Other|2|||
164359374|NCT02728895|593691648|FG000|Overall Study|Withdrawal by Subject|0|||
164359375|NCT02728895|593691649|FG001|Overall Study|Withdrawal by Subject|3|||
164359376|NCT02769247|593691650|FG000|Overall Study|Withdrawal by Subject|1|||
164359377|NCT02769247|593691651|FG001|Overall Study|Withdrawal by Subject|0|||
164359378|NCT02769247|593691652|FG002|Overall Study|Withdrawal by Subject|0|||
164359379|NCT02769247|593691653|FG003|Overall Study|Withdrawal by Subject|1|||
164359380|NCT02769247|593691650|FG000|Overall Study|Protocol Violation|0|||
164359381|NCT02769247|593691651|FG001|Overall Study|Protocol Violation|0|||
164359382|NCT02769247|593691652|FG002|Overall Study|Protocol Violation|1|||
164359383|NCT02769247|593691653|FG003|Overall Study|Protocol Violation|0|||
164359384|NCT02769247|593691650|FG000|Overall Study|Physician Decision|1|||
164359385|NCT02769247|593691651|FG001|Overall Study|Physician Decision|0|||
164359386|NCT02769247|593691652|FG002|Overall Study|Physician Decision|0|||
164359387|NCT02769247|593691653|FG003|Overall Study|Physician Decision|0|||
164359388|NCT04788953|593691654|FG000|Overall Study|Adverse Event|1|||
164359389|NCT04788953|593691655|FG001|Overall Study|Adverse Event|1|||
164359390|NCT04788953|593691654|FG000|Overall Study|Withdrawal by Subject|1|||
164359391|NCT04788953|593691655|FG001|Overall Study|Withdrawal by Subject|0|||
164359392|NCT04788953|593691654|FG000|Overall Study|Protocol Violation|0|||
164359393|NCT04788953|593691655|FG001|Overall Study|Protocol Violation|1|||
164359394|NCT00469092|593691656|FG000|Overall Study|Adverse Event|5|||
164359395|NCT00469092|593691657|FG001|Overall Study|Adverse Event|4|||
164359396|NCT00469092|593691656|FG000|Overall Study|Lack of Efficacy|1|||
164359397|NCT00469092|593691657|FG001|Overall Study|Lack of Efficacy|0|||
164359398|NCT00469092|593691656|FG000|Overall Study|Lost to Follow-up|1|||
164359399|NCT00469092|593691657|FG001|Overall Study|Lost to Follow-up|2|||
164359400|NCT00469092|593691656|FG000|Overall Study|Protocol Violation|3|||
164359401|NCT00469092|593691657|FG001|Overall Study|Protocol Violation|3|||
164359402|NCT00469092|593691656|FG000|Overall Study|Withdrawal by Subject|4|||
164359403|NCT00469092|593691657|FG001|Overall Study|Withdrawal by Subject|4|||
164359404|NCT00469092|593691656|FG000|Overall Study|Withdrawal Criteria|3|||
164359405|NCT00469092|593691657|FG001|Overall Study|Withdrawal Criteria|4|||
164359406|NCT00469092|593691656|FG000|Overall Study|Incorrectly Randomised|4|||
164359407|NCT00469092|593691657|FG001|Overall Study|Incorrectly Randomised|3|||
164359408|NCT00469092|593691656|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
164359409|NCT00469092|593691657|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
164438353|NCT02506257|593970750|FG002|Overall Study|Protocol Violation|1|||
164438354|NCT02506257|593970751|FG003|Overall Study|Protocol Violation|0|||
164438355|NCT04842604|593970755|FG000|Overall Study|Death|1|||
164590745|NCT00051558|594527106|FG001|Overall Study|Physician Decision|0|||
164590746|NCT02163993|594527108|FG000|Treatment Period|Adverse Event|0|||
164590747|NCT02163993|594527109|FG001|Treatment Period|Adverse Event|1|||
164590748|NCT02163993|594527110|FG002|Treatment Period|Adverse Event|0|||
164590749|NCT02163993|594527111|FG003|Treatment Period|Adverse Event|0|||
164590750|NCT02163993|594527112|FG004|Treatment Period|Adverse Event|1|||
164590751|NCT02163993|594527108|FG000|Treatment Period|Lost to Follow-up|2|||
164590752|NCT02163993|594527109|FG001|Treatment Period|Lost to Follow-up|3|||
164590753|NCT02163993|594527110|FG002|Treatment Period|Lost to Follow-up|1|||
164590754|NCT02163993|594527111|FG003|Treatment Period|Lost to Follow-up|3|||
164590755|NCT02163993|594527112|FG004|Treatment Period|Lost to Follow-up|1|||
164590756|NCT02163993|594527108|FG000|Treatment Period|Physician Decision|1|||
164590757|NCT02163993|594527109|FG001|Treatment Period|Physician Decision|0|||
164359410|NCT00469092|593691656|FG000|Overall Study|Use of lipid lowering drug|1|||
164359411|NCT00469092|593691657|FG001|Overall Study|Use of lipid lowering drug|0|||
164359412|NCT00469092|593691656|FG000|Overall Study|Hypoglycaemic Episodes|1|||
164359413|NCT00469092|593691657|FG001|Overall Study|Hypoglycaemic Episodes|1|||
164438356|NCT04842604|593970756|FG001|Overall Study|Death|0|||
164697883|NCT03069417|594916942|FG001|Overall Study|Reason Unknown|7|||
164697884|NCT00440115|594916943|FG000|Overall Study|Death|7|||
164697885|NCT00440115|594916944|FG001|Overall Study|Death|9|||
164697886|NCT00440115|594916945|FG002|Overall Study|Death|5|||
164697887|NCT00440115|594916943|FG000|Overall Study|Incarceration|0|||
164697888|NCT00440115|594916944|FG001|Overall Study|Incarceration|2|||
164697889|NCT00440115|594916945|FG002|Overall Study|Incarceration|1|||
164697890|NCT01660022|594916947|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
164697891|NCT01660022|594916948|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
164590758|NCT02163993|594527110|FG002|Treatment Period|Physician Decision|0|||
164590759|NCT02163993|594527111|FG003|Treatment Period|Physician Decision|0|||
164590760|NCT02163993|594527112|FG004|Treatment Period|Physician Decision|0|||
164590761|NCT02163993|594527108|FG000|Treatment Period|Protocol Violation|2|||
164590762|NCT02163993|594527109|FG001|Treatment Period|Protocol Violation|1|||
164590763|NCT02163993|594527110|FG002|Treatment Period|Protocol Violation|0|||
164590764|NCT02163993|594527111|FG003|Treatment Period|Protocol Violation|1|||
164697892|NCT01660022|594916949|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
164697893|NCT01660022|594916950|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
164359414|NCT00469092|593691656|FG000|Overall Study|Abnormal lab value|1|||
164359415|NCT00469092|593691657|FG001|Overall Study|Abnormal lab value|0|||
164359416|NCT00469092|593691656|FG000|Overall Study|Use of Corticosteroid|1|||
164359417|NCT00469092|593691657|FG001|Overall Study|Use of Corticosteroid|0|||
164359418|NCT01462084|593691659|FG000|Overall Study|Withdrawal by Subject|1|||
164359419|NCT01462084|593691660|FG001|Overall Study|Withdrawal by Subject|0|||
164359420|NCT01462084|593691659|FG000|Overall Study|Protocol Violation|1|||
164359421|NCT01462084|593691660|FG001|Overall Study|Protocol Violation|1|||
164359422|NCT01086540|593691661|FG000|Overall Study|Death|3|||
164359423|NCT01086540|593691662|FG001|Overall Study|Death|1|||
164359424|NCT01086540|593691661|FG000|Overall Study|Physician Decision|2|||
164359425|NCT01086540|593691662|FG001|Overall Study|Physician Decision|1|||
164359426|NCT01086540|593691661|FG000|Overall Study|Addition of new therapy for PAH|1|||
164359427|NCT01086540|593691662|FG001|Overall Study|Addition of new therapy for PAH|0|||
164359428|NCT02278263|593691663|FG000|Overall Study|Protocol Violation|7|||
164359429|NCT02278263|593691664|FG001|Overall Study|Protocol Violation|0|||
164359430|NCT02278263|593691665|FG002|Overall Study|Protocol Violation|9|||
164359431|NCT01998737|593691666|FG000|Overall Study|Corrupted database|23|||
164359432|NCT01998737|593691667|FG001|Overall Study|Corrupted database|0|||
164359433|NCT02092662|593691669|FG000|Overall Study|Lost to Follow-up|13|||
164359434|NCT02092662|593691670|FG001|Overall Study|Lost to Follow-up|0|||
164359435|NCT02707991|593691671|FG000|Overall Study|Protocol Violation|1|||
164359436|NCT02707991|593691672|FG001|Overall Study|Protocol Violation|0|||
164359437|NCT02707991|593691671|FG000|Overall Study|Became ineligible|0|||
164359438|NCT02707991|593691672|FG001|Overall Study|Became ineligible|1|||
164359439|NCT02659631|593691675|FG000|Overall Study|Lost to Follow-up|0|||
164359440|NCT02659631|593691676|FG001|Overall Study|Lost to Follow-up|0|||
164359441|NCT02659631|593691677|FG002|Overall Study|Lost to Follow-up|2|||
164359442|NCT02659631|593691678|FG003|Overall Study|Lost to Follow-up|0|||
164359443|NCT02659631|593691679|FG004|Overall Study|Lost to Follow-up|0|||
164359444|NCT02659631|593691680|FG005|Overall Study|Lost to Follow-up|1|||
164359445|NCT02659631|593691681|FG006|Overall Study|Lost to Follow-up|0|||
164359446|NCT02659631|593691682|FG007|Overall Study|Lost to Follow-up|0|||
164359447|NCT02659631|593691683|FG008|Overall Study|Lost to Follow-up|0|||
164359448|NCT02659631|593691684|FG009|Overall Study|Lost to Follow-up|0|||
164359449|NCT02659631|593691675|FG000|Overall Study|Withdrawal prior to treatment|0|||
164359450|NCT02659631|593691676|FG001|Overall Study|Withdrawal prior to treatment|0|||
164359451|NCT02659631|593691677|FG002|Overall Study|Withdrawal prior to treatment|0|||
164359452|NCT02659631|593691678|FG003|Overall Study|Withdrawal prior to treatment|0|||
164359453|NCT02659631|593691679|FG004|Overall Study|Withdrawal prior to treatment|1|||
164359454|NCT02659631|593691680|FG005|Overall Study|Withdrawal prior to treatment|0|||
164359455|NCT02659631|593691681|FG006|Overall Study|Withdrawal prior to treatment|0|||
164359456|NCT02659631|593691682|FG007|Overall Study|Withdrawal prior to treatment|0|||
164359457|NCT02659631|593691683|FG008|Overall Study|Withdrawal prior to treatment|0|||
164359458|NCT02659631|593691684|FG009|Overall Study|Withdrawal prior to treatment|0|||
164359459|NCT02659631|593691675|FG000|Overall Study|Participant refused further follow-up|0|||
164359460|NCT02659631|593691676|FG001|Overall Study|Participant refused further follow-up|0|||
164359461|NCT02659631|593691677|FG002|Overall Study|Participant refused further follow-up|0|||
164359462|NCT02659631|593691678|FG003|Overall Study|Participant refused further follow-up|1|||
164359463|NCT02659631|593691679|FG004|Overall Study|Participant refused further follow-up|0|||
164359464|NCT02659631|593691680|FG005|Overall Study|Participant refused further follow-up|0|||
164359465|NCT02659631|593691681|FG006|Overall Study|Participant refused further follow-up|0|||
164359466|NCT02659631|593691682|FG007|Overall Study|Participant refused further follow-up|0|||
164359467|NCT02659631|593691683|FG008|Overall Study|Participant refused further follow-up|1|||
164359468|NCT02659631|593691684|FG009|Overall Study|Participant refused further follow-up|0|||
164359469|NCT02659631|593691675|FG000|Overall Study|Death (follow-up phase)|1|||
164359470|NCT02659631|593691676|FG001|Overall Study|Death (follow-up phase)|2|||
164590765|NCT02163993|594527112|FG004|Treatment Period|Protocol Violation|2|||
164359471|NCT02659631|593691677|FG002|Overall Study|Death (follow-up phase)|1|||
164359472|NCT02659631|593691678|FG003|Overall Study|Death (follow-up phase)|1|||
164359473|NCT02659631|593691679|FG004|Overall Study|Death (follow-up phase)|3|||
164359474|NCT02659631|593691680|FG005|Overall Study|Death (follow-up phase)|2|||
164359475|NCT02659631|593691681|FG006|Overall Study|Death (follow-up phase)|0|||
164359476|NCT02659631|593691682|FG007|Overall Study|Death (follow-up phase)|3|||
164359477|NCT02659631|593691683|FG008|Overall Study|Death (follow-up phase)|1|||
164359478|NCT02659631|593691684|FG009|Overall Study|Death (follow-up phase)|0|||
164359479|NCT02659631|593691675|FG000|Overall Study|Death (treatment phase)|0|||
164359480|NCT02659631|593691676|FG001|Overall Study|Death (treatment phase)|0|||
164359481|NCT02659631|593691677|FG002|Overall Study|Death (treatment phase)|0|||
164359482|NCT02659631|593691678|FG003|Overall Study|Death (treatment phase)|0|||
164359483|NCT02659631|593691679|FG004|Overall Study|Death (treatment phase)|1|||
164359484|NCT02659631|593691680|FG005|Overall Study|Death (treatment phase)|0|||
164359485|NCT02659631|593691681|FG006|Overall Study|Death (treatment phase)|1|||
164359486|NCT02659631|593691682|FG007|Overall Study|Death (treatment phase)|0|||
164359487|NCT02659631|593691683|FG008|Overall Study|Death (treatment phase)|0|||
164359488|NCT02659631|593691684|FG009|Overall Study|Death (treatment phase)|0|||
164359489|NCT05407675|593691685|FG000|Overall Study|Withdrawal by Subject|0|||
164359490|NCT05407675|593691686|FG001|Overall Study|Withdrawal by Subject|2|||
164359491|NCT05407675|593691687|FG002|Overall Study|Withdrawal by Subject|3|||
164359492|NCT05407675|593691688|FG003|Overall Study|Withdrawal by Subject|5|||
164359493|NCT05407675|593691689|FG004|Overall Study|Withdrawal by Subject|0|||
164359494|NCT05407675|593691690|FG005|Overall Study|Withdrawal by Subject|2|||
164359495|NCT05407675|593691691|FG006|Overall Study|Withdrawal by Subject|0|||
164697894|NCT01660022|594916951|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
164697895|NCT01660022|594916952|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
164359496|NCT05407675|593691692|FG007|Overall Study|Withdrawal by Subject|0|||
164359497|NCT05407675|593691693|FG008|Overall Study|Withdrawal by Subject|2|||
164359498|NCT05407675|593691694|FG009|Overall Study|Withdrawal by Subject|0|||
164359499|NCT05407675|593691695|FG010|Overall Study|Withdrawal by Subject|1|||
164359500|NCT05407675|593691696|FG011|Overall Study|Withdrawal by Subject|0|||
164359501|NCT05407675|593691697|FG012|Overall Study|Withdrawal by Subject|0|||
164359502|NCT05407675|593691685|FG000|Overall Study|Site terminated by sponsor|0|||
164359503|NCT05407675|593691686|FG001|Overall Study|Site terminated by sponsor|0|||
164359504|NCT05407675|593691687|FG002|Overall Study|Site terminated by sponsor|1|||
164359505|NCT05407675|593691688|FG003|Overall Study|Site terminated by sponsor|0|||
164359506|NCT05407675|593691689|FG004|Overall Study|Site terminated by sponsor|2|||
164359507|NCT05407675|593691690|FG005|Overall Study|Site terminated by sponsor|0|||
164359508|NCT05407675|593691691|FG006|Overall Study|Site terminated by sponsor|1|||
164359509|NCT05407675|593691692|FG007|Overall Study|Site terminated by sponsor|0|||
164359510|NCT05407675|593691693|FG008|Overall Study|Site terminated by sponsor|0|||
164697896|NCT01660022|594916947|FG000|First Sequence (7 Days)|Adverse Event|0|||
164359511|NCT05407675|593691694|FG009|Overall Study|Site terminated by sponsor|2|||
164359512|NCT05407675|593691695|FG010|Overall Study|Site terminated by sponsor|2|||
164359513|NCT05407675|593691696|FG011|Overall Study|Site terminated by sponsor|2|||
164359514|NCT05407675|593691697|FG012|Overall Study|Site terminated by sponsor|1|||
164359515|NCT05407675|593691685|FG000|Overall Study|Disease Progression|0|||
164359516|NCT05407675|593691686|FG001|Overall Study|Disease Progression|0|||
164359517|NCT05407675|593691687|FG002|Overall Study|Disease Progression|0|||
164359518|NCT05407675|593691688|FG003|Overall Study|Disease Progression|0|||
164359519|NCT05407675|593691689|FG004|Overall Study|Disease Progression|0|||
164359520|NCT05407675|593691690|FG005|Overall Study|Disease Progression|0|||
164359521|NCT05407675|593691691|FG006|Overall Study|Disease Progression|0|||
164359522|NCT05407675|593691692|FG007|Overall Study|Disease Progression|0|||
164359523|NCT05407675|593691693|FG008|Overall Study|Disease Progression|0|||
164359524|NCT05407675|593691694|FG009|Overall Study|Disease Progression|0|||
164359525|NCT05407675|593691695|FG010|Overall Study|Disease Progression|1|||
164359526|NCT05407675|593691696|FG011|Overall Study|Disease Progression|0|||
164438357|NCT04842604|593970755|FG000|Overall Study|Other|4|||
164438358|NCT04842604|593970756|FG001|Overall Study|Other|4|||
164359527|NCT05407675|593691697|FG012|Overall Study|Disease Progression|0|||
164359528|NCT05407675|593691685|FG000|Overall Study|Physician Decision|0|||
164359529|NCT05407675|593691686|FG001|Overall Study|Physician Decision|0|||
164359530|NCT05407675|593691687|FG002|Overall Study|Physician Decision|0|||
164359531|NCT05407675|593691688|FG003|Overall Study|Physician Decision|0|||
164438359|NCT04842604|593970755|FG000|Overall Study|Randomized but not treated|1|||
164438360|NCT04842604|593970756|FG001|Overall Study|Randomized but not treated|0|||
164438361|NCT00344019|593970758|FG000|Overall Study|did not meet final inclusion criteria|0|||
164697897|NCT01660022|594916948|FG001|First Sequence (7 Days)|Adverse Event|0|||
164438362|NCT00344019|593970759|FG001|Overall Study|did not meet final inclusion criteria|0|||
164697898|NCT01660022|594916949|FG002|First Sequence (7 Days)|Adverse Event|0|||
164697899|NCT01660022|594916950|FG003|First Sequence (7 Days)|Adverse Event|0|||
164359532|NCT05407675|593691689|FG004|Overall Study|Physician Decision|0|||
164359533|NCT05407675|593691690|FG005|Overall Study|Physician Decision|0|||
164359534|NCT05407675|593691691|FG006|Overall Study|Physician Decision|0|||
164359535|NCT05407675|593691692|FG007|Overall Study|Physician Decision|0|||
164359536|NCT05407675|593691693|FG008|Overall Study|Physician Decision|0|||
164359537|NCT05407675|593691694|FG009|Overall Study|Physician Decision|0|||
164359538|NCT05407675|593691695|FG010|Overall Study|Physician Decision|1|||
164359539|NCT05407675|593691696|FG011|Overall Study|Physician Decision|0|||
164359540|NCT05407675|593691697|FG012|Overall Study|Physician Decision|0|||
164359541|NCT05407675|593691685|FG000|Overall Study|Other reasons|0|||
164359542|NCT05407675|593691686|FG001|Overall Study|Other reasons|0|||
164359543|NCT05407675|593691687|FG002|Overall Study|Other reasons|0|||
164359544|NCT05407675|593691688|FG003|Overall Study|Other reasons|0|||
164359545|NCT05407675|593691689|FG004|Overall Study|Other reasons|0|||
164359546|NCT05407675|593691690|FG005|Overall Study|Other reasons|0|||
164359547|NCT05407675|593691691|FG006|Overall Study|Other reasons|0|||
164359548|NCT05407675|593691692|FG007|Overall Study|Other reasons|0|||
164359549|NCT05407675|593691693|FG008|Overall Study|Other reasons|1|||
164359550|NCT05407675|593691694|FG009|Overall Study|Other reasons|1|||
164359551|NCT05407675|593691695|FG010|Overall Study|Other reasons|1|||
164359552|NCT05407675|593691696|FG011|Overall Study|Other reasons|1|||
164359553|NCT05407675|593691697|FG012|Overall Study|Other reasons|0|||
164359554|NCT05407675|593691685|FG000|Overall Study|Death|3|||
164359555|NCT05407675|593691686|FG001|Overall Study|Death|4|||
164359556|NCT05407675|593691687|FG002|Overall Study|Death|3|||
164359557|NCT05407675|593691688|FG003|Overall Study|Death|6|||
164359558|NCT05407675|593691689|FG004|Overall Study|Death|0|||
164359559|NCT05407675|593691690|FG005|Overall Study|Death|2|||
164359560|NCT05407675|593691691|FG006|Overall Study|Death|4|||
164359561|NCT05407675|593691692|FG007|Overall Study|Death|2|||
164359562|NCT05407675|593691693|FG008|Overall Study|Death|2|||
164359563|NCT05407675|593691694|FG009|Overall Study|Death|4|||
164359564|NCT05407675|593691695|FG010|Overall Study|Death|2|||
164359565|NCT05407675|593691696|FG011|Overall Study|Death|1|||
164359566|NCT05407675|593691697|FG012|Overall Study|Death|0|||
164359567|NCT05407675|593691685|FG000|Overall Study|Adverse Event|0|||
164359568|NCT05407675|593691686|FG001|Overall Study|Adverse Event|0|||
164359569|NCT05407675|593691687|FG002|Overall Study|Adverse Event|0|||
164359570|NCT05407675|593691688|FG003|Overall Study|Adverse Event|0|||
164359571|NCT05407675|593691689|FG004|Overall Study|Adverse Event|1|||
164359572|NCT05407675|593691690|FG005|Overall Study|Adverse Event|0|||
164359573|NCT05407675|593691691|FG006|Overall Study|Adverse Event|0|||
164359574|NCT05407675|593691692|FG007|Overall Study|Adverse Event|0|||
164359575|NCT05407675|593691693|FG008|Overall Study|Adverse Event|0|||
164359576|NCT05407675|593691694|FG009|Overall Study|Adverse Event|0|||
164359577|NCT05407675|593691695|FG010|Overall Study|Adverse Event|0|||
164359578|NCT05407675|593691696|FG011|Overall Study|Adverse Event|1|||
164359579|NCT05407675|593691697|FG012|Overall Study|Adverse Event|0|||
164359580|NCT05407675|593691685|FG000|Overall Study|Ongoing Treatment|0|||
164359581|NCT05407675|593691686|FG001|Overall Study|Ongoing Treatment|0|||
164359582|NCT05407675|593691687|FG002|Overall Study|Ongoing Treatment|0|||
164359583|NCT05407675|593691688|FG003|Overall Study|Ongoing Treatment|0|||
164359584|NCT05407675|593691689|FG004|Overall Study|Ongoing Treatment|0|||
164359585|NCT05407675|593691690|FG005|Overall Study|Ongoing Treatment|0|||
164359586|NCT05407675|593691691|FG006|Overall Study|Ongoing Treatment|0|||
164359587|NCT05407675|593691692|FG007|Overall Study|Ongoing Treatment|0|||
164359588|NCT05407675|593691693|FG008|Overall Study|Ongoing Treatment|1|||
164359589|NCT05407675|593691694|FG009|Overall Study|Ongoing Treatment|0|||
164359590|NCT05407675|593691695|FG010|Overall Study|Ongoing Treatment|0|||
164359591|NCT05407675|593691696|FG011|Overall Study|Ongoing Treatment|0|||
164359592|NCT05407675|593691697|FG012|Overall Study|Ongoing Treatment|0|||
164359593|NCT00857220|593691698|FG000|Overall Study|Adverse Event|35|||
164590766|NCT02163993|594527108|FG000|Treatment Period|Withdrawal by Subject|6|||
164359594|NCT00857220|593691698|FG000|Overall Study|Death|1|||
164359595|NCT00857220|593691698|FG000|Overall Study|Lack of Efficacy|11|||
164359596|NCT00857220|593691698|FG000|Overall Study|Lost to Follow-up|30|||
164359597|NCT00857220|593691698|FG000|Overall Study|Physician Decision|4|||
164359598|NCT00857220|593691698|FG000|Overall Study|Protocol Violation|16|||
164359599|NCT00857220|593691698|FG000|Overall Study|Withdrawal by Subject|67|||
164359600|NCT00857220|593691698|FG000|Overall Study|Clinical Hold|6|||
164359601|NCT00857220|593691698|FG000|Overall Study|Site Closed|5|||
164359602|NCT00857220|593691698|FG000|Overall Study|Miscellaneous|8|||
164359603|NCT02612428|593691699|FG000|VTL-308|Death|14|||
164359604|NCT02612428|593691700|FG001|VTL-308|Death|16|||
164590767|NCT02163993|594527109|FG001|Treatment Period|Withdrawal by Subject|4|||
164590768|NCT02163993|594527110|FG002|Treatment Period|Withdrawal by Subject|1|||
164359605|NCT02612428|593691699|FG000|VTL-308|Withdrawal by Subject|0|||
164359606|NCT02612428|593691700|FG001|VTL-308|Withdrawal by Subject|1|||
164359607|NCT02612428|593691699|FG000|VTL-308E|Death|9|||
164359608|NCT02612428|593691700|FG001|VTL-308E|Death|7|||
164359609|NCT02612428|593691699|FG000|VTL-308E|Lost to Follow-up|2|||
164359610|NCT02612428|593691700|FG001|VTL-308E|Lost to Follow-up|0|||
164359611|NCT00742001|593691701|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
164359612|NCT00742001|593691702|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
164359613|NCT00742001|593691703|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
164697900|NCT01660022|594916951|FG004|First Sequence (7 Days)|Adverse Event|1|||
164697901|NCT01660022|594916952|FG005|First Sequence (7 Days)|Adverse Event|3|||
164697902|NCT01660022|594916947|FG000|First Sequence (7 Days)|Protocol Violation|0|||
164359614|NCT00137423|593691706|FG000|Overall Study|Adverse Event|7|||
164359615|NCT00137423|593691707|FG001|Overall Study|Adverse Event|9|||
164359616|NCT00137423|593691706|FG000|Overall Study|consent withdrawn|1|||
164359617|NCT00137423|593691707|FG001|Overall Study|consent withdrawn|1|||
164359618|NCT00137423|593691706|FG000|Overall Study|Lack of Efficacy|31|||
164359619|NCT00137423|593691707|FG001|Overall Study|Lack of Efficacy|33|||
164359620|NCT00137423|593691706|FG000|Overall Study|Death|0|||
164359621|NCT00137423|593691707|FG001|Overall Study|Death|1|||
164359622|NCT01928329|593691708|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
164359623|NCT01928329|593691709|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
164359624|NCT01928329|593691708|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
164359625|NCT01928329|593691709|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
164359626|NCT01928329|593691708|FG000|Overall Study|Adverse Event|5|||
164359627|NCT01928329|593691709|FG001|Overall Study|Adverse Event|3|||
164359628|NCT01928329|593691708|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
164359629|NCT01928329|593691709|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
164359630|NCT01928329|593691708|FG000|Overall Study|Withdrawal by Subject|1|||
164359631|NCT01928329|593691709|FG001|Overall Study|Withdrawal by Subject|5|||
164359632|NCT01928329|593691708|FG000|Overall Study|Physician Decision|1|||
164359633|NCT01928329|593691709|FG001|Overall Study|Physician Decision|1|||
164359634|NCT03187262|593691710|FG000|Induction|Lack of Efficacy|2|||
164359635|NCT03187262|593691710|FG000|Induction|Progressive Disease|4|||
164359636|NCT03187262|593691710|FG000|Consolidation|Progressive Disease|5|||
164359637|NCT01496313|593691712|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
164359638|NCT01496313|593691713|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
164359639|NCT01496313|593691714|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
164359640|NCT01496313|593691715|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
164697903|NCT01660022|594916948|FG001|First Sequence (7 Days)|Protocol Violation|0|||
164697904|NCT01660022|594916949|FG002|First Sequence (7 Days)|Protocol Violation|0|||
164697905|NCT01660022|594916950|FG003|First Sequence (7 Days)|Protocol Violation|0|||
164697906|NCT01660022|594916951|FG004|First Sequence (7 Days)|Protocol Violation|0|||
164697907|NCT01660022|594916952|FG005|First Sequence (7 Days)|Protocol Violation|1|||
164697908|NCT03545191|594916955|FG000|Overall Study|Death|1|||
164697909|NCT03545191|594916956|FG001|Overall Study|Death|0|||
164697910|NCT03545191|594916957|FG002|Overall Study|Death|0|||
164359641|NCT01496313|593691716|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
164359642|NCT01496313|593691717|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
164697911|NCT03545191|594916955|FG000|Overall Study|Adverse Event|4|||
164697912|NCT03545191|594916956|FG001|Overall Study|Adverse Event|2|||
164697913|NCT03545191|594916957|FG002|Overall Study|Adverse Event|7|||
164697914|NCT03545191|594916955|FG000|Overall Study|Other reasons|3|||
164697915|NCT03545191|594916956|FG001|Overall Study|Other reasons|11|||
164697916|NCT03545191|594916957|FG002|Overall Study|Other reasons|8|||
164697917|NCT03545191|594916955|FG000|Overall Study|Withdrawal by Subject|13|||
164697918|NCT03545191|594916956|FG001|Overall Study|Withdrawal by Subject|10|||
164359643|NCT01496313|593691712|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
164359644|NCT01496313|593691713|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
164359645|NCT01496313|593691714|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
164359646|NCT01496313|593691715|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
164359647|NCT01496313|593691716|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
164359648|NCT01496313|593691717|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
164697919|NCT03545191|594916957|FG002|Overall Study|Withdrawal by Subject|12|||
164697920|NCT03545191|594916955|FG000|Overall Study|Lost to Follow-up|1|||
164697921|NCT03545191|594916956|FG001|Overall Study|Lost to Follow-up|2|||
164697922|NCT03545191|594916957|FG002|Overall Study|Lost to Follow-up|3|||
164697923|NCT01277718|594916961|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
164697924|NCT01277718|594916962|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
164359649|NCT01496313|593691712|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
164359650|NCT01496313|593691713|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
164359651|NCT01496313|593691714|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
164359652|NCT01496313|593691715|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
164359653|NCT01496313|593691716|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
164359654|NCT01496313|593691717|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
164359655|NCT01496313|593691712|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
164359656|NCT01496313|593691713|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
164359657|NCT01496313|593691714|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
164359658|NCT01496313|593691715|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
164359659|NCT01496313|593691716|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
164359660|NCT01496313|593691717|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
164359661|NCT01496313|593691712|FG000|Randomized Period (up to 14 Months)|Other|1|||
164359662|NCT01496313|593691713|FG001|Randomized Period (up to 14 Months)|Other|2|||
164359663|NCT01496313|593691714|FG002|Randomized Period (up to 14 Months)|Other|0|||
164359664|NCT01496313|593691715|FG003|Randomized Period (up to 14 Months)|Other|0|||
164359665|NCT01496313|593691716|FG004|Randomized Period (up to 14 Months)|Other|0|||
164359666|NCT01496313|593691717|FG005|Randomized Period (up to 14 Months)|Other|0|||
164359667|NCT01496313|593691712|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
164359668|NCT01496313|593691713|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
164359669|NCT01496313|593691714|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
164359670|NCT01496313|593691715|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
164359671|NCT01496313|593691716|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
164359672|NCT01496313|593691717|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
164359673|NCT01496313|593691712|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
164359674|NCT01496313|593691713|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
164359675|NCT01496313|593691714|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
164359676|NCT01496313|593691715|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
164359677|NCT01496313|593691716|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
164359678|NCT01496313|593691717|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
164359679|NCT01496313|593691712|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
164359680|NCT01496313|593691713|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
164359681|NCT01496313|593691714|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
164359682|NCT01496313|593691715|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
164359683|NCT01496313|593691716|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
164359684|NCT01496313|593691717|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
164359685|NCT01050257|593691725|FG000|Overall Study|Adverse Event|4|||
164359686|NCT01050257|593691726|FG001|Overall Study|Adverse Event|4|||
164359687|NCT01050257|593691727|FG002|Overall Study|Adverse Event|2|||
164359688|NCT01050257|593691725|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
164359689|NCT01050257|593691726|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
164359690|NCT01050257|593691727|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
164359691|NCT01050257|593691725|FG000|Overall Study|Withdrawal by Subject|0|||
164359692|NCT01050257|593691726|FG001|Overall Study|Withdrawal by Subject|3|||
164359693|NCT01050257|593691727|FG002|Overall Study|Withdrawal by Subject|0|||
164359694|NCT01050257|593691725|FG000|Overall Study|No reason specified|0|||
164359695|NCT01050257|593691726|FG001|Overall Study|No reason specified|0|||
164359696|NCT01050257|593691727|FG002|Overall Study|No reason specified|2|||
164359697|NCT01050257|593691725|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
164359698|NCT01050257|593691726|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
164359699|NCT01050257|593691727|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
164359700|NCT01050257|593691725|FG000|Overall Study|Violation criteria|0|||
164359701|NCT01050257|593691726|FG001|Overall Study|Violation criteria|1|||
164359702|NCT01050257|593691727|FG002|Overall Study|Violation criteria|0|||
164359703|NCT01050257|593691725|FG000|Overall Study|Failure to return|0|||
164359704|NCT01050257|593691726|FG001|Overall Study|Failure to return|2|||
164359705|NCT01050257|593691727|FG002|Overall Study|Failure to return|0|||
164359706|NCT01050257|593691725|FG000|Overall Study|Death|0|||
164359707|NCT01050257|593691726|FG001|Overall Study|Death|0|||
164438363|NCT00344019|593970760|FG002|Overall Study|did not meet final inclusion criteria|74|||
164438364|NCT01193153|593970761|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
164359708|NCT01050257|593691727|FG002|Overall Study|Death|1|||
164359709|NCT00171223|593691728|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
164359710|NCT00171223|593691729|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
164359711|NCT00171223|593691730|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
164438365|NCT01193153|593970762|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
164697925|NCT01277718|594916961|FG000|Period 2 - Second Intervention|Physician Decision|0|||
164697926|NCT01277718|594916962|FG001|Period 2 - Second Intervention|Physician Decision|2|||
164359712|NCT00171223|593691728|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
164359713|NCT00171223|593691729|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
164359714|NCT00171223|593691730|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
164359715|NCT00171223|593691728|FG000|Overall Study|Abnormal Procedure|1|||
164359716|NCT00171223|593691729|FG001|Overall Study|Abnormal Procedure|0|||
164359717|NCT00171223|593691730|FG002|Overall Study|Abnormal Procedure|0|||
164438366|NCT01193153|593970761|FG000|Open-label Lead in Period|Pregnancy|1|||
164590769|NCT02163993|594527111|FG003|Treatment Period|Withdrawal by Subject|4|||
164590770|NCT02163993|594527112|FG004|Treatment Period|Withdrawal by Subject|1|||
164590771|NCT02163993|594527108|FG000|Treatment Period|Not treated|1|||
164590772|NCT02163993|594527109|FG001|Treatment Period|Not treated|0|||
164590773|NCT02163993|594527110|FG002|Treatment Period|Not treated|0|||
164590774|NCT02163993|594527111|FG003|Treatment Period|Not treated|1|||
164590775|NCT02163993|594527112|FG004|Treatment Period|Not treated|2|||
164590776|NCT02163993|594527108|FG000|Post-treatment Period|Adverse Event|0|||
164590777|NCT02163993|594527109|FG001|Post-treatment Period|Adverse Event|0|||
164590778|NCT02163993|594527110|FG002|Post-treatment Period|Adverse Event|1|||
164697927|NCT03919162|594916965|FG000|Overall Study|Adverse Event|3|||
164697928|NCT03919162|594916966|FG001|Overall Study|Adverse Event|2|||
164697929|NCT03919162|594916965|FG000|Overall Study|Death|2|||
164697930|NCT03919162|594916966|FG001|Overall Study|Death|0|||
164697931|NCT03919162|594916965|FG000|Overall Study|Lost to Follow-up|1|||
164697932|NCT03919162|594916966|FG001|Overall Study|Lost to Follow-up|0|||
164697933|NCT03919162|594916965|FG000|Overall Study|Withdrawal by Subject|12|||
164359718|NCT00171223|593691728|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
164359719|NCT00171223|593691729|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
164359720|NCT00171223|593691730|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
164359721|NCT00171223|593691728|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
164359722|NCT00171223|593691729|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
164359723|NCT00171223|593691730|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
164359724|NCT00171223|593691728|FG000|Overall Study|Protocol Violation|2|||
164359725|NCT00171223|593691729|FG001|Overall Study|Protocol Violation|2|||
164359726|NCT00171223|593691730|FG002|Overall Study|Protocol Violation|3|||
164359727|NCT00171223|593691728|FG000|Overall Study|Participant Withdrew Consent|12|||
164359728|NCT00171223|593691729|FG001|Overall Study|Participant Withdrew Consent|21|||
164359729|NCT00171223|593691730|FG002|Overall Study|Participant Withdrew Consent|15|||
164359730|NCT00171223|593691728|FG000|Overall Study|Lost to Follow-up|5|||
164359731|NCT00171223|593691729|FG001|Overall Study|Lost to Follow-up|2|||
164359732|NCT00171223|593691730|FG002|Overall Study|Lost to Follow-up|3|||
164359733|NCT00171223|593691728|FG000|Overall Study|Administrative Problems|4|||
164359734|NCT00171223|593691729|FG001|Overall Study|Administrative Problems|7|||
164359735|NCT00171223|593691730|FG002|Overall Study|Administrative Problems|6|||
164359736|NCT00171223|593691728|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
164359737|NCT00171223|593691729|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
164359738|NCT00171223|593691730|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
164359739|NCT00171223|593691728|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
164359740|NCT00171223|593691729|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
164359741|NCT00171223|593691730|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
164359742|NCT02064166|593691731|FG000|Overall Study|Adverse Event|1|||
164359743|NCT02064166|593691732|FG001|Overall Study|Adverse Event|0|||
164359744|NCT04339296|593691736|FG000|Overall Study|Refuse to participate after allocation|1|||
164359745|NCT04339296|593691737|FG001|Overall Study|Refuse to participate after allocation|1|||
164359746|NCT04339296|593691736|FG000|Overall Study|Withdrew after completion of baseline|2|||
164359747|NCT04339296|593691737|FG001|Overall Study|Withdrew after completion of baseline|1|||
164359748|NCT04339296|593691736|FG000|Overall Study|Lost to Follow-up|0|||
164359749|NCT04339296|593691737|FG001|Overall Study|Lost to Follow-up|4|||
164359750|NCT04339296|593691736|FG000|Overall Study|Discontinued intervention|5|||
164359751|NCT04339296|593691737|FG001|Overall Study|Discontinued intervention|3|||
164359752|NCT03742037|593691739|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
164359753|NCT03742037|593691740|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
164359754|NCT03742037|593691741|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
164359755|NCT03742037|593691742|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
164359756|NCT03742037|593691743|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
164359757|NCT03742037|593691744|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
164359758|NCT03742037|593691745|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
164359759|NCT03742037|593691739|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
164359760|NCT03742037|593691740|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
164359761|NCT03742037|593691741|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
164359762|NCT03742037|593691742|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
164359763|NCT03742037|593691743|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
164359764|NCT03742037|593691744|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
164697934|NCT03919162|594916966|FG001|Overall Study|Withdrawal by Subject|12|||
164697935|NCT03919162|594916965|FG000|Overall Study|Study terminated by Sponsor|20|||
164697936|NCT03919162|594916966|FG001|Overall Study|Study terminated by Sponsor|24|||
164697937|NCT03919162|594916965|FG000|Overall Study|Screen failure|1|||
164697938|NCT03919162|594916966|FG001|Overall Study|Screen failure|0|||
164697939|NCT03919162|594916965|FG000|Overall Study|Missing|1|||
164697940|NCT03919162|594916966|FG001|Overall Study|Missing|1|||
164697941|NCT02746627|594916968|FG000|Overall Study|Withdrawal by Subject|1|||
164697942|NCT02746627|594916969|FG001|Overall Study|Withdrawal by Subject|1|||
164697943|NCT02746627|594916970|FG002|Overall Study|Withdrawal by Subject|1|||
164697944|NCT03078478|594916971|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
164697945|NCT03078478|594916972|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
164697946|NCT03078478|594916971|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
164697947|NCT03078478|594916972|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
164697948|NCT03078478|594916971|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
164697949|NCT03078478|594916972|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
164697950|NCT03078478|594916971|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
164697951|NCT03078478|594916972|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
164697952|NCT03078478|594916971|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
164697953|NCT03078478|594916972|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
164697954|NCT03078478|594916971|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
164697955|NCT03078478|594916972|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
164697956|NCT03078478|594916971|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
164697957|NCT03078478|594916972|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
164697958|NCT03078478|594916971|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
164697959|NCT03078478|594916972|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
164697960|NCT02858726|594916973|FG000|Overall Study|Adverse Event|4|||
164697961|NCT02858726|594916974|FG001|Overall Study|Adverse Event|4|||
164697962|NCT02858726|594916975|FG002|Overall Study|Adverse Event|9|||
164697963|NCT02858726|594916976|FG003|Overall Study|Adverse Event|1|||
164697964|NCT02858726|594916973|FG000|Overall Study|Physician Decision|0|||
164697965|NCT02858726|594916974|FG001|Overall Study|Physician Decision|0|||
164697966|NCT02858726|594916975|FG002|Overall Study|Physician Decision|1|||
164697967|NCT02858726|594916976|FG003|Overall Study|Physician Decision|0|||
164697968|NCT02858726|594916973|FG000|Overall Study|Protocol Violation|0|||
164697969|NCT02858726|594916974|FG001|Overall Study|Protocol Violation|0|||
164697970|NCT02858726|594916975|FG002|Overall Study|Protocol Violation|0|||
164697971|NCT02858726|594916976|FG003|Overall Study|Protocol Violation|1|||
164697972|NCT02858726|594916973|FG000|Overall Study|Study Terminated by Sponsor|0|||
164697973|NCT02858726|594916974|FG001|Overall Study|Study Terminated by Sponsor|0|||
164697974|NCT02858726|594916975|FG002|Overall Study|Study Terminated by Sponsor|0|||
164697975|NCT02858726|594916976|FG003|Overall Study|Study Terminated by Sponsor|1|||
164697976|NCT02858726|594916973|FG000|Overall Study|Withdrawal by Subject|1|||
164697977|NCT02858726|594916974|FG001|Overall Study|Withdrawal by Subject|2|||
164697978|NCT02858726|594916975|FG002|Overall Study|Withdrawal by Subject|1|||
164697979|NCT02858726|594916976|FG003|Overall Study|Withdrawal by Subject|0|||
164359765|NCT03742037|593691745|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
164359766|NCT03742037|593691739|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
164359767|NCT03742037|593691740|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
164359768|NCT03742037|593691741|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
164359769|NCT03742037|593691742|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
164359770|NCT03742037|593691743|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
164359771|NCT03742037|593691744|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
164359772|NCT03742037|593691745|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
164359773|NCT03742037|593691739|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
164359774|NCT03742037|593691740|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
164359775|NCT03742037|593691741|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
164359776|NCT03742037|593691742|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
164359777|NCT03742037|593691743|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
164359778|NCT03742037|593691744|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
164359779|NCT03742037|593691745|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
164697980|NCT02858726|594916973|FG000|Overall Study|Noncompliance|0|||
164697981|NCT02858726|594916974|FG001|Overall Study|Noncompliance|1|||
164697982|NCT02858726|594916975|FG002|Overall Study|Noncompliance|0|||
164697983|NCT02858726|594916976|FG003|Overall Study|Noncompliance|0|||
164697984|NCT01688726|594916979|FG000|Overall Study|Adverse Event|1|||
164697985|NCT01688726|594916980|FG001|Overall Study|Adverse Event|0|||
164697986|NCT01688726|594916979|FG000|Overall Study|Relocated abroad|0|||
164697987|NCT01688726|594916980|FG001|Overall Study|Relocated abroad|1|||
164697988|NCT00710749|594916981|FG000|First Intervention|Withdrawal by Subject|1|||
164697989|NCT00710749|594916982|FG001|First Intervention|Withdrawal by Subject|0|||
164697990|NCT05478252|594916984|FG000|Overall Study|Withdrawal by Subject|2|||
164697991|NCT05478252|594916985|FG001|Overall Study|Withdrawal by Subject|3|||
164697992|NCT05478252|594916984|FG000|Overall Study|Lost to Follow-up|4|||
164697993|NCT05478252|594916985|FG001|Overall Study|Lost to Follow-up|2|||
164438367|NCT01193153|593970762|FG001|Open-label Lead in Period|Pregnancy|0|||
164438368|NCT01193153|593970761|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
164438369|NCT01193153|593970762|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
164438370|NCT01193153|593970761|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
164438371|NCT01193153|593970762|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
164438372|NCT01193153|593970761|FG000|Open-label Lead in Period|Other|14|||
164438373|NCT01193153|593970762|FG001|Open-label Lead in Period|Other|0|||
164438374|NCT01193153|593970761|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
164438375|NCT01193153|593970762|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
164438376|NCT01193153|593970761|FG000|Open-label Lead in Period|Adverse Event|41|||
164438377|NCT01193153|593970762|FG001|Open-label Lead in Period|Adverse Event|0|||
164438378|NCT01193153|593970761|FG000|Open-label Lead in Period|Death|1|||
164438379|NCT01193153|593970762|FG001|Open-label Lead in Period|Death|0|||
164438380|NCT01193153|593970761|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
164438381|NCT01193153|593970762|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
164438382|NCT01193153|593970761|FG000|Open-label Stabilization Period|Adverse Event|9|||
164438383|NCT01193153|593970762|FG001|Open-label Stabilization Period|Adverse Event|0|||
164438384|NCT01193153|593970761|FG000|Open-label Stabilization Period|Death|2|||
164438385|NCT01193153|593970762|FG001|Open-label Stabilization Period|Death|0|||
164438386|NCT01193153|593970761|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
164438387|NCT01193153|593970762|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
164438388|NCT01193153|593970761|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
164438389|NCT01193153|593970762|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
164438390|NCT01193153|593970761|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
164438391|NCT01193153|593970762|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
164438392|NCT01193153|593970761|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
164438393|NCT01193153|593970762|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
164438394|NCT01193153|593970761|FG000|Open-label Stabilization Period|Other|8|||
164438395|NCT01193153|593970762|FG001|Open-label Stabilization Period|Other|0|||
164438396|NCT01193153|593970761|FG000|Double Blind Relapse Prevention Period|Other|2|||
164438397|NCT01193153|593970762|FG001|Double Blind Relapse Prevention Period|Other|3|||
164438398|NCT01193153|593970761|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
164438399|NCT01193153|593970762|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
164359780|NCT03742037|593691739|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
164359781|NCT03742037|593691740|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
164359782|NCT03742037|593691741|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
164359783|NCT03742037|593691742|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
164359784|NCT03742037|593691743|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
164359785|NCT03742037|593691744|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
164359786|NCT03742037|593691745|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
164359787|NCT03742037|593691739|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
164359788|NCT03742037|593691740|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
164359789|NCT03742037|593691741|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
164359790|NCT03742037|593691742|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
164359791|NCT03742037|593691743|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
164359792|NCT03742037|593691744|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
164359793|NCT03742037|593691745|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
164359794|NCT03742037|593691739|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
164359795|NCT03742037|593691740|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
164359796|NCT03742037|593691741|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
164359797|NCT03742037|593691742|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
164359798|NCT03742037|593691743|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
164359799|NCT03742037|593691744|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
164359800|NCT03742037|593691745|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
164359801|NCT03742037|593691739|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
164359802|NCT03742037|593691740|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
164359803|NCT03742037|593691741|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
164359804|NCT03742037|593691742|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
164359805|NCT03742037|593691743|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
164359806|NCT03742037|593691744|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
164359807|NCT03742037|593691745|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
164359808|NCT03742037|593691739|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
164438400|NCT01193153|593970761|FG000|Double Blind Relapse Prevention Period|Death|2|||
164438401|NCT01193153|593970762|FG001|Double Blind Relapse Prevention Period|Death|0|||
164438402|NCT01193153|593970761|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
164438403|NCT01193153|593970762|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
164590779|NCT02163993|594527111|FG003|Post-treatment Period|Adverse Event|0|||
164590780|NCT02163993|594527112|FG004|Post-treatment Period|Adverse Event|0|||
164359809|NCT03742037|593691740|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
164359810|NCT03742037|593691741|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
164359811|NCT03742037|593691742|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
164359812|NCT03742037|593691743|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
164359813|NCT03742037|593691744|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
164359814|NCT03742037|593691745|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
164359815|NCT03742037|593691739|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
164359816|NCT03742037|593691740|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
164359817|NCT03742037|593691741|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
164359818|NCT03742037|593691742|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
164359819|NCT03742037|593691743|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
164359820|NCT03742037|593691744|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
164359821|NCT03742037|593691745|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
164359822|NCT03742037|593691739|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
164359823|NCT03742037|593691740|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
164359824|NCT03742037|593691741|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
164359825|NCT03742037|593691742|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
164359826|NCT03742037|593691743|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
164359827|NCT03742037|593691744|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
164359828|NCT03742037|593691745|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
164359829|NCT03742037|593691739|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
164359830|NCT03742037|593691740|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
164359831|NCT03742037|593691741|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
164359832|NCT03742037|593691742|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
164359833|NCT03742037|593691743|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
164359834|NCT03742037|593691744|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
164359835|NCT03742037|593691745|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
164359836|NCT03742037|593691739|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
164359837|NCT03742037|593691740|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
164359838|NCT03742037|593691741|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
164359839|NCT03742037|593691742|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
164359840|NCT03742037|593691743|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
164359841|NCT03742037|593691744|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
164359842|NCT03742037|593691745|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
164359843|NCT03742037|593691739|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
164359844|NCT03742037|593691740|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
164359845|NCT03742037|593691741|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
164359846|NCT03742037|593691742|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
164359847|NCT03742037|593691743|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
164359848|NCT03742037|593691744|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
164359849|NCT03742037|593691745|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
164359850|NCT03742037|593691739|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
164359851|NCT03742037|593691740|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
164359852|NCT03742037|593691741|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
164359853|NCT03742037|593691742|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
164359854|NCT03742037|593691743|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
164359855|NCT03742037|593691744|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
164359856|NCT03742037|593691745|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
164359857|NCT00453544|593691746|FG000|Overall Study|Withdrawal by Subject|1|||
164359858|NCT00453544|593691747|FG001|Overall Study|Withdrawal by Subject|0|||
164359859|NCT00453544|593691748|FG002|Overall Study|Withdrawal by Subject|0|||
164359860|NCT00453544|593691749|FG003|Overall Study|Withdrawal by Subject|0|||
164359861|NCT00453544|593691746|FG000|Overall Study|Primary outcome measure not completed|1|||
164359862|NCT00453544|593691747|FG001|Overall Study|Primary outcome measure not completed|1|||
164359863|NCT00453544|593691748|FG002|Overall Study|Primary outcome measure not completed|0|||
164590781|NCT02163993|594527108|FG000|Post-treatment Period|Lost to Follow-up|2|||
164590782|NCT02163993|594527109|FG001|Post-treatment Period|Lost to Follow-up|2|||
164590783|NCT02163993|594527110|FG002|Post-treatment Period|Lost to Follow-up|3|||
164590784|NCT02163993|594527111|FG003|Post-treatment Period|Lost to Follow-up|1|||
164590785|NCT02163993|594527112|FG004|Post-treatment Period|Lost to Follow-up|0|||
164359864|NCT00453544|593691749|FG003|Overall Study|Primary outcome measure not completed|1|||
164359865|NCT01558752|593691750|FG000|Overall Study|Physician Decision|2|||
164359866|NCT01558752|593691751|FG001|Overall Study|Physician Decision|0|||
164359867|NCT00969150|593691752|FG000|Overall Study|Adverse Event|4|||
164359868|NCT00969150|593691753|FG001|Overall Study|Adverse Event|14|||
164359869|NCT00969150|593691752|FG000|Overall Study|Lack of Efficacy|1|||
164359870|NCT00969150|593691753|FG001|Overall Study|Lack of Efficacy|1|||
164590786|NCT02163993|594527108|FG000|Post-treatment Period|Protocol Violation|0|||
164590787|NCT02163993|594527109|FG001|Post-treatment Period|Protocol Violation|0|||
164590788|NCT02163993|594527110|FG002|Post-treatment Period|Protocol Violation|0|||
164590789|NCT02163993|594527111|FG003|Post-treatment Period|Protocol Violation|0|||
164590790|NCT02163993|594527112|FG004|Post-treatment Period|Protocol Violation|1|||
164590791|NCT02163993|594527108|FG000|Post-treatment Period|Withdrawal by Subject|2|||
164359871|NCT00969150|593691752|FG000|Overall Study|Protocol Violation|9|||
164359872|NCT00969150|593691753|FG001|Overall Study|Protocol Violation|12|||
164359873|NCT00969150|593691752|FG000|Overall Study|Withdrawal by Subject|13|||
164359874|NCT00969150|593691753|FG001|Overall Study|Withdrawal by Subject|9|||
164359875|NCT00969150|593691752|FG000|Overall Study|Lost to Follow-up|5|||
164359876|NCT00969150|593691753|FG001|Overall Study|Lost to Follow-up|4|||
164359877|NCT00969150|593691752|FG000|Overall Study|Other reasons|1|||
164359878|NCT00969150|593691753|FG001|Overall Study|Other reasons|0|||
164359879|NCT00461682|593691754|FG000|Overall Study|Protocol Violation|1|||
164359880|NCT04128267|593691757|FG000|Overall Study|Withdrawal by Subject|6|||
164359881|NCT04128267|593691757|FG000|Overall Study|Death|2|||
164359882|NCT04128267|593691757|FG000|Overall Study|Disease progression|1|||
164359883|NCT04128267|593691757|FG000|Overall Study|Participant had other medical issues|4|||
164359884|NCT04128267|593691757|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
164359885|NCT01705652|593691759|FG000|Overall Study|Adverse Event|1|||
164359886|NCT01705652|593691760|FG001|Overall Study|Adverse Event|0|||
164359887|NCT01705652|593691759|FG000|Overall Study|Withdrawal by Subject|1|||
164359888|NCT01705652|593691760|FG001|Overall Study|Withdrawal by Subject|2|||
164359889|NCT01705652|593691759|FG000|Overall Study|non-compliance|1|||
164359890|NCT01705652|593691760|FG001|Overall Study|non-compliance|1|||
164359891|NCT00056407|593691762|FG000|Overall Study|Adverse Event|282|||
164359892|NCT00056407|593691763|FG001|Overall Study|Adverse Event|364|||
164359893|NCT00056407|593691762|FG000|Overall Study|Withdrawal by Subject|377|||
164359894|NCT00056407|593691763|FG001|Overall Study|Withdrawal by Subject|361|||
164359895|NCT00056407|593691762|FG000|Overall Study|Lost to Follow-up|123|||
164359896|NCT00056407|593691763|FG001|Overall Study|Lost to Follow-up|113|||
164359897|NCT00056407|593691762|FG000|Overall Study|Protocol Violation|104|||
164359898|NCT00056407|593691763|FG001|Overall Study|Protocol Violation|95|||
164359899|NCT00056407|593691762|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
164359900|NCT00056407|593691763|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
164359901|NCT00056407|593691762|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
164359902|NCT00056407|593691763|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
164359903|NCT00056407|593691762|FG000|Overall Study|Missing|25|||
164359904|NCT00056407|593691763|FG001|Overall Study|Missing|34|||
164359905|NCT00616655|593691764|FG000|Overall Study|Adverse Event|10|||
164359906|NCT00616655|593691765|FG001|Overall Study|Adverse Event|7|||
164359907|NCT00616655|593691766|FG002|Overall Study|Adverse Event|12|||
164359908|NCT00616655|593691764|FG000|Overall Study|Lack of Efficacy|5|||
164359909|NCT00616655|593691765|FG001|Overall Study|Lack of Efficacy|5|||
164359910|NCT00616655|593691766|FG002|Overall Study|Lack of Efficacy|5|||
164359911|NCT00616655|593691764|FG000|Overall Study|Lost to Follow-up|3|||
164359912|NCT00616655|593691765|FG001|Overall Study|Lost to Follow-up|12|||
164359913|NCT00616655|593691766|FG002|Overall Study|Lost to Follow-up|10|||
164359914|NCT00616655|593691764|FG000|Overall Study|Protocol Violation|2|||
164359915|NCT00616655|593691765|FG001|Overall Study|Protocol Violation|4|||
164359916|NCT00616655|593691766|FG002|Overall Study|Protocol Violation|3|||
164359917|NCT00616655|593691764|FG000|Overall Study|Withdrawal by Subject|9|||
164359918|NCT00616655|593691765|FG001|Overall Study|Withdrawal by Subject|7|||
164359919|NCT00616655|593691766|FG002|Overall Study|Withdrawal by Subject|11|||
164359920|NCT00616655|593691764|FG000|Overall Study|Does not meet in/ex criteria|0|||
164359921|NCT00616655|593691765|FG001|Overall Study|Does not meet in/ex criteria|0|||
164359922|NCT00616655|593691766|FG002|Overall Study|Does not meet in/ex criteria|2|||
164359923|NCT00616655|593691764|FG000|Overall Study|Other|6|||
164359924|NCT00616655|593691765|FG001|Overall Study|Other|6|||
164359925|NCT00616655|593691766|FG002|Overall Study|Other|5|||
164359926|NCT00309842|593691767|FG000|Overall Study|Lost to Follow-up|1|||
164359927|NCT01026792|593691768|FG000|Overall Study|Protocol Violation|1|||
164359928|NCT02335099|593691771|FG000|Treatment|Withdrawal by Subject|1|||
164359929|NCT02335099|593691772|FG001|Treatment|Withdrawal by Subject|3|||
164359930|NCT02335099|593691771|FG000|Treatment|Lost to Follow-up|2|||
164359931|NCT02335099|593691772|FG001|Treatment|Lost to Follow-up|0|||
164359932|NCT02335099|593691771|FG000|Treatment|Death|1|||
164359933|NCT02335099|593691772|FG001|Treatment|Death|0|||
164359934|NCT02335099|593691771|FG000|Treatment|Adverse Event|1|||
164359935|NCT02335099|593691772|FG001|Treatment|Adverse Event|2|||
164359936|NCT02335099|593691771|FG000|Follow-up|Death|0|||
164359937|NCT02335099|593691772|FG001|Follow-up|Death|1|||
164359938|NCT01472081|593691773|FG000|Overall Study|Continuing treatment at time of analysis|1|||
164359939|NCT01472081|593691774|FG001|Overall Study|Continuing treatment at time of analysis|4|||
164359940|NCT01472081|593691775|FG002|Overall Study|Continuing treatment at time of analysis|1|||
164359941|NCT01472081|593691776|FG003|Overall Study|Continuing treatment at time of analysis|8|||
164359942|NCT01472081|593691777|FG004|Overall Study|Continuing treatment at time of analysis|9|||
164359943|NCT01472081|593691778|FG005|Overall Study|Continuing treatment at time of analysis|0|||
164359944|NCT01472081|593691773|FG000|Overall Study|Disease Progression|4|||
164359945|NCT01472081|593691774|FG001|Overall Study|Disease Progression|10|||
164359946|NCT01472081|593691775|FG002|Overall Study|Disease Progression|12|||
164359947|NCT01472081|593691776|FG003|Overall Study|Disease Progression|31|||
164359948|NCT01472081|593691777|FG004|Overall Study|Disease Progression|22|||
164359949|NCT01472081|593691778|FG005|Overall Study|Disease Progression|3|||
164359950|NCT01472081|593691773|FG000|Overall Study|Study drug toxicity|2|||
164359951|NCT01472081|593691774|FG001|Overall Study|Study drug toxicity|9|||
164359952|NCT01472081|593691775|FG002|Overall Study|Study drug toxicity|4|||
164359953|NCT01472081|593691776|FG003|Overall Study|Study drug toxicity|6|||
164359954|NCT01472081|593691777|FG004|Overall Study|Study drug toxicity|13|||
164359955|NCT01472081|593691778|FG005|Overall Study|Study drug toxicity|2|||
164359956|NCT01472081|593691773|FG000|Overall Study|Death|0|||
164359957|NCT01472081|593691774|FG001|Overall Study|Death|0|||
164359958|NCT01472081|593691775|FG002|Overall Study|Death|0|||
164359959|NCT01472081|593691776|FG003|Overall Study|Death|0|||
164359960|NCT01472081|593691777|FG004|Overall Study|Death|1|||
164359961|NCT01472081|593691778|FG005|Overall Study|Death|0|||
164359962|NCT01472081|593691773|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
164359963|NCT01472081|593691774|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
164359964|NCT01472081|593691775|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
164359965|NCT01472081|593691776|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
164359966|NCT01472081|593691777|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
164359967|NCT01472081|593691778|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
164359968|NCT01472081|593691773|FG000|Overall Study|Withdrawal by Subject|0|||
164359969|NCT01472081|593691774|FG001|Overall Study|Withdrawal by Subject|0|||
164359970|NCT01472081|593691775|FG002|Overall Study|Withdrawal by Subject|0|||
164359971|NCT01472081|593691776|FG003|Overall Study|Withdrawal by Subject|0|||
164359972|NCT01472081|593691777|FG004|Overall Study|Withdrawal by Subject|0|||
164359973|NCT01472081|593691778|FG005|Overall Study|Withdrawal by Subject|1|||
164359974|NCT01472081|593691773|FG000|Overall Study|Poor/non-compliance|0|||
164359975|NCT01472081|593691774|FG001|Overall Study|Poor/non-compliance|0|||
164359976|NCT01472081|593691775|FG002|Overall Study|Poor/non-compliance|1|||
164359977|NCT01472081|593691776|FG003|Overall Study|Poor/non-compliance|0|||
164359978|NCT01472081|593691777|FG004|Overall Study|Poor/non-compliance|1|||
164359979|NCT01472081|593691778|FG005|Overall Study|Poor/non-compliance|0|||
164359980|NCT01472081|593691773|FG000|Overall Study|No longer meets study criteria|0|||
164359981|NCT01472081|593691774|FG001|Overall Study|No longer meets study criteria|0|||
164438404|NCT01193153|593970761|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
164438405|NCT01193153|593970762|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
164697994|NCT05478252|594916984|FG000|Overall Study|Physician Decision|1|||
164697995|NCT05478252|594916985|FG001|Overall Study|Physician Decision|1|||
164697996|NCT05478252|594916984|FG000|Overall Study|Death|1|||
164697997|NCT05478252|594916985|FG001|Overall Study|Death|0|||
164697998|NCT04718194|594918706|FG000|Overall Study|Withdrawal by Subject|3|||
164697999|NCT04718194|594918707|FG001|Overall Study|Withdrawal by Subject|0|||
164698000|NCT04718194|594918706|FG000|Overall Study|Lost to Follow-up|3|||
164698001|NCT04718194|594918707|FG001|Overall Study|Lost to Follow-up|0|||
164698002|NCT01215513|594918708|FG000|Overall Study|Not completed CS42|9|||
164698003|NCT01215513|594918708|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
164698004|NCT01215513|594918708|FG000|Overall Study|Adverse event (CS42A)|2|||
164698005|NCT01215513|594918708|FG000|Overall Study|Physician decision (CS42A)|6|||
164698006|NCT01215513|594918708|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
164698007|NCT01215513|594918708|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
164698008|NCT00821873|594918709|FG000|Overall Study|Lost to Follow-up|4|||
164698009|NCT03861481|594918715|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
164359982|NCT01472081|593691775|FG002|Overall Study|No longer meets study criteria|1|||
164359983|NCT01472081|593691776|FG003|Overall Study|No longer meets study criteria|0|||
164359984|NCT01472081|593691777|FG004|Overall Study|No longer meets study criteria|0|||
164698010|NCT03861481|594918716|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
164698011|NCT03861481|594918715|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
164698012|NCT03861481|594918716|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
164359985|NCT01472081|593691778|FG005|Overall Study|No longer meets study criteria|0|||
164359986|NCT01472081|593691773|FG000|Overall Study|Subject request to discontinue treatment|0|||
164359987|NCT01472081|593691774|FG001|Overall Study|Subject request to discontinue treatment|3|||
164359988|NCT01472081|593691775|FG002|Overall Study|Subject request to discontinue treatment|1|||
164359989|NCT01472081|593691776|FG003|Overall Study|Subject request to discontinue treatment|1|||
164359990|NCT01472081|593691777|FG004|Overall Study|Subject request to discontinue treatment|0|||
164359991|NCT01472081|593691778|FG005|Overall Study|Subject request to discontinue treatment|0|||
164359992|NCT01367158|593691779|FG000|Overall Study|Withdrew consent|0|||
164359993|NCT01367158|593691780|FG001|Overall Study|Withdrew consent|2|||
164359994|NCT01367158|593691781|FG002|Overall Study|Withdrew consent|1|||
164359995|NCT01367158|593691782|FG003|Overall Study|Withdrew consent|0|||
164359996|NCT01367158|593691783|FG004|Overall Study|Withdrew consent|2|||
164359997|NCT01367158|593691784|FG005|Overall Study|Withdrew consent|0|||
164698013|NCT03861481|594918715|FG000|Overall Study|Relapse|1|||
164698014|NCT03861481|594918716|FG001|Overall Study|Relapse|0|||
164698015|NCT03861481|594918715|FG000|Overall Study|Withdrawal by Subject|0|||
164359998|NCT01367158|593691785|FG006|Overall Study|Withdrew consent|0|||
164359999|NCT01367158|593691786|FG007|Overall Study|Withdrew consent|1|||
164360000|NCT01367158|593691787|FG008|Overall Study|Withdrew consent|0|||
164360001|NCT01367158|593691788|FG009|Overall Study|Withdrew consent|0|||
164360002|NCT01367158|593691789|FG010|Overall Study|Withdrew consent|0|||
164360003|NCT01367158|593691779|FG000|Overall Study|Lost to Follow-up|0|||
164360004|NCT01367158|593691780|FG001|Overall Study|Lost to Follow-up|0|||
164360005|NCT01367158|593691781|FG002|Overall Study|Lost to Follow-up|0|||
164360006|NCT01367158|593691782|FG003|Overall Study|Lost to Follow-up|1|||
164360007|NCT01367158|593691783|FG004|Overall Study|Lost to Follow-up|0|||
164360008|NCT01367158|593691784|FG005|Overall Study|Lost to Follow-up|2|||
164360009|NCT01367158|593691785|FG006|Overall Study|Lost to Follow-up|0|||
164360010|NCT01367158|593691786|FG007|Overall Study|Lost to Follow-up|1|||
164360011|NCT01367158|593691787|FG008|Overall Study|Lost to Follow-up|0|||
164360012|NCT01367158|593691788|FG009|Overall Study|Lost to Follow-up|0|||
164360013|NCT01367158|593691789|FG010|Overall Study|Lost to Follow-up|1|||
164360014|NCT01367158|593691779|FG000|Overall Study|Protocol Violation|0|||
164360015|NCT01367158|593691780|FG001|Overall Study|Protocol Violation|1|||
164360016|NCT01367158|593691781|FG002|Overall Study|Protocol Violation|0|||
164360017|NCT01367158|593691782|FG003|Overall Study|Protocol Violation|0|||
164360018|NCT01367158|593691783|FG004|Overall Study|Protocol Violation|0|||
164360019|NCT01367158|593691784|FG005|Overall Study|Protocol Violation|0|||
164360020|NCT01367158|593691785|FG006|Overall Study|Protocol Violation|0|||
164360021|NCT01367158|593691786|FG007|Overall Study|Protocol Violation|0|||
164360022|NCT01367158|593691787|FG008|Overall Study|Protocol Violation|0|||
164360023|NCT01367158|593691788|FG009|Overall Study|Protocol Violation|0|||
164360024|NCT01367158|593691789|FG010|Overall Study|Protocol Violation|0|||
164360025|NCT04702997|593691790|FG000|Overall Study|Withdrawal by Subject|1|||
164360026|NCT04702997|593691791|FG001|Overall Study|Withdrawal by Subject|1|||
164360027|NCT03915496|593691792|FG000|Overall Study|Adverse Event|2|||
164360028|NCT03915496|593691793|FG001|Overall Study|Adverse Event|1|||
164360029|NCT03915496|593691794|FG002|Overall Study|Adverse Event|2|||
164360030|NCT02759471|593691795|FG000|Overall Study|discomfort|2|||
164360031|NCT01103284|593691796|FG000|Overall Study|Death|2|||
164360032|NCT01103284|593691797|FG001|Overall Study|Death|0|||
164360033|NCT01103284|593691796|FG000|Overall Study|Lost to Follow-up|9|||
164360034|NCT01103284|593691797|FG001|Overall Study|Lost to Follow-up|10|||
164360035|NCT01103284|593691796|FG000|Overall Study|Pregnancy|3|||
164360036|NCT01103284|593691797|FG001|Overall Study|Pregnancy|1|||
164360037|NCT01103284|593691796|FG000|Overall Study|Protocol Violation|12|||
164360038|NCT01103284|593691797|FG001|Overall Study|Protocol Violation|5|||
164360039|NCT01103284|593691796|FG000|Overall Study|Adverse Event|0|||
164360040|NCT01103284|593691797|FG001|Overall Study|Adverse Event|5|||
164360041|NCT01103284|593691796|FG000|Overall Study|Withdrawal by Subject|14|||
164360042|NCT01103284|593691797|FG001|Overall Study|Withdrawal by Subject|18|||
164360043|NCT01103284|593691796|FG000|Overall Study|Dermal Hypersensitivity|0|||
164360044|NCT01103284|593691797|FG001|Overall Study|Dermal Hypersensitivity|1|||
164360045|NCT01103284|593691796|FG000|Overall Study|Termination by the Sponsor|0|||
164360046|NCT01103284|593691797|FG001|Overall Study|Termination by the Sponsor|1|||
164360047|NCT01103284|593691796|FG000|Overall Study|Not described|2|||
164360048|NCT01103284|593691797|FG001|Overall Study|Not described|1|||
164360049|NCT01103284|593691796|FG000|Overall Study|Missing CRF entries for study completion|0|||
164360050|NCT01103284|593691797|FG001|Overall Study|Missing CRF entries for study completion|2|||
164360051|NCT03712904|593693157|FG000|Overall Study|Death|0|||
164360052|NCT03712904|593693158|FG001|Overall Study|Death|1|||
164360053|NCT03712904|593693157|FG000|Overall Study|Withdrawal by Subject|0|||
164360054|NCT03712904|593693158|FG001|Overall Study|Withdrawal by Subject|1|||
164360055|NCT03712904|593693157|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
164360056|NCT03712904|593693158|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
164360057|NCT04568590|593693159|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
164360058|NCT03745937|593693160|FG000|Overall Study|Withdrawal by Subject|0|||
164360059|NCT03745937|593693161|FG001|Overall Study|Withdrawal by Subject|0|||
164360060|NCT03745937|593693162|FG002|Overall Study|Withdrawal by Subject|0|||
164360061|NCT03745937|593693163|FG003|Overall Study|Withdrawal by Subject|1|||
164360062|NCT03745937|593693160|FG000|Overall Study|Not-specifed|0|||
164360063|NCT03745937|593693161|FG001|Overall Study|Not-specifed|1|||
164360064|NCT03745937|593693162|FG002|Overall Study|Not-specifed|0|||
164698016|NCT03861481|594918716|FG001|Overall Study|Withdrawal by Subject|1|||
164360065|NCT03745937|593693163|FG003|Overall Study|Not-specifed|1|||
164360066|NCT01190254|593693166|FG000|Overall Study|Adverse Event|3|||
164360067|NCT01190254|593693167|FG001|Overall Study|Adverse Event|6|||
164360068|NCT01190254|593693168|FG002|Overall Study|Adverse Event|8|||
164360069|NCT01190254|593693166|FG000|Overall Study|Lack of Efficacy|7|||
164360070|NCT01190254|593693167|FG001|Overall Study|Lack of Efficacy|4|||
164360071|NCT01190254|593693168|FG002|Overall Study|Lack of Efficacy|5|||
164360072|NCT01190254|593693166|FG000|Overall Study|Lost to Follow-up|4|||
164360073|NCT01190254|593693167|FG001|Overall Study|Lost to Follow-up|2|||
164360074|NCT01190254|593693168|FG002|Overall Study|Lost to Follow-up|0|||
164360075|NCT01190254|593693166|FG000|Overall Study|Withdrawal by Subject|4|||
164360076|NCT01190254|593693167|FG001|Overall Study|Withdrawal by Subject|5|||
164360077|NCT01190254|593693168|FG002|Overall Study|Withdrawal by Subject|7|||
164360078|NCT01190254|593693166|FG000|Overall Study|Protocol Violation|2|||
164360079|NCT01190254|593693167|FG001|Overall Study|Protocol Violation|0|||
164360080|NCT01190254|593693168|FG002|Overall Study|Protocol Violation|2|||
164360081|NCT01190254|593693166|FG000|Overall Study|Did not meet protocol eligibility|1|||
164360082|NCT01190254|593693167|FG001|Overall Study|Did not meet protocol eligibility|0|||
164360083|NCT01190254|593693168|FG002|Overall Study|Did not meet protocol eligibility|0|||
164360084|NCT02356783|593693169|FG000|Overall Study|Lost to Follow-up|1|||
164360085|NCT02356783|593693170|FG001|Overall Study|Lost to Follow-up|3|||
164360086|NCT01485640|593693171|FG000|Overall Study|Adverse Event|10|||
164360087|NCT01485640|593693171|FG000|Overall Study|Lack of Efficacy|2|||
164360088|NCT01485640|593693171|FG000|Overall Study|Protocol Violation|1|||
164360089|NCT01485640|593693171|FG000|Overall Study|Withdrawal by Subject|14|||
164360090|NCT01485640|593693171|FG000|Overall Study|Terminated by Sponsor|95|||
164360091|NCT00202644|593693174|FG000|Overall Study|Adverse Event|12|||
164360092|NCT00202644|593693175|FG001|Overall Study|Adverse Event|13|||
164360093|NCT00202644|593693174|FG000|Overall Study|Withdrawal by Subject|8|||
164360094|NCT00202644|593693175|FG001|Overall Study|Withdrawal by Subject|6|||
164360095|NCT00202644|593693174|FG000|Overall Study|Lack of Efficacy|6|||
164360096|NCT00202644|593693175|FG001|Overall Study|Lack of Efficacy|6|||
164360097|NCT00202644|593693174|FG000|Overall Study|Lost to Follow-up|0|||
164360098|NCT00202644|593693175|FG001|Overall Study|Lost to Follow-up|1|||
164360099|NCT00202644|593693174|FG000|Overall Study|Other|9|||
164360100|NCT00202644|593693175|FG001|Overall Study|Other|1|||
164360101|NCT03232281|593693181|FG000|Overall Study|Adverse Event|1|||
164360102|NCT03232281|593693182|FG001|Overall Study|Adverse Event|1|||
164360103|NCT03232281|593693181|FG000|Overall Study|Withdrawal by Subject|5|||
164360104|NCT03232281|593693182|FG001|Overall Study|Withdrawal by Subject|4|||
164438406|NCT01193153|593970761|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
164438407|NCT01193153|593970762|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
164438408|NCT01193153|593970761|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
164438409|NCT01193153|593970762|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
164438410|NCT01193153|593970761|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
164438411|NCT01193153|593970762|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
164438412|NCT02503202|593970763|FG000|Base Study: Up to Month 6|Death|1|||
164438413|NCT02503202|593970764|FG001|Base Study: Up to Month 6|Death|1|||
164438414|NCT02503202|593970765|FG002|Base Study: Up to Month 6|Death|0|||
164438415|NCT02503202|593970766|FG003|Base Study: Up to Month 6|Death|0|||
164360105|NCT03232281|593693181|FG000|Overall Study|Protocol Deviation|1|||
164360106|NCT03232281|593693182|FG001|Overall Study|Protocol Deviation|1|||
164360107|NCT01372501|593693186|FG000|Overall Study|Adverse Event|4|||
164360108|NCT01372501|593693186|FG000|Overall Study|Device migration|1|||
164360109|NCT05333900|593693187|FG000|Overall Study|Protocol Violation|0|||
164360110|NCT05333900|593693188|FG001|Overall Study|Protocol Violation|1|||
164360111|NCT05333900|593693187|FG000|Overall Study|Withdrawal by Subject|0|||
164360112|NCT05333900|593693188|FG001|Overall Study|Withdrawal by Subject|1|||
164360113|NCT05333900|593693187|FG000|Overall Study|COVID-19 Pandemic|1|||
164438416|NCT02503202|593970767|FG004|Base Study: Up to Month 6|Death|0|||
164438417|NCT02503202|593970763|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
164438418|NCT02503202|593970764|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
164438419|NCT02503202|593970765|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
164590792|NCT02163993|594527109|FG001|Post-treatment Period|Withdrawal by Subject|4|||
164590793|NCT02163993|594527110|FG002|Post-treatment Period|Withdrawal by Subject|0|||
164360114|NCT05333900|593693188|FG001|Overall Study|COVID-19 Pandemic|1|||
164438420|NCT02503202|593970766|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
164590794|NCT02163993|594527111|FG003|Post-treatment Period|Withdrawal by Subject|1|||
164590795|NCT02163993|594527112|FG004|Post-treatment Period|Withdrawal by Subject|2|||
164360115|NCT00573755|593693189|FG000|Overall Study|Still receiving treatment|1|||
164360116|NCT00573755|593693190|FG001|Overall Study|Still receiving treatment|0|||
164360117|NCT02024867|593693191|FG000|Overall Study|Protocol Violation|3|||
164360118|NCT02024867|593693192|FG001|Overall Study|Protocol Violation|3|||
164360119|NCT02024867|593693191|FG000|Overall Study|Lost to Follow-up|6|||
164360120|NCT02024867|593693192|FG001|Overall Study|Lost to Follow-up|4|||
164360121|NCT02369341|593693194|FG000|Overall Study|Migrated/moved from study area|1|||
164698017|NCT03861481|594918715|FG000|Overall Study|Lack of Efficacy|4|||
164698018|NCT03861481|594918716|FG001|Overall Study|Lack of Efficacy|5|||
164698019|NCT00773734|594918717|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
164698020|NCT00773734|594918718|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
164360122|NCT02369341|593693195|FG001|Overall Study|Migrated/moved from study area|0|||
164360123|NCT00772707|593693198|FG000|Overall Study|Withdrawn|3|||
164360124|NCT01266460|593693200|FG000|Overall Study|Adverse Event|3|||
164360125|NCT01266460|593693200|FG000|Overall Study|Withdrawal by Subject|5|||
164360126|NCT01266460|593693200|FG000|Overall Study|Disease Progression|18|||
164360127|NCT01266460|593693200|FG000|Overall Study|Not otherwise specified|8|||
164360128|NCT01132547|593693201|FG000|Overall Study|Withdrawal by Subject|3|||
164360129|NCT01132547|593693202|FG001|Overall Study|Withdrawal by Subject|1|||
164360130|NCT01132547|593693201|FG000|Overall Study|Death|1|||
164360131|NCT01132547|593693202|FG001|Overall Study|Death|0|||
164360132|NCT05811234|593693203|FG000|Overall Study|Loss of Effectiveness|2|||
164360133|NCT05811234|593693203|FG000|Overall Study|Adverse Event|4|||
164360134|NCT05811234|593693203|FG000|Overall Study|Pregnancy|1|||
164360135|NCT05811234|593693203|FG000|Overall Study|Disease progression|1|||
164360136|NCT05811234|593693203|FG000|Overall Study|Withdrawal by Subject|4|||
164360137|NCT05811234|593693203|FG000|Overall Study|Lost to Follow-up|13|||
164360138|NCT05811234|593693203|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
164360139|NCT02710045|593693204|FG000|Overall Study|Death|1|||
164360140|NCT02710045|593693205|FG001|Overall Study|Death|2|||
164360141|NCT02710045|593693206|FG002|Overall Study|Death|0|||
164360142|NCT02710045|593693204|FG000|Overall Study|Withdrawal by Subject|6|||
164360143|NCT02710045|593693205|FG001|Overall Study|Withdrawal by Subject|6|||
164360144|NCT02710045|593693206|FG002|Overall Study|Withdrawal by Subject|2|||
164360145|NCT02710045|593693204|FG000|Overall Study|Protocol Violation|1|||
164360146|NCT02710045|593693205|FG001|Overall Study|Protocol Violation|2|||
164360147|NCT02710045|593693206|FG002|Overall Study|Protocol Violation|3|||
164360148|NCT02710045|593693204|FG000|Overall Study|Lost to Follow-up|3|||
164360149|NCT02710045|593693205|FG001|Overall Study|Lost to Follow-up|6|||
164360150|NCT02710045|593693206|FG002|Overall Study|Lost to Follow-up|7|||
164360151|NCT02710045|593693204|FG000|Overall Study|Physician Decision|0|||
164360152|NCT02710045|593693205|FG001|Overall Study|Physician Decision|0|||
164360153|NCT02710045|593693206|FG002|Overall Study|Physician Decision|1|||
164360154|NCT02710045|593693204|FG000|Overall Study|Poor Attendance|0|||
164360155|NCT02710045|593693205|FG001|Overall Study|Poor Attendance|1|||
164360156|NCT02710045|593693206|FG002|Overall Study|Poor Attendance|0|||
164360157|NCT00227305|593693207|FG000|Overall Study|Adverse Event|40|||
164360158|NCT00227305|593693207|FG000|Overall Study|Withdrawal by Subject|42|||
164360159|NCT00227305|593693207|FG000|Overall Study|Lost to Follow-up|33|||
164360160|NCT00227305|593693207|FG000|Overall Study|Study specific discontinuation|13|||
164360161|NCT00227305|593693207|FG000|Overall Study|MOVED OUT OF AREA|3|||
164360162|NCT00227305|593693207|FG000|Overall Study|Lack of Efficacy|7|||
164360163|NCT00227305|593693207|FG000|Overall Study|Physician Decision|3|||
164360164|NCT00227305|593693207|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
164360165|NCT00227305|593693207|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
164360166|NCT00227305|593693207|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
164360167|NCT00278109|593693211|FG000|Overall Study|Adverse Event|3|||
164360168|NCT00278109|593693211|FG000|Overall Study|social circumstances|1|||
164360169|NCT02580357|593693212|FG000|Overall Study|Lost to Follow-up|2|||
164360170|NCT02580357|593693213|FG001|Overall Study|Lost to Follow-up|0|||
164360171|NCT02580357|593693214|FG002|Overall Study|Lost to Follow-up|0|||
164360172|NCT02580357|593693212|FG000|Overall Study|Protocol Violation|1|||
164698021|NCT00773734|594918719|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
164698022|NCT00773734|594918720|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
164698023|NCT00773734|594918721|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
164698024|NCT00773734|594918722|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
164698025|NCT00773734|594918717|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
164698026|NCT00773734|594918718|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
164698027|NCT00773734|594918719|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
164698028|NCT00773734|594918720|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
164698029|NCT00773734|594918721|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
164698030|NCT00773734|594918722|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
164360173|NCT02580357|593693213|FG001|Overall Study|Protocol Violation|0|||
164360174|NCT02580357|593693214|FG002|Overall Study|Protocol Violation|0|||
164360175|NCT03424265|593693215|FG000|Overall Study|screening failure|1|||
164438421|NCT02503202|593970767|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
164360176|NCT03424265|593693216|FG001|Overall Study|screening failure|0|||
164360177|NCT03424265|593693215|FG000|Overall Study|Withdrawal by Subject|0|||
164360178|NCT03424265|593693216|FG001|Overall Study|Withdrawal by Subject|2|||
164360179|NCT01829230|593693217|FG000|Overall Study|Protocol Violation|0|||
164360180|NCT01829230|593693218|FG001|Overall Study|Protocol Violation|2|||
164360181|NCT01829230|593693217|FG000|Overall Study|Withdrawal by Subject|0|||
164360182|NCT01829230|593693218|FG001|Overall Study|Withdrawal by Subject|1|||
164698031|NCT00773734|594918717|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
164698032|NCT00773734|594918718|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
164698033|NCT00773734|594918719|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
164698034|NCT00773734|594918720|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
164360183|NCT01829230|593693217|FG000|Overall Study|Lost to Follow-up|1|||
164590796|NCT01808118|594527113|FG000|Period 1|Adverse Event|15|||
164590797|NCT01808118|594527114|FG001|Period 1|Adverse Event|0|||
164590798|NCT01808118|594527115|FG002|Period 1|Adverse Event|0|||
164590799|NCT01808118|594527113|FG000|Period 1|Withdrew consent|24|||
164590800|NCT01808118|594527114|FG001|Period 1|Withdrew consent|0|||
164590801|NCT01808118|594527115|FG002|Period 1|Withdrew consent|0|||
164590802|NCT01808118|594527113|FG000|Period 1|Lost to Follow-up|9|||
164698035|NCT00773734|594918721|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
164360184|NCT01829230|593693218|FG001|Overall Study|Lost to Follow-up|1|||
164360185|NCT04501666|593693221|FG000|Overall Study|Physician Decision|0|||
164360186|NCT04501666|593693222|FG001|Overall Study|Physician Decision|1|||
164360187|NCT04501666|593693221|FG000|Overall Study|Adverse Event|12|||
164360188|NCT04501666|593693222|FG001|Overall Study|Adverse Event|4|||
164360189|NCT04501666|593693221|FG000|Overall Study|Subject's request|10|||
164360190|NCT04501666|593693222|FG001|Overall Study|Subject's request|6|||
164360191|NCT04501666|593693221|FG000|Overall Study|Protocol Deviation|2|||
164360192|NCT04501666|593693222|FG001|Overall Study|Protocol Deviation|1|||
164360193|NCT04501666|593693221|FG000|Overall Study|Other-- site permanently closing|0|||
164360194|NCT04501666|593693222|FG001|Overall Study|Other-- site permanently closing|1|||
164360195|NCT03338855|593693223|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
164360196|NCT03338855|593693224|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
164360197|NCT03605303|593693232|FG000|Period 1|Study Terminated|2|||
164360198|NCT03605303|593693233|FG001|Period 1|Study Terminated|1|||
164360199|NCT00399360|593693234|FG000|Overall Study|Lost to Follow-up|2|||
164360200|NCT00399360|593693235|FG001|Overall Study|Lost to Follow-up|1|||
164360201|NCT00399360|593693236|FG002|Overall Study|Lost to Follow-up|2|||
164360202|NCT00399360|593693237|FG003|Overall Study|Lost to Follow-up|4|||
164360203|NCT00399360|593693234|FG000|Overall Study|Adverse Event|0|||
164360204|NCT00399360|593693235|FG001|Overall Study|Adverse Event|0|||
164360205|NCT00399360|593693236|FG002|Overall Study|Adverse Event|1|||
164360206|NCT00399360|593693237|FG003|Overall Study|Adverse Event|0|||
164360207|NCT00399360|593693234|FG000|Overall Study|Withdrawal by Subject|0|||
164360208|NCT00399360|593693235|FG001|Overall Study|Withdrawal by Subject|2|||
164360209|NCT00399360|593693236|FG002|Overall Study|Withdrawal by Subject|0|||
164360210|NCT00399360|593693237|FG003|Overall Study|Withdrawal by Subject|2|||
164360211|NCT01765153|593693238|FG000|Training Phase 1|Format of intervention differed|1|||
164360212|NCT01765153|593693239|FG001|Training Phase 1|Format of intervention differed|0|||
164360213|NCT01765153|593693238|FG000|Training Phase 1|Poor participation in intervention|0|||
164698036|NCT00773734|594918722|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
164698037|NCT00773734|594918717|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
164698038|NCT00773734|594918718|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
164698039|NCT00773734|594918719|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
164360214|NCT01765153|593693239|FG001|Training Phase 1|Poor participation in intervention|1|||
164360215|NCT01765153|593693238|FG000|Rest Phase 1|Withdrawal by Subject|0|||
164360216|NCT01765153|593693239|FG001|Rest Phase 1|Withdrawal by Subject|1|||
164438422|NCT02503202|593970763|FG000|Base Study: Up to Month 6|Physician Decision|0|||
164590803|NCT01808118|594527114|FG001|Period 1|Lost to Follow-up|0|||
164590804|NCT01808118|594527115|FG002|Period 1|Lost to Follow-up|0|||
164590805|NCT01808118|594527113|FG000|Period 1|Did not meet criteria for remission|303|||
164360217|NCT01765153|593693238|FG000|Training Phase 2|Withdrawal by Subject|0|||
164360218|NCT01765153|593693239|FG001|Training Phase 2|Withdrawal by Subject|1|||
164360219|NCT01765153|593693238|FG000|Rest Phase 2|Lost to Follow-up|2|||
164360220|NCT01765153|593693239|FG001|Rest Phase 2|Lost to Follow-up|1|||
164360221|NCT02663674|593693240|FG000|Overall Study|Lost to Follow-up|5|||
164360222|NCT02663674|593693241|FG001|Overall Study|Lost to Follow-up|4|||
164360223|NCT02663674|593693240|FG000|Overall Study|Withdrawal by Subject|1|||
164360224|NCT02663674|593693241|FG001|Overall Study|Withdrawal by Subject|4|||
164360225|NCT02663674|593693240|FG000|Overall Study|Physician Decision|1|||
164360226|NCT02663674|593693241|FG001|Overall Study|Physician Decision|1|||
164360227|NCT02663674|593693240|FG000|Overall Study|Other Event (Health Related)|0|||
164360228|NCT02663674|593693241|FG001|Overall Study|Other Event (Health Related)|1|||
164360229|NCT01386554|593693244|FG000|Overall Study|Lost to Follow-up|0|||
164360230|NCT01386554|593693245|FG001|Overall Study|Lost to Follow-up|0|||
164360231|NCT01386554|593693246|FG002|Overall Study|Lost to Follow-up|1|||
164360232|NCT01386554|593693244|FG000|Overall Study|Adverse Event|2|||
164360233|NCT01386554|593693245|FG001|Overall Study|Adverse Event|5|||
164360234|NCT01386554|593693246|FG002|Overall Study|Adverse Event|2|||
164360235|NCT01386554|593693244|FG000|Overall Study|Progressive disease|1|||
164360236|NCT01386554|593693245|FG001|Overall Study|Progressive disease|2|||
164360237|NCT01386554|593693246|FG002|Overall Study|Progressive disease|2|||
164360238|NCT01386554|593693244|FG000|Overall Study|Administration of live vaccines|0|||
164360239|NCT01386554|593693245|FG001|Overall Study|Administration of live vaccines|1|||
164360240|NCT01386554|593693246|FG002|Overall Study|Administration of live vaccines|0|||
164360241|NCT01386554|593693244|FG000|Overall Study|Investigator discretion|0|||
164360242|NCT01386554|593693245|FG001|Overall Study|Investigator discretion|0|||
164360243|NCT01386554|593693246|FG002|Overall Study|Investigator discretion|1|||
164360244|NCT01386554|593693244|FG000|Overall Study|Reason not collected|0|||
164360245|NCT01386554|593693245|FG001|Overall Study|Reason not collected|1|||
164360246|NCT01386554|593693246|FG002|Overall Study|Reason not collected|0|||
164360247|NCT00353262|593693247|FG000|Overall Study|Adverse Event|8|||
164360248|NCT00353262|593693247|FG000|Overall Study|Withdrawal by Subject|2|||
164360249|NCT00353262|593693247|FG000|Overall Study|Insufficient Therapeutic Response|13|||
164360250|NCT00353262|593693247|FG000|Overall Study|Progression|1|||
164360251|NCT00353262|593693247|FG000|Overall Study|Surgery|4|||
164360252|NCT00353262|593693247|FG000|Overall Study|Break from Chemotherapy|1|||
164360253|NCT04166513|593693248|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
164360254|NCT04166513|593693249|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
164360255|NCT04166513|593693250|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
164360256|NCT04166513|593693251|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
164360257|NCT04166513|593693248|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
164360258|NCT04166513|593693249|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
164360259|NCT04166513|593693250|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
164360260|NCT04166513|593693251|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
164360261|NCT04166513|593693248|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
164360262|NCT04166513|593693249|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
164360263|NCT04166513|593693250|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
164360264|NCT04166513|593693251|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
164360265|NCT04166513|593693248|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
164360266|NCT04166513|593693249|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
164360267|NCT04166513|593693250|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
164360268|NCT04166513|593693251|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
164360269|NCT04166513|593693248|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
164360270|NCT04166513|593693249|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
164360271|NCT04166513|593693250|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
164360272|NCT04166513|593693251|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
164360273|NCT05286307|593693252|FG000|Overall Study|Incomplete outcome assessments|2|||
164360274|NCT05286307|593693253|FG001|Overall Study|Incomplete outcome assessments|1|||
164360275|NCT05286307|593693252|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
164360276|NCT05286307|593693253|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
164360277|NCT05286307|593693252|FG000|Overall Study|Lost to follow up at 6 months|25|||
164360278|NCT05286307|593693253|FG001|Overall Study|Lost to follow up at 6 months|35|||
164360279|NCT05286307|593693252|FG000|Overall Study|Study medication not available|1|||
164360280|NCT05286307|593693253|FG001|Overall Study|Study medication not available|1|||
164360281|NCT02489344|593694623|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
164360282|NCT02489344|593694623|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
164360283|NCT02489344|593694623|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
164360284|NCT02489344|593694623|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
164360285|NCT01132482|593694624|FG000|Overall Study|Adverse Event|1|||
164360286|NCT01132482|593694625|FG001|Overall Study|Adverse Event|0|||
164360287|NCT04499781|593694626|FG000|Overall Study|Lost to Follow-up|2|||
164360288|NCT04499781|593694627|FG001|Overall Study|Lost to Follow-up|3|||
164360289|NCT04499781|593694626|FG000|Overall Study|Withdrawal by Subject|2|||
164360290|NCT04499781|593694627|FG001|Overall Study|Withdrawal by Subject|0|||
164360291|NCT04105998|593694635|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
164360292|NCT04105998|593694636|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
164360293|NCT00613015|593694640|FG000|Overall Study|Lost to Follow-up|0|||
164360294|NCT00613015|593694641|FG001|Overall Study|Lost to Follow-up|1|||
164360295|NCT00613015|593694642|FG002|Overall Study|Lost to Follow-up|3|||
164360296|NCT00613015|593694643|FG003|Overall Study|Lost to Follow-up|3|||
164360297|NCT00613015|593694644|FG004|Overall Study|Lost to Follow-up|2|||
164360298|NCT00613015|593694645|FG005|Overall Study|Lost to Follow-up|3|||
164360299|NCT00071760|593694648|FG000|Overall Study|Adverse Event|2|||
164360300|NCT00071760|593694649|FG001|Overall Study|Adverse Event|1|||
164360301|NCT00071760|593694648|FG000|Overall Study|Lost to Follow-up|0|||
164360302|NCT00071760|593694649|FG001|Overall Study|Lost to Follow-up|3|||
164360303|NCT00071760|593694648|FG000|Overall Study|Protocol Violation|1|||
164360304|NCT00071760|593694649|FG001|Overall Study|Protocol Violation|0|||
164360305|NCT00071760|593694648|FG000|Overall Study|Withdrawal by Subject|0|||
164360306|NCT00071760|593694649|FG001|Overall Study|Withdrawal by Subject|1|||
164360307|NCT00071760|593694648|FG000|Overall Study|Insufficient Viral Load Response|1|||
164360308|NCT00071760|593694649|FG001|Overall Study|Insufficient Viral Load Response|1|||
164360309|NCT00071760|593694648|FG000|Overall Study|Lack of availability of RTV|1|||
164360310|NCT00071760|593694649|FG001|Overall Study|Lack of availability of RTV|0|||
164360311|NCT00071760|593694648|FG000|Overall Study|Physician Decision|2|||
164360312|NCT00071760|593694649|FG001|Overall Study|Physician Decision|1|||
164360313|NCT00071760|593694648|FG000|Overall Study|Relocation|0|||
164360314|NCT00071760|593694649|FG001|Overall Study|Relocation|1|||
164360315|NCT02073279|593694650|FG000|Double-blind Period|Adverse Event|1|||
164360316|NCT02073279|593694651|FG001|Double-blind Period|Adverse Event|1|||
164360317|NCT02073279|593694650|FG000|Double-blind Period|Switched to another treatment|1|||
164360318|NCT02073279|593694651|FG001|Double-blind Period|Switched to another treatment|2|||
164360319|NCT02073279|593694650|FG000|Double-blind Period|Protocol Violation|0|||
164360320|NCT02073279|593694651|FG001|Double-blind Period|Protocol Violation|1|||
164360321|NCT02073279|593694650|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
164360322|NCT02073279|593694651|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
164360323|NCT02073279|593694650|FG000|Double-blind Period|Withdrawal by Subject|2|||
164360324|NCT02073279|593694651|FG001|Double-blind Period|Withdrawal by Subject|2|||
164360325|NCT02073279|593694650|FG000|Open-label Extension Period|Adverse Event|1|||
164360326|NCT02073279|593694651|FG001|Open-label Extension Period|Adverse Event|0|||
164360327|NCT02073279|593694650|FG000|Open-label Extension Period|Lack of Efficacy|1|||
164360328|NCT02073279|593694651|FG001|Open-label Extension Period|Lack of Efficacy|0|||
164360329|NCT02073279|593694650|FG000|Open-label Extension Period|Lost to Follow-up|0|||
164360330|NCT02073279|593694651|FG001|Open-label Extension Period|Lost to Follow-up|4|||
164360331|NCT02073279|593694650|FG000|Open-label Extension Period|Switched to another treatment|1|||
164360332|NCT02073279|593694651|FG001|Open-label Extension Period|Switched to another treatment|4|||
164360333|NCT02073279|593694650|FG000|Open-label Extension Period|Protocol Violation|0|||
164360334|NCT02073279|593694651|FG001|Open-label Extension Period|Protocol Violation|1|||
164360335|NCT02073279|593694650|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
164360336|NCT02073279|593694651|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
164360337|NCT02073279|593694650|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
164360338|NCT02073279|593694651|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
164360339|NCT01994629|593694652|FG000|Overall Study|Withdrawal by Subject|1|||
164360340|NCT01994629|593694653|FG001|Overall Study|Withdrawal by Subject|0|||
164360341|NCT01994629|593694652|FG000|Overall Study|Lost to Follow-up|0|||
164360342|NCT01994629|593694653|FG001|Overall Study|Lost to Follow-up|3|||
164360343|NCT03338062|593694656|FG000|Overall Study|Alternative Therapy|1|||
164360344|NCT03338062|593694657|FG001|Overall Study|Alternative Therapy|0|||
164360345|NCT04340362|593694659|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
164360346|NCT02375113|593694663|FG000|Overall Study|Undisclosed Reason(s).|1|||
164360347|NCT02375113|593694664|FG001|Overall Study|Undisclosed Reason(s).|1|||
164360348|NCT02375113|593694663|FG000|Overall Study|Poor adherence (<70%).|1|||
164360349|NCT02375113|593694664|FG001|Overall Study|Poor adherence (<70%).|0|||
164360350|NCT02375113|593694663|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
164360351|NCT02375113|593694664|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
164360352|NCT01214629|593694665|FG000|Overall Study|Progressive Disease|1|||
164360353|NCT01214629|593694666|FG001|Overall Study|Progressive Disease|1|||
164360354|NCT01214629|593694667|FG002|Overall Study|Progressive Disease|0|||
164360355|NCT01214629|593694668|FG003|Overall Study|Progressive Disease|1|||
164360356|NCT01214629|593694669|FG004|Overall Study|Progressive Disease|2|||
164360357|NCT01214629|593694670|FG005|Overall Study|Progressive Disease|3|||
164360358|NCT01214629|593694671|FG006|Overall Study|Progressive Disease|1|||
164360359|NCT01214629|593694672|FG007|Overall Study|Progressive Disease|1|||
164360360|NCT01214629|593694673|FG008|Overall Study|Progressive Disease|1|||
164360361|NCT01214629|593694674|FG009|Overall Study|Progressive Disease|5|||
164438423|NCT02503202|593970764|FG001|Base Study: Up to Month 6|Physician Decision|0|||
164438424|NCT02503202|593970765|FG002|Base Study: Up to Month 6|Physician Decision|0|||
164438425|NCT02503202|593970766|FG003|Base Study: Up to Month 6|Physician Decision|0|||
164438426|NCT02503202|593970767|FG004|Base Study: Up to Month 6|Physician Decision|1|||
164438427|NCT02503202|593970763|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
164438428|NCT02503202|593970764|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
164438429|NCT02503202|593970765|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
164438430|NCT02503202|593970766|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
164438431|NCT02503202|593970767|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
164438432|NCT02503202|593970763|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
164438433|NCT02503202|593970764|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
164438434|NCT02503202|593970765|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
164438435|NCT02503202|593970766|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
164438436|NCT02503202|593970767|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
164438437|NCT02503202|593970763|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
164438438|NCT02503202|593970764|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
164438439|NCT02503202|593970765|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
164438440|NCT02503202|593970766|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
164438441|NCT02503202|593970767|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
164438442|NCT02503202|593970763|FG000|Extension: Month 6 to 24|Death|1|||
164438443|NCT02503202|593970764|FG001|Extension: Month 6 to 24|Death|0|||
164360362|NCT01214629|593694675|FG010|Overall Study|Progressive Disease|1|||
164360363|NCT01214629|593694665|FG000|Overall Study|Adverse Event|0|||
164360364|NCT01214629|593694666|FG001|Overall Study|Adverse Event|0|||
164360365|NCT01214629|593694667|FG002|Overall Study|Adverse Event|0|||
164360366|NCT01214629|593694668|FG003|Overall Study|Adverse Event|1|||
164360367|NCT01214629|593694669|FG004|Overall Study|Adverse Event|0|||
164360368|NCT01214629|593694670|FG005|Overall Study|Adverse Event|1|||
164360369|NCT01214629|593694671|FG006|Overall Study|Adverse Event|0|||
164360370|NCT01214629|593694672|FG007|Overall Study|Adverse Event|0|||
164360371|NCT01214629|593694673|FG008|Overall Study|Adverse Event|0|||
164360372|NCT01214629|593694674|FG009|Overall Study|Adverse Event|1|||
164360373|NCT01214629|593694675|FG010|Overall Study|Adverse Event|0|||
164360374|NCT01214629|593694665|FG000|Overall Study|Physician Decision|0|||
164360375|NCT01214629|593694666|FG001|Overall Study|Physician Decision|0|||
164360376|NCT01214629|593694667|FG002|Overall Study|Physician Decision|0|||
164360377|NCT01214629|593694668|FG003|Overall Study|Physician Decision|0|||
164360378|NCT01214629|593694669|FG004|Overall Study|Physician Decision|0|||
164360379|NCT01214629|593694670|FG005|Overall Study|Physician Decision|0|||
164360380|NCT01214629|593694671|FG006|Overall Study|Physician Decision|0|||
164360381|NCT01214629|593694672|FG007|Overall Study|Physician Decision|0|||
164360382|NCT01214629|593694673|FG008|Overall Study|Physician Decision|0|||
164360383|NCT01214629|593694674|FG009|Overall Study|Physician Decision|0|||
164360384|NCT01214629|593694675|FG010|Overall Study|Physician Decision|1|||
164360385|NCT01214629|593694665|FG000|Overall Study|Withdrawal by Subject|0|||
164360386|NCT01214629|593694666|FG001|Overall Study|Withdrawal by Subject|0|||
164360387|NCT01214629|593694667|FG002|Overall Study|Withdrawal by Subject|0|||
164360388|NCT01214629|593694668|FG003|Overall Study|Withdrawal by Subject|0|||
164360389|NCT01214629|593694669|FG004|Overall Study|Withdrawal by Subject|0|||
164360390|NCT01214629|593694670|FG005|Overall Study|Withdrawal by Subject|0|||
164360391|NCT01214629|593694671|FG006|Overall Study|Withdrawal by Subject|0|||
164360392|NCT01214629|593694672|FG007|Overall Study|Withdrawal by Subject|0|||
164360393|NCT01214629|593694673|FG008|Overall Study|Withdrawal by Subject|0|||
164360394|NCT01214629|593694674|FG009|Overall Study|Withdrawal by Subject|1|||
164360395|NCT01214629|593694675|FG010|Overall Study|Withdrawal by Subject|0|||
164438444|NCT02503202|593970765|FG002|Extension: Month 6 to 24|Death|0|||
164438445|NCT02503202|593970766|FG003|Extension: Month 6 to 24|Death|0|||
164438446|NCT02503202|593970767|FG004|Extension: Month 6 to 24|Death|0|||
164438447|NCT02503202|593970763|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
164438448|NCT02503202|593970764|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
164438449|NCT02503202|593970765|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
164438450|NCT02503202|593970766|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
164438451|NCT02503202|593970767|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
164438452|NCT02503202|593970763|FG000|Extension: Month 6 to 24|Physician Decision|1|||
164438453|NCT02503202|593970764|FG001|Extension: Month 6 to 24|Physician Decision|0|||
164360396|NCT00877383|593694678|FG000|Overall Study|Adverse Event|13|||
164360397|NCT00877383|593694679|FG001|Overall Study|Adverse Event|14|||
164438454|NCT02503202|593970765|FG002|Extension: Month 6 to 24|Physician Decision|1|||
164438455|NCT02503202|593970766|FG003|Extension: Month 6 to 24|Physician Decision|3|||
164438456|NCT02503202|593970767|FG004|Extension: Month 6 to 24|Physician Decision|0|||
164360398|NCT00877383|593694678|FG000|Overall Study|Lost to Follow-up|5|||
164360399|NCT00877383|593694679|FG001|Overall Study|Lost to Follow-up|3|||
164360400|NCT00877383|593694678|FG000|Overall Study|Subject withdrew consent|3|||
164360401|NCT00877383|593694679|FG001|Overall Study|Subject withdrew consent|12|||
164360402|NCT00877383|593694678|FG000|Overall Study|Subject no longer requires study drug|2|||
164360403|NCT00877383|593694679|FG001|Overall Study|Subject no longer requires study drug|0|||
164698040|NCT00773734|594918720|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
164698041|NCT00773734|594918721|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
164698042|NCT00773734|594918722|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
164698043|NCT00773734|594918717|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
164698044|NCT00773734|594918718|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
164698045|NCT00773734|594918719|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
164360404|NCT00877383|593694678|FG000|Overall Study|Administrative problems|2|||
164360405|NCT00877383|593694679|FG001|Overall Study|Administrative problems|0|||
164360406|NCT00877383|593694678|FG000|Overall Study|Protocol deviation|2|||
164360407|NCT00877383|593694679|FG001|Overall Study|Protocol deviation|6|||
164360408|NCT00877383|593694678|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164360409|NCT00877383|593694679|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164360410|NCT00877383|593694678|FG000|Overall Study|Death|1|||
164360411|NCT00877383|593694679|FG001|Overall Study|Death|2|||
164360412|NCT00459108|593694681|FG000|Overall Study|Withdrawal by Subject|5|||
164360413|NCT00459108|593694681|FG000|Overall Study|Adverse Event|3|||
164360414|NCT00459108|593694681|FG000|Overall Study|Death|2|||
164360415|NCT00459108|593694681|FG000|Overall Study|Progression|1|||
164360416|NCT04387435|593694690|FG000|Overall Study|Physician Decision|1|||
164360417|NCT00391274|593694693|FG000|Overall Study|Death Due to Study Disease|55|||
164360418|NCT00391274|593694694|FG001|Overall Study|Death Due to Study Disease|45|||
164360419|NCT00391274|593694693|FG000|Overall Study|Lost to Follow-up|0|||
164360420|NCT00391274|593694694|FG001|Overall Study|Lost to Follow-up|3|||
164360421|NCT00391274|593694693|FG000|Overall Study|Physician Decision|4|||
164360422|NCT00391274|593694694|FG001|Overall Study|Physician Decision|2|||
164360423|NCT00391274|593694693|FG000|Overall Study|Withdrawal by Subject|0|||
164360424|NCT00391274|593694694|FG001|Overall Study|Withdrawal by Subject|3|||
164360425|NCT00391274|593694693|FG000|Overall Study|Death Due to Adverse Event|1|||
164360426|NCT00391274|593694694|FG001|Overall Study|Death Due to Adverse Event|3|||
164360427|NCT00391274|593694693|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
164360428|NCT00391274|593694694|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
164360429|NCT00391274|593694693|FG000|Overall Study|Death Not Study Related|0|||
164360430|NCT00391274|593694694|FG001|Overall Study|Death Not Study Related|1|||
164360431|NCT00642941|593694696|FG000|Overall Study|Physician Decision|3|||
164360432|NCT00642941|593694697|FG001|Overall Study|Physician Decision|1|||
164360433|NCT00642941|593694698|FG002|Overall Study|Physician Decision|0|||
164360434|NCT00642941|593694699|FG003|Overall Study|Physician Decision|0|||
164360435|NCT00642941|593694700|FG004|Overall Study|Physician Decision|0|||
164360436|NCT00642941|593694701|FG005|Overall Study|Physician Decision|0|||
164360437|NCT00642941|593694702|FG006|Overall Study|Physician Decision|1|||
164360438|NCT00642941|593694703|FG007|Overall Study|Physician Decision|0|||
164360439|NCT00642941|593694704|FG008|Overall Study|Physician Decision|0|||
164360440|NCT00642941|593694705|FG009|Overall Study|Physician Decision|1|||
164360441|NCT00642941|593694706|FG010|Overall Study|Physician Decision|0|||
164360442|NCT00642941|593694707|FG011|Overall Study|Physician Decision|1|||
164360443|NCT00642941|593694696|FG000|Overall Study|Death|4|||
164360444|NCT00642941|593694697|FG001|Overall Study|Death|0|||
164360445|NCT00642941|593694698|FG002|Overall Study|Death|1|||
164360446|NCT00642941|593694699|FG003|Overall Study|Death|1|||
164360447|NCT00642941|593694700|FG004|Overall Study|Death|2|||
164360448|NCT00642941|593694701|FG005|Overall Study|Death|1|||
164360449|NCT00642941|593694702|FG006|Overall Study|Death|0|||
164360450|NCT00642941|593694703|FG007|Overall Study|Death|0|||
164360451|NCT00642941|593694704|FG008|Overall Study|Death|0|||
164360452|NCT00642941|593694705|FG009|Overall Study|Death|0|||
164360453|NCT00642941|593694706|FG010|Overall Study|Death|0|||
164360454|NCT00642941|593694707|FG011|Overall Study|Death|1|||
164360455|NCT00642941|593694696|FG000|Overall Study|Study closed by Sponsor|0|||
164360456|NCT00642941|593694697|FG001|Overall Study|Study closed by Sponsor|1|||
164360457|NCT00642941|593694698|FG002|Overall Study|Study closed by Sponsor|0|||
164360458|NCT00642941|593694699|FG003|Overall Study|Study closed by Sponsor|0|||
164360459|NCT00642941|593694700|FG004|Overall Study|Study closed by Sponsor|0|||
164360460|NCT00642941|593694701|FG005|Overall Study|Study closed by Sponsor|0|||
164360461|NCT00642941|593694702|FG006|Overall Study|Study closed by Sponsor|0|||
164360462|NCT00642941|593694703|FG007|Overall Study|Study closed by Sponsor|0|||
164360463|NCT00642941|593694704|FG008|Overall Study|Study closed by Sponsor|0|||
164360464|NCT00642941|593694705|FG009|Overall Study|Study closed by Sponsor|0|||
164360465|NCT00642941|593694706|FG010|Overall Study|Study closed by Sponsor|0|||
164360466|NCT00642941|593694707|FG011|Overall Study|Study closed by Sponsor|0|||
164360467|NCT00642941|593694696|FG000|Overall Study|Withdrawal by Subject|1|||
164360468|NCT00642941|593694697|FG001|Overall Study|Withdrawal by Subject|0|||
164360469|NCT00642941|593694698|FG002|Overall Study|Withdrawal by Subject|0|||
164360470|NCT00642941|593694699|FG003|Overall Study|Withdrawal by Subject|2|||
164360471|NCT00642941|593694700|FG004|Overall Study|Withdrawal by Subject|0|||
164360472|NCT00642941|593694701|FG005|Overall Study|Withdrawal by Subject|0|||
164438457|NCT02503202|593970763|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
164438458|NCT02503202|593970764|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
164360473|NCT00642941|593694702|FG006|Overall Study|Withdrawal by Subject|2|||
164360474|NCT00642941|593694703|FG007|Overall Study|Withdrawal by Subject|0|||
164360475|NCT00642941|593694704|FG008|Overall Study|Withdrawal by Subject|1|||
164360476|NCT00642941|593694705|FG009|Overall Study|Withdrawal by Subject|0|||
164360477|NCT00642941|593694706|FG010|Overall Study|Withdrawal by Subject|0|||
164360478|NCT00642941|593694707|FG011|Overall Study|Withdrawal by Subject|1|||
164438459|NCT02503202|593970765|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
164438460|NCT02503202|593970766|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
164360479|NCT00642941|593694696|FG000|Overall Study|Protocol Violation|0|||
164360480|NCT00642941|593694697|FG001|Overall Study|Protocol Violation|0|||
164360481|NCT00642941|593694698|FG002|Overall Study|Protocol Violation|0|||
164360482|NCT00642941|593694699|FG003|Overall Study|Protocol Violation|0|||
164360483|NCT00642941|593694700|FG004|Overall Study|Protocol Violation|0|||
164360484|NCT00642941|593694701|FG005|Overall Study|Protocol Violation|0|||
164360485|NCT00642941|593694702|FG006|Overall Study|Protocol Violation|1|||
164360486|NCT00642941|593694703|FG007|Overall Study|Protocol Violation|0|||
164360487|NCT00642941|593694704|FG008|Overall Study|Protocol Violation|0|||
164360488|NCT00642941|593694705|FG009|Overall Study|Protocol Violation|0|||
164360489|NCT00642941|593694706|FG010|Overall Study|Protocol Violation|0|||
164360490|NCT00642941|593694707|FG011|Overall Study|Protocol Violation|0|||
164360491|NCT00642941|593694696|FG000|Overall Study|Adverse Event|1|||
164360492|NCT00642941|593694697|FG001|Overall Study|Adverse Event|1|||
164360493|NCT00642941|593694698|FG002|Overall Study|Adverse Event|0|||
164360494|NCT00642941|593694699|FG003|Overall Study|Adverse Event|0|||
164360495|NCT00642941|593694700|FG004|Overall Study|Adverse Event|0|||
164360496|NCT00642941|593694701|FG005|Overall Study|Adverse Event|0|||
164360497|NCT00642941|593694702|FG006|Overall Study|Adverse Event|1|||
164360498|NCT00642941|593694703|FG007|Overall Study|Adverse Event|1|||
164360499|NCT00642941|593694704|FG008|Overall Study|Adverse Event|0|||
164360500|NCT00642941|593694705|FG009|Overall Study|Adverse Event|1|||
164360501|NCT00642941|593694706|FG010|Overall Study|Adverse Event|0|||
164360502|NCT00642941|593694707|FG011|Overall Study|Adverse Event|0|||
164360503|NCT00642941|593694696|FG000|Overall Study|Other|1|||
164360504|NCT00642941|593694697|FG001|Overall Study|Other|1|||
164360505|NCT00642941|593694698|FG002|Overall Study|Other|1|||
164360506|NCT00642941|593694699|FG003|Overall Study|Other|1|||
164360507|NCT00642941|593694700|FG004|Overall Study|Other|0|||
164360508|NCT00642941|593694701|FG005|Overall Study|Other|1|||
164360509|NCT00642941|593694702|FG006|Overall Study|Other|0|||
164360510|NCT00642941|593694703|FG007|Overall Study|Other|1|||
164360511|NCT00642941|593694704|FG008|Overall Study|Other|0|||
164360512|NCT00642941|593694705|FG009|Overall Study|Other|0|||
164360513|NCT00642941|593694706|FG010|Overall Study|Other|0|||
164360514|NCT00642941|593694707|FG011|Overall Study|Other|1|||
164360515|NCT00642941|593694696|FG000|Overall Study|Disease progression|60|||
164360516|NCT00642941|593694697|FG001|Overall Study|Disease progression|50|||
164360517|NCT00642941|593694698|FG002|Overall Study|Disease progression|5|||
164360518|NCT00642941|593694699|FG003|Overall Study|Disease progression|36|||
164360519|NCT00642941|593694700|FG004|Overall Study|Disease progression|23|||
164360520|NCT00642941|593694701|FG005|Overall Study|Disease progression|39|||
164360521|NCT00642941|593694702|FG006|Overall Study|Disease progression|18|||
164360522|NCT00642941|593694703|FG007|Overall Study|Disease progression|12|||
164360523|NCT00642941|593694704|FG008|Overall Study|Disease progression|10|||
164360524|NCT00642941|593694705|FG009|Overall Study|Disease progression|7|||
164360525|NCT00642941|593694706|FG010|Overall Study|Disease progression|12|||
164360526|NCT00642941|593694707|FG011|Overall Study|Disease progression|7|||
164438461|NCT02503202|593970767|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
164438462|NCT01119950|593970768|FG000|Overall Study|Adverse Event|25|||
164438463|NCT01119950|593970768|FG000|Overall Study|Withdrawal by Subject|9|||
164360527|NCT03051607|593694709|FG000|Overall Study|Adverse Event|66|||
164360528|NCT01505868|593694710|FG000|Overall Study|Withdrawal by Subject|1|||
164360529|NCT01505868|593694711|FG001|Overall Study|Withdrawal by Subject|0|||
164360530|NCT01505868|593694712|FG002|Overall Study|Withdrawal by Subject|0|||
164360531|NCT01505868|593694713|FG003|Overall Study|Withdrawal by Subject|0|||
164360532|NCT01505868|593694714|FG004|Overall Study|Withdrawal by Subject|0|||
164360533|NCT00894322|593694715|FG000|Overall Study|Withdrawal by Subject|1|||
164360534|NCT00894322|593694716|FG001|Overall Study|Withdrawal by Subject|0|||
164360535|NCT00894322|593694717|FG002|Overall Study|Withdrawal by Subject|0|||
164360536|NCT02626520|593694727|FG000|Overall Study|Physician Decision|1|||
164360537|NCT02626520|593694728|FG001|Overall Study|Physician Decision|1|||
164360538|NCT02626520|593694727|FG000|Overall Study|Adverse Event|0|||
164360539|NCT02626520|593694728|FG001|Overall Study|Adverse Event|4|||
164360540|NCT02626520|593694727|FG000|Overall Study|Lack of Efficacy|0|||
164360541|NCT02626520|593694728|FG001|Overall Study|Lack of Efficacy|2|||
164360542|NCT02626520|593694727|FG000|Overall Study|Did not start protocol therapy|0|||
164360543|NCT02626520|593694728|FG001|Overall Study|Did not start protocol therapy|2|||
164360544|NCT02626520|593694727|FG000|Overall Study|Study terminated|0|||
164360545|NCT02626520|593694728|FG001|Overall Study|Study terminated|1|||
164360546|NCT00535223|593694729|FG000|Overall Study|Withdrawal by Subject|4|||
164360547|NCT00535223|593694730|FG001|Overall Study|Withdrawal by Subject|1|||
164360548|NCT02953314|593694731|FG000|Overall Study|Adverse Event|0|||
164360549|NCT02953314|593694732|FG001|Overall Study|Adverse Event|1|||
164360550|NCT02953314|593694731|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
164360551|NCT02953314|593694732|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
164360552|NCT01288287|593694733|FG000|Overall Study|Lost to Follow-up|8|||
164360553|NCT01288287|593694733|FG000|Overall Study|Withdrawal by Subject|4|||
164360554|NCT01288287|593694733|FG000|Overall Study|Lack of Efficacy|13|||
164360555|NCT01288287|593694733|FG000|Overall Study|Other Reason|13|||
164360556|NCT01288287|593694733|FG000|Overall Study|Unknown Reason|1|||
164360557|NCT01288287|593694733|FG000|Overall Study|Unknown Status|7|||
164360558|NCT00238121|593694739|FG000|Overall Study|Withdrawal by Subject|1|||
164360559|NCT00238121|593694740|FG001|Overall Study|Withdrawal by Subject|1|||
164360560|NCT00238121|593694739|FG000|Overall Study|Adverse Event|2|||
164360561|NCT00238121|593694740|FG001|Overall Study|Adverse Event|1|||
164360562|NCT02221284|593694741|FG000|Overall Study|Case Report Forms Uncollected|56|||
164360563|NCT02221284|593694741|FG000|Overall Study|Protocol Deviation|5|||
164360564|NCT00101907|593694743|FG000|Overall Study|Adverse Event|1|||
164360565|NCT00101907|593694744|FG001|Overall Study|Adverse Event|0|||
164360566|NCT00101907|593694745|FG002|Overall Study|Adverse Event|0|||
164360567|NCT00101907|593694746|FG003|Overall Study|Adverse Event|0|||
164360568|NCT00101907|593694747|FG004|Overall Study|Adverse Event|0|||
164360569|NCT00101907|593694748|FG005|Overall Study|Adverse Event|0|||
164360570|NCT00101907|593694743|FG000|Overall Study|Death|0|||
164360571|NCT00101907|593694744|FG001|Overall Study|Death|1|||
164360572|NCT00101907|593694745|FG002|Overall Study|Death|0|||
164360573|NCT00101907|593694746|FG003|Overall Study|Death|0|||
164360574|NCT00101907|593694747|FG004|Overall Study|Death|3|||
164360575|NCT00101907|593694748|FG005|Overall Study|Death|0|||
164360576|NCT00101907|593694743|FG000|Overall Study|Physician Decision|0|||
164360577|NCT00101907|593694744|FG001|Overall Study|Physician Decision|0|||
164360578|NCT00101907|593694745|FG002|Overall Study|Physician Decision|0|||
164360579|NCT00101907|593694746|FG003|Overall Study|Physician Decision|1|||
164360580|NCT00101907|593694747|FG004|Overall Study|Physician Decision|1|||
164360581|NCT00101907|593694748|FG005|Overall Study|Physician Decision|0|||
164360582|NCT00101907|593694743|FG000|Overall Study|Withdrawal by Subject|1|||
164360583|NCT00101907|593694744|FG001|Overall Study|Withdrawal by Subject|0|||
164360584|NCT00101907|593694745|FG002|Overall Study|Withdrawal by Subject|1|||
164360585|NCT00101907|593694746|FG003|Overall Study|Withdrawal by Subject|0|||
164360586|NCT00101907|593694747|FG004|Overall Study|Withdrawal by Subject|1|||
164360587|NCT00101907|593694748|FG005|Overall Study|Withdrawal by Subject|0|||
164360588|NCT01474876|593694751|FG000|Overall Study|Adverse Event|11|||
164360589|NCT01474876|593694752|FG001|Overall Study|Adverse Event|5|||
164360590|NCT01474876|593694753|FG002|Overall Study|Adverse Event|0|||
164360591|NCT01474876|593694751|FG000|Overall Study|Serious Adverse Event|2|||
164360592|NCT01474876|593694752|FG001|Overall Study|Serious Adverse Event|3|||
164360593|NCT01474876|593694753|FG002|Overall Study|Serious Adverse Event|0|||
164360594|NCT01474876|593694751|FG000|Overall Study|Lost to Follow-up|5|||
164360595|NCT01474876|593694752|FG001|Overall Study|Lost to Follow-up|4|||
164360596|NCT01474876|593694753|FG002|Overall Study|Lost to Follow-up|0|||
164360597|NCT01474876|593694751|FG000|Overall Study|Investigator's decision|28|||
164360598|NCT01474876|593694752|FG001|Overall Study|Investigator's decision|6|||
164360599|NCT01474876|593694753|FG002|Overall Study|Investigator's decision|0|||
164360600|NCT01474876|593694751|FG000|Overall Study|Patient's request|19|||
164360601|NCT01474876|593694752|FG001|Overall Study|Patient's request|5|||
164360602|NCT01474876|593694753|FG002|Overall Study|Patient's request|0|||
164360603|NCT01474876|593694751|FG000|Overall Study|Investigator's decision and pt request|1|||
164360604|NCT01474876|593694752|FG001|Overall Study|Investigator's decision and pt request|0|||
164360605|NCT01474876|593694753|FG002|Overall Study|Investigator's decision and pt request|0|||
164360606|NCT03839212|593694755|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
164360607|NCT00733746|593694756|FG000|Overall Study|Ineligible|5|||
164360608|NCT02113956|593694757|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
164590806|NCT01808118|594527114|FG001|Period 1|Did not meet criteria for remission|0|||
164590807|NCT01808118|594527115|FG002|Period 1|Did not meet criteria for remission|0|||
164590808|NCT01808118|594527113|FG000|Period 1|Enrolled in error|7|||
164360609|NCT02113956|593694758|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
164360610|NCT02113956|593694757|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
164360611|NCT02113956|593694758|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
164360612|NCT02113956|593694757|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
164360613|NCT02113956|593694758|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
164360614|NCT02472795|593694759|FG000|Overall Study|Adverse Event|0|||
164360615|NCT02472795|593694760|FG001|Overall Study|Adverse Event|1|||
164360616|NCT02472795|593694761|FG002|Overall Study|Adverse Event|0|||
164590809|NCT01808118|594527114|FG001|Period 1|Enrolled in error|0|||
164590810|NCT01808118|594527115|FG002|Period 1|Enrolled in error|0|||
164360617|NCT02472795|593694762|FG003|Overall Study|Adverse Event|0|||
164360618|NCT02472795|593694763|FG004|Overall Study|Adverse Event|2|||
164360619|NCT02472795|593694759|FG000|Overall Study|Withdrawal by Subject|0|||
164360620|NCT02472795|593694760|FG001|Overall Study|Withdrawal by Subject|0|||
164360621|NCT02472795|593694761|FG002|Overall Study|Withdrawal by Subject|0|||
164360622|NCT02472795|593694762|FG003|Overall Study|Withdrawal by Subject|0|||
164360623|NCT02472795|593694763|FG004|Overall Study|Withdrawal by Subject|1|||
164360624|NCT04318080|593697109|FG000|Overall Study|Study closed by sponsor|10|||
164360625|NCT04318080|593697110|FG001|Overall Study|Study closed by sponsor|22|||
164360626|NCT04318080|593697109|FG000|Overall Study|Death|3|||
164360627|NCT04318080|593697110|FG001|Overall Study|Death|9|||
164360628|NCT04318080|593697109|FG000|Overall Study|Withdrawal by Subject|1|||
164360629|NCT04318080|593697110|FG001|Overall Study|Withdrawal by Subject|0|||
164360630|NCT04318080|593697109|FG000|Overall Study|Protocol Deviation|1|||
164360631|NCT04318080|593697110|FG001|Overall Study|Protocol Deviation|0|||
164360632|NCT06308822|593697111|FG000|Overall Study|Mutation Status Not Confirmed|17|||
164360633|NCT06308822|593697111|FG000|Overall Study|Adverse Event|1|||
164360634|NCT06308822|593697111|FG000|Overall Study|Death|5|||
164360635|NCT06308822|593697111|FG000|Overall Study|Disease progression|8|||
164360636|NCT06308822|593697111|FG000|Overall Study|Withdrawal by Subject|1|||
164360637|NCT06308822|593697111|FG000|Overall Study|Physician Decision|3|||
164360638|NCT02926924|593697112|FG000|Overall Study|withdrawal - reason unknown|0|||
164360639|NCT02926924|593697113|FG001|Overall Study|withdrawal - reason unknown|1|||
164360640|NCT01536379|593697114|FG000|Overall Study|Adverse Event|1|||
164360641|NCT01536379|593697115|FG001|Overall Study|Adverse Event|2|||
164360642|NCT01536379|593697114|FG000|Overall Study|Withdrawal by Subject|1|||
164360643|NCT01536379|593697115|FG001|Overall Study|Withdrawal by Subject|1|||
164360644|NCT04734652|593697128|FG000|Overall Study|Withdrawal by Subject|2|||
164360645|NCT04734652|593697129|FG001|Overall Study|Withdrawal by Subject|0|||
164360646|NCT04734652|593697128|FG000|Overall Study|Death|0|||
164360647|NCT04734652|593697129|FG001|Overall Study|Death|1|||
164360648|NCT04146545|593697132|FG000|Overall Study|deemed ineligible after randomization|1|||
164360649|NCT04146545|593697133|FG001|Overall Study|deemed ineligible after randomization|0|||
164360650|NCT04729127|593697134|FG000|Overall Study|Suspended/Terminated EI Services|4|||
164360651|NCT04729127|593697135|FG001|Overall Study|Suspended/Terminated EI Services|0|||
164360652|NCT04729127|593697136|FG002|Overall Study|Suspended/Terminated EI Services|4|||
164360653|NCT04729127|593697137|FG003|Overall Study|Suspended/Terminated EI Services|6|||
164360654|NCT04729127|593697138|FG004|Overall Study|Suspended/Terminated EI Services|0|||
164360655|NCT04729127|593697139|FG005|Overall Study|Suspended/Terminated EI Services|6|||
164360656|NCT04729127|593697140|FG006|Overall Study|Suspended/Terminated EI Services|2|||
164360657|NCT04729127|593697141|FG007|Overall Study|Suspended/Terminated EI Services|0|||
164360658|NCT04729127|593697142|FG008|Overall Study|Suspended/Terminated EI Services|2|||
164360659|NCT04729127|593697134|FG000|Overall Study|Withdrawal by Subject|1|||
164360660|NCT04729127|593697135|FG001|Overall Study|Withdrawal by Subject|0|||
164360661|NCT04729127|593697136|FG002|Overall Study|Withdrawal by Subject|1|||
164360662|NCT04729127|593697137|FG003|Overall Study|Withdrawal by Subject|0|||
164360663|NCT04729127|593697138|FG004|Overall Study|Withdrawal by Subject|0|||
164360664|NCT04729127|593697139|FG005|Overall Study|Withdrawal by Subject|0|||
164360665|NCT04729127|593697140|FG006|Overall Study|Withdrawal by Subject|0|||
164360666|NCT04729127|593697141|FG007|Overall Study|Withdrawal by Subject|0|||
164360667|NCT04729127|593697142|FG008|Overall Study|Withdrawal by Subject|0|||
164360668|NCT04729127|593697134|FG000|Overall Study|Switched Agency/Setting|1|||
164360669|NCT04729127|593697135|FG001|Overall Study|Switched Agency/Setting|0|||
164360670|NCT04729127|593697136|FG002|Overall Study|Switched Agency/Setting|1|||
164360671|NCT04729127|593697137|FG003|Overall Study|Switched Agency/Setting|1|||
164360672|NCT04729127|593697138|FG004|Overall Study|Switched Agency/Setting|0|||
164360673|NCT04729127|593697139|FG005|Overall Study|Switched Agency/Setting|1|||
164360674|NCT04729127|593697140|FG006|Overall Study|Switched Agency/Setting|1|||
164360675|NCT04729127|593697141|FG007|Overall Study|Switched Agency/Setting|0|||
164360676|NCT04729127|593697142|FG008|Overall Study|Switched Agency/Setting|1|||
164360677|NCT01139450|593697145|FG000|Overall Study|Withdrawal by Subject|7|||
164360678|NCT01139450|593697146|FG001|Overall Study|Withdrawal by Subject|10|||
164360679|NCT01139450|593697147|FG002|Overall Study|Withdrawal by Subject|13|||
164360680|NCT01139450|593697145|FG000|Overall Study|Lack of Efficacy|3|||
164360681|NCT01139450|593697146|FG001|Overall Study|Lack of Efficacy|1|||
164360682|NCT01139450|593697147|FG002|Overall Study|Lack of Efficacy|8|||
164360683|NCT01139450|593697145|FG000|Overall Study|Protocol Violation|6|||
164360684|NCT01139450|593697146|FG001|Overall Study|Protocol Violation|5|||
164360685|NCT01139450|593697147|FG002|Overall Study|Protocol Violation|2|||
164360686|NCT01139450|593697145|FG000|Overall Study|Lost to Follow-up|9|||
164360687|NCT01139450|593697146|FG001|Overall Study|Lost to Follow-up|7|||
164360688|NCT01139450|593697147|FG002|Overall Study|Lost to Follow-up|11|||
164360689|NCT01139450|593697145|FG000|Overall Study|Administrative|0|||
164360690|NCT01139450|593697146|FG001|Overall Study|Administrative|0|||
164360691|NCT01139450|593697147|FG002|Overall Study|Administrative|1|||
164360692|NCT01139450|593697145|FG000|Overall Study|Adverse Event|2|||
164360693|NCT01139450|593697146|FG001|Overall Study|Adverse Event|2|||
164698046|NCT00773734|594918720|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
164360694|NCT01139450|593697147|FG002|Overall Study|Adverse Event|3|||
164360695|NCT01277523|593697148|FG000|Overall Study|Adverse Event|1|||
164360696|NCT01277523|593697149|FG001|Overall Study|Adverse Event|0|||
164360697|NCT01277523|593697150|FG002|Overall Study|Adverse Event|0|||
164360698|NCT01277523|593697148|FG000|Overall Study|Protocol Violation|2|||
164360699|NCT01277523|593697149|FG001|Overall Study|Protocol Violation|0|||
164360700|NCT01277523|593697150|FG002|Overall Study|Protocol Violation|0|||
164360701|NCT01277523|593697148|FG000|Overall Study|Other Reason not Defined|0|||
164360702|NCT01277523|593697149|FG001|Overall Study|Other Reason not Defined|1|||
164698047|NCT00773734|594918721|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
164698048|NCT00773734|594918722|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
164698049|NCT00773734|594918717|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
164698050|NCT00773734|594918718|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
164698051|NCT00773734|594918719|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
164698052|NCT00773734|594918720|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
164698053|NCT00773734|594918721|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
164698054|NCT00773734|594918722|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
164698055|NCT00773734|594918717|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
164360703|NCT01277523|593697150|FG002|Overall Study|Other Reason not Defined|0|||
164360704|NCT03662542|593697155|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
164360705|NCT03662542|593697156|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
164360706|NCT03662542|593697157|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
164360707|NCT03662542|593697158|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
164360708|NCT03662542|593697159|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
164360709|NCT03662542|593697160|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
164360710|NCT03662542|593697161|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
164360711|NCT03662542|593697162|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
164360712|NCT03662542|593697163|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
164360713|NCT03662542|593697155|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
164360714|NCT03662542|593697156|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
164360715|NCT03662542|593697157|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
164360716|NCT03662542|593697158|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
164360717|NCT03662542|593697159|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
164360718|NCT03662542|593697160|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
164360719|NCT03662542|593697161|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
164360720|NCT03662542|593697162|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
164360721|NCT03662542|593697163|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
164360722|NCT03662542|593697155|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
164360723|NCT03662542|593697156|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
164360724|NCT03662542|593697157|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
164360725|NCT03662542|593697158|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
164360726|NCT03662542|593697159|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
164360727|NCT03662542|593697160|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
164360728|NCT03662542|593697161|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
164360729|NCT03662542|593697162|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
164360730|NCT03662542|593697163|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
164360731|NCT03662542|593697155|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
164360732|NCT03662542|593697156|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
164360733|NCT03662542|593697157|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
164360734|NCT03662542|593697158|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
164360735|NCT03662542|593697159|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
164360736|NCT03662542|593697160|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
164360737|NCT03662542|593697161|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
164360738|NCT03662542|593697162|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
164360739|NCT03662542|593697163|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
164360740|NCT03662542|593697155|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
164360741|NCT03662542|593697156|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
164360742|NCT03662542|593697157|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
164698056|NCT00773734|594918718|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
164698057|NCT00773734|594918719|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
164698058|NCT00773734|594918720|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
164698059|NCT00773734|594918721|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
164360743|NCT03662542|593697158|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
164360744|NCT03662542|593697159|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
164360745|NCT03662542|593697160|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
164360746|NCT03662542|593697161|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
164360747|NCT03662542|593697162|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
164360748|NCT03662542|593697163|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
164360749|NCT03662542|593697155|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
164360750|NCT03662542|593697156|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
164360751|NCT03662542|593697157|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
164360752|NCT03662542|593697158|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
164360753|NCT03662542|593697159|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
164360754|NCT03662542|593697160|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
164360755|NCT03662542|593697161|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
164360756|NCT03662542|593697162|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
164360757|NCT03662542|593697163|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
164360758|NCT03662542|593697155|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
164360759|NCT03662542|593697156|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
164360760|NCT03662542|593697157|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
164360761|NCT03662542|593697158|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
164360762|NCT03662542|593697159|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
164360763|NCT03662542|593697160|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
164360764|NCT03662542|593697161|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
164360765|NCT03662542|593697162|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
164360766|NCT03662542|593697163|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
164360767|NCT03662542|593697155|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
164360768|NCT03662542|593697156|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
164360769|NCT03662542|593697157|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
164360770|NCT03662542|593697158|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
164360771|NCT03662542|593697159|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
164360772|NCT03662542|593697160|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
164360773|NCT03662542|593697161|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
164360774|NCT03662542|593697162|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
164360775|NCT03662542|593697163|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
164360776|NCT03662542|593697155|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
164360777|NCT03662542|593697156|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
164360778|NCT03662542|593697157|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
164360779|NCT03662542|593697158|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
164360780|NCT03662542|593697159|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
164360781|NCT03662542|593697160|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
164360782|NCT03662542|593697161|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
164360783|NCT03662542|593697162|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
164360784|NCT03662542|593697163|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
164360785|NCT03662542|593697155|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
164360786|NCT03662542|593697156|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
164360787|NCT03662542|593697157|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
164360788|NCT03662542|593697158|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
164360789|NCT03662542|593697159|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
164360790|NCT03662542|593697160|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
164360791|NCT03662542|593697161|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
164360792|NCT03662542|593697162|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
164360793|NCT03662542|593697163|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
164360794|NCT03662542|593697155|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
164438464|NCT01119950|593970768|FG000|Overall Study|Protocol Violation|5|||
164438465|NCT01119950|593970768|FG000|Overall Study|Lost to Follow-up|4|||
164438466|NCT01119950|593970768|FG000|Overall Study|Administrative|2|||
164438467|NCT01119950|593970768|FG000|Overall Study|Abnormal lab value|1|||
164438468|NCT01119950|593970768|FG000|Overall Study|Death|1|||
164438469|NCT03058991|593970774|FG000|Overall Study|Lost to Follow-up|17|||
164438470|NCT03058991|593970775|FG001|Overall Study|Lost to Follow-up|12|||
164438471|NCT03058991|593970776|FG002|Overall Study|Lost to Follow-up|12|||
164590811|NCT01808118|594527113|FG000|Period 1|Did not meet inclusion criteria|3|||
164590812|NCT01808118|594527114|FG001|Period 1|Did not meet inclusion criteria|0|||
164590813|NCT01808118|594527115|FG002|Period 1|Did not meet inclusion criteria|0|||
164590814|NCT01808118|594527113|FG000|Period 1|Non-conformance with inclusion criteria|3|||
164590815|NCT01808118|594527114|FG001|Period 1|Non-conformance with inclusion criteria|0|||
164590816|NCT01808118|594527115|FG002|Period 1|Non-conformance with inclusion criteria|0|||
164590817|NCT01808118|594527113|FG000|Period 1|Investigator decision: site closure|2|||
164590818|NCT01808118|594527114|FG001|Period 1|Investigator decision: site closure|0|||
164590819|NCT01808118|594527115|FG002|Period 1|Investigator decision: site closure|0|||
164590820|NCT01808118|594527113|FG000|Period 1|Non-compliance per sponsor|1|||
164590821|NCT01808118|594527114|FG001|Period 1|Non-compliance per sponsor|0|||
164360795|NCT03662542|593697156|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
164360796|NCT03662542|593697157|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
164360797|NCT03662542|593697158|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
164438472|NCT03058991|593970774|FG000|Overall Study|Withdrawal by Subject|1|||
164438473|NCT03058991|593970775|FG001|Overall Study|Withdrawal by Subject|0|||
164438474|NCT03058991|593970776|FG002|Overall Study|Withdrawal by Subject|0|||
164438475|NCT01591616|593970779|FG000|Overall Study|Withdrawal by Subject|1|||
164438476|NCT00758602|593970780|FG000|Overall Study|Adverse Event|11|||
164438477|NCT00758602|593970781|FG001|Overall Study|Adverse Event|10|||
164438478|NCT00758602|593970780|FG000|Overall Study|Lost to Follow-up|4|||
164438479|NCT00758602|593970781|FG001|Overall Study|Lost to Follow-up|3|||
164438480|NCT00758602|593970780|FG000|Overall Study|Withdrawal by Subject|1|||
164438481|NCT00758602|593970781|FG001|Overall Study|Withdrawal by Subject|3|||
164438482|NCT00758602|593970780|FG000|Overall Study|Protocol Violation|0|||
164698060|NCT00773734|594918722|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
164698061|NCT00773734|594918717|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
164360798|NCT03662542|593697159|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
164360799|NCT03662542|593697160|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
164360800|NCT03662542|593697161|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
164360801|NCT03662542|593697162|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
164360802|NCT03662542|593697163|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
164360803|NCT03662542|593697155|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
164360804|NCT03662542|593697156|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
164360805|NCT03662542|593697157|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
164360806|NCT03662542|593697158|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
164360807|NCT03662542|593697159|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
164360808|NCT03662542|593697160|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
164360809|NCT03662542|593697161|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
164360810|NCT03662542|593697162|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
164360811|NCT03662542|593697163|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
164360812|NCT03662542|593697155|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
164360813|NCT03662542|593697156|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
164360814|NCT03662542|593697157|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
164360815|NCT03662542|593697158|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
164360816|NCT03662542|593697159|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
164360817|NCT03662542|593697160|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
164360818|NCT03662542|593697161|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
164360819|NCT03662542|593697162|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
164360820|NCT03662542|593697163|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
164360821|NCT01217060|593697164|FG000|Overall Study|Withdrawal by Subject|1|||
164360822|NCT04762680|593697173|FG000|Phase 2|Adverse Event|0|||
164360823|NCT04762680|593697174|FG001|Phase 2|Adverse Event|1|||
164360824|NCT04762680|593697175|FG002|Phase 2|Adverse Event|0|||
164360825|NCT04762680|593697176|FG003|Phase 2|Adverse Event|0|||
164360826|NCT04762680|593697177|FG004|Phase 2|Adverse Event|0|||
164360827|NCT04762680|593697178|FG005|Phase 2|Adverse Event|0|||
164360828|NCT04762680|593697179|FG006|Phase 2|Adverse Event|0|||
164360829|NCT04762680|593697180|FG007|Phase 2|Adverse Event|0|||
164360830|NCT04762680|593697181|FG008|Phase 2|Adverse Event|0|||
164360831|NCT04762680|593697182|FG009|Phase 2|Adverse Event|0|||
164360832|NCT04762680|593697183|FG010|Phase 2|Adverse Event|0|||
164360833|NCT04762680|593697184|FG011|Phase 2|Adverse Event|0|||
164360834|NCT04762680|593697185|FG012|Phase 2|Adverse Event|0|||
164360835|NCT04762680|593697186|FG013|Phase 2|Adverse Event|0|||
164360836|NCT04762680|593697187|FG014|Phase 2|Adverse Event|0|||
164360837|NCT04762680|593697188|FG015|Phase 2|Adverse Event|0|||
164360838|NCT04762680|593697189|FG016|Phase 2|Adverse Event|0|||
164360839|NCT04762680|593697190|FG017|Phase 2|Adverse Event|0|||
164360840|NCT04762680|593697191|FG018|Phase 2|Adverse Event|0|||
164360841|NCT04762680|593697192|FG019|Phase 2|Adverse Event|0|||
164360842|NCT04762680|593697193|FG020|Phase 2|Adverse Event|0|||
164360843|NCT04762680|593697194|FG021|Phase 2|Adverse Event|0|||
164360844|NCT04762680|593697173|FG000|Phase 2|Protocol Violation|5|||
164360845|NCT04762680|593697174|FG001|Phase 2|Protocol Violation|5|||
164360846|NCT04762680|593697175|FG002|Phase 2|Protocol Violation|1|||
164360847|NCT04762680|593697176|FG003|Phase 2|Protocol Violation|0|||
164360848|NCT04762680|593697177|FG004|Phase 2|Protocol Violation|0|||
164360849|NCT04762680|593697178|FG005|Phase 2|Protocol Violation|0|||
164360850|NCT04762680|593697179|FG006|Phase 2|Protocol Violation|0|||
164360851|NCT04762680|593697180|FG007|Phase 2|Protocol Violation|0|||
164360852|NCT04762680|593697181|FG008|Phase 2|Protocol Violation|0|||
164360853|NCT04762680|593697182|FG009|Phase 2|Protocol Violation|0|||
164438483|NCT00758602|593970781|FG001|Overall Study|Protocol Violation|2|||
164438484|NCT00758602|593970780|FG000|Overall Study|Death|0|||
164360854|NCT04762680|593697183|FG010|Phase 2|Protocol Violation|0|||
164360855|NCT04762680|593697184|FG011|Phase 2|Protocol Violation|0|||
164360856|NCT04762680|593697185|FG012|Phase 2|Protocol Violation|0|||
164360857|NCT04762680|593697186|FG013|Phase 2|Protocol Violation|0|||
164360858|NCT04762680|593697187|FG014|Phase 2|Protocol Violation|0|||
164360859|NCT04762680|593697188|FG015|Phase 2|Protocol Violation|0|||
164360860|NCT04762680|593697189|FG016|Phase 2|Protocol Violation|0|||
164360861|NCT04762680|593697190|FG017|Phase 2|Protocol Violation|0|||
164360862|NCT04762680|593697191|FG018|Phase 2|Protocol Violation|0|||
164698062|NCT00773734|594918718|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
164698063|NCT00773734|594918719|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
164698064|NCT00773734|594918720|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
164698065|NCT00773734|594918721|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
164698066|NCT00773734|594918722|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
164698067|NCT00773734|594918717|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
164698068|NCT00773734|594918718|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
164698069|NCT00773734|594918719|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
164698070|NCT00773734|594918720|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
164360863|NCT04762680|593697192|FG019|Phase 2|Protocol Violation|0|||
164360864|NCT04762680|593697193|FG020|Phase 2|Protocol Violation|0|||
164360865|NCT04762680|593697194|FG021|Phase 2|Protocol Violation|0|||
164360866|NCT04762680|593697173|FG000|Phase 2|Withdrawal by Subject|23|||
164360867|NCT04762680|593697174|FG001|Phase 2|Withdrawal by Subject|21|||
164360868|NCT04762680|593697175|FG002|Phase 2|Withdrawal by Subject|28|||
164360869|NCT04762680|593697176|FG003|Phase 2|Withdrawal by Subject|0|||
164360870|NCT04762680|593697177|FG004|Phase 2|Withdrawal by Subject|0|||
164360871|NCT04762680|593697178|FG005|Phase 2|Withdrawal by Subject|0|||
164360872|NCT04762680|593697179|FG006|Phase 2|Withdrawal by Subject|0|||
164360873|NCT04762680|593697180|FG007|Phase 2|Withdrawal by Subject|0|||
164360874|NCT04762680|593697181|FG008|Phase 2|Withdrawal by Subject|0|||
164360875|NCT04762680|593697182|FG009|Phase 2|Withdrawal by Subject|0|||
164360876|NCT04762680|593697183|FG010|Phase 2|Withdrawal by Subject|0|||
164360877|NCT04762680|593697184|FG011|Phase 2|Withdrawal by Subject|0|||
164360878|NCT04762680|593697185|FG012|Phase 2|Withdrawal by Subject|0|||
164360879|NCT04762680|593697186|FG013|Phase 2|Withdrawal by Subject|0|||
164360880|NCT04762680|593697187|FG014|Phase 2|Withdrawal by Subject|0|||
164360881|NCT04762680|593697188|FG015|Phase 2|Withdrawal by Subject|0|||
164360882|NCT04762680|593697189|FG016|Phase 2|Withdrawal by Subject|0|||
164360883|NCT04762680|593697190|FG017|Phase 2|Withdrawal by Subject|0|||
164360884|NCT04762680|593697191|FG018|Phase 2|Withdrawal by Subject|0|||
164360885|NCT04762680|593697192|FG019|Phase 2|Withdrawal by Subject|0|||
164360886|NCT04762680|593697193|FG020|Phase 2|Withdrawal by Subject|0|||
164360887|NCT04762680|593697194|FG021|Phase 2|Withdrawal by Subject|0|||
164360888|NCT04762680|593697173|FG000|Phase 2|Lost to Follow-up|14|||
164360889|NCT04762680|593697174|FG001|Phase 2|Lost to Follow-up|8|||
164360890|NCT04762680|593697175|FG002|Phase 2|Lost to Follow-up|9|||
164360891|NCT04762680|593697176|FG003|Phase 2|Lost to Follow-up|0|||
164360892|NCT04762680|593697177|FG004|Phase 2|Lost to Follow-up|0|||
164360893|NCT04762680|593697178|FG005|Phase 2|Lost to Follow-up|0|||
164360894|NCT04762680|593697179|FG006|Phase 2|Lost to Follow-up|0|||
164360895|NCT04762680|593697180|FG007|Phase 2|Lost to Follow-up|0|||
164360896|NCT04762680|593697181|FG008|Phase 2|Lost to Follow-up|0|||
164360897|NCT04762680|593697182|FG009|Phase 2|Lost to Follow-up|0|||
164360898|NCT04762680|593697183|FG010|Phase 2|Lost to Follow-up|0|||
164360899|NCT04762680|593697184|FG011|Phase 2|Lost to Follow-up|0|||
164360900|NCT04762680|593697185|FG012|Phase 2|Lost to Follow-up|0|||
164360901|NCT04762680|593697186|FG013|Phase 2|Lost to Follow-up|0|||
164360902|NCT04762680|593697187|FG014|Phase 2|Lost to Follow-up|0|||
164360903|NCT04762680|593697188|FG015|Phase 2|Lost to Follow-up|0|||
164360904|NCT04762680|593697189|FG016|Phase 2|Lost to Follow-up|0|||
164360905|NCT04762680|593697190|FG017|Phase 2|Lost to Follow-up|0|||
164360906|NCT04762680|593697191|FG018|Phase 2|Lost to Follow-up|0|||
164360907|NCT04762680|593697192|FG019|Phase 2|Lost to Follow-up|0|||
164360908|NCT04762680|593697193|FG020|Phase 2|Lost to Follow-up|0|||
164360909|NCT04762680|593697194|FG021|Phase 2|Lost to Follow-up|0|||
164360910|NCT04762680|593697173|FG000|Phase 3|Adverse Event|0|||
164698071|NCT00773734|594918721|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
164698072|NCT00773734|594918722|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
164698073|NCT00773734|594918717|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
164698074|NCT00773734|594918718|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
164698075|NCT00773734|594918719|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
164698076|NCT00773734|594918720|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
164698077|NCT00773734|594918721|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
164698078|NCT00773734|594918722|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
164698079|NCT00773734|594918717|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
164698080|NCT00773734|594918718|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
164698081|NCT00773734|594918719|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
164698082|NCT00773734|594918720|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
164698083|NCT00773734|594918721|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
164360911|NCT04762680|593697174|FG001|Phase 3|Adverse Event|0|||
164360912|NCT04762680|593697175|FG002|Phase 3|Adverse Event|0|||
164360913|NCT04762680|593697176|FG003|Phase 3|Adverse Event|1|||
164360914|NCT04762680|593697177|FG004|Phase 3|Adverse Event|0|||
164360915|NCT04762680|593697178|FG005|Phase 3|Adverse Event|0|||
164360916|NCT04762680|593697179|FG006|Phase 3|Adverse Event|0|||
164360917|NCT04762680|593697180|FG007|Phase 3|Adverse Event|0|||
164360918|NCT04762680|593697181|FG008|Phase 3|Adverse Event|0|||
164360919|NCT04762680|593697182|FG009|Phase 3|Adverse Event|0|||
164360920|NCT04762680|593697183|FG010|Phase 3|Adverse Event|0|||
164360921|NCT04762680|593697184|FG011|Phase 3|Adverse Event|0|||
164360922|NCT04762680|593697185|FG012|Phase 3|Adverse Event|0|||
164360923|NCT04762680|593697186|FG013|Phase 3|Adverse Event|0|||
164360924|NCT04762680|593697187|FG014|Phase 3|Adverse Event|0|||
164360925|NCT04762680|593697188|FG015|Phase 3|Adverse Event|0|||
164360926|NCT04762680|593697189|FG016|Phase 3|Adverse Event|0|||
164360927|NCT04762680|593697190|FG017|Phase 3|Adverse Event|3|||
164360928|NCT04762680|593697191|FG018|Phase 3|Adverse Event|0|||
164360929|NCT04762680|593697192|FG019|Phase 3|Adverse Event|0|||
164360930|NCT04762680|593697193|FG020|Phase 3|Adverse Event|0|||
164360931|NCT04762680|593697194|FG021|Phase 3|Adverse Event|0|||
164360932|NCT04762680|593697173|FG000|Phase 3|Protocol Violation|0|||
164360933|NCT04762680|593697174|FG001|Phase 3|Protocol Violation|0|||
164360934|NCT04762680|593697175|FG002|Phase 3|Protocol Violation|0|||
164360935|NCT04762680|593697176|FG003|Phase 3|Protocol Violation|4|||
164698084|NCT00773734|594918722|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
164698085|NCT00773734|594918717|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
164698086|NCT00773734|594918718|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
164698087|NCT00773734|594918719|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
164698088|NCT00773734|594918720|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
164698089|NCT00773734|594918721|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
164698090|NCT00773734|594918722|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
164360936|NCT04762680|593697177|FG004|Phase 3|Protocol Violation|1|||
164360937|NCT04762680|593697178|FG005|Phase 3|Protocol Violation|5|||
164698091|NCT00773734|594918717|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
164698092|NCT00773734|594918718|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
164698093|NCT00773734|594918719|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
164698094|NCT00773734|594918720|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
164698095|NCT00773734|594918721|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
164698096|NCT00773734|594918722|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
164698097|NCT00773734|594918717|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
164698098|NCT00773734|594918718|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
164698099|NCT00773734|594918719|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
164698100|NCT00773734|594918720|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
164698101|NCT00773734|594918721|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
164698102|NCT00773734|594918722|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
164698103|NCT00773734|594918717|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
164698104|NCT00773734|594918718|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
164698105|NCT00773734|594918719|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
164698106|NCT00773734|594918720|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
164698107|NCT00773734|594918721|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
164698108|NCT00773734|594918722|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
164698109|NCT00773734|594918717|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
164698110|NCT00773734|594918718|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
164698111|NCT00773734|594918719|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
164698112|NCT00773734|594918720|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
164698113|NCT00773734|594918721|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
164698114|NCT00773734|594918722|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
164698115|NCT00773734|594918717|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
164698116|NCT00773734|594918718|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
164698117|NCT00773734|594918719|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
164698118|NCT00773734|594918720|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
164698119|NCT00773734|594918721|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
164698120|NCT00773734|594918722|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
164698121|NCT00773734|594918717|FG000|Extension: Active Treatment Week 24-52|Other|0|||
164698122|NCT00773734|594918718|FG001|Extension: Active Treatment Week 24-52|Other|0|||
164698123|NCT00773734|594918719|FG002|Extension: Active Treatment Week 24-52|Other|1|||
164698124|NCT00773734|594918720|FG003|Extension: Active Treatment Week 24-52|Other|2|||
164698125|NCT00773734|594918721|FG004|Extension: Active Treatment Week 24-52|Other|0|||
164698126|NCT00773734|594918722|FG005|Extension: Active Treatment Week 24-52|Other|1|||
164698127|NCT00773734|594918717|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
164360938|NCT04762680|593697179|FG006|Phase 3|Protocol Violation|1|||
164360939|NCT04762680|593697180|FG007|Phase 3|Protocol Violation|0|||
164360940|NCT04762680|593697181|FG008|Phase 3|Protocol Violation|0|||
164360941|NCT04762680|593697182|FG009|Phase 3|Protocol Violation|0|||
164438485|NCT00758602|593970781|FG001|Overall Study|Death|1|||
164360942|NCT04762680|593697183|FG010|Phase 3|Protocol Violation|0|||
164360943|NCT04762680|593697184|FG011|Phase 3|Protocol Violation|2|||
164360944|NCT04762680|593697185|FG012|Phase 3|Protocol Violation|3|||
164360945|NCT04762680|593697186|FG013|Phase 3|Protocol Violation|0|||
164360946|NCT04762680|593697187|FG014|Phase 3|Protocol Violation|0|||
164360947|NCT04762680|593697188|FG015|Phase 3|Protocol Violation|1|||
164360948|NCT04762680|593697189|FG016|Phase 3|Protocol Violation|0|||
164360949|NCT04762680|593697190|FG017|Phase 3|Protocol Violation|10|||
164698128|NCT00773734|594918718|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
164698129|NCT00773734|594918719|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
164698130|NCT00773734|594918720|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
164698131|NCT00773734|594918721|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
164698132|NCT00773734|594918722|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
164698133|NCT00773734|594918717|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
164698134|NCT00773734|594918718|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
164698135|NCT00773734|594918719|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
164698136|NCT00773734|594918720|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
164698137|NCT00773734|594918721|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
164698138|NCT00773734|594918722|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
164698139|NCT00773734|594918717|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
164698140|NCT00773734|594918718|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
164698141|NCT00773734|594918719|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
164698142|NCT00773734|594918720|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
164698143|NCT00773734|594918721|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
164698144|NCT00773734|594918722|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
164698145|NCT00773734|594918717|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
164698146|NCT00773734|594918718|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
164698147|NCT00773734|594918719|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
164698148|NCT00773734|594918720|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
164698149|NCT00773734|594918721|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
164698150|NCT00773734|594918722|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
164698151|NCT00856830|594918726|FG000|Irinotecan & Bendamustine|Death|0|||
164698152|NCT00856830|594918727|FG001|Irinotecan & Bendamustine|Death|0|||
164698153|NCT00856830|594918728|FG002|Irinotecan & Bendamustine|Death|0|||
164698154|NCT00856830|594918729|FG003|Irinotecan & Bendamustine|Death|2|||
164698155|NCT00856830|594918726|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
164698156|NCT00856830|594918727|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
164698157|NCT00856830|594918728|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
164438486|NCT00758602|593970780|FG000|Overall Study|Reason not specified|3|||
164438487|NCT00758602|593970781|FG001|Overall Study|Reason not specified|3|||
164438488|NCT00619645|593970782|FG000|Overall Study|Adverse Event|1|||
164438489|NCT02026258|593970783|FG000|Randomized|Did not start treatment|2|||
164438490|NCT02026258|593970784|FG001|Randomized|Did not start treatment|1|||
164438491|NCT02026258|593970783|FG000|Randomized|Change in treatment plan|1|||
164438492|NCT02026258|593970784|FG001|Randomized|Change in treatment plan|0|||
164438493|NCT02026258|593970783|FG000|Randomized|Presence of periodontal disease|1|||
164438494|NCT02026258|593970784|FG001|Randomized|Presence of periodontal disease|1|||
164438495|NCT02026258|593970783|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
164438496|NCT02026258|593970784|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
164438497|NCT02026258|593970783|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
164438498|NCT02026258|593970784|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
164438499|NCT01161498|593970795|FG000|Overall Study|Disease Progression|0|||
164438500|NCT01161498|593970796|FG001|Overall Study|Disease Progression|1|||
164438501|NCT03310983|593970800|FG000|Overall Study|Lost to Follow-up|15|||
164438502|NCT03310983|593970801|FG001|Overall Study|Lost to Follow-up|17|||
164438503|NCT01656304|593970809|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
164438504|NCT00823979|593970810|FG000|Overall Study|Lack of Efficacy|13|||
164438505|NCT00823979|593970811|FG001|Overall Study|Lack of Efficacy|16|||
164438506|NCT00823979|593970812|FG002|Overall Study|Lack of Efficacy|9|||
164438507|NCT00823979|593970810|FG000|Overall Study|Lost to Follow-up|2|||
164438508|NCT00823979|593970811|FG001|Overall Study|Lost to Follow-up|1|||
164438509|NCT00823979|593970812|FG002|Overall Study|Lost to Follow-up|0|||
164438510|NCT00823979|593970810|FG000|Overall Study|Withdrawal by Subject|2|||
164360950|NCT04762680|593697191|FG018|Phase 3|Protocol Violation|0|||
164438511|NCT00823979|593970811|FG001|Overall Study|Withdrawal by Subject|3|||
164438512|NCT00823979|593970812|FG002|Overall Study|Withdrawal by Subject|2|||
164698158|NCT00856830|594918729|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
164698159|NCT03768726|594918730|FG000|Treatment Phase|Adverse Event|2|||
164698160|NCT03768726|594918731|FG001|Treatment Phase|Adverse Event|2|||
164698161|NCT03768726|594918730|FG000|Treatment Phase|Lost to Follow-up|1|||
164360951|NCT04762680|593697192|FG019|Phase 3|Protocol Violation|0|||
164360952|NCT04762680|593697193|FG020|Phase 3|Protocol Violation|0|||
164438513|NCT00823979|593970810|FG000|Overall Study|Protocol Violation|1|||
164438514|NCT00823979|593970811|FG001|Overall Study|Protocol Violation|1|||
164438515|NCT00823979|593970812|FG002|Overall Study|Protocol Violation|0|||
164438516|NCT00823979|593970810|FG000|Overall Study|Pregnancy|0|||
164698162|NCT03768726|594918731|FG001|Treatment Phase|Lost to Follow-up|0|||
164698163|NCT03768726|594918730|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
164698164|NCT03768726|594918731|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
164698165|NCT03768726|594918730|FG000|Treatment Phase|Withdrawal by Subject|3|||
164360953|NCT04762680|593697194|FG021|Phase 3|Protocol Violation|0|||
164360954|NCT04762680|593697173|FG000|Phase 3|Withdrawal by Subject|0|||
164360955|NCT04762680|593697174|FG001|Phase 3|Withdrawal by Subject|0|||
164360956|NCT04762680|593697175|FG002|Phase 3|Withdrawal by Subject|0|||
164360957|NCT04762680|593697176|FG003|Phase 3|Withdrawal by Subject|13|||
164360958|NCT04762680|593697177|FG004|Phase 3|Withdrawal by Subject|17|||
164360959|NCT04762680|593697178|FG005|Phase 3|Withdrawal by Subject|12|||
164360960|NCT04762680|593697179|FG006|Phase 3|Withdrawal by Subject|8|||
164360961|NCT04762680|593697180|FG007|Phase 3|Withdrawal by Subject|3|||
164360962|NCT04762680|593697181|FG008|Phase 3|Withdrawal by Subject|2|||
164360963|NCT04762680|593697182|FG009|Phase 3|Withdrawal by Subject|4|||
164360964|NCT04762680|593697183|FG010|Phase 3|Withdrawal by Subject|3|||
164360965|NCT04762680|593697184|FG011|Phase 3|Withdrawal by Subject|1|||
164360966|NCT04762680|593697185|FG012|Phase 3|Withdrawal by Subject|3|||
164360967|NCT04762680|593697186|FG013|Phase 3|Withdrawal by Subject|2|||
164360968|NCT04762680|593697187|FG014|Phase 3|Withdrawal by Subject|1|||
164360969|NCT04762680|593697188|FG015|Phase 3|Withdrawal by Subject|4|||
164360970|NCT04762680|593697189|FG016|Phase 3|Withdrawal by Subject|6|||
164360971|NCT04762680|593697190|FG017|Phase 3|Withdrawal by Subject|32|||
164360972|NCT04762680|593697191|FG018|Phase 3|Withdrawal by Subject|0|||
164360973|NCT04762680|593697192|FG019|Phase 3|Withdrawal by Subject|0|||
164360974|NCT04762680|593697193|FG020|Phase 3|Withdrawal by Subject|0|||
164360975|NCT04762680|593697194|FG021|Phase 3|Withdrawal by Subject|0|||
164360976|NCT04762680|593697173|FG000|Phase 3|Lost to Follow-up|0|||
164360977|NCT04762680|593697174|FG001|Phase 3|Lost to Follow-up|0|||
164360978|NCT04762680|593697175|FG002|Phase 3|Lost to Follow-up|0|||
164360979|NCT04762680|593697176|FG003|Phase 3|Lost to Follow-up|9|||
164360980|NCT04762680|593697177|FG004|Phase 3|Lost to Follow-up|22|||
164360981|NCT04762680|593697178|FG005|Phase 3|Lost to Follow-up|24|||
164360982|NCT04762680|593697179|FG006|Phase 3|Lost to Follow-up|2|||
164360983|NCT04762680|593697180|FG007|Phase 3|Lost to Follow-up|4|||
164360984|NCT04762680|593697181|FG008|Phase 3|Lost to Follow-up|6|||
164360985|NCT04762680|593697182|FG009|Phase 3|Lost to Follow-up|4|||
164360986|NCT04762680|593697183|FG010|Phase 3|Lost to Follow-up|3|||
164360987|NCT04762680|593697184|FG011|Phase 3|Lost to Follow-up|0|||
164360988|NCT04762680|593697185|FG012|Phase 3|Lost to Follow-up|5|||
164360989|NCT04762680|593697186|FG013|Phase 3|Lost to Follow-up|4|||
164360990|NCT04762680|593697187|FG014|Phase 3|Lost to Follow-up|6|||
164360991|NCT04762680|593697188|FG015|Phase 3|Lost to Follow-up|1|||
164360992|NCT04762680|593697189|FG016|Phase 3|Lost to Follow-up|1|||
164360993|NCT04762680|593697190|FG017|Phase 3|Lost to Follow-up|66|||
164360994|NCT04762680|593697191|FG018|Phase 3|Lost to Follow-up|0|||
164360995|NCT04762680|593697192|FG019|Phase 3|Lost to Follow-up|0|||
164360996|NCT04762680|593697193|FG020|Phase 3|Lost to Follow-up|0|||
164360997|NCT04762680|593697194|FG021|Phase 3|Lost to Follow-up|0|||
164360998|NCT04762680|593697173|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164360999|NCT04762680|593697174|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361000|NCT04762680|593697175|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361001|NCT04762680|593697176|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361002|NCT04762680|593697177|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361003|NCT04762680|593697178|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361004|NCT04762680|593697179|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361005|NCT04762680|593697180|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361006|NCT04762680|593697181|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361007|NCT04762680|593697182|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361008|NCT04762680|593697183|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361009|NCT04762680|593697184|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164438517|NCT00823979|593970811|FG001|Overall Study|Pregnancy|1|||
164438518|NCT00823979|593970812|FG002|Overall Study|Pregnancy|0|||
164361010|NCT04762680|593697185|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361011|NCT04762680|593697186|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361012|NCT04762680|593697187|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361013|NCT04762680|593697188|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361014|NCT04762680|593697189|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164438519|NCT00823979|593970810|FG000|Overall Study|Adverse Event|0|||
164438520|NCT00823979|593970811|FG001|Overall Study|Adverse Event|2|||
164361015|NCT04762680|593697190|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361016|NCT04762680|593697191|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361017|NCT04762680|593697192|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361018|NCT04762680|593697193|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361019|NCT04762680|593697194|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
164361020|NCT04762680|593697173|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361021|NCT04762680|593697174|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
164438521|NCT00823979|593970812|FG002|Overall Study|Adverse Event|4|||
164698166|NCT03768726|594918731|FG001|Treatment Phase|Withdrawal by Subject|1|||
164361022|NCT04762680|593697175|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361023|NCT04762680|593697176|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361024|NCT04762680|593697177|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361025|NCT04762680|593697178|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361026|NCT04762680|593697179|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361027|NCT04762680|593697180|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361028|NCT04762680|593697181|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361029|NCT04762680|593697182|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361030|NCT04762680|593697183|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361031|NCT04762680|593697184|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361032|NCT04762680|593697185|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361033|NCT04762680|593697186|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361034|NCT04762680|593697187|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
164698167|NCT03768726|594918730|FG000|Follow-Up|Adverse Event|2|||
164361035|NCT04762680|593697188|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361036|NCT04762680|593697189|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361037|NCT04762680|593697190|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361038|NCT04762680|593697191|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361039|NCT04762680|593697192|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
164361040|NCT04762680|593697193|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361041|NCT04762680|593697194|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361042|NCT03388138|593697195|FG000|Overall Study|Protocol Violation|1|||
164361043|NCT03388138|593697196|FG001|Overall Study|Protocol Violation|0|||
164361044|NCT01528072|593697197|FG000|Overall Study|Withdrawal by Subject|5|||
164361045|NCT01528072|593697197|FG000|Overall Study|Physician Decision|1|||
164361046|NCT01528072|593697197|FG000|Overall Study|Determined not eligible by AEAC|1|||
164361047|NCT01528072|593697197|FG000|Overall Study|Missed Visit|2|||
164361048|NCT01528072|593697197|FG000|Overall Study|Lost to Follow-up|5|||
164361049|NCT01528072|593697197|FG000|Overall Study|Explanted|2|||
164361050|NCT01528072|593697197|FG000|Overall Study|Site Closure|4|||
164361051|NCT01528072|593697197|FG000|Overall Study|Death|2|||
164361052|NCT01528072|593697197|FG000|Overall Study|Early Termination of Study|52|||
164361053|NCT02436759|593697204|FG000|Overall Study|Adverse Event|3|||
164361054|NCT02436759|593697205|FG001|Overall Study|Adverse Event|0|||
164361055|NCT02436759|593697204|FG000|Overall Study|Protocol Violation|1|||
164698168|NCT03768726|594918731|FG001|Follow-Up|Adverse Event|2|||
164698169|NCT03768726|594918730|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
164698170|NCT03768726|594918731|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
164698171|NCT03768726|594918730|FG000|Follow-Up|Withdrawal by Subject|2|||
164698172|NCT03768726|594918731|FG001|Follow-Up|Withdrawal by Subject|0|||
164698173|NCT03768726|594918730|FG000|Follow-Up|Other|1|||
164698174|NCT03768726|594918731|FG001|Follow-Up|Other|0|||
164698175|NCT01787279|594918732|FG000|Overall Study|Lost to Follow-up|2|||
164698176|NCT01787279|594918732|FG000|Overall Study|Lack of Efficacy|1|||
164698177|NCT02148913|594918733|FG000|Overall Study|Death|0|||
164698178|NCT02148913|594918734|FG001|Overall Study|Death|1|||
164698179|NCT02148913|594918735|FG002|Overall Study|Death|0|||
164698180|NCT02148913|594918736|FG003|Overall Study|Death|0|||
164698181|NCT01360866|594918738|FG000|Overall Study|Lost to Follow-up|11|||
164698182|NCT01360866|594918739|FG001|Overall Study|Lost to Follow-up|28|||
164698183|NCT01360866|594918740|FG002|Overall Study|Lost to Follow-up|41|||
164698184|NCT01360866|594918741|FG003|Overall Study|Lost to Follow-up|0|||
164698185|NCT01360866|594918738|FG000|Overall Study|Adverse Event|56|||
164698186|NCT01360866|594918739|FG001|Overall Study|Adverse Event|61|||
164698187|NCT01360866|594918740|FG002|Overall Study|Adverse Event|134|||
164361056|NCT02436759|593697205|FG001|Overall Study|Protocol Violation|0|||
164361057|NCT02436759|593697204|FG000|Overall Study|Withdrawal by Subject|0|||
164361058|NCT02436759|593697205|FG001|Overall Study|Withdrawal by Subject|1|||
164361059|NCT04014075|593697206|FG000|Overall Study|Progressive Disease|53|||
164361060|NCT04014075|593697206|FG000|Overall Study|Adverse Event|15|||
164361061|NCT04014075|593697206|FG000|Overall Study|Clinical Progression|4|||
164361062|NCT04014075|593697206|FG000|Overall Study|Death|2|||
164361063|NCT04014075|593697206|FG000|Overall Study|Withdrawal by Subject|2|||
164438522|NCT00823979|593970810|FG000|Overall Study|Other|2|||
164361064|NCT04014075|593697206|FG000|Overall Study|Miscellaneous|2|||
164361065|NCT04014075|593697206|FG000|Overall Study|Physician Decision|1|||
164361066|NCT02584504|593697209|FG000|Double-blind Treatment|Participant withdrew consent|0|||
164438523|NCT00823979|593970811|FG001|Overall Study|Other|0|||
164698188|NCT01360866|594918741|FG003|Overall Study|Adverse Event|6|||
164698189|NCT01360866|594918738|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
164698190|NCT01360866|594918739|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
164698191|NCT01360866|594918740|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
164698192|NCT01360866|594918741|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
164698193|NCT01360866|594918738|FG000|Overall Study|Withdrawn by Investigator|9|||
164698194|NCT01360866|594918739|FG001|Overall Study|Withdrawn by Investigator|8|||
164361067|NCT02584504|593697210|FG001|Double-blind Treatment|Participant withdrew consent|0|||
164361068|NCT02584504|593697211|FG002|Double-blind Treatment|Participant withdrew consent|1|||
164698195|NCT01360866|594918740|FG002|Overall Study|Withdrawn by Investigator|31|||
164698196|NCT01360866|594918741|FG003|Overall Study|Withdrawn by Investigator|2|||
164698197|NCT01360866|594918738|FG000|Overall Study|Withdrawal by participant|79|||
164698198|NCT01360866|594918739|FG001|Overall Study|Withdrawal by participant|89|||
164698199|NCT01360866|594918740|FG002|Overall Study|Withdrawal by participant|168|||
164698200|NCT01360866|594918741|FG003|Overall Study|Withdrawal by participant|8|||
164361069|NCT02584504|593697209|FG000|Double-blind Treatment|Adverse Event|0|||
164361070|NCT02584504|593697210|FG001|Double-blind Treatment|Adverse Event|1|||
164361071|NCT02584504|593697211|FG002|Double-blind Treatment|Adverse Event|0|||
164361072|NCT02584504|593697209|FG000|Double-blind Treatment|Family Matter|0|||
164361073|NCT02584504|593697210|FG001|Double-blind Treatment|Family Matter|1|||
164361074|NCT02584504|593697211|FG002|Double-blind Treatment|Family Matter|0|||
164361075|NCT02584504|593697209|FG000|Open-label Treatment|Participant withdrew consent|0|||
164361076|NCT02584504|593697210|FG001|Open-label Treatment|Participant withdrew consent|0|||
164361077|NCT02584504|593697211|FG002|Open-label Treatment|Participant withdrew consent|4|||
164361078|NCT02584504|593697209|FG000|Open-label Treatment|Adverse Event|2|||
164361079|NCT02584504|593697210|FG001|Open-label Treatment|Adverse Event|2|||
164361080|NCT02584504|593697211|FG002|Open-label Treatment|Adverse Event|3|||
164361081|NCT02584504|593697209|FG000|Open-label Treatment|Physician Decision|0|||
164361082|NCT02584504|593697210|FG001|Open-label Treatment|Physician Decision|1|||
164361083|NCT02584504|593697211|FG002|Open-label Treatment|Physician Decision|0|||
164361084|NCT02584504|593697209|FG000|Open-label Treatment|Entered but not treated|0|||
164361085|NCT02584504|593697210|FG001|Open-label Treatment|Entered but not treated|1|||
164361086|NCT02584504|593697211|FG002|Open-label Treatment|Entered but not treated|1|||
164361087|NCT02432846|593697212|FG000|Overall Study (4 Arms/Strata)|Death|3|||
164361088|NCT02432846|593697213|FG001|Overall Study (4 Arms/Strata)|Death|2|||
164361089|NCT02432846|593697214|FG002|Overall Study (4 Arms/Strata)|Death|4|||
164361090|NCT02432846|593697215|FG003|Overall Study (4 Arms/Strata)|Death|3|||
164361091|NCT02432846|593697216|FG004|Overall Study (4 Arms/Strata)|Death|0|||
164361092|NCT02432846|593697217|FG005|Overall Study (4 Arms/Strata)|Death|0|||
164361093|NCT02432846|593697212|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
164361094|NCT02432846|593697213|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
164361095|NCT02432846|593697214|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
164361096|NCT02432846|593697215|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
164361097|NCT02432846|593697216|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
164361098|NCT02432846|593697217|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
164361099|NCT02432846|593697212|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
164361100|NCT02432846|593697213|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
164361101|NCT02432846|593697214|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
164361102|NCT02432846|593697215|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
164361103|NCT02432846|593697216|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
164361104|NCT02432846|593697217|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
164361105|NCT02432846|593697212|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
164361106|NCT02432846|593697213|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
164361107|NCT02432846|593697214|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
164361108|NCT02432846|593697215|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
164361109|NCT02432846|593697216|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
164361110|NCT02432846|593697217|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
164361111|NCT02432846|593697212|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
164361112|NCT02432846|593697213|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
164361113|NCT02432846|593697214|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
164361114|NCT02432846|593697215|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
164361115|NCT02432846|593697216|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
164361116|NCT02432846|593697217|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
164361117|NCT02432846|593697212|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
164361118|NCT02432846|593697213|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
164361119|NCT02432846|593697214|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
164361120|NCT02432846|593697215|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
164361121|NCT02432846|593697216|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
164361122|NCT02432846|593697217|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
164361123|NCT02432846|593697212|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
164361124|NCT02432846|593697213|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
164361125|NCT02432846|593697214|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
164361126|NCT02432846|593697215|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
164698201|NCT01360866|594918738|FG000|Overall Study|Protocol Deviation|25|||
164698202|NCT01360866|594918739|FG001|Overall Study|Protocol Deviation|33|||
164698203|NCT01360866|594918740|FG002|Overall Study|Protocol Deviation|61|||
164698204|NCT01360866|594918741|FG003|Overall Study|Protocol Deviation|2|||
164698205|NCT01360866|594918738|FG000|Overall Study|Lack of Efficacy|30|||
164361127|NCT02432846|593697216|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
164361128|NCT02432846|593697217|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
164361129|NCT02432846|593697212|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
164361130|NCT02432846|593697213|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
164361131|NCT02432846|593697214|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
164361132|NCT02432846|593697215|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
164361133|NCT02432846|593697216|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
164698206|NCT01360866|594918739|FG001|Overall Study|Lack of Efficacy|40|||
164698207|NCT01360866|594918740|FG002|Overall Study|Lack of Efficacy|30|||
164361134|NCT02432846|593697217|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
164361135|NCT02432846|593697212|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
164361136|NCT02432846|593697213|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
164361137|NCT02432846|593697214|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
164361138|NCT02432846|593697215|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
164361139|NCT02432846|593697216|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
164361140|NCT02432846|593697217|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
164361141|NCT02432846|593697212|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
164361142|NCT02432846|593697213|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
164361143|NCT02432846|593697214|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
164361144|NCT02432846|593697215|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
164361145|NCT02432846|593697216|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
164361146|NCT02432846|593697217|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
164361147|NCT02432846|593697212|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
164361148|NCT02432846|593697213|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
164361149|NCT02432846|593697214|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
164361150|NCT02432846|593697215|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
164361151|NCT02432846|593697216|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
164361152|NCT02432846|593697217|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
164361153|NCT02432846|593697212|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
164361154|NCT02432846|593697213|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
164361155|NCT02432846|593697214|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
164361156|NCT02432846|593697215|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
164361157|NCT02432846|593697216|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
164361158|NCT02432846|593697217|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
164361159|NCT02432846|593697212|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
164361160|NCT02432846|593697213|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
164361161|NCT02432846|593697214|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
164361162|NCT02432846|593697215|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
164361163|NCT02432846|593697216|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
164361164|NCT02432846|593697217|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
164361165|NCT02432846|593697212|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
164361166|NCT02432846|593697213|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
164361167|NCT02432846|593697214|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
164361168|NCT02432846|593697215|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
164361169|NCT02432846|593697216|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
164361170|NCT02432846|593697217|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
164361171|NCT01912287|593697218|FG000|Overall Study|Ineligible|1|||
164361172|NCT01912287|593697219|FG001|Overall Study|Ineligible|0|||
164361173|NCT01912287|593697220|FG002|Overall Study|Ineligible|1|||
164361174|NCT01912287|593697218|FG000|Overall Study|No-show|0|||
164361175|NCT01912287|593697219|FG001|Overall Study|No-show|0|||
164361176|NCT01912287|593697220|FG002|Overall Study|No-show|1|||
164361177|NCT01912287|593697218|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
164361178|NCT01912287|593697219|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
164698208|NCT01360866|594918741|FG003|Overall Study|Lack of Efficacy|4|||
164698209|NCT05016622|594918742|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
164698210|NCT05016622|594918742|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
164361179|NCT01912287|593697220|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
164361180|NCT01912287|593697218|FG000|Overall Study|Felt treatment no longer needed|0|||
164361181|NCT01912287|593697219|FG001|Overall Study|Felt treatment no longer needed|1|||
164361182|NCT01912287|593697220|FG002|Overall Study|Felt treatment no longer needed|0|||
164361183|NCT01912287|593697218|FG000|Overall Study|Life circumstances|4|||
164361184|NCT01912287|593697219|FG001|Overall Study|Life circumstances|2|||
164361185|NCT01912287|593697220|FG002|Overall Study|Life circumstances|0|||
164361186|NCT01912287|593697218|FG000|Overall Study|Lost Interest|1|||
164698211|NCT02954159|594918744|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
164698212|NCT02954159|594918745|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
164361187|NCT01912287|593697219|FG001|Overall Study|Lost Interest|0|||
164361188|NCT01912287|593697220|FG002|Overall Study|Lost Interest|0|||
164361189|NCT01912287|593697218|FG000|Overall Study|Uknown reason - subject drop out|5|||
164361190|NCT01912287|593697219|FG001|Overall Study|Uknown reason - subject drop out|7|||
164361191|NCT01912287|593697220|FG002|Overall Study|Uknown reason - subject drop out|3|||
164361192|NCT01912287|593697218|FG000|Overall Study|Missed Assesment|1|||
164361193|NCT01912287|593697219|FG001|Overall Study|Missed Assesment|1|||
164361194|NCT01912287|593697220|FG002|Overall Study|Missed Assesment|1|||
164361195|NCT01912287|593697218|FG000|Overall Study|Scheduling/change in availability|17|||
164361196|NCT01912287|593697219|FG001|Overall Study|Scheduling/change in availability|10|||
164361197|NCT01912287|593697220|FG002|Overall Study|Scheduling/change in availability|8|||
164361198|NCT00413192|593697221|FG000|Overall Study|Disease progression|26|||
164361199|NCT00413192|593697222|FG001|Overall Study|Disease progression|31|||
164361200|NCT00413192|593697223|FG002|Overall Study|Disease progression|16|||
164361201|NCT00413192|593697224|FG003|Overall Study|Disease progression|25|||
164361202|NCT00413192|593697221|FG000|Overall Study|Toxicity|3|||
164361203|NCT00413192|593697222|FG001|Overall Study|Toxicity|2|||
164361204|NCT00413192|593697223|FG002|Overall Study|Toxicity|2|||
164361205|NCT00413192|593697224|FG003|Overall Study|Toxicity|2|||
164361206|NCT00413192|593697221|FG000|Overall Study|Withdrawal by Subject|3|||
164361207|NCT00413192|593697222|FG001|Overall Study|Withdrawal by Subject|5|||
164698213|NCT02954159|594918744|FG000|Overall Study|Withdrawal by Subject|0|||
164698214|NCT02954159|594918745|FG001|Overall Study|Withdrawal by Subject|1|||
164698215|NCT05506358|594918748|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
164698216|NCT05506358|594918749|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
164698217|NCT05506358|594918750|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
164698218|NCT05506358|594918751|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
164698219|NCT05506358|594918752|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
164698220|NCT05506358|594918748|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
164698221|NCT05506358|594918749|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
164698222|NCT05506358|594918750|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
164698223|NCT05506358|594918751|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
164698224|NCT05506358|594918752|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
164698225|NCT05506358|594918748|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
164698226|NCT05506358|594918749|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
164698227|NCT05506358|594918750|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
164698228|NCT05506358|594918751|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
164698229|NCT05506358|594918752|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
164698230|NCT05506358|594918748|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
164698231|NCT05506358|594918749|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
164698232|NCT05506358|594918750|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
164698233|NCT05506358|594918751|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
164698234|NCT05506358|594918752|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
164698235|NCT05506358|594918748|FG000|Overall Study|HbE trait|0|||
164698236|NCT05506358|594918749|FG001|Overall Study|HbE trait|0|||
164698237|NCT05506358|594918750|FG002|Overall Study|HbE trait|0|||
164698238|NCT05506358|594918751|FG003|Overall Study|HbE trait|1|||
164698239|NCT05506358|594918752|FG004|Overall Study|HbE trait|0|||
164698240|NCT03438396|594918759|FG000|Overall Study|Reason Not Specified|9|||
164698241|NCT03438396|594918759|FG000|Overall Study|Withdrawal by Subject|5|||
164698242|NCT03438396|594918759|FG000|Overall Study|Lost to Follow-up|2|||
164698243|NCT03438396|594918759|FG000|Overall Study|Death|85|||
164698244|NCT03438396|594918759|FG000|Overall Study|Not treated|1|||
164698245|NCT01744093|594918760|FG000|Overall Study|Withdrawal by Subject|6|||
164698246|NCT01744093|594918761|FG001|Overall Study|Withdrawal by Subject|1|||
164698247|NCT02006628|594918762|FG000|Overall Study|Adverse Event|1|||
164698248|NCT02006628|594918763|FG001|Overall Study|Adverse Event|1|||
164698249|NCT02006628|594918762|FG000|Overall Study|Withdrawal by Subject|2|||
164698250|NCT02006628|594918763|FG001|Overall Study|Withdrawal by Subject|1|||
164698251|NCT00262041|594918764|FG000|Overall Study|Withdrawal by Subject|0|||
164361208|NCT00413192|593697223|FG002|Overall Study|Withdrawal by Subject|0|||
164361209|NCT00413192|593697224|FG003|Overall Study|Withdrawal by Subject|1|||
164361210|NCT00413192|593697221|FG000|Overall Study|Intercurrent illness|0|||
164361211|NCT00413192|593697222|FG001|Overall Study|Intercurrent illness|0|||
164361212|NCT00413192|593697223|FG002|Overall Study|Intercurrent illness|0|||
164698252|NCT00262041|594918765|FG001|Overall Study|Withdrawal by Subject|3|||
164361213|NCT00413192|593697224|FG003|Overall Study|Intercurrent illness|1|||
164361214|NCT00413192|593697221|FG000|Overall Study|Intercurrent death|0|||
164361215|NCT00413192|593697222|FG001|Overall Study|Intercurrent death|1|||
164361216|NCT00413192|593697223|FG002|Overall Study|Intercurrent death|0|||
164361217|NCT00413192|593697224|FG003|Overall Study|Intercurrent death|0|||
164361218|NCT00413192|593697221|FG000|Overall Study|Other|5|||
164361219|NCT00413192|593697222|FG001|Overall Study|Other|1|||
164361220|NCT00413192|593697223|FG002|Overall Study|Other|1|||
164361221|NCT00413192|593697224|FG003|Overall Study|Other|2|||
164361222|NCT00413192|593697221|FG000|Overall Study|Not treated|0|||
164361223|NCT00413192|593697222|FG001|Overall Study|Not treated|0|||
164361224|NCT00413192|593697223|FG002|Overall Study|Not treated|0|||
164361225|NCT00413192|593697224|FG003|Overall Study|Not treated|1|||
164361226|NCT01998633|593697225|FG000|Overall Study|Death|1|||
164361227|NCT02631850|593697226|FG000|Treatment Period|Lost to Follow-up|0|||
164361228|NCT02631850|593697227|FG001|Treatment Period|Lost to Follow-up|1|||
164361229|NCT02631850|593697228|FG002|Treatment Period|Lost to Follow-up|0|||
164361230|NCT02631850|593697229|FG003|Treatment Period|Lost to Follow-up|0|||
164361231|NCT02631850|593697226|FG000|Treatment Period|Protocol Violation|1|||
164361232|NCT02631850|593697227|FG001|Treatment Period|Protocol Violation|0|||
164361233|NCT02631850|593697228|FG002|Treatment Period|Protocol Violation|0|||
164361234|NCT02631850|593697229|FG003|Treatment Period|Protocol Violation|0|||
164361235|NCT02631850|593697226|FG000|Treatment Period|Withdrawal by Subject|0|||
164361236|NCT02631850|593697227|FG001|Treatment Period|Withdrawal by Subject|5|||
164361237|NCT02631850|593697228|FG002|Treatment Period|Withdrawal by Subject|2|||
164361238|NCT02631850|593697229|FG003|Treatment Period|Withdrawal by Subject|2|||
164361239|NCT02631850|593697226|FG000|Treatment Period|Adverse Event|1|||
164361240|NCT02631850|593697227|FG001|Treatment Period|Adverse Event|0|||
164361241|NCT02631850|593697228|FG002|Treatment Period|Adverse Event|2|||
164361242|NCT02631850|593697229|FG003|Treatment Period|Adverse Event|3|||
164361243|NCT02631850|593697226|FG000|Treatment Period|Family medical issue|1|||
164361244|NCT02631850|593697227|FG001|Treatment Period|Family medical issue|0|||
164361245|NCT02631850|593697228|FG002|Treatment Period|Family medical issue|0|||
164361246|NCT02631850|593697229|FG003|Treatment Period|Family medical issue|0|||
164361247|NCT02631850|593697226|FG000|6 Month Follow up|Lost to Follow-up|5|||
164361248|NCT02631850|593697227|FG001|6 Month Follow up|Lost to Follow-up|8|||
164361249|NCT02631850|593697228|FG002|6 Month Follow up|Lost to Follow-up|3|||
164361250|NCT02631850|593697229|FG003|6 Month Follow up|Lost to Follow-up|5|||
164361251|NCT02631850|593697226|FG000|6 Month Follow up|Withdrawal by Subject|1|||
164361252|NCT02631850|593697227|FG001|6 Month Follow up|Withdrawal by Subject|0|||
164361253|NCT02631850|593697228|FG002|6 Month Follow up|Withdrawal by Subject|0|||
164361254|NCT02631850|593697229|FG003|6 Month Follow up|Withdrawal by Subject|2|||
164698253|NCT00262041|594918766|FG002|Overall Study|Withdrawal by Subject|1|||
164698254|NCT00262041|594918764|FG000|Overall Study|Lost to Follow-up|1|||
164698255|NCT00262041|594918765|FG001|Overall Study|Lost to Follow-up|1|||
164698256|NCT00262041|594918766|FG002|Overall Study|Lost to Follow-up|5|||
164698257|NCT00262041|594918764|FG000|Overall Study|Unable to classify|1|||
164698258|NCT00262041|594918765|FG001|Overall Study|Unable to classify|0|||
164698259|NCT00262041|594918766|FG002|Overall Study|Unable to classify|0|||
164698260|NCT03578237|594918769|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
164698261|NCT03578237|594918770|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
164698262|NCT01173471|594918771|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164698263|NCT01173471|594918772|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164698264|NCT01173471|594918773|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
164698265|NCT01173471|594918774|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
164698266|NCT01173471|594918771|FG000|Overall Study|Condition under investigation worsened|2|||
164698267|NCT01173471|594918772|FG001|Overall Study|Condition under investigation worsened|0|||
164698268|NCT01173471|594918773|FG002|Overall Study|Condition under investigation worsened|0|||
164698269|NCT01173471|594918774|FG003|Overall Study|Condition under investigation worsened|0|||
164698270|NCT01173471|594918771|FG000|Overall Study|Lost to Follow-up|0|||
164698271|NCT01173471|594918772|FG001|Overall Study|Lost to Follow-up|0|||
164698272|NCT01173471|594918773|FG002|Overall Study|Lost to Follow-up|1|||
164698273|NCT01173471|594918774|FG003|Overall Study|Lost to Follow-up|0|||
164698274|NCT01173471|594918771|FG000|Overall Study|Reason given as Other|0|||
164698275|NCT01173471|594918772|FG001|Overall Study|Reason given as Other|0|||
164361255|NCT02631850|593697226|FG000|6 Month Follow up|Adverse Event|1|||
164361256|NCT02631850|593697227|FG001|6 Month Follow up|Adverse Event|4|||
164361257|NCT02631850|593697228|FG002|6 Month Follow up|Adverse Event|1|||
164361258|NCT02631850|593697229|FG003|6 Month Follow up|Adverse Event|3|||
164361259|NCT02631850|593697226|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
164361260|NCT02631850|593697227|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
164361261|NCT02631850|593697228|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
164361262|NCT02631850|593697229|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
164361263|NCT00553150|593697250|FG000|Overall Study|Withdrawal by Subject|0|||
164438524|NCT00823979|593970812|FG002|Overall Study|Other|1|||
164698276|NCT01173471|594918773|FG002|Overall Study|Reason given as Other|1|||
164698277|NCT01173471|594918774|FG003|Overall Study|Reason given as Other|0|||
164698278|NCT03028740|594918776|FG000|Overall Study|Did not Receive Study Drug|4|||
164698279|NCT03028740|594918777|FG001|Overall Study|Did not Receive Study Drug|5|||
164361264|NCT00553150|593697251|FG001|Overall Study|Withdrawal by Subject|0|||
164361265|NCT00553150|593697252|FG002|Overall Study|Withdrawal by Subject|0|||
164361266|NCT00553150|593697253|FG003|Overall Study|Withdrawal by Subject|2|||
164361267|NCT00553150|593697250|FG000|Overall Study|Protocol Violation|0|||
164361268|NCT00553150|593697251|FG001|Overall Study|Protocol Violation|0|||
164361269|NCT00553150|593697252|FG002|Overall Study|Protocol Violation|0|||
164361270|NCT00553150|593697253|FG003|Overall Study|Protocol Violation|1|||
164361271|NCT00553150|593697250|FG000|Overall Study|Ineligible|0|||
164361272|NCT00553150|593697251|FG001|Overall Study|Ineligible|0|||
164361273|NCT00553150|593697252|FG002|Overall Study|Ineligible|0|||
164361274|NCT00553150|593697253|FG003|Overall Study|Ineligible|1|||
164361275|NCT00975481|593697255|FG000|Second Intervention Period|Adverse Event|2|||
164361276|NCT00975481|593697256|FG001|Second Intervention Period|Adverse Event|1|||
164361277|NCT00975481|593697257|FG002|Second Intervention Period|Adverse Event|0|||
164361278|NCT00975481|593697258|FG003|Second Intervention Period|Adverse Event|0|||
164361279|NCT00975481|593697259|FG004|Second Intervention Period|Adverse Event|0|||
164361280|NCT00975481|593697260|FG005|Second Intervention Period|Adverse Event|0|||
164361281|NCT00975481|593697255|FG000|Second Intervention Period|Withdrawal by Subject|0|||
164361282|NCT00975481|593697256|FG001|Second Intervention Period|Withdrawal by Subject|0|||
164361283|NCT00975481|593697257|FG002|Second Intervention Period|Withdrawal by Subject|1|||
164361284|NCT00975481|593697258|FG003|Second Intervention Period|Withdrawal by Subject|0|||
164361285|NCT00975481|593697259|FG004|Second Intervention Period|Withdrawal by Subject|0|||
164590822|NCT01808118|594527115|FG002|Period 1|Non-compliance per sponsor|0|||
164361286|NCT00975481|593697260|FG005|Second Intervention Period|Withdrawal by Subject|0|||
164361287|NCT00975481|593697255|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
164361288|NCT00975481|593697256|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
164361289|NCT00975481|593697257|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
164361290|NCT00975481|593697258|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
164361291|NCT00975481|593697259|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
164361292|NCT00975481|593697260|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
164361293|NCT00975481|593697255|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
164361294|NCT00975481|593697256|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
164361295|NCT00975481|593697257|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
164361296|NCT00975481|593697258|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
164361297|NCT00975481|593697259|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
164361298|NCT00975481|593697260|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
164361299|NCT03559257|593697263|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
164361300|NCT03559257|593697264|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
164361301|NCT03559257|593697263|FG000|Double Blind Treatment Period|Protocol Violation|1|||
164361302|NCT03559257|593697264|FG001|Double Blind Treatment Period|Protocol Violation|4|||
164361303|NCT03559257|593697263|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
164361304|NCT03559257|593697264|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
164361305|NCT03559257|593697263|FG000|Double Blind Treatment Period|Adverse Event|0|||
164590823|NCT01808118|594527113|FG000|Period 1|Lack of Efficacy|1|||
164590824|NCT01808118|594527114|FG001|Period 1|Lack of Efficacy|0|||
164590825|NCT01808118|594527115|FG002|Period 1|Lack of Efficacy|0|||
164590826|NCT01808118|594527113|FG000|Period 2|Adverse Event|0|||
164590827|NCT01808118|594527114|FG001|Period 2|Adverse Event|4|||
164590828|NCT01808118|594527115|FG002|Period 2|Adverse Event|0|||
164590829|NCT01808118|594527113|FG000|Period 2|Withdrew consent|0|||
164590830|NCT01808118|594527114|FG001|Period 2|Withdrew consent|7|||
164590831|NCT01808118|594527115|FG002|Period 2|Withdrew consent|6|||
164590832|NCT01808118|594527113|FG000|Period 2|Lost to Follow-up|0|||
164590833|NCT01808118|594527114|FG001|Period 2|Lost to Follow-up|0|||
164590834|NCT01808118|594527115|FG002|Period 2|Lost to Follow-up|2|||
164590835|NCT01808118|594527113|FG000|Period 2|Investigator no longer conducting trials|0|||
164590836|NCT01808118|594527114|FG001|Period 2|Investigator no longer conducting trials|1|||
164590837|NCT01808118|594527115|FG002|Period 2|Investigator no longer conducting trials|0|||
164590838|NCT01808118|594527113|FG000|Period 2|Switched to other therapy|0|||
164590839|NCT01808118|594527114|FG001|Period 2|Switched to other therapy|1|||
164590840|NCT01808118|594527115|FG002|Period 2|Switched to other therapy|0|||
164590841|NCT03041116|594527123|FG000|Double-blind|Death|0|||
164590842|NCT03041116|594527124|FG001|Double-blind|Death|2|||
164590843|NCT03041116|594527123|FG000|Double-blind|Withdrawal by Subject|0|||
164590844|NCT03041116|594527124|FG001|Double-blind|Withdrawal by Subject|4|||
164590845|NCT03041116|594527123|FG000|Open-label|Death|1|||
164590846|NCT03041116|594527124|FG001|Open-label|Death|0|||
164590847|NCT03041116|594527123|FG000|Open-label|Termination of the study by Sponsor|39|||
164590848|NCT03041116|594527124|FG001|Open-label|Termination of the study by Sponsor|37|||
164590849|NCT03041116|594527123|FG000|Open-label|Withdrawal by Subject|1|||
164361306|NCT03559257|593697264|FG001|Double Blind Treatment Period|Adverse Event|1|||
164361307|NCT03559257|593697263|FG000|Double Blind Treatment Period|Screen Failure|0|||
164361308|NCT03559257|593697264|FG001|Double Blind Treatment Period|Screen Failure|1|||
164361309|NCT03559257|593697263|FG000|Open-label Treatment Period|Adverse Event|1|||
164361310|NCT03559257|593697264|FG001|Open-label Treatment Period|Adverse Event|4|||
164361311|NCT03559257|593697263|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
164361312|NCT03559257|593697264|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
164361313|NCT03559257|593697263|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
164361314|NCT03559257|593697264|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
164361315|NCT03559257|593697263|FG000|Open-label Treatment Period|Protocol Violation|2|||
164361316|NCT03559257|593697264|FG001|Open-label Treatment Period|Protocol Violation|0|||
164361317|NCT03559257|593697263|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
164361318|NCT03559257|593697264|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
164361319|NCT03559257|593697263|FG000|Open-label Treatment Period|Physician Decision|0|||
164361320|NCT03559257|593697264|FG001|Open-label Treatment Period|Physician Decision|1|||
164361321|NCT03630120|593697266|FG000|Overall Study|Disease progression|0|||
164361322|NCT03630120|593697267|FG001|Overall Study|Disease progression|1|||
164361323|NCT03630120|593697268|FG002|Overall Study|Disease progression|1|||
164361324|NCT03630120|593697269|FG003|Overall Study|Disease progression|1|||
164361325|NCT03251079|593697270|FG000|Overall Study|Withdrawal by Subject|1|||
164361326|NCT01519960|593697271|FG000|Overall Study|Withdrawal from the study|26|||
164361327|NCT01519960|593697272|FG001|Overall Study|Withdrawal from the study|22|||
164361328|NCT01519960|593697273|FG002|Overall Study|Withdrawal from the study|5|||
164361329|NCT01387347|593697274|FG000|Overall Study|Lost to Follow-up|2|||
164698280|NCT03028740|594918776|FG000|Overall Study|Adverse Event|8|||
164698281|NCT03028740|594918777|FG001|Overall Study|Adverse Event|26|||
164698282|NCT03028740|594918776|FG000|Overall Study|Lack of Efficacy|0|||
164698283|NCT03028740|594918777|FG001|Overall Study|Lack of Efficacy|1|||
164698284|NCT03028740|594918776|FG000|Overall Study|Withdrawal by Subject|48|||
164698285|NCT03028740|594918777|FG001|Overall Study|Withdrawal by Subject|101|||
164698286|NCT03028740|594918776|FG000|Overall Study|Lost to Follow-up|30|||
164698287|NCT03028740|594918777|FG001|Overall Study|Lost to Follow-up|54|||
164698288|NCT03028740|594918776|FG000|Overall Study|Physician Decision|4|||
164698289|NCT03028740|594918777|FG001|Overall Study|Physician Decision|11|||
164698290|NCT03028740|594918776|FG000|Overall Study|Protocol Violation|4|||
164698291|NCT03028740|594918777|FG001|Overall Study|Protocol Violation|8|||
164698292|NCT03028740|594918776|FG000|Overall Study|Non-compliance with Study Drug|0|||
164698293|NCT03028740|594918777|FG001|Overall Study|Non-compliance with Study Drug|2|||
164698294|NCT03028740|594918776|FG000|Overall Study|Study Terminated by Sponsor|467|||
164698295|NCT03028740|594918777|FG001|Overall Study|Study Terminated by Sponsor|917|||
164698296|NCT03028740|594918776|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
164698297|NCT03028740|594918777|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
164698298|NCT03028740|594918776|FG000|Overall Study|Reason not Specified|1|||
164698299|NCT03028740|594918777|FG001|Overall Study|Reason not Specified|5|||
164698300|NCT00171301|594918778|FG000|Overall Study|Death|1|||
164698301|NCT00171301|594918779|FG001|Overall Study|Death|2|||
164698302|NCT00171301|594918778|FG000|Overall Study|Adverse Event|1|||
164698303|NCT00171301|594918779|FG001|Overall Study|Adverse Event|2|||
164698304|NCT00171301|594918778|FG000|Overall Study|Lost to Follow-up|6|||
164698305|NCT00171301|594918779|FG001|Overall Study|Lost to Follow-up|2|||
164698306|NCT00171301|594918778|FG000|Overall Study|Protocol Violation|0|||
164698307|NCT00171301|594918779|FG001|Overall Study|Protocol Violation|2|||
164698308|NCT00171301|594918778|FG000|Overall Study|Withdrawal by Subject|0|||
164698309|NCT00171301|594918779|FG001|Overall Study|Withdrawal by Subject|1|||
164698310|NCT00252174|594918783|FG000|Overall Study|Withdrawal by Subject|0|||
164698311|NCT00252174|594918784|FG001|Overall Study|Withdrawal by Subject|1|||
164698312|NCT00252174|594918785|FG002|Overall Study|Withdrawal by Subject|0|||
164698313|NCT01138826|594918786|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
164698314|NCT01138826|594918787|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
164698315|NCT01138826|594918788|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
164698316|NCT01138826|594918789|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
164698317|NCT01138826|594918790|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
164361330|NCT01387347|593697275|FG001|Overall Study|Lost to Follow-up|1|||
164361331|NCT00492115|593697281|FG000|Overall Study|Withdrawal by Subject|3|||
164361332|NCT00492115|593697282|FG001|Overall Study|Withdrawal by Subject|4|||
164361333|NCT02515045|593697290|FG000|Overall Study|Adverse Event|0|||
164361334|NCT02515045|593697291|FG001|Overall Study|Adverse Event|3|||
164361335|NCT02515045|593697292|FG002|Overall Study|Adverse Event|3|||
164698318|NCT01138826|594918791|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
164698319|NCT02566993|594918792|FG000|Overall Study|Randomized but not treated|5|||
164698320|NCT02566993|594918793|FG001|Overall Study|Randomized but not treated|16|||
164698321|NCT02566993|594918792|FG000|Overall Study|Progressive disease|213|||
164698322|NCT02566993|594918793|FG001|Overall Study|Progressive disease|152|||
164698323|NCT02566993|594918792|FG000|Overall Study|Withdrawal by Subject|12|||
164698324|NCT02566993|594918793|FG001|Overall Study|Withdrawal by Subject|28|||
164698325|NCT02566993|594918792|FG000|Overall Study|Death|17|||
164361336|NCT02515045|593697290|FG000|Overall Study|Lost to Follow-up|0|||
164361337|NCT02515045|593697291|FG001|Overall Study|Lost to Follow-up|1|||
164361338|NCT02515045|593697292|FG002|Overall Study|Lost to Follow-up|1|||
164361339|NCT03255382|593697293|FG000|Overall Study|Adverse Event|3|||
164361340|NCT03255382|593697294|FG001|Overall Study|Adverse Event|0|||
164361341|NCT03255382|593697293|FG000|Overall Study|Lost to Follow-up|2|||
164361342|NCT03255382|593697294|FG001|Overall Study|Lost to Follow-up|0|||
164361343|NCT03255382|593697293|FG000|Overall Study|Withdrawal by Subject|2|||
164361344|NCT03255382|593697294|FG001|Overall Study|Withdrawal by Subject|0|||
164361345|NCT03255382|593697293|FG000|Overall Study|Other|6|||
164361346|NCT03255382|593697294|FG001|Overall Study|Other|0|||
164361347|NCT00624052|593697297|FG000|Overall Study|Adverse Event|7|||
164361348|NCT00624052|593697298|FG001|Overall Study|Adverse Event|6|||
164361349|NCT00624052|593697299|FG002|Overall Study|Adverse Event|0|||
164361350|NCT00624052|593697300|FG003|Overall Study|Adverse Event|3|||
164361351|NCT00624052|593697297|FG000|Overall Study|Lack of Efficacy|1|||
164361352|NCT00624052|593697298|FG001|Overall Study|Lack of Efficacy|1|||
164361353|NCT00624052|593697299|FG002|Overall Study|Lack of Efficacy|0|||
164361354|NCT00624052|593697300|FG003|Overall Study|Lack of Efficacy|0|||
164361355|NCT00624052|593697297|FG000|Overall Study|Lost to Follow-up|2|||
164361356|NCT00624052|593697298|FG001|Overall Study|Lost to Follow-up|3|||
164361357|NCT00624052|593697299|FG002|Overall Study|Lost to Follow-up|1|||
164361358|NCT00624052|593697300|FG003|Overall Study|Lost to Follow-up|0|||
164361359|NCT00624052|593697297|FG000|Overall Study|Non compliant with the protocol|2|||
164361360|NCT00624052|593697298|FG001|Overall Study|Non compliant with the protocol|1|||
164361361|NCT00624052|593697299|FG002|Overall Study|Non compliant with the protocol|1|||
164361362|NCT00624052|593697300|FG003|Overall Study|Non compliant with the protocol|1|||
164361363|NCT00624052|593697297|FG000|Overall Study|Consent withdrawn|3|||
164361364|NCT00624052|593697298|FG001|Overall Study|Consent withdrawn|1|||
164361365|NCT00624052|593697299|FG002|Overall Study|Consent withdrawn|1|||
164361366|NCT00624052|593697300|FG003|Overall Study|Consent withdrawn|0|||
164361367|NCT00624052|593697297|FG000|Overall Study|Changed job/ran out if meds|0|||
164361368|NCT00624052|593697298|FG001|Overall Study|Changed job/ran out if meds|2|||
164698326|NCT02566993|594918793|FG001|Overall Study|Death|23|||
164698327|NCT02566993|594918792|FG000|Overall Study|Physician Decision|10|||
164698328|NCT02566993|594918793|FG001|Overall Study|Physician Decision|17|||
164698329|NCT02566993|594918792|FG000|Overall Study|Study drug-related adverse event|20|||
164698330|NCT02566993|594918793|FG001|Overall Study|Study drug-related adverse event|41|||
164698331|NCT02566993|594918792|FG000|Overall Study|Non study drug-related adverse event|9|||
164698332|NCT02566993|594918793|FG001|Overall Study|Non study drug-related adverse event|9|||
164698333|NCT02566993|594918792|FG000|Overall Study|Symptomatic deterioration|9|||
164698334|NCT02566993|594918793|FG001|Overall Study|Symptomatic deterioration|16|||
164698335|NCT02566993|594918792|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
164698336|NCT02566993|594918793|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
164698337|NCT02566993|594918792|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
164698338|NCT02566993|594918793|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
164698339|NCT02566993|594918792|FG000|Overall Study|Screening failure|2|||
164698340|NCT02566993|594918793|FG001|Overall Study|Screening failure|0|||
164698341|NCT02566993|594918792|FG000|Overall Study|Lost to Follow-up|0|||
164698342|NCT02566993|594918793|FG001|Overall Study|Lost to Follow-up|1|||
164698343|NCT02566993|594918792|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
164698344|NCT02566993|594918793|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
164698345|NCT05206448|594918794|FG000|Overall Study|Lost to Follow-up|2|||
164698346|NCT05206448|594918795|FG001|Overall Study|Lost to Follow-up|2|||
164698347|NCT05206448|594918794|FG000|Overall Study|Withdrawal by Subject|2|||
164698348|NCT05206448|594918795|FG001|Overall Study|Withdrawal by Subject|0|||
164698349|NCT05206448|594918794|FG000|Overall Study|found ineligible after randomization|1|||
164698350|NCT05206448|594918795|FG001|Overall Study|found ineligible after randomization|1|||
164698351|NCT05206448|594918794|FG000|Overall Study|unable to complete study due to personal constraints|1|||
164698352|NCT05206448|594918795|FG001|Overall Study|unable to complete study due to personal constraints|0|||
164698353|NCT05206448|594918794|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
164698354|NCT05206448|594918795|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
164698355|NCT04572243|594918796|FG000|Core Study: 14 Weeks|Adverse Event|1|||
164698356|NCT04572243|594918797|FG001|Core Study: 14 Weeks|Adverse Event|2|||
164698357|NCT04572243|594918798|FG002|Core Study: 14 Weeks|Adverse Event|0|||
164698358|NCT04572243|594918799|FG003|Core Study: 14 Weeks|Adverse Event|0|||
164361369|NCT00624052|593697299|FG002|Overall Study|Changed job/ran out if meds|0|||
164361370|NCT00624052|593697300|FG003|Overall Study|Changed job/ran out if meds|0|||
164361371|NCT02291055|593697303|FG000|Overall Study|Death|2|||
164361372|NCT02291055|593697304|FG001|Overall Study|Death|2|||
164361373|NCT02291055|593697305|FG002|Overall Study|Death|5|||
164361374|NCT02291055|593697306|FG003|Overall Study|Death|8|||
164361375|NCT02291055|593697307|FG004|Overall Study|Death|12|||
164361376|NCT02291055|593697303|FG000|Overall Study|Lost to Follow-up|0|||
164361377|NCT02291055|593697304|FG001|Overall Study|Lost to Follow-up|0|||
164361378|NCT02291055|593697305|FG002|Overall Study|Lost to Follow-up|0|||
164361379|NCT02291055|593697306|FG003|Overall Study|Lost to Follow-up|1|||
164361380|NCT02291055|593697307|FG004|Overall Study|Lost to Follow-up|2|||
164361381|NCT02291055|593697303|FG000|Overall Study|Withdrawal by Subject|3|||
164361382|NCT02291055|593697304|FG001|Overall Study|Withdrawal by Subject|1|||
164361383|NCT02291055|593697305|FG002|Overall Study|Withdrawal by Subject|1|||
164361384|NCT02291055|593697306|FG003|Overall Study|Withdrawal by Subject|5|||
164361385|NCT02291055|593697307|FG004|Overall Study|Withdrawal by Subject|10|||
164361386|NCT02291055|593697303|FG000|Overall Study|Progressive Disease|0|||
164361387|NCT02291055|593697304|FG001|Overall Study|Progressive Disease|0|||
164361388|NCT02291055|593697305|FG002|Overall Study|Progressive Disease|1|||
164361389|NCT02291055|593697306|FG003|Overall Study|Progressive Disease|4|||
164361390|NCT02291055|593697307|FG004|Overall Study|Progressive Disease|2|||
164361391|NCT02291055|593697303|FG000|Overall Study|Study Terminated by Sponsor|0|||
164361392|NCT02291055|593697304|FG001|Overall Study|Study Terminated by Sponsor|0|||
164361393|NCT02291055|593697305|FG002|Overall Study|Study Terminated by Sponsor|0|||
164361394|NCT02291055|593697306|FG003|Overall Study|Study Terminated by Sponsor|5|||
164698359|NCT04572243|594918796|FG000|Core Study: 14 Weeks|Subject choice|0|||
164698360|NCT04572243|594918797|FG001|Core Study: 14 Weeks|Subject choice|2|||
164698361|NCT04572243|594918798|FG002|Core Study: 14 Weeks|Subject choice|0|||
164698362|NCT04572243|594918799|FG003|Core Study: 14 Weeks|Subject choice|0|||
164698363|NCT04572243|594918796|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
164361395|NCT02291055|593697307|FG004|Overall Study|Study Terminated by Sponsor|1|||
164361396|NCT02291055|593697303|FG000|Overall Study|Other|0|||
164361397|NCT02291055|593697304|FG001|Overall Study|Other|2|||
164361398|NCT02291055|593697305|FG002|Overall Study|Other|1|||
164361399|NCT02291055|593697306|FG003|Overall Study|Other|4|||
164361400|NCT02291055|593697307|FG004|Overall Study|Other|0|||
164361401|NCT01523886|593697308|FG000|Overall Study|surgery cancelled|0|||
164361402|NCT01523886|593697309|FG001|Overall Study|surgery cancelled|1|||
164361403|NCT00679263|593697313|FG000|Visit 2/Dose 1|Adverse Event|1|||
164361404|NCT00679263|593697314|FG001|Visit 2/Dose 1|Adverse Event|0|||
164361405|NCT00679263|593697315|FG002|Visit 2/Dose 1|Adverse Event|0|||
164361406|NCT00679263|593697313|FG000|Visit 2/Dose 1|subject not compliance|1|||
164361407|NCT00679263|593697314|FG001|Visit 2/Dose 1|subject not compliance|1|||
164698364|NCT04572243|594918797|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
164361408|NCT00679263|593697315|FG002|Visit 2/Dose 1|subject not compliance|0|||
164361409|NCT01499563|593697323|FG000|Overall Study|Withdrawal by Subject|10|||
164361410|NCT01499563|593697324|FG001|Overall Study|Withdrawal by Subject|11|||
164361411|NCT01499563|593697325|FG002|Overall Study|Withdrawal by Subject|7|||
164698365|NCT04572243|594918798|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
164698366|NCT04572243|594918799|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
164698367|NCT04572243|594918796|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
164438525|NCT00823979|593970810|FG000|Overall Study|Randomized but not Treated|4|||
164698368|NCT04572243|594918797|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
164698369|NCT04572243|594918798|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
164698370|NCT04572243|594918799|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
164698371|NCT01661881|594918800|FG000|Overall Study|Disease Progression|1|||
164698372|NCT01790113|594918801|FG000|Overall Study|Adverse Event|2|||
164698373|NCT01790113|594918802|FG001|Overall Study|Adverse Event|7|||
164698374|NCT01790113|594918801|FG000|Overall Study|Study ended due to FDA clearance|1|||
164698375|NCT01790113|594918802|FG001|Overall Study|Study ended due to FDA clearance|68|||
164698376|NCT00775606|594918803|FG000|Overall Study|Study sponsor terminated funding|3|||
164698377|NCT00775606|594918804|FG001|Overall Study|Study sponsor terminated funding|0|||
164698378|NCT02278718|594918805|FG000|Overall Study|Adverse Event|1|||
164698379|NCT02278718|594918806|FG001|Overall Study|Adverse Event|0|||
164698380|NCT02278718|594918805|FG000|Overall Study|Lost to Follow-up|2|||
164698381|NCT02278718|594918806|FG001|Overall Study|Lost to Follow-up|4|||
164698382|NCT02278718|594918805|FG000|Overall Study|Withdrawal by Subject|1|||
164698383|NCT02278718|594918806|FG001|Overall Study|Withdrawal by Subject|4|||
164698384|NCT02278718|594918805|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
164698385|NCT02278718|594918806|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
164698386|NCT02278718|594918805|FG000|Overall Study|Missing|0|||
164698387|NCT02278718|594918806|FG001|Overall Study|Missing|1|||
164698388|NCT04440449|594918807|FG000|Overall Study|Lost to Follow-up|2|||
164698389|NCT04440449|594918808|FG001|Overall Study|Lost to Follow-up|0|||
164361412|NCT01499563|593697326|FG003|Overall Study|Withdrawal by Subject|8|||
164361413|NCT01499563|593697323|FG000|Overall Study|Physician Decision|2|||
164438526|NCT00823979|593970811|FG001|Overall Study|Randomized but not Treated|3|||
164361414|NCT01499563|593697324|FG001|Overall Study|Physician Decision|1|||
164361415|NCT01499563|593697325|FG002|Overall Study|Physician Decision|3|||
164361416|NCT01499563|593697326|FG003|Overall Study|Physician Decision|0|||
164438527|NCT00823979|593970812|FG002|Overall Study|Randomized but not Treated|1|||
164361417|NCT01499563|593697323|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
164361418|NCT01499563|593697324|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
164361419|NCT01499563|593697325|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
164361420|NCT01499563|593697326|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
164361421|NCT01499563|593697323|FG000|Overall Study|Adverse Event|2|||
164361422|NCT01499563|593697324|FG001|Overall Study|Adverse Event|0|||
164361423|NCT01499563|593697325|FG002|Overall Study|Adverse Event|1|||
164361424|NCT01499563|593697326|FG003|Overall Study|Adverse Event|3|||
164361425|NCT01499563|593697323|FG000|Overall Study|Lack of Efficacy|0|||
164361426|NCT01499563|593697324|FG001|Overall Study|Lack of Efficacy|1|||
164361427|NCT01499563|593697325|FG002|Overall Study|Lack of Efficacy|6|||
164361428|NCT01499563|593697326|FG003|Overall Study|Lack of Efficacy|3|||
164361429|NCT01499563|593697323|FG000|Overall Study|Other|8|||
164361430|NCT01499563|593697324|FG001|Overall Study|Other|6|||
164361431|NCT01499563|593697325|FG002|Overall Study|Other|6|||
164361432|NCT01499563|593697326|FG003|Overall Study|Other|4|||
164361433|NCT03658538|593697327|FG000|Overall Study|Death|2|||
164361434|NCT03658538|593697328|FG001|Overall Study|Death|1|||
164361435|NCT03658538|593697327|FG000|Overall Study|Cancer diagnosis|1|||
164361436|NCT03658538|593697328|FG001|Overall Study|Cancer diagnosis|0|||
164361437|NCT03658538|593697327|FG000|Overall Study|Change residence|1|||
164361438|NCT03658538|593697328|FG001|Overall Study|Change residence|2|||
164361439|NCT03658538|593697327|FG000|Overall Study|Lost to Follow-up|3|||
164361440|NCT03658538|593697328|FG001|Overall Study|Lost to Follow-up|3|||
164361441|NCT03658538|593697327|FG000|Overall Study|Unblinded|2|||
164361442|NCT03658538|593697328|FG001|Overall Study|Unblinded|3|||
164361443|NCT03658538|593697327|FG000|Overall Study|Physician Decision|0|||
164361444|NCT03658538|593697328|FG001|Overall Study|Physician Decision|1|||
164361445|NCT03658538|593697327|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
164361446|NCT03658538|593697328|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
164361447|NCT03658538|593697327|FG000|Overall Study|Evicted from home|1|||
164361448|NCT03658538|593697328|FG001|Overall Study|Evicted from home|0|||
164361449|NCT00597012|593697331|FG000|Overall Study|Death|1|||
164361450|NCT00597012|593697332|FG001|Overall Study|Death|1|||
164361451|NCT00597012|593697331|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
164361452|NCT00597012|593697332|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
164361453|NCT00597012|593697331|FG000|Overall Study|Withdrawal by Subject|7|||
164361454|NCT00597012|593697332|FG001|Overall Study|Withdrawal by Subject|4|||
164361455|NCT00597012|593697331|FG000|Overall Study|Ineligible|2|||
164361456|NCT00597012|593697332|FG001|Overall Study|Ineligible|0|||
164361457|NCT00597012|593697331|FG000|Overall Study|Lost to Follow-up|0|||
164361458|NCT00597012|593697332|FG001|Overall Study|Lost to Follow-up|2|||
164417411|NCT01474512|593899497|FG008|Long-Term Extension Period|Physician Decision|0|||
164417412|NCT01474512|593899498|FG009|Long-Term Extension Period|Physician Decision|0|||
164417413|NCT01474512|593899499|FG010|Long-Term Extension Period|Physician Decision|0|||
164417414|NCT01474512|593899500|FG011|Long-Term Extension Period|Physician Decision|0|||
164698390|NCT02547766|594918809|FG000|Overall Study|Withdrawal by Subject|1|||
164698391|NCT03212794|594918810|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
164698392|NCT03212794|594918811|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
164698393|NCT03212794|594918810|FG000|Overall Study|Lost to Follow-up|5|||
164698394|NCT03212794|594918811|FG001|Overall Study|Lost to Follow-up|6|||
164698395|NCT03212794|594918810|FG000|Overall Study|Incarcerated; unable to participate|2|||
164698396|NCT03212794|594918811|FG001|Overall Study|Incarcerated; unable to participate|0|||
164698397|NCT03212794|594918810|FG000|Overall Study|Withdrawal by Subject|1|||
164698398|NCT03212794|594918811|FG001|Overall Study|Withdrawal by Subject|0|||
164698399|NCT03212794|594918810|FG000|Overall Study|Death|0|||
164698400|NCT03212794|594918811|FG001|Overall Study|Death|1|||
164698401|NCT03212794|594918810|FG000|Overall Study|Found to be ineligible after allocation|0|||
164698402|NCT03212794|594918811|FG001|Overall Study|Found to be ineligible after allocation|1|||
164698403|NCT03212794|594918810|FG000|Overall Study|Relocated out of area|2|||
164698404|NCT03212794|594918811|FG001|Overall Study|Relocated out of area|0|||
164698405|NCT01144403|594918817|FG000|Overall Study|Lost to Follow-up|3|||
164698406|NCT01144403|594918817|FG000|Overall Study|Death|1|||
164698407|NCT01144403|594918817|FG000|Overall Study|Adverse Event|1|||
164698408|NCT02903238|594918821|FG000|Overall Study|Lost to Follow-up|4|||
164698409|NCT02777918|594918822|FG000|Overall Study|Medical reasons|1|||
164417415|NCT01474512|593899501|FG012|Long-Term Extension Period|Physician Decision|21|||
164417416|NCT01474512|593899502|FG013|Long-Term Extension Period|Physician Decision|21|||
164417417|NCT01474512|593899503|FG014|Long-Term Extension Period|Physician Decision|0|||
164417418|NCT01474512|593899504|FG015|Long-Term Extension Period|Physician Decision|0|||
164417419|NCT01474512|593899505|FG016|Long-Term Extension Period|Physician Decision|0|||
164417420|NCT01474512|593899506|FG017|Long-Term Extension Period|Physician Decision|0|||
164417421|NCT01474512|593899489|FG000|Long-Term Extension Period|Clinical Relapse|0|||
164417422|NCT01474512|593899490|FG001|Long-Term Extension Period|Clinical Relapse|0|||
164417423|NCT01474512|593899491|FG002|Long-Term Extension Period|Clinical Relapse|0|||
164417424|NCT01474512|593899492|FG003|Long-Term Extension Period|Clinical Relapse|0|||
164361459|NCT01290666|593699374|FG000|Overall Study|Lost to Follow-up|11|||
164361460|NCT01290666|593699374|FG000|Overall Study|Withdrawal by Subject|23|||
164361461|NCT01290666|593699374|FG000|Overall Study|Early Termination of Study|4|||
164361462|NCT05089682|593699375|FG000|Overall Study|Withdrawal by Subject|2|||
164361463|NCT03992781|593699376|FG000|Overall Study|Lost to Follow-up|5|||
164361464|NCT03992781|593699376|FG000|Overall Study|Adverse Event|1|||
164361465|NCT03992781|593699376|FG000|Overall Study|Lack of Efficacy|5|||
164361466|NCT01996826|593699377|FG000|Overall Study|Lost to Follow-up|6|||
164361467|NCT01996826|593699378|FG001|Overall Study|Lost to Follow-up|2|||
164361468|NCT01996826|593699377|FG000|Overall Study|Physician Decision|1|||
164361469|NCT01996826|593699378|FG001|Overall Study|Physician Decision|1|||
164361470|NCT00695396|593699379|FG000|Overall Study|Study Closed Prematurely|5|||
164361471|NCT00695396|593699380|FG001|Overall Study|Study Closed Prematurely|6|||
164361472|NCT00695396|593699381|FG002|Overall Study|Study Closed Prematurely|8|||
164361473|NCT00695396|593699379|FG000|Overall Study|Withdrawal by Subject|2|||
164361474|NCT00695396|593699380|FG001|Overall Study|Withdrawal by Subject|2|||
164361475|NCT00695396|593699381|FG002|Overall Study|Withdrawal by Subject|0|||
164361476|NCT00518323|593699383|FG000|Overall Study|Lack of Efficacy|14|||
164361477|NCT00518323|593699384|FG001|Overall Study|Lack of Efficacy|2|||
164361478|NCT00518323|593699385|FG002|Overall Study|Lack of Efficacy|4|||
164361479|NCT00518323|593699386|FG003|Overall Study|Lack of Efficacy|20|||
164361480|NCT00518323|593699383|FG000|Overall Study|Withdrawal by Subject|1|||
164361481|NCT00518323|593699384|FG001|Overall Study|Withdrawal by Subject|2|||
164361482|NCT00518323|593699385|FG002|Overall Study|Withdrawal by Subject|4|||
164361483|NCT00518323|593699386|FG003|Overall Study|Withdrawal by Subject|2|||
164361484|NCT00518323|593699383|FG000|Overall Study|Lost to Follow-up|0|||
164361485|NCT00518323|593699384|FG001|Overall Study|Lost to Follow-up|2|||
164361486|NCT00518323|593699385|FG002|Overall Study|Lost to Follow-up|1|||
164361487|NCT00518323|593699386|FG003|Overall Study|Lost to Follow-up|3|||
164361488|NCT00518323|593699383|FG000|Overall Study|Adverse Event|1|||
164361489|NCT00518323|593699384|FG001|Overall Study|Adverse Event|1|||
164361490|NCT00518323|593699385|FG002|Overall Study|Adverse Event|1|||
164361491|NCT00518323|593699386|FG003|Overall Study|Adverse Event|0|||
164361492|NCT00518323|593699383|FG000|Overall Study|Prohibited medication and others|3|||
164361493|NCT00518323|593699384|FG001|Overall Study|Prohibited medication and others|1|||
164361494|NCT00518323|593699385|FG002|Overall Study|Prohibited medication and others|1|||
164361495|NCT00518323|593699386|FG003|Overall Study|Prohibited medication and others|0|||
164361496|NCT03164928|593699387|FG000|Overall Study|Lost to Follow-up|1|||
164361497|NCT03164928|593699388|FG001|Overall Study|Lost to Follow-up|0|||
164361498|NCT00326950|593699393|FG000|Overall Study|Progressive Disease|1|||
164361499|NCT01514760|593699394|FG000|Overall Study|Lost to Follow-up|2|||
164361500|NCT01275833|593699395|FG000|Overall Study|Study terminated|1|||
164361501|NCT01275833|593699396|FG001|Overall Study|Study terminated|1|||
164361502|NCT02118012|593699398|FG000|Overall Study|Adverse Event|0|||
164361503|NCT02118012|593699399|FG001|Overall Study|Adverse Event|1|||
164361504|NCT02118012|593699398|FG000|Overall Study|Physician Decision|0|||
164361505|NCT02118012|593699399|FG001|Overall Study|Physician Decision|1|||
164361506|NCT00536107|593699400|FG000|Overall Study|Death|5|||
164361507|NCT00536107|593699401|FG001|Overall Study|Death|1|||
164361508|NCT00536107|593699400|FG000|Overall Study|Incorrect enrolment|1|||
164361509|NCT00536107|593699401|FG001|Overall Study|Incorrect enrolment|0|||
164361510|NCT00536107|593699400|FG000|Overall Study|Withdrawal by Subject|0|||
164361511|NCT00536107|593699401|FG001|Overall Study|Withdrawal by Subject|1|||
164361512|NCT00536107|593699400|FG000|Overall Study|Study Termination|2|||
164361513|NCT00536107|593699401|FG001|Overall Study|Study Termination|4|||
164361514|NCT03329690|593699402|FG000|Overall Study|Progressive disease per RECIST|85|||
164361515|NCT03329690|593699403|FG001|Overall Study|Progressive disease per RECIST|44|||
164361516|NCT03329690|593699404|FG002|Overall Study|Progressive disease per RECIST|6|||
164361517|NCT03329690|593699405|FG003|Overall Study|Progressive disease per RECIST|16|||
164361518|NCT03329690|593699406|FG004|Overall Study|Progressive disease per RECIST|20|||
164361519|NCT03329690|593699402|FG000|Overall Study|Clinical progression|7|||
164361520|NCT03329690|593699403|FG001|Overall Study|Clinical progression|4|||
164361521|NCT03329690|593699404|FG002|Overall Study|Clinical progression|1|||
164361522|NCT03329690|593699405|FG003|Overall Study|Clinical progression|1|||
164361523|NCT03329690|593699406|FG004|Overall Study|Clinical progression|1|||
164361524|NCT03329690|593699402|FG000|Overall Study|Adverse Event|22|||
164361525|NCT03329690|593699403|FG001|Overall Study|Adverse Event|4|||
164361526|NCT03329690|593699404|FG002|Overall Study|Adverse Event|0|||
164361527|NCT03329690|593699405|FG003|Overall Study|Adverse Event|1|||
164361528|NCT03329690|593699406|FG004|Overall Study|Adverse Event|2|||
164361529|NCT03329690|593699402|FG000|Overall Study|Death|2|||
164361530|NCT03329690|593699403|FG001|Overall Study|Death|0|||
164361531|NCT03329690|593699404|FG002|Overall Study|Death|0|||
164361532|NCT03329690|593699405|FG003|Overall Study|Death|1|||
164361533|NCT03329690|593699406|FG004|Overall Study|Death|0|||
164590850|NCT03041116|594527124|FG001|Open-label|Withdrawal by Subject|0|||
164590851|NCT03097328|594527125|FG000|Overall Study|Still on Therapy|2|||
164590852|NCT03097328|594527125|FG000|Overall Study|Progressive Disease|29|||
164590853|NCT03097328|594527125|FG000|Overall Study|Adverse Event|4|||
164361534|NCT03329690|593699402|FG000|Overall Study|Withdrawal by Subject|2|||
164361535|NCT03329690|593699403|FG001|Overall Study|Withdrawal by Subject|3|||
164361536|NCT03329690|593699404|FG002|Overall Study|Withdrawal by Subject|0|||
164361537|NCT03329690|593699405|FG003|Overall Study|Withdrawal by Subject|1|||
164361538|NCT03329690|593699406|FG004|Overall Study|Withdrawal by Subject|0|||
164361539|NCT03329690|593699402|FG000|Overall Study|Physician Decision|1|||
164361540|NCT03329690|593699403|FG001|Overall Study|Physician Decision|0|||
164361541|NCT03329690|593699404|FG002|Overall Study|Physician Decision|0|||
164361542|NCT03329690|593699405|FG003|Overall Study|Physician Decision|0|||
164361543|NCT03329690|593699406|FG004|Overall Study|Physician Decision|1|||
164361544|NCT03329690|593699402|FG000|Overall Study|Miscellaneous|6|||
164361545|NCT03329690|593699403|FG001|Overall Study|Miscellaneous|0|||
164361546|NCT03329690|593699404|FG002|Overall Study|Miscellaneous|0|||
164361547|NCT03329690|593699405|FG003|Overall Study|Miscellaneous|0|||
164361548|NCT03329690|593699406|FG004|Overall Study|Miscellaneous|0|||
164361549|NCT03329690|593699402|FG000|Overall Study|Did not receive treatment|1|||
164361550|NCT03329690|593699403|FG001|Overall Study|Did not receive treatment|0|||
164361551|NCT03329690|593699404|FG002|Overall Study|Did not receive treatment|0|||
164361552|NCT03329690|593699405|FG003|Overall Study|Did not receive treatment|1|||
164361553|NCT03329690|593699406|FG004|Overall Study|Did not receive treatment|0|||
164361554|NCT00619801|593699412|FG000|Overall Study|Lack of Efficacy|0|||
164361555|NCT00619801|593699413|FG001|Overall Study|Lack of Efficacy|1|||
164361556|NCT00619801|593699412|FG000|Overall Study|Withdrawal by Subject|1|||
164361557|NCT00619801|593699413|FG001|Overall Study|Withdrawal by Subject|1|||
164361558|NCT00619801|593699412|FG000|Overall Study|Loss of efficacy|0|||
164361559|NCT00619801|593699413|FG001|Overall Study|Loss of efficacy|1|||
164361560|NCT00450333|593699418|FG000|Overall Study|Study terminated|47|||
164361561|NCT00450333|593699419|FG001|Overall Study|Study terminated|54|||
164361562|NCT00450333|593699420|FG002|Overall Study|Study terminated|16|||
164361563|NCT00450333|593699421|FG003|Overall Study|Study terminated|21|||
164361564|NCT00450333|593699418|FG000|Overall Study|Adverse Event|1|||
164361565|NCT00450333|593699419|FG001|Overall Study|Adverse Event|7|||
164361566|NCT00450333|593699420|FG002|Overall Study|Adverse Event|2|||
164361567|NCT00450333|593699421|FG003|Overall Study|Adverse Event|2|||
164361568|NCT00450333|593699418|FG000|Overall Study|Protocol Violation|1|||
164361569|NCT00450333|593699419|FG001|Overall Study|Protocol Violation|0|||
164361570|NCT00450333|593699420|FG002|Overall Study|Protocol Violation|1|||
164361571|NCT00450333|593699421|FG003|Overall Study|Protocol Violation|0|||
164361572|NCT00450333|593699418|FG000|Overall Study|Withdrawal by Subject|1|||
164361573|NCT00450333|593699419|FG001|Overall Study|Withdrawal by Subject|0|||
164361574|NCT00450333|593699420|FG002|Overall Study|Withdrawal by Subject|3|||
164361575|NCT00450333|593699421|FG003|Overall Study|Withdrawal by Subject|0|||
164361576|NCT00450333|593699418|FG000|Overall Study|Kidney transplant|1|||
164361577|NCT00450333|593699419|FG001|Overall Study|Kidney transplant|0|||
164361578|NCT00450333|593699420|FG002|Overall Study|Kidney transplant|1|||
164361579|NCT00450333|593699421|FG003|Overall Study|Kidney transplant|3|||
164361580|NCT00450333|593699418|FG000|Overall Study|Death|3|||
164361581|NCT00450333|593699419|FG001|Overall Study|Death|2|||
164361582|NCT00450333|593699420|FG002|Overall Study|Death|2|||
164361583|NCT00450333|593699421|FG003|Overall Study|Death|2|||
164361584|NCT03855280|593699429|FG000|Treatment Phase|Adverse Event|1|||
164361585|NCT03855280|593699429|FG000|Treatment Phase|Withdrawal by Subject|1|||
164361586|NCT03855280|593699429|FG000|Continuation Phase|Protocol Violation|1|||
164361587|NCT03855280|593699429|FG000|Continuation Phase|Adverse Event|1|||
164361588|NCT03855280|593699429|FG000|Continuation Phase|Sponsor Concluded Study|1|||
164361589|NCT02738450|593699432|FG000|Overall Study|Withdrawal by Subject|0|||
164361590|NCT02738450|593699433|FG001|Overall Study|Withdrawal by Subject|2|||
164361591|NCT02738450|593699434|FG002|Overall Study|Withdrawal by Subject|0|||
164361592|NCT03204305|593699435|FG000|Overall Study|Lost to Follow-up|6|||
164361593|NCT03204305|593699436|FG001|Overall Study|Lost to Follow-up|4|||
164361594|NCT03204305|593699437|FG002|Overall Study|Lost to Follow-up|0|||
164361595|NCT03204305|593699438|FG003|Overall Study|Lost to Follow-up|0|||
164698410|NCT02777918|594918823|FG001|Overall Study|Medical reasons|2|||
164361596|NCT03204305|593699435|FG000|Overall Study|Physician Decision|1|||
164361597|NCT03204305|593699436|FG001|Overall Study|Physician Decision|0|||
164361598|NCT03204305|593699437|FG002|Overall Study|Physician Decision|0|||
164361599|NCT03204305|593699438|FG003|Overall Study|Physician Decision|0|||
164361600|NCT03204305|593699435|FG000|Overall Study|failure to place arterial line|2|||
164361601|NCT03204305|593699436|FG001|Overall Study|failure to place arterial line|1|||
164361602|NCT03204305|593699437|FG002|Overall Study|failure to place arterial line|0|||
164361603|NCT03204305|593699438|FG003|Overall Study|failure to place arterial line|0|||
164361604|NCT03204305|593699435|FG000|Overall Study|Withdrawal by Subject|2|||
164361605|NCT03204305|593699436|FG001|Overall Study|Withdrawal by Subject|0|||
164361606|NCT03204305|593699437|FG002|Overall Study|Withdrawal by Subject|0|||
164361607|NCT03204305|593699438|FG003|Overall Study|Withdrawal by Subject|0|||
164361608|NCT01165554|593699445|FG000|Overall Study|Withdrawal by Subject|23|||
164361609|NCT02951156|593699446|FG000|Overall Study|Death|3|||
164361610|NCT02951156|593699447|FG001|Overall Study|Death|8|||
164361611|NCT02951156|593699448|FG002|Overall Study|Death|5|||
164361612|NCT02951156|593699446|FG000|Overall Study|Progressive disease|1|||
164361613|NCT02951156|593699447|FG001|Overall Study|Progressive disease|0|||
164361614|NCT02951156|593699448|FG002|Overall Study|Progressive disease|1|||
164361615|NCT02951156|593699446|FG000|Overall Study|Withdrawal by Subject|0|||
164361616|NCT02951156|593699447|FG001|Overall Study|Withdrawal by Subject|0|||
164361617|NCT02951156|593699448|FG002|Overall Study|Withdrawal by Subject|1|||
164361618|NCT02951156|593699446|FG000|Overall Study|Study terminated by sponsor|0|||
164361619|NCT02951156|593699447|FG001|Overall Study|Study terminated by sponsor|0|||
164361620|NCT02951156|593699448|FG002|Overall Study|Study terminated by sponsor|1|||
164361621|NCT02951156|593699446|FG000|Overall Study|Other|5|||
164361622|NCT02951156|593699447|FG001|Overall Study|Other|1|||
164361623|NCT02951156|593699448|FG002|Overall Study|Other|2|||
164361624|NCT01603459|593699451|FG000|Overall Study|Adverse Event|5|||
164361625|NCT01603459|593699451|FG000|Overall Study|Withdrawal by Subject|5|||
164361626|NCT01603459|593699451|FG000|Overall Study|Lost to Follow-up|3|||
164361627|NCT01603459|593699451|FG000|Overall Study|Predefined discontinuation criteria|3|||
164361628|NCT01603459|593699451|FG000|Overall Study|Non-compliance|1|||
164361629|NCT01603459|593699451|FG000|Overall Study|Administrative reason|1|||
164361630|NCT01092182|593699452|FG000|Overall Study|Death|0|||
164361631|NCT01092182|593699453|FG001|Overall Study|Death|5|||
164361632|NCT01092182|593699454|FG002|Overall Study|Death|3|||
164361633|NCT01092182|593699452|FG000|Overall Study|participant safety|1|||
164361634|NCT01092182|593699453|FG001|Overall Study|participant safety|2|||
164361635|NCT01092182|593699454|FG002|Overall Study|participant safety|0|||
164361636|NCT01092182|593699452|FG000|Overall Study|Physician Decision|0|||
164361637|NCT01092182|593699453|FG001|Overall Study|Physician Decision|6|||
164361638|NCT01092182|593699454|FG002|Overall Study|Physician Decision|0|||
164361639|NCT01092182|593699452|FG000|Overall Study|Did not meet criteria|0|||
164361640|NCT01092182|593699453|FG001|Overall Study|Did not meet criteria|0|||
164361641|NCT01092182|593699454|FG002|Overall Study|Did not meet criteria|25|||
164361642|NCT01092182|593699452|FG000|Overall Study|Non-compliance|0|||
164361643|NCT01092182|593699453|FG001|Overall Study|Non-compliance|3|||
164361644|NCT01092182|593699454|FG002|Overall Study|Non-compliance|0|||
164361645|NCT01092182|593699452|FG000|Overall Study|Participant refused follow-up|0|||
164361646|NCT01092182|593699453|FG001|Overall Study|Participant refused follow-up|2|||
164361647|NCT01092182|593699454|FG002|Overall Study|Participant refused follow-up|0|||
164361648|NCT01641692|593699455|FG000|Treatment Period 1|Adverse Event|1|||
164361649|NCT01641692|593699456|FG001|Treatment Period 1|Adverse Event|0|||
164361650|NCT01641692|593699457|FG002|Treatment Period 1|Adverse Event|0|||
164361651|NCT01641692|593699458|FG003|Treatment Period 1|Adverse Event|0|||
164361652|NCT01641692|593699459|FG004|Treatment Period 1|Adverse Event|0|||
164361653|NCT01641692|593699460|FG005|Treatment Period 1|Adverse Event|0|||
164361654|NCT01641692|593699461|FG006|Treatment Period 1|Adverse Event|0|||
164361655|NCT01641692|593699462|FG007|Treatment Period 1|Adverse Event|0|||
164361656|NCT01641692|593699455|FG000|Treatment Period 1|Lack of Efficacy|0|||
164361657|NCT01641692|593699456|FG001|Treatment Period 1|Lack of Efficacy|0|||
164361658|NCT01641692|593699457|FG002|Treatment Period 1|Lack of Efficacy|0|||
164361659|NCT01641692|593699458|FG003|Treatment Period 1|Lack of Efficacy|0|||
164361660|NCT01641692|593699459|FG004|Treatment Period 1|Lack of Efficacy|0|||
164361661|NCT01641692|593699460|FG005|Treatment Period 1|Lack of Efficacy|0|||
164361662|NCT01641692|593699461|FG006|Treatment Period 1|Lack of Efficacy|0|||
164361663|NCT01641692|593699462|FG007|Treatment Period 1|Lack of Efficacy|1|||
164361664|NCT01641692|593699455|FG000|Treatment Period 1|Protocol Violation|1|||
164361665|NCT01641692|593699456|FG001|Treatment Period 1|Protocol Violation|0|||
164361666|NCT01641692|593699457|FG002|Treatment Period 1|Protocol Violation|0|||
164361667|NCT01641692|593699458|FG003|Treatment Period 1|Protocol Violation|0|||
164361668|NCT01641692|593699459|FG004|Treatment Period 1|Protocol Violation|2|||
164361669|NCT01641692|593699460|FG005|Treatment Period 1|Protocol Violation|0|||
164361670|NCT01641692|593699461|FG006|Treatment Period 1|Protocol Violation|0|||
164361671|NCT01641692|593699462|FG007|Treatment Period 1|Protocol Violation|0|||
164361672|NCT01641692|593699455|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
164438528|NCT00823979|593970810|FG000|Overall Study|Study Terminated by Sponsor|5|||
164361673|NCT01641692|593699456|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
164361674|NCT01641692|593699457|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
164361675|NCT01641692|593699458|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
164361676|NCT01641692|593699459|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
164361677|NCT01641692|593699460|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
164361678|NCT01641692|593699461|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
164361679|NCT01641692|593699462|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
164361680|NCT01641692|593699455|FG000|Treatment Period 1|Lost to Follow-up|0|||
164361681|NCT01641692|593699456|FG001|Treatment Period 1|Lost to Follow-up|0|||
164361682|NCT01641692|593699457|FG002|Treatment Period 1|Lost to Follow-up|1|||
164361683|NCT01641692|593699458|FG003|Treatment Period 1|Lost to Follow-up|0|||
164361684|NCT01641692|593699459|FG004|Treatment Period 1|Lost to Follow-up|0|||
164361685|NCT01641692|593699460|FG005|Treatment Period 1|Lost to Follow-up|0|||
164361686|NCT01641692|593699461|FG006|Treatment Period 1|Lost to Follow-up|0|||
164361687|NCT01641692|593699462|FG007|Treatment Period 1|Lost to Follow-up|0|||
164361688|NCT01641692|593699455|FG000|Treatment Period 1|Physician Decision|0|||
164361689|NCT01641692|593699456|FG001|Treatment Period 1|Physician Decision|0|||
164361690|NCT01641692|593699457|FG002|Treatment Period 1|Physician Decision|0|||
164361691|NCT01641692|593699458|FG003|Treatment Period 1|Physician Decision|0|||
164361692|NCT01641692|593699459|FG004|Treatment Period 1|Physician Decision|1|||
164361693|NCT01641692|593699460|FG005|Treatment Period 1|Physician Decision|0|||
164361694|NCT01641692|593699461|FG006|Treatment Period 1|Physician Decision|0|||
164361695|NCT01641692|593699462|FG007|Treatment Period 1|Physician Decision|0|||
164361696|NCT01641692|593699455|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164361697|NCT01641692|593699456|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164361698|NCT01641692|593699457|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164361699|NCT01641692|593699458|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164361700|NCT01641692|593699459|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164361701|NCT01641692|593699460|FG005|Treatment Period 1|Withdrawal by Subject|2|||
164361702|NCT01641692|593699461|FG006|Treatment Period 1|Withdrawal by Subject|0|||
164361703|NCT01641692|593699462|FG007|Treatment Period 1|Withdrawal by Subject|1|||
164361704|NCT01641692|593699455|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
164361705|NCT01641692|593699456|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
164361706|NCT01641692|593699457|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
164361707|NCT01641692|593699458|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
164361708|NCT01641692|593699459|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
164361709|NCT01641692|593699460|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
164361710|NCT01641692|593699461|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
164361711|NCT01641692|593699462|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
164361712|NCT01641692|593699455|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
164361713|NCT01641692|593699456|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
164361714|NCT01641692|593699457|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
164361715|NCT01641692|593699458|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
164361716|NCT01641692|593699459|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
164361717|NCT01641692|593699460|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
164361718|NCT01641692|593699461|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
164361719|NCT01641692|593699462|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
164361720|NCT01641692|593699455|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
164361721|NCT01641692|593699456|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
164361722|NCT01641692|593699457|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
164361723|NCT01641692|593699458|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
164361724|NCT01641692|593699459|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
164361725|NCT01641692|593699460|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
164361726|NCT01641692|593699461|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
164361727|NCT01641692|593699462|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
164361728|NCT01641692|593699455|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
164361729|NCT01641692|593699456|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
164361730|NCT01641692|593699457|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
164361731|NCT01641692|593699458|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
164361732|NCT01641692|593699459|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
164361733|NCT01641692|593699460|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
164361734|NCT01641692|593699461|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
164361735|NCT01641692|593699462|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
164361736|NCT01641692|593699455|FG000|Treatment Period 2|Lack of Efficacy|1|||
164361737|NCT01641692|593699456|FG001|Treatment Period 2|Lack of Efficacy|0|||
164361738|NCT01641692|593699457|FG002|Treatment Period 2|Lack of Efficacy|0|||
164361739|NCT01641692|593699458|FG003|Treatment Period 2|Lack of Efficacy|0|||
164361740|NCT01641692|593699459|FG004|Treatment Period 2|Lack of Efficacy|0|||
164361741|NCT01641692|593699460|FG005|Treatment Period 2|Lack of Efficacy|0|||
164361742|NCT01641692|593699461|FG006|Treatment Period 2|Lack of Efficacy|0|||
164361743|NCT01641692|593699462|FG007|Treatment Period 2|Lack of Efficacy|0|||
164361744|NCT01641692|593699455|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
164361745|NCT01641692|593699456|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164361746|NCT01641692|593699457|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164361747|NCT01641692|593699458|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164361748|NCT01641692|593699459|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164361749|NCT01641692|593699460|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164361750|NCT01641692|593699461|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164438529|NCT00823979|593970811|FG001|Overall Study|Study Terminated by Sponsor|5|||
164438530|NCT00823979|593970812|FG002|Overall Study|Study Terminated by Sponsor|7|||
164698411|NCT02777918|594918822|FG000|Overall Study|Too busy / stressed|1|||
164361751|NCT01641692|593699462|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164361752|NCT01641692|593699455|FG000|Treatment Period 2|Lost to Follow-up|0|||
164361753|NCT01641692|593699456|FG001|Treatment Period 2|Lost to Follow-up|0|||
164361754|NCT01641692|593699457|FG002|Treatment Period 2|Lost to Follow-up|0|||
164361755|NCT01641692|593699458|FG003|Treatment Period 2|Lost to Follow-up|0|||
164361756|NCT01641692|593699459|FG004|Treatment Period 2|Lost to Follow-up|0|||
164361757|NCT01641692|593699460|FG005|Treatment Period 2|Lost to Follow-up|1|||
164361758|NCT01641692|593699461|FG006|Treatment Period 2|Lost to Follow-up|0|||
164361759|NCT01641692|593699462|FG007|Treatment Period 2|Lost to Follow-up|0|||
164361760|NCT01641692|593699455|FG000|Treatment Period 2|Withdrawal by Subject|1|||
164361761|NCT01641692|593699456|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164361762|NCT01641692|593699457|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164361763|NCT01641692|593699458|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164361764|NCT01641692|593699459|FG004|Treatment Period 2|Withdrawal by Subject|0|||
164361765|NCT01641692|593699460|FG005|Treatment Period 2|Withdrawal by Subject|1|||
164361766|NCT01641692|593699461|FG006|Treatment Period 2|Withdrawal by Subject|0|||
164361767|NCT01641692|593699462|FG007|Treatment Period 2|Withdrawal by Subject|1|||
164361768|NCT01641692|593699455|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
164361769|NCT01641692|593699456|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
164361770|NCT01641692|593699457|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
164361771|NCT01641692|593699458|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
164361772|NCT01641692|593699459|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
164361773|NCT01641692|593699460|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
164361774|NCT01641692|593699461|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
164361775|NCT01641692|593699462|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
164361776|NCT01641692|593699455|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
164361777|NCT01641692|593699456|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
164361778|NCT01641692|593699457|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
164361779|NCT01641692|593699458|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
164361780|NCT01641692|593699459|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
164361781|NCT01641692|593699460|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
164361782|NCT01641692|593699461|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
164361783|NCT01641692|593699462|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
164361784|NCT01641692|593699455|FG000|Treatment Period 3|Adverse Event|0|||
164361785|NCT01641692|593699456|FG001|Treatment Period 3|Adverse Event|0|||
164361786|NCT01641692|593699457|FG002|Treatment Period 3|Adverse Event|0|||
164361787|NCT01641692|593699458|FG003|Treatment Period 3|Adverse Event|0|||
164361788|NCT01641692|593699459|FG004|Treatment Period 3|Adverse Event|0|||
164361789|NCT01641692|593699460|FG005|Treatment Period 3|Adverse Event|0|||
164361790|NCT01641692|593699461|FG006|Treatment Period 3|Adverse Event|1|||
164361791|NCT01641692|593699462|FG007|Treatment Period 3|Adverse Event|0|||
164361792|NCT01641692|593699455|FG000|Treatment Period 3|Protocol Violation|0|||
164361793|NCT01641692|593699456|FG001|Treatment Period 3|Protocol Violation|0|||
164361794|NCT01641692|593699457|FG002|Treatment Period 3|Protocol Violation|1|||
164361795|NCT01641692|593699458|FG003|Treatment Period 3|Protocol Violation|0|||
164361796|NCT01641692|593699459|FG004|Treatment Period 3|Protocol Violation|0|||
164698412|NCT02777918|594918823|FG001|Overall Study|Too busy / stressed|1|||
164698413|NCT02777918|594918822|FG000|Overall Study|Withdrawal by Subject|1|||
164361797|NCT01641692|593699460|FG005|Treatment Period 3|Protocol Violation|0|||
164361798|NCT01641692|593699461|FG006|Treatment Period 3|Protocol Violation|0|||
164361799|NCT01641692|593699462|FG007|Treatment Period 3|Protocol Violation|0|||
164361800|NCT01641692|593699455|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164361801|NCT01641692|593699456|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164361802|NCT01641692|593699457|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164361803|NCT01641692|593699458|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164361804|NCT01641692|593699459|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164361805|NCT01641692|593699460|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164361806|NCT01641692|593699461|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
164361807|NCT01641692|593699462|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164361808|NCT01641692|593699455|FG000|Treatment Period 3|Lost to Follow-up|0|||
164361809|NCT01641692|593699456|FG001|Treatment Period 3|Lost to Follow-up|1|||
164361810|NCT01641692|593699457|FG002|Treatment Period 3|Lost to Follow-up|0|||
164698414|NCT02777918|594918823|FG001|Overall Study|Withdrawal by Subject|1|||
164698415|NCT02510014|594918826|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
164698416|NCT02510014|594918827|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
164698417|NCT02510014|594918826|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
164361811|NCT01641692|593699458|FG003|Treatment Period 3|Lost to Follow-up|0|||
164698418|NCT02510014|594918827|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
164698419|NCT02510014|594918826|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
164438531|NCT05826431|593970813|FG000|Overall Study|Withdrawal by Subject|1|||
164361812|NCT01641692|593699459|FG004|Treatment Period 3|Lost to Follow-up|0|||
164361813|NCT01641692|593699460|FG005|Treatment Period 3|Lost to Follow-up|0|||
164361814|NCT01641692|593699461|FG006|Treatment Period 3|Lost to Follow-up|0|||
164361815|NCT01641692|593699462|FG007|Treatment Period 3|Lost to Follow-up|0|||
164361816|NCT01641692|593699455|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
164361817|NCT01641692|593699456|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
164361818|NCT01641692|593699457|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
164361819|NCT01641692|593699458|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
164361820|NCT01641692|593699459|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
164361821|NCT01641692|593699460|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
164361822|NCT01641692|593699461|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
164361823|NCT01641692|593699462|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
164361824|NCT01641692|593699455|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
164361825|NCT01641692|593699456|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
164361826|NCT01641692|593699457|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
164361827|NCT01641692|593699458|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
164361828|NCT01641692|593699459|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
164361829|NCT01641692|593699460|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
164361830|NCT01641692|593699461|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
164361831|NCT01641692|593699462|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
164361832|NCT01166178|593699463|FG000|Overall Study|Withdrawal by Subject|1|||
164361833|NCT01166178|593699464|FG001|Overall Study|Withdrawal by Subject|0|||
164361834|NCT01166178|593699463|FG000|Overall Study|Study was terminated|20|||
164361835|NCT01166178|593699464|FG001|Overall Study|Study was terminated|8|||
164361836|NCT04948450|593699465|FG000|Overall Study|Return home|1|||
164361837|NCT04948450|593699466|FG001|Overall Study|Return home|3|||
164361838|NCT01173718|593699477|FG000|Overall Study|Death|17|||
164361839|NCT01173718|593699477|FG000|Overall Study|Abandonment of study graft|27|||
164361840|NCT02005250|593699479|FG000|Overall Study|Lost to Follow-up|15|||
164361841|NCT02005250|593699480|FG001|Overall Study|Lost to Follow-up|5|||
164361842|NCT02738151|593699481|FG000|Overall Study|Randomized but not treated|4|||
164361843|NCT02738151|593699482|FG001|Overall Study|Randomized but not treated|1|||
164361844|NCT02738151|593699481|FG000|Overall Study|Adverse Event|4|||
164361845|NCT02738151|593699482|FG001|Overall Study|Adverse Event|5|||
164361846|NCT02738151|593699481|FG000|Overall Study|Hypoglycemia|0|||
164361847|NCT02738151|593699482|FG001|Overall Study|Hypoglycemia|1|||
164361848|NCT02738151|593699481|FG000|Overall Study|Poor Compliance to Protocol|4|||
164361849|NCT02738151|593699482|FG001|Overall Study|Poor Compliance to Protocol|3|||
164361850|NCT02738151|593699481|FG000|Overall Study|Other than specified above|11|||
164361851|NCT02738151|593699482|FG001|Overall Study|Other than specified above|21|||
164361852|NCT03333044|593699486|FG000|Overall Study|Pregnancy|1|||
164361853|NCT03333044|593699487|FG001|Overall Study|Pregnancy|0|||
164361854|NCT03333044|593699488|FG002|Overall Study|Pregnancy|0|||
164361855|NCT03333044|593699486|FG000|Overall Study|Lost to Follow-up|0|||
164361856|NCT03333044|593699487|FG001|Overall Study|Lost to Follow-up|14|||
164361857|NCT03333044|593699488|FG002|Overall Study|Lost to Follow-up|6|||
164361858|NCT04007094|593699496|FG000|Overall Study|Lost to Follow-up|1|||
164361859|NCT04007094|593699497|FG001|Overall Study|Lost to Follow-up|1|||
164361860|NCT02921776|593699502|FG000|Overall Study|patient deterioration, fatigue|2|||
164361861|NCT02921776|593699503|FG001|Overall Study|patient deterioration, fatigue|6|||
164361862|NCT02921776|593699504|FG002|Overall Study|patient deterioration, fatigue|0|||
164361863|NCT02921776|593699505|FG003|Overall Study|patient deterioration, fatigue|0|||
164361864|NCT02921776|593699506|FG004|Overall Study|patient deterioration, fatigue|0|||
164361865|NCT02921776|593699507|FG005|Overall Study|patient deterioration, fatigue|0|||
164361866|NCT02921776|593699508|FG006|Overall Study|patient deterioration, fatigue|0|||
164698420|NCT02510014|594918827|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
164698421|NCT02510014|594918826|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
164698422|NCT02510014|594918827|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
164698423|NCT02510014|594918826|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
164698424|NCT02510014|594918827|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
164698425|NCT02510014|594918826|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
164698426|NCT02510014|594918827|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
164698427|NCT02510014|594918826|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
164698428|NCT02510014|594918827|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
164698429|NCT02510014|594918826|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
164698430|NCT02510014|594918827|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
164698431|NCT02510014|594918826|FG000|Treatment Period|Adverse Event|11|||
164698432|NCT02510014|594918827|FG001|Treatment Period|Adverse Event|4|||
164698433|NCT02510014|594918826|FG000|Treatment Period|Withdrawal symptoms|3|||
164698434|NCT02510014|594918827|FG001|Treatment Period|Withdrawal symptoms|0|||
164361867|NCT02921776|593699509|FG007|Overall Study|patient deterioration, fatigue|0|||
164361868|NCT02921776|593699502|FG000|Overall Study|Withdrawal by Subject|0|||
164361869|NCT02921776|593699503|FG001|Overall Study|Withdrawal by Subject|2|||
164361870|NCT02921776|593699504|FG002|Overall Study|Withdrawal by Subject|0|||
164361871|NCT02921776|593699505|FG003|Overall Study|Withdrawal by Subject|1|||
164361872|NCT02921776|593699506|FG004|Overall Study|Withdrawal by Subject|1|||
164361873|NCT02921776|593699507|FG005|Overall Study|Withdrawal by Subject|0|||
164361874|NCT02921776|593699508|FG006|Overall Study|Withdrawal by Subject|8|||
164361875|NCT02921776|593699509|FG007|Overall Study|Withdrawal by Subject|1|||
164361876|NCT02921776|593699502|FG000|Overall Study|Death|0|||
164361877|NCT02921776|593699503|FG001|Overall Study|Death|0|||
164361878|NCT02921776|593699504|FG002|Overall Study|Death|0|||
164361879|NCT02921776|593699505|FG003|Overall Study|Death|2|||
164361880|NCT02921776|593699506|FG004|Overall Study|Death|0|||
164361881|NCT02921776|593699507|FG005|Overall Study|Death|0|||
164361882|NCT02921776|593699508|FG006|Overall Study|Death|0|||
164361883|NCT02921776|593699509|FG007|Overall Study|Death|0|||
164361884|NCT02921776|593699502|FG000|Overall Study|extubation or early discharge|0|||
164361885|NCT02921776|593699503|FG001|Overall Study|extubation or early discharge|0|||
164361886|NCT02921776|593699504|FG002|Overall Study|extubation or early discharge|0|||
164361887|NCT02921776|593699505|FG003|Overall Study|extubation or early discharge|5|||
164361888|NCT02921776|593699506|FG004|Overall Study|extubation or early discharge|5|||
164361889|NCT02921776|593699507|FG005|Overall Study|extubation or early discharge|0|||
164361890|NCT02921776|593699508|FG006|Overall Study|extubation or early discharge|0|||
164361891|NCT02921776|593699509|FG007|Overall Study|extubation or early discharge|0|||
164361892|NCT02921776|593699502|FG000|Overall Study|Lost to Follow-up|0|||
164361893|NCT02921776|593699503|FG001|Overall Study|Lost to Follow-up|0|||
164361894|NCT02921776|593699504|FG002|Overall Study|Lost to Follow-up|0|||
164361895|NCT02921776|593699505|FG003|Overall Study|Lost to Follow-up|0|||
164361896|NCT02921776|593699506|FG004|Overall Study|Lost to Follow-up|0|||
164361897|NCT02921776|593699507|FG005|Overall Study|Lost to Follow-up|2|||
164361898|NCT02921776|593699508|FG006|Overall Study|Lost to Follow-up|3|||
164361899|NCT02921776|593699509|FG007|Overall Study|Lost to Follow-up|6|||
164361900|NCT04350788|593699519|FG000|Overall Study|Lost to Follow-up|6|||
164361901|NCT04350788|593699520|FG001|Overall Study|Lost to Follow-up|2|||
164361902|NCT04350788|593699519|FG000|Overall Study|Withdrawal by Subject|2|||
164361903|NCT04350788|593699520|FG001|Overall Study|Withdrawal by Subject|4|||
164361904|NCT04350788|593699519|FG000|Overall Study|Protocol Violation|4|||
164361905|NCT04350788|593699520|FG001|Overall Study|Protocol Violation|0|||
164361906|NCT04537234|593699521|FG000|Overall Study|Withdrawal by Subject|2|||
164361907|NCT04537234|593699522|FG001|Overall Study|Withdrawal by Subject|0|||
164361908|NCT00378209|593699523|FG000|Overall Study|Progressive disease|11|||
164361909|NCT00378209|593699523|FG000|Overall Study|Adverse Event|3|||
164361910|NCT00378209|593699523|FG000|Overall Study|Initiation of non-protocol therapy|3|||
164361911|NCT00378209|593699523|FG000|Overall Study|Physician Decision|3|||
164361912|NCT00378209|593699523|FG000|Overall Study|Death|1|||
164361913|NCT00378209|593699523|FG000|Overall Study|Treatment delay|1|||
164361914|NCT02070744|593699524|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
164361915|NCT02070744|593699525|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
164361916|NCT02070744|593699526|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
164361917|NCT02070744|593699527|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
164361918|NCT02070744|593699528|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
164361919|NCT02070744|593699524|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
164361920|NCT02070744|593699525|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
164361921|NCT02070744|593699526|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
164361922|NCT02070744|593699527|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
164361923|NCT02070744|593699528|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
164361924|NCT02070744|593699524|FG000|OLE Phase (48 Weeks)|Other|0|||
164361925|NCT02070744|593699525|FG001|OLE Phase (48 Weeks)|Other|0|||
164361926|NCT02070744|593699526|FG002|OLE Phase (48 Weeks)|Other|0|||
164361927|NCT02070744|593699527|FG003|OLE Phase (48 Weeks)|Other|0|||
164361928|NCT02070744|593699528|FG004|OLE Phase (48 Weeks)|Other|1|||
164361929|NCT01239368|593701574|FG000|Overall Study|Principal investigator discretion|1|||
164361930|NCT01239368|593701575|FG001|Overall Study|Principal investigator discretion|0|||
164361931|NCT01239368|593701576|FG002|Overall Study|Principal investigator discretion|0|||
164590854|NCT03097328|594527125|FG000|Overall Study|Withdrawal by Subject|1|||
164590855|NCT03097328|594527125|FG000|Overall Study|Physician Decision|1|||
164590856|NCT03097328|594527125|FG000|Overall Study|Patient Decision|1|||
164590857|NCT03097328|594527125|FG000|Overall Study|Ineligible for Study Drug|1|||
164590858|NCT02023164|594527126|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
164590859|NCT02023164|594527127|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
164590860|NCT01675011|594527128|FG000|Overall Study|Trial terminated by Sponsor|3|||
164590861|NCT01675011|594527129|FG001|Overall Study|Trial terminated by Sponsor|1|||
164590862|NCT01984346|594527135|FG000|Overall Study|Physician Decision|4|||
164590863|NCT01984346|594527136|FG001|Overall Study|Physician Decision|2|||
164590864|NCT01984346|594527135|FG000|Overall Study|Withdrawal by Subject|2|||
164361932|NCT01239368|593701577|FG003|Overall Study|Principal investigator discretion|0|||
164361933|NCT01239368|593701578|FG004|Overall Study|Principal investigator discretion|1|||
164361934|NCT01239368|593701579|FG005|Overall Study|Principal investigator discretion|2|||
164361935|NCT01239368|593701580|FG006|Overall Study|Principal investigator discretion|0|||
164361936|NCT01239368|593701581|FG007|Overall Study|Principal investigator discretion|0|||
164361937|NCT01239368|593701582|FG008|Overall Study|Principal investigator discretion|0|||
164698435|NCT02510014|594918826|FG000|Treatment Period|Lost to Follow-up|80|||
164698436|NCT02510014|594918827|FG001|Treatment Period|Lost to Follow-up|19|||
164698437|NCT02510014|594918826|FG000|Treatment Period|Physician Decision|5|||
164361938|NCT01239368|593701583|FG009|Overall Study|Principal investigator discretion|1|||
164361939|NCT01239368|593701574|FG000|Overall Study|Disease progression on study|1|||
164361940|NCT01239368|593701575|FG001|Overall Study|Disease progression on study|1|||
164361941|NCT01239368|593701576|FG002|Overall Study|Disease progression on study|1|||
164361942|NCT01239368|593701577|FG003|Overall Study|Disease progression on study|1|||
164361943|NCT01239368|593701578|FG004|Overall Study|Disease progression on study|4|||
164361944|NCT01239368|593701579|FG005|Overall Study|Disease progression on study|2|||
164361945|NCT01239368|593701580|FG006|Overall Study|Disease progression on study|5|||
164361946|NCT01239368|593701581|FG007|Overall Study|Disease progression on study|0|||
164361947|NCT01239368|593701582|FG008|Overall Study|Disease progression on study|0|||
164361948|NCT01239368|593701583|FG009|Overall Study|Disease progression on study|2|||
164361949|NCT01239368|593701574|FG000|Overall Study|Refused further treatment|0|||
164361950|NCT01239368|593701575|FG001|Overall Study|Refused further treatment|0|||
164361951|NCT01239368|593701576|FG002|Overall Study|Refused further treatment|0|||
164361952|NCT01239368|593701577|FG003|Overall Study|Refused further treatment|0|||
164361953|NCT01239368|593701578|FG004|Overall Study|Refused further treatment|0|||
164361954|NCT01239368|593701579|FG005|Overall Study|Refused further treatment|0|||
164361955|NCT01239368|593701580|FG006|Overall Study|Refused further treatment|0|||
164361956|NCT01239368|593701581|FG007|Overall Study|Refused further treatment|0|||
164361957|NCT01239368|593701582|FG008|Overall Study|Refused further treatment|0|||
164361958|NCT01239368|593701583|FG009|Overall Study|Refused further treatment|1|||
164361959|NCT01239368|593701574|FG000|Overall Study|Death|0|||
164361960|NCT01239368|593701575|FG001|Overall Study|Death|0|||
164361961|NCT01239368|593701576|FG002|Overall Study|Death|0|||
164361962|NCT01239368|593701577|FG003|Overall Study|Death|0|||
164361963|NCT01239368|593701578|FG004|Overall Study|Death|0|||
164361964|NCT01239368|593701579|FG005|Overall Study|Death|0|||
164361965|NCT01239368|593701580|FG006|Overall Study|Death|1|||
164361966|NCT01239368|593701581|FG007|Overall Study|Death|0|||
164361967|NCT01239368|593701582|FG008|Overall Study|Death|0|||
164361968|NCT01239368|593701583|FG009|Overall Study|Death|0|||
164361969|NCT03181399|593701585|FG000|6 Months on Treatment|Protocol non-compliance|7|||
164361970|NCT03181399|593701585|FG000|6 Months on Treatment|Adverse Event|4|||
164361971|NCT03181399|593701585|FG000|6 Months on Treatment|Tried alternative treatment|2|||
164361972|NCT03181399|593701585|FG000|6 Months on Treatment|Lost to Follow-up|2|||
164361973|NCT03181399|593701585|FG000|6 Months on Treatment|Personal reasons|1|||
164361974|NCT03181399|593701585|FG000|3 Months Off-treatment|Parent unable to travel|1|||
164361975|NCT00939809|593701587|FG000|Overall Study|Adverse Event|2|||
164361976|NCT00939809|593701587|FG000|Overall Study|Death|1|||
164361977|NCT01921179|593701588|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
164361978|NCT01921179|593701589|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
164361979|NCT01921179|593701588|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
164361980|NCT01921179|593701589|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
164361981|NCT00858442|593701591|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
164361982|NCT00858442|593701592|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
164361983|NCT02016625|593701593|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
164361984|NCT02016625|593701594|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
164361985|NCT02016625|593701593|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
164361986|NCT02016625|593701594|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
164361987|NCT02016625|593701593|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
164361988|NCT02016625|593701594|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
164361989|NCT02603809|593701597|FG000|Overall Study|Withdrawal by Subject|4|||
164361990|NCT02603809|593701598|FG001|Overall Study|Withdrawal by Subject|1|||
164361991|NCT02603809|593701599|FG002|Overall Study|Withdrawal by Subject|2|||
164361992|NCT02603809|593701600|FG003|Overall Study|Withdrawal by Subject|3|||
164698438|NCT02510014|594918827|FG001|Treatment Period|Physician Decision|0|||
164698439|NCT02510014|594918826|FG000|Treatment Period|Withdrawal by Subject|67|||
164361993|NCT02603809|593701601|FG004|Overall Study|Withdrawal by Subject|3|||
164361994|NCT02603809|593701602|FG005|Overall Study|Withdrawal by Subject|4|||
164361995|NCT02603809|593701597|FG000|Overall Study|Lost to Follow-up|2|||
164361996|NCT02603809|593701598|FG001|Overall Study|Lost to Follow-up|3|||
164698440|NCT02510014|594918827|FG001|Treatment Period|Withdrawal by Subject|24|||
164698441|NCT02510014|594918826|FG000|Treatment Period|Withdrawn by the investigator|7|||
164698442|NCT02510014|594918827|FG001|Treatment Period|Withdrawn by the investigator|1|||
164361997|NCT02603809|593701599|FG002|Overall Study|Lost to Follow-up|1|||
164361998|NCT02603809|593701600|FG003|Overall Study|Lost to Follow-up|4|||
164361999|NCT02603809|593701601|FG004|Overall Study|Lost to Follow-up|2|||
164362000|NCT02603809|593701602|FG005|Overall Study|Lost to Follow-up|2|||
164362001|NCT02603809|593701597|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
164362002|NCT02603809|593701598|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
164362003|NCT02603809|593701599|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
164362004|NCT02603809|593701600|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
164362005|NCT02603809|593701601|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
164362006|NCT02603809|593701602|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
164362007|NCT02603809|593701597|FG000|Overall Study|Physician Decision|0|||
164362008|NCT02603809|593701598|FG001|Overall Study|Physician Decision|0|||
164362009|NCT02603809|593701599|FG002|Overall Study|Physician Decision|0|||
164362010|NCT02603809|593701600|FG003|Overall Study|Physician Decision|1|||
164362011|NCT02603809|593701601|FG004|Overall Study|Physician Decision|2|||
164362012|NCT02603809|593701602|FG005|Overall Study|Physician Decision|1|||
164362013|NCT02603809|593701597|FG000|Overall Study|Adverse Event|3|||
164362014|NCT02603809|593701598|FG001|Overall Study|Adverse Event|0|||
164362015|NCT02603809|593701599|FG002|Overall Study|Adverse Event|2|||
164362016|NCT02603809|593701600|FG003|Overall Study|Adverse Event|2|||
164362017|NCT02603809|593701601|FG004|Overall Study|Adverse Event|1|||
164362018|NCT02603809|593701602|FG005|Overall Study|Adverse Event|1|||
164362019|NCT02603809|593701597|FG000|Overall Study|Lack of Efficacy|0|||
164362020|NCT02603809|593701598|FG001|Overall Study|Lack of Efficacy|1|||
164362021|NCT02603809|593701599|FG002|Overall Study|Lack of Efficacy|0|||
164362022|NCT02603809|593701600|FG003|Overall Study|Lack of Efficacy|0|||
164362023|NCT02603809|593701601|FG004|Overall Study|Lack of Efficacy|0|||
164362024|NCT02603809|593701602|FG005|Overall Study|Lack of Efficacy|1|||
164362025|NCT00380978|593701604|FG000|Overall Study|Refused allocated intervention|0|||
164362026|NCT00380978|593701605|FG001|Overall Study|Refused allocated intervention|6|||
164362027|NCT00380978|593701604|FG000|Overall Study|Wrong study envelope|0|||
164362028|NCT00380978|593701605|FG001|Overall Study|Wrong study envelope|2|||
164362029|NCT00380978|593701604|FG000|Overall Study|Allocation prior to analgesia request|1|||
164362030|NCT00380978|593701605|FG001|Overall Study|Allocation prior to analgesia request|2|||
164362031|NCT00380978|593701604|FG000|Overall Study|Parous patient|1|||
164438532|NCT01697319|593970816|FG000|Primary Phase|Withdrawal by Subject|1|||
164438533|NCT01697319|593970816|FG000|Extension Phase|Terminated by Sponsor|15|||
164590865|NCT01984346|594527136|FG001|Overall Study|Withdrawal by Subject|2|||
164590866|NCT01984346|594527135|FG000|Overall Study|Enrollment Closed|8|||
164590867|NCT01984346|594527136|FG001|Overall Study|Enrollment Closed|1|||
164362032|NCT00380978|593701605|FG001|Overall Study|Parous patient|0|||
164362033|NCT01254227|593701606|FG000|Overall Study|Withdrawal by Subject|6|||
164362034|NCT01254227|593701606|FG000|Overall Study|Lost to Follow-up|6|||
164362035|NCT01254227|593701606|FG000|Overall Study|Adverse Event|5|||
164362036|NCT01254227|593701606|FG000|Overall Study|Abnormal test procedure result|5|||
164590868|NCT01984346|594527135|FG000|Overall Study|Insurance Coverage|1|||
164590869|NCT01984346|594527136|FG001|Overall Study|Insurance Coverage|0|||
164590870|NCT01984346|594527135|FG000|Overall Study|Intra-operative Exclusion|2|||
164590871|NCT01984346|594527136|FG001|Overall Study|Intra-operative Exclusion|0|||
164590872|NCT03100942|594527137|FG000|Randomized Treatment Period|Withdrew Consent|4|||
164590873|NCT03100942|594527138|FG001|Randomized Treatment Period|Withdrew Consent|5|||
164590874|NCT03100942|594527139|FG002|Randomized Treatment Period|Withdrew Consent|3|||
164590875|NCT03100942|594527140|FG003|Randomized Treatment Period|Withdrew Consent|3|||
164590876|NCT03100942|594527141|FG004|Randomized Treatment Period|Withdrew Consent|0|||
164590877|NCT03100942|594527142|FG005|Randomized Treatment Period|Withdrew Consent|0|||
164590878|NCT03100942|594527143|FG006|Randomized Treatment Period|Withdrew Consent|0|||
164590879|NCT03100942|594527137|FG000|Randomized Treatment Period|Adverse Event|5|||
164590880|NCT03100942|594527138|FG001|Randomized Treatment Period|Adverse Event|2|||
164590881|NCT03100942|594527139|FG002|Randomized Treatment Period|Adverse Event|1|||
164590882|NCT03100942|594527140|FG003|Randomized Treatment Period|Adverse Event|0|||
164590883|NCT03100942|594527141|FG004|Randomized Treatment Period|Adverse Event|0|||
164590884|NCT03100942|594527142|FG005|Randomized Treatment Period|Adverse Event|0|||
164590885|NCT03100942|594527143|FG006|Randomized Treatment Period|Adverse Event|0|||
164590886|NCT03100942|594527137|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
164590887|NCT03100942|594527138|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
164590888|NCT03100942|594527139|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
164590889|NCT03100942|594527140|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
164590890|NCT03100942|594527141|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
164590891|NCT03100942|594527142|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
164590892|NCT03100942|594527143|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
164590893|NCT03100942|594527137|FG000|Randomized Treatment Period|Protocol Violation|0|||
164590894|NCT03100942|594527138|FG001|Randomized Treatment Period|Protocol Violation|1|||
164590895|NCT03100942|594527139|FG002|Randomized Treatment Period|Protocol Violation|1|||
164590896|NCT03100942|594527140|FG003|Randomized Treatment Period|Protocol Violation|1|||
164590897|NCT03100942|594527141|FG004|Randomized Treatment Period|Protocol Violation|0|||
164590898|NCT03100942|594527142|FG005|Randomized Treatment Period|Protocol Violation|0|||
164590899|NCT03100942|594527143|FG006|Randomized Treatment Period|Protocol Violation|0|||
164590900|NCT03100942|594527137|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
164590901|NCT03100942|594527138|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
164590902|NCT03100942|594527139|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
164590903|NCT03100942|594527140|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
164362037|NCT01254227|593701606|FG000|Overall Study|Administrative problems|2|||
164362038|NCT01254227|593701606|FG000|Overall Study|Death|1|||
164362039|NCT01254227|593701606|FG000|Overall Study|Protocol deviation|1|||
164362040|NCT02750592|593701607|FG000|Overall Study|Adverse Event|3|||
164362041|NCT02750592|593701607|FG000|Overall Study|Lack of Efficacy|2|||
164362042|NCT02981342|593701608|FG000|Overall Study|Adverse Event|0|||
164362043|NCT02981342|593701609|FG001|Overall Study|Adverse Event|0|||
164362044|NCT02981342|593701610|FG002|Overall Study|Adverse Event|0|||
164362045|NCT02981342|593701611|FG003|Overall Study|Adverse Event|1|||
164362046|NCT02981342|593701608|FG000|Overall Study|Death|0|||
164362047|NCT02981342|593701609|FG001|Overall Study|Death|9|||
164362048|NCT02981342|593701610|FG002|Overall Study|Death|9|||
164362049|NCT02981342|593701611|FG003|Overall Study|Death|4|||
164362050|NCT02981342|593701608|FG000|Overall Study|Withdrawal by Subject|0|||
164362051|NCT02981342|593701609|FG001|Overall Study|Withdrawal by Subject|0|||
164362052|NCT02981342|593701610|FG002|Overall Study|Withdrawal by Subject|3|||
164362053|NCT02981342|593701611|FG003|Overall Study|Withdrawal by Subject|1|||
164362054|NCT02981342|593701608|FG000|Overall Study|Study closed by sponsor|0|||
164362055|NCT02981342|593701609|FG001|Overall Study|Study closed by sponsor|0|||
164362056|NCT02981342|593701610|FG002|Overall Study|Study closed by sponsor|1|||
164362057|NCT02981342|593701611|FG003|Overall Study|Study closed by sponsor|1|||
164362058|NCT02981342|593701608|FG000|Overall Study|Randomized, Never Treated|0|||
164362059|NCT02981342|593701609|FG001|Overall Study|Randomized, Never Treated|1|||
164362060|NCT02981342|593701610|FG002|Overall Study|Randomized, Never Treated|0|||
164362061|NCT02981342|593701611|FG003|Overall Study|Randomized, Never Treated|7|||
164362062|NCT02981342|593701608|FG000|Overall Study|Lost to Follow-up|0|||
164362063|NCT02981342|593701609|FG001|Overall Study|Lost to Follow-up|1|||
164362064|NCT02981342|593701610|FG002|Overall Study|Lost to Follow-up|0|||
164362065|NCT02981342|593701611|FG003|Overall Study|Lost to Follow-up|0|||
164362066|NCT03970733|593701612|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
164362067|NCT03970733|593701613|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
164362068|NCT03970733|593701614|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
164362069|NCT03970733|593701615|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
164362070|NCT03970733|593701616|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
164362071|NCT03970733|593701612|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
164362072|NCT03970733|593701613|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
164362073|NCT03970733|593701614|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
164362074|NCT03970733|593701615|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
164362075|NCT03970733|593701616|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
164362076|NCT03970733|593701612|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
164362077|NCT03970733|593701613|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
164362078|NCT03970733|593701614|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
164362079|NCT03970733|593701615|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
164362080|NCT03970733|593701616|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
164362081|NCT03970733|593701612|FG000|Main Study Phase (18 Months)|Other|1|||
164362082|NCT03970733|593701613|FG001|Main Study Phase (18 Months)|Other|1|||
164362083|NCT03970733|593701614|FG002|Main Study Phase (18 Months)|Other|0|||
164362084|NCT03970733|593701615|FG003|Main Study Phase (18 Months)|Other|0|||
164362085|NCT03970733|593701616|FG004|Main Study Phase (18 Months)|Other|0|||
164362086|NCT03970733|593701612|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
164362087|NCT03970733|593701613|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
164362088|NCT03970733|593701614|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
164362089|NCT03970733|593701615|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
164362090|NCT03970733|593701616|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
164362091|NCT02784821|593701620|FG000|Overall Study|Death|0|||
164438534|NCT04222959|593970819|FG000|Overall Study|Lost to Follow-up|76|||
164698443|NCT02510014|594918826|FG000|Treatment Period|Protocol Violation|4|||
164698444|NCT02510014|594918827|FG001|Treatment Period|Protocol Violation|4|||
164698445|NCT02510014|594918826|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
164698446|NCT02510014|594918827|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
164698447|NCT04179019|594918831|FG000|Overall Study|Lost to Follow-up|2|||
164698448|NCT04179019|594918831|FG000|Overall Study|Physician Decision|2|||
164698449|NCT04179019|594918831|FG000|Overall Study|Withdrawal by Subject|5|||
164698450|NCT04179019|594918831|FG000|Overall Study|Adverse Event|4|||
164362092|NCT02784821|593701621|FG001|Overall Study|Death|5|||
164362093|NCT02784821|593701622|FG002|Overall Study|Death|4|||
164362094|NCT02784821|593701623|FG003|Overall Study|Death|5|||
164362095|NCT02794103|593701624|FG000|Overall Study|Loss to follow up due to high sedation|3|||
164362096|NCT00112502|593701625|FG000|Overall Study|Withdrawal by Subject|0|||
164362097|NCT00112502|593701626|FG001|Overall Study|Withdrawal by Subject|1|||
164362098|NCT00112502|593701627|FG002|Overall Study|Withdrawal by Subject|1|||
164362099|NCT00112502|593701628|FG003|Overall Study|Withdrawal by Subject|4|||
164362100|NCT00112502|593701629|FG004|Overall Study|Withdrawal by Subject|2|||
164362101|NCT00112502|593701630|FG005|Overall Study|Withdrawal by Subject|5|||
164438535|NCT04222959|593970820|FG001|Overall Study|Lost to Follow-up|28|||
164362102|NCT00112502|593701631|FG006|Overall Study|Withdrawal by Subject|3|||
164362103|NCT00112502|593701632|FG007|Overall Study|Withdrawal by Subject|7|||
164362104|NCT00265343|593701635|FG000|Overall Study|Adverse Event|10|||
164362105|NCT00265343|593701636|FG001|Overall Study|Adverse Event|7|||
164362106|NCT00265343|593701635|FG000|Overall Study|Withdrawal by Subject|3|||
164362107|NCT00265343|593701636|FG001|Overall Study|Withdrawal by Subject|9|||
164362108|NCT00265343|593701635|FG000|Overall Study|Other|8|||
164362109|NCT00265343|593701636|FG001|Overall Study|Other|3|||
164362110|NCT02608268|593701637|FG000|Overall Study|Adverse Event|0|||
164362111|NCT02608268|593701638|FG001|Overall Study|Adverse Event|0|||
164362112|NCT02608268|593701639|FG002|Overall Study|Adverse Event|1|||
164362113|NCT02608268|593701640|FG003|Overall Study|Adverse Event|0|||
164362114|NCT02608268|593701641|FG004|Overall Study|Adverse Event|0|||
164362115|NCT02608268|593701642|FG005|Overall Study|Adverse Event|0|||
164362116|NCT02608268|593701643|FG006|Overall Study|Adverse Event|0|||
164362117|NCT02608268|593701644|FG007|Overall Study|Adverse Event|0|||
164362118|NCT02608268|593701645|FG008|Overall Study|Adverse Event|0|||
164362119|NCT02608268|593701646|FG009|Overall Study|Adverse Event|0|||
164362120|NCT02608268|593701647|FG010|Overall Study|Adverse Event|0|||
164362121|NCT02608268|593701648|FG011|Overall Study|Adverse Event|0|||
164362122|NCT02608268|593701649|FG012|Overall Study|Adverse Event|2|||
164362123|NCT02608268|593701650|FG013|Overall Study|Adverse Event|0|||
164362124|NCT02608268|593701651|FG014|Overall Study|Adverse Event|0|||
164362125|NCT02608268|593701652|FG015|Overall Study|Adverse Event|0|||
164362126|NCT02608268|593701653|FG016|Overall Study|Adverse Event|0|||
164362127|NCT02608268|593701654|FG017|Overall Study|Adverse Event|0|||
164362128|NCT02608268|593701655|FG018|Overall Study|Adverse Event|0|||
164362129|NCT02608268|593701656|FG019|Overall Study|Adverse Event|0|||
164362130|NCT02608268|593701657|FG020|Overall Study|Adverse Event|1|||
164362131|NCT02608268|593701658|FG021|Overall Study|Adverse Event|1|||
164362132|NCT02608268|593701659|FG022|Overall Study|Adverse Event|0|||
164362133|NCT02608268|593701660|FG023|Overall Study|Adverse Event|0|||
164362134|NCT02608268|593701661|FG024|Overall Study|Adverse Event|1|||
164362135|NCT02608268|593701662|FG025|Overall Study|Adverse Event|0|||
164362136|NCT02608268|593701663|FG026|Overall Study|Adverse Event|0|||
164698451|NCT01949116|594918832|FG000|Overall Study|Death|2|||
164698452|NCT01949116|594918833|FG001|Overall Study|Death|0|||
164698453|NCT01949116|594918832|FG000|Overall Study|Lost to Follow-up|1|||
164698454|NCT01949116|594918833|FG001|Overall Study|Lost to Follow-up|3|||
164698455|NCT01949116|594918832|FG000|Overall Study|Withdrawal by Subject|5|||
164698456|NCT01949116|594918833|FG001|Overall Study|Withdrawal by Subject|3|||
164698457|NCT00307931|594918844|FG000|Overall Study|Adverse Event|1|||
164698458|NCT00233987|594918849|FG000|Overall Study|Withdrawal by Subject|1|||
164698459|NCT00233987|594918849|FG000|Overall Study|Lack of Efficacy|2|||
164698460|NCT00233987|594918849|FG000|Overall Study|Reason Under Review|1|||
164698461|NCT00233987|594918849|FG000|Overall Study|Other - Not Protocol Specified|5|||
164698462|NCT00233987|594918849|FG000|Overall Study|Eligible but No Treatment Received|2|||
164698463|NCT00233987|594918849|FG000|Overall Study|Ineligible|4|||
164698464|NCT04553913|594918852|FG000|Overall Study|patient's block resolved prior to PACU|1|||
164698465|NCT04553913|594918852|FG000|Overall Study|did not use the device properly|5|||
164698466|NCT01481324|594918853|FG000|Overall Study|Missing Data|0|||
164698467|NCT01481324|594918854|FG001|Overall Study|Missing Data|2|||
164698468|NCT01481324|594918855|FG002|Overall Study|Missing Data|2|||
164698469|NCT04846881|594918858|FG000|Overall Study|Adverse Event|14|||
164698470|NCT04846881|594918859|FG001|Overall Study|Adverse Event|15|||
164698471|NCT04846881|594918858|FG000|Overall Study|Burden of study procedures|7|||
164698472|NCT04846881|594918859|FG001|Overall Study|Burden of study procedures|3|||
164698473|NCT04846881|594918858|FG000|Overall Study|Protocol deviation|6|||
164698474|NCT04846881|594918859|FG001|Overall Study|Protocol deviation|4|||
164698475|NCT04846881|594918858|FG000|Overall Study|Perceived lack of efficacy|5|||
164698476|NCT04846881|594918859|FG001|Overall Study|Perceived lack of efficacy|2|||
164698477|NCT04846881|594918858|FG000|Overall Study|Change of residence|2|||
164698478|NCT04846881|594918859|FG001|Overall Study|Change of residence|0|||
164698479|NCT04846881|594918858|FG000|Overall Study|Technical problems|0|||
164698480|NCT04846881|594918859|FG001|Overall Study|Technical problems|1|||
164698481|NCT04846881|594918858|FG000|Overall Study|Other than listed|3|||
164698482|NCT04846881|594918859|FG001|Overall Study|Other than listed|10|||
164698483|NCT04846881|594918858|FG000|Overall Study|No reason available|1|||
164698484|NCT04846881|594918859|FG001|Overall Study|No reason available|3|||
164698485|NCT04846881|594918858|FG000|Overall Study|Patient randomised in error|1|||
164698486|NCT04846881|594918859|FG001|Overall Study|Patient randomised in error|0|||
164362137|NCT02608268|593701664|FG027|Overall Study|Adverse Event|0|||
164362138|NCT02608268|593701665|FG028|Overall Study|Adverse Event|1|||
164362139|NCT02608268|593701666|FG029|Overall Study|Adverse Event|0|||
164362140|NCT02608268|593701637|FG000|Overall Study|Death|1|||
164362141|NCT02608268|593701638|FG001|Overall Study|Death|0|||
164362142|NCT02608268|593701639|FG002|Overall Study|Death|0|||
164362143|NCT02608268|593701640|FG003|Overall Study|Death|0|||
164362144|NCT02608268|593701641|FG004|Overall Study|Death|0|||
164362145|NCT02608268|593701642|FG005|Overall Study|Death|0|||
164362146|NCT02608268|593701643|FG006|Overall Study|Death|0|||
164362147|NCT02608268|593701644|FG007|Overall Study|Death|0|||
164362148|NCT02608268|593701645|FG008|Overall Study|Death|1|||
164362149|NCT02608268|593701646|FG009|Overall Study|Death|1|||
164362150|NCT02608268|593701647|FG010|Overall Study|Death|0|||
164362151|NCT02608268|593701648|FG011|Overall Study|Death|0|||
164362152|NCT02608268|593701649|FG012|Overall Study|Death|0|||
164362153|NCT02608268|593701650|FG013|Overall Study|Death|0|||
164362154|NCT02608268|593701651|FG014|Overall Study|Death|0|||
164362155|NCT02608268|593701652|FG015|Overall Study|Death|1|||
164362156|NCT02608268|593701653|FG016|Overall Study|Death|0|||
164362157|NCT02608268|593701654|FG017|Overall Study|Death|1|||
164362158|NCT02608268|593701655|FG018|Overall Study|Death|0|||
164362159|NCT02608268|593701656|FG019|Overall Study|Death|1|||
164362160|NCT02608268|593701657|FG020|Overall Study|Death|1|||
164362161|NCT02608268|593701658|FG021|Overall Study|Death|0|||
164362162|NCT02608268|593701659|FG022|Overall Study|Death|0|||
164362163|NCT02608268|593701660|FG023|Overall Study|Death|0|||
164362164|NCT02608268|593701661|FG024|Overall Study|Death|1|||
164362165|NCT02608268|593701662|FG025|Overall Study|Death|2|||
164362166|NCT02608268|593701663|FG026|Overall Study|Death|0|||
164362167|NCT02608268|593701664|FG027|Overall Study|Death|1|||
164362168|NCT02608268|593701665|FG028|Overall Study|Death|4|||
164362169|NCT02608268|593701666|FG029|Overall Study|Death|0|||
164362170|NCT02608268|593701637|FG000|Overall Study|Physician Decision|0|||
164362171|NCT02608268|593701638|FG001|Overall Study|Physician Decision|0|||
164362172|NCT02608268|593701639|FG002|Overall Study|Physician Decision|0|||
164362173|NCT02608268|593701640|FG003|Overall Study|Physician Decision|0|||
164362174|NCT02608268|593701641|FG004|Overall Study|Physician Decision|0|||
164362175|NCT02608268|593701642|FG005|Overall Study|Physician Decision|0|||
164362176|NCT02608268|593701643|FG006|Overall Study|Physician Decision|0|||
164362177|NCT02608268|593701644|FG007|Overall Study|Physician Decision|0|||
164362178|NCT02608268|593701645|FG008|Overall Study|Physician Decision|0|||
164362179|NCT02608268|593701646|FG009|Overall Study|Physician Decision|0|||
164362180|NCT02608268|593701647|FG010|Overall Study|Physician Decision|1|||
164362181|NCT02608268|593701648|FG011|Overall Study|Physician Decision|0|||
164362182|NCT02608268|593701649|FG012|Overall Study|Physician Decision|0|||
164362183|NCT02608268|593701650|FG013|Overall Study|Physician Decision|1|||
164362184|NCT02608268|593701651|FG014|Overall Study|Physician Decision|0|||
164362185|NCT02608268|593701652|FG015|Overall Study|Physician Decision|0|||
164362186|NCT02608268|593701653|FG016|Overall Study|Physician Decision|0|||
164362187|NCT02608268|593701654|FG017|Overall Study|Physician Decision|0|||
164362188|NCT02608268|593701655|FG018|Overall Study|Physician Decision|0|||
164698487|NCT01000610|594920518|FG000|Overall Study|Adverse Event|1|||
164698488|NCT01000610|594920518|FG000|Overall Study|Lost to Follow-up|4|||
164698489|NCT01000610|594920518|FG000|Overall Study|Treatment failure|1|||
164698490|NCT01010126|594920519|FG000|Overall Study|Withdrawal by Subject|1|||
164698491|NCT01010126|594920520|FG001|Overall Study|Withdrawal by Subject|0|||
164698492|NCT01010126|594920521|FG002|Overall Study|Withdrawal by Subject|1|||
164698493|NCT01010126|594920522|FG003|Overall Study|Withdrawal by Subject|0|||
164698494|NCT01010126|594920523|FG004|Overall Study|Withdrawal by Subject|3|||
164698495|NCT01010126|594920524|FG005|Overall Study|Withdrawal by Subject|0|||
164698496|NCT04495283|594920527|FG000|Overall Study|Physician Decision|0|||
164698497|NCT04495283|594920528|FG001|Overall Study|Physician Decision|0|||
164698498|NCT04495283|594920529|FG002|Overall Study|Physician Decision|1|||
164698499|NCT04495283|594920527|FG000|Overall Study|Withdrawal by Subject|0|||
164698500|NCT04495283|594920528|FG001|Overall Study|Withdrawal by Subject|1|||
164698501|NCT04495283|594920529|FG002|Overall Study|Withdrawal by Subject|1|||
164698502|NCT04495283|594920527|FG000|Overall Study|Other|1|||
164698503|NCT04495283|594920528|FG001|Overall Study|Other|0|||
164698504|NCT04495283|594920529|FG002|Overall Study|Other|1|||
164698505|NCT02177136|594920550|FG000|DB Phase|Withdrawal by Subject|2|||
164698506|NCT02177136|594920551|FG001|DB Phase|Withdrawal by Subject|0|||
164698507|NCT02177136|594920552|FG002|DB Phase|Withdrawal by Subject|0|||
164362189|NCT02608268|593701656|FG019|Overall Study|Physician Decision|0|||
164362190|NCT02608268|593701657|FG020|Overall Study|Physician Decision|0|||
164362191|NCT02608268|593701658|FG021|Overall Study|Physician Decision|0|||
164362192|NCT02608268|593701659|FG022|Overall Study|Physician Decision|1|||
164362193|NCT02608268|593701660|FG023|Overall Study|Physician Decision|1|||
164362194|NCT02608268|593701661|FG024|Overall Study|Physician Decision|1|||
164362195|NCT02608268|593701662|FG025|Overall Study|Physician Decision|0|||
164362196|NCT02608268|593701663|FG026|Overall Study|Physician Decision|0|||
164362197|NCT02608268|593701664|FG027|Overall Study|Physician Decision|2|||
164362198|NCT02608268|593701665|FG028|Overall Study|Physician Decision|1|||
164362199|NCT02608268|593701666|FG029|Overall Study|Physician Decision|1|||
164362200|NCT02608268|593701637|FG000|Overall Study|Progressive disease|12|||
164362201|NCT02608268|593701638|FG001|Overall Study|Progressive disease|8|||
164698508|NCT02177136|594920553|FG003|DB Phase|Withdrawal by Subject|0|||
164698509|NCT02177136|594920550|FG000|DB Phase|Discontinued Due to Pruritus|1|||
164698510|NCT02177136|594920551|FG001|DB Phase|Discontinued Due to Pruritus|3|||
164698511|NCT02177136|594920552|FG002|DB Phase|Discontinued Due to Pruritus|0|||
164362202|NCT02608268|593701639|FG002|Overall Study|Progressive disease|13|||
164362203|NCT02608268|593701640|FG003|Overall Study|Progressive disease|5|||
164362204|NCT02608268|593701641|FG004|Overall Study|Progressive disease|2|||
164362205|NCT02608268|593701642|FG005|Overall Study|Progressive disease|4|||
164362206|NCT02608268|593701643|FG006|Overall Study|Progressive disease|6|||
164362207|NCT02608268|593701644|FG007|Overall Study|Progressive disease|2|||
164362208|NCT02608268|593701645|FG008|Overall Study|Progressive disease|5|||
164362209|NCT02608268|593701646|FG009|Overall Study|Progressive disease|6|||
164362210|NCT02608268|593701647|FG010|Overall Study|Progressive disease|5|||
164362211|NCT02608268|593701648|FG011|Overall Study|Progressive disease|5|||
164362212|NCT02608268|593701649|FG012|Overall Study|Progressive disease|4|||
164362213|NCT02608268|593701650|FG013|Overall Study|Progressive disease|11|||
164362214|NCT02608268|593701651|FG014|Overall Study|Progressive disease|6|||
164362215|NCT02608268|593701652|FG015|Overall Study|Progressive disease|3|||
164362216|NCT02608268|593701653|FG016|Overall Study|Progressive disease|5|||
164362217|NCT02608268|593701654|FG017|Overall Study|Progressive disease|5|||
164362218|NCT02608268|593701655|FG018|Overall Study|Progressive disease|5|||
164362219|NCT02608268|593701656|FG019|Overall Study|Progressive disease|2|||
164362220|NCT02608268|593701657|FG020|Overall Study|Progressive disease|10|||
164362221|NCT02608268|593701658|FG021|Overall Study|Progressive disease|4|||
164362222|NCT02608268|593701659|FG022|Overall Study|Progressive disease|5|||
164362223|NCT02608268|593701660|FG023|Overall Study|Progressive disease|5|||
164362224|NCT02608268|593701661|FG024|Overall Study|Progressive disease|3|||
164362225|NCT02608268|593701662|FG025|Overall Study|Progressive disease|11|||
164362226|NCT02608268|593701663|FG026|Overall Study|Progressive disease|16|||
164362227|NCT02608268|593701664|FG027|Overall Study|Progressive disease|11|||
164362228|NCT02608268|593701665|FG028|Overall Study|Progressive disease|10|||
164362229|NCT02608268|593701666|FG029|Overall Study|Progressive disease|15|||
164362230|NCT02608268|593701637|FG000|Overall Study|Subject/guardian decision|1|||
164362231|NCT02608268|593701638|FG001|Overall Study|Subject/guardian decision|1|||
164362232|NCT02608268|593701639|FG002|Overall Study|Subject/guardian decision|2|||
164362233|NCT02608268|593701640|FG003|Overall Study|Subject/guardian decision|0|||
164362234|NCT02608268|593701641|FG004|Overall Study|Subject/guardian decision|0|||
164362235|NCT02608268|593701642|FG005|Overall Study|Subject/guardian decision|0|||
164362236|NCT02608268|593701643|FG006|Overall Study|Subject/guardian decision|0|||
164362237|NCT02608268|593701644|FG007|Overall Study|Subject/guardian decision|0|||
164362238|NCT02608268|593701645|FG008|Overall Study|Subject/guardian decision|2|||
164362239|NCT02608268|593701646|FG009|Overall Study|Subject/guardian decision|2|||
164362240|NCT02608268|593701647|FG010|Overall Study|Subject/guardian decision|0|||
164362241|NCT02608268|593701648|FG011|Overall Study|Subject/guardian decision|1|||
164362242|NCT02608268|593701649|FG012|Overall Study|Subject/guardian decision|0|||
164362243|NCT02608268|593701650|FG013|Overall Study|Subject/guardian decision|1|||
164362244|NCT02608268|593701651|FG014|Overall Study|Subject/guardian decision|0|||
164362245|NCT02608268|593701652|FG015|Overall Study|Subject/guardian decision|1|||
164362246|NCT02608268|593701653|FG016|Overall Study|Subject/guardian decision|0|||
164362247|NCT02608268|593701654|FG017|Overall Study|Subject/guardian decision|0|||
164362248|NCT02608268|593701655|FG018|Overall Study|Subject/guardian decision|1|||
164362249|NCT02608268|593701656|FG019|Overall Study|Subject/guardian decision|0|||
164362250|NCT02608268|593701657|FG020|Overall Study|Subject/guardian decision|0|||
164362251|NCT02608268|593701658|FG021|Overall Study|Subject/guardian decision|0|||
164362252|NCT02608268|593701659|FG022|Overall Study|Subject/guardian decision|1|||
164362253|NCT02608268|593701660|FG023|Overall Study|Subject/guardian decision|0|||
164362254|NCT02608268|593701661|FG024|Overall Study|Subject/guardian decision|0|||
164362255|NCT02608268|593701662|FG025|Overall Study|Subject/guardian decision|1|||
164362256|NCT02608268|593701663|FG026|Overall Study|Subject/guardian decision|1|||
164438536|NCT03254394|593970821|FG000|Overall Study|Withdrawal by Subject|0|||
164438537|NCT03254394|593970822|FG001|Overall Study|Withdrawal by Subject|2|||
164698512|NCT02177136|594920553|FG003|DB Phase|Discontinued Due to Pruritus|0|||
164698513|NCT02177136|594920550|FG000|DB Phase|Adverse Event|3|||
164698514|NCT02177136|594920551|FG001|DB Phase|Adverse Event|2|||
164698515|NCT02177136|594920552|FG002|DB Phase|Adverse Event|3|||
164698516|NCT02177136|594920553|FG003|DB Phase|Adverse Event|0|||
164698517|NCT02177136|594920550|FG000|DB Phase|Protocol Violation|0|||
164698518|NCT02177136|594920551|FG001|DB Phase|Protocol Violation|0|||
164698519|NCT02177136|594920552|FG002|DB Phase|Protocol Violation|1|||
164698520|NCT02177136|594920553|FG003|DB Phase|Protocol Violation|0|||
164362257|NCT02608268|593701664|FG027|Overall Study|Subject/guardian decision|1|||
164362258|NCT02608268|593701665|FG028|Overall Study|Subject/guardian decision|1|||
164362259|NCT02608268|593701666|FG029|Overall Study|Subject/guardian decision|0|||
164362260|NCT01859494|593701676|FG000|Overall Study|Adverse Event|1|||
164362261|NCT00297037|593701681|FG000|Overall Study|Withdrawal by Subject|2|||
164362262|NCT00297037|593701682|FG001|Overall Study|Withdrawal by Subject|0|||
164362263|NCT03814746|593701685|FG000|Overall Study|Participant decision|9|||
164362264|NCT03814746|593701686|FG001|Overall Study|Participant decision|6|||
164362265|NCT03814746|593701687|FG002|Overall Study|Participant decision|15|||
164362266|NCT03814746|593701685|FG000|Overall Study|Physician Decision|2|||
164698521|NCT02177136|594920550|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
164698522|NCT02177136|594920551|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
164362267|NCT03814746|593701686|FG001|Overall Study|Physician Decision|2|||
164362268|NCT03814746|593701687|FG002|Overall Study|Physician Decision|4|||
164362269|NCT03814746|593701685|FG000|Overall Study|Death|2|||
164362270|NCT03814746|593701686|FG001|Overall Study|Death|2|||
164362271|NCT03814746|593701687|FG002|Overall Study|Death|2|||
164362272|NCT03814746|593701685|FG000|Overall Study|Adverse Event|2|||
164362273|NCT03814746|593701686|FG001|Overall Study|Adverse Event|2|||
164362274|NCT03814746|593701687|FG002|Overall Study|Adverse Event|1|||
164362275|NCT03814746|593701685|FG000|Overall Study|Lost to Follow-up|2|||
164362276|NCT03814746|593701686|FG001|Overall Study|Lost to Follow-up|1|||
164362277|NCT03814746|593701687|FG002|Overall Study|Lost to Follow-up|2|||
164362278|NCT03814746|593701685|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164362279|NCT03814746|593701686|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
164362280|NCT03814746|593701687|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
164362281|NCT03814746|593701685|FG000|Overall Study|Pregnancy|0|||
164362282|NCT03814746|593701686|FG001|Overall Study|Pregnancy|1|||
164362283|NCT03814746|593701687|FG002|Overall Study|Pregnancy|1|||
164362284|NCT03814746|593701685|FG000|Overall Study|Protocol Violation|1|||
164362285|NCT03814746|593701686|FG001|Overall Study|Protocol Violation|0|||
164362286|NCT03814746|593701687|FG002|Overall Study|Protocol Violation|0|||
164362287|NCT00371254|593701693|FG000|Overall Study|Disease progression|13|||
164362288|NCT00371254|593701694|FG001|Overall Study|Disease progression|13|||
164362289|NCT00371254|593701693|FG000|Overall Study|Study drug toxicity|3|||
164362290|NCT00371254|593701694|FG001|Overall Study|Study drug toxicity|5|||
164362291|NCT00371254|593701693|FG000|Overall Study|Subject request|5|||
164362292|NCT00371254|593701694|FG001|Overall Study|Subject request|0|||
164362293|NCT00371254|593701693|FG000|Overall Study|Investigator Decision|2|||
164362294|NCT00371254|593701694|FG001|Overall Study|Investigator Decision|0|||
164362295|NCT00371254|593701693|FG000|Overall Study|Adverse event unrelated to study drug|0|||
164362296|NCT00371254|593701694|FG001|Overall Study|Adverse event unrelated to study drug|1|||
164362297|NCT00371254|593701693|FG000|Overall Study|Lost to Follow-up|0|||
164362298|NCT00371254|593701694|FG001|Overall Study|Lost to Follow-up|1|||
164362299|NCT00371254|593701693|FG000|Overall Study|Withdrawal by Subject|0|||
164362300|NCT00371254|593701694|FG001|Overall Study|Withdrawal by Subject|1|||
164362301|NCT01817725|593701695|FG000|Overall Study|Withdrawal by Subject|1|||
164362302|NCT00909779|593701696|FG000|Overall Study|Adverse Event|53|||
164362303|NCT00909779|593701697|FG001|Overall Study|Adverse Event|55|||
164362304|NCT00909779|593701696|FG000|Overall Study|Lack of Efficacy|7|||
164362305|NCT00909779|593701697|FG001|Overall Study|Lack of Efficacy|4|||
164362306|NCT00909779|593701696|FG000|Overall Study|Lost to Follow-up|19|||
164362307|NCT00909779|593701697|FG001|Overall Study|Lost to Follow-up|15|||
164362308|NCT00909779|593701696|FG000|Overall Study|Physician Decision|8|||
164362309|NCT00909779|593701697|FG001|Overall Study|Physician Decision|2|||
164362310|NCT00909779|593701696|FG000|Overall Study|Protocol Violation|2|||
164362311|NCT00909779|593701697|FG001|Overall Study|Protocol Violation|5|||
164362312|NCT00909779|593701696|FG000|Overall Study|Withdrawal by Subject|116|||
164362313|NCT00909779|593701697|FG001|Overall Study|Withdrawal by Subject|80|||
164362314|NCT00909779|593701696|FG000|Overall Study|Site Ceasing Operation|2|||
164362315|NCT00909779|593701697|FG001|Overall Study|Site Ceasing Operation|2|||
164362316|NCT00909779|593701696|FG000|Overall Study|Medical Monitor Decision|1|||
164362317|NCT00909779|593701697|FG001|Overall Study|Medical Monitor Decision|0|||
164362318|NCT00909779|593701696|FG000|Overall Study|Noncompliance|1|||
164362319|NCT00909779|593701697|FG001|Overall Study|Noncompliance|1|||
164362320|NCT00909779|593701696|FG000|Overall Study|Randomized in error|1|||
164362321|NCT00909779|593701697|FG001|Overall Study|Randomized in error|1|||
164362322|NCT02809677|593701698|FG000|Overall Study|Withdrawal by Subject|8|||
164362323|NCT05172544|593701701|FG000|Overall Study|Withdrawal by Subject|1|||
164362324|NCT05172544|593701702|FG001|Overall Study|Withdrawal by Subject|0|||
164362325|NCT05172544|593701703|FG002|Overall Study|Withdrawal by Subject|0|||
164362326|NCT05172544|593701701|FG000|Overall Study|Physician Decision|0|||
164362327|NCT05172544|593701702|FG001|Overall Study|Physician Decision|0|||
164362328|NCT05172544|593701703|FG002|Overall Study|Physician Decision|1|||
164362329|NCT04829318|593701704|FG000|Overall Study|Adverse Event|6|||
164362330|NCT04829318|593701704|FG000|Overall Study|Death|1|||
164362331|NCT04829318|593701704|FG000|Overall Study|Lost to Follow-up|1|||
164362332|NCT04829318|593701704|FG000|Overall Study|Physician Decision|1|||
164362333|NCT04829318|593701704|FG000|Overall Study|Withdrawal by Subject|19|||
164362334|NCT04829318|593701704|FG000|Overall Study|Site terminated by sponsor|1|||
164362335|NCT04829318|593701704|FG000|Overall Study|Sponsor decision|5|||
164362336|NCT04829318|593701704|FG000|Overall Study|Other|1|||
164362337|NCT00561080|593701710|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
164362338|NCT00561080|593701711|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
164362339|NCT00561080|593701712|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
164362340|NCT00561080|593701710|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
164362341|NCT00561080|593701711|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
164362342|NCT00561080|593701712|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
164362343|NCT00561080|593701710|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
164362344|NCT00561080|593701711|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
164362345|NCT00561080|593701712|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
164362346|NCT00561080|593701710|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
164362347|NCT00561080|593701711|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
164362348|NCT00561080|593701712|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
164362349|NCT00561080|593701710|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
164362350|NCT00561080|593701711|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
164362351|NCT00561080|593701712|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
164362352|NCT00561080|593701710|FG000|Vaccination Period (up to Month 4)|Other|0|||
164362353|NCT00561080|593701711|FG001|Vaccination Period (up to Month 4)|Other|2|||
164362354|NCT00561080|593701712|FG002|Vaccination Period (up to Month 4)|Other|1|||
164362355|NCT00561080|593701710|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
164362356|NCT00561080|593701711|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
164362357|NCT00561080|593701712|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
164362358|NCT00561080|593701710|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
164362359|NCT00561080|593701711|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
164362360|NCT00561080|593701712|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
164362361|NCT00561080|593701710|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
164362362|NCT00561080|593701711|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
164362363|NCT00561080|593701712|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
164698523|NCT02177136|594920552|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
164362364|NCT00561080|593701710|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
164362365|NCT00561080|593701711|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
164362366|NCT00561080|593701712|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
164362367|NCT02295995|593701713|FG000|Overall Study|Lost to Follow-up|5|||
164362368|NCT02295995|593701714|FG001|Overall Study|Lost to Follow-up|1|||
164362369|NCT03158051|593701717|FG000|Overall Study|Lost to Follow-up|41|||
164362370|NCT03158051|593701718|FG001|Overall Study|Lost to Follow-up|47|||
164362371|NCT03158051|593701717|FG000|Overall Study|Physician Decision|6|||
164362372|NCT03158051|593701718|FG001|Overall Study|Physician Decision|7|||
164362373|NCT03158051|593701717|FG000|Overall Study|Withdrawal by Subject|24|||
164362374|NCT03158051|593701718|FG001|Overall Study|Withdrawal by Subject|15|||
164362375|NCT03158051|593701717|FG000|Overall Study|Death|0|||
164362376|NCT03158051|593701718|FG001|Overall Study|Death|1|||
164362377|NCT02588833|593701719|FG000|Part 1|Withdrawal by Subject|1|||
164362378|NCT02588833|593701720|FG001|Part 1|Withdrawal by Subject|0|||
164362379|NCT02588833|593701719|FG000|Part 2A|Physician Decision|0|||
164362380|NCT02588833|593701720|FG001|Part 2A|Physician Decision|1|||
164362381|NCT02588833|593701719|FG000|Part 2A|Withdrawal by Subject|0|||
164362382|NCT02588833|593701720|FG001|Part 2A|Withdrawal by Subject|1|||
164362383|NCT02588833|593701719|FG000|Part 2B|Adverse Event|0|||
164362384|NCT02588833|593701720|FG001|Part 2B|Adverse Event|1|||
164362385|NCT02588833|593701719|FG000|Part 2C|Adverse Event|0|||
164362386|NCT02588833|593701720|FG001|Part 2C|Adverse Event|1|||
164698524|NCT02177136|594920553|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
164698525|NCT02177136|594920550|FG000|LTSE Phase|Withdrawal by Subject|0|||
164698526|NCT02177136|594920551|FG001|LTSE Phase|Withdrawal by Subject|0|||
164698527|NCT02177136|594920552|FG002|LTSE Phase|Withdrawal by Subject|0|||
164698528|NCT02177136|594920553|FG003|LTSE Phase|Withdrawal by Subject|6|||
164698529|NCT02177136|594920550|FG000|LTSE Phase|Adverse Event|0|||
164698530|NCT02177136|594920551|FG001|LTSE Phase|Adverse Event|0|||
164698531|NCT02177136|594920552|FG002|LTSE Phase|Adverse Event|0|||
164698532|NCT02177136|594920553|FG003|LTSE Phase|Adverse Event|10|||
164698533|NCT02177136|594920550|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
164698534|NCT02177136|594920551|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
164698535|NCT02177136|594920552|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
164698536|NCT02177136|594920553|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
164698537|NCT02177136|594920550|FG000|LTSE Phase|Physician Decision|0|||
164698538|NCT02177136|594920551|FG001|LTSE Phase|Physician Decision|0|||
164698539|NCT02177136|594920552|FG002|LTSE Phase|Physician Decision|0|||
164698540|NCT02177136|594920553|FG003|LTSE Phase|Physician Decision|2|||
164698541|NCT02177136|594920550|FG000|LTSE Phase|Lost to Follow-up|0|||
164698542|NCT02177136|594920551|FG001|LTSE Phase|Lost to Follow-up|0|||
164698543|NCT02177136|594920552|FG002|LTSE Phase|Lost to Follow-up|0|||
164698544|NCT02177136|594920553|FG003|LTSE Phase|Lost to Follow-up|1|||
164698545|NCT02177136|594920550|FG000|LTSE Phase|Participant Moved|0|||
164698546|NCT02177136|594920551|FG001|LTSE Phase|Participant Moved|0|||
164698547|NCT02177136|594920552|FG002|LTSE Phase|Participant Moved|0|||
164698548|NCT02177136|594920553|FG003|LTSE Phase|Participant Moved|1|||
164698549|NCT01386684|594920554|FG000|Overall Study|Lost to Follow-up|51|||
164362387|NCT02588833|593701719|FG000|Part 2C|Withdrawal by Subject|0|||
164362388|NCT02588833|593701720|FG001|Part 2C|Withdrawal by Subject|1|||
164698550|NCT01386684|594920554|FG000|Overall Study|Other|51|||
164698551|NCT01386684|594920554|FG000|Overall Study|Death|47|||
164698552|NCT01386684|594920554|FG000|Overall Study|Withdrawal of Consent|44|||
164362389|NCT02588833|593701719|FG000|Part 3 (Safety Follow-up)|Other|0|||
164362390|NCT02588833|593701720|FG001|Part 3 (Safety Follow-up)|Other|2|||
164362391|NCT03649711|593701723|FG000|Overall Study|Adverse Event|0|||
164362392|NCT03649711|593701724|FG001|Overall Study|Adverse Event|1|||
164362393|NCT03649711|593701725|FG002|Overall Study|Adverse Event|0|||
164362394|NCT03649711|593701723|FG000|Overall Study|Kidney Transplant|1|||
164362395|NCT03649711|593701724|FG001|Overall Study|Kidney Transplant|0|||
164362396|NCT03649711|593701725|FG002|Overall Study|Kidney Transplant|0|||
164362397|NCT01581307|593701726|FG000|Overall Study|Withdrawal by Subject|1|||
164698553|NCT01386684|594920554|FG000|Overall Study|Alternative Therapy Required|37|||
164698554|NCT01386684|594920554|FG000|Overall Study|Disease Progression|28|||
164698555|NCT01386684|594920554|FG000|Overall Study|Adverse Event|20|||
164698556|NCT01386684|594920554|FG000|Overall Study|Noncompliance|8|||
164362398|NCT07114198|593701731|FG000|Overall Study|Protocol Violation|1|||
164362399|NCT07114198|593701732|FG001|Overall Study|Protocol Violation|1|||
164362400|NCT04709575|593703911|FG000|Overall Study|Withdrawal by Subject|6|||
164698557|NCT01386684|594920554|FG000|Overall Study|Protocol Violation|4|||
164698558|NCT01386684|594920554|FG000|Overall Study|Missing|3|||
164698559|NCT02119286|594920560|FG000|Overall Study|Adverse Event|9|||
164698560|NCT02119286|594920561|FG001|Overall Study|Adverse Event|7|||
164698561|NCT02119286|594920562|FG002|Overall Study|Adverse Event|2|||
164698562|NCT02119286|594920560|FG000|Overall Study|Lack of Efficacy|11|||
164698563|NCT02119286|594920561|FG001|Overall Study|Lack of Efficacy|3|||
164698564|NCT02119286|594920562|FG002|Overall Study|Lack of Efficacy|4|||
164698565|NCT02119286|594920560|FG000|Overall Study|Lost to Follow-up|2|||
164698566|NCT02119286|594920561|FG001|Overall Study|Lost to Follow-up|0|||
164698567|NCT02119286|594920562|FG002|Overall Study|Lost to Follow-up|1|||
164698568|NCT02119286|594920560|FG000|Overall Study|Withdrawal by Subject|4|||
164698569|NCT02119286|594920561|FG001|Overall Study|Withdrawal by Subject|1|||
164698570|NCT02119286|594920562|FG002|Overall Study|Withdrawal by Subject|0|||
164698571|NCT04109313|594920563|FG000|Overall Study|Pregnancy|1|||
164698572|NCT04109313|594920563|FG000|Overall Study|Adverse Event|11|||
164698573|NCT04109313|594920563|FG000|Overall Study|Lack of Efficacy|11|||
164698574|NCT04109313|594920563|FG000|Overall Study|Lost to Follow-up|1|||
164698575|NCT04109313|594920563|FG000|Overall Study|Physician Decision|2|||
164698576|NCT04109313|594920563|FG000|Overall Study|Subject Decision|13|||
164698577|NCT04109313|594920563|FG000|Overall Study|Covid-19 situation|2|||
164698578|NCT02694549|594920564|FG000|Overall Study|screen failures|2|||
164698579|NCT01996332|594920567|FG000|Overall Study|Adverse Event|117|||
164698580|NCT01996332|594920567|FG000|Overall Study|Lack of Efficacy|1245|||
164698581|NCT01996332|594920567|FG000|Overall Study|Death|264|||
164698582|NCT01996332|594920567|FG000|Overall Study|Protocol Violation|9|||
164698583|NCT01996332|594920567|FG000|Overall Study|Withdrawal by Subject|71|||
164698584|NCT01996332|594920567|FG000|Overall Study|Other|20|||
164698585|NCT01996332|594920567|FG000|Overall Study|Clinical Deterioration|28|||
164698586|NCT01996332|594920567|FG000|Overall Study|Physician Decision|17|||
164698587|NCT01996332|594920567|FG000|Overall Study|Lost to Follow-up|34|||
164698588|NCT02113189|594920568|FG000|Overall Study|Lost to follow up|2|||
164698589|NCT02113189|594920569|FG001|Overall Study|Lost to follow up|1|||
164698590|NCT02113189|594920570|FG002|Overall Study|Lost to follow up|3|||
164698591|NCT00099268|594920573|FG000|Overall Study|Withdrawal by Subject|46|||
164698592|NCT00099268|594920574|FG001|Overall Study|Withdrawal by Subject|28|||
164698593|NCT00099268|594920573|FG000|Overall Study|Adverse Event|19|||
164698594|NCT00099268|594920574|FG001|Overall Study|Adverse Event|19|||
164698595|NCT00099268|594920573|FG000|Overall Study|Protocol Violation|9|||
164698596|NCT00099268|594920574|FG001|Overall Study|Protocol Violation|8|||
164698597|NCT00099268|594920573|FG000|Overall Study|Lost to Follow-up|6|||
164698598|NCT00099268|594920574|FG001|Overall Study|Lost to Follow-up|4|||
164698599|NCT00099268|594920573|FG000|Overall Study|Lack of Efficacy|5|||
164698600|NCT00099268|594920574|FG001|Overall Study|Lack of Efficacy|18|||
164698601|NCT00099268|594920573|FG000|Overall Study|Administrative problems|4|||
164698602|NCT00099268|594920574|FG001|Overall Study|Administrative problems|4|||
164698603|NCT00099268|594920573|FG000|Overall Study|Death|3|||
164698604|NCT00099268|594920574|FG001|Overall Study|Death|1|||
164698605|NCT03702049|594920575|FG000|Overall Study|Lost to Follow-up|4|||
164698606|NCT03702049|594920575|FG000|Overall Study|Physician Decision|1|||
164698607|NCT00897949|594920577|FG000|Overall Study|Adverse Event|1|||
164698608|NCT00897949|594920578|FG001|Overall Study|Adverse Event|1|||
164698609|NCT00897949|594920579|FG002|Overall Study|Adverse Event|0|||
164698610|NCT00897949|594920577|FG000|Overall Study|Lost to Follow-up|0|||
164698611|NCT00897949|594920578|FG001|Overall Study|Lost to Follow-up|2|||
164698612|NCT00897949|594920579|FG002|Overall Study|Lost to Follow-up|1|||
164698613|NCT00897949|594920577|FG000|Overall Study|Protocol Violation|6|||
164362401|NCT04709575|593703912|FG001|Overall Study|Withdrawal by Subject|2|||
164362402|NCT04709575|593703911|FG000|Overall Study|Lost to Follow-up|2|||
164698614|NCT00897949|594920578|FG001|Overall Study|Protocol Violation|3|||
164698615|NCT00897949|594920579|FG002|Overall Study|Protocol Violation|1|||
164698616|NCT00897949|594920577|FG000|Overall Study|Withdrawal by Subject|1|||
164698617|NCT00897949|594920578|FG001|Overall Study|Withdrawal by Subject|2|||
164362403|NCT04709575|593703912|FG001|Overall Study|Lost to Follow-up|2|||
164362404|NCT04709575|593703911|FG000|Overall Study|Adverse Event|1|||
164362405|NCT04709575|593703912|FG001|Overall Study|Adverse Event|0|||
164362406|NCT04709575|593703911|FG000|Overall Study|Protocol Violation|1|||
164362407|NCT04709575|593703912|FG001|Overall Study|Protocol Violation|1|||
164362408|NCT02967692|593703913|FG000|Overall Study|Progressive disease|3|||
164362409|NCT02967692|593703914|FG001|Overall Study|Progressive disease|15|||
164362410|NCT02967692|593703915|FG002|Overall Study|Progressive disease|114|||
164362411|NCT02967692|593703916|FG003|Overall Study|Progressive disease|151|||
164362412|NCT02967692|593703913|FG000|Overall Study|Subject/guardian decision|1|||
164362413|NCT02967692|593703914|FG001|Overall Study|Subject/guardian decision|1|||
164362414|NCT02967692|593703915|FG002|Overall Study|Subject/guardian decision|14|||
164362415|NCT02967692|593703916|FG003|Overall Study|Subject/guardian decision|22|||
164362416|NCT02967692|593703913|FG000|Overall Study|Death|0|||
164362417|NCT02967692|593703914|FG001|Overall Study|Death|1|||
164362418|NCT02967692|593703915|FG002|Overall Study|Death|13|||
164362419|NCT02967692|593703916|FG003|Overall Study|Death|13|||
164362420|NCT02967692|593703913|FG000|Overall Study|Protocol deviation|1|||
164362421|NCT02967692|593703914|FG001|Overall Study|Protocol deviation|0|||
164362422|NCT02967692|593703915|FG002|Overall Study|Protocol deviation|1|||
164362423|NCT02967692|593703916|FG003|Overall Study|Protocol deviation|1|||
164362424|NCT02967692|593703913|FG000|Overall Study|Lost to Follow-up|0|||
164362425|NCT02967692|593703914|FG001|Overall Study|Lost to Follow-up|0|||
164362426|NCT02967692|593703915|FG002|Overall Study|Lost to Follow-up|1|||
164362427|NCT02967692|593703916|FG003|Overall Study|Lost to Follow-up|0|||
164362428|NCT02967692|593703913|FG000|Overall Study|Physician Decision|0|||
164362429|NCT02967692|593703914|FG001|Overall Study|Physician Decision|0|||
164362430|NCT02967692|593703915|FG002|Overall Study|Physician Decision|22|||
164362431|NCT02967692|593703916|FG003|Overall Study|Physician Decision|13|||
164362432|NCT02967692|593703913|FG000|Overall Study|Adverse Event|2|||
164438538|NCT04248829|593970824|FG000|Overall Study|Disease progression|44|||
164438539|NCT04248829|593970825|FG001|Overall Study|Disease progression|109|||
164438540|NCT04248829|593970824|FG000|Overall Study|Adverse Event|19|||
164698618|NCT00897949|594920579|FG002|Overall Study|Withdrawal by Subject|0|||
164698619|NCT00897949|594920577|FG000|Overall Study|Patient Uncoorperative|0|||
164698620|NCT00897949|594920578|FG001|Overall Study|Patient Uncoorperative|2|||
164698621|NCT00897949|594920579|FG002|Overall Study|Patient Uncoorperative|1|||
164698622|NCT00897949|594920577|FG000|Overall Study|Lost to Follow-up|30|||
164698623|NCT00897949|594920578|FG001|Overall Study|Lost to Follow-up|23|||
164698624|NCT00897949|594920579|FG002|Overall Study|Lost to Follow-up|17|||
164698625|NCT00897949|594920577|FG000|Overall Study|Withdrawal by Subject|24|||
164698626|NCT00897949|594920578|FG001|Overall Study|Withdrawal by Subject|31|||
164698627|NCT00897949|594920579|FG002|Overall Study|Withdrawal by Subject|17|||
164698628|NCT00897949|594920577|FG000|Overall Study|Abnormal Prestudy Labs|2|||
164698629|NCT00897949|594920578|FG001|Overall Study|Abnormal Prestudy Labs|3|||
164698630|NCT00897949|594920579|FG002|Overall Study|Abnormal Prestudy Labs|4|||
164698631|NCT00897949|594920577|FG000|Overall Study|Abnormal Baseline ECG|2|||
164698632|NCT00897949|594920578|FG001|Overall Study|Abnormal Baseline ECG|2|||
164698633|NCT00897949|594920579|FG002|Overall Study|Abnormal Baseline ECG|4|||
164698634|NCT00897949|594920577|FG000|Overall Study|Need for Concom. Med.|0|||
164698635|NCT00897949|594920578|FG001|Overall Study|Need for Concom. Med.|1|||
164438541|NCT04248829|593970825|FG001|Overall Study|Adverse Event|18|||
164698636|NCT00897949|594920579|FG002|Overall Study|Need for Concom. Med.|1|||
164362433|NCT02967692|593703914|FG001|Overall Study|Adverse Event|9|||
164362434|NCT02967692|593703915|FG002|Overall Study|Adverse Event|60|||
164362435|NCT02967692|593703916|FG003|Overall Study|Adverse Event|28|||
164362436|NCT02967692|593703913|FG000|Overall Study|Study terminated by sponsor|2|||
164362437|NCT02967692|593703914|FG001|Overall Study|Study terminated by sponsor|1|||
164362438|NCT02967692|593703915|FG002|Overall Study|Study terminated by sponsor|42|||
164438542|NCT04248829|593970824|FG000|Overall Study|Withdrawal by Subject|11|||
164698637|NCT00897949|594920577|FG000|Overall Study|Lack of Migraine Attack|29|||
164698638|NCT00897949|594920578|FG001|Overall Study|Lack of Migraine Attack|30|||
164698639|NCT00897949|594920579|FG002|Overall Study|Lack of Migraine Attack|19|||
164698640|NCT00897949|594920577|FG000|Overall Study|Did not take study drug|9|||
164438543|NCT04248829|593970825|FG001|Overall Study|Withdrawal by Subject|2|||
164438544|NCT04248829|593970824|FG000|Overall Study|Lost to Follow-up|0|||
164438545|NCT04248829|593970825|FG001|Overall Study|Lost to Follow-up|1|||
164438546|NCT04248829|593970824|FG000|Overall Study|Death|12|||
164438547|NCT04248829|593970825|FG001|Overall Study|Death|14|||
164362439|NCT02967692|593703916|FG003|Overall Study|Study terminated by sponsor|37|||
164362440|NCT04447417|593703920|FG000|Overall Study|Withdrawal by Subject|1|||
164362441|NCT04447417|593703921|FG001|Overall Study|Withdrawal by Subject|0|||
164362442|NCT04447417|593703920|FG000|Overall Study|Failure to meet inclusion criteria|1|||
164362443|NCT04447417|593703921|FG001|Overall Study|Failure to meet inclusion criteria|0|||
164362444|NCT04447417|593703920|FG000|Overall Study|Lost to Follow-up|1|||
164362445|NCT04447417|593703921|FG001|Overall Study|Lost to Follow-up|0|||
164362446|NCT00702403|593703922|FG000|From Consent to Engraftment|Progressive leukemia|6|||
164362447|NCT00702403|593703922|FG000|From Consent to Engraftment|Critically ill|2|||
164362448|NCT00702403|593703922|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
164362449|NCT00702403|593703922|FG000|From Consent to Engraftment|Myocardial infarction|1|||
164362450|NCT00702403|593703922|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
164362451|NCT00702403|593703922|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
164362452|NCT00702403|593703922|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
164362453|NCT00702403|593703922|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
164362454|NCT00702403|593703922|FG000|From Engraftment to Study Completion|Non-compliance|2|||
164362455|NCT00702403|593703922|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
164362456|NCT00702403|593703922|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
164362457|NCT00702403|593703922|FG000|From Engraftment to Study Completion|Suicide|1|||
164362458|NCT00702403|593703922|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
164362459|NCT00702403|593703922|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
164362460|NCT00702403|593703922|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
164362461|NCT00066066|593703926|FG000|Overall Study|Lost to Follow-up|6|||
164362462|NCT00066066|593703927|FG001|Overall Study|Lost to Follow-up|4|||
164362463|NCT00066066|593703928|FG002|Overall Study|Lost to Follow-up|7|||
164362464|NCT00066066|593703929|FG003|Overall Study|Lost to Follow-up|4|||
164362465|NCT00066066|593703930|FG004|Overall Study|Lost to Follow-up|3|||
164362466|NCT00066066|593703931|FG005|Overall Study|Lost to Follow-up|5|||
164438548|NCT04248829|593970824|FG000|Overall Study|Physician Decision|2|||
164438549|NCT04248829|593970825|FG001|Overall Study|Physician Decision|4|||
164438550|NCT04248829|593970824|FG000|Overall Study|Any reason not specifically recorded|0|||
164438551|NCT04248829|593970825|FG001|Overall Study|Any reason not specifically recorded|2|||
164438552|NCT01278862|593970826|FG000|Overall Study|Lost to Follow-up|1|||
164438553|NCT01278862|593970827|FG001|Overall Study|Lost to Follow-up|1|||
164438554|NCT02952261|593970828|FG000|Overall Study|Withdrawal by Subject|4|||
164438555|NCT02952261|593970829|FG001|Overall Study|Withdrawal by Subject|5|||
164438556|NCT02952261|593970828|FG000|Overall Study|Protocol Violation|1|||
164438557|NCT02952261|593970829|FG001|Overall Study|Protocol Violation|0|||
164698641|NCT00897949|594920578|FG001|Overall Study|Did not take study drug|3|||
164698642|NCT00897949|594920579|FG002|Overall Study|Did not take study drug|4|||
164698643|NCT03253744|594920581|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
164698644|NCT03253744|594920582|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
164698645|NCT03253744|594920583|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
164698646|NCT03253744|594920584|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
164698647|NCT06279871|594920585|FG000|Overall Study|Death|0|||
164698648|NCT06279871|594920586|FG001|Overall Study|Death|0|||
164698649|NCT06279871|594920587|FG002|Overall Study|Death|0|||
164698650|NCT06279871|594920588|FG003|Overall Study|Death|0|||
164698651|NCT06279871|594920589|FG004|Overall Study|Death|0|||
164698652|NCT06279871|594920590|FG005|Overall Study|Death|1|||
164698653|NCT06279871|594920591|FG006|Overall Study|Death|0|||
164698654|NCT06279871|594920585|FG000|Overall Study|Other than Specified|1|||
164698655|NCT06279871|594920586|FG001|Overall Study|Other than Specified|0|||
164698656|NCT06279871|594920587|FG002|Overall Study|Other than Specified|4|||
164698657|NCT06279871|594920588|FG003|Overall Study|Other than Specified|0|||
164698658|NCT06279871|594920589|FG004|Overall Study|Other than Specified|0|||
164698659|NCT06279871|594920590|FG005|Overall Study|Other than Specified|0|||
164698660|NCT06279871|594920591|FG006|Overall Study|Other than Specified|0|||
164698661|NCT06279871|594920585|FG000|Overall Study|Withdrawal by Subject|4|||
164362467|NCT02155738|593703932|FG000|Overall Study|Missing critical information|1|||
164362468|NCT02155738|593703933|FG001|Overall Study|Missing critical information|0|||
164362469|NCT02155738|593703934|FG002|Overall Study|Missing critical information|0|||
164362470|NCT02155738|593703935|FG003|Overall Study|Missing critical information|1|||
164362471|NCT01466348|593703938|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
164438558|NCT05233085|593970830|FG000|Overall Study|Adverse Event|1|||
164438559|NCT05233085|593970831|FG001|Overall Study|Adverse Event|0|||
164698662|NCT06279871|594920586|FG001|Overall Study|Withdrawal by Subject|8|||
164698663|NCT06279871|594920587|FG002|Overall Study|Withdrawal by Subject|4|||
164698664|NCT06279871|594920588|FG003|Overall Study|Withdrawal by Subject|2|||
164698665|NCT06279871|594920589|FG004|Overall Study|Withdrawal by Subject|0|||
164698666|NCT06279871|594920590|FG005|Overall Study|Withdrawal by Subject|0|||
164698667|NCT06279871|594920591|FG006|Overall Study|Withdrawal by Subject|0|||
164698668|NCT06279871|594920585|FG000|Overall Study|Lost to Follow-up|11|||
164698669|NCT06279871|594920586|FG001|Overall Study|Lost to Follow-up|10|||
164698670|NCT06279871|594920587|FG002|Overall Study|Lost to Follow-up|8|||
164698671|NCT06279871|594920588|FG003|Overall Study|Lost to Follow-up|0|||
164698672|NCT06279871|594920589|FG004|Overall Study|Lost to Follow-up|0|||
164698673|NCT06279871|594920590|FG005|Overall Study|Lost to Follow-up|0|||
164362472|NCT01466348|593703939|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
164362473|NCT02189473|593703942|FG000|Overall Study|Death|22|||
164362474|NCT02189473|593703943|FG001|Overall Study|Death|23|||
164362475|NCT02189473|593703942|FG000|Overall Study|Lost to Follow-up|1|||
164362476|NCT02189473|593703943|FG001|Overall Study|Lost to Follow-up|2|||
164698674|NCT06279871|594920591|FG006|Overall Study|Lost to Follow-up|0|||
164698675|NCT06279871|594920585|FG000|Overall Study|Adverse Event|0|||
164698676|NCT06279871|594920586|FG001|Overall Study|Adverse Event|1|||
164698677|NCT06279871|594920587|FG002|Overall Study|Adverse Event|0|||
164698678|NCT06279871|594920588|FG003|Overall Study|Adverse Event|0|||
164698679|NCT06279871|594920589|FG004|Overall Study|Adverse Event|0|||
164698680|NCT06279871|594920590|FG005|Overall Study|Adverse Event|0|||
164698681|NCT06279871|594920591|FG006|Overall Study|Adverse Event|0|||
164698682|NCT03739138|594920600|FG000|Overall Study|Death|0|||
164698683|NCT03739138|594920601|FG001|Overall Study|Death|7|||
164698684|NCT03739138|594920602|FG002|Overall Study|Death|4|||
164698685|NCT03739138|594920603|FG003|Overall Study|Death|13|||
164698686|NCT03739138|594920604|FG004|Overall Study|Death|0|||
164698687|NCT03739138|594920600|FG000|Overall Study|Lost to Follow-up|0|||
164698688|NCT03739138|594920601|FG001|Overall Study|Lost to Follow-up|0|||
164698689|NCT03739138|594920602|FG002|Overall Study|Lost to Follow-up|1|||
164698690|NCT03739138|594920603|FG003|Overall Study|Lost to Follow-up|0|||
164698691|NCT03739138|594920604|FG004|Overall Study|Lost to Follow-up|0|||
164698692|NCT03739138|594920600|FG000|Overall Study|Study Terminated By Sponsor|0|||
164698693|NCT03739138|594920601|FG001|Overall Study|Study Terminated By Sponsor|0|||
164698694|NCT03739138|594920602|FG002|Overall Study|Study Terminated By Sponsor|0|||
164698695|NCT03739138|594920603|FG003|Overall Study|Study Terminated By Sponsor|4|||
164698696|NCT03739138|594920604|FG004|Overall Study|Study Terminated By Sponsor|0|||
164698697|NCT03739138|594920600|FG000|Overall Study|Withdrawal by Subject|0|||
164698698|NCT03739138|594920601|FG001|Overall Study|Withdrawal by Subject|0|||
164698699|NCT03739138|594920602|FG002|Overall Study|Withdrawal by Subject|0|||
164698700|NCT03739138|594920603|FG003|Overall Study|Withdrawal by Subject|1|||
164698701|NCT03739138|594920604|FG004|Overall Study|Withdrawal by Subject|0|||
164698702|NCT01056640|594920605|FG000|Overall Study|Withdrawal by Subject|11|||
164698703|NCT01056640|594920606|FG001|Overall Study|Withdrawal by Subject|8|||
164698704|NCT01056640|594920605|FG000|Overall Study|Death|15|||
164698705|NCT01056640|594920606|FG001|Overall Study|Death|4|||
164698706|NCT01803269|594920607|FG000|Overall Study|Withdrawal by Subject|3|||
164698707|NCT01803269|594920608|FG001|Overall Study|Withdrawal by Subject|0|||
164698708|NCT01803269|594920609|FG002|Overall Study|Withdrawal by Subject|0|||
164698709|NCT00518882|594920612|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
164698710|NCT00518882|594920613|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
164698711|NCT00518882|594920612|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
164698712|NCT00518882|594920613|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
164362477|NCT02385266|593703949|FG000|Overall Study|Withdrawal by Subject|1|||
164362478|NCT02385266|593703950|FG001|Overall Study|Withdrawal by Subject|3|||
164362479|NCT00914810|593703951|FG000|Overall Study|Withdrawal by Subject|1|||
164362480|NCT00914810|593703952|FG001|Overall Study|Withdrawal by Subject|0|||
164362481|NCT00914810|593703951|FG000|Overall Study|Relocated out of state|1|||
164362482|NCT00914810|593703952|FG001|Overall Study|Relocated out of state|0|||
164362483|NCT00914810|593703951|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
164362484|NCT00914810|593703952|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
164362485|NCT02082210|593703953|FG000|Overall Study|Death|0|||
164362486|NCT02082210|593703954|FG001|Overall Study|Death|0|||
164362487|NCT02082210|593703955|FG002|Overall Study|Death|1|||
164362488|NCT02082210|593703956|FG003|Overall Study|Death|1|||
164362489|NCT02082210|593703957|FG004|Overall Study|Death|1|||
164698713|NCT00518882|594920612|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
164698714|NCT00518882|594920613|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
164362490|NCT02082210|593703958|FG005|Overall Study|Death|0|||
164362491|NCT02082210|593703953|FG000|Overall Study|Withdrawal by Subject|0|||
164362492|NCT02082210|593703954|FG001|Overall Study|Withdrawal by Subject|0|||
164698715|NCT00518882|594920612|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
164698716|NCT00518882|594920613|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
164698717|NCT00518882|594920612|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
164698718|NCT00518882|594920613|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
164698719|NCT00518882|594920612|FG000|Double-Blind, Week 0-26|Subject decision|1|||
164698720|NCT00518882|594920613|FG001|Double-Blind, Week 0-26|Subject decision|1|||
164698721|NCT00518882|594920612|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
164698722|NCT00518882|594920613|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
164362493|NCT02082210|593703955|FG002|Overall Study|Withdrawal by Subject|0|||
164362494|NCT02082210|593703956|FG003|Overall Study|Withdrawal by Subject|1|||
164362495|NCT02082210|593703957|FG004|Overall Study|Withdrawal by Subject|2|||
164362496|NCT02082210|593703958|FG005|Overall Study|Withdrawal by Subject|2|||
164362497|NCT02082210|593703953|FG000|Overall Study|Clinical Progression|0|||
164362498|NCT02082210|593703954|FG001|Overall Study|Clinical Progression|0|||
164362499|NCT02082210|593703955|FG002|Overall Study|Clinical Progression|0|||
164362500|NCT02082210|593703956|FG003|Overall Study|Clinical Progression|1|||
164362501|NCT02082210|593703957|FG004|Overall Study|Clinical Progression|0|||
164362502|NCT02082210|593703958|FG005|Overall Study|Clinical Progression|0|||
164362503|NCT02082210|593703953|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
164362504|NCT02082210|593703954|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
164362505|NCT02082210|593703955|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
164362506|NCT02082210|593703956|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
164362507|NCT02082210|593703957|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
164362508|NCT02082210|593703958|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
164362509|NCT02082210|593703953|FG000|Overall Study|Physician Decision|0|||
164362510|NCT02082210|593703954|FG001|Overall Study|Physician Decision|0|||
164362511|NCT02082210|593703955|FG002|Overall Study|Physician Decision|1|||
164362512|NCT02082210|593703956|FG003|Overall Study|Physician Decision|1|||
164362513|NCT02082210|593703957|FG004|Overall Study|Physician Decision|0|||
164362514|NCT02082210|593703958|FG005|Overall Study|Physician Decision|0|||
164362515|NCT02529137|593703964|FG000|Overall Study|Discontinuation for different reasons|8|||
164362516|NCT02731729|593703965|FG000|Overall Study|Death|2|||
164362517|NCT02731729|593703966|FG001|Overall Study|Death|2|||
164362518|NCT02731729|593703965|FG000|Overall Study|Study terminated by Sponsor|6|||
164362519|NCT02731729|593703966|FG001|Overall Study|Study terminated by Sponsor|6|||
164362520|NCT02731729|593703965|FG000|Overall Study|Withdrawal by Subject|1|||
164362521|NCT02731729|593703966|FG001|Overall Study|Withdrawal by Subject|0|||
164362522|NCT01344447|593703967|FG000|Overall Study|Adverse Event|1|||
164362523|NCT01344447|593703967|FG000|Overall Study|Protocol Violation|1|||
164362524|NCT01344447|593703967|FG000|Overall Study|Withdrawal by Subject|1|||
164362525|NCT01344447|593703967|FG000|Overall Study|The contrast was not seen|1|||
164362526|NCT01344447|593703967|FG000|Overall Study|Physician Decision|1|||
164362527|NCT01344447|593703967|FG000|Overall Study|MRA unsuccessful|1|||
164362528|NCT01344447|593703967|FG000|Overall Study|Bolus tracking failed|1|||
164362529|NCT01344447|593703967|FG000|Overall Study|Error of power injector|1|||
164362530|NCT01660711|593703968|FG000|Overall Study|Adverse Event|7|||
164362531|NCT01660711|593703968|FG000|Overall Study|Withdrawal by Subject|1|||
164362532|NCT00952341|593703970|FG000|Cycle 1|Adverse Event|4|||
164362533|NCT00952341|593703971|FG001|Cycle 1|Adverse Event|1|||
164362534|NCT00952341|593703970|FG000|Cycle 1|Withdrawal by Subject|3|||
164362535|NCT00952341|593703971|FG001|Cycle 1|Withdrawal by Subject|8|||
164362536|NCT00952341|593703970|FG000|Cycle 1|Protocol Violation|2|||
164362537|NCT00952341|593703971|FG001|Cycle 1|Protocol Violation|1|||
164362538|NCT00952341|593703970|FG000|Cycle 1|Lost to Follow-up|11|||
164362539|NCT00952341|593703971|FG001|Cycle 1|Lost to Follow-up|2|||
164362540|NCT00952341|593703970|FG000|Cycle 1|Physician Decision|0|||
164362541|NCT00952341|593703971|FG001|Cycle 1|Physician Decision|1|||
164362542|NCT00952341|593703970|FG000|Cycle 2|Withdrawal by Subject|1|||
164362543|NCT00952341|593703971|FG001|Cycle 2|Withdrawal by Subject|1|||
164362544|NCT00952341|593703970|FG000|Cycle 2|Protocol Violation|1|||
164362545|NCT00952341|593703971|FG001|Cycle 2|Protocol Violation|0|||
164362546|NCT00952341|593703970|FG000|Cycle 2|Lost to Follow-up|6|||
164362547|NCT00952341|593703971|FG001|Cycle 2|Lost to Follow-up|9|||
164362548|NCT00952341|593703970|FG000|Cycle 2|Physician Decision|1|||
164362549|NCT00952341|593703971|FG001|Cycle 2|Physician Decision|1|||
164362550|NCT00952341|593703970|FG000|Cycle 2|Progressive Disease|0|||
164362551|NCT00952341|593703971|FG001|Cycle 2|Progressive Disease|1|||
164362552|NCT02066467|593703976|FG000|Overall Study|Did not undergo implant procedure|24|||
164362553|NCT02066467|593703976|FG000|Overall Study|Attempted to implant withoput success|43|||
164362554|NCT02066467|593703976|FG000|Overall Study|Consent ineligible|1|||
164362555|NCT02066467|593703976|FG000|Overall Study|Death|54|||
164362556|NCT02066467|593703976|FG000|Overall Study|Lost to Follow-up|51|||
164362557|NCT02066467|593703976|FG000|Overall Study|Adverse Event|20|||
164362558|NCT02066467|593703976|FG000|Overall Study|Withdrawal by Subject|16|||
164362559|NCT02066467|593703976|FG000|Overall Study|Physician Decision|2|||
164362560|NCT02066467|593703976|FG000|Overall Study|Not defined|4|||
164362561|NCT00581776|593703980|FG000|Overall Study|Disease progression or no response|3|||
164362562|NCT02357901|593703981|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
164362563|NCT02357901|593703982|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
164362564|NCT02357901|593703983|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
164362565|NCT02357901|593703984|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
164362566|NCT02357901|593703981|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
164362567|NCT02357901|593703982|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
164362568|NCT02357901|593703983|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
164362569|NCT02357901|593703984|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
164698723|NCT00518882|594920612|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
164698724|NCT00518882|594920613|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
164698725|NCT00518882|594920612|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
164698726|NCT00518882|594920613|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
164698727|NCT00518882|594920612|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
164362570|NCT02357901|593703981|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
164362571|NCT02357901|593703982|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
164362572|NCT02357901|593703983|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
164362573|NCT02357901|593703984|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
164362574|NCT02357901|593703981|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
164362575|NCT02357901|593703982|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
164362576|NCT02357901|593703983|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
164362577|NCT02357901|593703984|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
164362578|NCT02357901|593703981|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
164362579|NCT02357901|593703982|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
164362580|NCT02357901|593703983|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
164362581|NCT02357901|593703984|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
164362582|NCT02357901|593703981|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
164362583|NCT02357901|593703982|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
164362584|NCT02357901|593703983|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
164362585|NCT02357901|593703984|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
164362586|NCT02357901|593703981|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
164362587|NCT02357901|593703982|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
164362588|NCT02357901|593703983|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
164698728|NCT00518882|594920613|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
164698729|NCT00518882|594920612|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
164698730|NCT00518882|594920613|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
164698731|NCT00518882|594920612|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
164698732|NCT00518882|594920613|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
164698733|NCT00518882|594920612|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
164362589|NCT02357901|593703984|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
164362590|NCT02357901|593703981|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
164362591|NCT02357901|593703982|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
164362592|NCT02357901|593703983|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
164362593|NCT02357901|593703984|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
164417425|NCT01474512|593899493|FG004|Long-Term Extension Period|Clinical Relapse|0|||
164438560|NCT05233085|593970832|FG002|Overall Study|Adverse Event|0|||
164698734|NCT00518882|594920613|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
164698735|NCT00518882|594920612|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
164698736|NCT00518882|594920613|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
164698737|NCT00518882|594920612|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
164698738|NCT00518882|594920613|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
164698739|NCT00518882|594920612|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
164698740|NCT00518882|594920613|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
164698741|NCT00518882|594920612|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
164698742|NCT00518882|594920613|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
164698743|NCT00518882|594920612|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
164698744|NCT00518882|594920613|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
164698745|NCT00518882|594920612|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
164698746|NCT00518882|594920613|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
164698747|NCT00518882|594920612|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
164698748|NCT00518882|594920613|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
164698749|NCT00518882|594920612|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
164698750|NCT00518882|594920613|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
164698751|NCT00518882|594920612|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
164698752|NCT00518882|594920613|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
164698753|NCT00518882|594920612|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
164698754|NCT00518882|594920613|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
164698755|NCT00518882|594920612|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
164698756|NCT00518882|594920613|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
164698757|NCT04740931|594920616|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
164698758|NCT04740931|594920617|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
164698759|NCT04740931|594920616|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
164698760|NCT04740931|594920617|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
164698761|NCT04740931|594920616|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
164698762|NCT04740931|594920617|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
164362594|NCT02357901|593703981|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
164362595|NCT02357901|593703982|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
164362596|NCT02357901|593703983|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
164362597|NCT02357901|593703984|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
164362598|NCT02357901|593703981|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
164362599|NCT02357901|593703982|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
164362600|NCT02357901|593703983|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
164362601|NCT02357901|593703984|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
164362602|NCT02357901|593703981|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
164362603|NCT02357901|593703982|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
164362604|NCT02357901|593703983|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
164362605|NCT02357901|593703984|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
164362606|NCT02759120|593703991|FG000|Overall Study|Death|34|||
164362607|NCT02759120|593703992|FG001|Overall Study|Death|36|||
164362608|NCT02759120|593703991|FG000|Overall Study|Lost to Follow-up|4|||
164362609|NCT02759120|593703992|FG001|Overall Study|Lost to Follow-up|7|||
164362610|NCT02759120|593703991|FG000|Overall Study|Physician Decision|3|||
164362611|NCT02759120|593703992|FG001|Overall Study|Physician Decision|0|||
164362612|NCT02759120|593703991|FG000|Overall Study|Withdrawal by Subject|28|||
164362613|NCT02759120|593703992|FG001|Overall Study|Withdrawal by Subject|15|||
164362614|NCT02759120|593703991|FG000|Overall Study|Moved out of area|3|||
164362615|NCT02759120|593703992|FG001|Overall Study|Moved out of area|4|||
164362616|NCT02759120|593703991|FG000|Overall Study|Lung transplant|3|||
164362617|NCT02759120|593703992|FG001|Overall Study|Lung transplant|5|||
164362618|NCT02759120|593703991|FG000|Overall Study|Other reason not completed|10|||
164362619|NCT02759120|593703992|FG001|Overall Study|Other reason not completed|12|||
164362620|NCT04461015|593703996|FG000|Overall Study|IV access lost during the study|0|||
164362621|NCT04461015|593703997|FG001|Overall Study|IV access lost during the study|1|||
164362622|NCT04461015|593703996|FG000|Overall Study|Withdrawal by Subject|0|||
164362623|NCT04461015|593703997|FG001|Overall Study|Withdrawal by Subject|1|||
164362624|NCT00483379|593704001|FG000|Treatment Period|Adverse Event|1|||
164362625|NCT00483379|593704002|FG001|Treatment Period|Adverse Event|0|||
164362626|NCT00483379|593704001|FG000|Treatment Period|Withdrawal by Subject|1|||
164362627|NCT00483379|593704002|FG001|Treatment Period|Withdrawal by Subject|0|||
164362628|NCT02418468|593704004|FG000|Overall Study|Adverse Event|1|||
164362629|NCT02418468|593704005|FG001|Overall Study|Adverse Event|0|||
164362630|NCT02418468|593704004|FG000|Overall Study|Withdrawal of informed consent|1|||
164362631|NCT02418468|593704005|FG001|Overall Study|Withdrawal of informed consent|1|||
164362632|NCT02914769|593704006|FG000|Overall Study|Protocol Violation|3|||
164362633|NCT02914769|593704007|FG001|Overall Study|Protocol Violation|2|||
164362634|NCT02914769|593704006|FG000|Overall Study|Withdrawal by Subject|0|||
164362635|NCT02914769|593704007|FG001|Overall Study|Withdrawal by Subject|1|||
164362636|NCT02337907|593704008|FG000|Overall Study|Other than listed|1|||
164362637|NCT02337907|593704009|FG001|Overall Study|Other than listed|0|||
164362638|NCT02337907|593704010|FG002|Overall Study|Other than listed|0|||
164362639|NCT02337907|593704011|FG003|Overall Study|Other than listed|1|||
164362640|NCT02337907|593704012|FG004|Overall Study|Other than listed|1|||
164362641|NCT02337907|593704013|FG005|Overall Study|Other than listed|0|||
164362642|NCT02337907|593704008|FG000|Overall Study|Withdrawal by Subject|2|||
164362643|NCT02337907|593704009|FG001|Overall Study|Withdrawal by Subject|3|||
164362644|NCT02337907|593704010|FG002|Overall Study|Withdrawal by Subject|0|||
164362645|NCT02337907|593704011|FG003|Overall Study|Withdrawal by Subject|2|||
164362646|NCT02337907|593704012|FG004|Overall Study|Withdrawal by Subject|5|||
164362647|NCT02337907|593704013|FG005|Overall Study|Withdrawal by Subject|0|||
164362648|NCT02337907|593704008|FG000|Overall Study|Lost to Follow-up|0|||
164362649|NCT02337907|593704009|FG001|Overall Study|Lost to Follow-up|0|||
164362650|NCT02337907|593704010|FG002|Overall Study|Lost to Follow-up|0|||
164362651|NCT02337907|593704011|FG003|Overall Study|Lost to Follow-up|0|||
164362652|NCT02337907|593704012|FG004|Overall Study|Lost to Follow-up|0|||
164362653|NCT02337907|593704013|FG005|Overall Study|Lost to Follow-up|1|||
164362654|NCT02337907|593704008|FG000|Overall Study|Adverse Event|1|||
164362655|NCT02337907|593704009|FG001|Overall Study|Adverse Event|1|||
164362656|NCT02337907|593704010|FG002|Overall Study|Adverse Event|1|||
164362657|NCT02337907|593704011|FG003|Overall Study|Adverse Event|1|||
164362658|NCT02337907|593704012|FG004|Overall Study|Adverse Event|4|||
164362659|NCT02337907|593704013|FG005|Overall Study|Adverse Event|0|||
164698763|NCT04740931|594920616|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
164362660|NCT01592344|593704014|FG000|Overall Study|Adverse Event|1|||
164362661|NCT01592344|593704015|FG001|Overall Study|Adverse Event|1|||
164362662|NCT01592344|593704014|FG000|Overall Study|Lack of Efficacy|1|||
164362663|NCT01592344|593704015|FG001|Overall Study|Lack of Efficacy|0|||
164362664|NCT01592344|593704014|FG000|Overall Study|not available at primary outcome visit|2|||
164362665|NCT01592344|593704015|FG001|Overall Study|not available at primary outcome visit|4|||
164362666|NCT00099437|593704016|FG000|Overall Study|Lost to Follow-up|30|||
164362667|NCT00099437|593704017|FG001|Overall Study|Lost to Follow-up|33|||
164362668|NCT00099437|593704016|FG000|Overall Study|Death|293|||
164362669|NCT00099437|593704017|FG001|Overall Study|Death|261|||
164362670|NCT00099437|593704016|FG000|Overall Study|Withdrawal by Subject|6|||
164362671|NCT00099437|593704017|FG001|Overall Study|Withdrawal by Subject|10|||
164362672|NCT00099437|593704016|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
164362673|NCT00099437|593704017|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
164362674|NCT02738333|593704018|FG000|Overall Study|Death|1|||
164362675|NCT02738333|593704019|FG001|Overall Study|Death|0|||
164362676|NCT02738333|593704020|FG002|Overall Study|Death|0|||
164362677|NCT02738333|593704018|FG000|Overall Study|Lost to Follow-up|1|||
164362678|NCT02738333|593704019|FG001|Overall Study|Lost to Follow-up|0|||
164362679|NCT02738333|593704020|FG002|Overall Study|Lost to Follow-up|0|||
164362680|NCT00949325|593704021|FG000|Overall Study|Adverse Event|0|||
164362681|NCT00949325|593704022|FG001|Overall Study|Adverse Event|2|||
164362682|NCT00949325|593704023|FG002|Overall Study|Adverse Event|0|||
164362683|NCT03311659|593704032|FG000|Overall Study|Protocol Violation|1|||
164362684|NCT01176266|593704033|FG000|Overall Study|Death|6|||
164362685|NCT01176266|593704033|FG000|Overall Study|Withdrawal by Subject|3|||
164362686|NCT01179477|593704034|FG000|Overall Study|Death|542|||
164362687|NCT01179477|593704034|FG000|Overall Study|Unsuccessful implant|80|||
164362688|NCT01179477|593704034|FG000|Overall Study|Non-death withdrawal|438|||
164362689|NCT01179477|593704034|FG000|Overall Study|Did not complete final visit|27|||
164438561|NCT05233085|593970833|FG003|Overall Study|Adverse Event|0|||
164698764|NCT04740931|594920617|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
164698765|NCT04740931|594920616|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
164698766|NCT04740931|594920617|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
164698767|NCT04740931|594920616|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
164698768|NCT04740931|594920617|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
164698769|NCT04740931|594920616|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
164698770|NCT04740931|594920617|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
164698771|NCT04740931|594920616|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
164698772|NCT04740931|594920617|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
164698773|NCT04740931|594920616|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
164698774|NCT04740931|594920617|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
164698775|NCT04740931|594920616|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
164698776|NCT04740931|594920617|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
164698777|NCT04740931|594920616|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
164698778|NCT04740931|594920617|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
164698779|NCT04740931|594920616|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
164698780|NCT04740931|594920617|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
164698781|NCT04740931|594920616|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
164698782|NCT04740931|594920617|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
164698783|NCT04740931|594920616|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
164698784|NCT04740931|594920617|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
164698785|NCT04740931|594920616|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
164698786|NCT04740931|594920617|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
164698787|NCT02696031|594920619|FG000|Up to Week 24|Adverse Event|2|||
164698788|NCT02696031|594920620|FG001|Up to Week 24|Adverse Event|4|||
164698789|NCT02696031|594920621|FG002|Up to Week 24|Adverse Event|2|||
164698790|NCT02696031|594920622|FG003|Up to Week 24|Adverse Event|0|||
164698791|NCT02696031|594920623|FG004|Up to Week 24|Adverse Event|0|||
164698792|NCT02696031|594920624|FG005|Up to Week 24|Adverse Event|0|||
164698793|NCT02696031|594920619|FG000|Up to Week 24|Lack of Efficacy|2|||
164698794|NCT02696031|594920620|FG001|Up to Week 24|Lack of Efficacy|1|||
164698795|NCT02696031|594920621|FG002|Up to Week 24|Lack of Efficacy|2|||
164698796|NCT02696031|594920622|FG003|Up to Week 24|Lack of Efficacy|0|||
164698797|NCT02696031|594920623|FG004|Up to Week 24|Lack of Efficacy|0|||
164698798|NCT02696031|594920624|FG005|Up to Week 24|Lack of Efficacy|0|||
164698799|NCT02696031|594920619|FG000|Up to Week 24|Lost to Follow-up|0|||
164438562|NCT01049503|593972964|FG000|Overall Study|Lost to Follow-up|11|||
164438563|NCT01049503|593972965|FG001|Overall Study|Lost to Follow-up|12|||
164438564|NCT01049503|593972966|FG002|Overall Study|Lost to Follow-up|24|||
164438565|NCT01049503|593972967|FG003|Overall Study|Lost to Follow-up|26|||
164362690|NCT04327388|593704036|FG000|Overall Study|Adverse Event|17|||
164362691|NCT04327388|593704037|FG001|Overall Study|Adverse Event|18|||
164362692|NCT04327388|593704038|FG002|Overall Study|Adverse Event|9|||
164438566|NCT01049503|593972968|FG004|Overall Study|Lost to Follow-up|27|||
164438567|NCT01049503|593972969|FG005|Overall Study|Lost to Follow-up|8|||
164698800|NCT02696031|594920620|FG001|Up to Week 24|Lost to Follow-up|1|||
164698801|NCT02696031|594920621|FG002|Up to Week 24|Lost to Follow-up|1|||
164698802|NCT02696031|594920622|FG003|Up to Week 24|Lost to Follow-up|0|||
164698803|NCT02696031|594920623|FG004|Up to Week 24|Lost to Follow-up|0|||
164698804|NCT02696031|594920624|FG005|Up to Week 24|Lost to Follow-up|0|||
164698805|NCT02696031|594920619|FG000|Up to Week 24|Physician Decision|1|||
164698806|NCT02696031|594920620|FG001|Up to Week 24|Physician Decision|0|||
164698807|NCT02696031|594920621|FG002|Up to Week 24|Physician Decision|1|||
164698808|NCT02696031|594920622|FG003|Up to Week 24|Physician Decision|0|||
164362693|NCT04327388|593704036|FG000|Overall Study|Other|1|||
164362694|NCT04327388|593704037|FG001|Overall Study|Other|2|||
164362695|NCT04327388|593704038|FG002|Overall Study|Other|0|||
164362696|NCT04327388|593704036|FG000|Overall Study|Randomized and not treated|2|||
164362697|NCT04327388|593704037|FG001|Overall Study|Randomized and not treated|0|||
164362698|NCT04327388|593704038|FG002|Overall Study|Randomized and not treated|2|||
164362699|NCT00728130|593704039|FG000|Overall Study|Withdrawal by Subject|1|||
164362700|NCT00728130|593704039|FG000|Overall Study|Paperwork not completed in time|1|||
164362701|NCT00728130|593704039|FG000|Overall Study|Physician Decision|1|||
164362702|NCT04053023|593704042|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
164362703|NCT04053023|593704043|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
164362704|NCT03447990|593704044|FG000|Overall Study|Withdrawal by Subject|0|||
164362705|NCT03447990|593704045|FG001|Overall Study|Withdrawal by Subject|0|||
164362706|NCT03447990|593704046|FG002|Overall Study|Withdrawal by Subject|0|||
164362707|NCT03447990|593704047|FG003|Overall Study|Withdrawal by Subject|0|||
164362708|NCT03447990|593704048|FG004|Overall Study|Withdrawal by Subject|0|||
164362709|NCT03447990|593704049|FG005|Overall Study|Withdrawal by Subject|0|||
164362710|NCT03447990|593704050|FG006|Overall Study|Withdrawal by Subject|1|||
164362711|NCT03755414|593704051|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
164362712|NCT03755414|593704052|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
164362713|NCT03755414|593704053|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
164362714|NCT03755414|593704051|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
164362715|NCT03755414|593704052|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
164362716|NCT03755414|593704053|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
164362717|NCT03755414|593704051|FG000|Overall Study|Non-compliance|0|||
164362718|NCT03755414|593704052|FG001|Overall Study|Non-compliance|1|||
164698809|NCT02696031|594920623|FG004|Up to Week 24|Physician Decision|0|||
164362719|NCT03755414|593704053|FG002|Overall Study|Non-compliance|0|||
164362720|NCT02153112|593704054|FG000|Overall Study|Adverse Event|0|||
164362721|NCT02153112|593704055|FG001|Overall Study|Adverse Event|0|||
164362722|NCT02153112|593704056|FG002|Overall Study|Adverse Event|1|||
164362723|NCT02153112|593704057|FG003|Overall Study|Adverse Event|0|||
164362724|NCT02153112|593704058|FG004|Overall Study|Adverse Event|0|||
164362725|NCT02153112|593704059|FG005|Overall Study|Adverse Event|0|||
164362726|NCT02153112|593704060|FG006|Overall Study|Adverse Event|0|||
164362727|NCT02153112|593704061|FG007|Overall Study|Adverse Event|0|||
164362728|NCT02153112|593704062|FG008|Overall Study|Adverse Event|0|||
164362729|NCT02153112|593704063|FG009|Overall Study|Adverse Event|0|||
164362730|NCT02153112|593704054|FG000|Overall Study|Lost to Follow-up|1|||
164362731|NCT02153112|593704055|FG001|Overall Study|Lost to Follow-up|1|||
164362732|NCT02153112|593704056|FG002|Overall Study|Lost to Follow-up|0|||
164362733|NCT02153112|593704057|FG003|Overall Study|Lost to Follow-up|0|||
164362734|NCT02153112|593704058|FG004|Overall Study|Lost to Follow-up|2|||
164698810|NCT02696031|594920624|FG005|Up to Week 24|Physician Decision|0|||
164698811|NCT02696031|594920619|FG000|Up to Week 24|Protocol Violation|1|||
164698812|NCT02696031|594920620|FG001|Up to Week 24|Protocol Violation|0|||
164698813|NCT02696031|594920621|FG002|Up to Week 24|Protocol Violation|0|||
164698814|NCT02696031|594920622|FG003|Up to Week 24|Protocol Violation|0|||
164698815|NCT02696031|594920623|FG004|Up to Week 24|Protocol Violation|0|||
164698816|NCT02696031|594920624|FG005|Up to Week 24|Protocol Violation|0|||
164698817|NCT02696031|594920619|FG000|Up to Week 24|Withdrawal by Subject|4|||
164698818|NCT02696031|594920620|FG001|Up to Week 24|Withdrawal by Subject|1|||
164698819|NCT02696031|594920621|FG002|Up to Week 24|Withdrawal by Subject|5|||
164698820|NCT02696031|594920622|FG003|Up to Week 24|Withdrawal by Subject|0|||
164698821|NCT02696031|594920623|FG004|Up to Week 24|Withdrawal by Subject|0|||
164698822|NCT02696031|594920624|FG005|Up to Week 24|Withdrawal by Subject|0|||
164698823|NCT02696031|594920619|FG000|Up to Week 52|Adverse Event|4|||
164698824|NCT02696031|594920620|FG001|Up to Week 52|Adverse Event|5|||
164698825|NCT02696031|594920621|FG002|Up to Week 52|Adverse Event|3|||
164698826|NCT02696031|594920622|FG003|Up to Week 52|Adverse Event|0|||
164698827|NCT02696031|594920623|FG004|Up to Week 52|Adverse Event|0|||
164698828|NCT02696031|594920624|FG005|Up to Week 52|Adverse Event|0|||
164698829|NCT02696031|594920619|FG000|Up to Week 52|Lack of Efficacy|10|||
164362735|NCT02153112|593704059|FG005|Overall Study|Lost to Follow-up|1|||
164362736|NCT02153112|593704060|FG006|Overall Study|Lost to Follow-up|1|||
164698830|NCT02696031|594920620|FG001|Up to Week 52|Lack of Efficacy|7|||
164698831|NCT02696031|594920621|FG002|Up to Week 52|Lack of Efficacy|11|||
164698832|NCT02696031|594920622|FG003|Up to Week 52|Lack of Efficacy|0|||
164698833|NCT02696031|594920623|FG004|Up to Week 52|Lack of Efficacy|0|||
164362737|NCT02153112|593704061|FG007|Overall Study|Lost to Follow-up|0|||
164362738|NCT02153112|593704062|FG008|Overall Study|Lost to Follow-up|1|||
164698834|NCT02696031|594920624|FG005|Up to Week 52|Lack of Efficacy|0|||
164698835|NCT02696031|594920619|FG000|Up to Week 52|Lost to Follow-up|1|||
164698836|NCT02696031|594920620|FG001|Up to Week 52|Lost to Follow-up|1|||
164698837|NCT02696031|594920621|FG002|Up to Week 52|Lost to Follow-up|1|||
164698838|NCT02696031|594920622|FG003|Up to Week 52|Lost to Follow-up|0|||
164698839|NCT02696031|594920623|FG004|Up to Week 52|Lost to Follow-up|0|||
164698840|NCT02696031|594920624|FG005|Up to Week 52|Lost to Follow-up|0|||
164698841|NCT02696031|594920619|FG000|Up to Week 52|Physician Decision|1|||
164698842|NCT02696031|594920620|FG001|Up to Week 52|Physician Decision|1|||
164698843|NCT02696031|594920621|FG002|Up to Week 52|Physician Decision|2|||
164698844|NCT02696031|594920622|FG003|Up to Week 52|Physician Decision|0|||
164698845|NCT02696031|594920623|FG004|Up to Week 52|Physician Decision|0|||
164698846|NCT02696031|594920624|FG005|Up to Week 52|Physician Decision|0|||
164698847|NCT02696031|594920619|FG000|Up to Week 52|Pregnancy|0|||
164698848|NCT02696031|594920620|FG001|Up to Week 52|Pregnancy|2|||
164698849|NCT02696031|594920621|FG002|Up to Week 52|Pregnancy|0|||
164698850|NCT02696031|594920622|FG003|Up to Week 52|Pregnancy|0|||
164698851|NCT02696031|594920623|FG004|Up to Week 52|Pregnancy|0|||
164698852|NCT02696031|594920624|FG005|Up to Week 52|Pregnancy|0|||
164362739|NCT02153112|593704063|FG009|Overall Study|Lost to Follow-up|1|||
164362740|NCT02153112|593704054|FG000|Overall Study|Withdrawal by Subject|3|||
164362741|NCT02153112|593704055|FG001|Overall Study|Withdrawal by Subject|1|||
164362742|NCT02153112|593704056|FG002|Overall Study|Withdrawal by Subject|2|||
164362743|NCT02153112|593704057|FG003|Overall Study|Withdrawal by Subject|2|||
164362744|NCT02153112|593704058|FG004|Overall Study|Withdrawal by Subject|1|||
164362745|NCT02153112|593704059|FG005|Overall Study|Withdrawal by Subject|1|||
164362746|NCT02153112|593704060|FG006|Overall Study|Withdrawal by Subject|7|||
164362747|NCT02153112|593704061|FG007|Overall Study|Withdrawal by Subject|2|||
164362748|NCT02153112|593704062|FG008|Overall Study|Withdrawal by Subject|13|||
164362749|NCT02153112|593704063|FG009|Overall Study|Withdrawal by Subject|12|||
164698853|NCT02696031|594920619|FG000|Up to Week 52|Protocol Violation|1|||
164698854|NCT02696031|594920620|FG001|Up to Week 52|Protocol Violation|0|||
164698855|NCT02696031|594920621|FG002|Up to Week 52|Protocol Violation|0|||
164698856|NCT02696031|594920622|FG003|Up to Week 52|Protocol Violation|0|||
164698857|NCT02696031|594920623|FG004|Up to Week 52|Protocol Violation|0|||
164698858|NCT02696031|594920624|FG005|Up to Week 52|Protocol Violation|0|||
164698859|NCT02696031|594920619|FG000|Up to Week 52|Withdrawal by Subject|12|||
164698860|NCT02696031|594920620|FG001|Up to Week 52|Withdrawal by Subject|3|||
164698861|NCT02696031|594920621|FG002|Up to Week 52|Withdrawal by Subject|9|||
164698862|NCT02696031|594920622|FG003|Up to Week 52|Withdrawal by Subject|0|||
164698863|NCT02696031|594920623|FG004|Up to Week 52|Withdrawal by Subject|0|||
164698864|NCT02696031|594920624|FG005|Up to Week 52|Withdrawal by Subject|0|||
164698865|NCT02696031|594920619|FG000|Up to Week 104|Pregnancy|0|||
164698866|NCT02696031|594920620|FG001|Up to Week 104|Pregnancy|2|||
164698867|NCT02696031|594920621|FG002|Up to Week 104|Pregnancy|1|||
164698868|NCT02696031|594920622|FG003|Up to Week 104|Pregnancy|0|||
164698869|NCT02696031|594920623|FG004|Up to Week 104|Pregnancy|0|||
164698870|NCT02696031|594920624|FG005|Up to Week 104|Pregnancy|0|||
164698871|NCT02696031|594920619|FG000|Up to Week 104|Withdrawal by Subject|15|||
164698872|NCT02696031|594920620|FG001|Up to Week 104|Withdrawal by Subject|10|||
164698873|NCT02696031|594920621|FG002|Up to Week 104|Withdrawal by Subject|16|||
164698874|NCT02696031|594920622|FG003|Up to Week 104|Withdrawal by Subject|0|||
164698875|NCT02696031|594920623|FG004|Up to Week 104|Withdrawal by Subject|0|||
164698876|NCT02696031|594920624|FG005|Up to Week 104|Withdrawal by Subject|0|||
164698877|NCT02696031|594920619|FG000|Up to Week 104|Protocol Violation|1|||
164698878|NCT02696031|594920620|FG001|Up to Week 104|Protocol Violation|0|||
164698879|NCT02696031|594920621|FG002|Up to Week 104|Protocol Violation|0|||
164698880|NCT02696031|594920622|FG003|Up to Week 104|Protocol Violation|0|||
164698881|NCT02696031|594920623|FG004|Up to Week 104|Protocol Violation|0|||
164698882|NCT02696031|594920624|FG005|Up to Week 104|Protocol Violation|0|||
164698883|NCT02696031|594920619|FG000|Up to Week 104|Physician Decision|1|||
164698884|NCT02696031|594920620|FG001|Up to Week 104|Physician Decision|2|||
164698885|NCT02696031|594920621|FG002|Up to Week 104|Physician Decision|3|||
164362750|NCT02153112|593704054|FG000|Overall Study|Reason not Specified|0|||
164362751|NCT02153112|593704055|FG001|Overall Study|Reason not Specified|0|||
164362752|NCT02153112|593704056|FG002|Overall Study|Reason not Specified|0|||
164362753|NCT02153112|593704057|FG003|Overall Study|Reason not Specified|0|||
164362754|NCT02153112|593704058|FG004|Overall Study|Reason not Specified|0|||
164362755|NCT02153112|593704059|FG005|Overall Study|Reason not Specified|0|||
164362756|NCT02153112|593704060|FG006|Overall Study|Reason not Specified|0|||
164362757|NCT02153112|593704061|FG007|Overall Study|Reason not Specified|0|||
164362758|NCT02153112|593704062|FG008|Overall Study|Reason not Specified|1|||
164362759|NCT02153112|593704063|FG009|Overall Study|Reason not Specified|1|||
164698886|NCT02696031|594920622|FG003|Up to Week 104|Physician Decision|0|||
164698887|NCT02696031|594920623|FG004|Up to Week 104|Physician Decision|0|||
164698888|NCT02696031|594920624|FG005|Up to Week 104|Physician Decision|0|||
164698889|NCT02696031|594920619|FG000|Up to Week 104|Lost to Follow-up|2|||
164698890|NCT02696031|594920620|FG001|Up to Week 104|Lost to Follow-up|3|||
164698891|NCT02696031|594920621|FG002|Up to Week 104|Lost to Follow-up|1|||
164698892|NCT02696031|594920622|FG003|Up to Week 104|Lost to Follow-up|0|||
164698893|NCT02696031|594920623|FG004|Up to Week 104|Lost to Follow-up|0|||
164698894|NCT02696031|594920624|FG005|Up to Week 104|Lost to Follow-up|0|||
164698895|NCT02696031|594920619|FG000|Up to Week 104|Lack of Efficacy|13|||
164362760|NCT00423150|593704064|FG000|Overall Study|Adverse Event|11|||
164362761|NCT00423150|593704064|FG000|Overall Study|Progression of disease being studied|69|||
164362762|NCT00423150|593704064|FG000|Overall Study|Withdrawal by Subject|1|||
164698896|NCT02696031|594920620|FG001|Up to Week 104|Lack of Efficacy|12|||
164698897|NCT02696031|594920621|FG002|Up to Week 104|Lack of Efficacy|11|||
164698898|NCT02696031|594920622|FG003|Up to Week 104|Lack of Efficacy|0|||
164698899|NCT02696031|594920623|FG004|Up to Week 104|Lack of Efficacy|0|||
164698900|NCT02696031|594920624|FG005|Up to Week 104|Lack of Efficacy|0|||
164698901|NCT02696031|594920619|FG000|Up to Week 104|Adverse Event|7|||
164698902|NCT02696031|594920620|FG001|Up to Week 104|Adverse Event|11|||
164698903|NCT02696031|594920621|FG002|Up to Week 104|Adverse Event|5|||
164698904|NCT02696031|594920622|FG003|Up to Week 104|Adverse Event|0|||
164698905|NCT02696031|594920623|FG004|Up to Week 104|Adverse Event|0|||
164698906|NCT02696031|594920624|FG005|Up to Week 104|Adverse Event|0|||
164698907|NCT02696031|594920619|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
164698908|NCT02696031|594920620|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
164698909|NCT02696031|594920621|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
164698910|NCT02696031|594920622|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
164698911|NCT02696031|594920623|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
164698912|NCT02696031|594920624|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
164698913|NCT02696031|594920619|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
164698914|NCT02696031|594920620|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
164698915|NCT02696031|594920621|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
164698916|NCT02696031|594920622|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
164698917|NCT02696031|594920623|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
164698918|NCT02696031|594920624|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
164698919|NCT02696031|594920619|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
164698920|NCT02696031|594920620|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
164698921|NCT02696031|594920621|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
164362763|NCT00423150|593704064|FG000|Overall Study|Non-compliance with protocol|1|||
164362764|NCT00423150|593704064|FG000|Overall Study|Administrative|4|||
164362765|NCT05104567|593704066|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
164698922|NCT02696031|594920622|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
164698923|NCT02696031|594920623|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
164698924|NCT02696031|594920624|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
164698925|NCT02696031|594920619|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
164698926|NCT02696031|594920620|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
164698927|NCT02696031|594920621|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
164698928|NCT02696031|594920622|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
164698929|NCT02696031|594920623|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
164698930|NCT02696031|594920624|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
164698931|NCT02696031|594920619|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
164698932|NCT02696031|594920620|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
164698933|NCT02696031|594920621|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
164698934|NCT02696031|594920622|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
164698935|NCT02696031|594920623|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
164698936|NCT02696031|594920624|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
164698937|NCT02696031|594920619|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
164698938|NCT02696031|594920620|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
164698939|NCT02696031|594920621|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
164698940|NCT02696031|594920622|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
164698941|NCT02696031|594920623|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
164698942|NCT02696031|594920624|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
164698943|NCT02696031|594920619|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
164698944|NCT02696031|594920620|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
164698945|NCT02696031|594920621|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
164698946|NCT02696031|594920622|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
164698947|NCT02696031|594920623|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
164698948|NCT02696031|594920624|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
164698949|NCT02339740|594920625|FG000|Overall Study|Death|1|||
164698950|NCT02339740|594920626|FG001|Overall Study|Death|0|||
164698951|NCT02339740|594920625|FG000|Overall Study|Physician Decision|0|||
164698952|NCT02339740|594920626|FG001|Overall Study|Physician Decision|2|||
164698953|NCT02339740|594920625|FG000|Overall Study|Withdrawal by Subject|5|||
164698954|NCT02339740|594920626|FG001|Overall Study|Withdrawal by Subject|1|||
164698955|NCT02339740|594920625|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
164698956|NCT02339740|594920626|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
164698957|NCT00063882|594920627|FG000|Overall Study|Protocol Violation|3|||
164698958|NCT00063882|594920628|FG001|Overall Study|Protocol Violation|3|||
164698959|NCT00063882|594920627|FG000|Overall Study|Withdrawal by Subject|2|||
164698960|NCT00063882|594920628|FG001|Overall Study|Withdrawal by Subject|1|||
164698961|NCT01855048|594920631|FG000|Overall Study|Withdrawal by Subject|0|||
164698962|NCT01855048|594920632|FG001|Overall Study|Withdrawal by Subject|1|||
164698963|NCT01855048|594920633|FG002|Overall Study|Withdrawal by Subject|0|||
164698964|NCT01855048|594920634|FG003|Overall Study|Withdrawal by Subject|0|||
164698965|NCT01855048|594920635|FG004|Overall Study|Withdrawal by Subject|1|||
164698966|NCT01855048|594920636|FG005|Overall Study|Withdrawal by Subject|0|||
164698967|NCT02972502|594920641|FG000|Overall Study|Lost to Follow-up|3|||
164698968|NCT02972502|594920642|FG001|Overall Study|Lost to Follow-up|1|||
164698969|NCT02972502|594920641|FG000|Overall Study|Withdrawal by Subject|1|||
164698970|NCT02972502|594920642|FG001|Overall Study|Withdrawal by Subject|1|||
164698971|NCT03832738|594920643|FG000|Overall Study|Withdrawal by Subject|6|||
164698972|NCT03832738|594920644|FG001|Overall Study|Withdrawal by Subject|7|||
164698973|NCT03832738|594920645|FG002|Overall Study|Withdrawal by Subject|16|||
164698974|NCT03832738|594920643|FG000|Overall Study|Physician Decision|0|||
164698975|NCT03832738|594920644|FG001|Overall Study|Physician Decision|1|||
164698976|NCT03832738|594920645|FG002|Overall Study|Physician Decision|2|||
164698977|NCT03832738|594920643|FG000|Overall Study|Adverse Event|2|||
164698978|NCT03832738|594920644|FG001|Overall Study|Adverse Event|3|||
164698979|NCT03832738|594920645|FG002|Overall Study|Adverse Event|1|||
164698980|NCT03832738|594920643|FG000|Overall Study|Pregnancy|0|||
164698981|NCT03832738|594920644|FG001|Overall Study|Pregnancy|1|||
164698982|NCT03832738|594920645|FG002|Overall Study|Pregnancy|0|||
164698983|NCT03852459|594920646|FG000|Overall Study|Adverse Event|2|||
164698984|NCT03852459|594920647|FG001|Overall Study|Adverse Event|2|||
164698985|NCT03852459|594920646|FG000|Overall Study|Withdrawal by Subject|1|||
164698986|NCT03852459|594920647|FG001|Overall Study|Withdrawal by Subject|1|||
164698987|NCT00049842|594920648|FG000|Treatment Phase|Adverse Event|47|||
164698988|NCT00049842|594920649|FG001|Treatment Phase|Adverse Event|12|||
164698989|NCT00049842|594920648|FG000|Treatment Phase|Withdrawal by Subject|35|||
164698990|NCT00049842|594920649|FG001|Treatment Phase|Withdrawal by Subject|46|||
164698991|NCT00049842|594920648|FG000|Treatment Phase|Non-compliance with protocol|7|||
164698992|NCT00049842|594920649|FG001|Treatment Phase|Non-compliance with protocol|8|||
164698993|NCT00049842|594920648|FG000|Treatment Phase|Lost to Follow-up|4|||
164698994|NCT00049842|594920649|FG001|Treatment Phase|Lost to Follow-up|8|||
164698995|NCT00049842|594920648|FG000|Treatment Phase|Administrative|0|||
164698996|NCT00049842|594920649|FG001|Treatment Phase|Administrative|3|||
164698997|NCT00049842|594920648|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
164698998|NCT00049842|594920649|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
164698999|NCT00049842|594920648|FG000|Follow-up Phase|Adverse Event|6|||
164699000|NCT00049842|594920649|FG001|Follow-up Phase|Adverse Event|1|||
164699001|NCT00049842|594920648|FG000|Follow-up Phase|Other|1|||
164699002|NCT00049842|594920649|FG001|Follow-up Phase|Other|4|||
164699003|NCT05486065|594920651|FG000|Overall Study|Withdrawal by Subject|1|||
164699004|NCT05486065|594920652|FG001|Overall Study|Withdrawal by Subject|5|||
164699005|NCT05486065|594920653|FG002|Overall Study|Withdrawal by Subject|4|||
164699006|NCT05486065|594920654|FG003|Overall Study|Withdrawal by Subject|3|||
164699007|NCT05486065|594920651|FG000|Overall Study|Lost to Follow-up|4|||
164699008|NCT05486065|594920652|FG001|Overall Study|Lost to Follow-up|2|||
164699009|NCT05486065|594920653|FG002|Overall Study|Lost to Follow-up|2|||
164699010|NCT05486065|594920654|FG003|Overall Study|Lost to Follow-up|2|||
164699011|NCT05486065|594920651|FG000|Overall Study|Physician Decision|0|||
164699012|NCT05486065|594920652|FG001|Overall Study|Physician Decision|1|||
164699013|NCT05486065|594920653|FG002|Overall Study|Physician Decision|1|||
164699014|NCT05486065|594920654|FG003|Overall Study|Physician Decision|0|||
164699015|NCT05486065|594920651|FG000|Overall Study|Failure to meet randomization criteria|0|||
164699016|NCT05486065|594920652|FG001|Overall Study|Failure to meet randomization criteria|0|||
164699017|NCT05486065|594920653|FG002|Overall Study|Failure to meet randomization criteria|0|||
164699018|NCT05486065|594920654|FG003|Overall Study|Failure to meet randomization criteria|1|||
164699019|NCT02442271|594920657|FG000|Overall Study|Adverse Event|1|||
164699020|NCT02442271|594920657|FG000|Overall Study|Withdrew Consent|1|||
164699021|NCT02442271|594920657|FG000|Overall Study|Lost to Follow-up|1|||
164699022|NCT02442271|594920657|FG000|Overall Study|Other|1|||
164699023|NCT00831623|594920662|FG000|Overall Study|Withdrawal by Subject|9|||
164699024|NCT00831623|594920662|FG000|Overall Study|Lost to Follow-up|1|||
164699025|NCT00831623|594920662|FG000|Overall Study|Not 2 years post-treatment|12|||
164362766|NCT05104567|593704067|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
164362767|NCT05104567|593704068|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
164362768|NCT05104567|593704069|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
164362769|NCT05104567|593704070|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
164362770|NCT05104567|593704071|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
164362771|NCT05104567|593704072|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
164362772|NCT05104567|593704066|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
164362773|NCT05104567|593704067|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
164362774|NCT05104567|593704068|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
164362775|NCT05104567|593704069|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
164362776|NCT05104567|593704070|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
164362777|NCT05104567|593704071|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
164362778|NCT05104567|593704072|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
164362779|NCT05104567|593704066|FG000|Overall Study|Progressive disease|3|||
164362780|NCT05104567|593704067|FG001|Overall Study|Progressive disease|13|||
164362781|NCT05104567|593704068|FG002|Overall Study|Progressive disease|13|||
164362782|NCT05104567|593704069|FG003|Overall Study|Progressive disease|17|||
164362783|NCT05104567|593704070|FG004|Overall Study|Progressive disease|17|||
164362784|NCT05104567|593704071|FG005|Overall Study|Progressive disease|28|||
164362785|NCT05104567|593704072|FG006|Overall Study|Progressive disease|24|||
164362786|NCT05104567|593704066|FG000|Overall Study|Withdrawal by Subject|1|||
164362787|NCT05104567|593704067|FG001|Overall Study|Withdrawal by Subject|1|||
164362788|NCT05104567|593704068|FG002|Overall Study|Withdrawal by Subject|2|||
164362789|NCT05104567|593704069|FG003|Overall Study|Withdrawal by Subject|0|||
164362790|NCT05104567|593704070|FG004|Overall Study|Withdrawal by Subject|0|||
164362791|NCT05104567|593704071|FG005|Overall Study|Withdrawal by Subject|0|||
164362792|NCT05104567|593704072|FG006|Overall Study|Withdrawal by Subject|0|||
164362793|NCT05104567|593704066|FG000|Overall Study|Other|1|||
164362794|NCT05104567|593704067|FG001|Overall Study|Other|1|||
164362795|NCT05104567|593704068|FG002|Overall Study|Other|1|||
164362796|NCT05104567|593704069|FG003|Overall Study|Other|0|||
164362797|NCT05104567|593704070|FG004|Overall Study|Other|0|||
164362798|NCT05104567|593704071|FG005|Overall Study|Other|0|||
164362799|NCT05104567|593704072|FG006|Overall Study|Other|0|||
164362800|NCT01464346|593704073|FG000|Overall Study|Withdrawal by Subject|0|||
164362801|NCT01464346|593704074|FG001|Overall Study|Withdrawal by Subject|0|||
164362802|NCT01464346|593704075|FG002|Overall Study|Withdrawal by Subject|1|||
164362803|NCT03999892|593704076|FG000|Overall Study|Lost to Follow-up|1|||
164362804|NCT01848756|593704077|FG000|Overall Study|Adverse Event|1|||
164362805|NCT01848756|593704077|FG000|Overall Study|Withdrawal by Subject|1|||
164362806|NCT01848756|593704077|FG000|Overall Study|Enrolled in Error|1|||
164362807|NCT01286012|593704078|FG000|Overall Study|Adverse Event|3|||
164362808|NCT01286012|593704079|FG001|Overall Study|Adverse Event|3|||
164362809|NCT01286012|593704078|FG000|Overall Study|Death|2|||
164362810|NCT01286012|593704079|FG001|Overall Study|Death|3|||
164362811|NCT01286012|593704078|FG000|Overall Study|Protocol Violation|1|||
164362812|NCT01286012|593704079|FG001|Overall Study|Protocol Violation|1|||
164362813|NCT01286012|593704078|FG000|Overall Study|Withdrawal by Subject|4|||
164362814|NCT01286012|593704079|FG001|Overall Study|Withdrawal by Subject|4|||
164362815|NCT01286012|593704078|FG000|Overall Study|Physician Decision|2|||
164362816|NCT01286012|593704079|FG001|Overall Study|Physician Decision|0|||
164362817|NCT01286012|593704078|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
164362818|NCT01286012|593704079|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
164362819|NCT04056195|593704082|FG000|Overall Study|Adverse Event|1|||
164362820|NCT04056195|593704083|FG001|Overall Study|Adverse Event|0|||
164362821|NCT04056195|593704084|FG002|Overall Study|Adverse Event|0|||
164362822|NCT04056195|593704082|FG000|Overall Study|Withdrawal by Subject|0|||
164362823|NCT04056195|593704083|FG001|Overall Study|Withdrawal by Subject|1|||
164362824|NCT04056195|593704084|FG002|Overall Study|Withdrawal by Subject|1|||
164362825|NCT04056195|593704082|FG000|Overall Study|Physician Decision|1|||
164362826|NCT04056195|593704083|FG001|Overall Study|Physician Decision|1|||
164362827|NCT04056195|593704084|FG002|Overall Study|Physician Decision|1|||
164362828|NCT01498458|593704085|FG000|Overall Study|Adverse Event|4|||
164362829|NCT01498458|593704085|FG000|Overall Study|Physician Decision|3|||
164362830|NCT02226003|593704086|FG000|Overall Study|Lost to Follow-up|2|||
164362831|NCT02226003|593704087|FG001|Overall Study|Lost to Follow-up|1|||
164362832|NCT02226003|593704088|FG002|Overall Study|Lost to Follow-up|3|||
164438568|NCT05219253|593972979|FG000|Overall Study|Withdrawal by Subject|1|||
164362833|NCT02226003|593704086|FG000|Overall Study|Withdrawal by Subject|0|||
164362834|NCT02226003|593704087|FG001|Overall Study|Withdrawal by Subject|0|||
164362835|NCT02226003|593704088|FG002|Overall Study|Withdrawal by Subject|3|||
164362836|NCT03279692|593704094|FG000|Overall Study|Withdrawal by Subject|1|||
164362837|NCT02446990|593704095|FG000|Overall Study|Death|485|||
164362838|NCT02446990|593704096|FG001|Overall Study|Death|458|||
164438569|NCT05219253|593972980|FG001|Overall Study|Withdrawal by Subject|2|||
164362839|NCT02446990|593704095|FG000|Overall Study|Lost to Follow-up|3|||
164362840|NCT02446990|593704096|FG001|Overall Study|Lost to Follow-up|1|||
164362841|NCT02446990|593704095|FG000|Overall Study|Physician Decision|1|||
164362842|NCT02446990|593704096|FG001|Overall Study|Physician Decision|0|||
164362843|NCT02446990|593704095|FG000|Overall Study|Withdrawal by Subject|231|||
164362844|NCT02446990|593704096|FG001|Overall Study|Withdrawal by Subject|199|||
164362845|NCT01064401|593704097|FG000|Overall Study|Adverse Event|47|||
164362846|NCT01064401|593704098|FG001|Overall Study|Adverse Event|56|||
164362847|NCT01064401|593704097|FG000|Overall Study|Lack of Efficacy|46|||
164362848|NCT01064401|593704098|FG001|Overall Study|Lack of Efficacy|23|||
164362849|NCT01064401|593704097|FG000|Overall Study|Lost to Follow-up|12|||
164362850|NCT01064401|593704098|FG001|Overall Study|Lost to Follow-up|9|||
164362851|NCT01064401|593704097|FG000|Overall Study|Consent Withdrawn|98|||
164362852|NCT01064401|593704098|FG001|Overall Study|Consent Withdrawn|80|||
164362853|NCT01064401|593704097|FG000|Overall Study|Investigator Decision|4|||
164362854|NCT01064401|593704098|FG001|Overall Study|Investigator Decision|6|||
164362855|NCT01064401|593704097|FG000|Overall Study|Death|4|||
164362856|NCT01064401|593704098|FG001|Overall Study|Death|0|||
164362857|NCT01064401|593704097|FG000|Overall Study|Pregnancy|4|||
164362858|NCT01064401|593704098|FG001|Overall Study|Pregnancy|7|||
164362859|NCT01064401|593704097|FG000|Overall Study|Noncompliance|7|||
164362860|NCT01064401|593704098|FG001|Overall Study|Noncompliance|8|||
164362861|NCT01064401|593704097|FG000|Overall Study|Site Closure|4|||
164362862|NCT01064401|593704098|FG001|Overall Study|Site Closure|5|||
164362863|NCT01064401|593704097|FG000|Overall Study|Other|2|||
164362864|NCT01064401|593704098|FG001|Overall Study|Other|1|||
164699026|NCT01138111|594920666|FG000|Overall Study|Withdrawal by Subject|5|||
164699027|NCT01138111|594920666|FG000|Overall Study|Adverse Event|1|||
164699028|NCT01138111|594920666|FG000|Overall Study|Death|1|||
164699029|NCT01138111|594920666|FG000|Overall Study|Lost to Follow-up|2|||
164699030|NCT01118117|594920667|FG000|Overall Study|Death|8|||
164699031|NCT01118117|594920668|FG001|Overall Study|Death|0|||
164699032|NCT01118117|594920667|FG000|Overall Study|Lost to Follow-up|6|||
164699033|NCT01118117|594920668|FG001|Overall Study|Lost to Follow-up|0|||
164699034|NCT01118117|594920667|FG000|Overall Study|Missed 12 Month Visit|7|||
164699035|NCT01118117|594920668|FG001|Overall Study|Missed 12 Month Visit|0|||
164699036|NCT02149121|594920669|FG000|Main Study Period|Lack of Efficacy|2|||
164699037|NCT02149121|594920670|FG001|Main Study Period|Lack of Efficacy|2|||
164699038|NCT02149121|594920671|FG002|Main Study Period|Lack of Efficacy|1|||
164699039|NCT02149121|594920672|FG003|Main Study Period|Lack of Efficacy|0|||
164699040|NCT02149121|594920673|FG004|Main Study Period|Lack of Efficacy|0|||
164362865|NCT04439253|593705884|FG000|Overall Study|Adverse Event|1|||
164362866|NCT04439253|593705884|FG000|Overall Study|Disease progression|2|||
164362867|NCT04439253|593705884|FG000|Overall Study|Complicating disease|1|||
164699041|NCT02149121|594920674|FG005|Main Study Period|Lack of Efficacy|0|||
164699042|NCT02149121|594920675|FG006|Main Study Period|Lack of Efficacy|0|||
164699043|NCT02149121|594920669|FG000|Main Study Period|Withdrawal by Subject|9|||
164699044|NCT02149121|594920670|FG001|Main Study Period|Withdrawal by Subject|5|||
164699045|NCT02149121|594920671|FG002|Main Study Period|Withdrawal by Subject|1|||
164362868|NCT00887354|593705887|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
164362869|NCT00887354|593705888|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
164362870|NCT00887354|593705887|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
164362871|NCT00887354|593705888|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
164362872|NCT00887354|593705887|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
164362873|NCT00887354|593705888|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
164362874|NCT00887354|593705887|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
164362875|NCT00887354|593705888|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
164362876|NCT00887354|593705887|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
164362877|NCT00887354|593705888|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
164362878|NCT00887354|593705887|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
164362879|NCT00887354|593705888|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
164699046|NCT02149121|594920672|FG003|Main Study Period|Withdrawal by Subject|0|||
164699047|NCT02149121|594920673|FG004|Main Study Period|Withdrawal by Subject|0|||
164699048|NCT02149121|594920674|FG005|Main Study Period|Withdrawal by Subject|0|||
164699049|NCT02149121|594920675|FG006|Main Study Period|Withdrawal by Subject|0|||
164362880|NCT00887354|593705887|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
164362881|NCT00887354|593705888|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
164362882|NCT00887354|593705887|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
164362883|NCT00887354|593705888|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
164362884|NCT00887354|593705887|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
164362885|NCT00887354|593705888|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
164699050|NCT02149121|594920669|FG000|Main Study Period|Adverse Event|2|||
164699051|NCT02149121|594920670|FG001|Main Study Period|Adverse Event|5|||
164699052|NCT02149121|594920671|FG002|Main Study Period|Adverse Event|1|||
164699053|NCT02149121|594920672|FG003|Main Study Period|Adverse Event|0|||
164362886|NCT00887354|593705887|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
164362887|NCT00887354|593705888|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
164362888|NCT00887354|593705887|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
164362889|NCT00887354|593705888|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
164362890|NCT00887354|593705887|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
164362891|NCT00887354|593705888|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
164362892|NCT00887354|593705887|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
164362893|NCT00887354|593705888|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
164362894|NCT00887354|593705887|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
164362895|NCT00887354|593705888|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
164362896|NCT00887354|593705887|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
164362897|NCT00887354|593705888|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
164362898|NCT00192504|593705891|FG000|Overall Study|Lost to Follow-up|1|||
164362899|NCT00192504|593705892|FG001|Overall Study|Lost to Follow-up|0|||
164362900|NCT00192504|593705893|FG002|Overall Study|Lost to Follow-up|0|||
164362901|NCT00192504|593705894|FG003|Overall Study|Lost to Follow-up|0|||
164362902|NCT00192504|593705891|FG000|Overall Study|Dosing window missed|0|||
164362903|NCT00192504|593705892|FG001|Overall Study|Dosing window missed|0|||
164362904|NCT00192504|593705893|FG002|Overall Study|Dosing window missed|1|||
164362905|NCT00192504|593705894|FG003|Overall Study|Dosing window missed|0|||
164362906|NCT00542919|593705897|FG000|Overall Study|Adverse Event|1|||
164362907|NCT00542919|593705898|FG001|Overall Study|Adverse Event|5|||
164362908|NCT00542919|593705899|FG002|Overall Study|Adverse Event|1|||
164362909|NCT00542919|593705897|FG000|Overall Study|Withdrawal by Subject|1|||
164699054|NCT02149121|594920673|FG004|Main Study Period|Adverse Event|0|||
164699055|NCT02149121|594920674|FG005|Main Study Period|Adverse Event|0|||
164699056|NCT02149121|594920675|FG006|Main Study Period|Adverse Event|0|||
164699057|NCT02149121|594920669|FG000|Main Study Period|Protocol Violation|2|||
164699058|NCT02149121|594920670|FG001|Main Study Period|Protocol Violation|0|||
164362910|NCT00542919|593705898|FG001|Overall Study|Withdrawal by Subject|0|||
164362911|NCT00542919|593705899|FG002|Overall Study|Withdrawal by Subject|3|||
164362912|NCT00542919|593705897|FG000|Overall Study|Physician Decision|2|||
164362913|NCT00542919|593705898|FG001|Overall Study|Physician Decision|2|||
164362914|NCT00542919|593705899|FG002|Overall Study|Physician Decision|1|||
164362915|NCT00542919|593705897|FG000|Overall Study|Sponsor Decision|1|||
164362916|NCT00542919|593705898|FG001|Overall Study|Sponsor Decision|0|||
164362917|NCT00542919|593705899|FG002|Overall Study|Sponsor Decision|0|||
164362918|NCT00542919|593705897|FG000|Overall Study|Lost to Follow-up|2|||
164362919|NCT00542919|593705898|FG001|Overall Study|Lost to Follow-up|0|||
164699059|NCT02149121|594920671|FG002|Main Study Period|Protocol Violation|0|||
164362920|NCT00542919|593705899|FG002|Overall Study|Lost to Follow-up|1|||
164362921|NCT05123222|593705906|FG000|Overall Study|Lost to Follow-up|2|||
164362922|NCT05123222|593705907|FG001|Overall Study|Lost to Follow-up|0|||
164362923|NCT05123222|593705908|FG002|Overall Study|Lost to Follow-up|0|||
164362924|NCT05123222|593705909|FG003|Overall Study|Lost to Follow-up|0|||
164699060|NCT02149121|594920672|FG003|Main Study Period|Protocol Violation|0|||
164362925|NCT05123222|593705906|FG000|Overall Study|Protocol Violation|0|||
164699061|NCT02149121|594920673|FG004|Main Study Period|Protocol Violation|0|||
164699062|NCT02149121|594920674|FG005|Main Study Period|Protocol Violation|0|||
164362926|NCT05123222|593705907|FG001|Overall Study|Protocol Violation|0|||
164699063|NCT02149121|594920675|FG006|Main Study Period|Protocol Violation|0|||
164699064|NCT02149121|594920669|FG000|Main Study Period|Lost to Follow-up|2|||
164699065|NCT02149121|594920670|FG001|Main Study Period|Lost to Follow-up|1|||
164699066|NCT02149121|594920671|FG002|Main Study Period|Lost to Follow-up|0|||
164699067|NCT02149121|594920672|FG003|Main Study Period|Lost to Follow-up|0|||
164699068|NCT02149121|594920673|FG004|Main Study Period|Lost to Follow-up|0|||
164699069|NCT02149121|594920674|FG005|Main Study Period|Lost to Follow-up|0|||
164699070|NCT02149121|594920675|FG006|Main Study Period|Lost to Follow-up|0|||
164699071|NCT02149121|594920669|FG000|Main Study Period|Death|1|||
164699072|NCT02149121|594920670|FG001|Main Study Period|Death|0|||
164362927|NCT05123222|593705908|FG002|Overall Study|Protocol Violation|1|||
164362928|NCT05123222|593705909|FG003|Overall Study|Protocol Violation|0|||
164362929|NCT02535741|593705910|FG000|Overall Study|Adverse Event|3|||
164699073|NCT02149121|594920671|FG002|Main Study Period|Death|0|||
164699074|NCT02149121|594920672|FG003|Main Study Period|Death|0|||
164699075|NCT02149121|594920673|FG004|Main Study Period|Death|0|||
164699076|NCT02149121|594920674|FG005|Main Study Period|Death|0|||
164699077|NCT02149121|594920675|FG006|Main Study Period|Death|0|||
164699078|NCT02149121|594920669|FG000|Main Study Period|Physician Decision|1|||
164699079|NCT02149121|594920670|FG001|Main Study Period|Physician Decision|0|||
164699080|NCT02149121|594920671|FG002|Main Study Period|Physician Decision|0|||
164699081|NCT02149121|594920672|FG003|Main Study Period|Physician Decision|0|||
164699082|NCT02149121|594920673|FG004|Main Study Period|Physician Decision|0|||
164699083|NCT02149121|594920674|FG005|Main Study Period|Physician Decision|0|||
164699084|NCT02149121|594920675|FG006|Main Study Period|Physician Decision|0|||
164699085|NCT02149121|594920669|FG000|Main Study Period|Developed any malignancy|0|||
164699086|NCT02149121|594920670|FG001|Main Study Period|Developed any malignancy|1|||
164362930|NCT02535741|593705910|FG000|Overall Study|Withdrawal by Subject|9|||
164362931|NCT02535741|593705910|FG000|Overall Study|Lost to Follow-up|10|||
164362932|NCT02535741|593705910|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
164362933|NCT02535741|593705910|FG000|Overall Study|Missing data|6|||
164362934|NCT03020823|593705913|FG000|Overall Study|Physician Decision|4|||
164362935|NCT03020823|593705913|FG000|Overall Study|Lack of Efficacy|4|||
164362936|NCT03020823|593705913|FG000|Overall Study|Adverse Event|2|||
164362937|NCT03739112|593705914|FG000|Overall Study|Adverse Event|2|||
164362938|NCT03739112|593705915|FG001|Overall Study|Adverse Event|2|||
164362939|NCT03739112|593705914|FG000|Overall Study|Withdrawal by Subject|38|||
164362940|NCT03739112|593705915|FG001|Overall Study|Withdrawal by Subject|19|||
164362941|NCT03739112|593705914|FG000|Overall Study|Lost to Follow-up|31|||
164362942|NCT03739112|593705915|FG001|Overall Study|Lost to Follow-up|33|||
164362943|NCT03739112|593705914|FG000|Overall Study|Protocol Deviation|12|||
164362944|NCT03739112|593705915|FG001|Overall Study|Protocol Deviation|9|||
164362945|NCT03739112|593705914|FG000|Overall Study|Physician Decision|1|||
164362946|NCT03739112|593705915|FG001|Overall Study|Physician Decision|0|||
164362947|NCT03739112|593705914|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
164362948|NCT03739112|593705915|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
164362949|NCT03739112|593705914|FG000|Overall Study|Site went on hold|65|||
164362950|NCT03739112|593705915|FG001|Overall Study|Site went on hold|67|||
164362951|NCT03739112|593705914|FG000|Overall Study|Other than specified|8|||
164362952|NCT03739112|593705915|FG001|Overall Study|Other than specified|5|||
164362953|NCT03739112|593705914|FG000|Overall Study|Randomized but not vaccinated|31|||
164362954|NCT03739112|593705915|FG001|Overall Study|Randomized but not vaccinated|25|||
164362955|NCT00588822|593705917|FG000|Overall Study|progression of disease|8|||
164362956|NCT01727141|593705921|FG000|Overall Study|Physician Decision|0|||
164362957|NCT01727141|593705922|FG001|Overall Study|Physician Decision|1|||
164362958|NCT01727141|593705923|FG002|Overall Study|Physician Decision|0|||
164362959|NCT01727141|593705924|FG003|Overall Study|Physician Decision|2|||
164362960|NCT01727141|593705921|FG000|Overall Study|Lost to Follow-up|0|||
164362961|NCT01727141|593705922|FG001|Overall Study|Lost to Follow-up|2|||
164362962|NCT01727141|593705923|FG002|Overall Study|Lost to Follow-up|0|||
164362963|NCT01727141|593705924|FG003|Overall Study|Lost to Follow-up|0|||
164362964|NCT01727141|593705921|FG000|Overall Study|Death|0|||
164362965|NCT01727141|593705922|FG001|Overall Study|Death|1|||
164362966|NCT01727141|593705923|FG002|Overall Study|Death|1|||
164362967|NCT01727141|593705924|FG003|Overall Study|Death|1|||
164362968|NCT01727141|593705921|FG000|Overall Study|Protocol deviation|1|||
164362969|NCT01727141|593705922|FG001|Overall Study|Protocol deviation|1|||
164362970|NCT01727141|593705923|FG002|Overall Study|Protocol deviation|0|||
164362971|NCT01727141|593705924|FG003|Overall Study|Protocol deviation|1|||
164362972|NCT01727141|593705921|FG000|Overall Study|Withdrawal by Subject|4|||
164362973|NCT01727141|593705922|FG001|Overall Study|Withdrawal by Subject|4|||
164362974|NCT01727141|593705923|FG002|Overall Study|Withdrawal by Subject|2|||
164362975|NCT01727141|593705924|FG003|Overall Study|Withdrawal by Subject|11|||
164362976|NCT01957462|593705925|FG000|Test Period 1|Withdrawal by Subject|1|||
164362977|NCT01957462|593705926|FG001|Test Period 1|Withdrawal by Subject|0|||
164362978|NCT01957462|593705925|FG000|Test Period 1|Adverse Event|1|||
164362979|NCT01957462|593705926|FG001|Test Period 1|Adverse Event|0|||
164362980|NCT03102918|593705929|FG000|Overall Study|Protocol Violation|1|||
164362981|NCT03102918|593705930|FG001|Overall Study|Protocol Violation|0|||
164362982|NCT04765358|593705931|FG000|Overall Study|Withdrawal by Subject|1|||
164362983|NCT01652664|593705932|FG000|Overall Study|Treatment Failure|5|||
164362984|NCT01652664|593705933|FG001|Overall Study|Treatment Failure|1|||
164362985|NCT01652664|593705932|FG000|Overall Study|Inadequate IOP control|1|||
164362986|NCT01652664|593705933|FG001|Overall Study|Inadequate IOP control|0|||
164362987|NCT00491387|593705935|FG000|Overall Study|study terminated|20|||
164362988|NCT02063854|593705942|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
164362989|NCT02063854|593705943|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
164362990|NCT02063854|593705944|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
164362991|NCT02063854|593705945|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
164362992|NCT02063854|593705946|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
164362993|NCT02063854|593705947|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
164362994|NCT02063854|593705948|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
164362995|NCT02063854|593705942|FG000|Overall Study|Major Protocol Deviation|0|||
164362996|NCT02063854|593705943|FG001|Overall Study|Major Protocol Deviation|0|||
164362997|NCT02063854|593705944|FG002|Overall Study|Major Protocol Deviation|3|||
164362998|NCT02063854|593705945|FG003|Overall Study|Major Protocol Deviation|0|||
164362999|NCT02063854|593705946|FG004|Overall Study|Major Protocol Deviation|0|||
164363000|NCT02063854|593705947|FG005|Overall Study|Major Protocol Deviation|0|||
164363001|NCT02063854|593705948|FG006|Overall Study|Major Protocol Deviation|0|||
164363002|NCT02063854|593705942|FG000|Overall Study|Voluntary Withdrawal|2|||
164363003|NCT02063854|593705943|FG001|Overall Study|Voluntary Withdrawal|0|||
164363004|NCT02063854|593705944|FG002|Overall Study|Voluntary Withdrawal|8|||
164363005|NCT02063854|593705945|FG003|Overall Study|Voluntary Withdrawal|1|||
164363006|NCT02063854|593705946|FG004|Overall Study|Voluntary Withdrawal|3|||
164363007|NCT02063854|593705947|FG005|Overall Study|Voluntary Withdrawal|6|||
164363008|NCT02063854|593705948|FG006|Overall Study|Voluntary Withdrawal|1|||
164363009|NCT02063854|593705942|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
164363010|NCT02063854|593705943|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
164363011|NCT02063854|593705944|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
164363012|NCT02063854|593705945|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
164363013|NCT02063854|593705946|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
164363014|NCT02063854|593705947|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
164363015|NCT02063854|593705948|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
164363016|NCT02063854|593705942|FG000|Overall Study|Reason Not Specified|1|||
164363017|NCT02063854|593705943|FG001|Overall Study|Reason Not Specified|0|||
164363018|NCT02063854|593705944|FG002|Overall Study|Reason Not Specified|0|||
164363019|NCT02063854|593705945|FG003|Overall Study|Reason Not Specified|0|||
164363020|NCT02063854|593705946|FG004|Overall Study|Reason Not Specified|0|||
164363021|NCT02063854|593705947|FG005|Overall Study|Reason Not Specified|0|||
164363022|NCT02063854|593705948|FG006|Overall Study|Reason Not Specified|0|||
164363023|NCT02063854|593705942|FG000|Overall Study|Did Not Receive Study Drug|0|||
164363024|NCT02063854|593705943|FG001|Overall Study|Did Not Receive Study Drug|0|||
164363025|NCT02063854|593705944|FG002|Overall Study|Did Not Receive Study Drug|0|||
164363026|NCT02063854|593705945|FG003|Overall Study|Did Not Receive Study Drug|0|||
164363027|NCT02063854|593705946|FG004|Overall Study|Did Not Receive Study Drug|0|||
164363028|NCT02063854|593705947|FG005|Overall Study|Did Not Receive Study Drug|1|||
164363029|NCT02063854|593705948|FG006|Overall Study|Did Not Receive Study Drug|0|||
164363030|NCT02419742|593705949|FG000|Overall Study|Adverse Event|2|||
164363031|NCT02419742|593705950|FG001|Overall Study|Adverse Event|0|||
164363032|NCT02419742|593705949|FG000|Overall Study|Disease Progression|0|||
164363033|NCT02419742|593705950|FG001|Overall Study|Disease Progression|1|||
164363034|NCT02419742|593705949|FG000|Overall Study|Withdrew Consent|2|||
164363035|NCT02419742|593705950|FG001|Overall Study|Withdrew Consent|1|||
164363036|NCT02419742|593705949|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
164699087|NCT02149121|594920671|FG002|Main Study Period|Developed any malignancy|1|||
164363037|NCT02419742|593705950|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
164363038|NCT01413360|593705955|FG000|Overall Study|Lost to Follow-up|2|||
164363039|NCT01413360|593705955|FG000|Overall Study|Adverse Event|1|||
164699088|NCT02149121|594920672|FG003|Main Study Period|Developed any malignancy|0|||
164363040|NCT02246673|593705957|FG000|Overall Study|Sponsor Decision|1|||
164363041|NCT02246673|593705958|FG001|Overall Study|Sponsor Decision|0|||
164363042|NCT02246673|593705959|FG002|Overall Study|Sponsor Decision|0|||
164363043|NCT02246673|593705960|FG003|Overall Study|Sponsor Decision|0|||
164363044|NCT02246673|593705961|FG004|Overall Study|Sponsor Decision|0|||
164699089|NCT02149121|594920673|FG004|Main Study Period|Developed any malignancy|0|||
164590904|NCT03100942|594527141|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
164590905|NCT03100942|594527142|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
164590906|NCT03100942|594527143|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
164590907|NCT03100942|594527137|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
164590908|NCT03100942|594527138|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
164590909|NCT03100942|594527139|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
164590910|NCT03100942|594527140|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
164590911|NCT03100942|594527141|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
164590912|NCT03100942|594527142|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
164590913|NCT03100942|594527143|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
164590914|NCT03100942|594527137|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
164590915|NCT03100942|594527138|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
164590916|NCT03100942|594527139|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
164363045|NCT02246673|593705957|FG000|Overall Study|Withdrawal by Subject|0|||
164699090|NCT02149121|594920674|FG005|Main Study Period|Developed any malignancy|0|||
164699091|NCT02149121|594920675|FG006|Main Study Period|Developed any malignancy|0|||
164699092|NCT02149121|594920669|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
164699093|NCT02149121|594920670|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
164363046|NCT02246673|593705958|FG001|Overall Study|Withdrawal by Subject|0|||
164363047|NCT02246673|593705959|FG002|Overall Study|Withdrawal by Subject|0|||
164363048|NCT02246673|593705960|FG003|Overall Study|Withdrawal by Subject|0|||
164363049|NCT02246673|593705961|FG004|Overall Study|Withdrawal by Subject|1|||
164363050|NCT02246673|593705957|FG000|Overall Study|Lost to Follow-up|0|||
164363051|NCT02246673|593705958|FG001|Overall Study|Lost to Follow-up|0|||
164363052|NCT02246673|593705959|FG002|Overall Study|Lost to Follow-up|0|||
164363053|NCT02246673|593705960|FG003|Overall Study|Lost to Follow-up|1|||
164363054|NCT02246673|593705961|FG004|Overall Study|Lost to Follow-up|0|||
164363055|NCT02246673|593705957|FG000|Overall Study|Protocol Violation|0|||
164363056|NCT02246673|593705958|FG001|Overall Study|Protocol Violation|0|||
164363057|NCT02246673|593705959|FG002|Overall Study|Protocol Violation|0|||
164363058|NCT02246673|593705960|FG003|Overall Study|Protocol Violation|1|||
164363059|NCT02246673|593705961|FG004|Overall Study|Protocol Violation|0|||
164363060|NCT05413369|593705962|FG000|Overall Study|Adverse Event|1|||
164363061|NCT05413369|593705963|FG001|Overall Study|Adverse Event|1|||
164363062|NCT05413369|593705962|FG000|Overall Study|Withdrawal by Subject|13|||
164363063|NCT05413369|593705963|FG001|Overall Study|Withdrawal by Subject|4|||
164363064|NCT05413369|593705962|FG000|Overall Study|Non-compliance with study schedule|2|||
164363065|NCT05413369|593705963|FG001|Overall Study|Non-compliance with study schedule|1|||
164363066|NCT05413369|593705962|FG000|Overall Study|Other|1|||
164363067|NCT05413369|593705963|FG001|Overall Study|Other|1|||
164363068|NCT01679002|593705968|FG000|Overall Study|Adverse Event|1|||
164363069|NCT01679002|593705969|FG001|Overall Study|Adverse Event|1|||
164363070|NCT01679002|593705970|FG002|Overall Study|Adverse Event|0|||
164363071|NCT00730912|593705973|FG000|Overall Study|Discontinued|0|||
164363072|NCT00730912|593705974|FG001|Overall Study|Discontinued|0|||
164363073|NCT00730912|593705975|FG002|Overall Study|Discontinued|1|||
164363074|NCT02205333|593705979|FG000|Overall Study|Death|5|||
164363075|NCT02205333|593705980|FG001|Overall Study|Death|6|||
164363076|NCT02205333|593705981|FG002|Overall Study|Death|2|||
164363077|NCT02205333|593705982|FG003|Overall Study|Death|6|||
164363078|NCT02205333|593705983|FG004|Overall Study|Death|5|||
164363079|NCT02205333|593705984|FG005|Overall Study|Death|3|||
164363080|NCT02205333|593705985|FG006|Overall Study|Death|3|||
164363081|NCT02205333|593705986|FG007|Overall Study|Death|2|||
164363082|NCT02205333|593705987|FG008|Overall Study|Death|0|||
164363083|NCT02205333|593705979|FG000|Overall Study|Withdrawal by Subject|1|||
164363084|NCT02205333|593705980|FG001|Overall Study|Withdrawal by Subject|0|||
164363085|NCT02205333|593705981|FG002|Overall Study|Withdrawal by Subject|0|||
164363086|NCT02205333|593705982|FG003|Overall Study|Withdrawal by Subject|1|||
164590917|NCT03100942|594527140|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
164699094|NCT02149121|594920671|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
164699095|NCT02149121|594920672|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
164363087|NCT02205333|593705983|FG004|Overall Study|Withdrawal by Subject|0|||
164363088|NCT02205333|593705984|FG005|Overall Study|Withdrawal by Subject|0|||
164363089|NCT02205333|593705985|FG006|Overall Study|Withdrawal by Subject|2|||
164363090|NCT02205333|593705986|FG007|Overall Study|Withdrawal by Subject|0|||
164363091|NCT02205333|593705987|FG008|Overall Study|Withdrawal by Subject|0|||
164363092|NCT00455429|593705988|FG000|Overall Study|Study Terminated by Sponsor|0|||
164363093|NCT00455429|593705989|FG001|Overall Study|Study Terminated by Sponsor|0|||
164363094|NCT00455429|593705990|FG002|Overall Study|Study Terminated by Sponsor|0|||
164363095|NCT00455429|593705991|FG003|Overall Study|Study Terminated by Sponsor|3|||
164363096|NCT00455429|593705988|FG000|Overall Study|Lost to Follow-up|1|||
164363097|NCT00455429|593705989|FG001|Overall Study|Lost to Follow-up|0|||
164590918|NCT03100942|594527141|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
164699096|NCT02149121|594920673|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
164699097|NCT02149121|594920674|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
164699098|NCT02149121|594920675|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
164363098|NCT00455429|593705990|FG002|Overall Study|Lost to Follow-up|0|||
164363099|NCT00455429|593705991|FG003|Overall Study|Lost to Follow-up|3|||
164363100|NCT00455429|593705988|FG000|Overall Study|Withdrawal by Subject|0|||
164363101|NCT00455429|593705989|FG001|Overall Study|Withdrawal by Subject|1|||
164363102|NCT00455429|593705990|FG002|Overall Study|Withdrawal by Subject|1|||
164363103|NCT00455429|593705991|FG003|Overall Study|Withdrawal by Subject|0|||
164363104|NCT00455429|593705988|FG000|Overall Study|Lack of Efficacy|0|||
164363105|NCT00455429|593705989|FG001|Overall Study|Lack of Efficacy|1|||
164363106|NCT00455429|593705990|FG002|Overall Study|Lack of Efficacy|0|||
164363107|NCT00455429|593705991|FG003|Overall Study|Lack of Efficacy|1|||
164363108|NCT00455429|593705988|FG000|Overall Study|Adverse Event|0|||
164363109|NCT00455429|593705989|FG001|Overall Study|Adverse Event|1|||
164363110|NCT00455429|593705990|FG002|Overall Study|Adverse Event|0|||
164363111|NCT00455429|593705991|FG003|Overall Study|Adverse Event|3|||
164363112|NCT00455429|593705988|FG000|Overall Study|Randomly assigned but not treated|0|||
164363113|NCT00455429|593705989|FG001|Overall Study|Randomly assigned but not treated|0|||
164363114|NCT00455429|593705990|FG002|Overall Study|Randomly assigned but not treated|0|||
164363115|NCT00455429|593705991|FG003|Overall Study|Randomly assigned but not treated|2|||
164363116|NCT00455429|593705988|FG000|Overall Study|Personal Reason|1|||
164363117|NCT00455429|593705989|FG001|Overall Study|Personal Reason|0|||
164363118|NCT00455429|593705990|FG002|Overall Study|Personal Reason|0|||
164363119|NCT00455429|593705991|FG003|Overall Study|Personal Reason|0|||
164363120|NCT00455429|593705988|FG000|Overall Study|Non-compliance|0|||
164363121|NCT00455429|593705989|FG001|Overall Study|Non-compliance|0|||
164363122|NCT00455429|593705990|FG002|Overall Study|Non-compliance|0|||
164363123|NCT00455429|593705991|FG003|Overall Study|Non-compliance|1|||
164363124|NCT00455429|593705988|FG000|Overall Study|Other|0|||
164363125|NCT00455429|593705989|FG001|Overall Study|Other|2|||
164363126|NCT00455429|593705990|FG002|Overall Study|Other|0|||
164363127|NCT00455429|593705991|FG003|Overall Study|Other|1|||
164363128|NCT04351087|593705992|FG000|Overall Study|Lost to Follow-up|7|||
164363129|NCT04351087|593705993|FG001|Overall Study|Lost to Follow-up|3|||
164363130|NCT04351087|593705992|FG000|Overall Study|Withdrawal by Subject|3|||
164363131|NCT04351087|593705993|FG001|Overall Study|Withdrawal by Subject|4|||
164363132|NCT04351087|593705992|FG000|Overall Study|Lack of Efficacy|3|||
164363133|NCT04351087|593705993|FG001|Overall Study|Lack of Efficacy|2|||
164363134|NCT03519347|593705994|FG000|Interventional Crossover Period 1|Death|0|||
164363135|NCT03519347|593705995|FG001|Interventional Crossover Period 1|Death|0|||
164363136|NCT03519347|593705996|FG002|Interventional Crossover Period 1|Death|0|||
164363137|NCT03519347|593705997|FG003|Interventional Crossover Period 1|Death|1|||
164363138|NCT01412021|593705998|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
164363139|NCT01412021|593705998|FG000|Overall Study|Treatment Prior to Approval|3|||
164363140|NCT01412021|593705998|FG000|Overall Study|Transferred to Other Hospital|9|||
164363141|NCT01675128|593706003|FG000|Overall Study|Disease progression on study|1|||
164363142|NCT01675128|593706004|FG001|Overall Study|Disease progression on study|1|||
164363143|NCT01675128|593706005|FG002|Overall Study|Disease progression on study|1|||
164363144|NCT01675128|593706003|FG000|Overall Study|Refused further treatment|1|||
164363145|NCT01675128|593706004|FG001|Overall Study|Refused further treatment|0|||
164363146|NCT01675128|593706005|FG002|Overall Study|Refused further treatment|0|||
164363147|NCT01675128|593706003|FG000|Overall Study|Pulmonary complication; off study|0|||
164363148|NCT01675128|593706004|FG001|Overall Study|Pulmonary complication; off study|1|||
164363149|NCT01675128|593706005|FG002|Overall Study|Pulmonary complication; off study|0|||
164363150|NCT03526458|593706010|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
164363151|NCT03526458|593706011|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
164363152|NCT03526458|593706010|FG000|Overall Study|Stone passed, surgery cancelled|2|||
164363153|NCT03526458|593706011|FG001|Overall Study|Stone passed, surgery cancelled|1|||
164363154|NCT03526458|593706010|FG000|Overall Study|Withdrawal by Subject|1|||
164363155|NCT03526458|593706011|FG001|Overall Study|Withdrawal by Subject|0|||
164699099|NCT02149121|594920669|FG000|Main Study Period|Disease progression|0|||
164699100|NCT02149121|594920670|FG001|Main Study Period|Disease progression|1|||
164363156|NCT03526458|593706010|FG000|Overall Study|Physician Decision|2|||
164363157|NCT03526458|593706011|FG001|Overall Study|Physician Decision|1|||
164363158|NCT03526458|593706010|FG000|Overall Study|Lack of equipment|1|||
164363159|NCT03526458|593706011|FG001|Overall Study|Lack of equipment|1|||
164363160|NCT00484939|593706012|FG000|Overall Study|Death|9|||
164363161|NCT00484939|593706013|FG001|Overall Study|Death|13|||
164363162|NCT00484939|593706012|FG000|Overall Study|Adverse Event|22|||
164363163|NCT00484939|593706013|FG001|Overall Study|Adverse Event|12|||
164363164|NCT00484939|593706012|FG000|Overall Study|Patient Withdrew Consent|19|||
164363165|NCT00484939|593706013|FG001|Overall Study|Patient Withdrew Consent|10|||
164363166|NCT00484939|593706012|FG000|Overall Study|Protocol Violation|3|||
164363167|NCT00484939|593706013|FG001|Overall Study|Protocol Violation|3|||
164363168|NCT00484939|593706012|FG000|Overall Study|Lost to Follow-up|0|||
164363169|NCT00484939|593706013|FG001|Overall Study|Lost to Follow-up|3|||
164363170|NCT00484939|593706012|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
164363171|NCT00484939|593706013|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
164363172|NCT00484939|593706012|FG000|Overall Study|Disease progression|67|||
164363173|NCT00484939|593706013|FG001|Overall Study|Disease progression|88|||
164363174|NCT00484939|593706012|FG000|Overall Study|Screen Failure|2|||
164363175|NCT00484939|593706013|FG001|Overall Study|Screen Failure|2|||
164363176|NCT00484939|593706012|FG000|Overall Study|Reason Not Specified|11|||
164363177|NCT00484939|593706013|FG001|Overall Study|Reason Not Specified|6|||
164363178|NCT00735878|593706014|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
164363179|NCT00735878|593706015|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
164363180|NCT00735878|593706016|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
164363181|NCT04404855|593706017|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
164363182|NCT04404855|593706018|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
164363183|NCT01522365|593706021|FG000|Overall Study|Withdrawal by Subject|1|||
164363184|NCT01522365|593706022|FG001|Overall Study|Withdrawal by Subject|1|||
164363185|NCT01522365|593706021|FG000|Overall Study|Lost to Follow-up|1|||
164590919|NCT03100942|594527142|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
164363186|NCT01522365|593706022|FG001|Overall Study|Lost to Follow-up|1|||
164363187|NCT00651755|593706023|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
164363188|NCT00651755|593706024|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
164363189|NCT00651755|593706023|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
164363190|NCT00651755|593706024|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
164363191|NCT02466555|593706027|FG000|Overall Study|Lost to Follow-up|2|||
164363192|NCT01120756|593706028|FG000|Overall Study|Withdrawal by Subject|1|||
164363193|NCT01120756|593706029|FG001|Overall Study|Withdrawal by Subject|1|||
164363194|NCT03760146|593706032|FG000|Overall Study|Adverse Event|11|||
164363195|NCT03760146|593706033|FG001|Overall Study|Adverse Event|8|||
164363196|NCT03760146|593706034|FG002|Overall Study|Adverse Event|0|||
164363197|NCT03760146|593706035|FG003|Overall Study|Adverse Event|0|||
164363198|NCT03760146|593706036|FG004|Overall Study|Adverse Event|0|||
164363199|NCT03760146|593706037|FG005|Overall Study|Adverse Event|0|||
164363200|NCT03760146|593706032|FG000|Overall Study|Death|1|||
164363201|NCT03760146|593706033|FG001|Overall Study|Death|0|||
164363202|NCT03760146|593706034|FG002|Overall Study|Death|0|||
164363203|NCT03760146|593706035|FG003|Overall Study|Death|0|||
164363204|NCT03760146|593706036|FG004|Overall Study|Death|0|||
164363205|NCT03760146|593706037|FG005|Overall Study|Death|0|||
164363206|NCT03760146|593706032|FG000|Overall Study|Lost to Follow-up|41|||
164363207|NCT03760146|593706033|FG001|Overall Study|Lost to Follow-up|28|||
164363208|NCT03760146|593706034|FG002|Overall Study|Lost to Follow-up|9|||
164363209|NCT03760146|593706035|FG003|Overall Study|Lost to Follow-up|2|||
164590920|NCT03100942|594527143|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
164363210|NCT03760146|593706036|FG004|Overall Study|Lost to Follow-up|14|||
164363211|NCT03760146|593706037|FG005|Overall Study|Lost to Follow-up|8|||
164363212|NCT03760146|593706032|FG000|Overall Study|No longer met eligibility criteria|3|||
164363213|NCT03760146|593706033|FG001|Overall Study|No longer met eligibility criteria|9|||
164363214|NCT03760146|593706034|FG002|Overall Study|No longer met eligibility criteria|0|||
164363215|NCT03760146|593706035|FG003|Overall Study|No longer met eligibility criteria|0|||
164363216|NCT03760146|593706036|FG004|Overall Study|No longer met eligibility criteria|1|||
164363217|NCT03760146|593706037|FG005|Overall Study|No longer met eligibility criteria|0|||
164363218|NCT03760146|593706032|FG000|Overall Study|Protocol Violation|21|||
164590921|NCT01876732|594527144|FG000|Overall Study|MMA was not over 800mg/dL|75|||
164590922|NCT00536731|594527145|FG000|Overall Study|Adverse Event|3|||
164590923|NCT00536731|594527146|FG001|Overall Study|Adverse Event|2|||
164699101|NCT02149121|594920671|FG002|Main Study Period|Disease progression|0|||
164699102|NCT02149121|594920672|FG003|Main Study Period|Disease progression|0|||
164699103|NCT02149121|594920673|FG004|Main Study Period|Disease progression|0|||
164699104|NCT02149121|594920674|FG005|Main Study Period|Disease progression|0|||
164699105|NCT02149121|594920675|FG006|Main Study Period|Disease progression|0|||
164699106|NCT02149121|594920669|FG000|Extension Study Period|Withdrawal by Subject|0|||
164363219|NCT03760146|593706033|FG001|Overall Study|Protocol Violation|13|||
164363220|NCT03760146|593706034|FG002|Overall Study|Protocol Violation|1|||
164363221|NCT03760146|593706035|FG003|Overall Study|Protocol Violation|0|||
164363222|NCT03760146|593706036|FG004|Overall Study|Protocol Violation|1|||
164590924|NCT00536731|594527147|FG002|Overall Study|Adverse Event|3|||
164590925|NCT00536731|594527145|FG000|Overall Study|Withdrawal by Subject|0|||
164699107|NCT02149121|594920670|FG001|Extension Study Period|Withdrawal by Subject|0|||
164363223|NCT03760146|593706037|FG005|Overall Study|Protocol Violation|0|||
164363224|NCT03760146|593706032|FG000|Overall Study|Withdrawal by Subject|19|||
164363225|NCT03760146|593706033|FG001|Overall Study|Withdrawal by Subject|20|||
164363226|NCT03760146|593706034|FG002|Overall Study|Withdrawal by Subject|1|||
164363227|NCT03760146|593706035|FG003|Overall Study|Withdrawal by Subject|0|||
164363228|NCT03760146|593706036|FG004|Overall Study|Withdrawal by Subject|1|||
164363229|NCT03760146|593706037|FG005|Overall Study|Withdrawal by Subject|0|||
164590926|NCT00536731|594527146|FG001|Overall Study|Withdrawal by Subject|2|||
164363230|NCT00529542|593706038|FG000|Overall Study|Withdrawal by Subject|1|||
164363231|NCT00529542|593706039|FG001|Overall Study|Withdrawal by Subject|0|||
164363232|NCT00529542|593706038|FG000|Overall Study|Lost to Follow-up|0|||
164363233|NCT00529542|593706039|FG001|Overall Study|Lost to Follow-up|1|||
164363234|NCT00445965|593706042|FG000|Overall Study|Adverse Event|2|||
164363235|NCT00445965|593706042|FG000|Overall Study|Physician Decision|1|||
164363236|NCT00445965|593706042|FG000|Overall Study|Enrolled but not treated|1|||
164363237|NCT00445965|593706042|FG000|Overall Study|Removed due to progressive disease|29|||
164363238|NCT02865915|593706047|FG000|Overall Study|Pregnancy|1|||
164363239|NCT02865915|593706048|FG001|Overall Study|Pregnancy|0|||
164363240|NCT02865915|593706047|FG000|Overall Study|Withdrawal by Subject|1|||
164363241|NCT02865915|593706048|FG001|Overall Study|Withdrawal by Subject|1|||
164363242|NCT02865915|593706047|FG000|Overall Study|Adverse Event|0|||
164363243|NCT02865915|593706048|FG001|Overall Study|Adverse Event|4|||
164363244|NCT02865915|593706047|FG000|Overall Study|Lost to Follow-up|0|||
164363245|NCT02865915|593706048|FG001|Overall Study|Lost to Follow-up|1|||
164363246|NCT02865915|593706047|FG000|Overall Study|Protocol Violation|0|||
164363247|NCT02865915|593706048|FG001|Overall Study|Protocol Violation|1|||
164363248|NCT02865915|593706047|FG000|Overall Study|Study terminated by sponsor|23|||
164363249|NCT02865915|593706048|FG001|Overall Study|Study terminated by sponsor|18|||
164363250|NCT02865915|593706047|FG000|Overall Study|Dosing group discontinued|0|||
164363251|NCT02865915|593706048|FG001|Overall Study|Dosing group discontinued|5|||
164363252|NCT05760300|593706053|FG000|Overall Study|Adverse Event|0|||
164363253|NCT05760300|593706054|FG001|Overall Study|Adverse Event|0|||
164363254|NCT05760300|593706055|FG002|Overall Study|Adverse Event|1|||
164363255|NCT05760300|593706056|FG003|Overall Study|Adverse Event|0|||
164363256|NCT05760300|593706053|FG000|Overall Study|Participant Decision|1|||
164363257|NCT05760300|593706054|FG001|Overall Study|Participant Decision|0|||
164363258|NCT05760300|593706055|FG002|Overall Study|Participant Decision|0|||
164363259|NCT05760300|593706056|FG003|Overall Study|Participant Decision|0|||
164363260|NCT00699972|593707945|FG000|Overall Study|Adverse Event|7|||
164363261|NCT00699972|593707946|FG001|Overall Study|Adverse Event|9|||
164363262|NCT00699972|593707947|FG002|Overall Study|Adverse Event|24|||
164363263|NCT00699972|593707945|FG000|Overall Study|Lost to Follow-up|0|||
164363264|NCT00699972|593707946|FG001|Overall Study|Lost to Follow-up|2|||
164363265|NCT00699972|593707947|FG002|Overall Study|Lost to Follow-up|0|||
164363266|NCT00699972|593707945|FG000|Overall Study|Withdrawal by Subject|3|||
164699108|NCT02149121|594920671|FG002|Extension Study Period|Withdrawal by Subject|0|||
164699109|NCT02149121|594920672|FG003|Extension Study Period|Withdrawal by Subject|1|||
164699110|NCT02149121|594920673|FG004|Extension Study Period|Withdrawal by Subject|0|||
164363267|NCT00699972|593707946|FG001|Overall Study|Withdrawal by Subject|7|||
164363268|NCT00699972|593707947|FG002|Overall Study|Withdrawal by Subject|4|||
164363269|NCT00699972|593707945|FG000|Overall Study|Lack of Efficacy|2|||
164363270|NCT00699972|593707946|FG001|Overall Study|Lack of Efficacy|0|||
164363271|NCT00699972|593707947|FG002|Overall Study|Lack of Efficacy|2|||
164363272|NCT00699972|593707945|FG000|Overall Study|Administrative/Other|3|||
164363273|NCT00699972|593707946|FG001|Overall Study|Administrative/Other|1|||
164363274|NCT00699972|593707947|FG002|Overall Study|Administrative/Other|4|||
164363275|NCT00699972|593707945|FG000|Overall Study|Randomized, Not Treated|1|||
164363276|NCT00699972|593707946|FG001|Overall Study|Randomized, Not Treated|0|||
164363277|NCT00699972|593707947|FG002|Overall Study|Randomized, Not Treated|1|||
164363278|NCT01545817|593707948|FG000|Pazopanib|Disease progression|51|||
164363279|NCT01545817|593707949|FG001|Pazopanib|Disease progression|0|||
164363280|NCT01545817|593707948|FG000|Pazopanib|Adverse Event|19|||
164363281|NCT01545817|593707949|FG001|Pazopanib|Adverse Event|0|||
164590927|NCT00536731|594527147|FG002|Overall Study|Withdrawal by Subject|0|||
164590928|NCT00536731|594527145|FG000|Overall Study|Intake of prohibited conc. medication|0|||
164590929|NCT00536731|594527146|FG001|Overall Study|Intake of prohibited conc. medication|0|||
164590930|NCT00536731|594527147|FG002|Overall Study|Intake of prohibited conc. medication|1|||
164590931|NCT00536731|594527145|FG000|Overall Study|Safety reasons|0|||
164590932|NCT00536731|594527146|FG001|Overall Study|Safety reasons|0|||
164699111|NCT02149121|594920674|FG005|Extension Study Period|Withdrawal by Subject|2|||
164590933|NCT00536731|594527147|FG002|Overall Study|Safety reasons|1|||
164590934|NCT00536731|594527145|FG000|Overall Study|Other|1|||
164590935|NCT00536731|594527146|FG001|Overall Study|Other|1|||
164590936|NCT00536731|594527147|FG002|Overall Study|Other|0|||
164590937|NCT00718419|594527148|FG000|Overall Study|Adverse Event|2|||
164699112|NCT02149121|594920675|FG006|Extension Study Period|Withdrawal by Subject|0|||
164363282|NCT01545817|593707948|FG000|Pazopanib|Other reason|4|||
164363283|NCT01545817|593707949|FG001|Pazopanib|Other reason|0|||
164363284|NCT01545817|593707948|FG000|Everolimus|Other reason|0|||
164363285|NCT01545817|593707949|FG001|Everolimus|Other reason|7|||
164363286|NCT01545817|593707948|FG000|Everolimus|Disease progression|0|||
164363287|NCT01545817|593707949|FG001|Everolimus|Disease progression|25|||
164363288|NCT01545817|593707948|FG000|Everolimus|Adverse Event|0|||
164363289|NCT01545817|593707949|FG001|Everolimus|Adverse Event|6|||
164363290|NCT03989440|593707954|FG000|Overall Study|COVID-19 travel restrictions|0|||
164590938|NCT00718419|594527149|FG001|Overall Study|Adverse Event|1|||
164590939|NCT00718419|594527148|FG000|Overall Study|Physician Decision|1|||
164363291|NCT03989440|593707955|FG001|Overall Study|COVID-19 travel restrictions|0|||
164363292|NCT03989440|593707956|FG002|Overall Study|COVID-19 travel restrictions|1|||
164363293|NCT03989440|593707957|FG003|Overall Study|COVID-19 travel restrictions|0|||
164363294|NCT03989440|593707958|FG004|Overall Study|COVID-19 travel restrictions|0|||
164363295|NCT03989440|593707959|FG005|Overall Study|COVID-19 travel restrictions|0|||
164363296|NCT03989440|593707954|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
164363297|NCT03989440|593707955|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
164363298|NCT03989440|593707956|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
164363299|NCT03989440|593707957|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
164363300|NCT03989440|593707958|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
164363301|NCT03989440|593707959|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
164363302|NCT01955161|593707960|FG000|Overall Study|Withdrawal before treatment|2|||
164363303|NCT01955161|593707961|FG001|Overall Study|Withdrawal before treatment|0|||
164363304|NCT01955161|593707962|FG002|Overall Study|Withdrawal before treatment|1|||
164363305|NCT01955161|593707960|FG000|Overall Study|Adverse Event|10|||
164363306|NCT01955161|593707961|FG001|Overall Study|Adverse Event|14|||
164363307|NCT01955161|593707962|FG002|Overall Study|Adverse Event|15|||
164363308|NCT01955161|593707960|FG000|Overall Study|Death|1|||
164363309|NCT01955161|593707961|FG001|Overall Study|Death|1|||
164363310|NCT01955161|593707962|FG002|Overall Study|Death|3|||
164363311|NCT01955161|593707960|FG000|Overall Study|Withdrawal by Subject|9|||
164363312|NCT01955161|593707961|FG001|Overall Study|Withdrawal by Subject|8|||
164363313|NCT01955161|593707962|FG002|Overall Study|Withdrawal by Subject|12|||
164363314|NCT01955161|593707960|FG000|Overall Study|Protocol Violation|2|||
164363315|NCT01955161|593707961|FG001|Overall Study|Protocol Violation|0|||
164363316|NCT01955161|593707962|FG002|Overall Study|Protocol Violation|0|||
164363317|NCT01955161|593707960|FG000|Overall Study|Other reason: physician decision|0|||
164363318|NCT01955161|593707961|FG001|Overall Study|Other reason: physician decision|1|||
164363319|NCT01955161|593707962|FG002|Overall Study|Other reason: physician decision|1|||
164363320|NCT01955161|593707960|FG000|Overall Study|Other reason: disallowed medication|1|||
164363321|NCT01955161|593707961|FG001|Overall Study|Other reason: disallowed medication|0|||
164363322|NCT01955161|593707962|FG002|Overall Study|Other reason: disallowed medication|1|||
164363323|NCT01955161|593707960|FG000|Overall Study|Other reason: caregiver unavailable|1|||
164363324|NCT01955161|593707961|FG001|Overall Study|Other reason: caregiver unavailable|0|||
164363325|NCT01955161|593707962|FG002|Overall Study|Other reason: caregiver unavailable|0|||
164363326|NCT01955161|593707960|FG000|Overall Study|Other reason: moved to nursing home|0|||
164363327|NCT01955161|593707961|FG001|Overall Study|Other reason: moved to nursing home|1|||
164363328|NCT01955161|593707962|FG002|Overall Study|Other reason: moved to nursing home|0|||
164363329|NCT01955161|593707960|FG000|Overall Study|Other reason: insufficient compliance|0|||
164699113|NCT04560998|594920684|FG000|Overall Study|Withdrawal by Subject|18|||
164699114|NCT04560998|594920685|FG001|Overall Study|Withdrawal by Subject|12|||
164699115|NCT04560998|594920684|FG000|Overall Study|Lost to Follow-up|8|||
164699116|NCT04560998|594920685|FG001|Overall Study|Lost to Follow-up|5|||
164699117|NCT04560998|594920684|FG000|Overall Study|Physician Decision|4|||
164699118|NCT04560998|594920685|FG001|Overall Study|Physician Decision|0|||
164699119|NCT00493246|594922591|FG000|Overall Study|Withdrawal by Subject|0|||
164699120|NCT00493246|594922592|FG001|Overall Study|Withdrawal by Subject|0|||
164699121|NCT00493246|594922593|FG002|Overall Study|Withdrawal by Subject|0|||
164699122|NCT00493246|594922594|FG003|Overall Study|Withdrawal by Subject|0|||
164699123|NCT00493246|594922595|FG004|Overall Study|Withdrawal by Subject|1|||
164699124|NCT00493246|594922596|FG005|Overall Study|Withdrawal by Subject|0|||
164699125|NCT00493246|594922597|FG006|Overall Study|Withdrawal by Subject|0|||
164699126|NCT00493246|594922598|FG007|Overall Study|Withdrawal by Subject|0|||
164699127|NCT00493246|594922591|FG000|Overall Study|No access to draw blood|0|||
164699128|NCT00493246|594922592|FG001|Overall Study|No access to draw blood|0|||
164699129|NCT00493246|594922593|FG002|Overall Study|No access to draw blood|0|||
164699130|NCT00493246|594922594|FG003|Overall Study|No access to draw blood|0|||
164699131|NCT00493246|594922595|FG004|Overall Study|No access to draw blood|0|||
164699132|NCT00493246|594922596|FG005|Overall Study|No access to draw blood|1|||
164699133|NCT00493246|594922597|FG006|Overall Study|No access to draw blood|0|||
164699134|NCT00493246|594922598|FG007|Overall Study|No access to draw blood|0|||
164699135|NCT00493246|594922591|FG000|Overall Study|Lost to Follow-up|0|||
164699136|NCT00493246|594922592|FG001|Overall Study|Lost to Follow-up|0|||
164699137|NCT00493246|594922593|FG002|Overall Study|Lost to Follow-up|0|||
164699138|NCT00493246|594922594|FG003|Overall Study|Lost to Follow-up|0|||
164699139|NCT00493246|594922595|FG004|Overall Study|Lost to Follow-up|0|||
164363330|NCT01955161|593707961|FG001|Overall Study|Other reason: insufficient compliance|0|||
164363331|NCT01955161|593707962|FG002|Overall Study|Other reason: insufficient compliance|1|||
164363332|NCT01955161|593707960|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
164363333|NCT01955161|593707961|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
164363334|NCT01955161|593707962|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
164699140|NCT00493246|594922596|FG005|Overall Study|Lost to Follow-up|0|||
164699141|NCT00493246|594922597|FG006|Overall Study|Lost to Follow-up|1|||
164699142|NCT00493246|594922598|FG007|Overall Study|Lost to Follow-up|0|||
164699143|NCT00595335|594922600|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
164699144|NCT00595335|594922601|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
164699145|NCT00595335|594922600|FG000|Baseline to Six Months|Disease Progression|1|||
164699146|NCT00595335|594922601|FG001|Baseline to Six Months|Disease Progression|1|||
164699147|NCT00595335|594922600|FG000|Baseline to Six Months|Adverse Event|1|||
164699148|NCT00595335|594922601|FG001|Baseline to Six Months|Adverse Event|0|||
164699149|NCT00595335|594922600|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
164699150|NCT00595335|594922601|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
164699151|NCT00595335|594922600|FG000|Six Months to Twelve Months|Disease Progression|1|||
164699152|NCT00595335|594922601|FG001|Six Months to Twelve Months|Disease Progression|0|||
164699153|NCT01013649|594922606|FG000|First Step|Withdrawal by Subject|36|||
164363335|NCT01955161|593707960|FG000|Overall Study|Other reason: patient's will|0|||
164363336|NCT01955161|593707961|FG001|Overall Study|Other reason: patient's will|0|||
164363337|NCT01955161|593707962|FG002|Overall Study|Other reason: patient's will|1|||
164363338|NCT04608500|593707963|FG000|Overall Study|Adverse Event|2|||
164363339|NCT04608500|593707964|FG001|Overall Study|Adverse Event|0|||
164363340|NCT04608500|593707963|FG000|Overall Study|Lost to Follow-up|15|||
164363341|NCT04608500|593707964|FG001|Overall Study|Lost to Follow-up|9|||
164363342|NCT04608500|593707963|FG000|Overall Study|Participant request|11|||
164363343|NCT04608500|593707964|FG001|Overall Study|Participant request|7|||
164363344|NCT04608500|593707963|FG000|Overall Study|Protocol Violation|1|||
164363345|NCT04608500|593707964|FG001|Overall Study|Protocol Violation|0|||
164363346|NCT04608500|593707963|FG000|Overall Study|Other|6|||
164363347|NCT04608500|593707964|FG001|Overall Study|Other|2|||
164363348|NCT00706641|593707969|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
164363349|NCT00706641|593707969|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
164363350|NCT00706641|593707969|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
164363351|NCT04782856|593707970|FG000|Overall Study|Withdrawal by Subject|0|||
164363352|NCT04782856|593707971|FG001|Overall Study|Withdrawal by Subject|1|||
164363353|NCT01030523|593707972|FG000|Initial Study (5 Years)|Death|1|||
164363354|NCT01030523|593707973|FG001|Initial Study (5 Years)|Death|0|||
164363355|NCT01030523|593707972|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
164363356|NCT01030523|593707973|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
164363357|NCT01030523|593707972|FG000|Initial Study (5 Years)|Implant failure|1|||
164699154|NCT01013649|594922607|FG001|First Step|Withdrawal by Subject|19|||
164699155|NCT01013649|594922608|FG002|First Step|Withdrawal by Subject|0|||
164699156|NCT01013649|594922609|FG003|First Step|Withdrawal by Subject|0|||
164699157|NCT01013649|594922606|FG000|First Step|Progression|58|||
164699158|NCT01013649|594922607|FG001|First Step|Progression|23|||
164699159|NCT01013649|594922608|FG002|First Step|Progression|0|||
164699160|NCT01013649|594922609|FG003|First Step|Progression|0|||
164699161|NCT01013649|594922606|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
164699162|NCT01013649|594922607|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
164699163|NCT01013649|594922608|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
164699164|NCT01013649|594922609|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
164699165|NCT01013649|594922606|FG000|First Step|Death|3|||
164699166|NCT01013649|594922607|FG001|First Step|Death|4|||
164699167|NCT01013649|594922608|FG002|First Step|Death|0|||
164699168|NCT01013649|594922609|FG003|First Step|Death|0|||
164699169|NCT01013649|594922606|FG000|First Step|Adverse Event|9|||
164699170|NCT01013649|594922607|FG001|First Step|Adverse Event|5|||
164699171|NCT01013649|594922608|FG002|First Step|Adverse Event|0|||
164699172|NCT01013649|594922609|FG003|First Step|Adverse Event|0|||
164699173|NCT01013649|594922606|FG000|First Step|Other|4|||
164699174|NCT01013649|594922607|FG001|First Step|Other|6|||
164699175|NCT01013649|594922608|FG002|First Step|Other|0|||
164699176|NCT01013649|594922609|FG003|First Step|Other|0|||
164699177|NCT00493779|594922610|FG000|Overall Study|Logistical issue at site|1|||
164699178|NCT01647958|594922611|FG000|Initial Study|Lost to Follow-up|2|||
164699179|NCT01647958|594922612|FG001|Initial Study|Lost to Follow-up|3|||
164699180|NCT01647958|594922611|FG000|Continuation Phase|treatment received during Overall Study|39|||
164699181|NCT01647958|594922612|FG001|Continuation Phase|treatment received during Overall Study|0|||
164699182|NCT01647958|594922611|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
164699183|NCT01647958|594922612|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
164699184|NCT01131299|594922613|FG000|Overall Study|Withdrawal by Subject|4|||
164699185|NCT01131299|594922614|FG001|Overall Study|Withdrawal by Subject|7|||
164699186|NCT01207440|594922622|FG000|Overall Study|Adverse Event|46|||
164699187|NCT01207440|594922623|FG001|Overall Study|Adverse Event|11|||
164699188|NCT01207440|594922624|FG002|Overall Study|Adverse Event|7|||
164699189|NCT01207440|594922625|FG003|Overall Study|Adverse Event|2|||
164699190|NCT01207440|594922626|FG004|Overall Study|Adverse Event|6|||
164699191|NCT01207440|594922627|FG005|Overall Study|Adverse Event|6|||
164699192|NCT01207440|594922628|FG006|Overall Study|Adverse Event|2|||
164699193|NCT01207440|594922622|FG000|Overall Study|Death|6|||
164699194|NCT01207440|594922623|FG001|Overall Study|Death|3|||
164699195|NCT01207440|594922624|FG002|Overall Study|Death|2|||
164699196|NCT01207440|594922625|FG003|Overall Study|Death|2|||
164699197|NCT01207440|594922626|FG004|Overall Study|Death|7|||
164363358|NCT01030523|593707973|FG001|Initial Study (5 Years)|Implant failure|0|||
164363359|NCT01030523|593707972|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
164363360|NCT01030523|593707973|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
164363361|NCT01030523|593707972|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
164363362|NCT01030523|593707973|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
164363363|NCT01030523|593707972|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
164363364|NCT01030523|593707973|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
164363365|NCT04475588|593707976|FG000|Overall Study|Adverse Event|2|||
164363366|NCT04475588|593707977|FG001|Overall Study|Adverse Event|0|||
164363367|NCT01327300|593707978|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
164363368|NCT01327300|593707979|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
164363369|NCT01063764|593707980|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
164363370|NCT01063764|593707980|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
164699198|NCT01207440|594922627|FG005|Overall Study|Death|5|||
164699199|NCT01207440|594922628|FG006|Overall Study|Death|1|||
164699200|NCT01207440|594922622|FG000|Overall Study|Lack of Efficacy|13|||
164699201|NCT01207440|594922623|FG001|Overall Study|Lack of Efficacy|2|||
164699202|NCT01207440|594922624|FG002|Overall Study|Lack of Efficacy|5|||
164699203|NCT01207440|594922625|FG003|Overall Study|Lack of Efficacy|1|||
164699204|NCT01207440|594922626|FG004|Overall Study|Lack of Efficacy|2|||
164699205|NCT01207440|594922627|FG005|Overall Study|Lack of Efficacy|3|||
164699206|NCT01207440|594922628|FG006|Overall Study|Lack of Efficacy|0|||
164699207|NCT01207440|594922622|FG000|Overall Study|Lost to Follow-up|0|||
164699208|NCT01207440|594922623|FG001|Overall Study|Lost to Follow-up|0|||
164699209|NCT01207440|594922624|FG002|Overall Study|Lost to Follow-up|2|||
164699210|NCT01207440|594922625|FG003|Overall Study|Lost to Follow-up|1|||
164699211|NCT01207440|594922626|FG004|Overall Study|Lost to Follow-up|0|||
164699212|NCT01207440|594922627|FG005|Overall Study|Lost to Follow-up|0|||
164699213|NCT01207440|594922628|FG006|Overall Study|Lost to Follow-up|0|||
164699214|NCT01207440|594922622|FG000|Overall Study|Non-compliance with Study Drug|3|||
164699215|NCT01207440|594922623|FG001|Overall Study|Non-compliance with Study Drug|0|||
164699216|NCT01207440|594922624|FG002|Overall Study|Non-compliance with Study Drug|1|||
164699217|NCT01207440|594922625|FG003|Overall Study|Non-compliance with Study Drug|0|||
164699218|NCT01207440|594922626|FG004|Overall Study|Non-compliance with Study Drug|0|||
164699219|NCT01207440|594922627|FG005|Overall Study|Non-compliance with Study Drug|0|||
164699220|NCT01207440|594922628|FG006|Overall Study|Non-compliance with Study Drug|0|||
164699221|NCT01207440|594922622|FG000|Overall Study|Physician Decision|6|||
164699222|NCT01207440|594922623|FG001|Overall Study|Physician Decision|5|||
164699223|NCT01207440|594922624|FG002|Overall Study|Physician Decision|5|||
164699224|NCT01207440|594922625|FG003|Overall Study|Physician Decision|0|||
164699225|NCT01207440|594922626|FG004|Overall Study|Physician Decision|1|||
164699226|NCT01207440|594922627|FG005|Overall Study|Physician Decision|0|||
164699227|NCT01207440|594922628|FG006|Overall Study|Physician Decision|0|||
164699228|NCT01207440|594922622|FG000|Overall Study|Progressive Disease|19|||
164699229|NCT01207440|594922623|FG001|Overall Study|Progressive Disease|10|||
164699230|NCT01207440|594922624|FG002|Overall Study|Progressive Disease|19|||
164699231|NCT01207440|594922625|FG003|Overall Study|Progressive Disease|7|||
164699232|NCT01207440|594922626|FG004|Overall Study|Progressive Disease|23|||
164699233|NCT01207440|594922627|FG005|Overall Study|Progressive Disease|27|||
164699234|NCT01207440|594922628|FG006|Overall Study|Progressive Disease|0|||
164699235|NCT01207440|594922622|FG000|Overall Study|Protocol Violation|2|||
164699236|NCT01207440|594922623|FG001|Overall Study|Protocol Violation|0|||
164699237|NCT01207440|594922624|FG002|Overall Study|Protocol Violation|0|||
164699238|NCT01207440|594922625|FG003|Overall Study|Protocol Violation|0|||
164699239|NCT01207440|594922626|FG004|Overall Study|Protocol Violation|0|||
164699240|NCT01207440|594922627|FG005|Overall Study|Protocol Violation|0|||
164699241|NCT01207440|594922628|FG006|Overall Study|Protocol Violation|0|||
164699242|NCT01207440|594922622|FG000|Overall Study|Site Terminated by Sponsor|69|||
164699243|NCT01207440|594922623|FG001|Overall Study|Site Terminated by Sponsor|19|||
164699244|NCT01207440|594922624|FG002|Overall Study|Site Terminated by Sponsor|12|||
164699245|NCT01207440|594922625|FG003|Overall Study|Site Terminated by Sponsor|2|||
164699246|NCT01207440|594922626|FG004|Overall Study|Site Terminated by Sponsor|3|||
164699247|NCT01207440|594922627|FG005|Overall Study|Site Terminated by Sponsor|0|||
164699248|NCT01207440|594922628|FG006|Overall Study|Site Terminated by Sponsor|2|||
164699249|NCT01207440|594922622|FG000|Overall Study|Withdrawal by Subject|29|||
164699250|NCT01207440|594922623|FG001|Overall Study|Withdrawal by Subject|4|||
164699251|NCT01207440|594922624|FG002|Overall Study|Withdrawal by Subject|5|||
164699252|NCT01207440|594922625|FG003|Overall Study|Withdrawal by Subject|3|||
164699253|NCT01207440|594922626|FG004|Overall Study|Withdrawal by Subject|2|||
164699254|NCT01207440|594922627|FG005|Overall Study|Withdrawal by Subject|2|||
164699255|NCT01207440|594922628|FG006|Overall Study|Withdrawal by Subject|0|||
164699256|NCT01207440|594922622|FG000|Overall Study|Reason Not Specified|10|||
164699257|NCT01207440|594922623|FG001|Overall Study|Reason Not Specified|10|||
164699258|NCT01207440|594922624|FG002|Overall Study|Reason Not Specified|7|||
164699259|NCT01207440|594922625|FG003|Overall Study|Reason Not Specified|0|||
164699260|NCT01207440|594922626|FG004|Overall Study|Reason Not Specified|4|||
164363371|NCT01063764|593707980|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
164438570|NCT03086369|593972981|FG000|Overall Study|Lost to Follow-up|1|||
164438571|NCT03086369|593972982|FG001|Overall Study|Lost to Follow-up|0|||
164438572|NCT03086369|593972983|FG002|Overall Study|Lost to Follow-up|0|||
164438573|NCT03086369|593972984|FG003|Overall Study|Lost to Follow-up|2|||
164438574|NCT03086369|593972985|FG004|Overall Study|Lost to Follow-up|1|||
164438575|NCT03086369|593972981|FG000|Overall Study|Physician Decision|0|||
164438576|NCT03086369|593972982|FG001|Overall Study|Physician Decision|0|||
164438577|NCT03086369|593972983|FG002|Overall Study|Physician Decision|0|||
164438578|NCT03086369|593972984|FG003|Overall Study|Physician Decision|1|||
164438579|NCT03086369|593972985|FG004|Overall Study|Physician Decision|2|||
164438580|NCT03086369|593972981|FG000|Overall Study|Withdrawal by Subject|0|||
164438581|NCT03086369|593972982|FG001|Overall Study|Withdrawal by Subject|0|||
164438582|NCT03086369|593972983|FG002|Overall Study|Withdrawal by Subject|0|||
164438583|NCT03086369|593972984|FG003|Overall Study|Withdrawal by Subject|5|||
164438584|NCT03086369|593972985|FG004|Overall Study|Withdrawal by Subject|3|||
164438585|NCT03086369|593972981|FG000|Overall Study|Progressive Disease|0|||
164438586|NCT03086369|593972982|FG001|Overall Study|Progressive Disease|0|||
164438587|NCT03086369|593972983|FG002|Overall Study|Progressive Disease|0|||
164438588|NCT03086369|593972984|FG003|Overall Study|Progressive Disease|1|||
164438589|NCT03086369|593972985|FG004|Overall Study|Progressive Disease|1|||
164438590|NCT03544515|593972986|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
164438591|NCT03544515|593972987|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
164438592|NCT03544515|593972986|FG000|Overall Study|Lost to Follow-up|2|||
164438593|NCT03544515|593972987|FG001|Overall Study|Lost to Follow-up|0|||
164438594|NCT03169244|593972988|FG000|Overall Study|Lost to Follow-up|1|||
164438595|NCT03169244|593972989|FG001|Overall Study|Lost to Follow-up|2|||
164438596|NCT03169244|593972988|FG000|Overall Study|Adverse Event|1|||
164438597|NCT03169244|593972989|FG001|Overall Study|Adverse Event|0|||
164438598|NCT03169244|593972988|FG000|Overall Study|Withdrawal by Subject|2|||
164438599|NCT03169244|593972989|FG001|Overall Study|Withdrawal by Subject|2|||
164438600|NCT03169244|593972988|FG000|Overall Study|Physician Decision|1|||
164438601|NCT03169244|593972989|FG001|Overall Study|Physician Decision|0|||
164438602|NCT00178399|593972991|FG000|Overall Study|Physician Decision|4|||
164438603|NCT00178399|593972991|FG000|Overall Study|Withdrawal by Subject|8|||
164438604|NCT00178399|593972991|FG000|Overall Study|Lost to Follow-up|1|||
164438605|NCT02631148|593972992|FG000|Overall Study|8 were ineligible|8|||
164438606|NCT02631148|593972993|FG001|Overall Study|8 were ineligible|0|||
164438607|NCT02631148|593972992|FG000|Overall Study|Withdrawal by Subject|1|||
164438608|NCT02631148|593972993|FG001|Overall Study|Withdrawal by Subject|0|||
164438609|NCT02631148|593972992|FG000|Overall Study|PAH not available to study participant|1|||
164438610|NCT02631148|593972993|FG001|Overall Study|PAH not available to study participant|0|||
164438611|NCT00357396|593972996|FG000|Overall Study|Adverse Event|1|||
164438612|NCT00357396|593972997|FG001|Overall Study|Adverse Event|0|||
164438613|NCT00487578|593972998|FG000|Overall Study|Adverse Event|1|||
164590940|NCT00718419|594527149|FG001|Overall Study|Physician Decision|6|||
164590941|NCT00718419|594527148|FG000|Overall Study|Sponsor decision|0|||
164438614|NCT00487578|593972999|FG001|Overall Study|Adverse Event|2|||
164438615|NCT00487578|593972998|FG000|Overall Study|Lack of Efficacy|0|||
164438616|NCT00487578|593972999|FG001|Overall Study|Lack of Efficacy|1|||
164438617|NCT00487578|593972998|FG000|Overall Study|Lost to Follow-up|0|||
164438618|NCT00487578|593972999|FG001|Overall Study|Lost to Follow-up|1|||
164438619|NCT00726999|593973002|FG000|Overall Study|Physician Decision|0|||
164438620|NCT00726999|593973003|FG001|Overall Study|Physician Decision|1|||
164438621|NCT00726999|593973002|FG000|Overall Study|Withdrawal by Subject|2|||
164438622|NCT00726999|593973003|FG001|Overall Study|Withdrawal by Subject|0|||
164438623|NCT00726999|593973002|FG000|Overall Study|Protocol Violation|1|||
164363372|NCT01063764|593707980|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
164363373|NCT01063764|593707980|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
164363374|NCT01063764|593707980|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
164363375|NCT01063764|593707980|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
164363376|NCT00697515|593707981|FG000|Dose Optimization Period|Adverse Event|4|||
164363377|NCT00697515|593707982|FG001|Dose Optimization Period|Adverse Event|0|||
164363378|NCT00697515|593707981|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
164363379|NCT00697515|593707982|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
164363380|NCT00697515|593707981|FG000|Dose Optimization Period|Lost to Follow-up|2|||
164363381|NCT00697515|593707982|FG001|Dose Optimization Period|Lost to Follow-up|0|||
164363382|NCT00697515|593707981|FG000|Dose Optimization Period|sponsor request|2|||
164363383|NCT00697515|593707982|FG001|Dose Optimization Period|sponsor request|0|||
164363384|NCT00697515|593707981|FG000|Dose Optimization Period|called to active duty|1|||
164363385|NCT00697515|593707982|FG001|Dose Optimization Period|called to active duty|0|||
164363386|NCT00697515|593707981|FG000|Dose Optimization Period|elevated QTc|1|||
164363387|NCT00697515|593707982|FG001|Dose Optimization Period|elevated QTc|0|||
164363388|NCT00697515|593707981|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
164363389|NCT00697515|593707982|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
164363390|NCT00697515|593707981|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
164363391|NCT00697515|593707982|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
164363392|NCT00697515|593707981|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
164363393|NCT00697515|593707982|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
164363394|NCT00697515|593707981|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
164363395|NCT00697515|593707982|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
164363396|NCT02603432|593707983|FG000|Overall Study|Adverse Event|1|||
164363397|NCT02603432|593707984|FG001|Overall Study|Adverse Event|0|||
164363398|NCT02603432|593707983|FG000|Overall Study|Death|221|||
164363399|NCT02603432|593707984|FG001|Overall Study|Death|242|||
164363400|NCT02603432|593707983|FG000|Overall Study|Lost to Follow-up|3|||
164363401|NCT02603432|593707984|FG001|Overall Study|Lost to Follow-up|9|||
164363402|NCT02603432|593707983|FG000|Overall Study|Progressive Disease|7|||
164363403|NCT02603432|593707984|FG001|Overall Study|Progressive Disease|5|||
164363404|NCT02603432|593707983|FG000|Overall Study|Withdrawal by Subject|12|||
164363405|NCT02603432|593707984|FG001|Overall Study|Withdrawal by Subject|18|||
164363406|NCT02603432|593707983|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
164363407|NCT02603432|593707984|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
164363408|NCT02603432|593707983|FG000|Overall Study|Study terminated by sponsor|74|||
164363409|NCT02603432|593707984|FG001|Overall Study|Study terminated by sponsor|75|||
164363410|NCT02603432|593707983|FG000|Overall Study|Other|13|||
164363411|NCT02603432|593707984|FG001|Overall Study|Other|0|||
164363412|NCT01231581|593707985|FG000|Overall Study|Lost to Follow-up|2|||
164363413|NCT01231581|593707986|FG001|Overall Study|Lost to Follow-up|2|||
164363414|NCT01231581|593707985|FG000|Overall Study|Withdrawal by Subject|6|||
164363415|NCT01231581|593707986|FG001|Overall Study|Withdrawal by Subject|9|||
164363416|NCT01231581|593707985|FG000|Overall Study|Study Closed/Terminated|6|||
164363417|NCT01231581|593707986|FG001|Overall Study|Study Closed/Terminated|5|||
164363418|NCT01231581|593707985|FG000|Overall Study|Death|65|||
164363419|NCT01231581|593707986|FG001|Overall Study|Death|64|||
164363420|NCT01231581|593707985|FG000|Overall Study|Ongoing|1|||
164363421|NCT01231581|593707986|FG001|Overall Study|Ongoing|0|||
164363422|NCT05954052|593707987|FG000|Overall Study|Adverse Event|1|||
164363423|NCT01649375|593707988|FG000|Up to Week 16|Adverse Event|2|||
164363424|NCT01649375|593707989|FG001|Up to Week 16|Adverse Event|5|||
164363425|NCT01649375|593707990|FG002|Up to Week 16|Adverse Event|4|||
164363426|NCT01649375|593707991|FG003|Up to Week 16|Adverse Event|0|||
164363427|NCT01649375|593707992|FG004|Up to Week 16|Adverse Event|0|||
164363428|NCT01649375|593707988|FG000|Up to Week 16|Lack of Efficacy|0|||
164363429|NCT01649375|593707989|FG001|Up to Week 16|Lack of Efficacy|0|||
164363430|NCT01649375|593707990|FG002|Up to Week 16|Lack of Efficacy|1|||
164699261|NCT01207440|594922627|FG005|Overall Study|Reason Not Specified|3|||
164363431|NCT01649375|593707991|FG003|Up to Week 16|Lack of Efficacy|0|||
164363432|NCT01649375|593707992|FG004|Up to Week 16|Lack of Efficacy|0|||
164363433|NCT01649375|593707988|FG000|Up to Week 16|Physician Decision|0|||
164363434|NCT01649375|593707989|FG001|Up to Week 16|Physician Decision|0|||
164699262|NCT01207440|594922628|FG006|Overall Study|Reason Not Specified|0|||
164699263|NCT03341000|594922629|FG000|Overall Study|Adverse Event|1|||
164699264|NCT01592721|594922630|FG000|Long-term Follow-up|Death|1|||
164699265|NCT01408563|594922633|FG000|Overall Study|Ineligible after consent/ registration|2|||
164699266|NCT02091141|594922637|FG000|Overall Study|Death|280|||
164363435|NCT01649375|593707990|FG002|Up to Week 16|Physician Decision|1|||
164363436|NCT01649375|593707991|FG003|Up to Week 16|Physician Decision|0|||
164363437|NCT01649375|593707992|FG004|Up to Week 16|Physician Decision|0|||
164363438|NCT01649375|593707988|FG000|Up to Week 16|Withdrawal by Subject|2|||
164699267|NCT02091141|594922638|FG001|Overall Study|Death|118|||
164699268|NCT02091141|594922639|FG002|Overall Study|Death|46|||
164699269|NCT02091141|594922640|FG003|Overall Study|Death|13|||
164363439|NCT01649375|593707989|FG001|Up to Week 16|Withdrawal by Subject|1|||
164363440|NCT01649375|593707990|FG002|Up to Week 16|Withdrawal by Subject|2|||
164363441|NCT01649375|593707991|FG003|Up to Week 16|Withdrawal by Subject|0|||
164363442|NCT01649375|593707992|FG004|Up to Week 16|Withdrawal by Subject|0|||
164363443|NCT01649375|593707988|FG000|Up to Week 16|Death|1|||
164363444|NCT01649375|593707989|FG001|Up to Week 16|Death|0|||
164363445|NCT01649375|593707990|FG002|Up to Week 16|Death|0|||
164363446|NCT01649375|593707991|FG003|Up to Week 16|Death|0|||
164363447|NCT01649375|593707992|FG004|Up to Week 16|Death|0|||
164363448|NCT01649375|593707988|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
164363449|NCT01649375|593707989|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
164363450|NCT01649375|593707990|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
164363451|NCT01649375|593707991|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
164363452|NCT01649375|593707992|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
164363453|NCT01649375|593707988|FG000|Week 16 up to Week 260|Non-compliance|0|||
164363454|NCT01649375|593707989|FG001|Week 16 up to Week 260|Non-compliance|1|||
164363455|NCT01649375|593707990|FG002|Week 16 up to Week 260|Non-compliance|0|||
164363456|NCT01649375|593707991|FG003|Week 16 up to Week 260|Non-compliance|1|||
164363457|NCT01649375|593707992|FG004|Week 16 up to Week 260|Non-compliance|0|||
164363458|NCT01649375|593707988|FG000|Week 16 up to Week 260|Physician Decision|0|||
164363459|NCT01649375|593707989|FG001|Week 16 up to Week 260|Physician Decision|2|||
164363460|NCT01649375|593707990|FG002|Week 16 up to Week 260|Physician Decision|0|||
164363461|NCT01649375|593707991|FG003|Week 16 up to Week 260|Physician Decision|0|||
164363462|NCT01649375|593707992|FG004|Week 16 up to Week 260|Physician Decision|0|||
164363463|NCT01649375|593707988|FG000|Week 16 up to Week 260|Technical issues|0|||
164363464|NCT01649375|593707989|FG001|Week 16 up to Week 260|Technical issues|1|||
164363465|NCT01649375|593707990|FG002|Week 16 up to Week 260|Technical issues|0|||
164363466|NCT01649375|593707991|FG003|Week 16 up to Week 260|Technical issues|1|||
164363467|NCT01649375|593707992|FG004|Week 16 up to Week 260|Technical issues|0|||
164363468|NCT01649375|593707988|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
164363469|NCT01649375|593707989|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
164363470|NCT01649375|593707990|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
164363471|NCT01649375|593707991|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
164363472|NCT01649375|593707992|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
164363473|NCT01649375|593707988|FG000|Week 16 up to Week 260|Death|1|||
164363474|NCT01649375|593707989|FG001|Week 16 up to Week 260|Death|1|||
164363475|NCT01649375|593707990|FG002|Week 16 up to Week 260|Death|0|||
164363476|NCT01649375|593707991|FG003|Week 16 up to Week 260|Death|0|||
164363477|NCT01649375|593707992|FG004|Week 16 up to Week 260|Death|0|||
164363478|NCT01649375|593707988|FG000|Week 16 up to Week 260|Adverse Event|5|||
164363479|NCT01649375|593707989|FG001|Week 16 up to Week 260|Adverse Event|2|||
164363480|NCT01649375|593707990|FG002|Week 16 up to Week 260|Adverse Event|0|||
164590942|NCT00718419|594527149|FG001|Overall Study|Sponsor decision|1|||
164590943|NCT00718419|594527148|FG000|Overall Study|Withdrawal by Subject|0|||
164590944|NCT00718419|594527149|FG001|Overall Study|Withdrawal by Subject|5|||
164590945|NCT00718419|594527148|FG000|Overall Study|Progressive Disease|7|||
164590946|NCT00718419|594527149|FG001|Overall Study|Progressive Disease|25|||
164590947|NCT00718419|594527148|FG000|Overall Study|Death Due to Progressive Disease|2|||
164363481|NCT01649375|593707991|FG003|Week 16 up to Week 260|Adverse Event|3|||
164363482|NCT01649375|593707992|FG004|Week 16 up to Week 260|Adverse Event|2|||
164363483|NCT01921829|593707995|FG000|Overall Study|Withdrawal by Subject|0|||
164363484|NCT01921829|593707996|FG001|Overall Study|Withdrawal by Subject|1|||
164363485|NCT01316276|593708001|FG000|Overall Study|Death|1|||
164363486|NCT01316276|593708001|FG000|Overall Study|Adverse Event|19|||
164363487|NCT01316276|593708001|FG000|Overall Study|Withdrawal of consent|24|||
164363488|NCT01316276|593708001|FG000|Overall Study|Lost to Follow-up|1|||
164363489|NCT01316276|593708001|FG000|Overall Study|Other|22|||
164363490|NCT00605475|593708002|FG000|Overall Study|Abnormal Laboratory Values|0|||
164363491|NCT00605475|593708003|FG001|Overall Study|Abnormal Laboratory Values|0|||
164363492|NCT00605475|593708004|FG002|Overall Study|Abnormal Laboratory Values|0|||
164363493|NCT00605475|593708005|FG003|Overall Study|Abnormal Laboratory Values|0|||
164363494|NCT00605475|593708006|FG004|Overall Study|Abnormal Laboratory Values|0|||
164363495|NCT00605475|593708007|FG005|Overall Study|Abnormal Laboratory Values|0|||
164363496|NCT00605475|593708008|FG006|Overall Study|Abnormal Laboratory Values|0|||
164363497|NCT00605475|593708009|FG007|Overall Study|Abnormal Laboratory Values|0|||
164363498|NCT00605475|593708010|FG008|Overall Study|Abnormal Laboratory Values|1|||
164363499|NCT00605475|593708011|FG009|Overall Study|Abnormal Laboratory Values|0|||
164363500|NCT00605475|593708002|FG000|Overall Study|Administrative problems|0|||
164363501|NCT00605475|593708003|FG001|Overall Study|Administrative problems|0|||
164363502|NCT00605475|593708004|FG002|Overall Study|Administrative problems|0|||
164363503|NCT00605475|593708005|FG003|Overall Study|Administrative problems|0|||
164363504|NCT00605475|593708006|FG004|Overall Study|Administrative problems|0|||
164363505|NCT00605475|593708007|FG005|Overall Study|Administrative problems|0|||
164363506|NCT00605475|593708008|FG006|Overall Study|Administrative problems|1|||
164590948|NCT00718419|594527149|FG001|Overall Study|Death Due to Progressive Disease|0|||
164590949|NCT00718419|594527148|FG000|Overall Study|Death Due to Study Drug Related|0|||
164438624|NCT00726999|593973003|FG001|Overall Study|Protocol Violation|0|||
164438625|NCT00955825|593973004|FG000|Overall Study|Adverse Event|15|||
164438626|NCT00955825|593973005|FG001|Overall Study|Adverse Event|2|||
164438627|NCT00955825|593973004|FG000|Overall Study|Withdrawal by Subject|4|||
164363507|NCT00605475|593708009|FG007|Overall Study|Administrative problems|0|||
164363508|NCT00605475|593708010|FG008|Overall Study|Administrative problems|0|||
164363509|NCT00605475|593708011|FG009|Overall Study|Administrative problems|0|||
164363510|NCT00605475|593708002|FG000|Overall Study|Lost to Follow-up|0|||
164363511|NCT00605475|593708003|FG001|Overall Study|Lost to Follow-up|0|||
164363512|NCT00605475|593708004|FG002|Overall Study|Lost to Follow-up|0|||
164363513|NCT00605475|593708005|FG003|Overall Study|Lost to Follow-up|0|||
164363514|NCT00605475|593708006|FG004|Overall Study|Lost to Follow-up|0|||
164363515|NCT00605475|593708007|FG005|Overall Study|Lost to Follow-up|0|||
164363516|NCT00605475|593708008|FG006|Overall Study|Lost to Follow-up|0|||
164363517|NCT00605475|593708009|FG007|Overall Study|Lost to Follow-up|0|||
164363518|NCT00605475|593708010|FG008|Overall Study|Lost to Follow-up|1|||
164363519|NCT00605475|593708011|FG009|Overall Study|Lost to Follow-up|1|||
164363520|NCT00605475|593708002|FG000|Overall Study|Protocol Violation|0|||
164363521|NCT00605475|593708003|FG001|Overall Study|Protocol Violation|0|||
164363522|NCT00605475|593708004|FG002|Overall Study|Protocol Violation|0|||
164363523|NCT00605475|593708005|FG003|Overall Study|Protocol Violation|0|||
164363524|NCT00605475|593708006|FG004|Overall Study|Protocol Violation|1|||
164363525|NCT00605475|593708007|FG005|Overall Study|Protocol Violation|0|||
164363526|NCT00605475|593708008|FG006|Overall Study|Protocol Violation|0|||
164363527|NCT00605475|593708009|FG007|Overall Study|Protocol Violation|0|||
164363528|NCT00605475|593708010|FG008|Overall Study|Protocol Violation|0|||
164363529|NCT00605475|593708011|FG009|Overall Study|Protocol Violation|0|||
164363530|NCT00605475|593708002|FG000|Overall Study|Withdrawal by Subject|0|||
164363531|NCT00605475|593708003|FG001|Overall Study|Withdrawal by Subject|0|||
164363532|NCT00605475|593708004|FG002|Overall Study|Withdrawal by Subject|0|||
164363533|NCT00605475|593708005|FG003|Overall Study|Withdrawal by Subject|0|||
164363534|NCT00605475|593708006|FG004|Overall Study|Withdrawal by Subject|0|||
164363535|NCT00605475|593708007|FG005|Overall Study|Withdrawal by Subject|2|||
164363536|NCT00605475|593708008|FG006|Overall Study|Withdrawal by Subject|0|||
164363537|NCT00605475|593708009|FG007|Overall Study|Withdrawal by Subject|0|||
164363538|NCT00605475|593708010|FG008|Overall Study|Withdrawal by Subject|0|||
164363539|NCT00605475|593708011|FG009|Overall Study|Withdrawal by Subject|1|||
164363540|NCT03538158|593708017|FG000|Overall Study|Lost to Follow-up|13|||
164363541|NCT03538158|593708018|FG001|Overall Study|Lost to Follow-up|7|||
164363542|NCT03538158|593708017|FG000|Overall Study|Withdrawal by Subject|2|||
164363543|NCT03538158|593708018|FG001|Overall Study|Withdrawal by Subject|1|||
164363544|NCT04519645|593708025|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
164363545|NCT04519645|593708026|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
164363546|NCT04519645|593708027|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
164363547|NCT04519645|593708025|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
164363548|NCT04519645|593708026|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
164363549|NCT04519645|593708027|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
164363550|NCT04519645|593708025|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
164363551|NCT04519645|593708026|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
164363552|NCT04519645|593708027|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
164363553|NCT04519645|593708025|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
164363554|NCT04519645|593708026|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
164363555|NCT04519645|593708027|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
164438628|NCT00955825|593973005|FG001|Overall Study|Withdrawal by Subject|6|||
164438629|NCT00955825|593973004|FG000|Overall Study|Any other reason not above-mentioned|7|||
164438630|NCT00955825|593973005|FG001|Overall Study|Any other reason not above-mentioned|9|||
164438631|NCT02937831|593973009|FG000|Overall Study|Protocol Violation|4|||
164438632|NCT01759264|593973010|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
164590950|NCT00718419|594527149|FG001|Overall Study|Death Due to Study Drug Related|1|||
164363556|NCT05517382|593708036|FG000|Overall Study|Lost to Follow-up|0|||
164363557|NCT05517382|593708037|FG001|Overall Study|Lost to Follow-up|1|||
164363558|NCT03886220|593708040|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
164438633|NCT01759264|593973010|FG000|Overall Study|Adverse Event|1|||
164438634|NCT01759264|593973010|FG000|Overall Study|Other|2|||
164438635|NCT01759264|593973010|FG000|Overall Study|Lost to Follow-up|2|||
164438636|NCT01759264|593973010|FG000|Overall Study|Withdrawal by Subject|3|||
164438637|NCT01759264|593973010|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
164438638|NCT02034916|593973013|FG000|Overall Study|Death|39|||
164438639|NCT02034916|593973014|FG001|Overall Study|Death|28|||
164590951|NCT00718419|594527148|FG000|Overall Study|Death Due to Adverse Events|1|||
164590952|NCT00718419|594527149|FG001|Overall Study|Death Due to Adverse Events|0|||
164590953|NCT00879814|594527162|FG000|Overall Study|Adverse Event|0|||
164363559|NCT03886220|593708041|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
164363560|NCT03886220|593708040|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
164363561|NCT03886220|593708041|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164363562|NCT03886220|593708040|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
164363563|NCT03886220|593708041|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
164363564|NCT00271947|593708045|FG000|Overall Study|Lost to Follow-up|1|||
164363565|NCT00698581|593708048|FG000|Overall Study|Lack of Efficacy|23|||
164363566|NCT00698581|593708049|FG001|Overall Study|Lack of Efficacy|11|||
164363567|NCT00698581|593708048|FG000|Overall Study|Withdrawal by Subject|6|||
164363568|NCT00698581|593708049|FG001|Overall Study|Withdrawal by Subject|0|||
164363569|NCT00698581|593708048|FG000|Overall Study|Other reason|9|||
164363570|NCT00698581|593708049|FG001|Overall Study|Other reason|1|||
164363571|NCT00698581|593708048|FG000|Overall Study|SAE, non-fatal|1|||
164363572|NCT00698581|593708049|FG001|Overall Study|SAE, non-fatal|0|||
164363573|NCT00698581|593708048|FG000|Overall Study|AE, non-serious non-fatal|4|||
164363574|NCT00698581|593708049|FG001|Overall Study|AE, non-serious non-fatal|0|||
164363575|NCT00698581|593708048|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
164363576|NCT00698581|593708049|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
164363577|NCT00698581|593708048|FG000|Overall Study|AE of unknown type|1|||
164363578|NCT00698581|593708049|FG001|Overall Study|AE of unknown type|0|||
164363579|NCT00449644|593708050|FG000|Overall Study|Adverse Event|0|||
164363580|NCT00449644|593708051|FG001|Overall Study|Adverse Event|0|||
164363581|NCT00449644|593708052|FG002|Overall Study|Adverse Event|3|||
164363582|NCT00449644|593708053|FG003|Overall Study|Adverse Event|5|||
164363583|NCT00449644|593708050|FG000|Overall Study|Death|1|||
164363584|NCT00449644|593708051|FG001|Overall Study|Death|0|||
164363585|NCT00449644|593708052|FG002|Overall Study|Death|6|||
164363586|NCT00449644|593708053|FG003|Overall Study|Death|1|||
164363587|NCT00449644|593708050|FG000|Overall Study|Lost to Follow-up|1|||
164363588|NCT00449644|593708051|FG001|Overall Study|Lost to Follow-up|1|||
164363589|NCT00449644|593708052|FG002|Overall Study|Lost to Follow-up|5|||
164363590|NCT00449644|593708053|FG003|Overall Study|Lost to Follow-up|3|||
164363591|NCT00449644|593708050|FG000|Overall Study|Pregnancy|0|||
164363592|NCT00449644|593708051|FG001|Overall Study|Pregnancy|0|||
164363593|NCT00449644|593708052|FG002|Overall Study|Pregnancy|3|||
164363594|NCT00449644|593708053|FG003|Overall Study|Pregnancy|2|||
164363595|NCT00449644|593708050|FG000|Overall Study|Protocol Violation|4|||
164363596|NCT00449644|593708051|FG001|Overall Study|Protocol Violation|4|||
164363597|NCT00449644|593708052|FG002|Overall Study|Protocol Violation|3|||
164363598|NCT00449644|593708053|FG003|Overall Study|Protocol Violation|7|||
164363599|NCT00449644|593708050|FG000|Overall Study|Withdrawal by Subject|3|||
164363600|NCT00449644|593708051|FG001|Overall Study|Withdrawal by Subject|4|||
164363601|NCT00449644|593708052|FG002|Overall Study|Withdrawal by Subject|6|||
164363602|NCT00449644|593708053|FG003|Overall Study|Withdrawal by Subject|7|||
164363603|NCT00449644|593708050|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
164363604|NCT00449644|593708051|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
164363605|NCT00449644|593708052|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
164363606|NCT00449644|593708053|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
164363607|NCT00449644|593708050|FG000|Overall Study|Other|1|||
164363608|NCT00449644|593708051|FG001|Overall Study|Other|4|||
164363609|NCT00449644|593708052|FG002|Overall Study|Other|1|||
164363610|NCT00449644|593708053|FG003|Overall Study|Other|0|||
164363611|NCT00449644|593708050|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
164363612|NCT00449644|593708051|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
164363613|NCT00449644|593708052|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
164363614|NCT00449644|593708053|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
164363615|NCT05778786|593708058|FG000|Period 1|COVID-19 Related|3|||
164363616|NCT05778786|593708059|FG001|Period 1|COVID-19 Related|3|||
164363617|NCT05778786|593708058|FG000|Period 1|Withdrew Consent during Study|1|||
164363618|NCT05778786|593708059|FG001|Period 1|Withdrew Consent during Study|0|||
164363619|NCT05778786|593708058|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
164363620|NCT05778786|593708059|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
164363621|NCT05778786|593708058|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
164363622|NCT05778786|593708059|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
164363623|NCT02075658|593708060|FG000|Overall Study|Physician Decision|2|||
164363624|NCT02075658|593708061|FG001|Overall Study|Physician Decision|2|||
164363625|NCT02406651|593708063|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
164363626|NCT00718328|593708068|FG000|Overall Study|Lost to Follow-up|1|||
164363627|NCT00718328|593708069|FG001|Overall Study|Lost to Follow-up|0|||
164363628|NCT00663052|593708070|FG000|Overall Study|Adverse Event|6|||
164363629|NCT00663052|593708071|FG001|Overall Study|Adverse Event|3|||
164363630|NCT00663052|593708070|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
164363631|NCT00663052|593708071|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
164363632|NCT00663052|593708070|FG000|Overall Study|Protocol Violation|1|||
164363633|NCT00663052|593708071|FG001|Overall Study|Protocol Violation|0|||
164363634|NCT00663052|593708070|FG000|Overall Study|Withdrawal by Subject|2|||
164363635|NCT00663052|593708071|FG001|Overall Study|Withdrawal by Subject|5|||
164363636|NCT00663052|593708070|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
164363637|NCT00663052|593708071|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
164363638|NCT00663052|593708070|FG000|Overall Study|Other|0|||
164363639|NCT00663052|593708071|FG001|Overall Study|Other|1|||
164363640|NCT02946047|593708073|FG000|Overall Study|Adverse Event|1|||
164363641|NCT02946047|593708074|FG001|Overall Study|Adverse Event|0|||
164363642|NCT02946047|593708075|FG002|Overall Study|Adverse Event|0|||
164363643|NCT02946047|593708076|FG003|Overall Study|Adverse Event|0|||
164363644|NCT03615105|593708077|FG000|Overall Study|Protocol Violation|1|||
164363645|NCT03615105|593708078|FG001|Overall Study|Protocol Violation|0|||
164363646|NCT03615105|593708079|FG002|Overall Study|Protocol Violation|0|||
164363647|NCT03615105|593708077|FG000|Overall Study|Death|0|||
164363648|NCT03615105|593708078|FG001|Overall Study|Death|2|||
164363649|NCT03615105|593708079|FG002|Overall Study|Death|0|||
164363650|NCT05041322|593708080|FG000|Baseline|Withdrawal by Subject|1|||
164363651|NCT05041322|593708081|FG001|Baseline|Withdrawal by Subject|0|||
164363652|NCT05041322|593708080|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
164363653|NCT05041322|593708081|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
164363654|NCT05041322|593708080|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
164363655|NCT05041322|593708081|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
164363656|NCT01252940|593708082|FG000|Main Study Phase|Randomized but not treated|4|||
164363657|NCT01252940|593708083|FG001|Main Study Phase|Randomized but not treated|2|||
164363658|NCT01252940|593708082|FG000|Main Study Phase|Adverse Event|3|||
164363659|NCT01252940|593708083|FG001|Main Study Phase|Adverse Event|1|||
164363660|NCT01252940|593708082|FG000|Main Study Phase|Lack of Efficacy|1|||
164363661|NCT01252940|593708083|FG001|Main Study Phase|Lack of Efficacy|0|||
164363662|NCT01252940|593708082|FG000|Main Study Phase|Lost to Follow-up|6|||
164363663|NCT01252940|593708083|FG001|Main Study Phase|Lost to Follow-up|1|||
164363664|NCT01252940|593708082|FG000|Main Study Phase|Physician Decision|1|||
164363665|NCT01252940|593708083|FG001|Main Study Phase|Physician Decision|0|||
164363666|NCT01252940|593708082|FG000|Main Study Phase|Protocol Violation|4|||
164363667|NCT01252940|593708083|FG001|Main Study Phase|Protocol Violation|2|||
164363668|NCT01252940|593708082|FG000|Main Study Phase|Withdrawal by Subject|6|||
164363669|NCT01252940|593708083|FG001|Main Study Phase|Withdrawal by Subject|5|||
164363670|NCT01252940|593708082|FG000|Main Study Phase|Subject Non-compliance|1|||
164363671|NCT01252940|593708083|FG001|Main Study Phase|Subject Non-compliance|1|||
164363672|NCT01252940|593708082|FG000|Extension Phase|Adverse Event|2|||
164363673|NCT01252940|593708083|FG001|Extension Phase|Adverse Event|1|||
164363674|NCT01252940|593708082|FG000|Extension Phase|Lack of Efficacy|1|||
164363675|NCT01252940|593708083|FG001|Extension Phase|Lack of Efficacy|0|||
164363676|NCT01252940|593708082|FG000|Extension Phase|Lost to Follow-up|5|||
164363677|NCT01252940|593708083|FG001|Extension Phase|Lost to Follow-up|0|||
164363678|NCT01252940|593708082|FG000|Extension Phase|Physician Decision|0|||
164363679|NCT01252940|593708083|FG001|Extension Phase|Physician Decision|1|||
164363680|NCT01252940|593708082|FG000|Extension Phase|Subject Non-compliance|1|||
164363681|NCT01252940|593708083|FG001|Extension Phase|Subject Non-compliance|0|||
164363682|NCT01252940|593708082|FG000|Extension Phase|Withdrawal by Subject|1|||
164363683|NCT01252940|593708083|FG001|Extension Phase|Withdrawal by Subject|1|||
164363684|NCT01502423|593708084|FG000|Overall Study|Withdrawal by Subject|0|||
164363685|NCT01502423|593708085|FG001|Overall Study|Withdrawal by Subject|1|||
164363686|NCT04199117|593708086|FG000|Overall Study|Withdrawal by Subject|3|||
164363687|NCT04199117|593708087|FG001|Overall Study|Withdrawal by Subject|0|||
164363688|NCT04199117|593708088|FG002|Overall Study|Withdrawal by Subject|0|||
164363689|NCT04199117|593708089|FG003|Overall Study|Withdrawal by Subject|1|||
164363690|NCT04199117|593708090|FG004|Overall Study|Withdrawal by Subject|1|||
164363691|NCT04199117|593708091|FG005|Overall Study|Withdrawal by Subject|0|||
164363692|NCT04199117|593708092|FG006|Overall Study|Withdrawal by Subject|0|||
164363693|NCT04199117|593708093|FG007|Overall Study|Withdrawal by Subject|2|||
164363694|NCT04199117|593708094|FG008|Overall Study|Withdrawal by Subject|0|||
164363695|NCT04199117|593708095|FG009|Overall Study|Withdrawal by Subject|0|||
164363696|NCT04199117|593708096|FG010|Overall Study|Withdrawal by Subject|1|||
164363697|NCT04199117|593708097|FG011|Overall Study|Withdrawal by Subject|1|||
164699270|NCT02091141|594922641|FG004|Overall Study|Death|31|||
164699271|NCT02091141|594922642|FG005|Overall Study|Death|16|||
164699272|NCT02091141|594922643|FG006|Overall Study|Death|12|||
164699273|NCT02091141|594922637|FG000|Overall Study|Withdrawal by Subject|21|||
164363698|NCT04199117|593708098|FG012|Overall Study|Withdrawal by Subject|2|||
164363699|NCT04199117|593708099|FG013|Overall Study|Withdrawal by Subject|1|||
164363700|NCT04199117|593708100|FG014|Overall Study|Withdrawal by Subject|1|||
164363701|NCT04199117|593708101|FG015|Overall Study|Withdrawal by Subject|1|||
164363702|NCT04199117|593708086|FG000|Overall Study|Death|1|||
164363703|NCT04199117|593708087|FG001|Overall Study|Death|1|||
164363704|NCT04199117|593708088|FG002|Overall Study|Death|0|||
164363705|NCT04199117|593708089|FG003|Overall Study|Death|0|||
164699274|NCT02091141|594922638|FG001|Overall Study|Withdrawal by Subject|13|||
164363706|NCT04199117|593708090|FG004|Overall Study|Death|0|||
164363707|NCT04199117|593708091|FG005|Overall Study|Death|0|||
164363708|NCT04199117|593708092|FG006|Overall Study|Death|0|||
164363709|NCT04199117|593708093|FG007|Overall Study|Death|0|||
164699275|NCT02091141|594922639|FG002|Overall Study|Withdrawal by Subject|3|||
164363710|NCT04199117|593708094|FG008|Overall Study|Death|0|||
164363711|NCT04199117|593708095|FG009|Overall Study|Death|0|||
164363712|NCT04199117|593708096|FG010|Overall Study|Death|0|||
164363713|NCT04199117|593708097|FG011|Overall Study|Death|1|||
164363714|NCT04199117|593708098|FG012|Overall Study|Death|0|||
164363715|NCT04199117|593708099|FG013|Overall Study|Death|1|||
164363716|NCT04199117|593708100|FG014|Overall Study|Death|0|||
164363717|NCT04199117|593708101|FG015|Overall Study|Death|0|||
164363718|NCT04199117|593708086|FG000|Overall Study|Withdrawal by PI|0|||
164363719|NCT04199117|593708087|FG001|Overall Study|Withdrawal by PI|0|||
164363720|NCT04199117|593708088|FG002|Overall Study|Withdrawal by PI|0|||
164363721|NCT04199117|593708089|FG003|Overall Study|Withdrawal by PI|0|||
164363722|NCT04199117|593708090|FG004|Overall Study|Withdrawal by PI|0|||
164363723|NCT04199117|593708091|FG005|Overall Study|Withdrawal by PI|0|||
164363724|NCT04199117|593708092|FG006|Overall Study|Withdrawal by PI|0|||
164363725|NCT04199117|593708093|FG007|Overall Study|Withdrawal by PI|0|||
164363726|NCT04199117|593708094|FG008|Overall Study|Withdrawal by PI|0|||
164363727|NCT04199117|593708095|FG009|Overall Study|Withdrawal by PI|0|||
164363728|NCT04199117|593708096|FG010|Overall Study|Withdrawal by PI|0|||
164363729|NCT04199117|593708097|FG011|Overall Study|Withdrawal by PI|0|||
164363730|NCT04199117|593708098|FG012|Overall Study|Withdrawal by PI|1|||
164363731|NCT04199117|593708099|FG013|Overall Study|Withdrawal by PI|0|||
164363732|NCT04199117|593708100|FG014|Overall Study|Withdrawal by PI|0|||
164363733|NCT04199117|593708101|FG015|Overall Study|Withdrawal by PI|0|||
164363734|NCT04383743|593708102|FG000|Overall Study|Withdrawal by Subject|1|||
164363735|NCT04383743|593708102|FG000|Overall Study|Adverse Event|1|||
164363736|NCT04814433|593708105|FG000|Overall Study|Survey not returned|4|||
164363737|NCT04814433|593708106|FG001|Overall Study|Survey not returned|8|||
164363738|NCT04814433|593708107|FG002|Overall Study|Survey not returned|4|||
164363739|NCT04814433|593708108|FG003|Overall Study|Survey not returned|5|||
164363740|NCT03482791|593708113|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
164363741|NCT03482791|593708114|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
164363742|NCT01721330|593708116|FG000|Overall Study|Withdrawal by Subject|0|||
164363743|NCT01721330|593708117|FG001|Overall Study|Withdrawal by Subject|1|||
164363744|NCT00296374|593708118|FG000|Overall Study|Adverse Event|14|||
164363745|NCT00296374|593708119|FG001|Overall Study|Adverse Event|10|||
164363746|NCT00296374|593708120|FG002|Overall Study|Adverse Event|7|||
164363747|NCT00296374|593708118|FG000|Overall Study|Withdrawal by Subject|3|||
164363748|NCT00296374|593708119|FG001|Overall Study|Withdrawal by Subject|5|||
164363749|NCT00296374|593708120|FG002|Overall Study|Withdrawal by Subject|11|||
164363750|NCT00296374|593708118|FG000|Overall Study|Incorrect enrollment|3|||
164363751|NCT00296374|593708119|FG001|Overall Study|Incorrect enrollment|3|||
164363752|NCT00296374|593708120|FG002|Overall Study|Incorrect enrollment|4|||
164363753|NCT00296374|593708118|FG000|Overall Study|Protocol Violation|1|||
164363754|NCT00296374|593708119|FG001|Overall Study|Protocol Violation|2|||
164363755|NCT00296374|593708120|FG002|Overall Study|Protocol Violation|3|||
164363756|NCT00296374|593708118|FG000|Overall Study|Lost to Follow-up|3|||
164363757|NCT00296374|593708119|FG001|Overall Study|Lost to Follow-up|1|||
164363758|NCT00296374|593708120|FG002|Overall Study|Lost to Follow-up|1|||
164363759|NCT00296374|593708118|FG000|Overall Study|Relocated to another state|1|||
164363760|NCT00296374|593708119|FG001|Overall Study|Relocated to another state|0|||
164363761|NCT00296374|593708120|FG002|Overall Study|Relocated to another state|0|||
164363762|NCT00296374|593708118|FG000|Overall Study|Stopped drug before end of study visit|0|||
164363763|NCT00296374|593708119|FG001|Overall Study|Stopped drug before end of study visit|1|||
164363764|NCT00296374|593708120|FG002|Overall Study|Stopped drug before end of study visit|0|||
164363765|NCT00296374|593708118|FG000|Overall Study|Nephrologist introduced ACE|0|||
164363766|NCT00296374|593708119|FG001|Overall Study|Nephrologist introduced ACE|1|||
164363767|NCT00296374|593708120|FG002|Overall Study|Nephrologist introduced ACE|0|||
164363768|NCT00296374|593708118|FG000|Overall Study|Pregnancy|0|||
164363769|NCT00296374|593708119|FG001|Overall Study|Pregnancy|0|||
164363770|NCT00296374|593708120|FG002|Overall Study|Pregnancy|2|||
164363771|NCT00296374|593708118|FG000|Overall Study|Other|0|||
164363772|NCT00296374|593708119|FG001|Overall Study|Other|0|||
164363773|NCT00296374|593708120|FG002|Overall Study|Other|1|||
164363774|NCT01816893|593708121|FG000|Washout Period|Withdrawal by Subject|2|||
164363775|NCT01816893|593708122|FG001|Washout Period|Withdrawal by Subject|0|||
164363776|NCT02747420|593709460|FG000|Overall Study|Lost to Follow-up|4|||
164363777|NCT02747420|593709461|FG001|Overall Study|Lost to Follow-up|2|||
164363778|NCT02747420|593709460|FG000|Overall Study|Withdrawal by Subject|3|||
164363779|NCT02747420|593709461|FG001|Overall Study|Withdrawal by Subject|2|||
164363780|NCT00798369|593709462|FG000|Overall Study|Subject withdrew consent|0|||
164363781|NCT00798369|593709463|FG001|Overall Study|Subject withdrew consent|0|||
164363782|NCT00798369|593709464|FG002|Overall Study|Subject withdrew consent|1|||
164363783|NCT00798369|593709465|FG003|Overall Study|Subject withdrew consent|1|||
164363784|NCT00798369|593709466|FG004|Overall Study|Subject withdrew consent|0|||
164363785|NCT00798369|593709467|FG005|Overall Study|Subject withdrew consent|2|||
164590954|NCT00879814|594527163|FG001|Overall Study|Adverse Event|1|||
164590955|NCT00879814|594527164|FG002|Overall Study|Adverse Event|0|||
164590956|NCT00879814|594527165|FG003|Overall Study|Adverse Event|0|||
164590957|NCT00879814|594527162|FG000|Overall Study|Lost to Follow-up|1|||
164363786|NCT00798369|593709462|FG000|Overall Study|Lost to Follow-up|1|||
164363787|NCT00798369|593709463|FG001|Overall Study|Lost to Follow-up|1|||
164363788|NCT00798369|593709464|FG002|Overall Study|Lost to Follow-up|1|||
164363789|NCT00798369|593709465|FG003|Overall Study|Lost to Follow-up|0|||
164363790|NCT00798369|593709466|FG004|Overall Study|Lost to Follow-up|1|||
164363791|NCT00798369|593709467|FG005|Overall Study|Lost to Follow-up|0|||
164363792|NCT00798369|593709462|FG000|Overall Study|Adminstrative problems|0|||
164363793|NCT00798369|593709463|FG001|Overall Study|Adminstrative problems|0|||
164363794|NCT00798369|593709464|FG002|Overall Study|Adminstrative problems|0|||
164363795|NCT00798369|593709465|FG003|Overall Study|Adminstrative problems|0|||
164363796|NCT00798369|593709466|FG004|Overall Study|Adminstrative problems|0|||
164363797|NCT00798369|593709467|FG005|Overall Study|Adminstrative problems|1|||
164363798|NCT04307446|593709468|FG000|Overall Study|Lost to Follow-up|2|||
164363799|NCT04307446|593709469|FG001|Overall Study|Lost to Follow-up|0|||
164363800|NCT05620576|593709470|FG000|Overall Study|Adverse Event|1|||
164363801|NCT05620576|593709471|FG001|Overall Study|Adverse Event|1|||
164363802|NCT05620576|593709470|FG000|Overall Study|Lost to Follow-up|3|||
164363803|NCT05620576|593709471|FG001|Overall Study|Lost to Follow-up|1|||
164363804|NCT05620576|593709470|FG000|Overall Study|Physician Decision|0|||
164363805|NCT05620576|593709471|FG001|Overall Study|Physician Decision|1|||
164363806|NCT05620576|593709470|FG000|Overall Study|Protocol Deviation|1|||
164363807|NCT05620576|593709471|FG001|Overall Study|Protocol Deviation|1|||
164363808|NCT05620576|593709470|FG000|Overall Study|Withdrawal by Subject|2|||
164363809|NCT05620576|593709471|FG001|Overall Study|Withdrawal by Subject|3|||
164363810|NCT02622828|593709472|FG000|Overall Study|participant withdrew|3|||
164363811|NCT00666757|593709476|FG000|Overall Study|Lost to Follow-up|39|||
164363812|NCT00666757|593709477|FG001|Overall Study|Lost to Follow-up|35|||
164363813|NCT00666757|593709476|FG000|Overall Study|Protocol Violation|23|||
164363814|NCT00666757|593709477|FG001|Overall Study|Protocol Violation|24|||
164363815|NCT00666757|593709476|FG000|Overall Study|Adverse Event|22|||
164363816|NCT00666757|593709477|FG001|Overall Study|Adverse Event|12|||
164363817|NCT00666757|593709476|FG000|Overall Study|Withdrawal by Subject|13|||
164363818|NCT00666757|593709477|FG001|Overall Study|Withdrawal by Subject|17|||
164363819|NCT00666757|593709476|FG000|Overall Study|Lack of Efficacy|3|||
164363820|NCT00666757|593709477|FG001|Overall Study|Lack of Efficacy|6|||
164363821|NCT00666757|593709476|FG000|Overall Study|Physician Decision|0|||
164363822|NCT00666757|593709477|FG001|Overall Study|Physician Decision|2|||
164363823|NCT00666757|593709476|FG000|Overall Study|Sponsor decision|0|||
164363824|NCT00666757|593709477|FG001|Overall Study|Sponsor decision|1|||
164363825|NCT02510794|593709480|FG000|Overall Study|Adverse Event|0|||
164363826|NCT02510794|593709481|FG001|Overall Study|Adverse Event|1|||
164363827|NCT02510794|593709482|FG002|Overall Study|Adverse Event|0|||
164363828|NCT02510794|593709483|FG003|Overall Study|Adverse Event|0|||
164363829|NCT02510794|593709480|FG000|Overall Study|Death|1|||
164363830|NCT02510794|593709481|FG001|Overall Study|Death|2|||
164363831|NCT02510794|593709482|FG002|Overall Study|Death|1|||
164363832|NCT02510794|593709483|FG003|Overall Study|Death|1|||
164363833|NCT02510794|593709480|FG000|Overall Study|Lack of Efficacy|3|||
164363834|NCT02510794|593709481|FG001|Overall Study|Lack of Efficacy|1|||
164363835|NCT02510794|593709482|FG002|Overall Study|Lack of Efficacy|1|||
164363836|NCT02510794|593709483|FG003|Overall Study|Lack of Efficacy|0|||
164363837|NCT02510794|593709480|FG000|Overall Study|Participant moved out of the area|0|||
164363838|NCT02510794|593709481|FG001|Overall Study|Participant moved out of the area|0|||
164590958|NCT00879814|594527163|FG001|Overall Study|Lost to Follow-up|0|||
164363839|NCT02510794|593709482|FG002|Overall Study|Participant moved out of the area|0|||
164363840|NCT02510794|593709483|FG003|Overall Study|Participant moved out of the area|1|||
164363841|NCT02510794|593709480|FG000|Overall Study|Physician Decision|3|||
164363842|NCT02510794|593709481|FG001|Overall Study|Physician Decision|0|||
164363843|NCT02510794|593709482|FG002|Overall Study|Physician Decision|0|||
164363844|NCT02510794|593709483|FG003|Overall Study|Physician Decision|0|||
164363845|NCT02510794|593709480|FG000|Overall Study|Protocol Violation|0|||
164363846|NCT02510794|593709481|FG001|Overall Study|Protocol Violation|0|||
164363847|NCT02510794|593709482|FG002|Overall Study|Protocol Violation|1|||
164363848|NCT02510794|593709483|FG003|Overall Study|Protocol Violation|0|||
164363849|NCT02510794|593709480|FG000|Overall Study|Withdrawal by Subject|1|||
164363850|NCT02510794|593709481|FG001|Overall Study|Withdrawal by Subject|2|||
164363851|NCT02510794|593709482|FG002|Overall Study|Withdrawal by Subject|4|||
164699276|NCT02091141|594922640|FG003|Overall Study|Withdrawal by Subject|2|||
164363852|NCT02510794|593709483|FG003|Overall Study|Withdrawal by Subject|3|||
164363853|NCT01856790|593709484|FG000|Closed Loop Control|Withdrawal by Subject|2|||
164363854|NCT01856790|593709484|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
164363855|NCT04091646|593709485|FG000|Overall Study|Adverse Event|2|||
164590959|NCT00879814|594527164|FG002|Overall Study|Lost to Follow-up|0|||
164590960|NCT00879814|594527165|FG003|Overall Study|Lost to Follow-up|2|||
164590961|NCT00879814|594527162|FG000|Overall Study|Participant Failed to Return|0|||
164363856|NCT04091646|593709486|FG001|Overall Study|Adverse Event|1|||
164363857|NCT04091646|593709485|FG000|Overall Study|Lost to Follow-up|6|||
164363858|NCT04091646|593709486|FG001|Overall Study|Lost to Follow-up|2|||
164363859|NCT04091646|593709485|FG000|Overall Study|Protocol Violation|0|||
164363860|NCT04091646|593709486|FG001|Overall Study|Protocol Violation|1|||
164363861|NCT04091646|593709485|FG000|Overall Study|Withdrawal by Subject|4|||
164363862|NCT04091646|593709486|FG001|Overall Study|Withdrawal by Subject|1|||
164363863|NCT04091646|593709485|FG000|Overall Study|Participant Incarcerated|1|||
164363864|NCT04091646|593709486|FG001|Overall Study|Participant Incarcerated|0|||
164363865|NCT03168464|593709489|FG000|Overall Study|Death|9|||
164363866|NCT03168464|593709489|FG000|Overall Study|Progression of disease|6|||
164363867|NCT00634088|593709490|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
164363868|NCT00634088|593709491|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
164363869|NCT00634088|593709492|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
164363870|NCT00634088|593709493|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
164363871|NCT00634088|593709490|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
164363872|NCT00634088|593709491|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
164363873|NCT00634088|593709492|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
164363874|NCT00634088|593709493|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
164363875|NCT00634088|593709490|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
164363876|NCT00634088|593709491|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
164363877|NCT00634088|593709492|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
164363878|NCT00634088|593709493|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
164363879|NCT00634088|593709490|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
164363880|NCT00634088|593709491|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
164363881|NCT00634088|593709492|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
164363882|NCT00634088|593709493|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
164363883|NCT00634088|593709490|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
164363884|NCT00634088|593709491|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
164363885|NCT00634088|593709492|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
164363886|NCT00634088|593709493|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
164363887|NCT00634088|593709490|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
164363888|NCT00634088|593709491|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
164363889|NCT00634088|593709492|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
164363890|NCT00634088|593709493|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
164363891|NCT02438722|593709494|FG000|Overall Study|Adverse Event|12|||
164363892|NCT02438722|593709495|FG001|Overall Study|Adverse Event|9|||
164363893|NCT02438722|593709494|FG000|Overall Study|Refusal unrelated to AE|2|||
164363894|NCT02438722|593709495|FG001|Overall Study|Refusal unrelated to AE|5|||
164363895|NCT02438722|593709494|FG000|Overall Study|Disease progression/relapse|46|||
164363896|NCT02438722|593709495|FG001|Overall Study|Disease progression/relapse|51|||
164363897|NCT02438722|593709494|FG000|Overall Study|Death|0|||
164363898|NCT02438722|593709495|FG001|Overall Study|Death|3|||
164363899|NCT02438722|593709494|FG000|Overall Study|Physician Decision|2|||
164363900|NCT02438722|593709495|FG001|Overall Study|Physician Decision|2|||
164363901|NCT02438722|593709494|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
164363902|NCT02438722|593709495|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
164363903|NCT02438722|593709494|FG000|Overall Study|Withdrawal by Subject|0|||
164363904|NCT02438722|593709495|FG001|Overall Study|Withdrawal by Subject|1|||
164363905|NCT02438722|593709494|FG000|Overall Study|On protocol treatment|15|||
164363906|NCT02438722|593709495|FG001|Overall Study|On protocol treatment|14|||
164363907|NCT02438722|593709494|FG000|Overall Study|Did not receive protocol treatment|5|||
164363908|NCT02438722|593709495|FG001|Overall Study|Did not receive protocol treatment|0|||
164363909|NCT04356963|593709499|FG000|First Session|Withdrawal by Subject|1|||
164363910|NCT04356963|593709499|FG000|Second Session|Withdrawal by Subject|3|||
164590962|NCT00879814|594527163|FG001|Overall Study|Participant Failed to Return|0|||
164590963|NCT00879814|594527164|FG002|Overall Study|Participant Failed to Return|0|||
164590964|NCT00879814|594527165|FG003|Overall Study|Participant Failed to Return|1|||
164590965|NCT00879814|594527162|FG000|Overall Study|Withdrawal by Subject|3|||
164590966|NCT00879814|594527163|FG001|Overall Study|Withdrawal by Subject|1|||
164590967|NCT00879814|594527164|FG002|Overall Study|Withdrawal by Subject|1|||
164699277|NCT02091141|594922641|FG004|Overall Study|Withdrawal by Subject|2|||
164363911|NCT04356963|593709499|FG000|Second Session|Lost to Follow-up|1|||
164363912|NCT04356963|593709499|FG000|Third Session|Lost to Follow-up|6|||
164699278|NCT02091141|594922642|FG005|Overall Study|Withdrawal by Subject|3|||
164363913|NCT04356963|593709499|FG000|Third Session|Withdrawal by Subject|1|||
164363914|NCT01577758|593709501|FG000|Dose Escalation Phase|Adverse Event|0|||
164363915|NCT01577758|593709502|FG001|Dose Escalation Phase|Adverse Event|0|||
164363916|NCT01577758|593709503|FG002|Dose Escalation Phase|Adverse Event|0|||
164438640|NCT02034916|593973013|FG000|Overall Study|Withdrawal by Subject|2|||
164590968|NCT00879814|594527165|FG003|Overall Study|Withdrawal by Subject|2|||
164699279|NCT02091141|594922643|FG006|Overall Study|Withdrawal by Subject|0|||
164699280|NCT02091141|594922637|FG000|Overall Study|Lost to Follow-up|21|||
164699281|NCT02091141|594922638|FG001|Overall Study|Lost to Follow-up|5|||
164363917|NCT01577758|593709504|FG003|Dose Escalation Phase|Adverse Event|0|||
164363918|NCT01577758|593709505|FG004|Dose Escalation Phase|Adverse Event|0|||
164363919|NCT01577758|593709506|FG005|Dose Escalation Phase|Adverse Event|2|||
164363920|NCT01577758|593709507|FG006|Dose Escalation Phase|Adverse Event|1|||
164363921|NCT01577758|593709508|FG007|Dose Escalation Phase|Adverse Event|0|||
164363922|NCT01577758|593709501|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
164363923|NCT01577758|593709502|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
164363924|NCT01577758|593709503|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
164363925|NCT01577758|593709504|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
164363926|NCT01577758|593709505|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
164363927|NCT01577758|593709506|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
164363928|NCT01577758|593709507|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
164363929|NCT01577758|593709508|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
164363930|NCT01577758|593709501|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
164363931|NCT01577758|593709502|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
164363932|NCT01577758|593709503|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
164363933|NCT01577758|593709504|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
164363934|NCT01577758|593709505|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
164363935|NCT01577758|593709506|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
164363936|NCT01577758|593709507|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
164363937|NCT01577758|593709508|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
164363938|NCT01577758|593709501|FG000|Dose Escalation Phase|Progression Disease|2|||
164363939|NCT01577758|593709502|FG001|Dose Escalation Phase|Progression Disease|2|||
164363940|NCT01577758|593709503|FG002|Dose Escalation Phase|Progression Disease|1|||
164363941|NCT01577758|593709504|FG003|Dose Escalation Phase|Progression Disease|2|||
164363942|NCT01577758|593709505|FG004|Dose Escalation Phase|Progression Disease|5|||
164363943|NCT01577758|593709506|FG005|Dose Escalation Phase|Progression Disease|0|||
164363944|NCT01577758|593709507|FG006|Dose Escalation Phase|Progression Disease|0|||
164363945|NCT01577758|593709508|FG007|Dose Escalation Phase|Progression Disease|0|||
164363946|NCT01577758|593709501|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
164363947|NCT01577758|593709502|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
164363948|NCT01577758|593709503|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
164363949|NCT01577758|593709504|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
164363950|NCT01577758|593709505|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
164363951|NCT01577758|593709506|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
164363952|NCT01577758|593709507|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
164363953|NCT01577758|593709508|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
164363954|NCT01577758|593709501|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
164363955|NCT01577758|593709502|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
164363956|NCT01577758|593709503|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
164363957|NCT01577758|593709504|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
164363958|NCT01577758|593709505|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
164363959|NCT01577758|593709506|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
164363960|NCT01577758|593709507|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
164363961|NCT01577758|593709508|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
164363962|NCT01577758|593709501|FG000|mCRC Expansion Phase|Progression Disease|0|||
164363963|NCT01577758|593709502|FG001|mCRC Expansion Phase|Progression Disease|0|||
164363964|NCT01577758|593709503|FG002|mCRC Expansion Phase|Progression Disease|0|||
164363965|NCT01577758|593709504|FG003|mCRC Expansion Phase|Progression Disease|0|||
164363966|NCT01577758|593709505|FG004|mCRC Expansion Phase|Progression Disease|0|||
164363967|NCT01577758|593709506|FG005|mCRC Expansion Phase|Progression Disease|0|||
164363968|NCT01577758|593709507|FG006|mCRC Expansion Phase|Progression Disease|0|||
164363969|NCT01577758|593709508|FG007|mCRC Expansion Phase|Progression Disease|19|||
164363970|NCT02410954|593709510|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
164363971|NCT02410954|593709511|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
164363972|NCT02410954|593709510|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
164438641|NCT02034916|593973014|FG001|Overall Study|Withdrawal by Subject|1|||
164438642|NCT02034916|593973013|FG000|Overall Study|Lost to Follow-up|4|||
164438643|NCT02034916|593973014|FG001|Overall Study|Lost to Follow-up|1|||
164699282|NCT02091141|594922639|FG002|Overall Study|Lost to Follow-up|1|||
164363973|NCT02410954|593709511|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
164363974|NCT00791518|593709513|FG000|Overall Study|Protocol Violation|93|||
164363975|NCT02488681|593709514|FG000|Overall Study|Implant unsuccessful|7|||
164363976|NCT00720057|593709515|FG000|Overall Study|Lost to Follow-up|0|||
164363977|NCT00720057|593709516|FG001|Overall Study|Lost to Follow-up|2|||
164363978|NCT00720057|593709515|FG000|Overall Study|Protocol Violation|1|||
164363979|NCT00720057|593709516|FG001|Overall Study|Protocol Violation|0|||
164363980|NCT00720057|593709515|FG000|Overall Study|Withdrawal by Subject|0|||
164363981|NCT00720057|593709516|FG001|Overall Study|Withdrawal by Subject|1|||
164363982|NCT04969224|593709521|FG000|Overall Study|Adverse Event|1|||
164438644|NCT02034916|593973013|FG000|Overall Study|Study terminated by sponsor|4|||
164438645|NCT02034916|593973014|FG001|Overall Study|Study terminated by sponsor|5|||
164363983|NCT04969224|593709521|FG000|Overall Study|Enrolled but never dosed|1|||
164363984|NCT04191382|593709525|FG000|Overall Study|Withdrawal by Subject|1|||
164363985|NCT04191382|593709526|FG001|Overall Study|Withdrawal by Subject|0|||
164363986|NCT04191382|593709527|FG002|Overall Study|Withdrawal by Subject|0|||
164363987|NCT03054870|593709533|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
164363988|NCT03054870|593709533|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
164363989|NCT02009046|593709534|FG000|Overall Study|Lost to Follow-up|256|||
164363990|NCT02009046|593709535|FG001|Overall Study|Lost to Follow-up|206|||
164363991|NCT00271609|593709543|FG000|Overall Study|Adverse Event|11|||
164363992|NCT00271609|593709544|FG001|Overall Study|Adverse Event|3|||
164363993|NCT00271609|593709543|FG000|Overall Study|Withdrawal by Subject|2|||
164363994|NCT00271609|593709544|FG001|Overall Study|Withdrawal by Subject|0|||
164363995|NCT03341533|593709545|FG000|Overall Study|Withdrawal by Subject|1|||
164363996|NCT03341533|593709546|FG001|Overall Study|Withdrawal by Subject|1|||
164363997|NCT03341533|593709545|FG000|Overall Study|Not eligible after randomization|2|||
164363998|NCT03341533|593709546|FG001|Overall Study|Not eligible after randomization|1|||
164363999|NCT00643682|593709547|FG000|Overall Study|did not keep appointment|522|||
164364000|NCT00643682|593709548|FG001|Overall Study|did not keep appointment|509|||
164364001|NCT00003641|593709555|FG000|Overall Study|Withdrawal by Subject|0|||
164364002|NCT00003641|593709556|FG001|Overall Study|Withdrawal by Subject|100|||
164364003|NCT00003641|593709555|FG000|Overall Study|Adverse Event|0|||
164364004|NCT00003641|593709556|FG001|Overall Study|Adverse Event|38|||
164364005|NCT00003641|593709555|FG000|Overall Study|Disease progression|0|||
164364006|NCT00003641|593709556|FG001|Overall Study|Disease progression|2|||
164364007|NCT00003641|593709555|FG000|Overall Study|Unknown/missing|0|||
164364008|NCT00003641|593709556|FG001|Overall Study|Unknown/missing|22|||
164364009|NCT00003641|593709555|FG000|Overall Study|Should not receive interferon therapy|2|||
164364010|NCT00003641|593709556|FG001|Overall Study|Should not receive interferon therapy|0|||
164364011|NCT00003641|593709555|FG000|Overall Study|Never started interferon|567|||
164364012|NCT00003641|593709556|FG001|Overall Study|Never started interferon|12|||
164364013|NCT01782664|593709557|FG000|Overall Study|Adverse Event|2|||
164364014|NCT01782664|593709558|FG001|Overall Study|Adverse Event|2|||
164364015|NCT01782664|593709559|FG002|Overall Study|Adverse Event|2|||
164364016|NCT01782664|593709560|FG003|Overall Study|Adverse Event|2|||
164364017|NCT01782664|593709561|FG004|Overall Study|Adverse Event|0|||
164364018|NCT01782664|593709562|FG005|Overall Study|Adverse Event|0|||
164364019|NCT01782664|593709557|FG000|Overall Study|Lack of Efficacy|2|||
164364020|NCT01782664|593709558|FG001|Overall Study|Lack of Efficacy|0|||
164364021|NCT01782664|593709559|FG002|Overall Study|Lack of Efficacy|2|||
164364022|NCT01782664|593709560|FG003|Overall Study|Lack of Efficacy|2|||
164364023|NCT01782664|593709561|FG004|Overall Study|Lack of Efficacy|0|||
164364024|NCT01782664|593709562|FG005|Overall Study|Lack of Efficacy|0|||
164364025|NCT01782664|593709557|FG000|Overall Study|Protocol Violation|0|||
164364026|NCT01782664|593709558|FG001|Overall Study|Protocol Violation|1|||
164364027|NCT01782664|593709559|FG002|Overall Study|Protocol Violation|0|||
164364028|NCT01782664|593709560|FG003|Overall Study|Protocol Violation|1|||
164364029|NCT01782664|593709561|FG004|Overall Study|Protocol Violation|0|||
164364030|NCT01782664|593709562|FG005|Overall Study|Protocol Violation|0|||
164364031|NCT01782664|593709557|FG000|Overall Study|Withdrawal by Subject|2|||
164364032|NCT01782664|593709558|FG001|Overall Study|Withdrawal by Subject|2|||
164364033|NCT01782664|593709559|FG002|Overall Study|Withdrawal by Subject|0|||
164699283|NCT02091141|594922640|FG003|Overall Study|Lost to Follow-up|0|||
164699284|NCT02091141|594922641|FG004|Overall Study|Lost to Follow-up|1|||
164699285|NCT02091141|594922642|FG005|Overall Study|Lost to Follow-up|2|||
164699286|NCT02091141|594922643|FG006|Overall Study|Lost to Follow-up|0|||
164699287|NCT02091141|594922637|FG000|Overall Study|Reason Not Specified|6|||
164699288|NCT02091141|594922638|FG001|Overall Study|Reason Not Specified|5|||
164699289|NCT02091141|594922639|FG002|Overall Study|Reason Not Specified|2|||
164699290|NCT02091141|594922640|FG003|Overall Study|Reason Not Specified|0|||
164699291|NCT02091141|594922641|FG004|Overall Study|Reason Not Specified|0|||
164699292|NCT02091141|594922642|FG005|Overall Study|Reason Not Specified|0|||
164699293|NCT02091141|594922643|FG006|Overall Study|Reason Not Specified|1|||
164364034|NCT01782664|593709560|FG003|Overall Study|Withdrawal by Subject|0|||
164364035|NCT01782664|593709561|FG004|Overall Study|Withdrawal by Subject|0|||
164364036|NCT01782664|593709562|FG005|Overall Study|Withdrawal by Subject|0|||
164364037|NCT04170348|593709563|FG000|Overall Study|Lost to Follow-up|2|||
164364038|NCT04170348|593709564|FG001|Overall Study|Lost to Follow-up|2|||
164364039|NCT04170348|593709563|FG000|Overall Study|Withdrawal by Subject|1|||
164364040|NCT04170348|593709564|FG001|Overall Study|Withdrawal by Subject|5|||
164364041|NCT04170348|593709563|FG000|Overall Study|Non-adherence|1|||
164364042|NCT04170348|593709564|FG001|Overall Study|Non-adherence|1|||
164364043|NCT04170348|593709563|FG000|Overall Study|Adverse Event|1|||
164364044|NCT04170348|593709564|FG001|Overall Study|Adverse Event|0|||
164364045|NCT01082965|593709566|FG000|Overall Study|Protocol Violation|0|||
164364046|NCT01082965|593709567|FG001|Overall Study|Protocol Violation|1|||
164699294|NCT02091141|594922637|FG000|Overall Study|Study Ended by Sponsor|1|||
164364047|NCT01082965|593709566|FG000|Overall Study|Other|1|||
164699295|NCT02091141|594922638|FG001|Overall Study|Study Ended by Sponsor|9|||
164699296|NCT02091141|594922639|FG002|Overall Study|Study Ended by Sponsor|0|||
164699297|NCT02091141|594922640|FG003|Overall Study|Study Ended by Sponsor|0|||
164699298|NCT02091141|594922641|FG004|Overall Study|Study Ended by Sponsor|0|||
164699299|NCT02091141|594922642|FG005|Overall Study|Study Ended by Sponsor|0|||
164699300|NCT02091141|594922643|FG006|Overall Study|Study Ended by Sponsor|0|||
164699301|NCT02091141|594922637|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
164699302|NCT02091141|594922638|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
164699303|NCT02091141|594922639|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
164699304|NCT02091141|594922640|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
164699305|NCT02091141|594922641|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
164364048|NCT01082965|593709567|FG001|Overall Study|Other|1|||
164364049|NCT03642717|593709568|FG000|Overall Study|Lost to Follow-up|2|||
164364050|NCT03642717|593709568|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
164364051|NCT03642717|593709568|FG000|Overall Study|Taken study drug prior to contract date|3|||
164364052|NCT02587065|593709569|FG000|Overall Study|Adverse Event|14|||
164364053|NCT02587065|593709569|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
164364054|NCT02587065|593709569|FG000|Overall Study|Non-adherence to the Protocol|3|||
164364055|NCT02587065|593709569|FG000|Overall Study|Discontinuation of Study Medication|2|||
164364056|NCT02587065|593709569|FG000|Overall Study|Reason not Specified|3|||
164364057|NCT01559012|593709570|FG000|Overall Study|Withdrawal by Subject|0|||
164364058|NCT01559012|593709571|FG001|Overall Study|Withdrawal by Subject|1|||
164364059|NCT00946712|593709572|FG000|Overall Study|Adverse Event|118|||
164364060|NCT00946712|593709573|FG001|Overall Study|Adverse Event|124|||
164364061|NCT00946712|593709572|FG000|Overall Study|Disease progression|308|||
164364062|NCT00946712|593709573|FG001|Overall Study|Disease progression|404|||
164364063|NCT00946712|593709572|FG000|Overall Study|Death|21|||
164364064|NCT00946712|593709573|FG001|Overall Study|Death|22|||
164364065|NCT00946712|593709572|FG000|Overall Study|No treatment given|25|||
164364066|NCT00946712|593709573|FG001|Overall Study|No treatment given|29|||
164364067|NCT00946712|593709572|FG000|Overall Study|Other reasons|61|||
164364068|NCT00946712|593709573|FG001|Overall Study|Other reasons|73|||
164364069|NCT00946712|593709572|FG000|Overall Study|On Treatment|0|||
164364070|NCT00946712|593709573|FG001|Overall Study|On Treatment|4|||
164364071|NCT00946712|593709572|FG000|Overall Study|Ineligible|14|||
164364072|NCT00946712|593709573|FG001|Overall Study|Ineligible|6|||
164364073|NCT00302458|593709576|FG000|Overall Study|Lost to Follow-up|1|||
164364074|NCT00302458|593709576|FG000|Overall Study|Ineligible after screening|1|||
164364075|NCT00302458|593709576|FG000|Overall Study|Withdrawal by Subject|1|||
164364076|NCT00853723|593709577|FG000|Overall Study|Adverse Event|3|||
164364077|NCT00853723|593709578|FG001|Overall Study|Adverse Event|4|||
164590969|NCT00879814|594527162|FG000|Overall Study|Physician Decision|0|||
164590970|NCT00879814|594527163|FG001|Overall Study|Physician Decision|0|||
164590971|NCT00879814|594527164|FG002|Overall Study|Physician Decision|1|||
164364078|NCT00853723|593709579|FG002|Overall Study|Adverse Event|1|||
164364079|NCT00853723|593709577|FG000|Overall Study|Withdrawal by Subject|2|||
164364080|NCT00853723|593709578|FG001|Overall Study|Withdrawal by Subject|1|||
164364081|NCT00853723|593709579|FG002|Overall Study|Withdrawal by Subject|0|||
164364082|NCT00853723|593709577|FG000|Overall Study|Protocol Violation|1|||
164364083|NCT00853723|593709578|FG001|Overall Study|Protocol Violation|2|||
164364084|NCT00853723|593709579|FG002|Overall Study|Protocol Violation|1|||
164364085|NCT04248933|593709580|FG000|Overall Study|Lost to Follow-up|9|||
164364086|NCT04248933|593709580|FG000|Overall Study|Withdrawal by Subject|2|||
164364087|NCT02642432|593709583|FG000|Overall Study|Adverse Event|2|||
164364088|NCT02642432|593709583|FG000|Overall Study|Withdrew Consent|1|||
164364089|NCT02642432|593709583|FG000|Overall Study|Lost to Follow-up|2|||
164590972|NCT00879814|594527165|FG003|Overall Study|Physician Decision|0|||
164590973|NCT00879814|594527162|FG000|Overall Study|Other|0|||
164364090|NCT02642432|593709583|FG000|Overall Study|Other|3|||
164590974|NCT00879814|594527163|FG001|Overall Study|Other|0|||
164590975|NCT00879814|594527164|FG002|Overall Study|Other|1|||
164590976|NCT00879814|594527165|FG003|Overall Study|Other|0|||
164364091|NCT02447081|593709584|FG000|Overall Study|Death|161|||
164364092|NCT02447081|593709584|FG000|Overall Study|Lost to Follow-up|36|||
164364093|NCT02447081|593709584|FG000|Overall Study|Visit not completed|17|||
164364094|NCT02447081|593709584|FG000|Overall Study|unsuccessful implant procedure|10|||
164590977|NCT03508622|594527166|FG000|Overall Study|Protocol Violation|1|||
164364095|NCT02867709|593709587|FG000|Treatment Period|Adverse Event|1|||
164364096|NCT02867709|593709588|FG001|Treatment Period|Adverse Event|1|||
164364097|NCT02867709|593709589|FG002|Treatment Period|Adverse Event|2|||
164364098|NCT02867709|593709587|FG000|Treatment Period|Withdrawal of Consent|7|||
164590978|NCT03508622|594527167|FG001|Overall Study|Protocol Violation|0|||
164590979|NCT03508622|594527166|FG000|Overall Study|Withdrawal by Subject|1|||
164364099|NCT02867709|593709588|FG001|Treatment Period|Withdrawal of Consent|9|||
164364100|NCT02867709|593709589|FG002|Treatment Period|Withdrawal of Consent|8|||
164364101|NCT02867709|593709587|FG000|Treatment Period|Lost to Follow-up|17|||
164590980|NCT03508622|594527167|FG001|Overall Study|Withdrawal by Subject|0|||
164590981|NCT03508622|594527166|FG000|Overall Study|Lost to Follow-up|16|||
164364102|NCT02867709|593709588|FG001|Treatment Period|Lost to Follow-up|20|||
164364103|NCT02867709|593709589|FG002|Treatment Period|Lost to Follow-up|20|||
164364104|NCT02867709|593709587|FG000|Treatment Period|Lack of Qualifying Event|42|||
164364105|NCT02867709|593709588|FG001|Treatment Period|Lack of Qualifying Event|55|||
164364106|NCT02867709|593709589|FG002|Treatment Period|Lack of Qualifying Event|42|||
164364107|NCT02867709|593709587|FG000|Treatment Period|Protocol Violation|3|||
164364108|NCT02867709|593709588|FG001|Treatment Period|Protocol Violation|2|||
164364109|NCT02867709|593709589|FG002|Treatment Period|Protocol Violation|3|||
164364110|NCT02867709|593709587|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
164364111|NCT02867709|593709588|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
164364112|NCT02867709|593709589|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
164364113|NCT02867709|593709587|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
164364114|NCT02867709|593709588|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
164364115|NCT02867709|593709589|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
164364116|NCT02867709|593709587|FG000|Safety Follow-up Period|Pregnancy|0|||
164364117|NCT02867709|593709588|FG001|Safety Follow-up Period|Pregnancy|1|||
164364118|NCT02867709|593709589|FG002|Safety Follow-up Period|Pregnancy|0|||
164364119|NCT02867709|593709587|FG000|Safety Follow-up Period|Protocol Violation|0|||
164364120|NCT02867709|593709588|FG001|Safety Follow-up Period|Protocol Violation|1|||
164364121|NCT02867709|593709589|FG002|Safety Follow-up Period|Protocol Violation|1|||
164364122|NCT03188094|593709592|FG000|Overall Study|Screen failure|1|||
164364123|NCT03188094|593709593|FG001|Overall Study|Screen failure|0|||
164364124|NCT03188094|593709594|FG002|Overall Study|Screen failure|0|||
164364125|NCT03188094|593709592|FG000|Overall Study|Pregnancy|3|||
164364126|NCT03188094|593709593|FG001|Overall Study|Pregnancy|0|||
164364127|NCT03188094|593709594|FG002|Overall Study|Pregnancy|0|||
164364128|NCT03188094|593709592|FG000|Overall Study|Ineligible|1|||
164364129|NCT03188094|593709593|FG001|Overall Study|Ineligible|0|||
164364130|NCT03188094|593709594|FG002|Overall Study|Ineligible|0|||
164364131|NCT03188094|593709592|FG000|Overall Study|Lost to Follow-up|0|||
164364132|NCT03188094|593709593|FG001|Overall Study|Lost to Follow-up|0|||
164364133|NCT03188094|593709594|FG002|Overall Study|Lost to Follow-up|17|||
164364134|NCT01894581|593709595|FG000|Overall Study|Withdrawal by Subject|2|||
164364135|NCT01894581|593709596|FG001|Overall Study|Withdrawal by Subject|3|||
164364136|NCT01894581|593709595|FG000|Overall Study|Screen Failure|3|||
164364137|NCT01894581|593709596|FG001|Overall Study|Screen Failure|4|||
164364138|NCT03313804|593709597|FG000|Treatment|Death|5|||
164364139|NCT03313804|593709597|FG000|Treatment|still on treatment|2|||
164364140|NCT03313804|593709597|FG000|Follow Up|still on follow up|3|||
164364141|NCT03795298|593709598|FG000|Overall Study|Death|34|||
164364142|NCT03795298|593709599|FG001|Overall Study|Death|29|||
164364143|NCT03795298|593709598|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
164364144|NCT03795298|593709599|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
164364145|NCT03795298|593709598|FG000|Overall Study|Lost to Follow-up|28|||
164364146|NCT03795298|593709599|FG001|Overall Study|Lost to Follow-up|17|||
164364147|NCT03795298|593709598|FG000|Overall Study|Physician Decision|5|||
164364148|NCT03795298|593709599|FG001|Overall Study|Physician Decision|4|||
164364149|NCT03795298|593709598|FG000|Overall Study|Withdrawal by Subject|43|||
164364150|NCT03795298|593709599|FG001|Overall Study|Withdrawal by Subject|28|||
164364151|NCT03795298|593709598|FG000|Overall Study|Reason not reported|7|||
164364152|NCT03795298|593709599|FG001|Overall Study|Reason not reported|9|||
164364153|NCT03971695|593711480|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
164364154|NCT03971695|593711481|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
164364155|NCT03971695|593711482|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
164364156|NCT03971695|593711483|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
164364157|NCT03971695|593711484|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
164364158|NCT03971695|593711485|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
164364159|NCT03971695|593711486|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
164364160|NCT03971695|593711487|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
164364161|NCT03971695|593711488|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
164364162|NCT03971695|593711489|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
164364163|NCT03971695|593711490|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
164364164|NCT03971695|593711491|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
164364165|NCT03971695|593711492|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
164364166|NCT00156533|593711493|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
164364167|NCT00156533|593711494|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
164364168|NCT00156533|593711495|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
164364169|NCT00156533|593711496|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
164364170|NCT00156533|593711493|FG000|Overall Study|Withdrawal by Subject|1|||
164364171|NCT00156533|593711494|FG001|Overall Study|Withdrawal by Subject|0|||
164364172|NCT00156533|593711495|FG002|Overall Study|Withdrawal by Subject|0|||
164364173|NCT00156533|593711496|FG003|Overall Study|Withdrawal by Subject|1|||
164364174|NCT00156533|593711493|FG000|Overall Study|Failed Screening|1|||
164364175|NCT00156533|593711494|FG001|Overall Study|Failed Screening|0|||
164364176|NCT00156533|593711495|FG002|Overall Study|Failed Screening|1|||
164364177|NCT00156533|593711496|FG003|Overall Study|Failed Screening|1|||
164364178|NCT01881230|593711497|FG000|Overall Study|Death|2|||
164364179|NCT01881230|593711498|FG001|Overall Study|Death|0|||
164364180|NCT01881230|593711499|FG002|Overall Study|Death|1|||
164364181|NCT01881230|593711497|FG000|Overall Study|Adverse Event|9|||
164364182|NCT01881230|593711498|FG001|Overall Study|Adverse Event|13|||
164364183|NCT01881230|593711499|FG002|Overall Study|Adverse Event|12|||
164364184|NCT01881230|593711497|FG000|Overall Study|Progressive Disease|31|||
164364185|NCT01881230|593711498|FG001|Overall Study|Progressive Disease|35|||
164364186|NCT01881230|593711499|FG002|Overall Study|Progressive Disease|36|||
164364187|NCT01881230|593711497|FG000|Overall Study|Symptomatic Deterioration|3|||
164364188|NCT01881230|593711498|FG001|Overall Study|Symptomatic Deterioration|3|||
164364189|NCT01881230|593711499|FG002|Overall Study|Symptomatic Deterioration|1|||
164364190|NCT01881230|593711497|FG000|Overall Study|Withdrawal by Subject|6|||
164364191|NCT01881230|593711498|FG001|Overall Study|Withdrawal by Subject|4|||
164364192|NCT01881230|593711499|FG002|Overall Study|Withdrawal by Subject|6|||
164364193|NCT01881230|593711497|FG000|Overall Study|Physician Decision|4|||
164364194|NCT01881230|593711498|FG001|Overall Study|Physician Decision|3|||
164364195|NCT01881230|593711499|FG002|Overall Study|Physician Decision|6|||
164364196|NCT01881230|593711497|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164364197|NCT01881230|593711498|FG001|Overall Study|Non-Compliance with Study Drug|2|||
164364198|NCT01881230|593711499|FG002|Overall Study|Non-Compliance with Study Drug|0|||
164364199|NCT01881230|593711497|FG000|Overall Study|Given Commercially Available Drug|0|||
164364200|NCT01881230|593711498|FG001|Overall Study|Given Commercially Available Drug|0|||
164364201|NCT01881230|593711499|FG002|Overall Study|Given Commercially Available Drug|2|||
164364202|NCT01881230|593711497|FG000|Overall Study|Protocol Violation|1|||
164364203|NCT01881230|593711498|FG001|Overall Study|Protocol Violation|1|||
164364204|NCT01881230|593711499|FG002|Overall Study|Protocol Violation|0|||
164364205|NCT01881230|593711497|FG000|Overall Study|Miscellaneous|3|||
164364206|NCT01881230|593711498|FG001|Overall Study|Miscellaneous|3|||
164364207|NCT01881230|593711499|FG002|Overall Study|Miscellaneous|0|||
164364208|NCT01881230|593711497|FG000|Overall Study|Untreated: Other|0|||
164364209|NCT01881230|593711498|FG001|Overall Study|Untreated: Other|0|||
164364210|NCT01881230|593711499|FG002|Overall Study|Untreated: Other|1|||
164364211|NCT01881230|593711497|FG000|Overall Study|Untreated: Death|0|||
164364212|NCT01881230|593711498|FG001|Overall Study|Untreated: Death|0|||
164364213|NCT01881230|593711499|FG002|Overall Study|Untreated: Death|1|||
164364214|NCT01881230|593711497|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
164364215|NCT01881230|593711498|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
164364216|NCT01881230|593711499|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
164364217|NCT05129488|593711500|FG000|Overall Study|Protocol Violation|3|||
164364218|NCT02515942|593711501|FG000|Overall Study|Adverse Event|5|||
164364219|NCT02515942|593711502|FG001|Overall Study|Adverse Event|0|||
164364220|NCT02515942|593711503|FG002|Overall Study|Adverse Event|0|||
164364221|NCT02515942|593711501|FG000|Overall Study|Death|0|||
164364222|NCT02515942|593711502|FG001|Overall Study|Death|0|||
164364223|NCT02515942|593711503|FG002|Overall Study|Death|1|||
164364224|NCT02515942|593711501|FG000|Overall Study|Lack of Efficacy|0|||
164364225|NCT02515942|593711502|FG001|Overall Study|Lack of Efficacy|0|||
164364226|NCT02515942|593711503|FG002|Overall Study|Lack of Efficacy|1|||
164364227|NCT02515942|593711501|FG000|Overall Study|Lost to Follow-up|2|||
164364228|NCT02515942|593711502|FG001|Overall Study|Lost to Follow-up|0|||
164364229|NCT02515942|593711503|FG002|Overall Study|Lost to Follow-up|0|||
164364230|NCT02515942|593711501|FG000|Overall Study|Withdrawal by Subject|0|||
164364231|NCT02515942|593711502|FG001|Overall Study|Withdrawal by Subject|3|||
164364232|NCT02515942|593711503|FG002|Overall Study|Withdrawal by Subject|2|||
164364233|NCT03616912|593711504|FG000|Overall Study|Adverse Event|17|||
164364234|NCT03616912|593711505|FG001|Overall Study|Adverse Event|21|||
164364235|NCT03616912|593711506|FG002|Overall Study|Adverse Event|9|||
164364236|NCT03616912|593711507|FG003|Overall Study|Adverse Event|0|||
164364237|NCT03616912|593711508|FG004|Overall Study|Adverse Event|0|||
164364238|NCT03616912|593711509|FG005|Overall Study|Adverse Event|0|||
164364239|NCT03616912|593711504|FG000|Overall Study|Death|1|||
164364240|NCT03616912|593711505|FG001|Overall Study|Death|1|||
164364241|NCT03616912|593711506|FG002|Overall Study|Death|0|||
164364242|NCT03616912|593711507|FG003|Overall Study|Death|0|||
164364243|NCT03616912|593711508|FG004|Overall Study|Death|0|||
164364244|NCT03616912|593711509|FG005|Overall Study|Death|0|||
164364245|NCT03616912|593711504|FG000|Overall Study|Lack of Efficacy|13|||
164364246|NCT03616912|593711505|FG001|Overall Study|Lack of Efficacy|6|||
164364247|NCT03616912|593711506|FG002|Overall Study|Lack of Efficacy|8|||
164364248|NCT03616912|593711507|FG003|Overall Study|Lack of Efficacy|4|||
164364249|NCT03616912|593711508|FG004|Overall Study|Lack of Efficacy|5|||
164364250|NCT03616912|593711509|FG005|Overall Study|Lack of Efficacy|1|||
164364251|NCT03616912|593711504|FG000|Overall Study|Lost to Follow-up|1|||
164364252|NCT03616912|593711505|FG001|Overall Study|Lost to Follow-up|2|||
164364253|NCT03616912|593711506|FG002|Overall Study|Lost to Follow-up|3|||
164364254|NCT03616912|593711507|FG003|Overall Study|Lost to Follow-up|0|||
164364255|NCT03616912|593711508|FG004|Overall Study|Lost to Follow-up|0|||
164364256|NCT03616912|593711509|FG005|Overall Study|Lost to Follow-up|0|||
164364257|NCT03616912|593711504|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
164364258|NCT03616912|593711505|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
164364259|NCT03616912|593711506|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
164364260|NCT03616912|593711507|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
164364261|NCT03616912|593711508|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
164364262|NCT03616912|593711509|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
164364263|NCT03616912|593711504|FG000|Overall Study|Withdrawal by Subject|12|||
164364264|NCT03616912|593711505|FG001|Overall Study|Withdrawal by Subject|12|||
164364265|NCT03616912|593711506|FG002|Overall Study|Withdrawal by Subject|15|||
164364266|NCT03616912|593711507|FG003|Overall Study|Withdrawal by Subject|2|||
164364267|NCT03616912|593711508|FG004|Overall Study|Withdrawal by Subject|0|||
164364268|NCT03616912|593711509|FG005|Overall Study|Withdrawal by Subject|2|||
164364269|NCT03616912|593711504|FG000|Overall Study|Study Terminated by Sponsor|0|||
164364270|NCT03616912|593711505|FG001|Overall Study|Study Terminated by Sponsor|0|||
164364271|NCT03616912|593711506|FG002|Overall Study|Study Terminated by Sponsor|0|||
164364272|NCT03616912|593711507|FG003|Overall Study|Study Terminated by Sponsor|10|||
164364273|NCT03616912|593711508|FG004|Overall Study|Study Terminated by Sponsor|9|||
164364274|NCT03616912|593711509|FG005|Overall Study|Study Terminated by Sponsor|11|||
164364275|NCT03616912|593711504|FG000|Overall Study|Protocol Deviation|1|||
164364276|NCT03616912|593711505|FG001|Overall Study|Protocol Deviation|1|||
164364277|NCT03616912|593711506|FG002|Overall Study|Protocol Deviation|0|||
164364278|NCT03616912|593711507|FG003|Overall Study|Protocol Deviation|0|||
164364279|NCT03616912|593711508|FG004|Overall Study|Protocol Deviation|0|||
164364280|NCT03616912|593711509|FG005|Overall Study|Protocol Deviation|0|||
164364281|NCT03616912|593711504|FG000|Overall Study|Pregnancy|1|||
164364282|NCT03616912|593711505|FG001|Overall Study|Pregnancy|0|||
164364283|NCT03616912|593711506|FG002|Overall Study|Pregnancy|4|||
164364284|NCT03616912|593711507|FG003|Overall Study|Pregnancy|0|||
164364285|NCT03616912|593711508|FG004|Overall Study|Pregnancy|0|||
164364286|NCT03616912|593711509|FG005|Overall Study|Pregnancy|0|||
164364287|NCT03616912|593711504|FG000|Overall Study|Protocol Violation|1|||
164364288|NCT03616912|593711505|FG001|Overall Study|Protocol Violation|0|||
164364289|NCT03616912|593711506|FG002|Overall Study|Protocol Violation|2|||
164364290|NCT03616912|593711507|FG003|Overall Study|Protocol Violation|0|||
164364291|NCT03616912|593711508|FG004|Overall Study|Protocol Violation|0|||
164364292|NCT03616912|593711509|FG005|Overall Study|Protocol Violation|0|||
164364293|NCT03616912|593711504|FG000|Overall Study|Physician Decision|2|||
164364294|NCT03616912|593711505|FG001|Overall Study|Physician Decision|0|||
164364295|NCT03616912|593711506|FG002|Overall Study|Physician Decision|0|||
164364296|NCT03616912|593711507|FG003|Overall Study|Physician Decision|0|||
164364297|NCT03616912|593711508|FG004|Overall Study|Physician Decision|1|||
164364298|NCT03616912|593711509|FG005|Overall Study|Physician Decision|0|||
164364299|NCT03616912|593711504|FG000|Overall Study|Randomized But Never Treated|0|||
164364300|NCT03616912|593711505|FG001|Overall Study|Randomized But Never Treated|2|||
164364301|NCT03616912|593711506|FG002|Overall Study|Randomized But Never Treated|0|||
164364302|NCT03616912|593711507|FG003|Overall Study|Randomized But Never Treated|0|||
164364303|NCT03616912|593711508|FG004|Overall Study|Randomized But Never Treated|0|||
164364304|NCT03616912|593711509|FG005|Overall Study|Randomized But Never Treated|0|||
164364305|NCT01723163|593711510|FG000|Treatment Phase|Withdrawal by Subject|14|||
164364306|NCT01723163|593711511|FG001|Treatment Phase|Withdrawal by Subject|6|||
164364307|NCT01723163|593711510|FG000|Treatment Phase|Withdrawal by PI|5|||
164364308|NCT01723163|593711511|FG001|Treatment Phase|Withdrawal by PI|1|||
164364309|NCT01723163|593711510|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
164364310|NCT01723163|593711511|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
164364311|NCT01723163|593711510|FG000|3-Month Follow-up|Unable to Contact|12|||
164364312|NCT01723163|593711511|FG001|3-Month Follow-up|Unable to Contact|19|||
164364313|NCT01723163|593711510|FG000|6-Month Follow-up|Death|1|||
164364314|NCT01723163|593711511|FG001|6-Month Follow-up|Death|0|||
164364315|NCT01723163|593711510|FG000|6-Month Follow-up|Unable to Contact|17|||
164364316|NCT01723163|593711511|FG001|6-Month Follow-up|Unable to Contact|15|||
164590982|NCT03508622|594527167|FG001|Overall Study|Lost to Follow-up|0|||
164364317|NCT01723163|593711510|FG000|12-Month Follow-up|Death|1|||
164364318|NCT01723163|593711511|FG001|12-Month Follow-up|Death|0|||
164590983|NCT03508622|594527166|FG000|Overall Study|Incomplete data|0|||
164590984|NCT03508622|594527167|FG001|Overall Study|Incomplete data|24|||
164364319|NCT01723163|593711510|FG000|12-Month Follow-up|Unable to Contact|23|||
164364320|NCT01723163|593711511|FG001|12-Month Follow-up|Unable to Contact|28|||
164364321|NCT01124604|593711512|FG000|Overall Study|Adverse Event|10|||
164364322|NCT01124604|593711513|FG001|Overall Study|Adverse Event|1|||
164364323|NCT01124604|593711512|FG000|Overall Study|Lack of Efficacy|1|||
164364324|NCT01124604|593711513|FG001|Overall Study|Lack of Efficacy|0|||
164364325|NCT01124604|593711512|FG000|Overall Study|Withdrawal by Subject|4|||
164364326|NCT01124604|593711513|FG001|Overall Study|Withdrawal by Subject|0|||
164364327|NCT01124604|593711512|FG000|Overall Study|Disease Progression|0|||
164364328|NCT01124604|593711513|FG001|Overall Study|Disease Progression|1|||
164364329|NCT01859507|593711514|FG000|Overall Study|left the country|4|||
164364330|NCT01762943|593711515|FG000|Overall Study|Physician Decision|1|||
164364331|NCT01762943|593711516|FG001|Overall Study|Physician Decision|1|||
164364332|NCT01762943|593711515|FG000|Overall Study|Protocol Violation|1|||
164364333|NCT01762943|593711516|FG001|Overall Study|Protocol Violation|0|||
164364334|NCT01762943|593711515|FG000|Overall Study|Withdrawal by Subject|2|||
164364335|NCT01762943|593711516|FG001|Overall Study|Withdrawal by Subject|1|||
164364336|NCT00539838|593711517|FG000|Overall Study|Fail to return|2|||
164364337|NCT00539838|593711518|FG001|Overall Study|Fail to return|0|||
164364338|NCT00539838|593711519|FG002|Overall Study|Fail to return|0|||
164364339|NCT00539838|593711517|FG000|Overall Study|Withdrawal by Subject|0|||
164364340|NCT00539838|593711518|FG001|Overall Study|Withdrawal by Subject|4|||
164364341|NCT00539838|593711519|FG002|Overall Study|Withdrawal by Subject|0|||
164364342|NCT00539838|593711517|FG000|Overall Study|Death|0|||
164364343|NCT00539838|593711518|FG001|Overall Study|Death|2|||
164364344|NCT00539838|593711519|FG002|Overall Study|Death|0|||
164364345|NCT00539838|593711517|FG000|Overall Study|Did not cooperate|1|||
164364346|NCT00539838|593711518|FG001|Overall Study|Did not cooperate|0|||
164364347|NCT00539838|593711519|FG002|Overall Study|Did not cooperate|1|||
164364348|NCT00539838|593711517|FG000|Overall Study|Administrative|4|||
164364349|NCT00539838|593711518|FG001|Overall Study|Administrative|0|||
164364350|NCT00539838|593711519|FG002|Overall Study|Administrative|8|||
164364351|NCT03090100|593711523|FG000|Overall Study|Adverse Event|9|||
164364352|NCT03090100|593711524|FG001|Overall Study|Adverse Event|11|||
164364353|NCT03090100|593711523|FG000|Overall Study|Pregnancy|1|||
164364354|NCT03090100|593711524|FG001|Overall Study|Pregnancy|1|||
164364355|NCT03090100|593711523|FG000|Overall Study|Lack of Efficacy|2|||
164364356|NCT03090100|593711524|FG001|Overall Study|Lack of Efficacy|7|||
164364357|NCT03090100|593711523|FG000|Overall Study|Lost to Follow-up|2|||
164364358|NCT03090100|593711524|FG001|Overall Study|Lost to Follow-up|2|||
164364359|NCT03090100|593711523|FG000|Overall Study|Withdrawal by Subject|7|||
164364360|NCT03090100|593711524|FG001|Overall Study|Withdrawal by Subject|19|||
164364361|NCT03090100|593711523|FG000|Overall Study|Protocol Violation|2|||
164364362|NCT03090100|593711524|FG001|Overall Study|Protocol Violation|6|||
164364363|NCT03090100|593711523|FG000|Overall Study|Non-compliance|2|||
164364364|NCT03090100|593711524|FG001|Overall Study|Non-compliance|0|||
164364365|NCT03090100|593711523|FG000|Overall Study|Other|2|||
164364366|NCT03090100|593711524|FG001|Overall Study|Other|2|||
164364367|NCT03446040|593711525|FG000|Overall Study|Disease progression|3|||
164364368|NCT03446040|593711526|FG001|Overall Study|Disease progression|3|||
164364369|NCT03446040|593711527|FG002|Overall Study|Disease progression|3|||
164364370|NCT03446040|593711528|FG003|Overall Study|Disease progression|4|||
164364371|NCT03446040|593711529|FG004|Overall Study|Disease progression|4|||
164364372|NCT03446040|593711530|FG005|Overall Study|Disease progression|6|||
164364373|NCT03446040|593711531|FG006|Overall Study|Disease progression|3|||
164364374|NCT03446040|593711532|FG007|Overall Study|Disease progression|4|||
164364375|NCT03446040|593711533|FG008|Overall Study|Disease progression|2|||
164364376|NCT03446040|593711534|FG009|Overall Study|Disease progression|4|||
164364377|NCT03446040|593711535|FG010|Overall Study|Disease progression|9|||
164364378|NCT03446040|593711536|FG011|Overall Study|Disease progression|3|||
164364379|NCT03446040|593711537|FG012|Overall Study|Disease progression|7|||
164364380|NCT03446040|593711538|FG013|Overall Study|Disease progression|7|||
164364381|NCT03446040|593711525|FG000|Overall Study|Study drug toxicity|0|||
164364382|NCT03446040|593711526|FG001|Overall Study|Study drug toxicity|0|||
164364383|NCT03446040|593711527|FG002|Overall Study|Study drug toxicity|0|||
164364384|NCT03446040|593711528|FG003|Overall Study|Study drug toxicity|0|||
164364385|NCT03446040|593711529|FG004|Overall Study|Study drug toxicity|0|||
164438646|NCT03959241|593973015|FG000|Overall Study|Withdrawal by Subject|7|||
164438647|NCT03959241|593973016|FG001|Overall Study|Withdrawal by Subject|8|||
164438648|NCT03959241|593973015|FG000|Overall Study|Lost to Follow-up|1|||
164438649|NCT03959241|593973016|FG001|Overall Study|Lost to Follow-up|0|||
164438650|NCT03959241|593973015|FG000|Overall Study|Move to Hospice Care|1|||
164438651|NCT03959241|593973016|FG001|Overall Study|Move to Hospice Care|0|||
164590985|NCT01005719|594527168|FG000|Period 1|Adverse Event|0|||
164364386|NCT03446040|593711530|FG005|Overall Study|Study drug toxicity|0|||
164364387|NCT03446040|593711531|FG006|Overall Study|Study drug toxicity|0|||
164364388|NCT03446040|593711532|FG007|Overall Study|Study drug toxicity|0|||
164364389|NCT03446040|593711533|FG008|Overall Study|Study drug toxicity|1|||
164364390|NCT03446040|593711534|FG009|Overall Study|Study drug toxicity|0|||
164364391|NCT03446040|593711535|FG010|Overall Study|Study drug toxicity|0|||
164364392|NCT03446040|593711536|FG011|Overall Study|Study drug toxicity|0|||
164364393|NCT03446040|593711537|FG012|Overall Study|Study drug toxicity|0|||
164364394|NCT03446040|593711538|FG013|Overall Study|Study drug toxicity|0|||
164364395|NCT03446040|593711525|FG000|Overall Study|Adverse Event|0|||
164699306|NCT02091141|594922642|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
164364396|NCT03446040|593711526|FG001|Overall Study|Adverse Event|0|||
164364397|NCT03446040|593711527|FG002|Overall Study|Adverse Event|0|||
164364398|NCT03446040|593711528|FG003|Overall Study|Adverse Event|0|||
164364399|NCT03446040|593711529|FG004|Overall Study|Adverse Event|0|||
164364400|NCT03446040|593711530|FG005|Overall Study|Adverse Event|2|||
164364401|NCT03446040|593711531|FG006|Overall Study|Adverse Event|0|||
164364402|NCT03446040|593711532|FG007|Overall Study|Adverse Event|0|||
164364403|NCT03446040|593711533|FG008|Overall Study|Adverse Event|1|||
164699307|NCT02091141|594922643|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
164699308|NCT02246439|594922644|FG000|Overall Study|Adverse Event|3|||
164699309|NCT02246439|594922645|FG001|Overall Study|Adverse Event|0|||
164699310|NCT02246439|594922644|FG000|Overall Study|Lost to Follow-up|7|||
164699311|NCT02246439|594922645|FG001|Overall Study|Lost to Follow-up|5|||
164699312|NCT02246439|594922644|FG000|Overall Study|Protocol Violation|0|||
164699313|NCT02246439|594922645|FG001|Overall Study|Protocol Violation|2|||
164699314|NCT02246439|594922644|FG000|Overall Study|Physician Decision|0|||
164699315|NCT02246439|594922645|FG001|Overall Study|Physician Decision|1|||
164699316|NCT02246439|594922644|FG000|Overall Study|Unkonwn|1|||
164699317|NCT02246439|594922645|FG001|Overall Study|Unkonwn|3|||
164699318|NCT02246439|594922644|FG000|Overall Study|Withdrawal by Subject|1|||
164699319|NCT02246439|594922645|FG001|Overall Study|Withdrawal by Subject|0|||
164699320|NCT03439852|594922646|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
164699321|NCT03439852|594922647|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
164699322|NCT03439852|594922646|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
164699323|NCT03439852|594922647|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
164699324|NCT03439852|594922646|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
164699325|NCT03439852|594922647|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
164699326|NCT04551911|594922650|FG000|Overall Study|Lost to Follow-up|2|||
164699327|NCT04551911|594922651|FG001|Overall Study|Lost to Follow-up|1|||
164699328|NCT04551911|594922650|FG000|Overall Study|Withdrawal by Subject|10|||
164699329|NCT04551911|594922651|FG001|Overall Study|Withdrawal by Subject|10|||
164699330|NCT04551911|594922650|FG000|Overall Study|Did not receive the study drug|3|||
164699331|NCT04551911|594922651|FG001|Overall Study|Did not receive the study drug|4|||
164699332|NCT02698865|594922656|FG000|Overall Study|Other|11|||
164699333|NCT02698865|594922657|FG001|Overall Study|Other|11|||
164699334|NCT02698865|594922656|FG000|Overall Study|Withdrawal by Subject|20|||
164699335|NCT02698865|594922657|FG001|Overall Study|Withdrawal by Subject|16|||
164699336|NCT02698865|594922656|FG000|Overall Study|Physician Decision|0|||
164699337|NCT02698865|594922657|FG001|Overall Study|Physician Decision|4|||
164699338|NCT02698865|594922656|FG000|Overall Study|Lost to Follow-up|4|||
164699339|NCT02698865|594922657|FG001|Overall Study|Lost to Follow-up|2|||
164699340|NCT01272921|594922658|FG000|Overall Study|Protocol Violation|2|||
164699341|NCT01272921|594922659|FG001|Overall Study|Protocol Violation|1|||
164699342|NCT01132664|594922660|FG000|Phase lb|Adverse Event|0|||
164699343|NCT01132664|594922661|FG001|Phase lb|Adverse Event|1|||
164699344|NCT01132664|594922662|FG002|Phase lb|Adverse Event|0|||
164699345|NCT01132664|594922663|FG003|Phase lb|Adverse Event|0|||
164699346|NCT01132664|594922664|FG004|Phase lb|Adverse Event|0|||
164699347|NCT01132664|594922660|FG000|Phase lb|Withdrawal by Subject|1|||
164699348|NCT01132664|594922661|FG001|Phase lb|Withdrawal by Subject|2|||
164699349|NCT01132664|594922662|FG002|Phase lb|Withdrawal by Subject|0|||
164699350|NCT01132664|594922663|FG003|Phase lb|Withdrawal by Subject|0|||
164699351|NCT01132664|594922664|FG004|Phase lb|Withdrawal by Subject|0|||
164699352|NCT01132664|594922660|FG000|Phase lb|Disease Progression|4|||
164699353|NCT01132664|594922661|FG001|Phase lb|Disease Progression|9|||
164699354|NCT01132664|594922662|FG002|Phase lb|Disease Progression|0|||
164699355|NCT01132664|594922663|FG003|Phase lb|Disease Progression|0|||
164699356|NCT01132664|594922664|FG004|Phase lb|Disease Progression|0|||
164699357|NCT01132664|594922660|FG000|Phase ll|Death|0|||
164699358|NCT01132664|594922661|FG001|Phase ll|Death|0|||
164699359|NCT01132664|594922662|FG002|Phase ll|Death|2|||
164699360|NCT01132664|594922663|FG003|Phase ll|Death|0|||
164699361|NCT01132664|594922664|FG004|Phase ll|Death|0|||
164699362|NCT01132664|594922660|FG000|Phase ll|Adverse Event|0|||
164699363|NCT01132664|594922661|FG001|Phase ll|Adverse Event|0|||
164699364|NCT01132664|594922662|FG002|Phase ll|Adverse Event|10|||
164699365|NCT01132664|594922663|FG003|Phase ll|Adverse Event|0|||
164699366|NCT01132664|594922664|FG004|Phase ll|Adverse Event|0|||
164699367|NCT01132664|594922660|FG000|Phase ll|Withdrawal by Subject|0|||
164699368|NCT01132664|594922661|FG001|Phase ll|Withdrawal by Subject|0|||
164699369|NCT01132664|594922662|FG002|Phase ll|Withdrawal by Subject|3|||
164699370|NCT01132664|594922663|FG003|Phase ll|Withdrawal by Subject|0|||
164364404|NCT03446040|593711534|FG009|Overall Study|Adverse Event|0|||
164364405|NCT03446040|593711535|FG010|Overall Study|Adverse Event|0|||
164699371|NCT01132664|594922664|FG004|Phase ll|Withdrawal by Subject|0|||
164699372|NCT01132664|594922660|FG000|Phase ll|Disease progression|0|||
164699373|NCT01132664|594922661|FG001|Phase ll|Disease progression|0|||
164699374|NCT01132664|594922662|FG002|Phase ll|Disease progression|35|||
164699375|NCT01132664|594922663|FG003|Phase ll|Disease progression|0|||
164699376|NCT01132664|594922664|FG004|Phase ll|Disease progression|0|||
164438652|NCT03959241|593973015|FG000|Overall Study|Screen Failure|1|||
164699377|NCT01132664|594922660|FG000|BM Cohort|Disease progression|0|||
164699378|NCT01132664|594922661|FG001|BM Cohort|Disease progression|0|||
164699379|NCT01132664|594922662|FG002|BM Cohort|Disease progression|0|||
164699380|NCT01132664|594922663|FG003|BM Cohort|Disease progression|3|||
164699381|NCT01132664|594922664|FG004|BM Cohort|Disease progression|4|||
164699382|NCT01132664|594922660|FG000|BM Cohort|Adverse Event|0|||
164699383|NCT01132664|594922661|FG001|BM Cohort|Adverse Event|0|||
164699384|NCT01132664|594922662|FG002|BM Cohort|Adverse Event|0|||
164699385|NCT01132664|594922663|FG003|BM Cohort|Adverse Event|0|||
164699386|NCT01132664|594922664|FG004|BM Cohort|Adverse Event|1|||
164699387|NCT01132664|594922660|FG000|BM Cohort|Withdrawal by Subject|0|||
164699388|NCT01132664|594922661|FG001|BM Cohort|Withdrawal by Subject|0|||
164699389|NCT01132664|594922662|FG002|BM Cohort|Withdrawal by Subject|0|||
164699390|NCT01132664|594922663|FG003|BM Cohort|Withdrawal by Subject|0|||
164699391|NCT01132664|594922664|FG004|BM Cohort|Withdrawal by Subject|1|||
164699392|NCT04271735|594922666|FG000|Overall Study|Physician Decision|2|||
164699393|NCT04271735|594922667|FG001|Overall Study|Physician Decision|0|||
164699394|NCT04268316|594922668|FG000|Overall Study|Withdrawal by Subject|2|||
164699395|NCT04268316|594922669|FG001|Overall Study|Withdrawal by Subject|1|||
164699396|NCT04268316|594922670|FG002|Overall Study|Withdrawal by Subject|0|||
164699397|NCT02040779|594922672|FG000|Overall Study|Adverse Event|1|||
164699398|NCT02040779|594922673|FG001|Overall Study|Adverse Event|0|||
164699399|NCT02040779|594922674|FG002|Overall Study|Adverse Event|0|||
164699400|NCT02040779|594922672|FG000|Overall Study|Withdrawal by Subject|4|||
164699401|NCT02040779|594922673|FG001|Overall Study|Withdrawal by Subject|1|||
164699402|NCT02040779|594922674|FG002|Overall Study|Withdrawal by Subject|3|||
164699403|NCT02040779|594922672|FG000|Overall Study|Non-compliance|0|||
164699404|NCT02040779|594922673|FG001|Overall Study|Non-compliance|1|||
164699405|NCT02040779|594922674|FG002|Overall Study|Non-compliance|0|||
164699406|NCT02040779|594922672|FG000|Overall Study|Protocol Violation|2|||
164699407|NCT02040779|594922673|FG001|Overall Study|Protocol Violation|1|||
164699408|NCT02040779|594922674|FG002|Overall Study|Protocol Violation|0|||
164699409|NCT02040779|594922672|FG000|Overall Study|Lost to Follow-up|1|||
164699410|NCT02040779|594922673|FG001|Overall Study|Lost to Follow-up|2|||
164699411|NCT02040779|594922674|FG002|Overall Study|Lost to Follow-up|1|||
164699412|NCT02040779|594922672|FG000|Overall Study|Lack of Efficacy|4|||
164699413|NCT02040779|594922673|FG001|Overall Study|Lack of Efficacy|2|||
164699414|NCT02040779|594922674|FG002|Overall Study|Lack of Efficacy|0|||
164699415|NCT02132637|594922675|FG000|Study Period 1|Withdrawal by Subject|0|||
164699416|NCT02132637|594922676|FG001|Study Period 1|Withdrawal by Subject|4|||
164699417|NCT02132637|594922675|FG000|Study Period 1|Physician Decision|1|||
164699418|NCT02132637|594922676|FG001|Study Period 1|Physician Decision|0|||
164699419|NCT02132637|594922675|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
164699420|NCT02132637|594922676|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
164699421|NCT02132637|594922675|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
164699422|NCT02132637|594922676|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
164699423|NCT00922272|594922679|FG000|Open-label Phase|Adverse Event|5|||
164699424|NCT00922272|594922680|FG001|Open-label Phase|Adverse Event|0|||
164699425|NCT00922272|594922679|FG000|Open-label Phase|Protocol Violation|1|||
164699426|NCT00922272|594922680|FG001|Open-label Phase|Protocol Violation|0|||
164699427|NCT00922272|594922679|FG000|Open-label Phase|Withdrawal by Subject|11|||
164699428|NCT00922272|594922680|FG001|Open-label Phase|Withdrawal by Subject|0|||
164699429|NCT00922272|594922679|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
164699430|NCT00922272|594922680|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
164699431|NCT00922272|594922679|FG000|Open-label Phase|Withdrawal criteria met|5|||
164699432|NCT00922272|594922680|FG001|Open-label Phase|Withdrawal criteria met|0|||
164699433|NCT00922272|594922679|FG000|Double-blind Phase|Adverse Event|1|||
164699434|NCT00922272|594922680|FG001|Double-blind Phase|Adverse Event|1|||
164699435|NCT00922272|594922679|FG000|Double-blind Phase|Withdrawal by Subject|1|||
164699436|NCT00922272|594922680|FG001|Double-blind Phase|Withdrawal by Subject|1|||
164699437|NCT00922272|594922679|FG000|Double-blind Phase|Lost to Follow-up|2|||
164699438|NCT00922272|594922680|FG001|Double-blind Phase|Lost to Follow-up|1|||
164699439|NCT00922272|594922679|FG000|Double-blind Phase|Withdrawal criteria met|1|||
164699440|NCT00922272|594922680|FG001|Double-blind Phase|Withdrawal criteria met|1|||
164699441|NCT00922272|594922679|FG000|Double-blind Phase|Noncompliance|1|||
164699442|NCT00922272|594922680|FG001|Double-blind Phase|Noncompliance|1|||
164699443|NCT00922272|594922679|FG000|Double-blind Phase|Positive urine drug screen|1|||
164699444|NCT00922272|594922680|FG001|Double-blind Phase|Positive urine drug screen|1|||
164699445|NCT03197558|594922681|FG000|Overall Study|Tubes not placed|1|||
164699446|NCT02581163|594922683|FG000|Overall Study|Failure to return|15|||
164699447|NCT02581163|594922683|FG000|Overall Study|Insufficient virological response|3|||
164699448|NCT02581163|594922683|FG000|Overall Study|Withdrew consent|1|||
164699449|NCT02581163|594922683|FG000|Overall Study|Death|1|||
164699450|NCT02581163|594922683|FG000|Overall Study|Other, not specified|9|||
164699451|NCT02384941|594922693|FG000|Overall Study|Adverse Event|11|||
164699452|NCT02384941|594922694|FG001|Overall Study|Adverse Event|13|||
164590986|NCT01005719|594527169|FG001|Period 1|Adverse Event|0|||
164590987|NCT01005719|594527170|FG002|Period 1|Adverse Event|0|||
164590988|NCT01005719|594527171|FG003|Period 1|Adverse Event|1|||
164590989|NCT01005719|594527172|FG004|Period 1|Adverse Event|0|||
164590990|NCT01005719|594527173|FG005|Period 1|Adverse Event|0|||
164590991|NCT01005719|594527168|FG000|Period 1|Delay in completing study procedures|0|||
164590992|NCT01005719|594527169|FG001|Period 1|Delay in completing study procedures|0|||
164590993|NCT01005719|594527170|FG002|Period 1|Delay in completing study procedures|0|||
164590994|NCT01005719|594527171|FG003|Period 1|Delay in completing study procedures|0|||
164590995|NCT01005719|594527172|FG004|Period 1|Delay in completing study procedures|0|||
164590996|NCT01005719|594527173|FG005|Period 1|Delay in completing study procedures|1|||
164590997|NCT01005719|594527168|FG000|Period 2|Adverse Event|0|||
164590998|NCT01005719|594527169|FG001|Period 2|Adverse Event|0|||
164590999|NCT01005719|594527170|FG002|Period 2|Adverse Event|0|||
164591000|NCT01005719|594527171|FG003|Period 2|Adverse Event|0|||
164591001|NCT01005719|594527172|FG004|Period 2|Adverse Event|1|||
164591002|NCT01005719|594527173|FG005|Period 2|Adverse Event|1|||
164591003|NCT01753076|594527174|FG000|Overall Study|Adverse Event|17|||
164591004|NCT01753076|594527175|FG001|Overall Study|Adverse Event|18|||
164591005|NCT01753076|594527174|FG000|Overall Study|Lack of Efficacy|3|||
164591006|NCT01753076|594527175|FG001|Overall Study|Lack of Efficacy|1|||
164591007|NCT01753076|594527174|FG000|Overall Study|Lost to Follow-up|2|||
164591008|NCT01753076|594527175|FG001|Overall Study|Lost to Follow-up|1|||
164591009|NCT01753076|594527174|FG000|Overall Study|Physician Decision|4|||
164591010|NCT01753076|594527175|FG001|Overall Study|Physician Decision|2|||
164591011|NCT01753076|594527174|FG000|Overall Study|Withdrawal by Subject|14|||
164591012|NCT01753076|594527175|FG001|Overall Study|Withdrawal by Subject|24|||
164591013|NCT01753076|594527174|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
164591014|NCT01753076|594527175|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
164591015|NCT02985450|594527181|FG000|Overall Study|Lost to Follow-up|7|||
164591016|NCT00069576|594527182|FG000|Original Trial|Lost to Follow-up|25|||
164591017|NCT00069576|594527183|FG001|Original Trial|Lost to Follow-up|33|||
164591018|NCT00069576|594527182|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
164591019|NCT00069576|594527183|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
164591020|NCT00905307|594527184|FG000|Overall Study|Switched to Open Label Rescue|7|||
164591021|NCT00905307|594527185|FG001|Overall Study|Switched to Open Label Rescue|17|||
164591022|NCT00905307|594527186|FG002|Overall Study|Switched to Open Label Rescue|11|||
164591023|NCT00905307|594527187|FG003|Overall Study|Switched to Open Label Rescue|11|||
164591024|NCT00905307|594527188|FG004|Overall Study|Switched to Open Label Rescue|4|||
164591025|NCT00905307|594527189|FG005|Overall Study|Switched to Open Label Rescue|15|||
164591026|NCT00905307|594527184|FG000|Overall Study|Lost to Follow-up|0|||
164591027|NCT00905307|594527185|FG001|Overall Study|Lost to Follow-up|0|||
164591028|NCT00905307|594527186|FG002|Overall Study|Lost to Follow-up|0|||
164591029|NCT00905307|594527187|FG003|Overall Study|Lost to Follow-up|0|||
164591030|NCT00905307|594527188|FG004|Overall Study|Lost to Follow-up|1|||
164591031|NCT00905307|594527189|FG005|Overall Study|Lost to Follow-up|1|||
164591032|NCT00905307|594527184|FG000|Overall Study|Adverse Event|3|||
164591033|NCT00905307|594527185|FG001|Overall Study|Adverse Event|4|||
164591034|NCT00905307|594527186|FG002|Overall Study|Adverse Event|5|||
164591035|NCT00905307|594527187|FG003|Overall Study|Adverse Event|11|||
164591036|NCT00905307|594527188|FG004|Overall Study|Adverse Event|3|||
164591037|NCT00905307|594527189|FG005|Overall Study|Adverse Event|5|||
164591038|NCT00905307|594527184|FG000|Overall Study|Withdrawal by Subject|5|||
164591039|NCT00905307|594527185|FG001|Overall Study|Withdrawal by Subject|13|||
164591040|NCT00905307|594527186|FG002|Overall Study|Withdrawal by Subject|15|||
164591041|NCT00905307|594527187|FG003|Overall Study|Withdrawal by Subject|11|||
164591042|NCT00905307|594527188|FG004|Overall Study|Withdrawal by Subject|4|||
164591043|NCT00905307|594527189|FG005|Overall Study|Withdrawal by Subject|13|||
164591044|NCT00905307|594527184|FG000|Overall Study|Protocol Violation|1|||
164591045|NCT00905307|594527185|FG001|Overall Study|Protocol Violation|0|||
164591046|NCT00905307|594527186|FG002|Overall Study|Protocol Violation|1|||
164591047|NCT00905307|594527187|FG003|Overall Study|Protocol Violation|0|||
164591048|NCT00905307|594527188|FG004|Overall Study|Protocol Violation|0|||
164591049|NCT00905307|594527189|FG005|Overall Study|Protocol Violation|0|||
164591050|NCT00905307|594527184|FG000|Overall Study|Lack of Efficacy|6|||
164591051|NCT00905307|594527185|FG001|Overall Study|Lack of Efficacy|3|||
164591052|NCT00905307|594527186|FG002|Overall Study|Lack of Efficacy|5|||
164591053|NCT00905307|594527187|FG003|Overall Study|Lack of Efficacy|4|||
164699453|NCT02384941|594922695|FG002|Overall Study|Adverse Event|17|||
164591054|NCT00905307|594527188|FG004|Overall Study|Lack of Efficacy|4|||
164591055|NCT00905307|594527189|FG005|Overall Study|Lack of Efficacy|8|||
164591056|NCT05590793|594527190|FG000|Overall Study|Withdrawal by Subject|6|||
164591057|NCT05590793|594527190|FG000|Overall Study|Physician Decision|1|||
164591058|NCT04060667|594527191|FG000|Overall Study|Lost to Follow-up|75|||
164591059|NCT04060667|594527192|FG001|Overall Study|Lost to Follow-up|10|||
164591060|NCT03015610|594527193|FG000|Overall Study|Lost to Follow-up|1|||
164591061|NCT03015610|594527194|FG001|Overall Study|Lost to Follow-up|5|||
164591062|NCT01603641|594527195|FG000|Overall Study|Did not Receive Treatment|3|||
164438653|NCT03959241|593973016|FG001|Overall Study|Screen Failure|0|||
164699454|NCT02384941|594922693|FG000|Overall Study|Lost to Follow-up|3|||
164699455|NCT02384941|594922694|FG001|Overall Study|Lost to Follow-up|2|||
164699456|NCT02384941|594922695|FG002|Overall Study|Lost to Follow-up|1|||
164699457|NCT02384941|594922693|FG000|Overall Study|Non-Compliance With Study Drug|2|||
164699458|NCT02384941|594922694|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164699459|NCT02384941|594922695|FG002|Overall Study|Non-Compliance With Study Drug|1|||
164699460|NCT02384941|594922693|FG000|Overall Study|Physician Decision|1|||
164699461|NCT02384941|594922694|FG001|Overall Study|Physician Decision|1|||
164699462|NCT02384941|594922695|FG002|Overall Study|Physician Decision|0|||
164699463|NCT02384941|594922693|FG000|Overall Study|Protocol Violation|3|||
164699464|NCT02384941|594922694|FG001|Overall Study|Protocol Violation|0|||
164699465|NCT02384941|594922695|FG002|Overall Study|Protocol Violation|0|||
164699466|NCT02384941|594922693|FG000|Overall Study|Withdrawal by Subject|26|||
164699467|NCT02384941|594922694|FG001|Overall Study|Withdrawal by Subject|19|||
164699468|NCT02384941|594922695|FG002|Overall Study|Withdrawal by Subject|20|||
164699469|NCT02384941|594922693|FG000|Overall Study|Pregnancy|0|||
164699470|NCT02384941|594922694|FG001|Overall Study|Pregnancy|0|||
164699471|NCT02384941|594922695|FG002|Overall Study|Pregnancy|1|||
164699472|NCT02384941|594922693|FG000|Overall Study|Other than specified above|4|||
164699473|NCT02384941|594922694|FG001|Overall Study|Other than specified above|0|||
164699474|NCT02384941|594922695|FG002|Overall Study|Other than specified above|1|||
164699475|NCT02493777|594922696|FG000|Overall Study|Lost to Follow-up|0|||
164699476|NCT02493777|594922697|FG001|Overall Study|Lost to Follow-up|1|||
164699477|NCT00468728|594922698|FG000|Treatment|criteria for mITT population|4|||
164699478|NCT00468728|594922699|FG001|Treatment|criteria for mITT population|11|||
164699479|NCT00468728|594922698|FG000|Follow-up|mITT failure|34|||
164699480|NCT00468728|594922699|FG001|Follow-up|mITT failure|31|||
164699481|NCT01705236|594922700|FG000|Overall Study|Lost to Follow-up|1|||
164699482|NCT01705236|594922700|FG000|Overall Study|Administrative problems|2|||
164699483|NCT01705236|594922700|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
164699484|NCT01705236|594922700|FG000|Overall Study|Protocol Violation|3|||
164699485|NCT01705236|594922700|FG000|Overall Study|Abnormal test procedure result(s)|4|||
164699486|NCT01705236|594922700|FG000|Overall Study|Abnormal laboratory value(s)|4|||
164699487|NCT01705236|594922700|FG000|Overall Study|Withdrawal by Subject|5|||
164699488|NCT01705236|594922700|FG000|Overall Study|Adverse Event|5|||
164699489|NCT06005597|594922701|FG000|Overall Study|Lost to Follow-up|1|||
164699490|NCT06005597|594922702|FG001|Overall Study|Lost to Follow-up|2|||
164699491|NCT06005597|594922703|FG002|Overall Study|Lost to Follow-up|1|||
164699492|NCT06005597|594922704|FG003|Overall Study|Lost to Follow-up|2|||
164699493|NCT06005597|594922701|FG000|Overall Study|Death|1|||
164699494|NCT06005597|594922702|FG001|Overall Study|Death|1|||
164699495|NCT06005597|594922703|FG002|Overall Study|Death|1|||
164699496|NCT06005597|594922704|FG003|Overall Study|Death|0|||
164699497|NCT02224573|594922705|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
164699498|NCT02224573|594922706|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
164699499|NCT02224573|594922705|FG000|Treatment Phase|Started on Other IMP|1|||
164699500|NCT02224573|594922706|FG001|Treatment Phase|Started on Other IMP|0|||
164699501|NCT02224573|594922705|FG000|Treatment Phase|Participant Discontinued IMP|0|||
164699502|NCT02224573|594922706|FG001|Treatment Phase|Participant Discontinued IMP|1|||
164699503|NCT02224573|594922705|FG000|Treatment Phase|Lack of Efficacy|15|||
164699504|NCT02224573|594922706|FG001|Treatment Phase|Lack of Efficacy|8|||
164699505|NCT02224573|594922705|FG000|Treatment Phase|Began Commercial Product|1|||
164699506|NCT02224573|594922706|FG001|Treatment Phase|Began Commercial Product|0|||
164699507|NCT02224573|594922705|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
164699508|NCT02224573|594922706|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
164699509|NCT02224573|594922705|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
164699510|NCT02224573|594922706|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
164699511|NCT02224573|594922705|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
164699512|NCT02224573|594922706|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
164699513|NCT02224573|594922705|FG000|Treatment Phase|Continued Compassionate Use|1|||
164699514|NCT02224573|594922706|FG001|Treatment Phase|Continued Compassionate Use|0|||
164699515|NCT02224573|594922705|FG000|Treatment Phase|Lack of Efficiency|2|||
164699516|NCT02224573|594922706|FG001|Treatment Phase|Lack of Efficiency|1|||
164699517|NCT02224573|594922705|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
164699518|NCT02224573|594922706|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
164699519|NCT02224573|594922705|FG000|Treatment Phase|Participant Moved|2|||
164699520|NCT02224573|594922706|FG001|Treatment Phase|Participant Moved|0|||
164699521|NCT02224573|594922705|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
164699522|NCT02224573|594922706|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
164699523|NCT02224573|594922705|FG000|Treatment Phase|Refused Medication|1|||
164699524|NCT02224573|594922706|FG001|Treatment Phase|Refused Medication|1|||
164699525|NCT02224573|594922705|FG000|Treatment Phase|Adverse Event|26|||
164699526|NCT02224573|594922706|FG001|Treatment Phase|Adverse Event|38|||
164699527|NCT02224573|594922705|FG000|Treatment Phase|Placed in Group Home|0|||
164591063|NCT01603641|594527195|FG000|Overall Study|Adverse Event|1|||
164591064|NCT01603641|594527195|FG000|Overall Study|Lack of Efficacy|1|||
164591065|NCT01603641|594527195|FG000|Overall Study|Lost to Follow-up|6|||
164591066|NCT01603641|594527195|FG000|Overall Study|Personal Reasons|18|||
164591067|NCT01603641|594527195|FG000|Overall Study|Other Miscellaneous Reasons|6|||
164591068|NCT00114972|594527196|FG000|Overall Study|Withdrawal by Subject|40|||
164591069|NCT00114972|594527197|FG001|Overall Study|Withdrawal by Subject|7|||
164699528|NCT02224573|594922706|FG001|Treatment Phase|Placed in Group Home|1|||
164699529|NCT02224573|594922705|FG000|Treatment Phase|Pursued Other Trials|1|||
164699530|NCT02224573|594922706|FG001|Treatment Phase|Pursued Other Trials|0|||
164699531|NCT02224573|594922705|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
164699532|NCT02224573|594922706|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
164699533|NCT02224573|594922705|FG000|Treatment Phase|Lost to Follow-up|2|||
164699534|NCT02224573|594922706|FG001|Treatment Phase|Lost to Follow-up|1|||
164699535|NCT02224573|594922705|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
164699536|NCT02224573|594922706|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
164699537|NCT02224573|594922705|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
164699538|NCT02224573|594922706|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
164699539|NCT02224573|594922705|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
164699540|NCT02224573|594922706|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
164699541|NCT02224573|594922705|FG000|Taper Phase|Adverse Event|1|||
164699542|NCT02224573|594922706|FG001|Taper Phase|Adverse Event|1|||
164699543|NCT02546362|594922707|FG000|4-week Treatment Period|Lost to Follow-up|1|||
164699544|NCT02546362|594922707|FG000|4-week Treatment Period|Change in medication|2|||
164699545|NCT02546362|594922707|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
164699546|NCT02546362|594922707|FG000|12-week Treatment Period|Lost to Follow-up|2|||
164699547|NCT02546362|594922707|FG000|12-week Treatment Period|Change in medication|1|||
164699548|NCT02025010|594922708|FG000|Overall Study|Symptomatic or radiographic progression|36|||
164699549|NCT02025010|594922708|FG000|Overall Study|Adverse Event|6|||
164699550|NCT02025010|594922708|FG000|Overall Study|Physician Decision|7|||
164699551|NCT02025010|594922708|FG000|Overall Study|Withdrawal by Subject|3|||
164699552|NCT02025010|594922708|FG000|Overall Study|Intercurrent illness|3|||
164699553|NCT02025010|594922708|FG000|Overall Study|Patients still on treatment|3|||
164699554|NCT02025010|594922708|FG000|Overall Study|Never initiate the treatment|2|||
164699555|NCT01763918|594922716|FG000|Overall Study|Withdrawal by Subject|2|||
164699556|NCT01763918|594922717|FG001|Overall Study|Withdrawal by Subject|1|||
164699557|NCT01763918|594922718|FG002|Overall Study|Withdrawal by Subject|1|||
164699558|NCT01763918|594922719|FG003|Overall Study|Withdrawal by Subject|2|||
164699559|NCT01763918|594922716|FG000|Overall Study|Sponsor Decision|4|||
164699560|NCT01763918|594922717|FG001|Overall Study|Sponsor Decision|0|||
164699561|NCT01763918|594922718|FG002|Overall Study|Sponsor Decision|9|||
164699562|NCT01763918|594922719|FG003|Overall Study|Sponsor Decision|0|||
164699563|NCT01553747|594922720|FG000|Overall Study|Protocol Violation|0|||
164699564|NCT01553747|594922721|FG001|Overall Study|Protocol Violation|2|||
164699565|NCT01553747|594922722|FG002|Overall Study|Protocol Violation|0|||
164699566|NCT01553747|594922720|FG000|Overall Study|Voluntarily withdrew|70|||
164699567|NCT01553747|594922721|FG001|Overall Study|Voluntarily withdrew|66|||
164699568|NCT01553747|594922722|FG002|Overall Study|Voluntarily withdrew|74|||
164699569|NCT01553747|594922720|FG000|Overall Study|Adverse event or SAE|32|||
164699570|NCT01553747|594922721|FG001|Overall Study|Adverse event or SAE|28|||
164699571|NCT01553747|594922722|FG002|Overall Study|Adverse event or SAE|19|||
164699572|NCT01553747|594922720|FG000|Overall Study|Physician decision: other|10|||
164699573|NCT01553747|594922721|FG001|Overall Study|Physician decision: other|8|||
164699574|NCT01553747|594922722|FG002|Overall Study|Physician decision: other|7|||
164699575|NCT01553747|594922720|FG000|Overall Study|Lost to Follow-up|11|||
164699576|NCT01553747|594922721|FG001|Overall Study|Lost to Follow-up|5|||
164699577|NCT01553747|594922722|FG002|Overall Study|Lost to Follow-up|6|||
164699578|NCT01553747|594922720|FG000|Overall Study|Sponsor decision, specify|7|||
164699579|NCT01553747|594922721|FG001|Overall Study|Sponsor decision, specify|5|||
164699580|NCT01553747|594922722|FG002|Overall Study|Sponsor decision, specify|0|||
164699581|NCT01553747|594922720|FG000|Overall Study|Physician decision: lack of efficacy|1|||
164699582|NCT01553747|594922721|FG001|Overall Study|Physician decision: lack of efficacy|5|||
164699583|NCT01553747|594922722|FG002|Overall Study|Physician decision: lack of efficacy|3|||
164699584|NCT00102687|594922723|FG000|Initial Period|Withdrawal by Subject|6|||
164699585|NCT00102687|594922724|FG001|Initial Period|Withdrawal by Subject|3|||
164699586|NCT00102687|594922725|FG002|Initial Period|Withdrawal by Subject|5|||
164699587|NCT00102687|594922726|FG003|Initial Period|Withdrawal by Subject|0|||
164699588|NCT00102687|594922727|FG004|Initial Period|Withdrawal by Subject|0|||
164699589|NCT00102687|594922723|FG000|Initial Period|Adverse Event|4|||
164699590|NCT00102687|594922724|FG001|Initial Period|Adverse Event|7|||
164699591|NCT00102687|594922725|FG002|Initial Period|Adverse Event|9|||
164699592|NCT00102687|594922726|FG003|Initial Period|Adverse Event|0|||
164699593|NCT00102687|594922727|FG004|Initial Period|Adverse Event|0|||
164699594|NCT00102687|594922723|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
164699595|NCT00102687|594922724|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
164699596|NCT00102687|594922725|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
164699597|NCT00102687|594922726|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
164699598|NCT00102687|594922727|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
164699599|NCT00102687|594922723|FG000|Initial Period|Protocol Violation|0|||
164699600|NCT00102687|594922724|FG001|Initial Period|Protocol Violation|0|||
164699601|NCT00102687|594922725|FG002|Initial Period|Protocol Violation|2|||
164699602|NCT00102687|594922726|FG003|Initial Period|Protocol Violation|0|||
164699603|NCT00102687|594922727|FG004|Initial Period|Protocol Violation|0|||
164699604|NCT00102687|594922723|FG000|Initial Period|Physician Decision|2|||
164699605|NCT00102687|594922724|FG001|Initial Period|Physician Decision|9|||
164699606|NCT00102687|594922725|FG002|Initial Period|Physician Decision|6|||
164699607|NCT00102687|594922726|FG003|Initial Period|Physician Decision|0|||
164699608|NCT00102687|594922727|FG004|Initial Period|Physician Decision|0|||
164699609|NCT00102687|594922723|FG000|Initial Period|Sponsor's decision|0|||
164699610|NCT00102687|594922724|FG001|Initial Period|Sponsor's decision|1|||
164699611|NCT00102687|594922725|FG002|Initial Period|Sponsor's decision|1|||
164699612|NCT00102687|594922726|FG003|Initial Period|Sponsor's decision|0|||
164699613|NCT00102687|594922727|FG004|Initial Period|Sponsor's decision|0|||
164699614|NCT00102687|594922723|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
164699615|NCT00102687|594922724|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
164699616|NCT00102687|594922725|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
164699617|NCT00102687|594922726|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
164699618|NCT00102687|594922727|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
164699619|NCT00102687|594922723|FG000|Initial Period|Death|1|||
164699620|NCT00102687|594922724|FG001|Initial Period|Death|1|||
164699621|NCT00102687|594922725|FG002|Initial Period|Death|1|||
164699622|NCT00102687|594922726|FG003|Initial Period|Death|0|||
164699623|NCT00102687|594922727|FG004|Initial Period|Death|0|||
164699624|NCT00102687|594922723|FG000|Maintenance Period|Withdrawal by Subject|4|||
164699625|NCT00102687|594922724|FG001|Maintenance Period|Withdrawal by Subject|0|||
164699626|NCT00102687|594922725|FG002|Maintenance Period|Withdrawal by Subject|2|||
164699627|NCT00102687|594922726|FG003|Maintenance Period|Withdrawal by Subject|3|||
164699628|NCT00102687|594922727|FG004|Maintenance Period|Withdrawal by Subject|1|||
164699629|NCT00102687|594922723|FG000|Maintenance Period|Adverse Event|1|||
164699630|NCT00102687|594922724|FG001|Maintenance Period|Adverse Event|0|||
164699631|NCT00102687|594922725|FG002|Maintenance Period|Adverse Event|0|||
164699632|NCT00102687|594922726|FG003|Maintenance Period|Adverse Event|1|||
164699633|NCT00102687|594922727|FG004|Maintenance Period|Adverse Event|3|||
164699634|NCT00102687|594922723|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
164699635|NCT00102687|594922724|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
164699636|NCT00102687|594922725|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
164699637|NCT00102687|594922726|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
164699638|NCT00102687|594922727|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
164699639|NCT00102687|594922723|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
164699640|NCT00102687|594922724|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
164699641|NCT00102687|594922725|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
164699642|NCT00102687|594922726|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
164699643|NCT00102687|594922727|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
164699644|NCT00102687|594922723|FG000|Maintenance Period|Death|0|||
164699645|NCT00102687|594922724|FG001|Maintenance Period|Death|0|||
164699646|NCT00102687|594922725|FG002|Maintenance Period|Death|0|||
164699647|NCT00102687|594922726|FG003|Maintenance Period|Death|1|||
164699648|NCT00102687|594922727|FG004|Maintenance Period|Death|1|||
164699649|NCT00102687|594922723|FG000|Maintenance Period|Physician Decision|1|||
164699650|NCT00102687|594922724|FG001|Maintenance Period|Physician Decision|2|||
164699651|NCT00102687|594922725|FG002|Maintenance Period|Physician Decision|3|||
164699652|NCT00102687|594922726|FG003|Maintenance Period|Physician Decision|0|||
164699653|NCT00102687|594922727|FG004|Maintenance Period|Physician Decision|4|||
164699654|NCT05444543|594922734|FG000|Overall Study|Withdrawal by Subject|1|||
164699655|NCT05444543|594922735|FG001|Overall Study|Withdrawal by Subject|0|||
164699656|NCT05444543|594922734|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
164699657|NCT05444543|594922735|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
164699658|NCT05444543|594922734|FG000|Overall Study|Adverse Event|0|||
164699659|NCT05444543|594922735|FG001|Overall Study|Adverse Event|1|||
164699660|NCT05444543|594922734|FG000|Overall Study|Family relocating at a distance from study site|0|||
164699661|NCT05444543|594922735|FG001|Overall Study|Family relocating at a distance from study site|1|||
164699662|NCT01134627|594922738|FG000|Overall Study|Adverse Event|47|||
164699663|NCT01134627|594922739|FG001|Overall Study|Adverse Event|31|||
164699664|NCT01134627|594922738|FG000|Overall Study|Lost to Follow-up|1|||
164699665|NCT01134627|594922739|FG001|Overall Study|Lost to Follow-up|2|||
164699666|NCT01134627|594922738|FG000|Overall Study|Protocol Violation|3|||
164699667|NCT01134627|594922739|FG001|Overall Study|Protocol Violation|5|||
164699668|NCT01134627|594922738|FG000|Overall Study|Lack of Efficacy|2|||
164699669|NCT01134627|594922739|FG001|Overall Study|Lack of Efficacy|12|||
164699670|NCT01134627|594922738|FG000|Overall Study|Withdrawal by Subject|4|||
164699671|NCT01134627|594922739|FG001|Overall Study|Withdrawal by Subject|3|||
164699672|NCT01134627|594922738|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
164699673|NCT01134627|594922739|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
164699674|NCT01134627|594922738|FG000|Overall Study|Other|11|||
164699675|NCT01134627|594922739|FG001|Overall Study|Other|14|||
164699676|NCT00977431|594922740|FG000|Overall Study|Other than listed|1|||
164699677|NCT00977431|594922741|FG001|Overall Study|Other than listed|0|||
164699678|NCT00977431|594922742|FG002|Overall Study|Other than listed|0|||
164699679|NCT00977431|594922743|FG003|Overall Study|Other than listed|0|||
164699680|NCT00977431|594922744|FG004|Overall Study|Other than listed|2|||
164699681|NCT00977431|594922740|FG000|Overall Study|Protocol Violation|0|||
164699682|NCT00977431|594922741|FG001|Overall Study|Protocol Violation|0|||
164699683|NCT00977431|594922742|FG002|Overall Study|Protocol Violation|1|||
164699684|NCT00977431|594922743|FG003|Overall Study|Protocol Violation|0|||
164699685|NCT00977431|594922744|FG004|Overall Study|Protocol Violation|0|||
164699686|NCT00977431|594922740|FG000|Overall Study|Adverse Event|3|||
164699687|NCT00977431|594922741|FG001|Overall Study|Adverse Event|0|||
164699688|NCT00977431|594922742|FG002|Overall Study|Adverse Event|4|||
164699689|NCT00977431|594922743|FG003|Overall Study|Adverse Event|0|||
164699690|NCT00977431|594922744|FG004|Overall Study|Adverse Event|6|||
164699691|NCT00977431|594922740|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
164699692|NCT00977431|594922741|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
164699693|NCT00977431|594922742|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
164699694|NCT00977431|594922743|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
164699695|NCT00977431|594922744|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
164699696|NCT00977431|594922740|FG000|Overall Study|Progressive disease|2|||
164699697|NCT00977431|594922741|FG001|Overall Study|Progressive disease|6|||
164699698|NCT00977431|594922742|FG002|Overall Study|Progressive disease|1|||
164699699|NCT00977431|594922743|FG003|Overall Study|Progressive disease|3|||
164699700|NCT00977431|594922744|FG004|Overall Study|Progressive disease|5|||
164699701|NCT00597116|594922745|FG000|Overall Study|Adverse Event|2|||
164699702|NCT00597116|594922746|FG001|Overall Study|Adverse Event|1|||
164699703|NCT00597116|594922745|FG000|Overall Study|Withdrawal by Subject|0|||
164699704|NCT00597116|594922746|FG001|Overall Study|Withdrawal by Subject|2|||
164699705|NCT00597116|594922745|FG000|Overall Study|Physician Decision|0|||
164699706|NCT00597116|594922746|FG001|Overall Study|Physician Decision|1|||
164699707|NCT00597116|594922745|FG000|Overall Study|Death|0|||
164699708|NCT00597116|594922746|FG001|Overall Study|Death|1|||
164699709|NCT00597116|594922745|FG000|Overall Study|Lost to Follow-up|1|||
164699710|NCT00597116|594922746|FG001|Overall Study|Lost to Follow-up|0|||
164699711|NCT00597116|594922745|FG000|Overall Study|Progressive disease|11|||
164699712|NCT00597116|594922746|FG001|Overall Study|Progressive disease|6|||
164699713|NCT01470612|594922753|FG000|Overall Study|Adverse Event|20|||
164699714|NCT01470612|594922754|FG001|Overall Study|Adverse Event|80|||
164699715|NCT01470612|594922753|FG000|Overall Study|Death|0|||
164699716|NCT01470612|594922754|FG001|Overall Study|Death|1|||
164699717|NCT01470612|594922753|FG000|Overall Study|Lack of Efficacy|20|||
164699718|NCT01470612|594922754|FG001|Overall Study|Lack of Efficacy|326|||
164699719|NCT01470612|594922753|FG000|Overall Study|Lost to Follow-up|2|||
164699720|NCT01470612|594922754|FG001|Overall Study|Lost to Follow-up|5|||
164699721|NCT01470612|594922753|FG000|Overall Study|Did not meet entrance criteria|0|||
164699722|NCT01470612|594922754|FG001|Overall Study|Did not meet entrance criteria|1|||
164699723|NCT01470612|594922753|FG000|Overall Study|Pregnancy|2|||
164699724|NCT01470612|594922754|FG001|Overall Study|Pregnancy|10|||
164699725|NCT01470612|594922753|FG000|Overall Study|Protocol Violation|2|||
164699726|NCT01470612|594922754|FG001|Overall Study|Protocol Violation|7|||
164699727|NCT01470612|594922753|FG000|Overall Study|Withdrawal by Subject|24|||
164699728|NCT01470612|594922754|FG001|Overall Study|Withdrawal by Subject|79|||
164699729|NCT01470612|594922753|FG000|Overall Study|Other|14|||
164699730|NCT01470612|594922754|FG001|Overall Study|Other|156|||
164699731|NCT00123955|594922757|FG000|Overall Study|Adverse Event|1|||
164699732|NCT00123955|594922758|FG001|Overall Study|Adverse Event|0|||
164699733|NCT00123955|594922757|FG000|Overall Study|Withdrawal by Subject|4|||
164699734|NCT00123955|594922758|FG001|Overall Study|Withdrawal by Subject|3|||
164699735|NCT00123955|594922757|FG000|Overall Study|Death|0|||
164699736|NCT00123955|594922758|FG001|Overall Study|Death|1|||
164699737|NCT04459715|594922761|FG000|Overall Study|Adverse Event|3|||
164699738|NCT04459715|594922762|FG001|Overall Study|Adverse Event|3|||
164699739|NCT04459715|594922761|FG000|Overall Study|Death|111|||
164699740|NCT04459715|594922762|FG001|Overall Study|Death|93|||
164699741|NCT04459715|594922761|FG000|Overall Study|Lost to Follow-up|10|||
164699742|NCT04459715|594922762|FG001|Overall Study|Lost to Follow-up|9|||
164699743|NCT04459715|594922761|FG000|Overall Study|Other Reasons|4|||
164699744|NCT04459715|594922762|FG001|Overall Study|Other Reasons|5|||
164699745|NCT04459715|594922761|FG000|Overall Study|PROTOCOL DEVIATION|0|||
164699746|NCT04459715|594922762|FG001|Overall Study|PROTOCOL DEVIATION|1|||
164699747|NCT04459715|594922761|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
164699748|NCT04459715|594922762|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
164699749|NCT04459715|594922761|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
164699750|NCT04459715|594922762|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
164699751|NCT04459715|594922761|FG000|Overall Study|Withdrawal by Subject|22|||
164699752|NCT04459715|594922762|FG001|Overall Study|Withdrawal by Subject|22|||
164699753|NCT02427984|594922763|FG000|Overall Study|Lost to Follow-up|13|||
164699754|NCT02427984|594922764|FG001|Overall Study|Lost to Follow-up|5|||
164699755|NCT02427984|594922765|FG002|Overall Study|Lost to Follow-up|18|||
164699756|NCT02054130|594924750|FG000|Overall Study|Withdrawal by Subject|4|||
164699757|NCT02054130|594924751|FG001|Overall Study|Withdrawal by Subject|4|||
164438654|NCT03959241|593973015|FG000|Overall Study|Disease Relapse|0|||
164699758|NCT02054130|594924752|FG002|Overall Study|Withdrawal by Subject|7|||
164699759|NCT02054130|594924753|FG003|Overall Study|Withdrawal by Subject|10|||
164699760|NCT02054130|594924750|FG000|Overall Study|Death|0|||
164699761|NCT02054130|594924751|FG001|Overall Study|Death|1|||
164699762|NCT02054130|594924752|FG002|Overall Study|Death|0|||
164699763|NCT02054130|594924753|FG003|Overall Study|Death|0|||
164699764|NCT02054130|594924750|FG000|Overall Study|Lost to Follow-up|0|||
164699765|NCT02054130|594924751|FG001|Overall Study|Lost to Follow-up|0|||
164699766|NCT02054130|594924752|FG002|Overall Study|Lost to Follow-up|1|||
164699767|NCT02054130|594924753|FG003|Overall Study|Lost to Follow-up|2|||
164699768|NCT02054130|594924750|FG000|Overall Study|Missed dose|4|||
164699769|NCT02054130|594924751|FG001|Overall Study|Missed dose|6|||
164699770|NCT02054130|594924752|FG002|Overall Study|Missed dose|7|||
164699771|NCT02054130|594924753|FG003|Overall Study|Missed dose|10|||
164699772|NCT00866658|594924766|FG000|Overall Study|Adverse Event|5|||
164699773|NCT00866658|594924767|FG001|Overall Study|Adverse Event|14|||
164699774|NCT00866658|594924766|FG000|Overall Study|Lack of Efficacy|2|||
164699775|NCT00866658|594924767|FG001|Overall Study|Lack of Efficacy|1|||
164699776|NCT00866658|594924766|FG000|Overall Study|Withdrawal by Subject|1|||
164699777|NCT00866658|594924767|FG001|Overall Study|Withdrawal by Subject|0|||
164699778|NCT00866658|594924766|FG000|Overall Study|Protocol Violation|1|||
164699779|NCT00866658|594924767|FG001|Overall Study|Protocol Violation|1|||
164699780|NCT00866658|594924766|FG000|Overall Study|Familial and Personal Reasons|4|||
164699781|NCT00866658|594924767|FG001|Overall Study|Familial and Personal Reasons|5|||
164699782|NCT01304693|594924776|FG000|Overall Study|Adverse Event|0|||
164699783|NCT01304693|594924777|FG001|Overall Study|Adverse Event|0|||
164699784|NCT01304693|594924778|FG002|Overall Study|Adverse Event|0|||
164699785|NCT01304693|594924779|FG003|Overall Study|Adverse Event|0|||
164699786|NCT01304693|594924780|FG004|Overall Study|Adverse Event|1|||
164699787|NCT01304693|594924776|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
164699788|NCT01304693|594924777|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
164699789|NCT01304693|594924778|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
164699790|NCT01304693|594924779|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
164699791|NCT01304693|594924780|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
164699792|NCT00931268|594924781|FG000|Overall Study|Lost to Follow-up|6|||
164699793|NCT02072148|594924783|FG000|Overall Study|withdrew prior to surgery|23|||
164699794|NCT02072148|594924784|FG001|Overall Study|withdrew prior to surgery|0|||
164699795|NCT02072148|594924785|FG002|Overall Study|withdrew prior to surgery|0|||
164699796|NCT02072148|594924783|FG000|Overall Study|Death|0|||
164699797|NCT02072148|594924784|FG001|Overall Study|Death|0|||
164699798|NCT02072148|594924785|FG002|Overall Study|Death|1|||
164699799|NCT02072148|594924783|FG000|Overall Study|Withdrawal by Subject|0|||
164699800|NCT02072148|594924784|FG001|Overall Study|Withdrawal by Subject|13|||
164699801|NCT02072148|594924785|FG002|Overall Study|Withdrawal by Subject|12|||
164699802|NCT00430495|594924786|FG000|Overall Study|Adverse Event|2|||
164699803|NCT00430495|594924787|FG001|Overall Study|Adverse Event|3|||
164699804|NCT00430495|594924788|FG002|Overall Study|Adverse Event|2|||
164699805|NCT00430495|594924789|FG003|Overall Study|Adverse Event|0|||
164699806|NCT00430495|594924786|FG000|Overall Study|Death|0|||
164699807|NCT00430495|594924787|FG001|Overall Study|Death|0|||
164699808|NCT00430495|594924788|FG002|Overall Study|Death|1|||
164699809|NCT00430495|594924789|FG003|Overall Study|Death|0|||
164699810|NCT00430495|594924786|FG000|Overall Study|Lost to Follow-up|0|||
164699811|NCT00430495|594924787|FG001|Overall Study|Lost to Follow-up|1|||
164699812|NCT00430495|594924788|FG002|Overall Study|Lost to Follow-up|4|||
164699813|NCT00430495|594924789|FG003|Overall Study|Lost to Follow-up|0|||
164699814|NCT00430495|594924786|FG000|Overall Study|Protocol Violation|1|||
164699815|NCT00430495|594924787|FG001|Overall Study|Protocol Violation|0|||
164699816|NCT00430495|594924788|FG002|Overall Study|Protocol Violation|1|||
164699817|NCT00430495|594924789|FG003|Overall Study|Protocol Violation|0|||
164699818|NCT00430495|594924786|FG000|Overall Study|Disease Progression|1|||
164699819|NCT00430495|594924787|FG001|Overall Study|Disease Progression|1|||
164699820|NCT00430495|594924788|FG002|Overall Study|Disease Progression|0|||
164699821|NCT00430495|594924789|FG003|Overall Study|Disease Progression|0|||
164699822|NCT00430495|594924786|FG000|Overall Study|Other|8|||
164699823|NCT00430495|594924787|FG001|Overall Study|Other|2|||
164699824|NCT00430495|594924788|FG002|Overall Study|Other|5|||
164438655|NCT03959241|593973016|FG001|Overall Study|Disease Relapse|1|||
164699825|NCT00430495|594924789|FG003|Overall Study|Other|4|||
164699826|NCT00430495|594924786|FG000|Overall Study|Randomized but not Treated|2|||
164699827|NCT00430495|594924787|FG001|Overall Study|Randomized but not Treated|0|||
164699828|NCT00430495|594924788|FG002|Overall Study|Randomized but not Treated|0|||
164699829|NCT00430495|594924789|FG003|Overall Study|Randomized but not Treated|0|||
164699830|NCT04132336|594924790|FG000|Overall Study|Investigator Decision|0|||
164699831|NCT04132336|594924791|FG001|Overall Study|Investigator Decision|1|||
164699832|NCT04132336|594924792|FG002|Overall Study|Investigator Decision|0|||
164699833|NCT04132336|594924793|FG003|Overall Study|Investigator Decision|0|||
164699834|NCT04132336|594924794|FG004|Overall Study|Investigator Decision|0|||
164591070|NCT00114972|594527196|FG000|Overall Study|Lost to Follow-up|8|||
164591071|NCT00114972|594527197|FG001|Overall Study|Lost to Follow-up|5|||
164591072|NCT02086565|594527201|FG000|Overall Study|Lost to Follow-up|9|||
164591073|NCT02086565|594527202|FG001|Overall Study|Lost to Follow-up|7|||
164591074|NCT02086565|594527201|FG000|Overall Study|Withdrawal by Subject|2|||
164591075|NCT02086565|594527202|FG001|Overall Study|Withdrawal by Subject|1|||
164591076|NCT02086565|594527201|FG000|Overall Study|Death|3|||
164591077|NCT02086565|594527202|FG001|Overall Study|Death|2|||
164591078|NCT02086565|594527201|FG000|Overall Study|withdrawn by research team|2|||
164591079|NCT02086565|594527202|FG001|Overall Study|withdrawn by research team|2|||
164591080|NCT00739297|594527203|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
164591081|NCT00739297|594527204|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
164591082|NCT00739297|594527205|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
164591083|NCT00739297|594527206|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
164591084|NCT00739297|594527207|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
164591085|NCT00739297|594527208|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
164591086|NCT00739297|594527209|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
164591087|NCT00739297|594527203|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
164591088|NCT00739297|594527204|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
164699835|NCT04132336|594924795|FG005|Overall Study|Investigator Decision|0|||
164699836|NCT04132336|594924796|FG006|Overall Study|Investigator Decision|0|||
164699837|NCT02488330|594924797|FG000|Overall Study|Adverse Event|1|||
164699838|NCT02488330|594924797|FG000|Overall Study|Physician Decision|2|||
164699839|NCT02488330|594924797|FG000|Overall Study|Death|2|||
164699840|NCT02488330|594924797|FG000|Overall Study|Disease Progression|3|||
164699841|NCT02488330|594924797|FG000|Overall Study|Study Termination by Sponsor|4|||
164699842|NCT01621191|594924799|FG000|Overall Study|Adverse Event|9|||
164699843|NCT01621191|594924799|FG000|Overall Study|Withdrawal by Subject|8|||
164699844|NCT01621191|594924799|FG000|Overall Study|Lack of Efficacy|6|||
164699845|NCT01621191|594924799|FG000|Overall Study|Lost to Follow-up|1|||
164699846|NCT01621191|594924799|FG000|Overall Study|Site Removed From Study|1|||
164699847|NCT04355663|594924801|FG000|Overall Study|Physician Decision|2|||
164699848|NCT04355663|594924802|FG001|Overall Study|Physician Decision|7|||
164699849|NCT04355663|594924803|FG002|Overall Study|Physician Decision|0|||
164699850|NCT04355663|594924801|FG000|Overall Study|Adverse Event|0|||
164699851|NCT04355663|594924802|FG001|Overall Study|Adverse Event|0|||
164699852|NCT04355663|594924803|FG002|Overall Study|Adverse Event|1|||
164699853|NCT04355663|594924801|FG000|Overall Study|Withdrawal by Subject|0|||
164699854|NCT04355663|594924802|FG001|Overall Study|Withdrawal by Subject|8|||
164699855|NCT04355663|594924803|FG002|Overall Study|Withdrawal by Subject|3|||
164699856|NCT01782482|594924809|FG000|Overall Study|Adverse Event|2|||
164699857|NCT01782482|594924810|FG001|Overall Study|Adverse Event|1|||
164699858|NCT01782482|594924809|FG000|Overall Study|Lost to Follow-up|2|||
164699859|NCT01782482|594924810|FG001|Overall Study|Lost to Follow-up|3|||
164699860|NCT01782482|594924809|FG000|Overall Study|Physician Decision|1|||
164699861|NCT01782482|594924810|FG001|Overall Study|Physician Decision|0|||
164699862|NCT01782482|594924809|FG000|Overall Study|Protocol Violation|1|||
164699863|NCT01782482|594924810|FG001|Overall Study|Protocol Violation|0|||
164699864|NCT01782482|594924809|FG000|Overall Study|Withdrawal by Subject|2|||
164699865|NCT01782482|594924810|FG001|Overall Study|Withdrawal by Subject|3|||
164699866|NCT01782482|594924809|FG000|Overall Study|Randomized in Error|2|||
164699867|NCT01782482|594924810|FG001|Overall Study|Randomized in Error|2|||
164699868|NCT01782482|594924809|FG000|Overall Study|Habitually wearing toric lens OS|0|||
164699869|NCT01782482|594924810|FG001|Overall Study|Habitually wearing toric lens OS|1|||
164699870|NCT02408120|594924811|FG000|Overall Study|Withdrawal by Subject|0|||
164699871|NCT02408120|594924812|FG001|Overall Study|Withdrawal by Subject|1|||
164699872|NCT02408120|594924811|FG000|Overall Study|Treatment Refusal|1|||
164699873|NCT02408120|594924812|FG001|Overall Study|Treatment Refusal|0|||
164699874|NCT02408120|594924811|FG000|Overall Study|Received Steroids|1|||
164699875|NCT02408120|594924812|FG001|Overall Study|Received Steroids|1|||
164699876|NCT02408120|594924811|FG000|Overall Study|Discharged same day|1|||
164699877|NCT02408120|594924812|FG001|Overall Study|Discharged same day|1|||
164699878|NCT02408120|594924811|FG000|Overall Study|Did not receive insulin|1|||
164699879|NCT02408120|594924812|FG001|Overall Study|Did not receive insulin|2|||
164699880|NCT01010750|594924813|FG000|Second Intervention|Adverse Event|0|||
164699881|NCT01010750|594924814|FG001|Second Intervention|Adverse Event|1|||
164699882|NCT01010750|594924815|FG002|Second Intervention|Adverse Event|0|||
164699883|NCT01010750|594924816|FG003|Second Intervention|Adverse Event|0|||
164438656|NCT03959241|593973015|FG000|Overall Study|Off Study|1|||
164591089|NCT00739297|594527205|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
164591090|NCT00739297|594527206|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
164699884|NCT01010750|594924817|FG004|Second Intervention|Adverse Event|0|||
164699885|NCT01010750|594924818|FG005|Second Intervention|Adverse Event|0|||
164699886|NCT00466726|594924819|FG000|Overall Study|Not evaluable for response|14|||
164699887|NCT02096588|594924820|FG000|Overall Study|Lack of Efficacy|2|||
164699888|NCT02096588|594924821|FG001|Overall Study|Lack of Efficacy|0|||
164591091|NCT00739297|594527207|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
164591092|NCT00739297|594527208|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
164591093|NCT00739297|594527209|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
164591094|NCT01400971|594527210|FG000|Overall Study|Death|82|||
164591095|NCT01400971|594527210|FG000|Overall Study|Lost to Follow-up|196|||
164591096|NCT01400971|594527210|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
164364406|NCT03446040|593711536|FG011|Overall Study|Adverse Event|0|||
164591097|NCT01400971|594527210|FG000|Overall Study|Physician Decision|57|||
164591098|NCT01400971|594527210|FG000|Overall Study|Withdrawal by Subject|158|||
164591099|NCT01400971|594527210|FG000|Overall Study|Other|422|||
164591100|NCT01757704|594527211|FG000|Overall Study|Protocol Violation|1|||
164591101|NCT01757704|594527212|FG001|Overall Study|Protocol Violation|3|||
164591102|NCT01035255|594527217|FG000|Overall Study|Death|724|||
164591103|NCT01035255|594527218|FG001|Overall Study|Death|844|||
164591104|NCT01035255|594527217|FG000|Overall Study|Lost to Follow-up|2|||
164438657|NCT03959241|593973016|FG001|Overall Study|Off Study|0|||
164438658|NCT00545844|593973017|FG000|Overall Study|Lost to Follow-up|9|||
164364407|NCT03446040|593711537|FG012|Overall Study|Adverse Event|0|||
164364408|NCT03446040|593711538|FG013|Overall Study|Adverse Event|0|||
164364409|NCT03446040|593711525|FG000|Overall Study|Death|0|||
164364410|NCT03446040|593711526|FG001|Overall Study|Death|0|||
164364411|NCT03446040|593711527|FG002|Overall Study|Death|0|||
164364412|NCT03446040|593711528|FG003|Overall Study|Death|0|||
164364413|NCT03446040|593711529|FG004|Overall Study|Death|0|||
164364414|NCT03446040|593711530|FG005|Overall Study|Death|0|||
164364415|NCT03446040|593711531|FG006|Overall Study|Death|0|||
164364416|NCT03446040|593711532|FG007|Overall Study|Death|0|||
164364417|NCT03446040|593711533|FG008|Overall Study|Death|0|||
164364418|NCT03446040|593711534|FG009|Overall Study|Death|0|||
164364419|NCT03446040|593711535|FG010|Overall Study|Death|1|||
164364420|NCT03446040|593711536|FG011|Overall Study|Death|0|||
164364421|NCT03446040|593711537|FG012|Overall Study|Death|0|||
164364422|NCT03446040|593711538|FG013|Overall Study|Death|2|||
164364423|NCT03446040|593711525|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
164364424|NCT03446040|593711526|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
164438659|NCT00545844|593973017|FG000|Overall Study|Protocol Violation|1|||
164438660|NCT00545844|593973017|FG000|Overall Study|Withdrawal by Subject|2|||
164438661|NCT01329328|593973018|FG000|Overall Study|Withdrawal by Subject|2|||
164364425|NCT03446040|593711527|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
164364426|NCT03446040|593711528|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
164364427|NCT03446040|593711529|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
164364428|NCT03446040|593711530|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
164364429|NCT03446040|593711531|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
164364430|NCT03446040|593711532|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
164364431|NCT03446040|593711533|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
164364432|NCT03446040|593711534|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
164364433|NCT03446040|593711535|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
164364434|NCT03446040|593711536|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
164364435|NCT03446040|593711537|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
164364436|NCT03446040|593711538|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
164364437|NCT03446040|593711525|FG000|Overall Study|Participant withdrew consent|0|||
164364438|NCT03446040|593711526|FG001|Overall Study|Participant withdrew consent|0|||
164364439|NCT03446040|593711527|FG002|Overall Study|Participant withdrew consent|0|||
164364440|NCT03446040|593711528|FG003|Overall Study|Participant withdrew consent|0|||
164364441|NCT03446040|593711529|FG004|Overall Study|Participant withdrew consent|0|||
164364442|NCT03446040|593711530|FG005|Overall Study|Participant withdrew consent|1|||
164364443|NCT03446040|593711531|FG006|Overall Study|Participant withdrew consent|0|||
164364444|NCT03446040|593711532|FG007|Overall Study|Participant withdrew consent|1|||
164364445|NCT03446040|593711533|FG008|Overall Study|Participant withdrew consent|0|||
164364446|NCT03446040|593711534|FG009|Overall Study|Participant withdrew consent|0|||
164364447|NCT03446040|593711535|FG010|Overall Study|Participant withdrew consent|0|||
164364448|NCT03446040|593711536|FG011|Overall Study|Participant withdrew consent|0|||
164364449|NCT03446040|593711537|FG012|Overall Study|Participant withdrew consent|0|||
164364450|NCT03446040|593711538|FG013|Overall Study|Participant withdrew consent|0|||
164364451|NCT03446040|593711525|FG000|Overall Study|Not reported|0|||
164364452|NCT03446040|593711526|FG001|Overall Study|Not reported|0|||
164364453|NCT03446040|593711527|FG002|Overall Study|Not reported|1|||
164364454|NCT03446040|593711528|FG003|Overall Study|Not reported|0|||
164364455|NCT03446040|593711529|FG004|Overall Study|Not reported|0|||
164364456|NCT03446040|593711530|FG005|Overall Study|Not reported|0|||
164364457|NCT03446040|593711531|FG006|Overall Study|Not reported|0|||
164364458|NCT03446040|593711532|FG007|Overall Study|Not reported|0|||
164364459|NCT03446040|593711533|FG008|Overall Study|Not reported|0|||
164364460|NCT03446040|593711534|FG009|Overall Study|Not reported|0|||
164364461|NCT03446040|593711535|FG010|Overall Study|Not reported|0|||
164364462|NCT03446040|593711536|FG011|Overall Study|Not reported|0|||
164364463|NCT03446040|593711537|FG012|Overall Study|Not reported|0|||
164364464|NCT03446040|593711538|FG013|Overall Study|Not reported|0|||
164364465|NCT00456521|593711539|FG000|Overall Study|Adverse Event|150|||
164364466|NCT00456521|593711540|FG001|Overall Study|Adverse Event|25|||
164364467|NCT00456521|593711539|FG000|Overall Study|Withdrawal by Subject|43|||
164364468|NCT00456521|593711540|FG001|Overall Study|Withdrawal by Subject|24|||
164364469|NCT00456521|593711539|FG000|Overall Study|Lost to Follow-up|22|||
164364470|NCT00456521|593711540|FG001|Overall Study|Lost to Follow-up|17|||
164364471|NCT00456521|593711539|FG000|Overall Study|Lack of Efficacy|3|||
164364472|NCT00456521|593711540|FG001|Overall Study|Lack of Efficacy|6|||
164364473|NCT00456521|593711539|FG000|Overall Study|Protocol Violation|4|||
164364474|NCT00456521|593711540|FG001|Overall Study|Protocol Violation|0|||
164364475|NCT00456521|593711539|FG000|Overall Study|Pregnancy|1|||
164364476|NCT00456521|593711540|FG001|Overall Study|Pregnancy|1|||
164364477|NCT00456521|593711539|FG000|Overall Study|Drug non-compliance, moved, other|26|||
164364478|NCT00456521|593711540|FG001|Overall Study|Drug non-compliance, moved, other|11|||
164364479|NCT02596854|593711541|FG000|Overall Study|Withdrawn|8|||
164364480|NCT00464568|593711544|FG000|Overall Study|Adverse Event|2|||
164364481|NCT00405587|593711545|FG000|Overall Study|Death|0|||
164364482|NCT00405587|593711546|FG001|Overall Study|Death|0|||
164364483|NCT00405587|593711547|FG002|Overall Study|Death|0|||
164364484|NCT00405587|593711548|FG003|Overall Study|Death|1|||
164364485|NCT00405587|593711545|FG000|Overall Study|Disease Progression|22|||
164364486|NCT00405587|593711546|FG001|Overall Study|Disease Progression|23|||
164364487|NCT00405587|593711547|FG002|Overall Study|Disease Progression|21|||
164364488|NCT00405587|593711548|FG003|Overall Study|Disease Progression|17|||
164364489|NCT00405587|593711545|FG000|Overall Study|Physician Decision|3|||
164364490|NCT00405587|593711546|FG001|Overall Study|Physician Decision|2|||
164364491|NCT00405587|593711547|FG002|Overall Study|Physician Decision|0|||
164364492|NCT00405587|593711548|FG003|Overall Study|Physician Decision|0|||
164591105|NCT01035255|594527218|FG001|Overall Study|Lost to Follow-up|5|||
164364493|NCT00405587|593711545|FG000|Overall Study|Adverse Event|1|||
164364494|NCT00405587|593711546|FG001|Overall Study|Adverse Event|0|||
164364495|NCT00405587|593711547|FG002|Overall Study|Adverse Event|0|||
164364496|NCT00405587|593711548|FG003|Overall Study|Adverse Event|0|||
164364497|NCT00405587|593711545|FG000|Overall Study|Lost to Follow-up|0|||
164364498|NCT00405587|593711546|FG001|Overall Study|Lost to Follow-up|1|||
164591106|NCT01035255|594527217|FG000|Overall Study|patient's request|15|||
164591107|NCT01035255|594527218|FG001|Overall Study|patient's request|13|||
164591108|NCT01041573|594527221|FG000|Overall Study|Withdrawal by Subject|2|||
164699889|NCT02096588|594924820|FG000|Overall Study|Withdrawal by Subject|0|||
164699890|NCT02096588|594924821|FG001|Overall Study|Withdrawal by Subject|1|||
164699891|NCT01258101|594924822|FG000|Overall Study|Adverse Event|5|||
164699892|NCT01258101|594924823|FG001|Overall Study|Adverse Event|6|||
164364499|NCT00405587|593711547|FG002|Overall Study|Lost to Follow-up|1|||
164364500|NCT00405587|593711548|FG003|Overall Study|Lost to Follow-up|0|||
164364501|NCT00405587|593711545|FG000|Overall Study|Radiation induced necrosis|0|||
164364502|NCT00405587|593711546|FG001|Overall Study|Radiation induced necrosis|1|||
164364503|NCT00405587|593711547|FG002|Overall Study|Radiation induced necrosis|0|||
164364504|NCT00405587|593711548|FG003|Overall Study|Radiation induced necrosis|0|||
164364505|NCT00405587|593711545|FG000|Overall Study|Withdrawal by Subject|0|||
164364506|NCT00405587|593711546|FG001|Overall Study|Withdrawal by Subject|0|||
164364507|NCT00405587|593711547|FG002|Overall Study|Withdrawal by Subject|0|||
164364508|NCT00405587|593711548|FG003|Overall Study|Withdrawal by Subject|2|||
164364509|NCT00405587|593711545|FG000|Overall Study|Participant not dosed|0|||
164364510|NCT00405587|593711546|FG001|Overall Study|Participant not dosed|1|||
164364511|NCT00405587|593711547|FG002|Overall Study|Participant not dosed|0|||
164364512|NCT00405587|593711548|FG003|Overall Study|Participant not dosed|0|||
164364513|NCT00507442|593711551|FG000|Overall Study|Adverse Event|8|||
164364514|NCT00507442|593711552|FG001|Overall Study|Adverse Event|11|||
164364515|NCT00507442|593711553|FG002|Overall Study|Adverse Event|4|||
164364516|NCT00507442|593711554|FG003|Overall Study|Adverse Event|1|||
164364517|NCT00507442|593711551|FG000|Overall Study|Protocol Violation|0|||
164364518|NCT00507442|593711552|FG001|Overall Study|Protocol Violation|1|||
164364519|NCT00507442|593711553|FG002|Overall Study|Protocol Violation|0|||
164364520|NCT00507442|593711554|FG003|Overall Study|Protocol Violation|0|||
164364521|NCT00507442|593711551|FG000|Overall Study|Lost to Follow-up|0|||
164364522|NCT00507442|593711552|FG001|Overall Study|Lost to Follow-up|0|||
164364523|NCT00507442|593711553|FG002|Overall Study|Lost to Follow-up|1|||
164364524|NCT00507442|593711554|FG003|Overall Study|Lost to Follow-up|0|||
164364525|NCT00507442|593711551|FG000|Overall Study|Physician Decision|0|||
164364526|NCT00507442|593711552|FG001|Overall Study|Physician Decision|2|||
164364527|NCT00507442|593711553|FG002|Overall Study|Physician Decision|4|||
164364528|NCT00507442|593711554|FG003|Overall Study|Physician Decision|1|||
164364529|NCT00507442|593711551|FG000|Overall Study|Progressive Disease|2|||
164364530|NCT00507442|593711552|FG001|Overall Study|Progressive Disease|4|||
164364531|NCT00507442|593711553|FG002|Overall Study|Progressive Disease|2|||
164364532|NCT00507442|593711554|FG003|Overall Study|Progressive Disease|0|||
164364533|NCT00507442|593711551|FG000|Overall Study|Withdrawal by Subject|4|||
164364534|NCT00507442|593711552|FG001|Overall Study|Withdrawal by Subject|4|||
164364535|NCT00507442|593711553|FG002|Overall Study|Withdrawal by Subject|2|||
164364536|NCT00507442|593711554|FG003|Overall Study|Withdrawal by Subject|1|||
164364537|NCT00507442|593711551|FG000|Overall Study|Other|2|||
164364538|NCT00507442|593711552|FG001|Overall Study|Other|5|||
164364539|NCT00507442|593711553|FG002|Overall Study|Other|2|||
164364540|NCT00507442|593711554|FG003|Overall Study|Other|2|||
164364541|NCT00930579|593711555|FG000|Overall Study|Withdrawal by Subject|1|||
164364542|NCT00930579|593711555|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
164438662|NCT01329328|593973019|FG001|Overall Study|Withdrawal by Subject|4|||
164699893|NCT01258101|594924824|FG002|Overall Study|Adverse Event|0|||
164699894|NCT01258101|594924825|FG003|Overall Study|Adverse Event|0|||
164699895|NCT01258101|594924822|FG000|Overall Study|Extra exclusion criterion amended|2|||
164699896|NCT01258101|594924823|FG001|Overall Study|Extra exclusion criterion amended|1|||
164699897|NCT01258101|594924824|FG002|Overall Study|Extra exclusion criterion amended|1|||
164364543|NCT02255981|593711557|FG000|Overall Study|Lost to Follow-up|3|||
164364544|NCT02255981|593711557|FG000|Overall Study|Withdrawal by Subject|1|||
164364545|NCT02672423|593711558|FG000|Period 1|Adverse Event|0|||
164364546|NCT02672423|593711559|FG001|Period 1|Adverse Event|0|||
164364547|NCT02672423|593711560|FG002|Period 1|Adverse Event|0|||
164364548|NCT02672423|593711561|FG003|Period 1|Adverse Event|0|||
164364549|NCT02672423|593711562|FG004|Period 1|Adverse Event|1|||
164364550|NCT02672423|593711563|FG005|Period 1|Adverse Event|0|||
164364551|NCT02672423|593711564|FG006|Period 1|Adverse Event|0|||
164364552|NCT02672423|593711565|FG007|Period 1|Adverse Event|0|||
164364553|NCT02672423|593711566|FG008|Period 1|Adverse Event|0|||
164364554|NCT02672423|593711567|FG009|Period 1|Adverse Event|0|||
164364555|NCT02672423|593711558|FG000|Period 2|Withdrawal by Subject|0|||
164364556|NCT02672423|593711559|FG001|Period 2|Withdrawal by Subject|0|||
164364557|NCT02672423|593711560|FG002|Period 2|Withdrawal by Subject|1|||
164364558|NCT02672423|593711561|FG003|Period 2|Withdrawal by Subject|0|||
164364559|NCT02672423|593711562|FG004|Period 2|Withdrawal by Subject|0|||
164364560|NCT02672423|593711563|FG005|Period 2|Withdrawal by Subject|0|||
164364561|NCT02672423|593711564|FG006|Period 2|Withdrawal by Subject|0|||
164364562|NCT02672423|593711565|FG007|Period 2|Withdrawal by Subject|0|||
164364563|NCT02672423|593711566|FG008|Period 2|Withdrawal by Subject|0|||
164364564|NCT02672423|593711567|FG009|Period 2|Withdrawal by Subject|0|||
164364565|NCT02672423|593711558|FG000|Period 3|Withdrawal by Subject|0|||
164364566|NCT02672423|593711559|FG001|Period 3|Withdrawal by Subject|0|||
164364567|NCT02672423|593711560|FG002|Period 3|Withdrawal by Subject|0|||
164364568|NCT02672423|593711561|FG003|Period 3|Withdrawal by Subject|0|||
164364569|NCT02672423|593711562|FG004|Period 3|Withdrawal by Subject|0|||
164364570|NCT02672423|593711563|FG005|Period 3|Withdrawal by Subject|0|||
164364571|NCT02672423|593711564|FG006|Period 3|Withdrawal by Subject|0|||
164364572|NCT02672423|593711565|FG007|Period 3|Withdrawal by Subject|1|||
164364573|NCT02672423|593711566|FG008|Period 3|Withdrawal by Subject|0|||
164364574|NCT02672423|593711567|FG009|Period 3|Withdrawal by Subject|0|||
164364575|NCT02672423|593711558|FG000|Period 3|Physician Decision|0|||
164364576|NCT02672423|593711559|FG001|Period 3|Physician Decision|0|||
164364577|NCT02672423|593711560|FG002|Period 3|Physician Decision|0|||
164364578|NCT02672423|593711561|FG003|Period 3|Physician Decision|0|||
164364579|NCT02672423|593711562|FG004|Period 3|Physician Decision|0|||
164364580|NCT02672423|593711563|FG005|Period 3|Physician Decision|1|||
164364581|NCT02672423|593711564|FG006|Period 3|Physician Decision|0|||
164364582|NCT02672423|593711565|FG007|Period 3|Physician Decision|0|||
164364583|NCT02672423|593711566|FG008|Period 3|Physician Decision|0|||
164364584|NCT02672423|593711567|FG009|Period 3|Physician Decision|0|||
164364585|NCT01454570|593711576|FG000|Overall Study|Withdrawal by Subject|2|||
164364586|NCT01454570|593711576|FG000|Overall Study|Screen Failure|7|||
164364587|NCT00885755|593711577|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
164364588|NCT00885755|593711578|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
164364589|NCT00885755|593711579|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
164364590|NCT00885755|593711577|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
164364591|NCT00885755|593711578|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
164364592|NCT00885755|593711579|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
164364593|NCT00885755|593711577|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
164364594|NCT00885755|593711578|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
164364595|NCT00885755|593711579|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
164364596|NCT00885755|593711577|FG000|Part I: Trastuzumab+Taxane|Death|0|||
164364597|NCT00885755|593711578|FG001|Part I: Trastuzumab+Taxane|Death|0|||
164364598|NCT00885755|593711579|FG002|Part I: Trastuzumab+Taxane|Death|1|||
164438663|NCT01329328|593973020|FG002|Overall Study|Withdrawal by Subject|3|||
164438664|NCT01370694|593973021|FG000|Overall Study|Switched to rituximab|4|||
164438665|NCT01370694|593973021|FG000|Overall Study|Progressive disease|2|||
164438666|NCT02148133|593973031|FG000|Overall Study|Investigator discretion|1|||
164438667|NCT02148133|593973031|FG000|Overall Study|Lack of Efficacy|1|||
164364599|NCT00885755|593711577|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
164364600|NCT00885755|593711578|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
164364601|NCT00885755|593711579|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
164364602|NCT00325754|593711580|FG000|Overall Study|Adverse Event|4|||
164364603|NCT00325754|593711581|FG001|Overall Study|Adverse Event|1|||
164364604|NCT02625090|593711588|FG000|Overall Study|Participant wants to be pregnant|2|||
164364605|NCT02625090|593711588|FG000|Overall Study|For the Promoter|1|||
164364606|NCT02625090|593711588|FG000|Overall Study|Sponsor's Decision|9|||
164364607|NCT02625090|593711588|FG000|Overall Study|Somnolence|1|||
164364608|NCT02625090|593711588|FG000|Overall Study|Study terminated by Sponsor|7|||
164438668|NCT02148133|593973031|FG000|Overall Study|Protocol deviation|1|||
164364609|NCT02625090|593711588|FG000|Overall Study|Negative Benefit/Risk|1|||
164364610|NCT02625090|593711588|FG000|Overall Study|Protocol Deviation|2|||
164364611|NCT02625090|593711588|FG000|Overall Study|Lack of Efficacy|16|||
164364612|NCT02625090|593711588|FG000|Overall Study|Adverse Event|3|||
164364613|NCT04649164|593711589|FG000|Overall Study|Withdrawal by Subject|1|||
164364614|NCT04649164|593711590|FG001|Overall Study|Withdrawal by Subject|1|||
164364615|NCT04649164|593711591|FG002|Overall Study|Withdrawal by Subject|2|||
164364616|NCT04649164|593711589|FG000|Overall Study|Participant's care recipient expired|0|||
164364617|NCT04649164|593711590|FG001|Overall Study|Participant's care recipient expired|0|||
164364618|NCT04649164|593711591|FG002|Overall Study|Participant's care recipient expired|2|||
164364619|NCT02250443|593711592|FG000|Overall Study|Administrative problems|7|||
164364620|NCT02250443|593711592|FG000|Overall Study|Adverse Event|3|||
164364621|NCT01549964|593711593|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
164364622|NCT01549964|593711594|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
164364623|NCT01549964|593711595|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
164364624|NCT01549964|593711596|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
164438669|NCT02148133|593973031|FG000|Overall Study|Protocol-defined stopping criteria|2|||
164438670|NCT03808883|593973032|FG000|Overall Study|Withdrawal by Subject|2|||
164438671|NCT03808883|593973033|FG001|Overall Study|Withdrawal by Subject|0|||
164438672|NCT03808883|593973032|FG000|Overall Study|Did not complete pre test or post test survey|4|||
164438673|NCT03808883|593973033|FG001|Overall Study|Did not complete pre test or post test survey|3|||
164438674|NCT00855465|593973037|FG000|Treatment Period|Adverse Event|4|||
164438675|NCT00855465|593973038|FG001|Treatment Period|Adverse Event|2|||
164438676|NCT00855465|593973037|FG000|Treatment Period|Death|2|||
164438677|NCT00855465|593973038|FG001|Treatment Period|Death|2|||
164438678|NCT00855465|593973037|FG000|Treatment Period|Lack of Efficacy|2|||
164438679|NCT00855465|593973038|FG001|Treatment Period|Lack of Efficacy|1|||
164438680|NCT00855465|593973037|FG000|Treatment Period|Non-compliance|1|||
164699898|NCT01258101|594924825|FG003|Overall Study|Extra exclusion criterion amended|1|||
164699899|NCT01258101|594924822|FG000|Overall Study|Informed consent has been withdrawn|2|||
164699900|NCT01258101|594924823|FG001|Overall Study|Informed consent has been withdrawn|2|||
164699901|NCT01258101|594924824|FG002|Overall Study|Informed consent has been withdrawn|1|||
164699902|NCT01258101|594924825|FG003|Overall Study|Informed consent has been withdrawn|1|||
164699903|NCT01258101|594924822|FG000|Overall Study|Patient is not able to attend visits|8|||
164699904|NCT01258101|594924823|FG001|Overall Study|Patient is not able to attend visits|9|||
164699905|NCT01258101|594924824|FG002|Overall Study|Patient is not able to attend visits|7|||
164699906|NCT01258101|594924825|FG003|Overall Study|Patient is not able to attend visits|6|||
164699907|NCT01258101|594924822|FG000|Overall Study|Patient´s compliance|4|||
164699908|NCT01258101|594924823|FG001|Overall Study|Patient´s compliance|3|||
164699909|NCT01258101|594924824|FG002|Overall Study|Patient´s compliance|1|||
164699910|NCT01258101|594924825|FG003|Overall Study|Patient´s compliance|2|||
164364625|NCT01549964|593711593|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
164364626|NCT01549964|593711594|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
164364627|NCT01549964|593711595|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
164364628|NCT01549964|593711596|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
164364629|NCT01549964|593711593|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
164364630|NCT01549964|593711594|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
164364631|NCT01549964|593711595|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
164364632|NCT01549964|593711596|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
164364633|NCT01549964|593711593|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
164364634|NCT01549964|593711594|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
164364635|NCT01549964|593711595|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
164364636|NCT01549964|593711596|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
164364637|NCT01549964|593711593|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
164364638|NCT01549964|593711594|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
164364639|NCT01549964|593711595|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
164364640|NCT01549964|593711596|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
164364641|NCT01549964|593711593|FG000|24-Week Treatment Period|Other|1|||
164364642|NCT01549964|593711594|FG001|24-Week Treatment Period|Other|0|||
164364643|NCT01549964|593711595|FG002|24-Week Treatment Period|Other|1|||
164364644|NCT01549964|593711596|FG003|24-Week Treatment Period|Other|0|||
164364645|NCT01549964|593711593|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
164364646|NCT01549964|593711594|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
164364647|NCT01549964|593711595|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
164364648|NCT01549964|593711596|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
164364649|NCT01549964|593711593|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
164364650|NCT01549964|593711594|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
164364651|NCT01549964|593711595|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
164364652|NCT01549964|593711596|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
164364653|NCT01549964|593711593|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
164364654|NCT01549964|593711594|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
164364655|NCT01549964|593711595|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
164364656|NCT01549964|593711596|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
164364657|NCT01549964|593711593|FG000|80-Week Extension Period|Pregnancy|0|||
164364658|NCT01549964|593711594|FG001|80-Week Extension Period|Pregnancy|0|||
164364659|NCT01549964|593711595|FG002|80-Week Extension Period|Pregnancy|1|||
164364660|NCT01549964|593711596|FG003|80-Week Extension Period|Pregnancy|0|||
164699911|NCT01258101|594924822|FG000|Overall Study|Lost to Follow-up|5|||
164699912|NCT01258101|594924823|FG001|Overall Study|Lost to Follow-up|5|||
164364661|NCT01549964|593711593|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
164364662|NCT01549964|593711594|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
164364663|NCT01549964|593711595|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
164438681|NCT00855465|593973038|FG001|Treatment Period|Non-compliance|0|||
164438682|NCT00855465|593973037|FG000|Treatment Period|Protocol Violation|2|||
164438683|NCT00855465|593973038|FG001|Treatment Period|Protocol Violation|0|||
164699913|NCT01258101|594924824|FG002|Overall Study|Lost to Follow-up|0|||
164699914|NCT01258101|594924825|FG003|Overall Study|Lost to Follow-up|6|||
164699915|NCT01258101|594924822|FG000|Overall Study|PCR positive at week 24|0|||
164364664|NCT01549964|593711596|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
164364665|NCT01549964|593711593|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
164364666|NCT01549964|593711594|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
164364667|NCT01549964|593711595|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
164364668|NCT01549964|593711596|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
164364669|NCT01549964|593711593|FG000|80-Week Extension Period|Lost to Follow-up|1|||
164364670|NCT01549964|593711594|FG001|80-Week Extension Period|Lost to Follow-up|0|||
164364671|NCT01549964|593711595|FG002|80-Week Extension Period|Lost to Follow-up|2|||
164364672|NCT01549964|593711596|FG003|80-Week Extension Period|Lost to Follow-up|1|||
164364673|NCT01549964|593711593|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
164364674|NCT01549964|593711594|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
164364675|NCT01549964|593711595|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
164364676|NCT01549964|593711596|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
164364677|NCT02290821|593711601|FG000|Overall Study|Withdrawal by Subject|1|||
164364678|NCT02290821|593711602|FG001|Overall Study|Withdrawal by Subject|1|||
164364679|NCT02290821|593711601|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
164364680|NCT02290821|593711602|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
164364681|NCT02290821|593711601|FG000|Overall Study|Lost to Follow-up|3|||
164364682|NCT02290821|593711602|FG001|Overall Study|Lost to Follow-up|2|||
164364683|NCT03343483|593711608|FG000|Overall Study|Death|0|||
164364684|NCT03343483|593711609|FG001|Overall Study|Death|3|||
164364685|NCT03343483|593711608|FG000|Overall Study|Lost to Follow-up|9|||
164364686|NCT03343483|593711609|FG001|Overall Study|Lost to Follow-up|13|||
164364687|NCT03343483|593711608|FG000|Overall Study|Withdrawal by Subject|8|||
164364688|NCT03343483|593711609|FG001|Overall Study|Withdrawal by Subject|17|||
164364689|NCT01488097|593711612|FG000|Overall Study|Lost to Follow-up|1|||
164364690|NCT02726074|593711615|FG000|Overall Study|Withdrawal by Subject|4|||
164364691|NCT02726074|593711615|FG000|Overall Study|Adverse Event|14|||
164364692|NCT02726074|593711615|FG000|Overall Study|Protocol Violation|3|||
164364693|NCT02726074|593711615|FG000|Overall Study|Lost to Follow-up|2|||
164364694|NCT02726074|593711615|FG000|Overall Study|Others|3|||
164364695|NCT00579826|593711616|FG000|Overall Study|Withdrawal by Subject|5|||
164364696|NCT00579826|593711617|FG001|Overall Study|Withdrawal by Subject|3|||
164364697|NCT00454987|593711620|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
164364698|NCT00454987|593711621|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
164364699|NCT00454987|593711622|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
164364700|NCT00454987|593711620|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
164364701|NCT00454987|593711621|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
164364702|NCT00454987|593711622|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
164364703|NCT00454987|593711620|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
164364704|NCT00454987|593711621|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
164364705|NCT00454987|593711622|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
164364706|NCT00973479|593711626|FG000|Overall Study|Lost to Follow-up|0|||
164364707|NCT00973479|593711627|FG001|Overall Study|Lost to Follow-up|3|||
164364708|NCT00973479|593711626|FG000|Overall Study|Death|2|||
164364709|NCT00973479|593711627|FG001|Overall Study|Death|2|||
164364710|NCT00973479|593711626|FG000|Overall Study|Withdrawal by Subject|15|||
164364711|NCT00973479|593711627|FG001|Overall Study|Withdrawal by Subject|16|||
164364712|NCT00973479|593711626|FG000|Overall Study|Lack of Efficacy|5|||
164364713|NCT00973479|593711627|FG001|Overall Study|Lack of Efficacy|7|||
164364714|NCT00973479|593711626|FG000|Overall Study|Adverse Event|12|||
164364715|NCT00973479|593711627|FG001|Overall Study|Adverse Event|32|||
164364716|NCT00973479|593711626|FG000|Overall Study|Protocol Violation|2|||
164364717|NCT00973479|593711627|FG001|Overall Study|Protocol Violation|2|||
164364718|NCT00973479|593711626|FG000|Overall Study|Other|1|||
164364719|NCT00973479|593711627|FG001|Overall Study|Other|7|||
164364720|NCT05075850|593711628|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
164364721|NCT04256785|593711629|FG000|Overall Study|Adverse Event|8|||
164364722|NCT04256785|593711630|FG001|Overall Study|Adverse Event|6|||
164364723|NCT04256785|593711629|FG000|Overall Study|Lack of Efficacy|3|||
164364724|NCT04256785|593711630|FG001|Overall Study|Lack of Efficacy|4|||
164364725|NCT04256785|593711629|FG000|Overall Study|Lost to Follow-up|7|||
164364726|NCT04256785|593711630|FG001|Overall Study|Lost to Follow-up|7|||
164364727|NCT04256785|593711629|FG000|Overall Study|Protocol Violation|1|||
164364728|NCT04256785|593711630|FG001|Overall Study|Protocol Violation|0|||
164364729|NCT04256785|593711629|FG000|Overall Study|Withdrawal by Subject|4|||
164364730|NCT04256785|593711630|FG001|Overall Study|Withdrawal by Subject|1|||
164364731|NCT04256785|593711629|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
164364732|NCT04256785|593711630|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
164364733|NCT01265849|593711631|FG000|Overall Study|Randomized//Treatment not initiated|1|||
164364734|NCT01265849|593711632|FG001|Overall Study|Randomized//Treatment not initiated|4|||
164364735|NCT01265849|593711633|FG002|Overall Study|Randomized//Treatment not initiated|0|||
164364736|NCT01265849|593711631|FG000|Overall Study|Physician Decision|1|||
164364737|NCT01265849|593711632|FG001|Overall Study|Physician Decision|2|||
164364738|NCT01265849|593711633|FG002|Overall Study|Physician Decision|0|||
164699916|NCT01258101|594924823|FG001|Overall Study|PCR positive at week 24|0|||
164699917|NCT01258101|594924824|FG002|Overall Study|PCR positive at week 24|0|||
164699918|NCT01258101|594924825|FG003|Overall Study|PCR positive at week 24|1|||
164699919|NCT01258101|594924822|FG000|Overall Study|Other reason|7|||
164699920|NCT01258101|594924823|FG001|Overall Study|Other reason|8|||
164699921|NCT01258101|594924824|FG002|Overall Study|Other reason|1|||
164699922|NCT01258101|594924825|FG003|Overall Study|Other reason|8|||
164699923|NCT00757848|594924826|FG000|Overall Study|Voluntary discontinuation|1|||
164699924|NCT00757848|594924827|FG001|Overall Study|Voluntary discontinuation|0|||
164699925|NCT00757848|594924826|FG000|Overall Study|Adverse Event|1|||
164699926|NCT00757848|594924827|FG001|Overall Study|Adverse Event|2|||
164699927|NCT00757848|594924826|FG000|Overall Study|Incorrect enrolment|1|||
164699928|NCT00757848|594924827|FG001|Overall Study|Incorrect enrolment|0|||
164699929|NCT00958126|594924831|FG000|Overall Study|Serious Adverse Event|0|||
164699930|NCT00958126|594924832|FG001|Overall Study|Serious Adverse Event|2|||
164699931|NCT00958126|594924833|FG002|Overall Study|Serious Adverse Event|0|||
164364739|NCT01265849|593711631|FG000|Overall Study|Lost to Follow-up|18|||
164364740|NCT01265849|593711632|FG001|Overall Study|Lost to Follow-up|15|||
164364741|NCT01265849|593711633|FG002|Overall Study|Lost to Follow-up|5|||
164364742|NCT01265849|593711631|FG000|Overall Study|Not otherwise specified|1|||
164364743|NCT01265849|593711632|FG001|Overall Study|Not otherwise specified|6|||
164364744|NCT01265849|593711633|FG002|Overall Study|Not otherwise specified|1|||
164364745|NCT01265849|593711631|FG000|Overall Study|Withdrawal by Subject|25|||
164364746|NCT01265849|593711632|FG001|Overall Study|Withdrawal by Subject|34|||
164364747|NCT01265849|593711633|FG002|Overall Study|Withdrawal by Subject|13|||
164364748|NCT00362115|593711634|FG000|Overall Study|Adverse Event|0|||
164364749|NCT00362115|593711635|FG001|Overall Study|Adverse Event|1|||
164364750|NCT00362115|593711636|FG002|Overall Study|Adverse Event|1|||
164364751|NCT00362115|593711637|FG003|Overall Study|Adverse Event|1|||
164364752|NCT00362115|593711638|FG004|Overall Study|Adverse Event|2|||
164364753|NCT00362115|593711639|FG005|Overall Study|Adverse Event|2|||
164364754|NCT00362115|593711640|FG006|Overall Study|Adverse Event|1|||
164364755|NCT00362115|593711634|FG000|Overall Study|Protocol Violation|0|||
164364756|NCT00362115|593711635|FG001|Overall Study|Protocol Violation|0|||
164364757|NCT00362115|593711636|FG002|Overall Study|Protocol Violation|0|||
164364758|NCT00362115|593711637|FG003|Overall Study|Protocol Violation|0|||
164364759|NCT00362115|593711638|FG004|Overall Study|Protocol Violation|0|||
164364760|NCT00362115|593711639|FG005|Overall Study|Protocol Violation|1|||
164364761|NCT00362115|593711640|FG006|Overall Study|Protocol Violation|0|||
164364762|NCT00362115|593711634|FG000|Overall Study|Lost to Follow-up|0|||
164364763|NCT00362115|593711635|FG001|Overall Study|Lost to Follow-up|1|||
164364764|NCT00362115|593711636|FG002|Overall Study|Lost to Follow-up|0|||
164364765|NCT00362115|593711637|FG003|Overall Study|Lost to Follow-up|0|||
164364766|NCT00362115|593711638|FG004|Overall Study|Lost to Follow-up|2|||
164364767|NCT00362115|593711639|FG005|Overall Study|Lost to Follow-up|0|||
164364768|NCT00362115|593711640|FG006|Overall Study|Lost to Follow-up|1|||
164364769|NCT00362115|593711634|FG000|Overall Study|Withdrawal by Subject|1|||
164364770|NCT00362115|593711635|FG001|Overall Study|Withdrawal by Subject|3|||
164364771|NCT00362115|593711636|FG002|Overall Study|Withdrawal by Subject|1|||
164364772|NCT00362115|593711637|FG003|Overall Study|Withdrawal by Subject|0|||
164364773|NCT00362115|593711638|FG004|Overall Study|Withdrawal by Subject|1|||
164364774|NCT00362115|593711639|FG005|Overall Study|Withdrawal by Subject|3|||
164364775|NCT00362115|593711640|FG006|Overall Study|Withdrawal by Subject|4|||
164364776|NCT00362115|593711634|FG000|Overall Study|Lack of Efficacy|1|||
164364777|NCT00362115|593711635|FG001|Overall Study|Lack of Efficacy|0|||
164364778|NCT00362115|593711636|FG002|Overall Study|Lack of Efficacy|5|||
164364779|NCT00362115|593711637|FG003|Overall Study|Lack of Efficacy|2|||
164364780|NCT00362115|593711638|FG004|Overall Study|Lack of Efficacy|2|||
164364781|NCT00362115|593711639|FG005|Overall Study|Lack of Efficacy|0|||
164364782|NCT00362115|593711640|FG006|Overall Study|Lack of Efficacy|3|||
164364783|NCT00362115|593711634|FG000|Overall Study|Physician Decision|0|||
164699932|NCT00958126|594924834|FG003|Overall Study|Serious Adverse Event|0|||
164699933|NCT00958126|594924835|FG004|Overall Study|Serious Adverse Event|0|||
164699934|NCT00958126|594924836|FG005|Overall Study|Serious Adverse Event|0|||
164699935|NCT00958126|594924837|FG006|Overall Study|Serious Adverse Event|1|||
164699936|NCT00958126|594924838|FG007|Overall Study|Serious Adverse Event|0|||
164699937|NCT00958126|594924831|FG000|Overall Study|Withdrawal by Subject|0|||
164699938|NCT00958126|594924832|FG001|Overall Study|Withdrawal by Subject|2|||
164699939|NCT00958126|594924833|FG002|Overall Study|Withdrawal by Subject|0|||
164364784|NCT00362115|593711635|FG001|Overall Study|Physician Decision|0|||
164364785|NCT00362115|593711636|FG002|Overall Study|Physician Decision|0|||
164364786|NCT00362115|593711637|FG003|Overall Study|Physician Decision|0|||
164364787|NCT00362115|593711638|FG004|Overall Study|Physician Decision|0|||
164364788|NCT00362115|593711639|FG005|Overall Study|Physician Decision|0|||
164364789|NCT00362115|593711640|FG006|Overall Study|Physician Decision|3|||
164364790|NCT00362115|593711634|FG000|Overall Study|Other|0|||
164364791|NCT00362115|593711635|FG001|Overall Study|Other|1|||
164364792|NCT00362115|593711636|FG002|Overall Study|Other|0|||
164699940|NCT00958126|594924834|FG003|Overall Study|Withdrawal by Subject|0|||
164364793|NCT00362115|593711637|FG003|Overall Study|Other|1|||
164364794|NCT00362115|593711638|FG004|Overall Study|Other|0|||
164364795|NCT00362115|593711639|FG005|Overall Study|Other|1|||
164364796|NCT00362115|593711640|FG006|Overall Study|Other|0|||
164364797|NCT01170091|593711641|FG000|Overall Study|Missing efficacy evaluation|3|||
164364798|NCT01170091|593711641|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
164364799|NCT03194321|593711642|FG000|Overall Study|Withdrawal by Subject|1|||
164364800|NCT03194321|593711642|FG000|Overall Study|Lost to Follow-up|1|||
164364801|NCT03194321|593711642|FG000|Overall Study|Travel for Follow-up|1|||
164364802|NCT02188589|593711643|FG000|Overall Study|Withdrawal by Subject|5|||
164364803|NCT00741039|593711646|FG000|Overall Study|Patient non-compliance|2|||
164364804|NCT00741039|593711647|FG001|Overall Study|Patient non-compliance|0|||
164364805|NCT00878709|593711648|FG000|Overall Study|Withdrawal by Subject|197|||
164364806|NCT00878709|593711649|FG001|Overall Study|Withdrawal by Subject|120|||
164364807|NCT00878709|593711648|FG000|Overall Study|Lost to Follow-up|35|||
164364808|NCT00878709|593711649|FG001|Overall Study|Lost to Follow-up|33|||
164364809|NCT00878709|593711648|FG000|Overall Study|Other Reasons|93|||
164364810|NCT00878709|593711649|FG001|Overall Study|Other Reasons|84|||
164364811|NCT00768300|593711650|FG000|Overall Study|Randomized but not treated|1|||
164364812|NCT00768300|593711651|FG001|Overall Study|Randomized but not treated|1|||
164364813|NCT00768300|593711650|FG000|Overall Study|Adverse Event|10|||
164364814|NCT00768300|593711651|FG001|Overall Study|Adverse Event|2|||
164364815|NCT00768300|593711650|FG000|Overall Study|Protocol Violation|6|||
164364816|NCT00768300|593711651|FG001|Overall Study|Protocol Violation|1|||
164364817|NCT00768300|593711650|FG000|Overall Study|Withdrawal by Subject|13|||
164364818|NCT00768300|593711651|FG001|Overall Study|Withdrawal by Subject|7|||
164364819|NCT00768300|593711650|FG000|Overall Study|Physician Decision|2|||
164364820|NCT00768300|593711651|FG001|Overall Study|Physician Decision|3|||
164364821|NCT00768300|593711650|FG000|Overall Study|Study discontinued by Sponsor|271|||
164364822|NCT00768300|593711651|FG001|Overall Study|Study discontinued by Sponsor|140|||
164364823|NCT00768300|593711650|FG000|Overall Study|Death|21|||
164364824|NCT00768300|593711651|FG001|Overall Study|Death|5|||
164364825|NCT00768300|593711650|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
164364826|NCT00768300|593711651|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
164364827|NCT00768300|593711650|FG000|Overall Study|Screen failure following randomization|1|||
164364828|NCT00768300|593711651|FG001|Overall Study|Screen failure following randomization|0|||
164364829|NCT00768300|593711650|FG000|Overall Study|Received lung transplant|1|||
164364830|NCT00768300|593711651|FG001|Overall Study|Received lung transplant|1|||
164364831|NCT00768300|593711650|FG000|Overall Study|Lost to Follow-up|0|||
164364832|NCT00768300|593711651|FG001|Overall Study|Lost to Follow-up|1|||
164364833|NCT00768300|593711650|FG000|Overall Study|Began prohibited concomitant medication|0|||
164364834|NCT00768300|593711651|FG001|Overall Study|Began prohibited concomitant medication|1|||
164364835|NCT00768300|593711650|FG000|Overall Study|Treated but never dosed with Study drug|1|||
164364836|NCT00768300|593711651|FG001|Overall Study|Treated but never dosed with Study drug|0|||
164364837|NCT00768300|593711650|FG000|Overall Study|Missing data|1|||
164699941|NCT00958126|594924835|FG004|Overall Study|Withdrawal by Subject|0|||
164699942|NCT00958126|594924836|FG005|Overall Study|Withdrawal by Subject|0|||
164699943|NCT00958126|594924837|FG006|Overall Study|Withdrawal by Subject|0|||
164699944|NCT00958126|594924838|FG007|Overall Study|Withdrawal by Subject|0|||
164699945|NCT00958126|594924831|FG000|Overall Study|Moved away from study area|0|||
164699946|NCT00958126|594924832|FG001|Overall Study|Moved away from study area|0|||
164699947|NCT00958126|594924833|FG002|Overall Study|Moved away from study area|1|||
164699948|NCT00958126|594924834|FG003|Overall Study|Moved away from study area|1|||
164699949|NCT00958126|594924835|FG004|Overall Study|Moved away from study area|0|||
164699950|NCT00958126|594924836|FG005|Overall Study|Moved away from study area|0|||
164438684|NCT00855465|593973037|FG000|Treatment Period|Withdrawal by Subject|2|||
164438685|NCT00855465|593973038|FG001|Treatment Period|Withdrawal by Subject|0|||
164438686|NCT00855465|593973037|FG000|Treatment Period|Not treated|1|||
164699951|NCT00958126|594924837|FG006|Overall Study|Moved away from study area|0|||
164699952|NCT00958126|594924838|FG007|Overall Study|Moved away from study area|0|||
164699953|NCT00958126|594924831|FG000|Overall Study|Lost to Follow-up|1|||
164699954|NCT00958126|594924832|FG001|Overall Study|Lost to Follow-up|5|||
164699955|NCT00958126|594924833|FG002|Overall Study|Lost to Follow-up|9|||
164699956|NCT00958126|594924834|FG003|Overall Study|Lost to Follow-up|8|||
164699957|NCT00958126|594924835|FG004|Overall Study|Lost to Follow-up|0|||
164699958|NCT00958126|594924836|FG005|Overall Study|Lost to Follow-up|0|||
164364838|NCT00768300|593711651|FG001|Overall Study|Missing data|0|||
164364839|NCT02068222|593711652|FG000|Overall Study|Lost to Follow-up|1|||
164364840|NCT03011307|593711655|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
164364841|NCT03011307|593711656|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
164364842|NCT03011307|593711655|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
164364843|NCT03011307|593711656|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
164364844|NCT03011307|593711655|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
164699959|NCT00958126|594924837|FG006|Overall Study|Lost to Follow-up|0|||
164364845|NCT03011307|593711656|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
164364846|NCT05198843|593711658|FG000|Overall Study|Lack of Efficacy|1|||
164364847|NCT00567892|593711662|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
164364848|NCT00567892|593711663|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
164364849|NCT00567892|593711664|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
164364850|NCT00567892|593711665|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
164364851|NCT00567892|593711662|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
164364852|NCT00567892|593711663|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
164364853|NCT00567892|593711664|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
164364854|NCT00567892|593711665|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
164364855|NCT01541969|593713124|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
164364856|NCT01541969|593713125|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
164364857|NCT01541969|593713124|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
164364858|NCT01541969|593713125|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
164364859|NCT01541969|593713124|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
164364860|NCT01541969|593713125|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
164364861|NCT01541969|593713124|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
164364862|NCT01541969|593713125|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
164364863|NCT01541969|593713124|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
164364864|NCT01541969|593713125|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
164364865|NCT01541969|593713124|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
164364866|NCT01541969|593713125|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
164364867|NCT01541969|593713124|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
164364868|NCT01541969|593713125|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
164364869|NCT01541969|593713124|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
164364870|NCT01541969|593713125|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
164364871|NCT01541969|593713124|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
164364872|NCT01541969|593713125|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
164364873|NCT01541969|593713124|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
164364874|NCT01541969|593713125|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
164364875|NCT01365507|593713126|FG000|Overall Study|Withdrawal Criteria|8|||
164364876|NCT01365507|593713127|FG001|Overall Study|Withdrawal Criteria|5|||
164364877|NCT01365507|593713126|FG000|Overall Study|Unclassified|1|||
164364878|NCT01365507|593713127|FG001|Overall Study|Unclassified|4|||
164364879|NCT01614990|593713128|FG000|Overall Study|Protocol Violation|1|||
164364880|NCT01614990|593713129|FG001|Overall Study|Protocol Violation|1|||
164364881|NCT02255500|593713136|FG000|Overall Study|Withdrawal by Subject|1|||
164364882|NCT02255500|593713137|FG001|Overall Study|Withdrawal by Subject|0|||
164364883|NCT04254978|593713141|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
164364884|NCT04254978|593713141|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
164364885|NCT04254978|593713141|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
164364886|NCT04254978|593713141|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
164364887|NCT04254978|593713141|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
164364888|NCT04254978|593713141|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
164364889|NCT02449239|593713142|FG000|Induction Phase|Lack of Efficacy|64|||
164364890|NCT02449239|593713142|FG000|Induction Phase|Adverse Event|1|||
164364891|NCT02449239|593713142|FG000|Induction Phase|Lost to Follow-up|1|||
164364892|NCT02449239|593713142|FG000|Induction Phase|Protocol Violation|1|||
164364893|NCT02449239|593713142|FG000|Induction Phase|Physician Decision|1|||
164364894|NCT02449239|593713142|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
164364895|NCT02449239|593713142|FG000|Induction Phase|Withdrawal by Subject|1|||
164364896|NCT02449239|593713142|FG000|Maintenance Month 3|Lack of Efficacy|14|||
164364897|NCT02449239|593713142|FG000|Maintenance Month 6|Lack of Efficacy|10|||
164364898|NCT02449239|593713142|FG000|Maintenance Month 6|Adverse Event|2|||
164364899|NCT02449239|593713142|FG000|Maintenance Month 6|Physician Decision|1|||
164364900|NCT02449239|593713142|FG000|Maintenance Month 9|Lack of Efficacy|2|||
164364901|NCT02449239|593713142|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
164364902|NCT02449239|593713142|FG000|Maintenance Month 12|Lack of Efficacy|5|||
164364903|NCT02449239|593713142|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
164364904|NCT02449239|593713142|FG000|Maintenance Month 12|Subject moved from area|1|||
164364905|NCT02449239|593713142|FG000|Maintenance Month 15|Lack of Efficacy|1|||
164364906|NCT02449239|593713142|FG000|Maintenance Month 21|Lack of Efficacy|1|||
164364907|NCT02449239|593713142|FG000|Maintenance Month 21|Sponsor decision|1|||
164364908|NCT03257631|593713143|FG000|Overall Study|Death|1|||
164364909|NCT03257631|593713144|FG001|Overall Study|Death|0|||
164364910|NCT03257631|593713145|FG002|Overall Study|Death|1|||
164364911|NCT03257631|593713146|FG003|Overall Study|Death|1|||
164364912|NCT03257631|593713143|FG000|Overall Study|Progressive Disease|10|||
164364913|NCT03257631|593713144|FG001|Overall Study|Progressive Disease|9|||
164364914|NCT03257631|593713145|FG002|Overall Study|Progressive Disease|17|||
164364915|NCT03257631|593713146|FG003|Overall Study|Progressive Disease|8|||
164364916|NCT03257631|593713143|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164364917|NCT03257631|593713144|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164364918|NCT03257631|593713145|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
164364919|NCT03257631|593713146|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
164364920|NCT03257631|593713143|FG000|Overall Study|Adverse Event|0|||
164364921|NCT03257631|593713144|FG001|Overall Study|Adverse Event|0|||
164364922|NCT03257631|593713145|FG002|Overall Study|Adverse Event|2|||
164364923|NCT03257631|593713146|FG003|Overall Study|Adverse Event|0|||
164364924|NCT03509675|593713150|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
164364925|NCT03509675|593713151|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
164364926|NCT03509675|593713150|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
164364927|NCT03509675|593713151|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
164364928|NCT03509675|593713150|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
164364929|NCT03509675|593713151|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
164364930|NCT03509675|593713150|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
164364931|NCT03509675|593713151|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
164364932|NCT00277212|593713152|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
164364933|NCT00277212|593713153|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
164364934|NCT00277212|593713154|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
164364935|NCT00277212|593713152|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
164364936|NCT00277212|593713153|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
164364937|NCT00277212|593713154|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
164364938|NCT00277212|593713152|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
164364939|NCT00277212|593713153|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
164364940|NCT00277212|593713154|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
164364941|NCT00277212|593713152|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
164364942|NCT00277212|593713153|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
164364943|NCT00277212|593713154|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
164364944|NCT00277212|593713152|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
164364945|NCT00277212|593713153|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
164364946|NCT00277212|593713154|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
164364947|NCT00277212|593713152|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
164364948|NCT00277212|593713153|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
164364949|NCT00277212|593713154|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
164591109|NCT01041573|594527222|FG001|Overall Study|Withdrawal by Subject|5|||
164591110|NCT01041573|594527223|FG002|Overall Study|Withdrawal by Subject|2|||
164591111|NCT01041573|594527224|FG003|Overall Study|Withdrawal by Subject|0|||
164591112|NCT01041573|594527221|FG000|Overall Study|Death|1|||
164591113|NCT01041573|594527222|FG001|Overall Study|Death|0|||
164591114|NCT01041573|594527223|FG002|Overall Study|Death|0|||
164591115|NCT01041573|594527224|FG003|Overall Study|Death|0|||
164591116|NCT01041573|594527221|FG000|Overall Study|Lost to Follow-up|0|||
164591117|NCT01041573|594527222|FG001|Overall Study|Lost to Follow-up|1|||
164591118|NCT01041573|594527223|FG002|Overall Study|Lost to Follow-up|2|||
164591119|NCT01041573|594527224|FG003|Overall Study|Lost to Follow-up|1|||
164591120|NCT01041573|594527221|FG000|Overall Study|Adverse Event|0|||
164591121|NCT01041573|594527222|FG001|Overall Study|Adverse Event|2|||
164591122|NCT01041573|594527223|FG002|Overall Study|Adverse Event|0|||
164591123|NCT01041573|594527224|FG003|Overall Study|Adverse Event|0|||
164591124|NCT01041573|594527221|FG000|Overall Study|relocation|1|||
164591125|NCT01041573|594527222|FG001|Overall Study|relocation|4|||
164591126|NCT01041573|594527223|FG002|Overall Study|relocation|3|||
164591127|NCT01041573|594527224|FG003|Overall Study|relocation|1|||
164364950|NCT00277212|593713152|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
164364951|NCT00277212|593713153|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
164364952|NCT00277212|593713154|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
164364953|NCT00277212|593713152|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
164364954|NCT00277212|593713153|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
164364955|NCT00277212|593713154|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
164364956|NCT00277212|593713152|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
164364957|NCT00277212|593713153|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
164364958|NCT00277212|593713154|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
164364959|NCT00277212|593713152|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
164364960|NCT00277212|593713153|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
164364961|NCT00277212|593713154|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
164364962|NCT00277212|593713152|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
164364963|NCT00277212|593713153|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
164364964|NCT00277212|593713154|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
164364965|NCT00277212|593713152|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
164364966|NCT00277212|593713153|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
164364967|NCT00277212|593713154|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
164364968|NCT00277212|593713152|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
164364969|NCT00277212|593713153|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
164364970|NCT00277212|593713154|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
164364971|NCT00277212|593713152|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
164364972|NCT00277212|593713153|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
164364973|NCT00277212|593713154|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
164364974|NCT00277212|593713152|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
164364975|NCT00277212|593713153|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
164364976|NCT00277212|593713154|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
164364977|NCT00277212|593713152|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
164364978|NCT00277212|593713153|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
164364979|NCT00277212|593713154|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
164364980|NCT00277212|593713152|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
164364981|NCT00277212|593713153|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
164364982|NCT00277212|593713154|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
164364983|NCT00277212|593713152|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
164364984|NCT00277212|593713153|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
164364985|NCT00277212|593713154|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
164364986|NCT00902564|593713155|FG000|Overall Study|Withdrawal by Subject|2|||
164364987|NCT03239470|593713158|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
164364988|NCT03239470|593713159|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
164364989|NCT01023581|593713160|FG000|Overall Study|Adverse Event|4|||
164364990|NCT01023581|593713161|FG001|Overall Study|Adverse Event|4|||
164364991|NCT01023581|593713162|FG002|Overall Study|Adverse Event|7|||
164364992|NCT01023581|593713163|FG003|Overall Study|Adverse Event|3|||
164364993|NCT01023581|593713164|FG004|Overall Study|Adverse Event|2|||
164364994|NCT01023581|593713165|FG005|Overall Study|Adverse Event|5|||
164364995|NCT01023581|593713166|FG006|Overall Study|Adverse Event|11|||
164364996|NCT01023581|593713160|FG000|Overall Study|Major protocol deviation|2|||
164364997|NCT01023581|593713161|FG001|Overall Study|Major protocol deviation|0|||
164364998|NCT01023581|593713162|FG002|Overall Study|Major protocol deviation|3|||
164364999|NCT01023581|593713163|FG003|Overall Study|Major protocol deviation|0|||
164365000|NCT01023581|593713164|FG004|Overall Study|Major protocol deviation|0|||
164365001|NCT01023581|593713165|FG005|Overall Study|Major protocol deviation|0|||
164365002|NCT01023581|593713166|FG006|Overall Study|Major protocol deviation|0|||
164365003|NCT01023581|593713160|FG000|Overall Study|Lost to Follow-up|4|||
164365004|NCT01023581|593713161|FG001|Overall Study|Lost to Follow-up|8|||
164365005|NCT01023581|593713162|FG002|Overall Study|Lost to Follow-up|7|||
164365006|NCT01023581|593713163|FG003|Overall Study|Lost to Follow-up|2|||
164591128|NCT01041573|594527221|FG000|Overall Study|further blood extraction|0|||
164591129|NCT01041573|594527222|FG001|Overall Study|further blood extraction|1|||
164591130|NCT01041573|594527223|FG002|Overall Study|further blood extraction|0|||
164591131|NCT01041573|594527224|FG003|Overall Study|further blood extraction|0|||
164591132|NCT01041573|594527221|FG000|Overall Study|positive to anti-HCV|1|||
164591133|NCT01041573|594527222|FG001|Overall Study|positive to anti-HCV|0|||
164591134|NCT01041573|594527223|FG002|Overall Study|positive to anti-HCV|0|||
164591135|NCT01041573|594527224|FG003|Overall Study|positive to anti-HCV|0|||
164591136|NCT00616239|594527226|FG000|Overall Study|Withdrawal by Subject|2|||
164591137|NCT01632878|594527232|FG000|Screening|Physician Decision|268|||
164591138|NCT01632878|594527232|FG000|Treatment|Lost to Follow-up|41|||
164591139|NCT01632878|594527232|FG000|Treatment|Withdrawal by Subject|36|||
164591140|NCT01632878|594527232|FG000|Treatment|Physician Decision|34|||
164591141|NCT01632878|594527232|FG000|Treatment|missing information|4|||
164699960|NCT00958126|594924838|FG007|Overall Study|Lost to Follow-up|0|||
164699961|NCT00958126|594924831|FG000|Overall Study|Sponsor/Investigator decision|0|||
164699962|NCT00958126|594924832|FG001|Overall Study|Sponsor/Investigator decision|0|||
164365007|NCT01023581|593713164|FG004|Overall Study|Lost to Follow-up|5|||
164365008|NCT01023581|593713165|FG005|Overall Study|Lost to Follow-up|2|||
164365009|NCT01023581|593713166|FG006|Overall Study|Lost to Follow-up|2|||
164365010|NCT01023581|593713160|FG000|Overall Study|Withdrawal by Subject|13|||
164365011|NCT01023581|593713161|FG001|Overall Study|Withdrawal by Subject|8|||
164365012|NCT01023581|593713162|FG002|Overall Study|Withdrawal by Subject|16|||
164365013|NCT01023581|593713163|FG003|Overall Study|Withdrawal by Subject|10|||
164365014|NCT01023581|593713164|FG004|Overall Study|Withdrawal by Subject|6|||
164365015|NCT01023581|593713165|FG005|Overall Study|Withdrawal by Subject|8|||
164365016|NCT01023581|593713166|FG006|Overall Study|Withdrawal by Subject|5|||
164365017|NCT01023581|593713160|FG000|Overall Study|Pregnancy|0|||
164365018|NCT01023581|593713161|FG001|Overall Study|Pregnancy|0|||
164365019|NCT01023581|593713162|FG002|Overall Study|Pregnancy|0|||
164365020|NCT01023581|593713163|FG003|Overall Study|Pregnancy|2|||
164365021|NCT01023581|593713164|FG004|Overall Study|Pregnancy|0|||
164365022|NCT01023581|593713165|FG005|Overall Study|Pregnancy|1|||
164365023|NCT01023581|593713166|FG006|Overall Study|Pregnancy|0|||
164365024|NCT01023581|593713160|FG000|Overall Study|Lack of Efficacy|9|||
164365025|NCT01023581|593713161|FG001|Overall Study|Lack of Efficacy|3|||
164365026|NCT01023581|593713162|FG002|Overall Study|Lack of Efficacy|6|||
164365027|NCT01023581|593713163|FG003|Overall Study|Lack of Efficacy|2|||
164365028|NCT01023581|593713164|FG004|Overall Study|Lack of Efficacy|1|||
164365029|NCT01023581|593713165|FG005|Overall Study|Lack of Efficacy|2|||
164365030|NCT01023581|593713166|FG006|Overall Study|Lack of Efficacy|1|||
164365031|NCT01023581|593713160|FG000|Overall Study|Physician Decision|2|||
164365032|NCT01023581|593713161|FG001|Overall Study|Physician Decision|0|||
164365033|NCT01023581|593713162|FG002|Overall Study|Physician Decision|2|||
164365034|NCT01023581|593713163|FG003|Overall Study|Physician Decision|1|||
164365035|NCT01023581|593713164|FG004|Overall Study|Physician Decision|1|||
164365036|NCT01023581|593713165|FG005|Overall Study|Physician Decision|1|||
164365037|NCT01023581|593713166|FG006|Overall Study|Physician Decision|1|||
164365038|NCT01023581|593713160|FG000|Overall Study|Other|1|||
164365039|NCT01023581|593713161|FG001|Overall Study|Other|0|||
164365040|NCT01023581|593713162|FG002|Overall Study|Other|1|||
164365041|NCT01023581|593713163|FG003|Overall Study|Other|0|||
164365042|NCT01023581|593713164|FG004|Overall Study|Other|1|||
164365043|NCT01023581|593713165|FG005|Overall Study|Other|0|||
164365044|NCT01023581|593713166|FG006|Overall Study|Other|0|||
164365045|NCT02474199|593713167|FG000|Overall Study|Lost to Follow-up|1|||
164365046|NCT02474199|593713168|FG001|Overall Study|Lost to Follow-up|0|||
164591142|NCT01632878|594527232|FG000|Treatment|no information on study completion|43|||
164591143|NCT02698423|594527233|FG000|Overall Study|Lost to Follow-up|19|||
164591144|NCT02698423|594527234|FG001|Overall Study|Lost to Follow-up|24|||
164365047|NCT02474199|593713169|FG002|Overall Study|Lost to Follow-up|0|||
164365048|NCT02474199|593713170|FG003|Overall Study|Lost to Follow-up|0|||
164365049|NCT02474199|593713167|FG000|Overall Study|Withdrawal by Subject|1|||
164365050|NCT02474199|593713168|FG001|Overall Study|Withdrawal by Subject|2|||
164365051|NCT02474199|593713169|FG002|Overall Study|Withdrawal by Subject|0|||
164365052|NCT02474199|593713170|FG003|Overall Study|Withdrawal by Subject|1|||
164365053|NCT02474199|593713167|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
164365054|NCT02474199|593713168|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
164365055|NCT02474199|593713169|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
164365056|NCT02474199|593713170|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
164365057|NCT02474199|593713167|FG000|Overall Study|Did not meet eligibility criteria|0|||
164365058|NCT02474199|593713168|FG001|Overall Study|Did not meet eligibility criteria|0|||
164365059|NCT02474199|593713169|FG002|Overall Study|Did not meet eligibility criteria|2|||
164365060|NCT02474199|593713170|FG003|Overall Study|Did not meet eligibility criteria|2|||
164365061|NCT03314584|593713177|FG000|Overall Study|Withdrawal by Subject|3|||
164365062|NCT03314584|593713178|FG001|Overall Study|Withdrawal by Subject|3|||
164365063|NCT03314584|593713177|FG000|Overall Study|Lost to Follow-up|4|||
164365064|NCT03314584|593713178|FG001|Overall Study|Lost to Follow-up|0|||
164365065|NCT06134817|593713179|FG000|Overall Study|Physician Departure - termination of study|1|||
164365066|NCT03406858|593713186|FG000|Overall Study|Failure to receive treatment drug.|1|||
164365067|NCT03406858|593713186|FG000|Overall Study|ineligible|1|||
164365068|NCT06027866|593713187|FG000|Overall Study|Withdrawal by Subject|2|||
164365069|NCT01046682|593713194|FG000|Overall Study|Adverse Event|2|||
164591145|NCT03634072|594527235|FG000|Overall Study|Early termination of overall study|1|||
164591146|NCT03634072|594527236|FG001|Overall Study|Early termination of overall study|0|||
164699963|NCT00958126|594924833|FG002|Overall Study|Sponsor/Investigator decision|0|||
164365070|NCT01046682|593713195|FG001|Overall Study|Adverse Event|0|||
164365071|NCT05071183|593713198|FG000|Overall Study|Death|1|||
164365072|NCT05071183|593713199|FG001|Overall Study|Death|2|||
164365073|NCT05071183|593713200|FG002|Overall Study|Death|0|||
164365074|NCT05071183|593713198|FG000|Overall Study|Other Reasons|1|||
164365075|NCT05071183|593713199|FG001|Overall Study|Other Reasons|3|||
164365076|NCT05071183|593713200|FG002|Overall Study|Other Reasons|2|||
164365077|NCT02046148|593713201|FG000|Overall Study|Lost to Follow-up|1|||
164365078|NCT02046148|593713202|FG001|Overall Study|Lost to Follow-up|1|||
164365079|NCT02046148|593713201|FG000|Overall Study|Withdrawal by Subject|0|||
164365080|NCT02046148|593713202|FG001|Overall Study|Withdrawal by Subject|2|||
164365081|NCT03506373|593713204|FG000|Overall Study|Adverse Event|6|||
164365082|NCT03506373|593713204|FG000|Overall Study|Withdrawal by Subject|2|||
164365083|NCT03506373|593713204|FG000|Overall Study|Disease progression|5|||
164365084|NCT03506373|593713204|FG000|Overall Study|Other|3|||
164365085|NCT00107198|593713209|FG000|Overall Study|Lack of Efficacy|28|||
164365086|NCT00107198|593713209|FG000|Overall Study|Lost to Follow-up|12|||
164365087|NCT00107198|593713209|FG000|Overall Study|Protocol Violation|1|||
164365088|NCT00107198|593713209|FG000|Overall Study|Withdrawal by Subject|6|||
164365089|NCT00107198|593713209|FG000|Overall Study|Ineligible|5|||
164365090|NCT02939560|593713216|FG000|Overall Study|Withdrawal by Subject|2|||
164365091|NCT02939560|593713216|FG000|Overall Study|Protocol Violation|1|||
164365092|NCT03340025|593713217|FG000|Overall Study|Lost to Follow-up|2|||
164365093|NCT03340025|593713218|FG001|Overall Study|Lost to Follow-up|2|||
164365094|NCT02420691|593713219|FG000|Overall Study|Adverse Event|3|||
164365095|NCT02420691|593713219|FG000|Overall Study|Withdrawal by Subject|3|||
164365096|NCT01852812|593713220|FG000|Overall Study|Adverse Event|0|||
164365097|NCT01852812|593713221|FG001|Overall Study|Adverse Event|0|||
164365098|NCT01852812|593713222|FG002|Overall Study|Adverse Event|1|||
164438687|NCT00855465|593973038|FG001|Treatment Period|Not treated|0|||
164365099|NCT01852812|593713220|FG000|Overall Study|Non-compliance With Study Drug|0|||
164365100|NCT01852812|593713221|FG001|Overall Study|Non-compliance With Study Drug|1|||
164365101|NCT01852812|593713222|FG002|Overall Study|Non-compliance With Study Drug|0|||
164365102|NCT01293240|593713226|FG000|Overall Study|Noncompliance|2|||
164365103|NCT01520363|593713227|FG000|Overall Study|Withdrawal by Subject|2|||
164365104|NCT01520363|593713228|FG001|Overall Study|Withdrawal by Subject|0|||
164365105|NCT03165110|593713232|FG000|Overall Study|Anroid phone software incompatibility|1|||
164365106|NCT01498952|593713233|FG000|Overall Study|Death|2|||
164365107|NCT01498952|593713234|FG001|Overall Study|Death|2|||
164365108|NCT01498952|593713235|FG002|Overall Study|Death|0|||
164365109|NCT01498952|593713236|FG003|Overall Study|Death|0|||
164365110|NCT01498952|593713237|FG004|Overall Study|Death|0|||
164365111|NCT05533632|593713238|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
164365112|NCT05533632|593713238|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
164365113|NCT05533632|593713238|FG000|Overall Study|Lost to Follow-up|1|||
164365114|NCT05533632|593713238|FG000|Overall Study|Withdrawal by Subject|4|||
164365115|NCT05533632|593713238|FG000|Overall Study|Adverse Event|4|||
164365116|NCT00304356|593713239|FG000|Nitazoxanide|Physician Decision|5|||
164365117|NCT00304356|593713239|FG000|Nitazoxanide|Physician Decision|1|||
164365118|NCT00304356|593713239|FG000|Nitazoxanide|number is 0|1|||
164365119|NCT00304356|593713239|FG000|Nitazoxanide|Physician Decision|1|||
164365120|NCT00304356|593713239|FG000|Nitazoxanide|Physician Decision|1|||
164365121|NCT00304356|593713239|FG000|Nitazoxanide|Physician Decision|1|||
164365122|NCT01154218|593713240|FG000|Third Intervention Period|Adverse Event|0|||
164365123|NCT01154218|593713241|FG001|Third Intervention Period|Adverse Event|1|||
164365124|NCT01154218|593713242|FG002|Third Intervention Period|Adverse Event|0|||
164365125|NCT01154218|593713243|FG003|Third Intervention Period|Adverse Event|0|||
164365126|NCT01154218|593713240|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
164365127|NCT01154218|593713241|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
164365128|NCT01154218|593713242|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
164365129|NCT01154218|593713243|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
164365130|NCT01154218|593713240|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
164365131|NCT01154218|593713241|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
164365132|NCT01154218|593713242|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
164365133|NCT01154218|593713243|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
164365134|NCT01374087|593713247|FG000|Overall Study|Adverse Event|1|||
164438688|NCT00855465|593973037|FG000|Follow-up Period (FUP)|Adverse Event|0|||
164438689|NCT00855465|593973038|FG001|Follow-up Period (FUP)|Adverse Event|1|||
164438690|NCT00855465|593973037|FG000|Follow-up Period (FUP)|Death|0|||
164365135|NCT01374087|593713248|FG001|Overall Study|Adverse Event|0|||
164365136|NCT01374087|593713247|FG000|Overall Study|Disease progression|2|||
164365137|NCT01374087|593713248|FG001|Overall Study|Disease progression|2|||
164365138|NCT01374087|593713247|FG000|Overall Study|Study discontinued|13|||
164365139|NCT01374087|593713248|FG001|Overall Study|Study discontinued|13|||
164365140|NCT04690751|593713249|FG000|Overall Study|Protocol Violation|0|||
164365141|NCT04690751|593713250|FG001|Overall Study|Protocol Violation|1|||
164365142|NCT04690751|593713251|FG002|Overall Study|Protocol Violation|0|||
164438691|NCT00855465|593973038|FG001|Follow-up Period (FUP)|Death|1|||
164365143|NCT04690751|593713252|FG003|Overall Study|Protocol Violation|1|||
164365144|NCT04690751|593713253|FG004|Overall Study|Protocol Violation|2|||
164365145|NCT04690751|593713254|FG005|Overall Study|Protocol Violation|0|||
164365146|NCT04690751|593713249|FG000|Overall Study|Adverse Event|0|||
164365147|NCT04690751|593713250|FG001|Overall Study|Adverse Event|0|||
164365148|NCT04690751|593713251|FG002|Overall Study|Adverse Event|1|||
164365149|NCT04690751|593713252|FG003|Overall Study|Adverse Event|0|||
164365150|NCT04690751|593713253|FG004|Overall Study|Adverse Event|0|||
164365151|NCT04690751|593713254|FG005|Overall Study|Adverse Event|0|||
164365152|NCT04690751|593713249|FG000|Overall Study|Positive urine drug screen test|0|||
164365153|NCT04690751|593713250|FG001|Overall Study|Positive urine drug screen test|0|||
164365154|NCT04690751|593713251|FG002|Overall Study|Positive urine drug screen test|0|||
164365155|NCT04690751|593713252|FG003|Overall Study|Positive urine drug screen test|0|||
164365156|NCT04690751|593713253|FG004|Overall Study|Positive urine drug screen test|1|||
164365157|NCT04690751|593713254|FG005|Overall Study|Positive urine drug screen test|0|||
164365158|NCT01344161|593713255|FG000|Overall Study|Lost to Follow-up|4|||
164365159|NCT01344161|593713256|FG001|Overall Study|Lost to Follow-up|1|||
164365160|NCT01344161|593713255|FG000|Overall Study|Pregnancy|0|||
164365161|NCT01344161|593713256|FG001|Overall Study|Pregnancy|1|||
164365162|NCT01344161|593713255|FG000|Overall Study|Protocol Violation|1|||
164365163|NCT01344161|593713256|FG001|Overall Study|Protocol Violation|1|||
164365164|NCT04364620|593713257|FG000|Overall Study|Disease Progression|20|||
164365165|NCT04364620|593713257|FG000|Overall Study|Adverse Event|5|||
164365166|NCT04364620|593713257|FG000|Overall Study|Physician Decision|4|||
164365167|NCT04364620|593713257|FG000|Overall Study|Death|3|||
164365168|NCT04364620|593713257|FG000|Overall Study|Other|2|||
164365169|NCT04364620|593713257|FG000|Overall Study|Withdrawal by Subject|1|||
164365170|NCT03336216|593714995|FG000|Randomization|Not reported|2|||
164365171|NCT03336216|593714996|FG001|Randomization|Not reported|0|||
164365172|NCT03336216|593714997|FG002|Randomization|Not reported|1|||
164365173|NCT03336216|593714998|FG003|Randomization|Not reported|0|||
164365174|NCT03336216|593714995|FG000|Randomization|Other reasons|1|||
164365175|NCT03336216|593714996|FG001|Randomization|Other reasons|1|||
164365176|NCT03336216|593714997|FG002|Randomization|Other reasons|1|||
164365177|NCT03336216|593714998|FG003|Randomization|Other reasons|0|||
164365178|NCT03336216|593714995|FG000|Randomization|Participant no longer meets study criteria|0|||
164365179|NCT03336216|593714996|FG001|Randomization|Participant no longer meets study criteria|2|||
164365180|NCT03336216|593714997|FG002|Randomization|Participant no longer meets study criteria|4|||
164365181|NCT03336216|593714998|FG003|Randomization|Participant no longer meets study criteria|1|||
164365182|NCT03336216|593714995|FG000|Randomization|Lost to Follow-up|1|||
164365183|NCT03336216|593714996|FG001|Randomization|Lost to Follow-up|0|||
164365184|NCT03336216|593714997|FG002|Randomization|Lost to Follow-up|0|||
164365185|NCT03336216|593714998|FG003|Randomization|Lost to Follow-up|0|||
164365186|NCT03336216|593714995|FG000|Randomization|Participant withdrew consent|9|||
164365187|NCT03336216|593714996|FG001|Randomization|Participant withdrew consent|1|||
164365188|NCT03336216|593714997|FG002|Randomization|Participant withdrew consent|0|||
164365189|NCT03336216|593714998|FG003|Randomization|Participant withdrew consent|0|||
164365190|NCT03336216|593714995|FG000|Randomization|Adverse Event|1|||
164365191|NCT03336216|593714996|FG001|Randomization|Adverse Event|1|||
164365192|NCT03336216|593714997|FG002|Randomization|Adverse Event|0|||
164365193|NCT03336216|593714998|FG003|Randomization|Adverse Event|0|||
164365194|NCT03336216|593714995|FG000|Treatment|Adverse Event|2|||
164365195|NCT03336216|593714996|FG001|Treatment|Adverse Event|3|||
164365196|NCT03336216|593714997|FG002|Treatment|Adverse Event|4|||
164365197|NCT03336216|593714998|FG003|Treatment|Adverse Event|4|||
164365198|NCT03336216|593714995|FG000|Treatment|Participant request to discontinue treatment|2|||
164365199|NCT03336216|593714996|FG001|Treatment|Participant request to discontinue treatment|1|||
164365200|NCT03336216|593714997|FG002|Treatment|Participant request to discontinue treatment|2|||
164365201|NCT03336216|593714998|FG003|Treatment|Participant request to discontinue treatment|2|||
164365202|NCT03336216|593714995|FG000|Treatment|Participant withdrew consent|7|||
164591147|NCT01558089|594527239|FG000|Overall Study|Adverse Event|1|||
164591148|NCT01558089|594527239|FG000|Overall Study|Lack of Efficacy|1|||
164365203|NCT03336216|593714996|FG001|Treatment|Participant withdrew consent|2|||
164365204|NCT03336216|593714997|FG002|Treatment|Participant withdrew consent|3|||
164365205|NCT03336216|593714998|FG003|Treatment|Participant withdrew consent|2|||
164365206|NCT03336216|593714995|FG000|Treatment|Death|2|||
164365207|NCT03336216|593714996|FG001|Treatment|Death|3|||
164365208|NCT03336216|593714997|FG002|Treatment|Death|3|||
164591149|NCT01558089|594527239|FG000|Overall Study|Lost to Follow-up|5|||
164365209|NCT03336216|593714998|FG003|Treatment|Death|4|||
164365210|NCT03336216|593714995|FG000|Treatment|Participant no longer meets study criteria|0|||
164365211|NCT03336216|593714996|FG001|Treatment|Participant no longer meets study criteria|1|||
164365212|NCT03336216|593714997|FG002|Treatment|Participant no longer meets study criteria|0|||
164591150|NCT01558089|594527239|FG000|Overall Study|Withdrawal by Subject|6|||
164365213|NCT03336216|593714998|FG003|Treatment|Participant no longer meets study criteria|0|||
164365214|NCT03336216|593714995|FG000|Treatment|Other reasons|2|||
164365215|NCT03336216|593714996|FG001|Treatment|Other reasons|0|||
164365216|NCT03336216|593714997|FG002|Treatment|Other reasons|0|||
164591151|NCT01597193|594527240|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
164365217|NCT03336216|593714998|FG003|Treatment|Other reasons|3|||
164365218|NCT03336216|593714995|FG000|Treatment|Disease progression|23|||
164365219|NCT03336216|593714996|FG001|Treatment|Disease progression|34|||
164365220|NCT03336216|593714997|FG002|Treatment|Disease progression|33|||
164365221|NCT03336216|593714998|FG003|Treatment|Disease progression|26|||
164365222|NCT03336216|593714995|FG000|Treatment|Study drug toxicity|0|||
164365223|NCT03336216|593714996|FG001|Treatment|Study drug toxicity|3|||
164365224|NCT03336216|593714997|FG002|Treatment|Study drug toxicity|2|||
164365225|NCT03336216|593714998|FG003|Treatment|Study drug toxicity|0|||
164365226|NCT03336216|593714995|FG000|Treatment|Adverse Event unrelated to study drug|1|||
164365227|NCT03336216|593714996|FG001|Treatment|Adverse Event unrelated to study drug|1|||
164365228|NCT03336216|593714997|FG002|Treatment|Adverse Event unrelated to study drug|1|||
164699964|NCT00958126|594924834|FG003|Overall Study|Sponsor/Investigator decision|1|||
164699965|NCT00958126|594924835|FG004|Overall Study|Sponsor/Investigator decision|0|||
164699966|NCT00958126|594924836|FG005|Overall Study|Sponsor/Investigator decision|0|||
164699967|NCT00958126|594924837|FG006|Overall Study|Sponsor/Investigator decision|0|||
164699968|NCT00958126|594924838|FG007|Overall Study|Sponsor/Investigator decision|0|||
164699969|NCT00958126|594924831|FG000|Overall Study|Other Reason|0|||
164699970|NCT00958126|594924832|FG001|Overall Study|Other Reason|0|||
164699971|NCT00958126|594924833|FG002|Overall Study|Other Reason|0|||
164699972|NCT00958126|594924834|FG003|Overall Study|Other Reason|1|||
164699973|NCT00958126|594924835|FG004|Overall Study|Other Reason|0|||
164699974|NCT00958126|594924836|FG005|Overall Study|Other Reason|1|||
164699975|NCT00958126|594924837|FG006|Overall Study|Other Reason|0|||
164699976|NCT00958126|594924838|FG007|Overall Study|Other Reason|0|||
164699977|NCT00720226|594924839|FG000|Overall Study|Withdrawal by Subject|7|||
164365229|NCT03336216|593714998|FG003|Treatment|Adverse Event unrelated to study drug|0|||
164365230|NCT03336216|593714995|FG000|Treatment|Disease Recurrence|1|||
164365231|NCT03336216|593714996|FG001|Treatment|Disease Recurrence|0|||
164365232|NCT03336216|593714997|FG002|Treatment|Disease Recurrence|0|||
164365233|NCT03336216|593714998|FG003|Treatment|Disease Recurrence|0|||
164365234|NCT00922766|593715001|FG000|Overall Study|Death|3|||
164365235|NCT00922766|593715001|FG000|Overall Study|Withdrawal by Subject|2|||
164365236|NCT00922766|593715001|FG000|Overall Study|Other|1|||
164365237|NCT00922766|593715001|FG000|Overall Study|Adverse Event|1|||
164365238|NCT02658890|593715010|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365239|NCT02658890|593715011|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365240|NCT02658890|593715012|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365241|NCT02658890|593715013|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365242|NCT02658890|593715014|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365243|NCT02658890|593715015|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365244|NCT02658890|593715016|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365245|NCT02658890|593715017|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365246|NCT02658890|593715018|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
164365247|NCT02658890|593715019|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365248|NCT02658890|593715020|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365249|NCT02658890|593715021|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365250|NCT02658890|593715022|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365251|NCT02658890|593715023|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365252|NCT02658890|593715024|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365253|NCT02658890|593715025|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365254|NCT02658890|593715026|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365255|NCT02658890|593715027|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365256|NCT02658890|593715028|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365257|NCT02658890|593715029|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365258|NCT02658890|593715030|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365259|NCT02658890|593715031|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365260|NCT02658890|593715032|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365261|NCT02658890|593715033|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365262|NCT02658890|593715034|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365263|NCT02658890|593715035|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365264|NCT02658890|593715036|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365265|NCT02658890|593715010|FG000|Treatment Phase|Adverse Event|0|||
164365266|NCT02658890|593715011|FG001|Treatment Phase|Adverse Event|1|||
164365267|NCT02658890|593715012|FG002|Treatment Phase|Adverse Event|2|||
164365268|NCT02658890|593715013|FG003|Treatment Phase|Adverse Event|2|||
164699978|NCT00720226|594924840|FG001|Overall Study|Withdrawal by Subject|4|||
164699979|NCT03401073|594924841|FG000|Overall Study|Lost to Follow-up|1|||
164699980|NCT03401073|594924842|FG001|Overall Study|Lost to Follow-up|2|||
164365269|NCT02658890|593715014|FG004|Treatment Phase|Adverse Event|1|||
164365270|NCT02658890|593715015|FG005|Treatment Phase|Adverse Event|0|||
164365271|NCT02658890|593715016|FG006|Treatment Phase|Adverse Event|0|||
164365272|NCT02658890|593715017|FG007|Treatment Phase|Adverse Event|2|||
164365273|NCT02658890|593715018|FG008|Treatment Phase|Adverse Event|1|||
164365274|NCT02658890|593715019|FG009|Treatment Phase|Adverse Event|2|||
164365275|NCT02658890|593715020|FG010|Treatment Phase|Adverse Event|3|||
164365276|NCT02658890|593715021|FG011|Treatment Phase|Adverse Event|0|||
164365277|NCT02658890|593715022|FG012|Treatment Phase|Adverse Event|1|||
164365278|NCT02658890|593715023|FG013|Treatment Phase|Adverse Event|4|||
164365279|NCT02658890|593715024|FG014|Treatment Phase|Adverse Event|0|||
164365280|NCT02658890|593715025|FG015|Treatment Phase|Adverse Event|0|||
164365281|NCT02658890|593715026|FG016|Treatment Phase|Adverse Event|0|||
164365282|NCT02658890|593715027|FG017|Treatment Phase|Adverse Event|0|||
164365283|NCT02658890|593715028|FG018|Treatment Phase|Adverse Event|5|||
164365284|NCT02658890|593715029|FG019|Treatment Phase|Adverse Event|1|||
164365285|NCT02658890|593715030|FG020|Treatment Phase|Adverse Event|3|||
164365286|NCT02658890|593715031|FG021|Treatment Phase|Adverse Event|0|||
164365287|NCT02658890|593715032|FG022|Treatment Phase|Adverse Event|5|||
164365288|NCT02658890|593715033|FG023|Treatment Phase|Adverse Event|0|||
164365289|NCT02658890|593715034|FG024|Treatment Phase|Adverse Event|0|||
164365290|NCT02658890|593715035|FG025|Treatment Phase|Adverse Event|2|||
164365291|NCT02658890|593715036|FG026|Treatment Phase|Adverse Event|1|||
164365292|NCT02658890|593715010|FG000|Treatment Phase|Death|0|||
164365293|NCT02658890|593715011|FG001|Treatment Phase|Death|0|||
164365294|NCT02658890|593715012|FG002|Treatment Phase|Death|0|||
164365295|NCT02658890|593715013|FG003|Treatment Phase|Death|0|||
164365296|NCT02658890|593715014|FG004|Treatment Phase|Death|0|||
164365297|NCT02658890|593715015|FG005|Treatment Phase|Death|0|||
164365298|NCT02658890|593715016|FG006|Treatment Phase|Death|0|||
164365299|NCT02658890|593715017|FG007|Treatment Phase|Death|0|||
164365300|NCT02658890|593715018|FG008|Treatment Phase|Death|0|||
164365301|NCT02658890|593715019|FG009|Treatment Phase|Death|0|||
164365302|NCT02658890|593715020|FG010|Treatment Phase|Death|0|||
164365303|NCT02658890|593715021|FG011|Treatment Phase|Death|0|||
164365304|NCT02658890|593715022|FG012|Treatment Phase|Death|0|||
164365305|NCT02658890|593715023|FG013|Treatment Phase|Death|0|||
164365306|NCT02658890|593715024|FG014|Treatment Phase|Death|0|||
164365307|NCT02658890|593715025|FG015|Treatment Phase|Death|0|||
164365308|NCT02658890|593715026|FG016|Treatment Phase|Death|0|||
164365309|NCT02658890|593715027|FG017|Treatment Phase|Death|0|||
164365310|NCT02658890|593715028|FG018|Treatment Phase|Death|1|||
164365311|NCT02658890|593715029|FG019|Treatment Phase|Death|0|||
164365312|NCT02658890|593715030|FG020|Treatment Phase|Death|0|||
164365313|NCT02658890|593715031|FG021|Treatment Phase|Death|0|||
164365314|NCT02658890|593715032|FG022|Treatment Phase|Death|0|||
164365315|NCT02658890|593715033|FG023|Treatment Phase|Death|0|||
164365316|NCT02658890|593715034|FG024|Treatment Phase|Death|0|||
164365317|NCT02658890|593715035|FG025|Treatment Phase|Death|0|||
164365318|NCT02658890|593715036|FG026|Treatment Phase|Death|0|||
164365319|NCT02658890|593715010|FG000|Treatment Phase|Lost to Follow-up|0|||
164365320|NCT02658890|593715011|FG001|Treatment Phase|Lost to Follow-up|0|||
164365321|NCT02658890|593715012|FG002|Treatment Phase|Lost to Follow-up|0|||
164365322|NCT02658890|593715013|FG003|Treatment Phase|Lost to Follow-up|0|||
164365323|NCT02658890|593715014|FG004|Treatment Phase|Lost to Follow-up|0|||
164365324|NCT02658890|593715015|FG005|Treatment Phase|Lost to Follow-up|0|||
164365325|NCT02658890|593715016|FG006|Treatment Phase|Lost to Follow-up|1|||
164365326|NCT02658890|593715017|FG007|Treatment Phase|Lost to Follow-up|0|||
164365327|NCT02658890|593715018|FG008|Treatment Phase|Lost to Follow-up|0|||
164365328|NCT02658890|593715019|FG009|Treatment Phase|Lost to Follow-up|0|||
164365329|NCT02658890|593715020|FG010|Treatment Phase|Lost to Follow-up|0|||
164365330|NCT02658890|593715021|FG011|Treatment Phase|Lost to Follow-up|0|||
164365331|NCT02658890|593715022|FG012|Treatment Phase|Lost to Follow-up|0|||
164365332|NCT02658890|593715023|FG013|Treatment Phase|Lost to Follow-up|0|||
164365333|NCT02658890|593715024|FG014|Treatment Phase|Lost to Follow-up|0|||
164591152|NCT01597193|594527241|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
164591153|NCT01597193|594527242|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
164591154|NCT01597193|594527243|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
164591155|NCT01597193|594527244|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
164591156|NCT01597193|594527245|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
164591157|NCT01597193|594527246|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
164591158|NCT01597193|594527240|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
164591159|NCT01597193|594527241|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
164591160|NCT01597193|594527242|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
164365334|NCT02658890|593715025|FG015|Treatment Phase|Lost to Follow-up|0|||
164365335|NCT02658890|593715026|FG016|Treatment Phase|Lost to Follow-up|0|||
164365336|NCT02658890|593715027|FG017|Treatment Phase|Lost to Follow-up|0|||
164365337|NCT02658890|593715028|FG018|Treatment Phase|Lost to Follow-up|0|||
164365338|NCT02658890|593715029|FG019|Treatment Phase|Lost to Follow-up|0|||
164365339|NCT02658890|593715030|FG020|Treatment Phase|Lost to Follow-up|0|||
164365340|NCT02658890|593715031|FG021|Treatment Phase|Lost to Follow-up|0|||
164591161|NCT01597193|594527243|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
164591162|NCT01597193|594527244|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
164591163|NCT01597193|594527245|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
164591164|NCT01597193|594527246|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
164591165|NCT01597193|594527240|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
164591166|NCT01597193|594527241|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
164591167|NCT01597193|594527242|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
164591168|NCT01597193|594527243|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
164591169|NCT01597193|594527244|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
164591170|NCT01597193|594527245|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
164591171|NCT01597193|594527246|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
164591172|NCT01597193|594527240|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
164591173|NCT01597193|594527241|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
164591174|NCT01597193|594527242|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
164591175|NCT01597193|594527243|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
164591176|NCT01597193|594527244|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
164591177|NCT01597193|594527245|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
164591178|NCT01597193|594527246|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
164591179|NCT01597193|594527240|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
164591180|NCT01597193|594527241|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
164591181|NCT01597193|594527242|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
164591182|NCT01597193|594527243|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
164591183|NCT01597193|594527244|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
164591184|NCT01597193|594527245|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
164591185|NCT01597193|594527246|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
164591186|NCT03184701|594527248|FG000|Overall Study|Death|3|||
164365341|NCT02658890|593715032|FG022|Treatment Phase|Lost to Follow-up|0|||
164365342|NCT02658890|593715033|FG023|Treatment Phase|Lost to Follow-up|0|||
164365343|NCT02658890|593715034|FG024|Treatment Phase|Lost to Follow-up|0|||
164365344|NCT02658890|593715035|FG025|Treatment Phase|Lost to Follow-up|0|||
164365345|NCT02658890|593715036|FG026|Treatment Phase|Lost to Follow-up|0|||
164365346|NCT02658890|593715010|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
164365347|NCT02658890|593715011|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
164365348|NCT02658890|593715012|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
164365349|NCT02658890|593715013|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
164365350|NCT02658890|593715014|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
164365351|NCT02658890|593715015|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
164365352|NCT02658890|593715016|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
164365353|NCT02658890|593715017|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
164365354|NCT02658890|593715018|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
164365355|NCT02658890|593715019|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
164365356|NCT02658890|593715020|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
164365357|NCT02658890|593715021|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
164365358|NCT02658890|593715022|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
164365359|NCT02658890|593715023|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
164365360|NCT02658890|593715024|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
164365361|NCT02658890|593715025|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
164365362|NCT02658890|593715026|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
164365363|NCT02658890|593715027|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
164365364|NCT02658890|593715028|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
164365365|NCT02658890|593715029|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
164591187|NCT03184701|594527248|FG000|Overall Study|Physician Decision|3|||
164591188|NCT03184701|594527248|FG000|Overall Study|Withdrawal by Subject|6|||
164591189|NCT03184701|594527248|FG000|Overall Study|Lost to Follow-up|5|||
164591190|NCT00064662|594527251|FG000|Overall Study|Death|1|||
164591191|NCT00064662|594527252|FG001|Overall Study|Death|1|||
164591192|NCT00064662|594527251|FG000|Overall Study|Lost to Follow-up|57|||
164591193|NCT00064662|594527252|FG001|Overall Study|Lost to Follow-up|44|||
164591194|NCT00064662|594527251|FG000|Overall Study|Withdrawal by Subject|14|||
164591195|NCT00064662|594527252|FG001|Overall Study|Withdrawal by Subject|14|||
164591196|NCT00064662|594527251|FG000|Overall Study|Administratively withdrawn|2|||
164591197|NCT00064662|594527252|FG001|Overall Study|Administratively withdrawn|2|||
164591198|NCT00933335|594527253|FG000|Overall Study|Lost to Follow-up|1|||
164591199|NCT00933335|594527254|FG001|Overall Study|Lost to Follow-up|3|||
164591200|NCT00933335|594527253|FG000|Overall Study|Withdrawal by Subject|0|||
164591201|NCT00933335|594527254|FG001|Overall Study|Withdrawal by Subject|1|||
164365366|NCT02658890|593715030|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
164365367|NCT02658890|593715031|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
164365368|NCT02658890|593715032|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
164365369|NCT02658890|593715033|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
164365370|NCT02658890|593715034|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
164365371|NCT02658890|593715035|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
164365372|NCT02658890|593715036|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
164591202|NCT00933335|594527253|FG000|Overall Study|Progressive Disease|0|||
164365373|NCT02658890|593715010|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
164365374|NCT02658890|593715011|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
164365375|NCT02658890|593715012|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
164365376|NCT02658890|593715013|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
164365377|NCT02658890|593715014|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
164365378|NCT02658890|593715015|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
164365379|NCT02658890|593715016|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
164365380|NCT02658890|593715017|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
164365381|NCT02658890|593715018|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
164365382|NCT02658890|593715019|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
164365383|NCT02658890|593715020|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
164365384|NCT02658890|593715021|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
164365385|NCT02658890|593715022|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
164365386|NCT02658890|593715023|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
164365387|NCT02658890|593715024|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
164365388|NCT02658890|593715025|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
164365389|NCT02658890|593715026|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
164365390|NCT02658890|593715027|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
164365391|NCT02658890|593715028|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
164365392|NCT02658890|593715029|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
164365393|NCT02658890|593715030|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
164365394|NCT02658890|593715031|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
164365395|NCT02658890|593715032|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
164365396|NCT02658890|593715033|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
164365397|NCT02658890|593715034|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
164365398|NCT02658890|593715035|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
164365399|NCT02658890|593715036|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
164365400|NCT02658890|593715010|FG000|Treatment Phase|Other Reasons|0|||
164365401|NCT02658890|593715011|FG001|Treatment Phase|Other Reasons|0|||
164365402|NCT02658890|593715012|FG002|Treatment Phase|Other Reasons|0|||
164365403|NCT02658890|593715013|FG003|Treatment Phase|Other Reasons|0|||
164365404|NCT02658890|593715014|FG004|Treatment Phase|Other Reasons|0|||
164365405|NCT02658890|593715015|FG005|Treatment Phase|Other Reasons|0|||
164365406|NCT02658890|593715016|FG006|Treatment Phase|Other Reasons|1|||
164365407|NCT02658890|593715017|FG007|Treatment Phase|Other Reasons|0|||
164365408|NCT02658890|593715018|FG008|Treatment Phase|Other Reasons|1|||
164365409|NCT02658890|593715019|FG009|Treatment Phase|Other Reasons|0|||
164365410|NCT02658890|593715020|FG010|Treatment Phase|Other Reasons|0|||
164365411|NCT02658890|593715021|FG011|Treatment Phase|Other Reasons|0|||
164365412|NCT02658890|593715022|FG012|Treatment Phase|Other Reasons|0|||
164365413|NCT02658890|593715023|FG013|Treatment Phase|Other Reasons|2|||
164365414|NCT02658890|593715024|FG014|Treatment Phase|Other Reasons|0|||
164365415|NCT02658890|593715025|FG015|Treatment Phase|Other Reasons|0|||
164365416|NCT02658890|593715026|FG016|Treatment Phase|Other Reasons|0|||
164365417|NCT02658890|593715027|FG017|Treatment Phase|Other Reasons|0|||
164365418|NCT02658890|593715028|FG018|Treatment Phase|Other Reasons|1|||
164365419|NCT02658890|593715029|FG019|Treatment Phase|Other Reasons|0|||
164365420|NCT02658890|593715030|FG020|Treatment Phase|Other Reasons|0|||
164365421|NCT02658890|593715031|FG021|Treatment Phase|Other Reasons|0|||
164365422|NCT02658890|593715032|FG022|Treatment Phase|Other Reasons|0|||
164365423|NCT02658890|593715033|FG023|Treatment Phase|Other Reasons|0|||
164365424|NCT02658890|593715034|FG024|Treatment Phase|Other Reasons|1|||
164365425|NCT02658890|593715035|FG025|Treatment Phase|Other Reasons|0|||
164365426|NCT02658890|593715036|FG026|Treatment Phase|Other Reasons|1|||
164365427|NCT02658890|593715010|FG000|Treatment Phase|Progressive Disease|6|||
164365428|NCT02658890|593715011|FG001|Treatment Phase|Progressive Disease|7|||
164365429|NCT02658890|593715012|FG002|Treatment Phase|Progressive Disease|6|||
164365430|NCT02658890|593715013|FG003|Treatment Phase|Progressive Disease|12|||
164365431|NCT02658890|593715014|FG004|Treatment Phase|Progressive Disease|6|||
164365432|NCT02658890|593715015|FG005|Treatment Phase|Progressive Disease|18|||
164365433|NCT02658890|593715016|FG006|Treatment Phase|Progressive Disease|12|||
164365434|NCT02658890|593715017|FG007|Treatment Phase|Progressive Disease|19|||
164365435|NCT02658890|593715018|FG008|Treatment Phase|Progressive Disease|26|||
164591203|NCT00933335|594527254|FG001|Overall Study|Progressive Disease|11|||
164591204|NCT00933335|594527253|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
164591205|NCT00933335|594527254|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
164591206|NCT00933335|594527253|FG000|Overall Study|Co-morbid Illness|1|||
164591207|NCT00933335|594527254|FG001|Overall Study|Co-morbid Illness|0|||
164591208|NCT01165203|594527257|FG000|Active Phase|Serious Adverse Event|1|||
164591209|NCT01165203|594527258|FG001|Active Phase|Serious Adverse Event|0|||
164365436|NCT02658890|593715019|FG009|Treatment Phase|Progressive Disease|8|||
164591210|NCT01165203|594527257|FG000|Active Phase|Withdrawal by Subject|2|||
164365437|NCT02658890|593715020|FG010|Treatment Phase|Progressive Disease|7|||
164591211|NCT01165203|594527258|FG001|Active Phase|Withdrawal by Subject|1|||
164591212|NCT01165203|594527257|FG000|Active Phase|Migrated/moved from study area|0|||
164365438|NCT02658890|593715021|FG011|Treatment Phase|Progressive Disease|9|||
164365439|NCT02658890|593715022|FG012|Treatment Phase|Progressive Disease|8|||
164699981|NCT00733369|594924843|FG000|Overall Study|Lost to Follow-up|2|||
164699982|NCT00733369|594924844|FG001|Overall Study|Lost to Follow-up|1|||
164699983|NCT00733369|594924843|FG000|Overall Study|Adverse Event|4|||
164699984|NCT00733369|594924844|FG001|Overall Study|Adverse Event|4|||
164699985|NCT00733369|594924843|FG000|Overall Study|Protocol Violation|4|||
164699986|NCT00733369|594924844|FG001|Overall Study|Protocol Violation|4|||
164699987|NCT01020799|594924845|FG000|Overall Study|Adverse Event|4|||
164365440|NCT02658890|593715023|FG013|Treatment Phase|Progressive Disease|29|||
164365441|NCT02658890|593715024|FG014|Treatment Phase|Progressive Disease|6|||
164365442|NCT02658890|593715025|FG015|Treatment Phase|Progressive Disease|2|||
164365443|NCT02658890|593715026|FG016|Treatment Phase|Progressive Disease|32|||
164365444|NCT02658890|593715027|FG017|Treatment Phase|Progressive Disease|14|||
164365445|NCT02658890|593715028|FG018|Treatment Phase|Progressive Disease|40|||
164365446|NCT02658890|593715029|FG019|Treatment Phase|Progressive Disease|32|||
164365447|NCT02658890|593715030|FG020|Treatment Phase|Progressive Disease|19|||
164365448|NCT02658890|593715031|FG021|Treatment Phase|Progressive Disease|30|||
164365449|NCT02658890|593715032|FG022|Treatment Phase|Progressive Disease|15|||
164365450|NCT02658890|593715033|FG023|Treatment Phase|Progressive Disease|0|||
164365451|NCT02658890|593715034|FG024|Treatment Phase|Progressive Disease|0|||
164365452|NCT02658890|593715035|FG025|Treatment Phase|Progressive Disease|14|||
164365453|NCT02658890|593715036|FG026|Treatment Phase|Progressive Disease|11|||
164365454|NCT02658890|593715010|FG000|Treatment Phase|Study Drug Toxicity|0|||
164365455|NCT02658890|593715011|FG001|Treatment Phase|Study Drug Toxicity|0|||
164365456|NCT02658890|593715012|FG002|Treatment Phase|Study Drug Toxicity|2|||
164365457|NCT02658890|593715013|FG003|Treatment Phase|Study Drug Toxicity|0|||
164365458|NCT02658890|593715014|FG004|Treatment Phase|Study Drug Toxicity|0|||
164365459|NCT02658890|593715015|FG005|Treatment Phase|Study Drug Toxicity|0|||
164365460|NCT02658890|593715016|FG006|Treatment Phase|Study Drug Toxicity|0|||
164365461|NCT02658890|593715017|FG007|Treatment Phase|Study Drug Toxicity|0|||
164365462|NCT02658890|593715018|FG008|Treatment Phase|Study Drug Toxicity|3|||
164365463|NCT02658890|593715019|FG009|Treatment Phase|Study Drug Toxicity|0|||
164365464|NCT02658890|593715020|FG010|Treatment Phase|Study Drug Toxicity|1|||
164365465|NCT02658890|593715021|FG011|Treatment Phase|Study Drug Toxicity|1|||
164365466|NCT02658890|593715022|FG012|Treatment Phase|Study Drug Toxicity|2|||
164365467|NCT02658890|593715023|FG013|Treatment Phase|Study Drug Toxicity|9|||
164699988|NCT01020799|594924846|FG001|Overall Study|Adverse Event|3|||
164365468|NCT02658890|593715024|FG014|Treatment Phase|Study Drug Toxicity|0|||
164365469|NCT02658890|593715025|FG015|Treatment Phase|Study Drug Toxicity|1|||
164365470|NCT02658890|593715026|FG016|Treatment Phase|Study Drug Toxicity|1|||
164365471|NCT02658890|593715027|FG017|Treatment Phase|Study Drug Toxicity|0|||
164365472|NCT02658890|593715028|FG018|Treatment Phase|Study Drug Toxicity|8|||
164365473|NCT02658890|593715029|FG019|Treatment Phase|Study Drug Toxicity|3|||
164365474|NCT02658890|593715030|FG020|Treatment Phase|Study Drug Toxicity|2|||
164365475|NCT02658890|593715031|FG021|Treatment Phase|Study Drug Toxicity|0|||
164365476|NCT02658890|593715032|FG022|Treatment Phase|Study Drug Toxicity|8|||
164365477|NCT02658890|593715033|FG023|Treatment Phase|Study Drug Toxicity|0|||
164365478|NCT02658890|593715034|FG024|Treatment Phase|Study Drug Toxicity|0|||
164365479|NCT02658890|593715035|FG025|Treatment Phase|Study Drug Toxicity|2|||
164365480|NCT02658890|593715036|FG026|Treatment Phase|Study Drug Toxicity|0|||
164365481|NCT02658890|593715010|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365482|NCT02658890|593715011|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365483|NCT02658890|593715012|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365484|NCT02658890|593715013|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
164365485|NCT02658890|593715014|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365486|NCT02658890|593715015|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365487|NCT02658890|593715016|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365488|NCT02658890|593715017|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164438692|NCT00855465|593973037|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
164438693|NCT00855465|593973038|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
164438694|NCT00855465|593973037|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
164699989|NCT01020799|594924847|FG002|Overall Study|Adverse Event|2|||
164699990|NCT01020799|594924845|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
164365489|NCT02658890|593715018|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365490|NCT02658890|593715019|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
164365491|NCT02658890|593715020|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365492|NCT02658890|593715021|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365493|NCT02658890|593715022|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365494|NCT02658890|593715023|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365495|NCT02658890|593715024|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365496|NCT02658890|593715025|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365497|NCT02658890|593715026|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365498|NCT02658890|593715027|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365499|NCT02658890|593715028|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
164365500|NCT02658890|593715029|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365501|NCT02658890|593715030|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365502|NCT02658890|593715031|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365503|NCT02658890|593715032|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
164365504|NCT02658890|593715033|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365505|NCT02658890|593715034|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365506|NCT02658890|593715035|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365507|NCT02658890|593715036|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365508|NCT02658890|593715010|FG000|Treatment Phase|Withdrawal by Subject|0|||
164365509|NCT02658890|593715011|FG001|Treatment Phase|Withdrawal by Subject|1|||
164365510|NCT02658890|593715012|FG002|Treatment Phase|Withdrawal by Subject|0|||
164365511|NCT02658890|593715013|FG003|Treatment Phase|Withdrawal by Subject|0|||
164365512|NCT02658890|593715014|FG004|Treatment Phase|Withdrawal by Subject|0|||
164365513|NCT02658890|593715015|FG005|Treatment Phase|Withdrawal by Subject|0|||
164365514|NCT02658890|593715016|FG006|Treatment Phase|Withdrawal by Subject|1|||
164365515|NCT02658890|593715017|FG007|Treatment Phase|Withdrawal by Subject|0|||
164365516|NCT02658890|593715018|FG008|Treatment Phase|Withdrawal by Subject|0|||
164365517|NCT02658890|593715019|FG009|Treatment Phase|Withdrawal by Subject|1|||
164365518|NCT02658890|593715020|FG010|Treatment Phase|Withdrawal by Subject|0|||
164365519|NCT02658890|593715021|FG011|Treatment Phase|Withdrawal by Subject|0|||
164365520|NCT02658890|593715022|FG012|Treatment Phase|Withdrawal by Subject|1|||
164365521|NCT02658890|593715023|FG013|Treatment Phase|Withdrawal by Subject|3|||
164365522|NCT02658890|593715024|FG014|Treatment Phase|Withdrawal by Subject|0|||
164365523|NCT02658890|593715025|FG015|Treatment Phase|Withdrawal by Subject|0|||
164365524|NCT02658890|593715026|FG016|Treatment Phase|Withdrawal by Subject|1|||
164365525|NCT02658890|593715027|FG017|Treatment Phase|Withdrawal by Subject|0|||
164365526|NCT02658890|593715028|FG018|Treatment Phase|Withdrawal by Subject|4|||
164365527|NCT02658890|593715029|FG019|Treatment Phase|Withdrawal by Subject|3|||
164365528|NCT02658890|593715030|FG020|Treatment Phase|Withdrawal by Subject|0|||
164365529|NCT02658890|593715031|FG021|Treatment Phase|Withdrawal by Subject|4|||
164365530|NCT02658890|593715032|FG022|Treatment Phase|Withdrawal by Subject|1|||
164365531|NCT02658890|593715033|FG023|Treatment Phase|Withdrawal by Subject|1|||
164365532|NCT02658890|593715034|FG024|Treatment Phase|Withdrawal by Subject|0|||
164365533|NCT02658890|593715035|FG025|Treatment Phase|Withdrawal by Subject|0|||
164365534|NCT02658890|593715036|FG026|Treatment Phase|Withdrawal by Subject|0|||
164365535|NCT02404311|593715037|FG000|Part A: Month 0-18|Death|2|||
164365536|NCT02404311|593715038|FG001|Part A: Month 0-18|Death|0|||
164365537|NCT02404311|593715039|FG002|Part A: Month 0-18|Death|0|||
164365538|NCT02404311|593715040|FG003|Part A: Month 0-18|Death|0|||
164365539|NCT02404311|593715041|FG004|Part A: Month 0-18|Death|0|||
164365540|NCT02404311|593715037|FG000|Part A: Month 0-18|Physician Decision|1|||
164365541|NCT02404311|593715038|FG001|Part A: Month 0-18|Physician Decision|0|||
164365542|NCT02404311|593715039|FG002|Part A: Month 0-18|Physician Decision|0|||
164365543|NCT02404311|593715040|FG003|Part A: Month 0-18|Physician Decision|0|||
164365544|NCT02404311|593715041|FG004|Part A: Month 0-18|Physician Decision|0|||
164365545|NCT02404311|593715037|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
164365546|NCT02404311|593715038|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
164365547|NCT02404311|593715039|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
164365548|NCT02404311|593715040|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
164365549|NCT02404311|593715041|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
164365550|NCT02404311|593715037|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
164365551|NCT02404311|593715038|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
164365552|NCT02404311|593715039|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
164365553|NCT02404311|593715040|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
164365554|NCT02404311|593715041|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
164591213|NCT01165203|594527258|FG001|Active Phase|Migrated/moved from study area|1|||
164591214|NCT01165203|594527257|FG000|Active Phase|Lost to Follow-up|2|||
164365555|NCT02404311|593715037|FG000|Part A: Month 0-18|HIV Infection|6|||
164365556|NCT02404311|593715038|FG001|Part A: Month 0-18|HIV Infection|2|||
164365557|NCT02404311|593715039|FG002|Part A: Month 0-18|HIV Infection|0|||
164365558|NCT02404311|593715040|FG003|Part A: Month 0-18|HIV Infection|0|||
164365559|NCT02404311|593715041|FG004|Part A: Month 0-18|HIV Infection|0|||
164365560|NCT02404311|593715037|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
164365561|NCT02404311|593715038|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
164365562|NCT02404311|593715039|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
164365563|NCT02404311|593715040|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
164365564|NCT02404311|593715041|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
164365565|NCT00159588|593715042|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
164365566|NCT00159588|593715043|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
164365567|NCT00159588|593715044|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
164591215|NCT01165203|594527258|FG001|Active Phase|Lost to Follow-up|0|||
164365568|NCT02864251|593715050|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
164365569|NCT02864251|593715051|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
164365570|NCT02864251|593715052|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
164365571|NCT02864251|593715050|FG000|Pre-Treatment|Withdrawal by Participant|0|||
164365572|NCT02864251|593715051|FG001|Pre-Treatment|Withdrawal by Participant|0|||
164365573|NCT02864251|593715052|FG002|Pre-Treatment|Withdrawal by Participant|4|||
164365574|NCT02864251|593715050|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
164365575|NCT02864251|593715051|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
164365576|NCT02864251|593715052|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
164365577|NCT02864251|593715050|FG000|Pre-Treatment|Other Reasons|0|||
164365578|NCT02864251|593715051|FG001|Pre-Treatment|Other Reasons|1|||
164365579|NCT02864251|593715052|FG002|Pre-Treatment|Other Reasons|1|||
164365580|NCT02864251|593715050|FG000|Treatment|Disease Progression|109|||
164365581|NCT02864251|593715051|FG001|Treatment|Disease Progression|52|||
164365582|NCT02864251|593715052|FG002|Treatment|Disease Progression|101|||
164365583|NCT02864251|593715050|FG000|Treatment|Study Drug Toxicity|9|||
164365584|NCT02864251|593715051|FG001|Treatment|Study Drug Toxicity|4|||
164365585|NCT02864251|593715052|FG002|Treatment|Study Drug Toxicity|10|||
164365586|NCT02864251|593715050|FG000|Treatment|Death|0|||
164365587|NCT02864251|593715051|FG001|Treatment|Death|2|||
164365588|NCT02864251|593715052|FG002|Treatment|Death|3|||
164365589|NCT02864251|593715050|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
164365590|NCT02864251|593715051|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
164365591|NCT02864251|593715052|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
164365592|NCT02864251|593715050|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
164365593|NCT02864251|593715051|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
164365594|NCT02864251|593715052|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
164365595|NCT02864251|593715050|FG000|Treatment|Withdrawal by Participant|8|||
164365596|NCT02864251|593715051|FG001|Treatment|Withdrawal by Participant|5|||
164365597|NCT02864251|593715052|FG002|Treatment|Withdrawal by Participant|13|||
164365598|NCT02864251|593715050|FG000|Treatment|Maximum Clinical Benefit|1|||
164365599|NCT02864251|593715051|FG001|Treatment|Maximum Clinical Benefit|0|||
164365600|NCT02864251|593715052|FG002|Treatment|Maximum Clinical Benefit|1|||
164365601|NCT02864251|593715050|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
164365602|NCT02864251|593715051|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
164365603|NCT02864251|593715052|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
164365604|NCT02864251|593715050|FG000|Treatment|Other Reasons|1|||
164365605|NCT02864251|593715051|FG001|Treatment|Other Reasons|1|||
164365606|NCT02864251|593715052|FG002|Treatment|Other Reasons|4|||
164365607|NCT02864251|593715050|FG000|Treatment|Administrative Reason by Sponsor|1|||
164365608|NCT02864251|593715051|FG001|Treatment|Administrative Reason by Sponsor|0|||
164365609|NCT02864251|593715052|FG002|Treatment|Administrative Reason by Sponsor|0|||
164365610|NCT02532647|593715055|FG000|Overall Study|Did not receive trial medication|1|||
164365611|NCT02532647|593715056|FG001|Overall Study|Did not receive trial medication|0|||
164365612|NCT02532647|593715057|FG002|Overall Study|Did not receive trial medication|1|||
164365613|NCT03897179|593715064|FG000|Overall Study|Withdrawal by Subject|1|||
164365614|NCT01480076|593715065|FG000|Overall Study|Run-in Failure|52|||
164365615|NCT01480076|593715065|FG000|Overall Study|Adverse Event|39|||
164365616|NCT01480076|593715065|FG000|Overall Study|Death|2|||
164365617|NCT01480076|593715065|FG000|Overall Study|Disease Progression|5|||
164365618|NCT01480076|593715065|FG000|Overall Study|Non-compliance With Study Protocol|15|||
164365619|NCT01480076|593715065|FG000|Overall Study|Withdrawal by Subject|105|||
164365620|NCT01480076|593715065|FG000|Overall Study|Lost to Follow-up|7|||
164365621|NCT01480076|593715065|FG000|Overall Study|Investigator Decision|13|||
164365622|NCT01480076|593715065|FG000|Overall Study|Other|52|||
164365623|NCT02503332|593715066|FG000|Overall Study|Adverse Event|17|||
164365624|NCT02503332|593715067|FG001|Overall Study|Adverse Event|5|||
164365625|NCT02503332|593715068|FG002|Overall Study|Adverse Event|3|||
164365626|NCT02503332|593715069|FG003|Overall Study|Adverse Event|1|||
164365627|NCT02503332|593715066|FG000|Overall Study|Investigator's Decision|5|||
164365628|NCT02503332|593715067|FG001|Overall Study|Investigator's Decision|1|||
164365629|NCT02503332|593715068|FG002|Overall Study|Investigator's Decision|0|||
164365630|NCT02503332|593715069|FG003|Overall Study|Investigator's Decision|0|||
164365631|NCT02503332|593715066|FG000|Overall Study|Sponsor's Decision|1|||
164365632|NCT02503332|593715067|FG001|Overall Study|Sponsor's Decision|0|||
164365633|NCT02503332|593715068|FG002|Overall Study|Sponsor's Decision|0|||
164365634|NCT02503332|593715069|FG003|Overall Study|Sponsor's Decision|1|||
164365635|NCT02503332|593715066|FG000|Overall Study|Subject Request|6|||
164365636|NCT02503332|593715067|FG001|Overall Study|Subject Request|5|||
164591216|NCT01165203|594527257|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
164365637|NCT02503332|593715068|FG002|Overall Study|Subject Request|2|||
164365638|NCT02503332|593715069|FG003|Overall Study|Subject Request|1|||
164365639|NCT02503332|593715066|FG000|Overall Study|Death|0|||
164365640|NCT02503332|593715067|FG001|Overall Study|Death|2|||
164365641|NCT02503332|593715068|FG002|Overall Study|Death|2|||
164365642|NCT02503332|593715069|FG003|Overall Study|Death|0|||
164365643|NCT02503332|593715066|FG000|Overall Study|Other|5|||
164365644|NCT02503332|593715067|FG001|Overall Study|Other|6|||
164365645|NCT02503332|593715068|FG002|Overall Study|Other|1|||
164365646|NCT02503332|593715069|FG003|Overall Study|Other|1|||
164365647|NCT05694546|593715071|FG000|Overall Study|Lost to Follow-up|11|||
164365648|NCT02120950|593715072|FG000|Overall Study|Adverse Event|5|||
164365649|NCT02120950|593715073|FG001|Overall Study|Adverse Event|4|||
164365650|NCT02120950|593715074|FG002|Overall Study|Adverse Event|3|||
164365651|NCT02120950|593715072|FG000|Overall Study|Death|3|||
164365652|NCT02120950|593715073|FG001|Overall Study|Death|0|||
164365653|NCT02120950|593715074|FG002|Overall Study|Death|1|||
164365654|NCT02120950|593715072|FG000|Overall Study|Withdrawal by Subject|6|||
164365655|NCT02120950|593715073|FG001|Overall Study|Withdrawal by Subject|3|||
164365656|NCT02120950|593715074|FG002|Overall Study|Withdrawal by Subject|2|||
164365657|NCT02120950|593715072|FG000|Overall Study|Protocol Violation|1|||
164365658|NCT02120950|593715073|FG001|Overall Study|Protocol Violation|1|||
164365659|NCT02120950|593715074|FG002|Overall Study|Protocol Violation|7|||
164365660|NCT02120950|593715072|FG000|Overall Study|Other reasons|5|||
164365661|NCT02120950|593715073|FG001|Overall Study|Other reasons|4|||
164365662|NCT02120950|593715074|FG002|Overall Study|Other reasons|1|||
164365663|NCT02120950|593715072|FG000|Overall Study|Lost to Follow-up|0|||
164365664|NCT02120950|593715073|FG001|Overall Study|Lost to Follow-up|2|||
164365665|NCT02120950|593715074|FG002|Overall Study|Lost to Follow-up|1|||
164365666|NCT02424383|593715075|FG000|Overall Study|Withdrawal by Subject|32|||
164365667|NCT02424383|593715075|FG000|Overall Study|Death|170|||
164365668|NCT02424383|593715075|FG000|Overall Study|Sponsor's decision|3|||
164365669|NCT02424383|593715075|FG000|Overall Study|Investigator's decision|44|||
164365670|NCT02424383|593715075|FG000|Overall Study|Lost to Follow-up|81|||
164365671|NCT02424383|593715075|FG000|Overall Study|Other|7|||
164365672|NCT02424383|593715075|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
164365673|NCT03412084|593715079|FG000|Overall Study|Withdrawal by Subject|2|||
164365674|NCT03412084|593715080|FG001|Overall Study|Withdrawal by Subject|0|||
164365675|NCT03412084|593715079|FG000|Overall Study|Participant moved|1|||
164365676|NCT03412084|593715080|FG001|Overall Study|Participant moved|0|||
164365677|NCT03412084|593715079|FG000|Overall Study|Lost to Follow-up|1|||
164365678|NCT03412084|593715080|FG001|Overall Study|Lost to Follow-up|1|||
164365679|NCT01928862|593715084|FG000|Overall Study|Lost to Follow-up|1|||
164365680|NCT01928862|593715085|FG001|Overall Study|Lost to Follow-up|0|||
164365681|NCT01928862|593715086|FG002|Overall Study|Lost to Follow-up|0|||
164365682|NCT01928862|593715087|FG003|Overall Study|Lost to Follow-up|0|||
164365683|NCT01928862|593715088|FG004|Overall Study|Lost to Follow-up|1|||
164365684|NCT01752855|593715092|FG000|Overall Study|Adverse Event|1|||
164365685|NCT01752855|593715093|FG001|Overall Study|Adverse Event|0|||
164365686|NCT01752855|593715092|FG000|Overall Study|Withdrew Consent|0|||
164365687|NCT01752855|593715093|FG001|Overall Study|Withdrew Consent|2|||
164365688|NCT01752855|593715092|FG000|Overall Study|Lack of Efficacy|0|||
164365689|NCT01752855|593715093|FG001|Overall Study|Lack of Efficacy|2|||
164365690|NCT01478321|593715095|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
164365691|NCT01478321|593715095|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
164591217|NCT01165203|594527258|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
164591218|NCT01165203|594527257|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
164591219|NCT01165203|594527258|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
164591220|NCT01165203|594527257|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
164365692|NCT01478321|593715095|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
164365693|NCT01478321|593715095|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
164365694|NCT01478321|593715095|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
164591221|NCT01165203|594527258|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
164591222|NCT01165203|594527257|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
164591223|NCT01165203|594527258|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
164591224|NCT01165203|594527257|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
164591225|NCT01165203|594527258|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
164699991|NCT01020799|594924846|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
164365695|NCT01478321|593715095|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
164365696|NCT01478321|593715095|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
164365697|NCT01478321|593715095|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
164365698|NCT00314574|593715096|FG000|Overall Study|Death|3|||
164365699|NCT00314574|593715097|FG001|Overall Study|Death|0|||
164365700|NCT00314574|593715096|FG000|Overall Study|Adverse Event|11|||
164365701|NCT00314574|593715097|FG001|Overall Study|Adverse Event|16|||
164365702|NCT00314574|593715096|FG000|Overall Study|Lost to Follow-up|19|||
164699992|NCT01020799|594924847|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
164699993|NCT01020799|594924845|FG000|Overall Study|Protocol Violation|3|||
164438695|NCT00855465|593973038|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
164699994|NCT01020799|594924846|FG001|Overall Study|Protocol Violation|2|||
164699995|NCT01020799|594924847|FG002|Overall Study|Protocol Violation|0|||
164699996|NCT01020799|594924845|FG000|Overall Study|Withdrawal by Subject|2|||
164699997|NCT01020799|594924846|FG001|Overall Study|Withdrawal by Subject|2|||
164699998|NCT01020799|594924847|FG002|Overall Study|Withdrawal by Subject|3|||
164699999|NCT01020799|594924845|FG000|Overall Study|Lost to Follow-up|6|||
164700000|NCT01020799|594924846|FG001|Overall Study|Lost to Follow-up|4|||
164700001|NCT01020799|594924847|FG002|Overall Study|Lost to Follow-up|2|||
164700002|NCT02556307|594924850|FG000|Overall Study|Premature treatment interruption|11|||
164700003|NCT02556307|594924850|FG000|Overall Study|Lost to Follow-up|36|||
164700004|NCT02556307|594924850|FG000|Overall Study|Change to triple therapy|4|||
164700005|NCT02556307|594924850|FG000|Overall Study|Enrolled but not treated|2|||
164365703|NCT00314574|593715097|FG001|Overall Study|Lost to Follow-up|25|||
164365704|NCT00314574|593715096|FG000|Overall Study|Withdrawal by Subject|33|||
164365705|NCT00314574|593715097|FG001|Overall Study|Withdrawal by Subject|22|||
164365706|NCT00314574|593715096|FG000|Overall Study|Physician Decision|22|||
164365707|NCT00314574|593715097|FG001|Overall Study|Physician Decision|15|||
164365708|NCT00314574|593715096|FG000|Overall Study|Pregnancy|6|||
164365709|NCT00314574|593715097|FG001|Overall Study|Pregnancy|4|||
164365710|NCT00314574|593715096|FG000|Overall Study|Data unknown at database lock|0|||
164365711|NCT00314574|593715097|FG001|Overall Study|Data unknown at database lock|1|||
164365712|NCT02053753|593715098|FG000|Overall Study|Withdrawal by Subject|2|||
164365713|NCT02053753|593715099|FG001|Overall Study|Withdrawal by Subject|4|||
164365714|NCT02053753|593715098|FG000|Overall Study|Decision by Sponsor|1|||
164365715|NCT02053753|593715099|FG001|Overall Study|Decision by Sponsor|1|||
164365716|NCT02053753|593715098|FG000|Overall Study|Lost to Follow-up|4|||
164365717|NCT02053753|593715099|FG001|Overall Study|Lost to Follow-up|3|||
164365718|NCT02439320|593715100|FG000|Overall Study|Adverse Event|0|||
164365719|NCT02439320|593715101|FG001|Overall Study|Adverse Event|2|||
164365720|NCT02439320|593715102|FG002|Overall Study|Adverse Event|0|||
164365721|NCT02439320|593715100|FG000|Overall Study|Lost to Follow-up|37|||
164365722|NCT02439320|593715101|FG001|Overall Study|Lost to Follow-up|34|||
164365723|NCT02439320|593715102|FG002|Overall Study|Lost to Follow-up|42|||
164365724|NCT02439320|593715100|FG000|Overall Study|Death|0|||
164365725|NCT02439320|593715101|FG001|Overall Study|Death|1|||
164365726|NCT02439320|593715102|FG002|Overall Study|Death|0|||
164365727|NCT02439320|593715100|FG000|Overall Study|Noncompliance with Protocol|10|||
164365728|NCT02439320|593715101|FG001|Overall Study|Noncompliance with Protocol|11|||
164365729|NCT02439320|593715102|FG002|Overall Study|Noncompliance with Protocol|7|||
164365730|NCT02439320|593715100|FG000|Overall Study|Pregnancy|0|||
164365731|NCT02439320|593715101|FG001|Overall Study|Pregnancy|1|||
164365732|NCT02439320|593715102|FG002|Overall Study|Pregnancy|1|||
164365733|NCT02439320|593715100|FG000|Overall Study|Withdrawal by Subject|12|||
164365734|NCT02439320|593715101|FG001|Overall Study|Withdrawal by Subject|16|||
164365735|NCT02439320|593715102|FG002|Overall Study|Withdrawal by Subject|14|||
164365736|NCT02439320|593715100|FG000|Overall Study|Physician Decision|2|||
164365737|NCT02439320|593715101|FG001|Overall Study|Physician Decision|1|||
164365738|NCT02439320|593715102|FG002|Overall Study|Physician Decision|0|||
164365739|NCT02439320|593715100|FG000|Overall Study|Sponsor Request|0|||
164365740|NCT02439320|593715101|FG001|Overall Study|Sponsor Request|2|||
164365741|NCT02439320|593715102|FG002|Overall Study|Sponsor Request|1|||
164365742|NCT02439320|593715100|FG000|Overall Study|Randomization Failure|35|||
164365743|NCT02439320|593715101|FG001|Overall Study|Randomization Failure|46|||
164365744|NCT02439320|593715102|FG002|Overall Study|Randomization Failure|34|||
164365745|NCT01505608|593715103|FG000|Phase I|Lack of Efficacy|0|||
164365746|NCT01505608|593715104|FG001|Phase I|Lack of Efficacy|4|||
164365747|NCT01505608|593715103|FG000|Phase I|Adverse Event|0|||
164365748|NCT01505608|593715104|FG001|Phase I|Adverse Event|1|||
164700006|NCT03438227|594924851|FG000|Overall Study|Withdrawal by Subject|10|||
164365749|NCT01505608|593715103|FG000|Phase I|Withdrawal by Subject|0|||
164365750|NCT01505608|593715104|FG001|Phase I|Withdrawal by Subject|1|||
164365751|NCT01505608|593715103|FG000|Phase II|Lack of Efficacy|2|||
164365752|NCT01505608|593715104|FG001|Phase II|Lack of Efficacy|1|||
164365753|NCT01505608|593715103|FG000|Phase II|Protocol Violation|0|||
164438696|NCT00855465|593973037|FG000|Follow-up Period (FUP)|Missing|1|||
164700007|NCT03438227|594924852|FG001|Overall Study|Withdrawal by Subject|5|||
164365754|NCT01505608|593715104|FG001|Phase II|Protocol Violation|1|||
164365755|NCT01251380|593715114|FG000|Overall Study|Other (Not otherwise specified)|12|||
164365756|NCT01251380|593715114|FG000|Overall Study|Withdrawal by Subject|6|||
164365757|NCT01251380|593715114|FG000|Overall Study|Lack of Efficacy|1|||
164365758|NCT01251380|593715114|FG000|Overall Study|Adverse Event|1|||
164365759|NCT01251380|593715114|FG000|Overall Study|Lost to Follow-up|2|||
164365760|NCT00751348|593715115|FG000|Overall Study|Withdrawal by Subject|5|||
164700008|NCT01813071|594924853|FG000|Overall Study|Protocol Violation|0|||
164700009|NCT01813071|594924854|FG001|Overall Study|Protocol Violation|0|||
164365761|NCT00751348|593715116|FG001|Overall Study|Withdrawal by Subject|2|||
164700010|NCT01813071|594924855|FG002|Overall Study|Protocol Violation|0|||
164700011|NCT01813071|594924856|FG003|Overall Study|Protocol Violation|0|||
164700012|NCT01813071|594924857|FG004|Overall Study|Protocol Violation|1|||
164700013|NCT01813071|594924858|FG005|Overall Study|Protocol Violation|4|||
164700014|NCT01813071|594924859|FG006|Overall Study|Protocol Violation|2|||
164700015|NCT01813071|594924860|FG007|Overall Study|Protocol Violation|4|||
164700016|NCT01813071|594924861|FG008|Overall Study|Protocol Violation|2|||
164700017|NCT01813071|594924853|FG000|Overall Study|Withdrawal by Subject|0|||
164700018|NCT01813071|594924854|FG001|Overall Study|Withdrawal by Subject|0|||
164700019|NCT01813071|594924855|FG002|Overall Study|Withdrawal by Subject|0|||
164700020|NCT01813071|594924856|FG003|Overall Study|Withdrawal by Subject|0|||
164700021|NCT01813071|594924857|FG004|Overall Study|Withdrawal by Subject|0|||
164700022|NCT01813071|594924858|FG005|Overall Study|Withdrawal by Subject|1|||
164700023|NCT01813071|594924859|FG006|Overall Study|Withdrawal by Subject|0|||
164365762|NCT00751348|593715115|FG000|Overall Study|Migration from study area|1|||
164365763|NCT00751348|593715116|FG001|Overall Study|Migration from study area|0|||
164365764|NCT02404350|593715121|FG000|Overall Study|Adverse Event|2|||
164365765|NCT02404350|593715122|FG001|Overall Study|Adverse Event|2|||
164365766|NCT02404350|593715123|FG002|Overall Study|Adverse Event|3|||
164365767|NCT02404350|593715124|FG003|Overall Study|Adverse Event|9|||
164365768|NCT02404350|593715121|FG000|Overall Study|Lack of Efficacy|3|||
164365769|NCT02404350|593715122|FG001|Overall Study|Lack of Efficacy|1|||
164365770|NCT02404350|593715123|FG002|Overall Study|Lack of Efficacy|0|||
164365771|NCT02404350|593715124|FG003|Overall Study|Lack of Efficacy|3|||
164365772|NCT02404350|593715121|FG000|Overall Study|Lost to Follow-up|2|||
164365773|NCT02404350|593715122|FG001|Overall Study|Lost to Follow-up|0|||
164365774|NCT02404350|593715123|FG002|Overall Study|Lost to Follow-up|0|||
164365775|NCT02404350|593715124|FG003|Overall Study|Lost to Follow-up|1|||
164365776|NCT02404350|593715121|FG000|Overall Study|Physician Decision|1|||
164365777|NCT02404350|593715122|FG001|Overall Study|Physician Decision|0|||
164365778|NCT02404350|593715123|FG002|Overall Study|Physician Decision|0|||
164365779|NCT02404350|593715124|FG003|Overall Study|Physician Decision|2|||
164365780|NCT02404350|593715121|FG000|Overall Study|Pregnancy|0|||
164365781|NCT02404350|593715122|FG001|Overall Study|Pregnancy|0|||
164365782|NCT02404350|593715123|FG002|Overall Study|Pregnancy|0|||
164365783|NCT02404350|593715124|FG003|Overall Study|Pregnancy|1|||
164365784|NCT02404350|593715121|FG000|Overall Study|Withdrawal by Subject|7|||
164365785|NCT02404350|593715122|FG001|Overall Study|Withdrawal by Subject|3|||
164365786|NCT02404350|593715123|FG002|Overall Study|Withdrawal by Subject|3|||
164365787|NCT02404350|593715124|FG003|Overall Study|Withdrawal by Subject|19|||
164365788|NCT02404350|593715121|FG000|Overall Study|Due to Non-compliance with treatment|0|||
164365789|NCT02404350|593715122|FG001|Overall Study|Due to Non-compliance with treatment|0|||
164365790|NCT02404350|593715123|FG002|Overall Study|Due to Non-compliance with treatment|0|||
164365791|NCT02404350|593715124|FG003|Overall Study|Due to Non-compliance with treatment|1|||
164365792|NCT02404350|593715121|FG000|Overall Study|Due to Technical problems|0|||
164365793|NCT02404350|593715122|FG001|Overall Study|Due to Technical problems|0|||
164365794|NCT02404350|593715123|FG002|Overall Study|Due to Technical problems|0|||
164365795|NCT02404350|593715124|FG003|Overall Study|Due to Technical problems|1|||
164365796|NCT05389657|593715125|FG000|Overall Study|Lost to Follow-up|7|||
164365797|NCT05389657|593715126|FG001|Overall Study|Lost to Follow-up|8|||
164365798|NCT00743652|593715127|FG000|Overall Study|Parent/Legal Guardian Request|3|||
164365799|NCT00743652|593715128|FG001|Overall Study|Parent/Legal Guardian Request|2|||
164365800|NCT00743652|593715129|FG002|Overall Study|Parent/Legal Guardian Request|2|||
164365801|NCT00743652|593715130|FG003|Overall Study|Parent/Legal Guardian Request|2|||
164365802|NCT00743652|593715131|FG004|Overall Study|Parent/Legal Guardian Request|0|||
164365803|NCT00743652|593715127|FG000|Overall Study|Adverse Event|3|||
164365804|NCT00743652|593715128|FG001|Overall Study|Adverse Event|0|||
164365805|NCT00743652|593715129|FG002|Overall Study|Adverse Event|0|||
164438697|NCT00855465|593973038|FG001|Follow-up Period (FUP)|Missing|0|||
164700024|NCT01813071|594924860|FG007|Overall Study|Withdrawal by Subject|0|||
164700025|NCT01813071|594924861|FG008|Overall Study|Withdrawal by Subject|0|||
164700026|NCT01813071|594924853|FG000|Overall Study|Adverse Event|0|||
164365806|NCT00743652|593715130|FG003|Overall Study|Adverse Event|0|||
164365807|NCT00743652|593715131|FG004|Overall Study|Adverse Event|0|||
164365808|NCT00743652|593715127|FG000|Overall Study|Death|2|||
164365809|NCT00743652|593715128|FG001|Overall Study|Death|0|||
164365810|NCT00743652|593715129|FG002|Overall Study|Death|0|||
164365811|NCT00743652|593715130|FG003|Overall Study|Death|0|||
164365812|NCT00743652|593715131|FG004|Overall Study|Death|0|||
164365813|NCT00743652|593715127|FG000|Overall Study|Investigator Request|0|||
164365814|NCT00743652|593715128|FG001|Overall Study|Investigator Request|0|||
164365815|NCT00743652|593715129|FG002|Overall Study|Investigator Request|0|||
164365816|NCT00743652|593715130|FG003|Overall Study|Investigator Request|2|||
164700027|NCT01813071|594924854|FG001|Overall Study|Adverse Event|0|||
164700028|NCT01813071|594924855|FG002|Overall Study|Adverse Event|0|||
164700029|NCT01813071|594924856|FG003|Overall Study|Adverse Event|0|||
164700030|NCT01813071|594924857|FG004|Overall Study|Adverse Event|0|||
164365817|NCT00743652|593715131|FG004|Overall Study|Investigator Request|0|||
164365818|NCT00743652|593715127|FG000|Overall Study|Other|1|||
164365819|NCT00743652|593715128|FG001|Overall Study|Other|1|||
164365820|NCT00743652|593715129|FG002|Overall Study|Other|0|||
164365821|NCT00743652|593715130|FG003|Overall Study|Other|0|||
164365822|NCT00743652|593715131|FG004|Overall Study|Other|0|||
164365823|NCT00743652|593715127|FG000|Overall Study|Lost to Follow-up|1|||
164365824|NCT00743652|593715128|FG001|Overall Study|Lost to Follow-up|0|||
164365825|NCT00743652|593715129|FG002|Overall Study|Lost to Follow-up|0|||
164365826|NCT00743652|593715130|FG003|Overall Study|Lost to Follow-up|0|||
164365827|NCT00743652|593715131|FG004|Overall Study|Lost to Follow-up|0|||
164365828|NCT05237206|593715133|FG000|Overall Study|screen failure-did not receive treatment|8|||
164365829|NCT05237206|593715133|FG000|Overall Study|did not receive treatment|3|||
164365830|NCT01085097|593715136|FG000|Overall Study|Adverse Event|0|||
164365831|NCT01085097|593715137|FG001|Overall Study|Adverse Event|0|||
164365832|NCT01085097|593715138|FG002|Overall Study|Adverse Event|2|||
164365833|NCT01085097|593715136|FG000|Overall Study|Treatment failure|2|||
164365834|NCT01085097|593715137|FG001|Overall Study|Treatment failure|0|||
164365835|NCT01085097|593715138|FG002|Overall Study|Treatment failure|0|||
164365836|NCT06049043|593715139|FG000|Overall Study|Lost to Follow-up|11|||
164365837|NCT06049043|593715140|FG001|Overall Study|Lost to Follow-up|9|||
164365838|NCT03089606|593715143|FG000|Overall Study|Progression after Cycle 1|1|||
164365839|NCT00335972|593715144|FG000|Overall Study|not given treatments|0|||
164365840|NCT00335972|593715145|FG001|Overall Study|not given treatments|3|||
164365841|NCT03965962|593715147|FG000|Overall Study|Adverse Event|1|||
164365842|NCT03965962|593715148|FG001|Overall Study|Adverse Event|0|||
164365843|NCT03965962|593715149|FG002|Overall Study|Adverse Event|0|||
164365844|NCT03965962|593715150|FG003|Overall Study|Adverse Event|0|||
164365845|NCT03965962|593715147|FG000|Overall Study|Protocol Violation|21|||
164365846|NCT03965962|593715148|FG001|Overall Study|Protocol Violation|4|||
164365847|NCT03965962|593715149|FG002|Overall Study|Protocol Violation|10|||
164365848|NCT03965962|593715150|FG003|Overall Study|Protocol Violation|5|||
164365849|NCT03965962|593715147|FG000|Overall Study|Lost to Follow-up|0|||
164365850|NCT03965962|593715148|FG001|Overall Study|Lost to Follow-up|1|||
164365851|NCT03965962|593715149|FG002|Overall Study|Lost to Follow-up|0|||
164365852|NCT03965962|593715150|FG003|Overall Study|Lost to Follow-up|0|||
164365853|NCT03965962|593715147|FG000|Overall Study|Withdrawal by Subject|3|||
164365854|NCT03965962|593715148|FG001|Overall Study|Withdrawal by Subject|0|||
164365855|NCT03965962|593715149|FG002|Overall Study|Withdrawal by Subject|0|||
164365856|NCT03965962|593715150|FG003|Overall Study|Withdrawal by Subject|1|||
164365857|NCT02154581|593715158|FG000|Overall Study|Lost to Follow-up|7|||
164365858|NCT02154581|593715159|FG001|Overall Study|Lost to Follow-up|8|||
164700031|NCT01813071|594924858|FG005|Overall Study|Adverse Event|1|||
164365859|NCT00403273|593716966|FG000|Overall Study|Lost to Follow-up|3|||
164365860|NCT00403273|593716967|FG001|Overall Study|Lost to Follow-up|2|||
164365861|NCT00403273|593716966|FG000|Overall Study|Physician Decision|0|||
164365862|NCT00403273|593716967|FG001|Overall Study|Physician Decision|1|||
164365863|NCT00403273|593716966|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
164700032|NCT01813071|594924859|FG006|Overall Study|Adverse Event|0|||
164700033|NCT01813071|594924860|FG007|Overall Study|Adverse Event|0|||
164700034|NCT01813071|594924861|FG008|Overall Study|Adverse Event|0|||
164700035|NCT01813071|594924853|FG000|Overall Study|Physician Decision|0|||
164700036|NCT01813071|594924854|FG001|Overall Study|Physician Decision|0|||
164700037|NCT01813071|594924855|FG002|Overall Study|Physician Decision|0|||
164700038|NCT01813071|594924856|FG003|Overall Study|Physician Decision|0|||
164700039|NCT01813071|594924857|FG004|Overall Study|Physician Decision|0|||
164700040|NCT01813071|594924858|FG005|Overall Study|Physician Decision|0|||
164700041|NCT01813071|594924859|FG006|Overall Study|Physician Decision|1|||
164700042|NCT01813071|594924860|FG007|Overall Study|Physician Decision|0|||
164700043|NCT01813071|594924861|FG008|Overall Study|Physician Decision|0|||
164700044|NCT01813071|594924853|FG000|Overall Study|Met inc/exc criteria|0|||
164700045|NCT01813071|594924854|FG001|Overall Study|Met inc/exc criteria|0|||
164365864|NCT00403273|593716967|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
164365865|NCT00589108|593716972|FG000|Overall Study|Lost to Follow-up|1|||
164365866|NCT00589108|593716973|FG001|Overall Study|Lost to Follow-up|1|||
164365867|NCT00589108|593716974|FG002|Overall Study|Lost to Follow-up|1|||
164365868|NCT00589108|593716972|FG000|Overall Study|Death|3|||
164365869|NCT00589108|593716973|FG001|Overall Study|Death|3|||
164365870|NCT00589108|593716974|FG002|Overall Study|Death|4|||
164365871|NCT03256552|593716975|FG000|Overall Study|Protocol Violation|1|||
164365872|NCT03256552|593716975|FG000|Overall Study|Physician Decision|1|||
164365873|NCT03256552|593716975|FG000|Overall Study|Adverse Event|1|||
164365874|NCT03256552|593716975|FG000|Overall Study|Withdrawal by Subject|2|||
164365875|NCT01012622|593716976|FG000|Overall Study|Withdrawal by Subject|6|||
164365876|NCT01012622|593716976|FG000|Overall Study|Lost to Follow-up|5|||
164365877|NCT01012622|593716976|FG000|Overall Study|Adverse Event|7|||
164365878|NCT01012622|593716976|FG000|Overall Study|non-compliance with the drug|9|||
164700046|NCT01813071|594924855|FG002|Overall Study|Met inc/exc criteria|0|||
164700047|NCT01813071|594924856|FG003|Overall Study|Met inc/exc criteria|0|||
164700048|NCT01813071|594924857|FG004|Overall Study|Met inc/exc criteria|0|||
164700049|NCT01813071|594924858|FG005|Overall Study|Met inc/exc criteria|1|||
164700050|NCT01813071|594924859|FG006|Overall Study|Met inc/exc criteria|0|||
164700051|NCT01813071|594924860|FG007|Overall Study|Met inc/exc criteria|1|||
164365879|NCT01012622|593716976|FG000|Overall Study|Other|1|||
164365880|NCT01012622|593716976|FG000|Overall Study|screening failure|1|||
164365881|NCT01012622|593716976|FG000|Overall Study|withdrawal of consent by a parent|2|||
164365882|NCT01176292|593716977|FG000|Overall Study|Lost to Follow-up|2|||
164365883|NCT01176292|593716978|FG001|Overall Study|Lost to Follow-up|4|||
164365884|NCT01176292|593716977|FG000|Overall Study|Adverse Event|1|||
164365885|NCT01176292|593716978|FG001|Overall Study|Adverse Event|1|||
164365886|NCT01176292|593716977|FG000|Overall Study|Physician Decision|0|||
164365887|NCT01176292|593716978|FG001|Overall Study|Physician Decision|2|||
164365888|NCT01176292|593716977|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
164365889|NCT01176292|593716978|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
164365890|NCT00380393|593716979|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
164365891|NCT00380393|593716980|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
164365892|NCT00380393|593716979|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
164365893|NCT00380393|593716980|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
164365894|NCT00380393|593716979|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
164365895|NCT00380393|593716980|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
164365896|NCT00380393|593716979|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
164365897|NCT00380393|593716980|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
164365898|NCT00380393|593716979|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
164365899|NCT00380393|593716980|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
164365900|NCT00380393|593716979|FG000|Month 14|Withdrawal by Subject|9|||
164365901|NCT00380393|593716980|FG001|Month 14|Withdrawal by Subject|7|||
164365902|NCT00380393|593716979|FG000|Month 14|Death|1|||
164365903|NCT00380393|593716980|FG001|Month 14|Death|0|||
164365904|NCT00380393|593716979|FG000|Month 14|Lost to Follow-up|0|||
164365905|NCT00380393|593716980|FG001|Month 14|Lost to Follow-up|1|||
164365906|NCT00380393|593716979|FG000|Month 14|Migrated/moved from study area|39|||
164365907|NCT00380393|593716980|FG001|Month 14|Migrated/moved from study area|42|||
164365908|NCT00380393|593716979|FG000|Month 14|Protocol Violation|2|||
164365909|NCT00380393|593716980|FG001|Month 14|Protocol Violation|0|||
164365910|NCT00380393|593716979|FG000|Month 14|Others|6|||
164365911|NCT00380393|593716980|FG001|Month 14|Others|6|||
164365912|NCT00076011|593716993|FG000|Overall Study|Death|1|||
164365913|NCT00076011|593716993|FG000|Overall Study|Adverse Event|10|||
164365914|NCT00076011|593716993|FG000|Overall Study|Lack of Efficacy|25|||
164365915|NCT00076011|593716993|FG000|Overall Study|Withdrawal by Subject|1|||
164365916|NCT00076011|593716993|FG000|Overall Study|Study terminated by sponsor|3|||
164365917|NCT00076011|593716993|FG000|Overall Study|Other|11|||
164365918|NCT00076011|593716993|FG000|Overall Study|Ongoing|1|||
164365919|NCT00278954|593716997|FG000|Overall Study|Adverse Event|3|||
164365920|NCT00278954|593716997|FG000|Overall Study|Lost to Follow-up|1|||
164365921|NCT00278954|593716997|FG000|Overall Study|Withdrawal by Subject|1|||
164365922|NCT04343521|593717001|FG000|Overall Study|Adverse Event|0|||
164365923|NCT04343521|593717002|FG001|Overall Study|Adverse Event|2|||
164365924|NCT04343521|593717001|FG000|Overall Study|Death|1|||
164365925|NCT04343521|593717002|FG001|Overall Study|Death|2|||
164365926|NCT04343521|593717001|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
164365927|NCT04343521|593717002|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
164365928|NCT04343521|593717001|FG000|Overall Study|Withdrawal by Subject|70|||
164365929|NCT04343521|593717002|FG001|Overall Study|Withdrawal by Subject|95|||
164365930|NCT04343521|593717001|FG000|Overall Study|Withdrawal by study team|6|||
164365931|NCT04343521|593717002|FG001|Overall Study|Withdrawal by study team|12|||
164365932|NCT02211131|593717003|FG000|Overall Study|Death|26|||
164365933|NCT02211131|593717004|FG001|Overall Study|Death|16|||
164700052|NCT01813071|594924861|FG008|Overall Study|Met inc/exc criteria|1|||
164700053|NCT03977701|594924862|FG000|Overall Study|COVID-19 pandemic|0|||
164700054|NCT03977701|594924863|FG001|Overall Study|COVID-19 pandemic|0|||
164700055|NCT03977701|594924864|FG002|Overall Study|COVID-19 pandemic|0|||
164365934|NCT02211131|593717003|FG000|Overall Study|Lost to Follow-up|4|||
164365935|NCT02211131|593717004|FG001|Overall Study|Lost to Follow-up|3|||
164700056|NCT03977701|594924865|FG003|Overall Study|COVID-19 pandemic|0|||
164700057|NCT03977701|594924866|FG004|Overall Study|COVID-19 pandemic|0|||
164365936|NCT02211131|593717003|FG000|Overall Study|Decision by Sponsor|1|||
164365937|NCT02211131|593717004|FG001|Overall Study|Decision by Sponsor|1|||
164365938|NCT02211131|593717003|FG000|Overall Study|Withdrawal by Subject|3|||
164365939|NCT02211131|593717004|FG001|Overall Study|Withdrawal by Subject|8|||
164365940|NCT05664490|593717005|FG000|Overall Study|Withdrawal by Subject|0|||
164365941|NCT05664490|593717006|FG001|Overall Study|Withdrawal by Subject|1|||
164365942|NCT05664490|593717005|FG000|Overall Study|Lost to Follow-up|14|||
164365943|NCT05664490|593717006|FG001|Overall Study|Lost to Follow-up|22|||
164365944|NCT03144180|593717007|FG000|Overall Study|STAT Delivery|1|||
164365945|NCT03144180|593717008|FG001|Overall Study|STAT Delivery|1|||
164700058|NCT03977701|594924867|FG005|Overall Study|COVID-19 pandemic|1|||
164700059|NCT03977701|594924868|FG006|Overall Study|COVID-19 pandemic|0|||
164700060|NCT03977701|594924869|FG007|Overall Study|COVID-19 pandemic|1|||
164700061|NCT03977701|594924870|FG008|Overall Study|COVID-19 pandemic|0|||
164700062|NCT03977701|594924871|FG009|Overall Study|COVID-19 pandemic|0|||
164700063|NCT00430950|594924872|FG000|Overall Study|Adverse Event|7|||
164700064|NCT00430950|594924873|FG001|Overall Study|Adverse Event|6|||
164700065|NCT00430950|594924872|FG000|Overall Study|Withdrawal by Subject|1|||
164700066|NCT00430950|594924873|FG001|Overall Study|Withdrawal by Subject|0|||
164700067|NCT00430950|594924872|FG000|Overall Study|concomitant medication,etc.|5|||
164700068|NCT00430950|594924873|FG001|Overall Study|concomitant medication,etc.|7|||
164700069|NCT00293202|594924874|FG000|Overall Study|Withdrawal by Subject|1|||
164700070|NCT00293202|594924875|FG001|Overall Study|Withdrawal by Subject|2|||
164700071|NCT00293202|594924874|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
164700072|NCT00293202|594924875|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
164700073|NCT00293202|594924874|FG000|Overall Study|on-hold due to fistula maturation time|1|||
164700074|NCT00293202|594924875|FG001|Overall Study|on-hold due to fistula maturation time|0|||
164700075|NCT01698775|594924876|FG000|Phase A|Adverse Event|2|||
164700076|NCT01698775|594924877|FG001|Phase A|Adverse Event|1|||
164700077|NCT01698775|594924876|FG000|Phase A|Death|1|||
164700078|NCT01698775|594924877|FG001|Phase A|Death|1|||
164700079|NCT01698775|594924876|FG000|Phase A|Lack of Efficacy|1|||
164700080|NCT01698775|594924877|FG001|Phase A|Lack of Efficacy|0|||
164700081|NCT01698775|594924876|FG000|Phase A|Lost to Follow-up|1|||
164700082|NCT01698775|594924877|FG001|Phase A|Lost to Follow-up|2|||
164700083|NCT01698775|594924876|FG000|Phase A|Protocol Violation|1|||
164700084|NCT01698775|594924877|FG001|Phase A|Protocol Violation|0|||
164700085|NCT01698775|594924876|FG000|Phase A|Withdrawal by Subject|3|||
164365946|NCT03144180|593717007|FG000|Overall Study|Provider forgot to fill out forms|1|||
164365947|NCT03144180|593717008|FG001|Overall Study|Provider forgot to fill out forms|3|||
164365948|NCT03144180|593717007|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
164365949|NCT03144180|593717008|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
164365950|NCT03144180|593717007|FG000|Overall Study|Scrub tech removed tube cap|0|||
164365951|NCT03144180|593717008|FG001|Overall Study|Scrub tech removed tube cap|1|||
164365952|NCT03261947|593717009|FG000|Overall Study|Death|10|||
164365953|NCT03261947|593717010|FG001|Overall Study|Death|13|||
164365954|NCT03261947|593717011|FG002|Overall Study|Death|17|||
164365955|NCT03261947|593717012|FG003|Overall Study|Death|12|||
164365956|NCT03261947|593717013|FG004|Overall Study|Death|8|||
164365957|NCT03261947|593717009|FG000|Overall Study|Lost to Follow-up|0|||
164365958|NCT03261947|593717010|FG001|Overall Study|Lost to Follow-up|0|||
164365959|NCT03261947|593717011|FG002|Overall Study|Lost to Follow-up|2|||
164365960|NCT03261947|593717012|FG003|Overall Study|Lost to Follow-up|1|||
164365961|NCT03261947|593717013|FG004|Overall Study|Lost to Follow-up|0|||
164365962|NCT03261947|593717009|FG000|Overall Study|Withdrawal by Subject|0|||
164365963|NCT03261947|593717010|FG001|Overall Study|Withdrawal by Subject|0|||
164365964|NCT03261947|593717011|FG002|Overall Study|Withdrawal by Subject|3|||
164365965|NCT03261947|593717012|FG003|Overall Study|Withdrawal by Subject|0|||
164365966|NCT03261947|593717013|FG004|Overall Study|Withdrawal by Subject|1|||
164365967|NCT03261947|593717009|FG000|Overall Study|Site Terminated by Sponsor|0|||
164365968|NCT03261947|593717010|FG001|Overall Study|Site Terminated by Sponsor|0|||
164365969|NCT03261947|593717011|FG002|Overall Study|Site Terminated by Sponsor|4|||
164365970|NCT03261947|593717012|FG003|Overall Study|Site Terminated by Sponsor|7|||
164365971|NCT03261947|593717013|FG004|Overall Study|Site Terminated by Sponsor|5|||
164365972|NCT03261947|593717009|FG000|Overall Study|Reason not Specified|2|||
164365973|NCT03261947|593717010|FG001|Overall Study|Reason not Specified|0|||
164365974|NCT03261947|593717011|FG002|Overall Study|Reason not Specified|4|||
164365975|NCT03261947|593717012|FG003|Overall Study|Reason not Specified|1|||
164365976|NCT03261947|593717013|FG004|Overall Study|Reason not Specified|3|||
164365977|NCT03969992|593717014|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
164365978|NCT03969992|593717015|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
164365979|NCT03969992|593717016|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
164700086|NCT01698775|594924877|FG001|Phase A|Withdrawal by Subject|4|||
164700087|NCT01698775|594924876|FG000|Phase A|Kidney [transplant]|0|||
164365980|NCT03969992|593717014|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
164365981|NCT03969992|593717015|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
164365982|NCT03969992|593717016|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
164365983|NCT03969992|593717014|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
164365984|NCT03969992|593717015|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
164700088|NCT01698775|594924877|FG001|Phase A|Kidney [transplant]|1|||
164700089|NCT01698775|594924876|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
164438698|NCT00612586|593973047|FG000|Overall Study|Adverse Event|6|||
164700090|NCT01698775|594924877|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
164700091|NCT01698775|594924876|FG000|Phase B|Adverse Event|6|||
164700092|NCT01698775|594924877|FG001|Phase B|Adverse Event|3|||
164700093|NCT01698775|594924876|FG000|Phase B|Death|0|||
164700094|NCT01698775|594924877|FG001|Phase B|Death|1|||
164700095|NCT01698775|594924876|FG000|Phase B|Lack of Efficacy|0|||
164700096|NCT01698775|594924877|FG001|Phase B|Lack of Efficacy|1|||
164700097|NCT01698775|594924876|FG000|Phase B|Lost to Follow-up|0|||
164365985|NCT03969992|593717016|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
164365986|NCT03969992|593717014|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
164365987|NCT03969992|593717015|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
164365988|NCT03969992|593717016|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
164365989|NCT03969992|593717014|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
164365990|NCT03969992|593717015|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
164365991|NCT03969992|593717016|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
164365992|NCT00228917|593717017|FG000|Overall Study|Migrated/moved from study area|0|||
164365993|NCT00228917|593717018|FG001|Overall Study|Migrated/moved from study area|0|||
164365994|NCT00228917|593717019|FG002|Overall Study|Migrated/moved from study area|0|||
164365995|NCT00228917|593717020|FG003|Overall Study|Migrated/moved from study area|0|||
164365996|NCT00228917|593717021|FG004|Overall Study|Migrated/moved from study area|0|||
164365997|NCT00228917|593717022|FG005|Overall Study|Migrated/moved from study area|2|||
164365998|NCT00228917|593717023|FG006|Overall Study|Migrated/moved from study area|0|||
164365999|NCT00228917|593717024|FG007|Overall Study|Migrated/moved from study area|0|||
164366000|NCT02063737|593717027|FG000|Overall Study|Lost to Follow-up|11|||
164366001|NCT02063737|593717028|FG001|Overall Study|Lost to Follow-up|4|||
164366002|NCT04372602|593717029|FG000|Overall Study|Withdrawal by Subject|1|||
164366003|NCT04372602|593717030|FG001|Overall Study|Withdrawal by Subject|1|||
164366004|NCT04372602|593717029|FG000|Overall Study|Adverse Event|0|||
164366005|NCT04372602|593717030|FG001|Overall Study|Adverse Event|1|||
164366006|NCT04372602|593717029|FG000|Overall Study|Transitioned to comfort care|0|||
164366007|NCT04372602|593717030|FG001|Overall Study|Transitioned to comfort care|1|||
164366008|NCT04120974|593717031|FG000|Overall Study|Death|1|||
164366009|NCT04120974|593717031|FG000|Overall Study|Physician Decision|1|||
164366010|NCT04120974|593717031|FG000|Overall Study|Lost to Follow-up|6|||
164366011|NCT00129129|593717032|FG000|Primary Phase|Adverse Event|2|||
164700098|NCT01698775|594924877|FG001|Phase B|Lost to Follow-up|1|||
164700099|NCT01698775|594924876|FG000|Phase B|Physician Decision|1|||
164700100|NCT01698775|594924877|FG001|Phase B|Physician Decision|1|||
164700101|NCT01698775|594924876|FG000|Phase B|Protocol Violation|1|||
164700102|NCT01698775|594924877|FG001|Phase B|Protocol Violation|1|||
164700103|NCT01698775|594924876|FG000|Phase B|Withdrawal by Subject|6|||
164700104|NCT01698775|594924877|FG001|Phase B|Withdrawal by Subject|2|||
164700105|NCT01244061|594924882|FG000|Overall Study|Death|1|||
164700106|NCT01244061|594924883|FG001|Overall Study|Death|0|||
164700107|NCT01244061|594924882|FG000|Overall Study|Did not meet entrance criteria|1|||
164700108|NCT01244061|594924883|FG001|Overall Study|Did not meet entrance criteria|0|||
164700109|NCT01244061|594924882|FG000|Overall Study|Lack of Efficacy|1|||
164700110|NCT01244061|594924883|FG001|Overall Study|Lack of Efficacy|3|||
164700111|NCT01244061|594924882|FG000|Overall Study|Lost to Follow-up|34|||
164700112|NCT01244061|594924883|FG001|Overall Study|Lost to Follow-up|30|||
164700113|NCT01244061|594924882|FG000|Overall Study|Withdrawal by Subject|29|||
164700114|NCT01244061|594924883|FG001|Overall Study|Withdrawal by Subject|46|||
164700115|NCT01244061|594924882|FG000|Overall Study|Other|8|||
164700116|NCT01244061|594924883|FG001|Overall Study|Other|19|||
164700117|NCT01244061|594924882|FG000|Overall Study|Protocol Violation|1|||
164700118|NCT01244061|594924883|FG001|Overall Study|Protocol Violation|1|||
164700119|NCT01244061|594924882|FG000|Overall Study|Adverse Event|5|||
164700120|NCT01244061|594924883|FG001|Overall Study|Adverse Event|2|||
164700121|NCT01244061|594924882|FG000|Overall Study|Randomized but not treated|2|||
164366012|NCT00129129|593717033|FG001|Primary Phase|Adverse Event|1|||
164366013|NCT00129129|593717034|FG002|Primary Phase|Adverse Event|0|||
164366014|NCT00129129|593717035|FG003|Primary Phase|Adverse Event|0|||
164366015|NCT00129129|593717036|FG004|Primary Phase|Adverse Event|0|||
164366016|NCT00129129|593717032|FG000|Primary Phase|Withdrawal by Subject|12|||
164366017|NCT00129129|593717033|FG001|Primary Phase|Withdrawal by Subject|10|||
164366018|NCT00129129|593717034|FG002|Primary Phase|Withdrawal by Subject|0|||
164366019|NCT00129129|593717035|FG003|Primary Phase|Withdrawal by Subject|0|||
164366020|NCT00129129|593717036|FG004|Primary Phase|Withdrawal by Subject|0|||
164366021|NCT00129129|593717032|FG000|Primary Phase|Migration from study area|1|||
164366022|NCT00129129|593717033|FG001|Primary Phase|Migration from study area|3|||
164700122|NCT01244061|594924883|FG001|Overall Study|Randomized but not treated|2|||
164700123|NCT03166124|594924884|FG000|Treatment Period 1|Adverse Event|0|||
164700124|NCT03166124|594924885|FG001|Treatment Period 1|Adverse Event|0|||
164700125|NCT03166124|594924886|FG002|Treatment Period 1|Adverse Event|1|||
164366023|NCT00129129|593717034|FG002|Primary Phase|Migration from study area|0|||
164366024|NCT00129129|593717035|FG003|Primary Phase|Migration from study area|0|||
164366025|NCT00129129|593717036|FG004|Primary Phase|Migration from study area|0|||
164366026|NCT00129129|593717032|FG000|Primary Phase|Lost to Follow-up|8|||
164366027|NCT00129129|593717033|FG001|Primary Phase|Lost to Follow-up|6|||
164366028|NCT00129129|593717034|FG002|Primary Phase|Lost to Follow-up|0|||
164438699|NCT00612586|593973048|FG001|Overall Study|Adverse Event|2|||
164700126|NCT03166124|594924887|FG003|Treatment Period 1|Adverse Event|0|||
164700127|NCT03166124|594924884|FG000|Wash-out Period|Withdrawal by Subject|0|||
164700128|NCT03166124|594924885|FG001|Wash-out Period|Withdrawal by Subject|1|||
164366029|NCT00129129|593717035|FG003|Primary Phase|Lost to Follow-up|0|||
164366030|NCT00129129|593717036|FG004|Primary Phase|Lost to Follow-up|0|||
164366031|NCT00129129|593717032|FG000|Primary Phase|Other|2|||
164366032|NCT00129129|593717033|FG001|Primary Phase|Other|5|||
164366033|NCT00129129|593717034|FG002|Primary Phase|Other|0|||
164366034|NCT00129129|593717035|FG003|Primary Phase|Other|0|||
164366035|NCT00129129|593717036|FG004|Primary Phase|Other|0|||
164366036|NCT00129129|593717032|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
164366037|NCT00129129|593717033|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
164366038|NCT00129129|593717034|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
164366039|NCT00129129|593717035|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
164366040|NCT00129129|593717036|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
164366041|NCT00129129|593717032|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
164366042|NCT00129129|593717033|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
164366043|NCT00129129|593717034|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
164366044|NCT00129129|593717035|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
164366045|NCT00129129|593717036|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
164366046|NCT00129129|593717032|FG000|Fourth Dose Phase|Migration from study area|0|||
164366047|NCT00129129|593717033|FG001|Fourth Dose Phase|Migration from study area|0|||
164366048|NCT00129129|593717034|FG002|Fourth Dose Phase|Migration from study area|0|||
164366049|NCT00129129|593717035|FG003|Fourth Dose Phase|Migration from study area|0|||
164366050|NCT00129129|593717036|FG004|Fourth Dose Phase|Migration from study area|2|||
164366051|NCT00129129|593717032|FG000|Fourth Dose Phase|Other|0|||
164366052|NCT00129129|593717033|FG001|Fourth Dose Phase|Other|0|||
164366053|NCT00129129|593717034|FG002|Fourth Dose Phase|Other|0|||
164366054|NCT00129129|593717035|FG003|Fourth Dose Phase|Other|1|||
164366055|NCT00129129|593717036|FG004|Fourth Dose Phase|Other|1|||
164366056|NCT00129129|593717032|FG000|Fourth Dose Phase|Protocol Violation|0|||
164366057|NCT00129129|593717033|FG001|Fourth Dose Phase|Protocol Violation|0|||
164366058|NCT00129129|593717034|FG002|Fourth Dose Phase|Protocol Violation|0|||
164366059|NCT00129129|593717035|FG003|Fourth Dose Phase|Protocol Violation|1|||
164366060|NCT00129129|593717036|FG004|Fourth Dose Phase|Protocol Violation|0|||
164366061|NCT03190889|593717037|FG000|Overall Study|Lost to Follow-up|7|||
164366062|NCT03190889|593717038|FG001|Overall Study|Lost to Follow-up|7|||
164366063|NCT03190889|593717039|FG002|Overall Study|Lost to Follow-up|3|||
164366064|NCT03190889|593717037|FG000|Overall Study|Withdrawal by Subject|1|||
164366065|NCT03190889|593717038|FG001|Overall Study|Withdrawal by Subject|1|||
164366066|NCT03190889|593717039|FG002|Overall Study|Withdrawal by Subject|2|||
164366067|NCT03190889|593717037|FG000|Overall Study|Did not complete protocol|4|||
164366068|NCT03190889|593717038|FG001|Overall Study|Did not complete protocol|9|||
164366069|NCT03190889|593717039|FG002|Overall Study|Did not complete protocol|0|||
164366070|NCT03190889|593717037|FG000|Overall Study|COVID-19|1|||
164366071|NCT03190889|593717038|FG001|Overall Study|COVID-19|0|||
164366072|NCT03190889|593717039|FG002|Overall Study|COVID-19|2|||
164366073|NCT02140567|593717041|FG000|Overall Study|Problems with recording equipment|6|||
164366074|NCT02882854|593717044|FG000|Overall Study|Lost to Follow-up|1|||
164366075|NCT02882854|593717045|FG001|Overall Study|Lost to Follow-up|2|||
164366076|NCT02882854|593717044|FG000|Overall Study|Physician Decision|0|||
164366077|NCT02882854|593717045|FG001|Overall Study|Physician Decision|1|||
164366078|NCT02039674|593717046|FG000|Overall Study|Adverse Event|0|||
164366079|NCT02039674|593717047|FG001|Overall Study|Adverse Event|0|||
164366080|NCT02039674|593717048|FG002|Overall Study|Adverse Event|0|||
164366081|NCT02039674|593717049|FG003|Overall Study|Adverse Event|1|||
164366082|NCT02039674|593717050|FG004|Overall Study|Adverse Event|0|||
164366083|NCT02039674|593717051|FG005|Overall Study|Adverse Event|0|||
164366084|NCT02039674|593717052|FG006|Overall Study|Adverse Event|0|||
164366085|NCT02039674|593717053|FG007|Overall Study|Adverse Event|0|||
164366086|NCT02039674|593717054|FG008|Overall Study|Adverse Event|2|||
164366087|NCT02039674|593717055|FG009|Overall Study|Adverse Event|1|||
164366088|NCT02039674|593717056|FG010|Overall Study|Adverse Event|0|||
164366089|NCT02039674|593717057|FG011|Overall Study|Adverse Event|2|||
164366090|NCT02039674|593717058|FG012|Overall Study|Adverse Event|3|||
164366091|NCT02039674|593717059|FG013|Overall Study|Adverse Event|1|||
164366092|NCT02039674|593717046|FG000|Overall Study|Death|2|||
164366093|NCT02039674|593717047|FG001|Overall Study|Death|0|||
164366094|NCT02039674|593717048|FG002|Overall Study|Death|2|||
164366095|NCT02039674|593717049|FG003|Overall Study|Death|3|||
164366096|NCT02039674|593717050|FG004|Overall Study|Death|0|||
164366097|NCT02039674|593717051|FG005|Overall Study|Death|0|||
164366098|NCT02039674|593717052|FG006|Overall Study|Death|1|||
164366099|NCT02039674|593717053|FG007|Overall Study|Death|0|||
164366100|NCT02039674|593717054|FG008|Overall Study|Death|2|||
164366101|NCT02039674|593717055|FG009|Overall Study|Death|0|||
164366102|NCT02039674|593717056|FG010|Overall Study|Death|1|||
164366103|NCT02039674|593717057|FG011|Overall Study|Death|3|||
164366104|NCT02039674|593717058|FG012|Overall Study|Death|2|||
164366105|NCT02039674|593717059|FG013|Overall Study|Death|8|||
164366106|NCT02039674|593717046|FG000|Overall Study|Excluded Medication|1|||
164366107|NCT02039674|593717047|FG001|Overall Study|Excluded Medication|1|||
164366108|NCT02039674|593717048|FG002|Overall Study|Excluded Medication|0|||
164366109|NCT02039674|593717049|FG003|Overall Study|Excluded Medication|1|||
164366110|NCT02039674|593717050|FG004|Overall Study|Excluded Medication|0|||
164366111|NCT02039674|593717051|FG005|Overall Study|Excluded Medication|1|||
164366112|NCT02039674|593717052|FG006|Overall Study|Excluded Medication|0|||
164366113|NCT02039674|593717053|FG007|Overall Study|Excluded Medication|0|||
164366114|NCT02039674|593717054|FG008|Overall Study|Excluded Medication|2|||
164366115|NCT02039674|593717055|FG009|Overall Study|Excluded Medication|3|||
164366116|NCT02039674|593717056|FG010|Overall Study|Excluded Medication|5|||
164366117|NCT02039674|593717057|FG011|Overall Study|Excluded Medication|6|||
164366118|NCT02039674|593717058|FG012|Overall Study|Excluded Medication|8|||
164366119|NCT02039674|593717059|FG013|Overall Study|Excluded Medication|3|||
164366120|NCT02039674|593717046|FG000|Overall Study|Lost to Follow-up|0|||
164366121|NCT02039674|593717047|FG001|Overall Study|Lost to Follow-up|0|||
164366122|NCT02039674|593717048|FG002|Overall Study|Lost to Follow-up|0|||
164366123|NCT02039674|593717049|FG003|Overall Study|Lost to Follow-up|0|||
164366124|NCT02039674|593717050|FG004|Overall Study|Lost to Follow-up|1|||
164366125|NCT02039674|593717051|FG005|Overall Study|Lost to Follow-up|1|||
164366126|NCT02039674|593717052|FG006|Overall Study|Lost to Follow-up|0|||
164366127|NCT02039674|593717053|FG007|Overall Study|Lost to Follow-up|0|||
164366128|NCT02039674|593717054|FG008|Overall Study|Lost to Follow-up|0|||
164366129|NCT02039674|593717055|FG009|Overall Study|Lost to Follow-up|0|||
164366130|NCT02039674|593717056|FG010|Overall Study|Lost to Follow-up|0|||
164366131|NCT02039674|593717057|FG011|Overall Study|Lost to Follow-up|2|||
164366132|NCT02039674|593717058|FG012|Overall Study|Lost to Follow-up|2|||
164366133|NCT02039674|593717059|FG013|Overall Study|Lost to Follow-up|1|||
164366134|NCT02039674|593717046|FG000|Overall Study|Physician Decision|0|||
164366135|NCT02039674|593717047|FG001|Overall Study|Physician Decision|0|||
164366136|NCT02039674|593717048|FG002|Overall Study|Physician Decision|0|||
164366137|NCT02039674|593717049|FG003|Overall Study|Physician Decision|0|||
164366138|NCT02039674|593717050|FG004|Overall Study|Physician Decision|0|||
164366139|NCT02039674|593717051|FG005|Overall Study|Physician Decision|0|||
164366140|NCT02039674|593717052|FG006|Overall Study|Physician Decision|0|||
164366141|NCT02039674|593717053|FG007|Overall Study|Physician Decision|0|||
164366142|NCT02039674|593717054|FG008|Overall Study|Physician Decision|0|||
164366143|NCT02039674|593717055|FG009|Overall Study|Physician Decision|0|||
164366144|NCT02039674|593717056|FG010|Overall Study|Physician Decision|0|||
164366145|NCT02039674|593717057|FG011|Overall Study|Physician Decision|1|||
164366146|NCT02039674|593717058|FG012|Overall Study|Physician Decision|1|||
164366147|NCT02039674|593717059|FG013|Overall Study|Physician Decision|0|||
164366148|NCT02039674|593717046|FG000|Overall Study|Progressive Disease|8|||
164366149|NCT02039674|593717047|FG001|Overall Study|Progressive Disease|8|||
164366150|NCT02039674|593717048|FG002|Overall Study|Progressive Disease|6|||
164366151|NCT02039674|593717049|FG003|Overall Study|Progressive Disease|7|||
164366152|NCT02039674|593717050|FG004|Overall Study|Progressive Disease|9|||
164366153|NCT02039674|593717051|FG005|Overall Study|Progressive Disease|10|||
164366154|NCT02039674|593717052|FG006|Overall Study|Progressive Disease|1|||
164366155|NCT02039674|593717053|FG007|Overall Study|Progressive Disease|3|||
164366156|NCT02039674|593717054|FG008|Overall Study|Progressive Disease|6|||
164366157|NCT02039674|593717055|FG009|Overall Study|Progressive Disease|4|||
164366158|NCT02039674|593717056|FG010|Overall Study|Progressive Disease|0|||
164366159|NCT02039674|593717057|FG011|Overall Study|Progressive Disease|34|||
164366160|NCT02039674|593717058|FG012|Overall Study|Progressive Disease|34|||
164366161|NCT02039674|593717059|FG013|Overall Study|Progressive Disease|18|||
164438700|NCT00612586|593973047|FG000|Overall Study|Death|1|||
164438701|NCT00612586|593973048|FG001|Overall Study|Death|0|||
164438702|NCT00612586|593973047|FG000|Overall Study|Entry Criteria Not Met|0|||
164438703|NCT00612586|593973048|FG001|Overall Study|Entry Criteria Not Met|2|||
164438704|NCT00612586|593973047|FG000|Overall Study|Withdrawal by Subject|7|||
164438705|NCT00612586|593973048|FG001|Overall Study|Withdrawal by Subject|9|||
164438706|NCT00612586|593973047|FG000|Overall Study|Physician Decision|1|||
164591226|NCT00374907|594527259|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
164591227|NCT00374907|594527260|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
164366162|NCT02039674|593717046|FG000|Overall Study|Withdrawal by Subject|1|||
164366163|NCT02039674|593717047|FG001|Overall Study|Withdrawal by Subject|2|||
164366164|NCT02039674|593717048|FG002|Overall Study|Withdrawal by Subject|3|||
164366165|NCT02039674|593717049|FG003|Overall Study|Withdrawal by Subject|0|||
164366166|NCT02039674|593717050|FG004|Overall Study|Withdrawal by Subject|1|||
164366167|NCT02039674|593717051|FG005|Overall Study|Withdrawal by Subject|0|||
164366168|NCT02039674|593717052|FG006|Overall Study|Withdrawal by Subject|0|||
164366169|NCT02039674|593717053|FG007|Overall Study|Withdrawal by Subject|0|||
164366170|NCT02039674|593717054|FG008|Overall Study|Withdrawal by Subject|0|||
164366171|NCT02039674|593717055|FG009|Overall Study|Withdrawal by Subject|1|||
164366172|NCT02039674|593717056|FG010|Overall Study|Withdrawal by Subject|1|||
164591228|NCT00374907|594527259|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
164366173|NCT02039674|593717057|FG011|Overall Study|Withdrawal by Subject|4|||
164438707|NCT00612586|593973048|FG001|Overall Study|Physician Decision|2|||
164438708|NCT00612586|593973047|FG000|Overall Study|Sponsor Decision|1|||
164591229|NCT00374907|594527260|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
164591230|NCT00374907|594527259|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
164438709|NCT00612586|593973048|FG001|Overall Study|Sponsor Decision|1|||
164438710|NCT00612586|593973047|FG000|Overall Study|Progressive Disease|26|||
164438711|NCT00612586|593973048|FG001|Overall Study|Progressive Disease|24|||
164438712|NCT00612586|593973047|FG000|Overall Study|Randomized and Not Treated|1|||
164438713|NCT00612586|593973048|FG001|Overall Study|Randomized and Not Treated|1|||
164438714|NCT02613364|593973049|FG000|Overall Study|Other|19|||
164438715|NCT02613364|593973050|FG001|Overall Study|Other|29|||
164366174|NCT02039674|593717058|FG012|Overall Study|Withdrawal by Subject|6|||
164366175|NCT02039674|593717059|FG013|Overall Study|Withdrawal by Subject|2|||
164366176|NCT02039674|593717046|FG000|Overall Study|Clinical Progression|0|||
164366177|NCT02039674|593717047|FG001|Overall Study|Clinical Progression|0|||
164366178|NCT02039674|593717048|FG002|Overall Study|Clinical Progression|0|||
164366179|NCT02039674|593717049|FG003|Overall Study|Clinical Progression|0|||
164366180|NCT02039674|593717050|FG004|Overall Study|Clinical Progression|0|||
164366181|NCT02039674|593717051|FG005|Overall Study|Clinical Progression|0|||
164366182|NCT02039674|593717052|FG006|Overall Study|Clinical Progression|1|||
164366183|NCT02039674|593717053|FG007|Overall Study|Clinical Progression|0|||
164366184|NCT02039674|593717054|FG008|Overall Study|Clinical Progression|0|||
164366185|NCT02039674|593717055|FG009|Overall Study|Clinical Progression|0|||
164366186|NCT02039674|593717056|FG010|Overall Study|Clinical Progression|0|||
164366187|NCT02039674|593717057|FG011|Overall Study|Clinical Progression|0|||
164366188|NCT02039674|593717058|FG012|Overall Study|Clinical Progression|1|||
164366189|NCT02039674|593717059|FG013|Overall Study|Clinical Progression|0|||
164700129|NCT03166124|594924886|FG002|Wash-out Period|Withdrawal by Subject|0|||
164700130|NCT03166124|594924887|FG003|Wash-out Period|Withdrawal by Subject|1|||
164700131|NCT03166124|594924884|FG000|Wash-out Period|Adverse Event|0|||
164700132|NCT03166124|594924885|FG001|Wash-out Period|Adverse Event|1|||
164700133|NCT03166124|594924886|FG002|Wash-out Period|Adverse Event|1|||
164700134|NCT03166124|594924887|FG003|Wash-out Period|Adverse Event|0|||
164700135|NCT00766831|594924888|FG000|Overall Study|Withdrawal by Subject|4|||
164700136|NCT00766831|594924888|FG000|Overall Study|Lost to Follow-up|3|||
164700137|NCT00766831|594924888|FG000|Overall Study|Adverse Event|20|||
164700138|NCT00766831|594924888|FG000|Overall Study|Protocol Violation|15|||
164700139|NCT00766831|594924888|FG000|Overall Study|Physician Decision|5|||
164700140|NCT00766831|594924888|FG000|Overall Study|Withdrawal of consent|26|||
164700141|NCT00766831|594924888|FG000|Overall Study|Non cooperation by participants|14|||
164700142|NCT00766831|594924888|FG000|Overall Study|Other|28|||
164700143|NCT00788593|594924891|FG000|Placebo Run-in Phase|Adverse Event|2|||
164700144|NCT00788593|594924892|FG001|Placebo Run-in Phase|Adverse Event|0|||
164700145|NCT00788593|594924893|FG002|Placebo Run-in Phase|Adverse Event|0|||
164366190|NCT02039674|593717046|FG000|Overall Study|Sponsor Decision|1|||
164366191|NCT02039674|593717047|FG001|Overall Study|Sponsor Decision|1|||
164366192|NCT02039674|593717048|FG002|Overall Study|Sponsor Decision|1|||
164366193|NCT02039674|593717049|FG003|Overall Study|Sponsor Decision|1|||
164366194|NCT02039674|593717050|FG004|Overall Study|Sponsor Decision|1|||
164366195|NCT02039674|593717051|FG005|Overall Study|Sponsor Decision|0|||
164366196|NCT02039674|593717052|FG006|Overall Study|Sponsor Decision|0|||
164366197|NCT02039674|593717053|FG007|Overall Study|Sponsor Decision|0|||
164366198|NCT02039674|593717054|FG008|Overall Study|Sponsor Decision|0|||
164366199|NCT02039674|593717055|FG009|Overall Study|Sponsor Decision|3|||
164366200|NCT02039674|593717056|FG010|Overall Study|Sponsor Decision|0|||
164366201|NCT02039674|593717057|FG011|Overall Study|Sponsor Decision|8|||
164366202|NCT02039674|593717058|FG012|Overall Study|Sponsor Decision|5|||
164366203|NCT02039674|593717059|FG013|Overall Study|Sponsor Decision|0|||
164366204|NCT02039674|593717046|FG000|Overall Study|Other|0|||
164438716|NCT02613364|593973051|FG002|Overall Study|Other|17|||
164438717|NCT02613364|593973049|FG000|Overall Study|Too time consuming|21|||
164438718|NCT02613364|593973050|FG001|Overall Study|Too time consuming|26|||
164700146|NCT00788593|594924891|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
164700147|NCT00788593|594924892|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
164366205|NCT02039674|593717047|FG001|Overall Study|Other|0|||
164366206|NCT02039674|593717048|FG002|Overall Study|Other|0|||
164366207|NCT02039674|593717049|FG003|Overall Study|Other|0|||
164366208|NCT02039674|593717050|FG004|Overall Study|Other|0|||
164366209|NCT02039674|593717051|FG005|Overall Study|Other|0|||
164366210|NCT02039674|593717052|FG006|Overall Study|Other|0|||
164366211|NCT02039674|593717053|FG007|Overall Study|Other|0|||
164366212|NCT02039674|593717054|FG008|Overall Study|Other|0|||
164366213|NCT02039674|593717055|FG009|Overall Study|Other|0|||
164366214|NCT02039674|593717056|FG010|Overall Study|Other|0|||
164366215|NCT02039674|593717057|FG011|Overall Study|Other|0|||
164438719|NCT02613364|593973051|FG002|Overall Study|Too time consuming|26|||
164438720|NCT02613364|593973049|FG000|Overall Study|Withdrawal by Subject|13|||
164700148|NCT00788593|594924893|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
164438721|NCT02613364|593973050|FG001|Overall Study|Withdrawal by Subject|18|||
164700149|NCT00788593|594924891|FG000|Placebo Run-in Phase|Protocol Violation|2|||
164366216|NCT02039674|593717058|FG012|Overall Study|Other|1|||
164366217|NCT02039674|593717059|FG013|Overall Study|Other|0|||
164366218|NCT01358357|593717060|FG000|Open Label Phase|Adverse Event|0|||
164438722|NCT02613364|593973051|FG002|Overall Study|Withdrawal by Subject|17|||
164366219|NCT01358357|593717061|FG001|Open Label Phase|Adverse Event|0|||
164366220|NCT01358357|593717062|FG002|Open Label Phase|Adverse Event|59|||
164366221|NCT01358357|593717060|FG000|Open Label Phase|Lack of Efficacy|0|||
164366222|NCT01358357|593717061|FG001|Open Label Phase|Lack of Efficacy|0|||
164366223|NCT01358357|593717062|FG002|Open Label Phase|Lack of Efficacy|107|||
164366224|NCT01358357|593717060|FG000|Open Label Phase|Lost to Follow-up|0|||
164366225|NCT01358357|593717061|FG001|Open Label Phase|Lost to Follow-up|0|||
164366226|NCT01358357|593717062|FG002|Open Label Phase|Lost to Follow-up|76|||
164366227|NCT01358357|593717060|FG000|Open Label Phase|Protocol Violation|0|||
164366228|NCT01358357|593717061|FG001|Open Label Phase|Protocol Violation|0|||
164366229|NCT01358357|593717062|FG002|Open Label Phase|Protocol Violation|45|||
164366230|NCT01358357|593717060|FG000|Open Label Phase|Withdrawal by Subject|0|||
164366231|NCT01358357|593717061|FG001|Open Label Phase|Withdrawal by Subject|0|||
164366232|NCT01358357|593717062|FG002|Open Label Phase|Withdrawal by Subject|112|||
164366233|NCT01358357|593717060|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
164366234|NCT01358357|593717061|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
164366235|NCT01358357|593717062|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
164366236|NCT01358357|593717060|FG000|Open Label Phase|Terminated at study completion|0|||
164366237|NCT01358357|593717061|FG001|Open Label Phase|Terminated at study completion|0|||
164366238|NCT01358357|593717062|FG002|Open Label Phase|Terminated at study completion|5|||
164366239|NCT01358357|593717060|FG000|Open Label Phase|Mood episode|0|||
164366240|NCT01358357|593717061|FG001|Open Label Phase|Mood episode|0|||
164366241|NCT01358357|593717062|FG002|Open Label Phase|Mood episode|42|||
164366242|NCT01358357|593717060|FG000|Double-Blind Phase|Adverse Event|8|||
164366243|NCT01358357|593717061|FG001|Double-Blind Phase|Adverse Event|5|||
164366244|NCT01358357|593717062|FG002|Double-Blind Phase|Adverse Event|0|||
164366245|NCT01358357|593717060|FG000|Double-Blind Phase|Lost to Follow-up|5|||
164366246|NCT01358357|593717061|FG001|Double-Blind Phase|Lost to Follow-up|7|||
164366247|NCT01358357|593717062|FG002|Double-Blind Phase|Lost to Follow-up|0|||
164366248|NCT01358357|593717060|FG000|Double-Blind Phase|Protocol Violation|1|||
164366249|NCT01358357|593717061|FG001|Double-Blind Phase|Protocol Violation|11|||
164366250|NCT01358357|593717062|FG002|Double-Blind Phase|Protocol Violation|0|||
164366251|NCT01358357|593717060|FG000|Double-Blind Phase|Protocol Violation|16|||
164366252|NCT01358357|593717061|FG001|Double-Blind Phase|Protocol Violation|12|||
164366253|NCT01358357|593717062|FG002|Double-Blind Phase|Protocol Violation|0|||
164366254|NCT01358357|593717060|FG000|Double-Blind Phase|Terminated at study completion|2|||
164366255|NCT01358357|593717061|FG001|Double-Blind Phase|Terminated at study completion|0|||
164366256|NCT01358357|593717062|FG002|Double-Blind Phase|Terminated at study completion|0|||
164366257|NCT01358357|593717060|FG000|Double-Blind Phase|Recurrence of mood event|48|||
164366258|NCT01358357|593717061|FG001|Double-Blind Phase|Recurrence of mood event|64|||
164366259|NCT01358357|593717062|FG002|Double-Blind Phase|Recurrence of mood event|0|||
164366260|NCT01358357|593717060|FG000|Double-Blind Phase|Administrative|0|||
164366261|NCT01358357|593717061|FG001|Double-Blind Phase|Administrative|1|||
164366262|NCT01358357|593717062|FG002|Double-Blind Phase|Administrative|0|||
164366263|NCT03774433|593717067|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
164366264|NCT00108160|593717068|FG000|Overall Study|Lost to Follow-up|25|||
164366265|NCT00108160|593717069|FG001|Overall Study|Lost to Follow-up|12|||
164366266|NCT00108160|593717068|FG000|Overall Study|Death|1|||
164366267|NCT00108160|593717069|FG001|Overall Study|Death|2|||
164366268|NCT00108160|593717068|FG000|Overall Study|Withdrawal by Subject|4|||
164366269|NCT00108160|593717069|FG001|Overall Study|Withdrawal by Subject|2|||
164366270|NCT00108160|593717068|FG000|Overall Study|Protocol Violation|9|||
164366271|NCT00108160|593717069|FG001|Overall Study|Protocol Violation|5|||
164366272|NCT02081079|593717070|FG000|Overall Study|Lack of Efficacy|3|||
164366273|NCT02081079|593717071|FG001|Overall Study|Lack of Efficacy|2|||
164366274|NCT02081079|593717070|FG000|Overall Study|Lost to Follow-up|1|||
164366275|NCT02081079|593717071|FG001|Overall Study|Lost to Follow-up|0|||
164366276|NCT00768144|593717072|FG000|Overall Study|Adverse Event|13|||
164366277|NCT00768144|593717072|FG000|Overall Study|Progressive Disease|21|||
164366278|NCT00768144|593717072|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
164438723|NCT02613364|593973049|FG000|Overall Study|Medical|12|||
164438724|NCT02613364|593973050|FG001|Overall Study|Medical|13|||
164366279|NCT00768144|593717072|FG000|Overall Study|Pt Withdrew Consent|1|||
164366280|NCT01712854|593717073|FG000|Overall Study|Physician Decision|1|||
164366281|NCT01150123|593717074|FG000|Overall Study|Withdrawal by Subject|1|||
164438725|NCT02613364|593973051|FG002|Overall Study|Medical|9|||
164366282|NCT01150123|593717075|FG001|Overall Study|Withdrawal by Subject|1|||
164366283|NCT01150123|593717076|FG002|Overall Study|Withdrawal by Subject|2|||
164366284|NCT01150123|593717077|FG003|Overall Study|Withdrawal by Subject|1|||
164438726|NCT02613364|593973049|FG000|Overall Study|Disliked Study Procedure|1|||
164366285|NCT01150123|593717078|FG004|Overall Study|Withdrawal by Subject|1|||
164366286|NCT01150123|593717079|FG005|Overall Study|Withdrawal by Subject|1|||
164438727|NCT02613364|593973050|FG001|Overall Study|Disliked Study Procedure|1|||
164438728|NCT02613364|593973051|FG002|Overall Study|Disliked Study Procedure|4|||
164438729|NCT02613364|593973049|FG000|Overall Study|Disliked Intervention|0|||
164438730|NCT02613364|593973050|FG001|Overall Study|Disliked Intervention|3|||
164366287|NCT01150123|593717080|FG006|Overall Study|Withdrawal by Subject|0|||
164366288|NCT01150123|593717081|FG007|Overall Study|Withdrawal by Subject|3|||
164366289|NCT01150123|593717082|FG008|Overall Study|Withdrawal by Subject|2|||
164366290|NCT01150123|593717083|FG009|Overall Study|Withdrawal by Subject|0|||
164366291|NCT01150123|593717084|FG010|Overall Study|Withdrawal by Subject|1|||
164366292|NCT01150123|593717085|FG011|Overall Study|Withdrawal by Subject|0|||
164366293|NCT01150123|593717086|FG012|Overall Study|Withdrawal by Subject|1|||
164366294|NCT01150123|593717087|FG013|Overall Study|Withdrawal by Subject|0|||
164366295|NCT01150123|593717088|FG014|Overall Study|Withdrawal by Subject|0|||
164366296|NCT01150123|593717089|FG015|Overall Study|Withdrawal by Subject|1|||
164366297|NCT01150123|593717090|FG016|Overall Study|Withdrawal by Subject|0|||
164366298|NCT01150123|593717091|FG017|Overall Study|Withdrawal by Subject|1|||
164366299|NCT01150123|593717074|FG000|Overall Study|Lost to Follow-up|2|||
164366300|NCT01150123|593717075|FG001|Overall Study|Lost to Follow-up|1|||
164366301|NCT01150123|593717076|FG002|Overall Study|Lost to Follow-up|2|||
164366302|NCT01150123|593717077|FG003|Overall Study|Lost to Follow-up|2|||
164366303|NCT01150123|593717078|FG004|Overall Study|Lost to Follow-up|2|||
164366304|NCT01150123|593717079|FG005|Overall Study|Lost to Follow-up|5|||
164366305|NCT01150123|593717080|FG006|Overall Study|Lost to Follow-up|0|||
164366306|NCT01150123|593717081|FG007|Overall Study|Lost to Follow-up|0|||
164366307|NCT01150123|593717082|FG008|Overall Study|Lost to Follow-up|3|||
164366308|NCT01150123|593717083|FG009|Overall Study|Lost to Follow-up|1|||
164366309|NCT01150123|593717084|FG010|Overall Study|Lost to Follow-up|1|||
164366310|NCT01150123|593717085|FG011|Overall Study|Lost to Follow-up|1|||
164366311|NCT01150123|593717086|FG012|Overall Study|Lost to Follow-up|2|||
164366312|NCT01150123|593717087|FG013|Overall Study|Lost to Follow-up|0|||
164366313|NCT01150123|593717088|FG014|Overall Study|Lost to Follow-up|0|||
164366314|NCT01150123|593717089|FG015|Overall Study|Lost to Follow-up|0|||
164366315|NCT01150123|593717090|FG016|Overall Study|Lost to Follow-up|0|||
164366316|NCT01150123|593717091|FG017|Overall Study|Lost to Follow-up|0|||
164366317|NCT02171260|593717092|FG000|Overall Study|Death|0|||
164366318|NCT02171260|593717093|FG001|Overall Study|Death|0|||
164366319|NCT02171260|593717094|FG002|Overall Study|Death|0|||
164366320|NCT02171260|593717095|FG003|Overall Study|Death|1|||
164366321|NCT02171260|593717092|FG000|Overall Study|Physician Decision|1|||
164366322|NCT02171260|593717093|FG001|Overall Study|Physician Decision|0|||
164366323|NCT02171260|593717094|FG002|Overall Study|Physician Decision|1|||
164366324|NCT02171260|593717095|FG003|Overall Study|Physician Decision|0|||
164366325|NCT02171260|593717092|FG000|Overall Study|Withdrawal by Subject|1|||
164366326|NCT02171260|593717093|FG001|Overall Study|Withdrawal by Subject|0|||
164366327|NCT02171260|593717094|FG002|Overall Study|Withdrawal by Subject|0|||
164366328|NCT02171260|593717095|FG003|Overall Study|Withdrawal by Subject|0|||
164366329|NCT02171260|593717092|FG000|Overall Study|Evidence of progressive disease|4|||
164366330|NCT02171260|593717093|FG001|Overall Study|Evidence of progressive disease|6|||
164366331|NCT02171260|593717094|FG002|Overall Study|Evidence of progressive disease|4|||
164366332|NCT02171260|593717095|FG003|Overall Study|Evidence of progressive disease|4|||
164366333|NCT00322842|593717100|FG000|Overall Study|Withdrawal by Subject|0|||
164366334|NCT00322842|593717101|FG001|Overall Study|Withdrawal by Subject|1|||
164366335|NCT00322842|593717100|FG000|Overall Study|Lost to Follow-up|0|||
164366336|NCT00322842|593717101|FG001|Overall Study|Lost to Follow-up|1|||
164366337|NCT00322842|593717100|FG000|Overall Study|Refused transplant|1|||
164366338|NCT00322842|593717101|FG001|Overall Study|Refused transplant|0|||
164366339|NCT00322842|593717100|FG000|Overall Study|Death|1|||
164366340|NCT00322842|593717101|FG001|Overall Study|Death|0|||
164366341|NCT00323492|593717102|FG000|Study Phase 1|Adverse Event|2|||
164366342|NCT00323492|593717103|FG001|Study Phase 1|Adverse Event|0|||
164366343|NCT00323492|593717104|FG002|Study Phase 1|Adverse Event|0|||
164366344|NCT00323492|593717102|FG000|Study Phase 2|Adverse Event|1|||
164366345|NCT00323492|593717103|FG001|Study Phase 2|Adverse Event|0|||
164366346|NCT00323492|593717104|FG002|Study Phase 2|Adverse Event|0|||
164366347|NCT00323492|593717102|FG000|Study Phase 2|Physician Decision|1|||
164366348|NCT00323492|593717103|FG001|Study Phase 2|Physician Decision|0|||
164366349|NCT00323492|593717104|FG002|Study Phase 2|Physician Decision|0|||
164366350|NCT00323492|593717102|FG000|Study Phase 2|Lost to Follow-up|1|||
164366351|NCT00323492|593717103|FG001|Study Phase 2|Lost to Follow-up|0|||
164366352|NCT00323492|593717104|FG002|Study Phase 2|Lost to Follow-up|0|||
164366353|NCT00323492|593717102|FG000|Study Phase 2|Withdrawal by Subject|0|||
164366354|NCT00323492|593717103|FG001|Study Phase 2|Withdrawal by Subject|1|||
164366355|NCT00323492|593717104|FG002|Study Phase 2|Withdrawal by Subject|0|||
164366356|NCT00323492|593717102|FG000|Study Phase 2|Noncompliance with study schedule|0|||
164366357|NCT00323492|593717103|FG001|Study Phase 2|Noncompliance with study schedule|0|||
164366358|NCT00323492|593717104|FG002|Study Phase 2|Noncompliance with study schedule|1|||
164366359|NCT00323492|593717102|FG000|Study Phase 2|Protocol Violation|1|||
164366360|NCT00323492|593717103|FG001|Study Phase 2|Protocol Violation|0|||
164366361|NCT00323492|593717104|FG002|Study Phase 2|Protocol Violation|0|||
164366362|NCT03082599|593717105|FG000|Overall Study|Lost to Follow-up|1|||
164366363|NCT03082599|593717106|FG001|Overall Study|Lost to Follow-up|0|||
164366364|NCT02486042|593717107|FG000|Overall Study|Physician Decision|1|||
164366365|NCT02486042|593717108|FG001|Overall Study|Physician Decision|7|||
164366366|NCT02486042|593717107|FG000|Overall Study|Hospital transfer|2|||
164366367|NCT02486042|593717108|FG001|Overall Study|Hospital transfer|2|||
164366368|NCT02486042|593717107|FG000|Overall Study|Withdrawal by Subject|0|||
164366369|NCT02486042|593717108|FG001|Overall Study|Withdrawal by Subject|2|||
164366370|NCT01466387|593717109|FG000|Overall Study|Adverse Event|0|||
164366371|NCT01466387|593717110|FG001|Overall Study|Adverse Event|0|||
164366372|NCT01466387|593717111|FG002|Overall Study|Adverse Event|1|||
164366373|NCT01466387|593717112|FG003|Overall Study|Adverse Event|1|||
164366374|NCT01466387|593717113|FG004|Overall Study|Adverse Event|0|||
164366375|NCT01466387|593717114|FG005|Overall Study|Adverse Event|0|||
164366376|NCT01466387|593717109|FG000|Overall Study|Lost to Follow-up|0|||
164366377|NCT01466387|593717110|FG001|Overall Study|Lost to Follow-up|0|||
164366378|NCT01466387|593717111|FG002|Overall Study|Lost to Follow-up|0|||
164366379|NCT01466387|593717112|FG003|Overall Study|Lost to Follow-up|0|||
164366380|NCT01466387|593717113|FG004|Overall Study|Lost to Follow-up|0|||
164366381|NCT01466387|593717114|FG005|Overall Study|Lost to Follow-up|1|||
164366382|NCT01466387|593717109|FG000|Overall Study|Protocol Violation|1|||
164366383|NCT01466387|593717110|FG001|Overall Study|Protocol Violation|0|||
164366384|NCT01466387|593717111|FG002|Overall Study|Protocol Violation|0|||
164366385|NCT01466387|593717112|FG003|Overall Study|Protocol Violation|1|||
164366386|NCT01466387|593717113|FG004|Overall Study|Protocol Violation|0|||
164366387|NCT01466387|593717114|FG005|Overall Study|Protocol Violation|0|||
164366388|NCT00832585|593717125|FG000|Overall Study|Withdrawal by Subject|1|||
164366389|NCT00832585|593717125|FG000|Overall Study|Lost to Follow-up|1|||
164366390|NCT00673179|593717127|FG000|Overall Study|Toxicity/Complications|3|||
164366391|NCT00673179|593717128|FG001|Overall Study|Toxicity/Complications|0|||
164366392|NCT00352846|593717129|FG000|Overall Study|Disease progression|0|||
164366393|NCT00352846|593717130|FG001|Overall Study|Disease progression|2|||
164366394|NCT00352846|593717129|FG000|Overall Study|Withdrawal by Subject|3|||
164366395|NCT00352846|593717130|FG001|Overall Study|Withdrawal by Subject|8|||
164366396|NCT00352846|593717129|FG000|Overall Study|Ineligible|3|||
164366397|NCT00352846|593717130|FG001|Overall Study|Ineligible|2|||
164366398|NCT00352846|593717129|FG000|Overall Study|Non-compliance|2|||
164366399|NCT00352846|593717130|FG001|Overall Study|Non-compliance|0|||
164366400|NCT00352846|593717129|FG000|Overall Study|Death|0|||
164366401|NCT00352846|593717130|FG001|Overall Study|Death|1|||
164366402|NCT00281684|593717131|FG000|Overall Study|Lost to Follow-up|0|||
164366403|NCT00281684|593717132|FG001|Overall Study|Lost to Follow-up|0|||
164366404|NCT00281684|593717133|FG002|Overall Study|Lost to Follow-up|1|||
164366405|NCT00281684|593717134|FG003|Overall Study|Lost to Follow-up|0|||
164366406|NCT00281684|593717131|FG000|Overall Study|Withdrawal by Subject|1|||
164366407|NCT00281684|593717132|FG001|Overall Study|Withdrawal by Subject|0|||
164366408|NCT00281684|593717133|FG002|Overall Study|Withdrawal by Subject|0|||
164366409|NCT00281684|593717134|FG003|Overall Study|Withdrawal by Subject|0|||
164366410|NCT01531387|593717138|FG000|Overall Study|Early termination of study|11|||
164366411|NCT01531387|593717139|FG001|Overall Study|Early termination of study|11|||
164366412|NCT00578942|593717142|FG000|Overall Study|Lost to Follow-up|1|||
164366413|NCT01124643|593717143|FG000|Overall Study|Death|1|||
164366414|NCT04220411|593717144|FG000|Overall Study|Adverse Event|0|||
164366415|NCT04220411|593717145|FG001|Overall Study|Adverse Event|0|||
164366416|NCT04220411|593717146|FG002|Overall Study|Adverse Event|0|||
164366417|NCT04220411|593717147|FG003|Overall Study|Adverse Event|1|||
164366418|NCT00502697|593718492|FG000|Overall Study|Withdrawal by Subject|3|||
164366419|NCT00502697|593718493|FG001|Overall Study|Withdrawal by Subject|1|||
164366420|NCT00502697|593718492|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
164366421|NCT00502697|593718493|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
164366422|NCT00502697|593718492|FG000|Overall Study|found not to meet eligibility criteria|3|||
164366423|NCT00502697|593718493|FG001|Overall Study|found not to meet eligibility criteria|4|||
164366424|NCT00502697|593718492|FG000|Overall Study|did not meet assignment criteria|4|||
164366425|NCT00502697|593718493|FG001|Overall Study|did not meet assignment criteria|2|||
164438731|NCT02613364|593973051|FG002|Overall Study|Disliked Intervention|3|||
164438732|NCT01909336|593973052|FG000|Overall Study|Lost to Follow-up|4|||
164438733|NCT01909336|593973053|FG001|Overall Study|Lost to Follow-up|2|||
164366426|NCT02268409|593718505|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
164366427|NCT02268409|593718505|FG000|Overall Study|Death|1|||
164366428|NCT02268409|593718505|FG000|Overall Study|Lost to Follow-up|1|||
164366429|NCT02268409|593718505|FG000|Overall Study|Protocol Violation|3|||
164366430|NCT02268409|593718505|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
164591231|NCT00374907|594527260|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
164591232|NCT00374907|594527259|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
164591233|NCT00374907|594527260|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
164366431|NCT02268409|593718505|FG000|Overall Study|Withdrawal by Subject|5|||
164366432|NCT03026257|593718506|FG000|Overall Study|Adverse Event|3|||
164438734|NCT01909336|593973054|FG002|Overall Study|Lost to Follow-up|2|||
164366433|NCT03026257|593718507|FG001|Overall Study|Adverse Event|0|||
164366434|NCT03026257|593718508|FG002|Overall Study|Adverse Event|0|||
164366435|NCT03026257|593718509|FG003|Overall Study|Adverse Event|0|||
164366436|NCT03026257|593718510|FG004|Overall Study|Adverse Event|0|||
164366437|NCT03026257|593718511|FG005|Overall Study|Adverse Event|0|||
164366438|NCT03026257|593718506|FG000|Overall Study|Lost to Follow-up|1|||
164366439|NCT03026257|593718507|FG001|Overall Study|Lost to Follow-up|0|||
164366440|NCT03026257|593718508|FG002|Overall Study|Lost to Follow-up|0|||
164366441|NCT03026257|593718509|FG003|Overall Study|Lost to Follow-up|0|||
164366442|NCT03026257|593718510|FG004|Overall Study|Lost to Follow-up|0|||
164366443|NCT03026257|593718511|FG005|Overall Study|Lost to Follow-up|0|||
164366444|NCT03026257|593718506|FG000|Overall Study|Protocol Violation|1|||
164366445|NCT03026257|593718507|FG001|Overall Study|Protocol Violation|0|||
164366446|NCT03026257|593718508|FG002|Overall Study|Protocol Violation|0|||
164366447|NCT03026257|593718509|FG003|Overall Study|Protocol Violation|1|||
164366448|NCT03026257|593718510|FG004|Overall Study|Protocol Violation|1|||
164366449|NCT03026257|593718511|FG005|Overall Study|Protocol Violation|0|||
164366450|NCT03026257|593718506|FG000|Overall Study|Withdrawal by Subject|1|||
164366451|NCT03026257|593718507|FG001|Overall Study|Withdrawal by Subject|1|||
164366452|NCT03026257|593718508|FG002|Overall Study|Withdrawal by Subject|0|||
164366453|NCT03026257|593718509|FG003|Overall Study|Withdrawal by Subject|0|||
164366454|NCT03026257|593718510|FG004|Overall Study|Withdrawal by Subject|0|||
164366455|NCT03026257|593718511|FG005|Overall Study|Withdrawal by Subject|0|||
164366456|NCT02181556|593718513|FG000|Overall Study|Withdrawal by Subject|1|||
164366457|NCT00427635|593718514|FG000|Treatment Phase|Withdrawal by Subject|1|||
164366458|NCT00427635|593718515|FG001|Treatment Phase|Withdrawal by Subject|0|||
164366459|NCT00427635|593718514|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
164366460|NCT00427635|593718515|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
164366461|NCT00838201|593718518|FG000|Overall Study|Investigator decision, or other reasons|2|||
164366462|NCT00838201|593718519|FG001|Overall Study|Investigator decision, or other reasons|3|||
164366463|NCT00838201|593718518|FG000|Overall Study|Noncompliance|0|||
164366464|NCT00838201|593718519|FG001|Overall Study|Noncompliance|1|||
164366465|NCT00838201|593718518|FG000|Overall Study|Administrative decision|1|||
164366466|NCT00838201|593718519|FG001|Overall Study|Administrative decision|2|||
164366467|NCT00838201|593718518|FG000|Overall Study|Disease progression|3|||
164366468|NCT00838201|593718519|FG001|Overall Study|Disease progression|3|||
164366469|NCT00838201|593718518|FG000|Overall Study|Consent withdrawn|16|||
164366470|NCT00838201|593718519|FG001|Overall Study|Consent withdrawn|19|||
164366471|NCT00838201|593718518|FG000|Overall Study|Lost to Follow-up|4|||
164366472|NCT00838201|593718519|FG001|Overall Study|Lost to Follow-up|3|||
164366473|NCT00838201|593718518|FG000|Overall Study|Adverse Event|5|||
164366474|NCT00838201|593718519|FG001|Overall Study|Adverse Event|9|||
164366475|NCT00838201|593718518|FG000|Overall Study|Death|11|||
164366476|NCT00838201|593718519|FG001|Overall Study|Death|13|||
164366477|NCT00489853|593718520|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
164366478|NCT00489853|593718521|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
164366479|NCT00489853|593718522|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
164366480|NCT00489853|593718520|FG000|Wash-out Period 1|Adverse Event|0|||
164366481|NCT00489853|593718521|FG001|Wash-out Period 1|Adverse Event|1|||
164366482|NCT00489853|593718522|FG002|Wash-out Period 1|Adverse Event|1|||
164366483|NCT00489853|593718520|FG000|Wash-out Period 1|Protocol Violation|0|||
164366484|NCT00489853|593718521|FG001|Wash-out Period 1|Protocol Violation|1|||
164366485|NCT00489853|593718522|FG002|Wash-out Period 1|Protocol Violation|1|||
164366486|NCT00489853|593718520|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
164366487|NCT00489853|593718521|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
164366488|NCT00489853|593718522|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
164366489|NCT00489853|593718520|FG000|Wash-out Period 2|Adverse Event|1|||
164366490|NCT00489853|593718521|FG001|Wash-out Period 2|Adverse Event|1|||
164366491|NCT00489853|593718522|FG002|Wash-out Period 2|Adverse Event|0|||
164366492|NCT00489853|593718520|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
164366493|NCT00489853|593718521|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
164366494|NCT00489853|593718522|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
164366495|NCT00489853|593718520|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
164366496|NCT00489853|593718521|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
164366497|NCT00489853|593718522|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
164366498|NCT00704535|593718523|FG000|Overall Study|Adverse Event|2|||
164366499|NCT00704535|593718523|FG000|Overall Study|Death|2|||
164366500|NCT00704535|593718523|FG000|Overall Study|Lost to Follow-up|8|||
164366501|NCT00704535|593718523|FG000|Overall Study|Protocol Violation|10|||
164366502|NCT00704535|593718523|FG000|Overall Study|Completed status not on Case Report Form|124|||
164366503|NCT01589445|593718526|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
164366504|NCT01589445|593718526|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
164366505|NCT01589445|593718526|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
164366506|NCT01589445|593718526|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
164366507|NCT01589445|593718526|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
164700150|NCT00788593|594924892|FG001|Placebo Run-in Phase|Protocol Violation|0|||
164366508|NCT01589445|593718526|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
164366509|NCT01589445|593718526|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
164366510|NCT01589445|593718526|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
164366511|NCT01589445|593718526|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
164366512|NCT01589445|593718526|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
164366513|NCT00481195|593718538|FG000|Overall Study|Adverse Event|16|||
164366514|NCT00481195|593718539|FG001|Overall Study|Adverse Event|11|||
164366515|NCT00481195|593718538|FG000|Overall Study|Lack of Efficacy|1|||
164366516|NCT00481195|593718539|FG001|Overall Study|Lack of Efficacy|3|||
164366517|NCT00481195|593718538|FG000|Overall Study|Lost to Follow-up|4|||
164366518|NCT00481195|593718539|FG001|Overall Study|Lost to Follow-up|6|||
164366519|NCT00481195|593718538|FG000|Overall Study|Physician Decision|3|||
164366520|NCT00481195|593718539|FG001|Overall Study|Physician Decision|1|||
164366521|NCT00481195|593718538|FG000|Overall Study|Protocol Violation|10|||
164366522|NCT00481195|593718539|FG001|Overall Study|Protocol Violation|7|||
164366523|NCT00481195|593718538|FG000|Overall Study|Withdrawal by Subject|3|||
164366524|NCT00481195|593718539|FG001|Overall Study|Withdrawal by Subject|9|||
164366525|NCT00481195|593718538|FG000|Overall Study|Miscellaneous|2|||
164366526|NCT00481195|593718539|FG001|Overall Study|Miscellaneous|2|||
164366527|NCT02932904|593718540|FG000|Overall Study|Reason not Specified|1|||
164366528|NCT02932904|593718541|FG001|Overall Study|Reason not Specified|0|||
164366529|NCT02932904|593718542|FG002|Overall Study|Reason not Specified|2|||
164366530|NCT02932904|593718543|FG003|Overall Study|Reason not Specified|2|||
164366531|NCT02932904|593718540|FG000|Overall Study|Noncompliance with Study Drug|2|||
164366532|NCT02932904|593718541|FG001|Overall Study|Noncompliance with Study Drug|3|||
164366533|NCT02932904|593718542|FG002|Overall Study|Noncompliance with Study Drug|3|||
164366534|NCT02932904|593718543|FG003|Overall Study|Noncompliance with Study Drug|4|||
164366535|NCT02932904|593718540|FG000|Overall Study|Pregnancy|0|||
164366536|NCT02932904|593718541|FG001|Overall Study|Pregnancy|1|||
164366537|NCT02932904|593718542|FG002|Overall Study|Pregnancy|1|||
164366538|NCT02932904|593718543|FG003|Overall Study|Pregnancy|0|||
164366539|NCT02932904|593718540|FG000|Overall Study|Study Termination|0|||
164366540|NCT02932904|593718541|FG001|Overall Study|Study Termination|1|||
164366541|NCT02932904|593718542|FG002|Overall Study|Study Termination|0|||
164366542|NCT02932904|593718543|FG003|Overall Study|Study Termination|0|||
164366543|NCT02932904|593718540|FG000|Overall Study|Voluntary Withdrawal|2|||
164366544|NCT02932904|593718541|FG001|Overall Study|Voluntary Withdrawal|1|||
164366545|NCT02932904|593718542|FG002|Overall Study|Voluntary Withdrawal|4|||
164366546|NCT02932904|593718543|FG003|Overall Study|Voluntary Withdrawal|2|||
164366547|NCT02932904|593718540|FG000|Overall Study|Lost to Follow-up|5|||
164366548|NCT02932904|593718541|FG001|Overall Study|Lost to Follow-up|3|||
164366549|NCT02932904|593718542|FG002|Overall Study|Lost to Follow-up|6|||
164366550|NCT02932904|593718543|FG003|Overall Study|Lost to Follow-up|0|||
164366551|NCT02932904|593718540|FG000|Overall Study|Significant Protocol Deviation|2|||
164366552|NCT02932904|593718541|FG001|Overall Study|Significant Protocol Deviation|3|||
164366553|NCT02932904|593718542|FG002|Overall Study|Significant Protocol Deviation|6|||
164366554|NCT02932904|593718543|FG003|Overall Study|Significant Protocol Deviation|1|||
164366555|NCT02932904|593718540|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
164366556|NCT02932904|593718541|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
164366557|NCT02932904|593718542|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
164366558|NCT02932904|593718543|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
164366559|NCT02932904|593718540|FG000|Overall Study|Randomized But Not Treated|1|||
164366560|NCT02932904|593718541|FG001|Overall Study|Randomized But Not Treated|1|||
164366561|NCT02932904|593718542|FG002|Overall Study|Randomized But Not Treated|0|||
164366562|NCT02932904|593718543|FG003|Overall Study|Randomized But Not Treated|2|||
164700151|NCT00788593|594924893|FG002|Placebo Run-in Phase|Protocol Violation|0|||
164366563|NCT01476696|593718548|FG000|Overall Study|Sponsor decision|2|||
164700152|NCT00788593|594924891|FG000|First Intervention Period|Adverse Event|0|||
164366564|NCT01476696|593718549|FG001|Overall Study|Sponsor decision|1|||
164700153|NCT00788593|594924892|FG001|First Intervention Period|Adverse Event|1|||
164700154|NCT00788593|594924893|FG002|First Intervention Period|Adverse Event|0|||
164700155|NCT00788593|594924891|FG000|Second Intervention Period|Lost to Follow-up|0|||
164700156|NCT00788593|594924892|FG001|Second Intervention Period|Lost to Follow-up|1|||
164700157|NCT00788593|594924893|FG002|Second Intervention Period|Lost to Follow-up|0|||
164366565|NCT01476696|593718550|FG002|Overall Study|Sponsor decision|0|||
164366566|NCT01476696|593718548|FG000|Overall Study|Withdrawal by Subject|1|||
164366567|NCT01476696|593718549|FG001|Overall Study|Withdrawal by Subject|0|||
164366568|NCT01476696|593718550|FG002|Overall Study|Withdrawal by Subject|0|||
164366569|NCT01498640|593718554|FG000|Overall Study|Lost to Follow-up|1|||
164366570|NCT01498640|593718554|FG000|Overall Study|Death|1|||
164366571|NCT01498640|593718554|FG000|Overall Study|Other|3|||
164366572|NCT02590939|593718555|FG000|Overall Study|Withdrawal by Subject|3|||
164366573|NCT02590939|593718556|FG001|Overall Study|Withdrawal by Subject|1|||
164366574|NCT02590939|593718555|FG000|Overall Study|Failed the nociceptive test|2|||
164366575|NCT02590939|593718556|FG001|Overall Study|Failed the nociceptive test|1|||
164366576|NCT02225743|593718557|FG000|Overall Study|Withdrawal by Subject|18|||
164366577|NCT01319877|593718562|FG000|Overall Study|Lost to Follow-up|100|||
164366578|NCT01319877|593718563|FG001|Overall Study|Lost to Follow-up|37|||
164366579|NCT01319877|593718562|FG000|Overall Study|Physician Decision|2|||
164366580|NCT01319877|593718563|FG001|Overall Study|Physician Decision|0|||
164366581|NCT01319877|593718562|FG000|Overall Study|Disease Progression|2|||
164366582|NCT01319877|593718563|FG001|Overall Study|Disease Progression|2|||
164366583|NCT01319877|593718562|FG000|Overall Study|Withdrawal by Subject|0|||
164366584|NCT01319877|593718563|FG001|Overall Study|Withdrawal by Subject|1|||
164366585|NCT01319877|593718562|FG000|Overall Study|Reason Not Specified|4|||
164366586|NCT01319877|593718563|FG001|Overall Study|Reason Not Specified|5|||
164366587|NCT02347189|593718567|FG000|Overall Study|No implant attempted of study device|9|||
164366588|NCT02347189|593718567|FG000|Overall Study|No primary outcome data available|2|||
164366589|NCT02677987|593718568|FG000|Overall Study|Withdrawal by Subject|3|||
164366590|NCT02677987|593718569|FG001|Overall Study|Withdrawal by Subject|0|||
164366591|NCT02677987|593718568|FG000|Overall Study|Lost to Follow-up|1|||
164366592|NCT02677987|593718569|FG001|Overall Study|Lost to Follow-up|0|||
164366593|NCT03320564|593718570|FG000|Overall Study|Protocol Violation|1|||
164366594|NCT01527682|593718571|FG000|Overall Study|Protocol Violation|8|||
164366595|NCT01359254|593718572|FG000|Overall Study|Death|1|||
164366596|NCT01359254|593718573|FG001|Overall Study|Death|0|||
164366597|NCT04668950|593718574|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
164366598|NCT04668950|593718575|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
164366599|NCT04668950|593718574|FG000|Overall Study|Could not confirm started study medication|15|||
164366600|NCT04668950|593718575|FG001|Overall Study|Could not confirm started study medication|15|||
164366601|NCT04668950|593718574|FG000|Overall Study|Could not confirm baseline status|6|||
164366602|NCT04668950|593718575|FG001|Overall Study|Could not confirm baseline status|2|||
164366603|NCT04668950|593718574|FG000|Overall Study|Drop out and did not start medication|15|||
164366604|NCT04668950|593718575|FG001|Overall Study|Drop out and did not start medication|17|||
164366605|NCT04668950|593718574|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
164366606|NCT04668950|593718575|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
164366607|NCT04668950|593718574|FG000|Overall Study|Other|2|||
164366608|NCT04668950|593718575|FG001|Overall Study|Other|4|||
164366609|NCT03979638|593718576|FG000|Period 1|Physician Decision|1|||
164366610|NCT03979638|593718577|FG001|Period 1|Physician Decision|1|||
164366611|NCT03979638|593718576|FG000|Period 1|Withdrawal by Subject|4|||
164366612|NCT03979638|593718577|FG001|Period 1|Withdrawal by Subject|3|||
164366613|NCT03979638|593718576|FG000|Period 1|Study terminated by Sponsor|1|||
164366614|NCT03979638|593718577|FG001|Period 1|Study terminated by Sponsor|3|||
164366615|NCT03979638|593718576|FG000|Period 1|Protocol Violation|1|||
164366616|NCT03979638|593718577|FG001|Period 1|Protocol Violation|0|||
164366617|NCT03979638|593718576|FG000|Period 2|Study terminated by Sponsor|1|||
164366618|NCT03979638|593718577|FG001|Period 2|Study terminated by Sponsor|1|||
164366619|NCT00600938|593718578|FG000|Core Study|Abnormal test procedure result(s)|3|||
164366620|NCT00600938|593718579|FG001|Core Study|Abnormal test procedure result(s)|2|||
164366621|NCT00600938|593718580|FG002|Core Study|Abnormal test procedure result(s)|0|||
164366622|NCT00600938|593718581|FG003|Core Study|Abnormal test procedure result(s)|0|||
164366623|NCT00600938|593718578|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
164366624|NCT00600938|593718579|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
164366625|NCT00600938|593718580|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
164366626|NCT00600938|593718581|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
164366627|NCT00600938|593718578|FG000|Core Study|Patient withdrew consent|7|||
164366628|NCT00600938|593718579|FG001|Core Study|Patient withdrew consent|12|||
164366629|NCT00600938|593718580|FG002|Core Study|Patient withdrew consent|0|||
164366630|NCT00600938|593718581|FG003|Core Study|Patient withdrew consent|0|||
164366631|NCT00600938|593718578|FG000|Core Study|Lost to Follow-up|3|||
164366632|NCT00600938|593718579|FG001|Core Study|Lost to Follow-up|2|||
164366633|NCT00600938|593718580|FG002|Core Study|Lost to Follow-up|0|||
164366634|NCT00600938|593718581|FG003|Core Study|Lost to Follow-up|0|||
164366635|NCT00600938|593718578|FG000|Core Study|Death|1|||
164366636|NCT00600938|593718579|FG001|Core Study|Death|1|||
164366637|NCT00600938|593718580|FG002|Core Study|Death|0|||
164366638|NCT00600938|593718581|FG003|Core Study|Death|0|||
164366639|NCT00600938|593718578|FG000|Core Study|Protocol Violation|1|||
164366640|NCT00600938|593718579|FG001|Core Study|Protocol Violation|2|||
164700158|NCT00788593|594924891|FG000|Second Intervention Period|Other|0|||
164700159|NCT00788593|594924892|FG001|Second Intervention Period|Other|0|||
164700160|NCT00788593|594924893|FG002|Second Intervention Period|Other|1|||
164366641|NCT00600938|593718580|FG002|Core Study|Protocol Violation|0|||
164366642|NCT00600938|593718581|FG003|Core Study|Protocol Violation|0|||
164366643|NCT00600938|593718578|FG000|Extension Study|Adverse Event|1|||
164366644|NCT00600938|593718579|FG001|Extension Study|Adverse Event|0|||
164366645|NCT00600938|593718580|FG002|Extension Study|Adverse Event|2|||
164366646|NCT00600938|593718581|FG003|Extension Study|Adverse Event|0|||
164366647|NCT00600938|593718578|FG000|Extension Study|Abnormal test procedure results|0|||
164366648|NCT00600938|593718579|FG001|Extension Study|Abnormal test procedure results|1|||
164366649|NCT00600938|593718580|FG002|Extension Study|Abnormal test procedure results|1|||
164366650|NCT00600938|593718581|FG003|Extension Study|Abnormal test procedure results|1|||
164366651|NCT00600938|593718578|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
164366652|NCT00600938|593718579|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
164366653|NCT00600938|593718580|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
164366654|NCT00600938|593718581|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
164366655|NCT00600938|593718578|FG000|Extension Study|Withdrawal by Subject|2|||
164366656|NCT00600938|593718579|FG001|Extension Study|Withdrawal by Subject|2|||
164366657|NCT00600938|593718580|FG002|Extension Study|Withdrawal by Subject|3|||
164366658|NCT00600938|593718581|FG003|Extension Study|Withdrawal by Subject|0|||
164366659|NCT00600938|593718578|FG000|Extension Study|Lost to Follow-up|1|||
164366660|NCT00600938|593718579|FG001|Extension Study|Lost to Follow-up|1|||
164366661|NCT00600938|593718580|FG002|Extension Study|Lost to Follow-up|2|||
164366662|NCT00600938|593718581|FG003|Extension Study|Lost to Follow-up|0|||
164366663|NCT00600938|593718578|FG000|Extension Study|Death|1|||
164366664|NCT00600938|593718579|FG001|Extension Study|Death|0|||
164366665|NCT00600938|593718580|FG002|Extension Study|Death|0|||
164366666|NCT00600938|593718581|FG003|Extension Study|Death|0|||
164366667|NCT02680639|593718582|FG000|Screening Period|Screen Failure|7|||
164366668|NCT02680639|593718583|FG001|Screening Period|Screen Failure|0|||
164366669|NCT02680639|593718584|FG002|Screening Period|Screen Failure|0|||
164366670|NCT02678676|593718585|FG000|Overall Study|Death|619|||
164366671|NCT02678676|593718586|FG001|Overall Study|Death|649|||
164366672|NCT02678676|593718585|FG000|Overall Study|Withdrawal by Subject|13|||
164366673|NCT02678676|593718586|FG001|Overall Study|Withdrawal by Subject|5|||
164366674|NCT02678676|593718585|FG000|Overall Study|Lost to Follow-up|171|||
164366675|NCT02678676|593718586|FG001|Overall Study|Lost to Follow-up|151|||
164366676|NCT02678676|593718585|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
164366677|NCT02678676|593718586|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
164366678|NCT03200899|593718587|FG000|Overall Study|Lost to Follow-up|10|||
164366679|NCT03200899|593718588|FG001|Overall Study|Lost to Follow-up|23|||
164366680|NCT01342510|593718603|FG000|Overall Study|Protocol Violation|12|||
164366681|NCT01342510|593718604|FG001|Overall Study|Protocol Violation|6|||
164366682|NCT01342510|593718605|FG002|Overall Study|Protocol Violation|13|||
164366683|NCT01342510|593718606|FG003|Overall Study|Protocol Violation|11|||
164366684|NCT01400516|593718608|FG000|Primary Trial|Withdrawal by Subject|0|||
164366685|NCT01400516|593718609|FG001|Primary Trial|Withdrawal by Subject|2|||
164366686|NCT00549562|593718612|FG000|Overall Study|Adverse Event|1|||
164366687|NCT00549562|593718612|FG000|Overall Study|Lack of Efficacy|1|||
164366688|NCT00323115|593718616|FG000|Vaccine Administration|Adverse Event|1|||
164366689|NCT00323115|593718616|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
164366690|NCT02496533|593718617|FG000|Overall Study|Lack of data on outcome|3|||
164366691|NCT02496533|593718618|FG001|Overall Study|Lack of data on outcome|0|||
164366692|NCT02496533|593718617|FG000|Overall Study|Patient did not complete all measures|0|||
164366693|NCT02496533|593718618|FG001|Overall Study|Patient did not complete all measures|4|||
164366694|NCT02496533|593718617|FG000|Overall Study|Late for radiologic testing|0|||
164366695|NCT02496533|593718618|FG001|Overall Study|Late for radiologic testing|2|||
164366696|NCT05756790|593718619|FG000|Overall Study|Withdrawal by Subject|1|||
164366697|NCT05756790|593718620|FG001|Overall Study|Withdrawal by Subject|1|||
164366698|NCT05756790|593718621|FG002|Overall Study|Withdrawal by Subject|1|||
164366699|NCT05756790|593718622|FG003|Overall Study|Withdrawal by Subject|1|||
164366700|NCT05756790|593718623|FG004|Overall Study|Withdrawal by Subject|0|||
164366701|NCT05756790|593718624|FG005|Overall Study|Withdrawal by Subject|0|||
164366702|NCT05756790|593718619|FG000|Overall Study|Protocol Violation|0|||
164366703|NCT05756790|593718620|FG001|Overall Study|Protocol Violation|0|||
164366704|NCT05756790|593718621|FG002|Overall Study|Protocol Violation|1|||
164366705|NCT05756790|593718622|FG003|Overall Study|Protocol Violation|1|||
164366706|NCT05756790|593718623|FG004|Overall Study|Protocol Violation|0|||
164366707|NCT05756790|593718624|FG005|Overall Study|Protocol Violation|0|||
164366708|NCT05756790|593718619|FG000|Overall Study|Ineligible|0|||
164366709|NCT05756790|593718620|FG001|Overall Study|Ineligible|0|||
164366710|NCT05756790|593718621|FG002|Overall Study|Ineligible|0|||
164366711|NCT05756790|593718622|FG003|Overall Study|Ineligible|0|||
164366712|NCT05756790|593718623|FG004|Overall Study|Ineligible|2|||
164366713|NCT05756790|593718624|FG005|Overall Study|Ineligible|2|||
164366714|NCT03265249|593720172|FG000|Overall Study|Withdrawal by Subject|0|||
164366715|NCT03265249|593720173|FG001|Overall Study|Withdrawal by Subject|1|||
164366716|NCT03873987|593720177|FG000|Overall Study|Adverse Event|1|||
164366717|NCT03873987|593720178|FG001|Overall Study|Adverse Event|0|||
164366718|NCT03873987|593720177|FG000|Overall Study|staff was unable to start a new IV line|1|||
164366719|NCT03873987|593720178|FG001|Overall Study|staff was unable to start a new IV line|0|||
164366720|NCT03873987|593720177|FG000|Overall Study|Lost to Follow-up|0|||
164366721|NCT03873987|593720178|FG001|Overall Study|Lost to Follow-up|1|||
164366722|NCT01465022|593720179|FG000|Overall Study|Lost to Follow-up|15|||
164366723|NCT01465022|593720180|FG001|Overall Study|Lost to Follow-up|14|||
164366724|NCT01465022|593720181|FG002|Overall Study|Lost to Follow-up|0|||
164366725|NCT01465022|593720179|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
164366726|NCT01465022|593720180|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
164366727|NCT01465022|593720181|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
164366728|NCT01465022|593720179|FG000|Overall Study|Not Randomized|0|||
164366729|NCT01465022|593720180|FG001|Overall Study|Not Randomized|0|||
164366730|NCT01465022|593720181|FG002|Overall Study|Not Randomized|70|||
164366731|NCT00004888|593720182|FG000|Overall Study|Adverse Event|5|||
164366732|NCT00004888|593720183|FG001|Overall Study|Adverse Event|10|||
164366733|NCT00004888|593720182|FG000|Overall Study|Withdrawal by Subject|0|||
164366734|NCT00004888|593720183|FG001|Overall Study|Withdrawal by Subject|3|||
164366735|NCT00004888|593720182|FG000|Overall Study|Physician Decision|1|||
164366736|NCT00004888|593720183|FG001|Overall Study|Physician Decision|1|||
164366737|NCT00004888|593720182|FG000|Overall Study|Progressive Disease|4|||
164366738|NCT00004888|593720183|FG001|Overall Study|Progressive Disease|9|||
164366739|NCT00004888|593720182|FG000|Overall Study|Death without progressive disease|0|||
164366740|NCT00004888|593720183|FG001|Overall Study|Death without progressive disease|1|||
164366741|NCT00004888|593720182|FG000|Overall Study|Toxic death|1|||
164366742|NCT00004888|593720183|FG001|Overall Study|Toxic death|0|||
164366743|NCT00136084|593720184|FG000|Overall Study|Death|12|||
164366744|NCT00136084|593720185|FG001|Overall Study|Death|5|||
164366745|NCT00136084|593720184|FG000|Overall Study|Unacceptable toxicity|8|||
164366746|NCT00136084|593720185|FG001|Overall Study|Unacceptable toxicity|11|||
164366747|NCT00136084|593720184|FG000|Overall Study|Relapse|20|||
164366748|NCT00136084|593720185|FG001|Overall Study|Relapse|23|||
164366749|NCT00136084|593720184|FG000|Overall Study|Lost to Follow-up|2|||
164366750|NCT00136084|593720185|FG001|Overall Study|Lost to Follow-up|0|||
164366751|NCT00136084|593720184|FG000|Overall Study|No Response|1|||
164366752|NCT00136084|593720185|FG001|Overall Study|No Response|2|||
164366753|NCT00136084|593720184|FG000|Overall Study|Withdrawal by Subject|5|||
164366754|NCT00136084|593720185|FG001|Overall Study|Withdrawal by Subject|1|||
164366755|NCT02579265|593720186|FG000|Overall Study|Weaned off earlier than 28 days|44|||
164366756|NCT02579265|593720187|FG001|Overall Study|Weaned off earlier than 28 days|43|||
164366757|NCT02579265|593720186|FG000|Overall Study|Adverse Event|2|||
164366758|NCT02579265|593720187|FG001|Overall Study|Adverse Event|0|||
164366759|NCT02579265|593720186|FG000|Overall Study|Any other reason not specified|0|||
164366760|NCT02579265|593720187|FG001|Overall Study|Any other reason not specified|2|||
164366761|NCT02579265|593720186|FG000|Overall Study|Withdrawal by Subject|2|||
164366762|NCT02579265|593720187|FG001|Overall Study|Withdrawal by Subject|0|||
164366763|NCT02579265|593720186|FG000|Overall Study|Physician Decision|1|||
164366764|NCT02579265|593720187|FG001|Overall Study|Physician Decision|0|||
164366765|NCT02579265|593720186|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
164366766|NCT02579265|593720187|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
164366767|NCT02174848|593720188|FG000|Overall Study|Adverse Event|2|||
164366768|NCT02174848|593720189|FG001|Overall Study|Adverse Event|1|||
164366769|NCT02174848|593720188|FG000|Overall Study|Withdrawal by Subject|3|||
164366770|NCT02174848|593720189|FG001|Overall Study|Withdrawal by Subject|3|||
164366771|NCT02174848|593720188|FG000|Overall Study|Lost to Follow-up|0|||
164366772|NCT02174848|593720189|FG001|Overall Study|Lost to Follow-up|1|||
164366773|NCT02174848|593720188|FG000|Overall Study|Worsening of disease|1|||
164366774|NCT02174848|593720189|FG001|Overall Study|Worsening of disease|1|||
164366775|NCT02174848|593720188|FG000|Overall Study|Unable to comply with study requirements|1|||
164366776|NCT02174848|593720189|FG001|Overall Study|Unable to comply with study requirements|0|||
164366777|NCT02520011|593720191|FG000|Overall Study|Adverse Event|0|||
164366778|NCT02520011|593720192|FG001|Overall Study|Adverse Event|1|||
164366779|NCT02520011|593720193|FG002|Overall Study|Adverse Event|2|||
164366780|NCT02520011|593720191|FG000|Overall Study|Death|0|||
164366781|NCT02520011|593720192|FG001|Overall Study|Death|8|||
164366782|NCT02520011|593720193|FG002|Overall Study|Death|1|||
164366783|NCT02520011|593720191|FG000|Overall Study|Lack of Efficacy|4|||
164366784|NCT02520011|593720192|FG001|Overall Study|Lack of Efficacy|26|||
164366785|NCT02520011|593720193|FG002|Overall Study|Lack of Efficacy|4|||
164366786|NCT02520011|593720191|FG000|Overall Study|Physician Decision|0|||
164366787|NCT02520011|593720192|FG001|Overall Study|Physician Decision|2|||
164366788|NCT02520011|593720193|FG002|Overall Study|Physician Decision|0|||
164366789|NCT02520011|593720191|FG000|Overall Study|Withdrawal by Subject|1|||
164366790|NCT02520011|593720192|FG001|Overall Study|Withdrawal by Subject|3|||
164366791|NCT02520011|593720193|FG002|Overall Study|Withdrawal by Subject|0|||
164366792|NCT02520011|593720191|FG000|Overall Study|Protocol Deviation|0|||
164366793|NCT02520011|593720192|FG001|Overall Study|Protocol Deviation|1|||
164700161|NCT01392326|594924894|FG000|Overall Study|Death|2|||
164700162|NCT01392326|594924895|FG001|Overall Study|Death|0|||
164700163|NCT01392326|594924896|FG002|Overall Study|Death|0|||
164366794|NCT02520011|593720193|FG002|Overall Study|Protocol Deviation|0|||
164366795|NCT02520011|593720191|FG000|Overall Study|Patient went to hospice|0|||
164366796|NCT02520011|593720192|FG001|Overall Study|Patient went to hospice|1|||
164366797|NCT02520011|593720193|FG002|Overall Study|Patient went to hospice|0|||
164366798|NCT02520011|593720191|FG000|Overall Study|Progressive disease following response|0|||
164366799|NCT02520011|593720192|FG001|Overall Study|Progressive disease following response|4|||
164366800|NCT02520011|593720193|FG002|Overall Study|Progressive disease following response|2|||
164366801|NCT00644969|593720194|FG000|Treatment Phase|Randomized, not treated|1|||
164700164|NCT01392326|594924894|FG000|Overall Study|Withdrawal by Subject|12|||
164366802|NCT00644969|593720195|FG001|Treatment Phase|Randomized, not treated|0|||
164366803|NCT00644969|593720194|FG000|Treatment Phase|Adverse Event|3|||
164366804|NCT00644969|593720195|FG001|Treatment Phase|Adverse Event|0|||
164366805|NCT00644969|593720194|FG000|Treatment Phase|Withdrawal by Subject|4|||
164366806|NCT00644969|593720195|FG001|Treatment Phase|Withdrawal by Subject|0|||
164366807|NCT00644969|593720194|FG000|Treatment Phase|Lost to Follow-up|2|||
164366808|NCT00644969|593720195|FG001|Treatment Phase|Lost to Follow-up|2|||
164366809|NCT00644969|593720194|FG000|Treatment Phase|Other|4|||
164366810|NCT00644969|593720195|FG001|Treatment Phase|Other|1|||
164366811|NCT00644969|593720194|FG000|Post Treatment Phase|Death|1|||
164366812|NCT00644969|593720195|FG001|Post Treatment Phase|Death|0|||
164366813|NCT00644969|593720194|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
164366814|NCT00644969|593720195|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
164366815|NCT00644969|593720194|FG000|Post Treatment Phase|Lost to Follow-up|4|||
164366816|NCT00644969|593720195|FG001|Post Treatment Phase|Lost to Follow-up|1|||
164366817|NCT00644969|593720194|FG000|Post Treatment Phase|Other|1|||
164366818|NCT00644969|593720195|FG001|Post Treatment Phase|Other|0|||
164366819|NCT00997503|593720201|FG000|Overall Study|Death|53|||
164366820|NCT00997503|593720201|FG000|Overall Study|Withdrawal by Subject|76|||
164366821|NCT00997503|593720201|FG000|Overall Study|Lost to Follow-up|33|||
164366822|NCT00997503|593720201|FG000|Overall Study|Adverse Event|3|||
164366823|NCT00997503|593720201|FG000|Overall Study|Physician Decision|10|||
164366824|NCT00997503|593720201|FG000|Overall Study|Missed 12-month follow-up|85|||
164366825|NCT00997503|593720201|FG000|Overall Study|Other reason|13|||
164366826|NCT01933048|593720202|FG000|Overall Study|Lost to Follow-up|15|||
164366827|NCT01933048|593720203|FG001|Overall Study|Lost to Follow-up|18|||
164366828|NCT01933048|593720202|FG000|Overall Study|personal reasons|1|||
164366829|NCT01933048|593720203|FG001|Overall Study|personal reasons|1|||
164366830|NCT01933048|593720202|FG000|Overall Study|Protocol Violation|7|||
164366831|NCT01933048|593720203|FG001|Overall Study|Protocol Violation|8|||
164366832|NCT01933048|593720202|FG000|Overall Study|Physician Decision|1|||
164366833|NCT01933048|593720203|FG001|Overall Study|Physician Decision|0|||
164366834|NCT01933048|593720202|FG000|Overall Study|unknown reasons|1|||
164366835|NCT01933048|593720203|FG001|Overall Study|unknown reasons|1|||
164366836|NCT02780804|593720207|FG000|Overall Study|Death|1|||
164366837|NCT02780804|593720208|FG001|Overall Study|Death|0|||
164366838|NCT02780804|593720209|FG002|Overall Study|Death|0|||
164366839|NCT02780804|593720207|FG000|Overall Study|Lack of Efficacy|5|||
164366840|NCT02780804|593720208|FG001|Overall Study|Lack of Efficacy|8|||
164366841|NCT02780804|593720209|FG002|Overall Study|Lack of Efficacy|4|||
164366842|NCT02780804|593720207|FG000|Overall Study|Physician Decision|0|||
164366843|NCT02780804|593720208|FG001|Overall Study|Physician Decision|0|||
164366844|NCT02780804|593720209|FG002|Overall Study|Physician Decision|2|||
164366845|NCT02780804|593720207|FG000|Overall Study|Withdrawal by Subject|0|||
164366846|NCT02780804|593720208|FG001|Overall Study|Withdrawal by Subject|1|||
164366847|NCT02780804|593720209|FG002|Overall Study|Withdrawal by Subject|0|||
164366848|NCT02476968|593720210|FG000|Overall Study|Other|0|||
164366849|NCT02476968|593720211|FG001|Overall Study|Other|2|||
164366850|NCT02476968|593720212|FG002|Overall Study|Other|0|||
164366851|NCT02476968|593720210|FG000|Overall Study|Lost to Follow-up|10|||
164366852|NCT02476968|593720211|FG001|Overall Study|Lost to Follow-up|0|||
164366853|NCT02476968|593720212|FG002|Overall Study|Lost to Follow-up|1|||
164366854|NCT02476968|593720210|FG000|Overall Study|Death|48|||
164366855|NCT02476968|593720211|FG001|Overall Study|Death|8|||
164366856|NCT02476968|593720212|FG002|Overall Study|Death|1|||
164366857|NCT02476968|593720210|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164366858|NCT02476968|593720211|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164366859|NCT02476968|593720212|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
164366860|NCT02476968|593720210|FG000|Overall Study|Patient decision|37|||
164366861|NCT02476968|593720211|FG001|Overall Study|Patient decision|8|||
164366862|NCT02476968|593720212|FG002|Overall Study|Patient decision|0|||
164366863|NCT04171414|593720222|FG000|Overall Study|Death|1|||
164366864|NCT04171414|593720222|FG000|Overall Study|Withdrawal by Subject|1|||
164366865|NCT01714310|593720223|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
164366866|NCT01714310|593720224|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
164366867|NCT01714310|593720225|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
164366868|NCT01714310|593720223|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
164366869|NCT01714310|593720224|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
164366870|NCT01714310|593720225|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
164366871|NCT01714310|593720223|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
164366872|NCT01714310|593720224|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
164366873|NCT01714310|593720225|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
164366874|NCT01714310|593720223|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
164366875|NCT01714310|593720224|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
164366876|NCT01714310|593720225|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
164366877|NCT02487394|593720226|FG000|Phase 1|Withdrawal by Subject|0|||
164366878|NCT02487394|593720227|FG001|Phase 1|Withdrawal by Subject|1|||
164366879|NCT01641367|593720228|FG000|Cohorts|Death|18|||
164366880|NCT01641367|593720229|FG001|Cohorts|Death|1|||
164366881|NCT01641367|593720230|FG002|Cohorts|Death|2|||
164366882|NCT01641367|593720231|FG003|Cohorts|Death|0|||
164366883|NCT01641367|593720232|FG004|Cohorts|Death|1|||
164366884|NCT01641367|593720233|FG005|Cohorts|Death|1|||
164366885|NCT01641367|593720234|FG006|Cohorts|Death|0|||
164366886|NCT01641367|593720235|FG007|Cohorts|Death|0|||
164366887|NCT01641367|593720228|FG000|Cohorts|Lost to Follow-up|16|||
164366888|NCT01641367|593720229|FG001|Cohorts|Lost to Follow-up|0|||
164366889|NCT01641367|593720230|FG002|Cohorts|Lost to Follow-up|2|||
164366890|NCT01641367|593720231|FG003|Cohorts|Lost to Follow-up|0|||
164366891|NCT01641367|593720232|FG004|Cohorts|Lost to Follow-up|2|||
164366892|NCT01641367|593720233|FG005|Cohorts|Lost to Follow-up|0|||
164366893|NCT01641367|593720234|FG006|Cohorts|Lost to Follow-up|0|||
164366894|NCT01641367|593720235|FG007|Cohorts|Lost to Follow-up|0|||
164366895|NCT01641367|593720228|FG000|Randomized Adherence Intervention|Death|0|||
164366896|NCT01641367|593720229|FG001|Randomized Adherence Intervention|Death|0|||
164366897|NCT01641367|593720230|FG002|Randomized Adherence Intervention|Death|0|||
164366898|NCT01641367|593720231|FG003|Randomized Adherence Intervention|Death|0|||
164366899|NCT01641367|593720232|FG004|Randomized Adherence Intervention|Death|0|||
164366900|NCT01641367|593720233|FG005|Randomized Adherence Intervention|Death|0|||
164366901|NCT01641367|593720234|FG006|Randomized Adherence Intervention|Death|11|||
164366902|NCT01641367|593720235|FG007|Randomized Adherence Intervention|Death|12|||
164366903|NCT01641367|593720228|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
164366904|NCT01641367|593720229|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
164366905|NCT01641367|593720230|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
164366906|NCT01641367|593720231|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
164366907|NCT01641367|593720232|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
164366908|NCT01641367|593720233|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
164366909|NCT01641367|593720234|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
164366910|NCT01641367|593720235|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
164366911|NCT00218296|593720238|FG000|Overall Study|Lost to Follow-up|9|||
164366912|NCT00218296|593720239|FG001|Overall Study|Lost to Follow-up|7|||
164366913|NCT00218296|593720238|FG000|Overall Study|Withdrawal by Subject|36|||
164366914|NCT00218296|593720239|FG001|Overall Study|Withdrawal by Subject|47|||
164366915|NCT00218296|593720238|FG000|Overall Study|Randomized but did not enter treatment|66|||
164366916|NCT00218296|593720239|FG001|Overall Study|Randomized but did not enter treatment|67|||
164366917|NCT04064294|593720250|FG000|Overall Study|Adverse Event|1|||
164366918|NCT04064294|593720251|FG001|Overall Study|Adverse Event|0|||
164366919|NCT04064294|593720252|FG002|Overall Study|Adverse Event|0|||
164366920|NCT01289847|593720254|FG000|Overall Study|Patient could not comply with visits|1|||
164366921|NCT00006478|593720265|FG000|Overall Study|Vaccine could not be produced|1|||
164366922|NCT00006478|593720265|FG000|Overall Study|Physician Decision|6|||
164366923|NCT03161483|593720268|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
164366924|NCT03161483|593720269|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
164366925|NCT03161483|593720270|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
164366926|NCT03161483|593720271|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
164366927|NCT03161483|593720268|FG000|Treatment Period|Death|1|||
164366928|NCT03161483|593720269|FG001|Treatment Period|Death|0|||
164366929|NCT03161483|593720270|FG002|Treatment Period|Death|0|||
164366930|NCT03161483|593720271|FG003|Treatment Period|Death|0|||
164366931|NCT03161483|593720268|FG000|Treatment Period|Adverse Event|5|||
164366932|NCT03161483|593720269|FG001|Treatment Period|Adverse Event|2|||
164366933|NCT03161483|593720270|FG002|Treatment Period|Adverse Event|1|||
164366934|NCT03161483|593720271|FG003|Treatment Period|Adverse Event|11|||
164366935|NCT03161483|593720268|FG000|Treatment Period|Pregnancy|1|||
164366936|NCT03161483|593720269|FG001|Treatment Period|Pregnancy|0|||
164366937|NCT03161483|593720270|FG002|Treatment Period|Pregnancy|0|||
164366938|NCT03161483|593720271|FG003|Treatment Period|Pregnancy|0|||
164366939|NCT03161483|593720268|FG000|Treatment Period|Lack of Efficacy|0|||
164366940|NCT03161483|593720269|FG001|Treatment Period|Lack of Efficacy|0|||
164366941|NCT03161483|593720270|FG002|Treatment Period|Lack of Efficacy|0|||
164366942|NCT03161483|593720271|FG003|Treatment Period|Lack of Efficacy|1|||
164366943|NCT03161483|593720268|FG000|Treatment Period|Withdrawal by Subject|2|||
164366944|NCT03161483|593720269|FG001|Treatment Period|Withdrawal by Subject|5|||
164366945|NCT03161483|593720270|FG002|Treatment Period|Withdrawal by Subject|2|||
164366946|NCT03161483|593720271|FG003|Treatment Period|Withdrawal by Subject|6|||
164366947|NCT03161483|593720268|FG000|Treatment Period|Lost to Follow-up|0|||
164366948|NCT03161483|593720269|FG001|Treatment Period|Lost to Follow-up|0|||
164366949|NCT03161483|593720270|FG002|Treatment Period|Lost to Follow-up|0|||
164366950|NCT03161483|593720271|FG003|Treatment Period|Lost to Follow-up|1|||
164366951|NCT03161483|593720268|FG000|Treatment Period|Protocol Violation|0|||
164366952|NCT03161483|593720269|FG001|Treatment Period|Protocol Violation|0|||
164366953|NCT03161483|593720270|FG002|Treatment Period|Protocol Violation|0|||
164366954|NCT03161483|593720271|FG003|Treatment Period|Protocol Violation|1|||
164366955|NCT03161483|593720268|FG000|Treatment Period|Other reasons|1|||
164366956|NCT03161483|593720269|FG001|Treatment Period|Other reasons|1|||
164366957|NCT03161483|593720270|FG002|Treatment Period|Other reasons|0|||
164366958|NCT03161483|593720271|FG003|Treatment Period|Other reasons|0|||
164366959|NCT00600756|593720276|FG000|Analysis After 6 Months|Adverse Event|43|||
164366960|NCT00600756|593720277|FG001|Analysis After 6 Months|Adverse Event|33|||
164366961|NCT00600756|593720276|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
164366962|NCT00600756|593720277|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
164366963|NCT00600756|593720276|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
164366964|NCT00600756|593720277|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
164366965|NCT00600756|593720276|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
164366966|NCT00600756|593720277|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
164366967|NCT00600756|593720276|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
164366968|NCT00600756|593720277|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
164366969|NCT00600756|593720276|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
164366970|NCT00600756|593720277|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
164366971|NCT00600756|593720276|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
164366972|NCT00600756|593720277|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
164366973|NCT00600756|593720276|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
164366974|NCT00600756|593720277|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
164366975|NCT00600756|593720276|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
164366976|NCT00600756|593720277|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
164366977|NCT00600756|593720276|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
164366978|NCT00600756|593720277|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
164366979|NCT00600756|593720276|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
164366980|NCT00600756|593720277|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
164366981|NCT00600756|593720276|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
164366982|NCT00600756|593720277|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
164366983|NCT00600756|593720276|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
164366984|NCT00600756|593720277|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
164366985|NCT00600756|593720276|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
164366986|NCT00600756|593720277|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
164366987|NCT04753164|593720278|FG000|Overall Study|Adverse Event|0|||
164366988|NCT04753164|593720279|FG001|Overall Study|Adverse Event|2|||
164366989|NCT04753164|593720278|FG000|Overall Study|Withdrawal by Subject|9|||
164366990|NCT04753164|593720279|FG001|Overall Study|Withdrawal by Subject|7|||
164366991|NCT04753164|593720278|FG000|Overall Study|Lost to Follow-up|6|||
164366992|NCT04753164|593720279|FG001|Overall Study|Lost to Follow-up|6|||
164366993|NCT04753164|593720278|FG000|Overall Study|Other|12|||
164366994|NCT04753164|593720279|FG001|Overall Study|Other|5|||
164366995|NCT00694369|593720280|FG000|Overall Study|Adverse Event|0|||
164366996|NCT00694369|593720281|FG001|Overall Study|Adverse Event|1|||
164366997|NCT00694369|593720282|FG002|Overall Study|Adverse Event|0|||
164366998|NCT00694369|593720283|FG003|Overall Study|Adverse Event|1|||
164366999|NCT00694369|593720284|FG004|Overall Study|Adverse Event|3|||
164367000|NCT00694369|593720280|FG000|Overall Study|Lost to Follow-up|0|||
164367001|NCT00694369|593720281|FG001|Overall Study|Lost to Follow-up|0|||
164367002|NCT00694369|593720282|FG002|Overall Study|Lost to Follow-up|1|||
164367003|NCT00694369|593720283|FG003|Overall Study|Lost to Follow-up|1|||
164367004|NCT00694369|593720284|FG004|Overall Study|Lost to Follow-up|0|||
164367005|NCT00694369|593720280|FG000|Overall Study|Physician Decision|0|||
164367006|NCT00694369|593720281|FG001|Overall Study|Physician Decision|0|||
164367007|NCT00694369|593720282|FG002|Overall Study|Physician Decision|0|||
164367008|NCT00694369|593720283|FG003|Overall Study|Physician Decision|0|||
164367009|NCT00694369|593720284|FG004|Overall Study|Physician Decision|1|||
164367010|NCT00694369|593720280|FG000|Overall Study|Protocol Violation|0|||
164367011|NCT00694369|593720281|FG001|Overall Study|Protocol Violation|1|||
164367012|NCT00694369|593720282|FG002|Overall Study|Protocol Violation|0|||
164367013|NCT00694369|593720283|FG003|Overall Study|Protocol Violation|0|||
164367014|NCT00694369|593720284|FG004|Overall Study|Protocol Violation|0|||
164367015|NCT00694369|593720280|FG000|Overall Study|Withdrawal by Subject|1|||
164367016|NCT00694369|593720281|FG001|Overall Study|Withdrawal by Subject|1|||
164367017|NCT00694369|593720282|FG002|Overall Study|Withdrawal by Subject|1|||
164367018|NCT00694369|593720283|FG003|Overall Study|Withdrawal by Subject|1|||
164367019|NCT00694369|593720284|FG004|Overall Study|Withdrawal by Subject|2|||
164367020|NCT00439556|593720285|FG000|Overall Study|Patient was taken off study for non-comp|0|||
164367021|NCT00439556|593720286|FG001|Overall Study|Patient was taken off study for non-comp|1|||
164367022|NCT00439556|593720287|FG002|Overall Study|Patient was taken off study for non-comp|0|||
164367023|NCT02871739|593720288|FG000|Overall Study|Lost to Follow-up|3|||
164367024|NCT02871739|593720289|FG001|Overall Study|Lost to Follow-up|2|||
164367025|NCT02871739|593720290|FG002|Overall Study|Lost to Follow-up|0|||
164367026|NCT02871739|593720291|FG003|Overall Study|Lost to Follow-up|2|||
164367027|NCT01324388|593720294|FG000|Part 1 of Study|Adverse Event|2|||
164367028|NCT01324388|593720295|FG001|Part 1 of Study|Adverse Event|0|||
164367029|NCT01324388|593720296|FG002|Part 1 of Study|Adverse Event|0|||
164367030|NCT01324388|593720297|FG003|Part 1 of Study|Adverse Event|0|||
164367031|NCT01324388|593720294|FG000|Part 1 of Study|Protocol Violation|1|||
164367032|NCT01324388|593720295|FG001|Part 1 of Study|Protocol Violation|2|||
164367033|NCT01324388|593720296|FG002|Part 1 of Study|Protocol Violation|0|||
164367034|NCT01324388|593720297|FG003|Part 1 of Study|Protocol Violation|0|||
164367035|NCT01324388|593720294|FG000|Part 1 of Study|Physician Decision|1|||
164367036|NCT01324388|593720295|FG001|Part 1 of Study|Physician Decision|0|||
164367037|NCT01324388|593720296|FG002|Part 1 of Study|Physician Decision|0|||
164367038|NCT01324388|593720297|FG003|Part 1 of Study|Physician Decision|0|||
164367039|NCT01324388|593720294|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
164367040|NCT01324388|593720295|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
164367041|NCT01324388|593720296|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
164367042|NCT01324388|593720297|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
164367043|NCT01324388|593720294|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
164367044|NCT01324388|593720295|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
164367045|NCT01324388|593720296|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
164367046|NCT01324388|593720297|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
164367047|NCT01405963|593720298|FG000|Overall Study|Moved Away|2|||
164367048|NCT01405963|593720299|FG001|Overall Study|Moved Away|0|||
164367049|NCT01405963|593720298|FG000|Overall Study|Adverse Event|0|||
164367050|NCT01405963|593720299|FG001|Overall Study|Adverse Event|1|||
164367051|NCT01405963|593720298|FG000|Overall Study|Lost to Follow-up|0|||
164367052|NCT01405963|593720299|FG001|Overall Study|Lost to Follow-up|1|||
164367053|NCT00850395|593720306|FG000|Overall Study|Death|1|||
164367054|NCT00850395|593720306|FG000|Overall Study|Adverse Event|1|||
164367055|NCT00850395|593720306|FG000|Overall Study|Insufficient clinical response|3|||
164367056|NCT00850395|593720306|FG000|Overall Study|Other|5|||
164367057|NCT01737047|593720307|FG000|Overall Study|Death|10|||
164367058|NCT01737047|593720308|FG001|Overall Study|Death|0|||
164367059|NCT01737047|593720309|FG002|Overall Study|Death|1|||
164367060|NCT01737047|593720307|FG000|Overall Study|Withdrawal by Subject|17|||
164367061|NCT01737047|593720308|FG001|Overall Study|Withdrawal by Subject|11|||
164367062|NCT01737047|593720309|FG002|Overall Study|Withdrawal by Subject|4|||
164367063|NCT02802592|593720310|FG000|Overall Study|Study terminated due to loss of funding|4|||
164367064|NCT04007523|593720311|FG000|Overall Study|Withdrawal by Subject|0|||
164367065|NCT04007523|593720312|FG001|Overall Study|Withdrawal by Subject|1|||
164367066|NCT04007523|593720313|FG002|Overall Study|Withdrawal by Subject|1|||
164367067|NCT04007523|593720314|FG003|Overall Study|Withdrawal by Subject|0|||
164367068|NCT04007523|593720311|FG000|Overall Study|ICU Transfer|0|||
164367069|NCT04007523|593720312|FG001|Overall Study|ICU Transfer|1|||
164367070|NCT04007523|593720313|FG002|Overall Study|ICU Transfer|0|||
164367071|NCT04007523|593720314|FG003|Overall Study|ICU Transfer|0|||
164367072|NCT04007523|593720311|FG000|Overall Study|COVID hospital closure|0|||
164367073|NCT04007523|593720312|FG001|Overall Study|COVID hospital closure|0|||
164367074|NCT04007523|593720313|FG002|Overall Study|COVID hospital closure|1|||
164367075|NCT04007523|593720314|FG003|Overall Study|COVID hospital closure|2|||
164367076|NCT04007523|593720311|FG000|Overall Study|Surgery cancelled|0|||
164367077|NCT04007523|593720312|FG001|Overall Study|Surgery cancelled|0|||
164367078|NCT04007523|593720313|FG002|Overall Study|Surgery cancelled|1|||
164367079|NCT04007523|593720314|FG003|Overall Study|Surgery cancelled|1|||
164367080|NCT01826487|593720315|FG000|Overall Study|Adverse Event|1|||
164367081|NCT01826487|593720316|FG001|Overall Study|Adverse Event|1|||
164367082|NCT01826487|593720315|FG000|Overall Study|Lost to Follow-up|1|||
164367083|NCT01826487|593720316|FG001|Overall Study|Lost to Follow-up|0|||
164367084|NCT01826487|593720315|FG000|Overall Study|Withdrawal by Subject|1|||
164367085|NCT01826487|593720316|FG001|Overall Study|Withdrawal by Subject|3|||
164367086|NCT01826487|593720315|FG000|Overall Study|Protocol Violation|1|||
164367087|NCT01826487|593720316|FG001|Overall Study|Protocol Violation|1|||
164367088|NCT01408030|593720317|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
164367089|NCT01408030|593720318|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
164367090|NCT01408030|593720319|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
164367091|NCT01408030|593720320|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
164367092|NCT01408030|593720317|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
164367093|NCT01408030|593720318|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
164367094|NCT01408030|593720319|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
164367095|NCT01408030|593720320|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
164367096|NCT01408030|593720317|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
164367097|NCT01408030|593720318|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
164438735|NCT01909336|593973052|FG000|Overall Study|Physician Decision|0|||
164367098|NCT01408030|593720319|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
164367099|NCT01408030|593720320|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
164367100|NCT01408030|593720317|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
164367101|NCT01408030|593720318|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
164367102|NCT01408030|593720319|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
164367103|NCT01408030|593720320|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
164367104|NCT01408030|593720317|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
164367105|NCT01408030|593720318|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
164367106|NCT01408030|593720319|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
164367107|NCT01408030|593720320|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
164367108|NCT01408030|593720317|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
164367109|NCT01408030|593720318|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
164367110|NCT01408030|593720319|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
164367111|NCT01408030|593720320|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
164367112|NCT01408030|593720317|FG000|Observation Phase (Off Drug)|Other|1|||
164367113|NCT01408030|593720318|FG001|Observation Phase (Off Drug)|Other|1|||
164367114|NCT01408030|593720319|FG002|Observation Phase (Off Drug)|Other|1|||
164367115|NCT01408030|593720320|FG003|Observation Phase (Off Drug)|Other|1|||
164367116|NCT03608774|593720322|FG000|Overall Study|Lost to Follow-up|5|||
164367117|NCT03608774|593720323|FG001|Overall Study|Lost to Follow-up|5|||
164367118|NCT03608774|593720322|FG000|Overall Study|Withdrawal by Subject|1|||
164367119|NCT03608774|593720323|FG001|Overall Study|Withdrawal by Subject|0|||
164367120|NCT03608774|593720322|FG000|Overall Study|Protocol Violation|1|||
164367121|NCT03608774|593720323|FG001|Overall Study|Protocol Violation|0|||
164367122|NCT03608774|593720322|FG000|Overall Study|Not eligible at enrollment|0|||
164367123|NCT03608774|593720323|FG001|Overall Study|Not eligible at enrollment|1|||
164367124|NCT03608774|593720322|FG000|Overall Study|Health related event|0|||
164367125|NCT03608774|593720323|FG001|Overall Study|Health related event|1|||
164367126|NCT01586819|593720324|FG000|Overall Study|Withdrawal by Subject|1|||
164367127|NCT01586819|593720325|FG001|Overall Study|Withdrawal by Subject|0|||
164367128|NCT04837131|593720326|FG000|Overall Study|Death|1|||
164367129|NCT04837131|593720326|FG000|Overall Study|Withdrawal by Subject|1|||
164367130|NCT04837131|593720326|FG000|Overall Study|Adverse Event|1|||
164367131|NCT04837131|593720326|FG000|Overall Study|Protocol Violation|1|||
164367132|NCT04439318|593720327|FG000|Overall Study|Ineligible|1|||
164367133|NCT04439318|593720327|FG000|Overall Study|Never Started Treatment|3|||
164367134|NCT04439318|593720327|FG000|Overall Study|Adverse Event|10|||
164367135|NCT04439318|593720327|FG000|Overall Study|Death|2|||
164367136|NCT04439318|593720327|FG000|Overall Study|Disease Progression|25|||
164367137|NCT04439318|593720327|FG000|Overall Study|Other Complicating Disease|2|||
164367138|NCT04439318|593720327|FG000|Overall Study|Withdrawal by Subject|4|||
164367139|NCT04439318|593720327|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
164367140|NCT04439318|593720327|FG000|Overall Study|Non-Compliance|1|||
164367141|NCT04439318|593720327|FG000|Overall Study|Still on Treatment|1|||
164367142|NCT00409617|593721817|FG000|Overall Study|Adverse Event|57|||
164367143|NCT00409617|593721817|FG000|Overall Study|Lack of Efficacy|54|||
164367144|NCT00409617|593721817|FG000|Overall Study|Lost to Follow-up|2|||
164367145|NCT00409617|593721817|FG000|Overall Study|Protocol Violation|24|||
164367146|NCT00409617|593721817|FG000|Overall Study|Withdrawal by Subject|8|||
164367147|NCT00409617|593721817|FG000|Overall Study|Administrative reasons|1|||
164367148|NCT00409617|593721817|FG000|Overall Study|Not described|14|||
164367149|NCT00149747|593721828|FG000|Overall Study|Death|1|||
164367150|NCT00149747|593721829|FG001|Overall Study|Death|0|||
164367151|NCT00149747|593721828|FG000|Overall Study|Withdrawal by Subject|3|||
164367152|NCT00149747|593721829|FG001|Overall Study|Withdrawal by Subject|3|||
164367153|NCT02689258|593721830|FG000|Overall Study|Subject Non-Compliance|0|||
164367154|NCT02689258|593721831|FG001|Overall Study|Subject Non-Compliance|1|||
164367155|NCT02689258|593721832|FG002|Overall Study|Subject Non-Compliance|0|||
164367156|NCT02689258|593721833|FG003|Overall Study|Subject Non-Compliance|0|||
164367157|NCT02689258|593721834|FG004|Overall Study|Subject Non-Compliance|0|||
164367158|NCT02689258|593721835|FG005|Overall Study|Subject Non-Compliance|0|||
164367159|NCT02689258|593721836|FG006|Overall Study|Subject Non-Compliance|0|||
164367160|NCT02689258|593721837|FG007|Overall Study|Subject Non-Compliance|0|||
164367161|NCT02689258|593721838|FG008|Overall Study|Subject Non-Compliance|0|||
164367162|NCT02689258|593721839|FG009|Overall Study|Subject Non-Compliance|0|||
164367163|NCT02689258|593721840|FG010|Overall Study|Subject Non-Compliance|0|||
164367164|NCT02689258|593721841|FG011|Overall Study|Subject Non-Compliance|0|||
164367165|NCT02689258|593721830|FG000|Overall Study|Subject Refusal to Continue|0|||
164367166|NCT02689258|593721831|FG001|Overall Study|Subject Refusal to Continue|1|||
164367167|NCT02689258|593721832|FG002|Overall Study|Subject Refusal to Continue|0|||
164367168|NCT02689258|593721833|FG003|Overall Study|Subject Refusal to Continue|0|||
164367169|NCT02689258|593721834|FG004|Overall Study|Subject Refusal to Continue|0|||
164367170|NCT02689258|593721835|FG005|Overall Study|Subject Refusal to Continue|0|||
164367171|NCT02689258|593721836|FG006|Overall Study|Subject Refusal to Continue|0|||
164367172|NCT02689258|593721837|FG007|Overall Study|Subject Refusal to Continue|0|||
164367173|NCT02689258|593721838|FG008|Overall Study|Subject Refusal to Continue|1|||
164367174|NCT02689258|593721839|FG009|Overall Study|Subject Refusal to Continue|0|||
164367175|NCT02689258|593721840|FG010|Overall Study|Subject Refusal to Continue|0|||
164367176|NCT02689258|593721841|FG011|Overall Study|Subject Refusal to Continue|1|||
164367177|NCT02689258|593721830|FG000|Overall Study|Other|0|||
164367178|NCT02689258|593721831|FG001|Overall Study|Other|2|||
164367179|NCT02689258|593721832|FG002|Overall Study|Other|0|||
164367180|NCT02689258|593721833|FG003|Overall Study|Other|0|||
164367181|NCT02689258|593721834|FG004|Overall Study|Other|1|||
164367182|NCT02689258|593721835|FG005|Overall Study|Other|0|||
164367183|NCT02689258|593721836|FG006|Overall Study|Other|0|||
164367184|NCT02689258|593721837|FG007|Overall Study|Other|0|||
164367185|NCT02689258|593721838|FG008|Overall Study|Other|1|||
164367186|NCT02689258|593721839|FG009|Overall Study|Other|0|||
164367187|NCT02689258|593721840|FG010|Overall Study|Other|0|||
164367188|NCT02689258|593721841|FG011|Overall Study|Other|0|||
164367189|NCT03373383|593721842|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
164367190|NCT03373383|593721843|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
164367191|NCT03373383|593721844|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
164367192|NCT03373383|593721845|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
164367193|NCT03373383|593721846|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
164367194|NCT03373383|593721842|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
164367195|NCT03373383|593721843|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
164367196|NCT03373383|593721844|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
164367197|NCT03373383|593721845|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
164367198|NCT03373383|593721846|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
164367199|NCT03373383|593721842|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
164367200|NCT03373383|593721843|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
164367201|NCT03373383|593721844|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
164367202|NCT03373383|593721845|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
164367203|NCT03373383|593721846|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
164367204|NCT03373383|593721842|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
164367205|NCT03373383|593721843|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
164367206|NCT03373383|593721844|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
164367207|NCT03373383|593721845|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
164367208|NCT03373383|593721846|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
164367209|NCT03373383|593721842|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
164367210|NCT03373383|593721843|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
164367211|NCT03373383|593721844|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
164367212|NCT03373383|593721845|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
164367213|NCT03373383|593721846|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
164367214|NCT03373383|593721842|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
164367215|NCT03373383|593721843|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
164367216|NCT03373383|593721844|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
164367217|NCT03373383|593721845|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
164367218|NCT03373383|593721846|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
164367219|NCT03373383|593721842|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
164367220|NCT03373383|593721843|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
164367221|NCT03373383|593721844|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
164367222|NCT03373383|593721845|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
164367223|NCT03373383|593721846|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
164367224|NCT03373383|593721842|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
164367225|NCT03373383|593721843|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
164367226|NCT03373383|593721844|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
164367227|NCT03373383|593721845|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
164367228|NCT03373383|593721846|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
164367229|NCT03373383|593721842|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
164367230|NCT03373383|593721843|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
164367231|NCT03373383|593721844|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
164367232|NCT03373383|593721845|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
164367233|NCT03373383|593721846|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
164367234|NCT02159521|593721848|FG000|Overall Study|Enrolled but not treated|3|||
164367235|NCT02159521|593721848|FG000|Overall Study|Withdrawal by Subject|7|||
164367236|NCT02159521|593721848|FG000|Overall Study|Lost to Follow-up|6|||
164438736|NCT01909336|593973053|FG001|Overall Study|Physician Decision|1|||
164438737|NCT01909336|593973054|FG002|Overall Study|Physician Decision|1|||
164367237|NCT02159521|593721848|FG000|Overall Study|Death|1|||
164367238|NCT02159521|593721848|FG000|Overall Study|Other than specified|1|||
164367239|NCT00907374|593721851|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
164367240|NCT00907374|593721852|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
164367241|NCT03818516|593721853|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
164367242|NCT00594464|593721854|FG000|Overall Study|Withdrawal by Subject|1|||
164367243|NCT00594464|593721854|FG000|Overall Study|Delay in operation|2|||
164367244|NCT00785486|593721855|FG000|Midazolam Alone|Withdrawal by Subject|1|||
164367245|NCT02907359|593721862|FG000|Overall Study|Death|234|||
164367246|NCT02907359|593721863|FG001|Overall Study|Death|117|||
164367247|NCT02907359|593721862|FG000|Overall Study|Withdrawal by Subject|6|||
164367248|NCT02907359|593721863|FG001|Overall Study|Withdrawal by Subject|11|||
164367249|NCT02907359|593721862|FG000|Overall Study|Lost to Follow-up|1|||
164367250|NCT02907359|593721863|FG001|Overall Study|Lost to Follow-up|0|||
164367251|NCT00746941|593721866|FG000|Overall Study|Death|2|||
164367252|NCT00746941|593721867|FG001|Overall Study|Death|0|||
164367253|NCT00746941|593721868|FG002|Overall Study|Death|0|||
164367254|NCT00746941|593721869|FG003|Overall Study|Death|6|||
164367255|NCT00746941|593721866|FG000|Overall Study|Physician Decision|0|||
164367256|NCT00746941|593721867|FG001|Overall Study|Physician Decision|0|||
164367257|NCT00746941|593721868|FG002|Overall Study|Physician Decision|2|||
164367258|NCT00746941|593721869|FG003|Overall Study|Physician Decision|0|||
164367259|NCT00746941|593721866|FG000|Overall Study|Withdrawal by Subject|3|||
164367260|NCT00746941|593721867|FG001|Overall Study|Withdrawal by Subject|0|||
164367261|NCT00746941|593721868|FG002|Overall Study|Withdrawal by Subject|0|||
164367262|NCT00746941|593721869|FG003|Overall Study|Withdrawal by Subject|2|||
164367263|NCT00746941|593721866|FG000|Overall Study|Other, reason not provided|2|||
164367264|NCT00746941|593721867|FG001|Overall Study|Other, reason not provided|4|||
164367265|NCT00746941|593721868|FG002|Overall Study|Other, reason not provided|0|||
164367266|NCT00746941|593721869|FG003|Overall Study|Other, reason not provided|4|||
164367267|NCT00746941|593721866|FG000|Overall Study|Adverse Event|0|||
164367268|NCT00746941|593721867|FG001|Overall Study|Adverse Event|0|||
164367269|NCT00746941|593721868|FG002|Overall Study|Adverse Event|0|||
164367270|NCT00746941|593721869|FG003|Overall Study|Adverse Event|1|||
164367271|NCT01524692|593721877|FG000|Overall Study|Withdrawal by Subject|3|||
164367272|NCT01709695|593721879|FG000|Overall Study|Withdrawal by Subject|1|||
164367273|NCT01709695|593721880|FG001|Overall Study|Withdrawal by Subject|1|||
164367274|NCT03065244|593721884|FG000|Overall Study|Lost to Follow-up|1|||
164367275|NCT03065244|593721885|FG001|Overall Study|Lost to Follow-up|1|||
164367276|NCT03065244|593721884|FG000|Overall Study|Diagnosed with a different disease|1|||
164367277|NCT03065244|593721885|FG001|Overall Study|Diagnosed with a different disease|1|||
164367278|NCT03065244|593721884|FG000|Overall Study|Protocol Violation|0|||
164367279|NCT03065244|593721885|FG001|Overall Study|Protocol Violation|1|||
164367280|NCT03065244|593721884|FG000|Overall Study|Withdrawal by Subject|1|||
164367281|NCT03065244|593721885|FG001|Overall Study|Withdrawal by Subject|1|||
164367282|NCT03717480|593721886|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
164367283|NCT01894152|593721887|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
164367284|NCT02741700|593721888|FG000|Overall Study|Lost to Follow-up|17|||
164367285|NCT02741700|593721889|FG001|Overall Study|Lost to Follow-up|8|||
164367286|NCT02741700|593721888|FG000|Overall Study|Withdrawal by Subject|2|||
164367287|NCT02741700|593721889|FG001|Overall Study|Withdrawal by Subject|5|||
164367288|NCT02741700|593721888|FG000|Overall Study|Physician Decision|3|||
164367289|NCT02741700|593721889|FG001|Overall Study|Physician Decision|0|||
164367290|NCT02741700|593721888|FG000|Overall Study|Moved out of State|0|||
164367291|NCT02741700|593721889|FG001|Overall Study|Moved out of State|1|||
164367292|NCT02741700|593721888|FG000|Overall Study|Death|4|||
164367293|NCT02741700|593721889|FG001|Overall Study|Death|5|||
164367294|NCT01774786|593721891|FG000|Overall Study|Death|300|||
164367295|NCT01774786|593721892|FG001|Overall Study|Death|319|||
164367296|NCT01774786|593721891|FG000|Overall Study|Lost to Follow-up|6|||
164367297|NCT01774786|593721892|FG001|Overall Study|Lost to Follow-up|7|||
164367298|NCT01774786|593721891|FG000|Overall Study|Withdrawal by Subject|18|||
164367299|NCT01774786|593721892|FG001|Overall Study|Withdrawal by Subject|14|||
164367300|NCT01774786|593721891|FG000|Overall Study|Physician Decision|2|||
164367301|NCT01774786|593721892|FG001|Overall Study|Physician Decision|0|||
164367302|NCT01774786|593721891|FG000|Overall Study|Non-compliance|0|||
164367303|NCT01774786|593721892|FG001|Overall Study|Non-compliance|1|||
164367304|NCT01774786|593721891|FG000|Overall Study|Reason Not Specified|2|||
164367305|NCT01774786|593721892|FG001|Overall Study|Reason Not Specified|5|||
164367306|NCT00075582|593721893|FG000|Overall Study|Adverse Event|3|||
164367307|NCT00075582|593721894|FG001|Overall Study|Adverse Event|1|||
164367308|NCT00075582|593721893|FG000|Overall Study|Lack of Efficacy|4|||
164367309|NCT00075582|593721894|FG001|Overall Study|Lack of Efficacy|8|||
164367310|NCT00075582|593721893|FG000|Overall Study|Physician Decision|5|||
164367311|NCT00075582|593721894|FG001|Overall Study|Physician Decision|8|||
164367312|NCT00075582|593721893|FG000|Overall Study|Withdrawal by Subject|2|||
164367313|NCT00075582|593721894|FG001|Overall Study|Withdrawal by Subject|2|||
164367314|NCT00075582|593721893|FG000|Overall Study|Ineligible for study|36|||
164367315|NCT00075582|593721894|FG001|Overall Study|Ineligible for study|16|||
164367316|NCT04544293|593721895|FG000|Double-blind|Adverse Event|2|||
164367317|NCT04544293|593721896|FG001|Double-blind|Adverse Event|1|||
164367318|NCT04544293|593721895|FG000|Double-blind|Pregnancy|0|||
164367319|NCT04544293|593721896|FG001|Double-blind|Pregnancy|1|||
164367320|NCT04544293|593721895|FG000|Double-blind|Lost to Follow-up|0|||
164367321|NCT04544293|593721896|FG001|Double-blind|Lost to Follow-up|1|||
164367322|NCT04544293|593721895|FG000|Open-Label Extension|Study ongoing|79|||
164367323|NCT04544293|593721896|FG001|Open-Label Extension|Study ongoing|81|||
164367324|NCT02965703|593721901|FG000|Overall Study|Withdrawal by Subject|6|||
164367325|NCT02965703|593721902|FG001|Overall Study|Withdrawal by Subject|3|||
164367326|NCT02965703|593721903|FG002|Overall Study|Withdrawal by Subject|1|||
164367327|NCT02965703|593721901|FG000|Overall Study|Protocol Violation|1|||
164367328|NCT02965703|593721902|FG001|Overall Study|Protocol Violation|0|||
164367329|NCT02965703|593721903|FG002|Overall Study|Protocol Violation|0|||
164367330|NCT02965703|593721901|FG000|Overall Study|Adverse Event|1|||
164367331|NCT02965703|593721902|FG001|Overall Study|Adverse Event|1|||
164367332|NCT02965703|593721903|FG002|Overall Study|Adverse Event|0|||
164367333|NCT02965703|593721901|FG000|Overall Study|Lost to Follow-up|2|||
164367334|NCT02965703|593721902|FG001|Overall Study|Lost to Follow-up|1|||
164367335|NCT02965703|593721903|FG002|Overall Study|Lost to Follow-up|1|||
164367336|NCT00744627|593721904|FG000|Overall Study|Adverse Event|6|||
164367337|NCT00744627|593721905|FG001|Overall Study|Adverse Event|9|||
164367338|NCT00744627|593721904|FG000|Overall Study|Lack of Efficacy|7|||
164367339|NCT00744627|593721905|FG001|Overall Study|Lack of Efficacy|3|||
164367340|NCT00744627|593721904|FG000|Overall Study|Noncompliance|0|||
164367341|NCT00744627|593721905|FG001|Overall Study|Noncompliance|1|||
164367342|NCT00744627|593721904|FG000|Overall Study|Protocol Deviations|0|||
164367343|NCT00744627|593721905|FG001|Overall Study|Protocol Deviations|2|||
164367344|NCT00744627|593721904|FG000|Overall Study|Voluntary Withdrawal|9|||
164367345|NCT00744627|593721905|FG001|Overall Study|Voluntary Withdrawal|6|||
164367346|NCT00744627|593721904|FG000|Overall Study|Lost to Follow-up|2|||
164367347|NCT00744627|593721905|FG001|Overall Study|Lost to Follow-up|1|||
164367348|NCT00744627|593721904|FG000|Overall Study|Other|1|||
164367349|NCT00744627|593721905|FG001|Overall Study|Other|0|||
164367350|NCT02268786|593721906|FG000|Overall Study|No Euploid Embryos available|42|||
164367351|NCT02268786|593721907|FG001|Overall Study|No Euploid Embryos available|0|||
164367352|NCT02268786|593721906|FG000|Overall Study|Withdrawal by Subject|7|||
164367353|NCT02268786|593721907|FG001|Overall Study|Withdrawal by Subject|14|||
164367354|NCT02268786|593721906|FG000|Overall Study|Thaw Failure|6|||
164367355|NCT02268786|593721907|FG001|Overall Study|Thaw Failure|4|||
164367356|NCT02268786|593721906|FG000|Overall Study|Protocol Violation|1|||
164367357|NCT02268786|593721907|FG001|Overall Study|Protocol Violation|0|||
164367358|NCT01062555|593721918|FG000|Phase 1|Death|10|||
164367359|NCT01062555|593721919|FG001|Phase 1|Death|17|||
164367360|NCT01062555|593721920|FG002|Phase 1|Death|0|||
164367361|NCT01062555|593721921|FG003|Phase 1|Death|0|||
164367362|NCT01062555|593721918|FG000|Phase 1|Graft Failure|12|||
164367363|NCT01062555|593721919|FG001|Phase 1|Graft Failure|8|||
164367364|NCT01062555|593721920|FG002|Phase 1|Graft Failure|0|||
164367365|NCT01062555|593721921|FG003|Phase 1|Graft Failure|0|||
164367366|NCT01062555|593721918|FG000|Phase 1|Withdrawal by Subject|1|||
164367367|NCT01062555|593721919|FG001|Phase 1|Withdrawal by Subject|1|||
164367368|NCT01062555|593721920|FG002|Phase 1|Withdrawal by Subject|0|||
164367369|NCT01062555|593721921|FG003|Phase 1|Withdrawal by Subject|0|||
164367370|NCT01062555|593721918|FG000|Phase 2|Death|0|||
164367371|NCT01062555|593721919|FG001|Phase 2|Death|0|||
164367372|NCT01062555|593721920|FG002|Phase 2|Death|8|||
164367373|NCT01062555|593721921|FG003|Phase 2|Death|3|||
164367374|NCT01062555|593721918|FG000|Phase 2|Graft failure|0|||
164367375|NCT01062555|593721919|FG001|Phase 2|Graft failure|0|||
164367376|NCT01062555|593721920|FG002|Phase 2|Graft failure|7|||
164367377|NCT01062555|593721921|FG003|Phase 2|Graft failure|4|||
164367378|NCT01062555|593721918|FG000|Phase 2|Withdrawal by Subject|0|||
164367379|NCT01062555|593721919|FG001|Phase 2|Withdrawal by Subject|0|||
164367380|NCT01062555|593721920|FG002|Phase 2|Withdrawal by Subject|0|||
164367381|NCT01062555|593721921|FG003|Phase 2|Withdrawal by Subject|7|||
164367382|NCT01062555|593721918|FG000|Phase 2|Protocol Violation|0|||
164367383|NCT01062555|593721919|FG001|Phase 2|Protocol Violation|0|||
164367384|NCT01062555|593721920|FG002|Phase 2|Protocol Violation|0|||
164591234|NCT00374907|594527259|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
164367385|NCT01062555|593721921|FG003|Phase 2|Protocol Violation|3|||
164367386|NCT01062555|593721918|FG000|Phase 2|Physician Decision|0|||
164367387|NCT01062555|593721919|FG001|Phase 2|Physician Decision|0|||
164367388|NCT01062555|593721920|FG002|Phase 2|Physician Decision|0|||
164367389|NCT01062555|593721921|FG003|Phase 2|Physician Decision|17|||
164367390|NCT03560531|593721922|FG000|Overall Study|Death|4|||
164367391|NCT03560531|593721923|FG001|Overall Study|Death|1|||
164367392|NCT03560531|593721924|FG002|Overall Study|Death|1|||
164367393|NCT03560531|593721925|FG003|Overall Study|Death|2|||
164367394|NCT03560531|593721926|FG004|Overall Study|Death|6|||
164367395|NCT03560531|593721927|FG005|Overall Study|Death|1|||
164367396|NCT03560531|593721928|FG006|Overall Study|Death|4|||
164367397|NCT03560531|593721929|FG007|Overall Study|Death|8|||
164367398|NCT03560531|593721930|FG008|Overall Study|Death|1|||
164367399|NCT03560531|593721931|FG009|Overall Study|Death|3|||
164367400|NCT03560531|593721932|FG010|Overall Study|Death|2|||
164367401|NCT03560531|593721933|FG011|Overall Study|Death|0|||
164367402|NCT03560531|593721934|FG012|Overall Study|Death|4|||
164367403|NCT03560531|593721935|FG013|Overall Study|Death|1|||
164367404|NCT03560531|593721922|FG000|Overall Study|Lost to Follow-up|1|||
164367405|NCT03560531|593721923|FG001|Overall Study|Lost to Follow-up|1|||
164367406|NCT03560531|593721924|FG002|Overall Study|Lost to Follow-up|0|||
164367407|NCT03560531|593721925|FG003|Overall Study|Lost to Follow-up|0|||
164367408|NCT03560531|593721926|FG004|Overall Study|Lost to Follow-up|0|||
164367409|NCT03560531|593721927|FG005|Overall Study|Lost to Follow-up|0|||
164367410|NCT03560531|593721928|FG006|Overall Study|Lost to Follow-up|1|||
164367411|NCT03560531|593721929|FG007|Overall Study|Lost to Follow-up|0|||
164367412|NCT03560531|593721930|FG008|Overall Study|Lost to Follow-up|0|||
164367413|NCT03560531|593721931|FG009|Overall Study|Lost to Follow-up|0|||
164367414|NCT03560531|593721932|FG010|Overall Study|Lost to Follow-up|0|||
164367415|NCT03560531|593721933|FG011|Overall Study|Lost to Follow-up|0|||
164367416|NCT03560531|593721934|FG012|Overall Study|Lost to Follow-up|0|||
164367417|NCT03560531|593721935|FG013|Overall Study|Lost to Follow-up|0|||
164367418|NCT03560531|593721922|FG000|Overall Study|Withdrawal by Subject|1|||
164367419|NCT03560531|593721923|FG001|Overall Study|Withdrawal by Subject|0|||
164367420|NCT03560531|593721924|FG002|Overall Study|Withdrawal by Subject|0|||
164367421|NCT03560531|593721925|FG003|Overall Study|Withdrawal by Subject|0|||
164367422|NCT03560531|593721926|FG004|Overall Study|Withdrawal by Subject|0|||
164367423|NCT03560531|593721927|FG005|Overall Study|Withdrawal by Subject|0|||
164367424|NCT03560531|593721928|FG006|Overall Study|Withdrawal by Subject|0|||
164367425|NCT03560531|593721929|FG007|Overall Study|Withdrawal by Subject|3|||
164367426|NCT03560531|593721930|FG008|Overall Study|Withdrawal by Subject|2|||
164367427|NCT03560531|593721931|FG009|Overall Study|Withdrawal by Subject|0|||
164367428|NCT03560531|593721932|FG010|Overall Study|Withdrawal by Subject|0|||
164367429|NCT03560531|593721933|FG011|Overall Study|Withdrawal by Subject|0|||
164367430|NCT03560531|593721934|FG012|Overall Study|Withdrawal by Subject|2|||
164367431|NCT03560531|593721935|FG013|Overall Study|Withdrawal by Subject|0|||
164367432|NCT03560531|593721922|FG000|Overall Study|Study end per-protocol|1|||
164367433|NCT03560531|593721923|FG001|Overall Study|Study end per-protocol|1|||
164367434|NCT03560531|593721924|FG002|Overall Study|Study end per-protocol|2|||
164367435|NCT03560531|593721925|FG003|Overall Study|Study end per-protocol|0|||
164367436|NCT03560531|593721926|FG004|Overall Study|Study end per-protocol|1|||
164367437|NCT03560531|593721927|FG005|Overall Study|Study end per-protocol|0|||
164367438|NCT03560531|593721928|FG006|Overall Study|Study end per-protocol|0|||
164367439|NCT03560531|593721929|FG007|Overall Study|Study end per-protocol|0|||
164367440|NCT03560531|593721930|FG008|Overall Study|Study end per-protocol|0|||
164367441|NCT03560531|593721931|FG009|Overall Study|Study end per-protocol|0|||
164367442|NCT03560531|593721932|FG010|Overall Study|Study end per-protocol|0|||
164367443|NCT03560531|593721933|FG011|Overall Study|Study end per-protocol|0|||
164367444|NCT03560531|593721934|FG012|Overall Study|Study end per-protocol|0|||
164367445|NCT03560531|593721935|FG013|Overall Study|Study end per-protocol|0|||
164367446|NCT03560531|593721922|FG000|Overall Study|Early study termination by sponsor|9|||
164367447|NCT03560531|593721923|FG001|Overall Study|Early study termination by sponsor|0|||
164367448|NCT03560531|593721924|FG002|Overall Study|Early study termination by sponsor|0|||
164367449|NCT03560531|593721925|FG003|Overall Study|Early study termination by sponsor|4|||
164367450|NCT03560531|593721926|FG004|Overall Study|Early study termination by sponsor|8|||
164367451|NCT03560531|593721927|FG005|Overall Study|Early study termination by sponsor|2|||
164367452|NCT03560531|593721928|FG006|Overall Study|Early study termination by sponsor|5|||
164367453|NCT03560531|593721929|FG007|Overall Study|Early study termination by sponsor|64|||
164367454|NCT03560531|593721930|FG008|Overall Study|Early study termination by sponsor|7|||
164367455|NCT03560531|593721931|FG009|Overall Study|Early study termination by sponsor|2|||
164367456|NCT03560531|593721932|FG010|Overall Study|Early study termination by sponsor|16|||
164367457|NCT03560531|593721933|FG011|Overall Study|Early study termination by sponsor|2|||
164367458|NCT03560531|593721934|FG012|Overall Study|Early study termination by sponsor|6|||
164367459|NCT03560531|593721935|FG013|Overall Study|Early study termination by sponsor|2|||
164367460|NCT02968979|593721936|FG000|Overall Study|Protocol Violation|7|||
164367461|NCT02968979|593721936|FG000|Overall Study|Withdrawal by Subject|1|||
164367462|NCT01471379|593721937|FG000|Overall Study|Adverse Event|1|||
164367463|NCT01471379|593721938|FG001|Overall Study|Adverse Event|0|||
164367464|NCT01471379|593721939|FG002|Overall Study|Adverse Event|0|||
164367465|NCT01471379|593721937|FG000|Overall Study|Study terminated|0|||
164367466|NCT01471379|593721938|FG001|Overall Study|Study terminated|1|||
164700165|NCT01392326|594924895|FG001|Overall Study|Withdrawal by Subject|11|||
164700166|NCT01392326|594924896|FG002|Overall Study|Withdrawal by Subject|15|||
164700167|NCT01392326|594924894|FG000|Overall Study|Protocol Violation|2|||
164367467|NCT01471379|593721939|FG002|Overall Study|Study terminated|0|||
164367468|NCT00788827|593721940|FG000|Overall Study|Lack of Efficacy|2|||
164367469|NCT02818777|593721952|FG000|Overall Study|Adverse Event|3|||
164367470|NCT02028988|593721953|FG000|Overall Study|Withdrawal by Subject|2|||
164367471|NCT00747435|593721956|FG000|Overall Study|Lost to Follow-up|2|||
164367472|NCT00747435|593721956|FG000|Overall Study|Withdrawal by Subject|3|||
164367473|NCT00747435|593721956|FG000|Overall Study|Still undergoing follow up|1|||
164367474|NCT01324349|593721957|FG000|Overall Study|Death|1|||
164367475|NCT01324349|593721958|FG001|Overall Study|Death|1|||
164367476|NCT01324349|593721957|FG000|Overall Study|Withdrawal by Subject|0|||
164700168|NCT01392326|594924895|FG001|Overall Study|Protocol Violation|0|||
164367477|NCT01324349|593721958|FG001|Overall Study|Withdrawal by Subject|1|||
164367478|NCT00851799|593721959|FG000|Overall Study|Death|1|||
164367479|NCT00851799|593721960|FG001|Overall Study|Death|0|||
164367480|NCT00851799|593721961|FG002|Overall Study|Death|1|||
164367481|NCT00851799|593721959|FG000|Overall Study|Lost to Follow-up|5|||
164367482|NCT00851799|593721960|FG001|Overall Study|Lost to Follow-up|3|||
164367483|NCT00851799|593721961|FG002|Overall Study|Lost to Follow-up|10|||
164367484|NCT00851799|593721959|FG000|Overall Study|Not able to get to clinic|8|||
164367485|NCT00851799|593721960|FG001|Overall Study|Not able to get to clinic|5|||
164367486|NCT00851799|593721961|FG002|Overall Study|Not able to get to clinic|9|||
164367487|NCT00851799|593721959|FG000|Overall Study|Not willing to adhere to requirements|1|||
164367488|NCT00851799|593721960|FG001|Overall Study|Not willing to adhere to requirements|2|||
164367489|NCT00851799|593721961|FG002|Overall Study|Not willing to adhere to requirements|2|||
164367490|NCT00851799|593721959|FG000|Overall Study|Withdrew consent prior study completion|1|||
164367491|NCT00851799|593721960|FG001|Overall Study|Withdrew consent prior study completion|2|||
164367492|NCT00851799|593721961|FG002|Overall Study|Withdrew consent prior study completion|1|||
164367493|NCT00851799|593721959|FG000|Overall Study|Severe Debilitation|0|||
164367494|NCT00851799|593721960|FG001|Overall Study|Severe Debilitation|1|||
164367495|NCT00851799|593721961|FG002|Overall Study|Severe Debilitation|0|||
164367496|NCT00851799|593721959|FG000|Overall Study|Completed protocol due to pregnancy|0|||
164367497|NCT00851799|593721960|FG001|Overall Study|Completed protocol due to pregnancy|0|||
164367498|NCT00851799|593721961|FG002|Overall Study|Completed protocol due to pregnancy|1|||
164367499|NCT02276612|593721964|FG000|Overall Study|Death|1|||
164367500|NCT02276612|593721965|FG001|Overall Study|Death|0|||
164367501|NCT02276612|593721964|FG000|Overall Study|Pregnancy|1|||
164367502|NCT02276612|593721965|FG001|Overall Study|Pregnancy|0|||
164367503|NCT02276612|593721964|FG000|Overall Study|Withdrew Consent|1|||
164367504|NCT02276612|593721965|FG001|Overall Study|Withdrew Consent|0|||
164367505|NCT02276612|593721964|FG000|Overall Study|Lost to Follow-up|1|||
164367506|NCT02276612|593721965|FG001|Overall Study|Lost to Follow-up|0|||
164367507|NCT04365556|593721966|FG000|Overall Study|No longer eligible due to treatment plan|1|||
164367508|NCT04365556|593721967|FG001|Overall Study|No longer eligible due to treatment plan|0|||
164367509|NCT04365556|593721966|FG000|Overall Study|Lost to Follow-up|3|||
164367510|NCT04365556|593721967|FG001|Overall Study|Lost to Follow-up|2|||
164367511|NCT00302003|593723826|FG000|Overall Study|Lack of Efficacy|62|||
164367512|NCT00302003|593723826|FG000|Overall Study|Lost to Follow-up|1|||
164367513|NCT00302003|593723826|FG000|Overall Study|Physician Decision|2|||
164367514|NCT00302003|593723826|FG000|Overall Study|Withdrawal by Subject|5|||
164367515|NCT00302003|593723826|FG000|Overall Study|Ineligible|9|||
164367516|NCT00302003|593723826|FG000|Overall Study|Protocol Violation|1|||
164367517|NCT02042924|593723827|FG000|Overall Study|Early Death|1|||
164367518|NCT04033003|593723828|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
164367519|NCT04033003|593723829|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
164367520|NCT04033003|593723828|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
164367521|NCT04033003|593723829|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
164367522|NCT04033003|593723828|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
164367523|NCT04033003|593723829|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
164367524|NCT04033003|593723828|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
164367525|NCT04033003|593723829|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
164367526|NCT04033003|593723828|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
164367527|NCT04033003|593723829|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
164367528|NCT04033003|593723828|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
164367529|NCT04033003|593723829|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
164367530|NCT04033003|593723828|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
164367531|NCT04033003|593723829|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
164367532|NCT04033003|593723828|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
164367533|NCT04033003|593723829|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
164367534|NCT04033003|593723828|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
164367535|NCT04033003|593723829|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
164367536|NCT04033003|593723828|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
164367537|NCT04033003|593723829|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
164367538|NCT04033003|593723828|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
164367539|NCT04033003|593723829|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
164367540|NCT04033003|593723828|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
164367541|NCT04033003|593723829|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
164367542|NCT04033003|593723828|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
164367543|NCT04033003|593723829|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
164367544|NCT02919670|593723830|FG000|Overall Study|Only 17 participants met compliance|43|||
164367545|NCT02919670|593723831|FG001|Overall Study|Only 17 participants met compliance|39|||
164367546|NCT02256891|593723832|FG000|Overall Study|Death|0|||
164367547|NCT02256891|593723833|FG001|Overall Study|Death|2|||
164367548|NCT02256891|593723832|FG000|Overall Study|Lost to Follow-up|0|||
164367549|NCT02256891|593723833|FG001|Overall Study|Lost to Follow-up|3|||
164367550|NCT02256891|593723832|FG000|Overall Study|Physician Decision|7|||
164367551|NCT02256891|593723833|FG001|Overall Study|Physician Decision|3|||
164367552|NCT02256891|593723832|FG000|Overall Study|Screen Fail|5|||
164367553|NCT02256891|593723833|FG001|Overall Study|Screen Fail|4|||
164367554|NCT02256891|593723832|FG000|Overall Study|Equipment Malfunction|0|||
164367555|NCT02256891|593723833|FG001|Overall Study|Equipment Malfunction|1|||
164367556|NCT04920123|593723836|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
164367557|NCT04920123|593723837|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
164367558|NCT04920123|593723838|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
164367559|NCT00826267|593723839|FG000|Overall Study|Other Adverse Event|1|||
164367560|NCT00826267|593723840|FG001|Overall Study|Other Adverse Event|0|||
164367561|NCT00826267|593723841|FG002|Overall Study|Other Adverse Event|0|||
164367562|NCT02586493|593723854|FG000|Overall Study|Adverse Event|4|||
164367563|NCT02586493|593723854|FG000|Overall Study|Protocol Violation|6|||
164367564|NCT02586493|593723854|FG000|Overall Study|Lost to Follow-up|1|||
164367565|NCT02586493|593723854|FG000|Overall Study|Withdrawal by Subject|1|||
164367566|NCT01604343|593723862|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
164367567|NCT01604343|593723863|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
164367568|NCT01604343|593723864|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
164367569|NCT01604343|593723865|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
164367570|NCT01604343|593723866|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
164367571|NCT01604343|593723862|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
164367572|NCT01604343|593723863|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
164367573|NCT01604343|593723864|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
164367574|NCT01604343|593723865|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
164367575|NCT01604343|593723866|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
164367576|NCT01604343|593723862|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
164367577|NCT01604343|593723863|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
164367578|NCT01604343|593723864|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
164367579|NCT01604343|593723865|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
164367580|NCT01604343|593723866|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
164367581|NCT01604343|593723862|FG000|Prior to W52 Administration(Through W52)|Death|5|||
164367582|NCT01604343|593723863|FG001|Prior to W52 Administration(Through W52)|Death|0|||
164367583|NCT01604343|593723864|FG002|Prior to W52 Administration(Through W52)|Death|2|||
164367584|NCT01604343|593723865|FG003|Prior to W52 Administration(Through W52)|Death|0|||
164367585|NCT01604343|593723866|FG004|Prior to W52 Administration(Through W52)|Death|4|||
164367586|NCT01604343|593723862|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
164367587|NCT01604343|593723863|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
164367588|NCT01604343|593723864|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
164367589|NCT01604343|593723865|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
164367590|NCT01604343|593723866|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
164367591|NCT01604343|593723862|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
164367592|NCT01604343|593723863|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
164367593|NCT01604343|593723864|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
164367594|NCT01604343|593723865|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
164367595|NCT01604343|593723866|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
164367596|NCT01604343|593723862|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
164367597|NCT01604343|593723863|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
164367598|NCT01604343|593723864|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
164367599|NCT01604343|593723865|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
164367600|NCT01604343|593723866|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
164367601|NCT01604343|593723862|FG000|Prior to W52 Administration(Through W52)|Other|15|||
164367602|NCT01604343|593723863|FG001|Prior to W52 Administration(Through W52)|Other|0|||
164367603|NCT01604343|593723864|FG002|Prior to W52 Administration(Through W52)|Other|10|||
164367604|NCT01604343|593723865|FG003|Prior to W52 Administration(Through W52)|Other|0|||
164367605|NCT01604343|593723866|FG004|Prior to W52 Administration(Through W52)|Other|6|||
164367606|NCT01604343|593723862|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
164367607|NCT01604343|593723863|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
164367608|NCT01604343|593723864|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
164367609|NCT01604343|593723865|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
164367610|NCT01604343|593723866|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
164367611|NCT01604343|593723862|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
164367612|NCT01604343|593723863|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
164367613|NCT01604343|593723864|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
164367614|NCT01604343|593723865|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
164367615|NCT01604343|593723866|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
164367616|NCT01604343|593723862|FG000|Week 52 to Week 104|Adverse Event|0|||
164367617|NCT01604343|593723863|FG001|Week 52 to Week 104|Adverse Event|12|||
164367618|NCT01604343|593723864|FG002|Week 52 to Week 104|Adverse Event|26|||
164367619|NCT01604343|593723865|FG003|Week 52 to Week 104|Adverse Event|21|||
164367620|NCT01604343|593723866|FG004|Week 52 to Week 104|Adverse Event|27|||
164367621|NCT01604343|593723862|FG000|Week 52 to Week 104|Death|0|||
164367622|NCT01604343|593723863|FG001|Week 52 to Week 104|Death|4|||
164367623|NCT01604343|593723864|FG002|Week 52 to Week 104|Death|2|||
164367624|NCT01604343|593723865|FG003|Week 52 to Week 104|Death|5|||
164367625|NCT01604343|593723866|FG004|Week 52 to Week 104|Death|0|||
164367626|NCT01604343|593723862|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
164367627|NCT01604343|593723863|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
164367628|NCT01604343|593723864|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
164367629|NCT01604343|593723865|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
164367630|NCT01604343|593723866|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
164367631|NCT01604343|593723862|FG000|Week 52 to Week 104|Physician Decision|0|||
164367632|NCT01604343|593723863|FG001|Week 52 to Week 104|Physician Decision|1|||
164367633|NCT01604343|593723864|FG002|Week 52 to Week 104|Physician Decision|0|||
164367634|NCT01604343|593723865|FG003|Week 52 to Week 104|Physician Decision|0|||
164367635|NCT01604343|593723866|FG004|Week 52 to Week 104|Physician Decision|2|||
164367636|NCT01604343|593723862|FG000|Week 52 to Week 104|Pregnancy|0|||
164367637|NCT01604343|593723863|FG001|Week 52 to Week 104|Pregnancy|0|||
164367638|NCT01604343|593723864|FG002|Week 52 to Week 104|Pregnancy|1|||
164367639|NCT01604343|593723865|FG003|Week 52 to Week 104|Pregnancy|2|||
164367640|NCT01604343|593723866|FG004|Week 52 to Week 104|Pregnancy|1|||
164367641|NCT01604343|593723862|FG000|Week 52 to Week 104|Other|0|||
164367642|NCT01604343|593723863|FG001|Week 52 to Week 104|Other|11|||
164367643|NCT01604343|593723864|FG002|Week 52 to Week 104|Other|11|||
164367644|NCT01604343|593723865|FG003|Week 52 to Week 104|Other|6|||
164367645|NCT01604343|593723866|FG004|Week 52 to Week 104|Other|3|||
164367646|NCT01604343|593723862|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
164367647|NCT01604343|593723863|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
164367648|NCT01604343|593723864|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
164367649|NCT01604343|593723865|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
164367650|NCT01604343|593723866|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
164367651|NCT01604343|593723862|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
164367652|NCT01604343|593723863|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
164367653|NCT01604343|593723864|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
164367654|NCT01604343|593723865|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
164367655|NCT01604343|593723866|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
164367656|NCT01604343|593723862|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
164367657|NCT01604343|593723863|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
164367658|NCT01604343|593723864|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
164367659|NCT01604343|593723865|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
164367660|NCT01604343|593723866|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
164367661|NCT00436748|593723867|FG000|Overall Study|Ineligibility Determined|1|||
164367662|NCT00436748|593723868|FG001|Overall Study|Ineligibility Determined|1|||
164367663|NCT00436748|593723867|FG000|Overall Study|Adverse Event|0|||
164367664|NCT00436748|593723868|FG001|Overall Study|Adverse Event|2|||
164367665|NCT00436748|593723867|FG000|Overall Study|Consent Withdrawn|1|||
164367666|NCT00436748|593723868|FG001|Overall Study|Consent Withdrawn|4|||
164367667|NCT00436748|593723867|FG000|Overall Study|Administrative Decision|1|||
164367668|NCT00436748|593723868|FG001|Overall Study|Administrative Decision|0|||
164367669|NCT00436748|593723867|FG000|Overall Study|Lost to Follow-up|0|||
164367670|NCT00436748|593723868|FG001|Overall Study|Lost to Follow-up|1|||
164367671|NCT00436748|593723867|FG000|Overall Study|Protocol-specified Criteria|5|||
164367672|NCT00436748|593723868|FG001|Overall Study|Protocol-specified Criteria|4|||
164367673|NCT00436748|593723867|FG000|Overall Study|Other|3|||
164367674|NCT00436748|593723868|FG001|Overall Study|Other|0|||
164367675|NCT00850200|593723869|FG000|Overall Study|Physician Decision|2|||
164367676|NCT00850200|593723869|FG000|Overall Study|Did not recieve treatment|2|||
164367677|NCT00850200|593723869|FG000|Overall Study|Withdrawal by Subject|1|||
164367678|NCT02711800|593723870|FG000|Overall Study|Lost to Follow-up|1|||
164367679|NCT02711800|593723870|FG000|Overall Study|Withdrawal by Subject|1|||
164367680|NCT05442554|593723873|FG000|Overall Study|Adverse Event|1|||
164367681|NCT01990495|593723885|FG000|Overall Study|Physician Decision|5|||
164367682|NCT01990495|593723886|FG001|Overall Study|Physician Decision|4|||
164367683|NCT00097721|593723887|FG000|Overall Study|Adverse Event|8|||
164367684|NCT00097721|593723888|FG001|Overall Study|Adverse Event|1|||
164367685|NCT00097721|593723887|FG000|Overall Study|Withdrawal by Subject|6|||
164367686|NCT00097721|593723888|FG001|Overall Study|Withdrawal by Subject|1|||
164367687|NCT00097721|593723887|FG000|Overall Study|Progressive Disease|55|||
164367688|NCT00097721|593723888|FG001|Overall Study|Progressive Disease|27|||
164367689|NCT00097721|593723887|FG000|Overall Study|Physician Decision|1|||
164367690|NCT00097721|593723888|FG001|Overall Study|Physician Decision|3|||
164367691|NCT00097721|593723887|FG000|Overall Study|Reason not given|1|||
164367692|NCT00097721|593723888|FG001|Overall Study|Reason not given|1|||
164367693|NCT00449956|593723889|FG000|Overall Study|Adverse Event|7|||
164367694|NCT00449956|593723890|FG001|Overall Study|Adverse Event|1|||
164367695|NCT00449956|593723891|FG002|Overall Study|Adverse Event|6|||
164367696|NCT00449956|593723889|FG000|Overall Study|Lack of Efficacy|0|||
164367697|NCT00449956|593723890|FG001|Overall Study|Lack of Efficacy|0|||
164367698|NCT00449956|593723891|FG002|Overall Study|Lack of Efficacy|1|||
164367699|NCT00449956|593723889|FG000|Overall Study|Protocol Violation|1|||
164367700|NCT00449956|593723890|FG001|Overall Study|Protocol Violation|1|||
164367701|NCT00449956|593723891|FG002|Overall Study|Protocol Violation|1|||
164367702|NCT00449956|593723889|FG000|Overall Study|Withdrawal by Subject|0|||
164367703|NCT00449956|593723890|FG001|Overall Study|Withdrawal by Subject|1|||
164367704|NCT00449956|593723891|FG002|Overall Study|Withdrawal by Subject|0|||
164367705|NCT00449956|593723889|FG000|Overall Study|Physician Decision|2|||
164367706|NCT00449956|593723890|FG001|Overall Study|Physician Decision|1|||
164367707|NCT00449956|593723891|FG002|Overall Study|Physician Decision|1|||
164367708|NCT02972632|593723901|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
164367709|NCT02972632|593723901|FG000|Overall Study|Lost to Follow-up|4|||
164367710|NCT02972632|593723901|FG000|Overall Study|Voluntary Withdrawal|10|||
164367711|NCT02126969|593723902|FG000|Overall Study|Withdrawal by Subject|1|||
164367712|NCT02126969|593723903|FG001|Overall Study|Withdrawal by Subject|2|||
164367713|NCT00354172|593723904|FG000|Overall Study|Did not receive transplant|1|||
164367714|NCT01828034|593723905|FG000|Overall Study|Withdrawal by Subject|0|||
164367715|NCT01828034|593723906|FG001|Overall Study|Withdrawal by Subject|0|||
164367716|NCT01828034|593723907|FG002|Overall Study|Withdrawal by Subject|0|||
164367717|NCT01828034|593723908|FG003|Overall Study|Withdrawal by Subject|1|||
164367718|NCT02023151|593723909|FG000|Overall Study|Lost to Follow-up|4|||
164591235|NCT00374907|594527260|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
164591236|NCT04598165|594527261|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
164591237|NCT04598165|594527262|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
164591238|NCT04598165|594527261|FG000|Completed 6-week Follow-up|Death|2|||
164591239|NCT04598165|594527262|FG001|Completed 6-week Follow-up|Death|1|||
164591240|NCT04598165|594527261|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
164591241|NCT04598165|594527262|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
164591242|NCT04598165|594527261|FG000|Completed 6-week Follow-up|Ineligible|4|||
164591243|NCT04598165|594527262|FG001|Completed 6-week Follow-up|Ineligible|3|||
164591244|NCT04598165|594527261|FG000|Completed 6-week Follow-up|Partner refusal|0|||
164591245|NCT04598165|594527262|FG001|Completed 6-week Follow-up|Partner refusal|1|||
164591246|NCT04598165|594527261|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
164591247|NCT04598165|594527262|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
164591248|NCT00426751|594527263|FG000|Overall Study|Adverse Event|8|||
164591249|NCT00426751|594527264|FG001|Overall Study|Adverse Event|1|||
164591250|NCT00426751|594527263|FG000|Overall Study|Lost to Follow-up|7|||
164591251|NCT00426751|594527264|FG001|Overall Study|Lost to Follow-up|6|||
164591252|NCT00426751|594527263|FG000|Overall Study|Consent Withdrawn|0|||
164591253|NCT00426751|594527264|FG001|Overall Study|Consent Withdrawn|1|||
164591254|NCT00426751|594527263|FG000|Overall Study|Other Reasons|7|||
164591255|NCT00426751|594527264|FG001|Overall Study|Other Reasons|12|||
164591256|NCT04160468|594527265|FG000|Overall Study|Lost to Follow-up|19|||
164591257|NCT04160468|594527266|FG001|Overall Study|Lost to Follow-up|4|||
164591258|NCT04160468|594527265|FG000|Overall Study|Randomized but not dosed|6|||
164591259|NCT04160468|594527266|FG001|Overall Study|Randomized but not dosed|0|||
164591260|NCT04160468|594527265|FG000|Overall Study|Withdrawal by Subject|4|||
164591261|NCT04160468|594527266|FG001|Overall Study|Withdrawal by Subject|1|||
164367719|NCT03450707|593723910|FG000|Overall Study|Outside enrollment window|4|||
164367720|NCT03450707|593723911|FG001|Overall Study|Outside enrollment window|1|||
164367721|NCT03450707|593723910|FG000|Overall Study|Death|1|||
164367722|NCT03450707|593723911|FG001|Overall Study|Death|0|||
164367723|NCT03450707|593723910|FG000|Overall Study|Indication for thiamine|1|||
164367724|NCT03450707|593723911|FG001|Overall Study|Indication for thiamine|1|||
164367725|NCT03450707|593723910|FG000|Overall Study|Evidence of traumatic brain injury|1|||
164367726|NCT03450707|593723911|FG001|Overall Study|Evidence of traumatic brain injury|0|||
164367727|NCT03450707|593723910|FG000|Overall Study|Following commands|0|||
164367728|NCT03450707|593723911|FG001|Overall Study|Following commands|3|||
164591262|NCT04160468|594527265|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
164591263|NCT04160468|594527266|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
164591264|NCT04160468|594527265|FG000|Overall Study|Participant incarcerated|1|||
164591265|NCT04160468|594527266|FG001|Overall Study|Participant incarcerated|0|||
164591266|NCT03987620|594527267|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
164700169|NCT01392326|594924896|FG002|Overall Study|Protocol Violation|0|||
164700170|NCT01392326|594924894|FG000|Overall Study|Pregnancy|0|||
164700171|NCT01392326|594924895|FG001|Overall Study|Pregnancy|0|||
164367729|NCT03450707|593723910|FG000|Overall Study|Lactate < 3.5|0|||
164591267|NCT03987620|594527268|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
164591268|NCT03987620|594527267|FG000|Overall Study|Adverse Event|3|||
164591269|NCT03987620|594527268|FG001|Overall Study|Adverse Event|0|||
164367730|NCT03450707|593723911|FG001|Overall Study|Lactate < 3.5|2|||
164367731|NCT03450707|593723910|FG000|Overall Study|Rearrest with ECMO|0|||
164591270|NCT03987620|594527267|FG000|Overall Study|Lost to Follow-up|1|||
164144026|NCT00086281|592888580|FG009|Phase 1|Serious Adverse Event|0|||
164700172|NCT01392326|594924896|FG002|Overall Study|Pregnancy|1|||
164367732|NCT03450707|593723911|FG001|Overall Study|Rearrest with ECMO|1|||
164367733|NCT03450707|593723910|FG000|Overall Study|Indication for thiamine + head CT results|0|||
164367734|NCT03450707|593723911|FG001|Overall Study|Indication for thiamine + head CT results|1|||
164367735|NCT03450707|593723910|FG000|Overall Study|Family/patient goals of care|0|||
164367736|NCT03450707|593723911|FG001|Overall Study|Family/patient goals of care|1|||
164367737|NCT02871375|593723912|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
164367738|NCT02871375|593723913|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
164367739|NCT01988571|593723916|FG000|Overall Study|Death|3|||
164367740|NCT01988571|593723917|FG001|Overall Study|Death|1|||
164367741|NCT01988571|593723916|FG000|Overall Study|Physician Decision|2|||
164367742|NCT01988571|593723917|FG001|Overall Study|Physician Decision|1|||
164367743|NCT01988571|593723916|FG000|Overall Study|Lost to Follow-up|3|||
164367744|NCT01988571|593723917|FG001|Overall Study|Lost to Follow-up|0|||
164367745|NCT01988571|593723916|FG000|Overall Study|Withdrawal by Subject|31|||
164367746|NCT01988571|593723917|FG001|Overall Study|Withdrawal by Subject|33|||
164367747|NCT00004412|593723918|FG000|Randomized Period|Moved to Crossover Period|3|||
164367748|NCT00004412|593723919|FG001|Randomized Period|Moved to Crossover Period|0|||
164367749|NCT00004412|593723920|FG002|Randomized Period|Moved to Crossover Period|0|||
164367750|NCT00337103|593723921|FG000|Overall Study|Progressive Disease|414|||
164367751|NCT00337103|593723922|FG001|Overall Study|Progressive Disease|410|||
164367752|NCT00337103|593723921|FG000|Overall Study|Adverse Event|45|||
164367753|NCT00337103|593723922|FG001|Overall Study|Adverse Event|59|||
164367754|NCT00337103|593723921|FG000|Overall Study|Subject Choice|34|||
164367755|NCT00337103|593723922|FG001|Overall Study|Subject Choice|27|||
164367756|NCT00337103|593723921|FG000|Overall Study|Clinical Progression|27|||
164367757|NCT00337103|593723922|FG001|Overall Study|Clinical Progression|24|||
164367758|NCT00337103|593723921|FG000|Overall Study|Physician Decision|15|||
164367759|NCT00337103|593723922|FG001|Overall Study|Physician Decision|14|||
164367760|NCT00337103|593723921|FG000|Overall Study|Withdrawal by Subject|8|||
164367761|NCT00337103|593723922|FG001|Overall Study|Withdrawal by Subject|5|||
164367762|NCT00337103|593723921|FG000|Overall Study|Other|5|||
164367763|NCT00337103|593723922|FG001|Overall Study|Other|6|||
164367764|NCT00337103|593723921|FG000|Overall Study|Entry Criteria Not Met|4|||
164367765|NCT00337103|593723922|FG001|Overall Study|Entry Criteria Not Met|1|||
164367766|NCT00337103|593723921|FG000|Overall Study|Lost to Follow-up|1|||
164367767|NCT00337103|593723922|FG001|Overall Study|Lost to Follow-up|2|||
164367768|NCT00337103|593723921|FG000|Overall Study|Death|1|||
164367769|NCT00337103|593723922|FG001|Overall Study|Death|0|||
164367770|NCT03387813|593723923|FG000|Overall Study|Death|40|||
164367771|NCT03387813|593723924|FG001|Overall Study|Death|37|||
164367772|NCT03387813|593723925|FG002|Overall Study|Death|190|||
164367773|NCT03387813|593723923|FG000|Overall Study|Withdrawal by Subject|9|||
164367774|NCT03387813|593723924|FG001|Overall Study|Withdrawal by Subject|19|||
164367775|NCT03387813|593723925|FG002|Overall Study|Withdrawal by Subject|32|||
164367776|NCT03387813|593723923|FG000|Overall Study|Lost to Follow-up|3|||
164367777|NCT03387813|593723924|FG001|Overall Study|Lost to Follow-up|9|||
164367778|NCT03387813|593723925|FG002|Overall Study|Lost to Follow-up|15|||
164367779|NCT03387813|593723923|FG000|Overall Study|Non-Compliance|6|||
164367780|NCT03387813|593723924|FG001|Overall Study|Non-Compliance|6|||
164367781|NCT03387813|593723925|FG002|Overall Study|Non-Compliance|31|||
164367782|NCT03387813|593723923|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
164367783|NCT03387813|593723924|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
164367784|NCT03387813|593723925|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
164367785|NCT03131440|593723928|FG000|Overall Study|Withdrawal by Subject|1|||
164367786|NCT03131440|593723929|FG001|Overall Study|Withdrawal by Subject|3|||
164367787|NCT03131440|593723930|FG002|Overall Study|Withdrawal by Subject|0|||
164367788|NCT03131440|593723931|FG003|Overall Study|Withdrawal by Subject|0|||
164367789|NCT03131440|593723932|FG004|Overall Study|Withdrawal by Subject|1|||
164367790|NCT03131440|593723933|FG005|Overall Study|Withdrawal by Subject|0|||
164367791|NCT03131440|593723934|FG006|Overall Study|Withdrawal by Subject|0|||
164367792|NCT03131440|593723935|FG007|Overall Study|Withdrawal by Subject|1|||
164367793|NCT03131440|593723936|FG008|Overall Study|Withdrawal by Subject|1|||
164367794|NCT03131440|593723937|FG009|Overall Study|Withdrawal by Subject|1|||
164367795|NCT03131440|593723938|FG010|Overall Study|Withdrawal by Subject|0|||
164367796|NCT03131440|593723939|FG011|Overall Study|Withdrawal by Subject|1|||
164367797|NCT03131440|593723940|FG012|Overall Study|Withdrawal by Subject|1|||
164367798|NCT03131440|593723941|FG013|Overall Study|Withdrawal by Subject|0|||
164367799|NCT03131440|593723942|FG014|Overall Study|Withdrawal by Subject|1|||
164367800|NCT03131440|593723943|FG015|Overall Study|Withdrawal by Subject|0|||
164367801|NCT03131440|593723944|FG016|Overall Study|Withdrawal by Subject|0|||
164367802|NCT03131440|593723945|FG017|Overall Study|Withdrawal by Subject|0|||
164367803|NCT03131440|593723946|FG018|Overall Study|Withdrawal by Subject|1|||
164367804|NCT03131440|593723947|FG019|Overall Study|Withdrawal by Subject|0|||
164367805|NCT03131440|593723948|FG020|Overall Study|Withdrawal by Subject|1|||
164367806|NCT03131440|593723949|FG021|Overall Study|Withdrawal by Subject|1|||
164367807|NCT03131440|593723950|FG022|Overall Study|Withdrawal by Subject|1|||
164367808|NCT03131440|593723951|FG023|Overall Study|Withdrawal by Subject|0|||
164367809|NCT03131440|593723952|FG024|Overall Study|Withdrawal by Subject|0|||
164367810|NCT03131440|593723953|FG025|Overall Study|Withdrawal by Subject|0|||
164367811|NCT03131440|593723954|FG026|Overall Study|Withdrawal by Subject|0|||
164367812|NCT03131440|593723955|FG027|Overall Study|Withdrawal by Subject|0|||
164367813|NCT03131440|593723956|FG028|Overall Study|Withdrawal by Subject|0|||
164367814|NCT03131440|593723957|FG029|Overall Study|Withdrawal by Subject|0|||
164367815|NCT03131440|593723958|FG030|Overall Study|Withdrawal by Subject|1|||
164367816|NCT03131440|593723959|FG031|Overall Study|Withdrawal by Subject|0|||
164367817|NCT03131440|593723928|FG000|Overall Study|Lost to Follow-up|0|||
164367818|NCT03131440|593723929|FG001|Overall Study|Lost to Follow-up|0|||
164367819|NCT03131440|593723930|FG002|Overall Study|Lost to Follow-up|0|||
164700173|NCT01392326|594924894|FG000|Overall Study|Physician Decision|7|||
164700174|NCT01392326|594924895|FG001|Overall Study|Physician Decision|5|||
164700175|NCT01392326|594924896|FG002|Overall Study|Physician Decision|2|||
164700176|NCT01392326|594924894|FG000|Overall Study|Lost to Follow-up|1|||
164700177|NCT01392326|594924895|FG001|Overall Study|Lost to Follow-up|3|||
164367820|NCT03131440|593723931|FG003|Overall Study|Lost to Follow-up|0|||
164367821|NCT03131440|593723932|FG004|Overall Study|Lost to Follow-up|0|||
164367822|NCT03131440|593723933|FG005|Overall Study|Lost to Follow-up|1|||
164367823|NCT03131440|593723934|FG006|Overall Study|Lost to Follow-up|0|||
164367824|NCT03131440|593723935|FG007|Overall Study|Lost to Follow-up|0|||
164367825|NCT03131440|593723936|FG008|Overall Study|Lost to Follow-up|0|||
164367826|NCT03131440|593723937|FG009|Overall Study|Lost to Follow-up|0|||
164367827|NCT03131440|593723938|FG010|Overall Study|Lost to Follow-up|0|||
164367828|NCT03131440|593723939|FG011|Overall Study|Lost to Follow-up|0|||
164367829|NCT03131440|593723940|FG012|Overall Study|Lost to Follow-up|0|||
164367830|NCT03131440|593723941|FG013|Overall Study|Lost to Follow-up|0|||
164367831|NCT03131440|593723942|FG014|Overall Study|Lost to Follow-up|0|||
164367832|NCT03131440|593723943|FG015|Overall Study|Lost to Follow-up|0|||
164367833|NCT03131440|593723944|FG016|Overall Study|Lost to Follow-up|0|||
164367834|NCT03131440|593723945|FG017|Overall Study|Lost to Follow-up|0|||
164367835|NCT03131440|593723946|FG018|Overall Study|Lost to Follow-up|0|||
164367836|NCT03131440|593723947|FG019|Overall Study|Lost to Follow-up|2|||
164367837|NCT03131440|593723948|FG020|Overall Study|Lost to Follow-up|1|||
164367838|NCT03131440|593723949|FG021|Overall Study|Lost to Follow-up|0|||
164367839|NCT03131440|593723950|FG022|Overall Study|Lost to Follow-up|1|||
164367840|NCT03131440|593723951|FG023|Overall Study|Lost to Follow-up|0|||
164367841|NCT03131440|593723952|FG024|Overall Study|Lost to Follow-up|1|||
164367842|NCT03131440|593723953|FG025|Overall Study|Lost to Follow-up|0|||
164367843|NCT03131440|593723954|FG026|Overall Study|Lost to Follow-up|0|||
164367844|NCT03131440|593723955|FG027|Overall Study|Lost to Follow-up|2|||
164367845|NCT03131440|593723956|FG028|Overall Study|Lost to Follow-up|0|||
164367846|NCT03131440|593723957|FG029|Overall Study|Lost to Follow-up|2|||
164367847|NCT03131440|593723958|FG030|Overall Study|Lost to Follow-up|0|||
164367848|NCT03131440|593723959|FG031|Overall Study|Lost to Follow-up|0|||
164367849|NCT03131440|593723928|FG000|Overall Study|Death|0|||
164367850|NCT03131440|593723929|FG001|Overall Study|Death|0|||
164367851|NCT03131440|593723930|FG002|Overall Study|Death|0|||
164367852|NCT03131440|593723931|FG003|Overall Study|Death|0|||
164367853|NCT03131440|593723932|FG004|Overall Study|Death|0|||
164367854|NCT03131440|593723933|FG005|Overall Study|Death|0|||
164367855|NCT03131440|593723934|FG006|Overall Study|Death|0|||
164367856|NCT03131440|593723935|FG007|Overall Study|Death|0|||
164367857|NCT03131440|593723936|FG008|Overall Study|Death|0|||
164367858|NCT03131440|593723937|FG009|Overall Study|Death|0|||
164367859|NCT03131440|593723938|FG010|Overall Study|Death|0|||
164367860|NCT03131440|593723939|FG011|Overall Study|Death|0|||
164367861|NCT03131440|593723940|FG012|Overall Study|Death|0|||
164367862|NCT03131440|593723941|FG013|Overall Study|Death|0|||
164367863|NCT03131440|593723942|FG014|Overall Study|Death|0|||
164700178|NCT01392326|594924896|FG002|Overall Study|Lost to Follow-up|4|||
164700179|NCT01392326|594924894|FG000|Overall Study|Lack of Efficacy|14|||
164367864|NCT03131440|593723943|FG015|Overall Study|Death|0|||
164700180|NCT01392326|594924895|FG001|Overall Study|Lack of Efficacy|10|||
164367865|NCT03131440|593723944|FG016|Overall Study|Death|0|||
164367866|NCT03131440|593723945|FG017|Overall Study|Death|0|||
164700181|NCT01392326|594924896|FG002|Overall Study|Lack of Efficacy|15|||
164367867|NCT03131440|593723946|FG018|Overall Study|Death|0|||
164700182|NCT01392326|594924894|FG000|Overall Study|Adverse Event|9|||
164367868|NCT03131440|593723947|FG019|Overall Study|Death|0|||
164367869|NCT03131440|593723948|FG020|Overall Study|Death|0|||
164367870|NCT03131440|593723949|FG021|Overall Study|Death|0|||
164367871|NCT03131440|593723950|FG022|Overall Study|Death|0|||
164367872|NCT03131440|593723951|FG023|Overall Study|Death|0|||
164367873|NCT03131440|593723952|FG024|Overall Study|Death|0|||
164367874|NCT03131440|593723953|FG025|Overall Study|Death|1|||
164367875|NCT03131440|593723954|FG026|Overall Study|Death|0|||
164367876|NCT03131440|593723955|FG027|Overall Study|Death|0|||
164367877|NCT03131440|593723956|FG028|Overall Study|Death|0|||
164367878|NCT03131440|593723957|FG029|Overall Study|Death|0|||
164367879|NCT03131440|593723958|FG030|Overall Study|Death|0|||
164367880|NCT03131440|593723959|FG031|Overall Study|Death|0|||
164367881|NCT03742141|593723962|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
164367882|NCT01354496|593723968|FG000|Period 1|Adverse Event|0|||
164367883|NCT01354496|593723969|FG001|Period 1|Adverse Event|0|||
164367884|NCT01354496|593723970|FG002|Period 1|Adverse Event|1|||
164367885|NCT01354496|593723971|FG003|Period 1|Adverse Event|0|||
164367886|NCT01354496|593723972|FG004|Period 1|Adverse Event|0|||
164367887|NCT01354496|593723973|FG005|Period 1|Adverse Event|0|||
164367888|NCT01354496|593723968|FG000|Period 1|Physician Decision|0|||
164367889|NCT01354496|593723969|FG001|Period 1|Physician Decision|0|||
164367890|NCT01354496|593723970|FG002|Period 1|Physician Decision|1|||
164367891|NCT01354496|593723971|FG003|Period 1|Physician Decision|0|||
164367892|NCT01354496|593723972|FG004|Period 1|Physician Decision|0|||
164367893|NCT01354496|593723973|FG005|Period 1|Physician Decision|0|||
164367894|NCT01354496|593723968|FG000|Period 2|Adverse Event|0|||
164367895|NCT01354496|593723969|FG001|Period 2|Adverse Event|0|||
164367896|NCT01354496|593723970|FG002|Period 2|Adverse Event|0|||
164367897|NCT01354496|593723971|FG003|Period 2|Adverse Event|1|||
164367898|NCT01354496|593723972|FG004|Period 2|Adverse Event|0|||
164367899|NCT01354496|593723973|FG005|Period 2|Adverse Event|0|||
164367900|NCT01354496|593723968|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
164367901|NCT01354496|593723969|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
164367902|NCT01354496|593723970|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
164367903|NCT01354496|593723971|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
164367904|NCT01354496|593723972|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
164700183|NCT01392326|594924895|FG001|Overall Study|Adverse Event|6|||
164700184|NCT01392326|594924896|FG002|Overall Study|Adverse Event|11|||
164700185|NCT03487848|594924899|FG000|Overall Study|Lost to Follow-up|1|||
164367905|NCT01354496|593723973|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
164367906|NCT00500292|593723975|FG000|Overall Study|Adverse Event|3|||
164367907|NCT00500292|593723976|FG001|Overall Study|Adverse Event|6|||
164367908|NCT00500292|593723977|FG002|Overall Study|Adverse Event|4|||
164367909|NCT00500292|593723975|FG000|Overall Study|Condition under investigation worsened|21|||
164367910|NCT00500292|593723976|FG001|Overall Study|Condition under investigation worsened|23|||
164367911|NCT00500292|593723977|FG002|Overall Study|Condition under investigation worsened|19|||
164367912|NCT00500292|593723975|FG000|Overall Study|Withdrawal by Subject|0|||
164367913|NCT00500292|593723976|FG001|Overall Study|Withdrawal by Subject|1|||
164367914|NCT00500292|593723977|FG002|Overall Study|Withdrawal by Subject|0|||
164367915|NCT00500292|593723975|FG000|Overall Study|Other|1|||
164367916|NCT00500292|593723976|FG001|Overall Study|Other|1|||
164367917|NCT00500292|593723977|FG002|Overall Study|Other|4|||
164367918|NCT05045144|593723978|FG000|Overall Study|Lost to Follow-up|3|||
164367919|NCT05045144|593723979|FG001|Overall Study|Lost to Follow-up|2|||
164367920|NCT05045144|593723980|FG002|Overall Study|Lost to Follow-up|3|||
164367921|NCT05045144|593723981|FG003|Overall Study|Lost to Follow-up|5|||
164367922|NCT05045144|593723982|FG004|Overall Study|Lost to Follow-up|13|||
164367923|NCT05045144|593723978|FG000|Overall Study|Withdrawal by Subject|0|||
164367924|NCT05045144|593723979|FG001|Overall Study|Withdrawal by Subject|1|||
164367925|NCT05045144|593723980|FG002|Overall Study|Withdrawal by Subject|0|||
164367926|NCT05045144|593723981|FG003|Overall Study|Withdrawal by Subject|0|||
164367927|NCT05045144|593723982|FG004|Overall Study|Withdrawal by Subject|0|||
164367928|NCT05045144|593723978|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164367929|NCT05045144|593723979|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164367930|NCT05045144|593723980|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164367931|NCT05045144|593723981|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164367932|NCT05045144|593723982|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164367933|NCT02385084|593723983|FG000|Period 2|Protocol Violation|0|||
164367934|NCT02385084|593723984|FG001|Period 2|Protocol Violation|0|||
164367935|NCT02385084|593723985|FG002|Period 2|Protocol Violation|1|||
164367936|NCT02385084|593723986|FG003|Period 2|Protocol Violation|0|||
164700186|NCT01558297|594924902|FG000|Overall Study|Withdrawal by Subject|2|||
164700187|NCT01558297|594924903|FG001|Overall Study|Withdrawal by Subject|2|||
164700188|NCT01558297|594924904|FG002|Overall Study|Withdrawal by Subject|1|||
164367937|NCT02385084|593723987|FG004|Period 2|Protocol Violation|0|||
164367938|NCT02385084|593723988|FG005|Period 2|Protocol Violation|0|||
164367939|NCT04809220|593723989|FG000|Overall Study|Adverse Event|4|||
164367940|NCT04809220|593723990|FG001|Overall Study|Adverse Event|0|||
164367941|NCT04809220|593723989|FG000|Overall Study|Death|1|||
164367942|NCT04809220|593723990|FG001|Overall Study|Death|0|||
164367943|NCT04809220|593723989|FG000|Overall Study|Lost to Follow-up|3|||
164367944|NCT04809220|593723990|FG001|Overall Study|Lost to Follow-up|0|||
164367945|NCT04809220|593723989|FG000|Overall Study|Physician Decision|0|||
164367946|NCT04809220|593723990|FG001|Overall Study|Physician Decision|1|||
164367947|NCT04809220|593723989|FG000|Overall Study|Withdrawal by Subject|9|||
164367948|NCT04809220|593723990|FG001|Overall Study|Withdrawal by Subject|5|||
164367949|NCT04809220|593723989|FG000|Overall Study|Due to long-term overseas business trips|1|||
164367950|NCT04809220|593723990|FG001|Overall Study|Due to long-term overseas business trips|0|||
164367951|NCT00729183|593723991|FG000|Overall Study|Adverse Event|11|||
164367952|NCT00729183|593723992|FG001|Overall Study|Adverse Event|5|||
164367953|NCT00729183|593723991|FG000|Overall Study|Lack of Efficacy|0|||
164367954|NCT00729183|593723992|FG001|Overall Study|Lack of Efficacy|1|||
164367955|NCT00729183|593723991|FG000|Overall Study|Lost to Follow-up|3|||
164367956|NCT00729183|593723992|FG001|Overall Study|Lost to Follow-up|1|||
164367957|NCT00729183|593723991|FG000|Overall Study|Physician Decision|1|||
164367958|NCT00729183|593723992|FG001|Overall Study|Physician Decision|1|||
164367959|NCT00729183|593723991|FG000|Overall Study|Protocol Violation|1|||
164367960|NCT00729183|593723992|FG001|Overall Study|Protocol Violation|0|||
164367961|NCT00729183|593723991|FG000|Overall Study|Withdrawal by Subject|9|||
164367962|NCT00729183|593723992|FG001|Overall Study|Withdrawal by Subject|7|||
164367963|NCT01070316|593724000|FG000|Extension Phase|Lack of Efficacy|3|||
164367964|NCT01070316|593724000|FG000|Extension Phase|Withdrawal by Subject|1|||
164367965|NCT00748215|593724003|FG000|Overall Study|Withdrawal by Subject|7|||
164367966|NCT00748215|593724004|FG001|Overall Study|Withdrawal by Subject|7|||
164367967|NCT00748215|593724003|FG000|Overall Study|Treatment change|2|||
164367968|NCT00748215|593724004|FG001|Overall Study|Treatment change|1|||
164367969|NCT00748215|593724003|FG000|Overall Study|Change in patient condition|0|||
164367970|NCT00748215|593724004|FG001|Overall Study|Change in patient condition|3|||
164367971|NCT00748215|593724003|FG000|Overall Study|Non-compliant|0|||
164367972|NCT00748215|593724004|FG001|Overall Study|Non-compliant|2|||
164367973|NCT00748215|593724003|FG000|Overall Study|Adverse Event|0|||
164367974|NCT00748215|593724004|FG001|Overall Study|Adverse Event|5|||
164367975|NCT01113879|593724007|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
164367976|NCT01113879|593724008|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
164367977|NCT04151290|593724009|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
164367978|NCT00082433|593724013|FG000|Overall Study|Adverse Event|12|||
164367979|NCT00082433|593724014|FG001|Overall Study|Adverse Event|17|||
164367980|NCT00082433|593724013|FG000|Overall Study|Death|8|||
164367981|NCT00082433|593724014|FG001|Overall Study|Death|18|||
164367982|NCT00082433|593724013|FG000|Overall Study|Disease Progression/Relapse|270|||
164367983|NCT00082433|593724014|FG001|Overall Study|Disease Progression/Relapse|388|||
164367984|NCT00082433|593724013|FG000|Overall Study|Physician Decision|50|||
164367985|NCT00082433|593724014|FG001|Overall Study|Physician Decision|61|||
164367986|NCT00082433|593724013|FG000|Overall Study|Lost to Follow-up|1|||
164367987|NCT00082433|593724014|FG001|Overall Study|Lost to Follow-up|2|||
164367988|NCT00082433|593724013|FG000|Overall Study|Study Drug Toxicity|179|||
164367989|NCT00082433|593724014|FG001|Overall Study|Study Drug Toxicity|66|||
164367990|NCT00082433|593724013|FG000|Overall Study|Withdrawal by Subject|55|||
164367991|NCT00082433|593724014|FG001|Overall Study|Withdrawal by Subject|30|||
164367992|NCT00082433|593724013|FG000|Overall Study|Still On Treatment|2|||
164367993|NCT00082433|593724014|FG001|Overall Study|Still On Treatment|1|||
164367994|NCT00082433|593724013|FG000|Overall Study|Not Treated|12|||
164367995|NCT00082433|593724014|FG001|Overall Study|Not Treated|11|||
164367996|NCT00082433|593724013|FG000|Overall Study|Ineligible|2|||
164367997|NCT00082433|593724014|FG001|Overall Study|Ineligible|1|||
164367998|NCT00082433|593724013|FG000|Overall Study|Noncompliance|2|||
164367999|NCT00082433|593724014|FG001|Overall Study|Noncompliance|1|||
164368000|NCT00082433|593724013|FG000|Overall Study|New primary cancer|1|||
164368001|NCT00082433|593724014|FG001|Overall Study|New primary cancer|0|||
164368002|NCT00082433|593724013|FG000|Overall Study|Impending surgery|0|||
164368003|NCT00082433|593724014|FG001|Overall Study|Impending surgery|1|||
164368004|NCT01796197|593724015|FG000|Overall Study|Lost to Follow-up|1|||
164368005|NCT01796197|593724015|FG000|Overall Study|Lack of Efficacy|1|||
164368006|NCT04097821|593724016|FG000|Overall Study|Subject Decision|0|||
164368007|NCT04097821|593724017|FG001|Overall Study|Subject Decision|0|||
164368008|NCT04097821|593724018|FG002|Overall Study|Subject Decision|0|||
164368009|NCT04097821|593724019|FG003|Overall Study|Subject Decision|1|||
164368010|NCT04097821|593724020|FG004|Overall Study|Subject Decision|2|||
164368011|NCT04097821|593724021|FG005|Overall Study|Subject Decision|2|||
164368012|NCT04097821|593724022|FG006|Overall Study|Subject Decision|0|||
164368013|NCT04097821|593724023|FG007|Overall Study|Subject Decision|1|||
164368014|NCT04097821|593724016|FG000|Overall Study|Death|0|||
164368015|NCT04097821|593724017|FG001|Overall Study|Death|0|||
164368016|NCT04097821|593724018|FG002|Overall Study|Death|3|||
164368017|NCT04097821|593724019|FG003|Overall Study|Death|1|||
164368018|NCT04097821|593724020|FG004|Overall Study|Death|0|||
164368019|NCT04097821|593724021|FG005|Overall Study|Death|0|||
164368020|NCT04097821|593724022|FG006|Overall Study|Death|0|||
164368021|NCT04097821|593724023|FG007|Overall Study|Death|0|||
164368022|NCT04097821|593724016|FG000|Overall Study|Physician Decision|1|||
164368023|NCT04097821|593724017|FG001|Overall Study|Physician Decision|2|||
164368024|NCT04097821|593724018|FG002|Overall Study|Physician Decision|0|||
164368025|NCT04097821|593724019|FG003|Overall Study|Physician Decision|0|||
164368026|NCT04097821|593724020|FG004|Overall Study|Physician Decision|0|||
164368027|NCT04097821|593724021|FG005|Overall Study|Physician Decision|0|||
164368028|NCT04097821|593724022|FG006|Overall Study|Physician Decision|0|||
164144027|NCT00086281|592888581|FG010|Phase 1|Serious Adverse Event|0|||
164368029|NCT04097821|593724023|FG007|Overall Study|Physician Decision|0|||
164368030|NCT04097821|593724016|FG000|Overall Study|Adverse Event|0|||
164368031|NCT04097821|593724017|FG001|Overall Study|Adverse Event|0|||
164368032|NCT04097821|593724018|FG002|Overall Study|Adverse Event|1|||
164368033|NCT04097821|593724019|FG003|Overall Study|Adverse Event|1|||
164368034|NCT04097821|593724020|FG004|Overall Study|Adverse Event|0|||
164368035|NCT04097821|593724021|FG005|Overall Study|Adverse Event|0|||
164368036|NCT04097821|593724022|FG006|Overall Study|Adverse Event|0|||
164368037|NCT04097821|593724023|FG007|Overall Study|Adverse Event|0|||
164368038|NCT04097821|593724016|FG000|Overall Study|New Therapy For Study Indication|0|||
164368039|NCT04097821|593724017|FG001|Overall Study|New Therapy For Study Indication|0|||
164368040|NCT04097821|593724018|FG002|Overall Study|New Therapy For Study Indication|0|||
164368041|NCT04097821|593724019|FG003|Overall Study|New Therapy For Study Indication|0|||
164368042|NCT04097821|593724020|FG004|Overall Study|New Therapy For Study Indication|0|||
164368043|NCT04097821|593724021|FG005|Overall Study|New Therapy For Study Indication|0|||
164368044|NCT04097821|593724022|FG006|Overall Study|New Therapy For Study Indication|1|||
164368045|NCT04097821|593724023|FG007|Overall Study|New Therapy For Study Indication|0|||
164368046|NCT00244712|593724024|FG000|Overall Study|Adverse Event|20|||
164368047|NCT00244712|593724025|FG001|Overall Study|Adverse Event|21|||
164368048|NCT00244712|593724024|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
164368049|NCT00244712|593724025|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
164368050|NCT00244712|593724024|FG000|Overall Study|Lack of Compliance|10|||
164368051|NCT00244712|593724025|FG001|Overall Study|Lack of Compliance|11|||
164368052|NCT00244712|593724024|FG000|Overall Study|Lost to Follow-up|45|||
164368053|NCT00244712|593724025|FG001|Overall Study|Lost to Follow-up|52|||
164368054|NCT00244712|593724024|FG000|Overall Study|Withdrawal by Subject|13|||
164368055|NCT00244712|593724025|FG001|Overall Study|Withdrawal by Subject|23|||
164368056|NCT00244712|593724024|FG000|Overall Study|Protocol Violation, disease progression|13|||
164368057|NCT00244712|593724025|FG001|Overall Study|Protocol Violation, disease progression|11|||
164368058|NCT03299842|593725182|FG000|Overall Study|Caregiver withdrew consent|2|||
164368059|NCT03299842|593725182|FG000|Overall Study|Child would not keep the watch on|3|||
164368060|NCT04380857|593725183|FG000|Overall Study|Lost to Follow-up|3|||
164368061|NCT04380857|593725184|FG001|Overall Study|Lost to Follow-up|3|||
164368062|NCT02558790|593725185|FG000|Overall Study|Lost to Follow-up|2|||
164368063|NCT02558790|593725185|FG000|Overall Study|Physician Decision|1|||
164368064|NCT02558790|593725185|FG000|Overall Study|Withdrawal by Subject|1|||
164368065|NCT02558790|593725185|FG000|Overall Study|Screen Fail|3|||
164368066|NCT05083442|593725186|FG000|Overall Study|Lost to Follow-up|1|||
164368067|NCT05083442|593725187|FG001|Overall Study|Lost to Follow-up|0|||
164368068|NCT05083442|593725186|FG000|Overall Study|Lack of Efficacy|0|||
164368069|NCT05083442|593725187|FG001|Overall Study|Lack of Efficacy|1|||
164368070|NCT05083442|593725186|FG000|Overall Study|Withdrawal by Subject|1|||
164368071|NCT05083442|593725187|FG001|Overall Study|Withdrawal by Subject|3|||
164368072|NCT05083442|593725186|FG000|Overall Study|scheduling difficulties|1|||
164368073|NCT05083442|593725187|FG001|Overall Study|scheduling difficulties|2|||
164368074|NCT04865354|593725190|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
164368075|NCT04865354|593725191|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
164368076|NCT04865354|593725190|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
164368077|NCT04865354|593725191|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
164368078|NCT04865354|593725190|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
164368079|NCT04865354|593725191|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
164368080|NCT02945410|593725197|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
164368081|NCT02945410|593725198|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
164368082|NCT02945410|593725199|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
164368083|NCT02945410|593725200|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
164368084|NCT02945410|593725201|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
164368085|NCT02945410|593725202|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
164368086|NCT02945410|593725197|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
164368087|NCT02945410|593725198|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
164368088|NCT02945410|593725199|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
164368089|NCT02945410|593725200|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
164368090|NCT02945410|593725201|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
164368091|NCT02945410|593725202|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
164700189|NCT00094094|594924905|FG000|Overall Study|Death|2|||
164368092|NCT02945410|593725197|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
164368093|NCT02945410|593725198|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
164368094|NCT02945410|593725199|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
164368095|NCT02945410|593725200|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
164368096|NCT02945410|593725201|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
164368097|NCT02945410|593725202|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
164368098|NCT00110812|593725203|FG000|Main Study|Death|0|||
164368099|NCT00110812|593725204|FG001|Main Study|Death|0|||
164368100|NCT00110812|593725205|FG002|Main Study|Death|2|||
164368101|NCT00110812|593725203|FG000|Main Study|Withdrawal by Subject|0|||
164368102|NCT00110812|593725204|FG001|Main Study|Withdrawal by Subject|0|||
164368103|NCT00110812|593725205|FG002|Main Study|Withdrawal by Subject|1|||
164368104|NCT00110812|593725203|FG000|Main Study|Lost to Follow-up|8|||
164368105|NCT00110812|593725204|FG001|Main Study|Lost to Follow-up|11|||
164700190|NCT00094094|594924905|FG000|Overall Study|Lack of Efficacy|23|||
164368106|NCT00110812|593725205|FG002|Main Study|Lost to Follow-up|10|||
164368107|NCT00110812|593725203|FG000|Extended Follow-up|Death|1|||
164368108|NCT00110812|593725204|FG001|Extended Follow-up|Death|0|||
164368109|NCT00110812|593725205|FG002|Extended Follow-up|Death|3|||
164368110|NCT00110812|593725203|FG000|Extended Follow-up|Withdrawal by Subject|0|||
164368111|NCT00110812|593725204|FG001|Extended Follow-up|Withdrawal by Subject|1|||
164368112|NCT00110812|593725205|FG002|Extended Follow-up|Withdrawal by Subject|0|||
164368113|NCT00110812|593725203|FG000|Extended Follow-up|Lost to Follow-up|1|||
164368114|NCT00110812|593725204|FG001|Extended Follow-up|Lost to Follow-up|3|||
164368115|NCT00110812|593725205|FG002|Extended Follow-up|Lost to Follow-up|1|||
164368116|NCT04200248|593725206|FG000|Overall Study|Personal reasons|0|||
164368117|NCT04200248|593725207|FG001|Overall Study|Personal reasons|0|||
164368118|NCT04200248|593725208|FG002|Overall Study|Personal reasons|1|||
164368119|NCT04200248|593725206|FG000|Overall Study|Discontinued prior to treatment|3|||
164368120|NCT04200248|593725207|FG001|Overall Study|Discontinued prior to treatment|3|||
164368121|NCT04200248|593725208|FG002|Overall Study|Discontinued prior to treatment|2|||
164368122|NCT01454726|593725209|FG000|Overall Study|Withdrawal by Subject|0|||
164368123|NCT01454726|593725210|FG001|Overall Study|Withdrawal by Subject|1|||
164368124|NCT01886833|593725211|FG000|Overall Study|IgA not available from both periods|204|||
164368125|NCT04476030|593725212|FG000|Overall Study|Withdrawal by Subject|20|||
164368126|NCT04476030|593725213|FG001|Overall Study|Withdrawal by Subject|16|||
164368127|NCT04476030|593725212|FG000|Overall Study|Adverse Event|10|||
164368128|NCT04476030|593725213|FG001|Overall Study|Adverse Event|11|||
164368129|NCT04476030|593725212|FG000|Overall Study|Lost to Follow-up|7|||
164368130|NCT04476030|593725213|FG001|Overall Study|Lost to Follow-up|4|||
164368131|NCT04476030|593725212|FG000|Overall Study|Physician Decision|1|||
164368132|NCT04476030|593725213|FG001|Overall Study|Physician Decision|1|||
164368133|NCT04476030|593725212|FG000|Overall Study|Protocol Deviation|2|||
164368134|NCT04476030|593725213|FG001|Overall Study|Protocol Deviation|0|||
164368135|NCT04476030|593725212|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
164368136|NCT04476030|593725213|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
164368137|NCT04476030|593725212|FG000|Overall Study|Randomized but not Dosed|2|||
164368138|NCT04476030|593725213|FG001|Overall Study|Randomized but not Dosed|8|||
164368139|NCT02342704|593725214|FG000|Overall Study|Physician Decision|0|||
164368140|NCT02342704|593725215|FG001|Overall Study|Physician Decision|3|||
164368141|NCT02342704|593725214|FG000|Overall Study|Sponsor Termination|49|||
164368142|NCT02342704|593725215|FG001|Overall Study|Sponsor Termination|43|||
164368143|NCT02342704|593725214|FG000|Overall Study|Other|0|||
164368144|NCT02342704|593725215|FG001|Overall Study|Other|1|||
164368145|NCT02342704|593725214|FG000|Overall Study|Withdrawal by Subject|1|||
164368146|NCT02342704|593725215|FG001|Overall Study|Withdrawal by Subject|0|||
164368147|NCT02342704|593725214|FG000|Overall Study|Lost to Follow-up|2|||
164368148|NCT02342704|593725215|FG001|Overall Study|Lost to Follow-up|1|||
164368149|NCT02342704|593725214|FG000|Overall Study|Adverse Event|1|||
164368150|NCT02342704|593725215|FG001|Overall Study|Adverse Event|3|||
164368151|NCT01675882|593725216|FG000|Overall Study|Adverse Event|0|||
164368152|NCT01675882|593725217|FG001|Overall Study|Adverse Event|2|||
164368153|NCT01675882|593725218|FG002|Overall Study|Adverse Event|1|||
164368154|NCT01675882|593725219|FG003|Overall Study|Adverse Event|0|||
164368155|NCT01675882|593725216|FG000|Overall Study|Participant unwilling to continue|2|||
164368156|NCT01675882|593725217|FG001|Overall Study|Participant unwilling to continue|4|||
164368157|NCT01675882|593725218|FG002|Overall Study|Participant unwilling to continue|2|||
164368158|NCT01675882|593725219|FG003|Overall Study|Participant unwilling to continue|1|||
164368159|NCT01675882|593725216|FG000|Overall Study|Lost to Follow-up|0|||
164368160|NCT01675882|593725217|FG001|Overall Study|Lost to Follow-up|1|||
164368161|NCT01675882|593725218|FG002|Overall Study|Lost to Follow-up|0|||
164368162|NCT01675882|593725219|FG003|Overall Study|Lost to Follow-up|0|||
164368163|NCT01675882|593725216|FG000|Overall Study|Non-compliance|0|||
164368164|NCT01675882|593725217|FG001|Overall Study|Non-compliance|0|||
164368165|NCT01675882|593725218|FG002|Overall Study|Non-compliance|0|||
164368166|NCT01675882|593725219|FG003|Overall Study|Non-compliance|1|||
164368167|NCT01446965|593725222|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
164368168|NCT01446965|593725223|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
164144028|NCT00086281|592888582|FG011|Phase 1|Serious Adverse Event|0|||
164368169|NCT01446965|593725222|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
164368170|NCT01446965|593725223|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
164368171|NCT02016482|593725233|FG000|Period A|Adverse Event|3|||
164368172|NCT02016482|593725234|FG001|Period A|Adverse Event|5|||
164368173|NCT02016482|593725233|FG000|Period A|Withdrawal by Subject|3|||
164368174|NCT02016482|593725234|FG001|Period A|Withdrawal by Subject|4|||
164368175|NCT02016482|593725233|FG000|Period A|Lost to Follow-up|3|||
164368176|NCT02016482|593725234|FG001|Period A|Lost to Follow-up|3|||
164368177|NCT02016482|593725233|FG000|Period A|Lack of Efficacy|2|||
164368178|NCT02016482|593725234|FG001|Period A|Lack of Efficacy|1|||
164368179|NCT02016482|593725233|FG000|Period A|Other|3|||
164368180|NCT02016482|593725234|FG001|Period A|Other|0|||
164368181|NCT02016482|593725233|FG000|Period A|Protocol Violation|0|||
164368182|NCT02016482|593725234|FG001|Period A|Protocol Violation|1|||
164368183|NCT02016482|593725233|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
164368184|NCT02016482|593725234|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
164368185|NCT02016482|593725233|FG000|Period B|Withdrawal by Subject|1|||
164368186|NCT02016482|593725234|FG001|Period B|Withdrawal by Subject|1|||
164368187|NCT02016482|593725233|FG000|Period B|Lost to Follow-up|2|||
164368188|NCT02016482|593725234|FG001|Period B|Lost to Follow-up|0|||
164368189|NCT02016482|593725233|FG000|Period B|Lack of Efficacy|6|||
164368190|NCT02016482|593725234|FG001|Period B|Lack of Efficacy|4|||
164368191|NCT02016482|593725233|FG000|Period B|Other|4|||
164368192|NCT02016482|593725234|FG001|Period B|Other|0|||
164368193|NCT02016482|593725233|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
164368194|NCT02016482|593725234|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
164368195|NCT00606892|593725235|FG000|First Intervention|Protocol Violation|1|||
164368196|NCT00606892|593725236|FG001|First Intervention|Protocol Violation|4|||
164368197|NCT00855309|593725238|FG000|Overall Study|patient never recieved drug|1|||
164368198|NCT00855309|593725239|FG001|Overall Study|patient never recieved drug|0|||
164368199|NCT00829296|593725240|FG000|Overall Study|Adverse Event|5|||
164368200|NCT00829296|593725241|FG001|Overall Study|Adverse Event|4|||
164368201|NCT04960228|593725247|FG000|Overall Study|Withdrawal by Subject|216|||
164368202|NCT04960228|593725248|FG001|Overall Study|Withdrawal by Subject|35|||
164368203|NCT04960228|593725247|FG000|Overall Study|Failed attention check|69|||
164368204|NCT04960228|593725248|FG001|Overall Study|Failed attention check|148|||
164368205|NCT04960228|593725247|FG000|Overall Study|Flagged for response quality by Dynata|3|||
164368206|NCT04960228|593725248|FG001|Overall Study|Flagged for response quality by Dynata|3|||
164368207|NCT02547129|593725249|FG000|Overall Study|Difficulty with ongoing infection|1|||
164368208|NCT02547129|593725250|FG001|Overall Study|Difficulty with ongoing infection|0|||
164368209|NCT00794196|593725251|FG000|Overall Study|Lost to Follow-up|5|||
164368210|NCT00794196|593725252|FG001|Overall Study|Lost to Follow-up|23|||
164368211|NCT01640366|593725253|FG000|Overall Study|Withdrawal by Subject|1|||
164368212|NCT01640366|593725253|FG000|Overall Study|Protocol Violation|16|||
164368213|NCT01640366|593725253|FG000|Overall Study|Lost to Follow-up|5|||
164368214|NCT04964128|593725254|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
164368215|NCT04964128|593725254|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
164368216|NCT00994240|593725256|FG000|Overall Study|Lost to Follow-up|3|||
164368217|NCT00994240|593725257|FG001|Overall Study|Lost to Follow-up|2|||
164368218|NCT00994240|593725256|FG000|Overall Study|Withdrawal by Subject|1|||
164368219|NCT00994240|593725257|FG001|Overall Study|Withdrawal by Subject|0|||
164368220|NCT00994240|593725256|FG000|Overall Study|study termination|2|||
164368221|NCT00994240|593725257|FG001|Overall Study|study termination|3|||
164368222|NCT01200797|593725260|FG000|Overall Study|symptomatic deterioration|2|||
164368223|NCT01200797|593725260|FG000|Overall Study|Adverse Event|4|||
164368224|NCT01200797|593725260|FG000|Overall Study|Disease Progression|13|||
164368225|NCT03745144|593725263|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
164368226|NCT03745144|593725264|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
164368227|NCT03745144|593725265|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
164368228|NCT03745144|593725263|FG000|Period 1|Other|0|||
164368229|NCT03745144|593725264|FG001|Period 1|Other|0|||
164368230|NCT03745144|593725265|FG002|Period 1|Other|1|||
164368231|NCT00642668|593725270|FG000|Overall Study|Lost to Follow-up|1|||
164368232|NCT00642668|593725270|FG000|Overall Study|Adverse Event|2|||
164368233|NCT00642668|593725270|FG000|Overall Study|Death|2|||
164368234|NCT00642668|593725270|FG000|Overall Study|Insufficient Therapeutic Response|1|||
164368235|NCT00642668|593725270|FG000|Overall Study|Failure to Return|1|||
164368236|NCT00642668|593725270|FG000|Overall Study|Dialysis Initiation|5|||
164368237|NCT00642668|593725270|FG000|Overall Study|Blood Transfusion|2|||
164368238|NCT00896337|593725271|FG000|Overall Study|Death|7|||
164368239|NCT00896337|593725271|FG000|Overall Study|Withdrawal by Subject|7|||
164368240|NCT00896337|593725271|FG000|Overall Study|Lost to Follow-up|11|||
164368241|NCT01177540|593725272|FG000|Overall Study|Adverse Event|1|||
164368242|NCT01177540|593725273|FG001|Overall Study|Adverse Event|0|||
164368243|NCT02013167|593725275|FG000|Overall Study|Withdrawal by Subject|15|||
164368244|NCT02013167|593725276|FG001|Overall Study|Withdrawal by Subject|14|||
164368245|NCT02013167|593725275|FG000|Overall Study|Sponsor Decision|1|||
164368246|NCT02013167|593725276|FG001|Overall Study|Sponsor Decision|3|||
164368247|NCT02013167|593725275|FG000|Overall Study|Lost to Follow-up|0|||
164368248|NCT02013167|593725276|FG001|Overall Study|Lost to Follow-up|1|||
164368249|NCT02013167|593725275|FG000|Overall Study|Death|85|||
164368250|NCT02013167|593725276|FG001|Overall Study|Death|160|||
164368251|NCT01077804|593725288|FG000|Overall Study|Unreachable|102|||
164368252|NCT01077804|593725288|FG000|Overall Study|Refused to continue|79|||
164368253|NCT01077804|593725288|FG000|Overall Study|Other|18|||
164368254|NCT02776917|593725289|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
164368255|NCT00560950|593725296|FG000|Overall Study|Lost to Follow-up|1|||
164368256|NCT00560950|593725297|FG001|Overall Study|Lost to Follow-up|0|||
164368257|NCT00574405|593727158|FG000|Overall Study|Withdrawal by Subject|3|||
164368258|NCT00574405|593727159|FG001|Overall Study|Withdrawal by Subject|2|||
164368259|NCT01336738|593727160|FG000|Overall Study|Adverse Event|0|||
164368260|NCT01336738|593727161|FG001|Overall Study|Adverse Event|3|||
164368261|NCT01336738|593727162|FG002|Overall Study|Adverse Event|2|||
164368262|NCT01336738|593727163|FG003|Overall Study|Adverse Event|1|||
164368263|NCT01336738|593727164|FG004|Overall Study|Adverse Event|3|||
164368264|NCT01336738|593727160|FG000|Overall Study|Lost to Follow-up|2|||
164368265|NCT01336738|593727161|FG001|Overall Study|Lost to Follow-up|1|||
164368266|NCT01336738|593727162|FG002|Overall Study|Lost to Follow-up|2|||
164368267|NCT01336738|593727163|FG003|Overall Study|Lost to Follow-up|2|||
164368268|NCT01336738|593727164|FG004|Overall Study|Lost to Follow-up|2|||
164368269|NCT01336738|593727160|FG000|Overall Study|Did not meet entrance criteria|0|||
164368270|NCT01336738|593727161|FG001|Overall Study|Did not meet entrance criteria|1|||
164368271|NCT01336738|593727162|FG002|Overall Study|Did not meet entrance criteria|0|||
164368272|NCT01336738|593727163|FG003|Overall Study|Did not meet entrance criteria|0|||
164368273|NCT01336738|593727164|FG004|Overall Study|Did not meet entrance criteria|0|||
164368274|NCT01336738|593727160|FG000|Overall Study|Protocol Violation|0|||
164368275|NCT01336738|593727161|FG001|Overall Study|Protocol Violation|1|||
164368276|NCT01336738|593727162|FG002|Overall Study|Protocol Violation|0|||
164368277|NCT01336738|593727163|FG003|Overall Study|Protocol Violation|0|||
164368278|NCT01336738|593727164|FG004|Overall Study|Protocol Violation|0|||
164368279|NCT01336738|593727160|FG000|Overall Study|Withdrawal by Subject|2|||
164368280|NCT01336738|593727161|FG001|Overall Study|Withdrawal by Subject|0|||
164368281|NCT01336738|593727162|FG002|Overall Study|Withdrawal by Subject|2|||
164368282|NCT01336738|593727163|FG003|Overall Study|Withdrawal by Subject|1|||
164368283|NCT01336738|593727164|FG004|Overall Study|Withdrawal by Subject|1|||
164368284|NCT01336738|593727160|FG000|Overall Study|Other|3|||
164368285|NCT01336738|593727161|FG001|Overall Study|Other|3|||
164368286|NCT01336738|593727162|FG002|Overall Study|Other|2|||
164368287|NCT01336738|593727163|FG003|Overall Study|Other|3|||
164368288|NCT01336738|593727164|FG004|Overall Study|Other|4|||
164368289|NCT01083433|593727165|FG000|Overall Study|Lost to Follow-up|2|||
164368290|NCT01083433|593727166|FG001|Overall Study|Lost to Follow-up|1|||
164368291|NCT01083433|593727167|FG002|Overall Study|Lost to Follow-up|1|||
164368292|NCT01083433|593727165|FG000|Overall Study|Withdrawal by Subject|0|||
164368293|NCT01083433|593727166|FG001|Overall Study|Withdrawal by Subject|5|||
164368294|NCT01083433|593727167|FG002|Overall Study|Withdrawal by Subject|3|||
164368295|NCT01083433|593727165|FG000|Overall Study|Pregnancy|0|||
164368296|NCT01083433|593727166|FG001|Overall Study|Pregnancy|0|||
164368297|NCT01083433|593727167|FG002|Overall Study|Pregnancy|1|||
164368298|NCT02970968|593727169|FG000|Overall Study|Withdrawal by Subject|3|||
164368299|NCT02970968|593727170|FG001|Overall Study|Withdrawal by Subject|3|||
164368300|NCT02970968|593727169|FG000|Overall Study|Adverse Event|1|||
164368301|NCT02970968|593727170|FG001|Overall Study|Adverse Event|2|||
164368302|NCT02970968|593727169|FG000|Overall Study|Lost to Follow-up|1|||
164368303|NCT02970968|593727170|FG001|Overall Study|Lost to Follow-up|1|||
164368304|NCT02970968|593727169|FG000|Overall Study|Non-Compliance|0|||
164368305|NCT02970968|593727170|FG001|Overall Study|Non-Compliance|1|||
164368306|NCT03003520|593727171|FG000|Overall Study|Adverse Event|9|||
164368307|NCT03003520|593727172|FG001|Overall Study|Adverse Event|0|||
164368308|NCT03003520|593727171|FG000|Overall Study|Death|1|||
164368309|NCT03003520|593727172|FG001|Overall Study|Death|0|||
164368310|NCT03003520|593727171|FG000|Overall Study|Other reasons|4|||
164368311|NCT03003520|593727172|FG001|Overall Study|Other reasons|0|||
164368312|NCT03003520|593727171|FG000|Overall Study|Withdrawal by Subject|6|||
164368313|NCT03003520|593727172|FG001|Overall Study|Withdrawal by Subject|0|||
164368314|NCT03003520|593727171|FG000|Overall Study|Progressive disease|9|||
164368315|NCT03003520|593727172|FG001|Overall Study|Progressive disease|1|||
164368316|NCT01332149|593727173|FG000|Overall Study|Adverse Event|11|||
164368317|NCT01332149|593727174|FG001|Overall Study|Adverse Event|9|||
164368318|NCT01332149|593727173|FG000|Overall Study|Other unspecified|5|||
164591271|NCT03987620|594527268|FG001|Overall Study|Lost to Follow-up|2|||
164591272|NCT03987620|594527267|FG000|Overall Study|Physician Decision|0|||
164591273|NCT03987620|594527268|FG001|Overall Study|Physician Decision|1|||
164591274|NCT03987620|594527267|FG000|Overall Study|Pregnancy|1|||
164591275|NCT03987620|594527268|FG001|Overall Study|Pregnancy|0|||
164368319|NCT01332149|593727174|FG001|Overall Study|Other unspecified|7|||
164368320|NCT01332149|593727173|FG000|Overall Study|Protocol Violation|1|||
164368321|NCT01332149|593727174|FG001|Overall Study|Protocol Violation|3|||
164368322|NCT01332149|593727173|FG000|Overall Study|Withdrawal by Subject|4|||
164368323|NCT01332149|593727174|FG001|Overall Study|Withdrawal by Subject|5|||
164368324|NCT01332149|593727173|FG000|Overall Study|Lost to Follow-up|1|||
164368325|NCT01332149|593727174|FG001|Overall Study|Lost to Follow-up|1|||
164368326|NCT01332149|593727173|FG000|Overall Study|Insufficient clinical response|4|||
164368327|NCT01332149|593727174|FG001|Overall Study|Insufficient clinical response|7|||
164368328|NCT01332149|593727173|FG000|Overall Study|Did not meet entrance criteria|3|||
164368329|NCT01332149|593727174|FG001|Overall Study|Did not meet entrance criteria|4|||
164368330|NCT01332149|593727173|FG000|Overall Study|Randomized but not treated|1|||
164368331|NCT01332149|593727174|FG001|Overall Study|Randomized but not treated|2|||
164368332|NCT04982029|593727175|FG000|Overall Study|Lost to Follow-up|2|||
164591276|NCT03987620|594527267|FG000|Overall Study|Withdrawal by Subject|7|||
164368333|NCT04982029|593727176|FG001|Overall Study|Lost to Follow-up|3|||
164368334|NCT03264404|593727177|FG000|Overall Study|Death|2|||
164368335|NCT03264404|593727177|FG000|Overall Study|Physician Decision|1|||
164368336|NCT03264404|593727177|FG000|Overall Study|Disease Progression|28|||
164368337|NCT03264404|593727177|FG000|Overall Study|Adverse Event|1|||
164368338|NCT03264404|593727177|FG000|Overall Study|Off study prior to treatment|2|||
164368339|NCT02565381|593727178|FG000|Overall Study|Lost to Follow-up|1|||
164368340|NCT02565381|593727179|FG001|Overall Study|Lost to Follow-up|0|||
164368341|NCT02565381|593727180|FG002|Overall Study|Lost to Follow-up|1|||
164368342|NCT04615949|593727183|FG000|Overall Study|Withdrawal by Subject|2|||
164368343|NCT04615949|593727184|FG001|Overall Study|Withdrawal by Subject|4|||
164368344|NCT04615949|593727183|FG000|Overall Study|Lost to Follow-up|2|||
164368345|NCT04615949|593727184|FG001|Overall Study|Lost to Follow-up|2|||
164368346|NCT04615949|593727183|FG000|Overall Study|Death|0|||
164368347|NCT04615949|593727184|FG001|Overall Study|Death|2|||
164368348|NCT03036566|593727185|FG000|Overall Study|Lost to Follow-up|3|||
164368349|NCT05458856|593727186|FG000|Overall Study|Withdrawal by Subject|5|||
164368350|NCT05458856|593727186|FG000|Overall Study|Death|4|||
164368351|NCT05458856|593727186|FG000|Overall Study|Protocol Deviation|3|||
164368352|NCT05458856|593727186|FG000|Overall Study|Physician Decision|1|||
164368353|NCT01852292|593727190|FG000|Overall Study|Untreated - did not receive study drug|3|||
164368354|NCT01852292|593727191|FG001|Overall Study|Untreated - did not receive study drug|1|||
164368355|NCT01852292|593727190|FG000|Overall Study|Death|9|||
164368356|NCT01852292|593727191|FG001|Overall Study|Death|8|||
164368357|NCT01852292|593727190|FG000|Overall Study|Patient/guardian decision|8|||
164368358|NCT01852292|593727191|FG001|Overall Study|Patient/guardian decision|4|||
164368359|NCT01852292|593727190|FG000|Overall Study|Adverse Event|8|||
164368360|NCT01852292|593727191|FG001|Overall Study|Adverse Event|11|||
164368361|NCT01852292|593727190|FG000|Overall Study|Physician Decision|6|||
164368362|NCT01852292|593727191|FG001|Overall Study|Physician Decision|2|||
164368363|NCT01852292|593727190|FG000|Overall Study|Protocol Violation|2|||
164368364|NCT01852292|593727191|FG001|Overall Study|Protocol Violation|0|||
164368365|NCT01852292|593727190|FG000|Overall Study|Non-compliance with study treatment|1|||
164368366|NCT01852292|593727191|FG001|Overall Study|Non-compliance with study treatment|0|||
164368367|NCT01852292|593727190|FG000|Overall Study|Study terminated by Sponsor|0|||
164368368|NCT01852292|593727191|FG001|Overall Study|Study terminated by Sponsor|1|||
164368369|NCT01852292|593727190|FG000|Overall Study|Progressive disease|42|||
164368370|NCT01852292|593727191|FG001|Overall Study|Progressive disease|52|||
164368371|NCT00071812|593727194|FG000|24-Week Double-Blind Period|Adverse Event|2|||
164368372|NCT00071812|593727195|FG001|24-Week Double-Blind Period|Adverse Event|3|||
164368373|NCT00071812|593727196|FG002|24-Week Double-Blind Period|Adverse Event|4|||
164368374|NCT00071812|593727197|FG003|24-Week Double-Blind Period|Adverse Event|4|||
164368375|NCT00071812|593727194|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
164368376|NCT00071812|593727195|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
164591277|NCT03987620|594527268|FG001|Overall Study|Withdrawal by Subject|1|||
164368377|NCT00071812|593727196|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
164438738|NCT01235949|593973055|FG000|Primary Phase|Migrated/moved from study area|1|||
164591278|NCT03987620|594527267|FG000|Overall Study|Other|2|||
164591279|NCT03987620|594527268|FG001|Overall Study|Other|5|||
164368378|NCT00071812|593727197|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
164368379|NCT00071812|593727194|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
164368380|NCT00071812|593727195|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
164368381|NCT00071812|593727196|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
164368382|NCT00071812|593727197|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
164368383|NCT00071812|593727194|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
164368384|NCT00071812|593727195|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
164368385|NCT00071812|593727196|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
164368386|NCT00071812|593727197|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
164368387|NCT00071812|593727194|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
164368388|NCT00071812|593727195|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
164368389|NCT00071812|593727196|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
164368390|NCT00071812|593727197|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
164368391|NCT00071812|593727194|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
164368392|NCT00071812|593727195|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
164368393|NCT00071812|593727196|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
164368394|NCT00071812|593727197|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
164368395|NCT00071812|593727194|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
164368396|NCT00071812|593727195|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
164368397|NCT00071812|593727196|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
164368398|NCT00071812|593727197|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
164368399|NCT00071812|593727194|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
164368400|NCT00071812|593727195|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
164368401|NCT00071812|593727196|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
164368402|NCT00071812|593727197|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
164368403|NCT00071812|593727194|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
164368404|NCT00071812|593727195|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
164368405|NCT00071812|593727196|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
164368406|NCT00071812|593727197|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
164368407|NCT00071812|593727194|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
164368408|NCT00071812|593727195|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
164368409|NCT00071812|593727196|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
164368410|NCT00071812|593727197|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
164368411|NCT01940120|593727200|FG000|Overall Study|Death|40|||
164368412|NCT01940120|593727200|FG000|Overall Study|Withdrawal by Subject|8|||
164368413|NCT03711162|593727202|FG000|Overall Study|Adverse Event|5|||
164368414|NCT03711162|593727203|FG001|Overall Study|Adverse Event|2|||
164368415|NCT03711162|593727204|FG002|Overall Study|Adverse Event|4|||
164368416|NCT03711162|593727202|FG000|Overall Study|Death|11|||
164368417|NCT03711162|593727203|FG001|Overall Study|Death|7|||
164368418|NCT03711162|593727204|FG002|Overall Study|Death|8|||
164368419|NCT03711162|593727202|FG000|Overall Study|Lost to Follow-up|1|||
164368420|NCT03711162|593727203|FG001|Overall Study|Lost to Follow-up|0|||
164368421|NCT03711162|593727204|FG002|Overall Study|Lost to Follow-up|1|||
164368422|NCT03711162|593727202|FG000|Overall Study|Study Terminated by Sponsor|139|||
164368423|NCT03711162|593727203|FG001|Overall Study|Study Terminated by Sponsor|152|||
164368424|NCT03711162|593727204|FG002|Overall Study|Study Terminated by Sponsor|146|||
164368425|NCT03711162|593727202|FG000|Overall Study|Withdrawal by Subject|17|||
164368426|NCT03711162|593727203|FG001|Overall Study|Withdrawal by Subject|10|||
164368427|NCT03711162|593727204|FG002|Overall Study|Withdrawal by Subject|10|||
164368428|NCT03711162|593727202|FG000|Overall Study|Miscellaneous|1|||
164368429|NCT03711162|593727203|FG001|Overall Study|Miscellaneous|2|||
164368430|NCT03711162|593727204|FG002|Overall Study|Miscellaneous|2|||
164368431|NCT03711162|593727202|FG000|Overall Study|Not Treated|1|||
164368432|NCT03711162|593727203|FG001|Overall Study|Not Treated|0|||
164368433|NCT03711162|593727204|FG002|Overall Study|Not Treated|1|||
164368434|NCT03711162|593727202|FG000|Overall Study|Physician Decision|0|||
164368435|NCT03711162|593727203|FG001|Overall Study|Physician Decision|2|||
164368436|NCT03711162|593727204|FG002|Overall Study|Physician Decision|0|||
164368437|NCT03711162|593727202|FG000|Overall Study|Lack of Efficacy|0|||
164368438|NCT03711162|593727203|FG001|Overall Study|Lack of Efficacy|0|||
164368439|NCT03711162|593727204|FG002|Overall Study|Lack of Efficacy|2|||
164368440|NCT03711162|593727202|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
164368441|NCT03711162|593727203|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
164368442|NCT03711162|593727204|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
164591280|NCT05128162|594527269|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
164591281|NCT05128162|594527269|FG000|Overall Study|Physician Decision|1|||
164591282|NCT00370149|594527270|FG000|Overall Study|Physician Decision|16|||
164591283|NCT00370149|594527271|FG001|Overall Study|Physician Decision|16|||
164368443|NCT01275066|593727207|FG000|Overall Study|Withdrawal by Subject|0|||
164368444|NCT01275066|593727208|FG001|Overall Study|Withdrawal by Subject|0|||
164368445|NCT01275066|593727209|FG002|Overall Study|Withdrawal by Subject|1|||
164368446|NCT01275066|593727207|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
164368447|NCT01275066|593727208|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
164368448|NCT01275066|593727209|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
164591284|NCT00370149|594527270|FG000|Overall Study|Protocol Violation|1|||
164368449|NCT03240133|593727210|FG000|Overall Study|Withdrawal by Subject|0|||
164368450|NCT03240133|593727211|FG001|Overall Study|Withdrawal by Subject|1|||
164368451|NCT03240133|593727212|FG002|Overall Study|Withdrawal by Subject|0|||
164368452|NCT03240133|593727210|FG000|Overall Study|Adverse Event|1|||
164368453|NCT03240133|593727211|FG001|Overall Study|Adverse Event|1|||
164368454|NCT03240133|593727212|FG002|Overall Study|Adverse Event|0|||
164368455|NCT03240133|593727210|FG000|Overall Study|Rash|1|||
164368456|NCT03240133|593727211|FG001|Overall Study|Rash|0|||
164368457|NCT03240133|593727212|FG002|Overall Study|Rash|0|||
164368458|NCT03240133|593727210|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
164368459|NCT03240133|593727211|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
164368460|NCT03240133|593727212|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
164368461|NCT03240133|593727210|FG000|Overall Study|Intercurrent illness.|0|||
164368462|NCT03240133|593727211|FG001|Overall Study|Intercurrent illness.|1|||
164368463|NCT03240133|593727212|FG002|Overall Study|Intercurrent illness.|0|||
164368464|NCT03240133|593727210|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
164368465|NCT03240133|593727211|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
164368466|NCT03240133|593727212|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
164368467|NCT00749463|593727213|FG000|Overall Study|Adverse Event|0|||
164368468|NCT00749463|593727214|FG001|Overall Study|Adverse Event|4|||
164368469|NCT00749463|593727215|FG002|Overall Study|Adverse Event|1|||
164368470|NCT00749463|593727213|FG000|Overall Study|Withdrawal by Subject|1|||
164368471|NCT00749463|593727214|FG001|Overall Study|Withdrawal by Subject|0|||
164368472|NCT00749463|593727215|FG002|Overall Study|Withdrawal by Subject|0|||
164368473|NCT00116831|593727216|FG000|Overall Study|Adverse Event|14|||
164368474|NCT00116831|593727217|FG001|Overall Study|Adverse Event|16|||
164368475|NCT00116831|593727216|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
164368476|NCT00116831|593727217|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
164368477|NCT00116831|593727216|FG000|Overall Study|Lost to Follow-up|8|||
164368478|NCT00116831|593727217|FG001|Overall Study|Lost to Follow-up|6|||
164368479|NCT00116831|593727216|FG000|Overall Study|Protocol Violation|3|||
164368480|NCT00116831|593727217|FG001|Overall Study|Protocol Violation|6|||
164368481|NCT00116831|593727216|FG000|Overall Study|Hypoglycaemic events|1|||
164368482|NCT00116831|593727217|FG001|Overall Study|Hypoglycaemic events|0|||
164368483|NCT00116831|593727216|FG000|Overall Study|Low haemoglobin on screening|1|||
164368484|NCT00116831|593727217|FG001|Overall Study|Low haemoglobin on screening|0|||
164368485|NCT00116831|593727216|FG000|Overall Study|Withdrawn investigational product|1|||
164368486|NCT00116831|593727217|FG001|Overall Study|Withdrawn investigational product|0|||
164368487|NCT00116831|593727216|FG000|Overall Study|Withdrawal by Subject|32|||
164368488|NCT00116831|593727217|FG001|Overall Study|Withdrawal by Subject|32|||
164368489|NCT00116831|593727216|FG000|Overall Study|Insufficient therapeutic effect|0|||
164368490|NCT00116831|593727217|FG001|Overall Study|Insufficient therapeutic effect|1|||
164368491|NCT00116831|593727216|FG000|Overall Study|Missing data for participant|1|||
164368492|NCT00116831|593727217|FG001|Overall Study|Missing data for participant|0|||
164368493|NCT04904185|593727218|FG000|Overall Study|Expansion failure|1|||
164368494|NCT04904185|593727219|FG001|Overall Study|Expansion failure|0|||
164368495|NCT04904185|593727218|FG000|Overall Study|Late response on prior treatment|1|||
164368496|NCT04904185|593727219|FG001|Overall Study|Late response on prior treatment|0|||
164368497|NCT01344369|593727222|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
164368498|NCT01344369|593727223|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
164368499|NCT01344369|593727222|FG000|Washout of 28 Days|Physician Decision|0|||
164368500|NCT01344369|593727223|FG001|Washout of 28 Days|Physician Decision|1|||
164368501|NCT01344369|593727222|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
164368502|NCT01344369|593727223|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
164368503|NCT00333229|593727228|FG000|Overall Study|Lack of Efficacy|0|||
164368504|NCT00333229|593727229|FG001|Overall Study|Lack of Efficacy|1|||
164368505|NCT00735371|593727238|FG000|Overall Study|Adverse Event|3|||
164368506|NCT00735371|593727239|FG001|Overall Study|Adverse Event|3|||
164368507|NCT00735371|593727240|FG002|Overall Study|Adverse Event|4|||
164368508|NCT00735371|593727241|FG003|Overall Study|Adverse Event|1|||
164368509|NCT00735371|593727238|FG000|Overall Study|Protocol Violation|2|||
164368510|NCT00735371|593727239|FG001|Overall Study|Protocol Violation|2|||
164368511|NCT00735371|593727240|FG002|Overall Study|Protocol Violation|0|||
164368512|NCT00735371|593727241|FG003|Overall Study|Protocol Violation|3|||
164368513|NCT00735371|593727238|FG000|Overall Study|Withdrawal by Subject|0|||
164368514|NCT00735371|593727239|FG001|Overall Study|Withdrawal by Subject|2|||
164368515|NCT00735371|593727240|FG002|Overall Study|Withdrawal by Subject|2|||
164368516|NCT00735371|593727241|FG003|Overall Study|Withdrawal by Subject|0|||
164368517|NCT00735371|593727238|FG000|Overall Study|Lost to Follow-up|1|||
164591285|NCT00370149|594527271|FG001|Overall Study|Protocol Violation|0|||
164591286|NCT00370149|594527270|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
164368518|NCT00735371|593727239|FG001|Overall Study|Lost to Follow-up|1|||
164368519|NCT00735371|593727240|FG002|Overall Study|Lost to Follow-up|3|||
164368520|NCT00735371|593727241|FG003|Overall Study|Lost to Follow-up|1|||
164368521|NCT00735371|593727238|FG000|Overall Study|Lack of Efficacy|4|||
164368522|NCT00735371|593727239|FG001|Overall Study|Lack of Efficacy|2|||
164368523|NCT00735371|593727240|FG002|Overall Study|Lack of Efficacy|0|||
164368524|NCT00735371|593727241|FG003|Overall Study|Lack of Efficacy|4|||
164591287|NCT00370149|594527271|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
164368525|NCT00735371|593727238|FG000|Overall Study|Sponsor Decision|3|||
164368526|NCT00735371|593727239|FG001|Overall Study|Sponsor Decision|1|||
164368527|NCT00735371|593727240|FG002|Overall Study|Sponsor Decision|0|||
164368528|NCT00735371|593727241|FG003|Overall Study|Sponsor Decision|1|||
164368529|NCT00735371|593727238|FG000|Overall Study|Protocol Violation|0|||
164368530|NCT00735371|593727239|FG001|Overall Study|Protocol Violation|1|||
164368531|NCT00735371|593727240|FG002|Overall Study|Protocol Violation|2|||
164368532|NCT00735371|593727241|FG003|Overall Study|Protocol Violation|0|||
164368533|NCT00735371|593727238|FG000|Overall Study|Prior Vyvanse Exposure|1|||
164368534|NCT00735371|593727239|FG001|Overall Study|Prior Vyvanse Exposure|1|||
164368535|NCT00735371|593727240|FG002|Overall Study|Prior Vyvanse Exposure|0|||
164368536|NCT00735371|593727241|FG003|Overall Study|Prior Vyvanse Exposure|0|||
164368537|NCT00735371|593727238|FG000|Overall Study|Exclusion criteria|1|||
164368538|NCT00735371|593727239|FG001|Overall Study|Exclusion criteria|0|||
164368539|NCT00735371|593727240|FG002|Overall Study|Exclusion criteria|0|||
164368540|NCT00735371|593727241|FG003|Overall Study|Exclusion criteria|0|||
164368541|NCT01533246|593727242|FG000|Overall Study|Adverse Event|1|||
164368542|NCT01533246|593727242|FG000|Overall Study|Withdrawal by Subject|1|||
164368543|NCT04225923|593727265|FG000|Overall Study|Protocol Violation|1|||
164368544|NCT04225923|593727266|FG001|Overall Study|Protocol Violation|0|||
164368545|NCT04225923|593727267|FG002|Overall Study|Protocol Violation|1|||
164368546|NCT04225923|593727265|FG000|Overall Study|Withdrawal by Subject|4|||
164368547|NCT04225923|593727266|FG001|Overall Study|Withdrawal by Subject|1|||
164368548|NCT04225923|593727267|FG002|Overall Study|Withdrawal by Subject|3|||
164368549|NCT04225923|593727265|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
164368550|NCT04225923|593727266|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
164368551|NCT04225923|593727267|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
164368552|NCT01585766|593727273|FG000|Overall Study|Withdrawal by Subject|0|||
164368553|NCT01585766|593727274|FG001|Overall Study|Withdrawal by Subject|1|||
164368554|NCT01585766|593727275|FG002|Overall Study|Withdrawal by Subject|1|||
164368555|NCT01585766|593727276|FG003|Overall Study|Withdrawal by Subject|0|||
164368556|NCT01585766|593727277|FG004|Overall Study|Withdrawal by Subject|0|||
164368557|NCT01585766|593727278|FG005|Overall Study|Withdrawal by Subject|0|||
164368558|NCT01585766|593727273|FG000|Overall Study|Death|0|||
164368559|NCT01585766|593727274|FG001|Overall Study|Death|1|||
164368560|NCT01585766|593727275|FG002|Overall Study|Death|0|||
164368561|NCT01585766|593727276|FG003|Overall Study|Death|0|||
164368562|NCT01585766|593727277|FG004|Overall Study|Death|0|||
164368563|NCT01585766|593727278|FG005|Overall Study|Death|0|||
164368564|NCT01585766|593727273|FG000|Overall Study|Physician Decision|0|||
164368565|NCT01585766|593727274|FG001|Overall Study|Physician Decision|0|||
164368566|NCT01585766|593727275|FG002|Overall Study|Physician Decision|1|||
164368567|NCT01585766|593727276|FG003|Overall Study|Physician Decision|0|||
164368568|NCT01585766|593727277|FG004|Overall Study|Physician Decision|0|||
164368569|NCT01585766|593727278|FG005|Overall Study|Physician Decision|0|||
164368570|NCT01364428|593727279|FG000|Overall Study|Adverse Event|1|||
164368571|NCT01364428|593727280|FG001|Overall Study|Adverse Event|2|||
164368572|NCT01364428|593727279|FG000|Overall Study|Protocol Violation|2|||
164368573|NCT01364428|593727280|FG001|Overall Study|Protocol Violation|0|||
164368574|NCT01364428|593727279|FG000|Overall Study|Withdrawal Criteria|14|||
164368575|NCT01364428|593727280|FG001|Overall Study|Withdrawal Criteria|10|||
164368576|NCT01364428|593727279|FG000|Overall Study|Other|3|||
164368577|NCT01364428|593727280|FG001|Overall Study|Other|3|||
164368578|NCT01987427|593727281|FG000|Overall Study|Adverse Event|4|||
164368579|NCT01987427|593727282|FG001|Overall Study|Adverse Event|2|||
164368580|NCT01987427|593727283|FG002|Overall Study|Adverse Event|8|||
164368581|NCT01987427|593727281|FG000|Overall Study|Lost to Follow-up|6|||
164368582|NCT01987427|593727282|FG001|Overall Study|Lost to Follow-up|6|||
164438739|NCT01235949|593973056|FG001|Primary Phase|Migrated/moved from study area|1|||
164438740|NCT01235949|593973057|FG002|Primary Phase|Migrated/moved from study area|0|||
164700191|NCT00094094|594924905|FG000|Overall Study|Adverse Event|7|||
164700192|NCT02655016|594924908|FG000|Overall Study|Disease progression|6|||
164700193|NCT02655016|594924909|FG001|Overall Study|Disease progression|4|||
164700194|NCT02655016|594924908|FG000|Overall Study|Site closed|0|||
164368583|NCT01987427|593727283|FG002|Overall Study|Lost to Follow-up|9|||
164368584|NCT01987427|593727281|FG000|Overall Study|Withdrawal by Subject|2|||
164368585|NCT01987427|593727282|FG001|Overall Study|Withdrawal by Subject|1|||
164368586|NCT01987427|593727283|FG002|Overall Study|Withdrawal by Subject|3|||
164438741|NCT01235949|593973058|FG003|Primary Phase|Migrated/moved from study area|0|||
164438742|NCT01235949|593973059|FG004|Primary Phase|Migrated/moved from study area|1|||
164368587|NCT01987427|593727281|FG000|Overall Study|Lack of Efficacy|1|||
164368588|NCT01987427|593727282|FG001|Overall Study|Lack of Efficacy|0|||
164368589|NCT01987427|593727283|FG002|Overall Study|Lack of Efficacy|0|||
164438743|NCT01235949|593973060|FG005|Primary Phase|Migrated/moved from study area|2|||
164368590|NCT01987427|593727281|FG000|Overall Study|Other|1|||
164368591|NCT01987427|593727282|FG001|Overall Study|Other|1|||
164368592|NCT01987427|593727283|FG002|Overall Study|Other|0|||
164368593|NCT02129803|593727291|FG000|Overall Study|Protocol Violation|4|||
164700195|NCT02655016|594924909|FG001|Overall Study|Site closed|1|||
164368594|NCT02129803|593727292|FG001|Overall Study|Protocol Violation|0|||
164368595|NCT02129803|593727291|FG000|Overall Study|Physician Decision|0|||
164368596|NCT02129803|593727292|FG001|Overall Study|Physician Decision|1|||
164368597|NCT02129803|593727291|FG000|Overall Study|Difficulty sleeping|1|||
164368598|NCT02129803|593727292|FG001|Overall Study|Difficulty sleeping|0|||
164368599|NCT02129803|593727291|FG000|Overall Study|Morning headache|0|||
164368600|NCT02129803|593727292|FG001|Overall Study|Morning headache|1|||
164368601|NCT02129803|593727291|FG000|Overall Study|Withdrawal by Subject|1|||
164368602|NCT02129803|593727292|FG001|Overall Study|Withdrawal by Subject|1|||
164368603|NCT02319031|593727293|FG000|Treatment Period|Death|1|||
164368604|NCT02319031|593727294|FG001|Treatment Period|Death|0|||
164368605|NCT01465464|593727305|FG000|Overall Study|Adverse Event|96|||
164368606|NCT01465464|593727306|FG001|Overall Study|Adverse Event|49|||
164368607|NCT01465464|593727305|FG000|Overall Study|Lack of Efficacy|139|||
164368608|NCT01465464|593727306|FG001|Overall Study|Lack of Efficacy|190|||
164368609|NCT01465464|593727305|FG000|Overall Study|Physician Decision|13|||
164368610|NCT01465464|593727306|FG001|Overall Study|Physician Decision|5|||
164368611|NCT01465464|593727305|FG000|Overall Study|Protocol Violation|1|||
164368612|NCT01465464|593727306|FG001|Overall Study|Protocol Violation|1|||
164368613|NCT01465464|593727305|FG000|Overall Study|Withdrawal by Subject|46|||
164368614|NCT01465464|593727306|FG001|Overall Study|Withdrawal by Subject|30|||
164368615|NCT01465464|593727305|FG000|Overall Study|Other|9|||
164368616|NCT01465464|593727306|FG001|Overall Study|Other|3|||
164368617|NCT01465464|593727305|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
164368618|NCT01465464|593727306|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
164368619|NCT01183975|593727309|FG000|Overall Study|Lost to Follow-up|73|||
164368620|NCT04371380|593727310|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
164368621|NCT04371380|593727311|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
164368622|NCT04371380|593727312|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
164368623|NCT02376166|593727315|FG000|Overall Study|Adverse Event|1|||
164368624|NCT02376166|593727315|FG000|Overall Study|Discontinued metformin early|2|||
164368625|NCT02739269|593727321|FG000|Overall Study|Protocol Violation|5|||
164368626|NCT02739269|593727322|FG001|Overall Study|Protocol Violation|0|||
164368627|NCT02739269|593727321|FG000|Overall Study|Cycle cancellation|2|||
164368628|NCT02739269|593727322|FG001|Overall Study|Cycle cancellation|2|||
164368629|NCT02739269|593727321|FG000|Overall Study|Withdrawal by Subject|0|||
164368630|NCT02739269|593727322|FG001|Overall Study|Withdrawal by Subject|2|||
164368631|NCT02244580|593727323|FG000|Overall Study|No cancer tissues available|241|||
164368632|NCT01228747|593727324|FG000|Overall Study|Adverse Event|8|||
164368633|NCT01228747|593727325|FG001|Overall Study|Adverse Event|4|||
164368634|NCT01228747|593727324|FG000|Overall Study|Lack of Efficacy|40|||
164368635|NCT01228747|593727325|FG001|Overall Study|Lack of Efficacy|27|||
164368636|NCT01228747|593727324|FG000|Overall Study|Protocol Violation|6|||
164368637|NCT01228747|593727325|FG001|Overall Study|Protocol Violation|5|||
164368638|NCT01228747|593727324|FG000|Overall Study|Lost to Follow-up|4|||
164368639|NCT01228747|593727325|FG001|Overall Study|Lost to Follow-up|3|||
164368640|NCT01228747|593727324|FG000|Overall Study|Withdrawal by Subject|5|||
164368641|NCT01228747|593727325|FG001|Overall Study|Withdrawal by Subject|1|||
164368642|NCT01228747|593727324|FG000|Overall Study|Other Reason|2|||
164368643|NCT01228747|593727325|FG001|Overall Study|Other Reason|5|||
164368644|NCT02136576|593727327|FG000|Overall Study|Lost to Follow-up|2|||
164368645|NCT02136576|593727328|FG001|Overall Study|Lost to Follow-up|0|||
164368646|NCT02136576|593727329|FG002|Overall Study|Lost to Follow-up|0|||
164368647|NCT01708174|593727330|FG000|Treatment Period|Withdrawal by Subject|1|||
164368648|NCT01708174|593727331|FG001|Treatment Period|Withdrawal by Subject|0|||
164368649|NCT01708174|593727332|FG002|Treatment Period|Withdrawal by Subject|0|||
164368650|NCT01708174|593727330|FG000|Treatment Period|Progressive disease|0|||
164368651|NCT01708174|593727331|FG001|Treatment Period|Progressive disease|1|||
164368652|NCT01708174|593727332|FG002|Treatment Period|Progressive disease|0|||
164368653|NCT01708174|593727330|FG000|Treatment Period|Death|0|||
164700196|NCT02655016|594924908|FG000|Overall Study|Death|30|||
164700197|NCT02655016|594924909|FG001|Overall Study|Death|48|||
164700198|NCT02655016|594924908|FG000|Overall Study|Lost to Follow-up|1|||
164368654|NCT01708174|593727331|FG001|Treatment Period|Death|0|||
164368655|NCT01708174|593727332|FG002|Treatment Period|Death|1|||
164368656|NCT01708174|593727330|FG000|Treatment Period|Adverse Event|0|||
164368657|NCT01708174|593727331|FG001|Treatment Period|Adverse Event|1|||
164368658|NCT01708174|593727332|FG002|Treatment Period|Adverse Event|0|||
164368659|NCT00923559|593727333|FG000|Overall Study|Lost to Follow-up|2|||
164368660|NCT00923559|593727334|FG001|Overall Study|Lost to Follow-up|3|||
164368661|NCT02268812|593727335|FG000|Overall Study|Adverse Event|8|||
164368662|NCT02268812|593727336|FG001|Overall Study|Adverse Event|26|||
164368663|NCT02268812|593727337|FG002|Overall Study|Adverse Event|7|||
164368664|NCT02268812|593727338|FG003|Overall Study|Adverse Event|10|||
164368665|NCT02268812|593727335|FG000|Overall Study|Protocol deviation|0|||
164368666|NCT02268812|593727336|FG001|Overall Study|Protocol deviation|0|||
164368667|NCT02268812|593727337|FG002|Overall Study|Protocol deviation|1|||
164368668|NCT02268812|593727338|FG003|Overall Study|Protocol deviation|0|||
164368669|NCT02268812|593727335|FG000|Overall Study|Withdrawal by Subject|0|||
164368670|NCT02268812|593727336|FG001|Overall Study|Withdrawal by Subject|1|||
164368671|NCT02268812|593727337|FG002|Overall Study|Withdrawal by Subject|0|||
164368672|NCT02268812|593727338|FG003|Overall Study|Withdrawal by Subject|0|||
164368673|NCT02268812|593727335|FG000|Overall Study|Physician Decision|3|||
164368674|NCT02268812|593727336|FG001|Overall Study|Physician Decision|1|||
164368675|NCT02268812|593727337|FG002|Overall Study|Physician Decision|0|||
164368676|NCT02268812|593727338|FG003|Overall Study|Physician Decision|1|||
164368677|NCT02268812|593727335|FG000|Overall Study|Other|5|||
164368678|NCT02268812|593727336|FG001|Overall Study|Other|4|||
164368679|NCT02268812|593727337|FG002|Overall Study|Other|1|||
164368680|NCT02268812|593727338|FG003|Overall Study|Other|3|||
164368681|NCT01951157|593727341|FG000|Overall Study|Progressive Disease|12|||
164368682|NCT01951157|593727342|FG001|Overall Study|Progressive Disease|13|||
164368683|NCT01951157|593727343|FG002|Overall Study|Progressive Disease|10|||
164368684|NCT01951157|593727341|FG000|Overall Study|Treatment-unrelated AE|1|||
164368685|NCT01951157|593727342|FG001|Overall Study|Treatment-unrelated AE|0|||
164368686|NCT01951157|593727343|FG002|Overall Study|Treatment-unrelated AE|3|||
164368687|NCT01951157|593727341|FG000|Overall Study|Study Termination|0|||
164368688|NCT01951157|593727342|FG001|Overall Study|Study Termination|0|||
164368689|NCT01951157|593727343|FG002|Overall Study|Study Termination|1|||
164368690|NCT01951157|593727341|FG000|Overall Study|Physician Decision|5|||
164368691|NCT01951157|593727342|FG001|Overall Study|Physician Decision|3|||
164368692|NCT01951157|593727343|FG002|Overall Study|Physician Decision|2|||
164368693|NCT01951157|593727341|FG000|Overall Study|Non-treatmentrelated death|2|||
164368694|NCT01951157|593727342|FG001|Overall Study|Non-treatmentrelated death|2|||
164368695|NCT01951157|593727343|FG002|Overall Study|Non-treatmentrelated death|2|||
164368696|NCT01951157|593727341|FG000|Overall Study|No treated|0|||
164368697|NCT01951157|593727342|FG001|Overall Study|No treated|1|||
164368698|NCT01951157|593727343|FG002|Overall Study|No treated|0|||
164368699|NCT01951157|593727341|FG000|Overall Study|Treatment-related AE|2|||
164368700|NCT01951157|593727342|FG001|Overall Study|Treatment-related AE|0|||
164368701|NCT01951157|593727343|FG002|Overall Study|Treatment-related AE|4|||
164368702|NCT01951157|593727341|FG000|Overall Study|Consent withdrawn by subject|0|||
164368703|NCT01951157|593727342|FG001|Overall Study|Consent withdrawn by subject|1|||
164368704|NCT01951157|593727343|FG002|Overall Study|Consent withdrawn by subject|3|||
164368705|NCT01951157|593727341|FG000|Overall Study|Treatment-related death|0|||
164368706|NCT01951157|593727342|FG001|Overall Study|Treatment-related death|2|||
164368707|NCT01951157|593727343|FG002|Overall Study|Treatment-related death|0|||
164368708|NCT02620046|593727354|FG000|Overall Study|Adverse Event|22|||
164368709|NCT02620046|593727355|FG001|Overall Study|Adverse Event|42|||
164368710|NCT02620046|593727354|FG000|Overall Study|Lost to Follow-up|4|||
164368711|NCT02620046|593727355|FG001|Overall Study|Lost to Follow-up|10|||
164368712|NCT02620046|593727354|FG000|Overall Study|Withdrawal by Subject|36|||
164368713|NCT02620046|593727355|FG001|Overall Study|Withdrawal by Subject|66|||
164368714|NCT02620046|593727354|FG000|Overall Study|Site Termination|3|||
164368715|NCT02620046|593727355|FG001|Overall Study|Site Termination|3|||
164368716|NCT02620046|593727354|FG000|Overall Study|Pregnancy|3|||
164368717|NCT02620046|593727355|FG001|Overall Study|Pregnancy|7|||
164591288|NCT00370149|594527270|FG000|Overall Study|Pre-existing infection|0|||
164591289|NCT00370149|594527271|FG001|Overall Study|Pre-existing infection|1|||
164591290|NCT00370149|594527270|FG000|Overall Study|Antibiotic coated dressing placed|0|||
164591291|NCT00370149|594527271|FG001|Overall Study|Antibiotic coated dressing placed|1|||
164591292|NCT04920084|594528332|FG000|Overall Study|Adverse Event|1|||
164591293|NCT04920084|594528332|FG000|Overall Study|Lost to Follow-up|2|||
164591294|NCT04920084|594528332|FG000|Overall Study|Withdrawal by Subject|2|||
164591295|NCT01096446|594528333|FG000|Overall Study|Death|1|||
164591296|NCT01096446|594528334|FG001|Overall Study|Death|0|||
164591297|NCT01096446|594528333|FG000|Overall Study|Protocol Violation|2|||
164591298|NCT01096446|594528334|FG001|Overall Study|Protocol Violation|0|||
164591299|NCT00620321|594528335|FG000|Overall Study|Adverse Event|1|||
164591300|NCT00620321|594528336|FG001|Overall Study|Adverse Event|1|||
164591301|NCT00620321|594528335|FG000|Overall Study|Death|1|||
164591302|NCT00620321|594528336|FG001|Overall Study|Death|1|||
164591303|NCT00620321|594528335|FG000|Overall Study|Physician Decision|0|||
164368718|NCT02620046|593727354|FG000|Overall Study|Lack of Efficacy|81|||
164368719|NCT02620046|593727355|FG001|Overall Study|Lack of Efficacy|146|||
164591304|NCT00620321|594528336|FG001|Overall Study|Physician Decision|7|||
164700199|NCT02655016|594924909|FG001|Overall Study|Lost to Follow-up|1|||
164368720|NCT02620046|593727354|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
164368721|NCT02620046|593727355|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
164368722|NCT02620046|593727354|FG000|Overall Study|Reason Not Specified|13|||
164368723|NCT02620046|593727355|FG001|Overall Study|Reason Not Specified|21|||
164368724|NCT02620046|593727354|FG000|Overall Study|Significant Protocol Deviation|0|||
164368725|NCT02620046|593727355|FG001|Overall Study|Significant Protocol Deviation|1|||
164368726|NCT01914666|593729317|FG000|Treatment Period|Lack of Efficacy|0|||
164368727|NCT01914666|593729318|FG001|Treatment Period|Lack of Efficacy|0|||
164368728|NCT01914666|593729319|FG002|Treatment Period|Lack of Efficacy|2|||
164591305|NCT00620321|594528335|FG000|Overall Study|Progressive Disease|5|||
164591306|NCT00620321|594528336|FG001|Overall Study|Progressive Disease|5|||
164368729|NCT01914666|593729317|FG000|Treatment Period|Adverse Event|10|||
164368730|NCT01914666|593729318|FG001|Treatment Period|Adverse Event|4|||
164368731|NCT01914666|593729319|FG002|Treatment Period|Adverse Event|2|||
164368732|NCT01914666|593729317|FG000|Treatment Period|Withdrawal by Subject|3|||
164368733|NCT01914666|593729318|FG001|Treatment Period|Withdrawal by Subject|2|||
164368734|NCT01914666|593729319|FG002|Treatment Period|Withdrawal by Subject|2|||
164368735|NCT01914666|593729317|FG000|Treatment Period|Physician Decision|0|||
164368736|NCT01914666|593729318|FG001|Treatment Period|Physician Decision|0|||
164368737|NCT01914666|593729319|FG002|Treatment Period|Physician Decision|2|||
164368738|NCT02388737|593729321|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
164368739|NCT02388737|593729322|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
164368740|NCT02388737|593729323|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
164368741|NCT02388737|593729321|FG000|Overall Study|Major Protocol Deviation|18|||
164368742|NCT02388737|593729322|FG001|Overall Study|Major Protocol Deviation|25|||
164368743|NCT02388737|593729323|FG002|Overall Study|Major Protocol Deviation|22|||
164368744|NCT02388737|593729321|FG000|Overall Study|Lost to Follow-up|5|||
164368745|NCT02388737|593729322|FG001|Overall Study|Lost to Follow-up|1|||
164368746|NCT02388737|593729323|FG002|Overall Study|Lost to Follow-up|4|||
164368747|NCT02388737|593729321|FG000|Overall Study|Voluntary Withdrawal|10|||
164368748|NCT02388737|593729322|FG001|Overall Study|Voluntary Withdrawal|18|||
164368749|NCT02388737|593729323|FG002|Overall Study|Voluntary Withdrawal|17|||
164368750|NCT02388737|593729321|FG000|Overall Study|Lack of Efficacy|3|||
164368751|NCT02388737|593729322|FG001|Overall Study|Lack of Efficacy|0|||
164368752|NCT02388737|593729323|FG002|Overall Study|Lack of Efficacy|3|||
164368753|NCT02388737|593729321|FG000|Overall Study|Reason Not Specified|5|||
164368754|NCT02388737|593729322|FG001|Overall Study|Reason Not Specified|5|||
164368755|NCT02388737|593729323|FG002|Overall Study|Reason Not Specified|4|||
164368756|NCT03252522|593729324|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
164368757|NCT03252522|593729325|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
164368758|NCT03252522|593729326|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
164368759|NCT03252522|593729324|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
164368760|NCT03252522|593729325|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
164368761|NCT03252522|593729326|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
164368762|NCT03252522|593729324|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
164368763|NCT03252522|593729325|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
164368764|NCT03252522|593729326|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
164368765|NCT03252522|593729324|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
164368766|NCT03252522|593729325|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
164368767|NCT03252522|593729326|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
164368768|NCT03252522|593729324|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
164368769|NCT03252522|593729325|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
164368770|NCT03252522|593729326|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
164368771|NCT03252522|593729324|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
164368772|NCT03252522|593729325|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
164368773|NCT03252522|593729326|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
164368774|NCT03252522|593729324|FG000|Phase 2: Open Label|Adverse Event|0|||
164368775|NCT03252522|593729325|FG001|Phase 2: Open Label|Adverse Event|0|||
164368776|NCT03252522|593729326|FG002|Phase 2: Open Label|Adverse Event|2|||
164368777|NCT03252522|593729324|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
164368778|NCT03252522|593729325|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
164368779|NCT03252522|593729326|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
164368780|NCT04152447|593729328|FG000|Overall Study|Lost to Follow-up|1|||
164368781|NCT04152447|593729329|FG001|Overall Study|Lost to Follow-up|0|||
164368782|NCT04152447|593729328|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
164438744|NCT01235949|593973061|FG006|Primary Phase|Migrated/moved from study area|0|||
164438745|NCT01235949|593973062|FG007|Primary Phase|Migrated/moved from study area|0|||
164438746|NCT01235949|593973063|FG008|Primary Phase|Migrated/moved from study area|0|||
164438747|NCT01235949|593973064|FG009|Primary Phase|Migrated/moved from study area|0|||
164591307|NCT00620321|594528335|FG000|Overall Study|Sponsor Decision|0|||
164368783|NCT04152447|593729329|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
164591308|NCT00620321|594528336|FG001|Overall Study|Sponsor Decision|1|||
164368784|NCT04152447|593729328|FG000|Overall Study|Withdrawal by Subject|0|||
164368785|NCT04152447|593729329|FG001|Overall Study|Withdrawal by Subject|1|||
164368786|NCT04152447|593729328|FG000|Overall Study|Found ineligible after enrolling|1|||
164438748|NCT01235949|593973065|FG010|Primary Phase|Migrated/moved from study area|0|||
164591309|NCT00620321|594528335|FG000|Overall Study|Withdrawal by Subject|1|||
164591310|NCT00620321|594528336|FG001|Overall Study|Withdrawal by Subject|1|||
164591311|NCT02279524|594528338|FG000|Overall Study|Withdrawal by Subject|3|||
164591312|NCT02279524|594528339|FG001|Overall Study|Withdrawal by Subject|6|||
164591313|NCT02279524|594528340|FG002|Overall Study|Withdrawal by Subject|3|||
164591314|NCT02279524|594528338|FG000|Overall Study|Adverse Event|4|||
164591315|NCT02279524|594528339|FG001|Overall Study|Adverse Event|3|||
164591316|NCT02279524|594528340|FG002|Overall Study|Adverse Event|2|||
164368787|NCT04152447|593729329|FG001|Overall Study|Found ineligible after enrolling|1|||
164368788|NCT04152447|593729328|FG000|Overall Study|Did not receive VR headset in time.|0|||
164368789|NCT04152447|593729329|FG001|Overall Study|Did not receive VR headset in time.|2|||
164368790|NCT03240575|593729330|FG000|Overall Study|Adverse Event|0|||
164368791|NCT03240575|593729331|FG001|Overall Study|Adverse Event|2|||
164368792|NCT03240575|593729332|FG002|Overall Study|Adverse Event|0|||
164368793|NCT03240575|593729333|FG003|Overall Study|Adverse Event|1|||
164368794|NCT03240575|593729330|FG000|Overall Study|Withdrawal by Subject|2|||
164368795|NCT03240575|593729331|FG001|Overall Study|Withdrawal by Subject|11|||
164368796|NCT03240575|593729332|FG002|Overall Study|Withdrawal by Subject|0|||
164368797|NCT03240575|593729333|FG003|Overall Study|Withdrawal by Subject|1|||
164368798|NCT03240575|593729330|FG000|Overall Study|Other|0|||
164368799|NCT03240575|593729331|FG001|Overall Study|Other|1|||
164368800|NCT03240575|593729332|FG002|Overall Study|Other|0|||
164368801|NCT03240575|593729333|FG003|Overall Study|Other|0|||
164368802|NCT04482179|593729334|FG000|Overall Study|Death|1|||
164368803|NCT04482179|593729335|FG001|Overall Study|Death|0|||
164368804|NCT04482179|593729334|FG000|Overall Study|Withdrawal by Subject|1|||
164368805|NCT04482179|593729335|FG001|Overall Study|Withdrawal by Subject|0|||
164368806|NCT04127786|593729338|FG000|Primary Series|Adverse Event|1|||
164368807|NCT04127786|593729339|FG001|Primary Series|Adverse Event|0|||
164368808|NCT04127786|593729340|FG002|Primary Series|Adverse Event|0|||
164368809|NCT04127786|593729341|FG003|Primary Series|Adverse Event|1|||
164368810|NCT04127786|593729342|FG004|Primary Series|Adverse Event|0|||
164368811|NCT04127786|593729343|FG005|Primary Series|Adverse Event|1|||
164368812|NCT04127786|593729338|FG000|Primary Series|Protocol Violation|5|||
164368813|NCT04127786|593729339|FG001|Primary Series|Protocol Violation|3|||
164368814|NCT04127786|593729340|FG002|Primary Series|Protocol Violation|4|||
164368815|NCT04127786|593729341|FG003|Primary Series|Protocol Violation|3|||
164368816|NCT04127786|593729342|FG004|Primary Series|Protocol Violation|2|||
164368817|NCT04127786|593729343|FG005|Primary Series|Protocol Violation|0|||
164368818|NCT04127786|593729338|FG000|Primary Series|Withdrawal by Subject|0|||
164368819|NCT04127786|593729339|FG001|Primary Series|Withdrawal by Subject|0|||
164368820|NCT04127786|593729340|FG002|Primary Series|Withdrawal by Subject|0|||
164368821|NCT04127786|593729341|FG003|Primary Series|Withdrawal by Subject|1|||
164368822|NCT04127786|593729342|FG004|Primary Series|Withdrawal by Subject|0|||
164368823|NCT04127786|593729343|FG005|Primary Series|Withdrawal by Subject|0|||
164368824|NCT04127786|593729338|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
164368825|NCT04127786|593729339|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
164368826|NCT04127786|593729340|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
164368827|NCT04127786|593729341|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
164368828|NCT04127786|593729342|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
164368829|NCT04127786|593729343|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
164368830|NCT04127786|593729338|FG000|Booster Phase|Withdrawal by Subject|2|||
164368831|NCT04127786|593729339|FG001|Booster Phase|Withdrawal by Subject|0|||
164368832|NCT04127786|593729340|FG002|Booster Phase|Withdrawal by Subject|0|||
164368833|NCT04127786|593729341|FG003|Booster Phase|Withdrawal by Subject|0|||
164368834|NCT04127786|593729342|FG004|Booster Phase|Withdrawal by Subject|0|||
164368835|NCT04127786|593729343|FG005|Booster Phase|Withdrawal by Subject|0|||
164368836|NCT03034954|593729344|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
164368837|NCT03034954|593729345|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
164368838|NCT03568942|593729350|FG000|Overall Study|Family emergency|1|||
164368839|NCT03568942|593729350|FG000|Overall Study|Lost to Follow-up|1|||
164368840|NCT04145895|593729356|FG000|Overall Study|Physician Decision|2|||
164368841|NCT04145895|593729357|FG001|Overall Study|Physician Decision|0|||
164368842|NCT04145895|593729356|FG000|Overall Study|Withdrawal by Subject|0|||
164591317|NCT02279524|594528338|FG000|Overall Study|Lost to Follow-up|1|||
164591318|NCT02279524|594528339|FG001|Overall Study|Lost to Follow-up|1|||
164368843|NCT04145895|593729357|FG001|Overall Study|Withdrawal by Subject|2|||
164368844|NCT00913744|593729358|FG000|Overall Study|Adverse Event|2|||
164368845|NCT00913744|593729359|FG001|Overall Study|Adverse Event|0|||
164368846|NCT00913744|593729358|FG000|Overall Study|Withdrawal by Subject|2|||
164368847|NCT00913744|593729359|FG001|Overall Study|Withdrawal by Subject|1|||
164368848|NCT00913744|593729358|FG000|Overall Study|Death|1|||
164368849|NCT00913744|593729359|FG001|Overall Study|Death|0|||
164368850|NCT00805935|593729360|FG000|Overall Study|Stimulation Failure|1|||
164368851|NCT00805935|593729361|FG001|Overall Study|Stimulation Failure|5|||
164368852|NCT00805935|593729362|FG002|Overall Study|Stimulation Failure|2|||
164368853|NCT00805935|593729363|FG003|Overall Study|Stimulation Failure|2|||
164591319|NCT02279524|594528340|FG002|Overall Study|Lost to Follow-up|0|||
164591320|NCT02279524|594528338|FG000|Overall Study|Disallowed medication|1|||
164591321|NCT02279524|594528339|FG001|Overall Study|Disallowed medication|1|||
164591322|NCT02279524|594528340|FG002|Overall Study|Disallowed medication|2|||
164591323|NCT02279524|594528338|FG000|Overall Study|Bariatric surgery|1|||
164591324|NCT02279524|594528339|FG001|Overall Study|Bariatric surgery|0|||
164591325|NCT02279524|594528340|FG002|Overall Study|Bariatric surgery|0|||
164591326|NCT01043185|594528341|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
164368854|NCT00805935|593729360|FG000|Overall Study|Cycle cancelled|0|||
164368855|NCT00805935|593729361|FG001|Overall Study|Cycle cancelled|0|||
164368856|NCT00805935|593729362|FG002|Overall Study|Cycle cancelled|2|||
164368857|NCT00805935|593729363|FG003|Overall Study|Cycle cancelled|0|||
164368858|NCT00805935|593729360|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
164368859|NCT00805935|593729361|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
164368860|NCT00805935|593729362|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
164368861|NCT00805935|593729363|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
164368862|NCT00805935|593729360|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
164368863|NCT00805935|593729361|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
164368864|NCT00805935|593729362|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
164368865|NCT00805935|593729363|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
164368866|NCT00805935|593729360|FG000|Overall Study|Lost to Follow-up|1|||
164368867|NCT00805935|593729361|FG001|Overall Study|Lost to Follow-up|0|||
164368868|NCT00805935|593729362|FG002|Overall Study|Lost to Follow-up|0|||
164368869|NCT00805935|593729363|FG003|Overall Study|Lost to Follow-up|0|||
164368870|NCT00805935|593729360|FG000|Overall Study|No positive serum pregnancy|8|||
164368871|NCT00805935|593729361|FG001|Overall Study|No positive serum pregnancy|7|||
164368872|NCT00805935|593729362|FG002|Overall Study|No positive serum pregnancy|6|||
164368873|NCT00805935|593729363|FG003|Overall Study|No positive serum pregnancy|5|||
164368874|NCT00805935|593729360|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
164368875|NCT00805935|593729361|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
164368876|NCT00805935|593729362|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
164368877|NCT00805935|593729363|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
164368878|NCT00805935|593729360|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
164368879|NCT00805935|593729361|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
164368880|NCT00805935|593729362|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
164368881|NCT00805935|593729363|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
164368882|NCT00805935|593729360|FG000|Overall Study|Biochemical pregnancy|0|||
164368883|NCT00805935|593729361|FG001|Overall Study|Biochemical pregnancy|1|||
164368884|NCT00805935|593729362|FG002|Overall Study|Biochemical pregnancy|0|||
164368885|NCT00805935|593729363|FG003|Overall Study|Biochemical pregnancy|0|||
164368886|NCT00805935|593729360|FG000|Overall Study|Chemical pregnancy|0|||
164368887|NCT00805935|593729361|FG001|Overall Study|Chemical pregnancy|5|||
164368888|NCT00805935|593729362|FG002|Overall Study|Chemical pregnancy|3|||
164368889|NCT00805935|593729363|FG003|Overall Study|Chemical pregnancy|2|||
164368890|NCT00805935|593729360|FG000|Overall Study|Ectopic pregnancy|0|||
164368891|NCT00805935|593729361|FG001|Overall Study|Ectopic pregnancy|0|||
164368892|NCT00805935|593729362|FG002|Overall Study|Ectopic pregnancy|1|||
164368893|NCT00805935|593729363|FG003|Overall Study|Ectopic pregnancy|0|||
164368894|NCT00805935|593729360|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
164368895|NCT00805935|593729361|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
164368896|NCT00805935|593729362|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
164368897|NCT00805935|593729363|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
164368898|NCT00283439|593729364|FG000|Overall Study|Adverse Event|0|||
164368899|NCT00283439|593729365|FG001|Overall Study|Adverse Event|0|||
164368900|NCT00283439|593729366|FG002|Overall Study|Adverse Event|0|||
164368901|NCT00283439|593729367|FG003|Overall Study|Adverse Event|1|||
164368902|NCT00283439|593729364|FG000|Overall Study|Death|0|||
164438749|NCT01235949|593973066|FG011|Primary Phase|Migrated/moved from study area|0|||
164438750|NCT01235949|593973067|FG012|Primary Phase|Migrated/moved from study area|0|||
164438751|NCT01235949|593973068|FG013|Primary Phase|Migrated/moved from study area|0|||
164438752|NCT01235949|593973069|FG014|Primary Phase|Migrated/moved from study area|0|||
164438753|NCT01235949|593973070|FG015|Primary Phase|Migrated/moved from study area|0|||
164438754|NCT01235949|593973071|FG016|Primary Phase|Migrated/moved from study area|0|||
164438755|NCT01235949|593973072|FG017|Primary Phase|Migrated/moved from study area|0|||
164438756|NCT01235949|593973055|FG000|Primary Phase|Adverse Event|0|||
164438757|NCT01235949|593973056|FG001|Primary Phase|Adverse Event|0|||
164438758|NCT01235949|593973057|FG002|Primary Phase|Adverse Event|0|||
164438759|NCT01235949|593973058|FG003|Primary Phase|Adverse Event|1|||
164438760|NCT01235949|593973059|FG004|Primary Phase|Adverse Event|0|||
164591327|NCT01043185|594528342|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
164438761|NCT01235949|593973060|FG005|Primary Phase|Adverse Event|0|||
164438762|NCT01235949|593973061|FG006|Primary Phase|Adverse Event|0|||
164368903|NCT00283439|593729365|FG001|Overall Study|Death|0|||
164368904|NCT00283439|593729366|FG002|Overall Study|Death|1|||
164368905|NCT00283439|593729367|FG003|Overall Study|Death|0|||
164368906|NCT00283439|593729364|FG000|Overall Study|Disease progression|0|||
164368907|NCT00283439|593729365|FG001|Overall Study|Disease progression|1|||
164368908|NCT00283439|593729366|FG002|Overall Study|Disease progression|0|||
164368909|NCT00283439|593729367|FG003|Overall Study|Disease progression|0|||
164368910|NCT00283439|593729364|FG000|Overall Study|Requirement for alternative therapy|1|||
164368911|NCT00283439|593729365|FG001|Overall Study|Requirement for alternative therapy|2|||
164368912|NCT00283439|593729366|FG002|Overall Study|Requirement for alternative therapy|5|||
164368913|NCT00283439|593729367|FG003|Overall Study|Requirement for alternative therapy|2|||
164368914|NCT00283439|593729364|FG000|Overall Study|Stem cell transplant|6|||
164368915|NCT00283439|593729365|FG001|Overall Study|Stem cell transplant|6|||
164368916|NCT00283439|593729366|FG002|Overall Study|Stem cell transplant|4|||
164368917|NCT00283439|593729367|FG003|Overall Study|Stem cell transplant|3|||
164368918|NCT00283439|593729364|FG000|Overall Study|Treatment discontinued|0|||
164368919|NCT00283439|593729365|FG001|Overall Study|Treatment discontinued|2|||
164368920|NCT00283439|593729366|FG002|Overall Study|Treatment discontinued|1|||
164368921|NCT00283439|593729367|FG003|Overall Study|Treatment discontinued|3|||
164368922|NCT00283439|593729364|FG000|Overall Study|Other|1|||
164368923|NCT00283439|593729365|FG001|Overall Study|Other|0|||
164368924|NCT00283439|593729366|FG002|Overall Study|Other|0|||
164368925|NCT00283439|593729367|FG003|Overall Study|Other|0|||
164368926|NCT01539226|593729368|FG000|Overall Study|Withdrawal by Subject|24|||
164368927|NCT01539226|593729369|FG001|Overall Study|Withdrawal by Subject|54|||
164368928|NCT01539226|593729368|FG000|Overall Study|Lost to Follow-up|20|||
164368929|NCT01539226|593729369|FG001|Overall Study|Lost to Follow-up|54|||
164368930|NCT01539226|593729368|FG000|Overall Study|Death|1|||
164368931|NCT01539226|593729369|FG001|Overall Study|Death|2|||
164368932|NCT01539226|593729368|FG000|Overall Study|Adverse Event|2|||
164368933|NCT01539226|593729369|FG001|Overall Study|Adverse Event|0|||
164368934|NCT01539226|593729368|FG000|Overall Study|Pregnancy|13|||
164368935|NCT01539226|593729369|FG001|Overall Study|Pregnancy|29|||
164368936|NCT01539226|593729368|FG000|Overall Study|inappropriate enrollment|0|||
164368937|NCT01539226|593729369|FG001|Overall Study|inappropriate enrollment|1|||
164368938|NCT01539226|593729368|FG000|Overall Study|Multiple Reasons|3|||
164368939|NCT01539226|593729369|FG001|Overall Study|Multiple Reasons|1|||
164368940|NCT01539226|593729368|FG000|Overall Study|not HIV seroconversion-related|93|||
164368941|NCT01539226|593729369|FG001|Overall Study|not HIV seroconversion-related|176|||
164368942|NCT01539226|593729368|FG000|Overall Study|HIV seroconversion-related|55|||
164368943|NCT01539226|593729369|FG001|Overall Study|HIV seroconversion-related|80|||
164368944|NCT01539226|593729368|FG000|Overall Study|Non-compliance|6|||
164368945|NCT01539226|593729369|FG001|Overall Study|Non-compliance|8|||
164368946|NCT01218516|593729370|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
164368947|NCT01218516|593729371|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
164368948|NCT01218516|593729372|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
164368949|NCT01218516|593729373|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
164368950|NCT01218516|593729370|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
164368951|NCT01218516|593729371|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
164368952|NCT01218516|593729372|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
164368953|NCT01218516|593729373|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
164368954|NCT01218516|593729370|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
164368955|NCT01218516|593729371|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
164368956|NCT01218516|593729372|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
164368957|NCT01218516|593729373|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
164368958|NCT01218516|593729370|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
164368959|NCT01218516|593729371|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
164368960|NCT01218516|593729372|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
164368961|NCT01218516|593729373|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
164368962|NCT01218516|593729370|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
164368963|NCT01218516|593729371|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
164368964|NCT01218516|593729372|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
164700200|NCT02655016|594924908|FG000|Overall Study|Withdrawal by Subject|18|||
164368965|NCT01218516|593729373|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
164368966|NCT01218516|593729370|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
164368967|NCT01218516|593729371|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
164368968|NCT01218516|593729372|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
164368969|NCT01218516|593729373|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
164368970|NCT01218516|593729370|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
164368971|NCT01218516|593729371|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
164368972|NCT01218516|593729372|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
164368973|NCT01218516|593729373|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
164368974|NCT01218516|593729370|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
164368975|NCT01218516|593729371|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
164368976|NCT01218516|593729372|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
164700201|NCT02655016|594924909|FG001|Overall Study|Withdrawal by Subject|36|||
164368977|NCT01218516|593729373|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
164368978|NCT01218516|593729370|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
164700202|NCT00952276|594924914|FG000|Overall Study|Withdrawal by Subject|1|||
164700203|NCT00952276|594924915|FG001|Overall Study|Withdrawal by Subject|0|||
164368979|NCT01218516|593729371|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
164368980|NCT01218516|593729372|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
164368981|NCT01218516|593729373|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
164368982|NCT01218516|593729370|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
164368983|NCT01218516|593729371|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
164368984|NCT01218516|593729372|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
164368985|NCT01218516|593729373|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
164368986|NCT01218516|593729370|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
164368987|NCT01218516|593729371|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
164368988|NCT01218516|593729372|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
164368989|NCT01218516|593729373|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
164368990|NCT01218516|593729370|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
164368991|NCT01218516|593729371|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
164368992|NCT01218516|593729372|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
164368993|NCT01218516|593729373|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
164368994|NCT01632891|593729374|FG000|Overall Study|Lost to Follow-up|0|||
164368995|NCT01632891|593729375|FG001|Overall Study|Lost to Follow-up|1|||
164368996|NCT01632891|593729374|FG000|Overall Study|Withdrawal by Subject|1|||
164368997|NCT01632891|593729375|FG001|Overall Study|Withdrawal by Subject|0|||
164368998|NCT00240071|593729376|FG000|Overall Study|Withdrawal by Subject|3|||
164368999|NCT04206293|593729389|FG000|Overall Study|Consent withdrawal|1|||
164369000|NCT03325166|593729394|FG000|Overall Study|Adverse Event|1|||
164369001|NCT00782210|593729398|FG000|Overall Study|Adverse Event|21|||
164369002|NCT00782210|593729399|FG001|Overall Study|Adverse Event|17|||
164369003|NCT00782210|593729400|FG002|Overall Study|Adverse Event|16|||
164369004|NCT00782210|593729398|FG000|Overall Study|Lost to Follow-up|2|||
164369005|NCT00782210|593729399|FG001|Overall Study|Lost to Follow-up|1|||
164369006|NCT00782210|593729400|FG002|Overall Study|Lost to Follow-up|2|||
164369007|NCT00782210|593729398|FG000|Overall Study|Withdrawal by Subject|11|||
164369008|NCT00782210|593729399|FG001|Overall Study|Withdrawal by Subject|8|||
164369009|NCT00782210|593729400|FG002|Overall Study|Withdrawal by Subject|11|||
164369010|NCT00782210|593729398|FG000|Overall Study|Non compliance with protocol|0|||
164369011|NCT00782210|593729399|FG001|Overall Study|Non compliance with protocol|3|||
164369012|NCT00782210|593729400|FG002|Overall Study|Non compliance with protocol|2|||
164369013|NCT00782210|593729398|FG000|Overall Study|Lack of Efficacy|13|||
164369014|NCT00782210|593729399|FG001|Overall Study|Lack of Efficacy|4|||
164369015|NCT00782210|593729400|FG002|Overall Study|Lack of Efficacy|1|||
164369016|NCT00782210|593729398|FG000|Overall Study|Other reason not described above|3|||
164369017|NCT00782210|593729399|FG001|Overall Study|Other reason not described above|2|||
164369018|NCT00782210|593729400|FG002|Overall Study|Other reason not described above|3|||
164369019|NCT01610791|593729405|FG000|Overall Study|Lost to Follow-up|7|||
164369020|NCT01610791|593729405|FG000|Overall Study|Adverse Event|6|||
164369021|NCT01610791|593729405|FG000|Overall Study|Physician Decision|1|||
164369022|NCT01610791|593729405|FG000|Overall Study|Adverse event and Investigator decision|1|||
164369023|NCT01610791|593729405|FG000|Overall Study|Death|1|||
164369024|NCT01610791|593729405|FG000|Overall Study|Not determined|5|||
164369025|NCT05923229|593729408|FG000|Overall Study|Withdrawal by Subject|3|||
164369026|NCT05923229|593729409|FG001|Overall Study|Withdrawal by Subject|0|||
164369027|NCT05923229|593729408|FG000|Overall Study|Health related|2|||
164369028|NCT05923229|593729409|FG001|Overall Study|Health related|1|||
164369029|NCT04304001|593729410|FG000|Overall Study|Lost to Follow-up|13|||
164369030|NCT04304001|593729411|FG001|Overall Study|Lost to Follow-up|9|||
164369031|NCT04164901|593729412|FG000|Overall Study|Withdrawal by Subject|4|||
164369032|NCT04164901|593729413|FG001|Overall Study|Withdrawal by Subject|4|||
164369033|NCT02465528|593729414|FG000|Overall Study|Progressive disease|0|||
164369034|NCT02465528|593729415|FG001|Overall Study|Progressive disease|2|||
164369035|NCT02465528|593729416|FG002|Overall Study|Progressive disease|9|||
164369036|NCT02465528|593729417|FG003|Overall Study|Progressive disease|4|||
164369037|NCT02465528|593729414|FG000|Overall Study|Study terminated by sponsor|1|||
164369038|NCT02465528|593729415|FG001|Overall Study|Study terminated by sponsor|2|||
164369039|NCT02465528|593729416|FG002|Overall Study|Study terminated by sponsor|0|||
164438763|NCT01235949|593973062|FG007|Primary Phase|Adverse Event|0|||
164438764|NCT01235949|593973063|FG008|Primary Phase|Adverse Event|0|||
164369040|NCT02465528|593729417|FG003|Overall Study|Study terminated by sponsor|0|||
164369041|NCT02465528|593729414|FG000|Overall Study|Withdrawal by Subject|0|||
164369042|NCT02465528|593729415|FG001|Overall Study|Withdrawal by Subject|0|||
164369043|NCT02465528|593729416|FG002|Overall Study|Withdrawal by Subject|2|||
164369044|NCT02465528|593729417|FG003|Overall Study|Withdrawal by Subject|0|||
164369045|NCT02465528|593729414|FG000|Overall Study|Adverse Event|0|||
164369046|NCT02465528|593729415|FG001|Overall Study|Adverse Event|0|||
164369047|NCT02465528|593729416|FG002|Overall Study|Adverse Event|0|||
164369048|NCT02465528|593729417|FG003|Overall Study|Adverse Event|1|||
164369049|NCT02465528|593729414|FG000|Overall Study|Physician Decision|0|||
164438765|NCT01235949|593973064|FG009|Primary Phase|Adverse Event|0|||
164369050|NCT02465528|593729415|FG001|Overall Study|Physician Decision|0|||
164369051|NCT02465528|593729416|FG002|Overall Study|Physician Decision|1|||
164369052|NCT02465528|593729417|FG003|Overall Study|Physician Decision|0|||
164369053|NCT05358821|593729418|FG000|Overall Study|Withdrawal by Subject|0|||
164369054|NCT05358821|593729419|FG001|Overall Study|Withdrawal by Subject|1|||
164369055|NCT05358821|593729420|FG002|Overall Study|Withdrawal by Subject|0|||
164369056|NCT05358821|593729418|FG000|Overall Study|Withdrawal of Consent|0|||
164369057|NCT05358821|593729419|FG001|Overall Study|Withdrawal of Consent|0|||
164369058|NCT05358821|593729420|FG002|Overall Study|Withdrawal of Consent|1|||
164369059|NCT04627064|593729423|FG000|Overall Study|Progressive disease|8|||
164369060|NCT04627064|593729424|FG001|Overall Study|Progressive disease|0|||
164369061|NCT04627064|593729423|FG000|Overall Study|Withdrawal by Subject|2|||
164369062|NCT04627064|593729424|FG001|Overall Study|Withdrawal by Subject|0|||
164369063|NCT04627064|593729423|FG000|Overall Study|Physician Decision|1|||
164369064|NCT04627064|593729424|FG001|Overall Study|Physician Decision|0|||
164369065|NCT02086110|593729428|FG000|Overall Study|Withdrawal by Subject|1|||
164369066|NCT02086110|593729429|FG001|Overall Study|Withdrawal by Subject|1|||
164369067|NCT01869192|593729430|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
164369068|NCT01869192|593729431|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
164369069|NCT01869192|593729430|FG000|Postoperative Chemotherapy|Physician Decision|0|||
164369070|NCT01869192|593729431|FG001|Postoperative Chemotherapy|Physician Decision|2|||
164369071|NCT02286193|593729434|FG000|Overall Study|Referred: CRS unable to make contact|62|||
164369072|NCT02286193|593729434|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
164369073|NCT02286193|593729434|FG000|Overall Study|Referred: Declined service|38|||
164369074|NCT00423891|593729435|FG000|Enrolled|Withdrawal by Subject|0|||
164369075|NCT00423891|593729436|FG001|Enrolled|Withdrawal by Subject|0|||
164369076|NCT00423891|593729437|FG002|Enrolled|Withdrawal by Subject|1|||
164369077|NCT00423891|593729435|FG000|Enrolled|Lost to Follow-up|0|||
164369078|NCT00423891|593729436|FG001|Enrolled|Lost to Follow-up|0|||
164369079|NCT00423891|593729437|FG002|Enrolled|Lost to Follow-up|1|||
164369080|NCT00423891|593729435|FG000|Enrolled|No longer met criteria|11|||
164369081|NCT00423891|593729436|FG001|Enrolled|No longer met criteria|2|||
164369082|NCT00423891|593729437|FG002|Enrolled|No longer met criteria|1|||
164369083|NCT00423891|593729435|FG000|Treatment|Withdrawal by Subject|1|||
164369084|NCT00423891|593729436|FG001|Treatment|Withdrawal by Subject|0|||
164369085|NCT00423891|593729437|FG002|Treatment|Withdrawal by Subject|0|||
164369086|NCT00423891|593729435|FG000|Treatment|Lost to Follow-up|1|||
164369087|NCT00423891|593729436|FG001|Treatment|Lost to Follow-up|0|||
164369088|NCT00423891|593729437|FG002|Treatment|Lost to Follow-up|0|||
164369089|NCT00423891|593729435|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
164369090|NCT00423891|593729436|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
164369091|NCT00423891|593729437|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
164369092|NCT00423891|593729435|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
164369093|NCT00423891|593729436|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
164369094|NCT00423891|593729437|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
164369095|NCT01907828|593729442|FG000|Overall Study|Exclusion criteria not met|0|||
164369096|NCT01907828|593729443|FG001|Overall Study|Exclusion criteria not met|1|||
164369097|NCT01907828|593729442|FG000|Overall Study|Withdrawal by Subject|3|||
164369098|NCT01907828|593729443|FG001|Overall Study|Withdrawal by Subject|4|||
164369099|NCT01907828|593729442|FG000|Overall Study|Lost to Follow-up|3|||
164369100|NCT01907828|593729443|FG001|Overall Study|Lost to Follow-up|0|||
164369101|NCT01907828|593729442|FG000|Overall Study|Participant refused 24-month follow-up|1|||
164369102|NCT01907828|593729443|FG001|Overall Study|Participant refused 24-month follow-up|0|||
164369103|NCT01907828|593729442|FG000|Overall Study|Participant met exclusion criteria|0|||
164369104|NCT01907828|593729443|FG001|Overall Study|Participant met exclusion criteria|1|||
164369105|NCT01073865|593729444|FG000|Overall Study|Reasons other than below|19|||
164369106|NCT01073865|593729445|FG001|Overall Study|Reasons other than below|31|||
164369107|NCT01073865|593729444|FG000|Overall Study|Lost to Follow-up|1|||
164369108|NCT01073865|593729445|FG001|Overall Study|Lost to Follow-up|1|||
164369109|NCT01073865|593729444|FG000|Overall Study|Death|3|||
164369110|NCT01073865|593729445|FG001|Overall Study|Death|2|||
164369111|NCT01073865|593729444|FG000|Overall Study|Withdrawal by Subject|5|||
164369112|NCT01073865|593729445|FG001|Overall Study|Withdrawal by Subject|5|||
164369113|NCT03925324|593729446|FG000|Overall Study|Death|1|||
164369114|NCT03925324|593729447|FG001|Overall Study|Death|1|||
164369115|NCT00696137|593729451|FG000|Overall Study|Withdrawal by Subject|2|||
164369116|NCT02197806|593729459|FG000|Overall Study|Adverse Event|0|||
164369117|NCT02197806|593729460|FG001|Overall Study|Adverse Event|1|||
164369118|NCT02197806|593729461|FG002|Overall Study|Adverse Event|0|||
164369119|NCT02197806|593729462|FG003|Overall Study|Adverse Event|1|||
164369120|NCT00680901|593729463|FG000|Overall Study|Ongoing: On Study Treatment|1|||
164369121|NCT00680901|593729464|FG001|Overall Study|Ongoing: On Study Treatment|0|||
164369122|NCT00680901|593729463|FG000|Overall Study|Ongoing: In Follow Up|1|||
164369123|NCT00680901|593729464|FG001|Overall Study|Ongoing: In Follow Up|0|||
164369124|NCT00680901|593729463|FG000|Overall Study|Adverse Event|1|||
164369125|NCT00680901|593729464|FG001|Overall Study|Adverse Event|1|||
164369126|NCT00680901|593729463|FG000|Overall Study|Lost to Follow-up|3|||
164369127|NCT00680901|593729464|FG001|Overall Study|Lost to Follow-up|5|||
164369128|NCT00680901|593729463|FG000|Overall Study|Subject decided to withdraw from the study|4|||
164369129|NCT00680901|593729464|FG001|Overall Study|Subject decided to withdraw from the study|15|||
164369130|NCT00680901|593729463|FG000|Overall Study|Sponsor decision|1|||
164369131|NCT00680901|593729464|FG001|Overall Study|Sponsor decision|0|||
164369132|NCT00680901|593729463|FG000|Overall Study|Physician Decision|0|||
164369133|NCT00680901|593729464|FG001|Overall Study|Physician Decision|2|||
164369134|NCT00680901|593729463|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
164369135|NCT00680901|593729464|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
164369136|NCT00680901|593729463|FG000|Overall Study|Other protocol defined stopping criteria|17|||
164369137|NCT00680901|593729464|FG001|Overall Study|Other protocol defined stopping criteria|17|||
164369138|NCT04251221|593729467|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
164369139|NCT04251221|593729468|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
164369140|NCT02120794|593729471|FG000|Overall Study|Withdrawal by Subject|43|||
164369141|NCT02120794|593729471|FG000|Overall Study|Adverse Event|10|||
164369142|NCT02120794|593729471|FG000|Overall Study|Physician Decision|4|||
164369143|NCT02120794|593729471|FG000|Overall Study|Due to insurance coverage|1|||
164369144|NCT01148511|593729472|FG000|Exposed to Study Drug|Protocol Violation|2|||
164369145|NCT01148511|593729473|FG001|Exposed to Study Drug|Protocol Violation|0|||
164369146|NCT01148511|593729474|FG002|Exposed to Study Drug|Protocol Violation|0|||
164369147|NCT01148511|593729472|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
164369148|NCT01148511|593729473|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
164369149|NCT01148511|593729474|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
164369150|NCT01148511|593729472|FG000|Randomized|Adverse Event|0|||
164369151|NCT01148511|593729473|FG001|Randomized|Adverse Event|1|||
164369152|NCT01148511|593729474|FG002|Randomized|Adverse Event|0|||
164369153|NCT01148511|593729472|FG000|Randomized|Protocol Violation|0|||
164369154|NCT01148511|593729473|FG001|Randomized|Protocol Violation|2|||
164369155|NCT01148511|593729474|FG002|Randomized|Protocol Violation|1|||
164369156|NCT01148511|593729472|FG000|Randomized|Lost to Follow-up|0|||
164369157|NCT01148511|593729473|FG001|Randomized|Lost to Follow-up|1|||
164369158|NCT01148511|593729474|FG002|Randomized|Lost to Follow-up|1|||
164369159|NCT01148511|593729472|FG000|Randomized|Consent withdrawal|0|||
164369160|NCT01148511|593729473|FG001|Randomized|Consent withdrawal|5|||
164369161|NCT01148511|593729474|FG002|Randomized|Consent withdrawal|3|||
164369162|NCT01148511|593729472|FG000|Randomized|Other|0|||
164369163|NCT01148511|593729473|FG001|Randomized|Other|1|||
164369164|NCT01148511|593729474|FG002|Randomized|Other|1|||
164369165|NCT00969553|593729483|FG000|Overall Study|Progressive disease (PD)|2|||
164369166|NCT00969553|593729484|FG001|Overall Study|Progressive disease (PD)|2|||
164369167|NCT00969553|593729485|FG002|Overall Study|Progressive disease (PD)|6|||
164369168|NCT00969553|593729486|FG003|Overall Study|Progressive disease (PD)|9|||
164369169|NCT00969553|593729487|FG004|Overall Study|Progressive disease (PD)|2|||
164369170|NCT00969553|593729488|FG005|Overall Study|Progressive disease (PD)|4|||
164369171|NCT00969553|593729489|FG006|Overall Study|Progressive disease (PD)|2|||
164369172|NCT00969553|593729490|FG007|Overall Study|Progressive disease (PD)|12|||
164369173|NCT00969553|593729491|FG008|Overall Study|Progressive disease (PD)|3|||
164369174|NCT00969553|593729483|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
164369175|NCT00969553|593729484|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
164369176|NCT00969553|593729485|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
164369177|NCT00969553|593729486|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
164369178|NCT00969553|593729487|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
164369179|NCT00969553|593729488|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
164369180|NCT00969553|593729489|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
164369181|NCT00969553|593729490|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
164369182|NCT00969553|593729491|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
164369183|NCT00969553|593729483|FG000|Overall Study|Other Adverse Event|0|||
164369184|NCT00969553|593729484|FG001|Overall Study|Other Adverse Event|0|||
164369185|NCT00969553|593729485|FG002|Overall Study|Other Adverse Event|0|||
164700204|NCT00952276|594924916|FG002|Overall Study|Withdrawal by Subject|0|||
164700205|NCT00952276|594924917|FG003|Overall Study|Withdrawal by Subject|1|||
164700206|NCT00952276|594924918|FG004|Overall Study|Withdrawal by Subject|0|||
164700207|NCT03959527|594926782|FG000|Overall Study|Withdrawal by Subject|8|||
164369186|NCT00969553|593729486|FG003|Overall Study|Other Adverse Event|1|||
164369187|NCT00969553|593729487|FG004|Overall Study|Other Adverse Event|0|||
164369188|NCT00969553|593729488|FG005|Overall Study|Other Adverse Event|0|||
164369189|NCT00969553|593729489|FG006|Overall Study|Other Adverse Event|1|||
164369190|NCT00969553|593729490|FG007|Overall Study|Other Adverse Event|0|||
164369191|NCT00969553|593729491|FG008|Overall Study|Other Adverse Event|0|||
164369192|NCT00969553|593729483|FG000|Overall Study|Refused cont. medication|1|||
164369193|NCT00969553|593729484|FG001|Overall Study|Refused cont. medication|1|||
164369194|NCT00969553|593729485|FG002|Overall Study|Refused cont. medication|0|||
164369195|NCT00969553|593729486|FG003|Overall Study|Refused cont. medication|2|||
164369196|NCT00969553|593729487|FG004|Overall Study|Refused cont. medication|0|||
164369197|NCT00969553|593729488|FG005|Overall Study|Refused cont. medication|0|||
164369198|NCT00969553|593729489|FG006|Overall Study|Refused cont. medication|0|||
164369199|NCT00969553|593729490|FG007|Overall Study|Refused cont. medication|1|||
164369200|NCT00969553|593729491|FG008|Overall Study|Refused cont. medication|0|||
164369201|NCT00969553|593729483|FG000|Overall Study|Not specified above|0|||
164369202|NCT00969553|593729484|FG001|Overall Study|Not specified above|0|||
164369203|NCT00969553|593729485|FG002|Overall Study|Not specified above|0|||
164369204|NCT00969553|593729486|FG003|Overall Study|Not specified above|4|||
164369205|NCT00969553|593729487|FG004|Overall Study|Not specified above|0|||
164369206|NCT00969553|593729488|FG005|Overall Study|Not specified above|0|||
164369207|NCT00969553|593729489|FG006|Overall Study|Not specified above|1|||
164369208|NCT00969553|593729490|FG007|Overall Study|Not specified above|1|||
164369209|NCT00969553|593729491|FG008|Overall Study|Not specified above|0|||
164369210|NCT04243538|593729492|FG000|Overall Study|Withdrawal by Subject|0|||
164369211|NCT04243538|593729493|FG001|Overall Study|Withdrawal by Subject|2|||
164369212|NCT04243538|593729492|FG000|Overall Study|Lost to Follow-up|0|||
164369213|NCT04243538|593729493|FG001|Overall Study|Lost to Follow-up|3|||
164369214|NCT04536727|593729494|FG000|Overall Study|Lost to Follow-up|1|||
164369215|NCT04536727|593729495|FG001|Overall Study|Lost to Follow-up|1|||
164369216|NCT04536727|593729494|FG000|Overall Study|Death|0|||
164369217|NCT04536727|593729495|FG001|Overall Study|Death|1|||
164369218|NCT00500370|593729496|FG000|Overall Study|Adverse Event|9|||
164700208|NCT03959527|594926783|FG001|Overall Study|Withdrawal by Subject|3|||
164700209|NCT03959527|594926782|FG000|Overall Study|Lost to Follow-up|31|||
164700210|NCT03959527|594926783|FG001|Overall Study|Lost to Follow-up|15|||
164700211|NCT03959527|594926782|FG000|Overall Study|Did not meet eligibility criteria|1|||
164369219|NCT00500370|593729497|FG001|Overall Study|Adverse Event|3|||
164369220|NCT00500370|593729496|FG000|Overall Study|Lost to Follow-up|10|||
164369221|NCT00500370|593729497|FG001|Overall Study|Lost to Follow-up|10|||
164369222|NCT00500370|593729496|FG000|Overall Study|Protocol Violation|2|||
164369223|NCT00500370|593729497|FG001|Overall Study|Protocol Violation|4|||
164369224|NCT00500370|593729496|FG000|Overall Study|Sponsor Decision|2|||
164369225|NCT00500370|593729497|FG001|Overall Study|Sponsor Decision|0|||
164369226|NCT00500370|593729496|FG000|Overall Study|Subject Decision|10|||
164369227|NCT00500370|593729497|FG001|Overall Study|Subject Decision|17|||
164369228|NCT05308901|593731210|FG000|Overall Study|Death|6|||
164369229|NCT02586012|593731211|FG000|Overall Study|Withdrawal by Subject|1|||
164369230|NCT02586012|593731212|FG001|Overall Study|Withdrawal by Subject|1|||
164369231|NCT02586012|593731213|FG002|Overall Study|Withdrawal by Subject|0|||
164369232|NCT02586012|593731214|FG003|Overall Study|Withdrawal by Subject|1|||
164369233|NCT02586012|593731215|FG004|Overall Study|Withdrawal by Subject|0|||
164369234|NCT02586012|593731216|FG005|Overall Study|Withdrawal by Subject|2|||
164369235|NCT02586012|593731211|FG000|Overall Study|Protocol Violation|0|||
164369236|NCT02586012|593731212|FG001|Overall Study|Protocol Violation|0|||
164369237|NCT02586012|593731213|FG002|Overall Study|Protocol Violation|0|||
164369238|NCT02586012|593731214|FG003|Overall Study|Protocol Violation|0|||
164369239|NCT02586012|593731215|FG004|Overall Study|Protocol Violation|0|||
164369240|NCT02586012|593731216|FG005|Overall Study|Protocol Violation|1|||
164369241|NCT02586012|593731211|FG000|Overall Study|study terminated|0|||
164369242|NCT02586012|593731212|FG001|Overall Study|study terminated|2|||
164369243|NCT02586012|593731213|FG002|Overall Study|study terminated|1|||
164369244|NCT02586012|593731214|FG003|Overall Study|study terminated|1|||
164369245|NCT02586012|593731215|FG004|Overall Study|study terminated|1|||
164369246|NCT02586012|593731216|FG005|Overall Study|study terminated|0|||
164369247|NCT01816139|593731218|FG000|Overall Study|Adverse Event|6|||
164369248|NCT01816139|593731219|FG001|Overall Study|Adverse Event|8|||
164369249|NCT01816139|593731218|FG000|Overall Study|Lack of Efficacy|1|||
164369250|NCT01816139|593731219|FG001|Overall Study|Lack of Efficacy|2|||
164369251|NCT01816139|593731218|FG000|Overall Study|Lost to Follow-up|5|||
164369252|NCT01816139|593731219|FG001|Overall Study|Lost to Follow-up|3|||
164700212|NCT03959527|594926783|FG001|Overall Study|Did not meet eligibility criteria|1|||
164369253|NCT01816139|593731218|FG000|Overall Study|Withdrew Consent|6|||
164369254|NCT01816139|593731219|FG001|Overall Study|Withdrew Consent|4|||
164369255|NCT01816139|593731218|FG000|Overall Study|Protocol Violation|6|||
164369256|NCT01816139|593731219|FG001|Overall Study|Protocol Violation|3|||
164369257|NCT01816139|593731218|FG000|Overall Study|Reason not Specified|4|||
164369258|NCT01816139|593731219|FG001|Overall Study|Reason not Specified|2|||
164369259|NCT01572038|593731220|FG000|Overall Study|Death|648|||
164369260|NCT01572038|593731220|FG000|Overall Study|Withdrawal by Subject|204|||
164369261|NCT01572038|593731220|FG000|Overall Study|Lost to Follow-up|81|||
164369262|NCT01572038|593731220|FG000|Overall Study|Physician Decision|20|||
164369263|NCT01572038|593731220|FG000|Overall Study|Patient Decision|14|||
164369264|NCT01572038|593731220|FG000|Overall Study|Progressive Disease|8|||
164438766|NCT01235949|593973065|FG010|Primary Phase|Adverse Event|0|||
164369265|NCT01572038|593731220|FG000|Overall Study|Site Closed Before Completing Form|6|||
164369266|NCT01572038|593731220|FG000|Overall Study|Enrolled into Another Trial|3|||
164369267|NCT01572038|593731220|FG000|Overall Study|Participated in Another Trial|3|||
164369268|NCT01572038|593731220|FG000|Overall Study|Termination by Sponsor|2|||
164369269|NCT01572038|593731220|FG000|Overall Study|Patient Deterioration|1|||
164369270|NCT01572038|593731220|FG000|Overall Study|Sponsor Decision|1|||
164369271|NCT02554656|593731221|FG000|Overall Study|Protocol Violation|3|||
164369272|NCT01888497|593731222|FG000|Washout Period 1|Withdrawal by Subject|0|||
164369273|NCT01888497|593731223|FG001|Washout Period 1|Withdrawal by Subject|0|||
164369274|NCT01888497|593731224|FG002|Washout Period 1|Withdrawal by Subject|1|||
164369275|NCT01888497|593731225|FG003|Washout Period 1|Withdrawal by Subject|1|||
164369276|NCT01888497|593731222|FG000|Washout Period 2|Adverse Event|0|||
164369277|NCT01888497|593731223|FG001|Washout Period 2|Adverse Event|0|||
164369278|NCT01888497|593731224|FG002|Washout Period 2|Adverse Event|0|||
164369279|NCT01888497|593731225|FG003|Washout Period 2|Adverse Event|1|||
164369280|NCT01888497|593731222|FG000|Washout Period 2|Withdrawal by Subject|0|||
164369281|NCT01888497|593731223|FG001|Washout Period 2|Withdrawal by Subject|0|||
164369282|NCT01888497|593731224|FG002|Washout Period 2|Withdrawal by Subject|0|||
164369283|NCT01888497|593731225|FG003|Washout Period 2|Withdrawal by Subject|1|||
164369284|NCT01140477|593731228|FG000|Overall Study|Lost to Follow-up|4|||
164369285|NCT01140477|593731229|FG001|Overall Study|Lost to Follow-up|0|||
164369286|NCT01140477|593731228|FG000|Overall Study|Withdrawal by Subject|1|||
164369287|NCT01140477|593731229|FG001|Overall Study|Withdrawal by Subject|4|||
164369288|NCT01140477|593731228|FG000|Overall Study|Surgical complication preventing implant|2|||
164369289|NCT01140477|593731229|FG001|Overall Study|Surgical complication preventing implant|0|||
164369290|NCT01140477|593731228|FG000|Overall Study|Death|1|||
164369291|NCT01140477|593731229|FG001|Overall Study|Death|1|||
164369292|NCT01140477|593731228|FG000|Overall Study|Subject explanted|0|||
164369293|NCT01140477|593731229|FG001|Overall Study|Subject explanted|1|||
164369294|NCT04013191|593731230|FG000|Overall Study|Adverse Event|1|||
164369295|NCT04013191|593731231|FG001|Overall Study|Adverse Event|0|||
164369296|NCT01904604|593731234|FG000|Overall Study|Withdrew before receiving dosing|0|||
164369297|NCT01904604|593731235|FG001|Overall Study|Withdrew before receiving dosing|1|||
164369298|NCT01904604|593731236|FG002|Overall Study|Withdrew before receiving dosing|0|||
164369299|NCT01904604|593731234|FG000|Overall Study|Non-compliance|1|||
164369300|NCT01904604|593731235|FG001|Overall Study|Non-compliance|0|||
164369301|NCT01904604|593731236|FG002|Overall Study|Non-compliance|0|||
164369302|NCT01904604|593731234|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
164369303|NCT01904604|593731235|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
164369304|NCT01904604|593731236|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
164369305|NCT01904604|593731234|FG000|Overall Study|Patch site reactions|1|||
164369306|NCT01904604|593731235|FG001|Overall Study|Patch site reactions|1|||
164369307|NCT01904604|593731236|FG002|Overall Study|Patch site reactions|0|||
164369308|NCT01904604|593731234|FG000|Overall Study|Increased syncope|0|||
164369309|NCT01904604|593731235|FG001|Overall Study|Increased syncope|1|||
164369310|NCT01904604|593731236|FG002|Overall Study|Increased syncope|0|||
164369311|NCT01904604|593731234|FG000|Overall Study|Unrelated illness|0|||
164369312|NCT01904604|593731235|FG001|Overall Study|Unrelated illness|1|||
164369313|NCT01904604|593731236|FG002|Overall Study|Unrelated illness|0|||
164369314|NCT01904604|593731234|FG000|Overall Study|Passed Week 52 OFC|1|||
164369315|NCT01904604|593731235|FG001|Overall Study|Passed Week 52 OFC|0|||
164369316|NCT01904604|593731236|FG002|Overall Study|Passed Week 52 OFC|0|||
164369317|NCT01904604|593731234|FG000|Overall Study|Withdrawal by Subject|1|||
164369318|NCT01904604|593731235|FG001|Overall Study|Withdrawal by Subject|2|||
164369319|NCT01904604|593731236|FG002|Overall Study|Withdrawal by Subject|0|||
164369320|NCT01904604|593731234|FG000|Overall Study|Participant Relocated|1|||
164369321|NCT01904604|593731235|FG001|Overall Study|Participant Relocated|1|||
164369322|NCT01904604|593731236|FG002|Overall Study|Participant Relocated|1|||
164369323|NCT01904604|593731234|FG000|Overall Study|Lost to Follow-up|0|||
164369324|NCT01904604|593731235|FG001|Overall Study|Lost to Follow-up|0|||
164369325|NCT01904604|593731236|FG002|Overall Study|Lost to Follow-up|1|||
164369326|NCT04144166|593731240|FG000|Overall Study|Discharged before study start|1|||
164369327|NCT04144166|593731240|FG000|Overall Study|Pregnancy|1|||
164369328|NCT04144166|593731240|FG000|Overall Study|Nail polish could not be removed from finger|1|||
164438767|NCT01235949|593973066|FG011|Primary Phase|Adverse Event|0|||
164369329|NCT01236755|593731242|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
164369330|NCT01236755|593731242|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
164369331|NCT01236755|593731242|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
164369332|NCT01236755|593731242|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
164369333|NCT01481116|593731243|FG000|Overall Study|Adverse Event|26|||
164438768|NCT01235949|593973067|FG012|Primary Phase|Adverse Event|0|||
164438769|NCT01235949|593973068|FG013|Primary Phase|Adverse Event|0|||
164438770|NCT01235949|593973069|FG014|Primary Phase|Adverse Event|0|||
164438771|NCT01235949|593973070|FG015|Primary Phase|Adverse Event|0|||
164700213|NCT03959527|594926782|FG000|Overall Study|Protocol Violation|10|||
164369334|NCT01481116|593731244|FG001|Overall Study|Adverse Event|26|||
164369335|NCT01481116|593731245|FG002|Overall Study|Adverse Event|42|||
164369336|NCT01481116|593731243|FG000|Overall Study|Major Protocol Deviation|3|||
164369337|NCT01481116|593731244|FG001|Overall Study|Major Protocol Deviation|7|||
164369338|NCT01481116|593731245|FG002|Overall Study|Major Protocol Deviation|1|||
164369339|NCT01481116|593731243|FG000|Overall Study|Lost to Follow-up|8|||
164369340|NCT01481116|593731244|FG001|Overall Study|Lost to Follow-up|12|||
164438772|NCT01235949|593973071|FG016|Primary Phase|Adverse Event|0|||
164369341|NCT01481116|593731245|FG002|Overall Study|Lost to Follow-up|11|||
164369342|NCT01481116|593731243|FG000|Overall Study|Withdrawal by Subject|37|||
164369343|NCT01481116|593731244|FG001|Overall Study|Withdrawal by Subject|33|||
164369344|NCT01481116|593731245|FG002|Overall Study|Withdrawal by Subject|37|||
164369345|NCT01481116|593731243|FG000|Overall Study|Study Termination|730|||
164369346|NCT01481116|593731244|FG001|Overall Study|Study Termination|729|||
164369347|NCT01481116|593731245|FG002|Overall Study|Study Termination|713|||
164369348|NCT01481116|593731243|FG000|Overall Study|Pregnancy|0|||
164369349|NCT01481116|593731244|FG001|Overall Study|Pregnancy|0|||
164369350|NCT01481116|593731245|FG002|Overall Study|Pregnancy|1|||
164438773|NCT01235949|593973072|FG017|Primary Phase|Adverse Event|0|||
164438774|NCT01235949|593973055|FG000|Primary Phase|Withdrawal by Subject|3|||
164438775|NCT01235949|593973056|FG001|Primary Phase|Withdrawal by Subject|2|||
164438776|NCT01235949|593973057|FG002|Primary Phase|Withdrawal by Subject|2|||
164438777|NCT01235949|593973058|FG003|Primary Phase|Withdrawal by Subject|0|||
164438778|NCT01235949|593973059|FG004|Primary Phase|Withdrawal by Subject|0|||
164438779|NCT01235949|593973060|FG005|Primary Phase|Withdrawal by Subject|3|||
164438780|NCT01235949|593973061|FG006|Primary Phase|Withdrawal by Subject|0|||
164438781|NCT01235949|593973062|FG007|Primary Phase|Withdrawal by Subject|0|||
164438782|NCT01235949|593973063|FG008|Primary Phase|Withdrawal by Subject|0|||
164438783|NCT01235949|593973064|FG009|Primary Phase|Withdrawal by Subject|0|||
164438784|NCT01235949|593973065|FG010|Primary Phase|Withdrawal by Subject|0|||
164438785|NCT01235949|593973066|FG011|Primary Phase|Withdrawal by Subject|0|||
164438786|NCT01235949|593973067|FG012|Primary Phase|Withdrawal by Subject|0|||
164438787|NCT01235949|593973068|FG013|Primary Phase|Withdrawal by Subject|0|||
164438788|NCT01235949|593973069|FG014|Primary Phase|Withdrawal by Subject|0|||
164438789|NCT01235949|593973070|FG015|Primary Phase|Withdrawal by Subject|0|||
164438790|NCT01235949|593973071|FG016|Primary Phase|Withdrawal by Subject|0|||
164438791|NCT01235949|593973072|FG017|Primary Phase|Withdrawal by Subject|0|||
164438792|NCT01235949|593973055|FG000|Primary Phase|Lost to Follow-up|0|||
164438793|NCT01235949|593973056|FG001|Primary Phase|Lost to Follow-up|0|||
164438794|NCT01235949|593973057|FG002|Primary Phase|Lost to Follow-up|1|||
164438795|NCT01235949|593973058|FG003|Primary Phase|Lost to Follow-up|1|||
164438796|NCT01235949|593973059|FG004|Primary Phase|Lost to Follow-up|0|||
164438797|NCT01235949|593973060|FG005|Primary Phase|Lost to Follow-up|2|||
164438798|NCT01235949|593973061|FG006|Primary Phase|Lost to Follow-up|0|||
164438799|NCT01235949|593973062|FG007|Primary Phase|Lost to Follow-up|0|||
164438800|NCT01235949|593973063|FG008|Primary Phase|Lost to Follow-up|0|||
164438801|NCT01235949|593973064|FG009|Primary Phase|Lost to Follow-up|0|||
164438802|NCT01235949|593973065|FG010|Primary Phase|Lost to Follow-up|0|||
164438803|NCT01235949|593973066|FG011|Primary Phase|Lost to Follow-up|0|||
164438804|NCT01235949|593973067|FG012|Primary Phase|Lost to Follow-up|0|||
164438805|NCT01235949|593973068|FG013|Primary Phase|Lost to Follow-up|0|||
164438806|NCT01235949|593973069|FG014|Primary Phase|Lost to Follow-up|0|||
164438807|NCT01235949|593973070|FG015|Primary Phase|Lost to Follow-up|0|||
164438808|NCT01235949|593973071|FG016|Primary Phase|Lost to Follow-up|0|||
164438809|NCT01235949|593973072|FG017|Primary Phase|Lost to Follow-up|0|||
164438810|NCT01235949|593973055|FG000|Booster Phase|Migrated/moved from study area|0|||
164438811|NCT01235949|593973056|FG001|Booster Phase|Migrated/moved from study area|0|||
164438812|NCT01235949|593973057|FG002|Booster Phase|Migrated/moved from study area|0|||
164438813|NCT01235949|593973058|FG003|Booster Phase|Migrated/moved from study area|0|||
164438814|NCT01235949|593973059|FG004|Booster Phase|Migrated/moved from study area|0|||
164438815|NCT01235949|593973060|FG005|Booster Phase|Migrated/moved from study area|0|||
164438816|NCT01235949|593973061|FG006|Booster Phase|Migrated/moved from study area|0|||
164438817|NCT01235949|593973062|FG007|Booster Phase|Migrated/moved from study area|0|||
164438818|NCT01235949|593973063|FG008|Booster Phase|Migrated/moved from study area|0|||
164438819|NCT01235949|593973064|FG009|Booster Phase|Migrated/moved from study area|0|||
164438820|NCT01235949|593973065|FG010|Booster Phase|Migrated/moved from study area|0|||
164700214|NCT03959527|594926783|FG001|Overall Study|Protocol Violation|5|||
164700215|NCT06029959|594926784|FG000|Overall Study|Physician Decision|6|||
164700216|NCT02960893|594926789|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
164700217|NCT02960893|594926790|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
164438821|NCT01235949|593973066|FG011|Booster Phase|Migrated/moved from study area|1|||
164438822|NCT01235949|593973067|FG012|Booster Phase|Migrated/moved from study area|1|||
164438823|NCT01235949|593973068|FG013|Booster Phase|Migrated/moved from study area|0|||
164438824|NCT01235949|593973069|FG014|Booster Phase|Migrated/moved from study area|0|||
164438825|NCT01235949|593973070|FG015|Booster Phase|Migrated/moved from study area|0|||
164438826|NCT01235949|593973071|FG016|Booster Phase|Migrated/moved from study area|0|||
164438827|NCT01235949|593973072|FG017|Booster Phase|Migrated/moved from study area|1|||
164700218|NCT02960893|594926791|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
164700219|NCT02960893|594926792|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
164369351|NCT01481116|593731243|FG000|Overall Study|Lack of Efficacy|3|||
164369352|NCT01481116|593731244|FG001|Overall Study|Lack of Efficacy|3|||
164369353|NCT01481116|593731245|FG002|Overall Study|Lack of Efficacy|1|||
164438828|NCT01235949|593973055|FG000|Booster Phase|Adverse Event|0|||
164438829|NCT01235949|593973056|FG001|Booster Phase|Adverse Event|0|||
164369354|NCT01481116|593731243|FG000|Overall Study|Contraindications|1|||
164369355|NCT01481116|593731244|FG001|Overall Study|Contraindications|1|||
164369356|NCT01481116|593731245|FG002|Overall Study|Contraindications|0|||
164369357|NCT01481116|593731243|FG000|Overall Study|Other|1|||
164369358|NCT01481116|593731244|FG001|Overall Study|Other|1|||
164369359|NCT01481116|593731245|FG002|Overall Study|Other|0|||
164369360|NCT01481116|593731243|FG000|Overall Study|Participant Started Taking Glipizide|1|||
164369361|NCT01481116|593731244|FG001|Overall Study|Participant Started Taking Glipizide|0|||
164369362|NCT01481116|593731245|FG002|Overall Study|Participant Started Taking Glipizide|0|||
164369363|NCT01481116|593731243|FG000|Overall Study|Participant Moved Out of Area|2|||
164369364|NCT01481116|593731244|FG001|Overall Study|Participant Moved Out of Area|0|||
164369365|NCT01481116|593731245|FG002|Overall Study|Participant Moved Out of Area|1|||
164369366|NCT01481116|593731243|FG000|Overall Study|Participant Moved Out of Country|1|||
164369367|NCT01481116|593731244|FG001|Overall Study|Participant Moved Out of Country|0|||
164369368|NCT01481116|593731245|FG002|Overall Study|Participant Moved Out of Country|1|||
164369369|NCT01481116|593731243|FG000|Overall Study|Investigator Decision|3|||
164369370|NCT01481116|593731244|FG001|Overall Study|Investigator Decision|2|||
164369371|NCT01481116|593731245|FG002|Overall Study|Investigator Decision|1|||
164369372|NCT01481116|593731243|FG000|Overall Study|Sponsor Decision|0|||
164369373|NCT01481116|593731244|FG001|Overall Study|Sponsor Decision|1|||
164369374|NCT01481116|593731245|FG002|Overall Study|Sponsor Decision|3|||
164369375|NCT01481116|593731243|FG000|Overall Study|Non-Compliant With Study Drug|0|||
164369376|NCT01481116|593731244|FG001|Overall Study|Non-Compliant With Study Drug|1|||
164369377|NCT01481116|593731245|FG002|Overall Study|Non-Compliant With Study Drug|1|||
164369378|NCT01481116|593731243|FG000|Overall Study|Investigator's Discretion|2|||
164369379|NCT01481116|593731244|FG001|Overall Study|Investigator's Discretion|0|||
164369380|NCT01481116|593731245|FG002|Overall Study|Investigator's Discretion|0|||
164369381|NCT01481116|593731243|FG000|Overall Study|Death|2|||
164369382|NCT01481116|593731244|FG001|Overall Study|Death|1|||
164369383|NCT01481116|593731245|FG002|Overall Study|Death|0|||
164369384|NCT01481116|593731243|FG000|Overall Study|Hypoglycemic Event|4|||
164369385|NCT01481116|593731244|FG001|Overall Study|Hypoglycemic Event|0|||
164369386|NCT01481116|593731245|FG002|Overall Study|Hypoglycemic Event|0|||
164369387|NCT03848845|593731246|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
164369388|NCT03848845|593731247|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
164369389|NCT03848845|593731248|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
164369390|NCT03848845|593731249|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
164369391|NCT03848845|593731246|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
164369392|NCT03848845|593731247|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
164369393|NCT03848845|593731248|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
164369394|NCT03848845|593731249|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
164369395|NCT03848845|593731246|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
164369396|NCT03848845|593731247|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
164369397|NCT03848845|593731248|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
164369398|NCT03848845|593731249|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
164369399|NCT03848845|593731246|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
164369400|NCT03848845|593731247|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
164369401|NCT03848845|593731248|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
164369402|NCT03848845|593731249|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
164369403|NCT02433834|593731251|FG000|Overall Study|Protocol-specified criteria|7|||
164369404|NCT02433834|593731251|FG000|Overall Study|Protocol Violation|3|||
164369405|NCT02433834|593731251|FG000|Overall Study|Lost to Follow-up|6|||
164369406|NCT02433834|593731251|FG000|Overall Study|Withdrawal by Subject|14|||
164369407|NCT02433834|593731251|FG000|Overall Study|Adverse Event|6|||
164369408|NCT02433834|593731251|FG000|Overall Study|Physician Decision|1|||
164369409|NCT02821962|593731252|FG000|Overall Study|Lost to Follow-up|2|||
164369410|NCT02821962|593731253|FG001|Overall Study|Lost to Follow-up|0|||
164369411|NCT04098458|593731258|FG000|Overall Study|Death|1|||
164369412|NCT04098458|593731258|FG000|Overall Study|did not meet study inclusion criteria|3|||
164438830|NCT01235949|593973057|FG002|Booster Phase|Adverse Event|0|||
164369413|NCT02272413|593731263|FG000|Randomized Through Treatment Start|Not treated|3|||
164369414|NCT02272413|593731264|FG001|Randomized Through Treatment Start|Not treated|5|||
164144029|NCT00086281|592888583|FG012|Phase 1|Serious Adverse Event|0|||
164369415|NCT02272413|593731263|FG000|Pre-switch Period|Adverse Event|38|||
164369416|NCT02272413|593731264|FG001|Pre-switch Period|Adverse Event|37|||
164369417|NCT02272413|593731263|FG000|Pre-switch Period|Death|26|||
164369418|NCT02272413|593731264|FG001|Pre-switch Period|Death|26|||
164369419|NCT02272413|593731263|FG000|Pre-switch Period|Withdrawal by Subject|27|||
164369420|NCT02272413|593731264|FG001|Pre-switch Period|Withdrawal by Subject|15|||
164369421|NCT02272413|593731263|FG000|Pre-switch Period|Physician Decision|6|||
164369422|NCT02272413|593731264|FG001|Pre-switch Period|Physician Decision|18|||
164369423|NCT02272413|593731263|FG000|Pre-switch Period|Progressive disease|185|||
164369424|NCT02272413|593731264|FG001|Pre-switch Period|Progressive disease|173|||
164369425|NCT02272413|593731263|FG000|Pre-switch Period|Lost to Follow-up|0|||
164369426|NCT02272413|593731264|FG001|Pre-switch Period|Lost to Follow-up|2|||
164369427|NCT02272413|593731263|FG000|Pre-switch Period|Protocol Violation|1|||
164369428|NCT02272413|593731264|FG001|Pre-switch Period|Protocol Violation|0|||
164369429|NCT02272413|593731263|FG000|Pre-switch Period|Other than listed|10|||
164369430|NCT02272413|593731264|FG001|Pre-switch Period|Other than listed|11|||
164369431|NCT02272413|593731263|FG000|Post-switch Period|Adverse Event|4|||
164369432|NCT02272413|593731264|FG001|Post-switch Period|Adverse Event|4|||
164369433|NCT02272413|593731263|FG000|Post-switch Period|Death|3|||
164369434|NCT02272413|593731264|FG001|Post-switch Period|Death|2|||
164369435|NCT02272413|593731263|FG000|Post-switch Period|Withdrawal by Subject|1|||
164369436|NCT02272413|593731264|FG001|Post-switch Period|Withdrawal by Subject|2|||
164369437|NCT02272413|593731263|FG000|Post-switch Period|Physician Decision|1|||
164369438|NCT02272413|593731264|FG001|Post-switch Period|Physician Decision|1|||
164369439|NCT02272413|593731263|FG000|Post-switch Period|Progressive disease|21|||
164369440|NCT02272413|593731264|FG001|Post-switch Period|Progressive disease|21|||
164369441|NCT02272413|593731263|FG000|Post-switch Period|Study terminated by sponsor|8|||
164369442|NCT02272413|593731264|FG001|Post-switch Period|Study terminated by sponsor|11|||
164369443|NCT02272413|593731263|FG000|Post-switch Period|Other than listed|4|||
164700220|NCT02960893|594926789|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
164369444|NCT02272413|593731264|FG001|Post-switch Period|Other than listed|5|||
164369445|NCT04327999|593731265|FG000|Overall Study|Protocol Violation|1|||
164369446|NCT02872116|593731266|FG000|Pre-Treatment|Disease Progression|0|||
164369447|NCT02872116|593731267|FG001|Pre-Treatment|Disease Progression|1|||
164369448|NCT02872116|593731268|FG002|Pre-Treatment|Disease Progression|0|||
164369449|NCT02872116|593731266|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
164369450|NCT02872116|593731267|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
164369451|NCT02872116|593731268|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
164369452|NCT02872116|593731266|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
164369453|NCT02872116|593731267|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
164369454|NCT02872116|593731268|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
164369455|NCT02872116|593731266|FG000|Pre-Treatment|Participant withdrew consent|2|||
164369456|NCT02872116|593731267|FG001|Pre-Treatment|Participant withdrew consent|20|||
164369457|NCT02872116|593731268|FG002|Pre-Treatment|Participant withdrew consent|3|||
164369458|NCT02872116|593731266|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
164369459|NCT02872116|593731267|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
164369460|NCT02872116|593731268|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
164369461|NCT02872116|593731266|FG000|Pre-Treatment|Other reasons|1|||
164369462|NCT02872116|593731267|FG001|Pre-Treatment|Other reasons|2|||
164369463|NCT02872116|593731268|FG002|Pre-Treatment|Other reasons|2|||
164369464|NCT02872116|593731266|FG000|Treatment|Death|121|||
164369465|NCT02872116|593731267|FG001|Treatment|Death|94|||
164369466|NCT02872116|593731268|FG002|Treatment|Death|68|||
164369467|NCT02872116|593731266|FG000|Treatment|Lost to Follow-up|5|||
164369468|NCT02872116|593731267|FG001|Treatment|Lost to Follow-up|7|||
164369469|NCT02872116|593731268|FG002|Treatment|Lost to Follow-up|3|||
164369470|NCT02872116|593731266|FG000|Treatment|Participant withdrew consent|20|||
164369471|NCT02872116|593731267|FG001|Treatment|Participant withdrew consent|40|||
164369472|NCT02872116|593731268|FG002|Treatment|Participant withdrew consent|8|||
164369473|NCT02872116|593731266|FG000|Treatment|Other reasons|13|||
164369474|NCT02872116|593731267|FG001|Treatment|Other reasons|12|||
164438831|NCT01235949|593973058|FG003|Booster Phase|Adverse Event|0|||
164438832|NCT01235949|593973059|FG004|Booster Phase|Adverse Event|0|||
164700221|NCT02960893|594926790|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
164700222|NCT02960893|594926791|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
164700223|NCT02960893|594926792|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
164369475|NCT02872116|593731268|FG002|Treatment|Other reasons|5|||
164369476|NCT03792672|593731273|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
164369477|NCT03792672|593731274|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
164369478|NCT03792672|593731275|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
164369479|NCT03792672|593731276|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
164369480|NCT03792672|593731277|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
164369481|NCT03792672|593731278|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
164369482|NCT03792672|593731273|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
164369483|NCT03792672|593731274|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
164369484|NCT03792672|593731275|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
164369485|NCT03792672|593731276|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
164369486|NCT03792672|593731277|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
164369487|NCT03792672|593731278|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
164438833|NCT01235949|593973060|FG005|Booster Phase|Adverse Event|0|||
164369488|NCT03792672|593731273|FG000|Treatment Period 4 (2 Days)|Other|1|||
164369489|NCT03792672|593731274|FG001|Treatment Period 4 (2 Days)|Other|0|||
164369490|NCT03792672|593731275|FG002|Treatment Period 4 (2 Days)|Other|0|||
164369491|NCT03792672|593731276|FG003|Treatment Period 4 (2 Days)|Other|0|||
164369492|NCT03792672|593731277|FG004|Treatment Period 4 (2 Days)|Other|0|||
164369493|NCT03792672|593731278|FG005|Treatment Period 4 (2 Days)|Other|0|||
164369494|NCT00453999|593731279|FG000|Overall Study|Adverse Event|1|||
164369495|NCT00453999|593731280|FG001|Overall Study|Adverse Event|2|||
164369496|NCT00453999|593731281|FG002|Overall Study|Adverse Event|1|||
164438834|NCT01235949|593973061|FG006|Booster Phase|Adverse Event|0|||
164438835|NCT01235949|593973062|FG007|Booster Phase|Adverse Event|0|||
164438836|NCT01235949|593973063|FG008|Booster Phase|Adverse Event|0|||
164438837|NCT01235949|593973064|FG009|Booster Phase|Adverse Event|0|||
164438838|NCT01235949|593973065|FG010|Booster Phase|Adverse Event|0|||
164438839|NCT01235949|593973066|FG011|Booster Phase|Adverse Event|0|||
164438840|NCT01235949|593973067|FG012|Booster Phase|Adverse Event|0|||
164438841|NCT01235949|593973068|FG013|Booster Phase|Adverse Event|0|||
164438842|NCT01235949|593973069|FG014|Booster Phase|Adverse Event|0|||
164438843|NCT01235949|593973070|FG015|Booster Phase|Adverse Event|1|||
164438844|NCT01235949|593973071|FG016|Booster Phase|Adverse Event|0|||
164438845|NCT01235949|593973072|FG017|Booster Phase|Adverse Event|0|||
164438846|NCT01235949|593973055|FG000|Booster Phase|Withdrawal by Subject|0|||
164438847|NCT01235949|593973056|FG001|Booster Phase|Withdrawal by Subject|0|||
164438848|NCT01235949|593973057|FG002|Booster Phase|Withdrawal by Subject|0|||
164438849|NCT01235949|593973058|FG003|Booster Phase|Withdrawal by Subject|0|||
164438850|NCT01235949|593973059|FG004|Booster Phase|Withdrawal by Subject|0|||
164438851|NCT01235949|593973060|FG005|Booster Phase|Withdrawal by Subject|0|||
164591328|NCT01043185|594528343|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
164591329|NCT01043185|594528344|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
164591330|NCT01043185|594528345|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
164591331|NCT01043185|594528346|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
164591332|NCT01043185|594528347|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
164591333|NCT01043185|594528348|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
164591334|NCT01043185|594528349|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
164591335|NCT01043185|594528350|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
164591336|NCT01441440|594528354|FG000|Overall Study|Death|1|||
164591337|NCT01441440|594528355|FG001|Overall Study|Death|0|||
164591338|NCT01441440|594528356|FG002|Overall Study|Death|1|||
164591339|NCT01441440|594528354|FG000|Overall Study|Adverse Event|2|||
164591340|NCT01441440|594528355|FG001|Overall Study|Adverse Event|9|||
164591341|NCT01441440|594528356|FG002|Overall Study|Adverse Event|9|||
164591342|NCT01441440|594528354|FG000|Overall Study|Lost to Follow-up|0|||
164591343|NCT01441440|594528355|FG001|Overall Study|Lost to Follow-up|2|||
164591344|NCT01441440|594528356|FG002|Overall Study|Lost to Follow-up|1|||
164591345|NCT01441440|594528354|FG000|Overall Study|Withdrawal by Subject|11|||
164591346|NCT01441440|594528355|FG001|Overall Study|Withdrawal by Subject|9|||
164591347|NCT01441440|594528356|FG002|Overall Study|Withdrawal by Subject|9|||
164591348|NCT01441440|594528354|FG000|Overall Study|Pregnancy|1|||
164591349|NCT01441440|594528355|FG001|Overall Study|Pregnancy|0|||
164591350|NCT01441440|594528356|FG002|Overall Study|Pregnancy|0|||
164591351|NCT01441440|594528354|FG000|Overall Study|Lack of Efficacy|1|||
164591352|NCT01441440|594528355|FG001|Overall Study|Lack of Efficacy|0|||
164591353|NCT01441440|594528356|FG002|Overall Study|Lack of Efficacy|1|||
164591354|NCT01441440|594528354|FG000|Overall Study|Moving|0|||
164591355|NCT01441440|594528355|FG001|Overall Study|Moving|1|||
164591356|NCT01441440|594528356|FG002|Overall Study|Moving|1|||
164591357|NCT01441440|594528354|FG000|Overall Study|Work-related matter|0|||
164591358|NCT01441440|594528355|FG001|Overall Study|Work-related matter|1|||
164591359|NCT01441440|594528356|FG002|Overall Study|Work-related matter|0|||
164591360|NCT01441440|594528354|FG000|Overall Study|Difficllty in keeping the schedule|1|||
164591361|NCT01441440|594528355|FG001|Overall Study|Difficllty in keeping the schedule|1|||
164591362|NCT01441440|594528356|FG002|Overall Study|Difficllty in keeping the schedule|0|||
164591363|NCT01993329|594528357|FG000|Period 2|Adverse Event|0|||
164591364|NCT01993329|594528358|FG001|Period 2|Adverse Event|0|||
164591365|NCT01993329|594528359|FG002|Period 2|Adverse Event|0|||
164591366|NCT01993329|594528360|FG003|Period 2|Adverse Event|0|||
164591367|NCT01993329|594528361|FG004|Period 2|Adverse Event|0|||
164591368|NCT01993329|594528362|FG005|Period 2|Adverse Event|1|||
164591369|NCT01993329|594528357|FG000|Wash-out|Personal reasons|0|||
164591370|NCT01993329|594528358|FG001|Wash-out|Personal reasons|1|||
164591371|NCT01993329|594528359|FG002|Wash-out|Personal reasons|0|||
164591372|NCT01993329|594528360|FG003|Wash-out|Personal reasons|0|||
164591373|NCT01993329|594528361|FG004|Wash-out|Personal reasons|0|||
164591374|NCT01993329|594528362|FG005|Wash-out|Personal reasons|0|||
164591375|NCT00883558|594528363|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
164591376|NCT00883558|594528364|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
164591377|NCT00883558|594528365|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
164369497|NCT00453999|593731279|FG000|Overall Study|Lost to Follow-up|0|||
164438852|NCT01235949|593973061|FG006|Booster Phase|Withdrawal by Subject|0|||
164438853|NCT01235949|593973062|FG007|Booster Phase|Withdrawal by Subject|1|||
164438854|NCT01235949|593973063|FG008|Booster Phase|Withdrawal by Subject|1|||
164438855|NCT01235949|593973064|FG009|Booster Phase|Withdrawal by Subject|0|||
164438856|NCT01235949|593973065|FG010|Booster Phase|Withdrawal by Subject|1|||
164438857|NCT01235949|593973066|FG011|Booster Phase|Withdrawal by Subject|1|||
164438858|NCT01235949|593973067|FG012|Booster Phase|Withdrawal by Subject|2|||
164438859|NCT01235949|593973068|FG013|Booster Phase|Withdrawal by Subject|0|||
164438860|NCT01235949|593973069|FG014|Booster Phase|Withdrawal by Subject|2|||
164438861|NCT01235949|593973070|FG015|Booster Phase|Withdrawal by Subject|0|||
164438862|NCT01235949|593973071|FG016|Booster Phase|Withdrawal by Subject|0|||
164438863|NCT01235949|593973072|FG017|Booster Phase|Withdrawal by Subject|0|||
164438864|NCT01235949|593973055|FG000|Booster Phase|Lost to Follow-up|0|||
164700224|NCT02960893|594926789|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
164700225|NCT02960893|594926790|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
164700226|NCT02960893|594926791|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
164700227|NCT02960893|594926792|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
164700228|NCT02960893|594926789|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
164700229|NCT02960893|594926790|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
164700230|NCT02960893|594926791|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
164700231|NCT02960893|594926792|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
164700232|NCT02960893|594926789|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
164369498|NCT00453999|593731280|FG001|Overall Study|Lost to Follow-up|1|||
164369499|NCT00453999|593731281|FG002|Overall Study|Lost to Follow-up|1|||
164369500|NCT00453999|593731279|FG000|Overall Study|Withdrawal by Subject|2|||
164369501|NCT00453999|593731280|FG001|Overall Study|Withdrawal by Subject|1|||
164369502|NCT00453999|593731281|FG002|Overall Study|Withdrawal by Subject|1|||
164369503|NCT00453999|593731279|FG000|Overall Study|Subject Request|2|||
164369504|NCT00453999|593731280|FG001|Overall Study|Subject Request|1|||
164369505|NCT00453999|593731281|FG002|Overall Study|Subject Request|0|||
164369506|NCT04238728|593731284|FG000|Overall Study|Withdrawal by Subject|1|||
164369507|NCT04238728|593731284|FG000|Overall Study|Lost to Follow-up|2|||
164369508|NCT04414553|593731286|FG000|Overall Study|Lost to Follow-up|20|||
164369509|NCT00974571|593731288|FG000|Overall Study|Adverse Event|31|||
164369510|NCT00974571|593731289|FG001|Overall Study|Adverse Event|4|||
164369511|NCT00974571|593731290|FG002|Overall Study|Adverse Event|27|||
164369512|NCT00974571|593731288|FG000|Overall Study|Lack of Efficacy|3|||
164369513|NCT00974571|593731289|FG001|Overall Study|Lack of Efficacy|2|||
164369514|NCT00974571|593731290|FG002|Overall Study|Lack of Efficacy|9|||
164369515|NCT00974571|593731288|FG000|Overall Study|Lost to Follow-up|2|||
164369516|NCT00974571|593731289|FG001|Overall Study|Lost to Follow-up|1|||
164369517|NCT00974571|593731290|FG002|Overall Study|Lost to Follow-up|2|||
164369518|NCT00974571|593731288|FG000|Overall Study|Protocol Violation|13|||
164369519|NCT00974571|593731289|FG001|Overall Study|Protocol Violation|4|||
164369520|NCT00974571|593731290|FG002|Overall Study|Protocol Violation|18|||
164369521|NCT00974571|593731288|FG000|Overall Study|Withdrawal by Subject|14|||
164369522|NCT00974571|593731289|FG001|Overall Study|Withdrawal by Subject|5|||
164369523|NCT00974571|593731290|FG002|Overall Study|Withdrawal by Subject|16|||
164369524|NCT00974571|593731288|FG000|Overall Study|Patient Moved|1|||
164369525|NCT00974571|593731289|FG001|Overall Study|Patient Moved|0|||
164369526|NCT00974571|593731290|FG002|Overall Study|Patient Moved|1|||
164438865|NCT01235949|593973056|FG001|Booster Phase|Lost to Follow-up|0|||
164438866|NCT01235949|593973057|FG002|Booster Phase|Lost to Follow-up|0|||
164438867|NCT01235949|593973058|FG003|Booster Phase|Lost to Follow-up|0|||
164438868|NCT01235949|593973059|FG004|Booster Phase|Lost to Follow-up|0|||
164438869|NCT01235949|593973060|FG005|Booster Phase|Lost to Follow-up|0|||
164700233|NCT02960893|594926790|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
164700234|NCT02960893|594926791|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
164700235|NCT02960893|594926792|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
164700236|NCT02960893|594926789|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
164700237|NCT02960893|594926790|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
164700238|NCT02960893|594926791|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
164700239|NCT02960893|594926792|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
164438870|NCT01235949|593973061|FG006|Booster Phase|Lost to Follow-up|0|||
164369527|NCT00974571|593731288|FG000|Overall Study|Other|4|||
164438871|NCT01235949|593973062|FG007|Booster Phase|Lost to Follow-up|0|||
164369528|NCT00974571|593731289|FG001|Overall Study|Other|0|||
164369529|NCT00974571|593731290|FG002|Overall Study|Other|10|||
164369530|NCT03778931|593731302|FG000|Overall Study|Withdrawal by Subject|12|||
164369531|NCT03778931|593731303|FG001|Overall Study|Withdrawal by Subject|25|||
164369532|NCT03778931|593731302|FG000|Overall Study|Physician Decision|1|||
164369533|NCT03778931|593731303|FG001|Overall Study|Physician Decision|3|||
164369534|NCT03778931|593731302|FG000|Overall Study|Participant Noncompliance|1|||
164369535|NCT03778931|593731303|FG001|Overall Study|Participant Noncompliance|1|||
164369536|NCT03778931|593731302|FG000|Overall Study|Lost to Follow-up|4|||
164369537|NCT03778931|593731303|FG001|Overall Study|Lost to Follow-up|1|||
164369538|NCT03778931|593731302|FG000|Overall Study|Death|69|||
164369539|NCT03778931|593731303|FG001|Overall Study|Death|79|||
164369540|NCT04180020|593731306|FG000|Overall Study|missed visit|18|||
164369541|NCT04180020|593731307|FG001|Overall Study|missed visit|16|||
164369542|NCT04180020|593731306|FG000|Overall Study|Death|2|||
164369543|NCT04180020|593731307|FG001|Overall Study|Death|3|||
164369544|NCT04180020|593731306|FG000|Overall Study|Withdrawal by Subject|1|||
164369545|NCT04180020|593731307|FG001|Overall Study|Withdrawal by Subject|5|||
164369546|NCT04180020|593731306|FG000|Overall Study|incarcerated|1|||
164369547|NCT04180020|593731307|FG001|Overall Study|incarcerated|1|||
164369548|NCT04180020|593731306|FG000|Overall Study|Physician Decision|0|||
164369549|NCT04180020|593731307|FG001|Overall Study|Physician Decision|2|||
164369550|NCT03216850|593731312|FG000|Overall Study|Pre-analytical error|6|||
164369551|NCT03554291|593731315|FG000|Overall Study|Death|2|||
164369552|NCT03554291|593731316|FG001|Overall Study|Death|1|||
164369553|NCT03554291|593731315|FG000|Overall Study|Lost to Follow-up|1|||
164369554|NCT03554291|593731316|FG001|Overall Study|Lost to Follow-up|0|||
164369555|NCT03554291|593731315|FG000|Overall Study|Withdrawal by Subject|1|||
164369556|NCT03554291|593731316|FG001|Overall Study|Withdrawal by Subject|0|||
164369557|NCT03554291|593731315|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
164369558|NCT03554291|593731316|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
164369559|NCT00537381|593731317|FG000|Overall Study|Adverse Event|13|||
164369560|NCT00537381|593731318|FG001|Overall Study|Adverse Event|9|||
164369561|NCT00537381|593731317|FG000|Overall Study|Death|3|||
164369562|NCT00537381|593731318|FG001|Overall Study|Death|3|||
164369563|NCT00537381|593731317|FG000|Overall Study|Withdrawal by Subject|5|||
164369564|NCT00537381|593731318|FG001|Overall Study|Withdrawal by Subject|14|||
164369565|NCT00537381|593731317|FG000|Overall Study|Physician Decision|7|||
164369566|NCT00537381|593731318|FG001|Overall Study|Physician Decision|6|||
164369567|NCT00537381|593731317|FG000|Overall Study|Disease Progression|9|||
164369568|NCT00537381|593731318|FG001|Overall Study|Disease Progression|18|||
164369569|NCT00537381|593731317|FG000|Overall Study|Sponsor decision|14|||
164369570|NCT00537381|593731318|FG001|Overall Study|Sponsor decision|9|||
164369571|NCT00537381|593731317|FG000|Overall Study|Other|5|||
164369572|NCT00537381|593731318|FG001|Overall Study|Other|3|||
164369573|NCT02357940|593731325|FG000|Overall Study|Adverse Event|0|||
164369574|NCT02357940|593731326|FG001|Overall Study|Adverse Event|1|||
164369575|NCT02357940|593731325|FG000|Overall Study|Investigator's judgement|0|||
164369576|NCT02357940|593731326|FG001|Overall Study|Investigator's judgement|1|||
164438872|NCT01235949|593973063|FG008|Booster Phase|Lost to Follow-up|1|||
164438873|NCT01235949|593973064|FG009|Booster Phase|Lost to Follow-up|1|||
164700240|NCT02960893|594926789|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
164700241|NCT02960893|594926790|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
164700242|NCT02960893|594926791|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
164700243|NCT02960893|594926792|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
164700244|NCT02960893|594926789|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
164700245|NCT02960893|594926790|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
164700246|NCT02960893|594926791|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
164700247|NCT02960893|594926792|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
164700248|NCT02960893|594926789|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
164369577|NCT04258605|593731329|FG000|Overall Study|Death|1|||
164438874|NCT01235949|593973065|FG010|Booster Phase|Lost to Follow-up|1|||
164438875|NCT01235949|593973066|FG011|Booster Phase|Lost to Follow-up|1|||
164438876|NCT01235949|593973067|FG012|Booster Phase|Lost to Follow-up|0|||
164438877|NCT01235949|593973068|FG013|Booster Phase|Lost to Follow-up|0|||
164438878|NCT01235949|593973069|FG014|Booster Phase|Lost to Follow-up|0|||
164438879|NCT01235949|593973070|FG015|Booster Phase|Lost to Follow-up|0|||
164438880|NCT01235949|593973071|FG016|Booster Phase|Lost to Follow-up|0|||
164438881|NCT01235949|593973072|FG017|Booster Phase|Lost to Follow-up|1|||
164438882|NCT03743246|593973073|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
164438883|NCT03743246|593973074|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
164700249|NCT02960893|594926790|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
164438884|NCT03743246|593973075|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
164438885|NCT03743246|593973076|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
164369578|NCT04258605|593731330|FG001|Overall Study|Death|0|||
164438886|NCT03743246|593973073|FG000|Pre-Treatment Period|Death|0|||
164369579|NCT04258605|593731329|FG000|Overall Study|Early study termination|21|||
164369580|NCT04258605|593731330|FG001|Overall Study|Early study termination|2|||
164369581|NCT02910167|593731331|FG000|Overall Study|Adverse Event|1|||
164369582|NCT02910167|593731331|FG000|Overall Study|Lost to Follow-up|18|||
164369583|NCT00842348|593731339|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
164369584|NCT00842348|593731340|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
164369585|NCT00842348|593731339|FG000|Study 729|Disease progression/death|19|||
164369586|NCT00842348|593731340|FG001|Study 729|Disease progression/death|30|||
164438887|NCT03743246|593973074|FG001|Pre-Treatment Period|Death|1|||
164369587|NCT00842348|593731339|FG000|Study 729|Adverse Event|1|||
164369588|NCT00842348|593731340|FG001|Study 729|Adverse Event|1|||
164369589|NCT00842348|593731339|FG000|Study 729|Protocol Violation|1|||
164369590|NCT00842348|593731340|FG001|Study 729|Protocol Violation|1|||
164369591|NCT00842348|593731339|FG000|Study 729|Withdrawal by Subject|2|||
164369592|NCT00842348|593731340|FG001|Study 729|Withdrawal by Subject|4|||
164369593|NCT00842348|593731339|FG000|Study 729|Due to Sponsor stopping the study|1|||
164369594|NCT00842348|593731340|FG001|Study 729|Due to Sponsor stopping the study|1|||
164369595|NCT00842348|593731339|FG000|Study 729|Due to non-availability of IP|0|||
164369596|NCT00842348|593731340|FG001|Study 729|Due to non-availability of IP|1|||
164369597|NCT00842348|593731339|FG000|Study 729|Sponsor's decision|1|||
164369598|NCT00842348|593731340|FG001|Study 729|Sponsor's decision|0|||
164369599|NCT00842348|593731339|FG000|Study 729|Surgical resection|1|||
164369600|NCT00842348|593731340|FG001|Study 729|Surgical resection|0|||
164369601|NCT00603746|593731341|FG000|Overall Study|Adverse Event|2|||
164369602|NCT00603746|593731342|FG001|Overall Study|Adverse Event|3|||
164369603|NCT00603746|593731343|FG002|Overall Study|Adverse Event|0|||
164369604|NCT00603746|593731344|FG003|Overall Study|Adverse Event|1|||
164369605|NCT00603746|593731345|FG004|Overall Study|Adverse Event|0|||
164369606|NCT00603746|593731346|FG005|Overall Study|Adverse Event|4|||
164369607|NCT00603746|593731341|FG000|Overall Study|Lack of Efficacy|34|||
164369608|NCT00603746|593731342|FG001|Overall Study|Lack of Efficacy|11|||
164369609|NCT00603746|593731343|FG002|Overall Study|Lack of Efficacy|6|||
164369610|NCT00603746|593731344|FG003|Overall Study|Lack of Efficacy|11|||
164369611|NCT00603746|593731345|FG004|Overall Study|Lack of Efficacy|12|||
164369612|NCT00603746|593731346|FG005|Overall Study|Lack of Efficacy|8|||
164369613|NCT00603746|593731341|FG000|Overall Study|Protocol Violation|0|||
164369614|NCT00603746|593731342|FG001|Overall Study|Protocol Violation|3|||
164369615|NCT00603746|593731343|FG002|Overall Study|Protocol Violation|1|||
164369616|NCT00603746|593731344|FG003|Overall Study|Protocol Violation|0|||
164369617|NCT00603746|593731345|FG004|Overall Study|Protocol Violation|1|||
164369618|NCT00603746|593731346|FG005|Overall Study|Protocol Violation|0|||
164369619|NCT00603746|593731341|FG000|Overall Study|Lost to Follow-up|0|||
164369620|NCT00603746|593731342|FG001|Overall Study|Lost to Follow-up|1|||
164369621|NCT00603746|593731343|FG002|Overall Study|Lost to Follow-up|1|||
164369622|NCT00603746|593731344|FG003|Overall Study|Lost to Follow-up|0|||
164369623|NCT00603746|593731345|FG004|Overall Study|Lost to Follow-up|0|||
164369624|NCT00603746|593731346|FG005|Overall Study|Lost to Follow-up|0|||
164369625|NCT00603746|593731341|FG000|Overall Study|Physician Decision|1|||
164369626|NCT00603746|593731342|FG001|Overall Study|Physician Decision|0|||
164369627|NCT00603746|593731343|FG002|Overall Study|Physician Decision|0|||
164369628|NCT00603746|593731344|FG003|Overall Study|Physician Decision|0|||
164369629|NCT00603746|593731345|FG004|Overall Study|Physician Decision|1|||
164369630|NCT00603746|593731346|FG005|Overall Study|Physician Decision|0|||
164369631|NCT00603746|593731341|FG000|Overall Study|Withdrawal by Subject|1|||
164369632|NCT00603746|593731342|FG001|Overall Study|Withdrawal by Subject|0|||
164369633|NCT00603746|593731343|FG002|Overall Study|Withdrawal by Subject|0|||
164369634|NCT00603746|593731344|FG003|Overall Study|Withdrawal by Subject|1|||
164369635|NCT00603746|593731345|FG004|Overall Study|Withdrawal by Subject|3|||
164369636|NCT00603746|593731346|FG005|Overall Study|Withdrawal by Subject|1|||
164369637|NCT00026793|593731351|FG000|Overall Study|Death on study due to underlying disease|4|||
164369638|NCT00026793|593731351|FG000|Overall Study|Physician Decision|2|||
164369639|NCT00026793|593731351|FG000|Overall Study|Off study|2|||
164369640|NCT01449526|593731352|FG000|Overall Study|Lost to Follow-up|1|||
164369641|NCT01449526|593731353|FG001|Overall Study|Lost to Follow-up|2|||
164369642|NCT01449526|593731352|FG000|Overall Study|Withdrawal by Subject|1|||
164369643|NCT01449526|593731353|FG001|Overall Study|Withdrawal by Subject|1|||
164369644|NCT01449526|593731352|FG000|Overall Study|Symptoms/complaints|0|||
164369645|NCT01449526|593731353|FG001|Overall Study|Symptoms/complaints|1|||
164369646|NCT01449526|593731352|FG000|Overall Study|Lack of Motivation|0|||
164369647|NCT01449526|593731353|FG001|Overall Study|Lack of Motivation|1|||
164369648|NCT01449526|593731352|FG000|Overall Study|Cannot maintain visits|0|||
164369649|NCT01449526|593731353|FG001|Overall Study|Cannot maintain visits|1|||
164369650|NCT01132495|593731354|FG000|Overall Study|Various reasons|40|||
164369651|NCT01132495|593731355|FG001|Overall Study|Various reasons|38|||
164369652|NCT01132495|593731356|FG002|Overall Study|Various reasons|20|||
164369653|NCT01132495|593731357|FG003|Overall Study|Various reasons|12|||
164369654|NCT03913091|593731358|FG000|Overall Study|Lost to Follow-up|18|||
164369655|NCT03913091|593731359|FG001|Overall Study|Lost to Follow-up|11|||
164369656|NCT03913091|593731358|FG000|Overall Study|Required additional meds/surgery|1|||
164700250|NCT02960893|594926791|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
164369657|NCT03913091|593731359|FG001|Overall Study|Required additional meds/surgery|2|||
164369658|NCT03913091|593731358|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
164369659|NCT03913091|593731359|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
164369660|NCT00655564|593731360|FG000|Overall Study|Adverse Event|1|||
164369661|NCT00655564|593731360|FG000|Overall Study|Lost to Follow-up|1|||
164369662|NCT00655564|593731360|FG000|Overall Study|Desired Alternate Therapy|1|||
164369663|NCT01581593|593733333|FG000|Overall Study|Withdrawal by Subject|1|||
164369664|NCT00653224|593733334|FG000|Overall Study|Adverse Event|2|||
164369665|NCT00653224|593733335|FG001|Overall Study|Adverse Event|1|||
164369666|NCT00653224|593733334|FG000|Overall Study|Lack of Efficacy|1|||
164369667|NCT00653224|593733335|FG001|Overall Study|Lack of Efficacy|2|||
164369668|NCT00653224|593733334|FG000|Overall Study|Loss of efficacy|1|||
164369669|NCT00653224|593733335|FG001|Overall Study|Loss of efficacy|0|||
164369670|NCT00653224|593733334|FG000|Overall Study|Lost to Follow-up|1|||
164369671|NCT00653224|593733335|FG001|Overall Study|Lost to Follow-up|0|||
164369672|NCT00653224|593733334|FG000|Overall Study|Other|2|||
164369673|NCT00653224|593733335|FG001|Overall Study|Other|4|||
164369674|NCT03756558|593733336|FG000|Overall Study|Death|1|||
164369675|NCT03756558|593733336|FG000|Overall Study|Lost to Follow-up|2|||
164369676|NCT03756558|593733336|FG000|Overall Study|Withdrawal by Subject|2|||
164369677|NCT02896400|593733337|FG000|1 Month Follow-up|Lost to Follow-up|7|||
164369678|NCT02896400|593733338|FG001|1 Month Follow-up|Lost to Follow-up|7|||
164369679|NCT02896400|593733339|FG002|1 Month Follow-up|Lost to Follow-up|5|||
164369680|NCT02896400|593733340|FG003|1 Month Follow-up|Lost to Follow-up|8|||
164369681|NCT02896400|593733341|FG004|1 Month Follow-up|Lost to Follow-up|9|||
164369682|NCT02896400|593733342|FG005|1 Month Follow-up|Lost to Follow-up|6|||
164369683|NCT02896400|593733343|FG006|1 Month Follow-up|Lost to Follow-up|5|||
164369684|NCT02896400|593733344|FG007|1 Month Follow-up|Lost to Follow-up|6|||
164369685|NCT02896400|593733345|FG008|1 Month Follow-up|Lost to Follow-up|4|||
164369686|NCT02896400|593733346|FG009|1 Month Follow-up|Lost to Follow-up|7|||
164369687|NCT02896400|593733347|FG010|1 Month Follow-up|Lost to Follow-up|5|||
164369688|NCT02896400|593733348|FG011|1 Month Follow-up|Lost to Follow-up|5|||
164369689|NCT02896400|593733349|FG012|1 Month Follow-up|Lost to Follow-up|3|||
164369690|NCT02896400|593733350|FG013|1 Month Follow-up|Lost to Follow-up|4|||
164369691|NCT02896400|593733351|FG014|1 Month Follow-up|Lost to Follow-up|1|||
164369692|NCT02896400|593733352|FG015|1 Month Follow-up|Lost to Follow-up|2|||
164369693|NCT02896400|593733337|FG000|1 Month Follow-up|Death|0|||
164369694|NCT02896400|593733338|FG001|1 Month Follow-up|Death|0|||
164369695|NCT02896400|593733339|FG002|1 Month Follow-up|Death|0|||
164369696|NCT02896400|593733340|FG003|1 Month Follow-up|Death|0|||
164369697|NCT02896400|593733341|FG004|1 Month Follow-up|Death|0|||
164369698|NCT02896400|593733342|FG005|1 Month Follow-up|Death|0|||
164369699|NCT02896400|593733343|FG006|1 Month Follow-up|Death|0|||
164369700|NCT02896400|593733344|FG007|1 Month Follow-up|Death|0|||
164369701|NCT02896400|593733345|FG008|1 Month Follow-up|Death|0|||
164369702|NCT02896400|593733346|FG009|1 Month Follow-up|Death|0|||
164369703|NCT02896400|593733347|FG010|1 Month Follow-up|Death|0|||
164369704|NCT02896400|593733348|FG011|1 Month Follow-up|Death|0|||
164369705|NCT02896400|593733349|FG012|1 Month Follow-up|Death|0|||
164369706|NCT02896400|593733350|FG013|1 Month Follow-up|Death|0|||
164369707|NCT02896400|593733351|FG014|1 Month Follow-up|Death|0|||
164369708|NCT02896400|593733352|FG015|1 Month Follow-up|Death|1|||
164369709|NCT02896400|593733337|FG000|3 Month Follow-up|Lost to Follow-up|6|||
164369710|NCT02896400|593733338|FG001|3 Month Follow-up|Lost to Follow-up|3|||
164369711|NCT02896400|593733339|FG002|3 Month Follow-up|Lost to Follow-up|6|||
164369712|NCT02896400|593733340|FG003|3 Month Follow-up|Lost to Follow-up|11|||
164369713|NCT02896400|593733341|FG004|3 Month Follow-up|Lost to Follow-up|12|||
164369714|NCT02896400|593733342|FG005|3 Month Follow-up|Lost to Follow-up|6|||
164369715|NCT02896400|593733343|FG006|3 Month Follow-up|Lost to Follow-up|4|||
164369716|NCT02896400|593733344|FG007|3 Month Follow-up|Lost to Follow-up|3|||
164369717|NCT02896400|593733345|FG008|3 Month Follow-up|Lost to Follow-up|6|||
164369718|NCT02896400|593733346|FG009|3 Month Follow-up|Lost to Follow-up|5|||
164369719|NCT02896400|593733347|FG010|3 Month Follow-up|Lost to Follow-up|6|||
164369720|NCT02896400|593733348|FG011|3 Month Follow-up|Lost to Follow-up|6|||
164369721|NCT02896400|593733349|FG012|3 Month Follow-up|Lost to Follow-up|3|||
164369722|NCT02896400|593733350|FG013|3 Month Follow-up|Lost to Follow-up|5|||
164369723|NCT02896400|593733351|FG014|3 Month Follow-up|Lost to Follow-up|3|||
164369724|NCT02896400|593733352|FG015|3 Month Follow-up|Lost to Follow-up|2|||
164369725|NCT02896400|593733337|FG000|3 Month Follow-up|Death|0|||
164369726|NCT02896400|593733338|FG001|3 Month Follow-up|Death|0|||
164369727|NCT02896400|593733339|FG002|3 Month Follow-up|Death|0|||
164369728|NCT02896400|593733340|FG003|3 Month Follow-up|Death|0|||
164369729|NCT02896400|593733341|FG004|3 Month Follow-up|Death|0|||
164369730|NCT02896400|593733342|FG005|3 Month Follow-up|Death|0|||
164369731|NCT02896400|593733343|FG006|3 Month Follow-up|Death|0|||
164369732|NCT02896400|593733344|FG007|3 Month Follow-up|Death|0|||
164369733|NCT02896400|593733345|FG008|3 Month Follow-up|Death|0|||
164369734|NCT02896400|593733346|FG009|3 Month Follow-up|Death|0|||
164369735|NCT02896400|593733347|FG010|3 Month Follow-up|Death|0|||
164369736|NCT02896400|593733348|FG011|3 Month Follow-up|Death|0|||
164369737|NCT02896400|593733349|FG012|3 Month Follow-up|Death|0|||
164369738|NCT02896400|593733350|FG013|3 Month Follow-up|Death|1|||
164369739|NCT02896400|593733351|FG014|3 Month Follow-up|Death|1|||
164369740|NCT02896400|593733352|FG015|3 Month Follow-up|Death|0|||
164369741|NCT02896400|593733337|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
164369742|NCT02896400|593733338|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
164369743|NCT02896400|593733339|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
164438888|NCT03743246|593973075|FG002|Pre-Treatment Period|Death|0|||
164438889|NCT03743246|593973076|FG003|Pre-Treatment Period|Death|1|||
164438890|NCT03743246|593973073|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
164438891|NCT03743246|593973074|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
164438892|NCT03743246|593973075|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
164438893|NCT03743246|593973076|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
164438894|NCT03743246|593973073|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
164438895|NCT03743246|593973074|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
164438896|NCT03743246|593973075|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
164369744|NCT02896400|593733340|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
164369745|NCT02896400|593733341|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
164369746|NCT02896400|593733342|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
164369747|NCT02896400|593733343|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
164369748|NCT02896400|593733344|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
164369749|NCT02896400|593733345|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
164369750|NCT02896400|593733346|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
164369751|NCT02896400|593733347|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
164369752|NCT02896400|593733348|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
164369753|NCT02896400|593733349|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
164369754|NCT02896400|593733350|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
164369755|NCT02896400|593733351|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
164369756|NCT02896400|593733352|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
164369757|NCT02896400|593733337|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
164369758|NCT02896400|593733338|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
164369759|NCT02896400|593733339|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
164369760|NCT02896400|593733340|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
164369761|NCT02896400|593733341|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
164369762|NCT02896400|593733342|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
164369763|NCT02896400|593733343|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
164369764|NCT02896400|593733344|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
164369765|NCT02896400|593733345|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
164369766|NCT02896400|593733346|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
164369767|NCT02896400|593733347|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
164369768|NCT02896400|593733348|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
164369769|NCT02896400|593733349|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
164369770|NCT02896400|593733350|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
164369771|NCT02896400|593733351|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
164369772|NCT02896400|593733352|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
164369773|NCT02984020|593733353|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
164369774|NCT02984020|593733353|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
164369775|NCT02984020|593733353|FG000|Overall Study|Other significant protocol violation|2|||
164369776|NCT00588445|593733354|FG000|Overall Study|Protocol Violation|1|||
164369777|NCT00588445|593733354|FG000|Overall Study|Withdrawal by Subject|3|||
164369778|NCT00588445|593733354|FG000|Overall Study|Disease Progression|1|||
164369779|NCT00588445|593733354|FG000|Overall Study|Not Treated|10|||
164369780|NCT00358527|593733355|FG000|Overall Study|Adverse Event|4|||
164369781|NCT00358527|593733356|FG001|Overall Study|Adverse Event|0|||
164369782|NCT00358527|593733355|FG000|Overall Study|Withdrawal by Subject|1|||
164369783|NCT00358527|593733356|FG001|Overall Study|Withdrawal by Subject|1|||
164369784|NCT00358527|593733355|FG000|Overall Study|Non-compliance with protocol|6|||
164369785|NCT00358527|593733356|FG001|Overall Study|Non-compliance with protocol|1|||
164369786|NCT00358527|593733355|FG000|Overall Study|Administrative|2|||
164369787|NCT00358527|593733356|FG001|Overall Study|Administrative|1|||
164369788|NCT00934544|593733359|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
164369789|NCT00934544|593733360|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
164369790|NCT00934544|593733361|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
164369791|NCT00934544|593733359|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
164438897|NCT03743246|593973076|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
164438898|NCT03743246|593973073|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
164438899|NCT03743246|593973074|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
164438900|NCT03743246|593973075|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
164438901|NCT03743246|593973076|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
164700251|NCT02960893|594926792|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
164700252|NCT02960893|594926789|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
164700253|NCT02960893|594926790|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
164369792|NCT00934544|593733360|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
164369793|NCT00934544|593733361|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
164369794|NCT00934544|593733359|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
164369795|NCT00934544|593733360|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
164369796|NCT00934544|593733361|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
164369797|NCT00934544|593733359|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
164369798|NCT00934544|593733360|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
164369799|NCT00934544|593733361|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
164369800|NCT00934544|593733359|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
164369801|NCT00934544|593733360|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
164369802|NCT00934544|593733361|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
164369803|NCT00934544|593733359|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
164369804|NCT00934544|593733360|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
164369805|NCT00934544|593733361|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
164369806|NCT00934544|593733359|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
164369807|NCT00934544|593733360|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
164369808|NCT00934544|593733361|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
164369809|NCT00934544|593733359|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
164369810|NCT00934544|593733360|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
164369811|NCT00934544|593733361|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
164369812|NCT00934544|593733359|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
164369813|NCT00934544|593733360|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
164369814|NCT00934544|593733361|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
164369815|NCT00934544|593733359|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
164369816|NCT00934544|593733360|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
164369817|NCT00934544|593733361|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
164369818|NCT00934544|593733359|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
164369819|NCT00934544|593733360|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
164369820|NCT00934544|593733361|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
164369821|NCT00934544|593733359|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
164369822|NCT00934544|593733360|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
164369823|NCT00934544|593733361|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
164369824|NCT00934544|593733359|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
164369825|NCT00934544|593733360|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
164369826|NCT00934544|593733361|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
164369827|NCT00934544|593733359|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
164369828|NCT00934544|593733360|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
164369829|NCT00934544|593733361|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
164369830|NCT00934544|593733359|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
164369831|NCT00934544|593733360|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
164369832|NCT00934544|593733361|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
164369833|NCT00934544|593733359|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
164369834|NCT00934544|593733360|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
164369835|NCT00934544|593733361|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
164369836|NCT02643251|593733362|FG000|Overall Study|Adverse Event|3|||
164369837|NCT02643251|593733363|FG001|Overall Study|Adverse Event|1|||
164369838|NCT02643251|593733362|FG000|Overall Study|Withdrawal by Subject|2|||
164438902|NCT03743246|593973073|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
164438903|NCT03743246|593973074|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
164438904|NCT03743246|593973075|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
164438905|NCT03743246|593973076|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
164438906|NCT03743246|593973073|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
164438907|NCT03743246|593973074|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
164438908|NCT03743246|593973075|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
164438909|NCT03743246|593973076|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
164438910|NCT03743246|593973073|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
164438911|NCT03743246|593973074|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
164438912|NCT03743246|593973075|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
164438913|NCT03743246|593973076|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
164700254|NCT02960893|594926791|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
164700255|NCT02960893|594926792|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
164700256|NCT02631876|594926797|FG000|Overall Study|Death|96|||
164700257|NCT02631876|594926798|FG001|Overall Study|Death|50|||
164700258|NCT02631876|594926797|FG000|Overall Study|Investigator's discretion|1|||
164369839|NCT02643251|593733363|FG001|Overall Study|Withdrawal by Subject|0|||
164369840|NCT02643251|593733362|FG000|Overall Study|Lost to Follow-up|4|||
164369841|NCT02643251|593733363|FG001|Overall Study|Lost to Follow-up|1|||
164369842|NCT02643251|593733362|FG000|Overall Study|Protocol Violation|1|||
164369843|NCT02643251|593733363|FG001|Overall Study|Protocol Violation|0|||
164369844|NCT02643251|593733362|FG000|Overall Study|PI Decision to terminate patient|1|||
164369845|NCT02643251|593733363|FG001|Overall Study|PI Decision to terminate patient|0|||
164369846|NCT00348556|593733364|FG000|Overall Study|Adverse Event|1|||
164369847|NCT00192075|593733365|FG000|Overall Study|Disease Progression|23|||
164369848|NCT00192075|593733366|FG001|Overall Study|Disease Progression|6|||
164369849|NCT00192075|593733365|FG000|Overall Study|Adverse Event|1|||
164369850|NCT00192075|593733366|FG001|Overall Study|Adverse Event|3|||
164369851|NCT00192075|593733365|FG000|Overall Study|Death|0|||
164369852|NCT00192075|593733366|FG001|Overall Study|Death|1|||
164369853|NCT00192075|593733365|FG000|Overall Study|Lack of Efficacy|0|||
164369854|NCT00192075|593733366|FG001|Overall Study|Lack of Efficacy|0|||
164369855|NCT00192075|593733365|FG000|Overall Study|Physician Decision|3|||
164369856|NCT00192075|593733366|FG001|Overall Study|Physician Decision|0|||
164369857|NCT00192075|593733365|FG000|Overall Study|Withdrawal by Subject|5|||
164369858|NCT00192075|593733366|FG001|Overall Study|Withdrawal by Subject|5|||
164369859|NCT00192075|593733365|FG000|Overall Study|Patient Non-Compliance|0|||
164369860|NCT00192075|593733366|FG001|Overall Study|Patient Non-Compliance|1|||
164369861|NCT00192075|593733365|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
164369862|NCT00192075|593733366|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
164369863|NCT00192075|593733365|FG000|Overall Study|Other|5|||
164369864|NCT00192075|593733366|FG001|Overall Study|Other|2|||
164369865|NCT00779675|593733367|FG000|Treatment Period|Adverse Event|87|||
164369866|NCT00779675|593733367|FG000|Treatment Period|Treatment Failure|80|||
164369867|NCT00779675|593733367|FG000|Treatment Period|Transferred to Another Study|38|||
164369868|NCT00779675|593733367|FG000|Treatment Period|Lost to Follow-up|23|||
164369869|NCT00779675|593733367|FG000|Treatment Period|Withdrawal by Subject|46|||
164369870|NCT00779675|593733367|FG000|Treatment Period|Protocol Violation|54|||
164369871|NCT00779675|593733367|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
164369872|NCT00779675|593733367|FG000|Treatment Period|Administrative|3|||
164369873|NCT00779675|593733367|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
164369874|NCT00779675|593733367|FG000|Extended Treatment Period|Protocol Violation|13|||
164369875|NCT00779675|593733367|FG000|Extended Treatment Period|Adverse Event|6|||
164369876|NCT00779675|593733367|FG000|Extended Treatment Period|Treatment Failure|11|||
164369877|NCT00779675|593733367|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
164369878|NCT00779675|593733367|FG000|Extended Treatment Period|Lost to Follow-up|6|||
164369879|NCT01944059|593733368|FG000|Overall Study|Lost to Follow-up|1|||
164369880|NCT01944059|593733368|FG000|Overall Study|Physician Decision|3|||
164369881|NCT01944059|593733368|FG000|Overall Study|Withdrawal by Subject|1|||
164369882|NCT01944059|593733368|FG000|Overall Study|Adverse Event|2|||
164369883|NCT00430092|593733375|FG000|Overall Study|Adverse Event|0|||
164369884|NCT00430092|593733376|FG001|Overall Study|Adverse Event|0|||
164369885|NCT00430092|593733377|FG002|Overall Study|Adverse Event|1|||
164369886|NCT00430092|593733375|FG000|Overall Study|Lack of Efficacy|5|||
164369887|NCT00430092|593733376|FG001|Overall Study|Lack of Efficacy|2|||
164369888|NCT00430092|593733377|FG002|Overall Study|Lack of Efficacy|54|||
164369889|NCT00430092|593733375|FG000|Overall Study|Lost to Follow-up|1|||
164369890|NCT00430092|593733376|FG001|Overall Study|Lost to Follow-up|0|||
164369891|NCT00430092|593733377|FG002|Overall Study|Lost to Follow-up|0|||
164369892|NCT00430092|593733375|FG000|Overall Study|Protocol Violation|0|||
164369893|NCT00430092|593733376|FG001|Overall Study|Protocol Violation|1|||
164369894|NCT00430092|593733377|FG002|Overall Study|Protocol Violation|1|||
164369895|NCT00430092|593733375|FG000|Overall Study|Withdrawal by Subject|0|||
164369896|NCT00430092|593733376|FG001|Overall Study|Withdrawal by Subject|1|||
164369897|NCT00430092|593733377|FG002|Overall Study|Withdrawal by Subject|1|||
164369898|NCT01956110|593733378|FG000|Overall Study|Protocol Violation|25|||
164369899|NCT01956110|593733379|FG001|Overall Study|Protocol Violation|11|||
164369900|NCT01956110|593733378|FG000|Overall Study|Adverse Event|9|||
164369901|NCT01956110|593733379|FG001|Overall Study|Adverse Event|10|||
164369902|NCT01956110|593733378|FG000|Overall Study|Personal reasons|1|||
164369903|NCT01956110|593733379|FG001|Overall Study|Personal reasons|1|||
164369904|NCT02118428|593733384|FG000|Overall Study|Physician Decision|0|||
164369905|NCT02118428|593733385|FG001|Overall Study|Physician Decision|1|||
164369906|NCT02118428|593733386|FG002|Overall Study|Physician Decision|0|||
164369907|NCT02118428|593733384|FG000|Overall Study|Withdrawal by Subject|2|||
164369908|NCT02118428|593733385|FG001|Overall Study|Withdrawal by Subject|2|||
164369909|NCT02118428|593733386|FG002|Overall Study|Withdrawal by Subject|0|||
164369910|NCT02118428|593733384|FG000|Overall Study|Death|7|||
164369911|NCT02118428|593733385|FG001|Overall Study|Death|5|||
164369912|NCT02118428|593733386|FG002|Overall Study|Death|0|||
164369913|NCT02118428|593733384|FG000|Overall Study|Lost to Follow-up|3|||
164369914|NCT02118428|593733385|FG001|Overall Study|Lost to Follow-up|1|||
164369915|NCT02118428|593733386|FG002|Overall Study|Lost to Follow-up|0|||
164369916|NCT02118428|593733384|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
164369917|NCT02118428|593733385|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
164369918|NCT02118428|593733386|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
164369919|NCT01633944|593733389|FG000|Open-label Titration Phase|Adverse Event|109|||
164369920|NCT01633944|593733390|FG001|Open-label Titration Phase|Adverse Event|0|||
164369921|NCT01633944|593733391|FG002|Open-label Titration Phase|Adverse Event|0|||
164369922|NCT01633944|593733389|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
164369923|NCT01633944|593733390|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
164369924|NCT01633944|593733391|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
164369925|NCT01633944|593733389|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
164369926|NCT01633944|593733390|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
164369927|NCT01633944|593733391|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
164369928|NCT01633944|593733389|FG000|Open-label Titration Phase|Protocol Violation|24|||
164369929|NCT01633944|593733390|FG001|Open-label Titration Phase|Protocol Violation|0|||
164369930|NCT01633944|593733391|FG002|Open-label Titration Phase|Protocol Violation|0|||
164369931|NCT01633944|593733389|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
164369932|NCT01633944|593733390|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
164369933|NCT01633944|593733391|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
164369934|NCT01633944|593733389|FG000|Open-label Titration Phase|Other|68|||
164369935|NCT01633944|593733390|FG001|Open-label Titration Phase|Other|0|||
164369936|NCT01633944|593733391|FG002|Open-label Titration Phase|Other|0|||
164369937|NCT01633944|593733389|FG000|Double-blind Treatment Phase|Adverse Event|0|||
164369938|NCT01633944|593733390|FG001|Double-blind Treatment Phase|Adverse Event|13|||
164369939|NCT01633944|593733391|FG002|Double-blind Treatment Phase|Adverse Event|7|||
164369940|NCT01633944|593733389|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
164369941|NCT01633944|593733390|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
164369942|NCT01633944|593733391|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
164369943|NCT01633944|593733389|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
164369944|NCT01633944|593733390|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
164369945|NCT01633944|593733391|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
164369946|NCT01633944|593733389|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
164369947|NCT01633944|593733390|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
164369948|NCT01633944|593733391|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
164369949|NCT01633944|593733389|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
164369950|NCT01633944|593733390|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
164369951|NCT01633944|593733391|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
164369952|NCT01633944|593733389|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
164369953|NCT01633944|593733390|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
164369954|NCT01633944|593733391|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
164369955|NCT01633944|593733389|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
164369956|NCT01633944|593733390|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
164369957|NCT01633944|593733391|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
164369958|NCT01633944|593733389|FG000|Double-blind Treatment Phase|Other|0|||
164369959|NCT01633944|593733390|FG001|Double-blind Treatment Phase|Other|7|||
164369960|NCT01633944|593733391|FG002|Double-blind Treatment Phase|Other|0|||
164369961|NCT00463060|593733392|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
164369962|NCT00463060|593733392|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
164369963|NCT01400841|593733393|FG000|Initial Study Phase (6 Months)|Death|1|||
164369964|NCT01400841|593733393|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
164369965|NCT00701129|593733394|FG000|Overall Study|Death|2|||
164369966|NCT00910715|593733395|FG000|Overall Study|Lost to Follow-up|22|||
164369967|NCT00910715|593733396|FG001|Overall Study|Lost to Follow-up|26|||
164369968|NCT00910715|593733397|FG002|Overall Study|Lost to Follow-up|0|||
164369969|NCT00706966|593733398|FG000|Overall Study|Adverse Event|1|||
164369970|NCT02884089|593733399|FG000|Period 1|Dosing error|2|||
164369971|NCT02884089|593733400|FG001|Period 1|Dosing error|2|||
164369972|NCT02884089|593733401|FG002|Period 1|Dosing error|0|||
164369973|NCT02884089|593733402|FG003|Period 1|Dosing error|0|||
164369974|NCT02884089|593733399|FG000|Washout Period 1|Lost to Follow-up|0|||
164369975|NCT02884089|593733400|FG001|Washout Period 1|Lost to Follow-up|1|||
164369976|NCT02884089|593733401|FG002|Washout Period 1|Lost to Follow-up|0|||
164369977|NCT02884089|593733402|FG003|Washout Period 1|Lost to Follow-up|1|||
164369978|NCT02884089|593733399|FG000|Washout Period 1|Withdrawal by Subject|0|||
164369979|NCT02884089|593733400|FG001|Washout Period 1|Withdrawal by Subject|1|||
164369980|NCT02884089|593733401|FG002|Washout Period 1|Withdrawal by Subject|0|||
164369981|NCT02884089|593733402|FG003|Washout Period 1|Withdrawal by Subject|0|||
164369982|NCT02884089|593733399|FG000|Period 2|Adverse Event|1|||
164369983|NCT02884089|593733400|FG001|Period 2|Adverse Event|0|||
164369984|NCT02884089|593733401|FG002|Period 2|Adverse Event|0|||
164369985|NCT02884089|593733402|FG003|Period 2|Adverse Event|0|||
164369986|NCT02884089|593733399|FG000|Period 3|Withdrawal by Subject|0|||
164369987|NCT02884089|593733400|FG001|Period 3|Withdrawal by Subject|0|||
164369988|NCT02884089|593733401|FG002|Period 3|Withdrawal by Subject|1|||
164369989|NCT02884089|593733402|FG003|Period 3|Withdrawal by Subject|0|||
164369990|NCT02884089|593733399|FG000|Washout Period 3|Withdrawal by Subject|0|||
164369991|NCT02884089|593733400|FG001|Washout Period 3|Withdrawal by Subject|0|||
164369992|NCT02884089|593733401|FG002|Washout Period 3|Withdrawal by Subject|1|||
164369993|NCT02884089|593733402|FG003|Washout Period 3|Withdrawal by Subject|0|||
164369994|NCT02884089|593733399|FG000|Washout Period 3|Lost to Follow-up|0|||
164369995|NCT02884089|593733400|FG001|Washout Period 3|Lost to Follow-up|0|||
164369996|NCT02884089|593733401|FG002|Washout Period 3|Lost to Follow-up|0|||
164369997|NCT02884089|593733402|FG003|Washout Period 3|Lost to Follow-up|1|||
164369998|NCT02884089|593733399|FG000|Period 4|Withdrawal by Subject|0|||
164369999|NCT02884089|593733400|FG001|Period 4|Withdrawal by Subject|1|||
164370000|NCT02884089|593733401|FG002|Period 4|Withdrawal by Subject|0|||
164370001|NCT02884089|593733402|FG003|Period 4|Withdrawal by Subject|0|||
164370002|NCT02884089|593733399|FG000|Period 4|Lost to Follow-up|1|||
164370003|NCT02884089|593733400|FG001|Period 4|Lost to Follow-up|0|||
164370004|NCT02884089|593733401|FG002|Period 4|Lost to Follow-up|0|||
164370005|NCT02884089|593733402|FG003|Period 4|Lost to Follow-up|0|||
164370006|NCT02884089|593733399|FG000|Follow-up Visit|Withdrawal by Subject|1|||
164370007|NCT02884089|593733400|FG001|Follow-up Visit|Withdrawal by Subject|0|||
164370008|NCT02884089|593733401|FG002|Follow-up Visit|Withdrawal by Subject|0|||
164370009|NCT02884089|593733402|FG003|Follow-up Visit|Withdrawal by Subject|1|||
164370010|NCT01631474|593733403|FG000|Overall Study|Lost to Follow-up|8|||
164370011|NCT01631474|593733404|FG001|Overall Study|Lost to Follow-up|5|||
164370012|NCT01631474|593733405|FG002|Overall Study|Lost to Follow-up|7|||
164370013|NCT01631474|593733406|FG003|Overall Study|Lost to Follow-up|5|||
164370014|NCT01631474|593733407|FG004|Overall Study|Lost to Follow-up|5|||
164370015|NCT01631474|593733403|FG000|Overall Study|Withdrawal by Subject|4|||
164370016|NCT01631474|593733404|FG001|Overall Study|Withdrawal by Subject|4|||
164370017|NCT01631474|593733405|FG002|Overall Study|Withdrawal by Subject|2|||
164370018|NCT01631474|593733406|FG003|Overall Study|Withdrawal by Subject|6|||
164370019|NCT01631474|593733407|FG004|Overall Study|Withdrawal by Subject|5|||
164370020|NCT01631474|593733403|FG000|Overall Study|Lack of Efficacy|2|||
164370021|NCT01631474|593733404|FG001|Overall Study|Lack of Efficacy|2|||
164370022|NCT01631474|593733405|FG002|Overall Study|Lack of Efficacy|0|||
164370023|NCT01631474|593733406|FG003|Overall Study|Lack of Efficacy|0|||
164370024|NCT01631474|593733407|FG004|Overall Study|Lack of Efficacy|2|||
164370025|NCT01631474|593733403|FG000|Overall Study|Noncompliance with Study Drug|0|||
164370026|NCT01631474|593733404|FG001|Overall Study|Noncompliance with Study Drug|0|||
164370027|NCT01631474|593733405|FG002|Overall Study|Noncompliance with Study Drug|0|||
164370028|NCT01631474|593733406|FG003|Overall Study|Noncompliance with Study Drug|0|||
164370029|NCT01631474|593733407|FG004|Overall Study|Noncompliance with Study Drug|1|||
164370030|NCT01631474|593733403|FG000|Overall Study|Adverse Event|0|||
164370031|NCT01631474|593733404|FG001|Overall Study|Adverse Event|1|||
164370032|NCT01631474|593733405|FG002|Overall Study|Adverse Event|0|||
164370033|NCT01631474|593733406|FG003|Overall Study|Adverse Event|0|||
164370034|NCT01631474|593733407|FG004|Overall Study|Adverse Event|0|||
164370035|NCT01467076|593733408|FG000|Overall Study|Lost to Follow-up|1|||
164370036|NCT01467076|593733409|FG001|Overall Study|Lost to Follow-up|0|||
164370037|NCT01467076|593733410|FG002|Overall Study|Lost to Follow-up|0|||
164370038|NCT03354429|593733411|FG000|Overall Study|Withdrawal by Subject|8|||
164370039|NCT03354429|593733412|FG001|Overall Study|Withdrawal by Subject|7|||
164370040|NCT03354429|593733411|FG000|Overall Study|Lost to Follow-up|1|||
164370041|NCT03354429|593733412|FG001|Overall Study|Lost to Follow-up|0|||
164370042|NCT00654381|593733418|FG000|1st Stage|Adverse Event|3|||
164370043|NCT00654381|593733419|FG001|1st Stage|Adverse Event|3|||
164370044|NCT00654381|593733420|FG002|1st Stage|Adverse Event|3|||
164370045|NCT00654381|593733421|FG003|1st Stage|Adverse Event|3|||
164370046|NCT00654381|593733422|FG004|1st Stage|Adverse Event|2|||
164370047|NCT00654381|593733423|FG005|1st Stage|Adverse Event|1|||
164370048|NCT00654381|593733418|FG000|1st Stage|Withdrawal by Subject|0|||
164370049|NCT00654381|593733419|FG001|1st Stage|Withdrawal by Subject|0|||
164370050|NCT00654381|593733420|FG002|1st Stage|Withdrawal by Subject|0|||
164370051|NCT00654381|593733421|FG003|1st Stage|Withdrawal by Subject|1|||
164370052|NCT00654381|593733422|FG004|1st Stage|Withdrawal by Subject|0|||
164370053|NCT00654381|593733423|FG005|1st Stage|Withdrawal by Subject|1|||
164370054|NCT00654381|593733418|FG000|1st Stage|Investigator's decision|0|||
164370055|NCT00654381|593733419|FG001|1st Stage|Investigator's decision|0|||
164370056|NCT00654381|593733420|FG002|1st Stage|Investigator's decision|0|||
164370057|NCT00654381|593733421|FG003|1st Stage|Investigator's decision|1|||
164370058|NCT00654381|593733422|FG004|1st Stage|Investigator's decision|0|||
164370059|NCT00654381|593733423|FG005|1st Stage|Investigator's decision|0|||
164370060|NCT00654381|593733418|FG000|2nd Stage|Adverse Event|2|||
164370061|NCT00654381|593733419|FG001|2nd Stage|Adverse Event|0|||
164370062|NCT00654381|593733420|FG002|2nd Stage|Adverse Event|2|||
164370063|NCT00654381|593733421|FG003|2nd Stage|Adverse Event|3|||
164370064|NCT00654381|593733422|FG004|2nd Stage|Adverse Event|7|||
164370065|NCT00654381|593733423|FG005|2nd Stage|Adverse Event|2|||
164370066|NCT00654381|593733418|FG000|2nd Stage|Withdrawal by Subject|0|||
164370067|NCT00654381|593733419|FG001|2nd Stage|Withdrawal by Subject|0|||
164370068|NCT00654381|593733420|FG002|2nd Stage|Withdrawal by Subject|0|||
164370069|NCT00654381|593733421|FG003|2nd Stage|Withdrawal by Subject|0|||
164370070|NCT00654381|593733422|FG004|2nd Stage|Withdrawal by Subject|1|||
164370071|NCT00654381|593733423|FG005|2nd Stage|Withdrawal by Subject|1|||
164370072|NCT00654381|593733418|FG000|2nd Stage|Investigator's decision|0|||
164370073|NCT00654381|593733419|FG001|2nd Stage|Investigator's decision|0|||
164370074|NCT00654381|593733420|FG002|2nd Stage|Investigator's decision|1|||
164370075|NCT00654381|593733421|FG003|2nd Stage|Investigator's decision|1|||
164370076|NCT00654381|593733422|FG004|2nd Stage|Investigator's decision|0|||
164370077|NCT00654381|593733423|FG005|2nd Stage|Investigator's decision|0|||
164370078|NCT00654381|593733418|FG000|Extension Stage|Adverse Event|1|||
164370079|NCT00654381|593733419|FG001|Extension Stage|Adverse Event|2|||
164370080|NCT00654381|593733420|FG002|Extension Stage|Adverse Event|9|||
164370081|NCT00654381|593733421|FG003|Extension Stage|Adverse Event|7|||
164370082|NCT00654381|593733422|FG004|Extension Stage|Adverse Event|1|||
164370083|NCT00654381|593733423|FG005|Extension Stage|Adverse Event|1|||
164370084|NCT00654381|593733418|FG000|Extension Stage|Protocol Violation|0|||
164370085|NCT00654381|593733419|FG001|Extension Stage|Protocol Violation|0|||
164370086|NCT00654381|593733420|FG002|Extension Stage|Protocol Violation|0|||
164370087|NCT00654381|593733421|FG003|Extension Stage|Protocol Violation|1|||
164370088|NCT00654381|593733422|FG004|Extension Stage|Protocol Violation|0|||
164370089|NCT00654381|593733423|FG005|Extension Stage|Protocol Violation|0|||
164370090|NCT00654381|593733418|FG000|Extension Stage|Lack of Efficacy|0|||
164370091|NCT00654381|593733419|FG001|Extension Stage|Lack of Efficacy|0|||
164370092|NCT00654381|593733420|FG002|Extension Stage|Lack of Efficacy|1|||
164370093|NCT00654381|593733421|FG003|Extension Stage|Lack of Efficacy|0|||
164370094|NCT00654381|593733422|FG004|Extension Stage|Lack of Efficacy|0|||
164370095|NCT00654381|593733423|FG005|Extension Stage|Lack of Efficacy|0|||
164370096|NCT00654381|593733418|FG000|Extension Stage|Withdrawal by Subject|0|||
164370097|NCT00654381|593733419|FG001|Extension Stage|Withdrawal by Subject|0|||
164370098|NCT00654381|593733420|FG002|Extension Stage|Withdrawal by Subject|1|||
164438914|NCT03743246|593973073|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
164438915|NCT03743246|593973074|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
164438916|NCT03743246|593973075|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
164438917|NCT03743246|593973076|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
164438918|NCT00395018|593973077|FG000|On-Treatment|Death|4|||
164438919|NCT00395018|593973077|FG000|On-Treatment|Other Reason|2|||
164438920|NCT00395018|593973077|FG000|On-Treatment|Poor/non-compliance|2|||
164438921|NCT00395018|593973077|FG000|On-Treatment|Subject no longer meets study criteria|2|||
164438922|NCT00395018|593973077|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
164438923|NCT00395018|593973077|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
164438924|NCT00395018|593973077|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
164438925|NCT04439799|593973078|FG000|Overall Study|Lost to Follow-up|6|||
164438926|NCT04439799|593973079|FG001|Overall Study|Lost to Follow-up|6|||
164438927|NCT04439799|593973078|FG000|Overall Study|Withdrawal by Subject|2|||
164438928|NCT04439799|593973079|FG001|Overall Study|Withdrawal by Subject|6|||
164438929|NCT04439799|593973078|FG000|Overall Study|Adverse Event|2|||
164700259|NCT02631876|594926798|FG001|Overall Study|Investigator's discretion|0|||
164700260|NCT02631876|594926797|FG000|Overall Study|Lost to Follow-up|2|||
164700261|NCT02631876|594926798|FG001|Overall Study|Lost to Follow-up|0|||
164700262|NCT02631876|594926797|FG000|Overall Study|Withdrawal by Subject|16|||
164700263|NCT02631876|594926798|FG001|Overall Study|Withdrawal by Subject|9|||
164438930|NCT04439799|593973079|FG001|Overall Study|Adverse Event|5|||
164438931|NCT00371566|593973080|FG000|Treatment Phase|Withdrawal by Subject|0|||
164438932|NCT00371566|593973081|FG001|Treatment Phase|Withdrawal by Subject|1|||
164438933|NCT00371566|593973080|FG000|Treatment Phase|Adverse Event|0|||
164438934|NCT00371566|593973081|FG001|Treatment Phase|Adverse Event|1|||
164438935|NCT00371566|593973080|FG000|Treatment Phase|Protocol Violation|0|||
164438936|NCT00371566|593973081|FG001|Treatment Phase|Protocol Violation|1|||
164700264|NCT02631876|594926797|FG000|Overall Study|Other than specified|4|||
164370099|NCT00654381|593733421|FG003|Extension Stage|Withdrawal by Subject|1|||
164370100|NCT00654381|593733422|FG004|Extension Stage|Withdrawal by Subject|1|||
164700265|NCT02631876|594926798|FG001|Overall Study|Other than specified|4|||
164700266|NCT04285567|594926799|FG000|Overall Study|Death|3|||
164370101|NCT00654381|593733423|FG005|Extension Stage|Withdrawal by Subject|1|||
164370102|NCT00654381|593733418|FG000|Extension Stage|Closure of the trial site|0|||
164370103|NCT00654381|593733419|FG001|Extension Stage|Closure of the trial site|0|||
164370104|NCT00654381|593733420|FG002|Extension Stage|Closure of the trial site|0|||
164370105|NCT00654381|593733421|FG003|Extension Stage|Closure of the trial site|0|||
164370106|NCT00654381|593733422|FG004|Extension Stage|Closure of the trial site|1|||
164370107|NCT00654381|593733423|FG005|Extension Stage|Closure of the trial site|1|||
164370108|NCT05040152|593733429|FG000|Overall Study|Withdrawal by Subject|5|||
164700267|NCT04285567|594926800|FG001|Overall Study|Death|3|||
164370109|NCT05040152|593733430|FG001|Overall Study|Withdrawal by Subject|0|||
164370110|NCT05040152|593733429|FG000|Overall Study|Lost to Follow-up|0|||
164370111|NCT05040152|593733430|FG001|Overall Study|Lost to Follow-up|2|||
164370112|NCT00006489|593733432|FG000|Overall Study|Adverse Event|3|||
164370113|NCT00006489|593733433|FG001|Overall Study|Adverse Event|2|||
164370114|NCT00006489|593733434|FG002|Overall Study|Adverse Event|4|||
164370115|NCT00006489|593733435|FG003|Overall Study|Adverse Event|3|||
164370116|NCT00006489|593733432|FG000|Overall Study|Withdrawal by Subject|10|||
164370117|NCT00006489|593733433|FG001|Overall Study|Withdrawal by Subject|9|||
164370118|NCT00006489|593733434|FG002|Overall Study|Withdrawal by Subject|9|||
164370119|NCT00006489|593733435|FG003|Overall Study|Withdrawal by Subject|6|||
164370120|NCT00006489|593733432|FG000|Overall Study|Scheduling Conflict|0|||
164370121|NCT00006489|593733433|FG001|Overall Study|Scheduling Conflict|3|||
164370122|NCT00006489|593733434|FG002|Overall Study|Scheduling Conflict|2|||
164370123|NCT00006489|593733435|FG003|Overall Study|Scheduling Conflict|1|||
164370124|NCT00006489|593733432|FG000|Overall Study|Death|0|||
164370125|NCT00006489|593733433|FG001|Overall Study|Death|0|||
164370126|NCT00006489|593733434|FG002|Overall Study|Death|0|||
164370127|NCT00006489|593733435|FG003|Overall Study|Death|1|||
164370128|NCT00578175|593733436|FG000|Overall Study|Adverse Event|0|||
164370129|NCT00578175|593733437|FG001|Overall Study|Adverse Event|1|||
164370130|NCT00578175|593733438|FG002|Overall Study|Adverse Event|1|||
164370131|NCT00578175|593733436|FG000|Overall Study|Other reasons|70|||
164370132|NCT00578175|593733437|FG001|Overall Study|Other reasons|42|||
164370133|NCT00578175|593733438|FG002|Overall Study|Other reasons|23|||
164370134|NCT03029624|593733444|FG000|Overall Study|Adverse Event|1|||
164370135|NCT03029624|593733444|FG000|Overall Study|Withdrawal by Subject|1|||
164370136|NCT03029624|593733444|FG000|Overall Study|Lack of Efficacy|1|||
164370137|NCT03029624|593733444|FG000|Overall Study|MRI need|2|||
164370138|NCT01371656|593733445|FG000|Overall Study|Death|7|||
164370139|NCT01371656|593733446|FG001|Overall Study|Death|4|||
164370140|NCT01371656|593733445|FG000|Overall Study|Physician Decision|46|||
164370141|NCT01371656|593733446|FG001|Overall Study|Physician Decision|7|||
164370142|NCT01371656|593733445|FG000|Overall Study|Withdrawal by Subject|7|||
164370143|NCT01371656|593733446|FG001|Overall Study|Withdrawal by Subject|0|||
164370144|NCT01371656|593733445|FG000|Overall Study|Ineligible|4|||
164370145|NCT01371656|593733446|FG001|Overall Study|Ineligible|3|||
164370146|NCT04334460|593733453|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
164370147|NCT04334460|593733454|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
164370148|NCT04334460|593733453|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
164370149|NCT04334460|593733454|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
164370150|NCT00775437|593733455|FG000|Overall Study|Loss of efficacy|2|||
164370151|NCT00775437|593733455|FG000|Overall Study|Withdrawal by Subject|3|||
164370152|NCT00775437|593733455|FG000|Overall Study|Lost to Follow-up|1|||
164370153|NCT02442778|593733462|FG000|Overall Study|Adverse Event|2|||
164700268|NCT04285567|594926799|FG000|Overall Study|Lost to Follow-up|1|||
164700269|NCT04285567|594926800|FG001|Overall Study|Lost to Follow-up|1|||
164700270|NCT04285567|594926799|FG000|Overall Study|Reason Not Specified|1|||
164700271|NCT04285567|594926800|FG001|Overall Study|Reason Not Specified|1|||
164700272|NCT04285567|594926799|FG000|Overall Study|Physician Decision|2|||
164700273|NCT04285567|594926800|FG001|Overall Study|Physician Decision|1|||
164700274|NCT04285567|594926799|FG000|Overall Study|Withdrawal by Subject|2|||
164700275|NCT04285567|594926800|FG001|Overall Study|Withdrawal by Subject|6|||
164700276|NCT04285567|594926799|FG000|Overall Study|Adverse Event|1|||
164700277|NCT04285567|594926800|FG001|Overall Study|Adverse Event|0|||
164700278|NCT04285567|594926799|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
164700279|NCT04285567|594926800|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
164700280|NCT04556552|594926801|FG000|Overall Study|Lost to Follow-up|1|||
164700281|NCT04556552|594926802|FG001|Overall Study|Lost to Follow-up|0|||
164700282|NCT04556552|594926801|FG000|Overall Study|Claustrophobia|0|||
164370154|NCT02442778|593733463|FG001|Overall Study|Adverse Event|6|||
164370155|NCT02442778|593733464|FG002|Overall Study|Adverse Event|6|||
164370156|NCT02442778|593733462|FG000|Overall Study|Death|0|||
164370157|NCT02442778|593733463|FG001|Overall Study|Death|2|||
164370158|NCT02442778|593733464|FG002|Overall Study|Death|0|||
164370159|NCT02442778|593733462|FG000|Overall Study|Lack of Efficacy|1|||
164370160|NCT02442778|593733463|FG001|Overall Study|Lack of Efficacy|0|||
164370161|NCT02442778|593733464|FG002|Overall Study|Lack of Efficacy|0|||
164700283|NCT04556552|594926802|FG001|Overall Study|Claustrophobia|1|||
164700284|NCT04556552|594926801|FG000|Overall Study|Inability to continue|0|||
164700285|NCT04556552|594926802|FG001|Overall Study|Inability to continue|1|||
164700286|NCT00605865|594926803|FG000|Overall Study|Protocol Violation|115|||
164700287|NCT02856880|594926809|FG000|Overall Study|Withdrawal of consent|1|||
164700288|NCT00094458|594926810|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
164700289|NCT00094458|594926811|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
164700290|NCT00094458|594926812|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
164370162|NCT02442778|593733462|FG000|Overall Study|Lost to Follow-up|1|||
164370163|NCT02442778|593733463|FG001|Overall Study|Lost to Follow-up|1|||
164370164|NCT02442778|593733464|FG002|Overall Study|Lost to Follow-up|1|||
164370165|NCT02442778|593733462|FG000|Overall Study|Non-compliance with study drug|2|||
164370166|NCT02442778|593733463|FG001|Overall Study|Non-compliance with study drug|0|||
164370167|NCT02442778|593733464|FG002|Overall Study|Non-compliance with study drug|1|||
164370168|NCT02442778|593733462|FG000|Overall Study|Physician Decision|1|||
164370169|NCT02442778|593733463|FG001|Overall Study|Physician Decision|1|||
164370170|NCT02442778|593733464|FG002|Overall Study|Physician Decision|1|||
164370171|NCT02442778|593733462|FG000|Overall Study|Protocol Deviation|3|||
164370172|NCT02442778|593733463|FG001|Overall Study|Protocol Deviation|0|||
164370173|NCT02442778|593733464|FG002|Overall Study|Protocol Deviation|1|||
164370174|NCT02442778|593733462|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
164370175|NCT02442778|593733463|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
164370176|NCT02442778|593733464|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
164370177|NCT02442778|593733462|FG000|Overall Study|Withdrawal by Subject|4|||
164370178|NCT02442778|593733463|FG001|Overall Study|Withdrawal by Subject|4|||
164370179|NCT02442778|593733464|FG002|Overall Study|Withdrawal by Subject|3|||
164370180|NCT02442778|593733462|FG000|Overall Study|Reason not specified|1|||
164370181|NCT02442778|593733463|FG001|Overall Study|Reason not specified|4|||
164370182|NCT02442778|593733464|FG002|Overall Study|Reason not specified|0|||
164370183|NCT02641379|593733467|FG000|Overall Study|Exclusion criterion during screening|1|||
164370184|NCT02641379|593733468|FG001|Overall Study|Exclusion criterion during screening|0|||
164370185|NCT02641379|593733469|FG002|Overall Study|Exclusion criterion during screening|0|||
164370186|NCT02641379|593733470|FG003|Overall Study|Exclusion criterion during screening|1|||
164370187|NCT02641379|593733471|FG004|Overall Study|Exclusion criterion during screening|2|||
164370188|NCT02641379|593733472|FG005|Overall Study|Exclusion criterion during screening|0|||
164370189|NCT02641379|593733473|FG006|Overall Study|Exclusion criterion during screening|0|||
164370190|NCT02641379|593733474|FG007|Overall Study|Exclusion criterion during screening|0|||
164370191|NCT02641379|593733475|FG008|Overall Study|Exclusion criterion during screening|0|||
164370192|NCT02641379|593733476|FG009|Overall Study|Exclusion criterion during screening|0|||
164370193|NCT02641379|593733477|FG010|Overall Study|Exclusion criterion during screening|0|||
164370194|NCT02641379|593733467|FG000|Overall Study|Withdrawal of informed consent|0|||
164370195|NCT02641379|593733468|FG001|Overall Study|Withdrawal of informed consent|1|||
164370196|NCT02641379|593733469|FG002|Overall Study|Withdrawal of informed consent|0|||
164370197|NCT02641379|593733470|FG003|Overall Study|Withdrawal of informed consent|0|||
164370198|NCT02641379|593733471|FG004|Overall Study|Withdrawal of informed consent|0|||
164700291|NCT00094458|594926813|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
164700292|NCT00094458|594926814|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
164700293|NCT00094458|594926815|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
164700294|NCT00094458|594926810|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
164700295|NCT00094458|594926811|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
164700296|NCT00094458|594926812|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
164700297|NCT00094458|594926813|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
164700298|NCT00094458|594926814|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
164700299|NCT00094458|594926815|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
164700300|NCT00094458|594926810|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
164700301|NCT00094458|594926811|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
164700302|NCT00094458|594926812|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
164700303|NCT00094458|594926813|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
164700304|NCT00094458|594926814|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
164700305|NCT00094458|594926815|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
164700306|NCT00094458|594926810|FG000|Main Study: Through Week 30|Adverse Event|38|||
164700307|NCT00094458|594926811|FG001|Main Study: Through Week 30|Adverse Event|20|||
164700308|NCT00094458|594926812|FG002|Main Study: Through Week 30|Adverse Event|28|||
164700309|NCT00094458|594926813|FG003|Main Study: Through Week 30|Adverse Event|0|||
164700310|NCT00094458|594926814|FG004|Main Study: Through Week 30|Adverse Event|0|||
164700311|NCT00094458|594926815|FG005|Main Study: Through Week 30|Adverse Event|0|||
164700312|NCT00094458|594926810|FG000|Main Study: Through Week 30|Death|1|||
164700313|NCT00094458|594926811|FG001|Main Study: Through Week 30|Death|0|||
164700314|NCT00094458|594926812|FG002|Main Study: Through Week 30|Death|0|||
164700315|NCT00094458|594926813|FG003|Main Study: Through Week 30|Death|0|||
164700316|NCT00094458|594926814|FG004|Main Study: Through Week 30|Death|0|||
164700317|NCT00094458|594926815|FG005|Main Study: Through Week 30|Death|0|||
164700318|NCT00094458|594926810|FG000|Main Study: Through Week 30|Other|19|||
164700319|NCT00094458|594926811|FG001|Main Study: Through Week 30|Other|16|||
164370199|NCT02641379|593733472|FG005|Overall Study|Withdrawal of informed consent|0|||
164370200|NCT02641379|593733473|FG006|Overall Study|Withdrawal of informed consent|0|||
164370201|NCT02641379|593733474|FG007|Overall Study|Withdrawal of informed consent|1|||
164370202|NCT02641379|593733475|FG008|Overall Study|Withdrawal of informed consent|0|||
164700320|NCT00094458|594926812|FG002|Main Study: Through Week 30|Other|9|||
164700321|NCT00094458|594926813|FG003|Main Study: Through Week 30|Other|0|||
164370203|NCT02641379|593733476|FG009|Overall Study|Withdrawal of informed consent|0|||
164370204|NCT02641379|593733477|FG010|Overall Study|Withdrawal of informed consent|0|||
164370205|NCT02641379|593733467|FG000|Overall Study|Adverse Event|7|||
164370206|NCT02641379|593733468|FG001|Overall Study|Adverse Event|8|||
164370207|NCT02641379|593733469|FG002|Overall Study|Adverse Event|2|||
164370208|NCT02641379|593733470|FG003|Overall Study|Adverse Event|2|||
164370209|NCT02641379|593733471|FG004|Overall Study|Adverse Event|5|||
164370210|NCT02641379|593733472|FG005|Overall Study|Adverse Event|1|||
164370211|NCT02641379|593733473|FG006|Overall Study|Adverse Event|5|||
164370212|NCT02641379|593733474|FG007|Overall Study|Adverse Event|0|||
164370213|NCT02641379|593733475|FG008|Overall Study|Adverse Event|1|||
164370214|NCT02641379|593733476|FG009|Overall Study|Adverse Event|1|||
164370215|NCT02641379|593733477|FG010|Overall Study|Adverse Event|5|||
164370216|NCT02641379|593733467|FG000|Overall Study|Lack of Efficacy|0|||
164370217|NCT02641379|593733468|FG001|Overall Study|Lack of Efficacy|0|||
164370218|NCT02641379|593733469|FG002|Overall Study|Lack of Efficacy|2|||
164370219|NCT02641379|593733470|FG003|Overall Study|Lack of Efficacy|0|||
164370220|NCT02641379|593733471|FG004|Overall Study|Lack of Efficacy|0|||
164370221|NCT02641379|593733472|FG005|Overall Study|Lack of Efficacy|2|||
164370222|NCT02641379|593733473|FG006|Overall Study|Lack of Efficacy|0|||
164370223|NCT02641379|593733474|FG007|Overall Study|Lack of Efficacy|5|||
164370224|NCT02641379|593733475|FG008|Overall Study|Lack of Efficacy|0|||
164370225|NCT02641379|593733476|FG009|Overall Study|Lack of Efficacy|0|||
164370226|NCT02641379|593733477|FG010|Overall Study|Lack of Efficacy|0|||
164370227|NCT02641379|593733467|FG000|Overall Study|Participant unable to attend study visit|4|||
164370228|NCT02641379|593733468|FG001|Overall Study|Participant unable to attend study visit|10|||
164370229|NCT02641379|593733469|FG002|Overall Study|Participant unable to attend study visit|1|||
164370230|NCT02641379|593733470|FG003|Overall Study|Participant unable to attend study visit|2|||
164370231|NCT02641379|593733471|FG004|Overall Study|Participant unable to attend study visit|5|||
164370232|NCT02641379|593733472|FG005|Overall Study|Participant unable to attend study visit|1|||
164370233|NCT02641379|593733473|FG006|Overall Study|Participant unable to attend study visit|1|||
164370234|NCT02641379|593733474|FG007|Overall Study|Participant unable to attend study visit|1|||
164370235|NCT02641379|593733475|FG008|Overall Study|Participant unable to attend study visit|0|||
164370236|NCT02641379|593733476|FG009|Overall Study|Participant unable to attend study visit|2|||
164370237|NCT02641379|593733477|FG010|Overall Study|Participant unable to attend study visit|0|||
164370238|NCT02641379|593733467|FG000|Overall Study|Participant's compliance|0|||
164370239|NCT02641379|593733468|FG001|Overall Study|Participant's compliance|1|||
164370240|NCT02641379|593733469|FG002|Overall Study|Participant's compliance|0|||
164370241|NCT02641379|593733470|FG003|Overall Study|Participant's compliance|1|||
164370242|NCT02641379|593733471|FG004|Overall Study|Participant's compliance|0|||
164370243|NCT02641379|593733472|FG005|Overall Study|Participant's compliance|2|||
164370244|NCT02641379|593733473|FG006|Overall Study|Participant's compliance|0|||
164370245|NCT02641379|593733474|FG007|Overall Study|Participant's compliance|0|||
164370246|NCT02641379|593733475|FG008|Overall Study|Participant's compliance|1|||
164370247|NCT02641379|593733476|FG009|Overall Study|Participant's compliance|1|||
164370248|NCT02641379|593733477|FG010|Overall Study|Participant's compliance|1|||
164370249|NCT02641379|593733467|FG000|Overall Study|Participant cannot be reached|4|||
164370250|NCT02641379|593733468|FG001|Overall Study|Participant cannot be reached|4|||
164370251|NCT02641379|593733469|FG002|Overall Study|Participant cannot be reached|0|||
164370252|NCT02641379|593733470|FG003|Overall Study|Participant cannot be reached|8|||
164591378|NCT00883558|594528363|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
164591379|NCT00883558|594528364|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
164591380|NCT00883558|594528365|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
164591381|NCT00883558|594528363|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
164591382|NCT00883558|594528364|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
164591383|NCT00883558|594528365|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
164591384|NCT00883558|594528363|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
164700322|NCT00094458|594926814|FG004|Main Study: Through Week 30|Other|0|||
164700323|NCT00094458|594926815|FG005|Main Study: Through Week 30|Other|0|||
164700324|NCT00094458|594926810|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
164370253|NCT02641379|593733471|FG004|Overall Study|Participant cannot be reached|2|||
164370254|NCT02641379|593733472|FG005|Overall Study|Participant cannot be reached|1|||
164591385|NCT00883558|594528364|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
164591386|NCT00883558|594528365|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
164700325|NCT00094458|594926811|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
164370255|NCT02641379|593733473|FG006|Overall Study|Participant cannot be reached|0|||
164370256|NCT02641379|593733474|FG007|Overall Study|Participant cannot be reached|1|||
164370257|NCT02641379|593733475|FG008|Overall Study|Participant cannot be reached|0|||
164370258|NCT02641379|593733476|FG009|Overall Study|Participant cannot be reached|2|||
164370259|NCT02641379|593733477|FG010|Overall Study|Participant cannot be reached|1|||
164370260|NCT02641379|593733467|FG000|Overall Study|PCR positive at Week 24|15|||
164370261|NCT02641379|593733468|FG001|Overall Study|PCR positive at Week 24|21|||
164370262|NCT02641379|593733469|FG002|Overall Study|PCR positive at Week 24|62|||
164370263|NCT02641379|593733470|FG003|Overall Study|PCR positive at Week 24|0|||
164370264|NCT02641379|593733471|FG004|Overall Study|PCR positive at Week 24|0|||
164370265|NCT02641379|593733472|FG005|Overall Study|PCR positive at Week 24|6|||
164370266|NCT02641379|593733473|FG006|Overall Study|PCR positive at Week 24|3|||
164370267|NCT02641379|593733474|FG007|Overall Study|PCR positive at Week 24|8|||
164370268|NCT02641379|593733475|FG008|Overall Study|PCR positive at Week 24|0|||
164370269|NCT02641379|593733476|FG009|Overall Study|PCR positive at Week 24|1|||
164370270|NCT02641379|593733477|FG010|Overall Study|PCR positive at Week 24|0|||
164370271|NCT02641379|593733467|FG000|Overall Study|PCR positive at follow up 2|1|||
164370272|NCT02641379|593733468|FG001|Overall Study|PCR positive at follow up 2|0|||
164370273|NCT02641379|593733469|FG002|Overall Study|PCR positive at follow up 2|0|||
164370274|NCT02641379|593733470|FG003|Overall Study|PCR positive at follow up 2|0|||
164370275|NCT02641379|593733471|FG004|Overall Study|PCR positive at follow up 2|0|||
164370276|NCT02641379|593733472|FG005|Overall Study|PCR positive at follow up 2|0|||
164370277|NCT02641379|593733473|FG006|Overall Study|PCR positive at follow up 2|0|||
164370278|NCT02641379|593733474|FG007|Overall Study|PCR positive at follow up 2|0|||
164370279|NCT02641379|593733475|FG008|Overall Study|PCR positive at follow up 2|0|||
164370280|NCT02641379|593733476|FG009|Overall Study|PCR positive at follow up 2|0|||
164370281|NCT02641379|593733477|FG010|Overall Study|PCR positive at follow up 2|0|||
164370282|NCT02641379|593733467|FG000|Overall Study|Participant showed relapse|1|||
164370283|NCT02641379|593733468|FG001|Overall Study|Participant showed relapse|0|||
164370284|NCT02641379|593733469|FG002|Overall Study|Participant showed relapse|0|||
164370285|NCT02641379|593733470|FG003|Overall Study|Participant showed relapse|0|||
164370286|NCT02641379|593733471|FG004|Overall Study|Participant showed relapse|0|||
164370287|NCT02641379|593733472|FG005|Overall Study|Participant showed relapse|0|||
164370288|NCT02641379|593733473|FG006|Overall Study|Participant showed relapse|1|||
164370289|NCT02641379|593733474|FG007|Overall Study|Participant showed relapse|0|||
164370290|NCT02641379|593733475|FG008|Overall Study|Participant showed relapse|0|||
164370291|NCT02641379|593733476|FG009|Overall Study|Participant showed relapse|0|||
164370292|NCT02641379|593733477|FG010|Overall Study|Participant showed relapse|0|||
164370293|NCT02641379|593733467|FG000|Overall Study|Participant stopped study/treatment|1|||
164591387|NCT00883558|594528363|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
164370294|NCT02641379|593733468|FG001|Overall Study|Participant stopped study/treatment|3|||
164370295|NCT02641379|593733469|FG002|Overall Study|Participant stopped study/treatment|1|||
164370296|NCT02641379|593733470|FG003|Overall Study|Participant stopped study/treatment|0|||
164370297|NCT02641379|593733471|FG004|Overall Study|Participant stopped study/treatment|0|||
164370298|NCT02641379|593733472|FG005|Overall Study|Participant stopped study/treatment|1|||
164370299|NCT02641379|593733473|FG006|Overall Study|Participant stopped study/treatment|2|||
164370300|NCT02641379|593733474|FG007|Overall Study|Participant stopped study/treatment|0|||
164370301|NCT02641379|593733475|FG008|Overall Study|Participant stopped study/treatment|1|||
164370302|NCT02641379|593733476|FG009|Overall Study|Participant stopped study/treatment|0|||
164370303|NCT02641379|593733477|FG010|Overall Study|Participant stopped study/treatment|0|||
164370304|NCT02641379|593733467|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
164370305|NCT02641379|593733468|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
164370306|NCT02641379|593733469|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
164370307|NCT02641379|593733470|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
164370308|NCT02641379|593733471|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
164370309|NCT02641379|593733472|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
164370310|NCT02641379|593733473|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
164370311|NCT02641379|593733474|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
164370312|NCT02641379|593733475|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
164370313|NCT02641379|593733476|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
164370314|NCT02641379|593733477|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
164370315|NCT02641379|593733467|FG000|Overall Study|Financial problems|0|||
164591388|NCT00883558|594528364|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
164591389|NCT00883558|594528365|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
164591390|NCT03539458|594528366|FG000|Overall Study|Death|1|||
164591391|NCT02750800|594528371|FG000|Overall Study|Adverse Event|18|||
164591392|NCT02750800|594528371|FG000|Overall Study|Lost to Follow-up|12|||
164591393|NCT02750800|594528371|FG000|Overall Study|Investigator decision|53|||
164591394|NCT02750800|594528371|FG000|Overall Study|Patient request|12|||
164591395|NCT02750800|594528371|FG000|Overall Study|Other, not specified|3|||
164591396|NCT00643487|594528372|FG000|Overall Study|Technical difficulty|3|||
164591397|NCT00972478|594528373|FG000|Overall Study|Adverse Event|3|||
164370316|NCT02641379|593733468|FG001|Overall Study|Financial problems|1|||
164370317|NCT02641379|593733469|FG002|Overall Study|Financial problems|0|||
164370318|NCT02641379|593733470|FG003|Overall Study|Financial problems|0|||
164370319|NCT02641379|593733471|FG004|Overall Study|Financial problems|0|||
164370320|NCT02641379|593733472|FG005|Overall Study|Financial problems|0|||
164370321|NCT02641379|593733473|FG006|Overall Study|Financial problems|0|||
164370322|NCT02641379|593733474|FG007|Overall Study|Financial problems|0|||
164370323|NCT02641379|593733475|FG008|Overall Study|Financial problems|0|||
164370324|NCT02641379|593733476|FG009|Overall Study|Financial problems|0|||
164370325|NCT02641379|593733477|FG010|Overall Study|Financial problems|0|||
164370326|NCT02641379|593733467|FG000|Overall Study|PCR positive at Week 68|0|||
164370327|NCT02641379|593733468|FG001|Overall Study|PCR positive at Week 68|1|||
164370328|NCT02641379|593733469|FG002|Overall Study|PCR positive at Week 68|0|||
164370329|NCT02641379|593733470|FG003|Overall Study|PCR positive at Week 68|0|||
164370330|NCT02641379|593733471|FG004|Overall Study|PCR positive at Week 68|0|||
164370331|NCT02641379|593733472|FG005|Overall Study|PCR positive at Week 68|0|||
164370332|NCT02641379|593733473|FG006|Overall Study|PCR positive at Week 68|0|||
164370333|NCT02641379|593733474|FG007|Overall Study|PCR positive at Week 68|0|||
164370334|NCT02641379|593733475|FG008|Overall Study|PCR positive at Week 68|0|||
164370335|NCT02641379|593733476|FG009|Overall Study|PCR positive at Week 68|0|||
164370336|NCT02641379|593733477|FG010|Overall Study|PCR positive at Week 68|0|||
164370337|NCT02641379|593733467|FG000|Overall Study|PCR positive at Week 48|0|||
164370338|NCT02641379|593733468|FG001|Overall Study|PCR positive at Week 48|1|||
164370339|NCT02641379|593733469|FG002|Overall Study|PCR positive at Week 48|0|||
164370340|NCT02641379|593733470|FG003|Overall Study|PCR positive at Week 48|0|||
164370341|NCT02641379|593733471|FG004|Overall Study|PCR positive at Week 48|0|||
164370342|NCT02641379|593733472|FG005|Overall Study|PCR positive at Week 48|0|||
164370343|NCT02641379|593733473|FG006|Overall Study|PCR positive at Week 48|0|||
164370344|NCT02641379|593733474|FG007|Overall Study|PCR positive at Week 48|0|||
164370345|NCT02641379|593733475|FG008|Overall Study|PCR positive at Week 48|0|||
164370346|NCT02641379|593733476|FG009|Overall Study|PCR positive at Week 48|0|||
164370347|NCT02641379|593733477|FG010|Overall Study|PCR positive at Week 48|0|||
164370348|NCT02641379|593733467|FG000|Overall Study|PCR not performed at Week 12|0|||
164370349|NCT02641379|593733468|FG001|Overall Study|PCR not performed at Week 12|0|||
164370350|NCT02641379|593733469|FG002|Overall Study|PCR not performed at Week 12|1|||
164370351|NCT02641379|593733470|FG003|Overall Study|PCR not performed at Week 12|0|||
164370352|NCT02641379|593733471|FG004|Overall Study|PCR not performed at Week 12|0|||
164370353|NCT02641379|593733472|FG005|Overall Study|PCR not performed at Week 12|0|||
164370354|NCT02641379|593733473|FG006|Overall Study|PCR not performed at Week 12|0|||
164370355|NCT02641379|593733474|FG007|Overall Study|PCR not performed at Week 12|0|||
164370356|NCT02641379|593733475|FG008|Overall Study|PCR not performed at Week 12|0|||
164370357|NCT02641379|593733476|FG009|Overall Study|PCR not performed at Week 12|0|||
164370358|NCT02641379|593733477|FG010|Overall Study|PCR not performed at Week 12|0|||
164370359|NCT02641379|593733467|FG000|Overall Study|No PCR at baseline|0|||
164370360|NCT02641379|593733468|FG001|Overall Study|No PCR at baseline|0|||
164370361|NCT02641379|593733469|FG002|Overall Study|No PCR at baseline|1|||
164370362|NCT02641379|593733470|FG003|Overall Study|No PCR at baseline|0|||
164370363|NCT02641379|593733471|FG004|Overall Study|No PCR at baseline|0|||
164370364|NCT02641379|593733472|FG005|Overall Study|No PCR at baseline|0|||
164370365|NCT02641379|593733473|FG006|Overall Study|No PCR at baseline|0|||
164700326|NCT00094458|594926812|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
164700327|NCT00094458|594926813|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
164700328|NCT00094458|594926814|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
164700329|NCT00094458|594926815|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
164700330|NCT00094458|594926810|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
164700331|NCT00094458|594926811|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
164700332|NCT00094458|594926812|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
164700333|NCT00094458|594926813|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
164700334|NCT00094458|594926814|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
164700335|NCT00094458|594926815|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
164700336|NCT00094458|594926810|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
164700337|NCT00094458|594926811|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
164700338|NCT00094458|594926812|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
164700339|NCT00094458|594926813|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
164700340|NCT00094458|594926814|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
164700341|NCT00094458|594926815|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
164700342|NCT00094458|594926810|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
164370366|NCT02641379|593733474|FG007|Overall Study|No PCR at baseline|0|||
164370367|NCT02641379|593733475|FG008|Overall Study|No PCR at baseline|0|||
164370368|NCT02641379|593733476|FG009|Overall Study|No PCR at baseline|0|||
164370369|NCT02641379|593733477|FG010|Overall Study|No PCR at baseline|0|||
164370370|NCT02641379|593733467|FG000|Overall Study|PCR positive at Week 28|0|||
164370371|NCT02641379|593733468|FG001|Overall Study|PCR positive at Week 28|0|||
164370372|NCT02641379|593733469|FG002|Overall Study|PCR positive at Week 28|1|||
164370373|NCT02641379|593733470|FG003|Overall Study|PCR positive at Week 28|0|||
164370374|NCT02641379|593733471|FG004|Overall Study|PCR positive at Week 28|0|||
164370375|NCT02641379|593733472|FG005|Overall Study|PCR positive at Week 28|0|||
164370376|NCT02641379|593733473|FG006|Overall Study|PCR positive at Week 28|0|||
164700343|NCT00094458|594926811|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
164700344|NCT00094458|594926812|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
164370377|NCT02641379|593733474|FG007|Overall Study|PCR positive at Week 28|0|||
164370378|NCT02641379|593733475|FG008|Overall Study|PCR positive at Week 28|0|||
164370379|NCT02641379|593733476|FG009|Overall Study|PCR positive at Week 28|0|||
164370380|NCT02641379|593733477|FG010|Overall Study|PCR positive at Week 28|0|||
164370381|NCT02641379|593733467|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
164370382|NCT02641379|593733468|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
164370383|NCT02641379|593733469|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
164370384|NCT02641379|593733470|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
164370385|NCT02641379|593733471|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
164370386|NCT02641379|593733472|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
164370387|NCT02641379|593733473|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
164370388|NCT02641379|593733474|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
164370389|NCT02641379|593733475|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
164370390|NCT02641379|593733476|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
164370391|NCT02641379|593733477|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
164370392|NCT02641379|593733467|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
164370393|NCT02641379|593733468|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
164370394|NCT02641379|593733469|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
164370395|NCT02641379|593733470|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
164370396|NCT02641379|593733471|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
164370397|NCT02641379|593733472|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
164370398|NCT02641379|593733473|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
164370399|NCT02641379|593733474|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
164370400|NCT02641379|593733475|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
164370401|NCT02641379|593733476|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
164370402|NCT02641379|593733477|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
164370403|NCT02641379|593733467|FG000|Overall Study|Baseline viral load unavailable|0|||
164370404|NCT02641379|593733468|FG001|Overall Study|Baseline viral load unavailable|0|||
164370405|NCT02641379|593733469|FG002|Overall Study|Baseline viral load unavailable|0|||
164370406|NCT02641379|593733470|FG003|Overall Study|Baseline viral load unavailable|1|||
164438937|NCT00371566|593973080|FG000|Chemoradiation Phase|Physician Decision|2|||
164438938|NCT00371566|593973081|FG001|Chemoradiation Phase|Physician Decision|0|||
164438939|NCT00371566|593973080|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
164438940|NCT00371566|593973081|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
164438941|NCT00371566|593973080|FG000|Chemoradiation Phase|Non compliant|0|||
164438942|NCT00371566|593973081|FG001|Chemoradiation Phase|Non compliant|1|||
164438943|NCT00371566|593973080|FG000|Chemoradiation Phase|Progressive Disease|1|||
164438944|NCT00371566|593973081|FG001|Chemoradiation Phase|Progressive Disease|1|||
164438945|NCT00371566|593973080|FG000|Chemoradiation Phase|Death|2|||
164438946|NCT00371566|593973081|FG001|Chemoradiation Phase|Death|0|||
164438947|NCT00371566|593973080|FG000|Follow Up Phase|Death|0|||
164438948|NCT00371566|593973081|FG001|Follow Up Phase|Death|5|||
164438949|NCT00371566|593973080|FG000|Follow Up Phase|Disease progression|1|||
164438950|NCT00371566|593973081|FG001|Follow Up Phase|Disease progression|0|||
164438951|NCT00371566|593973080|FG000|Follow Up Phase|Withdrawal by Subject|0|||
164438952|NCT00371566|593973081|FG001|Follow Up Phase|Withdrawal by Subject|1|||
164438953|NCT00371566|593973080|FG000|Follow Up Phase|Physician Decision|1|||
164438954|NCT00371566|593973081|FG001|Follow Up Phase|Physician Decision|1|||
164438955|NCT00371566|593973080|FG000|Follow Up Phase|Lost to Follow-up|1|||
164438956|NCT00371566|593973081|FG001|Follow Up Phase|Lost to Follow-up|0|||
164438957|NCT02534350|593973086|FG000|Overall Study|Randomized But Not Treated|1|||
164438958|NCT02534350|593973087|FG001|Overall Study|Randomized But Not Treated|0|||
164438959|NCT02534350|593973086|FG000|Overall Study|Protocol Violation|1|||
164438960|NCT02534350|593973087|FG001|Overall Study|Protocol Violation|0|||
164438961|NCT02534350|593973086|FG000|Overall Study|Withdrew Consent|2|||
164438962|NCT02534350|593973087|FG001|Overall Study|Withdrew Consent|0|||
164438963|NCT00716144|593973100|FG000|Overall Study|Withdrawal by Subject|4|||
164438964|NCT00716144|593973101|FG001|Overall Study|Withdrawal by Subject|2|||
164700345|NCT00094458|594926813|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
164700346|NCT00094458|594926814|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
164438965|NCT00716144|593973102|FG002|Overall Study|Withdrawal by Subject|6|||
164438966|NCT00716144|593973103|FG003|Overall Study|Withdrawal by Subject|6|||
164370407|NCT02641379|593733471|FG004|Overall Study|Baseline viral load unavailable|0|||
164438967|NCT00716144|593973100|FG000|Overall Study|Lost to Follow-up|2|||
164438968|NCT00716144|593973101|FG001|Overall Study|Lost to Follow-up|2|||
164438969|NCT00716144|593973102|FG002|Overall Study|Lost to Follow-up|1|||
164438970|NCT00716144|593973103|FG003|Overall Study|Lost to Follow-up|2|||
164438971|NCT00716144|593973100|FG000|Overall Study|Adverse Event|0|||
164438972|NCT00716144|593973101|FG001|Overall Study|Adverse Event|0|||
164438973|NCT00716144|593973102|FG002|Overall Study|Adverse Event|0|||
164370408|NCT02641379|593733472|FG005|Overall Study|Baseline viral load unavailable|0|||
164370409|NCT02641379|593733473|FG006|Overall Study|Baseline viral load unavailable|0|||
164370410|NCT02641379|593733474|FG007|Overall Study|Baseline viral load unavailable|0|||
164438974|NCT00716144|593973103|FG003|Overall Study|Adverse Event|2|||
164700347|NCT00094458|594926815|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
164370411|NCT02641379|593733475|FG008|Overall Study|Baseline viral load unavailable|0|||
164370412|NCT02641379|593733476|FG009|Overall Study|Baseline viral load unavailable|0|||
164370413|NCT02641379|593733477|FG010|Overall Study|Baseline viral load unavailable|0|||
164370414|NCT02641379|593733467|FG000|Overall Study|Blood could not be drawn|0|||
164370415|NCT02641379|593733468|FG001|Overall Study|Blood could not be drawn|0|||
164370416|NCT02641379|593733469|FG002|Overall Study|Blood could not be drawn|0|||
164370417|NCT02641379|593733470|FG003|Overall Study|Blood could not be drawn|0|||
164370418|NCT02641379|593733471|FG004|Overall Study|Blood could not be drawn|1|||
164370419|NCT02641379|593733472|FG005|Overall Study|Blood could not be drawn|0|||
164370420|NCT02641379|593733473|FG006|Overall Study|Blood could not be drawn|0|||
164370421|NCT02641379|593733474|FG007|Overall Study|Blood could not be drawn|0|||
164370422|NCT02641379|593733475|FG008|Overall Study|Blood could not be drawn|0|||
164370423|NCT02641379|593733476|FG009|Overall Study|Blood could not be drawn|0|||
164370424|NCT02641379|593733477|FG010|Overall Study|Blood could not be drawn|0|||
164370425|NCT02641379|593733467|FG000|Overall Study|Protocol Violation|0|||
164370426|NCT02641379|593733468|FG001|Overall Study|Protocol Violation|0|||
164370427|NCT02641379|593733469|FG002|Overall Study|Protocol Violation|0|||
164370428|NCT02641379|593733470|FG003|Overall Study|Protocol Violation|0|||
164370429|NCT02641379|593733471|FG004|Overall Study|Protocol Violation|2|||
164370430|NCT02641379|593733472|FG005|Overall Study|Protocol Violation|0|||
164370431|NCT02641379|593733473|FG006|Overall Study|Protocol Violation|0|||
164370432|NCT02641379|593733474|FG007|Overall Study|Protocol Violation|0|||
164370433|NCT02641379|593733475|FG008|Overall Study|Protocol Violation|1|||
164370434|NCT02641379|593733476|FG009|Overall Study|Protocol Violation|0|||
164370435|NCT02641379|593733477|FG010|Overall Study|Protocol Violation|0|||
164370436|NCT02641379|593733467|FG000|Overall Study|Participation in sili rescue study|0|||
164370437|NCT02641379|593733468|FG001|Overall Study|Participation in sili rescue study|0|||
164370438|NCT02641379|593733469|FG002|Overall Study|Participation in sili rescue study|0|||
164370439|NCT02641379|593733470|FG003|Overall Study|Participation in sili rescue study|0|||
164370440|NCT02641379|593733471|FG004|Overall Study|Participation in sili rescue study|0|||
164370441|NCT02641379|593733472|FG005|Overall Study|Participation in sili rescue study|1|||
164370442|NCT02641379|593733473|FG006|Overall Study|Participation in sili rescue study|0|||
164370443|NCT02641379|593733474|FG007|Overall Study|Participation in sili rescue study|0|||
164370444|NCT02641379|593733475|FG008|Overall Study|Participation in sili rescue study|0|||
164370445|NCT02641379|593733476|FG009|Overall Study|Participation in sili rescue study|0|||
164370446|NCT02641379|593733477|FG010|Overall Study|Participation in sili rescue study|0|||
164370447|NCT02641379|593733467|FG000|Overall Study|Lost to Follow-up|0|||
164370448|NCT02641379|593733468|FG001|Overall Study|Lost to Follow-up|0|||
164370449|NCT02641379|593733469|FG002|Overall Study|Lost to Follow-up|0|||
164370450|NCT02641379|593733470|FG003|Overall Study|Lost to Follow-up|0|||
164370451|NCT02641379|593733471|FG004|Overall Study|Lost to Follow-up|0|||
164370452|NCT02641379|593733472|FG005|Overall Study|Lost to Follow-up|0|||
164370453|NCT02641379|593733473|FG006|Overall Study|Lost to Follow-up|0|||
164370454|NCT02641379|593733474|FG007|Overall Study|Lost to Follow-up|0|||
164370455|NCT02641379|593733475|FG008|Overall Study|Lost to Follow-up|1|||
164370456|NCT02641379|593733476|FG009|Overall Study|Lost to Follow-up|0|||
164370457|NCT02641379|593733477|FG010|Overall Study|Lost to Follow-up|0|||
164370458|NCT02641379|593733467|FG000|Overall Study|Source data not found|0|||
164370459|NCT02641379|593733468|FG001|Overall Study|Source data not found|0|||
164370460|NCT02641379|593733469|FG002|Overall Study|Source data not found|0|||
164370461|NCT02641379|593733470|FG003|Overall Study|Source data not found|0|||
164370462|NCT02641379|593733471|FG004|Overall Study|Source data not found|0|||
164370463|NCT02641379|593733472|FG005|Overall Study|Source data not found|1|||
164370464|NCT02641379|593733473|FG006|Overall Study|Source data not found|0|||
164370465|NCT02641379|593733474|FG007|Overall Study|Source data not found|0|||
164370466|NCT02641379|593733475|FG008|Overall Study|Source data not found|0|||
164370467|NCT02641379|593733476|FG009|Overall Study|Source data not found|0|||
164370468|NCT02641379|593733477|FG010|Overall Study|Source data not found|0|||
164370469|NCT02641379|593733467|FG000|Overall Study|Participant showed weight reduction|0|||
164370470|NCT02641379|593733468|FG001|Overall Study|Participant showed weight reduction|0|||
164370471|NCT02641379|593733469|FG002|Overall Study|Participant showed weight reduction|0|||
164370472|NCT02641379|593733470|FG003|Overall Study|Participant showed weight reduction|0|||
164370473|NCT02641379|593733471|FG004|Overall Study|Participant showed weight reduction|0|||
164370474|NCT02641379|593733472|FG005|Overall Study|Participant showed weight reduction|0|||
164370475|NCT02641379|593733473|FG006|Overall Study|Participant showed weight reduction|0|||
164700348|NCT00094458|594926810|FG000|OLE: Open-Label Extension|Adverse Event|0|||
164700349|NCT00094458|594926811|FG001|OLE: Open-Label Extension|Adverse Event|0|||
164370476|NCT02641379|593733474|FG007|Overall Study|Participant showed weight reduction|1|||
164370477|NCT02641379|593733475|FG008|Overall Study|Participant showed weight reduction|0|||
164370478|NCT02641379|593733476|FG009|Overall Study|Participant showed weight reduction|0|||
164370479|NCT02641379|593733477|FG010|Overall Study|Participant showed weight reduction|0|||
164370480|NCT02641379|593733467|FG000|Overall Study|Non-response Week 12|0|||
164370481|NCT02641379|593733468|FG001|Overall Study|Non-response Week 12|0|||
164370482|NCT02641379|593733469|FG002|Overall Study|Non-response Week 12|0|||
164370483|NCT02641379|593733470|FG003|Overall Study|Non-response Week 12|0|||
164370484|NCT02641379|593733471|FG004|Overall Study|Non-response Week 12|0|||
164370485|NCT02641379|593733472|FG005|Overall Study|Non-response Week 12|0|||
164370486|NCT02641379|593733473|FG006|Overall Study|Non-response Week 12|0|||
164370487|NCT02641379|593733474|FG007|Overall Study|Non-response Week 12|1|||
164370488|NCT02641379|593733475|FG008|Overall Study|Non-response Week 12|0|||
164370489|NCT02641379|593733476|FG009|Overall Study|Non-response Week 12|0|||
164370490|NCT02641379|593733477|FG010|Overall Study|Non-response Week 12|0|||
164370491|NCT02641379|593733467|FG000|Overall Study|No 2 Log drop at Week 12|0|||
164370492|NCT02641379|593733468|FG001|Overall Study|No 2 Log drop at Week 12|0|||
164370493|NCT02641379|593733469|FG002|Overall Study|No 2 Log drop at Week 12|0|||
164370494|NCT02641379|593733470|FG003|Overall Study|No 2 Log drop at Week 12|0|||
164370495|NCT02641379|593733471|FG004|Overall Study|No 2 Log drop at Week 12|0|||
164370496|NCT02641379|593733472|FG005|Overall Study|No 2 Log drop at Week 12|0|||
164370497|NCT02641379|593733473|FG006|Overall Study|No 2 Log drop at Week 12|0|||
164370498|NCT02641379|593733474|FG007|Overall Study|No 2 Log drop at Week 12|0|||
164370499|NCT02641379|593733475|FG008|Overall Study|No 2 Log drop at Week 12|0|||
164370500|NCT02641379|593733476|FG009|Overall Study|No 2 Log drop at Week 12|0|||
164370501|NCT02641379|593733477|FG010|Overall Study|No 2 Log drop at Week 12|1|||
164370502|NCT02641379|593733467|FG000|Overall Study|Negative PCR result|0|||
164370503|NCT02641379|593733468|FG001|Overall Study|Negative PCR result|0|||
164370504|NCT02641379|593733469|FG002|Overall Study|Negative PCR result|0|||
164370505|NCT02641379|593733470|FG003|Overall Study|Negative PCR result|0|||
164370506|NCT02641379|593733471|FG004|Overall Study|Negative PCR result|0|||
164370507|NCT02641379|593733472|FG005|Overall Study|Negative PCR result|0|||
164370508|NCT02641379|593733473|FG006|Overall Study|Negative PCR result|0|||
164370509|NCT02641379|593733474|FG007|Overall Study|Negative PCR result|0|||
164370510|NCT02641379|593733475|FG008|Overall Study|Negative PCR result|0|||
164370511|NCT02641379|593733476|FG009|Overall Study|Negative PCR result|1|||
164370512|NCT02641379|593733477|FG010|Overall Study|Negative PCR result|0|||
164370513|NCT02641379|593733467|FG000|Overall Study|Participant's PCR high|0|||
164370514|NCT02641379|593733468|FG001|Overall Study|Participant's PCR high|0|||
164370515|NCT02641379|593733469|FG002|Overall Study|Participant's PCR high|0|||
164370516|NCT02641379|593733470|FG003|Overall Study|Participant's PCR high|0|||
164700350|NCT00094458|594926812|FG002|OLE: Open-Label Extension|Adverse Event|0|||
164700351|NCT00094458|594926813|FG003|OLE: Open-Label Extension|Adverse Event|0|||
164700352|NCT00094458|594926814|FG004|OLE: Open-Label Extension|Adverse Event|3|||
164700353|NCT00094458|594926815|FG005|OLE: Open-Label Extension|Adverse Event|4|||
164700354|NCT00094458|594926810|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
164370517|NCT02641379|593733471|FG004|Overall Study|Participant's PCR high|0|||
164370518|NCT02641379|593733472|FG005|Overall Study|Participant's PCR high|0|||
164370519|NCT02641379|593733473|FG006|Overall Study|Participant's PCR high|0|||
164370520|NCT02641379|593733474|FG007|Overall Study|Participant's PCR high|1|||
164370521|NCT02641379|593733475|FG008|Overall Study|Participant's PCR high|0|||
164370522|NCT02641379|593733476|FG009|Overall Study|Participant's PCR high|0|||
164370523|NCT02641379|593733477|FG010|Overall Study|Participant's PCR high|0|||
164370524|NCT02641379|593733467|FG000|Overall Study|Participant treated after Week 24|0|||
164370525|NCT02641379|593733468|FG001|Overall Study|Participant treated after Week 24|0|||
164370526|NCT02641379|593733469|FG002|Overall Study|Participant treated after Week 24|0|||
164370527|NCT02641379|593733470|FG003|Overall Study|Participant treated after Week 24|0|||
164370528|NCT02641379|593733471|FG004|Overall Study|Participant treated after Week 24|0|||
164370529|NCT02641379|593733472|FG005|Overall Study|Participant treated after Week 24|0|||
164370530|NCT02641379|593733473|FG006|Overall Study|Participant treated after Week 24|0|||
164370531|NCT02641379|593733474|FG007|Overall Study|Participant treated after Week 24|0|||
164370532|NCT02641379|593733475|FG008|Overall Study|Participant treated after Week 24|1|||
164370533|NCT02641379|593733476|FG009|Overall Study|Participant treated after Week 24|0|||
164370534|NCT02641379|593733477|FG010|Overall Study|Participant treated after Week 24|0|||
164370535|NCT02641379|593733467|FG000|Overall Study|Missing PCR result at Week 8|0|||
164370536|NCT02641379|593733468|FG001|Overall Study|Missing PCR result at Week 8|0|||
164370537|NCT02641379|593733469|FG002|Overall Study|Missing PCR result at Week 8|0|||
164370538|NCT02641379|593733470|FG003|Overall Study|Missing PCR result at Week 8|0|||
164370539|NCT02641379|593733471|FG004|Overall Study|Missing PCR result at Week 8|0|||
164370540|NCT02641379|593733472|FG005|Overall Study|Missing PCR result at Week 8|0|||
164370541|NCT02641379|593733473|FG006|Overall Study|Missing PCR result at Week 8|0|||
164370542|NCT02641379|593733474|FG007|Overall Study|Missing PCR result at Week 8|0|||
164700355|NCT00094458|594926811|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
164370543|NCT02641379|593733475|FG008|Overall Study|Missing PCR result at Week 8|0|||
164370544|NCT02641379|593733476|FG009|Overall Study|Missing PCR result at Week 8|1|||
164370545|NCT02641379|593733477|FG010|Overall Study|Missing PCR result at Week 8|0|||
164370546|NCT02641379|593733467|FG000|Overall Study|PCR positive|0|||
164370547|NCT02641379|593733468|FG001|Overall Study|PCR positive|0|||
164370548|NCT02641379|593733469|FG002|Overall Study|PCR positive|0|||
164370549|NCT02641379|593733470|FG003|Overall Study|PCR positive|0|||
164370550|NCT02641379|593733471|FG004|Overall Study|PCR positive|0|||
164370551|NCT02641379|593733472|FG005|Overall Study|PCR positive|0|||
164370552|NCT02641379|593733473|FG006|Overall Study|PCR positive|1|||
164370553|NCT02641379|593733474|FG007|Overall Study|PCR positive|0|||
164370554|NCT02641379|593733475|FG008|Overall Study|PCR positive|0|||
164370555|NCT02641379|593733476|FG009|Overall Study|PCR positive|0|||
164370556|NCT02641379|593733477|FG010|Overall Study|PCR positive|0|||
164370557|NCT01165138|593733478|FG000|Overall Study|Adverse Event|0|||
164370558|NCT01165138|593733479|FG001|Overall Study|Adverse Event|1|||
164370559|NCT01165138|593733480|FG002|Overall Study|Adverse Event|0|||
164370560|NCT01165138|593733481|FG003|Overall Study|Adverse Event|2|||
164370561|NCT01165138|593733478|FG000|Overall Study|Lack of Efficacy|0|||
164370562|NCT01165138|593733479|FG001|Overall Study|Lack of Efficacy|32|||
164370563|NCT01165138|593733480|FG002|Overall Study|Lack of Efficacy|6|||
164370564|NCT01165138|593733481|FG003|Overall Study|Lack of Efficacy|7|||
164370565|NCT01165138|593733478|FG000|Overall Study|Protocol Violation|0|||
164370566|NCT01165138|593733479|FG001|Overall Study|Protocol Violation|7|||
164370567|NCT01165138|593733480|FG002|Overall Study|Protocol Violation|0|||
164370568|NCT01165138|593733481|FG003|Overall Study|Protocol Violation|2|||
164370569|NCT01165138|593733478|FG000|Overall Study|Lost to Follow-up|0|||
164370570|NCT01165138|593733479|FG001|Overall Study|Lost to Follow-up|0|||
164370571|NCT01165138|593733480|FG002|Overall Study|Lost to Follow-up|1|||
164370572|NCT01165138|593733481|FG003|Overall Study|Lost to Follow-up|2|||
164370573|NCT01165138|593733478|FG000|Overall Study|Physician Decision|0|||
164370574|NCT01165138|593733479|FG001|Overall Study|Physician Decision|6|||
164370575|NCT01165138|593733480|FG002|Overall Study|Physician Decision|7|||
164370576|NCT01165138|593733481|FG003|Overall Study|Physician Decision|6|||
164370577|NCT01165138|593733478|FG000|Overall Study|Withdrawal by Subject|0|||
164370578|NCT01165138|593733479|FG001|Overall Study|Withdrawal by Subject|6|||
164370579|NCT01165138|593733480|FG002|Overall Study|Withdrawal by Subject|6|||
164370580|NCT01165138|593733481|FG003|Overall Study|Withdrawal by Subject|3|||
164370581|NCT01644175|593733484|FG000|Overall Study|Randomized But Not Treated|0|||
164370582|NCT01644175|593733485|FG001|Overall Study|Randomized But Not Treated|2|||
164370583|NCT01644175|593733484|FG000|Overall Study|Adverse Event|8|||
164370584|NCT01644175|593733485|FG001|Overall Study|Adverse Event|13|||
164370585|NCT01644175|593733484|FG000|Overall Study|Death|1|||
164370586|NCT01644175|593733485|FG001|Overall Study|Death|2|||
164370587|NCT01644175|593733484|FG000|Overall Study|Poor compliance to protocol|9|||
164370588|NCT01644175|593733485|FG001|Overall Study|Poor compliance to protocol|10|||
164370589|NCT01644175|593733484|FG000|Overall Study|Physician Decision|1|||
164370590|NCT01644175|593733485|FG001|Overall Study|Physician Decision|2|||
164370591|NCT01644175|593733484|FG000|Overall Study|Participant Moved|1|||
164370592|NCT01644175|593733485|FG001|Overall Study|Participant Moved|2|||
164370593|NCT01644175|593733484|FG000|Overall Study|Consent withdrawn by participant|3|||
164370594|NCT01644175|593733485|FG001|Overall Study|Consent withdrawn by participant|4|||
164370595|NCT01644175|593733484|FG000|Overall Study|Related to Autoinjector Administration|2|||
164370596|NCT01644175|593733485|FG001|Overall Study|Related to Autoinjector Administration|1|||
164370597|NCT01644175|593733484|FG000|Overall Study|Last visit outside protocol visit window|4|||
164370598|NCT01644175|593733485|FG001|Overall Study|Last visit outside protocol visit window|11|||
164370599|NCT01644175|593733484|FG000|Overall Study|Selection criteria finally not met|0|||
164370600|NCT01644175|593733485|FG001|Overall Study|Selection criteria finally not met|1|||
164370601|NCT01644175|593733484|FG000|Overall Study|Site closure|2|||
164370602|NCT01644175|593733485|FG001|Overall Study|Site closure|2|||
164370603|NCT01644175|593733484|FG000|Overall Study|Lost to Follow-up|1|||
164370604|NCT01644175|593733485|FG001|Overall Study|Lost to Follow-up|0|||
164370605|NCT01644175|593733484|FG000|Overall Study|Other than specified above|0|||
164370606|NCT01644175|593733485|FG001|Overall Study|Other than specified above|3|||
164370607|NCT01398956|593733489|FG000|Overall Study|Withdrawal by Subject|4|||
164370608|NCT01398956|593733489|FG000|Overall Study|AE, non-serious non-fatal|4|||
164370609|NCT01398956|593733489|FG000|Overall Study|Withdrawal Criteria No.3|1|||
164370610|NCT01398956|593733489|FG000|Overall Study|Subject moved a long distance|1|||
164370611|NCT00856908|593733490|FG000|Overall Study|Lost to Follow-up|1|||
164370612|NCT00856908|593733491|FG001|Overall Study|Lost to Follow-up|0|||
164370613|NCT01063595|593733495|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
164370614|NCT01063595|593733496|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
164370615|NCT01063595|593733495|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
164370616|NCT01063595|593733496|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
164370617|NCT01063595|593733495|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
164370618|NCT01063595|593733496|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
164370619|NCT01063595|593733495|FG000|First Intervention|Adverse Event|1|||
164370620|NCT01063595|593733496|FG001|First Intervention|Adverse Event|4|||
164591398|NCT00972478|594528374|FG001|Overall Study|Adverse Event|16|||
164591399|NCT00972478|594528373|FG000|Overall Study|Withdrawal by Subject|1|||
164591400|NCT00972478|594528374|FG001|Overall Study|Withdrawal by Subject|8|||
164591401|NCT00972478|594528373|FG000|Overall Study|Progression/Relapse|0|||
164591402|NCT00972478|594528374|FG001|Overall Study|Progression/Relapse|2|||
164591403|NCT00972478|594528373|FG000|Overall Study|Death|0|||
164370621|NCT01063595|593733495|FG000|First Intervention|Withdrawal by Subject|1|||
164370622|NCT01063595|593733496|FG001|First Intervention|Withdrawal by Subject|0|||
164370623|NCT01063595|593733495|FG000|First Intervention|Reason not Specified|0|||
164370624|NCT01063595|593733496|FG001|First Intervention|Reason not Specified|1|||
164370625|NCT00451035|593733497|FG000|Overall Study|Disease progression|11|||
164370626|NCT00451035|593733497|FG000|Overall Study|Death|3|||
164370627|NCT00451035|593733497|FG000|Overall Study|New anti-neoplastic therapy|3|||
164370628|NCT01623596|593733498|FG000|Overall Study|Abnormal laboratory values|2|||
164370629|NCT01623596|593733499|FG001|Overall Study|Abnormal laboratory values|0|||
164370630|NCT01623596|593733498|FG000|Overall Study|Administrative problems|9|||
164370631|NCT01623596|593733499|FG001|Overall Study|Administrative problems|13|||
164370632|NCT01623596|593733498|FG000|Overall Study|Adverse Event|20|||
164370633|NCT01623596|593733499|FG001|Overall Study|Adverse Event|29|||
164370634|NCT01623596|593733498|FG000|Overall Study|Death|0|||
164370635|NCT01623596|593733499|FG001|Overall Study|Death|2|||
164370636|NCT01623596|593733498|FG000|Overall Study|Lost to Follow-up|12|||
164370637|NCT01623596|593733499|FG001|Overall Study|Lost to Follow-up|16|||
164370638|NCT01623596|593733498|FG000|Overall Study|Withdrawal by Subject|13|||
164370639|NCT01623596|593733499|FG001|Overall Study|Withdrawal by Subject|31|||
164370640|NCT01623596|593733498|FG000|Overall Study|Patient no longer requires study drug|1|||
164370641|NCT01623596|593733499|FG001|Overall Study|Patient no longer requires study drug|0|||
164370642|NCT01623596|593733498|FG000|Overall Study|Protocol Violation|0|||
164370643|NCT01623596|593733499|FG001|Overall Study|Protocol Violation|6|||
164370644|NCT01623596|593733498|FG000|Overall Study|Lack of Efficacy|5|||
164370645|NCT01623596|593733499|FG001|Overall Study|Lack of Efficacy|3|||
164370646|NCT04059146|593733500|FG000|Overall Study|Withdrawal by Subject|0|||
164370647|NCT04059146|593733501|FG001|Overall Study|Withdrawal by Subject|1|||
164370648|NCT01712256|593733507|FG000|Overall Study|Lost to Follow-up|1|||
164370649|NCT00962104|593733510|FG000|Overall Study|Adverse Event|10|||
164370650|NCT00962104|593733511|FG001|Overall Study|Adverse Event|3|||
164370651|NCT00962104|593733510|FG000|Overall Study|Entry Criteria Not Met|1|||
164370652|NCT00962104|593733511|FG001|Overall Study|Entry Criteria Not Met|2|||
164370653|NCT00962104|593733510|FG000|Overall Study|Lack of Efficacy|0|||
164370654|NCT00962104|593733511|FG001|Overall Study|Lack of Efficacy|1|||
164370655|NCT00962104|593733510|FG000|Overall Study|Lost to Follow-up|10|||
164370656|NCT00962104|593733511|FG001|Overall Study|Lost to Follow-up|4|||
164370657|NCT00962104|593733510|FG000|Overall Study|Physician Decision|1|||
164370658|NCT00962104|593733511|FG001|Overall Study|Physician Decision|0|||
164370659|NCT00962104|593733510|FG000|Overall Study|Protocol Violation|6|||
164370660|NCT00962104|593733511|FG001|Overall Study|Protocol Violation|8|||
164370661|NCT00962104|593733510|FG000|Overall Study|Sponsor Decision|0|||
164370662|NCT00962104|593733511|FG001|Overall Study|Sponsor Decision|1|||
164370663|NCT00962104|593733510|FG000|Overall Study|Withdrawal by Subject|10|||
164370664|NCT00962104|593733511|FG001|Overall Study|Withdrawal by Subject|6|||
164370665|NCT00962104|593733510|FG000|Overall Study|Other|2|||
164370666|NCT00962104|593733511|FG001|Overall Study|Other|0|||
164370667|NCT03274986|593733512|FG000|Overall Study|Withdrawal by Subject|0|||
164370668|NCT03274986|593733513|FG001|Overall Study|Withdrawal by Subject|1|||
164370669|NCT03274986|593733512|FG000|Overall Study|Lost to Follow-up|0|||
164370670|NCT03274986|593733513|FG001|Overall Study|Lost to Follow-up|1|||
164370671|NCT01524627|593733515|FG000|Overall Study|Physician Decision|0|||
164370672|NCT01524627|593733516|FG001|Overall Study|Physician Decision|1|||
164370673|NCT01524627|593733515|FG000|Overall Study|Lost to Follow-up|1|||
164370674|NCT01524627|593733516|FG001|Overall Study|Lost to Follow-up|1|||
164370675|NCT05627518|593733519|FG000|Treatment Period 1|Adverse Event|0|||
164370676|NCT05627518|593733520|FG001|Treatment Period 1|Adverse Event|0|||
164370677|NCT05627518|593733521|FG002|Treatment Period 1|Adverse Event|1|||
164370678|NCT05627518|593733522|FG003|Treatment Period 1|Adverse Event|0|||
164370679|NCT05627518|593733523|FG004|Treatment Period 1|Adverse Event|0|||
164370680|NCT05627518|593733524|FG005|Treatment Period 1|Adverse Event|0|||
164370681|NCT05627518|593733525|FG006|Treatment Period 1|Adverse Event|0|||
164370682|NCT05627518|593733526|FG007|Treatment Period 1|Adverse Event|1|||
164370683|NCT05627518|593733519|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164370684|NCT05627518|593733520|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164370685|NCT05627518|593733521|FG002|Treatment Period 1|Withdrawal by Subject|1|||
164370686|NCT05627518|593733522|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164370687|NCT05627518|593733523|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164370688|NCT05627518|593733524|FG005|Treatment Period 1|Withdrawal by Subject|1|||
164370689|NCT05627518|593733525|FG006|Treatment Period 1|Withdrawal by Subject|0|||
164370690|NCT05627518|593733526|FG007|Treatment Period 1|Withdrawal by Subject|0|||
164370691|NCT05627518|593733519|FG000|Treatment Period 1|Protocol Violation|0|||
164370692|NCT05627518|593733520|FG001|Treatment Period 1|Protocol Violation|0|||
164591404|NCT00972478|594528374|FG001|Overall Study|Death|2|||
164370693|NCT05627518|593733521|FG002|Treatment Period 1|Protocol Violation|0|||
164370694|NCT05627518|593733522|FG003|Treatment Period 1|Protocol Violation|0|||
164370695|NCT05627518|593733523|FG004|Treatment Period 1|Protocol Violation|0|||
164370696|NCT05627518|593733524|FG005|Treatment Period 1|Protocol Violation|0|||
164370697|NCT05627518|593733525|FG006|Treatment Period 1|Protocol Violation|6|||
164370698|NCT05627518|593733526|FG007|Treatment Period 1|Protocol Violation|6|||
164370699|NCT05627518|593733519|FG000|Treatment Period 2|Adverse Event|1|||
164370700|NCT05627518|593733520|FG001|Treatment Period 2|Adverse Event|0|||
164370701|NCT05627518|593733521|FG002|Treatment Period 2|Adverse Event|0|||
164370702|NCT05627518|593733522|FG003|Treatment Period 2|Adverse Event|0|||
164370703|NCT05627518|593733523|FG004|Treatment Period 2|Adverse Event|0|||
164370704|NCT05627518|593733524|FG005|Treatment Period 2|Adverse Event|0|||
164370705|NCT05627518|593733525|FG006|Treatment Period 2|Adverse Event|0|||
164370706|NCT05627518|593733526|FG007|Treatment Period 2|Adverse Event|0|||
164370707|NCT05627518|593733519|FG000|Treatment Period 2|Withdrawal by Subject|1|||
164370708|NCT05627518|593733520|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164370709|NCT05627518|593733521|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164370710|NCT05627518|593733522|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164370711|NCT05627518|593733523|FG004|Treatment Period 2|Withdrawal by Subject|0|||
164370712|NCT05627518|593733524|FG005|Treatment Period 2|Withdrawal by Subject|0|||
164370713|NCT05627518|593733525|FG006|Treatment Period 2|Withdrawal by Subject|0|||
164370714|NCT05627518|593733526|FG007|Treatment Period 2|Withdrawal by Subject|0|||
164370715|NCT01101841|593735826|FG000|Overall Study|Adverse Event|15|||
164370716|NCT01101841|593735827|FG001|Overall Study|Adverse Event|15|||
164370717|NCT01101841|593735826|FG000|Overall Study|Lost to Follow-up|9|||
164370718|NCT01101841|593735827|FG001|Overall Study|Lost to Follow-up|3|||
164370719|NCT01101841|593735826|FG000|Overall Study|Withdrawal by Subject|21|||
164370720|NCT01101841|593735827|FG001|Overall Study|Withdrawal by Subject|40|||
164370721|NCT01101841|593735826|FG000|Overall Study|Protocol Violation|1|||
164370722|NCT01101841|593735827|FG001|Overall Study|Protocol Violation|1|||
164370723|NCT01101841|593735826|FG000|Overall Study|Physician Decision|0|||
164370724|NCT01101841|593735827|FG001|Overall Study|Physician Decision|2|||
164370725|NCT01101841|593735826|FG000|Overall Study|Lack of Efficacy|0|||
164370726|NCT01101841|593735827|FG001|Overall Study|Lack of Efficacy|2|||
164370727|NCT01101841|593735826|FG000|Overall Study|Other|0|||
164370728|NCT01101841|593735827|FG001|Overall Study|Other|1|||
164370729|NCT01101841|593735826|FG000|Overall Study|Suicidality Tracking Scale|3|||
164370730|NCT01101841|593735827|FG001|Overall Study|Suicidality Tracking Scale|1|||
164370731|NCT01101841|593735826|FG000|Overall Study|Eligibility Criteria|1|||
164370732|NCT01101841|593735827|FG001|Overall Study|Eligibility Criteria|2|||
164370733|NCT00145509|593735830|FG000|Overall Study|Adverse Event|10|||
164370734|NCT00145509|593735831|FG001|Overall Study|Adverse Event|3|||
164370735|NCT00145509|593735830|FG000|Overall Study|Lack of Efficacy|3|||
164370736|NCT00145509|593735831|FG001|Overall Study|Lack of Efficacy|1|||
164370737|NCT00145509|593735830|FG000|Overall Study|Lost to Follow-up|5|||
164370738|NCT00145509|593735831|FG001|Overall Study|Lost to Follow-up|9|||
164370739|NCT00145509|593735830|FG000|Overall Study|Withdrew Consent|2|||
164370740|NCT00145509|593735831|FG001|Overall Study|Withdrew Consent|7|||
164370741|NCT00145509|593735830|FG000|Overall Study|Reason not provided|2|||
164370742|NCT00145509|593735831|FG001|Overall Study|Reason not provided|1|||
164370743|NCT00697346|593735836|FG000|Overall Study|Adverse Event|4|||
164370744|NCT00697346|593735837|FG001|Overall Study|Adverse Event|5|||
164370745|NCT00697346|593735838|FG002|Overall Study|Adverse Event|0|||
164370746|NCT00697346|593735836|FG000|Overall Study|Progressive Disease|19|||
164370747|NCT00697346|593735837|FG001|Overall Study|Progressive Disease|18|||
164370748|NCT00697346|593735838|FG002|Overall Study|Progressive Disease|0|||
164370749|NCT00697346|593735836|FG000|Overall Study|Symptomatic Deterioration|0|||
164370750|NCT00697346|593735837|FG001|Overall Study|Symptomatic Deterioration|1|||
164370751|NCT00697346|593735838|FG002|Overall Study|Symptomatic Deterioration|0|||
164370752|NCT00697346|593735836|FG000|Overall Study|Withdrawal by Subject|2|||
164370753|NCT00697346|593735837|FG001|Overall Study|Withdrawal by Subject|2|||
164370754|NCT00697346|593735838|FG002|Overall Study|Withdrawal by Subject|0|||
164370755|NCT00697346|593735836|FG000|Overall Study|Reason not Specified|3|||
164370756|NCT00697346|593735837|FG001|Overall Study|Reason not Specified|0|||
164370757|NCT00697346|593735838|FG002|Overall Study|Reason not Specified|1|||
164370758|NCT03569371|593735839|FG000|Overall Study|Lack of Efficacy|1|||
164700356|NCT00094458|594926812|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
164700357|NCT00094458|594926813|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
164700358|NCT00094458|594926814|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
164700359|NCT00094458|594926815|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
164370759|NCT03569371|593735839|FG000|Overall Study|Lost to Follow-up|1|||
164700360|NCT00094458|594926810|FG000|OLE: Open-Label Extension|Patient decision|0|||
164370760|NCT03569371|593735839|FG000|Overall Study|Adverse Event|1|||
164370761|NCT03643562|593735840|FG000|Overall Study|Adverse Event|1|||
164370762|NCT03643562|593735841|FG001|Overall Study|Adverse Event|0|||
164370763|NCT03643562|593735840|FG000|Overall Study|Lack of Efficacy|0|||
164370764|NCT03643562|593735841|FG001|Overall Study|Lack of Efficacy|1|||
164370765|NCT03643562|593735840|FG000|Overall Study|Physician Decision|0|||
164370766|NCT03643562|593735841|FG001|Overall Study|Physician Decision|1|||
164370767|NCT03643562|593735840|FG000|Overall Study|Study Terminated by Sponsor|2|||
164370768|NCT03643562|593735841|FG001|Overall Study|Study Terminated by Sponsor|10|||
164370769|NCT03643562|593735840|FG000|Overall Study|Withdrawal by Subject|2|||
164700361|NCT00094458|594926811|FG001|OLE: Open-Label Extension|Patient decision|0|||
164591405|NCT00972478|594528373|FG000|Overall Study|Not protocol specified|1|||
164591406|NCT00972478|594528374|FG001|Overall Study|Not protocol specified|1|||
164591407|NCT00972478|594528373|FG000|Overall Study|Ineligible|1|||
164591408|NCT00972478|594528374|FG001|Overall Study|Ineligible|7|||
164591409|NCT00972478|594528373|FG000|Overall Study|Not start protocol treatment|1|||
164591410|NCT00972478|594528374|FG001|Overall Study|Not start protocol treatment|2|||
164591411|NCT04742907|594528375|FG000|Overall Study|Adverse Event|1|||
164591412|NCT04742907|594528376|FG001|Overall Study|Adverse Event|0|||
164591413|NCT04742907|594528377|FG002|Overall Study|Adverse Event|1|||
164591414|NCT04742907|594528375|FG000|Overall Study|Lost to Follow-up|3|||
164591415|NCT04742907|594528376|FG001|Overall Study|Lost to Follow-up|3|||
164591416|NCT04742907|594528377|FG002|Overall Study|Lost to Follow-up|2|||
164591417|NCT04742907|594528375|FG000|Overall Study|Physician Decision|0|||
164591418|NCT04742907|594528376|FG001|Overall Study|Physician Decision|1|||
164591419|NCT04742907|594528377|FG002|Overall Study|Physician Decision|0|||
164591420|NCT04742907|594528375|FG000|Overall Study|Protocol Violation|1|||
164591421|NCT04742907|594528376|FG001|Overall Study|Protocol Violation|1|||
164591422|NCT04742907|594528377|FG002|Overall Study|Protocol Violation|1|||
164591423|NCT04742907|594528375|FG000|Overall Study|Withdrawal by Subject|5|||
164591424|NCT04742907|594528376|FG001|Overall Study|Withdrawal by Subject|6|||
164700362|NCT00094458|594926812|FG002|OLE: Open-Label Extension|Patient decision|0|||
164700363|NCT00094458|594926813|FG003|OLE: Open-Label Extension|Patient decision|0|||
164700364|NCT00094458|594926814|FG004|OLE: Open-Label Extension|Patient decision|1|||
164591425|NCT04742907|594528377|FG002|Overall Study|Withdrawal by Subject|4|||
164591426|NCT04742907|594528375|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
164591427|NCT04742907|594528376|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
164591428|NCT04742907|594528377|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
164591429|NCT04742907|594528375|FG000|Overall Study|Did Not Receive the Study Drug|2|||
164591430|NCT04742907|594528376|FG001|Overall Study|Did Not Receive the Study Drug|4|||
164591431|NCT04742907|594528377|FG002|Overall Study|Did Not Receive the Study Drug|4|||
164591432|NCT01259856|594528378|FG000|Overall Study|Adverse Event|12|||
164700365|NCT00094458|594926815|FG005|OLE: Open-Label Extension|Patient decision|0|||
164370770|NCT03643562|593735841|FG001|Overall Study|Withdrawal by Subject|2|||
164370771|NCT03643562|593735840|FG000|Overall Study|Other than specified|3|||
164370772|NCT03643562|593735841|FG001|Overall Study|Other than specified|2|||
164370773|NCT01982253|593735844|FG000|Overall Study|Withdrawal by Subject|1|||
164370774|NCT01982253|593735845|FG001|Overall Study|Withdrawal by Subject|0|||
164370775|NCT01982253|593735846|FG002|Overall Study|Withdrawal by Subject|0|||
164370776|NCT01982253|593735844|FG000|Overall Study|Study terminated by sponsor|1|||
164370777|NCT01982253|593735845|FG001|Overall Study|Study terminated by sponsor|4|||
164370778|NCT01982253|593735846|FG002|Overall Study|Study terminated by sponsor|4|||
164370779|NCT02223767|593735850|FG000|Overall Study|Withdrawal by Subject|4|||
164370780|NCT02223767|593735851|FG001|Overall Study|Withdrawal by Subject|4|||
164370781|NCT02789176|593735852|FG000|Overall Study|Death|0|||
164370782|NCT02789176|593735853|FG001|Overall Study|Death|0|||
164370783|NCT02789176|593735854|FG002|Overall Study|Death|3|||
164370784|NCT02789176|593735855|FG003|Overall Study|Death|0|||
164370785|NCT02789176|593735852|FG000|Overall Study|Withdrawal by Subject|0|||
164370786|NCT02789176|593735853|FG001|Overall Study|Withdrawal by Subject|0|||
164370787|NCT02789176|593735854|FG002|Overall Study|Withdrawal by Subject|1|||
164370788|NCT02789176|593735855|FG003|Overall Study|Withdrawal by Subject|0|||
164370789|NCT02789176|593735852|FG000|Overall Study|Lost to Follow-up|8|||
164370790|NCT02789176|593735853|FG001|Overall Study|Lost to Follow-up|2|||
164370791|NCT02789176|593735854|FG002|Overall Study|Lost to Follow-up|6|||
164370792|NCT02789176|593735855|FG003|Overall Study|Lost to Follow-up|1|||
164700366|NCT03247517|594926816|FG000|Overall Study|Adverse Event|0|||
164370793|NCT00770120|593735861|FG000|Overall Study|Progression|31|||
164591433|NCT01259856|594528379|FG001|Overall Study|Adverse Event|9|||
164591434|NCT01259856|594528378|FG000|Overall Study|Death|0|||
164591435|NCT01259856|594528379|FG001|Overall Study|Death|1|||
164591436|NCT01259856|594528378|FG000|Overall Study|Lack of Efficacy|3|||
164370794|NCT00770120|593735861|FG000|Overall Study|Adverse Event|11|||
164370795|NCT00770120|593735861|FG000|Overall Study|Not Protocol Specified|11|||
164370796|NCT00770120|593735861|FG000|Overall Study|Death|3|||
164370797|NCT00770120|593735861|FG000|Overall Study|Withdrawal by Subject|2|||
164370798|NCT00770120|593735861|FG000|Overall Study|Ineligible|1|||
164370799|NCT00770120|593735861|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
164370800|NCT00770120|593735861|FG000|Overall Study|Reason under Review|1|||
164370801|NCT02412631|593735862|FG000|Overall Study|Adverse Event|1|||
164591437|NCT01259856|594528379|FG001|Overall Study|Lack of Efficacy|1|||
164591438|NCT01259856|594528378|FG000|Overall Study|Lost to Follow-up|1|||
164591439|NCT01259856|594528379|FG001|Overall Study|Lost to Follow-up|1|||
164591440|NCT01259856|594528378|FG000|Overall Study|Physician Decision|2|||
164591441|NCT01259856|594528379|FG001|Overall Study|Physician Decision|1|||
164591442|NCT01259856|594528378|FG000|Overall Study|Withdrawal by Subject|9|||
164591443|NCT01259856|594528379|FG001|Overall Study|Withdrawal by Subject|10|||
164700367|NCT03247517|594926817|FG001|Overall Study|Adverse Event|4|||
164370802|NCT02412631|593735863|FG001|Overall Study|Adverse Event|2|||
164370803|NCT02412631|593735862|FG000|Overall Study|Lost to Follow-up|5|||
164370804|NCT02412631|593735863|FG001|Overall Study|Lost to Follow-up|9|||
164370805|NCT02412631|593735862|FG000|Overall Study|Withdrawal by Subject|9|||
164370806|NCT02412631|593735863|FG001|Overall Study|Withdrawal by Subject|3|||
164370807|NCT02412631|593735862|FG000|Overall Study|Early stop by FDA|5|||
164370808|NCT02412631|593735863|FG001|Overall Study|Early stop by FDA|2|||
164370809|NCT02412631|593735862|FG000|Overall Study|Unspecified reason|6|||
164370810|NCT02412631|593735863|FG001|Overall Study|Unspecified reason|8|||
164370811|NCT03100825|593735868|FG000|Overall Study|Participant/Guardian Decision|7|||
164370812|NCT03100825|593735868|FG000|Overall Study|Physician Decision|1|||
164370813|NCT00994448|593735869|FG000|Overall Study|Adverse Event|1|||
164370814|NCT00994448|593735870|FG001|Overall Study|Adverse Event|0|||
164370815|NCT00994448|593735869|FG000|Overall Study|Lost to Follow-up|5|||
164370816|NCT00994448|593735870|FG001|Overall Study|Lost to Follow-up|1|||
164370817|NCT00994448|593735869|FG000|Overall Study|Withdrawal by Subject|1|||
164370818|NCT00994448|593735870|FG001|Overall Study|Withdrawal by Subject|1|||
164370819|NCT00994448|593735869|FG000|Overall Study|Physician Decision|1|||
164370820|NCT00994448|593735870|FG001|Overall Study|Physician Decision|0|||
164370821|NCT05288556|593735872|FG000|Overall Study|Protocol Violation|1|||
164370822|NCT05288556|593735872|FG000|Overall Study|Withdrawal by Subject|1|||
164370823|NCT02704364|593735873|FG000|Overall Study|Adverse Event|1|||
164370824|NCT02704364|593735874|FG001|Overall Study|Adverse Event|1|||
164370825|NCT02704364|593735875|FG002|Overall Study|Adverse Event|0|||
164370826|NCT02704364|593735873|FG000|Overall Study|Noncompliance with study drug|1|||
164370827|NCT02704364|593735874|FG001|Overall Study|Noncompliance with study drug|1|||
164370828|NCT02704364|593735875|FG002|Overall Study|Noncompliance with study drug|0|||
164370829|NCT02704364|593735873|FG000|Overall Study|Other|0|||
164370830|NCT02704364|593735874|FG001|Overall Study|Other|1|||
164370831|NCT02704364|593735875|FG002|Overall Study|Other|1|||
164370832|NCT01232296|593735876|FG000|Overall Study|Adverse Event|24|||
164370833|NCT01232296|593735877|FG001|Overall Study|Adverse Event|12|||
164370834|NCT01232296|593735876|FG000|Overall Study|Physician Decision|1|||
164370835|NCT01232296|593735877|FG001|Overall Study|Physician Decision|1|||
164370836|NCT01232296|593735876|FG000|Overall Study|Progressive disease|43|||
164370837|NCT01232296|593735877|FG001|Overall Study|Progressive disease|61|||
164370838|NCT01232296|593735876|FG000|Overall Study|Study terminated by sponsor|0|||
164370839|NCT01232296|593735877|FG001|Overall Study|Study terminated by sponsor|1|||
164370840|NCT01232296|593735876|FG000|Overall Study|Technical problems|3|||
164370841|NCT01232296|593735877|FG001|Overall Study|Technical problems|0|||
164370842|NCT01232296|593735876|FG000|Overall Study|Subject/guardian decision|10|||
164370843|NCT01232296|593735877|FG001|Overall Study|Subject/guardian decision|2|||
164370844|NCT01232296|593735876|FG000|Overall Study|Death|1|||
164370845|NCT01232296|593735877|FG001|Overall Study|Death|6|||
164370846|NCT01461096|593735879|FG000|Overall Study|Death|3|||
164370847|NCT01461096|593735880|FG001|Overall Study|Death|6|||
164370848|NCT01461096|593735879|FG000|Overall Study|Severe debilitation, unable to continue|1|||
164370849|NCT01461096|593735880|FG001|Overall Study|Severe debilitation, unable to continue|1|||
164370850|NCT01461096|593735879|FG000|Overall Study|Subj not able to get to clinic|15|||
164370851|NCT01461096|593735880|FG001|Overall Study|Subj not able to get to clinic|13|||
164370852|NCT01461096|593735879|FG000|Overall Study|Site is closing|27|||
164370853|NCT01461096|593735880|FG001|Overall Study|Site is closing|30|||
164370854|NCT01461096|593735879|FG000|Overall Study|Withdrawal by Subject|5|||
164370855|NCT01461096|593735880|FG001|Overall Study|Withdrawal by Subject|3|||
164370856|NCT01461096|593735879|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
164370857|NCT01461096|593735880|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
164370858|NCT01461096|593735879|FG000|Overall Study|Lost to Follow-up|8|||
164370859|NCT01461096|593735880|FG001|Overall Study|Lost to Follow-up|4|||
164438975|NCT00716144|593973100|FG000|Overall Study|Non-compliance|1|||
164438976|NCT00716144|593973101|FG001|Overall Study|Non-compliance|0|||
164591444|NCT01259856|594528378|FG000|Overall Study|Treatment never started|0|||
164591445|NCT01259856|594528379|FG001|Overall Study|Treatment never started|6|||
164591446|NCT01259856|594528378|FG000|Overall Study|Study closure by sponsor|40|||
164370860|NCT04889625|593735882|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
164370861|NCT04889625|593735883|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
164370862|NCT04889625|593735882|FG000|Period 1|Subject out of window|0|||
164370863|NCT04889625|593735883|FG001|Period 1|Subject out of window|1|||
164370864|NCT04889625|593735882|FG000|Period 1|Wrong add power dispensed|0|||
164370865|NCT04889625|593735883|FG001|Period 1|Wrong add power dispensed|1|||
164370866|NCT04889625|593735882|FG000|Period 1|Discontinued due to fitting guide error|1|||
164591447|NCT01259856|594528379|FG001|Overall Study|Study closure by sponsor|41|||
164591448|NCT01259856|594528378|FG000|Overall Study|Patient developed other disease|0|||
164370867|NCT04889625|593735883|FG001|Period 1|Discontinued due to fitting guide error|1|||
164370868|NCT04889625|593735882|FG000|Period 2|Test article no longer available|1|||
164370869|NCT04889625|593735883|FG001|Period 2|Test article no longer available|0|||
164370870|NCT04889625|593735882|FG000|Period 2|Incorrect lens dispensed|1|||
164591449|NCT01259856|594528379|FG001|Overall Study|Patient developed other disease|1|||
164370871|NCT04889625|593735883|FG001|Period 2|Incorrect lens dispensed|0|||
164370872|NCT04889625|593735882|FG000|Period 2|Wrong add power dispensed|0|||
164370873|NCT04889625|593735883|FG001|Period 2|Wrong add power dispensed|1|||
164370874|NCT00404352|593735884|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
164370875|NCT00404352|593735885|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
164370876|NCT00404352|593735886|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
164370877|NCT00404352|593735887|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
164370878|NCT00404352|593735888|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
164370879|NCT00404352|593735889|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
164370880|NCT00404352|593735890|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
164370881|NCT00404352|593735891|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
164370882|NCT00404352|593735892|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
164370883|NCT00404352|593735884|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
164370884|NCT00404352|593735885|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
164370885|NCT00404352|593735886|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
164370886|NCT00404352|593735887|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
164370887|NCT00404352|593735888|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
164370888|NCT00404352|593735889|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
164370889|NCT00404352|593735890|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
164370890|NCT00404352|593735891|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
164370891|NCT00404352|593735892|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
164370892|NCT00404352|593735884|FG000|Double Blind (up to 24 Month)|Death|0|||
164370893|NCT00404352|593735885|FG001|Double Blind (up to 24 Month)|Death|0|||
164370894|NCT00404352|593735886|FG002|Double Blind (up to 24 Month)|Death|1|||
164370895|NCT00404352|593735887|FG003|Double Blind (up to 24 Month)|Death|0|||
164370896|NCT00404352|593735888|FG004|Double Blind (up to 24 Month)|Death|0|||
164370897|NCT00404352|593735889|FG005|Double Blind (up to 24 Month)|Death|0|||
164370898|NCT00404352|593735890|FG006|Double Blind (up to 24 Month)|Death|0|||
164370899|NCT00404352|593735891|FG007|Double Blind (up to 24 Month)|Death|0|||
164370900|NCT00404352|593735892|FG008|Double Blind (up to 24 Month)|Death|0|||
164370901|NCT00404352|593735884|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
164370902|NCT00404352|593735885|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
164370903|NCT00404352|593735886|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
164370904|NCT00404352|593735887|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
164370905|NCT00404352|593735888|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
164370906|NCT00404352|593735889|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
164370907|NCT00404352|593735890|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
164370908|NCT00404352|593735891|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
164370909|NCT00404352|593735892|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
164370910|NCT00404352|593735884|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
164370911|NCT00404352|593735885|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
164370912|NCT00404352|593735886|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
164370913|NCT00404352|593735887|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
164370914|NCT00404352|593735888|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
164370915|NCT00404352|593735889|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
164370916|NCT00404352|593735890|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
164370917|NCT00404352|593735891|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
164370918|NCT00404352|593735892|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
164370919|NCT00404352|593735884|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
164370920|NCT00404352|593735885|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
164370921|NCT00404352|593735886|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
164370922|NCT00404352|593735887|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
164370923|NCT00404352|593735888|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
164370924|NCT00404352|593735889|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
164438977|NCT00716144|593973102|FG002|Overall Study|Non-compliance|0|||
164700368|NCT03247517|594926818|FG002|Overall Study|Adverse Event|2|||
164700369|NCT03247517|594926816|FG000|Overall Study|Lost to Follow-up|2|||
164700370|NCT03247517|594926817|FG001|Overall Study|Lost to Follow-up|6|||
164700371|NCT03247517|594926818|FG002|Overall Study|Lost to Follow-up|4|||
164700372|NCT03247517|594926816|FG000|Overall Study|Consent withdrawn by caregiver|1|||
164700373|NCT03247517|594926817|FG001|Overall Study|Consent withdrawn by caregiver|4|||
164700374|NCT03247517|594926818|FG002|Overall Study|Consent withdrawn by caregiver|7|||
164700375|NCT03247517|594926816|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
164700376|NCT03247517|594926817|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
164700377|NCT03247517|594926818|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
164700378|NCT03247517|594926816|FG000|Overall Study|Protocol Violation|0|||
164700379|NCT03247517|594926817|FG001|Overall Study|Protocol Violation|2|||
164700380|NCT03247517|594926818|FG002|Overall Study|Protocol Violation|0|||
164700381|NCT03247517|594926816|FG000|Overall Study|Multiple reasons|3|||
164370925|NCT00404352|593735890|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
164370926|NCT00404352|593735891|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
164370927|NCT00404352|593735892|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
164370928|NCT00404352|593735884|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
164370929|NCT00404352|593735885|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
164370930|NCT00404352|593735886|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
164370931|NCT00404352|593735887|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
164370932|NCT00404352|593735888|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
164370933|NCT00404352|593735889|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
164370934|NCT00404352|593735890|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
164370935|NCT00404352|593735891|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
164370936|NCT00404352|593735892|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
164370937|NCT00404352|593735884|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
164370938|NCT00404352|593735885|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
164370939|NCT00404352|593735886|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
164370940|NCT00404352|593735887|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
164370941|NCT00404352|593735888|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
164370942|NCT00404352|593735889|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
164370943|NCT00404352|593735890|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
164370944|NCT00404352|593735891|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
164370945|NCT00404352|593735892|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
164370946|NCT00404352|593735884|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
164370947|NCT00404352|593735885|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
164370948|NCT00404352|593735886|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
164370949|NCT00404352|593735887|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
164370950|NCT00404352|593735888|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
164370951|NCT00404352|593735889|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
164370952|NCT00404352|593735890|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
164370953|NCT00404352|593735891|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
164370954|NCT00404352|593735892|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
164370955|NCT00404352|593735884|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
164370956|NCT00404352|593735885|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
164370957|NCT00404352|593735886|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
164370958|NCT00404352|593735887|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
164370959|NCT00404352|593735888|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
164370960|NCT00404352|593735889|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
164370961|NCT00404352|593735890|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
164370962|NCT00404352|593735891|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
164370963|NCT00404352|593735892|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
164370964|NCT00404352|593735884|FG000|Double Blind (up to 24 Month)|Other|0|||
164370965|NCT00404352|593735885|FG001|Double Blind (up to 24 Month)|Other|1|||
164370966|NCT00404352|593735886|FG002|Double Blind (up to 24 Month)|Other|0|||
164370967|NCT00404352|593735887|FG003|Double Blind (up to 24 Month)|Other|0|||
164370968|NCT00404352|593735888|FG004|Double Blind (up to 24 Month)|Other|0|||
164370969|NCT00404352|593735889|FG005|Double Blind (up to 24 Month)|Other|0|||
164370970|NCT00404352|593735890|FG006|Double Blind (up to 24 Month)|Other|0|||
164370971|NCT00404352|593735891|FG007|Double Blind (up to 24 Month)|Other|0|||
164370972|NCT00404352|593735892|FG008|Double Blind (up to 24 Month)|Other|0|||
164370973|NCT00404352|593735884|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
164370974|NCT00404352|593735885|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
164370975|NCT00404352|593735886|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
164370976|NCT00404352|593735887|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
164370977|NCT00404352|593735888|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
164370978|NCT00404352|593735889|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
164370979|NCT00404352|593735890|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
164370980|NCT00404352|593735891|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
164370981|NCT00404352|593735892|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
164370982|NCT00404352|593735884|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
164370983|NCT00404352|593735885|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
164370984|NCT00404352|593735886|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
164700382|NCT03247517|594926817|FG001|Overall Study|Multiple reasons|1|||
164700383|NCT03247517|594926818|FG002|Overall Study|Multiple reasons|0|||
164370985|NCT00404352|593735887|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
164370986|NCT00404352|593735888|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
164700384|NCT03310411|594926819|FG000|Period 1|Adverse Event|0|||
164370987|NCT00404352|593735889|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
164370988|NCT00404352|593735890|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
164370989|NCT00404352|593735891|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
164370990|NCT00404352|593735892|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
164370991|NCT00404352|593735884|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
164700385|NCT03310411|594926820|FG001|Period 1|Adverse Event|0|||
164370992|NCT00404352|593735885|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
164370993|NCT00404352|593735886|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
164370994|NCT00404352|593735887|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
164370995|NCT00404352|593735888|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
164370996|NCT00404352|593735889|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
164370997|NCT00404352|593735890|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
164370998|NCT00404352|593735891|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
164370999|NCT00404352|593735892|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
164371000|NCT00404352|593735884|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
164371001|NCT00404352|593735885|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
164371002|NCT00404352|593735886|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
164371003|NCT00404352|593735887|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
164371004|NCT00404352|593735888|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
164371005|NCT00404352|593735889|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
164371006|NCT00404352|593735890|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
164371007|NCT00404352|593735891|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
164371008|NCT00404352|593735892|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
164371009|NCT00404352|593735884|FG000|Open Label (up to 24 Month)|Disease progression|0|||
164371010|NCT00404352|593735885|FG001|Open Label (up to 24 Month)|Disease progression|0|||
164371011|NCT00404352|593735886|FG002|Open Label (up to 24 Month)|Disease progression|0|||
164371012|NCT00404352|593735887|FG003|Open Label (up to 24 Month)|Disease progression|1|||
164371013|NCT00404352|593735888|FG004|Open Label (up to 24 Month)|Disease progression|0|||
164371014|NCT00404352|593735889|FG005|Open Label (up to 24 Month)|Disease progression|0|||
164371015|NCT00404352|593735890|FG006|Open Label (up to 24 Month)|Disease progression|0|||
164371016|NCT00404352|593735891|FG007|Open Label (up to 24 Month)|Disease progression|0|||
164371017|NCT00404352|593735892|FG008|Open Label (up to 24 Month)|Disease progression|0|||
164371018|NCT00404352|593735884|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
164371019|NCT00404352|593735885|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
164371020|NCT00404352|593735886|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
164371021|NCT00404352|593735887|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
164371022|NCT00404352|593735888|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
164371023|NCT00404352|593735889|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
164371024|NCT00404352|593735890|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
164371025|NCT00404352|593735891|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
164371026|NCT00404352|593735892|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
164371027|NCT00404352|593735884|FG000|Open Label Extension (up to 36 Months)|Other|0|||
164371028|NCT00404352|593735885|FG001|Open Label Extension (up to 36 Months)|Other|0|||
164371029|NCT00404352|593735886|FG002|Open Label Extension (up to 36 Months)|Other|0|||
164371030|NCT00404352|593735887|FG003|Open Label Extension (up to 36 Months)|Other|0|||
164371031|NCT00404352|593735888|FG004|Open Label Extension (up to 36 Months)|Other|0|||
164371032|NCT00404352|593735889|FG005|Open Label Extension (up to 36 Months)|Other|0|||
164371033|NCT00404352|593735890|FG006|Open Label Extension (up to 36 Months)|Other|0|||
164371034|NCT00404352|593735891|FG007|Open Label Extension (up to 36 Months)|Other|0|||
164371035|NCT00404352|593735892|FG008|Open Label Extension (up to 36 Months)|Other|2|||
164371036|NCT01479621|593735895|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
164371037|NCT01479621|593735896|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
164371038|NCT01479621|593735897|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
164371039|NCT01479621|593735898|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
164371040|NCT01479621|593735899|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
164371041|NCT01479621|593735900|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
164371042|NCT01479621|593735901|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
164371043|NCT01479621|593735895|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
164371044|NCT01479621|593735896|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
164591450|NCT01259856|594528378|FG000|Overall Study|Transfer to another study|0|||
164591451|NCT01259856|594528379|FG001|Overall Study|Transfer to another study|1|||
164591452|NCT01259856|594528378|FG000|Overall Study|Unknown/missing|2|||
164371045|NCT01479621|593735897|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
164371046|NCT01479621|593735898|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
164371047|NCT01479621|593735899|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
164371048|NCT01479621|593735900|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
164371049|NCT01479621|593735901|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
164371050|NCT01479621|593735895|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
164371051|NCT01479621|593735896|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
164591453|NCT01259856|594528379|FG001|Overall Study|Unknown/missing|2|||
164371052|NCT01479621|593735897|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
164371053|NCT01479621|593735898|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
164371054|NCT01479621|593735899|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
164371055|NCT01479621|593735900|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
164371056|NCT01479621|593735901|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
164371057|NCT01479621|593735895|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
164371058|NCT01479621|593735896|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
164371059|NCT01479621|593735897|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
164371060|NCT01479621|593735898|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
164371061|NCT01479621|593735899|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
164371062|NCT01479621|593735900|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
164371063|NCT01479621|593735901|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
164371064|NCT01479621|593735895|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
164371065|NCT01479621|593735896|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
164371066|NCT01479621|593735897|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
164371067|NCT01479621|593735898|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
164371068|NCT01479621|593735899|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
164371069|NCT01479621|593735900|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
164371070|NCT01479621|593735901|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
164371071|NCT01479621|593735895|FG000|Treatment Period|Adverse Event|0|||
164371072|NCT01479621|593735896|FG001|Treatment Period|Adverse Event|0|||
164371073|NCT01479621|593735897|FG002|Treatment Period|Adverse Event|0|||
164371074|NCT01479621|593735898|FG003|Treatment Period|Adverse Event|0|||
164371075|NCT01479621|593735899|FG004|Treatment Period|Adverse Event|1|||
164371076|NCT01479621|593735900|FG005|Treatment Period|Adverse Event|2|||
164371077|NCT01479621|593735901|FG006|Treatment Period|Adverse Event|2|||
164371078|NCT01479621|593735895|FG000|Treatment Period|Withdrawal by Subject|0|||
164371079|NCT01479621|593735896|FG001|Treatment Period|Withdrawal by Subject|4|||
164371080|NCT01479621|593735897|FG002|Treatment Period|Withdrawal by Subject|2|||
164371081|NCT01479621|593735898|FG003|Treatment Period|Withdrawal by Subject|2|||
164371082|NCT01479621|593735899|FG004|Treatment Period|Withdrawal by Subject|5|||
164371083|NCT01479621|593735900|FG005|Treatment Period|Withdrawal by Subject|5|||
164371084|NCT01479621|593735901|FG006|Treatment Period|Withdrawal by Subject|1|||
164371085|NCT01479621|593735895|FG000|Treatment Period|Physician Decision|0|||
164371086|NCT01479621|593735896|FG001|Treatment Period|Physician Decision|0|||
164371087|NCT01479621|593735897|FG002|Treatment Period|Physician Decision|0|||
164371088|NCT01479621|593735898|FG003|Treatment Period|Physician Decision|0|||
164371089|NCT01479621|593735899|FG004|Treatment Period|Physician Decision|1|||
164371090|NCT01479621|593735900|FG005|Treatment Period|Physician Decision|1|||
164371091|NCT01479621|593735901|FG006|Treatment Period|Physician Decision|0|||
164371092|NCT01479621|593735895|FG000|Treatment Period|Non-compliance to study drug|0|||
164371093|NCT01479621|593735896|FG001|Treatment Period|Non-compliance to study drug|1|||
164371094|NCT01479621|593735897|FG002|Treatment Period|Non-compliance to study drug|0|||
164371095|NCT01479621|593735898|FG003|Treatment Period|Non-compliance to study drug|0|||
164371096|NCT01479621|593735899|FG004|Treatment Period|Non-compliance to study drug|0|||
164371097|NCT01479621|593735900|FG005|Treatment Period|Non-compliance to study drug|0|||
164371098|NCT01479621|593735901|FG006|Treatment Period|Non-compliance to study drug|1|||
164371099|NCT01479621|593735895|FG000|Treatment Period|Protocol Violation|0|||
164371100|NCT01479621|593735896|FG001|Treatment Period|Protocol Violation|9|||
164371101|NCT01479621|593735897|FG002|Treatment Period|Protocol Violation|6|||
164371102|NCT01479621|593735898|FG003|Treatment Period|Protocol Violation|5|||
164371103|NCT01479621|593735899|FG004|Treatment Period|Protocol Violation|2|||
164371104|NCT01479621|593735900|FG005|Treatment Period|Protocol Violation|10|||
164438978|NCT00716144|593973103|FG003|Overall Study|Non-compliance|0|||
164371105|NCT01479621|593735901|FG006|Treatment Period|Protocol Violation|6|||
164371106|NCT01479621|593735895|FG000|Treatment Period|Pregnancy|0|||
164371107|NCT01479621|593735896|FG001|Treatment Period|Pregnancy|0|||
164371108|NCT01479621|593735897|FG002|Treatment Period|Pregnancy|2|||
164371109|NCT01479621|593735898|FG003|Treatment Period|Pregnancy|0|||
164371110|NCT01479621|593735899|FG004|Treatment Period|Pregnancy|0|||
164438979|NCT00716144|593973100|FG000|Overall Study|Protocol Violation|2|||
164438980|NCT00716144|593973101|FG001|Overall Study|Protocol Violation|0|||
164371111|NCT01479621|593735900|FG005|Treatment Period|Pregnancy|0|||
164371112|NCT01479621|593735901|FG006|Treatment Period|Pregnancy|0|||
164371113|NCT01479621|593735895|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
164371114|NCT01479621|593735896|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
164371115|NCT01479621|593735897|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
164438981|NCT00716144|593973102|FG002|Overall Study|Protocol Violation|1|||
164371116|NCT01479621|593735898|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
164371117|NCT01479621|593735899|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
164371118|NCT01479621|593735900|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
164371119|NCT01479621|593735901|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
164371120|NCT01479621|593735895|FG000|Treatment Period|Lost to Follow-up|0|||
164371121|NCT01479621|593735896|FG001|Treatment Period|Lost to Follow-up|0|||
164371122|NCT01479621|593735897|FG002|Treatment Period|Lost to Follow-up|1|||
164371123|NCT01479621|593735898|FG003|Treatment Period|Lost to Follow-up|0|||
164371124|NCT01479621|593735899|FG004|Treatment Period|Lost to Follow-up|2|||
164371125|NCT01479621|593735900|FG005|Treatment Period|Lost to Follow-up|2|||
164371126|NCT01479621|593735901|FG006|Treatment Period|Lost to Follow-up|1|||
164371127|NCT01479621|593735895|FG000|Treatment Period|Met stopping criteria|0|||
164371128|NCT01479621|593735896|FG001|Treatment Period|Met stopping criteria|8|||
164371129|NCT01479621|593735897|FG002|Treatment Period|Met stopping criteria|7|||
164371130|NCT01479621|593735898|FG003|Treatment Period|Met stopping criteria|4|||
164371131|NCT01479621|593735899|FG004|Treatment Period|Met stopping criteria|9|||
164371132|NCT01479621|593735900|FG005|Treatment Period|Met stopping criteria|20|||
164371133|NCT01479621|593735901|FG006|Treatment Period|Met stopping criteria|6|||
164371134|NCT02308735|593735904|FG000|Overall Study|Physician Decision|2|||
164371135|NCT02308735|593735905|FG001|Overall Study|Physician Decision|0|||
164371136|NCT02308735|593735906|FG002|Overall Study|Physician Decision|0|||
164371137|NCT02308735|593735907|FG003|Overall Study|Physician Decision|2|||
164371138|NCT01417481|593735913|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
164371139|NCT01417481|593735914|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
164371140|NCT00582933|593735917|FG000|Overall Study|Physician Decision|3|||
164371141|NCT02457598|593735918|FG000|Overall Study|Progressive Disease|2|||
164371142|NCT02457598|593735919|FG001|Overall Study|Progressive Disease|2|||
164371143|NCT02457598|593735920|FG002|Overall Study|Progressive Disease|1|||
164371144|NCT02457598|593735921|FG003|Overall Study|Progressive Disease|11|||
164371145|NCT02457598|593735922|FG004|Overall Study|Progressive Disease|7|||
164371146|NCT02457598|593735923|FG005|Overall Study|Progressive Disease|3|||
164371147|NCT02457598|593735924|FG006|Overall Study|Progressive Disease|2|||
164371148|NCT02457598|593735925|FG007|Overall Study|Progressive Disease|1|||
164371149|NCT02457598|593735926|FG008|Overall Study|Progressive Disease|1|||
164371150|NCT02457598|593735927|FG009|Overall Study|Progressive Disease|2|||
164371151|NCT02457598|593735928|FG010|Overall Study|Progressive Disease|45|||
164371152|NCT02457598|593735929|FG011|Overall Study|Progressive Disease|6|||
164371153|NCT02457598|593735930|FG012|Overall Study|Progressive Disease|2|||
164371154|NCT02457598|593735931|FG013|Overall Study|Progressive Disease|2|||
164371155|NCT02457598|593735932|FG014|Overall Study|Progressive Disease|10|||
164371156|NCT02457598|593735933|FG015|Overall Study|Progressive Disease|1|||
164371157|NCT02457598|593735934|FG016|Overall Study|Progressive Disease|1|||
164371158|NCT02457598|593735918|FG000|Overall Study|Investigator's Discretion|0|||
164371159|NCT02457598|593735919|FG001|Overall Study|Investigator's Discretion|2|||
164371160|NCT02457598|593735920|FG002|Overall Study|Investigator's Discretion|2|||
164371161|NCT02457598|593735921|FG003|Overall Study|Investigator's Discretion|2|||
164371162|NCT02457598|593735922|FG004|Overall Study|Investigator's Discretion|0|||
164371163|NCT02457598|593735923|FG005|Overall Study|Investigator's Discretion|0|||
164371164|NCT02457598|593735924|FG006|Overall Study|Investigator's Discretion|0|||
164371165|NCT02457598|593735925|FG007|Overall Study|Investigator's Discretion|1|||
164371166|NCT02457598|593735926|FG008|Overall Study|Investigator's Discretion|2|||
164371167|NCT02457598|593735927|FG009|Overall Study|Investigator's Discretion|0|||
164371168|NCT02457598|593735928|FG010|Overall Study|Investigator's Discretion|10|||
164371169|NCT02457598|593735929|FG011|Overall Study|Investigator's Discretion|2|||
164371170|NCT02457598|593735930|FG012|Overall Study|Investigator's Discretion|2|||
164371171|NCT02457598|593735931|FG013|Overall Study|Investigator's Discretion|1|||
164371172|NCT02457598|593735932|FG014|Overall Study|Investigator's Discretion|5|||
164438982|NCT00716144|593973103|FG003|Overall Study|Protocol Violation|0|||
164371173|NCT02457598|593735933|FG015|Overall Study|Investigator's Discretion|0|||
164371174|NCT02457598|593735934|FG016|Overall Study|Investigator's Discretion|0|||
164371175|NCT02457598|593735918|FG000|Overall Study|Study Terminated by Sponsor|0|||
164371176|NCT02457598|593735919|FG001|Overall Study|Study Terminated by Sponsor|1|||
164371177|NCT02457598|593735920|FG002|Overall Study|Study Terminated by Sponsor|0|||
164371178|NCT02457598|593735921|FG003|Overall Study|Study Terminated by Sponsor|4|||
164371179|NCT02457598|593735922|FG004|Overall Study|Study Terminated by Sponsor|1|||
164371180|NCT02457598|593735923|FG005|Overall Study|Study Terminated by Sponsor|0|||
164438983|NCT00716144|593973100|FG000|Overall Study|Physician Decision|0|||
164371181|NCT02457598|593735924|FG006|Overall Study|Study Terminated by Sponsor|1|||
164371182|NCT02457598|593735925|FG007|Overall Study|Study Terminated by Sponsor|0|||
164371183|NCT02457598|593735926|FG008|Overall Study|Study Terminated by Sponsor|0|||
164371184|NCT02457598|593735927|FG009|Overall Study|Study Terminated by Sponsor|0|||
164371185|NCT02457598|593735928|FG010|Overall Study|Study Terminated by Sponsor|4|||
164371186|NCT02457598|593735929|FG011|Overall Study|Study Terminated by Sponsor|0|||
164371187|NCT02457598|593735930|FG012|Overall Study|Study Terminated by Sponsor|1|||
164371188|NCT02457598|593735931|FG013|Overall Study|Study Terminated by Sponsor|0|||
164371189|NCT02457598|593735932|FG014|Overall Study|Study Terminated by Sponsor|8|||
164371190|NCT02457598|593735933|FG015|Overall Study|Study Terminated by Sponsor|1|||
164371191|NCT02457598|593735934|FG016|Overall Study|Study Terminated by Sponsor|0|||
164371192|NCT02457598|593735918|FG000|Overall Study|Adverse Event|0|||
164371193|NCT02457598|593735919|FG001|Overall Study|Adverse Event|1|||
164371194|NCT02457598|593735920|FG002|Overall Study|Adverse Event|1|||
164371195|NCT02457598|593735921|FG003|Overall Study|Adverse Event|4|||
164371196|NCT02457598|593735922|FG004|Overall Study|Adverse Event|1|||
164371197|NCT02457598|593735923|FG005|Overall Study|Adverse Event|0|||
164371198|NCT02457598|593735924|FG006|Overall Study|Adverse Event|0|||
164371199|NCT02457598|593735925|FG007|Overall Study|Adverse Event|1|||
164371200|NCT02457598|593735926|FG008|Overall Study|Adverse Event|0|||
164371201|NCT02457598|593735927|FG009|Overall Study|Adverse Event|1|||
164371202|NCT02457598|593735928|FG010|Overall Study|Adverse Event|6|||
164371203|NCT02457598|593735929|FG011|Overall Study|Adverse Event|0|||
164371204|NCT02457598|593735930|FG012|Overall Study|Adverse Event|0|||
164371205|NCT02457598|593735931|FG013|Overall Study|Adverse Event|1|||
164371206|NCT02457598|593735932|FG014|Overall Study|Adverse Event|2|||
164371207|NCT02457598|593735933|FG015|Overall Study|Adverse Event|0|||
164371208|NCT02457598|593735934|FG016|Overall Study|Adverse Event|0|||
164371209|NCT02457598|593735918|FG000|Overall Study|Death|0|||
164371210|NCT02457598|593735919|FG001|Overall Study|Death|0|||
164371211|NCT02457598|593735920|FG002|Overall Study|Death|0|||
164371212|NCT02457598|593735921|FG003|Overall Study|Death|3|||
164371213|NCT02457598|593735922|FG004|Overall Study|Death|0|||
164371214|NCT02457598|593735923|FG005|Overall Study|Death|1|||
164371215|NCT02457598|593735924|FG006|Overall Study|Death|0|||
164371216|NCT02457598|593735925|FG007|Overall Study|Death|0|||
164371217|NCT02457598|593735926|FG008|Overall Study|Death|0|||
164371218|NCT02457598|593735927|FG009|Overall Study|Death|0|||
164371219|NCT02457598|593735928|FG010|Overall Study|Death|3|||
164371220|NCT02457598|593735929|FG011|Overall Study|Death|0|||
164371221|NCT02457598|593735930|FG012|Overall Study|Death|0|||
164371222|NCT02457598|593735931|FG013|Overall Study|Death|1|||
164371223|NCT02457598|593735932|FG014|Overall Study|Death|2|||
164371224|NCT02457598|593735933|FG015|Overall Study|Death|0|||
164371225|NCT02457598|593735934|FG016|Overall Study|Death|1|||
164371226|NCT02457598|593735918|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
164371227|NCT02457598|593735919|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
164371228|NCT02457598|593735920|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
164371229|NCT02457598|593735921|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
164371230|NCT02457598|593735922|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
164371231|NCT02457598|593735923|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
164371232|NCT02457598|593735924|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
164371233|NCT02457598|593735925|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
164371234|NCT02457598|593735926|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
164371235|NCT02457598|593735927|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
164371236|NCT02457598|593735928|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
164371237|NCT02457598|593735929|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
164371238|NCT02457598|593735930|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
164371239|NCT02457598|593735931|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
164371240|NCT02457598|593735932|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
164371241|NCT02457598|593735933|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
164371242|NCT02457598|593735934|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
164371243|NCT02457598|593735918|FG000|Overall Study|Withdrew Consent|0|||
164371244|NCT02457598|593735919|FG001|Overall Study|Withdrew Consent|0|||
164371245|NCT02457598|593735920|FG002|Overall Study|Withdrew Consent|0|||
164371246|NCT02457598|593735921|FG003|Overall Study|Withdrew Consent|0|||
164371247|NCT02457598|593735922|FG004|Overall Study|Withdrew Consent|0|||
164371248|NCT02457598|593735923|FG005|Overall Study|Withdrew Consent|0|||
164700386|NCT03310411|594926821|FG002|Period 1|Adverse Event|0|||
164700387|NCT03310411|594926822|FG003|Period 1|Adverse Event|1|||
164700388|NCT03573505|594926823|FG000|Overall Study|Adverse Event|1|||
164700389|NCT03573505|594926824|FG001|Overall Study|Adverse Event|1|||
164371249|NCT02457598|593735924|FG006|Overall Study|Withdrew Consent|0|||
164371250|NCT02457598|593735925|FG007|Overall Study|Withdrew Consent|2|||
164371251|NCT02457598|593735926|FG008|Overall Study|Withdrew Consent|0|||
164371252|NCT02457598|593735927|FG009|Overall Study|Withdrew Consent|0|||
164371253|NCT02457598|593735928|FG010|Overall Study|Withdrew Consent|3|||
164371254|NCT02457598|593735929|FG011|Overall Study|Withdrew Consent|0|||
164371255|NCT02457598|593735930|FG012|Overall Study|Withdrew Consent|0|||
164371256|NCT02457598|593735931|FG013|Overall Study|Withdrew Consent|1|||
164371257|NCT02457598|593735932|FG014|Overall Study|Withdrew Consent|0|||
164371258|NCT02457598|593735933|FG015|Overall Study|Withdrew Consent|0|||
164371259|NCT02457598|593735934|FG016|Overall Study|Withdrew Consent|0|||
164371260|NCT02457598|593735918|FG000|Overall Study|Unacceptable Toxicity|0|||
164700390|NCT03573505|594926823|FG000|Overall Study|Consent withdrawn|0|||
164371261|NCT02457598|593735919|FG001|Overall Study|Unacceptable Toxicity|0|||
164371262|NCT02457598|593735920|FG002|Overall Study|Unacceptable Toxicity|0|||
164371263|NCT02457598|593735921|FG003|Overall Study|Unacceptable Toxicity|0|||
164371264|NCT02457598|593735922|FG004|Overall Study|Unacceptable Toxicity|0|||
164371265|NCT02457598|593735923|FG005|Overall Study|Unacceptable Toxicity|0|||
164371266|NCT02457598|593735924|FG006|Overall Study|Unacceptable Toxicity|0|||
164371267|NCT02457598|593735925|FG007|Overall Study|Unacceptable Toxicity|0|||
164371268|NCT02457598|593735926|FG008|Overall Study|Unacceptable Toxicity|0|||
164371269|NCT02457598|593735927|FG009|Overall Study|Unacceptable Toxicity|0|||
164371270|NCT02457598|593735928|FG010|Overall Study|Unacceptable Toxicity|1|||
164371271|NCT02457598|593735929|FG011|Overall Study|Unacceptable Toxicity|0|||
164371272|NCT02457598|593735930|FG012|Overall Study|Unacceptable Toxicity|1|||
164371273|NCT02457598|593735931|FG013|Overall Study|Unacceptable Toxicity|1|||
164371274|NCT02457598|593735932|FG014|Overall Study|Unacceptable Toxicity|1|||
164371275|NCT02457598|593735933|FG015|Overall Study|Unacceptable Toxicity|0|||
164371276|NCT02457598|593735934|FG016|Overall Study|Unacceptable Toxicity|0|||
164371277|NCT02457598|593735918|FG000|Overall Study|Intercurrent Illness|0|||
164371278|NCT02457598|593735919|FG001|Overall Study|Intercurrent Illness|0|||
164371279|NCT02457598|593735920|FG002|Overall Study|Intercurrent Illness|0|||
164371280|NCT02457598|593735921|FG003|Overall Study|Intercurrent Illness|0|||
164371281|NCT02457598|593735922|FG004|Overall Study|Intercurrent Illness|0|||
164371282|NCT02457598|593735923|FG005|Overall Study|Intercurrent Illness|0|||
164371283|NCT02457598|593735924|FG006|Overall Study|Intercurrent Illness|0|||
164371284|NCT02457598|593735925|FG007|Overall Study|Intercurrent Illness|0|||
164371285|NCT02457598|593735926|FG008|Overall Study|Intercurrent Illness|0|||
164371286|NCT02457598|593735927|FG009|Overall Study|Intercurrent Illness|0|||
164371287|NCT02457598|593735928|FG010|Overall Study|Intercurrent Illness|1|||
164371288|NCT02457598|593735929|FG011|Overall Study|Intercurrent Illness|0|||
164371289|NCT02457598|593735930|FG012|Overall Study|Intercurrent Illness|0|||
164371290|NCT02457598|593735931|FG013|Overall Study|Intercurrent Illness|0|||
164371291|NCT02457598|593735932|FG014|Overall Study|Intercurrent Illness|0|||
164371292|NCT02457598|593735933|FG015|Overall Study|Intercurrent Illness|0|||
164371293|NCT02457598|593735934|FG016|Overall Study|Intercurrent Illness|0|||
164371294|NCT02457598|593735918|FG000|Overall Study|Protocol Violation|0|||
164371295|NCT02457598|593735919|FG001|Overall Study|Protocol Violation|0|||
164371296|NCT02457598|593735920|FG002|Overall Study|Protocol Violation|0|||
164371297|NCT02457598|593735921|FG003|Overall Study|Protocol Violation|0|||
164371298|NCT02457598|593735922|FG004|Overall Study|Protocol Violation|0|||
164371299|NCT02457598|593735923|FG005|Overall Study|Protocol Violation|0|||
164371300|NCT02457598|593735924|FG006|Overall Study|Protocol Violation|0|||
164371301|NCT02457598|593735925|FG007|Overall Study|Protocol Violation|0|||
164371302|NCT02457598|593735926|FG008|Overall Study|Protocol Violation|0|||
164371303|NCT02457598|593735927|FG009|Overall Study|Protocol Violation|0|||
164371304|NCT02457598|593735928|FG010|Overall Study|Protocol Violation|1|||
164371305|NCT02457598|593735929|FG011|Overall Study|Protocol Violation|0|||
164371306|NCT02457598|593735930|FG012|Overall Study|Protocol Violation|0|||
164371307|NCT02457598|593735931|FG013|Overall Study|Protocol Violation|0|||
164371308|NCT02457598|593735932|FG014|Overall Study|Protocol Violation|0|||
164371309|NCT02457598|593735933|FG015|Overall Study|Protocol Violation|0|||
164371310|NCT02457598|593735934|FG016|Overall Study|Protocol Violation|0|||
164371311|NCT03316885|593735941|FG000|Overall Study|Adverse Event|1|||
164371312|NCT03316885|593735941|FG000|Overall Study|Death|10|||
164371313|NCT03316885|593735941|FG000|Overall Study|Lost to Follow-up|4|||
164371314|NCT03316885|593735941|FG000|Overall Study|Withdrawal by Subject|9|||
164371315|NCT03316885|593735941|FG000|Overall Study|COVID related|8|||
164371316|NCT01736696|593735949|FG000|Overall Study|Withdrawal by Subject|0|||
164371317|NCT01736696|593735950|FG001|Overall Study|Withdrawal by Subject|0|||
164371318|NCT01736696|593735951|FG002|Overall Study|Withdrawal by Subject|1|||
164438984|NCT00716144|593973101|FG001|Overall Study|Physician Decision|1|||
164371319|NCT01736696|593735952|FG003|Overall Study|Withdrawal by Subject|0|||
164371320|NCT01736696|593735953|FG004|Overall Study|Withdrawal by Subject|0|||
164371321|NCT01736696|593735954|FG005|Overall Study|Withdrawal by Subject|0|||
164371322|NCT01736696|593735955|FG006|Overall Study|Withdrawal by Subject|0|||
164371323|NCT01116232|593735956|FG000|Overall Study|Progressive diease|4|||
164371324|NCT00405548|593735957|FG000|Overall Study|Cognitive Memory problems on study day|1|||
164591454|NCT03406104|594528382|FG000|Overall Study|Lost to Follow-up|2|||
164591455|NCT03406104|594528382|FG000|Overall Study|Withdrawal by Subject|2|||
164591456|NCT03406104|594528382|FG000|Overall Study|due to Covid patient did not want to travel|1|||
164591457|NCT03406104|594528382|FG000|Overall Study|Death|2|||
164591458|NCT00358917|594528383|FG000|Overall Study|Adverse Event|14|||
164371325|NCT00405548|593735958|FG001|Overall Study|Cognitive Memory problems on study day|0|||
164371326|NCT00405548|593735957|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
164371327|NCT00405548|593735958|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
164371328|NCT00405548|593735957|FG000|Overall Study|Unable to self-administer shots|1|||
164371329|NCT00405548|593735958|FG001|Overall Study|Unable to self-administer shots|0|||
164438985|NCT00716144|593973102|FG002|Overall Study|Physician Decision|2|||
164438986|NCT00716144|593973103|FG003|Overall Study|Physician Decision|2|||
164438987|NCT00716144|593973100|FG000|Overall Study|Intercurrent illness|0|||
164438988|NCT00716144|593973101|FG001|Overall Study|Intercurrent illness|0|||
164438989|NCT00716144|593973102|FG002|Overall Study|Intercurrent illness|1|||
164438990|NCT00716144|593973103|FG003|Overall Study|Intercurrent illness|0|||
164438991|NCT00716144|593973100|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
164438992|NCT00716144|593973101|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
164438993|NCT00716144|593973102|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
164438994|NCT00716144|593973103|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
164438995|NCT00716144|593973100|FG000|Overall Study|Adverse event: left foot pain|0|||
164438996|NCT00716144|593973101|FG001|Overall Study|Adverse event: left foot pain|1|||
164438997|NCT00716144|593973102|FG002|Overall Study|Adverse event: left foot pain|0|||
164438998|NCT00716144|593973103|FG003|Overall Study|Adverse event: left foot pain|0|||
164438999|NCT00716144|593973100|FG000|Overall Study|Clinical Depression|0|||
164439000|NCT00716144|593973101|FG001|Overall Study|Clinical Depression|1|||
164439001|NCT00716144|593973102|FG002|Overall Study|Clinical Depression|0|||
164439002|NCT00716144|593973103|FG003|Overall Study|Clinical Depression|0|||
164439003|NCT02341625|593973109|FG000|Overall Study|Disease Progression|2|||
164371330|NCT00405548|593735957|FG000|Overall Study|Venous access failed during study day|1|||
164371331|NCT00405548|593735958|FG001|Overall Study|Venous access failed during study day|0|||
164371332|NCT00405548|593735957|FG000|Overall Study|Withdrawal by Subject|1|||
164371333|NCT00405548|593735958|FG001|Overall Study|Withdrawal by Subject|0|||
164371334|NCT02036502|593735959|FG000|Part 1:Dose Determination/Escalation|Death|3|||
164371335|NCT02036502|593735960|FG001|Part 1:Dose Determination/Escalation|Death|2|||
164371336|NCT02036502|593735961|FG002|Part 1:Dose Determination/Escalation|Death|0|||
164371337|NCT02036502|593735962|FG003|Part 1:Dose Determination/Escalation|Death|0|||
164371338|NCT02036502|593735963|FG004|Part 1:Dose Determination/Escalation|Death|0|||
164371339|NCT02036502|593735964|FG005|Part 1:Dose Determination/Escalation|Death|0|||
164371340|NCT02036502|593735965|FG006|Part 1:Dose Determination/Escalation|Death|0|||
164371341|NCT02036502|593735966|FG007|Part 1:Dose Determination/Escalation|Death|0|||
164371342|NCT02036502|593735959|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
164371343|NCT02036502|593735960|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
164371344|NCT02036502|593735961|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
164371345|NCT02036502|593735962|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
164371346|NCT02036502|593735963|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
164371347|NCT02036502|593735964|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
164371348|NCT02036502|593735965|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
164371349|NCT02036502|593735966|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
164371350|NCT02036502|593735959|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
164371351|NCT02036502|593735960|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
164371352|NCT02036502|593735961|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
164371353|NCT02036502|593735962|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
164371354|NCT02036502|593735963|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
164371355|NCT02036502|593735964|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
164371356|NCT02036502|593735965|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
164371357|NCT02036502|593735966|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
164371358|NCT02036502|593735959|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
164371359|NCT02036502|593735960|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
164371360|NCT02036502|593735961|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
164371361|NCT02036502|593735962|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
164371362|NCT02036502|593735963|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
164371363|NCT02036502|593735964|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
164371364|NCT02036502|593735965|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
164371365|NCT02036502|593735966|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
164371366|NCT02036502|593735959|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
164371367|NCT02036502|593735960|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
164371368|NCT02036502|593735961|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
164371369|NCT02036502|593735962|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
164371370|NCT02036502|593735963|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
164371371|NCT02036502|593735964|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
164371372|NCT02036502|593735965|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
164439004|NCT02341625|593973110|FG001|Overall Study|Disease Progression|2|||
164439005|NCT02341625|593973111|FG002|Overall Study|Disease Progression|3|||
164439006|NCT02341625|593973112|FG003|Overall Study|Disease Progression|6|||
164439007|NCT02341625|593973113|FG004|Overall Study|Disease Progression|7|||
164371373|NCT02036502|593735966|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
164371374|NCT02036502|593735959|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
164371375|NCT02036502|593735960|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
164439008|NCT02341625|593973114|FG005|Overall Study|Disease Progression|7|||
164371376|NCT02036502|593735961|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
164371377|NCT02036502|593735962|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
164371378|NCT02036502|593735963|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
164371379|NCT02036502|593735964|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
164371380|NCT02036502|593735965|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
164371381|NCT02036502|593735966|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
164371382|NCT02036502|593735959|FG000|Part 2:Dose Confirmation|Death|0|||
164371383|NCT02036502|593735960|FG001|Part 2:Dose Confirmation|Death|0|||
164371384|NCT02036502|593735961|FG002|Part 2:Dose Confirmation|Death|1|||
164371385|NCT02036502|593735962|FG003|Part 2:Dose Confirmation|Death|0|||
164371386|NCT02036502|593735963|FG004|Part 2:Dose Confirmation|Death|0|||
164371387|NCT02036502|593735964|FG005|Part 2:Dose Confirmation|Death|0|||
164371388|NCT02036502|593735965|FG006|Part 2:Dose Confirmation|Death|0|||
164371389|NCT02036502|593735966|FG007|Part 2:Dose Confirmation|Death|0|||
164371390|NCT02036502|593735959|FG000|Part 2:Dose Confirmation|Not treated|0|||
164371391|NCT02036502|593735960|FG001|Part 2:Dose Confirmation|Not treated|0|||
164371392|NCT02036502|593735961|FG002|Part 2:Dose Confirmation|Not treated|0|||
164371393|NCT02036502|593735962|FG003|Part 2:Dose Confirmation|Not treated|1|||
164371394|NCT02036502|593735963|FG004|Part 2:Dose Confirmation|Not treated|0|||
164371395|NCT02036502|593735964|FG005|Part 2:Dose Confirmation|Not treated|0|||
164371396|NCT02036502|593735965|FG006|Part 2:Dose Confirmation|Not treated|0|||
164371397|NCT02036502|593735966|FG007|Part 2:Dose Confirmation|Not treated|0|||
164371398|NCT02036502|593735959|FG000|Part 3:Dose Expansion|Adverse Event|0|||
164371399|NCT02036502|593735960|FG001|Part 3:Dose Expansion|Adverse Event|0|||
164371400|NCT02036502|593735961|FG002|Part 3:Dose Expansion|Adverse Event|0|||
164371401|NCT02036502|593735962|FG003|Part 3:Dose Expansion|Adverse Event|0|||
164371402|NCT02036502|593735963|FG004|Part 3:Dose Expansion|Adverse Event|0|||
164371403|NCT02036502|593735964|FG005|Part 3:Dose Expansion|Adverse Event|4|||
164371404|NCT02036502|593735965|FG006|Part 3:Dose Expansion|Adverse Event|0|||
164371405|NCT02036502|593735966|FG007|Part 3:Dose Expansion|Adverse Event|2|||
164371406|NCT02036502|593735959|FG000|Part 3:Dose Expansion|Death|0|||
164371407|NCT02036502|593735960|FG001|Part 3:Dose Expansion|Death|0|||
164371408|NCT02036502|593735961|FG002|Part 3:Dose Expansion|Death|0|||
164371409|NCT02036502|593735962|FG003|Part 3:Dose Expansion|Death|0|||
164371410|NCT02036502|593735963|FG004|Part 3:Dose Expansion|Death|0|||
164371411|NCT02036502|593735964|FG005|Part 3:Dose Expansion|Death|24|||
164371412|NCT02036502|593735965|FG006|Part 3:Dose Expansion|Death|0|||
164371413|NCT02036502|593735966|FG007|Part 3:Dose Expansion|Death|3|||
164371414|NCT02036502|593735959|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
164371415|NCT02036502|593735960|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
164371416|NCT02036502|593735961|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
164371417|NCT02036502|593735962|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
164371418|NCT02036502|593735963|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
164371419|NCT02036502|593735964|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
164371420|NCT02036502|593735965|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
164371421|NCT02036502|593735966|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
164371422|NCT02036502|593735959|FG000|Part 3:Dose Expansion|Physician Decision|0|||
164371423|NCT02036502|593735960|FG001|Part 3:Dose Expansion|Physician Decision|0|||
164371424|NCT02036502|593735961|FG002|Part 3:Dose Expansion|Physician Decision|0|||
164371425|NCT02036502|593735962|FG003|Part 3:Dose Expansion|Physician Decision|0|||
164371426|NCT02036502|593735963|FG004|Part 3:Dose Expansion|Physician Decision|0|||
164371427|NCT02036502|593735964|FG005|Part 3:Dose Expansion|Physician Decision|1|||
164371428|NCT02036502|593735965|FG006|Part 3:Dose Expansion|Physician Decision|0|||
164371429|NCT02036502|593735966|FG007|Part 3:Dose Expansion|Physician Decision|0|||
164371430|NCT02036502|593735959|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
164700391|NCT03573505|594926824|FG001|Overall Study|Consent withdrawn|1|||
164700392|NCT03573505|594926823|FG000|Overall Study|Disease progression|0|||
164700393|NCT03573505|594926824|FG001|Overall Study|Disease progression|1|||
164700394|NCT03573505|594926823|FG000|Overall Study|Site Terminated by Sponsor|1|||
164700395|NCT03573505|594926824|FG001|Overall Study|Site Terminated by Sponsor|1|||
164700396|NCT03573505|594926823|FG000|Overall Study|Study terminated by sponsor|50|||
164700397|NCT03573505|594926824|FG001|Overall Study|Study terminated by sponsor|45|||
164700398|NCT03573505|594926823|FG000|Overall Study|Reason not specified|0|||
164700399|NCT03573505|594926824|FG001|Overall Study|Reason not specified|1|||
164700400|NCT03573505|594926823|FG000|Overall Study|Death|0|||
164371431|NCT02036502|593735960|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
164371432|NCT02036502|593735961|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
164371433|NCT02036502|593735962|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
164371434|NCT02036502|593735963|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
164371435|NCT02036502|593735964|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
164371436|NCT02036502|593735965|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
164371437|NCT02036502|593735966|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
164371438|NCT02036502|593735959|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
164371439|NCT02036502|593735960|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
164371440|NCT02036502|593735961|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
164371441|NCT02036502|593735962|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
164371442|NCT02036502|593735963|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
164371443|NCT02036502|593735964|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
164371444|NCT02036502|593735965|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
164371445|NCT02036502|593735966|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
164371446|NCT02036502|593735959|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
164371447|NCT02036502|593735960|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
164371448|NCT02036502|593735961|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
164371449|NCT02036502|593735962|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
164371450|NCT02036502|593735963|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
164371451|NCT02036502|593735964|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
164371452|NCT02036502|593735965|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
164371453|NCT02036502|593735966|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
164371454|NCT02036502|593735959|FG000|Part 3:Dose Expansion|Not Treated|0|||
164371455|NCT02036502|593735960|FG001|Part 3:Dose Expansion|Not Treated|0|||
164371456|NCT02036502|593735961|FG002|Part 3:Dose Expansion|Not Treated|0|||
164371457|NCT02036502|593735962|FG003|Part 3:Dose Expansion|Not Treated|0|||
164371458|NCT02036502|593735963|FG004|Part 3:Dose Expansion|Not Treated|0|||
164371459|NCT02036502|593735964|FG005|Part 3:Dose Expansion|Not Treated|2|||
164371460|NCT02036502|593735965|FG006|Part 3:Dose Expansion|Not Treated|0|||
164371461|NCT02036502|593735966|FG007|Part 3:Dose Expansion|Not Treated|0|||
164371462|NCT00811577|593735972|FG000|Overall Study|Lost to Follow-up|7|||
164371463|NCT00811577|593735973|FG001|Overall Study|Lost to Follow-up|1|||
164371464|NCT00811577|593735972|FG000|Overall Study|Withdrawal by Subject|3|||
164371465|NCT00811577|593735973|FG001|Overall Study|Withdrawal by Subject|0|||
164371466|NCT04011410|593735974|FG000|Overall Study|Withdrawal by Subject|1|||
164371467|NCT01068509|593735975|FG000|Overall Study|Death|0|||
164371468|NCT01068509|593735976|FG001|Overall Study|Death|0|||
164371469|NCT01068509|593735977|FG002|Overall Study|Death|1|||
164371470|NCT01068509|593735975|FG000|Overall Study|Disease Progression|5|||
164371471|NCT01068509|593735976|FG001|Overall Study|Disease Progression|20|||
164371472|NCT01068509|593735977|FG002|Overall Study|Disease Progression|18|||
164371473|NCT01068509|593735975|FG000|Overall Study|Lost to Follow-up|1|||
164371474|NCT01068509|593735976|FG001|Overall Study|Lost to Follow-up|0|||
164371475|NCT01068509|593735977|FG002|Overall Study|Lost to Follow-up|0|||
164371476|NCT01068509|593735975|FG000|Overall Study|Withdrew Consent|0|||
164371477|NCT01068509|593735976|FG001|Overall Study|Withdrew Consent|1|||
164371478|NCT01068509|593735977|FG002|Overall Study|Withdrew Consent|2|||
164371479|NCT01068509|593735975|FG000|Overall Study|Reason Not Specified|0|||
164371480|NCT01068509|593735976|FG001|Overall Study|Reason Not Specified|1|||
164371481|NCT01068509|593735977|FG002|Overall Study|Reason Not Specified|0|||
164371482|NCT01455012|593735978|FG000|Overall Study|Adverse Event|0|||
164371483|NCT01455012|593735979|FG001|Overall Study|Adverse Event|2|||
164371484|NCT01455012|593735978|FG000|Overall Study|Lack of Efficacy|6|||
164371485|NCT01455012|593735979|FG001|Overall Study|Lack of Efficacy|1|||
164371486|NCT01455012|593735978|FG000|Overall Study|Withdrawal by Subject|3|||
164371487|NCT01455012|593735979|FG001|Overall Study|Withdrawal by Subject|1|||
164371488|NCT01455012|593735978|FG000|Overall Study|Unknown reason|2|||
164371489|NCT01455012|593735979|FG001|Overall Study|Unknown reason|0|||
164371490|NCT01418937|593735982|FG000|Overall Study|Lost to Follow-up|5|||
164371491|NCT01418937|593735982|FG000|Overall Study|Protocol Violation|1|||
164371492|NCT01418937|593735982|FG000|Overall Study|Pregnancy|1|||
164371493|NCT01418937|593735982|FG000|Overall Study|Withdrawal by Subject|1|||
164371494|NCT03323658|593736005|FG000|Overall Study|Adverse Event|0|||
164371495|NCT03323658|593736006|FG001|Overall Study|Adverse Event|1|||
164371496|NCT03323658|593736007|FG002|Overall Study|Adverse Event|0|||
164371497|NCT00615056|593736008|FG000|Overall Study|Death|31|||
164371498|NCT00615056|593736009|FG001|Overall Study|Death|31|||
164371499|NCT00615056|593736010|FG002|Overall Study|Death|21|||
164371500|NCT00615056|593736011|FG003|Overall Study|Death|23|||
164371501|NCT00615056|593736008|FG000|Overall Study|Lost to Follow-up|1|||
164371502|NCT00615056|593736009|FG001|Overall Study|Lost to Follow-up|2|||
164371503|NCT00615056|593736010|FG002|Overall Study|Lost to Follow-up|4|||
164371504|NCT00615056|593736011|FG003|Overall Study|Lost to Follow-up|5|||
164371505|NCT00615056|593736008|FG000|Overall Study|Other|13|||
164371506|NCT00615056|593736009|FG001|Overall Study|Other|15|||
164371507|NCT00615056|593736010|FG002|Overall Study|Other|10|||
164371508|NCT00615056|593736011|FG003|Overall Study|Other|7|||
164371509|NCT00615056|593736008|FG000|Overall Study|Objective progression or relapse|0|||
164700401|NCT03573505|594926824|FG001|Overall Study|Death|4|||
164371510|NCT00615056|593736009|FG001|Overall Study|Objective progression or relapse|2|||
164371511|NCT00615056|593736010|FG002|Overall Study|Objective progression or relapse|0|||
164371512|NCT00615056|593736011|FG003|Overall Study|Objective progression or relapse|0|||
164371513|NCT00615056|593736008|FG000|Overall Study|Withdrawal by Subject|0|||
164371514|NCT00615056|593736009|FG001|Overall Study|Withdrawal by Subject|1|||
164371515|NCT00615056|593736010|FG002|Overall Study|Withdrawal by Subject|1|||
164371516|NCT00615056|593736011|FG003|Overall Study|Withdrawal by Subject|0|||
164371517|NCT00615056|593736008|FG000|Overall Study|Discontinued by Sponsor|1|||
164371518|NCT00615056|593736009|FG001|Overall Study|Discontinued by Sponsor|0|||
164371519|NCT00615056|593736010|FG002|Overall Study|Discontinued by Sponsor|0|||
164371520|NCT00615056|593736011|FG003|Overall Study|Discontinued by Sponsor|0|||
164371521|NCT00615056|593736008|FG000|Overall Study|Randomized but not treated|3|||
164371522|NCT00615056|593736009|FG001|Overall Study|Randomized but not treated|0|||
164371523|NCT00615056|593736010|FG002|Overall Study|Randomized but not treated|0|||
164371524|NCT00615056|593736011|FG003|Overall Study|Randomized but not treated|0|||
164371525|NCT00717769|593736012|FG000|Overall Study|Adverse Event|9|||
164371526|NCT00717769|593736013|FG001|Overall Study|Adverse Event|6|||
164371527|NCT00717769|593736014|FG002|Overall Study|Adverse Event|1|||
164371528|NCT00717769|593736012|FG000|Overall Study|Lack of compliance|0|||
164371529|NCT00717769|593736013|FG001|Overall Study|Lack of compliance|2|||
164371530|NCT00717769|593736014|FG002|Overall Study|Lack of compliance|0|||
164371531|NCT00717769|593736012|FG000|Overall Study|Lost to Follow-up|3|||
164371532|NCT00717769|593736013|FG001|Overall Study|Lost to Follow-up|4|||
164371533|NCT00717769|593736014|FG002|Overall Study|Lost to Follow-up|0|||
164371534|NCT00717769|593736012|FG000|Overall Study|Lack of Efficacy|1|||
164371535|NCT00717769|593736013|FG001|Overall Study|Lack of Efficacy|2|||
164371536|NCT00717769|593736014|FG002|Overall Study|Lack of Efficacy|0|||
164371537|NCT00717769|593736012|FG000|Overall Study|Protocol Violation|0|||
164371538|NCT00717769|593736013|FG001|Overall Study|Protocol Violation|2|||
164371539|NCT00717769|593736014|FG002|Overall Study|Protocol Violation|0|||
164371540|NCT00717769|593736012|FG000|Overall Study|Sponsor decision|1|||
164371541|NCT00717769|593736013|FG001|Overall Study|Sponsor decision|0|||
164371542|NCT00717769|593736014|FG002|Overall Study|Sponsor decision|10|||
164371543|NCT00717769|593736012|FG000|Overall Study|Withdrew consent|2|||
164371544|NCT00717769|593736013|FG001|Overall Study|Withdrew consent|2|||
164371545|NCT00717769|593736014|FG002|Overall Study|Withdrew consent|0|||
164371546|NCT01380184|593736017|FG000|Part 1 (19 Days)|Adverse Event|1|||
164371547|NCT01380184|593736017|FG000|Part 2|Adverse Event|5|||
164371548|NCT01380184|593736017|FG000|Part 2|Disease Progression|8|||
164371549|NCT01380184|593736017|FG000|Part 2|Lost to Follow-up|1|||
164371550|NCT00692770|593736021|FG000|Overall Study|Protocol Violation|2|||
164371551|NCT00692770|593736022|FG001|Overall Study|Protocol Violation|7|||
164371552|NCT00692770|593736021|FG000|Overall Study|Withdrawal by Subject|97|||
164371553|NCT00692770|593736022|FG001|Overall Study|Withdrawal by Subject|36|||
164371554|NCT00692770|593736021|FG000|Overall Study|Adverse Event|136|||
164371555|NCT00692770|593736022|FG001|Overall Study|Adverse Event|41|||
164371556|NCT00692770|593736021|FG000|Overall Study|Death|10|||
164371557|NCT00692770|593736022|FG001|Overall Study|Death|5|||
164371558|NCT00692770|593736021|FG000|Overall Study|Lost to Follow-up|7|||
164371559|NCT00692770|593736022|FG001|Overall Study|Lost to Follow-up|3|||
164371560|NCT00692770|593736021|FG000|Overall Study|Non-compliant with study medication|11|||
164371561|NCT00692770|593736022|FG001|Overall Study|Non-compliant with study medication|5|||
164371562|NCT00692770|593736021|FG000|Overall Study|Progression by clinical judgment|2|||
164371563|NCT00692770|593736022|FG001|Overall Study|Progression by clinical judgment|3|||
164371564|NCT00692770|593736021|FG000|Overall Study|Physician decision not protocol driven|10|||
164371565|NCT00692770|593736022|FG001|Overall Study|Physician decision not protocol driven|14|||
164371566|NCT00692770|593736021|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
164371567|NCT00692770|593736022|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
164700402|NCT00515541|594926825|FG000|Overall Study|Physician Decision|0|||
164700403|NCT00515541|594926826|FG001|Overall Study|Physician Decision|2|||
164700404|NCT00515541|594926827|FG002|Overall Study|Physician Decision|0|||
164700405|NCT00515541|594926828|FG003|Overall Study|Physician Decision|1|||
164700406|NCT00515541|594926825|FG000|Overall Study|No show for appointments|0|||
164371568|NCT00692770|593736021|FG000|Overall Study|Protocol driven decision point|3|||
164371569|NCT00692770|593736022|FG001|Overall Study|Protocol driven decision point|7|||
164371570|NCT00692770|593736021|FG000|Overall Study|Completed all planned assessments|79|||
164371571|NCT00692770|593736022|FG001|Overall Study|Completed all planned assessments|101|||
164371572|NCT00692770|593736021|FG000|Overall Study|Radiological and clinical progression|8|||
164371573|NCT00692770|593736022|FG001|Overall Study|Radiological and clinical progression|8|||
164700407|NCT00515541|594926826|FG001|Overall Study|No show for appointments|1|||
164700408|NCT00515541|594926827|FG002|Overall Study|No show for appointments|0|||
164371574|NCT00692770|593736021|FG000|Overall Study|Clinical endpoint reached|16|||
164371575|NCT00692770|593736022|FG001|Overall Study|Clinical endpoint reached|43|||
164371576|NCT00692770|593736021|FG000|Overall Study|Study terminated by sponsor|2|||
164371577|NCT00692770|593736022|FG001|Overall Study|Study terminated by sponsor|2|||
164371578|NCT00692770|593736021|FG000|Overall Study|Randomized but not treated|3|||
164371579|NCT00692770|593736022|FG001|Overall Study|Randomized but not treated|4|||
164371580|NCT04248816|593736023|FG000|Overall Study|Ineligible post-randomization|7|||
164371581|NCT04248816|593736024|FG001|Overall Study|Ineligible post-randomization|21|||
164700409|NCT00515541|594926828|FG003|Overall Study|No show for appointments|2|||
164371582|NCT04248816|593736025|FG002|Overall Study|Ineligible post-randomization|25|||
164371583|NCT04327986|593736026|FG000|Overall Study|Physician Decision|2|||
164371584|NCT04327986|593736027|FG001|Overall Study|Physician Decision|0|||
164371585|NCT04327986|593736028|FG002|Overall Study|Physician Decision|0|||
164371586|NCT04327986|593736026|FG000|Overall Study|Death|1|||
164700410|NCT00515541|594926825|FG000|Overall Study|Withdrawal by Subject|0|||
164371587|NCT04327986|593736027|FG001|Overall Study|Death|0|||
164371588|NCT04327986|593736028|FG002|Overall Study|Death|0|||
164371589|NCT03350503|593736032|FG000|Overall Study|Adverse Event|5|||
164371590|NCT03350503|593736032|FG000|Overall Study|Withdrawal by Subject|5|||
164371591|NCT03350503|593736032|FG000|Overall Study|Continuation impossible due to move|4|||
164371592|NCT03350503|593736032|FG000|Overall Study|Physician Decision|3|||
164371593|NCT03829046|593736035|FG000|Overall Study|Withdrawal by Subject|1|||
164371594|NCT03829046|593736036|FG001|Overall Study|Withdrawal by Subject|0|||
164371595|NCT00262067|593736037|FG000|Overall Study|Death|190|||
164371596|NCT00262067|593736038|FG001|Overall Study|Death|89|||
164371597|NCT00262067|593736039|FG002|Overall Study|Death|186|||
164371598|NCT00262067|593736040|FG003|Overall Study|Death|99|||
164371599|NCT00262067|593736037|FG000|Overall Study|Lost to Follow-up|5|||
164371600|NCT00262067|593736038|FG001|Overall Study|Lost to Follow-up|4|||
164371601|NCT00262067|593736039|FG002|Overall Study|Lost to Follow-up|7|||
164371602|NCT00262067|593736040|FG003|Overall Study|Lost to Follow-up|5|||
164371603|NCT00262067|593736037|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
164371604|NCT00262067|593736038|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
164371605|NCT00262067|593736039|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
164371606|NCT00262067|593736040|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
164371607|NCT00262067|593736037|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
164371608|NCT00262067|593736038|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
164371609|NCT00262067|593736039|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
164371610|NCT00262067|593736040|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
164371611|NCT04804813|593736041|FG000|Overall Study|Protocol Violation|2|||
164371612|NCT04804813|593736042|FG001|Overall Study|Protocol Violation|0|||
164371613|NCT04804813|593736041|FG000|Overall Study|Withdrawal by Subject|1|||
164371614|NCT04804813|593736042|FG001|Overall Study|Withdrawal by Subject|0|||
164371615|NCT01012817|593737861|FG000|Overall Study|Withdrawal by Subject|0|||
164371616|NCT01012817|593737862|FG001|Overall Study|Withdrawal by Subject|0|||
164371617|NCT01012817|593737863|FG002|Overall Study|Withdrawal by Subject|0|||
164371618|NCT01012817|593737864|FG003|Overall Study|Withdrawal by Subject|1|||
164371619|NCT01012817|593737865|FG004|Overall Study|Withdrawal by Subject|0|||
164371620|NCT01012817|593737866|FG005|Overall Study|Withdrawal by Subject|0|||
164371621|NCT01012817|593737867|FG006|Overall Study|Withdrawal by Subject|0|||
164371622|NCT01012817|593737868|FG007|Overall Study|Withdrawal by Subject|1|||
164371623|NCT01012817|593737869|FG008|Overall Study|Withdrawal by Subject|0|||
164371624|NCT01012817|593737870|FG009|Overall Study|Withdrawal by Subject|0|||
164371625|NCT01012817|593737871|FG010|Overall Study|Withdrawal by Subject|1|||
164371626|NCT01012817|593737872|FG011|Overall Study|Withdrawal by Subject|1|||
164371627|NCT01012817|593737873|FG012|Overall Study|Withdrawal by Subject|0|||
164371628|NCT01012817|593737874|FG013|Overall Study|Withdrawal by Subject|1|||
164371629|NCT01012817|593737861|FG000|Overall Study|Adverse Event|0|||
164371630|NCT01012817|593737862|FG001|Overall Study|Adverse Event|0|||
164371631|NCT01012817|593737863|FG002|Overall Study|Adverse Event|0|||
164371632|NCT01012817|593737864|FG003|Overall Study|Adverse Event|0|||
164371633|NCT01012817|593737865|FG004|Overall Study|Adverse Event|0|||
164371634|NCT01012817|593737866|FG005|Overall Study|Adverse Event|1|||
164371635|NCT01012817|593737867|FG006|Overall Study|Adverse Event|0|||
164371636|NCT01012817|593737868|FG007|Overall Study|Adverse Event|0|||
164371637|NCT01012817|593737869|FG008|Overall Study|Adverse Event|0|||
164371638|NCT01012817|593737870|FG009|Overall Study|Adverse Event|0|||
164371639|NCT01012817|593737871|FG010|Overall Study|Adverse Event|1|||
164371640|NCT01012817|593737872|FG011|Overall Study|Adverse Event|0|||
164371641|NCT01012817|593737873|FG012|Overall Study|Adverse Event|0|||
164371642|NCT01012817|593737874|FG013|Overall Study|Adverse Event|1|||
164371643|NCT00634647|593737875|FG000|Overall Study|death on study|3|||
164371644|NCT00634647|593737875|FG000|Overall Study|refused further treatment|3|||
164371645|NCT00634647|593737875|FG000|Overall Study|declined to participate before treatment|1|||
164371646|NCT01700179|593737876|FG000|Overall Study|Physician Decision|2|||
164371647|NCT01896895|593737877|FG000|Double-blind MP|Physician Decision|0|||
164371648|NCT01896895|593737878|FG001|Double-blind MP|Physician Decision|0|||
164371649|NCT01896895|593737879|FG002|Double-blind MP|Physician Decision|1|||
164371650|NCT01896895|593737880|FG003|Double-blind MP|Physician Decision|0|||
164371651|NCT01896895|593737877|FG000|Double-blind MP|Withdrawal by Subject|0|||
164371652|NCT01896895|593737878|FG001|Double-blind MP|Withdrawal by Subject|2|||
164371653|NCT01896895|593737879|FG002|Double-blind MP|Withdrawal by Subject|1|||
164371654|NCT01896895|593737880|FG003|Double-blind MP|Withdrawal by Subject|0|||
164371655|NCT01896895|593737877|FG000|Double-blind MP|Lost to Follow-up|1|||
164371656|NCT01896895|593737878|FG001|Double-blind MP|Lost to Follow-up|0|||
164439009|NCT02341625|593973115|FG006|Overall Study|Disease Progression|28|||
164371657|NCT01896895|593737879|FG002|Double-blind MP|Lost to Follow-up|1|||
164371658|NCT01896895|593737880|FG003|Double-blind MP|Lost to Follow-up|0|||
164371659|NCT03277846|593737881|FG000|Overall Study|Inpatient stay too brief|12|||
164371660|NCT03277846|593737882|FG001|Overall Study|Inpatient stay too brief|11|||
164371661|NCT01207778|593737883|FG000|Overall Study|Lost to Follow-up|0|||
164371662|NCT01207778|593737884|FG001|Overall Study|Lost to Follow-up|3|||
164371663|NCT01207778|593737885|FG002|Overall Study|Lost to Follow-up|3|||
164371664|NCT05168475|593737888|FG000|Period 1|Protocol Violation|1|||
164371665|NCT05168475|593737888|FG000|Period 1|IMP shortage|2|||
164371666|NCT05168475|593737888|FG000|Period 1|Not randomised|2|||
164371667|NCT05168475|593737888|FG000|Period 2|IMP shortage|1|||
164371668|NCT01589822|593737889|FG000|Overall Study|Withdrawal by Subject|1|||
164371669|NCT01589822|593737890|FG001|Overall Study|Withdrawal by Subject|2|||
164371670|NCT01589822|593737891|FG002|Overall Study|Withdrawal by Subject|0|||
164371671|NCT01589822|593737889|FG000|Overall Study|Death|1|||
164371672|NCT01589822|593737890|FG001|Overall Study|Death|0|||
164371673|NCT01589822|593737891|FG002|Overall Study|Death|0|||
164371674|NCT01589822|593737889|FG000|Overall Study|Missed 90 day visit|2|||
164371675|NCT01589822|593737890|FG001|Overall Study|Missed 90 day visit|1|||
164371676|NCT01589822|593737891|FG002|Overall Study|Missed 90 day visit|1|||
164371677|NCT00646204|593737892|FG000|Overall Study|Adverse Event|3|||
164371678|NCT00646204|593737893|FG001|Overall Study|Adverse Event|0|||
164371679|NCT00646204|593737892|FG000|Overall Study|Withdrawal by Subject|1|||
164371680|NCT00646204|593737893|FG001|Overall Study|Withdrawal by Subject|0|||
164371681|NCT00773175|593737903|FG000|Overall Study|Adverse Event|2|||
164371682|NCT00773175|593737904|FG001|Overall Study|Adverse Event|0|||
164371683|NCT00773175|593737903|FG000|Overall Study|Consent Withdrawn|0|||
164371684|NCT00773175|593737904|FG001|Overall Study|Consent Withdrawn|2|||
164371685|NCT00503841|593737905|FG000|Overall Study|All screen failures|44|||
164371686|NCT01302964|593737906|FG000|Overall Study|Adverse Event|1|||
164371687|NCT01302964|593737907|FG001|Overall Study|Adverse Event|0|||
164371688|NCT05723770|593737908|FG000|Overall Study|Lost to Follow-up|4|||
164371689|NCT05723770|593737908|FG000|Overall Study|Withdrawal by Subject|2|||
164371690|NCT01945489|593737909|FG000|Cycle 1|Adverse Event|2|||
164371691|NCT01945489|593737910|FG001|Cycle 1|Adverse Event|0|||
164371692|NCT01945489|593737909|FG000|Cycle 1|Lost to Follow-up|4|||
164371693|NCT01945489|593737910|FG001|Cycle 1|Lost to Follow-up|0|||
164371694|NCT01945489|593737909|FG000|Cycle 1|Personal Reasons|4|||
164371695|NCT01945489|593737910|FG001|Cycle 1|Personal Reasons|2|||
164371696|NCT01945489|593737909|FG000|Cycle 1|Protocol Violation|0|||
164371697|NCT01945489|593737910|FG001|Cycle 1|Protocol Violation|1|||
164371698|NCT01945489|593737909|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
164371699|NCT01945489|593737910|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
164371700|NCT01945489|593737909|FG000|Cycle 2|Adverse Event|1|||
164371701|NCT01945489|593737910|FG001|Cycle 2|Adverse Event|0|||
164371702|NCT01945489|593737909|FG000|Cycle 2|Lost to Follow-up|0|||
164371703|NCT01945489|593737910|FG001|Cycle 2|Lost to Follow-up|1|||
164371704|NCT00394212|593737913|FG000|Overall Study|Lost to Follow-up|3|||
164371705|NCT00394212|593737914|FG001|Overall Study|Lost to Follow-up|0|||
164371706|NCT00394212|593737913|FG000|Overall Study|Withdrawal by Subject|4|||
164371707|NCT00394212|593737914|FG001|Overall Study|Withdrawal by Subject|1|||
164371708|NCT00596011|593737916|FG000|Overall Study|Withdrawal by Subject|2|||
164371709|NCT00596011|593737917|FG001|Overall Study|Withdrawal by Subject|3|||
164371710|NCT00596011|593737916|FG000|Overall Study|Adverse Event|11|||
164371711|NCT00596011|593737917|FG001|Overall Study|Adverse Event|7|||
164371712|NCT02347527|593737918|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
164371713|NCT02347527|593737919|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
164371714|NCT02347527|593737920|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
164371715|NCT02347527|593737921|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
164591459|NCT00358917|594528384|FG001|Overall Study|Adverse Event|21|||
164591460|NCT00358917|594528383|FG000|Overall Study|Withdrawal by Subject|5|||
164371716|NCT02347527|593737918|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
164371717|NCT02347527|593737919|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
164371718|NCT02347527|593737920|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
164371719|NCT02347527|593737921|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
164371720|NCT02347527|593737918|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
164591461|NCT00358917|594528384|FG001|Overall Study|Withdrawal by Subject|7|||
164371721|NCT02347527|593737919|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
164371722|NCT02347527|593737920|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
164371723|NCT02347527|593737921|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
164591462|NCT00358917|594528383|FG000|Overall Study|Lost to Follow-up|20|||
164371724|NCT02347527|593737918|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
164371725|NCT02347527|593737919|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
164371726|NCT02347527|593737920|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
164591463|NCT00358917|594528384|FG001|Overall Study|Lost to Follow-up|17|||
164371727|NCT02347527|593737921|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
164371728|NCT02347527|593737918|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
164371729|NCT02347527|593737919|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
164417426|NCT01474512|593899494|FG005|Long-Term Extension Period|Clinical Relapse|0|||
164591464|NCT00358917|594528383|FG000|Overall Study|Noncompliance|12|||
164371730|NCT02347527|593737920|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
164371731|NCT02347527|593737921|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
164371732|NCT01466270|593737926|FG000|Overall Study|Withdrawal by Subject|4|||
164371733|NCT01466270|593737927|FG001|Overall Study|Withdrawal by Subject|1|||
164371734|NCT01466270|593737926|FG000|Overall Study|Physician Decision|1|||
164371735|NCT01466270|593737927|FG001|Overall Study|Physician Decision|0|||
164371736|NCT01466270|593737926|FG000|Overall Study|Lost to Follow-up|1|||
164371737|NCT01466270|593737927|FG001|Overall Study|Lost to Follow-up|3|||
164371738|NCT01466270|593737926|FG000|Overall Study|Progression|1|||
164371739|NCT01466270|593737927|FG001|Overall Study|Progression|0|||
164371740|NCT01466270|593737926|FG000|Overall Study|Toxicity|4|||
164371741|NCT01466270|593737927|FG001|Overall Study|Toxicity|1|||
164371742|NCT01466270|593737926|FG000|Overall Study|Multiple|1|||
164371743|NCT01466270|593737927|FG001|Overall Study|Multiple|1|||
164371744|NCT00749775|593737934|FG000|Overall Study|Protocol Violation|24|||
164371745|NCT00749775|593737934|FG000|Overall Study|Lost to Follow-up|36|||
164371746|NCT00749775|593737934|FG000|Overall Study|No visit after first day of treatment|44|||
164371747|NCT00749775|593737934|FG000|Overall Study|No drug administration|3|||
164371748|NCT03364049|593737945|FG000|Overall Study|Death|6|||
164371749|NCT03364049|593737946|FG001|Overall Study|Death|4|||
164371750|NCT03364049|593737947|FG002|Overall Study|Death|5|||
164371751|NCT03364049|593737948|FG003|Overall Study|Death|14|||
164371752|NCT03364049|593737945|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
164371753|NCT03364049|593737946|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
164371754|NCT03364049|593737947|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
164371755|NCT03364049|593737948|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
164371756|NCT03364049|593737945|FG000|Overall Study|Withdrawal by Subject|0|||
164371757|NCT03364049|593737946|FG001|Overall Study|Withdrawal by Subject|1|||
164371758|NCT03364049|593737947|FG002|Overall Study|Withdrawal by Subject|1|||
164371759|NCT03364049|593737948|FG003|Overall Study|Withdrawal by Subject|1|||
164371760|NCT01340976|593737951|FG000|Overall Study|Physician Decision|2|||
164371761|NCT01340976|593737952|FG001|Overall Study|Physician Decision|0|||
164371762|NCT01340976|593737953|FG002|Overall Study|Physician Decision|1|||
164371763|NCT01340976|593737954|FG003|Overall Study|Physician Decision|1|||
164371764|NCT01340976|593737955|FG004|Overall Study|Physician Decision|1|||
164371765|NCT01340976|593737956|FG005|Overall Study|Physician Decision|0|||
164371766|NCT01340976|593737951|FG000|Overall Study|Death|0|||
164371767|NCT01340976|593737952|FG001|Overall Study|Death|1|||
164371768|NCT01340976|593737953|FG002|Overall Study|Death|0|||
164371769|NCT01340976|593737954|FG003|Overall Study|Death|0|||
164371770|NCT01340976|593737955|FG004|Overall Study|Death|0|||
164371771|NCT01340976|593737956|FG005|Overall Study|Death|0|||
164371772|NCT01340976|593737951|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
164371773|NCT01340976|593737952|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
164371774|NCT01340976|593737953|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
164371775|NCT01340976|593737954|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
164371776|NCT01340976|593737955|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
164371777|NCT01340976|593737956|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
164371778|NCT01340976|593737951|FG000|Overall Study|Withdrawal by Subject|0|||
164371779|NCT01340976|593737952|FG001|Overall Study|Withdrawal by Subject|0|||
164371780|NCT01340976|593737953|FG002|Overall Study|Withdrawal by Subject|0|||
164371781|NCT01340976|593737954|FG003|Overall Study|Withdrawal by Subject|1|||
164371782|NCT01340976|593737955|FG004|Overall Study|Withdrawal by Subject|1|||
164371783|NCT01340976|593737956|FG005|Overall Study|Withdrawal by Subject|0|||
164371784|NCT01340976|593737951|FG000|Overall Study|Other anemia treatment|1|||
164371785|NCT01340976|593737952|FG001|Overall Study|Other anemia treatment|0|||
164371786|NCT01340976|593737953|FG002|Overall Study|Other anemia treatment|2|||
164371787|NCT01340976|593737954|FG003|Overall Study|Other anemia treatment|1|||
164371788|NCT01340976|593737955|FG004|Overall Study|Other anemia treatment|0|||
164371789|NCT01340976|593737956|FG005|Overall Study|Other anemia treatment|1|||
164371790|NCT01340976|593737951|FG000|Overall Study|Adverse Event|0|||
164371791|NCT01340976|593737952|FG001|Overall Study|Adverse Event|1|||
164371792|NCT01340976|593737953|FG002|Overall Study|Adverse Event|0|||
164371793|NCT01340976|593737954|FG003|Overall Study|Adverse Event|0|||
164371794|NCT01340976|593737955|FG004|Overall Study|Adverse Event|0|||
164371795|NCT01340976|593737956|FG005|Overall Study|Adverse Event|0|||
164371796|NCT02953821|593737957|FG000|Overall Study|Adverse Event|0|||
164371797|NCT02953821|593737958|FG001|Overall Study|Adverse Event|4|||
164371798|NCT02953821|593737957|FG000|Overall Study|Death|1|||
164371799|NCT02953821|593737958|FG001|Overall Study|Death|0|||
164371800|NCT02953821|593737957|FG000|Overall Study|Progressive Disease|5|||
164371801|NCT02953821|593737958|FG001|Overall Study|Progressive Disease|1|||
164371802|NCT02953821|593737957|FG000|Overall Study|Lost to Follow-up|2|||
164371803|NCT02953821|593737958|FG001|Overall Study|Lost to Follow-up|0|||
164371804|NCT02953821|593737957|FG000|Overall Study|Physician Decision|1|||
164439010|NCT02341625|593973116|FG007|Overall Study|Disease Progression|5|||
164439011|NCT02341625|593973117|FG008|Overall Study|Disease Progression|4|||
164439012|NCT02341625|593973118|FG009|Overall Study|Disease Progression|19|||
164439013|NCT02341625|593973109|FG000|Overall Study|Study Drug Toxicity|0|||
164439014|NCT02341625|593973110|FG001|Overall Study|Study Drug Toxicity|0|||
164439015|NCT02341625|593973111|FG002|Overall Study|Study Drug Toxicity|0|||
164439016|NCT02341625|593973112|FG003|Overall Study|Study Drug Toxicity|1|||
164439017|NCT02341625|593973113|FG004|Overall Study|Study Drug Toxicity|0|||
164371805|NCT02953821|593737958|FG001|Overall Study|Physician Decision|1|||
164371806|NCT02953821|593737957|FG000|Overall Study|Withdrawal by Subject|3|||
164371807|NCT02953821|593737958|FG001|Overall Study|Withdrawal by Subject|3|||
164371808|NCT02953821|593737957|FG000|Overall Study|Change of address|0|||
164371809|NCT02953821|593737958|FG001|Overall Study|Change of address|1|||
164371810|NCT02953821|593737957|FG000|Overall Study|Lack of Efficacy|1|||
164371811|NCT02953821|593737958|FG001|Overall Study|Lack of Efficacy|0|||
164371812|NCT02953821|593737957|FG000|Overall Study|Out of state for indeterminate time|0|||
164371813|NCT02953821|593737958|FG001|Overall Study|Out of state for indeterminate time|1|||
164371814|NCT02953821|593737957|FG000|Overall Study|No improvement|0|||
164371815|NCT02953821|593737958|FG001|Overall Study|No improvement|1|||
164371816|NCT02953821|593737957|FG000|Overall Study|Refused follow-up visit|2|||
164371817|NCT02953821|593737958|FG001|Overall Study|Refused follow-up visit|1|||
164371818|NCT03064126|593737959|FG000|Overall Study|Death|40|||
164371819|NCT03064126|593737960|FG001|Overall Study|Death|16|||
164371820|NCT03064126|593737961|FG002|Overall Study|Death|4|||
164371821|NCT03064126|593737962|FG003|Overall Study|Death|2|||
164371822|NCT03064126|593737959|FG000|Overall Study|Withdrawal by Subject|17|||
164371823|NCT03064126|593737960|FG001|Overall Study|Withdrawal by Subject|9|||
164371824|NCT03064126|593737961|FG002|Overall Study|Withdrawal by Subject|0|||
164371825|NCT03064126|593737962|FG003|Overall Study|Withdrawal by Subject|2|||
164371826|NCT03064126|593737959|FG000|Overall Study|Lost to Follow-up|7|||
164371827|NCT03064126|593737960|FG001|Overall Study|Lost to Follow-up|3|||
164371828|NCT03064126|593737961|FG002|Overall Study|Lost to Follow-up|0|||
164371829|NCT03064126|593737962|FG003|Overall Study|Lost to Follow-up|0|||
164371830|NCT03064126|593737959|FG000|Overall Study|Adverse Event|2|||
164371831|NCT03064126|593737960|FG001|Overall Study|Adverse Event|0|||
164371832|NCT03064126|593737961|FG002|Overall Study|Adverse Event|0|||
164371833|NCT03064126|593737962|FG003|Overall Study|Adverse Event|0|||
164371834|NCT03064126|593737959|FG000|Overall Study|Physician Decision|3|||
164371835|NCT03064126|593737960|FG001|Overall Study|Physician Decision|0|||
164371836|NCT03064126|593737961|FG002|Overall Study|Physician Decision|0|||
164371837|NCT03064126|593737962|FG003|Overall Study|Physician Decision|0|||
164371838|NCT03064126|593737959|FG000|Overall Study|Other reason for early termination|3|||
164371839|NCT03064126|593737960|FG001|Overall Study|Other reason for early termination|2|||
164371840|NCT03064126|593737961|FG002|Overall Study|Other reason for early termination|0|||
164371841|NCT03064126|593737962|FG003|Overall Study|Other reason for early termination|0|||
164371842|NCT03064126|593737959|FG000|Overall Study|Missed Visit|3|||
164371843|NCT03064126|593737960|FG001|Overall Study|Missed Visit|1|||
164371844|NCT03064126|593737961|FG002|Overall Study|Missed Visit|0|||
164371845|NCT03064126|593737962|FG003|Overall Study|Missed Visit|0|||
164371846|NCT03907683|593737968|FG000|Overall Study|Pregnancy|1|||
164371847|NCT03907683|593737968|FG000|Overall Study|Withdrawal by Subject|1|||
164371848|NCT03400332|593737969|FG000|Pre-Treatment|Other reasons|0|||
164371849|NCT03400332|593737970|FG001|Pre-Treatment|Other reasons|0|||
164371850|NCT03400332|593737971|FG002|Pre-Treatment|Other reasons|0|||
164371851|NCT03400332|593737972|FG003|Pre-Treatment|Other reasons|0|||
164371852|NCT03400332|593737973|FG004|Pre-Treatment|Other reasons|0|||
164371853|NCT03400332|593737974|FG005|Pre-Treatment|Other reasons|0|||
164371854|NCT03400332|593737975|FG006|Pre-Treatment|Other reasons|0|||
164371855|NCT03400332|593737976|FG007|Pre-Treatment|Other reasons|0|||
164371856|NCT03400332|593737977|FG008|Pre-Treatment|Other reasons|1|||
164371857|NCT03400332|593737969|FG000|Pre-Treatment|No longer met study criteria|0|||
164439018|NCT02341625|593973114|FG005|Overall Study|Study Drug Toxicity|3|||
164439019|NCT02341625|593973115|FG006|Overall Study|Study Drug Toxicity|10|||
164439020|NCT02341625|593973116|FG007|Overall Study|Study Drug Toxicity|0|||
164439021|NCT02341625|593973117|FG008|Overall Study|Study Drug Toxicity|0|||
164439022|NCT02341625|593973118|FG009|Overall Study|Study Drug Toxicity|3|||
164439023|NCT02341625|593973109|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
164371858|NCT03400332|593737970|FG001|Pre-Treatment|No longer met study criteria|0|||
164371859|NCT03400332|593737971|FG002|Pre-Treatment|No longer met study criteria|0|||
164371860|NCT03400332|593737972|FG003|Pre-Treatment|No longer met study criteria|0|||
164371861|NCT03400332|593737973|FG004|Pre-Treatment|No longer met study criteria|0|||
164371862|NCT03400332|593737974|FG005|Pre-Treatment|No longer met study criteria|0|||
164371863|NCT03400332|593737975|FG006|Pre-Treatment|No longer met study criteria|0|||
164371864|NCT03400332|593737976|FG007|Pre-Treatment|No longer met study criteria|0|||
164371865|NCT03400332|593737977|FG008|Pre-Treatment|No longer met study criteria|1|||
164371866|NCT03400332|593737969|FG000|Pre-Treatment|Withdrawal by Subject|0|||
164371867|NCT03400332|593737970|FG001|Pre-Treatment|Withdrawal by Subject|0|||
164439024|NCT02341625|593973110|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
164371868|NCT03400332|593737971|FG002|Pre-Treatment|Withdrawal by Subject|0|||
164371869|NCT03400332|593737972|FG003|Pre-Treatment|Withdrawal by Subject|0|||
164371870|NCT03400332|593737973|FG004|Pre-Treatment|Withdrawal by Subject|0|||
164371871|NCT03400332|593737974|FG005|Pre-Treatment|Withdrawal by Subject|0|||
164371872|NCT03400332|593737975|FG006|Pre-Treatment|Withdrawal by Subject|0|||
164371873|NCT03400332|593737976|FG007|Pre-Treatment|Withdrawal by Subject|0|||
164371874|NCT03400332|593737977|FG008|Pre-Treatment|Withdrawal by Subject|1|||
164371875|NCT03400332|593737969|FG000|Treatment|Participant withdrew consent|2|||
164371876|NCT03400332|593737970|FG001|Treatment|Participant withdrew consent|2|||
164371877|NCT03400332|593737971|FG002|Treatment|Participant withdrew consent|0|||
164371878|NCT03400332|593737972|FG003|Treatment|Participant withdrew consent|0|||
164371879|NCT03400332|593737973|FG004|Treatment|Participant withdrew consent|3|||
164371880|NCT03400332|593737974|FG005|Treatment|Participant withdrew consent|3|||
164371881|NCT03400332|593737975|FG006|Treatment|Participant withdrew consent|1|||
164371882|NCT03400332|593737976|FG007|Treatment|Participant withdrew consent|1|||
164371883|NCT03400332|593737977|FG008|Treatment|Participant withdrew consent|1|||
164371884|NCT03400332|593737969|FG000|Treatment|Other reasons|0|||
164371885|NCT03400332|593737970|FG001|Treatment|Other reasons|1|||
164371886|NCT03400332|593737971|FG002|Treatment|Other reasons|1|||
164371887|NCT03400332|593737972|FG003|Treatment|Other reasons|0|||
164371888|NCT03400332|593737973|FG004|Treatment|Other reasons|3|||
164371889|NCT03400332|593737974|FG005|Treatment|Other reasons|1|||
164371890|NCT03400332|593737975|FG006|Treatment|Other reasons|2|||
164371891|NCT03400332|593737976|FG007|Treatment|Other reasons|0|||
164371892|NCT03400332|593737977|FG008|Treatment|Other reasons|1|||
164371893|NCT03400332|593737969|FG000|Treatment|Lost to Follow-up|0|||
164371894|NCT03400332|593737970|FG001|Treatment|Lost to Follow-up|1|||
164371895|NCT03400332|593737971|FG002|Treatment|Lost to Follow-up|0|||
164371896|NCT03400332|593737972|FG003|Treatment|Lost to Follow-up|0|||
164371897|NCT03400332|593737973|FG004|Treatment|Lost to Follow-up|0|||
164371898|NCT03400332|593737974|FG005|Treatment|Lost to Follow-up|0|||
164371899|NCT03400332|593737975|FG006|Treatment|Lost to Follow-up|0|||
164371900|NCT03400332|593737976|FG007|Treatment|Lost to Follow-up|0|||
164371901|NCT03400332|593737977|FG008|Treatment|Lost to Follow-up|0|||
164371902|NCT03400332|593737969|FG000|Treatment|Death|3|||
164371903|NCT03400332|593737970|FG001|Treatment|Death|1|||
164371904|NCT03400332|593737971|FG002|Treatment|Death|2|||
164371905|NCT03400332|593737972|FG003|Treatment|Death|3|||
164371906|NCT03400332|593737973|FG004|Treatment|Death|6|||
164371907|NCT03400332|593737974|FG005|Treatment|Death|2|||
164371908|NCT03400332|593737975|FG006|Treatment|Death|1|||
164371909|NCT03400332|593737976|FG007|Treatment|Death|3|||
164371910|NCT03400332|593737977|FG008|Treatment|Death|6|||
164371911|NCT00048542|593737978|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
164371912|NCT00048542|593737979|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
164371913|NCT00048542|593737980|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
164371914|NCT00048542|593737981|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
164700411|NCT00515541|594926826|FG001|Overall Study|Withdrawal by Subject|2|||
164700412|NCT00515541|594926827|FG002|Overall Study|Withdrawal by Subject|0|||
164700413|NCT00515541|594926828|FG003|Overall Study|Withdrawal by Subject|2|||
164700414|NCT00158756|594926830|FG000|Overall Study|Withdrawal by Subject|5|||
164371915|NCT00048542|593737982|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
164371916|NCT00048542|593737983|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
164371917|NCT00048542|593737984|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
164371918|NCT00048542|593737985|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
164371919|NCT00048542|593737978|FG000|Double-Blind Phase|Protocol Violation|0|||
164371920|NCT00048542|593737979|FG001|Double-Blind Phase|Protocol Violation|0|||
164371921|NCT00048542|593737980|FG002|Double-Blind Phase|Protocol Violation|1|||
164371922|NCT00048542|593737981|FG003|Double-Blind Phase|Protocol Violation|0|||
164371923|NCT00048542|593737982|FG004|Double-Blind Phase|Protocol Violation|0|||
164371924|NCT00048542|593737983|FG005|Double-Blind Phase|Protocol Violation|0|||
164700415|NCT00158756|594926831|FG001|Overall Study|Withdrawal by Subject|0|||
164371925|NCT00048542|593737984|FG006|Double-Blind Phase|Protocol Violation|0|||
164371926|NCT00048542|593737985|FG007|Double-Blind Phase|Protocol Violation|0|||
164371927|NCT00048542|593737978|FG000|Double-Blind Phase|Sponsor request or decision|2|||
164371928|NCT00048542|593737979|FG001|Double-Blind Phase|Sponsor request or decision|0|||
164371929|NCT00048542|593737980|FG002|Double-Blind Phase|Sponsor request or decision|0|||
164371930|NCT00048542|593737981|FG003|Double-Blind Phase|Sponsor request or decision|0|||
164371931|NCT00048542|593737982|FG004|Double-Blind Phase|Sponsor request or decision|0|||
164371932|NCT00048542|593737983|FG005|Double-Blind Phase|Sponsor request or decision|0|||
164371933|NCT00048542|593737984|FG006|Double-Blind Phase|Sponsor request or decision|0|||
164700416|NCT00158756|594926832|FG002|Overall Study|Withdrawal by Subject|6|||
164700417|NCT00158756|594926833|FG003|Overall Study|Withdrawal by Subject|1|||
164700418|NCT00158756|594926834|FG004|Overall Study|Withdrawal by Subject|3|||
164371934|NCT00048542|593737985|FG007|Double-Blind Phase|Sponsor request or decision|0|||
164371935|NCT00048542|593737978|FG000|Double-Blind Phase|Randomized in error|1|||
164371936|NCT00048542|593737979|FG001|Double-Blind Phase|Randomized in error|0|||
164371937|NCT00048542|593737980|FG002|Double-Blind Phase|Randomized in error|0|||
164371938|NCT00048542|593737981|FG003|Double-Blind Phase|Randomized in error|0|||
164371939|NCT00048542|593737982|FG004|Double-Blind Phase|Randomized in error|0|||
164371940|NCT00048542|593737983|FG005|Double-Blind Phase|Randomized in error|0|||
164371941|NCT00048542|593737984|FG006|Double-Blind Phase|Randomized in error|0|||
164371942|NCT00048542|593737985|FG007|Double-Blind Phase|Randomized in error|0|||
164371943|NCT00048542|593737978|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
164371944|NCT00048542|593737979|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
164371945|NCT00048542|593737980|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
164371946|NCT00048542|593737981|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
164371947|NCT00048542|593737982|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
164371948|NCT00048542|593737983|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
164371949|NCT00048542|593737984|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
164371950|NCT00048542|593737985|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
164371951|NCT00048542|593737978|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
164371952|NCT00048542|593737979|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
164371953|NCT00048542|593737980|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
164371954|NCT00048542|593737981|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
164371955|NCT00048542|593737982|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
164371956|NCT00048542|593737983|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
164371957|NCT00048542|593737984|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
164371958|NCT00048542|593737985|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
164371959|NCT00048542|593737978|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
164371960|NCT00048542|593737979|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
164371961|NCT00048542|593737980|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
164371962|NCT00048542|593737981|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
164371963|NCT00048542|593737982|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
164371964|NCT00048542|593737983|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
164371965|NCT00048542|593737984|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
164371966|NCT00048542|593737985|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
164371967|NCT00048542|593737978|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
164371968|NCT00048542|593737979|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
164371969|NCT00048542|593737980|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
164371970|NCT00048542|593737981|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
164371971|NCT00048542|593737982|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
164371972|NCT00048542|593737983|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
164371973|NCT00048542|593737984|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
164371974|NCT00048542|593737985|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
164371975|NCT00048542|593737978|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
164371976|NCT00048542|593737979|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
164371977|NCT00048542|593737980|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
164371978|NCT00048542|593737981|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
164371979|NCT00048542|593737982|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
164371980|NCT00048542|593737983|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
164371981|NCT00048542|593737984|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
164371982|NCT00048542|593737985|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
164371983|NCT00048542|593737978|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
164371984|NCT00048542|593737979|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
164371985|NCT00048542|593737980|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
164371986|NCT00048542|593737981|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
164371987|NCT00048542|593737982|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
164371988|NCT00048542|593737983|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
164371989|NCT00048542|593737984|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
164371990|NCT00048542|593737985|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
164371991|NCT00048542|593737978|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
164371992|NCT00048542|593737979|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
164371993|NCT00048542|593737980|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
164371994|NCT00048542|593737981|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
164371995|NCT00048542|593737982|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
164371996|NCT00048542|593737983|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
164371997|NCT00048542|593737984|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
164371998|NCT00048542|593737985|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
164371999|NCT00048542|593737978|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
164372000|NCT00048542|593737979|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
164372001|NCT00048542|593737980|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
164372002|NCT00048542|593737981|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
164372003|NCT00048542|593737982|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
164372004|NCT00048542|593737983|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
164372005|NCT00048542|593737984|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
164372006|NCT00048542|593737985|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
164372007|NCT00048542|593737978|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
164372008|NCT00048542|593737979|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
164372009|NCT00048542|593737980|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
164372010|NCT00048542|593737981|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
164372011|NCT00048542|593737982|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
164372012|NCT00048542|593737983|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
164372013|NCT00048542|593737984|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
164372014|NCT00048542|593737985|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
164372015|NCT00048542|593737978|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
164372016|NCT00048542|593737979|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
164372017|NCT00048542|593737980|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
164372018|NCT00048542|593737981|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
164372019|NCT00048542|593737982|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
164372020|NCT00048542|593737983|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
164372021|NCT00048542|593737984|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
164372022|NCT00048542|593737985|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
164372023|NCT00048542|593737978|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
164372024|NCT00048542|593737979|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
164372025|NCT00048542|593737980|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
164372026|NCT00048542|593737981|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
164372027|NCT00048542|593737982|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
164372028|NCT00048542|593737983|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
164372029|NCT00048542|593737984|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
164372030|NCT00048542|593737985|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
164372031|NCT04033159|593737990|FG000|Washout Period|Physician Decision|0|||
164372032|NCT04033159|593737991|FG001|Washout Period|Physician Decision|1|||
164372033|NCT04033159|593737992|FG002|Washout Period|Physician Decision|0|||
164372034|NCT04033159|593737990|FG000|Washout Period|Study terminated by Sponsor|0|||
164372035|NCT04033159|593737991|FG001|Washout Period|Study terminated by Sponsor|7|||
164372036|NCT04033159|593737992|FG002|Washout Period|Study terminated by Sponsor|0|||
164372037|NCT04033159|593737990|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
164372038|NCT04033159|593737991|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
164372039|NCT04033159|593737992|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
164372040|NCT02027844|593737993|FG000|Overall Study|Withdrawal by Subject|3|||
164372041|NCT02027844|593737994|FG001|Overall Study|Withdrawal by Subject|2|||
164372042|NCT02027844|593737995|FG002|Overall Study|Withdrawal by Subject|1|||
164372043|NCT02027844|593737993|FG000|Overall Study|Lost to Follow-up|0|||
164372044|NCT02027844|593737994|FG001|Overall Study|Lost to Follow-up|2|||
164372045|NCT02027844|593737995|FG002|Overall Study|Lost to Follow-up|1|||
164372046|NCT02027844|593737993|FG000|Overall Study|Protocol Violation|0|||
164372047|NCT02027844|593737994|FG001|Overall Study|Protocol Violation|2|||
164372048|NCT02027844|593737995|FG002|Overall Study|Protocol Violation|0|||
164372049|NCT02027844|593737993|FG000|Overall Study|Incomlete data|2|||
164372050|NCT02027844|593737994|FG001|Overall Study|Incomlete data|0|||
164372051|NCT02027844|593737995|FG002|Overall Study|Incomlete data|0|||
164372052|NCT01452412|593738006|FG000|Overall Study|Withdrawal by Subject|15|||
164372053|NCT01452412|593738007|FG001|Overall Study|Withdrawal by Subject|11|||
164372054|NCT01452412|593738006|FG000|Overall Study|Adverse Event|4|||
164372055|NCT01452412|593738007|FG001|Overall Study|Adverse Event|3|||
164372056|NCT01452412|593738006|FG000|Overall Study|Lost to Follow-up|5|||
164372057|NCT01452412|593738007|FG001|Overall Study|Lost to Follow-up|3|||
164372058|NCT01452412|593738006|FG000|Overall Study|Death|1|||
164372059|NCT01452412|593738007|FG001|Overall Study|Death|0|||
164372060|NCT01452412|593738006|FG000|Overall Study|Initiated dialysis|1|||
164372061|NCT01452412|593738007|FG001|Overall Study|Initiated dialysis|0|||
164372062|NCT01452412|593738006|FG000|Overall Study|Other|2|||
164700419|NCT00158756|594926830|FG000|Overall Study|Adverse Event|0|||
164700420|NCT00158756|594926831|FG001|Overall Study|Adverse Event|0|||
164372063|NCT01452412|593738007|FG001|Overall Study|Other|0|||
164372064|NCT02346136|593738008|FG000|Overall Study|Withdrawal by Subject|7|||
164372065|NCT02346136|593738009|FG001|Overall Study|Withdrawal by Subject|5|||
164372066|NCT02346136|593738008|FG000|Overall Study|Death|1|||
164372067|NCT02346136|593738009|FG001|Overall Study|Death|0|||
164372068|NCT02346136|593738008|FG000|Overall Study|Study termination|14|||
164372069|NCT02346136|593738009|FG001|Overall Study|Study termination|18|||
164700421|NCT00158756|594926832|FG002|Overall Study|Adverse Event|1|||
164700422|NCT00158756|594926833|FG003|Overall Study|Adverse Event|0|||
164372070|NCT03047135|593738010|FG000|Overall Study|Still being treated|3|||
164700423|NCT00158756|594926834|FG004|Overall Study|Adverse Event|0|||
164700424|NCT00158756|594926830|FG000|Overall Study|Serious adverse event|0|||
164700425|NCT00158756|594926831|FG001|Overall Study|Serious adverse event|0|||
164372071|NCT00323414|593738011|FG000|Overall Study|Withdrawal by Subject|0|||
164372072|NCT00323414|593738012|FG001|Overall Study|Withdrawal by Subject|1|||
164372073|NCT04382911|593738013|FG000|Overall Study|unable to be imaged prior to surgery|2|||
164372074|NCT05619692|593738020|FG000|Overall Study|Adverse Event|2|||
164372075|NCT05619692|593738021|FG001|Overall Study|Adverse Event|2|||
164372076|NCT05619692|593738020|FG000|Overall Study|Withdrawal by Participant|3|||
164372077|NCT05619692|593738021|FG001|Overall Study|Withdrawal by Participant|4|||
164372078|NCT05619692|593738020|FG000|Overall Study|Lost to Follow-up|2|||
164372079|NCT05619692|593738021|FG001|Overall Study|Lost to Follow-up|1|||
164372080|NCT05619692|593738020|FG000|Overall Study|Randomized but not treated|1|||
164372081|NCT05619692|593738021|FG001|Overall Study|Randomized but not treated|3|||
164372082|NCT02703636|593738023|FG000|Overall Study|Adverse Event|14|||
164700426|NCT00158756|594926832|FG002|Overall Study|Serious adverse event|1|||
164700427|NCT00158756|594926833|FG003|Overall Study|Serious adverse event|0|||
164372083|NCT02703636|593738023|FG000|Overall Study|Study stopped by sponsor|1|||
164372084|NCT02703636|593738023|FG000|Overall Study|Withdrawal by Subject|1|||
164372085|NCT01224639|593738027|FG000|Overall Study|Withdrawal by Subject|0|||
164372086|NCT01224639|593738028|FG001|Overall Study|Withdrawal by Subject|0|||
164372087|NCT01224639|593738029|FG002|Overall Study|Withdrawal by Subject|0|||
164372088|NCT01224639|593738030|FG003|Overall Study|Withdrawal by Subject|0|||
164372089|NCT01224639|593738031|FG004|Overall Study|Withdrawal by Subject|2|||
164372090|NCT01224639|593738032|FG005|Overall Study|Withdrawal by Subject|0|||
164372091|NCT01224639|593738033|FG006|Overall Study|Withdrawal by Subject|1|||
164372092|NCT01224639|593738034|FG007|Overall Study|Withdrawal by Subject|1|||
164372093|NCT01224639|593738027|FG000|Overall Study|Adverse Event|0|||
164372094|NCT01224639|593738028|FG001|Overall Study|Adverse Event|0|||
164372095|NCT01224639|593738029|FG002|Overall Study|Adverse Event|0|||
164372096|NCT01224639|593738030|FG003|Overall Study|Adverse Event|0|||
164372097|NCT01224639|593738031|FG004|Overall Study|Adverse Event|0|||
164372098|NCT01224639|593738032|FG005|Overall Study|Adverse Event|0|||
164372099|NCT01224639|593738033|FG006|Overall Study|Adverse Event|0|||
164372100|NCT01224639|593738034|FG007|Overall Study|Adverse Event|1|||
164372101|NCT04656132|593738035|FG000|Overall Study|Lost to Follow-up|4|||
164372102|NCT04656132|593738035|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
164372103|NCT04365699|593738036|FG000|Overall Study|Death|2|||
164372104|NCT04365699|593738037|FG001|Overall Study|Death|5|||
164372105|NCT04365699|593738038|FG002|Overall Study|Death|15|||
164372106|NCT02196324|593738041|FG000|Overall Study|Withdrawal by Subject|8|||
164372107|NCT02196324|593738042|FG001|Overall Study|Withdrawal by Subject|4|||
164372108|NCT02196324|593738041|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
164372109|NCT02196324|593738042|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
164372110|NCT02196324|593738041|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
164372111|NCT02196324|593738042|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
164372112|NCT02196324|593738041|FG000|Overall Study|Other|1|||
164372113|NCT02196324|593738042|FG001|Overall Study|Other|0|||
164372114|NCT00834912|593738043|FG000|Treatment Period 1|Adverse Event|0|||
164372115|NCT00834912|593738044|FG001|Treatment Period 1|Adverse Event|1|||
164372116|NCT00834912|593738045|FG002|Treatment Period 1|Adverse Event|0|||
164372117|NCT00834912|593738046|FG003|Treatment Period 1|Adverse Event|1|||
164372118|NCT00834912|593738047|FG004|Treatment Period 1|Adverse Event|0|||
164372119|NCT00834912|593738048|FG005|Treatment Period 1|Adverse Event|0|||
164372120|NCT00834912|593738043|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164372121|NCT00834912|593738044|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164372122|NCT00834912|593738045|FG002|Treatment Period 2|Withdrawal by Subject|1|||
164372123|NCT00834912|593738046|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164372124|NCT00834912|593738047|FG004|Treatment Period 2|Withdrawal by Subject|1|||
164700428|NCT00158756|594926834|FG004|Overall Study|Serious adverse event|0|||
164700429|NCT01421342|594926835|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
164700430|NCT01421342|594926836|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
164700431|NCT01421342|594926837|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
164372125|NCT00834912|593738048|FG005|Treatment Period 2|Withdrawal by Subject|0|||
164372126|NCT01399593|593738052|FG000|Overall Study|Physician Decision|1|||
164372127|NCT01399593|593738053|FG001|Overall Study|Physician Decision|0|||
164372128|NCT01399593|593738052|FG000|Overall Study|Adverse Event|1|||
164372129|NCT01399593|593738053|FG001|Overall Study|Adverse Event|0|||
164372130|NCT01399593|593738052|FG000|Overall Study|Death|1|||
164372131|NCT01399593|593738053|FG001|Overall Study|Death|1|||
164372132|NCT01399593|593738052|FG000|Overall Study|Transplantectomy|0|||
164372133|NCT01399593|593738053|FG001|Overall Study|Transplantectomy|1|||
164372134|NCT00344773|593738055|FG000|Overall Study|Adverse Event|2|||
164372135|NCT00344773|593738055|FG000|Overall Study|Objective Disease Progression|16|||
164439025|NCT02341625|593973111|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
164700432|NCT01421342|594926835|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
164372136|NCT00344773|593738055|FG000|Overall Study|Withdrawal by Subject|1|||
164372137|NCT00344773|593738055|FG000|Overall Study|Not Eligible for the study|2|||
164372138|NCT02849548|593738063|FG000|Overall Study|Lost to Follow-up|1|||
164700433|NCT01421342|594926836|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
164372139|NCT02849548|593738064|FG001|Overall Study|Lost to Follow-up|2|||
164372140|NCT02849548|593738063|FG000|Overall Study|Protocol Violation|1|||
164372141|NCT02849548|593738064|FG001|Overall Study|Protocol Violation|0|||
164372142|NCT00714259|593738065|FG000|Overall Study|Death|2|||
164372143|NCT02357147|593738066|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
164372144|NCT02357147|593738067|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
164372145|NCT02357147|593738066|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
164372146|NCT02357147|593738067|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
164372147|NCT02357147|593738066|FG000|Combination Treatment Phase|Investigator Discretion|1|||
164372148|NCT02357147|593738067|FG001|Combination Treatment Phase|Investigator Discretion|1|||
164372149|NCT02357147|593738066|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
164372150|NCT02357147|593738067|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
164372151|NCT02357147|593738066|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
164372152|NCT02357147|593738067|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
164372153|NCT02357147|593738066|FG000|Combination Treatment Phase|Adverse Event|12|||
164372154|NCT02357147|593738067|FG001|Combination Treatment Phase|Adverse Event|4|||
164372155|NCT02357147|593738066|FG000|Combination Treatment Phase|Death|1|||
164372156|NCT02357147|593738067|FG001|Combination Treatment Phase|Death|1|||
164372157|NCT02357147|593738066|FG000|Combination Treatment Phase|Sponsor Decision|0|||
164591465|NCT00358917|594528384|FG001|Overall Study|Noncompliance|11|||
164591466|NCT00358917|594528383|FG000|Overall Study|Death|2|||
164591467|NCT00358917|594528384|FG001|Overall Study|Death|3|||
164591468|NCT00358917|594528383|FG000|Overall Study|Virologic failure|11|||
164591469|NCT00358917|594528384|FG001|Overall Study|Virologic failure|8|||
164591470|NCT00358917|594528383|FG000|Overall Study|Unable to Continue Participation|2|||
164591471|NCT00358917|594528384|FG001|Overall Study|Unable to Continue Participation|2|||
164591472|NCT02890329|594528391|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
164591473|NCT02890329|594528392|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
164591474|NCT02890329|594528393|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
164591475|NCT02890329|594528394|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
164591476|NCT02890329|594528395|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
164591477|NCT02890329|594528396|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
164591478|NCT02890329|594528391|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
164591479|NCT02890329|594528392|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
164591480|NCT02890329|594528393|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
164591481|NCT02890329|594528394|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
164591482|NCT02890329|594528395|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
164591483|NCT02890329|594528396|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
164591484|NCT02890329|594528391|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
164591485|NCT02890329|594528392|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
164591486|NCT02890329|594528393|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
164591487|NCT02890329|594528394|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
164591488|NCT02890329|594528395|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
164591489|NCT02890329|594528396|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
164591490|NCT02890329|594528391|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
164591491|NCT02890329|594528392|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
164591492|NCT02890329|594528393|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
164591493|NCT02890329|594528394|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
164591494|NCT02890329|594528395|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
164591495|NCT02890329|594528396|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
164591496|NCT01379534|594528397|FG000|Treatment Phase|Withdrawal by Subject|2|||
164591497|NCT01379534|594528398|FG001|Treatment Phase|Withdrawal by Subject|2|||
164591498|NCT01379534|594528397|FG000|Treatment Phase|Progressive disease|13|||
164591499|NCT01379534|594528398|FG001|Treatment Phase|Progressive disease|22|||
164591500|NCT01379534|594528397|FG000|Treatment Phase|Adverse Event|7|||
164591501|NCT01379534|594528398|FG001|Treatment Phase|Adverse Event|7|||
164591502|NCT01379534|594528397|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
164591503|NCT01379534|594528398|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
164591504|NCT01379534|594528397|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
164591505|NCT01379534|594528398|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
164591506|NCT01379534|594528397|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
164372158|NCT02357147|593738067|FG001|Combination Treatment Phase|Sponsor Decision|12|||
164372159|NCT02357147|593738066|FG000|Combination Treatment Phase|Other|1|||
164372160|NCT02357147|593738067|FG001|Combination Treatment Phase|Other|0|||
164372161|NCT02357147|593738066|FG000|Combination Treatment Phase|Not treated|0|||
164372162|NCT02357147|593738067|FG001|Combination Treatment Phase|Not treated|2|||
164372163|NCT02357147|593738066|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
164372164|NCT02357147|593738067|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
164372165|NCT02357147|593738066|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
164372166|NCT02357147|593738067|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
164372167|NCT02357147|593738066|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
164372168|NCT02357147|593738067|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
164372169|NCT02357147|593738066|FG000|Maintenance Treatment Phase|Adverse Event|0|||
164372170|NCT02357147|593738067|FG001|Maintenance Treatment Phase|Adverse Event|3|||
164372171|NCT02357147|593738066|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
164372172|NCT02357147|593738067|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
164372173|NCT02357147|593738066|FG000|Maintenance Treatment Phase|Not Treated|1|||
164372174|NCT02357147|593738067|FG001|Maintenance Treatment Phase|Not Treated|0|||
164372175|NCT02177266|593739830|FG000|Overall Study|Adverse Event|0|||
164372176|NCT02177266|593739831|FG001|Overall Study|Adverse Event|1|||
164372177|NCT02177266|593739830|FG000|Overall Study|Withdrawal by Subject|1|||
164372178|NCT02177266|593739831|FG001|Overall Study|Withdrawal by Subject|0|||
164372179|NCT03019627|593739832|FG000|Overall Study|Adverse Event|8|||
164372180|NCT03019627|593739833|FG001|Overall Study|Adverse Event|0|||
164372181|NCT03019627|593739832|FG000|Overall Study|Unrelated to adverse event|1|||
164372182|NCT03019627|593739833|FG001|Overall Study|Unrelated to adverse event|3|||
164372183|NCT03019627|593739832|FG000|Overall Study|Lost to Follow-up|2|||
164372184|NCT03019627|593739833|FG001|Overall Study|Lost to Follow-up|1|||
164372185|NCT03019627|593739832|FG000|Overall Study|not compliance|2|||
164372186|NCT03019627|593739833|FG001|Overall Study|not compliance|2|||
164372187|NCT03019627|593739832|FG000|Overall Study|Other|2|||
164372188|NCT03019627|593739833|FG001|Overall Study|Other|2|||
164372189|NCT05107128|593739834|FG000|Overall Study|Adverse Event|2|||
164372190|NCT05107128|593739835|FG001|Overall Study|Adverse Event|0|||
164372191|NCT05107128|593739834|FG000|Overall Study|Withdrawal by Subject|3|||
164372192|NCT05107128|593739835|FG001|Overall Study|Withdrawal by Subject|3|||
164372193|NCT05107128|593739834|FG000|Overall Study|Withdrawal of Consent|0|||
164372194|NCT05107128|593739835|FG001|Overall Study|Withdrawal of Consent|1|||
164372195|NCT05107128|593739834|FG000|Overall Study|Reason Not Specified|2|||
164372196|NCT05107128|593739835|FG001|Overall Study|Reason Not Specified|0|||
164372197|NCT03761628|593739836|FG000|Overall Study|Withdrawal by Subject|3|||
164372198|NCT03761628|593739836|FG000|Overall Study|Physician Decision|1|||
164372199|NCT03761628|593739836|FG000|Overall Study|Pregnancy|1|||
164372200|NCT03761628|593739836|FG000|Overall Study|Lost to Follow-up|1|||
164372201|NCT01470469|593739839|FG000|Overall Study|Withdrawal by Subject|4|||
164372202|NCT01470469|593739840|FG001|Overall Study|Withdrawal by Subject|6|||
164372203|NCT01470469|593739839|FG000|Overall Study|Lack of Efficacy|1|||
164372204|NCT01470469|593739840|FG001|Overall Study|Lack of Efficacy|7|||
164372205|NCT01470469|593739839|FG000|Overall Study|Adverse Event|0|||
164372206|NCT01470469|593739840|FG001|Overall Study|Adverse Event|7|||
164372207|NCT01470469|593739839|FG000|Overall Study|Lost to Follow-up|2|||
164372208|NCT01470469|593739840|FG001|Overall Study|Lost to Follow-up|2|||
164372209|NCT01470469|593739839|FG000|Overall Study|Protocol Violation|1|||
164372210|NCT01470469|593739840|FG001|Overall Study|Protocol Violation|1|||
164372211|NCT01470469|593739839|FG000|Overall Study|Other|2|||
164372212|NCT01470469|593739840|FG001|Overall Study|Other|1|||
164372213|NCT05459129|593739841|FG000|Overall Study|Death|1|||
164372214|NCT05459129|593739842|FG001|Overall Study|Death|0|||
164372215|NCT05459129|593739841|FG000|Overall Study|Study Terminated By Sponsor|5|||
164372216|NCT05459129|593739842|FG001|Overall Study|Study Terminated By Sponsor|6|||
164372217|NCT04649151|593739850|FG000|Overall Study|Pregnancy|0|||
164372218|NCT04649151|593739851|FG001|Overall Study|Pregnancy|0|||
164372219|NCT04649151|593739852|FG002|Overall Study|Pregnancy|0|||
164372220|NCT04649151|593739853|FG003|Overall Study|Pregnancy|0|||
164372221|NCT04649151|593739854|FG004|Overall Study|Pregnancy|3|||
164372222|NCT04649151|593739850|FG000|Overall Study|Physician Decision|10|||
164439026|NCT02341625|593973112|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
164372223|NCT04649151|593739851|FG001|Overall Study|Physician Decision|0|||
164372224|NCT04649151|593739852|FG002|Overall Study|Physician Decision|0|||
164372225|NCT04649151|593739853|FG003|Overall Study|Physician Decision|1|||
164372226|NCT04649151|593739854|FG004|Overall Study|Physician Decision|1|||
164372227|NCT04649151|593739850|FG000|Overall Study|Protocol Deviation|25|||
164372228|NCT04649151|593739851|FG001|Overall Study|Protocol Deviation|3|||
164372229|NCT04649151|593739852|FG002|Overall Study|Protocol Deviation|0|||
164372230|NCT04649151|593739853|FG003|Overall Study|Protocol Deviation|0|||
164372231|NCT04649151|593739854|FG004|Overall Study|Protocol Deviation|0|||
164372232|NCT04649151|593739850|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
164372233|NCT04649151|593739851|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
164372234|NCT04649151|593739852|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
164372235|NCT04649151|593739853|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
164372236|NCT04649151|593739854|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
164372237|NCT04649151|593739850|FG000|Overall Study|Withdrawal by Subject|370|||
164372238|NCT04649151|593739851|FG001|Overall Study|Withdrawal by Subject|113|||
164372239|NCT04649151|593739852|FG002|Overall Study|Withdrawal by Subject|2|||
164372240|NCT04649151|593739853|FG003|Overall Study|Withdrawal by Subject|7|||
164372241|NCT04649151|593739854|FG004|Overall Study|Withdrawal by Subject|15|||
164372242|NCT04649151|593739850|FG000|Overall Study|Adverse Event|1|||
164372243|NCT04649151|593739851|FG001|Overall Study|Adverse Event|0|||
164372244|NCT04649151|593739852|FG002|Overall Study|Adverse Event|0|||
164372245|NCT04649151|593739853|FG003|Overall Study|Adverse Event|0|||
164372246|NCT04649151|593739854|FG004|Overall Study|Adverse Event|0|||
164372247|NCT04649151|593739850|FG000|Overall Study|Lost to Follow-up|256|||
164372248|NCT04649151|593739851|FG001|Overall Study|Lost to Follow-up|29|||
164372249|NCT04649151|593739852|FG002|Overall Study|Lost to Follow-up|10|||
164372250|NCT04649151|593739853|FG003|Overall Study|Lost to Follow-up|3|||
164372251|NCT04649151|593739854|FG004|Overall Study|Lost to Follow-up|6|||
164372252|NCT04649151|593739850|FG000|Overall Study|Other than specified|59|||
164372253|NCT04649151|593739851|FG001|Overall Study|Other than specified|294|||
164372254|NCT04649151|593739852|FG002|Overall Study|Other than specified|0|||
164372255|NCT04649151|593739853|FG003|Overall Study|Other than specified|0|||
164372256|NCT04649151|593739854|FG004|Overall Study|Other than specified|4|||
164372257|NCT04649151|593739850|FG000|Overall Study|Death|0|||
164372258|NCT04649151|593739851|FG001|Overall Study|Death|0|||
164372259|NCT04649151|593739852|FG002|Overall Study|Death|0|||
164372260|NCT04649151|593739853|FG003|Overall Study|Death|0|||
164372261|NCT04649151|593739854|FG004|Overall Study|Death|1|||
164372262|NCT03752619|593739855|FG000|Overall Study|Lost to Follow-up|2|||
164372263|NCT03752619|593739856|FG001|Overall Study|Lost to Follow-up|1|||
164372264|NCT03752619|593739855|FG000|Overall Study|Withdrawal by Subject|1|||
164372265|NCT03752619|593739856|FG001|Overall Study|Withdrawal by Subject|1|||
164372266|NCT03752619|593739855|FG000|Overall Study|Adverse Event|0|||
164372267|NCT03752619|593739856|FG001|Overall Study|Adverse Event|1|||
164372268|NCT04476017|593739857|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
164372269|NCT04476017|593739858|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
164372270|NCT03362502|593739859|FG000|Overall Study|Death|0|||
164372271|NCT03362502|593739860|FG001|Overall Study|Death|0|||
164372272|NCT03362502|593739861|FG002|Overall Study|Death|1|||
164372273|NCT03795610|593739864|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
164372274|NCT03795610|593739864|FG000|Overall Study|Withdrawal by Subject|1|||
164372275|NCT03795610|593739864|FG000|Overall Study|Screen Failure (Unknown)|1|||
164372276|NCT02775344|593739865|FG000|Overall Study|No ovarian cyst identified|3|||
164372277|NCT02775344|593739866|FG001|Overall Study|No ovarian cyst identified|2|||
164372278|NCT03909165|593739877|FG000|Overall Study|Physician Decision|0|||
164372279|NCT03909165|593739878|FG001|Overall Study|Physician Decision|1|||
164372280|NCT03909165|593739879|FG002|Overall Study|Physician Decision|0|||
164372281|NCT03909165|593739880|FG003|Overall Study|Physician Decision|0|||
164372282|NCT03909165|593739881|FG004|Overall Study|Physician Decision|0|||
164372283|NCT03909165|593739877|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164591507|NCT01379534|594528398|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
164591508|NCT01379534|594528397|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
164372284|NCT03909165|593739878|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164372285|NCT03909165|593739879|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164372286|NCT03909165|593739880|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164372287|NCT03909165|593739881|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
164372288|NCT03909165|593739877|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
164372289|NCT03909165|593739878|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
164372290|NCT03909165|593739879|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
164372291|NCT03909165|593739880|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
164372292|NCT03909165|593739881|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
164372293|NCT03909165|593739877|FG000|Overall Study|Previous Drug Exposure|0|||
164372294|NCT03909165|593739878|FG001|Overall Study|Previous Drug Exposure|0|||
164591509|NCT01379534|594528398|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
164591510|NCT00590681|594528406|FG000|Overall Study|Withdrawal by Subject|7|||
164591511|NCT00590681|594528406|FG000|Overall Study|Adverse Event|8|||
164591512|NCT00590681|594528406|FG000|Overall Study|Death|3|||
164591513|NCT00590681|594528406|FG000|Overall Study|Lost to Follow-up|1|||
164591514|NCT00590681|594528406|FG000|Overall Study|disease progression|1|||
164591515|NCT01259297|594528407|FG000|Double Blind Randomized Period|Death|1|||
164591516|NCT01259297|594528408|FG001|Double Blind Randomized Period|Death|1|||
164591517|NCT01259297|594528409|FG002|Double Blind Randomized Period|Death|1|||
164591518|NCT01259297|594528410|FG003|Double Blind Randomized Period|Death|2|||
164372295|NCT03909165|593739879|FG002|Overall Study|Previous Drug Exposure|1|||
164372296|NCT03909165|593739880|FG003|Overall Study|Previous Drug Exposure|0|||
164372297|NCT03909165|593739881|FG004|Overall Study|Previous Drug Exposure|0|||
164372298|NCT03909165|593739877|FG000|Overall Study|Early Discharge|1|||
164372299|NCT03909165|593739878|FG001|Overall Study|Early Discharge|0|||
164372300|NCT03909165|593739879|FG002|Overall Study|Early Discharge|0|||
164372301|NCT03909165|593739880|FG003|Overall Study|Early Discharge|0|||
164372302|NCT03909165|593739881|FG004|Overall Study|Early Discharge|0|||
164372303|NCT06034496|593739882|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
164372304|NCT06034496|593739883|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
164372305|NCT06034496|593739882|FG000|Overall Study|Withdrawal by Subject|5|||
164372306|NCT06034496|593739883|FG001|Overall Study|Withdrawal by Subject|4|||
164372307|NCT02018458|593739884|FG000|Overall Study|Death|4|||
164372308|NCT03277261|593739891|FG000|Overall Study|Adverse Event|17|||
164372309|NCT03277261|593739892|FG001|Overall Study|Adverse Event|1|||
164372310|NCT03277261|593739891|FG000|Overall Study|Participant Withdrawal of Consent|6|||
164372311|NCT03277261|593739892|FG001|Overall Study|Participant Withdrawal of Consent|15|||
164372312|NCT03277261|593739891|FG000|Overall Study|Investigator / Sponsor Decision|4|||
164372313|NCT03277261|593739892|FG001|Overall Study|Investigator / Sponsor Decision|2|||
164372314|NCT03277261|593739891|FG000|Overall Study|Pregnancy|2|||
164372315|NCT03277261|593739892|FG001|Overall Study|Pregnancy|0|||
164372316|NCT03277261|593739891|FG000|Overall Study|Lost to Follow-up|2|||
164372317|NCT03277261|593739892|FG001|Overall Study|Lost to Follow-up|2|||
164372318|NCT03277261|593739891|FG000|Overall Study|Lack of Efficacy|2|||
164372319|NCT03277261|593739892|FG001|Overall Study|Lack of Efficacy|2|||
164372320|NCT03277261|593739891|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
164372321|NCT03277261|593739892|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
164372322|NCT03762083|593739893|FG000|Overall Study|Withdrawal by Subject|2|||
164372323|NCT03762083|593739893|FG000|Overall Study|Physician Decision|1|||
164372324|NCT01203072|593739894|FG000|Overall Study|Adverse Event|5|||
164372325|NCT01203072|593739895|FG001|Overall Study|Adverse Event|3|||
164372326|NCT01203072|593739896|FG002|Overall Study|Adverse Event|2|||
164372327|NCT01203072|593739897|FG003|Overall Study|Adverse Event|4|||
164372328|NCT01203072|593739898|FG004|Overall Study|Adverse Event|2|||
164372329|NCT01203072|593739894|FG000|Overall Study|Lack of Efficacy|1|||
164372330|NCT01203072|593739895|FG001|Overall Study|Lack of Efficacy|0|||
164372331|NCT01203072|593739896|FG002|Overall Study|Lack of Efficacy|0|||
164372332|NCT01203072|593739897|FG003|Overall Study|Lack of Efficacy|0|||
164372333|NCT01203072|593739898|FG004|Overall Study|Lack of Efficacy|0|||
164372334|NCT01203072|593739894|FG000|Overall Study|Lost to Follow-up|0|||
164372335|NCT01203072|593739895|FG001|Overall Study|Lost to Follow-up|1|||
164372336|NCT01203072|593739896|FG002|Overall Study|Lost to Follow-up|0|||
164372337|NCT01203072|593739897|FG003|Overall Study|Lost to Follow-up|0|||
164372338|NCT01203072|593739898|FG004|Overall Study|Lost to Follow-up|0|||
164372339|NCT01203072|593739894|FG000|Overall Study|Protocol Violation|2|||
164372340|NCT01203072|593739895|FG001|Overall Study|Protocol Violation|0|||
164372341|NCT01203072|593739896|FG002|Overall Study|Protocol Violation|0|||
164372342|NCT01203072|593739897|FG003|Overall Study|Protocol Violation|0|||
164372343|NCT01203072|593739898|FG004|Overall Study|Protocol Violation|1|||
164372344|NCT01203072|593739894|FG000|Overall Study|Withdrawal by Subject|2|||
164372345|NCT01203072|593739895|FG001|Overall Study|Withdrawal by Subject|2|||
164372346|NCT01203072|593739896|FG002|Overall Study|Withdrawal by Subject|1|||
164591519|NCT01259297|594528411|FG004|Double Blind Randomized Period|Death|1|||
164591520|NCT01259297|594528412|FG005|Double Blind Randomized Period|Death|5|||
164372347|NCT01203072|593739897|FG003|Overall Study|Withdrawal by Subject|2|||
164372348|NCT01203072|593739898|FG004|Overall Study|Withdrawal by Subject|3|||
164372349|NCT00235872|593739899|FG000|Overall Study|Adverse Event|34|||
164372350|NCT00235872|593739899|FG000|Overall Study|Death|1|||
164372351|NCT00235872|593739899|FG000|Overall Study|Lost to Follow-up|1|||
164372352|NCT00235872|593739899|FG000|Overall Study|Withdrawal by Subject|50|||
164372353|NCT00235872|593739899|FG000|Overall Study|Administrative reason|61|||
164372354|NCT00116558|593739900|FG000|Overall Study|Death|11|||
164372355|NCT00116558|593739901|FG001|Overall Study|Death|5|||
164372356|NCT00116558|593739902|FG002|Overall Study|Death|3|||
164591521|NCT01259297|594528413|FG006|Double Blind Randomized Period|Death|2|||
164591522|NCT01259297|594528414|FG007|Double Blind Randomized Period|Death|1|||
164591523|NCT01259297|594528407|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
164591524|NCT01259297|594528408|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
164591525|NCT01259297|594528409|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
164591526|NCT01259297|594528410|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
164591527|NCT01259297|594528411|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
164372357|NCT00116558|593739900|FG000|Overall Study|Withdrawal by Subject|17|||
164372358|NCT00116558|593739901|FG001|Overall Study|Withdrawal by Subject|3|||
164372359|NCT00116558|593739902|FG002|Overall Study|Withdrawal by Subject|12|||
164372360|NCT00116558|593739900|FG000|Overall Study|disease progression|3|||
164372361|NCT00116558|593739901|FG001|Overall Study|disease progression|7|||
164372362|NCT00116558|593739902|FG002|Overall Study|disease progression|18|||
164372363|NCT00378014|593739903|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
164372364|NCT00378014|593739904|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
164372365|NCT00378014|593739903|FG000|Core (Randomization to Month 11)|Graft loss|1|||
164372366|NCT00378014|593739904|FG001|Core (Randomization to Month 11)|Graft loss|2|||
164372367|NCT00378014|593739903|FG000|Core (Randomization to Month 11)|Death|5|||
164372368|NCT00378014|593739904|FG001|Core (Randomization to Month 11)|Death|3|||
164372369|NCT00378014|593739903|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
164372370|NCT00378014|593739904|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
164372371|NCT00378014|593739903|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
164372372|NCT00378014|593739904|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
164372373|NCT00378014|593739903|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
164372374|NCT00378014|593739904|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
164372375|NCT00378014|593739903|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
164372376|NCT00378014|593739904|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
164372377|NCT00378014|593739903|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
164372378|NCT00378014|593739904|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
164372379|NCT00378014|593739903|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
164372380|NCT00378014|593739904|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
164372381|NCT00378014|593739903|FG000|Extension (Month 12 to Month 59)|Death|1|||
164372382|NCT00378014|593739904|FG001|Extension (Month 12 to Month 59)|Death|2|||
164372383|NCT00378014|593739903|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
164372384|NCT00378014|593739904|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
164372385|NCT00378014|593739903|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
164372386|NCT00378014|593739904|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
164372387|NCT00378014|593739903|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
164372388|NCT00378014|593739904|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
164372389|NCT00378014|593739903|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
164372390|NCT00378014|593739904|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
164372391|NCT00414661|593739905|FG000|Overall Study|Death|2|||
164372392|NCT00414661|593739906|FG001|Overall Study|Death|5|||
164372393|NCT00414661|593739907|FG002|Overall Study|Death|0|||
164372394|NCT00414661|593739908|FG003|Overall Study|Death|0|||
164372395|NCT00414661|593739905|FG000|Overall Study|Lost to Follow-up|1|||
164372396|NCT00414661|593739906|FG001|Overall Study|Lost to Follow-up|4|||
164372397|NCT00414661|593739907|FG002|Overall Study|Lost to Follow-up|0|||
164372398|NCT00414661|593739908|FG003|Overall Study|Lost to Follow-up|1|||
164372399|NCT00414661|593739905|FG000|Overall Study|Withdrawal by Subject|5|||
164372400|NCT00414661|593739906|FG001|Overall Study|Withdrawal by Subject|2|||
164372401|NCT00414661|593739907|FG002|Overall Study|Withdrawal by Subject|2|||
164372402|NCT00414661|593739908|FG003|Overall Study|Withdrawal by Subject|2|||
164372403|NCT00414661|593739905|FG000|Overall Study|Other|6|||
164372404|NCT00414661|593739906|FG001|Overall Study|Other|3|||
164372405|NCT00414661|593739907|FG002|Overall Study|Other|0|||
164372406|NCT00414661|593739908|FG003|Overall Study|Other|0|||
164372407|NCT02852265|593739912|FG000|3-month Follow-up|Lost to Follow-up|1|||
164372408|NCT02852265|593739913|FG001|3-month Follow-up|Lost to Follow-up|1|||
164372409|NCT01143090|593739914|FG000|Overall Study|Lack of Efficacy|2|||
164372410|NCT01143090|593739914|FG000|Overall Study|Adverse Event|17|||
164372411|NCT01143090|593739914|FG000|Overall Study|Lost to Follow-up|9|||
164372412|NCT01143090|593739914|FG000|Overall Study|Protocol Violation|2|||
164372413|NCT01143090|593739914|FG000|Overall Study|Withdrawal by Subject|18|||
164372414|NCT01143090|593739914|FG000|Overall Study|Non-compliance with study drug|1|||
164372415|NCT01143090|593739914|FG000|Overall Study|Failure to meet eligibility criteria|1|||
164372416|NCT01143090|593739914|FG000|Overall Study|Administrative|1|||
164372417|NCT01800916|593739917|FG000|Test Period 1 (1 Week)|Convex product user|0|||
164372418|NCT01800916|593739918|FG001|Test Period 1 (1 Week)|Convex product user|0|||
164372419|NCT01800916|593739919|FG002|Test Period 1 (1 Week)|Convex product user|0|||
164372420|NCT01800916|593739920|FG003|Test Period 1 (1 Week)|Convex product user|1|||
164372421|NCT01800916|593739921|FG004|Test Period 1 (1 Week)|Convex product user|0|||
164372422|NCT01800916|593739922|FG005|Test Period 1 (1 Week)|Convex product user|0|||
164372423|NCT01800916|593739923|FG006|Test Period 1 (1 Week)|Convex product user|0|||
164700434|NCT01421342|594926837|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
164700435|NCT01421342|594926835|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
164372424|NCT01800916|593739924|FG007|Test Period 1 (1 Week)|Convex product user|0|||
164372425|NCT01800916|593739925|FG008|Test Period 1 (1 Week)|Convex product user|0|||
164372426|NCT01800916|593739917|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
164372427|NCT01800916|593739918|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
164372428|NCT01800916|593739919|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
164372429|NCT01800916|593739920|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
164372430|NCT01800916|593739921|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
164372431|NCT01800916|593739922|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
164372432|NCT01800916|593739923|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
164372433|NCT01800916|593739924|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
164372434|NCT01800916|593739925|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
164372435|NCT00727714|593739933|FG000|Overall Study|Lost to Follow-up|2|||
164372436|NCT00325234|593739936|FG000|Overall Study|Adverse Event|10|||
164372437|NCT00325234|593739937|FG001|Overall Study|Adverse Event|7|||
164439027|NCT02341625|593973113|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
164439028|NCT02341625|593973114|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
164439029|NCT02341625|593973115|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
164439030|NCT02341625|593973116|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
164439031|NCT02341625|593973117|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
164439032|NCT02341625|593973118|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
164439033|NCT02341625|593973109|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
164439034|NCT02341625|593973110|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
164439035|NCT02341625|593973111|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
164439036|NCT02341625|593973112|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
164439037|NCT02341625|593973113|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
164439038|NCT02341625|593973114|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
164439039|NCT02341625|593973115|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
164439040|NCT02341625|593973116|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
164439041|NCT02341625|593973117|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
164439042|NCT02341625|593973118|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
164439043|NCT02341625|593973109|FG000|Overall Study|Participant Withdrew Consent|0|||
164439044|NCT02341625|593973110|FG001|Overall Study|Participant Withdrew Consent|0|||
164439045|NCT02341625|593973111|FG002|Overall Study|Participant Withdrew Consent|0|||
164439046|NCT02341625|593973112|FG003|Overall Study|Participant Withdrew Consent|1|||
164439047|NCT02341625|593973113|FG004|Overall Study|Participant Withdrew Consent|0|||
164439048|NCT02341625|593973114|FG005|Overall Study|Participant Withdrew Consent|0|||
164439049|NCT02341625|593973115|FG006|Overall Study|Participant Withdrew Consent|0|||
164439050|NCT02341625|593973116|FG007|Overall Study|Participant Withdrew Consent|0|||
164439051|NCT02341625|593973117|FG008|Overall Study|Participant Withdrew Consent|0|||
164439052|NCT02341625|593973118|FG009|Overall Study|Participant Withdrew Consent|0|||
164439053|NCT02341625|593973109|FG000|Overall Study|Completed Treatment as per Protocol|0|||
164439054|NCT02341625|593973110|FG001|Overall Study|Completed Treatment as per Protocol|0|||
164439055|NCT02341625|593973111|FG002|Overall Study|Completed Treatment as per Protocol|0|||
164439056|NCT02341625|593973112|FG003|Overall Study|Completed Treatment as per Protocol|0|||
164372438|NCT00325234|593739936|FG000|Overall Study|Death due to Study Disease|1|||
164372439|NCT00325234|593739937|FG001|Overall Study|Death due to Study Disease|0|||
164372440|NCT00325234|593739936|FG000|Overall Study|Entry Criteria Not Met|1|||
164372441|NCT00325234|593739937|FG001|Overall Study|Entry Criteria Not Met|2|||
164372442|NCT00325234|593739936|FG000|Overall Study|Subject Decision|6|||
164372443|NCT00325234|593739937|FG001|Overall Study|Subject Decision|8|||
164372444|NCT00325234|593739936|FG000|Overall Study|Physician Decision|17|||
164372445|NCT00325234|593739937|FG001|Overall Study|Physician Decision|12|||
164372446|NCT00325234|593739936|FG000|Overall Study|Progressive Disease|34|||
164372447|NCT00325234|593739937|FG001|Overall Study|Progressive Disease|37|||
164372448|NCT01234467|593739938|FG000|Overall Study|Adverse Event|3|||
164372449|NCT01234467|593739938|FG000|Overall Study|Death|2|||
164372450|NCT01234467|593739938|FG000|Overall Study|Withdrawal by Subject|2|||
164372451|NCT01234467|593739938|FG000|Overall Study|Disease Progression|2|||
164372452|NCT01234467|593739938|FG000|Overall Study|Clinical deterioration|1|||
164372453|NCT01234467|593739938|FG000|Overall Study|Physician Decision|1|||
164372454|NCT01234467|593739938|FG000|Overall Study|Other complicating disease (stroke)|1|||
164372455|NCT00559962|593739941|FG000|Overall Study|Adverse Event|1|||
164372456|NCT00559962|593739942|FG001|Overall Study|Adverse Event|7|||
164372457|NCT00559962|593739943|FG002|Overall Study|Adverse Event|8|||
164372458|NCT00559962|593739944|FG003|Overall Study|Adverse Event|5|||
164372459|NCT00559962|593739945|FG004|Overall Study|Adverse Event|11|||
164372460|NCT00559962|593739946|FG005|Overall Study|Adverse Event|4|||
164372461|NCT00559962|593739947|FG006|Overall Study|Adverse Event|4|||
164372462|NCT00559962|593739948|FG007|Overall Study|Adverse Event|2|||
164372463|NCT00559962|593739941|FG000|Overall Study|Lost to Follow-up|0|||
164439057|NCT02341625|593973113|FG004|Overall Study|Completed Treatment as per Protocol|0|||
164439058|NCT02341625|593973114|FG005|Overall Study|Completed Treatment as per Protocol|0|||
164591528|NCT01259297|594528412|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
164591529|NCT01259297|594528413|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
164591530|NCT01259297|594528414|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
164591531|NCT01259297|594528407|FG000|Double Blind Randomized Period|Other reasons|0|||
164591532|NCT01259297|594528408|FG001|Double Blind Randomized Period|Other reasons|1|||
164372464|NCT00559962|593739942|FG001|Overall Study|Lost to Follow-up|1|||
164372465|NCT00559962|593739943|FG002|Overall Study|Lost to Follow-up|0|||
164372466|NCT00559962|593739944|FG003|Overall Study|Lost to Follow-up|0|||
164372467|NCT00559962|593739945|FG004|Overall Study|Lost to Follow-up|0|||
164372468|NCT00559962|593739946|FG005|Overall Study|Lost to Follow-up|0|||
164372469|NCT00559962|593739947|FG006|Overall Study|Lost to Follow-up|0|||
164372470|NCT00559962|593739948|FG007|Overall Study|Lost to Follow-up|0|||
164372471|NCT00559962|593739941|FG000|Overall Study|Withdrawal by Subject|1|||
164372472|NCT00559962|593739942|FG001|Overall Study|Withdrawal by Subject|1|||
164372473|NCT00559962|593739943|FG002|Overall Study|Withdrawal by Subject|2|||
164372474|NCT00559962|593739944|FG003|Overall Study|Withdrawal by Subject|0|||
164372475|NCT00559962|593739945|FG004|Overall Study|Withdrawal by Subject|3|||
164372476|NCT00559962|593739946|FG005|Overall Study|Withdrawal by Subject|1|||
164372477|NCT00559962|593739947|FG006|Overall Study|Withdrawal by Subject|0|||
164372478|NCT00559962|593739948|FG007|Overall Study|Withdrawal by Subject|2|||
164372479|NCT00559962|593739941|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
164372480|NCT00559962|593739942|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
164372481|NCT00559962|593739943|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
164372482|NCT00559962|593739944|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
164372483|NCT00559962|593739945|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
164372484|NCT00559962|593739946|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
164372485|NCT00559962|593739947|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
164439059|NCT02341625|593973115|FG006|Overall Study|Completed Treatment as per Protocol|0|||
164439060|NCT02341625|593973116|FG007|Overall Study|Completed Treatment as per Protocol|0|||
164372486|NCT00559962|593739948|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
164372487|NCT01639040|593739958|FG000|Overall Study|Adverse Event|1|||
164372488|NCT01639040|593739959|FG001|Overall Study|Adverse Event|0|||
164372489|NCT04370691|593739960|FG000|Overall Study|Pending visit|48|||
164372490|NCT04370691|593739960|FG000|Overall Study|Have Not Reached Lower Window|15|||
164372491|NCT04370691|593739960|FG000|Overall Study|Termination|14|||
164372492|NCT04370691|593739960|FG000|Overall Study|Missed or Overdue|10|||
164372493|NCT00486265|593739961|FG000|Overall Study|Adverse Event|1|||
164372494|NCT00486265|593739961|FG000|Overall Study|Lack of Efficacy|8|||
164372495|NCT03013543|593739962|FG000|Overall Study|Withdrawal by Subject|0|||
164372496|NCT03013543|593739963|FG001|Overall Study|Withdrawal by Subject|2|||
164372497|NCT03013543|593739964|FG002|Overall Study|Withdrawal by Subject|0|||
164372498|NCT03013543|593739965|FG003|Overall Study|Withdrawal by Subject|5|||
164372499|NCT03013543|593739966|FG004|Overall Study|Withdrawal by Subject|6|||
164372500|NCT03013543|593739967|FG005|Overall Study|Withdrawal by Subject|2|||
164372501|NCT03013543|593739968|FG006|Overall Study|Withdrawal by Subject|3|||
164372502|NCT03013543|593739969|FG007|Overall Study|Withdrawal by Subject|1|||
164372503|NCT03013543|593739970|FG008|Overall Study|Withdrawal by Subject|0|||
164372504|NCT03013543|593739971|FG009|Overall Study|Withdrawal by Subject|4|||
164372505|NCT03013543|593739962|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
164372506|NCT03013543|593739963|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
164372507|NCT03013543|593739964|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
164372508|NCT03013543|593739965|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
164372509|NCT03013543|593739966|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
164372510|NCT03013543|593739967|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
164372511|NCT03013543|593739968|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
164372512|NCT03013543|593739969|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
164372513|NCT03013543|593739970|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
164372514|NCT03013543|593739971|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
164372515|NCT03013543|593739962|FG000|Overall Study|Other|0|||
164372516|NCT03013543|593739963|FG001|Overall Study|Other|0|||
164372517|NCT03013543|593739964|FG002|Overall Study|Other|2|||
164372518|NCT03013543|593739965|FG003|Overall Study|Other|0|||
164372519|NCT03013543|593739966|FG004|Overall Study|Other|2|||
164372520|NCT03013543|593739967|FG005|Overall Study|Other|0|||
164372521|NCT03013543|593739968|FG006|Overall Study|Other|0|||
164439061|NCT02341625|593973117|FG008|Overall Study|Completed Treatment as per Protocol|0|||
164439062|NCT02341625|593973118|FG009|Overall Study|Completed Treatment as per Protocol|1|||
164439063|NCT02341625|593973109|FG000|Overall Study|Other Reasons|0|||
164439064|NCT02341625|593973110|FG001|Overall Study|Other Reasons|0|||
164439065|NCT02341625|593973111|FG002|Overall Study|Other Reasons|0|||
164439066|NCT02341625|593973112|FG003|Overall Study|Other Reasons|0|||
164439067|NCT02341625|593973113|FG004|Overall Study|Other Reasons|1|||
164439068|NCT02341625|593973114|FG005|Overall Study|Other Reasons|0|||
164372522|NCT03013543|593739969|FG007|Overall Study|Other|0|||
164372523|NCT03013543|593739970|FG008|Overall Study|Other|1|||
164439069|NCT02341625|593973115|FG006|Overall Study|Other Reasons|5|||
164439070|NCT02341625|593973116|FG007|Overall Study|Other Reasons|0|||
164372524|NCT03013543|593739971|FG009|Overall Study|Other|0|||
164372525|NCT03013543|593739962|FG000|Overall Study|Adverse Event|0|||
164372526|NCT03013543|593739963|FG001|Overall Study|Adverse Event|0|||
164372527|NCT03013543|593739964|FG002|Overall Study|Adverse Event|0|||
164372528|NCT03013543|593739965|FG003|Overall Study|Adverse Event|3|||
164372529|NCT03013543|593739966|FG004|Overall Study|Adverse Event|2|||
164372530|NCT03013543|593739967|FG005|Overall Study|Adverse Event|1|||
164439071|NCT02341625|593973117|FG008|Overall Study|Other Reasons|0|||
164439072|NCT02341625|593973118|FG009|Overall Study|Other Reasons|2|||
164439073|NCT02341625|593973109|FG000|Overall Study|Not Reported|0|||
164439074|NCT02341625|593973110|FG001|Overall Study|Not Reported|0|||
164372531|NCT03013543|593739968|FG006|Overall Study|Adverse Event|3|||
164372532|NCT03013543|593739969|FG007|Overall Study|Adverse Event|8|||
164372533|NCT03013543|593739970|FG008|Overall Study|Adverse Event|0|||
164372534|NCT03013543|593739971|FG009|Overall Study|Adverse Event|2|||
164372535|NCT03013543|593739962|FG000|Overall Study|Death|0|||
164372536|NCT03013543|593739963|FG001|Overall Study|Death|0|||
164372537|NCT03013543|593739964|FG002|Overall Study|Death|0|||
164372538|NCT03013543|593739965|FG003|Overall Study|Death|1|||
164372539|NCT03013543|593739966|FG004|Overall Study|Death|0|||
164372540|NCT03013543|593739967|FG005|Overall Study|Death|0|||
164372541|NCT03013543|593739968|FG006|Overall Study|Death|0|||
164372542|NCT03013543|593739969|FG007|Overall Study|Death|0|||
164372543|NCT03013543|593739970|FG008|Overall Study|Death|0|||
164372544|NCT03013543|593739971|FG009|Overall Study|Death|0|||
164372545|NCT03013543|593739962|FG000|Overall Study|Lack of Efficacy|0|||
164372546|NCT03013543|593739963|FG001|Overall Study|Lack of Efficacy|0|||
164372547|NCT03013543|593739964|FG002|Overall Study|Lack of Efficacy|0|||
164372548|NCT03013543|593739965|FG003|Overall Study|Lack of Efficacy|1|||
164372549|NCT03013543|593739966|FG004|Overall Study|Lack of Efficacy|0|||
164372550|NCT03013543|593739967|FG005|Overall Study|Lack of Efficacy|0|||
164372551|NCT03013543|593739968|FG006|Overall Study|Lack of Efficacy|0|||
164372552|NCT03013543|593739969|FG007|Overall Study|Lack of Efficacy|0|||
164372553|NCT03013543|593739970|FG008|Overall Study|Lack of Efficacy|0|||
164372554|NCT03013543|593739971|FG009|Overall Study|Lack of Efficacy|0|||
164372555|NCT03013543|593739962|FG000|Overall Study|Lost to Follow-up|0|||
164372556|NCT03013543|593739963|FG001|Overall Study|Lost to Follow-up|0|||
164372557|NCT03013543|593739964|FG002|Overall Study|Lost to Follow-up|0|||
164372558|NCT03013543|593739965|FG003|Overall Study|Lost to Follow-up|1|||
164372559|NCT03013543|593739966|FG004|Overall Study|Lost to Follow-up|0|||
164372560|NCT03013543|593739967|FG005|Overall Study|Lost to Follow-up|0|||
164372561|NCT03013543|593739968|FG006|Overall Study|Lost to Follow-up|1|||
164372562|NCT03013543|593739969|FG007|Overall Study|Lost to Follow-up|0|||
164372563|NCT03013543|593739970|FG008|Overall Study|Lost to Follow-up|0|||
164372564|NCT03013543|593739971|FG009|Overall Study|Lost to Follow-up|2|||
164372565|NCT03013543|593739962|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164372566|NCT03013543|593739963|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164372567|NCT03013543|593739964|FG002|Overall Study|Non-Compliance With Study Drug|0|||
164372568|NCT03013543|593739965|FG003|Overall Study|Non-Compliance With Study Drug|0|||
164372569|NCT03013543|593739966|FG004|Overall Study|Non-Compliance With Study Drug|0|||
164372570|NCT03013543|593739967|FG005|Overall Study|Non-Compliance With Study Drug|0|||
164372571|NCT03013543|593739968|FG006|Overall Study|Non-Compliance With Study Drug|0|||
164372572|NCT03013543|593739969|FG007|Overall Study|Non-Compliance With Study Drug|0|||
164372573|NCT03013543|593739970|FG008|Overall Study|Non-Compliance With Study Drug|1|||
164372574|NCT03013543|593739971|FG009|Overall Study|Non-Compliance With Study Drug|0|||
164372575|NCT03013543|593739962|FG000|Overall Study|Physician Decision|0|||
164372576|NCT03013543|593739963|FG001|Overall Study|Physician Decision|0|||
164372577|NCT03013543|593739964|FG002|Overall Study|Physician Decision|0|||
164372578|NCT03013543|593739965|FG003|Overall Study|Physician Decision|0|||
164372579|NCT03013543|593739966|FG004|Overall Study|Physician Decision|1|||
164372580|NCT03013543|593739967|FG005|Overall Study|Physician Decision|0|||
164372581|NCT03013543|593739968|FG006|Overall Study|Physician Decision|0|||
164372582|NCT03013543|593739969|FG007|Overall Study|Physician Decision|0|||
164372583|NCT03013543|593739970|FG008|Overall Study|Physician Decision|0|||
164372584|NCT03013543|593739971|FG009|Overall Study|Physician Decision|0|||
164372585|NCT03013543|593739962|FG000|Overall Study|Protocol Violation|0|||
164372586|NCT03013543|593739963|FG001|Overall Study|Protocol Violation|0|||
164372587|NCT03013543|593739964|FG002|Overall Study|Protocol Violation|0|||
164372588|NCT03013543|593739965|FG003|Overall Study|Protocol Violation|0|||
164372589|NCT03013543|593739966|FG004|Overall Study|Protocol Violation|0|||
164372590|NCT03013543|593739967|FG005|Overall Study|Protocol Violation|0|||
164372591|NCT03013543|593739968|FG006|Overall Study|Protocol Violation|0|||
164372592|NCT03013543|593739969|FG007|Overall Study|Protocol Violation|0|||
164372593|NCT03013543|593739970|FG008|Overall Study|Protocol Violation|0|||
164372594|NCT03013543|593739971|FG009|Overall Study|Protocol Violation|1|||
164372595|NCT02552316|593739973|FG000|Overall Study|Withdrawal by Subject|1|||
164372596|NCT02552316|593739973|FG000|Overall Study|Withdrawal due to non-compliance|1|||
164372597|NCT04116710|593739977|FG000|Overall Study|Death|4|||
164372598|NCT04116710|593739978|FG001|Overall Study|Death|6|||
164372599|NCT04116710|593739979|FG002|Overall Study|Death|3|||
164372600|NCT04116710|593739980|FG003|Overall Study|Death|1|||
164372601|NCT04116710|593739977|FG000|Overall Study|Withdrawal by Subject|0|||
164372602|NCT04116710|593739978|FG001|Overall Study|Withdrawal by Subject|0|||
164372603|NCT04116710|593739979|FG002|Overall Study|Withdrawal by Subject|0|||
164372604|NCT04116710|593739980|FG003|Overall Study|Withdrawal by Subject|1|||
164372605|NCT01256593|593739981|FG000|Overall Study|Protocol Violation|26|||
164372606|NCT01256593|593739981|FG000|Overall Study|No Drug Administration Information|2|||
164372607|NCT01256593|593739981|FG000|Overall Study|No Visit After Treatment|186|||
164372608|NCT01110915|593739984|FG000|Overall Study|Death|2|||
164372609|NCT01110915|593739985|FG001|Overall Study|Death|1|||
164372610|NCT01110915|593739984|FG000|Overall Study|Lost to Follow-up|1|||
164372611|NCT01110915|593739985|FG001|Overall Study|Lost to Follow-up|0|||
164372612|NCT01110915|593739984|FG000|Overall Study|Withdrawal by Subject|7|||
164372613|NCT01110915|593739985|FG001|Overall Study|Withdrawal by Subject|1|||
164372614|NCT02161718|593739988|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
164372615|NCT02161718|593739989|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
164372616|NCT02161718|593739990|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
164372617|NCT02161718|593739988|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
164372618|NCT02161718|593739989|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
164372619|NCT02161718|593739990|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
164372620|NCT02161718|593739988|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
164372621|NCT02161718|593739989|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
164372622|NCT02161718|593739990|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
164372623|NCT02161718|593739988|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
164372624|NCT02161718|593739989|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
164372625|NCT02161718|593739990|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
164372626|NCT02161718|593739988|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
164372627|NCT02161718|593739989|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
164372628|NCT02161718|593739990|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
164372629|NCT02161718|593739988|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
164372630|NCT02161718|593739989|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
164372631|NCT02161718|593739990|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
164372632|NCT02161718|593739988|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
164372633|NCT02161718|593739989|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
164372634|NCT02161718|593739990|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
164372635|NCT02161718|593739988|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
164372636|NCT02161718|593739989|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
164372637|NCT02161718|593739990|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
164372638|NCT02161718|593739988|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
164372639|NCT02161718|593739989|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
164372640|NCT02161718|593739990|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
164372641|NCT02161718|593739988|FG000|Post- Randomization Period|Lost to Follow-up|0|||
164372642|NCT02161718|593739989|FG001|Post- Randomization Period|Lost to Follow-up|9|||
164372643|NCT02161718|593739990|FG002|Post- Randomization Period|Lost to Follow-up|15|||
164372644|NCT02161718|593739988|FG000|Post- Randomization Period|Adverse Event|0|||
164372645|NCT02161718|593739989|FG001|Post- Randomization Period|Adverse Event|9|||
164372646|NCT02161718|593739990|FG002|Post- Randomization Period|Adverse Event|10|||
164372647|NCT02161718|593739988|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
164372648|NCT02161718|593739989|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
164372649|NCT02161718|593739990|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
164372650|NCT02161718|593739988|FG000|Post- Randomization Period|Physician Decision|0|||
164372651|NCT02161718|593739989|FG001|Post- Randomization Period|Physician Decision|2|||
164372652|NCT02161718|593739990|FG002|Post- Randomization Period|Physician Decision|4|||
164372653|NCT02161718|593739988|FG000|Post- Randomization Period|Protocol Violation|0|||
164372654|NCT02161718|593739989|FG001|Post- Randomization Period|Protocol Violation|2|||
164372655|NCT02161718|593739990|FG002|Post- Randomization Period|Protocol Violation|3|||
164372656|NCT02161718|593739988|FG000|Post- Randomization Period|Lack of Efficacy|0|||
164372657|NCT02161718|593739989|FG001|Post- Randomization Period|Lack of Efficacy|0|||
164372658|NCT02161718|593739990|FG002|Post- Randomization Period|Lack of Efficacy|1|||
164372659|NCT02161718|593739988|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
164372660|NCT02161718|593739989|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
164372661|NCT02161718|593739990|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
164372662|NCT02161718|593739988|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
164372663|NCT02161718|593739989|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
164372664|NCT02161718|593739990|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
164372665|NCT02161718|593739988|FG000|Post- Randomization Period|Relocation|0|||
164372666|NCT02161718|593739989|FG001|Post- Randomization Period|Relocation|3|||
164372667|NCT02161718|593739990|FG002|Post- Randomization Period|Relocation|0|||
164372668|NCT02948842|593739993|FG000|Overall Study|Withdrawal by Subject|4|||
164372669|NCT01537783|593739994|FG000|Overall Study|Lost to Follow-up|11|||
164372670|NCT01537783|593739995|FG001|Overall Study|Lost to Follow-up|2|||
164372671|NCT02350309|593739997|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
164372672|NCT02350309|593739998|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
164372673|NCT02350309|593739999|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
164372674|NCT02350309|593740000|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
164372675|NCT02350309|593740001|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
164372676|NCT02350309|593740002|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
164372677|NCT02350309|593739997|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
164372678|NCT02350309|593739998|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
164372679|NCT02350309|593739999|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
164372680|NCT02350309|593740000|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
164372681|NCT02350309|593740001|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
164372682|NCT02350309|593740002|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
164372683|NCT00207142|593740003|FG000|Induction Phase|Adverse Event|9|||
164372684|NCT00207142|593740004|FG001|Induction Phase|Adverse Event|0|||
164372685|NCT00207142|593740005|FG002|Induction Phase|Adverse Event|0|||
164372686|NCT00207142|593740006|FG003|Induction Phase|Adverse Event|0|||
164372687|NCT00207142|593740003|FG000|Induction Phase|Death|1|||
164372688|NCT00207142|593740004|FG001|Induction Phase|Death|0|||
164372689|NCT00207142|593740005|FG002|Induction Phase|Death|0|||
164372690|NCT00207142|593740006|FG003|Induction Phase|Death|0|||
164372691|NCT00207142|593740003|FG000|Induction Phase|Lack of Efficacy|1|||
164372692|NCT00207142|593740004|FG001|Induction Phase|Lack of Efficacy|0|||
164372693|NCT00207142|593740005|FG002|Induction Phase|Lack of Efficacy|0|||
164372694|NCT00207142|593740006|FG003|Induction Phase|Lack of Efficacy|0|||
164372695|NCT00207142|593740003|FG000|Induction Phase|Lost to Follow-up|5|||
164372696|NCT00207142|593740004|FG001|Induction Phase|Lost to Follow-up|0|||
164372697|NCT00207142|593740005|FG002|Induction Phase|Lost to Follow-up|0|||
164372698|NCT00207142|593740006|FG003|Induction Phase|Lost to Follow-up|0|||
164372699|NCT00207142|593740003|FG000|Induction Phase|Physician Decision|2|||
164372700|NCT00207142|593740004|FG001|Induction Phase|Physician Decision|0|||
164372701|NCT00207142|593740005|FG002|Induction Phase|Physician Decision|0|||
164372702|NCT00207142|593740006|FG003|Induction Phase|Physician Decision|0|||
164372703|NCT00207142|593740003|FG000|Induction Phase|Poor/noncompliance|2|||
164372704|NCT00207142|593740004|FG001|Induction Phase|Poor/noncompliance|0|||
164372705|NCT00207142|593740005|FG002|Induction Phase|Poor/noncompliance|0|||
164372706|NCT00207142|593740006|FG003|Induction Phase|Poor/noncompliance|0|||
164372707|NCT00207142|593740003|FG000|Induction Phase|Pregnancy|1|||
164372708|NCT00207142|593740004|FG001|Induction Phase|Pregnancy|0|||
164372709|NCT00207142|593740005|FG002|Induction Phase|Pregnancy|0|||
164372710|NCT00207142|593740006|FG003|Induction Phase|Pregnancy|0|||
164372711|NCT00207142|593740003|FG000|Induction Phase|Subject no longer meets study criteria|3|||
164372712|NCT00207142|593740004|FG001|Induction Phase|Subject no longer meets study criteria|0|||
164372713|NCT00207142|593740005|FG002|Induction Phase|Subject no longer meets study criteria|0|||
164372714|NCT00207142|593740006|FG003|Induction Phase|Subject no longer meets study criteria|0|||
164372715|NCT00207142|593740003|FG000|Induction Phase|Withdrawal by Subject|4|||
164372716|NCT00207142|593740004|FG001|Induction Phase|Withdrawal by Subject|0|||
164372717|NCT00207142|593740005|FG002|Induction Phase|Withdrawal by Subject|0|||
164372718|NCT00207142|593740006|FG003|Induction Phase|Withdrawal by Subject|0|||
164372719|NCT00207142|593740003|FG000|Induction Phase|Incarceration|1|||
164372720|NCT00207142|593740004|FG001|Induction Phase|Incarceration|0|||
164372721|NCT00207142|593740005|FG002|Induction Phase|Incarceration|0|||
164372722|NCT00207142|593740006|FG003|Induction Phase|Incarceration|0|||
164372723|NCT00207142|593740003|FG000|Induction Phase|Missing lab data|1|||
164372724|NCT00207142|593740004|FG001|Induction Phase|Missing lab data|0|||
164372725|NCT00207142|593740005|FG002|Induction Phase|Missing lab data|0|||
164372726|NCT00207142|593740006|FG003|Induction Phase|Missing lab data|0|||
164372727|NCT00207142|593740003|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
164372728|NCT00207142|593740004|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
164372729|NCT00207142|593740005|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
164372730|NCT00207142|593740006|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
164372731|NCT00207142|593740003|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
164372732|NCT00207142|593740004|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
164372733|NCT00207142|593740005|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
164372734|NCT00207142|593740006|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
164372735|NCT00207142|593740003|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
164372736|NCT00207142|593740004|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
164372737|NCT00207142|593740005|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
164372738|NCT00207142|593740006|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
164372739|NCT00207142|593740003|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
164372740|NCT00207142|593740004|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
164372741|NCT00207142|593740005|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
164372742|NCT00207142|593740006|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
164372743|NCT00207142|593740003|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
164372744|NCT00207142|593740004|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
164372745|NCT00207142|593740005|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
164372746|NCT00207142|593740006|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
164372747|NCT00207142|593740003|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
164372748|NCT00207142|593740004|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
164372749|NCT00207142|593740005|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
164372750|NCT00207142|593740006|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
164439075|NCT02341625|593973111|FG002|Overall Study|Not Reported|0|||
164439076|NCT02341625|593973112|FG003|Overall Study|Not Reported|0|||
164439077|NCT02341625|593973113|FG004|Overall Study|Not Reported|0|||
164439078|NCT02341625|593973114|FG005|Overall Study|Not Reported|0|||
164439079|NCT02341625|593973115|FG006|Overall Study|Not Reported|0|||
164439080|NCT02341625|593973116|FG007|Overall Study|Not Reported|0|||
164439081|NCT02341625|593973117|FG008|Overall Study|Not Reported|0|||
164439082|NCT02341625|593973118|FG009|Overall Study|Not Reported|3|||
164439083|NCT03396913|593973119|FG000|Overall Study|Lost to Follow-up|0|||
164439084|NCT03396913|593973120|FG001|Overall Study|Lost to Follow-up|6|||
164372751|NCT00207142|593740003|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
164372752|NCT00207142|593740004|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
164372753|NCT00207142|593740005|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
164372754|NCT00207142|593740006|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
164372755|NCT00207142|593740003|FG000|Maintenance Phase/Rescue Phase|Death|0|||
164372756|NCT00207142|593740004|FG001|Maintenance Phase/Rescue Phase|Death|0|||
164372757|NCT00207142|593740005|FG002|Maintenance Phase/Rescue Phase|Death|0|||
164372758|NCT00207142|593740006|FG003|Maintenance Phase/Rescue Phase|Death|1|||
164372759|NCT00207142|593740003|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
164372760|NCT00207142|593740004|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
164372761|NCT00207142|593740005|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
164372762|NCT00207142|593740006|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
164372763|NCT01554618|593740007|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
164372764|NCT01554618|593740008|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
164372765|NCT01554618|593740007|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
164372766|NCT01554618|593740008|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
164372767|NCT01554618|593740007|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
164372768|NCT01554618|593740008|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
164372769|NCT01554618|593740007|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
164372770|NCT01554618|593740008|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
164372771|NCT01554618|593740007|FG000|Open-Label Extension Period|Physician Decision|0|||
164372772|NCT01554618|593740008|FG001|Open-Label Extension Period|Physician Decision|1|||
164372773|NCT01554618|593740007|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
164372774|NCT01554618|593740008|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
164372775|NCT01857063|593740009|FG000|Period 1 (7 Days)|Adverse Event|0|||
164372776|NCT01857063|593740010|FG001|Period 1 (7 Days)|Adverse Event|1|||
164372777|NCT01857063|593740009|FG000|Period 1 (7 Days)|Physician Decision|1|||
164372778|NCT01857063|593740010|FG001|Period 1 (7 Days)|Physician Decision|0|||
164372779|NCT01857063|593740009|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
164372780|NCT01857063|593740010|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
164372781|NCT01857063|593740009|FG000|Period 2 (7 Days)|Adverse Event|2|||
164372782|NCT01857063|593740010|FG001|Period 2 (7 Days)|Adverse Event|1|||
164372783|NCT01857063|593740009|FG000|Period 2 (7 Days)|Physician Decision|1|||
164372784|NCT01857063|593740010|FG001|Period 2 (7 Days)|Physician Decision|1|||
164372785|NCT01857063|593740009|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
164372786|NCT01857063|593740010|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
164372787|NCT00058825|593740011|FG000|Overall Study|Relapse|9|||
164372788|NCT00058825|593740011|FG000|Overall Study|Progressive Disease|5|||
164372789|NCT00058825|593740011|FG000|Overall Study|Graft Failure|5|||
164372790|NCT00058825|593740011|FG000|Overall Study|Death|3|||
164372791|NCT01205165|593740013|FG000|Overall Study|Lost to Follow-up|2|||
164372792|NCT00329407|593740020|FG000|Overall Study|Withdrawal by Subject|1|||
164372793|NCT00978068|593740021|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
164372794|NCT00978068|593740022|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
164372795|NCT00978068|593740021|FG000|Overall Study|Death|1|||
164372796|NCT00978068|593740022|FG001|Overall Study|Death|2|||
164372797|NCT00978068|593740021|FG000|Overall Study|Lost to Follow-up|1|||
164372798|NCT00978068|593740022|FG001|Overall Study|Lost to Follow-up|2|||
164372799|NCT00978068|593740021|FG000|Overall Study|Physician Decision|0|||
164372800|NCT00978068|593740022|FG001|Overall Study|Physician Decision|1|||
164439085|NCT03523091|593973121|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
164700436|NCT01421342|594926836|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
164700437|NCT01421342|594926837|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
164372801|NCT00978068|593740021|FG000|Overall Study|Unable to Comply with Study|0|||
164372802|NCT00978068|593740022|FG001|Overall Study|Unable to Comply with Study|2|||
164372803|NCT02275481|593740023|FG000|Overall Study|Death|2|||
164372804|NCT02275481|593740024|FG001|Overall Study|Death|1|||
164372805|NCT02275481|593740023|FG000|Overall Study|Lost to Follow-up|2|||
164372806|NCT02275481|593740024|FG001|Overall Study|Lost to Follow-up|0|||
164439086|NCT03523091|593973122|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
164439087|NCT03523091|593973121|FG000|Overall Study|Withdrawal by Subject|0|||
164700438|NCT01421342|594926835|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
164372807|NCT02275481|593740023|FG000|Overall Study|Withdrawal by Subject|3|||
164439088|NCT03523091|593973122|FG001|Overall Study|Withdrawal by Subject|3|||
164700439|NCT01421342|594926836|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
164372808|NCT02275481|593740024|FG001|Overall Study|Withdrawal by Subject|0|||
164372809|NCT02275481|593740023|FG000|Overall Study|all other reasons combined|2|||
164372810|NCT02275481|593740024|FG001|Overall Study|all other reasons combined|1|||
164372811|NCT02275481|593740023|FG000|Overall Study|Physician Decision|0|||
164372812|NCT02275481|593740024|FG001|Overall Study|Physician Decision|1|||
164372813|NCT01215227|593740025|FG000|Overall Study|Adverse Event|11|||
164372814|NCT01215227|593740026|FG001|Overall Study|Adverse Event|11|||
164372815|NCT01215227|593740027|FG002|Overall Study|Adverse Event|4|||
164372816|NCT01215227|593740028|FG003|Overall Study|Adverse Event|8|||
164372817|NCT01215227|593740029|FG004|Overall Study|Adverse Event|7|||
164372818|NCT01215227|593740030|FG005|Overall Study|Adverse Event|6|||
164372819|NCT01215227|593740025|FG000|Overall Study|Treatment Failure|8|||
164372820|NCT01215227|593740026|FG001|Overall Study|Treatment Failure|4|||
164372821|NCT01215227|593740027|FG002|Overall Study|Treatment Failure|1|||
164372822|NCT01215227|593740028|FG003|Overall Study|Treatment Failure|5|||
164372823|NCT01215227|593740029|FG004|Overall Study|Treatment Failure|1|||
164372824|NCT01215227|593740030|FG005|Overall Study|Treatment Failure|1|||
164372825|NCT01215227|593740025|FG000|Overall Study|Lost to Follow-up|1|||
164372826|NCT01215227|593740026|FG001|Overall Study|Lost to Follow-up|4|||
164372827|NCT01215227|593740027|FG002|Overall Study|Lost to Follow-up|1|||
164372828|NCT01215227|593740028|FG003|Overall Study|Lost to Follow-up|1|||
164372829|NCT01215227|593740029|FG004|Overall Study|Lost to Follow-up|1|||
164372830|NCT01215227|593740030|FG005|Overall Study|Lost to Follow-up|2|||
164372831|NCT01215227|593740025|FG000|Overall Study|Subject Withdrew Consent|16|||
164372832|NCT01215227|593740026|FG001|Overall Study|Subject Withdrew Consent|20|||
164372833|NCT01215227|593740027|FG002|Overall Study|Subject Withdrew Consent|7|||
164372834|NCT01215227|593740028|FG003|Overall Study|Subject Withdrew Consent|10|||
164372835|NCT01215227|593740029|FG004|Overall Study|Subject Withdrew Consent|11|||
164372836|NCT01215227|593740030|FG005|Overall Study|Subject Withdrew Consent|8|||
164372837|NCT01215227|593740025|FG000|Overall Study|Non-Compliance With Protocol|2|||
164372838|NCT01215227|593740026|FG001|Overall Study|Non-Compliance With Protocol|6|||
164372839|NCT01215227|593740027|FG002|Overall Study|Non-Compliance With Protocol|1|||
164372840|NCT01215227|593740028|FG003|Overall Study|Non-Compliance With Protocol|0|||
164372841|NCT01215227|593740029|FG004|Overall Study|Non-Compliance With Protocol|0|||
164372842|NCT01215227|593740030|FG005|Overall Study|Non-Compliance With Protocol|0|||
164372843|NCT01215227|593740025|FG000|Overall Study|Administrative|83|||
164372844|NCT01215227|593740026|FG001|Overall Study|Administrative|73|||
164372845|NCT01215227|593740027|FG002|Overall Study|Administrative|42|||
164372846|NCT01215227|593740028|FG003|Overall Study|Administrative|24|||
164372847|NCT01215227|593740029|FG004|Overall Study|Administrative|28|||
164372848|NCT01215227|593740030|FG005|Overall Study|Administrative|40|||
164372849|NCT01215227|593740025|FG000|Overall Study|Missing Status|0|||
164372850|NCT01215227|593740026|FG001|Overall Study|Missing Status|1|||
164372851|NCT01215227|593740027|FG002|Overall Study|Missing Status|0|||
164372852|NCT01215227|593740028|FG003|Overall Study|Missing Status|0|||
164372853|NCT01215227|593740029|FG004|Overall Study|Missing Status|0|||
164372854|NCT01215227|593740030|FG005|Overall Study|Missing Status|0|||
164372855|NCT01215227|593740025|FG000|Overall Study|Randomized but not treated|0|||
164372856|NCT01215227|593740026|FG001|Overall Study|Randomized but not treated|0|||
164591533|NCT01259297|594528409|FG002|Double Blind Randomized Period|Other reasons|0|||
164372857|NCT01215227|593740027|FG002|Overall Study|Randomized but not treated|1|||
164372858|NCT01215227|593740028|FG003|Overall Study|Randomized but not treated|1|||
164591534|NCT01259297|594528410|FG003|Double Blind Randomized Period|Other reasons|0|||
164591535|NCT01259297|594528411|FG004|Double Blind Randomized Period|Other reasons|1|||
164372859|NCT01215227|593740029|FG004|Overall Study|Randomized but not treated|0|||
164372860|NCT01215227|593740030|FG005|Overall Study|Randomized but not treated|1|||
164372861|NCT01393405|593740031|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
164372862|NCT01393405|593740032|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
164372863|NCT01393405|593740033|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
164372864|NCT01393405|593740031|FG000|Induction Period (week1-16)|Adverse Event|16|||
164372865|NCT01393405|593740032|FG001|Induction Period (week1-16)|Adverse Event|0|||
164372866|NCT01393405|593740033|FG002|Induction Period (week1-16)|Adverse Event|0|||
164372867|NCT01393405|593740031|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
164372868|NCT01393405|593740032|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
164372869|NCT01393405|593740033|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
164372870|NCT01393405|593740031|FG000|Maintenance Period Week|Lack of Efficacy|0|||
164372871|NCT01393405|593740032|FG001|Maintenance Period Week|Lack of Efficacy|22|||
164372872|NCT01393405|593740033|FG002|Maintenance Period Week|Lack of Efficacy|22|||
164591536|NCT01259297|594528412|FG005|Double Blind Randomized Period|Other reasons|2|||
164372873|NCT01393405|593740031|FG000|Maintenance Period Week|Adverse Event|0|||
164372874|NCT01393405|593740032|FG001|Maintenance Period Week|Adverse Event|5|||
164372875|NCT01393405|593740033|FG002|Maintenance Period Week|Adverse Event|2|||
164372876|NCT01393405|593740031|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
164372877|NCT01393405|593740032|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
164591537|NCT01259297|594528413|FG006|Double Blind Randomized Period|Other reasons|3|||
164591538|NCT01259297|594528414|FG007|Double Blind Randomized Period|Other reasons|1|||
164372878|NCT01393405|593740033|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
164372879|NCT01393405|593740031|FG000|Maintenance Period Week|Lost to Follow-up|0|||
164372880|NCT01393405|593740032|FG001|Maintenance Period Week|Lost to Follow-up|1|||
164372881|NCT01393405|593740033|FG002|Maintenance Period Week|Lost to Follow-up|0|||
164372882|NCT01434290|593740034|FG000|Overall Study|Protocol Violation|6|||
164372883|NCT01434290|593740035|FG001|Overall Study|Protocol Violation|3|||
164591539|NCT00443430|594528417|FG000|Overall Study|Lack of Efficacy|3|||
164591540|NCT00443430|594528418|FG001|Overall Study|Lack of Efficacy|3|||
164591541|NCT00443430|594528417|FG000|Overall Study|Adverse Event|1|||
164591542|NCT00443430|594528418|FG001|Overall Study|Adverse Event|1|||
164372884|NCT01434290|593740034|FG000|Overall Study|No protocol treatment|2|||
164372885|NCT01434290|593740035|FG001|Overall Study|No protocol treatment|4|||
164372886|NCT02281552|593740036|FG000|Overall Study|Medication error|1|||
164372887|NCT02281552|593740037|FG001|Overall Study|Medication error|0|||
164372888|NCT02281552|593740036|FG000|Overall Study|Insufficient clinical response|0|||
164372889|NCT02281552|593740037|FG001|Overall Study|Insufficient clinical response|1|||
164372890|NCT02281552|593740036|FG000|Overall Study|Adverse Event|3|||
164372891|NCT02281552|593740037|FG001|Overall Study|Adverse Event|9|||
164372892|NCT01359592|593742062|FG000|Initial Registration|Adverse Event|1|||
164591543|NCT00053846|594528419|FG000|Overall Study|Changed mind|8|||
164591544|NCT00053846|594528420|FG001|Overall Study|Changed mind|13|||
164591545|NCT00053846|594528419|FG000|Overall Study|Became too ill|8|||
164591546|NCT00053846|594528420|FG001|Overall Study|Became too ill|7|||
164591547|NCT00053846|594528419|FG000|Overall Study|Expired|5|||
164591548|NCT00053846|594528420|FG001|Overall Study|Expired|0|||
164591549|NCT00053846|594528419|FG000|Overall Study|Became ineligible|3|||
164591550|NCT00053846|594528420|FG001|Overall Study|Became ineligible|1|||
164591551|NCT00053846|594528419|FG000|Overall Study|Did not return data|1|||
164591552|NCT00053846|594528420|FG001|Overall Study|Did not return data|2|||
164591553|NCT00053846|594528419|FG000|Overall Study|Quit due to side effects|1|||
164591554|NCT00053846|594528420|FG001|Overall Study|Quit due to side effects|3|||
164591555|NCT00053846|594528419|FG000|Overall Study|Pills too large|0|||
164591556|NCT00053846|594528420|FG001|Overall Study|Pills too large|1|||
164591557|NCT03880227|594528421|FG000|First Visit|Withdrawal by Subject|1|||
164591558|NCT03880227|594528422|FG001|First Visit|Withdrawal by Subject|0|||
164591559|NCT03880227|594528423|FG002|First Visit|Withdrawal by Subject|0|||
164591560|NCT03880227|594528424|FG003|First Visit|Withdrawal by Subject|0|||
164591561|NCT03880227|594528421|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
164591562|NCT03880227|594528422|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
164591563|NCT03880227|594528423|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
164591564|NCT03880227|594528424|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
164591565|NCT03880227|594528421|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
164591566|NCT03880227|594528422|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
164591567|NCT03880227|594528423|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
164591568|NCT03880227|594528424|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
164591569|NCT03880227|594528421|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
164372893|NCT01359592|593742063|FG001|Initial Registration|Adverse Event|0|||
164372894|NCT01359592|593742064|FG002|Initial Registration|Adverse Event|0|||
164372895|NCT01359592|593742065|FG003|Initial Registration|Adverse Event|0|||
164372896|NCT01359592|593742062|FG000|Initial Registration|Death|1|||
164372897|NCT01359592|593742063|FG001|Initial Registration|Death|0|||
164372898|NCT01359592|593742064|FG002|Initial Registration|Death|0|||
164372899|NCT01359592|593742065|FG003|Initial Registration|Death|0|||
164372900|NCT01359592|593742062|FG000|Initial Registration|Other reason not protocol specified|1|||
164372901|NCT01359592|593742063|FG001|Initial Registration|Other reason not protocol specified|0|||
164372902|NCT01359592|593742064|FG002|Initial Registration|Other reason not protocol specified|0|||
164591570|NCT03880227|594528422|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
164372903|NCT01359592|593742065|FG003|Initial Registration|Other reason not protocol specified|0|||
164591571|NCT03880227|594528423|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
164591572|NCT03880227|594528424|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
164591573|NCT02229864|594528425|FG000|Overall Study|Death|2|||
164591574|NCT02229864|594528425|FG000|Overall Study|Lost to Follow-up|1|||
164591575|NCT02650284|594528428|FG000|Overall Study|Lost to Follow-up|3|||
164591576|NCT02650284|594528429|FG001|Overall Study|Lost to Follow-up|3|||
164591577|NCT02650284|594528428|FG000|Overall Study|Consent incorrectly taken|0|||
164591578|NCT02650284|594528429|FG001|Overall Study|Consent incorrectly taken|1|||
164591579|NCT02815397|594528436|FG000|Overall Study|Physician Decision|2|||
164591580|NCT00085540|594528439|FG000|Overall Study|Withdrawal by Subject|0|||
164591581|NCT00085540|594528440|FG001|Overall Study|Withdrawal by Subject|1|||
164591582|NCT00085540|594528439|FG000|Overall Study|Protocol Violation|0|||
164372904|NCT01359592|593742062|FG000|Initial Registration|Ineligible|26|||
164372905|NCT01359592|593742063|FG001|Initial Registration|Ineligible|0|||
164591583|NCT00085540|594528440|FG001|Overall Study|Protocol Violation|1|||
164591584|NCT01605396|594528441|FG000|Overall Study|Adverse Event|5|||
164591585|NCT01605396|594528442|FG001|Overall Study|Adverse Event|3|||
164591586|NCT01605396|594528441|FG000|Overall Study|Lost to Follow-up|1|||
164372906|NCT01359592|593742064|FG002|Initial Registration|Ineligible|0|||
164372907|NCT01359592|593742065|FG003|Initial Registration|Ineligible|0|||
164372908|NCT01359592|593742062|FG000|PET-Directed Therapy|Adverse Event|0|||
164372909|NCT01359592|593742063|FG001|PET-Directed Therapy|Adverse Event|0|||
164372910|NCT01359592|593742064|FG002|PET-Directed Therapy|Adverse Event|1|||
164372911|NCT01359592|593742065|FG003|PET-Directed Therapy|Adverse Event|0|||
164372912|NCT01359592|593742062|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
164372913|NCT01359592|593742063|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
164372914|NCT01359592|593742064|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
164372915|NCT01359592|593742065|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
164372916|NCT01359592|593742062|FG000|PET-Directed Therapy|Ineligible|0|||
164372917|NCT01359592|593742063|FG001|PET-Directed Therapy|Ineligible|0|||
164372918|NCT01359592|593742064|FG002|PET-Directed Therapy|Ineligible|24|||
164372919|NCT01359592|593742065|FG003|PET-Directed Therapy|Ineligible|0|||
164372920|NCT02365636|593742066|FG000|Overall Study|Adverse Event|3|||
164372921|NCT02365636|593742067|FG001|Overall Study|Adverse Event|3|||
164372922|NCT02365636|593742068|FG002|Overall Study|Adverse Event|2|||
164372923|NCT02365636|593742066|FG000|Overall Study|Protocol Violation|1|||
164372924|NCT02365636|593742067|FG001|Overall Study|Protocol Violation|4|||
164372925|NCT02365636|593742068|FG002|Overall Study|Protocol Violation|0|||
164372926|NCT02365636|593742066|FG000|Overall Study|Lost to Follow-up|0|||
164372927|NCT02365636|593742067|FG001|Overall Study|Lost to Follow-up|0|||
164372928|NCT02365636|593742068|FG002|Overall Study|Lost to Follow-up|1|||
164372929|NCT02365636|593742066|FG000|Overall Study|Other|2|||
164372930|NCT02365636|593742067|FG001|Overall Study|Other|0|||
164372931|NCT02365636|593742068|FG002|Overall Study|Other|0|||
164372932|NCT01454934|593742069|FG000|Overall Study|Clinical progression|28|||
164372933|NCT01454934|593742070|FG001|Overall Study|Clinical progression|25|||
164372934|NCT01454934|593742069|FG000|Overall Study|Other|6|||
164372935|NCT01454934|593742070|FG001|Overall Study|Other|17|||
164372936|NCT01454934|593742069|FG000|Overall Study|Adverse Event|28|||
164372937|NCT01454934|593742070|FG001|Overall Study|Adverse Event|24|||
164372938|NCT01454934|593742069|FG000|Overall Study|Withdrawn consent|2|||
164372939|NCT01454934|593742070|FG001|Overall Study|Withdrawn consent|5|||
164372940|NCT01454934|593742069|FG000|Overall Study|Withdrawal by Subject|11|||
164372941|NCT01454934|593742070|FG001|Overall Study|Withdrawal by Subject|15|||
164372942|NCT01454934|593742069|FG000|Overall Study|Disease progression|194|||
164372943|NCT01454934|593742070|FG001|Overall Study|Disease progression|181|||
164372944|NCT01454934|593742069|FG000|Overall Study|Lost to Follow-up|0|||
164372945|NCT01454934|593742070|FG001|Overall Study|Lost to Follow-up|1|||
164372946|NCT01454934|593742069|FG000|Overall Study|Not treated|1|||
164372947|NCT01454934|593742070|FG001|Overall Study|Not treated|2|||
164372948|NCT03912233|593742071|FG000|Overall Study|Adverse Event|1|||
164372949|NCT03912233|593742072|FG001|Overall Study|Adverse Event|0|||
164372950|NCT03912233|593742073|FG002|Overall Study|Adverse Event|0|||
164372951|NCT03912233|593742074|FG003|Overall Study|Adverse Event|0|||
164372952|NCT03912233|593742075|FG004|Overall Study|Adverse Event|0|||
164372953|NCT03912233|593742076|FG005|Overall Study|Adverse Event|0|||
164372954|NCT03912233|593742071|FG000|Overall Study|Physician Decision|1|||
164372955|NCT03912233|593742072|FG001|Overall Study|Physician Decision|0|||
164372956|NCT03912233|593742073|FG002|Overall Study|Physician Decision|0|||
164372957|NCT03912233|593742074|FG003|Overall Study|Physician Decision|0|||
164372958|NCT03912233|593742075|FG004|Overall Study|Physician Decision|0|||
164372959|NCT03912233|593742076|FG005|Overall Study|Physician Decision|0|||
164372960|NCT03912233|593742071|FG000|Overall Study|Other|0|||
164372961|NCT03912233|593742072|FG001|Overall Study|Other|0|||
164372962|NCT03912233|593742073|FG002|Overall Study|Other|0|||
164372963|NCT03912233|593742074|FG003|Overall Study|Other|0|||
164372964|NCT03912233|593742075|FG004|Overall Study|Other|7|||
164372965|NCT03912233|593742076|FG005|Overall Study|Other|12|||
164372966|NCT02583256|593742077|FG000|Overall Study|Withdrawal by Subject|0|||
164372967|NCT02583256|593742078|FG001|Overall Study|Withdrawal by Subject|1|||
164372968|NCT02583256|593742079|FG002|Overall Study|Withdrawal by Subject|1|||
164372969|NCT02583256|593742080|FG003|Overall Study|Withdrawal by Subject|0|||
164372970|NCT02583256|593742077|FG000|Overall Study|Lost to Follow-up|1|||
164439089|NCT03523091|593973121|FG000|Overall Study|Increase Botox dose|0|||
164439090|NCT03523091|593973122|FG001|Overall Study|Increase Botox dose|1|||
164439091|NCT01093534|593973123|FG000|Overall Study|Adverse Event|2|||
164439092|NCT01093534|593973124|FG001|Overall Study|Adverse Event|5|||
164439093|NCT01093534|593973125|FG002|Overall Study|Adverse Event|2|||
164439094|NCT01093534|593973123|FG000|Overall Study|Lack of Efficacy|2|||
164439095|NCT01093534|593973124|FG001|Overall Study|Lack of Efficacy|1|||
164372971|NCT02583256|593742078|FG001|Overall Study|Lost to Follow-up|1|||
164372972|NCT02583256|593742079|FG002|Overall Study|Lost to Follow-up|0|||
164372973|NCT02583256|593742080|FG003|Overall Study|Lost to Follow-up|1|||
164372974|NCT02583256|593742077|FG000|Overall Study|Administrative/Other|2|||
164372975|NCT02583256|593742078|FG001|Overall Study|Administrative/Other|0|||
164372976|NCT02583256|593742079|FG002|Overall Study|Administrative/Other|1|||
164372977|NCT02583256|593742080|FG003|Overall Study|Administrative/Other|2|||
164439096|NCT01093534|593973125|FG002|Overall Study|Lack of Efficacy|1|||
164439097|NCT01093534|593973123|FG000|Overall Study|Withdrawal by Subject|5|||
164372978|NCT01023659|593742087|FG000|Overall Study|Lost to Follow-up|73|||
164372979|NCT01023659|593742088|FG001|Overall Study|Lost to Follow-up|228|||
164372980|NCT01023659|593742089|FG002|Overall Study|Lost to Follow-up|99|||
164372981|NCT04537806|593742090|FG000|Overall Study|Randomized but not treated|1|||
164372982|NCT04537806|593742091|FG001|Overall Study|Randomized but not treated|0|||
164372983|NCT04537806|593742090|FG000|Overall Study|Adverse Event|1|||
164372984|NCT04537806|593742091|FG001|Overall Study|Adverse Event|1|||
164372985|NCT01802775|593742094|FG000|Overall Study|Death|0|||
164372986|NCT01802775|593742095|FG001|Overall Study|Death|3|||
164372987|NCT01802775|593742094|FG000|Overall Study|Reason not provided|0|||
164372988|NCT01802775|593742095|FG001|Overall Study|Reason not provided|1|||
164372989|NCT01802775|593742094|FG000|Overall Study|Physician Decision|1|||
164372990|NCT01802775|593742095|FG001|Overall Study|Physician Decision|0|||
164372991|NCT01802775|593742094|FG000|Overall Study|Adverse Event|1|||
164372992|NCT01802775|593742095|FG001|Overall Study|Adverse Event|1|||
164372993|NCT01802775|593742094|FG000|Overall Study|Withdrawal by Subject|3|||
164372994|NCT01802775|593742095|FG001|Overall Study|Withdrawal by Subject|5|||
164372995|NCT01802775|593742094|FG000|Overall Study|Lost to Follow-up|1|||
164372996|NCT01802775|593742095|FG001|Overall Study|Lost to Follow-up|2|||
164372997|NCT00519649|593742096|FG000|Overall Study|Withdrawal by Subject|1|||
164372998|NCT01465802|593742097|FG000|Overall Study|Study terminated by sponsor|1|||
164372999|NCT01465802|593742098|FG001|Overall Study|Study terminated by sponsor|0|||
164373000|NCT01465802|593742099|FG002|Overall Study|Study terminated by sponsor|0|||
164373001|NCT01465802|593742100|FG003|Overall Study|Study terminated by sponsor|1|||
164373002|NCT01465802|593742101|FG004|Overall Study|Study terminated by sponsor|7|||
164373003|NCT01465802|593742097|FG000|Overall Study|Withdrawal by Subject|7|||
164373004|NCT01465802|593742098|FG001|Overall Study|Withdrawal by Subject|7|||
164373005|NCT01465802|593742099|FG002|Overall Study|Withdrawal by Subject|0|||
164373006|NCT01465802|593742100|FG003|Overall Study|Withdrawal by Subject|8|||
164373007|NCT01465802|593742101|FG004|Overall Study|Withdrawal by Subject|1|||
164373008|NCT01465802|593742097|FG000|Overall Study|Lost to Follow-up|1|||
164373009|NCT01465802|593742098|FG001|Overall Study|Lost to Follow-up|1|||
164373010|NCT01465802|593742099|FG002|Overall Study|Lost to Follow-up|0|||
164373011|NCT01465802|593742100|FG003|Overall Study|Lost to Follow-up|0|||
164373012|NCT01465802|593742101|FG004|Overall Study|Lost to Follow-up|0|||
164373013|NCT01465802|593742097|FG000|Overall Study|Reason not specified|9|||
164373014|NCT01465802|593742098|FG001|Overall Study|Reason not specified|4|||
164373015|NCT01465802|593742099|FG002|Overall Study|Reason not specified|0|||
164373016|NCT01465802|593742100|FG003|Overall Study|Reason not specified|10|||
164373017|NCT01465802|593742101|FG004|Overall Study|Reason not specified|2|||
164373018|NCT01465802|593742097|FG000|Overall Study|Death|15|||
164373019|NCT01465802|593742098|FG001|Overall Study|Death|12|||
164373020|NCT01465802|593742099|FG002|Overall Study|Death|0|||
164373021|NCT01465802|593742100|FG003|Overall Study|Death|10|||
164373022|NCT01465802|593742101|FG004|Overall Study|Death|2|||
164373023|NCT01067352|593742102|FG000|Overall Study|Withdrawal by Subject|1|||
164373024|NCT01067352|593742103|FG001|Overall Study|Withdrawal by Subject|2|||
164373025|NCT01067352|593742104|FG002|Overall Study|Withdrawal by Subject|1|||
164373026|NCT01067352|593742102|FG000|Overall Study|Physician Decision|0|||
164373027|NCT01067352|593742103|FG001|Overall Study|Physician Decision|1|||
164373028|NCT01067352|593742104|FG002|Overall Study|Physician Decision|0|||
164373029|NCT02103478|593742105|FG000|Overall Study|Adverse Event|0|||
164373030|NCT02103478|593742106|FG001|Overall Study|Adverse Event|0|||
164373031|NCT02103478|593742107|FG002|Overall Study|Adverse Event|1|||
164373032|NCT02103478|593742108|FG003|Overall Study|Adverse Event|1|||
164373033|NCT02103478|593742109|FG004|Overall Study|Adverse Event|2|||
164373034|NCT02103478|593742110|FG005|Overall Study|Adverse Event|1|||
164373035|NCT02103478|593742111|FG006|Overall Study|Adverse Event|0|||
164373036|NCT02103478|593742112|FG007|Overall Study|Adverse Event|0|||
164373037|NCT02103478|593742113|FG008|Overall Study|Adverse Event|0|||
164373038|NCT02103478|593742105|FG000|Overall Study|Death|2|||
164439098|NCT01093534|593973124|FG001|Overall Study|Withdrawal by Subject|7|||
164439099|NCT01093534|593973125|FG002|Overall Study|Withdrawal by Subject|2|||
164439100|NCT01093534|593973123|FG000|Overall Study|Other|1|||
164439101|NCT01093534|593973124|FG001|Overall Study|Other|3|||
164439102|NCT01093534|593973125|FG002|Overall Study|Other|4|||
164373039|NCT02103478|593742106|FG001|Overall Study|Death|2|||
164373040|NCT02103478|593742107|FG002|Overall Study|Death|1|||
164373041|NCT02103478|593742108|FG003|Overall Study|Death|1|||
164373042|NCT02103478|593742109|FG004|Overall Study|Death|5|||
164373043|NCT02103478|593742110|FG005|Overall Study|Death|15|||
164373044|NCT02103478|593742111|FG006|Overall Study|Death|14|||
164373045|NCT02103478|593742112|FG007|Overall Study|Death|10|||
164373046|NCT02103478|593742113|FG008|Overall Study|Death|11|||
164439103|NCT00741988|593973126|FG000|Overall Study|Adverse Event|2|||
164439104|NCT00741988|593973127|FG001|Overall Study|Adverse Event|4|||
164373047|NCT02103478|593742105|FG000|Overall Study|Progressive Disease|2|||
164373048|NCT02103478|593742106|FG001|Overall Study|Progressive Disease|1|||
164373049|NCT02103478|593742107|FG002|Overall Study|Progressive Disease|2|||
164373050|NCT02103478|593742108|FG003|Overall Study|Progressive Disease|0|||
164373051|NCT02103478|593742109|FG004|Overall Study|Progressive Disease|9|||
164373052|NCT02103478|593742110|FG005|Overall Study|Progressive Disease|1|||
164373053|NCT02103478|593742111|FG006|Overall Study|Progressive Disease|2|||
164373054|NCT02103478|593742112|FG007|Overall Study|Progressive Disease|0|||
164373055|NCT02103478|593742113|FG008|Overall Study|Progressive Disease|1|||
164373056|NCT02103478|593742105|FG000|Overall Study|Withdrawal by Subject|2|||
164373057|NCT02103478|593742106|FG001|Overall Study|Withdrawal by Subject|0|||
164373058|NCT02103478|593742107|FG002|Overall Study|Withdrawal by Subject|0|||
164373059|NCT02103478|593742108|FG003|Overall Study|Withdrawal by Subject|4|||
164373060|NCT02103478|593742109|FG004|Overall Study|Withdrawal by Subject|0|||
164373061|NCT02103478|593742110|FG005|Overall Study|Withdrawal by Subject|0|||
164373062|NCT02103478|593742111|FG006|Overall Study|Withdrawal by Subject|1|||
164373063|NCT02103478|593742112|FG007|Overall Study|Withdrawal by Subject|1|||
164373064|NCT02103478|593742113|FG008|Overall Study|Withdrawal by Subject|0|||
164373065|NCT02103478|593742105|FG000|Overall Study|Lost to Follow-up|0|||
164373066|NCT02103478|593742106|FG001|Overall Study|Lost to Follow-up|0|||
164373067|NCT02103478|593742107|FG002|Overall Study|Lost to Follow-up|0|||
164373068|NCT02103478|593742108|FG003|Overall Study|Lost to Follow-up|0|||
164373069|NCT02103478|593742109|FG004|Overall Study|Lost to Follow-up|0|||
164373070|NCT02103478|593742110|FG005|Overall Study|Lost to Follow-up|0|||
164373071|NCT02103478|593742111|FG006|Overall Study|Lost to Follow-up|0|||
164373072|NCT02103478|593742112|FG007|Overall Study|Lost to Follow-up|1|||
164373073|NCT02103478|593742113|FG008|Overall Study|Lost to Follow-up|0|||
164373074|NCT02103478|593742105|FG000|Overall Study|Other|1|||
164373075|NCT02103478|593742106|FG001|Overall Study|Other|3|||
164373076|NCT02103478|593742107|FG002|Overall Study|Other|2|||
164373077|NCT02103478|593742108|FG003|Overall Study|Other|0|||
164373078|NCT02103478|593742109|FG004|Overall Study|Other|3|||
164373079|NCT02103478|593742110|FG005|Overall Study|Other|8|||
164373080|NCT02103478|593742111|FG006|Overall Study|Other|8|||
164373081|NCT02103478|593742112|FG007|Overall Study|Other|4|||
164373082|NCT02103478|593742113|FG008|Overall Study|Other|2|||
164373083|NCT03219333|593742114|FG000|Overall Study|Withdrawal by Subject|9|||
164373084|NCT03219333|593742115|FG001|Overall Study|Withdrawal by Subject|4|||
164373085|NCT03219333|593742114|FG000|Overall Study|Lost to Follow-up|1|||
164373086|NCT03219333|593742115|FG001|Overall Study|Lost to Follow-up|1|||
164373087|NCT03219333|593742114|FG000|Overall Study|Death|104|||
164373088|NCT03219333|593742115|FG001|Overall Study|Death|72|||
164373089|NCT03219333|593742114|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
164373090|NCT03219333|593742115|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
164373091|NCT03219333|593742114|FG000|Overall Study|Other|2|||
164373092|NCT03219333|593742115|FG001|Overall Study|Other|2|||
164373093|NCT00723606|593742116|FG000|Overall Study|Adverse Event|2|||
164373094|NCT00723606|593742117|FG001|Overall Study|Adverse Event|5|||
164373095|NCT00723606|593742116|FG000|Overall Study|Other|2|||
164373096|NCT00723606|593742117|FG001|Overall Study|Other|0|||
164373097|NCT00723606|593742116|FG000|Overall Study|Withdrawal by Subject|0|||
164373098|NCT00723606|593742117|FG001|Overall Study|Withdrawal by Subject|2|||
164373099|NCT02566759|593742118|FG000|All Parts|Withdrawal by Subject|0|||
164373100|NCT02566759|593742119|FG001|All Parts|Withdrawal by Subject|1|||
164373101|NCT02566759|593742120|FG002|All Parts|Withdrawal by Subject|0|||
164373102|NCT02566759|593742121|FG003|All Parts|Withdrawal by Subject|0|||
164373103|NCT02566759|593742122|FG004|All Parts|Withdrawal by Subject|0|||
164373104|NCT02566759|593742123|FG005|All Parts|Withdrawal by Subject|0|||
164373105|NCT02566759|593742124|FG006|All Parts|Withdrawal by Subject|0|||
164373106|NCT02566759|593742125|FG007|All Parts|Withdrawal by Subject|0|||
164373107|NCT02566759|593742126|FG008|All Parts|Withdrawal by Subject|0|||
164373108|NCT02566759|593742127|FG009|All Parts|Withdrawal by Subject|0|||
164373109|NCT02566759|593742128|FG010|All Parts|Withdrawal by Subject|0|||
164373110|NCT02566759|593742129|FG011|All Parts|Withdrawal by Subject|0|||
164373111|NCT02566759|593742130|FG012|All Parts|Withdrawal by Subject|0|||
164373112|NCT02566759|593742131|FG013|All Parts|Withdrawal by Subject|0|||
164373113|NCT02566759|593742132|FG014|All Parts|Withdrawal by Subject|0|||
164373114|NCT02566759|593742133|FG015|All Parts|Withdrawal by Subject|0|||
164373115|NCT02566759|593742134|FG016|All Parts|Withdrawal by Subject|0|||
164373116|NCT02566759|593742118|FG000|All Parts|Adverse Event|0|||
164373117|NCT02566759|593742119|FG001|All Parts|Adverse Event|0|||
164373118|NCT02566759|593742120|FG002|All Parts|Adverse Event|0|||
164373119|NCT02566759|593742121|FG003|All Parts|Adverse Event|0|||
164373120|NCT02566759|593742122|FG004|All Parts|Adverse Event|0|||
164373121|NCT02566759|593742123|FG005|All Parts|Adverse Event|0|||
164373122|NCT02566759|593742124|FG006|All Parts|Adverse Event|0|||
164373123|NCT02566759|593742125|FG007|All Parts|Adverse Event|0|||
164373124|NCT02566759|593742126|FG008|All Parts|Adverse Event|0|||
164373125|NCT02566759|593742127|FG009|All Parts|Adverse Event|0|||
164373126|NCT02566759|593742128|FG010|All Parts|Adverse Event|0|||
164373127|NCT02566759|593742129|FG011|All Parts|Adverse Event|0|||
164373128|NCT02566759|593742130|FG012|All Parts|Adverse Event|1|||
164373129|NCT02566759|593742131|FG013|All Parts|Adverse Event|3|||
164373130|NCT02566759|593742132|FG014|All Parts|Adverse Event|0|||
164373131|NCT02566759|593742133|FG015|All Parts|Adverse Event|0|||
164373132|NCT02566759|593742134|FG016|All Parts|Adverse Event|0|||
164373133|NCT02566759|593742118|FG000|All Parts|Other|0|||
164373134|NCT02566759|593742119|FG001|All Parts|Other|0|||
164373135|NCT02566759|593742120|FG002|All Parts|Other|0|||
164373136|NCT02566759|593742121|FG003|All Parts|Other|0|||
164373137|NCT02566759|593742122|FG004|All Parts|Other|0|||
164373138|NCT02566759|593742123|FG005|All Parts|Other|0|||
164373139|NCT02566759|593742124|FG006|All Parts|Other|0|||
164373140|NCT02566759|593742125|FG007|All Parts|Other|0|||
164373141|NCT02566759|593742126|FG008|All Parts|Other|0|||
164373142|NCT02566759|593742127|FG009|All Parts|Other|0|||
164373143|NCT02566759|593742128|FG010|All Parts|Other|0|||
164373144|NCT02566759|593742129|FG011|All Parts|Other|0|||
164373145|NCT02566759|593742130|FG012|All Parts|Other|0|||
164373146|NCT02566759|593742131|FG013|All Parts|Other|2|||
164373147|NCT02566759|593742132|FG014|All Parts|Other|0|||
164373148|NCT02566759|593742133|FG015|All Parts|Other|0|||
164373149|NCT02566759|593742134|FG016|All Parts|Other|0|||
164373150|NCT02566759|593742118|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373151|NCT02566759|593742119|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373152|NCT02566759|593742120|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373153|NCT02566759|593742121|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373154|NCT02566759|593742122|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373155|NCT02566759|593742123|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373156|NCT02566759|593742124|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373157|NCT02566759|593742125|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373158|NCT02566759|593742126|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373159|NCT02566759|593742127|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373160|NCT02566759|593742128|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373161|NCT02566759|593742129|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373162|NCT02566759|593742130|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373163|NCT02566759|593742131|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373164|NCT02566759|593742132|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373165|NCT02566759|593742133|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373166|NCT02566759|593742134|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
164373167|NCT01096784|593742135|FG000|Overall Study|Withdrawal by Subject|2|||
164373168|NCT01096784|593742136|FG001|Overall Study|Withdrawal by Subject|1|||
164373169|NCT01096784|593742135|FG000|Overall Study|Adverse Event|11|||
164373170|NCT01096784|593742136|FG001|Overall Study|Adverse Event|9|||
164373171|NCT01096784|593742135|FG000|Overall Study|Protocol Deviation|2|||
164373172|NCT01096784|593742136|FG001|Overall Study|Protocol Deviation|2|||
164373173|NCT01096784|593742135|FG000|Overall Study|Administrative Decision|0|||
164373174|NCT01096784|593742136|FG001|Overall Study|Administrative Decision|1|||
164373175|NCT01096784|593742135|FG000|Overall Study|Other Unspecified|0|||
164373176|NCT01096784|593742136|FG001|Overall Study|Other Unspecified|1|||
164373177|NCT00976898|593742137|FG000|Overall Study|Protocol Violation|1|||
164373178|NCT00976898|593742137|FG000|Overall Study|Adverse Event|1|||
164373179|NCT00976898|593742137|FG000|Overall Study|Physician Decision|1|||
164373180|NCT00976898|593742137|FG000|Overall Study|Liver Transplant|1|||
164373181|NCT00976898|593742137|FG000|Overall Study|Progressive Disease|1|||
164373182|NCT05132127|593742142|FG000|Overall Study|Adverse Event|1|||
164373183|NCT05220397|593742143|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
164373184|NCT05220397|593742144|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
164373185|NCT05220397|593742145|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
164373186|NCT05220397|593742146|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
164373187|NCT05220397|593742147|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
164700440|NCT01421342|594926837|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
164700441|NCT01421342|594926835|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
164700442|NCT01421342|594926836|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
164700443|NCT01421342|594926837|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
164700444|NCT01421342|594926835|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
164700445|NCT01421342|594926836|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
164373188|NCT02659020|593742148|FG000|Overall Study|Adverse Event|0|||
164373189|NCT02659020|593742149|FG001|Overall Study|Adverse Event|0|||
164373190|NCT02659020|593742150|FG002|Overall Study|Adverse Event|0|||
164373191|NCT02659020|593742151|FG003|Overall Study|Adverse Event|2|||
164373192|NCT02659020|593742152|FG004|Overall Study|Adverse Event|0|||
164373193|NCT02659020|593742153|FG005|Overall Study|Adverse Event|0|||
164373194|NCT02659020|593742154|FG006|Overall Study|Adverse Event|2|||
164373195|NCT02659020|593742148|FG000|Overall Study|Lost to Follow-up|1|||
164373196|NCT02659020|593742149|FG001|Overall Study|Lost to Follow-up|2|||
164373197|NCT02659020|593742150|FG002|Overall Study|Lost to Follow-up|1|||
164373198|NCT02659020|593742151|FG003|Overall Study|Lost to Follow-up|6|||
164700446|NCT01421342|594926837|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
164700447|NCT01421342|594926835|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
164373199|NCT02659020|593742152|FG004|Overall Study|Lost to Follow-up|1|||
164373200|NCT02659020|593742153|FG005|Overall Study|Lost to Follow-up|5|||
164373201|NCT02659020|593742154|FG006|Overall Study|Lost to Follow-up|0|||
164373202|NCT02659020|593742148|FG000|Overall Study|Physician Decision|0|||
164373203|NCT02659020|593742149|FG001|Overall Study|Physician Decision|0|||
164373204|NCT02659020|593742150|FG002|Overall Study|Physician Decision|0|||
164373205|NCT02659020|593742151|FG003|Overall Study|Physician Decision|1|||
164373206|NCT02659020|593742152|FG004|Overall Study|Physician Decision|1|||
164373207|NCT02659020|593742153|FG005|Overall Study|Physician Decision|0|||
164373208|NCT02659020|593742154|FG006|Overall Study|Physician Decision|1|||
164373209|NCT02659020|593742148|FG000|Overall Study|Withdrawal by Subject|2|||
164373210|NCT02659020|593742149|FG001|Overall Study|Withdrawal by Subject|1|||
164373211|NCT02659020|593742150|FG002|Overall Study|Withdrawal by Subject|0|||
164373212|NCT02659020|593742151|FG003|Overall Study|Withdrawal by Subject|3|||
164373213|NCT02659020|593742152|FG004|Overall Study|Withdrawal by Subject|3|||
164373214|NCT02659020|593742153|FG005|Overall Study|Withdrawal by Subject|6|||
164373215|NCT02659020|593742154|FG006|Overall Study|Withdrawal by Subject|3|||
164373216|NCT02659020|593742148|FG000|Overall Study|Progressive Disease|0|||
164373217|NCT02659020|593742149|FG001|Overall Study|Progressive Disease|0|||
164373218|NCT02659020|593742150|FG002|Overall Study|Progressive Disease|0|||
164373219|NCT02659020|593742151|FG003|Overall Study|Progressive Disease|4|||
164373220|NCT02659020|593742152|FG004|Overall Study|Progressive Disease|1|||
164373221|NCT02659020|593742153|FG005|Overall Study|Progressive Disease|0|||
164373222|NCT02659020|593742154|FG006|Overall Study|Progressive Disease|2|||
164373223|NCT01120210|593742155|FG000|MAIN INFUSION|Adverse Event|1|||
164373224|NCT01120210|593742156|FG001|MAIN INFUSION|Adverse Event|0|||
164373225|NCT01120210|593742155|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
164373226|NCT01120210|593742156|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
164373227|NCT02043015|593742163|FG000|Overall Study|Lost to Follow-up|4|||
164373228|NCT02043015|593742163|FG000|Overall Study|Withdrawal by Subject|4|||
164373229|NCT02043015|593742163|FG000|Overall Study|Removed once target enrollment reached|15|||
164373230|NCT02043015|593742163|FG000|Overall Study|Participant moved away from study city|4|||
164373231|NCT02043015|593742163|FG000|Overall Study|Incarceration|1|||
164373232|NCT04049760|593742165|FG000|Overall Study|Withdrawal by Subject|1|||
164373233|NCT00393939|593742171|FG000|Overall Study|Protocol Violation|1|||
164373234|NCT00393939|593742172|FG001|Overall Study|Protocol Violation|1|||
164373235|NCT00393939|593742171|FG000|Overall Study|Lost to Follow-up|2|||
164373236|NCT00393939|593742172|FG001|Overall Study|Lost to Follow-up|4|||
164373237|NCT00393939|593742171|FG000|Overall Study|Death|10|||
164373238|NCT00393939|593742172|FG001|Overall Study|Death|4|||
164373239|NCT00393939|593742171|FG000|Overall Study|Sponsor|5|||
164373240|NCT00393939|593742172|FG001|Overall Study|Sponsor|13|||
164373241|NCT00393939|593742171|FG000|Overall Study|Objective progression or relapse|239|||
164373242|NCT00393939|593742172|FG001|Overall Study|Objective progression or relapse|223|||
164373243|NCT00393939|593742171|FG000|Overall Study|Withdrawal by Subject|2|||
164373244|NCT00393939|593742172|FG001|Overall Study|Withdrawal by Subject|7|||
164373245|NCT00393939|593742171|FG000|Overall Study|Other|37|||
164373246|NCT00393939|593742172|FG001|Overall Study|Other|45|||
164373247|NCT01494610|593742173|FG000|Period 1|Withdrawal by Subject|1|||
164373248|NCT01494610|593742174|FG001|Period 1|Withdrawal by Subject|1|||
164373249|NCT01494610|593742173|FG000|Period 3|Adverse Event|1|||
164373250|NCT01494610|593742174|FG001|Period 3|Adverse Event|0|||
164373251|NCT01494610|593742173|FG000|Period 3|Withdrawal by Subject|1|||
164373252|NCT01494610|593742174|FG001|Period 3|Withdrawal by Subject|0|||
164373253|NCT01494610|593742173|FG000|Period 4|Protocol Violation|1|||
164373254|NCT01494610|593742174|FG001|Period 4|Protocol Violation|0|||
164373255|NCT02385799|593742175|FG000|Overall Study|Lost to Follow-up|1|||
164373256|NCT02385799|593742176|FG001|Overall Study|Lost to Follow-up|2|||
164373257|NCT02385799|593742175|FG000|Overall Study|Adverse Event|4|||
164373258|NCT02385799|593742176|FG001|Overall Study|Adverse Event|2|||
164373259|NCT02385799|593742175|FG000|Overall Study|Withdrawal by Subject|0|||
164373260|NCT02385799|593742176|FG001|Overall Study|Withdrawal by Subject|4|||
164373261|NCT03995953|593742177|FG000|Overall Study|Death|3|||
164591587|NCT01605396|594528442|FG001|Overall Study|Lost to Follow-up|0|||
164373262|NCT03995953|593742178|FG001|Overall Study|Death|0|||
164373263|NCT03995953|593742179|FG002|Overall Study|Death|3|||
164373264|NCT03995953|593742180|FG003|Overall Study|Death|0|||
164373265|NCT03995953|593742181|FG004|Overall Study|Death|3|||
164373266|NCT03995953|593742182|FG005|Overall Study|Death|0|||
164373267|NCT03995953|593742183|FG006|Overall Study|Death|0|||
164591588|NCT01605396|594528441|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164591589|NCT01605396|594528442|FG001|Overall Study|Non-Compliance With Study Drug|1|||
164591590|NCT01605396|594528441|FG000|Overall Study|Physician Decision|2|||
164373268|NCT03995953|593742184|FG007|Overall Study|Death|0|||
164373269|NCT03995953|593742185|FG008|Overall Study|Death|1|||
164373270|NCT03995953|593742186|FG009|Overall Study|Death|0|||
164373271|NCT03995953|593742187|FG010|Overall Study|Death|0|||
164373272|NCT03995953|593742188|FG011|Overall Study|Death|0|||
164373273|NCT03995953|593742177|FG000|Overall Study|Lost to Follow-up|6|||
164373274|NCT03995953|593742178|FG001|Overall Study|Lost to Follow-up|54|||
164373275|NCT03995953|593742179|FG002|Overall Study|Lost to Follow-up|3|||
164373276|NCT03995953|593742180|FG003|Overall Study|Lost to Follow-up|32|||
164373277|NCT03995953|593742181|FG004|Overall Study|Lost to Follow-up|5|||
164439105|NCT00741988|593973126|FG000|Overall Study|Lack of Efficacy|2|||
164439106|NCT00741988|593973127|FG001|Overall Study|Lack of Efficacy|0|||
164439107|NCT03863834|593973137|FG000|Overall Study|Lost to Follow-up|3|||
164439108|NCT03386929|593973143|FG000|Overall Study|Death|0|||
164439109|NCT03386929|593973144|FG001|Overall Study|Death|0|||
164373278|NCT03995953|593742182|FG005|Overall Study|Lost to Follow-up|44|||
164373279|NCT03995953|593742183|FG006|Overall Study|Lost to Follow-up|0|||
164373280|NCT03995953|593742184|FG007|Overall Study|Lost to Follow-up|31|||
164373281|NCT03995953|593742185|FG008|Overall Study|Lost to Follow-up|8|||
164373282|NCT03995953|593742186|FG009|Overall Study|Lost to Follow-up|36|||
164373283|NCT03995953|593742187|FG010|Overall Study|Lost to Follow-up|5|||
164373284|NCT03995953|593742188|FG011|Overall Study|Lost to Follow-up|41|||
164373285|NCT03995953|593742177|FG000|Overall Study|Withdrawal by Subject|4|||
164373286|NCT03995953|593742178|FG001|Overall Study|Withdrawal by Subject|0|||
164373287|NCT03995953|593742179|FG002|Overall Study|Withdrawal by Subject|1|||
164373288|NCT03995953|593742180|FG003|Overall Study|Withdrawal by Subject|0|||
164373289|NCT03995953|593742181|FG004|Overall Study|Withdrawal by Subject|1|||
164373290|NCT03995953|593742182|FG005|Overall Study|Withdrawal by Subject|0|||
164373291|NCT03995953|593742183|FG006|Overall Study|Withdrawal by Subject|1|||
164373292|NCT03995953|593742184|FG007|Overall Study|Withdrawal by Subject|0|||
164373293|NCT03995953|593742185|FG008|Overall Study|Withdrawal by Subject|3|||
164373294|NCT03995953|593742186|FG009|Overall Study|Withdrawal by Subject|0|||
164373295|NCT03995953|593742187|FG010|Overall Study|Withdrawal by Subject|3|||
164373296|NCT03995953|593742188|FG011|Overall Study|Withdrawal by Subject|0|||
164373297|NCT03995953|593742177|FG000|Overall Study|Health Issues|0|||
164373298|NCT03995953|593742178|FG001|Overall Study|Health Issues|0|||
164373299|NCT03995953|593742179|FG002|Overall Study|Health Issues|0|||
164373300|NCT03995953|593742180|FG003|Overall Study|Health Issues|0|||
164373301|NCT03995953|593742181|FG004|Overall Study|Health Issues|1|||
164373302|NCT03995953|593742182|FG005|Overall Study|Health Issues|0|||
164373303|NCT03995953|593742183|FG006|Overall Study|Health Issues|0|||
164373304|NCT03995953|593742184|FG007|Overall Study|Health Issues|0|||
164373305|NCT03995953|593742185|FG008|Overall Study|Health Issues|4|||
164373306|NCT03995953|593742186|FG009|Overall Study|Health Issues|0|||
164373307|NCT03995953|593742187|FG010|Overall Study|Health Issues|0|||
164373308|NCT03995953|593742188|FG011|Overall Study|Health Issues|0|||
164373309|NCT03995953|593742177|FG000|Overall Study|Relocated|11|||
164373310|NCT03995953|593742178|FG001|Overall Study|Relocated|0|||
164373311|NCT03995953|593742179|FG002|Overall Study|Relocated|16|||
164373312|NCT03995953|593742180|FG003|Overall Study|Relocated|0|||
164373313|NCT03995953|593742181|FG004|Overall Study|Relocated|14|||
164373314|NCT03995953|593742182|FG005|Overall Study|Relocated|0|||
164373315|NCT03995953|593742183|FG006|Overall Study|Relocated|16|||
164373316|NCT03995953|593742184|FG007|Overall Study|Relocated|0|||
164373317|NCT03995953|593742185|FG008|Overall Study|Relocated|14|||
164373318|NCT03995953|593742186|FG009|Overall Study|Relocated|0|||
164373319|NCT03995953|593742187|FG010|Overall Study|Relocated|15|||
164373320|NCT03995953|593742188|FG011|Overall Study|Relocated|0|||
164373321|NCT02388997|593742189|FG000|Overall Study|Adverse Event|1|||
164373322|NCT02388997|593742190|FG001|Overall Study|Adverse Event|2|||
164373323|NCT02388997|593742189|FG000|Overall Study|Withdrawal by Subject|2|||
164373324|NCT02388997|593742190|FG001|Overall Study|Withdrawal by Subject|1|||
164373325|NCT02388997|593742189|FG000|Overall Study|Lung function exclusion criteria|0|||
164373326|NCT02388997|593742190|FG001|Overall Study|Lung function exclusion criteria|2|||
164373327|NCT02388997|593742189|FG000|Overall Study|Tested positive for virus during run-in|0|||
164373328|NCT02388997|593742190|FG001|Overall Study|Tested positive for virus during run-in|1|||
164439110|NCT03386929|593973145|FG002|Overall Study|Death|1|||
164439111|NCT03386929|593973143|FG000|Overall Study|Withdrawal by Subject|0|||
164439112|NCT03386929|593973144|FG001|Overall Study|Withdrawal by Subject|1|||
164439113|NCT03386929|593973145|FG002|Overall Study|Withdrawal by Subject|0|||
164373329|NCT02130765|593742191|FG000|Overall Study|Did not receive treatment|4|||
164373330|NCT02130765|593742192|FG001|Overall Study|Did not receive treatment|0|||
164373331|NCT02130765|593742193|FG002|Overall Study|Did not receive treatment|0|||
164373332|NCT02130765|593742194|FG003|Overall Study|Did not receive treatment|0|||
164373333|NCT00006184|593742197|FG000|Overall Study|Death|1|||
164373334|NCT00006184|593742198|FG001|Overall Study|Death|0|||
164373335|NCT04958109|593742199|FG000|Overall Study|Withdrawal by Subject|0|||
164373336|NCT04958109|593742200|FG001|Overall Study|Withdrawal by Subject|1|||
164439114|NCT03386929|593973143|FG000|Overall Study|Physician Decision|0|||
164439115|NCT03386929|593973144|FG001|Overall Study|Physician Decision|0|||
164373337|NCT04958109|593742199|FG000|Overall Study|Lost to Follow-up|0|||
164373338|NCT04958109|593742200|FG001|Overall Study|Lost to Follow-up|1|||
164439116|NCT03386929|593973145|FG002|Overall Study|Physician Decision|1|||
164373339|NCT01256710|593742201|FG000|Overall Study|Death|449|||
164373340|NCT01256710|593742201|FG000|Overall Study|System Explant|67|||
164373341|NCT01256710|593742201|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
164439117|NCT03386929|593973143|FG000|Overall Study|Progression|4|||
164373342|NCT01256710|593742201|FG000|Overall Study|Lost to Follow-up|67|||
164373343|NCT01256710|593742201|FG000|Overall Study|Withdrawal by Subject|29|||
164373344|NCT01256710|593742201|FG000|Overall Study|Physician Decision|9|||
164373345|NCT01256710|593742201|FG000|Overall Study|Subject Noncompliance|2|||
164373346|NCT01256710|593742201|FG000|Overall Study|Study Terminated by Sponsor|273|||
164373347|NCT00715793|593742202|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
164373348|NCT00715793|593742203|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
164373349|NCT00715793|593742202|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
164373350|NCT00715793|593742203|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
164373351|NCT02346240|593742204|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373352|NCT02346240|593742205|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
164373353|NCT02346240|593742206|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
164373354|NCT02346240|593742207|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
164373355|NCT02346240|593742208|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373356|NCT02346240|593742209|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373357|NCT02346240|593742210|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373358|NCT02346240|593742211|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373359|NCT02346240|593742212|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373360|NCT02346240|593742213|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373361|NCT02346240|593742214|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373362|NCT02346240|593742215|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373363|NCT02346240|593742216|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373364|NCT02346240|593742217|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373365|NCT02346240|593742218|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373366|NCT02346240|593742219|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373367|NCT02346240|593742220|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373368|NCT02346240|593742221|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373369|NCT02346240|593742222|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373370|NCT02346240|593742223|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373371|NCT02346240|593742224|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373372|NCT02346240|593742225|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373373|NCT02346240|593742226|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373374|NCT02346240|593742227|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373375|NCT02346240|593742204|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373376|NCT02346240|593742205|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
164373377|NCT02346240|593742206|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373378|NCT02346240|593742207|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373379|NCT02346240|593742208|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373380|NCT02346240|593742209|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373381|NCT02346240|593742210|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373382|NCT02346240|593742211|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373383|NCT02346240|593742212|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373384|NCT02346240|593742213|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373385|NCT02346240|593742214|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373386|NCT02346240|593742215|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373387|NCT02346240|593742216|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373388|NCT02346240|593742217|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373389|NCT02346240|593742218|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373390|NCT02346240|593742219|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373391|NCT02346240|593742220|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164700448|NCT01421342|594926836|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
164700449|NCT01421342|594926837|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
164373392|NCT02346240|593742221|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373393|NCT02346240|593742222|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373394|NCT02346240|593742223|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373395|NCT02346240|593742224|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373396|NCT02346240|593742225|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373397|NCT02346240|593742226|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373398|NCT02346240|593742227|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373399|NCT02346240|593742204|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373400|NCT02346240|593742205|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
164373401|NCT02346240|593742206|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373402|NCT02346240|593742207|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373403|NCT02346240|593742208|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373404|NCT02346240|593742209|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164700450|NCT01421342|594926835|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
164373405|NCT02346240|593742210|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373406|NCT02346240|593742211|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373407|NCT02346240|593742212|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373408|NCT02346240|593742213|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373409|NCT02346240|593742214|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373410|NCT02346240|593742215|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373411|NCT02346240|593742216|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373412|NCT02346240|593742217|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373413|NCT02346240|593742218|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373414|NCT02346240|593742219|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373415|NCT02346240|593742220|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373416|NCT02346240|593742221|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373417|NCT02346240|593742222|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373418|NCT02346240|593742223|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373419|NCT02346240|593742224|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373420|NCT02346240|593742225|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373421|NCT02346240|593742226|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373422|NCT02346240|593742227|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373423|NCT02346240|593742204|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
164373424|NCT02346240|593742205|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
164373425|NCT02346240|593742206|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
164373426|NCT02346240|593742207|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
164373427|NCT02346240|593742208|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373428|NCT02346240|593742209|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373429|NCT02346240|593742210|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373430|NCT02346240|593742211|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373431|NCT02346240|593742212|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373432|NCT02346240|593742213|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373433|NCT02346240|593742214|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373434|NCT02346240|593742215|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373435|NCT02346240|593742216|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373436|NCT02346240|593742217|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373437|NCT02346240|593742218|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373438|NCT02346240|593742219|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373439|NCT02346240|593742220|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373440|NCT02346240|593742221|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373441|NCT02346240|593742222|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373442|NCT02346240|593742223|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373443|NCT02346240|593742224|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373444|NCT02346240|593742225|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373445|NCT02346240|593742226|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373446|NCT02346240|593742227|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373447|NCT02346240|593742204|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
164373448|NCT02346240|593742205|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
164373449|NCT02346240|593742206|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
164373450|NCT02346240|593742207|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
164373451|NCT02346240|593742208|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373452|NCT02346240|593742209|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373453|NCT02346240|593742210|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373454|NCT02346240|593742211|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373455|NCT02346240|593742212|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373456|NCT02346240|593742213|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373457|NCT02346240|593742214|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373458|NCT02346240|593742215|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373459|NCT02346240|593742216|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373460|NCT02346240|593742217|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373461|NCT02346240|593742218|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373462|NCT02346240|593742219|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373463|NCT02346240|593742220|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373464|NCT02346240|593742221|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373465|NCT02346240|593742222|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373466|NCT02346240|593742223|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373467|NCT02346240|593742224|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373468|NCT02346240|593742225|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373469|NCT02346240|593742226|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373470|NCT02346240|593742227|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373471|NCT02346240|593742204|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373472|NCT02346240|593742205|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
164373473|NCT02346240|593742206|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373474|NCT02346240|593742207|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
164373475|NCT02346240|593742208|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373476|NCT02346240|593742209|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373477|NCT02346240|593742210|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373478|NCT02346240|593742211|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373479|NCT02346240|593742212|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373480|NCT02346240|593742213|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373481|NCT02346240|593742214|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373482|NCT02346240|593742215|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373483|NCT02346240|593742216|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373484|NCT02346240|593742217|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373485|NCT02346240|593742218|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373486|NCT02346240|593742219|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373487|NCT02346240|593742220|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373488|NCT02346240|593742221|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373489|NCT02346240|593742222|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373490|NCT02346240|593742223|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373491|NCT02346240|593742224|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373492|NCT02346240|593742225|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373493|NCT02346240|593742226|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373494|NCT02346240|593742227|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373495|NCT02346240|593742204|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373496|NCT02346240|593742205|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373497|NCT02346240|593742206|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
164373498|NCT02346240|593742207|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373499|NCT02346240|593742208|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373500|NCT02346240|593742209|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373501|NCT02346240|593742210|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373502|NCT02346240|593742211|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373503|NCT02346240|593742212|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373504|NCT02346240|593742213|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373505|NCT02346240|593742214|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373506|NCT02346240|593742215|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373507|NCT02346240|593742216|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373508|NCT02346240|593742217|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373509|NCT02346240|593742218|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373510|NCT02346240|593742219|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373511|NCT02346240|593742220|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373512|NCT02346240|593742221|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373513|NCT02346240|593742222|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373514|NCT02346240|593742223|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373515|NCT02346240|593742224|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373516|NCT02346240|593742225|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373517|NCT02346240|593742226|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373518|NCT02346240|593742227|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373519|NCT02346240|593742204|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373520|NCT02346240|593742205|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373521|NCT02346240|593742206|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373522|NCT02346240|593742207|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373523|NCT02346240|593742208|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373524|NCT02346240|593742209|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373525|NCT02346240|593742210|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373526|NCT02346240|593742211|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
164373527|NCT02346240|593742212|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
164373528|NCT02346240|593742213|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373529|NCT02346240|593742214|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373530|NCT02346240|593742215|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373531|NCT02346240|593742216|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373532|NCT02346240|593742217|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
164373533|NCT02346240|593742218|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
164373534|NCT02346240|593742219|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
164373535|NCT02346240|593742220|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
164373536|NCT02346240|593742221|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373537|NCT02346240|593742222|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373538|NCT02346240|593742223|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373539|NCT02346240|593742224|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373540|NCT02346240|593742225|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373541|NCT02346240|593742226|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373542|NCT02346240|593742227|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373543|NCT02346240|593742204|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373544|NCT02346240|593742205|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373545|NCT02346240|593742206|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373546|NCT02346240|593742207|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373547|NCT02346240|593742208|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373548|NCT02346240|593742209|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373549|NCT02346240|593742210|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373550|NCT02346240|593742211|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373551|NCT02346240|593742212|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373552|NCT02346240|593742213|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373553|NCT02346240|593742214|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373554|NCT02346240|593742215|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373555|NCT02346240|593742216|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373556|NCT02346240|593742217|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
164373557|NCT02346240|593742218|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373558|NCT02346240|593742219|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
164373559|NCT02346240|593742220|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373560|NCT02346240|593742221|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373561|NCT02346240|593742222|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373562|NCT02346240|593742223|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373563|NCT02346240|593742224|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373564|NCT02346240|593742225|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373565|NCT02346240|593742226|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373566|NCT02346240|593742227|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373567|NCT02346240|593742204|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373568|NCT02346240|593742205|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373569|NCT02346240|593742206|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373570|NCT02346240|593742207|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373571|NCT02346240|593742208|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373572|NCT02346240|593742209|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373573|NCT02346240|593742210|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373574|NCT02346240|593742211|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373575|NCT02346240|593742212|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373576|NCT02346240|593742213|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373577|NCT02346240|593742214|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373578|NCT02346240|593742215|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373579|NCT02346240|593742216|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373580|NCT02346240|593742217|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373581|NCT02346240|593742218|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
164373582|NCT02346240|593742219|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373583|NCT02346240|593742220|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373584|NCT02346240|593742221|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373585|NCT02346240|593742222|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373586|NCT02346240|593742223|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373587|NCT02346240|593742224|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373588|NCT02346240|593742225|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373589|NCT02346240|593742226|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373590|NCT02346240|593742227|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373591|NCT02346240|593742204|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373592|NCT02346240|593742205|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373593|NCT02346240|593742206|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373594|NCT02346240|593742207|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373595|NCT02346240|593742208|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373596|NCT02346240|593742209|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164439118|NCT03386929|593973144|FG001|Overall Study|Progression|4|||
164439119|NCT03386929|593973145|FG002|Overall Study|Progression|0|||
164439120|NCT03386929|593973143|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
164373597|NCT02346240|593742210|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164373598|NCT02346240|593742211|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164373599|NCT02346240|593742212|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164373600|NCT02346240|593742213|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373601|NCT02346240|593742214|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164373602|NCT02346240|593742215|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
164373603|NCT02346240|593742216|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373604|NCT02346240|593742217|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
164373605|NCT02346240|593742218|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
164373606|NCT02346240|593742219|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
164373607|NCT02346240|593742220|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164373608|NCT02346240|593742221|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373609|NCT02346240|593742222|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373610|NCT02346240|593742223|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164439121|NCT03386929|593973144|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
164373611|NCT02346240|593742224|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373612|NCT02346240|593742225|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373613|NCT02346240|593742226|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373614|NCT02346240|593742227|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373615|NCT02346240|593742204|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373616|NCT02346240|593742205|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373617|NCT02346240|593742206|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373618|NCT02346240|593742207|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373619|NCT02346240|593742208|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373620|NCT02346240|593742209|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373621|NCT02346240|593742210|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373622|NCT02346240|593742211|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373623|NCT02346240|593742212|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373624|NCT02346240|593742213|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373625|NCT02346240|593742214|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373626|NCT02346240|593742215|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373627|NCT02346240|593742216|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373628|NCT02346240|593742217|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
164373629|NCT02346240|593742218|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
164373630|NCT02346240|593742219|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
164373631|NCT02346240|593742220|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
164373632|NCT02346240|593742221|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373633|NCT02346240|593742222|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373634|NCT02346240|593742223|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373635|NCT02346240|593742224|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373636|NCT02346240|593742225|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373637|NCT02346240|593742226|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373638|NCT02346240|593742227|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373639|NCT02346240|593742204|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373640|NCT02346240|593742205|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373641|NCT02346240|593742206|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373642|NCT02346240|593742207|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373643|NCT02346240|593742208|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373644|NCT02346240|593742209|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373645|NCT02346240|593742210|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
164373646|NCT02346240|593742211|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373647|NCT02346240|593742212|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373648|NCT02346240|593742213|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373649|NCT02346240|593742214|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373650|NCT02346240|593742215|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164700451|NCT01421342|594926836|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
164700452|NCT01421342|594926837|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
164700453|NCT01421342|594926835|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
164700454|NCT01421342|594926836|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
164373651|NCT02346240|593742216|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373652|NCT02346240|593742217|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373653|NCT02346240|593742218|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373654|NCT02346240|593742219|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373655|NCT02346240|593742220|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373656|NCT02346240|593742221|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373657|NCT02346240|593742222|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373658|NCT02346240|593742223|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373659|NCT02346240|593742224|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373660|NCT02346240|593742225|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373661|NCT02346240|593742226|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373662|NCT02346240|593742227|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373663|NCT02346240|593742204|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373664|NCT02346240|593742205|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373665|NCT02346240|593742206|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373666|NCT02346240|593742207|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373667|NCT02346240|593742208|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373668|NCT02346240|593742209|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373669|NCT02346240|593742210|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373670|NCT02346240|593742211|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373671|NCT02346240|593742212|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
164373672|NCT02346240|593742213|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373673|NCT02346240|593742214|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373674|NCT02346240|593742215|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
164373675|NCT02346240|593742216|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373676|NCT02346240|593742217|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
164373677|NCT02346240|593742218|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
164373678|NCT02346240|593742219|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164439122|NCT03386929|593973145|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
164373679|NCT02346240|593742220|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373680|NCT02346240|593742221|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373681|NCT02346240|593742222|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373682|NCT02346240|593742223|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373683|NCT02346240|593742224|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373684|NCT02346240|593742225|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373685|NCT02346240|593742226|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373686|NCT02346240|593742227|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373687|NCT02346240|593742204|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373688|NCT02346240|593742205|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373689|NCT02346240|593742206|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373690|NCT02346240|593742207|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373691|NCT02346240|593742208|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373692|NCT02346240|593742209|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373693|NCT02346240|593742210|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373694|NCT02346240|593742211|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373695|NCT02346240|593742212|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373696|NCT02346240|593742213|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
164373697|NCT02346240|593742214|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373698|NCT02346240|593742215|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373699|NCT02346240|593742216|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373700|NCT02346240|593742217|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373701|NCT02346240|593742218|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164439123|NCT03386929|593973143|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
164439124|NCT03386929|593973144|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
164439125|NCT03386929|593973145|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
164439126|NCT03538054|593973146|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
164373702|NCT02346240|593742219|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373703|NCT02346240|593742220|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373704|NCT02346240|593742221|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373705|NCT02346240|593742222|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373706|NCT02346240|593742223|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373707|NCT02346240|593742224|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373708|NCT02346240|593742225|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373709|NCT02346240|593742226|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373710|NCT02346240|593742227|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373711|NCT02346240|593742204|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373712|NCT02346240|593742205|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373713|NCT02346240|593742206|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373714|NCT02346240|593742207|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373715|NCT02346240|593742208|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373716|NCT02346240|593742209|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164439127|NCT03538054|593973146|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
164439128|NCT03538054|593973146|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
164439129|NCT01981356|593973147|FG000|Overall Study|Lost to Follow-up|4|||
164373717|NCT02346240|593742210|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373718|NCT02346240|593742211|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373719|NCT02346240|593742212|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373720|NCT02346240|593742213|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373721|NCT02346240|593742214|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
164373722|NCT02346240|593742215|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373723|NCT02346240|593742216|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373724|NCT02346240|593742217|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373725|NCT02346240|593742218|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373726|NCT02346240|593742219|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373727|NCT02346240|593742220|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373728|NCT02346240|593742221|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373729|NCT02346240|593742222|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373730|NCT02346240|593742223|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373731|NCT02346240|593742224|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373732|NCT02346240|593742225|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373733|NCT02346240|593742226|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373734|NCT02346240|593742227|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373735|NCT02346240|593742204|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373736|NCT02346240|593742205|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373737|NCT02346240|593742206|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373738|NCT02346240|593742207|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373739|NCT02346240|593742208|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373740|NCT02346240|593742209|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373741|NCT02346240|593742210|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373742|NCT02346240|593742211|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373743|NCT02346240|593742212|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373744|NCT02346240|593742213|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373745|NCT02346240|593742214|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373746|NCT02346240|593742215|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373747|NCT02346240|593742216|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373748|NCT02346240|593742217|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373749|NCT02346240|593742218|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
164373750|NCT02346240|593742219|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373751|NCT02346240|593742220|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373752|NCT02346240|593742221|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373753|NCT02346240|593742222|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373754|NCT02346240|593742223|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164439130|NCT01981356|593973148|FG001|Overall Study|Lost to Follow-up|1|||
164439131|NCT01981356|593973147|FG000|Overall Study|Withdrawal by Subject|1|||
164439132|NCT01981356|593973148|FG001|Overall Study|Withdrawal by Subject|1|||
164373755|NCT02346240|593742224|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373756|NCT02346240|593742225|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373757|NCT02346240|593742226|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373758|NCT02346240|593742227|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373759|NCT02346240|593742204|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373760|NCT02346240|593742205|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373761|NCT02346240|593742206|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373762|NCT02346240|593742207|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373763|NCT02346240|593742208|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373764|NCT02346240|593742209|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373765|NCT02346240|593742210|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373766|NCT02346240|593742211|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373767|NCT02346240|593742212|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373768|NCT02346240|593742213|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373769|NCT02346240|593742214|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373770|NCT02346240|593742215|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373771|NCT02346240|593742216|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373772|NCT02346240|593742217|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373773|NCT02346240|593742218|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
164373774|NCT02346240|593742219|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373775|NCT02346240|593742220|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373776|NCT02346240|593742221|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373777|NCT02346240|593742222|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373778|NCT02346240|593742223|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373779|NCT02346240|593742224|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373780|NCT02346240|593742225|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373781|NCT02346240|593742226|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373782|NCT02346240|593742227|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373783|NCT02346240|593742204|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373784|NCT02346240|593742205|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373785|NCT02346240|593742206|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373786|NCT02346240|593742207|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373787|NCT02346240|593742208|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373788|NCT02346240|593742209|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373789|NCT02346240|593742210|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373790|NCT02346240|593742211|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373791|NCT02346240|593742212|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373792|NCT02346240|593742213|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373793|NCT02346240|593742214|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373794|NCT02346240|593742215|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373795|NCT02346240|593742216|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373796|NCT02346240|593742217|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373797|NCT02346240|593742218|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
164373798|NCT02346240|593742219|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373799|NCT02346240|593742220|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373800|NCT02346240|593742221|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373801|NCT02346240|593742222|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373802|NCT02346240|593742223|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373803|NCT02346240|593742224|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373804|NCT02346240|593742225|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373805|NCT02346240|593742226|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373806|NCT02346240|593742227|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373807|NCT02346240|593742204|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373808|NCT02346240|593742205|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373809|NCT02346240|593742206|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373810|NCT02346240|593742207|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373811|NCT02346240|593742208|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164439133|NCT01981356|593973147|FG000|Overall Study|Protocol Violation|2|||
164373812|NCT02346240|593742209|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373813|NCT02346240|593742210|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373814|NCT02346240|593742211|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373815|NCT02346240|593742212|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373816|NCT02346240|593742213|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373817|NCT02346240|593742214|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373818|NCT02346240|593742215|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373819|NCT02346240|593742216|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373820|NCT02346240|593742217|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373821|NCT02346240|593742218|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373822|NCT02346240|593742219|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373823|NCT02346240|593742220|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373824|NCT02346240|593742221|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
164373825|NCT02346240|593742222|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
164373826|NCT02346240|593742223|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
164373827|NCT02346240|593742224|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
164373828|NCT02346240|593742225|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
164373829|NCT02346240|593742226|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
164373830|NCT02346240|593742227|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
164373831|NCT02346240|593742204|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373832|NCT02346240|593742205|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373833|NCT02346240|593742206|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373834|NCT02346240|593742207|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373835|NCT02346240|593742208|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373836|NCT02346240|593742209|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373837|NCT02346240|593742210|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373838|NCT02346240|593742211|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373839|NCT02346240|593742212|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373840|NCT02346240|593742213|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373841|NCT02346240|593742214|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373842|NCT02346240|593742215|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373843|NCT02346240|593742216|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373844|NCT02346240|593742217|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373845|NCT02346240|593742218|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373846|NCT02346240|593742219|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373847|NCT02346240|593742220|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373848|NCT02346240|593742221|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373849|NCT02346240|593742222|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
164373850|NCT02346240|593742223|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
164373851|NCT02346240|593742224|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373852|NCT02346240|593742225|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
164373853|NCT02346240|593742226|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373854|NCT02346240|593742227|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373855|NCT02346240|593742204|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373856|NCT02346240|593742205|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373857|NCT02346240|593742206|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373858|NCT02346240|593742207|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373859|NCT02346240|593742208|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373860|NCT02346240|593742209|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373861|NCT02346240|593742210|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373862|NCT02346240|593742211|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373863|NCT02346240|593742212|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373864|NCT02346240|593742213|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164700455|NCT01421342|594926837|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
164700456|NCT01421342|594926835|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
164439134|NCT01981356|593973148|FG001|Overall Study|Protocol Violation|0|||
164700457|NCT01421342|594926836|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
164700458|NCT01421342|594926837|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
164373865|NCT02346240|593742214|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373866|NCT02346240|593742215|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373867|NCT02346240|593742216|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373868|NCT02346240|593742217|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373869|NCT02346240|593742218|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373870|NCT02346240|593742219|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373871|NCT02346240|593742220|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373872|NCT02346240|593742221|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164439135|NCT05147233|593975298|FG000|Overall Study|Adverse Event|0|||
164373873|NCT02346240|593742222|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
164373874|NCT02346240|593742223|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373875|NCT02346240|593742224|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373876|NCT02346240|593742225|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
164373877|NCT02346240|593742226|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373878|NCT02346240|593742227|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373879|NCT02346240|593742204|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373880|NCT02346240|593742205|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373881|NCT02346240|593742206|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373882|NCT02346240|593742207|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373883|NCT02346240|593742208|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373884|NCT02346240|593742209|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373885|NCT02346240|593742210|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373886|NCT02346240|593742211|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373887|NCT02346240|593742212|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373888|NCT02346240|593742213|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373889|NCT02346240|593742214|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373890|NCT02346240|593742215|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373891|NCT02346240|593742216|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373892|NCT02346240|593742217|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373893|NCT02346240|593742218|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373894|NCT02346240|593742219|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373895|NCT02346240|593742220|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373896|NCT02346240|593742221|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373897|NCT02346240|593742222|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373898|NCT02346240|593742223|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373899|NCT02346240|593742224|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373900|NCT02346240|593742225|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
164373901|NCT02346240|593742226|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373902|NCT02346240|593742227|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373903|NCT02346240|593742204|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373904|NCT02346240|593742205|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373905|NCT02346240|593742206|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373906|NCT02346240|593742207|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373907|NCT02346240|593742208|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373908|NCT02346240|593742209|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373909|NCT02346240|593742210|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373910|NCT02346240|593742211|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373911|NCT02346240|593742212|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373912|NCT02346240|593742213|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373913|NCT02346240|593742214|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373914|NCT02346240|593742215|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373915|NCT02346240|593742216|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373916|NCT02346240|593742217|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373917|NCT02346240|593742218|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373918|NCT02346240|593742219|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373919|NCT02346240|593742220|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373920|NCT02346240|593742221|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
164373921|NCT02346240|593742222|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
164373922|NCT02346240|593742223|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
164373923|NCT02346240|593742224|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373924|NCT02346240|593742225|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
164373925|NCT02346240|593742226|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
164373926|NCT02346240|593742227|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
164373927|NCT02346240|593742204|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373928|NCT02346240|593742205|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373929|NCT02346240|593742206|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373930|NCT02346240|593742207|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373931|NCT02346240|593742208|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373932|NCT02346240|593742209|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373933|NCT02346240|593742210|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373934|NCT02346240|593742211|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373935|NCT02346240|593742212|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373936|NCT02346240|593742213|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373937|NCT02346240|593742214|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373938|NCT02346240|593742215|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373939|NCT02346240|593742216|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373940|NCT02346240|593742217|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373941|NCT02346240|593742218|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373942|NCT02346240|593742219|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373943|NCT02346240|593742220|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164591591|NCT01605396|594528442|FG001|Overall Study|Physician Decision|2|||
164700459|NCT01421342|594926835|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
164700460|NCT01421342|594926836|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
164700461|NCT01421342|594926837|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
164700462|NCT01421342|594926835|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
164700463|NCT01421342|594926836|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
164373944|NCT02346240|593742221|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373945|NCT02346240|593742222|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
164373946|NCT02346240|593742223|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
164373947|NCT02346240|593742224|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373948|NCT02346240|593742225|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
164373949|NCT02346240|593742226|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
164373950|NCT02346240|593742227|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
164439136|NCT05147233|593975299|FG001|Overall Study|Adverse Event|1|||
164439137|NCT05147233|593975298|FG000|Overall Study|Lost to Follow-up|1|||
164373951|NCT02346240|593742204|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373952|NCT02346240|593742205|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373953|NCT02346240|593742206|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373954|NCT02346240|593742207|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373955|NCT02346240|593742208|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373956|NCT02346240|593742209|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373957|NCT02346240|593742210|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373958|NCT02346240|593742211|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373959|NCT02346240|593742212|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373960|NCT02346240|593742213|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373961|NCT02346240|593742214|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373962|NCT02346240|593742215|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373963|NCT02346240|593742216|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373964|NCT02346240|593742217|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373965|NCT02346240|593742218|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373966|NCT02346240|593742219|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373967|NCT02346240|593742220|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373968|NCT02346240|593742221|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373969|NCT02346240|593742222|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
164373970|NCT02346240|593742223|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373971|NCT02346240|593742224|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164439138|NCT05147233|593975299|FG001|Overall Study|Lost to Follow-up|1|||
164439139|NCT05147233|593975298|FG000|Overall Study|Protocol Violation|0|||
164439140|NCT05147233|593975299|FG001|Overall Study|Protocol Violation|1|||
164439141|NCT05147233|593975298|FG000|Overall Study|Withdrawal by Subject|2|||
164439142|NCT05147233|593975299|FG001|Overall Study|Withdrawal by Subject|1|||
164439143|NCT04513522|593975300|FG000|Overall Study|Other reasons|1|||
164439144|NCT04513522|593975300|FG000|Overall Study|Adverse event unrelated to study drug|9|||
164439145|NCT04513522|593975300|FG000|Overall Study|Study drug toxicity|14|||
164439146|NCT04513522|593975300|FG000|Overall Study|Disease progression|39|||
164439147|NCT04513522|593975300|FG000|Overall Study|Participants withdrew consent|2|||
164591592|NCT01605396|594528441|FG000|Overall Study|Progressive Disease|23|||
164591593|NCT01605396|594528442|FG001|Overall Study|Progressive Disease|27|||
164591594|NCT01605396|594528441|FG000|Overall Study|Withdrawal by Subject|4|||
164591595|NCT01605396|594528442|FG001|Overall Study|Withdrawal by Subject|2|||
164591596|NCT01605396|594528441|FG000|Overall Study|Transfer Off Study|4|||
164591597|NCT01605396|594528442|FG001|Overall Study|Transfer Off Study|5|||
164591598|NCT00705224|594528446|FG000|Overall Study|Adverse Event|1|||
164591599|NCT00705224|594528446|FG000|Overall Study|Lack of Efficacy|2|||
164591600|NCT00705224|594528446|FG000|Overall Study|Withdrawal by Subject|3|||
164591601|NCT00705224|594528446|FG000|Overall Study|Lost to Follow-up|5|||
164591602|NCT03283163|594528447|FG000|Overall Study|Lost to Follow-up|1|||
164591603|NCT03283163|594528447|FG000|Overall Study|other life commitments|6|||
164439148|NCT04517864|593975301|FG000|Placebo-Controlled Phase|Adverse Event|1|||
164373972|NCT02346240|593742225|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
164373973|NCT02346240|593742226|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
164373974|NCT02346240|593742227|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
164373975|NCT02346240|593742204|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373976|NCT02346240|593742205|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373977|NCT02346240|593742206|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373978|NCT02346240|593742207|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373979|NCT02346240|593742208|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373980|NCT02346240|593742209|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373981|NCT02346240|593742210|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373982|NCT02346240|593742211|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373983|NCT02346240|593742212|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373984|NCT02346240|593742213|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373985|NCT02346240|593742214|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373986|NCT02346240|593742215|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373987|NCT02346240|593742216|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373988|NCT02346240|593742217|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373989|NCT02346240|593742218|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373990|NCT02346240|593742219|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373991|NCT02346240|593742220|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373992|NCT02346240|593742221|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373993|NCT02346240|593742222|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
164373994|NCT02346240|593742223|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373995|NCT02346240|593742224|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373996|NCT02346240|593742225|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373997|NCT02346240|593742226|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373998|NCT02346240|593742227|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373999|NCT02681302|593742228|FG000|Overall Study|Withdrawal by Subject|1|||
164374000|NCT02681302|593742229|FG001|Overall Study|Withdrawal by Subject|1|||
164374001|NCT02681302|593742230|FG002|Overall Study|Withdrawal by Subject|0|||
164374002|NCT02681302|593742231|FG003|Overall Study|Withdrawal by Subject|0|||
164374003|NCT02681302|593742232|FG004|Overall Study|Withdrawal by Subject|1|||
164374004|NCT02681302|593742233|FG005|Overall Study|Withdrawal by Subject|0|||
164374005|NCT02681302|593742228|FG000|Overall Study|Screen Failure|2|||
164374006|NCT02681302|593742229|FG001|Overall Study|Screen Failure|4|||
164374007|NCT02681302|593742230|FG002|Overall Study|Screen Failure|2|||
164374008|NCT02681302|593742231|FG003|Overall Study|Screen Failure|0|||
164374009|NCT02681302|593742232|FG004|Overall Study|Screen Failure|1|||
164374010|NCT02681302|593742233|FG005|Overall Study|Screen Failure|1|||
164374011|NCT02681302|593742228|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
164374012|NCT02681302|593742229|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
164374013|NCT02681302|593742230|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
164374014|NCT02681302|593742231|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
164374015|NCT02681302|593742232|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
164374016|NCT02681302|593742233|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
164374017|NCT02942017|593742234|FG000|Overall Study|Adverse Event|0|||
164374018|NCT02942017|593742235|FG001|Overall Study|Adverse Event|1|||
164374019|NCT02942017|593742234|FG000|Overall Study|Withdrawal by Subject|0|||
164439149|NCT04517864|593975302|FG001|Placebo-Controlled Phase|Adverse Event|0|||
164439150|NCT04517864|593975303|FG002|Placebo-Controlled Phase|Adverse Event|0|||
164439151|NCT04517864|593975301|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
164374020|NCT02942017|593742235|FG001|Overall Study|Withdrawal by Subject|1|||
164374021|NCT02942017|593742234|FG000|Overall Study|Lost to Follow-up|1|||
164374022|NCT02942017|593742235|FG001|Overall Study|Lost to Follow-up|1|||
164374023|NCT02942017|593742234|FG000|Overall Study|Randomized but not dosed|1|||
164374024|NCT02942017|593742235|FG001|Overall Study|Randomized but not dosed|3|||
164374025|NCT00477672|593742236|FG000|Overall Study|Adverse Event|3|||
164374026|NCT00477672|593742237|FG001|Overall Study|Adverse Event|5|||
164374027|NCT00477672|593742238|FG002|Overall Study|Adverse Event|6|||
164374028|NCT00477672|593742236|FG000|Overall Study|Death|0|||
164439152|NCT04517864|593975302|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
164374029|NCT00477672|593742237|FG001|Overall Study|Death|1|||
164374030|NCT00477672|593742238|FG002|Overall Study|Death|0|||
164374031|NCT00477672|593742236|FG000|Overall Study|Disease progression|0|||
164374032|NCT00477672|593742237|FG001|Overall Study|Disease progression|1|||
164439153|NCT04517864|593975303|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
164439154|NCT04517864|593975301|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
164374033|NCT00477672|593742238|FG002|Overall Study|Disease progression|0|||
164374034|NCT00477672|593742236|FG000|Overall Study|Physician Decision|1|||
164374035|NCT00477672|593742237|FG001|Overall Study|Physician Decision|0|||
164374036|NCT00477672|593742238|FG002|Overall Study|Physician Decision|0|||
164374037|NCT00477672|593742236|FG000|Overall Study|Protocol noncompliance|0|||
164374038|NCT00477672|593742237|FG001|Overall Study|Protocol noncompliance|2|||
164374039|NCT00477672|593742238|FG002|Overall Study|Protocol noncompliance|0|||
164374040|NCT00477672|593742236|FG000|Overall Study|Consent withdrawn|2|||
164374041|NCT00477672|593742237|FG001|Overall Study|Consent withdrawn|5|||
164374042|NCT00477672|593742238|FG002|Overall Study|Consent withdrawn|10|||
164374043|NCT00477672|593742236|FG000|Overall Study|Discretion of Sponsor|1|||
164374044|NCT00477672|593742237|FG001|Overall Study|Discretion of Sponsor|2|||
164374045|NCT00477672|593742238|FG002|Overall Study|Discretion of Sponsor|0|||
164374046|NCT00838565|593742239|FG000|Overall Study|Withdrawal by Subject|0|||
164374047|NCT00838565|593742240|FG001|Overall Study|Withdrawal by Subject|0|||
164374048|NCT00838565|593742241|FG002|Overall Study|Withdrawal by Subject|1|||
164374049|NCT00838565|593742242|FG003|Overall Study|Withdrawal by Subject|0|||
164374050|NCT00838565|593742243|FG004|Overall Study|Withdrawal by Subject|0|||
164374051|NCT00838565|593742244|FG005|Overall Study|Withdrawal by Subject|2|||
164374052|NCT00838565|593742239|FG000|Overall Study|Other|0|||
164374053|NCT00838565|593742240|FG001|Overall Study|Other|2|||
164374054|NCT00838565|593742241|FG002|Overall Study|Other|0|||
164374055|NCT00838565|593742242|FG003|Overall Study|Other|0|||
164374056|NCT00838565|593742243|FG004|Overall Study|Other|0|||
164374057|NCT00838565|593742244|FG005|Overall Study|Other|0|||
164374058|NCT00838565|593742239|FG000|Overall Study|Randomized but not Treated|0|||
164374059|NCT00838565|593742240|FG001|Overall Study|Randomized but not Treated|1|||
164374060|NCT00838565|593742241|FG002|Overall Study|Randomized but not Treated|0|||
164374061|NCT00838565|593742242|FG003|Overall Study|Randomized but not Treated|0|||
164374062|NCT00838565|593742243|FG004|Overall Study|Randomized but not Treated|0|||
164374063|NCT00838565|593742244|FG005|Overall Study|Randomized but not Treated|0|||
164374064|NCT00458484|593742245|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
164374065|NCT00458484|593742246|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
164374066|NCT00458484|593742247|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
164374067|NCT00458484|593742248|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
164374068|NCT00458484|593742249|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
164374069|NCT00458484|593742250|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
164374070|NCT00458484|593742251|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
164374071|NCT01838642|593742252|FG000|Overall Study|Died on study|1|||
164374072|NCT02253810|593742253|FG000|Overall Study|Withdrawal by Subject|2|||
164374073|NCT02253810|593742254|FG001|Overall Study|Withdrawal by Subject|1|||
164374074|NCT02253810|593742253|FG000|Overall Study|Unknown concomitant procedure|3|||
164374075|NCT02253810|593742254|FG001|Overall Study|Unknown concomitant procedure|2|||
164374076|NCT00291668|593742256|FG000|Overall Study|Lack of Efficacy|1|||
164591604|NCT03283163|594528447|FG000|Overall Study|COVID-19 institution wide halting|1|||
164591605|NCT03283163|594528447|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
164374077|NCT00291668|593742257|FG001|Overall Study|Lack of Efficacy|0|||
164374078|NCT00291668|593742258|FG002|Overall Study|Lack of Efficacy|0|||
164374079|NCT00291668|593742256|FG000|Overall Study|SAE, non-fatal|1|||
164374080|NCT00291668|593742257|FG001|Overall Study|SAE, non-fatal|1|||
164374081|NCT00291668|593742258|FG002|Overall Study|SAE, non-fatal|1|||
164374082|NCT00291668|593742256|FG000|Overall Study|AE, non-serious non-fatal|1|||
164374083|NCT00291668|593742257|FG001|Overall Study|AE, non-serious non-fatal|0|||
164374084|NCT00291668|593742258|FG002|Overall Study|AE, non-serious non-fatal|0|||
164591606|NCT03283163|594528447|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
164374085|NCT00291668|593742256|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
164374086|NCT00291668|593742257|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
164374087|NCT00291668|593742258|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
164374088|NCT01557400|593742259|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
164374089|NCT01557400|593742259|FG000|Overall Study|Adverse Event|3|||
164374090|NCT01557400|593742259|FG000|Overall Study|Lost to Follow-up|5|||
164374091|NCT01557400|593742259|FG000|Overall Study|Withdrawal by Subject|9|||
164374092|NCT04019041|593742262|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
164374093|NCT04019041|593742263|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
164374094|NCT04019041|593742264|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
164374095|NCT04019041|593742265|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
164374096|NCT04019041|593742266|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
164439155|NCT04517864|593975302|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
164591607|NCT00237796|594528448|FG000|Overall Study|Baseline and one other ILSS required|10|||
164591608|NCT00237796|594528449|FG001|Overall Study|Baseline and one other ILSS required|5|||
164591609|NCT04238663|594528450|FG000|Overall Study|Lost to Follow-up|0|||
164591610|NCT04238663|594528451|FG001|Overall Study|Lost to Follow-up|1|||
164374097|NCT04019041|593742267|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
164374098|NCT04019041|593742262|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
164374099|NCT04019041|593742263|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
164374100|NCT04019041|593742264|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
164374101|NCT04019041|593742265|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
164374102|NCT04019041|593742266|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
164374103|NCT04019041|593742267|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
164374104|NCT04019041|593742262|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
164374105|NCT04019041|593742263|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
164374106|NCT04019041|593742264|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
164374107|NCT04019041|593742265|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
164374108|NCT04019041|593742266|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
164374109|NCT04019041|593742267|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
164374110|NCT04019041|593742262|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
164374111|NCT04019041|593742263|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
164374112|NCT04019041|593742264|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
164374113|NCT04019041|593742265|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
164374114|NCT04019041|593742266|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
164374115|NCT04019041|593742267|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
164374116|NCT04019041|593742262|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
164374117|NCT04019041|593742263|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
164374118|NCT04019041|593742264|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
164374119|NCT04019041|593742265|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
164374120|NCT04019041|593742266|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
164374121|NCT04019041|593742267|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
164374122|NCT04019041|593742262|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
164374123|NCT04019041|593742263|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
164374124|NCT04019041|593742264|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
164374125|NCT04019041|593742265|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
164374126|NCT04019041|593742266|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
164374127|NCT04019041|593742267|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
164374128|NCT04019041|593742262|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
164374129|NCT04019041|593742263|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
164374130|NCT04019041|593742264|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
164374131|NCT04019041|593742265|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
164374132|NCT04019041|593742266|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
164374133|NCT04019041|593742267|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
164374134|NCT04019041|593742262|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
164374135|NCT04019041|593742263|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
164374136|NCT04019041|593742264|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
164374137|NCT04019041|593742265|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
164374138|NCT04019041|593742266|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
164374139|NCT04019041|593742267|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
164374140|NCT04019041|593742262|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
164374141|NCT04019041|593742263|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
164374142|NCT04019041|593742264|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
164374143|NCT04019041|593742265|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
164374144|NCT04019041|593742266|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
164374145|NCT04019041|593742267|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
164374146|NCT03925727|593742268|FG000|Overall Study|Adverse Event|4|||
164374147|NCT03925727|593742269|FG001|Overall Study|Adverse Event|0|||
164374148|NCT03925727|593742270|FG002|Overall Study|Adverse Event|3|||
164374149|NCT03925727|593742268|FG000|Overall Study|Protocol Violation|1|||
164374150|NCT03925727|593742269|FG001|Overall Study|Protocol Violation|2|||
164374151|NCT03925727|593742270|FG002|Overall Study|Protocol Violation|2|||
164374152|NCT03925727|593742268|FG000|Overall Study|Withdrawal by Subject|3|||
164374153|NCT03925727|593742269|FG001|Overall Study|Withdrawal by Subject|2|||
164374154|NCT03925727|593742270|FG002|Overall Study|Withdrawal by Subject|4|||
164374155|NCT03925727|593742268|FG000|Overall Study|Administrative Reasons|3|||
164700464|NCT01421342|594926837|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
164700465|NCT01421342|594926835|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
164700466|NCT01421342|594926836|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
164700467|NCT01421342|594926837|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
164700468|NCT01421342|594926835|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
164374156|NCT03925727|593742269|FG001|Overall Study|Administrative Reasons|1|||
164374157|NCT03925727|593742270|FG002|Overall Study|Administrative Reasons|2|||
164374158|NCT03925727|593742268|FG000|Overall Study|Randomized in error or Disqualified|8|||
164439156|NCT04517864|593975303|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
164374159|NCT03925727|593742269|FG001|Overall Study|Randomized in error or Disqualified|1|||
164374160|NCT03925727|593742270|FG002|Overall Study|Randomized in error or Disqualified|7|||
164374161|NCT00213148|593742271|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
164374162|NCT00213148|593742272|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
164374163|NCT00213148|593742273|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
164374164|NCT00213148|593742274|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
164374165|NCT00213148|593742275|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
164374166|NCT00213148|593742271|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
164374167|NCT00213148|593742272|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
164374168|NCT00213148|593742273|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
164374169|NCT00213148|593742274|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
164374170|NCT00213148|593742275|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
164374171|NCT00213148|593742271|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
164374172|NCT00213148|593742272|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
164374173|NCT00213148|593742273|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
164374174|NCT00213148|593742274|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
164374175|NCT00213148|593742275|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
164374176|NCT00213148|593742271|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
164374177|NCT00213148|593742272|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
164374178|NCT00213148|593742273|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
164374179|NCT00213148|593742274|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
164374180|NCT00213148|593742275|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
164374181|NCT00213148|593742271|FG000|Cycle 1 (1 Month)|Other|3|||
164374182|NCT00213148|593742272|FG001|Cycle 1 (1 Month)|Other|0|||
164374183|NCT00213148|593742273|FG002|Cycle 1 (1 Month)|Other|2|||
164374184|NCT00213148|593742274|FG003|Cycle 1 (1 Month)|Other|2|||
164374185|NCT00213148|593742275|FG004|Cycle 1 (1 Month)|Other|7|||
164374186|NCT00213148|593742271|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
164374187|NCT00213148|593742272|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
164374188|NCT00213148|593742273|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
164374189|NCT00213148|593742274|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
164374190|NCT00213148|593742275|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
164374191|NCT00213148|593742271|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
164374192|NCT00213148|593742272|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
164374193|NCT00213148|593742273|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
164374194|NCT00213148|593742274|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
164374195|NCT00213148|593742275|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
164439157|NCT04517864|593975301|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
164439158|NCT04517864|593975302|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
164374196|NCT00213148|593742271|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
164374197|NCT00213148|593742272|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
164374198|NCT00213148|593742273|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
164374199|NCT00213148|593742274|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
164374200|NCT00213148|593742275|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
164374201|NCT00213148|593742271|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
164374202|NCT00213148|593742272|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
164439159|NCT04517864|593975303|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
164439160|NCT04517864|593975301|FG000|Active Therapy Extension Phase|Adverse Event|1|||
164439161|NCT04517864|593975302|FG001|Active Therapy Extension Phase|Adverse Event|0|||
164439162|NCT04517864|593975303|FG002|Active Therapy Extension Phase|Adverse Event|0|||
164439163|NCT04517864|593975301|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
164374203|NCT00213148|593742273|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
164374204|NCT00213148|593742274|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
164374205|NCT00213148|593742275|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
164439164|NCT04517864|593975302|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
164439165|NCT04517864|593975303|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
164374206|NCT00213148|593742271|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
164374207|NCT00213148|593742272|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
164374208|NCT00213148|593742273|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
164374209|NCT00213148|593742274|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
164374210|NCT00213148|593742275|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
164439166|NCT04517864|593975301|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
164439167|NCT04517864|593975302|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
164439168|NCT04517864|593975303|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
164439169|NCT04517864|593975301|FG000|Active Therapy Extension Phase|Physician Decision|1|||
164374211|NCT00213148|593742271|FG000|Cycle 2 (1 Month)|Other|2|||
164374212|NCT00213148|593742272|FG001|Cycle 2 (1 Month)|Other|1|||
164374213|NCT00213148|593742273|FG002|Cycle 2 (1 Month)|Other|2|||
164374214|NCT00213148|593742274|FG003|Cycle 2 (1 Month)|Other|8|||
164374215|NCT00213148|593742275|FG004|Cycle 2 (1 Month)|Other|7|||
164374216|NCT00213148|593742271|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
164374217|NCT00213148|593742272|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
164374218|NCT00213148|593742273|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
164374219|NCT00213148|593742274|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
164374220|NCT00213148|593742275|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
164374221|NCT00213148|593742271|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
164374222|NCT00213148|593742272|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
164374223|NCT00213148|593742273|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
164374224|NCT00213148|593742274|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
164374225|NCT00213148|593742275|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
164374226|NCT00213148|593742271|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
164374227|NCT00213148|593742272|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
164374228|NCT00213148|593742273|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
164374229|NCT00213148|593742274|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
164374230|NCT00213148|593742275|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
164374231|NCT00213148|593742271|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
164374232|NCT00213148|593742272|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
164374233|NCT00213148|593742273|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
164374234|NCT00213148|593742274|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
164374235|NCT00213148|593742275|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
164374236|NCT00213148|593742271|FG000|Cycle 3 (1 Month)|Other|0|||
164374237|NCT00213148|593742272|FG001|Cycle 3 (1 Month)|Other|0|||
164374238|NCT00213148|593742273|FG002|Cycle 3 (1 Month)|Other|1|||
164374239|NCT00213148|593742274|FG003|Cycle 3 (1 Month)|Other|1|||
164374240|NCT00213148|593742275|FG004|Cycle 3 (1 Month)|Other|0|||
164374241|NCT02321462|593742278|FG000|Overall Study|Withdrawal by Subject|5|||
164374242|NCT02321462|593742279|FG001|Overall Study|Withdrawal by Subject|2|||
164374243|NCT02321462|593742278|FG000|Overall Study|Subject withdrawn before any treatment|1|||
164374244|NCT02321462|593742279|FG001|Overall Study|Subject withdrawn before any treatment|1|||
164700469|NCT01421342|594926836|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
164700470|NCT01421342|594926837|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
164700471|NCT01421342|594926835|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
164374245|NCT03044197|593742283|FG000|Overall Study|Withdrawal by Subject|3|||
164374246|NCT03044197|593742284|FG001|Overall Study|Withdrawal by Subject|1|||
164374247|NCT01574352|593742286|FG000|Overall Study|Withdrawal by Subject|6|||
164374248|NCT01574352|593742287|FG001|Overall Study|Withdrawal by Subject|13|||
164374249|NCT01574352|593742286|FG000|Overall Study|Injury in non-camp related sport|1|||
164374250|NCT01574352|593742287|FG001|Overall Study|Injury in non-camp related sport|0|||
164374251|NCT00245765|593742288|FG000|Overall Study|Adverse Event|1|||
164374252|NCT00245765|593742289|FG001|Overall Study|Adverse Event|1|||
164374253|NCT00245765|593742290|FG002|Overall Study|Adverse Event|0|||
164374254|NCT00245765|593742288|FG000|Overall Study|Lack of Efficacy|14|||
164374255|NCT00245765|593742289|FG001|Overall Study|Lack of Efficacy|7|||
164374256|NCT00245765|593742290|FG002|Overall Study|Lack of Efficacy|0|||
164374257|NCT00245765|593742288|FG000|Overall Study|Lost to Follow-up|1|||
164374258|NCT00245765|593742289|FG001|Overall Study|Lost to Follow-up|2|||
164374259|NCT00245765|593742290|FG002|Overall Study|Lost to Follow-up|0|||
164374260|NCT00245765|593742288|FG000|Overall Study|Withdrawal by Subject|1|||
164374261|NCT00245765|593742289|FG001|Overall Study|Withdrawal by Subject|0|||
164374262|NCT00245765|593742290|FG002|Overall Study|Withdrawal by Subject|3|||
164374263|NCT00245765|593742288|FG000|Overall Study|Other reason|2|||
164374264|NCT00245765|593742289|FG001|Overall Study|Other reason|0|||
164374265|NCT00245765|593742290|FG002|Overall Study|Other reason|1|||
164439170|NCT04517864|593975302|FG001|Active Therapy Extension Phase|Physician Decision|0|||
164439171|NCT04517864|593975303|FG002|Active Therapy Extension Phase|Physician Decision|0|||
164439172|NCT04517864|593975301|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
164439173|NCT04517864|593975302|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
164374266|NCT00245765|593742288|FG000|Overall Study|Other|13|||
164374267|NCT00245765|593742289|FG001|Overall Study|Other|4|||
164374268|NCT00245765|593742290|FG002|Overall Study|Other|4|||
164374269|NCT00660348|593742291|FG000|Overall Study|Withdrawal by Subject|1|||
164374270|NCT00660348|593742292|FG001|Overall Study|Withdrawal by Subject|0|||
164374271|NCT02741115|593742293|FG000|Overall Study|Adverse Event|1|||
164374272|NCT02741115|593742294|FG001|Overall Study|Adverse Event|0|||
164374273|NCT02741115|593742293|FG000|Overall Study|Lost to Follow-up|7|||
164374274|NCT02741115|593742294|FG001|Overall Study|Lost to Follow-up|4|||
164374275|NCT02741115|593742293|FG000|Overall Study|Withdrawal by Subject|4|||
164374276|NCT02741115|593742294|FG001|Overall Study|Withdrawal by Subject|2|||
164374277|NCT06425458|593742295|FG000|Overall Study|Removed by study team|2|||
164374278|NCT06425458|593742295|FG000|Overall Study|Lost to Follow-up|5|||
164374279|NCT03945981|593742298|FG000|Overall Study|Lost to Follow-up|12|||
164439174|NCT04517864|593975303|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
164374280|NCT03945981|593742298|FG000|Overall Study|Physician Decision|4|||
164439175|NCT04517864|593975301|FG000|Extension Phase|Adverse Event|0|||
164700472|NCT01421342|594926836|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
164374281|NCT03945981|593742298|FG000|Overall Study|Withdrawal by Subject|6|||
164374282|NCT03945981|593742298|FG000|Overall Study|Protocol Violation|1|||
164374283|NCT00256698|593742301|FG000|Overall Study|Withdrawal by Subject|7|||
164374284|NCT00256698|593742302|FG001|Overall Study|Withdrawal by Subject|7|||
164374285|NCT00256698|593742301|FG000|Overall Study|Adverse Event|13|||
164374286|NCT00256698|593742302|FG001|Overall Study|Adverse Event|6|||
164374287|NCT00256698|593742301|FG000|Overall Study|Protocol Violation|6|||
164374288|NCT00256698|593742302|FG001|Overall Study|Protocol Violation|5|||
164374289|NCT00256698|593742301|FG000|Overall Study|Lost to Follow-up|1|||
164374290|NCT00256698|593742302|FG001|Overall Study|Lost to Follow-up|3|||
164374291|NCT00256698|593742301|FG000|Overall Study|disease progression|97|||
164374292|NCT00256698|593742302|FG001|Overall Study|disease progression|105|||
164374293|NCT00256698|593742301|FG000|Overall Study|still ongoing at data cut-off|41|||
164374294|NCT00256698|593742302|FG001|Overall Study|still ongoing at data cut-off|46|||
164374295|NCT00256698|593742301|FG000|Overall Study|withdrawn due to osteoporosis|1|||
164374296|NCT00256698|593742302|FG001|Overall Study|withdrawn due to osteoporosis|0|||
164374297|NCT00256698|593742301|FG000|Overall Study|Prematurely Discontinued|1|||
164374298|NCT00256698|593742302|FG001|Overall Study|Prematurely Discontinued|0|||
164374299|NCT03548584|593743528|FG000|Overall Study|Lost to Follow-up|0|||
164374300|NCT03548584|593743529|FG001|Overall Study|Lost to Follow-up|0|||
164374301|NCT03548584|593743530|FG002|Overall Study|Lost to Follow-up|1|||
164374302|NCT03548584|593743528|FG000|Overall Study|Adverse Event|1|||
164374303|NCT03548584|593743529|FG001|Overall Study|Adverse Event|11|||
164374304|NCT03548584|593743530|FG002|Overall Study|Adverse Event|5|||
164374305|NCT03548584|593743528|FG000|Overall Study|Site Terminated by Sponsor|1|||
164374306|NCT03548584|593743529|FG001|Overall Study|Site Terminated by Sponsor|3|||
164374307|NCT03548584|593743530|FG002|Overall Study|Site Terminated by Sponsor|2|||
164374308|NCT03548584|593743528|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
164374309|NCT03548584|593743529|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
164374310|NCT03548584|593743530|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
164374311|NCT03548584|593743528|FG000|Overall Study|Lack of Efficacy|0|||
164374312|NCT03548584|593743529|FG001|Overall Study|Lack of Efficacy|1|||
164374313|NCT03548584|593743530|FG002|Overall Study|Lack of Efficacy|0|||
164374314|NCT03548584|593743528|FG000|Overall Study|Non-compliance with Study Drug|0|||
164374315|NCT03548584|593743529|FG001|Overall Study|Non-compliance with Study Drug|1|||
164374316|NCT03548584|593743530|FG002|Overall Study|Non-compliance with Study Drug|0|||
164374317|NCT03548584|593743528|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
164374318|NCT03548584|593743529|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
164374319|NCT03548584|593743530|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
164374320|NCT04346615|593743531|FG000|Overall Study|Lost to Follow-up|0|||
164374321|NCT04346615|593743532|FG001|Overall Study|Lost to Follow-up|2|||
164374322|NCT04346615|593743531|FG000|Overall Study|Withdrawal by Subject|1|||
164374323|NCT04346615|593743532|FG001|Overall Study|Withdrawal by Subject|0|||
164374324|NCT04346615|593743531|FG000|Overall Study|Death|5|||
164374325|NCT04346615|593743532|FG001|Overall Study|Death|1|||
164374326|NCT04346615|593743531|FG000|Overall Study|Other|0|||
164374327|NCT04346615|593743532|FG001|Overall Study|Other|2|||
164374328|NCT04346615|593743531|FG000|Overall Study|Randomized not treated|1|||
164374329|NCT04346615|593743532|FG001|Overall Study|Randomized not treated|0|||
164374330|NCT02096835|593743537|FG000|Overall Study|Withdrawal by Subject|1|||
164374331|NCT02096835|593743538|FG001|Overall Study|Withdrawal by Subject|0|||
164374332|NCT02096835|593743539|FG002|Overall Study|Withdrawal by Subject|0|||
164374333|NCT02096835|593743537|FG000|Overall Study|converted to open procedures|1|||
164374334|NCT02096835|593743538|FG001|Overall Study|converted to open procedures|0|||
164374335|NCT02096835|593743539|FG002|Overall Study|converted to open procedures|0|||
164439176|NCT04517864|593975302|FG001|Extension Phase|Adverse Event|0|||
164439177|NCT04517864|593975303|FG002|Extension Phase|Adverse Event|1|||
164439178|NCT04517864|593975301|FG000|Extension Phase|Lack of Efficacy|0|||
164439179|NCT04517864|593975302|FG001|Extension Phase|Lack of Efficacy|0|||
164439180|NCT04517864|593975303|FG002|Extension Phase|Lack of Efficacy|2|||
164439181|NCT04517864|593975301|FG000|Extension Phase|Study Terminated By Sponsor|0|||
164374336|NCT02096835|593743537|FG000|Overall Study|Lost to Follow-up|1|||
164374337|NCT02096835|593743538|FG001|Overall Study|Lost to Follow-up|0|||
164374338|NCT02096835|593743539|FG002|Overall Study|Lost to Follow-up|1|||
164374339|NCT01677195|593743540|FG000|Overall Study|Lost to Follow-up|14|||
164374340|NCT01677195|593743541|FG001|Overall Study|Lost to Follow-up|22|||
164374341|NCT01677195|593743542|FG002|Overall Study|Lost to Follow-up|22|||
164374342|NCT01677195|593743540|FG000|Overall Study|Withdrawal by Subject|1|||
164374343|NCT01677195|593743541|FG001|Overall Study|Withdrawal by Subject|0|||
164374344|NCT01677195|593743542|FG002|Overall Study|Withdrawal by Subject|1|||
164374345|NCT01677195|593743540|FG000|Overall Study|Adverse Event|6|||
164374346|NCT01677195|593743541|FG001|Overall Study|Adverse Event|4|||
164374347|NCT01677195|593743542|FG002|Overall Study|Adverse Event|1|||
164374348|NCT01677195|593743540|FG000|Overall Study|Physician Decision|1|||
164374349|NCT01677195|593743541|FG001|Overall Study|Physician Decision|2|||
164374350|NCT01677195|593743542|FG002|Overall Study|Physician Decision|2|||
164374351|NCT01677195|593743540|FG000|Overall Study|Pregnancy|0|||
164374352|NCT01677195|593743541|FG001|Overall Study|Pregnancy|1|||
164374353|NCT01677195|593743542|FG002|Overall Study|Pregnancy|0|||
164374354|NCT01677195|593743540|FG000|Overall Study|Protocol Violation|7|||
164374355|NCT01677195|593743541|FG001|Overall Study|Protocol Violation|3|||
164374356|NCT01677195|593743542|FG002|Overall Study|Protocol Violation|4|||
164374357|NCT04368429|593743543|FG000|Overall Study|Adverse Event|1|||
164374358|NCT04368429|593743544|FG001|Overall Study|Adverse Event|0|||
164374359|NCT03633396|593743547|FG000|Overall Study|Withdrawal by Subject|4|||
164374360|NCT03633396|593743548|FG001|Overall Study|Withdrawal by Subject|4|||
164374361|NCT03633396|593743547|FG000|Overall Study|Adverse Event|1|||
164374362|NCT03633396|593743548|FG001|Overall Study|Adverse Event|1|||
164374363|NCT03633396|593743547|FG000|Overall Study|Lack of Efficacy|1|||
164374364|NCT03633396|593743548|FG001|Overall Study|Lack of Efficacy|0|||
164374365|NCT03633396|593743547|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
164374366|NCT03633396|593743548|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
164374367|NCT00023673|593743549|FG000|Overall Study|Ineligible / no protocol treatment|0|||
164374368|NCT00023673|593743550|FG001|Overall Study|Ineligible / no protocol treatment|0|||
164374369|NCT00023673|593743551|FG002|Overall Study|Ineligible / no protocol treatment|0|||
164374370|NCT00023673|593743552|FG003|Overall Study|Ineligible / no protocol treatment|1|||
164374371|NCT00023673|593743549|FG000|Overall Study|Patient withdrew consent|0|||
164374372|NCT00023673|593743550|FG001|Overall Study|Patient withdrew consent|0|||
164374373|NCT00023673|593743551|FG002|Overall Study|Patient withdrew consent|0|||
164374374|NCT00023673|593743552|FG003|Overall Study|Patient withdrew consent|1|||
164374375|NCT00110266|593743553|FG000|Overall Study|Adverse Event|27|||
164374376|NCT00110266|593743553|FG000|Overall Study|Abnormal laboratory value|15|||
164374377|NCT00110266|593743553|FG000|Overall Study|Withdrawal by Subject|16|||
164374378|NCT00110266|593743553|FG000|Overall Study|Death|17|||
164374379|NCT00110266|593743553|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164374380|NCT00110266|593743553|FG000|Overall Study|Participant condition no longer requires study drug|1|||
164374381|NCT00667342|593743558|FG000|Overall Study|Protocol Violation|1|||
164374382|NCT00667342|593743559|FG001|Overall Study|Protocol Violation|0|||
164374383|NCT00667342|593743560|FG002|Overall Study|Protocol Violation|0|||
164374384|NCT00667342|593743558|FG000|Overall Study|Withdrawal by Subject|1|||
164374385|NCT00667342|593743559|FG001|Overall Study|Withdrawal by Subject|0|||
164374386|NCT00667342|593743560|FG002|Overall Study|Withdrawal by Subject|0|||
164374387|NCT00667342|593743558|FG000|Overall Study|Physician Decision|3|||
164374388|NCT00667342|593743559|FG001|Overall Study|Physician Decision|0|||
164374389|NCT00667342|593743560|FG002|Overall Study|Physician Decision|0|||
164374390|NCT00667342|593743558|FG000|Overall Study|Relapse or tumor progression|9|||
164374391|NCT00667342|593743559|FG001|Overall Study|Relapse or tumor progression|0|||
164374392|NCT00667342|593743560|FG002|Overall Study|Relapse or tumor progression|7|||
164374393|NCT00667342|593743558|FG000|Overall Study|Adverse Event|0|||
164374394|NCT00667342|593743559|FG001|Overall Study|Adverse Event|0|||
164374395|NCT00667342|593743560|FG002|Overall Study|Adverse Event|1|||
164374396|NCT00667342|593743558|FG000|Overall Study|Ineligible|0|||
164374397|NCT00667342|593743559|FG001|Overall Study|Ineligible|0|||
164374398|NCT00667342|593743560|FG002|Overall Study|Ineligible|1|||
164374399|NCT01433263|593743561|FG000|Overall Study|Adverse Event|3|||
164374400|NCT01433263|593743562|FG001|Overall Study|Adverse Event|1|||
164374401|NCT01433263|593743561|FG000|Overall Study|Death|5|||
164374402|NCT01433263|593743562|FG001|Overall Study|Death|3|||
164374403|NCT01433263|593743561|FG000|Overall Study|Lost to Follow-up|0|||
164374404|NCT01433263|593743562|FG001|Overall Study|Lost to Follow-up|1|||
164374405|NCT01433263|593743561|FG000|Overall Study|Protocol Deviation|1|||
164439182|NCT04517864|593975302|FG001|Extension Phase|Study Terminated By Sponsor|0|||
164374406|NCT01433263|593743562|FG001|Overall Study|Protocol Deviation|0|||
164374407|NCT01433263|593743561|FG000|Overall Study|Withdrawal by Subject|10|||
164374408|NCT01433263|593743562|FG001|Overall Study|Withdrawal by Subject|7|||
164374409|NCT00293384|593743563|FG000|Overall Study|Non-compliance|2|||
164374410|NCT00293384|593743563|FG000|Overall Study|Missed dosage/study drug|1|||
164439183|NCT04517864|593975303|FG002|Extension Phase|Study Terminated By Sponsor|32|||
164374411|NCT00293384|593743563|FG000|Overall Study|Ineligible|2|||
164374412|NCT04709237|593743565|FG000|Overall Study|Lost to Follow-up|1|||
164439184|NCT04517864|593975301|FG000|Extension Phase|Withdrawal by Subject|0|||
164374413|NCT04709237|593743566|FG001|Overall Study|Lost to Follow-up|0|||
164374414|NCT04709237|593743567|FG002|Overall Study|Lost to Follow-up|0|||
164374415|NCT02610192|593743568|FG000|Overall Study|Received other treatment|8|||
164374416|NCT02610192|593743568|FG000|Overall Study|Physician Decision|1|||
164374417|NCT00326612|593743576|FG000|Overall Study|They did not have a seizure requiring tx|129|||
164374418|NCT00326612|593743577|FG001|Overall Study|They did not have a seizure requiring tx|137|||
164439185|NCT04517864|593975302|FG001|Extension Phase|Withdrawal by Subject|0|||
164439186|NCT04517864|593975303|FG002|Extension Phase|Withdrawal by Subject|3|||
164374419|NCT00419562|593743578|FG000|Overall Study|Lost to Follow-up|12|||
164374420|NCT00419562|593743579|FG001|Overall Study|Lost to Follow-up|13|||
164374421|NCT00419562|593743578|FG000|Overall Study|Withdrawal by Subject|20|||
164374422|NCT00419562|593743579|FG001|Overall Study|Withdrawal by Subject|18|||
164374423|NCT00419562|593743578|FG000|Overall Study|Participant Institutionalized|1|||
164374424|NCT00419562|593743579|FG001|Overall Study|Participant Institutionalized|0|||
164374425|NCT00640510|593743580|FG000|Overall Study|Lack of Efficacy|0|||
164374426|NCT00640510|593743581|FG001|Overall Study|Lack of Efficacy|1|||
164374427|NCT00640510|593743580|FG000|Overall Study|Protocol Violation|1|||
164374428|NCT00640510|593743581|FG001|Overall Study|Protocol Violation|0|||
164374429|NCT00640510|593743580|FG000|Overall Study|Physician Decision|0|||
164374430|NCT00640510|593743581|FG001|Overall Study|Physician Decision|1|||
164374431|NCT00355238|593743582|FG000|Overall Study|Adverse event unrelated to study drug|2|||
164374432|NCT00355238|593743583|FG001|Overall Study|Adverse event unrelated to study drug|2|||
164374433|NCT00355238|593743584|FG002|Overall Study|Adverse event unrelated to study drug|0|||
164374434|NCT00355238|593743585|FG003|Overall Study|Adverse event unrelated to study drug|1|||
164374435|NCT00355238|593743582|FG000|Overall Study|Death|1|||
164374436|NCT00355238|593743583|FG001|Overall Study|Death|0|||
164374437|NCT00355238|593743584|FG002|Overall Study|Death|0|||
164374438|NCT00355238|593743585|FG003|Overall Study|Death|0|||
164374439|NCT00355238|593743582|FG000|Overall Study|Disease progression|37|||
164374440|NCT00355238|593743583|FG001|Overall Study|Disease progression|36|||
164374441|NCT00355238|593743584|FG002|Overall Study|Disease progression|16|||
164374442|NCT00355238|593743585|FG003|Overall Study|Disease progression|11|||
164374443|NCT00355238|593743582|FG000|Overall Study|Study drug toxicity|11|||
164374444|NCT00355238|593743583|FG001|Overall Study|Study drug toxicity|7|||
164374445|NCT00355238|593743584|FG002|Overall Study|Study drug toxicity|5|||
164374446|NCT00355238|593743585|FG003|Overall Study|Study drug toxicity|2|||
164374447|NCT00355238|593743582|FG000|Overall Study|Participant withdrew consent|3|||
164374448|NCT00355238|593743583|FG001|Overall Study|Participant withdrew consent|1|||
164374449|NCT00355238|593743584|FG002|Overall Study|Participant withdrew consent|0|||
164374450|NCT00355238|593743585|FG003|Overall Study|Participant withdrew consent|0|||
164374451|NCT00355238|593743582|FG000|Overall Study|Participant request to discontinue study treatment|1|||
164374452|NCT00355238|593743583|FG001|Overall Study|Participant request to discontinue study treatment|0|||
164374453|NCT00355238|593743584|FG002|Overall Study|Participant request to discontinue study treatment|1|||
164374454|NCT00355238|593743585|FG003|Overall Study|Participant request to discontinue study treatment|0|||
164374455|NCT00480636|593743586|FG000|Overall Study|Death|12|||
164374456|NCT00480636|593743586|FG000|Overall Study|Lost to Follow-up|4|||
164374457|NCT00480636|593743586|FG000|Overall Study|Other|2|||
164374458|NCT00480636|593743586|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
164374459|NCT02506816|593743587|FG000|Overall Study|Adverse Event|3|||
164374460|NCT00546715|593743590|FG000|Overall Study|Withdrawal by Subject|0|||
164374461|NCT00546715|593743591|FG001|Overall Study|Withdrawal by Subject|1|||
164374462|NCT00546715|593743592|FG002|Overall Study|Withdrawal by Subject|0|||
164374463|NCT00546715|593743593|FG003|Overall Study|Withdrawal by Subject|0|||
164374464|NCT02477020|593743596|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
164374465|NCT02477020|593743597|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
164374466|NCT02477020|593743596|FG000|Overall Study|Voluntary Withdrawal|7|||
164374467|NCT02477020|593743597|FG001|Overall Study|Voluntary Withdrawal|16|||
164374468|NCT02477020|593743596|FG000|Overall Study|Reason not Specified|3|||
164374469|NCT02477020|593743597|FG001|Overall Study|Reason not Specified|1|||
164374470|NCT02477020|593743596|FG000|Overall Study|Lack of Efficacy|14|||
164374471|NCT02477020|593743597|FG001|Overall Study|Lack of Efficacy|5|||
164374472|NCT03852316|593743598|FG000|Overall Study|Protocol Violation|1|||
164374473|NCT03852316|593743598|FG000|Overall Study|Withdrawal by Subject|2|||
164374474|NCT03852316|593743598|FG000|Overall Study|Enrolled but Device not Utilized|1|||
164374475|NCT01049919|593743599|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
164374476|NCT01049919|593743600|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
164374477|NCT01049919|593743599|FG000|Overall Study|Withdrawal by Subject|5|||
164374478|NCT01049919|593743600|FG001|Overall Study|Withdrawal by Subject|0|||
164374479|NCT01049919|593743599|FG000|Overall Study|Lost to Follow-up|6|||
164374480|NCT01049919|593743600|FG001|Overall Study|Lost to Follow-up|1|||
164374481|NCT01049919|593743599|FG000|Overall Study|Physician Decision|2|||
164374482|NCT01049919|593743600|FG001|Overall Study|Physician Decision|0|||
164374483|NCT01049919|593743599|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
164374484|NCT01049919|593743600|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
164374485|NCT01049919|593743599|FG000|Overall Study|Early study termination by sponsor.|2|||
164374486|NCT01049919|593743600|FG001|Overall Study|Early study termination by sponsor.|0|||
164374487|NCT04354831|593743601|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
164374488|NCT04354831|593743602|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
164374489|NCT01018264|593743603|FG000|Overall Study|Withdrawal by Subject|1|||
164700473|NCT01421342|594926837|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
164700474|NCT01421342|594926835|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
164700475|NCT01421342|594926836|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
164700476|NCT01421342|594926837|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
164700477|NCT01421342|594926835|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
164374490|NCT01018264|593743604|FG001|Overall Study|Withdrawal by Subject|0|||
164374491|NCT01018264|593743603|FG000|Overall Study|Lost to Follow-up|0|||
164374492|NCT01018264|593743604|FG001|Overall Study|Lost to Follow-up|1|||
164374493|NCT02504372|593743605|FG000|Overall Study|Death|136|||
164374494|NCT02504372|593743606|FG001|Overall Study|Death|154|||
164374495|NCT02504372|593743605|FG000|Overall Study|Lost to Follow-up|0|||
164374496|NCT02504372|593743606|FG001|Overall Study|Lost to Follow-up|2|||
164374497|NCT02504372|593743605|FG000|Overall Study|Withdrawal of consent|25|||
164374498|NCT02504372|593743606|FG001|Overall Study|Withdrawal of consent|16|||
164374499|NCT02504372|593743605|FG000|Overall Study|Participants ongoing|429|||
164374500|NCT02504372|593743606|FG001|Overall Study|Participants ongoing|415|||
164374501|NCT03491150|593743608|FG000|Overall Study|Adverse Event|1|||
164374502|NCT03491150|593743609|FG001|Overall Study|Adverse Event|0|||
164374503|NCT03491150|593743608|FG000|Overall Study|Study Terminated by Sponsor|74|||
164374504|NCT03491150|593743609|FG001|Overall Study|Study Terminated by Sponsor|70|||
164374505|NCT03491150|593743608|FG000|Overall Study|Other|0|||
164374506|NCT03491150|593743609|FG001|Overall Study|Other|1|||
164374507|NCT03491150|593743608|FG000|Overall Study|Withdrawal by Subject|1|||
164374508|NCT03491150|593743609|FG001|Overall Study|Withdrawal by Subject|2|||
164374509|NCT05179421|593743612|FG000|First Infusion Day|Adverse Event|1|||
164374510|NCT05179421|593743613|FG001|First Infusion Day|Adverse Event|0|||
164374511|NCT00813124|593743615|FG000|Overall Study|Death|2|||
164374512|NCT00813124|593743615|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
164374513|NCT00813124|593743615|FG000|Overall Study|Withdrawal by Subject|1|||
164374514|NCT03746522|593743616|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
164374515|NCT03746522|593743617|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
164374516|NCT03746522|593743618|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
164374517|NCT03746522|593743616|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
164374518|NCT03746522|593743617|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
164374519|NCT03746522|593743618|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
164374520|NCT03746522|593743616|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
164374521|NCT03746522|593743617|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
164374522|NCT03746522|593743618|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
164374523|NCT03746522|593743616|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
164374524|NCT03746522|593743617|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
164374525|NCT03746522|593743618|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
164374526|NCT03746522|593743616|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
164374527|NCT03746522|593743617|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
164374528|NCT03746522|593743618|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
164374529|NCT03323099|593743619|FG000|Overall Study|Withdrawal by Subject|6|||
164374530|NCT03323099|593743620|FG001|Overall Study|Withdrawal by Subject|12|||
164374531|NCT03323099|593743619|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
164374532|NCT03323099|593743620|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
164374533|NCT00767676|593743621|FG000|Overall Study|Investigator error|54|||
164374534|NCT02052739|593743623|FG000|Overall Study|Withdrew due to Adverse Event|3|||
164374535|NCT02052739|593743624|FG001|Overall Study|Withdrew due to Adverse Event|0|||
164374536|NCT02052739|593743623|FG000|Overall Study|Participant Died|2|||
164374537|NCT02052739|593743624|FG001|Overall Study|Participant Died|1|||
164374538|NCT04907032|593743625|FG000|Overall Study|Withdrawal by Subject|7|||
164374539|NCT04907032|593743626|FG001|Overall Study|Withdrawal by Subject|1|||
164374540|NCT03962543|593743643|FG000|Treatment Phase|Death|0|||
164374541|NCT03962543|593743644|FG001|Treatment Phase|Death|1|||
164374542|NCT03962543|593743643|FG000|Treatment Phase|Withdrawal by Subject|3|||
164374543|NCT03962543|593743644|FG001|Treatment Phase|Withdrawal by Subject|0|||
164374544|NCT03962543|593743643|FG000|Treatment Phase|Adverse Event|3|||
164374545|NCT03962543|593743644|FG001|Treatment Phase|Adverse Event|12|||
164374546|NCT03962543|593743643|FG000|Treatment Phase|Lost to Follow-up|1|||
164374547|NCT03962543|593743644|FG001|Treatment Phase|Lost to Follow-up|2|||
164374548|NCT03962543|593743643|FG000|Treatment Phase|Radiographic PD|9|||
164374549|NCT03962543|593743644|FG001|Treatment Phase|Radiographic PD|3|||
164374550|NCT03962543|593743643|FG000|Treatment Phase|Participant Decision|3|||
164374551|NCT03962543|593743644|FG001|Treatment Phase|Participant Decision|8|||
164374552|NCT03962543|593743643|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
164374553|NCT03962543|593743644|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
164374554|NCT03962543|593743643|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
164374555|NCT03962543|593743644|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
164374556|NCT03962543|593743643|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
164374557|NCT03962543|593743644|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
164374558|NCT03962543|593743643|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
164374559|NCT03962543|593743644|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
164374560|NCT03962543|593743643|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
164374561|NCT03962543|593743644|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
164374562|NCT03962543|593743643|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
164374563|NCT03962543|593743644|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
164374564|NCT03962543|593743643|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
164374565|NCT03962543|593743644|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
164591611|NCT04238663|594528452|FG002|Overall Study|Lost to Follow-up|0|||
164591612|NCT02566525|594528453|FG000|Overall Study|Protocol Violation|3|||
164374566|NCT03962543|593743643|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
164374567|NCT03962543|593743644|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
164374568|NCT03962543|593743643|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
164374569|NCT03962543|593743644|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
164374570|NCT03962543|593743643|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
164374571|NCT03962543|593743644|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
164374572|NCT02777125|593743645|FG000|Overall Study|Consent form violation|14|||
164374573|NCT02777125|593743646|FG001|Overall Study|Consent form violation|12|||
164374574|NCT02777125|593743645|FG000|Overall Study|Assent form violation|21|||
164374575|NCT02777125|593743646|FG001|Overall Study|Assent form violation|23|||
164374576|NCT02777125|593743645|FG000|Overall Study|Protocol Violation|8|||
164374577|NCT02777125|593743646|FG001|Overall Study|Protocol Violation|12|||
164374578|NCT02917031|593743647|FG000|Overall Study|Reason not specified|7|||
164374579|NCT02917031|593743648|FG001|Overall Study|Reason not specified|5|||
164374580|NCT02917031|593743649|FG002|Overall Study|Reason not specified|6|||
164374581|NCT02917031|593743647|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
164374582|NCT02917031|593743648|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
164374583|NCT02917031|593743649|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
164374584|NCT02917031|593743647|FG000|Overall Study|Withdrawal by Subject|3|||
164374585|NCT02917031|593743648|FG001|Overall Study|Withdrawal by Subject|3|||
164374586|NCT02917031|593743649|FG002|Overall Study|Withdrawal by Subject|0|||
164374587|NCT02917031|593743647|FG000|Overall Study|Physician Decision|1|||
164374588|NCT02917031|593743648|FG001|Overall Study|Physician Decision|0|||
164374589|NCT02917031|593743649|FG002|Overall Study|Physician Decision|0|||
164374590|NCT02917031|593743647|FG000|Overall Study|Adverse Event|4|||
164374591|NCT02917031|593743648|FG001|Overall Study|Adverse Event|1|||
164374592|NCT02917031|593743649|FG002|Overall Study|Adverse Event|5|||
164374593|NCT02917031|593743647|FG000|Overall Study|Death|2|||
164374594|NCT02917031|593743648|FG001|Overall Study|Death|3|||
164374595|NCT02917031|593743649|FG002|Overall Study|Death|4|||
164374596|NCT02742103|593745347|FG000|Overall Study|Protocol Violation|1|||
164374597|NCT02742103|593745348|FG001|Overall Study|Protocol Violation|0|||
164374598|NCT02742103|593745347|FG000|Overall Study|Death|2|||
164374599|NCT02742103|593745348|FG001|Overall Study|Death|2|||
164374600|NCT02742103|593745347|FG000|Overall Study|Adverse Event|1|||
164374601|NCT02742103|593745348|FG001|Overall Study|Adverse Event|0|||
164374602|NCT02742103|593745347|FG000|Overall Study|Moved to another town|0|||
164374603|NCT02742103|593745348|FG001|Overall Study|Moved to another town|1|||
164374604|NCT02742103|593745347|FG000|Overall Study|Withdrawal by Subject|5|||
164374605|NCT02742103|593745348|FG001|Overall Study|Withdrawal by Subject|2|||
164374606|NCT00533949|593745351|FG000|Overall Study|Protocol Violation|12|||
164374607|NCT00533949|593745352|FG001|Overall Study|Protocol Violation|12|||
164374608|NCT00533949|593745353|FG002|Overall Study|Protocol Violation|9|||
164374609|NCT00533949|593745354|FG003|Overall Study|Protocol Violation|9|||
164374610|NCT00533949|593745351|FG000|Overall Study|Withdrawal by Subject|3|||
164374611|NCT00533949|593745352|FG001|Overall Study|Withdrawal by Subject|2|||
164374612|NCT00533949|593745353|FG002|Overall Study|Withdrawal by Subject|1|||
164374613|NCT00533949|593745354|FG003|Overall Study|Withdrawal by Subject|1|||
164374614|NCT00727194|593745355|FG000|Screening Period|Low QMG scores|0|||
164374615|NCT00727194|593745356|FG001|Screening Period|Low QMG scores|0|||
164374616|NCT00727194|593745357|FG002|Screening Period|Low QMG scores|6|||
164374617|NCT00727194|593745355|FG000|Screening Period|Lacked AChR antibodies|0|||
164374618|NCT00727194|593745356|FG001|Screening Period|Lacked AChR antibodies|0|||
164374619|NCT00727194|593745357|FG002|Screening Period|Lacked AChR antibodies|5|||
164374620|NCT00727194|593745355|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
164374621|NCT00727194|593745356|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
164374622|NCT00727194|593745357|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
164374623|NCT00727194|593745355|FG000|Screening Period|Severe infections|0|||
164374624|NCT00727194|593745356|FG001|Screening Period|Severe infections|0|||
164374625|NCT00727194|593745357|FG002|Screening Period|Severe infections|2|||
164374626|NCT00727194|593745355|FG000|Screening Period|History of thymoma|0|||
164374627|NCT00727194|593745356|FG001|Screening Period|History of thymoma|0|||
164374628|NCT00727194|593745357|FG002|Screening Period|History of thymoma|1|||
164374629|NCT00727194|593745355|FG000|Treatment Period 2|Lack of Efficacy|0|||
164374630|NCT00727194|593745356|FG001|Treatment Period 2|Lack of Efficacy|1|||
164374631|NCT00727194|593745357|FG002|Treatment Period 2|Lack of Efficacy|0|||
164374632|NCT02349711|593745361|FG000|Overall Study|Withdrawal by Subject|2|||
164374633|NCT02349711|593745362|FG001|Overall Study|Withdrawal by Subject|1|||
164374634|NCT02349711|593745361|FG000|Overall Study|Lost to Follow-up|1|||
164374635|NCT02349711|593745362|FG001|Overall Study|Lost to Follow-up|1|||
164374636|NCT04269161|593745367|FG000|Overall Study|Change of modality and no longer eligible|3|||
164374637|NCT04269161|593745368|FG001|Overall Study|Change of modality and no longer eligible|3|||
164374638|NCT04269161|593745367|FG000|Overall Study|Required procedure outside of NICU|1|||
164374639|NCT04269161|593745368|FG001|Overall Study|Required procedure outside of NICU|0|||
164374640|NCT04269161|593745367|FG000|Overall Study|Equipment issue|1|||
164374641|NCT04269161|593745368|FG001|Overall Study|Equipment issue|1|||
164374642|NCT02472756|593745369|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
164374643|NCT02472756|593745369|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
164374644|NCT02472756|593745369|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
164374645|NCT02472756|593745369|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
164374646|NCT02472756|593745369|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
164374647|NCT01440322|593745373|FG000|Overall Study|Discomfort|2|||
164374648|NCT01440322|593745374|FG001|Overall Study|Discomfort|0|||
164374649|NCT01440322|593745373|FG000|Overall Study|Biomicroscopy|1|||
164374650|NCT01440322|593745374|FG001|Overall Study|Biomicroscopy|0|||
164374651|NCT01440322|593745373|FG000|Overall Study|Symptoms and Problems|1|||
164374652|NCT01440322|593745374|FG001|Overall Study|Symptoms and Problems|0|||
164374653|NCT01440322|593745373|FG000|Overall Study|Unacceptable Subjective Vision|1|||
164374654|NCT01440322|593745374|FG001|Overall Study|Unacceptable Subjective Vision|0|||
164374655|NCT01440322|593745373|FG000|Overall Study|Other Product Related|1|||
164374656|NCT01440322|593745374|FG001|Overall Study|Other Product Related|0|||
164374657|NCT01440322|593745373|FG000|Overall Study|Unrelated Medical Problem|0|||
164374658|NCT01440322|593745374|FG001|Overall Study|Unrelated Medical Problem|1|||
164374659|NCT01440322|593745373|FG000|Overall Study|Other Non-Product Related|1|||
164374660|NCT01440322|593745374|FG001|Overall Study|Other Non-Product Related|0|||
164374661|NCT04300296|593745376|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
164374662|NCT04300296|593745377|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
164374663|NCT04300296|593745378|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
164374664|NCT04300296|593745379|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
164374665|NCT04300296|593745380|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
164374666|NCT04300296|593745381|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
164374667|NCT04300296|593745376|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
164374668|NCT04300296|593745377|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
164374669|NCT04300296|593745378|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
164374670|NCT04300296|593745379|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
164374671|NCT04300296|593745380|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
164374672|NCT04300296|593745381|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
164374673|NCT04300296|593745376|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
164374674|NCT04300296|593745377|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
164374675|NCT04300296|593745378|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
164374676|NCT04300296|593745379|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
164374677|NCT04300296|593745380|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
164374678|NCT04300296|593745381|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
164374679|NCT04300296|593745376|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
164374680|NCT04300296|593745377|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
164374681|NCT04300296|593745378|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
164374682|NCT04300296|593745379|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
164374683|NCT04300296|593745380|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
164374684|NCT04300296|593745381|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
164374685|NCT04300296|593745376|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
164374686|NCT04300296|593745377|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
164374687|NCT04300296|593745378|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
164374688|NCT04300296|593745379|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
164374689|NCT04300296|593745380|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
164374690|NCT04300296|593745381|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
164374691|NCT04300296|593745376|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
164374692|NCT04300296|593745377|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
164374693|NCT04300296|593745378|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
164374694|NCT04300296|593745379|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
164374695|NCT04300296|593745380|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
164374696|NCT04300296|593745381|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
164374697|NCT04300296|593745376|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
164374698|NCT04300296|593745377|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
164374699|NCT04300296|593745378|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
164374700|NCT04300296|593745379|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
164374701|NCT04300296|593745380|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
164374702|NCT04300296|593745381|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
164374703|NCT05044234|593745384|FG000|Overall Study|Lost to Follow-up|2|||
164374704|NCT05044234|593745385|FG001|Overall Study|Lost to Follow-up|1|||
164374705|NCT05044234|593745386|FG002|Overall Study|Lost to Follow-up|1|||
164374706|NCT05044234|593745387|FG003|Overall Study|Lost to Follow-up|2|||
164439187|NCT04517864|593975301|FG000|Extension Phase|Approved Drug Available for Indication|0|||
164374707|NCT05044234|593745384|FG000|Overall Study|Withdrawal by Subject|6|||
164374708|NCT05044234|593745385|FG001|Overall Study|Withdrawal by Subject|4|||
164374709|NCT05044234|593745386|FG002|Overall Study|Withdrawal by Subject|5|||
164374710|NCT05044234|593745387|FG003|Overall Study|Withdrawal by Subject|8|||
164374711|NCT05044234|593745384|FG000|Overall Study|Study terminated by Sponsor|21|||
164374712|NCT05044234|593745385|FG001|Overall Study|Study terminated by Sponsor|21|||
164374713|NCT05044234|593745386|FG002|Overall Study|Study terminated by Sponsor|20|||
164374714|NCT05044234|593745387|FG003|Overall Study|Study terminated by Sponsor|14|||
164374715|NCT05044234|593745384|FG000|Overall Study|Other, not specified|0|||
164374716|NCT05044234|593745385|FG001|Overall Study|Other, not specified|0|||
164374717|NCT05044234|593745386|FG002|Overall Study|Other, not specified|1|||
164374718|NCT05044234|593745387|FG003|Overall Study|Other, not specified|2|||
164374719|NCT05044234|593745384|FG000|Overall Study|Delayed data entry|0|||
164374720|NCT05044234|593745385|FG001|Overall Study|Delayed data entry|0|||
164374721|NCT05044234|593745386|FG002|Overall Study|Delayed data entry|0|||
164374722|NCT05044234|593745387|FG003|Overall Study|Delayed data entry|1|||
164374723|NCT00279708|593745395|FG000|Overall Study|Withdrawal by Subject|2|||
164374724|NCT00279708|593745396|FG001|Overall Study|Withdrawal by Subject|3|||
164374725|NCT00279708|593745395|FG000|Overall Study|Adverse Event|1|||
164374726|NCT00279708|593745396|FG001|Overall Study|Adverse Event|1|||
164374727|NCT02624284|593745397|FG000|Overall Study|Withdrawal by Subject|3|||
164374728|NCT02624284|593745398|FG001|Overall Study|Withdrawal by Subject|6|||
164374729|NCT02624284|593745399|FG002|Overall Study|Withdrawal by Subject|3|||
164374730|NCT02624284|593745397|FG000|Overall Study|Protocol Violation|9|||
164374731|NCT02624284|593745398|FG001|Overall Study|Protocol Violation|10|||
164374732|NCT02624284|593745399|FG002|Overall Study|Protocol Violation|7|||
164374733|NCT02624284|593745397|FG000|Overall Study|Revealed exclusionary condition|2|||
164374734|NCT02624284|593745398|FG001|Overall Study|Revealed exclusionary condition|2|||
164374735|NCT02624284|593745399|FG002|Overall Study|Revealed exclusionary condition|0|||
164374736|NCT02624284|593745397|FG000|Overall Study|Adverse Event|0|||
164374737|NCT02624284|593745398|FG001|Overall Study|Adverse Event|0|||
164374738|NCT02624284|593745399|FG002|Overall Study|Adverse Event|1|||
164374739|NCT02940691|593745400|FG000|Overall Study|Lost to Follow-up|5|||
164374740|NCT02940691|593745400|FG000|Overall Study|Incarceration|1|||
164374741|NCT00812929|593745403|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
164374742|NCT00812929|593745404|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
164374743|NCT00812929|593745405|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
164374744|NCT00812929|593745406|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
164374745|NCT00812929|593745407|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
164374746|NCT00812929|593745408|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
164374747|NCT00812929|593745409|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
164374748|NCT00812929|593745410|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
164374749|NCT00812929|593745411|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
164374750|NCT00812929|593745412|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
164374751|NCT00812929|593745403|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
164374752|NCT00812929|593745404|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
164374753|NCT00812929|593745405|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
164374754|NCT00812929|593745406|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
164374755|NCT00812929|593745407|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
164374756|NCT00812929|593745408|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
164374757|NCT00812929|593745409|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
164374758|NCT00812929|593745410|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
164374759|NCT00812929|593745411|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
164374760|NCT00812929|593745412|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
164374761|NCT00812929|593745403|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
164374762|NCT00812929|593745404|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
164374763|NCT00812929|593745405|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
164374764|NCT00812929|593745406|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
164374765|NCT00812929|593745407|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
164591613|NCT02566525|594528454|FG001|Overall Study|Protocol Violation|5|||
164591614|NCT01721408|594528455|FG000|Overall Study|Adverse Event|6|||
164591615|NCT01721408|594528456|FG001|Overall Study|Adverse Event|1|||
164591616|NCT01721408|594528455|FG000|Overall Study|Death|1|||
164591617|NCT01721408|594528456|FG001|Overall Study|Death|0|||
164591618|NCT01721408|594528455|FG000|Overall Study|Insufficient clinical response|15|||
164374766|NCT00812929|593745408|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
164374767|NCT00812929|593745409|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
164374768|NCT00812929|593745410|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
164374769|NCT00812929|593745411|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
164374770|NCT00812929|593745412|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
164374771|NCT02975934|593745414|FG000|Treatment Phase|Never initiated study drug|0|||
164374772|NCT02975934|593745415|FG001|Treatment Phase|Never initiated study drug|5|||
164374773|NCT02975934|593745416|FG002|Treatment Phase|Never initiated study drug|0|||
164591619|NCT01721408|594528456|FG001|Overall Study|Insufficient clinical response|6|||
164374774|NCT02075840|593745417|FG000|Overall Study|Withdrawal by Subject|13|||
164374775|NCT02075840|593745418|FG001|Overall Study|Withdrawal by Subject|22|||
164374776|NCT02075840|593745417|FG000|Overall Study|Reason not specified|1|||
164374777|NCT02075840|593745418|FG001|Overall Study|Reason not specified|0|||
164374778|NCT02075840|593745417|FG000|Overall Study|Adverse Event|0|||
164374779|NCT02075840|593745418|FG001|Overall Study|Adverse Event|2|||
164374780|NCT02075840|593745417|FG000|Overall Study|Death|35|||
164374781|NCT02075840|593745418|FG001|Overall Study|Death|40|||
164374782|NCT02075840|593745417|FG000|Overall Study|Lost to Follow-up|3|||
164374783|NCT02075840|593745418|FG001|Overall Study|Lost to Follow-up|2|||
164374784|NCT02075840|593745417|FG000|Overall Study|Physician Decision|1|||
164374785|NCT02075840|593745418|FG001|Overall Study|Physician Decision|3|||
164374786|NCT02075840|593745417|FG000|Overall Study|Ongoing at CCOD|99|||
164374787|NCT02075840|593745418|FG001|Overall Study|Ongoing at CCOD|82|||
164374788|NCT02644967|593745444|FG000|Overall Study|Death|26|||
164374789|NCT02644967|593745444|FG000|Overall Study|Physician Decision|1|||
164374790|NCT02644967|593745444|FG000|Overall Study|Withdrawal by Subject|2|||
164374791|NCT02644967|593745444|FG000|Overall Study|Protocol Violation|1|||
164374792|NCT02644967|593745444|FG000|Overall Study|Progressive Disease|1|||
164374793|NCT02644967|593745444|FG000|Overall Study|Study Terminated by Sponsor|4|||
164374794|NCT02287896|593745445|FG000|Second Injection Visit|Withdrawal by Subject|0|||
164374795|NCT02287896|593745446|FG001|Second Injection Visit|Withdrawal by Subject|1|||
164374796|NCT01147653|593745451|FG000|Year 2|Withdrawal by Subject|2|||
164374797|NCT01147653|593745452|FG001|Year 2|Withdrawal by Subject|3|||
164374798|NCT00280566|593745453|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
164374799|NCT00280566|593745454|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
164374800|NCT00280566|593745455|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
164374801|NCT00280566|593745453|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
164374802|NCT00280566|593745454|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
164374803|NCT00280566|593745455|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
164374804|NCT00280566|593745453|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
164374805|NCT00280566|593745454|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
164374806|NCT00280566|593745455|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
164374807|NCT00280566|593745453|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
164374808|NCT00280566|593745454|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
164374809|NCT00280566|593745455|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
164374810|NCT00280566|593745453|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
164374811|NCT00280566|593745454|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
164374812|NCT00280566|593745455|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
164374813|NCT00280566|593745453|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
164374814|NCT00280566|593745454|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
164374815|NCT00280566|593745455|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
164374816|NCT00280566|593745453|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
164374817|NCT00280566|593745454|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
164374818|NCT00280566|593745455|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
164374819|NCT00280566|593745453|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
164374820|NCT00280566|593745454|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
164374821|NCT00280566|593745455|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
164374822|NCT00280566|593745453|FG000|Period 2 Double Blind|Adverse Event|0|||
164374823|NCT00280566|593745454|FG001|Period 2 Double Blind|Adverse Event|11|||
164374824|NCT00280566|593745455|FG002|Period 2 Double Blind|Adverse Event|15|||
164374825|NCT00280566|593745453|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
164374826|NCT00280566|593745454|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
164374827|NCT00280566|593745455|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
164374828|NCT00280566|593745453|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
164374829|NCT00280566|593745454|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
164374830|NCT00280566|593745455|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
164374831|NCT00280566|593745453|FG000|Period 2 Double Blind|miscellaneous|0|||
164374832|NCT00280566|593745454|FG001|Period 2 Double Blind|miscellaneous|10|||
164374833|NCT00280566|593745455|FG002|Period 2 Double Blind|miscellaneous|5|||
164374834|NCT01077960|593745458|FG000|Overall Study|Adverse Event|6|||
164374835|NCT01077960|593745458|FG000|Overall Study|Protocol Violation|3|||
164374836|NCT01077960|593745458|FG000|Overall Study|Lost to Follow-up|5|||
164374837|NCT01077960|593745458|FG000|Overall Study|Subject decision|1|||
164374838|NCT01077960|593745458|FG000|Overall Study|Reason unspecified|1|||
164374839|NCT03837899|593745462|FG000|Overall Study|Death|6|||
164374840|NCT03837899|593745463|FG001|Overall Study|Death|8|||
164374841|NCT03837899|593745464|FG002|Overall Study|Death|3|||
164374842|NCT03837899|593745465|FG003|Overall Study|Death|7|||
164374843|NCT03837899|593745466|FG004|Overall Study|Death|8|||
164374844|NCT03837899|593745467|FG005|Overall Study|Death|7|||
164374845|NCT03837899|593745462|FG000|Overall Study|Moved to post-trial access program|0|||
164374846|NCT03837899|593745463|FG001|Overall Study|Moved to post-trial access program|1|||
164374847|NCT03837899|593745464|FG002|Overall Study|Moved to post-trial access program|0|||
164374848|NCT03837899|593745465|FG003|Overall Study|Moved to post-trial access program|0|||
164374849|NCT03837899|593745466|FG004|Overall Study|Moved to post-trial access program|0|||
164374850|NCT03837899|593745467|FG005|Overall Study|Moved to post-trial access program|0|||
164374851|NCT03837899|593745462|FG000|Overall Study|Other|0|||
164374852|NCT03837899|593745463|FG001|Overall Study|Other|0|||
164374853|NCT03837899|593745464|FG002|Overall Study|Other|0|||
164374854|NCT03837899|593745465|FG003|Overall Study|Other|0|||
164374855|NCT03837899|593745466|FG004|Overall Study|Other|0|||
164374856|NCT03837899|593745467|FG005|Overall Study|Other|2|||
164374857|NCT03837899|593745462|FG000|Overall Study|Lost to Follow-up|0|||
164374858|NCT03837899|593745463|FG001|Overall Study|Lost to Follow-up|1|||
164374859|NCT03837899|593745464|FG002|Overall Study|Lost to Follow-up|0|||
164374860|NCT03837899|593745465|FG003|Overall Study|Lost to Follow-up|0|||
164374861|NCT03837899|593745466|FG004|Overall Study|Lost to Follow-up|0|||
164374862|NCT03837899|593745467|FG005|Overall Study|Lost to Follow-up|0|||
164374863|NCT03837899|593745462|FG000|Overall Study|Withdrawal by Subject|0|||
164374864|NCT03837899|593745463|FG001|Overall Study|Withdrawal by Subject|0|||
164374865|NCT03837899|593745464|FG002|Overall Study|Withdrawal by Subject|0|||
164374866|NCT03837899|593745465|FG003|Overall Study|Withdrawal by Subject|1|||
164374867|NCT03837899|593745466|FG004|Overall Study|Withdrawal by Subject|0|||
164374868|NCT03837899|593745467|FG005|Overall Study|Withdrawal by Subject|0|||
164374869|NCT03837899|593745462|FG000|Overall Study|Study specific discontinuation criteria|0|||
164374870|NCT03837899|593745463|FG001|Overall Study|Study specific discontinuation criteria|1|||
164374871|NCT03837899|593745464|FG002|Overall Study|Study specific discontinuation criteria|0|||
164374872|NCT03837899|593745465|FG003|Overall Study|Study specific discontinuation criteria|0|||
164374873|NCT03837899|593745466|FG004|Overall Study|Study specific discontinuation criteria|3|||
164374874|NCT03837899|593745467|FG005|Overall Study|Study specific discontinuation criteria|1|||
164374875|NCT01403974|593745468|FG000|Overall Study|Progressive disease according to RECIST|3|||
164374876|NCT01403974|593745469|FG001|Overall Study|Progressive disease according to RECIST|3|||
164374877|NCT01403974|593745470|FG002|Overall Study|Progressive disease according to RECIST|2|||
164374878|NCT01403974|593745471|FG003|Overall Study|Progressive disease according to RECIST|3|||
164374879|NCT01403974|593745472|FG004|Overall Study|Progressive disease according to RECIST|3|||
164374880|NCT01403974|593745473|FG005|Overall Study|Progressive disease according to RECIST|2|||
164374881|NCT01403974|593745474|FG006|Overall Study|Progressive disease according to RECIST|3|||
164374882|NCT01403974|593745475|FG007|Overall Study|Progressive disease according to RECIST|2|||
164374883|NCT01403974|593745476|FG008|Overall Study|Progressive disease according to RECIST|6|||
164374884|NCT01403974|593745477|FG009|Overall Study|Progressive disease according to RECIST|2|||
164374885|NCT01403974|593745478|FG010|Overall Study|Progressive disease according to RECIST|3|||
164374886|NCT01403974|593745479|FG011|Overall Study|Progressive disease according to RECIST|2|||
164374887|NCT01403974|593745480|FG012|Overall Study|Progressive disease according to RECIST|2|||
164374888|NCT01403974|593745481|FG013|Overall Study|Progressive disease according to RECIST|3|||
164374889|NCT01403974|593745482|FG014|Overall Study|Progressive disease according to RECIST|1|||
164374890|NCT01403974|593745483|FG015|Overall Study|Progressive disease according to RECIST|8|||
164374891|NCT01403974|593745468|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
164374892|NCT01403974|593745469|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
164374893|NCT01403974|593745470|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
164374894|NCT01403974|593745471|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
164374895|NCT01403974|593745472|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
164374896|NCT01403974|593745473|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
164374897|NCT01403974|593745474|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
164374898|NCT01403974|593745475|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
164374899|NCT01403974|593745476|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
164374900|NCT01403974|593745477|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
164374901|NCT01403974|593745478|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
164374902|NCT01403974|593745479|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
164374903|NCT01403974|593745480|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
164374904|NCT01403974|593745481|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
164374905|NCT01403974|593745482|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
164374906|NCT01403974|593745483|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
164374907|NCT01403974|593745468|FG000|Overall Study|Refused to continue study medication|0|||
164700478|NCT01421342|594926836|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
164374908|NCT01403974|593745469|FG001|Overall Study|Refused to continue study medication|0|||
164374909|NCT01403974|593745470|FG002|Overall Study|Refused to continue study medication|0|||
164374910|NCT01403974|593745471|FG003|Overall Study|Refused to continue study medication|0|||
164374911|NCT01403974|593745472|FG004|Overall Study|Refused to continue study medication|0|||
164374912|NCT01403974|593745473|FG005|Overall Study|Refused to continue study medication|1|||
164374913|NCT01403974|593745474|FG006|Overall Study|Refused to continue study medication|0|||
164374914|NCT01403974|593745475|FG007|Overall Study|Refused to continue study medication|0|||
164374915|NCT01403974|593745476|FG008|Overall Study|Refused to continue study medication|1|||
164374916|NCT01403974|593745477|FG009|Overall Study|Refused to continue study medication|0|||
164439188|NCT04517864|593975302|FG001|Extension Phase|Approved Drug Available for Indication|0|||
164374917|NCT01403974|593745478|FG010|Overall Study|Refused to continue study medication|1|||
164374918|NCT01403974|593745479|FG011|Overall Study|Refused to continue study medication|0|||
164374919|NCT01403974|593745480|FG012|Overall Study|Refused to continue study medication|0|||
164374920|NCT01403974|593745481|FG013|Overall Study|Refused to continue study medication|0|||
164374921|NCT01403974|593745482|FG014|Overall Study|Refused to continue study medication|0|||
164374922|NCT01403974|593745483|FG015|Overall Study|Refused to continue study medication|4|||
164374923|NCT01403974|593745468|FG000|Overall Study|Adverse Event|0|||
164374924|NCT01403974|593745469|FG001|Overall Study|Adverse Event|0|||
164374925|NCT01403974|593745470|FG002|Overall Study|Adverse Event|1|||
164374926|NCT01403974|593745471|FG003|Overall Study|Adverse Event|0|||
164374927|NCT01403974|593745472|FG004|Overall Study|Adverse Event|0|||
164374928|NCT01403974|593745473|FG005|Overall Study|Adverse Event|0|||
164374929|NCT01403974|593745474|FG006|Overall Study|Adverse Event|0|||
164374930|NCT01403974|593745475|FG007|Overall Study|Adverse Event|1|||
164374931|NCT01403974|593745476|FG008|Overall Study|Adverse Event|0|||
164374932|NCT01403974|593745477|FG009|Overall Study|Adverse Event|0|||
164374933|NCT01403974|593745478|FG010|Overall Study|Adverse Event|0|||
164374934|NCT01403974|593745479|FG011|Overall Study|Adverse Event|0|||
164374935|NCT01403974|593745480|FG012|Overall Study|Adverse Event|1|||
164374936|NCT01403974|593745481|FG013|Overall Study|Adverse Event|0|||
164374937|NCT01403974|593745482|FG014|Overall Study|Adverse Event|0|||
164374938|NCT01403974|593745483|FG015|Overall Study|Adverse Event|0|||
164374939|NCT01403974|593745468|FG000|Overall Study|Other than specified|0|||
164374940|NCT01403974|593745469|FG001|Overall Study|Other than specified|0|||
164374941|NCT01403974|593745470|FG002|Overall Study|Other than specified|0|||
164374942|NCT01403974|593745471|FG003|Overall Study|Other than specified|0|||
164374943|NCT01403974|593745472|FG004|Overall Study|Other than specified|0|||
164374944|NCT01403974|593745473|FG005|Overall Study|Other than specified|0|||
164374945|NCT01403974|593745474|FG006|Overall Study|Other than specified|0|||
164374946|NCT01403974|593745475|FG007|Overall Study|Other than specified|0|||
164374947|NCT01403974|593745476|FG008|Overall Study|Other than specified|0|||
164374948|NCT01403974|593745477|FG009|Overall Study|Other than specified|1|||
164374949|NCT01403974|593745478|FG010|Overall Study|Other than specified|0|||
164374950|NCT01403974|593745479|FG011|Overall Study|Other than specified|1|||
164374951|NCT01403974|593745480|FG012|Overall Study|Other than specified|0|||
164374952|NCT01403974|593745481|FG013|Overall Study|Other than specified|0|||
164374953|NCT01403974|593745482|FG014|Overall Study|Other than specified|0|||
164374954|NCT01403974|593745483|FG015|Overall Study|Other than specified|0|||
164374955|NCT01526889|593745484|FG000|Treatment Period|Adverse Event|2|||
164374956|NCT01526889|593745485|FG001|Treatment Period|Adverse Event|0|||
164374957|NCT01526889|593745484|FG000|Treatment Extension Period|Administrative problems|1|||
164374958|NCT01526889|593745485|FG001|Treatment Extension Period|Administrative problems|0|||
164374959|NCT03571516|593745488|FG000|Overall Study|Severe diarrhea|1|||
164374960|NCT03571516|593745489|FG001|Overall Study|Severe diarrhea|0|||
164374961|NCT03571516|593745488|FG000|Overall Study|Withdrawal by Subject|0|||
164374962|NCT03571516|593745489|FG001|Overall Study|Withdrawal by Subject|1|||
164374963|NCT00613509|593745493|FG000|Cycle 1|Adverse Event|2|||
164374964|NCT00613509|593745494|FG001|Cycle 1|Adverse Event|1|||
164374965|NCT00613509|593745493|FG000|Cycle 1|Disease Progression|2|||
164374966|NCT00613509|593745494|FG001|Cycle 1|Disease Progression|6|||
164374967|NCT00613509|593745493|FG000|Cycle 1|Unacceptable Toxicity|1|||
164374968|NCT00613509|593745494|FG001|Cycle 1|Unacceptable Toxicity|0|||
164374969|NCT00613509|593745493|FG000|Cycle 1|Other administrative reason|0|||
164374970|NCT00613509|593745494|FG001|Cycle 1|Other administrative reason|1|||
164374971|NCT03465878|593745495|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
164374972|NCT03465878|593745496|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
164374973|NCT03465878|593745497|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
164374974|NCT03465878|593745498|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
164374975|NCT03465878|593745495|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
164374976|NCT03465878|593745496|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
164374977|NCT03465878|593745497|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
164374978|NCT03465878|593745498|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
164374979|NCT03465878|593745495|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
164374980|NCT03465878|593745496|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
164374981|NCT03465878|593745497|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
164374982|NCT03465878|593745498|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
164374983|NCT02540954|593745499|FG000|Overall Study|Physician Decision|3|||
164374984|NCT02540954|593745500|FG001|Overall Study|Physician Decision|1|||
164374985|NCT02540954|593745499|FG000|Overall Study|Withdrawal by Subject|6|||
164374986|NCT02540954|593745500|FG001|Overall Study|Withdrawal by Subject|5|||
164439189|NCT04517864|593975303|FG002|Extension Phase|Approved Drug Available for Indication|7|||
164374987|NCT02540954|593745499|FG000|Overall Study|Lost to Follow-up|1|||
164439190|NCT04722003|593975306|FG000|Overall Study|Lost to Follow-up|2|||
164439191|NCT04722003|593975307|FG001|Overall Study|Lost to Follow-up|0|||
164439192|NCT04722003|593975306|FG000|Overall Study|Physician Decision|1|||
164439193|NCT04722003|593975307|FG001|Overall Study|Physician Decision|0|||
164439194|NCT03351075|593975308|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
164439195|NCT03351075|593975309|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
164439196|NCT03351075|593975308|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
164439197|NCT03351075|593975309|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
164439198|NCT03351075|593975308|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
164439199|NCT03351075|593975309|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
164439200|NCT03351075|593975308|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
164374988|NCT02540954|593745500|FG001|Overall Study|Lost to Follow-up|1|||
164700479|NCT01421342|594926837|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
164374989|NCT02540954|593745499|FG000|Overall Study|Adverse Event|4|||
164374990|NCT02540954|593745500|FG001|Overall Study|Adverse Event|2|||
164374991|NCT02540954|593745499|FG000|Overall Study|Death|0|||
164374992|NCT02540954|593745500|FG001|Overall Study|Death|3|||
164374993|NCT02540954|593745499|FG000|Overall Study|Treatment failure|1|||
164374994|NCT02540954|593745500|FG001|Overall Study|Treatment failure|0|||
164374995|NCT02540954|593745499|FG000|Overall Study|Other reason|4|||
164374996|NCT02540954|593745500|FG001|Overall Study|Other reason|2|||
164374997|NCT02448875|593745504|FG000|Overall Study|Adverse Event|2|||
164374998|NCT02448875|593745505|FG001|Overall Study|Adverse Event|1|||
164374999|NCT02448875|593745506|FG002|Overall Study|Adverse Event|0|||
164375000|NCT02448875|593745504|FG000|Overall Study|Lost to Follow-up|1|||
164375001|NCT02448875|593745505|FG001|Overall Study|Lost to Follow-up|0|||
164375002|NCT02448875|593745506|FG002|Overall Study|Lost to Follow-up|0|||
164375003|NCT02448875|593745504|FG000|Overall Study|Investigator Decision|3|||
164375004|NCT02448875|593745505|FG001|Overall Study|Investigator Decision|0|||
164375005|NCT02448875|593745506|FG002|Overall Study|Investigator Decision|1|||
164375006|NCT02448875|593745504|FG000|Overall Study|Withdrawal by Subject|1|||
164375007|NCT02448875|593745505|FG001|Overall Study|Withdrawal by Subject|0|||
164375008|NCT02448875|593745506|FG002|Overall Study|Withdrawal by Subject|0|||
164375009|NCT01806896|593745507|FG000|Overall Study|Adverse Event|2|||
164375010|NCT01806896|593745508|FG001|Overall Study|Adverse Event|0|||
164375011|NCT01806896|593745507|FG000|Overall Study|Other|1|||
164375012|NCT01806896|593745508|FG001|Overall Study|Other|0|||
164375013|NCT02434770|593745509|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
164375014|NCT02434770|593745510|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
164375015|NCT02434770|593745511|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
164375016|NCT02434770|593745509|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
164375017|NCT02434770|593745510|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
164375018|NCT02434770|593745511|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
164375019|NCT02434770|593745509|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
164375020|NCT02434770|593745510|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
164375021|NCT02434770|593745511|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
164375022|NCT02434770|593745509|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
164375023|NCT02434770|593745510|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
164375024|NCT02434770|593745511|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
164375025|NCT02434770|593745509|FG000|Week 1 to Week 18|Death|1|||
164375026|NCT02434770|593745510|FG001|Week 1 to Week 18|Death|0|||
164375027|NCT02434770|593745511|FG002|Week 1 to Week 18|Death|0|||
164439201|NCT03351075|593975309|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
164439202|NCT04035668|593975310|FG000|Overall Study|Adverse Event|3|||
164439203|NCT04035668|593975311|FG001|Overall Study|Adverse Event|4|||
164700480|NCT01421342|594926835|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
164700481|NCT01421342|594926836|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
164700482|NCT01421342|594926837|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
164700483|NCT01421342|594926835|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
164700484|NCT01421342|594926836|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
164375028|NCT02434770|593745509|FG000|Week 18 to Week|Lost to Follow-up|2|||
164375029|NCT02434770|593745510|FG001|Week 18 to Week|Lost to Follow-up|2|||
164375030|NCT02434770|593745511|FG002|Week 18 to Week|Lost to Follow-up|1|||
164375031|NCT02434770|593745509|FG000|Week 18 to Week|Withdrawal by Subject|0|||
164375032|NCT02434770|593745510|FG001|Week 18 to Week|Withdrawal by Subject|0|||
164375033|NCT02434770|593745511|FG002|Week 18 to Week|Withdrawal by Subject|2|||
164375034|NCT02434770|593745509|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
164439204|NCT04035668|593975312|FG002|Overall Study|Adverse Event|2|||
164439205|NCT04035668|593975310|FG000|Overall Study|Lost to Follow-up|0|||
164439206|NCT04035668|593975311|FG001|Overall Study|Lost to Follow-up|1|||
164700485|NCT01421342|594926837|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
164700486|NCT01421342|594926835|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
164700487|NCT01421342|594926836|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
164375035|NCT02434770|593745510|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
164375036|NCT02434770|593745511|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
164375037|NCT01282424|593745517|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
164375038|NCT01282424|593745517|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
164375039|NCT01282424|593745517|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
164375040|NCT01282424|593745517|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
164375041|NCT01282424|593745517|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
164375042|NCT01282424|593745517|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
164375043|NCT01282424|593745517|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
164375044|NCT01282424|593745517|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
164375045|NCT03316872|593745519|FG000|Overall Study|Death|1|||
164375046|NCT04074317|593745520|FG000|Third Period|Withdrawal by Subject|0|||
164375047|NCT04074317|593745521|FG001|Third Period|Withdrawal by Subject|0|||
164375048|NCT04074317|593745522|FG002|Third Period|Withdrawal by Subject|0|||
164375049|NCT04074317|593745523|FG003|Third Period|Withdrawal by Subject|1|||
164375050|NCT04074317|593745524|FG004|Third Period|Withdrawal by Subject|0|||
164375051|NCT04074317|593745525|FG005|Third Period|Withdrawal by Subject|0|||
164375052|NCT01038778|593745527|FG000|Overall Study|Withdrawal by Subject|0|||
164375053|NCT01038778|593745528|FG001|Overall Study|Withdrawal by Subject|2|||
164375054|NCT01038778|593745529|FG002|Overall Study|Withdrawal by Subject|3|||
164375055|NCT02283788|593745530|FG000|Overall Study|Adverse Event|1|||
164375056|NCT02283788|593745531|FG001|Overall Study|Adverse Event|3|||
164375057|NCT02283788|593745532|FG002|Overall Study|Adverse Event|5|||
164375058|NCT02283788|593745533|FG003|Overall Study|Adverse Event|1|||
164375059|NCT02283788|593745530|FG000|Overall Study|Withdrawal by Subject|0|||
164375060|NCT02283788|593745531|FG001|Overall Study|Withdrawal by Subject|1|||
164375061|NCT02283788|593745532|FG002|Overall Study|Withdrawal by Subject|0|||
164375062|NCT02283788|593745533|FG003|Overall Study|Withdrawal by Subject|1|||
164375063|NCT01610700|593747092|FG000|Overall Study|Adverse Event|3|||
164375064|NCT01610700|593747093|FG001|Overall Study|Adverse Event|1|||
164375065|NCT01610700|593747092|FG000|Overall Study|Withdrawal by Subject|0|||
164375066|NCT01610700|593747093|FG001|Overall Study|Withdrawal by Subject|1|||
164375067|NCT01610700|593747092|FG000|Overall Study|subject took one dose of street cannabis|0|||
164375068|NCT01610700|593747093|FG001|Overall Study|subject took one dose of street cannabis|1|||
164375069|NCT02896127|593747097|FG000|COMPLETED WEEK 52|Adverse Event|9|||
164375070|NCT02896127|593747098|FG001|COMPLETED WEEK 52|Adverse Event|2|||
164375071|NCT02896127|593747097|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
164375072|NCT02896127|593747098|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
164375073|NCT02896127|593747097|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
164375074|NCT02896127|593747098|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
164375075|NCT02896127|593747097|FG000|COMPLETED WEEK 52|Physician Decision|1|||
164375076|NCT02896127|593747098|FG001|COMPLETED WEEK 52|Physician Decision|1|||
164375077|NCT02896127|593747097|FG000|COMPLETED WEEK 52|Pregnancy|2|||
164375078|NCT02896127|593747098|FG001|COMPLETED WEEK 52|Pregnancy|0|||
164375079|NCT02896127|593747097|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
164375080|NCT02896127|593747098|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
164375081|NCT02896127|593747097|FG000|COMPLETED WEEK 52|Technical problems|1|||
164375082|NCT02896127|593747098|FG001|COMPLETED WEEK 52|Technical problems|0|||
164375083|NCT02896127|593747097|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
164375084|NCT02896127|593747098|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
164375085|NCT02896127|593747097|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
164375086|NCT02896127|593747098|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
164375087|NCT02896127|593747097|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
164375088|NCT02896127|593747098|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
164375089|NCT02896127|593747097|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
164375090|NCT02896127|593747098|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
164375091|NCT02896127|593747097|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
164375092|NCT02896127|593747098|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
164375093|NCT01782313|593747099|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
164375094|NCT01782313|593747099|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
164375095|NCT01782313|593747099|FG000|Treated Cycle 3|Progressive Disease|21|||
164375096|NCT01782313|593747099|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
164375097|NCT01782313|593747099|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
164375098|NCT01782313|593747099|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
164375099|NCT01782313|593747099|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
164375100|NCT01782313|593747099|FG000|Survival Follow up|Lost to Follow-up|1|||
164375101|NCT00958776|593747100|FG000|Overall Study|Adverse Event|0|||
164375102|NCT00958776|593747101|FG001|Overall Study|Adverse Event|1|||
164375103|NCT00958776|593747100|FG000|Overall Study|Physician Decision|1|||
164375104|NCT00958776|593747101|FG001|Overall Study|Physician Decision|0|||
164375105|NCT00958776|593747100|FG000|Overall Study|Lost to Follow-up|2|||
164375106|NCT00958776|593747101|FG001|Overall Study|Lost to Follow-up|6|||
164375107|NCT00958776|593747100|FG000|Overall Study|Withdrawal by Subject|7|||
164375108|NCT00958776|593747101|FG001|Overall Study|Withdrawal by Subject|16|||
164375109|NCT00958776|593747100|FG000|Overall Study|Protocol Violation|1|||
164375110|NCT00958776|593747101|FG001|Overall Study|Protocol Violation|1|||
164375111|NCT00958776|593747100|FG000|Overall Study|Death|2|||
164375112|NCT00958776|593747101|FG001|Overall Study|Death|1|||
164375113|NCT00958776|593747100|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
164375114|NCT00958776|593747101|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
164375115|NCT00958776|593747100|FG000|Overall Study|Missing|1|||
164375116|NCT00958776|593747101|FG001|Overall Study|Missing|1|||
164375117|NCT00326911|593747102|FG000|Overall Study|Hospitalization prior to treatment|0|||
164375118|NCT00326911|593747103|FG001|Overall Study|Hospitalization prior to treatment|1|||
164375119|NCT00326911|593747102|FG000|Overall Study|Physician decision prior to treatment|1|||
164375120|NCT00326911|593747103|FG001|Overall Study|Physician decision prior to treatment|0|||
164375121|NCT00326911|593747102|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
164375122|NCT00326911|593747103|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
164375123|NCT00418691|593747112|FG000|Overall Study|Lost to Follow-up|1|||
164375124|NCT00418691|593747113|FG001|Overall Study|Lost to Follow-up|2|||
164375125|NCT00418691|593747114|FG002|Overall Study|Lost to Follow-up|3|||
164375126|NCT00418691|593747112|FG000|Overall Study|Started new medication voiding entry|0|||
164375127|NCT00418691|593747113|FG001|Overall Study|Started new medication voiding entry|0|||
164375128|NCT00418691|593747114|FG002|Overall Study|Started new medication voiding entry|1|||
164375129|NCT00418691|593747112|FG000|Overall Study|Progressive Disease|1|||
164375130|NCT00418691|593747113|FG001|Overall Study|Progressive Disease|0|||
164375131|NCT00418691|593747114|FG002|Overall Study|Progressive Disease|1|||
164375132|NCT00501540|593747115|FG000|Overall Study|Death|5|||
164375133|NCT02331446|593747116|FG000|Overall Study|Lost to Follow-up|2|||
164375134|NCT02331446|593747117|FG001|Overall Study|Lost to Follow-up|1|||
164375135|NCT02331446|593747118|FG002|Overall Study|Lost to Follow-up|0|||
164375136|NCT02331446|593747119|FG003|Overall Study|Lost to Follow-up|1|||
164375137|NCT02331446|593747116|FG000|Overall Study|Personal Problem|2|||
164375138|NCT02331446|593747117|FG001|Overall Study|Personal Problem|0|||
164375139|NCT02331446|593747118|FG002|Overall Study|Personal Problem|0|||
164375140|NCT02331446|593747119|FG003|Overall Study|Personal Problem|0|||
164375141|NCT02331446|593747116|FG000|Overall Study|Disease|0|||
164375142|NCT02331446|593747117|FG001|Overall Study|Disease|2|||
164375143|NCT02331446|593747118|FG002|Overall Study|Disease|2|||
164375144|NCT02331446|593747119|FG003|Overall Study|Disease|1|||
164375145|NCT02331446|593747116|FG000|Overall Study|Physician Decision|0|||
164375146|NCT02331446|593747117|FG001|Overall Study|Physician Decision|1|||
164375147|NCT02331446|593747118|FG002|Overall Study|Physician Decision|0|||
164375148|NCT02331446|593747119|FG003|Overall Study|Physician Decision|1|||
164375149|NCT02331446|593747116|FG000|Overall Study|Lost before baseline analysis|0|||
164375150|NCT02331446|593747117|FG001|Overall Study|Lost before baseline analysis|1|||
164591620|NCT01721408|594528455|FG000|Overall Study|No longer willing to participate study|9|||
164591621|NCT01721408|594528456|FG001|Overall Study|No longer willing to participate study|10|||
164591622|NCT01721408|594528455|FG000|Overall Study|Protocol Violation|0|||
164591623|NCT01721408|594528456|FG001|Overall Study|Protocol Violation|2|||
164591624|NCT01721408|594528455|FG000|Overall Study|Other|3|||
164591625|NCT01721408|594528456|FG001|Overall Study|Other|3|||
164591626|NCT01721408|594528455|FG000|Overall Study|Lost to Follow-up|1|||
164591627|NCT01721408|594528456|FG001|Overall Study|Lost to Follow-up|2|||
164375151|NCT02331446|593747118|FG002|Overall Study|Lost before baseline analysis|1|||
164591628|NCT01721408|594528455|FG000|Overall Study|Does not meet entrance criteria|1|||
164375152|NCT02331446|593747119|FG003|Overall Study|Lost before baseline analysis|0|||
164375153|NCT02984995|593747120|FG000|Overall Study|Required stem cell transplant|13|||
164375154|NCT02984995|593747121|FG001|Overall Study|Required stem cell transplant|2|||
164375155|NCT02984995|593747120|FG000|Overall Study|Progressive disease|11|||
164375156|NCT02984995|593747121|FG001|Overall Study|Progressive disease|1|||
164375157|NCT02984995|593747120|FG000|Overall Study|Adverse Event|1|||
164375158|NCT02984995|593747121|FG001|Overall Study|Adverse Event|0|||
164591629|NCT01721408|594528456|FG001|Overall Study|Does not meet entrance criteria|0|||
164375159|NCT04182100|593747122|FG000|Overall Study|Adverse Event|1|||
164375160|NCT04182100|593747122|FG000|Overall Study|Withdrawal by Subject|1|||
164375161|NCT00433654|593747124|FG000|Overall Study|Death|4|||
164591630|NCT02149836|594528457|FG000|Overall Study|Withdrawal by Subject|1|||
164591631|NCT04430582|594528459|FG000|Overall Study|Found to meet exclusionary criteria|1|||
164591632|NCT04430582|594528460|FG001|Overall Study|Found to meet exclusionary criteria|0|||
164591633|NCT04430582|594528459|FG000|Overall Study|Withdrawal by Subject|0|||
164591634|NCT04430582|594528460|FG001|Overall Study|Withdrawal by Subject|1|||
164591635|NCT05137041|594529906|FG000|Overall Study|Lost to Follow-up|1|||
164591636|NCT05137041|594529907|FG001|Overall Study|Lost to Follow-up|1|||
164591637|NCT05137041|594529906|FG000|Overall Study|Withdrawal by Subject|0|||
164591638|NCT05137041|594529907|FG001|Overall Study|Withdrawal by Subject|2|||
164591639|NCT05137041|594529906|FG000|Overall Study|Reason not Specified|0|||
164591640|NCT05137041|594529907|FG001|Overall Study|Reason not Specified|1|||
164591641|NCT02433210|594529908|FG000|Overall Study|Physician Decision|1|||
164591642|NCT02433210|594529909|FG001|Overall Study|Physician Decision|0|||
164375162|NCT00433654|593747125|FG001|Overall Study|Death|0|||
164375163|NCT00433654|593747124|FG000|Overall Study|Missed visit|6|||
164375164|NCT00433654|593747125|FG001|Overall Study|Missed visit|3|||
164375165|NCT00433654|593747124|FG000|Overall Study|Subject not yet due for visit|4|||
164375166|NCT00433654|593747125|FG001|Overall Study|Subject not yet due for visit|0|||
164375167|NCT00433654|593747124|FG000|Overall Study|Withdrawal by Subject|1|||
164375168|NCT00433654|593747125|FG001|Overall Study|Withdrawal by Subject|2|||
164375169|NCT00499603|593747128|FG000|Overall Study|Adverse Event|0|||
164375170|NCT00499603|593747129|FG001|Overall Study|Adverse Event|1|||
164375171|NCT00937547|593747130|FG000|Overall Study|misdiagnosis|1|||
164375172|NCT00937547|593747131|FG001|Overall Study|misdiagnosis|6|||
164375173|NCT00937547|593747132|FG002|Overall Study|misdiagnosis|7|||
164375174|NCT04439240|593747133|FG000|Overall Study|Ineligible|2|||
164375175|NCT04439240|593747133|FG000|Overall Study|Never started treatment|2|||
164375176|NCT04439240|593747133|FG000|Overall Study|Adverse Event|12|||
164375177|NCT04439240|593747133|FG000|Overall Study|Death|2|||
164375178|NCT04439240|593747133|FG000|Overall Study|Disease progression|25|||
164375179|NCT04439240|593747133|FG000|Overall Study|Other diseases|2|||
164375180|NCT04439240|593747133|FG000|Overall Study|Withdrawal by Subject|3|||
164375181|NCT04439240|593747133|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
164375182|NCT04439240|593747133|FG000|Overall Study|Symptomatic decline|1|||
164375183|NCT04439240|593747133|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
164375184|NCT04439240|593747133|FG000|Overall Study|Clinical progression|1|||
164375185|NCT00079274|593747135|FG000|Overall Study|Withdrawal by Subject|111|||
164375186|NCT00079274|593747136|FG001|Overall Study|Withdrawal by Subject|10|||
164375187|NCT00079274|593747137|FG002|Overall Study|Withdrawal by Subject|12|||
164375188|NCT00079274|593747138|FG003|Overall Study|Withdrawal by Subject|163|||
164375189|NCT00079274|593747139|FG004|Overall Study|Withdrawal by Subject|7|||
164375190|NCT00079274|593747140|FG005|Overall Study|Withdrawal by Subject|8|||
164375191|NCT00079274|593747141|FG006|Overall Study|Withdrawal by Subject|0|||
164375192|NCT00079274|593747135|FG000|Overall Study|Adverse Event|130|||
164375193|NCT00079274|593747136|FG001|Overall Study|Adverse Event|8|||
164375194|NCT00079274|593747137|FG002|Overall Study|Adverse Event|8|||
164375195|NCT00079274|593747138|FG003|Overall Study|Adverse Event|184|||
164375196|NCT00079274|593747139|FG004|Overall Study|Adverse Event|7|||
164375197|NCT00079274|593747140|FG005|Overall Study|Adverse Event|8|||
164375198|NCT00079274|593747141|FG006|Overall Study|Adverse Event|0|||
164375199|NCT00079274|593747135|FG000|Overall Study|Recurrence|21|||
164375200|NCT00079274|593747136|FG001|Overall Study|Recurrence|0|||
164375201|NCT00079274|593747137|FG002|Overall Study|Recurrence|1|||
164375202|NCT00079274|593747138|FG003|Overall Study|Recurrence|15|||
164375203|NCT00079274|593747139|FG004|Overall Study|Recurrence|0|||
164375204|NCT00079274|593747140|FG005|Overall Study|Recurrence|2|||
164375205|NCT00079274|593747141|FG006|Overall Study|Recurrence|0|||
164375206|NCT00079274|593747135|FG000|Overall Study|Alternate Treatment|6|||
164375207|NCT00079274|593747136|FG001|Overall Study|Alternate Treatment|1|||
164375208|NCT00079274|593747137|FG002|Overall Study|Alternate Treatment|0|||
164375209|NCT00079274|593747138|FG003|Overall Study|Alternate Treatment|3|||
164375210|NCT00079274|593747139|FG004|Overall Study|Alternate Treatment|0|||
164375211|NCT00079274|593747140|FG005|Overall Study|Alternate Treatment|0|||
164375212|NCT00079274|593747141|FG006|Overall Study|Alternate Treatment|0|||
164375213|NCT00079274|593747135|FG000|Overall Study|Other Medical Problems|6|||
164375214|NCT00079274|593747136|FG001|Overall Study|Other Medical Problems|1|||
164375215|NCT00079274|593747137|FG002|Overall Study|Other Medical Problems|0|||
164591643|NCT02433210|594529910|FG002|Overall Study|Physician Decision|0|||
164375216|NCT00079274|593747138|FG003|Overall Study|Other Medical Problems|7|||
164375217|NCT00079274|593747139|FG004|Overall Study|Other Medical Problems|0|||
164375218|NCT00079274|593747140|FG005|Overall Study|Other Medical Problems|0|||
164375219|NCT00079274|593747141|FG006|Overall Study|Other Medical Problems|0|||
164375220|NCT00079274|593747135|FG000|Overall Study|Death|4|||
164375221|NCT00079274|593747136|FG001|Overall Study|Death|0|||
164375222|NCT00079274|593747137|FG002|Overall Study|Death|1|||
164375223|NCT00079274|593747138|FG003|Overall Study|Death|15|||
164375224|NCT00079274|593747139|FG004|Overall Study|Death|0|||
164375225|NCT00079274|593747140|FG005|Overall Study|Death|0|||
164375226|NCT00079274|593747141|FG006|Overall Study|Death|0|||
164591644|NCT03488472|594529911|FG000|Overall Study|disease progression additional mets|1|||
164591645|NCT00028002|594529912|FG000|Overall Study|Withdrawal by Subject|3|||
164439207|NCT04035668|593975312|FG002|Overall Study|Lost to Follow-up|0|||
164439208|NCT04035668|593975310|FG000|Overall Study|Physician Decision|2|||
164439209|NCT04035668|593975311|FG001|Overall Study|Physician Decision|1|||
164439210|NCT04035668|593975312|FG002|Overall Study|Physician Decision|1|||
164439211|NCT04035668|593975310|FG000|Overall Study|Subject Decision|2|||
164375227|NCT00079274|593747135|FG000|Overall Study|Cytogenetic resistance|0|||
164375228|NCT00079274|593747136|FG001|Overall Study|Cytogenetic resistance|0|||
164375229|NCT00079274|593747137|FG002|Overall Study|Cytogenetic resistance|0|||
164375230|NCT00079274|593747138|FG003|Overall Study|Cytogenetic resistance|2|||
164375231|NCT00079274|593747139|FG004|Overall Study|Cytogenetic resistance|0|||
164375232|NCT00079274|593747140|FG005|Overall Study|Cytogenetic resistance|0|||
164375233|NCT00079274|593747141|FG006|Overall Study|Cytogenetic resistance|0|||
164375234|NCT00079274|593747135|FG000|Overall Study|Other|43|||
164439212|NCT04035668|593975311|FG001|Overall Study|Subject Decision|2|||
164375235|NCT00079274|593747136|FG001|Overall Study|Other|7|||
164375236|NCT00079274|593747137|FG002|Overall Study|Other|5|||
164375237|NCT00079274|593747138|FG003|Overall Study|Other|55|||
164375238|NCT00079274|593747139|FG004|Overall Study|Other|1|||
164375239|NCT00079274|593747140|FG005|Overall Study|Other|2|||
164375240|NCT00079274|593747141|FG006|Overall Study|Other|0|||
164375241|NCT01302392|593747142|FG000|Overall Study|Lost to Follow-up|1|||
164375242|NCT01302392|593747143|FG001|Overall Study|Lost to Follow-up|0|||
164375243|NCT01302392|593747142|FG000|Overall Study|Withdrawal by Subject|6|||
164375244|NCT01302392|593747143|FG001|Overall Study|Withdrawal by Subject|1|||
164375245|NCT00670228|593747144|FG000|Overall Study|Adverse Event|1|||
164375246|NCT00670228|593747145|FG001|Overall Study|Adverse Event|0|||
164375247|NCT00670228|593747144|FG000|Overall Study|Death or MACE|0|||
164375248|NCT00670228|593747145|FG001|Overall Study|Death or MACE|1|||
164375249|NCT00670228|593747144|FG000|Overall Study|Not treated|2|||
164375250|NCT00670228|593747145|FG001|Overall Study|Not treated|2|||
164375251|NCT00670228|593747144|FG000|Overall Study|Not meeting the selection criteria|2|||
164375252|NCT00670228|593747145|FG001|Overall Study|Not meeting the selection criteria|0|||
164375253|NCT03604692|593747146|FG000|Overall Study|Investigator's Decision|0|||
164375254|NCT03604692|593747147|FG001|Overall Study|Investigator's Decision|0|||
164375255|NCT03604692|593747148|FG002|Overall Study|Investigator's Decision|0|||
164375256|NCT03604692|593747149|FG003|Overall Study|Investigator's Decision|1|||
164375257|NCT03604692|593747150|FG004|Overall Study|Investigator's Decision|0|||
164375258|NCT03604692|593747151|FG005|Overall Study|Investigator's Decision|7|||
164375259|NCT03604692|593747146|FG000|Overall Study|Withdrawal by Subject|0|||
164375260|NCT03604692|593747147|FG001|Overall Study|Withdrawal by Subject|0|||
164375261|NCT03604692|593747148|FG002|Overall Study|Withdrawal by Subject|0|||
164375262|NCT03604692|593747149|FG003|Overall Study|Withdrawal by Subject|0|||
164375263|NCT03604692|593747150|FG004|Overall Study|Withdrawal by Subject|0|||
164375264|NCT03604692|593747151|FG005|Overall Study|Withdrawal by Subject|2|||
164375265|NCT03604692|593747146|FG000|Overall Study|Progressive Disease|1|||
164375266|NCT03604692|593747147|FG001|Overall Study|Progressive Disease|0|||
164375267|NCT03604692|593747148|FG002|Overall Study|Progressive Disease|1|||
164375268|NCT03604692|593747149|FG003|Overall Study|Progressive Disease|0|||
164375269|NCT03604692|593747150|FG004|Overall Study|Progressive Disease|3|||
164375270|NCT03604692|593747151|FG005|Overall Study|Progressive Disease|4|||
164375271|NCT03604692|593747146|FG000|Overall Study|Difficulty Coming into Site|0|||
164375272|NCT03604692|593747147|FG001|Overall Study|Difficulty Coming into Site|0|||
164375273|NCT03604692|593747148|FG002|Overall Study|Difficulty Coming into Site|0|||
164375274|NCT03604692|593747149|FG003|Overall Study|Difficulty Coming into Site|0|||
164375275|NCT03604692|593747150|FG004|Overall Study|Difficulty Coming into Site|0|||
164375276|NCT03604692|593747151|FG005|Overall Study|Difficulty Coming into Site|1|||
164375277|NCT03604692|593747146|FG000|Overall Study|Death|0|||
164375278|NCT03604692|593747147|FG001|Overall Study|Death|0|||
164439213|NCT04035668|593975312|FG002|Overall Study|Subject Decision|0|||
164439214|NCT02385669|593975313|FG000|Overall Study|Adverse Event|2|||
164591646|NCT00028002|594529912|FG000|Overall Study|Ineligible|8|||
164591647|NCT00414310|594529918|FG000|Overall Study|Not treated|1|||
164591648|NCT00414310|594529919|FG001|Overall Study|Not treated|0|||
164375279|NCT03604692|593747148|FG002|Overall Study|Death|1|||
164375280|NCT03604692|593747149|FG003|Overall Study|Death|0|||
164375281|NCT03604692|593747150|FG004|Overall Study|Death|0|||
164375282|NCT03604692|593747151|FG005|Overall Study|Death|0|||
164375283|NCT03604692|593747146|FG000|Overall Study|Drug Intolerance|0|||
164375284|NCT03604692|593747147|FG001|Overall Study|Drug Intolerance|0|||
164439215|NCT00004124|593975314|FG000|Overall Study|Received no protocol therapy|12|||
164591649|NCT02561000|594529923|FG000|Overall Study|Withdrawal by Subject|2|||
164375285|NCT03604692|593747148|FG002|Overall Study|Drug Intolerance|0|||
164375286|NCT03604692|593747149|FG003|Overall Study|Drug Intolerance|1|||
164375287|NCT03604692|593747150|FG004|Overall Study|Drug Intolerance|0|||
164375288|NCT03604692|593747151|FG005|Overall Study|Drug Intolerance|0|||
164375289|NCT03604692|593747146|FG000|Overall Study|Noncompliance with follow-up visit|0|||
164375290|NCT03604692|593747147|FG001|Overall Study|Noncompliance with follow-up visit|0|||
164375291|NCT03604692|593747148|FG002|Overall Study|Noncompliance with follow-up visit|0|||
164439216|NCT00004124|593975315|FG001|Overall Study|Received no protocol therapy|20|||
164375292|NCT03604692|593747149|FG003|Overall Study|Noncompliance with follow-up visit|1|||
164375293|NCT03604692|593747150|FG004|Overall Study|Noncompliance with follow-up visit|0|||
164375294|NCT03604692|593747151|FG005|Overall Study|Noncompliance with follow-up visit|0|||
164375295|NCT03604692|593747146|FG000|Overall Study|Not Treated|0|||
164375296|NCT03604692|593747147|FG001|Overall Study|Not Treated|0|||
164375297|NCT03604692|593747148|FG002|Overall Study|Not Treated|0|||
164375298|NCT03604692|593747149|FG003|Overall Study|Not Treated|0|||
164375299|NCT03604692|593747150|FG004|Overall Study|Not Treated|1|||
164375300|NCT03604692|593747151|FG005|Overall Study|Not Treated|0|||
164375301|NCT00637195|593747152|FG000|Overall Study|Lost to Follow-up|1|||
164375302|NCT00637195|593747153|FG001|Overall Study|Lost to Follow-up|0|||
164375303|NCT00637195|593747152|FG000|Overall Study|Other|2|||
164375304|NCT00637195|593747153|FG001|Overall Study|Other|0|||
164375305|NCT00637195|593747152|FG000|Overall Study|Withdrawal by Subject|0|||
164375306|NCT00637195|593747153|FG001|Overall Study|Withdrawal by Subject|1|||
164375307|NCT00547703|593747156|FG000|Overall Study|Lost to Follow-up|1|||
164375308|NCT00547703|593747157|FG001|Overall Study|Lost to Follow-up|0|||
164375309|NCT01193556|593747163|FG000|Overall Study|Study termination|26|||
164375310|NCT01193556|593747164|FG001|Overall Study|Study termination|25|||
164375311|NCT01696032|593747165|FG000|Overall Study|Withdrawal by Subject|0|||
164375312|NCT01696032|593747166|FG001|Overall Study|Withdrawal by Subject|0|||
164375313|NCT01696032|593747167|FG002|Overall Study|Withdrawal by Subject|1|||
164375314|NCT01696032|593747168|FG003|Overall Study|Withdrawal by Subject|2|||
164375315|NCT01696032|593747165|FG000|Overall Study|Death|14|||
164375316|NCT01696032|593747166|FG001|Overall Study|Death|4|||
164375317|NCT01696032|593747167|FG002|Overall Study|Death|43|||
164375318|NCT01696032|593747168|FG003|Overall Study|Death|18|||
164375319|NCT01696032|593747165|FG000|Overall Study|Lost to Follow-up|0|||
164375320|NCT01696032|593747166|FG001|Overall Study|Lost to Follow-up|1|||
164375321|NCT01696032|593747167|FG002|Overall Study|Lost to Follow-up|0|||
164375322|NCT01696032|593747168|FG003|Overall Study|Lost to Follow-up|0|||
164439217|NCT04218110|593975320|FG000|Overall Study|Withdrawal by Subject|0|||
164439218|NCT04218110|593975321|FG001|Overall Study|Withdrawal by Subject|0|||
164439219|NCT04218110|593975322|FG002|Overall Study|Withdrawal by Subject|0|||
164439220|NCT04218110|593975323|FG003|Overall Study|Withdrawal by Subject|1|||
164375323|NCT01696032|593747165|FG000|Overall Study|Database lock|0|||
164375324|NCT01696032|593747166|FG001|Overall Study|Database lock|1|||
164375325|NCT01696032|593747167|FG002|Overall Study|Database lock|7|||
164375326|NCT01696032|593747168|FG003|Overall Study|Database lock|2|||
164375327|NCT00376168|593747171|FG000|Overall Study|Adverse Event|1|||
164375328|NCT00376168|593747172|FG001|Overall Study|Adverse Event|1|||
164375329|NCT00376168|593747171|FG000|Overall Study|Pregnancy|1|||
164375330|NCT00376168|593747172|FG001|Overall Study|Pregnancy|0|||
164375331|NCT01020019|593747173|FG000|Overall Study|Lost to Follow-up|21|||
164375332|NCT01020019|593747174|FG001|Overall Study|Lost to Follow-up|18|||
164375333|NCT01020019|593747173|FG000|Overall Study|Adverse Event|1|||
164375334|NCT01020019|593747174|FG001|Overall Study|Adverse Event|5|||
164375335|NCT01020019|593747173|FG000|Overall Study|not interested in treatment|4|||
164375336|NCT01020019|593747174|FG001|Overall Study|not interested in treatment|4|||
164375337|NCT01020019|593747173|FG000|Overall Study|moving|0|||
164375338|NCT01020019|593747174|FG001|Overall Study|moving|2|||
164375339|NCT05091528|593747175|FG000|Overall Study|Study Termination by Sponsor|0|||
164375340|NCT05091528|593747176|FG001|Overall Study|Study Termination by Sponsor|1|||
164375341|NCT05091528|593747177|FG002|Overall Study|Study Termination by Sponsor|0|||
164375342|NCT05091528|593747178|FG003|Overall Study|Study Termination by Sponsor|1|||
164375343|NCT02214121|593747181|FG000|Part A|Patient decision|2|||
164375344|NCT02214121|593747182|FG001|Part A|Patient decision|0|||
164375345|NCT02214121|593747183|FG002|Part A|Patient decision|0|||
164439221|NCT00114244|593975324|FG000|Overall Study|Adverse Event|2|||
164375346|NCT02214121|593747181|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
164375347|NCT02214121|593747182|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
164439222|NCT00114244|593975325|FG001|Overall Study|Adverse Event|5|||
164700488|NCT01421342|594926837|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
164375348|NCT02214121|593747183|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
164375349|NCT02214121|593747181|FG000|Part A|Other|1|||
164375350|NCT02214121|593747182|FG001|Part A|Other|0|||
164375351|NCT02214121|593747183|FG002|Part A|Other|0|||
164375352|NCT02214121|593747181|FG000|Part B|Patient decision|0|||
164375353|NCT02214121|593747182|FG001|Part B|Patient decision|1|||
164375354|NCT02214121|593747183|FG002|Part B|Patient decision|0|||
164375355|NCT02214121|593747181|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
164375356|NCT02214121|593747182|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
164375357|NCT02214121|593747183|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
164375358|NCT02214121|593747181|FG000|Part B|Lost to Follow-up|0|||
164439223|NCT00114244|593975324|FG000|Overall Study|Withdrawal by Subject|0|||
164375359|NCT02214121|593747182|FG001|Part B|Lost to Follow-up|0|||
164375360|NCT02214121|593747183|FG002|Part B|Lost to Follow-up|1|||
164375361|NCT02375672|593747184|FG000|Overall Study|remain on follow up|20|||
164375362|NCT02203591|593747185|FG000|Overall Study|Did not meet treatment day baseline|147|||
164439224|NCT00114244|593975325|FG001|Overall Study|Withdrawal by Subject|2|||
164375363|NCT02203591|593747186|FG001|Overall Study|Did not meet treatment day baseline|141|||
164375364|NCT02203591|593747187|FG002|Overall Study|Did not meet treatment day baseline|150|||
164375365|NCT02203591|593747188|FG003|Overall Study|Did not meet treatment day baseline|45|||
164375366|NCT02203591|593747189|FG004|Overall Study|Did not meet treatment day baseline|33|||
164375367|NCT02203591|593747190|FG005|Overall Study|Did not meet treatment day baseline|35|||
164375368|NCT02203591|593747191|FG006|Overall Study|Did not meet treatment day baseline|29|||
164375369|NCT02203591|593747192|FG007|Overall Study|Did not meet treatment day baseline|12|||
164375370|NCT02203591|593747185|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
164375371|NCT02203591|593747186|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
164375372|NCT02203591|593747187|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
164375373|NCT02203591|593747188|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
164375374|NCT02203591|593747189|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
164375375|NCT02203591|593747190|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
164375376|NCT02203591|593747191|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
164375377|NCT02203591|593747192|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
164375378|NCT04115358|593747193|FG000|Overall Study|exfoliation|0|||
164375379|NCT04115358|593747194|FG001|Overall Study|exfoliation|0|||
164375380|NCT04115358|593747195|FG002|Overall Study|exfoliation|1|||
164375381|NCT01573624|593747198|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
164375382|NCT01573624|593747199|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
164375383|NCT01573624|593747200|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
164375384|NCT01573624|593747201|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
164375385|NCT01573624|593747202|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
164375386|NCT01573624|593747203|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
164375387|NCT01573624|593747204|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
164375388|NCT01573624|593747198|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
164375389|NCT01573624|593747199|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
164375390|NCT01573624|593747200|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
164375391|NCT01573624|593747201|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
164375392|NCT01573624|593747202|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
164375393|NCT01573624|593747203|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
164375394|NCT01573624|593747204|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
164375395|NCT01573624|593747198|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
164375396|NCT01573624|593747199|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
164375397|NCT01573624|593747200|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
164375398|NCT01573624|593747201|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
164375399|NCT01573624|593747202|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
164375400|NCT01573624|593747203|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
164375401|NCT01573624|593747204|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
164375402|NCT01573624|593747198|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
164375403|NCT01573624|593747199|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164375404|NCT01573624|593747200|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
164375405|NCT01573624|593747201|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164375406|NCT01573624|593747202|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164375407|NCT01573624|593747203|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
164375408|NCT01573624|593747204|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164375409|NCT01573624|593747198|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
164375410|NCT01573624|593747199|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
164375411|NCT01573624|593747200|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
164375412|NCT01573624|593747201|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
164375413|NCT01573624|593747202|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
164375414|NCT01573624|593747203|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
164375415|NCT01573624|593747204|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
164375416|NCT01573624|593747198|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
164375417|NCT01573624|593747199|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
164375418|NCT01573624|593747200|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
164375419|NCT01573624|593747201|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
164375420|NCT01573624|593747202|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
164375421|NCT01573624|593747203|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
164375422|NCT01573624|593747204|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
164375423|NCT01573624|593747198|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
164375424|NCT01573624|593747199|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
164375425|NCT01573624|593747200|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
164375426|NCT01573624|593747201|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
164375427|NCT01573624|593747202|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
164375428|NCT01573624|593747203|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
164375429|NCT01573624|593747204|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
164375430|NCT01573624|593747198|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
164375431|NCT01573624|593747199|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
164375432|NCT01573624|593747200|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
164375433|NCT01573624|593747201|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
164375434|NCT01573624|593747202|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
164375435|NCT01573624|593747203|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
164375436|NCT01573624|593747204|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
164375437|NCT01573624|593747198|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
164375438|NCT01573624|593747199|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
164375439|NCT01573624|593747200|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
164375440|NCT01573624|593747201|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
164375441|NCT01573624|593747202|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
164375442|NCT01573624|593747203|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
164375443|NCT01573624|593747204|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
164375444|NCT01573624|593747198|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
164375445|NCT01573624|593747199|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
164375446|NCT01573624|593747200|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
164375447|NCT01573624|593747201|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
164375448|NCT01573624|593747202|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
164375449|NCT01573624|593747203|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
164375450|NCT01573624|593747204|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
164375451|NCT01573624|593747198|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
164375452|NCT01573624|593747199|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
164375453|NCT01573624|593747200|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
164375454|NCT01573624|593747201|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
164375455|NCT01573624|593747202|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
164375456|NCT01573624|593747203|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
164375457|NCT01573624|593747204|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
164375458|NCT01573624|593747198|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
164375459|NCT01573624|593747199|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
164375460|NCT01573624|593747200|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
164375461|NCT01573624|593747201|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
164375462|NCT01573624|593747202|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
164375463|NCT01573624|593747203|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
164375464|NCT01573624|593747204|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
164375465|NCT01573624|593747198|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
164375466|NCT01573624|593747199|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
164375467|NCT01573624|593747200|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
164375468|NCT01573624|593747201|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
164375469|NCT01573624|593747202|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
164375470|NCT01573624|593747203|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
164375471|NCT01573624|593747204|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
164375472|NCT01573624|593747198|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
164375473|NCT01573624|593747199|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
164375474|NCT01573624|593747200|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
164375475|NCT01573624|593747201|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
164375476|NCT01573624|593747202|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
164375477|NCT01573624|593747203|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
164375478|NCT01573624|593747204|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
164375479|NCT01573624|593747198|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
164591650|NCT02561000|594529924|FG001|Overall Study|Withdrawal by Subject|3|||
164591651|NCT02561000|594529925|FG002|Overall Study|Withdrawal by Subject|0|||
164591652|NCT02561000|594529923|FG000|Overall Study|Adverse Event|0|||
164375480|NCT01573624|593747199|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
164375481|NCT01573624|593747200|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
164591653|NCT02561000|594529924|FG001|Overall Study|Adverse Event|1|||
164591654|NCT02561000|594529925|FG002|Overall Study|Adverse Event|0|||
164591655|NCT03656926|594529932|FG000|Overall Study|Adverse Event|5|||
164591656|NCT03656926|594529933|FG001|Overall Study|Adverse Event|4|||
164591657|NCT03656926|594529932|FG000|Overall Study|Withdrawal by Subject|7|||
164591658|NCT03656926|594529933|FG001|Overall Study|Withdrawal by Subject|2|||
164591659|NCT03656926|594529932|FG000|Overall Study|Screen fail after randomization|1|||
164591660|NCT03656926|594529933|FG001|Overall Study|Screen fail after randomization|0|||
164591661|NCT03656926|594529932|FG000|Overall Study|PI decision due to patient condition|1|||
164591662|NCT03656926|594529933|FG001|Overall Study|PI decision due to patient condition|0|||
164591663|NCT03656926|594529932|FG000|Overall Study|Patient unresponsiveness|1|||
164591664|NCT03656926|594529933|FG001|Overall Study|Patient unresponsiveness|0|||
164591665|NCT01428063|594529934|FG000|Overall Study|Lack of Efficacy|8|||
164591666|NCT01428063|594529935|FG001|Overall Study|Lack of Efficacy|4|||
164591667|NCT01428063|594529936|FG002|Overall Study|Lack of Efficacy|1|||
164591668|NCT01428063|594529934|FG000|Overall Study|Adverse Event|2|||
164591669|NCT01428063|594529935|FG001|Overall Study|Adverse Event|3|||
164591670|NCT01428063|594529936|FG002|Overall Study|Adverse Event|0|||
164375482|NCT01573624|593747201|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
164375483|NCT01573624|593747202|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
164375484|NCT01573624|593747203|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
164375485|NCT01573624|593747204|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
164375486|NCT01573624|593747198|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
164375487|NCT01573624|593747199|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
164375488|NCT01573624|593747200|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
164375489|NCT01573624|593747201|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
164375490|NCT01573624|593747202|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
164375491|NCT01573624|593747203|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
164375492|NCT01573624|593747204|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
164375493|NCT01573624|593747198|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
164375494|NCT01573624|593747199|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
164375495|NCT01573624|593747200|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
164375496|NCT01573624|593747201|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
164375497|NCT01573624|593747202|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
164375498|NCT01573624|593747203|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
164591671|NCT01428063|594529934|FG000|Overall Study|Lost to Follow-up|0|||
164375499|NCT01573624|593747204|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
164375500|NCT01573624|593747198|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
164375501|NCT01573624|593747199|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
164375502|NCT01573624|593747200|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
164375503|NCT01573624|593747201|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
164375504|NCT01573624|593747202|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
164375505|NCT01573624|593747203|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
164375506|NCT01573624|593747204|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
164375507|NCT01573624|593747198|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
164375508|NCT01573624|593747199|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
164375509|NCT01573624|593747200|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
164375510|NCT01573624|593747201|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
164375511|NCT01573624|593747202|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
164375512|NCT01573624|593747203|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
164375513|NCT01573624|593747204|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
164375514|NCT01573624|593747198|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
164375515|NCT01573624|593747199|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
164375516|NCT01573624|593747200|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
164375517|NCT01573624|593747201|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
164375518|NCT01573624|593747202|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
164375519|NCT01573624|593747203|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
164375520|NCT01573624|593747204|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
164375521|NCT01573624|593747198|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
164375522|NCT01573624|593747199|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
164375523|NCT01573624|593747200|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
164375524|NCT01573624|593747201|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
164375525|NCT01573624|593747202|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
164375526|NCT01573624|593747203|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
164375527|NCT01573624|593747204|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
164417427|NCT01474512|593899495|FG006|Long-Term Extension Period|Clinical Relapse|0|||
164591672|NCT01428063|594529935|FG001|Overall Study|Lost to Follow-up|2|||
164591673|NCT01428063|594529936|FG002|Overall Study|Lost to Follow-up|0|||
164700489|NCT01421342|594926835|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
164700490|NCT01421342|594926836|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
164591674|NCT01428063|594529934|FG000|Overall Study|No longer meets study criteria|0|||
164591675|NCT01428063|594529935|FG001|Overall Study|No longer meets study criteria|1|||
164591676|NCT01428063|594529936|FG002|Overall Study|No longer meets study criteria|0|||
164591677|NCT03196505|594529941|FG000|Overall Study|Physician Decision|26|||
164591678|NCT03196505|594529942|FG001|Overall Study|Physician Decision|26|||
164591679|NCT02575079|594529944|FG000|Overall Study|Death|3|||
164591680|NCT02575079|594529945|FG001|Overall Study|Death|0|||
164591681|NCT02575079|594529944|FG000|Overall Study|Withdrawal by Subject|3|||
164591682|NCT02575079|594529945|FG001|Overall Study|Withdrawal by Subject|0|||
164591683|NCT02918266|594529946|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
164591684|NCT02918266|594529947|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
164591685|NCT02918266|594529948|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
164591686|NCT02918266|594529949|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
164591687|NCT02918266|594529950|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
164591688|NCT02918266|594529951|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
164591689|NCT02918266|594529952|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
164591690|NCT02918266|594529953|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
164591691|NCT02918266|594529954|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
164591692|NCT02918266|594529955|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
164591693|NCT02918266|594529956|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
164591694|NCT00788775|594529959|FG000|Overall Study|Progressive Disease|8|||
164591695|NCT00788775|594529960|FG001|Overall Study|Progressive Disease|6|||
164591696|NCT00788775|594529959|FG000|Overall Study|Withdrawal by Subject|0|||
164591697|NCT00788775|594529960|FG001|Overall Study|Withdrawal by Subject|2|||
164591698|NCT00788775|594529959|FG000|Overall Study|Patient Non-Compliance|1|||
164591699|NCT00788775|594529960|FG001|Overall Study|Patient Non-Compliance|0|||
164591700|NCT00788775|594529959|FG000|Overall Study|Patient's measurable disease resected.|1|||
164591701|NCT00788775|594529960|FG001|Overall Study|Patient's measurable disease resected.|0|||
164591702|NCT03116399|594529961|FG000|Overall Study|Death|8|||
164591703|NCT03116399|594529962|FG001|Overall Study|Death|3|||
164591704|NCT03116399|594529961|FG000|Overall Study|Lost to Follow-up|7|||
164591705|NCT03116399|594529962|FG001|Overall Study|Lost to Follow-up|11|||
164591706|NCT03116399|594529961|FG000|Overall Study|Investigator Decision|1|||
164591707|NCT03116399|594529962|FG001|Overall Study|Investigator Decision|1|||
164591708|NCT03116399|594529961|FG000|Overall Study|Withdrawal by Subject|24|||
164591709|NCT03116399|594529962|FG001|Overall Study|Withdrawal by Subject|9|||
164591710|NCT00987623|594529963|FG000|Overall Study|Lost to Follow-up|2|||
164591711|NCT00987623|594529964|FG001|Overall Study|Lost to Follow-up|1|||
164591712|NCT00987623|594529963|FG000|Overall Study|Time/job conflict|2|||
164591713|NCT00987623|594529964|FG001|Overall Study|Time/job conflict|0|||
164591714|NCT00987623|594529963|FG000|Overall Study|Discomfort|1|||
164591715|NCT00987623|594529964|FG001|Overall Study|Discomfort|0|||
164591716|NCT00987623|594529963|FG000|Overall Study|Biomicroscopy|0|||
164591717|NCT00987623|594529964|FG001|Overall Study|Biomicroscopy|1|||
164591718|NCT00987623|594529963|FG000|Overall Study|Influenza|0|||
164591719|NCT00987623|594529964|FG001|Overall Study|Influenza|1|||
164591720|NCT04488822|594529965|FG000|Overall Study|Adverse Event|8|||
164591721|NCT04488822|594529965|FG000|Overall Study|Withdrawal by Subject|1|||
164591722|NCT03838367|594529966|FG000|Overall Study|Early termination of study|3|||
164591723|NCT03838367|594529967|FG001|Overall Study|Early termination of study|4|||
164591724|NCT03838367|594529968|FG002|Overall Study|Early termination of study|3|||
164591725|NCT03838367|594529969|FG003|Overall Study|Early termination of study|0|||
164591726|NCT00195260|594529982|FG000|Part 1: Dose Escalation|Adverse Event|0|||
164591727|NCT00195260|594529983|FG001|Part 1: Dose Escalation|Adverse Event|1|||
164591728|NCT00195260|594529984|FG002|Part 1: Dose Escalation|Adverse Event|0|||
164591729|NCT00195260|594529985|FG003|Part 1: Dose Escalation|Adverse Event|1|||
164591730|NCT00195260|594529986|FG004|Part 1: Dose Escalation|Adverse Event|1|||
164591731|NCT00195260|594529987|FG005|Part 1: Dose Escalation|Adverse Event|0|||
164591732|NCT00195260|594529988|FG006|Part 1: Dose Escalation|Adverse Event|3|||
164591733|NCT00195260|594529989|FG007|Part 1: Dose Escalation|Adverse Event|0|||
164700491|NCT01421342|594926837|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
164700492|NCT01421342|594926835|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
164700493|NCT01421342|594926836|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
164591734|NCT00195260|594529990|FG008|Part 1: Dose Escalation|Adverse Event|0|||
164591735|NCT00195260|594529991|FG009|Part 1: Dose Escalation|Adverse Event|0|||
164591736|NCT00195260|594529992|FG010|Part 1: Dose Escalation|Adverse Event|0|||
164591737|NCT00195260|594529982|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164591738|NCT00195260|594529983|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164591739|NCT00195260|594529984|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164591740|NCT00195260|594529985|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164591741|NCT00195260|594529986|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
164591742|NCT00195260|594529987|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164591743|NCT00195260|594529988|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164591744|NCT00195260|594529989|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
164375528|NCT01573624|593747198|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
164375529|NCT01573624|593747199|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
164375530|NCT01573624|593747200|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
164375531|NCT01573624|593747201|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
164375532|NCT01573624|593747202|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
164375533|NCT01573624|593747203|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
164375534|NCT01573624|593747204|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
164375535|NCT01573624|593747198|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
164375536|NCT01573624|593747199|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164375537|NCT01573624|593747200|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164375538|NCT01573624|593747201|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164375539|NCT01573624|593747202|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
164375540|NCT01573624|593747203|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
164375541|NCT01573624|593747204|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
164375542|NCT01573624|593747198|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
164375543|NCT01573624|593747199|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
164375544|NCT01573624|593747200|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
164375545|NCT01573624|593747201|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
164375546|NCT01573624|593747202|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
164375547|NCT01573624|593747203|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
164375548|NCT01573624|593747204|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
164375549|NCT01573624|593747198|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
164375550|NCT01573624|593747199|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
164375551|NCT01573624|593747200|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
164375552|NCT01573624|593747201|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
164375553|NCT01573624|593747202|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
164375554|NCT01573624|593747203|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
164375555|NCT01573624|593747204|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
164375556|NCT01573624|593747198|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
164375557|NCT01573624|593747199|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
164375558|NCT01573624|593747200|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
164375559|NCT01573624|593747201|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
164375560|NCT01573624|593747202|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
164375561|NCT01573624|593747203|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
164375562|NCT01573624|593747204|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
164375563|NCT01573624|593747198|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
164375564|NCT01573624|593747199|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
164375565|NCT01573624|593747200|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
164375566|NCT01573624|593747201|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
164375567|NCT01573624|593747202|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
164375568|NCT01573624|593747203|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
164375569|NCT01573624|593747204|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
164375570|NCT04399161|593747205|FG000|Overall Study|Withdrawal by Subject|1|||
164375571|NCT04399161|593747206|FG001|Overall Study|Withdrawal by Subject|0|||
164375572|NCT04399161|593747207|FG002|Overall Study|Withdrawal by Subject|2|||
164375573|NCT04399161|593747205|FG000|Overall Study|Protocol Violation|1|||
164591745|NCT00195260|594529990|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164591746|NCT00195260|594529991|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164591747|NCT00195260|594529992|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164591748|NCT00195260|594529982|FG000|Part 1: Dose Escalation|Death|0|||
164591749|NCT00195260|594529983|FG001|Part 1: Dose Escalation|Death|0|||
164144030|NCT00086281|592888584|FG013|Phase 1|Serious Adverse Event|0|||
164375574|NCT04399161|593747206|FG001|Overall Study|Protocol Violation|2|||
164375575|NCT04399161|593747207|FG002|Overall Study|Protocol Violation|0|||
164375576|NCT03417141|593747208|FG000|Overall Study|Withdrawal by Subject|1|||
164375577|NCT03417141|593747208|FG000|Overall Study|Protocol Violation|3|||
164375578|NCT01420081|593747209|FG000|Overall Study|Death|1|||
164375579|NCT01420081|593747210|FG001|Overall Study|Death|0|||
164375580|NCT01420081|593747211|FG002|Overall Study|Death|8|||
164375581|NCT01420081|593747212|FG003|Overall Study|Death|0|||
164375582|NCT01420081|593747213|FG004|Overall Study|Death|7|||
164375583|NCT01420081|593747214|FG005|Overall Study|Death|12|||
164375584|NCT01420081|593747215|FG006|Overall Study|Death|0|||
164375585|NCT01420081|593747216|FG007|Overall Study|Death|1|||
164375586|NCT01420081|593747217|FG008|Overall Study|Death|1|||
164375587|NCT01420081|593747209|FG000|Overall Study|Lost to Follow-up|0|||
164375588|NCT01420081|593747210|FG001|Overall Study|Lost to Follow-up|0|||
164439225|NCT01376089|593975332|FG000|Overall Study|Patient received no contrast media|3|||
164439226|NCT01376089|593975333|FG001|Overall Study|Patient received no contrast media|4|||
164439227|NCT03262935|593975334|FG000|Overall Study|Withdrawal by Subject|6|||
164375589|NCT01420081|593747211|FG002|Overall Study|Lost to Follow-up|0|||
164375590|NCT01420081|593747212|FG003|Overall Study|Lost to Follow-up|0|||
164375591|NCT01420081|593747213|FG004|Overall Study|Lost to Follow-up|1|||
164375592|NCT01420081|593747214|FG005|Overall Study|Lost to Follow-up|1|||
164375593|NCT01420081|593747215|FG006|Overall Study|Lost to Follow-up|0|||
164375594|NCT01420081|593747216|FG007|Overall Study|Lost to Follow-up|0|||
164375595|NCT01420081|593747217|FG008|Overall Study|Lost to Follow-up|0|||
164375596|NCT01420081|593747209|FG000|Overall Study|Study Terminated by Sponsor|2|||
164375597|NCT01420081|593747210|FG001|Overall Study|Study Terminated by Sponsor|1|||
164375598|NCT01420081|593747211|FG002|Overall Study|Study Terminated by Sponsor|1|||
164375599|NCT01420081|593747212|FG003|Overall Study|Study Terminated by Sponsor|3|||
164375600|NCT01420081|593747213|FG004|Overall Study|Study Terminated by Sponsor|11|||
164375601|NCT01420081|593747214|FG005|Overall Study|Study Terminated by Sponsor|7|||
164375602|NCT01420081|593747215|FG006|Overall Study|Study Terminated by Sponsor|3|||
164375603|NCT01420081|593747216|FG007|Overall Study|Study Terminated by Sponsor|2|||
164375604|NCT01420081|593747217|FG008|Overall Study|Study Terminated by Sponsor|2|||
164375605|NCT01420081|593747209|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
164375606|NCT01420081|593747210|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
164375607|NCT01420081|593747211|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
164375608|NCT01420081|593747212|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
164375609|NCT01420081|593747213|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
164375610|NCT01420081|593747214|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
164375611|NCT01420081|593747215|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
164375612|NCT01420081|593747216|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
164375613|NCT01420081|593747217|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
164375614|NCT01420081|593747209|FG000|Overall Study|Other Reasons|0|||
164375615|NCT01420081|593747210|FG001|Overall Study|Other Reasons|0|||
164375616|NCT01420081|593747211|FG002|Overall Study|Other Reasons|1|||
164375617|NCT01420081|593747212|FG003|Overall Study|Other Reasons|0|||
164375618|NCT01420081|593747213|FG004|Overall Study|Other Reasons|0|||
164375619|NCT01420081|593747214|FG005|Overall Study|Other Reasons|0|||
164439228|NCT03262935|593975335|FG001|Overall Study|Withdrawal by Subject|7|||
164439229|NCT03262935|593975334|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
164439230|NCT03262935|593975335|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
164439231|NCT03262935|593975334|FG000|Overall Study|Death|181|||
164439232|NCT03262935|593975335|FG001|Overall Study|Death|94|||
164375620|NCT01420081|593747215|FG006|Overall Study|Other Reasons|0|||
164375621|NCT01420081|593747216|FG007|Overall Study|Other Reasons|0|||
164375622|NCT01420081|593747217|FG008|Overall Study|Other Reasons|0|||
164375623|NCT01723228|593747219|FG000|Overall Study|Adverse Event|2|||
164439233|NCT03262935|593975334|FG000|Overall Study|Lost to Follow-up|9|||
164375624|NCT01723228|593747220|FG001|Overall Study|Adverse Event|6|||
164375625|NCT01723228|593747219|FG000|Overall Study|Withdrawal by Subject|2|||
164375626|NCT01723228|593747220|FG001|Overall Study|Withdrawal by Subject|1|||
164375627|NCT01723228|593747219|FG000|Overall Study|Protocol Violation|0|||
164375628|NCT01723228|593747220|FG001|Overall Study|Protocol Violation|2|||
164375629|NCT01723228|593747219|FG000|Overall Study|Lost to Follow-up|2|||
164375630|NCT01723228|593747220|FG001|Overall Study|Lost to Follow-up|1|||
164375631|NCT01723228|593747219|FG000|Overall Study|Other|2|||
164375632|NCT01723228|593747220|FG001|Overall Study|Other|1|||
164375633|NCT01864291|593747221|FG000|Overall Study|need for revision surgery|2|||
164439234|NCT03262935|593975335|FG001|Overall Study|Lost to Follow-up|4|||
164439235|NCT03262935|593975334|FG000|Overall Study|Other reason|5|||
164375634|NCT01282216|593747222|FG000|Overall Study|Graft failure|0|||
164375635|NCT01282216|593747223|FG001|Overall Study|Graft failure|0|||
164375636|NCT01282216|593747224|FG002|Overall Study|Graft failure|3|||
164375637|NCT01282216|593747225|FG003|Overall Study|Graft failure|2|||
164375638|NCT01282216|593747222|FG000|Overall Study|Physician Decision|0|||
164375639|NCT01282216|593747223|FG001|Overall Study|Physician Decision|0|||
164375640|NCT01282216|593747224|FG002|Overall Study|Physician Decision|11|||
164375641|NCT01282216|593747225|FG003|Overall Study|Physician Decision|0|||
164375642|NCT01282216|593747222|FG000|Overall Study|Relapse|0|||
164375643|NCT01282216|593747223|FG001|Overall Study|Relapse|0|||
164375644|NCT01282216|593747224|FG002|Overall Study|Relapse|17|||
164375645|NCT01282216|593747225|FG003|Overall Study|Relapse|6|||
164375646|NCT01282216|593747222|FG000|Overall Study|Death|0|||
164375647|NCT01282216|593747223|FG001|Overall Study|Death|0|||
164375648|NCT01282216|593747224|FG002|Overall Study|Death|2|||
164375649|NCT01282216|593747225|FG003|Overall Study|Death|0|||
164375650|NCT03080961|593747227|FG000|Overall Study|Withdrawal by Subject|3|||
164375651|NCT03508219|593747234|FG000|Overall Study|Death|2|||
164375652|NCT03508219|593747234|FG000|Overall Study|Withdrawal by Subject|1|||
164375653|NCT03508219|593747234|FG000|Overall Study|Lost to Follow-up|4|||
164375654|NCT03508219|593747234|FG000|Overall Study|Missed visit|2|||
164375655|NCT04466891|593747235|FG000|Overall Study|Death|60|||
164375656|NCT04466891|593747236|FG001|Overall Study|Death|6|||
164375657|NCT04466891|593747235|FG000|Overall Study|Withdrawal by Subject|8|||
164375658|NCT04466891|593747236|FG001|Overall Study|Withdrawal by Subject|1|||
164375659|NCT04466891|593747235|FG000|Overall Study|Study terminated by sponsor|5|||
164375660|NCT04466891|593747236|FG001|Overall Study|Study terminated by sponsor|0|||
164375661|NCT04466891|593747235|FG000|Overall Study|Lost to Follow-up|2|||
164375662|NCT04466891|593747236|FG001|Overall Study|Lost to Follow-up|0|||
164375663|NCT04466891|593747235|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
164375664|NCT04466891|593747236|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
164375665|NCT00445328|593747237|FG000|Overall Study|Death|0|||
164375666|NCT00445328|593747238|FG001|Overall Study|Death|1|||
164375667|NCT00445328|593747237|FG000|Overall Study|Adverse Event|0|||
164375668|NCT00445328|593747238|FG001|Overall Study|Adverse Event|3|||
164375669|NCT00445328|593747237|FG000|Overall Study|Other|0|||
164375670|NCT00445328|593747238|FG001|Overall Study|Other|2|||
164375671|NCT00445328|593747237|FG000|Overall Study|Withdrawal by Subject|2|||
164375672|NCT00445328|593747238|FG001|Overall Study|Withdrawal by Subject|0|||
164375673|NCT00445328|593747237|FG000|Overall Study|Protocol Violation|1|||
164375674|NCT00445328|593747238|FG001|Overall Study|Protocol Violation|0|||
164375675|NCT00590954|593747241|FG000|Overall Study|Inevaluable|2|||
164375676|NCT02239536|593747242|FG000|Overall Study|Non-neoplastic polyp|23|||
164375677|NCT02239536|593747243|FG001|Overall Study|Non-neoplastic polyp|17|||
164375678|NCT02143414|593748679|FG000|Induction|Adverse Event|1|||
164375679|NCT02143414|593748680|FG001|Induction|Adverse Event|2|||
164375680|NCT02143414|593748679|FG000|Induction|Death|1|||
164375681|NCT02143414|593748680|FG001|Induction|Death|2|||
164375682|NCT02143414|593748679|FG000|Induction|Patient refusal|1|||
164375683|NCT02143414|593748680|FG001|Induction|Patient refusal|1|||
164375684|NCT02143414|593748679|FG000|Induction|Refractory|1|||
164375685|NCT02143414|593748680|FG001|Induction|Refractory|0|||
164375686|NCT02143414|593748679|FG000|Induction|Began alternative treatment|1|||
164375687|NCT02143414|593748680|FG001|Induction|Began alternative treatment|0|||
164375688|NCT02143414|593748679|FG000|Induction|Ineligible for postremission|5|||
164375689|NCT02143414|593748680|FG001|Induction|Ineligible for postremission|1|||
164375690|NCT02143414|593748679|FG000|Post-remission|Adverse Event|0|||
164375691|NCT02143414|593748680|FG001|Post-remission|Adverse Event|2|||
164375692|NCT02143414|593748679|FG000|Post-remission|Disease progression/relapse|5|||
164375693|NCT02143414|593748680|FG001|Post-remission|Disease progression/relapse|0|||
164375694|NCT02143414|593748679|FG000|Maintenance|Adverse Event|4|||
164375695|NCT02143414|593748680|FG001|Maintenance|Adverse Event|6|||
164375696|NCT02143414|593748679|FG000|Maintenance|Disease progression/relapse|3|||
164375697|NCT02143414|593748680|FG001|Maintenance|Disease progression/relapse|2|||
164375698|NCT02143414|593748679|FG000|Maintenance|Patient refusal|2|||
164375699|NCT02143414|593748680|FG001|Maintenance|Patient refusal|1|||
164375700|NCT02143414|593748679|FG000|Maintenance|Physician Decision|1|||
164375701|NCT02143414|593748680|FG001|Maintenance|Physician Decision|0|||
164375702|NCT02143414|593748679|FG000|Maintenance|Death|0|||
164375703|NCT02143414|593748680|FG001|Maintenance|Death|1|||
164375704|NCT02143414|593748679|FG000|Maintenance|On protocol treatment|0|||
164375705|NCT02143414|593748680|FG001|Maintenance|On protocol treatment|6|||
164375706|NCT00978731|593748684|FG000|Overall Study|Death|4|||
164375707|NCT00978731|593748685|FG001|Overall Study|Death|1|||
164375708|NCT00978731|593748686|FG002|Overall Study|Death|1|||
164375709|NCT00978731|593748687|FG003|Overall Study|Death|0|||
164375710|NCT00978731|593748684|FG000|Overall Study|Lost to Follow-up|0|||
164375711|NCT00978731|593748685|FG001|Overall Study|Lost to Follow-up|0|||
164375712|NCT00978731|593748686|FG002|Overall Study|Lost to Follow-up|0|||
164375713|NCT00978731|593748687|FG003|Overall Study|Lost to Follow-up|1|||
164375714|NCT00978731|593748684|FG000|Overall Study|Adverse Event|5|||
164375715|NCT00978731|593748685|FG001|Overall Study|Adverse Event|2|||
164375716|NCT00978731|593748686|FG002|Overall Study|Adverse Event|0|||
164375717|NCT00978731|593748687|FG003|Overall Study|Adverse Event|0|||
164375718|NCT00978731|593748684|FG000|Overall Study|Participant's request|1|||
164375719|NCT00978731|593748685|FG001|Overall Study|Participant's request|0|||
164700494|NCT01421342|594926837|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
164700495|NCT01421342|594926835|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
164700496|NCT01421342|594926836|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
164700497|NCT01421342|594926837|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
164700498|NCT01421342|594926835|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
164700499|NCT01421342|594926836|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
164700500|NCT01421342|594926837|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
164700501|NCT01421342|594926835|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
164700502|NCT01421342|594926836|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
164700503|NCT01421342|594926837|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
164700504|NCT01421342|594926835|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
164700505|NCT01421342|594926836|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
164375720|NCT00978731|593748686|FG002|Overall Study|Participant's request|0|||
164375721|NCT00978731|593748687|FG003|Overall Study|Participant's request|0|||
164375722|NCT00978731|593748684|FG000|Overall Study|Administrative reason|3|||
164375723|NCT00978731|593748685|FG001|Overall Study|Administrative reason|3|||
164375724|NCT00978731|593748686|FG002|Overall Study|Administrative reason|1|||
164375725|NCT00978731|593748687|FG003|Overall Study|Administrative reason|0|||
164375726|NCT00978731|593748684|FG000|Overall Study|Deterioration without progression|0|||
164375727|NCT00978731|593748685|FG001|Overall Study|Deterioration without progression|1|||
164375728|NCT00978731|593748686|FG002|Overall Study|Deterioration without progression|0|||
164375729|NCT00978731|593748687|FG003|Overall Study|Deterioration without progression|0|||
164375730|NCT00978731|593748684|FG000|Overall Study|Disease progression/relapse|5|||
164375731|NCT00978731|593748685|FG001|Overall Study|Disease progression/relapse|4|||
164375732|NCT00978731|593748686|FG002|Overall Study|Disease progression/relapse|2|||
164375733|NCT00978731|593748687|FG003|Overall Study|Disease progression/relapse|2|||
164375734|NCT00978731|593748684|FG000|Overall Study|Study closure|3|||
164375735|NCT00978731|593748685|FG001|Overall Study|Study closure|4|||
164375736|NCT00978731|593748686|FG002|Overall Study|Study closure|1|||
164375737|NCT00978731|593748687|FG003|Overall Study|Study closure|1|||
164375738|NCT00978731|593748684|FG000|Overall Study|No response|1|||
164375739|NCT00978731|593748685|FG001|Overall Study|No response|0|||
164375740|NCT00978731|593748686|FG002|Overall Study|No response|0|||
164375741|NCT00978731|593748687|FG003|Overall Study|No response|0|||
164700506|NCT01421342|594926837|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
164375742|NCT02649972|593748692|FG000|Overall Study|Not treated|1|||
164375743|NCT03107988|593748693|FG000|Overall Study|Adverse Event|0|||
164375744|NCT03107988|593748694|FG001|Overall Study|Adverse Event|0|||
164375745|NCT03107988|593748695|FG002|Overall Study|Adverse Event|0|||
164439236|NCT03262935|593975335|FG001|Overall Study|Other reason|0|||
164439237|NCT03557008|593975336|FG000|Overall Study|Withdrawal by Subject|2|||
164700507|NCT01421342|594926835|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
164700508|NCT01421342|594926836|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
164439238|NCT03557008|593975337|FG001|Overall Study|Withdrawal by Subject|2|||
164439239|NCT03557008|593975336|FG000|Overall Study|Early termination from study|3|||
164439240|NCT03557008|593975337|FG001|Overall Study|Early termination from study|1|||
164439241|NCT01458210|593975340|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
164439242|NCT01458210|593975340|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
164439243|NCT01458210|593975340|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
164439244|NCT01458210|593975340|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
164439245|NCT02224924|593975341|FG000|Overall Study|Withdrawal by Subject|7|||
164439246|NCT02224924|593975342|FG001|Overall Study|Withdrawal by Subject|6|||
164439247|NCT02224924|593975341|FG000|Overall Study|Biopsy cancelled|20|||
164439248|NCT02224924|593975342|FG001|Overall Study|Biopsy cancelled|14|||
164439249|NCT02224924|593975341|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
164439250|NCT02224924|593975342|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
164439251|NCT02224924|593975341|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
164375746|NCT03107988|593748696|FG003|Overall Study|Adverse Event|1|||
164375747|NCT03107988|593748697|FG004|Overall Study|Adverse Event|0|||
164375748|NCT03107988|593748698|FG005|Overall Study|Adverse Event|1|||
164375749|NCT03107988|593748699|FG006|Overall Study|Adverse Event|0|||
164375750|NCT03107988|593748700|FG007|Overall Study|Adverse Event|1|||
164375751|NCT03107988|593748701|FG008|Overall Study|Adverse Event|0|||
164375752|NCT03107988|593748702|FG009|Overall Study|Adverse Event|0|||
164375753|NCT03107988|593748703|FG010|Overall Study|Adverse Event|0|||
164375754|NCT03107988|593748704|FG011|Overall Study|Adverse Event|0|||
164375755|NCT03107988|593748705|FG012|Overall Study|Adverse Event|0|||
164375756|NCT03107988|593748693|FG000|Overall Study|Disease Progression or Relapse|1|||
164375757|NCT03107988|593748694|FG001|Overall Study|Disease Progression or Relapse|2|||
164375758|NCT03107988|593748695|FG002|Overall Study|Disease Progression or Relapse|2|||
164375759|NCT03107988|593748696|FG003|Overall Study|Disease Progression or Relapse|5|||
164375760|NCT03107988|593748697|FG004|Overall Study|Disease Progression or Relapse|1|||
164375761|NCT03107988|593748698|FG005|Overall Study|Disease Progression or Relapse|1|||
164375762|NCT03107988|593748699|FG006|Overall Study|Disease Progression or Relapse|0|||
164375763|NCT03107988|593748700|FG007|Overall Study|Disease Progression or Relapse|0|||
164375764|NCT03107988|593748701|FG008|Overall Study|Disease Progression or Relapse|0|||
164375765|NCT03107988|593748702|FG009|Overall Study|Disease Progression or Relapse|1|||
164375766|NCT03107988|593748703|FG010|Overall Study|Disease Progression or Relapse|4|||
164375767|NCT03107988|593748704|FG011|Overall Study|Disease Progression or Relapse|0|||
164375768|NCT03107988|593748705|FG012|Overall Study|Disease Progression or Relapse|0|||
164375769|NCT03107988|593748693|FG000|Overall Study|Ineligible|0|||
164439252|NCT02224924|593975342|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
164439253|NCT01867216|593975343|FG000|Overall Study|Withdrawal by Subject|2|||
164439254|NCT01867216|593975344|FG001|Overall Study|Withdrawal by Subject|0|||
164439255|NCT01867216|593975345|FG002|Overall Study|Withdrawal by Subject|0|||
164439256|NCT01867216|593975346|FG003|Overall Study|Withdrawal by Subject|0|||
164439257|NCT01867216|593975347|FG004|Overall Study|Withdrawal by Subject|1|||
164439258|NCT01867216|593975348|FG005|Overall Study|Withdrawal by Subject|0|||
164439259|NCT01867216|593975349|FG006|Overall Study|Withdrawal by Subject|1|||
164439260|NCT01867216|593975343|FG000|Overall Study|Physician Decision|1|||
164439261|NCT01867216|593975344|FG001|Overall Study|Physician Decision|0|||
164439262|NCT01867216|593975345|FG002|Overall Study|Physician Decision|0|||
164439263|NCT01867216|593975346|FG003|Overall Study|Physician Decision|0|||
164439264|NCT01867216|593975347|FG004|Overall Study|Physician Decision|0|||
164439265|NCT01867216|593975348|FG005|Overall Study|Physician Decision|0|||
164439266|NCT01867216|593975349|FG006|Overall Study|Physician Decision|0|||
164439267|NCT01867216|593975343|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
164439268|NCT01867216|593975344|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
164439269|NCT01867216|593975345|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
164439270|NCT01867216|593975346|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
164439271|NCT01867216|593975347|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
164439272|NCT01867216|593975348|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
164439273|NCT01867216|593975349|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
164439274|NCT03020745|593975350|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
164439275|NCT03020745|593975351|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
164439276|NCT03020745|593975352|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
164439277|NCT03020745|593975353|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
164439278|NCT03020745|593975354|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
164439279|NCT03020745|593975355|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
164439280|NCT03020745|593975356|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
164439281|NCT03020745|593975357|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
164439282|NCT03020745|593975358|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
164439283|NCT03020745|593975359|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
164439284|NCT03020745|593975350|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
164439285|NCT03020745|593975351|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
164439286|NCT03020745|593975352|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
164439287|NCT03020745|593975353|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
164375770|NCT03107988|593748694|FG001|Overall Study|Ineligible|0|||
164375771|NCT03107988|593748695|FG002|Overall Study|Ineligible|0|||
164375772|NCT03107988|593748696|FG003|Overall Study|Ineligible|0|||
164375773|NCT03107988|593748697|FG004|Overall Study|Ineligible|0|||
164375774|NCT03107988|593748698|FG005|Overall Study|Ineligible|0|||
164375775|NCT03107988|593748699|FG006|Overall Study|Ineligible|0|||
164375776|NCT03107988|593748700|FG007|Overall Study|Ineligible|0|||
164375777|NCT03107988|593748701|FG008|Overall Study|Ineligible|1|||
164375778|NCT03107988|593748702|FG009|Overall Study|Ineligible|0|||
164375779|NCT03107988|593748703|FG010|Overall Study|Ineligible|0|||
164375780|NCT03107988|593748704|FG011|Overall Study|Ineligible|0|||
164375781|NCT03107988|593748705|FG012|Overall Study|Ineligible|0|||
164375782|NCT01344057|593748706|FG000|Overall Study|Premature Withdrawal|1|||
164375783|NCT00529386|593748707|FG000|Overall Study|Lost to Follow-up|1|||
164439288|NCT03020745|593975354|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
164439289|NCT03020745|593975355|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
164439290|NCT03020745|593975356|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
164439291|NCT03020745|593975357|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
164439292|NCT03020745|593975358|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
164375784|NCT04027686|593748708|FG000|Overall Study|Lost to Follow-up|2|||
164375785|NCT04027686|593748709|FG001|Overall Study|Lost to Follow-up|0|||
164375786|NCT04027686|593748708|FG000|Overall Study|Withdrawal by Subject|0|||
164375787|NCT04027686|593748709|FG001|Overall Study|Withdrawal by Subject|1|||
164591750|NCT00195260|594529984|FG002|Part 1: Dose Escalation|Death|0|||
164591751|NCT00195260|594529985|FG003|Part 1: Dose Escalation|Death|0|||
164591752|NCT00195260|594529986|FG004|Part 1: Dose Escalation|Death|0|||
164591753|NCT00195260|594529987|FG005|Part 1: Dose Escalation|Death|0|||
164591754|NCT00195260|594529988|FG006|Part 1: Dose Escalation|Death|0|||
164591755|NCT00195260|594529989|FG007|Part 1: Dose Escalation|Death|1|||
164591756|NCT00195260|594529990|FG008|Part 1: Dose Escalation|Death|0|||
164591757|NCT00195260|594529991|FG009|Part 1: Dose Escalation|Death|0|||
164591758|NCT00195260|594529992|FG010|Part 1: Dose Escalation|Death|0|||
164591759|NCT00195260|594529982|FG000|Part 1: Dose Escalation|Disease Progression|3|||
164591760|NCT00195260|594529983|FG001|Part 1: Dose Escalation|Disease Progression|2|||
164591761|NCT00195260|594529984|FG002|Part 1: Dose Escalation|Disease Progression|5|||
164591762|NCT00195260|594529985|FG003|Part 1: Dose Escalation|Disease Progression|6|||
164591763|NCT00195260|594529986|FG004|Part 1: Dose Escalation|Disease Progression|4|||
164591764|NCT00195260|594529987|FG005|Part 1: Dose Escalation|Disease Progression|6|||
164591765|NCT00195260|594529988|FG006|Part 1: Dose Escalation|Disease Progression|7|||
164591766|NCT00195260|594529989|FG007|Part 1: Dose Escalation|Disease Progression|4|||
164591767|NCT00195260|594529990|FG008|Part 1: Dose Escalation|Disease Progression|0|||
164591768|NCT00195260|594529991|FG009|Part 1: Dose Escalation|Disease Progression|0|||
164591769|NCT00195260|594529992|FG010|Part 1: Dose Escalation|Disease Progression|0|||
164591770|NCT00195260|594529982|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
164591771|NCT00195260|594529983|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
164591772|NCT00195260|594529984|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
164591773|NCT00195260|594529985|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
164591774|NCT00195260|594529986|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
164591775|NCT00195260|594529987|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
164591776|NCT00195260|594529988|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
164591777|NCT00195260|594529989|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
164591778|NCT00195260|594529990|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
164591779|NCT00195260|594529991|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
164591780|NCT00195260|594529992|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
164591781|NCT00195260|594529982|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
164591782|NCT00195260|594529983|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
164591783|NCT00195260|594529984|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
164591784|NCT00195260|594529985|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
164591785|NCT00195260|594529986|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
164591786|NCT00195260|594529987|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
164591787|NCT00195260|594529988|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
164591788|NCT00195260|594529989|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
164591789|NCT00195260|594529990|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
164591790|NCT00195260|594529991|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
164591791|NCT00195260|594529992|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
164591792|NCT00195260|594529982|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
164591793|NCT00195260|594529983|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
164591794|NCT00195260|594529984|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
164591795|NCT00195260|594529985|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
164591796|NCT00195260|594529986|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
164591797|NCT00195260|594529987|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
164591798|NCT00195260|594529988|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
164591799|NCT00195260|594529989|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
164591800|NCT00195260|594529990|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
164591801|NCT00195260|594529991|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
164591802|NCT00195260|594529992|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
164591803|NCT00195260|594529982|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
164591804|NCT00195260|594529983|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
164591805|NCT00195260|594529984|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
164591806|NCT00195260|594529985|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
164591807|NCT00195260|594529986|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
164591808|NCT00195260|594529987|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
164700509|NCT01421342|594926837|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
164375788|NCT02939404|593748710|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
164375789|NCT02939404|593748711|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
164591809|NCT00195260|594529988|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
164591810|NCT00195260|594529989|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
164591811|NCT00195260|594529990|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
164591812|NCT00195260|594529991|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
164700510|NCT01421342|594926835|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
164700511|NCT01421342|594926836|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
164375790|NCT02939404|593748710|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
164375791|NCT02939404|593748711|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
164375792|NCT01428193|593748712|FG000|Overall Study|Physician Decision|1|||
164375793|NCT01428193|593748712|FG000|Overall Study|Elevated screening liver enzymes|1|||
164375794|NCT00357370|593748717|FG000|Cohort 2|Lack of Efficacy|0|||
164375795|NCT00357370|593748718|FG001|Cohort 2|Lack of Efficacy|2|||
164375796|NCT00357370|593748719|FG002|Cohort 2|Lack of Efficacy|1|||
164375797|NCT00357370|593748717|FG000|Cohort 2|Adverse Event|1|||
164375798|NCT00357370|593748718|FG001|Cohort 2|Adverse Event|1|||
164375799|NCT00357370|593748719|FG002|Cohort 2|Adverse Event|1|||
164375800|NCT00357370|593748717|FG000|Cohort 2|Lost to Follow-up|0|||
164375801|NCT00357370|593748718|FG001|Cohort 2|Lost to Follow-up|1|||
164375802|NCT00357370|593748719|FG002|Cohort 2|Lost to Follow-up|0|||
164375803|NCT00357370|593748717|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
164375804|NCT00357370|593748718|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
164375805|NCT00357370|593748719|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
164375806|NCT00357370|593748717|FG000|Cohort 2|Withdrawal by Subject|0|||
164375807|NCT00357370|593748718|FG001|Cohort 2|Withdrawal by Subject|2|||
164375808|NCT00357370|593748719|FG002|Cohort 2|Withdrawal by Subject|0|||
164375809|NCT02075437|593748721|FG000|Overall Study|Withdrawal by Subject|5|||
164375810|NCT02075437|593748721|FG000|Overall Study|Lost to Follow-up|1|||
164375811|NCT01632800|593748722|FG000|Overall Study|Subject did not fit in apparatus|1|||
164375812|NCT01502644|593748725|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
164375813|NCT01502644|593748726|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
164375814|NCT01502644|593748727|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
164375815|NCT01502644|593748728|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
164375816|NCT01502644|593748725|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
164375817|NCT01502644|593748726|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
164375818|NCT01502644|593748727|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
164375819|NCT01502644|593748728|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
164375820|NCT01502644|593748725|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
164375821|NCT01502644|593748726|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
164375822|NCT01502644|593748727|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
164375823|NCT01502644|593748728|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
164375824|NCT01502644|593748725|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
164375825|NCT01502644|593748726|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
164375826|NCT01502644|593748727|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
164375827|NCT01502644|593748728|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
164375828|NCT01502644|593748725|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
164375829|NCT01502644|593748726|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
164375830|NCT01502644|593748727|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
164375831|NCT01502644|593748728|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
164375832|NCT03306264|593748731|FG000|Overall Study|Death|33|||
164375833|NCT03306264|593748732|FG001|Overall Study|Death|25|||
164375834|NCT03306264|593748733|FG002|Overall Study|Death|34|||
164375835|NCT03306264|593748734|FG003|Overall Study|Death|34|||
164375836|NCT03306264|593748731|FG000|Overall Study|Complete Consent Withdrawal|4|||
164375837|NCT03306264|593748732|FG001|Overall Study|Complete Consent Withdrawal|4|||
164375838|NCT03306264|593748733|FG002|Overall Study|Complete Consent Withdrawal|1|||
164375839|NCT03306264|593748734|FG003|Overall Study|Complete Consent Withdrawal|8|||
164375840|NCT03306264|593748731|FG000|Overall Study|Lost to Follow-up|1|||
164439293|NCT03020745|593975359|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
164439294|NCT03020745|593975350|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
164439295|NCT03020745|593975351|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
164375841|NCT03306264|593748732|FG001|Overall Study|Lost to Follow-up|0|||
164375842|NCT03306264|593748733|FG002|Overall Study|Lost to Follow-up|1|||
164375843|NCT03306264|593748734|FG003|Overall Study|Lost to Follow-up|0|||
164375844|NCT03306264|593748731|FG000|Overall Study|Rollover to ASTX727-06|10|||
164375845|NCT03306264|593748732|FG001|Overall Study|Rollover to ASTX727-06|18|||
164375846|NCT03306264|593748733|FG002|Overall Study|Rollover to ASTX727-06|4|||
164375847|NCT03306264|593748734|FG003|Overall Study|Rollover to ASTX727-06|2|||
164375848|NCT03306264|593748731|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
164375849|NCT03306264|593748732|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
164375850|NCT03306264|593748733|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
164375851|NCT03306264|593748734|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
164375852|NCT02722928|593748740|FG000|Overall Study|Standard CT was not as required per prot|5|||
164375853|NCT02722928|593748741|FG001|Overall Study|Standard CT was not as required per prot|13|||
164375854|NCT02722928|593748740|FG000|Overall Study|Required Intraoperative MRI|5|||
164375855|NCT02722928|593748741|FG001|Overall Study|Required Intraoperative MRI|7|||
164375856|NCT00094653|593748744|FG000|Overall Study|Death|306|||
164375857|NCT00094653|593748745|FG001|Overall Study|Death|100|||
164375858|NCT00094653|593748746|FG002|Overall Study|Death|119|||
164375859|NCT00094653|593748744|FG000|Overall Study|Subject Withdrew Consent|10|||
164375860|NCT00094653|593748745|FG001|Overall Study|Subject Withdrew Consent|2|||
164375861|NCT00094653|593748746|FG002|Overall Study|Subject Withdrew Consent|3|||
164375862|NCT00094653|593748744|FG000|Overall Study|Other|2|||
164375863|NCT00094653|593748745|FG001|Overall Study|Other|2|||
164375864|NCT00094653|593748746|FG002|Overall Study|Other|2|||
164375865|NCT00094653|593748744|FG000|Overall Study|Lost to Follow-up|3|||
164375866|NCT00094653|593748745|FG001|Overall Study|Lost to Follow-up|2|||
164375867|NCT00094653|593748746|FG002|Overall Study|Lost to Follow-up|1|||
164375868|NCT00094653|593748744|FG000|Overall Study|Protocol Violation|0|||
164375869|NCT00094653|593748745|FG001|Overall Study|Protocol Violation|0|||
164375870|NCT00094653|593748746|FG002|Overall Study|Protocol Violation|1|||
164375871|NCT03921411|593748747|FG000|Overall Study|Withdrawal by Subject|1|||
164375872|NCT03921411|593748747|FG000|Overall Study|Protocol Deviation|2|||
164375873|NCT03921411|593748747|FG000|Overall Study|Enrolled, but never treated|2|||
164375874|NCT03120013|593748751|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
164375875|NCT03120013|593748752|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
164375876|NCT05059600|593748753|FG000|Overall Study|Enrolled but not Treated|10|||
164375877|NCT02152995|593748754|FG000|Overall Study|Withdrawal by Subject|1|||
164375878|NCT02152995|593748755|FG001|Overall Study|Withdrawal by Subject|0|||
164375879|NCT02098109|593748756|FG000|Overall Study|Protocol Violation|3|||
164375880|NCT02098109|593748757|FG001|Overall Study|Protocol Violation|0|||
164375881|NCT01541826|593748758|FG000|Overall Study|Lost to Follow-up|2|||
164375882|NCT01541826|593748759|FG001|Overall Study|Lost to Follow-up|3|||
164375883|NCT01541826|593748760|FG002|Overall Study|Lost to Follow-up|0|||
164375884|NCT01541826|593748758|FG000|Overall Study|Withdrawal by Subject|2|||
164375885|NCT01541826|593748759|FG001|Overall Study|Withdrawal by Subject|0|||
164375886|NCT01541826|593748760|FG002|Overall Study|Withdrawal by Subject|0|||
164375887|NCT01565291|593748761|FG000|Overall Study|Withdrawal by Subject|1|||
164375888|NCT01565291|593748762|FG001|Overall Study|Withdrawal by Subject|0|||
164375889|NCT04552587|593748770|FG000|Overall Study|Lost to Follow-up|4|||
164375890|NCT01822132|593748771|FG000|Overall Study|Lost to Follow-up|4|||
164375891|NCT01822132|593748772|FG001|Overall Study|Lost to Follow-up|2|||
164375892|NCT00854581|593748774|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
164375893|NCT00854581|593748774|FG000|Induction (Up to Day 21)|Death|1|||
164375894|NCT00854581|593748774|FG000|Induction (Up to Day 21)|Physician Decision|1|||
164439296|NCT03020745|593975352|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
164439297|NCT03020745|593975353|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
164591813|NCT00195260|594529992|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
164375895|NCT00854581|593748774|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
164375896|NCT00313612|593748775|FG000|Overall Study|Patient never received treatment|0|||
164375897|NCT00313612|593748776|FG001|Overall Study|Patient never received treatment|1|||
164375898|NCT02705820|593748777|FG000|Overall Study|Death|2|||
164375899|NCT02705820|593748777|FG000|Overall Study|Disease Progression|34|||
164375900|NCT02705820|593748777|FG000|Overall Study|Clinical Deterioration|3|||
164375901|NCT02702401|593748781|FG000|Overall Study|Death|242|||
164375902|NCT02702401|593748782|FG001|Overall Study|Death|125|||
164375903|NCT02702401|593748781|FG000|Overall Study|Withdrawal by Subject|15|||
164375904|NCT02702401|593748782|FG001|Overall Study|Withdrawal by Subject|5|||
164375905|NCT02702401|593748781|FG000|Overall Study|Sponsor Decision|19|||
164375906|NCT02702401|593748782|FG001|Overall Study|Sponsor Decision|3|||
164375907|NCT02702401|593748781|FG000|Overall Study|Physician Decision|1|||
164375908|NCT02702401|593748782|FG001|Overall Study|Physician Decision|2|||
164375909|NCT02702401|593748781|FG000|Overall Study|Lost to Follow-up|1|||
164591814|NCT00195260|594529982|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
164144031|NCT00086281|592888585|FG014|Phase 1|Serious Adverse Event|1|||
164375910|NCT02702401|593748782|FG001|Overall Study|Lost to Follow-up|0|||
164375911|NCT00677807|593748783|FG000|Overall Study|Adverse Event|4|||
164375912|NCT00677807|593748784|FG001|Overall Study|Adverse Event|1|||
164375913|NCT00677807|593748785|FG002|Overall Study|Adverse Event|6|||
164375914|NCT00677807|593748783|FG000|Overall Study|Lack of Efficacy|0|||
164375915|NCT00677807|593748784|FG001|Overall Study|Lack of Efficacy|0|||
164375916|NCT00677807|593748785|FG002|Overall Study|Lack of Efficacy|2|||
164375917|NCT00677807|593748783|FG000|Overall Study|Participant no longer needs study drug|0|||
164375918|NCT00677807|593748784|FG001|Overall Study|Participant no longer needs study drug|0|||
164375919|NCT00677807|593748785|FG002|Overall Study|Participant no longer needs study drug|1|||
164375920|NCT00677807|593748783|FG000|Overall Study|Withdrawal by Subject|10|||
164375921|NCT00677807|593748784|FG001|Overall Study|Withdrawal by Subject|3|||
164375922|NCT00677807|593748785|FG002|Overall Study|Withdrawal by Subject|6|||
164375923|NCT00677807|593748783|FG000|Overall Study|Lost to Follow-up|2|||
164375924|NCT00677807|593748784|FG001|Overall Study|Lost to Follow-up|2|||
164375925|NCT00677807|593748785|FG002|Overall Study|Lost to Follow-up|2|||
164375926|NCT00677807|593748783|FG000|Overall Study|Administrative problems|1|||
164375927|NCT00677807|593748784|FG001|Overall Study|Administrative problems|1|||
164375928|NCT00677807|593748785|FG002|Overall Study|Administrative problems|2|||
164375929|NCT00677807|593748783|FG000|Overall Study|Death|0|||
164375930|NCT00677807|593748784|FG001|Overall Study|Death|1|||
164375931|NCT00677807|593748785|FG002|Overall Study|Death|1|||
164375932|NCT00677807|593748783|FG000|Overall Study|Protocol Deviation|1|||
164375933|NCT00677807|593748784|FG001|Overall Study|Protocol Deviation|3|||
164375934|NCT00677807|593748785|FG002|Overall Study|Protocol Deviation|0|||
164375935|NCT01393743|593748791|FG000|Core Study|Adverse Event|5|||
164375936|NCT01393743|593748792|FG001|Core Study|Adverse Event|9|||
164375937|NCT01393743|593748793|FG002|Core Study|Adverse Event|0|||
164375938|NCT01393743|593748791|FG000|Core Study|Lost to Follow-up|1|||
164375939|NCT01393743|593748792|FG001|Core Study|Lost to Follow-up|1|||
164375940|NCT01393743|593748793|FG002|Core Study|Lost to Follow-up|0|||
164375941|NCT01393743|593748791|FG000|Core Study|Participant's Choice|2|||
164375942|NCT01393743|593748792|FG001|Core Study|Participant's Choice|3|||
164375943|NCT01393743|593748793|FG002|Core Study|Participant's Choice|0|||
164375944|NCT01393743|593748791|FG000|Core Study|Inadequate therapeutic effect|2|||
164375945|NCT01393743|593748792|FG001|Core Study|Inadequate therapeutic effect|0|||
164375946|NCT01393743|593748793|FG002|Core Study|Inadequate therapeutic effect|0|||
164375947|NCT01393743|593748791|FG000|Extension Phase|Adverse Event|0|||
164375948|NCT01393743|593748792|FG001|Extension Phase|Adverse Event|0|||
164375949|NCT01393743|593748793|FG002|Extension Phase|Adverse Event|12|||
164375950|NCT01393743|593748791|FG000|Extension Phase|Lost to Follow-up|0|||
164375951|NCT01393743|593748792|FG001|Extension Phase|Lost to Follow-up|0|||
164375952|NCT01393743|593748793|FG002|Extension Phase|Lost to Follow-up|2|||
164375953|NCT01393743|593748791|FG000|Extension Phase|Participant choice|0|||
164375954|NCT01393743|593748792|FG001|Extension Phase|Participant choice|0|||
164375955|NCT01393743|593748793|FG002|Extension Phase|Participant choice|16|||
164375956|NCT01393743|593748791|FG000|Extension Phase|Inadequate therapeutic effect|0|||
164375957|NCT01393743|593748792|FG001|Extension Phase|Inadequate therapeutic effect|0|||
164375958|NCT01393743|593748793|FG002|Extension Phase|Inadequate therapeutic effect|7|||
164375959|NCT01393743|593748791|FG000|Extension Phase|Withdrawal by Subject|0|||
164375960|NCT01393743|593748792|FG001|Extension Phase|Withdrawal by Subject|0|||
164375961|NCT01393743|593748793|FG002|Extension Phase|Withdrawal by Subject|8|||
164375962|NCT01393743|593748791|FG000|Extension Phase|Pregnancy|0|||
164375963|NCT01393743|593748792|FG001|Extension Phase|Pregnancy|0|||
164375964|NCT01393743|593748793|FG002|Extension Phase|Pregnancy|1|||
164375965|NCT01393743|593748791|FG000|Extension Phase|Other|0|||
164375966|NCT01393743|593748792|FG001|Extension Phase|Other|0|||
164375967|NCT01393743|593748793|FG002|Extension Phase|Other|14|||
164375968|NCT00989833|593748798|FG000|Overall Study|Lost to Follow-up|0|||
164375969|NCT00989833|593748799|FG001|Overall Study|Lost to Follow-up|1|||
164375970|NCT00989833|593748800|FG002|Overall Study|Lost to Follow-up|0|||
164375971|NCT00989833|593748798|FG000|Overall Study|Protocol Violation|1|||
164375972|NCT00989833|593748799|FG001|Overall Study|Protocol Violation|2|||
164375973|NCT00989833|593748800|FG002|Overall Study|Protocol Violation|1|||
164375974|NCT00989833|593748798|FG000|Overall Study|Withdrawal by Subject|0|||
164375975|NCT00989833|593748799|FG001|Overall Study|Withdrawal by Subject|0|||
164375976|NCT00989833|593748800|FG002|Overall Study|Withdrawal by Subject|1|||
164375977|NCT00989833|593748798|FG000|Overall Study|Incorrectly randomized|1|||
164375978|NCT00989833|593748799|FG001|Overall Study|Incorrectly randomized|0|||
164375979|NCT00989833|593748800|FG002|Overall Study|Incorrectly randomized|0|||
164375980|NCT00678561|593748802|FG000|Overall Study|Adverse Event|0|||
164375981|NCT00678561|593748803|FG001|Overall Study|Adverse Event|1|||
164375982|NCT00678561|593748804|FG002|Overall Study|Adverse Event|1|||
164375983|NCT00678561|593748805|FG003|Overall Study|Adverse Event|0|||
164375984|NCT00678561|593748806|FG004|Overall Study|Adverse Event|1|||
164375985|NCT00678561|593748807|FG005|Overall Study|Adverse Event|0|||
164375986|NCT00678561|593748808|FG006|Overall Study|Adverse Event|0|||
164375987|NCT00678561|593748809|FG007|Overall Study|Adverse Event|0|||
164375988|NCT00678561|593748802|FG000|Overall Study|Protocol Violation|0|||
164375989|NCT00678561|593748803|FG001|Overall Study|Protocol Violation|0|||
164375990|NCT00678561|593748804|FG002|Overall Study|Protocol Violation|0|||
164375991|NCT00678561|593748805|FG003|Overall Study|Protocol Violation|0|||
164375992|NCT00678561|593748806|FG004|Overall Study|Protocol Violation|1|||
164375993|NCT00678561|593748807|FG005|Overall Study|Protocol Violation|1|||
164375994|NCT00678561|593748808|FG006|Overall Study|Protocol Violation|0|||
164375995|NCT00678561|593748809|FG007|Overall Study|Protocol Violation|0|||
164375996|NCT00678561|593748802|FG000|Overall Study|Withdrawal by Subject|0|||
164375997|NCT00678561|593748803|FG001|Overall Study|Withdrawal by Subject|0|||
164375998|NCT00678561|593748804|FG002|Overall Study|Withdrawal by Subject|0|||
164375999|NCT00678561|593748805|FG003|Overall Study|Withdrawal by Subject|0|||
164376000|NCT00678561|593748806|FG004|Overall Study|Withdrawal by Subject|0|||
164376001|NCT00678561|593748807|FG005|Overall Study|Withdrawal by Subject|0|||
164376002|NCT00678561|593748808|FG006|Overall Study|Withdrawal by Subject|0|||
164376003|NCT00678561|593748809|FG007|Overall Study|Withdrawal by Subject|1|||
164376004|NCT05645432|593748810|FG000|Overall Study|Withdrawal by Subject|1|||
164376005|NCT03195478|593748811|FG000|Overall Study|Disease Progression|5|||
164376006|NCT03195478|593748812|FG001|Overall Study|Disease Progression|4|||
164376007|NCT03195478|593748813|FG002|Overall Study|Disease Progression|6|||
164376008|NCT03195478|593748814|FG003|Overall Study|Disease Progression|1|||
164376009|NCT03195478|593748811|FG000|Overall Study|Study Drug Toxicity|2|||
164376010|NCT03195478|593748812|FG001|Overall Study|Study Drug Toxicity|0|||
164376011|NCT03195478|593748813|FG002|Overall Study|Study Drug Toxicity|0|||
164376012|NCT03195478|593748814|FG003|Overall Study|Study Drug Toxicity|1|||
164376013|NCT03195478|593748811|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
164376014|NCT03195478|593748812|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
164376015|NCT03195478|593748813|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
164376016|NCT03195478|593748814|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
164376017|NCT03195478|593748811|FG000|Overall Study|Participant Withdrew Consent|1|||
164376018|NCT03195478|593748812|FG001|Overall Study|Participant Withdrew Consent|0|||
164376019|NCT03195478|593748813|FG002|Overall Study|Participant Withdrew Consent|0|||
164376020|NCT03195478|593748814|FG003|Overall Study|Participant Withdrew Consent|0|||
164376021|NCT03195478|593748811|FG000|Overall Study|Maximum Clinical benefit|0|||
164376022|NCT03195478|593748812|FG001|Overall Study|Maximum Clinical benefit|0|||
164376023|NCT03195478|593748813|FG002|Overall Study|Maximum Clinical benefit|1|||
164376024|NCT03195478|593748814|FG003|Overall Study|Maximum Clinical benefit|0|||
164376025|NCT03195478|593748811|FG000|Overall Study|Other Reasons|0|||
164376026|NCT03195478|593748812|FG001|Overall Study|Other Reasons|0|||
164376027|NCT03195478|593748813|FG002|Overall Study|Other Reasons|1|||
164376028|NCT03195478|593748814|FG003|Overall Study|Other Reasons|0|||
164376029|NCT04101526|593749773|FG000|Overall Study|Did not complete all sleep diary entries|0|||
164376030|NCT04101526|593749774|FG001|Overall Study|Did not complete all sleep diary entries|1|||
164376031|NCT02944578|593749775|FG000|Overall Study|Physician Decision|1|||
164376032|NCT02944578|593749776|FG001|Overall Study|Physician Decision|0|||
164376033|NCT00548808|593749779|FG000|Overall Study|Lost to Follow-up|9|||
164376034|NCT00548808|593749780|FG001|Overall Study|Lost to Follow-up|3|||
164376035|NCT00548808|593749779|FG000|Overall Study|Protocol Violation|8|||
164376036|NCT00548808|593749780|FG001|Overall Study|Protocol Violation|8|||
164376037|NCT00548808|593749779|FG000|Overall Study|Withdrawal by Subject|8|||
164376038|NCT00548808|593749780|FG001|Overall Study|Withdrawal by Subject|4|||
164376039|NCT00548808|593749779|FG000|Overall Study|Physician Decision|6|||
164376040|NCT00548808|593749780|FG001|Overall Study|Physician Decision|3|||
164376041|NCT00548808|593749779|FG000|Overall Study|Adverse Event|4|||
164376042|NCT00548808|593749780|FG001|Overall Study|Adverse Event|5|||
164376043|NCT00548808|593749779|FG000|Overall Study|Death|2|||
164376044|NCT00548808|593749780|FG001|Overall Study|Death|0|||
164376045|NCT00548808|593749779|FG000|Overall Study|Entry Criteria Not Met|2|||
164376046|NCT00548808|593749780|FG001|Overall Study|Entry Criteria Not Met|2|||
164376047|NCT00548808|593749779|FG000|Overall Study|Lack of Efficacy|2|||
164376048|NCT00548808|593749780|FG001|Overall Study|Lack of Efficacy|0|||
164376049|NCT00548808|593749779|FG000|Overall Study|Sponsor Decision|1|||
164376050|NCT00548808|593749780|FG001|Overall Study|Sponsor Decision|1|||
164376051|NCT00424372|593749782|FG000|Overall Study|Death|1|||
164376052|NCT00424372|593749782|FG000|Overall Study|Adverse Event|18|||
164376053|NCT00424372|593749782|FG000|Overall Study|Lack of Efficacy|6|||
164376054|NCT00424372|593749782|FG000|Overall Study|Withdrawal by Subject|4|||
164376055|NCT00424372|593749782|FG000|Overall Study|Protocol Violation|1|||
164376056|NCT00424372|593749782|FG000|Overall Study|Health deterioration|1|||
164376057|NCT04879745|593749784|FG000|Overall Study|Lost to Follow-up|4|||
164376058|NCT04879745|593749785|FG001|Overall Study|Lost to Follow-up|1|||
164376059|NCT00120042|593749786|FG000|Overall Study|all completed protocl|0|||
164376060|NCT00120042|593749787|FG001|Overall Study|all completed protocl|0|||
164376061|NCT00120042|593749788|FG002|Overall Study|all completed protocl|0|||
164376062|NCT04532112|593749791|FG000|Overall Study|Adverse Event|3|||
164376063|NCT04532112|593749792|FG001|Overall Study|Adverse Event|0|||
164376064|NCT03592641|593749793|FG000|Overall Study|Withdrawal by Subject|1|||
164376065|NCT00844545|593749795|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
164376066|NCT00844545|593749795|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
164376067|NCT00844545|593749795|FG000|Extension Treatment Period|Adverse Event|2|||
164376068|NCT00844545|593749795|FG000|Post Treatment Period|Withdrawal by Subject|1|||
164376069|NCT01126541|593749796|FG000|Overall Study|Adverse Event|0|||
164376070|NCT01126541|593749797|FG001|Overall Study|Adverse Event|2|||
164376071|NCT01126541|593749798|FG002|Overall Study|Adverse Event|4|||
164376072|NCT01126541|593749796|FG000|Overall Study|Death|0|||
164376073|NCT01126541|593749797|FG001|Overall Study|Death|1|||
164376074|NCT01126541|593749798|FG002|Overall Study|Death|0|||
164376075|NCT01126541|593749796|FG000|Overall Study|Lack of Efficacy|6|||
164376076|NCT01126541|593749797|FG001|Overall Study|Lack of Efficacy|1|||
164376077|NCT01126541|593749798|FG002|Overall Study|Lack of Efficacy|11|||
164376078|NCT01126541|593749796|FG000|Overall Study|Lost to Follow-up|1|||
164376079|NCT01126541|593749797|FG001|Overall Study|Lost to Follow-up|2|||
164376080|NCT01126541|593749798|FG002|Overall Study|Lost to Follow-up|2|||
164376081|NCT01126541|593749796|FG000|Overall Study|Withdrawal by Subject|2|||
164376082|NCT01126541|593749797|FG001|Overall Study|Withdrawal by Subject|5|||
164376083|NCT01126541|593749798|FG002|Overall Study|Withdrawal by Subject|6|||
164376084|NCT01126541|593749796|FG000|Overall Study|Protocol Violation|0|||
164376085|NCT01126541|593749797|FG001|Overall Study|Protocol Violation|0|||
164376086|NCT01126541|593749798|FG002|Overall Study|Protocol Violation|1|||
164376087|NCT01126541|593749796|FG000|Overall Study|Administrative reason or other|1|||
164376088|NCT01126541|593749797|FG001|Overall Study|Administrative reason or other|1|||
164376089|NCT01126541|593749798|FG002|Overall Study|Administrative reason or other|2|||
164376090|NCT04456699|593749803|FG000|Overall Study|Death|48|||
164376091|NCT04456699|593749804|FG001|Overall Study|Death|50|||
164376092|NCT04456699|593749805|FG002|Overall Study|Death|52|||
164376093|NCT04456699|593749803|FG000|Overall Study|Physician Decision|0|||
164376094|NCT04456699|593749804|FG001|Overall Study|Physician Decision|0|||
164376095|NCT04456699|593749805|FG002|Overall Study|Physician Decision|2|||
164376096|NCT04456699|593749803|FG000|Overall Study|Sponsor Decision|55|||
164376097|NCT04456699|593749804|FG001|Overall Study|Sponsor Decision|61|||
164376098|NCT04456699|593749805|FG002|Overall Study|Sponsor Decision|50|||
164376099|NCT04456699|593749803|FG000|Overall Study|Withdrawal by Subject|8|||
164376100|NCT04456699|593749804|FG001|Overall Study|Withdrawal by Subject|4|||
164376101|NCT04456699|593749805|FG002|Overall Study|Withdrawal by Subject|5|||
164376102|NCT02114879|593749806|FG000|Overall Study|Withdrawal by Subject|9|||
164376103|NCT02114879|593749807|FG001|Overall Study|Withdrawal by Subject|5|||
164376104|NCT02114879|593749806|FG000|Overall Study|Death|6|||
164376105|NCT02114879|593749807|FG001|Overall Study|Death|11|||
164376106|NCT02114879|593749806|FG000|Overall Study|Lost to Follow-up|4|||
164376107|NCT02114879|593749807|FG001|Overall Study|Lost to Follow-up|6|||
164376108|NCT02114879|593749806|FG000|Overall Study|Physician Decision|0|||
164376109|NCT02114879|593749807|FG001|Overall Study|Physician Decision|2|||
164376110|NCT00480779|593749809|FG000|Overall Study|Other|2|||
164376111|NCT00480779|593749810|FG001|Overall Study|Other|0|||
164376112|NCT00480779|593749809|FG000|Overall Study|Job and Health-related|0|||
164376113|NCT00480779|593749810|FG001|Overall Study|Job and Health-related|3|||
164376114|NCT01365273|593749811|FG000|Overall Study|Lost to Follow-up|1|||
164376115|NCT01365273|593749812|FG001|Overall Study|Lost to Follow-up|0|||
164376116|NCT01365273|593749811|FG000|Overall Study|Protocol Violation|0|||
164376117|NCT01365273|593749812|FG001|Overall Study|Protocol Violation|1|||
164376118|NCT01365273|593749811|FG000|Overall Study|Physician Decision|1|||
164376119|NCT01365273|593749812|FG001|Overall Study|Physician Decision|0|||
164376120|NCT04847674|593749816|FG000|Overall Study|Withdrawal by Subject|0|||
164376121|NCT04847674|593749817|FG001|Overall Study|Withdrawal by Subject|1|||
164376122|NCT04847674|593749818|FG002|Overall Study|Withdrawal by Subject|0|||
164376123|NCT04847674|593749816|FG000|Overall Study|Lost to Follow-up|0|||
164376124|NCT04847674|593749817|FG001|Overall Study|Lost to Follow-up|0|||
164376125|NCT04847674|593749818|FG002|Overall Study|Lost to Follow-up|2|||
164376126|NCT04847674|593749816|FG000|Overall Study|Other than specified|21|||
164376127|NCT04847674|593749817|FG001|Overall Study|Other than specified|20|||
164376128|NCT04847674|593749818|FG002|Overall Study|Other than specified|20|||
164376129|NCT01524770|593749823|FG000|First Intervention|Withdrawal by Subject|1|||
164376130|NCT01524770|593749824|FG001|First Intervention|Withdrawal by Subject|0|||
164376131|NCT01524770|593749823|FG000|First Intervention|Adverse Event|1|||
164376132|NCT01524770|593749824|FG001|First Intervention|Adverse Event|1|||
164376133|NCT01524770|593749823|FG000|First Intervention|Protocol Violation|1|||
164376134|NCT01524770|593749824|FG001|First Intervention|Protocol Violation|0|||
164376135|NCT00689481|593749825|FG000|Overall Study|Adverse Event|7|||
164591815|NCT00195260|594529983|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
164591816|NCT00195260|594529984|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
164376136|NCT00689481|593749826|FG001|Overall Study|Adverse Event|1|||
164376137|NCT00689481|593749825|FG000|Overall Study|Lost to Follow-up|4|||
164376138|NCT00689481|593749826|FG001|Overall Study|Lost to Follow-up|3|||
164376139|NCT00689481|593749825|FG000|Overall Study|Lack of Efficacy|4|||
164376140|NCT00689481|593749826|FG001|Overall Study|Lack of Efficacy|3|||
164376141|NCT00689481|593749825|FG000|Overall Study|Non-compliance with study treatment|1|||
164376142|NCT00689481|593749826|FG001|Overall Study|Non-compliance with study treatment|1|||
164376143|NCT00689481|593749825|FG000|Overall Study|Withdrawal by Subject|8|||
164376144|NCT00689481|593749826|FG001|Overall Study|Withdrawal by Subject|4|||
164376145|NCT00689481|593749825|FG000|Overall Study|Excluded medication started during study|0|||
164376146|NCT00689481|593749826|FG001|Overall Study|Excluded medication started during study|1|||
164376147|NCT00689481|593749825|FG000|Overall Study|Subject early term, left on vacation|0|||
164376148|NCT00689481|593749826|FG001|Overall Study|Subject early term, left on vacation|1|||
164376149|NCT03337724|593749827|FG000|Overall Study|Reason not Specified|12|||
164376150|NCT03337724|593749828|FG001|Overall Study|Reason not Specified|21|||
164376151|NCT03337724|593749829|FG002|Overall Study|Reason not Specified|9|||
164376152|NCT03337724|593749830|FG003|Overall Study|Reason not Specified|9|||
164376153|NCT03337724|593749831|FG004|Overall Study|Reason not Specified|29|||
164376154|NCT03337724|593749827|FG000|Overall Study|Withdrawal by Subject|13|||
164376155|NCT03337724|593749828|FG001|Overall Study|Withdrawal by Subject|15|||
164376156|NCT03337724|593749829|FG002|Overall Study|Withdrawal by Subject|4|||
164376157|NCT03337724|593749830|FG003|Overall Study|Withdrawal by Subject|15|||
164376158|NCT03337724|593749831|FG004|Overall Study|Withdrawal by Subject|6|||
164376159|NCT03337724|593749827|FG000|Overall Study|Protocol Deviation|0|||
164376160|NCT03337724|593749828|FG001|Overall Study|Protocol Deviation|1|||
164376161|NCT03337724|593749829|FG002|Overall Study|Protocol Deviation|1|||
164376162|NCT03337724|593749830|FG003|Overall Study|Protocol Deviation|1|||
164376163|NCT03337724|593749831|FG004|Overall Study|Protocol Deviation|0|||
164376164|NCT03337724|593749827|FG000|Overall Study|Adverse Event|1|||
164376165|NCT03337724|593749828|FG001|Overall Study|Adverse Event|1|||
164376166|NCT03337724|593749829|FG002|Overall Study|Adverse Event|0|||
164376167|NCT03337724|593749830|FG003|Overall Study|Adverse Event|1|||
164376168|NCT03337724|593749831|FG004|Overall Study|Adverse Event|0|||
164376169|NCT03337724|593749827|FG000|Overall Study|Death|40|||
164376170|NCT03337724|593749828|FG001|Overall Study|Death|89|||
164376171|NCT03337724|593749829|FG002|Overall Study|Death|43|||
164376172|NCT03337724|593749830|FG003|Overall Study|Death|76|||
164376173|NCT03337724|593749831|FG004|Overall Study|Death|50|||
164376174|NCT03337724|593749827|FG000|Overall Study|Lost to Follow-up|5|||
164376175|NCT03337724|593749828|FG001|Overall Study|Lost to Follow-up|5|||
164376176|NCT03337724|593749829|FG002|Overall Study|Lost to Follow-up|4|||
164376177|NCT03337724|593749830|FG003|Overall Study|Lost to Follow-up|7|||
164376178|NCT03337724|593749831|FG004|Overall Study|Lost to Follow-up|4|||
164376179|NCT03337724|593749827|FG000|Overall Study|Physician Decision|16|||
164376180|NCT03337724|593749828|FG001|Overall Study|Physician Decision|34|||
164376181|NCT03337724|593749829|FG002|Overall Study|Physician Decision|14|||
164376182|NCT03337724|593749830|FG003|Overall Study|Physician Decision|34|||
164376183|NCT03337724|593749831|FG004|Overall Study|Physician Decision|13|||
164376184|NCT03337724|593749827|FG000|Overall Study|Progressive Disease|0|||
164376185|NCT03337724|593749828|FG001|Overall Study|Progressive Disease|2|||
164376186|NCT03337724|593749829|FG002|Overall Study|Progressive Disease|1|||
164376187|NCT03337724|593749830|FG003|Overall Study|Progressive Disease|2|||
164376188|NCT03337724|593749831|FG004|Overall Study|Progressive Disease|0|||
164376189|NCT03337724|593749827|FG000|Overall Study|Symptomatic Deterioration|0|||
164376190|NCT03337724|593749828|FG001|Overall Study|Symptomatic Deterioration|0|||
164376191|NCT03337724|593749829|FG002|Overall Study|Symptomatic Deterioration|0|||
164376192|NCT03337724|593749830|FG003|Overall Study|Symptomatic Deterioration|1|||
164376193|NCT03337724|593749831|FG004|Overall Study|Symptomatic Deterioration|0|||
164376194|NCT00528528|593749832|FG000|Overall Study|Lost to Follow-up|0|||
164376195|NCT00528528|593749833|FG001|Overall Study|Lost to Follow-up|0|||
164376196|NCT00528528|593749834|FG002|Overall Study|Lost to Follow-up|1|||
164376197|NCT00528528|593749835|FG003|Overall Study|Lost to Follow-up|1|||
164376198|NCT00528528|593749832|FG000|Overall Study|Ineligible to continue the trial|0|||
164376199|NCT00528528|593749833|FG001|Overall Study|Ineligible to continue the trial|0|||
164376200|NCT00528528|593749834|FG002|Overall Study|Ineligible to continue the trial|0|||
164376201|NCT00528528|593749835|FG003|Overall Study|Ineligible to continue the trial|1|||
164376202|NCT00528528|593749832|FG000|Overall Study|Other|0|||
164376203|NCT00528528|593749833|FG001|Overall Study|Other|1|||
164376204|NCT00528528|593749834|FG002|Overall Study|Other|0|||
164376205|NCT00528528|593749835|FG003|Overall Study|Other|0|||
164376206|NCT00528528|593749832|FG000|Overall Study|Withdrawal by Subject|3|||
164376207|NCT00528528|593749833|FG001|Overall Study|Withdrawal by Subject|2|||
164376208|NCT00528528|593749834|FG002|Overall Study|Withdrawal by Subject|1|||
164376209|NCT00528528|593749835|FG003|Overall Study|Withdrawal by Subject|1|||
164376210|NCT00528528|593749832|FG000|Overall Study|Ongoing participant|0|||
164376211|NCT00528528|593749833|FG001|Overall Study|Ongoing participant|0|||
164376212|NCT00528528|593749834|FG002|Overall Study|Ongoing participant|1|||
164376213|NCT00528528|593749835|FG003|Overall Study|Ongoing participant|0|||
164376214|NCT00773097|593749836|FG000|Overall Study|Withdrawal by Subject|1|||
164376215|NCT00773097|593749836|FG000|Overall Study|Physician Decision|6|||
164376216|NCT04602624|593749840|FG000|Overall Study|Protocol Deviation|1|||
164376217|NCT04602624|593749840|FG000|Overall Study|Withdrawal by Participant|1|||
164376218|NCT04084769|593749841|FG000|Overall Study|Protocol Violation|1|||
164376219|NCT04084769|593749842|FG001|Overall Study|Protocol Violation|3|||
164376220|NCT04084769|593749843|FG002|Overall Study|Protocol Violation|0|||
164376221|NCT04084769|593749844|FG003|Overall Study|Protocol Violation|1|||
164376222|NCT04084769|593749841|FG000|Overall Study|Withdrawal by Subject|0|||
164376223|NCT04084769|593749842|FG001|Overall Study|Withdrawal by Subject|1|||
164376224|NCT04084769|593749843|FG002|Overall Study|Withdrawal by Subject|0|||
164376225|NCT04084769|593749844|FG003|Overall Study|Withdrawal by Subject|0|||
164376226|NCT04084769|593749841|FG000|Overall Study|Withdrawal by parent/guardian|1|||
164376227|NCT04084769|593749842|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164376228|NCT04084769|593749843|FG002|Overall Study|Withdrawal by parent/guardian|0|||
164376229|NCT04084769|593749844|FG003|Overall Study|Withdrawal by parent/guardian|1|||
164376230|NCT04084769|593749841|FG000|Overall Study|Lost to Follow-up|2|||
164376231|NCT04084769|593749842|FG001|Overall Study|Lost to Follow-up|0|||
164376232|NCT04084769|593749843|FG002|Overall Study|Lost to Follow-up|0|||
164376233|NCT04084769|593749844|FG003|Overall Study|Lost to Follow-up|0|||
164376234|NCT00316199|593749845|FG000|Overall Study|Adverse Event|2|||
164376235|NCT00316199|593749845|FG000|Overall Study|Death|8|||
164376236|NCT00316199|593749845|FG000|Overall Study|Lost to Follow-up|2|||
164376237|NCT04477304|593749846|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
164376238|NCT04477304|593749847|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
164376239|NCT02782949|593749849|FG000|Overall Study|Protocol Violation|1|||
164376240|NCT02782949|593749850|FG001|Overall Study|Protocol Violation|0|||
164376241|NCT02782949|593749849|FG000|Overall Study|Withdrawal by Subject|0|||
164376242|NCT02782949|593749850|FG001|Overall Study|Withdrawal by Subject|1|||
164376243|NCT03238911|593749853|FG000|Overall Study|Withdrawal by Subject|1|||
164376244|NCT03238911|593749854|FG001|Overall Study|Withdrawal by Subject|2|||
164376245|NCT03238911|593749853|FG000|Overall Study|Lost to Follow-up|2|||
164376246|NCT03238911|593749854|FG001|Overall Study|Lost to Follow-up|1|||
164376247|NCT06023394|593749858|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
164376248|NCT06023394|593749859|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
164376249|NCT06023394|593749858|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
164376250|NCT06023394|593749859|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
164376251|NCT06023394|593749858|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
164376252|NCT06023394|593749859|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
164376253|NCT06023394|593749858|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
164376254|NCT06023394|593749859|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
164376255|NCT02556710|593751740|FG000|Overall Study|Surgical treatment|3|||
164376256|NCT02556710|593751741|FG001|Overall Study|Surgical treatment|0|||
164376257|NCT02556710|593751740|FG000|Overall Study|Required proscribed pain medication|2|||
164376258|NCT02556710|593751741|FG001|Overall Study|Required proscribed pain medication|1|||
164376259|NCT02556710|593751740|FG000|Overall Study|Lack of Efficacy|1|||
164376260|NCT02556710|593751741|FG001|Overall Study|Lack of Efficacy|0|||
164376261|NCT02556710|593751740|FG000|Overall Study|Worsening osteoarthritis|1|||
164376262|NCT02556710|593751741|FG001|Overall Study|Worsening osteoarthritis|0|||
164376263|NCT02556710|593751740|FG000|Overall Study|Moved out of state|1|||
164376264|NCT02556710|593751741|FG001|Overall Study|Moved out of state|0|||
164376265|NCT02556710|593751740|FG000|Overall Study|Missing reason|3|||
164376266|NCT02556710|593751741|FG001|Overall Study|Missing reason|1|||
164376267|NCT02556710|593751740|FG000|Overall Study|Pain as lack of efficacy|0|||
164376268|NCT02556710|593751741|FG001|Overall Study|Pain as lack of efficacy|4|||
164376269|NCT03370341|593751746|FG000|Overall Study|Lost to Follow-up|0|||
164376270|NCT03370341|593751747|FG001|Overall Study|Lost to Follow-up|1|||
164376271|NCT01707004|593751750|FG000|Overall Study|Physician Decision|3|||
164376272|NCT02573324|593751754|FG000|Overall Study|Withdrawal by Subject|26|||
164376273|NCT02573324|593751755|FG001|Overall Study|Withdrawal by Subject|23|||
164376274|NCT02573324|593751756|FG002|Overall Study|Withdrawal by Subject|3|||
164376275|NCT02573324|593751754|FG000|Overall Study|Lost to Follow-up|4|||
164376276|NCT02573324|593751755|FG001|Overall Study|Lost to Follow-up|5|||
164376277|NCT02573324|593751756|FG002|Overall Study|Lost to Follow-up|0|||
164376278|NCT02573324|593751754|FG000|Overall Study|Study Terminated by Sponsor|107|||
164376279|NCT02573324|593751755|FG001|Overall Study|Study Terminated by Sponsor|89|||
164376280|NCT02573324|593751756|FG002|Overall Study|Study Terminated by Sponsor|2|||
164376281|NCT02573324|593751754|FG000|Overall Study|Death|182|||
164376282|NCT02573324|593751755|FG001|Overall Study|Death|200|||
164376283|NCT02573324|593751756|FG002|Overall Study|Death|1|||
164376284|NCT02573324|593751754|FG000|Overall Study|Other, Not Specified|20|||
164376285|NCT02573324|593751755|FG001|Overall Study|Other, Not Specified|27|||
164376286|NCT02573324|593751756|FG002|Overall Study|Other, Not Specified|0|||
164591817|NCT00195260|594529985|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
164591818|NCT00195260|594529986|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
164376287|NCT02573324|593751754|FG000|Overall Study|Unknown Reason|2|||
164376288|NCT02573324|593751755|FG001|Overall Study|Unknown Reason|0|||
164376289|NCT02573324|593751756|FG002|Overall Study|Unknown Reason|0|||
164376290|NCT01607905|593751757|FG000|Overall Study|Withdrawal by participant|7|||
164376291|NCT01607905|593751758|FG001|Overall Study|Withdrawal by participant|2|||
164376292|NCT01607905|593751759|FG002|Overall Study|Withdrawal by participant|4|||
164591819|NCT00195260|594529987|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
164376293|NCT01607905|593751760|FG003|Overall Study|Withdrawal by participant|6|||
164376294|NCT01607905|593751761|FG004|Overall Study|Withdrawal by participant|0|||
164376295|NCT01607905|593751762|FG005|Overall Study|Withdrawal by participant|4|||
164376296|NCT01607905|593751763|FG006|Overall Study|Withdrawal by participant|12|||
164376297|NCT01607905|593751757|FG000|Overall Study|Incidence or severity of AEs|5|||
164376298|NCT01607905|593751758|FG001|Overall Study|Incidence or severity of AEs|1|||
164376299|NCT01607905|593751759|FG002|Overall Study|Incidence or severity of AEs|1|||
164376300|NCT01607905|593751760|FG003|Overall Study|Incidence or severity of AEs|3|||
164376301|NCT01607905|593751761|FG004|Overall Study|Incidence or severity of AEs|0|||
164376302|NCT01607905|593751762|FG005|Overall Study|Incidence or severity of AEs|2|||
164376303|NCT01607905|593751763|FG006|Overall Study|Incidence or severity of AEs|8|||
164376304|NCT01607905|593751757|FG000|Overall Study|Disease progression|44|||
164376305|NCT01607905|593751758|FG001|Overall Study|Disease progression|16|||
164376306|NCT01607905|593751759|FG002|Overall Study|Disease progression|15|||
164376307|NCT01607905|593751760|FG003|Overall Study|Disease progression|11|||
164376308|NCT01607905|593751761|FG004|Overall Study|Disease progression|6|||
164376309|NCT01607905|593751762|FG005|Overall Study|Disease progression|7|||
164376310|NCT01607905|593751763|FG006|Overall Study|Disease progression|21|||
164376311|NCT01607905|593751757|FG000|Overall Study|Non-compliance with study procedures|0|||
164376312|NCT01607905|593751758|FG001|Overall Study|Non-compliance with study procedures|0|||
164376313|NCT01607905|593751759|FG002|Overall Study|Non-compliance with study procedures|0|||
164376314|NCT01607905|593751760|FG003|Overall Study|Non-compliance with study procedures|0|||
164376315|NCT01607905|593751761|FG004|Overall Study|Non-compliance with study procedures|0|||
164376316|NCT01607905|593751762|FG005|Overall Study|Non-compliance with study procedures|0|||
164376317|NCT01607905|593751763|FG006|Overall Study|Non-compliance with study procedures|1|||
164376318|NCT01607905|593751757|FG000|Overall Study|Death|1|||
164376319|NCT01607905|593751758|FG001|Overall Study|Death|1|||
164376320|NCT01607905|593751759|FG002|Overall Study|Death|1|||
164376321|NCT01607905|593751760|FG003|Overall Study|Death|1|||
164376322|NCT01607905|593751761|FG004|Overall Study|Death|0|||
164376323|NCT01607905|593751762|FG005|Overall Study|Death|0|||
164376324|NCT01607905|593751763|FG006|Overall Study|Death|3|||
164376325|NCT01607905|593751757|FG000|Overall Study|Other treatments become available|1|||
164376326|NCT01607905|593751758|FG001|Overall Study|Other treatments become available|0|||
164376327|NCT01607905|593751759|FG002|Overall Study|Other treatments become available|0|||
164376328|NCT01607905|593751760|FG003|Overall Study|Other treatments become available|0|||
164376329|NCT01607905|593751761|FG004|Overall Study|Other treatments become available|0|||
164376330|NCT01607905|593751762|FG005|Overall Study|Other treatments become available|0|||
164376331|NCT01607905|593751763|FG006|Overall Study|Other treatments become available|1|||
164376332|NCT01607905|593751757|FG000|Overall Study|Investigator discretion|0|||
164376333|NCT01607905|593751758|FG001|Overall Study|Investigator discretion|0|||
164376334|NCT01607905|593751759|FG002|Overall Study|Investigator discretion|0|||
164376335|NCT01607905|593751760|FG003|Overall Study|Investigator discretion|0|||
164376336|NCT01607905|593751761|FG004|Overall Study|Investigator discretion|0|||
164376337|NCT01607905|593751762|FG005|Overall Study|Investigator discretion|1|||
164376338|NCT01607905|593751763|FG006|Overall Study|Investigator discretion|0|||
164376339|NCT01607905|593751757|FG000|Overall Study|Other|1|||
164376340|NCT01607905|593751758|FG001|Overall Study|Other|0|||
164376341|NCT01607905|593751759|FG002|Overall Study|Other|0|||
164376342|NCT01607905|593751760|FG003|Overall Study|Other|0|||
164376343|NCT01607905|593751761|FG004|Overall Study|Other|0|||
164376344|NCT01607905|593751762|FG005|Overall Study|Other|0|||
164376345|NCT01607905|593751763|FG006|Overall Study|Other|1|||
164376346|NCT01607905|593751757|FG000|Overall Study|Randomized but not treated|1|||
164376347|NCT01607905|593751758|FG001|Overall Study|Randomized but not treated|0|||
164376348|NCT01607905|593751759|FG002|Overall Study|Randomized but not treated|0|||
164376349|NCT01607905|593751760|FG003|Overall Study|Randomized but not treated|0|||
164376350|NCT01607905|593751761|FG004|Overall Study|Randomized but not treated|1|||
164376351|NCT01607905|593751762|FG005|Overall Study|Randomized but not treated|1|||
164376352|NCT01607905|593751763|FG006|Overall Study|Randomized but not treated|0|||
164376353|NCT00941733|593751764|FG000|Overall Study|Death|24|||
164376354|NCT00941733|593751765|FG001|Overall Study|Death|10|||
164376355|NCT00941733|593751764|FG000|Overall Study|Withdrawal by Subject|14|||
164376356|NCT00941733|593751765|FG001|Overall Study|Withdrawal by Subject|6|||
164376357|NCT00941733|593751764|FG000|Overall Study|Adverse Event|20|||
164376358|NCT00941733|593751765|FG001|Overall Study|Adverse Event|4|||
164376359|NCT00941733|593751764|FG000|Overall Study|Lost to Follow-up|1|||
164376360|NCT00941733|593751765|FG001|Overall Study|Lost to Follow-up|2|||
164439298|NCT03020745|593975354|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
164439299|NCT03020745|593975355|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
164700512|NCT01421342|594926837|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
164376361|NCT00941733|593751764|FG000|Overall Study|Protocol Violation|15|||
164376362|NCT00941733|593751765|FG001|Overall Study|Protocol Violation|6|||
164376363|NCT00194012|593751766|FG000|Randomized Phase|Lack of Efficacy|8|||
164376364|NCT00194012|593751767|FG001|Randomized Phase|Lack of Efficacy|18|||
164376365|NCT00194012|593751766|FG000|Randomized Phase|Study nonadherence|2|||
164376366|NCT00194012|593751767|FG001|Randomized Phase|Study nonadherence|1|||
164376367|NCT00194012|593751766|FG000|Randomized Phase|Withdrawal by Subject|3|||
164376368|NCT00194012|593751767|FG001|Randomized Phase|Withdrawal by Subject|3|||
164376369|NCT00194012|593751766|FG000|Randomized Phase|Adverse Event|2|||
164376370|NCT00194012|593751767|FG001|Randomized Phase|Adverse Event|1|||
164376371|NCT00194012|593751766|FG000|Randomized Phase|Participant reported having a rash|1|||
164376372|NCT00194012|593751767|FG001|Randomized Phase|Participant reported having a rash|0|||
164376373|NCT00194012|593751766|FG000|Randomized Phase|Emesis and enuresis|0|||
164376374|NCT00194012|593751767|FG001|Randomized Phase|Emesis and enuresis|1|||
164376375|NCT00194012|593751766|FG000|Randomized Phase|Oral/nasal twitching|0|||
164376376|NCT00194012|593751767|FG001|Randomized Phase|Oral/nasal twitching|1|||
164376377|NCT00194012|593751766|FG000|Open Label Extension (OLE)|Weight Gain|1|||
164376378|NCT00194012|593751767|FG001|Open Label Extension (OLE)|Weight Gain|0|||
164700513|NCT03656874|594926838|FG000|Overall Study|Lost to Follow-up|3|||
164376379|NCT00194012|593751766|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
164376380|NCT00194012|593751767|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
164376381|NCT00194012|593751766|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
164376382|NCT00194012|593751767|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
164376383|NCT00194012|593751766|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
164376384|NCT00194012|593751767|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
164376385|NCT01105533|593751768|FG000|Overall Study|Death|0|||
164376386|NCT01105533|593751769|FG001|Overall Study|Death|0|||
164376387|NCT01105533|593751770|FG002|Overall Study|Death|0|||
164376388|NCT01105533|593751771|FG003|Overall Study|Death|0|||
164376389|NCT01105533|593751772|FG004|Overall Study|Death|1|||
164376390|NCT01105533|593751773|FG005|Overall Study|Death|0|||
164376391|NCT01105533|593751774|FG006|Overall Study|Death|0|||
164376392|NCT01105533|593751775|FG007|Overall Study|Death|0|||
164376393|NCT01105533|593751776|FG008|Overall Study|Death|0|||
164376394|NCT01105533|593751768|FG000|Overall Study|Lack of Efficacy|1|||
164376395|NCT01105533|593751769|FG001|Overall Study|Lack of Efficacy|1|||
164376396|NCT01105533|593751770|FG002|Overall Study|Lack of Efficacy|3|||
164376397|NCT01105533|593751771|FG003|Overall Study|Lack of Efficacy|3|||
164376398|NCT01105533|593751772|FG004|Overall Study|Lack of Efficacy|4|||
164376399|NCT01105533|593751773|FG005|Overall Study|Lack of Efficacy|5|||
164376400|NCT01105533|593751774|FG006|Overall Study|Lack of Efficacy|3|||
164376401|NCT01105533|593751775|FG007|Overall Study|Lack of Efficacy|2|||
164376402|NCT01105533|593751776|FG008|Overall Study|Lack of Efficacy|9|||
164376403|NCT01105533|593751768|FG000|Overall Study|Adverse Event|0|||
164376404|NCT01105533|593751769|FG001|Overall Study|Adverse Event|0|||
164376405|NCT01105533|593751770|FG002|Overall Study|Adverse Event|0|||
164376406|NCT01105533|593751771|FG003|Overall Study|Adverse Event|0|||
164376407|NCT01105533|593751772|FG004|Overall Study|Adverse Event|1|||
164376408|NCT01105533|593751773|FG005|Overall Study|Adverse Event|2|||
164376409|NCT01105533|593751774|FG006|Overall Study|Adverse Event|2|||
164376410|NCT01105533|593751775|FG007|Overall Study|Adverse Event|0|||
164376411|NCT01105533|593751776|FG008|Overall Study|Adverse Event|1|||
164376412|NCT01105533|593751768|FG000|Overall Study|Other|0|||
164376413|NCT01105533|593751769|FG001|Overall Study|Other|0|||
164376414|NCT01105533|593751770|FG002|Overall Study|Other|0|||
164376415|NCT01105533|593751771|FG003|Overall Study|Other|0|||
164376416|NCT01105533|593751772|FG004|Overall Study|Other|1|||
164376417|NCT01105533|593751773|FG005|Overall Study|Other|0|||
164376418|NCT01105533|593751774|FG006|Overall Study|Other|3|||
164376419|NCT01105533|593751775|FG007|Overall Study|Other|1|||
164376420|NCT01105533|593751776|FG008|Overall Study|Other|2|||
164376421|NCT01105533|593751768|FG000|Overall Study|Physician Decision|0|||
164376422|NCT01105533|593751769|FG001|Overall Study|Physician Decision|0|||
164376423|NCT01105533|593751770|FG002|Overall Study|Physician Decision|0|||
164376424|NCT01105533|593751771|FG003|Overall Study|Physician Decision|0|||
164376425|NCT01105533|593751772|FG004|Overall Study|Physician Decision|0|||
164376426|NCT01105533|593751773|FG005|Overall Study|Physician Decision|0|||
164376427|NCT01105533|593751774|FG006|Overall Study|Physician Decision|0|||
164376428|NCT01105533|593751775|FG007|Overall Study|Physician Decision|1|||
164376429|NCT01105533|593751776|FG008|Overall Study|Physician Decision|0|||
164376430|NCT03892889|593751777|FG000|Overall Study|Adverse Event|17|||
164376431|NCT03892889|593751777|FG000|Overall Study|Lack of Efficacy|1|||
164376432|NCT03892889|593751777|FG000|Overall Study|Lost to Follow-up|46|||
164376433|NCT03892889|593751777|FG000|Overall Study|Non-compliance with study drug|22|||
164376434|NCT03892889|593751777|FG000|Overall Study|Pregnancy|1|||
164376435|NCT03892889|593751777|FG000|Overall Study|Protocol Deviation|3|||
164376436|NCT03892889|593751777|FG000|Overall Study|Withdrawal by Subject|50|||
164376437|NCT03892889|593751777|FG000|Overall Study|Withdrawal by Caregiver|1|||
164376438|NCT03892889|593751777|FG000|Overall Study|Study Terminated by Sponsor|50|||
164376439|NCT03892889|593751777|FG000|Overall Study|Physician Decision|8|||
164376440|NCT03892889|593751777|FG000|Overall Study|Reason not Specified|5|||
164376441|NCT00630877|593751780|FG000|Overall Study|Adverse Event|11|||
164376442|NCT00630877|593751781|FG001|Overall Study|Adverse Event|8|||
164700514|NCT03656874|594926839|FG001|Overall Study|Lost to Follow-up|17|||
164700515|NCT01206816|594926840|FG000|Overall Study|Protocol Violation|0|||
164700516|NCT01206816|594926841|FG001|Overall Study|Protocol Violation|0|||
164700517|NCT01206816|594926842|FG002|Overall Study|Protocol Violation|1|||
164700518|NCT01206816|594926843|FG003|Overall Study|Protocol Violation|0|||
164376443|NCT00630877|593751782|FG002|Overall Study|Adverse Event|7|||
164376444|NCT00630877|593751780|FG000|Overall Study|Withdrawal by Subject|3|||
164376445|NCT00630877|593751781|FG001|Overall Study|Withdrawal by Subject|4|||
164376446|NCT00630877|593751782|FG002|Overall Study|Withdrawal by Subject|0|||
164376447|NCT00630877|593751780|FG000|Overall Study|Lost to Follow-up|2|||
164376448|NCT00630877|593751781|FG001|Overall Study|Lost to Follow-up|0|||
164376449|NCT00630877|593751782|FG002|Overall Study|Lost to Follow-up|0|||
164376450|NCT00630877|593751780|FG000|Overall Study|Noncompliance|2|||
164376451|NCT00630877|593751781|FG001|Overall Study|Noncompliance|3|||
164376452|NCT00630877|593751782|FG002|Overall Study|Noncompliance|1|||
164376453|NCT00630877|593751780|FG000|Overall Study|Protocol violation|1|||
164376454|NCT00630877|593751781|FG001|Overall Study|Protocol violation|0|||
164376455|NCT00630877|593751782|FG002|Overall Study|Protocol violation|1|||
164376456|NCT00630877|593751780|FG000|Overall Study|Personal reasons|0|||
164591820|NCT00195260|594529988|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
164591821|NCT00195260|594529989|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
164376457|NCT00630877|593751781|FG001|Overall Study|Personal reasons|0|||
164376458|NCT00630877|593751782|FG002|Overall Study|Personal reasons|1|||
164376459|NCT01639001|593751789|FG000|Overall Study|Refused further follow-up|9|||
164376460|NCT01639001|593751790|FG001|Overall Study|Refused further follow-up|12|||
164376461|NCT01639001|593751789|FG000|Overall Study|Lost to Follow-up|3|||
164376462|NCT01639001|593751790|FG001|Overall Study|Lost to Follow-up|0|||
164376463|NCT01639001|593751789|FG000|Overall Study|Death|62|||
164376464|NCT01639001|593751790|FG001|Overall Study|Death|61|||
164376465|NCT01639001|593751789|FG000|Overall Study|Randomized but not treated|0|||
164376466|NCT01639001|593751790|FG001|Overall Study|Randomized but not treated|2|||
164376467|NCT01639001|593751789|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
164376468|NCT01639001|593751790|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
164376469|NCT02097134|593751791|FG000|Overall Study|Physician Decision|4|||
164376470|NCT02097134|593751791|FG000|Overall Study|Non-Protocol Therapy|1|||
164376471|NCT02097134|593751791|FG000|Overall Study|Progressive Disease|3|||
164376472|NCT02097134|593751791|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
164376473|NCT00679341|593751793|FG000|Overall Study|Disease progression|42|||
164376474|NCT00679341|593751794|FG001|Overall Study|Disease progression|36|||
164376475|NCT00679341|593751793|FG000|Overall Study|Adverse Event|5|||
164376476|NCT00679341|593751794|FG001|Overall Study|Adverse Event|6|||
164376477|NCT00679341|593751793|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
164376478|NCT00679341|593751794|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
164376479|NCT00679341|593751793|FG000|Overall Study|Death|1|||
164376480|NCT00679341|593751794|FG001|Overall Study|Death|1|||
164376481|NCT00679341|593751793|FG000|Overall Study|Other|1|||
164376482|NCT00679341|593751794|FG001|Overall Study|Other|0|||
164376483|NCT00679341|593751793|FG000|Overall Study|Physician Decision|1|||
164376484|NCT00679341|593751794|FG001|Overall Study|Physician Decision|0|||
164376485|NCT00679341|593751793|FG000|Overall Study|Not treated|0|||
164376486|NCT00679341|593751794|FG001|Overall Study|Not treated|2|||
164376487|NCT00679341|593751793|FG000|Overall Study|Physician/patient decision to withdraw|0|||
164376488|NCT00679341|593751794|FG001|Overall Study|Physician/patient decision to withdraw|6|||
164376489|NCT00298896|593751798|FG000|Overall Study|Death|3|||
164376490|NCT00298896|593751798|FG000|Overall Study|Physician Decision|2|||
164376491|NCT00298896|593751798|FG000|Overall Study|Intercurrent Illness|1|||
164376492|NCT00298896|593751798|FG000|Overall Study|Disease Progression|41|||
164376493|NCT00298896|593751798|FG000|Overall Study|Withdrawal by Subject|2|||
164376494|NCT00298896|593751798|FG000|Overall Study|Assigned to treatment in error|1|||
164376495|NCT02880371|593751799|FG000|Phase 1b|Lost to Follow-up|1|||
164376496|NCT02880371|593751800|FG001|Phase 1b|Lost to Follow-up|0|||
164376497|NCT02880371|593751801|FG002|Phase 1b|Lost to Follow-up|0|||
164376498|NCT02880371|593751802|FG003|Phase 1b|Lost to Follow-up|0|||
164376499|NCT02880371|593751803|FG004|Phase 1b|Lost to Follow-up|0|||
164376500|NCT02880371|593751804|FG005|Phase 1b|Lost to Follow-up|0|||
164376501|NCT02880371|593751805|FG006|Phase 1b|Lost to Follow-up|0|||
164376502|NCT02880371|593751806|FG007|Phase 1b|Lost to Follow-up|0|||
164376503|NCT02880371|593751799|FG000|Phase 1b|Participants terminated by Sponsor|1|||
164376504|NCT02880371|593751800|FG001|Phase 1b|Participants terminated by Sponsor|0|||
164376505|NCT02880371|593751801|FG002|Phase 1b|Participants terminated by Sponsor|0|||
164376506|NCT02880371|593751802|FG003|Phase 1b|Participants terminated by Sponsor|0|||
164591822|NCT00195260|594529990|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
164591823|NCT00195260|594529991|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
164591824|NCT00195260|594529992|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
164591825|NCT02749721|594529993|FG000|Screening|Withdrawal by Subject|1|||
164591826|NCT02749721|594529993|FG000|Screening|Lost to Follow-up|2|||
164591827|NCT02749721|594529993|FG000|Screening|Protocol Violation|3|||
164591828|NCT02749721|594529993|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
164591829|NCT02749721|594529993|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
164376507|NCT02880371|593751803|FG004|Phase 1b|Participants terminated by Sponsor|0|||
164376508|NCT02880371|593751804|FG005|Phase 1b|Participants terminated by Sponsor|0|||
164376509|NCT02880371|593751805|FG006|Phase 1b|Participants terminated by Sponsor|0|||
164376510|NCT02880371|593751806|FG007|Phase 1b|Participants terminated by Sponsor|0|||
164591830|NCT02691247|594529994|FG000|Overall Study|Withdrawal by Subject|1|||
164591831|NCT02691247|594529995|FG001|Overall Study|Withdrawal by Subject|2|||
164700519|NCT01206816|594926844|FG004|Overall Study|Protocol Violation|0|||
164700520|NCT01206816|594926845|FG005|Overall Study|Protocol Violation|0|||
164376511|NCT02880371|593751799|FG000|Phase 1b|Withdrawal by Subject|0|||
164376512|NCT02880371|593751800|FG001|Phase 1b|Withdrawal by Subject|0|||
164376513|NCT02880371|593751801|FG002|Phase 1b|Withdrawal by Subject|1|||
164376514|NCT02880371|593751802|FG003|Phase 1b|Withdrawal by Subject|0|||
164700521|NCT01206816|594926846|FG006|Overall Study|Protocol Violation|0|||
164376515|NCT02880371|593751803|FG004|Phase 1b|Withdrawal by Subject|0|||
164376516|NCT02880371|593751804|FG005|Phase 1b|Withdrawal by Subject|0|||
164376517|NCT02880371|593751805|FG006|Phase 1b|Withdrawal by Subject|0|||
164376518|NCT02880371|593751806|FG007|Phase 1b|Withdrawal by Subject|0|||
164376519|NCT02880371|593751799|FG000|Phase 1b|Death|4|||
164376520|NCT02880371|593751800|FG001|Phase 1b|Death|6|||
164376521|NCT02880371|593751801|FG002|Phase 1b|Death|5|||
164376522|NCT02880371|593751802|FG003|Phase 1b|Death|1|||
164376523|NCT02880371|593751803|FG004|Phase 1b|Death|0|||
164376524|NCT02880371|593751804|FG005|Phase 1b|Death|0|||
164376525|NCT02880371|593751805|FG006|Phase 1b|Death|0|||
164376526|NCT02880371|593751806|FG007|Phase 1b|Death|0|||
164376527|NCT02880371|593751799|FG000|Phase 1b|Enrolled but not Treated|0|||
164376528|NCT02880371|593751800|FG001|Phase 1b|Enrolled but not Treated|1|||
164376529|NCT02880371|593751801|FG002|Phase 1b|Enrolled but not Treated|0|||
164376530|NCT02880371|593751802|FG003|Phase 1b|Enrolled but not Treated|0|||
164376531|NCT02880371|593751803|FG004|Phase 1b|Enrolled but not Treated|0|||
164376532|NCT02880371|593751804|FG005|Phase 1b|Enrolled but not Treated|0|||
164376533|NCT02880371|593751805|FG006|Phase 1b|Enrolled but not Treated|0|||
164376534|NCT02880371|593751806|FG007|Phase 1b|Enrolled but not Treated|0|||
164376535|NCT02880371|593751799|FG000|Phase 2|Enrolled but not Treated|0|||
164376536|NCT02880371|593751800|FG001|Phase 2|Enrolled but not Treated|0|||
164376537|NCT02880371|593751801|FG002|Phase 2|Enrolled but not Treated|0|||
164376538|NCT02880371|593751802|FG003|Phase 2|Enrolled but not Treated|0|||
164376539|NCT02880371|593751803|FG004|Phase 2|Enrolled but not Treated|0|||
164376540|NCT02880371|593751804|FG005|Phase 2|Enrolled but not Treated|1|||
164376541|NCT02880371|593751805|FG006|Phase 2|Enrolled but not Treated|1|||
164376542|NCT02880371|593751806|FG007|Phase 2|Enrolled but not Treated|0|||
164376543|NCT02880371|593751799|FG000|Phase 2|Other|0|||
164376544|NCT02880371|593751800|FG001|Phase 2|Other|0|||
164376545|NCT02880371|593751801|FG002|Phase 2|Other|0|||
164376546|NCT02880371|593751802|FG003|Phase 2|Other|0|||
164376547|NCT02880371|593751803|FG004|Phase 2|Other|0|||
164376548|NCT02880371|593751804|FG005|Phase 2|Other|1|||
164376549|NCT02880371|593751805|FG006|Phase 2|Other|2|||
164376550|NCT02880371|593751806|FG007|Phase 2|Other|1|||
164376551|NCT02880371|593751799|FG000|Phase 2|Participants terminated by Sponsor|0|||
164376552|NCT02880371|593751800|FG001|Phase 2|Participants terminated by Sponsor|0|||
164376553|NCT02880371|593751801|FG002|Phase 2|Participants terminated by Sponsor|0|||
164376554|NCT02880371|593751802|FG003|Phase 2|Participants terminated by Sponsor|0|||
164376555|NCT02880371|593751803|FG004|Phase 2|Participants terminated by Sponsor|1|||
164376556|NCT02880371|593751804|FG005|Phase 2|Participants terminated by Sponsor|6|||
164376557|NCT02880371|593751805|FG006|Phase 2|Participants terminated by Sponsor|1|||
164376558|NCT02880371|593751806|FG007|Phase 2|Participants terminated by Sponsor|5|||
164376559|NCT02880371|593751799|FG000|Phase 2|Death|0|||
164376560|NCT02880371|593751800|FG001|Phase 2|Death|0|||
164376561|NCT02880371|593751801|FG002|Phase 2|Death|0|||
164376562|NCT02880371|593751802|FG003|Phase 2|Death|0|||
164376563|NCT02880371|593751803|FG004|Phase 2|Death|1|||
164376564|NCT02880371|593751804|FG005|Phase 2|Death|10|||
164376565|NCT02880371|593751805|FG006|Phase 2|Death|20|||
164376566|NCT02880371|593751806|FG007|Phase 2|Death|5|||
164376567|NCT02880371|593751799|FG000|Phase 2|Lost to Follow-up|0|||
164376568|NCT02880371|593751800|FG001|Phase 2|Lost to Follow-up|0|||
164376569|NCT02880371|593751801|FG002|Phase 2|Lost to Follow-up|0|||
164376570|NCT02880371|593751802|FG003|Phase 2|Lost to Follow-up|0|||
164376571|NCT02880371|593751803|FG004|Phase 2|Lost to Follow-up|0|||
164376572|NCT02880371|593751804|FG005|Phase 2|Lost to Follow-up|0|||
164376573|NCT02880371|593751805|FG006|Phase 2|Lost to Follow-up|3|||
164376574|NCT02880371|593751806|FG007|Phase 2|Lost to Follow-up|0|||
164376575|NCT02880371|593751799|FG000|Phase 2|Withdrawal by Subject|0|||
164376576|NCT02880371|593751800|FG001|Phase 2|Withdrawal by Subject|0|||
164376577|NCT02880371|593751801|FG002|Phase 2|Withdrawal by Subject|0|||
164376578|NCT02880371|593751802|FG003|Phase 2|Withdrawal by Subject|0|||
164376579|NCT02880371|593751803|FG004|Phase 2|Withdrawal by Subject|0|||
164376580|NCT02880371|593751804|FG005|Phase 2|Withdrawal by Subject|1|||
164376581|NCT02880371|593751805|FG006|Phase 2|Withdrawal by Subject|1|||
164376582|NCT02880371|593751806|FG007|Phase 2|Withdrawal by Subject|0|||
164376583|NCT02880371|593751799|FG000|Phase 2|End of Study page not completed by error|0|||
164376584|NCT02880371|593751800|FG001|Phase 2|End of Study page not completed by error|0|||
164144032|NCT00086281|592888571|FG000|Phase 2|Adverse Event|0|||
164376585|NCT02880371|593751801|FG002|Phase 2|End of Study page not completed by error|0|||
164376586|NCT02880371|593751802|FG003|Phase 2|End of Study page not completed by error|0|||
164376587|NCT02880371|593751803|FG004|Phase 2|End of Study page not completed by error|0|||
164376588|NCT02880371|593751804|FG005|Phase 2|End of Study page not completed by error|1|||
164376589|NCT02880371|593751805|FG006|Phase 2|End of Study page not completed by error|0|||
164376590|NCT02880371|593751806|FG007|Phase 2|End of Study page not completed by error|0|||
164376591|NCT03285646|593751811|FG000|Overall Study|Adverse Event|1|||
164376592|NCT03285646|593751812|FG001|Overall Study|Adverse Event|0|||
164376593|NCT03285646|593751811|FG000|Overall Study|Withdrawal by Subject|10|||
164376594|NCT03285646|593751812|FG001|Overall Study|Withdrawal by Subject|2|||
164376595|NCT03285646|593751811|FG000|Overall Study|Lost to Follow-up|2|||
164376596|NCT03285646|593751812|FG001|Overall Study|Lost to Follow-up|1|||
164376597|NCT03285646|593751811|FG000|Overall Study|Investigator/Sponsor Decision|0|||
164376598|NCT03285646|593751812|FG001|Overall Study|Investigator/Sponsor Decision|1|||
164376599|NCT02660359|593751813|FG000|Overall Study|Protocol Deviation|0|||
164376600|NCT02660359|593751814|FG001|Overall Study|Protocol Deviation|0|||
164376601|NCT02660359|593751815|FG002|Overall Study|Protocol Deviation|1|||
164376602|NCT02660359|593751813|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
164376603|NCT02660359|593751814|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
164376604|NCT02660359|593751815|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
164376605|NCT02660359|593751813|FG000|Overall Study|Lack of Efficacy|1|||
164376606|NCT02660359|593751814|FG001|Overall Study|Lack of Efficacy|1|||
164376607|NCT02660359|593751815|FG002|Overall Study|Lack of Efficacy|1|||
164376608|NCT02660359|593751813|FG000|Overall Study|Adverse Event|0|||
164376609|NCT02660359|593751814|FG001|Overall Study|Adverse Event|1|||
164376610|NCT02660359|593751815|FG002|Overall Study|Adverse Event|0|||
164376611|NCT02660359|593751813|FG000|Overall Study|Other|2|||
164376612|NCT02660359|593751814|FG001|Overall Study|Other|1|||
164376613|NCT02660359|593751815|FG002|Overall Study|Other|3|||
164376614|NCT02660359|593751813|FG000|Overall Study|Withdrawal by Subject|7|||
164376615|NCT02660359|593751814|FG001|Overall Study|Withdrawal by Subject|5|||
164376616|NCT02660359|593751815|FG002|Overall Study|Withdrawal by Subject|8|||
164376617|NCT02660359|593751813|FG000|Overall Study|Lost to Follow-up|3|||
164376618|NCT02660359|593751814|FG001|Overall Study|Lost to Follow-up|3|||
164376619|NCT02660359|593751815|FG002|Overall Study|Lost to Follow-up|0|||
164376620|NCT02664038|593751816|FG000|13 Week|Lost to Follow-up|7|||
164376621|NCT02664038|593751817|FG001|13 Week|Lost to Follow-up|14|||
164376622|NCT02664038|593751816|FG000|13 Week|Withdrawal by Subject|1|||
164376623|NCT02664038|593751817|FG001|13 Week|Withdrawal by Subject|0|||
164376624|NCT02664038|593751816|FG000|26 Week|Lost to Follow-up|5|||
164376625|NCT02664038|593751817|FG001|26 Week|Lost to Follow-up|4|||
164376626|NCT06640829|593751826|FG000|Overall Study|Withdrawal by Subject|1|||
164376627|NCT06640829|593751826|FG000|Overall Study|Lost to Follow-up|1|||
164376628|NCT00673452|593751831|FG000|Acute Double-Blind Phase|Adverse Event|41|||
164376629|NCT00673452|593751832|FG001|Acute Double-Blind Phase|Adverse Event|24|||
164376630|NCT00673452|593751831|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
164376631|NCT00673452|593751832|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
164376632|NCT00673452|593751831|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
164376633|NCT00673452|593751832|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
164376634|NCT00673452|593751831|FG000|Acute Double-Blind Phase|Physician Decision|0|||
164376635|NCT00673452|593751832|FG001|Acute Double-Blind Phase|Physician Decision|6|||
164376636|NCT00673452|593751831|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
164376637|NCT00673452|593751832|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
164376638|NCT00673452|593751831|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
164376639|NCT00673452|593751832|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
164376640|NCT00673452|593751831|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
164376641|NCT00673452|593751832|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
164376642|NCT00673452|593751831|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
164376643|NCT00673452|593751832|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
164376644|NCT00673452|593751831|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
164376645|NCT00673452|593751832|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
164376646|NCT00673452|593751831|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
164376647|NCT00673452|593751832|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
164376648|NCT00673452|593751831|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
164376649|NCT00673452|593751832|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
164376650|NCT00673452|593751831|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
164376651|NCT00673452|593751832|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
164376652|NCT00673452|593751831|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
164376653|NCT00673452|593751832|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
164376654|NCT00673452|593751831|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
164376655|NCT00673452|593751832|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
164376656|NCT00673452|593751831|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
164376657|NCT00673452|593751832|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
164376658|NCT04936685|593751833|FG000|Overall Study|Protocol Violation|1|||
164376659|NCT04936685|593751834|FG001|Overall Study|Protocol Violation|0|||
164376660|NCT03049813|593751835|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
164376661|NCT03049813|593751836|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
164376662|NCT03049813|593751837|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
164376663|NCT03049813|593751838|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
164439300|NCT03020745|593975356|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
164376664|NCT03049813|593751835|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
164376665|NCT03049813|593751836|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
164376666|NCT03049813|593751837|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
164376667|NCT03049813|593751838|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
164376668|NCT03049813|593751835|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
164376669|NCT03049813|593751836|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
164376670|NCT03049813|593751837|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
164376671|NCT03049813|593751838|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
164376672|NCT03049813|593751835|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
164376673|NCT03049813|593751836|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
164376674|NCT03049813|593751837|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
164376675|NCT03049813|593751838|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
164376676|NCT00179413|593751839|FG000|Overall Study|Adverse Event|38|||
164376677|NCT00179413|593751840|FG001|Overall Study|Adverse Event|20|||
164376678|NCT00179413|593751839|FG000|Overall Study|Withdrawal by Subject|87|||
164376679|NCT00179413|593751840|FG001|Overall Study|Withdrawal by Subject|95|||
164376680|NCT01813019|593751841|FG000|Overall Study|Adverse Event|0|||
164376681|NCT01813019|593751842|FG001|Overall Study|Adverse Event|3|||
164376682|NCT01813019|593751841|FG000|Overall Study|Withdrawal by Subject|3|||
164376683|NCT01813019|593751842|FG001|Overall Study|Withdrawal by Subject|2|||
164376684|NCT01813019|593751841|FG000|Overall Study|administrative problems|2|||
164376685|NCT01813019|593751842|FG001|Overall Study|administrative problems|0|||
164376686|NCT01813019|593751841|FG000|Overall Study|Protocol Deviation|2|||
164376687|NCT01813019|593751842|FG001|Overall Study|Protocol Deviation|1|||
164376688|NCT00439140|593751845|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
164376689|NCT00439140|593751846|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
164376690|NCT00439140|593751847|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
164376691|NCT00439140|593751845|FG000|Treatment Cycle 1|Personal reasons|0|||
164376692|NCT00439140|593751846|FG001|Treatment Cycle 1|Personal reasons|2|||
164376693|NCT00439140|593751847|FG002|Treatment Cycle 1|Personal reasons|0|||
164376694|NCT00439140|593751845|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
164376695|NCT00439140|593751846|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
164376696|NCT00439140|593751847|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
164376697|NCT00439140|593751845|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
164376698|NCT00439140|593751846|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
164376699|NCT00439140|593751847|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
164376700|NCT00439140|593751845|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
164376701|NCT00439140|593751846|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
164376702|NCT00439140|593751847|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
164376703|NCT01458171|593751851|FG000|Overall Study|Adverse Event|1|||
164376704|NCT00578565|593751856|FG000|Overall Study|Adverse Event|3|||
164376705|NCT03025828|593751857|FG000|Overall Study|Lost to Follow-up|1|||
164376706|NCT01192152|593751858|FG000|Period 1|left prematurely (while on treatment B)|0|||
164376707|NCT01192152|593751859|FG001|Period 1|left prematurely (while on treatment B)|1|||
164376708|NCT01192152|593751858|FG000|Period 3|family emergency|1|||
164376709|NCT01192152|593751859|FG001|Period 3|family emergency|0|||
164376710|NCT02143843|593751860|FG000|Overall Study|Adverse Event|8|||
164376711|NCT02143843|593751860|FG000|Overall Study|Lack of Efficacy|2|||
164376712|NCT02143843|593751860|FG000|Overall Study|Withdrawal by Subject|2|||
164376713|NCT02519712|593751863|FG000|Overall Study|Disease Relapse|1|||
164376714|NCT02519712|593751863|FG000|Overall Study|Disease Progression|1|||
164376715|NCT02519712|593751863|FG000|Overall Study|Accruals are donors|2|||
164376716|NCT01339390|593751874|FG000|Overall Study|Death|32|||
164376717|NCT01339390|593751875|FG001|Overall Study|Death|29|||
164376718|NCT01339390|593751874|FG000|Overall Study|Lost to Follow-up|125|||
164376719|NCT01339390|593751875|FG001|Overall Study|Lost to Follow-up|127|||
164376720|NCT00378703|593751876|FG000|Overall Study|Disease progression|59|||
164376721|NCT00378703|593751877|FG001|Overall Study|Disease progression|43|||
164376722|NCT00378703|593751878|FG002|Overall Study|Disease progression|48|||
164376723|NCT00378703|593751879|FG003|Overall Study|Disease progression|49|||
164376724|NCT00378703|593751876|FG000|Overall Study|Adverse Event|11|||
164376725|NCT00378703|593751877|FG001|Overall Study|Adverse Event|17|||
164376726|NCT00378703|593751878|FG002|Overall Study|Adverse Event|20|||
164376727|NCT00378703|593751879|FG003|Overall Study|Adverse Event|18|||
164376728|NCT00378703|593751876|FG000|Overall Study|Death|2|||
164376729|NCT00378703|593751877|FG001|Overall Study|Death|2|||
164376730|NCT00378703|593751878|FG002|Overall Study|Death|4|||
164376731|NCT00378703|593751879|FG003|Overall Study|Death|3|||
164376732|NCT00378703|593751876|FG000|Overall Study|Withdrawal by Subject|4|||
164376733|NCT00378703|593751877|FG001|Overall Study|Withdrawal by Subject|8|||
164376734|NCT00378703|593751878|FG002|Overall Study|Withdrawal by Subject|5|||
164376735|NCT00378703|593751879|FG003|Overall Study|Withdrawal by Subject|7|||
164376736|NCT00378703|593751876|FG000|Overall Study|Physician Decision|1|||
164376737|NCT00378703|593751877|FG001|Overall Study|Physician Decision|4|||
164376738|NCT00378703|593751878|FG002|Overall Study|Physician Decision|1|||
164376739|NCT00378703|593751879|FG003|Overall Study|Physician Decision|0|||
164376740|NCT00378703|593751876|FG000|Overall Study|Alternative therapy|4|||
164376741|NCT00378703|593751877|FG001|Overall Study|Alternative therapy|2|||
164376742|NCT00378703|593751878|FG002|Overall Study|Alternative therapy|0|||
164376743|NCT00378703|593751879|FG003|Overall Study|Alternative therapy|0|||
164591832|NCT02691247|594529996|FG002|Overall Study|Withdrawal by Subject|2|||
164591833|NCT02691247|594529994|FG000|Overall Study|Lost to Follow-up|2|||
164591834|NCT02691247|594529995|FG001|Overall Study|Lost to Follow-up|0|||
164591835|NCT02691247|594529996|FG002|Overall Study|Lost to Follow-up|1|||
164591836|NCT00772967|594529997|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
164591837|NCT00772967|594529998|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
164591838|NCT00772967|594529999|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
164591839|NCT00772967|594530000|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
164591840|NCT00772967|594530001|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
164700522|NCT01206816|594926840|FG000|Overall Study|Withdrawal by Subject|0|||
164700523|NCT01206816|594926841|FG001|Overall Study|Withdrawal by Subject|0|||
164700524|NCT01206816|594926842|FG002|Overall Study|Withdrawal by Subject|1|||
164700525|NCT01206816|594926843|FG003|Overall Study|Withdrawal by Subject|0|||
164700526|NCT01206816|594926844|FG004|Overall Study|Withdrawal by Subject|0|||
164700527|NCT01206816|594926845|FG005|Overall Study|Withdrawal by Subject|0|||
164700528|NCT01206816|594926846|FG006|Overall Study|Withdrawal by Subject|0|||
164700529|NCT01206816|594926840|FG000|Overall Study|Progressive disease|3|||
164700530|NCT01206816|594926841|FG001|Overall Study|Progressive disease|3|||
164700531|NCT01206816|594926842|FG002|Overall Study|Progressive disease|13|||
164700532|NCT01206816|594926843|FG003|Overall Study|Progressive disease|3|||
164700533|NCT01206816|594926844|FG004|Overall Study|Progressive disease|3|||
164700534|NCT01206816|594926845|FG005|Overall Study|Progressive disease|16|||
164700535|NCT01206816|594926846|FG006|Overall Study|Progressive disease|3|||
164700536|NCT01206816|594926840|FG000|Overall Study|Other AE|0|||
164700537|NCT01206816|594926841|FG001|Overall Study|Other AE|0|||
164700538|NCT01206816|594926842|FG002|Overall Study|Other AE|4|||
164700539|NCT01206816|594926843|FG003|Overall Study|Other AE|0|||
164700540|NCT01206816|594926844|FG004|Overall Study|Other AE|0|||
164700541|NCT01206816|594926845|FG005|Overall Study|Other AE|3|||
164700542|NCT01206816|594926846|FG006|Overall Study|Other AE|2|||
164700543|NCT01206816|594926840|FG000|Overall Study|other than stated above|0|||
164700544|NCT01206816|594926841|FG001|Overall Study|other than stated above|0|||
164700545|NCT01206816|594926842|FG002|Overall Study|other than stated above|1|||
164700546|NCT01206816|594926843|FG003|Overall Study|other than stated above|0|||
164700547|NCT01206816|594926844|FG004|Overall Study|other than stated above|0|||
164700548|NCT01206816|594926845|FG005|Overall Study|other than stated above|0|||
164700549|NCT01206816|594926846|FG006|Overall Study|other than stated above|1|||
164700550|NCT02528123|594926848|FG000|Overall Study|Lost to Follow-up|1|||
164700551|NCT01939496|594926849|FG000|Overall Study|Adverse Event|2|||
164700552|NCT01939496|594926850|FG001|Overall Study|Adverse Event|0|||
164700553|NCT01939496|594926851|FG002|Overall Study|Adverse Event|0|||
164700554|NCT01939496|594926849|FG000|Overall Study|Lost to Follow-up|1|||
164700555|NCT01939496|594926850|FG001|Overall Study|Lost to Follow-up|1|||
164700556|NCT01939496|594926851|FG002|Overall Study|Lost to Follow-up|0|||
164700557|NCT01939496|594926849|FG000|Overall Study|Physician Decision|1|||
164700558|NCT01939496|594926850|FG001|Overall Study|Physician Decision|0|||
164700559|NCT01939496|594926851|FG002|Overall Study|Physician Decision|0|||
164700560|NCT01939496|594926849|FG000|Overall Study|Protocol Violation|3|||
164700561|NCT01939496|594926850|FG001|Overall Study|Protocol Violation|0|||
164700562|NCT01939496|594926851|FG002|Overall Study|Protocol Violation|0|||
164700563|NCT01939496|594926849|FG000|Overall Study|Withdrawal by Subject|0|||
164700564|NCT01939496|594926850|FG001|Overall Study|Withdrawal by Subject|1|||
164700565|NCT01939496|594926851|FG002|Overall Study|Withdrawal by Subject|1|||
164700566|NCT01939496|594926849|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
164700567|NCT01939496|594926850|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
164700568|NCT01939496|594926851|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
164700569|NCT01939496|594926849|FG000|Overall Study|Other|2|||
164700570|NCT01939496|594926850|FG001|Overall Study|Other|0|||
164700571|NCT01939496|594926851|FG002|Overall Study|Other|1|||
164700572|NCT03052322|594926852|FG000|Overall Study|Other un-specified|1|||
164700573|NCT03052322|594926853|FG001|Overall Study|Other un-specified|2|||
164700574|NCT03052322|594926852|FG000|Overall Study|Withdrawal by Subject|10|||
164700575|NCT03052322|594926853|FG001|Overall Study|Withdrawal by Subject|9|||
164700576|NCT03052322|594926852|FG000|Overall Study|Death|0|||
164700577|NCT03052322|594926853|FG001|Overall Study|Death|2|||
164376744|NCT00378703|593751876|FG000|Overall Study|Other complicated disease|0|||
164376745|NCT00378703|593751877|FG001|Overall Study|Other complicated disease|2|||
164376746|NCT00378703|593751878|FG002|Overall Study|Other complicated disease|2|||
164700578|NCT03052322|594926852|FG000|Overall Study|Lack of Efficacy|1|||
164700579|NCT03052322|594926853|FG001|Overall Study|Lack of Efficacy|2|||
164700580|NCT03052322|594926852|FG000|Overall Study|Protocol Violation|1|||
164700581|NCT03052322|594926853|FG001|Overall Study|Protocol Violation|0|||
164700582|NCT03052322|594926852|FG000|Overall Study|Lost to Follow-up|2|||
164700583|NCT03052322|594926853|FG001|Overall Study|Lost to Follow-up|4|||
164700584|NCT03052322|594926852|FG000|Overall Study|Adverse Event|6|||
164591841|NCT00772967|594530002|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
164591842|NCT00772967|594529997|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
164591843|NCT00772967|594529998|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
164591844|NCT00772967|594529999|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
164591845|NCT00772967|594530000|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
164591846|NCT00772967|594530001|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
164591847|NCT00772967|594530002|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
164591848|NCT00772967|594529997|FG000|Crossover Treatment 3|Adverse Event|0|||
164591849|NCT00772967|594529998|FG001|Crossover Treatment 3|Adverse Event|0|||
164591850|NCT00772967|594529999|FG002|Crossover Treatment 3|Adverse Event|0|||
164591851|NCT00772967|594530000|FG003|Crossover Treatment 3|Adverse Event|0|||
164591852|NCT00772967|594530001|FG004|Crossover Treatment 3|Adverse Event|1|||
164591853|NCT00772967|594530002|FG005|Crossover Treatment 3|Adverse Event|0|||
164591854|NCT00231062|594530005|FG000|Overall Study|Physician Decision|6|||
164591855|NCT00803244|594530006|FG000|Overall Study|Adverse Event|1|||
164591856|NCT00803244|594530007|FG001|Overall Study|Adverse Event|2|||
164591857|NCT00803244|594530006|FG000|Overall Study|Withdrawal by Subject|2|||
164591858|NCT00803244|594530007|FG001|Overall Study|Withdrawal by Subject|3|||
164591859|NCT00803244|594530006|FG000|Overall Study|Any other reason not above-mentioned|4|||
164591860|NCT00803244|594530007|FG001|Overall Study|Any other reason not above-mentioned|10|||
164591861|NCT03321929|594530008|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
164591862|NCT04590937|594530009|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
164591863|NCT01635933|594530010|FG000|Overall Study|Adverse Event|1|||
164591864|NCT01635933|594530011|FG001|Overall Study|Adverse Event|0|||
164591865|NCT01635933|594530010|FG000|Overall Study|Lost to Follow-up|0|||
164591866|NCT01635933|594530011|FG001|Overall Study|Lost to Follow-up|5|||
164376747|NCT00378703|593751879|FG003|Overall Study|Other complicated disease|0|||
164376748|NCT00378703|593751876|FG000|Overall Study|Symptomatic deterioration|0|||
164376749|NCT00378703|593751877|FG001|Overall Study|Symptomatic deterioration|1|||
164376750|NCT00378703|593751878|FG002|Overall Study|Symptomatic deterioration|0|||
164376751|NCT00378703|593751879|FG003|Overall Study|Symptomatic deterioration|2|||
164376752|NCT00378703|593751876|FG000|Overall Study|Surgery|1|||
164376753|NCT00378703|593751877|FG001|Overall Study|Surgery|0|||
164376754|NCT00378703|593751878|FG002|Overall Study|Surgery|0|||
164376755|NCT00378703|593751879|FG003|Overall Study|Surgery|1|||
164376756|NCT00378703|593751876|FG000|Overall Study|Joint decision of physician and patient|1|||
164376757|NCT00378703|593751877|FG001|Overall Study|Joint decision of physician and patient|0|||
164376758|NCT00378703|593751878|FG002|Overall Study|Joint decision of physician and patient|0|||
164376759|NCT00378703|593751879|FG003|Overall Study|Joint decision of physician and patient|0|||
164376760|NCT00378703|593751876|FG000|Overall Study|Adverse events and progressive disease|0|||
164376761|NCT00378703|593751877|FG001|Overall Study|Adverse events and progressive disease|0|||
164376762|NCT00378703|593751878|FG002|Overall Study|Adverse events and progressive disease|0|||
164376763|NCT00378703|593751879|FG003|Overall Study|Adverse events and progressive disease|1|||
164376764|NCT00378703|593751876|FG000|Overall Study|Relocation|0|||
164376765|NCT00378703|593751877|FG001|Overall Study|Relocation|0|||
164376766|NCT00378703|593751878|FG002|Overall Study|Relocation|1|||
164376767|NCT00378703|593751879|FG003|Overall Study|Relocation|0|||
164376768|NCT00378703|593751876|FG000|Overall Study|Ineligible|4|||
164376769|NCT00378703|593751877|FG001|Overall Study|Ineligible|7|||
164376770|NCT00378703|593751878|FG002|Overall Study|Ineligible|7|||
164376771|NCT00378703|593751879|FG003|Overall Study|Ineligible|7|||
164376772|NCT00378703|593751876|FG000|Overall Study|Never started treatment|1|||
164376773|NCT00378703|593751877|FG001|Overall Study|Never started treatment|4|||
164376774|NCT00378703|593751878|FG002|Overall Study|Never started treatment|0|||
164376775|NCT00378703|593751879|FG003|Overall Study|Never started treatment|0|||
164376776|NCT00378703|593751876|FG000|Overall Study|Other|1|||
164591867|NCT01635933|594530010|FG000|Overall Study|Subject decision|1|||
164591868|NCT01635933|594530011|FG001|Overall Study|Subject decision|1|||
164591869|NCT01635933|594530010|FG000|Overall Study|Noncompliance|0|||
164591870|NCT01635933|594530011|FG001|Overall Study|Noncompliance|1|||
164591871|NCT01635933|594530010|FG000|Overall Study|No longer had transportation|0|||
164591872|NCT01635933|594530011|FG001|Overall Study|No longer had transportation|1|||
164376777|NCT00378703|593751877|FG001|Overall Study|Other|1|||
164376778|NCT00378703|593751878|FG002|Overall Study|Other|2|||
164376779|NCT00378703|593751879|FG003|Overall Study|Other|3|||
164376780|NCT03181542|593751882|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
164591873|NCT01544595|594530012|FG000|Status at Week 68|Adverse Event|3|||
164591874|NCT01544595|594530013|FG001|Status at Week 68|Adverse Event|2|||
164591875|NCT01544595|594530014|FG002|Status at Week 68|Adverse Event|1|||
164376781|NCT03181542|593751883|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
164376782|NCT01462357|593751885|FG000|Overall Study|Death|0|||
164376783|NCT01462357|593751886|FG001|Overall Study|Death|0|||
164376784|NCT01462357|593751887|FG002|Overall Study|Death|1|||
164376785|NCT01462357|593751885|FG000|Overall Study|Withdrawal by Subject|3|||
164376786|NCT01462357|593751886|FG001|Overall Study|Withdrawal by Subject|11|||
164376787|NCT01462357|593751887|FG002|Overall Study|Withdrawal by Subject|3|||
164439301|NCT03020745|593975357|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
164376788|NCT01462357|593751885|FG000|Overall Study|Migrated/moved from study area|2|||
164376789|NCT01462357|593751886|FG001|Overall Study|Migrated/moved from study area|3|||
164376790|NCT01462357|593751887|FG002|Overall Study|Migrated/moved from study area|1|||
164376791|NCT01462357|593751885|FG000|Overall Study|Lost to Follow-up|3|||
164376792|NCT01462357|593751886|FG001|Overall Study|Lost to Follow-up|5|||
164376793|NCT01462357|593751887|FG002|Overall Study|Lost to Follow-up|7|||
164376794|NCT02908529|593751888|FG000|Overall Study|Lost to Follow-up|0|||
164376795|NCT02908529|593751889|FG001|Overall Study|Lost to Follow-up|2|||
164376796|NCT04497987|593751890|FG000|Overall Study|Adverse Event|1|||
164376797|NCT04497987|593751891|FG001|Overall Study|Adverse Event|0|||
164376798|NCT04497987|593751890|FG000|Overall Study|Death|21|||
164376799|NCT04497987|593751891|FG001|Overall Study|Death|13|||
164376800|NCT04497987|593751890|FG000|Overall Study|Lost to Follow-up|19|||
164376801|NCT04497987|593751891|FG001|Overall Study|Lost to Follow-up|17|||
164376802|NCT04497987|593751890|FG000|Overall Study|Other - as reported by the investigator|22|||
164376803|NCT04497987|593751891|FG001|Overall Study|Other - as reported by the investigator|16|||
164376804|NCT04497987|593751890|FG000|Overall Study|Physician Decision|1|||
164376805|NCT04497987|593751891|FG001|Overall Study|Physician Decision|0|||
164376806|NCT04497987|593751890|FG000|Overall Study|Withdrawal by Subject|35|||
164376807|NCT04497987|593751891|FG001|Overall Study|Withdrawal by Subject|21|||
164376808|NCT04579679|593751899|FG000|Overall Study|New Antitumor Therapy|6|||
164376809|NCT04579679|593751900|FG001|Overall Study|New Antitumor Therapy|4|||
164376810|NCT04579679|593751901|FG002|Overall Study|New Antitumor Therapy|7|||
164376811|NCT04579679|593751902|FG003|Overall Study|New Antitumor Therapy|0|||
164376812|NCT04579679|593751899|FG000|Overall Study|Withdrawal of Consent|1|||
164376813|NCT04579679|593751900|FG001|Overall Study|Withdrawal of Consent|1|||
164376814|NCT04579679|593751901|FG002|Overall Study|Withdrawal of Consent|2|||
164376815|NCT04579679|593751902|FG003|Overall Study|Withdrawal of Consent|4|||
164376816|NCT04579679|593751899|FG000|Overall Study|Death|2|||
164376817|NCT04579679|593751900|FG001|Overall Study|Death|2|||
164376818|NCT04579679|593751901|FG002|Overall Study|Death|2|||
164376819|NCT04579679|593751902|FG003|Overall Study|Death|0|||
164376820|NCT04579679|593751899|FG000|Overall Study|Adverse Event|0|||
164376821|NCT04579679|593751900|FG001|Overall Study|Adverse Event|4|||
164376822|NCT04579679|593751901|FG002|Overall Study|Adverse Event|0|||
164376823|NCT04579679|593751902|FG003|Overall Study|Adverse Event|0|||
164376824|NCT04579679|593751899|FG000|Overall Study|Disease Progression|9|||
164376825|NCT04579679|593751900|FG001|Overall Study|Disease Progression|13|||
164376826|NCT04579679|593751901|FG002|Overall Study|Disease Progression|7|||
164376827|NCT04579679|593751902|FG003|Overall Study|Disease Progression|0|||
164376828|NCT04579679|593751899|FG000|Overall Study|Physician Decision|0|||
164376829|NCT04579679|593751900|FG001|Overall Study|Physician Decision|0|||
164376830|NCT04579679|593751901|FG002|Overall Study|Physician Decision|1|||
164376831|NCT04579679|593751902|FG003|Overall Study|Physician Decision|0|||
164376832|NCT04579679|593751899|FG000|Overall Study|Study Terminated by Sponsor|2|||
164376833|NCT04579679|593751900|FG001|Overall Study|Study Terminated by Sponsor|7|||
164376834|NCT04579679|593751901|FG002|Overall Study|Study Terminated by Sponsor|1|||
164376835|NCT04579679|593751902|FG003|Overall Study|Study Terminated by Sponsor|0|||
164376836|NCT00646958|593754157|FG000|Overall Study|Lack of Efficacy|1|||
164376837|NCT00646958|593754158|FG001|Overall Study|Lack of Efficacy|0|||
164376838|NCT00646958|593754159|FG002|Overall Study|Lack of Efficacy|0|||
164376839|NCT00646958|593754157|FG000|Overall Study|Adverse Event|4|||
164376840|NCT00646958|593754158|FG001|Overall Study|Adverse Event|0|||
164439302|NCT03020745|593975358|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
164439303|NCT03020745|593975359|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
164439304|NCT03020745|593975350|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
164376841|NCT00646958|593754159|FG002|Overall Study|Adverse Event|0|||
164376842|NCT00646958|593754157|FG000|Overall Study|Lost to Follow-up|1|||
164376843|NCT00646958|593754158|FG001|Overall Study|Lost to Follow-up|5|||
164376844|NCT00646958|593754159|FG002|Overall Study|Lost to Follow-up|7|||
164376845|NCT00646958|593754157|FG000|Overall Study|Protocol Violation|1|||
164376846|NCT00646958|593754158|FG001|Overall Study|Protocol Violation|1|||
164376847|NCT00646958|593754159|FG002|Overall Study|Protocol Violation|0|||
164376848|NCT00646958|593754157|FG000|Overall Study|Abnormal screening lab tests|1|||
164376849|NCT00646958|593754158|FG001|Overall Study|Abnormal screening lab tests|1|||
164376850|NCT00646958|593754159|FG002|Overall Study|Abnormal screening lab tests|0|||
164376851|NCT00646958|593754157|FG000|Overall Study|Withdrawal by Subject|1|||
164376852|NCT00646958|593754158|FG001|Overall Study|Withdrawal by Subject|2|||
164376853|NCT00646958|593754159|FG002|Overall Study|Withdrawal by Subject|0|||
164376854|NCT00646958|593754157|FG000|Overall Study|Did not receive study drug|2|||
164376855|NCT00646958|593754158|FG001|Overall Study|Did not receive study drug|0|||
164376856|NCT00646958|593754159|FG002|Overall Study|Did not receive study drug|2|||
164376857|NCT02139644|593754160|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
164700585|NCT03052322|594926853|FG001|Overall Study|Adverse Event|13|||
164700586|NCT05065983|594926856|FG000|Overall Study|Lost to Follow-up|2|||
164700587|NCT00506129|594926857|FG000|Overall Study|Disease Progression/Relapse|15|||
164700588|NCT00506129|594926857|FG000|Overall Study|Death|7|||
164700589|NCT01642914|594926858|FG000|Overall Study|Adverse Event|11|||
164700590|NCT01642914|594926859|FG001|Overall Study|Adverse Event|7|||
164700591|NCT01642914|594926860|FG002|Overall Study|Adverse Event|15|||
164700592|NCT01642914|594926858|FG000|Overall Study|Lack of Efficacy|9|||
164700593|NCT01642914|594926859|FG001|Overall Study|Lack of Efficacy|4|||
164700594|NCT01642914|594926860|FG002|Overall Study|Lack of Efficacy|2|||
164700595|NCT01642914|594926858|FG000|Overall Study|Protocol Violation|15|||
164700596|NCT01642914|594926859|FG001|Overall Study|Protocol Violation|13|||
164700597|NCT01642914|594926860|FG002|Overall Study|Protocol Violation|6|||
164700598|NCT01642914|594926858|FG000|Overall Study|Withdrawal by Subject|5|||
164700599|NCT01642914|594926859|FG001|Overall Study|Withdrawal by Subject|5|||
164700600|NCT01642914|594926860|FG002|Overall Study|Withdrawal by Subject|10|||
164700601|NCT01642914|594926858|FG000|Overall Study|Lost to Follow-up|5|||
164700602|NCT01642914|594926859|FG001|Overall Study|Lost to Follow-up|3|||
164700603|NCT01642914|594926860|FG002|Overall Study|Lost to Follow-up|7|||
164700604|NCT01642914|594926858|FG000|Overall Study|Other Reason|1|||
164700605|NCT01642914|594926859|FG001|Overall Study|Other Reason|0|||
164700606|NCT01642914|594926860|FG002|Overall Study|Other Reason|0|||
164700607|NCT04295135|594926861|FG000|Overall Study|Withdrawal by Subject|2|||
164700608|NCT04295135|594926862|FG001|Overall Study|Withdrawal by Subject|1|||
164700609|NCT04295135|594926861|FG000|Overall Study|Subject left organization|8|||
164700610|NCT04295135|594926862|FG001|Overall Study|Subject left organization|4|||
164700611|NCT02923674|594926863|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
164700612|NCT02923674|594926864|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
164376858|NCT02139644|593754161|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164376859|NCT02139644|593754162|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164376860|NCT02139644|593754163|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164376861|NCT02139644|593754164|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164376862|NCT02139644|593754165|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164376863|NCT02139644|593754160|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
164376864|NCT02139644|593754161|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164376865|NCT02139644|593754162|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164376866|NCT02139644|593754163|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164376867|NCT02139644|593754164|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164376868|NCT02139644|593754165|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164376869|NCT02139644|593754160|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
164376870|NCT02139644|593754161|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164376871|NCT02139644|593754162|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164376872|NCT02139644|593754163|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164376873|NCT02139644|593754164|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164376874|NCT02139644|593754165|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164376875|NCT02139644|593754160|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
164376876|NCT02139644|593754161|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164376877|NCT02139644|593754162|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164376878|NCT02139644|593754163|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164700613|NCT02923674|594926865|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
164700614|NCT02923674|594926863|FG000|Overall Study|Lost to Follow-up|7|||
164700615|NCT02923674|594926864|FG001|Overall Study|Lost to Follow-up|12|||
164700616|NCT02923674|594926865|FG002|Overall Study|Lost to Follow-up|7|||
164700617|NCT02923674|594926863|FG000|Overall Study|Problem with intervention|2|||
164376879|NCT02139644|593754164|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164376880|NCT02139644|593754165|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164376881|NCT02139644|593754160|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
164376882|NCT02139644|593754161|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164376883|NCT02139644|593754162|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164376884|NCT02139644|593754163|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164376885|NCT02139644|593754164|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164376886|NCT02139644|593754165|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164376887|NCT02139644|593754160|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
164376888|NCT02139644|593754161|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
164376889|NCT02139644|593754162|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
164700618|NCT02923674|594926864|FG001|Overall Study|Problem with intervention|2|||
164700619|NCT02923674|594926865|FG002|Overall Study|Problem with intervention|1|||
164700620|NCT02923674|594926863|FG000|Overall Study|Adverse Event|3|||
164700621|NCT02923674|594926864|FG001|Overall Study|Adverse Event|1|||
164700622|NCT02923674|594926865|FG002|Overall Study|Adverse Event|1|||
164700623|NCT02923674|594926863|FG000|Overall Study|Withdrawal by Subject|2|||
164376890|NCT02139644|593754163|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
164376891|NCT02139644|593754164|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
164376892|NCT02139644|593754165|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
164376893|NCT02139644|593754160|FG000|Run-In Period (Pre-assignment)|Other|6|||
164376894|NCT02139644|593754161|FG001|Run-In Period (Pre-assignment)|Other|0|||
164376895|NCT02139644|593754162|FG002|Run-In Period (Pre-assignment)|Other|0|||
164376896|NCT02139644|593754163|FG003|Run-In Period (Pre-assignment)|Other|0|||
164376897|NCT02139644|593754164|FG004|Run-In Period (Pre-assignment)|Other|0|||
164376898|NCT02139644|593754165|FG005|Run-In Period (Pre-assignment)|Other|0|||
164376899|NCT02139644|593754160|FG000|Treatment Period|Adverse Event|0|||
164376900|NCT02139644|593754161|FG001|Treatment Period|Adverse Event|0|||
164376901|NCT02139644|593754162|FG002|Treatment Period|Adverse Event|3|||
164376902|NCT02139644|593754163|FG003|Treatment Period|Adverse Event|2|||
164376903|NCT02139644|593754164|FG004|Treatment Period|Adverse Event|1|||
164376904|NCT02139644|593754165|FG005|Treatment Period|Adverse Event|6|||
164376905|NCT02139644|593754160|FG000|Treatment Period|Withdrawal by Subject|0|||
164376906|NCT02139644|593754161|FG001|Treatment Period|Withdrawal by Subject|0|||
164376907|NCT02139644|593754162|FG002|Treatment Period|Withdrawal by Subject|2|||
164376908|NCT02139644|593754163|FG003|Treatment Period|Withdrawal by Subject|2|||
164376909|NCT02139644|593754164|FG004|Treatment Period|Withdrawal by Subject|3|||
164376910|NCT02139644|593754165|FG005|Treatment Period|Withdrawal by Subject|2|||
164376911|NCT02139644|593754160|FG000|Treatment Period|Non-compliance|0|||
164376912|NCT02139644|593754161|FG001|Treatment Period|Non-compliance|0|||
164376913|NCT02139644|593754162|FG002|Treatment Period|Non-compliance|0|||
164376914|NCT02139644|593754163|FG003|Treatment Period|Non-compliance|1|||
164376915|NCT02139644|593754164|FG004|Treatment Period|Non-compliance|0|||
164376916|NCT02139644|593754165|FG005|Treatment Period|Non-compliance|0|||
164376917|NCT02139644|593754160|FG000|Treatment Period|Protocol Violation|0|||
164376918|NCT02139644|593754161|FG001|Treatment Period|Protocol Violation|0|||
164376919|NCT02139644|593754162|FG002|Treatment Period|Protocol Violation|0|||
164376920|NCT02139644|593754163|FG003|Treatment Period|Protocol Violation|1|||
164376921|NCT02139644|593754164|FG004|Treatment Period|Protocol Violation|1|||
164376922|NCT02139644|593754165|FG005|Treatment Period|Protocol Violation|1|||
164376923|NCT02139644|593754160|FG000|Treatment Period|Disease progression|0|||
164376924|NCT02139644|593754161|FG001|Treatment Period|Disease progression|0|||
164376925|NCT02139644|593754162|FG002|Treatment Period|Disease progression|0|||
164376926|NCT02139644|593754163|FG003|Treatment Period|Disease progression|1|||
164376927|NCT02139644|593754164|FG004|Treatment Period|Disease progression|1|||
164376928|NCT02139644|593754165|FG005|Treatment Period|Disease progression|2|||
164376929|NCT02139644|593754160|FG000|Treatment Period|Lost to Follow-up|0|||
164376930|NCT02139644|593754161|FG001|Treatment Period|Lost to Follow-up|0|||
164376931|NCT02139644|593754162|FG002|Treatment Period|Lost to Follow-up|1|||
164376932|NCT02139644|593754163|FG003|Treatment Period|Lost to Follow-up|1|||
164376933|NCT02139644|593754164|FG004|Treatment Period|Lost to Follow-up|1|||
164376934|NCT02139644|593754165|FG005|Treatment Period|Lost to Follow-up|1|||
164376935|NCT02139644|593754160|FG000|Treatment Period|Lack of Efficacy|0|||
164376936|NCT02139644|593754161|FG001|Treatment Period|Lack of Efficacy|0|||
164376937|NCT02139644|593754162|FG002|Treatment Period|Lack of Efficacy|1|||
164376938|NCT02139644|593754163|FG003|Treatment Period|Lack of Efficacy|0|||
164376939|NCT02139644|593754164|FG004|Treatment Period|Lack of Efficacy|1|||
164376940|NCT02139644|593754165|FG005|Treatment Period|Lack of Efficacy|4|||
164376941|NCT02139644|593754160|FG000|Treatment Period|Other|0|||
164376942|NCT02139644|593754161|FG001|Treatment Period|Other|3|||
164376943|NCT02139644|593754162|FG002|Treatment Period|Other|1|||
164376944|NCT02139644|593754163|FG003|Treatment Period|Other|1|||
164439305|NCT03020745|593975351|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
164376945|NCT02139644|593754164|FG004|Treatment Period|Other|0|||
164376946|NCT02139644|593754165|FG005|Treatment Period|Other|1|||
164376947|NCT02453594|593754168|FG000|Overall Study|Protocol Violation|0|||
164439306|NCT03020745|593975352|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
164376948|NCT02453594|593754169|FG001|Overall Study|Protocol Violation|0|||
164376949|NCT02453594|593754170|FG002|Overall Study|Protocol Violation|1|||
164376950|NCT02453594|593754168|FG000|Overall Study|Cohort Was Closed|17|||
164376951|NCT02453594|593754169|FG001|Overall Study|Cohort Was Closed|21|||
164376952|NCT02453594|593754170|FG002|Overall Study|Cohort Was Closed|14|||
164376953|NCT02453594|593754168|FG000|Overall Study|Death|20|||
164591876|NCT01544595|594530015|FG003|Status at Week 68|Adverse Event|0|||
164376954|NCT02453594|593754169|FG001|Overall Study|Death|24|||
164376955|NCT02453594|593754170|FG002|Overall Study|Death|16|||
164376956|NCT02453594|593754168|FG000|Overall Study|Lost to Follow-up|6|||
164376957|NCT02453594|593754169|FG001|Overall Study|Lost to Follow-up|14|||
164376958|NCT02453594|593754170|FG002|Overall Study|Lost to Follow-up|2|||
164591877|NCT01544595|594530016|FG004|Status at Week 68|Adverse Event|0|||
164591878|NCT01544595|594530017|FG005|Status at Week 68|Adverse Event|0|||
164591879|NCT01544595|594530012|FG000|Status at Week 68|Lack of Efficacy|1|||
164591880|NCT01544595|594530013|FG001|Status at Week 68|Lack of Efficacy|0|||
164591881|NCT01544595|594530014|FG002|Status at Week 68|Lack of Efficacy|0|||
164591882|NCT01544595|594530015|FG003|Status at Week 68|Lack of Efficacy|0|||
164376959|NCT02453594|593754168|FG000|Overall Study|Physician Decision|2|||
164376960|NCT02453594|593754169|FG001|Overall Study|Physician Decision|4|||
164376961|NCT02453594|593754170|FG002|Overall Study|Physician Decision|0|||
164376962|NCT02453594|593754168|FG000|Overall Study|Site Terminated by Sponsor|1|||
164376963|NCT02453594|593754169|FG001|Overall Study|Site Terminated by Sponsor|0|||
164376964|NCT02453594|593754170|FG002|Overall Study|Site Terminated by Sponsor|1|||
164376965|NCT02453594|593754168|FG000|Overall Study|Transitioned to Extension Study|16|||
164376966|NCT02453594|593754169|FG001|Overall Study|Transitioned to Extension Study|9|||
164376967|NCT02453594|593754170|FG002|Overall Study|Transitioned to Extension Study|16|||
164700624|NCT02923674|594926864|FG001|Overall Study|Withdrawal by Subject|2|||
164700625|NCT02923674|594926865|FG002|Overall Study|Withdrawal by Subject|2|||
164700626|NCT02712333|594926869|FG000|First Period|Withdrawal by Subject|3|||
164376968|NCT02453594|593754168|FG000|Overall Study|Withdrawal by Subject|7|||
164376969|NCT02453594|593754169|FG001|Overall Study|Withdrawal by Subject|9|||
164376970|NCT02453594|593754170|FG002|Overall Study|Withdrawal by Subject|11|||
164376971|NCT01694706|593754179|FG000|Overall Study|Adverse Event|0|||
164376972|NCT01694706|593754180|FG001|Overall Study|Adverse Event|1|||
164376973|NCT01694706|593754181|FG002|Overall Study|Adverse Event|0|||
164376974|NCT01694706|593754179|FG000|Overall Study|other reason not defined above|1|||
164376975|NCT01694706|593754180|FG001|Overall Study|other reason not defined above|0|||
164376976|NCT01694706|593754181|FG002|Overall Study|other reason not defined above|0|||
164376977|NCT00451282|593754182|FG000|Overall Study|Lost to Follow-up|6|||
164376978|NCT00451282|593754183|FG001|Overall Study|Lost to Follow-up|5|||
164376979|NCT01797536|593754184|FG000|Overall Study|Adverse Event|0|||
164376980|NCT01797536|593754185|FG001|Overall Study|Adverse Event|1|||
164376981|NCT01797536|593754186|FG002|Overall Study|Adverse Event|0|||
164376982|NCT01797536|593754187|FG003|Overall Study|Adverse Event|0|||
164376983|NCT00098839|593754188|FG000|Overall Study|Adverse Event|5|||
164376984|NCT00098839|593754189|FG001|Overall Study|Adverse Event|2|||
164376985|NCT00098839|593754188|FG000|Overall Study|Death|1|||
164376986|NCT00098839|593754189|FG001|Overall Study|Death|2|||
164376987|NCT00098839|593754188|FG000|Overall Study|Physician Decision|4|||
164376988|NCT00098839|593754189|FG001|Overall Study|Physician Decision|14|||
164376989|NCT00098839|593754188|FG000|Overall Study|Withdrawal by Subject|1|||
164376990|NCT00098839|593754189|FG001|Overall Study|Withdrawal by Subject|0|||
164376991|NCT00098839|593754188|FG000|Overall Study|Refusal of further protocol therapy|3|||
164376992|NCT00098839|593754189|FG001|Overall Study|Refusal of further protocol therapy|1|||
164376993|NCT00098839|593754188|FG000|Overall Study|Relapse|6|||
164376994|NCT00098839|593754189|FG001|Overall Study|Relapse|3|||
164376995|NCT00098839|593754188|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
164376996|NCT00098839|593754189|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
164376997|NCT00098839|593754188|FG000|Overall Study|Ineligible|2|||
164376998|NCT00098839|593754189|FG001|Overall Study|Ineligible|0|||
164376999|NCT00456092|593754190|FG000|Extension Phase|Grade 2 or Greater AE|2|||
164377000|NCT00456092|593754191|FG001|Extension Phase|Grade 2 or Greater AE|2|||
164377001|NCT00456092|593754192|FG002|Extension Phase|Grade 2 or Greater AE|0|||
164377002|NCT00456092|593754193|FG003|Extension Phase|Grade 2 or Greater AE|0|||
164377003|NCT00456092|593754194|FG004|Extension Phase|Grade 2 or Greater AE|2|||
164377004|NCT00456092|593754190|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
164377005|NCT00456092|593754191|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
164377006|NCT00456092|593754192|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
164377007|NCT00456092|593754193|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
164377008|NCT00456092|593754194|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
164377009|NCT00456092|593754190|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
164700627|NCT02712333|594926870|FG001|First Period|Withdrawal by Subject|2|||
164700628|NCT03463993|594926871|FG000|Overall Study|Lost to Follow-up|7|||
164700629|NCT03463993|594926872|FG001|Overall Study|Lost to Follow-up|8|||
164700630|NCT03463993|594926871|FG000|Overall Study|Withdrawal by Subject|2|||
164700631|NCT03463993|594926872|FG001|Overall Study|Withdrawal by Subject|0|||
164377010|NCT00456092|593754191|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
164377011|NCT00456092|593754192|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
164377012|NCT00456092|593754193|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
164377013|NCT00456092|593754194|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
164377014|NCT00456092|593754190|FG000|Extension Phase|Withdrew Consent|2|||
164377015|NCT00456092|593754191|FG001|Extension Phase|Withdrew Consent|0|||
164700632|NCT03463993|594926871|FG000|Overall Study|Protocol Violation|4|||
164700633|NCT03463993|594926872|FG001|Overall Study|Protocol Violation|1|||
164700634|NCT03463993|594926871|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
164700635|NCT03463993|594926872|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
164377016|NCT00456092|593754192|FG002|Extension Phase|Withdrew Consent|0|||
164377017|NCT00456092|593754193|FG003|Extension Phase|Withdrew Consent|0|||
164377018|NCT00456092|593754194|FG004|Extension Phase|Withdrew Consent|0|||
164377019|NCT00456092|593754190|FG000|Extension Phase|Lost to Follow-up|1|||
164377020|NCT00456092|593754191|FG001|Extension Phase|Lost to Follow-up|1|||
164377021|NCT00456092|593754192|FG002|Extension Phase|Lost to Follow-up|0|||
164377022|NCT00456092|593754193|FG003|Extension Phase|Lost to Follow-up|0|||
164377023|NCT00456092|593754194|FG004|Extension Phase|Lost to Follow-up|1|||
164377024|NCT00456092|593754190|FG000|Extension Phase|Other|2|||
164377025|NCT00456092|593754191|FG001|Extension Phase|Other|0|||
164377026|NCT00456092|593754192|FG002|Extension Phase|Other|0|||
164377027|NCT00456092|593754193|FG003|Extension Phase|Other|1|||
164377028|NCT00456092|593754194|FG004|Extension Phase|Other|1|||
164377029|NCT00456092|593754190|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
164377030|NCT00456092|593754191|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
164377031|NCT00456092|593754192|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
164377032|NCT00456092|593754193|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
164377033|NCT00456092|593754194|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
164377034|NCT00456092|593754190|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
164377035|NCT00456092|593754191|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
164377036|NCT00456092|593754192|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
164377037|NCT00456092|593754193|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
164377038|NCT00456092|593754194|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
164377039|NCT00456092|593754190|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
164377040|NCT00456092|593754191|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
164377041|NCT00456092|593754192|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
164377042|NCT00456092|593754193|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
164377043|NCT00456092|593754194|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
164377044|NCT00456092|593754190|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
164377045|NCT00456092|593754191|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
164377046|NCT00456092|593754192|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
164377047|NCT00456092|593754193|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
164377048|NCT00456092|593754194|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
164377049|NCT00456092|593754190|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
164377050|NCT00456092|593754191|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
164377051|NCT00456092|593754192|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
164377052|NCT00456092|593754193|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
164377053|NCT00456092|593754194|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
164377054|NCT00456092|593754190|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
164377055|NCT00456092|593754191|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
164377056|NCT00456092|593754192|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
164377057|NCT00456092|593754193|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
164377058|NCT00456092|593754194|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
164439307|NCT03020745|593975353|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
164439308|NCT03020745|593975354|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
164439309|NCT03020745|593975355|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
164439310|NCT03020745|593975356|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
164439311|NCT03020745|593975357|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
164439312|NCT03020745|593975358|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
164439313|NCT03020745|593975359|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
164439314|NCT00186186|593975360|FG000|Overall Study|Lack of Efficacy|3|||
164439315|NCT00186186|593975360|FG000|Overall Study|Withdrawal by Subject|3|||
164439316|NCT00186186|593975360|FG000|Overall Study|Not reported as to reason|2|||
164439317|NCT03622580|593975364|FG000|Overall Study|Death|16|||
164439318|NCT03622580|593975365|FG001|Overall Study|Death|21|||
164439319|NCT03622580|593975366|FG002|Overall Study|Death|13|||
164439320|NCT03622580|593975364|FG000|Overall Study|Adverse Event|6|||
164439321|NCT03622580|593975365|FG001|Overall Study|Adverse Event|6|||
164439322|NCT03622580|593975366|FG002|Overall Study|Adverse Event|5|||
164377059|NCT00456092|593754190|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
164377060|NCT00456092|593754191|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
164377061|NCT00456092|593754192|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
164377062|NCT00456092|593754193|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
164377063|NCT00456092|593754194|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
164377064|NCT00456092|593754190|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
164377065|NCT00456092|593754191|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
164377066|NCT00456092|593754192|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
164439323|NCT03622580|593975364|FG000|Overall Study|Withdrawal by Subject|12|||
164439324|NCT03622580|593975365|FG001|Overall Study|Withdrawal by Subject|7|||
164439325|NCT03622580|593975366|FG002|Overall Study|Withdrawal by Subject|19|||
164377067|NCT00456092|593754193|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
164377068|NCT00456092|593754194|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
164377069|NCT00456092|593754190|FG000|Treatment Phase (12 Weeks)|Other|1|||
164439326|NCT03622580|593975364|FG000|Overall Study|Lost to Follow-up|12|||
164439327|NCT03622580|593975365|FG001|Overall Study|Lost to Follow-up|9|||
164439328|NCT03622580|593975366|FG002|Overall Study|Lost to Follow-up|9|||
164377070|NCT00456092|593754191|FG001|Treatment Phase (12 Weeks)|Other|0|||
164377071|NCT00456092|593754192|FG002|Treatment Phase (12 Weeks)|Other|1|||
164377072|NCT00456092|593754193|FG003|Treatment Phase (12 Weeks)|Other|0|||
164377073|NCT00456092|593754194|FG004|Treatment Phase (12 Weeks)|Other|0|||
164377074|NCT01358981|593754198|FG000|Period 1|Withdrawal by Subject|0|||
164377075|NCT01358981|593754199|FG001|Period 1|Withdrawal by Subject|0|||
164377076|NCT01358981|593754200|FG002|Period 1|Withdrawal by Subject|0|||
164377077|NCT01358981|593754201|FG003|Period 1|Withdrawal by Subject|1|||
164377078|NCT01358981|593754202|FG004|Period 1|Withdrawal by Subject|0|||
164377079|NCT01358981|593754203|FG005|Period 1|Withdrawal by Subject|0|||
164377080|NCT01358981|593754204|FG006|Period 1|Withdrawal by Subject|0|||
164377081|NCT01332305|593754205|FG000|Overall Study|Adverse Event|1|||
164377082|NCT01332305|593754206|FG001|Overall Study|Adverse Event|4|||
164377083|NCT01332305|593754207|FG002|Overall Study|Adverse Event|6|||
164377084|NCT01332305|593754208|FG003|Overall Study|Adverse Event|3|||
164377085|NCT01332305|593754209|FG004|Overall Study|Adverse Event|5|||
164377086|NCT01332305|593754205|FG000|Overall Study|Withdrawal by Subject|6|||
164377087|NCT01332305|593754206|FG001|Overall Study|Withdrawal by Subject|5|||
164377088|NCT01332305|593754207|FG002|Overall Study|Withdrawal by Subject|4|||
164377089|NCT01332305|593754208|FG003|Overall Study|Withdrawal by Subject|1|||
164377090|NCT01332305|593754209|FG004|Overall Study|Withdrawal by Subject|0|||
164377091|NCT01332305|593754205|FG000|Overall Study|Lost to Follow-up|0|||
164377092|NCT01332305|593754206|FG001|Overall Study|Lost to Follow-up|2|||
164377093|NCT01332305|593754207|FG002|Overall Study|Lost to Follow-up|3|||
164377094|NCT01332305|593754208|FG003|Overall Study|Lost to Follow-up|2|||
164377095|NCT01332305|593754209|FG004|Overall Study|Lost to Follow-up|3|||
164377096|NCT01332305|593754205|FG000|Overall Study|Protocol Violation|1|||
164377097|NCT01332305|593754206|FG001|Overall Study|Protocol Violation|2|||
164377098|NCT01332305|593754207|FG002|Overall Study|Protocol Violation|1|||
164377099|NCT01332305|593754208|FG003|Overall Study|Protocol Violation|0|||
164377100|NCT01332305|593754209|FG004|Overall Study|Protocol Violation|3|||
164377101|NCT01332305|593754205|FG000|Overall Study|Withdrawal by Sponsor|1|||
164377102|NCT01332305|593754206|FG001|Overall Study|Withdrawal by Sponsor|0|||
164377103|NCT01332305|593754207|FG002|Overall Study|Withdrawal by Sponsor|0|||
164377104|NCT01332305|593754208|FG003|Overall Study|Withdrawal by Sponsor|1|||
164377105|NCT01332305|593754209|FG004|Overall Study|Withdrawal by Sponsor|1|||
164377106|NCT01332305|593754205|FG000|Overall Study|Treatment Failure|1|||
164377107|NCT01332305|593754206|FG001|Overall Study|Treatment Failure|1|||
164377108|NCT01332305|593754207|FG002|Overall Study|Treatment Failure|0|||
164377109|NCT01332305|593754208|FG003|Overall Study|Treatment Failure|0|||
164377110|NCT01332305|593754209|FG004|Overall Study|Treatment Failure|0|||
164377111|NCT01332305|593754205|FG000|Overall Study|Physician Decision|0|||
164377112|NCT01332305|593754206|FG001|Overall Study|Physician Decision|0|||
164377113|NCT01332305|593754207|FG002|Overall Study|Physician Decision|0|||
164377114|NCT01332305|593754208|FG003|Overall Study|Physician Decision|1|||
164377115|NCT01332305|593754209|FG004|Overall Study|Physician Decision|0|||
164377116|NCT01600040|593754210|FG000|Overall Study|Withdrawal by Subject|1|||
164377117|NCT01401530|593754216|FG000|Overall Study|Disease Progression|1|||
164377118|NCT01401530|593754217|FG001|Overall Study|Disease Progression|2|||
164377119|NCT01401530|593754218|FG002|Overall Study|Disease Progression|1|||
164377120|NCT01401530|593754216|FG000|Overall Study|Adverse Event|1|||
164377121|NCT01401530|593754217|FG001|Overall Study|Adverse Event|1|||
164377122|NCT01401530|593754218|FG002|Overall Study|Adverse Event|1|||
164377123|NCT01401530|593754216|FG000|Overall Study|Participant Choice|1|||
164377124|NCT01401530|593754217|FG001|Overall Study|Participant Choice|2|||
164377125|NCT01401530|593754218|FG002|Overall Study|Participant Choice|1|||
164377126|NCT01401530|593754216|FG000|Overall Study|Physician Decision|0|||
164377127|NCT01401530|593754217|FG001|Overall Study|Physician Decision|1|||
164377128|NCT01401530|593754218|FG002|Overall Study|Physician Decision|0|||
164377129|NCT03670810|593754219|FG000|Main Study|Adverse Event|37|||
164377130|NCT03670810|593754220|FG001|Main Study|Adverse Event|38|||
164377131|NCT03670810|593754221|FG002|Main Study|Adverse Event|3|||
164377132|NCT03670810|593754222|FG003|Main Study|Adverse Event|4|||
164377133|NCT03670810|593754223|FG004|Main Study|Adverse Event|4|||
164377134|NCT03670810|593754224|FG005|Main Study|Adverse Event|5|||
164377135|NCT03670810|593754225|FG006|Main Study|Adverse Event|0|||
164377136|NCT03670810|593754226|FG007|Main Study|Adverse Event|0|||
164377137|NCT03670810|593754227|FG008|Main Study|Adverse Event|0|||
164377138|NCT03670810|593754219|FG000|Main Study|Lack of Efficacy|8|||
164377139|NCT03670810|593754220|FG001|Main Study|Lack of Efficacy|9|||
164377140|NCT03670810|593754221|FG002|Main Study|Lack of Efficacy|3|||
164377141|NCT03670810|593754222|FG003|Main Study|Lack of Efficacy|4|||
164377142|NCT03670810|593754223|FG004|Main Study|Lack of Efficacy|0|||
164377143|NCT03670810|593754224|FG005|Main Study|Lack of Efficacy|0|||
164377144|NCT03670810|593754225|FG006|Main Study|Lack of Efficacy|0|||
164377145|NCT03670810|593754226|FG007|Main Study|Lack of Efficacy|0|||
164377146|NCT03670810|593754227|FG008|Main Study|Lack of Efficacy|0|||
164377147|NCT03670810|593754219|FG000|Main Study|Lost to Follow-up|9|||
164377148|NCT03670810|593754220|FG001|Main Study|Lost to Follow-up|7|||
164377149|NCT03670810|593754221|FG002|Main Study|Lost to Follow-up|4|||
164377150|NCT03670810|593754222|FG003|Main Study|Lost to Follow-up|6|||
164377151|NCT03670810|593754223|FG004|Main Study|Lost to Follow-up|1|||
164377152|NCT03670810|593754224|FG005|Main Study|Lost to Follow-up|0|||
164377153|NCT03670810|593754225|FG006|Main Study|Lost to Follow-up|0|||
164377154|NCT03670810|593754226|FG007|Main Study|Lost to Follow-up|0|||
164377155|NCT03670810|593754227|FG008|Main Study|Lost to Follow-up|0|||
164377156|NCT03670810|593754219|FG000|Main Study|Non-compliance with Study Drug|0|||
164377157|NCT03670810|593754220|FG001|Main Study|Non-compliance with Study Drug|2|||
164377158|NCT03670810|593754221|FG002|Main Study|Non-compliance with Study Drug|3|||
164377159|NCT03670810|593754222|FG003|Main Study|Non-compliance with Study Drug|0|||
164377160|NCT03670810|593754223|FG004|Main Study|Non-compliance with Study Drug|0|||
164377161|NCT03670810|593754224|FG005|Main Study|Non-compliance with Study Drug|0|||
164377162|NCT03670810|593754225|FG006|Main Study|Non-compliance with Study Drug|0|||
164377163|NCT03670810|593754226|FG007|Main Study|Non-compliance with Study Drug|1|||
164377164|NCT03670810|593754227|FG008|Main Study|Non-compliance with Study Drug|0|||
164377165|NCT03670810|593754219|FG000|Main Study|Physician Decision|3|||
164377166|NCT03670810|593754220|FG001|Main Study|Physician Decision|0|||
164377167|NCT03670810|593754221|FG002|Main Study|Physician Decision|1|||
164377168|NCT03670810|593754222|FG003|Main Study|Physician Decision|0|||
164377169|NCT03670810|593754223|FG004|Main Study|Physician Decision|0|||
164377170|NCT03670810|593754224|FG005|Main Study|Physician Decision|0|||
164377171|NCT03670810|593754225|FG006|Main Study|Physician Decision|1|||
164377172|NCT03670810|593754226|FG007|Main Study|Physician Decision|1|||
164377173|NCT03670810|593754227|FG008|Main Study|Physician Decision|0|||
164377174|NCT03670810|593754219|FG000|Main Study|Pregnancy|1|||
164377175|NCT03670810|593754220|FG001|Main Study|Pregnancy|2|||
164377176|NCT03670810|593754221|FG002|Main Study|Pregnancy|0|||
164377177|NCT03670810|593754222|FG003|Main Study|Pregnancy|0|||
164377178|NCT03670810|593754223|FG004|Main Study|Pregnancy|0|||
164377179|NCT03670810|593754224|FG005|Main Study|Pregnancy|0|||
164377180|NCT03670810|593754225|FG006|Main Study|Pregnancy|0|||
164377181|NCT03670810|593754226|FG007|Main Study|Pregnancy|0|||
164377182|NCT03670810|593754227|FG008|Main Study|Pregnancy|0|||
164377183|NCT03670810|593754219|FG000|Main Study|Protocol Deviation|2|||
164377184|NCT03670810|593754220|FG001|Main Study|Protocol Deviation|12|||
164377185|NCT03670810|593754221|FG002|Main Study|Protocol Deviation|8|||
164377186|NCT03670810|593754222|FG003|Main Study|Protocol Deviation|4|||
164377187|NCT03670810|593754223|FG004|Main Study|Protocol Deviation|0|||
164377188|NCT03670810|593754224|FG005|Main Study|Protocol Deviation|0|||
164377189|NCT03670810|593754225|FG006|Main Study|Protocol Deviation|0|||
164377190|NCT03670810|593754226|FG007|Main Study|Protocol Deviation|0|||
164377191|NCT03670810|593754227|FG008|Main Study|Protocol Deviation|0|||
164377192|NCT03670810|593754219|FG000|Main Study|Withdrawal by Subject|21|||
164377193|NCT03670810|593754220|FG001|Main Study|Withdrawal by Subject|21|||
164377194|NCT03670810|593754221|FG002|Main Study|Withdrawal by Subject|8|||
164377195|NCT03670810|593754222|FG003|Main Study|Withdrawal by Subject|9|||
164377196|NCT03670810|593754223|FG004|Main Study|Withdrawal by Subject|5|||
164377197|NCT03670810|593754224|FG005|Main Study|Withdrawal by Subject|2|||
164377198|NCT03670810|593754225|FG006|Main Study|Withdrawal by Subject|1|||
164377199|NCT03670810|593754226|FG007|Main Study|Withdrawal by Subject|1|||
164377200|NCT03670810|593754227|FG008|Main Study|Withdrawal by Subject|0|||
164377201|NCT03670810|593754219|FG000|Main Study|Participant did not want to take the three other treatments|1|||
164377202|NCT03670810|593754220|FG001|Main Study|Participant did not want to take the three other treatments|0|||
164377203|NCT03670810|593754221|FG002|Main Study|Participant did not want to take the three other treatments|0|||
164377204|NCT03670810|593754222|FG003|Main Study|Participant did not want to take the three other treatments|0|||
164377205|NCT03670810|593754223|FG004|Main Study|Participant did not want to take the three other treatments|0|||
164377206|NCT03670810|593754224|FG005|Main Study|Participant did not want to take the three other treatments|0|||
164377207|NCT03670810|593754225|FG006|Main Study|Participant did not want to take the three other treatments|0|||
164377208|NCT03670810|593754226|FG007|Main Study|Participant did not want to take the three other treatments|0|||
164377209|NCT03670810|593754227|FG008|Main Study|Participant did not want to take the three other treatments|0|||
164377210|NCT03670810|593754219|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
164377211|NCT03670810|593754220|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
164377212|NCT03670810|593754221|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
164377213|NCT03670810|593754222|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
164377214|NCT03670810|593754223|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
164377215|NCT03670810|593754224|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
164439329|NCT03622580|593975364|FG000|Overall Study|Protocol Violation|1|||
164439330|NCT03622580|593975365|FG001|Overall Study|Protocol Violation|0|||
164439331|NCT03622580|593975366|FG002|Overall Study|Protocol Violation|1|||
164377216|NCT03670810|593754225|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
164439332|NCT03622580|593975364|FG000|Overall Study|Physician Decision|3|||
164591883|NCT01544595|594530016|FG004|Status at Week 68|Lack of Efficacy|0|||
164377217|NCT03670810|593754226|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
164377218|NCT03670810|593754227|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
164439333|NCT03622580|593975365|FG001|Overall Study|Physician Decision|0|||
164700636|NCT03463993|594926871|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
164377219|NCT03670810|593754219|FG000|Main Study|Travel and Coronavirus issues|0|||
164377220|NCT03670810|593754220|FG001|Main Study|Travel and Coronavirus issues|0|||
164377221|NCT03670810|593754221|FG002|Main Study|Travel and Coronavirus issues|0|||
164377222|NCT03670810|593754222|FG003|Main Study|Travel and Coronavirus issues|1|||
164377223|NCT03670810|593754223|FG004|Main Study|Travel and Coronavirus issues|0|||
164377224|NCT03670810|593754224|FG005|Main Study|Travel and Coronavirus issues|0|||
164377225|NCT03670810|593754225|FG006|Main Study|Travel and Coronavirus issues|0|||
164377226|NCT03670810|593754226|FG007|Main Study|Travel and Coronavirus issues|0|||
164377227|NCT03670810|593754227|FG008|Main Study|Travel and Coronavirus issues|0|||
164377228|NCT03670810|593754219|FG000|Open Label Extension|Protocol Deviation|0|||
164377229|NCT03670810|593754220|FG001|Open Label Extension|Protocol Deviation|0|||
164377230|NCT03670810|593754221|FG002|Open Label Extension|Protocol Deviation|0|||
164377231|NCT03670810|593754222|FG003|Open Label Extension|Protocol Deviation|0|||
164377232|NCT03670810|593754223|FG004|Open Label Extension|Protocol Deviation|0|||
164377233|NCT03670810|593754224|FG005|Open Label Extension|Protocol Deviation|0|||
164377234|NCT03670810|593754225|FG006|Open Label Extension|Protocol Deviation|0|||
164377235|NCT03670810|593754226|FG007|Open Label Extension|Protocol Deviation|0|||
164377236|NCT03670810|593754227|FG008|Open Label Extension|Protocol Deviation|5|||
164377237|NCT03670810|593754219|FG000|Open Label Extension|Death|0|||
164377238|NCT03670810|593754220|FG001|Open Label Extension|Death|0|||
164377239|NCT03670810|593754221|FG002|Open Label Extension|Death|0|||
164377240|NCT03670810|593754222|FG003|Open Label Extension|Death|0|||
164377241|NCT03670810|593754223|FG004|Open Label Extension|Death|0|||
164377242|NCT03670810|593754224|FG005|Open Label Extension|Death|0|||
164377243|NCT03670810|593754225|FG006|Open Label Extension|Death|0|||
164377244|NCT03670810|593754226|FG007|Open Label Extension|Death|0|||
164700637|NCT03463993|594926872|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
164700638|NCT01231373|594926879|FG000|Overall Study|Withdrew consent prior to randomization|2|||
164700639|NCT01231373|594926880|FG001|Overall Study|Withdrew consent prior to randomization|1|||
164700640|NCT01231373|594926881|FG002|Overall Study|Withdrew consent prior to randomization|0|||
164700641|NCT01231373|594926882|FG003|Overall Study|Withdrew consent prior to randomization|0|||
164377245|NCT03670810|593754227|FG008|Open Label Extension|Death|1|||
164377246|NCT03670810|593754219|FG000|Open Label Extension|COVID-19|0|||
164377247|NCT03670810|593754220|FG001|Open Label Extension|COVID-19|0|||
164377248|NCT03670810|593754221|FG002|Open Label Extension|COVID-19|0|||
164377249|NCT03670810|593754222|FG003|Open Label Extension|COVID-19|0|||
164377250|NCT03670810|593754223|FG004|Open Label Extension|COVID-19|0|||
164377251|NCT03670810|593754224|FG005|Open Label Extension|COVID-19|0|||
164377252|NCT03670810|593754225|FG006|Open Label Extension|COVID-19|0|||
164377253|NCT03670810|593754226|FG007|Open Label Extension|COVID-19|0|||
164377254|NCT03670810|593754227|FG008|Open Label Extension|COVID-19|1|||
164377255|NCT03670810|593754219|FG000|Open Label Extension|Lack of Efficacy|0|||
164377256|NCT03670810|593754220|FG001|Open Label Extension|Lack of Efficacy|0|||
164377257|NCT03670810|593754221|FG002|Open Label Extension|Lack of Efficacy|0|||
164377258|NCT03670810|593754222|FG003|Open Label Extension|Lack of Efficacy|0|||
164377259|NCT03670810|593754223|FG004|Open Label Extension|Lack of Efficacy|0|||
164377260|NCT03670810|593754224|FG005|Open Label Extension|Lack of Efficacy|0|||
164377261|NCT03670810|593754225|FG006|Open Label Extension|Lack of Efficacy|0|||
164377262|NCT03670810|593754226|FG007|Open Label Extension|Lack of Efficacy|0|||
164377263|NCT03670810|593754227|FG008|Open Label Extension|Lack of Efficacy|39|||
164377264|NCT03670810|593754219|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
164377265|NCT03670810|593754220|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
164377266|NCT03670810|593754221|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
164377267|NCT03670810|593754222|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
164377268|NCT03670810|593754223|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
164377269|NCT03670810|593754224|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
164377270|NCT03670810|593754225|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
164377271|NCT03670810|593754226|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
164377272|NCT03670810|593754227|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
164377273|NCT03670810|593754219|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
164377274|NCT03670810|593754220|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
164377275|NCT03670810|593754221|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
164377276|NCT03670810|593754222|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
164377277|NCT03670810|593754223|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
164377278|NCT03670810|593754224|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
164377279|NCT03670810|593754225|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
164377280|NCT03670810|593754226|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
164377281|NCT03670810|593754227|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
164377282|NCT03670810|593754219|FG000|Open Label Extension|Withdrawal by Subject|0|||
164377283|NCT03670810|593754220|FG001|Open Label Extension|Withdrawal by Subject|0|||
164377284|NCT03670810|593754221|FG002|Open Label Extension|Withdrawal by Subject|0|||
164377285|NCT03670810|593754222|FG003|Open Label Extension|Withdrawal by Subject|0|||
164377286|NCT03670810|593754223|FG004|Open Label Extension|Withdrawal by Subject|0|||
164377287|NCT03670810|593754224|FG005|Open Label Extension|Withdrawal by Subject|0|||
164377288|NCT03670810|593754225|FG006|Open Label Extension|Withdrawal by Subject|0|||
164377289|NCT03670810|593754226|FG007|Open Label Extension|Withdrawal by Subject|0|||
164377290|NCT03670810|593754227|FG008|Open Label Extension|Withdrawal by Subject|46|||
164377291|NCT03670810|593754219|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
164377292|NCT03670810|593754220|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
164377293|NCT03670810|593754221|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
164377294|NCT03670810|593754222|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
164377295|NCT03670810|593754223|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
164377296|NCT03670810|593754224|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
164377297|NCT03670810|593754225|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
164377298|NCT03670810|593754226|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
164377299|NCT03670810|593754227|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
164377300|NCT03670810|593754219|FG000|Open Label Extension|Physician Decision|0|||
164377301|NCT03670810|593754220|FG001|Open Label Extension|Physician Decision|0|||
164377302|NCT03670810|593754221|FG002|Open Label Extension|Physician Decision|0|||
164377303|NCT03670810|593754222|FG003|Open Label Extension|Physician Decision|0|||
164377304|NCT03670810|593754223|FG004|Open Label Extension|Physician Decision|0|||
164377305|NCT03670810|593754224|FG005|Open Label Extension|Physician Decision|0|||
164377306|NCT03670810|593754225|FG006|Open Label Extension|Physician Decision|0|||
164377307|NCT03670810|593754226|FG007|Open Label Extension|Physician Decision|0|||
164377308|NCT03670810|593754227|FG008|Open Label Extension|Physician Decision|2|||
164377309|NCT03670810|593754219|FG000|Open Label Extension|Non-compliance with study drug|0|||
164377310|NCT03670810|593754220|FG001|Open Label Extension|Non-compliance with study drug|0|||
164377311|NCT03670810|593754221|FG002|Open Label Extension|Non-compliance with study drug|0|||
164377312|NCT03670810|593754222|FG003|Open Label Extension|Non-compliance with study drug|0|||
164377313|NCT03670810|593754223|FG004|Open Label Extension|Non-compliance with study drug|0|||
164377314|NCT03670810|593754224|FG005|Open Label Extension|Non-compliance with study drug|0|||
164377315|NCT03670810|593754225|FG006|Open Label Extension|Non-compliance with study drug|0|||
164377316|NCT03670810|593754226|FG007|Open Label Extension|Non-compliance with study drug|0|||
164377317|NCT03670810|593754227|FG008|Open Label Extension|Non-compliance with study drug|5|||
164377318|NCT03670810|593754219|FG000|Open Label Extension|Pregnancy|0|||
164377319|NCT03670810|593754220|FG001|Open Label Extension|Pregnancy|0|||
164377320|NCT03670810|593754221|FG002|Open Label Extension|Pregnancy|0|||
164377321|NCT03670810|593754222|FG003|Open Label Extension|Pregnancy|0|||
164377322|NCT03670810|593754223|FG004|Open Label Extension|Pregnancy|0|||
164377323|NCT03670810|593754224|FG005|Open Label Extension|Pregnancy|0|||
164377324|NCT03670810|593754225|FG006|Open Label Extension|Pregnancy|0|||
164377325|NCT03670810|593754226|FG007|Open Label Extension|Pregnancy|0|||
164377326|NCT03670810|593754227|FG008|Open Label Extension|Pregnancy|3|||
164377327|NCT03670810|593754219|FG000|Open Label Extension|Adverse Event|0|||
164377328|NCT03670810|593754220|FG001|Open Label Extension|Adverse Event|0|||
164377329|NCT03670810|593754221|FG002|Open Label Extension|Adverse Event|0|||
164377330|NCT03670810|593754222|FG003|Open Label Extension|Adverse Event|0|||
164377331|NCT03670810|593754223|FG004|Open Label Extension|Adverse Event|0|||
164377332|NCT03670810|593754224|FG005|Open Label Extension|Adverse Event|0|||
164377333|NCT03670810|593754225|FG006|Open Label Extension|Adverse Event|0|||
164377334|NCT03670810|593754226|FG007|Open Label Extension|Adverse Event|0|||
164377335|NCT03670810|593754227|FG008|Open Label Extension|Adverse Event|24|||
164377336|NCT03670810|593754219|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
164377337|NCT03670810|593754220|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
164377338|NCT03670810|593754221|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
164377339|NCT03670810|593754222|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
164377340|NCT03670810|593754223|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
164377341|NCT03670810|593754224|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
164700642|NCT01231373|594926879|FG000|Overall Study|Lost to Follow-up|0|||
164377342|NCT03670810|593754225|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
164377343|NCT03670810|593754226|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
164377344|NCT03670810|593754227|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
164377345|NCT03670810|593754219|FG000|Open Label Extension|Lost to Follow-up|0|||
164377346|NCT03670810|593754220|FG001|Open Label Extension|Lost to Follow-up|0|||
164377347|NCT03670810|593754221|FG002|Open Label Extension|Lost to Follow-up|0|||
164700643|NCT01231373|594926880|FG001|Overall Study|Lost to Follow-up|0|||
164700644|NCT01231373|594926881|FG002|Overall Study|Lost to Follow-up|0|||
164700645|NCT01231373|594926882|FG003|Overall Study|Lost to Follow-up|1|||
164700646|NCT01231373|594926879|FG000|Overall Study|Withdrew Consent|1|||
164591884|NCT01544595|594530017|FG005|Status at Week 68|Lack of Efficacy|0|||
164591885|NCT01544595|594530012|FG000|Status at Week 68|Lost to Follow-up|1|||
164591886|NCT01544595|594530013|FG001|Status at Week 68|Lost to Follow-up|1|||
164591887|NCT01544595|594530014|FG002|Status at Week 68|Lost to Follow-up|0|||
164591888|NCT01544595|594530015|FG003|Status at Week 68|Lost to Follow-up|0|||
164591889|NCT01544595|594530016|FG004|Status at Week 68|Lost to Follow-up|0|||
164591890|NCT01544595|594530017|FG005|Status at Week 68|Lost to Follow-up|0|||
164591891|NCT01544595|594530012|FG000|Status at Week 68|Non-compliance with study treatment|1|||
164591892|NCT01544595|594530013|FG001|Status at Week 68|Non-compliance with study treatment|0|||
164377348|NCT03670810|593754222|FG003|Open Label Extension|Lost to Follow-up|0|||
164377349|NCT03670810|593754223|FG004|Open Label Extension|Lost to Follow-up|0|||
164377350|NCT03670810|593754224|FG005|Open Label Extension|Lost to Follow-up|0|||
164377351|NCT03670810|593754225|FG006|Open Label Extension|Lost to Follow-up|0|||
164377352|NCT03670810|593754226|FG007|Open Label Extension|Lost to Follow-up|0|||
164377353|NCT03670810|593754227|FG008|Open Label Extension|Lost to Follow-up|23|||
164377354|NCT00678691|593754228|FG000|Overall Study|Adverse Event|6|||
164377355|NCT00678691|593754229|FG001|Overall Study|Adverse Event|4|||
164377356|NCT00779766|593754230|FG000|Month 24|Serious Adverse Event|2|||
164377357|NCT00779766|593754231|FG001|Month 24|Serious Adverse Event|3|||
164377358|NCT00779766|593754230|FG000|Month 24|Adverse Event|3|||
164377359|NCT00779766|593754231|FG001|Month 24|Adverse Event|3|||
164377360|NCT00779766|593754230|FG000|Month 24|Protocol Violation|3|||
164377361|NCT00779766|593754231|FG001|Month 24|Protocol Violation|1|||
164377362|NCT00779766|593754230|FG000|Month 24|Withdrawal by Subject|159|||
164377363|NCT00779766|593754231|FG001|Month 24|Withdrawal by Subject|127|||
164377364|NCT00779766|593754230|FG000|Month 24|Migrated/moved from study area|138|||
164377365|NCT00779766|593754231|FG001|Month 24|Migrated/moved from study area|162|||
164377366|NCT00779766|593754230|FG000|Month 24|Lost to Follow-up|9|||
164377367|NCT00779766|593754231|FG001|Month 24|Lost to Follow-up|9|||
164377368|NCT00779766|593754230|FG000|Month 24|Other|18|||
164377369|NCT00779766|593754231|FG001|Month 24|Other|27|||
164377370|NCT00779766|593754230|FG000|Month 48|Withdrawal by Subject|68|||
164377371|NCT00779766|593754231|FG001|Month 48|Withdrawal by Subject|63|||
164377372|NCT00779766|593754230|FG000|Month 48|Migrated/moved from study area|76|||
164377373|NCT00779766|593754231|FG001|Month 48|Migrated/moved from study area|75|||
164377374|NCT00779766|593754230|FG000|Month 48|Lost to Follow-up|29|||
164377375|NCT00779766|593754231|FG001|Month 48|Lost to Follow-up|30|||
164377376|NCT00779766|593754230|FG000|Month 48|Other|1|||
164377377|NCT00779766|593754231|FG001|Month 48|Other|0|||
164377378|NCT00779766|593754230|FG000|Month 72|Withdrawal by Subject|55|||
164377379|NCT00779766|593754231|FG001|Month 72|Withdrawal by Subject|71|||
164377380|NCT00779766|593754230|FG000|Month 72|Migrated/moved from study area|124|||
164377381|NCT00779766|593754231|FG001|Month 72|Migrated/moved from study area|109|||
164377382|NCT00779766|593754230|FG000|Month 72|Lost to Follow-up|6|||
164377383|NCT00779766|593754231|FG001|Month 72|Lost to Follow-up|8|||
164377384|NCT00779766|593754230|FG000|Month 72|Other|0|||
164377385|NCT00779766|593754231|FG001|Month 72|Other|1|||
164377386|NCT01412424|593754232|FG000|Core Treatment Period|Treatment Failure|24|||
164377387|NCT01412424|593754232|FG000|Core Treatment Period|Adverse Event|21|||
164377388|NCT01412424|593754232|FG000|Core Treatment Period|Patient Request|5|||
164377389|NCT01412424|593754232|FG000|Core Treatment Period|Lost to Follow-up|2|||
164591893|NCT01544595|594530014|FG002|Status at Week 68|Non-compliance with study treatment|0|||
164591894|NCT01544595|594530015|FG003|Status at Week 68|Non-compliance with study treatment|1|||
164591895|NCT01544595|594530016|FG004|Status at Week 68|Non-compliance with study treatment|0|||
164377390|NCT01412424|593754232|FG000|Core Treatment Period|Sponsor Request|1|||
164377391|NCT01412424|593754232|FG000|Extension Treatment Period|Adverse Event|2|||
164377392|NCT01412424|593754232|FG000|Extension Treatment Period|Treatment Failure|2|||
164377393|NCT01412424|593754232|FG000|Extension Treatment Period|Patient Request|2|||
164377394|NCT01252290|593754235|FG000|Overall Study|Withdrawal by Subject|1|||
164377395|NCT02247349|593754236|FG000|Overall Study|Disease Progression|7|||
164377396|NCT02247349|593754237|FG001|Overall Study|Disease Progression|4|||
164377397|NCT02247349|593754238|FG002|Overall Study|Disease Progression|26|||
164377398|NCT02247349|593754239|FG003|Overall Study|Disease Progression|31|||
164377399|NCT02247349|593754240|FG004|Overall Study|Disease Progression|16|||
164377400|NCT02247349|593754241|FG005|Overall Study|Disease Progression|6|||
164377401|NCT02247349|593754236|FG000|Overall Study|Study drug toxicity|0|||
164377402|NCT02247349|593754237|FG001|Overall Study|Study drug toxicity|1|||
164591896|NCT01544595|594530017|FG005|Status at Week 68|Non-compliance with study treatment|0|||
164591897|NCT01544595|594530012|FG000|Status at Week 68|Protocol Violation|2|||
164591898|NCT01544595|594530013|FG001|Status at Week 68|Protocol Violation|0|||
164700647|NCT01231373|594926880|FG001|Overall Study|Withdrew Consent|0|||
164377403|NCT02247349|593754238|FG002|Overall Study|Study drug toxicity|1|||
164377404|NCT02247349|593754239|FG003|Overall Study|Study drug toxicity|1|||
164377405|NCT02247349|593754240|FG004|Overall Study|Study drug toxicity|2|||
164700648|NCT01231373|594926881|FG002|Overall Study|Withdrew Consent|0|||
164377406|NCT02247349|593754241|FG005|Overall Study|Study drug toxicity|2|||
164377407|NCT02247349|593754236|FG000|Overall Study|Death|0|||
164377408|NCT02247349|593754237|FG001|Overall Study|Death|0|||
164377409|NCT02247349|593754238|FG002|Overall Study|Death|0|||
164377410|NCT02247349|593754239|FG003|Overall Study|Death|1|||
164377411|NCT02247349|593754240|FG004|Overall Study|Death|0|||
164377412|NCT02247349|593754241|FG005|Overall Study|Death|0|||
164377413|NCT02247349|593754236|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
164377414|NCT02247349|593754237|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
164377415|NCT02247349|593754238|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
164377416|NCT02247349|593754239|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
164377417|NCT02247349|593754240|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
164377418|NCT02247349|593754241|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
164377419|NCT02247349|593754236|FG000|Overall Study|Participant request to discontinue study treatment|0|||
164377420|NCT02247349|593754237|FG001|Overall Study|Participant request to discontinue study treatment|0|||
164377421|NCT02247349|593754238|FG002|Overall Study|Participant request to discontinue study treatment|1|||
164377422|NCT02247349|593754239|FG003|Overall Study|Participant request to discontinue study treatment|2|||
164377423|NCT02247349|593754240|FG004|Overall Study|Participant request to discontinue study treatment|1|||
164377424|NCT02247349|593754241|FG005|Overall Study|Participant request to discontinue study treatment|0|||
164377425|NCT02247349|593754236|FG000|Overall Study|Withdrawal by Subject|0|||
164377426|NCT02247349|593754237|FG001|Overall Study|Withdrawal by Subject|1|||
164377427|NCT02247349|593754238|FG002|Overall Study|Withdrawal by Subject|0|||
164377428|NCT02247349|593754239|FG003|Overall Study|Withdrawal by Subject|0|||
164377429|NCT02247349|593754240|FG004|Overall Study|Withdrawal by Subject|0|||
164377430|NCT02247349|593754241|FG005|Overall Study|Withdrawal by Subject|0|||
164377431|NCT02247349|593754236|FG000|Overall Study|Administrative reason by sponsor|0|||
164377432|NCT02247349|593754237|FG001|Overall Study|Administrative reason by sponsor|0|||
164377433|NCT02247349|593754238|FG002|Overall Study|Administrative reason by sponsor|0|||
164377434|NCT02247349|593754239|FG003|Overall Study|Administrative reason by sponsor|0|||
164377435|NCT02247349|593754240|FG004|Overall Study|Administrative reason by sponsor|1|||
164377436|NCT02247349|593754241|FG005|Overall Study|Administrative reason by sponsor|0|||
164377437|NCT02247349|593754236|FG000|Overall Study|Other reasons|0|||
164377438|NCT02247349|593754237|FG001|Overall Study|Other reasons|0|||
164377439|NCT02247349|593754238|FG002|Overall Study|Other reasons|1|||
164377440|NCT02247349|593754239|FG003|Overall Study|Other reasons|0|||
164377441|NCT02247349|593754240|FG004|Overall Study|Other reasons|0|||
164377442|NCT02247349|593754241|FG005|Overall Study|Other reasons|0|||
164377443|NCT00617240|593754243|FG000|Overall Study|Lack of Efficacy|1|||
164377444|NCT00617240|593754244|FG001|Overall Study|Lack of Efficacy|0|||
164377445|NCT01611259|593754245|FG000|Overall Study|Physician Decision|1|||
164377446|NCT01611259|593754245|FG000|Overall Study|Lack of Efficacy|2|||
164377447|NCT01611259|593754245|FG000|Overall Study|Adverse Event|4|||
164377448|NCT01611259|593754245|FG000|Overall Study|Withdrawal by Subject|7|||
164377449|NCT00382733|593754247|FG000|Overall Study|Withdrawal by Subject|0|||
164377450|NCT00382733|593754248|FG001|Overall Study|Withdrawal by Subject|1|||
164377451|NCT00382733|593754249|FG002|Overall Study|Withdrawal by Subject|0|||
164377452|NCT00382733|593754250|FG003|Overall Study|Withdrawal by Subject|0|||
164377453|NCT00382733|593754251|FG004|Overall Study|Withdrawal by Subject|0|||
164377454|NCT03075644|593754254|FG000|Overall Study|Withdrawal by Subject|1|||
164377455|NCT03075644|593754255|FG001|Overall Study|Withdrawal by Subject|1|||
164377456|NCT04292730|593754270|FG000|Overall Study|Lost to Follow-up|8|||
164377457|NCT04292730|593754271|FG001|Overall Study|Lost to Follow-up|12|||
164377458|NCT04292730|593754272|FG002|Overall Study|Lost to Follow-up|12|||
164377459|NCT04292730|593754273|FG003|Overall Study|Lost to Follow-up|48|||
164377460|NCT04292730|593754270|FG000|Overall Study|Death|2|||
164377461|NCT04292730|593754271|FG001|Overall Study|Death|2|||
164591899|NCT01544595|594530014|FG002|Status at Week 68|Protocol Violation|1|||
164591900|NCT01544595|594530015|FG003|Status at Week 68|Protocol Violation|1|||
164591901|NCT01544595|594530016|FG004|Status at Week 68|Protocol Violation|0|||
164591902|NCT01544595|594530017|FG005|Status at Week 68|Protocol Violation|0|||
164377462|NCT04292730|593754272|FG002|Overall Study|Death|4|||
164377463|NCT04292730|593754273|FG003|Overall Study|Death|12|||
164377464|NCT04292730|593754270|FG000|Overall Study|Withdrew Consent|2|||
164377465|NCT04292730|593754271|FG001|Overall Study|Withdrew Consent|2|||
164377466|NCT04292730|593754272|FG002|Overall Study|Withdrew Consent|5|||
164377467|NCT04292730|593754273|FG003|Overall Study|Withdrew Consent|6|||
164377468|NCT04292730|593754270|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164377469|NCT04292730|593754271|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164377470|NCT04292730|593754272|FG002|Overall Study|Non-Compliance with Study Drug|0|||
164377471|NCT04292730|593754273|FG003|Overall Study|Non-Compliance with Study Drug|0|||
164377472|NCT04292730|593754270|FG000|Overall Study|Protocol Violation|0|||
164377473|NCT04292730|593754271|FG001|Overall Study|Protocol Violation|0|||
164377474|NCT04292730|593754272|FG002|Overall Study|Protocol Violation|1|||
164377475|NCT04292730|593754273|FG003|Overall Study|Protocol Violation|0|||
164377476|NCT04292730|593754270|FG000|Overall Study|Randomized but not Treated|8|||
164377477|NCT04292730|593754271|FG001|Overall Study|Randomized but not Treated|4|||
164377478|NCT04292730|593754272|FG002|Overall Study|Randomized but not Treated|0|||
164591903|NCT01544595|594530012|FG000|Status at Week 68|Technical problems|1|||
164377479|NCT04292730|593754273|FG003|Overall Study|Randomized but not Treated|14|||
164377480|NCT01527292|593754274|FG000|Overall Study|Physician Decision|0|||
164377481|NCT01527292|593754275|FG001|Overall Study|Physician Decision|3|||
164377482|NCT00314366|593754278|FG000|Overall Study|not treated due to patient medical condi|1|||
164377483|NCT00314366|593754279|FG001|Overall Study|not treated due to patient medical condi|0|||
164377484|NCT01482767|593754280|FG000|Overall Study|Death|1|||
164377485|NCT01482767|593754281|FG001|Overall Study|Death|1|||
164377486|NCT01482767|593754280|FG000|Overall Study|Withdrawal by Subject|7|||
164377487|NCT01482767|593754281|FG001|Overall Study|Withdrawal by Subject|5|||
164377488|NCT01482767|593754280|FG000|Overall Study|Lost to Follow-up|12|||
164377489|NCT01482767|593754281|FG001|Overall Study|Lost to Follow-up|6|||
164591904|NCT01544595|594530013|FG001|Status at Week 68|Technical problems|0|||
164591905|NCT01544595|594530014|FG002|Status at Week 68|Technical problems|0|||
164591906|NCT01544595|594530015|FG003|Status at Week 68|Technical problems|1|||
164591907|NCT01544595|594530016|FG004|Status at Week 68|Technical problems|0|||
164591908|NCT01544595|594530017|FG005|Status at Week 68|Technical problems|0|||
164591909|NCT01544595|594530012|FG000|Status at Week 68|Withdrawal by Subject|0|||
164591910|NCT01544595|594530013|FG001|Status at Week 68|Withdrawal by Subject|1|||
164377490|NCT01482767|593754280|FG000|Overall Study|Adverse Event|0|||
164377491|NCT01482767|593754281|FG001|Overall Study|Adverse Event|3|||
164377492|NCT01482767|593754280|FG000|Overall Study|Site closure|22|||
164377493|NCT01482767|593754281|FG001|Overall Study|Site closure|14|||
164377494|NCT01482767|593754280|FG000|Overall Study|Non-adherence to study requirements|4|||
164377495|NCT01482767|593754281|FG001|Overall Study|Non-adherence to study requirements|7|||
164377496|NCT01482767|593754280|FG000|Overall Study|Alternate HCV treatment|7|||
164377497|NCT01482767|593754281|FG001|Overall Study|Alternate HCV treatment|8|||
164377498|NCT01482767|593754280|FG000|Overall Study|Ineligible|0|||
164377499|NCT01482767|593754281|FG001|Overall Study|Ineligible|5|||
164591911|NCT01544595|594530014|FG002|Status at Week 68|Withdrawal by Subject|1|||
164591912|NCT01544595|594530015|FG003|Status at Week 68|Withdrawal by Subject|2|||
164591913|NCT01544595|594530016|FG004|Status at Week 68|Withdrawal by Subject|0|||
164591914|NCT01544595|594530017|FG005|Status at Week 68|Withdrawal by Subject|0|||
164591915|NCT01544595|594530012|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
164591916|NCT01544595|594530013|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
164591917|NCT01544595|594530014|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
164591918|NCT01544595|594530015|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
164591919|NCT01544595|594530016|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
164591920|NCT01544595|594530017|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
164591921|NCT01544595|594530012|FG000|Status at Week 156|Withdrawal by Subject|9|||
164591922|NCT01544595|594530013|FG001|Status at Week 156|Withdrawal by Subject|10|||
164591923|NCT01544595|594530014|FG002|Status at Week 156|Withdrawal by Subject|4|||
164591924|NCT01544595|594530015|FG003|Status at Week 156|Withdrawal by Subject|9|||
164591925|NCT01544595|594530016|FG004|Status at Week 156|Withdrawal by Subject|20|||
164591926|NCT01544595|594530017|FG005|Status at Week 156|Withdrawal by Subject|6|||
164591927|NCT01544595|594530012|FG000|Status at Week 156|Adverse Event|9|||
164591928|NCT01544595|594530013|FG001|Status at Week 156|Adverse Event|11|||
164591929|NCT01544595|594530014|FG002|Status at Week 156|Adverse Event|1|||
164591930|NCT01544595|594530015|FG003|Status at Week 156|Adverse Event|3|||
164591931|NCT01544595|594530016|FG004|Status at Week 156|Adverse Event|4|||
164591932|NCT01544595|594530017|FG005|Status at Week 156|Adverse Event|2|||
164591933|NCT01544595|594530012|FG000|Status at Week 156|Lost to Follow-up|4|||
164591934|NCT01544595|594530013|FG001|Status at Week 156|Lost to Follow-up|4|||
164591935|NCT01544595|594530014|FG002|Status at Week 156|Lost to Follow-up|0|||
164591936|NCT01544595|594530015|FG003|Status at Week 156|Lost to Follow-up|1|||
164591937|NCT01544595|594530016|FG004|Status at Week 156|Lost to Follow-up|4|||
164591938|NCT01544595|594530017|FG005|Status at Week 156|Lost to Follow-up|1|||
164591939|NCT01544595|594530012|FG000|Status at Week 156|Non-compliance with study treatement|0|||
164591940|NCT01544595|594530013|FG001|Status at Week 156|Non-compliance with study treatement|1|||
164377500|NCT01482767|593754280|FG000|Overall Study|Nurse error|1|||
164377501|NCT01482767|593754281|FG001|Overall Study|Nurse error|0|||
164377502|NCT03400033|593754291|FG000|Overall Study|Withdrawal by Subject|1|||
164377503|NCT03400033|593754292|FG001|Overall Study|Withdrawal by Subject|2|||
164377504|NCT01247090|593754295|FG000|Overall Study|Physician Decision|1|||
164700649|NCT01231373|594926882|FG003|Overall Study|Withdrew Consent|0|||
164700650|NCT02787408|594926883|FG000|Overall Study|Death|16|||
164700651|NCT02787408|594926883|FG000|Overall Study|Withdrawal by Subject|1|||
164377505|NCT01247090|593754296|FG001|Overall Study|Physician Decision|0|||
164377506|NCT01247090|593754297|FG002|Overall Study|Physician Decision|0|||
164700652|NCT02787408|594926883|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
164377507|NCT01247090|593754295|FG000|Overall Study|Withdrawal by Subject|0|||
164377508|NCT01247090|593754296|FG001|Overall Study|Withdrawal by Subject|1|||
164591941|NCT01544595|594530014|FG002|Status at Week 156|Non-compliance with study treatement|0|||
164591942|NCT01544595|594530015|FG003|Status at Week 156|Non-compliance with study treatement|1|||
164700653|NCT01901874|594926884|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
164439334|NCT03622580|593975366|FG002|Overall Study|Physician Decision|1|||
164377509|NCT01247090|593754297|FG002|Overall Study|Withdrawal by Subject|0|||
164377510|NCT00006916|593754299|FG000|Overall Study|Device not inserted|4|||
164377511|NCT00006916|593754299|FG000|Overall Study|Complication of device insertion|1|||
164377512|NCT02457325|593754304|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
164377513|NCT02457325|593754305|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
164377514|NCT01541930|593754310|FG000|Overall Study|Withdrawal by Subject|1|||
164377515|NCT03385239|593754311|FG000|Overall Study|Voluntary Withdrawal|2|||
164377516|NCT03385239|593754312|FG001|Overall Study|Voluntary Withdrawal|3|||
164377517|NCT03385239|593754313|FG002|Overall Study|Voluntary Withdrawal|2|||
164377518|NCT03385239|593754314|FG003|Overall Study|Voluntary Withdrawal|3|||
164377519|NCT03385239|593754315|FG004|Overall Study|Voluntary Withdrawal|0|||
164377520|NCT03385239|593754311|FG000|Overall Study|Adverse Event|0|||
164377521|NCT03385239|593754312|FG001|Overall Study|Adverse Event|0|||
164377522|NCT03385239|593754313|FG002|Overall Study|Adverse Event|1|||
164377523|NCT03385239|593754314|FG003|Overall Study|Adverse Event|0|||
164377524|NCT03385239|593754315|FG004|Overall Study|Adverse Event|0|||
164377525|NCT03385239|593754311|FG000|Overall Study|Other|0|||
164377526|NCT03385239|593754312|FG001|Overall Study|Other|0|||
164377527|NCT03385239|593754313|FG002|Overall Study|Other|0|||
164377528|NCT03385239|593754314|FG003|Overall Study|Other|1|||
164377529|NCT03385239|593754315|FG004|Overall Study|Other|0|||
164377530|NCT01574703|593754316|FG000|Overall Study|Adverse Event|0|||
164377531|NCT01574703|593754317|FG001|Overall Study|Adverse Event|2|||
164377532|NCT01574703|593754318|FG002|Overall Study|Adverse Event|1|||
164377533|NCT01574703|593754319|FG003|Overall Study|Adverse Event|1|||
164377534|NCT01574703|593754316|FG000|Overall Study|Protocol Violation|0|||
164377535|NCT01574703|593754317|FG001|Overall Study|Protocol Violation|0|||
164377536|NCT01574703|593754318|FG002|Overall Study|Protocol Violation|0|||
164377537|NCT01574703|593754319|FG003|Overall Study|Protocol Violation|1|||
164377538|NCT01574703|593754316|FG000|Overall Study|Unspecified Reason|27|||
164377539|NCT01574703|593754317|FG001|Overall Study|Unspecified Reason|15|||
164377540|NCT01574703|593754318|FG002|Overall Study|Unspecified Reason|20|||
164377541|NCT01574703|593754319|FG003|Overall Study|Unspecified Reason|16|||
164377542|NCT01574703|593754316|FG000|Overall Study|Withdrawal by Subject|53|||
164377543|NCT01574703|593754317|FG001|Overall Study|Withdrawal by Subject|52|||
164377544|NCT01574703|593754318|FG002|Overall Study|Withdrawal by Subject|36|||
164377545|NCT01574703|593754319|FG003|Overall Study|Withdrawal by Subject|61|||
164377546|NCT01574703|593754316|FG000|Overall Study|Met Withdrawal Criteria|0|||
164377547|NCT01574703|593754317|FG001|Overall Study|Met Withdrawal Criteria|1|||
164377548|NCT01574703|593754318|FG002|Overall Study|Met Withdrawal Criteria|1|||
164377549|NCT01574703|593754319|FG003|Overall Study|Met Withdrawal Criteria|0|||
164377550|NCT01574703|593754316|FG000|Overall Study|Lost to Follow-up|43|||
164377551|NCT01574703|593754317|FG001|Overall Study|Lost to Follow-up|41|||
164377552|NCT01574703|593754318|FG002|Overall Study|Lost to Follow-up|46|||
164377553|NCT01574703|593754319|FG003|Overall Study|Lost to Follow-up|35|||
164377554|NCT01574703|593754316|FG000|Overall Study|Death|2|||
164377555|NCT01574703|593754317|FG001|Overall Study|Death|1|||
164377556|NCT01574703|593754318|FG002|Overall Study|Death|1|||
164377557|NCT01574703|593754319|FG003|Overall Study|Death|0|||
164377558|NCT02751983|593754324|FG000|Treatment|Stopped ACT, but Remained in study|2|||
164377559|NCT02751983|593754325|FG001|Treatment|Stopped ACT, but Remained in study|0|||
164377560|NCT02751983|593754324|FG000|Treatment|Discharged prior to beginning ACT|2|||
164377561|NCT02751983|593754325|FG001|Treatment|Discharged prior to beginning ACT|0|||
164377562|NCT02751983|593754324|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
164377563|NCT02751983|593754325|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
164377564|NCT02751983|593754324|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
164377565|NCT02751983|593754325|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
164377566|NCT02751983|593754324|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
164377567|NCT02751983|593754325|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
164377568|NCT02167256|593754326|FG000|Overall Study|Adverse Event|13|||
164377569|NCT02167256|593754327|FG001|Overall Study|Adverse Event|6|||
164377570|NCT02167256|593754326|FG000|Overall Study|Withdrawal by Subject|4|||
164377571|NCT02167256|593754327|FG001|Overall Study|Withdrawal by Subject|4|||
164377572|NCT02167256|593754326|FG000|Overall Study|non-compliance|3|||
164377573|NCT02167256|593754327|FG001|Overall Study|non-compliance|0|||
164377574|NCT02167256|593754326|FG000|Overall Study|Study partner unable to participate|1|||
164377575|NCT02167256|593754327|FG001|Overall Study|Study partner unable to participate|0|||
164377576|NCT03467425|593754328|FG000|Overall Study|Adverse Event|9|||
164377577|NCT03467425|593754329|FG001|Overall Study|Adverse Event|9|||
164377578|NCT03467425|593754328|FG000|Overall Study|Lack of Efficacy|3|||
164377579|NCT03467425|593754329|FG001|Overall Study|Lack of Efficacy|1|||
164377580|NCT03467425|593754328|FG000|Overall Study|Protocol Violation|0|||
164377581|NCT03467425|593754329|FG001|Overall Study|Protocol Violation|1|||
164377582|NCT03467425|593754328|FG000|Overall Study|Lost to Follow-up|18|||
164377583|NCT03467425|593754329|FG001|Overall Study|Lost to Follow-up|25|||
164377584|NCT03467425|593754328|FG000|Overall Study|Physician Decision|2|||
164377585|NCT03467425|593754329|FG001|Overall Study|Physician Decision|1|||
164377586|NCT03467425|593754328|FG000|Overall Study|Withdrawal by Subject|15|||
164591943|NCT01544595|594530016|FG004|Status at Week 156|Non-compliance with study treatement|0|||
164591944|NCT01544595|594530017|FG005|Status at Week 156|Non-compliance with study treatement|1|||
164591945|NCT01544595|594530012|FG000|Status at Week 156|Physician Decision|0|||
164591946|NCT01544595|594530013|FG001|Status at Week 156|Physician Decision|3|||
164591947|NCT01544595|594530014|FG002|Status at Week 156|Physician Decision|1|||
164591948|NCT01544595|594530015|FG003|Status at Week 156|Physician Decision|0|||
164591949|NCT01544595|594530016|FG004|Status at Week 156|Physician Decision|0|||
164591950|NCT01544595|594530017|FG005|Status at Week 156|Physician Decision|0|||
164591951|NCT01544595|594530012|FG000|Status at Week 156|Pregnancy|2|||
164591952|NCT01544595|594530013|FG001|Status at Week 156|Pregnancy|3|||
164591953|NCT01544595|594530014|FG002|Status at Week 156|Pregnancy|0|||
164591954|NCT01544595|594530015|FG003|Status at Week 156|Pregnancy|0|||
164591955|NCT01544595|594530016|FG004|Status at Week 156|Pregnancy|0|||
164591956|NCT01544595|594530017|FG005|Status at Week 156|Pregnancy|0|||
164591957|NCT01544595|594530012|FG000|Status at Week 156|Protocol Violation|3|||
164591958|NCT01544595|594530013|FG001|Status at Week 156|Protocol Violation|1|||
164591959|NCT01544595|594530014|FG002|Status at Week 156|Protocol Violation|2|||
164591960|NCT01544595|594530015|FG003|Status at Week 156|Protocol Violation|2|||
164591961|NCT01544595|594530016|FG004|Status at Week 156|Protocol Violation|0|||
164591962|NCT01544595|594530017|FG005|Status at Week 156|Protocol Violation|0|||
164591963|NCT01544595|594530012|FG000|Status at Week 156|Technical problems|3|||
164591964|NCT01544595|594530013|FG001|Status at Week 156|Technical problems|1|||
164591965|NCT01544595|594530014|FG002|Status at Week 156|Technical problems|0|||
164591966|NCT01544595|594530015|FG003|Status at Week 156|Technical problems|1|||
164591967|NCT01544595|594530016|FG004|Status at Week 156|Technical problems|0|||
164591968|NCT01544595|594530017|FG005|Status at Week 156|Technical problems|0|||
164591969|NCT01544595|594530012|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
164591970|NCT01544595|594530013|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
164591971|NCT01544595|594530014|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
164591972|NCT01544595|594530015|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
164591973|NCT01544595|594530016|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
164591974|NCT01544595|594530017|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
164700654|NCT01901874|594926884|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
164700655|NCT01901874|594926884|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
164700656|NCT01901874|594926884|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
164700657|NCT01901874|594926884|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
164700658|NCT01901874|594926884|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
164700659|NCT03078582|594926885|FG000|Overall Study|Adverse Event|0|||
164700660|NCT03078582|594926886|FG001|Overall Study|Adverse Event|8|||
164700661|NCT02039414|594926887|FG000|Overall Study|Delivered|1|||
164700662|NCT02039414|594926888|FG001|Overall Study|Delivered|1|||
164700663|NCT02039414|594926887|FG000|Overall Study|Lost to Follow-up|2|||
164700664|NCT02039414|594926888|FG001|Overall Study|Lost to Follow-up|0|||
164377587|NCT03467425|593754329|FG001|Overall Study|Withdrawal by Subject|17|||
164377588|NCT00025883|593754330|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
164377589|NCT00025883|593754330|FG000|Overall Study|no baseline data|1|||
164377590|NCT00025883|593754330|FG000|Overall Study|Death|1|||
164377591|NCT00025883|593754330|FG000|Overall Study|Adverse Event|1|||
164377592|NCT00025883|593754330|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
164377593|NCT02920983|593754331|FG000|Dispense 1|Unacceptable Lens Fit|0|||
164377594|NCT02920983|593754332|FG001|Dispense 1|Unacceptable Lens Fit|0|||
164377595|NCT02920983|593754333|FG002|Dispense 1|Unacceptable Lens Fit|0|||
164377596|NCT02920983|593754334|FG003|Dispense 1|Unacceptable Lens Fit|0|||
164377597|NCT02920983|593754335|FG004|Dispense 1|Unacceptable Lens Fit|1|||
164377598|NCT02920983|593754336|FG005|Dispense 1|Unacceptable Lens Fit|0|||
164377599|NCT02920983|593754331|FG000|Dispense 2|Unscceptable lens fit|1|||
164377600|NCT02920983|593754332|FG001|Dispense 2|Unscceptable lens fit|0|||
164377601|NCT02920983|593754333|FG002|Dispense 2|Unscceptable lens fit|0|||
164377602|NCT02920983|593754334|FG003|Dispense 2|Unscceptable lens fit|0|||
164377603|NCT02920983|593754335|FG004|Dispense 2|Unscceptable lens fit|1|||
164700665|NCT02039414|594926887|FG000|Overall Study|Protocol Violation|3|||
164377604|NCT02920983|593754336|FG005|Dispense 2|Unscceptable lens fit|0|||
164377605|NCT02920983|593754331|FG000|Dispense 3|Unacceptable Lens Fit|1|||
164591975|NCT01544595|594530012|FG000|Status at Week 156|Lack of Efficacy|1|||
164591976|NCT01544595|594530013|FG001|Status at Week 156|Lack of Efficacy|0|||
164591977|NCT01544595|594530014|FG002|Status at Week 156|Lack of Efficacy|1|||
164591978|NCT01544595|594530015|FG003|Status at Week 156|Lack of Efficacy|4|||
164591979|NCT01544595|594530016|FG004|Status at Week 156|Lack of Efficacy|10|||
164591980|NCT01544595|594530017|FG005|Status at Week 156|Lack of Efficacy|5|||
164591981|NCT01929044|594530018|FG000|Overall Study|Adverse Event|1|||
164591982|NCT01929044|594530019|FG001|Overall Study|Adverse Event|0|||
164700666|NCT02039414|594926888|FG001|Overall Study|Protocol Violation|1|||
164377606|NCT02920983|593754332|FG001|Dispense 3|Unacceptable Lens Fit|1|||
164377607|NCT02920983|593754333|FG002|Dispense 3|Unacceptable Lens Fit|0|||
164377608|NCT02920983|593754334|FG003|Dispense 3|Unacceptable Lens Fit|0|||
164377609|NCT02920983|593754335|FG004|Dispense 3|Unacceptable Lens Fit|1|||
164377610|NCT02920983|593754336|FG005|Dispense 3|Unacceptable Lens Fit|0|||
164377611|NCT01451424|593754337|FG000|Overall Study|Withdrawal by Subject|1|||
164377612|NCT01451424|593754338|FG001|Overall Study|Withdrawal by Subject|1|||
164377613|NCT01451424|593754339|FG002|Overall Study|Withdrawal by Subject|0|||
164377614|NCT01451424|593754340|FG003|Overall Study|Withdrawal by Subject|2|||
164377615|NCT01451424|593754337|FG000|Overall Study|Lost to Follow-up|0|||
164377616|NCT01451424|593754338|FG001|Overall Study|Lost to Follow-up|1|||
164377617|NCT01451424|593754339|FG002|Overall Study|Lost to Follow-up|0|||
164377618|NCT01451424|593754340|FG003|Overall Study|Lost to Follow-up|1|||
164377619|NCT01451424|593754337|FG000|Overall Study|Physician Decision|0|||
164377620|NCT01451424|593754338|FG001|Overall Study|Physician Decision|0|||
164377621|NCT01451424|593754339|FG002|Overall Study|Physician Decision|1|||
164377622|NCT01451424|593754340|FG003|Overall Study|Physician Decision|1|||
164377623|NCT01451424|593754337|FG000|Overall Study|Adverse Event|0|||
164377624|NCT01451424|593754338|FG001|Overall Study|Adverse Event|0|||
164377625|NCT01451424|593754339|FG002|Overall Study|Adverse Event|0|||
164377626|NCT01451424|593754340|FG003|Overall Study|Adverse Event|1|||
164377627|NCT01387607|593754346|FG000|Overall Study|Adverse Event|23|||
164377628|NCT01387607|593754347|FG001|Overall Study|Adverse Event|11|||
164377629|NCT01387607|593754346|FG000|Overall Study|Lack of Efficacy|8|||
164377630|NCT01387607|593754347|FG001|Overall Study|Lack of Efficacy|6|||
164377631|NCT01387607|593754346|FG000|Overall Study|Lost to Follow-up|2|||
164377632|NCT01387607|593754347|FG001|Overall Study|Lost to Follow-up|1|||
164377633|NCT01387607|593754346|FG000|Overall Study|No longer meets eligibility criteria|0|||
164377634|NCT01387607|593754347|FG001|Overall Study|No longer meets eligibility criteria|1|||
164377635|NCT01387607|593754346|FG000|Overall Study|Protocol Violation|1|||
164377636|NCT01387607|593754347|FG001|Overall Study|Protocol Violation|5|||
164377637|NCT01387607|593754346|FG000|Overall Study|Withdrawal by Subject|13|||
164377638|NCT01387607|593754347|FG001|Overall Study|Withdrawal by Subject|14|||
164377639|NCT01387607|593754346|FG000|Overall Study|Other|1|||
164377640|NCT01387607|593754347|FG001|Overall Study|Other|1|||
164377641|NCT01387607|593754346|FG000|Overall Study|Randomized, not treated|3|||
164377642|NCT01387607|593754347|FG001|Overall Study|Randomized, not treated|6|||
164377643|NCT02553421|593754349|FG000|Overall Study|Lost to Follow-up|21|||
164377644|NCT02553421|593754350|FG001|Overall Study|Lost to Follow-up|1|||
164377645|NCT02553421|593754349|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
164377646|NCT02553421|593754350|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
164377647|NCT02553421|593754349|FG000|Overall Study|Improper Device Placement|3|||
164377648|NCT02553421|593754350|FG001|Overall Study|Improper Device Placement|0|||
164377649|NCT03665038|593754353|FG000|Overall Study|Lost to Follow-up|0|||
164377650|NCT03665038|593754354|FG001|Overall Study|Lost to Follow-up|0|||
164377651|NCT03665038|593754355|FG002|Overall Study|Lost to Follow-up|1|||
164377652|NCT03013491|593754356|FG000|Main Study|Death|2|||
164377653|NCT03013491|593754357|FG001|Main Study|Death|2|||
164377654|NCT03013491|593754358|FG002|Main Study|Death|5|||
164377655|NCT03013491|593754359|FG003|Main Study|Death|3|||
164377656|NCT03013491|593754360|FG004|Main Study|Death|9|||
164377657|NCT03013491|593754361|FG005|Main Study|Death|12|||
164377658|NCT03013491|593754362|FG006|Main Study|Death|3|||
164377659|NCT03013491|593754363|FG007|Main Study|Death|5|||
164377660|NCT03013491|593754364|FG008|Main Study|Death|1|||
164377661|NCT03013491|593754365|FG009|Main Study|Death|2|||
164377662|NCT03013491|593754366|FG010|Main Study|Death|4|||
164377663|NCT03013491|593754367|FG011|Main Study|Death|1|||
164377664|NCT03013491|593754368|FG012|Main Study|Death|1|||
164377665|NCT03013491|593754369|FG013|Main Study|Death|4|||
164377666|NCT03013491|593754370|FG014|Main Study|Death|0|||
164377667|NCT03013491|593754371|FG015|Main Study|Death|3|||
164377668|NCT03013491|593754372|FG016|Main Study|Death|5|||
164377669|NCT03013491|593754373|FG017|Main Study|Death|1|||
164377670|NCT03013491|593754374|FG018|Main Study|Death|47|||
164377671|NCT03013491|593754356|FG000|Main Study|Lost to Follow-up|0|||
164377672|NCT03013491|593754357|FG001|Main Study|Lost to Follow-up|0|||
164377673|NCT03013491|593754358|FG002|Main Study|Lost to Follow-up|1|||
164377674|NCT03013491|593754359|FG003|Main Study|Lost to Follow-up|0|||
164377675|NCT03013491|593754360|FG004|Main Study|Lost to Follow-up|1|||
164377676|NCT03013491|593754361|FG005|Main Study|Lost to Follow-up|0|||
164377677|NCT03013491|593754362|FG006|Main Study|Lost to Follow-up|0|||
164377678|NCT03013491|593754363|FG007|Main Study|Lost to Follow-up|0|||
164377679|NCT03013491|593754364|FG008|Main Study|Lost to Follow-up|0|||
164377680|NCT03013491|593754365|FG009|Main Study|Lost to Follow-up|0|||
164377681|NCT03013491|593754366|FG010|Main Study|Lost to Follow-up|0|||
164377682|NCT03013491|593754367|FG011|Main Study|Lost to Follow-up|0|||
164377683|NCT03013491|593754368|FG012|Main Study|Lost to Follow-up|0|||
164377684|NCT03013491|593754369|FG013|Main Study|Lost to Follow-up|0|||
164377685|NCT03013491|593754370|FG014|Main Study|Lost to Follow-up|0|||
164377686|NCT03013491|593754371|FG015|Main Study|Lost to Follow-up|0|||
164377687|NCT03013491|593754372|FG016|Main Study|Lost to Follow-up|0|||
164591983|NCT01929044|594530018|FG000|Overall Study|Protocol Violation|9|||
164591984|NCT01929044|594530019|FG001|Overall Study|Protocol Violation|14|||
164591985|NCT01929044|594530018|FG000|Overall Study|Not Treated|1|||
164377688|NCT03013491|593754373|FG017|Main Study|Lost to Follow-up|0|||
164377689|NCT03013491|593754374|FG018|Main Study|Lost to Follow-up|3|||
164377690|NCT03013491|593754356|FG000|Main Study|Termination of the study by Sponsor|0|||
164377691|NCT03013491|593754357|FG001|Main Study|Termination of the study by Sponsor|0|||
164377692|NCT03013491|593754358|FG002|Main Study|Termination of the study by Sponsor|2|||
164377693|NCT03013491|593754359|FG003|Main Study|Termination of the study by Sponsor|0|||
164377694|NCT03013491|593754360|FG004|Main Study|Termination of the study by Sponsor|1|||
164377695|NCT03013491|593754361|FG005|Main Study|Termination of the study by Sponsor|2|||
164377696|NCT03013491|593754362|FG006|Main Study|Termination of the study by Sponsor|0|||
164377697|NCT03013491|593754363|FG007|Main Study|Termination of the study by Sponsor|0|||
164377698|NCT03013491|593754364|FG008|Main Study|Termination of the study by Sponsor|1|||
164377699|NCT03013491|593754365|FG009|Main Study|Termination of the study by Sponsor|1|||
164377700|NCT03013491|593754366|FG010|Main Study|Termination of the study by Sponsor|1|||
164377701|NCT03013491|593754367|FG011|Main Study|Termination of the study by Sponsor|2|||
164377702|NCT03013491|593754368|FG012|Main Study|Termination of the study by Sponsor|0|||
164377703|NCT03013491|593754369|FG013|Main Study|Termination of the study by Sponsor|0|||
164377704|NCT03013491|593754370|FG014|Main Study|Termination of the study by Sponsor|0|||
164377705|NCT03013491|593754371|FG015|Main Study|Termination of the study by Sponsor|0|||
164377706|NCT03013491|593754372|FG016|Main Study|Termination of the study by Sponsor|0|||
164377707|NCT03013491|593754373|FG017|Main Study|Termination of the study by Sponsor|1|||
164377708|NCT03013491|593754374|FG018|Main Study|Termination of the study by Sponsor|13|||
164377709|NCT03013491|593754356|FG000|Main Study|Withdrawal by Subject|0|||
164377710|NCT03013491|593754357|FG001|Main Study|Withdrawal by Subject|0|||
164377711|NCT03013491|593754358|FG002|Main Study|Withdrawal by Subject|0|||
164377712|NCT03013491|593754359|FG003|Main Study|Withdrawal by Subject|4|||
164377713|NCT03013491|593754360|FG004|Main Study|Withdrawal by Subject|2|||
164377714|NCT03013491|593754361|FG005|Main Study|Withdrawal by Subject|1|||
164377715|NCT03013491|593754362|FG006|Main Study|Withdrawal by Subject|0|||
164377716|NCT03013491|593754363|FG007|Main Study|Withdrawal by Subject|0|||
164377717|NCT03013491|593754364|FG008|Main Study|Withdrawal by Subject|0|||
164377718|NCT03013491|593754365|FG009|Main Study|Withdrawal by Subject|0|||
164377719|NCT03013491|593754366|FG010|Main Study|Withdrawal by Subject|1|||
164377720|NCT03013491|593754367|FG011|Main Study|Withdrawal by Subject|2|||
164377721|NCT03013491|593754368|FG012|Main Study|Withdrawal by Subject|0|||
164377722|NCT03013491|593754369|FG013|Main Study|Withdrawal by Subject|2|||
164377723|NCT03013491|593754370|FG014|Main Study|Withdrawal by Subject|0|||
164377724|NCT03013491|593754371|FG015|Main Study|Withdrawal by Subject|0|||
164377725|NCT03013491|593754372|FG016|Main Study|Withdrawal by Subject|0|||
164377726|NCT03013491|593754373|FG017|Main Study|Withdrawal by Subject|0|||
164377727|NCT03013491|593754374|FG018|Main Study|Withdrawal by Subject|18|||
164377728|NCT03013491|593754356|FG000|Main Study|Disease progression|0|||
164377729|NCT03013491|593754357|FG001|Main Study|Disease progression|0|||
164377730|NCT03013491|593754358|FG002|Main Study|Disease progression|0|||
164377731|NCT03013491|593754359|FG003|Main Study|Disease progression|1|||
164377732|NCT03013491|593754360|FG004|Main Study|Disease progression|0|||
164377733|NCT03013491|593754361|FG005|Main Study|Disease progression|0|||
164377734|NCT03013491|593754362|FG006|Main Study|Disease progression|0|||
164377735|NCT03013491|593754363|FG007|Main Study|Disease progression|0|||
164377736|NCT03013491|593754364|FG008|Main Study|Disease progression|1|||
164377737|NCT03013491|593754365|FG009|Main Study|Disease progression|0|||
164377738|NCT03013491|593754366|FG010|Main Study|Disease progression|1|||
164377739|NCT03013491|593754367|FG011|Main Study|Disease progression|0|||
164377740|NCT03013491|593754368|FG012|Main Study|Disease progression|0|||
164377741|NCT03013491|593754369|FG013|Main Study|Disease progression|0|||
164377742|NCT03013491|593754370|FG014|Main Study|Disease progression|0|||
164377743|NCT03013491|593754371|FG015|Main Study|Disease progression|0|||
164377744|NCT03013491|593754372|FG016|Main Study|Disease progression|0|||
164377745|NCT03013491|593754373|FG017|Main Study|Disease progression|0|||
164377746|NCT03013491|593754374|FG018|Main Study|Disease progression|4|||
164377747|NCT03013491|593754356|FG000|Main Study|Symptomatic deterioration|0|||
164377748|NCT03013491|593754357|FG001|Main Study|Symptomatic deterioration|0|||
164377749|NCT03013491|593754358|FG002|Main Study|Symptomatic deterioration|0|||
164591986|NCT01929044|594530019|FG001|Overall Study|Not Treated|3|||
164591987|NCT02275026|594530026|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
164377750|NCT03013491|593754359|FG003|Main Study|Symptomatic deterioration|0|||
164377751|NCT03013491|593754360|FG004|Main Study|Symptomatic deterioration|0|||
164377752|NCT03013491|593754361|FG005|Main Study|Symptomatic deterioration|1|||
164377753|NCT03013491|593754362|FG006|Main Study|Symptomatic deterioration|0|||
164377754|NCT03013491|593754363|FG007|Main Study|Symptomatic deterioration|0|||
164377755|NCT03013491|593754364|FG008|Main Study|Symptomatic deterioration|0|||
164700667|NCT02429934|594926890|FG000|Overall Study|Withdrawal by Subject|0|||
164700668|NCT02429934|594926891|FG001|Overall Study|Withdrawal by Subject|2|||
164700669|NCT02429934|594926890|FG000|Overall Study|Adverse Event|2|||
164700670|NCT02429934|594926891|FG001|Overall Study|Adverse Event|0|||
164700671|NCT02429934|594926890|FG000|Overall Study|Lost to Follow-up|1|||
164700672|NCT02429934|594926891|FG001|Overall Study|Lost to Follow-up|1|||
164377756|NCT03013491|593754365|FG009|Main Study|Symptomatic deterioration|0|||
164377757|NCT03013491|593754366|FG010|Main Study|Symptomatic deterioration|0|||
164377758|NCT03013491|593754367|FG011|Main Study|Symptomatic deterioration|0|||
164377759|NCT03013491|593754368|FG012|Main Study|Symptomatic deterioration|0|||
164377760|NCT03013491|593754369|FG013|Main Study|Symptomatic deterioration|0|||
164377761|NCT03013491|593754370|FG014|Main Study|Symptomatic deterioration|0|||
164377762|NCT03013491|593754371|FG015|Main Study|Symptomatic deterioration|0|||
164377763|NCT03013491|593754372|FG016|Main Study|Symptomatic deterioration|0|||
164377764|NCT03013491|593754373|FG017|Main Study|Symptomatic deterioration|0|||
164377765|NCT03013491|593754374|FG018|Main Study|Symptomatic deterioration|0|||
164377766|NCT03013491|593754356|FG000|Main Study|Protocol version 8.0 approval|0|||
164377767|NCT03013491|593754357|FG001|Main Study|Protocol version 8.0 approval|0|||
164377768|NCT03013491|593754358|FG002|Main Study|Protocol version 8.0 approval|0|||
164377769|NCT03013491|593754359|FG003|Main Study|Protocol version 8.0 approval|0|||
164377770|NCT03013491|593754360|FG004|Main Study|Protocol version 8.0 approval|0|||
164377771|NCT03013491|593754361|FG005|Main Study|Protocol version 8.0 approval|0|||
164377772|NCT03013491|593754362|FG006|Main Study|Protocol version 8.0 approval|0|||
164377773|NCT03013491|593754363|FG007|Main Study|Protocol version 8.0 approval|0|||
164377774|NCT03013491|593754364|FG008|Main Study|Protocol version 8.0 approval|0|||
164377775|NCT03013491|593754365|FG009|Main Study|Protocol version 8.0 approval|0|||
164377776|NCT03013491|593754366|FG010|Main Study|Protocol version 8.0 approval|1|||
164377777|NCT03013491|593754367|FG011|Main Study|Protocol version 8.0 approval|0|||
164377778|NCT03013491|593754368|FG012|Main Study|Protocol version 8.0 approval|0|||
164377779|NCT03013491|593754369|FG013|Main Study|Protocol version 8.0 approval|0|||
164377780|NCT03013491|593754370|FG014|Main Study|Protocol version 8.0 approval|0|||
164377781|NCT03013491|593754371|FG015|Main Study|Protocol version 8.0 approval|0|||
164377782|NCT03013491|593754372|FG016|Main Study|Protocol version 8.0 approval|0|||
164377783|NCT03013491|593754373|FG017|Main Study|Protocol version 8.0 approval|0|||
164377784|NCT03013491|593754374|FG018|Main Study|Protocol version 8.0 approval|0|||
164377785|NCT03013491|593754356|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
164377786|NCT03013491|593754357|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
164377787|NCT03013491|593754358|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
164377788|NCT03013491|593754359|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
164377789|NCT03013491|593754360|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
164377790|NCT03013491|593754361|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
164377791|NCT03013491|593754362|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
164439335|NCT03622580|593975364|FG000|Overall Study|Pregnancy|0|||
164439336|NCT03622580|593975365|FG001|Overall Study|Pregnancy|1|||
164439337|NCT03622580|593975366|FG002|Overall Study|Pregnancy|0|||
164439338|NCT03622580|593975364|FG000|Overall Study|Lack of Efficacy|0|||
164439339|NCT03622580|593975365|FG001|Overall Study|Lack of Efficacy|0|||
164439340|NCT03622580|593975366|FG002|Overall Study|Lack of Efficacy|1|||
164439341|NCT03622580|593975364|FG000|Overall Study|Other|2|||
164439342|NCT03622580|593975365|FG001|Overall Study|Other|0|||
164439343|NCT03622580|593975366|FG002|Overall Study|Other|3|||
164439344|NCT00943735|593975371|FG000|Overall Study|Adverse Event|12|||
164439345|NCT00943735|593975371|FG000|Overall Study|Withdrawal by Subject|8|||
164439346|NCT00943735|593975371|FG000|Overall Study|Death|1|||
164439347|NCT00943735|593975371|FG000|Overall Study|Other|8|||
164439348|NCT00943735|593975371|FG000|Overall Study|Other|3|||
164439349|NCT01713530|593975372|FG000|Overall Study|Adverse Event|0|||
164439350|NCT01713530|593975373|FG001|Overall Study|Adverse Event|5|||
164439351|NCT01713530|593975372|FG000|Overall Study|Withdrawal criteria|21|||
164439352|NCT01713530|593975373|FG001|Overall Study|Withdrawal criteria|12|||
164439353|NCT01713530|593975372|FG000|Overall Study|Unclassified|4|||
164700673|NCT02429934|594926890|FG000|Overall Study|Physician Decision|1|||
164377792|NCT03013491|593754363|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
164377793|NCT03013491|593754364|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
164377794|NCT03013491|593754365|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
164377795|NCT03013491|593754366|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
164439354|NCT01713530|593975373|FG001|Overall Study|Unclassified|2|||
164439355|NCT03939819|593975374|FG000|Overall Study|Death|2|||
164439356|NCT03939819|593975375|FG001|Overall Study|Death|0|||
164439357|NCT03987451|593975376|FG000|Overall Study|Lost to Follow-up|1|||
164700674|NCT02429934|594926891|FG001|Overall Study|Physician Decision|0|||
164700675|NCT00869024|594926892|FG000|Overall Study|Death|2|||
164439358|NCT03987451|593975377|FG001|Overall Study|Lost to Follow-up|0|||
164439359|NCT03987451|593975376|FG000|Overall Study|Withdrawal by Subject|1|||
164700676|NCT00869024|594926893|FG001|Overall Study|Death|3|||
164700677|NCT00869024|594926892|FG000|Overall Study|Lost to Follow-up|0|||
164377796|NCT03013491|593754367|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
164377797|NCT03013491|593754368|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
164377798|NCT03013491|593754369|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
164377799|NCT03013491|593754370|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
164377800|NCT03013491|593754371|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
164377801|NCT03013491|593754372|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
164377802|NCT03013491|593754373|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
164377803|NCT03013491|593754374|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
164377804|NCT03013491|593754356|FG000|Main Study|Start of new anticancer therapy|0|||
164377805|NCT03013491|593754357|FG001|Main Study|Start of new anticancer therapy|0|||
164377806|NCT03013491|593754358|FG002|Main Study|Start of new anticancer therapy|0|||
164377807|NCT03013491|593754359|FG003|Main Study|Start of new anticancer therapy|0|||
164377808|NCT03013491|593754360|FG004|Main Study|Start of new anticancer therapy|0|||
164377809|NCT03013491|593754361|FG005|Main Study|Start of new anticancer therapy|0|||
164377810|NCT03013491|593754362|FG006|Main Study|Start of new anticancer therapy|0|||
164377811|NCT03013491|593754363|FG007|Main Study|Start of new anticancer therapy|0|||
164377812|NCT03013491|593754364|FG008|Main Study|Start of new anticancer therapy|0|||
164377813|NCT03013491|593754365|FG009|Main Study|Start of new anticancer therapy|0|||
164377814|NCT03013491|593754366|FG010|Main Study|Start of new anticancer therapy|0|||
164377815|NCT03013491|593754367|FG011|Main Study|Start of new anticancer therapy|0|||
164377816|NCT03013491|593754368|FG012|Main Study|Start of new anticancer therapy|0|||
164377817|NCT03013491|593754369|FG013|Main Study|Start of new anticancer therapy|0|||
164591988|NCT02275026|594530026|FG000|Overall Study|Withdrawal by Subject|4|||
164591989|NCT02275026|594530026|FG000|Overall Study|Ineligible due to medical history|13|||
164377818|NCT03013491|593754370|FG014|Main Study|Start of new anticancer therapy|0|||
164377819|NCT03013491|593754371|FG015|Main Study|Start of new anticancer therapy|0|||
164377820|NCT03013491|593754372|FG016|Main Study|Start of new anticancer therapy|0|||
164377821|NCT03013491|593754373|FG017|Main Study|Start of new anticancer therapy|0|||
164377822|NCT03013491|593754374|FG018|Main Study|Start of new anticancer therapy|2|||
164377823|NCT03013491|593754356|FG000|Long-term Extension|Disease progression|0|||
164377824|NCT03013491|593754357|FG001|Long-term Extension|Disease progression|0|||
164377825|NCT03013491|593754358|FG002|Long-term Extension|Disease progression|0|||
164377826|NCT03013491|593754359|FG003|Long-term Extension|Disease progression|1|||
164377827|NCT03013491|593754360|FG004|Long-term Extension|Disease progression|0|||
164377828|NCT03013491|593754361|FG005|Long-term Extension|Disease progression|0|||
164377829|NCT03013491|593754362|FG006|Long-term Extension|Disease progression|0|||
164377830|NCT03013491|593754363|FG007|Long-term Extension|Disease progression|0|||
164377831|NCT03013491|593754364|FG008|Long-term Extension|Disease progression|0|||
164377832|NCT03013491|593754365|FG009|Long-term Extension|Disease progression|0|||
164377833|NCT03013491|593754366|FG010|Long-term Extension|Disease progression|0|||
164377834|NCT03013491|593754367|FG011|Long-term Extension|Disease progression|0|||
164377835|NCT03013491|593754368|FG012|Long-term Extension|Disease progression|0|||
164377836|NCT03013491|593754369|FG013|Long-term Extension|Disease progression|0|||
164377837|NCT03013491|593754370|FG014|Long-term Extension|Disease progression|0|||
164377838|NCT03013491|593754371|FG015|Long-term Extension|Disease progression|0|||
164377839|NCT03013491|593754372|FG016|Long-term Extension|Disease progression|0|||
164377840|NCT03013491|593754373|FG017|Long-term Extension|Disease progression|0|||
164377841|NCT03013491|593754374|FG018|Long-term Extension|Disease progression|1|||
164377842|NCT03013491|593754356|FG000|Long-term Extension|Withdrawal by Subject|0|||
164377843|NCT03013491|593754357|FG001|Long-term Extension|Withdrawal by Subject|0|||
164377844|NCT03013491|593754358|FG002|Long-term Extension|Withdrawal by Subject|0|||
164377845|NCT03013491|593754359|FG003|Long-term Extension|Withdrawal by Subject|0|||
164377846|NCT03013491|593754360|FG004|Long-term Extension|Withdrawal by Subject|0|||
164377847|NCT03013491|593754361|FG005|Long-term Extension|Withdrawal by Subject|0|||
164377848|NCT03013491|593754362|FG006|Long-term Extension|Withdrawal by Subject|0|||
164377849|NCT03013491|593754363|FG007|Long-term Extension|Withdrawal by Subject|1|||
164377850|NCT03013491|593754364|FG008|Long-term Extension|Withdrawal by Subject|0|||
164591990|NCT02275026|594530026|FG000|Overall Study|MRI malfunction precluded testing|1|||
164591991|NCT02275026|594530026|FG000|Overall Study|Ineligible after MRI findings|1|||
164591992|NCT02275026|594530026|FG000|Overall Study|Lost to Follow-up|2|||
164591993|NCT02275026|594530026|FG000|Overall Study|Scanner failure|1|||
164591994|NCT00878072|594530027|FG000|Overall Study|Withdrew consent|2|||
164377851|NCT03013491|593754365|FG009|Long-term Extension|Withdrawal by Subject|0|||
164377852|NCT03013491|593754366|FG010|Long-term Extension|Withdrawal by Subject|0|||
164377853|NCT03013491|593754367|FG011|Long-term Extension|Withdrawal by Subject|0|||
164377854|NCT03013491|593754368|FG012|Long-term Extension|Withdrawal by Subject|0|||
164377855|NCT03013491|593754369|FG013|Long-term Extension|Withdrawal by Subject|0|||
164377856|NCT03013491|593754370|FG014|Long-term Extension|Withdrawal by Subject|0|||
164377857|NCT03013491|593754371|FG015|Long-term Extension|Withdrawal by Subject|0|||
164377858|NCT03013491|593754372|FG016|Long-term Extension|Withdrawal by Subject|0|||
164377859|NCT03013491|593754373|FG017|Long-term Extension|Withdrawal by Subject|0|||
164591995|NCT01200511|594530039|FG000|Overall Study|Lost to Follow-up|3|||
164377860|NCT03013491|593754374|FG018|Long-term Extension|Withdrawal by Subject|0|||
164377861|NCT03013491|593754356|FG000|Long-term Extension|Adverse Event|0|||
164377862|NCT03013491|593754357|FG001|Long-term Extension|Adverse Event|0|||
164377863|NCT03013491|593754358|FG002|Long-term Extension|Adverse Event|0|||
164377864|NCT03013491|593754359|FG003|Long-term Extension|Adverse Event|0|||
164377865|NCT03013491|593754360|FG004|Long-term Extension|Adverse Event|0|||
164377866|NCT03013491|593754361|FG005|Long-term Extension|Adverse Event|0|||
164377867|NCT03013491|593754362|FG006|Long-term Extension|Adverse Event|0|||
164377868|NCT03013491|593754363|FG007|Long-term Extension|Adverse Event|0|||
164377869|NCT03013491|593754364|FG008|Long-term Extension|Adverse Event|0|||
164377870|NCT03013491|593754365|FG009|Long-term Extension|Adverse Event|0|||
164377871|NCT03013491|593754366|FG010|Long-term Extension|Adverse Event|0|||
164377872|NCT03013491|593754367|FG011|Long-term Extension|Adverse Event|0|||
164377873|NCT03013491|593754368|FG012|Long-term Extension|Adverse Event|0|||
164377874|NCT03013491|593754369|FG013|Long-term Extension|Adverse Event|0|||
164377875|NCT03013491|593754370|FG014|Long-term Extension|Adverse Event|0|||
164377876|NCT03013491|593754371|FG015|Long-term Extension|Adverse Event|0|||
164377877|NCT03013491|593754372|FG016|Long-term Extension|Adverse Event|0|||
164377878|NCT03013491|593754373|FG017|Long-term Extension|Adverse Event|0|||
164377879|NCT03013491|593754374|FG018|Long-term Extension|Adverse Event|1|||
164377880|NCT03013491|593754356|FG000|Long-term Extension|Death|0|||
164377881|NCT03013491|593754357|FG001|Long-term Extension|Death|0|||
164377882|NCT03013491|593754358|FG002|Long-term Extension|Death|0|||
164377883|NCT03013491|593754359|FG003|Long-term Extension|Death|0|||
164377884|NCT03013491|593754360|FG004|Long-term Extension|Death|0|||
164377885|NCT03013491|593754361|FG005|Long-term Extension|Death|0|||
164377886|NCT03013491|593754362|FG006|Long-term Extension|Death|0|||
164377887|NCT03013491|593754363|FG007|Long-term Extension|Death|0|||
164377888|NCT03013491|593754364|FG008|Long-term Extension|Death|0|||
164377889|NCT03013491|593754365|FG009|Long-term Extension|Death|0|||
164377890|NCT03013491|593754366|FG010|Long-term Extension|Death|0|||
164377891|NCT03013491|593754367|FG011|Long-term Extension|Death|0|||
164377892|NCT03013491|593754368|FG012|Long-term Extension|Death|0|||
164377893|NCT03013491|593754369|FG013|Long-term Extension|Death|0|||
164377894|NCT03013491|593754370|FG014|Long-term Extension|Death|0|||
164377895|NCT03013491|593754371|FG015|Long-term Extension|Death|0|||
164377896|NCT03013491|593754372|FG016|Long-term Extension|Death|0|||
164700678|NCT00869024|594926893|FG001|Overall Study|Lost to Follow-up|1|||
164700679|NCT00869024|594926892|FG000|Overall Study|Protocol Violation|0|||
164700680|NCT00869024|594926893|FG001|Overall Study|Protocol Violation|1|||
164700681|NCT01564459|594926897|FG000|Run-In|Adverse Event|7|||
164700682|NCT01564459|594926898|FG001|Run-In|Adverse Event|0|||
164700683|NCT01564459|594926899|FG002|Run-In|Adverse Event|0|||
164377897|NCT03013491|593754373|FG017|Long-term Extension|Death|0|||
164377898|NCT03013491|593754374|FG018|Long-term Extension|Death|1|||
164377899|NCT03890367|593754378|FG000|Overall Study|Withdrawal by parent/guardian|1|||
164377900|NCT03890367|593754379|FG001|Overall Study|Withdrawal by parent/guardian|3|||
164377901|NCT03890367|593754380|FG002|Overall Study|Withdrawal by parent/guardian|0|||
164377902|NCT03890367|593754378|FG000|Overall Study|Protocol deviation|2|||
164377903|NCT03890367|593754379|FG001|Overall Study|Protocol deviation|2|||
164377904|NCT03890367|593754380|FG002|Overall Study|Protocol deviation|1|||
164377905|NCT03890367|593754378|FG000|Overall Study|Lost to Follow-up|1|||
164377906|NCT03890367|593754379|FG001|Overall Study|Lost to Follow-up|1|||
164377907|NCT03890367|593754380|FG002|Overall Study|Lost to Follow-up|0|||
164377908|NCT04524403|593756237|FG000|Overall Study|Withdrawal by Subject|10|||
164377909|NCT04524403|593756238|FG001|Overall Study|Withdrawal by Subject|3|||
164377910|NCT04524403|593756239|FG002|Overall Study|Withdrawal by Subject|8|||
164439360|NCT03987451|593975377|FG001|Overall Study|Withdrawal by Subject|1|||
164439361|NCT00530842|593975378|FG000|Overall Study|Adverse Event|10|||
164439362|NCT00530842|593975379|FG001|Overall Study|Adverse Event|6|||
164700684|NCT01564459|594926897|FG000|Run-In|Lost to Follow-up|1|||
164700685|NCT01564459|594926898|FG001|Run-In|Lost to Follow-up|0|||
164700686|NCT01564459|594926899|FG002|Run-In|Lost to Follow-up|0|||
164377911|NCT04524403|593756237|FG000|Overall Study|Lost to Follow-up|3|||
164377912|NCT04524403|593756238|FG001|Overall Study|Lost to Follow-up|4|||
164377913|NCT04524403|593756239|FG002|Overall Study|Lost to Follow-up|3|||
164377914|NCT04524403|593756237|FG000|Overall Study|Adverse Event|3|||
164700687|NCT01564459|594926897|FG000|Run-In|Non-compliance with study drug|2|||
164700688|NCT01564459|594926898|FG001|Run-In|Non-compliance with study drug|0|||
164377915|NCT04524403|593756238|FG001|Overall Study|Adverse Event|1|||
164377916|NCT04524403|593756239|FG002|Overall Study|Adverse Event|4|||
164377917|NCT04524403|593756237|FG000|Overall Study|Non-compliant with study drug|1|||
164377918|NCT04524403|593756238|FG001|Overall Study|Non-compliant with study drug|2|||
164377919|NCT04524403|593756239|FG002|Overall Study|Non-compliant with study drug|3|||
164377920|NCT04524403|593756237|FG000|Overall Study|Moved|0|||
164700689|NCT01564459|594926899|FG002|Run-In|Non-compliance with study drug|0|||
164377921|NCT04524403|593756238|FG001|Overall Study|Moved|1|||
164377922|NCT04524403|593756239|FG002|Overall Study|Moved|0|||
164377923|NCT00991302|593756240|FG000|Overall Study|Death|0|||
164377924|NCT00991302|593756241|FG001|Overall Study|Death|1|||
164377925|NCT00991302|593756240|FG000|Overall Study|Lost to Follow-up|14|||
164377926|NCT00991302|593756241|FG001|Overall Study|Lost to Follow-up|12|||
164377927|NCT01709318|593756242|FG000|Overall Study|Adverse Event|3|||
164377928|NCT01709318|593756243|FG001|Overall Study|Adverse Event|4|||
164377929|NCT01709318|593756244|FG002|Overall Study|Adverse Event|2|||
164377930|NCT01709318|593756245|FG003|Overall Study|Adverse Event|2|||
164377931|NCT01709318|593756246|FG004|Overall Study|Adverse Event|0|||
164377932|NCT01709318|593756247|FG005|Overall Study|Adverse Event|1|||
164377933|NCT01709318|593756248|FG006|Overall Study|Adverse Event|2|||
164377934|NCT01709318|593756242|FG000|Overall Study|Lost to Follow-up|2|||
164377935|NCT01709318|593756243|FG001|Overall Study|Lost to Follow-up|0|||
164377936|NCT01709318|593756244|FG002|Overall Study|Lost to Follow-up|0|||
164377937|NCT01709318|593756245|FG003|Overall Study|Lost to Follow-up|0|||
164377938|NCT01709318|593756246|FG004|Overall Study|Lost to Follow-up|1|||
164377939|NCT01709318|593756247|FG005|Overall Study|Lost to Follow-up|1|||
164377940|NCT01709318|593756248|FG006|Overall Study|Lost to Follow-up|1|||
164377941|NCT01709318|593756242|FG000|Overall Study|Non-compliance with Study Drug|0|||
164377942|NCT01709318|593756243|FG001|Overall Study|Non-compliance with Study Drug|2|||
164377943|NCT01709318|593756244|FG002|Overall Study|Non-compliance with Study Drug|1|||
164377944|NCT01709318|593756245|FG003|Overall Study|Non-compliance with Study Drug|1|||
164377945|NCT01709318|593756246|FG004|Overall Study|Non-compliance with Study Drug|0|||
164377946|NCT01709318|593756247|FG005|Overall Study|Non-compliance with Study Drug|0|||
164377947|NCT01709318|593756248|FG006|Overall Study|Non-compliance with Study Drug|2|||
164377948|NCT01709318|593756242|FG000|Overall Study|Physician Decision|0|||
164377949|NCT01709318|593756243|FG001|Overall Study|Physician Decision|0|||
164377950|NCT01709318|593756244|FG002|Overall Study|Physician Decision|0|||
164377951|NCT01709318|593756245|FG003|Overall Study|Physician Decision|0|||
164377952|NCT01709318|593756246|FG004|Overall Study|Physician Decision|0|||
164377953|NCT01709318|593756247|FG005|Overall Study|Physician Decision|0|||
164377954|NCT01709318|593756248|FG006|Overall Study|Physician Decision|1|||
164377955|NCT01709318|593756242|FG000|Overall Study|Pregnancy|0|||
164377956|NCT01709318|593756243|FG001|Overall Study|Pregnancy|0|||
164377957|NCT01709318|593756244|FG002|Overall Study|Pregnancy|0|||
164377958|NCT01709318|593756245|FG003|Overall Study|Pregnancy|0|||
164377959|NCT01709318|593756246|FG004|Overall Study|Pregnancy|1|||
164377960|NCT01709318|593756247|FG005|Overall Study|Pregnancy|0|||
164377961|NCT01709318|593756248|FG006|Overall Study|Pregnancy|0|||
164377962|NCT01709318|593756242|FG000|Overall Study|Protocol Violation|0|||
164377963|NCT01709318|593756243|FG001|Overall Study|Protocol Violation|0|||
164377964|NCT01709318|593756244|FG002|Overall Study|Protocol Violation|0|||
164377965|NCT01709318|593756245|FG003|Overall Study|Protocol Violation|0|||
164377966|NCT01709318|593756246|FG004|Overall Study|Protocol Violation|2|||
164377967|NCT01709318|593756247|FG005|Overall Study|Protocol Violation|0|||
164377968|NCT01709318|593756248|FG006|Overall Study|Protocol Violation|1|||
164377969|NCT01709318|593756242|FG000|Overall Study|Technical Problems|1|||
164377970|NCT01709318|593756243|FG001|Overall Study|Technical Problems|0|||
164377971|NCT01709318|593756244|FG002|Overall Study|Technical Problems|0|||
164377972|NCT01709318|593756245|FG003|Overall Study|Technical Problems|0|||
164377973|NCT01709318|593756246|FG004|Overall Study|Technical Problems|0|||
164377974|NCT01709318|593756247|FG005|Overall Study|Technical Problems|0|||
164377975|NCT01709318|593756248|FG006|Overall Study|Technical Problems|0|||
164377976|NCT01709318|593756242|FG000|Overall Study|Withdrawal by Subject|3|||
164377977|NCT01709318|593756243|FG001|Overall Study|Withdrawal by Subject|0|||
164591996|NCT01200511|594530039|FG000|Overall Study|Withdrawal by Subject|1|||
164591997|NCT01200511|594530039|FG000|Overall Study|Adverse Event|1|||
164591998|NCT03288779|594530040|FG000|Overall Study|Withdrawal by Subject|3|||
164591999|NCT03382899|594530041|FG000|Overall Study|Ineligibility Determined|0|||
164592000|NCT03382899|594530042|FG001|Overall Study|Ineligibility Determined|1|||
164592001|NCT03382899|594530041|FG000|Overall Study|Lost to Follow-up|0|||
164592002|NCT03382899|594530042|FG001|Overall Study|Lost to Follow-up|1|||
164592003|NCT03382899|594530041|FG000|Overall Study|Sponsor's decision|31|||
164592004|NCT03382899|594530042|FG001|Overall Study|Sponsor's decision|28|||
164592005|NCT03382899|594530041|FG000|Overall Study|Withdrawal by Subject|0|||
164592006|NCT03382899|594530042|FG001|Overall Study|Withdrawal by Subject|5|||
164592007|NCT02504892|594530044|FG000|Overall Study|Adverse event-pneumonitis|2|||
164592008|NCT00524745|594530045|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
164592009|NCT00524745|594530046|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
164592010|NCT00524745|594530047|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
164592011|NCT00524745|594530048|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
164592012|NCT00576693|594530049|FG000|Overall Study|Lost to Follow-up|7|||
164592013|NCT00576693|594530050|FG001|Overall Study|Lost to Follow-up|11|||
164592014|NCT00576693|594530049|FG000|Overall Study|Withdrawal by Subject|3|||
164377978|NCT01709318|593756244|FG002|Overall Study|Withdrawal by Subject|3|||
164377979|NCT01709318|593756245|FG003|Overall Study|Withdrawal by Subject|3|||
164377980|NCT01709318|593756246|FG004|Overall Study|Withdrawal by Subject|0|||
164377981|NCT01709318|593756247|FG005|Overall Study|Withdrawal by Subject|2|||
164377982|NCT01709318|593756248|FG006|Overall Study|Withdrawal by Subject|4|||
164377983|NCT01709318|593756242|FG000|Overall Study|Other Protocol Specified Criteria|0|||
164377984|NCT01709318|593756243|FG001|Overall Study|Other Protocol Specified Criteria|1|||
164377985|NCT01709318|593756244|FG002|Overall Study|Other Protocol Specified Criteria|0|||
164377986|NCT01709318|593756245|FG003|Overall Study|Other Protocol Specified Criteria|0|||
164377987|NCT01709318|593756246|FG004|Overall Study|Other Protocol Specified Criteria|0|||
164377988|NCT01709318|593756247|FG005|Overall Study|Other Protocol Specified Criteria|0|||
164377989|NCT01709318|593756248|FG006|Overall Study|Other Protocol Specified Criteria|0|||
164377990|NCT00827372|593756253|FG000|Overall Study|Adverse Event|5|||
164377991|NCT00827372|593756253|FG000|Overall Study|Lack of Efficacy|3|||
164377992|NCT03085927|593756254|FG000|Overall Study|Withdrawal by Subject|1|||
164377993|NCT03085927|593756255|FG001|Overall Study|Withdrawal by Subject|4|||
164377994|NCT03085927|593756254|FG000|Overall Study|Lost to Follow-up|3|||
164377995|NCT03085927|593756255|FG001|Overall Study|Lost to Follow-up|1|||
164377996|NCT03085927|593756254|FG000|Overall Study|Death|1|||
164377997|NCT03085927|593756255|FG001|Overall Study|Death|0|||
164377998|NCT03085927|593756254|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
164377999|NCT03085927|593756255|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
164378000|NCT03085927|593756254|FG000|Overall Study|Dyad Became Ineligible|0|||
164378001|NCT03085927|593756255|FG001|Overall Study|Dyad Became Ineligible|1|||
164378002|NCT02564471|593756256|FG000|Overall Study|Adverse Event|1|||
164378003|NCT02564471|593756257|FG001|Overall Study|Adverse Event|0|||
164378004|NCT02564471|593756258|FG002|Overall Study|Adverse Event|0|||
164378005|NCT02564471|593756259|FG003|Overall Study|Adverse Event|0|||
164378006|NCT02564471|593756256|FG000|Overall Study|Withdrawal by Subject|2|||
164378007|NCT02564471|593756257|FG001|Overall Study|Withdrawal by Subject|1|||
164378008|NCT02564471|593756258|FG002|Overall Study|Withdrawal by Subject|3|||
164378009|NCT02564471|593756259|FG003|Overall Study|Withdrawal by Subject|0|||
164378010|NCT02564471|593756256|FG000|Overall Study|Lost to Follow-up|0|||
164378011|NCT02564471|593756257|FG001|Overall Study|Lost to Follow-up|2|||
164378012|NCT02564471|593756258|FG002|Overall Study|Lost to Follow-up|0|||
164378013|NCT02564471|593756259|FG003|Overall Study|Lost to Follow-up|0|||
164378014|NCT01312909|593756260|FG000|Overall Study|Randomized but not treated|1|||
164378015|NCT01312909|593756261|FG001|Overall Study|Randomized but not treated|3|||
164378016|NCT01312909|593756262|FG002|Overall Study|Randomized but not treated|1|||
164378017|NCT01312909|593756260|FG000|Overall Study|Adverse Event|1|||
164378018|NCT01312909|593756261|FG001|Overall Study|Adverse Event|0|||
164378019|NCT01312909|593756262|FG002|Overall Study|Adverse Event|3|||
164378020|NCT01312909|593756260|FG000|Overall Study|Protocol Violation|2|||
164378021|NCT01312909|593756261|FG001|Overall Study|Protocol Violation|0|||
164378022|NCT01312909|593756262|FG002|Overall Study|Protocol Violation|2|||
164378023|NCT01312909|593756260|FG000|Overall Study|Other|9|||
164378024|NCT01312909|593756261|FG001|Overall Study|Other|6|||
164378025|NCT01312909|593756262|FG002|Overall Study|Other|11|||
164378026|NCT01312909|593756260|FG000|Overall Study|Withdrawal by Subject|8|||
164378027|NCT01312909|593756261|FG001|Overall Study|Withdrawal by Subject|10|||
164378028|NCT01312909|593756262|FG002|Overall Study|Withdrawal by Subject|7|||
164378029|NCT01312909|593756260|FG000|Overall Study|Lost to Follow-up|21|||
164378030|NCT01312909|593756261|FG001|Overall Study|Lost to Follow-up|17|||
164378031|NCT01312909|593756262|FG002|Overall Study|Lost to Follow-up|20|||
164378032|NCT01312909|593756260|FG000|Overall Study|Insufficient clinical response|0|||
164378033|NCT01312909|593756261|FG001|Overall Study|Insufficient clinical response|0|||
164378034|NCT01312909|593756262|FG002|Overall Study|Insufficient clinical response|1|||
164378035|NCT01312909|593756260|FG000|Overall Study|Entrance criteria not met|0|||
164378036|NCT01312909|593756261|FG001|Overall Study|Entrance criteria not met|0|||
164378037|NCT01312909|593756262|FG002|Overall Study|Entrance criteria not met|2|||
164378038|NCT02200042|593756263|FG000|Overall Study|Withdrawal by Subject|0|||
164378039|NCT02200042|593756264|FG001|Overall Study|Withdrawal by Subject|1|||
164378040|NCT01777997|593756267|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
164378041|NCT01777997|593756267|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
164378042|NCT01777997|593756267|FG000|Weeks 48 to 72/96 on ART|Death|1|||
164378043|NCT01777997|593756267|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
164378044|NCT00306592|593756268|FG000|Overall Study|Adverse Event|8|||
164378045|NCT00306592|593756269|FG001|Overall Study|Adverse Event|15|||
164378046|NCT00306592|593756268|FG000|Overall Study|Lost to Follow-up|1|||
164378047|NCT00306592|593756269|FG001|Overall Study|Lost to Follow-up|0|||
164378048|NCT00306592|593756268|FG000|Overall Study|Noncompliance|0|||
164378049|NCT00306592|593756269|FG001|Overall Study|Noncompliance|2|||
164378050|NCT00306592|593756268|FG000|Overall Study|Persistent Antibodies|6|||
164378051|NCT00306592|593756269|FG001|Overall Study|Persistent Antibodies|3|||
164378052|NCT00306592|593756268|FG000|Overall Study|Voluntary|10|||
164378053|NCT00306592|593756269|FG001|Overall Study|Voluntary|6|||
164378054|NCT00306592|593756268|FG000|Overall Study|Other|5|||
164378055|NCT00306592|593756269|FG001|Overall Study|Other|10|||
164378056|NCT00306592|593756268|FG000|Overall Study|Other|1|||
164378057|NCT00306592|593756269|FG001|Overall Study|Other|2|||
164378058|NCT00306592|593756268|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
164378059|NCT00306592|593756269|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
164378060|NCT01923181|593756270|FG000|Overall Study|Protocol Violation|2|||
164378061|NCT01923181|593756271|FG001|Overall Study|Protocol Violation|2|||
164378062|NCT01923181|593756272|FG002|Overall Study|Protocol Violation|0|||
164378063|NCT01923181|593756273|FG003|Overall Study|Protocol Violation|2|||
164378064|NCT01923181|593756274|FG004|Overall Study|Protocol Violation|2|||
164378065|NCT01923181|593756275|FG005|Overall Study|Protocol Violation|1|||
164378066|NCT01923181|593756276|FG006|Overall Study|Protocol Violation|1|||
164378067|NCT01923181|593756277|FG007|Overall Study|Protocol Violation|2|||
164378068|NCT01923181|593756278|FG008|Overall Study|Protocol Violation|1|||
164378069|NCT01923181|593756270|FG000|Overall Study|Withdrawal by Subject|0|||
164378070|NCT01923181|593756271|FG001|Overall Study|Withdrawal by Subject|1|||
164378071|NCT01923181|593756272|FG002|Overall Study|Withdrawal by Subject|0|||
164378072|NCT01923181|593756273|FG003|Overall Study|Withdrawal by Subject|1|||
164378073|NCT01923181|593756274|FG004|Overall Study|Withdrawal by Subject|4|||
164378074|NCT01923181|593756275|FG005|Overall Study|Withdrawal by Subject|2|||
164378075|NCT01923181|593756276|FG006|Overall Study|Withdrawal by Subject|4|||
164378076|NCT01923181|593756277|FG007|Overall Study|Withdrawal by Subject|3|||
164378077|NCT01923181|593756278|FG008|Overall Study|Withdrawal by Subject|1|||
164378078|NCT01923181|593756270|FG000|Overall Study|Other|1|||
164378079|NCT01923181|593756271|FG001|Overall Study|Other|0|||
164378080|NCT01923181|593756272|FG002|Overall Study|Other|0|||
164378081|NCT01923181|593756273|FG003|Overall Study|Other|1|||
164378082|NCT01923181|593756274|FG004|Overall Study|Other|0|||
164378083|NCT01923181|593756275|FG005|Overall Study|Other|0|||
164378084|NCT01923181|593756276|FG006|Overall Study|Other|0|||
164378085|NCT01923181|593756277|FG007|Overall Study|Other|0|||
164378086|NCT01923181|593756278|FG008|Overall Study|Other|0|||
164378087|NCT01923181|593756270|FG000|Overall Study|Lost to Follow-up|0|||
164378088|NCT01923181|593756271|FG001|Overall Study|Lost to Follow-up|3|||
164378089|NCT01923181|593756272|FG002|Overall Study|Lost to Follow-up|2|||
164378090|NCT01923181|593756273|FG003|Overall Study|Lost to Follow-up|1|||
164378091|NCT01923181|593756274|FG004|Overall Study|Lost to Follow-up|2|||
164378092|NCT01923181|593756275|FG005|Overall Study|Lost to Follow-up|1|||
164378093|NCT01923181|593756276|FG006|Overall Study|Lost to Follow-up|3|||
164378094|NCT01923181|593756277|FG007|Overall Study|Lost to Follow-up|3|||
164378095|NCT01923181|593756278|FG008|Overall Study|Lost to Follow-up|1|||
164378096|NCT02932891|593756281|FG000|Overall Study|Lost to Follow-up|2|||
164378097|NCT02932891|593756281|FG000|Overall Study|HPA Suppress|2|||
164378098|NCT04622254|593756282|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
164378099|NCT04622254|593756283|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
164378100|NCT04622254|593756284|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
164378101|NCT04622254|593756285|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
164378102|NCT04622254|593756286|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
164378103|NCT04622254|593756287|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
164378104|NCT04622254|593756282|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
164378105|NCT04622254|593756283|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
164378106|NCT04622254|593756284|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
164378107|NCT04622254|593756285|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
164378108|NCT04622254|593756286|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
164378109|NCT04622254|593756287|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
164378110|NCT04622254|593756282|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
164378111|NCT04622254|593756283|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
164378112|NCT04622254|593756284|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
164378113|NCT04622254|593756285|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
164378114|NCT04622254|593756286|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
164378115|NCT04622254|593756287|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
164378116|NCT04622254|593756282|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
164378117|NCT04622254|593756283|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
164378118|NCT04622254|593756284|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
164378119|NCT04622254|593756285|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
164378120|NCT04622254|593756286|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
164378121|NCT04622254|593756287|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
164378122|NCT04622254|593756282|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
164378123|NCT04622254|593756283|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
164378124|NCT04622254|593756284|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
164378125|NCT04622254|593756285|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
164378126|NCT04622254|593756286|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
164378127|NCT04622254|593756287|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
164378128|NCT04622254|593756282|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
164378129|NCT04622254|593756283|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
164378130|NCT04622254|593756284|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
164378131|NCT04622254|593756285|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
164378132|NCT04622254|593756286|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
164378133|NCT04622254|593756287|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
164378134|NCT04622254|593756282|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
164378135|NCT04622254|593756283|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
164378136|NCT04622254|593756284|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
164378137|NCT04622254|593756285|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
164378138|NCT04622254|593756286|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
164378139|NCT04622254|593756287|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
164378140|NCT04622254|593756282|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
164378141|NCT04622254|593756283|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
164378142|NCT04622254|593756284|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
164378143|NCT04622254|593756285|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
164378144|NCT04622254|593756286|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
164378145|NCT04622254|593756287|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
164378146|NCT04622254|593756282|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
164378147|NCT04622254|593756283|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
164378148|NCT04622254|593756284|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
164378149|NCT04622254|593756285|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
164378150|NCT04622254|593756286|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
164378151|NCT04622254|593756287|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
164378152|NCT04622254|593756282|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
164378153|NCT04622254|593756283|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
164378154|NCT04622254|593756284|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
164378155|NCT04622254|593756285|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
164378156|NCT04622254|593756286|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
164378157|NCT04622254|593756287|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
164378158|NCT04622254|593756282|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
164378159|NCT04622254|593756283|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
164378160|NCT04622254|593756284|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
164378161|NCT04622254|593756285|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
164378162|NCT04622254|593756286|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
164378163|NCT04622254|593756287|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
164378164|NCT02652624|593756288|FG000|Randomized Phase|Pregnancy|3|||
164378165|NCT02652624|593756289|FG001|Randomized Phase|Pregnancy|1|||
164378166|NCT02652624|593756288|FG000|Randomized Phase|Investigator's Discretion|0|||
164378167|NCT02652624|593756289|FG001|Randomized Phase|Investigator's Discretion|2|||
164378168|NCT02652624|593756288|FG000|Randomized Phase|Death|0|||
164378169|NCT02652624|593756289|FG001|Randomized Phase|Death|1|||
164378170|NCT02652624|593756288|FG000|Randomized Phase|Lost to Follow-up|0|||
164378171|NCT02652624|593756289|FG001|Randomized Phase|Lost to Follow-up|1|||
164378172|NCT02652624|593756288|FG000|Extension Phase|Lost to Follow-up|3|||
164378173|NCT02652624|593756289|FG001|Extension Phase|Lost to Follow-up|1|||
164378174|NCT02652624|593756288|FG000|Extension Phase|Pregnancy|1|||
164378175|NCT02652624|593756289|FG001|Extension Phase|Pregnancy|1|||
164378176|NCT02652624|593756288|FG000|Extension Phase|Adverse Event|0|||
164378177|NCT02652624|593756289|FG001|Extension Phase|Adverse Event|1|||
164378178|NCT02652624|593756288|FG000|Extension Phase|Withdrew Consent|0|||
164378179|NCT02652624|593756289|FG001|Extension Phase|Withdrew Consent|1|||
164378180|NCT00654628|593756290|FG000|6-week Active Treatment Period|Adverse Event|9|||
164378181|NCT00654628|593756290|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
164378182|NCT00654628|593756290|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
164378183|NCT00654628|593756290|FG000|6-week Active Treatment Period|Out of window period|1|||
164378184|NCT00654628|593756290|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
164378185|NCT00654628|593756290|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
164378186|NCT00912405|593756293|FG000|Overall Study|Lost to Follow-up|5|||
164378187|NCT00953329|593756294|FG000|Overall Study|Lack of Efficacy|1|||
164378188|NCT01434823|593756297|FG000|Overall Study|Incomplete data in medical record|4|||
164378189|NCT01434823|593756298|FG001|Overall Study|Incomplete data in medical record|7|||
164378190|NCT03228680|593756304|FG000|Overall Study|Adverse Event|13|||
164378191|NCT03228680|593756305|FG001|Overall Study|Adverse Event|18|||
164378192|NCT03228680|593756304|FG000|Overall Study|Randomization failure|0|||
164378193|NCT03228680|593756305|FG001|Overall Study|Randomization failure|1|||
164378194|NCT03228680|593756304|FG000|Overall Study|Withdrawal by Subject|1|||
164378195|NCT03228680|593756305|FG001|Overall Study|Withdrawal by Subject|0|||
164378196|NCT03228680|593756304|FG000|Overall Study|Other|9|||
164378197|NCT03228680|593756305|FG001|Overall Study|Other|16|||
164378198|NCT02167035|593756306|FG000|Overall Study|Adverse Event|2|||
164378199|NCT02167035|593756307|FG001|Overall Study|Adverse Event|2|||
164378200|NCT02167035|593756306|FG000|Overall Study|Lost to Follow-up|3|||
164378201|NCT02167035|593756307|FG001|Overall Study|Lost to Follow-up|3|||
164378202|NCT02167035|593756306|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
164378203|NCT02167035|593756307|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
164378204|NCT00796861|593756314|FG000|Overall Study|Withdrawal by Subject|2|||
164700690|NCT01564459|594926897|FG000|Run-In|Protocol Violation|1|||
164700691|NCT01564459|594926898|FG001|Run-In|Protocol Violation|0|||
164378205|NCT00796861|593756314|FG000|Overall Study|Death|2|||
164378206|NCT02252081|593756315|FG000|Overall Study|Withdrawal by Subject|2|||
164378207|NCT02252081|593756316|FG001|Overall Study|Withdrawal by Subject|1|||
164700692|NCT01564459|594926899|FG002|Run-In|Protocol Violation|0|||
164700693|NCT01564459|594926897|FG000|Run-In|Withdrawal by Subject|1|||
164700694|NCT01564459|594926898|FG001|Run-In|Withdrawal by Subject|0|||
164700695|NCT01564459|594926899|FG002|Run-In|Withdrawal by Subject|0|||
164700696|NCT01564459|594926897|FG000|Double-blind Treatment|Adverse Event|0|||
164700697|NCT01564459|594926898|FG001|Double-blind Treatment|Adverse Event|0|||
164700698|NCT01564459|594926899|FG002|Double-blind Treatment|Adverse Event|1|||
164700699|NCT01491035|594926902|FG000|Overall Study|Lost to Follow-up|0|||
164700700|NCT01491035|594926903|FG001|Overall Study|Lost to Follow-up|0|||
164700701|NCT01491035|594926904|FG002|Overall Study|Lost to Follow-up|0|||
164700702|NCT01491035|594926905|FG003|Overall Study|Lost to Follow-up|0|||
164700703|NCT01491035|594926906|FG004|Overall Study|Lost to Follow-up|1|||
164700704|NCT01491035|594926907|FG005|Overall Study|Lost to Follow-up|0|||
164700705|NCT01491035|594926908|FG006|Overall Study|Lost to Follow-up|0|||
164700706|NCT01491035|594926909|FG007|Overall Study|Lost to Follow-up|0|||
164700707|NCT02687360|594926916|FG000|Overall Study|Withdrawal by Subject|3|||
164700708|NCT02687360|594926917|FG001|Overall Study|Withdrawal by Subject|0|||
164700709|NCT00653991|594926919|FG000|3 Month Follow-up|Participant would not respond|150|||
164700710|NCT00653991|594926920|FG001|3 Month Follow-up|Participant would not respond|157|||
164700711|NCT00653991|594926919|FG000|6 Month Follow-up|Participant would not respond|133|||
164700712|NCT00653991|594926920|FG001|6 Month Follow-up|Participant would not respond|141|||
164700713|NCT02181296|594926921|FG000|Overall Study|Lost to Follow-up|7|||
164700714|NCT02181296|594926922|FG001|Overall Study|Lost to Follow-up|6|||
164378208|NCT02252081|593756315|FG000|Overall Study|Adverse Event|4|||
164378209|NCT02252081|593756316|FG001|Overall Study|Adverse Event|1|||
164378210|NCT02252081|593756315|FG000|Overall Study|non compliance & others|0|||
164378211|NCT02252081|593756316|FG001|Overall Study|non compliance & others|2|||
164378212|NCT00403455|593756320|FG000|Overall Study|Withdrawal by Subject|1|||
164378213|NCT03732638|593756327|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
164378214|NCT03732638|593756328|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
164378215|NCT03732638|593756327|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
164378216|NCT03732638|593756328|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
164378217|NCT03732638|593756327|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
164592015|NCT00576693|594530050|FG001|Overall Study|Withdrawal by Subject|13|||
164592016|NCT01413178|594530051|FG000|Overall Study|Toxicity|1|||
164592017|NCT01413178|594530052|FG001|Overall Study|Toxicity|0|||
164592018|NCT01413178|594530051|FG000|Overall Study|Ineligible|0|||
164592019|NCT01413178|594530052|FG001|Overall Study|Ineligible|2|||
164378218|NCT03732638|593756328|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
164378219|NCT03732638|593756327|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
164378220|NCT03732638|593756328|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
164378221|NCT03732638|593756327|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
164378222|NCT03732638|593756328|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
164378223|NCT03732638|593756327|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
164378224|NCT03732638|593756328|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
164378225|NCT03732638|593756327|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
164378226|NCT03732638|593756328|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
164378227|NCT03732638|593756327|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
164592020|NCT00540449|594530053|FG000|Overall Study|Adverse Event|12|||
164592021|NCT00540449|594530054|FG001|Overall Study|Adverse Event|32|||
164378228|NCT03732638|593756328|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
164378229|NCT03732638|593756327|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
164592022|NCT00540449|594530053|FG000|Overall Study|Sponsor's Decision|1|||
164592023|NCT00540449|594530054|FG001|Overall Study|Sponsor's Decision|1|||
164592024|NCT00540449|594530053|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
164592025|NCT00540449|594530054|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
164592026|NCT00540449|594530053|FG000|Overall Study|Lost to Follow-up|19|||
164592027|NCT00540449|594530054|FG001|Overall Study|Lost to Follow-up|17|||
164592028|NCT00540449|594530053|FG000|Overall Study|Subject Non-Compliant|7|||
164592029|NCT00540449|594530054|FG001|Overall Study|Subject Non-Compliant|5|||
164592030|NCT00540449|594530053|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
164592031|NCT00540449|594530054|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
164592032|NCT00540449|594530053|FG000|Overall Study|Withdrawal by Subject|10|||
164592033|NCT00540449|594530054|FG001|Overall Study|Withdrawal by Subject|10|||
164592034|NCT00540449|594530053|FG000|Overall Study|Other|1|||
164592035|NCT00540449|594530054|FG001|Overall Study|Other|4|||
164592036|NCT03643432|594530055|FG000|Overall Study|Lost to Follow-up|1|||
164592037|NCT03643432|594530056|FG001|Overall Study|Lost to Follow-up|0|||
164592038|NCT00337467|594530057|FG000|Overall Study|Adverse Event|3|||
164592039|NCT00337467|594530057|FG000|Overall Study|Subject Withdrew Consent|2|||
164700715|NCT01568866|594926923|FG000|Overall Study|Disease Progression|208|||
164700716|NCT01568866|594926924|FG001|Overall Study|Disease Progression|183|||
164700717|NCT01568866|594926923|FG000|Overall Study|Adverse Event|94|||
164700718|NCT01568866|594926924|FG001|Overall Study|Adverse Event|96|||
164700719|NCT01568866|594926923|FG000|Overall Study|Patient Request|55|||
164700720|NCT01568866|594926924|FG001|Overall Study|Patient Request|71|||
164700721|NCT01568866|594926923|FG000|Overall Study|Physician Decision|40|||
164700722|NCT01568866|594926924|FG001|Overall Study|Physician Decision|32|||
164700723|NCT01568866|594926923|FG000|Overall Study|Withdrawal by Subject|19|||
164700724|NCT01568866|594926924|FG001|Overall Study|Withdrawal by Subject|11|||
164700725|NCT01568866|594926923|FG000|Overall Study|Death|10|||
164700726|NCT01568866|594926924|FG001|Overall Study|Death|18|||
164700727|NCT01568866|594926923|FG000|Overall Study|Protocol Non-compliance|2|||
164378230|NCT03732638|593756328|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
164378231|NCT03732638|593756327|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
164378232|NCT03732638|593756328|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
164378233|NCT03732638|593756327|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
164378234|NCT03732638|593756328|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
164378235|NCT03732638|593756327|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
164378236|NCT03732638|593756328|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
164378237|NCT03732638|593756327|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
164378238|NCT03732638|593756328|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
164378239|NCT03732638|593756327|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
164378240|NCT03732638|593756328|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
164378241|NCT03732638|593756327|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
164378242|NCT03732638|593756328|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
164378243|NCT03732638|593756327|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
164378244|NCT03732638|593756328|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
164378245|NCT03732638|593756327|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
164378246|NCT03732638|593756328|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
164378247|NCT03732638|593756327|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
164378248|NCT03732638|593756328|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
164378249|NCT03732638|593756327|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
164378250|NCT03732638|593756328|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
164378251|NCT03732638|593756327|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
164378252|NCT03732638|593756328|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
164378253|NCT03732638|593756327|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
164378254|NCT03732638|593756328|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
164378255|NCT03732638|593756327|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
164378256|NCT03732638|593756328|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
164378257|NCT03732638|593756327|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
164378258|NCT03732638|593756328|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
164378259|NCT03732638|593756327|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
164378260|NCT03732638|593756328|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
164378261|NCT02992899|593756329|FG000|Overall Study|Withdrawal by Subject|1|||
164378262|NCT02992899|593756330|FG001|Overall Study|Withdrawal by Subject|0|||
164378263|NCT02992899|593756329|FG000|Overall Study|Lost to Follow-up|1|||
164700728|NCT01568866|594926924|FG001|Overall Study|Protocol Non-compliance|4|||
164700729|NCT01568866|594926923|FG000|Overall Study|Lost to Follow-up|1|||
164700730|NCT01568866|594926924|FG001|Overall Study|Lost to Follow-up|0|||
164700731|NCT01568866|594926923|FG000|Overall Study|Randomized but Not Dosed|9|||
164378264|NCT02992899|593756330|FG001|Overall Study|Lost to Follow-up|3|||
164378265|NCT02738775|593756331|FG000|Overall Study|Withdrawal by Subject|0|||
164378266|NCT02738775|593756332|FG001|Overall Study|Withdrawal by Subject|1|||
164378267|NCT02738775|593756333|FG002|Overall Study|Withdrawal by Subject|0|||
164378268|NCT02738775|593756334|FG003|Overall Study|Withdrawal by Subject|0|||
164378269|NCT02738775|593756335|FG004|Overall Study|Withdrawal by Subject|0|||
164378270|NCT02738775|593756336|FG005|Overall Study|Withdrawal by Subject|0|||
164378271|NCT02738775|593756331|FG000|Overall Study|Adverse Event|0|||
164378272|NCT02738775|593756332|FG001|Overall Study|Adverse Event|0|||
164378273|NCT02738775|593756333|FG002|Overall Study|Adverse Event|0|||
164378274|NCT02738775|593756334|FG003|Overall Study|Adverse Event|1|||
164378275|NCT02738775|593756335|FG004|Overall Study|Adverse Event|0|||
164378276|NCT02738775|593756336|FG005|Overall Study|Adverse Event|0|||
164378277|NCT02738775|593756331|FG000|Overall Study|Pregnancy|0|||
164378278|NCT02738775|593756332|FG001|Overall Study|Pregnancy|1|||
164378279|NCT02738775|593756333|FG002|Overall Study|Pregnancy|0|||
164378280|NCT02738775|593756334|FG003|Overall Study|Pregnancy|0|||
164378281|NCT02738775|593756335|FG004|Overall Study|Pregnancy|0|||
164378282|NCT02738775|593756336|FG005|Overall Study|Pregnancy|0|||
164700732|NCT01568866|594926924|FG001|Overall Study|Randomized but Not Dosed|1|||
164700733|NCT03864042|594926925|FG000|DDI Phase|Adverse Event|2|||
164700734|NCT03864042|594926926|FG001|DDI Phase|Adverse Event|0|||
164700735|NCT03864042|594926927|FG002|DDI Phase|Adverse Event|0|||
164700736|NCT03864042|594926925|FG000|DDI Phase|Physician Decision|1|||
164378283|NCT02738775|593756331|FG000|Overall Study|Missing|0|||
164378284|NCT02738775|593756332|FG001|Overall Study|Missing|0|||
164378285|NCT02738775|593756333|FG002|Overall Study|Missing|0|||
164378286|NCT02738775|593756334|FG003|Overall Study|Missing|0|||
164378287|NCT02738775|593756335|FG004|Overall Study|Missing|0|||
164378288|NCT02738775|593756336|FG005|Overall Study|Missing|1|||
164378289|NCT02370888|593756337|FG000|Overall Study|disease progression|2|||
164378290|NCT02370888|593756337|FG000|Overall Study|did not meet chimerism criteria|6|||
164378291|NCT04574362|593756338|FG000|Overall Study|Other|0|||
164378292|NCT04574362|593756339|FG001|Overall Study|Other|5|||
164378293|NCT04574362|593756338|FG000|Overall Study|COVID-19|0|||
164378294|NCT04574362|593756339|FG001|Overall Study|COVID-19|1|||
164378295|NCT04574362|593756338|FG000|Overall Study|Adverse Event|1|||
164378296|NCT04574362|593756339|FG001|Overall Study|Adverse Event|1|||
164378297|NCT04574362|593756338|FG000|Overall Study|Withdrawal by Subject|2|||
164378298|NCT04574362|593756339|FG001|Overall Study|Withdrawal by Subject|4|||
164378299|NCT04574362|593756338|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
164378300|NCT04574362|593756339|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
164378301|NCT04574362|593756338|FG000|Overall Study|Participant refused to come to the hospital|1|||
164378302|NCT04574362|593756339|FG001|Overall Study|Participant refused to come to the hospital|0|||
164378303|NCT04574362|593756338|FG000|Overall Study|Participant refused the visit|1|||
164378304|NCT04574362|593756339|FG001|Overall Study|Participant refused the visit|0|||
164378305|NCT04574362|593756338|FG000|Overall Study|Participant quit early because of business trip|1|||
164378306|NCT04574362|593756339|FG001|Overall Study|Participant quit early because of business trip|0|||
164378307|NCT01785524|593756340|FG000|Overall Study|Withdrawal by Subject|2|||
164378308|NCT01785524|593756341|FG001|Overall Study|Withdrawal by Subject|2|||
164378309|NCT01060384|593756342|FG000|Overall Study|Withdrawal by Subject|0|||
164378310|NCT01060384|593756343|FG001|Overall Study|Withdrawal by Subject|1|||
164378311|NCT01060384|593756344|FG002|Overall Study|Withdrawal by Subject|0|||
164378312|NCT01060384|593756345|FG003|Overall Study|Withdrawal by Subject|0|||
164378313|NCT01060384|593756346|FG004|Overall Study|Withdrawal by Subject|0|||
164378314|NCT01060384|593756342|FG000|Overall Study|Death|0|||
164378315|NCT01060384|593756343|FG001|Overall Study|Death|0|||
164378316|NCT01060384|593756344|FG002|Overall Study|Death|0|||
164378317|NCT01060384|593756345|FG003|Overall Study|Death|0|||
164378318|NCT01060384|593756346|FG004|Overall Study|Death|1|||
164378319|NCT01060384|593756342|FG000|Overall Study|Intercurrent illness|0|||
164378320|NCT01060384|593756343|FG001|Overall Study|Intercurrent illness|0|||
164378321|NCT01060384|593756344|FG002|Overall Study|Intercurrent illness|0|||
164378322|NCT01060384|593756345|FG003|Overall Study|Intercurrent illness|0|||
164378323|NCT01060384|593756346|FG004|Overall Study|Intercurrent illness|1|||
164378324|NCT00642304|593756347|FG000|Overall Study|Adverse Event|1|||
164378325|NCT00642304|593756347|FG000|Overall Study|Death|1|||
164378326|NCT00642304|593756347|FG000|Overall Study|Blood transfusion|2|||
164378327|NCT00642304|593756347|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
164378328|NCT00642304|593756347|FG000|Overall Study|Transplantation|1|||
164378329|NCT03192150|593756354|FG000|Overall Study|Adverse Event|14|||
164378330|NCT03192150|593756355|FG001|Overall Study|Adverse Event|12|||
164378331|NCT03192150|593756354|FG000|Overall Study|Lack of Efficacy|23|||
164378332|NCT03192150|593756355|FG001|Overall Study|Lack of Efficacy|30|||
164378333|NCT03192150|593756354|FG000|Overall Study|Lost to Follow-up|1|||
164378334|NCT03192150|593756355|FG001|Overall Study|Lost to Follow-up|1|||
164378335|NCT03192150|593756354|FG000|Overall Study|Withdrawal by Subject|4|||
164378336|NCT03192150|593756355|FG001|Overall Study|Withdrawal by Subject|2|||
164378337|NCT03192150|593756354|FG000|Overall Study|Protocol Violation|5|||
164378338|NCT03192150|593756355|FG001|Overall Study|Protocol Violation|2|||
164378339|NCT03192150|593756354|FG000|Overall Study|Surgery Canceled|6|||
164378340|NCT03192150|593756355|FG001|Overall Study|Surgery Canceled|2|||
164592040|NCT00337467|594530057|FG000|Overall Study|Pregnancy|1|||
164592041|NCT00337467|594530057|FG000|Overall Study|Lost to Follow-up|2|||
164592042|NCT00337467|594530057|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
164592043|NCT01187901|594530060|FG000|Overall Study|Protocol Violation|1|||
164592044|NCT01187901|594530061|FG001|Overall Study|Protocol Violation|0|||
164592045|NCT01187901|594530060|FG000|Overall Study|Lost to Follow-up|1|||
164592046|NCT01187901|594530061|FG001|Overall Study|Lost to Follow-up|2|||
164592047|NCT01187901|594530060|FG000|Overall Study|Unrelated Health Reasons|1|||
164592048|NCT01187901|594530061|FG001|Overall Study|Unrelated Health Reasons|2|||
164592049|NCT01187901|594530060|FG000|Overall Study|Suspected Allergic Reaction|1|||
164592050|NCT01187901|594530061|FG001|Overall Study|Suspected Allergic Reaction|1|||
164592051|NCT01187901|594530060|FG000|Overall Study|Adverse Event|3|||
164592052|NCT01187901|594530061|FG001|Overall Study|Adverse Event|0|||
164378341|NCT03192150|593756354|FG000|Overall Study|Other-Various Administrative Reasons|2|||
164378342|NCT03192150|593756355|FG001|Overall Study|Other-Various Administrative Reasons|5|||
164378343|NCT00482391|593756356|FG000|Overall Study|Withdrawal by Subject|1|||
164378344|NCT00482391|593756356|FG000|Overall Study|Adverse Event|1|||
164378345|NCT00482391|593756356|FG000|Overall Study|Death|1|||
164378346|NCT02606136|593756362|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
164592053|NCT01187901|594530060|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
164592054|NCT01187901|594530061|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
164592055|NCT01187901|594530060|FG000|Overall Study|Pregnancy|0|||
164592056|NCT01187901|594530061|FG001|Overall Study|Pregnancy|2|||
164592057|NCT01770353|594530064|FG000|Overall Study|Progressive disease|2|||
164592058|NCT01770353|594530065|FG001|Overall Study|Progressive disease|1|||
164592059|NCT01770353|594530064|FG000|Overall Study|Adverse Event|0|||
164592060|NCT01770353|594530065|FG001|Overall Study|Adverse Event|1|||
164378347|NCT02606136|593756362|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
164378348|NCT02606136|593756362|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
164378349|NCT02606136|593756362|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
164378350|NCT04694131|593756365|FG000|Overall Study|Withdrawal by Subject|7|||
164378351|NCT04694131|593756365|FG000|Overall Study|Screen Failure|1|||
164378352|NCT04694131|593756365|FG000|Overall Study|High stimulation threshold|3|||
164378353|NCT02399085|593756366|FG000|Overall Study|Adverse Event|16|||
164378354|NCT02399085|593756366|FG000|Overall Study|Death|2|||
164378355|NCT02399085|593756366|FG000|Overall Study|Withdrawal by Subject|8|||
164378356|NCT02399085|593756366|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
164378357|NCT02399085|593756366|FG000|Overall Study|Physician Decision|5|||
164378358|NCT02410811|593756370|FG000|Overall Study|Withdrawal by Subject|0|||
164378359|NCT02410811|593756371|FG001|Overall Study|Withdrawal by Subject|0|||
164378360|NCT02410811|593756372|FG002|Overall Study|Withdrawal by Subject|1|||
164378361|NCT02410811|593756373|FG003|Overall Study|Withdrawal by Subject|0|||
164378362|NCT00353366|593756374|FG000|Overall Study|Adverse Event|8|||
164378363|NCT00353366|593756374|FG000|Overall Study|Protocol Violation|12|||
164378364|NCT00353366|593756374|FG000|Overall Study|Withdrawal by Subject|12|||
164378365|NCT00353366|593756374|FG000|Overall Study|Lost to Follow-up|92|||
164378366|NCT00353366|593756374|FG000|Overall Study|Other|19|||
164378367|NCT00259857|593756375|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
164378368|NCT00259857|593756376|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
164378369|NCT00259857|593756375|FG000|24 Months Treatment|Lost to Follow-up|0|||
164378370|NCT00259857|593756376|FG001|24 Months Treatment|Lost to Follow-up|3|||
164378371|NCT05267054|593756377|FG000|Overall Study|Death|13|||
164378372|NCT05267054|593756378|FG001|Overall Study|Death|14|||
164378373|NCT05267054|593756377|FG000|Overall Study|Study Ended by Sponsor|9|||
164378374|NCT05267054|593756378|FG001|Overall Study|Study Ended by Sponsor|13|||
164378375|NCT05267054|593756377|FG000|Overall Study|Lost to Follow-up|1|||
164378376|NCT05267054|593756378|FG001|Overall Study|Lost to Follow-up|1|||
164378377|NCT05267054|593756377|FG000|Overall Study|Withdrawal by Subject|1|||
164378378|NCT05267054|593756378|FG001|Overall Study|Withdrawal by Subject|1|||
164378379|NCT01552226|593756381|FG000|Overall Study|Withdrawal by Subject|4|||
164378380|NCT01552226|593756382|FG001|Overall Study|Withdrawal by Subject|4|||
164378381|NCT01469065|593756386|FG000|Overall Study|Lack of Efficacy|0|||
164378382|NCT01469065|593756387|FG001|Overall Study|Lack of Efficacy|0|||
164378383|NCT01469065|593756388|FG002|Overall Study|Lack of Efficacy|0|||
164378384|NCT01469065|593756389|FG003|Overall Study|Lack of Efficacy|0|||
164378385|NCT01469065|593756390|FG004|Overall Study|Lack of Efficacy|1|||
164378386|NCT01469065|593756386|FG000|Overall Study|Other|0|||
164378387|NCT01469065|593756387|FG001|Overall Study|Other|1|||
164378388|NCT01469065|593756388|FG002|Overall Study|Other|0|||
164378389|NCT01469065|593756389|FG003|Overall Study|Other|0|||
164378390|NCT01469065|593756390|FG004|Overall Study|Other|0|||
164378391|NCT04542070|593756391|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
164378392|NCT04542070|593756392|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
164378393|NCT04542070|593756393|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
164378394|NCT04542070|593756394|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
164378395|NCT04542070|593756391|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
164378396|NCT04542070|593756392|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
164378397|NCT04542070|593756393|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
164378398|NCT04542070|593756394|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
164378399|NCT04542070|593756391|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
164592061|NCT01770353|594530064|FG000|Overall Study|Protocol Violation|1|||
164592062|NCT01770353|594530065|FG001|Overall Study|Protocol Violation|0|||
164592063|NCT01770353|594530064|FG000|Overall Study|Physician Decision|0|||
164592064|NCT01770353|594530065|FG001|Overall Study|Physician Decision|3|||
164700737|NCT03864042|594926926|FG001|DDI Phase|Physician Decision|0|||
164700738|NCT03864042|594926927|FG002|DDI Phase|Physician Decision|0|||
164592065|NCT01770353|594530064|FG000|Overall Study|Clinical deterioration|3|||
164378400|NCT04542070|593756392|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
164378401|NCT04542070|593756393|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
164378402|NCT04542070|593756394|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
164378403|NCT04542070|593756391|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
164378404|NCT04542070|593756392|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
164592066|NCT01770353|594530065|FG001|Overall Study|Clinical deterioration|6|||
164439363|NCT00530842|593975378|FG000|Overall Study|Lack of Efficacy|2|||
164378405|NCT04542070|593756393|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
164378406|NCT04542070|593756394|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
164378407|NCT04542070|593756391|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
164378408|NCT04542070|593756392|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
164378409|NCT04542070|593756393|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
164378410|NCT04542070|593756394|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
164378411|NCT04542070|593756391|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
164378412|NCT04542070|593756392|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
164378413|NCT04542070|593756393|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
164378414|NCT04542070|593756394|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
164378415|NCT04542070|593756391|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
164378416|NCT04542070|593756392|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
164378417|NCT04542070|593756393|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
164378418|NCT04542070|593756394|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
164378419|NCT04542070|593756391|FG000|Maintenance + Extension Period|Adverse Event|10|||
164378420|NCT04542070|593756392|FG001|Maintenance + Extension Period|Adverse Event|2|||
164378421|NCT04542070|593756393|FG002|Maintenance + Extension Period|Adverse Event|0|||
164378422|NCT04542070|593756394|FG003|Maintenance + Extension Period|Adverse Event|0|||
164378423|NCT04542070|593756391|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
164378424|NCT04542070|593756392|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
164378425|NCT04542070|593756393|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
164378426|NCT04542070|593756394|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
164378427|NCT04542070|593756391|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
164378428|NCT04542070|593756392|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
164378429|NCT04542070|593756393|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
164378430|NCT04542070|593756394|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
164378431|NCT04542070|593756391|FG000|Maintenance + Extension Period|Physician Decision|1|||
164378432|NCT04542070|593756392|FG001|Maintenance + Extension Period|Physician Decision|1|||
164378433|NCT04542070|593756393|FG002|Maintenance + Extension Period|Physician Decision|0|||
164378434|NCT04542070|593756394|FG003|Maintenance + Extension Period|Physician Decision|0|||
164378435|NCT04542070|593756391|FG000|Maintenance + Extension Period|Protocol Violation|2|||
164378436|NCT04542070|593756392|FG001|Maintenance + Extension Period|Protocol Violation|5|||
164378437|NCT04542070|593756393|FG002|Maintenance + Extension Period|Protocol Violation|0|||
164378438|NCT04542070|593756394|FG003|Maintenance + Extension Period|Protocol Violation|0|||
164378439|NCT04542070|593756391|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
164378440|NCT04542070|593756392|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
164378441|NCT04542070|593756393|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
164378442|NCT04542070|593756394|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
164378443|NCT04542070|593756391|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
164378444|NCT04542070|593756392|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
164378445|NCT04542070|593756393|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
164378446|NCT04542070|593756394|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
164378447|NCT04542070|593756391|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
164378448|NCT04542070|593756392|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
164378449|NCT04542070|593756393|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
164378450|NCT04542070|593756394|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
164378451|NCT04542070|593756391|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
164378452|NCT04542070|593756392|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
164378453|NCT04542070|593756393|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
164378454|NCT04542070|593756394|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
164378455|NCT04542070|593756391|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
164378456|NCT04542070|593756392|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
164378457|NCT04542070|593756393|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
164378458|NCT04542070|593756394|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
164378459|NCT04542070|593756391|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
164378460|NCT04542070|593756392|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
164378461|NCT04542070|593756393|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
164378462|NCT04542070|593756394|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
164378463|NCT04542070|593756391|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
164378464|NCT04542070|593756392|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
164378465|NCT04542070|593756393|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
164378466|NCT04542070|593756394|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
164378467|NCT03511560|593756397|FG000|Overall Study|Death|0|||
164378468|NCT03511560|593756398|FG001|Overall Study|Death|1|||
164378469|NCT03511560|593756397|FG000|Overall Study|Adverse Event|0|||
164378470|NCT03511560|593756398|FG001|Overall Study|Adverse Event|2|||
164700739|NCT03864042|594926925|FG000|DDI Phase|Progressive Disease|1|||
164378471|NCT03511560|593756397|FG000|Overall Study|Transplant cancelled|0|||
164378472|NCT03511560|593756398|FG001|Overall Study|Transplant cancelled|1|||
164378473|NCT03511560|593756397|FG000|Overall Study|Patient switched to another drug|1|||
164378474|NCT03511560|593756398|FG001|Overall Study|Patient switched to another drug|0|||
164378475|NCT02383758|593758499|FG000|Overall Study|Withdrawal by Subject|0|||
164378476|NCT02383758|593758500|FG001|Overall Study|Withdrawal by Subject|2|||
164378477|NCT00600821|593758502|FG000|Overall Study|Death|45|||
164378478|NCT00600821|593758503|FG001|Overall Study|Death|46|||
164378479|NCT00600821|593758502|FG000|Overall Study|Lost to Follow-up|2|||
164378480|NCT00600821|593758503|FG001|Overall Study|Lost to Follow-up|2|||
164700740|NCT03864042|594926926|FG001|DDI Phase|Progressive Disease|0|||
164700741|NCT03864042|594926927|FG002|DDI Phase|Progressive Disease|0|||
164700742|NCT03864042|594926925|FG000|Post-DDI Phase|Adverse Event|5|||
164700743|NCT03864042|594926926|FG001|Post-DDI Phase|Adverse Event|3|||
164378481|NCT00600821|593758502|FG000|Overall Study|Withdrawal by Subject|1|||
164700744|NCT03864042|594926927|FG002|Post-DDI Phase|Adverse Event|2|||
164700745|NCT03864042|594926925|FG000|Post-DDI Phase|Progressive Disease|11|||
164700746|NCT03864042|594926926|FG001|Post-DDI Phase|Progressive Disease|6|||
164700747|NCT03864042|594926927|FG002|Post-DDI Phase|Progressive Disease|13|||
164700748|NCT03864042|594926925|FG000|Post-DDI Phase|Discretion of investigator|1|||
164700749|NCT03864042|594926926|FG001|Post-DDI Phase|Discretion of investigator|1|||
164700750|NCT03864042|594926927|FG002|Post-DDI Phase|Discretion of investigator|0|||
164700751|NCT03864042|594926925|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
164700752|NCT03864042|594926926|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
164700753|NCT03864042|594926927|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
164700754|NCT03864042|594926925|FG000|Post-DDI Phase|Withdrawal of consent|1|||
164700755|NCT03864042|594926926|FG001|Post-DDI Phase|Withdrawal of consent|2|||
164700756|NCT03864042|594926927|FG002|Post-DDI Phase|Withdrawal of consent|0|||
164700757|NCT00515034|594926928|FG000|Overall Study|Adverse Event|2|||
164700758|NCT00515034|594926929|FG001|Overall Study|Adverse Event|0|||
164700759|NCT00515034|594926930|FG002|Overall Study|Adverse Event|1|||
164700760|NCT00515034|594926931|FG003|Overall Study|Adverse Event|0|||
164700761|NCT00515034|594926928|FG000|Overall Study|Death|4|||
164700762|NCT00515034|594926929|FG001|Overall Study|Death|2|||
164700763|NCT00515034|594926930|FG002|Overall Study|Death|1|||
164700764|NCT00515034|594926931|FG003|Overall Study|Death|3|||
164700765|NCT00515034|594926928|FG000|Overall Study|Withdrawal by Subject|1|||
164700766|NCT00515034|594926929|FG001|Overall Study|Withdrawal by Subject|0|||
164700767|NCT00515034|594926930|FG002|Overall Study|Withdrawal by Subject|3|||
164700768|NCT00515034|594926931|FG003|Overall Study|Withdrawal by Subject|0|||
164700769|NCT00515034|594926928|FG000|Overall Study|Physician Decision|0|||
164700770|NCT00515034|594926929|FG001|Overall Study|Physician Decision|0|||
164700771|NCT00515034|594926930|FG002|Overall Study|Physician Decision|1|||
164700772|NCT00515034|594926931|FG003|Overall Study|Physician Decision|1|||
164700773|NCT00515034|594926928|FG000|Overall Study|Other|1|||
164700774|NCT00515034|594926929|FG001|Overall Study|Other|0|||
164700775|NCT00515034|594926930|FG002|Overall Study|Other|2|||
164700776|NCT00515034|594926931|FG003|Overall Study|Other|1|||
164378482|NCT00600821|593758503|FG001|Overall Study|Withdrawal by Subject|1|||
164378483|NCT00600821|593758502|FG000|Overall Study|Terminated by sponsor|8|||
164378484|NCT00600821|593758503|FG001|Overall Study|Terminated by sponsor|6|||
164378485|NCT00600821|593758502|FG000|Overall Study|Objective progression or relapse|0|||
164378486|NCT00600821|593758503|FG001|Overall Study|Objective progression or relapse|1|||
164378487|NCT00600821|593758502|FG000|Overall Study|Randomized but not treated|0|||
164378488|NCT00600821|593758503|FG001|Overall Study|Randomized but not treated|1|||
164378489|NCT00600821|593758502|FG000|Overall Study|Other|2|||
164378490|NCT00600821|593758503|FG001|Overall Study|Other|3|||
164378491|NCT02602288|593758506|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
164378492|NCT02602288|593758507|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
164378493|NCT02602288|593758506|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
164378494|NCT02602288|593758507|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
164378495|NCT02602288|593758506|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
164700777|NCT03499119|594926932|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
164700778|NCT03499119|594926933|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
164700779|NCT03499119|594926934|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
164378496|NCT02602288|593758507|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
164378497|NCT02602288|593758506|FG000|12 Month Follow-up|Lost to Follow-up|0|||
164378498|NCT02602288|593758507|FG001|12 Month Follow-up|Lost to Follow-up|4|||
164378499|NCT02602288|593758506|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
164700780|NCT03499119|594926935|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
164700781|NCT03499119|594926932|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
164700782|NCT03499119|594926933|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
164700783|NCT03499119|594926934|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
164700784|NCT03499119|594926935|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
164700785|NCT03499119|594926932|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
164378500|NCT02602288|593758507|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
164378501|NCT01310413|593758508|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
164378502|NCT01310413|593758509|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
164378503|NCT01310413|593758510|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
164378504|NCT01310413|593758511|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
164378505|NCT01310413|593758512|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
164378506|NCT01310413|593758513|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
164378507|NCT01310413|593758514|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
164378508|NCT01310413|593758508|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
164378509|NCT01310413|593758509|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
164378510|NCT01310413|593758510|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
164378511|NCT01310413|593758511|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
164378512|NCT01310413|593758512|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
164378513|NCT01310413|593758513|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
164378514|NCT01310413|593758514|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
164378515|NCT01310413|593758508|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
164378516|NCT01310413|593758509|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
164378517|NCT01310413|593758510|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
164378518|NCT01310413|593758511|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
164378519|NCT01310413|593758512|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
164378520|NCT01310413|593758513|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
164378521|NCT01310413|593758514|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
164378522|NCT01310413|593758508|FG000|Day 0 to Day 385|Other|1|||
164378523|NCT01310413|593758509|FG001|Day 0 to Day 385|Other|0|||
164378524|NCT01310413|593758510|FG002|Day 0 to Day 385|Other|3|||
164378525|NCT01310413|593758511|FG003|Day 0 to Day 385|Other|0|||
164378526|NCT01310413|593758512|FG004|Day 0 to Day 385|Other|0|||
164378527|NCT01310413|593758513|FG005|Day 0 to Day 385|Other|0|||
164378528|NCT01310413|593758514|FG006|Day 0 to Day 385|Other|0|||
164378529|NCT01310413|593758508|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
164378530|NCT01310413|593758509|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
164378531|NCT01310413|593758510|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
164378532|NCT01310413|593758511|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
164378533|NCT01310413|593758512|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
164378534|NCT01310413|593758513|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
164378535|NCT01310413|593758514|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
164378536|NCT01310413|593758508|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
164378537|NCT01310413|593758509|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
164378538|NCT01310413|593758510|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
164378539|NCT01310413|593758511|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
164378540|NCT01310413|593758512|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
164378541|NCT01310413|593758513|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
164378542|NCT01310413|593758514|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
164378543|NCT01076400|593758516|FG000|Overall Study|Adverse Event|2|||
164378544|NCT01076400|593758517|FG001|Overall Study|Adverse Event|0|||
164378545|NCT01076400|593758518|FG002|Overall Study|Adverse Event|0|||
164378546|NCT01076400|593758516|FG000|Overall Study|Progressive Disease|5|||
164378547|NCT01076400|593758517|FG001|Overall Study|Progressive Disease|0|||
164378548|NCT01076400|593758518|FG002|Overall Study|Progressive Disease|0|||
164378549|NCT02066298|593758523|FG000|Overall Study|Lost to Follow-up|3|||
164378550|NCT02066298|593758524|FG001|Overall Study|Lost to Follow-up|2|||
164378551|NCT02066298|593758525|FG002|Overall Study|Lost to Follow-up|3|||
164378552|NCT02066298|593758526|FG003|Overall Study|Lost to Follow-up|2|||
164378553|NCT02066298|593758527|FG004|Overall Study|Lost to Follow-up|3|||
164378554|NCT02066298|593758528|FG005|Overall Study|Lost to Follow-up|4|||
164378555|NCT02066298|593758523|FG000|Overall Study|Withdrawal by Subject|6|||
164378556|NCT02066298|593758524|FG001|Overall Study|Withdrawal by Subject|6|||
164378557|NCT02066298|593758525|FG002|Overall Study|Withdrawal by Subject|6|||
164378558|NCT02066298|593758526|FG003|Overall Study|Withdrawal by Subject|4|||
164378559|NCT02066298|593758527|FG004|Overall Study|Withdrawal by Subject|5|||
164378560|NCT02066298|593758528|FG005|Overall Study|Withdrawal by Subject|8|||
164378561|NCT02066298|593758523|FG000|Overall Study|Physician Decision|0|||
164378562|NCT02066298|593758524|FG001|Overall Study|Physician Decision|0|||
164378563|NCT02066298|593758525|FG002|Overall Study|Physician Decision|1|||
164378564|NCT02066298|593758526|FG003|Overall Study|Physician Decision|0|||
164378565|NCT02066298|593758527|FG004|Overall Study|Physician Decision|1|||
164378566|NCT02066298|593758528|FG005|Overall Study|Physician Decision|0|||
164378567|NCT01643473|593758529|FG000|Overall Study|Lost to Follow-up|1|||
164378568|NCT01643473|593758530|FG001|Overall Study|Lost to Follow-up|0|||
164378569|NCT01519518|593758532|FG000|Overall Study|Consent not available|7|||
164378570|NCT01519518|593758533|FG001|Overall Study|Consent not available|10|||
164378571|NCT02033889|593758534|FG000|Overall Study|Adverse Event|3|||
164378572|NCT02033889|593758535|FG001|Overall Study|Adverse Event|1|||
164378573|NCT02033889|593758536|FG002|Overall Study|Adverse Event|3|||
164378574|NCT02033889|593758534|FG000|Overall Study|Death|3|||
164378575|NCT02033889|593758535|FG001|Overall Study|Death|1|||
164378576|NCT02033889|593758536|FG002|Overall Study|Death|2|||
164378577|NCT02033889|593758534|FG000|Overall Study|Excluded Medication|1|||
164378578|NCT02033889|593758535|FG001|Overall Study|Excluded Medication|1|||
164378579|NCT02033889|593758536|FG002|Overall Study|Excluded Medication|0|||
164378580|NCT02033889|593758534|FG000|Overall Study|Lost to Follow-up|8|||
164378581|NCT02033889|593758535|FG001|Overall Study|Lost to Follow-up|5|||
164378582|NCT02033889|593758536|FG002|Overall Study|Lost to Follow-up|6|||
164378583|NCT02033889|593758534|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164378584|NCT02033889|593758535|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164378585|NCT02033889|593758536|FG002|Overall Study|Non-Compliance With Study Drug|0|||
164378586|NCT02033889|593758534|FG000|Overall Study|Physician Decision|0|||
164378587|NCT02033889|593758535|FG001|Overall Study|Physician Decision|1|||
164378588|NCT02033889|593758536|FG002|Overall Study|Physician Decision|1|||
164378589|NCT02033889|593758534|FG000|Overall Study|Participant moved|0|||
164378590|NCT02033889|593758535|FG001|Overall Study|Participant moved|1|||
164378591|NCT02033889|593758536|FG002|Overall Study|Participant moved|0|||
164378592|NCT02033889|593758534|FG000|Overall Study|Withdrawal by Subject|18|||
164378593|NCT02033889|593758535|FG001|Overall Study|Withdrawal by Subject|10|||
164378594|NCT02033889|593758536|FG002|Overall Study|Withdrawal by Subject|13|||
164378595|NCT01265953|593758542|FG000|Overall Study|Non compliance|5|||
164378596|NCT01265953|593758543|FG001|Overall Study|Non compliance|3|||
164378597|NCT00182689|593758544|FG000|Overall Study|Adverse Event|8|||
164378598|NCT00182689|593758545|FG001|Overall Study|Adverse Event|11|||
164378599|NCT00182689|593758544|FG000|Overall Study|Withdrawal by Subject|2|||
164378600|NCT00182689|593758545|FG001|Overall Study|Withdrawal by Subject|2|||
164378601|NCT00182689|593758544|FG000|Overall Study|Progression|27|||
164378602|NCT00182689|593758545|FG001|Overall Study|Progression|29|||
164378603|NCT00182689|593758544|FG000|Overall Study|Death|1|||
164378604|NCT00182689|593758545|FG001|Overall Study|Death|0|||
164378605|NCT00182689|593758544|FG000|Overall Study|not protocol specified|0|||
164378606|NCT00182689|593758545|FG001|Overall Study|not protocol specified|3|||
164378607|NCT00182689|593758544|FG000|Overall Study|Ineligible|1|||
164378608|NCT00182689|593758545|FG001|Overall Study|Ineligible|4|||
164378609|NCT00182689|593758544|FG000|Overall Study|Never received treatment|1|||
164378610|NCT00182689|593758545|FG001|Overall Study|Never received treatment|0|||
164378611|NCT01640301|593758546|FG000|Overall Study|Death|0|||
164378612|NCT01640301|593758547|FG001|Overall Study|Death|8|||
164378613|NCT00659646|593758548|FG000|Overall Study|Protocol Violation|12|||
164378614|NCT00659646|593758549|FG001|Overall Study|Protocol Violation|8|||
164378615|NCT00659646|593758548|FG000|Overall Study|Adverse Event|1|||
164378616|NCT00659646|593758549|FG001|Overall Study|Adverse Event|0|||
164378617|NCT00659646|593758548|FG000|Overall Study|Lost to Follow-up|1|||
164378618|NCT00659646|593758549|FG001|Overall Study|Lost to Follow-up|0|||
164378619|NCT00659646|593758548|FG000|Overall Study|protocol noncompliance after randomized|1|||
164378620|NCT00659646|593758549|FG001|Overall Study|protocol noncompliance after randomized|0|||
164378621|NCT02391948|593758555|FG000|6-month Assessment|Death|0|||
164378622|NCT02391948|593758556|FG001|6-month Assessment|Death|0|||
164378623|NCT02391948|593758557|FG002|6-month Assessment|Death|0|||
164378624|NCT02391948|593758558|FG003|6-month Assessment|Death|0|||
164378625|NCT02391948|593758559|FG004|6-month Assessment|Death|1|||
164378626|NCT02391948|593758555|FG000|6-month Assessment|Withdrawal by Subject|0|||
164378627|NCT02391948|593758556|FG001|6-month Assessment|Withdrawal by Subject|0|||
164378628|NCT02391948|593758557|FG002|6-month Assessment|Withdrawal by Subject|1|||
164378629|NCT02391948|593758558|FG003|6-month Assessment|Withdrawal by Subject|2|||
164378630|NCT02391948|593758559|FG004|6-month Assessment|Withdrawal by Subject|0|||
164378631|NCT02391948|593758555|FG000|6-month Assessment|Lost to Follow-up|4|||
164378632|NCT02391948|593758556|FG001|6-month Assessment|Lost to Follow-up|5|||
164378633|NCT02391948|593758557|FG002|6-month Assessment|Lost to Follow-up|2|||
164378634|NCT02391948|593758558|FG003|6-month Assessment|Lost to Follow-up|3|||
164378635|NCT02391948|593758559|FG004|6-month Assessment|Lost to Follow-up|1|||
164378636|NCT02391948|593758555|FG000|6-month Assessment|Medical issue/illness|1|||
164378637|NCT02391948|593758556|FG001|6-month Assessment|Medical issue/illness|1|||
164378638|NCT02391948|593758557|FG002|6-month Assessment|Medical issue/illness|0|||
164378639|NCT02391948|593758558|FG003|6-month Assessment|Medical issue/illness|0|||
164378640|NCT02391948|593758559|FG004|6-month Assessment|Medical issue/illness|0|||
164378641|NCT02391948|593758555|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
164378642|NCT02391948|593758556|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
164378643|NCT02391948|593758557|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
164378644|NCT02391948|593758558|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
164378645|NCT02391948|593758559|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
164378646|NCT02391948|593758555|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
164378647|NCT02391948|593758556|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
164378648|NCT02391948|593758557|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
164592067|NCT01770353|594530064|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
164592068|NCT01770353|594530065|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
164592069|NCT00376688|594530066|FG000|Overall Study|Adverse Event|3|||
164592070|NCT00376688|594530066|FG000|Overall Study|Death|1|||
164378649|NCT02391948|593758558|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
164378650|NCT02391948|593758559|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
164378651|NCT02391948|593758555|FG000|12-month Assessment|Death|0|||
164378652|NCT02391948|593758556|FG001|12-month Assessment|Death|0|||
164378653|NCT02391948|593758557|FG002|12-month Assessment|Death|0|||
164378654|NCT02391948|593758558|FG003|12-month Assessment|Death|1|||
164378655|NCT02391948|593758559|FG004|12-month Assessment|Death|0|||
164378656|NCT02391948|593758555|FG000|12-month Assessment|Withdrawal by Subject|1|||
164378657|NCT02391948|593758556|FG001|12-month Assessment|Withdrawal by Subject|0|||
164378658|NCT02391948|593758557|FG002|12-month Assessment|Withdrawal by Subject|0|||
164378659|NCT02391948|593758558|FG003|12-month Assessment|Withdrawal by Subject|1|||
164378660|NCT02391948|593758559|FG004|12-month Assessment|Withdrawal by Subject|0|||
164378661|NCT02391948|593758555|FG000|12-month Assessment|Lost to Follow-up|5|||
164378662|NCT02391948|593758556|FG001|12-month Assessment|Lost to Follow-up|4|||
164378663|NCT02391948|593758557|FG002|12-month Assessment|Lost to Follow-up|4|||
164378664|NCT02391948|593758558|FG003|12-month Assessment|Lost to Follow-up|4|||
164378665|NCT02391948|593758559|FG004|12-month Assessment|Lost to Follow-up|5|||
164378666|NCT02391948|593758555|FG000|12-month Assessment|Medical issue/illness|0|||
164378667|NCT02391948|593758556|FG001|12-month Assessment|Medical issue/illness|1|||
164378668|NCT02391948|593758557|FG002|12-month Assessment|Medical issue/illness|0|||
164378669|NCT02391948|593758558|FG003|12-month Assessment|Medical issue/illness|1|||
164378670|NCT02391948|593758559|FG004|12-month Assessment|Medical issue/illness|0|||
164378671|NCT02391948|593758555|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
164378672|NCT02391948|593758556|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
164378673|NCT02391948|593758557|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
164378674|NCT02391948|593758558|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
164378675|NCT02391948|593758559|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
164378676|NCT02391948|593758555|FG000|18-month Assessment|Death|0|||
164378677|NCT02391948|593758556|FG001|18-month Assessment|Death|0|||
164378678|NCT02391948|593758557|FG002|18-month Assessment|Death|0|||
164378679|NCT02391948|593758558|FG003|18-month Assessment|Death|1|||
164378680|NCT02391948|593758559|FG004|18-month Assessment|Death|1|||
164378681|NCT02391948|593758555|FG000|18-month Assessment|Withdrawal by Subject|1|||
164378682|NCT02391948|593758556|FG001|18-month Assessment|Withdrawal by Subject|0|||
164378683|NCT02391948|593758557|FG002|18-month Assessment|Withdrawal by Subject|0|||
164378684|NCT02391948|593758558|FG003|18-month Assessment|Withdrawal by Subject|1|||
164378685|NCT02391948|593758559|FG004|18-month Assessment|Withdrawal by Subject|0|||
164378686|NCT02391948|593758555|FG000|18-month Assessment|Lost to Follow-up|2|||
164378687|NCT02391948|593758556|FG001|18-month Assessment|Lost to Follow-up|6|||
164378688|NCT02391948|593758557|FG002|18-month Assessment|Lost to Follow-up|2|||
164378689|NCT02391948|593758558|FG003|18-month Assessment|Lost to Follow-up|2|||
164378690|NCT02391948|593758559|FG004|18-month Assessment|Lost to Follow-up|3|||
164378691|NCT02391948|593758555|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
164378692|NCT02391948|593758556|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
164378693|NCT02391948|593758557|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
164378694|NCT02391948|593758558|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
164378695|NCT02391948|593758559|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
164378696|NCT02391948|593758555|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
164378697|NCT02391948|593758556|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
164378698|NCT02391948|593758557|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
164378699|NCT02391948|593758558|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
164378700|NCT02391948|593758559|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
164378701|NCT02391948|593758555|FG000|24-month Assessment|Death|0|||
164378702|NCT02391948|593758556|FG001|24-month Assessment|Death|0|||
164378703|NCT02391948|593758557|FG002|24-month Assessment|Death|0|||
164378704|NCT02391948|593758558|FG003|24-month Assessment|Death|0|||
164378705|NCT02391948|593758559|FG004|24-month Assessment|Death|1|||
164378706|NCT02391948|593758555|FG000|24-month Assessment|Withdrawal by Subject|1|||
164378707|NCT02391948|593758556|FG001|24-month Assessment|Withdrawal by Subject|1|||
164378708|NCT02391948|593758557|FG002|24-month Assessment|Withdrawal by Subject|0|||
164378709|NCT02391948|593758558|FG003|24-month Assessment|Withdrawal by Subject|0|||
164378710|NCT02391948|593758559|FG004|24-month Assessment|Withdrawal by Subject|1|||
164378711|NCT02391948|593758555|FG000|24-month Assessment|Lost to Follow-up|5|||
164378712|NCT02391948|593758556|FG001|24-month Assessment|Lost to Follow-up|4|||
164378713|NCT02391948|593758557|FG002|24-month Assessment|Lost to Follow-up|0|||
164378714|NCT02391948|593758558|FG003|24-month Assessment|Lost to Follow-up|0|||
164378715|NCT02391948|593758559|FG004|24-month Assessment|Lost to Follow-up|0|||
164378716|NCT02391948|593758555|FG000|24-month Assessment|Medical issue/illness|0|||
164592071|NCT02574312|594530067|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
164378717|NCT02391948|593758556|FG001|24-month Assessment|Medical issue/illness|0|||
164378718|NCT02391948|593758557|FG002|24-month Assessment|Medical issue/illness|1|||
164592072|NCT02574312|594530068|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
164592073|NCT02410902|594531315|FG000|Overall Study|Adverse Event|2|||
164592074|NCT02410902|594531316|FG001|Overall Study|Adverse Event|3|||
164592075|NCT02410902|594531315|FG000|Overall Study|Lost to Follow-up|4|||
164378719|NCT02391948|593758558|FG003|24-month Assessment|Medical issue/illness|0|||
164378720|NCT02391948|593758559|FG004|24-month Assessment|Medical issue/illness|0|||
164378721|NCT02391948|593758555|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
164378722|NCT02391948|593758556|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
164378723|NCT02391948|593758557|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
164378724|NCT02391948|593758558|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
164378725|NCT02391948|593758559|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
164378726|NCT02348489|593758560|FG000|Overall Study|Death|336|||
164378727|NCT02348489|593758561|FG001|Overall Study|Death|335|||
164378728|NCT02348489|593758560|FG000|Overall Study|Withdrawal by Subject|14|||
164378729|NCT02348489|593758561|FG001|Overall Study|Withdrawal by Subject|27|||
164378730|NCT02348489|593758560|FG000|Overall Study|Lost to Follow-up|3|||
164378731|NCT02348489|593758561|FG001|Overall Study|Lost to Follow-up|5|||
164378732|NCT00201006|593758562|FG000|Overall Study|Withdrawal by Subject|7|||
164378733|NCT00201006|593758563|FG001|Overall Study|Withdrawal by Subject|2|||
164378734|NCT00201006|593758564|FG002|Overall Study|Withdrawal by Subject|3|||
164378735|NCT00201006|593758562|FG000|Overall Study|Adverse Event|1|||
164378736|NCT00201006|593758563|FG001|Overall Study|Adverse Event|0|||
164378737|NCT00201006|593758564|FG002|Overall Study|Adverse Event|1|||
164378738|NCT01969838|593758567|FG000|Double-blind Phase|Adverse Event|10|||
164378739|NCT01969838|593758568|FG001|Double-blind Phase|Adverse Event|4|||
164378740|NCT01969838|593758569|FG002|Double-blind Phase|Adverse Event|0|||
164378741|NCT01969838|593758570|FG003|Double-blind Phase|Adverse Event|0|||
164378742|NCT01969838|593758567|FG000|Double-blind Phase|Death|5|||
164378743|NCT01969838|593758568|FG001|Double-blind Phase|Death|2|||
164378744|NCT01969838|593758569|FG002|Double-blind Phase|Death|0|||
164592076|NCT02410902|594531316|FG001|Overall Study|Lost to Follow-up|1|||
164592077|NCT02410902|594531315|FG000|Overall Study|Protocol Violation|1|||
164592078|NCT02410902|594531316|FG001|Overall Study|Protocol Violation|4|||
164592079|NCT02410902|594531315|FG000|Overall Study|Withdrawal by Subject|6|||
164592080|NCT02410902|594531316|FG001|Overall Study|Withdrawal by Subject|8|||
164592081|NCT02410902|594531315|FG000|Overall Study|Non-Compliance|8|||
164592082|NCT02410902|594531316|FG001|Overall Study|Non-Compliance|2|||
164592083|NCT00074412|594531317|FG000|Overall Study|Death|30|||
164592084|NCT00074412|594531318|FG001|Overall Study|Death|26|||
164592085|NCT00074412|594531317|FG000|Overall Study|Lost to Follow-up|52|||
164592086|NCT00074412|594531318|FG001|Overall Study|Lost to Follow-up|58|||
164592087|NCT00392171|594531319|FG000|Overall Study|Did not meet inclusion criteria|4|||
164592088|NCT00392171|594531319|FG000|Overall Study|Disease progression|101|||
164592089|NCT01881620|594531320|FG000|Overall Study|Protocol Violation|4|||
164592090|NCT01457118|594531328|FG000|Overall Study|Adverse Event|1|||
164592091|NCT01457118|594531329|FG001|Overall Study|Adverse Event|0|||
164592092|NCT01457118|594531330|FG002|Overall Study|Adverse Event|0|||
164592093|NCT01457118|594531331|FG003|Overall Study|Adverse Event|1|||
164592094|NCT01457118|594531328|FG000|Overall Study|Clinical Progression|0|||
164592095|NCT01457118|594531329|FG001|Overall Study|Clinical Progression|1|||
164592096|NCT01457118|594531330|FG002|Overall Study|Clinical Progression|0|||
164700786|NCT03499119|594926933|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
164700787|NCT03499119|594926934|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
164378745|NCT01969838|593758570|FG003|Double-blind Phase|Death|0|||
164378746|NCT01969838|593758567|FG000|Double-blind Phase|Physician Decision|5|||
164378747|NCT01969838|593758568|FG001|Double-blind Phase|Physician Decision|1|||
164378748|NCT01969838|593758569|FG002|Double-blind Phase|Physician Decision|0|||
164378749|NCT01969838|593758570|FG003|Double-blind Phase|Physician Decision|0|||
164378750|NCT01969838|593758567|FG000|Double-blind Phase|Subject Decision|4|||
164378751|NCT01969838|593758568|FG001|Double-blind Phase|Subject Decision|2|||
164592097|NCT01457118|594531331|FG003|Overall Study|Clinical Progression|1|||
164592098|NCT01457118|594531328|FG000|Overall Study|Physician Decision|2|||
164592099|NCT01457118|594531329|FG001|Overall Study|Physician Decision|0|||
164592100|NCT01457118|594531330|FG002|Overall Study|Physician Decision|0|||
164592101|NCT01457118|594531331|FG003|Overall Study|Physician Decision|0|||
164592102|NCT01457118|594531328|FG000|Overall Study|Progressive Disease by RECIST|12|||
164700788|NCT03499119|594926935|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
164700789|NCT03499119|594926932|FG000|Optional Extension Phase|Lost to Follow-up|0|||
164592103|NCT01457118|594531329|FG001|Overall Study|Progressive Disease by RECIST|3|||
164592104|NCT01457118|594531330|FG002|Overall Study|Progressive Disease by RECIST|1|||
164592105|NCT01457118|594531331|FG003|Overall Study|Progressive Disease by RECIST|0|||
164378752|NCT01969838|593758569|FG002|Double-blind Phase|Subject Decision|0|||
164378753|NCT01969838|593758570|FG003|Double-blind Phase|Subject Decision|0|||
164378754|NCT01969838|593758567|FG000|Double-blind Phase|Disease Progression|2|||
164378755|NCT01969838|593758568|FG001|Double-blind Phase|Disease Progression|0|||
164378756|NCT01969838|593758569|FG002|Double-blind Phase|Disease Progression|0|||
164378757|NCT01969838|593758570|FG003|Double-blind Phase|Disease Progression|0|||
164592106|NCT01457118|594531328|FG000|Overall Study|Withdrawal by Subject|5|||
164592107|NCT01457118|594531329|FG001|Overall Study|Withdrawal by Subject|0|||
164592108|NCT01457118|594531330|FG002|Overall Study|Withdrawal by Subject|0|||
164700790|NCT03499119|594926933|FG001|Optional Extension Phase|Lost to Follow-up|0|||
164700791|NCT03499119|594926934|FG002|Optional Extension Phase|Lost to Follow-up|0|||
164700792|NCT03499119|594926935|FG003|Optional Extension Phase|Lost to Follow-up|1|||
164700793|NCT03499119|594926932|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
164700794|NCT03499119|594926933|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
164700795|NCT03499119|594926934|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
164700796|NCT03499119|594926935|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
164700797|NCT03499119|594926932|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
164700798|NCT03499119|594926933|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
164700799|NCT03499119|594926934|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
164700800|NCT03499119|594926935|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
164700801|NCT04189445|594927873|FG000|Overall Study|Withdrawal of consent|8|||
164700802|NCT04189445|594927874|FG001|Overall Study|Withdrawal of consent|1|||
164378758|NCT01969838|593758567|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
164378759|NCT01969838|593758568|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
164378760|NCT01969838|593758569|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
164378761|NCT01969838|593758570|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
164378762|NCT01969838|593758567|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
164378763|NCT01969838|593758568|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
164378764|NCT01969838|593758569|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
164378765|NCT01969838|593758570|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
164378766|NCT01969838|593758567|FG000|Open-label Phase|Adverse Event|0|||
164378767|NCT01969838|593758568|FG001|Open-label Phase|Adverse Event|0|||
164378768|NCT01969838|593758569|FG002|Open-label Phase|Adverse Event|37|||
164378769|NCT01969838|593758570|FG003|Open-label Phase|Adverse Event|49|||
164378770|NCT01969838|593758567|FG000|Open-label Phase|Disease Progression|0|||
164378771|NCT01969838|593758568|FG001|Open-label Phase|Disease Progression|0|||
164378772|NCT01969838|593758569|FG002|Open-label Phase|Disease Progression|26|||
164378773|NCT01969838|593758570|FG003|Open-label Phase|Disease Progression|27|||
164378774|NCT01969838|593758567|FG000|Open-label Phase|Lack of Efficacy|0|||
164378775|NCT01969838|593758568|FG001|Open-label Phase|Lack of Efficacy|0|||
164378776|NCT01969838|593758569|FG002|Open-label Phase|Lack of Efficacy|17|||
164378777|NCT01969838|593758570|FG003|Open-label Phase|Lack of Efficacy|19|||
164378778|NCT01969838|593758567|FG000|Open-label Phase|Subject Decision|0|||
164378779|NCT01969838|593758568|FG001|Open-label Phase|Subject Decision|0|||
164378780|NCT01969838|593758569|FG002|Open-label Phase|Subject Decision|14|||
164378781|NCT01969838|593758570|FG003|Open-label Phase|Subject Decision|15|||
164378782|NCT01969838|593758567|FG000|Open-label Phase|Death|0|||
164378783|NCT01969838|593758568|FG001|Open-label Phase|Death|0|||
164378784|NCT01969838|593758569|FG002|Open-label Phase|Death|13|||
164378785|NCT01969838|593758570|FG003|Open-label Phase|Death|11|||
164378786|NCT01969838|593758567|FG000|Open-label Phase|Physician Decision|0|||
164378787|NCT01969838|593758568|FG001|Open-label Phase|Physician Decision|0|||
164378788|NCT01969838|593758569|FG002|Open-label Phase|Physician Decision|9|||
164378789|NCT01969838|593758570|FG003|Open-label Phase|Physician Decision|14|||
164378790|NCT01969838|593758567|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
164378791|NCT01969838|593758568|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
164378792|NCT01969838|593758569|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
164700803|NCT04189445|594927875|FG002|Overall Study|Withdrawal of consent|0|||
164700804|NCT04189445|594927873|FG000|Overall Study|Study Terminated by Sponsor|25|||
164700805|NCT04189445|594927874|FG001|Overall Study|Study Terminated by Sponsor|3|||
164700806|NCT04189445|594927875|FG002|Overall Study|Study Terminated by Sponsor|0|||
164700807|NCT04189445|594927873|FG000|Overall Study|Death|54|||
164700808|NCT04189445|594927874|FG001|Overall Study|Death|24|||
164700809|NCT04189445|594927875|FG002|Overall Study|Death|0|||
164700810|NCT00003138|594927876|FG000|Step 1|Reasons off treatment not documented|60|||
164700811|NCT00003138|594927877|FG001|Step 1|Reasons off treatment not documented|57|||
164700812|NCT00003138|594927876|FG000|Step 1|Never started treatment|1|||
164378793|NCT01969838|593758570|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
164378794|NCT00408993|593758571|FG000|Overall Study|Adverse Event|15|||
164378795|NCT00408993|593758572|FG001|Overall Study|Adverse Event|4|||
164378796|NCT00408993|593758571|FG000|Overall Study|Protocol Violation|1|||
164378797|NCT00408993|593758572|FG001|Overall Study|Protocol Violation|6|||
164378798|NCT00408993|593758571|FG000|Overall Study|Lack of Efficacy|1|||
164378799|NCT00408993|593758572|FG001|Overall Study|Lack of Efficacy|4|||
164378800|NCT00408993|593758571|FG000|Overall Study|Withdrawal by Subject|2|||
164378801|NCT00408993|593758572|FG001|Overall Study|Withdrawal by Subject|3|||
164700813|NCT00003138|594927877|FG001|Step 1|Never started treatment|0|||
164700814|NCT00003138|594927876|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
164700815|NCT00003138|594927877|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
164378802|NCT04193202|593758573|FG000|Overall Study|Adverse Event|2|||
164378803|NCT04193202|593758574|FG001|Overall Study|Adverse Event|1|||
164378804|NCT04193202|593758573|FG000|Overall Study|Death|0|||
164378805|NCT04193202|593758574|FG001|Overall Study|Death|1|||
164378806|NCT04193202|593758573|FG000|Overall Study|Physician Decision|1|||
164378807|NCT04193202|593758574|FG001|Overall Study|Physician Decision|1|||
164378808|NCT04193202|593758573|FG000|Overall Study|Protocol Violation|2|||
164378809|NCT04193202|593758574|FG001|Overall Study|Protocol Violation|2|||
164439364|NCT00530842|593975379|FG001|Overall Study|Lack of Efficacy|1|||
164439365|NCT00530842|593975378|FG000|Overall Study|Lost to Follow-up|0|||
164439366|NCT00530842|593975379|FG001|Overall Study|Lost to Follow-up|4|||
164439367|NCT00530842|593975378|FG000|Overall Study|Protocol Violation|3|||
164439368|NCT00530842|593975379|FG001|Overall Study|Protocol Violation|2|||
164439369|NCT00530842|593975378|FG000|Overall Study|Withdrawal by Subject|4|||
164439370|NCT00530842|593975379|FG001|Overall Study|Withdrawal by Subject|5|||
164439371|NCT00530842|593975378|FG000|Overall Study|Individual different reasons|4|||
164439372|NCT00530842|593975379|FG001|Overall Study|Individual different reasons|3|||
164439373|NCT00530842|593975378|FG000|Period 1|Adverse Event|7|||
164439374|NCT00530842|593975379|FG001|Period 1|Adverse Event|3|||
164439375|NCT00530842|593975378|FG000|Period 1|Lack of Efficacy|1|||
164439376|NCT00530842|593975379|FG001|Period 1|Lack of Efficacy|1|||
164439377|NCT00530842|593975378|FG000|Period 1|Protocol Violation|2|||
164439378|NCT00530842|593975379|FG001|Period 1|Protocol Violation|1|||
164439379|NCT00530842|593975378|FG000|Period 1|Withdrawal by Subject|2|||
164439380|NCT00530842|593975379|FG001|Period 1|Withdrawal by Subject|3|||
164439381|NCT00530842|593975378|FG000|Period 1|Individual different reasons|2|||
164439382|NCT00530842|593975379|FG001|Period 1|Individual different reasons|3|||
164439383|NCT00530842|593975378|FG000|Period 2|Adverse Event|3|||
164439384|NCT00530842|593975379|FG001|Period 2|Adverse Event|3|||
164439385|NCT00530842|593975378|FG000|Period 2|Lack of Efficacy|1|||
164439386|NCT00530842|593975379|FG001|Period 2|Lack of Efficacy|0|||
164439387|NCT00530842|593975378|FG000|Period 2|Lost to Follow-up|0|||
164439388|NCT00530842|593975379|FG001|Period 2|Lost to Follow-up|4|||
164439389|NCT00530842|593975378|FG000|Period 2|Protocol Violation|1|||
164439390|NCT00530842|593975379|FG001|Period 2|Protocol Violation|0|||
164439391|NCT00530842|593975378|FG000|Period 2|Withdrawal by Subject|1|||
164439392|NCT00530842|593975379|FG001|Period 2|Withdrawal by Subject|2|||
164439393|NCT00530842|593975378|FG000|Period 2|Individual different reasons|2|||
164439394|NCT00530842|593975379|FG001|Period 2|Individual different reasons|0|||
164439395|NCT00949975|593975380|FG000|Overall Study|Voluntary discontinuation|6|||
164439396|NCT00949975|593975381|FG001|Overall Study|Voluntary discontinuation|5|||
164439397|NCT00949975|593975382|FG002|Overall Study|Voluntary discontinuation|3|||
164439398|NCT00949975|593975383|FG003|Overall Study|Voluntary discontinuation|6|||
164439399|NCT00949975|593975380|FG000|Overall Study|Adverse Event|11|||
164439400|NCT00949975|593975381|FG001|Overall Study|Adverse Event|11|||
164439401|NCT00949975|593975382|FG002|Overall Study|Adverse Event|10|||
164592109|NCT01457118|594531331|FG003|Overall Study|Withdrawal by Subject|0|||
164592110|NCT00630812|594531332|FG000|Randomisation to First Dose|Adverse Event|1|||
164592111|NCT00630812|594531333|FG001|Randomisation to First Dose|Adverse Event|1|||
164592112|NCT00630812|594531332|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
164592113|NCT00630812|594531333|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
164592114|NCT00630812|594531332|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
164592115|NCT00630812|594531333|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
164592116|NCT00630812|594531332|FG000|Randomisation to First Dose|Protocol Violation|4|||
164592117|NCT00630812|594531333|FG001|Randomisation to First Dose|Protocol Violation|1|||
164378810|NCT04193202|593758573|FG000|Overall Study|Withdrawal by Subject|11|||
164378811|NCT04193202|593758574|FG001|Overall Study|Withdrawal by Subject|5|||
164378812|NCT02488629|593758575|FG000|Overall Study|Lack of Efficacy|3|||
164378813|NCT02488629|593758576|FG001|Overall Study|Lack of Efficacy|1|||
164378814|NCT02488629|593758577|FG002|Overall Study|Lack of Efficacy|0|||
164378815|NCT02488629|593758578|FG003|Overall Study|Lack of Efficacy|0|||
164378816|NCT02488629|593758575|FG000|Overall Study|Withdrawal by Subject|0|||
164378817|NCT02488629|593758576|FG001|Overall Study|Withdrawal by Subject|1|||
164378818|NCT02488629|593758577|FG002|Overall Study|Withdrawal by Subject|0|||
164378819|NCT02488629|593758578|FG003|Overall Study|Withdrawal by Subject|0|||
164378820|NCT00577122|593758579|FG000|Overall Study|Adverse Event|0|||
164378821|NCT00577122|593758580|FG001|Overall Study|Adverse Event|2|||
164378822|NCT00577122|593758579|FG000|Overall Study|Progression, relapse during active trt|6|||
164592118|NCT00630812|594531332|FG000|Double Blind Treatment Period|Adverse Event|13|||
164592119|NCT00630812|594531333|FG001|Double Blind Treatment Period|Adverse Event|5|||
164439402|NCT00949975|593975383|FG003|Overall Study|Adverse Event|10|||
164439403|NCT00949975|593975380|FG000|Overall Study|Safety reason|0|||
164439404|NCT00949975|593975381|FG001|Overall Study|Safety reason|1|||
164439405|NCT00949975|593975382|FG002|Overall Study|Safety reason|0|||
164378823|NCT00577122|593758580|FG001|Overall Study|Progression, relapse during active trt|8|||
164378824|NCT00577122|593758579|FG000|Overall Study|Prog, refract disease during active trt|8|||
164439406|NCT00949975|593975383|FG003|Overall Study|Safety reason|0|||
164439407|NCT00949975|593975380|FG000|Overall Study|Study-specific criteria|0|||
164439408|NCT00949975|593975381|FG001|Overall Study|Study-specific criteria|1|||
164439409|NCT00949975|593975382|FG002|Overall Study|Study-specific criteria|1|||
164439410|NCT00949975|593975383|FG003|Overall Study|Study-specific criteria|0|||
164592120|NCT00630812|594531332|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
164378825|NCT00577122|593758580|FG001|Overall Study|Prog, refract disease during active trt|5|||
164378826|NCT00577122|593758579|FG000|Overall Study|Alternative Therapy|0|||
164378827|NCT00577122|593758580|FG001|Overall Study|Alternative Therapy|1|||
164378828|NCT02148003|593758581|FG000|Overall Study|Failed inclusion criteria|1|||
164378829|NCT02148003|593758582|FG001|Overall Study|Failed inclusion criteria|0|||
164378830|NCT02148003|593758581|FG000|Overall Study|Met exclusion criteria|0|||
164378831|NCT02148003|593758582|FG001|Overall Study|Met exclusion criteria|1|||
164378832|NCT02148003|593758581|FG000|Overall Study|Withdrawal by Subject|0|||
164378833|NCT02148003|593758582|FG001|Overall Study|Withdrawal by Subject|1|||
164378834|NCT00436280|593758588|FG000|Period 1: Induction|Adverse Event|8|||
164378835|NCT00436280|593758588|FG000|Period 1: Induction|Progressive Disease|12|||
164378836|NCT00436280|593758588|FG000|Period 1: Induction|Stable Disease|6|||
164378837|NCT00436280|593758588|FG000|Period 1: Induction|Withdrawal by Subject|1|||
164378838|NCT00436280|593758588|FG000|Period 1: Induction|Death|1|||
164378839|NCT00436280|593758588|FG000|Period 2: Consolidation|Adverse Event|1|||
164378840|NCT00436280|593758588|FG000|Period 2: Consolidation|Progressive Disease|10|||
164378841|NCT00436280|593758588|FG000|Period 2: Consolidation|Stable Disease|1|||
164378842|NCT00436280|593758588|FG000|Period 2: Consolidation|Physician Decision|2|||
164378843|NCT00436280|593758588|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
164378844|NCT00436280|593758588|FG000|Period 2: Consolidation|Death|1|||
164378845|NCT00436280|593758588|FG000|Period 3: Maintenance|Adverse Event|6|||
164378846|NCT00436280|593758588|FG000|Period 3: Maintenance|Progressive Disease|12|||
164378847|NCT02039427|593758589|FG000|Overall Study|Duration of surgery > 3h|1|||
164378848|NCT02039427|593758590|FG001|Overall Study|Duration of surgery > 3h|1|||
164378849|NCT02039427|593758591|FG002|Overall Study|Duration of surgery > 3h|0|||
164378850|NCT02039427|593758592|FG003|Overall Study|Duration of surgery > 3h|0|||
164378851|NCT02039427|593758589|FG000|Overall Study|Withdrawal on concent|0|||
164378852|NCT02039427|593758590|FG001|Overall Study|Withdrawal on concent|0|||
164378853|NCT02039427|593758591|FG002|Overall Study|Withdrawal on concent|0|||
164378854|NCT02039427|593758592|FG003|Overall Study|Withdrawal on concent|1|||
164378855|NCT02039427|593758589|FG000|Overall Study|Cancellation of surgery|0|||
164378856|NCT02039427|593758590|FG001|Overall Study|Cancellation of surgery|0|||
164378857|NCT02039427|593758591|FG002|Overall Study|Cancellation of surgery|1|||
164378858|NCT02039427|593758592|FG003|Overall Study|Cancellation of surgery|0|||
164378859|NCT02039427|593758589|FG000|Overall Study|Loss of follow - up|1|||
164378860|NCT02039427|593758590|FG001|Overall Study|Loss of follow - up|0|||
164378861|NCT02039427|593758591|FG002|Overall Study|Loss of follow - up|2|||
164378862|NCT02039427|593758592|FG003|Overall Study|Loss of follow - up|4|||
164378863|NCT02039427|593758589|FG000|Overall Study|Steroid Use|1|||
164378864|NCT02039427|593758590|FG001|Overall Study|Steroid Use|0|||
164378865|NCT02039427|593758591|FG002|Overall Study|Steroid Use|0|||
164378866|NCT02039427|593758592|FG003|Overall Study|Steroid Use|0|||
164378867|NCT03160703|593758596|FG000|Overall Study|Withdrawal by Subject|0|||
164378868|NCT03160703|593758597|FG001|Overall Study|Withdrawal by Subject|0|||
164439411|NCT00949975|593975380|FG000|Overall Study|Incorrect enrolment|5|||
164378869|NCT03160703|593758598|FG002|Overall Study|Withdrawal by Subject|0|||
164378870|NCT03160703|593758599|FG003|Overall Study|Withdrawal by Subject|1|||
164378871|NCT00087568|593758600|FG000|Overall Study|Adverse Event|4|||
164378872|NCT00087568|593758601|FG001|Overall Study|Adverse Event|0|||
164378873|NCT00087568|593758600|FG000|Overall Study|Withdrawal by Subject|1|||
164378874|NCT00087568|593758601|FG001|Overall Study|Withdrawal by Subject|1|||
164378875|NCT00087568|593758600|FG000|Overall Study|Lost to Follow-up|1|||
164378876|NCT00087568|593758601|FG001|Overall Study|Lost to Follow-up|0|||
164378877|NCT00087568|593758600|FG000|Overall Study|Lack of Efficacy|24|||
164378878|NCT00087568|593758601|FG001|Overall Study|Lack of Efficacy|1|||
164378879|NCT03728582|593758606|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
164378880|NCT03728582|593758607|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
164378881|NCT03728582|593758606|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
164378882|NCT03728582|593758607|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
164378883|NCT00047463|593758608|FG000|Overall Study|Withdrawal by Subject|0|||
164378884|NCT00047463|593758609|FG001|Overall Study|Withdrawal by Subject|3|||
164378885|NCT01274637|593758616|FG000|Overall Study|Withdrawal by Subject|0|||
164378886|NCT01274637|593758617|FG001|Overall Study|Withdrawal by Subject|1|||
164378887|NCT01274637|593758616|FG000|Overall Study|Lost to Follow-up|0|||
164378888|NCT01274637|593758617|FG001|Overall Study|Lost to Follow-up|1|||
164378889|NCT01824303|593758629|FG000|Randomized Study|Withdrawal by Subject|1|||
164378890|NCT01824303|593758630|FG001|Randomized Study|Withdrawal by Subject|1|||
164378891|NCT01824303|593758629|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
164378892|NCT01824303|593758630|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
164378893|NCT03296696|593758635|FG000|Overall Study|Started Other Antitumor Therapy|1|||
164378894|NCT03296696|593758636|FG001|Overall Study|Started Other Antitumor Therapy|2|||
164378895|NCT03296696|593758637|FG002|Overall Study|Started Other Antitumor Therapy|1|||
164378896|NCT03296696|593758638|FG003|Overall Study|Started Other Antitumor Therapy|2|||
164378897|NCT03296696|593758639|FG004|Overall Study|Started Other Antitumor Therapy|1|||
164378898|NCT03296696|593758640|FG005|Overall Study|Started Other Antitumor Therapy|1|||
164378899|NCT03296696|593758641|FG006|Overall Study|Started Other Antitumor Therapy|2|||
164378900|NCT03296696|593758642|FG007|Overall Study|Started Other Antitumor Therapy|3|||
164378901|NCT03296696|593758643|FG008|Overall Study|Started Other Antitumor Therapy|1|||
164378902|NCT03296696|593758644|FG009|Overall Study|Started Other Antitumor Therapy|0|||
164378903|NCT03296696|593758635|FG000|Overall Study|Death|0|||
164378904|NCT03296696|593758636|FG001|Overall Study|Death|1|||
164378905|NCT03296696|593758637|FG002|Overall Study|Death|1|||
164378906|NCT03296696|593758638|FG003|Overall Study|Death|2|||
164378907|NCT03296696|593758639|FG004|Overall Study|Death|2|||
164378908|NCT03296696|593758640|FG005|Overall Study|Death|3|||
164378909|NCT03296696|593758641|FG006|Overall Study|Death|1|||
164378910|NCT03296696|593758642|FG007|Overall Study|Death|2|||
164378911|NCT03296696|593758643|FG008|Overall Study|Death|0|||
164378912|NCT03296696|593758644|FG009|Overall Study|Death|0|||
164378913|NCT03296696|593758635|FG000|Overall Study|Withdrawal by Subject|0|||
164378914|NCT03296696|593758636|FG001|Overall Study|Withdrawal by Subject|0|||
164378915|NCT03296696|593758637|FG002|Overall Study|Withdrawal by Subject|1|||
164378916|NCT03296696|593758638|FG003|Overall Study|Withdrawal by Subject|0|||
164378917|NCT03296696|593758639|FG004|Overall Study|Withdrawal by Subject|1|||
164378918|NCT03296696|593758640|FG005|Overall Study|Withdrawal by Subject|0|||
164378919|NCT03296696|593758641|FG006|Overall Study|Withdrawal by Subject|0|||
164378920|NCT03296696|593758642|FG007|Overall Study|Withdrawal by Subject|0|||
164378921|NCT03296696|593758643|FG008|Overall Study|Withdrawal by Subject|0|||
164378922|NCT03296696|593758644|FG009|Overall Study|Withdrawal by Subject|1|||
164378923|NCT01350128|593758645|FG000|Overall Study|Withdrawal by Subject|3|||
164378924|NCT01350128|593758645|FG000|Overall Study|Protocol discontinuation criteria|8|||
164378925|NCT01350128|593758645|FG000|Overall Study|Physician Decision|1|||
164378926|NCT01350128|593758645|FG000|Overall Study|Lost to Follow-up|2|||
164378927|NCT01859715|593758649|FG000|Overall Study|No 2nd VAS|16|||
164378928|NCT01859715|593758650|FG001|Overall Study|No 2nd VAS|8|||
164378929|NCT01859715|593758651|FG002|Overall Study|No 2nd VAS|23|||
164378930|NCT00086580|593758655|FG000|Treatment Period|Disease progression|9|||
164378931|NCT00086580|593758656|FG001|Treatment Period|Disease progression|8|||
164378932|NCT00086580|593758655|FG000|Treatment Period|Unable to comply with protocol|3|||
164378933|NCT00086580|593758656|FG001|Treatment Period|Unable to comply with protocol|1|||
164378934|NCT00086580|593758655|FG000|Treatment Period|Withdrawal by Subject|7|||
164378935|NCT00086580|593758656|FG001|Treatment Period|Withdrawal by Subject|8|||
164378936|NCT00086580|593758655|FG000|Treatment Period|Physician Decision|13|||
164378937|NCT00086580|593758656|FG001|Treatment Period|Physician Decision|7|||
164439412|NCT00949975|593975381|FG001|Overall Study|Incorrect enrolment|10|||
164439413|NCT00949975|593975382|FG002|Overall Study|Incorrect enrolment|4|||
164378938|NCT00086580|593758655|FG000|Treatment Period|AE - not treatment related|7|||
164378939|NCT00086580|593758656|FG001|Treatment Period|AE - not treatment related|7|||
164378940|NCT00086580|593758655|FG000|Treatment Period|Toxicity - treatment related|15|||
164378941|NCT00086580|593758656|FG001|Treatment Period|Toxicity - treatment related|15|||
164378942|NCT00086580|593758655|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
164378943|NCT00086580|593758656|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
164378944|NCT00086580|593758655|FG000|Treatment Period|Death|5|||
164378945|NCT00086580|593758656|FG001|Treatment Period|Death|7|||
164378946|NCT00086580|593758655|FG000|Treatment Period|Other|5|||
164378947|NCT00086580|593758656|FG001|Treatment Period|Other|3|||
164378948|NCT00086580|593758655|FG000|Follow-up Period|Disease progression|72|||
164378949|NCT00086580|593758656|FG001|Follow-up Period|Disease progression|99|||
164378950|NCT00086580|593758655|FG000|Follow-up Period|Unable to comply with protocol|5|||
164378951|NCT00086580|593758656|FG001|Follow-up Period|Unable to comply with protocol|0|||
164378952|NCT00086580|593758655|FG000|Follow-up Period|Withdrawal by Subject|6|||
164439414|NCT00949975|593975383|FG003|Overall Study|Incorrect enrolment|7|||
164378953|NCT00086580|593758656|FG001|Follow-up Period|Withdrawal by Subject|6|||
164378954|NCT00086580|593758655|FG000|Follow-up Period|Physician Decision|0|||
164378955|NCT00086580|593758656|FG001|Follow-up Period|Physician Decision|1|||
164378956|NCT00086580|593758655|FG000|Follow-up Period|AE - not related|1|||
164378957|NCT00086580|593758656|FG001|Follow-up Period|AE - not related|0|||
164378958|NCT00086580|593758655|FG000|Follow-up Period|Death|13|||
164378959|NCT00086580|593758656|FG001|Follow-up Period|Death|7|||
164378960|NCT00086580|593758655|FG000|Follow-up Period|Other|7|||
164378961|NCT00086580|593758656|FG001|Follow-up Period|Other|6|||
164378962|NCT00086580|593758655|FG000|Observation Period|Unable to comply with protocol|1|||
164378963|NCT00086580|593758656|FG001|Observation Period|Unable to comply with protocol|1|||
164378964|NCT00086580|593758655|FG000|Observation Period|Withdrawal by Subject|4|||
164378965|NCT00086580|593758656|FG001|Observation Period|Withdrawal by Subject|2|||
164378966|NCT00086580|593758655|FG000|Observation Period|Death|33|||
164378967|NCT00086580|593758656|FG001|Observation Period|Death|55|||
164378968|NCT00086580|593758655|FG000|Observation Period|Other|8|||
164378969|NCT00086580|593758656|FG001|Observation Period|Other|7|||
164378970|NCT00806546|593758663|FG000|Overall Study|Enrolled, not treated|35|||
164378971|NCT00806546|593758663|FG000|Overall Study|Lost to Follow-up|32|||
164439415|NCT00949975|593975380|FG000|Overall Study|Severe non-compliance|3|||
164439416|NCT00949975|593975381|FG001|Overall Study|Severe non-compliance|1|||
164439417|NCT00949975|593975382|FG002|Overall Study|Severe non-compliance|0|||
164439418|NCT00949975|593975383|FG003|Overall Study|Severe non-compliance|2|||
164439419|NCT00949975|593975380|FG000|Overall Study|Lost to Follow-up|1|||
164439420|NCT00949975|593975381|FG001|Overall Study|Lost to Follow-up|0|||
164439421|NCT00949975|593975382|FG002|Overall Study|Lost to Follow-up|1|||
164439422|NCT00949975|593975383|FG003|Overall Study|Lost to Follow-up|3|||
164439423|NCT00949975|593975380|FG000|Overall Study|Other|1|||
164439424|NCT00949975|593975381|FG001|Overall Study|Other|0|||
164439425|NCT00949975|593975382|FG002|Overall Study|Other|0|||
164439426|NCT00949975|593975383|FG003|Overall Study|Other|0|||
164439427|NCT04347954|593975384|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
164439428|NCT04347954|593975385|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
164439429|NCT04347954|593975386|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
164439430|NCT04347954|593975384|FG000|Overall Study|Lost to Follow-up|0|||
164439431|NCT04347954|593975385|FG001|Overall Study|Lost to Follow-up|1|||
164439432|NCT04347954|593975386|FG002|Overall Study|Lost to Follow-up|0|||
164439433|NCT02878330|593975387|FG000|Overall Study|Death|3|||
164439434|NCT02878330|593975388|FG001|Overall Study|Death|2|||
164439435|NCT02878330|593975387|FG000|Overall Study|Lost to Follow-up|11|||
164439436|NCT02878330|593975388|FG001|Overall Study|Lost to Follow-up|26|||
164439437|NCT02878330|593975387|FG000|Overall Study|Withdrawal by Subject|11|||
164439438|NCT02878330|593975388|FG001|Overall Study|Withdrawal by Subject|21|||
164439439|NCT02878330|593975387|FG000|Overall Study|Other|4|||
164439440|NCT02878330|593975388|FG001|Overall Study|Other|7|||
164439441|NCT04246762|593975389|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
164439442|NCT02954848|593975392|FG000|Overall Study|Randomized but Not Treated|0|||
164439443|NCT02954848|593975393|FG001|Overall Study|Randomized but Not Treated|1|||
164439444|NCT02954848|593975392|FG000|Overall Study|Adverse Event|2|||
164439445|NCT02954848|593975393|FG001|Overall Study|Adverse Event|3|||
164439446|NCT02954848|593975392|FG000|Overall Study|Withdrawal by Participant|0|||
164439447|NCT02954848|593975393|FG001|Overall Study|Withdrawal by Participant|1|||
164439448|NCT01069341|593975394|FG000|Overall Study|Lost to Follow-up|1|||
164439449|NCT01802632|593975395|FG000|Overall Study|Death|28|||
164439450|NCT01802632|593975396|FG001|Overall Study|Death|1|||
164439451|NCT01802632|593975397|FG002|Overall Study|Death|38|||
164439452|NCT01802632|593975398|FG003|Overall Study|Death|0|||
164439453|NCT01802632|593975399|FG004|Overall Study|Death|2|||
164378972|NCT00806546|593758663|FG000|Overall Study|Adverse Event|74|||
164378973|NCT00806546|593758663|FG000|Overall Study|Withdrawal by Subject|75|||
164439454|NCT01802632|593975400|FG005|Overall Study|Death|0|||
164439455|NCT01802632|593975395|FG000|Overall Study|Withdrawal by Subject|4|||
164439456|NCT01802632|593975396|FG001|Overall Study|Withdrawal by Subject|2|||
164439457|NCT01802632|593975397|FG002|Overall Study|Withdrawal by Subject|7|||
164439458|NCT01802632|593975398|FG003|Overall Study|Withdrawal by Subject|3|||
164439459|NCT01802632|593975399|FG004|Overall Study|Withdrawal by Subject|0|||
164439460|NCT01802632|593975400|FG005|Overall Study|Withdrawal by Subject|1|||
164378974|NCT00806546|593758663|FG000|Overall Study|Protocol Violation|49|||
164378975|NCT00806546|593758663|FG000|Overall Study|Various|42|||
164378976|NCT00558103|593758664|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
164439461|NCT01802632|593975395|FG000|Overall Study|Objective Disease Progression|1|||
164439462|NCT01802632|593975396|FG001|Overall Study|Objective Disease Progression|12|||
164439463|NCT01802632|593975397|FG002|Overall Study|Objective Disease Progression|104|||
164439464|NCT01802632|593975398|FG003|Overall Study|Objective Disease Progression|6|||
164439465|NCT01802632|593975399|FG004|Overall Study|Objective Disease Progression|4|||
164439466|NCT01802632|593975400|FG005|Overall Study|Objective Disease Progression|4|||
164378977|NCT00558103|593758665|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
164378978|NCT00558103|593758666|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
164378979|NCT00558103|593758667|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
164378980|NCT00558103|593758668|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
164378981|NCT00558103|593758669|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
164378982|NCT00558103|593758664|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
164378983|NCT00558103|593758665|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
164378984|NCT00558103|593758666|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
164378985|NCT00558103|593758667|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
164378986|NCT00558103|593758668|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
164378987|NCT00558103|593758669|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
164378988|NCT00558103|593758664|FG000|Randomized Treatment Phase|Disease Progression|1|||
164378989|NCT00558103|593758665|FG001|Randomized Treatment Phase|Disease Progression|0|||
164378990|NCT00558103|593758666|FG002|Randomized Treatment Phase|Disease Progression|1|||
164378991|NCT00558103|593758667|FG003|Randomized Treatment Phase|Disease Progression|0|||
164378992|NCT00558103|593758668|FG004|Randomized Treatment Phase|Disease Progression|0|||
164378993|NCT00558103|593758669|FG005|Randomized Treatment Phase|Disease Progression|0|||
164378994|NCT00558103|593758664|FG000|Randomized Treatment Phase|Adverse Event|0|||
164378995|NCT00558103|593758665|FG001|Randomized Treatment Phase|Adverse Event|0|||
164378996|NCT00558103|593758666|FG002|Randomized Treatment Phase|Adverse Event|0|||
164378997|NCT00558103|593758667|FG003|Randomized Treatment Phase|Adverse Event|1|||
164378998|NCT00558103|593758668|FG004|Randomized Treatment Phase|Adverse Event|1|||
164378999|NCT00558103|593758669|FG005|Randomized Treatment Phase|Adverse Event|0|||
164379000|NCT00558103|593758664|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
164379001|NCT00558103|593758665|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
164379002|NCT00558103|593758666|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
164379003|NCT00558103|593758667|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
164379004|NCT00558103|593758668|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
164379005|NCT00558103|593758669|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
164379006|NCT00558103|593758664|FG000|Monotherapy Extension Phase|Disease Progression|0|||
164379007|NCT00558103|593758665|FG001|Monotherapy Extension Phase|Disease Progression|0|||
164379008|NCT00558103|593758666|FG002|Monotherapy Extension Phase|Disease Progression|0|||
164379009|NCT00558103|593758667|FG003|Monotherapy Extension Phase|Disease Progression|0|||
164379010|NCT00558103|593758668|FG004|Monotherapy Extension Phase|Disease Progression|0|||
164379011|NCT00558103|593758669|FG005|Monotherapy Extension Phase|Disease Progression|8|||
164379012|NCT00308711|593758672|FG000|Overall Study|Withdrawal by Subject|1|||
164379013|NCT00308711|593758673|FG001|Overall Study|Withdrawal by Subject|0|||
164379014|NCT00308711|593758674|FG002|Overall Study|Withdrawal by Subject|1|||
164379015|NCT00308711|593758672|FG000|Overall Study|Protocol Violation|0|||
164379016|NCT00308711|593758673|FG001|Overall Study|Protocol Violation|1|||
164379017|NCT00308711|593758674|FG002|Overall Study|Protocol Violation|1|||
164379018|NCT00308711|593758672|FG000|Overall Study|Lost to Follow-up|0|||
164379019|NCT00308711|593758673|FG001|Overall Study|Lost to Follow-up|1|||
164379020|NCT00308711|593758674|FG002|Overall Study|Lost to Follow-up|0|||
164379021|NCT00308711|593758672|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
164379022|NCT00308711|593758673|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
164379023|NCT00308711|593758674|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
164379024|NCT00308711|593758672|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
164379025|NCT00308711|593758673|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
164379026|NCT00308711|593758674|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
164379027|NCT03139916|593758677|FG000|Overall Study|Withdrawal by Subject|2|||
164379028|NCT03139916|593758677|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
164379029|NCT01957475|593758678|FG000|Test Period 1|Withdrawal by Subject|1|||
164379030|NCT01957475|593758679|FG001|Test Period 1|Withdrawal by Subject|0|||
164379031|NCT01957475|593758678|FG000|Test Period 1|Other|1|||
164379032|NCT01957475|593758679|FG001|Test Period 1|Other|0|||
164379033|NCT01957475|593758678|FG000|Test Period 1|Lack of Efficacy|0|||
164379034|NCT01957475|593758679|FG001|Test Period 1|Lack of Efficacy|1|||
164379035|NCT01957475|593758678|FG000|Test Period 2|Adverse Event|1|||
164379036|NCT01957475|593758679|FG001|Test Period 2|Adverse Event|0|||
164379037|NCT02469610|593758680|FG000|Overall Study|Death|1|||
164379038|NCT02469610|593758681|FG001|Overall Study|Death|0|||
164379039|NCT02469610|593758680|FG000|Overall Study|Lost to Follow-up|1|||
164379040|NCT02469610|593758681|FG001|Overall Study|Lost to Follow-up|0|||
164379041|NCT02469610|593758680|FG000|Overall Study|exclusion criteria|2|||
164379042|NCT02469610|593758681|FG001|Overall Study|exclusion criteria|1|||
164379043|NCT00414388|593758684|FG000|Overall Study|Adverse Event|1|||
164379044|NCT02318693|593758685|FG000|Overall Study|Protocol Violation|0|||
164379045|NCT02318693|593758686|FG001|Overall Study|Protocol Violation|1|||
164379046|NCT03591575|593758687|FG000|Overall Study|Adverse Event|2|||
164379047|NCT03591575|593758688|FG001|Overall Study|Adverse Event|0|||
164379048|NCT03591575|593758687|FG000|Overall Study|Withdrawal by Subject|4|||
164379049|NCT03591575|593758688|FG001|Overall Study|Withdrawal by Subject|1|||
164379050|NCT00813358|593758691|FG000|Overall Study|Death|32|||
164379051|NCT00813358|593758691|FG000|Overall Study|Lost to Follow-up|12|||
164379052|NCT00813358|593758691|FG000|Overall Study|other endpoints|5|||
164700816|NCT00003138|594927876|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
164700817|NCT00003138|594927877|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
164700818|NCT00003138|594927876|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
164700819|NCT00003138|594927877|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
164700820|NCT00003138|594927876|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
164700821|NCT00003138|594927877|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
164700822|NCT05142566|594927878|FG000|Overall Study|Protocol Violation|1|||
164700823|NCT01859130|594927879|FG000|Overall Study|Death|4|||
164700824|NCT01859130|594927879|FG000|Overall Study|Lost to Follow-up|16|||
164700825|NCT01859130|594927879|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
164700826|NCT01859130|594927879|FG000|Overall Study|Physician Decision|6|||
164700827|NCT01859130|594927879|FG000|Overall Study|Withdrawal by Subject|17|||
164700828|NCT01859130|594927879|FG000|Overall Study|Adverse Event|11|||
164700829|NCT02145026|594927883|FG000|Overall Study|Adverse Event|2|||
164700830|NCT02145026|594927883|FG000|Overall Study|Death|4|||
164700831|NCT02145026|594927883|FG000|Overall Study|Withdrawal by Subject|2|||
164700832|NCT02145026|594927883|FG000|Overall Study|Physician Decision|4|||
164700833|NCT04505293|594927886|FG000|Overall Study|Lost to Follow-up|2|||
164700834|NCT04505293|594927886|FG000|Overall Study|Withdrawal by Subject|6|||
164700835|NCT04505293|594927886|FG000|Overall Study|CT scan unreadable|277|||
164700836|NCT01249365|594927887|FG000|Overall Study|Lost to Follow-up|1|||
164700837|NCT00003875|594927888|FG000|Overall Study|Screen Failed|1|||
164700838|NCT01300052|594927889|FG000|Overall Study|Adverse Event|3|||
164700839|NCT01300052|594927890|FG001|Overall Study|Adverse Event|0|||
164700840|NCT01300052|594927889|FG000|Overall Study|Withdrawal by Subject|2|||
164700841|NCT01300052|594927890|FG001|Overall Study|Withdrawal by Subject|2|||
164379053|NCT00813358|593758691|FG000|Overall Study|Withdrawal by Subject|20|||
164379054|NCT00218543|593758692|FG000|Overall Study|Lost to Follow-up|8|||
164379055|NCT00218543|593758692|FG000|Overall Study|relocated|1|||
164379056|NCT00218543|593758692|FG000|Overall Study|Withdrawal by Subject|1|||
164379057|NCT00218543|593758692|FG000|Overall Study|Physician Decision|3|||
164700842|NCT01300052|594927889|FG000|Overall Study|Protocol Violation|1|||
164700843|NCT01300052|594927890|FG001|Overall Study|Protocol Violation|1|||
164700844|NCT03835325|594927891|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
164700845|NCT03835325|594927891|FG000|Overall Study|Selection failure|1|||
164700846|NCT01546649|594927894|FG000|Overall Study|Adverse Event|4|||
164700847|NCT01546649|594927895|FG001|Overall Study|Adverse Event|5|||
164700848|NCT01546649|594927894|FG000|Overall Study|Protocol Violation|1|||
164700849|NCT01546649|594927895|FG001|Overall Study|Protocol Violation|0|||
164700850|NCT01546649|594927894|FG000|Overall Study|Lack of Efficacy|1|||
164700851|NCT01546649|594927895|FG001|Overall Study|Lack of Efficacy|0|||
164700852|NCT01546649|594927894|FG000|Overall Study|Recurrence|1|||
164700853|NCT01546649|594927895|FG001|Overall Study|Recurrence|1|||
164700854|NCT01546649|594927894|FG000|Overall Study|Discovery of secondary cancer|0|||
164700855|NCT01546649|594927895|FG001|Overall Study|Discovery of secondary cancer|1|||
164700856|NCT01546649|594927894|FG000|Overall Study|Withdrawal by Subject|1|||
164700857|NCT01546649|594927895|FG001|Overall Study|Withdrawal by Subject|2|||
164700858|NCT01370213|594927896|FG000|Overall Study|Early Death|1|||
164379058|NCT00218543|593758692|FG000|Overall Study|Adverse Event|2|||
164700859|NCT01370213|594927897|FG001|Overall Study|Early Death|0|||
164700860|NCT01370213|594927898|FG002|Overall Study|Early Death|0|||
164379059|NCT03265119|593758693|FG000|Overall Study|Adverse Event|2|||
164379060|NCT03265119|593758694|FG001|Overall Study|Adverse Event|1|||
164379061|NCT03265119|593758693|FG000|Overall Study|Lack of Efficacy|3|||
164379062|NCT03265119|593758694|FG001|Overall Study|Lack of Efficacy|0|||
164379063|NCT03265119|593758693|FG000|Overall Study|Protocol Violation|1|||
164379064|NCT03265119|593758694|FG001|Overall Study|Protocol Violation|2|||
164379065|NCT03265119|593758693|FG000|Overall Study|Withdrawal by Subject|2|||
164379066|NCT03265119|593758694|FG001|Overall Study|Withdrawal by Subject|4|||
164379067|NCT03265119|593758693|FG000|Overall Study|Lost to Follow-up|1|||
164379068|NCT03265119|593758694|FG001|Overall Study|Lost to Follow-up|0|||
164439467|NCT01802632|593975395|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
164700861|NCT01370213|594927896|FG000|Overall Study|Not evaluable|0|||
164700862|NCT01370213|594927897|FG001|Overall Study|Not evaluable|2|||
164379069|NCT03265119|593758693|FG000|Overall Study|Lack of Compliance|1|||
164700863|NCT01370213|594927898|FG002|Overall Study|Not evaluable|0|||
164700864|NCT01550744|594927902|FG000|Open-Label|Lost to Follow-up|7|||
164700865|NCT01550744|594927903|FG001|Open-Label|Lost to Follow-up|0|||
164700866|NCT01550744|594927904|FG002|Open-Label|Lost to Follow-up|0|||
164700867|NCT01550744|594927902|FG000|Open-Label|Withdrawal by Subject|13|||
164700868|NCT01550744|594927903|FG001|Open-Label|Withdrawal by Subject|0|||
164379070|NCT03265119|593758694|FG001|Overall Study|Lack of Compliance|0|||
164379071|NCT04740034|593758695|FG000|Overall Study|Death|0|||
164379072|NCT04740034|593758696|FG001|Overall Study|Death|1|||
164379073|NCT04740034|593758697|FG002|Overall Study|Death|2|||
164379074|NCT04740034|593758698|FG003|Overall Study|Death|3|||
164379075|NCT04740034|593758699|FG004|Overall Study|Death|4|||
164379076|NCT04740034|593758700|FG005|Overall Study|Death|4|||
164379077|NCT04740034|593758701|FG006|Overall Study|Death|2|||
164379078|NCT04740034|593758702|FG007|Overall Study|Death|2|||
164379079|NCT04740034|593758703|FG008|Overall Study|Death|2|||
164379080|NCT04740034|593758704|FG009|Overall Study|Death|4|||
164379081|NCT04740034|593758705|FG010|Overall Study|Death|0|||
164379082|NCT04740034|593758695|FG000|Overall Study|Lost to Follow-up|0|||
164379083|NCT04740034|593758696|FG001|Overall Study|Lost to Follow-up|0|||
164379084|NCT04740034|593758697|FG002|Overall Study|Lost to Follow-up|0|||
164379085|NCT04740034|593758698|FG003|Overall Study|Lost to Follow-up|1|||
164379086|NCT04740034|593758699|FG004|Overall Study|Lost to Follow-up|2|||
164379087|NCT04740034|593758700|FG005|Overall Study|Lost to Follow-up|2|||
164379088|NCT04740034|593758701|FG006|Overall Study|Lost to Follow-up|0|||
164379089|NCT04740034|593758702|FG007|Overall Study|Lost to Follow-up|0|||
164379090|NCT04740034|593758703|FG008|Overall Study|Lost to Follow-up|0|||
164379091|NCT04740034|593758704|FG009|Overall Study|Lost to Follow-up|1|||
164379092|NCT04740034|593758705|FG010|Overall Study|Lost to Follow-up|0|||
164379093|NCT04740034|593758695|FG000|Overall Study|Withdrawal by Subject|1|||
164379094|NCT04740034|593758696|FG001|Overall Study|Withdrawal by Subject|0|||
164379095|NCT04740034|593758697|FG002|Overall Study|Withdrawal by Subject|0|||
164379096|NCT04740034|593758698|FG003|Overall Study|Withdrawal by Subject|0|||
164379097|NCT04740034|593758699|FG004|Overall Study|Withdrawal by Subject|0|||
164379098|NCT04740034|593758700|FG005|Overall Study|Withdrawal by Subject|0|||
164379099|NCT04740034|593758701|FG006|Overall Study|Withdrawal by Subject|0|||
164379100|NCT04740034|593758702|FG007|Overall Study|Withdrawal by Subject|1|||
164379101|NCT04740034|593758703|FG008|Overall Study|Withdrawal by Subject|0|||
164379102|NCT04740034|593758704|FG009|Overall Study|Withdrawal by Subject|1|||
164379103|NCT04740034|593758705|FG010|Overall Study|Withdrawal by Subject|0|||
164379104|NCT04740034|593758695|FG000|Overall Study|Decision by sponsor|0|||
164379105|NCT04740034|593758696|FG001|Overall Study|Decision by sponsor|0|||
164379106|NCT04740034|593758697|FG002|Overall Study|Decision by sponsor|1|||
164379107|NCT04740034|593758698|FG003|Overall Study|Decision by sponsor|0|||
164379108|NCT04740034|593758699|FG004|Overall Study|Decision by sponsor|0|||
164379109|NCT04740034|593758700|FG005|Overall Study|Decision by sponsor|0|||
164379110|NCT04740034|593758701|FG006|Overall Study|Decision by sponsor|1|||
164379111|NCT04740034|593758702|FG007|Overall Study|Decision by sponsor|2|||
164379112|NCT04740034|593758703|FG008|Overall Study|Decision by sponsor|1|||
164379113|NCT04740034|593758704|FG009|Overall Study|Decision by sponsor|1|||
164379114|NCT04740034|593758705|FG010|Overall Study|Decision by sponsor|2|||
164379115|NCT02086591|593760351|FG000|Overall Study|Adverse Event|1|||
164379116|NCT02086591|593760351|FG000|Overall Study|Withdrawal by Subject|1|||
164379117|NCT02086591|593760351|FG000|Overall Study|protocol terminated|3|||
164379118|NCT00274716|593760356|FG000|Phase A|Other non-reported reason|4|||
164379119|NCT00274716|593760357|FG001|Phase A|Other non-reported reason|2|||
164379120|NCT00274716|593760358|FG002|Phase A|Other non-reported reason|1|||
164379121|NCT00274716|593760359|FG003|Phase A|Other non-reported reason|2|||
164379122|NCT00274716|593760360|FG004|Phase A|Other non-reported reason|0|||
164379123|NCT00274716|593760361|FG005|Phase A|Other non-reported reason|1|||
164379124|NCT00274716|593760356|FG000|Phase A|Participant moved|0|||
164379125|NCT00274716|593760357|FG001|Phase A|Participant moved|0|||
164379126|NCT00274716|593760358|FG002|Phase A|Participant moved|1|||
164379127|NCT00274716|593760359|FG003|Phase A|Participant moved|0|||
164379128|NCT00274716|593760360|FG004|Phase A|Participant moved|0|||
164379129|NCT00274716|593760361|FG005|Phase A|Participant moved|1|||
164700869|NCT01550744|594927904|FG002|Open-Label|Withdrawal by Subject|0|||
164700870|NCT01550744|594927902|FG000|Open-Label|Adverse Event|11|||
164700871|NCT01550744|594927903|FG001|Open-Label|Adverse Event|0|||
164700872|NCT01550744|594927904|FG002|Open-Label|Adverse Event|0|||
164379130|NCT00274716|593760356|FG000|Phase A|Site Terminated|0|||
164379131|NCT00274716|593760357|FG001|Phase A|Site Terminated|0|||
164379132|NCT00274716|593760358|FG002|Phase A|Site Terminated|0|||
164379133|NCT00274716|593760359|FG003|Phase A|Site Terminated|1|||
164379134|NCT00274716|593760360|FG004|Phase A|Site Terminated|0|||
164379135|NCT00274716|593760361|FG005|Phase A|Site Terminated|0|||
164379136|NCT00274716|593760356|FG000|Phase A|Protocol Violation|1|||
164379137|NCT00274716|593760357|FG001|Phase A|Protocol Violation|0|||
164379138|NCT00274716|593760358|FG002|Phase A|Protocol Violation|0|||
164379139|NCT00274716|593760359|FG003|Phase A|Protocol Violation|1|||
164379140|NCT00274716|593760360|FG004|Phase A|Protocol Violation|0|||
164379141|NCT00274716|593760361|FG005|Phase A|Protocol Violation|0|||
164379142|NCT00274716|593760356|FG000|Phase A|Met criteria for discontinuation|1|||
164379143|NCT00274716|593760357|FG001|Phase A|Met criteria for discontinuation|1|||
164379144|NCT00274716|593760358|FG002|Phase A|Met criteria for discontinuation|0|||
164379145|NCT00274716|593760359|FG003|Phase A|Met criteria for discontinuation|0|||
164379146|NCT00274716|593760360|FG004|Phase A|Met criteria for discontinuation|0|||
164700873|NCT01550744|594927902|FG000|Open-Label|Lack of Efficacy|4|||
164379147|NCT00274716|593760361|FG005|Phase A|Met criteria for discontinuation|0|||
164379148|NCT00274716|593760356|FG000|Phase A|Withdrawal by Subject|2|||
164700874|NCT01550744|594927903|FG001|Open-Label|Lack of Efficacy|0|||
164700875|NCT01550744|594927904|FG002|Open-Label|Lack of Efficacy|0|||
164700876|NCT01550744|594927902|FG000|Open-Label|Protocol Violation|4|||
164379149|NCT00274716|593760357|FG001|Phase A|Withdrawal by Subject|2|||
164379150|NCT00274716|593760358|FG002|Phase A|Withdrawal by Subject|1|||
164379151|NCT00274716|593760359|FG003|Phase A|Withdrawal by Subject|3|||
164379152|NCT00274716|593760360|FG004|Phase A|Withdrawal by Subject|0|||
164379153|NCT00274716|593760361|FG005|Phase A|Withdrawal by Subject|1|||
164379154|NCT00274716|593760356|FG000|Phase A|Adverse Event|2|||
164379155|NCT00274716|593760357|FG001|Phase A|Adverse Event|3|||
164379156|NCT00274716|593760358|FG002|Phase A|Adverse Event|3|||
164379157|NCT00274716|593760359|FG003|Phase A|Adverse Event|0|||
164379158|NCT00274716|593760360|FG004|Phase A|Adverse Event|2|||
164379159|NCT00274716|593760361|FG005|Phase A|Adverse Event|0|||
164379160|NCT00274716|593760356|FG000|Phase A|Completed but did not enter Phase B|1|||
164379161|NCT00274716|593760357|FG001|Phase A|Completed but did not enter Phase B|2|||
164379162|NCT00274716|593760358|FG002|Phase A|Completed but did not enter Phase B|2|||
164379163|NCT00274716|593760359|FG003|Phase A|Completed but did not enter Phase B|2|||
164379164|NCT00274716|593760360|FG004|Phase A|Completed but did not enter Phase B|1|||
164379165|NCT00274716|593760361|FG005|Phase A|Completed but did not enter Phase B|1|||
164379166|NCT00274716|593760356|FG000|Phase B|Adverse Event|0|||
164379167|NCT00274716|593760357|FG001|Phase B|Adverse Event|0|||
164379168|NCT00274716|593760358|FG002|Phase B|Adverse Event|2|||
164379169|NCT00274716|593760359|FG003|Phase B|Adverse Event|0|||
164379170|NCT00274716|593760360|FG004|Phase B|Adverse Event|0|||
164379171|NCT00274716|593760361|FG005|Phase B|Adverse Event|1|||
164379172|NCT00274716|593760356|FG000|Phase B|Protocol Violation|0|||
164379173|NCT00274716|593760357|FG001|Phase B|Protocol Violation|2|||
164379174|NCT00274716|593760358|FG002|Phase B|Protocol Violation|0|||
164379175|NCT00274716|593760359|FG003|Phase B|Protocol Violation|0|||
164379176|NCT00274716|593760360|FG004|Phase B|Protocol Violation|0|||
164379177|NCT00274716|593760361|FG005|Phase B|Protocol Violation|0|||
164379178|NCT00274716|593760356|FG000|Phase B|Withdrawal by Subject|0|||
164379179|NCT00274716|593760357|FG001|Phase B|Withdrawal by Subject|1|||
164379180|NCT00274716|593760358|FG002|Phase B|Withdrawal by Subject|0|||
164379181|NCT00274716|593760359|FG003|Phase B|Withdrawal by Subject|0|||
164379182|NCT00274716|593760360|FG004|Phase B|Withdrawal by Subject|0|||
164379183|NCT00274716|593760361|FG005|Phase B|Withdrawal by Subject|0|||
164379184|NCT00274716|593760356|FG000|Phase B|Participant moved|1|||
164379185|NCT00274716|593760357|FG001|Phase B|Participant moved|0|||
164379186|NCT00274716|593760358|FG002|Phase B|Participant moved|0|||
164379187|NCT00274716|593760359|FG003|Phase B|Participant moved|0|||
164379188|NCT00274716|593760360|FG004|Phase B|Participant moved|0|||
164379189|NCT00274716|593760361|FG005|Phase B|Participant moved|0|||
164379190|NCT00274716|593760356|FG000|Phase B|Other non-reported reason|0|||
164379191|NCT00274716|593760357|FG001|Phase B|Other non-reported reason|0|||
164379192|NCT00274716|593760358|FG002|Phase B|Other non-reported reason|1|||
164379193|NCT00274716|593760359|FG003|Phase B|Other non-reported reason|1|||
164379194|NCT00274716|593760360|FG004|Phase B|Other non-reported reason|0|||
164379195|NCT00274716|593760361|FG005|Phase B|Other non-reported reason|0|||
164379196|NCT00274716|593760356|FG000|Phase B|Lost to Follow-up|0|||
164379197|NCT00274716|593760357|FG001|Phase B|Lost to Follow-up|1|||
164379198|NCT00274716|593760358|FG002|Phase B|Lost to Follow-up|0|||
164379199|NCT00274716|593760359|FG003|Phase B|Lost to Follow-up|0|||
164379200|NCT00274716|593760360|FG004|Phase B|Lost to Follow-up|0|||
164379201|NCT00274716|593760361|FG005|Phase B|Lost to Follow-up|0|||
164700877|NCT01550744|594927903|FG001|Open-Label|Protocol Violation|0|||
164700878|NCT01550744|594927904|FG002|Open-Label|Protocol Violation|0|||
164700879|NCT01550744|594927902|FG000|Open-Label|Not all 3 study drug injections received|2|||
164700880|NCT01550744|594927903|FG001|Open-Label|Not all 3 study drug injections received|0|||
164700881|NCT01550744|594927904|FG002|Open-Label|Not all 3 study drug injections received|0|||
164700882|NCT01550744|594927902|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
164379202|NCT01257204|593760362|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
164379203|NCT01257204|593760363|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
164379204|NCT01257204|593760364|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
164379205|NCT01257204|593760362|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
164379206|NCT01257204|593760363|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
164379207|NCT01257204|593760364|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
164379208|NCT01257204|593760362|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
164379209|NCT01257204|593760363|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
164379210|NCT01257204|593760364|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
164379211|NCT01257204|593760362|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
164379212|NCT01257204|593760363|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
164379213|NCT01257204|593760364|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
164379214|NCT01257204|593760362|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
164700883|NCT01550744|594927903|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
164379215|NCT01257204|593760363|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
164379216|NCT01257204|593760364|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
164379217|NCT01257204|593760362|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
164379218|NCT01257204|593760363|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
164379219|NCT01257204|593760364|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
164379220|NCT01257204|593760362|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
164379221|NCT01257204|593760363|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
164379222|NCT01257204|593760364|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
164379223|NCT01257204|593760362|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
164379224|NCT01257204|593760363|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
164379225|NCT01257204|593760364|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
164379226|NCT01257204|593760362|FG000|Follow-up Period (up to Week 48)|Other|0|||
164379227|NCT01257204|593760363|FG001|Follow-up Period (up to Week 48)|Other|0|||
164379228|NCT01257204|593760364|FG002|Follow-up Period (up to Week 48)|Other|5|||
164379229|NCT02489981|593760366|FG000|Overall Study|Adverse Event|21|||
164379230|NCT02489981|593760366|FG000|Overall Study|Insufficient effectiveness|16|||
164379231|NCT02489981|593760366|FG000|Overall Study|Improved|31|||
164379232|NCT02489981|593760366|FG000|Overall Study|Lost to Follow-up|31|||
164379233|NCT02489981|593760366|FG000|Overall Study|Other than listed|28|||
164379234|NCT01565993|593760367|FG000|Overall Study|Physician Decision|0|||
164379235|NCT01565993|593760368|FG001|Overall Study|Physician Decision|3|||
164379236|NCT04086472|593760371|FG000|Overall Study|Lost to Follow-up|1|||
164379237|NCT04086472|593760372|FG001|Overall Study|Lost to Follow-up|0|||
164379238|NCT04086472|593760373|FG002|Overall Study|Lost to Follow-up|0|||
164379239|NCT04086472|593760374|FG003|Overall Study|Lost to Follow-up|0|||
164379240|NCT04086472|593760375|FG004|Overall Study|Lost to Follow-up|1|||
164379241|NCT04086472|593760371|FG000|Overall Study|Physician Decision|0|||
164379242|NCT04086472|593760372|FG001|Overall Study|Physician Decision|1|||
164379243|NCT04086472|593760373|FG002|Overall Study|Physician Decision|1|||
164379244|NCT04086472|593760374|FG003|Overall Study|Physician Decision|0|||
164379245|NCT04086472|593760375|FG004|Overall Study|Physician Decision|0|||
164379246|NCT04086472|593760371|FG000|Overall Study|Withdrawal by Subject|1|||
164379247|NCT04086472|593760372|FG001|Overall Study|Withdrawal by Subject|1|||
164592121|NCT00630812|594531333|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
164592122|NCT00630812|594531332|FG000|Double Blind Treatment Period|Physician Decision|2|||
164379248|NCT04086472|593760373|FG002|Overall Study|Withdrawal by Subject|1|||
164379249|NCT04086472|593760374|FG003|Overall Study|Withdrawal by Subject|0|||
164379250|NCT04086472|593760375|FG004|Overall Study|Withdrawal by Subject|0|||
164379251|NCT04086472|593760371|FG000|Overall Study|Various reasons|2|||
164379252|NCT04086472|593760372|FG001|Overall Study|Various reasons|0|||
164379253|NCT04086472|593760373|FG002|Overall Study|Various reasons|0|||
164379254|NCT04086472|593760374|FG003|Overall Study|Various reasons|3|||
164379255|NCT04086472|593760375|FG004|Overall Study|Various reasons|1|||
164379256|NCT03348904|593760376|FG000|Overall Study|Administrative reason by the sponsor|0|||
164379257|NCT03348904|593760377|FG001|Overall Study|Administrative reason by the sponsor|1|||
164379258|NCT03348904|593760378|FG002|Overall Study|Administrative reason by the sponsor|0|||
164379259|NCT01513291|593760383|FG000|Treatment Period|Adverse Event|8|||
164379260|NCT01513291|593760384|FG001|Treatment Period|Adverse Event|4|||
164379261|NCT01513291|593760385|FG002|Treatment Period|Adverse Event|0|||
164379262|NCT01513291|593760386|FG003|Treatment Period|Adverse Event|0|||
164379263|NCT01513291|593760387|FG004|Treatment Period|Adverse Event|0|||
164379264|NCT01513291|593760383|FG000|Treatment Period|Lack of Efficacy|3|||
164379265|NCT01513291|593760384|FG001|Treatment Period|Lack of Efficacy|0|||
164379266|NCT01513291|593760385|FG002|Treatment Period|Lack of Efficacy|0|||
164379267|NCT01513291|593760386|FG003|Treatment Period|Lack of Efficacy|0|||
164379268|NCT01513291|593760387|FG004|Treatment Period|Lack of Efficacy|0|||
164379269|NCT01513291|593760383|FG000|Treatment Period|Lost to Follow-up|2|||
164379270|NCT01513291|593760384|FG001|Treatment Period|Lost to Follow-up|3|||
164379271|NCT01513291|593760385|FG002|Treatment Period|Lost to Follow-up|0|||
164379272|NCT01513291|593760386|FG003|Treatment Period|Lost to Follow-up|0|||
164379273|NCT01513291|593760387|FG004|Treatment Period|Lost to Follow-up|0|||
164379274|NCT01513291|593760383|FG000|Treatment Period|Physician Decision|1|||
164379275|NCT01513291|593760384|FG001|Treatment Period|Physician Decision|0|||
164379276|NCT01513291|593760385|FG002|Treatment Period|Physician Decision|0|||
164379277|NCT01513291|593760386|FG003|Treatment Period|Physician Decision|0|||
164379278|NCT01513291|593760387|FG004|Treatment Period|Physician Decision|0|||
164379279|NCT01513291|593760383|FG000|Treatment Period|Protocol Violation|1|||
164379280|NCT01513291|593760384|FG001|Treatment Period|Protocol Violation|2|||
164379281|NCT01513291|593760385|FG002|Treatment Period|Protocol Violation|0|||
164592123|NCT00630812|594531333|FG001|Double Blind Treatment Period|Physician Decision|1|||
164379282|NCT01513291|593760386|FG003|Treatment Period|Protocol Violation|0|||
164379283|NCT01513291|593760387|FG004|Treatment Period|Protocol Violation|0|||
164379284|NCT01513291|593760383|FG000|Treatment Period|Withdrawal by Subject|8|||
164592124|NCT00630812|594531332|FG000|Double Blind Treatment Period|Protocol Violation|1|||
164379285|NCT01513291|593760384|FG001|Treatment Period|Withdrawal by Subject|5|||
164379286|NCT01513291|593760385|FG002|Treatment Period|Withdrawal by Subject|0|||
164379287|NCT01513291|593760386|FG003|Treatment Period|Withdrawal by Subject|0|||
164379288|NCT01513291|593760387|FG004|Treatment Period|Withdrawal by Subject|0|||
164379289|NCT01513291|593760383|FG000|Treatment Period|Randomized not treated|0|||
164379290|NCT01513291|593760384|FG001|Treatment Period|Randomized not treated|2|||
164379291|NCT01513291|593760385|FG002|Treatment Period|Randomized not treated|0|||
164379292|NCT01513291|593760386|FG003|Treatment Period|Randomized not treated|0|||
164379293|NCT01513291|593760387|FG004|Treatment Period|Randomized not treated|0|||
164379294|NCT01513291|593760383|FG000|Run-out Period|Lost to Follow-up|0|||
164379295|NCT01513291|593760384|FG001|Run-out Period|Lost to Follow-up|0|||
164379296|NCT01513291|593760385|FG002|Run-out Period|Lost to Follow-up|0|||
164379297|NCT01513291|593760386|FG003|Run-out Period|Lost to Follow-up|1|||
164379298|NCT01513291|593760387|FG004|Run-out Period|Lost to Follow-up|0|||
164379299|NCT01513291|593760383|FG000|Run-out Period|Withdrawal by Subject|0|||
164379300|NCT01513291|593760384|FG001|Run-out Period|Withdrawal by Subject|0|||
164379301|NCT01513291|593760385|FG002|Run-out Period|Withdrawal by Subject|0|||
164379302|NCT01513291|593760386|FG003|Run-out Period|Withdrawal by Subject|1|||
164379303|NCT01513291|593760387|FG004|Run-out Period|Withdrawal by Subject|0|||
164379304|NCT01034397|593760388|FG000|Overall Study|Lack of compliance|0|||
164379305|NCT01034397|593760389|FG001|Overall Study|Lack of compliance|1|||
164379306|NCT01034397|593760388|FG000|Overall Study|Lack of Efficacy|3|||
164379307|NCT01034397|593760389|FG001|Overall Study|Lack of Efficacy|0|||
164379308|NCT01034397|593760388|FG000|Overall Study|Adverse Event|4|||
164379309|NCT01034397|593760389|FG001|Overall Study|Adverse Event|0|||
164379310|NCT01034397|593760388|FG000|Overall Study|Other|0|||
164379311|NCT01034397|593760389|FG001|Overall Study|Other|1|||
164379312|NCT01931839|593760390|FG000|Overall Study|Death|0|||
164379313|NCT01931839|593760391|FG001|Overall Study|Death|1|||
164379314|NCT01931839|593760392|FG002|Overall Study|Death|2|||
164379315|NCT01931839|593760393|FG003|Overall Study|Death|0|||
164379316|NCT01931839|593760394|FG004|Overall Study|Death|0|||
164379317|NCT01931839|593760395|FG005|Overall Study|Death|0|||
164379318|NCT01931839|593760396|FG006|Overall Study|Death|0|||
164379319|NCT01931839|593760390|FG000|Overall Study|Physician Decision|1|||
164379320|NCT01931839|593760391|FG001|Overall Study|Physician Decision|0|||
164379321|NCT01931839|593760392|FG002|Overall Study|Physician Decision|1|||
164379322|NCT01931839|593760393|FG003|Overall Study|Physician Decision|0|||
164379323|NCT01931839|593760394|FG004|Overall Study|Physician Decision|0|||
164379324|NCT01931839|593760395|FG005|Overall Study|Physician Decision|0|||
164592125|NCT00630812|594531333|FG001|Double Blind Treatment Period|Protocol Violation|0|||
164379325|NCT01931839|593760396|FG006|Overall Study|Physician Decision|1|||
164379326|NCT01931839|593760390|FG000|Overall Study|Withdrawal of consent|0|||
164379327|NCT01931839|593760391|FG001|Overall Study|Withdrawal of consent|0|||
164379328|NCT01931839|593760392|FG002|Overall Study|Withdrawal of consent|0|||
164379329|NCT01931839|593760393|FG003|Overall Study|Withdrawal of consent|0|||
164379330|NCT01931839|593760394|FG004|Overall Study|Withdrawal of consent|1|||
164379331|NCT01931839|593760395|FG005|Overall Study|Withdrawal of consent|0|||
164379332|NCT01931839|593760396|FG006|Overall Study|Withdrawal of consent|0|||
164379333|NCT01931839|593760390|FG000|Overall Study|Adverse Event|9|||
164379334|NCT01931839|593760391|FG001|Overall Study|Adverse Event|4|||
164379335|NCT01931839|593760392|FG002|Overall Study|Adverse Event|1|||
164379336|NCT01931839|593760393|FG003|Overall Study|Adverse Event|3|||
164379337|NCT01931839|593760394|FG004|Overall Study|Adverse Event|0|||
164379338|NCT01931839|593760395|FG005|Overall Study|Adverse Event|0|||
164379339|NCT01931839|593760396|FG006|Overall Study|Adverse Event|1|||
164379340|NCT01931839|593760390|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
164379341|NCT01931839|593760391|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
164379342|NCT01931839|593760392|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
164379343|NCT01931839|593760393|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
164379344|NCT01931839|593760394|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
164379345|NCT01931839|593760395|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
164379346|NCT01931839|593760396|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
164379347|NCT01931839|593760390|FG000|Overall Study|Other non-compliance|15|||
164592126|NCT00630812|594531332|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
164379348|NCT01931839|593760391|FG001|Overall Study|Other non-compliance|9|||
164379349|NCT01931839|593760392|FG002|Overall Study|Other non-compliance|12|||
164379350|NCT01931839|593760393|FG003|Overall Study|Other non-compliance|3|||
164379351|NCT01931839|593760394|FG004|Overall Study|Other non-compliance|0|||
164379352|NCT01931839|593760395|FG005|Overall Study|Other non-compliance|3|||
164379353|NCT01931839|593760396|FG006|Overall Study|Other non-compliance|0|||
164379354|NCT01931839|593760390|FG000|Overall Study|Lost to Follow-up|1|||
164379355|NCT01931839|593760391|FG001|Overall Study|Lost to Follow-up|2|||
164379356|NCT01931839|593760392|FG002|Overall Study|Lost to Follow-up|4|||
164379357|NCT01931839|593760393|FG003|Overall Study|Lost to Follow-up|5|||
164379358|NCT01931839|593760394|FG004|Overall Study|Lost to Follow-up|0|||
164379359|NCT01931839|593760395|FG005|Overall Study|Lost to Follow-up|0|||
164379360|NCT01931839|593760396|FG006|Overall Study|Lost to Follow-up|0|||
164379361|NCT01931839|593760390|FG000|Overall Study|Other|4|||
164379362|NCT01931839|593760391|FG001|Overall Study|Other|2|||
164379363|NCT01931839|593760392|FG002|Overall Study|Other|6|||
164379364|NCT01931839|593760393|FG003|Overall Study|Other|0|||
164379365|NCT01931839|593760394|FG004|Overall Study|Other|0|||
164379366|NCT01931839|593760395|FG005|Overall Study|Other|0|||
164379367|NCT01931839|593760396|FG006|Overall Study|Other|0|||
164379368|NCT01430585|593760397|FG000|Overall Study|Death|1|||
164379369|NCT01430585|593760397|FG000|Overall Study|Objective Progression or Relapse|3|||
164379370|NCT01430585|593760397|FG000|Overall Study|Study Terminated by Sponsor|3|||
164379371|NCT01430585|593760397|FG000|Overall Study|Other|7|||
164379372|NCT01448850|593760398|FG000|Overall Study|Death|3|||
164379373|NCT01448850|593760399|FG001|Overall Study|Death|6|||
164379374|NCT01448850|593760398|FG000|Overall Study|Withdrawal by Subject|13|||
164379375|NCT01448850|593760399|FG001|Overall Study|Withdrawal by Subject|21|||
164379376|NCT01448850|593760398|FG000|Overall Study|Lost to Follow-up|3|||
164379377|NCT01448850|593760399|FG001|Overall Study|Lost to Follow-up|1|||
164379378|NCT01448850|593760398|FG000|Overall Study|Other|15|||
164379379|NCT01448850|593760399|FG001|Overall Study|Other|12|||
164379380|NCT03235024|593760402|FG000|Overall Study|Adverse Event|2|||
164379381|NCT03235024|593760403|FG001|Overall Study|Adverse Event|2|||
164379382|NCT03235024|593760402|FG000|Overall Study|Death|1|||
164379383|NCT03235024|593760403|FG001|Overall Study|Death|0|||
164379384|NCT03235024|593760402|FG000|Overall Study|Lost to Follow-up|2|||
164379385|NCT03235024|593760403|FG001|Overall Study|Lost to Follow-up|5|||
164379386|NCT03235024|593760402|FG000|Overall Study|Protocol Violation|1|||
164379387|NCT03235024|593760403|FG001|Overall Study|Protocol Violation|0|||
164379388|NCT03235024|593760402|FG000|Overall Study|Withdrawal by Subject|0|||
164379389|NCT03235024|593760403|FG001|Overall Study|Withdrawal by Subject|3|||
164379390|NCT02357576|593760404|FG000|Treatment Period|Withdrawal by Subject|0|||
164379391|NCT02357576|593760405|FG001|Treatment Period|Withdrawal by Subject|1|||
164379392|NCT02357576|593760404|FG000|Treatment Period|Physician Decision|0|||
164379393|NCT02357576|593760405|FG001|Treatment Period|Physician Decision|1|||
164379394|NCT02357576|593760404|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
164379395|NCT02357576|593760405|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
164379396|NCT02357576|593760404|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
164379397|NCT02357576|593760405|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
164379398|NCT02357576|593760404|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
164379399|NCT02357576|593760405|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
164379400|NCT02357576|593760404|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
164379401|NCT02357576|593760405|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
164379402|NCT00261716|593760406|FG000|Overall Study|Withdrawal by Subject|6|||
164379403|NCT00261716|593760407|FG001|Overall Study|Withdrawal by Subject|8|||
164379404|NCT00261716|593760406|FG000|Overall Study|Lost to Follow-up|0|||
164379405|NCT00261716|593760407|FG001|Overall Study|Lost to Follow-up|2|||
164379406|NCT00699699|593760410|FG000|Overall Study|Adverse Event|36|||
164379407|NCT00699699|593760410|FG000|Overall Study|Individual different reasons|21|||
164379408|NCT02047110|593760411|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
164379409|NCT02047110|593760412|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
164379410|NCT02047110|593760413|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
164379411|NCT02047110|593760414|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
164379412|NCT02047110|593760411|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
164379413|NCT02047110|593760412|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
164379414|NCT02047110|593760413|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
164379415|NCT02047110|593760414|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
164379416|NCT02047110|593760411|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
164379417|NCT02047110|593760412|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
164379418|NCT02047110|593760413|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
164379419|NCT02047110|593760414|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
164379420|NCT02047110|593760411|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
164379421|NCT02047110|593760412|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
164379422|NCT02047110|593760413|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
164379423|NCT02047110|593760414|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
164379424|NCT02047110|593760411|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
164379425|NCT02047110|593760412|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
164379426|NCT02047110|593760413|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
164379427|NCT02047110|593760414|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
164379428|NCT02047110|593760411|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
164379429|NCT02047110|593760412|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
164379430|NCT02047110|593760413|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
164379431|NCT02047110|593760414|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
164379432|NCT02047110|593760411|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
164379433|NCT02047110|593760412|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
164379434|NCT02047110|593760413|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
164379435|NCT02047110|593760414|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
164379436|NCT02047110|593760411|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
164379437|NCT02047110|593760412|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
164379438|NCT02047110|593760413|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
164379439|NCT02047110|593760414|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
164379440|NCT02047110|593760411|FG000|Escape Treatment Period|Adverse Event|1|||
164379441|NCT02047110|593760412|FG001|Escape Treatment Period|Adverse Event|2|||
164379442|NCT02047110|593760413|FG002|Escape Treatment Period|Adverse Event|2|||
164379443|NCT02047110|593760414|FG003|Escape Treatment Period|Adverse Event|0|||
164379444|NCT02047110|593760411|FG000|Escape Treatment Period|Other than specified|1|||
164379445|NCT02047110|593760412|FG001|Escape Treatment Period|Other than specified|2|||
164379446|NCT02047110|593760413|FG002|Escape Treatment Period|Other than specified|0|||
164379447|NCT02047110|593760414|FG003|Escape Treatment Period|Other than specified|1|||
164379448|NCT02047110|593760411|FG000|OLE Treatment Period|Other than specified|0|||
164379449|NCT02047110|593760412|FG001|OLE Treatment Period|Other than specified|0|||
164379450|NCT02047110|593760413|FG002|OLE Treatment Period|Other than specified|1|||
164379451|NCT02047110|593760414|FG003|OLE Treatment Period|Other than specified|0|||
164379452|NCT00705575|593760415|FG000|Overall Study|Abnormal laboratory value(s)|0|||
164379453|NCT00705575|593760416|FG001|Overall Study|Abnormal laboratory value(s)|3|||
164379454|NCT00705575|593760415|FG000|Overall Study|Abnormal test procedure result(s)|2|||
164379455|NCT00705575|593760416|FG001|Overall Study|Abnormal test procedure result(s)|12|||
164379456|NCT00705575|593760415|FG000|Overall Study|Adverse Event|11|||
164379457|NCT00705575|593760416|FG001|Overall Study|Adverse Event|15|||
164379458|NCT00705575|593760415|FG000|Overall Study|Lost to Follow-up|3|||
164379459|NCT00705575|593760416|FG001|Overall Study|Lost to Follow-up|4|||
164379460|NCT00705575|593760415|FG000|Overall Study|Protocol Violation|2|||
164379461|NCT00705575|593760416|FG001|Overall Study|Protocol Violation|2|||
164379462|NCT00705575|593760415|FG000|Overall Study|Withdrawal by Subject|5|||
164379463|NCT00705575|593760416|FG001|Overall Study|Withdrawal by Subject|10|||
164379464|NCT01000051|593760418|FG000|Overall Study|Withdrawal by Subject|1|||
164379465|NCT01000051|593760419|FG001|Overall Study|Withdrawal by Subject|1|||
164379466|NCT01000051|593760418|FG000|Overall Study|Disease Progression|1|||
164379467|NCT01000051|593760419|FG001|Overall Study|Disease Progression|0|||
164379468|NCT01000051|593760418|FG000|Overall Study|Serious noncompliance|1|||
164379469|NCT01000051|593760419|FG001|Overall Study|Serious noncompliance|0|||
164379470|NCT02170727|593760420|FG000|Overall Study|Lost to Follow-up|1|||
164379471|NCT02170727|593760421|FG001|Overall Study|Lost to Follow-up|0|||
164379472|NCT02170727|593760420|FG000|Overall Study|Withdrawal by Subject|2|||
164379473|NCT02170727|593760421|FG001|Overall Study|Withdrawal by Subject|0|||
164379474|NCT01959581|593760424|FG000|Overall Study|Lost to Follow-up|5|||
164379475|NCT03304379|593760435|FG000|Overall Study|Protocol Violation|8|||
164379476|NCT03304379|593760436|FG001|Overall Study|Protocol Violation|10|||
164379477|NCT03304379|593760437|FG002|Overall Study|Protocol Violation|5|||
164379478|NCT03304379|593760438|FG003|Overall Study|Protocol Violation|0|||
164379479|NCT03304379|593760439|FG004|Overall Study|Protocol Violation|2|||
164379480|NCT03304379|593760435|FG000|Overall Study|Adverse Event|4|||
164379481|NCT03304379|593760436|FG001|Overall Study|Adverse Event|20|||
164379482|NCT03304379|593760437|FG002|Overall Study|Adverse Event|17|||
164379483|NCT03304379|593760438|FG003|Overall Study|Adverse Event|1|||
164379484|NCT03304379|593760439|FG004|Overall Study|Adverse Event|0|||
164379485|NCT03304379|593760435|FG000|Overall Study|Lack of Efficacy|17|||
164379486|NCT03304379|593760436|FG001|Overall Study|Lack of Efficacy|16|||
164379487|NCT03304379|593760437|FG002|Overall Study|Lack of Efficacy|20|||
164379488|NCT03304379|593760438|FG003|Overall Study|Lack of Efficacy|0|||
164379489|NCT03304379|593760439|FG004|Overall Study|Lack of Efficacy|0|||
164379490|NCT03304379|593760435|FG000|Overall Study|Physician Decision|6|||
164379491|NCT03304379|593760436|FG001|Overall Study|Physician Decision|10|||
164379492|NCT03304379|593760437|FG002|Overall Study|Physician Decision|6|||
164379493|NCT03304379|593760438|FG003|Overall Study|Physician Decision|9|||
164379494|NCT03304379|593760439|FG004|Overall Study|Physician Decision|10|||
164379495|NCT03304379|593760435|FG000|Overall Study|Withdrawal by Subject|26|||
164379496|NCT03304379|593760436|FG001|Overall Study|Withdrawal by Subject|58|||
164379497|NCT03304379|593760437|FG002|Overall Study|Withdrawal by Subject|66|||
164379498|NCT03304379|593760438|FG003|Overall Study|Withdrawal by Subject|3|||
164379499|NCT03304379|593760439|FG004|Overall Study|Withdrawal by Subject|5|||
164379500|NCT03304379|593760435|FG000|Overall Study|Lost to Follow-up|8|||
164379501|NCT03304379|593760436|FG001|Overall Study|Lost to Follow-up|24|||
164379502|NCT03304379|593760437|FG002|Overall Study|Lost to Follow-up|35|||
164592127|NCT00630812|594531333|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
164592128|NCT00630812|594531332|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
164592129|NCT00630812|594531333|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
164592130|NCT00630812|594531332|FG000|Double Blind Treatment Period|Non-compliance|0|||
164592131|NCT00630812|594531333|FG001|Double Blind Treatment Period|Non-compliance|1|||
164379503|NCT03304379|593760438|FG003|Overall Study|Lost to Follow-up|4|||
164379504|NCT03304379|593760439|FG004|Overall Study|Lost to Follow-up|0|||
164379505|NCT03304379|593760435|FG000|Overall Study|Death|1|||
164379506|NCT03304379|593760436|FG001|Overall Study|Death|2|||
164379507|NCT03304379|593760437|FG002|Overall Study|Death|0|||
164379508|NCT03304379|593760438|FG003|Overall Study|Death|0|||
164379509|NCT03304379|593760439|FG004|Overall Study|Death|0|||
164379510|NCT03304379|593760435|FG000|Overall Study|Other|0|||
164379511|NCT03304379|593760436|FG001|Overall Study|Other|1|||
164379512|NCT03304379|593760437|FG002|Overall Study|Other|0|||
164379513|NCT03304379|593760438|FG003|Overall Study|Other|0|||
164379514|NCT03304379|593760439|FG004|Overall Study|Other|0|||
164379515|NCT02802345|593760447|FG000|Overall Study|Not Treated|0|||
164379516|NCT02802345|593760448|FG001|Overall Study|Not Treated|1|||
164379517|NCT02802345|593760447|FG000|Overall Study|Adverse Event|28|||
164379518|NCT02802345|593760448|FG001|Overall Study|Adverse Event|20|||
164379519|NCT02802345|593760447|FG000|Overall Study|Withdrawal by Subject|3|||
164379520|NCT02802345|593760448|FG001|Overall Study|Withdrawal by Subject|3|||
164379521|NCT02802345|593760447|FG000|Overall Study|Protocol Violation|0|||
164379522|NCT02802345|593760448|FG001|Overall Study|Protocol Violation|1|||
164379523|NCT02802345|593760447|FG000|Overall Study|Other than listed|1|||
164379524|NCT02802345|593760448|FG001|Overall Study|Other than listed|5|||
164379525|NCT03969212|593760451|FG000|Overall Study|Adverse Event|1|||
164379526|NCT03969212|593760452|FG001|Overall Study|Adverse Event|0|||
164379527|NCT03969212|593760453|FG002|Overall Study|Adverse Event|0|||
164379528|NCT03969212|593760454|FG003|Overall Study|Adverse Event|0|||
164379529|NCT03969212|593760451|FG000|Overall Study|Lost to Follow-up|2|||
164379530|NCT03969212|593760452|FG001|Overall Study|Lost to Follow-up|2|||
164379531|NCT03969212|593760453|FG002|Overall Study|Lost to Follow-up|2|||
164379532|NCT03969212|593760454|FG003|Overall Study|Lost to Follow-up|2|||
164379533|NCT03969212|593760451|FG000|Overall Study|Protocol Violation|0|||
164379534|NCT03969212|593760452|FG001|Overall Study|Protocol Violation|0|||
164379535|NCT03969212|593760453|FG002|Overall Study|Protocol Violation|0|||
164379536|NCT03969212|593760454|FG003|Overall Study|Protocol Violation|1|||
164379537|NCT03969212|593760451|FG000|Overall Study|Withdrawal by Subject|7|||
164379538|NCT03969212|593760452|FG001|Overall Study|Withdrawal by Subject|13|||
164379539|NCT03969212|593760453|FG002|Overall Study|Withdrawal by Subject|5|||
164379540|NCT03969212|593760454|FG003|Overall Study|Withdrawal by Subject|11|||
164379541|NCT03969212|593760451|FG000|Overall Study|Physician Decision|0|||
164379542|NCT03969212|593760452|FG001|Overall Study|Physician Decision|0|||
164379543|NCT03969212|593760453|FG002|Overall Study|Physician Decision|1|||
164379544|NCT03969212|593760454|FG003|Overall Study|Physician Decision|0|||
164379545|NCT03969212|593760451|FG000|Overall Study|Reason not Specified|22|||
164379546|NCT03969212|593760452|FG001|Overall Study|Reason not Specified|23|||
164379547|NCT03969212|593760453|FG002|Overall Study|Reason not Specified|28|||
164379548|NCT03969212|593760454|FG003|Overall Study|Reason not Specified|26|||
164379549|NCT02075320|593760456|FG000|Overall Study|Withdrawal by Subject|2|||
164379550|NCT03773757|593760457|FG000|Overall Study|Withdrawal by Subject|2|||
164379551|NCT03773757|593760458|FG001|Overall Study|Withdrawal by Subject|4|||
164379552|NCT00057746|593760459|FG000|Overall Study|Withdrawal by Subject|0|||
164379553|NCT00057746|593760460|FG001|Overall Study|Withdrawal by Subject|0|||
164379554|NCT00057746|593760461|FG002|Overall Study|Withdrawal by Subject|1|||
164379555|NCT01109316|593760462|FG000|Study Period 1|Adverse Event|0|||
164379556|NCT01109316|593760463|FG001|Study Period 1|Adverse Event|0|||
164439468|NCT01802632|593975396|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
164439469|NCT01802632|593975397|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
164439470|NCT01802632|593975398|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
164439471|NCT01802632|593975399|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
164439472|NCT01802632|593975400|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
164379557|NCT01109316|593760464|FG002|Study Period 1|Adverse Event|1|||
164379558|NCT01109316|593760465|FG003|Study Period 1|Adverse Event|0|||
164379559|NCT01109316|593760466|FG004|Study Period 1|Adverse Event|0|||
164439473|NCT01802632|593975395|FG000|Overall Study|Other (not specified)|0|||
164592132|NCT03430245|594531336|FG000|Overall Study|Withdrawal by Subject|6|||
164379560|NCT01109316|593760467|FG005|Study Period 1|Adverse Event|0|||
164379561|NCT01109316|593760462|FG000|Study Period 1|Lost to Follow-up|0|||
164379562|NCT01109316|593760463|FG001|Study Period 1|Lost to Follow-up|0|||
164379563|NCT01109316|593760464|FG002|Study Period 1|Lost to Follow-up|1|||
164592133|NCT03430245|594531336|FG000|Overall Study|Lost to Follow-up|1|||
164439474|NCT01802632|593975396|FG001|Overall Study|Other (not specified)|0|||
164379564|NCT01109316|593760465|FG003|Study Period 1|Lost to Follow-up|1|||
164379565|NCT01109316|593760466|FG004|Study Period 1|Lost to Follow-up|0|||
164379566|NCT01109316|593760467|FG005|Study Period 1|Lost to Follow-up|0|||
164379567|NCT01109316|593760462|FG000|Study Period 1|Withdrawal by Subject|0|||
164379568|NCT01109316|593760463|FG001|Study Period 1|Withdrawal by Subject|0|||
164379569|NCT01109316|593760464|FG002|Study Period 1|Withdrawal by Subject|1|||
164439475|NCT01802632|593975397|FG002|Overall Study|Other (not specified)|7|||
164379570|NCT01109316|593760465|FG003|Study Period 1|Withdrawal by Subject|0|||
164379571|NCT01109316|593760466|FG004|Study Period 1|Withdrawal by Subject|2|||
164379572|NCT01109316|593760467|FG005|Study Period 1|Withdrawal by Subject|0|||
164379573|NCT01109316|593760462|FG000|Study Period 1|Sponsor Decision|0|||
164379574|NCT01109316|593760463|FG001|Study Period 1|Sponsor Decision|0|||
164379575|NCT01109316|593760464|FG002|Study Period 1|Sponsor Decision|0|||
164379576|NCT01109316|593760465|FG003|Study Period 1|Sponsor Decision|0|||
164379577|NCT01109316|593760466|FG004|Study Period 1|Sponsor Decision|0|||
164379578|NCT01109316|593760467|FG005|Study Period 1|Sponsor Decision|2|||
164379579|NCT01109316|593760462|FG000|Study Period 2|Entry Criteria Not Met|0|||
164379580|NCT01109316|593760463|FG001|Study Period 2|Entry Criteria Not Met|1|||
164379581|NCT01109316|593760464|FG002|Study Period 2|Entry Criteria Not Met|0|||
164379582|NCT01109316|593760465|FG003|Study Period 2|Entry Criteria Not Met|0|||
164379583|NCT01109316|593760466|FG004|Study Period 2|Entry Criteria Not Met|0|||
164379584|NCT01109316|593760467|FG005|Study Period 2|Entry Criteria Not Met|0|||
164379585|NCT01109316|593760462|FG000|Study Period 2|Physician Decision|0|||
164379586|NCT01109316|593760463|FG001|Study Period 2|Physician Decision|0|||
164379587|NCT01109316|593760464|FG002|Study Period 2|Physician Decision|0|||
164379588|NCT01109316|593760465|FG003|Study Period 2|Physician Decision|1|||
164379589|NCT01109316|593760466|FG004|Study Period 2|Physician Decision|0|||
164379590|NCT01109316|593760467|FG005|Study Period 2|Physician Decision|0|||
164379591|NCT01109316|593760462|FG000|Study Period 2|Protocol Violation|1|||
164379592|NCT01109316|593760463|FG001|Study Period 2|Protocol Violation|0|||
164379593|NCT01109316|593760464|FG002|Study Period 2|Protocol Violation|0|||
164379594|NCT01109316|593760465|FG003|Study Period 2|Protocol Violation|0|||
164379595|NCT01109316|593760466|FG004|Study Period 2|Protocol Violation|0|||
164379596|NCT01109316|593760467|FG005|Study Period 2|Protocol Violation|0|||
164379597|NCT01109316|593760462|FG000|Study Period 2|Withdrawal by Subject|0|||
164379598|NCT01109316|593760463|FG001|Study Period 2|Withdrawal by Subject|0|||
164379599|NCT01109316|593760464|FG002|Study Period 2|Withdrawal by Subject|1|||
164439476|NCT01802632|593975398|FG003|Overall Study|Other (not specified)|1|||
164439477|NCT01802632|593975399|FG004|Overall Study|Other (not specified)|0|||
164439478|NCT01802632|593975400|FG005|Overall Study|Other (not specified)|1|||
164439479|NCT03299816|593975401|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
164439480|NCT03299816|593975402|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
164439481|NCT03299816|593975401|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
164439482|NCT03299816|593975402|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
164592134|NCT00578864|594531337|FG000|Overall Study|Death|1|||
164592135|NCT00578864|594531338|FG001|Overall Study|Death|0|||
164592136|NCT01293032|594531342|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
164592137|NCT01293032|594531343|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
164592138|NCT01293032|594531344|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
164592139|NCT01293032|594531345|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
164592140|NCT01293032|594531342|FG000|Treatment|Adverse Event|0|||
164592141|NCT01293032|594531343|FG001|Treatment|Adverse Event|0|||
164592142|NCT01293032|594531344|FG002|Treatment|Adverse Event|1|||
164592143|NCT01293032|594531345|FG003|Treatment|Adverse Event|1|||
164592144|NCT01293032|594531342|FG000|Treatment|Withdrawal by Subject|2|||
164592145|NCT01293032|594531343|FG001|Treatment|Withdrawal by Subject|4|||
164700884|NCT01550744|594927904|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
164700885|NCT01550744|594927902|FG000|Open-Label|Other|1|||
164700886|NCT01550744|594927903|FG001|Open-Label|Other|0|||
164700887|NCT01550744|594927904|FG002|Open-Label|Other|0|||
164700888|NCT01550744|594927902|FG000|Double-Blind|Lost to Follow-up|0|||
164700889|NCT01550744|594927903|FG001|Double-Blind|Lost to Follow-up|6|||
164700890|NCT01550744|594927904|FG002|Double-Blind|Lost to Follow-up|12|||
164700891|NCT01550744|594927902|FG000|Double-Blind|Withdrawal by Subject|0|||
164700892|NCT01550744|594927903|FG001|Double-Blind|Withdrawal by Subject|2|||
164700893|NCT01550744|594927904|FG002|Double-Blind|Withdrawal by Subject|15|||
164592146|NCT01293032|594531344|FG002|Treatment|Withdrawal by Subject|0|||
164700894|NCT01550744|594927902|FG000|Double-Blind|Adverse Event|0|||
164700895|NCT01550744|594927903|FG001|Double-Blind|Adverse Event|4|||
164700896|NCT01550744|594927904|FG002|Double-Blind|Adverse Event|15|||
164700897|NCT01550744|594927902|FG000|Double-Blind|Death|0|||
164700898|NCT01550744|594927903|FG001|Double-Blind|Death|1|||
164700899|NCT01550744|594927904|FG002|Double-Blind|Death|0|||
164700900|NCT01550744|594927902|FG000|Double-Blind|Lack of Efficacy|0|||
164700901|NCT01550744|594927903|FG001|Double-Blind|Lack of Efficacy|2|||
164700902|NCT01550744|594927904|FG002|Double-Blind|Lack of Efficacy|8|||
164700903|NCT01550744|594927902|FG000|Double-Blind|Protocol Violation|0|||
164700904|NCT01550744|594927903|FG001|Double-Blind|Protocol Violation|0|||
164700905|NCT01550744|594927904|FG002|Double-Blind|Protocol Violation|4|||
164700906|NCT01550744|594927902|FG000|Double-Blind|Pregnancy|0|||
164700907|NCT01550744|594927903|FG001|Double-Blind|Pregnancy|0|||
164700908|NCT01550744|594927904|FG002|Double-Blind|Pregnancy|3|||
164700909|NCT01550744|594927902|FG000|Double-Blind|Other|0|||
164700910|NCT01550744|594927903|FG001|Double-Blind|Other|2|||
164379600|NCT01109316|593760465|FG003|Study Period 2|Withdrawal by Subject|0|||
164700911|NCT01550744|594927904|FG002|Double-Blind|Other|10|||
164700912|NCT00706381|594927907|FG000|Overall Study|Lost to Follow-up|0|||
164700913|NCT00706381|594927908|FG001|Overall Study|Lost to Follow-up|1|||
164700914|NCT00706381|594927909|FG002|Overall Study|Lost to Follow-up|1|||
164700915|NCT00706381|594927910|FG003|Overall Study|Lost to Follow-up|0|||
164700916|NCT05420012|594927911|FG000|Overall Study|Lost to Follow-up|0|||
164700917|NCT05420012|594927912|FG001|Overall Study|Lost to Follow-up|1|||
164700918|NCT00038649|594927916|FG000|Overall Study|Adverse Event|9|||
164700919|NCT03395639|594927917|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
164700920|NCT03395639|594927918|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
164700921|NCT03395639|594927919|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
164700922|NCT03395639|594927917|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
164700923|NCT03395639|594927918|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
164700924|NCT03395639|594927919|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
164700925|NCT03395639|594927917|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
164700926|NCT03395639|594927918|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
164700927|NCT03395639|594927919|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
164700928|NCT03395639|594927917|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
164700929|NCT03395639|594927918|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
164700930|NCT03395639|594927919|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
164700931|NCT03395639|594927917|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
164700932|NCT03395639|594927918|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
164700933|NCT03395639|594927919|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
164700934|NCT00995085|594927921|FG000|Overall Study|Withdrawal by Subject|5|||
164700935|NCT01194973|594927923|FG000|Screening Period|Screen Failure|3|||
164379601|NCT01109316|593760466|FG004|Study Period 2|Withdrawal by Subject|0|||
164379602|NCT01109316|593760467|FG005|Study Period 2|Withdrawal by Subject|1|||
164379603|NCT01109316|593760462|FG000|Study Period 3|Lost to Follow-up|0|||
164379604|NCT01109316|593760463|FG001|Study Period 3|Lost to Follow-up|0|||
164379605|NCT01109316|593760464|FG002|Study Period 3|Lost to Follow-up|0|||
164379606|NCT01109316|593760465|FG003|Study Period 3|Lost to Follow-up|0|||
164379607|NCT01109316|593760466|FG004|Study Period 3|Lost to Follow-up|1|||
164379608|NCT01109316|593760467|FG005|Study Period 3|Lost to Follow-up|0|||
164700936|NCT01194973|594927923|FG000|26 Week Treatment Period|Adverse Event|1|||
164700937|NCT01194973|594927923|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
164700938|NCT01194973|594927923|FG000|26 Week Treatment Period|Pregnancy|1|||
164700939|NCT00767520|594927926|FG000|Overall Study|Participants still on treatment|11|||
164700940|NCT00767520|594927927|FG001|Overall Study|Participants still on treatment|15|||
164700941|NCT00767520|594927926|FG000|Overall Study|Randomized in error and Never treated|0|||
164700942|NCT00767520|594927927|FG001|Overall Study|Randomized in error and Never treated|2|||
164700943|NCT01338987|594927928|FG000|Overall Study|enrolled on new protocol|0|||
164700944|NCT01338987|594927929|FG001|Overall Study|enrolled on new protocol|0|||
164700945|NCT01338987|594927930|FG002|Overall Study|enrolled on new protocol|1|||
164700946|NCT01338987|594927931|FG003|Overall Study|enrolled on new protocol|0|||
164700947|NCT01338987|594927932|FG004|Overall Study|enrolled on new protocol|0|||
164700948|NCT01338987|594927928|FG000|Overall Study|Disease progression on study|2|||
164700949|NCT01338987|594927929|FG001|Overall Study|Disease progression on study|1|||
164700950|NCT01338987|594927930|FG002|Overall Study|Disease progression on study|1|||
164700951|NCT01338987|594927931|FG003|Overall Study|Disease progression on study|0|||
164379609|NCT01109316|593760462|FG000|Study Period 3|Withdrawal by Subject|1|||
164439483|NCT03299816|593975401|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
164439484|NCT03299816|593975402|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
164439485|NCT00082810|593975403|FG000|Overall Study|Adverse Event|3|||
164439486|NCT00082810|593975403|FG000|Overall Study|Progressive disease|24|||
164439487|NCT00082810|593975403|FG000|Overall Study|Withdrawal by Subject|4|||
164439488|NCT00177216|593975405|FG000|Overall Study|Withdrawal by Subject|6|||
164439489|NCT00177216|593975406|FG001|Overall Study|Withdrawal by Subject|3|||
164439490|NCT00177216|593975407|FG002|Overall Study|Withdrawal by Subject|1|||
164439491|NCT02685488|593975414|FG000|Overall Study|Withdrawal by Subject|0|||
164439492|NCT02685488|593975415|FG001|Overall Study|Withdrawal by Subject|1|||
164439493|NCT04436120|593975416|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
164439494|NCT04436120|593975417|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
164439495|NCT04436120|593975418|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
164439496|NCT04436120|593975419|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
164439497|NCT04436120|593975420|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
164439498|NCT04436120|593975421|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
164439499|NCT04436120|593975422|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
164379610|NCT01109316|593760463|FG001|Study Period 3|Withdrawal by Subject|0|||
164379611|NCT01109316|593760464|FG002|Study Period 3|Withdrawal by Subject|0|||
164439500|NCT05019729|593975423|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
164532201|NCT00150969|594320500|FG001|24 Month Main Study|Withdrawal by Subject|4|||
164700952|NCT01338987|594927932|FG004|Overall Study|Disease progression on study|0|||
164700953|NCT00706992|594927946|FG000|Overall Study|Study termination|5|||
164379612|NCT01109316|593760465|FG003|Study Period 3|Withdrawal by Subject|0|||
164379613|NCT01109316|593760466|FG004|Study Period 3|Withdrawal by Subject|1|||
164379614|NCT01109316|593760467|FG005|Study Period 3|Withdrawal by Subject|0|||
164379615|NCT02985736|593760474|FG000|Overall Study|Lost to Follow-up|3|||
164379616|NCT00550836|593760475|FG000|Overall Study|Withdrawal by Subject|3|||
164379617|NCT00550836|593760476|FG001|Overall Study|Withdrawal by Subject|9|||
164379618|NCT01826825|593760477|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
164379619|NCT01826825|593760478|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
164379620|NCT01858194|593760479|FG000|Overall Study|Total Artificial Heart Implant|0|||
164379621|NCT01858194|593760480|FG001|Overall Study|Total Artificial Heart Implant|1|||
164379622|NCT01858194|593760479|FG000|Overall Study|Lost to Follow-up|0|||
164379623|NCT01858194|593760480|FG001|Overall Study|Lost to Follow-up|1|||
164379624|NCT02563028|593760482|FG000|Overall Study|Lack of equipment|1|||
164379625|NCT02563028|593760482|FG000|Overall Study|Unable to elicit VEP post induction|1|||
164379626|NCT01856543|593760483|FG000|Overall Study|Treatment discontinued|6|||
164379627|NCT01856543|593760484|FG001|Overall Study|Treatment discontinued|3|||
164379628|NCT01856543|593760483|FG000|Overall Study|Withdrawn before start|7|||
164379629|NCT01856543|593760484|FG001|Overall Study|Withdrawn before start|3|||
164379630|NCT04545515|593760485|FG000|Overall Study|Adverse Event|1|||
164379631|NCT04545515|593760485|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
164379632|NCT04545515|593760485|FG000|Overall Study|Commercial drug is available for participant|7|||
164379633|NCT01552772|593760486|FG000|Overall Study|Lost to Follow-up|2|||
164379634|NCT01552772|593760486|FG000|Overall Study|Adverse Event|1|||
164379635|NCT01552772|593760486|FG000|Overall Study|Protocol Deviation|1|||
164379636|NCT01848990|593760488|FG000|Overall Study|Adverse Event|6|||
164379637|NCT01848990|593760489|FG001|Overall Study|Adverse Event|2|||
164379638|NCT01848990|593760490|FG002|Overall Study|Adverse Event|0|||
164379639|NCT01848990|593760488|FG000|Overall Study|Lost to Follow-up|6|||
164379640|NCT01848990|593760489|FG001|Overall Study|Lost to Follow-up|2|||
164379641|NCT01848990|593760490|FG002|Overall Study|Lost to Follow-up|2|||
164379642|NCT01848990|593760488|FG000|Overall Study|Protocol Violation|1|||
164379643|NCT01848990|593760489|FG001|Overall Study|Protocol Violation|1|||
164379644|NCT01848990|593760490|FG002|Overall Study|Protocol Violation|0|||
164379645|NCT01848990|593760488|FG000|Overall Study|Withdrawal by Subject|29|||
164700954|NCT00706992|594927947|FG001|Overall Study|Study termination|5|||
164700955|NCT00706992|594927948|FG002|Overall Study|Study termination|6|||
164700956|NCT00706992|594927949|FG003|Overall Study|Study termination|2|||
164700957|NCT00706992|594927950|FG004|Overall Study|Study termination|3|||
164700958|NCT00706992|594927951|FG005|Overall Study|Study termination|2|||
164700959|NCT00706992|594927952|FG006|Overall Study|Study termination|3|||
164700960|NCT00706992|594927946|FG000|Overall Study|Disease progression before treatment|0|||
164700961|NCT00706992|594927947|FG001|Overall Study|Disease progression before treatment|0|||
164700962|NCT00706992|594927948|FG002|Overall Study|Disease progression before treatment|0|||
164700963|NCT00706992|594927949|FG003|Overall Study|Disease progression before treatment|0|||
164700964|NCT00706992|594927950|FG004|Overall Study|Disease progression before treatment|1|||
164700965|NCT00706992|594927951|FG005|Overall Study|Disease progression before treatment|0|||
164700966|NCT00706992|594927952|FG006|Overall Study|Disease progression before treatment|0|||
164700967|NCT02025751|594927960|FG000|Overall Study|Lost to Follow-up|1|||
164700968|NCT02025751|594927961|FG001|Overall Study|Lost to Follow-up|0|||
164700969|NCT02025751|594927960|FG000|Overall Study|Adverse Event|0|||
164700970|NCT02025751|594927961|FG001|Overall Study|Adverse Event|1|||
164700971|NCT02025751|594927960|FG000|Overall Study|Physician Decision|0|||
164700972|NCT02025751|594927961|FG001|Overall Study|Physician Decision|1|||
164700973|NCT02025751|594927960|FG000|Overall Study|Withdrawal by Subject|0|||
164700974|NCT02025751|594927961|FG001|Overall Study|Withdrawal by Subject|1|||
164700975|NCT00851643|594927962|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
164700976|NCT00851643|594927963|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
164700977|NCT00851643|594927964|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
164700978|NCT00851643|594927965|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
164700979|NCT00851643|594927966|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
164700980|NCT00851643|594927967|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
164379646|NCT01848990|593760489|FG001|Overall Study|Withdrawal by Subject|10|||
164379647|NCT01848990|593760490|FG002|Overall Study|Withdrawal by Subject|11|||
164379648|NCT01848990|593760488|FG000|Overall Study|Physician Decision|1|||
164379649|NCT01848990|593760489|FG001|Overall Study|Physician Decision|1|||
164379650|NCT01848990|593760490|FG002|Overall Study|Physician Decision|0|||
164700981|NCT00851643|594927962|FG000|Base Study (Up to 12 Months)|Other|0|||
164700982|NCT00851643|594927963|FG001|Base Study (Up to 12 Months)|Other|0|||
164379651|NCT01848990|593760488|FG000|Overall Study|Non Compliance|1|||
164379652|NCT01848990|593760489|FG001|Overall Study|Non Compliance|0|||
164379653|NCT01848990|593760490|FG002|Overall Study|Non Compliance|0|||
164379654|NCT01848990|593760488|FG000|Overall Study|Death|1|||
164700983|NCT00851643|594927964|FG002|Base Study (Up to 12 Months)|Other|0|||
164700984|NCT00851643|594927965|FG003|Base Study (Up to 12 Months)|Other|0|||
164379655|NCT01848990|593760489|FG001|Overall Study|Death|0|||
164700985|NCT00851643|594927966|FG004|Base Study (Up to 12 Months)|Other|0|||
164700986|NCT00851643|594927967|FG005|Base Study (Up to 12 Months)|Other|1|||
164700987|NCT00851643|594927962|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
164700988|NCT00851643|594927963|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
164700989|NCT00851643|594927964|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
164700990|NCT00851643|594927965|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
164700991|NCT00851643|594927966|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
164700992|NCT00851643|594927967|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
164700993|NCT00851643|594927962|FG000|Extension Study (Up to 36 Months)|Moved|0|||
164700994|NCT00851643|594927963|FG001|Extension Study (Up to 36 Months)|Moved|2|||
164700995|NCT00851643|594927964|FG002|Extension Study (Up to 36 Months)|Moved|1|||
164700996|NCT00851643|594927965|FG003|Extension Study (Up to 36 Months)|Moved|1|||
164700997|NCT00851643|594927966|FG004|Extension Study (Up to 36 Months)|Moved|0|||
164700998|NCT00851643|594927967|FG005|Extension Study (Up to 36 Months)|Moved|1|||
164700999|NCT01641133|594927968|FG000|Overall Study|Protocol Violation|0|||
164701000|NCT01641133|594927969|FG001|Overall Study|Protocol Violation|1|||
164701001|NCT01641133|594927970|FG002|Overall Study|Protocol Violation|1|||
164701002|NCT01641133|594927968|FG000|Overall Study|Migrated/moved from study area|5|||
164701003|NCT01641133|594927969|FG001|Overall Study|Migrated/moved from study area|3|||
164701004|NCT01641133|594927970|FG002|Overall Study|Migrated/moved from study area|1|||
164701005|NCT01641133|594927968|FG000|Overall Study|Adverse Event|0|||
164701006|NCT01641133|594927969|FG001|Overall Study|Adverse Event|0|||
164701007|NCT01641133|594927970|FG002|Overall Study|Adverse Event|1|||
164701008|NCT01641133|594927968|FG000|Overall Study|Withdrawal by Subject|5|||
164701009|NCT01641133|594927969|FG001|Overall Study|Withdrawal by Subject|3|||
164701010|NCT01641133|594927970|FG002|Overall Study|Withdrawal by Subject|3|||
164701011|NCT01641133|594927968|FG000|Overall Study|Lost to Follow-up|0|||
164701012|NCT01641133|594927969|FG001|Overall Study|Lost to Follow-up|2|||
164701013|NCT01641133|594927970|FG002|Overall Study|Lost to Follow-up|2|||
164701014|NCT03351231|594927971|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
164701015|NCT03351231|594927971|FG000|Combination Therapy Period|Disease progression|2|||
164701016|NCT03351231|594927971|FG000|Combination Therapy Period|Study drug toxicity|1|||
164701017|NCT03351231|594927971|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
164701018|NCT03351231|594927971|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
164701019|NCT03351231|594927971|FG000|Safety Follow-Up Period|Other reason|2|||
164701020|NCT02340221|594927978|FG000|Overall Study|Death|100|||
164379656|NCT01848990|593760490|FG002|Overall Study|Death|1|||
164379657|NCT01848990|593760488|FG000|Overall Study|Other|1|||
164379658|NCT01848990|593760489|FG001|Overall Study|Other|4|||
164379659|NCT01848990|593760490|FG002|Overall Study|Other|2|||
164379660|NCT00700011|593760491|FG000|Overall Study|Death|0|||
164379661|NCT00700011|593760492|FG001|Overall Study|Death|1|||
164379662|NCT00004031|593760493|FG000|Overall Study|Adverse Event|5|||
164379663|NCT00004031|593760494|FG001|Overall Study|Adverse Event|0|||
164379664|NCT00004031|593760493|FG000|Overall Study|Refusal unrelated to adverse events|2|||
164379665|NCT00004031|593760494|FG001|Overall Study|Refusal unrelated to adverse events|11|||
164379666|NCT00004031|593760493|FG000|Overall Study|Progression/relapse|9|||
164379667|NCT00004031|593760494|FG001|Overall Study|Progression/relapse|4|||
164379668|NCT00004031|593760493|FG000|Overall Study|Death|3|||
164379669|NCT00004031|593760494|FG001|Overall Study|Death|1|||
164379670|NCT00004031|593760493|FG000|Overall Study|Other- not protocol specified|3|||
164379671|NCT00004031|593760494|FG001|Overall Study|Other- not protocol specified|3|||
164379672|NCT00004031|593760493|FG000|Overall Study|Reason under review|3|||
164379673|NCT00004031|593760494|FG001|Overall Study|Reason under review|2|||
164379674|NCT00512096|593760498|FG000|Overall Study|Adverse Event|2|||
164379675|NCT00512096|593760498|FG000|Overall Study|Withdrawal by Subject|2|||
164379676|NCT00512096|593760498|FG000|Overall Study|Lack of Efficacy|3|||
164379677|NCT00298038|593760505|FG000|Overall Study|Lost to Follow-up|0|||
164379678|NCT00298038|593760506|FG001|Overall Study|Lost to Follow-up|1|||
164379679|NCT00298038|593760505|FG000|Overall Study|Liver Transplant|0|||
164379680|NCT00298038|593760506|FG001|Overall Study|Liver Transplant|1|||
164701021|NCT02340221|594927979|FG001|Overall Study|Death|197|||
164701022|NCT02340221|594927978|FG000|Overall Study|Withdrawal by Participant|24|||
164701023|NCT02340221|594927979|FG001|Overall Study|Withdrawal by Participant|37|||
164701024|NCT02340221|594927978|FG000|Overall Study|Lost to Follow-up|4|||
164701025|NCT02340221|594927979|FG001|Overall Study|Lost to Follow-up|15|||
164379681|NCT00298038|593760505|FG000|Overall Study|Protocol Violation|1|||
164379682|NCT00298038|593760506|FG001|Overall Study|Protocol Violation|3|||
164379683|NCT00298038|593760505|FG000|Overall Study|Death|6|||
164379684|NCT00298038|593760506|FG001|Overall Study|Death|3|||
164379685|NCT00298038|593760505|FG000|Overall Study|Withdrawal by Subject|6|||
164379686|NCT00298038|593760506|FG001|Overall Study|Withdrawal by Subject|9|||
164379687|NCT00298038|593760505|FG000|Overall Study|Adverse Event|8|||
164379688|NCT00298038|593760506|FG001|Overall Study|Adverse Event|7|||
164701026|NCT02340221|594927978|FG000|Overall Study|Reason Not Specified|85|||
164701027|NCT02340221|594927979|FG001|Overall Study|Reason Not Specified|165|||
164701028|NCT02340221|594927978|FG000|Overall Study|Study Terminated by Sponsor|1|||
164701029|NCT02340221|594927979|FG001|Overall Study|Study Terminated by Sponsor|3|||
164701030|NCT00518622|594927980|FG000|Overall Study|Lost to Follow-up|0|||
164701031|NCT00518622|594927981|FG001|Overall Study|Lost to Follow-up|0|||
164701032|NCT00518622|594927982|FG002|Overall Study|Lost to Follow-up|1|||
164701033|NCT00518622|594927983|FG003|Overall Study|Lost to Follow-up|0|||
164701034|NCT00518622|594927984|FG004|Overall Study|Lost to Follow-up|0|||
164701035|NCT00518622|594927985|FG005|Overall Study|Lost to Follow-up|0|||
164701036|NCT00518622|594927986|FG006|Overall Study|Lost to Follow-up|0|||
164701037|NCT00518622|594927987|FG007|Overall Study|Lost to Follow-up|0|||
164701038|NCT00518622|594927980|FG000|Overall Study|Study medication taken incorrectly|0|||
164701039|NCT00518622|594927981|FG001|Overall Study|Study medication taken incorrectly|1|||
164701040|NCT00518622|594927982|FG002|Overall Study|Study medication taken incorrectly|0|||
164701041|NCT00518622|594927983|FG003|Overall Study|Study medication taken incorrectly|0|||
164701042|NCT00518622|594927984|FG004|Overall Study|Study medication taken incorrectly|0|||
164701043|NCT00518622|594927985|FG005|Overall Study|Study medication taken incorrectly|0|||
164701044|NCT00518622|594927986|FG006|Overall Study|Study medication taken incorrectly|0|||
164701045|NCT00518622|594927987|FG007|Overall Study|Study medication taken incorrectly|0|||
164379689|NCT00298038|593760505|FG000|Overall Study|Breakthrough overt HE episode|28|||
164379690|NCT00298038|593760506|FG001|Overall Study|Breakthrough overt HE episode|69|||
164379691|NCT00298038|593760505|FG000|Overall Study|Noncompliance|1|||
164379692|NCT00298038|593760506|FG001|Overall Study|Noncompliance|0|||
164379693|NCT00298038|593760505|FG000|Overall Study|Cocaine Abuse|1|||
164379694|NCT00298038|593760506|FG001|Overall Study|Cocaine Abuse|0|||
164379695|NCT00298038|593760505|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
164379696|NCT00298038|593760506|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
164379697|NCT02696096|593760507|FG000|Overall Study|ruled out at screening|1|||
164379698|NCT02696096|593760507|FG000|Overall Study|did not attend second fMRI|1|||
164379699|NCT01940705|593760508|FG000|Overall Study|Lost to Follow-up|1|||
164379700|NCT01940705|593760509|FG001|Overall Study|Lost to Follow-up|3|||
164379701|NCT01940705|593760510|FG002|Overall Study|Lost to Follow-up|2|||
164379702|NCT01940705|593760511|FG003|Overall Study|Lost to Follow-up|2|||
164379703|NCT01940705|593760508|FG000|Overall Study|Withdrawal by Subject|2|||
164379704|NCT01940705|593760509|FG001|Overall Study|Withdrawal by Subject|2|||
164379705|NCT01940705|593760510|FG002|Overall Study|Withdrawal by Subject|3|||
164379706|NCT01940705|593760511|FG003|Overall Study|Withdrawal by Subject|2|||
164379707|NCT01940705|593760508|FG000|Overall Study|Intervention not given|0|||
164379708|NCT01940705|593760509|FG001|Overall Study|Intervention not given|3|||
164379709|NCT01940705|593760510|FG002|Overall Study|Intervention not given|3|||
164379710|NCT01940705|593760511|FG003|Overall Study|Intervention not given|0|||
164379711|NCT01940705|593760508|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
164379712|NCT01940705|593760509|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
164379713|NCT01940705|593760510|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
164379714|NCT01940705|593760511|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
164379715|NCT02447991|593760512|FG000|Overall Study|Withdrawn by subject - no data|0|||
164379716|NCT02447991|593760513|FG001|Overall Study|Withdrawn by subject - no data|2|||
164379717|NCT02447991|593760512|FG000|Overall Study|Withdrawn by Subject - with data|4|||
164379718|NCT02447991|593760513|FG001|Overall Study|Withdrawn by Subject - with data|4|||
164379719|NCT02447991|593760512|FG000|Overall Study|Lost to Follow-up - no data|3|||
164379720|NCT02447991|593760513|FG001|Overall Study|Lost to Follow-up - no data|6|||
164379721|NCT02447991|593760512|FG000|Overall Study|Lost to follow-up - with data|0|||
164379722|NCT02447991|593760513|FG001|Overall Study|Lost to follow-up - with data|3|||
164379723|NCT02447991|593760512|FG000|Overall Study|End of study - no treatment results|3|||
164379724|NCT02447991|593760513|FG001|Overall Study|End of study - no treatment results|6|||
164592147|NCT01293032|594531345|FG003|Treatment|Withdrawal by Subject|0|||
164592148|NCT01293032|594531342|FG000|Treatment|Disease Progression, relapse|0|||
164592149|NCT01293032|594531343|FG001|Treatment|Disease Progression, relapse|1|||
164592150|NCT01293032|594531344|FG002|Treatment|Disease Progression, relapse|0|||
164592151|NCT01293032|594531345|FG003|Treatment|Disease Progression, relapse|0|||
164592152|NCT01253044|594531346|FG000|Overall Study|Lost to Follow-up|38|||
164592153|NCT01253044|594531347|FG001|Overall Study|Lost to Follow-up|29|||
164592154|NCT00938327|594531351|FG000|Overall Study|Adverse Event|2|||
164592155|NCT00938327|594531351|FG000|Overall Study|Protocol Violation|1|||
164592156|NCT00938327|594531351|FG000|Overall Study|Withdrawal by Subject|4|||
164592157|NCT00938327|594531351|FG000|Overall Study|Lost to Follow-up|37|||
164592158|NCT00938327|594531351|FG000|Overall Study|2nd dose received outside of the study|7|||
164592159|NCT00938327|594531351|FG000|Overall Study|Vaccine not received as out of stock|9|||
164592160|NCT01425190|594531352|FG000|Overall Study|Full dose not consumed.|1|||
164592161|NCT01425190|594531353|FG001|Overall Study|Full dose not consumed.|0|||
164592162|NCT01425190|594531354|FG002|Overall Study|Full dose not consumed.|0|||
164592163|NCT02552355|594531356|FG000|Overall Study|Adverse Event|0|||
164592164|NCT02552355|594531357|FG001|Overall Study|Adverse Event|2|||
164592165|NCT02552355|594531358|FG002|Overall Study|Adverse Event|2|||
164701046|NCT00103402|594927988|FG000|Overall Study|Adverse Event|3|||
164701047|NCT00103402|594927989|FG001|Overall Study|Adverse Event|4|||
164701048|NCT00103402|594927988|FG000|Overall Study|Lost to Follow-up|8|||
164701049|NCT00103402|594927989|FG001|Overall Study|Lost to Follow-up|7|||
164701050|NCT00103402|594927988|FG000|Overall Study|Dissatisfied/No longer interested|6|||
164701051|NCT00103402|594927989|FG001|Overall Study|Dissatisfied/No longer interested|6|||
164701052|NCT00103402|594927988|FG000|Overall Study|Personal constraints/Other|5|||
164701053|NCT00103402|594927989|FG001|Overall Study|Personal constraints/Other|0|||
164701054|NCT01902628|594927992|FG000|Overall Study|Withdrawal of participant's consent|7|||
164701055|NCT01902628|594927992|FG000|Overall Study|Adverse Event|41|||
164701056|NCT01902628|594927992|FG000|Overall Study|Lost to Follow-up|35|||
164701057|NCT02522403|594930130|FG000|Overall Study|Lost to Follow-up|2|||
164701058|NCT02522403|594930131|FG001|Overall Study|Lost to Follow-up|2|||
164701059|NCT02522403|594930130|FG000|Overall Study|Withdrawal by Subject|2|||
164701060|NCT02522403|594930131|FG001|Overall Study|Withdrawal by Subject|4|||
164701061|NCT01553279|594930132|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
164701062|NCT01553279|594930133|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
164701063|NCT01553279|594930132|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
164701064|NCT01553279|594930133|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
164701065|NCT01553279|594930132|FG000|Interim Period|Withdrawal by Subject|2|||
164701066|NCT01553279|594930133|FG001|Interim Period|Withdrawal by Subject|2|||
164701067|NCT01553279|594930132|FG000|Interim Period|Lost to Follow-up|1|||
164701068|NCT01553279|594930133|FG001|Interim Period|Lost to Follow-up|0|||
164701069|NCT01553279|594930132|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
164701070|NCT01553279|594930133|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
164701071|NCT01553279|594930132|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
164701072|NCT01553279|594930133|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
164701073|NCT00619112|594930134|FG000|Overall Study|Adverse Event|1|||
164701074|NCT00619112|594930135|FG001|Overall Study|Adverse Event|2|||
164701075|NCT00729248|594930136|FG000|Overall Study|Physician Decision|2|||
164701076|NCT02588950|594930137|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
164701077|NCT02588950|594930138|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
164701078|NCT02588950|594930139|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
164701079|NCT02588950|594930140|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
164701080|NCT02588950|594930137|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
164701081|NCT02588950|594930138|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
164379725|NCT02447991|593760512|FG000|Overall Study|End of study - partial treatment results|0|||
164379726|NCT02447991|593760513|FG001|Overall Study|End of study - partial treatment results|9|||
164439501|NCT05019729|593975424|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
164439502|NCT05019729|593975425|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
164439503|NCT05019729|593975426|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
164439504|NCT05019729|593975427|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
164439505|NCT05019729|593975428|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
164439506|NCT03008915|593975429|FG000|Treatment 1|Withdrawal by Subject|0|||
164439507|NCT03008915|593975430|FG001|Treatment 1|Withdrawal by Subject|1|||
164439508|NCT00712166|593975431|FG000|Overall Study|Noncompliance|0|||
164439509|NCT00712166|593975432|FG001|Overall Study|Noncompliance|1|||
164701082|NCT02588950|594930139|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
164701083|NCT02588950|594930140|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
164701084|NCT05855616|594930141|FG000|Overall Study|Lost to Follow-up|1|||
164701085|NCT05855616|594930142|FG001|Overall Study|Lost to Follow-up|2|||
164701086|NCT00652028|594930145|FG000|Overall Study|Adverse Event|1|||
164379727|NCT00829621|593760514|FG000|Overall Study|Death|1|||
164379728|NCT00829621|593760515|FG001|Overall Study|Death|0|||
164379729|NCT00829621|593760514|FG000|Overall Study|Lost to Follow-up|3|||
164379730|NCT00829621|593760515|FG001|Overall Study|Lost to Follow-up|4|||
164379731|NCT03551210|593760516|FG000|Overall Study|Adverse Event|5|||
164379732|NCT03551210|593760517|FG001|Overall Study|Adverse Event|6|||
164379733|NCT03551210|593760516|FG000|Overall Study|Withdrawal by Subject|1|||
164379734|NCT03551210|593760517|FG001|Overall Study|Withdrawal by Subject|7|||
164379735|NCT03551210|593760516|FG000|Overall Study|Needed in other antibiotic treatment|2|||
164379736|NCT03551210|593760517|FG001|Overall Study|Needed in other antibiotic treatment|5|||
164379737|NCT03551210|593760516|FG000|Overall Study|Lost to Follow-up|1|||
164379738|NCT03551210|593760517|FG001|Overall Study|Lost to Follow-up|1|||
164379739|NCT03551210|593760516|FG000|Overall Study|Absence of visit 4 and 5|1|||
164379740|NCT03551210|593760517|FG001|Overall Study|Absence of visit 4 and 5|0|||
164701087|NCT00652028|594930146|FG001|Overall Study|Adverse Event|0|||
164701088|NCT00652028|594930147|FG002|Overall Study|Adverse Event|0|||
164701089|NCT00652028|594930148|FG003|Overall Study|Adverse Event|0|||
164701090|NCT00652028|594930145|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
164701091|NCT00652028|594930146|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
164701092|NCT00652028|594930147|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
164379741|NCT03551210|593760516|FG000|Overall Study|No drug for dispensing|0|||
164379742|NCT03551210|593760517|FG001|Overall Study|No drug for dispensing|1|||
164379743|NCT04260191|593761829|FG000|Overall Study|Decision by Sponsor|0|||
164379744|NCT04260191|593761830|FG001|Overall Study|Decision by Sponsor|1|||
164379745|NCT04260191|593761831|FG002|Overall Study|Decision by Sponsor|0|||
164379746|NCT04260191|593761829|FG000|Overall Study|Withdrawal by Subject|1|||
164379747|NCT04260191|593761830|FG001|Overall Study|Withdrawal by Subject|0|||
164379748|NCT04260191|593761831|FG002|Overall Study|Withdrawal by Subject|3|||
164379749|NCT04260191|593761829|FG000|Overall Study|Death|4|||
164379750|NCT04260191|593761830|FG001|Overall Study|Death|3|||
164379751|NCT04260191|593761831|FG002|Overall Study|Death|2|||
164379752|NCT02343458|593761832|FG000|Overall Study|Adverse Event|15|||
164379753|NCT02343458|593761833|FG001|Overall Study|Adverse Event|14|||
164379754|NCT02343458|593761834|FG002|Overall Study|Adverse Event|15|||
164379755|NCT02343458|593761835|FG003|Overall Study|Adverse Event|3|||
164379756|NCT02343458|593761832|FG000|Overall Study|Lack of Efficacy|3|||
164379757|NCT02343458|593761833|FG001|Overall Study|Lack of Efficacy|8|||
164379758|NCT02343458|593761834|FG002|Overall Study|Lack of Efficacy|4|||
164379759|NCT02343458|593761835|FG003|Overall Study|Lack of Efficacy|8|||
164379760|NCT02343458|593761832|FG000|Overall Study|Withdrawal by Subject|18|||
164379761|NCT02343458|593761833|FG001|Overall Study|Withdrawal by Subject|17|||
164379762|NCT02343458|593761834|FG002|Overall Study|Withdrawal by Subject|23|||
164379763|NCT02343458|593761835|FG003|Overall Study|Withdrawal by Subject|14|||
164379764|NCT02343458|593761832|FG000|Overall Study|Physician Decision|1|||
164379765|NCT02343458|593761833|FG001|Overall Study|Physician Decision|4|||
164379766|NCT02343458|593761834|FG002|Overall Study|Physician Decision|2|||
164379767|NCT02343458|593761835|FG003|Overall Study|Physician Decision|2|||
164379768|NCT02343458|593761832|FG000|Overall Study|Lost to Follow-up|5|||
164379769|NCT02343458|593761833|FG001|Overall Study|Lost to Follow-up|5|||
164379770|NCT02343458|593761834|FG002|Overall Study|Lost to Follow-up|3|||
164379771|NCT02343458|593761835|FG003|Overall Study|Lost to Follow-up|1|||
164379772|NCT02343458|593761832|FG000|Overall Study|Protocol Violation|2|||
164379773|NCT02343458|593761833|FG001|Overall Study|Protocol Violation|5|||
164379774|NCT02343458|593761834|FG002|Overall Study|Protocol Violation|2|||
164592166|NCT02552355|594531359|FG003|Overall Study|Adverse Event|0|||
164379775|NCT02343458|593761835|FG003|Overall Study|Protocol Violation|2|||
164379776|NCT02343458|593761832|FG000|Overall Study|Protocol Specified Criteria|17|||
164379777|NCT02343458|593761833|FG001|Overall Study|Protocol Specified Criteria|13|||
164379778|NCT02343458|593761834|FG002|Overall Study|Protocol Specified Criteria|14|||
164379779|NCT02343458|593761835|FG003|Overall Study|Protocol Specified Criteria|8|||
164379780|NCT01913041|593761836|FG000|Overall Study|Protocol Violation|35|||
164379781|NCT01913041|593761836|FG000|Overall Study|Withdrawal by Subject|3|||
164379782|NCT01913041|593761836|FG000|Overall Study|Physician Decision|1|||
164379783|NCT01513317|593761837|FG000|Overall Study|Withdrawal by Subject|15|||
164379784|NCT01513317|593761838|FG001|Overall Study|Withdrawal by Subject|4|||
164592167|NCT02552355|594531356|FG000|Overall Study|Withdrawal by Subject|0|||
164592168|NCT02552355|594531357|FG001|Overall Study|Withdrawal by Subject|0|||
164592169|NCT02552355|594531358|FG002|Overall Study|Withdrawal by Subject|0|||
164592170|NCT02552355|594531359|FG003|Overall Study|Withdrawal by Subject|1|||
164592171|NCT01519245|594531360|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
164592172|NCT01519245|594531361|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
164592173|NCT02873715|594531364|FG000|Overall Study|Lost to Follow-up|84|||
164592174|NCT02873715|594531365|FG001|Overall Study|Lost to Follow-up|94|||
164592175|NCT02873715|594531364|FG000|Overall Study|Withdrawal by Subject|7|||
164592176|NCT02873715|594531365|FG001|Overall Study|Withdrawal by Subject|26|||
164592177|NCT00592501|594531371|FG000|Overall Study|Withdrawal by Subject|1|||
164592178|NCT00592501|594531371|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
164592179|NCT02084134|594531372|FG000|Overall Study|Protocol Violation|4|||
164592180|NCT02084134|594531373|FG001|Overall Study|Protocol Violation|2|||
164592181|NCT02084134|594531372|FG000|Overall Study|Death|0|||
164592182|NCT02084134|594531373|FG001|Overall Study|Death|1|||
164592183|NCT04333433|594531374|FG000|Overall Study|Withdrawal by Subject|6|||
164592184|NCT04333433|594531375|FG001|Overall Study|Withdrawal by Subject|3|||
164592185|NCT04333433|594531374|FG000|Overall Study|Death|3|||
164592186|NCT04333433|594531375|FG001|Overall Study|Death|0|||
164592187|NCT04333433|594531374|FG000|Overall Study|Lost to Follow-up|6|||
164592188|NCT04333433|594531375|FG001|Overall Study|Lost to Follow-up|1|||
164592189|NCT04333433|594531374|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
164592190|NCT04333433|594531375|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
164592191|NCT02026271|594531376|FG000|Overall Study|Adverse Event|2|||
164592192|NCT02026271|594531377|FG001|Overall Study|Adverse Event|3|||
164592193|NCT02026271|594531378|FG002|Overall Study|Adverse Event|2|||
164592194|NCT02026271|594531379|FG003|Overall Study|Adverse Event|3|||
164592195|NCT02026271|594531380|FG004|Overall Study|Adverse Event|0|||
164592196|NCT02026271|594531376|FG000|Overall Study|Withdrawal by Subject|0|||
164592197|NCT02026271|594531377|FG001|Overall Study|Withdrawal by Subject|0|||
164592198|NCT02026271|594531378|FG002|Overall Study|Withdrawal by Subject|0|||
164379785|NCT01513317|593761837|FG000|Overall Study|Death|1|||
164379786|NCT01513317|593761838|FG001|Overall Study|Death|1|||
164379787|NCT01513317|593761837|FG000|Overall Study|Study terminated by sponsor|18|||
164379788|NCT01513317|593761838|FG001|Overall Study|Study terminated by sponsor|18|||
164379789|NCT01513317|593761837|FG000|Overall Study|Other|0|||
164379790|NCT01513317|593761838|FG001|Overall Study|Other|1|||
164379791|NCT02564198|593761839|FG000|Overall Study|Withdrawal by Subject|2|||
164379792|NCT02564198|593761840|FG001|Overall Study|Withdrawal by Subject|4|||
164439510|NCT01773122|593975433|FG000|Overall Study|Due to amended age eligibility criteria|3|||
164439511|NCT01773122|593975434|FG001|Overall Study|Due to amended age eligibility criteria|1|||
164439512|NCT01773122|593975435|FG002|Overall Study|Due to amended age eligibility criteria|0|||
164439513|NCT01773122|593975436|FG003|Overall Study|Due to amended age eligibility criteria|1|||
164439514|NCT02289560|593975437|FG000|Overall Study|Lost to Follow-up|6|||
164439515|NCT02289560|593975437|FG000|Overall Study|Alternative Treatment|4|||
164439516|NCT02289560|593975437|FG000|Overall Study|Inadequate Treatment|2|||
164701093|NCT00652028|594930148|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
164701094|NCT00652028|594930145|FG000|Overall Study|Physician Decision|0|||
164701095|NCT00652028|594930146|FG001|Overall Study|Physician Decision|0|||
164701096|NCT00652028|594930147|FG002|Overall Study|Physician Decision|1|||
164701097|NCT00652028|594930148|FG003|Overall Study|Physician Decision|0|||
164701098|NCT02072824|594930149|FG000|Overall Study|Insufficient clinical response|1|||
164701099|NCT02072824|594930150|FG001|Overall Study|Insufficient clinical response|0|||
164701100|NCT02072824|594930151|FG002|Overall Study|Insufficient clinical response|1|||
164701101|NCT02072824|594930149|FG000|Overall Study|No longer willing to participate|1|||
164701102|NCT02072824|594930150|FG001|Overall Study|No longer willing to participate|0|||
164701103|NCT02072824|594930151|FG002|Overall Study|No longer willing to participate|1|||
164701104|NCT02072824|594930149|FG000|Overall Study|Medication error|0|||
164701105|NCT02072824|594930150|FG001|Overall Study|Medication error|1|||
164701106|NCT02072824|594930151|FG002|Overall Study|Medication error|0|||
164701107|NCT02072824|594930149|FG000|Overall Study|Adverse Event|0|||
164701108|NCT02072824|594930150|FG001|Overall Study|Adverse Event|0|||
164701109|NCT02072824|594930151|FG002|Overall Study|Adverse Event|1|||
164701110|NCT01388166|594930152|FG000|Overall Study|Adverse Event|16|||
164701111|NCT01388166|594930152|FG000|Overall Study|Lost to Follow-up|30|||
164701112|NCT01388166|594930152|FG000|Overall Study|Others than specified above|13|||
164701113|NCT00127036|594930154|FG000|Overall Study|Insufficient Data for Analysis|6|||
164701114|NCT00127036|594930155|FG001|Overall Study|Insufficient Data for Analysis|11|||
164701115|NCT00127036|594930154|FG000|Overall Study|Screen Failure|2|||
164701116|NCT00127036|594930155|FG001|Overall Study|Screen Failure|0|||
164701117|NCT01429051|594930158|FG000|Titration Phase|Death|1|||
164701118|NCT01429051|594930158|FG000|Titration Phase|Withdrawal by Subject|7|||
164701119|NCT01429051|594930158|FG000|Titration Phase|Physician Decision|1|||
164701120|NCT01429051|594930158|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
164701121|NCT01429051|594930158|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
164379793|NCT02564198|593761841|FG002|Overall Study|Withdrawal by Subject|0|||
164379794|NCT02564198|593761839|FG000|Overall Study|Adverse Event|0|||
164379795|NCT02564198|593761840|FG001|Overall Study|Adverse Event|1|||
164379796|NCT02564198|593761841|FG002|Overall Study|Adverse Event|0|||
164379797|NCT02866682|593761844|FG000|Overall Study|Death|0|||
164379798|NCT02866682|593761845|FG001|Overall Study|Death|1|||
164379799|NCT02866682|593761844|FG000|Overall Study|Lost to Follow-up|0|||
164379800|NCT02866682|593761845|FG001|Overall Study|Lost to Follow-up|4|||
164379801|NCT02866682|593761844|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
164439517|NCT02289560|593975437|FG000|Overall Study|Withdrawal by Subject|23|||
164439518|NCT01264718|593975438|FG000|Overall Study|Lost to Follow-up|3|||
164439519|NCT01264718|593975439|FG001|Overall Study|Lost to Follow-up|2|||
164439520|NCT01264718|593975438|FG000|Overall Study|Withdrawal by Subject|9|||
164439521|NCT01264718|593975439|FG001|Overall Study|Withdrawal by Subject|15|||
164439522|NCT01264718|593975438|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
164439523|NCT01264718|593975439|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
164439524|NCT02908464|593975440|FG000|Overall Study|Withdrawal by Subject|2|||
164439525|NCT02908464|593975441|FG001|Overall Study|Withdrawal by Subject|1|||
164439526|NCT02908464|593975440|FG000|Overall Study|Found ineligible after randomization|0|||
164439527|NCT02908464|593975441|FG001|Overall Study|Found ineligible after randomization|2|||
164439528|NCT01769391|593975442|FG000|Overall Study|Death|10|||
164701122|NCT01429051|594930158|FG000|Efficacy Phase|Adverse Event|1|||
164439529|NCT01769391|593975443|FG001|Overall Study|Death|1|||
164701123|NCT01429051|594930158|FG000|Efficacy Phase|Death|1|||
164701124|NCT01429051|594930158|FG000|Tolerability Phase|Death|5|||
164701125|NCT01429051|594930158|FG000|Tolerability Phase|Adverse Event|2|||
164701126|NCT01429051|594930158|FG000|Tolerability Phase|Withdrawal by Subject|5|||
164379802|NCT02866682|593761845|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
164379803|NCT02866682|593761844|FG000|Overall Study|Other|0|||
164379804|NCT02866682|593761845|FG001|Overall Study|Other|1|||
164379805|NCT01750268|593761846|FG000|Overall Study|Lost to Follow-up|0|||
164379806|NCT01750268|593761847|FG001|Overall Study|Lost to Follow-up|2|||
164379807|NCT01750268|593761846|FG000|Overall Study|Physician Decision|0|||
164379808|NCT01750268|593761847|FG001|Overall Study|Physician Decision|3|||
164379809|NCT01750268|593761846|FG000|Overall Study|Withdrawal by Subject|2|||
164379810|NCT01750268|593761847|FG001|Overall Study|Withdrawal by Subject|0|||
164379811|NCT01529645|593761850|FG000|Overall Study|Lost to Follow-up|0|||
164379812|NCT01529645|593761851|FG001|Overall Study|Lost to Follow-up|1|||
164379813|NCT01529645|593761852|FG002|Overall Study|Lost to Follow-up|1|||
164379814|NCT01529645|593761853|FG003|Overall Study|Lost to Follow-up|1|||
164379815|NCT01529645|593761854|FG004|Overall Study|Lost to Follow-up|1|||
164379816|NCT01529645|593761855|FG005|Overall Study|Lost to Follow-up|0|||
164379817|NCT01529645|593761856|FG006|Overall Study|Lost to Follow-up|2|||
164379818|NCT01529645|593761857|FG007|Overall Study|Lost to Follow-up|0|||
164379819|NCT01529645|593761858|FG008|Overall Study|Lost to Follow-up|1|||
164379820|NCT01529645|593761859|FG009|Overall Study|Lost to Follow-up|0|||
164379821|NCT01529645|593761850|FG000|Overall Study|SAE - Premature contractions|0|||
164379822|NCT01529645|593761851|FG001|Overall Study|SAE - Premature contractions|0|||
164379823|NCT01529645|593761852|FG002|Overall Study|SAE - Premature contractions|1|||
164379824|NCT01529645|593761853|FG003|Overall Study|SAE - Premature contractions|0|||
164379825|NCT01529645|593761854|FG004|Overall Study|SAE - Premature contractions|0|||
164379826|NCT01529645|593761855|FG005|Overall Study|SAE - Premature contractions|0|||
164379827|NCT01529645|593761856|FG006|Overall Study|SAE - Premature contractions|0|||
164379828|NCT01529645|593761857|FG007|Overall Study|SAE - Premature contractions|0|||
164379829|NCT01529645|593761858|FG008|Overall Study|SAE - Premature contractions|0|||
164379830|NCT01529645|593761859|FG009|Overall Study|SAE - Premature contractions|0|||
164379831|NCT01529645|593761850|FG000|Overall Study|Withdrawal by Subject|2|||
164379832|NCT01529645|593761851|FG001|Overall Study|Withdrawal by Subject|0|||
164379833|NCT01529645|593761852|FG002|Overall Study|Withdrawal by Subject|0|||
164379834|NCT01529645|593761853|FG003|Overall Study|Withdrawal by Subject|1|||
164379835|NCT01529645|593761854|FG004|Overall Study|Withdrawal by Subject|1|||
164379836|NCT01529645|593761855|FG005|Overall Study|Withdrawal by Subject|1|||
164379837|NCT01529645|593761856|FG006|Overall Study|Withdrawal by Subject|0|||
164379838|NCT01529645|593761857|FG007|Overall Study|Withdrawal by Subject|0|||
164379839|NCT01529645|593761858|FG008|Overall Study|Withdrawal by Subject|0|||
164379840|NCT01529645|593761859|FG009|Overall Study|Withdrawal by Subject|0|||
164379841|NCT03455855|593761860|FG000|Overall Study|Lost to Follow-up|4|||
164379842|NCT03455855|593761861|FG001|Overall Study|Lost to Follow-up|2|||
164379843|NCT00924950|593761862|FG000|Overall Study|Lost to Follow-up|2|||
164379844|NCT01602315|593761863|FG000|Overall Study|Protocol Violation|0|||
164379845|NCT01602315|593761864|FG001|Overall Study|Protocol Violation|0|||
164379846|NCT01602315|593761865|FG002|Overall Study|Protocol Violation|0|||
164379847|NCT01602315|593761866|FG003|Overall Study|Protocol Violation|0|||
164379848|NCT01602315|593761867|FG004|Overall Study|Protocol Violation|0|||
164379849|NCT01602315|593761868|FG005|Overall Study|Protocol Violation|1|||
164379850|NCT01602315|593761869|FG006|Overall Study|Protocol Violation|0|||
164379851|NCT01602315|593761863|FG000|Overall Study|Physician Decision|2|||
164379852|NCT01602315|593761864|FG001|Overall Study|Physician Decision|0|||
164379853|NCT01602315|593761865|FG002|Overall Study|Physician Decision|0|||
164379854|NCT01602315|593761866|FG003|Overall Study|Physician Decision|0|||
164379855|NCT01602315|593761867|FG004|Overall Study|Physician Decision|2|||
164379856|NCT01602315|593761868|FG005|Overall Study|Physician Decision|1|||
164379857|NCT01602315|593761869|FG006|Overall Study|Physician Decision|1|||
164379858|NCT01602315|593761863|FG000|Overall Study|Disease progression|6|||
164379859|NCT01602315|593761864|FG001|Overall Study|Disease progression|3|||
164379860|NCT01602315|593761865|FG002|Overall Study|Disease progression|10|||
164379861|NCT01602315|593761866|FG003|Overall Study|Disease progression|1|||
164379862|NCT01602315|593761867|FG004|Overall Study|Disease progression|41|||
164379863|NCT01602315|593761868|FG005|Overall Study|Disease progression|12|||
164439530|NCT01769391|593975442|FG000|Overall Study|Adverse Event|0|||
164439531|NCT01769391|593975443|FG001|Overall Study|Adverse Event|3|||
164379864|NCT01602315|593761869|FG006|Overall Study|Disease progression|15|||
164379865|NCT01602315|593761863|FG000|Overall Study|Death|1|||
164379866|NCT01602315|593761864|FG001|Overall Study|Death|1|||
164379867|NCT01602315|593761865|FG002|Overall Study|Death|1|||
164379868|NCT01602315|593761866|FG003|Overall Study|Death|1|||
164379869|NCT01602315|593761867|FG004|Overall Study|Death|7|||
164379870|NCT01602315|593761868|FG005|Overall Study|Death|2|||
164379871|NCT01602315|593761869|FG006|Overall Study|Death|2|||
164439532|NCT01769391|593975442|FG000|Overall Study|Progressive Disease|1|||
164439533|NCT01769391|593975443|FG001|Overall Study|Progressive Disease|2|||
164379872|NCT01602315|593761863|FG000|Overall Study|Withdrawal by Subject|2|||
164379873|NCT01602315|593761864|FG001|Overall Study|Withdrawal by Subject|0|||
164379874|NCT01602315|593761865|FG002|Overall Study|Withdrawal by Subject|2|||
164379875|NCT01602315|593761866|FG003|Overall Study|Withdrawal by Subject|0|||
164379876|NCT01602315|593761867|FG004|Overall Study|Withdrawal by Subject|6|||
164379877|NCT01602315|593761868|FG005|Overall Study|Withdrawal by Subject|0|||
164379878|NCT01602315|593761869|FG006|Overall Study|Withdrawal by Subject|1|||
164379879|NCT01602315|593761863|FG000|Overall Study|Adverse Event|5|||
164379880|NCT01602315|593761864|FG001|Overall Study|Adverse Event|1|||
164379881|NCT01602315|593761865|FG002|Overall Study|Adverse Event|5|||
164439534|NCT01769391|593975442|FG000|Overall Study|Withdrawal by Subject|4|||
164439535|NCT01769391|593975443|FG001|Overall Study|Withdrawal by Subject|3|||
164439536|NCT01769391|593975442|FG000|Overall Study|Investigator Decision|2|||
164439537|NCT01769391|593975443|FG001|Overall Study|Investigator Decision|0|||
164439538|NCT02351180|593975446|FG000|Overall Study|Withdrawal by Subject|1|||
164439539|NCT02351180|593975447|FG001|Overall Study|Withdrawal by Subject|0|||
164439540|NCT00208767|593975448|FG000|Overall Study|Adverse Event|9|||
164439541|NCT00208767|593975449|FG001|Overall Study|Adverse Event|1|||
164439542|NCT00208767|593975448|FG000|Overall Study|Withdrawal by Subject|14|||
164439543|NCT00208767|593975449|FG001|Overall Study|Withdrawal by Subject|3|||
164439544|NCT00208767|593975448|FG000|Overall Study|Death|1|||
164439545|NCT00208767|593975449|FG001|Overall Study|Death|0|||
164592199|NCT02026271|594531379|FG003|Overall Study|Withdrawal by Subject|0|||
164592200|NCT02026271|594531380|FG004|Overall Study|Withdrawal by Subject|1|||
164439546|NCT00208767|593975448|FG000|Overall Study|Lost to Follow-up|3|||
164439547|NCT00208767|593975449|FG001|Overall Study|Lost to Follow-up|3|||
164439548|NCT02317016|593975450|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
164439549|NCT02317016|593975450|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
164439550|NCT02317016|593975450|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
164439551|NCT02317016|593975450|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
164439552|NCT02317016|593975450|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
164439553|NCT02317016|593975450|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
164439554|NCT02317016|593975450|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
164439555|NCT03545984|593975451|FG000|Overall Study|CSF cases not present during rotation|11|||
164439556|NCT03545984|593975452|FG001|Overall Study|CSF cases not present during rotation|9|||
164439557|NCT03418324|593975453|FG000|Overall Study|Death|0|||
164701127|NCT01429051|594930158|FG000|Tolerability Phase|Physician Decision|1|||
164701128|NCT01429051|594930158|FG000|Tolerability Phase|Other|2|||
164701129|NCT01797835|594930166|FG000|Overall Study|Lost to Follow-up|31|||
164701130|NCT01797835|594930167|FG001|Overall Study|Lost to Follow-up|27|||
164701131|NCT03001219|594930168|FG000|Proof of Concept|Study Termination by Sponsor|0|||
164701132|NCT03001219|594930169|FG001|Proof of Concept|Study Termination by Sponsor|1|||
164701133|NCT03001219|594930168|FG000|Proof of Concept|Withdrawal by Subject|0|||
164701134|NCT03001219|594930169|FG001|Proof of Concept|Withdrawal by Subject|4|||
164701135|NCT03001219|594930168|FG000|Proof of Concept|Protocol Deviation|0|||
164701136|NCT03001219|594930169|FG001|Proof of Concept|Protocol Deviation|1|||
164701137|NCT03001219|594930168|FG000|Proof of Concept|Adverse Event|1|||
164701138|NCT03001219|594930169|FG001|Proof of Concept|Adverse Event|1|||
164701139|NCT03001219|594930168|FG000|Proof of Concept|Physician Decision|1|||
164701140|NCT03001219|594930169|FG001|Proof of Concept|Physician Decision|0|||
164701141|NCT03001219|594930168|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
164701142|NCT03001219|594930169|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
164701143|NCT03001219|594930168|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
164701144|NCT03001219|594930169|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
164701145|NCT03001219|594930168|FG000|Extension Period Analysis|Physician Decision|0|||
164701146|NCT03001219|594930169|FG001|Extension Period Analysis|Physician Decision|1|||
164701147|NCT03001219|594930168|FG000|Extension Period Analysis|Adverse Event|1|||
164701148|NCT03001219|594930169|FG001|Extension Period Analysis|Adverse Event|1|||
164701149|NCT03001219|594930168|FG000|Extension Period Analysis|Protocol Deviation|0|||
164701150|NCT03001219|594930169|FG001|Extension Period Analysis|Protocol Deviation|1|||
164701151|NCT03001219|594930168|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
164701152|NCT03001219|594930169|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
164701153|NCT01403064|594930170|FG000|Overall Study|Death|0|||
164701154|NCT01403064|594930171|FG001|Overall Study|Death|0|||
164439558|NCT03418324|593975454|FG001|Overall Study|Death|1|||
164592201|NCT02807454|594531381|FG000|Overall Study|Adverse Event|1|||
164592202|NCT02807454|594531382|FG001|Overall Study|Adverse Event|0|||
164592203|NCT02807454|594531381|FG000|Overall Study|Withdrawal by Subject|0|||
164592204|NCT02807454|594531382|FG001|Overall Study|Withdrawal by Subject|1|||
164592205|NCT02807454|594531381|FG000|Overall Study|Progressive Disease|30|||
164592206|NCT02807454|594531382|FG001|Overall Study|Progressive Disease|3|||
164701155|NCT01403064|594930172|FG002|Overall Study|Death|1|||
164701156|NCT01403064|594930173|FG003|Overall Study|Death|1|||
164701157|NCT01403064|594930170|FG000|Overall Study|Withdrawal by Subject|0|||
164439559|NCT03418324|593975453|FG000|Overall Study|Physician Decision|1|||
164439560|NCT03418324|593975454|FG001|Overall Study|Physician Decision|1|||
164439561|NCT01768676|593975455|FG000|Overall Study|Adverse Event|3|||
164592207|NCT02807454|594531381|FG000|Overall Study|Other Reasons|1|||
164592208|NCT02807454|594531382|FG001|Overall Study|Other Reasons|1|||
164592209|NCT05468086|594531385|FG000|Overall Study|Withdrawal by Subject|3|||
164439562|NCT01768676|593975456|FG001|Overall Study|Adverse Event|3|||
164439563|NCT01768676|593975455|FG000|Overall Study|Lost to Follow-up|13|||
164439564|NCT01768676|593975456|FG001|Overall Study|Lost to Follow-up|16|||
164592210|NCT05468086|594531385|FG000|Overall Study|Subject was found ineligible after consent|1|||
164701158|NCT01403064|594930171|FG001|Overall Study|Withdrawal by Subject|0|||
164379882|NCT01602315|593761866|FG003|Overall Study|Adverse Event|4|||
164379883|NCT01602315|593761867|FG004|Overall Study|Adverse Event|15|||
164379884|NCT01602315|593761868|FG005|Overall Study|Adverse Event|3|||
164379885|NCT01602315|593761869|FG006|Overall Study|Adverse Event|9|||
164379886|NCT01602315|593761863|FG000|Overall Study|Subject/guardian decision|0|||
164379887|NCT01602315|593761864|FG001|Overall Study|Subject/guardian decision|0|||
164379888|NCT01602315|593761865|FG002|Overall Study|Subject/guardian decision|0|||
164379889|NCT01602315|593761866|FG003|Overall Study|Subject/guardian decision|0|||
164439565|NCT01768676|593975455|FG000|Overall Study|Protocol Violation|1|||
164439566|NCT01768676|593975456|FG001|Overall Study|Protocol Violation|1|||
164439567|NCT01768676|593975455|FG000|Overall Study|Physician Decision|4|||
164439568|NCT01768676|593975456|FG001|Overall Study|Physician Decision|1|||
164439569|NCT01768676|593975455|FG000|Overall Study|Withdrawal by Subject|3|||
164439570|NCT01768676|593975456|FG001|Overall Study|Withdrawal by Subject|10|||
164439571|NCT00605033|593975457|FG000|Overall Study|Adverse Event|2|||
164439572|NCT00605033|593975458|FG001|Overall Study|Adverse Event|2|||
164439573|NCT00605033|593975457|FG000|Overall Study|Lost to Follow-up|1|||
164439574|NCT00605033|593975458|FG001|Overall Study|Lost to Follow-up|1|||
164439575|NCT00605033|593975457|FG000|Overall Study|Withdrawal by Subject|3|||
164439576|NCT00605033|593975458|FG001|Overall Study|Withdrawal by Subject|4|||
164439577|NCT00605033|593975457|FG000|Overall Study|Protocol Violation|1|||
164439578|NCT00605033|593975458|FG001|Overall Study|Protocol Violation|1|||
164439579|NCT03121950|593975459|FG000|Overall Study|Withdrawal by Subject|11|||
164439580|NCT03121950|593975460|FG001|Overall Study|Withdrawal by Subject|2|||
164439581|NCT00849147|593975461|FG000|Overall Study|Withdrawal by Subject|1|||
164439582|NCT00849147|593975461|FG000|Overall Study|Protocol Violation|2|||
164439583|NCT00849147|593975461|FG000|Overall Study|Disease Relapse/Progression|2|||
164439584|NCT03175172|593977151|FG000|Overall Study|Death|3|||
164439585|NCT03175172|593977151|FG000|Overall Study|Withdrawal by Subject|3|||
164439586|NCT03175172|593977151|FG000|Overall Study|Lost to Follow-up|1|||
164439587|NCT03175172|593977151|FG000|Overall Study|Study Terminated by Sponsor|3|||
164439588|NCT00028769|593977154|FG000|Overall Study|Adverse Event|2|||
164439589|NCT00028769|593977154|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
164439590|NCT00028769|593977154|FG000|Overall Study|Progression or Death|31|||
164439591|NCT00028769|593977154|FG000|Overall Study|Other - Not Protocol Specified|1|||
164439592|NCT00028769|593977154|FG000|Overall Study|Ineligible|5|||
164439593|NCT00028769|593977154|FG000|Overall Study|Not Analyzable|1|||
164439594|NCT02496702|593977157|FG000|Overall Study|Lost to Follow-up|8|||
164439595|NCT02496702|593977158|FG001|Overall Study|Lost to Follow-up|6|||
164439596|NCT02496702|593977157|FG000|Overall Study|Only partially tested|0|||
164439597|NCT02496702|593977158|FG001|Overall Study|Only partially tested|2|||
164439598|NCT02983617|593977159|FG000|Overall Study|Adverse Event|0|||
164439599|NCT02983617|593977160|FG001|Overall Study|Adverse Event|7|||
164439600|NCT02983617|593977159|FG000|Overall Study|Death|0|||
164439601|NCT02983617|593977160|FG001|Overall Study|Death|1|||
164439602|NCT02983617|593977159|FG000|Overall Study|Investigator's Discretion|0|||
164439603|NCT02983617|593977160|FG001|Overall Study|Investigator's Discretion|1|||
164439604|NCT02027558|593977163|FG000|Overall Study|Death|0|||
164439605|NCT02027558|593977164|FG001|Overall Study|Death|1|||
164439606|NCT02027558|593977163|FG000|Overall Study|Withdrawal by Subject|2|||
164439607|NCT02027558|593977164|FG001|Overall Study|Withdrawal by Subject|0|||
164439608|NCT02027558|593977163|FG000|Overall Study|Lost to Follow-up|4|||
164439609|NCT02027558|593977164|FG001|Overall Study|Lost to Follow-up|1|||
164439610|NCT02027558|593977163|FG000|Overall Study|Refused assessment|3|||
164439611|NCT02027558|593977164|FG001|Overall Study|Refused assessment|0|||
164439612|NCT02698891|593977165|FG000|Overall Study|Withdrawal by Subject|2|||
164439613|NCT02698891|593977165|FG000|Overall Study|deemed ineligible|1|||
164439614|NCT02698891|593977165|FG000|Overall Study|Adverse Event|9|||
164439615|NCT00516386|593977166|FG000|Overall Study|not interested in the study|4|||
164592211|NCT01108809|594531386|FG000|Overall Study|Adverse Event|3|||
164439616|NCT00516386|593977166|FG000|Overall Study|Lost to Follow-up|2|||
164439617|NCT00002842|593977167|FG000|Overall Study|ineligible for surgical resection|27|||
164439618|NCT00393848|593977168|FG000|Overall Study|Surgical schedule|0|||
164439619|NCT00393848|593977169|FG001|Overall Study|Surgical schedule|0|||
164439620|NCT00393848|593977170|FG002|Overall Study|Surgical schedule|0|||
164439621|NCT00393848|593977171|FG003|Overall Study|Surgical schedule|1|||
164439622|NCT00393848|593977168|FG000|Overall Study|Personal reasons|0|||
164439623|NCT00393848|593977169|FG001|Overall Study|Personal reasons|0|||
164439624|NCT00393848|593977170|FG002|Overall Study|Personal reasons|2|||
164439625|NCT00393848|593977171|FG003|Overall Study|Personal reasons|0|||
164439626|NCT02694978|593977174|FG000|Overall Study|Adverse Event|10|||
164439627|NCT02694978|593977175|FG001|Overall Study|Adverse Event|9|||
164592212|NCT01108809|594531386|FG000|Overall Study|Lost to Follow-up|1|||
164592213|NCT00001262|594531392|FG000|Overall Study|Death|10|||
164592214|NCT00001262|594531393|FG001|Overall Study|Death|11|||
164592215|NCT00001262|594531394|FG002|Overall Study|Death|0|||
164439628|NCT02694978|593977174|FG000|Overall Study|Withdrawal by Subject|22|||
164379890|NCT01602315|593761867|FG004|Overall Study|Subject/guardian decision|0|||
164439629|NCT02694978|593977175|FG001|Overall Study|Withdrawal by Subject|19|||
164379891|NCT01602315|593761868|FG005|Overall Study|Subject/guardian decision|0|||
164379892|NCT01602315|593761869|FG006|Overall Study|Subject/guardian decision|1|||
164379893|NCT01602315|593761863|FG000|Overall Study|Cross-over patients to combo treatment|0|||
164379894|NCT01602315|593761864|FG001|Overall Study|Cross-over patients to combo treatment|0|||
164379895|NCT01602315|593761865|FG002|Overall Study|Cross-over patients to combo treatment|0|||
164379896|NCT01602315|593761866|FG003|Overall Study|Cross-over patients to combo treatment|0|||
164379897|NCT01602315|593761867|FG004|Overall Study|Cross-over patients to combo treatment|0|||
164379898|NCT01602315|593761868|FG005|Overall Study|Cross-over patients to combo treatment|16|||
164379899|NCT01602315|593761869|FG006|Overall Study|Cross-over patients to combo treatment|0|||
164379900|NCT02212730|593761872|FG000|Overall Study|Tumor not of the required cell histology|1|||
164379901|NCT02212730|593761873|FG001|Overall Study|Tumor not of the required cell histology|0|||
164379902|NCT02212730|593761872|FG000|Overall Study|Withdrawal by Subject|1|||
164379903|NCT02212730|593761873|FG001|Overall Study|Withdrawal by Subject|0|||
164379904|NCT02212730|593761872|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
164379905|NCT02212730|593761873|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
164379906|NCT00961259|593761874|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
164379907|NCT00961259|593761875|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
164379908|NCT00961259|593761876|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
164379909|NCT02691455|593761879|FG000|Overall Study|Withdrawal by Subject|1|||
164701159|NCT01403064|594930172|FG002|Overall Study|Withdrawal by Subject|1|||
164701160|NCT01403064|594930173|FG003|Overall Study|Withdrawal by Subject|1|||
164701161|NCT01403064|594930170|FG000|Overall Study|Other|1|||
164701162|NCT01403064|594930171|FG001|Overall Study|Other|0|||
164701163|NCT01403064|594930172|FG002|Overall Study|Other|2|||
164701164|NCT01403064|594930173|FG003|Overall Study|Other|1|||
164701165|NCT00973765|594930174|FG000|Overall Study|Lost to Follow-up|8|||
164701166|NCT00973765|594930175|FG001|Overall Study|Lost to Follow-up|14|||
164701167|NCT02669940|594930176|FG000|Overall Study|Failure to return|0|||
164701168|NCT02669940|594930177|FG001|Overall Study|Failure to return|3|||
164701169|NCT02669940|594930176|FG000|Overall Study|Insufficient follow-up data|1|||
164701170|NCT02669940|594930177|FG001|Overall Study|Insufficient follow-up data|0|||
164701171|NCT01892657|594930178|FG000|Overall Study|Withdrawal by Subject|6|||
164701172|NCT01892657|594930178|FG000|Overall Study|Protocol Violation|12|||
164701173|NCT00986180|594930179|FG000|Overall Study|Adverse Event|21|||
164701174|NCT00986180|594930180|FG001|Overall Study|Adverse Event|23|||
164701175|NCT00986180|594930179|FG000|Overall Study|Lack of Efficacy|4|||
164701176|NCT00986180|594930180|FG001|Overall Study|Lack of Efficacy|3|||
164701177|NCT00986180|594930179|FG000|Overall Study|Lost to Follow-up|5|||
164701178|NCT00986180|594930180|FG001|Overall Study|Lost to Follow-up|7|||
164701179|NCT00986180|594930179|FG000|Overall Study|Physician Decision|1|||
164701180|NCT00986180|594930180|FG001|Overall Study|Physician Decision|3|||
164701181|NCT00986180|594930179|FG000|Overall Study|Protocol Violation|2|||
164701182|NCT00986180|594930180|FG001|Overall Study|Protocol Violation|0|||
164701183|NCT00986180|594930179|FG000|Overall Study|Withdrawal by Subject|1|||
164701184|NCT00986180|594930180|FG001|Overall Study|Withdrawal by Subject|9|||
164701185|NCT00986180|594930179|FG000|Overall Study|Miscellanies|10|||
164701186|NCT00986180|594930180|FG001|Overall Study|Miscellanies|11|||
164701187|NCT03579966|594930190|FG000|Overall Study|Adverse Event|6|||
164701188|NCT03579966|594930190|FG000|Overall Study|Lost to Follow-up|4|||
164701189|NCT03579966|594930190|FG000|Overall Study|Physician Decision|10|||
164701190|NCT03579966|594930190|FG000|Overall Study|Pregnancy|1|||
164701191|NCT03579966|594930190|FG000|Overall Study|Withdrawal by Subject|16|||
164701192|NCT03579966|594930190|FG000|Overall Study|Study terminated by Sponsor|22|||
164701193|NCT03579966|594930190|FG000|Overall Study|Protocol Violation|1|||
164701194|NCT02408068|594930191|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
164701195|NCT02408068|594930192|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
164701196|NCT02408068|594930193|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
164701197|NCT02408068|594930194|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
164701198|NCT02408068|594930195|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
164701199|NCT02408068|594930196|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
164379910|NCT02691455|593761880|FG001|Overall Study|Withdrawal by Subject|2|||
164379911|NCT02691455|593761879|FG000|Overall Study|Lost to Follow-up|15|||
164701200|NCT03484117|594930200|FG000|Overall Study|Lost to Follow-up|1|||
164701201|NCT03484117|594930201|FG001|Overall Study|Lost to Follow-up|3|||
164701202|NCT03484117|594930200|FG000|Overall Study|Declined participation in exit assess|1|||
164439630|NCT02694978|593977174|FG000|Overall Study|Lost to Follow-up|14|||
164439631|NCT02694978|593977175|FG001|Overall Study|Lost to Follow-up|17|||
164701203|NCT03484117|594930201|FG001|Overall Study|Declined participation in exit assess|1|||
164701204|NCT03551496|594930202|FG000|Overall Study|Death|11|||
164701205|NCT03551496|594930203|FG001|Overall Study|Death|7|||
164701206|NCT03551496|594930202|FG000|Overall Study|Withdrawal by Subject|4|||
164701207|NCT03551496|594930203|FG001|Overall Study|Withdrawal by Subject|3|||
164701208|NCT03551496|594930202|FG000|Overall Study|Other Reasons|1|||
164701209|NCT03551496|594930203|FG001|Overall Study|Other Reasons|0|||
164701210|NCT00942331|594930206|FG000|Overall Study|Did not start treatment|15|||
164701211|NCT00942331|594930207|FG001|Overall Study|Did not start treatment|22|||
164701212|NCT00567476|594930211|FG000|Overall Study|Adverse Event|2|||
164701213|NCT00567476|594930212|FG001|Overall Study|Adverse Event|0|||
164701214|NCT00567476|594930211|FG000|Overall Study|Pregnancy|1|||
164701215|NCT00567476|594930212|FG001|Overall Study|Pregnancy|0|||
164701216|NCT00567476|594930211|FG000|Overall Study|Protocol Violation|4|||
164701217|NCT00567476|594930212|FG001|Overall Study|Protocol Violation|1|||
164701218|NCT00567476|594930211|FG000|Overall Study|Lost to Follow-up|0|||
164701219|NCT00567476|594930212|FG001|Overall Study|Lost to Follow-up|1|||
164701220|NCT00567476|594930211|FG000|Overall Study|Administrative issues|1|||
164701221|NCT00567476|594930212|FG001|Overall Study|Administrative issues|0|||
164701222|NCT00567476|594930211|FG000|Overall Study|Medical Decision|0|||
164701223|NCT00567476|594930212|FG001|Overall Study|Medical Decision|1|||
164701224|NCT00567476|594930211|FG000|Overall Study|Non-adherence to protocol|0|||
164701225|NCT00567476|594930212|FG001|Overall Study|Non-adherence to protocol|1|||
164701226|NCT03856593|594930215|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
164701227|NCT03856593|594930216|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
164701228|NCT02595008|594930217|FG000|Overall Study|Enrolled In Error|1|||
164701229|NCT02595008|594930218|FG001|Overall Study|Enrolled In Error|0|||
164701230|NCT03407118|594930219|FG000|Period 2|Withdrawal by Subject|1|||
164701231|NCT03407118|594930220|FG001|Period 2|Withdrawal by Subject|0|||
164701232|NCT01347866|594930237|FG000|Overall Study|Death|0|||
164701233|NCT01347866|594930238|FG001|Overall Study|Death|0|||
164701234|NCT01347866|594930239|FG002|Overall Study|Death|0|||
164701235|NCT01347866|594930240|FG003|Overall Study|Death|1|||
164701236|NCT01347866|594930241|FG004|Overall Study|Death|2|||
164701237|NCT01347866|594930242|FG005|Overall Study|Death|2|||
164701238|NCT01347866|594930243|FG006|Overall Study|Death|1|||
164701239|NCT01347866|594930244|FG007|Overall Study|Death|0|||
164701240|NCT01347866|594930245|FG008|Overall Study|Death|4|||
164701241|NCT01347866|594930246|FG009|Overall Study|Death|1|||
164701242|NCT01347866|594930247|FG010|Overall Study|Death|3|||
164701243|NCT01347866|594930248|FG011|Overall Study|Death|1|||
164701244|NCT01347866|594930249|FG012|Overall Study|Death|2|||
164701245|NCT01347866|594930250|FG013|Overall Study|Death|0|||
164701246|NCT01347866|594930251|FG014|Overall Study|Death|0|||
164701247|NCT01347866|594930252|FG015|Overall Study|Death|1|||
164701248|NCT01347866|594930253|FG016|Overall Study|Death|0|||
164701249|NCT01347866|594930237|FG000|Overall Study|Lost to Follow-up|0|||
164701250|NCT01347866|594930238|FG001|Overall Study|Lost to Follow-up|0|||
164701251|NCT01347866|594930239|FG002|Overall Study|Lost to Follow-up|0|||
164701252|NCT01347866|594930240|FG003|Overall Study|Lost to Follow-up|0|||
164701253|NCT01347866|594930241|FG004|Overall Study|Lost to Follow-up|0|||
164379912|NCT02691455|593761880|FG001|Overall Study|Lost to Follow-up|15|||
164379913|NCT03394391|593761881|FG000|Overall Study|Lost to Follow-up|1|||
164379914|NCT03394391|593761882|FG001|Overall Study|Lost to Follow-up|2|||
164379915|NCT00723801|593761887|FG000|Overall Study|Lost to Follow-up|1|||
164379916|NCT00723801|593761888|FG001|Overall Study|Lost to Follow-up|2|||
164379917|NCT00723801|593761887|FG000|Overall Study|Protocol Violation|2|||
164379918|NCT00723801|593761888|FG001|Overall Study|Protocol Violation|1|||
164379919|NCT01532687|593761899|FG000|Overall Study|Death|2|||
164379920|NCT01532687|593761900|FG001|Overall Study|Death|0|||
164379921|NCT01532687|593761899|FG000|Overall Study|Adverse Event|6|||
164379922|NCT01532687|593761900|FG001|Overall Study|Adverse Event|1|||
164379923|NCT01532687|593761899|FG000|Overall Study|Withdrawal by Subject|1|||
164379924|NCT01532687|593761900|FG001|Overall Study|Withdrawal by Subject|0|||
164379925|NCT01532687|593761899|FG000|Overall Study|Physician Decision|2|||
164379926|NCT01532687|593761900|FG001|Overall Study|Physician Decision|1|||
164379927|NCT01532687|593761899|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
164379928|NCT01532687|593761900|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
164379929|NCT04116229|593761901|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
164379930|NCT04116229|593761902|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
164379931|NCT04116229|593761901|FG000|Overall Study|Scheduling not possible.|0|||
164379932|NCT04116229|593761902|FG001|Overall Study|Scheduling not possible.|1|||
164379933|NCT02809976|593761903|FG000|Overall Study|Lost to Follow-up|1|||
164701254|NCT01347866|594930242|FG005|Overall Study|Lost to Follow-up|0|||
164701255|NCT01347866|594930243|FG006|Overall Study|Lost to Follow-up|0|||
164379934|NCT02809976|593761903|FG000|Overall Study|Withdrawal by Subject|1|||
164379935|NCT01163682|593761905|FG000|Overall Study|Lost to Follow-up|6|||
164379936|NCT01163682|593761906|FG001|Overall Study|Lost to Follow-up|9|||
164379937|NCT00211081|593761910|FG000|Overall Study|Withdrawal by Subject|2|||
164379938|NCT01263873|593761911|FG000|Overall Study|One provider unable to complete numbers|1|||
164379939|NCT01263873|593761912|FG001|Overall Study|One provider unable to complete numbers|1|||
164379940|NCT00113516|593761913|FG000|Part 1|Adverse Event|6|||
164379941|NCT00113516|593761914|FG001|Part 1|Adverse Event|0|||
164379942|NCT00113516|593761913|FG000|Part 1|Death|3|||
164379943|NCT00113516|593761914|FG001|Part 1|Death|0|||
164379944|NCT00113516|593761913|FG000|Part 1|Other|3|||
164379945|NCT00113516|593761914|FG001|Part 1|Other|0|||
164379946|NCT00113516|593761913|FG000|Part 1|Withdrawal by Subject|2|||
164379947|NCT00113516|593761914|FG001|Part 1|Withdrawal by Subject|0|||
164379948|NCT00113516|593761913|FG000|Part 1|Lack of Efficacy|2|||
164379949|NCT00113516|593761914|FG001|Part 1|Lack of Efficacy|0|||
164379950|NCT00113516|593761913|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
164379951|NCT00113516|593761914|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
164379952|NCT00113516|593761913|FG000|Part 1|Laboratory Abnormality|1|||
164379953|NCT00113516|593761914|FG001|Part 1|Laboratory Abnormality|0|||
164379954|NCT00113516|593761913|FG000|Part 1|Ongoing|1|||
164379955|NCT00113516|593761914|FG001|Part 1|Ongoing|0|||
164379956|NCT00113516|593761913|FG000|Part 1|Missing|65|||
164379957|NCT00113516|593761914|FG001|Part 1|Missing|0|||
164379958|NCT00113516|593761913|FG000|Part 2|Adverse Event|0|||
164379959|NCT00113516|593761914|FG001|Part 2|Adverse Event|16|||
164379960|NCT00113516|593761913|FG000|Part 2|Death|0|||
164379961|NCT00113516|593761914|FG001|Part 2|Death|5|||
164379962|NCT00113516|593761913|FG000|Part 2|Lack of Efficacy|0|||
164379963|NCT00113516|593761914|FG001|Part 2|Lack of Efficacy|37|||
164379964|NCT00113516|593761913|FG000|Part 2|Withdrawal by Subject|0|||
164379965|NCT00113516|593761914|FG001|Part 2|Withdrawal by Subject|3|||
164379966|NCT00113516|593761913|FG000|Part 2|Other|0|||
164379967|NCT00113516|593761914|FG001|Part 2|Other|3|||
164379968|NCT00113516|593761913|FG000|Part 2|Laboratory Abnormality|0|||
164379969|NCT00113516|593761914|FG001|Part 2|Laboratory Abnormality|1|||
164379970|NCT00113516|593761913|FG000|Part 2|Ongoing|0|||
164379971|NCT00113516|593761914|FG001|Part 2|Ongoing|1|||
164379972|NCT03217136|593761923|FG000|Overall Study|Lost to Follow-up|2|||
164379973|NCT03217136|593761924|FG001|Overall Study|Lost to Follow-up|1|||
164379974|NCT03217136|593761923|FG000|Overall Study|Site Randomized Participant in Error|0|||
164379975|NCT03217136|593761924|FG001|Overall Study|Site Randomized Participant in Error|1|||
164379976|NCT03217136|593761923|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
164379977|NCT03217136|593761924|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
164379978|NCT03217136|593761923|FG000|Overall Study|Dispensing Error|1|||
164379979|NCT03217136|593761924|FG001|Overall Study|Dispensing Error|0|||
164379980|NCT03217136|593761923|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
164379981|NCT03217136|593761924|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164379982|NCT03755765|593761925|FG000|Overall Study|Withdrawal by Subject|2|||
164379983|NCT03755765|593761926|FG001|Overall Study|Withdrawal by Subject|4|||
164379984|NCT03755765|593761927|FG002|Overall Study|Withdrawal by Subject|4|||
164379985|NCT02104557|593761928|FG000|Overall Study|Adverse Event|24|||
164379986|NCT02104557|593761928|FG000|Overall Study|Lost to Follow-up|34|||
164379987|NCT02104557|593761928|FG000|Overall Study|Violated the usage and dosage|14|||
164379988|NCT02104557|593761928|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
164379989|NCT02104557|593761928|FG000|Overall Study|Administered Sayana prior to the contract|1|||
164379990|NCT02104557|593761928|FG000|Overall Study|Other|17|||
164379991|NCT02104557|593761928|FG000|Overall Study|Change to other contraception methods|5|||
164379992|NCT02104557|593761928|FG000|Overall Study|Discontinuation due to no pain|1|||
164379993|NCT02104557|593761928|FG000|Overall Study|Withdrawal consent|2|||
164379994|NCT02104557|593761928|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
164379995|NCT02104557|593761928|FG000|Overall Study|Discontinuation of contraception|9|||
164379996|NCT01158222|593761932|FG000|Overall Study|Not eligible for intermediate phase|17|||
164379997|NCT00111228|593761935|FG000|Overall Study|Withdrawal by Subject|5|||
164379998|NCT00111228|593761936|FG001|Overall Study|Withdrawal by Subject|1|||
164379999|NCT00111228|593761937|FG002|Overall Study|Withdrawal by Subject|0|||
164380000|NCT02579616|593761938|FG000|Overall Study|Participants did not receive treatment|3|||
164380001|NCT01490060|593761939|FG000|Cycle 1|Change of Treatment|0|||
164380002|NCT01490060|593761940|FG001|Cycle 1|Change of Treatment|1|||
164380003|NCT01490060|593761941|FG002|Cycle 1|Change of Treatment|1|||
164380004|NCT01490060|593761942|FG003|Cycle 1|Change of Treatment|1|||
164380005|NCT01490060|593761939|FG000|Cycle 1|Insurance Denied|0|||
164380006|NCT01490060|593761940|FG001|Cycle 1|Insurance Denied|0|||
164380007|NCT01490060|593761941|FG002|Cycle 1|Insurance Denied|2|||
164380008|NCT01490060|593761942|FG003|Cycle 1|Insurance Denied|0|||
164380009|NCT01490060|593761939|FG000|Cycle 1|Withdrawal by Subject|0|||
164380010|NCT01490060|593761940|FG001|Cycle 1|Withdrawal by Subject|0|||
164380011|NCT01490060|593761941|FG002|Cycle 1|Withdrawal by Subject|0|||
164380012|NCT01490060|593761942|FG003|Cycle 1|Withdrawal by Subject|1|||
164380013|NCT01490060|593761939|FG000|Cycle 1|Treatment at Another Facility|0|||
164380014|NCT01490060|593761940|FG001|Cycle 1|Treatment at Another Facility|0|||
164380015|NCT01490060|593761941|FG002|Cycle 1|Treatment at Another Facility|0|||
164380016|NCT01490060|593761942|FG003|Cycle 1|Treatment at Another Facility|1|||
164380017|NCT01490060|593761939|FG000|Cycle 2|Change of Treatment|1|||
164380018|NCT01490060|593761940|FG001|Cycle 2|Change of Treatment|1|||
164380019|NCT01490060|593761941|FG002|Cycle 2|Change of Treatment|0|||
164380020|NCT01490060|593761942|FG003|Cycle 2|Change of Treatment|0|||
164380021|NCT01490060|593761939|FG000|Cycle 2|Non-Compliance|0|||
164380022|NCT01490060|593761940|FG001|Cycle 2|Non-Compliance|0|||
164380023|NCT01490060|593761941|FG002|Cycle 2|Non-Compliance|1|||
164380024|NCT01490060|593761942|FG003|Cycle 2|Non-Compliance|0|||
164380025|NCT01490060|593761939|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
164380026|NCT01490060|593761940|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
164380027|NCT01490060|593761941|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
164380028|NCT01490060|593761942|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
164380029|NCT02464969|593761943|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
164380030|NCT02464969|593761944|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
164380031|NCT02464969|593761943|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
164380032|NCT02464969|593761944|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
164380033|NCT02464969|593761943|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
164380034|NCT02464969|593761944|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
164380035|NCT02464969|593761943|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
164380036|NCT02464969|593761944|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
164380037|NCT02464969|593761943|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
164380038|NCT02464969|593761944|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
164380039|NCT02464969|593761943|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
164380040|NCT02464969|593761944|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
164380041|NCT02464969|593761943|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
164380042|NCT02464969|593761944|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
164380043|NCT02464969|593761943|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
164380044|NCT02464969|593761944|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
164380045|NCT02464969|593761943|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
164380046|NCT02464969|593761944|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
164380047|NCT02464969|593761943|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
164380048|NCT02464969|593761944|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
164380049|NCT02464969|593761943|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
164380050|NCT02464969|593761944|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
164380051|NCT02863354|593761945|FG000|Year 1|Lost to Follow-up|1|||
164380052|NCT02863354|593761946|FG001|Year 1|Lost to Follow-up|1|||
164380053|NCT02863354|593761945|FG000|Year 1|Withdrawal by Subject|3|||
164380054|NCT02863354|593761946|FG001|Year 1|Withdrawal by Subject|0|||
164380055|NCT02863354|593761945|FG000|Year 1|Death|0|||
164380056|NCT02863354|593761946|FG001|Year 1|Death|1|||
164380057|NCT02863354|593761945|FG000|Year 2|Lost to Follow-up|2|||
164380058|NCT02863354|593761946|FG001|Year 2|Lost to Follow-up|2|||
164380059|NCT00724451|593761952|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
164380060|NCT00724451|593761952|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
164380061|NCT00724451|593761952|FG000|Overall Study|Not Eligible for Treatment|431|||
164380062|NCT00724451|593761952|FG000|Overall Study|Participant Refused Treatment|89|||
164380063|NCT00724451|593761952|FG000|Overall Study|Never Started Treatment|89|||
164380064|NCT00724451|593761952|FG000|Overall Study|Unknown; No Data Sources Available|9|||
164380065|NCT00724451|593761952|FG000|Overall Study|Physician Decision|116|||
164380066|NCT00724451|593761952|FG000|Overall Study|Withdrawal by Subject|45|||
164380067|NCT00724451|593761952|FG000|Overall Study|Investigator + Participant Decision|13|||
164439632|NCT02694978|593977174|FG000|Overall Study|Death|4|||
164592216|NCT00001262|594531392|FG000|Overall Study|Withdrawal by Subject|0|||
164380068|NCT00720876|593761953|FG000|Overall Study|found to be ineligible after starting tx|2|||
164380069|NCT03495908|593761955|FG000|Overall Study|Withdrawal by Subject|3|||
164380070|NCT03495908|593761956|FG001|Overall Study|Withdrawal by Subject|1|||
164380071|NCT03495908|593761955|FG000|Overall Study|Lost to Follow-up|1|||
164380072|NCT03495908|593761956|FG001|Overall Study|Lost to Follow-up|4|||
164380073|NCT03495908|593761955|FG000|Overall Study|Adverse Event|0|||
164380074|NCT03495908|593761956|FG001|Overall Study|Adverse Event|2|||
164380075|NCT03495908|593761955|FG000|Overall Study|Death|1|||
164380076|NCT03495908|593761956|FG001|Overall Study|Death|0|||
164380077|NCT03495908|593761955|FG000|Overall Study|Physician Decision|5|||
164380078|NCT03495908|593761956|FG001|Overall Study|Physician Decision|4|||
164380079|NCT03495908|593761955|FG000|Overall Study|No documented reason|0|||
164439633|NCT02694978|593977175|FG001|Overall Study|Death|1|||
164380080|NCT03495908|593761956|FG001|Overall Study|No documented reason|2|||
164380081|NCT01559311|593761959|FG000|Overall Study|Protocol Violation|0|||
164380082|NCT01559311|593761960|FG001|Overall Study|Protocol Violation|0|||
164380083|NCT01559311|593761961|FG002|Overall Study|Protocol Violation|2|||
164380084|NCT01559311|593761959|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
164380085|NCT01559311|593761960|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
164380086|NCT01559311|593761961|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
164380087|NCT01559311|593761959|FG000|Overall Study|Withdrawal by Subject|2|||
164380088|NCT01559311|593761960|FG001|Overall Study|Withdrawal by Subject|1|||
164380089|NCT01559311|593761961|FG002|Overall Study|Withdrawal by Subject|0|||
164380090|NCT01559311|593761959|FG000|Overall Study|Death|0|||
164380091|NCT01559311|593761960|FG001|Overall Study|Death|2|||
164380092|NCT01559311|593761961|FG002|Overall Study|Death|3|||
164380093|NCT01559311|593761959|FG000|Overall Study|Lost to Follow-up|0|||
164380094|NCT01559311|593761960|FG001|Overall Study|Lost to Follow-up|3|||
164380095|NCT01559311|593761961|FG002|Overall Study|Lost to Follow-up|2|||
164380096|NCT01559311|593761959|FG000|Overall Study|Adverse Event|0|||
164592217|NCT00001262|594531393|FG001|Overall Study|Withdrawal by Subject|3|||
164592218|NCT00001262|594531394|FG002|Overall Study|Withdrawal by Subject|0|||
164380097|NCT01559311|593761960|FG001|Overall Study|Adverse Event|0|||
164380098|NCT01559311|593761961|FG002|Overall Study|Adverse Event|1|||
164380099|NCT03027466|593761962|FG000|Overall Study|Opting out of the app|1869|||
164380100|NCT03027466|593761963|FG001|Overall Study|Opting out of the app|1819|||
164380101|NCT03027466|593761964|FG002|Overall Study|Opting out of the app|1743|||
164380102|NCT03027466|593761965|FG003|Overall Study|Opting out of the app|1821|||
164380103|NCT03286140|593761966|FG000|Overall Study|Withdrawal by Subject|10|||
164380104|NCT03286140|593761967|FG001|Overall Study|Withdrawal by Subject|5|||
164380105|NCT03286140|593761966|FG000|Overall Study|Lost to Follow-up|5|||
164380106|NCT03286140|593761967|FG001|Overall Study|Lost to Follow-up|10|||
164380107|NCT03286140|593761966|FG000|Overall Study|Failure to comply|0|||
164380108|NCT03286140|593761967|FG001|Overall Study|Failure to comply|1|||
164380109|NCT02158039|593761968|FG000|Overall Study|Withdrawal by Subject|1|||
164380110|NCT02158039|593761968|FG000|Overall Study|Screen Failure|9|||
164380111|NCT00515827|593761969|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
164380112|NCT00515827|593761970|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
164380113|NCT00515827|593761969|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
164380114|NCT00515827|593761970|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
164380115|NCT02052466|593761971|FG000|Overall Study|Withdrawal by Subject|1|||
164380116|NCT02052466|593761971|FG000|Overall Study|Acromial fracture|1|||
164380117|NCT02293005|593763392|FG000|Overall Study|Adverse Event|2|||
164380118|NCT02293005|593763392|FG000|Overall Study|Death|4|||
164380119|NCT02293005|593763392|FG000|Overall Study|Lost to Follow-up|1|||
164380120|NCT02293005|593763392|FG000|Overall Study|Withdrawal by Subject|2|||
164380121|NCT02293005|593763392|FG000|Overall Study|Progression|17|||
164380122|NCT02766608|593763393|FG000|Overall Study|Adverse Event|27|||
164380123|NCT02766608|593763394|FG001|Overall Study|Adverse Event|22|||
164380124|NCT02766608|593763395|FG002|Overall Study|Adverse Event|17|||
164380125|NCT02766608|593763396|FG003|Overall Study|Adverse Event|13|||
164380126|NCT02766608|593763397|FG004|Overall Study|Adverse Event|12|||
164380127|NCT02766608|593763393|FG000|Overall Study|Withdrawal by Subject|21|||
164380128|NCT02766608|593763394|FG001|Overall Study|Withdrawal by Subject|20|||
164380129|NCT02766608|593763395|FG002|Overall Study|Withdrawal by Subject|24|||
164380130|NCT02766608|593763396|FG003|Overall Study|Withdrawal by Subject|13|||
164380131|NCT02766608|593763397|FG004|Overall Study|Withdrawal by Subject|10|||
164380132|NCT02766608|593763393|FG000|Overall Study|Lack of Efficacy|16|||
164380133|NCT02766608|593763394|FG001|Overall Study|Lack of Efficacy|15|||
164380134|NCT02766608|593763395|FG002|Overall Study|Lack of Efficacy|32|||
164380135|NCT02766608|593763396|FG003|Overall Study|Lack of Efficacy|8|||
164592219|NCT00783705|594531395|FG000|Overall Study|Adverse Event|2|||
164592220|NCT00783705|594531396|FG001|Overall Study|Adverse Event|0|||
164380136|NCT02766608|593763397|FG004|Overall Study|Lack of Efficacy|2|||
164380137|NCT02766608|593763393|FG000|Overall Study|Lost to Follow-up|6|||
164380138|NCT02766608|593763394|FG001|Overall Study|Lost to Follow-up|3|||
164380139|NCT02766608|593763395|FG002|Overall Study|Lost to Follow-up|5|||
164380140|NCT02766608|593763396|FG003|Overall Study|Lost to Follow-up|2|||
164380141|NCT02766608|593763397|FG004|Overall Study|Lost to Follow-up|2|||
164380142|NCT02766608|593763393|FG000|Overall Study|Physician Decision|3|||
164380143|NCT02766608|593763394|FG001|Overall Study|Physician Decision|2|||
164380144|NCT02766608|593763395|FG002|Overall Study|Physician Decision|3|||
164380145|NCT02766608|593763396|FG003|Overall Study|Physician Decision|1|||
164380146|NCT02766608|593763397|FG004|Overall Study|Physician Decision|2|||
164380147|NCT02766608|593763393|FG000|Overall Study|Protocol disc criteria|3|||
164380148|NCT02766608|593763394|FG001|Overall Study|Protocol disc criteria|3|||
164380149|NCT02766608|593763395|FG002|Overall Study|Protocol disc criteria|4|||
164380150|NCT02766608|593763396|FG003|Overall Study|Protocol disc criteria|0|||
164380151|NCT02766608|593763397|FG004|Overall Study|Protocol disc criteria|0|||
164380152|NCT02766608|593763393|FG000|Overall Study|Protocol Violation|0|||
164380153|NCT02766608|593763394|FG001|Overall Study|Protocol Violation|4|||
164380154|NCT02766608|593763395|FG002|Overall Study|Protocol Violation|4|||
164380155|NCT02766608|593763396|FG003|Overall Study|Protocol Violation|0|||
164380156|NCT02766608|593763397|FG004|Overall Study|Protocol Violation|1|||
164380157|NCT02766608|593763393|FG000|Overall Study|Administrative Reasons|3|||
164380158|NCT02766608|593763394|FG001|Overall Study|Administrative Reasons|1|||
164380159|NCT02766608|593763395|FG002|Overall Study|Administrative Reasons|1|||
164380160|NCT02766608|593763396|FG003|Overall Study|Administrative Reasons|0|||
164380161|NCT02766608|593763397|FG004|Overall Study|Administrative Reasons|0|||
164380162|NCT02648698|593763405|FG000|Overall Study|Protocol Violation|1|||
164380163|NCT02648698|593763406|FG001|Overall Study|Protocol Violation|5|||
164380164|NCT03143829|593763409|FG000|Overall Study|Withdrawal by Subject|2|||
164380165|NCT03143829|593763410|FG001|Overall Study|Withdrawal by Subject|5|||
164380166|NCT03143829|593763409|FG000|Overall Study|Lost to Follow-up|0|||
164380167|NCT03143829|593763410|FG001|Overall Study|Lost to Follow-up|2|||
164380168|NCT03143829|593763409|FG000|Overall Study|Death|1|||
164380169|NCT03143829|593763410|FG001|Overall Study|Death|1|||
164380170|NCT03143829|593763409|FG000|Overall Study|changed treatment, no longer eligible|2|||
164380171|NCT03143829|593763410|FG001|Overall Study|changed treatment, no longer eligible|2|||
164380172|NCT00672477|593763411|FG000|Overall Study|Adverse Event|10|||
164380173|NCT00672477|593763412|FG001|Overall Study|Adverse Event|7|||
164380174|NCT00672477|593763411|FG000|Overall Study|Death|7|||
164380175|NCT00672477|593763412|FG001|Overall Study|Death|11|||
164380176|NCT00672477|593763411|FG000|Overall Study|Physician Decision|2|||
164380177|NCT00672477|593763412|FG001|Overall Study|Physician Decision|0|||
164380178|NCT00672477|593763411|FG000|Overall Study|Protocol Violation|1|||
164380179|NCT00672477|593763412|FG001|Overall Study|Protocol Violation|1|||
164380180|NCT00672477|593763411|FG000|Overall Study|Withdrawal by Subject|5|||
164380181|NCT00672477|593763412|FG001|Overall Study|Withdrawal by Subject|3|||
164380182|NCT00672477|593763411|FG000|Overall Study|Lack of Efficacy|1|||
164380183|NCT00672477|593763412|FG001|Overall Study|Lack of Efficacy|1|||
164380184|NCT00672477|593763411|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
164380185|NCT00672477|593763412|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
164380186|NCT00938431|593763416|FG000|Overall Study|Adverse Event|5|||
164380187|NCT00938431|593763417|FG001|Overall Study|Adverse Event|8|||
164380188|NCT00938431|593763418|FG002|Overall Study|Adverse Event|6|||
164380189|NCT00938431|593763416|FG000|Overall Study|Lack of Efficacy|0|||
164380190|NCT00938431|593763417|FG001|Overall Study|Lack of Efficacy|1|||
164380191|NCT00938431|593763418|FG002|Overall Study|Lack of Efficacy|0|||
164380192|NCT00938431|593763416|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
164380193|NCT00938431|593763417|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
164380194|NCT00938431|593763418|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
164380195|NCT00938431|593763416|FG000|Overall Study|Dosing compliance issue|0|||
164380196|NCT00938431|593763417|FG001|Overall Study|Dosing compliance issue|0|||
164380197|NCT00938431|593763418|FG002|Overall Study|Dosing compliance issue|1|||
164380198|NCT00938431|593763416|FG000|Overall Study|Reached maximum dose early|0|||
164380199|NCT00938431|593763417|FG001|Overall Study|Reached maximum dose early|0|||
164380200|NCT00938431|593763418|FG002|Overall Study|Reached maximum dose early|1|||
164380201|NCT03738865|593763421|FG000|Overall Study|Withdrawal by Subject|3|||
164380202|NCT03738865|593763422|FG001|Overall Study|Withdrawal by Subject|3|||
164380203|NCT03738865|593763421|FG000|Overall Study|Adverse Event|2|||
164380204|NCT03738865|593763422|FG001|Overall Study|Adverse Event|0|||
164380205|NCT03738865|593763421|FG000|Overall Study|Physician Decision|0|||
164380206|NCT03738865|593763422|FG001|Overall Study|Physician Decision|1|||
164380207|NCT02057757|593763423|FG000|Overall Study|Withdrawal by Subject|3|||
164380208|NCT02057757|593763424|FG001|Overall Study|Withdrawal by Subject|5|||
164380209|NCT02057757|593763423|FG000|Overall Study|Death|2|||
164380210|NCT02057757|593763424|FG001|Overall Study|Death|0|||
164380211|NCT02057757|593763423|FG000|Overall Study|Lost to Follow-up|8|||
164380212|NCT02057757|593763424|FG001|Overall Study|Lost to Follow-up|3|||
164380213|NCT02057757|593763423|FG000|Overall Study|Non-compliance|1|||
164380214|NCT02057757|593763424|FG001|Overall Study|Non-compliance|0|||
164380215|NCT00440271|593763425|FG000|Overall Study|Protocol Violation|1|||
164380216|NCT00440271|593763426|FG001|Overall Study|Protocol Violation|1|||
164380217|NCT00440271|593763425|FG000|Overall Study|Adverse Event|0|||
164380218|NCT00440271|593763426|FG001|Overall Study|Adverse Event|1|||
164380219|NCT00440271|593763425|FG000|Overall Study|Lost to Follow-up|1|||
164380220|NCT00440271|593763426|FG001|Overall Study|Lost to Follow-up|0|||
164380221|NCT00440271|593763425|FG000|Overall Study|Withdrawal by Subject|0|||
164380222|NCT00440271|593763426|FG001|Overall Study|Withdrawal by Subject|2|||
164380223|NCT00440271|593763425|FG000|Overall Study|Lack of Efficacy|0|||
164380224|NCT00440271|593763426|FG001|Overall Study|Lack of Efficacy|1|||
164380225|NCT00440271|593763425|FG000|Overall Study|Due to closure of trial|8|||
164380226|NCT00440271|593763426|FG001|Overall Study|Due to closure of trial|10|||
164380227|NCT00440271|593763425|FG000|Overall Study|Other|2|||
164380228|NCT00440271|593763426|FG001|Overall Study|Other|0|||
164380229|NCT00048724|593763430|FG000|Overall Study|Adverse Event|53|||
164380230|NCT00048724|593763431|FG001|Overall Study|Adverse Event|12|||
164380231|NCT00048724|593763430|FG000|Overall Study|Withdrawal by Subject|34|||
164380232|NCT00048724|593763431|FG001|Overall Study|Withdrawal by Subject|54|||
164380233|NCT00048724|593763430|FG000|Overall Study|Lost to Follow-up|5|||
164380234|NCT00048724|593763431|FG001|Overall Study|Lost to Follow-up|5|||
164380235|NCT00048724|593763430|FG000|Overall Study|Protocol-defined Clinical Event|17|||
164380236|NCT00048724|593763431|FG001|Overall Study|Protocol-defined Clinical Event|32|||
164380237|NCT00048724|593763430|FG000|Overall Study|Noncompliance With Protocol|4|||
164380238|NCT00048724|593763431|FG001|Overall Study|Noncompliance With Protocol|12|||
164380239|NCT00048724|593763430|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
164380240|NCT00048724|593763431|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
164701256|NCT01347866|594930244|FG007|Overall Study|Lost to Follow-up|1|||
164701257|NCT01347866|594930245|FG008|Overall Study|Lost to Follow-up|1|||
164701258|NCT01347866|594930246|FG009|Overall Study|Lost to Follow-up|0|||
164701259|NCT01347866|594930247|FG010|Overall Study|Lost to Follow-up|0|||
164701260|NCT01347866|594930248|FG011|Overall Study|Lost to Follow-up|0|||
164701261|NCT01347866|594930249|FG012|Overall Study|Lost to Follow-up|0|||
164701262|NCT01347866|594930250|FG013|Overall Study|Lost to Follow-up|0|||
164701263|NCT01347866|594930251|FG014|Overall Study|Lost to Follow-up|0|||
164701264|NCT01347866|594930252|FG015|Overall Study|Lost to Follow-up|0|||
164701265|NCT01347866|594930253|FG016|Overall Study|Lost to Follow-up|0|||
164701266|NCT01347866|594930237|FG000|Overall Study|Other|3|||
164701267|NCT01347866|594930238|FG001|Overall Study|Other|1|||
164701268|NCT01347866|594930239|FG002|Overall Study|Other|1|||
164701269|NCT01347866|594930240|FG003|Overall Study|Other|4|||
164701270|NCT01347866|594930241|FG004|Overall Study|Other|5|||
164701271|NCT01347866|594930242|FG005|Overall Study|Other|0|||
164701272|NCT01347866|594930243|FG006|Overall Study|Other|5|||
164701273|NCT01347866|594930244|FG007|Overall Study|Other|3|||
164701274|NCT01347866|594930245|FG008|Overall Study|Other|22|||
164701275|NCT01347866|594930246|FG009|Overall Study|Other|5|||
164701276|NCT01347866|594930247|FG010|Overall Study|Other|0|||
164701277|NCT01347866|594930248|FG011|Overall Study|Other|3|||
164701278|NCT01347866|594930249|FG012|Overall Study|Other|4|||
164701279|NCT01347866|594930250|FG013|Overall Study|Other|4|||
164701280|NCT01347866|594930251|FG014|Overall Study|Other|2|||
164701281|NCT01347866|594930252|FG015|Overall Study|Other|3|||
164701282|NCT01347866|594930253|FG016|Overall Study|Other|0|||
164701283|NCT01347866|594930237|FG000|Overall Study|Subject refused further follow-up|2|||
164701284|NCT01347866|594930238|FG001|Overall Study|Subject refused further follow-up|0|||
164701285|NCT01347866|594930239|FG002|Overall Study|Subject refused further follow-up|0|||
164701286|NCT01347866|594930240|FG003|Overall Study|Subject refused further follow-up|2|||
164701287|NCT01347866|594930241|FG004|Overall Study|Subject refused further follow-up|0|||
164701288|NCT01347866|594930242|FG005|Overall Study|Subject refused further follow-up|1|||
164701289|NCT01347866|594930243|FG006|Overall Study|Subject refused further follow-up|0|||
164701290|NCT01347866|594930244|FG007|Overall Study|Subject refused further follow-up|0|||
164701291|NCT01347866|594930245|FG008|Overall Study|Subject refused further follow-up|4|||
164701292|NCT01347866|594930246|FG009|Overall Study|Subject refused further follow-up|1|||
164701293|NCT01347866|594930247|FG010|Overall Study|Subject refused further follow-up|0|||
164701294|NCT01347866|594930248|FG011|Overall Study|Subject refused further follow-up|0|||
164701295|NCT01347866|594930249|FG012|Overall Study|Subject refused further follow-up|1|||
164701296|NCT01347866|594930250|FG013|Overall Study|Subject refused further follow-up|3|||
164701297|NCT01347866|594930251|FG014|Overall Study|Subject refused further follow-up|1|||
164701298|NCT01347866|594930252|FG015|Overall Study|Subject refused further follow-up|0|||
164701299|NCT01347866|594930253|FG016|Overall Study|Subject refused further follow-up|2|||
164701300|NCT02999477|594930256|FG000|Overall Study|found ineligible after first dose|0|||
164701301|NCT02999477|594930257|FG001|Overall Study|found ineligible after first dose|1|||
164701302|NCT02999477|594930256|FG000|Overall Study|Withdrawal by Subject|1|||
164701303|NCT02999477|594930257|FG001|Overall Study|Withdrawal by Subject|1|||
164701304|NCT01846273|594930258|FG000|Overall Study|Adverse Event|9|||
164701305|NCT01846273|594930259|FG001|Overall Study|Adverse Event|7|||
164701306|NCT01846273|594930260|FG002|Overall Study|Adverse Event|0|||
164380241|NCT00048724|593763430|FG000|Overall Study|Administrative|1|||
164380242|NCT00048724|593763431|FG001|Overall Study|Administrative|1|||
164380243|NCT03586869|593763432|FG000|Overall Study|Progressive Disease|3|||
164701307|NCT01846273|594930258|FG000|Overall Study|Subject withdrew consent|5|||
164701308|NCT01846273|594930259|FG001|Overall Study|Subject withdrew consent|8|||
164701309|NCT01846273|594930260|FG002|Overall Study|Subject withdrew consent|0|||
164701310|NCT01846273|594930258|FG000|Overall Study|Lost to Follow-up|2|||
164701311|NCT01846273|594930259|FG001|Overall Study|Lost to Follow-up|1|||
164701312|NCT01846273|594930260|FG002|Overall Study|Lost to Follow-up|0|||
164380244|NCT00226941|593763433|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
164701313|NCT01846273|594930258|FG000|Overall Study|Administrative problems|1|||
164701314|NCT01846273|594930259|FG001|Overall Study|Administrative problems|0|||
164701315|NCT01846273|594930260|FG002|Overall Study|Administrative problems|0|||
164701316|NCT01846273|594930258|FG000|Overall Study|Death|2|||
164701317|NCT01846273|594930259|FG001|Overall Study|Death|1|||
164701318|NCT01846273|594930260|FG002|Overall Study|Death|0|||
164701319|NCT01846273|594930258|FG000|Overall Study|Disease Progression|0|||
164701320|NCT01846273|594930259|FG001|Overall Study|Disease Progression|4|||
164701321|NCT01846273|594930260|FG002|Overall Study|Disease Progression|0|||
164701322|NCT01846273|594930258|FG000|Overall Study|Protocol Deviation|2|||
164701323|NCT01846273|594930259|FG001|Overall Study|Protocol Deviation|3|||
164701324|NCT01846273|594930260|FG002|Overall Study|Protocol Deviation|0|||
164701325|NCT01846273|594930258|FG000|Overall Study|Physician Decision|1|||
164701326|NCT01846273|594930259|FG001|Overall Study|Physician Decision|2|||
164701327|NCT01846273|594930260|FG002|Overall Study|Physician Decision|0|||
164701328|NCT02939014|594930261|FG000|Overall Study|Lost to Follow-up|1|||
164701329|NCT02939014|594930262|FG001|Overall Study|Lost to Follow-up|0|||
164701330|NCT02939014|594930261|FG000|Overall Study|Death|4|||
164701331|NCT02939014|594930262|FG001|Overall Study|Death|3|||
164701332|NCT00359788|594930263|FG000|Overall Study|Adverse Event|11|||
164701333|NCT00359788|594930264|FG001|Overall Study|Adverse Event|10|||
164701334|NCT00359788|594930263|FG000|Overall Study|Lack of Efficacy|1|||
164701335|NCT00359788|594930264|FG001|Overall Study|Lack of Efficacy|2|||
164701336|NCT00359788|594930263|FG000|Overall Study|Lost to Follow-up|3|||
164701337|NCT00359788|594930264|FG001|Overall Study|Lost to Follow-up|2|||
164701338|NCT00359788|594930263|FG000|Overall Study|Withdrawal by Subject|4|||
164701339|NCT00359788|594930264|FG001|Overall Study|Withdrawal by Subject|1|||
164701340|NCT00359788|594930263|FG000|Overall Study|Protocol Violation|4|||
164701341|NCT00359788|594930264|FG001|Overall Study|Protocol Violation|2|||
164701342|NCT02143583|594930267|FG000|Overall Study|Withdrawal by Subject|1|||
164701343|NCT02143583|594930268|FG001|Overall Study|Withdrawal by Subject|0|||
164701344|NCT02143583|594930269|FG002|Overall Study|Withdrawal by Subject|1|||
164701345|NCT02143583|594930267|FG000|Overall Study|husband illness|0|||
164701346|NCT02143583|594930268|FG001|Overall Study|husband illness|0|||
164701347|NCT02143583|594930269|FG002|Overall Study|husband illness|1|||
164701348|NCT02220725|594930270|FG000|Overall Study|Lost to Follow-up|0|||
164701349|NCT02220725|594930271|FG001|Overall Study|Lost to Follow-up|0|||
164701350|NCT02220725|594930272|FG002|Overall Study|Lost to Follow-up|0|||
164701351|NCT02220725|594930273|FG003|Overall Study|Lost to Follow-up|1|||
164701352|NCT02220725|594930270|FG000|Overall Study|Withdrawal by Subject|0|||
164701353|NCT02220725|594930271|FG001|Overall Study|Withdrawal by Subject|0|||
164701354|NCT02220725|594930272|FG002|Overall Study|Withdrawal by Subject|0|||
164701355|NCT02220725|594930273|FG003|Overall Study|Withdrawal by Subject|1|||
164380245|NCT00226941|593763434|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
164380246|NCT00226941|593763435|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
164380247|NCT00226941|593763436|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
164380248|NCT00226941|593763433|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
164380249|NCT00226941|593763434|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
164380250|NCT00226941|593763435|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
164380251|NCT00226941|593763436|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
164380252|NCT00009737|593763437|FG000|Overall Study|Adverse Event|112|||
164380253|NCT00009737|593763438|FG001|Overall Study|Adverse Event|75|||
164380254|NCT00009737|593763437|FG000|Overall Study|Death|4|||
164380255|NCT00009737|593763438|FG001|Overall Study|Death|6|||
164380256|NCT00009737|593763437|FG000|Overall Study|Lack of Efficacy|17|||
164380257|NCT00009737|593763438|FG001|Overall Study|Lack of Efficacy|15|||
164380258|NCT00009737|593763437|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
164380259|NCT00009737|593763438|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
164380260|NCT00009737|593763437|FG000|Overall Study|Other Protocol Violation|1|||
164380261|NCT00009737|593763438|FG001|Overall Study|Other Protocol Violation|0|||
164380262|NCT00009737|593763437|FG000|Overall Study|Refused Treatment|15|||
164380263|NCT00009737|593763438|FG001|Overall Study|Refused Treatment|16|||
164380264|NCT00009737|593763437|FG000|Overall Study|Lost to Follow-up|1|||
164380265|NCT00009737|593763438|FG001|Overall Study|Lost to Follow-up|1|||
164380266|NCT00009737|593763437|FG000|Overall Study|Administrative/Other Reasons|7|||
164380267|NCT00009737|593763438|FG001|Overall Study|Administrative/Other Reasons|1|||
164380268|NCT02732847|593763439|FG000|Overall Study|some filled early|42|||
164439634|NCT02694978|593977174|FG000|Overall Study|Other-Decision of Participant|6|||
164380269|NCT02732847|593763440|FG001|Overall Study|some filled early|42|||
164380270|NCT00003498|593763441|FG000|Overall Study|Not evaluable.|4|||
164439635|NCT02694978|593977175|FG001|Overall Study|Other-Decision of Participant|1|||
164380271|NCT01260922|593763444|FG000|First Intervention|Withdrawal by Subject|0|||
164380272|NCT01260922|593763445|FG001|First Intervention|Withdrawal by Subject|1|||
164439636|NCT02694978|593977174|FG000|Overall Study|Other-Investigator's decision|1|||
164439637|NCT02694978|593977175|FG001|Overall Study|Other-Investigator's decision|0|||
164701356|NCT01673698|594930274|FG000|Overall Study|Lost to Follow-up|51|||
164701357|NCT01673698|594930275|FG001|Overall Study|Lost to Follow-up|13|||
164380273|NCT01260922|593763444|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
164439638|NCT02694978|593977174|FG000|Overall Study|Other-Unable to be reached|0|||
164701358|NCT02333487|594930276|FG000|Overall Study|Adverse Event|0|||
164380274|NCT01260922|593763445|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
164701359|NCT02333487|594930277|FG001|Overall Study|Adverse Event|2|||
164701360|NCT02333487|594930278|FG002|Overall Study|Adverse Event|0|||
164701361|NCT01297322|594930279|FG000|Overall Study|Lost to Follow-up|1|||
164701362|NCT01297322|594930280|FG001|Overall Study|Lost to Follow-up|0|||
164380275|NCT01260922|593763444|FG000|Second Intervention|Emesis|0|||
164380276|NCT01260922|593763445|FG001|Second Intervention|Emesis|2|||
164380277|NCT03732248|593763448|FG000|Overall Study|Withdrawal by Subject|1|||
164380278|NCT03732248|593763449|FG001|Overall Study|Withdrawal by Subject|0|||
164380279|NCT00414050|593763450|FG000|Overall Study|Adverse Event|1|||
164380280|NCT00414050|593763451|FG001|Overall Study|Adverse Event|1|||
164380281|NCT00414050|593763452|FG002|Overall Study|Adverse Event|1|||
164380282|NCT00414050|593763453|FG003|Overall Study|Adverse Event|1|||
164380283|NCT00414050|593763450|FG000|Overall Study|Lost to Follow-up|2|||
164380284|NCT00414050|593763451|FG001|Overall Study|Lost to Follow-up|2|||
164380285|NCT00414050|593763452|FG002|Overall Study|Lost to Follow-up|1|||
164380286|NCT00414050|593763453|FG003|Overall Study|Lost to Follow-up|1|||
164380287|NCT00414050|593763450|FG000|Overall Study|Withdrawal by Subject|5|||
164380288|NCT00414050|593763451|FG001|Overall Study|Withdrawal by Subject|3|||
164380289|NCT00414050|593763452|FG002|Overall Study|Withdrawal by Subject|2|||
164380290|NCT00414050|593763453|FG003|Overall Study|Withdrawal by Subject|4|||
164380291|NCT00414050|593763450|FG000|Overall Study|Subject discontinued for other reason|1|||
164380292|NCT00414050|593763451|FG001|Overall Study|Subject discontinued for other reason|2|||
164380293|NCT00414050|593763452|FG002|Overall Study|Subject discontinued for other reason|2|||
164380294|NCT00414050|593763453|FG003|Overall Study|Subject discontinued for other reason|1|||
164380295|NCT00414050|593763450|FG000|Overall Study|Subject Moved|0|||
164380296|NCT00414050|593763451|FG001|Overall Study|Subject Moved|0|||
164380297|NCT00414050|593763452|FG002|Overall Study|Subject Moved|0|||
164380298|NCT00414050|593763453|FG003|Overall Study|Subject Moved|1|||
164380299|NCT02604589|593763460|FG000|Overall Study|catheter dislodgement|0|||
164380300|NCT02604589|593763461|FG001|Overall Study|catheter dislodgement|0|||
164380301|NCT02604589|593763462|FG002|Overall Study|catheter dislodgement|1|||
164380302|NCT05013905|593763472|FG000|Overall Study|Adverse Event|1|||
164380303|NCT05013905|593763472|FG000|Overall Study|Lack of Efficacy|1|||
164380304|NCT02550652|593763483|FG000|Overall Study|Death|1|||
164380305|NCT02550652|593763484|FG001|Overall Study|Death|4|||
164380306|NCT02550652|593763483|FG000|Overall Study|Lack of Efficacy|1|||
164380307|NCT02550652|593763484|FG001|Overall Study|Lack of Efficacy|0|||
164380308|NCT02550652|593763483|FG000|Overall Study|Withdrawal by Subject|4|||
164380309|NCT02550652|593763484|FG001|Overall Study|Withdrawal by Subject|7|||
164380310|NCT02550652|593763483|FG000|Overall Study|Post Trial Access|1|||
164380311|NCT02550652|593763484|FG001|Overall Study|Post Trial Access|0|||
164380312|NCT02550652|593763483|FG000|Overall Study|Lost to Follow-up|1|||
164380313|NCT02550652|593763484|FG001|Overall Study|Lost to Follow-up|3|||
164380314|NCT02550652|593763483|FG000|Overall Study|Physician Decision|0|||
164380315|NCT02550652|593763484|FG001|Overall Study|Physician Decision|2|||
164380316|NCT02550652|593763483|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
164380317|NCT02550652|593763484|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
164380318|NCT02486406|593763485|FG000|Overall Study|Withdrew consent|1|||
164439639|NCT02694978|593977175|FG001|Overall Study|Other-Unable to be reached|1|||
164439640|NCT02694978|593977174|FG000|Overall Study|Other-Protocol noncompliant|2|||
164439641|NCT02694978|593977175|FG001|Overall Study|Other-Protocol noncompliant|1|||
164439642|NCT02694978|593977174|FG000|Overall Study|Other-Personal reasons|3|||
164592221|NCT00783705|594531395|FG000|Overall Study|Withdrawal by Subject|3|||
164592222|NCT00783705|594531396|FG001|Overall Study|Withdrawal by Subject|2|||
164592223|NCT00783705|594531395|FG000|Overall Study|Lost to Follow-up|1|||
164592224|NCT00783705|594531396|FG001|Overall Study|Lost to Follow-up|3|||
164592225|NCT00748540|594531398|FG000|Overall Study|Physician Decision|1|||
164592226|NCT04743635|594531399|FG000|Overall Study|Lost to Follow-up|2|||
164592227|NCT04743635|594531400|FG001|Overall Study|Lost to Follow-up|0|||
164592228|NCT02379923|594531401|FG000|Overall Study|Death|5|||
164592229|NCT00804193|594531402|FG000|Overall Study|Lack of baseline fungus|32|||
164592230|NCT00804193|594531403|FG001|Overall Study|Lack of baseline fungus|31|||
164592231|NCT00804193|594531404|FG002|Overall Study|Lack of baseline fungus|19|||
164592232|NCT00804193|594531402|FG000|Overall Study|Adverse Event|0|||
164592233|NCT00804193|594531403|FG001|Overall Study|Adverse Event|0|||
164380319|NCT02486406|593763486|FG001|Overall Study|Withdrew consent|0|||
164439643|NCT02694978|593977175|FG001|Overall Study|Other-Personal reasons|3|||
164439644|NCT02694978|593977174|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
164592234|NCT00804193|594531404|FG002|Overall Study|Adverse Event|2|||
164592235|NCT00804193|594531402|FG000|Overall Study|Lack of Efficacy|1|||
164592236|NCT00804193|594531403|FG001|Overall Study|Lack of Efficacy|1|||
164592237|NCT00804193|594531404|FG002|Overall Study|Lack of Efficacy|3|||
164380320|NCT02486406|593763487|FG002|Overall Study|Withdrew consent|0|||
164592238|NCT00804193|594531402|FG000|Overall Study|Protocol Violation|0|||
164380321|NCT02486406|593763488|FG003|Overall Study|Withdrew consent|1|||
164380322|NCT02486406|593763485|FG000|Overall Study|Lost to Follow-up|1|||
164380323|NCT02486406|593763486|FG001|Overall Study|Lost to Follow-up|3|||
164380324|NCT02486406|593763487|FG002|Overall Study|Lost to Follow-up|1|||
164380325|NCT02486406|593763488|FG003|Overall Study|Lost to Follow-up|3|||
164380326|NCT02486406|593763485|FG000|Overall Study|Other, not specified|0|||
164592239|NCT00804193|594531403|FG001|Overall Study|Protocol Violation|8|||
164380327|NCT02486406|593763486|FG001|Overall Study|Other, not specified|0|||
164380328|NCT02486406|593763487|FG002|Overall Study|Other, not specified|1|||
164380329|NCT02486406|593763488|FG003|Overall Study|Other, not specified|0|||
164380330|NCT03509948|593763506|FG000|Overall Study|Protocol Violation|0|||
164380331|NCT03509948|593763507|FG001|Overall Study|Protocol Violation|1|||
164380332|NCT03254134|593763509|FG000|Overall Study|Not eligible patients|599|||
164380333|NCT03254134|593763510|FG001|Overall Study|Not eligible patients|3630|||
164380334|NCT00205712|593763511|FG000|Overall Study|Lost to Follow-up|0|||
164380335|NCT00205712|593763512|FG001|Overall Study|Lost to Follow-up|1|||
164592240|NCT00804193|594531404|FG002|Overall Study|Protocol Violation|2|||
164592241|NCT00804193|594531402|FG000|Overall Study|Lost to Follow-up|3|||
164592242|NCT00804193|594531403|FG001|Overall Study|Lost to Follow-up|3|||
164592243|NCT00804193|594531404|FG002|Overall Study|Lost to Follow-up|4|||
164592244|NCT00804193|594531402|FG000|Overall Study|Withdrawal by Subject|3|||
164592245|NCT00804193|594531403|FG001|Overall Study|Withdrawal by Subject|1|||
164592246|NCT00804193|594531404|FG002|Overall Study|Withdrawal by Subject|2|||
164592247|NCT01193348|594531405|FG000|Screening Period|Screen Failure|5|||
164592248|NCT01193348|594531405|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
164592249|NCT01193348|594531405|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
164592250|NCT01193348|594531405|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
164592251|NCT01193348|594531405|FG000|Extension Treatment Period|Physician Decision|1|||
164592252|NCT01193348|594531405|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
164592253|NCT00968253|594531406|FG000|Overall Study|Death|0|||
164592254|NCT00968253|594531407|FG001|Overall Study|Death|0|||
164592255|NCT00968253|594531408|FG002|Overall Study|Death|2|||
164592256|NCT00968253|594531406|FG000|Overall Study|Withdrawal by Subject|0|||
164592257|NCT00968253|594531407|FG001|Overall Study|Withdrawal by Subject|0|||
164592258|NCT00968253|594531408|FG002|Overall Study|Withdrawal by Subject|1|||
164592259|NCT00968253|594531406|FG000|Overall Study|Disease Progression|0|||
164592260|NCT00968253|594531407|FG001|Overall Study|Disease Progression|3|||
164592261|NCT00968253|594531408|FG002|Overall Study|Disease Progression|3|||
164592262|NCT00968253|594531406|FG000|Overall Study|Adverse Event|0|||
164592263|NCT00968253|594531407|FG001|Overall Study|Adverse Event|0|||
164592264|NCT00968253|594531408|FG002|Overall Study|Adverse Event|1|||
164592265|NCT03141086|594531409|FG000|Overall Study|Study Terminated By Sponsor|1|||
164592266|NCT03141086|594531410|FG001|Overall Study|Study Terminated By Sponsor|1|||
164592267|NCT03141086|594531409|FG000|Overall Study|Withdrawal by Subject|0|||
164592268|NCT03141086|594531410|FG001|Overall Study|Withdrawal by Subject|1|||
164592269|NCT03141086|594531409|FG000|Overall Study|Protocol Violation|0|||
164592270|NCT03141086|594531410|FG001|Overall Study|Protocol Violation|1|||
164592271|NCT03141086|594531409|FG000|Overall Study|Adverse Event|0|||
164592272|NCT03141086|594531410|FG001|Overall Study|Adverse Event|2|||
164592273|NCT02488759|594531412|FG000|Overall Study|Disease progression|73|||
164592274|NCT02488759|594531413|FG001|Overall Study|Disease progression|111|||
164592275|NCT02488759|594531414|FG002|Overall Study|Disease progression|62|||
164592276|NCT02488759|594531415|FG003|Overall Study|Disease progression|7|||
164592277|NCT02488759|594531416|FG004|Overall Study|Disease progression|4|||
164592278|NCT02488759|594531417|FG005|Overall Study|Disease progression|2|||
164592279|NCT02488759|594531412|FG000|Overall Study|Study drug toxicity|11|||
164592280|NCT02488759|594531413|FG001|Overall Study|Study drug toxicity|33|||
164592281|NCT02488759|594531414|FG002|Overall Study|Study drug toxicity|31|||
164592282|NCT02488759|594531415|FG003|Overall Study|Study drug toxicity|0|||
164592283|NCT02488759|594531416|FG004|Overall Study|Study drug toxicity|0|||
164592284|NCT02488759|594531417|FG005|Overall Study|Study drug toxicity|2|||
164592285|NCT02488759|594531412|FG000|Overall Study|Adverse event unrelated to study drug|9|||
164592286|NCT02488759|594531413|FG001|Overall Study|Adverse event unrelated to study drug|11|||
164592287|NCT02488759|594531414|FG002|Overall Study|Adverse event unrelated to study drug|7|||
164592288|NCT02488759|594531415|FG003|Overall Study|Adverse event unrelated to study drug|0|||
164592289|NCT02488759|594531416|FG004|Overall Study|Adverse event unrelated to study drug|1|||
164701363|NCT01297322|594930279|FG000|Overall Study|Withdrawal by Subject|0|||
164701364|NCT01297322|594930280|FG001|Overall Study|Withdrawal by Subject|1|||
164701365|NCT01297322|594930279|FG000|Overall Study|Protocol Violation|0|||
164701366|NCT01297322|594930280|FG001|Overall Study|Protocol Violation|3|||
164701367|NCT01111019|594930281|FG000|Overall Study|Withdrew Prematurely|2|||
164701368|NCT01111019|594930281|FG000|Overall Study|Other|1|||
164592290|NCT02488759|594531417|FG005|Overall Study|Adverse event unrelated to study drug|0|||
164592291|NCT02488759|594531412|FG000|Overall Study|Participant request to discontinue study treatment|6|||
164592292|NCT02488759|594531413|FG001|Overall Study|Participant request to discontinue study treatment|8|||
164592293|NCT02488759|594531414|FG002|Overall Study|Participant request to discontinue study treatment|4|||
164701369|NCT01583218|594930282|FG000|Overall Study|Withdrawal by Subject|43|||
164380336|NCT01009099|593763513|FG000|Overall Study|Lost to Follow-up|1|||
164380337|NCT01009099|593763514|FG001|Overall Study|Lost to Follow-up|0|||
164592294|NCT02488759|594531415|FG003|Overall Study|Participant request to discontinue study treatment|0|||
164592295|NCT02488759|594531416|FG004|Overall Study|Participant request to discontinue study treatment|0|||
164592296|NCT02488759|594531417|FG005|Overall Study|Participant request to discontinue study treatment|0|||
164380338|NCT01009099|593763513|FG000|Overall Study|Physician Decision|3|||
164701370|NCT01583218|594930283|FG001|Overall Study|Withdrawal by Subject|29|||
164701371|NCT01583218|594930282|FG000|Overall Study|Death|206|||
164701372|NCT01583218|594930283|FG001|Overall Study|Death|211|||
164701373|NCT01583218|594930282|FG000|Overall Study|Lost to Follow-up|11|||
164701374|NCT01583218|594930283|FG001|Overall Study|Lost to Follow-up|17|||
164701375|NCT01583218|594930282|FG000|Overall Study|Adverse event or serious adverse event|3|||
164701376|NCT01583218|594930283|FG001|Overall Study|Adverse event or serious adverse event|3|||
164701377|NCT01583218|594930282|FG000|Overall Study|Patient /Family decision|3|||
164701378|NCT01583218|594930283|FG001|Overall Study|Patient /Family decision|0|||
164701379|NCT01583218|594930282|FG000|Overall Study|Cannot contact patient directly|1|||
164701380|NCT01583218|594930283|FG001|Overall Study|Cannot contact patient directly|2|||
164701381|NCT01583218|594930282|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
164701382|NCT01583218|594930283|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
164701383|NCT01583218|594930282|FG000|Overall Study|Patient did not wish to attend visits|0|||
164701384|NCT01583218|594930283|FG001|Overall Study|Patient did not wish to attend visits|1|||
164701385|NCT01583218|594930282|FG000|Overall Study|Patient randomized but not dosed|17|||
164701386|NCT01583218|594930283|FG001|Overall Study|Patient randomized but not dosed|16|||
164701387|NCT01583218|594930282|FG000|Overall Study|Patient was assessed via phone in person|1|||
164701388|NCT01583218|594930283|FG001|Overall Study|Patient was assessed via phone in person|0|||
164701389|NCT01583218|594930282|FG000|Overall Study|Patient deemed ineligible after random|2|||
164701390|NCT01583218|594930283|FG001|Overall Study|Patient deemed ineligible after random|0|||
164701391|NCT01583218|594930282|FG000|Overall Study|Patient was early terminated from study|0|||
164701392|NCT01583218|594930283|FG001|Overall Study|Patient was early terminated from study|1|||
164701393|NCT01583218|594930282|FG000|Overall Study|Patient was randomized due to mistake|1|||
164701394|NCT01583218|594930283|FG001|Overall Study|Patient was randomized due to mistake|0|||
164701395|NCT01583218|594930282|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
164701396|NCT01583218|594930283|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
164701397|NCT01583218|594930282|FG000|Overall Study|Withdraw of consent on day of random|1|||
164701398|NCT01583218|594930283|FG001|Overall Study|Withdraw of consent on day of random|0|||
164701399|NCT02013375|594930284|FG000|Overall Study|Did not engraft|1|||
164701400|NCT02013375|594930284|FG000|Overall Study|Did not engraft|1|||
164701401|NCT00712985|594930285|FG000|Overall Study|1 withdrew prior to start of drug|1|||
164701402|NCT00712985|594930285|FG000|Overall Study|1 patient moved out of state|1|||
164701403|NCT00712985|594930285|FG000|Overall Study|Lack of Efficacy|3|||
164701404|NCT01663727|594930288|FG000|Overall Study|Death|161|||
164701405|NCT01663727|594930289|FG001|Overall Study|Death|155|||
164701406|NCT01663727|594930288|FG000|Overall Study|Lost to Follow-up|10|||
164701407|NCT01663727|594930289|FG001|Overall Study|Lost to Follow-up|8|||
164701408|NCT01663727|594930288|FG000|Overall Study|Withdrawal by Subject|18|||
164701409|NCT01663727|594930289|FG001|Overall Study|Withdrawal by Subject|25|||
164701410|NCT01663727|594930288|FG000|Overall Study|Study Terminated|51|||
164701411|NCT01663727|594930289|FG001|Overall Study|Study Terminated|50|||
164701412|NCT01663727|594930288|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
164701413|NCT01663727|594930289|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
164701414|NCT01663727|594930288|FG000|Overall Study|Withdrawal prior to dosing.|1|||
164701415|NCT01663727|594930289|FG001|Overall Study|Withdrawal prior to dosing.|0|||
164701416|NCT01232491|594930290|FG000|Overall Study|Adverse Event|13|||
164701417|NCT01232491|594930291|FG001|Overall Study|Adverse Event|8|||
164701418|NCT01232491|594930290|FG000|Overall Study|Lack of Efficacy|1|||
164701419|NCT01232491|594930291|FG001|Overall Study|Lack of Efficacy|5|||
164701420|NCT01232491|594930290|FG000|Overall Study|Protocol Violation|13|||
164701421|NCT01232491|594930291|FG001|Overall Study|Protocol Violation|11|||
164701422|NCT01232491|594930290|FG000|Overall Study|Withdrawal Criteria|12|||
164701423|NCT01232491|594930291|FG001|Overall Study|Withdrawal Criteria|21|||
164701424|NCT01232491|594930290|FG000|Overall Study|Other|21|||
164701425|NCT01232491|594930291|FG001|Overall Study|Other|18|||
164701426|NCT02932228|594930292|FG000|Overall Study|Death|8|||
164701427|NCT02932228|594930293|FG001|Overall Study|Death|23|||
164380339|NCT01009099|593763514|FG001|Overall Study|Physician Decision|2|||
164380340|NCT01009099|593763513|FG000|Overall Study|Withdrawal by Subject|1|||
164380341|NCT01009099|593763514|FG001|Overall Study|Withdrawal by Subject|1|||
164380342|NCT01009099|593763513|FG000|Overall Study|Death|0|||
164380343|NCT01009099|593763514|FG001|Overall Study|Death|1|||
164701428|NCT02932228|594930292|FG000|Overall Study|not eligible upon chart review|2|||
164701429|NCT02932228|594930293|FG001|Overall Study|not eligible upon chart review|5|||
164701430|NCT04385277|594932609|FG000|Overall Study|Physician Decision|2|||
164701431|NCT04385277|594932609|FG000|Overall Study|Ineligible|1|||
164701432|NCT04385277|594932609|FG000|Overall Study|Patient/Parent Refusal|2|||
164701433|NCT04905290|594932610|FG000|Overall Study|Adverse Event|4|||
164701434|NCT04905290|594932610|FG000|Overall Study|Death|2|||
164380344|NCT02188485|593763525|FG000|Overall Study|Withdrawal by Subject|2|||
164380345|NCT02188485|593763526|FG001|Overall Study|Withdrawal by Subject|1|||
164701435|NCT04905290|594932610|FG000|Overall Study|Withdrawal by Subject|4|||
164380346|NCT02188485|593763525|FG000|Overall Study|PI withdrew, lack of capacity|0|||
164380347|NCT02188485|593763526|FG001|Overall Study|PI withdrew, lack of capacity|2|||
164380348|NCT00799617|593763527|FG000|Main Testosterone Trial|Randomized in error|1|||
164592297|NCT02488759|594531412|FG000|Overall Study|Withdrawal by Subject|4|||
164592298|NCT02488759|594531413|FG001|Overall Study|Withdrawal by Subject|0|||
164592299|NCT02488759|594531414|FG002|Overall Study|Withdrawal by Subject|3|||
164592300|NCT02488759|594531415|FG003|Overall Study|Withdrawal by Subject|0|||
164592301|NCT02488759|594531416|FG004|Overall Study|Withdrawal by Subject|0|||
164592302|NCT02488759|594531417|FG005|Overall Study|Withdrawal by Subject|2|||
164592303|NCT02488759|594531412|FG000|Overall Study|Lost to Follow-up|0|||
164592304|NCT02488759|594531413|FG001|Overall Study|Lost to Follow-up|0|||
164592305|NCT02488759|594531414|FG002|Overall Study|Lost to Follow-up|2|||
164380349|NCT00799617|593763528|FG001|Main Testosterone Trial|Randomized in error|1|||
164380350|NCT00799617|593763527|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
164380351|NCT00799617|593763528|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
164380352|NCT00799617|593763527|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
164380353|NCT00799617|593763528|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
164380354|NCT00799617|593763527|FG000|Sexual Funtion Trial|No Baseline Data|4|||
164380355|NCT00799617|593763528|FG001|Sexual Funtion Trial|No Baseline Data|7|||
164380356|NCT00799617|593763527|FG000|Physical Function Trial|Lost to Follow-up|6|||
164380357|NCT00799617|593763528|FG001|Physical Function Trial|Lost to Follow-up|11|||
164380358|NCT00799617|593763527|FG000|Vitality Trial|Lost to Follow-up|7|||
164380359|NCT00799617|593763528|FG001|Vitality Trial|Lost to Follow-up|22|||
164380360|NCT00799617|593763527|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
164592306|NCT02488759|594531415|FG003|Overall Study|Lost to Follow-up|0|||
164592307|NCT02488759|594531416|FG004|Overall Study|Lost to Follow-up|0|||
164592308|NCT02488759|594531417|FG005|Overall Study|Lost to Follow-up|0|||
164592309|NCT02488759|594531412|FG000|Overall Study|Maximum clinical benefit|3|||
164592310|NCT02488759|594531413|FG001|Overall Study|Maximum clinical benefit|0|||
164592311|NCT02488759|594531414|FG002|Overall Study|Maximum clinical benefit|1|||
164592312|NCT02488759|594531415|FG003|Overall Study|Maximum clinical benefit|0|||
164592313|NCT02488759|594531416|FG004|Overall Study|Maximum clinical benefit|0|||
164592314|NCT02488759|594531417|FG005|Overall Study|Maximum clinical benefit|0|||
164592315|NCT02488759|594531412|FG000|Overall Study|Other reasons|7|||
164592316|NCT02488759|594531413|FG001|Overall Study|Other reasons|32|||
164592317|NCT02488759|594531414|FG002|Overall Study|Other reasons|23|||
164592318|NCT02488759|594531415|FG003|Overall Study|Other reasons|1|||
164592319|NCT02488759|594531416|FG004|Overall Study|Other reasons|1|||
164592320|NCT02488759|594531417|FG005|Overall Study|Other reasons|1|||
164592321|NCT03860844|594531418|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
164592322|NCT03860844|594531419|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
164592323|NCT03860844|594531420|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
164592324|NCT03860844|594531418|FG000|Overall Study|Progressive disease|5|||
164592325|NCT03860844|594531419|FG001|Overall Study|Progressive disease|3|||
164592326|NCT03860844|594531420|FG002|Overall Study|Progressive disease|4|||
164592327|NCT03860844|594531418|FG000|Overall Study|Other, Not related to COVID-19|0|||
164592328|NCT03860844|594531419|FG001|Overall Study|Other, Not related to COVID-19|1|||
164592329|NCT03860844|594531420|FG002|Overall Study|Other, Not related to COVID-19|0|||
164592330|NCT01678807|594531428|FG000|Overall Study|Adverse Event|4|||
164592331|NCT01678807|594531429|FG001|Overall Study|Adverse Event|4|||
164592332|NCT01678807|594531430|FG002|Overall Study|Adverse Event|0|||
164592333|NCT01678807|594531428|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
164380361|NCT00799617|593763528|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
164380362|NCT00799617|593763527|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
164380363|NCT00799617|593763528|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
164380364|NCT00799617|593763527|FG000|Bone Trial|Month 12 scan not available|6|||
164380365|NCT00799617|593763528|FG001|Bone Trial|Month 12 scan not available|16|||
164380366|NCT00799617|593763527|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
164380367|NCT00799617|593763528|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
164380368|NCT00799617|593763527|FG000|Anemia Trial|Withdrawal by Subject|3|||
164380369|NCT00799617|593763528|FG001|Anemia Trial|Withdrawal by Subject|3|||
164380370|NCT01712984|593763529|FG000|Overall Study|Adverse Event|0|||
164380371|NCT01712984|593763530|FG001|Overall Study|Adverse Event|0|||
164380372|NCT01712984|593763531|FG002|Overall Study|Adverse Event|1|||
164439645|NCT02694978|593977175|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
164439646|NCT00807144|593977180|FG000|Overall Study|Lost to Follow-up|0|||
164592334|NCT01678807|594531429|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
164592335|NCT01678807|594531430|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
164592336|NCT03607682|594531431|FG000|Overall Study|Withdrawal by Subject|1|||
164380373|NCT01712984|593763529|FG000|Overall Study|Protocol Violation|2|||
164380374|NCT01712984|593763530|FG001|Overall Study|Protocol Violation|0|||
164380375|NCT01712984|593763531|FG002|Overall Study|Protocol Violation|1|||
164380376|NCT01712984|593763529|FG000|Overall Study|Lost to Follow-up|8|||
164380377|NCT01712984|593763530|FG001|Overall Study|Lost to Follow-up|10|||
164592337|NCT03607682|594531431|FG000|Overall Study|Disease progression|1|||
164592338|NCT05281523|594531432|FG000|Overall Study|Adverse Event|1|||
164439647|NCT00807144|593977181|FG001|Overall Study|Lost to Follow-up|1|||
164439648|NCT02567656|593977182|FG000|Overall Study|Premature discontinuation due to PD|1|||
164439649|NCT02567656|593977183|FG001|Overall Study|Premature discontinuation due to PD|1|||
164439650|NCT02567656|593977184|FG002|Overall Study|Premature discontinuation due to PD|2|||
164439651|NCT02567656|593977185|FG003|Overall Study|Premature discontinuation due to PD|0|||
164701436|NCT04905290|594932610|FG000|Overall Study|Physician Decision|2|||
164701437|NCT04905290|594932610|FG000|Overall Study|Lost to Follow-up|2|||
164701438|NCT04905290|594932610|FG000|Overall Study|Screen Failure|2|||
164701439|NCT04905290|594932610|FG000|Overall Study|Unsuccessful Procedure|2|||
164701440|NCT03303625|594932611|FG000|Overall Study|Withdrawal by Subject|2|||
164701441|NCT03303625|594932612|FG001|Overall Study|Withdrawal by Subject|0|||
164701442|NCT03303625|594932613|FG002|Overall Study|Withdrawal by Subject|0|||
164701443|NCT03303625|594932614|FG003|Overall Study|Withdrawal by Subject|0|||
164701444|NCT01045421|594932619|FG000|Phase 1|Progressive Disease|0|||
164701445|NCT01045421|594932620|FG001|Phase 1|Progressive Disease|0|||
164701446|NCT01045421|594932621|FG002|Phase 1|Progressive Disease|0|||
164701447|NCT01045421|594932622|FG003|Phase 1|Progressive Disease|0|||
164701448|NCT01045421|594932623|FG004|Phase 1|Progressive Disease|1|||
164701449|NCT01045421|594932624|FG005|Phase 1|Progressive Disease|0|||
164701450|NCT01045421|594932625|FG006|Phase 1|Progressive Disease|0|||
164701451|NCT01045421|594932626|FG007|Phase 1|Progressive Disease|0|||
164701452|NCT01045421|594932627|FG008|Phase 1|Progressive Disease|0|||
164701453|NCT01045421|594932628|FG009|Phase 1|Progressive Disease|0|||
164380378|NCT01712984|593763531|FG002|Overall Study|Lost to Follow-up|1|||
164380379|NCT01712984|593763529|FG000|Overall Study|Withdrawal by Subject|6|||
164380380|NCT01712984|593763530|FG001|Overall Study|Withdrawal by Subject|6|||
164380381|NCT01712984|593763531|FG002|Overall Study|Withdrawal by Subject|7|||
164380382|NCT00096044|593763534|FG000|Overall Study|Withdrawal by Subject|9|||
164380383|NCT00096044|593763534|FG000|Overall Study|Adverse Event|21|||
164380384|NCT00096044|593763534|FG000|Overall Study|Disease Progression|4|||
164380385|NCT03149237|593763535|FG000|Overall Study|Withdrawal by Subject|4|||
164380386|NCT03149237|593763536|FG001|Overall Study|Withdrawal by Subject|5|||
164380387|NCT02442830|593763537|FG000|Overall Study|Technical Failure|0|||
164380388|NCT02442830|593763538|FG001|Overall Study|Technical Failure|1|||
164380389|NCT00595582|593763540|FG000|Overall Study|Pilot study that PI terminated|2|||
164380390|NCT00595582|593763540|FG000|Overall Study|Lost to Follow-up|1|||
164380391|NCT00595582|593763540|FG000|Overall Study|Adverse Event|2|||
164380392|NCT00595582|593763540|FG000|Overall Study|Physician Decision|5|||
164380393|NCT03851016|593763541|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
164380394|NCT03851016|593763542|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
164380395|NCT03878134|593763543|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
164380396|NCT00586469|593763544|FG000|Overall Study|Adverse Event|0|||
164380397|NCT00586469|593763545|FG001|Overall Study|Adverse Event|1|||
164380398|NCT04055116|593763548|FG000|First Intervention|Physician Decision|2|||
164380399|NCT04055116|593763549|FG001|First Intervention|Physician Decision|7|||
164380400|NCT01976845|593763555|FG000|Overall Study|Physician Decision|8|||
164380401|NCT01976845|593763556|FG001|Overall Study|Physician Decision|8|||
164380402|NCT01976845|593763557|FG002|Overall Study|Physician Decision|3|||
164380403|NCT01660412|593763558|FG000|Overall Study|Protocol Violation|0|||
164380404|NCT01660412|593763559|FG001|Overall Study|Protocol Violation|3|||
164380405|NCT01818336|593765059|FG000|Overall Study|Declined retest visit|0|||
164380406|NCT01818336|593765060|FG001|Overall Study|Declined retest visit|11|||
164380407|NCT01818336|593765059|FG000|Overall Study|Lost to Follow-up|0|||
164380408|NCT01818336|593765060|FG001|Overall Study|Lost to Follow-up|1|||
164380409|NCT03042312|593765063|FG000|Overall Study|Administrative Reason|1|||
164380410|NCT03042312|593765064|FG001|Overall Study|Administrative Reason|1|||
164380411|NCT03042312|593765063|FG000|Overall Study|Adverse Event|0|||
164380412|NCT03042312|593765064|FG001|Overall Study|Adverse Event|1|||
164380413|NCT03042312|593765063|FG000|Overall Study|Lost to Follow-up|1|||
164380414|NCT03042312|593765064|FG001|Overall Study|Lost to Follow-up|3|||
164380415|NCT03042312|593765063|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
164380416|NCT03042312|593765064|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
164380417|NCT03042312|593765063|FG000|Overall Study|Withdrawal by Subject|4|||
164380418|NCT03042312|593765064|FG001|Overall Study|Withdrawal by Subject|5|||
164701454|NCT01045421|594932629|FG010|Phase 1|Progressive Disease|0|||
164701455|NCT01045421|594932619|FG000|Phase 1|Withdrawal by Subject|0|||
164701456|NCT01045421|594932620|FG001|Phase 1|Withdrawal by Subject|0|||
164380419|NCT04258839|593765065|FG000|Overall Study|Adverse Event|2|||
164380420|NCT04258839|593765066|FG001|Overall Study|Adverse Event|4|||
164380421|NCT04258839|593765065|FG000|Overall Study|Lack of Efficacy|0|||
164380422|NCT04258839|593765066|FG001|Overall Study|Lack of Efficacy|2|||
164380423|NCT04258839|593765065|FG000|Overall Study|Lost to Follow-up|2|||
164380424|NCT04258839|593765066|FG001|Overall Study|Lost to Follow-up|0|||
164380425|NCT04258839|593765065|FG000|Overall Study|Withdrawal by Subject|1|||
164380426|NCT04258839|593765066|FG001|Overall Study|Withdrawal by Subject|2|||
164380427|NCT04258839|593765065|FG000|Overall Study|Withdrawal by Caregiver|5|||
164380428|NCT04258839|593765066|FG001|Overall Study|Withdrawal by Caregiver|6|||
164380429|NCT04258839|593765065|FG000|Overall Study|Reason not Specified|0|||
164380430|NCT04258839|593765066|FG001|Overall Study|Reason not Specified|1|||
164380431|NCT03328897|593765067|FG000|Randomized-treatment Epoch|Adverse Event|4|||
164380432|NCT03328897|593765068|FG001|Randomized-treatment Epoch|Adverse Event|1|||
164380433|NCT03328897|593765069|FG002|Randomized-treatment Epoch|Adverse Event|1|||
164380434|NCT03328897|593765067|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
164380435|NCT03328897|593765068|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
164380436|NCT03328897|593765069|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
164380437|NCT03328897|593765067|FG000|Randomized-treatment Epoch|Pregnancy|3|||
164380438|NCT03328897|593765068|FG001|Randomized-treatment Epoch|Pregnancy|0|||
164380439|NCT03328897|593765069|FG002|Randomized-treatment Epoch|Pregnancy|0|||
164380440|NCT03328897|593765067|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
164380441|NCT03328897|593765068|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
164380442|NCT03328897|593765069|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
164380443|NCT03328897|593765067|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
164439652|NCT02567656|593977186|FG004|Overall Study|Premature discontinuation due to PD|0|||
164439653|NCT02567656|593977187|FG005|Overall Study|Premature discontinuation due to PD|0|||
164439654|NCT01924767|593977189|FG000|Overall Study|Adverse Event|1|||
164439655|NCT01924767|593977190|FG001|Overall Study|Adverse Event|0|||
164439656|NCT01924767|593977191|FG002|Overall Study|Adverse Event|1|||
164439657|NCT01924767|593977192|FG003|Overall Study|Adverse Event|0|||
164439658|NCT01924767|593977193|FG004|Overall Study|Adverse Event|0|||
164439659|NCT01648140|593977194|FG000|Overall Study|Physician Decision|1|||
164439660|NCT01648140|593977195|FG001|Overall Study|Physician Decision|0|||
164439661|NCT01648140|593977196|FG002|Overall Study|Physician Decision|0|||
164439662|NCT01648140|593977197|FG003|Overall Study|Physician Decision|0|||
164439663|NCT01648140|593977194|FG000|Overall Study|Lack of Efficacy|4|||
164439664|NCT01648140|593977195|FG001|Overall Study|Lack of Efficacy|7|||
164439665|NCT01648140|593977196|FG002|Overall Study|Lack of Efficacy|1|||
164439666|NCT01648140|593977197|FG003|Overall Study|Lack of Efficacy|0|||
164439667|NCT01648140|593977194|FG000|Overall Study|Adverse Event|3|||
164439668|NCT01648140|593977195|FG001|Overall Study|Adverse Event|1|||
164439669|NCT01648140|593977196|FG002|Overall Study|Adverse Event|2|||
164439670|NCT01648140|593977197|FG003|Overall Study|Adverse Event|0|||
164439671|NCT01648140|593977194|FG000|Overall Study|Withdrawal by Subject|2|||
164439672|NCT01648140|593977195|FG001|Overall Study|Withdrawal by Subject|3|||
164701457|NCT01045421|594932621|FG002|Phase 1|Withdrawal by Subject|0|||
164701458|NCT01045421|594932622|FG003|Phase 1|Withdrawal by Subject|1|||
164701459|NCT01045421|594932623|FG004|Phase 1|Withdrawal by Subject|0|||
164701460|NCT01045421|594932624|FG005|Phase 1|Withdrawal by Subject|0|||
164701461|NCT01045421|594932625|FG006|Phase 1|Withdrawal by Subject|0|||
164701462|NCT01045421|594932626|FG007|Phase 1|Withdrawal by Subject|0|||
164701463|NCT01045421|594932627|FG008|Phase 1|Withdrawal by Subject|0|||
164701464|NCT01045421|594932628|FG009|Phase 1|Withdrawal by Subject|0|||
164701465|NCT01045421|594932629|FG010|Phase 1|Withdrawal by Subject|0|||
164701466|NCT01045421|594932619|FG000|Phase 2|Progressive Disease|0|||
164701467|NCT01045421|594932620|FG001|Phase 2|Progressive Disease|0|||
164701468|NCT01045421|594932621|FG002|Phase 2|Progressive Disease|0|||
164701469|NCT01045421|594932622|FG003|Phase 2|Progressive Disease|0|||
164701470|NCT01045421|594932623|FG004|Phase 2|Progressive Disease|0|||
164701471|NCT01045421|594932624|FG005|Phase 2|Progressive Disease|0|||
164701472|NCT01045421|594932625|FG006|Phase 2|Progressive Disease|0|||
164701473|NCT01045421|594932626|FG007|Phase 2|Progressive Disease|1|||
164701474|NCT01045421|594932627|FG008|Phase 2|Progressive Disease|1|||
164701475|NCT01045421|594932628|FG009|Phase 2|Progressive Disease|1|||
164701476|NCT01045421|594932629|FG010|Phase 2|Progressive Disease|1|||
164701477|NCT01045421|594932619|FG000|Phase 2|Death|0|||
164701478|NCT01045421|594932620|FG001|Phase 2|Death|0|||
164701479|NCT01045421|594932621|FG002|Phase 2|Death|0|||
164439673|NCT01648140|593977196|FG002|Overall Study|Withdrawal by Subject|3|||
164439674|NCT01648140|593977197|FG003|Overall Study|Withdrawal by Subject|2|||
164701480|NCT01045421|594932622|FG003|Phase 2|Death|0|||
164701481|NCT01045421|594932623|FG004|Phase 2|Death|0|||
164701482|NCT01045421|594932624|FG005|Phase 2|Death|0|||
164701483|NCT01045421|594932625|FG006|Phase 2|Death|0|||
164701484|NCT01045421|594932626|FG007|Phase 2|Death|1|||
164701485|NCT01045421|594932627|FG008|Phase 2|Death|1|||
164439675|NCT01648140|593977194|FG000|Overall Study|Lost to Follow-up|2|||
164439676|NCT01648140|593977195|FG001|Overall Study|Lost to Follow-up|1|||
164701486|NCT01045421|594932628|FG009|Phase 2|Death|2|||
164701487|NCT01045421|594932629|FG010|Phase 2|Death|0|||
164701488|NCT01045421|594932619|FG000|Phase 2|Other|0|||
164380444|NCT03328897|593765068|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
164380445|NCT03328897|593765069|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
164439677|NCT01648140|593977196|FG002|Overall Study|Lost to Follow-up|2|||
164701489|NCT01045421|594932620|FG001|Phase 2|Other|0|||
164701490|NCT01045421|594932621|FG002|Phase 2|Other|0|||
164701491|NCT01045421|594932622|FG003|Phase 2|Other|0|||
164701492|NCT01045421|594932623|FG004|Phase 2|Other|0|||
164701493|NCT01045421|594932624|FG005|Phase 2|Other|0|||
164380446|NCT03328897|593765067|FG000|Follow-up Epoch|Adverse Event|4|||
164380447|NCT03328897|593765068|FG001|Follow-up Epoch|Adverse Event|0|||
164380448|NCT03328897|593765069|FG002|Follow-up Epoch|Adverse Event|1|||
164380449|NCT03328897|593765067|FG000|Follow-up Epoch|Lack of Efficacy|1|||
164380450|NCT03328897|593765068|FG001|Follow-up Epoch|Lack of Efficacy|1|||
164380451|NCT03328897|593765069|FG002|Follow-up Epoch|Lack of Efficacy|1|||
164380452|NCT03328897|593765067|FG000|Follow-up Epoch|Lost to Follow-up|0|||
164380453|NCT03328897|593765068|FG001|Follow-up Epoch|Lost to Follow-up|1|||
164380454|NCT03328897|593765069|FG002|Follow-up Epoch|Lost to Follow-up|0|||
164380455|NCT03328897|593765067|FG000|Follow-up Epoch|Pregnancy|1|||
164380456|NCT03328897|593765068|FG001|Follow-up Epoch|Pregnancy|0|||
164380457|NCT03328897|593765069|FG002|Follow-up Epoch|Pregnancy|0|||
164380458|NCT03328897|593765067|FG000|Follow-up Epoch|Patient/guardian decision|2|||
164380459|NCT03328897|593765068|FG001|Follow-up Epoch|Patient/guardian decision|1|||
164380460|NCT03328897|593765069|FG002|Follow-up Epoch|Patient/guardian decision|0|||
164380461|NCT00608829|593765070|FG000|Overall Study|Death|6|||
164380462|NCT00608829|593765070|FG000|Overall Study|Withdrawal by Subject|4|||
164380463|NCT00608829|593765070|FG000|Overall Study|Subject refuses to follow up or return.|5|||
164380464|NCT02080091|593765082|FG000|Overall Study|Study Terminated|22|||
164380465|NCT02080091|593765082|FG000|Overall Study|Death|1|||
164380466|NCT02080091|593765082|FG000|Overall Study|Withdrawal by Subject|1|||
164380467|NCT02080091|593765082|FG000|Overall Study|Other|1|||
164380468|NCT03019536|593765084|FG000|Overall Study|Withdrawal by Subject|1|||
164380469|NCT03019536|593765085|FG001|Overall Study|Withdrawal by Subject|1|||
164380470|NCT03019536|593765086|FG002|Overall Study|Withdrawal by Subject|0|||
164380471|NCT03019536|593765084|FG000|Overall Study|Adverse Event|0|||
164380472|NCT03019536|593765085|FG001|Overall Study|Adverse Event|0|||
164380473|NCT03019536|593765086|FG002|Overall Study|Adverse Event|2|||
164380474|NCT03422003|593765087|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
164380475|NCT03422003|593765088|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
164380476|NCT03422003|593765087|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
164380477|NCT03422003|593765088|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
164380478|NCT00317772|593765089|FG000|Overall Study|Adverse Event|0|||
164380479|NCT00317772|593765090|FG001|Overall Study|Adverse Event|0|||
164380480|NCT00317772|593765091|FG002|Overall Study|Adverse Event|0|||
164380481|NCT00317772|593765092|FG003|Overall Study|Adverse Event|2|||
164380482|NCT00317772|593765089|FG000|Overall Study|Disease Progression|2|||
164380483|NCT00317772|593765090|FG001|Overall Study|Disease Progression|2|||
164380484|NCT00317772|593765091|FG002|Overall Study|Disease Progression|1|||
164380485|NCT00317772|593765092|FG003|Overall Study|Disease Progression|7|||
164380486|NCT00966940|593765093|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
164380487|NCT00966940|593765094|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
164380488|NCT00966940|593765093|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
164380489|NCT00966940|593765094|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
164380490|NCT01040871|593765097|FG000|Overall Study|Adverse Event|6|||
164380491|NCT01040871|593765098|FG001|Overall Study|Adverse Event|2|||
164380492|NCT01040871|593765097|FG000|Overall Study|Withdrawal by Subject|2|||
164380493|NCT01040871|593765098|FG001|Overall Study|Withdrawal by Subject|0|||
164380494|NCT01040871|593765097|FG000|Overall Study|Death|1|||
164380495|NCT01040871|593765098|FG001|Overall Study|Death|3|||
164380496|NCT01040871|593765097|FG000|Overall Study|Lack of Efficacy|1|||
164380497|NCT01040871|593765098|FG001|Overall Study|Lack of Efficacy|1|||
164380498|NCT01040871|593765097|FG000|Overall Study|drug supply issue|1|||
164380499|NCT01040871|593765098|FG001|Overall Study|drug supply issue|0|||
164380500|NCT01040871|593765097|FG000|Overall Study|Randomized and Not Treated|2|||
164380501|NCT01040871|593765098|FG001|Overall Study|Randomized and Not Treated|1|||
164380502|NCT02886572|593765099|FG000|Overall Study|Death|8|||
164380503|NCT03087591|593765101|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
164380504|NCT03087591|593765101|FG000|Overall Study|Withdrawal by Subject|1|||
164380505|NCT02621606|593765102|FG000|Overall Study|Withdrawal by Subject|0|||
164380506|NCT02621606|593765103|FG001|Overall Study|Withdrawal by Subject|1|||
164380507|NCT02621606|593765104|FG002|Overall Study|Withdrawal by Subject|0|||
164380508|NCT01175824|593765105|FG000|Overall Study|Adverse Event|2|||
164592339|NCT05281523|594531433|FG001|Overall Study|Adverse Event|1|||
164592340|NCT05281523|594531432|FG000|Overall Study|Physician Decision|1|||
164592341|NCT05281523|594531433|FG001|Overall Study|Physician Decision|1|||
164592342|NCT05281523|594531432|FG000|Overall Study|Withdrawal by Subject|5|||
164592343|NCT05281523|594531433|FG001|Overall Study|Withdrawal by Subject|15|||
164592344|NCT05281523|594531432|FG000|Overall Study|GCP violations|3|||
164380509|NCT01175824|593765106|FG001|Overall Study|Adverse Event|1|||
164380510|NCT01175824|593765105|FG000|Overall Study|Lack of Efficacy|2|||
164380511|NCT01175824|593765106|FG001|Overall Study|Lack of Efficacy|0|||
164380512|NCT01175824|593765105|FG000|Overall Study|Lost to Follow-up|0|||
164380513|NCT01175824|593765106|FG001|Overall Study|Lost to Follow-up|1|||
164380514|NCT01175824|593765105|FG000|Overall Study|Physician Decision|0|||
164592345|NCT05281523|594531433|FG001|Overall Study|GCP violations|4|||
164592346|NCT04038255|594532489|FG000|Overall Study|Lost to Follow-up|0|||
164701494|NCT01045421|594932625|FG006|Phase 2|Other|0|||
164701495|NCT01045421|594932626|FG007|Phase 2|Other|3|||
164701496|NCT01045421|594932627|FG008|Phase 2|Other|0|||
164701497|NCT01045421|594932628|FG009|Phase 2|Other|0|||
164701498|NCT01045421|594932629|FG010|Phase 2|Other|1|||
164701499|NCT03340064|594932630|FG000|First Period|Adverse Event, non-fatal|2|||
164701500|NCT03340064|594932631|FG001|First Period|Adverse Event, non-fatal|0|||
164701501|NCT03340064|594932630|FG000|First Period|Lack of Efficacy|3|||
164701502|NCT03340064|594932631|FG001|First Period|Lack of Efficacy|0|||
164701503|NCT03340064|594932630|FG000|Second Period|Adverse Event, non-fatal|1|||
164701504|NCT03340064|594932631|FG001|Second Period|Adverse Event, non-fatal|1|||
164701505|NCT03340064|594932630|FG000|Second Period|Lack of Efficacy|11|||
164701506|NCT03340064|594932631|FG001|Second Period|Lack of Efficacy|0|||
164701507|NCT03340064|594932630|FG000|Second Period|Physician Decision|3|||
164701508|NCT03340064|594932631|FG001|Second Period|Physician Decision|0|||
164701509|NCT03340064|594932630|FG000|Second Period|Withdrawal by Subject|2|||
164701510|NCT03340064|594932631|FG001|Second Period|Withdrawal by Subject|1|||
164701511|NCT03340064|594932630|FG000|Second Period|Approved Drug Available For Indication|1|||
164701512|NCT03340064|594932631|FG001|Second Period|Approved Drug Available For Indication|0|||
164701513|NCT03340064|594932630|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
164701514|NCT03340064|594932631|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
164701515|NCT00856973|594932632|FG000|Overall Study|Adverse Event|5|||
164701516|NCT00856973|594932633|FG001|Overall Study|Adverse Event|5|||
164701517|NCT00856973|594932634|FG002|Overall Study|Adverse Event|3|||
164701518|NCT00856973|594932632|FG000|Overall Study|Lost to Follow-up|6|||
164701519|NCT00856973|594932633|FG001|Overall Study|Lost to Follow-up|3|||
164701520|NCT00856973|594932634|FG002|Overall Study|Lost to Follow-up|5|||
164380515|NCT01175824|593765106|FG001|Overall Study|Physician Decision|4|||
164380516|NCT01175824|593765105|FG000|Overall Study|Protocol Violation|2|||
164380517|NCT01175824|593765106|FG001|Overall Study|Protocol Violation|5|||
164380518|NCT01175824|593765105|FG000|Overall Study|Withdrawal by Subject|3|||
164380519|NCT01175824|593765106|FG001|Overall Study|Withdrawal by Subject|7|||
164380520|NCT01175824|593765105|FG000|Overall Study|Sponsor Decision|1|||
164380521|NCT01175824|593765106|FG001|Overall Study|Sponsor Decision|0|||
164380522|NCT01175824|593765105|FG000|Overall Study|Entry Criteria Not Met|6|||
164380523|NCT01175824|593765106|FG001|Overall Study|Entry Criteria Not Met|4|||
164380524|NCT01774903|593765107|FG000|Overall Study|Adverse Event|7|||
164380525|NCT01774903|593765107|FG000|Overall Study|Withdrawal by Subject|2|||
164380526|NCT01774903|593765107|FG000|Overall Study|Lack of Efficacy|1|||
164380527|NCT01774903|593765107|FG000|Overall Study|Ineligible to continue the trial|1|||
164380528|NCT00982319|593765108|FG000|Overall Study|Surgery date change|1|||
164380529|NCT00982319|593765109|FG001|Overall Study|Surgery date change|0|||
164380530|NCT00982319|593765108|FG000|Overall Study|Preop values out of acceptable range|1|||
164380531|NCT00982319|593765109|FG001|Overall Study|Preop values out of acceptable range|1|||
164380532|NCT00982319|593765108|FG000|Overall Study|Pregnancy|0|||
164380533|NCT00982319|593765109|FG001|Overall Study|Pregnancy|1|||
164380534|NCT00767000|593765110|FG000|54-week Study|Adverse Event|4|||
164380535|NCT00767000|593765111|FG001|54-week Study|Adverse Event|6|||
164380536|NCT00767000|593765112|FG002|54-week Study|Adverse Event|6|||
164380537|NCT00767000|593765113|FG003|54-week Study|Adverse Event|8|||
164380538|NCT00767000|593765114|FG004|54-week Study|Adverse Event|4|||
164380539|NCT00767000|593765110|FG000|54-week Study|Creaninine/creatinine clearance|2|||
164380540|NCT00767000|593765111|FG001|54-week Study|Creaninine/creatinine clearance|1|||
164380541|NCT00767000|593765112|FG002|54-week Study|Creaninine/creatinine clearance|2|||
164380542|NCT00767000|593765113|FG003|54-week Study|Creaninine/creatinine clearance|2|||
164380543|NCT00767000|593765114|FG004|54-week Study|Creaninine/creatinine clearance|4|||
164380544|NCT00767000|593765110|FG000|54-week Study|Hyperglycemia|0|||
164380545|NCT00767000|593765111|FG001|54-week Study|Hyperglycemia|0|||
164380546|NCT00767000|593765112|FG002|54-week Study|Hyperglycemia|1|||
164380547|NCT00767000|593765113|FG003|54-week Study|Hyperglycemia|0|||
164380548|NCT00767000|593765114|FG004|54-week Study|Hyperglycemia|1|||
164380549|NCT00767000|593765110|FG000|54-week Study|Hypoglycemia|0|||
164380550|NCT00767000|593765111|FG001|54-week Study|Hypoglycemia|1|||
164380551|NCT00767000|593765112|FG002|54-week Study|Hypoglycemia|0|||
164380552|NCT00767000|593765113|FG003|54-week Study|Hypoglycemia|0|||
164380553|NCT00767000|593765114|FG004|54-week Study|Hypoglycemia|0|||
164701521|NCT00856973|594932632|FG000|Overall Study|Physician Decision|0|||
164380554|NCT00767000|593765110|FG000|54-week Study|Interruption of study medication|0|||
164380555|NCT00767000|593765111|FG001|54-week Study|Interruption of study medication|0|||
164380556|NCT00767000|593765112|FG002|54-week Study|Interruption of study medication|1|||
164701522|NCT00856973|594932633|FG001|Overall Study|Physician Decision|3|||
164380557|NCT00767000|593765113|FG003|54-week Study|Interruption of study medication|0|||
164380558|NCT00767000|593765114|FG004|54-week Study|Interruption of study medication|0|||
164380559|NCT00767000|593765110|FG000|54-week Study|Lack of Efficacy|2|||
164380560|NCT00767000|593765111|FG001|54-week Study|Lack of Efficacy|0|||
164701523|NCT00856973|594932634|FG002|Overall Study|Physician Decision|1|||
164701524|NCT00856973|594932632|FG000|Overall Study|Protocol Violation|1|||
164701525|NCT00856973|594932633|FG001|Overall Study|Protocol Violation|2|||
164380561|NCT00767000|593765112|FG002|54-week Study|Lack of Efficacy|1|||
164380562|NCT00767000|593765113|FG003|54-week Study|Lack of Efficacy|0|||
164380563|NCT00767000|593765114|FG004|54-week Study|Lack of Efficacy|5|||
164380564|NCT00767000|593765110|FG000|54-week Study|Lost to Follow-up|4|||
164380565|NCT00767000|593765111|FG001|54-week Study|Lost to Follow-up|0|||
164380566|NCT00767000|593765112|FG002|54-week Study|Lost to Follow-up|1|||
164380567|NCT00767000|593765113|FG003|54-week Study|Lost to Follow-up|4|||
164380568|NCT00767000|593765114|FG004|54-week Study|Lost to Follow-up|2|||
164380569|NCT00767000|593765110|FG000|54-week Study|Physician Decision|4|||
164380570|NCT00767000|593765111|FG001|54-week Study|Physician Decision|0|||
164380571|NCT00767000|593765112|FG002|54-week Study|Physician Decision|1|||
164380572|NCT00767000|593765113|FG003|54-week Study|Physician Decision|1|||
164380573|NCT00767000|593765114|FG004|54-week Study|Physician Decision|1|||
164380574|NCT00767000|593765110|FG000|54-week Study|Progressive disease|0|||
164380575|NCT00767000|593765111|FG001|54-week Study|Progressive disease|0|||
164380576|NCT00767000|593765112|FG002|54-week Study|Progressive disease|1|||
164380577|NCT00767000|593765113|FG003|54-week Study|Progressive disease|0|||
164380578|NCT00767000|593765114|FG004|54-week Study|Progressive disease|0|||
164380579|NCT00767000|593765110|FG000|54-week Study|Protocol Violation|0|||
164380580|NCT00767000|593765111|FG001|54-week Study|Protocol Violation|0|||
164380581|NCT00767000|593765112|FG002|54-week Study|Protocol Violation|1|||
164380582|NCT00767000|593765113|FG003|54-week Study|Protocol Violation|2|||
164380583|NCT00767000|593765114|FG004|54-week Study|Protocol Violation|0|||
164380584|NCT00767000|593765110|FG000|54-week Study|Withdrawal by Subject|2|||
164380585|NCT00767000|593765111|FG001|54-week Study|Withdrawal by Subject|3|||
164380586|NCT00767000|593765112|FG002|54-week Study|Withdrawal by Subject|5|||
164380587|NCT00767000|593765113|FG003|54-week Study|Withdrawal by Subject|11|||
164380588|NCT00767000|593765114|FG004|54-week Study|Withdrawal by Subject|13|||
164380589|NCT00767000|593765110|FG000|54-week Study|Study terminated by sponsor|90|||
164380590|NCT00767000|593765111|FG001|54-week Study|Study terminated by sponsor|102|||
164380591|NCT00767000|593765112|FG002|54-week Study|Study terminated by sponsor|89|||
164380592|NCT00767000|593765113|FG003|54-week Study|Study terminated by sponsor|196|||
164380593|NCT00767000|593765114|FG004|54-week Study|Study terminated by sponsor|194|||
164380594|NCT00767000|593765110|FG000|54-week Study|Reason not reported|0|||
164380595|NCT00767000|593765111|FG001|54-week Study|Reason not reported|0|||
164380596|NCT00767000|593765112|FG002|54-week Study|Reason not reported|0|||
164380597|NCT00767000|593765113|FG003|54-week Study|Reason not reported|1|||
164380598|NCT00767000|593765114|FG004|54-week Study|Reason not reported|0|||
164380599|NCT00767000|593765110|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
164380600|NCT00767000|593765111|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
164380601|NCT00767000|593765112|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
164380602|NCT00767000|593765113|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
164380603|NCT00767000|593765114|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
164380604|NCT01252251|593765121|FG000|Overall Study|Withdrawal by Subject|1|||
164380605|NCT01324024|593765122|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
164380606|NCT01324024|593765123|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
164380607|NCT00097591|593765125|FG000|Overall Study|Withdrawal of consent|342|||
164380608|NCT00097591|593765126|FG001|Overall Study|Withdrawal of consent|323|||
164380609|NCT00097591|593765125|FG000|Overall Study|Less than 6 months on study drug|9|||
164380610|NCT00097591|593765126|FG001|Overall Study|Less than 6 months on study drug|7|||
164380611|NCT00097591|593765125|FG000|Overall Study|Unable to attend termination visit|53|||
164380612|NCT00097591|593765126|FG001|Overall Study|Unable to attend termination visit|51|||
164380613|NCT00097591|593765125|FG000|Overall Study|Lost to follow up|6|||
164380614|NCT00097591|593765126|FG001|Overall Study|Lost to follow up|10|||
164380615|NCT00097591|593765125|FG000|Overall Study|Other|0|||
164380616|NCT00097591|593765126|FG001|Overall Study|Other|3|||
164380617|NCT01743092|593765131|FG000|Overall Study|Lost to Follow-up|14|||
164380618|NCT01743092|593765132|FG001|Overall Study|Lost to Follow-up|15|||
164380619|NCT03603964|593765133|FG000|Overall Study|Death|9|||
164380620|NCT03603964|593765133|FG000|Overall Study|Withdrawal by participant|7|||
164380621|NCT03603964|593765133|FG000|Overall Study|Study terminated by Sponsor|19|||
164380622|NCT00563797|593765134|FG000|Overall Study|Lost to Follow-up|7|||
164380623|NCT00563797|593765135|FG001|Overall Study|Lost to Follow-up|2|||
164380624|NCT00530023|593765138|FG000|Overall Study|Withdrawal by Subject|0|||
164380625|NCT00530023|593765139|FG001|Overall Study|Withdrawal by Subject|1|||
164380626|NCT01877421|593765147|FG000|Phase 2|Lost to Follow-up|0|||
164380627|NCT01877421|593765148|FG001|Phase 2|Lost to Follow-up|0|||
164380628|NCT01877421|593765149|FG002|Phase 2|Lost to Follow-up|0|||
164380629|NCT01877421|593765150|FG003|Phase 2|Lost to Follow-up|0|||
164380630|NCT01877421|593765151|FG004|Phase 2|Lost to Follow-up|0|||
164380631|NCT01877421|593765152|FG005|Phase 2|Lost to Follow-up|0|||
164380632|NCT01877421|593765153|FG006|Phase 2|Lost to Follow-up|1|||
164439678|NCT01648140|593977197|FG003|Overall Study|Lost to Follow-up|0|||
164380633|NCT01877421|593765154|FG007|Phase 2|Lost to Follow-up|0|||
164380634|NCT01877421|593765155|FG008|Phase 2|Lost to Follow-up|0|||
164380635|NCT01877421|593765156|FG009|Phase 2|Lost to Follow-up|0|||
164380636|NCT01877421|593765157|FG010|Phase 2|Lost to Follow-up|0|||
164380637|NCT01877421|593765158|FG011|Phase 2|Lost to Follow-up|0|||
164380638|NCT01877421|593765159|FG012|Phase 2|Lost to Follow-up|0|||
164380639|NCT01877421|593765160|FG013|Phase 2|Lost to Follow-up|0|||
164380640|NCT01877421|593765161|FG014|Phase 2|Lost to Follow-up|0|||
164380641|NCT01877421|593765162|FG015|Phase 2|Lost to Follow-up|0|||
164380642|NCT01877421|593765163|FG016|Phase 2|Lost to Follow-up|0|||
164380643|NCT01877421|593765164|FG017|Phase 2|Lost to Follow-up|0|||
164380644|NCT01877421|593765147|FG000|Phase 2|Withdrawal by Subject|0|||
164380645|NCT01877421|593765148|FG001|Phase 2|Withdrawal by Subject|0|||
164380646|NCT01877421|593765149|FG002|Phase 2|Withdrawal by Subject|0|||
164380647|NCT01877421|593765150|FG003|Phase 2|Withdrawal by Subject|0|||
164380648|NCT01877421|593765151|FG004|Phase 2|Withdrawal by Subject|0|||
164380649|NCT01877421|593765152|FG005|Phase 2|Withdrawal by Subject|0|||
164380650|NCT01877421|593765153|FG006|Phase 2|Withdrawal by Subject|0|||
164380651|NCT01877421|593765154|FG007|Phase 2|Withdrawal by Subject|0|||
164380652|NCT01877421|593765155|FG008|Phase 2|Withdrawal by Subject|1|||
164380653|NCT01877421|593765156|FG009|Phase 2|Withdrawal by Subject|0|||
164380654|NCT01877421|593765157|FG010|Phase 2|Withdrawal by Subject|1|||
164380655|NCT01877421|593765158|FG011|Phase 2|Withdrawal by Subject|0|||
164380656|NCT01877421|593765159|FG012|Phase 2|Withdrawal by Subject|1|||
164380657|NCT01877421|593765160|FG013|Phase 2|Withdrawal by Subject|0|||
164380658|NCT01877421|593765161|FG014|Phase 2|Withdrawal by Subject|0|||
164380659|NCT01877421|593765162|FG015|Phase 2|Withdrawal by Subject|1|||
164380660|NCT01877421|593765163|FG016|Phase 2|Withdrawal by Subject|0|||
164380661|NCT01877421|593765164|FG017|Phase 2|Withdrawal by Subject|0|||
164380662|NCT01877421|593765147|FG000|Phase 2|Protocol Violation|0|||
164380663|NCT01877421|593765148|FG001|Phase 2|Protocol Violation|0|||
164380664|NCT01877421|593765149|FG002|Phase 2|Protocol Violation|0|||
164380665|NCT01877421|593765150|FG003|Phase 2|Protocol Violation|0|||
164380666|NCT01877421|593765151|FG004|Phase 2|Protocol Violation|0|||
164380667|NCT01877421|593765152|FG005|Phase 2|Protocol Violation|0|||
164380668|NCT01877421|593765153|FG006|Phase 2|Protocol Violation|0|||
164380669|NCT01877421|593765154|FG007|Phase 2|Protocol Violation|0|||
164380670|NCT01877421|593765155|FG008|Phase 2|Protocol Violation|0|||
164380671|NCT01877421|593765156|FG009|Phase 2|Protocol Violation|0|||
164380672|NCT01877421|593765157|FG010|Phase 2|Protocol Violation|1|||
164380673|NCT01877421|593765158|FG011|Phase 2|Protocol Violation|0|||
164380674|NCT01877421|593765159|FG012|Phase 2|Protocol Violation|0|||
164380675|NCT01877421|593765160|FG013|Phase 2|Protocol Violation|0|||
164380676|NCT01877421|593765161|FG014|Phase 2|Protocol Violation|0|||
164439679|NCT01183780|593977199|FG000|Overall Study|Withdrawal by Subject|25|||
164439680|NCT01183780|593977200|FG001|Overall Study|Withdrawal by Subject|14|||
164439681|NCT01183780|593977199|FG000|Overall Study|Lost to Follow-up|6|||
164439682|NCT01183780|593977200|FG001|Overall Study|Lost to Follow-up|11|||
164439683|NCT00079183|593977201|FG000|Overall Study|Withdrawal by Subject|4|||
164439684|NCT00079183|593977201|FG000|Overall Study|Study medication non-compliance|2|||
164439685|NCT00079183|593977201|FG000|Overall Study|Specimen collection non-compliance|1|||
164439686|NCT00762606|593977202|FG000|Overall Study|Lost to Follow-up|18|||
164439687|NCT00762606|593977203|FG001|Overall Study|Lost to Follow-up|13|||
164439688|NCT03257813|593977204|FG000|Overall Study|Protocol Violation|6|||
164439689|NCT03257813|593977205|FG001|Overall Study|Protocol Violation|3|||
164439690|NCT03615924|593977206|FG000|Overall Study|Withdrawal by Subject|2|||
164439691|NCT03615924|593977207|FG001|Overall Study|Withdrawal by Subject|5|||
164439692|NCT03615924|593977206|FG000|Overall Study|Death|3|||
164439693|NCT03615924|593977207|FG001|Overall Study|Death|1|||
164439694|NCT03615924|593977206|FG000|Overall Study|Lost to Follow-up|1|||
164439695|NCT03615924|593977207|FG001|Overall Study|Lost to Follow-up|0|||
164380677|NCT01877421|593765162|FG015|Phase 2|Protocol Violation|0|||
164380678|NCT01877421|593765163|FG016|Phase 2|Protocol Violation|0|||
164380679|NCT01877421|593765164|FG017|Phase 2|Protocol Violation|0|||
164380680|NCT01416805|593765170|FG000|Overall Study|Lost to Follow-up|4|||
164439696|NCT03615924|593977206|FG000|Overall Study|Randomized in error|1|||
164439697|NCT03615924|593977207|FG001|Overall Study|Randomized in error|0|||
164439698|NCT03615924|593977206|FG000|Overall Study|Study termination by Sponsor|94|||
164592347|NCT04038255|594532490|FG001|Overall Study|Lost to Follow-up|9|||
164592348|NCT04038255|594532491|FG002|Overall Study|Lost to Follow-up|5|||
164592349|NCT04038255|594532489|FG000|Overall Study|Withdrawal by Subject|0|||
164592350|NCT04038255|594532490|FG001|Overall Study|Withdrawal by Subject|0|||
164592351|NCT04038255|594532491|FG002|Overall Study|Withdrawal by Subject|1|||
164592352|NCT05183867|594532492|FG000|Overall Study|Withdrawal by Subject|3|||
164592353|NCT05183867|594532493|FG001|Overall Study|Withdrawal by Subject|2|||
164592354|NCT05183867|594532494|FG002|Overall Study|Withdrawal by Subject|0|||
164592355|NCT01755195|594532495|FG000|Overall Study|Participant noncompliance|2|||
164380681|NCT01416805|593765171|FG001|Overall Study|Lost to Follow-up|4|||
164380682|NCT04632940|593765175|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
164380683|NCT04632940|593765176|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
164380684|NCT04632940|593765175|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
164380685|NCT04632940|593765176|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
164439699|NCT03615924|593977207|FG001|Overall Study|Study termination by Sponsor|86|||
164439700|NCT01184508|593977208|FG000|Overall Study|Adverse Event|4|||
164592356|NCT01755195|594532495|FG000|Overall Study|Switched to alternative treatment|4|||
164380686|NCT04632940|593765175|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
164380687|NCT04632940|593765176|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
164380688|NCT04632940|593765175|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
164380689|NCT04632940|593765176|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
164380690|NCT04632940|593765175|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
164380691|NCT04632940|593765176|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
164380692|NCT04632940|593765175|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
164380693|NCT04632940|593765176|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
164380694|NCT04632940|593765175|FG000|OLE Period (52 Weeks)|Other than specified|0|||
164380695|NCT04632940|593765176|FG001|OLE Period (52 Weeks)|Other than specified|1|||
164380696|NCT04632940|593765175|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
164380697|NCT04632940|593765176|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
164380698|NCT01649856|593765180|FG000|Overall Study|Withdrawal by Subject|14|||
164380699|NCT01649856|593765181|FG001|Overall Study|Withdrawal by Subject|14|||
164592357|NCT01755195|594532495|FG000|Overall Study|Withdrawal by Subject|1|||
164380700|NCT01649856|593765180|FG000|Overall Study|Protocol Violation|4|||
164592358|NCT01755195|594532495|FG000|Overall Study|Participant refused to start treatment|1|||
164380701|NCT01649856|593765181|FG001|Overall Study|Protocol Violation|4|||
164380702|NCT01649856|593765180|FG000|Overall Study|Treatment Failure|1|||
164380703|NCT01649856|593765181|FG001|Overall Study|Treatment Failure|1|||
164380704|NCT01649856|593765180|FG000|Overall Study|Death|69|||
164380705|NCT01649856|593765181|FG001|Overall Study|Death|34|||
164380706|NCT01649856|593765180|FG000|Overall Study|Stable or Progressed Disease|5|||
164380707|NCT01649856|593765181|FG001|Overall Study|Stable or Progressed Disease|3|||
164380708|NCT01649856|593765180|FG000|Overall Study|Lost to Follow-up|20|||
164380709|NCT01649856|593765181|FG001|Overall Study|Lost to Follow-up|16|||
164380710|NCT01649856|593765180|FG000|Overall Study|Lack of Compliance|6|||
164380711|NCT01649856|593765181|FG001|Overall Study|Lack of Compliance|1|||
164380712|NCT01649856|593765180|FG000|Overall Study|Other|20|||
164380713|NCT01649856|593765181|FG001|Overall Study|Other|5|||
164380714|NCT00179647|593765182|FG000|Overall Study|Adverse Event|294|||
164380715|NCT00179647|593765182|FG000|Overall Study|Lack of Efficacy|478|||
164380716|NCT00179647|593765182|FG000|Overall Study|Withdrawal by Subject|83|||
164380717|NCT00179647|593765182|FG000|Overall Study|Lost to Follow-up|4|||
164380718|NCT00179647|593765182|FG000|Overall Study|Death|94|||
164380719|NCT00179647|593765182|FG000|Overall Study|Other|960|||
164380720|NCT00622635|593765183|FG000|Treatment Period 1|Adverse Event|0|||
164380721|NCT00622635|593765184|FG001|Treatment Period 1|Adverse Event|0|||
164380722|NCT00622635|593765185|FG002|Treatment Period 1|Adverse Event|1|||
164380723|NCT00622635|593765186|FG003|Treatment Period 1|Adverse Event|0|||
164380724|NCT00622635|593765187|FG004|Treatment Period 1|Adverse Event|0|||
164380725|NCT00622635|593765188|FG005|Treatment Period 1|Adverse Event|0|||
164380726|NCT00622635|593765183|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164380727|NCT00622635|593765184|FG001|Treatment Period 1|Withdrawal by Subject|1|||
164380728|NCT00622635|593765185|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164380729|NCT00622635|593765186|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164380730|NCT00622635|593765187|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164380731|NCT00622635|593765188|FG005|Treatment Period 1|Withdrawal by Subject|0|||
164380732|NCT00622635|593765183|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
164380733|NCT00622635|593765184|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
164380734|NCT00622635|593765185|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
164380735|NCT00622635|593765186|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
164380736|NCT00622635|593765187|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
164380737|NCT00622635|593765188|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
164380738|NCT00622635|593765183|FG000|Treatment Period 2|Adverse Event|1|||
164380739|NCT00622635|593765184|FG001|Treatment Period 2|Adverse Event|0|||
164380740|NCT00622635|593765185|FG002|Treatment Period 2|Adverse Event|0|||
164380741|NCT00622635|593765186|FG003|Treatment Period 2|Adverse Event|0|||
164380742|NCT00622635|593765187|FG004|Treatment Period 2|Adverse Event|0|||
164380743|NCT00622635|593765188|FG005|Treatment Period 2|Adverse Event|0|||
164380744|NCT00622635|593765183|FG000|Treatment Period 3|Adverse Event|0|||
164380745|NCT00622635|593765184|FG001|Treatment Period 3|Adverse Event|0|||
164380746|NCT00622635|593765185|FG002|Treatment Period 3|Adverse Event|0|||
164380747|NCT00622635|593765186|FG003|Treatment Period 3|Adverse Event|2|||
164380748|NCT00622635|593765187|FG004|Treatment Period 3|Adverse Event|0|||
164380749|NCT00622635|593765188|FG005|Treatment Period 3|Adverse Event|0|||
164380750|NCT00622635|593765183|FG000|Treatment Period 3|Withdrawal by Subject|0|||
164380751|NCT00622635|593765184|FG001|Treatment Period 3|Withdrawal by Subject|0|||
164380752|NCT00622635|593765185|FG002|Treatment Period 3|Withdrawal by Subject|0|||
164380753|NCT00622635|593765186|FG003|Treatment Period 3|Withdrawal by Subject|1|||
164380754|NCT00622635|593765187|FG004|Treatment Period 3|Withdrawal by Subject|0|||
164592359|NCT01755195|594532495|FG000|Overall Study|Participant has been consented for another trial|1|||
164380755|NCT00622635|593765188|FG005|Treatment Period 3|Withdrawal by Subject|0|||
164380756|NCT00281840|593765189|FG000|Overall Study|Adverse Event|12|||
164592360|NCT01755195|594532495|FG000|Overall Study|Refused further treatment|3|||
164380757|NCT00281840|593765189|FG000|Overall Study|Physician Decision|6|||
164380758|NCT00281840|593765189|FG000|Overall Study|Withdrawal by Subject|3|||
164380759|NCT00281840|593765189|FG000|Overall Study|Disease Progression|2|||
164380760|NCT00281840|593765189|FG000|Overall Study|exceed maximum delay in treatment|1|||
164380761|NCT00281840|593765189|FG000|Overall Study|Complicating Disease|1|||
164380762|NCT00835406|593765190|FG000|Period: First Intervention|Adverse Event|0|||
164380763|NCT00835406|593765191|FG001|Period: First Intervention|Adverse Event|1|||
164380764|NCT00835406|593765190|FG000|Period: First Intervention|Withdrawal by Subject|2|||
164380765|NCT00835406|593765191|FG001|Period: First Intervention|Withdrawal by Subject|0|||
164380766|NCT00835406|593765190|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
164380767|NCT00835406|593765191|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
164380768|NCT01849588|593765195|FG000|Overall Study|Lack of Efficacy|3|||
164380769|NCT01706250|593765196|FG000|Overall Study|Lost to Follow-up|2|||
164380770|NCT01079234|593765202|FG000|Main: Week 0 to 26|Adverse Event|5|||
164380771|NCT01079234|593765203|FG001|Main: Week 0 to 26|Adverse Event|4|||
164380772|NCT01079234|593765204|FG002|Main: Week 0 to 26|Adverse Event|1|||
164380773|NCT01079234|593765205|FG003|Main: Week 0 to 26|Adverse Event|0|||
164380774|NCT01079234|593765202|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
164380775|NCT01079234|593765203|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
164380776|NCT01079234|593765204|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
164380777|NCT01079234|593765205|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
164380778|NCT01079234|593765202|FG000|Main: Week 0 to 26|Protocol Violation|6|||
164380779|NCT01079234|593765203|FG001|Main: Week 0 to 26|Protocol Violation|2|||
164380780|NCT01079234|593765204|FG002|Main: Week 0 to 26|Protocol Violation|4|||
164380781|NCT01079234|593765205|FG003|Main: Week 0 to 26|Protocol Violation|0|||
164380782|NCT01079234|593765202|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
164380783|NCT01079234|593765203|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
164380784|NCT01079234|593765204|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
164380785|NCT01079234|593765205|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
164380786|NCT01079234|593765202|FG000|Main: Week 0 to 26|Unclassified|7|||
164380787|NCT01079234|593765203|FG001|Main: Week 0 to 26|Unclassified|13|||
164380788|NCT01079234|593765204|FG002|Main: Week 0 to 26|Unclassified|4|||
164380789|NCT01079234|593765205|FG003|Main: Week 0 to 26|Unclassified|0|||
164380790|NCT01079234|593765202|FG000|Extension: Week 27 to 52|Adverse Event|0|||
164380791|NCT01079234|593765203|FG001|Extension: Week 27 to 52|Adverse Event|0|||
164380792|NCT01079234|593765204|FG002|Extension: Week 27 to 52|Adverse Event|1|||
164380793|NCT01079234|593765205|FG003|Extension: Week 27 to 52|Adverse Event|0|||
164380794|NCT01079234|593765202|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
164380795|NCT01079234|593765203|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
164380796|NCT01079234|593765204|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
164380797|NCT01079234|593765205|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
164380798|NCT01079234|593765202|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
164380799|NCT01079234|593765203|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
164380800|NCT01079234|593765204|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
164380801|NCT01079234|593765205|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
164380802|NCT01079234|593765202|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
164380803|NCT01079234|593765203|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
164380804|NCT01079234|593765204|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
164380805|NCT01079234|593765205|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
164380806|NCT01079234|593765202|FG000|Extension: Week 27 to 52|Unclassified|0|||
164380807|NCT01079234|593765203|FG001|Extension: Week 27 to 52|Unclassified|0|||
164380808|NCT01079234|593765204|FG002|Extension: Week 27 to 52|Unclassified|4|||
164380809|NCT01079234|593765205|FG003|Extension: Week 27 to 52|Unclassified|7|||
164380810|NCT01071512|593765214|FG000|Overall Study|Adverse Event|1|||
164380811|NCT01071512|593765214|FG000|Overall Study|Development of antibodies to drug|2|||
164380812|NCT01071512|593765214|FG000|Overall Study|positive anti-JC virus antibody test|2|||
164380813|NCT00183872|593765215|FG000|Overall Study|Death|3|||
164380814|NCT00183872|593765215|FG000|Overall Study|Adverse Event|9|||
164380815|NCT00183872|593765215|FG000|Overall Study|Withdrawal by Subject|2|||
164380816|NCT00183872|593765215|FG000|Overall Study|Drug delayed more than 28 days|2|||
164380817|NCT04587193|593765216|FG000|Overall Study|Screen failure after consent|3|||
164380818|NCT04587193|593765217|FG001|Overall Study|Screen failure after consent|0|||
164380819|NCT04587193|593765216|FG000|Overall Study|Device broke during study|3|||
164380820|NCT04587193|593765217|FG001|Overall Study|Device broke during study|2|||
164380821|NCT00508742|593765218|FG000|Period 1: Infant Series|Adverse Event|5|||
164380822|NCT00508742|593765219|FG001|Period 1: Infant Series|Adverse Event|4|||
164380823|NCT00508742|593765218|FG000|Period 1: Infant Series|Protocol Violation|1|||
164380824|NCT00508742|593765219|FG001|Period 1: Infant Series|Protocol Violation|0|||
164380825|NCT00508742|593765218|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
164380826|NCT00508742|593765219|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
164380827|NCT00508742|593765218|FG000|Period 1: Infant Series|Physician Decision|1|||
164380828|NCT00508742|593765219|FG001|Period 1: Infant Series|Physician Decision|0|||
164380829|NCT00508742|593765218|FG000|Period 1: Infant Series|Other|4|||
164380830|NCT00508742|593765219|FG001|Period 1: Infant Series|Other|1|||
164592361|NCT01755195|594532495|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
164380831|NCT00508742|593765218|FG000|Period 2: After Infant Series|Adverse Event|2|||
164380832|NCT00508742|593765219|FG001|Period 2: After Infant Series|Adverse Event|6|||
164380833|NCT00508742|593765218|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
164380834|NCT00508742|593765219|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
164380835|NCT00508742|593765218|FG000|Period 2: After Infant Series|Protocol Violation|1|||
164380836|NCT00508742|593765219|FG001|Period 2: After Infant Series|Protocol Violation|0|||
164380837|NCT00508742|593765218|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
164380838|NCT00508742|593765219|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
164380839|NCT00508742|593765218|FG000|Period 2: After Infant Series|Failed to Return|1|||
164380840|NCT00508742|593765219|FG001|Period 2: After Infant Series|Failed to Return|0|||
164380841|NCT00508742|593765218|FG000|Period 2: After Infant Series|Other|2|||
164380842|NCT00508742|593765219|FG001|Period 2: After Infant Series|Other|1|||
164380843|NCT00508742|593765218|FG000|Period 3: Toddler Dose|Adverse Event|1|||
164380844|NCT00508742|593765219|FG001|Period 3: Toddler Dose|Adverse Event|0|||
164380845|NCT00508742|593765218|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
164380846|NCT00508742|593765219|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
164380847|NCT00508742|593765218|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
164380848|NCT00508742|593765219|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
164380849|NCT00508742|593765218|FG000|Period 3: Toddler Dose|Other|5|||
164380850|NCT00508742|593765219|FG001|Period 3: Toddler Dose|Other|4|||
164380851|NCT02501096|593765220|FG000|Overall Study|Lost to Follow-up|0|||
164380852|NCT02501096|593765221|FG001|Overall Study|Lost to Follow-up|0|||
164380853|NCT02501096|593765222|FG002|Overall Study|Lost to Follow-up|0|||
164380854|NCT02501096|593765223|FG003|Overall Study|Lost to Follow-up|0|||
164380855|NCT02501096|593765224|FG004|Overall Study|Lost to Follow-up|1|||
164380856|NCT02501096|593765225|FG005|Overall Study|Lost to Follow-up|1|||
164380857|NCT02501096|593765226|FG006|Overall Study|Lost to Follow-up|3|||
164380858|NCT02501096|593765227|FG007|Overall Study|Lost to Follow-up|0|||
164380859|NCT02501096|593765228|FG008|Overall Study|Lost to Follow-up|0|||
164380860|NCT02501096|593765220|FG000|Overall Study|Withdrawal by Subject|1|||
164380861|NCT02501096|593765221|FG001|Overall Study|Withdrawal by Subject|0|||
164380862|NCT02501096|593765222|FG002|Overall Study|Withdrawal by Subject|7|||
164380863|NCT02501096|593765223|FG003|Overall Study|Withdrawal by Subject|13|||
164380864|NCT02501096|593765224|FG004|Overall Study|Withdrawal by Subject|2|||
164380865|NCT02501096|593765225|FG005|Overall Study|Withdrawal by Subject|2|||
164380866|NCT02501096|593765226|FG006|Overall Study|Withdrawal by Subject|2|||
164380867|NCT02501096|593765227|FG007|Overall Study|Withdrawal by Subject|3|||
164380868|NCT02501096|593765228|FG008|Overall Study|Withdrawal by Subject|0|||
164380869|NCT02501096|593765220|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
164380870|NCT02501096|593765221|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
164380871|NCT02501096|593765222|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
164380872|NCT02501096|593765223|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
164380873|NCT02501096|593765224|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
164380874|NCT02501096|593765225|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
164380875|NCT02501096|593765226|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
164380876|NCT02501096|593765227|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
164380877|NCT02501096|593765228|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
164380878|NCT02501096|593765220|FG000|Overall Study|Death|1|||
164380879|NCT02501096|593765221|FG001|Overall Study|Death|1|||
164380880|NCT02501096|593765222|FG002|Overall Study|Death|88|||
164380881|NCT02501096|593765223|FG003|Overall Study|Death|74|||
164380882|NCT02501096|593765224|FG004|Overall Study|Death|15|||
164439701|NCT01184508|593977209|FG001|Overall Study|Adverse Event|6|||
164439702|NCT01184508|593977208|FG000|Overall Study|Lack of Efficacy|1|||
164439703|NCT01184508|593977209|FG001|Overall Study|Lack of Efficacy|1|||
164439704|NCT01184508|593977208|FG000|Overall Study|Lost to Follow-up|1|||
164439705|NCT01184508|593977209|FG001|Overall Study|Lost to Follow-up|1|||
164380883|NCT02501096|593765225|FG005|Overall Study|Death|16|||
164439706|NCT01184508|593977208|FG000|Overall Study|Physician Decision|1|||
164439707|NCT01184508|593977209|FG001|Overall Study|Physician Decision|0|||
164439708|NCT01184508|593977208|FG000|Overall Study|Protocol Violation|3|||
164439709|NCT01184508|593977209|FG001|Overall Study|Protocol Violation|1|||
164439710|NCT01184508|593977208|FG000|Overall Study|Sponsor Decision|5|||
164439711|NCT01184508|593977209|FG001|Overall Study|Sponsor Decision|2|||
164380884|NCT02501096|593765226|FG006|Overall Study|Death|15|||
164380885|NCT02501096|593765227|FG007|Overall Study|Death|16|||
164380886|NCT02501096|593765228|FG008|Overall Study|Death|1|||
164380887|NCT00437034|593765229|FG000|Overall Study|Adverse Event|1|||
164380888|NCT00437034|593765229|FG000|Overall Study|Disease progression during treatment|5|||
164380889|NCT00853658|593765231|FG000|Overall Study|Death|713|||
164380890|NCT00853658|593765232|FG001|Overall Study|Death|768|||
164439712|NCT01184508|593977208|FG000|Overall Study|Withdrawal by Subject|1|||
164380891|NCT00853658|593765233|FG002|Overall Study|Death|753|||
164380892|NCT00853658|593765231|FG000|Overall Study|Lost to Follow-up|11|||
164439713|NCT01184508|593977209|FG001|Overall Study|Withdrawal by Subject|3|||
164439714|NCT01184508|593977208|FG000|Overall Study|Randomized, Not Treated|0|||
164380893|NCT00853658|593765232|FG001|Overall Study|Lost to Follow-up|6|||
164380894|NCT00853658|593765233|FG002|Overall Study|Lost to Follow-up|11|||
164380895|NCT00853658|593765231|FG000|Overall Study|H.A. Request|26|||
164380896|NCT00853658|593765232|FG001|Overall Study|H.A. Request|23|||
164380897|NCT00853658|593765233|FG002|Overall Study|H.A. Request|19|||
164380898|NCT00853658|593765231|FG000|Overall Study|IRB request|0|||
164380899|NCT00853658|593765232|FG001|Overall Study|IRB request|0|||
164380900|NCT00853658|593765233|FG002|Overall Study|IRB request|2|||
164380901|NCT00853658|593765231|FG000|Overall Study|Vital Status known (alive) at study end|2|||
164380902|NCT00853658|593765232|FG001|Overall Study|Vital Status known (alive) at study end|3|||
164380903|NCT00853658|593765233|FG002|Overall Study|Vital Status known (alive) at study end|3|||
164380904|NCT00853658|593765231|FG000|Overall Study|Vital Status unknown at study end|1|||
164380905|NCT00853658|593765232|FG001|Overall Study|Vital Status unknown at study end|1|||
164380906|NCT00853658|593765233|FG002|Overall Study|Vital Status unknown at study end|0|||
164380907|NCT00853658|593765231|FG000|Overall Study|Vital Status at study end N/A|8|||
164380908|NCT00853658|593765232|FG001|Overall Study|Vital Status at study end N/A|10|||
164380909|NCT00853658|593765233|FG002|Overall Study|Vital Status at study end N/A|10|||
164380910|NCT00853658|593765231|FG000|Overall Study|Patient's request|21|||
164380911|NCT00853658|593765232|FG001|Overall Study|Patient's request|17|||
164380912|NCT00853658|593765233|FG002|Overall Study|Patient's request|11|||
164380913|NCT00853658|593765231|FG000|Overall Study|Missing study completion information|5|||
164439715|NCT01184508|593977209|FG001|Overall Study|Randomized, Not Treated|1|||
164439716|NCT00790790|593977210|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
164439717|NCT00790790|593977211|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
164439718|NCT00790790|593977212|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
164439719|NCT00790790|593977210|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
164439720|NCT00790790|593977211|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
164439721|NCT00790790|593977212|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
164439722|NCT00790790|593977210|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
164439723|NCT00790790|593977211|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
164439724|NCT00790790|593977212|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
164439725|NCT00790790|593977210|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
164439726|NCT00790790|593977211|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
164439727|NCT00790790|593977212|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
164439728|NCT00790790|593977210|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
164439729|NCT00790790|593977211|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
164439730|NCT00790790|593977212|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
164439731|NCT02969863|593977213|FG000|Overall Study|Physician Decision|1|||
164439732|NCT02969863|593977214|FG001|Overall Study|Physician Decision|0|||
164439733|NCT02969863|593977215|FG002|Overall Study|Physician Decision|0|||
164439734|NCT02969863|593977216|FG003|Overall Study|Physician Decision|0|||
164439735|NCT02969863|593977217|FG004|Overall Study|Physician Decision|0|||
164439736|NCT02969863|593977218|FG005|Overall Study|Physician Decision|0|||
164439737|NCT02194933|593977220|FG000|Overall Study|Lost to Follow-up|1|||
164439738|NCT02194933|593977221|FG001|Overall Study|Lost to Follow-up|2|||
164439739|NCT02194933|593977220|FG000|Overall Study|Participant met withdrawal criteria|1|||
164439740|NCT02194933|593977221|FG001|Overall Study|Participant met withdrawal criteria|3|||
164439741|NCT02194933|593977220|FG000|Overall Study|Withdrawal by Subject|0|||
164439742|NCT02194933|593977221|FG001|Overall Study|Withdrawal by Subject|2|||
164439743|NCT02194933|593977220|FG000|Overall Study|Lack of Efficacy|1|||
164439744|NCT02194933|593977221|FG001|Overall Study|Lack of Efficacy|2|||
164439745|NCT00756730|593977224|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
164439746|NCT00756730|593977225|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
164439747|NCT00756730|593977224|FG000|Overall Study|persistent low-level viremmia|0|||
164439748|NCT00756730|593977225|FG001|Overall Study|persistent low-level viremmia|1|||
164439749|NCT05382104|593977229|FG000|Period 2 (2 Days)|Adverse Event|0|||
164439750|NCT05382104|593977230|FG001|Period 2 (2 Days)|Adverse Event|1|||
164439751|NCT05382104|593977231|FG002|Period 2 (2 Days)|Adverse Event|0|||
164439752|NCT05382104|593977232|FG003|Period 2 (2 Days)|Adverse Event|0|||
164439753|NCT05382104|593977233|FG004|Period 2 (2 Days)|Adverse Event|0|||
164439754|NCT05382104|593977234|FG005|Period 2 (2 Days)|Adverse Event|0|||
164439755|NCT00988637|593977235|FG000|Overall Study|Lost to Follow-up|2|||
164439756|NCT00988637|593977236|FG001|Overall Study|Lost to Follow-up|1|||
164439757|NCT00988637|593977235|FG000|Overall Study|Withdrawal by Subject|1|||
164439758|NCT00988637|593977236|FG001|Overall Study|Withdrawal by Subject|1|||
164701526|NCT00856973|594932634|FG002|Overall Study|Protocol Violation|1|||
164380914|NCT00853658|593765232|FG001|Overall Study|Missing study completion information|4|||
164380915|NCT00853658|593765233|FG002|Overall Study|Missing study completion information|6|||
164439759|NCT00988637|593977235|FG000|Overall Study|non-compliance with study drug|0|||
164439760|NCT00988637|593977236|FG001|Overall Study|non-compliance with study drug|1|||
164439761|NCT02807493|593977238|FG000|Overall Study|Adverse Event|5|||
164439762|NCT02807493|593977239|FG001|Overall Study|Adverse Event|2|||
164439763|NCT02807493|593977238|FG000|Overall Study|Lost to Follow-up|6|||
164701527|NCT00856973|594932632|FG000|Overall Study|Withdrawal by Subject|13|||
164380916|NCT02797262|593765234|FG000|Overall Study|Withdrawal by Subject|5|||
164380917|NCT02797262|593765235|FG001|Overall Study|Withdrawal by Subject|1|||
164380918|NCT02797262|593765234|FG000|Overall Study|Lost to Follow-up|10|||
164380919|NCT02797262|593765235|FG001|Overall Study|Lost to Follow-up|7|||
164380920|NCT02797262|593765234|FG000|Overall Study|Death|1|||
164380921|NCT02797262|593765235|FG001|Overall Study|Death|2|||
164380922|NCT02797262|593765234|FG000|Overall Study|Adverse Event|1|||
164380923|NCT02797262|593765235|FG001|Overall Study|Adverse Event|0|||
164380924|NCT02797262|593765234|FG000|Overall Study|COVID-19|2|||
164380925|NCT02797262|593765235|FG001|Overall Study|COVID-19|1|||
164380926|NCT02797262|593765234|FG000|Overall Study|Out-of-country|1|||
164380927|NCT02797262|593765235|FG001|Overall Study|Out-of-country|0|||
164380928|NCT01337089|593766922|FG000|Overall Study|Adverse Event|237|||
164380929|NCT01337089|593766922|FG000|Overall Study|Withdrawal by Subject|129|||
164380930|NCT01337089|593766922|FG000|Overall Study|Withdrawal by Investigator|33|||
164380931|NCT01337089|593766922|FG000|Overall Study|Met Withdrawal Criteria|3|||
164380932|NCT01337089|593766922|FG000|Overall Study|Lost to Follow-up|2|||
164380933|NCT01404312|593766923|FG000|Overall Study|Death|21|||
164380934|NCT01404312|593766924|FG001|Overall Study|Death|27|||
164380935|NCT01404312|593766923|FG000|Overall Study|Withdrawal by Subject|15|||
164380936|NCT01404312|593766924|FG001|Overall Study|Withdrawal by Subject|18|||
164380937|NCT01404312|593766923|FG000|Overall Study|Participant Unable to get to clinic|93|||
164380938|NCT01404312|593766924|FG001|Overall Study|Participant Unable to get to clinic|103|||
164380939|NCT01404312|593766923|FG000|Overall Study|Lost to Follow-up|115|||
164380940|NCT01404312|593766924|FG001|Overall Study|Lost to Follow-up|111|||
164380941|NCT01404312|593766923|FG000|Overall Study|Site closed|22|||
164380942|NCT01404312|593766924|FG001|Overall Study|Site closed|21|||
164380943|NCT01404312|593766923|FG000|Overall Study|Participant not willing to adhere to req|31|||
164380944|NCT01404312|593766924|FG001|Overall Study|Participant not willing to adhere to req|29|||
164380945|NCT01404312|593766923|FG000|Overall Study|Severe debilitation, unable to continue|1|||
164380946|NCT01404312|593766924|FG001|Overall Study|Severe debilitation, unable to continue|2|||
164380947|NCT02627677|593766925|FG000|Overall Study|Adverse event (not progressive disease)|1|||
164380948|NCT02627677|593766926|FG001|Overall Study|Adverse event (not progressive disease)|4|||
164380949|NCT02627677|593766927|FG002|Overall Study|Adverse event (not progressive disease)|1|||
164380950|NCT02627677|593766925|FG000|Overall Study|Progressive disease|1|||
164380951|NCT02627677|593766926|FG001|Overall Study|Progressive disease|3|||
164380952|NCT02627677|593766927|FG002|Overall Study|Progressive disease|0|||
164380953|NCT02627677|593766925|FG000|Overall Study|Lack of Efficacy|1|||
164380954|NCT02627677|593766926|FG001|Overall Study|Lack of Efficacy|2|||
164380955|NCT02627677|593766927|FG002|Overall Study|Lack of Efficacy|0|||
164380956|NCT02627677|593766925|FG000|Overall Study|Lost to Follow-up|0|||
164380957|NCT02627677|593766926|FG001|Overall Study|Lost to Follow-up|0|||
164380958|NCT02627677|593766927|FG002|Overall Study|Lost to Follow-up|1|||
164380959|NCT02627677|593766925|FG000|Overall Study|Pregnancy|0|||
164380960|NCT02627677|593766926|FG001|Overall Study|Pregnancy|1|||
164380961|NCT02627677|593766927|FG002|Overall Study|Pregnancy|0|||
164380962|NCT02627677|593766925|FG000|Overall Study|Study Terminated by Sponsor|5|||
164380963|NCT02627677|593766926|FG001|Overall Study|Study Terminated by Sponsor|10|||
164380964|NCT02627677|593766927|FG002|Overall Study|Study Terminated by Sponsor|6|||
164380965|NCT02627677|593766925|FG000|Overall Study|Physician Decision|0|||
164380966|NCT02627677|593766926|FG001|Overall Study|Physician Decision|0|||
164380967|NCT02627677|593766927|FG002|Overall Study|Physician Decision|2|||
164380968|NCT02627677|593766925|FG000|Overall Study|Withdrawal by Subject|2|||
164380969|NCT02627677|593766926|FG001|Overall Study|Withdrawal by Subject|1|||
164380970|NCT02627677|593766927|FG002|Overall Study|Withdrawal by Subject|1|||
164380971|NCT02627677|593766925|FG000|Overall Study|Reason not Specified|0|||
164380972|NCT02627677|593766926|FG001|Overall Study|Reason not Specified|0|||
164380973|NCT02627677|593766927|FG002|Overall Study|Reason not Specified|1|||
164380974|NCT02627677|593766925|FG000|Overall Study|Randomized but not Treated|1|||
164380975|NCT02627677|593766926|FG001|Overall Study|Randomized but not Treated|0|||
164380976|NCT02627677|593766927|FG002|Overall Study|Randomized but not Treated|0|||
164380977|NCT00673049|593766932|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
164380978|NCT00673049|593766933|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
164380979|NCT00673049|593766934|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
164380980|NCT00673049|593766935|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
164380981|NCT00673049|593766932|FG000|Before Progression on Erlotinib|Death|235|||
164380982|NCT00673049|593766933|FG001|Before Progression on Erlotinib|Death|167|||
164380983|NCT00673049|593766934|FG002|Before Progression on Erlotinib|Death|1|||
164380984|NCT00673049|593766935|FG003|Before Progression on Erlotinib|Death|0|||
164380985|NCT00673049|593766932|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
164380986|NCT00673049|593766933|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
164380987|NCT00673049|593766934|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
164380988|NCT00673049|593766935|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
164380989|NCT00673049|593766932|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
164380990|NCT00673049|593766933|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
164380991|NCT00673049|593766934|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
164380992|NCT00673049|593766935|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
164380993|NCT00673049|593766932|FG000|Before Progression on Erlotinib|Other|1|||
164380994|NCT00673049|593766933|FG001|Before Progression on Erlotinib|Other|2|||
164380995|NCT00673049|593766934|FG002|Before Progression on Erlotinib|Other|0|||
164380996|NCT00673049|593766935|FG003|Before Progression on Erlotinib|Other|0|||
164380997|NCT00673049|593766932|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
164380998|NCT00673049|593766933|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
164380999|NCT00673049|593766934|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
164381000|NCT00673049|593766935|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
164381001|NCT00673049|593766932|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
164381002|NCT00673049|593766933|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
164381003|NCT00673049|593766934|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
164381004|NCT00673049|593766935|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
164381005|NCT00673049|593766932|FG000|After Progression on Erlotinib|Death|0|||
164381006|NCT00673049|593766933|FG001|After Progression on Erlotinib|Death|0|||
164381007|NCT00673049|593766934|FG002|After Progression on Erlotinib|Death|0|||
164381008|NCT00673049|593766935|FG003|After Progression on Erlotinib|Death|71|||
164381009|NCT00673049|593766932|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
164381010|NCT00673049|593766933|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
164381011|NCT00673049|593766934|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
164381012|NCT00673049|593766935|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
164381013|NCT00673049|593766932|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
164381014|NCT00673049|593766933|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
164381015|NCT00673049|593766934|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
164381016|NCT00673049|593766935|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
164381017|NCT00673049|593766932|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
164381018|NCT00673049|593766933|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
164381019|NCT00673049|593766934|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
164381020|NCT00673049|593766935|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
164381021|NCT00975975|593766939|FG000|Overall Study|Death|6|||
164381022|NCT01863446|593766940|FG000|Overall Study|Withdrawal by Subject|1|||
164381023|NCT01863446|593766941|FG001|Overall Study|Withdrawal by Subject|0|||
164439764|NCT02807493|593977239|FG001|Overall Study|Lost to Follow-up|0|||
164439765|NCT02807493|593977238|FG000|Overall Study|Physician Decision|4|||
164439766|NCT02807493|593977239|FG001|Overall Study|Physician Decision|1|||
164439767|NCT02807493|593977238|FG000|Overall Study|Protocol Violation|7|||
164439768|NCT02807493|593977239|FG001|Overall Study|Protocol Violation|0|||
164439769|NCT02807493|593977238|FG000|Overall Study|Withdrawal by Subject|17|||
164439770|NCT02807493|593977239|FG001|Overall Study|Withdrawal by Subject|10|||
164439771|NCT02807493|593977238|FG000|Overall Study|Other withdrawal|17|||
164381024|NCT01863446|593766942|FG002|Overall Study|Withdrawal by Subject|1|||
164439772|NCT02807493|593977239|FG001|Overall Study|Other withdrawal|0|||
164592362|NCT05113953|594532496|FG000|Overall Study|Adverse Event|5|||
164381025|NCT01863446|593766943|FG003|Overall Study|Withdrawal by Subject|2|||
164381026|NCT01863446|593766940|FG000|Overall Study|Physician Decision|0|||
164381027|NCT01863446|593766941|FG001|Overall Study|Physician Decision|0|||
164381028|NCT01863446|593766942|FG002|Overall Study|Physician Decision|1|||
164381029|NCT01863446|593766943|FG003|Overall Study|Physician Decision|0|||
164381030|NCT02554773|593766944|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
164381031|NCT02554773|593766945|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
164381032|NCT02554773|593766944|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
164381033|NCT02554773|593766945|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
164381034|NCT02554773|593766944|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
164381035|NCT02554773|593766945|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
164381036|NCT02554773|593766944|FG000|Original Dose Regimen (SAS 1)|Death|1|||
164381037|NCT02554773|593766945|FG001|Original Dose Regimen (SAS 1)|Death|0|||
164381038|NCT02554773|593766944|FG000|Original Dose Regimen (SAS 1)|Other|4|||
164381039|NCT02554773|593766945|FG001|Original Dose Regimen (SAS 1)|Other|0|||
164381040|NCT02554773|593766944|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
164381041|NCT02554773|593766945|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
164381042|NCT02554773|593766944|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
164381043|NCT02554773|593766945|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
164381044|NCT02554773|593766944|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
164381045|NCT02554773|593766945|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
164381046|NCT02554773|593766944|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
164381047|NCT02554773|593766945|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
164381048|NCT02956629|593766949|FG000|Overall Study|Adverse Event|0|||
164381049|NCT02956629|593766950|FG001|Overall Study|Adverse Event|0|||
164381050|NCT02956629|593766951|FG002|Overall Study|Adverse Event|1|||
164381051|NCT02956629|593766952|FG003|Overall Study|Adverse Event|0|||
164381052|NCT02956629|593766953|FG004|Overall Study|Adverse Event|0|||
164381053|NCT02956629|593766954|FG005|Overall Study|Adverse Event|0|||
164381054|NCT02956629|593766949|FG000|Overall Study|Lost to Follow-up|2|||
164381055|NCT02956629|593766950|FG001|Overall Study|Lost to Follow-up|5|||
164381056|NCT02956629|593766951|FG002|Overall Study|Lost to Follow-up|3|||
164381057|NCT02956629|593766952|FG003|Overall Study|Lost to Follow-up|1|||
164381058|NCT02956629|593766953|FG004|Overall Study|Lost to Follow-up|0|||
164381059|NCT02956629|593766954|FG005|Overall Study|Lost to Follow-up|1|||
164381060|NCT02956629|593766949|FG000|Overall Study|Withdrawal by Subject|3|||
164381061|NCT02956629|593766950|FG001|Overall Study|Withdrawal by Subject|1|||
164381062|NCT02956629|593766951|FG002|Overall Study|Withdrawal by Subject|0|||
164381063|NCT02956629|593766952|FG003|Overall Study|Withdrawal by Subject|0|||
164381064|NCT02956629|593766953|FG004|Overall Study|Withdrawal by Subject|0|||
164381065|NCT02956629|593766954|FG005|Overall Study|Withdrawal by Subject|0|||
164381066|NCT03224468|593766958|FG000|Overall Study|Did not obtain MM card|53|||
164381067|NCT03224468|593766959|FG001|Overall Study|Did not obtain MM card|0|||
164381068|NCT03224468|593766958|FG000|Overall Study|Lost to Follow-up|4|||
164381069|NCT03224468|593766959|FG001|Overall Study|Lost to Follow-up|11|||
164381070|NCT03224468|593766958|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
164381071|NCT03224468|593766959|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
164381072|NCT04713748|593766960|FG000|Overall Study|Not enough kits allocated|35|||
164381073|NCT01557946|593766961|FG000|Overall Study|Adverse Event|3|||
164381074|NCT01557946|593766962|FG001|Overall Study|Adverse Event|0|||
164381075|NCT00406029|593766963|FG000|Overall Study|Adverse Event|12|||
164381076|NCT00406029|593766964|FG001|Overall Study|Adverse Event|2|||
164381077|NCT00406029|593766965|FG002|Overall Study|Adverse Event|5|||
164381078|NCT00406029|593766966|FG003|Overall Study|Adverse Event|10|||
164381079|NCT00406029|593766967|FG004|Overall Study|Adverse Event|7|||
164381080|NCT00406029|593766963|FG000|Overall Study|Withdrawal by Subject|3|||
164381081|NCT00406029|593766964|FG001|Overall Study|Withdrawal by Subject|4|||
164381082|NCT00406029|593766965|FG002|Overall Study|Withdrawal by Subject|2|||
164381083|NCT00406029|593766966|FG003|Overall Study|Withdrawal by Subject|2|||
164381084|NCT00406029|593766967|FG004|Overall Study|Withdrawal by Subject|0|||
164381085|NCT00406029|593766963|FG000|Overall Study|Protocol Violation|1|||
164439773|NCT02807493|593977238|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
164439774|NCT02807493|593977239|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
164439775|NCT01493778|593977240|FG000|Overall Study|Withdrawal by Subject|8|||
164439776|NCT05190419|593977241|FG000|Overall Study|Lack of Efficacy|8|||
164439777|NCT05190419|593977242|FG001|Overall Study|Lack of Efficacy|0|||
164381086|NCT00406029|593766964|FG001|Overall Study|Protocol Violation|2|||
164381087|NCT00406029|593766965|FG002|Overall Study|Protocol Violation|0|||
164381088|NCT00406029|593766966|FG003|Overall Study|Protocol Violation|2|||
164381089|NCT00406029|593766967|FG004|Overall Study|Protocol Violation|0|||
164381090|NCT00406029|593766963|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
164381091|NCT00406029|593766964|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
164381092|NCT00406029|593766965|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
164381093|NCT00406029|593766966|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
164381094|NCT00406029|593766967|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
164381095|NCT00406029|593766963|FG000|Overall Study|Randomized in Error|0|||
164381096|NCT00406029|593766964|FG001|Overall Study|Randomized in Error|0|||
164381097|NCT00406029|593766965|FG002|Overall Study|Randomized in Error|2|||
164381098|NCT00406029|593766966|FG003|Overall Study|Randomized in Error|3|||
164381099|NCT00406029|593766967|FG004|Overall Study|Randomized in Error|1|||
164381100|NCT00812812|593766968|FG000|Overall Study|Adverse Event|2|||
164381101|NCT00812812|593766969|FG001|Overall Study|Adverse Event|1|||
164381102|NCT00812812|593766968|FG000|Overall Study|Lack of Efficacy|1|||
164381103|NCT00812812|593766969|FG001|Overall Study|Lack of Efficacy|0|||
164381104|NCT00812812|593766968|FG000|Overall Study|Lost to Follow-up|0|||
164381105|NCT00812812|593766969|FG001|Overall Study|Lost to Follow-up|1|||
164381106|NCT00812812|593766968|FG000|Overall Study|Withdrawal by Subject|0|||
164381107|NCT00812812|593766969|FG001|Overall Study|Withdrawal by Subject|2|||
164381108|NCT02114892|593766970|FG000|Overall Study|Lost to Follow-up|1|||
164381109|NCT02114892|593766971|FG001|Overall Study|Lost to Follow-up|2|||
164381110|NCT02178475|593766976|FG000|Overall Study|Withdrawal by Subject|7|||
164381111|NCT02178475|593766976|FG000|Overall Study|Lost to Follow-up|10|||
164381112|NCT02178475|593766976|FG000|Overall Study|Death|13|||
164381113|NCT02178475|593766976|FG000|Overall Study|Protocol-specified Criteria|99|||
164381114|NCT00718042|593766977|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
164381115|NCT00718042|593766978|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
164381116|NCT00718042|593766979|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
164381117|NCT00718042|593766980|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
164381118|NCT00718042|593766981|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
164381119|NCT00718042|593766982|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
164381120|NCT00718042|593766977|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
164381121|NCT00718042|593766978|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
164381122|NCT00718042|593766979|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
164381123|NCT00718042|593766980|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
164381124|NCT00718042|593766981|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
164381125|NCT00718042|593766982|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
164381126|NCT00718042|593766977|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
164381127|NCT00718042|593766978|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
164381128|NCT00718042|593766979|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
164381129|NCT00718042|593766980|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
164381130|NCT00718042|593766981|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
164381131|NCT00718042|593766982|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
164381132|NCT00718042|593766977|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
164381133|NCT00718042|593766978|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
164381134|NCT00718042|593766979|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
164381135|NCT00718042|593766980|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
164381136|NCT00718042|593766981|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
164381137|NCT00718042|593766982|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
164381138|NCT00718042|593766977|FG000|Donor Follow-up|Lost to Follow-up|13|||
164381139|NCT00718042|593766978|FG001|Donor Follow-up|Lost to Follow-up|0|||
164381140|NCT00718042|593766979|FG002|Donor Follow-up|Lost to Follow-up|0|||
164381141|NCT00718042|593766980|FG003|Donor Follow-up|Lost to Follow-up|0|||
164381142|NCT00718042|593766981|FG004|Donor Follow-up|Lost to Follow-up|19|||
164381143|NCT00718042|593766982|FG005|Donor Follow-up|Lost to Follow-up|0|||
164381144|NCT04327934|593766983|FG000|Overall Study|Did not qualify|7|||
164381145|NCT04327934|593766984|FG001|Overall Study|Did not qualify|4|||
164381146|NCT04327934|593766983|FG000|Overall Study|Physician Decision|0|||
164381147|NCT04327934|593766984|FG001|Overall Study|Physician Decision|1|||
164381148|NCT02443298|593766985|FG000|Overall Study|Adverse Event|3|||
164381149|NCT02443298|593766986|FG001|Overall Study|Adverse Event|3|||
164381150|NCT02443298|593766985|FG000|Overall Study|Withdrawal by Subject|1|||
164381151|NCT02443298|593766986|FG001|Overall Study|Withdrawal by Subject|2|||
164381152|NCT03095417|593766987|FG000|Overall Study|missed|1|||
164381153|NCT03095417|593766988|FG001|Overall Study|missed|2|||
164381154|NCT03095417|593766989|FG002|Overall Study|missed|0|||
164381155|NCT03095417|593766990|FG003|Overall Study|missed|1|||
164381156|NCT03095417|593766987|FG000|Overall Study|Lost to Follow-up|2|||
164381157|NCT03095417|593766988|FG001|Overall Study|Lost to Follow-up|2|||
164381158|NCT03095417|593766989|FG002|Overall Study|Lost to Follow-up|1|||
164381159|NCT03095417|593766990|FG003|Overall Study|Lost to Follow-up|0|||
164381160|NCT03095417|593766987|FG000|Overall Study|refusal|0|||
164381161|NCT03095417|593766988|FG001|Overall Study|refusal|1|||
164381162|NCT03095417|593766989|FG002|Overall Study|refusal|0|||
164381163|NCT03095417|593766990|FG003|Overall Study|refusal|1|||
164381164|NCT03095417|593766987|FG000|Overall Study|Withdrawal by Subject|8|||
164381165|NCT03095417|593766988|FG001|Overall Study|Withdrawal by Subject|2|||
164381166|NCT03095417|593766989|FG002|Overall Study|Withdrawal by Subject|5|||
164381167|NCT03095417|593766990|FG003|Overall Study|Withdrawal by Subject|4|||
164381168|NCT03095417|593766987|FG000|Overall Study|Physician Decision|1|||
164381169|NCT03095417|593766988|FG001|Overall Study|Physician Decision|2|||
164381170|NCT03095417|593766989|FG002|Overall Study|Physician Decision|2|||
164439778|NCT05190419|593977243|FG002|Overall Study|Lack of Efficacy|1|||
164300020|NCT05138653|593472971|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
164300021|NCT05138653|593472972|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164300022|NCT05138653|593472973|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
164300023|NCT05138653|593472974|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164300024|NCT05138653|593472975|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
164300025|NCT05138653|593472976|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164300026|NCT05138653|593472961|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300027|NCT05138653|593472962|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300028|NCT05138653|593472963|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300029|NCT05138653|593472964|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300030|NCT05138653|593472965|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300031|NCT05138653|593472966|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300032|NCT05138653|593472967|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300033|NCT05138653|593472968|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300034|NCT05138653|593472969|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300035|NCT05138653|593472970|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300036|NCT05138653|593472971|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300037|NCT05138653|593472972|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300038|NCT05138653|593472973|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300039|NCT05138653|593472974|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300040|NCT05138653|593472975|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300041|NCT05138653|593472976|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
164300042|NCT05138653|593472961|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300043|NCT05138653|593472962|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300044|NCT05138653|593472963|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300045|NCT05138653|593472964|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300046|NCT05138653|593472965|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300047|NCT05138653|593472966|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300048|NCT05138653|593472967|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300049|NCT05138653|593472968|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300050|NCT05138653|593472969|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300051|NCT05138653|593472970|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300052|NCT05138653|593472971|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300053|NCT05138653|593472972|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300054|NCT05138653|593472973|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300055|NCT05138653|593472974|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
164300056|NCT05138653|593472975|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300057|NCT05138653|593472976|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300058|NCT03204188|593472984|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
164300059|NCT03204188|593472984|FG000|Immunotherapy Phase (1 Year)|Death|1|||
164300060|NCT03204188|593472984|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
164300061|NCT03204188|593472984|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
164300062|NCT00091949|593475092|FG000|Overall Study|Withdrawal by Subject|117|||
164300063|NCT00091949|593475093|FG001|Overall Study|Withdrawal by Subject|110|||
164300064|NCT00091949|593475092|FG000|Overall Study|Lost to Follow-up|58|||
164300065|NCT00091949|593475093|FG001|Overall Study|Lost to Follow-up|41|||
164300066|NCT01256788|593475097|FG000|Overall Study|Lost to Follow-up|5|||
164300067|NCT01256788|593475098|FG001|Overall Study|Lost to Follow-up|8|||
164300068|NCT01256788|593475099|FG002|Overall Study|Lost to Follow-up|3|||
164300069|NCT01148979|593475108|FG000|Overall Study|Lost to Follow-up|0|||
164300070|NCT01148979|593475109|FG001|Overall Study|Lost to Follow-up|1|||
164300071|NCT00777153|593475110|FG000|Overall Study|Lost to Follow-up|1|||
164300072|NCT00777153|593475111|FG001|Overall Study|Lost to Follow-up|1|||
164300073|NCT00777153|593475112|FG002|Overall Study|Lost to Follow-up|0|||
164300074|NCT00777153|593475110|FG000|Overall Study|Death|85|||
164300075|NCT00777153|593475111|FG001|Overall Study|Death|73|||
164300076|NCT00777153|593475112|FG002|Overall Study|Death|33|||
164300077|NCT00777153|593475110|FG000|Overall Study|Withdrawal by Subject|3|||
164300078|NCT00777153|593475111|FG001|Overall Study|Withdrawal by Subject|4|||
164300079|NCT00777153|593475112|FG002|Overall Study|Withdrawal by Subject|3|||
164300080|NCT00777153|593475110|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
164300081|NCT00777153|593475111|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
164300082|NCT00777153|593475112|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
164300083|NCT01597596|593475113|FG000|Overall Study|Study terminated by sponsor|1|||
164300084|NCT01597596|593475114|FG001|Overall Study|Study terminated by sponsor|0|||
164439779|NCT05190419|593977244|FG003|Overall Study|Lack of Efficacy|0|||
164439780|NCT05190419|593977241|FG000|Overall Study|Withdrawal by Subject|7|||
164701528|NCT00856973|594932633|FG001|Overall Study|Withdrawal by Subject|16|||
164701529|NCT00856973|594932634|FG002|Overall Study|Withdrawal by Subject|15|||
164701530|NCT00856973|594932632|FG000|Overall Study|Other|11|||
164701531|NCT00856973|594932633|FG001|Overall Study|Other|12|||
164701532|NCT00856973|594932634|FG002|Overall Study|Other|13|||
164701533|NCT01884311|594932636|FG000|Overall Study|Withdrawal by Subject|3|||
164701534|NCT01884311|594932636|FG000|Overall Study|withdrew consent due to AEs|1|||
164300085|NCT01597596|593475113|FG000|Overall Study|Physician Decision|0|||
164300086|NCT01597596|593475114|FG001|Overall Study|Physician Decision|1|||
164300087|NCT02266888|593475126|FG000|Overall Study|Death|2|||
164300088|NCT02266888|593475127|FG001|Overall Study|Death|2|||
164701535|NCT01884311|594932636|FG000|Overall Study|Precautionary measure|1|||
164701536|NCT02858492|594932637|FG000|Overall Study|Withdrawal by Subject|0|||
164701537|NCT02858492|594932638|FG001|Overall Study|Withdrawal by Subject|1|||
164701538|NCT02858492|594932639|FG002|Overall Study|Withdrawal by Subject|0|||
164701539|NCT02858492|594932640|FG003|Overall Study|Withdrawal by Subject|1|||
164701540|NCT02858492|594932637|FG000|Overall Study|Adverse Event|0|||
164701541|NCT02858492|594932638|FG001|Overall Study|Adverse Event|0|||
164701542|NCT02858492|594932639|FG002|Overall Study|Adverse Event|0|||
164300089|NCT02266888|593475128|FG002|Overall Study|Death|4|||
164300090|NCT02266888|593475129|FG003|Overall Study|Death|2|||
164300091|NCT02266888|593475126|FG000|Overall Study|Physician Decision|0|||
164300092|NCT02266888|593475127|FG001|Overall Study|Physician Decision|1|||
164300093|NCT02266888|593475128|FG002|Overall Study|Physician Decision|2|||
164300094|NCT02266888|593475129|FG003|Overall Study|Physician Decision|2|||
164300095|NCT02266888|593475126|FG000|Overall Study|Study Terminated|5|||
164300096|NCT02266888|593475127|FG001|Overall Study|Study Terminated|1|||
164300097|NCT02266888|593475128|FG002|Overall Study|Study Terminated|0|||
164300098|NCT02266888|593475129|FG003|Overall Study|Study Terminated|0|||
164300099|NCT02266888|593475126|FG000|Overall Study|No Longer Eligible|0|||
164300100|NCT02266888|593475127|FG001|Overall Study|No Longer Eligible|0|||
164300101|NCT02266888|593475128|FG002|Overall Study|No Longer Eligible|0|||
164300102|NCT02266888|593475129|FG003|Overall Study|No Longer Eligible|2|||
164300103|NCT02266888|593475126|FG000|Overall Study|Randomization Closed|0|||
164300104|NCT02266888|593475127|FG001|Overall Study|Randomization Closed|0|||
164300105|NCT02266888|593475128|FG002|Overall Study|Randomization Closed|4|||
164300106|NCT02266888|593475129|FG003|Overall Study|Randomization Closed|0|||
164300107|NCT02266888|593475126|FG000|Overall Study|Personnel unavailable at transplant|0|||
164300108|NCT02266888|593475127|FG001|Overall Study|Personnel unavailable at transplant|0|||
164300109|NCT02266888|593475128|FG002|Overall Study|Personnel unavailable at transplant|0|||
164300110|NCT02266888|593475129|FG003|Overall Study|Personnel unavailable at transplant|1|||
164300111|NCT02266888|593475126|FG000|Overall Study|Transfer of care|0|||
164300112|NCT02266888|593475127|FG001|Overall Study|Transfer of care|0|||
164300113|NCT02266888|593475128|FG002|Overall Study|Transfer of care|1|||
164300114|NCT02266888|593475129|FG003|Overall Study|Transfer of care|0|||
164300115|NCT02224560|593475134|FG000|Overall Study|Protocol Deviation|1|||
164300116|NCT02224560|593475135|FG001|Overall Study|Protocol Deviation|0|||
164300117|NCT02224560|593475136|FG002|Overall Study|Protocol Deviation|0|||
164300118|NCT02224560|593475134|FG000|Overall Study|Withdrawal by Subject|2|||
164300119|NCT02224560|593475135|FG001|Overall Study|Withdrawal by Subject|0|||
164300120|NCT02224560|593475136|FG002|Overall Study|Withdrawal by Subject|1|||
164300121|NCT02224560|593475134|FG000|Overall Study|Met Withdrawal Criteria|1|||
164300122|NCT02224560|593475135|FG001|Overall Study|Met Withdrawal Criteria|0|||
164300123|NCT02224560|593475136|FG002|Overall Study|Met Withdrawal Criteria|0|||
164300124|NCT02224560|593475134|FG000|Overall Study|Adverse Event|4|||
164300125|NCT02224560|593475135|FG001|Overall Study|Adverse Event|1|||
164300126|NCT02224560|593475136|FG002|Overall Study|Adverse Event|1|||
164300127|NCT02224560|593475134|FG000|Overall Study|Withdrawn by Investigator|1|||
164300128|NCT02224560|593475135|FG001|Overall Study|Withdrawn by Investigator|1|||
164300129|NCT02224560|593475136|FG002|Overall Study|Withdrawn by Investigator|0|||
164300130|NCT00728689|593475137|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
164300131|NCT00728689|593475138|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
164300132|NCT01523366|593475139|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164300133|NCT01523366|593475140|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164300134|NCT01523366|593475139|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
164300135|NCT01523366|593475140|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
164300136|NCT02461758|593475141|FG000|Overall Study|Lost to Follow-up|0|||
164300137|NCT02461758|593475142|FG001|Overall Study|Lost to Follow-up|1|||
164300138|NCT02461758|593475143|FG002|Overall Study|Lost to Follow-up|1|||
164300139|NCT02461758|593475144|FG003|Overall Study|Lost to Follow-up|0|||
164300140|NCT04543279|593475146|FG000|Overall Study|Withdrawal by Subject|1|||
164300141|NCT04543279|593475147|FG001|Overall Study|Withdrawal by Subject|0|||
164300142|NCT04543279|593475146|FG000|Overall Study|Adverse Event|1|||
164300143|NCT04543279|593475147|FG001|Overall Study|Adverse Event|0|||
164381171|NCT03095417|593766990|FG003|Overall Study|Physician Decision|2|||
164381172|NCT03095417|593766987|FG000|Overall Study|Death|1|||
164381173|NCT03095417|593766988|FG001|Overall Study|Death|2|||
164381174|NCT03095417|593766989|FG002|Overall Study|Death|1|||
164381175|NCT03095417|593766990|FG003|Overall Study|Death|3|||
164381176|NCT02571452|593766991|FG000|Overall Study Treatment|Protocol Violation|0|||
164381177|NCT02571452|593766992|FG001|Overall Study Treatment|Protocol Violation|1|||
164381178|NCT02571452|593766991|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
164381179|NCT02571452|593766992|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
164381180|NCT02571452|593766991|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
164381181|NCT02571452|593766992|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
164381182|NCT03698773|593767006|FG000|Overall Study|Lost to Follow-up|2|||
164381183|NCT03698773|593767007|FG001|Overall Study|Lost to Follow-up|1|||
164381184|NCT01158924|593767008|FG000|Overall Study|Withdrawal by Subject|1|||
164381185|NCT01158924|593767009|FG001|Overall Study|Withdrawal by Subject|2|||
164381186|NCT01158924|593767008|FG000|Overall Study|Lost to Follow-up|0|||
164381187|NCT01158924|593767009|FG001|Overall Study|Lost to Follow-up|1|||
164381188|NCT01599650|593767010|FG000|Overall Study|Administrative issue|1|||
164381189|NCT01599650|593767011|FG001|Overall Study|Administrative issue|0|||
164381190|NCT01599650|593767012|FG002|Overall Study|Administrative issue|1|||
164381191|NCT01599650|593767010|FG000|Overall Study|Physician Decision|2|||
164381192|NCT01599650|593767011|FG001|Overall Study|Physician Decision|0|||
164439781|NCT05190419|593977242|FG001|Overall Study|Withdrawal by Subject|1|||
164439782|NCT05190419|593977243|FG002|Overall Study|Withdrawal by Subject|2|||
164439783|NCT05190419|593977244|FG003|Overall Study|Withdrawal by Subject|2|||
164439784|NCT05190419|593977241|FG000|Overall Study|Adverse Event|2|||
164439785|NCT05190419|593977242|FG001|Overall Study|Adverse Event|10|||
164439786|NCT05190419|593977243|FG002|Overall Study|Adverse Event|11|||
164381193|NCT01599650|593767012|FG002|Overall Study|Physician Decision|7|||
164381194|NCT01599650|593767010|FG000|Overall Study|Protocol Violation|0|||
164439787|NCT05190419|593977244|FG003|Overall Study|Adverse Event|21|||
164439788|NCT05190419|593977241|FG000|Overall Study|Lost to Follow-up|1|||
164439789|NCT05190419|593977242|FG001|Overall Study|Lost to Follow-up|2|||
164439790|NCT05190419|593977243|FG002|Overall Study|Lost to Follow-up|3|||
164439791|NCT05190419|593977244|FG003|Overall Study|Lost to Follow-up|1|||
164439792|NCT05190419|593977241|FG000|Overall Study|Other|1|||
164701543|NCT02858492|594932640|FG003|Overall Study|Adverse Event|3|||
164701544|NCT02858492|594932637|FG000|Overall Study|Lack of Efficacy|0|||
164701545|NCT02858492|594932638|FG001|Overall Study|Lack of Efficacy|0|||
164701546|NCT02858492|594932639|FG002|Overall Study|Lack of Efficacy|0|||
164701547|NCT02858492|594932640|FG003|Overall Study|Lack of Efficacy|1|||
164701548|NCT02858492|594932637|FG000|Overall Study|Protocol defined stopping criteria|0|||
164701549|NCT02858492|594932638|FG001|Overall Study|Protocol defined stopping criteria|0|||
164701550|NCT02858492|594932639|FG002|Overall Study|Protocol defined stopping criteria|0|||
164701551|NCT02858492|594932640|FG003|Overall Study|Protocol defined stopping criteria|1|||
164701552|NCT02944383|594932641|FG000|Overall Study|Lost to Follow-up|0|||
164439793|NCT05190419|593977242|FG001|Overall Study|Other|1|||
164439794|NCT05190419|593977243|FG002|Overall Study|Other|0|||
164439795|NCT05190419|593977244|FG003|Overall Study|Other|3|||
164439796|NCT01227707|593977245|FG000|Overall Study|Adverse Event|10|||
164439797|NCT01227707|593977245|FG000|Overall Study|Progression of disease|3|||
164439798|NCT01227707|593977245|FG000|Overall Study|Withdrawal by Subject|1|||
164439799|NCT01227707|593977245|FG000|Overall Study|Patient non-compliance|3|||
164439800|NCT01227707|593977245|FG000|Overall Study|Medical decision|6|||
164439801|NCT01227707|593977245|FG000|Overall Study|Death|1|||
164701553|NCT02944383|594932642|FG001|Overall Study|Lost to Follow-up|0|||
164701554|NCT02944383|594932643|FG002|Overall Study|Lost to Follow-up|1|||
164701555|NCT02944383|594932641|FG000|Overall Study|Withdrawal by Subject|1|||
164701556|NCT02944383|594932642|FG001|Overall Study|Withdrawal by Subject|0|||
164701557|NCT02944383|594932643|FG002|Overall Study|Withdrawal by Subject|0|||
164701558|NCT01995266|594932645|FG000|Overall Study|Death|1|||
164381195|NCT01599650|593767011|FG001|Overall Study|Protocol Violation|3|||
164381196|NCT01599650|593767012|FG002|Overall Study|Protocol Violation|0|||
164381197|NCT01599650|593767010|FG000|Overall Study|Death|2|||
164381198|NCT01599650|593767011|FG001|Overall Study|Death|1|||
164381199|NCT01599650|593767012|FG002|Overall Study|Death|2|||
164381200|NCT01599650|593767010|FG000|Overall Study|Lost to Follow-up|3|||
164381201|NCT01599650|593767011|FG001|Overall Study|Lost to Follow-up|3|||
164381202|NCT01599650|593767012|FG002|Overall Study|Lost to Follow-up|3|||
164381203|NCT01599650|593767010|FG000|Overall Study|Withdrawal by Subject|11|||
164381204|NCT01599650|593767011|FG001|Overall Study|Withdrawal by Subject|11|||
164439802|NCT03210402|593977246|FG000|Overall Study|Withdrawal by Subject|0|||
164439803|NCT03210402|593977247|FG001|Overall Study|Withdrawal by Subject|1|||
164439804|NCT00811057|593977248|FG000|Overall Study|Protocol Violation|5|||
164439805|NCT00811057|593977249|FG001|Overall Study|Protocol Violation|10|||
164439806|NCT00811057|593977250|FG002|Overall Study|Protocol Violation|10|||
164381205|NCT01599650|593767012|FG002|Overall Study|Withdrawal by Subject|10|||
164439807|NCT02020616|593977251|FG000|Overall Study|Adverse Event|0|||
164439808|NCT02020616|593977252|FG001|Overall Study|Adverse Event|0|||
164381206|NCT01599650|593767010|FG000|Overall Study|Adverse Event|3|||
164381207|NCT01599650|593767011|FG001|Overall Study|Adverse Event|8|||
164381208|NCT01599650|593767012|FG002|Overall Study|Adverse Event|4|||
164381209|NCT01731171|593767013|FG000|Overall Study|Withdrawal by Subject|4|||
164381210|NCT01731171|593767014|FG001|Overall Study|Withdrawal by Subject|1|||
164381211|NCT01731171|593767013|FG000|Overall Study|Lost to Follow-up|3|||
164381212|NCT01731171|593767014|FG001|Overall Study|Lost to Follow-up|2|||
164381213|NCT01731171|593767013|FG000|Overall Study|Moved out of Area|0|||
164381214|NCT01731171|593767014|FG001|Overall Study|Moved out of Area|2|||
164381215|NCT01731171|593767013|FG000|Overall Study|Terminated for Lack of Adherence|0|||
164381216|NCT01731171|593767014|FG001|Overall Study|Terminated for Lack of Adherence|1|||
164381217|NCT01731171|593767013|FG000|Overall Study|Terminated for Safety Reasons|0|||
164381218|NCT01731171|593767014|FG001|Overall Study|Terminated for Safety Reasons|1|||
164381219|NCT01410110|593767015|FG000|Overall Study|Withdrawal by Subject|4|||
164381220|NCT01410110|593767016|FG001|Overall Study|Withdrawal by Subject|2|||
164381221|NCT01700946|593767017|FG000|Overall Study|Lost to Follow-up|1|||
164381222|NCT01700946|593767018|FG001|Overall Study|Lost to Follow-up|0|||
164381223|NCT01700946|593767017|FG000|Overall Study|Physician Decision|7|||
164381224|NCT01700946|593767018|FG001|Overall Study|Physician Decision|12|||
164381225|NCT01700946|593767017|FG000|Overall Study|Withdrawal by Subject|0|||
164381226|NCT01700946|593767018|FG001|Overall Study|Withdrawal by Subject|2|||
164381227|NCT01700946|593767017|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
164381228|NCT01700946|593767018|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
164381229|NCT01700946|593767017|FG000|Overall Study|Relapse|2|||
164381230|NCT01700946|593767018|FG001|Overall Study|Relapse|1|||
164381231|NCT01700946|593767017|FG000|Overall Study|Unacceptable toxicity|1|||
164381232|NCT01700946|593767018|FG001|Overall Study|Unacceptable toxicity|0|||
164381233|NCT00684424|593767019|FG000|Overall Study|Adverse Event|1|||
164381234|NCT00684424|593767019|FG000|Overall Study|Lost to Follow-up|2|||
164381235|NCT00684424|593767019|FG000|Overall Study|Other|2|||
164381236|NCT02138214|593767020|FG000|Overall Study|Withdrawal by Subject|0|||
164381237|NCT02138214|593767021|FG001|Overall Study|Withdrawal by Subject|1|||
164381238|NCT02138214|593767022|FG002|Overall Study|Withdrawal by Subject|0|||
164381239|NCT02138214|593767020|FG000|Overall Study|Lost to Follow-up|0|||
164381240|NCT02138214|593767021|FG001|Overall Study|Lost to Follow-up|2|||
164381241|NCT02138214|593767022|FG002|Overall Study|Lost to Follow-up|4|||
164381242|NCT02138214|593767020|FG000|Overall Study|Screen Failure|0|||
164381243|NCT02138214|593767021|FG001|Overall Study|Screen Failure|1|||
164381244|NCT02138214|593767022|FG002|Overall Study|Screen Failure|0|||
164381245|NCT02185768|593767023|FG000|Overall Study|Patients were not treated|2|||
164381246|NCT03221257|593767024|FG000|Overall Study|Lost to Follow-up|0|||
164381247|NCT03221257|593767025|FG001|Overall Study|Lost to Follow-up|1|||
164381248|NCT03221257|593767024|FG000|Overall Study|Withdrawal by Subject|1|||
164381249|NCT03221257|593767025|FG001|Overall Study|Withdrawal by Subject|1|||
164381250|NCT01334866|593767026|FG000|Overall Study|Withdrawal by Subject|10|||
164381251|NCT01334866|593767026|FG000|Overall Study|Lost to Follow-up|3|||
164381252|NCT01334866|593767026|FG000|Overall Study|Physician Decision|3|||
164381253|NCT01334866|593767026|FG000|Overall Study|medically necessary prior to procedure|2|||
164381254|NCT01334866|593767026|FG000|Overall Study|medically necessary post-procedure|1|||
164381255|NCT01971346|593767030|FG000|Overall Study|Protocol Violation|3|||
164381256|NCT01971346|593767030|FG000|Overall Study|Lost to Follow-up|2|||
164381257|NCT01971346|593767030|FG000|Overall Study|Withdrawal by Subject|2|||
164381258|NCT01971346|593767030|FG000|Overall Study|Physician Decision|1|||
164381259|NCT04187196|593767031|FG000|Overall Study|Screen Failure|2|||
164381260|NCT04187196|593767032|FG001|Overall Study|Screen Failure|0|||
164381261|NCT01687166|593767033|FG000|Overall Study|Attempt subject|2|||
164381262|NCT01687166|593767034|FG001|Overall Study|Attempt subject|3|||
164381263|NCT01687166|593767035|FG002|Overall Study|Attempt subject|2|||
164381264|NCT01687166|593767036|FG003|Overall Study|Attempt subject|0|||
164381265|NCT01687166|593767033|FG000|Overall Study|Did not meet eligibility criteria|4|||
164381266|NCT01687166|593767034|FG001|Overall Study|Did not meet eligibility criteria|6|||
164381267|NCT01687166|593767035|FG002|Overall Study|Did not meet eligibility criteria|1|||
164381268|NCT01687166|593767036|FG003|Overall Study|Did not meet eligibility criteria|1|||
164381269|NCT01687166|593767033|FG000|Overall Study|Adverse Event|2|||
164439809|NCT02020616|593977253|FG002|Overall Study|Adverse Event|0|||
164381270|NCT01687166|593767034|FG001|Overall Study|Adverse Event|1|||
164381271|NCT01687166|593767035|FG002|Overall Study|Adverse Event|0|||
164381272|NCT01687166|593767036|FG003|Overall Study|Adverse Event|0|||
164381273|NCT01687166|593767033|FG000|Overall Study|Physician Decision|3|||
164381274|NCT01687166|593767034|FG001|Overall Study|Physician Decision|2|||
164381275|NCT01687166|593767035|FG002|Overall Study|Physician Decision|1|||
164381276|NCT01687166|593767036|FG003|Overall Study|Physician Decision|0|||
164381277|NCT01687166|593767033|FG000|Overall Study|Withdrawal by Subject|11|||
164381278|NCT01687166|593767034|FG001|Overall Study|Withdrawal by Subject|4|||
164381279|NCT01687166|593767035|FG002|Overall Study|Withdrawal by Subject|3|||
164381280|NCT01687166|593767036|FG003|Overall Study|Withdrawal by Subject|0|||
164381281|NCT01687166|593767033|FG000|Overall Study|Lost to Follow-up|2|||
164381282|NCT01687166|593767034|FG001|Overall Study|Lost to Follow-up|5|||
164381283|NCT01687166|593767035|FG002|Overall Study|Lost to Follow-up|1|||
164381284|NCT01687166|593767036|FG003|Overall Study|Lost to Follow-up|0|||
164381285|NCT01687166|593767033|FG000|Overall Study|Equipment/Device Availability|0|||
164381286|NCT01687166|593767034|FG001|Overall Study|Equipment/Device Availability|1|||
164381287|NCT01687166|593767035|FG002|Overall Study|Equipment/Device Availability|0|||
164381288|NCT01687166|593767036|FG003|Overall Study|Equipment/Device Availability|0|||
164381289|NCT01687166|593767033|FG000|Overall Study|Death|1|||
164381290|NCT01687166|593767034|FG001|Overall Study|Death|1|||
164381291|NCT01687166|593767035|FG002|Overall Study|Death|0|||
164381292|NCT01687166|593767036|FG003|Overall Study|Death|0|||
164381293|NCT01687166|593767033|FG000|Overall Study|Protocol Violation|1|||
164381294|NCT01687166|593767034|FG001|Overall Study|Protocol Violation|1|||
164381295|NCT01687166|593767035|FG002|Overall Study|Protocol Violation|1|||
164381296|NCT01687166|593767036|FG003|Overall Study|Protocol Violation|0|||
164381297|NCT01687166|593767033|FG000|Overall Study|Subject moved out of state|0|||
164381298|NCT01687166|593767034|FG001|Overall Study|Subject moved out of state|1|||
164381299|NCT01687166|593767035|FG002|Overall Study|Subject moved out of state|0|||
164381300|NCT01687166|593767036|FG003|Overall Study|Subject moved out of state|0|||
164381301|NCT01687166|593767033|FG000|Overall Study|Patient unable to be compliant|1|||
164381302|NCT01687166|593767034|FG001|Overall Study|Patient unable to be compliant|0|||
164381303|NCT01687166|593767035|FG002|Overall Study|Patient unable to be compliant|0|||
164381304|NCT01687166|593767036|FG003|Overall Study|Patient unable to be compliant|0|||
164381305|NCT01687166|593767033|FG000|Overall Study|Physician choice to use different device|1|||
164381306|NCT01687166|593767034|FG001|Overall Study|Physician choice to use different device|2|||
164381307|NCT01687166|593767035|FG002|Overall Study|Physician choice to use different device|4|||
164381308|NCT01687166|593767036|FG003|Overall Study|Physician choice to use different device|0|||
164381309|NCT01687166|593767033|FG000|Overall Study|Insurance|0|||
164381310|NCT01687166|593767034|FG001|Overall Study|Insurance|0|||
164439810|NCT02020616|593977254|FG003|Overall Study|Adverse Event|0|||
164439811|NCT02020616|593977255|FG004|Overall Study|Adverse Event|0|||
164439812|NCT02020616|593977256|FG005|Overall Study|Adverse Event|1|||
164439813|NCT02020616|593977257|FG006|Overall Study|Adverse Event|1|||
164439814|NCT02020616|593977251|FG000|Overall Study|Physician Decision|0|||
164439815|NCT02020616|593977252|FG001|Overall Study|Physician Decision|0|||
164439816|NCT02020616|593977253|FG002|Overall Study|Physician Decision|0|||
164439817|NCT02020616|593977254|FG003|Overall Study|Physician Decision|0|||
164439818|NCT02020616|593977255|FG004|Overall Study|Physician Decision|0|||
164439819|NCT02020616|593977256|FG005|Overall Study|Physician Decision|1|||
164439820|NCT02020616|593977257|FG006|Overall Study|Physician Decision|2|||
164439821|NCT02020616|593977251|FG000|Overall Study|Withdrawal by Subject|0|||
164439822|NCT02020616|593977252|FG001|Overall Study|Withdrawal by Subject|0|||
164439823|NCT02020616|593977253|FG002|Overall Study|Withdrawal by Subject|1|||
164439824|NCT02020616|593977254|FG003|Overall Study|Withdrawal by Subject|0|||
164439825|NCT02020616|593977255|FG004|Overall Study|Withdrawal by Subject|0|||
164439826|NCT02020616|593977256|FG005|Overall Study|Withdrawal by Subject|1|||
164439827|NCT02020616|593977257|FG006|Overall Study|Withdrawal by Subject|1|||
164439828|NCT02020616|593977251|FG000|Overall Study|Lost to Follow-up|0|||
164439829|NCT02020616|593977252|FG001|Overall Study|Lost to Follow-up|1|||
164439830|NCT02020616|593977253|FG002|Overall Study|Lost to Follow-up|0|||
164439831|NCT02020616|593977254|FG003|Overall Study|Lost to Follow-up|1|||
164439832|NCT02020616|593977255|FG004|Overall Study|Lost to Follow-up|1|||
164439833|NCT02020616|593977256|FG005|Overall Study|Lost to Follow-up|1|||
164439834|NCT02020616|593977257|FG006|Overall Study|Lost to Follow-up|0|||
164439835|NCT02020616|593977251|FG000|Overall Study|Early Termination Criteria Met|0|||
164439836|NCT02020616|593977252|FG001|Overall Study|Early Termination Criteria Met|0|||
164439837|NCT02020616|593977253|FG002|Overall Study|Early Termination Criteria Met|1|||
164439838|NCT02020616|593977254|FG003|Overall Study|Early Termination Criteria Met|0|||
164439839|NCT02020616|593977255|FG004|Overall Study|Early Termination Criteria Met|0|||
164439840|NCT02020616|593977256|FG005|Overall Study|Early Termination Criteria Met|1|||
164439841|NCT02020616|593977257|FG006|Overall Study|Early Termination Criteria Met|0|||
164439842|NCT02020616|593977251|FG000|Overall Study|Randomized in Error|0|||
164439843|NCT02020616|593977252|FG001|Overall Study|Randomized in Error|0|||
164381311|NCT01687166|593767035|FG002|Overall Study|Insurance|1|||
164381312|NCT01687166|593767036|FG003|Overall Study|Insurance|1|||
164381313|NCT02755831|593767037|FG000|Overall Study|Lost to Follow-up|3|||
164381314|NCT02755831|593767038|FG001|Overall Study|Lost to Follow-up|3|||
164381315|NCT01600586|593767039|FG000|Overall Study|Physician Decision|3|||
164381316|NCT01600586|593767040|FG001|Overall Study|Physician Decision|3|||
164381317|NCT01227512|593767042|FG000|Overall Study|Physician Decision|6|||
164381318|NCT01227512|593767043|FG001|Overall Study|Physician Decision|6|||
164439844|NCT02020616|593977253|FG002|Overall Study|Randomized in Error|0|||
164439845|NCT02020616|593977254|FG003|Overall Study|Randomized in Error|1|||
164439846|NCT02020616|593977255|FG004|Overall Study|Randomized in Error|0|||
164439847|NCT02020616|593977256|FG005|Overall Study|Randomized in Error|0|||
164439848|NCT02020616|593977257|FG006|Overall Study|Randomized in Error|0|||
164439849|NCT02020616|593977251|FG000|Overall Study|Lack of Efficacy|0|||
164439850|NCT02020616|593977252|FG001|Overall Study|Lack of Efficacy|0|||
164381319|NCT01227512|593767042|FG000|Overall Study|Adverse Event|4|||
164381320|NCT01227512|593767043|FG001|Overall Study|Adverse Event|3|||
164381321|NCT01227512|593767042|FG000|Overall Study|Withdrawal by Subject|3|||
164381322|NCT01227512|593767043|FG001|Overall Study|Withdrawal by Subject|0|||
164381323|NCT01227512|593767042|FG000|Overall Study|Participant met withdrawal criteria|0|||
164381324|NCT01227512|593767043|FG001|Overall Study|Participant met withdrawal criteria|1|||
164381325|NCT01978184|593767045|FG000|Overall Study|Progressive disease|5|||
164381326|NCT01978184|593767046|FG001|Overall Study|Progressive disease|5|||
164381327|NCT01978184|593767045|FG000|Overall Study|Other than PDA|2|||
164381328|NCT01978184|593767046|FG001|Overall Study|Other than PDA|2|||
164381329|NCT01978184|593767045|FG000|Overall Study|Physician Decision|0|||
164381330|NCT01978184|593767046|FG001|Overall Study|Physician Decision|3|||
164381331|NCT01978184|593767045|FG000|Overall Study|Noncompliance|1|||
164381332|NCT01978184|593767046|FG001|Overall Study|Noncompliance|2|||
164381333|NCT01978184|593767045|FG000|Overall Study|Death|1|||
164381334|NCT01978184|593767046|FG001|Overall Study|Death|0|||
164381335|NCT01978184|593767045|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
164381336|NCT01978184|593767046|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
164381337|NCT02460198|593767049|FG000|Overall Study|Adverse Event|1|||
164381338|NCT02460198|593767050|FG001|Overall Study|Adverse Event|3|||
164381339|NCT02460198|593767049|FG000|Overall Study|Death|36|||
164381340|NCT02460198|593767050|FG001|Overall Study|Death|28|||
164381341|NCT02460198|593767049|FG000|Overall Study|Lost to Follow-up|1|||
164381342|NCT02460198|593767050|FG001|Overall Study|Lost to Follow-up|1|||
164381343|NCT02460198|593767049|FG000|Overall Study|Transferred to Extension Study|15|||
164381344|NCT02460198|593767050|FG001|Overall Study|Transferred to Extension Study|15|||
164381345|NCT02460198|593767049|FG000|Overall Study|Withdrawal by Subject|2|||
164381346|NCT02460198|593767050|FG001|Overall Study|Withdrawal by Subject|4|||
164381347|NCT02460198|593767049|FG000|Overall Study|Site Terminated By Sponsor|0|||
164381348|NCT02460198|593767050|FG001|Overall Study|Site Terminated By Sponsor|1|||
164381349|NCT02460198|593767049|FG000|Overall Study|Did Not Continue on Extension Study|6|||
164381350|NCT02460198|593767050|FG001|Overall Study|Did Not Continue on Extension Study|11|||
164381351|NCT01069289|593767053|FG000|Overall Study|Withdrawal by Subject|15|||
164381352|NCT01069289|593767054|FG001|Overall Study|Withdrawal by Subject|26|||
164381353|NCT01069289|593767053|FG000|Overall Study|Adverse Event|21|||
164381354|NCT01069289|593767054|FG001|Overall Study|Adverse Event|28|||
164701559|NCT01995266|594932645|FG000|Overall Study|Lack of Efficacy|6|||
164701560|NCT01995266|594932645|FG000|Overall Study|Adverse Event|2|||
164701561|NCT03853148|594932646|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
164701562|NCT03853148|594932647|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
164701563|NCT03853148|594932648|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
164701564|NCT03853148|594932649|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
164701565|NCT00090610|594932650|FG000|Overall Study|Withdrawal by Subject|1|||
164701566|NCT00090610|594932651|FG001|Overall Study|Withdrawal by Subject|1|||
164701567|NCT03623386|594932654|FG000|Overall Study|Protocol Violation|3|||
164701568|NCT03623386|594932655|FG001|Overall Study|Protocol Violation|2|||
164701569|NCT03623386|594932656|FG002|Overall Study|Protocol Violation|0|||
164701570|NCT03623386|594932654|FG000|Overall Study|Physician Decision|1|||
164381355|NCT01069289|593767053|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
164381356|NCT01069289|593767054|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164381357|NCT01069289|593767053|FG000|Overall Study|Severe non-compliance to protocol|3|||
164381358|NCT01069289|593767054|FG001|Overall Study|Severe non-compliance to protocol|2|||
164381359|NCT01069289|593767053|FG000|Overall Study|Due to deteriorating health condition|1|||
164381360|NCT01069289|593767054|FG001|Overall Study|Due to deteriorating health condition|0|||
164381361|NCT00965848|593767055|FG000|Overall Study|Protocol Violation|3|||
164381362|NCT00965848|593767056|FG001|Overall Study|Protocol Violation|0|||
164381363|NCT00965848|593767057|FG002|Overall Study|Protocol Violation|1|||
164381364|NCT00965848|593767055|FG000|Overall Study|Death|11|||
164381365|NCT00965848|593767056|FG001|Overall Study|Death|1|||
164381366|NCT00965848|593767057|FG002|Overall Study|Death|5|||
164381367|NCT00965848|593767055|FG000|Overall Study|Lost to Follow-up|0|||
164381368|NCT00965848|593767056|FG001|Overall Study|Lost to Follow-up|0|||
164381369|NCT00965848|593767057|FG002|Overall Study|Lost to Follow-up|1|||
164381370|NCT00965848|593767055|FG000|Overall Study|Withdrawal by Subject|1|||
164381371|NCT00965848|593767056|FG001|Overall Study|Withdrawal by Subject|0|||
164701571|NCT03623386|594932655|FG001|Overall Study|Physician Decision|1|||
164381372|NCT00965848|593767057|FG002|Overall Study|Withdrawal by Subject|0|||
164381373|NCT00965848|593767055|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
164381374|NCT00965848|593767056|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
164381375|NCT00965848|593767057|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
164701572|NCT03623386|594932656|FG002|Overall Study|Physician Decision|0|||
164381376|NCT00965848|593767055|FG000|Overall Study|Not Clinically Evaluable|7|||
164381377|NCT00965848|593767056|FG001|Overall Study|Not Clinically Evaluable|1|||
164381378|NCT00965848|593767057|FG002|Overall Study|Not Clinically Evaluable|1|||
164701573|NCT03623386|594932654|FG000|Overall Study|Lost to Follow-up|0|||
164701574|NCT03623386|594932655|FG001|Overall Study|Lost to Follow-up|2|||
164701575|NCT03623386|594932656|FG002|Overall Study|Lost to Follow-up|0|||
164381379|NCT00965848|593767055|FG000|Overall Study|Other|5|||
164381380|NCT00965848|593767056|FG001|Overall Study|Other|0|||
164381381|NCT00965848|593767057|FG002|Overall Study|Other|1|||
164381382|NCT00691210|593767058|FG000|Overall Study|Progression of Disease|0|||
164381383|NCT00691210|593767059|FG001|Overall Study|Progression of Disease|0|||
164381384|NCT00691210|593767060|FG002|Overall Study|Progression of Disease|0|||
164381385|NCT00691210|593767061|FG003|Overall Study|Progression of Disease|2|||
164381386|NCT00691210|593767062|FG004|Overall Study|Progression of Disease|0|||
164381387|NCT00691210|593767063|FG005|Overall Study|Progression of Disease|0|||
164381388|NCT00691210|593767064|FG006|Overall Study|Progression of Disease|0|||
164381389|NCT00691210|593767065|FG007|Overall Study|Progression of Disease|0|||
164381390|NCT00691210|593767058|FG000|Overall Study|Lack of Efficacy|0|||
164381391|NCT00691210|593767059|FG001|Overall Study|Lack of Efficacy|0|||
164381392|NCT00691210|593767060|FG002|Overall Study|Lack of Efficacy|0|||
164381393|NCT00691210|593767061|FG003|Overall Study|Lack of Efficacy|1|||
164381394|NCT00691210|593767062|FG004|Overall Study|Lack of Efficacy|0|||
164381395|NCT00691210|593767063|FG005|Overall Study|Lack of Efficacy|1|||
164381396|NCT00691210|593767064|FG006|Overall Study|Lack of Efficacy|0|||
164381397|NCT00691210|593767065|FG007|Overall Study|Lack of Efficacy|0|||
164381398|NCT02707640|593767066|FG000|Overall Study|Adverse Event|4|||
164381399|NCT02707640|593767067|FG001|Overall Study|Adverse Event|2|||
164381400|NCT02707640|593767066|FG000|Overall Study|Death|1|||
164381401|NCT02707640|593767067|FG001|Overall Study|Death|2|||
164381402|NCT02707640|593767066|FG000|Overall Study|Physician Decision|2|||
164381403|NCT02707640|593767067|FG001|Overall Study|Physician Decision|0|||
164381404|NCT02707640|593767066|FG000|Overall Study|Withdrawal by Subject|0|||
164381405|NCT02707640|593767067|FG001|Overall Study|Withdrawal by Subject|1|||
164381406|NCT02707640|593767066|FG000|Overall Study|Participant's Personal Decision|1|||
164381407|NCT02707640|593767067|FG001|Overall Study|Participant's Personal Decision|2|||
164381408|NCT02707640|593767066|FG000|Overall Study|Sponsor Discretion|1|||
164381409|NCT02707640|593767067|FG001|Overall Study|Sponsor Discretion|0|||
164381410|NCT02517905|593767068|FG000|Overall Study|Lost to Follow-up|4|||
164381411|NCT02517905|593767069|FG001|Overall Study|Lost to Follow-up|0|||
164381412|NCT02517905|593767068|FG000|Overall Study|Withdrawal by Subject|4|||
164381413|NCT02517905|593767069|FG001|Overall Study|Withdrawal by Subject|0|||
164381414|NCT02517905|593767068|FG000|Overall Study|Screen failure|2|||
164381415|NCT02517905|593767069|FG001|Overall Study|Screen failure|2|||
164381416|NCT00023452|593767070|FG000|Overall Study|Ineligible for Study|163|||
164381417|NCT00023452|593767071|FG001|Overall Study|Ineligible for Study|159|||
164381418|NCT00023452|593767070|FG000|Overall Study|Out of Window|129|||
164381419|NCT00023452|593767071|FG001|Overall Study|Out of Window|69|||
164381420|NCT00023452|593767070|FG000|Overall Study|Death|2|||
164381421|NCT00023452|593767071|FG001|Overall Study|Death|0|||
164381422|NCT00023452|593767070|FG000|Overall Study|Withdrawal by Subject|66|||
164381423|NCT00023452|593767071|FG001|Overall Study|Withdrawal by Subject|54|||
164381424|NCT00023452|593767070|FG000|Overall Study|Adverse Event|139|||
164381425|NCT00023452|593767071|FG001|Overall Study|Adverse Event|196|||
164381426|NCT00023452|593767070|FG000|Overall Study|Lost to Follow-up|293|||
164381427|NCT00023452|593767071|FG001|Overall Study|Lost to Follow-up|60|||
164381428|NCT00023452|593767070|FG000|Overall Study|Physician Decision|49|||
164381429|NCT00023452|593767071|FG001|Overall Study|Physician Decision|21|||
164381430|NCT00023452|593767070|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
164381431|NCT00023452|593767071|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
164381432|NCT00023452|593767070|FG000|Overall Study|Pregnant|53|||
164381433|NCT00023452|593767071|FG001|Overall Study|Pregnant|20|||
164381434|NCT00023452|593767070|FG000|Overall Study|Other|204|||
164381435|NCT00023452|593767071|FG001|Overall Study|Other|69|||
164701576|NCT03623386|594932654|FG000|Overall Study|COVID-19|0|||
164701577|NCT03623386|594932655|FG001|Overall Study|COVID-19|1|||
164381436|NCT05789875|593767072|FG000|Overall Study|Lost to Follow-up|6|||
164381437|NCT01994395|593767073|FG000|Overall Study|Withdrawal by Subject|1|||
164381438|NCT01994395|593767074|FG001|Overall Study|Withdrawal by Subject|2|||
164381439|NCT00459134|593767082|FG000|Overall Study|Physician Decision|1|||
164381440|NCT00459134|593767083|FG001|Overall Study|Physician Decision|1|||
164701578|NCT03623386|594932656|FG002|Overall Study|COVID-19|0|||
164381441|NCT00459134|593767082|FG000|Overall Study|Withdrawal by Subject|8|||
164381442|NCT00459134|593767083|FG001|Overall Study|Withdrawal by Subject|7|||
164381443|NCT00459134|593767082|FG000|Overall Study|Lost to Follow-up|6|||
164381444|NCT00459134|593767083|FG001|Overall Study|Lost to Follow-up|7|||
164381445|NCT00459134|593767082|FG000|Overall Study|Surgery|1|||
164701579|NCT00599521|594932661|FG000|Overall Study|Lack of Efficacy|4|||
164381446|NCT00459134|593767083|FG001|Overall Study|Surgery|2|||
164381447|NCT00459134|593767082|FG000|Overall Study|Toxicity|4|||
164381448|NCT00459134|593767083|FG001|Overall Study|Toxicity|5|||
164381449|NCT00459134|593767082|FG000|Overall Study|Progression|1|||
164381450|NCT00459134|593767083|FG001|Overall Study|Progression|0|||
164381451|NCT00459134|593767082|FG000|Overall Study|Multiple Reasons|2|||
164381452|NCT00459134|593767083|FG001|Overall Study|Multiple Reasons|3|||
164381453|NCT02770391|593767084|FG000|Overall Study|Lost to Follow-up|2|||
164439851|NCT02020616|593977253|FG002|Overall Study|Lack of Efficacy|0|||
164439852|NCT02020616|593977254|FG003|Overall Study|Lack of Efficacy|0|||
164439853|NCT02020616|593977255|FG004|Overall Study|Lack of Efficacy|1|||
164439854|NCT02020616|593977256|FG005|Overall Study|Lack of Efficacy|0|||
164439855|NCT02020616|593977257|FG006|Overall Study|Lack of Efficacy|0|||
164439856|NCT02540213|593977269|FG000|Overall Study|Death/adverse event|18|||
164439857|NCT02540213|593977269|FG000|Overall Study|Administrative reasons|3|||
164439858|NCT02540213|593977269|FG000|Overall Study|Kidney transplant|3|||
164439859|NCT02540213|593977269|FG000|Overall Study|Lack of Efficacy|6|||
164439860|NCT02540213|593977269|FG000|Overall Study|Consent withdrawn|7|||
164439861|NCT02540213|593977269|FG000|Overall Study|Enrolled but not treated|2|||
164439862|NCT00536380|593977274|FG000|Overall Study|Adverse Event|0|||
164439863|NCT00536380|593977275|FG001|Overall Study|Adverse Event|2|||
164439864|NCT00536380|593977276|FG002|Overall Study|Adverse Event|2|||
164439865|NCT00536380|593977274|FG000|Overall Study|Lost to Follow-up|0|||
164439866|NCT00536380|593977275|FG001|Overall Study|Lost to Follow-up|0|||
164439867|NCT00536380|593977276|FG002|Overall Study|Lost to Follow-up|1|||
164439868|NCT00536380|593977274|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
164439869|NCT00536380|593977275|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
164439870|NCT00536380|593977276|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
164439871|NCT00536380|593977274|FG000|Overall Study|Withdrawal related to study drug|7|||
164439872|NCT00536380|593977275|FG001|Overall Study|Withdrawal related to study drug|5|||
164439873|NCT00536380|593977276|FG002|Overall Study|Withdrawal related to study drug|2|||
164439874|NCT00536380|593977274|FG000|Overall Study|Noncompliance with protocol|3|||
164439875|NCT00536380|593977275|FG001|Overall Study|Noncompliance with protocol|2|||
164439876|NCT00536380|593977276|FG002|Overall Study|Noncompliance with protocol|2|||
164439877|NCT00536380|593977274|FG000|Overall Study|Did not meet protocol eligibility|0|||
164439878|NCT00536380|593977275|FG001|Overall Study|Did not meet protocol eligibility|0|||
164381454|NCT02770391|593767084|FG000|Overall Study|Withdrawal by Subject|1|||
164381455|NCT02770391|593767084|FG000|Overall Study|Surgery delayed unevaluable|2|||
164381456|NCT02770391|593767084|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
164381457|NCT03333486|593767085|FG000|Overall Study|Withdrawal by Subject|1|||
164381458|NCT03333486|593767085|FG000|Overall Study|Lost to Follow-up|1|||
164381459|NCT01755416|593767091|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
164381460|NCT01755416|593767092|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
164381461|NCT02805257|593769427|FG000|Overall Study|Lost to Follow-up|7|||
164381462|NCT02805257|593769428|FG001|Overall Study|Lost to Follow-up|6|||
164381463|NCT02805257|593769427|FG000|Overall Study|Death|0|||
164381464|NCT02805257|593769428|FG001|Overall Study|Death|1|||
164381465|NCT00612066|593769429|FG000|Overall Study|Adverse Event|1|||
164381466|NCT01043874|593769433|FG000|Overall Study|Adverse Event|3|||
164381467|NCT01043874|593769433|FG000|Overall Study|Withdrawal by Subject|1|||
164381468|NCT01043874|593769433|FG000|Overall Study|Lack of Efficacy|1|||
164381469|NCT01043874|593769433|FG000|Overall Study|Administrative Problems|1|||
164381470|NCT01627249|593769434|FG000|Overall Study|Death|3|||
164381471|NCT01627249|593769435|FG001|Overall Study|Death|5|||
164381472|NCT01627249|593769436|FG002|Overall Study|Death|3|||
164381473|NCT01627249|593769434|FG000|Overall Study|Withdrawal by Subject|12|||
164381474|NCT01627249|593769435|FG001|Overall Study|Withdrawal by Subject|6|||
164381475|NCT01627249|593769436|FG002|Overall Study|Withdrawal by Subject|9|||
164381476|NCT01627249|593769434|FG000|Overall Study|Missed Visit|1|||
164381477|NCT01627249|593769435|FG001|Overall Study|Missed Visit|1|||
164381478|NCT01627249|593769436|FG002|Overall Study|Missed Visit|0|||
164381479|NCT03266588|593769437|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
164381480|NCT03266588|593769438|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
164381481|NCT03266588|593769439|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
164381482|NCT03266588|593769437|FG000|Observational Period|Withdrawal by Subject|44|||
164381483|NCT03266588|593769438|FG001|Observational Period|Withdrawal by Subject|22|||
164439879|NCT00536380|593977276|FG002|Overall Study|Did not meet protocol eligibility|1|||
164439880|NCT00536380|593977274|FG000|Overall Study|Administrative|0|||
164439881|NCT00536380|593977275|FG001|Overall Study|Administrative|0|||
164381484|NCT03266588|593769439|FG002|Observational Period|Withdrawal by Subject|13|||
164381485|NCT03266588|593769437|FG000|Observational Period|Non-compliance|18|||
164439882|NCT00536380|593977276|FG002|Overall Study|Administrative|1|||
164439883|NCT00387465|593977277|FG000|Overall Study|Withdrawal by Subject|0|||
164439884|NCT00387465|593977278|FG001|Overall Study|Withdrawal by Subject|1|||
164701580|NCT00599521|594932662|FG001|Overall Study|Lack of Efficacy|8|||
164381486|NCT03266588|593769438|FG001|Observational Period|Non-compliance|12|||
164381487|NCT03266588|593769439|FG002|Observational Period|Non-compliance|10|||
164381488|NCT03266588|593769437|FG000|Observational Period|Lost to Follow-up|8|||
164439885|NCT00387465|593977279|FG002|Overall Study|Withdrawal by Subject|0|||
164439886|NCT00430300|593977282|FG000|Overall Study|Adverse Event|0|||
164439887|NCT00430300|593977283|FG001|Overall Study|Adverse Event|2|||
164439888|NCT00430300|593977284|FG002|Overall Study|Adverse Event|1|||
164381489|NCT03266588|593769438|FG001|Observational Period|Lost to Follow-up|12|||
164381490|NCT03266588|593769439|FG002|Observational Period|Lost to Follow-up|4|||
164381491|NCT03266588|593769437|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
164381492|NCT03266588|593769438|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
164381493|NCT03266588|593769439|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
164381494|NCT03266588|593769437|FG000|Observational Period|Protocol Deviation|1|||
164381495|NCT03266588|593769438|FG001|Observational Period|Protocol Deviation|0|||
164381496|NCT03266588|593769439|FG002|Observational Period|Protocol Deviation|0|||
164381497|NCT03266588|593769437|FG000|Observational Period|Other Reasons|3|||
164381498|NCT03266588|593769438|FG001|Observational Period|Other Reasons|0|||
164381499|NCT03266588|593769439|FG002|Observational Period|Other Reasons|1|||
164381500|NCT03266588|593769437|FG000|Long-term Treatment Period|Adverse Event|33|||
164381501|NCT03266588|593769438|FG001|Long-term Treatment Period|Adverse Event|17|||
164381502|NCT03266588|593769439|FG002|Long-term Treatment Period|Adverse Event|8|||
164381503|NCT03266588|593769437|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
164381504|NCT03266588|593769438|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
164381505|NCT03266588|593769439|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
164381506|NCT03266588|593769437|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
164381507|NCT03266588|593769438|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
164381508|NCT03266588|593769439|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
164381509|NCT03266588|593769437|FG000|Long-term Treatment Period|Non-Compliance|126|||
164381510|NCT03266588|593769438|FG001|Long-term Treatment Period|Non-Compliance|57|||
164381511|NCT03266588|593769439|FG002|Long-term Treatment Period|Non-Compliance|7|||
164381512|NCT03266588|593769437|FG000|Long-term Treatment Period|Pregnancy|11|||
164381513|NCT03266588|593769438|FG001|Long-term Treatment Period|Pregnancy|5|||
164381514|NCT03266588|593769439|FG002|Long-term Treatment Period|Pregnancy|0|||
164381515|NCT03266588|593769437|FG000|Long-term Treatment Period|Protocol Deviation|17|||
164381516|NCT03266588|593769438|FG001|Long-term Treatment Period|Protocol Deviation|10|||
164381517|NCT03266588|593769439|FG002|Long-term Treatment Period|Protocol Deviation|4|||
164381518|NCT03266588|593769437|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
164381519|NCT03266588|593769438|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
164381520|NCT03266588|593769439|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
164381521|NCT03266588|593769437|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
164381522|NCT03266588|593769438|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
164381523|NCT03266588|593769439|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
164381524|NCT03266588|593769437|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
164381525|NCT03266588|593769438|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
164381526|NCT03266588|593769439|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
164381527|NCT03266588|593769437|FG000|Long-term Treatment Period|Other Reasons|5|||
164381528|NCT03266588|593769438|FG001|Long-term Treatment Period|Other Reasons|0|||
164381529|NCT03266588|593769439|FG002|Long-term Treatment Period|Other Reasons|0|||
164381530|NCT03266588|593769437|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
164381531|NCT03266588|593769438|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
164381532|NCT03266588|593769439|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
164381533|NCT00071487|593769444|FG000|52-Week Double-Blind Period|Adverse Event|5|||
164381534|NCT00071487|593769445|FG001|52-Week Double-Blind Period|Adverse Event|8|||
164381535|NCT00071487|593769446|FG002|52-Week Double-Blind Period|Adverse Event|4|||
164381536|NCT00071487|593769447|FG003|52-Week Double-Blind Period|Adverse Event|8|||
164381537|NCT00071487|593769444|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
164381538|NCT00071487|593769445|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
164381539|NCT00071487|593769446|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
164381540|NCT00071487|593769447|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
164381541|NCT00071487|593769444|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
164381542|NCT00071487|593769445|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
164381543|NCT00071487|593769446|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
164381544|NCT00071487|593769447|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
164381545|NCT00071487|593769444|FG000|52-Week Double-Blind Period|Physician Decision|1|||
164381546|NCT00071487|593769445|FG001|52-Week Double-Blind Period|Physician Decision|0|||
164381547|NCT00071487|593769446|FG002|52-Week Double-Blind Period|Physician Decision|0|||
164381548|NCT00071487|593769447|FG003|52-Week Double-Blind Period|Physician Decision|0|||
164381549|NCT00071487|593769444|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
164701581|NCT00599521|594932661|FG000|Overall Study|Adverse Event|4|||
164701582|NCT00599521|594932662|FG001|Overall Study|Adverse Event|1|||
164381550|NCT00071487|593769445|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
164381551|NCT00071487|593769446|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
164381552|NCT00071487|593769447|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
164381553|NCT00071487|593769444|FG000|52-Week Double-Blind Period|Pregnancy|0|||
164381554|NCT00071487|593769445|FG001|52-Week Double-Blind Period|Pregnancy|1|||
164381555|NCT00071487|593769446|FG002|52-Week Double-Blind Period|Pregnancy|0|||
164439889|NCT00430300|593977285|FG003|Overall Study|Adverse Event|1|||
164701583|NCT00599521|594932661|FG000|Overall Study|Withdrawal by Subject|28|||
164701584|NCT00599521|594932662|FG001|Overall Study|Withdrawal by Subject|34|||
164701585|NCT00599521|594932661|FG000|Overall Study|Protocol Violation|1|||
164701586|NCT00599521|594932662|FG001|Overall Study|Protocol Violation|1|||
164701587|NCT00599521|594932661|FG000|Overall Study|Lost to Follow-up|23|||
164701588|NCT00599521|594932662|FG001|Overall Study|Lost to Follow-up|23|||
164701589|NCT00599521|594932661|FG000|Overall Study|Pregnancy|0|||
164381556|NCT00071487|593769447|FG003|52-Week Double-Blind Period|Pregnancy|0|||
164381557|NCT00071487|593769444|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
164381558|NCT00071487|593769445|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
164381559|NCT00071487|593769446|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
164381560|NCT00071487|593769447|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
164381561|NCT00071487|593769444|FG000|52-Week Double-Blind Period|Death|0|||
164381562|NCT00071487|593769445|FG001|52-Week Double-Blind Period|Death|1|||
164381563|NCT00071487|593769446|FG002|52-Week Double-Blind Period|Death|0|||
164381564|NCT00071487|593769447|FG003|52-Week Double-Blind Period|Death|0|||
164381565|NCT00071487|593769444|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
164381566|NCT00071487|593769445|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
164381567|NCT00071487|593769446|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
164381568|NCT00071487|593769447|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
164381569|NCT00071487|593769444|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
164381570|NCT00071487|593769445|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
164381571|NCT00071487|593769446|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
164381572|NCT00071487|593769447|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
164381573|NCT00071487|593769444|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
164381574|NCT00071487|593769445|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
164381575|NCT00071487|593769446|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
164381576|NCT00071487|593769447|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
164381577|NCT00071487|593769444|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
164381578|NCT00071487|593769445|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
164381579|NCT00071487|593769446|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
164381580|NCT00071487|593769447|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
164381581|NCT00071487|593769444|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
164381582|NCT00071487|593769445|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
164381583|NCT00071487|593769446|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
164381584|NCT00071487|593769447|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
164381585|NCT00071487|593769444|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
164381586|NCT00071487|593769445|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
164381587|NCT00071487|593769446|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
164381588|NCT00071487|593769447|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
164381589|NCT00071487|593769444|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
164381590|NCT00071487|593769445|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
164381591|NCT00071487|593769446|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
164381592|NCT00071487|593769447|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
164381593|NCT02696850|593769450|FG000|Overall Study|Withdrawal by Subject|3|||
164381594|NCT02696850|593769451|FG001|Overall Study|Withdrawal by Subject|3|||
164381595|NCT02696850|593769450|FG000|Overall Study|Lost to Follow-up|8|||
164381596|NCT02696850|593769451|FG001|Overall Study|Lost to Follow-up|5|||
164381597|NCT02044510|593769454|FG000|Overall Study|Adverse Event|1|||
164381598|NCT02044510|593769455|FG001|Overall Study|Adverse Event|2|||
164381599|NCT01933334|593769462|FG000|Overall Study|Adverse Event|5|||
164381600|NCT01933334|593769463|FG001|Overall Study|Adverse Event|1|||
164381601|NCT01933334|593769462|FG000|Overall Study|Withdrawal by Subject|0|||
164381602|NCT01933334|593769463|FG001|Overall Study|Withdrawal by Subject|1|||
164381603|NCT02039505|593769464|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
164381604|NCT02039505|593769465|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
164381605|NCT02039505|593769466|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
164439890|NCT00430300|593977282|FG000|Overall Study|Withdrawal by Subject|1|||
164439891|NCT00430300|593977283|FG001|Overall Study|Withdrawal by Subject|0|||
164701590|NCT00599521|594932662|FG001|Overall Study|Pregnancy|2|||
164701591|NCT02751359|594932667|FG000|Overall Study|Lost to Follow-up|1|||
164701592|NCT02667288|594932668|FG000|Overall Study|Protocol Violation|5|||
164701593|NCT02667288|594932668|FG000|Overall Study|Lost to Follow-up|3|||
164381606|NCT02039505|593769467|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
164381607|NCT02039505|593769468|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
164381608|NCT02039505|593769469|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
164381609|NCT02039505|593769470|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
164439892|NCT00430300|593977284|FG002|Overall Study|Withdrawal by Subject|5|||
164701594|NCT02667288|594932668|FG000|Overall Study|Withdrawal by Subject|5|||
164381610|NCT02039505|593769464|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
164381611|NCT02039505|593769465|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
164381612|NCT02039505|593769466|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
164381613|NCT02039505|593769467|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
164381614|NCT02039505|593769468|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
164381615|NCT02039505|593769469|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
164381616|NCT02039505|593769470|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
164381617|NCT02039505|593769464|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
164381618|NCT02039505|593769465|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
164381619|NCT02039505|593769466|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
164381620|NCT02039505|593769467|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
164381621|NCT02039505|593769468|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
164381622|NCT02039505|593769469|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
164381623|NCT02039505|593769470|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
164381624|NCT02039505|593769464|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
164381625|NCT02039505|593769465|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
164381626|NCT02039505|593769466|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
164381627|NCT02039505|593769467|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
164381628|NCT02039505|593769468|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
164381629|NCT02039505|593769469|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
164381630|NCT02039505|593769470|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
164381631|NCT02039505|593769464|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
164381632|NCT02039505|593769465|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
164381633|NCT02039505|593769466|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
164381634|NCT02039505|593769467|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
164381635|NCT02039505|593769468|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
164381636|NCT02039505|593769469|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
164381637|NCT02039505|593769470|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
164381638|NCT02039505|593769464|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
164381639|NCT02039505|593769465|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
164381640|NCT02039505|593769466|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
164381641|NCT02039505|593769467|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
164381642|NCT02039505|593769468|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
164381643|NCT02039505|593769469|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
164381644|NCT02039505|593769470|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
164381645|NCT02039505|593769464|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
164381646|NCT02039505|593769465|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
164381647|NCT02039505|593769466|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
164381648|NCT02039505|593769467|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
164381649|NCT02039505|593769468|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
164381650|NCT02039505|593769469|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
164381651|NCT02039505|593769470|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
164381652|NCT02039505|593769464|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
164381653|NCT02039505|593769465|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
164381654|NCT02039505|593769466|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
164381655|NCT02039505|593769467|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
164381656|NCT02039505|593769468|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
164381657|NCT02039505|593769469|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
164381658|NCT02039505|593769470|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
164381659|NCT02039505|593769464|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
164381660|NCT02039505|593769465|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
164381661|NCT02039505|593769466|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
164381662|NCT02039505|593769467|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
164381663|NCT02039505|593769468|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
164381664|NCT02039505|593769469|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
164381665|NCT02039505|593769470|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
164381666|NCT02039505|593769464|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
164381667|NCT02039505|593769465|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
164381668|NCT02039505|593769466|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
164381669|NCT02039505|593769467|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
164381670|NCT02039505|593769468|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
164381671|NCT02039505|593769469|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
164381672|NCT02039505|593769470|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
164381673|NCT02039505|593769464|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
164381674|NCT02039505|593769465|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
164381675|NCT02039505|593769466|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
164381676|NCT02039505|593769467|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
164381677|NCT02039505|593769468|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
164381678|NCT02039505|593769469|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
164381679|NCT02039505|593769470|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
164381680|NCT01722331|593769471|FG000|Part 1|Adverse Event|5|||
164381681|NCT01722331|593769472|FG001|Part 1|Adverse Event|0|||
164381682|NCT01722331|593769473|FG002|Part 1|Adverse Event|0|||
164381683|NCT01722331|593769474|FG003|Part 1|Adverse Event|0|||
164381684|NCT01722331|593769475|FG004|Part 1|Adverse Event|0|||
164381685|NCT01722331|593769476|FG005|Part 1|Adverse Event|0|||
164381686|NCT01722331|593769477|FG006|Part 1|Adverse Event|0|||
164381687|NCT01722331|593769471|FG000|Part 1|Lack of Efficacy|0|||
164381688|NCT01722331|593769472|FG001|Part 1|Lack of Efficacy|0|||
164381689|NCT01722331|593769473|FG002|Part 1|Lack of Efficacy|1|||
164381690|NCT01722331|593769474|FG003|Part 1|Lack of Efficacy|0|||
164381691|NCT01722331|593769475|FG004|Part 1|Lack of Efficacy|2|||
164381692|NCT01722331|593769476|FG005|Part 1|Lack of Efficacy|0|||
164381693|NCT01722331|593769477|FG006|Part 1|Lack of Efficacy|0|||
164381694|NCT01722331|593769471|FG000|Part 1|Lost to Follow-up|1|||
164381695|NCT01722331|593769472|FG001|Part 1|Lost to Follow-up|0|||
164381696|NCT01722331|593769473|FG002|Part 1|Lost to Follow-up|2|||
164381697|NCT01722331|593769474|FG003|Part 1|Lost to Follow-up|0|||
164381698|NCT01722331|593769475|FG004|Part 1|Lost to Follow-up|1|||
164381699|NCT01722331|593769476|FG005|Part 1|Lost to Follow-up|0|||
164381700|NCT01722331|593769477|FG006|Part 1|Lost to Follow-up|0|||
164381701|NCT01722331|593769471|FG000|Part 1|Physician Decision|0|||
164381702|NCT01722331|593769472|FG001|Part 1|Physician Decision|0|||
164381703|NCT01722331|593769473|FG002|Part 1|Physician Decision|3|||
164381704|NCT01722331|593769474|FG003|Part 1|Physician Decision|0|||
164381705|NCT01722331|593769475|FG004|Part 1|Physician Decision|1|||
164381706|NCT01722331|593769476|FG005|Part 1|Physician Decision|0|||
164381707|NCT01722331|593769477|FG006|Part 1|Physician Decision|0|||
164381708|NCT01722331|593769471|FG000|Part 1|Pregnancy|1|||
164381709|NCT01722331|593769472|FG001|Part 1|Pregnancy|0|||
164381710|NCT01722331|593769473|FG002|Part 1|Pregnancy|0|||
164381711|NCT01722331|593769474|FG003|Part 1|Pregnancy|0|||
164381712|NCT01722331|593769475|FG004|Part 1|Pregnancy|0|||
164381713|NCT01722331|593769476|FG005|Part 1|Pregnancy|0|||
164381714|NCT01722331|593769477|FG006|Part 1|Pregnancy|0|||
164381715|NCT01722331|593769471|FG000|Part 1|Progressive Disease|0|||
164381716|NCT01722331|593769472|FG001|Part 1|Progressive Disease|0|||
164381717|NCT01722331|593769473|FG002|Part 1|Progressive Disease|0|||
164381718|NCT01722331|593769474|FG003|Part 1|Progressive Disease|0|||
164381719|NCT01722331|593769475|FG004|Part 1|Progressive Disease|1|||
164381720|NCT01722331|593769476|FG005|Part 1|Progressive Disease|0|||
164381721|NCT01722331|593769477|FG006|Part 1|Progressive Disease|0|||
164381722|NCT01722331|593769471|FG000|Part 1|Protocol Violation|1|||
164381723|NCT01722331|593769472|FG001|Part 1|Protocol Violation|0|||
164701595|NCT01196078|594932669|FG000|Overall Study|Withdrawal by Subject|3|||
164701596|NCT01196078|594932670|FG001|Overall Study|Withdrawal by Subject|5|||
164381724|NCT01722331|593769473|FG002|Part 1|Protocol Violation|0|||
164381725|NCT01722331|593769474|FG003|Part 1|Protocol Violation|0|||
164381726|NCT01722331|593769475|FG004|Part 1|Protocol Violation|1|||
164381727|NCT01722331|593769476|FG005|Part 1|Protocol Violation|0|||
164381728|NCT01722331|593769477|FG006|Part 1|Protocol Violation|0|||
164381729|NCT01722331|593769471|FG000|Part 1|Withdrawal by Subject|2|||
164701597|NCT01196078|594932669|FG000|Overall Study|Adverse Event|4|||
164701598|NCT01196078|594932670|FG001|Overall Study|Adverse Event|4|||
164701599|NCT01196078|594932669|FG000|Overall Study|Protocol Violation|2|||
164701600|NCT01196078|594932670|FG001|Overall Study|Protocol Violation|1|||
164381730|NCT01722331|593769472|FG001|Part 1|Withdrawal by Subject|0|||
164381731|NCT01722331|593769473|FG002|Part 1|Withdrawal by Subject|3|||
164381732|NCT01722331|593769474|FG003|Part 1|Withdrawal by Subject|0|||
164381733|NCT01722331|593769475|FG004|Part 1|Withdrawal by Subject|3|||
164381734|NCT01722331|593769476|FG005|Part 1|Withdrawal by Subject|0|||
164701601|NCT01196078|594932669|FG000|Overall Study|Lack of Efficacy|17|||
164381735|NCT01722331|593769477|FG006|Part 1|Withdrawal by Subject|0|||
164381736|NCT01722331|593769471|FG000|Part 2|Adverse Event|3|||
164381737|NCT01722331|593769472|FG001|Part 2|Adverse Event|0|||
164381738|NCT01722331|593769473|FG002|Part 2|Adverse Event|0|||
164381739|NCT01722331|593769474|FG003|Part 2|Adverse Event|0|||
164381740|NCT01722331|593769475|FG004|Part 2|Adverse Event|0|||
164381741|NCT01722331|593769476|FG005|Part 2|Adverse Event|1|||
164381742|NCT01722331|593769477|FG006|Part 2|Adverse Event|0|||
164381743|NCT01722331|593769471|FG000|Part 2|Lack of Efficacy|3|||
164381744|NCT01722331|593769472|FG001|Part 2|Lack of Efficacy|0|||
164381745|NCT01722331|593769473|FG002|Part 2|Lack of Efficacy|11|||
164381746|NCT01722331|593769474|FG003|Part 2|Lack of Efficacy|0|||
164381747|NCT01722331|593769475|FG004|Part 2|Lack of Efficacy|0|||
164381748|NCT01722331|593769476|FG005|Part 2|Lack of Efficacy|3|||
164701602|NCT01196078|594932670|FG001|Overall Study|Lack of Efficacy|23|||
164381749|NCT01722331|593769477|FG006|Part 2|Lack of Efficacy|3|||
164381750|NCT01722331|593769471|FG000|Part 2|Lost to Follow-up|0|||
164381751|NCT01722331|593769472|FG001|Part 2|Lost to Follow-up|0|||
164381752|NCT01722331|593769473|FG002|Part 2|Lost to Follow-up|3|||
164381753|NCT01722331|593769474|FG003|Part 2|Lost to Follow-up|0|||
164381754|NCT01722331|593769475|FG004|Part 2|Lost to Follow-up|0|||
164381755|NCT01722331|593769476|FG005|Part 2|Lost to Follow-up|1|||
164381756|NCT01722331|593769477|FG006|Part 2|Lost to Follow-up|1|||
164381757|NCT01722331|593769471|FG000|Part 2|Non-Compliance with Study Drug|1|||
164381758|NCT01722331|593769472|FG001|Part 2|Non-Compliance with Study Drug|0|||
164381759|NCT01722331|593769473|FG002|Part 2|Non-Compliance with Study Drug|1|||
164381760|NCT01722331|593769474|FG003|Part 2|Non-Compliance with Study Drug|0|||
164381761|NCT01722331|593769475|FG004|Part 2|Non-Compliance with Study Drug|0|||
164381762|NCT01722331|593769476|FG005|Part 2|Non-Compliance with Study Drug|0|||
164381763|NCT01722331|593769477|FG006|Part 2|Non-Compliance with Study Drug|0|||
164381764|NCT01722331|593769471|FG000|Part 2|Physician Decision|0|||
164381765|NCT01722331|593769472|FG001|Part 2|Physician Decision|0|||
164381766|NCT01722331|593769473|FG002|Part 2|Physician Decision|2|||
164381767|NCT01722331|593769474|FG003|Part 2|Physician Decision|0|||
164381768|NCT01722331|593769475|FG004|Part 2|Physician Decision|0|||
164381769|NCT01722331|593769476|FG005|Part 2|Physician Decision|0|||
164381770|NCT01722331|593769477|FG006|Part 2|Physician Decision|0|||
164381771|NCT01722331|593769471|FG000|Part 2|Pregnancy|0|||
164381772|NCT01722331|593769472|FG001|Part 2|Pregnancy|0|||
164381773|NCT01722331|593769473|FG002|Part 2|Pregnancy|0|||
164381774|NCT01722331|593769474|FG003|Part 2|Pregnancy|0|||
164381775|NCT01722331|593769475|FG004|Part 2|Pregnancy|0|||
164381776|NCT01722331|593769476|FG005|Part 2|Pregnancy|1|||
164381777|NCT01722331|593769477|FG006|Part 2|Pregnancy|0|||
164381778|NCT01722331|593769471|FG000|Part 2|Progressive Disease|0|||
164381779|NCT01722331|593769472|FG001|Part 2|Progressive Disease|0|||
164381780|NCT01722331|593769473|FG002|Part 2|Progressive Disease|1|||
164381781|NCT01722331|593769474|FG003|Part 2|Progressive Disease|0|||
164381782|NCT01722331|593769475|FG004|Part 2|Progressive Disease|0|||
164381783|NCT01722331|593769476|FG005|Part 2|Progressive Disease|0|||
164381784|NCT01722331|593769477|FG006|Part 2|Progressive Disease|0|||
164381785|NCT01722331|593769471|FG000|Part 2|Protocol Violation|1|||
164381786|NCT01722331|593769472|FG001|Part 2|Protocol Violation|0|||
164381787|NCT01722331|593769473|FG002|Part 2|Protocol Violation|0|||
164381788|NCT01722331|593769474|FG003|Part 2|Protocol Violation|0|||
164381789|NCT01722331|593769475|FG004|Part 2|Protocol Violation|0|||
164381790|NCT01722331|593769476|FG005|Part 2|Protocol Violation|0|||
164381791|NCT01722331|593769477|FG006|Part 2|Protocol Violation|0|||
164381792|NCT01722331|593769471|FG000|Part 2|Withdrawal by Subject|5|||
164381793|NCT01722331|593769472|FG001|Part 2|Withdrawal by Subject|0|||
164381794|NCT01722331|593769473|FG002|Part 2|Withdrawal by Subject|3|||
164381795|NCT01722331|593769474|FG003|Part 2|Withdrawal by Subject|0|||
164381796|NCT01722331|593769475|FG004|Part 2|Withdrawal by Subject|0|||
164381797|NCT01722331|593769476|FG005|Part 2|Withdrawal by Subject|2|||
164381798|NCT01722331|593769477|FG006|Part 2|Withdrawal by Subject|2|||
164381799|NCT01722331|593769471|FG000|Part 2|Other Protocol Specified Criteria|6|||
164381800|NCT01722331|593769472|FG001|Part 2|Other Protocol Specified Criteria|0|||
164381801|NCT01722331|593769473|FG002|Part 2|Other Protocol Specified Criteria|10|||
164381802|NCT01722331|593769474|FG003|Part 2|Other Protocol Specified Criteria|0|||
164381803|NCT01722331|593769475|FG004|Part 2|Other Protocol Specified Criteria|0|||
164381804|NCT01722331|593769476|FG005|Part 2|Other Protocol Specified Criteria|2|||
164381805|NCT01722331|593769477|FG006|Part 2|Other Protocol Specified Criteria|1|||
164381806|NCT01722331|593769471|FG000|Part 3|Adverse Event|2|||
164381807|NCT01722331|593769472|FG001|Part 3|Adverse Event|2|||
164381808|NCT01722331|593769473|FG002|Part 3|Adverse Event|0|||
164381809|NCT01722331|593769474|FG003|Part 3|Adverse Event|1|||
164381810|NCT01722331|593769475|FG004|Part 3|Adverse Event|0|||
164381811|NCT01722331|593769476|FG005|Part 3|Adverse Event|0|||
164381812|NCT01722331|593769477|FG006|Part 3|Adverse Event|0|||
164592363|NCT05113953|594532497|FG001|Overall Study|Adverse Event|0|||
164381813|NCT01722331|593769471|FG000|Part 3|Death|1|||
164381814|NCT01722331|593769472|FG001|Part 3|Death|0|||
164381815|NCT01722331|593769473|FG002|Part 3|Death|0|||
164381816|NCT01722331|593769474|FG003|Part 3|Death|0|||
164381817|NCT01722331|593769475|FG004|Part 3|Death|0|||
164381818|NCT01722331|593769476|FG005|Part 3|Death|0|||
164381819|NCT01722331|593769477|FG006|Part 3|Death|0|||
164381820|NCT01722331|593769471|FG000|Part 3|Lack of Efficacy|1|||
164381821|NCT01722331|593769472|FG001|Part 3|Lack of Efficacy|0|||
164381822|NCT01722331|593769473|FG002|Part 3|Lack of Efficacy|0|||
164381823|NCT01722331|593769474|FG003|Part 3|Lack of Efficacy|0|||
164381824|NCT01722331|593769475|FG004|Part 3|Lack of Efficacy|0|||
164381825|NCT01722331|593769476|FG005|Part 3|Lack of Efficacy|0|||
164381826|NCT01722331|593769477|FG006|Part 3|Lack of Efficacy|0|||
164381827|NCT01722331|593769471|FG000|Part 3|Lost to Follow-up|3|||
164381828|NCT01722331|593769472|FG001|Part 3|Lost to Follow-up|4|||
164381829|NCT01722331|593769473|FG002|Part 3|Lost to Follow-up|0|||
164381830|NCT01722331|593769474|FG003|Part 3|Lost to Follow-up|0|||
164381831|NCT01722331|593769475|FG004|Part 3|Lost to Follow-up|0|||
164381832|NCT01722331|593769476|FG005|Part 3|Lost to Follow-up|1|||
164381833|NCT01722331|593769477|FG006|Part 3|Lost to Follow-up|0|||
164701603|NCT01196078|594932669|FG000|Overall Study|Lost to Follow-up|1|||
164701604|NCT01196078|594932670|FG001|Overall Study|Lost to Follow-up|0|||
164381834|NCT01722331|593769471|FG000|Part 3|Non-Compliance with Study Drug|0|||
164381835|NCT01722331|593769472|FG001|Part 3|Non-Compliance with Study Drug|1|||
164381836|NCT01722331|593769473|FG002|Part 3|Non-Compliance with Study Drug|0|||
164381837|NCT01722331|593769474|FG003|Part 3|Non-Compliance with Study Drug|0|||
164381838|NCT01722331|593769475|FG004|Part 3|Non-Compliance with Study Drug|0|||
164381839|NCT01722331|593769476|FG005|Part 3|Non-Compliance with Study Drug|0|||
164381840|NCT01722331|593769477|FG006|Part 3|Non-Compliance with Study Drug|0|||
164381841|NCT01722331|593769471|FG000|Part 3|Physician Decision|1|||
164381842|NCT01722331|593769472|FG001|Part 3|Physician Decision|1|||
164381843|NCT01722331|593769473|FG002|Part 3|Physician Decision|0|||
164381844|NCT01722331|593769474|FG003|Part 3|Physician Decision|0|||
164381845|NCT01722331|593769475|FG004|Part 3|Physician Decision|0|||
164381846|NCT01722331|593769476|FG005|Part 3|Physician Decision|0|||
164381847|NCT01722331|593769477|FG006|Part 3|Physician Decision|1|||
164381848|NCT01722331|593769471|FG000|Part 3|Protocol Violation|2|||
164381849|NCT01722331|593769472|FG001|Part 3|Protocol Violation|1|||
164381850|NCT01722331|593769473|FG002|Part 3|Protocol Violation|0|||
164381851|NCT01722331|593769474|FG003|Part 3|Protocol Violation|0|||
164381852|NCT01722331|593769475|FG004|Part 3|Protocol Violation|0|||
164381853|NCT01722331|593769476|FG005|Part 3|Protocol Violation|0|||
164381854|NCT01722331|593769477|FG006|Part 3|Protocol Violation|0|||
164381855|NCT01722331|593769471|FG000|Part 3|Withdrawal by Subject|4|||
164381856|NCT01722331|593769472|FG001|Part 3|Withdrawal by Subject|7|||
164381857|NCT01722331|593769473|FG002|Part 3|Withdrawal by Subject|0|||
164381858|NCT01722331|593769474|FG003|Part 3|Withdrawal by Subject|0|||
164381859|NCT01722331|593769475|FG004|Part 3|Withdrawal by Subject|0|||
164381860|NCT01722331|593769476|FG005|Part 3|Withdrawal by Subject|2|||
164381861|NCT01722331|593769477|FG006|Part 3|Withdrawal by Subject|1|||
164381862|NCT01722331|593769471|FG000|Part 3|Other Protocol Specified Criteria|1|||
164381863|NCT01722331|593769472|FG001|Part 3|Other Protocol Specified Criteria|1|||
164381864|NCT01722331|593769473|FG002|Part 3|Other Protocol Specified Criteria|0|||
164381865|NCT01722331|593769474|FG003|Part 3|Other Protocol Specified Criteria|0|||
164381866|NCT01722331|593769475|FG004|Part 3|Other Protocol Specified Criteria|0|||
164381867|NCT01722331|593769476|FG005|Part 3|Other Protocol Specified Criteria|0|||
164381868|NCT01722331|593769477|FG006|Part 3|Other Protocol Specified Criteria|0|||
164381869|NCT04265755|593769480|FG000|Overall Study|Withdrawal by Subject|39|||
164381870|NCT04265755|593769480|FG000|Overall Study|Decision by sponsor|2|||
164381871|NCT04265755|593769480|FG000|Overall Study|Lost to Follow-up|11|||
164381872|NCT04265755|593769480|FG000|Overall Study|Death|1|||
164381873|NCT04067141|593769483|FG000|First Intervention|Withdrawal by Subject|0|||
164381874|NCT04067141|593769484|FG001|First Intervention|Withdrawal by Subject|1|||
164381875|NCT04067141|593769483|FG000|Second Intervention|Adverse Event|0|||
164381876|NCT04067141|593769484|FG001|Second Intervention|Adverse Event|2|||
164381877|NCT02013765|593769487|FG000|Overall Study|Trial was terminated by sponsor|1|||
164381878|NCT02822794|593769489|FG000|Overall Study|Withdrew Consent|1|||
164381879|NCT02822794|593769490|FG001|Overall Study|Withdrew Consent|0|||
164381880|NCT04788147|593769491|FG000|Overall Study|Screen Failure|3|||
164381881|NCT04788147|593769492|FG001|Overall Study|Screen Failure|10|||
164381882|NCT04788147|593769491|FG000|Overall Study|Incomplete RMRS image session|2|||
164381883|NCT04788147|593769492|FG001|Overall Study|Incomplete RMRS image session|0|||
164381884|NCT02266381|593769493|FG000|Overall Study|Physician Decision|3|||
164381885|NCT02266381|593769494|FG001|Overall Study|Physician Decision|5|||
164381886|NCT02266381|593769495|FG002|Overall Study|Physician Decision|4|||
164381887|NCT05101252|593769496|FG000|Overall Study|Unsatisfactory Test Article|1|||
164381888|NCT05101252|593769497|FG001|Overall Study|Unsatisfactory Test Article|0|||
164381889|NCT05101252|593769496|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
164381890|NCT05101252|593769497|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
164381891|NCT05101252|593769496|FG000|Overall Study|Withdrew Consent during study|0|||
164381892|NCT05101252|593769497|FG001|Overall Study|Withdrew Consent during study|1|||
164381893|NCT05101252|593769496|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
164381894|NCT05101252|593769497|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
164381895|NCT02520531|593769504|FG000|Overall Study|Revision of study device components|2|||
164701605|NCT01196078|594932669|FG000|Overall Study|Death|6|||
164701606|NCT01196078|594932670|FG001|Overall Study|Death|4|||
164381896|NCT02520531|593769505|FG001|Overall Study|Revision of study device components|2|||
164381897|NCT02520531|593769504|FG000|Overall Study|Death|1|||
164381898|NCT02520531|593769505|FG001|Overall Study|Death|2|||
164381899|NCT02520531|593769504|FG000|Overall Study|Lost to Follow-up|1|||
164381900|NCT02520531|593769505|FG001|Overall Study|Lost to Follow-up|1|||
164381901|NCT02520531|593769504|FG000|Overall Study|Meet exclusion criterion|0|||
164381902|NCT02520531|593769505|FG001|Overall Study|Meet exclusion criterion|1|||
164381903|NCT02520531|593769504|FG000|Overall Study|Withdrawal by Subject|1|||
164381904|NCT02520531|593769505|FG001|Overall Study|Withdrawal by Subject|0|||
164381905|NCT02520531|593769504|FG000|Overall Study|Not study device|1|||
164381906|NCT02520531|593769505|FG001|Overall Study|Not study device|0|||
164381907|NCT00958880|593769515|FG000|Overall Study|Lost to Follow-up|2|||
164701607|NCT02400671|594932671|FG000|Overall Study|Death|5|||
164381908|NCT00958880|593769516|FG001|Overall Study|Lost to Follow-up|2|||
164381909|NCT02316717|593769519|FG000|Overall Study|Adverse Event|2|||
164381910|NCT02316717|593769520|FG001|Overall Study|Adverse Event|2|||
164381911|NCT02316717|593769521|FG002|Overall Study|Adverse Event|0|||
164381912|NCT02316717|593769519|FG000|Overall Study|Lost to Follow-up|1|||
164381913|NCT02316717|593769520|FG001|Overall Study|Lost to Follow-up|2|||
164381914|NCT02316717|593769521|FG002|Overall Study|Lost to Follow-up|1|||
164381915|NCT02316717|593769519|FG000|Overall Study|Non compliance|3|||
164381916|NCT02316717|593769520|FG001|Overall Study|Non compliance|1|||
164381917|NCT02316717|593769521|FG002|Overall Study|Non compliance|0|||
164381918|NCT02316717|593769519|FG000|Overall Study|Protocol Violation|2|||
164381919|NCT02316717|593769520|FG001|Overall Study|Protocol Violation|0|||
164381920|NCT02316717|593769521|FG002|Overall Study|Protocol Violation|0|||
164381921|NCT02316717|593769519|FG000|Overall Study|Withdrawal by Subject|2|||
164381922|NCT02316717|593769520|FG001|Overall Study|Withdrawal by Subject|1|||
164381923|NCT02316717|593769521|FG002|Overall Study|Withdrawal by Subject|1|||
164381924|NCT02316717|593769519|FG000|Overall Study|Death|0|||
164381925|NCT02316717|593769520|FG001|Overall Study|Death|0|||
164381926|NCT02316717|593769521|FG002|Overall Study|Death|1|||
164381927|NCT02316717|593769519|FG000|Overall Study|Physician Decision|0|||
164381928|NCT02316717|593769520|FG001|Overall Study|Physician Decision|1|||
164381929|NCT02316717|593769521|FG002|Overall Study|Physician Decision|0|||
164381930|NCT02316717|593769519|FG000|Overall Study|TBC|1|||
164381931|NCT02316717|593769520|FG001|Overall Study|TBC|0|||
164381932|NCT02316717|593769521|FG002|Overall Study|TBC|0|||
164381933|NCT00298831|593769522|FG000|Overall Study|Adverse Event|1|||
164381934|NCT00298831|593769522|FG000|Overall Study|Lost to Follow-up|3|||
164381935|NCT00298831|593769522|FG000|Overall Study|Withdrawal by Subject|1|||
164381936|NCT00298831|593769522|FG000|Overall Study|Participants did not receive treatment|27|||
164381937|NCT01516879|593769523|FG000|Overall Study|Withdrawal by Subject|9|||
164381938|NCT01516879|593769524|FG001|Overall Study|Withdrawal by Subject|11|||
164381939|NCT01516879|593769523|FG000|Overall Study|Death|0|||
164381940|NCT01516879|593769524|FG001|Overall Study|Death|2|||
164381941|NCT01516879|593769523|FG000|Overall Study|Lost to Follow-up|2|||
164381942|NCT01516879|593769524|FG001|Overall Study|Lost to Follow-up|11|||
164381943|NCT01516879|593769523|FG000|Overall Study|Other|5|||
164381944|NCT01516879|593769524|FG001|Overall Study|Other|10|||
164381945|NCT04568122|593769525|FG000|Overall Study|Lost to Follow-up|48|||
164381946|NCT04568122|593769526|FG001|Overall Study|Lost to Follow-up|44|||
164381947|NCT04568122|593769527|FG002|Overall Study|Lost to Follow-up|4|||
164381948|NCT04568122|593769528|FG003|Overall Study|Lost to Follow-up|0|||
164381949|NCT04568122|593769529|FG004|Overall Study|Lost to Follow-up|0|||
164381950|NCT02460224|593769535|FG000|Overall Study|Adverse Event|0|||
164381951|NCT02460224|593769536|FG001|Overall Study|Adverse Event|0|||
164381952|NCT02460224|593769537|FG002|Overall Study|Adverse Event|0|||
164381953|NCT02460224|593769538|FG003|Overall Study|Adverse Event|0|||
164381954|NCT02460224|593769539|FG004|Overall Study|Adverse Event|0|||
164381955|NCT02460224|593769540|FG005|Overall Study|Adverse Event|0|||
164381956|NCT02460224|593769541|FG006|Overall Study|Adverse Event|1|||
164381957|NCT02460224|593769542|FG007|Overall Study|Adverse Event|0|||
164381958|NCT02460224|593769543|FG008|Overall Study|Adverse Event|0|||
164381959|NCT02460224|593769544|FG009|Overall Study|Adverse Event|0|||
164381960|NCT02460224|593769545|FG010|Overall Study|Adverse Event|0|||
164381961|NCT02460224|593769546|FG011|Overall Study|Adverse Event|0|||
164381962|NCT02460224|593769547|FG012|Overall Study|Adverse Event|1|||
164381963|NCT02460224|593769548|FG013|Overall Study|Adverse Event|0|||
164381964|NCT02460224|593769549|FG014|Overall Study|Adverse Event|0|||
164381965|NCT02460224|593769550|FG015|Overall Study|Adverse Event|0|||
164381966|NCT02460224|593769551|FG016|Overall Study|Adverse Event|1|||
164381967|NCT02460224|593769552|FG017|Overall Study|Adverse Event|0|||
164381968|NCT02460224|593769553|FG018|Overall Study|Adverse Event|1|||
164381969|NCT02460224|593769554|FG019|Overall Study|Adverse Event|0|||
164381970|NCT02460224|593769555|FG020|Overall Study|Adverse Event|1|||
164381971|NCT02460224|593769556|FG021|Overall Study|Adverse Event|1|||
164381972|NCT02460224|593769557|FG022|Overall Study|Adverse Event|1|||
164381973|NCT02460224|593769558|FG023|Overall Study|Adverse Event|0|||
164381974|NCT02460224|593769559|FG024|Overall Study|Adverse Event|0|||
164381975|NCT02460224|593769560|FG025|Overall Study|Adverse Event|0|||
164381976|NCT02460224|593769561|FG026|Overall Study|Adverse Event|11|||
164381977|NCT02460224|593769562|FG027|Overall Study|Adverse Event|1|||
164381978|NCT02460224|593769563|FG028|Overall Study|Adverse Event|6|||
164381979|NCT02460224|593769535|FG000|Overall Study|Death|0|||
164381980|NCT02460224|593769536|FG001|Overall Study|Death|0|||
164381981|NCT02460224|593769537|FG002|Overall Study|Death|0|||
164381982|NCT02460224|593769538|FG003|Overall Study|Death|0|||
164701608|NCT02400671|594932672|FG001|Overall Study|Death|3|||
164381983|NCT02460224|593769539|FG004|Overall Study|Death|0|||
164381984|NCT02460224|593769540|FG005|Overall Study|Death|2|||
164381985|NCT02460224|593769541|FG006|Overall Study|Death|1|||
164381986|NCT02460224|593769542|FG007|Overall Study|Death|0|||
164381987|NCT02460224|593769543|FG008|Overall Study|Death|0|||
164381988|NCT02460224|593769544|FG009|Overall Study|Death|1|||
164439893|NCT00430300|593977285|FG003|Overall Study|Withdrawal by Subject|0|||
164439894|NCT00430300|593977282|FG000|Overall Study|Laboratory abnormality|1|||
164439895|NCT00430300|593977283|FG001|Overall Study|Laboratory abnormality|0|||
164439896|NCT00430300|593977284|FG002|Overall Study|Laboratory abnormality|0|||
164439897|NCT00430300|593977285|FG003|Overall Study|Laboratory abnormality|0|||
164439898|NCT00430300|593977282|FG000|Overall Study|Other|0|||
164439899|NCT00430300|593977283|FG001|Overall Study|Other|0|||
164439900|NCT00430300|593977284|FG002|Overall Study|Other|0|||
164439901|NCT00430300|593977285|FG003|Overall Study|Other|1|||
164439902|NCT02754479|593977286|FG000|Overall Study|Lost to Follow-up|1|||
164439903|NCT02041104|593977289|FG000|Overall Study|Lost to Follow-up|1|||
164439904|NCT02041104|593977290|FG001|Overall Study|Lost to Follow-up|4|||
164439905|NCT02041104|593977289|FG000|Overall Study|discomfort during OGTT|0|||
164439906|NCT02041104|593977290|FG001|Overall Study|discomfort during OGTT|3|||
164439907|NCT03183518|593977291|FG000|Overall Study|Other (Not specified)|2|||
164439908|NCT03183518|593977291|FG000|Overall Study|Other (Withdrawal of consent)|1|||
164439909|NCT02132702|593977292|FG000|Overall Study|Protocol Violation|2|||
164439910|NCT02132702|593977292|FG000|Overall Study|Adverse Event|3|||
164439911|NCT02132702|593977292|FG000|Overall Study|Withdrawal by Subject|3|||
164439912|NCT01244828|593977295|FG000|Overall Study|Adverse Event|37|||
164701609|NCT02400671|594932673|FG002|Overall Study|Death|4|||
164701610|NCT02400671|594932671|FG000|Overall Study|Lost to Follow-up|20|||
164439913|NCT01244828|593977295|FG000|Overall Study|Withdrawal by Subject|31|||
164439914|NCT01244828|593977295|FG000|Overall Study|Lack of Efficacy|7|||
164439915|NCT01244828|593977295|FG000|Overall Study|Lost to Follow-up|2|||
164439916|NCT01244828|593977295|FG000|Overall Study|Other reason (not specified)|1|||
164439917|NCT00573833|593977296|FG000|Overall Study|Not Treated|2|||
164439918|NCT05052983|593977297|FG000|Overall Study|Lack of Efficacy|3|||
164439919|NCT05052983|593977298|FG001|Overall Study|Lack of Efficacy|12|||
164439920|NCT05052983|593977297|FG000|Overall Study|Adverse Event|1|||
164701611|NCT02400671|594932672|FG001|Overall Study|Lost to Follow-up|27|||
164701612|NCT02400671|594932673|FG002|Overall Study|Lost to Follow-up|24|||
164701613|NCT02400671|594932671|FG000|Overall Study|Withdrawal by Subject|2|||
164701614|NCT02400671|594932672|FG001|Overall Study|Withdrawal by Subject|2|||
164381989|NCT02460224|593769545|FG010|Overall Study|Death|0|||
164381990|NCT02460224|593769546|FG011|Overall Study|Death|0|||
164381991|NCT02460224|593769547|FG012|Overall Study|Death|0|||
164381992|NCT02460224|593769548|FG013|Overall Study|Death|1|||
164381993|NCT02460224|593769549|FG014|Overall Study|Death|0|||
164381994|NCT02460224|593769550|FG015|Overall Study|Death|0|||
164381995|NCT02460224|593769551|FG016|Overall Study|Death|2|||
164381996|NCT02460224|593769552|FG017|Overall Study|Death|1|||
164381997|NCT02460224|593769553|FG018|Overall Study|Death|0|||
164381998|NCT02460224|593769554|FG019|Overall Study|Death|2|||
164381999|NCT02460224|593769555|FG020|Overall Study|Death|0|||
164382000|NCT02460224|593769556|FG021|Overall Study|Death|0|||
164382001|NCT02460224|593769557|FG022|Overall Study|Death|0|||
164382002|NCT02460224|593769558|FG023|Overall Study|Death|0|||
164382003|NCT02460224|593769559|FG024|Overall Study|Death|1|||
164382004|NCT02460224|593769560|FG025|Overall Study|Death|1|||
164382005|NCT02460224|593769561|FG026|Overall Study|Death|5|||
164382006|NCT02460224|593769562|FG027|Overall Study|Death|0|||
164382007|NCT02460224|593769563|FG028|Overall Study|Death|1|||
164382008|NCT02460224|593769535|FG000|Overall Study|Lost to Follow-up|0|||
164382009|NCT02460224|593769536|FG001|Overall Study|Lost to Follow-up|0|||
164382010|NCT02460224|593769537|FG002|Overall Study|Lost to Follow-up|0|||
164382011|NCT02460224|593769538|FG003|Overall Study|Lost to Follow-up|0|||
164382012|NCT02460224|593769539|FG004|Overall Study|Lost to Follow-up|0|||
164382013|NCT02460224|593769540|FG005|Overall Study|Lost to Follow-up|0|||
164382014|NCT02460224|593769541|FG006|Overall Study|Lost to Follow-up|0|||
164382015|NCT02460224|593769542|FG007|Overall Study|Lost to Follow-up|0|||
164382016|NCT02460224|593769543|FG008|Overall Study|Lost to Follow-up|0|||
164382017|NCT02460224|593769544|FG009|Overall Study|Lost to Follow-up|0|||
164382018|NCT02460224|593769545|FG010|Overall Study|Lost to Follow-up|0|||
164382019|NCT02460224|593769546|FG011|Overall Study|Lost to Follow-up|0|||
164382020|NCT02460224|593769547|FG012|Overall Study|Lost to Follow-up|0|||
164382021|NCT02460224|593769548|FG013|Overall Study|Lost to Follow-up|0|||
164382022|NCT02460224|593769549|FG014|Overall Study|Lost to Follow-up|0|||
164382023|NCT02460224|593769550|FG015|Overall Study|Lost to Follow-up|0|||
164382024|NCT02460224|593769551|FG016|Overall Study|Lost to Follow-up|0|||
164382025|NCT02460224|593769552|FG017|Overall Study|Lost to Follow-up|0|||
164382026|NCT02460224|593769553|FG018|Overall Study|Lost to Follow-up|0|||
164382027|NCT02460224|593769554|FG019|Overall Study|Lost to Follow-up|0|||
164382028|NCT02460224|593769555|FG020|Overall Study|Lost to Follow-up|0|||
164382029|NCT02460224|593769556|FG021|Overall Study|Lost to Follow-up|0|||
164439921|NCT05052983|593977298|FG001|Overall Study|Adverse Event|0|||
164439922|NCT04493242|593977299|FG000|Overall Study|Death|10|||
164439923|NCT04493242|593977300|FG001|Overall Study|Death|14|||
164439924|NCT04493242|593977301|FG002|Overall Study|Death|16|||
164439925|NCT04493242|593977299|FG000|Overall Study|Lost to Follow-up|1|||
164439926|NCT04493242|593977300|FG001|Overall Study|Lost to Follow-up|1|||
164439927|NCT04493242|593977301|FG002|Overall Study|Lost to Follow-up|0|||
164382030|NCT02460224|593769557|FG022|Overall Study|Lost to Follow-up|1|||
164382031|NCT02460224|593769558|FG023|Overall Study|Lost to Follow-up|0|||
164382032|NCT02460224|593769559|FG024|Overall Study|Lost to Follow-up|0|||
164382033|NCT02460224|593769560|FG025|Overall Study|Lost to Follow-up|0|||
164382034|NCT02460224|593769561|FG026|Overall Study|Lost to Follow-up|0|||
164382035|NCT02460224|593769562|FG027|Overall Study|Lost to Follow-up|0|||
164382036|NCT02460224|593769563|FG028|Overall Study|Lost to Follow-up|0|||
164382037|NCT02460224|593769535|FG000|Overall Study|Physician Decision|0|||
164382038|NCT02460224|593769536|FG001|Overall Study|Physician Decision|1|||
164382039|NCT02460224|593769537|FG002|Overall Study|Physician Decision|0|||
164382040|NCT02460224|593769538|FG003|Overall Study|Physician Decision|0|||
164382041|NCT02460224|593769539|FG004|Overall Study|Physician Decision|1|||
164382042|NCT02460224|593769540|FG005|Overall Study|Physician Decision|0|||
164382043|NCT02460224|593769541|FG006|Overall Study|Physician Decision|0|||
164382044|NCT02460224|593769542|FG007|Overall Study|Physician Decision|1|||
164382045|NCT02460224|593769543|FG008|Overall Study|Physician Decision|0|||
164382046|NCT02460224|593769544|FG009|Overall Study|Physician Decision|0|||
164382047|NCT02460224|593769545|FG010|Overall Study|Physician Decision|0|||
164592364|NCT05113953|594532498|FG002|Overall Study|Adverse Event|3|||
164592365|NCT05113953|594532496|FG000|Overall Study|Lost to Follow-up|3|||
164382048|NCT02460224|593769546|FG011|Overall Study|Physician Decision|1|||
164382049|NCT02460224|593769547|FG012|Overall Study|Physician Decision|0|||
164382050|NCT02460224|593769548|FG013|Overall Study|Physician Decision|1|||
164382051|NCT02460224|593769549|FG014|Overall Study|Physician Decision|0|||
164382052|NCT02460224|593769550|FG015|Overall Study|Physician Decision|0|||
164382053|NCT02460224|593769551|FG016|Overall Study|Physician Decision|2|||
164382054|NCT02460224|593769552|FG017|Overall Study|Physician Decision|1|||
164382055|NCT02460224|593769553|FG018|Overall Study|Physician Decision|1|||
164382056|NCT02460224|593769554|FG019|Overall Study|Physician Decision|2|||
164382057|NCT02460224|593769555|FG020|Overall Study|Physician Decision|1|||
164382058|NCT02460224|593769556|FG021|Overall Study|Physician Decision|1|||
164382059|NCT02460224|593769557|FG022|Overall Study|Physician Decision|0|||
164382060|NCT02460224|593769558|FG023|Overall Study|Physician Decision|0|||
164382061|NCT02460224|593769559|FG024|Overall Study|Physician Decision|1|||
164382062|NCT02460224|593769560|FG025|Overall Study|Physician Decision|0|||
164382063|NCT02460224|593769561|FG026|Overall Study|Physician Decision|14|||
164382064|NCT02460224|593769562|FG027|Overall Study|Physician Decision|1|||
164382065|NCT02460224|593769563|FG028|Overall Study|Physician Decision|6|||
164382066|NCT02460224|593769535|FG000|Overall Study|Progressive disease|15|||
164382067|NCT02460224|593769536|FG001|Overall Study|Progressive disease|11|||
164382068|NCT02460224|593769537|FG002|Overall Study|Progressive disease|5|||
164382069|NCT02460224|593769538|FG003|Overall Study|Progressive disease|6|||
164382070|NCT02460224|593769539|FG004|Overall Study|Progressive disease|3|||
164382071|NCT02460224|593769540|FG005|Overall Study|Progressive disease|26|||
164382072|NCT02460224|593769541|FG006|Overall Study|Progressive disease|28|||
164382073|NCT02460224|593769542|FG007|Overall Study|Progressive disease|4|||
164382074|NCT02460224|593769543|FG008|Overall Study|Progressive disease|5|||
164382075|NCT02460224|593769544|FG009|Overall Study|Progressive disease|9|||
164382076|NCT02460224|593769545|FG010|Overall Study|Progressive disease|5|||
164382077|NCT02460224|593769546|FG011|Overall Study|Progressive disease|4|||
164382078|NCT02460224|593769547|FG012|Overall Study|Progressive disease|5|||
164382079|NCT02460224|593769548|FG013|Overall Study|Progressive disease|4|||
164382080|NCT02460224|593769549|FG014|Overall Study|Progressive disease|5|||
164382081|NCT02460224|593769550|FG015|Overall Study|Progressive disease|5|||
164382082|NCT02460224|593769551|FG016|Overall Study|Progressive disease|15|||
164382083|NCT02460224|593769552|FG017|Overall Study|Progressive disease|3|||
164382084|NCT02460224|593769553|FG018|Overall Study|Progressive disease|8|||
164382085|NCT02460224|593769554|FG019|Overall Study|Progressive disease|3|||
164382086|NCT02460224|593769555|FG020|Overall Study|Progressive disease|4|||
164382087|NCT02460224|593769556|FG021|Overall Study|Progressive disease|9|||
164382088|NCT02460224|593769557|FG022|Overall Study|Progressive disease|4|||
164382089|NCT02460224|593769558|FG023|Overall Study|Progressive disease|11|||
164592366|NCT05113953|594532497|FG001|Overall Study|Lost to Follow-up|4|||
164382090|NCT02460224|593769559|FG024|Overall Study|Progressive disease|4|||
164382091|NCT02460224|593769560|FG025|Overall Study|Progressive disease|5|||
164382092|NCT02460224|593769561|FG026|Overall Study|Progressive disease|85|||
164382093|NCT02460224|593769562|FG027|Overall Study|Progressive disease|17|||
164382094|NCT02460224|593769563|FG028|Overall Study|Progressive disease|77|||
164382095|NCT02460224|593769535|FG000|Overall Study|Subject/guardian decision|2|||
164382096|NCT02460224|593769536|FG001|Overall Study|Subject/guardian decision|0|||
164382097|NCT02460224|593769537|FG002|Overall Study|Subject/guardian decision|1|||
164382098|NCT02460224|593769538|FG003|Overall Study|Subject/guardian decision|0|||
164382099|NCT02460224|593769539|FG004|Overall Study|Subject/guardian decision|2|||
164382100|NCT02460224|593769540|FG005|Overall Study|Subject/guardian decision|2|||
164382101|NCT02460224|593769541|FG006|Overall Study|Subject/guardian decision|0|||
164592367|NCT05113953|594532498|FG002|Overall Study|Lost to Follow-up|2|||
164382102|NCT02460224|593769542|FG007|Overall Study|Subject/guardian decision|0|||
164382103|NCT02460224|593769543|FG008|Overall Study|Subject/guardian decision|1|||
164382104|NCT02460224|593769544|FG009|Overall Study|Subject/guardian decision|1|||
164382105|NCT02460224|593769545|FG010|Overall Study|Subject/guardian decision|0|||
164382106|NCT02460224|593769546|FG011|Overall Study|Subject/guardian decision|1|||
164382107|NCT02460224|593769547|FG012|Overall Study|Subject/guardian decision|0|||
164382108|NCT02460224|593769548|FG013|Overall Study|Subject/guardian decision|0|||
164382109|NCT02460224|593769549|FG014|Overall Study|Subject/guardian decision|0|||
164382110|NCT02460224|593769550|FG015|Overall Study|Subject/guardian decision|1|||
164382111|NCT02460224|593769551|FG016|Overall Study|Subject/guardian decision|0|||
164382112|NCT02460224|593769552|FG017|Overall Study|Subject/guardian decision|1|||
164382113|NCT02460224|593769553|FG018|Overall Study|Subject/guardian decision|2|||
164382114|NCT02460224|593769554|FG019|Overall Study|Subject/guardian decision|0|||
164382115|NCT02460224|593769555|FG020|Overall Study|Subject/guardian decision|0|||
164382116|NCT02460224|593769556|FG021|Overall Study|Subject/guardian decision|1|||
164382117|NCT02460224|593769557|FG022|Overall Study|Subject/guardian decision|0|||
164382118|NCT02460224|593769558|FG023|Overall Study|Subject/guardian decision|0|||
164382119|NCT02460224|593769559|FG024|Overall Study|Subject/guardian decision|0|||
164382120|NCT02460224|593769560|FG025|Overall Study|Subject/guardian decision|0|||
164382121|NCT02460224|593769561|FG026|Overall Study|Subject/guardian decision|6|||
164382122|NCT02460224|593769562|FG027|Overall Study|Subject/guardian decision|2|||
164382123|NCT02460224|593769563|FG028|Overall Study|Subject/guardian decision|3|||
164382124|NCT01916304|593769564|FG000|Overall Study|Screening failure|17|||
164382125|NCT02774681|593769571|FG000|Treatment on Study|Progressive Disease|7|||
164382126|NCT02774681|593769571|FG000|Follow-Up for 3 Years|Death|11|||
164382127|NCT02774681|593769571|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
164382128|NCT03146650|593769576|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
164382129|NCT03146650|593769576|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
164382130|NCT03146650|593769576|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
164382131|NCT03146650|593769576|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
164382132|NCT03146650|593769576|FG000|2 Year Follow-up|Death|11|||
164382133|NCT03146650|593769576|FG000|2 Year Follow-up|Still in follow-up|7|||
164382134|NCT03146650|593769576|FG000|2 Year Follow-up|Lost to Follow-up|1|||
164382135|NCT00931307|593769577|FG000|Overall Study|Lack of Efficacy|12|||
164382136|NCT00931307|593769577|FG000|Overall Study|Biomicroscopy|1|||
164382137|NCT04666441|593769578|FG000|Overall Study|Lost to Follow-up|1|||
164382138|NCT04666441|593769579|FG001|Overall Study|Lost to Follow-up|4|||
164382139|NCT04666441|593769580|FG002|Overall Study|Lost to Follow-up|1|||
164382140|NCT04666441|593769581|FG003|Overall Study|Lost to Follow-up|3|||
164382141|NCT04666441|593769582|FG004|Overall Study|Lost to Follow-up|0|||
164382142|NCT04666441|593769583|FG005|Overall Study|Lost to Follow-up|2|||
164382143|NCT04666441|593769584|FG006|Overall Study|Lost to Follow-up|2|||
164382144|NCT04666441|593769585|FG007|Overall Study|Lost to Follow-up|2|||
164382145|NCT04666441|593769578|FG000|Overall Study|Subject Decision|1|||
164382146|NCT04666441|593769579|FG001|Overall Study|Subject Decision|1|||
164382147|NCT04666441|593769580|FG002|Overall Study|Subject Decision|3|||
164382148|NCT04666441|593769581|FG003|Overall Study|Subject Decision|1|||
164382149|NCT04666441|593769582|FG004|Overall Study|Subject Decision|0|||
164382150|NCT04666441|593769583|FG005|Overall Study|Subject Decision|1|||
164382151|NCT04666441|593769584|FG006|Overall Study|Subject Decision|3|||
164382152|NCT04666441|593769585|FG007|Overall Study|Subject Decision|2|||
164382153|NCT00813761|593769586|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
164382154|NCT00813761|593769587|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
164382155|NCT00813761|593769588|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
164382156|NCT00813761|593769589|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
164382157|NCT00813761|593769586|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
164382158|NCT00813761|593769587|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
164382159|NCT00813761|593769588|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
164382160|NCT00813761|593769589|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
164382161|NCT00813761|593769586|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
164382162|NCT00813761|593769587|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
164382163|NCT00813761|593769588|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
164382164|NCT00813761|593769589|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
164382165|NCT00813761|593769586|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
164382166|NCT00813761|593769587|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
164382167|NCT00813761|593769588|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
164382168|NCT00813761|593769589|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
164382169|NCT00813761|593769586|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
164382170|NCT00813761|593769587|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
164382171|NCT00813761|593769588|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
164382172|NCT00813761|593769589|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
164382173|NCT00813761|593769586|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
164382174|NCT00813761|593769587|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
164382175|NCT00813761|593769588|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
164382176|NCT00813761|593769589|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
164382177|NCT00813761|593769586|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
164382178|NCT00813761|593769587|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
164439928|NCT04493242|593977299|FG000|Overall Study|Withdrawal by Subject|1|||
164382179|NCT00813761|593769588|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
164382180|NCT00813761|593769589|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
164382181|NCT00813761|593769586|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
164382182|NCT00813761|593769587|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
164382183|NCT00813761|593769588|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
164382184|NCT00813761|593769589|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
164382185|NCT00813761|593769586|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
164382186|NCT00813761|593769587|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
164382187|NCT00813761|593769588|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
164382188|NCT00813761|593769589|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
164382189|NCT00813761|593769586|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
164382190|NCT00813761|593769587|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
164382191|NCT00813761|593769588|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
164382192|NCT00813761|593769589|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
164382193|NCT00813761|593769586|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
164382194|NCT00813761|593769587|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
164382195|NCT00813761|593769588|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
164382196|NCT00813761|593769589|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
164382197|NCT00813761|593769586|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
164382198|NCT00813761|593769587|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
164382199|NCT00813761|593769588|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
164382200|NCT00813761|593769589|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
164382201|NCT02047604|593769594|FG000|Overall Study|Withdrawal by Subject|0|||
164382202|NCT02047604|593769595|FG001|Overall Study|Withdrawal by Subject|0|||
164382203|NCT02047604|593769596|FG002|Overall Study|Withdrawal by Subject|0|||
164382204|NCT02047604|593769597|FG003|Overall Study|Withdrawal by Subject|0|||
164382205|NCT02047604|593769598|FG004|Overall Study|Withdrawal by Subject|1|||
164382206|NCT02047604|593769599|FG005|Overall Study|Withdrawal by Subject|1|||
164382207|NCT00983814|593769600|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
164382208|NCT00983814|593769601|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
164382209|NCT00983814|593769602|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
164382210|NCT00983814|593769600|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
164382211|NCT00983814|593769601|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
164382212|NCT00983814|593769602|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
164382213|NCT00983814|593769600|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
164382214|NCT00983814|593769601|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
164382215|NCT00983814|593769602|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
164382216|NCT00983814|593769600|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
164382217|NCT00983814|593769601|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
164382218|NCT00983814|593769602|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
164382219|NCT00983814|593769600|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
164382220|NCT00983814|593769601|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
164382221|NCT00983814|593769602|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
164382222|NCT01181895|593769603|FG000|Overall Study|Adverse Event|3|||
164382223|NCT01181895|593769604|FG001|Overall Study|Adverse Event|1|||
164382224|NCT01181895|593769605|FG002|Overall Study|Adverse Event|1|||
164382225|NCT01181895|593769603|FG000|Overall Study|Lack of Efficacy|8|||
164382226|NCT01181895|593769604|FG001|Overall Study|Lack of Efficacy|9|||
164382227|NCT01181895|593769605|FG002|Overall Study|Lack of Efficacy|9|||
164382228|NCT01181895|593769603|FG000|Overall Study|Protocol Violation|2|||
164382229|NCT01181895|593769604|FG001|Overall Study|Protocol Violation|1|||
164382230|NCT01181895|593769605|FG002|Overall Study|Protocol Violation|0|||
164382231|NCT01181895|593769603|FG000|Overall Study|Lost to Follow-up|0|||
164382232|NCT01181895|593769604|FG001|Overall Study|Lost to Follow-up|1|||
164382233|NCT01181895|593769605|FG002|Overall Study|Lost to Follow-up|2|||
164382234|NCT01181895|593769603|FG000|Overall Study|Investigator Discretion|1|||
164382235|NCT01181895|593769604|FG001|Overall Study|Investigator Discretion|2|||
164382236|NCT01181895|593769605|FG002|Overall Study|Investigator Discretion|1|||
164382237|NCT01181895|593769603|FG000|Overall Study|Withdrawal by Subject|3|||
164382238|NCT01181895|593769604|FG001|Overall Study|Withdrawal by Subject|0|||
164382239|NCT01181895|593769605|FG002|Overall Study|Withdrawal by Subject|5|||
164382240|NCT00555438|593769606|FG000|10 Days Post-operative|Death|4|||
164382241|NCT00555438|593769606|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
164382242|NCT00766415|593769607|FG000|Overall Study|Withdrawal by Subject|0|||
164382243|NCT00766415|593769608|FG001|Overall Study|Withdrawal by Subject|1|||
164382244|NCT01114516|593769609|FG000|Overall Study|Lost to Follow-up|2|||
164382245|NCT01114516|593769610|FG001|Overall Study|Lost to Follow-up|1|||
164382246|NCT03136068|593771130|FG000|Overall Study|Lost to Follow-up|1|||
164382247|NCT03136068|593771131|FG001|Overall Study|Lost to Follow-up|1|||
164382248|NCT03136068|593771130|FG000|Overall Study|Protocol Violation|1|||
164382249|NCT03136068|593771131|FG001|Overall Study|Protocol Violation|0|||
164382250|NCT00432380|593771132|FG000|Overall Study|Migrated/moved from study area|3|||
164382251|NCT00432380|593771133|FG001|Overall Study|Migrated/moved from study area|4|||
164382252|NCT00432380|593771134|FG002|Overall Study|Migrated/moved from study area|1|||
164382253|NCT00432380|593771132|FG000|Overall Study|Adverse Event|1|||
164382254|NCT00432380|593771133|FG001|Overall Study|Adverse Event|0|||
164382255|NCT00432380|593771134|FG002|Overall Study|Adverse Event|0|||
164382256|NCT01071395|593771135|FG000|Overall Study|Withdrawal by Subject|2|||
164382257|NCT01071395|593771136|FG001|Overall Study|Withdrawal by Subject|1|||
164382258|NCT01071395|593771135|FG000|Overall Study|Adverse Event|3|||
164382259|NCT01071395|593771136|FG001|Overall Study|Adverse Event|1|||
164382260|NCT04419493|593771137|FG000|Wash-out After Period 1|Adverse Event|1|||
164382261|NCT04419493|593771138|FG001|Wash-out After Period 1|Adverse Event|2|||
164382262|NCT04419493|593771139|FG002|Wash-out After Period 1|Adverse Event|1|||
164382263|NCT04419493|593771140|FG003|Wash-out After Period 1|Adverse Event|0|||
164382264|NCT00524134|593771141|FG000|Overall Study|Withdrawal by Subject|1|||
164382265|NCT00524134|593771141|FG000|Overall Study|Physician Decision|1|||
164382266|NCT03794089|593771142|FG000|Overall Study|Lost to Follow-up|4|||
164382267|NCT03794089|593771143|FG001|Overall Study|Lost to Follow-up|1|||
164382268|NCT03794089|593771142|FG000|Overall Study|Withdrawal by Subject|2|||
164382269|NCT03794089|593771143|FG001|Overall Study|Withdrawal by Subject|0|||
164382270|NCT03985423|593771144|FG000|Overall Study|Adverse Event|1|||
164382271|NCT03985423|593771144|FG000|Overall Study|Death|2|||
164382272|NCT03985423|593771144|FG000|Overall Study|Physician Decision|1|||
164382273|NCT03985423|593771144|FG000|Overall Study|Withdrawal by Subject|2|||
164382274|NCT03985423|593771144|FG000|Overall Study|Lack of insurance and citizenship|1|||
164382275|NCT01045447|593771155|FG000|Overall Study|Adverse Event|0|||
164382276|NCT01045447|593771156|FG001|Overall Study|Adverse Event|1|||
164382277|NCT01045447|593771155|FG000|Overall Study|Lack of Efficacy|3|||
164382278|NCT01045447|593771156|FG001|Overall Study|Lack of Efficacy|1|||
164382279|NCT01045447|593771155|FG000|Overall Study|Protocol Violation|6|||
164382280|NCT01045447|593771156|FG001|Overall Study|Protocol Violation|3|||
164382281|NCT01045447|593771155|FG000|Overall Study|Withdrawal Criteria|10|||
164382282|NCT01045447|593771156|FG001|Overall Study|Withdrawal Criteria|10|||
164382283|NCT01045447|593771155|FG000|Overall Study|Unclassified|17|||
164382284|NCT01045447|593771156|FG001|Overall Study|Unclassified|13|||
164382285|NCT01782131|593771160|FG000|Overall Study|Death|93|||
164382286|NCT01782131|593771161|FG001|Overall Study|Death|96|||
164382287|NCT01782131|593771160|FG000|Overall Study|Lost to Follow-up|1|||
164382288|NCT01782131|593771161|FG001|Overall Study|Lost to Follow-up|3|||
164382289|NCT01782131|593771160|FG000|Overall Study|Withdrawal by Subject|10|||
164382290|NCT01782131|593771161|FG001|Overall Study|Withdrawal by Subject|10|||
164382291|NCT01782131|593771160|FG000|Overall Study|Randomized but not treated|5|||
164382292|NCT01782131|593771161|FG001|Overall Study|Randomized but not treated|5|||
164382293|NCT01782131|593771160|FG000|Overall Study|Reason not provided|0|||
164382294|NCT01782131|593771161|FG001|Overall Study|Reason not provided|1|||
164382295|NCT00796718|593771162|FG000|Overall Study|Adverse Event|2|||
164382296|NCT00796718|593771162|FG000|Overall Study|Exclusion Criteria|1|||
164382297|NCT00796718|593771162|FG000|Overall Study|Lost to Follow-up|5|||
164382298|NCT00796718|593771162|FG000|Overall Study|Withdrawal by Informed Consent|1|||
164382299|NCT01073618|593771163|FG000|Overall Study|Death|208|||
164382300|NCT01073618|593771163|FG000|Overall Study|Adverse Event|19|||
164382301|NCT01073618|593771163|FG000|Overall Study|Other|80|||
164382302|NCT00353704|593771175|FG000|Overall Study|Protocol Violation|3|||
164382303|NCT00353704|593771176|FG001|Overall Study|Protocol Violation|1|||
164382304|NCT02807948|593771177|FG000|Overall Study|Physician Decision|1|||
164382305|NCT02807948|593771178|FG001|Overall Study|Physician Decision|0|||
164382306|NCT03727750|593771179|FG000|Overall Study|Death|45|||
164382307|NCT03727750|593771179|FG000|Overall Study|Withdrawal by Subject|2|||
164382308|NCT03727750|593771179|FG000|Overall Study|Lost to Follow-up|1|||
164382309|NCT03727750|593771179|FG000|Overall Study|Other|1|||
164382310|NCT01154166|593771180|FG000|Overall Study|Adverse Event|14|||
164382311|NCT01154166|593771181|FG001|Overall Study|Adverse Event|9|||
164382312|NCT01154166|593771180|FG000|Overall Study|Lost to Follow-up|1|||
164382313|NCT01154166|593771181|FG001|Overall Study|Lost to Follow-up|1|||
164382314|NCT01154166|593771180|FG000|Overall Study|Protocol Violation|4|||
164382315|NCT01154166|593771181|FG001|Overall Study|Protocol Violation|1|||
164382316|NCT01154166|593771180|FG000|Overall Study|Withdrawal by Subject|10|||
164382317|NCT01154166|593771181|FG001|Overall Study|Withdrawal by Subject|1|||
164382318|NCT01154166|593771180|FG000|Overall Study|Lack of Efficacy|3|||
164382319|NCT01154166|593771181|FG001|Overall Study|Lack of Efficacy|0|||
164382320|NCT01154166|593771180|FG000|Overall Study|Disease Progression|1|||
164382321|NCT01154166|593771181|FG001|Overall Study|Disease Progression|0|||
164382322|NCT01154166|593771180|FG000|Overall Study|Poor Compliance|1|||
164382323|NCT01154166|593771181|FG001|Overall Study|Poor Compliance|0|||
164382324|NCT03614793|593771182|FG000|Overall Study|Lost to Follow-up|1|||
164382325|NCT03614793|593771183|FG001|Overall Study|Lost to Follow-up|2|||
164382326|NCT03614793|593771182|FG000|Overall Study|Lack of Efficacy|0|||
164382327|NCT03614793|593771183|FG001|Overall Study|Lack of Efficacy|5|||
164382328|NCT03614793|593771182|FG000|Overall Study|Withdrawal by Subject|0|||
164382329|NCT03614793|593771183|FG001|Overall Study|Withdrawal by Subject|1|||
164382330|NCT03614793|593771182|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
164382331|NCT03614793|593771183|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
164382332|NCT02840877|593771184|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
164382333|NCT02840877|593771184|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
164382334|NCT02840877|593771184|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
164382335|NCT02840877|593771184|FG000|Baseline to 12 Weeks|Death|1|||
164382336|NCT02840877|593771184|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
164382337|NCT02840877|593771184|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
164382338|NCT02840877|593771184|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
164382339|NCT02840877|593771184|FG000|12 Weeks to 6 Months|Treatment failure|1|||
164382340|NCT02840877|593771184|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
164382341|NCT02840877|593771184|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
164382342|NCT02840877|593771184|FG000|12 Weeks to 6 Months|Death|1|||
164382343|NCT02840877|593771184|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
164382344|NCT02840877|593771184|FG000|6 Months to 18 Months|Treatment failure|7|||
164382345|NCT02840877|593771184|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
164382346|NCT02840877|593771184|FG000|6 Months to 18 Months|Moved/transferred out|6|||
164382347|NCT02840877|593771184|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
164382348|NCT02840877|593771184|FG000|6 Months to 18 Months|Death|4|||
164382349|NCT02840877|593771184|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
164382350|NCT02840877|593771184|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
164382351|NCT02840877|593771184|FG000|6 Months to 18 Months|Still in study.|14|||
164382352|NCT04317586|593771185|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
164382353|NCT04317586|593771185|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
164382354|NCT01276327|593771188|FG000|Overall Study|Adverse Event|1|||
164382355|NCT01276327|593771189|FG001|Overall Study|Adverse Event|3|||
164382356|NCT01276327|593771188|FG000|Overall Study|Withdrawal by Subject|1|||
164382357|NCT01276327|593771189|FG001|Overall Study|Withdrawal by Subject|0|||
164382358|NCT00807092|593771190|FG000|Overall Study|Adverse Event|0|||
164382359|NCT00807092|593771191|FG001|Overall Study|Adverse Event|1|||
164439929|NCT04493242|593977300|FG001|Overall Study|Withdrawal by Subject|0|||
164439930|NCT04493242|593977301|FG002|Overall Study|Withdrawal by Subject|0|||
164439931|NCT04493242|593977299|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
164439932|NCT04493242|593977300|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
164439933|NCT04493242|593977301|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
164439934|NCT04493242|593977299|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
164439935|NCT04493242|593977300|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
164439936|NCT04493242|593977301|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
164439937|NCT03215927|593978841|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
164439938|NCT03215927|593978842|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
164439939|NCT03215927|593978841|FG000|Open Label Extension|Adverse Event|1|||
164439940|NCT03215927|593978842|FG001|Open Label Extension|Adverse Event|0|||
164439941|NCT03215927|593978841|FG000|Open Label Extension|Lack of Efficacy|1|||
164439942|NCT03215927|593978842|FG001|Open Label Extension|Lack of Efficacy|0|||
164439943|NCT03215927|593978841|FG000|Open Label Extension|Death|0|||
164439944|NCT03215927|593978842|FG001|Open Label Extension|Death|1|||
164439945|NCT03779048|593978843|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
164439946|NCT03779048|593978844|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
164439947|NCT03779048|593978845|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
164439948|NCT03779048|593978843|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
164439949|NCT03779048|593978844|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
164439950|NCT03779048|593978845|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
164439951|NCT03779048|593978843|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
164439952|NCT03779048|593978844|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
164439953|NCT03779048|593978845|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
164439954|NCT05328297|593978846|FG000|Overall Study|Adverse Event|5|||
164439955|NCT05328297|593978847|FG001|Overall Study|Adverse Event|7|||
164439956|NCT05328297|593978846|FG000|Overall Study|Withdrawal by Subject|4|||
164439957|NCT05328297|593978847|FG001|Overall Study|Withdrawal by Subject|3|||
164439958|NCT05328297|593978846|FG000|Overall Study|Lack of Efficacy|1|||
164439959|NCT05328297|593978847|FG001|Overall Study|Lack of Efficacy|0|||
164439960|NCT05328297|593978846|FG000|Overall Study|Lost to Follow-up|1|||
164439961|NCT05328297|593978847|FG001|Overall Study|Lost to Follow-up|0|||
164382360|NCT00807092|593771190|FG000|Overall Study|Protocol Violation|0|||
164382361|NCT00807092|593771191|FG001|Overall Study|Protocol Violation|2|||
164382362|NCT00807092|593771190|FG000|Overall Study|Withdrawal by Subject|1|||
164382363|NCT00807092|593771191|FG001|Overall Study|Withdrawal by Subject|0|||
164382364|NCT00807092|593771190|FG000|Overall Study|CGMS data collection failed|0|||
164382365|NCT00807092|593771191|FG001|Overall Study|CGMS data collection failed|1|||
164382366|NCT01794949|593771192|FG000|Overall Study|Lost to Follow-up|1|||
164382367|NCT01794949|593771193|FG001|Overall Study|Lost to Follow-up|0|||
164382368|NCT03003676|593771194|FG000|Overall Study|Lack of Efficacy|5|||
164382369|NCT03003676|593771195|FG001|Overall Study|Lack of Efficacy|7|||
164382370|NCT03003676|593771194|FG000|Overall Study|Withdrawal by Subject|0|||
164382371|NCT03003676|593771195|FG001|Overall Study|Withdrawal by Subject|1|||
164382372|NCT03003676|593771194|FG000|Overall Study|Hepatitis B infection|1|||
164382373|NCT03003676|593771195|FG001|Overall Study|Hepatitis B infection|0|||
164382374|NCT02530619|593771210|FG000|Registered for Study|Withdrawal by Subject|2|||
164382375|NCT02530619|593771210|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
164382376|NCT02530619|593771210|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
164382377|NCT02530619|593771210|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
164382378|NCT02530619|593771210|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
164382379|NCT02530619|593771210|FG000|Follow-up Period (6 Months)|Death|4|||
164382380|NCT02530619|593771210|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
164382381|NCT02530619|593771210|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
164701615|NCT02400671|594932673|FG002|Overall Study|Withdrawal by Subject|0|||
164382382|NCT00359762|593771222|FG000|Period II|Adverse Event|17|||
164382383|NCT00359762|593771223|FG001|Period II|Adverse Event|0|||
164382384|NCT00359762|593771224|FG002|Period II|Adverse Event|0|||
164382385|NCT00359762|593771225|FG003|Period II|Adverse Event|0|||
164382386|NCT00359762|593771226|FG004|Period II|Adverse Event|49|||
164382387|NCT00359762|593771222|FG000|Period II|Protocol Violation|18|||
164382388|NCT00359762|593771223|FG001|Period II|Protocol Violation|0|||
164382389|NCT00359762|593771224|FG002|Period II|Protocol Violation|0|||
164382390|NCT00359762|593771225|FG003|Period II|Protocol Violation|0|||
164382391|NCT00359762|593771226|FG004|Period II|Protocol Violation|11|||
164382392|NCT00359762|593771222|FG000|Period II|Physician Decision|17|||
164382393|NCT00359762|593771223|FG001|Period II|Physician Decision|0|||
164382394|NCT00359762|593771224|FG002|Period II|Physician Decision|0|||
164382395|NCT00359762|593771225|FG003|Period II|Physician Decision|0|||
164382396|NCT00359762|593771226|FG004|Period II|Physician Decision|23|||
164382397|NCT00359762|593771222|FG000|Period II|Death|2|||
164382398|NCT00359762|593771223|FG001|Period II|Death|0|||
164382399|NCT00359762|593771224|FG002|Period II|Death|0|||
164382400|NCT00359762|593771225|FG003|Period II|Death|0|||
164701616|NCT04397445|594932676|FG000|Overall Study|Withdrawal by Subject|1|||
164701617|NCT04397445|594932677|FG001|Overall Study|Withdrawal by Subject|0|||
164701618|NCT04397445|594932678|FG002|Overall Study|Withdrawal by Subject|0|||
164701619|NCT04397445|594932679|FG003|Overall Study|Withdrawal by Subject|0|||
164382401|NCT00359762|593771226|FG004|Period II|Death|4|||
164382402|NCT00359762|593771222|FG000|Period II|Lack of Efficacy|11|||
164382403|NCT00359762|593771223|FG001|Period II|Lack of Efficacy|0|||
164382404|NCT00359762|593771224|FG002|Period II|Lack of Efficacy|0|||
164382405|NCT00359762|593771225|FG003|Period II|Lack of Efficacy|0|||
164382406|NCT00359762|593771226|FG004|Period II|Lack of Efficacy|8|||
164382407|NCT00359762|593771222|FG000|Period II|Lost to follow up|5|||
164382408|NCT00359762|593771223|FG001|Period II|Lost to follow up|0|||
164382409|NCT00359762|593771224|FG002|Period II|Lost to follow up|0|||
164382410|NCT00359762|593771225|FG003|Period II|Lost to follow up|0|||
164382411|NCT00359762|593771226|FG004|Period II|Lost to follow up|5|||
164382412|NCT00359762|593771222|FG000|Period II|Entry Criteria Not Met|8|||
164382413|NCT00359762|593771223|FG001|Period II|Entry Criteria Not Met|0|||
164382414|NCT00359762|593771224|FG002|Period II|Entry Criteria Not Met|0|||
164382415|NCT00359762|593771225|FG003|Period II|Entry Criteria Not Met|0|||
164382416|NCT00359762|593771226|FG004|Period II|Entry Criteria Not Met|4|||
164382417|NCT00359762|593771222|FG000|Period II|Subject Decision|50|||
164382418|NCT00359762|593771223|FG001|Period II|Subject Decision|0|||
164382419|NCT00359762|593771224|FG002|Period II|Subject Decision|0|||
164382420|NCT00359762|593771225|FG003|Period II|Subject Decision|0|||
164382421|NCT00359762|593771226|FG004|Period II|Subject Decision|70|||
164382422|NCT00359762|593771222|FG000|Period III|Protocol Violation|0|||
164382423|NCT00359762|593771223|FG001|Period III|Protocol Violation|5|||
164382424|NCT00359762|593771224|FG002|Period III|Protocol Violation|3|||
164382425|NCT00359762|593771225|FG003|Period III|Protocol Violation|8|||
164382426|NCT00359762|593771226|FG004|Period III|Protocol Violation|0|||
164382427|NCT00359762|593771222|FG000|Period III|Adverse Event|0|||
164382428|NCT00359762|593771223|FG001|Period III|Adverse Event|3|||
164382429|NCT00359762|593771224|FG002|Period III|Adverse Event|4|||
164382430|NCT00359762|593771225|FG003|Period III|Adverse Event|10|||
164382431|NCT00359762|593771226|FG004|Period III|Adverse Event|0|||
164382432|NCT00359762|593771222|FG000|Period III|Physician Decision|0|||
164382433|NCT00359762|593771223|FG001|Period III|Physician Decision|5|||
164382434|NCT00359762|593771224|FG002|Period III|Physician Decision|9|||
164382435|NCT00359762|593771225|FG003|Period III|Physician Decision|15|||
164382436|NCT00359762|593771226|FG004|Period III|Physician Decision|0|||
164382437|NCT00359762|593771222|FG000|Period III|Lack of Efficacy|0|||
164382438|NCT00359762|593771223|FG001|Period III|Lack of Efficacy|7|||
164382439|NCT00359762|593771224|FG002|Period III|Lack of Efficacy|5|||
164382440|NCT00359762|593771225|FG003|Period III|Lack of Efficacy|9|||
164382441|NCT00359762|593771226|FG004|Period III|Lack of Efficacy|0|||
164382442|NCT00359762|593771222|FG000|Period III|Lost to follow up|0|||
164382443|NCT00359762|593771223|FG001|Period III|Lost to follow up|1|||
164382444|NCT00359762|593771224|FG002|Period III|Lost to follow up|1|||
164382445|NCT00359762|593771225|FG003|Period III|Lost to follow up|2|||
164382446|NCT00359762|593771226|FG004|Period III|Lost to follow up|0|||
164382447|NCT00359762|593771222|FG000|Period III|Entry Criteria Not Met|0|||
164382448|NCT00359762|593771223|FG001|Period III|Entry Criteria Not Met|1|||
164382449|NCT00359762|593771224|FG002|Period III|Entry Criteria Not Met|0|||
164382450|NCT00359762|593771225|FG003|Period III|Entry Criteria Not Met|1|||
164382451|NCT00359762|593771226|FG004|Period III|Entry Criteria Not Met|0|||
164382452|NCT00359762|593771222|FG000|Period III|Subject Decision|0|||
164382453|NCT00359762|593771223|FG001|Period III|Subject Decision|7|||
164382454|NCT00359762|593771224|FG002|Period III|Subject Decision|8|||
164382455|NCT00359762|593771225|FG003|Period III|Subject Decision|20|||
164382456|NCT00359762|593771226|FG004|Period III|Subject Decision|0|||
164382457|NCT01172938|593771227|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
164382458|NCT01172938|593771228|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
164382459|NCT01172938|593771229|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
164382460|NCT01172938|593771230|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
164382461|NCT01172938|593771231|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
164382462|NCT01172938|593771232|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
164382463|NCT01172938|593771233|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
164382464|NCT01172938|593771234|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
164382465|NCT01172938|593771235|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
164382466|NCT01172938|593771227|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
164382467|NCT01172938|593771228|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
164382468|NCT01172938|593771229|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
164382469|NCT01172938|593771230|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
164382470|NCT01172938|593771231|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
164382471|NCT01172938|593771232|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
164382472|NCT01172938|593771233|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
164382473|NCT01172938|593771234|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
164382474|NCT01172938|593771235|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
164439962|NCT05328297|593978846|FG000|Overall Study|Protocol Violation|1|||
164439963|NCT05328297|593978847|FG001|Overall Study|Protocol Violation|0|||
164439964|NCT05328297|593978846|FG000|Overall Study|Randomized but not treated|1|||
164439965|NCT05328297|593978847|FG001|Overall Study|Randomized but not treated|1|||
164439966|NCT03979365|593978848|FG000|Overall Study|Death|1|||
164439967|NCT03979365|593978849|FG001|Overall Study|Death|3|||
164439968|NCT03979365|593978848|FG000|Overall Study|Withdrawal by Subject|0|||
164439969|NCT03979365|593978849|FG001|Overall Study|Withdrawal by Subject|1|||
164439970|NCT03979365|593978848|FG000|Overall Study|Drug Conversion|0|||
164439971|NCT03979365|593978849|FG001|Overall Study|Drug Conversion|3|||
164439972|NCT04496960|593978850|FG000|Overall Study|Physician Decision|0|||
164439973|NCT04496960|593978851|FG001|Overall Study|Physician Decision|1|||
164439974|NCT04668339|593978854|FG000|Overall Study|Physician Decision|1|||
164439975|NCT04668339|593978855|FG001|Overall Study|Physician Decision|0|||
164439976|NCT04668339|593978856|FG002|Overall Study|Physician Decision|1|||
164439977|NCT04668339|593978857|FG003|Overall Study|Physician Decision|1|||
164439978|NCT04668339|593978854|FG000|Overall Study|Lost to Follow-up|14|||
164439979|NCT04668339|593978855|FG001|Overall Study|Lost to Follow-up|12|||
164439980|NCT04668339|593978856|FG002|Overall Study|Lost to Follow-up|8|||
164439981|NCT04668339|593978857|FG003|Overall Study|Lost to Follow-up|5|||
164439982|NCT04668339|593978854|FG000|Overall Study|Adverse Event|0|||
164439983|NCT04668339|593978855|FG001|Overall Study|Adverse Event|0|||
164439984|NCT04668339|593978856|FG002|Overall Study|Adverse Event|1|||
164439985|NCT04668339|593978857|FG003|Overall Study|Adverse Event|0|||
164439986|NCT04668339|593978854|FG000|Overall Study|Other than specified|3|||
164439987|NCT04668339|593978855|FG001|Overall Study|Other than specified|0|||
164439988|NCT04668339|593978856|FG002|Overall Study|Other than specified|1|||
164439989|NCT04668339|593978857|FG003|Overall Study|Other than specified|0|||
164439990|NCT04668339|593978854|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
164439991|NCT04668339|593978855|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
164439992|NCT04668339|593978856|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
164439993|NCT04668339|593978857|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
164382475|NCT01172938|593771227|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
164382476|NCT01172938|593771228|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
164382477|NCT01172938|593771229|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
164382478|NCT01172938|593771230|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
164382479|NCT01172938|593771231|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
164439994|NCT04668339|593978854|FG000|Overall Study|Vaccine not Administered|0|||
164439995|NCT04668339|593978855|FG001|Overall Study|Vaccine not Administered|0|||
164382480|NCT01172938|593771232|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
164701620|NCT03921151|594932680|FG000|Overall Study|Withdrawal by Subject|11|||
164701621|NCT03921151|594932681|FG001|Overall Study|Withdrawal by Subject|16|||
164701622|NCT00857792|594932683|FG000|Overall Study|inadequate image quality for analysis|12|||
164701623|NCT00307034|594932685|FG000|Overall Study|Adverse Event|1|||
164701624|NCT00307034|594932686|FG001|Overall Study|Adverse Event|2|||
164701625|NCT00307034|594932685|FG000|Overall Study|Withdrawal by Subject|1|||
164701626|NCT00307034|594932686|FG001|Overall Study|Withdrawal by Subject|2|||
164701627|NCT00307034|594932685|FG000|Overall Study|Lost to Follow-up|0|||
164701628|NCT00307034|594932686|FG001|Overall Study|Lost to Follow-up|3|||
164701629|NCT04920916|594932687|FG000|Phase IIa 60 Day Study|Death|2|||
164701630|NCT04920916|594932688|FG001|Phase IIa 60 Day Study|Death|5|||
164701631|NCT04920916|594932687|FG000|1 Year Follow up (Phone Call)|Death|1|||
164701632|NCT04920916|594932688|FG001|1 Year Follow up (Phone Call)|Death|3|||
164701633|NCT04920916|594932687|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
164701634|NCT04920916|594932688|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
164701635|NCT02011113|594932689|FG000|Overall Study|Adverse Event|4|||
164701636|NCT02011113|594932689|FG000|Overall Study|Disease Progression (DP)|16|||
164701637|NCT02011113|594932689|FG000|Overall Study|Death|1|||
164701638|NCT02011113|594932689|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
164701639|NCT02011113|594932689|FG000|Overall Study|Investigator's judgement- DP|3|||
164701640|NCT02011113|594932689|FG000|Overall Study|Study terminated by sponsor|11|||
164701641|NCT04688931|594932692|FG000|Overall Study|Adverse Event|4|||
164701642|NCT04688931|594932693|FG001|Overall Study|Adverse Event|1|||
164701643|NCT04688931|594932692|FG000|Overall Study|Withdrawal by Subject|5|||
164701644|NCT04688931|594932693|FG001|Overall Study|Withdrawal by Subject|16|||
164701645|NCT04688931|594932692|FG000|Overall Study|Physician Decision|3|||
164701646|NCT04688931|594932693|FG001|Overall Study|Physician Decision|5|||
164701647|NCT04688931|594932692|FG000|Overall Study|Noncompliance|0|||
164701648|NCT04688931|594932693|FG001|Overall Study|Noncompliance|1|||
164701649|NCT04688931|594932692|FG000|Overall Study|Lost to Follow-up|1|||
164701650|NCT04688931|594932693|FG001|Overall Study|Lost to Follow-up|3|||
164701651|NCT04688931|594932692|FG000|Overall Study|Randomization Error|3|||
164701652|NCT04688931|594932693|FG001|Overall Study|Randomization Error|0|||
164701653|NCT04688931|594932692|FG000|Overall Study|Not Eligible|1|||
164701654|NCT04688931|594932693|FG001|Overall Study|Not Eligible|3|||
164701655|NCT04688931|594932692|FG000|Overall Study|Disease Progression|0|||
164701656|NCT04688931|594932693|FG001|Overall Study|Disease Progression|2|||
164701657|NCT04688931|594932692|FG000|Overall Study|Sponsor Requirement|1|||
164701658|NCT04688931|594932693|FG001|Overall Study|Sponsor Requirement|1|||
164701659|NCT04688931|594932692|FG000|Overall Study|Other Reason|1|||
164701660|NCT04688931|594932693|FG001|Overall Study|Other Reason|2|||
164382481|NCT01172938|593771233|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
164382482|NCT01172938|593771234|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
164382483|NCT01172938|593771235|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
164382484|NCT01172938|593771227|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
164382485|NCT01172938|593771228|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
164382486|NCT01172938|593771229|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
164382487|NCT01172938|593771230|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
164382488|NCT01172938|593771231|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
164382489|NCT01172938|593771232|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
164382490|NCT01172938|593771233|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
164382491|NCT01172938|593771234|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
164382492|NCT01172938|593771235|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
164382493|NCT01172938|593771227|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
164382494|NCT01172938|593771228|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
164382495|NCT01172938|593771229|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
164701661|NCT00361335|594932694|FG000|IV Period: Baseline to E0|Adverse Event|9|||
164382496|NCT01172938|593771230|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
164382497|NCT01172938|593771231|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
164382498|NCT01172938|593771232|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
164382499|NCT01172938|593771233|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
164382500|NCT01172938|593771234|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
164701662|NCT00361335|594932695|FG001|IV Period: Baseline to E0|Adverse Event|4|||
164701663|NCT00361335|594932696|FG002|IV Period: Baseline to E0|Adverse Event|5|||
164701664|NCT00361335|594932697|FG003|IV Period: Baseline to E0|Adverse Event|9|||
164701665|NCT00361335|594932698|FG004|IV Period: Baseline to E0|Adverse Event|8|||
164701666|NCT00361335|594932699|FG005|IV Period: Baseline to E0|Adverse Event|0|||
164701667|NCT00361335|594932700|FG006|IV Period: Baseline to E0|Adverse Event|0|||
164701668|NCT00361335|594932694|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
164701669|NCT00361335|594932695|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
164701670|NCT00361335|594932696|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
164701671|NCT00361335|594932697|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
164701672|NCT00361335|594932698|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
164382501|NCT01172938|593771235|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
164382502|NCT01172938|593771227|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
164701673|NCT00361335|594932699|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
164701674|NCT00361335|594932700|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
164701675|NCT00361335|594932694|FG000|IV Period: Baseline to E0|Death|1|||
164382503|NCT01172938|593771228|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
164382504|NCT01172938|593771229|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
164382505|NCT01172938|593771230|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
164382506|NCT01172938|593771231|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
164382507|NCT01172938|593771232|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
164382508|NCT01172938|593771233|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
164382509|NCT01172938|593771234|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
164382510|NCT01172938|593771235|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
164382511|NCT01172938|593771227|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
164382512|NCT01172938|593771228|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
164382513|NCT01172938|593771229|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
164382514|NCT01172938|593771230|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
164382515|NCT01172938|593771231|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
164382516|NCT01172938|593771232|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
164382517|NCT01172938|593771233|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
164382518|NCT01172938|593771234|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
164382519|NCT01172938|593771235|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
164382520|NCT01172938|593771227|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
164382521|NCT01172938|593771228|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
164382522|NCT01172938|593771229|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
164382523|NCT01172938|593771230|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
164382524|NCT01172938|593771231|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
164382525|NCT01172938|593771232|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
164382526|NCT01172938|593771233|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
164701676|NCT00361335|594932695|FG001|IV Period: Baseline to E0|Death|1|||
164701677|NCT00361335|594932696|FG002|IV Period: Baseline to E0|Death|1|||
164701678|NCT00361335|594932697|FG003|IV Period: Baseline to E0|Death|1|||
164701679|NCT00361335|594932698|FG004|IV Period: Baseline to E0|Death|0|||
164701680|NCT00361335|594932699|FG005|IV Period: Baseline to E0|Death|0|||
164382527|NCT01172938|593771234|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
164382528|NCT01172938|593771235|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
164382529|NCT01172938|593771227|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
164382530|NCT01172938|593771228|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
164382531|NCT01172938|593771229|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
164382532|NCT01172938|593771230|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
164382533|NCT01172938|593771231|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
164382534|NCT01172938|593771232|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
164382535|NCT01172938|593771233|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
164382536|NCT01172938|593771234|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
164382537|NCT01172938|593771235|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
164382538|NCT01172938|593771227|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
164382539|NCT01172938|593771228|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
164382540|NCT01172938|593771229|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
164382541|NCT01172938|593771230|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
164382542|NCT01172938|593771231|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
164382543|NCT01172938|593771232|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
164382544|NCT01172938|593771233|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
164439996|NCT04668339|593978856|FG002|Overall Study|Vaccine not Administered|1|||
164701681|NCT00361335|594932700|FG006|IV Period: Baseline to E0|Death|0|||
164701682|NCT00361335|594932694|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
164701683|NCT00361335|594932695|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
164382545|NCT01172938|593771234|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
164382546|NCT01172938|593771235|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
164382547|NCT01172938|593771227|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
164382548|NCT01172938|593771228|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
164382549|NCT01172938|593771229|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
164439997|NCT04668339|593978857|FG003|Overall Study|Vaccine not Administered|0|||
164701684|NCT00361335|594932696|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
164701685|NCT00361335|594932697|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
164701686|NCT00361335|594932698|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
164701687|NCT00361335|594932699|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
164382550|NCT01172938|593771230|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
164382551|NCT01172938|593771231|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
164382552|NCT01172938|593771232|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
164382553|NCT01172938|593771233|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
164382554|NCT01172938|593771234|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
164382555|NCT01172938|593771235|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
164382556|NCT01172938|593771227|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
164382557|NCT01172938|593771228|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
164382558|NCT01172938|593771229|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
164382559|NCT01172938|593771230|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
164382560|NCT01172938|593771231|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
164382561|NCT01172938|593771232|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
164382562|NCT01172938|593771233|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
164382563|NCT01172938|593771234|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
164382564|NCT01172938|593771235|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
164382565|NCT01172938|593771227|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
164382566|NCT01172938|593771228|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
164382567|NCT01172938|593771229|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
164382568|NCT01172938|593771230|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
164382569|NCT01172938|593771231|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
164382570|NCT01172938|593771232|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
164382571|NCT01172938|593771233|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
164382572|NCT01172938|593771234|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
164382573|NCT01172938|593771235|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
164382574|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
164382575|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
164382576|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
164382577|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
164382578|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
164382579|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
164382580|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
164382581|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
164382582|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
164382583|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
164382584|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
164382585|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
164382586|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
164382587|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
164382588|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
164382589|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
164382590|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
164382591|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
164382592|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
164382593|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
164382594|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
164382595|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
164382596|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
164382597|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
164382598|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
164382599|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
164382600|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
164382601|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
164382602|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
164382603|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
164382604|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
164382605|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
164439998|NCT04668339|593978854|FG000|Overall Study|Protocol Violation|18|||
164592368|NCT05113953|594532496|FG000|Overall Study|Non-compliance with Study Drug|1|||
164592369|NCT05113953|594532497|FG001|Overall Study|Non-compliance with Study Drug|0|||
164592370|NCT05113953|594532498|FG002|Overall Study|Non-compliance with Study Drug|0|||
164592371|NCT05113953|594532496|FG000|Overall Study|Withdrawal by Subject|2|||
164592372|NCT05113953|594532497|FG001|Overall Study|Withdrawal by Subject|6|||
164592373|NCT05113953|594532498|FG002|Overall Study|Withdrawal by Subject|4|||
164592374|NCT05113953|594532496|FG000|Overall Study|Reason not Specified|2|||
164592375|NCT05113953|594532497|FG001|Overall Study|Reason not Specified|0|||
164382606|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
164382607|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
164382608|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
164382609|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
164382610|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
164382611|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
164382612|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
164382613|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
164382614|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
164382615|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
164382616|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
164382617|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
164382618|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
164382619|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
164382620|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
164382621|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
164382622|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
164382623|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
164382624|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
164382625|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
164382626|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
164382627|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
164382628|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
164382629|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
164382630|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
164382631|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
164382632|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
164382633|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
164382634|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
164382635|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
164382636|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
164382637|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
164382638|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
164382639|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
164382640|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
164382641|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
164382642|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
164382643|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
164382644|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
164382645|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
164382646|NCT01172938|593771227|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
164382647|NCT01172938|593771228|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
164382648|NCT01172938|593771229|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
164382649|NCT01172938|593771230|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
164382650|NCT01172938|593771231|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
164382651|NCT01172938|593771232|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
164382652|NCT01172938|593771233|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
164382653|NCT01172938|593771234|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
164382654|NCT01172938|593771235|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
164382655|NCT01172938|593771227|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
164382656|NCT01172938|593771228|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
164382657|NCT01172938|593771229|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
164382658|NCT01172938|593771230|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
164382659|NCT01172938|593771231|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
164382660|NCT01172938|593771232|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
164382661|NCT01172938|593771233|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
164382662|NCT01172938|593771234|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
164382663|NCT01172938|593771235|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
164382664|NCT01172938|593771227|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
164439999|NCT04668339|593978855|FG001|Overall Study|Protocol Violation|23|||
164440000|NCT04668339|593978856|FG002|Overall Study|Protocol Violation|12|||
164440001|NCT04668339|593978857|FG003|Overall Study|Protocol Violation|20|||
164440002|NCT04668339|593978854|FG000|Overall Study|Withdrawal by Subject|45|||
164592376|NCT05113953|594532498|FG002|Overall Study|Reason not Specified|0|||
164592377|NCT02340819|594532500|FG000|Overall Study|Adverse Event|1|||
164382665|NCT01172938|593771228|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
164382666|NCT01172938|593771229|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
164382667|NCT01172938|593771230|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
164382668|NCT01172938|593771231|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
164382669|NCT01172938|593771232|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
164382670|NCT01172938|593771233|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
164382671|NCT01172938|593771234|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
164382672|NCT01172938|593771235|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
164382673|NCT01172938|593771227|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
164382674|NCT01172938|593771228|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
164382675|NCT01172938|593771229|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
164382676|NCT01172938|593771230|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
164382677|NCT01172938|593771231|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
164382678|NCT01172938|593771232|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
164382679|NCT01172938|593771233|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
164382680|NCT01172938|593771234|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
164382681|NCT01172938|593771235|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
164382682|NCT01172938|593771227|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
164382683|NCT01172938|593771228|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
164382684|NCT01172938|593771229|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
164382685|NCT01172938|593771230|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
164382686|NCT01172938|593771231|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
164382687|NCT01172938|593771232|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
164382688|NCT01172938|593771233|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
164382689|NCT01172938|593771234|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
164382690|NCT01172938|593771235|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
164382691|NCT01172938|593771227|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
164382692|NCT01172938|593771228|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
164382693|NCT01172938|593771229|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
164382694|NCT01172938|593771230|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
164382695|NCT01172938|593771231|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
164382696|NCT01172938|593771232|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
164382697|NCT01172938|593771233|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
164382698|NCT01172938|593771234|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
164382699|NCT01172938|593771235|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
164382700|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
164382701|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
164382702|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
164382703|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
164382704|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
164382705|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
164382706|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
164382707|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
164382708|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
164382709|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
164382710|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
164382711|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
164382712|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
164382713|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
164382714|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
164382715|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
164382716|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
164382717|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
164382718|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
164382719|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
164382720|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
164701688|NCT00361335|594932700|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
164701689|NCT00361335|594932694|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
164701690|NCT00361335|594932695|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
164701691|NCT00361335|594932696|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
164701692|NCT00361335|594932697|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
164701693|NCT00361335|594932698|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
164701694|NCT00361335|594932699|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
164701695|NCT00361335|594932700|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
164701696|NCT00361335|594932694|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
164440003|NCT04668339|593978855|FG001|Overall Study|Withdrawal by Subject|46|||
164440004|NCT04668339|593978856|FG002|Overall Study|Withdrawal by Subject|46|||
164701697|NCT00361335|594932695|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
164382721|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
164382722|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
164382723|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
164382724|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
164382725|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
164382726|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
164382727|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
164382728|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
164382729|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
164382730|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
164382731|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
164382732|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
164382733|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
164382734|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
164382735|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
164382736|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
164382737|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
164382738|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
164382739|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
164382740|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
164382741|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
164382742|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
164382743|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
164382744|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
164382745|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
164382746|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
164382747|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
164382748|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
164382749|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
164382750|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
164382751|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
164592378|NCT02340819|594532500|FG000|Overall Study|Withdrawal by Subject|2|||
164592379|NCT02340819|594532500|FG000|Overall Study|Discontinued with other reason|1|||
164592380|NCT01328249|594532501|FG000|Overall Study|Adverse Event|3|||
164592381|NCT01328249|594532502|FG001|Overall Study|Adverse Event|0|||
164592382|NCT01328249|594532501|FG000|Overall Study|Disease progression|1|||
164592383|NCT01328249|594532502|FG001|Overall Study|Disease progression|0|||
164592384|NCT01328249|594532501|FG000|Overall Study|Withdrawal by Subject|1|||
164592385|NCT01328249|594532502|FG001|Overall Study|Withdrawal by Subject|1|||
164592386|NCT01328249|594532501|FG000|Overall Study|Moved before end of treatment visit|1|||
164592387|NCT01328249|594532502|FG001|Overall Study|Moved before end of treatment visit|0|||
164592388|NCT01328249|594532501|FG000|Overall Study|Subject choice|1|||
164592389|NCT01328249|594532502|FG001|Overall Study|Subject choice|1|||
164592390|NCT01328249|594532501|FG000|Overall Study|Protocol Violation|0|||
164592391|NCT01328249|594532502|FG001|Overall Study|Protocol Violation|1|||
164592392|NCT03331666|594532503|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
164592393|NCT03331666|594532504|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
164592394|NCT02273752|594532506|FG000|Overall Study|Trial was terminated early|2|||
164592395|NCT00903032|594532507|FG000|Overall Study|Withdrawal by Subject|5|||
164382752|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
164382753|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
164382754|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
164382755|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
164382756|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
164382757|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
164382758|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
164382759|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
164382760|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
164382761|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
164382762|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
164382763|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
164382764|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
164382765|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
164382766|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
164592396|NCT00903032|594532508|FG001|Overall Study|Withdrawal by Subject|3|||
164382767|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
164382768|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
164382769|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
164382770|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
164382771|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
164382772|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
164382773|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
164382774|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
164382775|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
164382776|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
164382777|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
164382778|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
164382779|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
164382780|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
164382781|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
164382782|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
164382783|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
164382784|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
164382785|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
164382786|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
164382787|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
164382788|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
164382789|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
164382790|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
164382791|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
164382792|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
164382793|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
164382794|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
164382795|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
164382796|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
164382797|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
164382798|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
164382799|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
164382800|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
164382801|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
164382802|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
164382803|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
164382804|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
164382805|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
164382806|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
164382807|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
164382808|NCT00403546|593771239|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
164382809|NCT00403546|593771240|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
164382810|NCT00403546|593771241|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
164382811|NCT00403546|593771239|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
164382812|NCT00403546|593771240|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
164382813|NCT00403546|593771241|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
164382814|NCT00403546|593771239|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
164382815|NCT00403546|593771240|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
164382816|NCT00403546|593771241|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
164382817|NCT00403546|593771239|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
164382818|NCT00403546|593771240|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
164382819|NCT00403546|593771241|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
164440005|NCT04668339|593978857|FG003|Overall Study|Withdrawal by Subject|27|||
164440006|NCT04668339|593978854|FG000|Overall Study|Study Terminated by Sponsor|59|||
164701698|NCT00361335|594932696|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
164701699|NCT00361335|594932697|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
164701700|NCT00361335|594932698|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
164701701|NCT00361335|594932699|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
164701702|NCT00361335|594932700|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
164701703|NCT00361335|594932694|FG000|IV Period: Baseline to E0|Other|2|||
164440007|NCT04668339|593978855|FG001|Overall Study|Study Terminated by Sponsor|59|||
164440008|NCT04668339|593978856|FG002|Overall Study|Study Terminated by Sponsor|71|||
164440009|NCT04668339|593978857|FG003|Overall Study|Study Terminated by Sponsor|1|||
164701704|NCT00361335|594932695|FG001|IV Period: Baseline to E0|Other|9|||
164701705|NCT00361335|594932696|FG002|IV Period: Baseline to E0|Other|9|||
164701706|NCT00361335|594932697|FG003|IV Period: Baseline to E0|Other|3|||
164382820|NCT00403546|593771239|FG000|Screening Phase|Screening Failure|22|||
164382821|NCT00403546|593771240|FG001|Screening Phase|Screening Failure|0|||
164382822|NCT00403546|593771241|FG002|Screening Phase|Screening Failure|0|||
164382823|NCT00403546|593771239|FG000|Screening Phase|Adverse Event|1|||
164382824|NCT00403546|593771240|FG001|Screening Phase|Adverse Event|0|||
164382825|NCT00403546|593771241|FG002|Screening Phase|Adverse Event|0|||
164382826|NCT00403546|593771239|FG000|Screening Phase|Terminated Prior to Randomization|5|||
164382827|NCT00403546|593771240|FG001|Screening Phase|Terminated Prior to Randomization|0|||
164382828|NCT00403546|593771241|FG002|Screening Phase|Terminated Prior to Randomization|0|||
164382829|NCT00403546|593771239|FG000|Randomized Trial|Early Terminations|0|||
164382830|NCT00403546|593771240|FG001|Randomized Trial|Early Terminations|17|||
164382831|NCT00403546|593771241|FG002|Randomized Trial|Early Terminations|16|||
164382832|NCT00793910|593771242|FG000|Overall Study|discarded study pills|0|||
164382833|NCT00793910|593771243|FG001|Overall Study|discarded study pills|1|||
164382834|NCT00793910|593771242|FG000|Overall Study|did not pick up medications|1|||
164382835|NCT00793910|593771243|FG001|Overall Study|did not pick up medications|1|||
164382836|NCT00793910|593771242|FG000|Overall Study|ineligible based on entry criteria|2|||
164382837|NCT00793910|593771243|FG001|Overall Study|ineligible based on entry criteria|3|||
164382838|NCT00793910|593771242|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
164382839|NCT00793910|593771243|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
164382840|NCT00793910|593771242|FG000|Overall Study|Withdrawal by Subject|0|||
164382841|NCT00793910|593771243|FG001|Overall Study|Withdrawal by Subject|1|||
164382842|NCT03634579|593771244|FG000|Overall Study|study termination|9|||
164382843|NCT05061446|593771245|FG000|Overall Study|Adverse Event|2|||
164382844|NCT05061446|593771246|FG001|Overall Study|Adverse Event|0|||
164382845|NCT05061446|593771247|FG002|Overall Study|Adverse Event|0|||
164382846|NCT05061446|593771245|FG000|Overall Study|Participant no longer available due to personal reason|0|||
164382847|NCT05061446|593771246|FG001|Overall Study|Participant no longer available due to personal reason|1|||
164382848|NCT05061446|593771247|FG002|Overall Study|Participant no longer available due to personal reason|0|||
164382849|NCT04111497|593771248|FG000|Overall Study|relapse of primary disease|1|||
164382850|NCT04111497|593771248|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
164382851|NCT01993719|593771251|FG000|First Drug Administration|Not treated|1|||
164382852|NCT01993719|593771252|FG001|First Drug Administration|Not treated|0|||
164382853|NCT01993719|593771253|FG002|First Drug Administration|Not treated|0|||
164382854|NCT01993719|593771254|FG003|First Drug Administration|Not treated|0|||
164382855|NCT01993719|593771255|FG004|First Drug Administration|Not treated|0|||
164382856|NCT02799082|593771256|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
164382857|NCT02799082|593771257|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
164382858|NCT02799082|593771256|FG000|Overall Study|Protocol Violation|0|||
164382859|NCT02799082|593771257|FG001|Overall Study|Protocol Violation|1|||
164382860|NCT01723904|593771262|FG000|Overall Study|Noncompliant|3|||
164382861|NCT01723904|593771262|FG000|Overall Study|Adverse Event|5|||
164382862|NCT01723904|593771262|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
164382863|NCT02617589|593771265|FG000|Randomization|Request to Discontinue Study Treatment|1|||
164382864|NCT02617589|593771266|FG001|Randomization|Request to Discontinue Study Treatment|3|||
164382865|NCT02617589|593771265|FG000|Randomization|Participant Withdrew Consent|1|||
164382866|NCT02617589|593771266|FG001|Randomization|Participant Withdrew Consent|2|||
164382867|NCT02617589|593771265|FG000|Treatment|Other Reasons|3|||
164382868|NCT02617589|593771266|FG001|Treatment|Other Reasons|3|||
164382869|NCT02617589|593771265|FG000|Treatment|Poor/Non Compliance|1|||
164382870|NCT02617589|593771266|FG001|Treatment|Poor/Non Compliance|1|||
164382871|NCT02617589|593771265|FG000|Treatment|Maximum Clinical Benefit|0|||
164382872|NCT02617589|593771266|FG001|Treatment|Maximum Clinical Benefit|2|||
164382873|NCT02617589|593771265|FG000|Treatment|Participant Withdrew Consent|2|||
164382874|NCT02617589|593771266|FG001|Treatment|Participant Withdrew Consent|6|||
164382875|NCT02617589|593771265|FG000|Treatment|Participant Request to Discontinue|12|||
164382876|NCT02617589|593771266|FG001|Treatment|Participant Request to Discontinue|21|||
164382877|NCT02617589|593771265|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
164382878|NCT02617589|593771266|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
164382879|NCT02617589|593771265|FG000|Treatment|Death|1|||
164382880|NCT02617589|593771266|FG001|Treatment|Death|1|||
164382881|NCT02617589|593771265|FG000|Treatment|Study Drug Toxicity|27|||
164382882|NCT02617589|593771266|FG001|Treatment|Study Drug Toxicity|20|||
164592397|NCT00903032|594532507|FG000|Overall Study|Lost to Follow-up|2|||
164592398|NCT00903032|594532508|FG001|Overall Study|Lost to Follow-up|2|||
164382883|NCT02617589|593771265|FG000|Treatment|Disease Progression|216|||
164382884|NCT02617589|593771266|FG001|Treatment|Disease Progression|136|||
164382885|NCT01752933|593771267|FG000|Treatment|Disease Progression|3|||
164592399|NCT05619172|594532509|FG000|Safety Cohort 1|Death|7|||
164592400|NCT05619172|594532510|FG001|Safety Cohort 1|Death|0|||
164592401|NCT05619172|594532509|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
164382886|NCT01752933|593771268|FG001|Treatment|Disease Progression|29|||
164382887|NCT01752933|593771267|FG000|Treatment|Withdrawal by Subject|0|||
164382888|NCT01752933|593771268|FG001|Treatment|Withdrawal by Subject|5|||
164382889|NCT01752933|593771267|FG000|Treatment|Adverse Event|1|||
164382890|NCT01752933|593771268|FG001|Treatment|Adverse Event|4|||
164382891|NCT01752933|593771267|FG000|Treatment|Physician Decision|0|||
164382892|NCT01752933|593771268|FG001|Treatment|Physician Decision|3|||
164382893|NCT01752933|593771267|FG000|Treatment|Death|0|||
164382894|NCT01752933|593771268|FG001|Treatment|Death|2|||
164382895|NCT01752933|593771267|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
164382896|NCT01752933|593771268|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
164382897|NCT01752933|593771267|FG000|Treatment|Patient noncompliant|0|||
164382898|NCT01752933|593771268|FG001|Treatment|Patient noncompliant|1|||
164382899|NCT01752933|593771267|FG000|Treatment|Patient unable to travel to appointments|0|||
164382900|NCT01752933|593771268|FG001|Treatment|Patient unable to travel to appointments|1|||
164382901|NCT01752933|593771267|FG000|Overall Study and Follow-up|Death|4|||
164382902|NCT01752933|593771268|FG001|Overall Study and Follow-up|Death|34|||
164382903|NCT01752933|593771267|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
164382904|NCT01752933|593771268|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
164382905|NCT01752933|593771267|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
164382906|NCT01752933|593771268|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
164382907|NCT01752933|593771267|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
164382908|NCT01752933|593771268|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
164382909|NCT01591681|593771269|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
164382910|NCT01591681|593771269|FG000|Overall Study|Failed to use system during run-in|1|||
164382911|NCT03062891|593771270|FG000|Overall Study|Withdrawal by Subject|2|||
164382912|NCT03062891|593771271|FG001|Overall Study|Withdrawal by Subject|0|||
164382913|NCT03062891|593771270|FG000|Overall Study|Lost to Follow-up|50|||
164382914|NCT03062891|593771271|FG001|Overall Study|Lost to Follow-up|38|||
164382915|NCT01431508|593771285|FG000|Overall Study|Lack of Efficacy|1|||
164382916|NCT01431508|593771285|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
164382917|NCT00132769|593771286|FG000|Overall Study|Withdrawal by Subject|1|||
164382918|NCT00132769|593771287|FG001|Overall Study|Withdrawal by Subject|3|||
164382919|NCT00132769|593771286|FG000|Overall Study|Lack of Efficacy|7|||
164382920|NCT00132769|593771287|FG001|Overall Study|Lack of Efficacy|6|||
164382921|NCT00132769|593771286|FG000|Overall Study|Adverse Event|2|||
164382922|NCT00132769|593771287|FG001|Overall Study|Adverse Event|1|||
164382923|NCT00132769|593771286|FG000|Overall Study|Protocol Violation|1|||
164382924|NCT00132769|593771287|FG001|Overall Study|Protocol Violation|1|||
164382925|NCT02758236|593771289|FG000|Overall Study|Investigator discretion|43|||
164382926|NCT00441337|593771292|FG000|Overall Study|Disease Progression|6|||
164382927|NCT00441337|593771293|FG001|Overall Study|Disease Progression|6|||
164382928|NCT00441337|593771294|FG002|Overall Study|Disease Progression|4|||
164382929|NCT00441337|593771295|FG003|Overall Study|Disease Progression|18|||
164382930|NCT00441337|593771292|FG000|Overall Study|Lost to Follow-up|0|||
164382931|NCT00441337|593771293|FG001|Overall Study|Lost to Follow-up|0|||
164382932|NCT00441337|593771294|FG002|Overall Study|Lost to Follow-up|0|||
164382933|NCT00441337|593771295|FG003|Overall Study|Lost to Follow-up|1|||
164382934|NCT00441337|593771292|FG000|Overall Study|Sponsor Decision|0|||
164382935|NCT00441337|593771293|FG001|Overall Study|Sponsor Decision|0|||
164382936|NCT00441337|593771294|FG002|Overall Study|Sponsor Decision|1|||
164382937|NCT00441337|593771295|FG003|Overall Study|Sponsor Decision|2|||
164382938|NCT00441337|593771292|FG000|Overall Study|Did not meet inclusion criteria|0|||
164382939|NCT00441337|593771293|FG001|Overall Study|Did not meet inclusion criteria|0|||
164382940|NCT00441337|593771294|FG002|Overall Study|Did not meet inclusion criteria|1|||
164382941|NCT00441337|593771295|FG003|Overall Study|Did not meet inclusion criteria|0|||
164382942|NCT03655236|593771296|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
164382943|NCT03655236|593771297|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
164382944|NCT03655236|593771298|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
164382945|NCT03655236|593771296|FG000|Subject Disposition in Part 1 Period|Death|1|||
164382946|NCT03655236|593771297|FG001|Subject Disposition in Part 1 Period|Death|0|||
164382947|NCT03655236|593771298|FG002|Subject Disposition in Part 1 Period|Death|0|||
164382948|NCT03655236|593771296|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
164382949|NCT03655236|593771297|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
164701707|NCT00361335|594932698|FG004|IV Period: Baseline to E0|Other|2|||
164701708|NCT00361335|594932699|FG005|IV Period: Baseline to E0|Other|0|||
164382950|NCT03655236|593771298|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
164382951|NCT03655236|593771296|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
164382952|NCT03655236|593771297|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
164382953|NCT03655236|593771298|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
164382954|NCT03655236|593771296|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
164382955|NCT03655236|593771297|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
164382956|NCT03655236|593771298|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
164382957|NCT03655236|593771296|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
164382958|NCT03655236|593771297|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
164382959|NCT03655236|593771298|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
164382960|NCT03655236|593771296|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
164382961|NCT03655236|593771297|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
164382962|NCT03655236|593771298|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
164382963|NCT03655236|593771296|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
164382964|NCT03655236|593771297|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
164382965|NCT03655236|593771298|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
164382966|NCT03655236|593771296|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
164382967|NCT03655236|593771297|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
164382968|NCT03655236|593771298|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
164382969|NCT03655236|593771296|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
164382970|NCT03655236|593771297|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
164382971|NCT03655236|593771298|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
164382972|NCT03655236|593771296|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
164382973|NCT03655236|593771297|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
164382974|NCT03655236|593771298|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
164382975|NCT03655236|593771296|FG000|Subject Disposition in Part 1 Period|Other|0|||
164382976|NCT03655236|593771297|FG001|Subject Disposition in Part 1 Period|Other|2|||
164382977|NCT03655236|593771298|FG002|Subject Disposition in Part 1 Period|Other|2|||
164382978|NCT03655236|593771296|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
164382979|NCT03655236|593771297|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
164382980|NCT03655236|593771298|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
164382981|NCT03655236|593771296|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
164382982|NCT03655236|593771297|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
164382983|NCT03655236|593771298|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
164382984|NCT03655236|593771296|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
164382985|NCT03655236|593771297|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
164382986|NCT03655236|593771298|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
164382987|NCT03655236|593771296|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
164382988|NCT03655236|593771297|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
164701709|NCT00361335|594932700|FG006|IV Period: Baseline to E0|Other|0|||
164701710|NCT00361335|594932694|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
164701711|NCT00361335|594932695|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
164701712|NCT00361335|594932696|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
164382989|NCT03655236|593771298|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
164382990|NCT03655236|593771296|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
164382991|NCT03655236|593771297|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
164382992|NCT03655236|593771298|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
164382993|NCT03655236|593771296|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
164382994|NCT03655236|593771297|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
164382995|NCT03655236|593771298|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
164382996|NCT03655236|593771296|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
164382997|NCT03655236|593771297|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
164382998|NCT03655236|593771298|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
164382999|NCT03655236|593771296|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
164383000|NCT03655236|593771297|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
164383001|NCT03655236|593771298|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
164383002|NCT03655236|593771296|FG000|Subject Disposition in Part 2 Period|Other|1|||
164383003|NCT03655236|593771297|FG001|Subject Disposition in Part 2 Period|Other|0|||
164383004|NCT03655236|593771298|FG002|Subject Disposition in Part 2 Period|Other|0|||
164383005|NCT06748040|593771299|FG000|Overall Study|Death|3|||
164383006|NCT06748040|593771300|FG001|Overall Study|Death|4|||
164383007|NCT06748040|593771299|FG000|Overall Study|Lost to Follow-up|134|||
164383008|NCT06748040|593771300|FG001|Overall Study|Lost to Follow-up|132|||
164383009|NCT06748040|593771299|FG000|Overall Study|Withdrawal by Subject|3|||
164383010|NCT06748040|593771300|FG001|Overall Study|Withdrawal by Subject|5|||
164383011|NCT01159938|593773435|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
164383012|NCT01159938|593773436|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
164383013|NCT01159938|593773437|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
164383014|NCT01159938|593773438|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
164383015|NCT01159938|593773439|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
164701713|NCT00361335|594932697|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
164701714|NCT00361335|594932698|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
164701715|NCT00361335|594932699|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
164701716|NCT00361335|594932700|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
164701717|NCT00361335|594932694|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
164701718|NCT00361335|594932695|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
164701719|NCT00361335|594932696|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
164701720|NCT00361335|594932697|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
164701721|NCT00361335|594932698|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
164701722|NCT00361335|594932699|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
164701723|NCT00361335|594932700|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
164701724|NCT00361335|594932694|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
164701725|NCT00361335|594932695|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
164701726|NCT00361335|594932696|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
164701727|NCT00361335|594932697|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
164383016|NCT02105116|593773441|FG000|Overall Study|not eligible for step 2 of trial|5|||
164383017|NCT02105116|593773441|FG000|Overall Study|Death|1|||
164383018|NCT02318329|593773443|FG000|Overall Study|Progressive Disease|2|||
164383019|NCT02318329|593773444|FG001|Overall Study|Progressive Disease|3|||
164383020|NCT02318329|593773445|FG002|Overall Study|Progressive Disease|2|||
164383021|NCT02318329|593773446|FG003|Overall Study|Progressive Disease|3|||
164383022|NCT02318329|593773447|FG004|Overall Study|Progressive Disease|3|||
164383023|NCT02318329|593773448|FG005|Overall Study|Progressive Disease|3|||
164383024|NCT02318329|593773449|FG006|Overall Study|Progressive Disease|1|||
164383025|NCT02318329|593773450|FG007|Overall Study|Progressive Disease|1|||
164383026|NCT02318329|593773451|FG008|Overall Study|Progressive Disease|5|||
164383027|NCT02318329|593773452|FG009|Overall Study|Progressive Disease|39|||
164383028|NCT02318329|593773443|FG000|Overall Study|Death|0|||
164383029|NCT02318329|593773444|FG001|Overall Study|Death|0|||
164383030|NCT02318329|593773445|FG002|Overall Study|Death|0|||
164383031|NCT02318329|593773446|FG003|Overall Study|Death|0|||
164383032|NCT02318329|593773447|FG004|Overall Study|Death|0|||
164383033|NCT02318329|593773448|FG005|Overall Study|Death|0|||
164383034|NCT02318329|593773449|FG006|Overall Study|Death|0|||
164383035|NCT02318329|593773450|FG007|Overall Study|Death|0|||
164383036|NCT02318329|593773451|FG008|Overall Study|Death|0|||
164383037|NCT02318329|593773452|FG009|Overall Study|Death|5|||
164383038|NCT02318329|593773443|FG000|Overall Study|Lost to Follow-up|0|||
164383039|NCT02318329|593773444|FG001|Overall Study|Lost to Follow-up|0|||
164383040|NCT02318329|593773445|FG002|Overall Study|Lost to Follow-up|0|||
164383041|NCT02318329|593773446|FG003|Overall Study|Lost to Follow-up|0|||
164383042|NCT02318329|593773447|FG004|Overall Study|Lost to Follow-up|0|||
164383043|NCT02318329|593773448|FG005|Overall Study|Lost to Follow-up|0|||
164383044|NCT02318329|593773449|FG006|Overall Study|Lost to Follow-up|0|||
164383045|NCT02318329|593773450|FG007|Overall Study|Lost to Follow-up|0|||
164383046|NCT02318329|593773451|FG008|Overall Study|Lost to Follow-up|0|||
164383047|NCT02318329|593773452|FG009|Overall Study|Lost to Follow-up|1|||
164383048|NCT02318329|593773443|FG000|Overall Study|Withdrawal by Subject|0|||
164383049|NCT02318329|593773444|FG001|Overall Study|Withdrawal by Subject|0|||
164383050|NCT02318329|593773445|FG002|Overall Study|Withdrawal by Subject|0|||
164383051|NCT02318329|593773446|FG003|Overall Study|Withdrawal by Subject|0|||
164383052|NCT02318329|593773447|FG004|Overall Study|Withdrawal by Subject|0|||
164383053|NCT02318329|593773448|FG005|Overall Study|Withdrawal by Subject|0|||
164383054|NCT02318329|593773449|FG006|Overall Study|Withdrawal by Subject|0|||
164383055|NCT02318329|593773450|FG007|Overall Study|Withdrawal by Subject|0|||
164383056|NCT02318329|593773451|FG008|Overall Study|Withdrawal by Subject|0|||
164383057|NCT02318329|593773452|FG009|Overall Study|Withdrawal by Subject|6|||
164383058|NCT02318329|593773443|FG000|Overall Study|Other|1|||
164383059|NCT02318329|593773444|FG001|Overall Study|Other|1|||
164383060|NCT02318329|593773445|FG002|Overall Study|Other|1|||
164383061|NCT02318329|593773446|FG003|Overall Study|Other|0|||
164383062|NCT02318329|593773447|FG004|Overall Study|Other|0|||
164383063|NCT02318329|593773448|FG005|Overall Study|Other|0|||
164383064|NCT02318329|593773449|FG006|Overall Study|Other|0|||
164383065|NCT02318329|593773450|FG007|Overall Study|Other|0|||
164383066|NCT02318329|593773451|FG008|Overall Study|Other|1|||
164383067|NCT02318329|593773452|FG009|Overall Study|Other|1|||
164383068|NCT04837482|593773453|FG000|Period 2|Withdrawal by Subject|0|||
164383069|NCT04837482|593773454|FG001|Period 2|Withdrawal by Subject|1|||
164383070|NCT00581945|593773455|FG000|Overall Study|Adverse Event|4|||
164383071|NCT00581945|593773456|FG001|Overall Study|Adverse Event|4|||
164701728|NCT00361335|594932698|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
164701729|NCT00361335|594932699|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
164701730|NCT00361335|594932700|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
164383072|NCT00581945|593773455|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164383073|NCT00581945|593773456|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164383074|NCT00581945|593773455|FG000|Overall Study|Withdrawal by Subject|2|||
164383075|NCT00581945|593773456|FG001|Overall Study|Withdrawal by Subject|6|||
164383076|NCT00581945|593773455|FG000|Overall Study|Death|1|||
164383077|NCT00581945|593773456|FG001|Overall Study|Death|0|||
164383078|NCT02979535|593773457|FG000|Overall Study|Non compliance with the protocol|78|||
164383079|NCT02979535|593773458|FG001|Overall Study|Non compliance with the protocol|82|||
164383080|NCT02979535|593773457|FG000|Overall Study|Consent withdrawn by participant|11|||
164383081|NCT02979535|593773458|FG001|Overall Study|Consent withdrawn by participant|18|||
164383082|NCT02979535|593773457|FG000|Overall Study|Lost to Follow-up|6|||
164701731|NCT00361335|594932694|FG000|SC Period: Week E0 to Week E24|Death|0|||
164701732|NCT00361335|594932695|FG001|SC Period: Week E0 to Week E24|Death|0|||
164701733|NCT00361335|594932696|FG002|SC Period: Week E0 to Week E24|Death|0|||
164701734|NCT00361335|594932697|FG003|SC Period: Week E0 to Week E24|Death|0|||
164701735|NCT00361335|594932698|FG004|SC Period: Week E0 to Week E24|Death|0|||
164701736|NCT00361335|594932699|FG005|SC Period: Week E0 to Week E24|Death|0|||
164701737|NCT00361335|594932700|FG006|SC Period: Week E0 to Week E24|Death|1|||
164701738|NCT00361335|594932694|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
164701739|NCT00361335|594932695|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
164701740|NCT00361335|594932696|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
164701741|NCT00361335|594932697|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
164701742|NCT00361335|594932698|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
164701743|NCT00361335|594932699|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
164701744|NCT00361335|594932700|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
164701745|NCT00361335|594932694|FG000|SC Period: Week E0 to Week E24|Other|1|||
164701746|NCT00361335|594932695|FG001|SC Period: Week E0 to Week E24|Other|0|||
164701747|NCT00361335|594932696|FG002|SC Period: Week E0 to Week E24|Other|0|||
164701748|NCT00361335|594932697|FG003|SC Period: Week E0 to Week E24|Other|1|||
164701749|NCT00361335|594932698|FG004|SC Period: Week E0 to Week E24|Other|0|||
164701750|NCT00361335|594932699|FG005|SC Period: Week E0 to Week E24|Other|1|||
164701751|NCT00361335|594932700|FG006|SC Period: Week E0 to Week E24|Other|2|||
164701752|NCT00361335|594932694|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
164701753|NCT00361335|594932695|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
164701754|NCT00361335|594932696|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
164701755|NCT00361335|594932697|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
164701756|NCT00361335|594932698|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
164701757|NCT00361335|594932699|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
164701758|NCT00361335|594932700|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
164701759|NCT01765582|594932707|FG000|Overall Study|Other|3|||
164701760|NCT01765582|594932708|FG001|Overall Study|Other|6|||
164701761|NCT01765582|594932709|FG002|Overall Study|Other|9|||
164701762|NCT01765582|594932707|FG000|Overall Study|Lost to Follow-up|2|||
164701763|NCT01765582|594932708|FG001|Overall Study|Lost to Follow-up|2|||
164701764|NCT01765582|594932709|FG002|Overall Study|Lost to Follow-up|1|||
164701765|NCT01765582|594932707|FG000|Overall Study|Death|31|||
164701766|NCT01765582|594932708|FG001|Overall Study|Death|36|||
164701767|NCT01765582|594932709|FG002|Overall Study|Death|33|||
164701768|NCT01765582|594932707|FG000|Overall Study|Sponsor Decision|46|||
164701769|NCT01765582|594932708|FG001|Overall Study|Sponsor Decision|42|||
164701770|NCT01765582|594932709|FG002|Overall Study|Sponsor Decision|42|||
164701771|NCT01765582|594932707|FG000|Overall Study|Withdrawal of Consent|11|||
164701772|NCT01765582|594932708|FG001|Overall Study|Withdrawal of Consent|6|||
164701773|NCT01765582|594932709|FG002|Overall Study|Withdrawal of Consent|10|||
164701774|NCT03251963|594932712|FG000|Overall Study|inappropriate Xa level timing|6|||
164701775|NCT03251963|594932713|FG001|Overall Study|inappropriate Xa level timing|3|||
164701776|NCT03251963|594932712|FG000|Overall Study|no peak Xa level drawn|2|||
164701777|NCT03251963|594932713|FG001|Overall Study|no peak Xa level drawn|0|||
164701778|NCT03251963|594932712|FG000|Overall Study|bled prior to Xa level|1|||
164701779|NCT03251963|594932713|FG001|Overall Study|bled prior to Xa level|2|||
164701780|NCT00616941|594932714|FG000|Overall Study|Progressive Disease|1|||
164701781|NCT00616941|594932715|FG001|Overall Study|Progressive Disease|2|||
164701782|NCT00616941|594932716|FG002|Overall Study|Progressive Disease|1|||
164701783|NCT00616941|594932714|FG000|Overall Study|Adverse Event|0|||
164701784|NCT00616941|594932715|FG001|Overall Study|Adverse Event|1|||
164701785|NCT00616941|594932716|FG002|Overall Study|Adverse Event|1|||
164701786|NCT00616941|594932714|FG000|Overall Study|Subject Non-compliance|0|||
164701787|NCT00616941|594932715|FG001|Overall Study|Subject Non-compliance|0|||
164701788|NCT00616941|594932716|FG002|Overall Study|Subject Non-compliance|1|||
164701789|NCT00616941|594932714|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
164701790|NCT00616941|594932715|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
164701791|NCT00616941|594932716|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
164701792|NCT00616941|594932714|FG000|Overall Study|Vaccination Suspended|0|||
164701793|NCT00616941|594932715|FG001|Overall Study|Vaccination Suspended|0|||
164701794|NCT00616941|594932716|FG002|Overall Study|Vaccination Suspended|3|||
164701795|NCT00714493|594932727|FG000|Overall Study|Adverse Event|11|||
164701796|NCT00714493|594932727|FG000|Overall Study|Death|3|||
164701797|NCT00714493|594932727|FG000|Overall Study|Lack of Efficacy|10|||
164701798|NCT00714493|594932727|FG000|Overall Study|Lost to Follow-up|3|||
164701799|NCT00714493|594932727|FG000|Overall Study|Protocol Violation|12|||
164701800|NCT00714493|594932727|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
164701801|NCT00714493|594932727|FG000|Overall Study|OTHER|2|||
164701802|NCT00076804|594932728|FG000|Overall Study|Death|9|||
164701803|NCT00076804|594932729|FG001|Overall Study|Death|20|||
164701804|NCT00076804|594932728|FG000|Overall Study|Lost to Follow-up|9|||
164701805|NCT00076804|594932729|FG001|Overall Study|Lost to Follow-up|9|||
164701806|NCT00076804|594932728|FG000|Overall Study|Withdrawal by Subject|10|||
164592402|NCT05619172|594532510|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
164592403|NCT05619172|594532509|FG000|Safety Cohort 2|Death|0|||
164592404|NCT05619172|594532510|FG001|Safety Cohort 2|Death|1|||
164592405|NCT05619172|594532509|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
164592406|NCT05619172|594532510|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
164592407|NCT01429792|594532511|FG000|Overall Study|Other Reasons|67|||
164592408|NCT01429792|594532511|FG000|Overall Study|Unknown Disposition|94|||
164592409|NCT01429792|594532511|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
164592410|NCT01429792|594532511|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
164592411|NCT01429792|594532511|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
164592412|NCT01429792|594532511|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
164592413|NCT01429792|594532511|FG000|Overall Study|Withdrawal by Subject|70|||
164592414|NCT01429792|594532511|FG000|Overall Study|Lost to Follow-up|88|||
164592415|NCT01763905|594532514|FG000|Overall Study|Withdrawal by Subject|1|||
164592416|NCT01763905|594532515|FG001|Overall Study|Withdrawal by Subject|1|||
164592417|NCT01763905|594532516|FG002|Overall Study|Withdrawal by Subject|0|||
164592418|NCT01763905|594532517|FG003|Overall Study|Withdrawal by Subject|1|||
164592419|NCT01763905|594532514|FG000|Overall Study|Decision by sponsor|5|||
164592420|NCT01763905|594532515|FG001|Overall Study|Decision by sponsor|0|||
164592421|NCT01763905|594532516|FG002|Overall Study|Decision by sponsor|8|||
164592422|NCT01763905|594532517|FG003|Overall Study|Decision by sponsor|0|||
164701807|NCT00076804|594932729|FG001|Overall Study|Withdrawal by Subject|8|||
164701808|NCT00076804|594932728|FG000|Overall Study|Early study Closure|32|||
164701809|NCT00076804|594932729|FG001|Overall Study|Early study Closure|32|||
164383083|NCT02979535|593773458|FG001|Overall Study|Lost to Follow-up|1|||
164383084|NCT04820673|593773459|FG000|Overall Study|Adverse Event|6|||
164383085|NCT04820673|593773459|FG000|Overall Study|Due to Lack of Effectiveness|1|||
164383086|NCT04820673|593773459|FG000|Overall Study|Pregnancy|1|||
164383087|NCT04820673|593773459|FG000|Overall Study|Voluntary Withdrawal|20|||
164383088|NCT04820673|593773459|FG000|Overall Study|Lost to Follow-up|10|||
164383089|NCT00587587|593773462|FG000|Overall Study|Lost to Follow-up|6|||
164383090|NCT00587587|593773463|FG001|Overall Study|Lost to Follow-up|1|||
164383091|NCT02032901|593773466|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
164383092|NCT02032901|593773467|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
164383093|NCT02032901|593773466|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
164383094|NCT02032901|593773467|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
164383095|NCT00466193|593773468|FG000|Overall Study|Adverse Event|0|||
164383096|NCT00466193|593773469|FG001|Overall Study|Adverse Event|1|||
164383097|NCT00466193|593773468|FG000|Overall Study|Lost to Follow-up|2|||
164383098|NCT00466193|593773469|FG001|Overall Study|Lost to Follow-up|4|||
164383099|NCT00466193|593773468|FG000|Overall Study|Physician Decision|1|||
164383100|NCT00466193|593773469|FG001|Overall Study|Physician Decision|0|||
164383101|NCT00466193|593773468|FG000|Overall Study|Protocol Violation|1|||
164383102|NCT00466193|593773469|FG001|Overall Study|Protocol Violation|1|||
164383103|NCT00466193|593773468|FG000|Overall Study|Withdrawal by Subject|7|||
164383104|NCT00466193|593773469|FG001|Overall Study|Withdrawal by Subject|2|||
164383105|NCT00466193|593773468|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
164383106|NCT00466193|593773469|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
164383107|NCT00086346|593773476|FG000|Randomization|Did not receive test article|4|||
164383108|NCT00086346|593773477|FG001|Randomization|Did not receive test article|4|||
164383109|NCT00086346|593773476|FG000|Patients Dosed With Test Article|Adverse Event|94|||
164383110|NCT00086346|593773477|FG001|Patients Dosed With Test Article|Adverse Event|11|||
164440010|NCT05758415|593978858|FG000|Overall Study|Subject Decision|2|||
164440011|NCT05758415|593978859|FG001|Overall Study|Subject Decision|5|||
164440012|NCT05758415|593978858|FG000|Overall Study|Lost to Follow-up|0|||
164440013|NCT05758415|593978859|FG001|Overall Study|Lost to Follow-up|1|||
164440014|NCT01266265|593978860|FG000|Overall Study|Death|95|||
164440015|NCT01266265|593978861|FG001|Overall Study|Death|73|||
164440016|NCT01266265|593978860|FG000|Overall Study|Lost to Follow-up|23|||
164440017|NCT01266265|593978861|FG001|Overall Study|Lost to Follow-up|28|||
164440018|NCT01266265|593978860|FG000|Overall Study|Withdrawal by Subject|13|||
164701810|NCT00354341|594932730|FG000|Overall Study|Adverse Event|1|||
164701811|NCT00354341|594932731|FG001|Overall Study|Adverse Event|0|||
164592423|NCT01763905|594532514|FG000|Overall Study|Lost to Follow-up|0|||
164701812|NCT00354341|594932730|FG000|Overall Study|Death|0|||
164383111|NCT00086346|593773476|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
164383112|NCT00086346|593773477|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
164383113|NCT00086346|593773476|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
164592424|NCT01763905|594532515|FG001|Overall Study|Lost to Follow-up|0|||
164592425|NCT01763905|594532516|FG002|Overall Study|Lost to Follow-up|1|||
164592426|NCT01763905|594532517|FG003|Overall Study|Lost to Follow-up|0|||
164701813|NCT00354341|594932731|FG001|Overall Study|Death|2|||
164383114|NCT00086346|593773477|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
164383115|NCT00086346|593773476|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
164440019|NCT01266265|593978861|FG001|Overall Study|Withdrawal by Subject|11|||
164440020|NCT01266265|593978860|FG000|Overall Study|Respiratory-related adverse event|2|||
164592427|NCT03165721|594532518|FG000|Overall Study|Refused further treatment|3|||
164383116|NCT00086346|593773477|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
164383117|NCT00086346|593773476|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
164383118|NCT00086346|593773477|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
164383119|NCT00086346|593773476|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
164383120|NCT00086346|593773477|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
164383121|NCT04495374|593773478|FG000|Overall Study|Protocol Violation|2|||
164383122|NCT04495374|593773479|FG001|Overall Study|Protocol Violation|1|||
164440021|NCT01266265|593978861|FG001|Overall Study|Respiratory-related adverse event|1|||
164440022|NCT01266265|593978860|FG000|Overall Study|Transferred care to another provider|22|||
164440023|NCT01266265|593978861|FG001|Overall Study|Transferred care to another provider|28|||
164440024|NCT01266265|593978860|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
164440025|NCT01266265|593978861|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
164440026|NCT01266265|593978860|FG000|Overall Study|Enrolled in another clinical study|15|||
164440027|NCT01266265|593978861|FG001|Overall Study|Enrolled in another clinical study|26|||
164440028|NCT01266265|593978860|FG000|Overall Study|Non-compliance|8|||
164440029|NCT01266265|593978861|FG001|Overall Study|Non-compliance|5|||
164440030|NCT01266265|593978860|FG000|Overall Study|Lung transplant|6|||
164440031|NCT01266265|593978861|FG001|Overall Study|Lung transplant|5|||
164440032|NCT01266265|593978860|FG000|Overall Study|Site closed early|4|||
164440033|NCT01266265|593978861|FG001|Overall Study|Site closed early|3|||
164440034|NCT01266265|593978860|FG000|Overall Study|Clinical worsening|1|||
164440035|NCT01266265|593978861|FG001|Overall Study|Clinical worsening|1|||
164440036|NCT01134562|593978862|FG000|Overall Study|Adverse Event|0|||
164440037|NCT01134562|593978863|FG001|Overall Study|Adverse Event|1|||
164440038|NCT01134562|593978864|FG002|Overall Study|Adverse Event|0|||
164440039|NCT01134562|593978865|FG003|Overall Study|Adverse Event|0|||
164440040|NCT01134562|593978866|FG004|Overall Study|Adverse Event|0|||
164440041|NCT00941655|593978869|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
164440042|NCT00941655|593978870|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
164440043|NCT00941655|593978869|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
164440044|NCT00941655|593978870|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
164440045|NCT00941655|593978869|FG000|Overall Study|progressed while on chemo|0|||
164440046|NCT00941655|593978870|FG001|Overall Study|progressed while on chemo|2|||
164440047|NCT00941655|593978869|FG000|Overall Study|refused further treatment|0|||
164440048|NCT00941655|593978870|FG001|Overall Study|refused further treatment|1|||
164440049|NCT00941655|593978869|FG000|Overall Study|withdrew consent|0|||
164383123|NCT02473614|593773480|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
164383124|NCT02473614|593773481|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
164440050|NCT00941655|593978870|FG001|Overall Study|withdrew consent|1|||
164440051|NCT00941655|593978869|FG000|Overall Study|non-compliant|0|||
164440052|NCT00941655|593978870|FG001|Overall Study|non-compliant|1|||
164440053|NCT00446550|593978871|FG000|Overall Study|Adverse Event|1|||
164440054|NCT00446550|593978872|FG001|Overall Study|Adverse Event|0|||
164440055|NCT01616654|593978873|FG000|Overall Study|Lack of Efficacy|1|||
164440056|NCT01616654|593978874|FG001|Overall Study|Lack of Efficacy|0|||
164440057|NCT01616654|593978875|FG002|Overall Study|Lack of Efficacy|0|||
164440058|NCT01616654|593978876|FG003|Overall Study|Lack of Efficacy|0|||
164440059|NCT01616654|593978877|FG004|Overall Study|Lack of Efficacy|1|||
164440060|NCT01616654|593978873|FG000|Overall Study|Adverse Event|0|||
164440061|NCT01616654|593978874|FG001|Overall Study|Adverse Event|1|||
164440062|NCT01616654|593978875|FG002|Overall Study|Adverse Event|2|||
164440063|NCT01616654|593978876|FG003|Overall Study|Adverse Event|1|||
164440064|NCT01616654|593978877|FG004|Overall Study|Adverse Event|0|||
164440065|NCT01616654|593978873|FG000|Overall Study|Withdrawal by Subject|2|||
164440066|NCT01616654|593978874|FG001|Overall Study|Withdrawal by Subject|2|||
164440067|NCT01616654|593978875|FG002|Overall Study|Withdrawal by Subject|3|||
164440068|NCT01616654|593978876|FG003|Overall Study|Withdrawal by Subject|1|||
164440069|NCT01616654|593978877|FG004|Overall Study|Withdrawal by Subject|5|||
164440070|NCT01616654|593978873|FG000|Overall Study|Protocol Violation|0|||
164440071|NCT01616654|593978874|FG001|Overall Study|Protocol Violation|5|||
164440072|NCT01616654|593978875|FG002|Overall Study|Protocol Violation|2|||
164440073|NCT01616654|593978876|FG003|Overall Study|Protocol Violation|4|||
164440074|NCT01616654|593978877|FG004|Overall Study|Protocol Violation|4|||
164440075|NCT01616654|593978873|FG000|Overall Study|Lost to Follow-up|1|||
164440076|NCT01616654|593978874|FG001|Overall Study|Lost to Follow-up|0|||
164440077|NCT01616654|593978875|FG002|Overall Study|Lost to Follow-up|3|||
164440078|NCT01616654|593978876|FG003|Overall Study|Lost to Follow-up|2|||
164440079|NCT01616654|593978877|FG004|Overall Study|Lost to Follow-up|1|||
164440080|NCT01616654|593978873|FG000|Overall Study|Pregnancy|1|||
164440081|NCT01616654|593978874|FG001|Overall Study|Pregnancy|0|||
164440082|NCT01616654|593978875|FG002|Overall Study|Pregnancy|0|||
164440083|NCT01616654|593978876|FG003|Overall Study|Pregnancy|0|||
164701814|NCT00354341|594932730|FG000|Overall Study|Refused treatment|1|||
164440084|NCT01616654|593978877|FG004|Overall Study|Pregnancy|1|||
164440085|NCT02057692|593978878|FG000|Overall Study|Adverse Event|1|||
164440086|NCT02057692|593978879|FG001|Overall Study|Adverse Event|0|||
164440087|NCT02057692|593978880|FG002|Overall Study|Adverse Event|0|||
164383125|NCT02525133|593773482|FG000|Overall Study|Adverse Event|0|||
164383126|NCT02525133|593773483|FG001|Overall Study|Adverse Event|1|||
164383127|NCT02525133|593773482|FG000|Overall Study|Death|0|||
164383128|NCT02525133|593773483|FG001|Overall Study|Death|1|||
164383129|NCT02525133|593773482|FG000|Overall Study|did not meet randomization criteria|1|||
164383130|NCT02525133|593773483|FG001|Overall Study|did not meet randomization criteria|0|||
164383131|NCT02525133|593773482|FG000|Overall Study|Lost to Follow-up|5|||
164383132|NCT02525133|593773483|FG001|Overall Study|Lost to Follow-up|1|||
164383133|NCT02525133|593773482|FG000|Overall Study|randomized not enrolled|3|||
164383134|NCT02525133|593773483|FG001|Overall Study|randomized not enrolled|0|||
164383135|NCT02525133|593773482|FG000|Overall Study|Withdrawal by Subject|1|||
164383136|NCT02525133|593773483|FG001|Overall Study|Withdrawal by Subject|0|||
164383137|NCT01343082|593773484|FG000|The run-in Period|Not meeting criteria|3|||
164383138|NCT01343082|593773485|FG001|The run-in Period|Not meeting criteria|4|||
164383139|NCT01343082|593773486|FG002|The run-in Period|Not meeting criteria|5|||
164383140|NCT01343082|593773484|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
164383141|NCT01343082|593773485|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
164383142|NCT01343082|593773486|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
164383143|NCT01343082|593773484|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
164383144|NCT01343082|593773485|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
164383145|NCT01343082|593773486|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
164383146|NCT01343082|593773484|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
164383147|NCT01343082|593773485|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
164383148|NCT01343082|593773486|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
164701815|NCT00354341|594932731|FG001|Overall Study|Refused treatment|2|||
164701816|NCT00354341|594932730|FG000|Overall Study|Failure to return|0|||
164701817|NCT00354341|594932731|FG001|Overall Study|Failure to return|1|||
164701818|NCT00354341|594932730|FG000|Overall Study|Other|1|||
164701819|NCT00354341|594932731|FG001|Overall Study|Other|2|||
164701820|NCT00251719|594932732|FG000|Overall Study|Adverse Event|14|||
164701821|NCT00251719|594932733|FG001|Overall Study|Adverse Event|8|||
164701822|NCT00251719|594932734|FG002|Overall Study|Adverse Event|7|||
164701823|NCT00251719|594932732|FG000|Overall Study|Protocol Violation|1|||
164701824|NCT00251719|594932733|FG001|Overall Study|Protocol Violation|1|||
164701825|NCT00251719|594932734|FG002|Overall Study|Protocol Violation|1|||
164701826|NCT00251719|594932732|FG000|Overall Study|Lost to Follow-up|5|||
164701827|NCT00251719|594932733|FG001|Overall Study|Lost to Follow-up|11|||
164701828|NCT00251719|594932734|FG002|Overall Study|Lost to Follow-up|8|||
164701829|NCT00251719|594932732|FG000|Overall Study|Withdrawal by Subject|14|||
164701830|NCT00251719|594932733|FG001|Overall Study|Withdrawal by Subject|12|||
164701831|NCT00251719|594932734|FG002|Overall Study|Withdrawal by Subject|11|||
164701832|NCT00251719|594932732|FG000|Overall Study|Lack of Efficacy|2|||
164701833|NCT00251719|594932733|FG001|Overall Study|Lack of Efficacy|1|||
164701834|NCT00251719|594932734|FG002|Overall Study|Lack of Efficacy|0|||
164701835|NCT00251719|594932732|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
164701836|NCT00251719|594932733|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
164701837|NCT00251719|594932734|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
164701838|NCT00251719|594932732|FG000|Overall Study|Investigator decision|1|||
164701839|NCT00251719|594932733|FG001|Overall Study|Investigator decision|1|||
164383149|NCT01343082|593773484|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
164383150|NCT01343082|593773485|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
164383151|NCT01343082|593773486|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
164383152|NCT01075074|593773487|FG000|Overall Study|Surgeon changed to open incisional case|1|||
164383153|NCT01075074|593773488|FG001|Overall Study|Surgeon changed to open incisional case|2|||
164383154|NCT01075074|593773489|FG002|Overall Study|Surgeon changed to open incisional case|2|||
164383155|NCT01375049|593773491|FG000|Overall Study|Adverse Event|2|||
164383156|NCT01375049|593773491|FG000|Overall Study|Lost to Follow-up|1|||
164383157|NCT01375049|593773491|FG000|Overall Study|Withdrawal by Subject|2|||
164383158|NCT01375049|593773491|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
164383159|NCT02082522|593773492|FG000|Overall Study|Sponsor termination|5|||
164383160|NCT02082522|593773493|FG001|Overall Study|Sponsor termination|3|||
164383161|NCT02082522|593773492|FG000|Overall Study|Withdrawal by Subject|2|||
164383162|NCT02082522|593773493|FG001|Overall Study|Withdrawal by Subject|4|||
164701840|NCT00251719|594932734|FG002|Overall Study|Investigator decision|0|||
164701841|NCT00251719|594932732|FG000|Overall Study|Noncompliance|2|||
164383163|NCT02082522|593773492|FG000|Overall Study|Death|1|||
164701842|NCT00251719|594932733|FG001|Overall Study|Noncompliance|3|||
164701843|NCT00251719|594932734|FG002|Overall Study|Noncompliance|1|||
164383164|NCT02082522|593773493|FG001|Overall Study|Death|0|||
164383165|NCT02082522|593773492|FG000|Overall Study|Lost to Follow-up|1|||
164383166|NCT02082522|593773493|FG001|Overall Study|Lost to Follow-up|0|||
164383167|NCT02082522|593773492|FG000|Overall Study|Physician Decision|3|||
164383168|NCT02082522|593773493|FG001|Overall Study|Physician Decision|1|||
164383169|NCT02082522|593773492|FG000|Overall Study|Disease progression|2|||
164383170|NCT02082522|593773493|FG001|Overall Study|Disease progression|2|||
164383171|NCT02082522|593773492|FG000|Overall Study|Chemotherapy change|1|||
164383172|NCT02082522|593773493|FG001|Overall Study|Chemotherapy change|3|||
164383173|NCT00633984|593773494|FG000|Overall Study|Lost to Follow-up|0|||
164383174|NCT00633984|593773495|FG001|Overall Study|Lost to Follow-up|6|||
164383175|NCT00633984|593773494|FG000|Overall Study|Withdrawal by Subject|8|||
164383176|NCT00633984|593773495|FG001|Overall Study|Withdrawal by Subject|7|||
164383177|NCT00633984|593773494|FG000|Overall Study|Hospitalized|1|||
164383178|NCT00633984|593773495|FG001|Overall Study|Hospitalized|0|||
164383179|NCT02496884|593773496|FG000|Overall Study|Counted twice as enrolled|2|||
164383180|NCT02496884|593773497|FG001|Overall Study|Counted twice as enrolled|0|||
164383181|NCT02496884|593773498|FG002|Overall Study|Counted twice as enrolled|0|||
164383182|NCT02496884|593773499|FG003|Overall Study|Counted twice as enrolled|0|||
164383183|NCT02496884|593773496|FG000|Overall Study|Withdrawal by Subject|0|||
164383184|NCT02496884|593773497|FG001|Overall Study|Withdrawal by Subject|3|||
164383185|NCT02496884|593773498|FG002|Overall Study|Withdrawal by Subject|0|||
164383186|NCT02496884|593773499|FG003|Overall Study|Withdrawal by Subject|0|||
164383187|NCT01168999|593773500|FG000|Overall Study|Lost to Follow-up|2|||
164383188|NCT01168999|593773501|FG001|Overall Study|Lost to Follow-up|1|||
164383189|NCT01168999|593773502|FG002|Overall Study|Lost to Follow-up|0|||
164383190|NCT01168999|593773503|FG003|Overall Study|Lost to Follow-up|0|||
164383191|NCT03766646|593773504|FG000|Overall Study|Withdrawal by Subject|1|||
164383192|NCT03766646|593773505|FG001|Overall Study|Withdrawal by Subject|0|||
164383193|NCT03766646|593773504|FG000|Overall Study|Protocol Violation|0|||
164383194|NCT03766646|593773505|FG001|Overall Study|Protocol Violation|3|||
164383195|NCT01854554|593773509|FG000|Overall Study|Denial of Insurance Coverage|12|||
164383196|NCT01854554|593773510|FG001|Overall Study|Denial of Insurance Coverage|0|||
164383197|NCT01854554|593773509|FG000|Overall Study|Decided to get treatment locally|1|||
164383198|NCT01854554|593773510|FG001|Overall Study|Decided to get treatment locally|5|||
164383199|NCT01854554|593773509|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
164383200|NCT01854554|593773510|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
164383201|NCT01854554|593773509|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
164383202|NCT01854554|593773510|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
164383203|NCT01854554|593773509|FG000|Overall Study|Progression|0|||
164383204|NCT01854554|593773510|FG001|Overall Study|Progression|1|||
164383205|NCT01854554|593773509|FG000|Overall Study|Lost to Follow-up|0|||
164383206|NCT01854554|593773510|FG001|Overall Study|Lost to Follow-up|1|||
164383207|NCT02819726|593773511|FG000|Part A (All Participants)|Lost to Follow-up|0|||
164383208|NCT02819726|593773512|FG001|Part A (All Participants)|Lost to Follow-up|1|||
164383209|NCT02819726|593773513|FG002|Part A (All Participants)|Lost to Follow-up|0|||
164383210|NCT02819726|593773514|FG003|Part A (All Participants)|Lost to Follow-up|0|||
164383211|NCT02819726|593773511|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
164383212|NCT02819726|593773512|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
164383213|NCT02819726|593773513|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
164383214|NCT02819726|593773514|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
164383215|NCT02819726|593773511|FG000|Part A (All Participants)|Protocol non-compliance|3|||
164383216|NCT02819726|593773512|FG001|Part A (All Participants)|Protocol non-compliance|4|||
164383217|NCT02819726|593773513|FG002|Part A (All Participants)|Protocol non-compliance|5|||
164383218|NCT02819726|593773514|FG003|Part A (All Participants)|Protocol non-compliance|0|||
164383219|NCT02819726|593773511|FG000|Part B (All Participants)|Lost to Follow-up|1|||
164383220|NCT02819726|593773512|FG001|Part B (All Participants)|Lost to Follow-up|1|||
164383221|NCT02819726|593773513|FG002|Part B (All Participants)|Lost to Follow-up|2|||
164383222|NCT02819726|593773514|FG003|Part B (All Participants)|Lost to Follow-up|2|||
164383223|NCT02819726|593773511|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
164383224|NCT02819726|593773512|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
164383225|NCT02819726|593773513|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
164383226|NCT02819726|593773514|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
164383227|NCT02819726|593773511|FG000|Part B (All Participants)|Protocol non-compliance|0|||
164383228|NCT02819726|593773512|FG001|Part B (All Participants)|Protocol non-compliance|0|||
164383229|NCT02819726|593773513|FG002|Part B (All Participants)|Protocol non-compliance|1|||
164383230|NCT02819726|593773514|FG003|Part B (All Participants)|Protocol non-compliance|0|||
164383231|NCT00803023|593773517|FG000|Overall Study|Adverse Event|5|||
164383232|NCT00803023|593773518|FG001|Overall Study|Adverse Event|4|||
164383233|NCT00803023|593773519|FG002|Overall Study|Adverse Event|8|||
164383234|NCT00803023|593773520|FG003|Overall Study|Adverse Event|6|||
164383235|NCT00803023|593773517|FG000|Overall Study|Withdrawal by Subject|0|||
164383236|NCT00803023|593773518|FG001|Overall Study|Withdrawal by Subject|2|||
164383237|NCT00803023|593773519|FG002|Overall Study|Withdrawal by Subject|0|||
164383238|NCT00803023|593773520|FG003|Overall Study|Withdrawal by Subject|0|||
164383239|NCT00803023|593773517|FG000|Overall Study|Lost to Follow-up|0|||
164383240|NCT00803023|593773518|FG001|Overall Study|Lost to Follow-up|1|||
164383241|NCT00803023|593773519|FG002|Overall Study|Lost to Follow-up|2|||
164383242|NCT00803023|593773520|FG003|Overall Study|Lost to Follow-up|1|||
164383243|NCT00803023|593773517|FG000|Overall Study|Lack of Efficacy|0|||
164383244|NCT00803023|593773518|FG001|Overall Study|Lack of Efficacy|1|||
164383245|NCT00803023|593773519|FG002|Overall Study|Lack of Efficacy|1|||
164592428|NCT03165721|594532519|FG001|Overall Study|Refused further treatment|0|||
164592429|NCT03165721|594532520|FG002|Overall Study|Refused further treatment|0|||
164592430|NCT03165721|594532518|FG000|Overall Study|Physician Decision|1|||
164592431|NCT03165721|594532519|FG001|Overall Study|Physician Decision|0|||
164592432|NCT03165721|594532520|FG002|Overall Study|Physician Decision|0|||
164592433|NCT02324842|594532521|FG000|Overall Study|Lost to Follow-up|1|||
164592434|NCT02324842|594532522|FG001|Overall Study|Lost to Follow-up|1|||
164383246|NCT00803023|593773520|FG003|Overall Study|Lack of Efficacy|1|||
164592435|NCT02324842|594532523|FG002|Overall Study|Lost to Follow-up|2|||
164592436|NCT01202227|594532524|FG000|Overall Study|Adverse Event|16|||
164592437|NCT01202227|594532524|FG000|Overall Study|Withdrawal by Subject|2|||
164592438|NCT01202227|594532524|FG000|Overall Study|Lack of Efficacy|1|||
164592439|NCT01894477|594532525|FG000|Overall Study|Protocol Violation|0|||
164383247|NCT02647658|593773521|FG000|Overall Study|Consent refusal|15|||
164383248|NCT02647658|593773522|FG001|Overall Study|Consent refusal|24|||
164383249|NCT04382326|593773524|FG000|Overall Study|Adverse Event, not serious|1|||
164383250|NCT04382326|593773525|FG001|Overall Study|Adverse Event, not serious|2|||
164383251|NCT04382326|593773524|FG000|Overall Study|Other|1|||
164383252|NCT04382326|593773525|FG001|Overall Study|Other|0|||
164383253|NCT04382326|593773524|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
164383254|NCT04382326|593773525|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
164383255|NCT04382326|593773524|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
164383256|NCT04382326|593773525|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
164383257|NCT04382326|593773524|FG000|Overall Study|Protocol Violation|29|||
164383258|NCT04382326|593773525|FG001|Overall Study|Protocol Violation|23|||
164383259|NCT04382326|593773524|FG000|Overall Study|Physician Decision|0|||
164383260|NCT04382326|593773525|FG001|Overall Study|Physician Decision|1|||
164383261|NCT04382326|593773524|FG000|Overall Study|Lost to Follow-up|48|||
164592440|NCT01894477|594532526|FG001|Overall Study|Protocol Violation|1|||
164592441|NCT01894477|594532525|FG000|Overall Study|protocol changed due SC changed to cord|0|||
164592442|NCT01894477|594532526|FG001|Overall Study|protocol changed due SC changed to cord|1|||
164592443|NCT01554956|594532528|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
164592444|NCT01554956|594532529|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
164592445|NCT01554956|594532530|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
164592446|NCT01554956|594532528|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
164592447|NCT01554956|594532529|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
164592448|NCT01554956|594532530|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
164592449|NCT01554956|594532528|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
164592450|NCT01554956|594532529|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
164592451|NCT01554956|594532530|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
164592452|NCT05761444|594532531|FG000|Overall Study|Protocol Violation|2|||
164592453|NCT05761444|594532532|FG001|Overall Study|Protocol Violation|1|||
164592454|NCT05761444|594532531|FG000|Overall Study|Adverse Event|2|||
164440088|NCT02057692|593978881|FG003|Overall Study|Adverse Event|0|||
164440089|NCT02057692|593978878|FG000|Overall Study|Lost to Follow-up|0|||
164440090|NCT02057692|593978879|FG001|Overall Study|Lost to Follow-up|0|||
164592455|NCT05761444|594532532|FG001|Overall Study|Adverse Event|2|||
164592456|NCT05761444|594532531|FG000|Overall Study|Withdrawal by Subject|3|||
164383262|NCT04382326|593773525|FG001|Overall Study|Lost to Follow-up|63|||
164383263|NCT04382326|593773524|FG000|Overall Study|Adverse Event, non-fatal|1|||
164383264|NCT04382326|593773525|FG001|Overall Study|Adverse Event, non-fatal|1|||
164383265|NCT01181921|593773526|FG000|Overall Study|Lost to Follow-up|1|||
164383266|NCT02461589|593773527|FG000|Overall Study|Withdrawal by Subject|5|||
164383267|NCT02461589|593773528|FG001|Overall Study|Withdrawal by Subject|1|||
164383268|NCT02461589|593773529|FG002|Overall Study|Withdrawal by Subject|3|||
164383269|NCT02461589|593773530|FG003|Overall Study|Withdrawal by Subject|2|||
164383270|NCT02461589|593773531|FG004|Overall Study|Withdrawal by Subject|1|||
164383271|NCT02461589|593773532|FG005|Overall Study|Withdrawal by Subject|2|||
164383272|NCT02461589|593773533|FG006|Overall Study|Withdrawal by Subject|1|||
164383273|NCT02461589|593773534|FG007|Overall Study|Withdrawal by Subject|3|||
164383274|NCT02461589|593773535|FG008|Overall Study|Withdrawal by Subject|3|||
164440091|NCT02057692|593978880|FG002|Overall Study|Lost to Follow-up|0|||
164592457|NCT05761444|594532532|FG001|Overall Study|Withdrawal by Subject|2|||
164592458|NCT05761444|594532531|FG000|Overall Study|Other|1|||
164701844|NCT00251719|594932732|FG000|Overall Study|Barrett's esophagus|2|||
164383275|NCT02461589|593773536|FG009|Overall Study|Withdrawal by Subject|1|||
164383276|NCT02461589|593773527|FG000|Overall Study|Lost to Follow-up|0|||
164383277|NCT02461589|593773528|FG001|Overall Study|Lost to Follow-up|0|||
164383278|NCT02461589|593773529|FG002|Overall Study|Lost to Follow-up|2|||
164440092|NCT02057692|593978881|FG003|Overall Study|Lost to Follow-up|1|||
164592459|NCT05761444|594532532|FG001|Overall Study|Other|0|||
164592460|NCT05610176|594532533|FG000|Overall Study|Death|6|||
164383279|NCT02461589|593773530|FG003|Overall Study|Lost to Follow-up|3|||
164383280|NCT02461589|593773531|FG004|Overall Study|Lost to Follow-up|1|||
164383281|NCT02461589|593773532|FG005|Overall Study|Lost to Follow-up|1|||
164383282|NCT02461589|593773533|FG006|Overall Study|Lost to Follow-up|3|||
164383283|NCT02461589|593773534|FG007|Overall Study|Lost to Follow-up|1|||
164383284|NCT02461589|593773535|FG008|Overall Study|Lost to Follow-up|3|||
164383285|NCT02461589|593773536|FG009|Overall Study|Lost to Follow-up|1|||
164383286|NCT02461589|593773527|FG000|Overall Study|Death|0|||
164383287|NCT02461589|593773528|FG001|Overall Study|Death|0|||
164383288|NCT02461589|593773529|FG002|Overall Study|Death|0|||
164383289|NCT02461589|593773530|FG003|Overall Study|Death|0|||
164383290|NCT02461589|593773531|FG004|Overall Study|Death|0|||
164383291|NCT02461589|593773532|FG005|Overall Study|Death|0|||
164383292|NCT02461589|593773533|FG006|Overall Study|Death|0|||
164383293|NCT02461589|593773534|FG007|Overall Study|Death|1|||
164383294|NCT02461589|593773535|FG008|Overall Study|Death|0|||
164383295|NCT02461589|593773536|FG009|Overall Study|Death|0|||
164383296|NCT02461589|593773527|FG000|Overall Study|Unclassified|0|||
164383297|NCT02461589|593773528|FG001|Overall Study|Unclassified|0|||
164383298|NCT02461589|593773529|FG002|Overall Study|Unclassified|0|||
164383299|NCT02461589|593773530|FG003|Overall Study|Unclassified|0|||
164383300|NCT02461589|593773531|FG004|Overall Study|Unclassified|0|||
164383301|NCT02461589|593773532|FG005|Overall Study|Unclassified|0|||
164383302|NCT02461589|593773533|FG006|Overall Study|Unclassified|1|||
164383303|NCT02461589|593773534|FG007|Overall Study|Unclassified|0|||
164383304|NCT02461589|593773535|FG008|Overall Study|Unclassified|0|||
164383305|NCT02461589|593773536|FG009|Overall Study|Unclassified|2|||
164383306|NCT02461589|593773527|FG000|Overall Study|Missing follow-up information|1|||
164383307|NCT02461589|593773528|FG001|Overall Study|Missing follow-up information|1|||
164383308|NCT02461589|593773529|FG002|Overall Study|Missing follow-up information|0|||
164383309|NCT02461589|593773530|FG003|Overall Study|Missing follow-up information|0|||
164383310|NCT02461589|593773531|FG004|Overall Study|Missing follow-up information|0|||
164383311|NCT02461589|593773532|FG005|Overall Study|Missing follow-up information|0|||
164383312|NCT02461589|593773533|FG006|Overall Study|Missing follow-up information|1|||
164383313|NCT02461589|593773534|FG007|Overall Study|Missing follow-up information|0|||
164383314|NCT02461589|593773535|FG008|Overall Study|Missing follow-up information|0|||
164383315|NCT02461589|593773536|FG009|Overall Study|Missing follow-up information|0|||
164383316|NCT02461589|593773527|FG000|Overall Study|Withdrawal from trial before exposure|0|||
164383317|NCT02461589|593773528|FG001|Overall Study|Withdrawal from trial before exposure|0|||
164383318|NCT02461589|593773529|FG002|Overall Study|Withdrawal from trial before exposure|0|||
164383319|NCT02461589|593773530|FG003|Overall Study|Withdrawal from trial before exposure|0|||
164383320|NCT02461589|593773531|FG004|Overall Study|Withdrawal from trial before exposure|0|||
164383321|NCT02461589|593773532|FG005|Overall Study|Withdrawal from trial before exposure|0|||
164383322|NCT02461589|593773533|FG006|Overall Study|Withdrawal from trial before exposure|0|||
164383323|NCT02461589|593773534|FG007|Overall Study|Withdrawal from trial before exposure|0|||
164383324|NCT02461589|593773535|FG008|Overall Study|Withdrawal from trial before exposure|0|||
164383325|NCT02461589|593773536|FG009|Overall Study|Withdrawal from trial before exposure|1|||
164383326|NCT01038921|593773541|FG000|Overall Study|Withdrawal by Subject|1|||
164383327|NCT01038921|593773542|FG001|Overall Study|Withdrawal by Subject|0|||
164383328|NCT01038921|593773541|FG000|Overall Study|Physician Decision|1|||
164383329|NCT01038921|593773542|FG001|Overall Study|Physician Decision|0|||
164383330|NCT01978119|593773543|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
164383331|NCT01978119|593773544|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
164383332|NCT01978119|593773543|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
164383333|NCT01978119|593773544|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
164383334|NCT01978119|593773543|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
164383335|NCT01978119|593773544|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
164383336|NCT03295201|593773547|FG000|Overall Study|Lost to Follow-up|1|||
164383337|NCT03295201|593773548|FG001|Overall Study|Lost to Follow-up|1|||
164383338|NCT03295201|593773547|FG000|Overall Study|Hospital admission|0|||
164383339|NCT03295201|593773548|FG001|Overall Study|Hospital admission|1|||
164383340|NCT02519504|593773549|FG000|Overall Study|Protocol Violation|6|||
164383341|NCT02519504|593773550|FG001|Overall Study|Protocol Violation|5|||
164383342|NCT02519504|593773549|FG000|Overall Study|Ineligible for direct testing|12|||
164383343|NCT02519504|593773550|FG001|Overall Study|Ineligible for direct testing|12|||
164383344|NCT02519504|593773549|FG000|Overall Study|Did not participate in direct testing|95|||
164383345|NCT02519504|593773550|FG001|Overall Study|Did not participate in direct testing|86|||
164383346|NCT02548962|593773551|FG000|Overall Study|Withdrawal by Subject|1|||
164383347|NCT02548962|593773552|FG001|Overall Study|Withdrawal by Subject|0|||
164701845|NCT00251719|594932733|FG001|Overall Study|Barrett's esophagus|2|||
164701846|NCT00251719|594932734|FG002|Overall Study|Barrett's esophagus|0|||
164383348|NCT01958918|593773556|FG000|Overall Study|Death|1|||
164383349|NCT01958918|593773557|FG001|Overall Study|Death|3|||
164383350|NCT01958918|593773556|FG000|Overall Study|Lost to Follow-up|4|||
164383351|NCT01958918|593773557|FG001|Overall Study|Lost to Follow-up|7|||
164383352|NCT01958918|593773556|FG000|Overall Study|Withdrawal by Subject|13|||
164701847|NCT01732874|594932736|FG000|Overall Study|Withdrawal by Subject|5|||
164383353|NCT01958918|593773557|FG001|Overall Study|Withdrawal by Subject|8|||
164383354|NCT01958918|593773556|FG000|Overall Study|Lack of Efficacy|13|||
164383355|NCT01958918|593773557|FG001|Overall Study|Lack of Efficacy|10|||
164383356|NCT01958918|593773556|FG000|Overall Study|Adverse Event|12|||
164383357|NCT01958918|593773557|FG001|Overall Study|Adverse Event|12|||
164383358|NCT01958918|593773556|FG000|Overall Study|administrative problems|0|||
164383359|NCT01958918|593773557|FG001|Overall Study|administrative problems|2|||
164383360|NCT00659269|593773561|FG000|Overall Study|Physician Decision|1|||
164383361|NCT00659269|593773562|FG001|Overall Study|Physician Decision|1|||
164383362|NCT00908960|593773563|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
164383363|NCT00908960|593773564|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
164383364|NCT00908960|593773565|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
164383365|NCT02401672|593773566|FG000|Overall Study|Withdrawal by Subject|1|||
164383366|NCT02401672|593773567|FG001|Overall Study|Withdrawal by Subject|3|||
164383367|NCT03653429|593773570|FG000|Overall Study|Physician Decision|4|||
164383368|NCT03653429|593773571|FG001|Overall Study|Physician Decision|10|||
164383369|NCT05857527|593773579|FG000|Overall Study|Withdrawal by Subject|0|||
164383370|NCT05857527|593773580|FG001|Overall Study|Withdrawal by Subject|1|||
164383371|NCT01592708|593773581|FG000|Overall Study|Protocol Violation|3|||
164383372|NCT01592708|593773582|FG001|Overall Study|Protocol Violation|0|||
164383373|NCT02610140|593773591|FG000|Randomization and Treatment Period|Radiological progression|23|||
164383374|NCT02610140|593773592|FG001|Randomization and Treatment Period|Radiological progression|15|||
164383375|NCT02610140|593773591|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
164383376|NCT02610140|593773592|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
164383377|NCT02610140|593773591|FG000|Randomization and Treatment Period|Protocol Violation|1|||
164383378|NCT02610140|593773592|FG001|Randomization and Treatment Period|Protocol Violation|0|||
164383379|NCT02610140|593773591|FG000|Randomization and Treatment Period|Physician Decision|0|||
164383380|NCT02610140|593773592|FG001|Randomization and Treatment Period|Physician Decision|1|||
164383381|NCT02610140|593773591|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
164383382|NCT02610140|593773592|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
164383383|NCT02610140|593773591|FG000|Randomization and Treatment Period|Death|7|||
164383384|NCT02610140|593773592|FG001|Randomization and Treatment Period|Death|1|||
164383385|NCT02610140|593773591|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
164383386|NCT02610140|593773592|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
164383387|NCT02610140|593773591|FG000|Randomization and Treatment Period|Adverse Event|44|||
164383388|NCT02610140|593773592|FG001|Randomization and Treatment Period|Adverse Event|13|||
164383389|NCT02610140|593773591|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
164383390|NCT02610140|593773592|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
164383391|NCT02610140|593773591|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
164383392|NCT02610140|593773592|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
164383393|NCT02610140|593773591|FG000|Randomization and Treatment Period|Not treated|3|||
164383394|NCT02610140|593773592|FG001|Randomization and Treatment Period|Not treated|10|||
164383395|NCT02610140|593773591|FG000|Safety Follow-up|Other|0|||
164383396|NCT02610140|593773592|FG001|Safety Follow-up|Other|2|||
164383397|NCT02610140|593773591|FG000|Safety Follow-up|Lost to Follow-up|1|||
164383398|NCT02610140|593773592|FG001|Safety Follow-up|Lost to Follow-up|0|||
164383399|NCT02610140|593773591|FG000|Safety Follow-up|No follow-up|5|||
164383400|NCT02610140|593773592|FG001|Safety Follow-up|No follow-up|3|||
164383401|NCT02610140|593773591|FG000|Safety Follow-up|Death|12|||
164383402|NCT02610140|593773592|FG001|Safety Follow-up|Death|2|||
164383403|NCT02610140|593773591|FG000|Safety Follow-up|Deterioration of general conditions|15|||
164383404|NCT02610140|593773592|FG001|Safety Follow-up|Deterioration of general conditions|5|||
164383405|NCT02610140|593773591|FG000|Safety Follow-up|Withdrawal by Subject|12|||
164383406|NCT02610140|593773592|FG001|Safety Follow-up|Withdrawal by Subject|12|||
164383407|NCT02610140|593773591|FG000|Active Follow-up|Progressive disease - radiological|30|||
164383408|NCT02610140|593773592|FG001|Active Follow-up|Progressive disease - radiological|22|||
164383409|NCT02610140|593773591|FG000|Active Follow-up|Death|8|||
164383410|NCT02610140|593773592|FG001|Active Follow-up|Death|1|||
164383411|NCT02610140|593773591|FG000|Active Follow-up|Withdrawal by Subject|4|||
164383412|NCT02610140|593773592|FG001|Active Follow-up|Withdrawal by Subject|0|||
164440093|NCT03923491|593978882|FG000|Overall Study|Lost to Follow-up|5|||
164440094|NCT03923491|593978883|FG001|Overall Study|Lost to Follow-up|8|||
164440095|NCT03923491|593978882|FG000|Overall Study|Withdrawal by Subject|4|||
164701848|NCT01732874|594932737|FG001|Overall Study|Withdrawal by Subject|1|||
164701849|NCT01732874|594932736|FG000|Overall Study|Death of Infant|3|||
164383413|NCT02610140|593773591|FG000|Active Follow-up|Progressive disease - clinical|1|||
164383414|NCT02610140|593773592|FG001|Active Follow-up|Progressive disease - clinical|2|||
164383415|NCT02610140|593773591|FG000|Active Follow-up|Deterioration of general conditions|1|||
164383416|NCT02610140|593773592|FG001|Active Follow-up|Deterioration of general conditions|0|||
164383417|NCT02610140|593773591|FG000|Active Follow-up|Ongoing but not completed|4|||
164383418|NCT02610140|593773592|FG001|Active Follow-up|Ongoing but not completed|1|||
164383419|NCT02610140|593773591|FG000|Long-term Follow-up|Death|86|||
164701850|NCT01732874|594932737|FG001|Overall Study|Death of Infant|2|||
164701851|NCT03709823|594932738|FG000|Overall Study|Adverse Event|0|||
164383420|NCT02610140|593773592|FG001|Long-term Follow-up|Death|44|||
164383421|NCT02610140|593773591|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
164383422|NCT02610140|593773592|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
164383423|NCT02610140|593773591|FG000|Long-term Follow-up|Lost to Follow-up|1|||
164383424|NCT02610140|593773592|FG001|Long-term Follow-up|Lost to Follow-up|2|||
164383425|NCT02610140|593773591|FG000|Long-term Follow-up|Ongoing but not completed|30|||
164383426|NCT02610140|593773592|FG001|Long-term Follow-up|Ongoing but not completed|17|||
164383427|NCT00887341|593773593|FG000|Overall Study|Refused treatment|1|||
164383428|NCT00887341|593773594|FG001|Overall Study|Refused treatment|0|||
164383429|NCT00887341|593773593|FG000|Overall Study|Withdrawal by Subject|1|||
164383430|NCT00887341|593773594|FG001|Overall Study|Withdrawal by Subject|1|||
164383431|NCT00887341|593773593|FG000|Overall Study|Adverse Event|0|||
164383432|NCT00887341|593773594|FG001|Overall Study|Adverse Event|1|||
164383433|NCT00887341|593773593|FG000|Overall Study|Lost to Follow-up|0|||
164383434|NCT00887341|593773594|FG001|Overall Study|Lost to Follow-up|1|||
164383435|NCT01312961|593773597|FG000|Overall Study|Adverse Event|3|||
164383436|NCT01312961|593773598|FG001|Overall Study|Adverse Event|3|||
164383437|NCT01312961|593773597|FG000|Overall Study|Lack of Efficacy|11|||
164383438|NCT01312961|593773598|FG001|Overall Study|Lack of Efficacy|1|||
164383439|NCT01312961|593773597|FG000|Overall Study|Poor compliance to protocol|1|||
164383440|NCT01312961|593773598|FG001|Overall Study|Poor compliance to protocol|0|||
164383441|NCT01312961|593773597|FG000|Overall Study|Other than specified above|2|||
164383442|NCT01312961|593773598|FG001|Overall Study|Other than specified above|3|||
164383443|NCT05402995|593773600|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
164383444|NCT05402995|593773601|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
164383445|NCT05402995|593773602|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
164383446|NCT05402995|593773603|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
164383447|NCT01337297|593773606|FG000|Overall Study|They entered to single anodal tDCS|4|||
164383448|NCT01337297|593773607|FG001|Overall Study|They entered to single anodal tDCS|3|||
164383449|NCT01337297|593773606|FG000|Overall Study|Lost to Follow-up|1|||
164383450|NCT01337297|593773607|FG001|Overall Study|Lost to Follow-up|3|||
164383451|NCT01800903|593773608|FG000|Second Test Period|unable to catheterise|1|||
164383452|NCT01800903|593773609|FG001|Second Test Period|unable to catheterise|0|||
164383453|NCT01800903|593773610|FG002|Second Test Period|unable to catheterise|0|||
164383454|NCT01800903|593773611|FG003|Second Test Period|unable to catheterise|0|||
164383455|NCT01800903|593773612|FG004|Second Test Period|unable to catheterise|0|||
164383456|NCT01800903|593773613|FG005|Second Test Period|unable to catheterise|0|||
164383457|NCT01306617|593773615|FG000|Overall Study|Adverse Event|1|||
164383458|NCT01306617|593773616|FG001|Overall Study|Adverse Event|0|||
164383459|NCT01306617|593773617|FG002|Overall Study|Adverse Event|0|||
164383460|NCT01306617|593773615|FG000|Overall Study|Virologic Failure|0|||
164383461|NCT01306617|593773616|FG001|Overall Study|Virologic Failure|0|||
164383462|NCT01306617|593773617|FG002|Overall Study|Virologic Failure|5|||
164383463|NCT01306617|593773615|FG000|Overall Study|Non-compliance|0|||
164383464|NCT01306617|593773616|FG001|Overall Study|Non-compliance|1|||
164383465|NCT01306617|593773617|FG002|Overall Study|Non-compliance|0|||
164383466|NCT01208233|593773619|FG000|Overall Study|Adverse Event|0|||
164383467|NCT01208233|593773620|FG001|Overall Study|Adverse Event|1|||
164383468|NCT01208233|593773621|FG002|Overall Study|Adverse Event|2|||
164383469|NCT01208233|593773622|FG003|Overall Study|Adverse Event|0|||
164383470|NCT01208233|593773623|FG004|Overall Study|Adverse Event|3|||
164383471|NCT01208233|593773624|FG005|Overall Study|Adverse Event|5|||
164383472|NCT01208233|593773619|FG000|Overall Study|Death|0|||
164383473|NCT01208233|593773620|FG001|Overall Study|Death|0|||
164383474|NCT01208233|593773621|FG002|Overall Study|Death|0|||
164440096|NCT03923491|593978883|FG001|Overall Study|Withdrawal by Subject|6|||
164440097|NCT03823300|593978888|FG000|Overall Study|Withdrawal by Subject|16|||
164383475|NCT01208233|593773622|FG003|Overall Study|Death|0|||
164383476|NCT01208233|593773623|FG004|Overall Study|Death|3|||
164383477|NCT01208233|593773624|FG005|Overall Study|Death|5|||
164383478|NCT01208233|593773619|FG000|Overall Study|Did not meet entrance criteria|2|||
164383479|NCT01208233|593773620|FG001|Overall Study|Did not meet entrance criteria|1|||
164383480|NCT01208233|593773621|FG002|Overall Study|Did not meet entrance criteria|1|||
164383481|NCT01208233|593773622|FG003|Overall Study|Did not meet entrance criteria|0|||
164383482|NCT01208233|593773623|FG004|Overall Study|Did not meet entrance criteria|1|||
164383483|NCT01208233|593773624|FG005|Overall Study|Did not meet entrance criteria|0|||
164383484|NCT01208233|593773619|FG000|Overall Study|Medication error without adverse event|0|||
164383485|NCT01208233|593773620|FG001|Overall Study|Medication error without adverse event|0|||
164383486|NCT01208233|593773621|FG002|Overall Study|Medication error without adverse event|0|||
164383487|NCT01208233|593773622|FG003|Overall Study|Medication error without adverse event|0|||
164383488|NCT01208233|593773623|FG004|Overall Study|Medication error without adverse event|0|||
164592461|NCT00850759|594532539|FG000|Overall Study|Lost to Follow-up|7|||
164592462|NCT00850759|594532540|FG001|Overall Study|Lost to Follow-up|5|||
164592463|NCT00850759|594532541|FG002|Overall Study|Lost to Follow-up|5|||
164592464|NCT00850759|594532542|FG003|Overall Study|Lost to Follow-up|3|||
164592465|NCT01727713|594532543|FG000|Overall Study|Lost to Follow-up|5|||
164383489|NCT01208233|593773624|FG005|Overall Study|Medication error without adverse event|1|||
164383490|NCT01208233|593773619|FG000|Overall Study|Study terminated by sponsor|0|||
164383491|NCT01208233|593773620|FG001|Overall Study|Study terminated by sponsor|0|||
164383492|NCT01208233|593773621|FG002|Overall Study|Study terminated by sponsor|0|||
164383493|NCT01208233|593773622|FG003|Overall Study|Study terminated by sponsor|0|||
164383494|NCT01208233|593773623|FG004|Overall Study|Study terminated by sponsor|10|||
164383495|NCT01208233|593773624|FG005|Overall Study|Study terminated by sponsor|7|||
164383496|NCT01208233|593773619|FG000|Overall Study|Protocol Violation|0|||
164383497|NCT01208233|593773620|FG001|Overall Study|Protocol Violation|0|||
164383498|NCT01208233|593773621|FG002|Overall Study|Protocol Violation|0|||
164383499|NCT01208233|593773622|FG003|Overall Study|Protocol Violation|0|||
164383500|NCT01208233|593773623|FG004|Overall Study|Protocol Violation|3|||
164383501|NCT01208233|593773624|FG005|Overall Study|Protocol Violation|0|||
164383502|NCT01208233|593773619|FG000|Overall Study|Other|2|||
164383503|NCT01208233|593773620|FG001|Overall Study|Other|1|||
164383504|NCT01208233|593773621|FG002|Overall Study|Other|0|||
164383505|NCT01208233|593773622|FG003|Overall Study|Other|0|||
164383506|NCT01208233|593773623|FG004|Overall Study|Other|0|||
164383507|NCT01208233|593773624|FG005|Overall Study|Other|1|||
164383508|NCT01208233|593773619|FG000|Overall Study|Withdrawal by Subject|1|||
164383509|NCT01208233|593773620|FG001|Overall Study|Withdrawal by Subject|0|||
164383510|NCT01208233|593773621|FG002|Overall Study|Withdrawal by Subject|1|||
164383511|NCT01208233|593773622|FG003|Overall Study|Withdrawal by Subject|1|||
164383512|NCT01208233|593773623|FG004|Overall Study|Withdrawal by Subject|4|||
164383513|NCT01208233|593773624|FG005|Overall Study|Withdrawal by Subject|2|||
164383514|NCT04028388|593773628|FG000|Overall Study|Evaluations missing|3|||
164383515|NCT04028388|593773629|FG001|Overall Study|Evaluations missing|6|||
164383516|NCT04028388|593773628|FG000|Overall Study|Not started|2|||
164383517|NCT04028388|593773629|FG001|Overall Study|Not started|0|||
164383518|NCT00129259|593773636|FG000|Overall Study|Lost to Follow-up|1|||
164383519|NCT00129259|593773637|FG001|Overall Study|Lost to Follow-up|1|||
164383520|NCT00129259|593773636|FG000|Overall Study|Withdrawal by Subject|2|||
164383521|NCT00129259|593773637|FG001|Overall Study|Withdrawal by Subject|1|||
164383522|NCT00129259|593773636|FG000|Overall Study|Only available minimal phone assessments|0|||
164383523|NCT00129259|593773637|FG001|Overall Study|Only available minimal phone assessments|1|||
164383524|NCT01609556|593773638|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
164383525|NCT01609556|593773639|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
164383526|NCT01609556|593773640|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
164383527|NCT01609556|593773641|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
164383528|NCT01609556|593773642|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
164383529|NCT01609556|593773643|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
164383530|NCT01609556|593773644|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
164383531|NCT01609556|593773645|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
164383532|NCT01609556|593773646|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
164383533|NCT01609556|593773647|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
164383534|NCT01609556|593773648|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
164383535|NCT01609556|593773649|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
164383536|NCT01609556|593773650|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
164383537|NCT01609556|593773651|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
164383538|NCT01609556|593773652|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
164383539|NCT01609556|593773653|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
164383540|NCT01609556|593773638|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
164383541|NCT01609556|593773639|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
164383542|NCT01609556|593773640|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
164383543|NCT01609556|593773641|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
164383544|NCT01609556|593773642|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
164383545|NCT01609556|593773643|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
164383546|NCT01609556|593773644|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
164383547|NCT01609556|593773645|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
164383548|NCT01609556|593773646|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
164383549|NCT01609556|593773647|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
164383550|NCT01609556|593773648|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
164383551|NCT01609556|593773649|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
164383552|NCT01609556|593773650|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
164383553|NCT01609556|593773651|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
164383554|NCT01609556|593773652|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
164383555|NCT01609556|593773653|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
164383556|NCT01609556|593773638|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
164383557|NCT01609556|593773639|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
164383558|NCT01609556|593773640|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
164383559|NCT01609556|593773641|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
164701852|NCT03709823|594932739|FG001|Overall Study|Adverse Event|0|||
164383560|NCT01609556|593773642|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
164383561|NCT01609556|593773643|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
164383562|NCT01609556|593773644|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
164383563|NCT01609556|593773645|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
164383564|NCT01609556|593773646|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
164383565|NCT01609556|593773647|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
164383566|NCT01609556|593773648|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
164383567|NCT01609556|593773649|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
164383568|NCT01609556|593773650|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
164383569|NCT01609556|593773651|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
164383570|NCT01609556|593773652|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
164383571|NCT01609556|593773653|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
164383572|NCT01609556|593773638|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383573|NCT01609556|593773639|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383574|NCT01609556|593773640|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383575|NCT01609556|593773641|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383576|NCT01609556|593773642|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383577|NCT01609556|593773643|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
164383578|NCT01609556|593773644|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383579|NCT01609556|593773645|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383580|NCT01609556|593773646|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383581|NCT01609556|593773647|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383582|NCT01609556|593773648|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383583|NCT01609556|593773649|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
164383584|NCT01609556|593773650|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383585|NCT01609556|593773651|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383586|NCT01609556|593773652|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383587|NCT01609556|593773653|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383588|NCT01609556|593773638|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383589|NCT01609556|593773639|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383590|NCT01609556|593773640|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383591|NCT01609556|593773641|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383592|NCT01609556|593773642|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383593|NCT01609556|593773643|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
164383594|NCT01609556|593773644|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383595|NCT01609556|593773645|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383596|NCT01609556|593773646|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383597|NCT01609556|593773647|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383598|NCT01609556|593773648|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383599|NCT01609556|593773649|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383600|NCT01609556|593773650|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383601|NCT01609556|593773651|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383602|NCT01609556|593773652|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383603|NCT01609556|593773653|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383604|NCT01609556|593773638|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383605|NCT01609556|593773639|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383606|NCT01609556|593773640|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383607|NCT01609556|593773641|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383608|NCT01609556|593773642|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383609|NCT01609556|593773643|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383610|NCT01609556|593773644|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383611|NCT01609556|593773645|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383612|NCT01609556|593773646|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
164383613|NCT01609556|593773647|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383614|NCT01609556|593773648|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383615|NCT01609556|593773649|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383616|NCT01609556|593773650|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383617|NCT01609556|593773651|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383618|NCT01609556|593773652|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164440098|NCT03823300|593978889|FG001|Overall Study|Withdrawal by Subject|22|||
164701853|NCT03709823|594932740|FG002|Overall Study|Adverse Event|1|||
164701854|NCT03709823|594932741|FG003|Overall Study|Adverse Event|0|||
164383619|NCT01609556|593773653|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383620|NCT01609556|593773638|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
164383621|NCT01609556|593773639|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383622|NCT01609556|593773640|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383623|NCT01609556|593773641|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383624|NCT01609556|593773642|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383625|NCT01609556|593773643|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
164383626|NCT01609556|593773644|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383627|NCT01609556|593773645|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383628|NCT01609556|593773646|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383629|NCT01609556|593773647|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383630|NCT01609556|593773648|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
164383631|NCT01609556|593773649|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383632|NCT01609556|593773650|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383633|NCT01609556|593773651|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383634|NCT01609556|593773652|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383635|NCT01609556|593773653|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383636|NCT01609556|593773638|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
164383637|NCT01609556|593773639|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
164383638|NCT01609556|593773640|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
164383639|NCT01609556|593773641|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
164383640|NCT01609556|593773642|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
164383641|NCT01609556|593773643|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
164383642|NCT01609556|593773644|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
164383643|NCT01609556|593773645|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
164383644|NCT01609556|593773646|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
164383645|NCT01609556|593773647|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
164383646|NCT01609556|593773648|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
164383647|NCT01609556|593773649|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
164383648|NCT01609556|593773650|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
164383649|NCT01609556|593773651|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
164383650|NCT01609556|593773652|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
164383651|NCT01609556|593773653|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
164383652|NCT01609556|593773638|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
164383653|NCT01609556|593773639|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
164383654|NCT01609556|593773640|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
164383655|NCT01609556|593773641|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
164383656|NCT01609556|593773642|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
164383657|NCT01609556|593773643|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
164383658|NCT01609556|593773644|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
164383659|NCT01609556|593773645|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
164383660|NCT01609556|593773646|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
164383661|NCT01609556|593773647|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
164383662|NCT01609556|593773648|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
164383663|NCT01609556|593773649|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
164383664|NCT01609556|593773650|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
164383665|NCT01609556|593773651|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
164383666|NCT01609556|593773652|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
164383667|NCT01609556|593773653|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
164383668|NCT01609556|593773638|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
164383669|NCT01609556|593773639|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
164383670|NCT01609556|593773640|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
164383671|NCT01609556|593773641|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
164383672|NCT01609556|593773642|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
164383673|NCT01609556|593773643|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
164383674|NCT01609556|593773644|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
164383675|NCT01609556|593773645|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
164383676|NCT01609556|593773646|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
164383677|NCT01609556|593773647|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
164383678|NCT01609556|593773648|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
164383679|NCT01609556|593773649|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
164383680|NCT01609556|593773650|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
164383681|NCT01609556|593773651|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
164383682|NCT01609556|593773652|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
164383683|NCT01609556|593773653|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
164383684|NCT01609556|593773638|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164592466|NCT01727713|594532543|FG000|Overall Study|Adverse Event|10|||
164592467|NCT01727713|594532543|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
164592468|NCT01727713|594532543|FG000|Overall Study|Withdrawal by Subject|13|||
164592469|NCT01727713|594532543|FG000|Overall Study|Protocol Deviation|2|||
164592470|NCT02389816|594532544|FG000|Overall Study|Randomized but Not Treated|1|||
164592471|NCT02389816|594532545|FG001|Overall Study|Randomized but Not Treated|0|||
164592472|NCT02389816|594532546|FG002|Overall Study|Randomized but Not Treated|0|||
164592473|NCT02389816|594532544|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
164592474|NCT02389816|594532545|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
164592475|NCT02389816|594532546|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
164383685|NCT01609556|593773639|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383686|NCT01609556|593773640|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383687|NCT01609556|593773641|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383688|NCT01609556|593773642|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383689|NCT01609556|593773643|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383690|NCT01609556|593773644|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383691|NCT01609556|593773645|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383692|NCT01609556|593773646|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383693|NCT01609556|593773647|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383694|NCT01609556|593773648|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383695|NCT01609556|593773649|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383696|NCT01609556|593773650|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
164383697|NCT01609556|593773651|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383698|NCT01609556|593773652|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383699|NCT01609556|593773653|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383700|NCT01609556|593773638|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
164383701|NCT01609556|593773639|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
164383702|NCT01609556|593773640|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
164383703|NCT01609556|593773641|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
164383704|NCT01609556|593773642|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
164383705|NCT01609556|593773643|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
164383706|NCT01609556|593773644|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
164383707|NCT01609556|593773645|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
164383708|NCT01609556|593773646|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
164383709|NCT01609556|593773647|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
164592476|NCT02389816|594532544|FG000|Overall Study|Major Protocol Deviation|1|||
164592477|NCT02389816|594532545|FG001|Overall Study|Major Protocol Deviation|0|||
164592478|NCT02389816|594532546|FG002|Overall Study|Major Protocol Deviation|0|||
164592479|NCT02389816|594532544|FG000|Overall Study|Lost to Follow-up|1|||
164592480|NCT02389816|594532545|FG001|Overall Study|Lost to Follow-up|0|||
164592481|NCT02389816|594532546|FG002|Overall Study|Lost to Follow-up|0|||
164592482|NCT02389816|594532544|FG000|Overall Study|Withdrawal of Consent|6|||
164592483|NCT02389816|594532545|FG001|Overall Study|Withdrawal of Consent|4|||
164592484|NCT02389816|594532546|FG002|Overall Study|Withdrawal of Consent|4|||
164592485|NCT02389816|594532544|FG000|Overall Study|Lack of Efficacy|1|||
164592486|NCT02389816|594532545|FG001|Overall Study|Lack of Efficacy|0|||
164592487|NCT02389816|594532546|FG002|Overall Study|Lack of Efficacy|0|||
164592488|NCT02389816|594532544|FG000|Overall Study|Non Compliance with Study Drug|1|||
164592489|NCT02389816|594532545|FG001|Overall Study|Non Compliance with Study Drug|1|||
164592490|NCT02389816|594532546|FG002|Overall Study|Non Compliance with Study Drug|1|||
164592491|NCT02389816|594532544|FG000|Overall Study|Reason not Specified|0|||
164592492|NCT02389816|594532545|FG001|Overall Study|Reason not Specified|2|||
164592493|NCT02389816|594532546|FG002|Overall Study|Reason not Specified|0|||
164592494|NCT01842308|594532547|FG000|Overall Study|Withdrawal by Subject|0|||
164592495|NCT01842308|594532548|FG001|Overall Study|Withdrawal by Subject|0|||
164383710|NCT01609556|593773648|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
164383711|NCT01609556|593773649|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
164383712|NCT01609556|593773650|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
164383713|NCT01609556|593773651|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
164383714|NCT01609556|593773652|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
164383715|NCT01609556|593773653|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
164383716|NCT01609556|593773638|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383717|NCT01609556|593773639|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383718|NCT01609556|593773640|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383719|NCT01609556|593773641|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383720|NCT01609556|593773642|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164592496|NCT01842308|594532549|FG002|Overall Study|Withdrawal by Subject|0|||
164592497|NCT01842308|594532550|FG003|Overall Study|Withdrawal by Subject|0|||
164592498|NCT01842308|594532551|FG004|Overall Study|Withdrawal by Subject|1|||
164440099|NCT03823300|593978888|FG000|Overall Study|Death|10|||
164592499|NCT01594476|594532552|FG000|Overall Study|Protocol Violation|1|||
164383721|NCT01609556|593773643|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383722|NCT01609556|593773644|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383723|NCT01609556|593773645|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383724|NCT01609556|593773646|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383725|NCT01609556|593773647|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383726|NCT01609556|593773648|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383727|NCT01609556|593773649|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383728|NCT01609556|593773650|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383729|NCT01609556|593773651|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383730|NCT01609556|593773652|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383731|NCT01609556|593773653|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
164383732|NCT01609556|593773638|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383733|NCT01609556|593773639|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383734|NCT01609556|593773640|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383735|NCT01609556|593773641|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383736|NCT01609556|593773642|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383737|NCT01609556|593773643|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383738|NCT01609556|593773644|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383739|NCT01609556|593773645|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383740|NCT01609556|593773646|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383741|NCT01609556|593773647|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383742|NCT01609556|593773648|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383743|NCT01609556|593773649|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383744|NCT01609556|593773650|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
164383745|NCT01609556|593773651|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
164383746|NCT01609556|593773652|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383747|NCT01609556|593773653|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
164383748|NCT01609556|593773638|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383749|NCT01609556|593773639|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383750|NCT01609556|593773640|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383751|NCT01609556|593773641|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383752|NCT01609556|593773642|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383753|NCT01609556|593773643|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383754|NCT01609556|593773644|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383755|NCT01609556|593773645|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383756|NCT01609556|593773646|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383757|NCT01609556|593773647|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383758|NCT01609556|593773648|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383759|NCT01609556|593773649|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383760|NCT01609556|593773650|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
164383761|NCT01609556|593773651|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383762|NCT01609556|593773652|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383763|NCT01609556|593773653|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383764|NCT01632579|593773656|FG000|Washout Period|Adverse Event|1|||
164383765|NCT01632579|593773657|FG001|Washout Period|Adverse Event|0|||
164383766|NCT01632579|593773658|FG002|Washout Period|Adverse Event|0|||
164383767|NCT01632579|593773659|FG003|Washout Period|Adverse Event|0|||
164383768|NCT01632579|593773660|FG004|Washout Period|Adverse Event|0|||
164383769|NCT01632579|593773661|FG005|Washout Period|Adverse Event|0|||
164383770|NCT01632579|593773662|FG006|Washout Period|Adverse Event|0|||
164383771|NCT01632579|593773663|FG007|Washout Period|Adverse Event|0|||
164383772|NCT01632579|593773664|FG008|Washout Period|Adverse Event|0|||
164383773|NCT01632579|593773656|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
164383774|NCT01632579|593773657|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
164383775|NCT01632579|593773658|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
164383776|NCT01632579|593773659|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
164383777|NCT01632579|593773660|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
164383778|NCT01632579|593773661|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
164383779|NCT01632579|593773662|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
164383780|NCT01632579|593773663|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
164383781|NCT01632579|593773664|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
164383782|NCT00162136|593773665|FG000|Overall Study|Adverse Event|1|||
164383783|NCT00162136|593773665|FG000|Overall Study|Death|1|||
164383784|NCT00162136|593773665|FG000|Overall Study|Disease Progression/Relapse|23|||
164383785|NCT00162136|593773665|FG000|Overall Study|Investigator Request|5|||
164383786|NCT00162136|593773665|FG000|Overall Study|Study Drug Toxicity|4|||
164383787|NCT00162136|593773665|FG000|Overall Study|Withdrawal by Subject|1|||
164383788|NCT01539291|593775650|FG000|Study GS-US-312-0116|Adverse Event|9|||
164383789|NCT01539291|593775651|FG001|Study GS-US-312-0116|Adverse Event|0|||
164383790|NCT01539291|593775652|FG002|Study GS-US-312-0116|Adverse Event|0|||
164383791|NCT01539291|593775653|FG003|Study GS-US-312-0116|Adverse Event|0|||
164383792|NCT01539291|593775650|FG000|Study GS-US-312-0116|Physician Decision|1|||
164383793|NCT01539291|593775651|FG001|Study GS-US-312-0116|Physician Decision|0|||
164383794|NCT01539291|593775652|FG002|Study GS-US-312-0116|Physician Decision|0|||
164383795|NCT01539291|593775653|FG003|Study GS-US-312-0116|Physician Decision|0|||
164383796|NCT01539291|593775650|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
164383797|NCT01539291|593775651|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
164383798|NCT01539291|593775652|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
164383799|NCT01539291|593775653|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
164383800|NCT01539291|593775650|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
164383801|NCT01539291|593775651|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
164383802|NCT01539291|593775652|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
164383803|NCT01539291|593775653|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
164383804|NCT01539291|593775650|FG000|Study GS-US-312-0116|Other|1|||
164383805|NCT01539291|593775651|FG001|Study GS-US-312-0116|Other|0|||
164383806|NCT01539291|593775652|FG002|Study GS-US-312-0116|Other|0|||
164383807|NCT01539291|593775653|FG003|Study GS-US-312-0116|Other|0|||
164383808|NCT01539291|593775650|FG000|Study GS-US-312-0117|Adverse Event|22|||
164383809|NCT01539291|593775651|FG001|Study GS-US-312-0117|Adverse Event|1|||
164383810|NCT01539291|593775652|FG002|Study GS-US-312-0117|Adverse Event|9|||
164383811|NCT01539291|593775653|FG003|Study GS-US-312-0117|Adverse Event|12|||
164383812|NCT01539291|593775650|FG000|Study GS-US-312-0117|Physician Decision|9|||
164383813|NCT01539291|593775651|FG001|Study GS-US-312-0117|Physician Decision|0|||
164383814|NCT01539291|593775652|FG002|Study GS-US-312-0117|Physician Decision|6|||
164383815|NCT01539291|593775653|FG003|Study GS-US-312-0117|Physician Decision|4|||
164383816|NCT01539291|593775650|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
164383817|NCT01539291|593775651|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
164383818|NCT01539291|593775652|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
164383819|NCT01539291|593775653|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
164383820|NCT01539291|593775650|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
164383821|NCT01539291|593775651|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
164383822|NCT01539291|593775652|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
164383823|NCT01539291|593775653|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
164383824|NCT01539291|593775650|FG000|Study GS-US-312-0117|Other|2|||
164383825|NCT01539291|593775651|FG001|Study GS-US-312-0117|Other|1|||
164383826|NCT01539291|593775652|FG002|Study GS-US-312-0117|Other|1|||
164383827|NCT01539291|593775653|FG003|Study GS-US-312-0117|Other|1|||
164383828|NCT04450264|593775654|FG000|Overall Study|Incomplete survey|13|||
164383829|NCT04450264|593775655|FG001|Overall Study|Incomplete survey|19|||
164383830|NCT00074282|593775658|FG000|Step 1|Adverse Event|32|||
164383831|NCT00074282|593775659|FG001|Step 1|Adverse Event|0|||
164383832|NCT00074282|593775660|FG002|Step 1|Adverse Event|0|||
164383833|NCT00074282|593775658|FG000|Step 1|Death|6|||
164383834|NCT00074282|593775659|FG001|Step 1|Death|0|||
164383835|NCT00074282|593775660|FG002|Step 1|Death|0|||
164383836|NCT00074282|593775658|FG000|Step 1|Withdrawal by Subject|7|||
164383837|NCT00074282|593775659|FG001|Step 1|Withdrawal by Subject|0|||
164383838|NCT00074282|593775660|FG002|Step 1|Withdrawal by Subject|0|||
164383839|NCT00074282|593775658|FG000|Step 1|Disease progression|2|||
164383840|NCT00074282|593775659|FG001|Step 1|Disease progression|0|||
164383841|NCT00074282|593775660|FG002|Step 1|Disease progression|0|||
164383842|NCT00074282|593775658|FG000|Step 1|Alternative therapy|2|||
164383843|NCT00074282|593775659|FG001|Step 1|Alternative therapy|0|||
164383844|NCT00074282|593775660|FG002|Step 1|Alternative therapy|0|||
164383845|NCT00074282|593775658|FG000|Step 1|Other complicating disease|2|||
164383846|NCT00074282|593775659|FG001|Step 1|Other complicating disease|0|||
164383847|NCT00074282|593775660|FG002|Step 1|Other complicating disease|0|||
164383848|NCT00074282|593775658|FG000|Step 1|Physician Decision|1|||
164383849|NCT00074282|593775659|FG001|Step 1|Physician Decision|0|||
164383850|NCT00074282|593775660|FG002|Step 1|Physician Decision|0|||
164383851|NCT00074282|593775658|FG000|Step 1|Ineligible|4|||
164383852|NCT00074282|593775659|FG001|Step 1|Ineligible|0|||
164383853|NCT00074282|593775660|FG002|Step 1|Ineligible|0|||
164383854|NCT00074282|593775658|FG000|Step 1|Never started treatment|2|||
164383855|NCT00074282|593775659|FG001|Step 1|Never started treatment|0|||
164383856|NCT00074282|593775660|FG002|Step 1|Never started treatment|0|||
164440100|NCT03823300|593978889|FG001|Overall Study|Death|14|||
164592500|NCT01594476|594532553|FG001|Overall Study|Protocol Violation|3|||
164383857|NCT00074282|593775658|FG000|Step 2|Adverse Event|0|||
164383858|NCT00074282|593775659|FG001|Step 2|Adverse Event|2|||
164383859|NCT00074282|593775660|FG002|Step 2|Adverse Event|12|||
164383860|NCT00074282|593775658|FG000|Step 2|Disease progression|0|||
164383861|NCT00074282|593775659|FG001|Step 2|Disease progression|0|||
164383862|NCT00074282|593775660|FG002|Step 2|Disease progression|5|||
164383863|NCT00074282|593775658|FG000|Step 2|Death|0|||
164383864|NCT00074282|593775659|FG001|Step 2|Death|0|||
164383865|NCT00074282|593775660|FG002|Step 2|Death|3|||
164383866|NCT00074282|593775658|FG000|Step 2|Withdrawal by Subject|0|||
164383867|NCT00074282|593775659|FG001|Step 2|Withdrawal by Subject|0|||
164592501|NCT01087528|594532554|FG000|Overall Study|Withdrawal by Subject|1|||
164383868|NCT00074282|593775660|FG002|Step 2|Withdrawal by Subject|2|||
164701855|NCT03709823|594932742|FG004|Overall Study|Adverse Event|0|||
164701856|NCT03709823|594932743|FG005|Overall Study|Adverse Event|0|||
164701857|NCT03709823|594932738|FG000|Overall Study|Lost to Follow-up|2|||
164701858|NCT03709823|594932739|FG001|Overall Study|Lost to Follow-up|2|||
164701859|NCT03709823|594932740|FG002|Overall Study|Lost to Follow-up|2|||
164701860|NCT03709823|594932741|FG003|Overall Study|Lost to Follow-up|1|||
164701861|NCT03709823|594932742|FG004|Overall Study|Lost to Follow-up|1|||
164701862|NCT03709823|594932743|FG005|Overall Study|Lost to Follow-up|0|||
164701863|NCT03709823|594932738|FG000|Overall Study|Withdrawal by Subject|1|||
164701864|NCT03709823|594932739|FG001|Overall Study|Withdrawal by Subject|3|||
164701865|NCT03709823|594932740|FG002|Overall Study|Withdrawal by Subject|0|||
164701866|NCT03709823|594932741|FG003|Overall Study|Withdrawal by Subject|0|||
164701867|NCT03709823|594932742|FG004|Overall Study|Withdrawal by Subject|0|||
164701868|NCT03709823|594932743|FG005|Overall Study|Withdrawal by Subject|0|||
164701869|NCT03709823|594932738|FG000|Overall Study|Other, Not Specified|0|||
164701870|NCT03709823|594932739|FG001|Overall Study|Other, Not Specified|0|||
164701871|NCT03709823|594932740|FG002|Overall Study|Other, Not Specified|0|||
164383869|NCT00074282|593775658|FG000|Step 2|Physician Decision|0|||
164383870|NCT00074282|593775659|FG001|Step 2|Physician Decision|0|||
164383871|NCT00074282|593775660|FG002|Step 2|Physician Decision|1|||
164383872|NCT00074282|593775658|FG000|Step 2|Ineligible|0|||
164383873|NCT00074282|593775659|FG001|Step 2|Ineligible|0|||
164383874|NCT00074282|593775660|FG002|Step 2|Ineligible|1|||
164383875|NCT02055352|593775664|FG000|Overall Study|Adverse Event|0|||
164383876|NCT02055352|593775665|FG001|Overall Study|Adverse Event|1|||
164383877|NCT02055352|593775664|FG000|Overall Study|Non-eligible|0|||
164383878|NCT02055352|593775665|FG001|Overall Study|Non-eligible|1|||
164383879|NCT02055352|593775664|FG000|Overall Study|Poor compliance|1|||
164383880|NCT02055352|593775665|FG001|Overall Study|Poor compliance|1|||
164383881|NCT02055352|593775664|FG000|Overall Study|Death|1|||
164383882|NCT02055352|593775665|FG001|Overall Study|Death|2|||
164383883|NCT02055352|593775664|FG000|Overall Study|Patient decision|1|||
164383884|NCT02055352|593775665|FG001|Overall Study|Patient decision|1|||
164383885|NCT02055352|593775664|FG000|Overall Study|Use of prohibited treatment|0|||
164383886|NCT02055352|593775665|FG001|Overall Study|Use of prohibited treatment|3|||
164383887|NCT02055352|593775664|FG000|Overall Study|AE, study drug would be detrimental|1|||
164383888|NCT02055352|593775665|FG001|Overall Study|AE, study drug would be detrimental|3|||
164383889|NCT02055352|593775664|FG000|Overall Study|Withdrawal of informed consent|1|||
164383890|NCT02055352|593775665|FG001|Overall Study|Withdrawal of informed consent|0|||
164383891|NCT02055352|593775664|FG000|Overall Study|Reason unknown|1|||
164383892|NCT02055352|593775665|FG001|Overall Study|Reason unknown|5|||
164383893|NCT04745169|593775666|FG000|Overall Study|Kidney transplantation|1|||
164383894|NCT04745169|593775666|FG000|Overall Study|Participant health problems|3|||
164383895|NCT04745169|593775666|FG000|Overall Study|Physician Decision|2|||
164383896|NCT00129987|593775670|FG000|1st Educational Session|Withdrawal by Subject|141|||
164383897|NCT00129987|593775671|FG001|1st Educational Session|Withdrawal by Subject|109|||
164383898|NCT00129987|593775670|FG000|1 Year|Withdrawal by Subject|32|||
164383899|NCT00129987|593775671|FG001|1 Year|Withdrawal by Subject|21|||
164383900|NCT00116805|593775672|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
164383901|NCT00116805|593775673|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
164383902|NCT00116805|593775672|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
164383903|NCT00116805|593775673|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
164383904|NCT00116805|593775672|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
164383905|NCT00116805|593775673|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
164383906|NCT00116805|593775672|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
164383907|NCT00116805|593775673|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
164383908|NCT00116805|593775672|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
164383909|NCT00116805|593775673|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
164383910|NCT00116805|593775672|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
164383911|NCT00116805|593775673|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
164383912|NCT00116805|593775672|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
164383913|NCT00116805|593775673|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
164383914|NCT00116805|593775672|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
164701872|NCT03709823|594932741|FG003|Overall Study|Other, Not Specified|1|||
164701873|NCT03709823|594932742|FG004|Overall Study|Other, Not Specified|0|||
164383915|NCT00116805|593775673|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
164383916|NCT00116805|593775672|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
164383917|NCT00116805|593775673|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
164383918|NCT00116805|593775672|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
164701874|NCT03709823|594932743|FG005|Overall Study|Other, Not Specified|0|||
164701875|NCT00557076|594932746|FG000|Overall Study|Unblinding|0|||
164701876|NCT00557076|594932747|FG001|Overall Study|Unblinding|1|||
164701877|NCT00688376|594932748|FG000|Double-Blind Phase|Adverse Event|4|||
164701878|NCT00688376|594932749|FG001|Double-Blind Phase|Adverse Event|4|||
164701879|NCT00688376|594932748|FG000|Double-Blind Phase|Protocol Violation|1|||
164701880|NCT00688376|594932749|FG001|Double-Blind Phase|Protocol Violation|2|||
164701881|NCT00688376|594932748|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
164701882|NCT00688376|594932749|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
164701883|NCT00688376|594932748|FG000|Double-Blind Phase|Not treated|0|||
164701884|NCT00688376|594932749|FG001|Double-Blind Phase|Not treated|1|||
164701885|NCT00688376|594932748|FG000|Blinded Extension Phase|Adverse Event|3|||
164701886|NCT00688376|594932749|FG001|Blinded Extension Phase|Adverse Event|4|||
164701887|NCT00688376|594932748|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
164383919|NCT00116805|593775673|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
164383920|NCT00116805|593775672|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
164383921|NCT00116805|593775673|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
164383922|NCT00116805|593775672|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
164383923|NCT00116805|593775673|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
164383924|NCT00116805|593775672|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
164383925|NCT00116805|593775673|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
164383926|NCT00116805|593775672|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
164383927|NCT00116805|593775673|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
164383928|NCT00116805|593775672|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
164383929|NCT00116805|593775673|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
164383930|NCT00116805|593775672|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
164383931|NCT00116805|593775673|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
164383932|NCT00116805|593775672|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
164383933|NCT00116805|593775673|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
164383934|NCT00116805|593775672|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
164383935|NCT00116805|593775673|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
164383936|NCT00116805|593775672|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
164383937|NCT00116805|593775673|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
164383938|NCT00116805|593775672|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
164383939|NCT00116805|593775673|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
164383940|NCT00116805|593775672|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
164383941|NCT00116805|593775673|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
164383942|NCT00116805|593775672|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
164383943|NCT00116805|593775673|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
164383944|NCT00116805|593775672|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
164383945|NCT00116805|593775673|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
164383946|NCT00116805|593775672|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
164383947|NCT00116805|593775673|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
164383948|NCT00116805|593775672|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
164383949|NCT00116805|593775673|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
164383950|NCT00116805|593775672|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
164383951|NCT00116805|593775673|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
164383952|NCT00116805|593775672|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
164383953|NCT00116805|593775673|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
164383954|NCT00116805|593775672|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
164383955|NCT00116805|593775673|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
164383956|NCT00116805|593775672|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
164383957|NCT00116805|593775673|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
164383958|NCT00116805|593775672|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
164383959|NCT00116805|593775673|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
164383960|NCT00116805|593775672|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
164383961|NCT00116805|593775673|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
164383962|NCT00116805|593775672|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
164383963|NCT00116805|593775673|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
164383964|NCT00116805|593775672|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
164383965|NCT00116805|593775673|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
164417428|NCT01474512|593899496|FG007|Long-Term Extension Period|Clinical Relapse|0|||
164417429|NCT01474512|593899497|FG008|Long-Term Extension Period|Clinical Relapse|0|||
164417430|NCT01474512|593899498|FG009|Long-Term Extension Period|Clinical Relapse|0|||
164417431|NCT01474512|593899499|FG010|Long-Term Extension Period|Clinical Relapse|0|||
164417432|NCT01474512|593899500|FG011|Long-Term Extension Period|Clinical Relapse|0|||
164417433|NCT01474512|593899501|FG012|Long-Term Extension Period|Clinical Relapse|9|||
164417434|NCT01474512|593899502|FG013|Long-Term Extension Period|Clinical Relapse|9|||
164417435|NCT01474512|593899503|FG014|Long-Term Extension Period|Clinical Relapse|0|||
164417436|NCT01474512|593899504|FG015|Long-Term Extension Period|Clinical Relapse|0|||
164417437|NCT01474512|593899505|FG016|Long-Term Extension Period|Clinical Relapse|0|||
164417438|NCT01474512|593899506|FG017|Long-Term Extension Period|Clinical Relapse|0|||
164417439|NCT01474512|593899489|FG000|Long-Term Extension Period|Death|0|||
164383966|NCT00116805|593775672|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
164383967|NCT00116805|593775673|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
164383968|NCT00116805|593775672|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
164383969|NCT00116805|593775673|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
164383970|NCT00116805|593775672|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
164383971|NCT00116805|593775673|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
164383972|NCT00116805|593775672|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
164383973|NCT00116805|593775673|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
164383974|NCT00116805|593775672|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
164383975|NCT00116805|593775673|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
164383976|NCT00116805|593775672|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
164383977|NCT00116805|593775673|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
164383978|NCT00116805|593775672|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
164383979|NCT00116805|593775673|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
164383980|NCT00116805|593775672|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
164383981|NCT00116805|593775673|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
164383982|NCT00116805|593775672|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
164383983|NCT00116805|593775673|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
164383984|NCT00116805|593775672|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
164383985|NCT00116805|593775673|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
164383986|NCT00116805|593775672|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
164383987|NCT00116805|593775673|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
164383988|NCT00116805|593775672|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
164383989|NCT00116805|593775673|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
164383990|NCT01575561|593775674|FG000|Overall Study|Adverse Event|9|||
164383991|NCT01575561|593775674|FG000|Overall Study|Lack of Efficacy|8|||
164383992|NCT01575561|593775674|FG000|Overall Study|Lost to Follow-up|6|||
164383993|NCT01575561|593775674|FG000|Overall Study|Protocol Violation|4|||
164383994|NCT01575561|593775674|FG000|Overall Study|Withdrawal by Subject|11|||
164383995|NCT01575561|593775674|FG000|Overall Study|administration|1|||
164383996|NCT01033747|593775676|FG000|Overall Study|Adverse Event|9|||
164383997|NCT01033747|593775677|FG001|Overall Study|Adverse Event|4|||
164383998|NCT01033747|593775676|FG000|Overall Study|Abnormal Laboratory Value|1|||
164383999|NCT01033747|593775677|FG001|Overall Study|Abnormal Laboratory Value|0|||
164384000|NCT01033747|593775676|FG000|Overall Study|Abnormal test procedure|0|||
164384001|NCT01033747|593775677|FG001|Overall Study|Abnormal test procedure|1|||
164384002|NCT01033747|593775676|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
164384003|NCT01033747|593775677|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
164384004|NCT01033747|593775676|FG000|Overall Study|Protocol Violation|1|||
164384005|NCT01033747|593775677|FG001|Overall Study|Protocol Violation|0|||
164384006|NCT01033747|593775676|FG000|Overall Study|Withdrawal by Subject|9|||
164384007|NCT01033747|593775677|FG001|Overall Study|Withdrawal by Subject|6|||
164384008|NCT01033747|593775676|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
164384009|NCT01033747|593775677|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
164384010|NCT01033747|593775676|FG000|Overall Study|Stopped at end of Extension 1|2|||
164384011|NCT01033747|593775677|FG001|Overall Study|Stopped at end of Extension 1|0|||
164384012|NCT02613481|593775678|FG000|Overall Study|Lost to Follow-up|7|||
164384013|NCT02613481|593775678|FG000|Overall Study|Withdrawal by Subject|2|||
164384014|NCT00844194|593775679|FG000|Overall Study|Adverse Event|17|||
164384015|NCT00844194|593775680|FG001|Overall Study|Adverse Event|5|||
164384016|NCT00844194|593775679|FG000|Overall Study|Protocol Violation|1|||
164384017|NCT00844194|593775680|FG001|Overall Study|Protocol Violation|1|||
164384018|NCT00844194|593775679|FG000|Overall Study|Lost to Follow-up|1|||
164384019|NCT00844194|593775680|FG001|Overall Study|Lost to Follow-up|1|||
164384020|NCT00844194|593775679|FG000|Overall Study|Withdrawal by Subject|2|||
164384021|NCT00844194|593775680|FG001|Overall Study|Withdrawal by Subject|1|||
164384022|NCT00844194|593775679|FG000|Overall Study|Lack of Efficacy|3|||
164384023|NCT00844194|593775680|FG001|Overall Study|Lack of Efficacy|0|||
164384024|NCT00844194|593775679|FG000|Overall Study|Other reason (not specified)|1|||
164384025|NCT00844194|593775680|FG001|Overall Study|Other reason (not specified)|0|||
164384026|NCT01542528|593775685|FG000|Overall Study|Lost to Follow-up|2|||
164384027|NCT01542528|593775686|FG001|Overall Study|Lost to Follow-up|1|||
164384028|NCT01542528|593775685|FG000|Overall Study|Physician Decision|1|||
164384029|NCT01542528|593775686|FG001|Overall Study|Physician Decision|0|||
164592502|NCT01087528|594532554|FG000|Overall Study|Incomplete CE procedure|6|||
164384030|NCT01542528|593775685|FG000|Overall Study|Withdrawal by Subject|9|||
164384031|NCT01542528|593775686|FG001|Overall Study|Withdrawal by Subject|6|||
164384032|NCT05282004|593775687|FG000|Overall Study|Adverse Event|2|||
164384033|NCT04808609|593775688|FG000|Overall Study|Lost to Follow-up|0|||
164592503|NCT02868216|594532555|FG000|Overall Study|Death|0|||
164592504|NCT02868216|594532556|FG001|Overall Study|Death|1|||
164384034|NCT04808609|593775689|FG001|Overall Study|Lost to Follow-up|2|||
164701888|NCT00688376|594932749|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
164701889|NCT00688376|594932748|FG000|Blinded Extension Phase|Physician Decision|1|||
164701890|NCT00688376|594932749|FG001|Blinded Extension Phase|Physician Decision|0|||
164701891|NCT00688376|594932748|FG000|Blinded Extension Phase|Other|1|||
164701892|NCT00688376|594932749|FG001|Blinded Extension Phase|Other|0|||
164701893|NCT02303041|594932750|FG000|Overall Study|Adverse Event|1|||
164701894|NCT02303041|594932751|FG001|Overall Study|Adverse Event|2|||
164701895|NCT00886288|594932752|FG000|Overall Study|no respect of the 12 weeks period|657|||
164701896|NCT00886288|594932753|FG001|Overall Study|no respect of the 12 weeks period|227|||
164384035|NCT04808609|593775688|FG000|Overall Study|Administrative Withdrawal|0|||
164384036|NCT04808609|593775689|FG001|Overall Study|Administrative Withdrawal|1|||
164384037|NCT00562159|593775690|FG000|Overall Study|Adverse Event|11|||
164384038|NCT00562159|593775691|FG001|Overall Study|Adverse Event|8|||
164384039|NCT00562159|593775690|FG000|Overall Study|Lost to Follow-up|5|||
164384040|NCT00562159|593775691|FG001|Overall Study|Lost to Follow-up|4|||
164384041|NCT00562159|593775690|FG000|Overall Study|Withdrawal by Subject|9|||
164384042|NCT00562159|593775691|FG001|Overall Study|Withdrawal by Subject|8|||
164384043|NCT00562159|593775690|FG000|Overall Study|Protocol Violation|12|||
164384044|NCT00562159|593775691|FG001|Overall Study|Protocol Violation|12|||
164384045|NCT00562159|593775690|FG000|Overall Study|Did not meet protocol eligibility|1|||
164384046|NCT00562159|593775691|FG001|Overall Study|Did not meet protocol eligibility|1|||
164384047|NCT01992536|593775703|FG000|Overall Study|Administrative Reason|0|||
164384048|NCT01992536|593775704|FG001|Overall Study|Administrative Reason|0|||
164384049|NCT01992536|593775705|FG002|Overall Study|Administrative Reason|0|||
164384050|NCT01992536|593775706|FG003|Overall Study|Administrative Reason|0|||
164384051|NCT01992536|593775707|FG004|Overall Study|Administrative Reason|0|||
164384052|NCT01992536|593775708|FG005|Overall Study|Administrative Reason|0|||
164384053|NCT01992536|593775709|FG006|Overall Study|Administrative Reason|7|||
164384054|NCT01992536|593775710|FG007|Overall Study|Administrative Reason|0|||
164384055|NCT01992536|593775711|FG008|Overall Study|Administrative Reason|0|||
164384056|NCT01992536|593775712|FG009|Overall Study|Administrative Reason|0|||
164384057|NCT01992536|593775703|FG000|Overall Study|Lost to Follow-up|4|||
164384058|NCT01992536|593775704|FG001|Overall Study|Lost to Follow-up|2|||
164384059|NCT01992536|593775705|FG002|Overall Study|Lost to Follow-up|1|||
164384060|NCT01992536|593775706|FG003|Overall Study|Lost to Follow-up|0|||
164384061|NCT01992536|593775707|FG004|Overall Study|Lost to Follow-up|0|||
164384062|NCT01992536|593775708|FG005|Overall Study|Lost to Follow-up|1|||
164384063|NCT01992536|593775709|FG006|Overall Study|Lost to Follow-up|0|||
164384064|NCT01992536|593775710|FG007|Overall Study|Lost to Follow-up|0|||
164384065|NCT01992536|593775711|FG008|Overall Study|Lost to Follow-up|1|||
164384066|NCT01992536|593775712|FG009|Overall Study|Lost to Follow-up|1|||
164384067|NCT01992536|593775703|FG000|Overall Study|Withdrawal by Subject|0|||
164384068|NCT01992536|593775704|FG001|Overall Study|Withdrawal by Subject|1|||
164440101|NCT03823300|593978888|FG000|Overall Study|Adverse Event|3|||
164440102|NCT03823300|593978889|FG001|Overall Study|Adverse Event|5|||
164440103|NCT03823300|593978888|FG000|Overall Study|Physician Decision|1|||
164440104|NCT03823300|593978889|FG001|Overall Study|Physician Decision|7|||
164440105|NCT03823300|593978888|FG000|Overall Study|Lost to Follow-up|1|||
164440106|NCT03823300|593978889|FG001|Overall Study|Lost to Follow-up|3|||
164440107|NCT03823300|593978888|FG000|Overall Study|Protocol Violation|1|||
164440108|NCT03823300|593978889|FG001|Overall Study|Protocol Violation|1|||
164440109|NCT03823300|593978888|FG000|Overall Study|Lack of Efficacy|1|||
164440110|NCT03823300|593978889|FG001|Overall Study|Lack of Efficacy|1|||
164701897|NCT00886288|594932752|FG000|Overall Study|Lost to Follow-up|86|||
164701898|NCT00886288|594932753|FG001|Overall Study|Lost to Follow-up|0|||
164701899|NCT01070771|594932754|FG000|Overall Study|Adverse Event|2|||
164701900|NCT01070771|594932754|FG000|Overall Study|Protocol Violation|1|||
164384069|NCT01992536|593775705|FG002|Overall Study|Withdrawal by Subject|0|||
164384070|NCT01992536|593775706|FG003|Overall Study|Withdrawal by Subject|2|||
164384071|NCT01992536|593775707|FG004|Overall Study|Withdrawal by Subject|0|||
164384072|NCT01992536|593775708|FG005|Overall Study|Withdrawal by Subject|0|||
164384073|NCT01992536|593775709|FG006|Overall Study|Withdrawal by Subject|0|||
164384074|NCT01992536|593775710|FG007|Overall Study|Withdrawal by Subject|0|||
164384075|NCT01992536|593775711|FG008|Overall Study|Withdrawal by Subject|0|||
164384076|NCT01992536|593775712|FG009|Overall Study|Withdrawal by Subject|0|||
164384077|NCT01762761|593775713|FG000|Overall Study|Adverse Event|15|||
164440111|NCT03823300|593978888|FG000|Overall Study|Not Eligible|0|||
164440112|NCT03823300|593978889|FG001|Overall Study|Not Eligible|1|||
164440113|NCT03823300|593978888|FG000|Overall Study|Other|1|||
164440114|NCT03823300|593978889|FG001|Overall Study|Other|0|||
164701901|NCT00700817|594932759|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
164701902|NCT00700817|594932760|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
164701903|NCT00700817|594932761|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
164384078|NCT01762761|593775714|FG001|Overall Study|Adverse Event|17|||
164384079|NCT01762761|593775713|FG000|Overall Study|Lack of Efficacy|9|||
164384080|NCT01762761|593775714|FG001|Overall Study|Lack of Efficacy|25|||
164384081|NCT01762761|593775713|FG000|Overall Study|Protocol Violation|1|||
164440115|NCT00831415|593978890|FG000|Overall Study|Adverse Event|14|||
164384082|NCT01762761|593775714|FG001|Overall Study|Protocol Violation|1|||
164384083|NCT01762761|593775713|FG000|Overall Study|Study closed/terminated|0|||
164384084|NCT01762761|593775714|FG001|Overall Study|Study closed/terminated|2|||
164384085|NCT01762761|593775713|FG000|Overall Study|Lost to Follow-up|3|||
164384086|NCT01762761|593775714|FG001|Overall Study|Lost to Follow-up|6|||
164384087|NCT01762761|593775713|FG000|Overall Study|Physician Decision|4|||
164384088|NCT01762761|593775714|FG001|Overall Study|Physician Decision|6|||
164384089|NCT01762761|593775713|FG000|Overall Study|Withdrawal by Subject|7|||
164384090|NCT01762761|593775714|FG001|Overall Study|Withdrawal by Subject|8|||
164384091|NCT02352493|593775717|FG000|Overall Study|Pregnancy|0|||
164384092|NCT02352493|593775718|FG001|Overall Study|Pregnancy|0|||
164384093|NCT02352493|593775719|FG002|Overall Study|Pregnancy|0|||
164384094|NCT02352493|593775720|FG003|Overall Study|Pregnancy|0|||
164384095|NCT02352493|593775721|FG004|Overall Study|Pregnancy|0|||
164384096|NCT02352493|593775722|FG005|Overall Study|Pregnancy|0|||
164384097|NCT02352493|593775723|FG006|Overall Study|Pregnancy|1|||
164384098|NCT02352493|593775724|FG007|Overall Study|Pregnancy|0|||
164384099|NCT02352493|593775725|FG008|Overall Study|Pregnancy|1|||
164384100|NCT02352493|593775726|FG009|Overall Study|Pregnancy|0|||
164384101|NCT02352493|593775727|FG010|Overall Study|Pregnancy|0|||
164384102|NCT02352493|593775728|FG011|Overall Study|Pregnancy|0|||
164384103|NCT02352493|593775729|FG012|Overall Study|Pregnancy|0|||
164384104|NCT02352493|593775730|FG013|Overall Study|Pregnancy|0|||
164384105|NCT02352493|593775731|FG014|Overall Study|Pregnancy|0|||
164384106|NCT02352493|593775732|FG015|Overall Study|Pregnancy|0|||
164384107|NCT02352493|593775733|FG016|Overall Study|Pregnancy|0|||
164384108|NCT02352493|593775734|FG017|Overall Study|Pregnancy|0|||
164384109|NCT02352493|593775717|FG000|Overall Study|Withdrawal by Subject|0|||
164384110|NCT02352493|593775718|FG001|Overall Study|Withdrawal by Subject|0|||
164384111|NCT02352493|593775719|FG002|Overall Study|Withdrawal by Subject|0|||
164384112|NCT02352493|593775720|FG003|Overall Study|Withdrawal by Subject|0|||
164384113|NCT02352493|593775721|FG004|Overall Study|Withdrawal by Subject|0|||
164384114|NCT02352493|593775722|FG005|Overall Study|Withdrawal by Subject|0|||
164384115|NCT02352493|593775723|FG006|Overall Study|Withdrawal by Subject|0|||
164384116|NCT02352493|593775724|FG007|Overall Study|Withdrawal by Subject|0|||
164384117|NCT02352493|593775725|FG008|Overall Study|Withdrawal by Subject|1|||
164384118|NCT02352493|593775726|FG009|Overall Study|Withdrawal by Subject|0|||
164384119|NCT02352493|593775727|FG010|Overall Study|Withdrawal by Subject|0|||
164384120|NCT02352493|593775728|FG011|Overall Study|Withdrawal by Subject|0|||
164384121|NCT02352493|593775729|FG012|Overall Study|Withdrawal by Subject|0|||
164384122|NCT02352493|593775730|FG013|Overall Study|Withdrawal by Subject|0|||
164384123|NCT02352493|593775731|FG014|Overall Study|Withdrawal by Subject|1|||
164384124|NCT02352493|593775732|FG015|Overall Study|Withdrawal by Subject|0|||
164384125|NCT02352493|593775733|FG016|Overall Study|Withdrawal by Subject|0|||
164384126|NCT02352493|593775734|FG017|Overall Study|Withdrawal by Subject|0|||
164384127|NCT02352493|593775717|FG000|Overall Study|Lost to Follow-up|0|||
164384128|NCT02352493|593775718|FG001|Overall Study|Lost to Follow-up|0|||
164384129|NCT02352493|593775719|FG002|Overall Study|Lost to Follow-up|0|||
164384130|NCT02352493|593775720|FG003|Overall Study|Lost to Follow-up|0|||
164384131|NCT02352493|593775721|FG004|Overall Study|Lost to Follow-up|0|||
164384132|NCT02352493|593775722|FG005|Overall Study|Lost to Follow-up|0|||
164384133|NCT02352493|593775723|FG006|Overall Study|Lost to Follow-up|0|||
164384134|NCT02352493|593775724|FG007|Overall Study|Lost to Follow-up|0|||
164384135|NCT02352493|593775725|FG008|Overall Study|Lost to Follow-up|0|||
164384136|NCT02352493|593775726|FG009|Overall Study|Lost to Follow-up|1|||
164384137|NCT02352493|593775727|FG010|Overall Study|Lost to Follow-up|0|||
164384138|NCT02352493|593775728|FG011|Overall Study|Lost to Follow-up|0|||
164384139|NCT02352493|593775729|FG012|Overall Study|Lost to Follow-up|1|||
164384140|NCT02352493|593775730|FG013|Overall Study|Lost to Follow-up|2|||
164384141|NCT02352493|593775731|FG014|Overall Study|Lost to Follow-up|0|||
164384142|NCT02352493|593775732|FG015|Overall Study|Lost to Follow-up|0|||
164384143|NCT02352493|593775733|FG016|Overall Study|Lost to Follow-up|0|||
164384144|NCT02352493|593775734|FG017|Overall Study|Lost to Follow-up|0|||
164384145|NCT02162810|593775735|FG000|Overall Study|Protocol Violation|1|||
164384146|NCT02162810|593775736|FG001|Overall Study|Protocol Violation|0|||
164384147|NCT02162810|593775735|FG000|Overall Study|patients did not report compliance|4|||
164384148|NCT02162810|593775736|FG001|Overall Study|patients did not report compliance|1|||
164384149|NCT00389324|593775737|FG000|Run-In Phase|Adverse Event|1|||
164384150|NCT00389324|593775737|FG000|Run-In Phase|Lost to Follow-up|1|||
164384151|NCT00389324|593775737|FG000|Run-In Phase|Withdrawal by Subject|1|||
164384152|NCT00389324|593775737|FG000|Subcutaneous Phase|Adverse Event|2|||
164384153|NCT00389324|593775737|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
164384154|NCT00389324|593775737|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
164384155|NCT00389324|593775737|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
164384156|NCT02317575|593775738|FG000|Period 1|Difficulty with venous cannulation|0|||
164384157|NCT02317575|593775739|FG001|Period 1|Difficulty with venous cannulation|1|||
164384158|NCT02317575|593775740|FG002|Period 1|Difficulty with venous cannulation|0|||
164384159|NCT02317575|593775741|FG003|Period 1|Difficulty with venous cannulation|0|||
164384160|NCT02317575|593775742|FG004|Period 1|Difficulty with venous cannulation|0|||
164701904|NCT00700817|594932762|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
164701905|NCT00700817|594932763|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
164701906|NCT00700817|594932759|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
164701907|NCT00700817|594932760|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
164701908|NCT00700817|594932761|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
164701909|NCT00700817|594932762|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
164701910|NCT00700817|594932763|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
164701911|NCT00700817|594932759|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
164701912|NCT00700817|594932760|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
164701913|NCT00700817|594932761|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
164701914|NCT00700817|594932762|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
164701915|NCT00700817|594932763|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
164701916|NCT00700817|594932759|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
164701917|NCT00700817|594932760|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
164701918|NCT00700817|594932761|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
164701919|NCT00700817|594932762|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
164701920|NCT00700817|594932763|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
164701921|NCT00700817|594932759|FG000|Week 0-26 (Main Period)|Unclassified|14|||
164701922|NCT00700817|594932760|FG001|Week 0-26 (Main Period)|Unclassified|4|||
164701923|NCT00700817|594932761|FG002|Week 0-26 (Main Period)|Unclassified|8|||
164701924|NCT00700817|594932762|FG003|Week 0-26 (Main Period)|Unclassified|0|||
164701925|NCT00700817|594932763|FG004|Week 0-26 (Main Period)|Unclassified|0|||
164701926|NCT00700817|594932759|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
164701927|NCT00700817|594932760|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
164701928|NCT00700817|594932761|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
164701929|NCT00700817|594932762|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
164701930|NCT00700817|594932763|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
164701931|NCT00700817|594932759|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
164701932|NCT00700817|594932760|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
164701933|NCT00700817|594932761|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
164701934|NCT00700817|594932762|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
164701935|NCT00700817|594932763|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
164701936|NCT00700817|594932759|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
164701937|NCT00700817|594932760|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
164701938|NCT00700817|594932761|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
164701939|NCT00700817|594932762|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
164701940|NCT00700817|594932763|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
164701941|NCT00700817|594932759|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
164701942|NCT00700817|594932760|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
164701943|NCT00700817|594932761|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
164701944|NCT00700817|594932762|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
164701945|NCT00700817|594932763|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
164701946|NCT00700817|594932759|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
164701947|NCT00700817|594932760|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
164701948|NCT00700817|594932761|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
164701949|NCT00700817|594932762|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
164701950|NCT00700817|594932763|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
164701951|NCT00700817|594932759|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
164701952|NCT00700817|594932760|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
164701953|NCT00700817|594932761|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
164701954|NCT00700817|594932762|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
164701955|NCT00700817|594932763|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
164701956|NCT00700817|594932759|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
164701957|NCT00700817|594932760|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
164701958|NCT00700817|594932761|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
164701959|NCT00700817|594932762|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
164701960|NCT00700817|594932763|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
164701961|NCT00700817|594932759|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
164701962|NCT00700817|594932760|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
164701963|NCT00700817|594932761|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
164701964|NCT00700817|594932762|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
164701965|NCT00700817|594932763|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
164701966|NCT00700817|594932759|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
164701967|NCT00700817|594932760|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
164701968|NCT00700817|594932761|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
164701969|NCT00700817|594932762|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
164701970|NCT00700817|594932763|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
164701971|NCT00700817|594932759|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
164701972|NCT00700817|594932760|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
164384161|NCT02317575|593775738|FG000|Period 1|Withdrawal by Subject|1|||
164384162|NCT02317575|593775739|FG001|Period 1|Withdrawal by Subject|0|||
164384163|NCT02317575|593775740|FG002|Period 1|Withdrawal by Subject|0|||
164384164|NCT02317575|593775741|FG003|Period 1|Withdrawal by Subject|0|||
164384165|NCT02317575|593775742|FG004|Period 1|Withdrawal by Subject|0|||
164384166|NCT01465334|593775743|FG000|Overall Study|Disease Progression|1|||
164384167|NCT01465334|593775744|FG001|Overall Study|Disease Progression|0|||
164384168|NCT01465334|593775743|FG000|Overall Study|Adverse Event|1|||
164384169|NCT01465334|593775744|FG001|Overall Study|Adverse Event|0|||
164384170|NCT01465334|593775743|FG000|Overall Study|Richter's transformation|0|||
164384171|NCT01465334|593775744|FG001|Overall Study|Richter's transformation|3|||
164384172|NCT01465334|593775743|FG000|Overall Study|Refractory Disease|0|||
164384173|NCT01465334|593775744|FG001|Overall Study|Refractory Disease|3|||
164384174|NCT00572572|593775745|FG000|Overall Study|Withdrawal by Subject|3|||
164384175|NCT00572572|593775746|FG001|Overall Study|Withdrawal by Subject|6|||
164384176|NCT01831089|593775747|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
164384177|NCT01831089|593775748|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
164384178|NCT01831089|593775749|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
164384179|NCT01831089|593775750|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
164384180|NCT01831089|593775751|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
164384181|NCT01831089|593775752|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
164384182|NCT01831089|593775747|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
164384183|NCT01831089|593775748|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
164384184|NCT01831089|593775749|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
164384185|NCT01831089|593775750|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
164384186|NCT01831089|593775751|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
164384187|NCT01831089|593775752|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
164384188|NCT01831089|593775747|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
164384189|NCT01831089|593775748|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
164384190|NCT01831089|593775749|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
164384191|NCT01831089|593775750|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
164384192|NCT01831089|593775751|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
164440116|NCT00831415|593978890|FG000|Overall Study|Failed to return|3|||
164440117|NCT00831415|593978890|FG000|Overall Study|Physician Decision|6|||
164440118|NCT00831415|593978890|FG000|Overall Study|Lost to Follow-up|9|||
164440119|NCT00831415|593978890|FG000|Overall Study|Protocol Violation|3|||
164440120|NCT00831415|593978890|FG000|Overall Study|Withdrawal by Subject|35|||
164440121|NCT00831415|593978890|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
164440122|NCT00831415|593978890|FG000|Overall Study|Death|1|||
164440123|NCT00486330|593978891|FG000|Overall Study|Adverse Event|2|||
164440124|NCT01290224|593978892|FG000|Overall Study|Adverse Event|1|||
164440125|NCT01290224|593978892|FG000|Overall Study|Refused Further Treatment|4|||
164440126|NCT01027286|593978893|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
164440127|NCT01027286|593978894|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
164701973|NCT00700817|594932761|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
164701974|NCT00700817|594932762|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
164701975|NCT00700817|594932763|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
164701976|NCT00058214|594932764|FG000|Overall Study|Adverse Event|1|||
164701977|NCT03097588|594932765|FG000|Overall Study|Adverse Event|1|||
164701978|NCT01144364|594932766|FG000|Induction Phase|Disease progression|14|||
164701979|NCT01144364|594932767|FG001|Induction Phase|Disease progression|0|||
164701980|NCT01144364|594932768|FG002|Induction Phase|Disease progression|0|||
164701981|NCT01144364|594932766|FG000|Induction Phase|Adverse Event|9|||
164701982|NCT01144364|594932767|FG001|Induction Phase|Adverse Event|0|||
164701983|NCT01144364|594932768|FG002|Induction Phase|Adverse Event|0|||
164701984|NCT01144364|594932766|FG000|Induction Phase|Death|1|||
164701985|NCT01144364|594932767|FG001|Induction Phase|Death|0|||
164701986|NCT01144364|594932768|FG002|Induction Phase|Death|0|||
164701987|NCT01144364|594932766|FG000|Induction Phase|Withdrawal by Subject|1|||
164701988|NCT01144364|594932767|FG001|Induction Phase|Withdrawal by Subject|0|||
164701989|NCT01144364|594932768|FG002|Induction Phase|Withdrawal by Subject|0|||
164701990|NCT01144364|594932766|FG000|Induction Phase|Lost to Follow-up|2|||
164701991|NCT01144364|594932767|FG001|Induction Phase|Lost to Follow-up|0|||
164384193|NCT01831089|593775752|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
164384194|NCT01831089|593775747|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
164384195|NCT01831089|593775748|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
164384196|NCT01831089|593775749|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
164384197|NCT01831089|593775750|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
164384198|NCT01831089|593775751|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
164384199|NCT01831089|593775752|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
164384200|NCT01831089|593775747|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
164701992|NCT01144364|594932768|FG002|Induction Phase|Lost to Follow-up|0|||
164701993|NCT01144364|594932766|FG000|Induction Phase|Physician Decision|1|||
164384201|NCT01831089|593775748|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
164701994|NCT01144364|594932767|FG001|Induction Phase|Physician Decision|0|||
164701995|NCT01144364|594932768|FG002|Induction Phase|Physician Decision|0|||
164701996|NCT01144364|594932766|FG000|Induction Phase|Stable disease|2|||
164701997|NCT01144364|594932767|FG001|Induction Phase|Stable disease|0|||
164701998|NCT01144364|594932768|FG002|Induction Phase|Stable disease|0|||
164701999|NCT01144364|594932766|FG000|Induction Phase|Secondary neoplasia|1|||
164702000|NCT01144364|594932767|FG001|Induction Phase|Secondary neoplasia|0|||
164702001|NCT01144364|594932768|FG002|Induction Phase|Secondary neoplasia|0|||
164702002|NCT01144364|594932766|FG000|Induction Phase|Protocol Violation|1|||
164384202|NCT01831089|593775749|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
164384203|NCT01831089|593775750|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
164384204|NCT01831089|593775751|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
164384205|NCT01831089|593775752|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
164384206|NCT01831089|593775747|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
164384207|NCT01831089|593775748|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
164384208|NCT01831089|593775749|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
164384209|NCT01831089|593775750|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
164384210|NCT01831089|593775751|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
164384211|NCT01831089|593775752|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
164384212|NCT01831089|593775747|FG000|Cohort III: Dose Level 3|Global end of study|0|||
164384213|NCT01831089|593775748|FG001|Cohort III: Dose Level 3|Global end of study|0|||
164384214|NCT01831089|593775749|FG002|Cohort III: Dose Level 3|Global end of study|1|||
164384215|NCT01831089|593775750|FG003|Cohort III: Dose Level 3|Global end of study|0|||
164384216|NCT01831089|593775751|FG004|Cohort III: Dose Level 3|Global end of study|0|||
164384217|NCT01831089|593775752|FG005|Cohort III: Dose Level 3|Global end of study|0|||
164384218|NCT01831089|593775747|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
164384219|NCT01831089|593775748|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
164384220|NCT01831089|593775749|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
164384221|NCT01831089|593775750|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
164384222|NCT01831089|593775751|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
164384223|NCT01831089|593775752|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
164384224|NCT01831089|593775747|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
164384225|NCT01831089|593775748|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
164384226|NCT01831089|593775749|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
164384227|NCT01831089|593775750|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
164384228|NCT01831089|593775751|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
164384229|NCT01831089|593775752|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
164384230|NCT01831089|593775747|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
164384231|NCT01831089|593775748|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
164384232|NCT01831089|593775749|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
164384233|NCT01831089|593775750|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
164384234|NCT01831089|593775751|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
164384235|NCT01831089|593775752|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
164384236|NCT01831089|593775747|FG000|Cohort V: Dose Level 5|Death|0|||
164384237|NCT01831089|593775748|FG001|Cohort V: Dose Level 5|Death|0|||
164384238|NCT01831089|593775749|FG002|Cohort V: Dose Level 5|Death|0|||
164384239|NCT01831089|593775750|FG003|Cohort V: Dose Level 5|Death|0|||
164384240|NCT01831089|593775751|FG004|Cohort V: Dose Level 5|Death|1|||
164384241|NCT01831089|593775752|FG005|Cohort V: Dose Level 5|Death|0|||
164384242|NCT01831089|593775747|FG000|Cohort V: Dose Level 5|Global end of study|0|||
164384243|NCT01831089|593775748|FG001|Cohort V: Dose Level 5|Global end of study|0|||
164384244|NCT01831089|593775749|FG002|Cohort V: Dose Level 5|Global end of study|0|||
164384245|NCT01831089|593775750|FG003|Cohort V: Dose Level 5|Global end of study|0|||
164384246|NCT01831089|593775751|FG004|Cohort V: Dose Level 5|Global end of study|2|||
164384247|NCT01831089|593775752|FG005|Cohort V: Dose Level 5|Global end of study|0|||
164384248|NCT01831089|593775747|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
164384249|NCT01831089|593775748|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
164384250|NCT01831089|593775749|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
164702003|NCT01144364|594932767|FG001|Induction Phase|Protocol Violation|0|||
164702004|NCT01144364|594932768|FG002|Induction Phase|Protocol Violation|0|||
164702005|NCT01144364|594932766|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
164384251|NCT01831089|593775750|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
164384252|NCT01831089|593775751|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
164384253|NCT01831089|593775752|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
164384254|NCT01831089|593775747|FG000|Cohort B: Arm B|Progressive disease|0|||
164384255|NCT01831089|593775748|FG001|Cohort B: Arm B|Progressive disease|0|||
164384256|NCT01831089|593775749|FG002|Cohort B: Arm B|Progressive disease|0|||
164384257|NCT01831089|593775750|FG003|Cohort B: Arm B|Progressive disease|0|||
164384258|NCT01831089|593775751|FG004|Cohort B: Arm B|Progressive disease|0|||
164384259|NCT01831089|593775752|FG005|Cohort B: Arm B|Progressive disease|8|||
164384260|NCT01831089|593775747|FG000|Cohort B: Arm B|Physician Decision|0|||
164384261|NCT01831089|593775748|FG001|Cohort B: Arm B|Physician Decision|0|||
164417440|NCT01474512|593899490|FG001|Long-Term Extension Period|Death|0|||
164702006|NCT01144364|594932767|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
164592505|NCT02868216|594532555|FG000|Overall Study|coronary artery bypass|1|||
164592506|NCT02868216|594532556|FG001|Overall Study|coronary artery bypass|0|||
164592507|NCT02868216|594532555|FG000|Overall Study|Withdrawal by Subject|7|||
164592508|NCT02868216|594532556|FG001|Overall Study|Withdrawal by Subject|5|||
164592509|NCT03161678|594532557|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
164592510|NCT03161678|594532558|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
164592511|NCT03161678|594532559|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
164592512|NCT03161678|594532560|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
164592513|NCT03161678|594532561|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
164592514|NCT03161678|594532562|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
164592515|NCT03161678|594532557|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
164592516|NCT03161678|594532558|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
164592517|NCT03161678|594532559|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
164592518|NCT03161678|594532560|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
164592519|NCT03161678|594532561|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
164592520|NCT03161678|594532562|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
164592521|NCT03161678|594532557|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
164592522|NCT03161678|594532558|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
164592523|NCT03161678|594532559|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
164592524|NCT03161678|594532560|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
164592525|NCT03161678|594532561|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
164592526|NCT03161678|594532562|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
164592527|NCT03161678|594532557|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
164592528|NCT03161678|594532558|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
164592529|NCT03161678|594532559|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
164592530|NCT03161678|594532560|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
164592531|NCT03161678|594532561|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
164592532|NCT03161678|594532562|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
164592533|NCT00752609|594532563|FG000|Overall Study|Adverse Event|2|||
164592534|NCT00752609|594532564|FG001|Overall Study|Adverse Event|2|||
164592535|NCT00752609|594532563|FG000|Overall Study|Withdrawal by Subject|3|||
164592536|NCT00752609|594532564|FG001|Overall Study|Withdrawal by Subject|0|||
164592537|NCT00752609|594532563|FG000|Overall Study|Physician Decision|1|||
164592538|NCT00752609|594532564|FG001|Overall Study|Physician Decision|0|||
164592539|NCT00752609|594532563|FG000|Overall Study|Death|1|||
164592540|NCT00752609|594532564|FG001|Overall Study|Death|0|||
164592541|NCT00752609|594532563|FG000|Overall Study|Met exclusion criteria|1|||
164592542|NCT00752609|594532564|FG001|Overall Study|Met exclusion criteria|0|||
164592543|NCT00752609|594532563|FG000|Overall Study|Received Aranesp in error|1|||
164592544|NCT00752609|594532564|FG001|Overall Study|Received Aranesp in error|0|||
164592545|NCT05114590|594532565|FG000|Overall Study|Adverse Event|1|||
164592546|NCT05114590|594532565|FG000|Overall Study|Investigator decision|1|||
164592547|NCT05114590|594532565|FG000|Overall Study|Lost to Follow-up|5|||
164592548|NCT05114590|594532565|FG000|Overall Study|Withdrawal by Subject|5|||
164592549|NCT05114590|594532565|FG000|Overall Study|Other|2|||
164592550|NCT00850460|594532566|FG000|Overall Study|Lost to Follow-up|4|||
164592551|NCT00850460|594532567|FG001|Overall Study|Lost to Follow-up|4|||
164592552|NCT03007953|594532570|FG000|Overall Study|Withdrawal by Subject|5|||
164592553|NCT03007953|594532571|FG001|Overall Study|Withdrawal by Subject|2|||
164592554|NCT03007953|594532570|FG000|Overall Study|Death|5|||
164592555|NCT03007953|594532571|FG001|Overall Study|Death|7|||
164592556|NCT03007953|594532570|FG000|Overall Study|Lost to Follow-up|3|||
164592557|NCT03007953|594532571|FG001|Overall Study|Lost to Follow-up|2|||
164592558|NCT03007953|594532570|FG000|Overall Study|Enrolled in Hospice|3|||
164592559|NCT03007953|594532571|FG001|Overall Study|Enrolled in Hospice|2|||
164592560|NCT02224846|594532574|FG000|Period 1 (Month 3)|Adverse Event|2|||
164592561|NCT02224846|594532575|FG001|Period 1 (Month 3)|Adverse Event|1|||
164592562|NCT02224846|594532574|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
164592563|NCT02224846|594532575|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
164592564|NCT02224846|594532574|FG000|Period 1 (Month 3)|Protocol Violation|4|||
164384262|NCT01831089|593775749|FG002|Cohort B: Arm B|Physician Decision|0|||
164592565|NCT02224846|594532575|FG001|Period 1 (Month 3)|Protocol Violation|8|||
164384263|NCT01831089|593775750|FG003|Cohort B: Arm B|Physician Decision|0|||
164384264|NCT01831089|593775751|FG004|Cohort B: Arm B|Physician Decision|0|||
164384265|NCT01831089|593775752|FG005|Cohort B: Arm B|Physician Decision|2|||
164592566|NCT02224846|594532574|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
164592567|NCT02224846|594532575|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
164592568|NCT02224846|594532574|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
164592569|NCT02224846|594532575|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
164592570|NCT02224846|594532574|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
164592571|NCT02224846|594532575|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
164592572|NCT02224846|594532574|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
164592573|NCT02224846|594532575|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
164592574|NCT02224846|594532574|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
164592575|NCT02224846|594532575|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
164384266|NCT01831089|593775747|FG000|Cohort B: Arm B|Never treated|0|||
164384267|NCT01831089|593775748|FG001|Cohort B: Arm B|Never treated|0|||
164384268|NCT01831089|593775749|FG002|Cohort B: Arm B|Never treated|0|||
164384269|NCT01831089|593775750|FG003|Cohort B: Arm B|Never treated|0|||
164384270|NCT01831089|593775751|FG004|Cohort B: Arm B|Never treated|0|||
164384271|NCT01831089|593775752|FG005|Cohort B: Arm B|Never treated|2|||
164384272|NCT01831089|593775747|FG000|Cohort B: Arm B|Adverse Event|0|||
164384273|NCT01831089|593775748|FG001|Cohort B: Arm B|Adverse Event|0|||
164384274|NCT01831089|593775749|FG002|Cohort B: Arm B|Adverse Event|0|||
164384275|NCT01831089|593775750|FG003|Cohort B: Arm B|Adverse Event|0|||
164440128|NCT01027286|593978893|FG000|Overall Study|Lost to Follow-up|0|||
164440129|NCT01027286|593978894|FG001|Overall Study|Lost to Follow-up|1|||
164440130|NCT05694065|593978895|FG000|Overall Study|Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion|3|||
164440131|NCT05694065|593978895|FG000|Overall Study|Ineligible for diagnostic intervention (IVUS or FFR examination)|2|||
164440132|NCT05694065|593978895|FG000|Overall Study|Target vessel with severe myocardial bridge|1|||
164440133|NCT01087762|593978896|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
164440134|NCT01087762|593978897|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
164440135|NCT01087762|593978898|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
164440136|NCT01087762|593978899|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
164440137|NCT01087762|593978900|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
164440138|NCT01087762|593978896|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
164440139|NCT01087762|593978897|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
164440140|NCT01087762|593978898|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
164440141|NCT01087762|593978899|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
164440142|NCT01087762|593978900|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
164440143|NCT01087762|593978896|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
164440144|NCT01087762|593978897|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
164440145|NCT01087762|593978898|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
164440146|NCT01087762|593978899|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
164440147|NCT01087762|593978900|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
164440148|NCT01087762|593978896|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
164440149|NCT01087762|593978897|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
164440150|NCT01087762|593978898|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
164440151|NCT01087762|593978899|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
164440152|NCT01087762|593978900|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
164440153|NCT01087762|593978896|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
164440154|NCT01087762|593978897|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
164440155|NCT01087762|593978898|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
164440156|NCT01087762|593978899|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
164440157|NCT01087762|593978900|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
164440158|NCT01087762|593978896|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
164440159|NCT01087762|593978897|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
164440160|NCT01087762|593978898|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
164440161|NCT01087762|593978899|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
164440162|NCT01087762|593978900|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
164440163|NCT01087762|593978896|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
164440164|NCT01087762|593978897|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
164440165|NCT01087762|593978898|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
164440166|NCT01087762|593978899|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
164440167|NCT01087762|593978900|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
164440168|NCT01087762|593978896|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
164440169|NCT01087762|593978897|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
164440170|NCT01087762|593978898|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
164440171|NCT01087762|593978899|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
164440172|NCT01087762|593978900|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
164440173|NCT01087762|593978896|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
164592576|NCT02224846|594532574|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
164592577|NCT02224846|594532575|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
164592578|NCT02224846|594532574|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
164592579|NCT02224846|594532575|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
164384276|NCT01831089|593775751|FG004|Cohort B: Arm B|Adverse Event|0|||
164384277|NCT01831089|593775752|FG005|Cohort B: Arm B|Adverse Event|1|||
164384278|NCT01831089|593775747|FG000|Cohort B: Arm B|Global end of study|0|||
164384279|NCT01831089|593775748|FG001|Cohort B: Arm B|Global end of study|0|||
164384280|NCT01831089|593775749|FG002|Cohort B: Arm B|Global end of study|0|||
164384281|NCT01831089|593775750|FG003|Cohort B: Arm B|Global end of study|0|||
164384282|NCT01831089|593775751|FG004|Cohort B: Arm B|Global end of study|0|||
164384283|NCT01831089|593775752|FG005|Cohort B: Arm B|Global end of study|1|||
164384284|NCT00889421|593775753|FG000|Overall Study|Lack of Efficacy|3|||
164702007|NCT01144364|594932768|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
164702008|NCT01144364|594932766|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
164384285|NCT03936244|593775757|FG000|Overall Study|Lost to Follow-up|5|||
164384286|NCT03936244|593775758|FG001|Overall Study|Lost to Follow-up|1|||
164384287|NCT03936244|593775757|FG000|Overall Study|Physician Decision|7|||
164384288|NCT03936244|593775758|FG001|Overall Study|Physician Decision|3|||
164384289|NCT02480621|593775772|FG000|Randomization|Withdrawal by Subject|1|||
164384290|NCT02480621|593775773|FG001|Randomization|Withdrawal by Subject|0|||
164384291|NCT02480621|593775772|FG000|Randomization|Surgeon did not give intervention|0|||
164384292|NCT02480621|593775773|FG001|Randomization|Surgeon did not give intervention|1|||
164384293|NCT02480621|593775772|FG000|Follow Up|Lost to Follow-up|4|||
164702009|NCT01144364|594932767|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
164702010|NCT01144364|594932768|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
164702011|NCT01144364|594932766|FG000|Follow-Up/Maintenance Phase|Death|0|||
164702012|NCT01144364|594932767|FG001|Follow-Up/Maintenance Phase|Death|2|||
164702013|NCT01144364|594932768|FG002|Follow-Up/Maintenance Phase|Death|0|||
164702014|NCT01144364|594932766|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
164702015|NCT01144364|594932767|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
164702016|NCT01144364|594932768|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
164702017|NCT01144364|594932766|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
164702018|NCT01144364|594932767|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
164702019|NCT01144364|594932768|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
164702020|NCT01144364|594932766|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
164702021|NCT01144364|594932767|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
164702022|NCT01144364|594932768|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
164702023|NCT01144364|594932766|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
164702024|NCT01144364|594932767|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
164702025|NCT01144364|594932768|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
164702026|NCT00891839|594932769|FG000|Overall Study|Adverse Event|2|||
164702027|NCT00891839|594932769|FG000|Overall Study|Withdrawal by Subject|2|||
164702028|NCT00891839|594932769|FG000|Overall Study|Disease progression|3|||
164702029|NCT02037165|594932770|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
164702030|NCT02037165|594932771|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
164702031|NCT02037165|594932772|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
164702032|NCT02037165|594932773|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
164702033|NCT02037165|594932774|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
164702034|NCT02674061|594932775|FG000|Overall Study|Death|229|||
164702035|NCT02674061|594932776|FG001|Overall Study|Death|77|||
164702036|NCT02674061|594932775|FG000|Overall Study|Lost to Follow-up|3|||
164702037|NCT02674061|594932776|FG001|Overall Study|Lost to Follow-up|3|||
164702038|NCT02674061|594932775|FG000|Overall Study|Withdrawal by Subject|9|||
164384294|NCT02480621|593775773|FG001|Follow Up|Lost to Follow-up|2|||
164384295|NCT01748994|593775774|FG000|Overall Study|Lost to Follow-up|8|||
164384296|NCT01748994|593775775|FG001|Overall Study|Lost to Follow-up|6|||
164384297|NCT03105362|593775776|FG000|Overall Study|Withdrawal by Subject|1|||
164384298|NCT03105362|593775776|FG000|Overall Study|Lost to Follow-up|1|||
164384299|NCT00861341|593775778|FG000|Overall Study|Withdrawal by Subject|2|||
164384300|NCT01440946|593775779|FG000|Overall Study|Lost to Follow-up|1|||
164384301|NCT01440946|593775780|FG001|Overall Study|Lost to Follow-up|1|||
164384302|NCT01440946|593775779|FG000|Overall Study|Physician Decision|1|||
164384303|NCT01440946|593775780|FG001|Overall Study|Physician Decision|0|||
164384304|NCT01975389|593775781|FG000|Overall Study|Adverse Event|10|||
164384305|NCT01975389|593775782|FG001|Overall Study|Adverse Event|6|||
164384306|NCT01975389|593775781|FG000|Overall Study|Death|61|||
164384307|NCT01975389|593775782|FG001|Overall Study|Death|54|||
164384308|NCT01975389|593775781|FG000|Overall Study|Lost to Follow-up|81|||
164384309|NCT01975389|593775782|FG001|Overall Study|Lost to Follow-up|86|||
164384310|NCT01975389|593775781|FG000|Overall Study|Withdrawal by Subject|90|||
164384311|NCT01975389|593775782|FG001|Overall Study|Withdrawal by Subject|76|||
164384312|NCT01975389|593775781|FG000|Overall Study|Other|6|||
164384313|NCT01975389|593775782|FG001|Overall Study|Other|9|||
164384314|NCT01975389|593775781|FG000|Overall Study|Randomized, not treated|4|||
164384315|NCT01975389|593775782|FG001|Overall Study|Randomized, not treated|5|||
164384316|NCT02296112|593775789|FG000|Overall Study|Disease progression|7|||
164384317|NCT02296112|593775789|FG000|Overall Study|Toxicity|1|||
164384318|NCT02296112|593775789|FG000|Overall Study|Began an alternate therapy|1|||
164384319|NCT02778204|593775790|FG000|Overall Study|Adverse Event|1|||
164702039|NCT02674061|594932776|FG001|Overall Study|Withdrawal by Subject|1|||
164384320|NCT02778204|593775791|FG001|Overall Study|Adverse Event|0|||
164384321|NCT02778204|593775792|FG002|Overall Study|Adverse Event|0|||
164384322|NCT02778204|593775793|FG003|Overall Study|Adverse Event|0|||
164384323|NCT02778204|593775790|FG000|Overall Study|Withdrawal by Subject|0|||
164384324|NCT02778204|593775791|FG001|Overall Study|Withdrawal by Subject|0|||
164384325|NCT02778204|593775792|FG002|Overall Study|Withdrawal by Subject|1|||
164384326|NCT02778204|593775793|FG003|Overall Study|Withdrawal by Subject|2|||
164384327|NCT02778204|593775790|FG000|Overall Study|Lost to Follow-up|1|||
164384328|NCT02778204|593775791|FG001|Overall Study|Lost to Follow-up|0|||
164384329|NCT02778204|593775792|FG002|Overall Study|Lost to Follow-up|2|||
164384330|NCT02778204|593775793|FG003|Overall Study|Lost to Follow-up|1|||
164384331|NCT02778204|593775790|FG000|Overall Study|Protocol Violation|0|||
164384332|NCT02778204|593775791|FG001|Overall Study|Protocol Violation|0|||
164384333|NCT02778204|593775792|FG002|Overall Study|Protocol Violation|1|||
164384334|NCT02778204|593775793|FG003|Overall Study|Protocol Violation|0|||
164384335|NCT02778204|593775790|FG000|Overall Study|Eligibility Violation|0|||
164384336|NCT02778204|593775791|FG001|Overall Study|Eligibility Violation|0|||
164384337|NCT02778204|593775792|FG002|Overall Study|Eligibility Violation|0|||
164384338|NCT02778204|593775793|FG003|Overall Study|Eligibility Violation|1|||
164384339|NCT01720069|593775794|FG000|Overall Study|Could not use e-diary correctly|0|||
164384340|NCT01720069|593775795|FG001|Overall Study|Could not use e-diary correctly|1|||
164384341|NCT01720069|593775796|FG002|Overall Study|Could not use e-diary correctly|1|||
164384342|NCT01720069|593775794|FG000|Overall Study|Randomised without baseline values|0|||
164384343|NCT01720069|593775795|FG001|Overall Study|Randomised without baseline values|0|||
164384344|NCT01720069|593775796|FG002|Overall Study|Randomised without baseline values|1|||
164384345|NCT01720069|593775794|FG000|Overall Study|Adverse Event|0|||
164384346|NCT01720069|593775795|FG001|Overall Study|Adverse Event|0|||
164384347|NCT01720069|593775796|FG002|Overall Study|Adverse Event|1|||
164384348|NCT01720069|593775794|FG000|Overall Study|Lack of Efficacy|0|||
164384349|NCT01720069|593775795|FG001|Overall Study|Lack of Efficacy|4|||
164384350|NCT01720069|593775796|FG002|Overall Study|Lack of Efficacy|0|||
164384351|NCT01720069|593775794|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
164384352|NCT01720069|593775795|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
164384353|NCT01720069|593775796|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
164384354|NCT01720069|593775794|FG000|Overall Study|Withdrawal by Subject|0|||
164384355|NCT01720069|593775795|FG001|Overall Study|Withdrawal by Subject|2|||
164384356|NCT01720069|593775796|FG002|Overall Study|Withdrawal by Subject|1|||
164384357|NCT01720069|593775794|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
164384358|NCT01720069|593775795|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
164384359|NCT01720069|593775796|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
164384360|NCT01720069|593775794|FG000|Overall Study|Non-compliance on using e-diary|0|||
164384361|NCT01720069|593775795|FG001|Overall Study|Non-compliance on using e-diary|0|||
164384362|NCT01720069|593775796|FG002|Overall Study|Non-compliance on using e-diary|1|||
164384363|NCT01720069|593775794|FG000|Overall Study|Lost to Follow-up|0|||
164384364|NCT01720069|593775795|FG001|Overall Study|Lost to Follow-up|0|||
164384365|NCT01720069|593775796|FG002|Overall Study|Lost to Follow-up|1|||
164384366|NCT00360334|593775797|FG000|Overall Study|Adverse Event|7|||
164384367|NCT00360334|593775798|FG001|Overall Study|Adverse Event|4|||
164384368|NCT00360334|593775797|FG000|Overall Study|Protocol Violation|1|||
164384369|NCT00360334|593775798|FG001|Overall Study|Protocol Violation|1|||
164384370|NCT00360334|593775797|FG000|Overall Study|Physician Decision|2|||
164384371|NCT00360334|593775798|FG001|Overall Study|Physician Decision|3|||
164384372|NCT00360334|593775797|FG000|Overall Study|Lack of Efficacy|0|||
164384373|NCT00360334|593775798|FG001|Overall Study|Lack of Efficacy|1|||
164384374|NCT00360334|593775797|FG000|Overall Study|Entry criterion not met|1|||
164384375|NCT00360334|593775798|FG001|Overall Study|Entry criterion not met|2|||
164384376|NCT00360334|593775797|FG000|Overall Study|Subject decision|8|||
164384377|NCT00360334|593775798|FG001|Overall Study|Subject decision|2|||
164384378|NCT01898793|593775799|FG000|Overall Study|Death|2|||
164384379|NCT01898793|593775800|FG001|Overall Study|Death|1|||
164384380|NCT01898793|593775801|FG002|Overall Study|Death|4|||
164384381|NCT01898793|593775802|FG003|Overall Study|Death|0|||
164384382|NCT01898793|593775803|FG004|Overall Study|Death|0|||
164384383|NCT01898793|593775804|FG005|Overall Study|Death|0|||
164384384|NCT01898793|593775805|FG006|Overall Study|Death|0|||
164440174|NCT01087762|593978897|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
164384385|NCT02239510|593777356|FG000|Overall Study|Lost to Follow-up|2|||
164384386|NCT02239510|593777357|FG001|Overall Study|Lost to Follow-up|1|||
164384387|NCT00982020|593777358|FG000|Overall Study|Adverse Event|19|||
164384388|NCT00982020|593777359|FG001|Overall Study|Adverse Event|15|||
164384389|NCT00982020|593777358|FG000|Overall Study|Withdrawal by Subject|11|||
164384390|NCT00982020|593777359|FG001|Overall Study|Withdrawal by Subject|14|||
164384391|NCT00982020|593777358|FG000|Overall Study|Lost to Follow-up|5|||
164384392|NCT00982020|593777359|FG001|Overall Study|Lost to Follow-up|11|||
164384393|NCT00982020|593777358|FG000|Overall Study|Lack of Efficacy|10|||
164384394|NCT00982020|593777359|FG001|Overall Study|Lack of Efficacy|4|||
164384395|NCT00982020|593777358|FG000|Overall Study|Parent/Caregiver Decision|5|||
164440175|NCT01087762|593978898|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
164384396|NCT00982020|593777359|FG001|Overall Study|Parent/Caregiver Decision|5|||
164384397|NCT00982020|593777358|FG000|Overall Study|Treatment Non-compliance|3|||
164384398|NCT00982020|593777359|FG001|Overall Study|Treatment Non-compliance|6|||
164384399|NCT00982020|593777358|FG000|Overall Study|Physician Decision|2|||
164384400|NCT00982020|593777359|FG001|Overall Study|Physician Decision|5|||
164384401|NCT00982020|593777358|FG000|Overall Study|Entry Criteria Not Met|2|||
164384402|NCT00982020|593777359|FG001|Overall Study|Entry Criteria Not Met|1|||
164384403|NCT00982020|593777358|FG000|Overall Study|Protocol Violation|0|||
164384404|NCT00982020|593777359|FG001|Overall Study|Protocol Violation|2|||
164384405|NCT00982020|593777358|FG000|Overall Study|Clinical Relapse|0|||
164384406|NCT00982020|593777359|FG001|Overall Study|Clinical Relapse|1|||
164384407|NCT03551938|593777360|FG000|3-Month Follow Up|Lost to Follow-up|39|||
164384408|NCT03551938|593777361|FG001|3-Month Follow Up|Lost to Follow-up|38|||
164384409|NCT03551938|593777360|FG000|6-Month Follow Up|Lost to Follow-up|46|||
164384410|NCT03551938|593777361|FG001|6-Month Follow Up|Lost to Follow-up|42|||
164384411|NCT03551938|593777360|FG000|9-Month Follow Up|Lost to Follow-up|44|||
164384412|NCT03551938|593777361|FG001|9-Month Follow Up|Lost to Follow-up|43|||
164384413|NCT01925183|593777362|FG000|Overall Study|Adverse Event|1|||
164384414|NCT01925183|593777363|FG001|Overall Study|Adverse Event|0|||
164384415|NCT01114646|593777364|FG000|Overall Study|Withdrawal by Subject|3|||
164384416|NCT01114646|593777365|FG001|Overall Study|Withdrawal by Subject|2|||
164384417|NCT01046110|593777366|FG000|Overall Study|Adverse Event|9|||
164384418|NCT01046110|593777367|FG001|Overall Study|Adverse Event|2|||
164384419|NCT01046110|593777366|FG000|Overall Study|Lack of Efficacy|0|||
164384420|NCT01046110|593777367|FG001|Overall Study|Lack of Efficacy|1|||
164384421|NCT01046110|593777366|FG000|Overall Study|Protocol Violation|7|||
164384422|NCT01046110|593777367|FG001|Overall Study|Protocol Violation|12|||
164384423|NCT01046110|593777366|FG000|Overall Study|Withdrawal Criteria|3|||
164384424|NCT01046110|593777367|FG001|Overall Study|Withdrawal Criteria|5|||
164384425|NCT01046110|593777366|FG000|Overall Study|Unclassified|36|||
164384426|NCT01046110|593777367|FG001|Overall Study|Unclassified|35|||
164384427|NCT02667912|593777377|FG000|Overall Study|Death|3|||
164384428|NCT02667912|593777378|FG001|Overall Study|Death|1|||
164384429|NCT02667912|593777377|FG000|Overall Study|Withdrawal by Subject|1|||
164384430|NCT02667912|593777378|FG001|Overall Study|Withdrawal by Subject|2|||
164384431|NCT02667912|593777377|FG000|Overall Study|Withdrawal by Subject|1|||
164384432|NCT02667912|593777378|FG001|Overall Study|Withdrawal by Subject|0|||
164384433|NCT04443218|593777379|FG000|Overall Study|Exited study for other reasons|9|||
164384434|NCT04443218|593777379|FG000|Overall Study|Withdrawal by Subject|1|||
164384435|NCT04443218|593777379|FG000|Overall Study|Lost to Follow-up|4|||
164384436|NCT04443218|593777379|FG000|Overall Study|Death|19|||
164384437|NCT01047683|593777380|FG000|Overall Study|Adverse Event|3|||
164384438|NCT01047683|593777381|FG001|Overall Study|Adverse Event|1|||
164384439|NCT01047683|593777382|FG002|Overall Study|Adverse Event|0|||
164384440|NCT01047683|593777380|FG000|Overall Study|Withdrew Consent|1|||
164384441|NCT01047683|593777381|FG001|Overall Study|Withdrew Consent|4|||
164384442|NCT01047683|593777382|FG002|Overall Study|Withdrew Consent|2|||
164384443|NCT01047683|593777380|FG000|Overall Study|Lost to Follow-up|0|||
164384444|NCT01047683|593777381|FG001|Overall Study|Lost to Follow-up|1|||
164384445|NCT01047683|593777382|FG002|Overall Study|Lost to Follow-up|0|||
164384446|NCT01047683|593777380|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
164384447|NCT01047683|593777381|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
164384448|NCT01047683|593777382|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
164384449|NCT03447769|593777383|FG000|Overall Study|Progressive disease|138|||
164384450|NCT03447769|593777384|FG001|Overall Study|Progressive disease|148|||
164384451|NCT03447769|593777383|FG000|Overall Study|Study terminated by Sponsor|60|||
164384452|NCT03447769|593777384|FG001|Overall Study|Study terminated by Sponsor|44|||
164384453|NCT03447769|593777383|FG000|Overall Study|Adverse Event|34|||
164592580|NCT02224846|594532574|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
164592581|NCT02224846|594532575|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
164592582|NCT02224846|594532574|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
164592583|NCT02224846|594532575|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
164592584|NCT02224846|594532574|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
164592585|NCT02224846|594532575|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
164592586|NCT02224846|594532574|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
164592587|NCT02224846|594532575|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
164384454|NCT03447769|593777384|FG001|Overall Study|Adverse Event|31|||
164384455|NCT03447769|593777383|FG000|Overall Study|Patient decision|27|||
164384456|NCT03447769|593777384|FG001|Overall Study|Patient decision|27|||
164384457|NCT03447769|593777383|FG000|Overall Study|Protocol deviation|4|||
164384458|NCT03447769|593777384|FG001|Overall Study|Protocol deviation|6|||
164384459|NCT03447769|593777383|FG000|Overall Study|Death|2|||
164384460|NCT03447769|593777384|FG001|Overall Study|Death|7|||
164384461|NCT03447769|593777383|FG000|Overall Study|Technical problems|1|||
164384462|NCT03447769|593777384|FG001|Overall Study|Technical problems|0|||
164384463|NCT03447769|593777383|FG000|Overall Study|Lost to Follow-up|0|||
164384464|NCT03447769|593777384|FG001|Overall Study|Lost to Follow-up|1|||
164384465|NCT03447769|593777383|FG000|Overall Study|Physician Decision|13|||
164384466|NCT03447769|593777384|FG001|Overall Study|Physician Decision|5|||
164384467|NCT00781326|593777387|FG000|Phase I|Adverse Event|1|||
164384468|NCT00781326|593777387|FG000|Phase I|Withdrawal by Subject|1|||
164384469|NCT00781326|593777387|FG000|Phase I|Physician Decision|2|||
164384470|NCT00096941|593777388|FG000|Overall Study|disease progression|3|||
164384471|NCT03029208|593777394|FG000|Overall Study|Withdrawal by Subject|2|||
164417441|NCT01474512|593899491|FG002|Long-Term Extension Period|Death|0|||
164417442|NCT01474512|593899492|FG003|Long-Term Extension Period|Death|0|||
164417443|NCT01474512|593899493|FG004|Long-Term Extension Period|Death|0|||
164384472|NCT03029208|593777395|FG001|Overall Study|Withdrawal by Subject|3|||
164384473|NCT03029208|593777394|FG000|Overall Study|Lost to Follow-up|0|||
164384474|NCT03029208|593777395|FG001|Overall Study|Lost to Follow-up|1|||
164384475|NCT03893448|593777396|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
164384476|NCT03893448|593777397|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
164384477|NCT03893448|593777396|FG000|Overall Study|Physician Decision|8|||
164384478|NCT03893448|593777397|FG001|Overall Study|Physician Decision|14|||
164384479|NCT03893448|593777396|FG000|Overall Study|Lost to Follow-up|34|||
164384480|NCT03893448|593777397|FG001|Overall Study|Lost to Follow-up|27|||
164384481|NCT03893448|593777396|FG000|Overall Study|Death|1|||
164384482|NCT03893448|593777397|FG001|Overall Study|Death|0|||
164384483|NCT01525082|593777400|FG000|Overall Study|Death|1|||
164384484|NCT03321981|593777401|FG000|Overall Study|Progressive Disease (PD)|15|||
164384485|NCT03321981|593777402|FG001|Overall Study|Progressive Disease (PD)|30|||
164384486|NCT03321981|593777403|FG002|Overall Study|Progressive Disease (PD)|47|||
164384487|NCT03321981|593777401|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
164384488|NCT03321981|593777402|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
164384489|NCT03321981|593777403|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
164384490|NCT03321981|593777401|FG000|Overall Study|Adverse Event|0|||
164384491|NCT03321981|593777402|FG001|Overall Study|Adverse Event|0|||
164384492|NCT03321981|593777403|FG002|Overall Study|Adverse Event|2|||
164384493|NCT03321981|593777401|FG000|Overall Study|symptomatic deterioration|0|||
164384494|NCT03321981|593777402|FG001|Overall Study|symptomatic deterioration|1|||
164384495|NCT03321981|593777403|FG002|Overall Study|symptomatic deterioration|1|||
164384496|NCT03321981|593777401|FG000|Overall Study|Lack of compliance|0|||
164384497|NCT03321981|593777402|FG001|Overall Study|Lack of compliance|1|||
164384498|NCT03321981|593777403|FG002|Overall Study|Lack of compliance|0|||
164384499|NCT03321981|593777401|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
164384500|NCT03321981|593777402|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
164384501|NCT03321981|593777403|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
164384502|NCT03321981|593777401|FG000|Overall Study|Death|0|||
164384503|NCT03321981|593777402|FG001|Overall Study|Death|1|||
164384504|NCT03321981|593777403|FG002|Overall Study|Death|0|||
164384505|NCT03321981|593777401|FG000|Overall Study|Subject withdrawal of investigational product|0|||
164384506|NCT03321981|593777402|FG001|Overall Study|Subject withdrawal of investigational product|1|||
164384507|NCT03321981|593777403|FG002|Overall Study|Subject withdrawal of investigational product|0|||
164384508|NCT03321981|593777401|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
164384509|NCT03321981|593777402|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
164384510|NCT03321981|593777403|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
164384511|NCT03321981|593777401|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
164384512|NCT03321981|593777402|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
164384513|NCT03321981|593777403|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
164384514|NCT00022516|593777413|FG000|Overall Study|Adverse Event|0|||
164384515|NCT00022516|593777414|FG001|Overall Study|Adverse Event|59|||
164384516|NCT00022516|593777413|FG000|Overall Study|Lack of Efficacy|0|||
164384517|NCT00022516|593777414|FG001|Overall Study|Lack of Efficacy|27|||
164384518|NCT00022516|593777413|FG000|Overall Study|Physician Decision|0|||
164384519|NCT00022516|593777414|FG001|Overall Study|Physician Decision|1|||
164384520|NCT00022516|593777413|FG000|Overall Study|Protocol Violation|1|||
164384521|NCT00022516|593777414|FG001|Overall Study|Protocol Violation|3|||
164440176|NCT01087762|593978899|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
164440177|NCT01087762|593978900|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
164440178|NCT01087762|593978896|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
164440179|NCT01087762|593978897|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
164440180|NCT01087762|593978898|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
164440181|NCT01087762|593978899|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
164440182|NCT01087762|593978900|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
164440183|NCT01087762|593978896|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
164440184|NCT01087762|593978897|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
164440185|NCT01087762|593978898|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
164440186|NCT01087762|593978899|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
164384522|NCT00022516|593777413|FG000|Overall Study|Withdrawal by Subject|2|||
164384523|NCT00022516|593777414|FG001|Overall Study|Withdrawal by Subject|113|||
164384524|NCT00022516|593777413|FG000|Overall Study|Incomplete documentation|0|||
164384525|NCT00022516|593777414|FG001|Overall Study|Incomplete documentation|27|||
164384526|NCT01568047|593777417|FG000|Overall Study|Ineligibility|1|||
164384527|NCT01568047|593777418|FG001|Overall Study|Ineligibility|0|||
164384528|NCT01568047|593777419|FG002|Overall Study|Ineligibility|0|||
164384529|NCT01568047|593777420|FG003|Overall Study|Ineligibility|0|||
164440187|NCT01087762|593978900|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
164702040|NCT02674061|594932775|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
164702041|NCT02674061|594932776|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
164702042|NCT04062448|594934378|FG000|Overall Study|Lost to Follow-up|1|||
164702043|NCT04062448|594934378|FG000|Overall Study|Withdrawal by Subject|2|||
164702044|NCT00573157|594934379|FG000|Overall Study|Adverse Event|3|||
164702045|NCT00573157|594934380|FG001|Overall Study|Adverse Event|1|||
164702046|NCT00573157|594934379|FG000|Overall Study|Other|1|||
164702047|NCT00573157|594934380|FG001|Overall Study|Other|1|||
164702048|NCT00609518|594934381|FG000|Overall Study|Death from Study Disease|32|||
164702049|NCT00609518|594934382|FG001|Overall Study|Death from Study Disease|32|||
164384530|NCT01568047|593777417|FG000|Overall Study|Withdrawal by Subject|0|||
164702050|NCT00609518|594934381|FG000|Overall Study|Withdrawal by Subject|5|||
164702051|NCT00609518|594934382|FG001|Overall Study|Withdrawal by Subject|3|||
164702052|NCT00609518|594934381|FG000|Overall Study|Lost to Follow-up|3|||
164702053|NCT00609518|594934382|FG001|Overall Study|Lost to Follow-up|0|||
164702054|NCT00609518|594934381|FG000|Overall Study|Physician Decision|1|||
164702055|NCT00609518|594934382|FG001|Overall Study|Physician Decision|3|||
164702056|NCT00609518|594934381|FG000|Overall Study|Death from Adverse Event|2|||
164702057|NCT00609518|594934382|FG001|Overall Study|Death from Adverse Event|2|||
164702058|NCT03760250|594934388|FG000|Overall Study|Withdrawal by Subject|1|||
164702059|NCT03760250|594934388|FG000|Overall Study|Physician Decision|1|||
164702060|NCT03733210|594934389|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
164702061|NCT03733210|594934390|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
164702062|NCT02034058|594934401|FG000|Overall Study|Death|3|||
164702063|NCT01400919|594934404|FG000|Overall Study|Withdrawal by Subject|4|||
164702064|NCT01400919|594934404|FG000|Overall Study|Lost to Follow-up|2|||
164702065|NCT01400919|594934404|FG000|Overall Study|Missed visit|2|||
164702066|NCT01449279|594934405|FG000|Overall Study|Lack of Efficacy|5|||
164702067|NCT01449279|594934405|FG000|Overall Study|Toxicity|2|||
164702068|NCT00846521|594934406|FG000|Overall Study|Withdrawal by Subject|5|||
164702069|NCT00846521|594934406|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
164702070|NCT00846521|594934406|FG000|Overall Study|Protocol Violation|1|||
164702071|NCT02792959|594934408|FG000|Overall Study|Protocol Violation|1|||
164702072|NCT04392583|594934409|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
164702073|NCT03201250|594934410|FG000|Overall Study|screen failures|3|||
164702074|NCT03201250|594934411|FG001|Overall Study|screen failures|0|||
164702075|NCT03201250|594934412|FG002|Overall Study|screen failures|0|||
164702076|NCT02575911|594934415|FG000|Overall Study|Lost to Follow-up|1|||
164702077|NCT01340768|594934416|FG000|Overall Study|Lost to Follow-up|10|||
164702078|NCT01340768|594934417|FG001|Overall Study|Lost to Follow-up|4|||
164702079|NCT01340768|594934416|FG000|Overall Study|Withdrawal by Subject|5|||
164702080|NCT01340768|594934417|FG001|Overall Study|Withdrawal by Subject|1|||
164702081|NCT01340768|594934416|FG000|Overall Study|Other|2|||
164702082|NCT01340768|594934417|FG001|Overall Study|Other|0|||
164702083|NCT03052959|594934422|FG000|Overall Study|Lost to Follow-up|4|||
164384531|NCT01568047|593777418|FG001|Overall Study|Withdrawal by Subject|1|||
164384532|NCT01568047|593777419|FG002|Overall Study|Withdrawal by Subject|0|||
164384533|NCT01568047|593777420|FG003|Overall Study|Withdrawal by Subject|0|||
164384534|NCT01568047|593777417|FG000|Overall Study|Adverse Event|0|||
164384535|NCT01568047|593777418|FG001|Overall Study|Adverse Event|0|||
164384536|NCT01568047|593777419|FG002|Overall Study|Adverse Event|1|||
164384537|NCT01568047|593777420|FG003|Overall Study|Adverse Event|1|||
164384538|NCT03783923|593777421|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
164384539|NCT03783923|593777422|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
164384540|NCT03783923|593777421|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
164384541|NCT03783923|593777422|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
164384542|NCT03783923|593777421|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
164702084|NCT03052959|594934423|FG001|Overall Study|Lost to Follow-up|5|||
164702085|NCT02397408|594934424|FG000|Overall Study|Physician Decision|4|||
164702086|NCT02397408|594934424|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
164702087|NCT02335983|594934425|FG000|Overall Study|Sponsor Decision|0|||
164702088|NCT02335983|594934426|FG001|Overall Study|Sponsor Decision|0|||
164702089|NCT02335983|594934427|FG002|Overall Study|Sponsor Decision|1|||
164384543|NCT03783923|593777422|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
164384544|NCT03783923|593777421|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
164384545|NCT03783923|593777422|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
164384546|NCT03783923|593777421|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
164384547|NCT03783923|593777422|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
164384548|NCT02328326|593777427|FG000|Overall Study|Withdrawal by Subject|10|||
164702090|NCT02335983|594934428|FG003|Overall Study|Sponsor Decision|1|||
164384549|NCT02328326|593777428|FG001|Overall Study|Withdrawal by Subject|3|||
164384550|NCT02328326|593777427|FG000|Overall Study|Death|2|||
164384551|NCT02328326|593777428|FG001|Overall Study|Death|1|||
164384552|NCT02328326|593777427|FG000|Overall Study|Lost to Follow-up|10|||
164384553|NCT02328326|593777428|FG001|Overall Study|Lost to Follow-up|4|||
164384554|NCT02543346|593777429|FG000|Second Priming Visit|Withdrawal by Subject|0|||
164384555|NCT02543346|593777430|FG001|Second Priming Visit|Withdrawal by Subject|2|||
164384556|NCT02543346|593777431|FG002|Second Priming Visit|Withdrawal by Subject|2|||
164384557|NCT02543346|593777432|FG003|Second Priming Visit|Withdrawal by Subject|2|||
164384558|NCT02543346|593777429|FG000|Second Priming Visit|Adverse Event|1|||
164384559|NCT02543346|593777430|FG001|Second Priming Visit|Adverse Event|0|||
164384560|NCT02543346|593777431|FG002|Second Priming Visit|Adverse Event|0|||
164384561|NCT02543346|593777432|FG003|Second Priming Visit|Adverse Event|0|||
164384562|NCT02209324|593777435|FG000|Overall Study|Adverse Event|2|||
164384563|NCT02209324|593777435|FG000|Overall Study|Lack of Efficacy|1|||
164384564|NCT02209324|593777435|FG000|Overall Study|Lost to Follow-up|1|||
164384565|NCT02209324|593777435|FG000|Overall Study|Physician Decision|3|||
164384566|NCT02209324|593777435|FG000|Overall Study|Protocol Violation|14|||
164384567|NCT02209324|593777435|FG000|Overall Study|Withdrawal by Subject|8|||
164384568|NCT02209324|593777435|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
164702091|NCT02335983|594934429|FG004|Overall Study|Sponsor Decision|0|||
164702092|NCT02335983|594934430|FG005|Overall Study|Sponsor Decision|1|||
164702093|NCT02335983|594934425|FG000|Overall Study|Withdrawal by Subject|3|||
164702094|NCT02335983|594934426|FG001|Overall Study|Withdrawal by Subject|2|||
164702095|NCT02335983|594934427|FG002|Overall Study|Withdrawal by Subject|2|||
164384569|NCT02209324|593777435|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
164384570|NCT02209324|593777435|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
164384571|NCT01985126|593777436|FG000|Overall Study|Death|15|||
164384572|NCT01985126|593777437|FG001|Overall Study|Death|69|||
164384573|NCT01985126|593777436|FG000|Overall Study|Lost to Follow-up|0|||
164384574|NCT01985126|593777437|FG001|Overall Study|Lost to Follow-up|8|||
164384575|NCT01985126|593777436|FG000|Overall Study|Study Terminated By Sponsor|1|||
164384576|NCT01985126|593777437|FG001|Overall Study|Study Terminated By Sponsor|22|||
164592588|NCT02224846|594532574|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
164592589|NCT02224846|594532575|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
164592590|NCT02224846|594532574|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
164592591|NCT02224846|594532575|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
164592592|NCT02224846|594532574|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
164592593|NCT02224846|594532575|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
164592594|NCT02144220|594532576|FG000|Overall Study|technology incompatibility|9|||
164592595|NCT02144220|594532576|FG000|Overall Study|Lack of Efficacy|4|||
164592596|NCT02144220|594532576|FG000|Overall Study|Physician Decision|3|||
164592597|NCT02144220|594532576|FG000|Overall Study|Withdrawal by Subject|2|||
164592598|NCT02144220|594532576|FG000|Overall Study|Protocol Violation|1|||
164592599|NCT00872170|594532579|FG000|Overall Study|Adverse Event|1|||
164592600|NCT00872170|594532580|FG001|Overall Study|Adverse Event|0|||
164592601|NCT01402284|594532581|FG000|Overall Study|Withdrawal consent|2|||
164592602|NCT01402284|594532581|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
164592603|NCT01402284|594532581|FG000|Overall Study|Physician Decision|1|||
164592604|NCT01402284|594532581|FG000|Overall Study|Disease progression on study|10|||
164592605|NCT00905021|594532587|FG000|Overall Study|Adverse Event|2|||
164592606|NCT00786838|594532588|FG000|Overall Study|Physician Decision|4|||
164592607|NCT00786838|594532588|FG000|Overall Study|Death|4|||
164592608|NCT00786838|594532588|FG000|Overall Study|Adverse Event|6|||
164592609|NCT00786838|594532588|FG000|Overall Study|Progressive disease|31|||
164592610|NCT00786838|594532588|FG000|Overall Study|Withdrawal by Subject|4|||
164592611|NCT04937816|594532589|FG000|Overall Study|Study drug stopped, reason missing|5|||
164592612|NCT04937816|594532590|FG001|Overall Study|Study drug stopped, reason missing|3|||
164592613|NCT04937816|594532591|FG002|Overall Study|Study drug stopped, reason missing|4|||
164592614|NCT04937816|594532592|FG003|Overall Study|Study drug stopped, reason missing|6|||
164592615|NCT04937816|594532593|FG004|Overall Study|Study drug stopped, reason missing|1|||
164592616|NCT04937816|594532594|FG005|Overall Study|Study drug stopped, reason missing|0|||
164592617|NCT04937816|594532595|FG006|Overall Study|Study drug stopped, reason missing|0|||
164592618|NCT04937816|594532589|FG000|Overall Study|Other than stated below|173|||
164592619|NCT04937816|594532590|FG001|Overall Study|Other than stated below|143|||
164592620|NCT04937816|594532591|FG002|Overall Study|Other than stated below|125|||
164592621|NCT04937816|594532592|FG003|Overall Study|Other than stated below|44|||
164592622|NCT04937816|594532593|FG004|Overall Study|Other than stated below|45|||
164592623|NCT04937816|594532594|FG005|Overall Study|Other than stated below|28|||
164384577|NCT01985126|593777436|FG000|Overall Study|Withdrawal by Subject|2|||
164384578|NCT01985126|593777437|FG001|Overall Study|Withdrawal by Subject|7|||
164384579|NCT03433456|593777440|FG000|Overall Study|Death|1|||
164384580|NCT03433456|593777441|FG001|Overall Study|Death|1|||
164384581|NCT03433456|593777440|FG000|Overall Study|Lost to Follow-up|14|||
164384582|NCT03433456|593777441|FG001|Overall Study|Lost to Follow-up|11|||
164384583|NCT03433456|593777440|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
164384584|NCT03433456|593777441|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
164417444|NCT01474512|593899494|FG005|Long-Term Extension Period|Death|0|||
164417445|NCT01474512|593899495|FG006|Long-Term Extension Period|Death|0|||
164417446|NCT01474512|593899496|FG007|Long-Term Extension Period|Death|0|||
164417447|NCT01474512|593899497|FG008|Long-Term Extension Period|Death|0|||
164592624|NCT04937816|594532595|FG006|Overall Study|Other than stated below|31|||
164592625|NCT04937816|594532589|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
164592626|NCT04937816|594532590|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
164592627|NCT04937816|594532591|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
164592628|NCT04937816|594532592|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
164592629|NCT04937816|594532593|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
164592630|NCT04937816|594532594|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
164592631|NCT04937816|594532595|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
164592632|NCT04937816|594532589|FG000|Overall Study|Lost to Follow-up|15|||
164592633|NCT04937816|594532590|FG001|Overall Study|Lost to Follow-up|9|||
164592634|NCT04937816|594532591|FG002|Overall Study|Lost to Follow-up|6|||
164592635|NCT04937816|594532592|FG003|Overall Study|Lost to Follow-up|6|||
164592636|NCT04937816|594532593|FG004|Overall Study|Lost to Follow-up|16|||
164592637|NCT04937816|594532594|FG005|Overall Study|Lost to Follow-up|11|||
164592638|NCT04937816|594532595|FG006|Overall Study|Lost to Follow-up|17|||
164592639|NCT04937816|594532589|FG000|Overall Study|Protocol Violation|15|||
164592640|NCT04937816|594532590|FG001|Overall Study|Protocol Violation|15|||
164592641|NCT04937816|594532591|FG002|Overall Study|Protocol Violation|12|||
164384585|NCT01198600|593777446|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
164384586|NCT01198600|593777447|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
164384587|NCT01198600|593777448|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
164384588|NCT01198600|593777449|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
164384589|NCT01198600|593777446|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
164384590|NCT01198600|593777447|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
164384591|NCT01198600|593777448|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
164384592|NCT01198600|593777449|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
164384593|NCT01198600|593777446|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
164384594|NCT01198600|593777447|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
164384595|NCT01198600|593777448|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
164384596|NCT01198600|593777449|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
164592642|NCT04937816|594532592|FG003|Overall Study|Protocol Violation|30|||
164592643|NCT04937816|594532593|FG004|Overall Study|Protocol Violation|24|||
164384597|NCT01198600|593777446|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
164384598|NCT01198600|593777447|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
164384599|NCT01198600|593777448|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
164384600|NCT01198600|593777449|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
164592644|NCT04937816|594532594|FG005|Overall Study|Protocol Violation|5|||
164592645|NCT04937816|594532595|FG006|Overall Study|Protocol Violation|5|||
164592646|NCT04937816|594532589|FG000|Overall Study|Adverse Event|303|||
164592647|NCT04937816|594532590|FG001|Overall Study|Adverse Event|267|||
164592648|NCT04937816|594532591|FG002|Overall Study|Adverse Event|273|||
164592649|NCT04937816|594532592|FG003|Overall Study|Adverse Event|553|||
164592650|NCT04937816|594532593|FG004|Overall Study|Adverse Event|575|||
164592651|NCT04937816|594532594|FG005|Overall Study|Adverse Event|343|||
164592652|NCT04937816|594532595|FG006|Overall Study|Adverse Event|337|||
164592653|NCT04937816|594532589|FG000|Overall Study|Not treated|4|||
164592654|NCT04937816|594532590|FG001|Overall Study|Not treated|2|||
164592655|NCT04937816|594532591|FG002|Overall Study|Not treated|2|||
164592656|NCT04937816|594532592|FG003|Overall Study|Not treated|2|||
164592657|NCT04937816|594532593|FG004|Overall Study|Not treated|1|||
164592658|NCT04937816|594532594|FG005|Overall Study|Not treated|4|||
164592659|NCT04937816|594532595|FG006|Overall Study|Not treated|0|||
164592660|NCT00436215|594532596|FG000|Overall Study|Refused further treatment|3|||
164592661|NCT00436215|594532596|FG000|Overall Study|Small bowel obstruction|1|||
164592662|NCT05513053|594532597|FG000|Overall Study|Lost to Follow-up|9|||
164592663|NCT05513053|594532598|FG001|Overall Study|Lost to Follow-up|11|||
164592664|NCT05513053|594532597|FG000|Overall Study|Withdrawal by parent/guardian|2|||
164592665|NCT05513053|594532598|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164592666|NCT05513053|594532597|FG000|Overall Study|Withdrawal by Subject|2|||
164592667|NCT05513053|594532598|FG001|Overall Study|Withdrawal by Subject|9|||
164592668|NCT05513053|594532597|FG000|Overall Study|Protocol Violation|6|||
164592669|NCT05513053|594532598|FG001|Overall Study|Protocol Violation|3|||
164592670|NCT05513053|594532597|FG000|Overall Study|Adverse Event|0|||
164592671|NCT05513053|594532598|FG001|Overall Study|Adverse Event|2|||
164592672|NCT04491877|594534551|FG000|Overall Study|Protocol Deviation|1|||
164592673|NCT04491877|594534552|FG001|Overall Study|Protocol Deviation|0|||
164592674|NCT04491877|594534553|FG002|Overall Study|Protocol Deviation|2|||
164592675|NCT04491877|594534554|FG003|Overall Study|Protocol Deviation|0|||
164592676|NCT04491877|594534555|FG004|Overall Study|Protocol Deviation|0|||
164384601|NCT01198600|593777446|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
164384602|NCT01198600|593777447|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
164592677|NCT04491877|594534556|FG005|Overall Study|Protocol Deviation|0|||
164592678|NCT04491877|594534557|FG006|Overall Study|Protocol Deviation|1|||
164592679|NCT04491877|594534558|FG007|Overall Study|Protocol Deviation|1|||
164384603|NCT01198600|593777448|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
164384604|NCT01198600|593777449|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
164384605|NCT01198600|593777446|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
164384606|NCT01198600|593777447|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
164384607|NCT01198600|593777448|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
164384608|NCT01198600|593777449|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
164384609|NCT01198600|593777446|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
164384610|NCT01198600|593777447|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
164384611|NCT01198600|593777448|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
164384612|NCT01198600|593777449|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
164384613|NCT01785602|593777450|FG000|Overall Study|Withdrawal by Subject|2|||
164384614|NCT01785602|593777451|FG001|Overall Study|Withdrawal by Subject|0|||
164702096|NCT02335983|594934428|FG003|Overall Study|Withdrawal by Subject|1|||
164702097|NCT02335983|594934429|FG004|Overall Study|Withdrawal by Subject|3|||
164702098|NCT02335983|594934430|FG005|Overall Study|Withdrawal by Subject|9|||
164702099|NCT02335983|594934425|FG000|Overall Study|Death|0|||
164702100|NCT02335983|594934426|FG001|Overall Study|Death|0|||
164702101|NCT02335983|594934427|FG002|Overall Study|Death|2|||
164702102|NCT02335983|594934428|FG003|Overall Study|Death|0|||
164702103|NCT02335983|594934429|FG004|Overall Study|Death|0|||
164702104|NCT02335983|594934430|FG005|Overall Study|Death|0|||
164702105|NCT02335983|594934425|FG000|Overall Study|Lost to Follow-up|0|||
164702106|NCT02335983|594934426|FG001|Overall Study|Lost to Follow-up|0|||
164702107|NCT02335983|594934427|FG002|Overall Study|Lost to Follow-up|0|||
164384615|NCT01785602|593777450|FG000|Overall Study|Lost to Follow-up|1|||
164384616|NCT01785602|593777451|FG001|Overall Study|Lost to Follow-up|1|||
164384617|NCT01785602|593777450|FG000|Overall Study|Adverse Event|3|||
164384618|NCT01785602|593777451|FG001|Overall Study|Adverse Event|5|||
164384619|NCT01785602|593777450|FG000|Overall Study|Administrative problems|7|||
164384620|NCT01785602|593777451|FG001|Overall Study|Administrative problems|3|||
164384621|NCT04496258|593777454|FG000|Overall Study|Withdrawal by Subject|2|||
164384622|NCT04496258|593777455|FG001|Overall Study|Withdrawal by Subject|1|||
164384623|NCT02141516|593777456|FG000|Overall Study|Adverse Event|0|||
164384624|NCT02141516|593777457|FG001|Overall Study|Adverse Event|1|||
164384625|NCT02141516|593777458|FG002|Overall Study|Adverse Event|0|||
164384626|NCT02141516|593777456|FG000|Overall Study|Lost to Follow-up|0|||
164384627|NCT02141516|593777457|FG001|Overall Study|Lost to Follow-up|1|||
164384628|NCT02141516|593777458|FG002|Overall Study|Lost to Follow-up|0|||
164384629|NCT02141516|593777456|FG000|Overall Study|Other|0|||
164384630|NCT02141516|593777457|FG001|Overall Study|Other|3|||
164384631|NCT02141516|593777458|FG002|Overall Study|Other|0|||
164384632|NCT02041429|593777460|FG000|Overall Study|Progressive Disease|2|||
164384633|NCT02041429|593777461|FG001|Overall Study|Progressive Disease|2|||
164384634|NCT02041429|593777462|FG002|Overall Study|Progressive Disease|3|||
164384635|NCT02041429|593777463|FG003|Overall Study|Progressive Disease|2|||
164384636|NCT02041429|593777460|FG000|Overall Study|Toxicity|0|||
164384637|NCT02041429|593777461|FG001|Overall Study|Toxicity|1|||
164384638|NCT02041429|593777462|FG002|Overall Study|Toxicity|4|||
164384639|NCT02041429|593777463|FG003|Overall Study|Toxicity|2|||
164384640|NCT02041429|593777460|FG000|Overall Study|Withdrawal by Subject|0|||
164384641|NCT02041429|593777461|FG001|Overall Study|Withdrawal by Subject|1|||
164384642|NCT02041429|593777462|FG002|Overall Study|Withdrawal by Subject|0|||
164384643|NCT02041429|593777463|FG003|Overall Study|Withdrawal by Subject|0|||
164384644|NCT02041429|593777460|FG000|Overall Study|On Maintenance Therapy|1|||
164384645|NCT02041429|593777461|FG001|Overall Study|On Maintenance Therapy|0|||
164384646|NCT02041429|593777462|FG002|Overall Study|On Maintenance Therapy|0|||
164384647|NCT02041429|593777463|FG003|Overall Study|On Maintenance Therapy|2|||
164384648|NCT03251924|593777464|FG000|Overall Study|Disease Progression|6|||
164384649|NCT03251924|593777465|FG001|Overall Study|Disease Progression|6|||
164384650|NCT03251924|593777466|FG002|Overall Study|Disease Progression|7|||
164702108|NCT02335983|594934428|FG003|Overall Study|Lost to Follow-up|0|||
164702109|NCT02335983|594934429|FG004|Overall Study|Lost to Follow-up|0|||
164384651|NCT03251924|593777467|FG003|Overall Study|Disease Progression|8|||
164384652|NCT03251924|593777468|FG004|Overall Study|Disease Progression|8|||
164384653|NCT03251924|593777469|FG005|Overall Study|Disease Progression|7|||
164384654|NCT03251924|593777470|FG006|Overall Study|Disease Progression|6|||
164702110|NCT02335983|594934430|FG005|Overall Study|Lost to Follow-up|1|||
164702111|NCT02335983|594934425|FG000|Overall Study|Protocol Specified Criteria|5|||
164384655|NCT03251924|593777471|FG007|Overall Study|Disease Progression|10|||
164384656|NCT03251924|593777472|FG008|Overall Study|Disease Progression|6|||
164702112|NCT02335983|594934426|FG001|Overall Study|Protocol Specified Criteria|7|||
164702113|NCT02335983|594934427|FG002|Overall Study|Protocol Specified Criteria|27|||
164384657|NCT03251924|593777464|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
164384658|NCT03251924|593777465|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
164384659|NCT03251924|593777466|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
164384660|NCT03251924|593777467|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
164384661|NCT03251924|593777468|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
164417448|NCT01474512|593899498|FG009|Long-Term Extension Period|Death|0|||
164702114|NCT02335983|594934428|FG003|Overall Study|Protocol Specified Criteria|7|||
164702115|NCT02335983|594934429|FG004|Overall Study|Protocol Specified Criteria|5|||
164702116|NCT02335983|594934430|FG005|Overall Study|Protocol Specified Criteria|21|||
164702117|NCT00629265|594934435|FG000|Overall Study|Lost to Follow-up|4|||
164702118|NCT00629265|594934436|FG001|Overall Study|Lost to Follow-up|5|||
164702119|NCT00629265|594934435|FG000|Overall Study|Withdrawal by Subject|11|||
164702120|NCT00629265|594934436|FG001|Overall Study|Withdrawal by Subject|8|||
164702121|NCT00629265|594934435|FG000|Overall Study|Death|1|||
164702122|NCT00629265|594934436|FG001|Overall Study|Death|0|||
164702123|NCT00629265|594934435|FG000|Overall Study|Adverse Event|2|||
164702124|NCT00629265|594934436|FG001|Overall Study|Adverse Event|0|||
164702125|NCT00629265|594934435|FG000|Overall Study|HNC Recurrence|4|||
164702126|NCT00629265|594934436|FG001|Overall Study|HNC Recurrence|0|||
164702127|NCT00629265|594934435|FG000|Overall Study|Other CA Requiring Treatment|1|||
164702128|NCT00629265|594934436|FG001|Overall Study|Other CA Requiring Treatment|3|||
164702129|NCT00629265|594934435|FG000|Overall Study|Needed Esophageal Dilation|4|||
164702130|NCT00629265|594934436|FG001|Overall Study|Needed Esophageal Dilation|1|||
164702131|NCT00629265|594934435|FG000|Overall Study|Unrelated Medical Complications|3|||
164702132|NCT00629265|594934436|FG001|Overall Study|Unrelated Medical Complications|1|||
164702133|NCT00629265|594934435|FG000|Overall Study|Unknown Reason|2|||
164702134|NCT00629265|594934436|FG001|Overall Study|Unknown Reason|2|||
164702135|NCT04465630|594934437|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
164702136|NCT04465630|594934437|FG000|Overall Study|Screen failure|8|||
164702137|NCT04465630|594934437|FG000|Overall Study|Baseline failure|16|||
164702138|NCT01732484|594934441|FG000|Overall Study|Death|7|||
164702139|NCT01732484|594934441|FG000|Overall Study|Lost to Follow-up|14|||
164702140|NCT01732484|594934441|FG000|Overall Study|chronical illness|5|||
164702141|NCT00289874|594934442|FG000|Overall Study|Adverse Event|1|||
164702142|NCT00289874|594934443|FG001|Overall Study|Adverse Event|5|||
164702143|NCT00289874|594934442|FG000|Overall Study|Lost to Follow-up|1|||
164702144|NCT00289874|594934443|FG001|Overall Study|Lost to Follow-up|1|||
164702145|NCT00289874|594934442|FG000|Overall Study|Protocol Violation|3|||
164702146|NCT00289874|594934443|FG001|Overall Study|Protocol Violation|2|||
164702147|NCT00289874|594934442|FG000|Overall Study|Did not meet eligibility|1|||
164702148|NCT00289874|594934443|FG001|Overall Study|Did not meet eligibility|0|||
164702149|NCT01087489|594934444|FG000|Overall Study|enrolled in another VA study|0|||
164702150|NCT01087489|594934445|FG001|Overall Study|enrolled in another VA study|1|||
164702151|NCT01087489|594934444|FG000|Overall Study|Death|0|||
164702152|NCT01087489|594934445|FG001|Overall Study|Death|1|||
164702153|NCT01087489|594934444|FG000|Overall Study|unable to survey by telephone|0|||
164702154|NCT01087489|594934445|FG001|Overall Study|unable to survey by telephone|1|||
164702155|NCT05070546|594934453|FG000|Overall Study|Death|0|||
164702156|NCT05070546|594934454|FG001|Overall Study|Death|0|||
164702157|NCT05070546|594934455|FG002|Overall Study|Death|0|||
164702158|NCT05070546|594934456|FG003|Overall Study|Death|0|||
164702159|NCT05070546|594934457|FG004|Overall Study|Death|0|||
164702160|NCT05070546|594934458|FG005|Overall Study|Death|1|||
164702161|NCT05070546|594934453|FG000|Overall Study|Lost to Follow-up|8|||
164702162|NCT05070546|594934454|FG001|Overall Study|Lost to Follow-up|2|||
164702163|NCT05070546|594934455|FG002|Overall Study|Lost to Follow-up|7|||
164702164|NCT05070546|594934456|FG003|Overall Study|Lost to Follow-up|1|||
164702165|NCT05070546|594934457|FG004|Overall Study|Lost to Follow-up|2|||
164702166|NCT05070546|594934458|FG005|Overall Study|Lost to Follow-up|0|||
164702167|NCT05070546|594934453|FG000|Overall Study|Withdrawal by Subject|1|||
164702168|NCT05070546|594934454|FG001|Overall Study|Withdrawal by Subject|1|||
164702169|NCT05070546|594934455|FG002|Overall Study|Withdrawal by Subject|3|||
164384662|NCT03251924|593777469|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
164384663|NCT03251924|593777470|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
164384664|NCT03251924|593777471|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
164384665|NCT03251924|593777472|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
164702170|NCT05070546|594934456|FG003|Overall Study|Withdrawal by Subject|0|||
164702171|NCT05070546|594934457|FG004|Overall Study|Withdrawal by Subject|0|||
164702172|NCT05070546|594934458|FG005|Overall Study|Withdrawal by Subject|0|||
164384666|NCT03251924|593777464|FG000|Overall Study|Death|0|||
164384667|NCT03251924|593777465|FG001|Overall Study|Death|1|||
164384668|NCT03251924|593777466|FG002|Overall Study|Death|0|||
164702173|NCT05070546|594934453|FG000|Overall Study|Other|0|||
164702174|NCT05070546|594934454|FG001|Overall Study|Other|0|||
164702175|NCT05070546|594934455|FG002|Overall Study|Other|0|||
164702176|NCT05070546|594934456|FG003|Overall Study|Other|0|||
164702177|NCT05070546|594934457|FG004|Overall Study|Other|3|||
164702178|NCT05070546|594934458|FG005|Overall Study|Other|0|||
164702179|NCT05070546|594934453|FG000|Overall Study|Randomized but not vaccinated|1|||
164384669|NCT03251924|593777467|FG003|Overall Study|Death|1|||
164702180|NCT05070546|594934454|FG001|Overall Study|Randomized but not vaccinated|0|||
164384670|NCT03251924|593777468|FG004|Overall Study|Death|1|||
164702181|NCT05070546|594934455|FG002|Overall Study|Randomized but not vaccinated|1|||
164702182|NCT05070546|594934456|FG003|Overall Study|Randomized but not vaccinated|1|||
164384671|NCT03251924|593777469|FG005|Overall Study|Death|1|||
164384672|NCT03251924|593777470|FG006|Overall Study|Death|0|||
164384673|NCT03251924|593777471|FG007|Overall Study|Death|0|||
164384674|NCT03251924|593777472|FG008|Overall Study|Death|0|||
164384675|NCT03251924|593777464|FG000|Overall Study|Study Drug Toxicity|0|||
164384676|NCT03251924|593777465|FG001|Overall Study|Study Drug Toxicity|0|||
164384677|NCT03251924|593777466|FG002|Overall Study|Study Drug Toxicity|0|||
164384678|NCT03251924|593777467|FG003|Overall Study|Study Drug Toxicity|1|||
164384679|NCT03251924|593777468|FG004|Overall Study|Study Drug Toxicity|0|||
164384680|NCT03251924|593777469|FG005|Overall Study|Study Drug Toxicity|0|||
164384681|NCT03251924|593777470|FG006|Overall Study|Study Drug Toxicity|0|||
164384682|NCT03251924|593777471|FG007|Overall Study|Study Drug Toxicity|0|||
164384683|NCT03251924|593777472|FG008|Overall Study|Study Drug Toxicity|1|||
164384684|NCT03251924|593777464|FG000|Overall Study|Other Reasons|0|||
164384685|NCT03251924|593777465|FG001|Overall Study|Other Reasons|0|||
164384686|NCT03251924|593777466|FG002|Overall Study|Other Reasons|0|||
164384687|NCT03251924|593777467|FG003|Overall Study|Other Reasons|0|||
164384688|NCT03251924|593777468|FG004|Overall Study|Other Reasons|0|||
164384689|NCT03251924|593777469|FG005|Overall Study|Other Reasons|0|||
164384690|NCT03251924|593777470|FG006|Overall Study|Other Reasons|0|||
164384691|NCT03251924|593777471|FG007|Overall Study|Other Reasons|0|||
164384692|NCT03251924|593777472|FG008|Overall Study|Other Reasons|1|||
164384693|NCT03251924|593777464|FG000|Overall Study|Participant request to discontinue study treatment|0|||
164384694|NCT03251924|593777465|FG001|Overall Study|Participant request to discontinue study treatment|0|||
164384695|NCT03251924|593777466|FG002|Overall Study|Participant request to discontinue study treatment|0|||
164384696|NCT03251924|593777467|FG003|Overall Study|Participant request to discontinue study treatment|0|||
164384697|NCT03251924|593777468|FG004|Overall Study|Participant request to discontinue study treatment|0|||
164384698|NCT03251924|593777469|FG005|Overall Study|Participant request to discontinue study treatment|0|||
164384699|NCT03251924|593777470|FG006|Overall Study|Participant request to discontinue study treatment|0|||
164384700|NCT03251924|593777471|FG007|Overall Study|Participant request to discontinue study treatment|1|||
164384701|NCT03251924|593777472|FG008|Overall Study|Participant request to discontinue study treatment|0|||
164384702|NCT01427712|593777473|FG000|Overall Study|Transfer to a different hospital|2|||
164384703|NCT01427712|593777473|FG000|Overall Study|Lost to Follow-up|1|||
164384704|NCT01427712|593777473|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
164384705|NCT01427712|593777473|FG000|Overall Study|Failure to visit|1|||
164384706|NCT03169153|593777474|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
164384707|NCT03169153|593777475|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
164384708|NCT03169153|593777474|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
164384709|NCT03169153|593777475|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
164384710|NCT03169153|593777474|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
164384711|NCT03169153|593777475|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
164384712|NCT03169153|593777474|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
164384713|NCT03169153|593777475|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
164384714|NCT00784043|593777476|FG000|Overall Study|Withdrawal by Subject|8|||
164384715|NCT00784043|593777477|FG001|Overall Study|Withdrawal by Subject|5|||
164384716|NCT00784043|593777476|FG000|Overall Study|Protocol Terminated|23|||
164384717|NCT00784043|593777477|FG001|Overall Study|Protocol Terminated|1|||
164384718|NCT02127307|593777484|FG000|Overall Study|Protocol Violation|36|||
164384719|NCT02127307|593777484|FG000|Overall Study|Lost to Follow-up|2|||
164384720|NCT02127307|593777484|FG000|Overall Study|Death|101|||
164384721|NCT02127307|593777484|FG000|Overall Study|Other than specified above|169|||
164384722|NCT00766376|593777485|FG000|Overall Study|Withdrawal by Subject|27|||
164384723|NCT00235989|593777486|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
164384724|NCT00235989|593777487|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
164384725|NCT00235989|593777488|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
164384726|NCT00235989|593777489|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
164384727|NCT00235989|593777490|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
164384728|NCT00235989|593777491|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
164384729|NCT00235989|593777486|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
164384730|NCT00235989|593777487|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
164384731|NCT00235989|593777488|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
164384732|NCT00235989|593777489|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
164384733|NCT00235989|593777490|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
164384734|NCT00235989|593777491|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
164592680|NCT04491877|594534559|FG008|Overall Study|Protocol Deviation|0|||
164384735|NCT00235989|593777486|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
164384736|NCT00235989|593777487|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
164384737|NCT00235989|593777488|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
164384738|NCT00235989|593777489|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
164702183|NCT05070546|594934457|FG004|Overall Study|Randomized but not vaccinated|3|||
164384739|NCT00235989|593777490|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
164384740|NCT00235989|593777491|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
164384741|NCT00235989|593777486|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
164702184|NCT05070546|594934458|FG005|Overall Study|Randomized but not vaccinated|0|||
164702185|NCT02643355|594934459|FG000|Overall Study|Withdrawal by Subject|1|||
164702186|NCT02643355|594934460|FG001|Overall Study|Withdrawal by Subject|3|||
164702187|NCT02643355|594934459|FG000|Overall Study|Protocol Violation|0|||
164702188|NCT02643355|594934460|FG001|Overall Study|Protocol Violation|2|||
164702189|NCT01974440|594934464|FG000|Overall Study|Lost to Follow-up|7|||
164702190|NCT01974440|594934465|FG001|Overall Study|Lost to Follow-up|7|||
164702191|NCT01974440|594934464|FG000|Overall Study|Withdrawal by Subject|24|||
164702192|NCT01974440|594934465|FG001|Overall Study|Withdrawal by Subject|20|||
164702193|NCT01974440|594934464|FG000|Overall Study|Sponsor decision|109|||
164702194|NCT01974440|594934465|FG001|Overall Study|Sponsor decision|110|||
164702195|NCT01615263|594934474|FG000|Overall Study|Post-randomization exclusion|0|||
164702196|NCT01615263|594934475|FG001|Overall Study|Post-randomization exclusion|2|||
164702197|NCT00988065|594934480|FG000|Overall Study|Adverse Event|4|||
164702198|NCT00988065|594934481|FG001|Overall Study|Adverse Event|10|||
164702199|NCT00988065|594934482|FG002|Overall Study|Adverse Event|2|||
164702200|NCT00988065|594934480|FG000|Overall Study|Lost to Follow-up|1|||
164702201|NCT00988065|594934481|FG001|Overall Study|Lost to Follow-up|2|||
164702202|NCT00988065|594934482|FG002|Overall Study|Lost to Follow-up|2|||
164702203|NCT00988065|594934480|FG000|Overall Study|Subject withdrew consent|3|||
164702204|NCT00988065|594934481|FG001|Overall Study|Subject withdrew consent|5|||
164702205|NCT00988065|594934482|FG002|Overall Study|Subject withdrew consent|2|||
164702206|NCT00988065|594934480|FG000|Overall Study|Noncompliance with protocol|5|||
164702207|NCT00988065|594934481|FG001|Overall Study|Noncompliance with protocol|6|||
164702208|NCT00988065|594934482|FG002|Overall Study|Noncompliance with protocol|9|||
164702209|NCT00985712|594934483|FG000|Overall Study|Adverse Event|0|||
164702210|NCT00985712|594934484|FG001|Overall Study|Adverse Event|1|||
164702211|NCT00985712|594934483|FG000|Overall Study|Lost to Follow-up|2|||
164702212|NCT00985712|594934484|FG001|Overall Study|Lost to Follow-up|2|||
164702213|NCT00985712|594934483|FG000|Overall Study|Protocol Violation|0|||
164702214|NCT00985712|594934484|FG001|Overall Study|Protocol Violation|1|||
164702215|NCT00985712|594934483|FG000|Overall Study|Withdrawal by Subject|4|||
164702216|NCT00985712|594934484|FG001|Overall Study|Withdrawal by Subject|1|||
164702217|NCT00985712|594934483|FG000|Overall Study|Sponsor decision|0|||
164702218|NCT00985712|594934484|FG001|Overall Study|Sponsor decision|2|||
164702219|NCT03096847|594934490|FG000|Overall Study|Other|2|||
164702220|NCT03096847|594934491|FG001|Overall Study|Other|1|||
164384742|NCT00235989|593777487|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
164384743|NCT00235989|593777488|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
164384744|NCT00235989|593777489|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
164384745|NCT00235989|593777490|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
164384746|NCT00235989|593777491|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
164384747|NCT00235989|593777486|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
164384748|NCT00235989|593777487|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
164384749|NCT00235989|593777488|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
164384750|NCT00235989|593777489|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
164384751|NCT00235989|593777490|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
164384752|NCT00235989|593777491|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
164384753|NCT00983580|593777497|FG000|Overall Study|Cancel Prior to treatment|1|||
164384754|NCT00983580|593777498|FG001|Overall Study|Cancel Prior to treatment|3|||
164384755|NCT00983580|593777497|FG000|Overall Study|Protocol Violation|1|||
164384756|NCT00983580|593777498|FG001|Overall Study|Protocol Violation|1|||
164384757|NCT00983580|593777497|FG000|Overall Study|Ineligible|3|||
164384758|NCT00983580|593777498|FG001|Overall Study|Ineligible|0|||
164384759|NCT04382612|593777499|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
164384760|NCT01328002|593777501|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
164384761|NCT01328002|593777502|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
164384762|NCT01328002|593777501|FG000|Open-Label Period|Adverse Event|8|||
164384763|NCT01328002|593777502|FG001|Open-Label Period|Adverse Event|0|||
164384764|NCT01328002|593777501|FG000|Open-Label Period|Lack of Efficacy|3|||
164440188|NCT01087762|593978896|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
164702221|NCT03096847|594934492|FG002|Overall Study|Other|2|||
164702222|NCT03096847|594934490|FG000|Overall Study|Lost to Follow-up|1|||
164702223|NCT03096847|594934491|FG001|Overall Study|Lost to Follow-up|0|||
164440189|NCT01087762|593978897|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
164440190|NCT01087762|593978898|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
164440191|NCT01087762|593978899|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
164702224|NCT03096847|594934492|FG002|Overall Study|Lost to Follow-up|1|||
164702225|NCT03096847|594934490|FG000|Overall Study|Death|6|||
164702226|NCT03096847|594934491|FG001|Overall Study|Death|0|||
164702227|NCT03096847|594934492|FG002|Overall Study|Death|2|||
164702228|NCT03096847|594934490|FG000|Overall Study|Protocol Violation|3|||
164702229|NCT03096847|594934491|FG001|Overall Study|Protocol Violation|0|||
164702230|NCT03096847|594934492|FG002|Overall Study|Protocol Violation|6|||
164702231|NCT03096847|594934490|FG000|Overall Study|Physician Decision|12|||
164384765|NCT01328002|593777502|FG001|Open-Label Period|Lack of Efficacy|0|||
164384766|NCT01328002|593777501|FG000|Open-Label Period|Protocol Violation|2|||
164384767|NCT01328002|593777502|FG001|Open-Label Period|Protocol Violation|0|||
164384768|NCT01328002|593777501|FG000|Open-Label Period|Withdrawal by Subject|9|||
164384769|NCT01328002|593777502|FG001|Open-Label Period|Withdrawal by Subject|0|||
164384770|NCT01328002|593777501|FG000|Open-Label Period|Lost to Follow-up|6|||
164384771|NCT01328002|593777502|FG001|Open-Label Period|Lost to Follow-up|0|||
164384772|NCT01328002|593777501|FG000|Open-Label Period|Other Reason|2|||
164384773|NCT01328002|593777502|FG001|Open-Label Period|Other Reason|0|||
164384774|NCT01328002|593777501|FG000|Double-Blind Period|Adverse Event|1|||
164384775|NCT01328002|593777502|FG001|Double-Blind Period|Adverse Event|0|||
164384776|NCT01328002|593777501|FG000|Double-Blind Period|Lack of Efficacy|1|||
164384777|NCT01328002|593777502|FG001|Double-Blind Period|Lack of Efficacy|0|||
164384778|NCT01578551|593777503|FG000|Overall Study|Adverse Event|1|||
164384779|NCT01578551|593777504|FG001|Overall Study|Adverse Event|0|||
164384780|NCT02752048|593777506|FG000|Overall Study|Withdrawal by Subject|0|||
164384781|NCT02752048|593777507|FG001|Overall Study|Withdrawal by Subject|0|||
164384782|NCT02752048|593777508|FG002|Overall Study|Withdrawal by Subject|3|||
164384783|NCT00061048|593777509|FG000|Overall Study|Adverse Event|2|||
164384784|NCT00061048|593777509|FG000|Overall Study|disease progression|20|||
164384785|NCT00898677|593777510|FG000|Overall Study|Adverse Event|0|||
164384786|NCT00898677|593777511|FG001|Overall Study|Adverse Event|0|||
164384787|NCT00898677|593777512|FG002|Overall Study|Adverse Event|1|||
164384788|NCT00898677|593777513|FG003|Overall Study|Adverse Event|0|||
164384789|NCT00898677|593777510|FG000|Overall Study|Lost to Follow-up|0|||
164384790|NCT00898677|593777511|FG001|Overall Study|Lost to Follow-up|0|||
164384791|NCT00898677|593777512|FG002|Overall Study|Lost to Follow-up|2|||
164384792|NCT00898677|593777513|FG003|Overall Study|Lost to Follow-up|0|||
164384793|NCT00898677|593777510|FG000|Overall Study|Protocol Violation|1|||
164384794|NCT00898677|593777511|FG001|Overall Study|Protocol Violation|1|||
164384795|NCT00898677|593777512|FG002|Overall Study|Protocol Violation|2|||
164384796|NCT00898677|593777513|FG003|Overall Study|Protocol Violation|0|||
164384797|NCT00898677|593777510|FG000|Overall Study|Withdrawal by Subject|0|||
164384798|NCT00898677|593777511|FG001|Overall Study|Withdrawal by Subject|0|||
164384799|NCT00898677|593777512|FG002|Overall Study|Withdrawal by Subject|0|||
164384800|NCT00898677|593777513|FG003|Overall Study|Withdrawal by Subject|1|||
164384801|NCT00898677|593777510|FG000|Overall Study|Not Treated: Adverse Event|0|||
164384802|NCT00898677|593777511|FG001|Overall Study|Not Treated: Adverse Event|2|||
164384803|NCT00898677|593777512|FG002|Overall Study|Not Treated: Adverse Event|1|||
164384804|NCT00898677|593777513|FG003|Overall Study|Not Treated: Adverse Event|0|||
164384805|NCT00898677|593777510|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
164384806|NCT00898677|593777511|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
164384807|NCT00898677|593777512|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
164384808|NCT00898677|593777513|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
164384809|NCT00898677|593777510|FG000|Overall Study|Not Treated: Pregnancy|0|||
164384810|NCT00898677|593777511|FG001|Overall Study|Not Treated: Pregnancy|0|||
164384811|NCT00898677|593777512|FG002|Overall Study|Not Treated: Pregnancy|1|||
164440192|NCT01087762|593978900|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
164440193|NCT01087762|593978896|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
164440194|NCT01087762|593978897|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
164440195|NCT01087762|593978898|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
164440196|NCT01087762|593978899|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
164440197|NCT01087762|593978900|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
164592681|NCT04491877|594534551|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164592682|NCT04491877|594534552|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164592683|NCT04491877|594534553|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
164592684|NCT04491877|594534554|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
164592685|NCT04491877|594534555|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
164592686|NCT04491877|594534556|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
164592687|NCT04491877|594534557|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
164592688|NCT04491877|594534558|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
164592689|NCT04491877|594534559|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
164592690|NCT04491877|594534551|FG000|Overall Study|Lost to Follow-up|0|||
164592691|NCT04491877|594534552|FG001|Overall Study|Lost to Follow-up|2|||
164592692|NCT04491877|594534553|FG002|Overall Study|Lost to Follow-up|0|||
164592693|NCT04491877|594534554|FG003|Overall Study|Lost to Follow-up|0|||
164592694|NCT04491877|594534555|FG004|Overall Study|Lost to Follow-up|0|||
164592695|NCT04491877|594534556|FG005|Overall Study|Lost to Follow-up|0|||
164592696|NCT04491877|594534557|FG006|Overall Study|Lost to Follow-up|2|||
164592697|NCT04491877|594534558|FG007|Overall Study|Lost to Follow-up|1|||
164592698|NCT04491877|594534559|FG008|Overall Study|Lost to Follow-up|1|||
164592699|NCT05306873|594534560|FG000|Stage 2|Study stopped|1|||
164592700|NCT05306873|594534561|FG001|Stage 2|Study stopped|1|||
164384812|NCT00898677|593777513|FG003|Overall Study|Not Treated: Pregnancy|0|||
164384813|NCT00898677|593777510|FG000|Overall Study|Not Treated: Protocol Violation|2|||
164440198|NCT00813904|593978901|FG000|Overall Study|Death|1|||
164440199|NCT01405924|593978904|FG000|Overall Study|Protocol Violation|8|||
164440200|NCT01405924|593978904|FG000|Overall Study|Missing/Incomplete Data|2|||
164440201|NCT02393716|593978905|FG000|Overall Study|Death|29|||
164440202|NCT02393716|593978905|FG000|Overall Study|Withdrawal by Subject|8|||
164440203|NCT02393716|593978905|FG000|Overall Study|Device Explanted|8|||
164440204|NCT02393716|593978905|FG000|Overall Study|Missed visit|16|||
164440205|NCT01565928|593978906|FG000|Overall Study|Adverse Event|3|||
164440206|NCT01565928|593978906|FG000|Overall Study|Other|3|||
164440207|NCT01565928|593978906|FG000|Overall Study|Progressive Disease|13|||
164440208|NCT01565928|593978906|FG000|Overall Study|Withdrawal by Subject|1|||
164440209|NCT01565928|593978906|FG000|Overall Study|Death|2|||
164440210|NCT01191788|593978908|FG000|Overall Study|Lost to Follow-up|21|||
164440211|NCT01191788|593978909|FG001|Overall Study|Lost to Follow-up|22|||
164440212|NCT03621761|593978914|FG000|Overall Study|Lost to Follow-up|1|||
164440213|NCT03621761|593978915|FG001|Overall Study|Lost to Follow-up|1|||
164440214|NCT03621761|593978916|FG002|Overall Study|Lost to Follow-up|2|||
164440215|NCT03621761|593978914|FG000|Overall Study|Withdrawal by Subject|2|||
164440216|NCT03621761|593978915|FG001|Overall Study|Withdrawal by Subject|1|||
164440217|NCT03621761|593978916|FG002|Overall Study|Withdrawal by Subject|1|||
164440218|NCT03621761|593978914|FG000|Overall Study|Became Ineligible|0|||
164440219|NCT03621761|593978915|FG001|Overall Study|Became Ineligible|2|||
164440220|NCT03621761|593978916|FG002|Overall Study|Became Ineligible|0|||
164440221|NCT02441036|593978923|FG000|Overall Study|No tissue resected|0|||
164440222|NCT02441036|593978924|FG001|Overall Study|No tissue resected|1|||
164440223|NCT02441036|593978925|FG002|Overall Study|No tissue resected|0|||
164440224|NCT02441036|593978926|FG003|Overall Study|No tissue resected|1|||
164384814|NCT00898677|593777511|FG001|Overall Study|Not Treated: Protocol Violation|0|||
164384815|NCT00898677|593777512|FG002|Overall Study|Not Treated: Protocol Violation|2|||
164384816|NCT00898677|593777513|FG003|Overall Study|Not Treated: Protocol Violation|0|||
164384817|NCT00898677|593777510|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
164384818|NCT00898677|593777511|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
164384819|NCT00898677|593777512|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
164384820|NCT00898677|593777513|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
164384821|NCT00898677|593777510|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
164384822|NCT00898677|593777511|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
164384823|NCT00898677|593777512|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
164384824|NCT00898677|593777513|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
164440225|NCT02441036|593978927|FG004|Overall Study|No tissue resected|0|||
164440226|NCT03192046|593978930|FG000|Overall Study|Withdrawal by Subject|1|||
164440227|NCT03192046|593978931|FG001|Overall Study|Withdrawal by Subject|1|||
164440228|NCT01505881|593978934|FG000|Overall Study|Adverse Event|0|||
164592701|NCT05306873|594534562|FG002|Stage 2|Study stopped|0|||
164384825|NCT00898677|593777510|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
164384826|NCT00898677|593777511|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
164384827|NCT00898677|593777512|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
164440229|NCT01505881|593978935|FG001|Overall Study|Adverse Event|1|||
164592702|NCT05306873|594534563|FG003|Stage 2|Study stopped|0|||
164592703|NCT05306873|594534560|FG000|Stage 2|Stage 2 Treatment Failure|2|||
164592704|NCT05306873|594534561|FG001|Stage 2|Stage 2 Treatment Failure|3|||
164592705|NCT05306873|594534562|FG002|Stage 2|Stage 2 Treatment Failure|0|||
164592706|NCT05306873|594534563|FG003|Stage 2|Stage 2 Treatment Failure|0|||
164592707|NCT05306873|594534560|FG000|Stage 2|Logistical issues due to participant moving|1|||
164592708|NCT05306873|594534561|FG001|Stage 2|Logistical issues due to participant moving|0|||
164592709|NCT05306873|594534562|FG002|Stage 2|Logistical issues due to participant moving|0|||
164592710|NCT05306873|594534563|FG003|Stage 2|Logistical issues due to participant moving|0|||
164592711|NCT05306873|594534560|FG000|Stage 3|Stage 3 Treatment Failure|0|||
164592712|NCT05306873|594534561|FG001|Stage 3|Stage 3 Treatment Failure|0|||
164592713|NCT05306873|594534562|FG002|Stage 3|Stage 3 Treatment Failure|0|||
164592714|NCT05306873|594534563|FG003|Stage 3|Stage 3 Treatment Failure|1|||
164592715|NCT05306873|594534560|FG000|Stage 3|Study Stopped|0|||
164592716|NCT05306873|594534561|FG001|Stage 3|Study Stopped|0|||
164592717|NCT05306873|594534562|FG002|Stage 3|Study Stopped|1|||
164592718|NCT05306873|594534563|FG003|Stage 3|Study Stopped|0|||
164592719|NCT02614287|594534564|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
164592720|NCT02614287|594534565|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
164592721|NCT02614287|594534564|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
164592722|NCT02614287|594534565|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
164702232|NCT03096847|594934491|FG001|Overall Study|Physician Decision|2|||
164592723|NCT02614287|594534564|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
164440230|NCT01505881|593978934|FG000|Overall Study|Lost to Follow-up|2|||
164440231|NCT01505881|593978935|FG001|Overall Study|Lost to Follow-up|0|||
164440232|NCT01505881|593978934|FG000|Overall Study|Withdrawal by Subject|2|||
164440233|NCT01505881|593978935|FG001|Overall Study|Withdrawal by Subject|0|||
164440234|NCT01194154|593978936|FG000|Overall Study|Adverse Event|12|||
164440235|NCT01194154|593978937|FG001|Overall Study|Adverse Event|7|||
164440236|NCT01194154|593978936|FG000|Overall Study|Lost to Follow-up|2|||
164384828|NCT00898677|593777513|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
164384829|NCT00898677|593777510|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
164384830|NCT00898677|593777511|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
164384831|NCT00898677|593777512|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
164384832|NCT00898677|593777513|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
164384833|NCT00898677|593777510|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
164384834|NCT00898677|593777511|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
164384835|NCT00898677|593777512|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
164384836|NCT00898677|593777513|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
164384837|NCT00898677|593777510|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
164384838|NCT00898677|593777511|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
164384839|NCT00898677|593777512|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
164384840|NCT00898677|593777513|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
164384841|NCT00898677|593777510|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
164384842|NCT00898677|593777511|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
164384843|NCT00898677|593777512|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
164384844|NCT00898677|593777513|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
164384845|NCT00852397|593777514|FG000|Overall Study|Adverse Event|4|||
164384846|NCT00852397|593777515|FG001|Overall Study|Adverse Event|6|||
164384847|NCT00852397|593777516|FG002|Overall Study|Adverse Event|4|||
164384848|NCT00852397|593777514|FG000|Overall Study|Death|0|||
164384849|NCT00852397|593777515|FG001|Overall Study|Death|0|||
164384850|NCT00852397|593777516|FG002|Overall Study|Death|1|||
164384851|NCT00852397|593777514|FG000|Overall Study|Withdrawal by Subject|4|||
164384852|NCT00852397|593777515|FG001|Overall Study|Withdrawal by Subject|1|||
164384853|NCT00852397|593777516|FG002|Overall Study|Withdrawal by Subject|2|||
164384854|NCT00852397|593777514|FG000|Overall Study|Study terminated by sponsor|2|||
164384855|NCT00852397|593777515|FG001|Overall Study|Study terminated by sponsor|1|||
164384856|NCT00852397|593777516|FG002|Overall Study|Study terminated by sponsor|6|||
164384857|NCT00852397|593777514|FG000|Overall Study|Difficulty in study site visit|1|||
164384858|NCT00852397|593777515|FG001|Overall Study|Difficulty in study site visit|0|||
164384859|NCT00852397|593777516|FG002|Overall Study|Difficulty in study site visit|0|||
164384860|NCT00852397|593777514|FG000|Overall Study|Protocol Violation|0|||
164384861|NCT00852397|593777515|FG001|Overall Study|Protocol Violation|0|||
164384862|NCT00852397|593777516|FG002|Overall Study|Protocol Violation|1|||
164384863|NCT00836875|593777519|FG000|Overall Study|Death|3|||
164384864|NCT00836875|593777520|FG001|Overall Study|Death|2|||
164384865|NCT00836875|593777519|FG000|Overall Study|Withdrawal by Subject|0|||
164384866|NCT00836875|593777520|FG001|Overall Study|Withdrawal by Subject|1|||
164384867|NCT03964454|593777530|FG000|Overall Study|Lost to Follow-up|13|||
164384868|NCT03964454|593777531|FG001|Overall Study|Lost to Follow-up|7|||
164384869|NCT03964454|593777530|FG000|Overall Study|Withdrawal by Subject|4|||
164384870|NCT03964454|593777531|FG001|Overall Study|Withdrawal by Subject|11|||
164384871|NCT00464542|593779124|FG000|Pre-treatment|Withdrawal by Subject|2|||
164384872|NCT00993447|593779125|FG000|Overall Study|Withdrawal by Subject|23|||
164384873|NCT00993447|593779126|FG001|Overall Study|Withdrawal by Subject|8|||
164384874|NCT00993447|593779125|FG000|Overall Study|Protocol Violation|12|||
164384875|NCT00993447|593779126|FG001|Overall Study|Protocol Violation|8|||
164384876|NCT00993447|593779125|FG000|Overall Study|Lost to Follow-up|1|||
164384877|NCT00993447|593779126|FG001|Overall Study|Lost to Follow-up|3|||
164384878|NCT00993447|593779125|FG000|Overall Study|Adverse Event|1|||
164384879|NCT00993447|593779126|FG001|Overall Study|Adverse Event|0|||
164384880|NCT01760954|593779127|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
164384881|NCT01760954|593779128|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
164384882|NCT01760954|593779129|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
164384883|NCT01760954|593779130|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
164384884|NCT01760954|593779127|FG000|Treatment Period (6 Months)|Adverse Event|5|||
164384885|NCT01760954|593779128|FG001|Treatment Period (6 Months)|Adverse Event|3|||
164384886|NCT01760954|593779129|FG002|Treatment Period (6 Months)|Adverse Event|4|||
164384887|NCT01760954|593779130|FG003|Treatment Period (6 Months)|Adverse Event|10|||
164384888|NCT01760954|593779127|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
164384889|NCT01760954|593779128|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
164384890|NCT01760954|593779129|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
164384891|NCT01760954|593779130|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
164384892|NCT01760954|593779127|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
164384893|NCT01760954|593779128|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
164384894|NCT01760954|593779129|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
164384895|NCT01760954|593779130|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
164384896|NCT01760954|593779127|FG000|Treatment Period (6 Months)|Pregnancy|5|||
164440237|NCT01194154|593978937|FG001|Overall Study|Lost to Follow-up|3|||
164440238|NCT01194154|593978936|FG000|Overall Study|Protocol Violation|0|||
164592724|NCT02614287|594534565|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
164592725|NCT02614287|594534564|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
164702233|NCT03096847|594934492|FG002|Overall Study|Physician Decision|8|||
164702234|NCT03096847|594934490|FG000|Overall Study|Withdrawal by Subject|24|||
164384897|NCT01760954|593779128|FG001|Treatment Period (6 Months)|Pregnancy|0|||
164384898|NCT01760954|593779129|FG002|Treatment Period (6 Months)|Pregnancy|3|||
164384899|NCT01760954|593779130|FG003|Treatment Period (6 Months)|Pregnancy|2|||
164384900|NCT01760954|593779127|FG000|Treatment Period (6 Months)|Non-compliance|1|||
164384901|NCT01760954|593779128|FG001|Treatment Period (6 Months)|Non-compliance|4|||
164384902|NCT01760954|593779129|FG002|Treatment Period (6 Months)|Non-compliance|0|||
164384903|NCT01760954|593779130|FG003|Treatment Period (6 Months)|Non-compliance|3|||
164384904|NCT01760954|593779127|FG000|Treatment Period (6 Months)|Other|0|||
164384905|NCT01760954|593779128|FG001|Treatment Period (6 Months)|Other|3|||
164384906|NCT01760954|593779129|FG002|Treatment Period (6 Months)|Other|3|||
164384907|NCT01760954|593779130|FG003|Treatment Period (6 Months)|Other|1|||
164384908|NCT01760954|593779127|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
164384909|NCT01760954|593779128|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
164384910|NCT01760954|593779129|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
164384911|NCT01760954|593779130|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
164384912|NCT01760954|593779127|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
164384913|NCT01760954|593779128|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
164384914|NCT01760954|593779129|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
164384915|NCT01760954|593779130|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
164384916|NCT01760954|593779127|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
164384917|NCT01760954|593779128|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
164384918|NCT01760954|593779129|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
164384919|NCT01760954|593779130|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
164384920|NCT01760954|593779127|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
164384921|NCT01760954|593779128|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
164384922|NCT01760954|593779129|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
164384923|NCT01760954|593779130|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
164384924|NCT01760954|593779127|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
164384925|NCT01760954|593779128|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
164384926|NCT01760954|593779129|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
164384927|NCT01760954|593779130|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
164384928|NCT01760954|593779127|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
164384929|NCT01760954|593779128|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
164384930|NCT01760954|593779129|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
164384931|NCT01760954|593779130|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
164384932|NCT01760954|593779127|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
164384933|NCT01760954|593779128|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
164384934|NCT01760954|593779129|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
164384935|NCT01760954|593779130|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
164384936|NCT01760954|593779127|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
164384937|NCT01760954|593779128|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
164384938|NCT01760954|593779129|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
164384939|NCT01760954|593779130|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
164384940|NCT02707055|593779131|FG000|Phase 1|Withdrawal by Subject|1|||
164384941|NCT02707055|593779132|FG001|Phase 1|Withdrawal by Subject|2|||
164384942|NCT02707055|593779131|FG000|Phase 1|Physician Decision|0|||
164384943|NCT02707055|593779132|FG001|Phase 1|Physician Decision|1|||
164384944|NCT02707055|593779131|FG000|Phase 2|Adverse Event|1|||
164384945|NCT02707055|593779132|FG001|Phase 2|Adverse Event|2|||
164384946|NCT01880424|593779133|FG000|Overall Study|Adverse Event|7|||
164440239|NCT01194154|593978937|FG001|Overall Study|Protocol Violation|1|||
164440240|NCT01194154|593978936|FG000|Overall Study|Withdrawal by Subject|5|||
164440241|NCT01194154|593978937|FG001|Overall Study|Withdrawal by Subject|6|||
164440242|NCT01194154|593978936|FG000|Overall Study|Blood pressure increase|5|||
164702235|NCT03096847|594934491|FG001|Overall Study|Withdrawal by Subject|1|||
164702236|NCT03096847|594934492|FG002|Overall Study|Withdrawal by Subject|12|||
164702237|NCT03096847|594934490|FG000|Overall Study|Adverse Event|72|||
164702238|NCT03096847|594934491|FG001|Overall Study|Adverse Event|6|||
164702239|NCT03096847|594934492|FG002|Overall Study|Adverse Event|28|||
164702240|NCT03096847|594934490|FG000|Overall Study|Progressive disease|97|||
164702241|NCT03096847|594934491|FG001|Overall Study|Progressive disease|10|||
164702242|NCT03096847|594934492|FG002|Overall Study|Progressive disease|78|||
164702243|NCT03096847|594934490|FG000|Overall Study|Non-compliance with study medication|1|||
164384947|NCT01880424|593779134|FG001|Overall Study|Adverse Event|6|||
164440243|NCT01194154|593978937|FG001|Overall Study|Blood pressure increase|3|||
164440244|NCT01194154|593978936|FG000|Overall Study|Hemoglobin decrease|0|||
164702244|NCT03096847|594934491|FG001|Overall Study|Non-compliance with study medication|0|||
164384948|NCT01880424|593779133|FG000|Overall Study|Lack of Efficacy|1|||
164384949|NCT01880424|593779134|FG001|Overall Study|Lack of Efficacy|4|||
164384950|NCT01880424|593779133|FG000|Overall Study|Lost to Follow-up|3|||
164384951|NCT01880424|593779134|FG001|Overall Study|Lost to Follow-up|2|||
164384952|NCT01880424|593779133|FG000|Overall Study|Protocol Violation|11|||
164384953|NCT01880424|593779134|FG001|Overall Study|Protocol Violation|13|||
164384954|NCT01880424|593779133|FG000|Overall Study|Withdrawal by Subject|10|||
164384955|NCT01880424|593779134|FG001|Overall Study|Withdrawal by Subject|30|||
164384956|NCT01880424|593779133|FG000|Overall Study|Other|1|||
164384957|NCT01880424|593779134|FG001|Overall Study|Other|0|||
164384958|NCT02280044|593779137|FG000|Overall Study|Planned alternate|0|||
164384959|NCT02280044|593779138|FG001|Overall Study|Planned alternate|2|||
164384960|NCT05706506|593779139|FG000|Overall Study|Adverse Event|1|||
164384961|NCT05706506|593779139|FG000|Overall Study|Withdrawal by Subject|4|||
164384962|NCT05706506|593779139|FG000|Overall Study|Lost to Follow-up|2|||
164384963|NCT05706506|593779139|FG000|Overall Study|Inadvertent Enrolment|12|||
164384964|NCT05706506|593779139|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
164384965|NCT05706506|593779139|FG000|Overall Study|Participant Moved Out of State|1|||
164384966|NCT01075321|593779140|FG000|Overall Study|Withdrawal by Subject|0|||
164384967|NCT01075321|593779141|FG001|Overall Study|Withdrawal by Subject|0|||
164384968|NCT01075321|593779142|FG002|Overall Study|Withdrawal by Subject|1|||
164384969|NCT01075321|593779143|FG003|Overall Study|Withdrawal by Subject|1|||
164384970|NCT01075321|593779140|FG000|Overall Study|Protocol Violation|0|||
164384971|NCT01075321|593779141|FG001|Overall Study|Protocol Violation|0|||
164384972|NCT01075321|593779142|FG002|Overall Study|Protocol Violation|1|||
164384973|NCT01075321|593779143|FG003|Overall Study|Protocol Violation|0|||
164384974|NCT01075321|593779140|FG000|Overall Study|Treatment Incomplete due to progression|1|||
164384975|NCT01075321|593779141|FG001|Overall Study|Treatment Incomplete due to progression|0|||
164384976|NCT01075321|593779142|FG002|Overall Study|Treatment Incomplete due to progression|0|||
164384977|NCT01075321|593779143|FG003|Overall Study|Treatment Incomplete due to progression|0|||
164384978|NCT01075321|593779140|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
164384979|NCT01075321|593779141|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
164384980|NCT01075321|593779142|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
164384981|NCT01075321|593779143|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
164384982|NCT02646423|593779144|FG000|Overall Study|Adverse Event|5|||
164384983|NCT02646423|593779145|FG001|Overall Study|Adverse Event|7|||
164384984|NCT02646423|593779144|FG000|Overall Study|Ineligible|2|||
164384985|NCT02646423|593779145|FG001|Overall Study|Ineligible|1|||
164384986|NCT02246998|593779149|FG000|Overall Study|Adverse Event|0|||
164384987|NCT02246998|593779150|FG001|Overall Study|Adverse Event|1|||
164384988|NCT02246998|593779151|FG002|Overall Study|Adverse Event|1|||
164384989|NCT02246998|593779152|FG003|Overall Study|Adverse Event|0|||
164384990|NCT02246998|593779149|FG000|Overall Study|Lost to Follow-up|1|||
164384991|NCT02246998|593779150|FG001|Overall Study|Lost to Follow-up|0|||
164592726|NCT02614287|594534565|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
164592727|NCT02614287|594534564|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
164384992|NCT02246998|593779151|FG002|Overall Study|Lost to Follow-up|0|||
164384993|NCT02246998|593779152|FG003|Overall Study|Lost to Follow-up|1|||
164384994|NCT02246998|593779149|FG000|Overall Study|Randomized but Never Dosed|1|||
164384995|NCT02246998|593779150|FG001|Overall Study|Randomized but Never Dosed|2|||
164384996|NCT02246998|593779151|FG002|Overall Study|Randomized but Never Dosed|2|||
164384997|NCT02246998|593779152|FG003|Overall Study|Randomized but Never Dosed|1|||
164384998|NCT01303627|593779156|FG000|Overall Study|the failure while performing URS|0|||
164384999|NCT01303627|593779157|FG001|Overall Study|the failure while performing URS|1|||
164385000|NCT03489304|593779159|FG000|Overall Study|Lost to Follow-up|4|||
164385001|NCT00321919|593779160|FG000|Overall Study|Adverse Event|17|||
164385002|NCT00321919|593779161|FG001|Overall Study|Adverse Event|10|||
164385003|NCT00321919|593779160|FG000|Overall Study|Death|21|||
164385004|NCT00321919|593779161|FG001|Overall Study|Death|17|||
164385005|NCT00321919|593779160|FG000|Overall Study|Insufficient Therapeutic Response|1|||
164385006|NCT00321919|593779161|FG001|Overall Study|Insufficient Therapeutic Response|0|||
164385007|NCT00321919|593779160|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
164385008|NCT00321919|593779161|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
164385009|NCT00321919|593779160|FG000|Overall Study|Refused Treatment|23|||
164385010|NCT00321919|593779161|FG001|Overall Study|Refused Treatment|14|||
164385011|NCT00321919|593779160|FG000|Overall Study|Other Protocol Violation|2|||
164385012|NCT00321919|593779161|FG001|Overall Study|Other Protocol Violation|3|||
164385013|NCT00321919|593779160|FG000|Overall Study|Failure to Return|3|||
164385014|NCT00321919|593779161|FG001|Overall Study|Failure to Return|1|||
164385015|NCT00321919|593779160|FG000|Overall Study|Other withdrawal reason|7|||
164385016|NCT00321919|593779161|FG001|Overall Study|Other withdrawal reason|6|||
164385017|NCT02624804|593779162|FG000|Overall Study|Screen Failure|5|||
164385018|NCT02590354|593779163|FG000|Phase 1|Active hepatitis B or C infection|1|||
164385019|NCT02590354|593779163|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
164385020|NCT02590354|593779163|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
164385021|NCT02590354|593779163|FG000|Phase 1|Subject does not want to participate|20|||
164385022|NCT02590354|593779163|FG000|Phase 1|Lost to Follow-up|1|||
164385023|NCT02590354|593779163|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
164385024|NCT00996996|593779164|FG000|Overall Study|Progressive Disease|10|||
164385025|NCT00996996|593779164|FG000|Overall Study|Non-compliance|8|||
164385026|NCT00996996|593779164|FG000|Overall Study|Lost to Follow-up|9|||
164385027|NCT00996996|593779164|FG000|Overall Study|Death|5|||
164385028|NCT00996996|593779164|FG000|Overall Study|Did Not Receive Study Medications|1|||
164385029|NCT01227889|593779165|FG000|Randomized Phase (RP)|Adverse Event|13|||
164385030|NCT01227889|593779166|FG001|Randomized Phase (RP)|Adverse Event|0|||
164385031|NCT01227889|593779165|FG000|Randomized Phase (RP)|Physician Decision|13|||
164385032|NCT01227889|593779166|FG001|Randomized Phase (RP)|Physician Decision|5|||
164385033|NCT01227889|593779165|FG000|Randomized Phase (RP)|Progressive Disease|135|||
164385034|NCT01227889|593779166|FG001|Randomized Phase (RP)|Progressive Disease|52|||
164385035|NCT01227889|593779165|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
164385036|NCT01227889|593779166|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
164385037|NCT01227889|593779165|FG000|Randomized Phase (RP)|Missing|1|||
164702245|NCT03096847|594934492|FG002|Overall Study|Non-compliance with study medication|0|||
164702246|NCT03096847|594934490|FG000|Overall Study|New therapy for study indication|1|||
164702247|NCT03096847|594934491|FG001|Overall Study|New therapy for study indication|0|||
164702248|NCT03096847|594934492|FG002|Overall Study|New therapy for study indication|1|||
164702249|NCT00359632|594934496|FG000|Overall Study|Death|2|||
164702250|NCT00359632|594934497|FG001|Overall Study|Death|0|||
164702251|NCT00359632|594934496|FG000|Overall Study|Adverse Event|1|||
164702252|NCT00359632|594934497|FG001|Overall Study|Adverse Event|0|||
164702253|NCT00359632|594934496|FG000|Overall Study|Non-compliance with visit schedule|1|||
164702254|NCT00359632|594934497|FG001|Overall Study|Non-compliance with visit schedule|0|||
164702255|NCT03978091|594934500|FG000|Overall Study|Lost to Follow-up|0|||
164702256|NCT03978091|594934501|FG001|Overall Study|Lost to Follow-up|0|||
164702257|NCT03978091|594934502|FG002|Overall Study|Lost to Follow-up|1|||
164702258|NCT03978091|594934503|FG003|Overall Study|Lost to Follow-up|0|||
164702259|NCT03978091|594934504|FG004|Overall Study|Lost to Follow-up|0|||
164702260|NCT03978091|594934505|FG005|Overall Study|Lost to Follow-up|0|||
164702261|NCT03978091|594934500|FG000|Overall Study|Withdrawal by Subject|0|||
164702262|NCT03978091|594934501|FG001|Overall Study|Withdrawal by Subject|0|||
164702263|NCT03978091|594934502|FG002|Overall Study|Withdrawal by Subject|0|||
164702264|NCT03978091|594934503|FG003|Overall Study|Withdrawal by Subject|1|||
164702265|NCT03978091|594934504|FG004|Overall Study|Withdrawal by Subject|1|||
164702266|NCT03978091|594934505|FG005|Overall Study|Withdrawal by Subject|0|||
164702267|NCT01843348|594934513|FG000|Overall Study|Withdrawal by Subject|4|||
164702268|NCT01843348|594934514|FG001|Overall Study|Withdrawal by Subject|16|||
164702269|NCT01843348|594934515|FG002|Overall Study|Withdrawal by Subject|18|||
164702270|NCT01843348|594934513|FG000|Overall Study|Lost to Follow-up|5|||
164702271|NCT01843348|594934514|FG001|Overall Study|Lost to Follow-up|4|||
164702272|NCT01843348|594934515|FG002|Overall Study|Lost to Follow-up|2|||
164702273|NCT01843348|594934513|FG000|Overall Study|Death|5|||
164702274|NCT01843348|594934514|FG001|Overall Study|Death|3|||
164702275|NCT01843348|594934515|FG002|Overall Study|Death|4|||
164702276|NCT01843348|594934513|FG000|Overall Study|Graft loss/retransplantation|5|||
164702277|NCT01843348|594934514|FG001|Overall Study|Graft loss/retransplantation|8|||
164702278|NCT01843348|594934515|FG002|Overall Study|Graft loss/retransplantation|11|||
164702279|NCT01843348|594934513|FG000|Overall Study|Various reasons|4|||
164702280|NCT01843348|594934514|FG001|Overall Study|Various reasons|9|||
164702281|NCT01843348|594934515|FG002|Overall Study|Various reasons|6|||
164702282|NCT00770692|594934516|FG000|Overall Study|Withdrawal by Subject|7|||
164702283|NCT00770692|594934517|FG001|Overall Study|Withdrawal by Subject|9|||
164702284|NCT00770692|594934518|FG002|Overall Study|Withdrawal by Subject|9|||
164702285|NCT00770692|594934519|FG003|Overall Study|Withdrawal by Subject|6|||
164702286|NCT00770692|594934516|FG000|Overall Study|Adverse Event|3|||
164702287|NCT00770692|594934517|FG001|Overall Study|Adverse Event|0|||
164702288|NCT00770692|594934518|FG002|Overall Study|Adverse Event|4|||
164702289|NCT00770692|594934519|FG003|Overall Study|Adverse Event|4|||
164702290|NCT00770692|594934516|FG000|Overall Study|Investigator judgment|2|||
164702291|NCT00770692|594934517|FG001|Overall Study|Investigator judgment|0|||
164702292|NCT00770692|594934518|FG002|Overall Study|Investigator judgment|1|||
164702293|NCT00770692|594934519|FG003|Overall Study|Investigator judgment|1|||
164702294|NCT01189500|594934520|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
164702295|NCT01189500|594934520|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
164702296|NCT00673933|594934528|FG000|Overall Study|Withdrawal by Subject|2|||
164702297|NCT00673933|594934528|FG000|Overall Study|Lost to Follow-up|1|||
164702298|NCT02206620|594934529|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
164702299|NCT02206620|594934530|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
164702300|NCT02206620|594934529|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
164385038|NCT01227889|593779166|FG001|Randomized Phase (RP)|Missing|3|||
164385039|NCT01227889|593779165|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
164702301|NCT02206620|594934530|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
164385040|NCT01227889|593779166|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
164702302|NCT05816200|594934531|FG000|Overall Study|Lost to Follow-up|2|||
164702303|NCT05816200|594934532|FG001|Overall Study|Lost to Follow-up|1|||
164702304|NCT03334721|594934533|FG000|Overall Study|Withdrawal by Subject|1|||
164702305|NCT03334721|594934534|FG001|Overall Study|Withdrawal by Subject|0|||
164702306|NCT03334721|594934533|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
164702307|NCT03334721|594934534|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
164702308|NCT03295318|594935960|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
164702309|NCT03295318|594935961|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
164702310|NCT03295318|594935962|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
164702311|NCT03295318|594935960|FG000|Overall Study|Death|1|||
164702312|NCT03295318|594935961|FG001|Overall Study|Death|1|||
164702313|NCT03295318|594935962|FG002|Overall Study|Death|1|||
164702314|NCT03295318|594935960|FG000|Overall Study|Protocol Violation|4|||
164702315|NCT03295318|594935961|FG001|Overall Study|Protocol Violation|3|||
164702316|NCT03295318|594935962|FG002|Overall Study|Protocol Violation|3|||
164702317|NCT03295318|594935960|FG000|Overall Study|Withdrawal by Subject|0|||
164702318|NCT03295318|594935961|FG001|Overall Study|Withdrawal by Subject|0|||
164702319|NCT03295318|594935962|FG002|Overall Study|Withdrawal by Subject|1|||
164702320|NCT03295318|594935960|FG000|Overall Study|Subject discontinued due to travel|0|||
164702321|NCT03295318|594935961|FG001|Overall Study|Subject discontinued due to travel|1|||
164702322|NCT03295318|594935962|FG002|Overall Study|Subject discontinued due to travel|0|||
164702323|NCT03747601|594935963|FG000|Overall Study|COVID halt to visits|4|||
164702324|NCT04319718|594935964|FG000|Overall Study|Adverse Event|0|||
164702325|NCT04319718|594935965|FG001|Overall Study|Adverse Event|2|||
164702326|NCT04319718|594935964|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
164702327|NCT04319718|594935965|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
164702328|NCT02221037|594935966|FG000|Overall Study|Physician Decision|0|||
164702329|NCT02221037|594935967|FG001|Overall Study|Physician Decision|0|||
164702330|NCT02221037|594935968|FG002|Overall Study|Physician Decision|1|||
164702331|NCT02221037|594935969|FG003|Overall Study|Physician Decision|0|||
164702332|NCT03955471|594935971|FG000|Overall Study|Death|22|||
164702333|NCT03955471|594935971|FG000|Overall Study|Lost to Follow-up|1|||
164702334|NCT03955471|594935971|FG000|Overall Study|Withdrawal by Subject|6|||
164702335|NCT03955471|594935971|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
164702336|NCT01030341|594935972|FG000|Overall Study|Withdrawal by Subject|1|||
164702337|NCT01030341|594935972|FG000|Overall Study|Lost to Follow-up|2|||
164702338|NCT01032018|594935975|FG000|Overall Study|Lost to Follow-up|6|||
164702339|NCT01032018|594935976|FG001|Overall Study|Lost to Follow-up|5|||
164702340|NCT01032018|594935975|FG000|Overall Study|Death|0|||
164702341|NCT01032018|594935976|FG001|Overall Study|Death|1|||
164702342|NCT00858143|594935977|FG000|Overall Study|Adverse Event|16|||
164702343|NCT00858143|594935977|FG000|Overall Study|Lack of Efficacy|4|||
164702344|NCT00858143|594935977|FG000|Overall Study|Death|7|||
164702345|NCT00858143|594935977|FG000|Overall Study|Other|23|||
164702346|NCT01293539|594935980|FG000|Overall Study|Physician Decision|1|||
164702347|NCT04032158|594935982|FG000|Overall Study|Study Termination|2|||
164702348|NCT04032158|594935983|FG001|Overall Study|Study Termination|1|||
164702349|NCT00059787|594935984|FG000|Overall Study|Adverse Event|13|||
164702350|NCT00059787|594935984|FG000|Overall Study|disease progression|2|||
164702351|NCT00059787|594935984|FG000|Overall Study|ineligible|1|||
164702352|NCT00059787|594935984|FG000|Overall Study|Other|4|||
164702353|NCT01248013|594935987|FG000|Overall Study|Withdrawal by Subject|14|||
164702354|NCT04325204|594935990|FG000|Overall Study|Death|0|||
164702355|NCT04325204|594935991|FG001|Overall Study|Death|1|||
164385041|NCT01227889|593779165|FG000|Crossover Phase|Adverse Event|0|||
164385042|NCT01227889|593779166|FG001|Crossover Phase|Adverse Event|1|||
164385043|NCT01227889|593779165|FG000|Crossover Phase|Physician Decision|0|||
164385044|NCT01227889|593779166|FG001|Crossover Phase|Physician Decision|3|||
164385045|NCT01227889|593779165|FG000|Crossover Phase|Progressive Disease|0|||
164385046|NCT01227889|593779166|FG001|Crossover Phase|Progressive Disease|31|||
164385047|NCT01227889|593779165|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
164385048|NCT01227889|593779166|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
164385049|NCT01227889|593779165|FG000|Crossover Phase|Withdrawal by Subject|0|||
164385050|NCT01227889|593779166|FG001|Crossover Phase|Withdrawal by Subject|1|||
164385051|NCT01709227|593779172|FG000|Overall Study|Physician Decision|1|||
164385052|NCT01709227|593779173|FG001|Overall Study|Physician Decision|0|||
164702356|NCT04325204|594935990|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
164702357|NCT04325204|594935991|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
164385053|NCT01709227|593779172|FG000|Overall Study|Pleural Peritoneal communication|0|||
164702358|NCT04325204|594935990|FG000|Overall Study|Lost to Follow-up|8|||
164702359|NCT04325204|594935991|FG001|Overall Study|Lost to Follow-up|8|||
164702360|NCT04325204|594935990|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
164702361|NCT04325204|594935991|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
164702362|NCT00841906|594935992|FG000|Overall Study|Withdrawal by Subject|2|||
164385054|NCT01709227|593779173|FG001|Overall Study|Pleural Peritoneal communication|9|||
164385055|NCT02159482|593779174|FG000|Overall Study|Withdrawal by Subject|2|||
164385056|NCT02159482|593779174|FG000|Overall Study|Physician Decision|3|||
164385057|NCT04479618|593779175|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
164385058|NCT04479618|593779176|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
164385059|NCT04479618|593779177|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
164385060|NCT04479618|593779175|FG000|Overall Study|Lack of Efficacy|1|||
164385061|NCT04479618|593779176|FG001|Overall Study|Lack of Efficacy|0|||
164385062|NCT04479618|593779177|FG002|Overall Study|Lack of Efficacy|0|||
164385063|NCT04479618|593779175|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
164385064|NCT04479618|593779176|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
164385065|NCT04479618|593779177|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
164385066|NCT04479618|593779175|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
164702363|NCT00841906|594935993|FG001|Overall Study|Withdrawal by Subject|0|||
164702364|NCT04710979|594935994|FG000|Overall Study|Lost to Follow-up|2|||
164702365|NCT04710979|594935995|FG001|Overall Study|Lost to Follow-up|4|||
164702366|NCT04710979|594935994|FG000|Overall Study|Withdrawal by Subject|1|||
164702367|NCT04710979|594935995|FG001|Overall Study|Withdrawal by Subject|0|||
164385067|NCT04479618|593779176|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
164385068|NCT04479618|593779177|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
164385069|NCT04479618|593779175|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
164385070|NCT04479618|593779176|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
164385071|NCT04479618|593779177|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
164385072|NCT04479618|593779175|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
164385073|NCT04479618|593779176|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
164385074|NCT04479618|593779177|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
164385075|NCT01430130|593779178|FG000|Overall Study|Lost to Follow-up|1|||
164385076|NCT01430130|593779178|FG000|Overall Study|Infection on Control Side of Incision|1|||
164385077|NCT00797667|593779179|FG000|Overall Study|Lack of Efficacy|0|||
164385078|NCT00797667|593779180|FG001|Overall Study|Lack of Efficacy|1|||
164385079|NCT00797667|593779181|FG002|Overall Study|Lack of Efficacy|0|||
164385080|NCT00797667|593779179|FG000|Overall Study|Lost to Follow-up|8|||
164385081|NCT00797667|593779180|FG001|Overall Study|Lost to Follow-up|12|||
164385082|NCT00797667|593779181|FG002|Overall Study|Lost to Follow-up|2|||
164385083|NCT00797667|593779179|FG000|Overall Study|Physician Decision|3|||
164385084|NCT00797667|593779180|FG001|Overall Study|Physician Decision|1|||
164385085|NCT00797667|593779181|FG002|Overall Study|Physician Decision|0|||
164385086|NCT00797667|593779179|FG000|Overall Study|Pregnancy|2|||
164385087|NCT00797667|593779180|FG001|Overall Study|Pregnancy|0|||
164385088|NCT00797667|593779181|FG002|Overall Study|Pregnancy|0|||
164385089|NCT00797667|593779179|FG000|Overall Study|Protocol Violation|2|||
164385090|NCT00797667|593779180|FG001|Overall Study|Protocol Violation|7|||
164385091|NCT00797667|593779181|FG002|Overall Study|Protocol Violation|0|||
164385092|NCT00797667|593779179|FG000|Overall Study|Study Terminated by Sponsor|217|||
164385093|NCT00797667|593779180|FG001|Overall Study|Study Terminated by Sponsor|216|||
164385094|NCT00797667|593779181|FG002|Overall Study|Study Terminated by Sponsor|115|||
164385095|NCT00797667|593779179|FG000|Overall Study|Withdrawal by Subject|9|||
164385096|NCT00797667|593779180|FG001|Overall Study|Withdrawal by Subject|14|||
164385097|NCT00797667|593779181|FG002|Overall Study|Withdrawal by Subject|2|||
164385098|NCT00797667|593779179|FG000|Overall Study|Adverse Event|19|||
164385099|NCT00797667|593779180|FG001|Overall Study|Adverse Event|8|||
164385100|NCT00797667|593779181|FG002|Overall Study|Adverse Event|8|||
164385101|NCT01485861|593779182|FG000|Phase Ib|Death|1|||
164385102|NCT01485861|593779183|FG001|Phase Ib|Death|0|||
164385103|NCT01485861|593779184|FG002|Phase Ib|Death|0|||
164385104|NCT01485861|593779185|FG003|Phase Ib|Death|0|||
164385105|NCT01485861|593779186|FG004|Phase Ib|Death|0|||
164385106|NCT01485861|593779187|FG005|Phase Ib|Death|0|||
164385107|NCT01485861|593779182|FG000|Phase Ib|Physician Decision|1|||
164385108|NCT01485861|593779183|FG001|Phase Ib|Physician Decision|1|||
164702368|NCT00394524|594935999|FG000|Overall Study|Protocol Violation|2|||
164702369|NCT00394524|594936000|FG001|Overall Study|Protocol Violation|3|||
164702370|NCT00394524|594935999|FG000|Overall Study|Death|1|||
164702371|NCT00394524|594936000|FG001|Overall Study|Death|0|||
164385109|NCT01485861|593779184|FG002|Phase Ib|Physician Decision|0|||
164385110|NCT01485861|593779185|FG003|Phase Ib|Physician Decision|0|||
164385111|NCT01485861|593779186|FG004|Phase Ib|Physician Decision|0|||
164702372|NCT00394524|594935999|FG000|Overall Study|Withdrawal by Subject|0|||
164702373|NCT00394524|594936000|FG001|Overall Study|Withdrawal by Subject|1|||
164702374|NCT03827564|594936001|FG000|Overall Study|Discontinued due to Study Termination|1|||
164702375|NCT03827564|594936002|FG001|Overall Study|Discontinued due to Study Termination|0|||
164702376|NCT00891371|594936005|FG000|Pre-assignment|Inclusion/exclusion|5|||
164702377|NCT00891371|594936005|FG000|Pre-assignment|Consent withdrawal|1|||
164702378|NCT00891371|594936005|FG000|Treatment|Lack of Efficacy|5|||
164702379|NCT00891371|594936005|FG000|Treatment|Adverse Event|2|||
164702380|NCT00891371|594936005|FG000|Treatment|Death|1|||
164702381|NCT00891371|594936005|FG000|Treatment|Lost to Follow-up|1|||
164702382|NCT02238626|594936006|FG000|Overall Study|Adverse Event|3|||
164702383|NCT02238626|594936007|FG001|Overall Study|Adverse Event|5|||
164702384|NCT02238626|594936008|FG002|Overall Study|Adverse Event|0|||
164702385|NCT02238626|594936009|FG003|Overall Study|Adverse Event|3|||
164702386|NCT02238626|594936006|FG000|Overall Study|Lost to Follow-up|2|||
164702387|NCT02238626|594936007|FG001|Overall Study|Lost to Follow-up|4|||
164702388|NCT02238626|594936008|FG002|Overall Study|Lost to Follow-up|2|||
164702389|NCT02238626|594936009|FG003|Overall Study|Lost to Follow-up|2|||
164702390|NCT02238626|594936006|FG000|Overall Study|Withdrawal by Subject|0|||
164702391|NCT02238626|594936007|FG001|Overall Study|Withdrawal by Subject|3|||
164702392|NCT02238626|594936008|FG002|Overall Study|Withdrawal by Subject|0|||
164702393|NCT02238626|594936009|FG003|Overall Study|Withdrawal by Subject|1|||
164702394|NCT02238626|594936006|FG000|Overall Study|Death|0|||
164702395|NCT02238626|594936007|FG001|Overall Study|Death|0|||
164702396|NCT02238626|594936008|FG002|Overall Study|Death|1|||
164702397|NCT02238626|594936009|FG003|Overall Study|Death|1|||
164702398|NCT02238626|594936006|FG000|Overall Study|Other|0|||
164702399|NCT02238626|594936007|FG001|Overall Study|Other|2|||
164702400|NCT02238626|594936008|FG002|Overall Study|Other|0|||
164702401|NCT02238626|594936009|FG003|Overall Study|Other|0|||
164385112|NCT01485861|593779187|FG005|Phase Ib|Physician Decision|0|||
164385113|NCT01485861|593779182|FG000|Phase Ib|Adverse Event|0|||
164385114|NCT01485861|593779183|FG001|Phase Ib|Adverse Event|4|||
164385115|NCT01485861|593779184|FG002|Phase Ib|Adverse Event|0|||
164592728|NCT02614287|594534565|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
164592729|NCT02614287|594534564|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
164592730|NCT02614287|594534565|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
164592731|NCT02614287|594534564|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
164592732|NCT02614287|594534565|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
164592733|NCT02614287|594534564|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
164592734|NCT02614287|594534565|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
164592735|NCT00418834|594534566|FG000|Overall Study|Adverse Event|16|||
164592736|NCT00418834|594534567|FG001|Overall Study|Adverse Event|9|||
164385116|NCT01485861|593779185|FG003|Phase Ib|Adverse Event|0|||
164385117|NCT01485861|593779186|FG004|Phase Ib|Adverse Event|0|||
164385118|NCT01485861|593779187|FG005|Phase Ib|Adverse Event|0|||
164385119|NCT01485861|593779182|FG000|Phase Ib|Progression of disease|5|||
164385120|NCT01485861|593779183|FG001|Phase Ib|Progression of disease|0|||
164385121|NCT01485861|593779184|FG002|Phase Ib|Progression of disease|0|||
164385122|NCT01485861|593779185|FG003|Phase Ib|Progression of disease|0|||
164385123|NCT01485861|593779186|FG004|Phase Ib|Progression of disease|0|||
164385124|NCT01485861|593779187|FG005|Phase Ib|Progression of disease|0|||
164592737|NCT00418834|594534566|FG000|Overall Study|Lost to Follow-up|0|||
164702402|NCT02621034|594936010|FG000|Overall Study|Lost to Follow-up|3|||
164702403|NCT02621034|594936011|FG001|Overall Study|Lost to Follow-up|2|||
164702404|NCT02621034|594936012|FG002|Overall Study|Lost to Follow-up|5|||
164702405|NCT04421586|594936021|FG000|Overall Study|Death|0|||
164702406|NCT04421586|594936022|FG001|Overall Study|Death|1|||
164702407|NCT04421586|594936021|FG000|Overall Study|Lost to Follow-up|2|||
164702408|NCT04421586|594936022|FG001|Overall Study|Lost to Follow-up|2|||
164702409|NCT04421586|594936021|FG000|Overall Study|Withdrawn by PI|1|||
164702410|NCT04421586|594936022|FG001|Overall Study|Withdrawn by PI|0|||
164702411|NCT04421586|594936021|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
164385125|NCT01485861|593779182|FG000|Phase Ib|Other|3|||
164385126|NCT01485861|593779183|FG001|Phase Ib|Other|0|||
164385127|NCT01485861|593779184|FG002|Phase Ib|Other|0|||
164385128|NCT01485861|593779185|FG003|Phase Ib|Other|0|||
164385129|NCT01485861|593779186|FG004|Phase Ib|Other|0|||
164385130|NCT01485861|593779187|FG005|Phase Ib|Other|0|||
164702412|NCT04421586|594936022|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
164702413|NCT02963441|594936023|FG000|Overall Study|Protocol violation or withdrawn|8|||
164702414|NCT02963441|594936023|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
164702415|NCT02963441|594936023|FG000|Overall Study|IDx-DR insufficient quality|33|||
164385131|NCT01485861|593779182|FG000|Phase Ib|Withdrawal by Subject|4|||
164385132|NCT01485861|593779183|FG001|Phase Ib|Withdrawal by Subject|1|||
164385133|NCT01485861|593779184|FG002|Phase Ib|Withdrawal by Subject|0|||
164385134|NCT01485861|593779185|FG003|Phase Ib|Withdrawal by Subject|0|||
164385135|NCT01485861|593779186|FG004|Phase Ib|Withdrawal by Subject|0|||
164385136|NCT01485861|593779187|FG005|Phase Ib|Withdrawal by Subject|0|||
164592738|NCT00418834|594534567|FG001|Overall Study|Lost to Follow-up|1|||
164592739|NCT00418834|594534566|FG000|Overall Study|Protocol Violation|4|||
164702416|NCT00974974|594936025|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
164702417|NCT00974974|594936026|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
164385137|NCT01485861|593779182|FG000|Phase II|Death|0|||
164385138|NCT01485861|593779183|FG001|Phase II|Death|0|||
164702418|NCT00974974|594936025|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
164385139|NCT01485861|593779184|FG002|Phase II|Death|67|||
164385140|NCT01485861|593779185|FG003|Phase II|Death|71|||
164385141|NCT01485861|593779186|FG004|Phase II|Death|68|||
164385142|NCT01485861|593779187|FG005|Phase II|Death|0|||
164385143|NCT01485861|593779182|FG000|Phase II|Progression of Disease|0|||
164385144|NCT01485861|593779183|FG001|Phase II|Progression of Disease|0|||
164385145|NCT01485861|593779184|FG002|Phase II|Progression of Disease|1|||
164385146|NCT01485861|593779185|FG003|Phase II|Progression of Disease|0|||
164385147|NCT01485861|593779186|FG004|Phase II|Progression of Disease|0|||
164385148|NCT01485861|593779187|FG005|Phase II|Progression of Disease|0|||
164385149|NCT01485861|593779182|FG000|Phase II|Other|0|||
164385150|NCT01485861|593779183|FG001|Phase II|Other|0|||
164385151|NCT01485861|593779184|FG002|Phase II|Other|0|||
164385152|NCT01485861|593779185|FG003|Phase II|Other|1|||
164385153|NCT01485861|593779186|FG004|Phase II|Other|0|||
164385154|NCT01485861|593779187|FG005|Phase II|Other|0|||
164385155|NCT01485861|593779182|FG000|Phase II|Withdrawal by Subject|0|||
164385156|NCT01485861|593779183|FG001|Phase II|Withdrawal by Subject|0|||
164385157|NCT01485861|593779184|FG002|Phase II|Withdrawal by Subject|6|||
164385158|NCT01485861|593779185|FG003|Phase II|Withdrawal by Subject|3|||
164385159|NCT01485861|593779186|FG004|Phase II|Withdrawal by Subject|4|||
164385160|NCT01485861|593779187|FG005|Phase II|Withdrawal by Subject|0|||
164385161|NCT01485861|593779182|FG000|Phase II|Lost to Follow-up|0|||
164385162|NCT01485861|593779183|FG001|Phase II|Lost to Follow-up|0|||
164385163|NCT01485861|593779184|FG002|Phase II|Lost to Follow-up|2|||
164385164|NCT01485861|593779185|FG003|Phase II|Lost to Follow-up|3|||
164385165|NCT01485861|593779186|FG004|Phase II|Lost to Follow-up|5|||
164385166|NCT01485861|593779187|FG005|Phase II|Lost to Follow-up|0|||
164385167|NCT01485861|593779182|FG000|Phase II|Study Ended|0|||
164385168|NCT01485861|593779183|FG001|Phase II|Study Ended|0|||
164385169|NCT01485861|593779184|FG002|Phase II|Study Ended|7|||
164385170|NCT01485861|593779185|FG003|Phase II|Study Ended|8|||
164385171|NCT01485861|593779186|FG004|Phase II|Study Ended|6|||
164385172|NCT01485861|593779187|FG005|Phase II|Study Ended|0|||
164385173|NCT01485861|593779182|FG000|Safety Phase|Death|0|||
164385174|NCT01485861|593779183|FG001|Safety Phase|Death|0|||
164385175|NCT01485861|593779184|FG002|Safety Phase|Death|0|||
164385176|NCT01485861|593779185|FG003|Safety Phase|Death|0|||
164385177|NCT01485861|593779186|FG004|Safety Phase|Death|0|||
164385178|NCT01485861|593779187|FG005|Safety Phase|Death|2|||
164385179|NCT01485861|593779182|FG000|Safety Phase|Adverse Event|0|||
164385180|NCT01485861|593779183|FG001|Safety Phase|Adverse Event|0|||
164385181|NCT01485861|593779184|FG002|Safety Phase|Adverse Event|0|||
164702419|NCT00974974|594936026|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
164702420|NCT00974974|594936025|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
164385182|NCT01485861|593779185|FG003|Safety Phase|Adverse Event|0|||
164385183|NCT01485861|593779186|FG004|Safety Phase|Adverse Event|0|||
164385184|NCT01485861|593779187|FG005|Safety Phase|Adverse Event|1|||
164385185|NCT01485861|593779182|FG000|Safety Phase|Other|0|||
164385186|NCT01485861|593779183|FG001|Safety Phase|Other|0|||
164385187|NCT01485861|593779184|FG002|Safety Phase|Other|0|||
164385188|NCT01485861|593779185|FG003|Safety Phase|Other|0|||
164385189|NCT01485861|593779186|FG004|Safety Phase|Other|0|||
164385190|NCT01485861|593779187|FG005|Safety Phase|Other|5|||
164385191|NCT01485861|593779182|FG000|Safety Phase|Progression of Disease|0|||
164385192|NCT01485861|593779183|FG001|Safety Phase|Progression of Disease|0|||
164385193|NCT01485861|593779184|FG002|Safety Phase|Progression of Disease|0|||
164385194|NCT01485861|593779185|FG003|Safety Phase|Progression of Disease|0|||
164385195|NCT01485861|593779186|FG004|Safety Phase|Progression of Disease|0|||
164385196|NCT01485861|593779187|FG005|Safety Phase|Progression of Disease|9|||
164702421|NCT00974974|594936026|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
164702422|NCT00974974|594936025|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
164385197|NCT01485861|593779182|FG000|Safety Phase|Withdrawal by Subject|0|||
164702423|NCT00974974|594936026|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
164385198|NCT01485861|593779183|FG001|Safety Phase|Withdrawal by Subject|0|||
164385199|NCT01485861|593779184|FG002|Safety Phase|Withdrawal by Subject|0|||
164385200|NCT01485861|593779185|FG003|Safety Phase|Withdrawal by Subject|0|||
164385201|NCT01485861|593779186|FG004|Safety Phase|Withdrawal by Subject|0|||
164385202|NCT01485861|593779187|FG005|Safety Phase|Withdrawal by Subject|6|||
164385203|NCT01485861|593779182|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
164385204|NCT01485861|593779183|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
164385205|NCT01485861|593779184|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
164385206|NCT01485861|593779185|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
164385207|NCT01485861|593779186|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
164385208|NCT01485861|593779187|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
164385209|NCT01986829|593779192|FG000|Overall Study|Death|1|||
164385210|NCT03795922|593779193|FG000|Overall Study|Adverse Event|2|||
164385211|NCT03795922|593779194|FG001|Overall Study|Adverse Event|1|||
164385212|NCT03795922|593779193|FG000|Overall Study|Withdrawal by Subject|5|||
164385213|NCT03795922|593779194|FG001|Overall Study|Withdrawal by Subject|13|||
164385214|NCT03795922|593779193|FG000|Overall Study|Lost to Follow-up|2|||
164385215|NCT03795922|593779194|FG001|Overall Study|Lost to Follow-up|3|||
164385216|NCT03795922|593779193|FG000|Overall Study|Pregnancy|0|||
164385217|NCT03795922|593779194|FG001|Overall Study|Pregnancy|1|||
164385218|NCT03795922|593779193|FG000|Overall Study|Physician Decision|1|||
164385219|NCT03795922|593779194|FG001|Overall Study|Physician Decision|2|||
164385220|NCT03795922|593779193|FG000|Overall Study|Protocol Violation|0|||
164385221|NCT03795922|593779194|FG001|Overall Study|Protocol Violation|1|||
164385222|NCT03795922|593779193|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
164385223|NCT03795922|593779194|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
164385224|NCT00701051|593779197|FG000|Screening|Failed Screening|40|||
164385225|NCT00701051|593779198|FG001|Screening|Failed Screening|0|||
164385226|NCT00701051|593779199|FG002|Screening|Failed Screening|0|||
164385227|NCT00701051|593779197|FG000|Screening|Time conflicts|19|||
164385228|NCT00701051|593779198|FG001|Screening|Time conflicts|0|||
164385229|NCT00701051|593779199|FG002|Screening|Time conflicts|0|||
164385230|NCT00701051|593779197|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
164385231|NCT00701051|593779198|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
164385232|NCT00701051|593779199|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
164385233|NCT01243944|593779200|FG000|Overall Study|Adverse Event|15|||
164385234|NCT01243944|593779201|FG001|Overall Study|Adverse Event|13|||
164385235|NCT01243944|593779200|FG000|Overall Study|Lost to Follow-up|2|||
164385236|NCT01243944|593779201|FG001|Overall Study|Lost to Follow-up|1|||
164385237|NCT01243944|593779200|FG000|Overall Study|Physician Decision|2|||
164385238|NCT01243944|593779201|FG001|Overall Study|Physician Decision|7|||
164385239|NCT01243944|593779200|FG000|Overall Study|Disease progression|12|||
164385240|NCT01243944|593779201|FG001|Overall Study|Disease progression|11|||
164385241|NCT01243944|593779200|FG000|Overall Study|Protocol deviation|1|||
164385242|NCT01243944|593779201|FG001|Overall Study|Protocol deviation|1|||
164385243|NCT01243944|593779200|FG000|Overall Study|Participant decision|10|||
164385244|NCT01243944|593779201|FG001|Overall Study|Participant decision|15|||
164385245|NCT01243944|593779200|FG000|Overall Study|Death|2|||
164385246|NCT01243944|593779201|FG001|Overall Study|Death|3|||
164385247|NCT01243944|593779200|FG000|Overall Study|Non-compliance with study treatment|1|||
164385248|NCT01243944|593779201|FG001|Overall Study|Non-compliance with study treatment|0|||
164385249|NCT02673697|593779208|FG000|Overall Study|Adverse Event|2|||
164385250|NCT02673697|593779209|FG001|Overall Study|Adverse Event|0|||
164385251|NCT02673697|593779208|FG000|Overall Study|Death|32|||
164385252|NCT02673697|593779209|FG001|Overall Study|Death|24|||
164385253|NCT02673697|593779208|FG000|Overall Study|Lost to Follow-up|5|||
164385254|NCT02673697|593779209|FG001|Overall Study|Lost to Follow-up|2|||
164385255|NCT02673697|593779208|FG000|Overall Study|Physician Decision|2|||
164385256|NCT02673697|593779209|FG001|Overall Study|Physician Decision|1|||
164385257|NCT02673697|593779208|FG000|Overall Study|Withdrawal by Subject|10|||
164385258|NCT02673697|593779209|FG001|Overall Study|Withdrawal by Subject|7|||
164385259|NCT02673697|593779208|FG000|Overall Study|Change subj medical status|1|||
164385260|NCT02673697|593779209|FG001|Overall Study|Change subj medical status|2|||
164385261|NCT02673697|593779208|FG000|Overall Study|Explant|10|||
164385262|NCT02673697|593779209|FG001|Overall Study|Explant|5|||
164385263|NCT02673697|593779208|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
164385264|NCT02673697|593779209|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
164385265|NCT00437489|593779210|FG000|Overall Study|Study terminated by sponsor|23|||
164385266|NCT00437489|593779211|FG001|Overall Study|Study terminated by sponsor|21|||
164385267|NCT00437489|593779210|FG000|Overall Study|Lost to Follow-up|0|||
164385268|NCT00437489|593779211|FG001|Overall Study|Lost to Follow-up|1|||
164385269|NCT03321019|593779216|FG000|Overall Study|Withdrawal by Subject|0|||
164385270|NCT03321019|593779217|FG001|Overall Study|Withdrawal by Subject|6|||
164385271|NCT03321019|593779216|FG000|Overall Study|Lost to Follow-up|0|||
164385272|NCT03321019|593779217|FG001|Overall Study|Lost to Follow-up|22|||
164385273|NCT03880578|593779218|FG000|Overall Study|Withdrawal by Subject|0|||
164385274|NCT03880578|593779219|FG001|Overall Study|Withdrawal by Subject|3|||
164702424|NCT00974974|594936025|FG000|IR CD-LD Dose Adjustment|Various|0|||
164702425|NCT00974974|594936026|FG001|IR CD-LD Dose Adjustment|Various|9|||
164385275|NCT03880578|593779220|FG002|Overall Study|Withdrawal by Subject|1|||
164385276|NCT03880578|593779218|FG000|Overall Study|Death|0|||
164385277|NCT03880578|593779219|FG001|Overall Study|Death|1|||
164385278|NCT03880578|593779220|FG002|Overall Study|Death|0|||
164385279|NCT04934670|593779221|FG000|Overall Study|Death|4|||
164385280|NCT04934670|593779222|FG001|Overall Study|Death|0|||
164385281|NCT04934670|593779221|FG000|Overall Study|Lost to Follow-up|1|||
164385282|NCT04934670|593779222|FG001|Overall Study|Lost to Follow-up|4|||
164385283|NCT03056690|593779224|FG000|Overall Study|Adverse Event|3|||
164385284|NCT03056690|593779225|FG001|Overall Study|Adverse Event|2|||
164385285|NCT03056690|593779224|FG000|Overall Study|Lack of Efficacy|1|||
164385286|NCT03056690|593779225|FG001|Overall Study|Lack of Efficacy|2|||
164385287|NCT03056690|593779224|FG000|Overall Study|Lost to Follow-up|3|||
164385288|NCT03056690|593779225|FG001|Overall Study|Lost to Follow-up|2|||
164385289|NCT03056690|593779224|FG000|Overall Study|Protocol Violation|2|||
164385290|NCT03056690|593779225|FG001|Overall Study|Protocol Violation|2|||
164385291|NCT03056690|593779224|FG000|Overall Study|Withdrawal by Subject|3|||
164385292|NCT03056690|593779225|FG001|Overall Study|Withdrawal by Subject|6|||
164385293|NCT03056690|593779224|FG000|Overall Study|Non-compliance with Study Drug|1|||
164385294|NCT03056690|593779225|FG001|Overall Study|Non-compliance with Study Drug|0|||
164385295|NCT03056690|593779224|FG000|Overall Study|Miscellaneous|1|||
164385296|NCT03056690|593779225|FG001|Overall Study|Miscellaneous|2|||
164385297|NCT01944046|593779229|FG000|Randomized to DB|Adverse Event|5|||
164385298|NCT01944046|593779230|FG001|Randomized to DB|Adverse Event|2|||
164385299|NCT01944046|593779229|FG000|Randomized to DB|Clinical Worsening|3|||
164385300|NCT01944046|593779230|FG001|Randomized to DB|Clinical Worsening|2|||
164385301|NCT01944046|593779229|FG000|Randomized to DB|Lost to Follow-up|3|||
164385302|NCT01944046|593779230|FG001|Randomized to DB|Lost to Follow-up|3|||
164385303|NCT01944046|593779229|FG000|Randomized to DB|Withdrawal by Subject|2|||
164385304|NCT01944046|593779230|FG001|Randomized to DB|Withdrawal by Subject|4|||
164385305|NCT01944046|593779229|FG000|Randomized to DB|Physician Decision|1|||
164385306|NCT01944046|593779230|FG001|Randomized to DB|Physician Decision|2|||
164385307|NCT01944046|593779229|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
164385308|NCT01944046|593779230|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
164385309|NCT01944046|593779229|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
164385310|NCT01944046|593779230|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
164385311|NCT01944046|593779229|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
164385312|NCT01944046|593779230|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
164385313|NCT01944046|593779229|FG000|Open Label Eligible and Consented|Adverse Event|6|||
164385314|NCT01944046|593779230|FG001|Open Label Eligible and Consented|Adverse Event|1|||
164385315|NCT01944046|593779229|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
164385316|NCT01944046|593779230|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
164385317|NCT01944046|593779229|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
164385318|NCT01944046|593779230|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
164385319|NCT00153101|593779236|FG000|Overall Study|Lost to Follow-up|14|||
164385320|NCT00153101|593779237|FG001|Overall Study|Lost to Follow-up|14|||
164385321|NCT00153101|593779238|FG002|Overall Study|Lost to Follow-up|12|||
164385322|NCT00153101|593779239|FG003|Overall Study|Lost to Follow-up|5|||
164385323|NCT00153101|593779240|FG004|Overall Study|Lost to Follow-up|5|||
164385324|NCT00153101|593779236|FG000|Overall Study|Withdrawal by Subject|3|||
164385325|NCT00153101|593779237|FG001|Overall Study|Withdrawal by Subject|4|||
164702426|NCT00974974|594936025|FG000|IPX066 Dose Conversion|Adverse Event|23|||
164702427|NCT00974974|594936026|FG001|IPX066 Dose Conversion|Adverse Event|0|||
164702428|NCT00974974|594936025|FG000|IPX066 Dose Conversion|Death|2|||
164702429|NCT00974974|594936026|FG001|IPX066 Dose Conversion|Death|0|||
164702430|NCT00974974|594936025|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
164702431|NCT00974974|594936026|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
164702432|NCT00974974|594936025|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
164702433|NCT00974974|594936026|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
164702434|NCT00974974|594936025|FG000|IPX066 Dose Conversion|Various|3|||
164702435|NCT00974974|594936026|FG001|IPX066 Dose Conversion|Various|0|||
164592740|NCT00418834|594534567|FG001|Overall Study|Protocol Violation|3|||
164592741|NCT00418834|594534566|FG000|Overall Study|Withdrawal by Subject|3|||
164702436|NCT00974974|594936025|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
164702437|NCT00974974|594936026|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
164385326|NCT00153101|593779238|FG002|Overall Study|Withdrawal by Subject|3|||
164592742|NCT00418834|594534567|FG001|Overall Study|Withdrawal by Subject|7|||
164702438|NCT00974974|594936025|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
164592743|NCT01953328|594534568|FG000|Overall Study|Withdrawal by Subject|0|||
164592744|NCT01953328|594534569|FG001|Overall Study|Withdrawal by Subject|0|||
164592745|NCT01953328|594534570|FG002|Overall Study|Withdrawal by Subject|0|||
164592746|NCT01953328|594534571|FG003|Overall Study|Withdrawal by Subject|0|||
164592747|NCT01953328|594534572|FG004|Overall Study|Withdrawal by Subject|1|||
164592748|NCT01953328|594534573|FG005|Overall Study|Withdrawal by Subject|0|||
164592749|NCT01953328|594534574|FG006|Overall Study|Withdrawal by Subject|0|||
164592750|NCT01953328|594534575|FG007|Overall Study|Withdrawal by Subject|0|||
164592751|NCT01953328|594534568|FG000|Overall Study|Lost to Follow-up|0|||
164702439|NCT00974974|594936026|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
164702440|NCT00974974|594936025|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
164702441|NCT00974974|594936026|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
164385327|NCT00153101|593779239|FG003|Overall Study|Withdrawal by Subject|3|||
164385328|NCT00153101|593779240|FG004|Overall Study|Withdrawal by Subject|5|||
164385329|NCT00439777|593779241|FG000|Treatment Period|Death|29|||
164385330|NCT00439777|593779242|FG001|Treatment Period|Death|21|||
164385331|NCT00439777|593779241|FG000|Treatment Period|Study terminated by sponsor|125|||
164592752|NCT01953328|594534569|FG001|Overall Study|Lost to Follow-up|0|||
164592753|NCT01953328|594534570|FG002|Overall Study|Lost to Follow-up|0|||
164592754|NCT01953328|594534571|FG003|Overall Study|Lost to Follow-up|0|||
164592755|NCT01953328|594534572|FG004|Overall Study|Lost to Follow-up|1|||
164592756|NCT01953328|594534573|FG005|Overall Study|Lost to Follow-up|0|||
164385332|NCT00439777|593779242|FG001|Treatment Period|Study terminated by sponsor|132|||
164385333|NCT00439777|593779241|FG000|Treatment Period|Site closed by investigator|0|||
164385334|NCT00439777|593779242|FG001|Treatment Period|Site closed by investigator|1|||
164385335|NCT00439777|593779241|FG000|Treatment Period|Did not take study treatment|7|||
164592757|NCT01953328|594534574|FG006|Overall Study|Lost to Follow-up|0|||
164592758|NCT01953328|594534575|FG007|Overall Study|Lost to Follow-up|0|||
164592759|NCT03987919|594534579|FG000|Overall Study|Adverse Event|1|||
164592760|NCT03987919|594534580|FG001|Overall Study|Adverse Event|4|||
164592761|NCT03987919|594534581|FG002|Overall Study|Adverse Event|1|||
164592762|NCT03987919|594534582|FG003|Overall Study|Adverse Event|3|||
164592763|NCT03987919|594534579|FG000|Overall Study|Death|4|||
164592764|NCT03987919|594534580|FG001|Overall Study|Death|4|||
164592765|NCT03987919|594534581|FG002|Overall Study|Death|4|||
164592766|NCT03987919|594534582|FG003|Overall Study|Death|1|||
164592767|NCT03987919|594534579|FG000|Overall Study|Lost to Follow-up|5|||
164592768|NCT03987919|594534580|FG001|Overall Study|Lost to Follow-up|6|||
164592769|NCT03987919|594534581|FG002|Overall Study|Lost to Follow-up|8|||
164592770|NCT03987919|594534582|FG003|Overall Study|Lost to Follow-up|12|||
164592771|NCT03987919|594534579|FG000|Overall Study|Physician Decision|0|||
164592772|NCT03987919|594534580|FG001|Overall Study|Physician Decision|2|||
164592773|NCT03987919|594534581|FG002|Overall Study|Physician Decision|0|||
164592774|NCT03987919|594534582|FG003|Overall Study|Physician Decision|4|||
164592775|NCT03987919|594534579|FG000|Overall Study|Pregnancy|1|||
164592776|NCT03987919|594534580|FG001|Overall Study|Pregnancy|0|||
164592777|NCT03987919|594534581|FG002|Overall Study|Pregnancy|1|||
164592778|NCT03987919|594534582|FG003|Overall Study|Pregnancy|1|||
164592779|NCT03987919|594534579|FG000|Overall Study|Protocol Violation|0|||
164592780|NCT03987919|594534580|FG001|Overall Study|Protocol Violation|1|||
164592781|NCT03987919|594534581|FG002|Overall Study|Protocol Violation|0|||
164592782|NCT03987919|594534582|FG003|Overall Study|Protocol Violation|0|||
164592783|NCT03987919|594534579|FG000|Overall Study|Site terminated by Sponsor|0|||
164592784|NCT03987919|594534580|FG001|Overall Study|Site terminated by Sponsor|0|||
164592785|NCT03987919|594534581|FG002|Overall Study|Site terminated by Sponsor|0|||
164592786|NCT03987919|594534582|FG003|Overall Study|Site terminated by Sponsor|1|||
164592787|NCT03987919|594534579|FG000|Overall Study|Withdrawal by Subject|7|||
164592788|NCT03987919|594534580|FG001|Overall Study|Withdrawal by Subject|7|||
164592789|NCT03987919|594534581|FG002|Overall Study|Withdrawal by Subject|8|||
164592790|NCT03987919|594534582|FG003|Overall Study|Withdrawal by Subject|4|||
164592791|NCT03987919|594534579|FG000|Overall Study|Other - as reported by the investigator|1|||
164592792|NCT03987919|594534580|FG001|Overall Study|Other - as reported by the investigator|3|||
164592793|NCT03987919|594534581|FG002|Overall Study|Other - as reported by the investigator|2|||
164702442|NCT00974974|594936025|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
164702443|NCT00974974|594936026|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
164702444|NCT00974974|594936025|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
164702445|NCT00974974|594936026|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
164702446|NCT00974974|594936025|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
164702447|NCT00974974|594936026|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
164702448|NCT00974974|594936025|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
164702449|NCT00974974|594936026|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
164702450|NCT00974974|594936025|FG000|Maintenance - Double Blind Treatment|Various|4|||
164702451|NCT00974974|594936026|FG001|Maintenance - Double Blind Treatment|Various|0|||
164702452|NCT01297465|594936027|FG000|Overall Study|Lack of Ovarian Response|1|||
164702453|NCT01297465|594936028|FG001|Overall Study|Lack of Ovarian Response|1|||
164702454|NCT01297465|594936027|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
164702455|NCT01297465|594936028|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
164702456|NCT01297465|594936027|FG000|Overall Study|No Oocytes Retrieved|1|||
164702457|NCT01297465|594936028|FG001|Overall Study|No Oocytes Retrieved|1|||
164702458|NCT01297465|594936027|FG000|Overall Study|Poor oocyte quality|0|||
164702459|NCT01297465|594936028|FG001|Overall Study|Poor oocyte quality|1|||
164702460|NCT01297465|594936027|FG000|Overall Study|No Fertilization|6|||
164385336|NCT00439777|593779242|FG001|Treatment Period|Did not take study treatment|8|||
164592794|NCT03987919|594534582|FG003|Overall Study|Other - as reported by the investigator|0|||
164592795|NCT01520324|594534587|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
164592796|NCT00502307|594534588|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
164592797|NCT00502307|594534589|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
164702461|NCT01297465|594936028|FG001|Overall Study|No Fertilization|4|||
164592798|NCT00502307|594534590|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
164592799|NCT00502307|594534588|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
164592800|NCT00502307|594534589|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
164592801|NCT00502307|594534590|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
164592802|NCT00502307|594534588|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
164592803|NCT00502307|594534589|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
164592804|NCT00502307|594534590|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
164440245|NCT01194154|593978937|FG001|Overall Study|Hemoglobin decrease|1|||
164440246|NCT01194154|593978936|FG000|Overall Study|Hemoglobin increase|12|||
164440247|NCT01194154|593978937|FG001|Overall Study|Hemoglobin increase|3|||
164440248|NCT01194154|593978936|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
164440249|NCT01194154|593978937|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
164440250|NCT01194154|593978936|FG000|Overall Study|Treatment with prohibited medication|4|||
164440251|NCT01194154|593978937|FG001|Overall Study|Treatment with prohibited medication|5|||
164440252|NCT01194154|593978936|FG000|Overall Study|Other|4|||
164440253|NCT01194154|593978937|FG001|Overall Study|Other|0|||
164440254|NCT01194154|593978936|FG000|Overall Study|Did not receive study medication|2|||
164440255|NCT01194154|593978937|FG001|Overall Study|Did not receive study medication|4|||
164440256|NCT01147341|593978938|FG000|Double Blind Period|Lack of Efficacy|1|||
164440257|NCT01147341|593978939|FG001|Double Blind Period|Lack of Efficacy|1|||
164440258|NCT01147341|593978938|FG000|Double Blind Period|Withdrawal by Subject|0|||
164440259|NCT01147341|593978939|FG001|Double Blind Period|Withdrawal by Subject|1|||
164440260|NCT01147341|593978938|FG000|Open Label Period|Lack of Efficacy|3|||
164440261|NCT01147341|593978939|FG001|Open Label Period|Lack of Efficacy|0|||
164440262|NCT01147341|593978938|FG000|Open Label Period|Subject moved|1|||
164440263|NCT01147341|593978939|FG001|Open Label Period|Subject moved|0|||
164440264|NCT01596504|593978940|FG000|Overall Study|Participant's Private Reason|0|||
164440265|NCT01596504|593978941|FG001|Overall Study|Participant's Private Reason|1|||
164440266|NCT01596504|593978942|FG002|Overall Study|Participant's Private Reason|0|||
164440267|NCT01596504|593978940|FG000|Overall Study|Adverse Event|1|||
164440268|NCT01596504|593978941|FG001|Overall Study|Adverse Event|2|||
164440269|NCT01596504|593978942|FG002|Overall Study|Adverse Event|1|||
164440270|NCT01596504|593978940|FG000|Overall Study|Withdrawal by Subject|1|||
164440271|NCT01596504|593978941|FG001|Overall Study|Withdrawal by Subject|0|||
164440272|NCT01596504|593978942|FG002|Overall Study|Withdrawal by Subject|0|||
164440273|NCT01901276|593978943|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
164440274|NCT01901276|593978944|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
164440275|NCT02314117|593978945|FG000|Overall Study|Lost to Follow-up|9|||
164440276|NCT02314117|593978946|FG001|Overall Study|Lost to Follow-up|14|||
164440277|NCT02314117|593978945|FG000|Overall Study|Withdrawal by Subject|3|||
164440278|NCT02314117|593978946|FG001|Overall Study|Withdrawal by Subject|2|||
164592805|NCT00502307|594534588|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
164592806|NCT00502307|594534589|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
164592807|NCT00502307|594534590|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
164592808|NCT00502307|594534588|FG000|Maintenance Period|Progressive disease|80|||
164592809|NCT00502307|594534589|FG001|Maintenance Period|Progressive disease|0|||
164592810|NCT00502307|594534590|FG002|Maintenance Period|Progressive disease|0|||
164592811|NCT00502307|594534588|FG000|Maintenance Period|Discontinued due to other reasons|68|||
164592812|NCT00502307|594534589|FG001|Maintenance Period|Discontinued due to other reasons|0|||
164592813|NCT00502307|594534590|FG002|Maintenance Period|Discontinued due to other reasons|0|||
164592814|NCT00748553|594534591|FG000|Overall Study|Adverse Event|0|||
164592815|NCT00748553|594534592|FG001|Overall Study|Adverse Event|1|||
164592816|NCT00748553|594534591|FG000|Overall Study|disease progression|2|||
164592817|NCT00748553|594534592|FG001|Overall Study|disease progression|0|||
164592818|NCT00748553|594534591|FG000|Overall Study|noncompliance|1|||
164592819|NCT00748553|594534592|FG001|Overall Study|noncompliance|0|||
164592820|NCT00495495|594534593|FG000|Overall Study|Protocol Violation|99|||
164592821|NCT02326467|594534595|FG000|Overall Study|Withdrawal by Subject|1|||
164592822|NCT00434512|594534596|FG000|Overall Study|Migrated/moved from study area|0|||
164592823|NCT00434512|594534597|FG001|Overall Study|Migrated/moved from study area|0|||
164592824|NCT00434512|594534598|FG002|Overall Study|Migrated/moved from study area|0|||
164592825|NCT00434512|594534599|FG003|Overall Study|Migrated/moved from study area|1|||
164592826|NCT00434512|594534600|FG004|Overall Study|Migrated/moved from study area|1|||
164592827|NCT00434512|594534601|FG005|Overall Study|Migrated/moved from study area|1|||
164592828|NCT00434512|594534596|FG000|Overall Study|Other|0|||
164592829|NCT00434512|594534597|FG001|Overall Study|Other|1|||
164592830|NCT00434512|594534598|FG002|Overall Study|Other|0|||
164592831|NCT00434512|594534599|FG003|Overall Study|Other|0|||
164592832|NCT00434512|594534600|FG004|Overall Study|Other|0|||
164592833|NCT00434512|594534601|FG005|Overall Study|Other|0|||
164592834|NCT04467164|594534602|FG000|Washout (1 Week)|Lost to Follow-up|2|||
164592835|NCT04467164|594534603|FG001|Washout (1 Week)|Lost to Follow-up|0|||
164592836|NCT02750813|594534604|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
164592837|NCT02750813|594534605|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
164592838|NCT02750813|594534604|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
164592839|NCT02750813|594534605|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
164592840|NCT01998581|594534606|FG000|Overall Study|Refused repeat treatment|20|||
164592841|NCT01998581|594534607|FG001|Overall Study|Refused repeat treatment|4|||
164592842|NCT01998581|594534606|FG000|Overall Study|Protocol Violation|1|||
164592843|NCT01998581|594534607|FG001|Overall Study|Protocol Violation|0|||
164440279|NCT05641311|593978950|FG000|Dosing Period 1|Adverse Event|1|||
164592844|NCT01998581|594534606|FG000|Overall Study|Withdrawal by Subject|8|||
164440280|NCT05641311|593978951|FG001|Dosing Period 1|Adverse Event|0|||
164440281|NCT00909363|593978952|FG000|Overall Study|Withdrawal by Subject|1|||
164440282|NCT00909363|593978953|FG001|Overall Study|Withdrawal by Subject|0|||
164440283|NCT00909363|593978954|FG002|Overall Study|Withdrawal by Subject|0|||
164440284|NCT00909363|593978952|FG000|Overall Study|Lack of Efficacy|1|||
164440285|NCT00909363|593978953|FG001|Overall Study|Lack of Efficacy|0|||
164440286|NCT00909363|593978954|FG002|Overall Study|Lack of Efficacy|0|||
164440287|NCT00922207|593978961|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
164440288|NCT00922207|593978962|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
164440289|NCT00922207|593978963|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
164440290|NCT00922207|593978961|FG000|Overall Study|Insufficient Therapeutic Response|0|||
164440291|NCT00922207|593978962|FG001|Overall Study|Insufficient Therapeutic Response|0|||
164702462|NCT01297465|594936027|FG000|Overall Study|All Embryos Discarded|0|||
164702463|NCT01297465|594936028|FG001|Overall Study|All Embryos Discarded|1|||
164702464|NCT01297465|594936027|FG000|Overall Study|Intention to Freeze all Embryos|0|||
164702465|NCT01297465|594936028|FG001|Overall Study|Intention to Freeze all Embryos|1|||
164702466|NCT00969540|594936029|FG000|Overall Study|Lost to Follow-up|1|||
164702467|NCT00969540|594936030|FG001|Overall Study|Lost to Follow-up|1|||
164702468|NCT00801099|594936031|FG000|Overall Study|Lost to Follow-up|101|||
164702469|NCT00950963|594936032|FG000|Overall Study|Lost to Follow-up|29|||
164702470|NCT00950963|594936033|FG001|Overall Study|Lost to Follow-up|24|||
164702471|NCT04647721|594936034|FG000|Overall Study|Withdrawal by Subject|0|||
164702472|NCT04647721|594936035|FG001|Overall Study|Withdrawal by Subject|2|||
164702473|NCT04647721|594936034|FG000|Overall Study|Lost to Follow-up|2|||
164702474|NCT04647721|594936035|FG001|Overall Study|Lost to Follow-up|0|||
164702475|NCT00136318|594936038|FG000|Overall Study|Adverse Event|5|||
164702476|NCT00136318|594936039|FG001|Overall Study|Adverse Event|5|||
164702477|NCT00136318|594936038|FG000|Overall Study|Withdrawal by Subject|2|||
164702478|NCT00136318|594936039|FG001|Overall Study|Withdrawal by Subject|2|||
164702479|NCT02005887|594936040|FG000|Overall Study|Protocol Violation|0|||
164702480|NCT02005887|594936041|FG001|Overall Study|Protocol Violation|2|||
164702481|NCT04700280|594936043|FG000|Overall Study|Adverse Event|4|||
164702482|NCT04700280|594936044|FG001|Overall Study|Adverse Event|0|||
164702483|NCT04700280|594936043|FG000|Overall Study|Lack of Efficacy|1|||
164702484|NCT04700280|594936044|FG001|Overall Study|Lack of Efficacy|0|||
164385337|NCT00439777|593779241|FG000|Treatment Period|Adverse Event|111|||
164385338|NCT00439777|593779242|FG001|Treatment Period|Adverse Event|92|||
164385339|NCT00439777|593779241|FG000|Treatment Period|Protocol Violation|23|||
164385340|NCT00439777|593779242|FG001|Treatment Period|Protocol Violation|30|||
164385341|NCT00439777|593779241|FG000|Treatment Period|Withdrawal by Subject|66|||
164385342|NCT00439777|593779242|FG001|Treatment Period|Withdrawal by Subject|118|||
164385343|NCT00439777|593779241|FG000|Treatment Period|Lack of Efficacy|1|||
164385344|NCT00439777|593779242|FG001|Treatment Period|Lack of Efficacy|4|||
164385345|NCT00439777|593779241|FG000|Treatment Period|Lost to Follow-up|8|||
164385346|NCT00439777|593779242|FG001|Treatment Period|Lost to Follow-up|10|||
164385347|NCT00439777|593779241|FG000|Treatment Period|Protocol driven decision point|1|||
164385348|NCT00439777|593779242|FG001|Treatment Period|Protocol driven decision point|3|||
164385349|NCT00439777|593779241|FG000|Treatment Period|Physician Decision|7|||
164385350|NCT00439777|593779242|FG001|Treatment Period|Physician Decision|18|||
164385351|NCT00439777|593779241|FG000|Treatment Period|Clinical endpoint reached|26|||
164385352|NCT00439777|593779242|FG001|Treatment Period|Clinical endpoint reached|13|||
164385353|NCT00439777|593779241|FG000|Treatment Period|Technical problems|3|||
164385354|NCT00439777|593779242|FG001|Treatment Period|Technical problems|1|||
164385355|NCT00439777|593779241|FG000|Treatment Period|Participant convenience|12|||
164385356|NCT00439777|593779242|FG001|Treatment Period|Participant convenience|8|||
164385357|NCT00439777|593779241|FG000|Observational Period|Protocol Violation|0|||
164385358|NCT00439777|593779242|FG001|Observational Period|Protocol Violation|2|||
164385359|NCT00439777|593779241|FG000|Observational Period|Withdrawal by Subject|9|||
164385360|NCT00439777|593779242|FG001|Observational Period|Withdrawal by Subject|5|||
164385361|NCT00439777|593779241|FG000|Observational Period|Lost to Follow-up|1|||
164385362|NCT00439777|593779242|FG001|Observational Period|Lost to Follow-up|11|||
164385363|NCT00439777|593779241|FG000|Observational Period|Death|27|||
164385364|NCT00439777|593779242|FG001|Observational Period|Death|20|||
164385365|NCT00439777|593779241|FG000|Observational Period|Study terminated by sponsor|3|||
164385366|NCT00439777|593779242|FG001|Observational Period|Study terminated by sponsor|1|||
164385367|NCT00439777|593779241|FG000|Observational Period|Protocol driven decision point|0|||
164385368|NCT00439777|593779242|FG001|Observational Period|Protocol driven decision point|1|||
164385369|NCT00439777|593779241|FG000|Observational Period|Lack of Efficacy|1|||
164385370|NCT00439777|593779242|FG001|Observational Period|Lack of Efficacy|0|||
164385371|NCT00439777|593779241|FG000|Observational Period|Technical problems|0|||
164440292|NCT00922207|593978963|FG002|Overall Study|Insufficient Therapeutic Response|1|||
164440293|NCT00922207|593978961|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
164702485|NCT04700280|594936043|FG000|Overall Study|Study terminated by sponsor|5|||
164702486|NCT04700280|594936044|FG001|Overall Study|Study terminated by sponsor|3|||
164702487|NCT04700280|594936043|FG000|Overall Study|Other than specified|1|||
164385372|NCT00439777|593779242|FG001|Observational Period|Technical problems|1|||
164385373|NCT00661492|593779243|FG000|Overall Study|Adverse Event|16|||
164385374|NCT00661492|593779244|FG001|Overall Study|Adverse Event|13|||
164385375|NCT00661492|593779243|FG000|Overall Study|Disease Progression|44|||
164385376|NCT00661492|593779244|FG001|Overall Study|Disease Progression|14|||
164385377|NCT00661492|593779243|FG000|Overall Study|Patient Request|6|||
164385378|NCT00661492|593779244|FG001|Overall Study|Patient Request|1|||
164385379|NCT00661492|593779243|FG000|Overall Study|Investigator Request|1|||
164385380|NCT00661492|593779244|FG001|Overall Study|Investigator Request|0|||
164385381|NCT00661492|593779243|FG000|Overall Study|Lost to Follow-up|0|||
164702488|NCT04700280|594936044|FG001|Overall Study|Other than specified|0|||
164702489|NCT02749292|594936045|FG000|Overall Study|Physician Decision|1|||
164702490|NCT02749292|594936046|FG001|Overall Study|Physician Decision|0|||
164702491|NCT02749292|594936045|FG000|Overall Study|Withdrawal by Subject|5|||
164702492|NCT02749292|594936046|FG001|Overall Study|Withdrawal by Subject|7|||
164702493|NCT02749292|594936045|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
164702494|NCT02749292|594936046|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
164702495|NCT02749292|594936045|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
164702496|NCT02749292|594936046|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
164702497|NCT02749292|594936045|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
164702498|NCT02749292|594936046|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
164702499|NCT02749292|594936045|FG000|Overall Study|Adverse Event|4|||
164702500|NCT02749292|594936046|FG001|Overall Study|Adverse Event|1|||
164702501|NCT02749292|594936045|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
164702502|NCT02749292|594936046|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
164385382|NCT00661492|593779244|FG001|Overall Study|Lost to Follow-up|1|||
164385383|NCT00661492|593779243|FG000|Overall Study|Other|1|||
164385384|NCT00661492|593779244|FG001|Overall Study|Other|0|||
164385385|NCT00803634|593779245|FG000|Overall Study|Withdrew Consent|1|||
164385386|NCT00803634|593779246|FG001|Overall Study|Withdrew Consent|0|||
164385387|NCT00803634|593779245|FG000|Overall Study|Lost to Follow-up|2|||
164385388|NCT00803634|593779246|FG001|Overall Study|Lost to Follow-up|3|||
164385389|NCT00803634|593779245|FG000|Overall Study|Death|3|||
164385390|NCT00803634|593779246|FG001|Overall Study|Death|2|||
164385391|NCT03791398|593779249|FG000|Overall Study|Progression of Disease Under Study|2|||
164702503|NCT02749292|594936045|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
164702504|NCT02749292|594936046|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
164702505|NCT02749292|594936045|FG000|Overall Study|Requiring glucocorticoids|0|||
164702506|NCT02749292|594936046|FG001|Overall Study|Requiring glucocorticoids|3|||
164702507|NCT02749292|594936045|FG000|Overall Study|Cancer|1|||
164702508|NCT02749292|594936046|FG001|Overall Study|Cancer|0|||
164702509|NCT00251641|594936047|FG000|Overall Study|Adverse Event|80|||
164702510|NCT00251641|594936048|FG001|Overall Study|Adverse Event|8|||
164702511|NCT00251641|594936047|FG000|Overall Study|Lack of Efficacy|2|||
164702512|NCT00251641|594936048|FG001|Overall Study|Lack of Efficacy|1|||
164702513|NCT00251641|594936047|FG000|Overall Study|Progression of Disease|0|||
164702514|NCT00251641|594936048|FG001|Overall Study|Progression of Disease|2|||
164702515|NCT00251641|594936047|FG000|Overall Study|Lost to Follow-up|3|||
164702516|NCT00251641|594936048|FG001|Overall Study|Lost to Follow-up|3|||
164702517|NCT00251641|594936047|FG000|Overall Study|Withdrawal by Subject|6|||
164702518|NCT00251641|594936048|FG001|Overall Study|Withdrawal by Subject|8|||
164702519|NCT00251641|594936047|FG000|Overall Study|Protocol Violation|10|||
164702520|NCT00251641|594936048|FG001|Overall Study|Protocol Violation|2|||
164702521|NCT00251641|594936047|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
164702522|NCT00251641|594936048|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
164702523|NCT00251641|594936047|FG000|Overall Study|Switched Treatment|9|||
164702524|NCT00251641|594936048|FG001|Overall Study|Switched Treatment|63|||
164702525|NCT02093221|594936049|FG000|Overall Study|Adverse Event|1|||
164702526|NCT02093221|594936050|FG001|Overall Study|Adverse Event|0|||
164702527|NCT02093221|594936051|FG002|Overall Study|Adverse Event|0|||
164702528|NCT02093221|594936052|FG003|Overall Study|Adverse Event|0|||
164702529|NCT02093221|594936053|FG004|Overall Study|Adverse Event|0|||
164702530|NCT02093221|594936049|FG000|Overall Study|Withdrawal by Subject|1|||
164702531|NCT02093221|594936050|FG001|Overall Study|Withdrawal by Subject|1|||
164702532|NCT02093221|594936051|FG002|Overall Study|Withdrawal by Subject|4|||
164385392|NCT03791398|593779250|FG001|Overall Study|Progression of Disease Under Study|0|||
164385393|NCT03791398|593779251|FG002|Overall Study|Progression of Disease Under Study|0|||
164385394|NCT01072201|593779252|FG000|Overall Study|Lost to Follow-up|0|||
164385395|NCT01072201|593779253|FG001|Overall Study|Lost to Follow-up|1|||
164702533|NCT02093221|594936052|FG003|Overall Study|Withdrawal by Subject|1|||
164702534|NCT02093221|594936053|FG004|Overall Study|Withdrawal by Subject|1|||
164702535|NCT02093221|594936049|FG000|Overall Study|Lost to Follow-up|2|||
164702536|NCT02093221|594936050|FG001|Overall Study|Lost to Follow-up|0|||
164385396|NCT00818441|593779257|FG000|Overall Study|Death|69|||
164385397|NCT00818441|593779258|FG001|Overall Study|Death|26|||
164385398|NCT00818441|593779257|FG000|Overall Study|Other|5|||
164385399|NCT00818441|593779258|FG001|Overall Study|Other|0|||
164385400|NCT00818441|593779257|FG000|Overall Study|Lost to Follow-up|2|||
164385401|NCT00818441|593779258|FG001|Overall Study|Lost to Follow-up|1|||
164385402|NCT00818441|593779257|FG000|Overall Study|Withdrawal by Subject|2|||
164385403|NCT00818441|593779258|FG001|Overall Study|Withdrawal by Subject|0|||
164385404|NCT00818441|593779257|FG000|Overall Study|Adverse Event|0|||
164385405|NCT00818441|593779258|FG001|Overall Study|Adverse Event|1|||
164385406|NCT00818441|593779257|FG000|Overall Study|Study terminated by sponsor|11|||
164385407|NCT00818441|593779258|FG001|Overall Study|Study terminated by sponsor|2|||
164385408|NCT00774995|593779264|FG000|Overall Study|Protocol Violation|0|||
164385409|NCT00774995|593779265|FG001|Overall Study|Protocol Violation|0|||
164385410|NCT00774995|593779266|FG002|Overall Study|Protocol Violation|1|||
164385411|NCT00774995|593779267|FG003|Overall Study|Protocol Violation|0|||
164385412|NCT05349617|593781176|FG000|Overall Study|Death|1|||
164385413|NCT05349617|593781177|FG001|Overall Study|Death|1|||
164385414|NCT05349617|593781176|FG000|Overall Study|Lost to Follow-up|3|||
164385415|NCT05349617|593781177|FG001|Overall Study|Lost to Follow-up|8|||
164385416|NCT05349617|593781176|FG000|Overall Study|Withdrawal by Subject|2|||
164385417|NCT05349617|593781177|FG001|Overall Study|Withdrawal by Subject|10|||
164385418|NCT04401579|593781182|FG000|Overall Study|Death|23|||
164385419|NCT04401579|593781183|FG001|Overall Study|Death|36|||
164385420|NCT04401579|593781182|FG000|Overall Study|Lost to Follow-up|40|||
164385421|NCT04401579|593781183|FG001|Overall Study|Lost to Follow-up|41|||
164385422|NCT04401579|593781182|FG000|Overall Study|Withdrawal by Subject|8|||
164385423|NCT04401579|593781183|FG001|Overall Study|Withdrawal by Subject|16|||
164385424|NCT04401579|593781182|FG000|Overall Study|Physician Decision|1|||
164385425|NCT04401579|593781183|FG001|Overall Study|Physician Decision|2|||
164385426|NCT04401579|593781182|FG000|Overall Study|Became ineligible after enrollment|1|||
164385427|NCT04401579|593781183|FG001|Overall Study|Became ineligible after enrollment|1|||
164385428|NCT04401579|593781182|FG000|Overall Study|Enrolled but treatment not administered|7|||
164385429|NCT04401579|593781183|FG001|Overall Study|Enrolled but treatment not administered|9|||
164385430|NCT04401579|593781182|FG000|Overall Study|Adverse Event|2|||
164385431|NCT04401579|593781183|FG001|Overall Study|Adverse Event|1|||
164385432|NCT04401579|593781182|FG000|Overall Study|Scheduling error|1|||
164385433|NCT04401579|593781183|FG001|Overall Study|Scheduling error|2|||
164385434|NCT04401579|593781182|FG000|Overall Study|Transferred to another hospital|1|||
164385435|NCT04401579|593781183|FG001|Overall Study|Transferred to another hospital|2|||
164385436|NCT00489970|593781184|FG000|Persistence Year 9|Lost to Follow-up|2|||
164385437|NCT00489970|593781185|FG001|Persistence Year 9|Lost to Follow-up|2|||
164385438|NCT00489970|593781186|FG002|Persistence Year 9|Lost to Follow-up|3|||
164385439|NCT00489970|593781184|FG000|Persistence Year 9|Other|1|||
164385440|NCT00489970|593781185|FG001|Persistence Year 9|Other|0|||
164385441|NCT00489970|593781186|FG002|Persistence Year 9|Other|2|||
164385442|NCT00896168|593781189|FG000|Overall Study|Adverse Event|4|||
164385443|NCT00896168|593781190|FG001|Overall Study|Adverse Event|7|||
164385444|NCT00896168|593781189|FG000|Overall Study|Treatment failure|8|||
164385445|NCT00896168|593781190|FG001|Overall Study|Treatment failure|10|||
164385446|NCT00896168|593781189|FG000|Overall Study|Lost to Follow-up|1|||
164385447|NCT00896168|593781190|FG001|Overall Study|Lost to Follow-up|1|||
164385448|NCT00896168|593781189|FG000|Overall Study|Other|1|||
164385449|NCT00896168|593781190|FG001|Overall Study|Other|1|||
164385450|NCT00902304|593781191|FG000|Overall Study|Adverse Event|4|||
164385451|NCT00902304|593781192|FG001|Overall Study|Adverse Event|10|||
164385452|NCT00902304|593781193|FG002|Overall Study|Adverse Event|25|||
164385453|NCT00902304|593781191|FG000|Overall Study|Investigator discretion|3|||
164385454|NCT00902304|593781192|FG001|Overall Study|Investigator discretion|5|||
164385455|NCT00902304|593781193|FG002|Overall Study|Investigator discretion|13|||
164592845|NCT01998581|594534607|FG001|Overall Study|Withdrawal by Subject|1|||
164385456|NCT00902304|593781191|FG000|Overall Study|Lost to Follow-up|7|||
164385457|NCT00902304|593781192|FG001|Overall Study|Lost to Follow-up|7|||
164385458|NCT00902304|593781193|FG002|Overall Study|Lost to Follow-up|7|||
164385459|NCT00902304|593781191|FG000|Overall Study|Protocol Violation|9|||
164592846|NCT01998581|594534606|FG000|Overall Study|Lost to Follow-up|12|||
164592847|NCT01998581|594534607|FG001|Overall Study|Lost to Follow-up|4|||
164592848|NCT01998581|594534606|FG000|Overall Study|Adverse Event|1|||
164385460|NCT00902304|593781192|FG001|Overall Study|Protocol Violation|18|||
164385461|NCT00902304|593781193|FG002|Overall Study|Protocol Violation|20|||
164385462|NCT00902304|593781191|FG000|Overall Study|Withdrawal by Subject|32|||
164385463|NCT00902304|593781192|FG001|Overall Study|Withdrawal by Subject|22|||
164385464|NCT00902304|593781193|FG002|Overall Study|Withdrawal by Subject|43|||
164385465|NCT00902304|593781191|FG000|Overall Study|includes pregnancy|3|||
164385466|NCT00902304|593781192|FG001|Overall Study|includes pregnancy|9|||
164592849|NCT01998581|594534607|FG001|Overall Study|Adverse Event|1|||
164385467|NCT00902304|593781193|FG002|Overall Study|includes pregnancy|2|||
164385468|NCT00003457|593781197|FG000|Overall Study|Not evaluable|9|||
164385469|NCT01054729|593781198|FG000|Overall Study|Randomized but Not Treated|0|||
164385470|NCT01054729|593781199|FG001|Overall Study|Randomized but Not Treated|1|||
164385471|NCT01054729|593781200|FG002|Overall Study|Randomized but Not Treated|0|||
164385472|NCT01054729|593781201|FG003|Overall Study|Randomized but Not Treated|0|||
164592850|NCT01998581|594534606|FG000|Overall Study|Other reasons|3|||
164385473|NCT01054729|593781198|FG000|Overall Study|Adverse Event|1|||
164385474|NCT01054729|593781199|FG001|Overall Study|Adverse Event|1|||
164385475|NCT01054729|593781200|FG002|Overall Study|Adverse Event|2|||
164385476|NCT01054729|593781201|FG003|Overall Study|Adverse Event|1|||
164385477|NCT01054729|593781198|FG000|Overall Study|Withdrawal by Subject|1|||
164385478|NCT01054729|593781199|FG001|Overall Study|Withdrawal by Subject|0|||
164385479|NCT01054729|593781200|FG002|Overall Study|Withdrawal by Subject|1|||
164702537|NCT02093221|594936051|FG002|Overall Study|Lost to Follow-up|1|||
164702538|NCT02093221|594936052|FG003|Overall Study|Lost to Follow-up|1|||
164702539|NCT02093221|594936053|FG004|Overall Study|Lost to Follow-up|0|||
164702540|NCT02093221|594936049|FG000|Overall Study|Death|0|||
164702541|NCT02093221|594936050|FG001|Overall Study|Death|1|||
164702542|NCT02093221|594936051|FG002|Overall Study|Death|0|||
164702543|NCT02093221|594936052|FG003|Overall Study|Death|0|||
164702544|NCT02093221|594936053|FG004|Overall Study|Death|0|||
164702545|NCT02093221|594936049|FG000|Overall Study|Protocol Violation|0|||
164702546|NCT02093221|594936050|FG001|Overall Study|Protocol Violation|1|||
164702547|NCT02093221|594936051|FG002|Overall Study|Protocol Violation|0|||
164702548|NCT02093221|594936052|FG003|Overall Study|Protocol Violation|0|||
164702549|NCT02093221|594936053|FG004|Overall Study|Protocol Violation|0|||
164702550|NCT02093221|594936049|FG000|Overall Study|Study termination|6|||
164702551|NCT02093221|594936050|FG001|Overall Study|Study termination|5|||
164702552|NCT02093221|594936051|FG002|Overall Study|Study termination|4|||
164702553|NCT02093221|594936052|FG003|Overall Study|Study termination|6|||
164702554|NCT02093221|594936053|FG004|Overall Study|Study termination|7|||
164702555|NCT00876018|594936054|FG000|Overall Study|Lost to Follow-up|0|||
164702556|NCT00876018|594936055|FG001|Overall Study|Lost to Follow-up|1|||
164702557|NCT00876018|594936056|FG002|Overall Study|Lost to Follow-up|1|||
164702558|NCT00876018|594936054|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
164702559|NCT00876018|594936055|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
164702560|NCT00876018|594936056|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
164702561|NCT00257920|594936057|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
164702562|NCT00257920|594936058|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
164702563|NCT00257920|594936057|FG000|Period: Second Intervention|Other|2|||
164702564|NCT00257920|594936058|FG001|Period: Second Intervention|Other|1|||
164702565|NCT01230892|594936059|FG000|Overall Study|Withdrawal by Subject|1|||
164702566|NCT01230892|594936060|FG001|Overall Study|Withdrawal by Subject|1|||
164702567|NCT01230892|594936059|FG000|Overall Study|Lost to Follow-up|2|||
164702568|NCT01230892|594936060|FG001|Overall Study|Lost to Follow-up|0|||
164702569|NCT00725621|594936063|FG000|Overall Study|Adverse Event|25|||
164702570|NCT00725621|594936063|FG000|Overall Study|Lack of Efficacy|46|||
164702571|NCT00725621|594936063|FG000|Overall Study|Withdrawal by Subject|57|||
164702572|NCT00725621|594936063|FG000|Overall Study|Physician Decision|19|||
164702573|NCT00725621|594936063|FG000|Overall Study|Lost to Follow-up|52|||
164702574|NCT00725621|594936063|FG000|Overall Study|Non-compliance|8|||
164702575|NCT00725621|594936063|FG000|Overall Study|Continued treatment by other physician|6|||
164702576|NCT00725621|594936063|FG000|Overall Study|Switched to other study|1|||
164702577|NCT00725621|594936063|FG000|Overall Study|Switched to other drug|1|||
164702578|NCT00725621|594936063|FG000|Overall Study|Prepared for elective surgery|1|||
164702579|NCT00725621|594936063|FG000|Overall Study|Reason not specified|55|||
164385480|NCT01054729|593781201|FG003|Overall Study|Withdrawal by Subject|0|||
164385481|NCT01054729|593781198|FG000|Overall Study|Lost to Follow-up|0|||
164385482|NCT01054729|593781199|FG001|Overall Study|Lost to Follow-up|1|||
164385483|NCT01054729|593781200|FG002|Overall Study|Lost to Follow-up|0|||
164385484|NCT01054729|593781201|FG003|Overall Study|Lost to Follow-up|0|||
164385485|NCT01054729|593781198|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
164702580|NCT00062751|594936064|FG000|Overall Study|Disease progression|24|||
164702581|NCT00062751|594936065|FG001|Overall Study|Disease progression|17|||
164702582|NCT00062751|594936066|FG002|Overall Study|Disease progression|24|||
164702583|NCT00062751|594936067|FG003|Overall Study|Disease progression|2|||
164702584|NCT00062751|594936068|FG004|Overall Study|Disease progression|2|||
164702585|NCT00062751|594936064|FG000|Overall Study|Adverse Event|4|||
164702586|NCT00062751|594936065|FG001|Overall Study|Adverse Event|7|||
164702587|NCT00062751|594936066|FG002|Overall Study|Adverse Event|2|||
164702588|NCT00062751|594936067|FG003|Overall Study|Adverse Event|2|||
164702589|NCT00062751|594936068|FG004|Overall Study|Adverse Event|2|||
164702590|NCT00062751|594936064|FG000|Overall Study|Other|2|||
164702591|NCT00062751|594936065|FG001|Overall Study|Other|3|||
164702592|NCT00062751|594936066|FG002|Overall Study|Other|1|||
164702593|NCT00062751|594936067|FG003|Overall Study|Other|0|||
164702594|NCT00062751|594936068|FG004|Overall Study|Other|1|||
164702595|NCT00062751|594936064|FG000|Overall Study|Withdrawal by Subject|1|||
164702596|NCT00062751|594936065|FG001|Overall Study|Withdrawal by Subject|2|||
164702597|NCT00062751|594936066|FG002|Overall Study|Withdrawal by Subject|2|||
164702598|NCT00062751|594936067|FG003|Overall Study|Withdrawal by Subject|1|||
164385486|NCT01054729|593781199|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
164702599|NCT00062751|594936068|FG004|Overall Study|Withdrawal by Subject|0|||
164702600|NCT00062751|594936064|FG000|Overall Study|Symptomatic deterioration|1|||
164702601|NCT00062751|594936065|FG001|Overall Study|Symptomatic deterioration|1|||
164385487|NCT01054729|593781200|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
164385488|NCT01054729|593781201|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
164385489|NCT01054729|593781198|FG000|Overall Study|Non-responder|1|||
164385490|NCT01054729|593781199|FG001|Overall Study|Non-responder|0|||
164385491|NCT01054729|593781200|FG002|Overall Study|Non-responder|1|||
164385492|NCT01054729|593781201|FG003|Overall Study|Non-responder|1|||
164385493|NCT01054729|593781198|FG000|Overall Study|PEG/RBV Non-responder|1|||
164385494|NCT01054729|593781199|FG001|Overall Study|PEG/RBV Non-responder|0|||
164385495|NCT01054729|593781200|FG002|Overall Study|PEG/RBV Non-responder|1|||
164385496|NCT01054729|593781201|FG003|Overall Study|PEG/RBV Non-responder|0|||
164385497|NCT01054729|593781198|FG000|Overall Study|Personal/Obligations|0|||
164385498|NCT01054729|593781199|FG001|Overall Study|Personal/Obligations|1|||
164385499|NCT01054729|593781200|FG002|Overall Study|Personal/Obligations|0|||
164385500|NCT01054729|593781201|FG003|Overall Study|Personal/Obligations|0|||
164385501|NCT01054729|593781198|FG000|Overall Study|Subject moved|0|||
164385502|NCT01054729|593781199|FG001|Overall Study|Subject moved|0|||
164385503|NCT01054729|593781200|FG002|Overall Study|Subject moved|1|||
164385504|NCT01054729|593781201|FG003|Overall Study|Subject moved|0|||
164385505|NCT01054729|593781198|FG000|Overall Study|Lack of Efficacy|0|||
164385506|NCT01054729|593781199|FG001|Overall Study|Lack of Efficacy|0|||
164385507|NCT01054729|593781200|FG002|Overall Study|Lack of Efficacy|0|||
164385508|NCT01054729|593781201|FG003|Overall Study|Lack of Efficacy|1|||
164702602|NCT00062751|594936066|FG002|Overall Study|Symptomatic deterioration|0|||
164385509|NCT01148810|593781202|FG000|Overall Study|Adverse Event|0|||
164385510|NCT01148810|593781203|FG001|Overall Study|Adverse Event|2|||
164385511|NCT01148810|593781202|FG000|Overall Study|Lack of Efficacy|0|||
164385512|NCT01148810|593781203|FG001|Overall Study|Lack of Efficacy|1|||
164385513|NCT01148810|593781202|FG000|Overall Study|Withdrawal by Subject|0|||
164385514|NCT01148810|593781203|FG001|Overall Study|Withdrawal by Subject|2|||
164385515|NCT01148810|593781202|FG000|Overall Study|Protocol Violation|1|||
164385516|NCT01148810|593781203|FG001|Overall Study|Protocol Violation|0|||
164702603|NCT00062751|594936067|FG003|Overall Study|Symptomatic deterioration|0|||
164385517|NCT02731131|593781209|FG000|Overall Study|Psychiatric Disorder|0|||
164385518|NCT02731131|593781210|FG001|Overall Study|Psychiatric Disorder|1|||
164385519|NCT02731131|593781209|FG000|Overall Study|Refused Therapy|0|||
164385520|NCT02731131|593781210|FG001|Overall Study|Refused Therapy|1|||
164385521|NCT04831736|593781217|FG000|Overall Study|Withdrawal by Subject|0|||
164385522|NCT04831736|593781218|FG001|Overall Study|Withdrawal by Subject|1|||
164385523|NCT00795600|593781219|FG000|Overall Study|Adverse Event|1|||
164702604|NCT00062751|594936068|FG004|Overall Study|Symptomatic deterioration|1|||
164702605|NCT00062751|594936064|FG000|Overall Study|Death|1|||
164702606|NCT00062751|594936065|FG001|Overall Study|Death|0|||
164702607|NCT00062751|594936066|FG002|Overall Study|Death|1|||
164702608|NCT00062751|594936067|FG003|Overall Study|Death|0|||
164702609|NCT00062751|594936068|FG004|Overall Study|Death|0|||
164702610|NCT01000493|594936069|FG000|Overall Study|Adverse Event|3|||
164702611|NCT01000493|594936070|FG001|Overall Study|Adverse Event|6|||
164702612|NCT01000493|594936069|FG000|Overall Study|Lack of Efficacy|1|||
164702613|NCT01000493|594936070|FG001|Overall Study|Lack of Efficacy|1|||
164702614|NCT01000493|594936069|FG000|Overall Study|Protocol Violation|1|||
164702615|NCT01000493|594936070|FG001|Overall Study|Protocol Violation|8|||
164702616|NCT01000493|594936069|FG000|Overall Study|Study closed/terminated|25|||
164702617|NCT01000493|594936070|FG001|Overall Study|Study closed/terminated|23|||
164702618|NCT01000493|594936069|FG000|Overall Study|Lost to Follow-up|5|||
164702619|NCT01000493|594936070|FG001|Overall Study|Lost to Follow-up|9|||
164702620|NCT01000493|594936069|FG000|Overall Study|Physician Decision|1|||
164702621|NCT01000493|594936070|FG001|Overall Study|Physician Decision|1|||
164702622|NCT01000493|594936069|FG000|Overall Study|Withdrawal by Subject|3|||
164702623|NCT01000493|594936070|FG001|Overall Study|Withdrawal by Subject|7|||
164385524|NCT00795600|593781220|FG001|Overall Study|Adverse Event|1|||
164385525|NCT00795600|593781219|FG000|Overall Study|Protocol Violation|1|||
164385526|NCT00795600|593781220|FG001|Overall Study|Protocol Violation|2|||
164385527|NCT00795600|593781219|FG000|Overall Study|Withdrawal by Subject|1|||
164385528|NCT00795600|593781220|FG001|Overall Study|Withdrawal by Subject|0|||
164385529|NCT00795600|593781219|FG000|Overall Study|Unclassified|1|||
164385530|NCT00795600|593781220|FG001|Overall Study|Unclassified|1|||
164385531|NCT01659021|593781221|FG000|Main Study|Adverse Event|2|||
164385532|NCT01659021|593781222|FG001|Main Study|Adverse Event|3|||
164385533|NCT01659021|593781221|FG000|Main Study|Lost to Follow-up|1|||
164385534|NCT01659021|593781222|FG001|Main Study|Lost to Follow-up|0|||
164385535|NCT01659021|593781221|FG000|Main Study|Unknown Reasons|2|||
164385536|NCT01659021|593781222|FG001|Main Study|Unknown Reasons|1|||
164702624|NCT03629028|594936071|FG000|Overall Study|Lost to Follow-up|26|||
164702625|NCT03629028|594936072|FG001|Overall Study|Lost to Follow-up|23|||
164702626|NCT03629028|594936071|FG000|Overall Study|Pregnancy|4|||
164702627|NCT03629028|594936072|FG001|Overall Study|Pregnancy|2|||
164702628|NCT03629028|594936071|FG000|Overall Study|intolerance to examination|2|||
164702629|NCT03629028|594936072|FG001|Overall Study|intolerance to examination|0|||
164702630|NCT03828448|594936073|FG000|Overall Study|Sponsor's Discretion|34|||
164702631|NCT02192164|594936077|FG000|Overall Study|Other|8|||
164702632|NCT02192164|594936077|FG000|Overall Study|Withdrawal by Subject|1|||
164702633|NCT02192164|594936077|FG000|Overall Study|Physician Decision|4|||
164702634|NCT02192164|594936077|FG000|Overall Study|Did not meet the exclusion criteria|1|||
164702635|NCT03123861|594936078|FG000|Overall Study|Protocol Violation|1|||
164702636|NCT03123861|594936079|FG001|Overall Study|Protocol Violation|1|||
164702637|NCT03123861|594936078|FG000|Overall Study|Withdrawal by Subject|2|||
164702638|NCT03123861|594936079|FG001|Overall Study|Withdrawal by Subject|2|||
164702639|NCT04932941|594936080|FG000|Overall Study|Lost to Follow-up|3|||
164702640|NCT04932941|594936081|FG001|Overall Study|Lost to Follow-up|1|||
164702641|NCT04932941|594936080|FG000|Overall Study|Withdrawal by Subject|7|||
164702642|NCT04932941|594936081|FG001|Overall Study|Withdrawal by Subject|4|||
164702643|NCT04932941|594936080|FG000|Overall Study|Other|4|||
164702644|NCT04932941|594936081|FG001|Overall Study|Other|2|||
164702645|NCT02394730|594936082|FG000|Overall Study|Lost to Follow-up|1|||
164702646|NCT02394730|594936083|FG001|Overall Study|Lost to Follow-up|0|||
164702647|NCT02394730|594936082|FG000|Overall Study|Withdrawal by Subject|0|||
164702648|NCT02394730|594936083|FG001|Overall Study|Withdrawal by Subject|1|||
164702649|NCT00588640|594936084|FG000|Overall Study|Physician Decision|1|||
164702650|NCT00588640|594936084|FG000|Overall Study|Ineligible Patient|1|||
164702651|NCT01393730|594936085|FG000|Overall Study|Withdrawal by Subject|3|||
164702652|NCT01393730|594936085|FG000|Overall Study|Other|2|||
164702653|NCT01393730|594936085|FG000|Overall Study|Adverse Event|1|||
164702654|NCT00448136|594936089|FG000|Overall Study|Death|3|||
164385537|NCT01659021|593781221|FG000|Main Study|Physician Decision|34|||
164702655|NCT00448136|594936090|FG001|Overall Study|Death|8|||
164702656|NCT00448136|594936089|FG000|Overall Study|Investigator's decision (progression)|1|||
164702657|NCT00448136|594936090|FG001|Overall Study|Investigator's decision (progression)|0|||
164702658|NCT03407430|594936093|FG000|Washout|Protocol Violation|1|||
164702659|NCT03407430|594936094|FG001|Washout|Protocol Violation|0|||
164702660|NCT00922987|594936096|FG000|Overall Study|Insufficient clinical response|1|||
164702661|NCT00922987|594936096|FG000|Overall Study|Protocol Violation|2|||
164702662|NCT00922987|594936096|FG000|Overall Study|Adverse Event|1|||
164385538|NCT01659021|593781222|FG001|Main Study|Physician Decision|16|||
164385539|NCT01659021|593781221|FG000|Main Study|Withdrawal by Subject|19|||
164385540|NCT01659021|593781222|FG001|Main Study|Withdrawal by Subject|16|||
164385541|NCT01659021|593781221|FG000|Main Study|Study Terminated by Sponsor|16|||
164385542|NCT01659021|593781222|FG001|Main Study|Study Terminated by Sponsor|1|||
164385543|NCT01659021|593781221|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
164385544|NCT01659021|593781222|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
164385545|NCT01659021|593781221|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
164385546|NCT01659021|593781222|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
164385547|NCT01233817|593781223|FG000|Overall Study|Lost to Follow-up|1|||
164385548|NCT01233817|593781223|FG000|Overall Study|Withdrawal by Subject|2|||
164385549|NCT01248884|593781224|FG000|Overall Study|Withdrawal by Subject|1|||
164385550|NCT01248884|593781225|FG001|Overall Study|Withdrawal by Subject|3|||
164385551|NCT01248884|593781226|FG002|Overall Study|Withdrawal by Subject|1|||
164385552|NCT01248884|593781224|FG000|Overall Study|Adverse Event|1|||
164385553|NCT01248884|593781225|FG001|Overall Study|Adverse Event|0|||
164385554|NCT01248884|593781226|FG002|Overall Study|Adverse Event|0|||
164385555|NCT00840970|593781229|FG000|Overall Study|Adverse Event|0|||
164385556|NCT00840970|593781230|FG001|Overall Study|Adverse Event|0|||
164385557|NCT00840970|593781231|FG002|Overall Study|Adverse Event|1|||
164385558|NCT00504829|593781232|FG000|Overall Study|Protocol Violation|6|||
164385559|NCT00504829|593781233|FG001|Overall Study|Protocol Violation|4|||
164385560|NCT00504829|593781234|FG002|Overall Study|Protocol Violation|10|||
164385561|NCT03465540|593781235|FG000|Overall Study|Withdrawal by Subject|0|||
164385562|NCT03465540|593781236|FG001|Overall Study|Withdrawal by Subject|0|||
164385563|NCT03465540|593781237|FG002|Overall Study|Withdrawal by Subject|1|||
164385564|NCT03465540|593781238|FG003|Overall Study|Withdrawal by Subject|1|||
164385565|NCT03465540|593781239|FG004|Overall Study|Withdrawal by Subject|1|||
164385566|NCT03465540|593781240|FG005|Overall Study|Withdrawal by Subject|0|||
164385567|NCT03465540|593781235|FG000|Overall Study|Lost to Follow-up|0|||
164385568|NCT03465540|593781236|FG001|Overall Study|Lost to Follow-up|1|||
164702663|NCT03510182|594936097|FG000|Overall Study|Withdrawal by Subject|2|||
164702664|NCT00375492|594936098|FG000|Overall Study|Adverse Event|4|||
164702665|NCT00375492|594936099|FG001|Overall Study|Adverse Event|5|||
164702666|NCT00375492|594936098|FG000|Overall Study|Entry Criteria Not Met|0|||
164385569|NCT03465540|593781237|FG002|Overall Study|Lost to Follow-up|0|||
164385570|NCT03465540|593781238|FG003|Overall Study|Lost to Follow-up|0|||
164385571|NCT03465540|593781239|FG004|Overall Study|Lost to Follow-up|1|||
164702667|NCT00375492|594936099|FG001|Overall Study|Entry Criteria Not Met|1|||
164702668|NCT00375492|594936098|FG000|Overall Study|Loss of Glucose Control|0|||
164385572|NCT03465540|593781240|FG005|Overall Study|Lost to Follow-up|0|||
164385573|NCT03465540|593781235|FG000|Overall Study|Death|1|||
164702669|NCT00375492|594936099|FG001|Overall Study|Loss of Glucose Control|1|||
164702670|NCT00375492|594936098|FG000|Overall Study|Lost to Follow-up|10|||
164702671|NCT00375492|594936099|FG001|Overall Study|Lost to Follow-up|5|||
164702672|NCT00375492|594936098|FG000|Overall Study|Physician Decision|0|||
164702673|NCT00375492|594936099|FG001|Overall Study|Physician Decision|4|||
164702674|NCT00375492|594936098|FG000|Overall Study|Protocol Violation|6|||
164702675|NCT00375492|594936099|FG001|Overall Study|Protocol Violation|3|||
164702676|NCT00375492|594936098|FG000|Overall Study|Sponsor Decision|0|||
164702677|NCT00375492|594936099|FG001|Overall Study|Sponsor Decision|1|||
164702678|NCT00375492|594936098|FG000|Overall Study|Withdrawal by Subject|6|||
164702679|NCT00375492|594936099|FG001|Overall Study|Withdrawal by Subject|6|||
164702680|NCT05011123|594937636|FG000|Overall Study|Withdrawal by Subject|4|||
164702681|NCT05011123|594937637|FG001|Overall Study|Withdrawal by Subject|2|||
164702682|NCT05011123|594937636|FG000|Overall Study|Lost to Follow-up|7|||
164702683|NCT05011123|594937637|FG001|Overall Study|Lost to Follow-up|6|||
164702684|NCT05011123|594937636|FG000|Overall Study|Ongoing at the time of DBL date|36|||
164702685|NCT05011123|594937637|FG001|Overall Study|Ongoing at the time of DBL date|10|||
164702686|NCT05011123|594937636|FG000|Overall Study|Randomized but did not receive vaccination|1|||
164702687|NCT05011123|594937637|FG001|Overall Study|Randomized but did not receive vaccination|0|||
164702688|NCT00461253|594937638|FG000|Overall Study|Death|985|||
164702689|NCT00461253|594937639|FG001|Overall Study|Death|0|||
164702690|NCT00461253|594937638|FG000|Overall Study|Protocol Violation|613|||
164702691|NCT00461253|594937639|FG001|Overall Study|Protocol Violation|236|||
164702692|NCT00461253|594937638|FG000|Overall Study|no response|2609|||
164702693|NCT00461253|594937639|FG001|Overall Study|no response|11789|||
164702694|NCT00461253|594937638|FG000|Overall Study|administrative|773|||
164702695|NCT00461253|594937639|FG001|Overall Study|administrative|7773|||
164702696|NCT01933113|594937640|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
164702697|NCT02297438|594937641|FG000|Overall Study|Death|79|||
164702698|NCT02297438|594937642|FG001|Overall Study|Death|86|||
164702699|NCT02297438|594937641|FG000|Overall Study|Lost to Follow-up|9|||
164702700|NCT02297438|594937642|FG001|Overall Study|Lost to Follow-up|7|||
164702701|NCT02297438|594937641|FG000|Overall Study|Withdrawal by Subject|7|||
164702702|NCT02297438|594937642|FG001|Overall Study|Withdrawal by Subject|0|||
164702703|NCT02297438|594937641|FG000|Overall Study|Other|9|||
164702704|NCT02297438|594937642|FG001|Overall Study|Other|5|||
164702705|NCT02297438|594937641|FG000|Overall Study|Ongoing|65|||
164702706|NCT02297438|594937642|FG001|Overall Study|Ongoing|73|||
164702707|NCT02307266|594937643|FG000|Overall Study|Adverse Event|3|||
164702708|NCT02307266|594937644|FG001|Overall Study|Adverse Event|1|||
164702709|NCT02307266|594937645|FG002|Overall Study|Adverse Event|5|||
164702710|NCT02307266|594937643|FG000|Overall Study|Withdrawal by Subject|2|||
164702711|NCT02307266|594937644|FG001|Overall Study|Withdrawal by Subject|0|||
164702712|NCT02307266|594937645|FG002|Overall Study|Withdrawal by Subject|1|||
164702713|NCT02307266|594937643|FG000|Overall Study|Lost to Follow-up|3|||
164702714|NCT02307266|594937644|FG001|Overall Study|Lost to Follow-up|0|||
164702715|NCT02307266|594937645|FG002|Overall Study|Lost to Follow-up|0|||
164702716|NCT00793780|594937646|FG000|Overall Study|Withdrawal by Subject|2|||
164702717|NCT00793780|594937647|FG001|Overall Study|Withdrawal by Subject|1|||
164702718|NCT00792935|594937657|FG000|Overall Study|Adverse Event|2|||
164702719|NCT00792935|594937658|FG001|Overall Study|Adverse Event|1|||
164702720|NCT00792935|594937657|FG000|Overall Study|Lost to Follow-up|0|||
164702721|NCT00792935|594937658|FG001|Overall Study|Lost to Follow-up|1|||
164702722|NCT00792935|594937657|FG000|Overall Study|Protocol Violation|2|||
164702723|NCT00792935|594937658|FG001|Overall Study|Protocol Violation|0|||
164702724|NCT00792935|594937657|FG000|Overall Study|Withdrawal by Subject|0|||
164702725|NCT00792935|594937658|FG001|Overall Study|Withdrawal by Subject|1|||
164702726|NCT01959035|594937667|FG000|Overall Study|Adverse Event|5|||
164702727|NCT01959035|594937667|FG000|Overall Study|Withdrawal by Subject|4|||
164702728|NCT01959035|594937667|FG000|Overall Study|Lost to Follow-up|1|||
164702729|NCT01959035|594937667|FG000|Overall Study|Other (no primary reason given)|1|||
164702730|NCT00450619|594937668|FG000|Overall Study|refused treatment after randomization|2|||
164702731|NCT00450619|594937669|FG001|Overall Study|refused treatment after randomization|0|||
164702732|NCT00450619|594937668|FG000|Overall Study|did not progress; refused further trmt|1|||
164702733|NCT00450619|594937669|FG001|Overall Study|did not progress; refused further trmt|1|||
164702734|NCT00450619|594937668|FG000|Overall Study|Adverse Event|1|||
164440294|NCT00922207|593978962|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
164440295|NCT00922207|593978963|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
164440296|NCT00922207|593978961|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
164702735|NCT00450619|594937669|FG001|Overall Study|Adverse Event|0|||
164702736|NCT03254602|594937670|FG000|Overall Study|Lost to Follow-up|4|||
164702737|NCT02963311|594937673|FG000|Overall Study|Withdrawal by Subject|1|||
164702738|NCT02963311|594937673|FG000|Overall Study|Screen Failure|4|||
164440297|NCT00922207|593978962|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
164702739|NCT01691820|594937674|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
164702740|NCT01691820|594937675|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
164702741|NCT01691820|594937674|FG000|Overall Study|Migrated/moved from study area|7|||
164702742|NCT01691820|594937675|FG001|Overall Study|Migrated/moved from study area|4|||
164702743|NCT01691820|594937674|FG000|Overall Study|Lost to Follow-up|6|||
164385574|NCT03465540|593781236|FG001|Overall Study|Death|1|||
164385575|NCT03465540|593781237|FG002|Overall Study|Death|0|||
164385576|NCT03465540|593781238|FG003|Overall Study|Death|2|||
164385577|NCT03465540|593781239|FG004|Overall Study|Death|0|||
164385578|NCT03465540|593781240|FG005|Overall Study|Death|2|||
164385579|NCT03465540|593781235|FG000|Overall Study|Protocol specified criteria|0|||
164385580|NCT03465540|593781236|FG001|Overall Study|Protocol specified criteria|2|||
164385581|NCT03465540|593781237|FG002|Overall Study|Protocol specified criteria|2|||
164385582|NCT03465540|593781238|FG003|Overall Study|Protocol specified criteria|0|||
164385583|NCT03465540|593781239|FG004|Overall Study|Protocol specified criteria|2|||
164385584|NCT03465540|593781240|FG005|Overall Study|Protocol specified criteria|0|||
164385585|NCT01854827|593781241|FG000|Overall Study|Death|1|||
164385586|NCT00736996|593781242|FG000|Overall Study|Lost to Follow-up|1|||
164385587|NCT00736996|593781243|FG001|Overall Study|Lost to Follow-up|9|||
164385588|NCT00736996|593781244|FG002|Overall Study|Lost to Follow-up|2|||
164385589|NCT00462384|593781245|FG000|Overall Study|Adverse Event|2|||
164385590|NCT00462384|593781245|FG000|Overall Study|Death|2|||
164385591|NCT00462384|593781245|FG000|Overall Study|Withdrawal by Subject|1|||
164385592|NCT00462384|593781245|FG000|Overall Study|Other|4|||
164385593|NCT04000165|593781246|FG000|Overall Study|Physician Decision|1|||
164385594|NCT04000165|593781246|FG000|Overall Study|Withdrawal by Subject|1|||
164385595|NCT01751568|593781251|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
164385596|NCT01751568|593781252|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
164385597|NCT01751568|593781253|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
164385598|NCT02660944|593781262|FG000|Overall Study|Adverse Event|3|||
164385599|NCT02660944|593781263|FG001|Overall Study|Adverse Event|4|||
164385600|NCT02660944|593781262|FG000|Overall Study|Physician Decision|3|||
164385601|NCT02660944|593781263|FG001|Overall Study|Physician Decision|1|||
164385602|NCT02660944|593781262|FG000|Overall Study|Withdrawal by Subject|5|||
164385603|NCT02660944|593781263|FG001|Overall Study|Withdrawal by Subject|3|||
164385604|NCT02660944|593781262|FG000|Overall Study|Lost to Follow-up|4|||
164385605|NCT02660944|593781263|FG001|Overall Study|Lost to Follow-up|1|||
164385606|NCT02660944|593781262|FG000|Overall Study|Subject schedule|0|||
164385607|NCT02660944|593781263|FG001|Overall Study|Subject schedule|1|||
164385608|NCT02660944|593781262|FG000|Overall Study|Exclusion criteria met|2|||
164385609|NCT02660944|593781263|FG001|Overall Study|Exclusion criteria met|0|||
164385610|NCT02843568|593781264|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
164385611|NCT02843568|593781265|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
164385612|NCT02843568|593781264|FG000|Overall Study|Death|3|||
164385613|NCT02843568|593781265|FG001|Overall Study|Death|3|||
164385614|NCT02843568|593781264|FG000|Overall Study|Withdrawal by Subject|1|||
164385615|NCT02843568|593781265|FG001|Overall Study|Withdrawal by Subject|1|||
164385616|NCT02843568|593781264|FG000|Overall Study|Lost to Follow-up|2|||
164385617|NCT02843568|593781265|FG001|Overall Study|Lost to Follow-up|0|||
164385618|NCT03586999|593781266|FG000|Overall Study|Lack of Efficacy|2|||
164385619|NCT04096560|593781267|FG000|Overall Study|Reason not Specified|1|||
164385620|NCT04096560|593781268|FG001|Overall Study|Reason not Specified|0|||
164385621|NCT04096560|593781269|FG002|Overall Study|Reason not Specified|0|||
164385622|NCT04096560|593781270|FG003|Overall Study|Reason not Specified|0|||
164385623|NCT04096560|593781271|FG004|Overall Study|Reason not Specified|1|||
164385624|NCT04096560|593781272|FG005|Overall Study|Reason not Specified|1|||
164385625|NCT04096560|593781273|FG006|Overall Study|Reason not Specified|1|||
164385626|NCT04096560|593781274|FG007|Overall Study|Reason not Specified|0|||
164385627|NCT04096560|593781267|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
164385628|NCT04096560|593781268|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
164385629|NCT04096560|593781269|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
164385630|NCT04096560|593781270|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
164385631|NCT04096560|593781271|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
164385632|NCT04096560|593781272|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
164385633|NCT04096560|593781273|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
164385634|NCT04096560|593781274|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
164385635|NCT04096560|593781267|FG000|Overall Study|Study Terminated by Sponsor|0|||
164385636|NCT04096560|593781268|FG001|Overall Study|Study Terminated by Sponsor|0|||
164385637|NCT04096560|593781269|FG002|Overall Study|Study Terminated by Sponsor|0|||
164385638|NCT04096560|593781270|FG003|Overall Study|Study Terminated by Sponsor|5|||
164385639|NCT04096560|593781271|FG004|Overall Study|Study Terminated by Sponsor|6|||
164385640|NCT04096560|593781272|FG005|Overall Study|Study Terminated by Sponsor|4|||
164385641|NCT04096560|593781273|FG006|Overall Study|Study Terminated by Sponsor|6|||
164385642|NCT04096560|593781274|FG007|Overall Study|Study Terminated by Sponsor|1|||
164385643|NCT04096560|593781267|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
164385644|NCT04096560|593781268|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
164385645|NCT04096560|593781269|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
164385646|NCT04096560|593781270|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
164385647|NCT04096560|593781271|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
164385648|NCT04096560|593781272|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
164385649|NCT04096560|593781273|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
164385650|NCT04096560|593781274|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
164385651|NCT00534352|593781277|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
164385652|NCT00534352|593781277|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
164385653|NCT00534352|593781277|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
164385654|NCT00534352|593781277|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
164385655|NCT00534352|593781277|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
164385656|NCT00534352|593781277|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
164385657|NCT03264989|593781280|FG000|Overall Study|Lost to Follow-up|1|||
164385658|NCT03264989|593781281|FG001|Overall Study|Lost to Follow-up|0|||
164385659|NCT03264989|593781280|FG000|Overall Study|New Therapy for study Indication|1|||
164385660|NCT03264989|593781281|FG001|Overall Study|New Therapy for study Indication|0|||
164385661|NCT03264989|593781280|FG000|Overall Study|Protocol Violation|0|||
164385662|NCT03264989|593781281|FG001|Overall Study|Protocol Violation|1|||
164385663|NCT03264989|593781280|FG000|Overall Study|Patient decision|13|||
164702744|NCT01691820|594937675|FG001|Overall Study|Lost to Follow-up|17|||
164702745|NCT01691820|594937674|FG000|Overall Study|Other (unspecified)|4|||
164702746|NCT01691820|594937675|FG001|Overall Study|Other (unspecified)|1|||
164702747|NCT04442490|594937678|FG000|Overall Study|Withdrawal by Subject|18|||
164702748|NCT04442490|594937679|FG001|Overall Study|Withdrawal by Subject|10|||
164702749|NCT04442490|594937678|FG000|Overall Study|Lost to Follow-up|7|||
164702750|NCT04442490|594937679|FG001|Overall Study|Lost to Follow-up|7|||
164702751|NCT04442490|594937678|FG000|Overall Study|Adverse Event|2|||
164702752|NCT04442490|594937679|FG001|Overall Study|Adverse Event|6|||
164702753|NCT04442490|594937678|FG000|Overall Study|Noncompliance|3|||
164702754|NCT04442490|594937679|FG001|Overall Study|Noncompliance|1|||
164702755|NCT04442490|594937678|FG000|Overall Study|Physician Decision|2|||
164702756|NCT04442490|594937679|FG001|Overall Study|Physician Decision|1|||
164702757|NCT04442490|594937678|FG000|Overall Study|Reason not Specified|2|||
164702758|NCT04442490|594937679|FG001|Overall Study|Reason not Specified|1|||
164702759|NCT04442490|594937678|FG000|Overall Study|Randomized but not Treated|3|||
164702760|NCT04442490|594937679|FG001|Overall Study|Randomized but not Treated|3|||
164702761|NCT01968694|594937681|FG000|Washout (1 Month)|Lost to Follow-up|0|||
164702762|NCT01968694|594937682|FG001|Washout (1 Month)|Lost to Follow-up|1|||
164702763|NCT02836496|594937683|FG000|Overall Study|Adverse Event|2|||
164702764|NCT02836496|594937684|FG001|Overall Study|Adverse Event|1|||
164702765|NCT02836496|594937683|FG000|Overall Study|Withdrawal by Subject|0|||
164702766|NCT02836496|594937684|FG001|Overall Study|Withdrawal by Subject|1|||
164702767|NCT01246011|594937685|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
164702768|NCT01246011|594937686|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
164702769|NCT01246011|594937687|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
164702770|NCT01246011|594937685|FG000|Overall Study|Withdrawal by Subject|0|||
164702771|NCT01246011|594937686|FG001|Overall Study|Withdrawal by Subject|0|||
164702772|NCT01246011|594937687|FG002|Overall Study|Withdrawal by Subject|1|||
164702773|NCT00415194|594937691|FG000|Overall Study|Adverse Event|37|||
164702774|NCT00415194|594937692|FG001|Overall Study|Adverse Event|32|||
164702775|NCT00415194|594937691|FG000|Overall Study|Entry Criteria Not Met|4|||
164702776|NCT00415194|594937692|FG001|Overall Study|Entry Criteria Not Met|8|||
164702777|NCT00415194|594937691|FG000|Overall Study|Lost to Follow-up|1|||
164702778|NCT00415194|594937692|FG001|Overall Study|Lost to Follow-up|0|||
164702779|NCT00415194|594937691|FG000|Overall Study|Physician Decision|10|||
164702780|NCT00415194|594937692|FG001|Overall Study|Physician Decision|16|||
164702781|NCT00415194|594937691|FG000|Overall Study|Progressive Disease|180|||
164702782|NCT00415194|594937692|FG001|Overall Study|Progressive Disease|217|||
164702783|NCT00415194|594937691|FG000|Overall Study|Protocol Violation|4|||
164702784|NCT00415194|594937692|FG001|Overall Study|Protocol Violation|2|||
164702785|NCT00415194|594937691|FG000|Overall Study|Withdrawal by Subject|28|||
164702786|NCT00415194|594937692|FG001|Overall Study|Withdrawal by Subject|21|||
164702787|NCT00415194|594937691|FG000|Overall Study|Death Due to Study Disease|26|||
164702788|NCT00415194|594937692|FG001|Overall Study|Death Due to Study Disease|29|||
164702789|NCT00415194|594937691|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
164702790|NCT00415194|594937692|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
164702791|NCT00415194|594937691|FG000|Overall Study|Death Due to Procedural Related AE|0|||
164702792|NCT00415194|594937692|FG001|Overall Study|Death Due to Procedural Related AE|1|||
164702793|NCT00415194|594937691|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
164385664|NCT03264989|593781281|FG001|Overall Study|Patient decision|0|||
164385665|NCT03264989|593781280|FG000|Overall Study|Physician Decision|6|||
164385666|NCT03264989|593781281|FG001|Overall Study|Physician Decision|4|||
164385667|NCT03264989|593781280|FG000|Overall Study|Adverse Event|2|||
164702794|NCT00415194|594937692|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
164702795|NCT01646138|594937693|FG000|Overall Study|Lost to Follow-up|0|||
164702796|NCT01646138|594937694|FG001|Overall Study|Lost to Follow-up|0|||
164385668|NCT03264989|593781281|FG001|Overall Study|Adverse Event|1|||
164702797|NCT01646138|594937695|FG002|Overall Study|Lost to Follow-up|0|||
164702798|NCT01646138|594937696|FG003|Overall Study|Lost to Follow-up|0|||
164702799|NCT01646138|594937697|FG004|Overall Study|Lost to Follow-up|2|||
164702800|NCT01683838|594937698|FG000|Overall Study|Adverse Event|12|||
164702801|NCT01683838|594937699|FG001|Overall Study|Adverse Event|2|||
164702802|NCT01683838|594937698|FG000|Overall Study|Protocol Violation|3|||
164702803|NCT01683838|594937699|FG001|Overall Study|Protocol Violation|1|||
164702804|NCT01683838|594937698|FG000|Overall Study|Withdrawal by Subject|6|||
164702805|NCT01683838|594937699|FG001|Overall Study|Withdrawal by Subject|5|||
164702806|NCT01683838|594937698|FG000|Overall Study|Lost to Follow-up|1|||
164702807|NCT01683838|594937699|FG001|Overall Study|Lost to Follow-up|1|||
164702808|NCT01683838|594937698|FG000|Overall Study|Other|4|||
164702809|NCT01683838|594937699|FG001|Overall Study|Other|3|||
164702810|NCT01524679|594937700|FG000|Overall Study|Lost to Follow-up|1|||
164702811|NCT01524679|594937701|FG001|Overall Study|Lost to Follow-up|4|||
164702812|NCT01524679|594937700|FG000|Overall Study|Withdrawal by Subject|4|||
164702813|NCT01524679|594937701|FG001|Overall Study|Withdrawal by Subject|4|||
164702814|NCT01524679|594937700|FG000|Overall Study|Adverse Event|9|||
164702815|NCT01524679|594937701|FG001|Overall Study|Adverse Event|0|||
164702816|NCT01524679|594937700|FG000|Overall Study|Protocol Violation|1|||
164702817|NCT01524679|594937701|FG001|Overall Study|Protocol Violation|0|||
164702818|NCT01524679|594937700|FG000|Overall Study|Lack of Efficacy|2|||
164702819|NCT01524679|594937701|FG001|Overall Study|Lack of Efficacy|0|||
164702820|NCT01524679|594937700|FG000|Overall Study|e.g.wish for children, relocation|6|||
164702821|NCT01524679|594937701|FG001|Overall Study|e.g.wish for children, relocation|1|||
164702822|NCT04078126|594937704|FG000|Washout|Study put on hold due to COVID-19|0|||
164702823|NCT04078126|594937705|FG001|Washout|Study put on hold due to COVID-19|2|||
164702824|NCT04078126|594937704|FG000|Period 2|Study put on hold due to COVID-19|1|||
164702825|NCT04078126|594937705|FG001|Period 2|Study put on hold due to COVID-19|1|||
164702826|NCT03321630|594937708|FG000|Overall Study|Adverse Event|1|||
164702827|NCT03321630|594937708|FG000|Overall Study|Investigator Discretion|2|||
164702828|NCT03321630|594937708|FG000|Overall Study|Withdrawal by Subject|1|||
164702829|NCT00140426|594937709|FG000|Overall Study|Withdrawal by Subject|0|||
164702830|NCT00140426|594937710|FG001|Overall Study|Withdrawal by Subject|3|||
164702831|NCT02149108|594937711|FG000|Overall Study|Not treated|1|||
164702832|NCT02149108|594937712|FG001|Overall Study|Not treated|2|||
164702833|NCT02149108|594937711|FG000|Overall Study|Progressive Disease (PD)|324|||
164702834|NCT02149108|594937712|FG001|Overall Study|Progressive Disease (PD)|318|||
164702835|NCT02149108|594937711|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
164702836|NCT02149108|594937712|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
164702837|NCT02149108|594937711|FG000|Overall Study|Other Adverse Event (AE)|8|||
164702838|NCT02149108|594937712|FG001|Overall Study|Other Adverse Event (AE)|18|||
164702839|NCT02149108|594937711|FG000|Overall Study|Other not defined above|0|||
164702840|NCT02149108|594937712|FG001|Overall Study|Other not defined above|2|||
164702841|NCT02149108|594937711|FG000|Overall Study|Refusal to continue trial medication|15|||
164702842|NCT02149108|594937712|FG001|Overall Study|Refusal to continue trial medication|11|||
164385669|NCT03264989|593781280|FG000|Overall Study|Death|1|||
164385670|NCT03264989|593781281|FG001|Overall Study|Death|1|||
164385671|NCT03264989|593781280|FG000|Overall Study|Pregnancy|2|||
164385672|NCT03264989|593781281|FG001|Overall Study|Pregnancy|0|||
164385673|NCT03264989|593781280|FG000|Overall Study|End of Study|19|||
164385674|NCT03264989|593781281|FG001|Overall Study|End of Study|5|||
164385675|NCT00833924|593781287|FG000|Overall Study|Death|21|||
164385676|NCT00833924|593781287|FG000|Overall Study|Conversion|2|||
164385677|NCT00833924|593781287|FG000|Overall Study|Lost to Follow-up|2|||
164385678|NCT00833924|593781287|FG000|Overall Study|Withdrawal by Subject|13|||
164385679|NCT00833924|593781287|FG000|Overall Study|In study follow-up|71|||
164385680|NCT02504866|593781288|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
164385681|NCT02504866|593781289|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
164385682|NCT02504866|593781290|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
164385683|NCT01229436|593781291|FG000|Overall Study|Withdrawal by Subject|2|||
164385684|NCT01229436|593781291|FG000|Overall Study|Lost to Follow-up|3|||
164385685|NCT01775137|593781294|FG000|Overall Study|Death|1|||
164385686|NCT01775137|593781294|FG000|Overall Study|Protocol deviation|2|||
164385687|NCT01775137|593781294|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164385688|NCT01775137|593781294|FG000|Overall Study|Adverse Event|1|||
164702843|NCT02149108|594937711|FG000|Overall Study|Lost to Follow-up|1|||
164702844|NCT02149108|594937712|FG001|Overall Study|Lost to Follow-up|0|||
164702845|NCT04168190|594937713|FG000|Overall Study|Lost to Follow-up|0|||
164702846|NCT04168190|594937714|FG001|Overall Study|Lost to Follow-up|1|||
164702847|NCT04168190|594937715|FG002|Overall Study|Lost to Follow-up|0|||
164592851|NCT01998581|594534607|FG001|Overall Study|Other reasons|2|||
164592852|NCT01998581|594534606|FG000|Overall Study|Randomized but withdrew before treatment|1|||
164592853|NCT01998581|594534607|FG001|Overall Study|Randomized but withdrew before treatment|0|||
164592854|NCT02245568|594534609|FG000|Overall Study|Study terminated by Sponsor|346|||
164592855|NCT02245568|594534609|FG000|Overall Study|Adverse Event|144|||
164592856|NCT02245568|594534609|FG000|Overall Study|Lack of Efficacy|98|||
164592857|NCT02245568|594534609|FG000|Overall Study|Withdrawal by Caregiver|85|||
164592858|NCT02245568|594534609|FG000|Overall Study|Withdrawal by Subject|77|||
164592859|NCT02245568|594534609|FG000|Overall Study|Withdrawal by Legal Representative|31|||
164592860|NCT02245568|594534609|FG000|Overall Study|Missing (Site closure)|16|||
164592861|NCT02245568|594534609|FG000|Overall Study|Physician Decision|14|||
164592862|NCT02245568|594534609|FG000|Overall Study|Non-compliance with study drug|11|||
164592863|NCT02245568|594534609|FG000|Overall Study|Death|9|||
164592864|NCT02245568|594534609|FG000|Overall Study|Blue staining|6|||
164592865|NCT02245568|594534609|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
164385689|NCT01775137|593781294|FG000|Overall Study|Withdrawal by participants|5|||
164385690|NCT04796610|593781295|FG000|Overall Study|Withdrawal by Subject|1|||
164385691|NCT04796610|593781296|FG001|Overall Study|Withdrawal by Subject|0|||
164385692|NCT04796610|593781297|FG002|Overall Study|Withdrawal by Subject|0|||
164385693|NCT04796610|593781298|FG003|Overall Study|Withdrawal by Subject|0|||
164385694|NCT04796610|593781295|FG000|Overall Study|Lost to Follow-up|2|||
164385695|NCT04796610|593781296|FG001|Overall Study|Lost to Follow-up|0|||
164385696|NCT04796610|593781297|FG002|Overall Study|Lost to Follow-up|1|||
164385697|NCT04796610|593781298|FG003|Overall Study|Lost to Follow-up|1|||
164385698|NCT01459796|593781299|FG000|Overall Study|Non compliance with protocol|2|||
164385699|NCT01459796|593781300|FG001|Overall Study|Non compliance with protocol|4|||
164385700|NCT01459796|593781299|FG000|Overall Study|Adverse Event|5|||
164385701|NCT01459796|593781300|FG001|Overall Study|Adverse Event|5|||
164385702|NCT01459796|593781299|FG000|Overall Study|Withdrawal by Subject|6|||
164385703|NCT01459796|593781300|FG001|Overall Study|Withdrawal by Subject|3|||
164385704|NCT01459796|593781299|FG000|Overall Study|Lost to Follow-up|5|||
164385705|NCT01459796|593781300|FG001|Overall Study|Lost to Follow-up|4|||
164385706|NCT01459796|593781299|FG000|Overall Study|Reason unspecified|1|||
164385707|NCT01459796|593781300|FG001|Overall Study|Reason unspecified|2|||
164385708|NCT01459796|593781299|FG000|Overall Study|Decision by the sponsor|75|||
164385709|NCT01459796|593781300|FG001|Overall Study|Decision by the sponsor|108|||
164385710|NCT00733824|593781301|FG000|Phase I|Withdrawal by Subject|1|||
164385711|NCT00733824|593781302|FG001|Phase I|Withdrawal by Subject|0|||
164385712|NCT00733824|593781303|FG002|Phase I|Withdrawal by Subject|0|||
164385713|NCT00733824|593781304|FG003|Phase I|Withdrawal by Subject|0|||
164385714|NCT00733824|593781305|FG004|Phase I|Withdrawal by Subject|0|||
164385715|NCT01343056|593781306|FG000|Overall Study|Lost to Follow-up|7|||
164385716|NCT01343056|593781307|FG001|Overall Study|Lost to Follow-up|5|||
164385717|NCT01343056|593781308|FG002|Overall Study|Lost to Follow-up|3|||
164385718|NCT01343056|593781309|FG003|Overall Study|Lost to Follow-up|9|||
164385719|NCT02059148|593781310|FG000|Treatment 1|Protocol Violation|0|||
164385720|NCT02059148|593781311|FG001|Treatment 1|Protocol Violation|0|||
164385721|NCT02059148|593781312|FG002|Treatment 1|Protocol Violation|0|||
164385722|NCT02059148|593781313|FG003|Treatment 1|Protocol Violation|0|||
164385723|NCT02059148|593781314|FG004|Treatment 1|Protocol Violation|0|||
164385724|NCT02059148|593781315|FG005|Treatment 1|Protocol Violation|1|||
164385725|NCT03231371|593781316|FG000|Overall Study|Withdrawal by Subject|1|||
164385726|NCT03231371|593781316|FG000|Overall Study|chose or were ineligible to have MRI|12|||
164385727|NCT03067441|593781321|FG000|Overall Study|Withdrawal by Subject|16|||
164385728|NCT03067441|593781322|FG001|Overall Study|Withdrawal by Subject|34|||
164385729|NCT03067441|593781321|FG000|Overall Study|Lost to Follow-up|7|||
164385730|NCT03067441|593781322|FG001|Overall Study|Lost to Follow-up|5|||
164385731|NCT03067441|593781321|FG000|Overall Study|Adverse Event|7|||
164385732|NCT03067441|593781322|FG001|Overall Study|Adverse Event|14|||
164385733|NCT03067441|593781321|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
164385734|NCT03067441|593781322|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
164385735|NCT03067441|593781321|FG000|Overall Study|Physician Decision|1|||
164385736|NCT03067441|593781322|FG001|Overall Study|Physician Decision|3|||
164385737|NCT03067441|593781321|FG000|Overall Study|Other|1|||
164385738|NCT03067441|593781322|FG001|Overall Study|Other|1|||
164385739|NCT00856583|593781323|FG000|Overall Study|Lack of Efficacy|389|||
164385740|NCT00856583|593781324|FG001|Overall Study|Lack of Efficacy|377|||
164385741|NCT00856583|593781323|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
164385742|NCT00856583|593781324|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
164385743|NCT00856583|593781323|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
164385744|NCT00856583|593781324|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
164385745|NCT00856583|593781323|FG000|Overall Study|Non-compliance|305|||
164385746|NCT00856583|593781324|FG001|Overall Study|Non-compliance|262|||
164385747|NCT00856583|593781323|FG000|Overall Study|Withdrawal by Subject|1092|||
164385748|NCT00856583|593781324|FG001|Overall Study|Withdrawal by Subject|919|||
164385749|NCT00856583|593781323|FG000|Overall Study|Physician Decision|59|||
164592866|NCT02245568|594534609|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
164702848|NCT04168190|594937716|FG003|Overall Study|Lost to Follow-up|7|||
164702849|NCT04168190|594937717|FG004|Overall Study|Lost to Follow-up|5|||
164702850|NCT04168190|594937713|FG000|Overall Study|Withdrawal by Subject|1|||
164702851|NCT04168190|594937714|FG001|Overall Study|Withdrawal by Subject|0|||
164702852|NCT04168190|594937715|FG002|Overall Study|Withdrawal by Subject|0|||
164702853|NCT04168190|594937716|FG003|Overall Study|Withdrawal by Subject|2|||
164702854|NCT04168190|594937717|FG004|Overall Study|Withdrawal by Subject|4|||
164702855|NCT04168190|594937713|FG000|Overall Study|Death|0|||
164702856|NCT04168190|594937714|FG001|Overall Study|Death|0|||
164702857|NCT04168190|594937715|FG002|Overall Study|Death|0|||
164702858|NCT04168190|594937716|FG003|Overall Study|Death|1|||
164702859|NCT04168190|594937717|FG004|Overall Study|Death|0|||
164702860|NCT02325518|594937718|FG000|Overall Study|Adverse Event|4|||
164702861|NCT02325518|594937719|FG001|Overall Study|Adverse Event|1|||
164702862|NCT02325518|594937718|FG000|Overall Study|Physician Decision|0|||
164702863|NCT02325518|594937719|FG001|Overall Study|Physician Decision|1|||
164702864|NCT02325518|594937718|FG000|Overall Study|Withdrawal by Subject|0|||
164702865|NCT02325518|594937719|FG001|Overall Study|Withdrawal by Subject|1|||
164702866|NCT01675661|594937720|FG000|Overall Study|Lost to Follow-up|22|||
164702867|NCT01675661|594937721|FG001|Overall Study|Lost to Follow-up|23|||
164702868|NCT01675661|594937720|FG000|Overall Study|Practical problems|9|||
164702869|NCT01675661|594937721|FG001|Overall Study|Practical problems|5|||
164702870|NCT01675661|594937720|FG000|Overall Study|Moved away|5|||
164702871|NCT01675661|594937721|FG001|Overall Study|Moved away|6|||
164702872|NCT01675661|594937720|FG000|Overall Study|Withdrawal by Subject|3|||
164702873|NCT01675661|594937721|FG001|Overall Study|Withdrawal by Subject|7|||
164702874|NCT01675661|594937720|FG000|Overall Study|Physician Decision|0|||
164702875|NCT01675661|594937721|FG001|Overall Study|Physician Decision|2|||
164702876|NCT01675661|594937720|FG000|Overall Study|Death|0|||
164702877|NCT01675661|594937721|FG001|Overall Study|Death|1|||
164702878|NCT01675661|594937720|FG000|Overall Study|Other reason|1|||
164702879|NCT01675661|594937721|FG001|Overall Study|Other reason|2|||
164702880|NCT04765384|594937722|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
164702881|NCT04765384|594937723|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
164702882|NCT04765384|594937724|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
164702883|NCT04765384|594937725|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
164702884|NCT04765384|594937726|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
164702885|NCT04765384|594937727|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
164702886|NCT04765384|594937722|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
164702887|NCT04765384|594937723|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
164702888|NCT04765384|594937724|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
164702889|NCT04765384|594937725|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
164702890|NCT04765384|594937726|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
164702891|NCT04765384|594937727|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
164702892|NCT04765384|594937722|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
164702893|NCT04765384|594937723|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
164702894|NCT04765384|594937724|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
164702895|NCT04765384|594937725|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
164702896|NCT04765384|594937726|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
164702897|NCT04765384|594937727|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
164702898|NCT04765384|594937722|FG000|Post-natal: Neonates and Infants|Death|0|||
164702899|NCT04765384|594937723|FG001|Post-natal: Neonates and Infants|Death|0|||
164702900|NCT04765384|594937724|FG002|Post-natal: Neonates and Infants|Death|0|||
164702901|NCT04765384|594937725|FG003|Post-natal: Neonates and Infants|Death|1|||
164702902|NCT04765384|594937726|FG004|Post-natal: Neonates and Infants|Death|0|||
164702903|NCT04765384|594937727|FG005|Post-natal: Neonates and Infants|Death|0|||
164702904|NCT04765384|594937722|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
164702905|NCT04765384|594937723|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
164385750|NCT00856583|593781324|FG001|Overall Study|Physician Decision|82|||
164385751|NCT00856583|593781323|FG000|Overall Study|Pregnancy|14|||
164702906|NCT04765384|594937724|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
164702907|NCT04765384|594937725|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
164702908|NCT04765384|594937726|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
164385752|NCT00856583|593781324|FG001|Overall Study|Pregnancy|5|||
164385753|NCT00856583|593781323|FG000|Overall Study|Other|92|||
164385754|NCT00856583|593781324|FG001|Overall Study|Other|104|||
164702909|NCT04765384|594937727|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
164385755|NCT00856583|593781323|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
164385756|NCT00856583|593781324|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
164385757|NCT02056301|593781328|FG000|Overall Study|Protocol Violation|1|||
164702910|NCT00987389|594937728|FG000|Overall Study|Ineligible|0|||
164702911|NCT00987389|594937729|FG001|Overall Study|Ineligible|3|||
164702912|NCT00987389|594937730|FG002|Overall Study|Ineligible|0|||
164702913|NCT00987389|594937731|FG003|Overall Study|Ineligible|0|||
164702914|NCT00987389|594937728|FG000|Overall Study|Lost to Follow-up|4|||
164702915|NCT00987389|594937729|FG001|Overall Study|Lost to Follow-up|1|||
164440298|NCT00922207|593978963|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
164440299|NCT00922207|593978961|FG000|Overall Study|Withdrew Consent|2|||
164440300|NCT00922207|593978962|FG001|Overall Study|Withdrew Consent|5|||
164440301|NCT00922207|593978963|FG002|Overall Study|Withdrew Consent|2|||
164440302|NCT00922207|593978961|FG000|Overall Study|Abnormality of Laboratory Test|0|||
164440303|NCT00922207|593978962|FG001|Overall Study|Abnormality of Laboratory Test|1|||
164440304|NCT00922207|593978963|FG002|Overall Study|Abnormality of Laboratory Test|1|||
164440305|NCT00367991|593978968|FG000|Overall Study|Withdrawal by Subject|1|||
164440306|NCT00367991|593978969|FG001|Overall Study|Withdrawal by Subject|1|||
164440307|NCT00367991|593978968|FG000|Overall Study|Adverse Event|1|||
164702916|NCT00987389|594937730|FG002|Overall Study|Lost to Follow-up|3|||
164702917|NCT00987389|594937731|FG003|Overall Study|Lost to Follow-up|1|||
164702918|NCT00987389|594937728|FG000|Overall Study|Withdrawal by Subject|4|||
164702919|NCT00987389|594937729|FG001|Overall Study|Withdrawal by Subject|3|||
164702920|NCT00987389|594937730|FG002|Overall Study|Withdrawal by Subject|2|||
164702921|NCT00987389|594937731|FG003|Overall Study|Withdrawal by Subject|1|||
164702922|NCT00987389|594937728|FG000|Overall Study|Withdrawn from Treatment|0|||
164702923|NCT00987389|594937729|FG001|Overall Study|Withdrawn from Treatment|1|||
164702924|NCT00987389|594937730|FG002|Overall Study|Withdrawn from Treatment|0|||
164702925|NCT00987389|594937731|FG003|Overall Study|Withdrawn from Treatment|0|||
164702926|NCT00987389|594937728|FG000|Overall Study|Multiple different reasons|1|||
164702927|NCT00987389|594937729|FG001|Overall Study|Multiple different reasons|0|||
164702928|NCT00987389|594937730|FG002|Overall Study|Multiple different reasons|3|||
164702929|NCT00987389|594937731|FG003|Overall Study|Multiple different reasons|1|||
164702930|NCT02992418|594937734|FG000|Overall Study|Withdrawal by Subject|11|||
164702931|NCT02992418|594937735|FG001|Overall Study|Withdrawal by Subject|12|||
164702932|NCT02992418|594937734|FG000|Overall Study|Non-compliance with the protocol|308|||
164702933|NCT02992418|594937735|FG001|Overall Study|Non-compliance with the protocol|308|||
164702934|NCT02992418|594937734|FG000|Overall Study|Lost to Follow-up|27|||
164702935|NCT02992418|594937735|FG001|Overall Study|Lost to Follow-up|22|||
164702936|NCT00289536|594937736|FG000|Period 3|Lost to Follow-up|0|||
164702937|NCT00289536|594937737|FG001|Period 3|Lost to Follow-up|0|||
164702938|NCT00289536|594937738|FG002|Period 3|Lost to Follow-up|1|||
164702939|NCT03246126|594937739|FG000|Overall Study|Withdrawal by Subject|0|||
164702940|NCT03246126|594937740|FG001|Overall Study|Withdrawal by Subject|1|||
164702941|NCT01006135|594937743|FG000|Overall Study|Adverse Event|22|||
164702942|NCT01006135|594937743|FG000|Overall Study|Protocol Violation|14|||
164702943|NCT01006135|594937743|FG000|Overall Study|Lost to Follow-up|32|||
164702944|NCT01006135|594937743|FG000|Overall Study|Other|72|||
164702945|NCT05297578|594937744|FG000|Overall Study|Lost to Follow-up|1|||
164702946|NCT05297578|594937745|FG001|Overall Study|Lost to Follow-up|1|||
164702947|NCT05297578|594937746|FG002|Overall Study|Lost to Follow-up|2|||
164702948|NCT05297578|594937747|FG003|Overall Study|Lost to Follow-up|1|||
164702949|NCT05297578|594937744|FG000|Overall Study|Death|0|||
164702950|NCT05297578|594937745|FG001|Overall Study|Death|1|||
164702951|NCT05297578|594937746|FG002|Overall Study|Death|0|||
164702952|NCT05297578|594937747|FG003|Overall Study|Death|0|||
164702953|NCT05297578|594937744|FG000|Overall Study|Withdrawal by Subject|0|||
164702954|NCT05297578|594937745|FG001|Overall Study|Withdrawal by Subject|0|||
164702955|NCT05297578|594937746|FG002|Overall Study|Withdrawal by Subject|1|||
164702956|NCT05297578|594937747|FG003|Overall Study|Withdrawal by Subject|0|||
164702957|NCT03127644|594937748|FG000|Overall Study|Study-specific withdrawal criteria|0|||
164702958|NCT03127644|594937749|FG001|Overall Study|Study-specific withdrawal criteria|0|||
164702959|NCT03127644|594937750|FG002|Overall Study|Study-specific withdrawal criteria|2|||
164702960|NCT02032706|594937753|FG000|Overall Study|Did not qualify|5|||
164702961|NCT02032706|594937753|FG000|Overall Study|Protocol Violation|1|||
164440308|NCT00367991|593978969|FG001|Overall Study|Adverse Event|1|||
164702962|NCT01156142|594937754|FG000|Overall Study|Withdrawal by Subject|8|||
164702963|NCT01156142|594937755|FG001|Overall Study|Withdrawal by Subject|6|||
164702964|NCT01156142|594937754|FG000|Overall Study|Ineligible|0|||
164702965|NCT01156142|594937755|FG001|Overall Study|Ineligible|1|||
164702966|NCT00893737|594937756|FG000|Overall Study|Adverse Event|4|||
164702967|NCT00893737|594937756|FG000|Overall Study|Withdrawal by Subject|2|||
164440309|NCT02705586|593978974|FG000|Overall Study|Health Issues|2|||
164440310|NCT02705586|593978974|FG000|Overall Study|Transportation Difficulties|5|||
164440311|NCT02705586|593978974|FG000|Overall Study|Vacation/Planned Absence|1|||
164702968|NCT00893737|594937756|FG000|Overall Study|Lost to Follow-up|6|||
164702969|NCT00928707|594937757|FG000|Overall Study|Protocol Violation|1|||
164702970|NCT00928707|594937758|FG001|Overall Study|Protocol Violation|0|||
164702971|NCT00132028|594937759|FG000|Overall Study|Adverse Event|7|||
164440312|NCT02808338|593978975|FG000|Screening|Screen Failure|10|||
164440313|NCT02808338|593978975|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
164440314|NCT02808338|593978975|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
164702972|NCT00132028|594937759|FG000|Overall Study|Death|2|||
164702973|NCT00132028|594937759|FG000|Overall Study|Lack of Efficacy|11|||
164385758|NCT02056301|593781329|FG001|Overall Study|Protocol Violation|2|||
164385759|NCT02056301|593781328|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
164385760|NCT02056301|593781329|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
164385761|NCT02056301|593781328|FG000|Overall Study|Withdrawal by Subject|0|||
164592867|NCT02245568|594534609|FG000|Overall Study|Lost to Follow-up|5|||
164592868|NCT00441441|594534611|FG000|Overall Study|Adverse Event|2|||
164592869|NCT00441441|594534612|FG001|Overall Study|Adverse Event|1|||
164385762|NCT02056301|593781329|FG001|Overall Study|Withdrawal by Subject|1|||
164385763|NCT02056301|593781328|FG000|Overall Study|Issues with epidural|0|||
164385764|NCT02056301|593781329|FG001|Overall Study|Issues with epidural|3|||
164385765|NCT00499889|593781335|FG000|Overall Study|Infection prior to treatment|1|||
164385766|NCT03299192|593781336|FG000|Overall Study|Fell before classes started|1|||
164385767|NCT03299192|593781337|FG001|Overall Study|Fell before classes started|0|||
164385768|NCT03299192|593781338|FG002|Overall Study|Fell before classes started|0|||
164385769|NCT03299192|593781336|FG000|Overall Study|Other|0|||
164385770|NCT03299192|593781337|FG001|Overall Study|Other|2|||
164385771|NCT03299192|593781338|FG002|Overall Study|Other|1|||
164385772|NCT01418209|593781344|FG000|Overall Study|Withdrawal by Subject|1|||
164385773|NCT01418209|593781345|FG001|Overall Study|Withdrawal by Subject|0|||
164385774|NCT01418209|593781346|FG002|Overall Study|Withdrawal by Subject|1|||
164385775|NCT01418209|593781344|FG000|Overall Study|Did not provide hot flash diary data|1|||
164385776|NCT01418209|593781345|FG001|Overall Study|Did not provide hot flash diary data|3|||
164385777|NCT01418209|593781346|FG002|Overall Study|Did not provide hot flash diary data|3|||
164385778|NCT03779841|593781347|FG000|Randomized Population|Did Not Receive Treatment|3|||
164385779|NCT03779841|593781348|FG001|Randomized Population|Did Not Receive Treatment|1|||
164385780|NCT03779841|593781349|FG002|Randomized Population|Did Not Receive Treatment|0|||
164385781|NCT03779841|593781347|FG000|Treated (Safety) Population|Adverse Event|1|||
164385782|NCT03779841|593781348|FG001|Treated (Safety) Population|Adverse Event|1|||
164385783|NCT03779841|593781349|FG002|Treated (Safety) Population|Adverse Event|0|||
164385784|NCT03779841|593781347|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
164385785|NCT03779841|593781348|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
164385786|NCT03779841|593781349|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
164385787|NCT03779841|593781347|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
164385788|NCT03779841|593781348|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
164385789|NCT03779841|593781349|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
164385790|NCT03779841|593781347|FG000|Treated (Safety) Population|Death|1|||
164385791|NCT03779841|593781348|FG001|Treated (Safety) Population|Death|0|||
164385792|NCT03779841|593781349|FG002|Treated (Safety) Population|Death|2|||
164385793|NCT02788175|593781350|FG000|Overall Study|Protocol Violation|3|||
164385794|NCT02788175|593781350|FG000|Overall Study|Withdrawal by Subject|4|||
164385795|NCT02788175|593781350|FG000|Overall Study|Ineligible prior to study agent|6|||
164385796|NCT00136955|593783851|FG000|Overall Study|Adverse Event|8|||
164385797|NCT00136955|593783851|FG000|Overall Study|Lost to Follow-up|1|||
164385798|NCT00136955|593783851|FG000|Overall Study|Withdrawal by Subject|2|||
164385799|NCT00136955|593783851|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
164592870|NCT00441441|594534611|FG000|Overall Study|Protocol Violation|4|||
164592871|NCT00441441|594534612|FG001|Overall Study|Protocol Violation|6|||
164592872|NCT00441441|594534611|FG000|Overall Study|Exacerbation of asthma|1|||
164592873|NCT00441441|594534612|FG001|Overall Study|Exacerbation of asthma|2|||
164592874|NCT00441441|594534611|FG000|Overall Study|Withdrawal by Subject|1|||
164592875|NCT00441441|594534612|FG001|Overall Study|Withdrawal by Subject|2|||
164592876|NCT00441441|594534611|FG000|Overall Study|Other|3|||
164592877|NCT00441441|594534612|FG001|Overall Study|Other|3|||
164592878|NCT02273050|594534613|FG000|Overall Study|Adverse Event|4|||
164592879|NCT02273050|594534614|FG001|Overall Study|Adverse Event|3|||
164592880|NCT02273050|594534615|FG002|Overall Study|Adverse Event|3|||
164702974|NCT00132028|594937759|FG000|Overall Study|Withdrawal by Subject|2|||
164702975|NCT00132028|594937759|FG000|Overall Study|not eligible|2|||
164385800|NCT04827576|593783852|FG000|Overall Study|Death|5|||
164385801|NCT04827576|593783853|FG001|Overall Study|Death|17|||
164385802|NCT04827576|593783854|FG002|Overall Study|Death|17|||
164385803|NCT04827576|593783855|FG003|Overall Study|Death|32|||
164440315|NCT02045836|593978976|FG000|Overall Study|Adverse Event|4|||
164592881|NCT02273050|594534613|FG000|Overall Study|Death|0|||
164592882|NCT02273050|594534614|FG001|Overall Study|Death|0|||
164592883|NCT02273050|594534615|FG002|Overall Study|Death|1|||
164592884|NCT02273050|594534613|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
164592885|NCT02273050|594534614|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
164702976|NCT00132028|594937759|FG000|Overall Study|Physician Decision|3|||
164385804|NCT04827576|593783852|FG000|Overall Study|Study Terminated by Sponsor|2|||
164385805|NCT04827576|593783853|FG001|Overall Study|Study Terminated by Sponsor|9|||
164385806|NCT04827576|593783854|FG002|Overall Study|Study Terminated by Sponsor|7|||
164592886|NCT02273050|594534615|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
164592887|NCT02273050|594534613|FG000|Overall Study|Lack of Efficacy|0|||
164592888|NCT02273050|594534614|FG001|Overall Study|Lack of Efficacy|1|||
164592889|NCT02273050|594534615|FG002|Overall Study|Lack of Efficacy|1|||
164592890|NCT02273050|594534613|FG000|Overall Study|Withdrawal by Subject|17|||
164592891|NCT02273050|594534614|FG001|Overall Study|Withdrawal by Subject|14|||
164592892|NCT02273050|594534615|FG002|Overall Study|Withdrawal by Subject|16|||
164592893|NCT02273050|594534613|FG000|Overall Study|Lost to Follow-up|0|||
164592894|NCT02273050|594534614|FG001|Overall Study|Lost to Follow-up|2|||
164592895|NCT02273050|594534615|FG002|Overall Study|Lost to Follow-up|3|||
164592896|NCT02273050|594534613|FG000|Overall Study|Protocol Violation|3|||
164592897|NCT02273050|594534614|FG001|Overall Study|Protocol Violation|1|||
164592898|NCT02273050|594534615|FG002|Overall Study|Protocol Violation|4|||
164385807|NCT04827576|593783855|FG003|Overall Study|Study Terminated by Sponsor|5|||
164385808|NCT04827576|593783852|FG000|Overall Study|Investigator's Discretion|1|||
164385809|NCT04827576|593783853|FG001|Overall Study|Investigator's Discretion|0|||
164385810|NCT04827576|593783854|FG002|Overall Study|Investigator's Discretion|2|||
164385811|NCT04827576|593783855|FG003|Overall Study|Investigator's Discretion|5|||
164385812|NCT04827576|593783852|FG000|Overall Study|Withdrew Consent|0|||
164385813|NCT04827576|593783853|FG001|Overall Study|Withdrew Consent|3|||
164385814|NCT04827576|593783854|FG002|Overall Study|Withdrew Consent|0|||
164385815|NCT04827576|593783855|FG003|Overall Study|Withdrew Consent|0|||
164385816|NCT04827576|593783852|FG000|Overall Study|Lost to Follow-up|1|||
164385817|NCT04827576|593783853|FG001|Overall Study|Lost to Follow-up|0|||
164385818|NCT04827576|593783854|FG002|Overall Study|Lost to Follow-up|0|||
164385819|NCT04827576|593783855|FG003|Overall Study|Lost to Follow-up|0|||
164592899|NCT04009096|594534622|FG000|Overall Study|Withdrawal by Subject|0|||
164592900|NCT04009096|594534623|FG001|Overall Study|Withdrawal by Subject|7|||
164592901|NCT04009096|594534624|FG002|Overall Study|Withdrawal by Subject|0|||
164592902|NCT04009096|594534622|FG000|Overall Study|Physician Decision|0|||
164592903|NCT04009096|594534623|FG001|Overall Study|Physician Decision|1|||
164592904|NCT04009096|594534624|FG002|Overall Study|Physician Decision|0|||
164385820|NCT01773226|593783856|FG000|Overall Study|Withdrawal by Subject|1|||
164385821|NCT00724282|593783857|FG000|Overall Study|Withdrawal by Subject|3|||
164385822|NCT00724282|593783857|FG000|Overall Study|Physician Decision|1|||
164385823|NCT00970502|593783858|FG000|Overall Study|Withdrawal by Subject|1|||
164385824|NCT01438411|593783859|FG000|Overall Study|Adverse Event|8|||
164385825|NCT01438411|593783859|FG000|Overall Study|Lost to Follow-up|1|||
164385826|NCT01438411|593783859|FG000|Overall Study|Lack of Efficacy|1|||
164385827|NCT01438411|593783859|FG000|Overall Study|Withdrawal by Subject|3|||
164385828|NCT01863680|593783860|FG000|Overall Study|Adverse Event|17|||
164385829|NCT01863680|593783860|FG000|Overall Study|Risk of OHSS|17|||
164385830|NCT01863680|593783860|FG000|Overall Study|Spontaneous pregnancy|2|||
164385831|NCT01863680|593783860|FG000|Overall Study|Withdrawal by Subject|1|||
164385832|NCT01863680|593783860|FG000|Overall Study|Did not undergo IVF/ET|14|||
164385833|NCT01863680|593783860|FG000|Overall Study|Other|6|||
164385834|NCT00618514|593783861|FG000|Overall Study|Lost to Follow-up|11|||
164385835|NCT00618514|593783862|FG001|Overall Study|Lost to Follow-up|12|||
164385836|NCT00618514|593783863|FG002|Overall Study|Lost to Follow-up|4|||
164385837|NCT00566228|593783870|FG000|Overall Study|Withdrawal by Subject|1|||
164385838|NCT00566228|593783871|FG001|Overall Study|Withdrawal by Subject|0|||
164385839|NCT00566228|593783870|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
164385840|NCT00566228|593783871|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
164385841|NCT00566228|593783870|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
164385842|NCT00566228|593783871|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
164385843|NCT00566228|593783870|FG000|Overall Study|progressed before infusion could occur|0|||
164385844|NCT00566228|593783871|FG001|Overall Study|progressed before infusion could occur|1|||
164385845|NCT03320070|593783874|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
164385846|NCT03320070|593783875|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
164385847|NCT03320070|593783874|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
164385848|NCT03320070|593783875|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
164385849|NCT03320070|593783874|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
164592905|NCT00450372|594534625|FG000|Overall Study|Physician Decision|1|||
164385850|NCT03320070|593783875|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
164385851|NCT03320070|593783874|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
164385852|NCT03320070|593783875|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
164592906|NCT00520676|594534626|FG000|Overall Study|Death|84|||
164592907|NCT00520676|594534627|FG001|Overall Study|Death|81|||
164592908|NCT00520676|594534626|FG000|Overall Study|Lost to Follow-up|6|||
164385853|NCT03320070|593783874|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
164385854|NCT03320070|593783875|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
164385855|NCT03320070|593783874|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
164385856|NCT03320070|593783875|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
164385857|NCT03586648|593783876|FG000|Period 1|Withdrawal by Subject|0|||
164592909|NCT00520676|594534627|FG001|Overall Study|Lost to Follow-up|10|||
164592910|NCT00520676|594534626|FG000|Overall Study|Physician Decision|4|||
164592911|NCT00520676|594534627|FG001|Overall Study|Physician Decision|1|||
164592912|NCT00520676|594534626|FG000|Overall Study|Withdrawal by Subject|7|||
164592913|NCT00520676|594534627|FG001|Overall Study|Withdrawal by Subject|11|||
164592914|NCT05131451|594534628|FG000|Overall Study|Protocol Violation|1|||
164385858|NCT03586648|593783877|FG001|Period 1|Withdrawal by Subject|1|||
164385859|NCT03586648|593783876|FG000|Period 1|Lost to Follow-up|1|||
164385860|NCT03586648|593783877|FG001|Period 1|Lost to Follow-up|1|||
164385861|NCT03586648|593783876|FG000|Period 1|Adverse Event|1|||
164385862|NCT03586648|593783877|FG001|Period 1|Adverse Event|0|||
164385863|NCT03586648|593783876|FG000|Period 1|Study related symptoms or complaints|2|||
164385864|NCT03586648|593783877|FG001|Period 1|Study related symptoms or complaints|1|||
164385865|NCT03586648|593783876|FG000|Period 1|Physician Decision|0|||
164385866|NCT03586648|593783877|FG001|Period 1|Physician Decision|1|||
164385867|NCT03586648|593783876|FG000|Period 2|Adverse Event|1|||
164385868|NCT03586648|593783877|FG001|Period 2|Adverse Event|0|||
164385869|NCT02041195|593783878|FG000|Overall Study|Adverse Event|1|||
164385870|NCT02041195|593783879|FG001|Overall Study|Adverse Event|2|||
164385871|NCT02041195|593783880|FG002|Overall Study|Adverse Event|0|||
164385872|NCT02041195|593783881|FG003|Overall Study|Adverse Event|0|||
164385873|NCT02041195|593783882|FG004|Overall Study|Adverse Event|0|||
164385874|NCT02041195|593783883|FG005|Overall Study|Adverse Event|0|||
164385875|NCT02041195|593783884|FG006|Overall Study|Adverse Event|3|||
164385876|NCT02041195|593783885|FG007|Overall Study|Adverse Event|0|||
164385877|NCT02041195|593783878|FG000|Overall Study|Withdrawal by Subject|1|||
164385878|NCT02041195|593783879|FG001|Overall Study|Withdrawal by Subject|0|||
164385879|NCT02041195|593783880|FG002|Overall Study|Withdrawal by Subject|0|||
164385880|NCT02041195|593783881|FG003|Overall Study|Withdrawal by Subject|0|||
164385881|NCT02041195|593783882|FG004|Overall Study|Withdrawal by Subject|0|||
164385882|NCT02041195|593783883|FG005|Overall Study|Withdrawal by Subject|0|||
164385883|NCT02041195|593783884|FG006|Overall Study|Withdrawal by Subject|4|||
164385884|NCT02041195|593783885|FG007|Overall Study|Withdrawal by Subject|3|||
164385885|NCT02041195|593783878|FG000|Overall Study|Unable to comply with study visits|0|||
164385886|NCT02041195|593783879|FG001|Overall Study|Unable to comply with study visits|1|||
164385887|NCT02041195|593783880|FG002|Overall Study|Unable to comply with study visits|0|||
164385888|NCT02041195|593783881|FG003|Overall Study|Unable to comply with study visits|0|||
164385889|NCT02041195|593783882|FG004|Overall Study|Unable to comply with study visits|1|||
164385890|NCT02041195|593783883|FG005|Overall Study|Unable to comply with study visits|0|||
164385891|NCT02041195|593783884|FG006|Overall Study|Unable to comply with study visits|0|||
164385892|NCT02041195|593783885|FG007|Overall Study|Unable to comply with study visits|0|||
164385893|NCT02367911|593783888|FG000|Overall Study|Withdrawal by Subject|3|||
164385894|NCT02367911|593783889|FG001|Overall Study|Withdrawal by Subject|2|||
164385895|NCT02367911|593783888|FG000|Overall Study|Lost to Follow-up|2|||
164385896|NCT02367911|593783889|FG001|Overall Study|Lost to Follow-up|2|||
164385897|NCT00263666|593783890|FG000|Overall Study|Adverse Event|6|||
164385898|NCT00263666|593783891|FG001|Overall Study|Adverse Event|8|||
164385899|NCT00263666|593783890|FG000|Overall Study|Lost to Follow-up|1|||
164592915|NCT05131451|594534629|FG001|Overall Study|Protocol Violation|0|||
164592916|NCT04426825|594534637|FG000|Overall Study|Death|17|||
164592917|NCT04426825|594534637|FG000|Overall Study|Lost to Follow-up|1|||
164592918|NCT04426825|594534637|FG000|Overall Study|Study terminated by sponsor|5|||
164592919|NCT04346628|594534638|FG000|Overall Study|Lost to Follow-up|4|||
164592920|NCT04346628|594534639|FG001|Overall Study|Lost to Follow-up|4|||
164592921|NCT04346628|594534638|FG000|Overall Study|Withdrew (had personal reasons)|2|||
164592922|NCT04346628|594534639|FG001|Overall Study|Withdrew (had personal reasons)|5|||
164592923|NCT04346628|594534638|FG000|Overall Study|Withdrew (medication intolerant)|0|||
164592924|NCT04346628|594534639|FG001|Overall Study|Withdrew (medication intolerant)|3|||
164592925|NCT04346628|594534638|FG000|Overall Study|Withdrew (declined intervention)|0|||
164592926|NCT04346628|594534639|FG001|Overall Study|Withdrew (declined intervention)|1|||
164592927|NCT03298412|594534644|FG000|Run-in Period|Other, Not Specified|1|||
164592928|NCT03298412|594534644|FG000|Run-in Period|Disease Progression|1|||
164592929|NCT03298412|594534644|FG000|Run-in Period|Ineligibility Determined|1|||
164592930|NCT03298412|594534644|FG000|Run-in Period|Decision by Sponsor|6|||
164592931|NCT03456713|594534647|FG000|Overall Study|Lost to Follow-up|1|||
164592932|NCT03456713|594534648|FG001|Overall Study|Lost to Follow-up|0|||
164592933|NCT03456713|594534649|FG002|Overall Study|Lost to Follow-up|0|||
164592934|NCT03456713|594534650|FG003|Overall Study|Lost to Follow-up|0|||
164592935|NCT01263691|594534651|FG000|Overall Study|Lost to Follow-up|1|||
164592936|NCT01263691|594534652|FG001|Overall Study|Lost to Follow-up|0|||
164592937|NCT01263691|594534653|FG002|Overall Study|Lost to Follow-up|1|||
164592938|NCT01263691|594534654|FG003|Overall Study|Lost to Follow-up|1|||
164592939|NCT01263691|594534655|FG004|Overall Study|Lost to Follow-up|0|||
164592940|NCT01263691|594534656|FG005|Overall Study|Lost to Follow-up|0|||
164592941|NCT01263691|594534651|FG000|Overall Study|Withdrawal by Subject|1|||
164592942|NCT01263691|594534652|FG001|Overall Study|Withdrawal by Subject|0|||
164592943|NCT01263691|594534653|FG002|Overall Study|Withdrawal by Subject|0|||
164592944|NCT01263691|594534654|FG003|Overall Study|Withdrawal by Subject|0|||
164592945|NCT01263691|594534655|FG004|Overall Study|Withdrawal by Subject|0|||
164592946|NCT01263691|594534656|FG005|Overall Study|Withdrawal by Subject|0|||
164592947|NCT01263691|594534651|FG000|Overall Study|Adverse Event|1|||
164592948|NCT01263691|594534652|FG001|Overall Study|Adverse Event|0|||
164592949|NCT01263691|594534653|FG002|Overall Study|Adverse Event|0|||
164385900|NCT00263666|593783891|FG001|Overall Study|Lost to Follow-up|2|||
164385901|NCT00263666|593783890|FG000|Overall Study|Withdrawal by Subject|0|||
164385902|NCT00263666|593783891|FG001|Overall Study|Withdrawal by Subject|1|||
164385903|NCT02492100|593783892|FG000|Overall Study|Death|1|||
164385904|NCT03832010|593783893|FG000|Overall Study|Withdrawal by Subject|2|||
164385905|NCT03832010|593783894|FG001|Overall Study|Withdrawal by Subject|1|||
164385906|NCT03832010|593783895|FG002|Overall Study|Withdrawal by Subject|0|||
164385907|NCT03832010|593783893|FG000|Overall Study|Lost to Follow-up|2|||
164385908|NCT03832010|593783894|FG001|Overall Study|Lost to Follow-up|1|||
164385909|NCT03832010|593783895|FG002|Overall Study|Lost to Follow-up|1|||
164385910|NCT02348216|593783896|FG000|Overall Study|Death|5|||
164385911|NCT02348216|593783897|FG001|Overall Study|Death|53|||
164385912|NCT02348216|593783898|FG002|Overall Study|Death|11|||
164385913|NCT02348216|593783899|FG003|Overall Study|Death|20|||
164385914|NCT02348216|593783900|FG004|Overall Study|Death|16|||
164385915|NCT02348216|593783901|FG005|Overall Study|Death|32|||
164385916|NCT02348216|593783902|FG006|Overall Study|Death|17|||
164385917|NCT02348216|593783896|FG000|Overall Study|Full consent withdrawal|0|||
164385918|NCT02348216|593783897|FG001|Overall Study|Full consent withdrawal|0|||
164385919|NCT02348216|593783898|FG002|Overall Study|Full consent withdrawal|0|||
164385920|NCT02348216|593783899|FG003|Overall Study|Full consent withdrawal|1|||
164385921|NCT02348216|593783900|FG004|Overall Study|Full consent withdrawal|3|||
164385922|NCT02348216|593783901|FG005|Overall Study|Full consent withdrawal|0|||
164385923|NCT02348216|593783902|FG006|Overall Study|Full consent withdrawal|3|||
164385924|NCT02348216|593783896|FG000|Overall Study|Lost to Follow-up|0|||
164385925|NCT02348216|593783897|FG001|Overall Study|Lost to Follow-up|5|||
164385926|NCT02348216|593783898|FG002|Overall Study|Lost to Follow-up|2|||
164385927|NCT02348216|593783899|FG003|Overall Study|Lost to Follow-up|0|||
164385928|NCT02348216|593783900|FG004|Overall Study|Lost to Follow-up|1|||
164385929|NCT02348216|593783901|FG005|Overall Study|Lost to Follow-up|1|||
164385930|NCT02348216|593783902|FG006|Overall Study|Lost to Follow-up|1|||
164385931|NCT02348216|593783896|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
164385932|NCT02348216|593783897|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
164385933|NCT02348216|593783898|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
164385934|NCT02348216|593783899|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
164385935|NCT02348216|593783900|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
164385936|NCT02348216|593783901|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
164385937|NCT02348216|593783902|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
164385938|NCT02348216|593783896|FG000|Overall Study|Reason not specified|2|||
164385939|NCT02348216|593783897|FG001|Overall Study|Reason not specified|19|||
164385940|NCT02348216|593783898|FG002|Overall Study|Reason not specified|11|||
164385941|NCT02348216|593783899|FG003|Overall Study|Reason not specified|17|||
164385942|NCT02348216|593783900|FG004|Overall Study|Reason not specified|21|||
164385943|NCT02348216|593783901|FG005|Overall Study|Reason not specified|17|||
164385944|NCT02348216|593783902|FG006|Overall Study|Reason not specified|19|||
164385945|NCT01055639|593783903|FG000|Overall Study|Adverse Event|0|||
164385946|NCT01055639|593783904|FG001|Overall Study|Adverse Event|1|||
164385947|NCT01055639|593783903|FG000|Overall Study|Lack of Efficacy|0|||
164385948|NCT01055639|593783904|FG001|Overall Study|Lack of Efficacy|1|||
164385949|NCT01055639|593783903|FG000|Overall Study|Lost to Follow-up|8|||
164385950|NCT01055639|593783904|FG001|Overall Study|Lost to Follow-up|11|||
164385951|NCT01055639|593783903|FG000|Overall Study|Protocol Violation|5|||
164385952|NCT01055639|593783904|FG001|Overall Study|Protocol Violation|5|||
164385953|NCT01055639|593783903|FG000|Overall Study|Withdrawal by Subject|8|||
164385954|NCT01055639|593783904|FG001|Overall Study|Withdrawal by Subject|11|||
164385955|NCT01202773|593783906|FG000|Overall Study|Adverse Event|4|||
164385956|NCT01202773|593783907|FG001|Overall Study|Adverse Event|5|||
164385957|NCT01202773|593783908|FG002|Overall Study|Adverse Event|5|||
164385958|NCT01202773|593783906|FG000|Overall Study|Lack of Efficacy|5|||
164385959|NCT01202773|593783907|FG001|Overall Study|Lack of Efficacy|4|||
164385960|NCT01202773|593783908|FG002|Overall Study|Lack of Efficacy|9|||
164385961|NCT01202773|593783906|FG000|Overall Study|Entry Criteria Not Met|2|||
164385962|NCT01202773|593783907|FG001|Overall Study|Entry Criteria Not Met|0|||
164385963|NCT01202773|593783908|FG002|Overall Study|Entry Criteria Not Met|1|||
164702977|NCT02140411|594937760|FG000|Overall Study|Adverse Event|1|||
164385964|NCT01202773|593783906|FG000|Overall Study|Lost to Follow-up|1|||
164385965|NCT01202773|593783907|FG001|Overall Study|Lost to Follow-up|2|||
164385966|NCT01202773|593783908|FG002|Overall Study|Lost to Follow-up|2|||
164385967|NCT01202773|593783906|FG000|Overall Study|Withdrawal by Subject|13|||
164385968|NCT01202773|593783907|FG001|Overall Study|Withdrawal by Subject|6|||
164385969|NCT01202773|593783908|FG002|Overall Study|Withdrawal by Subject|5|||
164385970|NCT01202773|593783906|FG000|Overall Study|Physician Decision|2|||
164385971|NCT01202773|593783907|FG001|Overall Study|Physician Decision|0|||
164385972|NCT01202773|593783908|FG002|Overall Study|Physician Decision|0|||
164385973|NCT01202773|593783906|FG000|Overall Study|Protocol Violation|11|||
164385974|NCT01202773|593783907|FG001|Overall Study|Protocol Violation|6|||
164385975|NCT01202773|593783908|FG002|Overall Study|Protocol Violation|10|||
164385976|NCT01202773|593783906|FG000|Overall Study|Sponsor Decision|19|||
164385977|NCT01202773|593783907|FG001|Overall Study|Sponsor Decision|20|||
164385978|NCT01202773|593783908|FG002|Overall Study|Sponsor Decision|23|||
164385979|NCT03058679|593783914|FG000|Baseline to Week 6|Lost to Follow-up|3|||
164385980|NCT03058679|593783915|FG001|Baseline to Week 6|Lost to Follow-up|2|||
164385981|NCT03058679|593783914|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
164385982|NCT03058679|593783915|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
164385983|NCT03058679|593783914|FG000|Baseline to Week 6|Adverse Event|6|||
164385984|NCT03058679|593783915|FG001|Baseline to Week 6|Adverse Event|6|||
164385985|NCT03058679|593783914|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
164440316|NCT02045836|593978977|FG001|Overall Study|Adverse Event|4|||
164385986|NCT03058679|593783915|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
164385987|NCT03058679|593783914|FG000|Baseline to Week 6|Difficulty following the diet|0|||
164385988|NCT03058679|593783915|FG001|Baseline to Week 6|Difficulty following the diet|2|||
164385989|NCT03058679|593783914|FG000|Baseline to Week 6|Physician Decision|1|||
164385990|NCT03058679|593783915|FG001|Baseline to Week 6|Physician Decision|0|||
164385991|NCT03058679|593783914|FG000|Week 6 to Week 12|Change in medication|5|||
164385992|NCT03058679|593783915|FG001|Week 6 to Week 12|Change in medication|7|||
164385993|NCT03058679|593783914|FG000|Week 6 to Week 12|Adverse Event|4|||
164592950|NCT01263691|594534654|FG003|Overall Study|Adverse Event|0|||
164592951|NCT01263691|594534655|FG004|Overall Study|Adverse Event|0|||
164592952|NCT01263691|594534656|FG005|Overall Study|Adverse Event|0|||
164592953|NCT01533935|594534657|FG000|Overall Study|Adverse Event|5|||
164592954|NCT01533935|594534658|FG001|Overall Study|Adverse Event|7|||
164592955|NCT01533935|594534659|FG002|Overall Study|Adverse Event|1|||
164592956|NCT01533935|594534660|FG003|Overall Study|Adverse Event|5|||
164592957|NCT01533935|594534661|FG004|Overall Study|Adverse Event|3|||
164592958|NCT01533935|594534657|FG000|Overall Study|Protocol Violation|0|||
164592959|NCT01533935|594534658|FG001|Overall Study|Protocol Violation|2|||
164592960|NCT01533935|594534659|FG002|Overall Study|Protocol Violation|0|||
164592961|NCT01533935|594534660|FG003|Overall Study|Protocol Violation|0|||
164592962|NCT01533935|594534661|FG004|Overall Study|Protocol Violation|0|||
164592963|NCT01533935|594534657|FG000|Overall Study|Lost to Follow-up|0|||
164592964|NCT01533935|594534658|FG001|Overall Study|Lost to Follow-up|0|||
164592965|NCT01533935|594534659|FG002|Overall Study|Lost to Follow-up|1|||
164592966|NCT01533935|594534660|FG003|Overall Study|Lost to Follow-up|0|||
164592967|NCT01533935|594534661|FG004|Overall Study|Lost to Follow-up|0|||
164592968|NCT01533935|594534657|FG000|Overall Study|Withdrawal by Subject|0|||
164592969|NCT01533935|594534658|FG001|Overall Study|Withdrawal by Subject|4|||
164592970|NCT01533935|594534659|FG002|Overall Study|Withdrawal by Subject|5|||
164592971|NCT01533935|594534660|FG003|Overall Study|Withdrawal by Subject|2|||
164592972|NCT01533935|594534661|FG004|Overall Study|Withdrawal by Subject|4|||
164592973|NCT01533935|594534657|FG000|Overall Study|Other reason not defined above|1|||
164592974|NCT01533935|594534658|FG001|Overall Study|Other reason not defined above|0|||
164592975|NCT01533935|594534659|FG002|Overall Study|Other reason not defined above|1|||
164592976|NCT01533935|594534660|FG003|Overall Study|Other reason not defined above|0|||
164592977|NCT01533935|594534661|FG004|Overall Study|Other reason not defined above|1|||
164592978|NCT00069095|594534674|FG000|Primary Treatment Phase|Ongoing|0|||
164592979|NCT00069095|594534675|FG001|Primary Treatment Phase|Ongoing|0|||
164592980|NCT00069095|594534676|FG002|Primary Treatment Phase|Ongoing|5|||
164592981|NCT00069095|594534677|FG003|Primary Treatment Phase|Ongoing|7|||
164592982|NCT00069095|594534678|FG004|Primary Treatment Phase|Ongoing|7|||
164592983|NCT00069095|594534679|FG005|Primary Treatment Phase|Ongoing|4|||
164592984|NCT00069095|594534674|FG000|Primary Treatment Phase|Admin/Other|29|||
164592985|NCT00069095|594534675|FG001|Primary Treatment Phase|Admin/Other|38|||
164592986|NCT00069095|594534676|FG002|Primary Treatment Phase|Admin/Other|31|||
164592987|NCT00069095|594534677|FG003|Primary Treatment Phase|Admin/Other|45|||
164592988|NCT00069095|594534678|FG004|Primary Treatment Phase|Admin/Other|48|||
164592989|NCT00069095|594534679|FG005|Primary Treatment Phase|Admin/Other|42|||
164592990|NCT00069095|594534674|FG000|Primary Treatment Phase|Adverse Event|99|||
164592991|NCT00069095|594534675|FG001|Primary Treatment Phase|Adverse Event|92|||
164592992|NCT00069095|594534676|FG002|Primary Treatment Phase|Adverse Event|71|||
164592993|NCT00069095|594534677|FG003|Primary Treatment Phase|Adverse Event|72|||
164592994|NCT00069095|594534678|FG004|Primary Treatment Phase|Adverse Event|109|||
164592995|NCT00069095|594534679|FG005|Primary Treatment Phase|Adverse Event|101|||
164592996|NCT00069095|594534674|FG000|Primary Treatment Phase|Death|14|||
164592997|NCT00069095|594534675|FG001|Primary Treatment Phase|Death|8|||
164592998|NCT00069095|594534676|FG002|Primary Treatment Phase|Death|2|||
164592999|NCT00069095|594534677|FG003|Primary Treatment Phase|Death|5|||
164593000|NCT00069095|594534678|FG004|Primary Treatment Phase|Death|8|||
164593001|NCT00069095|594534679|FG005|Primary Treatment Phase|Death|8|||
164593002|NCT00069095|594534674|FG000|Primary Treatment Phase|Failure to return|5|||
164593003|NCT00069095|594534675|FG001|Primary Treatment Phase|Failure to return|5|||
164593004|NCT00069095|594534676|FG002|Primary Treatment Phase|Failure to return|0|||
164593005|NCT00069095|594534677|FG003|Primary Treatment Phase|Failure to return|0|||
164593006|NCT00069095|594534678|FG004|Primary Treatment Phase|Failure to return|0|||
164385994|NCT03058679|593783915|FG001|Week 6 to Week 12|Adverse Event|3|||
164385995|NCT03058679|593783914|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
164385996|NCT03058679|593783915|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
164385997|NCT03058679|593783914|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
164385998|NCT03058679|593783915|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
164385999|NCT04137380|593783920|FG000|Overall Study|Physician Decision|0|||
164386000|NCT04137380|593783921|FG001|Overall Study|Physician Decision|0|||
164386001|NCT04137380|593783922|FG002|Overall Study|Physician Decision|0|||
164386002|NCT04137380|593783923|FG003|Overall Study|Physician Decision|1|||
164386003|NCT04137380|593783924|FG004|Overall Study|Physician Decision|0|||
164386004|NCT04137380|593783925|FG005|Overall Study|Physician Decision|0|||
164386005|NCT04137380|593783926|FG006|Overall Study|Physician Decision|0|||
164386006|NCT00575588|593783932|FG000|Overall Study|Adverse Event|11|||
164386007|NCT00575588|593783933|FG001|Overall Study|Adverse Event|13|||
164386008|NCT00575588|593783932|FG000|Overall Study|Withdrawal by Subject|27|||
164386009|NCT00575588|593783933|FG001|Overall Study|Withdrawal by Subject|31|||
164386010|NCT00575588|593783932|FG000|Overall Study|Lost to Follow-up|1|||
164386011|NCT00575588|593783933|FG001|Overall Study|Lost to Follow-up|3|||
164386012|NCT00575588|593783932|FG000|Overall Study|Death|4|||
164386013|NCT00575588|593783933|FG001|Overall Study|Death|2|||
164386014|NCT00575588|593783932|FG000|Overall Study|Incorrect enrollment|8|||
164386015|NCT00575588|593783933|FG001|Overall Study|Incorrect enrollment|4|||
164386016|NCT00575588|593783932|FG000|Overall Study|Study specific discontinuation criteria|203|||
164386017|NCT00575588|593783933|FG001|Overall Study|Study specific discontinuation criteria|218|||
164386018|NCT00575588|593783932|FG000|Overall Study|Severe non-compliance to protocol|5|||
164386019|NCT00575588|593783933|FG001|Overall Study|Severe non-compliance to protocol|7|||
164386020|NCT00575588|593783932|FG000|Overall Study|Safety reasons|2|||
164386021|NCT00575588|593783933|FG001|Overall Study|Safety reasons|1|||
164386022|NCT00575588|593783932|FG000|Overall Study|Elevated triglyceride|1|||
164386023|NCT00575588|593783933|FG001|Overall Study|Elevated triglyceride|0|||
164386024|NCT00575588|593783932|FG000|Overall Study|Patient moved|1|||
164386025|NCT00575588|593783933|FG001|Overall Study|Patient moved|3|||
164386026|NCT00575588|593783932|FG000|Overall Study|Impossible to determine HbA1c|0|||
164386027|NCT00575588|593783933|FG001|Overall Study|Impossible to determine HbA1c|1|||
164386028|NCT02265705|593783934|FG000|Treatment Period Week 0-24|Adverse Event|3|||
164386029|NCT02265705|593783935|FG001|Treatment Period Week 0-24|Adverse Event|2|||
164386030|NCT02265705|593783936|FG002|Treatment Period Week 0-24|Adverse Event|0|||
164386031|NCT02265705|593783937|FG003|Treatment Period Week 0-24|Adverse Event|0|||
164386032|NCT02265705|593783938|FG004|Treatment Period Week 0-24|Adverse Event|0|||
164386033|NCT02265705|593783939|FG005|Treatment Period Week 0-24|Adverse Event|0|||
164386034|NCT02265705|593783940|FG006|Treatment Period Week 0-24|Adverse Event|0|||
164386035|NCT02265705|593783934|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
164386036|NCT02265705|593783935|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
164386037|NCT02265705|593783936|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
164386038|NCT02265705|593783937|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
164386039|NCT02265705|593783938|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
164386040|NCT02265705|593783939|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
164386041|NCT02265705|593783940|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
164386042|NCT02265705|593783934|FG000|Treatment Period Week 0-24|Physician Decision|1|||
164386043|NCT02265705|593783935|FG001|Treatment Period Week 0-24|Physician Decision|0|||
164386044|NCT02265705|593783936|FG002|Treatment Period Week 0-24|Physician Decision|0|||
164386045|NCT02265705|593783937|FG003|Treatment Period Week 0-24|Physician Decision|0|||
164386046|NCT02265705|593783938|FG004|Treatment Period Week 0-24|Physician Decision|0|||
164386047|NCT02265705|593783939|FG005|Treatment Period Week 0-24|Physician Decision|0|||
164386048|NCT02265705|593783940|FG006|Treatment Period Week 0-24|Physician Decision|0|||
164386049|NCT02265705|593783934|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
164386050|NCT02265705|593783935|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
164386051|NCT02265705|593783936|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
164386052|NCT02265705|593783937|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
164386053|NCT02265705|593783938|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
164386054|NCT02265705|593783939|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
164440317|NCT02045836|593978976|FG000|Overall Study|Withdrawal by Subject|1|||
164386055|NCT02265705|593783940|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
164386056|NCT02265705|593783934|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
164386057|NCT02265705|593783935|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
164386058|NCT02265705|593783936|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
164386059|NCT02265705|593783937|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
164386060|NCT02265705|593783938|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
164386061|NCT02265705|593783939|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
164440318|NCT02045836|593978977|FG001|Overall Study|Withdrawal by Subject|1|||
164440319|NCT02045836|593978976|FG000|Overall Study|Lost to Follow-up|4|||
164593007|NCT00069095|594534679|FG005|Primary Treatment Phase|Failure to return|2|||
164386062|NCT02265705|593783940|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
164386063|NCT02265705|593783934|FG000|Rescue Period|Withdrawal by Subject|0|||
164386064|NCT02265705|593783935|FG001|Rescue Period|Withdrawal by Subject|0|||
164386065|NCT02265705|593783936|FG002|Rescue Period|Withdrawal by Subject|1|||
164386066|NCT02265705|593783937|FG003|Rescue Period|Withdrawal by Subject|0|||
164386067|NCT02265705|593783938|FG004|Rescue Period|Withdrawal by Subject|0|||
164386068|NCT02265705|593783939|FG005|Rescue Period|Withdrawal by Subject|0|||
164386069|NCT02265705|593783940|FG006|Rescue Period|Withdrawal by Subject|0|||
164386070|NCT02265705|593783934|FG000|Rescue Period|Death|0|||
164386071|NCT02265705|593783935|FG001|Rescue Period|Death|0|||
164386072|NCT02265705|593783936|FG002|Rescue Period|Death|1|||
164386073|NCT02265705|593783937|FG003|Rescue Period|Death|0|||
164386074|NCT02265705|593783938|FG004|Rescue Period|Death|0|||
164386075|NCT02265705|593783939|FG005|Rescue Period|Death|0|||
164386076|NCT02265705|593783940|FG006|Rescue Period|Death|0|||
164386077|NCT02265705|593783934|FG000|Rescue Period|Lack of Efficacy|0|||
164386078|NCT02265705|593783935|FG001|Rescue Period|Lack of Efficacy|0|||
164386079|NCT02265705|593783936|FG002|Rescue Period|Lack of Efficacy|1|||
164386080|NCT02265705|593783937|FG003|Rescue Period|Lack of Efficacy|0|||
164386081|NCT02265705|593783938|FG004|Rescue Period|Lack of Efficacy|0|||
164386082|NCT02265705|593783939|FG005|Rescue Period|Lack of Efficacy|0|||
164386083|NCT02265705|593783940|FG006|Rescue Period|Lack of Efficacy|0|||
164386084|NCT02265705|593783934|FG000|Open Label Period|Adverse Event|0|||
164386085|NCT02265705|593783935|FG001|Open Label Period|Adverse Event|0|||
164386086|NCT02265705|593783936|FG002|Open Label Period|Adverse Event|0|||
164386087|NCT02265705|593783937|FG003|Open Label Period|Adverse Event|2|||
164386088|NCT02265705|593783938|FG004|Open Label Period|Adverse Event|2|||
164386089|NCT02265705|593783939|FG005|Open Label Period|Adverse Event|0|||
164386090|NCT02265705|593783940|FG006|Open Label Period|Adverse Event|0|||
164386091|NCT02265705|593783934|FG000|Open Label Period|Physician Decision|0|||
164386092|NCT02265705|593783935|FG001|Open Label Period|Physician Decision|0|||
164386093|NCT02265705|593783936|FG002|Open Label Period|Physician Decision|0|||
164386094|NCT02265705|593783937|FG003|Open Label Period|Physician Decision|0|||
164386095|NCT02265705|593783938|FG004|Open Label Period|Physician Decision|1|||
164386096|NCT02265705|593783939|FG005|Open Label Period|Physician Decision|0|||
164386097|NCT02265705|593783940|FG006|Open Label Period|Physician Decision|0|||
164386098|NCT02265705|593783934|FG000|Open Label Period|Withdrawal by Subject|0|||
164386099|NCT02265705|593783935|FG001|Open Label Period|Withdrawal by Subject|0|||
164386100|NCT02265705|593783936|FG002|Open Label Period|Withdrawal by Subject|0|||
164386101|NCT02265705|593783937|FG003|Open Label Period|Withdrawal by Subject|0|||
164386102|NCT02265705|593783938|FG004|Open Label Period|Withdrawal by Subject|2|||
164386103|NCT02265705|593783939|FG005|Open Label Period|Withdrawal by Subject|0|||
164386104|NCT02265705|593783940|FG006|Open Label Period|Withdrawal by Subject|0|||
164386105|NCT02265705|593783934|FG000|Follow-up Period|Sponsor Decision|0|||
164386106|NCT02265705|593783935|FG001|Follow-up Period|Sponsor Decision|0|||
164386107|NCT02265705|593783936|FG002|Follow-up Period|Sponsor Decision|0|||
164386108|NCT02265705|593783937|FG003|Follow-up Period|Sponsor Decision|0|||
164386109|NCT02265705|593783938|FG004|Follow-up Period|Sponsor Decision|0|||
164386110|NCT02265705|593783939|FG005|Follow-up Period|Sponsor Decision|1|||
164386111|NCT02265705|593783940|FG006|Follow-up Period|Sponsor Decision|6|||
164386112|NCT02265705|593783934|FG000|Follow-up Period|Adverse Event|0|||
164386113|NCT02265705|593783935|FG001|Follow-up Period|Adverse Event|0|||
164386114|NCT02265705|593783936|FG002|Follow-up Period|Adverse Event|0|||
164386115|NCT02265705|593783937|FG003|Follow-up Period|Adverse Event|0|||
164386116|NCT02265705|593783938|FG004|Follow-up Period|Adverse Event|0|||
164386117|NCT02265705|593783939|FG005|Follow-up Period|Adverse Event|0|||
164386118|NCT02265705|593783940|FG006|Follow-up Period|Adverse Event|3|||
164386119|NCT02265705|593783934|FG000|Follow-up Period|Physician Decision|0|||
164440320|NCT02045836|593978977|FG001|Overall Study|Lost to Follow-up|7|||
164440321|NCT02045836|593978976|FG000|Overall Study|Migrated from study area|0|||
164440322|NCT02045836|593978977|FG001|Overall Study|Migrated from study area|2|||
164386120|NCT02265705|593783935|FG001|Follow-up Period|Physician Decision|0|||
164386121|NCT02265705|593783936|FG002|Follow-up Period|Physician Decision|0|||
164386122|NCT02265705|593783937|FG003|Follow-up Period|Physician Decision|0|||
164386123|NCT02265705|593783938|FG004|Follow-up Period|Physician Decision|0|||
164386124|NCT02265705|593783939|FG005|Follow-up Period|Physician Decision|0|||
164386125|NCT02265705|593783940|FG006|Follow-up Period|Physician Decision|1|||
164386126|NCT02265705|593783934|FG000|Follow-up Period|Withdrawal by Subject|0|||
164386127|NCT02265705|593783935|FG001|Follow-up Period|Withdrawal by Subject|0|||
164386128|NCT02265705|593783936|FG002|Follow-up Period|Withdrawal by Subject|0|||
164386129|NCT02265705|593783937|FG003|Follow-up Period|Withdrawal by Subject|0|||
164386130|NCT02265705|593783938|FG004|Follow-up Period|Withdrawal by Subject|0|||
164386131|NCT02265705|593783939|FG005|Follow-up Period|Withdrawal by Subject|0|||
164386132|NCT02265705|593783940|FG006|Follow-up Period|Withdrawal by Subject|1|||
164386133|NCT02828111|593783945|FG000|Overall Study|Withdrawal by Subject|0|||
164386134|NCT02828111|593783946|FG001|Overall Study|Withdrawal by Subject|0|||
164386135|NCT02828111|593783947|FG002|Overall Study|Withdrawal by Subject|2|||
164386136|NCT02828111|593783948|FG003|Overall Study|Withdrawal by Subject|0|||
164386137|NCT02828111|593783949|FG004|Overall Study|Withdrawal by Subject|0|||
164386138|NCT02828111|593783945|FG000|Overall Study|Lost to Follow-up|0|||
164386139|NCT02828111|593783946|FG001|Overall Study|Lost to Follow-up|0|||
164386140|NCT02828111|593783947|FG002|Overall Study|Lost to Follow-up|0|||
164386141|NCT02828111|593783948|FG003|Overall Study|Lost to Follow-up|1|||
164386142|NCT02828111|593783949|FG004|Overall Study|Lost to Follow-up|1|||
164386143|NCT00614939|593783950|FG000|Overall Study|Withdrawal by Subject|10|||
164386144|NCT00614939|593783951|FG001|Overall Study|Withdrawal by Subject|17|||
164386145|NCT00614939|593783950|FG000|Overall Study|Study specific discontinuation criteris|13|||
164386146|NCT00614939|593783951|FG001|Overall Study|Study specific discontinuation criteris|16|||
164386147|NCT00614939|593783950|FG000|Overall Study|Adverse Event|2|||
164386148|NCT00614939|593783951|FG001|Overall Study|Adverse Event|5|||
164386149|NCT00614939|593783950|FG000|Overall Study|Incorrect enrollment|1|||
164386150|NCT00614939|593783951|FG001|Overall Study|Incorrect enrollment|2|||
164386151|NCT00614939|593783950|FG000|Overall Study|Death|4|||
164386152|NCT00614939|593783951|FG001|Overall Study|Death|3|||
164386153|NCT00614939|593783950|FG000|Overall Study|Poor/non-compliance|4|||
164386154|NCT00614939|593783951|FG001|Overall Study|Poor/non-compliance|0|||
164386155|NCT00614939|593783950|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
164386156|NCT00614939|593783951|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
164386157|NCT02079805|593783955|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
164386158|NCT02079805|593783956|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
164386159|NCT02079805|593783955|FG000|Overall Study|Voluntary Withdrawal|0|||
164386160|NCT02079805|593783956|FG001|Overall Study|Voluntary Withdrawal|1|||
164386161|NCT00383435|593783957|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
164386162|NCT00383435|593783958|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
164386163|NCT00383435|593783959|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
164386164|NCT00383435|593783960|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
164386165|NCT00383435|593783961|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
164386166|NCT00383435|593783957|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
164386167|NCT00383435|593783958|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
164386168|NCT00383435|593783959|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
164386169|NCT00383435|593783960|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
164386170|NCT00383435|593783961|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
164702978|NCT03981419|594937763|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
164702979|NCT03981419|594937764|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
164702980|NCT01330459|594937765|FG000|Overall Study|Physician Decision|0|||
164702981|NCT01330459|594937766|FG001|Overall Study|Physician Decision|2|||
164702982|NCT02272634|594937774|FG000|Overall Study|Adverse Event|1|||
164702983|NCT02272634|594937775|FG001|Overall Study|Adverse Event|0|||
164702984|NCT02272634|594937776|FG002|Overall Study|Adverse Event|0|||
164702985|NCT02272634|594937774|FG000|Overall Study|Protocol Violation|0|||
164702986|NCT02272634|594937775|FG001|Overall Study|Protocol Violation|0|||
164702987|NCT02272634|594937776|FG002|Overall Study|Protocol Violation|1|||
164702988|NCT02272634|594937774|FG000|Overall Study|Withdrawal by Subject|0|||
164702989|NCT02272634|594937775|FG001|Overall Study|Withdrawal by Subject|1|||
164702990|NCT02272634|594937776|FG002|Overall Study|Withdrawal by Subject|0|||
164702991|NCT01437943|594937777|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
164702992|NCT01437943|594937778|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
164702993|NCT01437943|594937777|FG000|Overall Study|Subject expressed pregnancy plans|1|||
164702994|NCT01437943|594937778|FG001|Overall Study|Subject expressed pregnancy plans|0|||
164702995|NCT01437943|594937777|FG000|Overall Study|Adverse Event|2|||
164702996|NCT01437943|594937778|FG001|Overall Study|Adverse Event|0|||
164702997|NCT01660334|594937779|FG000|Overall Study|Lost to Follow-up|1|||
164386171|NCT00383435|593783957|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
164386172|NCT00383435|593783958|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
164386173|NCT00383435|593783959|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
164386174|NCT00383435|593783960|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
164386175|NCT00383435|593783961|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
164386176|NCT00383435|593783957|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
164386177|NCT00383435|593783958|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
164417449|NCT01474512|593899499|FG010|Long-Term Extension Period|Death|0|||
164417450|NCT01474512|593899500|FG011|Long-Term Extension Period|Death|0|||
164417451|NCT01474512|593899501|FG012|Long-Term Extension Period|Death|9|||
164417452|NCT01474512|593899502|FG013|Long-Term Extension Period|Death|9|||
164417453|NCT01474512|593899503|FG014|Long-Term Extension Period|Death|0|||
164386178|NCT00383435|593783959|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
164386179|NCT00383435|593783960|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
164386180|NCT00383435|593783961|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
164386181|NCT00383435|593783957|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
164386182|NCT00383435|593783958|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
164386183|NCT00383435|593783959|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
164386184|NCT00383435|593783960|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
164386185|NCT00383435|593783961|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
164386186|NCT00383435|593783957|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
164386187|NCT00383435|593783958|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
164386188|NCT00383435|593783959|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
164386189|NCT00383435|593783960|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
164386190|NCT00383435|593783961|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
164386191|NCT00383435|593783957|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
164386192|NCT00383435|593783958|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
164386193|NCT00383435|593783959|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
164386194|NCT00383435|593783960|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
164386195|NCT00383435|593783961|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
164386196|NCT00383435|593783957|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
164386197|NCT00383435|593783958|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
164386198|NCT00383435|593783959|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
164386199|NCT00383435|593783960|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
164386200|NCT00383435|593783961|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
164386201|NCT00383435|593783957|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
164386202|NCT00383435|593783958|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
164386203|NCT00383435|593783959|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
164386204|NCT00383435|593783960|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
164386205|NCT00383435|593783961|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
164386206|NCT00383435|593783957|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
164386207|NCT00383435|593783958|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
164386208|NCT00383435|593783959|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
164702998|NCT00536263|594937780|FG000|Overall Study|Adverse Event|5|||
164702999|NCT00536263|594937781|FG001|Overall Study|Adverse Event|5|||
164703000|NCT00536263|594937782|FG002|Overall Study|Adverse Event|7|||
164703001|NCT00536263|594937780|FG000|Overall Study|Lost to Follow-up|3|||
164703002|NCT00536263|594937781|FG001|Overall Study|Lost to Follow-up|4|||
164703003|NCT00536263|594937782|FG002|Overall Study|Lost to Follow-up|4|||
164703004|NCT00536263|594937780|FG000|Overall Study|Subject withdrew - not treatment related|2|||
164703005|NCT00536263|594937781|FG001|Overall Study|Subject withdrew - not treatment related|0|||
164703006|NCT00536263|594937782|FG002|Overall Study|Subject withdrew - not treatment related|5|||
164703007|NCT00536263|594937780|FG000|Overall Study|Subject withdrew - treatment related|0|||
164703008|NCT00536263|594937781|FG001|Overall Study|Subject withdrew - treatment related|3|||
164703009|NCT00536263|594937782|FG002|Overall Study|Subject withdrew - treatment related|2|||
164703010|NCT00536263|594937780|FG000|Overall Study|Noncompliance with protocol|0|||
164703011|NCT00536263|594937781|FG001|Overall Study|Noncompliance with protocol|0|||
164703012|NCT00536263|594937782|FG002|Overall Study|Noncompliance with protocol|1|||
164703013|NCT00536263|594937780|FG000|Overall Study|Did not meet protocol eligibility|1|||
164703014|NCT00536263|594937781|FG001|Overall Study|Did not meet protocol eligibility|2|||
164703015|NCT00536263|594937782|FG002|Overall Study|Did not meet protocol eligibility|2|||
164703016|NCT01640873|594937789|FG000|Overall Study|Protocol Violation|2|||
164703017|NCT01640873|594937790|FG001|Overall Study|Protocol Violation|1|||
164703018|NCT01321008|594937791|FG000|Overall Study|Early Study Termination|1|||
164703019|NCT00679913|594937792|FG000|Overall Study|Protocol Violation|18|||
164703020|NCT00679913|594937793|FG001|Overall Study|Protocol Violation|13|||
164703021|NCT05069155|594937800|FG000|Overall Study|Withdrawal by Subject|1|||
164703022|NCT05069155|594937801|FG001|Overall Study|Withdrawal by Subject|3|||
164703023|NCT00369382|594937807|FG000|Overall Study|Death|0|||
164703024|NCT00369382|594937808|FG001|Overall Study|Death|2|||
164703025|NCT00369382|594937807|FG000|Overall Study|Physician Decision|2|||
164703026|NCT00369382|594937808|FG001|Overall Study|Physician Decision|1|||
164703027|NCT00369382|594937807|FG000|Overall Study|Withdrawal by Subject|5|||
164386209|NCT00383435|593783960|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
164703028|NCT00369382|594937808|FG001|Overall Study|Withdrawal by Subject|0|||
164703029|NCT00369382|594937807|FG000|Overall Study|Randomized, not treated|2|||
164703030|NCT00369382|594937808|FG001|Overall Study|Randomized, not treated|0|||
164703031|NCT00369382|594937807|FG000|Overall Study|Other|1|||
164703032|NCT00369382|594937808|FG001|Overall Study|Other|0|||
164386210|NCT00383435|593783961|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
164386211|NCT00383435|593783957|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
164386212|NCT00383435|593783958|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
164386213|NCT00383435|593783959|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
164386214|NCT00383435|593783960|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
164386215|NCT00383435|593783961|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
164593008|NCT00069095|594534674|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
164593009|NCT00069095|594534675|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
164593010|NCT00069095|594534676|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
164593011|NCT00069095|594534677|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
164593012|NCT00069095|594534678|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
164593013|NCT00069095|594534679|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
164593014|NCT00069095|594534674|FG000|Primary Treatment Phase|Refused treatment|15|||
164593015|NCT00069095|594534675|FG001|Primary Treatment Phase|Refused treatment|26|||
164593016|NCT00069095|594534676|FG002|Primary Treatment Phase|Refused treatment|17|||
164593017|NCT00069095|594534677|FG003|Primary Treatment Phase|Refused treatment|31|||
164593018|NCT00069095|594534678|FG004|Primary Treatment Phase|Refused treatment|24|||
164593019|NCT00069095|594534679|FG005|Primary Treatment Phase|Refused treatment|27|||
164593020|NCT00069095|594534674|FG000|Primary Treatment Phase|Withdrew|2|||
164593021|NCT00069095|594534675|FG001|Primary Treatment Phase|Withdrew|3|||
164593022|NCT00069095|594534676|FG002|Primary Treatment Phase|Withdrew|8|||
164593023|NCT00069095|594534677|FG003|Primary Treatment Phase|Withdrew|2|||
164593024|NCT00069095|594534678|FG004|Primary Treatment Phase|Withdrew|4|||
164593025|NCT00069095|594534679|FG005|Primary Treatment Phase|Withdrew|9|||
164593026|NCT00069095|594534674|FG000|Primary Treatment Phase|Other Violation|0|||
164593027|NCT00069095|594534675|FG001|Primary Treatment Phase|Other Violation|1|||
164593028|NCT00069095|594534676|FG002|Primary Treatment Phase|Other Violation|1|||
164593029|NCT00069095|594534677|FG003|Primary Treatment Phase|Other Violation|1|||
164593030|NCT00069095|594534678|FG004|Primary Treatment Phase|Other Violation|0|||
164593031|NCT00069095|594534679|FG005|Primary Treatment Phase|Other Violation|1|||
164593032|NCT00069095|594534674|FG000|Primary Treatment Phase|Violation criteria|0|||
164593033|NCT00069095|594534675|FG001|Primary Treatment Phase|Violation criteria|2|||
164593034|NCT00069095|594534676|FG002|Primary Treatment Phase|Violation criteria|4|||
164593035|NCT00069095|594534677|FG003|Primary Treatment Phase|Violation criteria|3|||
164593036|NCT00069095|594534678|FG004|Primary Treatment Phase|Violation criteria|1|||
164593037|NCT00069095|594534679|FG005|Primary Treatment Phase|Violation criteria|5|||
164593038|NCT00069095|594534674|FG000|Post-study Treatment Phase|Missing reason|1|||
164593039|NCT00069095|594534675|FG001|Post-study Treatment Phase|Missing reason|3|||
164144033|NCT00086281|592888572|FG001|Phase 2|Adverse Event|0|||
164386216|NCT00383435|593783957|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
164386217|NCT00383435|593783958|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
164386218|NCT00383435|593783959|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
164386219|NCT00383435|593783960|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
164386220|NCT00383435|593783961|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
164386221|NCT00383435|593783957|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
164386222|NCT00383435|593783958|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
164386223|NCT00383435|593783959|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
164386224|NCT00383435|593783960|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
164386225|NCT00383435|593783961|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
164386226|NCT00383435|593783957|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
164386227|NCT00383435|593783958|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
164386228|NCT00383435|593783959|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
164386229|NCT00383435|593783960|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
164386230|NCT00383435|593783961|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
164386231|NCT00383435|593783957|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
164386232|NCT00383435|593783958|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
164386233|NCT00383435|593783959|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
164386234|NCT00383435|593783960|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
164386235|NCT00383435|593783961|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
164386236|NCT00383435|593783957|FG000|26-Week Treatment Safety Extension|Administrative|1|||
164386237|NCT00383435|593783958|FG001|26-Week Treatment Safety Extension|Administrative|1|||
164386238|NCT00383435|593783959|FG002|26-Week Treatment Safety Extension|Administrative|0|||
164593040|NCT00069095|594534676|FG002|Post-study Treatment Phase|Missing reason|12|||
164593041|NCT00069095|594534677|FG003|Post-study Treatment Phase|Missing reason|8|||
164593042|NCT00069095|594534678|FG004|Post-study Treatment Phase|Missing reason|18|||
164593043|NCT00069095|594534679|FG005|Post-study Treatment Phase|Missing reason|17|||
164593044|NCT00069095|594534674|FG000|Post-study Treatment Phase|Adverse Event|2|||
164593045|NCT00069095|594534675|FG001|Post-study Treatment Phase|Adverse Event|3|||
164386239|NCT00383435|593783960|FG003|26-Week Treatment Safety Extension|Administrative|1|||
164386240|NCT00383435|593783961|FG004|26-Week Treatment Safety Extension|Administrative|0|||
164386241|NCT01753193|593783962|FG000|Overall Study|Withdrawal by Subject|23|||
164386242|NCT01753193|593783962|FG000|Overall Study|Lost to Follow-up|6|||
164386243|NCT01753193|593783962|FG000|Overall Study|Death|1|||
164386244|NCT01753193|593783962|FG000|Overall Study|Other|16|||
164386245|NCT00583557|593783963|FG000|Overall Study|Withdrawal by Subject|18|||
164386246|NCT00583557|593783963|FG000|Overall Study|Adverse Event|9|||
164386247|NCT00583557|593783963|FG000|Overall Study|Lack of Efficacy|31|||
164386248|NCT00583557|593783963|FG000|Overall Study|Lack of Compliance|5|||
164386249|NCT00583557|593783963|FG000|Overall Study|Other|5|||
164386250|NCT00583557|593783963|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
164386251|NCT02682264|593783964|FG000|Overall Study|Withdrawal by Subject|56|||
164386252|NCT02682264|593783965|FG001|Overall Study|Withdrawal by Subject|45|||
164386253|NCT02682264|593783964|FG000|Overall Study|Lost to Follow-up|49|||
164386254|NCT02682264|593783965|FG001|Overall Study|Lost to Follow-up|41|||
164386255|NCT02682264|593783964|FG000|Overall Study|Lack of Efficacy|14|||
164386256|NCT02682264|593783965|FG001|Overall Study|Lack of Efficacy|16|||
164386257|NCT02682264|593783964|FG000|Overall Study|Withdrawal by Parent|6|||
164386258|NCT02682264|593783965|FG001|Overall Study|Withdrawal by Parent|7|||
164386259|NCT02682264|593783964|FG000|Overall Study|Adverse Event|9|||
164386260|NCT02682264|593783965|FG001|Overall Study|Adverse Event|0|||
164386261|NCT02682264|593783964|FG000|Overall Study|Noncompliance with study drug|1|||
164386262|NCT02682264|593783965|FG001|Overall Study|Noncompliance with study drug|4|||
164386263|NCT02682264|593783964|FG000|Overall Study|Pregnancy|1|||
164386264|NCT02682264|593783965|FG001|Overall Study|Pregnancy|2|||
164386265|NCT02682264|593783964|FG000|Overall Study|Recovery|1|||
164386266|NCT02682264|593783965|FG001|Overall Study|Recovery|2|||
164386267|NCT02682264|593783964|FG000|Overall Study|Progressive Disease|1|||
164386268|NCT02682264|593783965|FG001|Overall Study|Progressive Disease|0|||
164386269|NCT02682264|593783964|FG000|Overall Study|Technical Problems|0|||
164386270|NCT02682264|593783965|FG001|Overall Study|Technical Problems|1|||
164386271|NCT02682264|593783964|FG000|Overall Study|Moved abroad and unable to continue|0|||
164386272|NCT02682264|593783965|FG001|Overall Study|Moved abroad and unable to continue|3|||
164386273|NCT02682264|593783964|FG000|Overall Study|Stopped test article application|0|||
164440323|NCT00057837|593978978|FG000|Overall Study|Progression/relapse|12|||
164440324|NCT00057837|593978979|FG001|Overall Study|Progression/relapse|14|||
164440325|NCT00057837|593978978|FG000|Overall Study|Adverse Event|2|||
164440326|NCT00057837|593978979|FG001|Overall Study|Adverse Event|12|||
164440327|NCT00057837|593978978|FG000|Overall Study|Death|5|||
164440328|NCT00057837|593978979|FG001|Overall Study|Death|4|||
164440329|NCT00057837|593978978|FG000|Overall Study|Withdrawal by Subject|5|||
164440330|NCT00057837|593978979|FG001|Overall Study|Withdrawal by Subject|3|||
164440331|NCT00057837|593978978|FG000|Overall Study|Alternative therapy|0|||
164593046|NCT00069095|594534676|FG002|Post-study Treatment Phase|Adverse Event|1|||
164593047|NCT00069095|594534677|FG003|Post-study Treatment Phase|Adverse Event|0|||
164593048|NCT00069095|594534678|FG004|Post-study Treatment Phase|Adverse Event|5|||
164593049|NCT00069095|594534679|FG005|Post-study Treatment Phase|Adverse Event|1|||
164593050|NCT00069095|594534674|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
164593051|NCT00069095|594534675|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
164593052|NCT00069095|594534676|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
164593053|NCT00069095|594534677|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
164593054|NCT00069095|594534678|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
164593055|NCT00069095|594534679|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
164593056|NCT00069095|594534674|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
164593057|NCT00069095|594534675|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
164593058|NCT00069095|594534676|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
164593059|NCT00069095|594534677|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
164593060|NCT00069095|594534678|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
164593061|NCT00069095|594534679|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
164593062|NCT00069095|594534674|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
164593063|NCT00069095|594534675|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
164593064|NCT00069095|594534676|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
164593065|NCT00069095|594534677|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
164593066|NCT00069095|594534678|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
164593067|NCT00069095|594534679|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
164593068|NCT00069095|594534674|FG000|Post-study Treatment Phase|Participant had complete response|1|||
164593069|NCT00069095|594534675|FG001|Post-study Treatment Phase|Participant had complete response|1|||
164593070|NCT00069095|594534676|FG002|Post-study Treatment Phase|Participant had complete response|0|||
164593071|NCT00069095|594534677|FG003|Post-study Treatment Phase|Participant had complete response|0|||
164386274|NCT02682264|593783965|FG001|Overall Study|Stopped test article application|1|||
164386275|NCT01131312|593783966|FG000|Overall Study|Lost to Follow-up|425|||
164386276|NCT01131312|593783967|FG001|Overall Study|Lost to Follow-up|229|||
164386277|NCT01131312|593783968|FG002|Overall Study|Lost to Follow-up|351|||
164386278|NCT02347761|593783969|FG000|All Collected|Death|1|||
164386279|NCT02347761|593783970|FG001|All Collected|Death|0|||
164386280|NCT02347761|593783971|FG002|All Collected|Death|0|||
164386281|NCT02347761|593783969|FG000|All Collected|Lost to Follow-up|3|||
164386282|NCT02347761|593783970|FG001|All Collected|Lost to Follow-up|2|||
164386283|NCT02347761|593783971|FG002|All Collected|Lost to Follow-up|3|||
164386284|NCT02347761|593783969|FG000|All Collected|Withdrawal by Subject|11|||
164386285|NCT02347761|593783970|FG001|All Collected|Withdrawal by Subject|11|||
164386286|NCT02347761|593783971|FG002|All Collected|Withdrawal by Subject|22|||
164386287|NCT02347761|593783969|FG000|All Collected|invetigator disretion|2|||
164386288|NCT02347761|593783970|FG001|All Collected|invetigator disretion|0|||
164386289|NCT02347761|593783971|FG002|All Collected|invetigator disretion|0|||
164386290|NCT02347761|593783969|FG000|All Collected|instillation site pain|0|||
164386291|NCT02347761|593783970|FG001|All Collected|instillation site pain|0|||
164386292|NCT02347761|593783971|FG002|All Collected|instillation site pain|1|||
164386293|NCT02347761|593783969|FG000|All Collected|exacerbation of COPD|0|||
164386294|NCT02347761|593783970|FG001|All Collected|exacerbation of COPD|0|||
164386295|NCT02347761|593783971|FG002|All Collected|exacerbation of COPD|1|||
164386296|NCT02347761|593783969|FG000|All Collected|moved/travel|0|||
164386297|NCT02347761|593783970|FG001|All Collected|moved/travel|1|||
164386298|NCT02347761|593783971|FG002|All Collected|moved/travel|0|||
164386299|NCT02347761|593783969|FG000|On Study Treatment|Lack of Efficacy|2|||
164386300|NCT02347761|593783970|FG001|On Study Treatment|Lack of Efficacy|3|||
164386301|NCT02347761|593783971|FG002|On Study Treatment|Lack of Efficacy|4|||
164386302|NCT02347761|593783969|FG000|On Study Treatment|non-compliance with study medication|0|||
164386303|NCT02347761|593783970|FG001|On Study Treatment|non-compliance with study medication|0|||
164386304|NCT02347761|593783971|FG002|On Study Treatment|non-compliance with study medication|2|||
164386305|NCT02347761|593783969|FG000|On Study Treatment|Withdrawal by Subject|7|||
164386306|NCT02347761|593783970|FG001|On Study Treatment|Withdrawal by Subject|3|||
164386307|NCT02347761|593783971|FG002|On Study Treatment|Withdrawal by Subject|5|||
164386308|NCT02347761|593783969|FG000|On Study Treatment|move/travel|2|||
164386309|NCT02347761|593783970|FG001|On Study Treatment|move/travel|6|||
164386310|NCT02347761|593783971|FG002|On Study Treatment|move/travel|5|||
164386311|NCT02347761|593783969|FG000|On Study Treatment|dissastisfaction with device|2|||
164417454|NCT01474512|593899504|FG015|Long-Term Extension Period|Death|0|||
164593072|NCT00069095|594534678|FG004|Post-study Treatment Phase|Participant had complete response|0|||
164593073|NCT00069095|594534679|FG005|Post-study Treatment Phase|Participant had complete response|0|||
164593074|NCT00069095|594534674|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
164593075|NCT00069095|594534675|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
164593076|NCT00069095|594534676|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
164593077|NCT00069095|594534677|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
164593078|NCT00069095|594534678|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
164593079|NCT00069095|594534679|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
164593080|NCT00069095|594534674|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
164593081|NCT00069095|594534675|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
164593082|NCT00069095|594534676|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
164593083|NCT00069095|594534677|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
164593084|NCT00069095|594534678|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
164593085|NCT00069095|594534679|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
164593086|NCT00069095|594534674|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
164593087|NCT00069095|594534675|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
164593088|NCT00069095|594534676|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
164593089|NCT00069095|594534677|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
164593090|NCT00069095|594534678|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
164593091|NCT00069095|594534679|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
164593092|NCT00069095|594534674|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
164593093|NCT00069095|594534675|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
164593094|NCT00069095|594534676|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
164593095|NCT00069095|594534677|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
164593096|NCT00069095|594534678|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
164593097|NCT00069095|594534679|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
164593098|NCT00069095|594534674|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
164593099|NCT00069095|594534675|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
164593100|NCT00069095|594534676|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
164593101|NCT00069095|594534677|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
164703033|NCT01334710|594937815|FG000|Overall Study|Trial was terminated|3|||
164703034|NCT00321828|594939015|FG000|Overall Study|Ineligible|3|||
164703035|NCT00321828|594939015|FG000|Overall Study|No follow up data|1|||
164703036|NCT02358343|594939018|FG000|Screening Intervention|Death|0|||
164703037|NCT02358343|594939019|FG001|Screening Intervention|Death|2|||
164703038|NCT02358343|594939020|FG002|Screening Intervention|Death|0|||
164703039|NCT02358343|594939021|FG003|Screening Intervention|Death|0|||
164703040|NCT02358343|594939022|FG004|Screening Intervention|Death|0|||
164703041|NCT02358343|594939018|FG000|Screening Intervention|Withdrawal by Subject|1|||
164703042|NCT02358343|594939019|FG001|Screening Intervention|Withdrawal by Subject|0|||
164703043|NCT02358343|594939020|FG002|Screening Intervention|Withdrawal by Subject|0|||
164703044|NCT02358343|594939021|FG003|Screening Intervention|Withdrawal by Subject|0|||
164703045|NCT02358343|594939022|FG004|Screening Intervention|Withdrawal by Subject|0|||
164703046|NCT02358343|594939018|FG000|Screening Intervention|Determined Ineligible|5|||
164703047|NCT02358343|594939019|FG001|Screening Intervention|Determined Ineligible|6|||
164703048|NCT02358343|594939020|FG002|Screening Intervention|Determined Ineligible|0|||
164703049|NCT02358343|594939021|FG003|Screening Intervention|Determined Ineligible|0|||
164703050|NCT02358343|594939022|FG004|Screening Intervention|Determined Ineligible|0|||
164703051|NCT02358343|594939018|FG000|Comparative Efficacy Trial / Observation|Death|0|||
164703052|NCT02358343|594939019|FG001|Comparative Efficacy Trial / Observation|Death|0|||
164703053|NCT02358343|594939020|FG002|Comparative Efficacy Trial / Observation|Death|2|||
164703054|NCT02358343|594939021|FG003|Comparative Efficacy Trial / Observation|Death|0|||
164703055|NCT02358343|594939022|FG004|Comparative Efficacy Trial / Observation|Death|0|||
164703056|NCT02358343|594939018|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
164703057|NCT02358343|594939019|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
164703058|NCT02358343|594939020|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
164703059|NCT02358343|594939021|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
164703060|NCT02358343|594939022|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
164703061|NCT02358343|594939018|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
164703062|NCT02358343|594939019|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
164703063|NCT02358343|594939020|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
164703064|NCT02358343|594939021|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
164703065|NCT02358343|594939022|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
164703066|NCT00577395|594939026|FG000|Overall Study|Study was terminated early by Sponsor|7|||
164703067|NCT00577395|594939027|FG001|Overall Study|Study was terminated early by Sponsor|6|||
164703068|NCT04322149|594939028|FG000|Overall Study|Adverse Event|1|||
164703069|NCT04322149|594939029|FG001|Overall Study|Adverse Event|1|||
164703070|NCT04322149|594939030|FG002|Overall Study|Adverse Event|0|||
164703071|NCT04322149|594939031|FG003|Overall Study|Adverse Event|0|||
164386312|NCT02347761|593783970|FG001|On Study Treatment|dissastisfaction with device|1|||
164703072|NCT04322149|594939028|FG000|Overall Study|Withdrawal by Subject|0|||
164703073|NCT04322149|594939029|FG001|Overall Study|Withdrawal by Subject|0|||
164703074|NCT04322149|594939030|FG002|Overall Study|Withdrawal by Subject|0|||
164703075|NCT04322149|594939031|FG003|Overall Study|Withdrawal by Subject|2|||
164703076|NCT04322149|594939028|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
164703077|NCT04322149|594939029|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
164703078|NCT04322149|594939030|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
164386313|NCT02347761|593783971|FG002|On Study Treatment|dissastisfaction with device|4|||
164386314|NCT02347761|593783969|FG000|On Study Treatment|Lost to Follow-up|2|||
164386315|NCT02347761|593783970|FG001|On Study Treatment|Lost to Follow-up|1|||
164386316|NCT02347761|593783971|FG002|On Study Treatment|Lost to Follow-up|1|||
164386317|NCT02347761|593783969|FG000|On Study Treatment|investigator discretion|2|||
164386318|NCT02347761|593783970|FG001|On Study Treatment|investigator discretion|0|||
164386319|NCT02347761|593783971|FG002|On Study Treatment|investigator discretion|0|||
164386320|NCT02347761|593783969|FG000|On Study Treatment|durg not working|0|||
164386321|NCT02347761|593783970|FG001|On Study Treatment|durg not working|1|||
164703079|NCT04322149|594939031|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
164703080|NCT01700049|594939036|FG000|Overall Study|Withdrawal by Subject|1|||
164703081|NCT00368979|594939040|FG000|Overall Study|Adverse Event|9|||
164703082|NCT00368979|594939041|FG001|Overall Study|Adverse Event|16|||
164703083|NCT00368979|594939040|FG000|Overall Study|Lack of Efficacy|5|||
164703084|NCT00368979|594939041|FG001|Overall Study|Lack of Efficacy|3|||
164703085|NCT00368979|594939040|FG000|Overall Study|Other|3|||
164703086|NCT00368979|594939041|FG001|Overall Study|Other|1|||
164703087|NCT00368979|594939040|FG000|Overall Study|Lost to Follow-up|1|||
164703088|NCT00368979|594939041|FG001|Overall Study|Lost to Follow-up|0|||
164703089|NCT00368979|594939040|FG000|Overall Study|Protocol Violation|2|||
164703090|NCT00368979|594939041|FG001|Overall Study|Protocol Violation|1|||
164703091|NCT00368979|594939040|FG000|Overall Study|Withdrawal by Subject|5|||
164703092|NCT00368979|594939041|FG001|Overall Study|Withdrawal by Subject|9|||
164703093|NCT00103311|594939042|FG000|Overall Study|Lost to Follow-up|1|||
164703094|NCT00103311|594939043|FG001|Overall Study|Lost to Follow-up|0|||
164703095|NCT00103311|594939042|FG000|Overall Study|Withdrawal by Subject|2|||
164703096|NCT00103311|594939043|FG001|Overall Study|Withdrawal by Subject|1|||
164703097|NCT00103311|594939042|FG000|Overall Study|Adverse Event|1|||
164703098|NCT00103311|594939043|FG001|Overall Study|Adverse Event|0|||
164703099|NCT00912093|594939044|FG000|The Controlled Phase|Death|0|||
164703100|NCT00912093|594939045|FG001|The Controlled Phase|Death|1|||
164703101|NCT00912093|594939046|FG002|The Controlled Phase|Death|0|||
164703102|NCT00912093|594939047|FG003|The Controlled Phase|Death|0|||
164703103|NCT00912093|594939048|FG004|The Controlled Phase|Death|0|||
164703104|NCT00912093|594939044|FG000|The Controlled Phase|Medical Condition|0|||
164703105|NCT00912093|594939045|FG001|The Controlled Phase|Medical Condition|1|||
164703106|NCT00912093|594939046|FG002|The Controlled Phase|Medical Condition|0|||
164703107|NCT00912093|594939047|FG003|The Controlled Phase|Medical Condition|0|||
164703108|NCT00912093|594939048|FG004|The Controlled Phase|Medical Condition|0|||
164703109|NCT00912093|594939044|FG000|The Controlled Phase|Lost to Follow-up|0|||
164703110|NCT00912093|594939045|FG001|The Controlled Phase|Lost to Follow-up|0|||
164703111|NCT00912093|594939046|FG002|The Controlled Phase|Lost to Follow-up|0|||
164703112|NCT00912093|594939047|FG003|The Controlled Phase|Lost to Follow-up|0|||
164703113|NCT00912093|594939048|FG004|The Controlled Phase|Lost to Follow-up|1|||
164703114|NCT00270257|594939053|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
164703115|NCT00270257|594939054|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
164703116|NCT01195103|594939055|FG000|Overall Study|Withdrawal by Subject|1|||
164703117|NCT01195103|594939056|FG001|Overall Study|Withdrawal by Subject|0|||
164703118|NCT01195103|594939057|FG002|Overall Study|Withdrawal by Subject|0|||
164703119|NCT01593696|594939061|FG000|Dose Escalation|Progressive Disease|2|||
164703120|NCT01593696|594939062|FG001|Dose Escalation|Progressive Disease|0|||
164703121|NCT01593696|594939063|FG002|Dose Escalation|Progressive Disease|0|||
164703122|NCT01593696|594939064|FG003|Dose Escalation|Progressive Disease|0|||
164703123|NCT01593696|594939061|FG000|Dose Expansion|Fungal infection|0|||
164703124|NCT01593696|594939062|FG001|Dose Expansion|Fungal infection|0|||
164703125|NCT01593696|594939063|FG002|Dose Expansion|Fungal infection|1|||
164703126|NCT01593696|594939064|FG003|Dose Expansion|Fungal infection|0|||
164703127|NCT00369655|594939065|FG000|Overall Study|Refusal of further treatment|2|||
164703128|NCT04049617|594939066|FG000|Overall Study|Adverse Event|0|||
164703129|NCT04049617|594939067|FG001|Overall Study|Adverse Event|0|||
164703130|NCT04049617|594939068|FG002|Overall Study|Adverse Event|0|||
164703131|NCT04049617|594939069|FG003|Overall Study|Adverse Event|1|||
164703132|NCT04049617|594939070|FG004|Overall Study|Adverse Event|0|||
164703133|NCT04049617|594939071|FG005|Overall Study|Adverse Event|0|||
164703134|NCT04049617|594939066|FG000|Overall Study|Death|0|||
164703135|NCT04049617|594939067|FG001|Overall Study|Death|0|||
164703136|NCT04049617|594939068|FG002|Overall Study|Death|0|||
164703137|NCT04049617|594939069|FG003|Overall Study|Death|0|||
164386322|NCT02347761|593783971|FG002|On Study Treatment|durg not working|1|||
164703138|NCT04049617|594939070|FG004|Overall Study|Death|0|||
164593102|NCT00069095|594534678|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
164703139|NCT04049617|594939071|FG005|Overall Study|Death|1|||
164703140|NCT04049617|594939066|FG000|Overall Study|Lost to Follow-up|0|||
164703141|NCT04049617|594939067|FG001|Overall Study|Lost to Follow-up|0|||
164703142|NCT04049617|594939068|FG002|Overall Study|Lost to Follow-up|0|||
164703143|NCT04049617|594939069|FG003|Overall Study|Lost to Follow-up|1|||
164703144|NCT04049617|594939070|FG004|Overall Study|Lost to Follow-up|0|||
164703145|NCT04049617|594939071|FG005|Overall Study|Lost to Follow-up|0|||
164703146|NCT04049617|594939066|FG000|Overall Study|Withdrew consent|0|||
164703147|NCT04049617|594939067|FG001|Overall Study|Withdrew consent|0|||
164703148|NCT04049617|594939068|FG002|Overall Study|Withdrew consent|1|||
164703149|NCT04049617|594939069|FG003|Overall Study|Withdrew consent|0|||
164703150|NCT04049617|594939070|FG004|Overall Study|Withdrew consent|0|||
164703151|NCT04049617|594939071|FG005|Overall Study|Withdrew consent|0|||
164703152|NCT01780987|594939072|FG000|Overall Study|Adverse Event|0|||
164703153|NCT01780987|594939073|FG001|Overall Study|Adverse Event|4|||
164703154|NCT01780987|594939072|FG000|Overall Study|Withdrawal by Subject|2|||
164703155|NCT01780987|594939073|FG001|Overall Study|Withdrawal by Subject|0|||
164703156|NCT01780987|594939072|FG000|Overall Study|Request of Changing Hospital|0|||
164703157|NCT01780987|594939073|FG001|Overall Study|Request of Changing Hospital|1|||
164703158|NCT01780987|594939072|FG000|Overall Study|Changing Residence|1|||
164703159|NCT01780987|594939073|FG001|Overall Study|Changing Residence|0|||
164703160|NCT01780987|594939072|FG000|Overall Study|Not Receiving any Study Medication|0|||
164703161|NCT01780987|594939073|FG001|Overall Study|Not Receiving any Study Medication|1|||
164703162|NCT03402750|594939074|FG000|Overall Study|Lost to Follow-up|2|||
164703163|NCT03402750|594939075|FG001|Overall Study|Lost to Follow-up|1|||
164703164|NCT02534844|594939076|FG000|Part B|Withdrawal by Subject|0|||
164703165|NCT02534844|594939077|FG001|Part B|Withdrawal by Subject|0|||
164386323|NCT02347761|593783969|FG000|On Study Treatment|Adverse Event|10|||
164386324|NCT02347761|593783970|FG001|On Study Treatment|Adverse Event|8|||
164386325|NCT02347761|593783971|FG002|On Study Treatment|Adverse Event|20|||
164386326|NCT01255358|593783972|FG000|Overall Study|Adverse Event|2|||
164386327|NCT01255358|593783972|FG000|Overall Study|Protocol Violation|2|||
164386328|NCT04079933|593783975|FG000|Overall Study|Withdrawal by Subject|3|||
164386329|NCT04079933|593783976|FG001|Overall Study|Withdrawal by Subject|4|||
164386330|NCT04079933|593783975|FG000|Overall Study|Lost to Follow-up|0|||
164386331|NCT04079933|593783976|FG001|Overall Study|Lost to Follow-up|1|||
164386332|NCT03207750|593783977|FG000|Overall Study|Adverse Event|3|||
164386333|NCT03207750|593783978|FG001|Overall Study|Adverse Event|2|||
164593103|NCT00069095|594534679|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
164593104|NCT00069095|594534674|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
164593105|NCT00069095|594534675|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
164593106|NCT00069095|594534676|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
164593107|NCT00069095|594534677|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
164593108|NCT00069095|594534678|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
164593109|NCT00069095|594534679|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
164593110|NCT00069095|594534674|FG000|Post-study Treatment Phase|Surgery|0|||
164593111|NCT00069095|594534675|FG001|Post-study Treatment Phase|Surgery|0|||
164593112|NCT00069095|594534676|FG002|Post-study Treatment Phase|Surgery|0|||
164593113|NCT00069095|594534677|FG003|Post-study Treatment Phase|Surgery|1|||
164593114|NCT00069095|594534678|FG004|Post-study Treatment Phase|Surgery|1|||
164593115|NCT00069095|594534679|FG005|Post-study Treatment Phase|Surgery|0|||
164593116|NCT00069095|594534674|FG000|Post-study Treatment Phase|Death|0|||
164593117|NCT00069095|594534675|FG001|Post-study Treatment Phase|Death|0|||
164593118|NCT00069095|594534676|FG002|Post-study Treatment Phase|Death|0|||
164593119|NCT00069095|594534677|FG003|Post-study Treatment Phase|Death|0|||
164593120|NCT00069095|594534678|FG004|Post-study Treatment Phase|Death|1|||
164593121|NCT00069095|594534679|FG005|Post-study Treatment Phase|Death|0|||
164593122|NCT00069095|594534674|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
164593123|NCT00069095|594534675|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
164593124|NCT00069095|594534676|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
164593125|NCT00069095|594534677|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
164593126|NCT00069095|594534678|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
164593127|NCT00069095|594534679|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
164593128|NCT00069095|594534674|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
164593129|NCT00069095|594534675|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
164593130|NCT00069095|594534676|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
164593131|NCT00069095|594534677|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
164593132|NCT00069095|594534678|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
164593133|NCT00069095|594534679|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
164703166|NCT02534844|594939078|FG002|Part B|Withdrawal by Subject|0|||
164386334|NCT03207750|593783977|FG000|Overall Study|Lost to Follow-up|21|||
164593134|NCT00069095|594534674|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
164593135|NCT00069095|594534675|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
164386335|NCT03207750|593783978|FG001|Overall Study|Lost to Follow-up|29|||
164386336|NCT03207750|593783977|FG000|Overall Study|Protocol Violation|0|||
164386337|NCT03207750|593783978|FG001|Overall Study|Protocol Violation|1|||
164386338|NCT03207750|593783977|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
164386339|NCT03207750|593783978|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
164386340|NCT03207750|593783977|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
164386341|NCT03207750|593783978|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
164386342|NCT03207750|593783977|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
164386343|NCT03207750|593783978|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
164386344|NCT03207750|593783977|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
164386345|NCT03207750|593783978|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
164386346|NCT03207750|593783977|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
164386347|NCT03207750|593783978|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
164386348|NCT02493361|593783979|FG000|Overall Study|Withdrawal by Subject|3|||
164386349|NCT02937545|593783983|FG000|Overall Study|Withdrawal by Subject|1|||
164386350|NCT02937545|593783984|FG001|Overall Study|Withdrawal by Subject|2|||
164386351|NCT02937545|593783985|FG002|Overall Study|Withdrawal by Subject|6|||
164386352|NCT02937545|593783986|FG003|Overall Study|Withdrawal by Subject|7|||
164386353|NCT02937545|593783983|FG000|Overall Study|Lost to Follow-up|1|||
164593136|NCT00069095|594534676|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
164703167|NCT02534844|594939079|FG003|Part B|Withdrawal by Subject|0|||
164703168|NCT02534844|594939080|FG004|Part B|Withdrawal by Subject|2|||
164703169|NCT02534844|594939081|FG005|Part B|Withdrawal by Subject|1|||
164703170|NCT00848107|594939082|FG000|Overall Study|Lost to Follow-up|2|||
164703171|NCT00848107|594939082|FG000|Overall Study|Withdrawal by Subject|8|||
164703172|NCT00848107|594939082|FG000|Overall Study|Adverse Event|9|||
164703173|NCT00848107|594939082|FG000|Overall Study|Death|1|||
164703174|NCT00848107|594939082|FG000|Overall Study|Pregnancy|1|||
164386354|NCT02937545|593783984|FG001|Overall Study|Lost to Follow-up|0|||
164386355|NCT02937545|593783985|FG002|Overall Study|Lost to Follow-up|0|||
164386356|NCT02937545|593783986|FG003|Overall Study|Lost to Follow-up|0|||
164386357|NCT02504294|593783989|FG000|Overall Study|Adverse Event|15|||
164593137|NCT00069095|594534677|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
164593138|NCT00069095|594534678|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
164593139|NCT00069095|594534679|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
164593140|NCT00069095|594534674|FG000|Post-study Treatment Phase|Investigator decision|0|||
164593141|NCT00069095|594534675|FG001|Post-study Treatment Phase|Investigator decision|0|||
164593142|NCT00069095|594534676|FG002|Post-study Treatment Phase|Investigator decision|0|||
164593143|NCT00069095|594534677|FG003|Post-study Treatment Phase|Investigator decision|0|||
164593144|NCT00069095|594534678|FG004|Post-study Treatment Phase|Investigator decision|0|||
164593145|NCT00069095|594534679|FG005|Post-study Treatment Phase|Investigator decision|1|||
164593146|NCT00069095|594534674|FG000|Follow-up Phase|Death|174|||
164593147|NCT00069095|594534675|FG001|Follow-up Phase|Death|206|||
164593148|NCT00069095|594534676|FG002|Follow-up Phase|Death|120|||
164593149|NCT00069095|594534677|FG003|Follow-up Phase|Death|112|||
164593150|NCT00069095|594534678|FG004|Follow-up Phase|Death|92|||
164593151|NCT00069095|594534679|FG005|Follow-up Phase|Death|101|||
164593152|NCT01217190|594534686|FG000|Second Dosing|Withdrawal by Subject|0|||
164593153|NCT01217190|594534687|FG001|Second Dosing|Withdrawal by Subject|2|||
164593154|NCT03196297|594534688|FG000|Main Period|Withdrawal by Subject|4|||
164593155|NCT03196297|594534688|FG000|Extension Period|Withdrawal by Subject|1|||
164593156|NCT03196297|594534688|FG000|Extension Period|Lack of Efficacy|2|||
164593157|NCT02213198|594534691|FG000|Baseline|No show for intake|7|||
164593158|NCT02213198|594534692|FG001|Baseline|No show for intake|9|||
164593159|NCT02213198|594534691|FG000|Baseline|Withdrawal by Subject|34|||
164593160|NCT02213198|594534692|FG001|Baseline|Withdrawal by Subject|11|||
164593161|NCT02213198|594534691|FG000|Baseline|transferred out of clinic|7|||
164593162|NCT02213198|594534692|FG001|Baseline|transferred out of clinic|9|||
164593163|NCT02213198|594534691|FG000|Baseline|Lost to Follow-up|40|||
164593164|NCT02213198|594534692|FG001|Baseline|Lost to Follow-up|21|||
164593165|NCT02213198|594534691|FG000|Baseline|incarcerated,violent|0|||
164593166|NCT02213198|594534692|FG001|Baseline|incarcerated,violent|1|||
164593167|NCT02213198|594534691|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
164593168|NCT02213198|594534692|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
164593169|NCT02213198|594534691|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
164593170|NCT02213198|594534692|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
164593171|NCT02213198|594534691|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
164593172|NCT02213198|594534692|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
164593173|NCT02213198|594534691|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
164593174|NCT02213198|594534692|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
164593175|NCT02213198|594534691|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
164386358|NCT02504294|593783990|FG001|Overall Study|Adverse Event|12|||
164386359|NCT02504294|593783989|FG000|Overall Study|Withdrawal by Subject|7|||
164386360|NCT02504294|593783990|FG001|Overall Study|Withdrawal by Subject|1|||
164386361|NCT02504294|593783989|FG000|Overall Study|Protocol Violation|27|||
164386362|NCT02504294|593783990|FG001|Overall Study|Protocol Violation|26|||
164386363|NCT02504294|593783989|FG000|Overall Study|Physician Decision|1|||
164386364|NCT02504294|593783990|FG001|Overall Study|Physician Decision|2|||
164386365|NCT02504294|593783989|FG000|Overall Study|Lost to Follow-up|6|||
164386366|NCT02504294|593783990|FG001|Overall Study|Lost to Follow-up|7|||
164703175|NCT00859586|594939083|FG000|Overall Study|Donors|4|||
164703176|NCT00080938|594939084|FG000|Overall Study|Adverse Event|3|||
164703177|NCT00080938|594939084|FG000|Overall Study|Withdrawal by Subject|6|||
164703178|NCT00080938|594939084|FG000|Overall Study|Death|2|||
164703179|NCT00080938|594939084|FG000|Overall Study|Lack of Efficacy|7|||
164703180|NCT00080938|594939084|FG000|Overall Study|other disease|1|||
164703181|NCT00080938|594939084|FG000|Overall Study|Not started protocol therapy|1|||
164703182|NCT00080938|594939084|FG000|Overall Study|Ineligible|4|||
164703183|NCT00706511|594939087|FG000|Overall Study|Withdrawal by Subject|1|||
164703184|NCT00706511|594939088|FG001|Overall Study|Withdrawal by Subject|0|||
164703185|NCT00706511|594939089|FG002|Overall Study|Withdrawal by Subject|0|||
164703186|NCT00706511|594939090|FG003|Overall Study|Withdrawal by Subject|0|||
164703187|NCT02116608|594939093|FG000|Overall Study|Lost to Follow-up|0|||
164703188|NCT02116608|594939094|FG001|Overall Study|Lost to Follow-up|0|||
164703189|NCT02116608|594939095|FG002|Overall Study|Lost to Follow-up|1|||
164703190|NCT02116608|594939093|FG000|Overall Study|Physician Decision|0|||
164703191|NCT02116608|594939094|FG001|Overall Study|Physician Decision|1|||
164703192|NCT02116608|594939095|FG002|Overall Study|Physician Decision|0|||
164703193|NCT02116608|594939093|FG000|Overall Study|Death|0|||
164703194|NCT02116608|594939094|FG001|Overall Study|Death|1|||
164703195|NCT02116608|594939095|FG002|Overall Study|Death|0|||
164703196|NCT01169532|594939097|FG000|Overall Study|Withdrawal by Subject|1|||
164703197|NCT00117325|594939101|FG000|Overall Study|Adverse Event|3|||
164703198|NCT00117325|594939102|FG001|Overall Study|Adverse Event|3|||
164703199|NCT00117325|594939101|FG000|Overall Study|Lost to Follow-up|1|||
164703200|NCT00117325|594939102|FG001|Overall Study|Lost to Follow-up|1|||
164703201|NCT00117325|594939101|FG000|Overall Study|Protocol Violation|2|||
164703202|NCT00117325|594939102|FG001|Overall Study|Protocol Violation|3|||
164703203|NCT00117325|594939101|FG000|Overall Study|Withdrawal by Subject|3|||
164386367|NCT02252211|593783991|FG000|Overall Study|Adverse Event|0|||
164386368|NCT02252211|593783992|FG001|Overall Study|Adverse Event|1|||
164386369|NCT02252211|593783993|FG002|Overall Study|Adverse Event|0|||
164386370|NCT02252211|593783991|FG000|Overall Study|Progressive disease|3|||
164386371|NCT02252211|593783992|FG001|Overall Study|Progressive disease|2|||
164386372|NCT02252211|593783993|FG002|Overall Study|Progressive disease|0|||
164386373|NCT02252211|593783991|FG000|Overall Study|Withdrawal by Subject|1|||
164386374|NCT02252211|593783992|FG001|Overall Study|Withdrawal by Subject|0|||
164386375|NCT02252211|593783993|FG002|Overall Study|Withdrawal by Subject|0|||
164386376|NCT02252211|593783991|FG000|Overall Study|Serious Adverse Event During Screening|1|||
164386377|NCT02252211|593783992|FG001|Overall Study|Serious Adverse Event During Screening|0|||
164386378|NCT02252211|593783993|FG002|Overall Study|Serious Adverse Event During Screening|1|||
164386379|NCT05799495|593784000|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
164386380|NCT05799495|593784001|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
164386381|NCT05799495|593784002|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
164386382|NCT05799495|593784003|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
164386383|NCT05799495|593784000|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
164386384|NCT05799495|593784001|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
164386385|NCT05799495|593784002|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
164386386|NCT05799495|593784003|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
164386387|NCT05799495|593784000|FG000|Treatment (Up to 5 Days)|Other|0|||
164386388|NCT05799495|593784001|FG001|Treatment (Up to 5 Days)|Other|1|||
164386389|NCT05799495|593784002|FG002|Treatment (Up to 5 Days)|Other|0|||
164386390|NCT05799495|593784003|FG003|Treatment (Up to 5 Days)|Other|0|||
164386391|NCT05799495|593784000|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
164386392|NCT05799495|593784001|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
164386393|NCT05799495|593784002|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
164386394|NCT05799495|593784003|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
164703204|NCT00117325|594939102|FG001|Overall Study|Withdrawal by Subject|2|||
164703205|NCT00117325|594939101|FG000|Overall Study|Lack of Efficacy|1|||
164703206|NCT00117325|594939102|FG001|Overall Study|Lack of Efficacy|0|||
164703207|NCT00117325|594939101|FG000|Overall Study|Use of prohibited medicine|1|||
164703208|NCT00117325|594939102|FG001|Overall Study|Use of prohibited medicine|2|||
164386395|NCT05799495|593784000|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
164386396|NCT05799495|593784001|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
164386397|NCT05799495|593784002|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
164703209|NCT00117325|594939101|FG000|Overall Study|Early termination|1|||
164703210|NCT00117325|594939102|FG001|Overall Study|Early termination|1|||
164386398|NCT05799495|593784003|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
164386399|NCT05799495|593784000|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
164386400|NCT05799495|593784001|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
164386401|NCT05799495|593784002|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
164386402|NCT05799495|593784003|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
164386403|NCT03694548|593784007|FG000|Part A Survey|Protocol Violation|3|||
164386404|NCT03694548|593784008|FG001|Part A Survey|Protocol Violation|3|||
164386405|NCT03694548|593784009|FG002|Part A Survey|Protocol Violation|0|||
164386406|NCT03694548|593784007|FG000|Part B Yoga Program|Protocol Violation|0|||
164386407|NCT03694548|593784008|FG001|Part B Yoga Program|Protocol Violation|0|||
164386408|NCT03694548|593784009|FG002|Part B Yoga Program|Protocol Violation|3|||
164386409|NCT03694548|593784007|FG000|Part B Yoga Program|Did not attend intervention|0|||
164386410|NCT03694548|593784008|FG001|Part B Yoga Program|Did not attend intervention|0|||
164386411|NCT03694548|593784009|FG002|Part B Yoga Program|Did not attend intervention|8|||
164386412|NCT04177108|593784010|FG000|Overall Study|Withdrawal by Subject|4|||
164386413|NCT04177108|593784011|FG001|Overall Study|Withdrawal by Subject|8|||
164386414|NCT04177108|593784012|FG002|Overall Study|Withdrawal by Subject|9|||
164386415|NCT04177108|593784013|FG003|Overall Study|Withdrawal by Subject|11|||
164386416|NCT04177108|593784014|FG004|Overall Study|Withdrawal by Subject|13|||
164386417|NCT04177108|593784010|FG000|Overall Study|Physician Decision|23|||
164386418|NCT04177108|593784011|FG001|Overall Study|Physician Decision|15|||
164386419|NCT04177108|593784012|FG002|Overall Study|Physician Decision|18|||
164386420|NCT04177108|593784013|FG003|Overall Study|Physician Decision|29|||
164386421|NCT04177108|593784014|FG004|Overall Study|Physician Decision|23|||
164386422|NCT04177108|593784010|FG000|Overall Study|Reason Not Specified|0|||
164386423|NCT04177108|593784011|FG001|Overall Study|Reason Not Specified|1|||
164386424|NCT04177108|593784012|FG002|Overall Study|Reason Not Specified|0|||
164386425|NCT04177108|593784013|FG003|Overall Study|Reason Not Specified|0|||
164386426|NCT04177108|593784014|FG004|Overall Study|Reason Not Specified|2|||
164386427|NCT04177108|593784010|FG000|Overall Study|Lost to Follow-up|0|||
164386428|NCT04177108|593784011|FG001|Overall Study|Lost to Follow-up|0|||
164386429|NCT04177108|593784012|FG002|Overall Study|Lost to Follow-up|1|||
164386430|NCT04177108|593784013|FG003|Overall Study|Lost to Follow-up|1|||
164386431|NCT04177108|593784014|FG004|Overall Study|Lost to Follow-up|1|||
164386432|NCT04177108|593784010|FG000|Overall Study|Death|16|||
164386433|NCT04177108|593784011|FG001|Overall Study|Death|19|||
164386434|NCT04177108|593784012|FG002|Overall Study|Death|13|||
164386435|NCT04177108|593784013|FG003|Overall Study|Death|17|||
164386436|NCT04177108|593784014|FG004|Overall Study|Death|18|||
164703211|NCT00117325|594939101|FG000|Overall Study|Admisnitrative|1|||
164703212|NCT00117325|594939102|FG001|Overall Study|Admisnitrative|0|||
164703213|NCT01468818|594939106|FG000|Overall Study|Death during treatment|2|||
164703214|NCT02266134|594939107|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
164703215|NCT02266134|594939108|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
164703216|NCT02266134|594939109|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
164703217|NCT02266134|594939110|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
164703218|NCT02266134|594939107|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
164703219|NCT02266134|594939108|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
164703220|NCT02266134|594939109|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
164703221|NCT02266134|594939110|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
164703222|NCT02266134|594939107|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
164703223|NCT02266134|594939108|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
164703224|NCT02266134|594939109|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
164703225|NCT02266134|594939110|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
164703226|NCT02266134|594939107|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
164703227|NCT02266134|594939108|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
164703228|NCT02266134|594939109|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
164703229|NCT02266134|594939110|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
164386437|NCT00099983|593784015|FG000|Overall Study|Lost to Follow-up|2|||
164386438|NCT00099983|593784016|FG001|Overall Study|Lost to Follow-up|3|||
164386439|NCT00099983|593784015|FG000|Overall Study|Missing Source Documents|14|||
164386440|NCT00099983|593784016|FG001|Overall Study|Missing Source Documents|15|||
164386441|NCT00099983|593784015|FG000|Overall Study|Withdrawal by Subject|3|||
164386442|NCT00099983|593784016|FG001|Overall Study|Withdrawal by Subject|2|||
164703230|NCT02266134|594939107|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
164703231|NCT02266134|594939108|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
164386443|NCT00099983|593784015|FG000|Overall Study|Adverse Event|1|||
164386444|NCT00099983|593784016|FG001|Overall Study|Adverse Event|1|||
164386445|NCT00099983|593784015|FG000|Overall Study|Lack of Efficacy|0|||
164386446|NCT00099983|593784016|FG001|Overall Study|Lack of Efficacy|1|||
164386447|NCT00099983|593784015|FG000|Overall Study|Unable to return for appointments|1|||
164386448|NCT00099983|593784016|FG001|Overall Study|Unable to return for appointments|1|||
164386449|NCT00099983|593784015|FG000|Overall Study|Moved|1|||
164386450|NCT00099983|593784016|FG001|Overall Study|Moved|0|||
164386451|NCT00099983|593784015|FG000|Overall Study|Other psychiatric problem|1|||
164386452|NCT00099983|593784016|FG001|Overall Study|Other psychiatric problem|0|||
164386453|NCT00099983|593784015|FG000|Overall Study|Incarcerated|0|||
164386454|NCT00099983|593784016|FG001|Overall Study|Incarcerated|1|||
164386455|NCT00099983|593784015|FG000|Overall Study|Intolerant of burden of visits|0|||
164386456|NCT00099983|593784016|FG001|Overall Study|Intolerant of burden of visits|1|||
164386457|NCT00099983|593784015|FG000|Overall Study|Other issue|1|||
164386458|NCT00099983|593784016|FG001|Overall Study|Other issue|0|||
164386459|NCT00101101|593784017|FG000|Overall Study|never received vaccine|20|||
164386460|NCT01603875|593784018|FG000|Overall Study|Preexisting rabies antibody|3|||
164386461|NCT01603875|593784019|FG001|Overall Study|Preexisting rabies antibody|4|||
164386462|NCT01603875|593784020|FG002|Overall Study|Preexisting rabies antibody|3|||
164386463|NCT01603875|593784018|FG000|Overall Study|Lost to Follow-up|4|||
164386464|NCT01603875|593784019|FG001|Overall Study|Lost to Follow-up|3|||
164386465|NCT01603875|593784020|FG002|Overall Study|Lost to Follow-up|6|||
164386466|NCT01603875|593784018|FG000|Overall Study|Protocol Violation|0|||
164440332|NCT00057837|593978979|FG001|Overall Study|Alternative therapy|1|||
164593176|NCT02213198|594534692|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
164386467|NCT01603875|593784019|FG001|Overall Study|Protocol Violation|1|||
164386468|NCT01603875|593784020|FG002|Overall Study|Protocol Violation|0|||
164386469|NCT01652716|593784024|FG000|Overall Study|Loss of glucose control|1|||
164386470|NCT01652716|593784025|FG001|Overall Study|Loss of glucose control|0|||
164386471|NCT01652716|593784024|FG000|Overall Study|Administrative|0|||
164386472|NCT01652716|593784025|FG001|Overall Study|Administrative|2|||
164386473|NCT01652716|593784024|FG000|Overall Study|Investigator decision|1|||
164386474|NCT01652716|593784025|FG001|Overall Study|Investigator decision|4|||
164386475|NCT01652716|593784024|FG000|Overall Study|Lost to Follow-up|12|||
164386476|NCT01652716|593784025|FG001|Overall Study|Lost to Follow-up|11|||
164386477|NCT01652716|593784024|FG000|Overall Study|Protocol Violation|2|||
164386478|NCT01652716|593784025|FG001|Overall Study|Protocol Violation|1|||
164386479|NCT01652716|593784024|FG000|Overall Study|Adverse Event|7|||
164386480|NCT01652716|593784025|FG001|Overall Study|Adverse Event|10|||
164386481|NCT01652716|593784024|FG000|Overall Study|Withdrawal by Subject|33|||
164386482|NCT01652716|593784025|FG001|Overall Study|Withdrawal by Subject|18|||
164386483|NCT04122443|593784028|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
164386484|NCT04122443|593784029|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
164386485|NCT04122443|593784030|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
164386486|NCT04122443|593784028|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
164386487|NCT04122443|593784029|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
164386488|NCT04122443|593784030|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
164386489|NCT05204134|593784031|FG000|Overall Study|Withdrawal by Subject|3|||
164386490|NCT05204134|593784031|FG000|Overall Study|Physician Decision|1|||
164386491|NCT01312467|593784035|FG000|Overall Study|Adverse Event|4|||
164386492|NCT01312467|593784035|FG000|Overall Study|Lost to Follow-up|1|||
164386493|NCT01312467|593784035|FG000|Overall Study|Withdrawal by Subject|2|||
164386494|NCT01312467|593784035|FG000|Overall Study|Deported to country of origin|1|||
164440333|NCT00057837|593978978|FG000|Overall Study|Other complicating disease|2|||
164593177|NCT02213198|594534691|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
164593178|NCT02213198|594534692|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
164593179|NCT01954121|594534693|FG000|Overall Study|Lack of Efficacy|94|||
164593180|NCT01954121|594534694|FG001|Overall Study|Lack of Efficacy|41|||
164593181|NCT01954121|594534693|FG000|Overall Study|Protocol Violation|0|||
164593182|NCT01954121|594534694|FG001|Overall Study|Protocol Violation|2|||
164593183|NCT01954121|594534693|FG000|Overall Study|Lost to Follow-up|5|||
164593184|NCT01954121|594534694|FG001|Overall Study|Lost to Follow-up|6|||
164593185|NCT01954121|594534693|FG000|Overall Study|Withdrawal by Subject|18|||
164593186|NCT01954121|594534694|FG001|Overall Study|Withdrawal by Subject|12|||
164593187|NCT01954121|594534693|FG000|Overall Study|Pregnancy|1|||
164593188|NCT01954121|594534694|FG001|Overall Study|Pregnancy|1|||
164593189|NCT01954121|594534693|FG000|Overall Study|AE, serious fatal|1|||
164593190|NCT01954121|594534694|FG001|Overall Study|AE, serious fatal|0|||
164593191|NCT01954121|594534693|FG000|Overall Study|AE, non-serious non-fatal|5|||
164593192|NCT01954121|594534694|FG001|Overall Study|AE, non-serious non-fatal|22|||
164593193|NCT01954121|594534693|FG000|Overall Study|SAE, non-fatal|1|||
164593194|NCT01954121|594534694|FG001|Overall Study|SAE, non-fatal|4|||
164593195|NCT01954121|594534693|FG000|Overall Study|Non-compliant with study procedures|1|||
164593196|NCT01954121|594534694|FG001|Overall Study|Non-compliant with study procedures|0|||
164593197|NCT01954121|594534693|FG000|Overall Study|Non-compliant patient|1|||
164593198|NCT01954121|594534694|FG001|Overall Study|Non-compliant patient|1|||
164386495|NCT01312467|593784035|FG000|Overall Study|Another medical condition|1|||
164386496|NCT01312467|593784035|FG000|Overall Study|Ineligible|4|||
164386497|NCT03283670|593784036|FG000|Placebo Gas|Withdrawal by Subject|2|||
164386498|NCT03283670|593784036|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
164386499|NCT03283670|593784036|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
164386500|NCT01059617|593784037|FG000|Overall Study|Other|7|||
164386501|NCT01059617|593784038|FG001|Overall Study|Other|1|||
164703232|NCT02266134|594939109|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
164703233|NCT02266134|594939110|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
164703234|NCT02266134|594939107|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
164703235|NCT02266134|594939108|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
164703236|NCT02266134|594939109|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
164703237|NCT02266134|594939110|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
164703238|NCT00302081|594939111|FG000|Overall Study|Adverse Event|6|||
164703239|NCT00302081|594939112|FG001|Overall Study|Adverse Event|5|||
164386502|NCT01059617|593784039|FG002|Overall Study|Other|8|||
164386503|NCT01059617|593784040|FG003|Overall Study|Other|6|||
164386504|NCT01968434|593784043|FG000|Overall Study|Lost to Follow-up|3|||
164386505|NCT01968434|593784044|FG001|Overall Study|Lost to Follow-up|6|||
164386506|NCT02199691|593784045|FG000|Overall Study|Protocol Violation|3|||
164386507|NCT02199691|593784046|FG001|Overall Study|Protocol Violation|3|||
164386508|NCT02199691|593784047|FG002|Overall Study|Protocol Violation|6|||
164386509|NCT02199691|593784048|FG003|Overall Study|Protocol Violation|7|||
164386510|NCT02199691|593784045|FG000|Overall Study|Withdrawal by Subject|5|||
164386511|NCT02199691|593784046|FG001|Overall Study|Withdrawal by Subject|3|||
164386512|NCT02199691|593784047|FG002|Overall Study|Withdrawal by Subject|12|||
164386513|NCT02199691|593784048|FG003|Overall Study|Withdrawal by Subject|13|||
164386514|NCT02199691|593784045|FG000|Overall Study|Lost to Follow-up|2|||
164386515|NCT02199691|593784046|FG001|Overall Study|Lost to Follow-up|1|||
164386516|NCT02199691|593784047|FG002|Overall Study|Lost to Follow-up|9|||
164386517|NCT02199691|593784048|FG003|Overall Study|Lost to Follow-up|10|||
164386518|NCT00612313|593784051|FG000|Overall Study|Withdrawal by Subject|6|||
164386519|NCT00612313|593784052|FG001|Overall Study|Withdrawal by Subject|9|||
164386520|NCT00612313|593784051|FG000|Overall Study|Lost to Follow-up|11|||
164386521|NCT00612313|593784052|FG001|Overall Study|Lost to Follow-up|4|||
164386522|NCT00791765|593786195|FG000|Weeks 1 to 12|Adverse Event|0|||
164386523|NCT00791765|593786196|FG001|Weeks 1 to 12|Adverse Event|1|||
164386524|NCT00791765|593786195|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
164386525|NCT00791765|593786196|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
164386526|NCT00791765|593786195|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
164386527|NCT00791765|593786196|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
164386528|NCT00791765|593786195|FG000|Weeks 1 to 12|Physician Decision|1|||
164386529|NCT00791765|593786196|FG001|Weeks 1 to 12|Physician Decision|0|||
164386530|NCT00791765|593786195|FG000|Weeks 1 to 12|Disease progression|3|||
164386531|NCT00791765|593786196|FG001|Weeks 1 to 12|Disease progression|0|||
164386532|NCT00791765|593786195|FG000|Weeks 1 to 12|Ineligibility determined|0|||
164386533|NCT00791765|593786196|FG001|Weeks 1 to 12|Ineligibility determined|3|||
164386534|NCT00791765|593786195|FG000|Weeks 13 to 24|Protocol deviation|2|||
164386535|NCT00791765|593786196|FG001|Weeks 13 to 24|Protocol deviation|0|||
164386536|NCT00791765|593786195|FG000|Weeks 13 to 24|Adverse Event|0|||
164386537|NCT00791765|593786196|FG001|Weeks 13 to 24|Adverse Event|3|||
164386538|NCT00791765|593786195|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
164386539|NCT00791765|593786196|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
164386540|NCT00791765|593786195|FG000|Weeks 13 to 24|Disease progression|0|||
164386541|NCT00791765|593786196|FG001|Weeks 13 to 24|Disease progression|1|||
164386542|NCT00791765|593786195|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
164386543|NCT00791765|593786196|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
164386544|NCT00791765|593786195|FG000|Weeks 13 to 24|Other|0|||
164386545|NCT00791765|593786196|FG001|Weeks 13 to 24|Other|1|||
164386546|NCT04295564|593786197|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
164386547|NCT04295564|593786198|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
164386548|NCT04537923|593786199|FG000|Overall Study|Adverse Event|2|||
164386549|NCT04537923|593786200|FG001|Overall Study|Adverse Event|1|||
164386550|NCT04537923|593786201|FG002|Overall Study|Adverse Event|2|||
164386551|NCT04537923|593786202|FG003|Overall Study|Adverse Event|4|||
164386552|NCT04537923|593786199|FG000|Overall Study|Death|3|||
164386553|NCT04537923|593786200|FG001|Overall Study|Death|3|||
164386554|NCT04537923|593786201|FG002|Overall Study|Death|1|||
164593199|NCT01954121|594534693|FG000|Overall Study|Subject did not follow instructions|0|||
164593200|NCT01954121|594534694|FG001|Overall Study|Subject did not follow instructions|2|||
164593201|NCT00601523|594534695|FG000|Overall Study|Adverse Event|42|||
164593202|NCT00601523|594534696|FG001|Overall Study|Adverse Event|14|||
164593203|NCT00601523|594534695|FG000|Overall Study|Lack of Efficacy|3|||
164593204|NCT00601523|594534696|FG001|Overall Study|Lack of Efficacy|0|||
164593205|NCT00601523|594534695|FG000|Overall Study|Protocol Violation|5|||
164593206|NCT00601523|594534696|FG001|Overall Study|Protocol Violation|1|||
164593207|NCT00601523|594534695|FG000|Overall Study|Lost to Follow-up|0|||
164593208|NCT00601523|594534696|FG001|Overall Study|Lost to Follow-up|1|||
164593209|NCT00601523|594534695|FG000|Overall Study|Withdrawal by Subject|18|||
164593210|NCT00601523|594534696|FG001|Overall Study|Withdrawal by Subject|9|||
164593211|NCT00601523|594534695|FG000|Overall Study|Other|9|||
164703240|NCT00302081|594939113|FG002|Overall Study|Adverse Event|4|||
164386555|NCT04537923|593786202|FG003|Overall Study|Death|11|||
164386556|NCT04537923|593786199|FG000|Overall Study|Lost to Follow-up|1|||
164386557|NCT04537923|593786200|FG001|Overall Study|Lost to Follow-up|2|||
164703241|NCT00302081|594939111|FG000|Overall Study|Lost to Follow-up|21|||
164703242|NCT00302081|594939112|FG001|Overall Study|Lost to Follow-up|18|||
164703243|NCT00302081|594939113|FG002|Overall Study|Lost to Follow-up|28|||
164703244|NCT00302081|594939111|FG000|Overall Study|Withdrawal by Subject|8|||
164703245|NCT00302081|594939112|FG001|Overall Study|Withdrawal by Subject|12|||
164703246|NCT00302081|594939113|FG002|Overall Study|Withdrawal by Subject|8|||
164703247|NCT00302081|594939111|FG000|Overall Study|Protocol Violation|5|||
164703248|NCT00302081|594939112|FG001|Overall Study|Protocol Violation|1|||
164703249|NCT00302081|594939113|FG002|Overall Study|Protocol Violation|2|||
164703250|NCT00302081|594939111|FG000|Overall Study|Lack of Efficacy|1|||
164703251|NCT00302081|594939112|FG001|Overall Study|Lack of Efficacy|0|||
164703252|NCT00302081|594939113|FG002|Overall Study|Lack of Efficacy|5|||
164703253|NCT00302081|594939111|FG000|Overall Study|Death|2|||
164703254|NCT00302081|594939112|FG001|Overall Study|Death|1|||
164703255|NCT00302081|594939113|FG002|Overall Study|Death|0|||
164703256|NCT00302081|594939111|FG000|Overall Study|Other|13|||
164703257|NCT00302081|594939112|FG001|Overall Study|Other|6|||
164703258|NCT00302081|594939113|FG002|Overall Study|Other|5|||
164703259|NCT02701413|594939114|FG000|Overall Study|Withdrawal by Subject|7|||
164703260|NCT02701413|594939115|FG001|Overall Study|Withdrawal by Subject|11|||
164703261|NCT02138136|594939116|FG000|Overall Study|Protocol Violation|4|||
164703262|NCT02138136|594939116|FG000|Overall Study|Physician Decision|7|||
164703263|NCT02138136|594939116|FG000|Overall Study|Lack of Efficacy|35|||
164703264|NCT02138136|594939116|FG000|Overall Study|Pregnancy|2|||
164703265|NCT02138136|594939116|FG000|Overall Study|Adverse Event|18|||
164703266|NCT02138136|594939116|FG000|Overall Study|Withdrawal by Subject|36|||
164703267|NCT02138136|594939116|FG000|Overall Study|Lost to Follow-up|32|||
164703268|NCT02138136|594939116|FG000|Overall Study|Withdrawn by Sponsor|5|||
164703269|NCT01359644|594939121|FG000|Treatment Period|Lack of Efficacy|0|||
164703270|NCT01359644|594939122|FG001|Treatment Period|Lack of Efficacy|1|||
164703271|NCT01359644|594939123|FG002|Treatment Period|Lack of Efficacy|0|||
164703272|NCT01359644|594939124|FG003|Treatment Period|Lack of Efficacy|0|||
164703273|NCT01359644|594939125|FG004|Treatment Period|Lack of Efficacy|0|||
164386558|NCT04537923|593786201|FG002|Overall Study|Lost to Follow-up|1|||
164386559|NCT04537923|593786202|FG003|Overall Study|Lost to Follow-up|6|||
164386560|NCT04537923|593786199|FG000|Overall Study|Physician Decision|1|||
164386561|NCT04537923|593786200|FG001|Overall Study|Physician Decision|0|||
164386562|NCT04537923|593786201|FG002|Overall Study|Physician Decision|2|||
164386563|NCT04537923|593786202|FG003|Overall Study|Physician Decision|5|||
164386564|NCT04537923|593786199|FG000|Overall Study|Pregnancy|1|||
164386565|NCT04537923|593786200|FG001|Overall Study|Pregnancy|0|||
164386566|NCT04537923|593786201|FG002|Overall Study|Pregnancy|0|||
164386567|NCT04537923|593786202|FG003|Overall Study|Pregnancy|0|||
164386568|NCT04537923|593786199|FG000|Overall Study|Withdrawal by Subject|4|||
164386569|NCT04537923|593786200|FG001|Overall Study|Withdrawal by Subject|4|||
164386570|NCT04537923|593786201|FG002|Overall Study|Withdrawal by Subject|4|||
164386571|NCT04537923|593786202|FG003|Overall Study|Withdrawal by Subject|58|||
164386572|NCT04537923|593786199|FG000|Overall Study|Missed study visits|2|||
164386573|NCT04537923|593786200|FG001|Overall Study|Missed study visits|0|||
164386574|NCT04537923|593786201|FG002|Overall Study|Missed study visits|0|||
164386575|NCT04537923|593786202|FG003|Overall Study|Missed study visits|3|||
164386576|NCT04537923|593786199|FG000|Overall Study|Sponsor's decision|0|||
164386577|NCT04537923|593786200|FG001|Overall Study|Sponsor's decision|0|||
164386578|NCT04537923|593786201|FG002|Overall Study|Sponsor's decision|1|||
164386579|NCT04537923|593786202|FG003|Overall Study|Sponsor's decision|1|||
164386580|NCT04537923|593786199|FG000|Overall Study|Safety reasons|1|||
164386581|NCT04537923|593786200|FG001|Overall Study|Safety reasons|0|||
164386582|NCT04537923|593786201|FG002|Overall Study|Safety reasons|0|||
164386583|NCT04537923|593786202|FG003|Overall Study|Safety reasons|0|||
164386584|NCT01261611|593786203|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
164386585|NCT01261611|593786204|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
164386586|NCT01261611|593786205|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
164386587|NCT01261611|593786203|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
164386588|NCT01261611|593786204|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
164386589|NCT01261611|593786205|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
164386590|NCT01261611|593786203|FG000|Treatment Cycle 1|Adverse Event|0|||
164386591|NCT01261611|593786204|FG001|Treatment Cycle 1|Adverse Event|1|||
164386592|NCT01261611|593786205|FG002|Treatment Cycle 1|Adverse Event|0|||
164386593|NCT01261611|593786203|FG000|Treatment Cycle 1|Protocol Violation|0|||
164386594|NCT01261611|593786204|FG001|Treatment Cycle 1|Protocol Violation|0|||
164703274|NCT01359644|594939126|FG005|Treatment Period|Lack of Efficacy|0|||
164703275|NCT01359644|594939127|FG006|Treatment Period|Lack of Efficacy|0|||
164386595|NCT01261611|593786205|FG002|Treatment Cycle 1|Protocol Violation|2|||
164386596|NCT01261611|593786203|FG000|Treatment Cycle 2|Completed study|4|||
164386597|NCT01261611|593786204|FG001|Treatment Cycle 2|Completed study|0|||
164703276|NCT01359644|594939128|FG007|Treatment Period|Lack of Efficacy|0|||
164703277|NCT01359644|594939129|FG008|Treatment Period|Lack of Efficacy|0|||
164703278|NCT01359644|594939130|FG009|Treatment Period|Lack of Efficacy|0|||
164703279|NCT01359644|594939121|FG000|Treatment Period|Adverse Event|0|||
164703280|NCT01359644|594939122|FG001|Treatment Period|Adverse Event|0|||
164703281|NCT01359644|594939123|FG002|Treatment Period|Adverse Event|1|||
164703282|NCT01359644|594939124|FG003|Treatment Period|Adverse Event|0|||
164703283|NCT01359644|594939125|FG004|Treatment Period|Adverse Event|0|||
164703284|NCT01359644|594939126|FG005|Treatment Period|Adverse Event|1|||
164703285|NCT01359644|594939127|FG006|Treatment Period|Adverse Event|0|||
164703286|NCT01359644|594939128|FG007|Treatment Period|Adverse Event|0|||
164703287|NCT01359644|594939129|FG008|Treatment Period|Adverse Event|0|||
164703288|NCT01359644|594939130|FG009|Treatment Period|Adverse Event|0|||
164703289|NCT01359644|594939121|FG000|Treatment Period|Lost to Follow-up|0|||
164703290|NCT01359644|594939122|FG001|Treatment Period|Lost to Follow-up|0|||
164703291|NCT01359644|594939123|FG002|Treatment Period|Lost to Follow-up|0|||
164703292|NCT01359644|594939124|FG003|Treatment Period|Lost to Follow-up|0|||
164703293|NCT01359644|594939125|FG004|Treatment Period|Lost to Follow-up|0|||
164703294|NCT01359644|594939126|FG005|Treatment Period|Lost to Follow-up|1|||
164703295|NCT01359644|594939127|FG006|Treatment Period|Lost to Follow-up|0|||
164703296|NCT01359644|594939128|FG007|Treatment Period|Lost to Follow-up|0|||
164703297|NCT01359644|594939129|FG008|Treatment Period|Lost to Follow-up|0|||
164703298|NCT01359644|594939130|FG009|Treatment Period|Lost to Follow-up|0|||
164703299|NCT01359644|594939121|FG000|Follow-up Period|Withdrawal by Subject|0|||
164703300|NCT01359644|594939122|FG001|Follow-up Period|Withdrawal by Subject|0|||
164703301|NCT01359644|594939123|FG002|Follow-up Period|Withdrawal by Subject|0|||
164703302|NCT01359644|594939124|FG003|Follow-up Period|Withdrawal by Subject|0|||
164703303|NCT01359644|594939125|FG004|Follow-up Period|Withdrawal by Subject|0|||
164703304|NCT01359644|594939126|FG005|Follow-up Period|Withdrawal by Subject|1|||
164703305|NCT01359644|594939127|FG006|Follow-up Period|Withdrawal by Subject|0|||
164703306|NCT01359644|594939128|FG007|Follow-up Period|Withdrawal by Subject|0|||
164703307|NCT01359644|594939129|FG008|Follow-up Period|Withdrawal by Subject|0|||
164703308|NCT01359644|594939130|FG009|Follow-up Period|Withdrawal by Subject|0|||
164703309|NCT01359644|594939121|FG000|Follow-up Period|Lost to Follow-up|0|||
164703310|NCT01359644|594939122|FG001|Follow-up Period|Lost to Follow-up|0|||
164703311|NCT01359644|594939123|FG002|Follow-up Period|Lost to Follow-up|0|||
164703312|NCT01359644|594939124|FG003|Follow-up Period|Lost to Follow-up|0|||
164703313|NCT01359644|594939125|FG004|Follow-up Period|Lost to Follow-up|0|||
164703314|NCT01359644|594939126|FG005|Follow-up Period|Lost to Follow-up|0|||
164703315|NCT01359644|594939127|FG006|Follow-up Period|Lost to Follow-up|1|||
164703316|NCT01359644|594939128|FG007|Follow-up Period|Lost to Follow-up|2|||
164703317|NCT01359644|594939129|FG008|Follow-up Period|Lost to Follow-up|0|||
164703318|NCT01359644|594939130|FG009|Follow-up Period|Lost to Follow-up|0|||
164703319|NCT00311311|594939132|FG000|Overall Study|Adverse Event|3|||
164703320|NCT00311311|594939133|FG001|Overall Study|Adverse Event|2|||
164703321|NCT00311311|594939132|FG000|Overall Study|Withdrawal by Subject|1|||
164703322|NCT00311311|594939133|FG001|Overall Study|Withdrawal by Subject|1|||
164703323|NCT00311311|594939132|FG000|Overall Study|Noncompliance|0|||
164703324|NCT00311311|594939133|FG001|Overall Study|Noncompliance|1|||
164703325|NCT00311311|594939132|FG000|Overall Study|Study Termination by Sponsor|3|||
164703326|NCT00311311|594939133|FG001|Overall Study|Study Termination by Sponsor|4|||
164703327|NCT00311311|594939132|FG000|Overall Study|Death|1|||
164703328|NCT00311311|594939133|FG001|Overall Study|Death|0|||
164703329|NCT00311311|594939132|FG000|Overall Study|Lack of ancillary assistance|0|||
164703330|NCT00311311|594939133|FG001|Overall Study|Lack of ancillary assistance|1|||
164703331|NCT00826449|594939136|FG000|Overall Study|Disease Progression|4|||
164703332|NCT00826449|594939136|FG000|Overall Study|Withdrawal by Subject|1|||
164703333|NCT00160641|594939151|FG000|Overall Study|Adverse Event|102|||
164703334|NCT00160641|594939151|FG000|Overall Study|Withdrawal by Subject|87|||
164703335|NCT00160641|594939151|FG000|Overall Study|Lost to Follow-up|8|||
164386598|NCT01261611|593786205|FG002|Treatment Cycle 2|Completed study|0|||
164386599|NCT01261611|593786203|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
164386600|NCT01261611|593786204|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
164386601|NCT01261611|593786205|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
164386602|NCT01261611|593786203|FG000|Treatment Cycle 2|Adverse Event|1|||
164703336|NCT00160641|594939151|FG000|Overall Study|Lack of Efficacy|12|||
164703337|NCT00160641|594939151|FG000|Overall Study|Protocol Violation|3|||
164703338|NCT00160641|594939151|FG000|Overall Study|Other|9|||
164703339|NCT01875471|594939152|FG000|Overall Study|Adverse Event|0|||
164703340|NCT01875471|594939153|FG001|Overall Study|Adverse Event|1|||
164386603|NCT01261611|593786204|FG001|Treatment Cycle 2|Adverse Event|0|||
164386604|NCT01261611|593786205|FG002|Treatment Cycle 2|Adverse Event|0|||
164386605|NCT01261611|593786203|FG000|Treatment Cycle 2|Protocol Violation|2|||
164386606|NCT01261611|593786204|FG001|Treatment Cycle 2|Protocol Violation|0|||
164386607|NCT01261611|593786205|FG002|Treatment Cycle 2|Protocol Violation|0|||
164703341|NCT01875471|594939152|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
164703342|NCT01875471|594939153|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
164703343|NCT02458092|594939154|FG000|Overall Study|Withdrawal by Subject|1|||
164703344|NCT02458092|594939155|FG001|Overall Study|Withdrawal by Subject|0|||
164703345|NCT00975286|594939159|FG000|Overall Study|Adverse Event|9|||
164703346|NCT00975286|594939160|FG001|Overall Study|Adverse Event|19|||
164703347|NCT00975286|594939159|FG000|Overall Study|Protocol Violation|1|||
164386608|NCT01261611|593786203|FG000|Treatment Cycle 2|Not otherwise specified|2|||
164386609|NCT01261611|593786204|FG001|Treatment Cycle 2|Not otherwise specified|0|||
164386610|NCT01261611|593786205|FG002|Treatment Cycle 2|Not otherwise specified|0|||
164386611|NCT01261611|593786203|FG000|Treatment Cycle 3|Completed study|24|||
164386612|NCT01261611|593786204|FG001|Treatment Cycle 3|Completed study|0|||
164386613|NCT01261611|593786205|FG002|Treatment Cycle 3|Completed study|0|||
164386614|NCT01261611|593786203|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
164386615|NCT01261611|593786204|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
164386616|NCT01261611|593786205|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
164386617|NCT01261611|593786203|FG000|Treatment Cycle 3|Adverse Event|1|||
164386618|NCT01261611|593786204|FG001|Treatment Cycle 3|Adverse Event|0|||
164386619|NCT01261611|593786205|FG002|Treatment Cycle 3|Adverse Event|0|||
164386620|NCT01261611|593786203|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
164386621|NCT01261611|593786204|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
164386622|NCT01261611|593786205|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
164386623|NCT01261611|593786203|FG000|Treatment Cycle 4|Completed study|87|||
164386624|NCT01261611|593786204|FG001|Treatment Cycle 4|Completed study|0|||
164386625|NCT01261611|593786205|FG002|Treatment Cycle 4|Completed study|0|||
164386626|NCT01261611|593786203|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
164386627|NCT01261611|593786204|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
164386628|NCT01261611|593786205|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
164386629|NCT01261611|593786203|FG000|Treatment Cycle 4|Adverse Event|1|||
164386630|NCT01261611|593786204|FG001|Treatment Cycle 4|Adverse Event|0|||
164386631|NCT01261611|593786205|FG002|Treatment Cycle 4|Adverse Event|0|||
164386632|NCT01261611|593786203|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
164386633|NCT01261611|593786204|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
164386634|NCT01261611|593786205|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
164386635|NCT01261611|593786203|FG000|Treatment Cycle 4|Not otherwise specified|3|||
164386636|NCT01261611|593786204|FG001|Treatment Cycle 4|Not otherwise specified|0|||
164440334|NCT00057837|593978979|FG001|Overall Study|Other complicating disease|1|||
164440335|NCT00057837|593978978|FG000|Overall Study|Physician Decision|1|||
164440336|NCT00057837|593978979|FG001|Overall Study|Physician Decision|0|||
164440337|NCT00057837|593978978|FG000|Overall Study|Ineligible|3|||
164440338|NCT00057837|593978979|FG001|Overall Study|Ineligible|3|||
164440339|NCT00057837|593978978|FG000|Overall Study|Never started treatment|1|||
164440340|NCT00057837|593978979|FG001|Overall Study|Never started treatment|1|||
164440341|NCT01317420|593978980|FG000|Overall Study|Progressive disease according to RECIST|2|||
164440342|NCT01317420|593978981|FG001|Overall Study|Progressive disease according to RECIST|3|||
164440343|NCT01317420|593978982|FG002|Overall Study|Progressive disease according to RECIST|3|||
164440344|NCT01317420|593978983|FG003|Overall Study|Progressive disease according to RECIST|3|||
164440345|NCT01317420|593978984|FG004|Overall Study|Progressive disease according to RECIST|3|||
164440346|NCT01317420|593978985|FG005|Overall Study|Progressive disease according to RECIST|3|||
164440347|NCT01317420|593978986|FG006|Overall Study|Progressive disease according to RECIST|3|||
164440348|NCT01317420|593978987|FG007|Overall Study|Progressive disease according to RECIST|3|||
164440349|NCT01317420|593978988|FG008|Overall Study|Progressive disease according to RECIST|3|||
164440350|NCT01317420|593978989|FG009|Overall Study|Progressive disease according to RECIST|2|||
164440351|NCT01317420|593978990|FG010|Overall Study|Progressive disease according to RECIST|3|||
164440352|NCT01317420|593978991|FG011|Overall Study|Progressive disease according to RECIST|11|||
164440353|NCT01317420|593978992|FG012|Overall Study|Progressive disease according to RECIST|16|||
164440354|NCT01317420|593978980|FG000|Overall Study|Other adverse event|1|||
164440355|NCT01317420|593978981|FG001|Overall Study|Other adverse event|0|||
164440356|NCT01317420|593978982|FG002|Overall Study|Other adverse event|0|||
164703348|NCT00975286|594939160|FG001|Overall Study|Protocol Violation|2|||
164703349|NCT00975286|594939159|FG000|Overall Study|Withdrawal by Subject|0|||
164703350|NCT00975286|594939160|FG001|Overall Study|Withdrawal by Subject|2|||
164703351|NCT00975286|594939159|FG000|Overall Study|Familial and Personal Reasons|2|||
164703352|NCT00975286|594939160|FG001|Overall Study|Familial and Personal Reasons|2|||
164703353|NCT00975286|594939159|FG000|Overall Study|Poor Compliance to Protocol|0|||
164703354|NCT00975286|594939160|FG001|Overall Study|Poor Compliance to Protocol|2|||
164703355|NCT00975286|594939159|FG000|Overall Study|Sponsor Decision|0|||
164703356|NCT00975286|594939160|FG001|Overall Study|Sponsor Decision|2|||
164703357|NCT00456495|594939164|FG000|Overall Study|Physician Decision|2|||
164703358|NCT01301508|594939165|FG000|Overall Study|Withdrawal by Subject|1|||
164703359|NCT01301508|594939166|FG001|Overall Study|Withdrawal by Subject|2|||
164703360|NCT01301508|594939165|FG000|Overall Study|Lost to Follow-up|0|||
164703361|NCT01301508|594939166|FG001|Overall Study|Lost to Follow-up|1|||
164703362|NCT01346774|594939169|FG000|Overall Study|Did not take a single dose|6|||
164703363|NCT01346774|594939170|FG001|Overall Study|Did not take a single dose|4|||
164703364|NCT01346774|594939169|FG000|Overall Study|Lost to Follow-up|3|||
164703365|NCT01346774|594939170|FG001|Overall Study|Lost to Follow-up|4|||
164703366|NCT01346774|594939169|FG000|Overall Study|Withdrawal by Subject|1|||
164703367|NCT01346774|594939170|FG001|Overall Study|Withdrawal by Subject|4|||
164386637|NCT01261611|593786205|FG002|Treatment Cycle 4|Not otherwise specified|0|||
164386638|NCT01261611|593786203|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
164440357|NCT01317420|593978983|FG003|Overall Study|Other adverse event|0|||
164703368|NCT01346774|594939169|FG000|Overall Study|Protocol Violation|2|||
164703369|NCT01346774|594939170|FG001|Overall Study|Protocol Violation|3|||
164703370|NCT01346774|594939169|FG000|Overall Study|Adverse Event|1|||
164703371|NCT01346774|594939170|FG001|Overall Study|Adverse Event|2|||
164703372|NCT01929031|594939171|FG000|Overall Study|Adverse Event|3|||
164703373|NCT01929031|594939172|FG001|Overall Study|Adverse Event|1|||
164703374|NCT01929031|594939173|FG002|Overall Study|Adverse Event|1|||
164703375|NCT01929031|594939174|FG003|Overall Study|Adverse Event|0|||
164703376|NCT01929031|594939175|FG004|Overall Study|Adverse Event|0|||
164703377|NCT01929031|594939176|FG005|Overall Study|Adverse Event|0|||
164703378|NCT01929031|594939171|FG000|Overall Study|Protocol Violation|1|||
164703379|NCT01929031|594939172|FG001|Overall Study|Protocol Violation|0|||
164386639|NCT01261611|593786204|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
164386640|NCT01261611|593786205|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
164386641|NCT01261611|593786203|FG000|Treatment Cycle 5|Adverse Event|1|||
164386642|NCT01261611|593786204|FG001|Treatment Cycle 5|Adverse Event|0|||
164386643|NCT01261611|593786205|FG002|Treatment Cycle 5|Adverse Event|0|||
164386644|NCT01261611|593786203|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
164386645|NCT01261611|593786204|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
164386646|NCT01261611|593786205|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
164386647|NCT02527798|593786206|FG000|Overall Study|Physician Decision|1|||
164386648|NCT02527798|593786207|FG001|Overall Study|Physician Decision|0|||
164386649|NCT02527798|593786208|FG002|Overall Study|Physician Decision|1|||
164386650|NCT02527798|593786209|FG003|Overall Study|Physician Decision|1|||
164386651|NCT02527798|593786210|FG004|Overall Study|Physician Decision|0|||
164386652|NCT02527798|593786211|FG005|Overall Study|Physician Decision|0|||
164386653|NCT02527798|593786206|FG000|Overall Study|Death|0|||
164386654|NCT02527798|593786207|FG001|Overall Study|Death|0|||
164386655|NCT02527798|593786208|FG002|Overall Study|Death|1|||
164386656|NCT02527798|593786209|FG003|Overall Study|Death|0|||
164386657|NCT02527798|593786210|FG004|Overall Study|Death|0|||
164386658|NCT02527798|593786211|FG005|Overall Study|Death|0|||
164386659|NCT02527798|593786206|FG000|Overall Study|Withdrawal by Subject|0|||
164386660|NCT02527798|593786207|FG001|Overall Study|Withdrawal by Subject|1|||
164386661|NCT02527798|593786208|FG002|Overall Study|Withdrawal by Subject|2|||
164386662|NCT02527798|593786209|FG003|Overall Study|Withdrawal by Subject|0|||
164386663|NCT02527798|593786210|FG004|Overall Study|Withdrawal by Subject|0|||
164386664|NCT02527798|593786211|FG005|Overall Study|Withdrawal by Subject|0|||
164386665|NCT02527798|593786206|FG000|Overall Study|Reason undisclosed|1|||
164386666|NCT02527798|593786207|FG001|Overall Study|Reason undisclosed|0|||
164386667|NCT02527798|593786208|FG002|Overall Study|Reason undisclosed|1|||
164386668|NCT02527798|593786209|FG003|Overall Study|Reason undisclosed|0|||
164386669|NCT02527798|593786210|FG004|Overall Study|Reason undisclosed|0|||
164386670|NCT02527798|593786211|FG005|Overall Study|Reason undisclosed|0|||
164386671|NCT02527798|593786206|FG000|Overall Study|Did not receive intervention|1|||
164386672|NCT02527798|593786207|FG001|Overall Study|Did not receive intervention|1|||
164386673|NCT02527798|593786208|FG002|Overall Study|Did not receive intervention|0|||
164386674|NCT02527798|593786209|FG003|Overall Study|Did not receive intervention|0|||
164386675|NCT02527798|593786210|FG004|Overall Study|Did not receive intervention|0|||
164386676|NCT02527798|593786211|FG005|Overall Study|Did not receive intervention|0|||
164386677|NCT03859323|593786213|FG000|Overall Study|Lost to Follow-up|0|||
164386678|NCT03859323|593786214|FG001|Overall Study|Lost to Follow-up|0|||
164386679|NCT03859323|593786215|FG002|Overall Study|Lost to Follow-up|0|||
164386680|NCT03859323|593786216|FG003|Overall Study|Lost to Follow-up|0|||
164386681|NCT03859323|593786217|FG004|Overall Study|Lost to Follow-up|0|||
164386682|NCT03859323|593786218|FG005|Overall Study|Lost to Follow-up|0|||
164386683|NCT03859323|593786219|FG006|Overall Study|Lost to Follow-up|1|||
164386684|NCT03859323|593786220|FG007|Overall Study|Lost to Follow-up|0|||
164386685|NCT03859323|593786221|FG008|Overall Study|Lost to Follow-up|0|||
164386686|NCT03859323|593786222|FG009|Overall Study|Lost to Follow-up|0|||
164386687|NCT03859323|593786223|FG010|Overall Study|Lost to Follow-up|0|||
164386688|NCT03859323|593786224|FG011|Overall Study|Lost to Follow-up|0|||
164386689|NCT03859323|593786225|FG012|Overall Study|Lost to Follow-up|0|||
164386690|NCT03859323|593786213|FG000|Overall Study|Withdrawal by Subject|0|||
164386691|NCT03859323|593786214|FG001|Overall Study|Withdrawal by Subject|0|||
164386692|NCT03859323|593786215|FG002|Overall Study|Withdrawal by Subject|1|||
164386693|NCT03859323|593786216|FG003|Overall Study|Withdrawal by Subject|0|||
164386694|NCT03859323|593786217|FG004|Overall Study|Withdrawal by Subject|0|||
164386695|NCT03859323|593786218|FG005|Overall Study|Withdrawal by Subject|1|||
164386696|NCT03859323|593786219|FG006|Overall Study|Withdrawal by Subject|0|||
164386697|NCT03859323|593786220|FG007|Overall Study|Withdrawal by Subject|0|||
164386698|NCT03859323|593786221|FG008|Overall Study|Withdrawal by Subject|0|||
164386699|NCT03859323|593786222|FG009|Overall Study|Withdrawal by Subject|1|||
164386700|NCT03859323|593786223|FG010|Overall Study|Withdrawal by Subject|1|||
164386701|NCT03859323|593786224|FG011|Overall Study|Withdrawal by Subject|2|||
164386702|NCT03859323|593786225|FG012|Overall Study|Withdrawal by Subject|1|||
164386703|NCT03859323|593786213|FG000|Overall Study|Pregnancy|0|||
164386704|NCT03859323|593786214|FG001|Overall Study|Pregnancy|0|||
164703380|NCT01929031|594939173|FG002|Overall Study|Protocol Violation|0|||
164386705|NCT03859323|593786215|FG002|Overall Study|Pregnancy|0|||
164386706|NCT03859323|593786216|FG003|Overall Study|Pregnancy|0|||
164386707|NCT03859323|593786217|FG004|Overall Study|Pregnancy|0|||
164386708|NCT03859323|593786218|FG005|Overall Study|Pregnancy|0|||
164386709|NCT03859323|593786219|FG006|Overall Study|Pregnancy|0|||
164386710|NCT03859323|593786220|FG007|Overall Study|Pregnancy|0|||
164386711|NCT03859323|593786221|FG008|Overall Study|Pregnancy|0|||
164386712|NCT03859323|593786222|FG009|Overall Study|Pregnancy|1|||
164386713|NCT03859323|593786223|FG010|Overall Study|Pregnancy|0|||
164386714|NCT03859323|593786224|FG011|Overall Study|Pregnancy|0|||
164386715|NCT03859323|593786225|FG012|Overall Study|Pregnancy|0|||
164386716|NCT01682460|593786227|FG000|Overall Study|Withdrawal by Subject|2|||
164386717|NCT01682460|593786227|FG000|Overall Study|Did not meet inclusion criteria|2|||
164386718|NCT02053350|593786231|FG000|Overall Study|Withdrawal by Subject|1|||
164386719|NCT02053350|593786231|FG000|Overall Study|Adverse Event|4|||
164386720|NCT01275625|593786232|FG000|Overall Study|Death|1|||
164386721|NCT01275625|593786232|FG000|Overall Study|Lack of Efficacy|2|||
164386722|NCT01275625|593786232|FG000|Overall Study|Lost to Follow-up|1|||
164386723|NCT01275625|593786232|FG000|Overall Study|Withdrawal by Subject|3|||
164386724|NCT01275625|593786232|FG000|Overall Study|Protocol Violation|1|||
164386725|NCT01275625|593786232|FG000|Overall Study|Adverse Event|4|||
164386726|NCT01275625|593786232|FG000|Overall Study|Other|1|||
164386727|NCT01585103|593786234|FG000|Overall Study|Unable to swallow Cytosponge|6|||
164386728|NCT03521635|593786235|FG000|Overall Study|Adverse Event|1|||
164386729|NCT03521635|593786236|FG001|Overall Study|Adverse Event|1|||
164386730|NCT03521635|593786235|FG000|Overall Study|Refused to complete study visit|1|||
164386731|NCT03521635|593786236|FG001|Overall Study|Refused to complete study visit|0|||
164386732|NCT03521635|593786235|FG000|Overall Study|Refused to continue trial medication|2|||
164386733|NCT03521635|593786236|FG001|Overall Study|Refused to continue trial medication|2|||
164386734|NCT03521635|593786235|FG000|Overall Study|Lost to Follow-up|0|||
164386735|NCT03521635|593786236|FG001|Overall Study|Lost to Follow-up|1|||
164386736|NCT03521635|593786235|FG000|Overall Study|Meet exclusion criteria|0|||
164386737|NCT03521635|593786236|FG001|Overall Study|Meet exclusion criteria|1|||
164386738|NCT03521635|593786235|FG000|Overall Study|Patient not taken study medicine|0|||
164386739|NCT03521635|593786236|FG001|Overall Study|Patient not taken study medicine|1|||
164386740|NCT01349569|593786237|FG000|Overall Study|Lack of Efficacy|4|||
164386741|NCT03581305|593786238|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
164386742|NCT03581305|593786239|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
164386743|NCT03581305|593786238|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
164386744|NCT03581305|593786239|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
164386745|NCT03581305|593786238|FG000|Serotonergic Study|Withdrawal by Subject|5|||
164386746|NCT03581305|593786239|FG001|Serotonergic Study|Withdrawal by Subject|1|||
164440358|NCT01317420|593978984|FG004|Overall Study|Other adverse event|0|||
164440359|NCT01317420|593978985|FG005|Overall Study|Other adverse event|0|||
164440360|NCT01317420|593978986|FG006|Overall Study|Other adverse event|0|||
164440361|NCT01317420|593978987|FG007|Overall Study|Other adverse event|0|||
164593212|NCT00601523|594534696|FG001|Overall Study|Other|1|||
164593213|NCT01987986|594534699|FG000|Overall Study|Lost to Follow-up|1|||
164593214|NCT01987986|594534700|FG001|Overall Study|Lost to Follow-up|0|||
164593215|NCT01987986|594534701|FG002|Overall Study|Lost to Follow-up|0|||
164593216|NCT01987986|594534702|FG003|Overall Study|Lost to Follow-up|0|||
164593217|NCT01987986|594534699|FG000|Overall Study|Adverse Event|1|||
164593218|NCT01987986|594534700|FG001|Overall Study|Adverse Event|0|||
164593219|NCT01987986|594534701|FG002|Overall Study|Adverse Event|2|||
164593220|NCT01987986|594534702|FG003|Overall Study|Adverse Event|0|||
164593221|NCT03342469|594534703|FG000|Overall Study|Withdrawal by Subject|0|||
164593222|NCT03342469|594534704|FG001|Overall Study|Withdrawal by Subject|1|||
164593223|NCT03342469|594534705|FG002|Overall Study|Withdrawal by Subject|0|||
164593224|NCT03342469|594534706|FG003|Overall Study|Withdrawal by Subject|0|||
164593225|NCT05515601|594534707|FG000|Overall Study|Withdrawal by Subject|1|||
164593226|NCT05515601|594534708|FG001|Overall Study|Withdrawal by Subject|3|||
164593227|NCT05515601|594534709|FG002|Overall Study|Withdrawal by Subject|2|||
164593228|NCT05515601|594534710|FG003|Overall Study|Withdrawal by Subject|1|||
164593229|NCT05515601|594534711|FG004|Overall Study|Withdrawal by Subject|1|||
164593230|NCT05515601|594534712|FG005|Overall Study|Withdrawal by Subject|1|||
164593231|NCT05515601|594534707|FG000|Overall Study|Lost to Follow-up|0|||
164593232|NCT05515601|594534708|FG001|Overall Study|Lost to Follow-up|0|||
164593233|NCT05515601|594534709|FG002|Overall Study|Lost to Follow-up|0|||
164593234|NCT05515601|594534710|FG003|Overall Study|Lost to Follow-up|0|||
164593235|NCT05515601|594534711|FG004|Overall Study|Lost to Follow-up|1|||
164593236|NCT05515601|594534712|FG005|Overall Study|Lost to Follow-up|0|||
164593237|NCT02928406|594534713|FG000|Overall Study|Death|780|||
164593238|NCT02928406|594534713|FG000|Overall Study|Progressive disease|3|||
164593239|NCT02928406|594534713|FG000|Overall Study|Lost to Follow-up|49|||
164593240|NCT02928406|594534713|FG000|Overall Study|Non-compliance|2|||
164593241|NCT02928406|594534713|FG000|Overall Study|Withdrawal by Subject|40|||
164386747|NCT01747772|593786240|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
164593242|NCT02928406|594534713|FG000|Overall Study|Study terminated by sponsor|57|||
164593243|NCT02928406|594534713|FG000|Overall Study|Physician Decision|1|||
164386748|NCT02244944|593786241|FG000|Overall Study|Withdrawal by Subject|1|||
164386749|NCT02244944|593786241|FG000|Overall Study|Study Terminated|1|||
164386750|NCT01003899|593786244|FG000|Overall Study|Other Adverse Event|8|||
164386751|NCT01003899|593786244|FG000|Overall Study|Not entered|4|||
164386752|NCT01003899|593786244|FG000|Overall Study|Not treated|1|||
164386753|NCT01003899|593786244|FG000|Overall Study|Progressive disease|34|||
164386754|NCT04969783|593786245|FG000|Overall Study|Lost to Follow-up|2|||
164386755|NCT04969783|593786246|FG001|Overall Study|Lost to Follow-up|0|||
164386756|NCT04969783|593786245|FG000|Overall Study|Withdrawal by Subject|4|||
164386757|NCT04969783|593786246|FG001|Overall Study|Withdrawal by Subject|0|||
164386758|NCT04969783|593786245|FG000|Overall Study|Physician Decision|6|||
164386759|NCT04969783|593786246|FG001|Overall Study|Physician Decision|0|||
164386760|NCT02489500|593786247|FG000|Overall Study|Death|1|||
164386761|NCT02489500|593786248|FG001|Overall Study|Death|1|||
164386762|NCT00987467|593786253|FG000|Overall Study|Lost to Follow-up|2|||
164386763|NCT00512135|593786254|FG000|Overall Study|Not Treated|5|||
164386764|NCT00512135|593786254|FG000|Overall Study|Lack of Efficacy|2|||
164386765|NCT00512135|593786254|FG000|Overall Study|Adverse Event|6|||
164386766|NCT00512135|593786254|FG000|Overall Study|Withdrawal by Subject|22|||
164386767|NCT00512135|593786254|FG000|Overall Study|Lost to Follow-up|27|||
164386768|NCT00512135|593786254|FG000|Overall Study|Other|22|||
164386769|NCT00262834|593786255|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
164386770|NCT00262834|593786256|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
164386771|NCT03422250|593786257|FG000|Intervention|Adverse Event|0|||
164386772|NCT03422250|593786258|FG001|Intervention|Adverse Event|1|||
164386773|NCT03422250|593786259|FG002|Intervention|Adverse Event|0|||
164386774|NCT03422250|593786260|FG003|Intervention|Adverse Event|1|||
164386775|NCT03422250|593786257|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
164386776|NCT03422250|593786258|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
164386777|NCT03422250|593786259|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
164386778|NCT03422250|593786260|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
164386779|NCT03422250|593786257|FG000|Follow-up|Withdrawal by Subject|0|||
164386780|NCT03422250|593786258|FG001|Follow-up|Withdrawal by Subject|0|||
164386781|NCT03422250|593786259|FG002|Follow-up|Withdrawal by Subject|0|||
164386782|NCT03422250|593786260|FG003|Follow-up|Withdrawal by Subject|1|||
164386783|NCT03422250|593786257|FG000|Follow-up|Adverse Event|0|||
164386784|NCT03422250|593786258|FG001|Follow-up|Adverse Event|0|||
164386785|NCT03422250|593786259|FG002|Follow-up|Adverse Event|0|||
164386786|NCT03422250|593786260|FG003|Follow-up|Adverse Event|1|||
164386787|NCT00377819|593786263|FG000|Overall Study|Adverse Event|2|||
164386788|NCT00377819|593786264|FG001|Overall Study|Adverse Event|3|||
164386789|NCT00377819|593786263|FG000|Overall Study|Withdrawal by Subject|10|||
164386790|NCT00377819|593786264|FG001|Overall Study|Withdrawal by Subject|4|||
164386791|NCT00377819|593786263|FG000|Overall Study|Death|0|||
164386792|NCT00377819|593786264|FG001|Overall Study|Death|1|||
164386793|NCT00377819|593786263|FG000|Overall Study|Lost to Follow-up|0|||
164386794|NCT00377819|593786264|FG001|Overall Study|Lost to Follow-up|1|||
164386795|NCT00377819|593786263|FG000|Overall Study|Protocol Violation|1|||
164386796|NCT00377819|593786264|FG001|Overall Study|Protocol Violation|1|||
164386797|NCT02416791|593786265|FG000|6 Months|Lost to Follow-up|0|||
164440362|NCT01317420|593978988|FG008|Overall Study|Other adverse event|0|||
164440363|NCT01317420|593978989|FG009|Overall Study|Other adverse event|0|||
164440364|NCT01317420|593978990|FG010|Overall Study|Other adverse event|0|||
164440365|NCT01317420|593978991|FG011|Overall Study|Other adverse event|0|||
164440366|NCT01317420|593978992|FG012|Overall Study|Other adverse event|2|||
164440367|NCT01317420|593978980|FG000|Overall Study|Non-compliant with protocol|0|||
164440368|NCT01317420|593978981|FG001|Overall Study|Non-compliant with protocol|0|||
164440369|NCT01317420|593978982|FG002|Overall Study|Non-compliant with protocol|0|||
164440370|NCT01317420|593978983|FG003|Overall Study|Non-compliant with protocol|0|||
164593244|NCT02928406|594534713|FG000|Overall Study|Various reasons|72|||
164593245|NCT01745393|594534714|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
164593246|NCT01745393|594534715|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
164386798|NCT02416791|593786266|FG001|6 Months|Lost to Follow-up|0|||
164440371|NCT01317420|593978984|FG004|Overall Study|Non-compliant with protocol|0|||
164593247|NCT01745393|594534714|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
164386799|NCT02416791|593786267|FG002|6 Months|Lost to Follow-up|1|||
164440372|NCT01317420|593978985|FG005|Overall Study|Non-compliant with protocol|0|||
164386800|NCT01054820|593786268|FG000|Overall Study|Withdrawal by Subject|2|||
164386801|NCT00467870|593786269|FG000|Overall Study|Adverse Event|13|||
164386802|NCT00467870|593786270|FG001|Overall Study|Adverse Event|9|||
164386803|NCT00467870|593786271|FG002|Overall Study|Adverse Event|1|||
164386804|NCT00467870|593786272|FG003|Overall Study|Adverse Event|15|||
164386805|NCT00467870|593786273|FG004|Overall Study|Adverse Event|15|||
164386806|NCT00467870|593786274|FG005|Overall Study|Adverse Event|1|||
164593248|NCT01745393|594534715|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
164386807|NCT00467870|593786269|FG000|Overall Study|Protocol Violation|2|||
164386808|NCT00467870|593786270|FG001|Overall Study|Protocol Violation|1|||
164386809|NCT00467870|593786271|FG002|Overall Study|Protocol Violation|1|||
164386810|NCT00467870|593786272|FG003|Overall Study|Protocol Violation|2|||
164386811|NCT00467870|593786273|FG004|Overall Study|Protocol Violation|0|||
164386812|NCT00467870|593786274|FG005|Overall Study|Protocol Violation|0|||
164386813|NCT00467870|593786269|FG000|Overall Study|Withdrawal by Subject|14|||
164386814|NCT00467870|593786270|FG001|Overall Study|Withdrawal by Subject|21|||
164386815|NCT00467870|593786271|FG002|Overall Study|Withdrawal by Subject|0|||
164386816|NCT00467870|593786272|FG003|Overall Study|Withdrawal by Subject|9|||
164386817|NCT00467870|593786273|FG004|Overall Study|Withdrawal by Subject|10|||
164386818|NCT00467870|593786274|FG005|Overall Study|Withdrawal by Subject|1|||
164386819|NCT00467870|593786269|FG000|Overall Study|Lost to Follow-up|5|||
164386820|NCT00467870|593786270|FG001|Overall Study|Lost to Follow-up|3|||
164386821|NCT00467870|593786271|FG002|Overall Study|Lost to Follow-up|1|||
164386822|NCT00467870|593786272|FG003|Overall Study|Lost to Follow-up|1|||
164386823|NCT00467870|593786273|FG004|Overall Study|Lost to Follow-up|3|||
164386824|NCT00467870|593786274|FG005|Overall Study|Lost to Follow-up|0|||
164386825|NCT00467870|593786269|FG000|Overall Study|Subject Non-compliance|3|||
164386826|NCT00467870|593786270|FG001|Overall Study|Subject Non-compliance|4|||
164386827|NCT00467870|593786271|FG002|Overall Study|Subject Non-compliance|0|||
164386828|NCT00467870|593786272|FG003|Overall Study|Subject Non-compliance|1|||
164386829|NCT00467870|593786273|FG004|Overall Study|Subject Non-compliance|5|||
164386830|NCT00467870|593786274|FG005|Overall Study|Subject Non-compliance|0|||
164386831|NCT00467870|593786269|FG000|Overall Study|Other/Unknown|8|||
164386832|NCT00467870|593786270|FG001|Overall Study|Other/Unknown|5|||
164386833|NCT00467870|593786271|FG002|Overall Study|Other/Unknown|1|||
164386834|NCT00467870|593786272|FG003|Overall Study|Other/Unknown|5|||
164386835|NCT00467870|593786273|FG004|Overall Study|Other/Unknown|4|||
164386836|NCT00467870|593786274|FG005|Overall Study|Other/Unknown|0|||
164386837|NCT02239679|593786275|FG000|Overall Study|Lost to Follow-up|1|||
164386838|NCT02239679|593786276|FG001|Overall Study|Lost to Follow-up|0|||
164386839|NCT02239679|593786277|FG002|Overall Study|Lost to Follow-up|0|||
164386840|NCT02239679|593786275|FG000|Overall Study|Withdrawal by Subject|2|||
164386841|NCT02239679|593786276|FG001|Overall Study|Withdrawal by Subject|3|||
164386842|NCT02239679|593786277|FG002|Overall Study|Withdrawal by Subject|1|||
164386843|NCT01917526|593786278|FG000|Overall Study|Protocol Violation|1|||
164386844|NCT01917526|593786279|FG001|Overall Study|Protocol Violation|1|||
164386845|NCT00760929|593786283|FG000|Overall Study|Adverse Event|2|||
164386846|NCT00760929|593786284|FG001|Overall Study|Adverse Event|0|||
164386847|NCT00760929|593786285|FG002|Overall Study|Adverse Event|6|||
164386848|NCT00760929|593786286|FG003|Overall Study|Adverse Event|10|||
164386849|NCT00760929|593786283|FG000|Overall Study|Lack of Efficacy|0|||
164386850|NCT00760929|593786284|FG001|Overall Study|Lack of Efficacy|2|||
164386851|NCT00760929|593786285|FG002|Overall Study|Lack of Efficacy|1|||
164386852|NCT00760929|593786286|FG003|Overall Study|Lack of Efficacy|0|||
164386853|NCT00760929|593786283|FG000|Overall Study|Withdrawal by Subject|1|||
164386854|NCT00760929|593786284|FG001|Overall Study|Withdrawal by Subject|0|||
164386855|NCT00760929|593786285|FG002|Overall Study|Withdrawal by Subject|9|||
164386856|NCT00760929|593786286|FG003|Overall Study|Withdrawal by Subject|1|||
164386857|NCT00760929|593786283|FG000|Overall Study|Lost to Follow-up|0|||
164386858|NCT00760929|593786284|FG001|Overall Study|Lost to Follow-up|0|||
164386859|NCT00760929|593786285|FG002|Overall Study|Lost to Follow-up|1|||
164386860|NCT00760929|593786286|FG003|Overall Study|Lost to Follow-up|0|||
164386861|NCT00760929|593786283|FG000|Overall Study|Progression of Disease|21|||
164386862|NCT00760929|593786284|FG001|Overall Study|Progression of Disease|26|||
164386863|NCT00760929|593786285|FG002|Overall Study|Progression of Disease|38|||
164386864|NCT00760929|593786286|FG003|Overall Study|Progression of Disease|42|||
164386865|NCT00760929|593786283|FG000|Overall Study|Other|2|||
164386866|NCT00760929|593786284|FG001|Overall Study|Other|0|||
164386867|NCT00760929|593786285|FG002|Overall Study|Other|2|||
164386868|NCT00760929|593786286|FG003|Overall Study|Other|1|||
164386869|NCT00760929|593786283|FG000|Overall Study|Death|0|||
164386870|NCT00760929|593786284|FG001|Overall Study|Death|0|||
164386871|NCT00760929|593786285|FG002|Overall Study|Death|1|||
164386872|NCT00760929|593786286|FG003|Overall Study|Death|0|||
164386873|NCT00760929|593786283|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
164386874|NCT00760929|593786284|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
164386875|NCT00760929|593786285|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
164386876|NCT00760929|593786286|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
164386877|NCT02099838|593786287|FG000|Overall Study|Death|1|||
164386878|NCT02099838|593786288|FG001|Overall Study|Death|0|||
164386879|NCT02099838|593786287|FG000|Overall Study|Lost to Follow-up|3|||
164386880|NCT02099838|593786288|FG001|Overall Study|Lost to Follow-up|1|||
164386881|NCT02099838|593786287|FG000|Overall Study|Withdrawal by Subject|0|||
164386882|NCT02099838|593786288|FG001|Overall Study|Withdrawal by Subject|1|||
164386883|NCT04121962|593786289|FG000|Overall Study|Lost to Follow-up|42|||
164386884|NCT04121962|593786290|FG001|Overall Study|Lost to Follow-up|39|||
164386885|NCT01175382|593786291|FG000|Overall Study|Lost to Follow-up|4|||
164386886|NCT01175382|593786292|FG001|Overall Study|Lost to Follow-up|3|||
164386887|NCT01175382|593786293|FG002|Overall Study|Lost to Follow-up|1|||
164386888|NCT01175382|593786291|FG000|Overall Study|Physician Decision|0|||
164386889|NCT01175382|593786292|FG001|Overall Study|Physician Decision|1|||
164386890|NCT01175382|593786293|FG002|Overall Study|Physician Decision|0|||
164386891|NCT01175382|593786291|FG000|Overall Study|Withdrawal by Subject|0|||
164440373|NCT01317420|593978986|FG006|Overall Study|Non-compliant with protocol|0|||
164440374|NCT01317420|593978987|FG007|Overall Study|Non-compliant with protocol|0|||
164440375|NCT01317420|593978988|FG008|Overall Study|Non-compliant with protocol|0|||
164440376|NCT01317420|593978989|FG009|Overall Study|Non-compliant with protocol|0|||
164440377|NCT01317420|593978990|FG010|Overall Study|Non-compliant with protocol|0|||
164440378|NCT01317420|593978991|FG011|Overall Study|Non-compliant with protocol|0|||
164440379|NCT01317420|593978992|FG012|Overall Study|Non-compliant with protocol|1|||
164440380|NCT01317420|593978980|FG000|Overall Study|Refused to cont. taking trial medication|0|||
164440381|NCT01317420|593978981|FG001|Overall Study|Refused to cont. taking trial medication|0|||
164440382|NCT01317420|593978982|FG002|Overall Study|Refused to cont. taking trial medication|0|||
164440383|NCT01317420|593978983|FG003|Overall Study|Refused to cont. taking trial medication|0|||
164440384|NCT01317420|593978984|FG004|Overall Study|Refused to cont. taking trial medication|0|||
164440385|NCT01317420|593978985|FG005|Overall Study|Refused to cont. taking trial medication|0|||
164440386|NCT01317420|593978986|FG006|Overall Study|Refused to cont. taking trial medication|0|||
164440387|NCT01317420|593978987|FG007|Overall Study|Refused to cont. taking trial medication|0|||
164440388|NCT01317420|593978988|FG008|Overall Study|Refused to cont. taking trial medication|0|||
164440389|NCT01317420|593978989|FG009|Overall Study|Refused to cont. taking trial medication|0|||
164440390|NCT01317420|593978990|FG010|Overall Study|Refused to cont. taking trial medication|0|||
164440391|NCT01317420|593978991|FG011|Overall Study|Refused to cont. taking trial medication|0|||
164440392|NCT01317420|593978992|FG012|Overall Study|Refused to cont. taking trial medication|1|||
164440393|NCT01317420|593978980|FG000|Overall Study|Reason other than those specified|0|||
164440394|NCT01317420|593978981|FG001|Overall Study|Reason other than those specified|0|||
164440395|NCT01317420|593978982|FG002|Overall Study|Reason other than those specified|0|||
164440396|NCT01317420|593978983|FG003|Overall Study|Reason other than those specified|0|||
164440397|NCT01317420|593978984|FG004|Overall Study|Reason other than those specified|0|||
164440398|NCT01317420|593978985|FG005|Overall Study|Reason other than those specified|0|||
164440399|NCT01317420|593978986|FG006|Overall Study|Reason other than those specified|0|||
164440400|NCT01317420|593978987|FG007|Overall Study|Reason other than those specified|0|||
164440401|NCT01317420|593978988|FG008|Overall Study|Reason other than those specified|0|||
164440402|NCT01317420|593978989|FG009|Overall Study|Reason other than those specified|1|||
164440403|NCT01317420|593978990|FG010|Overall Study|Reason other than those specified|0|||
164440404|NCT01317420|593978991|FG011|Overall Study|Reason other than those specified|0|||
164440405|NCT01317420|593978992|FG012|Overall Study|Reason other than those specified|0|||
164440406|NCT05686421|593978993|FG000|Overall Study|Screen failure|22|||
164440407|NCT05686421|593978994|FG001|Overall Study|Screen failure|0|||
164440408|NCT05686421|593978995|FG002|Overall Study|Screen failure|0|||
164440409|NCT05686421|593978996|FG003|Overall Study|Screen failure|0|||
164440410|NCT04210180|593978997|FG000|Overall Study|Withdrawal by Subject|2|||
164440411|NCT01286272|593980587|FG000|Overall Study|Ineligible after beginning treatment|1|||
164440412|NCT01286272|593980588|FG001|Overall Study|Ineligible after beginning treatment|3|||
164440413|NCT03253848|593980594|FG000|Overall Study|Adverse Event|7|||
164386892|NCT01175382|593786292|FG001|Overall Study|Withdrawal by Subject|0|||
164440414|NCT03253848|593980594|FG000|Overall Study|Death|5|||
164440415|NCT03253848|593980594|FG000|Overall Study|initiation of other treatments|3|||
164440416|NCT03253848|593980594|FG000|Overall Study|Other complicating disease|1|||
164440417|NCT03253848|593980594|FG000|Overall Study|Withdrawal by Subject|1|||
164440418|NCT03253848|593980594|FG000|Overall Study|Declining health|1|||
164440419|NCT03622593|593980596|FG000|Overall Study|Withdrawal by Subject|11|||
164440420|NCT03622593|593980597|FG001|Overall Study|Withdrawal by Subject|9|||
164440421|NCT03622593|593980598|FG002|Overall Study|Withdrawal by Subject|13|||
164440422|NCT03622593|593980596|FG000|Overall Study|Death|12|||
164440423|NCT03622593|593980597|FG001|Overall Study|Death|9|||
164440424|NCT03622593|593980598|FG002|Overall Study|Death|10|||
164440425|NCT03622593|593980596|FG000|Overall Study|Lost to Follow-up|11|||
164440426|NCT03622593|593980597|FG001|Overall Study|Lost to Follow-up|5|||
164440427|NCT03622593|593980598|FG002|Overall Study|Lost to Follow-up|8|||
164440428|NCT03622593|593980596|FG000|Overall Study|Adverse Event|4|||
164440429|NCT03622593|593980597|FG001|Overall Study|Adverse Event|5|||
164440430|NCT03622593|593980598|FG002|Overall Study|Adverse Event|6|||
164593249|NCT01745393|594534714|FG000|12-month Follow-up|Lost to Follow-up|6|||
164386893|NCT01175382|593786293|FG002|Overall Study|Withdrawal by Subject|1|||
164440431|NCT03622593|593980596|FG000|Overall Study|Physician Decision|2|||
164440432|NCT03622593|593980597|FG001|Overall Study|Physician Decision|1|||
164440433|NCT03622593|593980598|FG002|Overall Study|Physician Decision|6|||
164440434|NCT03622593|593980596|FG000|Overall Study|Other|2|||
164593250|NCT01745393|594534715|FG001|12-month Follow-up|Lost to Follow-up|5|||
164593251|NCT02678780|594534717|FG000|Overall Study|Adverse Event|11|||
164593252|NCT02678780|594534718|FG001|Overall Study|Adverse Event|14|||
164593253|NCT02678780|594534717|FG000|Overall Study|Withdrawal by Subject|2|||
164593254|NCT02678780|594534718|FG001|Overall Study|Withdrawal by Subject|1|||
164593255|NCT02678780|594534717|FG000|Overall Study|Sponsor discontinuation|7|||
164593256|NCT02678780|594534718|FG001|Overall Study|Sponsor discontinuation|4|||
164593257|NCT02678780|594534717|FG000|Overall Study|Death|1|||
164593258|NCT02678780|594534718|FG001|Overall Study|Death|1|||
164593259|NCT02678780|594534717|FG000|Overall Study|Other|6|||
164593260|NCT02678780|594534718|FG001|Overall Study|Other|8|||
164593261|NCT01064648|594534731|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
164593262|NCT01064648|594534732|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
164593263|NCT01064648|594534733|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
164593264|NCT01064648|594534734|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
164593265|NCT01064648|594534731|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
164593266|NCT01064648|594534732|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
164386894|NCT01175382|593786291|FG000|Overall Study|No longer having problem|1|||
164386895|NCT01175382|593786292|FG001|Overall Study|No longer having problem|0|||
164386896|NCT01175382|593786293|FG002|Overall Study|No longer having problem|1|||
164386897|NCT01175382|593786291|FG000|Overall Study|Unable/unwilling to attend visits|3|||
164386898|NCT01175382|593786292|FG001|Overall Study|Unable/unwilling to attend visits|1|||
164386899|NCT01175382|593786293|FG002|Overall Study|Unable/unwilling to attend visits|2|||
164386900|NCT01175382|593786291|FG000|Overall Study|Unwilling to follow protocol|0|||
164386901|NCT01175382|593786292|FG001|Overall Study|Unwilling to follow protocol|1|||
164386902|NCT01175382|593786293|FG002|Overall Study|Unwilling to follow protocol|0|||
164386903|NCT01175382|593786291|FG000|Overall Study|Unable to tolerate study meds|0|||
164386904|NCT01175382|593786292|FG001|Overall Study|Unable to tolerate study meds|1|||
164386905|NCT01175382|593786293|FG002|Overall Study|Unable to tolerate study meds|1|||
164386906|NCT00774787|593786294|FG000|Overall Study|Lost to Follow-up|1|||
164386907|NCT04535037|593786295|FG000|Overall Study|Protocol Violation|1|||
164386908|NCT04535037|593786296|FG001|Overall Study|Protocol Violation|0|||
164386909|NCT04535037|593786295|FG000|Overall Study|Withdrawal by Subject|8|||
164386910|NCT04535037|593786296|FG001|Overall Study|Withdrawal by Subject|9|||
164386911|NCT04535037|593786295|FG000|Overall Study|Migrated / moved from the study area|1|||
164386912|NCT04535037|593786296|FG001|Overall Study|Migrated / moved from the study area|4|||
164386913|NCT04535037|593786295|FG000|Overall Study|Other|2|||
164386914|NCT04535037|593786296|FG001|Overall Study|Other|5|||
164386915|NCT02031276|593786297|FG000|Period 1 Double-blind IV|Adverse Event|6|||
164386916|NCT02031276|593786298|FG001|Period 1 Double-blind IV|Adverse Event|5|||
164386917|NCT02031276|593786299|FG002|Period 1 Double-blind IV|Adverse Event|1|||
164386918|NCT02031276|593786297|FG000|Period 1 Double-blind IV|Other|0|||
164386919|NCT02031276|593786298|FG001|Period 1 Double-blind IV|Other|1|||
164386920|NCT02031276|593786299|FG002|Period 1 Double-blind IV|Other|0|||
164386921|NCT02031276|593786297|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
164386922|NCT02031276|593786298|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
164386923|NCT02031276|593786299|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
164386924|NCT02031276|593786297|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
164386925|NCT02031276|593786298|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
164386926|NCT02031276|593786299|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
164386927|NCT02031276|593786297|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
164386928|NCT02031276|593786298|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
164386929|NCT02031276|593786299|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
164386930|NCT02031276|593786297|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
164386931|NCT02031276|593786298|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
164386932|NCT02031276|593786299|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
164386933|NCT02031276|593786297|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
164386934|NCT02031276|593786298|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
164386935|NCT02031276|593786299|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
164386936|NCT02031276|593786297|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
164386937|NCT02031276|593786298|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
164386938|NCT02031276|593786299|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
164593267|NCT01064648|594534733|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
164593268|NCT01064648|594534734|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
164593269|NCT01064648|594534731|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
164386939|NCT02031276|593786297|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
164386940|NCT02031276|593786298|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
164386941|NCT02031276|593786299|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
164386942|NCT00765245|593786301|FG000|Overall Study|disease progression|3|||
164386943|NCT00765245|593786302|FG001|Overall Study|disease progression|2|||
164386944|NCT00765245|593786301|FG000|Overall Study|Withdrawal by Subject|3|||
164386945|NCT00765245|593786302|FG001|Overall Study|Withdrawal by Subject|0|||
164593270|NCT01064648|594534732|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
164593271|NCT01064648|594534733|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
164593272|NCT01064648|594534734|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
164703381|NCT01929031|594939174|FG003|Overall Study|Protocol Violation|0|||
164703382|NCT01929031|594939175|FG004|Overall Study|Protocol Violation|0|||
164703383|NCT01929031|594939176|FG005|Overall Study|Protocol Violation|1|||
164703384|NCT01929031|594939171|FG000|Overall Study|Reason other than specified above|0|||
164703385|NCT01929031|594939172|FG001|Overall Study|Reason other than specified above|1|||
164703386|NCT01929031|594939173|FG002|Overall Study|Reason other than specified above|0|||
164703387|NCT01929031|594939174|FG003|Overall Study|Reason other than specified above|0|||
164703388|NCT01929031|594939175|FG004|Overall Study|Reason other than specified above|1|||
164703389|NCT01929031|594939176|FG005|Overall Study|Reason other than specified above|0|||
164703390|NCT01366443|594939177|FG000|Overall Study|Lost to Follow-up|2|||
164703391|NCT01366443|594939177|FG000|Overall Study|Under 18 yo|1|||
164703392|NCT03512262|594939178|FG000|Overall Study|Adverse Event|8|||
164703393|NCT03512262|594939179|FG001|Overall Study|Adverse Event|3|||
164703394|NCT03512262|594939178|FG000|Overall Study|Death (non-treatment emergent)|1|||
164703395|NCT03512262|594939179|FG001|Overall Study|Death (non-treatment emergent)|0|||
164703396|NCT03512262|594939178|FG000|Overall Study|Withdrawal by Subject|17|||
164703397|NCT03512262|594939179|FG001|Overall Study|Withdrawal by Subject|9|||
164703398|NCT03512262|594939178|FG000|Overall Study|Lost to Follow-up|7|||
164703399|NCT03512262|594939179|FG001|Overall Study|Lost to Follow-up|1|||
164703400|NCT03512262|594939178|FG000|Overall Study|Other than Specified|2|||
164703401|NCT03512262|594939179|FG001|Overall Study|Other than Specified|2|||
164703402|NCT04221789|594941715|FG000|Overall Study|deviation from protoco|22|||
164703403|NCT04221789|594941716|FG001|Overall Study|deviation from protoco|8|||
164703404|NCT04394351|594941727|FG000|Part A (16 Weeks)|Adverse Event|1|||
164703405|NCT04394351|594941728|FG001|Part A (16 Weeks)|Adverse Event|0|||
164703406|NCT04394351|594941729|FG002|Part A (16 Weeks)|Adverse Event|0|||
164703407|NCT04394351|594941730|FG003|Part A (16 Weeks)|Adverse Event|0|||
164703408|NCT04394351|594941731|FG004|Part A (16 Weeks)|Adverse Event|0|||
164703409|NCT04394351|594941732|FG005|Part A (16 Weeks)|Adverse Event|0|||
164703410|NCT04394351|594941733|FG006|Part A (16 Weeks)|Adverse Event|0|||
164703411|NCT04394351|594941734|FG007|Part A (16 Weeks)|Adverse Event|0|||
164703412|NCT04394351|594941727|FG000|Part A (16 Weeks)|Physician Decision|0|||
164703413|NCT04394351|594941728|FG001|Part A (16 Weeks)|Physician Decision|1|||
164703414|NCT04394351|594941729|FG002|Part A (16 Weeks)|Physician Decision|0|||
164703415|NCT04394351|594941730|FG003|Part A (16 Weeks)|Physician Decision|0|||
164703416|NCT04394351|594941731|FG004|Part A (16 Weeks)|Physician Decision|0|||
164703417|NCT04394351|594941732|FG005|Part A (16 Weeks)|Physician Decision|0|||
164703418|NCT04394351|594941733|FG006|Part A (16 Weeks)|Physician Decision|0|||
164703419|NCT04394351|594941734|FG007|Part A (16 Weeks)|Physician Decision|0|||
164703420|NCT04394351|594941727|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
164703421|NCT04394351|594941728|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
164703422|NCT04394351|594941729|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
164703423|NCT04394351|594941730|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
164703424|NCT04394351|594941731|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
164703425|NCT04394351|594941732|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
164703426|NCT04394351|594941733|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
164703427|NCT04394351|594941734|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
164703428|NCT04394351|594941727|FG000|Part B (36 Weeks)|Adverse Event|0|||
164703429|NCT04394351|594941728|FG001|Part B (36 Weeks)|Adverse Event|0|||
164703430|NCT04394351|594941729|FG002|Part B (36 Weeks)|Adverse Event|0|||
164703431|NCT04394351|594941730|FG003|Part B (36 Weeks)|Adverse Event|0|||
164703432|NCT04394351|594941731|FG004|Part B (36 Weeks)|Adverse Event|0|||
164703433|NCT04394351|594941732|FG005|Part B (36 Weeks)|Adverse Event|0|||
164703434|NCT04394351|594941733|FG006|Part B (36 Weeks)|Adverse Event|1|||
164703435|NCT04394351|594941734|FG007|Part B (36 Weeks)|Adverse Event|0|||
164703436|NCT04394351|594941727|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
164386946|NCT00765245|593786301|FG000|Overall Study|Adverse Event|5|||
164386947|NCT00765245|593786302|FG001|Overall Study|Adverse Event|0|||
164386948|NCT00765245|593786301|FG000|Overall Study|Physician Decision|1|||
164386949|NCT00765245|593786302|FG001|Overall Study|Physician Decision|0|||
164386950|NCT00765245|593786301|FG000|Overall Study|Death|1|||
164386951|NCT00765245|593786302|FG001|Overall Study|Death|0|||
164386952|NCT04408469|593786308|FG000|Overall Study|Lost to Follow-up|6|||
164386953|NCT04408469|593786309|FG001|Overall Study|Lost to Follow-up|9|||
164386954|NCT04408469|593786308|FG000|Overall Study|Withdrawal by Subject|6|||
164386955|NCT04408469|593786309|FG001|Overall Study|Withdrawal by Subject|1|||
164386956|NCT04408469|593786308|FG000|Overall Study|Dismissal due to ineligibility|0|||
164386957|NCT04408469|593786309|FG001|Overall Study|Dismissal due to ineligibility|1|||
164386958|NCT04321460|593786310|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
164386959|NCT04321460|593786311|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
164386960|NCT03669081|593786314|FG000|Overall Study|Data could not be validated|1|||
164386961|NCT03669081|593786315|FG001|Overall Study|Data could not be validated|1|||
164386962|NCT01308749|593786320|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
164386963|NCT01308749|593786321|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
164386964|NCT01308749|593786320|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
164703437|NCT04394351|594941728|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
164386965|NCT01308749|593786321|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
164386966|NCT01308749|593786320|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
164386967|NCT01308749|593786321|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
164386968|NCT02546544|593786322|FG000|Overall Study|Disease Progression|14|||
164386969|NCT02546544|593786322|FG000|Overall Study|Adverse Event|1|||
164386970|NCT02546544|593786322|FG000|Overall Study|Withdrawal by Subject|1|||
164386971|NCT02223390|593786323|FG000|Overall Study|Lost to Follow-up|9|||
164386972|NCT02223390|593786324|FG001|Overall Study|Lost to Follow-up|4|||
164386973|NCT01197950|593786328|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
164386974|NCT01197950|593786329|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
164386975|NCT01197950|593786330|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
164386976|NCT02553330|593786331|FG000|Overall Study|Study Terminated by Sponsor|2|||
164386977|NCT02553330|593786332|FG001|Overall Study|Study Terminated by Sponsor|13|||
164386978|NCT02553330|593786333|FG002|Overall Study|Study Terminated by Sponsor|12|||
164386979|NCT02553330|593786331|FG000|Overall Study|Withdrawal by Subject|3|||
164386980|NCT02553330|593786332|FG001|Overall Study|Withdrawal by Subject|19|||
164386981|NCT02553330|593786333|FG002|Overall Study|Withdrawal by Subject|21|||
164386982|NCT02553330|593786331|FG000|Overall Study|Other|0|||
164386983|NCT02553330|593786332|FG001|Overall Study|Other|1|||
164386984|NCT02553330|593786333|FG002|Overall Study|Other|0|||
164386985|NCT02553330|593786331|FG000|Overall Study|Non compliance to study treatment|0|||
164386986|NCT02553330|593786332|FG001|Overall Study|Non compliance to study treatment|1|||
164386987|NCT02553330|593786333|FG002|Overall Study|Non compliance to study treatment|0|||
164386988|NCT02553330|593786331|FG000|Overall Study|Adverse Event|0|||
164386989|NCT02553330|593786332|FG001|Overall Study|Adverse Event|1|||
164386990|NCT02553330|593786333|FG002|Overall Study|Adverse Event|0|||
164386991|NCT02553330|593786331|FG000|Overall Study|Lost to Follow-up|0|||
164386992|NCT02553330|593786332|FG001|Overall Study|Lost to Follow-up|4|||
164386993|NCT02553330|593786333|FG002|Overall Study|Lost to Follow-up|4|||
164386994|NCT01666002|593786334|FG000|Overall Study|Lost to Follow-up|5|||
164386995|NCT01666002|593786335|FG001|Overall Study|Lost to Follow-up|0|||
164386996|NCT02511431|593786336|FG000|Treatment|Lost to Follow-up|0|||
164386997|NCT02511431|593786337|FG001|Treatment|Lost to Follow-up|0|||
164386998|NCT02511431|593786338|FG002|Treatment|Lost to Follow-up|1|||
164440435|NCT03622593|593980597|FG001|Overall Study|Other|2|||
164703438|NCT04394351|594941729|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
164703439|NCT04394351|594941730|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
164703440|NCT04394351|594941731|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
164703441|NCT04394351|594941732|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
164703442|NCT04394351|594941733|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
164703443|NCT04394351|594941734|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|3|||
164703444|NCT04394351|594941727|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
164703445|NCT04394351|594941728|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
164703446|NCT04394351|594941729|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
164703447|NCT04394351|594941730|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
164703448|NCT04394351|594941731|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
164703449|NCT04394351|594941732|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
164703450|NCT04394351|594941733|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
164703451|NCT04394351|594941734|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|16|||
164703452|NCT04394351|594941727|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
164703453|NCT04394351|594941728|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
164703454|NCT04394351|594941729|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
164703455|NCT04394351|594941730|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
164703456|NCT04394351|594941731|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
164703457|NCT04394351|594941732|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
164386999|NCT02511431|593786339|FG003|Treatment|Lost to Follow-up|0|||
164387000|NCT02511431|593786340|FG004|Treatment|Lost to Follow-up|0|||
164387001|NCT02511431|593786341|FG005|Treatment|Lost to Follow-up|1|||
164387002|NCT00346034|593786353|FG000|Overall Study|Adverse Event|34|||
164387003|NCT00346034|593786353|FG000|Overall Study|Lack of Efficacy|8|||
164387004|NCT00346034|593786353|FG000|Overall Study|Withdrawal by Subject|13|||
164387005|NCT00346034|593786353|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
164387006|NCT00346034|593786353|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
164387007|NCT02641080|593786355|FG000|Overall Study|Physician Decision|2|||
164387008|NCT02641080|593786356|FG001|Overall Study|Physician Decision|0|||
164387009|NCT02641080|593786355|FG000|Overall Study|Withdrawal by Subject|0|||
164387010|NCT02641080|593786356|FG001|Overall Study|Withdrawal by Subject|1|||
164440436|NCT03622593|593980598|FG002|Overall Study|Other|3|||
164387011|NCT02641080|593786355|FG000|Overall Study|Rehab Center denied use of pumps|0|||
164387012|NCT02641080|593786356|FG001|Overall Study|Rehab Center denied use of pumps|3|||
164387013|NCT02641080|593786355|FG000|Overall Study|Lost to Follow-up|0|||
164387014|NCT02641080|593786356|FG001|Overall Study|Lost to Follow-up|3|||
164387015|NCT06281548|593786361|FG000|Overall Study|Lost to Follow-up|3|||
164387016|NCT03835533|593786362|FG000|Overall Study|Death|5|||
164387017|NCT03835533|593786363|FG001|Overall Study|Death|10|||
164387018|NCT03835533|593786364|FG002|Overall Study|Death|9|||
164387019|NCT03835533|593786362|FG000|Overall Study|Withdrawal by Subject|2|||
164387020|NCT03835533|593786363|FG001|Overall Study|Withdrawal by Subject|2|||
164387021|NCT03835533|593786364|FG002|Overall Study|Withdrawal by Subject|2|||
164387022|NCT03835533|593786362|FG000|Overall Study|Lost to Follow-up|1|||
164387023|NCT03835533|593786363|FG001|Overall Study|Lost to Follow-up|0|||
164387024|NCT03835533|593786364|FG002|Overall Study|Lost to Follow-up|0|||
164387025|NCT03864900|593786367|FG000|Overall Study|Withdrawal by Subject|1|||
164387026|NCT03864900|593786368|FG001|Overall Study|Withdrawal by Subject|1|||
164387027|NCT03864900|593786367|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
164387028|NCT03864900|593786368|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
164387029|NCT03238001|593786369|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
164387030|NCT03238001|593786369|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
164387031|NCT03238001|593786369|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
164387032|NCT03238001|593786369|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
164387033|NCT03238001|593786369|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
164387034|NCT03238001|593786369|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
164593273|NCT01064648|594534731|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
164593274|NCT01064648|594534732|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
164593275|NCT01064648|594534733|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
164593276|NCT01064648|594534734|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
164593277|NCT01064648|594534731|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
164593278|NCT01064648|594534732|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
164593279|NCT01064648|594534733|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
164593280|NCT01064648|594534734|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
164593281|NCT01064648|594534731|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
164593282|NCT01064648|594534732|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
164593283|NCT01064648|594534733|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
164593284|NCT01064648|594534734|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
164593285|NCT01064648|594534731|FG000|Phase II|Adverse Event|0|||
164593286|NCT01064648|594534732|FG001|Phase II|Adverse Event|0|||
164593287|NCT01064648|594534733|FG002|Phase II|Adverse Event|15|||
164593288|NCT01064648|594534734|FG003|Phase II|Adverse Event|8|||
164593289|NCT01064648|594534731|FG000|Phase II|Death|0|||
164593290|NCT01064648|594534732|FG001|Phase II|Death|0|||
164593291|NCT01064648|594534733|FG002|Phase II|Death|4|||
164593292|NCT01064648|594534734|FG003|Phase II|Death|5|||
164593293|NCT01064648|594534731|FG000|Phase II|Withdrawal by Subject|0|||
164593294|NCT01064648|594534732|FG001|Phase II|Withdrawal by Subject|0|||
164593295|NCT01064648|594534733|FG002|Phase II|Withdrawal by Subject|2|||
164593296|NCT01064648|594534734|FG003|Phase II|Withdrawal by Subject|5|||
164593297|NCT01064648|594534731|FG000|Phase II|Progression|0|||
164593298|NCT01064648|594534732|FG001|Phase II|Progression|0|||
164593299|NCT01064648|594534733|FG002|Phase II|Progression|21|||
164593300|NCT01064648|594534734|FG003|Phase II|Progression|27|||
164593301|NCT01064648|594534731|FG000|Phase II|Non-protocol specified|0|||
164593302|NCT01064648|594534732|FG001|Phase II|Non-protocol specified|0|||
164593303|NCT01064648|594534733|FG002|Phase II|Non-protocol specified|5|||
164593304|NCT01064648|594534734|FG003|Phase II|Non-protocol specified|3|||
164593305|NCT01064648|594534731|FG000|Phase II|Under Review|0|||
164593306|NCT01064648|594534732|FG001|Phase II|Under Review|0|||
164593307|NCT01064648|594534733|FG002|Phase II|Under Review|2|||
164593308|NCT01064648|594534734|FG003|Phase II|Under Review|0|||
164593309|NCT05513391|594534735|FG000|Overall Study|Adverse Event|1|||
164593310|NCT05513391|594534736|FG001|Overall Study|Adverse Event|0|||
164593311|NCT05513391|594534735|FG000|Overall Study|Protocol Deviation|0|||
164593312|NCT05513391|594534736|FG001|Overall Study|Protocol Deviation|1|||
164593313|NCT05513391|594534735|FG000|Overall Study|Withdrawal by Subject|3|||
164593314|NCT05513391|594534736|FG001|Overall Study|Withdrawal by Subject|1|||
164593315|NCT05513391|594534735|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
164593316|NCT05513391|594534736|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
164593317|NCT05513391|594534735|FG000|Overall Study|Lost to Follow-up|0|||
164593318|NCT05513391|594534736|FG001|Overall Study|Lost to Follow-up|2|||
164593319|NCT02429427|594534737|FG000|Overall Study|Adverse Event|220|||
164593320|NCT02429427|594534738|FG001|Overall Study|Adverse Event|92|||
164593321|NCT02429427|594534737|FG000|Overall Study|Protocol Violation|10|||
164593322|NCT02429427|594534738|FG001|Overall Study|Protocol Violation|6|||
164593323|NCT02429427|594534737|FG000|Overall Study|Lost to Follow-up|15|||
164593324|NCT02429427|594534738|FG001|Overall Study|Lost to Follow-up|6|||
164703458|NCT04394351|594941733|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
164703459|NCT04394351|594941734|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|2|||
164703460|NCT04394351|594941727|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
164703461|NCT04394351|594941728|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
164703462|NCT04394351|594941729|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
164703463|NCT04394351|594941730|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
164387035|NCT03238001|593786369|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
164387036|NCT03238001|593786369|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
164387037|NCT01866709|593786376|FG000|Overall Study|Adverse Event|1|||
164387038|NCT01866709|593786377|FG001|Overall Study|Adverse Event|0|||
164387039|NCT02207829|593786379|FG000|Overall Study|Adverse Event|10|||
164387040|NCT02207829|593786380|FG001|Overall Study|Adverse Event|9|||
164387041|NCT02207829|593786379|FG000|Overall Study|Lack of Efficacy|7|||
164387042|NCT02207829|593786380|FG001|Overall Study|Lack of Efficacy|5|||
164387043|NCT02207829|593786379|FG000|Overall Study|Lost to Follow-up|2|||
164387044|NCT02207829|593786380|FG001|Overall Study|Lost to Follow-up|2|||
164387045|NCT02207829|593786379|FG000|Overall Study|Protocol deviation|5|||
164387046|NCT02207829|593786380|FG001|Overall Study|Protocol deviation|4|||
164387047|NCT02207829|593786379|FG000|Overall Study|Withdrew consent|18|||
164387048|NCT02207829|593786380|FG001|Overall Study|Withdrew consent|14|||
164387049|NCT03285477|593786394|FG000|Treatment and Response Assessment Period|Death|1|||
164387050|NCT03285477|593786395|FG001|Treatment and Response Assessment Period|Death|0|||
164387051|NCT03285477|593786394|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
164387052|NCT03285477|593786395|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
164387053|NCT03285477|593786394|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
164387054|NCT03285477|593786395|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
164387055|NCT03285477|593786394|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
164387056|NCT03285477|593786395|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
164387057|NCT03285477|593786394|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
164387058|NCT03285477|593786395|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
164387059|NCT00560833|593786396|FG000|Overall Study|Adverse Event|16|||
164387060|NCT00560833|593786397|FG001|Overall Study|Adverse Event|10|||
164387061|NCT00560833|593786398|FG002|Overall Study|Adverse Event|25|||
164387062|NCT00560833|593786399|FG003|Overall Study|Adverse Event|23|||
164387063|NCT00560833|593786400|FG004|Overall Study|Adverse Event|35|||
164387064|NCT00560833|593786396|FG000|Overall Study|Lost to Follow-up|0|||
164387065|NCT00560833|593786397|FG001|Overall Study|Lost to Follow-up|0|||
164387066|NCT00560833|593786398|FG002|Overall Study|Lost to Follow-up|1|||
164387067|NCT00560833|593786399|FG003|Overall Study|Lost to Follow-up|0|||
164387068|NCT00560833|593786400|FG004|Overall Study|Lost to Follow-up|0|||
164387069|NCT00560833|593786396|FG000|Overall Study|Lack of Efficacy|22|||
164387070|NCT00560833|593786397|FG001|Overall Study|Lack of Efficacy|9|||
164387071|NCT00560833|593786398|FG002|Overall Study|Lack of Efficacy|6|||
164387072|NCT00560833|593786399|FG003|Overall Study|Lack of Efficacy|4|||
164387073|NCT00560833|593786400|FG004|Overall Study|Lack of Efficacy|4|||
164387074|NCT00560833|593786396|FG000|Overall Study|Participant uncooperative|5|||
164387075|NCT00560833|593786397|FG001|Overall Study|Participant uncooperative|5|||
164387076|NCT00560833|593786398|FG002|Overall Study|Participant uncooperative|4|||
164387077|NCT00560833|593786399|FG003|Overall Study|Participant uncooperative|4|||
164387078|NCT00560833|593786400|FG004|Overall Study|Participant uncooperative|2|||
164387079|NCT00560833|593786396|FG000|Overall Study|Other|1|||
164387080|NCT00560833|593786397|FG001|Overall Study|Other|1|||
164387081|NCT00560833|593786398|FG002|Overall Study|Other|3|||
164387082|NCT00560833|593786399|FG003|Overall Study|Other|0|||
164387083|NCT00560833|593786400|FG004|Overall Study|Other|0|||
164387084|NCT00560833|593786396|FG000|Overall Study|Never received drug|0|||
164387085|NCT00560833|593786397|FG001|Overall Study|Never received drug|1|||
164387086|NCT00560833|593786398|FG002|Overall Study|Never received drug|0|||
164387087|NCT00560833|593786399|FG003|Overall Study|Never received drug|0|||
164387088|NCT00560833|593786400|FG004|Overall Study|Never received drug|1|||
164387089|NCT01307501|593786403|FG000|Overall Study|Treatment Failure|1|||
164387090|NCT01307501|593786403|FG000|Overall Study|Death|20|||
164387091|NCT01307501|593786403|FG000|Overall Study|Lost to Follow-up|1|||
164440437|NCT03622593|593980596|FG000|Overall Study|Protocol Violation|0|||
164387092|NCT01307501|593786403|FG000|Overall Study|Starting Hospice|1|||
164387093|NCT01209624|593786407|FG000|Overall Study|Death|2|||
164387094|NCT01209624|593786407|FG000|Overall Study|Adverse Event|13|||
164387095|NCT01209624|593786407|FG000|Overall Study|Lack of Efficacy|17|||
164387096|NCT01209624|593786407|FG000|Overall Study|Lost to Follow-up|290|||
164387097|NCT01209624|593786407|FG000|Overall Study|Other|4|||
164387098|NCT03564496|593786408|FG000|Overall Study|Withdrawal by Subject|1|||
164387099|NCT03564496|593786409|FG001|Overall Study|Withdrawal by Subject|1|||
164387100|NCT03564496|593786410|FG002|Overall Study|Withdrawal by Subject|0|||
164387101|NCT03564496|593786408|FG000|Overall Study|Screen failure|0|||
164387102|NCT03564496|593786409|FG001|Overall Study|Screen failure|3|||
164387103|NCT03564496|593786410|FG002|Overall Study|Screen failure|0|||
164387104|NCT00428610|593786411|FG000|Overall Study|Death Due to Adverse Event|3|||
164387105|NCT00428610|593786412|FG001|Overall Study|Death Due to Adverse Event|0|||
164387106|NCT00428610|593786413|FG002|Overall Study|Death Due to Adverse Event|5|||
164387107|NCT00428610|593786411|FG000|Overall Study|Death Due to Progressive Disease|0|||
164387108|NCT00428610|593786412|FG001|Overall Study|Death Due to Progressive Disease|0|||
164387109|NCT00428610|593786413|FG002|Overall Study|Death Due to Progressive Disease|2|||
164387110|NCT00428610|593786411|FG000|Overall Study|Adverse Event|2|||
164387111|NCT00428610|593786412|FG001|Overall Study|Adverse Event|3|||
164387112|NCT00428610|593786413|FG002|Overall Study|Adverse Event|2|||
164387113|NCT00428610|593786411|FG000|Overall Study|Investigator Decision|2|||
164387114|NCT00428610|593786412|FG001|Overall Study|Investigator Decision|1|||
164387115|NCT00428610|593786413|FG002|Overall Study|Investigator Decision|1|||
164387116|NCT00428610|593786411|FG000|Overall Study|Progressive Disease|42|||
164387117|NCT00428610|593786412|FG001|Overall Study|Progressive Disease|14|||
164387118|NCT00428610|593786413|FG002|Overall Study|Progressive Disease|22|||
164387119|NCT00428610|593786411|FG000|Overall Study|Withdrawal by Subject|4|||
164387120|NCT00428610|593786412|FG001|Overall Study|Withdrawal by Subject|0|||
164387121|NCT00428610|593786413|FG002|Overall Study|Withdrawal by Subject|0|||
164387122|NCT01432366|593788414|FG000|Overall Study|Non-Responder|7|||
164387123|NCT01432366|593788414|FG000|Overall Study|Adverse Event|8|||
164387124|NCT01432366|593788414|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
164387125|NCT01432366|593788414|FG000|Overall Study|Pregnancy|1|||
164387126|NCT01432366|593788414|FG000|Overall Study|Lost to Follow-up|13|||
164387127|NCT01432366|593788414|FG000|Overall Study|Lack of Efficacy|1|||
164387128|NCT01432366|593788414|FG000|Overall Study|Site Closed|20|||
164387129|NCT01432366|593788414|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
164387130|NCT01432366|593788414|FG000|Overall Study|Other|14|||
164387131|NCT01808690|593788415|FG000|Overall Study|Withdrawal by Subject|1|||
164387132|NCT01808690|593788416|FG001|Overall Study|Withdrawal by Subject|2|||
164387133|NCT03811912|593788417|FG000|Overall Study|Withdrew Consent|4|||
164387134|NCT03811912|593788418|FG001|Overall Study|Withdrew Consent|2|||
164387135|NCT02891187|593788419|FG000|Overall Study|Lost to Follow-up|1|||
164387136|NCT02891187|593788420|FG001|Overall Study|Lost to Follow-up|2|||
164387137|NCT02395120|593788421|FG000|Overall Study|Missed follow-up dental exam|57|||
164387138|NCT02395120|593788422|FG001|Overall Study|Missed follow-up dental exam|62|||
164387139|NCT02395120|593788423|FG002|Overall Study|Missed follow-up dental exam|6|||
164387140|NCT02395120|593788424|FG003|Overall Study|Missed follow-up dental exam|6|||
164387141|NCT02395120|593788425|FG004|Overall Study|Missed follow-up dental exam|51|||
164387142|NCT00674986|593788426|FG000|Overall Study|Adverse Event|2|||
164387143|NCT00674986|593788427|FG001|Overall Study|Adverse Event|1|||
164387144|NCT00674986|593788426|FG000|Overall Study|Subject withdrew consent|12|||
164387145|NCT00674986|593788427|FG001|Overall Study|Subject withdrew consent|19|||
164387146|NCT00674986|593788426|FG000|Overall Study|Lost to Follow-up|25|||
164387147|NCT00674986|593788427|FG001|Overall Study|Lost to Follow-up|53|||
164387148|NCT00674986|593788426|FG000|Overall Study|Other reasons|4|||
164387149|NCT00674986|593788427|FG001|Overall Study|Other reasons|8|||
164387150|NCT00377234|593788428|FG000|Overall Study|Adverse Event|14|||
164387151|NCT00377234|593788429|FG001|Overall Study|Adverse Event|17|||
164387152|NCT00377234|593788428|FG000|Overall Study|Withdrawal by Subject|11|||
164387153|NCT00377234|593788429|FG001|Overall Study|Withdrawal by Subject|9|||
164387154|NCT00377234|593788428|FG000|Overall Study|Lost to Follow-up|4|||
164387155|NCT00377234|593788429|FG001|Overall Study|Lost to Follow-up|2|||
164387156|NCT00377234|593788428|FG000|Overall Study|Administrative|2|||
164387157|NCT00377234|593788429|FG001|Overall Study|Administrative|1|||
164593325|NCT02429427|594534737|FG000|Overall Study|Withdrawal by Subject|64|||
164593326|NCT02429427|594534738|FG001|Overall Study|Withdrawal by Subject|34|||
164593327|NCT02429427|594534737|FG000|Overall Study|Other|62|||
164593328|NCT02429427|594534738|FG001|Overall Study|Other|41|||
164387158|NCT00377234|593788428|FG000|Overall Study|Not assigned|3|||
164387159|NCT00377234|593788429|FG001|Overall Study|Not assigned|2|||
164387160|NCT04546581|593788437|FG000|Overall Study|Adverse Event|9|||
164387161|NCT04546581|593788438|FG001|Overall Study|Adverse Event|3|||
164387162|NCT04546581|593788437|FG000|Overall Study|Physician Decision|0|||
164387163|NCT04546581|593788438|FG001|Overall Study|Physician Decision|1|||
164387164|NCT04546581|593788437|FG000|Overall Study|Protocol Violation|1|||
164387165|NCT04546581|593788438|FG001|Overall Study|Protocol Violation|2|||
164593329|NCT00719732|594534739|FG000|Overall Study|Lost to Follow-up|20|||
164387166|NCT04546581|593788437|FG000|Overall Study|Withdrawal by Subject|3|||
164387167|NCT04546581|593788438|FG001|Overall Study|Withdrawal by Subject|7|||
164387168|NCT02526693|593788439|FG000|Overall Study|Physician Decision|3|||
164387169|NCT02526693|593788440|FG001|Overall Study|Physician Decision|1|||
164387170|NCT01798927|593788441|FG000|Overall Study|Withdrawal by Subject|1|||
164387171|NCT00626522|593788442|FG000|Overall Study|Protocol Violation|0|||
164387172|NCT00626522|593788443|FG001|Overall Study|Protocol Violation|0|||
164387173|NCT00626522|593788444|FG002|Overall Study|Protocol Violation|0|||
164387174|NCT00626522|593788445|FG003|Overall Study|Protocol Violation|0|||
164387175|NCT00626522|593788446|FG004|Overall Study|Protocol Violation|1|||
164387176|NCT00626522|593788447|FG005|Overall Study|Protocol Violation|0|||
164593330|NCT00719732|594534739|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
164387177|NCT00626522|593788442|FG000|Overall Study|Adverse Event|2|||
164387178|NCT00626522|593788443|FG001|Overall Study|Adverse Event|1|||
164387179|NCT00626522|593788444|FG002|Overall Study|Adverse Event|2|||
164387180|NCT00626522|593788445|FG003|Overall Study|Adverse Event|0|||
164387181|NCT00626522|593788446|FG004|Overall Study|Adverse Event|1|||
164387182|NCT00626522|593788447|FG005|Overall Study|Adverse Event|1|||
164387183|NCT00626522|593788442|FG000|Overall Study|Withdrawal by Subject|2|||
164387184|NCT00626522|593788443|FG001|Overall Study|Withdrawal by Subject|5|||
164387185|NCT00626522|593788444|FG002|Overall Study|Withdrawal by Subject|5|||
164387186|NCT00626522|593788445|FG003|Overall Study|Withdrawal by Subject|0|||
164387187|NCT00626522|593788446|FG004|Overall Study|Withdrawal by Subject|4|||
164387188|NCT00626522|593788447|FG005|Overall Study|Withdrawal by Subject|1|||
164387189|NCT00626522|593788442|FG000|Overall Study|COPD exacerbation|0|||
164387190|NCT00626522|593788443|FG001|Overall Study|COPD exacerbation|0|||
164387191|NCT00626522|593788444|FG002|Overall Study|COPD exacerbation|0|||
164387192|NCT00626522|593788445|FG003|Overall Study|COPD exacerbation|1|||
164387193|NCT00626522|593788446|FG004|Overall Study|COPD exacerbation|1|||
164387194|NCT00626522|593788447|FG005|Overall Study|COPD exacerbation|0|||
164387195|NCT00626522|593788442|FG000|Overall Study|Lost to Follow-up|0|||
164387196|NCT00626522|593788443|FG001|Overall Study|Lost to Follow-up|1|||
164387197|NCT00626522|593788444|FG002|Overall Study|Lost to Follow-up|0|||
164387198|NCT00626522|593788445|FG003|Overall Study|Lost to Follow-up|0|||
164387199|NCT00626522|593788446|FG004|Overall Study|Lost to Follow-up|0|||
164387200|NCT00626522|593788447|FG005|Overall Study|Lost to Follow-up|0|||
164387201|NCT00626522|593788442|FG000|Overall Study|Inconsistent reason reported|1|||
164387202|NCT00626522|593788443|FG001|Overall Study|Inconsistent reason reported|0|||
164387203|NCT00626522|593788444|FG002|Overall Study|Inconsistent reason reported|0|||
164387204|NCT00626522|593788445|FG003|Overall Study|Inconsistent reason reported|0|||
164387205|NCT00626522|593788446|FG004|Overall Study|Inconsistent reason reported|0|||
164387206|NCT00626522|593788447|FG005|Overall Study|Inconsistent reason reported|0|||
164387207|NCT00626522|593788442|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
164387208|NCT00626522|593788443|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
164387209|NCT00626522|593788444|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
164387210|NCT00626522|593788445|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
164387211|NCT00626522|593788446|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
164387212|NCT00626522|593788447|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
164387213|NCT01159691|593788448|FG000|Overall Study|Lost to Follow-up|2|||
164387214|NCT01159691|593788448|FG000|Overall Study|Unknown reasons|1|||
164387215|NCT01159691|593788448|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
164387216|NCT01159691|593788448|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
164387217|NCT01159691|593788448|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
164387218|NCT01159691|593788448|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
164387219|NCT01159691|593788448|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
164387220|NCT01159691|593788448|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
164387221|NCT01928719|593788449|FG000|Overall Study|Lost to Follow-up|26|||
164387222|NCT01928719|593788450|FG001|Overall Study|Lost to Follow-up|11|||
164387223|NCT01928719|593788449|FG000|Overall Study|Withdrawal by Subject|22|||
164387224|NCT01928719|593788450|FG001|Overall Study|Withdrawal by Subject|7|||
164387225|NCT01928719|593788449|FG000|Overall Study|Protocol Violation|3|||
164387226|NCT01928719|593788450|FG001|Overall Study|Protocol Violation|1|||
164387227|NCT01928719|593788449|FG000|Overall Study|Adverse Event|1|||
164387228|NCT01928719|593788450|FG001|Overall Study|Adverse Event|0|||
164387229|NCT01490632|593788451|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
164703464|NCT04394351|594941731|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
164703465|NCT04394351|594941732|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
164703466|NCT04394351|594941733|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
164703467|NCT04394351|594941734|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Other|32|||
164703468|NCT03653507|594941735|FG000|Overall Study|Miscellaneous|28|||
164387230|NCT01490632|593788452|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
164387231|NCT01490632|593788453|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
164387232|NCT01490632|593788454|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
164387233|NCT01490632|593788455|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
164703469|NCT03653507|594941736|FG001|Overall Study|Miscellaneous|19|||
164703470|NCT03653507|594941735|FG000|Overall Study|Withdrawal by Subject|37|||
164387234|NCT01490632|593788456|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
164387235|NCT01490632|593788457|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
164387236|NCT01490632|593788458|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
164387237|NCT01490632|593788459|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
164387238|NCT01490632|593788460|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
164387239|NCT01490632|593788461|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
164387240|NCT01490632|593788462|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
164387241|NCT01490632|593788463|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
164387242|NCT01490632|593788464|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
164417455|NCT01474512|593899505|FG016|Long-Term Extension Period|Death|0|||
164387243|NCT01490632|593788465|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
164387244|NCT01490632|593788466|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
164387245|NCT01490632|593788467|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
164387246|NCT01490632|593788468|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
164387247|NCT01490632|593788469|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
164387248|NCT01490632|593788470|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
164387249|NCT01490632|593788451|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
164387250|NCT01490632|593788452|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
164387251|NCT01490632|593788453|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
164387252|NCT01490632|593788454|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
164387253|NCT01490632|593788455|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387254|NCT01490632|593788456|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387255|NCT01490632|593788457|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387256|NCT01490632|593788458|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387257|NCT01490632|593788459|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387258|NCT01490632|593788460|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387259|NCT01490632|593788461|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387260|NCT01490632|593788462|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387261|NCT01490632|593788463|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387262|NCT01490632|593788464|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387263|NCT01490632|593788465|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387264|NCT01490632|593788466|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387265|NCT01490632|593788467|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387266|NCT01490632|593788468|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387267|NCT01490632|593788469|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387268|NCT01490632|593788470|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387269|NCT01490632|593788451|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387270|NCT01490632|593788452|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387271|NCT01490632|593788453|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
164387272|NCT01490632|593788454|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
164387273|NCT01490632|593788455|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
164387274|NCT01490632|593788456|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387275|NCT01490632|593788457|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387276|NCT01490632|593788458|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387277|NCT01490632|593788459|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387278|NCT01490632|593788460|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387279|NCT01490632|593788461|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387280|NCT01490632|593788462|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387281|NCT01490632|593788463|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387282|NCT01490632|593788464|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387283|NCT01490632|593788465|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387284|NCT01490632|593788466|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387285|NCT01490632|593788467|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387286|NCT01490632|593788468|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387287|NCT01490632|593788469|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387288|NCT01490632|593788470|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164703471|NCT03653507|594941736|FG001|Overall Study|Withdrawal by Subject|22|||
164387289|NCT01490632|593788451|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
164387290|NCT01490632|593788452|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
164387291|NCT01490632|593788453|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
164387292|NCT01490632|593788454|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
164387293|NCT01490632|593788455|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
164703472|NCT03653507|594941735|FG000|Overall Study|Protocol Deviation|2|||
164703473|NCT03653507|594941736|FG001|Overall Study|Protocol Deviation|1|||
164703474|NCT03653507|594941735|FG000|Overall Study|Progressive disease|117|||
164703475|NCT03653507|594941736|FG001|Overall Study|Progressive disease|168|||
164387294|NCT01490632|593788456|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
164387295|NCT01490632|593788457|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
164703476|NCT03653507|594941735|FG000|Overall Study|Lost to Follow-up|1|||
164703477|NCT03653507|594941736|FG001|Overall Study|Lost to Follow-up|1|||
164387296|NCT01490632|593788458|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
164440438|NCT03622593|593980597|FG001|Overall Study|Protocol Violation|0|||
164440439|NCT03622593|593980598|FG002|Overall Study|Protocol Violation|1|||
164440440|NCT03622593|593980596|FG000|Overall Study|Pregnancy|0|||
164387297|NCT01490632|593788459|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
164387298|NCT01490632|593788460|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
164387299|NCT01490632|593788461|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
164440441|NCT03622593|593980597|FG001|Overall Study|Pregnancy|0|||
164703478|NCT03653507|594941735|FG000|Overall Study|Death|25|||
164703479|NCT03653507|594941736|FG001|Overall Study|Death|22|||
164387300|NCT01490632|593788462|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
164387301|NCT01490632|593788463|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
164387302|NCT01490632|593788464|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
164387303|NCT01490632|593788465|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
164387304|NCT01490632|593788466|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
164387305|NCT01490632|593788467|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
164387306|NCT01490632|593788468|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
164387307|NCT01490632|593788469|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
164387308|NCT01490632|593788470|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
164387309|NCT01490632|593788451|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
164387310|NCT01490632|593788452|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387311|NCT01490632|593788453|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387312|NCT01490632|593788454|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387313|NCT01490632|593788455|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387314|NCT01490632|593788456|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387315|NCT01490632|593788457|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387316|NCT01490632|593788458|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387317|NCT01490632|593788459|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387318|NCT01490632|593788460|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387319|NCT01490632|593788461|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387320|NCT01490632|593788462|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387321|NCT01490632|593788463|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387322|NCT01490632|593788464|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387323|NCT01490632|593788465|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387324|NCT01490632|593788466|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387325|NCT01490632|593788467|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387326|NCT01490632|593788468|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387327|NCT01490632|593788469|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387328|NCT01490632|593788470|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387329|NCT01490632|593788451|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
164387330|NCT01490632|593788452|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
164387331|NCT01490632|593788453|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387332|NCT01490632|593788454|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
164387333|NCT01490632|593788455|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
164387334|NCT01490632|593788456|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387335|NCT01490632|593788457|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387336|NCT01490632|593788458|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387337|NCT01490632|593788459|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387338|NCT01490632|593788460|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387339|NCT01490632|593788461|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387340|NCT01490632|593788462|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387341|NCT01490632|593788463|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387342|NCT01490632|593788464|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387343|NCT01490632|593788465|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387344|NCT01490632|593788466|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387345|NCT01490632|593788467|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387346|NCT01490632|593788468|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387347|NCT01490632|593788469|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387348|NCT01490632|593788470|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387349|NCT01490632|593788451|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387350|NCT01490632|593788452|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387351|NCT01490632|593788453|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387352|NCT01490632|593788454|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387353|NCT01490632|593788455|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
164387354|NCT01490632|593788456|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387355|NCT01490632|593788457|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387356|NCT01490632|593788458|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387357|NCT01490632|593788459|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164440442|NCT03622593|593980598|FG002|Overall Study|Pregnancy|1|||
164703480|NCT03653507|594941735|FG000|Overall Study|Adverse Event|35|||
164703481|NCT03653507|594941736|FG001|Overall Study|Adverse Event|14|||
164703482|NCT01288053|594941743|FG000|Overall Study|Death|1|||
164703483|NCT03188666|594941744|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
164387358|NCT01490632|593788460|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387359|NCT01490632|593788461|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164440443|NCT01393119|593980601|FG000|Overall Study|Adverse Event|1|||
164440444|NCT01393119|593980602|FG001|Overall Study|Adverse Event|1|||
164593331|NCT00719732|594534739|FG000|Overall Study|Illness not associated with device|1|||
164387360|NCT01490632|593788462|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387361|NCT01490632|593788463|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387362|NCT01490632|593788464|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387363|NCT01490632|593788465|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387364|NCT01490632|593788466|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387365|NCT01490632|593788467|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387366|NCT01490632|593788468|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387367|NCT01490632|593788469|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387368|NCT01490632|593788470|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387369|NCT01490632|593788451|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387370|NCT01490632|593788452|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387371|NCT01490632|593788453|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387372|NCT01490632|593788454|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387373|NCT01490632|593788455|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387374|NCT01490632|593788456|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
164387375|NCT01490632|593788457|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
164387376|NCT01490632|593788458|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387377|NCT01490632|593788459|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387378|NCT01490632|593788460|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
164387379|NCT01490632|593788461|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
164387380|NCT01490632|593788462|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
164387381|NCT01490632|593788463|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387382|NCT01490632|593788464|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387383|NCT01490632|593788465|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387384|NCT01490632|593788466|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387385|NCT01490632|593788467|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387386|NCT01490632|593788468|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387387|NCT01490632|593788469|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387388|NCT01490632|593788470|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387389|NCT01490632|593788451|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387390|NCT01490632|593788452|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387391|NCT01490632|593788453|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387392|NCT01490632|593788454|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387393|NCT01490632|593788455|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387394|NCT01490632|593788456|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387395|NCT01490632|593788457|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
164387396|NCT01490632|593788458|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387397|NCT01490632|593788459|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
164387398|NCT01490632|593788460|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
164387399|NCT01490632|593788461|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
164387400|NCT01490632|593788462|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387401|NCT01490632|593788463|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387402|NCT01490632|593788464|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387403|NCT01490632|593788465|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387404|NCT01490632|593788466|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387405|NCT01490632|593788467|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387406|NCT01490632|593788468|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387407|NCT01490632|593788469|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387408|NCT01490632|593788470|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387409|NCT01490632|593788451|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387410|NCT01490632|593788452|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387411|NCT01490632|593788453|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387412|NCT01490632|593788454|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387413|NCT01490632|593788455|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387414|NCT01490632|593788456|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387415|NCT01490632|593788457|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
164387416|NCT01490632|593788458|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387417|NCT01490632|593788459|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387418|NCT01490632|593788460|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
164387419|NCT01490632|593788461|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387420|NCT01490632|593788462|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387421|NCT01490632|593788463|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387422|NCT01490632|593788464|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164593332|NCT00309777|594534744|FG000|Overall Study|Adverse Event|13|||
164593333|NCT00309777|594534745|FG001|Overall Study|Adverse Event|2|||
164387423|NCT01490632|593788465|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387424|NCT01490632|593788466|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387425|NCT01490632|593788467|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387426|NCT01490632|593788468|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387427|NCT01490632|593788469|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387428|NCT01490632|593788470|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387429|NCT01490632|593788451|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387430|NCT01490632|593788452|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387431|NCT01490632|593788453|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387432|NCT01490632|593788454|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387433|NCT01490632|593788455|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387434|NCT01490632|593788456|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387435|NCT01490632|593788457|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
164387436|NCT01490632|593788458|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387437|NCT01490632|593788459|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387438|NCT01490632|593788460|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387439|NCT01490632|593788461|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387440|NCT01490632|593788462|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387441|NCT01490632|593788463|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387442|NCT01490632|593788464|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387443|NCT01490632|593788465|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387444|NCT01490632|593788466|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387445|NCT01490632|593788467|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387446|NCT01490632|593788468|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387447|NCT01490632|593788469|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387448|NCT01490632|593788470|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387449|NCT01490632|593788451|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387450|NCT01490632|593788452|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387451|NCT01490632|593788453|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387452|NCT01490632|593788454|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164593334|NCT00309777|594534746|FG002|Overall Study|Adverse Event|8|||
164593335|NCT00309777|594534747|FG003|Overall Study|Adverse Event|1|||
164593336|NCT00309777|594534744|FG000|Overall Study|Protocol Violation|4|||
164593337|NCT00309777|594534745|FG001|Overall Study|Protocol Violation|1|||
164593338|NCT00309777|594534746|FG002|Overall Study|Protocol Violation|3|||
164593339|NCT00309777|594534747|FG003|Overall Study|Protocol Violation|1|||
164417456|NCT01474512|593899506|FG017|Long-Term Extension Period|Death|0|||
164417457|NCT01474512|593899489|FG000|Long-Term Extension Period|Sponsor Decision|0|||
164417458|NCT01474512|593899490|FG001|Long-Term Extension Period|Sponsor Decision|0|||
164417459|NCT01474512|593899491|FG002|Long-Term Extension Period|Sponsor Decision|0|||
164417460|NCT01474512|593899492|FG003|Long-Term Extension Period|Sponsor Decision|0|||
164417461|NCT01474512|593899493|FG004|Long-Term Extension Period|Sponsor Decision|0|||
164417462|NCT01474512|593899494|FG005|Long-Term Extension Period|Sponsor Decision|0|||
164417463|NCT01474512|593899495|FG006|Long-Term Extension Period|Sponsor Decision|0|||
164417464|NCT01474512|593899496|FG007|Long-Term Extension Period|Sponsor Decision|0|||
164417465|NCT01474512|593899497|FG008|Long-Term Extension Period|Sponsor Decision|0|||
164417466|NCT01474512|593899498|FG009|Long-Term Extension Period|Sponsor Decision|0|||
164417467|NCT01474512|593899499|FG010|Long-Term Extension Period|Sponsor Decision|0|||
164417468|NCT01474512|593899500|FG011|Long-Term Extension Period|Sponsor Decision|0|||
164417469|NCT01474512|593899501|FG012|Long-Term Extension Period|Sponsor Decision|6|||
164417470|NCT01474512|593899502|FG013|Long-Term Extension Period|Sponsor Decision|6|||
164417471|NCT01474512|593899503|FG014|Long-Term Extension Period|Sponsor Decision|0|||
164417472|NCT01474512|593899504|FG015|Long-Term Extension Period|Sponsor Decision|0|||
164417473|NCT01474512|593899505|FG016|Long-Term Extension Period|Sponsor Decision|0|||
164417474|NCT01474512|593899506|FG017|Long-Term Extension Period|Sponsor Decision|0|||
164417475|NCT01474512|593899489|FG000|Long-Term Extension Period|Protocol Violation|0|||
164417476|NCT01474512|593899490|FG001|Long-Term Extension Period|Protocol Violation|0|||
164417477|NCT01474512|593899491|FG002|Long-Term Extension Period|Protocol Violation|0|||
164417478|NCT01474512|593899492|FG003|Long-Term Extension Period|Protocol Violation|0|||
164417479|NCT01474512|593899493|FG004|Long-Term Extension Period|Protocol Violation|0|||
164417480|NCT01474512|593899494|FG005|Long-Term Extension Period|Protocol Violation|0|||
164417481|NCT01474512|593899495|FG006|Long-Term Extension Period|Protocol Violation|0|||
164417482|NCT01474512|593899496|FG007|Long-Term Extension Period|Protocol Violation|0|||
164417483|NCT01474512|593899497|FG008|Long-Term Extension Period|Protocol Violation|0|||
164417484|NCT01474512|593899498|FG009|Long-Term Extension Period|Protocol Violation|0|||
164417485|NCT01474512|593899499|FG010|Long-Term Extension Period|Protocol Violation|0|||
164417486|NCT01474512|593899500|FG011|Long-Term Extension Period|Protocol Violation|0|||
164417487|NCT01474512|593899501|FG012|Long-Term Extension Period|Protocol Violation|5|||
164440445|NCT01393119|593980603|FG002|Overall Study|Adverse Event|0|||
164440446|NCT01393119|593980604|FG003|Overall Study|Adverse Event|1|||
164440447|NCT01393119|593980601|FG000|Overall Study|Withdrawal by Subject|0|||
164440448|NCT01393119|593980602|FG001|Overall Study|Withdrawal by Subject|1|||
164440449|NCT01393119|593980603|FG002|Overall Study|Withdrawal by Subject|1|||
164440450|NCT01393119|593980604|FG003|Overall Study|Withdrawal by Subject|0|||
164440451|NCT01393119|593980601|FG000|Overall Study|Lack of Efficacy|1|||
164440452|NCT01393119|593980602|FG001|Overall Study|Lack of Efficacy|0|||
164440453|NCT01393119|593980603|FG002|Overall Study|Lack of Efficacy|2|||
164440454|NCT01393119|593980604|FG003|Overall Study|Lack of Efficacy|1|||
164440455|NCT01393119|593980601|FG000|Overall Study|Protocol Violation|0|||
164440456|NCT01393119|593980602|FG001|Overall Study|Protocol Violation|0|||
164440457|NCT01393119|593980603|FG002|Overall Study|Protocol Violation|1|||
164440458|NCT01393119|593980604|FG003|Overall Study|Protocol Violation|0|||
164440459|NCT01393119|593980601|FG000|Overall Study|Death|0|||
164440460|NCT01393119|593980602|FG001|Overall Study|Death|0|||
164440461|NCT01393119|593980603|FG002|Overall Study|Death|0|||
164440462|NCT01393119|593980604|FG003|Overall Study|Death|1|||
164440463|NCT01393119|593980601|FG000|Overall Study|Randomized but Not treated|1|||
164440464|NCT01393119|593980602|FG001|Overall Study|Randomized but Not treated|0|||
164440465|NCT01393119|593980603|FG002|Overall Study|Randomized but Not treated|1|||
164440466|NCT01393119|593980604|FG003|Overall Study|Randomized but Not treated|1|||
164440467|NCT01393119|593980601|FG000|Overall Study|Sponsor Termination of Study|11|||
164440468|NCT01393119|593980602|FG001|Overall Study|Sponsor Termination of Study|12|||
164440469|NCT01393119|593980603|FG002|Overall Study|Sponsor Termination of Study|9|||
164440470|NCT01393119|593980604|FG003|Overall Study|Sponsor Termination of Study|12|||
164440471|NCT04860258|593980605|FG000|Overall Study|Withdrawal by Subject|0|||
164440472|NCT04860258|593980606|FG001|Overall Study|Withdrawal by Subject|0|||
164440473|NCT04860258|593980607|FG002|Overall Study|Withdrawal by Subject|4|||
164440474|NCT04860258|593980608|FG003|Overall Study|Withdrawal by Subject|1|||
164440475|NCT04860258|593980609|FG004|Overall Study|Withdrawal by Subject|4|||
164440476|NCT04860258|593980610|FG005|Overall Study|Withdrawal by Subject|1|||
164440477|NCT04860258|593980611|FG006|Overall Study|Withdrawal by Subject|0|||
164440478|NCT01580293|593980612|FG000|Part A_Main Trial|Adverse Event|0|||
164440479|NCT01580293|593980613|FG001|Part A_Main Trial|Adverse Event|2|||
164440480|NCT01580293|593980614|FG002|Part A_Main Trial|Adverse Event|0|||
164440481|NCT01580293|593980612|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
164440482|NCT01580293|593980613|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
164440483|NCT01580293|593980614|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
164440484|NCT01580293|593980612|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
164440485|NCT01580293|593980613|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
164440486|NCT01580293|593980614|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
164440487|NCT01580293|593980612|FG000|Part A_Extension|Adverse Event|0|||
164440488|NCT01580293|593980613|FG001|Part A_Extension|Adverse Event|2|||
164440489|NCT01580293|593980614|FG002|Part A_Extension|Adverse Event|0|||
164440490|NCT01580293|593980612|FG000|Part A_Extension|Withdrawal by Subject|0|||
164440491|NCT01580293|593980613|FG001|Part A_Extension|Withdrawal by Subject|3|||
164440492|NCT01580293|593980614|FG002|Part A_Extension|Withdrawal by Subject|0|||
164440493|NCT01580293|593980612|FG000|Part A_Extension|Lost to Follow-up|0|||
164440494|NCT01580293|593980613|FG001|Part A_Extension|Lost to Follow-up|1|||
164440495|NCT01580293|593980614|FG002|Part A_Extension|Lost to Follow-up|0|||
164440496|NCT01580293|593980612|FG000|Part A_Extension|Other Reason|0|||
164440497|NCT01580293|593980613|FG001|Part A_Extension|Other Reason|1|||
164440498|NCT01580293|593980614|FG002|Part A_Extension|Other Reason|0|||
164440499|NCT01580293|593980612|FG000|Part A_Extension|Completed Japan only|0|||
164440500|NCT01580293|593980613|FG001|Part A_Extension|Completed Japan only|5|||
164440501|NCT01580293|593980614|FG002|Part A_Extension|Completed Japan only|0|||
164440502|NCT01580293|593980612|FG000|Part B|Withdrawal by Subject|0|||
164440503|NCT01580293|593980613|FG001|Part B|Withdrawal by Subject|0|||
164703484|NCT03188666|594941745|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
164703485|NCT03188666|594941746|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
164703486|NCT03188666|594941747|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
164703487|NCT03188666|594941744|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
164440504|NCT01580293|593980614|FG002|Part B|Withdrawal by Subject|1|||
164440505|NCT01580293|593980612|FG000|Part B|Other reason|0|||
164440506|NCT01580293|593980613|FG001|Part B|Other reason|0|||
164440507|NCT01580293|593980614|FG002|Part B|Other reason|1|||
164440508|NCT01499134|593980617|FG000|Overall Study|Withdrawal by Subject|0|||
164440509|NCT01499134|593980618|FG001|Overall Study|Withdrawal by Subject|1|||
164440510|NCT05855655|593980623|FG000|Overall Study|Withdrawal by Subject|0|||
164440511|NCT05855655|593980624|FG001|Overall Study|Withdrawal by Subject|1|||
164440512|NCT05855655|593980623|FG000|Overall Study|Lost to Follow-up|4|||
164440513|NCT05855655|593980624|FG001|Overall Study|Lost to Follow-up|0|||
164440514|NCT01613716|593980625|FG000|Overall Study|screen failures|3|||
164440515|NCT01613716|593980625|FG000|Overall Study|Lost to Follow-up|4|||
164440516|NCT01426269|593980626|FG000|Period 1: 12 Weeks|Adverse Event|5|||
164440517|NCT01426269|593980627|FG001|Period 1: 12 Weeks|Adverse Event|0|||
164440518|NCT01426269|593980628|FG002|Period 1: 12 Weeks|Adverse Event|0|||
164703488|NCT03188666|594941745|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
164703489|NCT03188666|594941746|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
164703490|NCT03188666|594941747|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
164703491|NCT03188666|594941744|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
164703492|NCT03188666|594941745|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
164703493|NCT03188666|594941746|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
164703494|NCT03188666|594941747|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
164703495|NCT03188666|594941744|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
164703496|NCT03188666|594941745|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
164703497|NCT03188666|594941746|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
164703498|NCT03188666|594941747|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
164703499|NCT00144781|594941748|FG000|Overall Study|Adverse Event|0|||
164703500|NCT00144781|594941749|FG001|Overall Study|Adverse Event|1|||
164703501|NCT00144781|594941750|FG002|Overall Study|Adverse Event|0|||
164387453|NCT01490632|593788455|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387454|NCT01490632|593788456|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
164387455|NCT01490632|593788457|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387456|NCT01490632|593788458|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387457|NCT01490632|593788459|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387458|NCT01490632|593788460|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387459|NCT01490632|593788461|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387460|NCT01490632|593788462|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387461|NCT01490632|593788463|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387462|NCT01490632|593788464|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387463|NCT01490632|593788465|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387464|NCT01490632|593788466|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387465|NCT01490632|593788467|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387466|NCT01490632|593788468|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387467|NCT01490632|593788469|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387468|NCT01490632|593788470|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387469|NCT01490632|593788451|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387470|NCT01490632|593788452|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387471|NCT01490632|593788453|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387472|NCT01490632|593788454|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387473|NCT01490632|593788455|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387474|NCT01490632|593788456|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387475|NCT01490632|593788457|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
164387476|NCT01490632|593788458|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387477|NCT01490632|593788459|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
164387478|NCT01490632|593788460|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387479|NCT01490632|593788461|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
164387480|NCT01490632|593788462|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
164387481|NCT01490632|593788463|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387482|NCT01490632|593788464|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387483|NCT01490632|593788465|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387484|NCT01490632|593788466|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387485|NCT01490632|593788467|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387486|NCT01490632|593788468|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387487|NCT01490632|593788469|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387488|NCT01490632|593788470|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387489|NCT01490632|593788451|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164387490|NCT01490632|593788452|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164387491|NCT01490632|593788453|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164387492|NCT01490632|593788454|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164387493|NCT01490632|593788455|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164387494|NCT01490632|593788456|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
164387495|NCT01490632|593788457|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
164387496|NCT01490632|593788458|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
164387497|NCT01490632|593788459|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
164387498|NCT01490632|593788460|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
164417488|NCT01474512|593899502|FG013|Long-Term Extension Period|Protocol Violation|5|||
164417489|NCT01474512|593899503|FG014|Long-Term Extension Period|Protocol Violation|0|||
164417490|NCT01474512|593899504|FG015|Long-Term Extension Period|Protocol Violation|0|||
164593340|NCT00309777|594534744|FG000|Overall Study|Withdrawal by Subject|6|||
164593341|NCT00309777|594534745|FG001|Overall Study|Withdrawal by Subject|5|||
164593342|NCT00309777|594534746|FG002|Overall Study|Withdrawal by Subject|7|||
164593343|NCT00309777|594534747|FG003|Overall Study|Withdrawal by Subject|2|||
164593344|NCT00309777|594534744|FG000|Overall Study|Lost to Follow-up|0|||
164593345|NCT00309777|594534745|FG001|Overall Study|Lost to Follow-up|0|||
164593346|NCT00309777|594534746|FG002|Overall Study|Lost to Follow-up|1|||
164593347|NCT00309777|594534747|FG003|Overall Study|Lost to Follow-up|0|||
164593348|NCT00309777|594534744|FG000|Overall Study|Death|0|||
164593349|NCT00309777|594534745|FG001|Overall Study|Death|1|||
164593350|NCT00309777|594534746|FG002|Overall Study|Death|0|||
164593351|NCT00309777|594534747|FG003|Overall Study|Death|0|||
164387499|NCT01490632|593788461|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
164387500|NCT01490632|593788462|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
164387501|NCT01490632|593788463|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164387502|NCT01490632|593788464|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164387503|NCT01490632|593788465|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164387504|NCT01490632|593788466|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164593352|NCT02429258|594536978|FG000|Overall Study|Withdrawal by Subject|2|||
164593353|NCT02429258|594536979|FG001|Overall Study|Withdrawal by Subject|0|||
164593354|NCT02429258|594536978|FG000|Overall Study|Protocol Violation|0|||
164593355|NCT02429258|594536979|FG001|Overall Study|Protocol Violation|1|||
164593356|NCT00492856|594536980|FG000|Induction|Adverse Event|2|||
164593357|NCT00492856|594536981|FG001|Induction|Adverse Event|0|||
164593358|NCT00492856|594536982|FG002|Induction|Adverse Event|0|||
164593359|NCT00492856|594536983|FG003|Induction|Adverse Event|0|||
164593360|NCT00492856|594536980|FG000|Induction|Withdrawal by Subject|1|||
164593361|NCT00492856|594536981|FG001|Induction|Withdrawal by Subject|0|||
164593362|NCT00492856|594536982|FG002|Induction|Withdrawal by Subject|0|||
164593363|NCT00492856|594536983|FG003|Induction|Withdrawal by Subject|0|||
164593364|NCT00492856|594536980|FG000|Induction|Death|3|||
164593365|NCT00492856|594536981|FG001|Induction|Death|0|||
164593366|NCT00492856|594536982|FG002|Induction|Death|0|||
164593367|NCT00492856|594536983|FG003|Induction|Death|0|||
164593368|NCT00492856|594536980|FG000|Consolidation|Adverse Event|6|||
164593369|NCT00492856|594536981|FG001|Consolidation|Adverse Event|0|||
164593370|NCT00492856|594536982|FG002|Consolidation|Adverse Event|0|||
164593371|NCT00492856|594536983|FG003|Consolidation|Adverse Event|0|||
164593372|NCT00492856|594536980|FG000|Consolidation|Not protocol specified|2|||
164593373|NCT00492856|594536981|FG001|Consolidation|Not protocol specified|0|||
164703502|NCT00144781|594941751|FG003|Overall Study|Adverse Event|0|||
164703503|NCT00144781|594941748|FG000|Overall Study|Non-compliant|0|||
164703504|NCT00144781|594941749|FG001|Overall Study|Non-compliant|1|||
164703505|NCT00144781|594941750|FG002|Overall Study|Non-compliant|0|||
164387505|NCT01490632|593788467|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164387506|NCT01490632|593788468|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164387507|NCT01490632|593788469|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164387508|NCT01490632|593788470|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164387509|NCT01490632|593788451|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387510|NCT01490632|593788452|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387511|NCT01490632|593788453|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387512|NCT01490632|593788454|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387513|NCT01490632|593788455|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387514|NCT01490632|593788456|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387515|NCT01490632|593788457|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387516|NCT01490632|593788458|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387517|NCT01490632|593788459|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
164440519|NCT01426269|593980626|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
164440520|NCT01426269|593980627|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
164593374|NCT00492856|594536982|FG002|Consolidation|Not protocol specified|0|||
164593375|NCT00492856|594536983|FG003|Consolidation|Not protocol specified|0|||
164593376|NCT00492856|594536980|FG000|Consolidation|Lost to Follow-up|1|||
164703506|NCT00144781|594941751|FG003|Overall Study|Non-compliant|0|||
164593377|NCT00492856|594536981|FG001|Consolidation|Lost to Follow-up|0|||
164593378|NCT00492856|594536982|FG002|Consolidation|Lost to Follow-up|0|||
164593379|NCT00492856|594536983|FG003|Consolidation|Lost to Follow-up|0|||
164703507|NCT02068092|594941752|FG000|Overall Study|Physician Decision|2|||
164703508|NCT02068092|594941752|FG000|Overall Study|Adverse Event|2|||
164703509|NCT02068092|594941752|FG000|Overall Study|Lost to Follow-up|4|||
164593380|NCT00492856|594536980|FG000|Post-consolidation|Adverse Event|0|||
164593381|NCT00492856|594536981|FG001|Post-consolidation|Adverse Event|4|||
164593382|NCT00492856|594536982|FG002|Post-consolidation|Adverse Event|0|||
164593383|NCT00492856|594536983|FG003|Post-consolidation|Adverse Event|1|||
164593384|NCT00492856|594536980|FG000|Post-consolidation|Withdrawal by Subject|0|||
164593385|NCT00492856|594536981|FG001|Post-consolidation|Withdrawal by Subject|4|||
164703510|NCT02068092|594941752|FG000|Overall Study|Withdrawal by Subject|2|||
164703511|NCT03696953|594941753|FG000|Overall Study|Withdrawal by Subject|6|||
164703512|NCT03696953|594941754|FG001|Overall Study|Withdrawal by Subject|1|||
164703513|NCT03696953|594941753|FG000|Overall Study|missed GBS swabs|2|||
164703514|NCT03696953|594941754|FG001|Overall Study|missed GBS swabs|2|||
164703515|NCT03696953|594941753|FG000|Overall Study|lost study bottle containing capsules|2|||
164703516|NCT03696953|594941754|FG001|Overall Study|lost study bottle containing capsules|0|||
164703517|NCT03696953|594941753|FG000|Overall Study|Premature birth|1|||
164703518|NCT03696953|594941754|FG001|Overall Study|Premature birth|4|||
164703519|NCT03696953|594941753|FG000|Overall Study|Gestational hypertension|1|||
164703520|NCT03696953|594941754|FG001|Overall Study|Gestational hypertension|1|||
164703521|NCT03696953|594941753|FG000|Overall Study|Gestational diabetes|2|||
164703522|NCT03696953|594941754|FG001|Overall Study|Gestational diabetes|1|||
164703523|NCT03696953|594941753|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
164703524|NCT03696953|594941754|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
164703525|NCT03696953|594941753|FG000|Overall Study|Changed prenatal provider|1|||
164703526|NCT03696953|594941754|FG001|Overall Study|Changed prenatal provider|1|||
164703527|NCT03502707|594941755|FG000|Overall Study|Adverse Event|0|||
164703528|NCT03502707|594941756|FG001|Overall Study|Adverse Event|0|||
164703529|NCT03502707|594941757|FG002|Overall Study|Adverse Event|0|||
164703530|NCT03502707|594941758|FG003|Overall Study|Adverse Event|0|||
164703531|NCT03502707|594941759|FG004|Overall Study|Adverse Event|0|||
164703532|NCT03502707|594941760|FG005|Overall Study|Adverse Event|0|||
164703533|NCT03502707|594941761|FG006|Overall Study|Adverse Event|0|||
164703534|NCT03502707|594941762|FG007|Overall Study|Adverse Event|0|||
164703535|NCT03502707|594941763|FG008|Overall Study|Adverse Event|0|||
164703536|NCT03502707|594941764|FG009|Overall Study|Adverse Event|0|||
164703537|NCT03502707|594941765|FG010|Overall Study|Adverse Event|0|||
164703538|NCT03502707|594941766|FG011|Overall Study|Adverse Event|0|||
164703539|NCT03502707|594941767|FG012|Overall Study|Adverse Event|0|||
164703540|NCT03502707|594941768|FG013|Overall Study|Adverse Event|0|||
164703541|NCT03502707|594941769|FG014|Overall Study|Adverse Event|0|||
164703542|NCT03502707|594941770|FG015|Overall Study|Adverse Event|1|||
164703543|NCT03502707|594941771|FG016|Overall Study|Adverse Event|5|||
164703544|NCT03502707|594941772|FG017|Overall Study|Adverse Event|0|||
164703545|NCT03502707|594941755|FG000|Overall Study|Death|0|||
164703546|NCT03502707|594941756|FG001|Overall Study|Death|0|||
164703547|NCT03502707|594941757|FG002|Overall Study|Death|0|||
164703548|NCT03502707|594941758|FG003|Overall Study|Death|1|||
164703549|NCT03502707|594941759|FG004|Overall Study|Death|0|||
164703550|NCT03502707|594941760|FG005|Overall Study|Death|0|||
164703551|NCT03502707|594941761|FG006|Overall Study|Death|0|||
164703552|NCT03502707|594941762|FG007|Overall Study|Death|0|||
164703553|NCT03502707|594941763|FG008|Overall Study|Death|1|||
164703554|NCT03502707|594941764|FG009|Overall Study|Death|1|||
164703555|NCT03502707|594941765|FG010|Overall Study|Death|0|||
164703556|NCT03502707|594941766|FG011|Overall Study|Death|0|||
164703557|NCT03502707|594941767|FG012|Overall Study|Death|1|||
164703558|NCT03502707|594941768|FG013|Overall Study|Death|0|||
164703559|NCT03502707|594941769|FG014|Overall Study|Death|0|||
164703560|NCT03502707|594941770|FG015|Overall Study|Death|1|||
164703561|NCT03502707|594941771|FG016|Overall Study|Death|0|||
164703562|NCT03502707|594941772|FG017|Overall Study|Death|0|||
164703563|NCT03502707|594941755|FG000|Overall Study|Lost to Follow-up|0|||
164703564|NCT03502707|594941756|FG001|Overall Study|Lost to Follow-up|0|||
164703565|NCT03502707|594941757|FG002|Overall Study|Lost to Follow-up|0|||
164703566|NCT03502707|594941758|FG003|Overall Study|Lost to Follow-up|0|||
164703567|NCT03502707|594941759|FG004|Overall Study|Lost to Follow-up|0|||
164703568|NCT03502707|594941760|FG005|Overall Study|Lost to Follow-up|0|||
164703569|NCT03502707|594941761|FG006|Overall Study|Lost to Follow-up|0|||
164703570|NCT03502707|594941762|FG007|Overall Study|Lost to Follow-up|5|||
164703571|NCT03502707|594941763|FG008|Overall Study|Lost to Follow-up|0|||
164703572|NCT03502707|594941764|FG009|Overall Study|Lost to Follow-up|2|||
164703573|NCT03502707|594941765|FG010|Overall Study|Lost to Follow-up|1|||
164703574|NCT03502707|594941766|FG011|Overall Study|Lost to Follow-up|2|||
164703575|NCT03502707|594941767|FG012|Overall Study|Lost to Follow-up|1|||
164703576|NCT03502707|594941768|FG013|Overall Study|Lost to Follow-up|1|||
164703577|NCT03502707|594941769|FG014|Overall Study|Lost to Follow-up|0|||
164703578|NCT03502707|594941770|FG015|Overall Study|Lost to Follow-up|4|||
164703579|NCT03502707|594941771|FG016|Overall Study|Lost to Follow-up|9|||
164703580|NCT03502707|594941772|FG017|Overall Study|Lost to Follow-up|2|||
164703581|NCT03502707|594941755|FG000|Overall Study|Physician Decision|0|||
164703582|NCT03502707|594941756|FG001|Overall Study|Physician Decision|0|||
164703583|NCT03502707|594941757|FG002|Overall Study|Physician Decision|0|||
164703584|NCT03502707|594941758|FG003|Overall Study|Physician Decision|0|||
164703585|NCT03502707|594941759|FG004|Overall Study|Physician Decision|0|||
164703586|NCT03502707|594941760|FG005|Overall Study|Physician Decision|0|||
164703587|NCT03502707|594941761|FG006|Overall Study|Physician Decision|0|||
164703588|NCT03502707|594941762|FG007|Overall Study|Physician Decision|0|||
164703589|NCT03502707|594941763|FG008|Overall Study|Physician Decision|2|||
164703590|NCT03502707|594941764|FG009|Overall Study|Physician Decision|1|||
164703591|NCT03502707|594941765|FG010|Overall Study|Physician Decision|0|||
164703592|NCT03502707|594941766|FG011|Overall Study|Physician Decision|0|||
164703593|NCT03502707|594941767|FG012|Overall Study|Physician Decision|0|||
164703594|NCT03502707|594941768|FG013|Overall Study|Physician Decision|0|||
164703595|NCT03502707|594941769|FG014|Overall Study|Physician Decision|1|||
164703596|NCT03502707|594941770|FG015|Overall Study|Physician Decision|3|||
164703597|NCT03502707|594941771|FG016|Overall Study|Physician Decision|0|||
164703598|NCT03502707|594941772|FG017|Overall Study|Physician Decision|0|||
164440521|NCT01426269|593980628|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
164440522|NCT01426269|593980626|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
164440523|NCT01426269|593980627|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
164440524|NCT01426269|593980628|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
164440525|NCT01426269|593980626|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
164440526|NCT01426269|593980627|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
164440527|NCT01426269|593980628|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
164440528|NCT01426269|593980626|FG000|Period 1: 12 Weeks|Pregnancy|1|||
164703599|NCT03502707|594941755|FG000|Overall Study|Protocol Violation|0|||
164703600|NCT03502707|594941756|FG001|Overall Study|Protocol Violation|0|||
164703601|NCT03502707|594941757|FG002|Overall Study|Protocol Violation|0|||
164703602|NCT03502707|594941758|FG003|Overall Study|Protocol Violation|0|||
164703603|NCT03502707|594941759|FG004|Overall Study|Protocol Violation|0|||
164703604|NCT03502707|594941760|FG005|Overall Study|Protocol Violation|0|||
164703605|NCT03502707|594941761|FG006|Overall Study|Protocol Violation|0|||
164703606|NCT03502707|594941762|FG007|Overall Study|Protocol Violation|0|||
164703607|NCT03502707|594941763|FG008|Overall Study|Protocol Violation|0|||
164703608|NCT03502707|594941764|FG009|Overall Study|Protocol Violation|0|||
164703609|NCT03502707|594941765|FG010|Overall Study|Protocol Violation|0|||
164703610|NCT03502707|594941766|FG011|Overall Study|Protocol Violation|0|||
164703611|NCT03502707|594941767|FG012|Overall Study|Protocol Violation|0|||
164703612|NCT03502707|594941768|FG013|Overall Study|Protocol Violation|0|||
164703613|NCT03502707|594941769|FG014|Overall Study|Protocol Violation|0|||
164703614|NCT03502707|594941770|FG015|Overall Study|Protocol Violation|1|||
164703615|NCT03502707|594941771|FG016|Overall Study|Protocol Violation|0|||
164703616|NCT03502707|594941772|FG017|Overall Study|Protocol Violation|0|||
164703617|NCT03502707|594941755|FG000|Overall Study|Withdrawal by Subject|1|||
164703618|NCT03502707|594941756|FG001|Overall Study|Withdrawal by Subject|1|||
164703619|NCT03502707|594941757|FG002|Overall Study|Withdrawal by Subject|0|||
164703620|NCT03502707|594941758|FG003|Overall Study|Withdrawal by Subject|0|||
164703621|NCT03502707|594941759|FG004|Overall Study|Withdrawal by Subject|0|||
164703622|NCT03502707|594941760|FG005|Overall Study|Withdrawal by Subject|2|||
164703623|NCT03502707|594941761|FG006|Overall Study|Withdrawal by Subject|0|||
164703624|NCT03502707|594941762|FG007|Overall Study|Withdrawal by Subject|3|||
164703625|NCT03502707|594941763|FG008|Overall Study|Withdrawal by Subject|1|||
164703626|NCT03502707|594941764|FG009|Overall Study|Withdrawal by Subject|2|||
164703627|NCT03502707|594941765|FG010|Overall Study|Withdrawal by Subject|12|||
164387518|NCT01490632|593788460|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387519|NCT01490632|593788461|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387520|NCT01490632|593788462|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387521|NCT01490632|593788463|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387522|NCT01490632|593788464|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387523|NCT01490632|593788465|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
164387524|NCT01490632|593788466|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
164387525|NCT01490632|593788467|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387526|NCT01490632|593788468|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387527|NCT01490632|593788469|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387528|NCT01490632|593788470|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387529|NCT01490632|593788451|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387530|NCT01490632|593788452|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387531|NCT01490632|593788453|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387532|NCT01490632|593788454|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387533|NCT01490632|593788455|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387534|NCT01490632|593788456|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387535|NCT01490632|593788457|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387536|NCT01490632|593788458|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387537|NCT01490632|593788459|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387538|NCT01490632|593788460|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387539|NCT01490632|593788461|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387540|NCT01490632|593788462|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387541|NCT01490632|593788463|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387542|NCT01490632|593788464|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
164703628|NCT03502707|594941766|FG011|Overall Study|Withdrawal by Subject|23|||
164440529|NCT01426269|593980627|FG001|Period 1: 12 Weeks|Pregnancy|0|||
164440530|NCT01426269|593980628|FG002|Period 1: 12 Weeks|Pregnancy|0|||
164703629|NCT03502707|594941767|FG012|Overall Study|Withdrawal by Subject|5|||
164387543|NCT01490632|593788465|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387544|NCT01490632|593788466|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387545|NCT01490632|593788467|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387546|NCT01490632|593788468|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387547|NCT01490632|593788469|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387548|NCT01490632|593788470|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387549|NCT01490632|593788451|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387550|NCT01490632|593788452|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387551|NCT01490632|593788453|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387552|NCT01490632|593788454|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387553|NCT01490632|593788455|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387554|NCT01490632|593788456|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387555|NCT01490632|593788457|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387556|NCT01490632|593788458|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387557|NCT01490632|593788459|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387558|NCT01490632|593788460|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387559|NCT01490632|593788461|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387560|NCT01490632|593788462|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387561|NCT01490632|593788463|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387562|NCT01490632|593788464|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387563|NCT01490632|593788465|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
164387564|NCT01490632|593788466|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
164387565|NCT01490632|593788467|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387566|NCT01490632|593788468|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387567|NCT01490632|593788469|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387568|NCT01490632|593788470|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387569|NCT01490632|593788451|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387570|NCT01490632|593788452|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387571|NCT01490632|593788453|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164440531|NCT01426269|593980626|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
164440532|NCT01426269|593980627|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
164440533|NCT01426269|593980628|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
164440534|NCT01426269|593980626|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
164440535|NCT01426269|593980627|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
164440536|NCT01426269|593980628|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
164440537|NCT01426269|593980626|FG000|Period 2: 40 Weeks|Adverse Event|0|||
164440538|NCT01426269|593980627|FG001|Period 2: 40 Weeks|Adverse Event|1|||
164440539|NCT01426269|593980628|FG002|Period 2: 40 Weeks|Adverse Event|2|||
164440540|NCT01426269|593980626|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
164440541|NCT01426269|593980627|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
164440542|NCT01426269|593980628|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
164440543|NCT01426269|593980626|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
164440544|NCT01426269|593980627|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
164440545|NCT01426269|593980628|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
164440546|NCT01426269|593980626|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
164440547|NCT01426269|593980627|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
164440548|NCT01426269|593980628|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
164440549|NCT01426269|593980626|FG000|Period 2: 40 Weeks|Site closed|0|||
164440550|NCT01426269|593980627|FG001|Period 2: 40 Weeks|Site closed|6|||
164440551|NCT01426269|593980628|FG002|Period 2: 40 Weeks|Site closed|5|||
164440552|NCT01426269|593980626|FG000|Period 2: 40 Weeks|Relapsed|0|||
164440553|NCT01426269|593980627|FG001|Period 2: 40 Weeks|Relapsed|9|||
164440554|NCT01426269|593980628|FG002|Period 2: 40 Weeks|Relapsed|18|||
164440555|NCT00419094|593980632|FG000|Overall Study|Adverse Event|3|||
164440556|NCT00419094|593980633|FG001|Overall Study|Adverse Event|7|||
164440557|NCT00419094|593980632|FG000|Overall Study|Lack of Efficacy|1|||
164440558|NCT00419094|593980633|FG001|Overall Study|Lack of Efficacy|0|||
164703630|NCT03502707|594941768|FG013|Overall Study|Withdrawal by Subject|3|||
164703631|NCT03502707|594941769|FG014|Overall Study|Withdrawal by Subject|3|||
164703632|NCT03502707|594941770|FG015|Overall Study|Withdrawal by Subject|43|||
164703633|NCT03502707|594941771|FG016|Overall Study|Withdrawal by Subject|44|||
164703634|NCT03502707|594941772|FG017|Overall Study|Withdrawal by Subject|18|||
164703635|NCT03502707|594941755|FG000|Overall Study|Sponsor's Decision|1|||
164703636|NCT03502707|594941756|FG001|Overall Study|Sponsor's Decision|0|||
164703637|NCT03502707|594941757|FG002|Overall Study|Sponsor's Decision|0|||
164703638|NCT03502707|594941758|FG003|Overall Study|Sponsor's Decision|0|||
164440559|NCT00419094|593980632|FG000|Overall Study|Lost to Follow-up|0|||
164440560|NCT00419094|593980633|FG001|Overall Study|Lost to Follow-up|2|||
164440561|NCT00419094|593980632|FG000|Overall Study|Protocol Violation|1|||
164440562|NCT00419094|593980633|FG001|Overall Study|Protocol Violation|14|||
164703639|NCT03502707|594941759|FG004|Overall Study|Sponsor's Decision|0|||
164440563|NCT00419094|593980632|FG000|Overall Study|Withdrawal of consent|1|||
164440564|NCT00419094|593980633|FG001|Overall Study|Withdrawal of consent|5|||
164440565|NCT00419094|593980632|FG000|Overall Study|Other: Error determining exit criteria|1|||
164440566|NCT00419094|593980633|FG001|Overall Study|Other: Error determining exit criteria|0|||
164593386|NCT00492856|594536982|FG002|Post-consolidation|Withdrawal by Subject|0|||
164387572|NCT01490632|593788454|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387573|NCT01490632|593788455|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387574|NCT01490632|593788456|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387575|NCT01490632|593788457|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387576|NCT01490632|593788458|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387577|NCT01490632|593788459|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387578|NCT01490632|593788460|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387579|NCT01490632|593788461|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387580|NCT01490632|593788462|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387581|NCT01490632|593788463|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
164387582|NCT01490632|593788464|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
164387583|NCT01490632|593788465|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
164387584|NCT01490632|593788466|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
164387585|NCT01490632|593788467|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387586|NCT01490632|593788468|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387587|NCT01490632|593788469|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387588|NCT01490632|593788470|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387589|NCT01490632|593788451|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
164387590|NCT01490632|593788452|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
164387591|NCT01490632|593788453|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
164387592|NCT01490632|593788454|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
164387593|NCT01490632|593788455|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
164387594|NCT01490632|593788456|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
164387595|NCT01490632|593788457|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
164387596|NCT01490632|593788458|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
164387597|NCT01490632|593788459|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
164387598|NCT01490632|593788460|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
164387599|NCT01490632|593788461|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
164387600|NCT01490632|593788462|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
164387601|NCT01490632|593788463|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
164387602|NCT01490632|593788464|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
164387603|NCT01490632|593788465|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
164440567|NCT00419094|593980632|FG000|Overall Study|Other: Patient non-compliant|0|||
164593387|NCT00492856|594536983|FG003|Post-consolidation|Withdrawal by Subject|0|||
164593388|NCT00492856|594536980|FG000|Post-consolidation|Death|0|||
164593389|NCT00492856|594536981|FG001|Post-consolidation|Death|1|||
164593390|NCT00492856|594536982|FG002|Post-consolidation|Death|0|||
164593391|NCT00492856|594536983|FG003|Post-consolidation|Death|0|||
164593392|NCT00492856|594536980|FG000|Post-consolidation|Not protocol specified|0|||
164593393|NCT00492856|594536981|FG001|Post-consolidation|Not protocol specified|1|||
164593394|NCT00492856|594536982|FG002|Post-consolidation|Not protocol specified|0|||
164593395|NCT00492856|594536983|FG003|Post-consolidation|Not protocol specified|0|||
164593396|NCT00492856|594536980|FG000|Post-consolidation|Lost to Follow-up|0|||
164593397|NCT00492856|594536981|FG001|Post-consolidation|Lost to Follow-up|2|||
164593398|NCT00492856|594536982|FG002|Post-consolidation|Lost to Follow-up|0|||
164593399|NCT00492856|594536983|FG003|Post-consolidation|Lost to Follow-up|0|||
164593400|NCT00492856|594536980|FG000|Post-consolidation|Observation Arm|0|||
164593401|NCT00492856|594536981|FG001|Post-consolidation|Observation Arm|0|||
164593402|NCT00492856|594536982|FG002|Post-consolidation|Observation Arm|27|||
164593403|NCT00492856|594536983|FG003|Post-consolidation|Observation Arm|0|||
164593404|NCT03470922|594536986|FG000|Overall Study|Death|107|||
164593405|NCT03470922|594536987|FG001|Overall Study|Death|118|||
164593406|NCT03470922|594536986|FG000|Overall Study|Lost to Follow-up|5|||
164593407|NCT03470922|594536987|FG001|Overall Study|Lost to Follow-up|5|||
164593408|NCT03470922|594536986|FG000|Overall Study|Participant Withdrew Consent|4|||
164593409|NCT03470922|594536987|FG001|Overall Study|Participant Withdrew Consent|9|||
164593410|NCT03470922|594536986|FG000|Overall Study|Other reasons|1|||
164593411|NCT03470922|594536987|FG001|Overall Study|Other reasons|0|||
164593412|NCT03470922|594536986|FG000|Overall Study|Not reported|1|||
164593413|NCT03470922|594536987|FG001|Overall Study|Not reported|0|||
164593414|NCT02626819|594536988|FG000|Overall Study|Lost to Follow-up|3|||
164703640|NCT03502707|594941760|FG005|Overall Study|Sponsor's Decision|0|||
164703641|NCT03502707|594941761|FG006|Overall Study|Sponsor's Decision|0|||
164703642|NCT03502707|594941762|FG007|Overall Study|Sponsor's Decision|0|||
164703643|NCT03502707|594941763|FG008|Overall Study|Sponsor's Decision|0|||
164703644|NCT03502707|594941764|FG009|Overall Study|Sponsor's Decision|1|||
164703645|NCT03502707|594941765|FG010|Overall Study|Sponsor's Decision|0|||
164703646|NCT03502707|594941766|FG011|Overall Study|Sponsor's Decision|0|||
164703647|NCT03502707|594941767|FG012|Overall Study|Sponsor's Decision|0|||
164703648|NCT03502707|594941768|FG013|Overall Study|Sponsor's Decision|0|||
164703649|NCT03502707|594941769|FG014|Overall Study|Sponsor's Decision|0|||
164703650|NCT03502707|594941770|FG015|Overall Study|Sponsor's Decision|2|||
164703651|NCT03502707|594941771|FG016|Overall Study|Sponsor's Decision|1|||
164703652|NCT03502707|594941772|FG017|Overall Study|Sponsor's Decision|0|||
164703653|NCT03502707|594941755|FG000|Overall Study|Initiated Prohibited Medication|0|||
164703654|NCT03502707|594941756|FG001|Overall Study|Initiated Prohibited Medication|0|||
164703655|NCT03502707|594941757|FG002|Overall Study|Initiated Prohibited Medication|0|||
164703656|NCT03502707|594941758|FG003|Overall Study|Initiated Prohibited Medication|0|||
164703657|NCT03502707|594941759|FG004|Overall Study|Initiated Prohibited Medication|0|||
164703658|NCT03502707|594941760|FG005|Overall Study|Initiated Prohibited Medication|0|||
164703659|NCT03502707|594941761|FG006|Overall Study|Initiated Prohibited Medication|0|||
164703660|NCT03502707|594941762|FG007|Overall Study|Initiated Prohibited Medication|0|||
164703661|NCT03502707|594941763|FG008|Overall Study|Initiated Prohibited Medication|0|||
164703662|NCT03502707|594941764|FG009|Overall Study|Initiated Prohibited Medication|0|||
164703663|NCT03502707|594941765|FG010|Overall Study|Initiated Prohibited Medication|0|||
164703664|NCT03502707|594941766|FG011|Overall Study|Initiated Prohibited Medication|0|||
164703665|NCT03502707|594941767|FG012|Overall Study|Initiated Prohibited Medication|0|||
164703666|NCT03502707|594941768|FG013|Overall Study|Initiated Prohibited Medication|0|||
164703667|NCT03502707|594941769|FG014|Overall Study|Initiated Prohibited Medication|0|||
164703668|NCT03502707|594941770|FG015|Overall Study|Initiated Prohibited Medication|0|||
164703669|NCT03502707|594941771|FG016|Overall Study|Initiated Prohibited Medication|1|||
164703670|NCT03502707|594941772|FG017|Overall Study|Initiated Prohibited Medication|0|||
164703671|NCT03502707|594941755|FG000|Overall Study|Other|0|||
164703672|NCT03502707|594941756|FG001|Overall Study|Other|0|||
164703673|NCT03502707|594941757|FG002|Overall Study|Other|0|||
164703674|NCT03502707|594941758|FG003|Overall Study|Other|0|||
164703675|NCT03502707|594941759|FG004|Overall Study|Other|0|||
164703676|NCT03502707|594941760|FG005|Overall Study|Other|0|||
164703677|NCT03502707|594941761|FG006|Overall Study|Other|0|||
164703678|NCT03502707|594941762|FG007|Overall Study|Other|0|||
164703679|NCT03502707|594941763|FG008|Overall Study|Other|1|||
164703680|NCT03502707|594941764|FG009|Overall Study|Other|1|||
164703681|NCT03502707|594941765|FG010|Overall Study|Other|2|||
164703682|NCT03502707|594941766|FG011|Overall Study|Other|0|||
164703683|NCT03502707|594941767|FG012|Overall Study|Other|0|||
164703684|NCT03502707|594941768|FG013|Overall Study|Other|0|||
164703685|NCT03502707|594941769|FG014|Overall Study|Other|0|||
164703686|NCT03502707|594941770|FG015|Overall Study|Other|4|||
164703687|NCT03502707|594941771|FG016|Overall Study|Other|1|||
164703688|NCT03502707|594941772|FG017|Overall Study|Other|0|||
164703689|NCT03502707|594941755|FG000|Overall Study|Randomized but not vaccinated|0|||
164703690|NCT03502707|594941756|FG001|Overall Study|Randomized but not vaccinated|0|||
164703691|NCT03502707|594941757|FG002|Overall Study|Randomized but not vaccinated|0|||
164703692|NCT03502707|594941758|FG003|Overall Study|Randomized but not vaccinated|0|||
164703693|NCT03502707|594941759|FG004|Overall Study|Randomized but not vaccinated|0|||
164703694|NCT03502707|594941760|FG005|Overall Study|Randomized but not vaccinated|0|||
164703695|NCT03502707|594941761|FG006|Overall Study|Randomized but not vaccinated|0|||
164703696|NCT03502707|594941762|FG007|Overall Study|Randomized but not vaccinated|0|||
164703697|NCT03502707|594941763|FG008|Overall Study|Randomized but not vaccinated|0|||
164703698|NCT03502707|594941764|FG009|Overall Study|Randomized but not vaccinated|0|||
164703699|NCT03502707|594941765|FG010|Overall Study|Randomized but not vaccinated|0|||
164703700|NCT03502707|594941766|FG011|Overall Study|Randomized but not vaccinated|1|||
164703701|NCT03502707|594941767|FG012|Overall Study|Randomized but not vaccinated|0|||
164703702|NCT03502707|594941768|FG013|Overall Study|Randomized but not vaccinated|0|||
164703703|NCT03502707|594941769|FG014|Overall Study|Randomized but not vaccinated|0|||
164703704|NCT03502707|594941770|FG015|Overall Study|Randomized but not vaccinated|0|||
164703705|NCT03502707|594941771|FG016|Overall Study|Randomized but not vaccinated|0|||
164387604|NCT01490632|593788466|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
164387605|NCT01490632|593788467|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
164387606|NCT01490632|593788468|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
164387607|NCT01490632|593788469|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
164703706|NCT03502707|594941772|FG017|Overall Study|Randomized but not vaccinated|1|||
164703707|NCT04092894|594941773|FG000|Overall Study|Withdrawal by Subject|2|||
164387608|NCT01490632|593788470|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
164387609|NCT01490632|593788451|FG000|Part D: Re-Treatment Period|Death|0|||
164387610|NCT01490632|593788452|FG001|Part D: Re-Treatment Period|Death|0|||
164387611|NCT01490632|593788453|FG002|Part D: Re-Treatment Period|Death|0|||
164387612|NCT01490632|593788454|FG003|Part D: Re-Treatment Period|Death|0|||
164387613|NCT01490632|593788455|FG004|Part D: Re-Treatment Period|Death|0|||
164387614|NCT01490632|593788456|FG005|Part D: Re-Treatment Period|Death|0|||
164387615|NCT01490632|593788457|FG006|Part D: Re-Treatment Period|Death|0|||
164387616|NCT01490632|593788458|FG007|Part D: Re-Treatment Period|Death|0|||
164387617|NCT01490632|593788459|FG008|Part D: Re-Treatment Period|Death|0|||
164387618|NCT01490632|593788460|FG009|Part D: Re-Treatment Period|Death|0|||
164387619|NCT01490632|593788461|FG010|Part D: Re-Treatment Period|Death|0|||
164387620|NCT01490632|593788462|FG011|Part D: Re-Treatment Period|Death|0|||
164387621|NCT01490632|593788463|FG012|Part D: Re-Treatment Period|Death|0|||
164387622|NCT01490632|593788464|FG013|Part D: Re-Treatment Period|Death|0|||
164387623|NCT01490632|593788465|FG014|Part D: Re-Treatment Period|Death|0|||
164703708|NCT04092894|594941774|FG001|Overall Study|Withdrawal by Subject|4|||
164387624|NCT01490632|593788466|FG015|Part D: Re-Treatment Period|Death|0|||
164387625|NCT01490632|593788467|FG016|Part D: Re-Treatment Period|Death|0|||
164387626|NCT01490632|593788468|FG017|Part D: Re-Treatment Period|Death|0|||
164387627|NCT01490632|593788469|FG018|Part D: Re-Treatment Period|Death|1|||
164387628|NCT01490632|593788470|FG019|Part D: Re-Treatment Period|Death|0|||
164387629|NCT01490632|593788451|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387630|NCT01490632|593788452|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387631|NCT01490632|593788453|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387632|NCT01490632|593788454|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387633|NCT01490632|593788455|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387634|NCT01490632|593788456|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387635|NCT01490632|593788457|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387636|NCT01490632|593788458|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387637|NCT01490632|593788459|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387638|NCT01490632|593788460|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387639|NCT01490632|593788461|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387640|NCT01490632|593788462|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387641|NCT01490632|593788463|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387642|NCT01490632|593788464|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387643|NCT01490632|593788465|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387644|NCT01490632|593788466|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387645|NCT01490632|593788467|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387646|NCT01490632|593788468|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
164387647|NCT01490632|593788469|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
164387648|NCT01490632|593788470|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
164387649|NCT01490632|593788451|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387650|NCT01490632|593788452|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387651|NCT01490632|593788453|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387652|NCT01490632|593788454|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387653|NCT01490632|593788455|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387654|NCT01490632|593788456|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387655|NCT01490632|593788457|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387656|NCT01490632|593788458|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387657|NCT01490632|593788459|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387658|NCT01490632|593788460|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387659|NCT01490632|593788461|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387660|NCT01490632|593788462|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387661|NCT01490632|593788463|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387662|NCT01490632|593788464|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387663|NCT01490632|593788465|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387664|NCT01490632|593788466|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387665|NCT01490632|593788467|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387666|NCT01490632|593788468|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387667|NCT01490632|593788469|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
164387668|NCT01490632|593788470|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387669|NCT01490632|593788451|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
164387670|NCT01490632|593788452|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
164387671|NCT01490632|593788453|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
164387672|NCT01490632|593788454|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
164387673|NCT01490632|593788455|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
164703709|NCT04092894|594941773|FG000|Overall Study|Discontinued EEG after randomization|10|||
164387674|NCT01490632|593788456|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
164387675|NCT01490632|593788457|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
164387676|NCT01490632|593788458|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
164387677|NCT01490632|593788459|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
164387678|NCT01490632|593788460|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
164387679|NCT01490632|593788461|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
164387680|NCT01490632|593788462|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
164440568|NCT00419094|593980633|FG001|Overall Study|Other: Patient non-compliant|1|||
164440569|NCT00419094|593980632|FG000|Overall Study|Other: No contact for extended period|0|||
164440570|NCT00419094|593980633|FG001|Overall Study|Other: No contact for extended period|1|||
164440571|NCT02296424|593980634|FG000|Part 1|New therapy for study indication|0|||
164440572|NCT02296424|593980635|FG001|Part 1|New therapy for study indication|1|||
164440573|NCT02296424|593980636|FG002|Part 1|New therapy for study indication|0|||
164440574|NCT02296424|593980637|FG003|Part 1|New therapy for study indication|0|||
164440575|NCT02296424|593980634|FG000|Part 1|Protocol Violation|0|||
164440576|NCT02296424|593980635|FG001|Part 1|Protocol Violation|1|||
164703710|NCT04092894|594941774|FG001|Overall Study|Discontinued EEG after randomization|6|||
164703711|NCT01106014|594941779|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
164703712|NCT01106014|594941780|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
164703713|NCT01106014|594941779|FG000|Overall Study|Adverse Event|78|||
164703714|NCT01106014|594941780|FG001|Overall Study|Adverse Event|42|||
164703715|NCT01106014|594941779|FG000|Overall Study|Withdrawal by Subject|43|||
164703716|NCT01106014|594941780|FG001|Overall Study|Withdrawal by Subject|37|||
164703717|NCT01106014|594941779|FG000|Overall Study|Administrative reason|7|||
164703718|NCT01106014|594941780|FG001|Overall Study|Administrative reason|6|||
164703719|NCT01106014|594941779|FG000|Overall Study|Lost to Follow-up|2|||
164440577|NCT02296424|593980636|FG002|Part 1|Protocol Violation|0|||
164703720|NCT01106014|594941780|FG001|Overall Study|Lost to Follow-up|3|||
164703721|NCT02935686|594941781|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
164387681|NCT01490632|593788463|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
164387682|NCT01490632|593788464|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
164387683|NCT01490632|593788465|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
164387684|NCT01490632|593788466|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
164387685|NCT01490632|593788467|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
164387686|NCT01490632|593788468|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
164387687|NCT01490632|593788469|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
164387688|NCT01490632|593788470|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
164387689|NCT01490632|593788451|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
164387690|NCT01490632|593788452|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
164387691|NCT01490632|593788453|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
164387692|NCT01490632|593788454|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
164387693|NCT01490632|593788455|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
164387694|NCT01490632|593788456|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
164387695|NCT01490632|593788457|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
164387696|NCT01490632|593788458|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
164387697|NCT01490632|593788459|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
164387698|NCT01490632|593788460|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
164387699|NCT01490632|593788461|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
164387700|NCT01490632|593788462|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
164387701|NCT01490632|593788463|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
164387702|NCT01490632|593788464|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
164387703|NCT01490632|593788465|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
164387704|NCT01490632|593788466|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
164387705|NCT01490632|593788467|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
164387706|NCT01490632|593788468|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
164387707|NCT01490632|593788469|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
164387708|NCT01490632|593788470|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
164387709|NCT01490632|593788451|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387710|NCT01490632|593788452|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387711|NCT01490632|593788453|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387712|NCT01490632|593788454|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387713|NCT01490632|593788455|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387714|NCT01490632|593788456|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387715|NCT01490632|593788457|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387716|NCT01490632|593788458|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387717|NCT01490632|593788459|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164703722|NCT02935686|594941782|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
164703723|NCT02935686|594941783|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
164387718|NCT01490632|593788460|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387719|NCT01490632|593788461|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387720|NCT01490632|593788462|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387721|NCT01490632|593788463|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387722|NCT01490632|593788464|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164440578|NCT02296424|593980637|FG003|Part 1|Protocol Violation|0|||
164440579|NCT02296424|593980634|FG000|Part 1|Withdrawal by Subject|0|||
164703724|NCT02935686|594941784|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
164703725|NCT02935686|594941785|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
164593415|NCT02626819|594536989|FG001|Overall Study|Lost to Follow-up|2|||
164593416|NCT02626819|594536988|FG000|Overall Study|Withdrawal by Subject|1|||
164593417|NCT02626819|594536989|FG001|Overall Study|Withdrawal by Subject|0|||
164593418|NCT02626819|594536988|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
164593419|NCT02626819|594536989|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
164593420|NCT02330549|594536993|FG000|Overall Study|Adverse Event|1|||
164593421|NCT02330549|594536994|FG001|Overall Study|Adverse Event|0|||
164593422|NCT02330549|594536993|FG000|Overall Study|Subject withdrew consent|2|||
164593423|NCT02330549|594536994|FG001|Overall Study|Subject withdrew consent|1|||
164593424|NCT02330549|594536993|FG000|Overall Study|Failure to meet randomization criteria|1|||
164593425|NCT02330549|594536994|FG001|Overall Study|Failure to meet randomization criteria|0|||
164593426|NCT00745368|594536995|FG000|Overall Study|Unable to provide sample|3|||
164593427|NCT02364947|594536996|FG000|Overall Study|Withdrawal by Subject|10|||
164593428|NCT02364947|594536997|FG001|Overall Study|Withdrawal by Subject|8|||
164593429|NCT02364947|594536998|FG002|Overall Study|Withdrawal by Subject|9|||
164593430|NCT02364947|594536996|FG000|Overall Study|Adverse Event|45|||
164593431|NCT02364947|594536997|FG001|Overall Study|Adverse Event|33|||
164593432|NCT02364947|594536998|FG002|Overall Study|Adverse Event|11|||
164593433|NCT02364947|594536996|FG000|Overall Study|Protocol Violation|1|||
164593434|NCT02364947|594536997|FG001|Overall Study|Protocol Violation|1|||
164593435|NCT02364947|594536998|FG002|Overall Study|Protocol Violation|1|||
164593436|NCT02364947|594536996|FG000|Overall Study|Physician Decision|3|||
164593437|NCT02364947|594536997|FG001|Overall Study|Physician Decision|2|||
164593438|NCT02364947|594536998|FG002|Overall Study|Physician Decision|5|||
164593439|NCT02364947|594536996|FG000|Overall Study|Death|0|||
164593440|NCT02364947|594536997|FG001|Overall Study|Death|1|||
164593441|NCT02364947|594536998|FG002|Overall Study|Death|0|||
164593442|NCT02702518|594536999|FG000|Overall Study|Lost to Follow-up|3|||
164593443|NCT02702518|594537000|FG001|Overall Study|Lost to Follow-up|4|||
164593444|NCT00423085|594537001|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
164593445|NCT00423085|594537002|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
164593446|NCT00423085|594537003|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
164593447|NCT00423085|594537004|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
164593448|NCT00423085|594537001|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
164593449|NCT00423085|594537002|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
164593450|NCT00423085|594537003|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
164593451|NCT00423085|594537004|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
164593452|NCT00423085|594537001|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
164593453|NCT00423085|594537002|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
164593454|NCT00423085|594537003|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
164593455|NCT00423085|594537004|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
164593456|NCT00423085|594537001|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
164593457|NCT00423085|594537002|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
164593458|NCT00423085|594537003|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
164593459|NCT00423085|594537004|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
164593460|NCT00423085|594537001|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
164593461|NCT00423085|594537002|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
164593462|NCT00423085|594537003|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
164593463|NCT00423085|594537004|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
164593464|NCT00423085|594537001|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
164593465|NCT00423085|594537002|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
164593466|NCT00423085|594537003|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
164593467|NCT00423085|594537004|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
164593468|NCT00423085|594537001|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
164593469|NCT00423085|594537002|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
164703726|NCT02935686|594941781|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
164703727|NCT02935686|594941782|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
164703728|NCT02935686|594941783|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
164703729|NCT02935686|594941784|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
164593470|NCT00423085|594537003|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
164593471|NCT00423085|594537004|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
164593472|NCT00423085|594537001|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
164593473|NCT00423085|594537002|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
164593474|NCT00423085|594537003|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
164593475|NCT00423085|594537004|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
164593476|NCT00423085|594537001|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
164593477|NCT00423085|594537002|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
164703730|NCT02935686|594941785|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
164703731|NCT02935686|594941781|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
164703732|NCT02935686|594941782|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
164440580|NCT02296424|593980635|FG001|Part 1|Withdrawal by Subject|2|||
164440581|NCT02296424|593980636|FG002|Part 1|Withdrawal by Subject|0|||
164440582|NCT02296424|593980637|FG003|Part 1|Withdrawal by Subject|0|||
164440583|NCT02296424|593980634|FG000|Part 1|Study terminated by sponsor|0|||
164440584|NCT02296424|593980635|FG001|Part 1|Study terminated by sponsor|1|||
164440585|NCT02296424|593980636|FG002|Part 1|Study terminated by sponsor|0|||
164440586|NCT02296424|593980637|FG003|Part 1|Study terminated by sponsor|0|||
164440587|NCT02296424|593980634|FG000|Part 1|Adverse Event|2|||
164440588|NCT02296424|593980635|FG001|Part 1|Adverse Event|11|||
164440589|NCT02296424|593980636|FG002|Part 1|Adverse Event|0|||
164440590|NCT02296424|593980637|FG003|Part 1|Adverse Event|0|||
164440591|NCT02296424|593980634|FG000|Part 1|Lack of Efficacy|5|||
164440592|NCT02296424|593980635|FG001|Part 1|Lack of Efficacy|17|||
164440593|NCT02296424|593980636|FG002|Part 1|Lack of Efficacy|0|||
164440594|NCT02296424|593980637|FG003|Part 1|Lack of Efficacy|0|||
164440595|NCT02296424|593980634|FG000|Part 1|16 directly started part II|16|||
164440596|NCT02296424|593980635|FG001|Part 1|16 directly started part II|0|||
164440597|NCT02296424|593980636|FG002|Part 1|16 directly started part II|0|||
164440598|NCT02296424|593980637|FG003|Part 1|16 directly started part II|0|||
164440599|NCT02296424|593980634|FG000|Part 2|Lack of Efficacy|0|||
164440600|NCT02296424|593980635|FG001|Part 2|Lack of Efficacy|0|||
164440601|NCT02296424|593980636|FG002|Part 2|Lack of Efficacy|1|||
164440602|NCT02296424|593980637|FG003|Part 2|Lack of Efficacy|0|||
164440603|NCT02296424|593980634|FG000|Part 2|Adverse Event|0|||
164440604|NCT02296424|593980635|FG001|Part 2|Adverse Event|0|||
164440605|NCT02296424|593980636|FG002|Part 2|Adverse Event|1|||
164440606|NCT02296424|593980637|FG003|Part 2|Adverse Event|0|||
164440607|NCT02296424|593980634|FG000|Part 2|Lost to Follow-up|0|||
164440608|NCT02296424|593980635|FG001|Part 2|Lost to Follow-up|0|||
164440609|NCT02296424|593980636|FG002|Part 2|Lost to Follow-up|1|||
164440610|NCT02296424|593980637|FG003|Part 2|Lost to Follow-up|0|||
164440611|NCT00743444|593980638|FG000|First Intervention|Catheter placement problems|0|||
164440612|NCT00743444|593980639|FG001|First Intervention|Catheter placement problems|1|||
164440613|NCT00743444|593980638|FG000|Washout Period|Adverse Event|0|||
164440614|NCT00743444|593980639|FG001|Washout Period|Adverse Event|1|||
164440615|NCT01337635|593980648|FG000|Overall Study|Lost to Follow-up|0|||
164440616|NCT01337635|593980649|FG001|Overall Study|Lost to Follow-up|1|||
164440617|NCT03287622|593980652|FG000|Overall Study|Withdrawal by Subject|1|||
164440618|NCT03287622|593980653|FG001|Overall Study|Withdrawal by Subject|0|||
164440619|NCT03287622|593980652|FG000|Overall Study|Lost to Follow-up|27|||
164440620|NCT03287622|593980653|FG001|Overall Study|Lost to Follow-up|15|||
164593478|NCT00423085|594537003|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
164387723|NCT01490632|593788465|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387724|NCT01490632|593788466|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387725|NCT01490632|593788467|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387726|NCT01490632|593788468|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
164387727|NCT01490632|593788469|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
164387728|NCT01490632|593788470|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
164387729|NCT02332720|593788471|FG000|Part A and Part B|Lost to Follow-up|1|||
164387730|NCT02332720|593788472|FG001|Part A and Part B|Lost to Follow-up|0|||
164387731|NCT02332720|593788473|FG002|Part A and Part B|Lost to Follow-up|0|||
164387732|NCT02332720|593788474|FG003|Part A and Part B|Lost to Follow-up|0|||
164387733|NCT02332720|593788475|FG004|Part A and Part B|Lost to Follow-up|0|||
164387734|NCT02332720|593788476|FG005|Part A and Part B|Lost to Follow-up|2|||
164387735|NCT02332720|593788477|FG006|Part A and Part B|Lost to Follow-up|1|||
164387736|NCT02332720|593788478|FG007|Part A and Part B|Lost to Follow-up|1|||
164387737|NCT02332720|593788479|FG008|Part A and Part B|Lost to Follow-up|0|||
164387738|NCT02332720|593788480|FG009|Part A and Part B|Lost to Follow-up|0|||
164387739|NCT02332720|593788481|FG010|Part A and Part B|Lost to Follow-up|0|||
164387740|NCT02332720|593788482|FG011|Part A and Part B|Lost to Follow-up|0|||
164387741|NCT02332720|593788483|FG012|Part A and Part B|Lost to Follow-up|0|||
164387742|NCT02332720|593788484|FG013|Part A and Part B|Lost to Follow-up|0|||
164387743|NCT02332720|593788485|FG014|Part A and Part B|Lost to Follow-up|0|||
164387744|NCT02332720|593788486|FG015|Part A and Part B|Lost to Follow-up|1|||
164387745|NCT02332720|593788487|FG016|Part A and Part B|Lost to Follow-up|0|||
164387746|NCT02332720|593788488|FG017|Part A and Part B|Lost to Follow-up|0|||
164387747|NCT02332720|593788489|FG018|Part A and Part B|Lost to Follow-up|0|||
164440621|NCT03287622|593980652|FG000|Overall Study|No prescripion after surgery|28|||
164440622|NCT03287622|593980653|FG001|Overall Study|No prescripion after surgery|31|||
164440623|NCT03287622|593980652|FG000|Overall Study|prolonged Length of stay|2|||
164440624|NCT03287622|593980653|FG001|Overall Study|prolonged Length of stay|0|||
164440625|NCT03287622|593980652|FG000|Overall Study|surgery related|0|||
164440626|NCT03287622|593980653|FG001|Overall Study|surgery related|2|||
164440627|NCT03804918|593980662|FG000|Overall Study|Participant did not use the app|1|||
164440628|NCT00842257|593980663|FG000|Overall Study|Adverse Event|1|||
164440629|NCT03515304|593980666|FG000|Overall Study|Lost to Follow-up|0|||
164440630|NCT03515304|593980667|FG001|Overall Study|Lost to Follow-up|3|||
164440631|NCT02000817|593980673|FG000|Overall Study|Withdrawal by Subject|2|||
164440632|NCT02000817|593980674|FG001|Overall Study|Withdrawal by Subject|0|||
164440633|NCT02000817|593980675|FG002|Overall Study|Withdrawal by Subject|0|||
164440634|NCT02000817|593980676|FG003|Overall Study|Withdrawal by Subject|0|||
164440635|NCT02000817|593980673|FG000|Overall Study|Adverse Event|0|||
164440636|NCT02000817|593980674|FG001|Overall Study|Adverse Event|1|||
164440637|NCT02000817|593980675|FG002|Overall Study|Adverse Event|0|||
164440638|NCT02000817|593980676|FG003|Overall Study|Adverse Event|0|||
164440639|NCT02000817|593980673|FG000|Overall Study|Lost to Follow-up|0|||
164440640|NCT02000817|593980674|FG001|Overall Study|Lost to Follow-up|0|||
164440641|NCT02000817|593980675|FG002|Overall Study|Lost to Follow-up|1|||
164440642|NCT02000817|593980676|FG003|Overall Study|Lost to Follow-up|0|||
164440643|NCT00585533|593980677|FG000|Overall Study|objective or symptomatic progression|9|||
164440644|NCT03383146|593980678|FG000|Overall Study|Screen Failure|1|||
164440645|NCT03383146|593980679|FG001|Overall Study|Screen Failure|0|||
164440646|NCT03383146|593980678|FG000|Overall Study|Adverse Event|6|||
164440647|NCT03383146|593980679|FG001|Overall Study|Adverse Event|18|||
164440648|NCT03383146|593980678|FG000|Overall Study|Lack of Efficacy|0|||
164440649|NCT03383146|593980679|FG001|Overall Study|Lack of Efficacy|3|||
164440650|NCT03383146|593980678|FG000|Overall Study|Withdrawal by Subject|20|||
164440651|NCT03383146|593980679|FG001|Overall Study|Withdrawal by Subject|36|||
164440652|NCT03383146|593980678|FG000|Overall Study|Lost to Follow-up|5|||
164440653|NCT03383146|593980679|FG001|Overall Study|Lost to Follow-up|15|||
164440654|NCT03383146|593980678|FG000|Overall Study|Death|0|||
164440655|NCT03383146|593980679|FG001|Overall Study|Death|2|||
164440656|NCT03383146|593980678|FG000|Overall Study|Physician Decision|0|||
164440657|NCT03383146|593980679|FG001|Overall Study|Physician Decision|1|||
164440658|NCT03383146|593980678|FG000|Overall Study|Protocol Deviation|1|||
164440659|NCT03383146|593980679|FG001|Overall Study|Protocol Deviation|8|||
164440660|NCT03383146|593980678|FG000|Overall Study|Study Terminated by the Sponsor|48|||
164440661|NCT03383146|593980679|FG001|Overall Study|Study Terminated by the Sponsor|95|||
164440662|NCT03383146|593980678|FG000|Overall Study|Reason not Specified|4|||
164440663|NCT03383146|593980679|FG001|Overall Study|Reason not Specified|6|||
164440664|NCT03482011|593980681|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
164440665|NCT03482011|593980682|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
164440666|NCT03482011|593980683|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
164440667|NCT03482011|593980684|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
164440668|NCT03482011|593980685|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
164440669|NCT03482011|593980686|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
164440670|NCT03482011|593980687|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
164440671|NCT03482011|593980688|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
164440672|NCT03482011|593980681|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
164440673|NCT03482011|593980682|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
164440674|NCT03482011|593980683|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164440675|NCT03482011|593980684|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164440676|NCT03482011|593980685|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164440677|NCT03482011|593980686|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164440678|NCT03482011|593980687|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164703733|NCT02935686|594941783|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
164703734|NCT02935686|594941784|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
164703735|NCT02935686|594941785|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
164703736|NCT02935686|594941781|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
164703737|NCT02935686|594941782|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
164703738|NCT02935686|594941783|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
164703739|NCT02935686|594941784|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
164703740|NCT02935686|594941785|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
164703741|NCT02935686|594941781|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
164703742|NCT02935686|594941782|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
164440679|NCT03482011|593980688|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164440680|NCT03482011|593980681|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
164440681|NCT03482011|593980682|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
164440682|NCT03482011|593980683|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
164440683|NCT03482011|593980684|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
164440684|NCT03482011|593980685|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
164440685|NCT03482011|593980686|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
164440686|NCT03482011|593980687|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
164440687|NCT03482011|593980688|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
164440688|NCT03482011|593980681|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
164440689|NCT03482011|593980682|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
164440690|NCT03482011|593980683|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
164440691|NCT03482011|593980684|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
164440692|NCT03482011|593980685|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
164440693|NCT03482011|593980686|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
164440694|NCT03482011|593980687|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
164440695|NCT03482011|593980688|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
164440696|NCT03482011|593980681|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
164440697|NCT03482011|593980682|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
164440698|NCT03482011|593980683|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164440699|NCT03482011|593980684|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164440700|NCT03482011|593980685|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164440701|NCT03482011|593980686|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164387748|NCT02332720|593788490|FG019|Part A and Part B|Lost to Follow-up|0|||
164387749|NCT02332720|593788491|FG020|Part A and Part B|Lost to Follow-up|0|||
164387750|NCT02332720|593788492|FG021|Part A and Part B|Lost to Follow-up|0|||
164387751|NCT02332720|593788493|FG022|Part A and Part B|Lost to Follow-up|0|||
164387752|NCT02332720|593788471|FG000|Part A and Part B|Adverse Event|0|||
164387753|NCT02332720|593788472|FG001|Part A and Part B|Adverse Event|0|||
164387754|NCT02332720|593788473|FG002|Part A and Part B|Adverse Event|0|||
164387755|NCT02332720|593788474|FG003|Part A and Part B|Adverse Event|0|||
164440702|NCT03482011|593980687|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164440703|NCT03482011|593980688|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164440704|NCT03482011|593980681|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
164440705|NCT03482011|593980682|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
164440706|NCT03482011|593980683|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
164440707|NCT03482011|593980684|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
164440708|NCT03482011|593980685|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
164440709|NCT03482011|593980686|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
164440710|NCT03482011|593980687|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
164440711|NCT03482011|593980688|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
164440712|NCT03482011|593980681|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
164440713|NCT03482011|593980682|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
164440714|NCT03482011|593980683|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
164440715|NCT03482011|593980684|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
164440716|NCT03482011|593980685|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
164440717|NCT03482011|593980686|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
164440718|NCT03482011|593980687|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
164440719|NCT03482011|593980688|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
164440720|NCT03482011|593980681|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164440721|NCT03482011|593980682|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164440722|NCT03482011|593980683|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164440723|NCT03482011|593980684|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164440724|NCT03482011|593980685|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
164440725|NCT03482011|593980686|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164440726|NCT03482011|593980687|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164440727|NCT03482011|593980688|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
164440728|NCT03482011|593980681|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
164440729|NCT03482011|593980682|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
164440730|NCT03482011|593980683|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
164440731|NCT03482011|593980684|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
164440732|NCT03482011|593980685|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
164440733|NCT03482011|593980686|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
164440734|NCT03482011|593980687|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
164440735|NCT03482011|593980688|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
164440736|NCT03482011|593980681|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164440737|NCT03482011|593980682|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164440738|NCT03482011|593980683|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164440739|NCT03482011|593980684|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
164440740|NCT03482011|593980685|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
164440741|NCT03482011|593980686|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
164440742|NCT03482011|593980687|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
164440743|NCT03482011|593980688|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
164440744|NCT03482011|593980681|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
164440745|NCT03482011|593980682|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
164440746|NCT03482011|593980683|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
164593479|NCT00423085|594537004|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
164387756|NCT02332720|593788475|FG004|Part A and Part B|Adverse Event|0|||
164387757|NCT02332720|593788476|FG005|Part A and Part B|Adverse Event|0|||
164440747|NCT03482011|593980684|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
164440748|NCT03482011|593980685|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
164440749|NCT03482011|593980686|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
164440750|NCT03482011|593980687|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
164440751|NCT03482011|593980688|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
164440752|NCT03482011|593980681|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
164440753|NCT03482011|593980682|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
164440754|NCT03482011|593980683|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
164387758|NCT02332720|593788477|FG006|Part A and Part B|Adverse Event|0|||
164387759|NCT02332720|593788478|FG007|Part A and Part B|Adverse Event|0|||
164387760|NCT02332720|593788479|FG008|Part A and Part B|Adverse Event|0|||
164387761|NCT02332720|593788480|FG009|Part A and Part B|Adverse Event|0|||
164387762|NCT02332720|593788481|FG010|Part A and Part B|Adverse Event|0|||
164387763|NCT02332720|593788482|FG011|Part A and Part B|Adverse Event|0|||
164387764|NCT02332720|593788483|FG012|Part A and Part B|Adverse Event|0|||
164387765|NCT02332720|593788484|FG013|Part A and Part B|Adverse Event|0|||
164387766|NCT02332720|593788485|FG014|Part A and Part B|Adverse Event|0|||
164387767|NCT02332720|593788486|FG015|Part A and Part B|Adverse Event|0|||
164440755|NCT03482011|593980684|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
164440756|NCT03482011|593980685|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
164440757|NCT03482011|593980686|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
164440758|NCT03482011|593980687|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
164440759|NCT03482011|593980688|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
164440760|NCT03482011|593980681|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
164440761|NCT03482011|593980682|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
164440762|NCT03482011|593980683|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
164440763|NCT03482011|593980684|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
164440764|NCT03482011|593980685|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
164440765|NCT03482011|593980686|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
164440766|NCT03482011|593980687|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
164440767|NCT03482011|593980688|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
164440768|NCT03482011|593980681|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
164440769|NCT03482011|593980682|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
164440770|NCT03482011|593980683|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
164440771|NCT03482011|593980684|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
164440772|NCT03482011|593980685|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
164440773|NCT03482011|593980686|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
164440774|NCT03482011|593980687|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
164440775|NCT03482011|593980688|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
164440776|NCT03482011|593980681|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
164440777|NCT03482011|593980682|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
164440778|NCT03482011|593980683|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
164440779|NCT03482011|593980684|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
164440780|NCT03482011|593980685|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
164440781|NCT03482011|593980686|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
164440782|NCT03482011|593980687|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
164440783|NCT03482011|593980688|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
164440784|NCT00468052|593980689|FG000|Overall Study|Protocol Violation|7|||
164440785|NCT00468052|593980690|FG001|Overall Study|Protocol Violation|8|||
164440786|NCT00367055|593980691|FG000|Overall Study|Adverse Event|6|||
164440787|NCT00367055|593980692|FG001|Overall Study|Adverse Event|3|||
164440788|NCT00367055|593980691|FG000|Overall Study|Patient's Willing|3|||
164440789|NCT00367055|593980692|FG001|Overall Study|Patient's Willing|2|||
164440790|NCT00367055|593980691|FG000|Overall Study|Lack of Efficacy|1|||
164440791|NCT00367055|593980692|FG001|Overall Study|Lack of Efficacy|2|||
164440792|NCT00367055|593980691|FG000|Overall Study|Lost to Follow-up|1|||
164593480|NCT00423085|594537001|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
164593481|NCT00423085|594537002|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
164593482|NCT00423085|594537003|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
164387768|NCT02332720|593788487|FG016|Part A and Part B|Adverse Event|0|||
164387769|NCT02332720|593788488|FG017|Part A and Part B|Adverse Event|1|||
164387770|NCT02332720|593788489|FG018|Part A and Part B|Adverse Event|0|||
164387771|NCT02332720|593788490|FG019|Part A and Part B|Adverse Event|0|||
164387772|NCT02332720|593788491|FG020|Part A and Part B|Adverse Event|0|||
164387773|NCT02332720|593788492|FG021|Part A and Part B|Adverse Event|0|||
164387774|NCT02332720|593788493|FG022|Part A and Part B|Adverse Event|0|||
164387775|NCT02332720|593788471|FG000|Part A and Part B|Physician Decision|0|||
164387776|NCT02332720|593788472|FG001|Part A and Part B|Physician Decision|0|||
164387777|NCT02332720|593788473|FG002|Part A and Part B|Physician Decision|0|||
164387778|NCT02332720|593788474|FG003|Part A and Part B|Physician Decision|0|||
164387779|NCT02332720|593788475|FG004|Part A and Part B|Physician Decision|0|||
164387780|NCT02332720|593788476|FG005|Part A and Part B|Physician Decision|0|||
164387781|NCT02332720|593788477|FG006|Part A and Part B|Physician Decision|0|||
164387782|NCT02332720|593788478|FG007|Part A and Part B|Physician Decision|0|||
164387783|NCT02332720|593788479|FG008|Part A and Part B|Physician Decision|0|||
164387784|NCT02332720|593788480|FG009|Part A and Part B|Physician Decision|0|||
164387785|NCT02332720|593788481|FG010|Part A and Part B|Physician Decision|0|||
164387786|NCT02332720|593788482|FG011|Part A and Part B|Physician Decision|0|||
164387787|NCT02332720|593788483|FG012|Part A and Part B|Physician Decision|0|||
164387788|NCT02332720|593788484|FG013|Part A and Part B|Physician Decision|0|||
164440793|NCT00367055|593980692|FG001|Overall Study|Lost to Follow-up|1|||
164440794|NCT00367055|593980691|FG000|Overall Study|Protocol Violation|0|||
164440795|NCT00367055|593980692|FG001|Overall Study|Protocol Violation|1|||
164387789|NCT02332720|593788485|FG014|Part A and Part B|Physician Decision|0|||
164387790|NCT02332720|593788486|FG015|Part A and Part B|Physician Decision|0|||
164387791|NCT02332720|593788487|FG016|Part A and Part B|Physician Decision|0|||
164387792|NCT02332720|593788488|FG017|Part A and Part B|Physician Decision|0|||
164387793|NCT02332720|593788489|FG018|Part A and Part B|Physician Decision|1|||
164387794|NCT02332720|593788490|FG019|Part A and Part B|Physician Decision|0|||
164387795|NCT02332720|593788491|FG020|Part A and Part B|Physician Decision|0|||
164387796|NCT02332720|593788492|FG021|Part A and Part B|Physician Decision|0|||
164387797|NCT02332720|593788493|FG022|Part A and Part B|Physician Decision|0|||
164387798|NCT02332720|593788471|FG000|Part A and Part B|Withdrawal by Subject|0|||
164387799|NCT02332720|593788472|FG001|Part A and Part B|Withdrawal by Subject|0|||
164387800|NCT02332720|593788473|FG002|Part A and Part B|Withdrawal by Subject|0|||
164387801|NCT02332720|593788474|FG003|Part A and Part B|Withdrawal by Subject|0|||
164387802|NCT02332720|593788475|FG004|Part A and Part B|Withdrawal by Subject|0|||
164387803|NCT02332720|593788476|FG005|Part A and Part B|Withdrawal by Subject|1|||
164387804|NCT02332720|593788477|FG006|Part A and Part B|Withdrawal by Subject|0|||
164387805|NCT02332720|593788478|FG007|Part A and Part B|Withdrawal by Subject|0|||
164387806|NCT02332720|593788479|FG008|Part A and Part B|Withdrawal by Subject|0|||
164387807|NCT02332720|593788480|FG009|Part A and Part B|Withdrawal by Subject|0|||
164387808|NCT02332720|593788481|FG010|Part A and Part B|Withdrawal by Subject|0|||
164387809|NCT02332720|593788482|FG011|Part A and Part B|Withdrawal by Subject|0|||
164387810|NCT02332720|593788483|FG012|Part A and Part B|Withdrawal by Subject|0|||
164440796|NCT00367055|593980691|FG000|Overall Study|Stopping Criterion Met|0|||
164440797|NCT00367055|593980692|FG001|Overall Study|Stopping Criterion Met|1|||
164440798|NCT00367055|593980691|FG000|Overall Study|Participant Living too Far from Hospital|0|||
164440799|NCT00367055|593980692|FG001|Overall Study|Participant Living too Far from Hospital|1|||
164440800|NCT04707313|593980693|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
164440801|NCT04707313|593980694|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
164440802|NCT04707313|593980695|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
164440803|NCT04707313|593980696|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
164440804|NCT04707313|593980697|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
164440805|NCT04707313|593980698|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
164440806|NCT04707313|593980699|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
164440807|NCT04707313|593980700|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
164440808|NCT04707313|593980701|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
164440809|NCT04707313|593980702|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
164440810|NCT04707313|593980703|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
164440811|NCT04707313|593980704|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
164440812|NCT04707313|593980705|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
164440813|NCT04707313|593980693|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
164440814|NCT04707313|593980694|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
164440815|NCT04707313|593980695|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
164440816|NCT04707313|593980696|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
164440817|NCT04707313|593980697|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
164440818|NCT04707313|593980698|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
164387811|NCT02332720|593788484|FG013|Part A and Part B|Withdrawal by Subject|0|||
164387812|NCT02332720|593788485|FG014|Part A and Part B|Withdrawal by Subject|0|||
164387813|NCT02332720|593788486|FG015|Part A and Part B|Withdrawal by Subject|0|||
164387814|NCT02332720|593788487|FG016|Part A and Part B|Withdrawal by Subject|0|||
164387815|NCT02332720|593788488|FG017|Part A and Part B|Withdrawal by Subject|0|||
164387816|NCT02332720|593788489|FG018|Part A and Part B|Withdrawal by Subject|0|||
164387817|NCT02332720|593788490|FG019|Part A and Part B|Withdrawal by Subject|1|||
164387818|NCT02332720|593788491|FG020|Part A and Part B|Withdrawal by Subject|0|||
164387819|NCT02332720|593788492|FG021|Part A and Part B|Withdrawal by Subject|0|||
164387820|NCT02332720|593788493|FG022|Part A and Part B|Withdrawal by Subject|0|||
164387821|NCT05732454|593788494|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
164387822|NCT05732454|593788495|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
164387823|NCT05732454|593788494|FG000|Part 1: DB Period|Adverse Event|1|||
164387824|NCT05732454|593788495|FG001|Part 1: DB Period|Adverse Event|0|||
164387825|NCT05732454|593788494|FG000|Part 1: DB Period|Lost to Follow-up|1|||
164387826|NCT05732454|593788495|FG001|Part 1: DB Period|Lost to Follow-up|0|||
164387827|NCT05732454|593788494|FG000|Part 1: DB Period|Protocol Violation|0|||
164387828|NCT05732454|593788495|FG001|Part 1: DB Period|Protocol Violation|1|||
164387829|NCT05732454|593788494|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
164387830|NCT05732454|593788495|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
164387831|NCT05732454|593788494|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
164387832|NCT05732454|593788495|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
164387833|NCT05732454|593788494|FG000|Part 1: OLE Period|Adverse Event|0|||
164387834|NCT05732454|593788495|FG001|Part 1: OLE Period|Adverse Event|1|||
164387835|NCT05732454|593788494|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
164387836|NCT05732454|593788495|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
164387837|NCT03725982|593788498|FG000|First Intervention|Withdrawal by Subject|0|||
164387838|NCT03725982|593788499|FG001|First Intervention|Withdrawal by Subject|1|||
164387839|NCT03725982|593788498|FG000|First Intervention|Physician Decision|1|||
164387840|NCT03725982|593788499|FG001|First Intervention|Physician Decision|1|||
164387841|NCT05912400|593788500|FG000|Overall Study|Lost to Follow-up|1|||
164387842|NCT05912400|593788501|FG001|Overall Study|Lost to Follow-up|0|||
164387843|NCT05912400|593788500|FG000|Overall Study|Physician Decision|6|||
164387844|NCT05912400|593788501|FG001|Overall Study|Physician Decision|0|||
164387845|NCT05912400|593788500|FG000|Overall Study|Withdrawal by Subject|1|||
164387846|NCT05912400|593788501|FG001|Overall Study|Withdrawal by Subject|0|||
164387847|NCT00838110|593788505|FG000|Overall Study|Death|0|||
164387848|NCT00838110|593788506|FG001|Overall Study|Death|0|||
164387849|NCT00838110|593788507|FG002|Overall Study|Death|1|||
164387850|NCT00838110|593788508|FG003|Overall Study|Death|2|||
164387851|NCT00838110|593788505|FG000|Overall Study|Adverse Event|11|||
164387852|NCT00838110|593788506|FG001|Overall Study|Adverse Event|10|||
164387853|NCT00838110|593788507|FG002|Overall Study|Adverse Event|8|||
164387854|NCT00838110|593788508|FG003|Overall Study|Adverse Event|7|||
164387855|NCT00838110|593788505|FG000|Overall Study|Withdrawal by Subject|5|||
164387856|NCT00838110|593788506|FG001|Overall Study|Withdrawal by Subject|6|||
164387857|NCT00838110|593788507|FG002|Overall Study|Withdrawal by Subject|3|||
164387858|NCT00838110|593788508|FG003|Overall Study|Withdrawal by Subject|4|||
164387859|NCT00838110|593788505|FG000|Overall Study|Other|3|||
164387860|NCT00838110|593788506|FG001|Overall Study|Other|3|||
164387861|NCT00838110|593788507|FG002|Overall Study|Other|3|||
164387862|NCT00838110|593788508|FG003|Overall Study|Other|2|||
164387863|NCT00838110|593788505|FG000|Overall Study|Protocol Violation|0|||
164387864|NCT00838110|593788506|FG001|Overall Study|Protocol Violation|2|||
164387865|NCT00838110|593788507|FG002|Overall Study|Protocol Violation|1|||
164387866|NCT00838110|593788508|FG003|Overall Study|Protocol Violation|1|||
164387867|NCT00838110|593788505|FG000|Overall Study|Lost to Follow-up|3|||
164387868|NCT00838110|593788506|FG001|Overall Study|Lost to Follow-up|0|||
164387869|NCT00838110|593788507|FG002|Overall Study|Lost to Follow-up|0|||
164387870|NCT00838110|593788508|FG003|Overall Study|Lost to Follow-up|0|||
164387871|NCT00838110|593788505|FG000|Overall Study|Did not meet eligibility criteria|0|||
164387872|NCT00838110|593788506|FG001|Overall Study|Did not meet eligibility criteria|0|||
164387873|NCT00838110|593788507|FG002|Overall Study|Did not meet eligibility criteria|1|||
164387874|NCT00838110|593788508|FG003|Overall Study|Did not meet eligibility criteria|2|||
164387875|NCT00838110|593788505|FG000|Overall Study|Randomized but not treated|0|||
164387876|NCT00838110|593788506|FG001|Overall Study|Randomized but not treated|1|||
164387877|NCT00838110|593788507|FG002|Overall Study|Randomized but not treated|0|||
164387878|NCT00838110|593788508|FG003|Overall Study|Randomized but not treated|0|||
164387879|NCT00352365|593788509|FG000|Induction Therapy|Adverse Event|7|||
164387880|NCT00352365|593788509|FG000|Induction Therapy|Progression/Relapse|8|||
164387881|NCT00352365|593788509|FG000|Induction Therapy|Death|7|||
164387882|NCT00352365|593788509|FG000|Induction Therapy|Not protocol specified|1|||
164387883|NCT00352365|593788509|FG000|Induction Therapy|Not eligible|3|||
164387884|NCT00352365|593788509|FG000|Induction Therapy|Death before starting protocol therapy|1|||
164387885|NCT00352365|593788509|FG000|Maintenance Therapy|Progression/Relapse|3|||
164387886|NCT00352365|593788509|FG000|Maintenance Therapy|Death|2|||
164387887|NCT00352365|593788509|FG000|Maintenance Therapy|Not protocol specified|3|||
164387888|NCT00352365|593788509|FG000|Maintenance Therapy|Not eligible|4|||
164387889|NCT01262651|593788510|FG000|Overall Study|Adverse Event|40|||
164387890|NCT01262651|593788511|FG001|Overall Study|Adverse Event|35|||
164387891|NCT01262651|593788510|FG000|Overall Study|Withdrawal by Subject|15|||
164387892|NCT01262651|593788511|FG001|Overall Study|Withdrawal by Subject|11|||
164387893|NCT01262651|593788510|FG000|Overall Study|Withdrawal by Investigator|2|||
164387894|NCT01262651|593788511|FG001|Overall Study|Withdrawal by Investigator|2|||
164387895|NCT01262651|593788510|FG000|Overall Study|Met Withdrawal Criteria|1|||
164387896|NCT01262651|593788511|FG001|Overall Study|Met Withdrawal Criteria|0|||
164387897|NCT04743908|593788512|FG000|Overall Study|Death|1|||
164387898|NCT04743908|593788513|FG001|Overall Study|Death|0|||
164387899|NCT04743908|593788512|FG000|Overall Study|Lost to Follow-up|181|||
164387900|NCT04743908|593788513|FG001|Overall Study|Lost to Follow-up|180|||
164387901|NCT04743908|593788512|FG000|Overall Study|Withdrawal by Subject|1|||
164387902|NCT04743908|593788513|FG001|Overall Study|Withdrawal by Subject|2|||
164387903|NCT03822533|593788514|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
164387904|NCT03822533|593788515|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
164387905|NCT03822533|593788514|FG000|3 Month Follow-up|Lost to Follow-up|2|||
164387906|NCT03822533|593788515|FG001|3 Month Follow-up|Lost to Follow-up|2|||
164387907|NCT03822533|593788514|FG000|6 Month Follow-up|Lost to Follow-up|3|||
164387908|NCT03822533|593788515|FG001|6 Month Follow-up|Lost to Follow-up|0|||
164387909|NCT03822533|593788514|FG000|12 Month Follow-up|Lost to Follow-up|2|||
164387910|NCT03822533|593788515|FG001|12 Month Follow-up|Lost to Follow-up|3|||
164387911|NCT03822533|593788514|FG000|12 Month Follow-up|Pregnancy|0|||
164387912|NCT03822533|593788515|FG001|12 Month Follow-up|Pregnancy|1|||
164387913|NCT03822533|593788514|FG000|12 Month Follow-up|Surgery|2|||
164387914|NCT03822533|593788515|FG001|12 Month Follow-up|Surgery|0|||
164387915|NCT03822533|593788514|FG000|12 Month Follow-up|Wrong address|1|||
164387916|NCT03822533|593788515|FG001|12 Month Follow-up|Wrong address|0|||
164387917|NCT03822533|593788514|FG000|12 Month Follow-up|No symptoms|1|||
164593483|NCT00423085|594537004|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
164593484|NCT00423085|594537001|FG000|52-Week Open-Label Extension Phase|Death|0|||
164593485|NCT00423085|594537002|FG001|52-Week Open-Label Extension Phase|Death|0|||
164593486|NCT00423085|594537003|FG002|52-Week Open-Label Extension Phase|Death|0|||
164593487|NCT00423085|594537004|FG003|52-Week Open-Label Extension Phase|Death|2|||
164593488|NCT00853489|594537005|FG000|Overall Study|Lost to Follow-up|5|||
164593489|NCT00853489|594537006|FG001|Overall Study|Lost to Follow-up|2|||
164593490|NCT01725152|594537010|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
164593491|NCT01725152|594537011|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
164593492|NCT01725152|594537010|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
164593493|NCT01725152|594537011|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
164593494|NCT01725152|594537010|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
164593495|NCT01725152|594537011|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
164593496|NCT01725152|594537010|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
164593497|NCT01725152|594537011|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
164593498|NCT02420223|594537014|FG000|Overall Study|Adverse Event|1|||
164593499|NCT02420223|594537015|FG001|Overall Study|Adverse Event|0|||
164593500|NCT02420223|594537014|FG000|Overall Study|Physician Decision|0|||
164593501|NCT02420223|594537015|FG001|Overall Study|Physician Decision|2|||
164593502|NCT00769704|594537016|FG000|Overall Study|Lost to Follow-up|3|||
164593503|NCT00769704|594537017|FG001|Overall Study|Lost to Follow-up|2|||
164593504|NCT00769704|594537016|FG000|Overall Study|Death|95|||
164593505|NCT00769704|594537017|FG001|Overall Study|Death|190|||
164593506|NCT00769704|594537016|FG000|Overall Study|Withdrawal by Subject|12|||
164593507|NCT00769704|594537017|FG001|Overall Study|Withdrawal by Subject|5|||
164593508|NCT00769704|594537016|FG000|Overall Study|Other|1|||
164593509|NCT00769704|594537017|FG001|Overall Study|Other|2|||
164593510|NCT03010423|594537018|FG000|Overall Study|Study termination|8|||
164593511|NCT03484923|594537023|FG000|Overall Study|Adverse Event|3|||
164593512|NCT03484923|594537024|FG001|Overall Study|Adverse Event|3|||
164593513|NCT03484923|594537025|FG002|Overall Study|Adverse Event|5|||
164593514|NCT03484923|594537026|FG003|Overall Study|Adverse Event|11|||
164593515|NCT03484923|594537027|FG004|Overall Study|Adverse Event|1|||
164593516|NCT03484923|594537023|FG000|Overall Study|Death|2|||
164593517|NCT03484923|594537024|FG001|Overall Study|Death|2|||
164593518|NCT03484923|594537025|FG002|Overall Study|Death|3|||
164593519|NCT03484923|594537026|FG003|Overall Study|Death|0|||
164593520|NCT03484923|594537027|FG004|Overall Study|Death|1|||
164593521|NCT03484923|594537023|FG000|Overall Study|Physician Decision|6|||
164593522|NCT03484923|594537024|FG001|Overall Study|Physician Decision|7|||
164593523|NCT03484923|594537025|FG002|Overall Study|Physician Decision|6|||
164593524|NCT03484923|594537026|FG003|Overall Study|Physician Decision|3|||
164593525|NCT03484923|594537027|FG004|Overall Study|Physician Decision|2|||
164593526|NCT03484923|594537023|FG000|Overall Study|Progressive disease|33|||
164593527|NCT03484923|594537024|FG001|Overall Study|Progressive disease|28|||
164593528|NCT03484923|594537025|FG002|Overall Study|Progressive disease|26|||
164593529|NCT03484923|594537026|FG003|Overall Study|Progressive disease|30|||
164593530|NCT03484923|594537027|FG004|Overall Study|Progressive disease|16|||
164593531|NCT03484923|594537023|FG000|Overall Study|Subject Decision|1|||
164593532|NCT03484923|594537024|FG001|Overall Study|Subject Decision|3|||
164593533|NCT03484923|594537025|FG002|Overall Study|Subject Decision|3|||
164593534|NCT03484923|594537026|FG003|Overall Study|Subject Decision|0|||
164593535|NCT03484923|594537027|FG004|Overall Study|Subject Decision|1|||
164593536|NCT03439748|594537028|FG000|Overall Study|Withdrawal by Subject|11|||
164593537|NCT03439748|594537029|FG001|Overall Study|Withdrawal by Subject|17|||
164593538|NCT01856595|594537030|FG000|Overall Study|Withdrawal by Subject|0|||
164593539|NCT01856595|594537031|FG001|Overall Study|Withdrawal by Subject|1|||
164593540|NCT01856595|594537032|FG002|Overall Study|Withdrawal by Subject|0|||
164593541|NCT01856595|594537033|FG003|Overall Study|Withdrawal by Subject|0|||
164593542|NCT01856595|594537034|FG004|Overall Study|Withdrawal by Subject|0|||
164593543|NCT01856595|594537035|FG005|Overall Study|Withdrawal by Subject|0|||
164593544|NCT01856595|594537036|FG006|Overall Study|Withdrawal by Subject|1|||
164593545|NCT01856595|594537037|FG007|Overall Study|Withdrawal by Subject|0|||
164593546|NCT01856595|594537038|FG008|Overall Study|Withdrawal by Subject|0|||
164593547|NCT01863849|594537044|FG000|Overall Study|Lost to Follow-up|1|||
164593548|NCT01863849|594537045|FG001|Overall Study|Lost to Follow-up|0|||
164593549|NCT00913978|594537048|FG000|Overall Study|Surgeon choice|1|||
164593550|NCT00913978|594537049|FG001|Overall Study|Surgeon choice|3|||
164593551|NCT04716933|594537050|FG000|Overall Study|Sponsor Decision|36|||
164593552|NCT04716933|594537051|FG001|Overall Study|Sponsor Decision|33|||
164593553|NCT04716933|594537050|FG000|Overall Study|Death|65|||
164593554|NCT04716933|594537051|FG001|Overall Study|Death|67|||
164593555|NCT01327651|594537052|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
164593556|NCT01327651|594537053|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
164703743|NCT02935686|594941783|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
164703744|NCT02935686|594941784|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
164703745|NCT02935686|594941785|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
164387918|NCT03822533|593788515|FG001|12 Month Follow-up|No symptoms|0|||
164387919|NCT03822533|593788514|FG000|12 Month Follow-up|Changed primary care center|0|||
164387920|NCT03822533|593788515|FG001|12 Month Follow-up|Changed primary care center|1|||
164387921|NCT01412944|593788518|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
164387922|NCT01412944|593788519|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
164387923|NCT01412944|593788520|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
164387924|NCT01412944|593788521|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
164387925|NCT01412944|593788522|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
164387926|NCT01412944|593788523|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
164387927|NCT01412944|593788518|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
164387928|NCT01412944|593788519|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
164387929|NCT01412944|593788520|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
164387930|NCT01412944|593788521|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
164387931|NCT01412944|593788522|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
164387932|NCT01412944|593788523|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
164387933|NCT01412944|593788518|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
164387934|NCT01412944|593788519|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
164387935|NCT01412944|593788520|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
164387936|NCT01412944|593788521|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
164387937|NCT01412944|593788522|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
164387938|NCT01412944|593788523|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
164387939|NCT01412944|593788518|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
164387940|NCT01412944|593788519|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
164387941|NCT01412944|593788520|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
164387942|NCT01412944|593788521|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
164387943|NCT01412944|593788522|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
164387944|NCT01412944|593788523|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
164387945|NCT01412944|593788518|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
164387946|NCT01412944|593788519|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
164387947|NCT01412944|593788520|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
164387948|NCT01412944|593788521|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
164387949|NCT01412944|593788522|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
164387950|NCT01412944|593788523|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
164387951|NCT01412944|593788518|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
164387952|NCT01412944|593788519|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
164387953|NCT01412944|593788520|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
164387954|NCT01412944|593788521|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
164387955|NCT01412944|593788522|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
164387956|NCT01412944|593788523|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
164387957|NCT01412944|593788518|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
164387958|NCT01412944|593788519|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
164387959|NCT01412944|593788520|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
164387960|NCT01412944|593788521|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
164387961|NCT01412944|593788522|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
164387962|NCT01412944|593788523|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
164387963|NCT01412944|593788518|FG000|Entire: IV + Maintenance|Adverse Event|0|||
164387964|NCT01412944|593788519|FG001|Entire: IV + Maintenance|Adverse Event|0|||
164387965|NCT01412944|593788520|FG002|Entire: IV + Maintenance|Adverse Event|0|||
164387966|NCT01412944|593788521|FG003|Entire: IV + Maintenance|Adverse Event|0|||
164387967|NCT01412944|593788522|FG004|Entire: IV + Maintenance|Adverse Event|1|||
164387968|NCT01412944|593788523|FG005|Entire: IV + Maintenance|Adverse Event|0|||
164387969|NCT01412944|593788518|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
164387970|NCT01412944|593788519|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
164387971|NCT01412944|593788520|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
164387972|NCT01412944|593788521|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
164387973|NCT01412944|593788522|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
164387974|NCT01412944|593788523|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
164440819|NCT04707313|593980699|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
164440820|NCT04707313|593980700|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
164440821|NCT04707313|593980701|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
164387975|NCT01412944|593788518|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
164387976|NCT01412944|593788519|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
164387977|NCT01412944|593788520|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
164387978|NCT01412944|593788521|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
164387979|NCT01412944|593788522|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
164387980|NCT01412944|593788523|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
164387981|NCT01412944|593788518|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
164387982|NCT01412944|593788519|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
164387983|NCT01412944|593788520|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
164387984|NCT01412944|593788521|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
164387985|NCT01412944|593788522|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
164387986|NCT01412944|593788523|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
164387987|NCT01412944|593788518|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
164387988|NCT01412944|593788519|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
164387989|NCT01412944|593788520|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
164387990|NCT01412944|593788521|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
164387991|NCT01412944|593788522|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
164387992|NCT01412944|593788523|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
164387993|NCT01412944|593788518|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
164387994|NCT01412944|593788519|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
164387995|NCT01412944|593788520|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
164387996|NCT01412944|593788521|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
164387997|NCT01412944|593788522|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
164387998|NCT01412944|593788523|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
164387999|NCT01412944|593788518|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
164388000|NCT01412944|593788519|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
164388001|NCT01412944|593788520|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
164388002|NCT01412944|593788521|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
164388003|NCT01412944|593788522|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
164388004|NCT01412944|593788523|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
164388005|NCT01412944|593788518|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
164388006|NCT01412944|593788519|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
164388007|NCT01412944|593788520|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
164388008|NCT01412944|593788521|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
164388009|NCT01412944|593788522|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
164388010|NCT01412944|593788523|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
164388011|NCT01412944|593788518|FG000|Entire: IV + Maintenance|Adverse Event|0|||
164388012|NCT01412944|593788519|FG001|Entire: IV + Maintenance|Adverse Event|1|||
164388013|NCT01412944|593788520|FG002|Entire: IV + Maintenance|Adverse Event|0|||
164388014|NCT01412944|593788521|FG003|Entire: IV + Maintenance|Adverse Event|0|||
164388015|NCT01412944|593788522|FG004|Entire: IV + Maintenance|Adverse Event|0|||
164388016|NCT01412944|593788523|FG005|Entire: IV + Maintenance|Adverse Event|0|||
164388017|NCT01990950|593788524|FG000|Overall Study|Death|3|||
164388018|NCT01990950|593788524|FG000|Overall Study|Lost to Follow-up|2|||
164388019|NCT01990950|593788524|FG000|Overall Study|Withdrawal by Subject|6|||
164388020|NCT02863926|593788525|FG000|Overall Study|Physician Decision|1|||
164388021|NCT02863926|593788526|FG001|Overall Study|Physician Decision|0|||
164388022|NCT02863926|593788525|FG000|Overall Study|Lost to Follow-up|1|||
164388023|NCT02863926|593788526|FG001|Overall Study|Lost to Follow-up|1|||
164388024|NCT02019719|593788532|FG000|Overall Study|Adverse Event|1|||
164388025|NCT02019719|593788533|FG001|Overall Study|Adverse Event|0|||
164388026|NCT02019719|593788534|FG002|Overall Study|Adverse Event|0|||
164388027|NCT02019719|593788535|FG003|Overall Study|Adverse Event|1|||
164388028|NCT02019719|593788536|FG004|Overall Study|Adverse Event|1|||
164388029|NCT02019719|593788532|FG000|Overall Study|Protocol Violation|1|||
164388030|NCT02019719|593788533|FG001|Overall Study|Protocol Violation|1|||
164388031|NCT02019719|593788534|FG002|Overall Study|Protocol Violation|0|||
164388032|NCT02019719|593788535|FG003|Overall Study|Protocol Violation|0|||
164388033|NCT02019719|593788536|FG004|Overall Study|Protocol Violation|0|||
164388034|NCT02019719|593788532|FG000|Overall Study|Protocol defined stopping criteria|2|||
164388035|NCT02019719|593788533|FG001|Overall Study|Protocol defined stopping criteria|0|||
164388036|NCT02019719|593788534|FG002|Overall Study|Protocol defined stopping criteria|0|||
164388037|NCT02019719|593788535|FG003|Overall Study|Protocol defined stopping criteria|1|||
164388038|NCT02019719|593788536|FG004|Overall Study|Protocol defined stopping criteria|1|||
164388039|NCT02019719|593788532|FG000|Overall Study|Physician Decision|2|||
164388040|NCT02019719|593788533|FG001|Overall Study|Physician Decision|0|||
164388041|NCT02019719|593788534|FG002|Overall Study|Physician Decision|0|||
164388042|NCT02019719|593788535|FG003|Overall Study|Physician Decision|0|||
164388043|NCT02019719|593788536|FG004|Overall Study|Physician Decision|0|||
164440822|NCT04707313|593980702|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
164440823|NCT04707313|593980703|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
164440824|NCT04707313|593980704|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
164440825|NCT04707313|593980705|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
164388044|NCT02417246|593788537|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
164388045|NCT02417246|593788538|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
164388046|NCT02417246|593788537|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
164388047|NCT02417246|593788538|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
164388048|NCT02417246|593788537|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
164388049|NCT02417246|593788538|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
164388050|NCT02417246|593788537|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
164388051|NCT02417246|593788538|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
164388052|NCT01921348|593788543|FG000|Overall Study|Withdrawal by Subject|1|||
164388053|NCT01921348|593788544|FG001|Overall Study|Withdrawal by Subject|0|||
164593557|NCT01327651|594537054|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
164593558|NCT01327651|594537055|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
164593559|NCT01327651|594537056|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
164388054|NCT01921348|593788543|FG000|Overall Study|Lost to Follow-up|0|||
164388055|NCT01921348|593788544|FG001|Overall Study|Lost to Follow-up|2|||
164388056|NCT02896855|593788547|FG000|Overall Study|Death|50|||
164388057|NCT02896855|593788548|FG001|Overall Study|Death|40|||
164388058|NCT02896855|593788547|FG000|Overall Study|Lost to Follow-up|15|||
164593560|NCT01327651|594537057|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
164593561|NCT01327651|594537058|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
164593562|NCT01327651|594537059|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
164593563|NCT01327651|594537060|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
164593564|NCT01327651|594537052|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
164593565|NCT01327651|594537053|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
164593566|NCT01327651|594537054|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
164593567|NCT01327651|594537055|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
164593568|NCT01327651|594537056|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
164593569|NCT01327651|594537057|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
164593570|NCT01327651|594537058|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
164593571|NCT01327651|594537059|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
164593572|NCT01327651|594537060|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
164593573|NCT01327651|594537052|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
164593574|NCT01327651|594537053|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
164593575|NCT01327651|594537054|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
164593576|NCT01327651|594537055|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
164593577|NCT01327651|594537056|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
164593578|NCT01327651|594537057|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
164593579|NCT01327651|594537058|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
164593580|NCT01327651|594537059|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
164593581|NCT01327651|594537060|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
164593582|NCT01327651|594537052|FG000|Post Study Follow-up|Lost to Follow-up|0|||
164593583|NCT01327651|594537053|FG001|Post Study Follow-up|Lost to Follow-up|1|||
164593584|NCT01327651|594537054|FG002|Post Study Follow-up|Lost to Follow-up|1|||
164593585|NCT01327651|594537055|FG003|Post Study Follow-up|Lost to Follow-up|0|||
164593586|NCT01327651|594537056|FG004|Post Study Follow-up|Lost to Follow-up|0|||
164593587|NCT01327651|594537057|FG005|Post Study Follow-up|Lost to Follow-up|0|||
164593588|NCT01327651|594537058|FG006|Post Study Follow-up|Lost to Follow-up|4|||
164593589|NCT01327651|594537059|FG007|Post Study Follow-up|Lost to Follow-up|1|||
164593590|NCT01327651|594537060|FG008|Post Study Follow-up|Lost to Follow-up|2|||
164593591|NCT03249792|594537061|FG000|Arms 1, 2, and 4|Death|1|||
164593592|NCT03249792|594537062|FG001|Arms 1, 2, and 4|Death|1|||
164593593|NCT03249792|594537063|FG002|Arms 1, 2, and 4|Death|0|||
164593594|NCT03249792|594537064|FG003|Arms 1, 2, and 4|Death|2|||
164593595|NCT03249792|594537065|FG004|Arms 1, 2, and 4|Death|3|||
164593596|NCT03249792|594537066|FG005|Arms 1, 2, and 4|Death|2|||
164593597|NCT03249792|594537067|FG006|Arms 1, 2, and 4|Death|2|||
164593598|NCT03249792|594537068|FG007|Arms 1, 2, and 4|Death|4|||
164593599|NCT03249792|594537069|FG008|Arms 1, 2, and 4|Death|2|||
164593600|NCT03249792|594537070|FG009|Arms 1, 2, and 4|Death|1|||
164593601|NCT03249792|594537071|FG010|Arms 1, 2, and 4|Death|7|||
164593602|NCT03249792|594537072|FG011|Arms 1, 2, and 4|Death|7|||
164593603|NCT03249792|594537073|FG012|Arms 1, 2, and 4|Death|12|||
164593604|NCT03249792|594537074|FG013|Arms 1, 2, and 4|Death|7|||
164593605|NCT03249792|594537075|FG014|Arms 1, 2, and 4|Death|0|||
164593606|NCT03249792|594537076|FG015|Arms 1, 2, and 4|Death|4|||
164593607|NCT03249792|594537077|FG016|Arms 1, 2, and 4|Death|4|||
164593608|NCT03249792|594537078|FG017|Arms 1, 2, and 4|Death|12|||
164593609|NCT03249792|594537079|FG018|Arms 1, 2, and 4|Death|6|||
164593610|NCT03249792|594537080|FG019|Arms 1, 2, and 4|Death|4|||
164593611|NCT03249792|594537081|FG020|Arms 1, 2, and 4|Death|2|||
164593612|NCT03249792|594537082|FG021|Arms 1, 2, and 4|Death|3|||
164593613|NCT03249792|594537083|FG022|Arms 1, 2, and 4|Death|1|||
164388059|NCT02896855|593788548|FG001|Overall Study|Lost to Follow-up|9|||
164593614|NCT03249792|594537084|FG023|Arms 1, 2, and 4|Death|1|||
164593615|NCT03249792|594537085|FG024|Arms 1, 2, and 4|Death|4|||
164593616|NCT03249792|594537086|FG025|Arms 1, 2, and 4|Death|0|||
164593617|NCT03249792|594537087|FG026|Arms 1, 2, and 4|Death|0|||
164593618|NCT03249792|594537088|FG027|Arms 1, 2, and 4|Death|0|||
164593619|NCT03249792|594537089|FG028|Arms 1, 2, and 4|Death|0|||
164593620|NCT03249792|594537090|FG029|Arms 1, 2, and 4|Death|0|||
164593621|NCT03249792|594537091|FG030|Arms 1, 2, and 4|Death|0|||
164388060|NCT02896855|593788547|FG000|Overall Study|Withdrawal by Subject|7|||
164440826|NCT04707313|593980693|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
164593622|NCT03249792|594537092|FG031|Arms 1, 2, and 4|Death|0|||
164388061|NCT02896855|593788548|FG001|Overall Study|Withdrawal by Subject|4|||
164388062|NCT01205685|593788549|FG000|Overall Study|Disease Progression|10|||
164593623|NCT03249792|594537093|FG032|Arms 1, 2, and 4|Death|0|||
164388063|NCT01205685|593788549|FG000|Overall Study|Withdrawal by Subject|1|||
164388064|NCT02169674|593788550|FG000|Overall Study|Withdrawal by Subject|2|||
164388065|NCT02169674|593788551|FG001|Overall Study|Withdrawal by Subject|1|||
164388066|NCT02169674|593788550|FG000|Overall Study|Seroprotected|30|||
164388067|NCT02169674|593788551|FG001|Overall Study|Seroprotected|76|||
164388068|NCT02169674|593788550|FG000|Overall Study|Lost to Follow-up|0|||
164388069|NCT02169674|593788551|FG001|Overall Study|Lost to Follow-up|1|||
164388070|NCT03525834|593788554|FG000|Overall Study|Progressive disease|1|||
164388071|NCT00941603|593788557|FG000|Overall Study|Adverse Event|10|||
164388072|NCT00941603|593788558|FG001|Overall Study|Adverse Event|15|||
164440827|NCT04707313|593980694|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
164440828|NCT04707313|593980695|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
164440829|NCT04707313|593980696|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
164440830|NCT04707313|593980697|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
164440831|NCT04707313|593980698|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
164440832|NCT04707313|593980699|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
164388073|NCT00941603|593788559|FG002|Overall Study|Adverse Event|5|||
164440833|NCT04707313|593980700|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
164388074|NCT00941603|593788560|FG003|Overall Study|Adverse Event|1|||
164440834|NCT04707313|593980701|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
164440835|NCT04707313|593980702|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
164440836|NCT04707313|593980703|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
164440837|NCT04707313|593980704|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
164440838|NCT04707313|593980705|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
164440839|NCT04707313|593980693|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
164440840|NCT04707313|593980694|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
164440841|NCT04707313|593980695|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
164440842|NCT04707313|593980696|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
164440843|NCT04707313|593980697|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
164440844|NCT04707313|593980698|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
164440845|NCT04707313|593980699|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
164440846|NCT04707313|593980700|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
164440847|NCT04707313|593980701|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
164440848|NCT04707313|593980702|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
164440849|NCT04707313|593980703|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
164440850|NCT04707313|593980704|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
164440851|NCT04707313|593980705|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
164440852|NCT04707313|593980693|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
164440853|NCT04707313|593980694|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
164440854|NCT04707313|593980695|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
164440855|NCT04707313|593980696|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
164440856|NCT04707313|593980697|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
164440857|NCT04707313|593980698|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
164440858|NCT04707313|593980699|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
164440859|NCT04707313|593980700|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
164440860|NCT04707313|593980701|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
164440861|NCT04707313|593980702|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
164593624|NCT03249792|594537061|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164593625|NCT03249792|594537062|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164593626|NCT03249792|594537063|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
164593627|NCT03249792|594537064|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164593628|NCT03249792|594537065|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164593629|NCT03249792|594537066|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
164593630|NCT03249792|594537067|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
164593631|NCT03249792|594537068|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164593632|NCT03249792|594537069|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
164593633|NCT03249792|594537070|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
164593634|NCT03249792|594537071|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
164593635|NCT03249792|594537072|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
164593636|NCT03249792|594537073|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
164593637|NCT03249792|594537074|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
164593638|NCT03249792|594537075|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164593639|NCT03249792|594537076|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164593640|NCT03249792|594537077|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
164703746|NCT02935686|594941781|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
164703747|NCT02935686|594941782|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
164703748|NCT02935686|594941783|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
164703749|NCT02935686|594941784|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
164703750|NCT02935686|594941785|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
164703751|NCT02935686|594941781|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
164388075|NCT00941603|593788561|FG004|Overall Study|Adverse Event|4|||
164388076|NCT00941603|593788562|FG005|Overall Study|Adverse Event|0|||
164388077|NCT00941603|593788557|FG000|Overall Study|Lost to Follow-up|0|||
164388078|NCT00941603|593788558|FG001|Overall Study|Lost to Follow-up|0|||
164388079|NCT00941603|593788559|FG002|Overall Study|Lost to Follow-up|0|||
164388080|NCT00941603|593788560|FG003|Overall Study|Lost to Follow-up|1|||
164388081|NCT00941603|593788561|FG004|Overall Study|Lost to Follow-up|0|||
164388082|NCT00941603|593788562|FG005|Overall Study|Lost to Follow-up|2|||
164388083|NCT00941603|593788557|FG000|Overall Study|Withdrawal by Subject|0|||
164388084|NCT00941603|593788558|FG001|Overall Study|Withdrawal by Subject|0|||
164388085|NCT00941603|593788559|FG002|Overall Study|Withdrawal by Subject|0|||
164388086|NCT00941603|593788560|FG003|Overall Study|Withdrawal by Subject|2|||
164388087|NCT00941603|593788561|FG004|Overall Study|Withdrawal by Subject|0|||
164388088|NCT00941603|593788562|FG005|Overall Study|Withdrawal by Subject|1|||
164388089|NCT00941603|593788557|FG000|Overall Study|Protocol Violation|0|||
164388090|NCT00941603|593788558|FG001|Overall Study|Protocol Violation|1|||
164388091|NCT00941603|593788559|FG002|Overall Study|Protocol Violation|0|||
164388092|NCT00941603|593788560|FG003|Overall Study|Protocol Violation|0|||
164388093|NCT00941603|593788561|FG004|Overall Study|Protocol Violation|0|||
164388094|NCT00941603|593788562|FG005|Overall Study|Protocol Violation|0|||
164388095|NCT00941603|593788557|FG000|Overall Study|Did not meet protocol eligibility|1|||
164388096|NCT00941603|593788558|FG001|Overall Study|Did not meet protocol eligibility|0|||
164388097|NCT00941603|593788559|FG002|Overall Study|Did not meet protocol eligibility|0|||
164388098|NCT00941603|593788560|FG003|Overall Study|Did not meet protocol eligibility|0|||
164388099|NCT00941603|593788561|FG004|Overall Study|Did not meet protocol eligibility|0|||
164388100|NCT00941603|593788562|FG005|Overall Study|Did not meet protocol eligibility|0|||
164388101|NCT03879798|593788565|FG000|Overall Study|Adverse Event|0|||
164388102|NCT03879798|593788566|FG001|Overall Study|Adverse Event|0|||
164388103|NCT03879798|593788567|FG002|Overall Study|Adverse Event|0|||
164388104|NCT03879798|593788568|FG003|Overall Study|Adverse Event|0|||
164388105|NCT03879798|593788569|FG004|Overall Study|Adverse Event|0|||
164388106|NCT03879798|593788570|FG005|Overall Study|Adverse Event|1|||
164388107|NCT03879798|593788565|FG000|Overall Study|Lack of Efficacy|0|||
164388108|NCT03879798|593788566|FG001|Overall Study|Lack of Efficacy|0|||
164388109|NCT03879798|593788567|FG002|Overall Study|Lack of Efficacy|0|||
164388110|NCT03879798|593788568|FG003|Overall Study|Lack of Efficacy|0|||
164388111|NCT03879798|593788569|FG004|Overall Study|Lack of Efficacy|0|||
164388112|NCT03879798|593788570|FG005|Overall Study|Lack of Efficacy|1|||
164388113|NCT03879798|593788565|FG000|Overall Study|Withdrawal by Subject|0|||
164388114|NCT03879798|593788566|FG001|Overall Study|Withdrawal by Subject|0|||
164388115|NCT03879798|593788567|FG002|Overall Study|Withdrawal by Subject|0|||
164388116|NCT03879798|593788568|FG003|Overall Study|Withdrawal by Subject|0|||
164388117|NCT03879798|593788569|FG004|Overall Study|Withdrawal by Subject|0|||
164388118|NCT03879798|593788570|FG005|Overall Study|Withdrawal by Subject|1|||
164388119|NCT01343407|593788571|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
164388120|NCT01343407|593788572|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
164388121|NCT01343407|593788573|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
164388122|NCT01343407|593788574|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
164388123|NCT01343407|593788575|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
164388124|NCT01343407|593788576|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
164388125|NCT01343407|593788571|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
164388126|NCT01343407|593788572|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
164388127|NCT01343407|593788573|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
164388128|NCT01343407|593788574|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
164388129|NCT01343407|593788575|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
164388130|NCT01343407|593788576|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
164388131|NCT06027216|593788577|FG000|Overall Study|Did not qualify|8|||
164388132|NCT01732835|593788581|FG000|6-month Primary Endpoint|Did not receive device|19|||
164440862|NCT04707313|593980703|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
164388133|NCT01732835|593788581|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
164440863|NCT04707313|593980704|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
164440864|NCT04707313|593980705|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
164388134|NCT01732835|593788581|FG000|6-month Primary Endpoint|Adverse Event|3|||
164388135|NCT01732835|593788581|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
164388136|NCT01732835|593788581|FG000|2-year Extended Follow-up|Adverse Event|3|||
164388137|NCT01732835|593788581|FG000|2-year Extended Follow-up|Death|1|||
164388138|NCT00874029|593788586|FG000|Overall Study|Withdrawal by Subject|10|||
164388139|NCT00874029|593788586|FG000|Overall Study|Pregnancy|4|||
164388140|NCT00874029|593788586|FG000|Overall Study|Physician Decision|1|||
164388141|NCT00874029|593788586|FG000|Overall Study|Adverse Event|1|||
164388142|NCT00874029|593788586|FG000|Overall Study|Lost to Follow-up|5|||
164388143|NCT01767116|593788587|FG000|Overall Study|Lost to Follow-up|2|||
164388144|NCT01767116|593788588|FG001|Overall Study|Lost to Follow-up|2|||
164388145|NCT00968669|593788589|FG000|Overall Study|Lost to Follow-up|5|||
164388146|NCT00968669|593788590|FG001|Overall Study|Lost to Follow-up|2|||
164388147|NCT00968669|593788591|FG002|Overall Study|Lost to Follow-up|1|||
164388148|NCT00968669|593788592|FG003|Overall Study|Lost to Follow-up|4|||
164388149|NCT00968669|593788589|FG000|Overall Study|Withdrawal by Subject|9|||
164388150|NCT00968669|593788590|FG001|Overall Study|Withdrawal by Subject|7|||
164388151|NCT00968669|593788591|FG002|Overall Study|Withdrawal by Subject|5|||
164388152|NCT00968669|593788592|FG003|Overall Study|Withdrawal by Subject|3|||
164388153|NCT00968669|593788589|FG000|Overall Study|Pregnancy|0|||
164388154|NCT00968669|593788590|FG001|Overall Study|Pregnancy|0|||
164593641|NCT03249792|594537078|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164593642|NCT03249792|594537079|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
164593643|NCT03249792|594537080|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164593644|NCT03249792|594537081|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164593645|NCT03249792|594537082|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164593646|NCT03249792|594537083|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
164593647|NCT03249792|594537084|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
164593648|NCT03249792|594537085|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164593649|NCT03249792|594537086|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164593650|NCT03249792|594537087|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164593651|NCT03249792|594537088|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164593652|NCT03249792|594537089|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164593653|NCT03249792|594537090|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164593654|NCT03249792|594537091|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164593655|NCT03249792|594537092|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164593656|NCT03249792|594537093|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164593657|NCT03249792|594537061|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
164593658|NCT03249792|594537062|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
164593659|NCT03249792|594537063|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
164593660|NCT03249792|594537064|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
164593661|NCT03249792|594537065|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
164593662|NCT03249792|594537066|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
164593663|NCT03249792|594537067|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
164593664|NCT03249792|594537068|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
164593665|NCT03249792|594537069|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
164593666|NCT03249792|594537070|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
164593667|NCT03249792|594537071|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
164593668|NCT03249792|594537072|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
164593669|NCT03249792|594537073|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
164593670|NCT03249792|594537074|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
164593671|NCT03249792|594537075|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
164593672|NCT03249792|594537076|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
164593673|NCT03249792|594537077|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
164593674|NCT03249792|594537078|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
164593675|NCT03249792|594537079|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
164593676|NCT03249792|594537080|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
164593677|NCT03249792|594537081|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
164593678|NCT03249792|594537082|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
164593679|NCT03249792|594537083|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
164593680|NCT03249792|594537084|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
164593681|NCT03249792|594537085|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
164593682|NCT03249792|594537086|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
164593683|NCT03249792|594537087|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
164593684|NCT03249792|594537088|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
164593685|NCT03249792|594537089|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
164593686|NCT03249792|594537090|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
164388155|NCT00968669|593788591|FG002|Overall Study|Pregnancy|2|||
164388156|NCT00968669|593788592|FG003|Overall Study|Pregnancy|0|||
164388157|NCT00968669|593788589|FG000|Overall Study|AE|1|||
164388158|NCT00968669|593788590|FG001|Overall Study|AE|0|||
164388159|NCT00968669|593788591|FG002|Overall Study|AE|0|||
164388160|NCT00968669|593788592|FG003|Overall Study|AE|0|||
164388161|NCT00968669|593788589|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
164388162|NCT00968669|593788590|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
164388163|NCT00968669|593788591|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
164388164|NCT00968669|593788592|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
164388165|NCT00968669|593788589|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
164388166|NCT00968669|593788590|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
164388167|NCT00968669|593788591|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
164593687|NCT03249792|594537091|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
164388168|NCT00968669|593788592|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
164388169|NCT00968669|593788589|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
164593688|NCT03249792|594537092|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
164593689|NCT03249792|594537093|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
164593690|NCT03249792|594537061|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
164144034|NCT00086281|592888573|FG002|Phase 2|Adverse Event|0|||
164593691|NCT03249792|594537062|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593692|NCT03249792|594537063|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
164388170|NCT00968669|593788590|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
164388171|NCT00968669|593788591|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
164388172|NCT00968669|593788592|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
164388173|NCT00968669|593788589|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
164388174|NCT00968669|593788590|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
164388175|NCT00968669|593788591|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
164388176|NCT00968669|593788592|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
164388177|NCT00968669|593788589|FG000|Overall Study|EARLY WITHDRAWAL|0|||
164388178|NCT00968669|593788590|FG001|Overall Study|EARLY WITHDRAWAL|1|||
164388179|NCT00968669|593788591|FG002|Overall Study|EARLY WITHDRAWAL|0|||
164388180|NCT00968669|593788592|FG003|Overall Study|EARLY WITHDRAWAL|0|||
164388181|NCT00968669|593788589|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
164388182|NCT00968669|593788590|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
164388183|NCT00968669|593788591|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
164388184|NCT00968669|593788592|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
164388185|NCT00968669|593788589|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
164388186|NCT00968669|593788590|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
164388187|NCT00968669|593788591|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
164388188|NCT00968669|593788592|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
164388189|NCT00968669|593788589|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
164388190|NCT00968669|593788590|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
164388191|NCT00968669|593788591|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
164388192|NCT00968669|593788592|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
164388193|NCT00968669|593788589|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
164388194|NCT00968669|593788590|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
164388195|NCT00968669|593788591|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
164388196|NCT00968669|593788592|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
164388197|NCT00968669|593788589|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
164388198|NCT00968669|593788590|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
164440865|NCT04707313|593980693|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
164440866|NCT04707313|593980694|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
164440867|NCT04707313|593980695|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
164440868|NCT04707313|593980696|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
164440869|NCT04707313|593980697|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
164440870|NCT04707313|593980698|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
164440871|NCT04707313|593980699|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
164440872|NCT04707313|593980700|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
164440873|NCT04707313|593980701|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
164440874|NCT04707313|593980702|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
164440875|NCT04707313|593980703|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
164440876|NCT04707313|593980704|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
164440877|NCT04707313|593980705|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
164440878|NCT04707313|593980693|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
164440879|NCT04707313|593980694|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
164440880|NCT04707313|593980695|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
164440881|NCT04707313|593980696|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
164440882|NCT04707313|593980697|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
164440883|NCT04707313|593980698|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
164440884|NCT04707313|593980699|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
164440885|NCT04707313|593980700|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
164440886|NCT04707313|593980701|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
164440887|NCT04707313|593980702|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
164440888|NCT04707313|593980703|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
164440889|NCT04707313|593980704|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
164440890|NCT04707313|593980705|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
164440891|NCT04707313|593980693|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
164440892|NCT04707313|593980694|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
164593693|NCT03249792|594537064|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593694|NCT03249792|594537065|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593695|NCT03249792|594537066|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593696|NCT03249792|594537067|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593697|NCT03249792|594537068|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
164388199|NCT00968669|593788591|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
164388200|NCT00968669|593788592|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
164388201|NCT00968669|593788589|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
164388202|NCT00968669|593788590|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
164388203|NCT00968669|593788591|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
164388204|NCT00968669|593788592|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
164388205|NCT00968669|593788589|FG000|Overall Study|SPONSOR DECISION|0|||
164593698|NCT03249792|594537069|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
164593699|NCT03249792|594537070|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593700|NCT03249792|594537071|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593701|NCT03249792|594537072|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593702|NCT03249792|594537073|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593703|NCT03249792|594537074|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593704|NCT03249792|594537075|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593705|NCT03249792|594537076|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593706|NCT03249792|594537077|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
164593707|NCT03249792|594537078|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
164593708|NCT03249792|594537079|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593709|NCT03249792|594537080|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
164593710|NCT03249792|594537081|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593711|NCT03249792|594537082|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593712|NCT03249792|594537083|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593713|NCT03249792|594537084|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593714|NCT03249792|594537085|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593715|NCT03249792|594537086|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593716|NCT03249792|594537087|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593717|NCT03249792|594537088|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593718|NCT03249792|594537089|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593719|NCT03249792|594537090|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593720|NCT03249792|594537091|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593721|NCT03249792|594537092|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593722|NCT03249792|594537093|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
164593723|NCT03249792|594537061|FG000|Switch Over Period|Withdrawal by Subject|0|||
164593724|NCT03249792|594537062|FG001|Switch Over Period|Withdrawal by Subject|0|||
164593725|NCT03249792|594537063|FG002|Switch Over Period|Withdrawal by Subject|0|||
164593726|NCT03249792|594537064|FG003|Switch Over Period|Withdrawal by Subject|0|||
164593727|NCT03249792|594537065|FG004|Switch Over Period|Withdrawal by Subject|0|||
164593728|NCT03249792|594537066|FG005|Switch Over Period|Withdrawal by Subject|0|||
164593729|NCT03249792|594537067|FG006|Switch Over Period|Withdrawal by Subject|0|||
164593730|NCT03249792|594537068|FG007|Switch Over Period|Withdrawal by Subject|0|||
164593731|NCT03249792|594537069|FG008|Switch Over Period|Withdrawal by Subject|0|||
164593732|NCT03249792|594537070|FG009|Switch Over Period|Withdrawal by Subject|0|||
164593733|NCT03249792|594537071|FG010|Switch Over Period|Withdrawal by Subject|0|||
164593734|NCT03249792|594537072|FG011|Switch Over Period|Withdrawal by Subject|0|||
164593735|NCT03249792|594537073|FG012|Switch Over Period|Withdrawal by Subject|0|||
164593736|NCT03249792|594537074|FG013|Switch Over Period|Withdrawal by Subject|0|||
164593737|NCT03249792|594537075|FG014|Switch Over Period|Withdrawal by Subject|0|||
164593738|NCT03249792|594537076|FG015|Switch Over Period|Withdrawal by Subject|0|||
164593739|NCT03249792|594537077|FG016|Switch Over Period|Withdrawal by Subject|0|||
164593740|NCT03249792|594537078|FG017|Switch Over Period|Withdrawal by Subject|0|||
164593741|NCT03249792|594537079|FG018|Switch Over Period|Withdrawal by Subject|0|||
164593742|NCT03249792|594537080|FG019|Switch Over Period|Withdrawal by Subject|0|||
164593743|NCT03249792|594537081|FG020|Switch Over Period|Withdrawal by Subject|0|||
164593744|NCT03249792|594537082|FG021|Switch Over Period|Withdrawal by Subject|0|||
164593745|NCT03249792|594537083|FG022|Switch Over Period|Withdrawal by Subject|0|||
164593746|NCT03249792|594537084|FG023|Switch Over Period|Withdrawal by Subject|0|||
164593747|NCT03249792|594537085|FG024|Switch Over Period|Withdrawal by Subject|0|||
164593748|NCT03249792|594537086|FG025|Switch Over Period|Withdrawal by Subject|0|||
164593749|NCT03249792|594537087|FG026|Switch Over Period|Withdrawal by Subject|0|||
164593750|NCT03249792|594537088|FG027|Switch Over Period|Withdrawal by Subject|0|||
164593751|NCT03249792|594537089|FG028|Switch Over Period|Withdrawal by Subject|0|||
164593752|NCT03249792|594537090|FG029|Switch Over Period|Withdrawal by Subject|0|||
164593753|NCT03249792|594537091|FG030|Switch Over Period|Withdrawal by Subject|0|||
164703752|NCT02935686|594941782|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
164703753|NCT02935686|594941783|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
164593754|NCT03249792|594537092|FG031|Switch Over Period|Withdrawal by Subject|1|||
164593755|NCT03249792|594537093|FG032|Switch Over Period|Withdrawal by Subject|0|||
164703754|NCT02935686|594941784|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
164703755|NCT02935686|594941785|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
164703756|NCT02935686|594941781|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
164703757|NCT02935686|594941782|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
164703758|NCT02935686|594941783|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
164703759|NCT02935686|594941784|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
164703760|NCT02935686|594941785|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
164703761|NCT02935686|594941781|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
164703762|NCT02935686|594941782|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
164593756|NCT03249792|594537061|FG000|Switch Over Period|Progressive Disease|0|||
164593757|NCT03249792|594537062|FG001|Switch Over Period|Progressive Disease|0|||
164593758|NCT03249792|594537063|FG002|Switch Over Period|Progressive Disease|0|||
164593759|NCT03249792|594537064|FG003|Switch Over Period|Progressive Disease|0|||
164593760|NCT03249792|594537065|FG004|Switch Over Period|Progressive Disease|0|||
164593761|NCT03249792|594537066|FG005|Switch Over Period|Progressive Disease|0|||
164593762|NCT03249792|594537067|FG006|Switch Over Period|Progressive Disease|0|||
164593763|NCT03249792|594537068|FG007|Switch Over Period|Progressive Disease|0|||
164593764|NCT03249792|594537069|FG008|Switch Over Period|Progressive Disease|0|||
164593765|NCT03249792|594537070|FG009|Switch Over Period|Progressive Disease|0|||
164593766|NCT03249792|594537071|FG010|Switch Over Period|Progressive Disease|0|||
164593767|NCT03249792|594537072|FG011|Switch Over Period|Progressive Disease|0|||
164593768|NCT03249792|594537073|FG012|Switch Over Period|Progressive Disease|0|||
164593769|NCT03249792|594537074|FG013|Switch Over Period|Progressive Disease|0|||
164593770|NCT03249792|594537075|FG014|Switch Over Period|Progressive Disease|0|||
164593771|NCT03249792|594537076|FG015|Switch Over Period|Progressive Disease|0|||
164593772|NCT03249792|594537077|FG016|Switch Over Period|Progressive Disease|0|||
164593773|NCT03249792|594537078|FG017|Switch Over Period|Progressive Disease|0|||
164593774|NCT03249792|594537079|FG018|Switch Over Period|Progressive Disease|0|||
164593775|NCT03249792|594537080|FG019|Switch Over Period|Progressive Disease|0|||
164593776|NCT03249792|594537081|FG020|Switch Over Period|Progressive Disease|0|||
164593777|NCT03249792|594537082|FG021|Switch Over Period|Progressive Disease|0|||
164593778|NCT03249792|594537083|FG022|Switch Over Period|Progressive Disease|0|||
164593779|NCT03249792|594537084|FG023|Switch Over Period|Progressive Disease|0|||
164593780|NCT03249792|594537085|FG024|Switch Over Period|Progressive Disease|0|||
164593781|NCT03249792|594537086|FG025|Switch Over Period|Progressive Disease|0|||
164593782|NCT03249792|594537087|FG026|Switch Over Period|Progressive Disease|1|||
164593783|NCT03249792|594537088|FG027|Switch Over Period|Progressive Disease|0|||
164593784|NCT03249792|594537089|FG028|Switch Over Period|Progressive Disease|1|||
164593785|NCT03249792|594537090|FG029|Switch Over Period|Progressive Disease|2|||
164593786|NCT03249792|594537091|FG030|Switch Over Period|Progressive Disease|1|||
164593787|NCT03249792|594537092|FG031|Switch Over Period|Progressive Disease|0|||
164593788|NCT03249792|594537093|FG032|Switch Over Period|Progressive Disease|1|||
164593789|NCT03249792|594537061|FG000|Switch Over Period|Adverse Event|0|||
164593790|NCT03249792|594537062|FG001|Switch Over Period|Adverse Event|0|||
164593791|NCT03249792|594537063|FG002|Switch Over Period|Adverse Event|0|||
164593792|NCT03249792|594537064|FG003|Switch Over Period|Adverse Event|0|||
164593793|NCT03249792|594537065|FG004|Switch Over Period|Adverse Event|0|||
164593794|NCT03249792|594537066|FG005|Switch Over Period|Adverse Event|0|||
164593795|NCT03249792|594537067|FG006|Switch Over Period|Adverse Event|0|||
164593796|NCT03249792|594537068|FG007|Switch Over Period|Adverse Event|0|||
164593797|NCT03249792|594537069|FG008|Switch Over Period|Adverse Event|0|||
164593798|NCT03249792|594537070|FG009|Switch Over Period|Adverse Event|0|||
164593799|NCT03249792|594537071|FG010|Switch Over Period|Adverse Event|0|||
164593800|NCT03249792|594537072|FG011|Switch Over Period|Adverse Event|0|||
164593801|NCT03249792|594537073|FG012|Switch Over Period|Adverse Event|0|||
164593802|NCT03249792|594537074|FG013|Switch Over Period|Adverse Event|0|||
164593803|NCT03249792|594537075|FG014|Switch Over Period|Adverse Event|0|||
164593804|NCT03249792|594537076|FG015|Switch Over Period|Adverse Event|0|||
164593805|NCT03249792|594537077|FG016|Switch Over Period|Adverse Event|0|||
164593806|NCT03249792|594537078|FG017|Switch Over Period|Adverse Event|0|||
164593807|NCT03249792|594537079|FG018|Switch Over Period|Adverse Event|0|||
164593808|NCT03249792|594537080|FG019|Switch Over Period|Adverse Event|0|||
164593809|NCT03249792|594537081|FG020|Switch Over Period|Adverse Event|0|||
164593810|NCT03249792|594537082|FG021|Switch Over Period|Adverse Event|0|||
164593811|NCT03249792|594537083|FG022|Switch Over Period|Adverse Event|0|||
164593812|NCT03249792|594537084|FG023|Switch Over Period|Adverse Event|0|||
164593813|NCT03249792|594537085|FG024|Switch Over Period|Adverse Event|0|||
164593814|NCT03249792|594537086|FG025|Switch Over Period|Adverse Event|1|||
164593815|NCT03249792|594537087|FG026|Switch Over Period|Adverse Event|0|||
164593816|NCT03249792|594537088|FG027|Switch Over Period|Adverse Event|1|||
164593817|NCT03249792|594537089|FG028|Switch Over Period|Adverse Event|0|||
164593818|NCT03249792|594537090|FG029|Switch Over Period|Adverse Event|0|||
164593819|NCT03249792|594537091|FG030|Switch Over Period|Adverse Event|0|||
164593820|NCT03249792|594537092|FG031|Switch Over Period|Adverse Event|0|||
164593821|NCT03249792|594537093|FG032|Switch Over Period|Adverse Event|0|||
164593822|NCT01409031|594537095|FG000|Overall Study|transferred to other hosp|1|||
164593823|NCT01409031|594537096|FG001|Overall Study|transferred to other hosp|0|||
164593824|NCT00532948|594537097|FG000|Overall Study|Protocol Violation|1|||
164593825|NCT00532948|594537098|FG001|Overall Study|Protocol Violation|0|||
164593826|NCT00532948|594537099|FG002|Overall Study|Protocol Violation|0|||
164703763|NCT02935686|594941783|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
164388206|NCT00968669|593788590|FG001|Overall Study|SPONSOR DECISION|1|||
164388207|NCT00968669|593788591|FG002|Overall Study|SPONSOR DECISION|0|||
164388208|NCT00968669|593788592|FG003|Overall Study|SPONSOR DECISION|0|||
164593827|NCT00532948|594537097|FG000|Overall Study|Death|3|||
164593828|NCT00532948|594537098|FG001|Overall Study|Death|3|||
164593829|NCT00532948|594537099|FG002|Overall Study|Death|4|||
164593830|NCT00532948|594537097|FG000|Overall Study|Violation of selection criteria at entry|0|||
164593831|NCT00532948|594537098|FG001|Overall Study|Violation of selection criteria at entry|1|||
164593832|NCT00532948|594537099|FG002|Overall Study|Violation of selection criteria at entry|0|||
164593833|NCT00532948|594537097|FG000|Overall Study|Failure to return|0|||
164593834|NCT00532948|594537098|FG001|Overall Study|Failure to return|1|||
164388209|NCT00968669|593788589|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
164388210|NCT00968669|593788590|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
164388211|NCT00968669|593788591|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
164388212|NCT00968669|593788592|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
164388213|NCT00968669|593788589|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
164388214|NCT00968669|593788590|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
164388215|NCT00968669|593788591|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
164388216|NCT00968669|593788592|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
164388217|NCT00968669|593788589|FG000|Overall Study|SUBJECT INCARCERATED|0|||
164388218|NCT00968669|593788590|FG001|Overall Study|SUBJECT INCARCERATED|1|||
164388219|NCT00968669|593788591|FG002|Overall Study|SUBJECT INCARCERATED|0|||
164388220|NCT00968669|593788592|FG003|Overall Study|SUBJECT INCARCERATED|0|||
164388221|NCT00968669|593788589|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
164388222|NCT00968669|593788590|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
164388223|NCT00968669|593788591|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
164440893|NCT04707313|593980695|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
164440894|NCT04707313|593980696|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
164440895|NCT04707313|593980697|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
164440896|NCT04707313|593980698|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
164440897|NCT04707313|593980699|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
164440898|NCT04707313|593980700|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
164440899|NCT04707313|593980701|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
164440900|NCT04707313|593980702|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
164440901|NCT04707313|593980703|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
164440902|NCT04707313|593980704|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
164440903|NCT04707313|593980705|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
164440904|NCT04707313|593980693|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
164440905|NCT04707313|593980694|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
164440906|NCT04707313|593980695|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
164440907|NCT04707313|593980696|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
164440908|NCT04707313|593980697|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
164440909|NCT04707313|593980698|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
164440910|NCT04707313|593980699|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
164440911|NCT04707313|593980700|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
164440912|NCT04707313|593980701|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
164440913|NCT04707313|593980702|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
164440914|NCT04707313|593980703|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
164440915|NCT04707313|593980704|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
164440916|NCT04707313|593980705|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
164440917|NCT04707313|593980693|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
164440918|NCT04707313|593980694|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
164440919|NCT04707313|593980695|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
164440920|NCT04707313|593980696|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
164440921|NCT04707313|593980697|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
164440922|NCT04707313|593980698|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
164440923|NCT04707313|593980699|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
164440924|NCT04707313|593980700|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
164440925|NCT04707313|593980701|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
164440926|NCT04707313|593980702|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
164440927|NCT04707313|593980703|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
164440928|NCT04707313|593980704|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
164440929|NCT04707313|593980705|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
164440930|NCT04707313|593980693|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
164440931|NCT04707313|593980694|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
164440932|NCT04707313|593980695|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
164440933|NCT04707313|593980696|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
164440934|NCT04707313|593980697|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
164440935|NCT04707313|593980698|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
164388224|NCT00968669|593788592|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
164388225|NCT00968669|593788589|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
164440936|NCT04707313|593980699|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
164440937|NCT04707313|593980700|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
164440938|NCT04707313|593980701|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
164440939|NCT04707313|593980702|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
164440940|NCT04707313|593980703|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
164440941|NCT04707313|593980704|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
164388226|NCT00968669|593788590|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
164440942|NCT04707313|593980705|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
164440943|NCT04707313|593980693|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
164388227|NCT00968669|593788591|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
164388228|NCT00968669|593788592|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
164388229|NCT04798586|593788595|FG000|Overall Study|Death|2|||
164388230|NCT01669343|593788597|FG000|Part A: All Patients|Withdrawal by Subject|7|||
164388231|NCT01669343|593788597|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
164388232|NCT01669343|593788597|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
164388233|NCT01669343|593788597|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
164388234|NCT01669343|593788597|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
164388235|NCT00968617|593788598|FG000|Overall Study|Study terminated by sponsor|6|||
164388236|NCT04433767|593788599|FG000|Overall Study|Adverse Event|1|||
164388237|NCT02371369|593788604|FG000|Part 1|Physician Decision|0|||
164440944|NCT04707313|593980694|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
164440945|NCT04707313|593980695|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
164440946|NCT04707313|593980696|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
164440947|NCT04707313|593980697|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
164440948|NCT04707313|593980698|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
164440949|NCT04707313|593980699|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
164440950|NCT04707313|593980700|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
164440951|NCT04707313|593980701|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
164440952|NCT04707313|593980702|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
164440953|NCT04707313|593980703|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
164440954|NCT04707313|593980704|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
164440955|NCT04707313|593980705|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
164440956|NCT04707313|593980693|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
164440957|NCT04707313|593980694|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
164440958|NCT04707313|593980695|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
164440959|NCT04707313|593980696|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
164440960|NCT04707313|593980697|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
164388238|NCT02371369|593788605|FG001|Part 1|Physician Decision|3|||
164388239|NCT02371369|593788604|FG000|Part 1|Adverse Event|8|||
164388240|NCT02371369|593788605|FG001|Part 1|Adverse Event|0|||
164440961|NCT04707313|593980698|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
164440962|NCT04707313|593980699|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
164440963|NCT04707313|593980700|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
164440964|NCT04707313|593980701|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
164440965|NCT04707313|593980702|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
164440966|NCT04707313|593980703|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
164440967|NCT04707313|593980704|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
164440968|NCT04707313|593980705|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
164388241|NCT02371369|593788604|FG000|Part 1|Withdrawal by Subject|1|||
164440969|NCT04707313|593980693|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
164440970|NCT04707313|593980694|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
164440971|NCT04707313|593980695|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
164440972|NCT04707313|593980696|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
164440973|NCT04707313|593980697|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
164440974|NCT04707313|593980698|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
164440975|NCT04707313|593980699|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
164440976|NCT04707313|593980700|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
164593835|NCT00532948|594537099|FG002|Overall Study|Failure to return|0|||
164388242|NCT02371369|593788605|FG001|Part 1|Withdrawal by Subject|6|||
164388243|NCT02371369|593788604|FG000|Part 1|Disease progression|0|||
164388244|NCT02371369|593788605|FG001|Part 1|Disease progression|1|||
164388245|NCT02371369|593788604|FG000|Part 1|Protocol Violation|0|||
164388246|NCT02371369|593788605|FG001|Part 1|Protocol Violation|1|||
164388247|NCT02371369|593788604|FG000|Part 2|Adverse Event|6|||
164388248|NCT02371369|593788605|FG001|Part 2|Adverse Event|5|||
164388249|NCT02371369|593788604|FG000|Part 2|Withdrawal by Subject|16|||
164388250|NCT02371369|593788605|FG001|Part 2|Withdrawal by Subject|6|||
164388251|NCT02371369|593788604|FG000|Part 2|Investigator decision|1|||
164388252|NCT02371369|593788605|FG001|Part 2|Investigator decision|2|||
164388253|NCT02371369|593788604|FG000|Part 2|Death|0|||
164388254|NCT02371369|593788605|FG001|Part 2|Death|1|||
164388255|NCT02371369|593788604|FG000|Part 2|Disease progression|1|||
164388256|NCT02371369|593788605|FG001|Part 2|Disease progression|0|||
164388257|NCT02371369|593788604|FG000|Part 2|Subject Noncompliance|1|||
164388258|NCT02371369|593788605|FG001|Part 2|Subject Noncompliance|0|||
164388259|NCT02371369|593788604|FG000|Part 2|Lost to Follow-up|1|||
164388260|NCT02371369|593788605|FG001|Part 2|Lost to Follow-up|1|||
164388261|NCT02371369|593788604|FG000|Part 2|Subject transitioned to commercial supply|6|||
164388262|NCT02371369|593788605|FG001|Part 2|Subject transitioned to commercial supply|4|||
164388263|NCT02371369|593788604|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
164388264|NCT02371369|593788605|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
164388265|NCT02371369|593788604|FG000|Part 2|Surgical resection of tumor|1|||
164388266|NCT02371369|593788605|FG001|Part 2|Surgical resection of tumor|1|||
164388267|NCT02371369|593788604|FG000|Part 2|Other|0|||
164388268|NCT02371369|593788605|FG001|Part 2|Other|1|||
164388269|NCT01024387|593788606|FG000|Overall Study|Radiographic Progression|29|||
164388270|NCT01024387|593788606|FG000|Overall Study|Symptomatic Progression|10|||
164388271|NCT01024387|593788606|FG000|Overall Study|Physician Decision|5|||
164388272|NCT01024387|593788606|FG000|Overall Study|Withdrawal by Subject|5|||
164388273|NCT01024387|593788606|FG000|Overall Study|Death|2|||
164388274|NCT01024387|593788606|FG000|Overall Study|Prolonged Treatment Delay|1|||
164388275|NCT01024387|593788606|FG000|Overall Study|Adverse Event|3|||
164388276|NCT01024387|593788606|FG000|Overall Study|Other|5|||
164388277|NCT03855189|593788607|FG000|Overall Study|Adverse Event|5|||
164388278|NCT03855189|593788608|FG001|Overall Study|Adverse Event|2|||
164388279|NCT03855189|593788609|FG002|Overall Study|Adverse Event|4|||
164388280|NCT03855189|593788607|FG000|Overall Study|Treatment Failure|1|||
164388281|NCT03855189|593788608|FG001|Overall Study|Treatment Failure|1|||
164388282|NCT03855189|593788609|FG002|Overall Study|Treatment Failure|2|||
164388283|NCT03855189|593788607|FG000|Overall Study|Noncompliance with Protocol|0|||
164388284|NCT03855189|593788608|FG001|Overall Study|Noncompliance with Protocol|1|||
164388285|NCT03855189|593788609|FG002|Overall Study|Noncompliance with Protocol|0|||
164388286|NCT03855189|593788607|FG000|Overall Study|Did Not Return|4|||
164388287|NCT03855189|593788608|FG001|Overall Study|Did Not Return|3|||
164388288|NCT03855189|593788609|FG002|Overall Study|Did Not Return|0|||
164388289|NCT01143259|593788610|FG000|Overall Study|Withdrawal by Subject|3|||
164388290|NCT01143259|593788611|FG001|Overall Study|Withdrawal by Subject|2|||
164388291|NCT01143259|593788610|FG000|Overall Study|Protocol Violation|13|||
164388292|NCT01143259|593788611|FG001|Overall Study|Protocol Violation|9|||
164388293|NCT01143259|593788610|FG000|Overall Study|Screen Failure|7|||
164388294|NCT01143259|593788611|FG001|Overall Study|Screen Failure|9|||
164388295|NCT04307186|593788612|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
164388296|NCT04307186|593788612|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
164388297|NCT04307186|593788612|FG000|Washout 3-14 Days|Progressive disease|1|||
164388298|NCT04307186|593788612|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
164388299|NCT04307186|593788612|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
164388300|NCT01618838|593788613|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
164388301|NCT01434602|593788614|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
164388302|NCT01434602|593788615|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
164388303|NCT01434602|593788616|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
164388304|NCT01434602|593788617|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
164388305|NCT01434602|593788618|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
164388306|NCT01434602|593788614|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
164388307|NCT01434602|593788615|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
164388308|NCT01434602|593788616|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
164388309|NCT01434602|593788617|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
164388310|NCT01434602|593788618|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
164440977|NCT04707313|593980701|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
164703764|NCT02935686|594941784|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
164388311|NCT01434602|593788614|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
164703765|NCT02935686|594941785|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
164703766|NCT02935686|594941781|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
164388312|NCT01434602|593788615|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
164388313|NCT01434602|593788616|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
164388314|NCT01434602|593788617|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
164388315|NCT01434602|593788618|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
164388316|NCT01434602|593788614|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
164388317|NCT01434602|593788615|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
164388318|NCT01434602|593788616|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
164388319|NCT01434602|593788617|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
164388320|NCT01434602|593788618|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
164388321|NCT01434602|593788614|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
164388322|NCT01434602|593788615|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
164388323|NCT01434602|593788616|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
164388324|NCT01434602|593788617|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
164388325|NCT01434602|593788618|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
164388326|NCT01434602|593788614|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
164388327|NCT01434602|593788615|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
164388328|NCT01434602|593788616|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
164388329|NCT01434602|593788617|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
164388330|NCT01434602|593788618|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
164388331|NCT01434602|593788614|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
164388332|NCT01434602|593788615|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
164388333|NCT01434602|593788616|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
164388334|NCT01434602|593788617|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
164388335|NCT01434602|593788618|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
164388336|NCT01434602|593788614|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
164388337|NCT01434602|593788615|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
164388338|NCT01434602|593788616|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
164388339|NCT01434602|593788617|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
164388340|NCT01434602|593788618|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
164388341|NCT01434602|593788614|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
164388342|NCT01434602|593788615|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
164388343|NCT01434602|593788616|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
164388344|NCT01434602|593788617|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
164388345|NCT01434602|593788618|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
164388346|NCT01434602|593788614|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
164388347|NCT01434602|593788615|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
164388348|NCT01434602|593788616|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
164703767|NCT02935686|594941782|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
164703768|NCT02935686|594941783|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
164703769|NCT02935686|594941784|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
164388349|NCT01434602|593788617|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
164388350|NCT01434602|593788618|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
164388351|NCT01587651|593788623|FG000|Overall Study|Adverse Event|0|||
164388352|NCT01587651|593788624|FG001|Overall Study|Adverse Event|1|||
164388353|NCT01587651|593788625|FG002|Overall Study|Adverse Event|0|||
164388354|NCT01587651|593788623|FG000|Overall Study|Protocol Violation|0|||
164388355|NCT01587651|593788624|FG001|Overall Study|Protocol Violation|1|||
164388356|NCT01587651|593788625|FG002|Overall Study|Protocol Violation|1|||
164388357|NCT01587651|593788623|FG000|Overall Study|Withdrawal by Subject|0|||
164388358|NCT01587651|593788624|FG001|Overall Study|Withdrawal by Subject|1|||
164388359|NCT01587651|593788625|FG002|Overall Study|Withdrawal by Subject|0|||
164388360|NCT00759109|593788628|FG000|Overall Study|Adverse Event|17|||
164388361|NCT00759109|593788629|FG001|Overall Study|Adverse Event|12|||
164388362|NCT00759109|593788628|FG000|Overall Study|Inability to comply|1|||
164388363|NCT00759109|593788629|FG001|Overall Study|Inability to comply|1|||
164388364|NCT00759109|593788628|FG000|Overall Study|Withdrawal by Subject|9|||
164388365|NCT00759109|593788629|FG001|Overall Study|Withdrawal by Subject|5|||
164388366|NCT00759109|593788628|FG000|Overall Study|Death|4|||
164388367|NCT00759109|593788629|FG001|Overall Study|Death|3|||
164388368|NCT00759109|593788628|FG000|Overall Study|Lost to Follow-up|4|||
164388369|NCT00759109|593788629|FG001|Overall Study|Lost to Follow-up|6|||
164388370|NCT00759109|593788628|FG000|Overall Study|Started new therapy|2|||
164388371|NCT00759109|593788629|FG001|Overall Study|Started new therapy|6|||
164388372|NCT00759109|593788628|FG000|Overall Study|HCV RNA negative|1|||
164388373|NCT00759109|593788629|FG001|Overall Study|HCV RNA negative|0|||
164388374|NCT00759109|593788628|FG000|Overall Study|Participant moved to a different city|0|||
164388375|NCT00759109|593788629|FG001|Overall Study|Participant moved to a different city|1|||
164388376|NCT00759109|593788628|FG000|Overall Study|Participant had a liver transplant|0|||
164388377|NCT00759109|593788629|FG001|Overall Study|Participant had a liver transplant|1|||
164388378|NCT00759109|593788628|FG000|Overall Study|Lost during study|1|||
164388379|NCT00759109|593788629|FG001|Overall Study|Lost during study|0|||
164388380|NCT00924287|593790219|FG000|Overall Study|Death|1|||
164388381|NCT00156065|593790222|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
164388382|NCT00156065|593790223|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
164388383|NCT00156065|593790224|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
164388384|NCT00156065|593790222|FG000|Overall Study|Adverse Event|8|||
164388385|NCT00156065|593790223|FG001|Overall Study|Adverse Event|11|||
164388386|NCT00156065|593790224|FG002|Overall Study|Adverse Event|4|||
164388387|NCT00156065|593790222|FG000|Overall Study|Lack of Efficacy|2|||
164388388|NCT00156065|593790223|FG001|Overall Study|Lack of Efficacy|9|||
164388389|NCT00156065|593790224|FG002|Overall Study|Lack of Efficacy|3|||
164388390|NCT00156065|593790222|FG000|Overall Study|Withdrawal by Subject|13|||
164388391|NCT00156065|593790223|FG001|Overall Study|Withdrawal by Subject|26|||
164388392|NCT00156065|593790224|FG002|Overall Study|Withdrawal by Subject|16|||
164388393|NCT00156065|593790222|FG000|Overall Study|Lost to Follow-up|5|||
164388394|NCT00156065|593790223|FG001|Overall Study|Lost to Follow-up|7|||
164388395|NCT00156065|593790224|FG002|Overall Study|Lost to Follow-up|1|||
164388396|NCT00156065|593790222|FG000|Overall Study|Other|2|||
164388397|NCT00156065|593790223|FG001|Overall Study|Other|9|||
164388398|NCT00156065|593790224|FG002|Overall Study|Other|3|||
164388399|NCT04579757|593790235|FG000|Overall Study|Adverse Event|0|||
164388400|NCT04579757|593790236|FG001|Overall Study|Adverse Event|0|||
164388401|NCT04579757|593790237|FG002|Overall Study|Adverse Event|0|||
164388402|NCT04579757|593790238|FG003|Overall Study|Adverse Event|2|||
164440978|NCT04707313|593980702|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
164440979|NCT04707313|593980703|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
164440980|NCT04707313|593980704|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
164440981|NCT04707313|593980705|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
164440982|NCT02459899|593980706|FG000|Overall Study|Adverse Event|1|||
164440983|NCT02459899|593980707|FG001|Overall Study|Adverse Event|1|||
164440984|NCT02459899|593980708|FG002|Overall Study|Adverse Event|0|||
164440985|NCT02459899|593980709|FG003|Overall Study|Adverse Event|0|||
164440986|NCT02459899|593980706|FG000|Overall Study|Lost to Follow-up|1|||
164440987|NCT02459899|593980707|FG001|Overall Study|Lost to Follow-up|2|||
164440988|NCT02459899|593980708|FG002|Overall Study|Lost to Follow-up|0|||
164440989|NCT02459899|593980709|FG003|Overall Study|Lost to Follow-up|1|||
164440990|NCT02459899|593980706|FG000|Overall Study|Non-compliance with the treatment|0|||
164440991|NCT02459899|593980707|FG001|Overall Study|Non-compliance with the treatment|0|||
164440992|NCT02459899|593980708|FG002|Overall Study|Non-compliance with the treatment|0|||
164440993|NCT02459899|593980709|FG003|Overall Study|Non-compliance with the treatment|1|||
164440994|NCT02459899|593980706|FG000|Overall Study|Withdrawal by Subject|1|||
164593836|NCT00995345|594537100|FG000|Overall Study|Withdrawal by Subject|4|||
164593837|NCT00995345|594537101|FG001|Overall Study|Withdrawal by Subject|2|||
164593838|NCT00995345|594537102|FG002|Overall Study|Withdrawal by Subject|1|||
164593839|NCT00995345|594537103|FG003|Overall Study|Withdrawal by Subject|3|||
164593840|NCT00995345|594537104|FG004|Overall Study|Withdrawal by Subject|1|||
164593841|NCT00995345|594537100|FG000|Overall Study|Adverse Event|3|||
164593842|NCT00995345|594537101|FG001|Overall Study|Adverse Event|1|||
164593843|NCT00995345|594537102|FG002|Overall Study|Adverse Event|2|||
164593844|NCT00995345|594537103|FG003|Overall Study|Adverse Event|0|||
164593845|NCT00995345|594537104|FG004|Overall Study|Adverse Event|1|||
164593846|NCT00995345|594537100|FG000|Overall Study|Lost to Follow-up|2|||
164593847|NCT00995345|594537101|FG001|Overall Study|Lost to Follow-up|2|||
164593848|NCT00995345|594537102|FG002|Overall Study|Lost to Follow-up|2|||
164388403|NCT04579757|593790239|FG004|Overall Study|Adverse Event|1|||
164388404|NCT04579757|593790240|FG005|Overall Study|Adverse Event|1|||
164388405|NCT04579757|593790241|FG006|Overall Study|Adverse Event|0|||
164388406|NCT04579757|593790242|FG007|Overall Study|Adverse Event|0|||
164388407|NCT04579757|593790243|FG008|Overall Study|Adverse Event|0|||
164440995|NCT02459899|593980707|FG001|Overall Study|Withdrawal by Subject|3|||
164440996|NCT02459899|593980708|FG002|Overall Study|Withdrawal by Subject|0|||
164440997|NCT02459899|593980709|FG003|Overall Study|Withdrawal by Subject|0|||
164440998|NCT00940992|593980710|FG000|Overall Study|Adverse Event|2|||
164440999|NCT00940992|593980711|FG001|Overall Study|Adverse Event|0|||
164441000|NCT00940992|593980712|FG002|Overall Study|Adverse Event|1|||
164441001|NCT00940992|593980710|FG000|Overall Study|subject request|2|||
164441002|NCT00940992|593980711|FG001|Overall Study|subject request|1|||
164593849|NCT00995345|594537103|FG003|Overall Study|Lost to Follow-up|1|||
164388408|NCT04579757|593790235|FG000|Overall Study|Death|4|||
164388409|NCT04579757|593790236|FG001|Overall Study|Death|1|||
164388410|NCT04579757|593790237|FG002|Overall Study|Death|14|||
164593850|NCT00995345|594537104|FG004|Overall Study|Lost to Follow-up|0|||
164593851|NCT00995345|594537100|FG000|Overall Study|all other reasons combined|2|||
164593852|NCT00995345|594537101|FG001|Overall Study|all other reasons combined|2|||
164593853|NCT00995345|594537102|FG002|Overall Study|all other reasons combined|2|||
164593854|NCT00995345|594537103|FG003|Overall Study|all other reasons combined|1|||
164593855|NCT00995345|594537104|FG004|Overall Study|all other reasons combined|3|||
164593856|NCT02509598|594537113|FG000|Overall Study|Withdrawal by Subject|1|||
164593857|NCT01201798|594537114|FG000|Overall Study|Adverse Event|2|||
164593858|NCT01201798|594537115|FG001|Overall Study|Adverse Event|0|||
164593859|NCT01201798|594537114|FG000|Overall Study|Lost to Follow-up|3|||
164593860|NCT01201798|594537115|FG001|Overall Study|Lost to Follow-up|5|||
164593861|NCT01201798|594537114|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
164593862|NCT01201798|594537115|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
164703770|NCT02935686|594941785|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
164703771|NCT02935686|594941781|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
164388411|NCT04579757|593790238|FG003|Overall Study|Death|3|||
164388412|NCT04579757|593790239|FG004|Overall Study|Death|2|||
164388413|NCT04579757|593790240|FG005|Overall Study|Death|7|||
164388414|NCT04579757|593790241|FG006|Overall Study|Death|0|||
164388415|NCT04579757|593790242|FG007|Overall Study|Death|1|||
164388416|NCT04579757|593790243|FG008|Overall Study|Death|3|||
164388417|NCT04579757|593790235|FG000|Overall Study|Physician Decision|0|||
164388418|NCT04579757|593790236|FG001|Overall Study|Physician Decision|0|||
164388419|NCT04579757|593790237|FG002|Overall Study|Physician Decision|0|||
164388420|NCT04579757|593790238|FG003|Overall Study|Physician Decision|2|||
164388421|NCT04579757|593790239|FG004|Overall Study|Physician Decision|1|||
164388422|NCT04579757|593790240|FG005|Overall Study|Physician Decision|1|||
164388423|NCT04579757|593790241|FG006|Overall Study|Physician Decision|1|||
164388424|NCT04579757|593790242|FG007|Overall Study|Physician Decision|0|||
164388425|NCT04579757|593790243|FG008|Overall Study|Physician Decision|0|||
164388426|NCT04579757|593790235|FG000|Overall Study|Study Terminated By Sponsor|0|||
164388427|NCT04579757|593790236|FG001|Overall Study|Study Terminated By Sponsor|0|||
164388428|NCT04579757|593790237|FG002|Overall Study|Study Terminated By Sponsor|0|||
164388429|NCT04579757|593790238|FG003|Overall Study|Study Terminated By Sponsor|0|||
164388430|NCT04579757|593790239|FG004|Overall Study|Study Terminated By Sponsor|2|||
164388431|NCT04579757|593790240|FG005|Overall Study|Study Terminated By Sponsor|0|||
164388432|NCT04579757|593790241|FG006|Overall Study|Study Terminated By Sponsor|0|||
164388433|NCT04579757|593790242|FG007|Overall Study|Study Terminated By Sponsor|2|||
164388434|NCT04579757|593790243|FG008|Overall Study|Study Terminated By Sponsor|0|||
164388435|NCT04579757|593790235|FG000|Overall Study|Withdrawal by Subject|1|||
164388436|NCT04579757|593790236|FG001|Overall Study|Withdrawal by Subject|1|||
164388437|NCT04579757|593790237|FG002|Overall Study|Withdrawal by Subject|0|||
164388438|NCT04579757|593790238|FG003|Overall Study|Withdrawal by Subject|0|||
164388439|NCT04579757|593790239|FG004|Overall Study|Withdrawal by Subject|2|||
164388440|NCT04579757|593790240|FG005|Overall Study|Withdrawal by Subject|1|||
164388441|NCT04579757|593790241|FG006|Overall Study|Withdrawal by Subject|0|||
164388442|NCT04579757|593790242|FG007|Overall Study|Withdrawal by Subject|3|||
164388443|NCT04579757|593790243|FG008|Overall Study|Withdrawal by Subject|0|||
164388444|NCT04579757|593790235|FG000|Overall Study|Radiological or Clinical PD|1|||
164388445|NCT04579757|593790236|FG001|Overall Study|Radiological or Clinical PD|4|||
164388446|NCT04579757|593790237|FG002|Overall Study|Radiological or Clinical PD|1|||
164388447|NCT04579757|593790238|FG003|Overall Study|Radiological or Clinical PD|3|||
164388448|NCT04579757|593790239|FG004|Overall Study|Radiological or Clinical PD|9|||
164388449|NCT04579757|593790240|FG005|Overall Study|Radiological or Clinical PD|4|||
164388450|NCT04579757|593790241|FG006|Overall Study|Radiological or Clinical PD|2|||
164388451|NCT04579757|593790242|FG007|Overall Study|Radiological or Clinical PD|2|||
164388452|NCT04579757|593790243|FG008|Overall Study|Radiological or Clinical PD|0|||
164703772|NCT02935686|594941782|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
164703773|NCT02935686|594941783|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
164703774|NCT02935686|594941784|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
164703775|NCT02935686|594941785|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
164388453|NCT04579757|593790235|FG000|Overall Study|Start of New Therapy|0|||
164388454|NCT04579757|593790236|FG001|Overall Study|Start of New Therapy|0|||
164388455|NCT04579757|593790237|FG002|Overall Study|Start of New Therapy|0|||
164388456|NCT04579757|593790238|FG003|Overall Study|Start of New Therapy|0|||
164388457|NCT04579757|593790239|FG004|Overall Study|Start of New Therapy|2|||
164593863|NCT01201798|594537114|FG000|Overall Study|Noncompliance|1|||
164593864|NCT01201798|594537115|FG001|Overall Study|Noncompliance|0|||
164388458|NCT04579757|593790240|FG005|Overall Study|Start of New Therapy|1|||
164388459|NCT04579757|593790241|FG006|Overall Study|Start of New Therapy|0|||
164388460|NCT04579757|593790242|FG007|Overall Study|Start of New Therapy|0|||
164388461|NCT04579757|593790243|FG008|Overall Study|Start of New Therapy|0|||
164388462|NCT01153633|593790244|FG000|Overall Study|Protocol Violation|1|||
164388463|NCT01153633|593790245|FG001|Overall Study|Protocol Violation|1|||
164388464|NCT01153633|593790244|FG000|Overall Study|Therapeutic failure|3|||
164593865|NCT01201798|594537114|FG000|Overall Study|Protocol Violation|1|||
164593866|NCT01201798|594537115|FG001|Overall Study|Protocol Violation|1|||
164388465|NCT01153633|593790245|FG001|Overall Study|Therapeutic failure|3|||
164388466|NCT00384085|593790246|FG000|Overall Study|Adverse Event|5|||
164388467|NCT00384085|593790247|FG001|Overall Study|Adverse Event|5|||
164388468|NCT00384085|593790248|FG002|Overall Study|Adverse Event|4|||
164388469|NCT00384085|593790246|FG000|Overall Study|Lack of Efficacy|0|||
164388470|NCT00384085|593790247|FG001|Overall Study|Lack of Efficacy|3|||
164388471|NCT00384085|593790248|FG002|Overall Study|Lack of Efficacy|2|||
164388472|NCT00384085|593790246|FG000|Overall Study|No longer Requires Study Treatment|1|||
164388473|NCT00384085|593790247|FG001|Overall Study|No longer Requires Study Treatment|0|||
164388474|NCT00384085|593790248|FG002|Overall Study|No longer Requires Study Treatment|1|||
164388475|NCT00384085|593790246|FG000|Overall Study|Protocol Violation|2|||
164388476|NCT00384085|593790247|FG001|Overall Study|Protocol Violation|2|||
164388477|NCT00384085|593790248|FG002|Overall Study|Protocol Violation|2|||
164388478|NCT00384085|593790246|FG000|Overall Study|Lost to Follow-up|9|||
164388479|NCT00384085|593790247|FG001|Overall Study|Lost to Follow-up|9|||
164388480|NCT00384085|593790248|FG002|Overall Study|Lost to Follow-up|10|||
164388481|NCT00384085|593790246|FG000|Overall Study|Progressive Disease|0|||
164388482|NCT00384085|593790247|FG001|Overall Study|Progressive Disease|1|||
164388483|NCT00384085|593790248|FG002|Overall Study|Progressive Disease|0|||
164388484|NCT00384085|593790246|FG000|Overall Study|Withdrawal by Subject|14|||
164388485|NCT00384085|593790247|FG001|Overall Study|Withdrawal by Subject|19|||
164388486|NCT00384085|593790248|FG002|Overall Study|Withdrawal by Subject|29|||
164388487|NCT00384085|593790246|FG000|Overall Study|Patient non-compliant|4|||
164388488|NCT00384085|593790247|FG001|Overall Study|Patient non-compliant|4|||
164388489|NCT00384085|593790248|FG002|Overall Study|Patient non-compliant|5|||
164388490|NCT00384085|593790246|FG000|Overall Study|Physician Decision|1|||
164388491|NCT00384085|593790247|FG001|Overall Study|Physician Decision|0|||
164388492|NCT00384085|593790248|FG002|Overall Study|Physician Decision|0|||
164388493|NCT00384085|593790246|FG000|Overall Study|Loss of site personnel|1|||
164388494|NCT00384085|593790247|FG001|Overall Study|Loss of site personnel|0|||
164388495|NCT00384085|593790248|FG002|Overall Study|Loss of site personnel|1|||
164388496|NCT00384085|593790246|FG000|Overall Study|Sponsor decision|1|||
164388497|NCT00384085|593790247|FG001|Overall Study|Sponsor decision|2|||
164388498|NCT00384085|593790248|FG002|Overall Study|Sponsor decision|1|||
164388499|NCT00384085|593790246|FG000|Overall Study|Patient moved|1|||
164388500|NCT00384085|593790247|FG001|Overall Study|Patient moved|0|||
164388501|NCT00384085|593790248|FG002|Overall Study|Patient moved|1|||
164388502|NCT00384085|593790246|FG000|Overall Study|Patient required surgery|0|||
164388503|NCT00384085|593790247|FG001|Overall Study|Patient required surgery|1|||
164388504|NCT00384085|593790248|FG002|Overall Study|Patient required surgery|0|||
164388505|NCT01944631|593790249|FG000|Overall Study|Adverse Event|1|||
164388506|NCT01944631|593790250|FG001|Overall Study|Adverse Event|0|||
164388507|NCT01944631|593790249|FG000|Overall Study|Lost to Follow-up|3|||
164388508|NCT01944631|593790250|FG001|Overall Study|Lost to Follow-up|1|||
164388509|NCT01944631|593790249|FG000|Overall Study|Withdrawal by Subject|0|||
164388510|NCT01944631|593790250|FG001|Overall Study|Withdrawal by Subject|1|||
164388511|NCT01843192|593790251|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
164388512|NCT01843192|593790252|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
164388513|NCT01843192|593790253|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
164388514|NCT00328510|593790256|FG000|Overall Study|Gag disorder, could not use frame|4|||
164388515|NCT00328510|593790257|FG001|Overall Study|Gag disorder, could not use frame|0|||
164388516|NCT00328510|593790256|FG000|Overall Study|Dentition problems, could not use frame|1|||
164388517|NCT00328510|593790257|FG001|Overall Study|Dentition problems, could not use frame|0|||
164388518|NCT00328510|593790256|FG000|Overall Study|Withdrawal by Subject|4|||
164388519|NCT00328510|593790257|FG001|Overall Study|Withdrawal by Subject|2|||
164388520|NCT00328510|593790256|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
164388521|NCT00328510|593790257|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
164388522|NCT00328510|593790256|FG000|Overall Study|Treatment changed to a single fraction|1|||
164388523|NCT00328510|593790257|FG001|Overall Study|Treatment changed to a single fraction|1|||
164388524|NCT00455195|593790258|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
164388525|NCT00455195|593790259|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
164388526|NCT00455195|593790258|FG000|Double-blind Study AGLU02704|Death|1|||
164388527|NCT00455195|593790259|FG001|Double-blind Study AGLU02704|Death|0|||
164388528|NCT00455195|593790258|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
164593867|NCT01201798|594537114|FG000|Overall Study|Treatment Failure|1|||
164388529|NCT00455195|593790259|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
164388530|NCT00455195|593790258|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
164388531|NCT00455195|593790259|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
164593868|NCT01201798|594537115|FG001|Overall Study|Treatment Failure|8|||
164388532|NCT01286779|593790260|FG000|Overall Study|Withdrawal by Subject|9|||
164388533|NCT01286779|593790260|FG000|Overall Study|Protocol Violation|5|||
164388534|NCT01286779|593790260|FG000|Overall Study|Physician Decision|2|||
164388535|NCT01286779|593790260|FG000|Overall Study|Participant had scheduled surgery|1|||
164388536|NCT01286779|593790260|FG000|Overall Study|Participant moved to another country|1|||
164441003|NCT00940992|593980712|FG002|Overall Study|subject request|0|||
164441004|NCT00940992|593980710|FG000|Overall Study|Lost to Follow-up|0|||
164441005|NCT00940992|593980711|FG001|Overall Study|Lost to Follow-up|1|||
164441006|NCT00940992|593980712|FG002|Overall Study|Lost to Follow-up|1|||
164441007|NCT03586544|593980728|FG000|First Intervention|Adverse Event|0|||
164441008|NCT03586544|593980729|FG001|First Intervention|Adverse Event|1|||
164441009|NCT03586544|593980728|FG000|Second Intervention|Withdrawal by Subject|0|||
164441010|NCT03586544|593980729|FG001|Second Intervention|Withdrawal by Subject|1|||
164441011|NCT00539292|593980730|FG000|Overall Study|Physician Decision|1|||
164441012|NCT00539292|593980731|FG001|Overall Study|Physician Decision|0|||
164441013|NCT00361283|593980736|FG000|Overall Study|Lost to Follow-up|27|||
164441014|NCT00290706|593980737|FG000|Overall Study|Withdrawal by Subject|2|||
164441015|NCT00290706|593980738|FG001|Overall Study|Withdrawal by Subject|0|||
164441016|NCT00290706|593980739|FG002|Overall Study|Withdrawal by Subject|0|||
164441017|NCT00290706|593980740|FG003|Overall Study|Withdrawal by Subject|0|||
164441018|NCT00290706|593980737|FG000|Overall Study|Progressive Disease|3|||
164441019|NCT00290706|593980738|FG001|Overall Study|Progressive Disease|5|||
164441020|NCT00290706|593980739|FG002|Overall Study|Progressive Disease|4|||
164441021|NCT00290706|593980740|FG003|Overall Study|Progressive Disease|10|||
164441022|NCT00290706|593980737|FG000|Overall Study|Adverse Event|0|||
164441023|NCT00290706|593980738|FG001|Overall Study|Adverse Event|1|||
164441024|NCT00290706|593980739|FG002|Overall Study|Adverse Event|2|||
164441025|NCT00290706|593980740|FG003|Overall Study|Adverse Event|0|||
164441026|NCT00290706|593980737|FG000|Overall Study|Receive auto transplant or radiation|0|||
164441027|NCT00290706|593980738|FG001|Overall Study|Receive auto transplant or radiation|0|||
164441028|NCT00290706|593980739|FG002|Overall Study|Receive auto transplant or radiation|0|||
164441029|NCT00290706|593980740|FG003|Overall Study|Receive auto transplant or radiation|1|||
164441030|NCT00290706|593980737|FG000|Overall Study|Physician Decision|0|||
164441031|NCT00290706|593980738|FG001|Overall Study|Physician Decision|0|||
164441032|NCT00290706|593980739|FG002|Overall Study|Physician Decision|0|||
164441033|NCT00290706|593980740|FG003|Overall Study|Physician Decision|1|||
164441034|NCT01196429|593980744|FG000|Overall Study|Ineligible - inadequate pathology|1|||
164441035|NCT01196429|593980745|FG001|Overall Study|Ineligible - inadequate pathology|0|||
164441036|NCT01196429|593980744|FG000|Overall Study|Ineligible - wrong cell type|1|||
164441037|NCT01196429|593980745|FG001|Overall Study|Ineligible - wrong cell type|0|||
164441038|NCT01196429|593980744|FG000|Overall Study|Refused - Never Treated|1|||
164441039|NCT01196429|593980745|FG001|Overall Study|Refused - Never Treated|0|||
164441040|NCT03768206|593980746|FG000|Overall Study|Lost to Follow-up|2|||
164441041|NCT03768206|593980747|FG001|Overall Study|Lost to Follow-up|1|||
164441042|NCT03768206|593980746|FG000|Overall Study|Withdrawal by Subject|0|||
164441043|NCT03768206|593980747|FG001|Overall Study|Withdrawal by Subject|1|||
164441044|NCT00688519|593980748|FG000|Overall Study|Adverse Event|2|||
164441045|NCT00688519|593980749|FG001|Overall Study|Adverse Event|3|||
164441046|NCT00688519|593980748|FG000|Overall Study|Lost to Follow-up|3|||
164441047|NCT00688519|593980749|FG001|Overall Study|Lost to Follow-up|3|||
164441048|NCT00688519|593980748|FG000|Overall Study|Lack of Efficacy|3|||
164441049|NCT00688519|593980749|FG001|Overall Study|Lack of Efficacy|1|||
164441050|NCT00688519|593980748|FG000|Overall Study|Withdrawal by Subject|7|||
164441051|NCT00688519|593980749|FG001|Overall Study|Withdrawal by Subject|6|||
164441052|NCT00688519|593980748|FG000|Overall Study|Prohibited medication|1|||
164441053|NCT00688519|593980749|FG001|Overall Study|Prohibited medication|0|||
164441054|NCT00688519|593980748|FG000|Overall Study|Non-compliance|0|||
164441055|NCT00688519|593980749|FG001|Overall Study|Non-compliance|1|||
164441056|NCT00688519|593980748|FG000|Overall Study|Subject moved out of state|1|||
164441057|NCT00688519|593980749|FG001|Overall Study|Subject moved out of state|0|||
164441058|NCT00688519|593980748|FG000|Overall Study|Investigator decision|1|||
164441059|NCT00688519|593980749|FG001|Overall Study|Investigator decision|0|||
164441060|NCT00688519|593980748|FG000|Overall Study|Subject moved out of area|1|||
164441061|NCT00688519|593980749|FG001|Overall Study|Subject moved out of area|0|||
164441062|NCT00688519|593980748|FG000|Overall Study|Pregnancy|0|||
164441063|NCT00688519|593980749|FG001|Overall Study|Pregnancy|1|||
164441064|NCT01063517|593980752|FG000|Overall Study|Consent withdrawal|1|||
164441065|NCT01063517|593980753|FG001|Overall Study|Consent withdrawal|0|||
164441066|NCT01063517|593980752|FG000|Overall Study|Study reached data cut-off|19|||
164441067|NCT01063517|593980753|FG001|Overall Study|Study reached data cut-off|7|||
164441068|NCT01063517|593980752|FG000|Overall Study|Lost to Follow-up|4|||
164441069|NCT01063517|593980753|FG001|Overall Study|Lost to Follow-up|3|||
164441070|NCT01063517|593980752|FG000|Overall Study|Withdrawal by Subject|1|||
164441071|NCT01063517|593980753|FG001|Overall Study|Withdrawal by Subject|2|||
164441072|NCT01063517|593980752|FG000|Overall Study|Death|33|||
164441073|NCT01063517|593980753|FG001|Overall Study|Death|48|||
164441074|NCT06269640|593982680|FG000|Overall Study|Death|1|||
164441075|NCT02974634|593982683|FG000|Overall Study|Advanced disease|12|||
164441076|NCT02974634|593982684|FG001|Overall Study|Advanced disease|3|||
164441077|NCT02974634|593982683|FG000|Overall Study|Noncompliance|3|||
164441078|NCT02974634|593982684|FG001|Overall Study|Noncompliance|7|||
164441079|NCT02974634|593982683|FG000|Overall Study|intervention technology related issues|5|||
164441080|NCT02974634|593982684|FG001|Overall Study|intervention technology related issues|0|||
164388537|NCT01286779|593790260|FG000|Overall Study|Discontinued by sponsor|1|||
164388538|NCT00304070|593790261|FG000|Overall Study|Death|0|||
164388539|NCT00304070|593790262|FG001|Overall Study|Death|0|||
164388540|NCT00304070|593790263|FG002|Overall Study|Death|3|||
164388541|NCT00304070|593790261|FG000|Overall Study|Lost to Follow-up|0|||
164388542|NCT00304070|593790262|FG001|Overall Study|Lost to Follow-up|0|||
164388543|NCT00304070|593790263|FG002|Overall Study|Lost to Follow-up|1|||
164388544|NCT00304070|593790261|FG000|Overall Study|Physician Decision|0|||
164388545|NCT00304070|593790262|FG001|Overall Study|Physician Decision|0|||
164388546|NCT00304070|593790263|FG002|Overall Study|Physician Decision|3|||
164388547|NCT00304070|593790261|FG000|Overall Study|Withdrawal by Subject|0|||
164388548|NCT00304070|593790262|FG001|Overall Study|Withdrawal by Subject|0|||
164388549|NCT00304070|593790263|FG002|Overall Study|Withdrawal by Subject|1|||
164388550|NCT00304070|593790261|FG000|Overall Study|Progressive Disease|3|||
164388551|NCT00304070|593790262|FG001|Overall Study|Progressive Disease|7|||
164388552|NCT00304070|593790263|FG002|Overall Study|Progressive Disease|4|||
164388553|NCT00779246|593790272|FG000|Overall Study|Missing sufficient data for analysis|33|||
164388554|NCT00779246|593790273|FG001|Overall Study|Missing sufficient data for analysis|53|||
164388555|NCT02844946|593790274|FG000|Overall Study|Lost to Follow-up|7|||
164388556|NCT02844946|593790275|FG001|Overall Study|Lost to Follow-up|0|||
164388557|NCT02806986|593790276|FG000|Treatment Stage 1|Adverse Event|1|||
164388558|NCT02806986|593790276|FG000|Treatment Stage 2|Adverse Event|3|||
164388559|NCT02806986|593790276|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
164388560|NCT03646513|593790278|FG000|Overall Study|Premature study termination|4|||
164388561|NCT02334748|593790279|FG000|Overall Study|Adverse Event|1|||
164388562|NCT02334748|593790279|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
164388563|NCT02334748|593790279|FG000|Overall Study|Patient no longer required study drug|2|||
164388564|NCT02334748|593790279|FG000|Overall Study|Lack of Efficacy|4|||
164388565|NCT01046643|593790280|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
164388566|NCT01046643|593790281|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
164388567|NCT01046643|593790282|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
164388568|NCT01046643|593790283|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
164388569|NCT00093145|593790284|FG000|Overall Study|Unacceptable Toxicity Only|2|||
164388570|NCT00093145|593790284|FG000|Overall Study|Physician Decision|5|||
164388571|NCT00093145|593790284|FG000|Overall Study|Withdrawal by Subject|9|||
164388572|NCT00093145|593790284|FG000|Overall Study|Other|1|||
164388573|NCT01310036|593790285|FG000|Overall Study|Administrative/other|10|||
164388574|NCT01310036|593790285|FG000|Overall Study|Withdrew Consent|11|||
164703776|NCT02128217|594941788|FG000|Overall Study|Lost to Follow-up|0|||
164388575|NCT01310036|593790285|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
164388576|NCT01310036|593790285|FG000|Overall Study|Progression of Disease|164|||
164388577|NCT01310036|593790285|FG000|Overall Study|Death|1|||
164388578|NCT01310036|593790285|FG000|Overall Study|Adverse event or intercurrent illness|12|||
164388579|NCT01175668|593790286|FG000|Overall Study|Withdrawal by Subject|2|||
164388580|NCT01175668|593790287|FG001|Overall Study|Withdrawal by Subject|0|||
164388581|NCT00817089|593790288|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
164388582|NCT00817089|593790289|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
164388583|NCT00817089|593790290|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
164388584|NCT00817089|593790291|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
164388585|NCT00817089|593790288|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
164388586|NCT00817089|593790289|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
164388587|NCT00817089|593790290|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
164388588|NCT00817089|593790291|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
164388589|NCT02043782|593790292|FG000|Period 1|Adverse Event|0|||
164388590|NCT02043782|593790293|FG001|Period 1|Adverse Event|0|||
164388591|NCT02043782|593790294|FG002|Period 1|Adverse Event|1|||
164388592|NCT02043782|593790295|FG003|Period 1|Adverse Event|0|||
164388593|NCT02043782|593790296|FG004|Period 1|Adverse Event|0|||
164441081|NCT02974634|593982683|FG000|Overall Study|Death|8|||
164441082|NCT02974634|593982684|FG001|Overall Study|Death|11|||
164441083|NCT05011396|593982685|FG000|Overall Study|Lost to Follow-up|3|||
164441084|NCT05011396|593982686|FG001|Overall Study|Lost to Follow-up|1|||
164703777|NCT02128217|594941789|FG001|Overall Study|Lost to Follow-up|1|||
164388594|NCT02043782|593790297|FG005|Period 1|Adverse Event|0|||
164388595|NCT00709722|593790298|FG000|Overall Study|Adverse Event|1|||
164388596|NCT04667117|593790299|FG000|Investigational Period|Lost to Follow-up|0|||
164388597|NCT04667117|593790300|FG001|Investigational Period|Lost to Follow-up|0|||
164388598|NCT04667117|593790301|FG002|Investigational Period|Lost to Follow-up|1|||
164388599|NCT04667117|593790299|FG000|Investigational Period|Protocol Deviation|0|||
164388600|NCT04667117|593790300|FG001|Investigational Period|Protocol Deviation|1|||
164388601|NCT04667117|593790301|FG002|Investigational Period|Protocol Deviation|0|||
164388602|NCT04667117|593790299|FG000|Extension Period|Lost to Follow-up|1|||
164388603|NCT04667117|593790300|FG001|Extension Period|Lost to Follow-up|0|||
164388604|NCT04667117|593790301|FG002|Extension Period|Lost to Follow-up|0|||
164441085|NCT05011396|593982685|FG000|Overall Study|Withdrawal by Subject|0|||
164441086|NCT05011396|593982686|FG001|Overall Study|Withdrawal by Subject|1|||
164703778|NCT05071313|594941792|FG000|Overall Study|Lost to Follow-up|17|||
164593869|NCT03521687|594537116|FG000|Overall Study|Adverse Event|4|||
164593870|NCT03521687|594537116|FG000|Overall Study|Physician Decision|1|||
164593871|NCT04891770|594537120|FG000|Overall Study|Withdrew consent|1|||
164593872|NCT04891770|594537121|FG001|Overall Study|Withdrew consent|3|||
164593873|NCT04891770|594537122|FG002|Overall Study|Withdrew consent|0|||
164593874|NCT04891770|594537120|FG000|Overall Study|Enrolled but never treated|0|||
164593875|NCT04891770|594537121|FG001|Overall Study|Enrolled but never treated|0|||
164593876|NCT04891770|594537122|FG002|Overall Study|Enrolled but never treated|1|||
164593877|NCT04891770|594537120|FG000|Overall Study|Investigator's discretion|0|||
164593878|NCT04891770|594537121|FG001|Overall Study|Investigator's discretion|1|||
164593879|NCT04891770|594537122|FG002|Overall Study|Investigator's discretion|0|||
164593880|NCT05692154|594537124|FG000|Overall Study|Adverse Event|0|||
164593881|NCT05692154|594537125|FG001|Overall Study|Adverse Event|1|||
164593882|NCT03609359|594537128|FG000|Overall Study|Progression of primary disease (PD)|25|||
164593883|NCT03609359|594537128|FG000|Overall Study|Patient's refusal|1|||
164593884|NCT03609359|594537128|FG000|Overall Study|Physician Decision|1|||
164593885|NCT03609359|594537128|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
164593886|NCT01912729|594537129|FG000|Overall Study|Withdrawal by Subject|0|||
164593887|NCT01912729|594537130|FG001|Overall Study|Withdrawal by Subject|1|||
164593888|NCT01952834|594537137|FG000|Overall Study|Adverse Event|1|||
164593889|NCT01975272|594537140|FG000|Overall Study|Excluded after protocol amendment|1|||
164388605|NCT03359096|593790302|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
164593890|NCT01975272|594537141|FG001|Overall Study|Excluded after protocol amendment|1|||
164593891|NCT01975272|594537142|FG002|Overall Study|Excluded after protocol amendment|2|||
164593892|NCT00740779|594537149|FG000|Overall Study|Adverse Event|4|||
164593893|NCT00740779|594537150|FG001|Overall Study|Adverse Event|6|||
164593894|NCT00740779|594537151|FG002|Overall Study|Adverse Event|3|||
164593895|NCT00740779|594537149|FG000|Overall Study|Protocol Violation|1|||
164388606|NCT03359096|593790303|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
164388607|NCT03359096|593790302|FG000|First Intervention (4 Weeks)|Death|1|||
164388608|NCT03359096|593790303|FG001|First Intervention (4 Weeks)|Death|0|||
164388609|NCT03359096|593790302|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
164388610|NCT03359096|593790303|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
164388611|NCT02007577|593790314|FG000|Overall Study|Adverse Event|1|||
164388612|NCT02007577|593790315|FG001|Overall Study|Adverse Event|0|||
164388613|NCT02007577|593790314|FG000|Overall Study|Withdrawal by Subject|0|||
164388614|NCT02007577|593790315|FG001|Overall Study|Withdrawal by Subject|1|||
164388615|NCT01953926|593790316|FG000|Overall Study|Withdrawal by Subject|23|||
164388616|NCT01953926|593790317|FG001|Overall Study|Withdrawal by Subject|3|||
164388617|NCT01953926|593790318|FG002|Overall Study|Withdrawal by Subject|3|||
164388618|NCT01953926|593790319|FG003|Overall Study|Withdrawal by Subject|5|||
164388619|NCT01953926|593790320|FG004|Overall Study|Withdrawal by Subject|6|||
164388620|NCT01953926|593790321|FG005|Overall Study|Withdrawal by Subject|0|||
164388621|NCT01953926|593790322|FG006|Overall Study|Withdrawal by Subject|1|||
164388622|NCT01953926|593790316|FG000|Overall Study|Physician Decision|1|||
164388623|NCT01953926|593790317|FG001|Overall Study|Physician Decision|0|||
164388624|NCT01953926|593790318|FG002|Overall Study|Physician Decision|0|||
164388625|NCT01953926|593790319|FG003|Overall Study|Physician Decision|0|||
164388626|NCT01953926|593790320|FG004|Overall Study|Physician Decision|2|||
164388627|NCT01953926|593790321|FG005|Overall Study|Physician Decision|0|||
164388628|NCT01953926|593790322|FG006|Overall Study|Physician Decision|0|||
164388629|NCT01953926|593790316|FG000|Overall Study|Lost to Follow-up|18|||
164388630|NCT01953926|593790317|FG001|Overall Study|Lost to Follow-up|3|||
164388631|NCT01953926|593790318|FG002|Overall Study|Lost to Follow-up|0|||
164388632|NCT01953926|593790319|FG003|Overall Study|Lost to Follow-up|5|||
164388633|NCT01953926|593790320|FG004|Overall Study|Lost to Follow-up|3|||
164388634|NCT01953926|593790321|FG005|Overall Study|Lost to Follow-up|0|||
164388635|NCT01953926|593790322|FG006|Overall Study|Lost to Follow-up|0|||
164388636|NCT01953926|593790316|FG000|Overall Study|Protocol Violation|1|||
164388637|NCT01953926|593790317|FG001|Overall Study|Protocol Violation|0|||
164388638|NCT01953926|593790318|FG002|Overall Study|Protocol Violation|0|||
164388639|NCT01953926|593790319|FG003|Overall Study|Protocol Violation|0|||
164388640|NCT01953926|593790320|FG004|Overall Study|Protocol Violation|0|||
164388641|NCT01953926|593790321|FG005|Overall Study|Protocol Violation|0|||
164388642|NCT01953926|593790322|FG006|Overall Study|Protocol Violation|0|||
164388643|NCT01953926|593790316|FG000|Overall Study|Other, Disease progression|2|||
164388644|NCT01953926|593790317|FG001|Overall Study|Other, Disease progression|1|||
164593896|NCT00740779|594537150|FG001|Overall Study|Protocol Violation|1|||
164593897|NCT00740779|594537151|FG002|Overall Study|Protocol Violation|1|||
164593898|NCT00740779|594537149|FG000|Overall Study|Lack of Efficacy|0|||
164593899|NCT00740779|594537150|FG001|Overall Study|Lack of Efficacy|0|||
164593900|NCT00740779|594537151|FG002|Overall Study|Lack of Efficacy|2|||
164388645|NCT01953926|593790318|FG002|Overall Study|Other, Disease progression|0|||
164388646|NCT01953926|593790319|FG003|Overall Study|Other, Disease progression|0|||
164388647|NCT01953926|593790320|FG004|Overall Study|Other, Disease progression|1|||
164388648|NCT01953926|593790321|FG005|Overall Study|Other, Disease progression|0|||
164388649|NCT01953926|593790322|FG006|Overall Study|Other, Disease progression|0|||
164388650|NCT01953926|593790316|FG000|Overall Study|Discontinuation of study by sponsor|41|||
164388651|NCT01953926|593790317|FG001|Overall Study|Discontinuation of study by sponsor|7|||
164388652|NCT01953926|593790318|FG002|Overall Study|Discontinuation of study by sponsor|5|||
164388653|NCT01953926|593790319|FG003|Overall Study|Discontinuation of study by sponsor|12|||
164388654|NCT01953926|593790320|FG004|Overall Study|Discontinuation of study by sponsor|46|||
164388655|NCT01953926|593790321|FG005|Overall Study|Discontinuation of study by sponsor|5|||
164388656|NCT01953926|593790322|FG006|Overall Study|Discontinuation of study by sponsor|6|||
164388657|NCT01953926|593790316|FG000|Overall Study|Not Treated|1|||
164388658|NCT01953926|593790317|FG001|Overall Study|Not Treated|0|||
164388659|NCT01953926|593790318|FG002|Overall Study|Not Treated|1|||
164388660|NCT01953926|593790319|FG003|Overall Study|Not Treated|0|||
164388661|NCT01953926|593790320|FG004|Overall Study|Not Treated|0|||
164388662|NCT01953926|593790321|FG005|Overall Study|Not Treated|0|||
164388663|NCT01953926|593790322|FG006|Overall Study|Not Treated|0|||
164388664|NCT04102501|593790326|FG000|Overall Study|Withdrawal by Subject|7|||
164388665|NCT04102501|593790327|FG001|Overall Study|Withdrawal by Subject|9|||
164388666|NCT04102501|593790326|FG000|Overall Study|Adverse Event|1|||
164593901|NCT00740779|594537149|FG000|Overall Study|Withdrawal by Subject|2|||
164593902|NCT00740779|594537150|FG001|Overall Study|Withdrawal by Subject|4|||
164388667|NCT04102501|593790327|FG001|Overall Study|Adverse Event|3|||
164388668|NCT02338362|593790329|FG000|Overall Study|Withdrawal by Subject|1|||
164388669|NCT02338362|593790330|FG001|Overall Study|Withdrawal by Subject|1|||
164388670|NCT03325712|593790335|FG000|Overall Study|Protocol Violation|0|||
164388671|NCT03325712|593790336|FG001|Overall Study|Protocol Violation|0|||
164388672|NCT03325712|593790337|FG002|Overall Study|Protocol Violation|0|||
164388673|NCT03325712|593790338|FG003|Overall Study|Protocol Violation|0|||
164388674|NCT03325712|593790339|FG004|Overall Study|Protocol Violation|1|||
164388675|NCT03325712|593790340|FG005|Overall Study|Protocol Violation|0|||
164388676|NCT03325712|593790341|FG006|Overall Study|Protocol Violation|0|||
164388677|NCT03325712|593790342|FG007|Overall Study|Protocol Violation|0|||
164388678|NCT03325712|593790335|FG000|Overall Study|Adverse Event|0|||
164388679|NCT03325712|593790336|FG001|Overall Study|Adverse Event|0|||
164388680|NCT03325712|593790337|FG002|Overall Study|Adverse Event|0|||
164388681|NCT03325712|593790338|FG003|Overall Study|Adverse Event|0|||
164388682|NCT03325712|593790339|FG004|Overall Study|Adverse Event|1|||
164388683|NCT03325712|593790340|FG005|Overall Study|Adverse Event|0|||
164388684|NCT03325712|593790341|FG006|Overall Study|Adverse Event|0|||
164388685|NCT03325712|593790342|FG007|Overall Study|Adverse Event|0|||
164388686|NCT02265237|593790343|FG000|As Treated (Overall Study)|Adverse Event|1|||
164388687|NCT02265237|593790344|FG001|As Treated (Overall Study)|Adverse Event|1|||
164388688|NCT02265237|593790345|FG002|As Treated (Overall Study)|Adverse Event|0|||
164388689|NCT02265237|593790346|FG003|As Treated (Overall Study)|Adverse Event|0|||
164388690|NCT02265237|593790343|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
164388691|NCT02265237|593790344|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
164388692|NCT02265237|593790345|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
164388693|NCT02265237|593790346|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
164388694|NCT02265237|593790343|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
164388695|NCT02265237|593790344|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
164388696|NCT02265237|593790345|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
164388697|NCT02265237|593790346|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
164388698|NCT02265237|593790343|FG000|As Treated (Overall Study)|Other|2|||
164388699|NCT02265237|593790344|FG001|As Treated (Overall Study)|Other|0|||
164388700|NCT02265237|593790345|FG002|As Treated (Overall Study)|Other|3|||
164388701|NCT02265237|593790346|FG003|As Treated (Overall Study)|Other|1|||
164388702|NCT01178853|593790348|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
164388703|NCT01178853|593790349|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
164388704|NCT01178853|593790348|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
164388705|NCT01178853|593790349|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
164388706|NCT01178853|593790348|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
164388707|NCT01178853|593790349|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
164388708|NCT01178853|593790348|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
164388709|NCT01178853|593790349|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
164388710|NCT01178853|593790348|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
164388711|NCT01178853|593790349|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
164388712|NCT03550313|593790350|FG000|Overall Study|Adverse Event|0|||
164388713|NCT03550313|593790351|FG001|Overall Study|Adverse Event|1|||
164388714|NCT03550313|593790352|FG002|Overall Study|Adverse Event|0|||
164388715|NCT03550313|593790350|FG000|Overall Study|Lost to Follow-up|5|||
164388716|NCT03550313|593790351|FG001|Overall Study|Lost to Follow-up|7|||
164388717|NCT03550313|593790352|FG002|Overall Study|Lost to Follow-up|12|||
164388718|NCT03550313|593790350|FG000|Overall Study|Study terminated by sponsor|44|||
164388719|NCT03550313|593790351|FG001|Overall Study|Study terminated by sponsor|37|||
164388720|NCT03550313|593790352|FG002|Overall Study|Study terminated by sponsor|48|||
164593903|NCT00740779|594537151|FG002|Overall Study|Withdrawal by Subject|2|||
164593904|NCT00740779|594537149|FG000|Overall Study|Lost to Follow-up|2|||
164388721|NCT03550313|593790350|FG000|Overall Study|No longer met eligibility criteria|3|||
164388722|NCT03550313|593790351|FG001|Overall Study|No longer met eligibility criteria|5|||
164388723|NCT03550313|593790352|FG002|Overall Study|No longer met eligibility criteria|6|||
164388724|NCT03550313|593790350|FG000|Overall Study|Withdrawal by parent/guardian|20|||
164388725|NCT03550313|593790351|FG001|Overall Study|Withdrawal by parent/guardian|18|||
164388726|NCT03550313|593790352|FG002|Overall Study|Withdrawal by parent/guardian|26|||
164388727|NCT03550313|593790350|FG000|Overall Study|Other|4|||
164388728|NCT03550313|593790351|FG001|Overall Study|Other|2|||
164388729|NCT03550313|593790352|FG002|Overall Study|Other|2|||
164388730|NCT03550313|593790350|FG000|Overall Study|Randomized but not vaccinated|3|||
164388731|NCT03550313|593790351|FG001|Overall Study|Randomized but not vaccinated|23|||
164388732|NCT03550313|593790352|FG002|Overall Study|Randomized but not vaccinated|2|||
164388733|NCT03550313|593790350|FG000|Overall Study|Sites terminated due to quality issues|18|||
164388734|NCT03550313|593790351|FG001|Overall Study|Sites terminated due to quality issues|17|||
164388735|NCT03550313|593790352|FG002|Overall Study|Sites terminated due to quality issues|18|||
164388736|NCT00839072|593790353|FG000|First Intervention Period|Withdrawal by Subject|1|||
164388737|NCT00839072|593790354|FG001|First Intervention Period|Withdrawal by Subject|0|||
164388738|NCT00839072|593790353|FG000|First Intervention Period|Adverse Event|1|||
164388739|NCT00839072|593790354|FG001|First Intervention Period|Adverse Event|1|||
164388740|NCT00839072|593790353|FG000|Second Intervention Period|Withdrawal by Subject|1|||
164388741|NCT00839072|593790354|FG001|Second Intervention Period|Withdrawal by Subject|0|||
164388742|NCT00380068|593790355|FG000|Overall Study|Adverse Event|40|||
164388743|NCT00380068|593790355|FG000|Overall Study|Withdrawal by Subject|10|||
164388744|NCT00380068|593790355|FG000|Overall Study|Not compliant|6|||
164388745|NCT00380068|593790355|FG000|Overall Study|Lost to Follow-up|1|||
164388746|NCT00380068|593790355|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
164388747|NCT00380068|593790355|FG000|Overall Study|Lung transplant|3|||
164388748|NCT00380068|593790355|FG000|Overall Study|Physician Decision|2|||
164388749|NCT00380068|593790355|FG000|Overall Study|Partipant moved away|1|||
164388750|NCT00380068|593790355|FG000|Overall Study|Lack of Efficacy|5|||
164388751|NCT01297062|593790356|FG000|Overall Study|Adverse Event|2|||
164388752|NCT01297062|593790357|FG001|Overall Study|Adverse Event|0|||
164388753|NCT01297062|593790358|FG002|Overall Study|Adverse Event|1|||
164388754|NCT01297062|593790359|FG003|Overall Study|Adverse Event|0|||
164388755|NCT01297062|593790360|FG004|Overall Study|Adverse Event|0|||
164388756|NCT01297062|593790361|FG005|Overall Study|Adverse Event|0|||
164388757|NCT01297062|593790362|FG006|Overall Study|Adverse Event|0|||
164388758|NCT01297062|593790356|FG000|Overall Study|Physician Decision|1|||
164388759|NCT01297062|593790357|FG001|Overall Study|Physician Decision|0|||
164388760|NCT01297062|593790358|FG002|Overall Study|Physician Decision|1|||
164388761|NCT01297062|593790359|FG003|Overall Study|Physician Decision|0|||
164388762|NCT01297062|593790360|FG004|Overall Study|Physician Decision|0|||
164388763|NCT01297062|593790361|FG005|Overall Study|Physician Decision|0|||
164388764|NCT01297062|593790362|FG006|Overall Study|Physician Decision|6|||
164388765|NCT01297062|593790356|FG000|Overall Study|Protocol Violation|0|||
164388766|NCT01297062|593790357|FG001|Overall Study|Protocol Violation|0|||
164388767|NCT01297062|593790358|FG002|Overall Study|Protocol Violation|0|||
164388768|NCT01297062|593790359|FG003|Overall Study|Protocol Violation|0|||
164388769|NCT01297062|593790360|FG004|Overall Study|Protocol Violation|1|||
164388770|NCT01297062|593790361|FG005|Overall Study|Protocol Violation|0|||
164388771|NCT01297062|593790362|FG006|Overall Study|Protocol Violation|0|||
164388772|NCT01297062|593790356|FG000|Overall Study|Subject Decision|1|||
164388773|NCT01297062|593790357|FG001|Overall Study|Subject Decision|1|||
164388774|NCT01297062|593790358|FG002|Overall Study|Subject Decision|0|||
164388775|NCT01297062|593790359|FG003|Overall Study|Subject Decision|1|||
164388776|NCT01297062|593790360|FG004|Overall Study|Subject Decision|1|||
164703779|NCT05071313|594941793|FG001|Overall Study|Lost to Follow-up|10|||
164703780|NCT05071313|594941792|FG000|Overall Study|Physician Decision|1|||
164703781|NCT05071313|594941793|FG001|Overall Study|Physician Decision|6|||
164703782|NCT05071313|594941792|FG000|Overall Study|Death|1|||
164703783|NCT05071313|594941793|FG001|Overall Study|Death|0|||
164388777|NCT01297062|593790361|FG005|Overall Study|Subject Decision|1|||
164388778|NCT01297062|593790362|FG006|Overall Study|Subject Decision|2|||
164388779|NCT03191903|593790363|FG000|Overall Study|Withdrawal by Subject|6|||
164388780|NCT03191903|593790364|FG001|Overall Study|Withdrawal by Subject|5|||
164388781|NCT03191903|593790365|FG002|Overall Study|Withdrawal by Subject|4|||
164388782|NCT03191903|593790363|FG000|Overall Study|Adverse Event|1|||
164388783|NCT03191903|593790364|FG001|Overall Study|Adverse Event|0|||
164388784|NCT03191903|593790365|FG002|Overall Study|Adverse Event|0|||
164388785|NCT03149328|593790366|FG000|Overall Study|Withdrawal by Subject|30|||
164388786|NCT03149328|593790367|FG001|Overall Study|Withdrawal by Subject|26|||
164388787|NCT03149328|593790366|FG000|Overall Study|Changed Dialysis Modality|18|||
164388788|NCT03149328|593790367|FG001|Overall Study|Changed Dialysis Modality|1|||
164703784|NCT05071313|594941792|FG000|Overall Study|Withdrawal by Subject|10|||
164388789|NCT03149328|593790366|FG000|Overall Study|Transplant|9|||
164388790|NCT03149328|593790367|FG001|Overall Study|Transplant|1|||
164388791|NCT03149328|593790366|FG000|Overall Study|Lost to Follow-up|25|||
164388792|NCT03149328|593790367|FG001|Overall Study|Lost to Follow-up|16|||
164703785|NCT05071313|594941793|FG001|Overall Study|Withdrawal by Subject|15|||
164388793|NCT03149328|593790366|FG000|Overall Study|Left Study Site|1|||
164388794|NCT03149328|593790367|FG001|Overall Study|Left Study Site|2|||
164388795|NCT03149328|593790366|FG000|Overall Study|Language Barrier|1|||
164388796|NCT03149328|593790367|FG001|Overall Study|Language Barrier|0|||
164388797|NCT00503685|593790371|FG000|Overall Study|Adverse Event|0|||
164388798|NCT00503685|593790372|FG001|Overall Study|Adverse Event|0|||
164388799|NCT00503685|593790373|FG002|Overall Study|Adverse Event|2|||
164388800|NCT00503685|593790371|FG000|Overall Study|Withdrawal by Subject|0|||
164388801|NCT00503685|593790372|FG001|Overall Study|Withdrawal by Subject|1|||
164388802|NCT00503685|593790373|FG002|Overall Study|Withdrawal by Subject|0|||
164388803|NCT00503685|593790371|FG000|Overall Study|Protocol Violation|0|||
164388804|NCT00503685|593790372|FG001|Overall Study|Protocol Violation|1|||
164388805|NCT00503685|593790373|FG002|Overall Study|Protocol Violation|0|||
164388806|NCT00503685|593790371|FG000|Overall Study|Eligibility Criteria Not Met|0|||
164388807|NCT00503685|593790372|FG001|Overall Study|Eligibility Criteria Not Met|1|||
164388808|NCT00503685|593790373|FG002|Overall Study|Eligibility Criteria Not Met|0|||
164388809|NCT00927927|593790376|FG000|Overall Study|Withdrawal by Subject|0|||
164388810|NCT00927927|593790377|FG001|Overall Study|Withdrawal by Subject|0|||
164388811|NCT00927927|593790378|FG002|Overall Study|Withdrawal by Subject|0|||
164388812|NCT00927927|593790379|FG003|Overall Study|Withdrawal by Subject|0|||
164388813|NCT00927927|593790380|FG004|Overall Study|Withdrawal by Subject|0|||
164388814|NCT00927927|593790381|FG005|Overall Study|Withdrawal by Subject|0|||
164388815|NCT00927927|593790382|FG006|Overall Study|Withdrawal by Subject|0|||
164388816|NCT00927927|593790383|FG007|Overall Study|Withdrawal by Subject|2|||
164388817|NCT00927927|593790384|FG008|Overall Study|Withdrawal by Subject|0|||
164388818|NCT00927927|593790385|FG009|Overall Study|Withdrawal by Subject|0|||
164388819|NCT00927927|593790386|FG010|Overall Study|Withdrawal by Subject|0|||
164388820|NCT00927927|593790387|FG011|Overall Study|Withdrawal by Subject|2|||
164388821|NCT00927927|593790388|FG012|Overall Study|Withdrawal by Subject|0|||
164388822|NCT00927927|593790389|FG013|Overall Study|Withdrawal by Subject|0|||
164388823|NCT00927927|593790390|FG014|Overall Study|Withdrawal by Subject|0|||
164388824|NCT01110239|593790395|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
164388825|NCT01110239|593790396|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
164388826|NCT01110239|593790397|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
164388827|NCT01110239|593790398|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
164388828|NCT01110239|593790395|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
164388829|NCT01110239|593790396|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
164388830|NCT01110239|593790397|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
164388831|NCT01110239|593790398|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
164388832|NCT00080223|593790401|FG000|Overall Study|Adverse Event|23|||
164388833|NCT00080223|593790401|FG000|Overall Study|Death|21|||
164388834|NCT00080223|593790401|FG000|Overall Study|Withdrawal by Subject|13|||
164388835|NCT00080223|593790401|FG000|Overall Study|Lung Transplantation|9|||
164388836|NCT00080223|593790401|FG000|Overall Study|Non-compliance With Study Treatment|7|||
164388837|NCT00080223|593790401|FG000|Overall Study|Participant unwilling to continue|2|||
164388838|NCT00080223|593790401|FG000|Overall Study|Physician Decision|1|||
164388839|NCT02261363|593792353|FG000|Overall Study|Lost to Follow-up|21|||
164388840|NCT01517802|593792354|FG000|Overall Study|Death|1|||
164388841|NCT02605954|593792355|FG000|Overall Study|Adverse Event|5|||
164388842|NCT02605954|593792356|FG001|Overall Study|Adverse Event|1|||
164388843|NCT02605954|593792355|FG000|Overall Study|Investigator's Discretion|1|||
164388844|NCT02605954|593792356|FG001|Overall Study|Investigator's Discretion|0|||
164388845|NCT02605954|593792355|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164388846|NCT02605954|593792356|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164388847|NCT02605954|593792355|FG000|Overall Study|Withdrew Consent|2|||
164388848|NCT02605954|593792356|FG001|Overall Study|Withdrew Consent|2|||
164388849|NCT02605954|593792355|FG000|Overall Study|Lost to Follow-up|3|||
164388850|NCT02605954|593792356|FG001|Overall Study|Lost to Follow-up|0|||
164388851|NCT02605954|593792355|FG000|Overall Study|Randomized but not treated|0|||
164388852|NCT02605954|593792356|FG001|Overall Study|Randomized but not treated|1|||
164388853|NCT02301143|593792357|FG000|Induction Period|Enrolled But Not Treated|1|||
164388854|NCT02301143|593792358|FG001|Induction Period|Enrolled But Not Treated|0|||
164388855|NCT02301143|593792357|FG000|Induction Period|Death|1|||
164388856|NCT02301143|593792358|FG001|Induction Period|Death|0|||
164388857|NCT02301143|593792357|FG000|Induction Period|Adverse Event|22|||
164388858|NCT02301143|593792358|FG001|Induction Period|Adverse Event|0|||
164388859|NCT02301143|593792357|FG000|Induction Period|Progressive Disease|8|||
164388860|NCT02301143|593792358|FG001|Induction Period|Progressive Disease|0|||
164388861|NCT02301143|593792357|FG000|Induction Period|Withdrawal by Subject|3|||
164388862|NCT02301143|593792358|FG001|Induction Period|Withdrawal by Subject|0|||
164388863|NCT02301143|593792357|FG000|Induction Period|Noncompliance with Study Drug|1|||
164388864|NCT02301143|593792358|FG001|Induction Period|Noncompliance with Study Drug|0|||
164388865|NCT02301143|593792357|FG000|Induction Period|Physician Decision|4|||
164388866|NCT02301143|593792358|FG001|Induction Period|Physician Decision|0|||
164388867|NCT02301143|593792357|FG000|Induction Period|Symptomatic Deterioration|2|||
164388868|NCT02301143|593792358|FG001|Induction Period|Symptomatic Deterioration|0|||
164388869|NCT02301143|593792357|FG000|Induction Period|Protocol Violation|2|||
164388870|NCT02301143|593792358|FG001|Induction Period|Protocol Violation|0|||
164388871|NCT02301143|593792357|FG000|Induction Period|Other|1|||
164388872|NCT02301143|593792358|FG001|Induction Period|Other|0|||
164388873|NCT02301143|593792357|FG000|Investigator's Choice|Adverse Event|0|||
164388874|NCT02301143|593792358|FG001|Investigator's Choice|Adverse Event|3|||
164388875|NCT02301143|593792357|FG000|Investigator's Choice|Progressive Disease|0|||
164388876|NCT02301143|593792358|FG001|Investigator's Choice|Progressive Disease|3|||
164388877|NCT02301143|593792357|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
164388878|NCT02301143|593792358|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
164388879|NCT02301143|593792357|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
164388880|NCT02301143|593792358|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
164388881|NCT02301143|593792357|FG000|Investigator's Choice|Other|0|||
164388882|NCT02301143|593792358|FG001|Investigator's Choice|Other|1|||
164388883|NCT02301143|593792357|FG000|Investigator's Choice|Unresectable Surgery|0|||
164388884|NCT02301143|593792358|FG001|Investigator's Choice|Unresectable Surgery|1|||
164388885|NCT03214367|593792361|FG000|Lead-in Period|Withdrawal by Subject|50|||
164388886|NCT03214367|593792362|FG001|Lead-in Period|Withdrawal by Subject|0|||
164388887|NCT03214367|593792363|FG002|Lead-in Period|Withdrawal by Subject|0|||
164388888|NCT03214367|593792364|FG003|Lead-in Period|Withdrawal by Subject|0|||
164388889|NCT03214367|593792365|FG004|Lead-in Period|Withdrawal by Subject|2|||
164388890|NCT03214367|593792366|FG005|Lead-in Period|Withdrawal by Subject|0|||
164388891|NCT03214367|593792367|FG006|Lead-in Period|Withdrawal by Subject|0|||
164388892|NCT03214367|593792368|FG007|Lead-in Period|Withdrawal by Subject|0|||
164388893|NCT03214367|593792361|FG000|Lead-in Period|Adverse Event|3|||
164388894|NCT03214367|593792362|FG001|Lead-in Period|Adverse Event|0|||
164388895|NCT03214367|593792363|FG002|Lead-in Period|Adverse Event|0|||
164388896|NCT03214367|593792364|FG003|Lead-in Period|Adverse Event|0|||
164388897|NCT03214367|593792365|FG004|Lead-in Period|Adverse Event|0|||
164388898|NCT03214367|593792366|FG005|Lead-in Period|Adverse Event|0|||
164388899|NCT03214367|593792367|FG006|Lead-in Period|Adverse Event|0|||
164388900|NCT03214367|593792368|FG007|Lead-in Period|Adverse Event|0|||
164388901|NCT03214367|593792361|FG000|Lead-in Period|Lost to Follow-up|12|||
164388902|NCT03214367|593792362|FG001|Lead-in Period|Lost to Follow-up|0|||
164388903|NCT03214367|593792363|FG002|Lead-in Period|Lost to Follow-up|0|||
164388904|NCT03214367|593792364|FG003|Lead-in Period|Lost to Follow-up|0|||
164388905|NCT03214367|593792365|FG004|Lead-in Period|Lost to Follow-up|0|||
164388906|NCT03214367|593792366|FG005|Lead-in Period|Lost to Follow-up|0|||
164388907|NCT03214367|593792367|FG006|Lead-in Period|Lost to Follow-up|0|||
164388908|NCT03214367|593792368|FG007|Lead-in Period|Lost to Follow-up|0|||
164388909|NCT03214367|593792361|FG000|Lead-in Period|Sponsor Decision|11|||
164388910|NCT03214367|593792362|FG001|Lead-in Period|Sponsor Decision|0|||
164388911|NCT03214367|593792363|FG002|Lead-in Period|Sponsor Decision|0|||
164388912|NCT03214367|593792364|FG003|Lead-in Period|Sponsor Decision|0|||
164388913|NCT03214367|593792365|FG004|Lead-in Period|Sponsor Decision|0|||
164388914|NCT03214367|593792366|FG005|Lead-in Period|Sponsor Decision|0|||
164388915|NCT03214367|593792367|FG006|Lead-in Period|Sponsor Decision|0|||
164388916|NCT03214367|593792368|FG007|Lead-in Period|Sponsor Decision|0|||
164388917|NCT03214367|593792361|FG000|Lead-in Period|Physician Decision|12|||
164388918|NCT03214367|593792362|FG001|Lead-in Period|Physician Decision|0|||
164388919|NCT03214367|593792363|FG002|Lead-in Period|Physician Decision|0|||
164388920|NCT03214367|593792364|FG003|Lead-in Period|Physician Decision|0|||
164388921|NCT03214367|593792365|FG004|Lead-in Period|Physician Decision|0|||
164388922|NCT03214367|593792366|FG005|Lead-in Period|Physician Decision|0|||
164388923|NCT03214367|593792367|FG006|Lead-in Period|Physician Decision|0|||
164388924|NCT03214367|593792368|FG007|Lead-in Period|Physician Decision|0|||
164388925|NCT03214367|593792361|FG000|Lead-in Period|Protocol Violation|5|||
164388926|NCT03214367|593792362|FG001|Lead-in Period|Protocol Violation|0|||
164388927|NCT03214367|593792363|FG002|Lead-in Period|Protocol Violation|0|||
164388928|NCT03214367|593792364|FG003|Lead-in Period|Protocol Violation|0|||
164388929|NCT03214367|593792365|FG004|Lead-in Period|Protocol Violation|0|||
164388930|NCT03214367|593792366|FG005|Lead-in Period|Protocol Violation|0|||
164593905|NCT00740779|594537150|FG001|Overall Study|Lost to Follow-up|3|||
164388931|NCT03214367|593792367|FG006|Lead-in Period|Protocol Violation|0|||
164388932|NCT03214367|593792368|FG007|Lead-in Period|Protocol Violation|0|||
164388933|NCT03214367|593792361|FG000|Lead-in Period|Treatment Interruption|1|||
164388934|NCT03214367|593792362|FG001|Lead-in Period|Treatment Interruption|0|||
164388935|NCT03214367|593792363|FG002|Lead-in Period|Treatment Interruption|0|||
164388936|NCT03214367|593792364|FG003|Lead-in Period|Treatment Interruption|0|||
164388937|NCT03214367|593792365|FG004|Lead-in Period|Treatment Interruption|0|||
164388938|NCT03214367|593792366|FG005|Lead-in Period|Treatment Interruption|0|||
164388939|NCT03214367|593792367|FG006|Lead-in Period|Treatment Interruption|0|||
164388940|NCT03214367|593792368|FG007|Lead-in Period|Treatment Interruption|0|||
164388941|NCT03214367|593792361|FG000|Treatment Period|Adverse Event|0|||
164388942|NCT03214367|593792362|FG001|Treatment Period|Adverse Event|1|||
164388943|NCT03214367|593792363|FG002|Treatment Period|Adverse Event|4|||
164388944|NCT03214367|593792364|FG003|Treatment Period|Adverse Event|2|||
164593906|NCT00740779|594537151|FG002|Overall Study|Lost to Follow-up|5|||
164593907|NCT00988559|594537155|FG000|Overall Study|Withdrawal by Subject|1|||
164593908|NCT00988559|594537156|FG001|Overall Study|Withdrawal by Subject|1|||
164593909|NCT00988559|594537157|FG002|Overall Study|Withdrawal by Subject|0|||
164593910|NCT00988559|594537158|FG003|Overall Study|Withdrawal by Subject|1|||
164593911|NCT00988559|594537155|FG000|Overall Study|Pregnancy|0|||
164593912|NCT00988559|594537156|FG001|Overall Study|Pregnancy|1|||
164593913|NCT00988559|594537157|FG002|Overall Study|Pregnancy|1|||
164593914|NCT00988559|594537158|FG003|Overall Study|Pregnancy|0|||
164593915|NCT00988559|594537155|FG000|Overall Study|Lost to Follow-up|0|||
164593916|NCT00988559|594537156|FG001|Overall Study|Lost to Follow-up|0|||
164593917|NCT00988559|594537157|FG002|Overall Study|Lost to Follow-up|1|||
164593918|NCT00988559|594537158|FG003|Overall Study|Lost to Follow-up|0|||
164593919|NCT01052012|594537159|FG000|Overall Study|Not treated|2|||
164593920|NCT01052012|594537160|FG001|Overall Study|Not treated|5|||
164593921|NCT01052012|594537161|FG002|Overall Study|Not treated|0|||
164593922|NCT01052012|594537162|FG003|Overall Study|Not treated|0|||
164593923|NCT01052012|594537163|FG004|Overall Study|Not treated|11|||
164593924|NCT01052012|594537164|FG005|Overall Study|Not treated|8|||
164388945|NCT03214367|593792365|FG004|Treatment Period|Adverse Event|0|||
164388946|NCT03214367|593792366|FG005|Treatment Period|Adverse Event|0|||
164388947|NCT03214367|593792367|FG006|Treatment Period|Adverse Event|0|||
164388948|NCT03214367|593792368|FG007|Treatment Period|Adverse Event|0|||
164388949|NCT03214367|593792361|FG000|Treatment Period|Death|0|||
164388950|NCT03214367|593792362|FG001|Treatment Period|Death|1|||
164388951|NCT03214367|593792363|FG002|Treatment Period|Death|1|||
164388952|NCT03214367|593792364|FG003|Treatment Period|Death|1|||
164388953|NCT03214367|593792365|FG004|Treatment Period|Death|0|||
164388954|NCT03214367|593792366|FG005|Treatment Period|Death|0|||
164388955|NCT03214367|593792367|FG006|Treatment Period|Death|0|||
164388956|NCT03214367|593792368|FG007|Treatment Period|Death|0|||
164388957|NCT03214367|593792361|FG000|Treatment Period|Lost to Follow-up|0|||
164388958|NCT03214367|593792362|FG001|Treatment Period|Lost to Follow-up|5|||
164388959|NCT03214367|593792363|FG002|Treatment Period|Lost to Follow-up|3|||
164388960|NCT03214367|593792364|FG003|Treatment Period|Lost to Follow-up|2|||
164388961|NCT03214367|593792365|FG004|Treatment Period|Lost to Follow-up|0|||
164388962|NCT03214367|593792366|FG005|Treatment Period|Lost to Follow-up|2|||
164388963|NCT03214367|593792367|FG006|Treatment Period|Lost to Follow-up|1|||
164388964|NCT03214367|593792368|FG007|Treatment Period|Lost to Follow-up|0|||
164388965|NCT03214367|593792361|FG000|Treatment Period|Sponsor Decision|0|||
164388966|NCT03214367|593792362|FG001|Treatment Period|Sponsor Decision|3|||
164388967|NCT03214367|593792363|FG002|Treatment Period|Sponsor Decision|0|||
164388968|NCT03214367|593792364|FG003|Treatment Period|Sponsor Decision|0|||
164388969|NCT03214367|593792365|FG004|Treatment Period|Sponsor Decision|0|||
164388970|NCT03214367|593792366|FG005|Treatment Period|Sponsor Decision|0|||
164388971|NCT03214367|593792367|FG006|Treatment Period|Sponsor Decision|0|||
164388972|NCT03214367|593792368|FG007|Treatment Period|Sponsor Decision|0|||
164388973|NCT03214367|593792361|FG000|Treatment Period|Physician Decision|0|||
164388974|NCT03214367|593792362|FG001|Treatment Period|Physician Decision|1|||
164388975|NCT03214367|593792363|FG002|Treatment Period|Physician Decision|2|||
164388976|NCT03214367|593792364|FG003|Treatment Period|Physician Decision|0|||
164388977|NCT03214367|593792365|FG004|Treatment Period|Physician Decision|0|||
164388978|NCT03214367|593792366|FG005|Treatment Period|Physician Decision|0|||
164388979|NCT03214367|593792367|FG006|Treatment Period|Physician Decision|0|||
164388980|NCT03214367|593792368|FG007|Treatment Period|Physician Decision|0|||
164388981|NCT03214367|593792361|FG000|Treatment Period|Protocol Violation|0|||
164388982|NCT03214367|593792362|FG001|Treatment Period|Protocol Violation|3|||
164388983|NCT03214367|593792363|FG002|Treatment Period|Protocol Violation|0|||
164388984|NCT03214367|593792364|FG003|Treatment Period|Protocol Violation|0|||
164388985|NCT03214367|593792365|FG004|Treatment Period|Protocol Violation|0|||
164388986|NCT03214367|593792366|FG005|Treatment Period|Protocol Violation|0|||
164388987|NCT03214367|593792367|FG006|Treatment Period|Protocol Violation|0|||
164388988|NCT03214367|593792368|FG007|Treatment Period|Protocol Violation|0|||
164388989|NCT03214367|593792361|FG000|Treatment Period|Withdrawal by Subject|0|||
164388990|NCT03214367|593792362|FG001|Treatment Period|Withdrawal by Subject|20|||
164593925|NCT01052012|594537159|FG000|Overall Study|Adverse Event|1|||
164593926|NCT01052012|594537160|FG001|Overall Study|Adverse Event|0|||
164593927|NCT01052012|594537161|FG002|Overall Study|Adverse Event|0|||
164388991|NCT03214367|593792363|FG002|Treatment Period|Withdrawal by Subject|23|||
164388992|NCT03214367|593792364|FG003|Treatment Period|Withdrawal by Subject|14|||
164388993|NCT03214367|593792365|FG004|Treatment Period|Withdrawal by Subject|0|||
164388994|NCT03214367|593792366|FG005|Treatment Period|Withdrawal by Subject|1|||
164388995|NCT03214367|593792367|FG006|Treatment Period|Withdrawal by Subject|1|||
164388996|NCT03214367|593792368|FG007|Treatment Period|Withdrawal by Subject|1|||
164388997|NCT03268811|593792371|FG000|Overall Study|Adverse Event|0|||
164388998|NCT03268811|593792372|FG001|Overall Study|Adverse Event|1|||
164388999|NCT04726709|593792373|FG000|Overall Study|Withdrawal by Subject|2|||
164593928|NCT01052012|594537162|FG003|Overall Study|Adverse Event|1|||
164593929|NCT01052012|594537163|FG004|Overall Study|Adverse Event|0|||
164593930|NCT01052012|594537164|FG005|Overall Study|Adverse Event|0|||
164441087|NCT05011396|593982685|FG000|Overall Study|Positive Drug Screen|0|||
164441088|NCT05011396|593982686|FG001|Overall Study|Positive Drug Screen|1|||
164389000|NCT04726709|593792374|FG001|Overall Study|Withdrawal by Subject|2|||
164389001|NCT02117570|593792377|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
164389002|NCT02117570|593792378|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
164389003|NCT02117570|593792379|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
164389004|NCT02117570|593792377|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
164389005|NCT02117570|593792378|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
164389006|NCT02117570|593792379|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
164389007|NCT02117570|593792377|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
164389008|NCT02117570|593792378|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
164389009|NCT02117570|593792379|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
164389010|NCT02117570|593792377|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
164389011|NCT02117570|593792378|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
164389012|NCT02117570|593792379|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
164389013|NCT02117570|593792377|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
164389014|NCT02117570|593792378|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
164389015|NCT02117570|593792379|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
164389016|NCT02117570|593792377|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
164389017|NCT02117570|593792378|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
164389018|NCT02117570|593792379|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
164389019|NCT02117570|593792377|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
164389020|NCT02117570|593792378|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
164389021|NCT02117570|593792379|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
164389022|NCT02148250|593792380|FG000|Screening|Withdrawal by Subject|5|||
164389023|NCT02148250|593792381|FG001|Screening|Withdrawal by Subject|0|||
164389024|NCT04447404|593792393|FG000|Overall Study|Death|2|||
164389025|NCT04447404|593792394|FG001|Overall Study|Death|0|||
164389026|NCT00574080|593792395|FG000|Overall Study|Death|10|||
164389027|NCT00574080|593792396|FG001|Overall Study|Death|10|||
164389028|NCT01221597|593792397|FG000|Overall Study|Adverse Event|4|||
164389029|NCT01221597|593792398|FG001|Overall Study|Adverse Event|1|||
164389030|NCT01221597|593792397|FG000|Overall Study|Withdrawal by Subject|20|||
164389031|NCT01221597|593792398|FG001|Overall Study|Withdrawal by Subject|6|||
164389032|NCT01221597|593792397|FG000|Overall Study|Lost to Follow-up|6|||
164389033|NCT01221597|593792398|FG001|Overall Study|Lost to Follow-up|5|||
164389034|NCT01221597|593792397|FG000|Overall Study|Protocol Violation|1|||
164389035|NCT01221597|593792398|FG001|Overall Study|Protocol Violation|0|||
164389036|NCT01221597|593792397|FG000|Overall Study|Other|3|||
164389037|NCT01221597|593792398|FG001|Overall Study|Other|4|||
164389038|NCT01221597|593792397|FG000|Overall Study|Death|2|||
164389039|NCT01221597|593792398|FG001|Overall Study|Death|0|||
164389040|NCT00563784|593792400|FG000|Overall Study|Withdrawal by Subject|2|||
164389041|NCT00563784|593792400|FG000|Overall Study|Screen Failures|20|||
164389042|NCT04004611|593792401|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
164389043|NCT04004611|593792402|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
164389044|NCT04004611|593792403|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
164389045|NCT04004611|593792404|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
164389046|NCT04004611|593792405|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
164389047|NCT04004611|593792406|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
164389048|NCT04004611|593792407|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
164389049|NCT04004611|593792408|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
164389050|NCT04004611|593792409|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
164389051|NCT04004611|593792401|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
164389052|NCT04004611|593792402|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
164389053|NCT04004611|593792403|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
164389054|NCT04004611|593792404|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
164389055|NCT04004611|593792405|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
164389056|NCT04004611|593792406|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
164389057|NCT04004611|593792407|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
164389058|NCT04004611|593792408|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
164389059|NCT04004611|593792409|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
164389060|NCT04004611|593792401|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
164389061|NCT04004611|593792402|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
164389062|NCT04004611|593792403|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
164389063|NCT04004611|593792404|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
164389064|NCT04004611|593792405|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
164441089|NCT01400776|593982687|FG000|Overall Study|Adverse Event|7|||
164389065|NCT04004611|593792406|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
164389066|NCT04004611|593792407|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
164389067|NCT04004611|593792408|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
164389068|NCT04004611|593792409|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
164389069|NCT04004611|593792401|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
164389070|NCT04004611|593792402|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
164389071|NCT04004611|593792403|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
164389072|NCT04004611|593792404|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
164389073|NCT04004611|593792405|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
164389074|NCT04004611|593792406|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
164389075|NCT04004611|593792407|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
164389076|NCT04004611|593792408|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
164389077|NCT04004611|593792409|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
164389078|NCT04004611|593792401|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
164389079|NCT04004611|593792402|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
164389080|NCT04004611|593792403|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
164389081|NCT04004611|593792404|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
164389082|NCT04004611|593792405|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
164389083|NCT04004611|593792406|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
164389084|NCT04004611|593792407|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
164389085|NCT04004611|593792408|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
164389086|NCT04004611|593792409|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
164389087|NCT04004611|593792401|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
164389088|NCT04004611|593792402|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
164389089|NCT04004611|593792403|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
164389090|NCT04004611|593792404|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
164389091|NCT04004611|593792405|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
164389092|NCT04004611|593792406|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
164389093|NCT04004611|593792407|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
164389094|NCT04004611|593792408|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
164389095|NCT04004611|593792409|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
164389096|NCT00320216|593792410|FG000|Overall Study|Adverse Event|0|||
164389097|NCT00320216|593792411|FG001|Overall Study|Adverse Event|6|||
164389098|NCT00320216|593792412|FG002|Overall Study|Adverse Event|0|||
164389099|NCT00320216|593792413|FG003|Overall Study|Adverse Event|2|||
164389100|NCT00320216|593792414|FG004|Overall Study|Adverse Event|2|||
164389101|NCT00320216|593792410|FG000|Overall Study|Lack of Efficacy|6|||
164389102|NCT00320216|593792411|FG001|Overall Study|Lack of Efficacy|2|||
164389103|NCT00320216|593792412|FG002|Overall Study|Lack of Efficacy|1|||
164389104|NCT00320216|593792413|FG003|Overall Study|Lack of Efficacy|0|||
164389105|NCT00320216|593792414|FG004|Overall Study|Lack of Efficacy|1|||
164389106|NCT00320216|593792410|FG000|Overall Study|Lost to Follow-up|3|||
164389107|NCT00320216|593792411|FG001|Overall Study|Lost to Follow-up|0|||
164389108|NCT00320216|593792412|FG002|Overall Study|Lost to Follow-up|0|||
164389109|NCT00320216|593792413|FG003|Overall Study|Lost to Follow-up|0|||
164389110|NCT00320216|593792414|FG004|Overall Study|Lost to Follow-up|0|||
164389111|NCT00320216|593792410|FG000|Overall Study|Other|7|||
164389112|NCT00320216|593792411|FG001|Overall Study|Other|2|||
164389113|NCT00320216|593792412|FG002|Overall Study|Other|5|||
164389114|NCT00320216|593792413|FG003|Overall Study|Other|1|||
164389115|NCT00320216|593792414|FG004|Overall Study|Other|3|||
164389116|NCT00148343|593792415|FG000|Overall Study|Withdrawal by Subject|12|||
164389117|NCT00148343|593792416|FG001|Overall Study|Withdrawal by Subject|7|||
164389118|NCT00148343|593792415|FG000|Overall Study|Physician Decision|3|||
164441090|NCT01400776|593982688|FG001|Overall Study|Adverse Event|2|||
164441091|NCT01400776|593982689|FG002|Overall Study|Adverse Event|9|||
164441092|NCT01400776|593982690|FG003|Overall Study|Adverse Event|2|||
164441093|NCT01400776|593982687|FG000|Overall Study|Lost to Follow-up|1|||
164441094|NCT01400776|593982688|FG001|Overall Study|Lost to Follow-up|0|||
164441095|NCT01400776|593982689|FG002|Overall Study|Lost to Follow-up|4|||
164441096|NCT01400776|593982690|FG003|Overall Study|Lost to Follow-up|1|||
164441097|NCT01400776|593982687|FG000|Overall Study|Withdrew Consent|4|||
164441098|NCT01400776|593982688|FG001|Overall Study|Withdrew Consent|2|||
164441099|NCT01400776|593982689|FG002|Overall Study|Withdrew Consent|6|||
164441100|NCT01400776|593982690|FG003|Overall Study|Withdrew Consent|1|||
164441101|NCT01400776|593982687|FG000|Overall Study|Protocol Deviation|6|||
164441102|NCT01400776|593982688|FG001|Overall Study|Protocol Deviation|1|||
164441103|NCT01400776|593982689|FG002|Overall Study|Protocol Deviation|5|||
164441104|NCT01400776|593982690|FG003|Overall Study|Protocol Deviation|2|||
164441105|NCT01400776|593982687|FG000|Overall Study|Reason not Specified|3|||
164441106|NCT01400776|593982688|FG001|Overall Study|Reason not Specified|0|||
164441107|NCT01400776|593982689|FG002|Overall Study|Reason not Specified|4|||
164441108|NCT01400776|593982690|FG003|Overall Study|Reason not Specified|3|||
164441109|NCT00423098|593982691|FG000|Overall Study|Adverse Event|1|||
164703786|NCT05071313|594941792|FG000|Overall Study|Other|1|||
164389119|NCT00148343|593792416|FG001|Overall Study|Physician Decision|4|||
164389120|NCT02384759|593792430|FG000|Overall Study|Patients not treated|3|||
164389121|NCT02384759|593792431|FG001|Overall Study|Patients not treated|2|||
164389122|NCT01605617|593792432|FG000|First Intervention|Adverse Event|0|||
164389123|NCT01605617|593792433|FG001|First Intervention|Adverse Event|1|||
164389124|NCT01605617|593792432|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
164389125|NCT01605617|593792433|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
164389126|NCT00121238|593792434|FG000|Overall Study|disease progression before intervention|1|||
164389127|NCT00121238|593792434|FG000|Overall Study|Protocol Violation|2|||
164389128|NCT01380327|593792435|FG000|Overall Study|Lost to Follow-up|0|||
164389129|NCT01380327|593792436|FG001|Overall Study|Lost to Follow-up|1|||
164389130|NCT01380327|593792437|FG002|Overall Study|Lost to Follow-up|1|||
164389131|NCT01380327|593792435|FG000|Overall Study|Protocol Violation|3|||
164703787|NCT05071313|594941793|FG001|Overall Study|Other|0|||
164703788|NCT05071313|594941792|FG000|Overall Study|Randomized but not vaccinated|4|||
164703789|NCT05071313|594941793|FG001|Overall Study|Randomized but not vaccinated|2|||
164703790|NCT00541970|594941794|FG000|Month 7|Protocol Violation|9|||
164300144|NCT04543279|593475146|FG000|Overall Study|Physician Decision|1|||
164300145|NCT04543279|593475147|FG001|Overall Study|Physician Decision|0|||
164300146|NCT00929695|593475150|FG000|Overall Study|Death|2|||
164300147|NCT00929695|593475151|FG001|Overall Study|Death|1|||
164300148|NCT00929695|593475150|FG000|Overall Study|Withdrawal by Subject|0|||
164300149|NCT00929695|593475151|FG001|Overall Study|Withdrawal by Subject|2|||
164300150|NCT00929695|593475150|FG000|Overall Study|discharge home|4|||
164300151|NCT00929695|593475151|FG001|Overall Study|discharge home|3|||
164300152|NCT00929695|593475150|FG000|Overall Study|incorrect stratification|2|||
164300153|NCT00929695|593475151|FG001|Overall Study|incorrect stratification|0|||
164300154|NCT04030143|593475152|FG000|Overall Study|Adverse Event|5|||
164300155|NCT04030143|593475153|FG001|Overall Study|Adverse Event|10|||
164300156|NCT04030143|593475152|FG000|Overall Study|Lost to Follow-up|3|||
164300157|NCT04030143|593475153|FG001|Overall Study|Lost to Follow-up|7|||
164300158|NCT04030143|593475152|FG000|Overall Study|Protocol Deviation|2|||
164300159|NCT04030143|593475153|FG001|Overall Study|Protocol Deviation|2|||
164300160|NCT04030143|593475152|FG000|Overall Study|Withdrawal by Subject|16|||
164300161|NCT04030143|593475153|FG001|Overall Study|Withdrawal by Subject|18|||
164300162|NCT04030143|593475152|FG000|Overall Study|Physician Decision|1|||
164300163|NCT04030143|593475153|FG001|Overall Study|Physician Decision|1|||
164300164|NCT04030143|593475152|FG000|Overall Study|Due to Covid-19|2|||
164300165|NCT04030143|593475153|FG001|Overall Study|Due to Covid-19|3|||
164300166|NCT04030143|593475152|FG000|Overall Study|Not Due to Covid-19|1|||
164300167|NCT04030143|593475153|FG001|Overall Study|Not Due to Covid-19|1|||
164300168|NCT03216226|593475154|FG000|Overall Study|Adverse Event|3|||
164300169|NCT03216226|593475155|FG001|Overall Study|Adverse Event|0|||
164300170|NCT03216226|593475154|FG000|Overall Study|Protocol Violation|1|||
164300171|NCT03216226|593475155|FG001|Overall Study|Protocol Violation|3|||
164300172|NCT03216226|593475154|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
164300173|NCT03216226|593475155|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
164300174|NCT03216226|593475154|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
164300175|NCT03216226|593475155|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
164300176|NCT03216226|593475154|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
164300177|NCT03216226|593475155|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
164300178|NCT01352715|593475157|FG000|Overall Study|Death|3|||
164300179|NCT01352715|593475158|FG001|Overall Study|Death|3|||
164300180|NCT01352715|593475157|FG000|Overall Study|Lost to Follow-up|5|||
164300181|NCT01352715|593475158|FG001|Overall Study|Lost to Follow-up|7|||
164300182|NCT01352715|593475157|FG000|Overall Study|Withdrawal by Subject|4|||
164300183|NCT01352715|593475158|FG001|Overall Study|Withdrawal by Subject|8|||
164300184|NCT01352715|593475157|FG000|Overall Study|site closure|16|||
164300185|NCT01352715|593475158|FG001|Overall Study|site closure|15|||
164300186|NCT01352715|593475157|FG000|Overall Study|no final visit in closeout period|15|||
164300187|NCT01352715|593475158|FG001|Overall Study|no final visit in closeout period|12|||
164300188|NCT01352715|593475157|FG000|Overall Study|major ineligibility|2|||
164300189|NCT01352715|593475158|FG001|Overall Study|major ineligibility|1|||
164300190|NCT05966142|593475159|FG000|Overall Study|Death|3|||
164300191|NCT05966142|593475160|FG001|Overall Study|Death|3|||
164300192|NCT05966142|593475159|FG000|Overall Study|Lost to Follow-up|55|||
164300193|NCT05966142|593475160|FG001|Overall Study|Lost to Follow-up|52|||
164300194|NCT05966142|593475159|FG000|Overall Study|Physician Decision|1|||
164300195|NCT05966142|593475160|FG001|Overall Study|Physician Decision|0|||
164300196|NCT05966142|593475159|FG000|Overall Study|Withdrawal by Subject|9|||
164300197|NCT05966142|593475160|FG001|Overall Study|Withdrawal by Subject|8|||
164300198|NCT05966142|593475159|FG000|Overall Study|Duplicate Enrollment|1|||
164300199|NCT05966142|593475160|FG001|Overall Study|Duplicate Enrollment|0|||
164593931|NCT01052012|594537159|FG000|Overall Study|Lost to Follow-up|0|||
164593932|NCT01052012|594537160|FG001|Overall Study|Lost to Follow-up|0|||
164593933|NCT01052012|594537161|FG002|Overall Study|Lost to Follow-up|0|||
164593934|NCT01052012|594537162|FG003|Overall Study|Lost to Follow-up|0|||
164593935|NCT01052012|594537163|FG004|Overall Study|Lost to Follow-up|1|||
164593936|NCT01052012|594537164|FG005|Overall Study|Lost to Follow-up|0|||
164593937|NCT01052012|594537159|FG000|Overall Study|Withdrawal by Subject|1|||
164593938|NCT01052012|594537160|FG001|Overall Study|Withdrawal by Subject|1|||
164593939|NCT01052012|594537161|FG002|Overall Study|Withdrawal by Subject|0|||
164593940|NCT01052012|594537162|FG003|Overall Study|Withdrawal by Subject|0|||
164593941|NCT01052012|594537163|FG004|Overall Study|Withdrawal by Subject|3|||
164593942|NCT01052012|594537164|FG005|Overall Study|Withdrawal by Subject|1|||
164593943|NCT01052012|594537159|FG000|Overall Study|Physician Decision|0|||
164593944|NCT01052012|594537160|FG001|Overall Study|Physician Decision|0|||
164593945|NCT01052012|594537161|FG002|Overall Study|Physician Decision|0|||
164593946|NCT01052012|594537162|FG003|Overall Study|Physician Decision|0|||
164593947|NCT01052012|594537163|FG004|Overall Study|Physician Decision|0|||
164593948|NCT01052012|594537164|FG005|Overall Study|Physician Decision|1|||
164593949|NCT01052012|594537159|FG000|Overall Study|Other|0|||
164593950|NCT01052012|594537160|FG001|Overall Study|Other|0|||
164593951|NCT01052012|594537161|FG002|Overall Study|Other|0|||
164593952|NCT01052012|594537162|FG003|Overall Study|Other|0|||
164593953|NCT01052012|594537163|FG004|Overall Study|Other|1|||
164593954|NCT01052012|594537164|FG005|Overall Study|Other|0|||
164593955|NCT00829166|594537168|FG000|Overall Study|Death|305|||
164593956|NCT00829166|594537169|FG001|Overall Study|Death|333|||
164593957|NCT00829166|594537168|FG000|Overall Study|Lost to Follow-up|5|||
164593958|NCT00829166|594537169|FG001|Overall Study|Lost to Follow-up|4|||
164593959|NCT00829166|594537168|FG000|Overall Study|Physician's Decision|4|||
164593960|NCT00829166|594537169|FG001|Overall Study|Physician's Decision|3|||
164593961|NCT00829166|594537168|FG000|Overall Study|Subject's Decision|41|||
164593962|NCT00829166|594537169|FG001|Overall Study|Subject's Decision|55|||
164593963|NCT00829166|594537168|FG000|Overall Study|Sponsor's Decision|137|||
164593964|NCT00829166|594537169|FG001|Overall Study|Sponsor's Decision|98|||
164593965|NCT00829166|594537168|FG000|Overall Study|Reason Not Specified|3|||
164593966|NCT00829166|594537169|FG001|Overall Study|Reason Not Specified|3|||
164593967|NCT02538666|594537170|FG000|Pre-Treatment|Disease progression|1|||
164593968|NCT02538666|594537171|FG001|Pre-Treatment|Disease progression|0|||
164593969|NCT02538666|594537172|FG002|Pre-Treatment|Disease progression|0|||
164593970|NCT02538666|594537170|FG000|Pre-Treatment|no longer meets study criteria|1|||
164593971|NCT02538666|594537171|FG001|Pre-Treatment|no longer meets study criteria|0|||
164593972|NCT02538666|594537172|FG002|Pre-Treatment|no longer meets study criteria|0|||
164593973|NCT02538666|594537170|FG000|Pre-Treatment|Withdrew Consent|0|||
164593974|NCT02538666|594537171|FG001|Pre-Treatment|Withdrew Consent|1|||
164593975|NCT02538666|594537172|FG002|Pre-Treatment|Withdrew Consent|1|||
164593976|NCT02538666|594537170|FG000|Treatment|Disease progression|270|||
164593977|NCT02538666|594537171|FG001|Treatment|Disease progression|227|||
164593978|NCT02538666|594537172|FG002|Treatment|Disease progression|165|||
164593979|NCT02538666|594537170|FG000|Treatment|Study drug toxicity|1|||
164593980|NCT02538666|594537171|FG001|Treatment|Study drug toxicity|29|||
164593981|NCT02538666|594537172|FG002|Treatment|Study drug toxicity|92|||
164593982|NCT02538666|594537170|FG000|Treatment|Death|0|||
164593983|NCT02538666|594537171|FG001|Treatment|Death|2|||
164593984|NCT02538666|594537172|FG002|Treatment|Death|3|||
164593985|NCT02538666|594537170|FG000|Treatment|Adverse event unrelated to study drug|8|||
164593986|NCT02538666|594537171|FG001|Treatment|Adverse event unrelated to study drug|10|||
164593987|NCT02538666|594537172|FG002|Treatment|Adverse event unrelated to study drug|15|||
164593988|NCT02538666|594537170|FG000|Treatment|Participant request to discontinue study treatment|3|||
164593989|NCT02538666|594537171|FG001|Treatment|Participant request to discontinue study treatment|6|||
164593990|NCT02538666|594537172|FG002|Treatment|Participant request to discontinue study treatment|11|||
164593991|NCT02538666|594537170|FG000|Treatment|Participant withdrew consent|2|||
164593992|NCT02538666|594537171|FG001|Treatment|Participant withdrew consent|5|||
164593993|NCT02538666|594537172|FG002|Treatment|Participant withdrew consent|3|||
164593994|NCT02538666|594537170|FG000|Treatment|Lost to Follow-up|0|||
164593995|NCT02538666|594537171|FG001|Treatment|Lost to Follow-up|1|||
164593996|NCT02538666|594537172|FG002|Treatment|Lost to Follow-up|1|||
164593997|NCT02538666|594537170|FG000|Treatment|Maximum clinical benefit|4|||
164593998|NCT02538666|594537171|FG001|Treatment|Maximum clinical benefit|3|||
164593999|NCT02538666|594537172|FG002|Treatment|Maximum clinical benefit|4|||
164594000|NCT02538666|594537170|FG000|Treatment|Poor/non-compliance|0|||
164594001|NCT02538666|594537171|FG001|Treatment|Poor/non-compliance|1|||
164594002|NCT02538666|594537172|FG002|Treatment|Poor/non-compliance|0|||
164594003|NCT02538666|594537170|FG000|Treatment|Participant no longer meets study criteria|0|||
164594004|NCT02538666|594537171|FG001|Treatment|Participant no longer meets study criteria|2|||
164594005|NCT02538666|594537172|FG002|Treatment|Participant no longer meets study criteria|0|||
164594006|NCT02538666|594537170|FG000|Treatment|Administrative reason by sponsor|0|||
164594007|NCT02538666|594537171|FG001|Treatment|Administrative reason by sponsor|0|||
164594008|NCT02538666|594537172|FG002|Treatment|Administrative reason by sponsor|1|||
164389132|NCT01380327|593792436|FG001|Overall Study|Protocol Violation|2|||
164389133|NCT01380327|593792437|FG002|Overall Study|Protocol Violation|3|||
164389134|NCT01380327|593792435|FG000|Overall Study|Withdrawal by Subject|0|||
164389135|NCT01380327|593792436|FG001|Overall Study|Withdrawal by Subject|0|||
164389136|NCT01380327|593792437|FG002|Overall Study|Withdrawal by Subject|1|||
164389137|NCT01380327|593792435|FG000|Overall Study|Housing situation precluded ability to k|0|||
164389138|NCT01380327|593792436|FG001|Overall Study|Housing situation precluded ability to k|0|||
164389139|NCT01380327|593792437|FG002|Overall Study|Housing situation precluded ability to k|1|||
164389140|NCT01380327|593792435|FG000|Overall Study|Questionable onset of epilepsy|0|||
164389141|NCT01380327|593792436|FG001|Overall Study|Questionable onset of epilepsy|0|||
164389142|NCT01380327|593792437|FG002|Overall Study|Questionable onset of epilepsy|1|||
164389143|NCT03043664|593792438|FG000|Overall Study|Lost to Follow-up|1|||
164389144|NCT01540851|593792439|FG000|Overall Study|Lost to Follow-up|14|||
164389145|NCT01540851|593792440|FG001|Overall Study|Lost to Follow-up|15|||
164389146|NCT01540851|593792439|FG000|Overall Study|Withdrawal by Subject|7|||
164389147|NCT01540851|593792440|FG001|Overall Study|Withdrawal by Subject|3|||
164389148|NCT00325468|593792441|FG000|Overall Study|Adverse Event|1|||
164389149|NCT00325468|593792442|FG001|Overall Study|Adverse Event|1|||
164389150|NCT00325468|593792443|FG002|Overall Study|Adverse Event|0|||
164389151|NCT00325468|593792444|FG003|Overall Study|Adverse Event|5|||
164389152|NCT00325468|593792445|FG004|Overall Study|Adverse Event|1|||
164389153|NCT00325468|593792441|FG000|Overall Study|Death|2|||
164389154|NCT00325468|593792442|FG001|Overall Study|Death|0|||
164389155|NCT00325468|593792443|FG002|Overall Study|Death|2|||
164389156|NCT00325468|593792444|FG003|Overall Study|Death|4|||
164389157|NCT00325468|593792445|FG004|Overall Study|Death|0|||
164389158|NCT00325468|593792441|FG000|Overall Study|Lost to Follow-up|0|||
164389159|NCT00325468|593792442|FG001|Overall Study|Lost to Follow-up|0|||
164389160|NCT00325468|593792443|FG002|Overall Study|Lost to Follow-up|1|||
164389161|NCT00325468|593792444|FG003|Overall Study|Lost to Follow-up|2|||
164441110|NCT00423098|593982692|FG001|Overall Study|Adverse Event|2|||
164441111|NCT00423098|593982691|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164441112|NCT00423098|593982692|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
164441113|NCT00423098|593982691|FG000|Overall Study|Administrative problems|0|||
164441114|NCT00423098|593982692|FG001|Overall Study|Administrative problems|1|||
164441115|NCT00423098|593982691|FG000|Overall Study|Death|2|||
164441116|NCT00423098|593982692|FG001|Overall Study|Death|0|||
164441117|NCT00711958|593982705|FG000|Overall Study|Withdrawal by Subject|6|||
164441118|NCT00711958|593982706|FG001|Overall Study|Withdrawal by Subject|8|||
164441119|NCT00711958|593982705|FG000|Overall Study|Lack of Efficacy|3|||
164441120|NCT00711958|593982706|FG001|Overall Study|Lack of Efficacy|1|||
164441121|NCT00711958|593982705|FG000|Overall Study|Clinical deterioration|1|||
164441122|NCT00711958|593982706|FG001|Overall Study|Clinical deterioration|0|||
164441123|NCT00711958|593982705|FG000|Overall Study|Adverse Event|9|||
164441124|NCT00711958|593982706|FG001|Overall Study|Adverse Event|7|||
164441125|NCT00711958|593982705|FG000|Overall Study|Protocol Violation|1|||
164441126|NCT00711958|593982706|FG001|Overall Study|Protocol Violation|0|||
164441127|NCT00711958|593982705|FG000|Overall Study|Lost to Follow-up|2|||
164441128|NCT00711958|593982706|FG001|Overall Study|Lost to Follow-up|2|||
164441129|NCT00711958|593982705|FG000|Overall Study|Death|10|||
164441130|NCT00711958|593982706|FG001|Overall Study|Death|5|||
164441131|NCT00711958|593982705|FG000|Overall Study|Progression of disease|1|||
164441132|NCT00711958|593982706|FG001|Overall Study|Progression of disease|0|||
164441133|NCT02383472|593982707|FG000|Overall Study|Withdrawal by Subject|1|||
164441134|NCT02383472|593982708|FG001|Overall Study|Withdrawal by Subject|1|||
164441135|NCT01111526|593982709|FG000|Overall Study|GVHD Disease Progression|0|||
164441136|NCT01111526|593982710|FG001|Overall Study|GVHD Disease Progression|1|||
164441137|NCT01111526|593982711|FG002|Overall Study|GVHD Disease Progression|2|||
164441138|NCT02013830|593982712|FG000|Overall Study|Adverse Event|3|||
164441139|NCT02013830|593982712|FG000|Overall Study|Death|1|||
164441140|NCT02013830|593982712|FG000|Overall Study|Insufficient therapeutic response|25|||
164441141|NCT02013830|593982712|FG000|Overall Study|Refused treatment|1|||
164441142|NCT04424641|593982713|FG000|Overall Study|Death|1|||
164441143|NCT04424641|593982714|FG001|Overall Study|Death|2|||
164441144|NCT04424641|593982715|FG002|Overall Study|Death|3|||
164441145|NCT04424641|593982716|FG003|Overall Study|Death|0|||
164389162|NCT00325468|593792445|FG004|Overall Study|Lost to Follow-up|2|||
164389163|NCT00325468|593792441|FG000|Overall Study|Physician Decision|1|||
164441146|NCT04424641|593982717|FG004|Overall Study|Death|3|||
164441147|NCT04424641|593982718|FG005|Overall Study|Death|0|||
164441148|NCT04424641|593982719|FG006|Overall Study|Death|1|||
164441149|NCT04424641|593982720|FG007|Overall Study|Death|2|||
164441150|NCT04424641|593982713|FG000|Overall Study|Sponsor decision|0|||
164441151|NCT04424641|593982714|FG001|Overall Study|Sponsor decision|2|||
164441152|NCT04424641|593982715|FG002|Overall Study|Sponsor decision|3|||
164441153|NCT04424641|593982716|FG003|Overall Study|Sponsor decision|7|||
164441154|NCT04424641|593982717|FG004|Overall Study|Sponsor decision|2|||
164441155|NCT04424641|593982718|FG005|Overall Study|Sponsor decision|2|||
164441156|NCT04424641|593982719|FG006|Overall Study|Sponsor decision|3|||
164594009|NCT02538666|594537170|FG000|Treatment|Other reasons|8|||
164594010|NCT02538666|594537171|FG001|Treatment|Other reasons|15|||
164594011|NCT02538666|594537172|FG002|Treatment|Other reasons|5|||
164594012|NCT02538666|594537170|FG000|Treatment|Not reported|2|||
164594013|NCT02538666|594537171|FG001|Treatment|Not reported|2|||
164594014|NCT02538666|594537172|FG002|Treatment|Not reported|2|||
164594015|NCT00320385|594537176|FG000|Overall Study|Lost to Follow-up|7|||
164594016|NCT00320385|594537177|FG001|Overall Study|Lost to Follow-up|10|||
164594017|NCT00320385|594537176|FG000|Overall Study|Withdrawal by Subject|6|||
164594018|NCT00320385|594537177|FG001|Overall Study|Withdrawal by Subject|7|||
164594019|NCT00320385|594537176|FG000|Overall Study|Sponsor Terminated Study|2|||
164594020|NCT00320385|594537177|FG001|Overall Study|Sponsor Terminated Study|1|||
164594021|NCT00320385|594537176|FG000|Overall Study|Investigator Decision|0|||
164594022|NCT00320385|594537177|FG001|Overall Study|Investigator Decision|1|||
164594023|NCT00320385|594537176|FG000|Overall Study|Death|1|||
164594024|NCT00320385|594537177|FG001|Overall Study|Death|2|||
164594025|NCT00320385|594537176|FG000|Overall Study|Serious Adverse Event|1|||
164594026|NCT00320385|594537177|FG001|Overall Study|Serious Adverse Event|0|||
164594027|NCT00320385|594537176|FG000|Overall Study|Withdrew Consent|1|||
164594028|NCT00320385|594537177|FG001|Overall Study|Withdrew Consent|0|||
164594029|NCT00320385|594537176|FG000|Overall Study|Adverse Event|0|||
164594030|NCT00320385|594537177|FG001|Overall Study|Adverse Event|1|||
164594031|NCT04370028|594537178|FG000|Overall Study|Withdrawal by Subject|695|||
164594032|NCT04370028|594537178|FG000|Overall Study|Protocol Violation|9|||
164594033|NCT04370028|594537178|FG000|Overall Study|Adverse Event|3|||
164594034|NCT02582749|594537184|FG000|Overall Study|Study terminated by funder|5|||
164594035|NCT02582749|594537185|FG001|Overall Study|Study terminated by funder|10|||
164441157|NCT04424641|593982720|FG007|Overall Study|Sponsor decision|4|||
164441158|NCT04424641|593982713|FG000|Overall Study|Withdrawal by Subject|0|||
164441159|NCT04424641|593982714|FG001|Overall Study|Withdrawal by Subject|0|||
164441160|NCT04424641|593982715|FG002|Overall Study|Withdrawal by Subject|0|||
164441161|NCT04424641|593982716|FG003|Overall Study|Withdrawal by Subject|0|||
164441162|NCT04424641|593982717|FG004|Overall Study|Withdrawal by Subject|1|||
164441163|NCT04424641|593982718|FG005|Overall Study|Withdrawal by Subject|0|||
164441164|NCT04424641|593982719|FG006|Overall Study|Withdrawal by Subject|0|||
164441165|NCT04424641|593982720|FG007|Overall Study|Withdrawal by Subject|0|||
164441166|NCT04424641|593982713|FG000|Overall Study|Other|0|||
164594036|NCT02582749|594537184|FG000|Overall Study|Withdrawal by Subject|0|||
164594037|NCT02582749|594537185|FG001|Overall Study|Withdrawal by Subject|1|||
164594038|NCT01518192|594537186|FG000|Overall Study|Lost to Follow-up|29|||
164594039|NCT01518192|594537187|FG001|Overall Study|Lost to Follow-up|26|||
164594040|NCT01518192|594537188|FG002|Overall Study|Lost to Follow-up|35|||
164594041|NCT00540436|594537194|FG000|First 12-Week Treatment Period|Adverse Event|1|||
164594042|NCT00540436|594537194|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
164594043|NCT00540436|594537194|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
164594044|NCT00540436|594537194|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
164594045|NCT01515306|594537195|FG000|Overall Study|Adverse Event|3|||
164594046|NCT01515306|594537196|FG001|Overall Study|Adverse Event|2|||
164594047|NCT01515306|594537195|FG000|Overall Study|Progressive Disease|19|||
164594048|NCT01515306|594537196|FG001|Overall Study|Progressive Disease|9|||
164594049|NCT01515306|594537195|FG000|Overall Study|Withdrawal by Subject|1|||
164594050|NCT01515306|594537196|FG001|Overall Study|Withdrawal by Subject|2|||
164594051|NCT01515306|594537195|FG000|Overall Study|Physician Decision|1|||
164594052|NCT01515306|594537196|FG001|Overall Study|Physician Decision|1|||
164703791|NCT00541970|594941795|FG001|Month 7|Protocol Violation|13|||
164703792|NCT00541970|594941796|FG002|Month 7|Protocol Violation|11|||
164703793|NCT00541970|594941797|FG003|Month 7|Protocol Violation|5|||
164703794|NCT00541970|594941794|FG000|Month 12|Adverse Event|0|||
164703795|NCT00541970|594941795|FG001|Month 12|Adverse Event|1|||
164703796|NCT00541970|594941796|FG002|Month 12|Adverse Event|1|||
164703797|NCT00541970|594941797|FG003|Month 12|Adverse Event|1|||
164703798|NCT00541970|594941794|FG000|Month 12|Protocol Violation|12|||
164703799|NCT00541970|594941795|FG001|Month 12|Protocol Violation|21|||
164441167|NCT04424641|593982714|FG001|Overall Study|Other|0|||
164594053|NCT00683475|594539087|FG000|Overall Study|Withdrawal by Subject|1|||
164594054|NCT00683475|594539088|FG001|Overall Study|Withdrawal by Subject|0|||
164594055|NCT00683475|594539087|FG000|Overall Study|Never Treated: Adverse Event|2|||
164594056|NCT00683475|594539088|FG001|Overall Study|Never Treated: Adverse Event|3|||
164594057|NCT00683475|594539087|FG000|Overall Study|Never Treated: Progressive Disease|1|||
164594058|NCT00683475|594539088|FG001|Overall Study|Never Treated: Progressive Disease|0|||
164594059|NCT03364335|594539091|FG000|Overall Study|Adverse Event|3|||
164594060|NCT03364335|594539092|FG001|Overall Study|Adverse Event|4|||
164594061|NCT03364335|594539093|FG002|Overall Study|Adverse Event|1|||
164594062|NCT03364335|594539094|FG003|Overall Study|Adverse Event|2|||
164594063|NCT03364335|594539095|FG004|Overall Study|Adverse Event|0|||
164703800|NCT00541970|594941796|FG002|Month 12|Protocol Violation|20|||
164703801|NCT00541970|594941797|FG003|Month 12|Protocol Violation|15|||
164703802|NCT00541970|594941794|FG000|Month 18|Adverse Event|0|||
164703803|NCT00541970|594941795|FG001|Month 18|Adverse Event|1|||
164594064|NCT03364335|594539091|FG000|Overall Study|Lost to Follow-up|7|||
164594065|NCT03364335|594539092|FG001|Overall Study|Lost to Follow-up|7|||
164594066|NCT03364335|594539093|FG002|Overall Study|Lost to Follow-up|10|||
164594067|NCT03364335|594539094|FG003|Overall Study|Lost to Follow-up|11|||
164594068|NCT03364335|594539095|FG004|Overall Study|Lost to Follow-up|11|||
164594069|NCT03725202|594539096|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
164594070|NCT03725202|594539097|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
164594071|NCT03725202|594539098|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
164594072|NCT03725202|594539099|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
164594073|NCT03725202|594539100|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
164594074|NCT03725202|594539101|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
164594075|NCT03725202|594539102|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
164594076|NCT03725202|594539103|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
164594077|NCT03725202|594539096|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
164594078|NCT03725202|594539097|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
164594079|NCT03725202|594539098|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
164594080|NCT03725202|594539099|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
164594081|NCT03725202|594539100|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
164594082|NCT03725202|594539101|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
164594083|NCT03725202|594539102|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
164594084|NCT03725202|594539103|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
164594085|NCT03725202|594539096|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
164594086|NCT03725202|594539097|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
164594087|NCT03725202|594539098|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
164703804|NCT00541970|594941796|FG002|Month 18|Adverse Event|1|||
164703805|NCT00541970|594941797|FG003|Month 18|Adverse Event|1|||
164703806|NCT00541970|594941794|FG000|Month 18|Protocol Violation|14|||
164703807|NCT00541970|594941795|FG001|Month 18|Protocol Violation|23|||
164703808|NCT00541970|594941796|FG002|Month 18|Protocol Violation|24|||
164703809|NCT00541970|594941797|FG003|Month 18|Protocol Violation|16|||
164703810|NCT00541970|594941794|FG000|Month 24|Adverse Event|0|||
164703811|NCT00541970|594941795|FG001|Month 24|Adverse Event|1|||
164594088|NCT03725202|594539099|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
164594089|NCT03725202|594539100|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
164594090|NCT03725202|594539101|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
164594091|NCT03725202|594539102|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
164594092|NCT03725202|594539103|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
164594093|NCT03725202|594539096|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
164594094|NCT03725202|594539097|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
164594095|NCT03725202|594539098|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
164594096|NCT03725202|594539099|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
164594097|NCT03725202|594539100|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
164594098|NCT03725202|594539101|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
164594099|NCT03725202|594539102|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
164594100|NCT03725202|594539103|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
164594101|NCT03725202|594539096|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
164594102|NCT03725202|594539097|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
164594103|NCT03725202|594539098|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
164594104|NCT03725202|594539099|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
164594105|NCT03725202|594539100|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
164594106|NCT03725202|594539101|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
164594107|NCT03725202|594539102|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
164594108|NCT03725202|594539103|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
164594109|NCT03725202|594539096|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
164594110|NCT03725202|594539097|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
164594111|NCT03725202|594539098|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
164594112|NCT03725202|594539099|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
164594113|NCT03725202|594539100|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
164594114|NCT03725202|594539101|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
164441168|NCT04424641|593982715|FG002|Overall Study|Other|1|||
164441169|NCT04424641|593982716|FG003|Overall Study|Other|0|||
164703812|NCT00541970|594941796|FG002|Month 24|Adverse Event|1|||
164703813|NCT00541970|594941797|FG003|Month 24|Adverse Event|1|||
164703814|NCT00541970|594941794|FG000|Month 24|Protocol Violation|29|||
164594115|NCT03725202|594539102|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
164594116|NCT03725202|594539103|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
164594117|NCT03725202|594539096|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
164594118|NCT03725202|594539097|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
164594119|NCT03725202|594539098|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
164594120|NCT03725202|594539099|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
164594121|NCT03725202|594539100|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
164594122|NCT03725202|594539101|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
164594123|NCT03725202|594539102|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
164594124|NCT03725202|594539103|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
164594125|NCT03725202|594539096|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
164594126|NCT03725202|594539097|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
164594127|NCT03725202|594539098|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
164594128|NCT03725202|594539099|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
164594129|NCT03725202|594539100|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
164594130|NCT03725202|594539101|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
164594131|NCT03725202|594539102|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
164594132|NCT03725202|594539103|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
164594133|NCT03725202|594539096|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
164594134|NCT03725202|594539097|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
164594135|NCT03725202|594539098|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
164594136|NCT03725202|594539099|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
164594137|NCT03725202|594539100|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
164594138|NCT03725202|594539101|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
164594139|NCT03725202|594539102|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
164594140|NCT03725202|594539103|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
164594141|NCT03725202|594539096|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
164594142|NCT03725202|594539097|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
164594143|NCT03725202|594539098|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
164594144|NCT03725202|594539099|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
164594145|NCT03725202|594539100|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
164594146|NCT03725202|594539101|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
164594147|NCT03725202|594539102|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
164594148|NCT03725202|594539103|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
164594149|NCT03725202|594539096|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
164594150|NCT03725202|594539097|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
164594151|NCT03725202|594539098|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
164594152|NCT03725202|594539099|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
164594153|NCT03725202|594539100|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
164594154|NCT03725202|594539101|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
164594155|NCT03725202|594539102|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
164594156|NCT03725202|594539103|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
164594157|NCT03725202|594539096|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
164594158|NCT03725202|594539097|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
164594159|NCT03725202|594539098|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
164594160|NCT03725202|594539099|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
164594161|NCT03725202|594539100|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
164703815|NCT00541970|594941795|FG001|Month 24|Protocol Violation|31|||
164703816|NCT00541970|594941796|FG002|Month 24|Protocol Violation|31|||
164703817|NCT00541970|594941797|FG003|Month 24|Protocol Violation|21|||
164703818|NCT00541970|594941794|FG000|Month 36|Protocol Violation|61|||
164703819|NCT00541970|594941795|FG001|Month 36|Protocol Violation|66|||
164703820|NCT00541970|594941796|FG002|Month 36|Protocol Violation|66|||
164703821|NCT00541970|594941797|FG003|Month 36|Protocol Violation|60|||
164703822|NCT00541970|594941794|FG000|Month 48|Withdrawal by Subject|2|||
164703823|NCT00541970|594941795|FG001|Month 48|Withdrawal by Subject|4|||
164703824|NCT00541970|594941796|FG002|Month 48|Withdrawal by Subject|4|||
164703825|NCT00541970|594941797|FG003|Month 48|Withdrawal by Subject|2|||
164703826|NCT00541970|594941794|FG000|Month 48|Other|3|||
164703827|NCT00541970|594941795|FG001|Month 48|Other|1|||
164389164|NCT00325468|593792442|FG001|Overall Study|Physician Decision|1|||
164594162|NCT03725202|594539101|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
164594163|NCT03725202|594539102|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
164389165|NCT00325468|593792443|FG002|Overall Study|Physician Decision|0|||
164594164|NCT03725202|594539103|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
164389166|NCT00325468|593792444|FG003|Overall Study|Physician Decision|1|||
164389167|NCT00325468|593792445|FG004|Overall Study|Physician Decision|0|||
164389168|NCT00325468|593792441|FG000|Overall Study|Withdrawal by Subject|3|||
164703828|NCT00541970|594941796|FG002|Month 48|Other|1|||
164703829|NCT00541970|594941797|FG003|Month 48|Other|0|||
164703830|NCT00541970|594941794|FG000|Month 48|Lost to Follow-up|66|||
164389169|NCT00325468|593792442|FG001|Overall Study|Withdrawal by Subject|1|||
164389170|NCT00325468|593792443|FG002|Overall Study|Withdrawal by Subject|0|||
164389171|NCT00325468|593792444|FG003|Overall Study|Withdrawal by Subject|14|||
164389172|NCT00325468|593792445|FG004|Overall Study|Withdrawal by Subject|4|||
164389173|NCT00325468|593792441|FG000|Overall Study|site closure etc|4|||
164389174|NCT00325468|593792442|FG001|Overall Study|site closure etc|2|||
164389175|NCT00325468|593792443|FG002|Overall Study|site closure etc|1|||
164389176|NCT00325468|593792444|FG003|Overall Study|site closure etc|8|||
164389177|NCT00325468|593792445|FG004|Overall Study|site closure etc|1|||
164389178|NCT03732209|593792446|FG000|Overall Study|Lost to Follow-up|4|||
164389179|NCT03732209|593792447|FG001|Overall Study|Lost to Follow-up|4|||
164389180|NCT03732209|593792446|FG000|Overall Study|Withdrawal by Subject|8|||
164389181|NCT03732209|593792447|FG001|Overall Study|Withdrawal by Subject|9|||
164389182|NCT05046795|593792448|FG000|Overall Study|Adverse Event|13|||
164389183|NCT05046795|593792449|FG001|Overall Study|Adverse Event|15|||
164389184|NCT05046795|593792448|FG000|Overall Study|Withdrawal by Subject|4|||
164389185|NCT05046795|593792449|FG001|Overall Study|Withdrawal by Subject|7|||
164389186|NCT05046795|593792448|FG000|Overall Study|Physician Decision|1|||
164389187|NCT05046795|593792449|FG001|Overall Study|Physician Decision|2|||
164389188|NCT05046795|593792448|FG000|Overall Study|Protocol Violation|1|||
164389189|NCT05046795|593792449|FG001|Overall Study|Protocol Violation|2|||
164389190|NCT05046795|593792448|FG000|Overall Study|Death|1|||
164389191|NCT05046795|593792449|FG001|Overall Study|Death|0|||
164389192|NCT05046795|593792448|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
164389193|NCT05046795|593792449|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
164389194|NCT01127178|593792450|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
164389195|NCT01127178|593792451|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
164389196|NCT01127178|593792450|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
164389197|NCT01127178|593792451|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
164389198|NCT01127178|593792450|FG000|Dose Escalation: Treatment Phase|Other|2|||
164389199|NCT01127178|593792451|FG001|Dose Escalation: Treatment Phase|Other|0|||
164389200|NCT01127178|593792450|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
164389201|NCT01127178|593792451|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
164389202|NCT01127178|593792450|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
164389203|NCT01127178|593792451|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
164389204|NCT01127178|593792450|FG000|Dose Escalation: Extension Phase|Other|1|||
164389205|NCT01127178|593792451|FG001|Dose Escalation: Extension Phase|Other|0|||
164389206|NCT03950739|593792452|FG000|Treatment Phase|Adverse Event|2|||
164389207|NCT03950739|593792452|FG000|Optional Extension Phase|Death|1|||
164389208|NCT03950739|593792452|FG000|Optional Extension Phase|Progressive Disease|5|||
164389209|NCT03950739|593792452|FG000|Optional Extension Phase|Adverse Event|7|||
164389210|NCT03950739|593792452|FG000|Optional Extension Phase|Lost to Follow-up|2|||
164389211|NCT03950739|593792452|FG000|Optional Extension Phase|Site Closure|2|||
164389212|NCT03950739|593792452|FG000|Optional Extension Phase|Pregnancy|1|||
164389213|NCT03625570|593792453|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
164389214|NCT03625570|593792454|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
164389215|NCT03625570|593792453|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
164389216|NCT03625570|593792454|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
164389217|NCT03625570|593792453|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
164389218|NCT03625570|593792454|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
164389219|NCT04139317|593792455|FG000|Overall Study|Adverse Event|10|||
164389220|NCT04139317|593792456|FG001|Overall Study|Adverse Event|2|||
164389221|NCT04139317|593792455|FG000|Overall Study|Death|6|||
164389222|NCT04139317|593792456|FG001|Overall Study|Death|4|||
164389223|NCT04139317|593792455|FG000|Overall Study|Lost to Follow-up|1|||
164389224|NCT04139317|593792456|FG001|Overall Study|Lost to Follow-up|0|||
164389225|NCT04139317|593792455|FG000|Overall Study|Physician Decision|3|||
164389226|NCT04139317|593792456|FG001|Overall Study|Physician Decision|1|||
164389227|NCT04139317|593792455|FG000|Overall Study|Progressive Disease|19|||
164389228|NCT04139317|593792456|FG001|Overall Study|Progressive Disease|9|||
164389229|NCT04139317|593792455|FG000|Overall Study|Subject Decision|2|||
164389230|NCT04139317|593792456|FG001|Overall Study|Subject Decision|2|||
164389231|NCT00345579|593792459|FG000|Overall Study|Adverse Event|9|||
164389232|NCT00345579|593792460|FG001|Overall Study|Adverse Event|6|||
164389233|NCT00345579|593792459|FG000|Overall Study|Protocol Violation|14|||
164389234|NCT00345579|593792460|FG001|Overall Study|Protocol Violation|5|||
164389235|NCT00345579|593792459|FG000|Overall Study|Withdrawal by Subject|50|||
164389236|NCT00345579|593792460|FG001|Overall Study|Withdrawal by Subject|17|||
164389237|NCT00345579|593792459|FG000|Overall Study|Lost to Follow-up|82|||
164389238|NCT00345579|593792460|FG001|Overall Study|Lost to Follow-up|36|||
164389239|NCT00345579|593792459|FG000|Overall Study|Other|9|||
164389240|NCT00345579|593792460|FG001|Overall Study|Other|1|||
164389241|NCT00782340|593792461|FG000|Open Label Titration|Adverse Event|12|||
164389242|NCT00782340|593792462|FG001|Open Label Titration|Adverse Event|0|||
164389243|NCT00782340|593792463|FG002|Open Label Titration|Adverse Event|0|||
164441170|NCT04424641|593982717|FG004|Overall Study|Other|0|||
164441171|NCT04424641|593982718|FG005|Overall Study|Other|0|||
164441172|NCT04424641|593982719|FG006|Overall Study|Other|0|||
164441173|NCT04424641|593982720|FG007|Overall Study|Other|0|||
164441174|NCT02015546|593982721|FG000|Overall Study|Withdrawal by Subject|1|||
164441175|NCT02015546|593982722|FG001|Overall Study|Withdrawal by Subject|1|||
164441176|NCT02015546|593982723|FG002|Overall Study|Withdrawal by Subject|1|||
164441177|NCT02015546|593982721|FG000|Overall Study|Screem Failure|2|||
164441178|NCT02015546|593982722|FG001|Overall Study|Screem Failure|1|||
164441179|NCT02015546|593982723|FG002|Overall Study|Screem Failure|3|||
164441180|NCT01171625|593982724|FG000|Overall Study|On-Protocol|67|||
164441181|NCT01171625|593982724|FG000|Overall Study|Death|38|||
164441182|NCT01171625|593982724|FG000|Overall Study|Withdrawal by Subject|31|||
164389244|NCT00782340|593792461|FG000|Open Label Titration|Treatment failure|50|||
164389245|NCT00782340|593792462|FG001|Open Label Titration|Treatment failure|0|||
164389246|NCT00782340|593792463|FG002|Open Label Titration|Treatment failure|0|||
164389247|NCT00782340|593792461|FG000|Open Label Titration|Protocol Violation|5|||
164389248|NCT00782340|593792462|FG001|Open Label Titration|Protocol Violation|0|||
164389249|NCT00782340|593792463|FG002|Open Label Titration|Protocol Violation|0|||
164389250|NCT00782340|593792461|FG000|Open Label Titration|Withdrawal by Subject|5|||
164389251|NCT00782340|593792462|FG001|Open Label Titration|Withdrawal by Subject|0|||
164389252|NCT00782340|593792463|FG002|Open Label Titration|Withdrawal by Subject|0|||
164389253|NCT00782340|593792461|FG000|Open Label Titration|Enrollment capped|16|||
164389254|NCT00782340|593792462|FG001|Open Label Titration|Enrollment capped|0|||
164389255|NCT00782340|593792463|FG002|Open Label Titration|Enrollment capped|0|||
164389256|NCT00782340|593792461|FG000|Open Label Titration|Did not meet responder criteria|2|||
164389257|NCT00782340|593792462|FG001|Open Label Titration|Did not meet responder criteria|0|||
164441183|NCT01171625|593982724|FG000|Overall Study|Explanted|10|||
164441184|NCT01171625|593982724|FG000|Overall Study|Lost to Follow-up|5|||
164441185|NCT01171625|593982724|FG000|Overall Study|Patient received valve-in-valve|3|||
164441186|NCT01171625|593982724|FG000|Overall Study|Other|1|||
164441187|NCT01171625|593982724|FG000|Overall Study|Consented but did not receive device|25|||
164441188|NCT00799396|593982727|FG000|Clopidogrel Treatment|Adverse Event|6|||
164441189|NCT00799396|593982727|FG000|Clopidogrel Treatment|Physician Decision|5|||
164441190|NCT00799396|593982727|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
164441191|NCT00799396|593982727|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
164441192|NCT00799396|593982727|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
164441193|NCT01113931|593982728|FG000|Overall Study|Adverse Event|2|||
164441194|NCT01113931|593982729|FG001|Overall Study|Adverse Event|2|||
164441195|NCT01113931|593982728|FG000|Overall Study|Physician Decision|0|||
164441196|NCT01113931|593982729|FG001|Overall Study|Physician Decision|2|||
164441197|NCT01113931|593982728|FG000|Overall Study|Lost to Follow-up|12|||
164441198|NCT01113931|593982729|FG001|Overall Study|Lost to Follow-up|9|||
164441199|NCT01113931|593982728|FG000|Overall Study|Various|2|||
164441200|NCT01113931|593982729|FG001|Overall Study|Various|4|||
164441201|NCT01113931|593982728|FG000|Overall Study|Withdrawal by Subject|3|||
164441202|NCT01113931|593982729|FG001|Overall Study|Withdrawal by Subject|0|||
164441203|NCT01307267|593982730|FG000|Overall Study|Death|4|||
164441204|NCT01307267|593982731|FG001|Overall Study|Death|3|||
164441205|NCT01307267|593982732|FG002|Overall Study|Death|5|||
164441206|NCT01307267|593982733|FG003|Overall Study|Death|3|||
164441207|NCT01307267|593982734|FG004|Overall Study|Death|1|||
164441208|NCT01307267|593982735|FG005|Overall Study|Death|26|||
164441209|NCT01307267|593982736|FG006|Overall Study|Death|2|||
164441210|NCT01307267|593982737|FG007|Overall Study|Death|2|||
164703831|NCT00541970|594941795|FG001|Month 48|Lost to Follow-up|68|||
164703832|NCT00541970|594941796|FG002|Month 48|Lost to Follow-up|68|||
164703833|NCT00541970|594941797|FG003|Month 48|Lost to Follow-up|73|||
164703834|NCT00541970|594941794|FG000|Month 60|Protocol Violation|78|||
164703835|NCT00541970|594941795|FG001|Month 60|Protocol Violation|77|||
164389258|NCT00782340|593792463|FG002|Open Label Titration|Did not meet responder criteria|0|||
164389259|NCT00782340|593792461|FG000|Open Label Titration|Lost to Follow-up|5|||
164389260|NCT00782340|593792462|FG001|Open Label Titration|Lost to Follow-up|0|||
164389261|NCT00782340|593792463|FG002|Open Label Titration|Lost to Follow-up|0|||
164441211|NCT01307267|593982738|FG008|Overall Study|Death|21|||
164441212|NCT01307267|593982739|FG009|Overall Study|Death|2|||
164441213|NCT01307267|593982740|FG010|Overall Study|Death|3|||
164441214|NCT01307267|593982741|FG011|Overall Study|Death|9|||
164441215|NCT01307267|593982742|FG012|Overall Study|Death|0|||
164441216|NCT01307267|593982743|FG013|Overall Study|Death|0|||
164441217|NCT01307267|593982744|FG014|Overall Study|Death|0|||
164441218|NCT01307267|593982745|FG015|Overall Study|Death|0|||
164441219|NCT01307267|593982746|FG016|Overall Study|Death|1|||
164441220|NCT01307267|593982747|FG017|Overall Study|Death|1|||
164441221|NCT01307267|593982748|FG018|Overall Study|Death|2|||
164441222|NCT01307267|593982749|FG019|Overall Study|Death|8|||
164441223|NCT01307267|593982750|FG020|Overall Study|Death|1|||
164441224|NCT01307267|593982751|FG021|Overall Study|Death|2|||
164441225|NCT01307267|593982752|FG022|Overall Study|Death|2|||
164441226|NCT01307267|593982730|FG000|Overall Study|Lost to Follow-up|0|||
164389262|NCT00782340|593792461|FG000|Open Label Titration|Randomized in error|6|||
164389263|NCT00782340|593792462|FG001|Open Label Titration|Randomized in error|0|||
164389264|NCT00782340|593792463|FG002|Open Label Titration|Randomized in error|0|||
164389265|NCT01949480|593792464|FG000|Overall Study|Physician Decision|5|||
164389266|NCT01949480|593792465|FG001|Overall Study|Physician Decision|8|||
164389267|NCT00144339|593792466|FG000|Overall Study|Adverse Event|746|||
164389268|NCT00144339|593792467|FG001|Overall Study|Adverse Event|627|||
164389269|NCT00144339|593792466|FG000|Overall Study|Protocol Violation|75|||
164389270|NCT00144339|593792467|FG001|Overall Study|Protocol Violation|48|||
164389271|NCT00144339|593792466|FG000|Overall Study|Withdrawal by Subject|403|||
164389272|NCT00144339|593792467|FG001|Overall Study|Withdrawal by Subject|300|||
164389273|NCT00144339|593792466|FG000|Overall Study|Lost to Follow-up|76|||
164389274|NCT00144339|593792467|FG001|Overall Study|Lost to Follow-up|64|||
164389275|NCT00144339|593792466|FG000|Overall Study|Other|58|||
164389276|NCT00144339|593792467|FG001|Overall Study|Other|60|||
164389277|NCT00305058|593792468|FG000|Overall Study|Participant too young|1|||
164389278|NCT00305058|593792469|FG001|Overall Study|Participant too young|0|||
164389279|NCT00305058|593792468|FG000|Overall Study|Missing data collection instrument|3|||
164389280|NCT00305058|593792469|FG001|Overall Study|Missing data collection instrument|2|||
164389281|NCT00305058|593792468|FG000|Overall Study|Missing outcome data|3|||
164389282|NCT00305058|593792469|FG001|Overall Study|Missing outcome data|2|||
164389283|NCT03538626|593792470|FG000|Overall Study|Withdrawal by Subject|0|||
164389284|NCT03538626|593792471|FG001|Overall Study|Withdrawal by Subject|1|||
164389285|NCT03538626|593792472|FG002|Overall Study|Withdrawal by Subject|0|||
164389286|NCT03538626|593792473|FG003|Overall Study|Withdrawal by Subject|0|||
164389287|NCT03538626|593792474|FG004|Overall Study|Withdrawal by Subject|0|||
164389288|NCT03538626|593792475|FG005|Overall Study|Withdrawal by Subject|0|||
164389289|NCT03538626|593792476|FG006|Overall Study|Withdrawal by Subject|0|||
164389290|NCT03538626|593792477|FG007|Overall Study|Withdrawal by Subject|0|||
164389291|NCT03538626|593792470|FG000|Overall Study|Lost to Follow-up|0|||
164389292|NCT03538626|593792471|FG001|Overall Study|Lost to Follow-up|0|||
164389293|NCT03538626|593792472|FG002|Overall Study|Lost to Follow-up|0|||
164389294|NCT03538626|593792473|FG003|Overall Study|Lost to Follow-up|0|||
164389295|NCT03538626|593792474|FG004|Overall Study|Lost to Follow-up|0|||
164389296|NCT03538626|593792475|FG005|Overall Study|Lost to Follow-up|0|||
164389297|NCT03538626|593792476|FG006|Overall Study|Lost to Follow-up|1|||
164389298|NCT03538626|593792477|FG007|Overall Study|Lost to Follow-up|0|||
164389299|NCT00288587|593792478|FG000|Overall Study|Death|4|||
164389300|NCT00288587|593792479|FG001|Overall Study|Death|4|||
164389301|NCT00288587|593792478|FG000|Overall Study|Transplant|0|||
164389302|NCT00288587|593792479|FG001|Overall Study|Transplant|3|||
164389303|NCT00288587|593792478|FG000|Overall Study|Adverse Event|0|||
164389304|NCT00288587|593792479|FG001|Overall Study|Adverse Event|1|||
164389305|NCT00288587|593792478|FG000|Overall Study|Physician Decision|0|||
164389306|NCT00288587|593792479|FG001|Overall Study|Physician Decision|2|||
164389307|NCT00288587|593792478|FG000|Overall Study|Severe Aortic Stenosis|1|||
164389308|NCT00288587|593792479|FG001|Overall Study|Severe Aortic Stenosis|0|||
164389309|NCT02232893|593792485|FG000|Overall Study|Withdrawal by Subject|4|||
164389310|NCT02232893|593792486|FG001|Overall Study|Withdrawal by Subject|1|||
164389311|NCT02232893|593792485|FG000|Overall Study|Adverse Event|0|||
164389312|NCT02232893|593792486|FG001|Overall Study|Adverse Event|1|||
164389313|NCT02232893|593792485|FG000|Overall Study|Sponsor request early termination|0|||
164389314|NCT02232893|593792486|FG001|Overall Study|Sponsor request early termination|1|||
164389315|NCT02232893|593792485|FG000|Overall Study|Developed exclusion criteria|0|||
164389316|NCT02232893|593792486|FG001|Overall Study|Developed exclusion criteria|1|||
164389317|NCT02232893|593792485|FG000|Overall Study|Other|0|||
164389318|NCT02232893|593792486|FG001|Overall Study|Other|3|||
164389319|NCT01764945|593792487|FG000|Overall Study|Adverse Event|0|||
164389320|NCT01764945|593792488|FG001|Overall Study|Adverse Event|1|||
164389321|NCT01764945|593792489|FG002|Overall Study|Adverse Event|0|||
164389322|NCT01764945|593792490|FG003|Overall Study|Adverse Event|0|||
164389323|NCT01764945|593792491|FG004|Overall Study|Adverse Event|0|||
164389324|NCT01764945|593792492|FG005|Overall Study|Adverse Event|0|||
164389325|NCT01764945|593792493|FG006|Overall Study|Adverse Event|1|||
164389326|NCT01764945|593792494|FG007|Overall Study|Adverse Event|0|||
164389327|NCT05077267|593792497|FG000|Treatment Period|Lost to Follow-up|0|||
164389328|NCT05077267|593792498|FG001|Treatment Period|Lost to Follow-up|1|||
164389329|NCT05077267|593792499|FG002|Treatment Period|Lost to Follow-up|0|||
164389330|NCT05077267|593792497|FG000|Treatment Period|Withdrawal by Subject|0|||
164389331|NCT05077267|593792498|FG001|Treatment Period|Withdrawal by Subject|1|||
164389332|NCT05077267|593792499|FG002|Treatment Period|Withdrawal by Subject|0|||
164389333|NCT05077267|593792497|FG000|Follow-up Period|Lost to Follow-up|0|||
164389334|NCT05077267|593792498|FG001|Follow-up Period|Lost to Follow-up|5|||
164389335|NCT05077267|593792499|FG002|Follow-up Period|Lost to Follow-up|7|||
164389336|NCT05077267|593792497|FG000|Follow-up Period|Withdrawal by Subject|0|||
164389337|NCT05077267|593792498|FG001|Follow-up Period|Withdrawal by Subject|2|||
164389338|NCT05077267|593792499|FG002|Follow-up Period|Withdrawal by Subject|5|||
164389339|NCT05077267|593792497|FG000|Follow-up Period|Study terminated by sponsor|0|||
164594165|NCT02361762|594539104|FG000|Overall Study|Withdrawal by Subject|0|||
164594166|NCT02361762|594539105|FG001|Overall Study|Withdrawal by Subject|1|||
164594167|NCT02361762|594539104|FG000|Overall Study|Lost to Follow-up|0|||
164594168|NCT02361762|594539105|FG001|Overall Study|Lost to Follow-up|1|||
164594169|NCT00948818|594539106|FG000|Overall Study|Adverse Event|10|||
164594170|NCT00948818|594539107|FG001|Overall Study|Adverse Event|32|||
164594171|NCT00948818|594539106|FG000|Overall Study|Protocol Violation|9|||
164594172|NCT00948818|594539107|FG001|Overall Study|Protocol Violation|10|||
164594173|NCT00948818|594539106|FG000|Overall Study|Withdrawal by Subject|25|||
164594174|NCT00948818|594539107|FG001|Overall Study|Withdrawal by Subject|25|||
164594175|NCT00948818|594539106|FG000|Overall Study|Lost to Follow-up|10|||
164594176|NCT00948818|594539107|FG001|Overall Study|Lost to Follow-up|17|||
164594177|NCT00948818|594539106|FG000|Overall Study|Lack of Efficacy|4|||
164594178|NCT00948818|594539107|FG001|Overall Study|Lack of Efficacy|5|||
164594179|NCT00948818|594539106|FG000|Overall Study|Other Reason|4|||
164594180|NCT00948818|594539107|FG001|Overall Study|Other Reason|5|||
164594181|NCT01251276|594539114|FG000|Overall Study|Protocol Violation|1|||
164594182|NCT01251276|594539115|FG001|Overall Study|Protocol Violation|0|||
164594183|NCT01251276|594539114|FG000|Overall Study|Lost to Follow-up|0|||
164594184|NCT01251276|594539115|FG001|Overall Study|Lost to Follow-up|1|||
164594185|NCT00262080|594539121|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
164594186|NCT00262080|594539122|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
164594187|NCT00262080|594539123|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
164594188|NCT00262080|594539121|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
164594189|NCT00262080|594539122|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
164594190|NCT00262080|594539123|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
164594191|NCT00262080|594539121|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
164594192|NCT00262080|594539122|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
164594193|NCT00262080|594539123|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
164594194|NCT00262080|594539121|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
164594195|NCT00262080|594539122|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
164594196|NCT00262080|594539123|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
164594197|NCT00262080|594539121|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
164594198|NCT00262080|594539122|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
164389340|NCT05077267|593792498|FG001|Follow-up Period|Study terminated by sponsor|27|||
164389341|NCT05077267|593792499|FG002|Follow-up Period|Study terminated by sponsor|23|||
164389342|NCT05077267|593792497|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
164594199|NCT00262080|594539123|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
164594200|NCT00262080|594539121|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
164594201|NCT00262080|594539122|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
164594202|NCT00262080|594539123|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
164594203|NCT01051986|594539124|FG000|Overall Study|Death|1|||
164594204|NCT01051986|594539125|FG001|Overall Study|Death|0|||
164594205|NCT01051986|594539124|FG000|Overall Study|Withdrawal by Subject|2|||
164594206|NCT01051986|594539125|FG001|Overall Study|Withdrawal by Subject|1|||
164594207|NCT01051986|594539124|FG000|Overall Study|Protocol Violation|2|||
164594208|NCT01051986|594539125|FG001|Overall Study|Protocol Violation|3|||
164594209|NCT02044159|594539126|FG000|Overall Study|Consent declined (deferred consent)|2|||
164594210|NCT02044159|594539127|FG001|Overall Study|Consent declined (deferred consent)|4|||
164594211|NCT02044159|594539126|FG000|Overall Study|No longer eligible, drug not given|1|||
164594212|NCT02044159|594539127|FG001|Overall Study|No longer eligible, drug not given|0|||
164594213|NCT02044159|594539126|FG000|Overall Study|Nurse declined to give study drug|1|||
164594214|NCT02044159|594539127|FG001|Overall Study|Nurse declined to give study drug|0|||
164594215|NCT01111539|594539128|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
164594216|NCT01111539|594539129|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
164594217|NCT01111539|594539130|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
164594218|NCT01111539|594539131|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
164594219|NCT01111539|594539132|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
164703836|NCT00541970|594941796|FG002|Month 60|Protocol Violation|82|||
164703837|NCT00541970|594941797|FG003|Month 60|Protocol Violation|72|||
164389343|NCT05077267|593792498|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
164389344|NCT05077267|593792499|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
164389345|NCT05077267|593792497|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
164594220|NCT01111539|594539128|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
164594221|NCT01111539|594539129|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
164389346|NCT05077267|593792498|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
164703838|NCT03107026|594941798|FG000|Overall Study|Adverse Event|2|||
164441227|NCT01307267|593982731|FG001|Overall Study|Lost to Follow-up|0|||
164594222|NCT01111539|594539130|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
164594223|NCT01111539|594539131|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
164594224|NCT01111539|594539132|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
164594225|NCT01111539|594539128|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
164703839|NCT03107026|594941799|FG001|Overall Study|Adverse Event|14|||
164389347|NCT05077267|593792499|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
164389348|NCT02911948|593792500|FG000|Overall Study|Protocol Violation|0|||
164389349|NCT02911948|593792501|FG001|Overall Study|Protocol Violation|1|||
164389350|NCT02911948|593792500|FG000|Overall Study|Withdrawal by Subject|0|||
164389351|NCT02911948|593792501|FG001|Overall Study|Withdrawal by Subject|2|||
164389352|NCT02911948|593792500|FG000|Overall Study|Lack of Efficacy|0|||
164389353|NCT02911948|593792501|FG001|Overall Study|Lack of Efficacy|1|||
164389354|NCT02911948|593792500|FG000|Overall Study|Unclassified|0|||
164389355|NCT02911948|593792501|FG001|Overall Study|Unclassified|3|||
164389356|NCT00586105|593792508|FG000|Overall Study|Adverse Event|4|||
164389357|NCT00586105|593792508|FG000|Overall Study|Death|2|||
164389358|NCT00586105|593792508|FG000|Overall Study|Protocol Violation|1|||
164389359|NCT00586105|593792508|FG000|Overall Study|Withdrawal by Subject|3|||
164389360|NCT00586105|593792508|FG000|Overall Study|Disease progression|19|||
164389361|NCT00586105|593792508|FG000|Overall Study|Switched to commercial drug|9|||
164389362|NCT00586105|593792508|FG000|Overall Study|Reason not reported|1|||
164389363|NCT01136291|593792512|FG000|Overall Study|Lost to Follow-up|1|||
164389364|NCT01136291|593792513|FG001|Overall Study|Lost to Follow-up|1|||
164389365|NCT03965052|593792514|FG000|Overall Study|Protocol Violation|1|||
164389366|NCT03965052|593792515|FG001|Overall Study|Protocol Violation|0|||
164389367|NCT02308033|593792525|FG000|Overall Study|Normal Gram stain at Baseline|13|||
164389368|NCT02308033|593792526|FG001|Overall Study|Normal Gram stain at Baseline|10|||
164389369|NCT02308033|593792525|FG000|Overall Study|Positive for STD at Baseline|7|||
164389370|NCT02308033|593792526|FG001|Overall Study|Positive for STD at Baseline|4|||
164389371|NCT02308033|593792525|FG000|Overall Study|Lost to Follow-up|6|||
164389372|NCT02308033|593792526|FG001|Overall Study|Lost to Follow-up|5|||
164389373|NCT03165045|593792527|FG000|Visit 1|No registration after visit 1|9|||
164389374|NCT03165045|593792527|FG000|Visit 1|No treatment documented|10|||
164389375|NCT03165045|593792527|FG000|Visit 1|No visit 1|10|||
164389376|NCT03165045|593792527|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
164389377|NCT03165045|593792527|FG000|Visit 2|No available total CCQ score at all|29|||
164389378|NCT03165045|593792527|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
164389379|NCT04964089|593792530|FG000|Overall Study|Adverse Event|8|||
164389380|NCT04964089|593792531|FG001|Overall Study|Adverse Event|6|||
164389381|NCT04964089|593792530|FG000|Overall Study|Non-compliance with study schedule|1|||
164389382|NCT04964089|593792531|FG001|Overall Study|Non-compliance with study schedule|0|||
164389383|NCT04964089|593792530|FG000|Overall Study|Withdrawal by Subject|6|||
164389384|NCT04964089|593792531|FG001|Overall Study|Withdrawal by Subject|5|||
164389385|NCT04964089|593792530|FG000|Overall Study|Lost to Follow-up|1|||
164389386|NCT04964089|593792531|FG001|Overall Study|Lost to Follow-up|1|||
164389387|NCT04964089|593792530|FG000|Overall Study|Progressive disease|4|||
164389388|NCT04964089|593792531|FG001|Overall Study|Progressive disease|0|||
164389389|NCT04964089|593792530|FG000|Overall Study|Physician Decision|1|||
164389390|NCT04964089|593792531|FG001|Overall Study|Physician Decision|0|||
164389391|NCT04964089|593792530|FG000|Overall Study|Participant did not want to continue study treatment|1|||
164389392|NCT04964089|593792531|FG001|Overall Study|Participant did not want to continue study treatment|0|||
164389393|NCT04964089|593792530|FG000|Overall Study|Participant moved to different state|1|||
164389394|NCT04964089|593792531|FG001|Overall Study|Participant moved to different state|0|||
164389395|NCT04964089|593792530|FG000|Overall Study|Participant decided to discontinue|0|||
164389396|NCT04964089|593792531|FG001|Overall Study|Participant decided to discontinue|1|||
164389397|NCT00499369|593792534|FG000|Overall Study|Adverse Event|2|||
164389398|NCT00499369|593792535|FG001|Overall Study|Adverse Event|2|||
164389399|NCT00499369|593792536|FG002|Overall Study|Adverse Event|3|||
164389400|NCT00499369|593792537|FG003|Overall Study|Adverse Event|1|||
164594226|NCT01111539|594539129|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
164594227|NCT01111539|594539130|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
164389401|NCT00499369|593792538|FG004|Overall Study|Adverse Event|2|||
164389402|NCT00499369|593792534|FG000|Overall Study|Withdrawal by Subject|0|||
164389403|NCT00499369|593792535|FG001|Overall Study|Withdrawal by Subject|1|||
164389404|NCT00499369|593792536|FG002|Overall Study|Withdrawal by Subject|1|||
164389405|NCT00499369|593792537|FG003|Overall Study|Withdrawal by Subject|0|||
164389406|NCT00499369|593792538|FG004|Overall Study|Withdrawal by Subject|0|||
164389407|NCT00499369|593792534|FG000|Overall Study|Progression|10|||
164389408|NCT00499369|593792535|FG001|Overall Study|Progression|12|||
164389409|NCT00499369|593792536|FG002|Overall Study|Progression|9|||
164389410|NCT00499369|593792537|FG003|Overall Study|Progression|6|||
164389411|NCT00499369|593792538|FG004|Overall Study|Progression|10|||
164389412|NCT00499369|593792534|FG000|Overall Study|Death|0|||
164389413|NCT00499369|593792535|FG001|Overall Study|Death|1|||
164389414|NCT00499369|593792536|FG002|Overall Study|Death|0|||
164389415|NCT00499369|593792537|FG003|Overall Study|Death|0|||
164389416|NCT00499369|593792538|FG004|Overall Study|Death|0|||
164389417|NCT00499369|593792534|FG000|Overall Study|Not protocol specified|2|||
164389418|NCT00499369|593792535|FG001|Overall Study|Not protocol specified|0|||
164389419|NCT00499369|593792536|FG002|Overall Study|Not protocol specified|3|||
164389420|NCT00499369|593792537|FG003|Overall Study|Not protocol specified|1|||
164594228|NCT01111539|594539131|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
164594229|NCT01111539|594539132|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
164594230|NCT01111539|594539128|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
164594231|NCT01111539|594539129|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
164594232|NCT01111539|594539130|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
164594233|NCT01111539|594539131|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
164594234|NCT01111539|594539132|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
164594235|NCT01111539|594539128|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
164389421|NCT00499369|593792538|FG004|Overall Study|Not protocol specified|0|||
164389422|NCT00499369|593792534|FG000|Overall Study|Ineligible|2|||
164389423|NCT00499369|593792535|FG001|Overall Study|Ineligible|2|||
164389424|NCT00499369|593792536|FG002|Overall Study|Ineligible|1|||
164594236|NCT01111539|594539129|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
164594237|NCT01111539|594539130|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
164594238|NCT01111539|594539131|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
164594239|NCT01111539|594539132|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
164594240|NCT01111539|594539128|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
164594241|NCT01111539|594539129|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
164594242|NCT01111539|594539130|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
164594243|NCT01111539|594539131|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
164594244|NCT01111539|594539132|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
164594245|NCT01111539|594539128|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
164594246|NCT01111539|594539129|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
164594247|NCT01111539|594539130|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
164594248|NCT01111539|594539131|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
164594249|NCT01111539|594539132|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
164594250|NCT01111539|594539128|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
164594251|NCT01111539|594539129|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
164594252|NCT01111539|594539130|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
164594253|NCT01111539|594539131|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
164594254|NCT01111539|594539132|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
164594255|NCT01111539|594539128|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
164594256|NCT01111539|594539129|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
164594257|NCT01111539|594539130|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
164594258|NCT01111539|594539131|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
164594259|NCT01111539|594539132|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
164594260|NCT01111539|594539128|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
164594261|NCT01111539|594539129|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
164594262|NCT01111539|594539130|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
164594263|NCT01111539|594539131|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
164594264|NCT01111539|594539132|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
164594265|NCT01111539|594539128|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
164594266|NCT01111539|594539129|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
164594267|NCT01111539|594539130|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
164594268|NCT01111539|594539131|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
164594269|NCT01111539|594539132|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
164594270|NCT01111539|594539128|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
164594271|NCT01111539|594539129|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
164594272|NCT01111539|594539130|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
164594273|NCT01111539|594539131|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
164594274|NCT01111539|594539132|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
164594275|NCT01111539|594539128|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
164594276|NCT01111539|594539129|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
164594277|NCT01111539|594539130|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
164594278|NCT01111539|594539131|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
164594279|NCT01111539|594539132|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
164389425|NCT00499369|593792537|FG003|Overall Study|Ineligible|1|||
164389426|NCT00499369|593792538|FG004|Overall Study|Ineligible|0|||
164389427|NCT01898195|593792539|FG000|Smoking Abstinence|Did not have good measurements|35|||
164389428|NCT01898195|593792540|FG001|Smoking Abstinence|Did not have good measurements|38|||
164389429|NCT01898195|593792541|FG002|Smoking Abstinence|Did not have good measurements|36|||
164389430|NCT02536508|593794257|FG000|Overall Study|Withdrawal by Subject|18|||
164389431|NCT02536508|593794258|FG001|Overall Study|Withdrawal by Subject|13|||
164389432|NCT02536508|593794259|FG002|Overall Study|Withdrawal by Subject|7|||
164389433|NCT02536508|593794257|FG000|Overall Study|Adverse Event|14|||
164389434|NCT02536508|593794258|FG001|Overall Study|Adverse Event|13|||
164389435|NCT02536508|593794259|FG002|Overall Study|Adverse Event|6|||
164389436|NCT02536508|593794257|FG000|Overall Study|Lost to Follow-up|12|||
164389437|NCT02536508|593794258|FG001|Overall Study|Lost to Follow-up|4|||
164389438|NCT02536508|593794259|FG002|Overall Study|Lost to Follow-up|0|||
164389439|NCT02536508|593794257|FG000|Overall Study|Lack of Efficacy|3|||
164389440|NCT02536508|593794258|FG001|Overall Study|Lack of Efficacy|5|||
164389441|NCT02536508|593794259|FG002|Overall Study|Lack of Efficacy|4|||
164389442|NCT02536508|593794257|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
164389443|NCT02536508|593794258|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
164389444|NCT02536508|593794259|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
164389445|NCT02536508|593794257|FG000|Overall Study|Physician Decision|0|||
164389446|NCT02536508|593794258|FG001|Overall Study|Physician Decision|4|||
164389447|NCT02536508|593794259|FG002|Overall Study|Physician Decision|2|||
164389448|NCT02536508|593794257|FG000|Overall Study|Major Protocol Deviation|2|||
164389449|NCT02536508|593794258|FG001|Overall Study|Major Protocol Deviation|2|||
164389450|NCT02536508|593794259|FG002|Overall Study|Major Protocol Deviation|2|||
164389451|NCT02536508|593794257|FG000|Overall Study|Administrative Reasons|0|||
164389452|NCT02536508|593794258|FG001|Overall Study|Administrative Reasons|1|||
164389453|NCT02536508|593794259|FG002|Overall Study|Administrative Reasons|0|||
164389454|NCT00434057|593794261|FG000|Overall Study|Withdrawal by Subject|1|||
164389455|NCT00823719|593794266|FG000|Overall Study|Adverse Event|1|||
164389456|NCT00823719|593794267|FG001|Overall Study|Adverse Event|2|||
164389457|NCT00823719|593794266|FG000|Overall Study|Physician Decision|1|||
164389458|NCT00823719|593794267|FG001|Overall Study|Physician Decision|4|||
164389459|NCT00823719|593794266|FG000|Overall Study|Withdrawal by Subject|0|||
164389460|NCT00823719|593794267|FG001|Overall Study|Withdrawal by Subject|1|||
164389461|NCT00823719|593794266|FG000|Overall Study|Disease Progression|4|||
164389462|NCT00823719|593794267|FG001|Overall Study|Disease Progression|4|||
164389463|NCT02103439|593794273|FG000|Overall Study|Adverse Event|0|||
164389464|NCT02103439|593794274|FG001|Overall Study|Adverse Event|2|||
164389465|NCT02103439|593794273|FG000|Overall Study|Withdrawal by Subject|3|||
164389466|NCT02103439|593794274|FG001|Overall Study|Withdrawal by Subject|1|||
164389467|NCT02370602|593794275|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
164389468|NCT02370602|593794276|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
164389469|NCT02370602|593794277|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
164389470|NCT02370602|593794278|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
164389471|NCT02370602|593794279|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
164389472|NCT02370602|593794280|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
164389473|NCT00599326|593794284|FG000|Overall Study|Lost to Follow-up|1|||
164389474|NCT00599326|593794284|FG000|Overall Study|Noncompliant|1|||
164389475|NCT00784810|593794285|FG000|Overall Study|Adverse Event|32|||
164389476|NCT00784810|593794286|FG001|Overall Study|Adverse Event|20|||
164389477|NCT00784810|593794285|FG000|Overall Study|Lack of Efficacy|14|||
164389478|NCT00784810|593794286|FG001|Overall Study|Lack of Efficacy|11|||
164389479|NCT00784810|593794285|FG000|Overall Study|Withdrawal by Subject|11|||
164389480|NCT00784810|593794286|FG001|Overall Study|Withdrawal by Subject|9|||
164389481|NCT00784810|593794285|FG000|Overall Study|Administrative|5|||
164389482|NCT00784810|593794286|FG001|Overall Study|Administrative|8|||
164389483|NCT00784810|593794285|FG000|Overall Study|Lost to Follow-up|1|||
164389484|NCT00784810|593794286|FG001|Overall Study|Lost to Follow-up|1|||
164389485|NCT03305016|593794289|FG000|Overall Study|Withdrawal by Subject|2|||
164389486|NCT02119416|593794290|FG000|Overall Study|Protocol Violation|1|||
164389487|NCT02119416|593794291|FG001|Overall Study|Protocol Violation|1|||
164389488|NCT02119416|593794292|FG002|Overall Study|Protocol Violation|1|||
164389489|NCT02119416|593794290|FG000|Overall Study|wrong pubertal stage|1|||
164389490|NCT02119416|593794291|FG001|Overall Study|wrong pubertal stage|0|||
164389491|NCT02119416|593794292|FG002|Overall Study|wrong pubertal stage|1|||
164389492|NCT03434119|593794293|FG000|Overall Study|Randomized but not treated|1|||
164389493|NCT03434119|593794294|FG001|Overall Study|Randomized but not treated|0|||
164389494|NCT03434119|593794293|FG000|Overall Study|Adverse Event|1|||
164389495|NCT03434119|593794294|FG001|Overall Study|Adverse Event|0|||
164389496|NCT03434119|593794293|FG000|Overall Study|Poor Compliance to Protocol|0|||
164389497|NCT03434119|593794294|FG001|Overall Study|Poor Compliance to Protocol|1|||
164441228|NCT01307267|593982732|FG002|Overall Study|Lost to Follow-up|0|||
164441229|NCT01307267|593982733|FG003|Overall Study|Lost to Follow-up|0|||
164389498|NCT03434119|593794293|FG000|Overall Study|Study Terminated by Sponsor|91|||
164441230|NCT01307267|593982734|FG004|Overall Study|Lost to Follow-up|0|||
164441231|NCT01307267|593982735|FG005|Overall Study|Lost to Follow-up|7|||
164389499|NCT03434119|593794294|FG001|Overall Study|Study Terminated by Sponsor|102|||
164389500|NCT03434119|593794293|FG000|Overall Study|Withdrawal by Subject|7|||
164389501|NCT03434119|593794294|FG001|Overall Study|Withdrawal by Subject|5|||
164389502|NCT03434119|593794293|FG000|Overall Study|Other than specified|7|||
164389503|NCT03434119|593794294|FG001|Overall Study|Other than specified|5|||
164389504|NCT04420689|593794295|FG000|Overall Study|COVID-19 related hospitalization|0|||
164389505|NCT04420689|593794296|FG001|Overall Study|COVID-19 related hospitalization|0|||
164389506|NCT04420689|593794297|FG002|Overall Study|COVID-19 related hospitalization|0|||
164441232|NCT01307267|593982736|FG006|Overall Study|Lost to Follow-up|0|||
164389507|NCT04420689|593794298|FG003|Overall Study|COVID-19 related hospitalization|0|||
164389508|NCT04420689|593794299|FG004|Overall Study|COVID-19 related hospitalization|1|||
164389509|NCT04420689|593794300|FG005|Overall Study|COVID-19 related hospitalization|0|||
164389510|NCT04420689|593794301|FG006|Overall Study|COVID-19 related hospitalization|0|||
164389511|NCT04420689|593794295|FG000|Overall Study|Physician Decision|0|||
164389512|NCT04420689|593794296|FG001|Overall Study|Physician Decision|0|||
164389513|NCT04420689|593794297|FG002|Overall Study|Physician Decision|0|||
164594280|NCT01111539|594539128|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
164594281|NCT01111539|594539129|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
164594282|NCT01111539|594539130|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
164594283|NCT01111539|594539131|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
164594284|NCT01111539|594539132|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
164594285|NCT03580382|594539137|FG000|Overall Study|Early Termination of Study|0|||
164594286|NCT03580382|594539138|FG001|Overall Study|Early Termination of Study|3|||
164594287|NCT02808312|594539139|FG000|Overall Study|Enrolled but Never Treated|0|||
164594288|NCT02808312|594539140|FG001|Overall Study|Enrolled but Never Treated|0|||
164594289|NCT02808312|594539141|FG002|Overall Study|Enrolled but Never Treated|1|||
164594290|NCT02808312|594539142|FG003|Overall Study|Enrolled but Never Treated|0|||
164594291|NCT02808312|594539143|FG004|Overall Study|Enrolled but Never Treated|0|||
164594292|NCT03628417|594539144|FG000|Overall Study|Death|1|||
164594293|NCT03628417|594539145|FG001|Overall Study|Death|1|||
164594294|NCT01361009|594539146|FG000|Overall Study|Protocol Violation|116|||
164594295|NCT01826422|594539147|FG000|Overall Study|Withdrawal by Subject|1|||
164594296|NCT01826422|594539148|FG001|Overall Study|Withdrawal by Subject|3|||
164594297|NCT04263142|594539149|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
164594298|NCT04263142|594539150|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
164594299|NCT04263142|594539151|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
164594300|NCT04263142|594539152|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
164594301|NCT04263142|594539153|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
164594302|NCT04263142|594539149|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
164594303|NCT04263142|594539150|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
164594304|NCT04263142|594539151|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
164594305|NCT04263142|594539152|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
164594306|NCT04263142|594539153|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
164594307|NCT01597557|594539158|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
164594308|NCT01597557|594539159|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
164594309|NCT04402008|594539161|FG000|Overall Study|Adverse Event|0|||
164594310|NCT04402008|594539162|FG001|Overall Study|Adverse Event|0|||
164594311|NCT04402008|594539163|FG002|Overall Study|Adverse Event|0|||
164594312|NCT04402008|594539164|FG003|Overall Study|Adverse Event|1|||
164594313|NCT04402008|594539165|FG004|Overall Study|Adverse Event|0|||
164594314|NCT04402008|594539166|FG005|Overall Study|Adverse Event|0|||
164594315|NCT04402008|594539167|FG006|Overall Study|Adverse Event|0|||
164594316|NCT04402008|594539161|FG000|Overall Study|Disease Progression|3|||
164594317|NCT04402008|594539162|FG001|Overall Study|Disease Progression|2|||
164594318|NCT04402008|594539163|FG002|Overall Study|Disease Progression|3|||
164594319|NCT04402008|594539164|FG003|Overall Study|Disease Progression|3|||
164594320|NCT04402008|594539165|FG004|Overall Study|Disease Progression|4|||
164594321|NCT04402008|594539166|FG005|Overall Study|Disease Progression|3|||
164594322|NCT04402008|594539167|FG006|Overall Study|Disease Progression|10|||
164594323|NCT04402008|594539161|FG000|Overall Study|Withdrawal by Subject|0|||
164594324|NCT04402008|594539162|FG001|Overall Study|Withdrawal by Subject|1|||
164594325|NCT04402008|594539163|FG002|Overall Study|Withdrawal by Subject|0|||
164594326|NCT04402008|594539164|FG003|Overall Study|Withdrawal by Subject|0|||
164594327|NCT04402008|594539165|FG004|Overall Study|Withdrawal by Subject|1|||
164594328|NCT04402008|594539166|FG005|Overall Study|Withdrawal by Subject|0|||
164594329|NCT04402008|594539167|FG006|Overall Study|Withdrawal by Subject|0|||
164594330|NCT04402008|594539161|FG000|Overall Study|Sponsor Decision|0|||
164594331|NCT04402008|594539162|FG001|Overall Study|Sponsor Decision|0|||
164594332|NCT04402008|594539163|FG002|Overall Study|Sponsor Decision|0|||
164389514|NCT04420689|593794298|FG003|Overall Study|Physician Decision|0|||
164389515|NCT04420689|593794299|FG004|Overall Study|Physician Decision|0|||
164389516|NCT04420689|593794300|FG005|Overall Study|Physician Decision|1|||
164594333|NCT04402008|594539164|FG003|Overall Study|Sponsor Decision|0|||
164594334|NCT04402008|594539165|FG004|Overall Study|Sponsor Decision|0|||
164594335|NCT04402008|594539166|FG005|Overall Study|Sponsor Decision|0|||
164594336|NCT04402008|594539167|FG006|Overall Study|Sponsor Decision|3|||
164594337|NCT04402008|594539161|FG000|Overall Study|Death|0|||
164594338|NCT04402008|594539162|FG001|Overall Study|Death|0|||
164594339|NCT04402008|594539163|FG002|Overall Study|Death|0|||
164594340|NCT04402008|594539164|FG003|Overall Study|Death|0|||
164594341|NCT04402008|594539165|FG004|Overall Study|Death|1|||
164594342|NCT04402008|594539166|FG005|Overall Study|Death|0|||
164594343|NCT04402008|594539167|FG006|Overall Study|Death|2|||
164594344|NCT04402008|594539161|FG000|Overall Study|Other|0|||
164594345|NCT04402008|594539162|FG001|Overall Study|Other|0|||
164441233|NCT01307267|593982737|FG007|Overall Study|Lost to Follow-up|0|||
164441234|NCT01307267|593982738|FG008|Overall Study|Lost to Follow-up|1|||
164441235|NCT01307267|593982739|FG009|Overall Study|Lost to Follow-up|2|||
164441236|NCT01307267|593982740|FG010|Overall Study|Lost to Follow-up|1|||
164441237|NCT01307267|593982741|FG011|Overall Study|Lost to Follow-up|0|||
164441238|NCT01307267|593982742|FG012|Overall Study|Lost to Follow-up|0|||
164441239|NCT01307267|593982743|FG013|Overall Study|Lost to Follow-up|0|||
164441240|NCT01307267|593982744|FG014|Overall Study|Lost to Follow-up|0|||
164441241|NCT01307267|593982745|FG015|Overall Study|Lost to Follow-up|0|||
164441242|NCT01307267|593982746|FG016|Overall Study|Lost to Follow-up|0|||
164441243|NCT01307267|593982747|FG017|Overall Study|Lost to Follow-up|0|||
164441244|NCT01307267|593982748|FG018|Overall Study|Lost to Follow-up|0|||
164441245|NCT01307267|593982749|FG019|Overall Study|Lost to Follow-up|2|||
164441246|NCT01307267|593982750|FG020|Overall Study|Lost to Follow-up|0|||
164441247|NCT01307267|593982751|FG021|Overall Study|Lost to Follow-up|0|||
164441248|NCT01307267|593982752|FG022|Overall Study|Lost to Follow-up|0|||
164441249|NCT01307267|593982730|FG000|Overall Study|Withdrawal by Subject|0|||
164441250|NCT01307267|593982731|FG001|Overall Study|Withdrawal by Subject|0|||
164441251|NCT01307267|593982732|FG002|Overall Study|Withdrawal by Subject|0|||
164441252|NCT01307267|593982733|FG003|Overall Study|Withdrawal by Subject|0|||
164441253|NCT01307267|593982734|FG004|Overall Study|Withdrawal by Subject|0|||
164441254|NCT01307267|593982735|FG005|Overall Study|Withdrawal by Subject|1|||
164441255|NCT01307267|593982736|FG006|Overall Study|Withdrawal by Subject|0|||
164441256|NCT01307267|593982737|FG007|Overall Study|Withdrawal by Subject|1|||
164441257|NCT01307267|593982738|FG008|Overall Study|Withdrawal by Subject|5|||
164441258|NCT01307267|593982739|FG009|Overall Study|Withdrawal by Subject|1|||
164441259|NCT01307267|593982740|FG010|Overall Study|Withdrawal by Subject|1|||
164594346|NCT04402008|594539163|FG002|Overall Study|Other|0|||
164594347|NCT04402008|594539164|FG003|Overall Study|Other|0|||
164594348|NCT04402008|594539165|FG004|Overall Study|Other|0|||
164441260|NCT01307267|593982741|FG011|Overall Study|Withdrawal by Subject|1|||
164441261|NCT01307267|593982742|FG012|Overall Study|Withdrawal by Subject|0|||
164441262|NCT01307267|593982743|FG013|Overall Study|Withdrawal by Subject|0|||
164441263|NCT01307267|593982744|FG014|Overall Study|Withdrawal by Subject|0|||
164441264|NCT01307267|593982745|FG015|Overall Study|Withdrawal by Subject|0|||
164441265|NCT01307267|593982746|FG016|Overall Study|Withdrawal by Subject|0|||
164441266|NCT01307267|593982747|FG017|Overall Study|Withdrawal by Subject|0|||
164441267|NCT01307267|593982748|FG018|Overall Study|Withdrawal by Subject|0|||
164441268|NCT01307267|593982749|FG019|Overall Study|Withdrawal by Subject|3|||
164441269|NCT01307267|593982750|FG020|Overall Study|Withdrawal by Subject|0|||
164441270|NCT01307267|593982751|FG021|Overall Study|Withdrawal by Subject|0|||
164594349|NCT04402008|594539166|FG005|Overall Study|Other|0|||
164594350|NCT04402008|594539167|FG006|Overall Study|Other|5|||
164594351|NCT02935634|594539170|FG000|Randomization|Participant withdrew consent|0|||
164594352|NCT02935634|594539171|FG001|Randomization|Participant withdrew consent|1|||
164594353|NCT02935634|594539172|FG002|Randomization|Participant withdrew consent|0|||
164594354|NCT02935634|594539173|FG003|Randomization|Participant withdrew consent|0|||
164594355|NCT02935634|594539174|FG004|Randomization|Participant withdrew consent|0|||
164594356|NCT02935634|594539175|FG005|Randomization|Participant withdrew consent|0|||
164594357|NCT02935634|594539170|FG000|Randomization|Death|2|||
164594358|NCT02935634|594539171|FG001|Randomization|Death|1|||
164594359|NCT02935634|594539172|FG002|Randomization|Death|1|||
164594360|NCT02935634|594539173|FG003|Randomization|Death|0|||
164594361|NCT02935634|594539174|FG004|Randomization|Death|0|||
164594362|NCT02935634|594539175|FG005|Randomization|Death|0|||
164441271|NCT01307267|593982752|FG022|Overall Study|Withdrawal by Subject|0|||
164441272|NCT01307267|593982730|FG000|Overall Study|Other|0|||
164441273|NCT01307267|593982731|FG001|Overall Study|Other|0|||
164441274|NCT01307267|593982732|FG002|Overall Study|Other|0|||
164441275|NCT01307267|593982733|FG003|Overall Study|Other|0|||
164441276|NCT01307267|593982734|FG004|Overall Study|Other|0|||
164441277|NCT01307267|593982735|FG005|Overall Study|Other|7|||
164441278|NCT01307267|593982736|FG006|Overall Study|Other|0|||
164441279|NCT01307267|593982737|FG007|Overall Study|Other|1|||
164441280|NCT01307267|593982738|FG008|Overall Study|Other|3|||
164594363|NCT02935634|594539170|FG000|Randomization|Other reasons|0|||
164594364|NCT02935634|594539171|FG001|Randomization|Other reasons|2|||
164594365|NCT02935634|594539172|FG002|Randomization|Other reasons|2|||
164594366|NCT02935634|594539173|FG003|Randomization|Other reasons|0|||
164594367|NCT02935634|594539174|FG004|Randomization|Other reasons|0|||
164594368|NCT02935634|594539175|FG005|Randomization|Other reasons|0|||
164594369|NCT02935634|594539170|FG000|Treatment: Track 1|Disease progression|15|||
164594370|NCT02935634|594539171|FG001|Treatment: Track 1|Disease progression|17|||
164594371|NCT02935634|594539172|FG002|Treatment: Track 1|Disease progression|28|||
164594372|NCT02935634|594539173|FG003|Treatment: Track 1|Disease progression|4|||
164594373|NCT02935634|594539174|FG004|Treatment: Track 1|Disease progression|6|||
164441281|NCT01307267|593982739|FG009|Overall Study|Other|0|||
164441282|NCT01307267|593982740|FG010|Overall Study|Other|1|||
164441283|NCT01307267|593982741|FG011|Overall Study|Other|1|||
164441284|NCT01307267|593982742|FG012|Overall Study|Other|1|||
164703840|NCT03107026|594941800|FG002|Overall Study|Adverse Event|23|||
164703841|NCT03107026|594941798|FG000|Overall Study|Lost to Follow-up|12|||
164703842|NCT03107026|594941799|FG001|Overall Study|Lost to Follow-up|12|||
164703843|NCT03107026|594941800|FG002|Overall Study|Lost to Follow-up|13|||
164703844|NCT03107026|594941798|FG000|Overall Study|Protocol Violation|1|||
164389517|NCT04420689|593794301|FG006|Overall Study|Physician Decision|0|||
164389518|NCT04360824|593794304|FG000|Overall Study|Withdrawal by Subject|2|||
164389519|NCT04360824|593794305|FG001|Overall Study|Withdrawal by Subject|1|||
164389520|NCT04360824|593794304|FG000|Overall Study|Did not receive assigned treatment|1|||
164389521|NCT04360824|593794305|FG001|Overall Study|Did not receive assigned treatment|3|||
164389522|NCT02278328|593794309|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
164389523|NCT02278328|593794310|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
164389524|NCT02278328|593794311|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
164389525|NCT02278328|593794309|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
164389526|NCT02278328|593794310|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
164389527|NCT02278328|593794311|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
164389528|NCT02278328|593794309|FG000|Neuropsych Screening|incomplete consent|0|||
164389529|NCT02278328|593794310|FG001|Neuropsych Screening|incomplete consent|0|||
164389530|NCT02278328|593794311|FG002|Neuropsych Screening|incomplete consent|2|||
164389531|NCT02365467|593794312|FG000|Overall Study|Death|3|||
164389532|NCT01306162|593794313|FG000|Period 1|Adverse Event|0|||
164389533|NCT01306162|593794314|FG001|Period 1|Adverse Event|0|||
164703845|NCT03107026|594941799|FG001|Overall Study|Protocol Violation|2|||
164703846|NCT03107026|594941800|FG002|Overall Study|Protocol Violation|0|||
164703847|NCT03107026|594941798|FG000|Overall Study|Pregnancy|1|||
164389534|NCT01306162|593794315|FG002|Period 1|Adverse Event|0|||
164389535|NCT01306162|593794316|FG003|Period 1|Adverse Event|1|||
164389536|NCT01306162|593794313|FG000|Washout 1|Non-compliance to protocol|0|||
164389537|NCT01306162|593794314|FG001|Washout 1|Non-compliance to protocol|1|||
164389538|NCT01306162|593794315|FG002|Washout 1|Non-compliance to protocol|0|||
164441285|NCT01307267|593982743|FG013|Overall Study|Other|0|||
164441286|NCT01307267|593982744|FG014|Overall Study|Other|2|||
164441287|NCT01307267|593982745|FG015|Overall Study|Other|1|||
164441288|NCT01307267|593982746|FG016|Overall Study|Other|0|||
164441289|NCT01307267|593982747|FG017|Overall Study|Other|0|||
164441290|NCT01307267|593982748|FG018|Overall Study|Other|0|||
164441291|NCT01307267|593982749|FG019|Overall Study|Other|19|||
164441292|NCT01307267|593982750|FG020|Overall Study|Other|2|||
164441293|NCT01307267|593982751|FG021|Overall Study|Other|3|||
164441294|NCT01307267|593982752|FG022|Overall Study|Other|2|||
164441295|NCT04956575|593982755|FG000|Overall Study|Death|1|||
164441296|NCT04956575|593982756|FG001|Overall Study|Death|0|||
164441297|NCT04956575|593982757|FG002|Overall Study|Death|0|||
164441298|NCT04956575|593982758|FG003|Overall Study|Death|0|||
164441299|NCT04956575|593982759|FG004|Overall Study|Death|0|||
164441300|NCT04956575|593982760|FG005|Overall Study|Death|0|||
164441301|NCT04956575|593982761|FG006|Overall Study|Death|0|||
164441302|NCT04956575|593982762|FG007|Overall Study|Death|1|||
164441303|NCT04956575|593982763|FG008|Overall Study|Death|0|||
164441304|NCT04956575|593982764|FG009|Overall Study|Death|1|||
164441305|NCT04956575|593982765|FG010|Overall Study|Death|0|||
164441306|NCT04956575|593982766|FG011|Overall Study|Death|0|||
164441307|NCT04956575|593982755|FG000|Overall Study|Lost to Follow-up|3|||
164441308|NCT04956575|593982756|FG001|Overall Study|Lost to Follow-up|4|||
164441309|NCT04956575|593982757|FG002|Overall Study|Lost to Follow-up|2|||
164441310|NCT04956575|593982758|FG003|Overall Study|Lost to Follow-up|3|||
164441311|NCT04956575|593982759|FG004|Overall Study|Lost to Follow-up|1|||
164441312|NCT04956575|593982760|FG005|Overall Study|Lost to Follow-up|10|||
164441313|NCT04956575|593982761|FG006|Overall Study|Lost to Follow-up|11|||
164441314|NCT04956575|593982762|FG007|Overall Study|Lost to Follow-up|7|||
164441315|NCT04956575|593982763|FG008|Overall Study|Lost to Follow-up|4|||
164441316|NCT04956575|593982764|FG009|Overall Study|Lost to Follow-up|2|||
164441317|NCT04956575|593982765|FG010|Overall Study|Lost to Follow-up|3|||
164441318|NCT04956575|593982766|FG011|Overall Study|Lost to Follow-up|8|||
164441319|NCT04956575|593982755|FG000|Overall Study|Withdrawal by Subject|1|||
164441320|NCT04956575|593982756|FG001|Overall Study|Withdrawal by Subject|2|||
164441321|NCT04956575|593982757|FG002|Overall Study|Withdrawal by Subject|1|||
164441322|NCT04956575|593982758|FG003|Overall Study|Withdrawal by Subject|4|||
164441323|NCT04956575|593982759|FG004|Overall Study|Withdrawal by Subject|2|||
164441324|NCT04956575|593982760|FG005|Overall Study|Withdrawal by Subject|8|||
164441325|NCT04956575|593982761|FG006|Overall Study|Withdrawal by Subject|5|||
164441326|NCT04956575|593982762|FG007|Overall Study|Withdrawal by Subject|1|||
164441327|NCT04956575|593982763|FG008|Overall Study|Withdrawal by Subject|1|||
164441328|NCT04956575|593982764|FG009|Overall Study|Withdrawal by Subject|0|||
164441329|NCT04956575|593982765|FG010|Overall Study|Withdrawal by Subject|3|||
164441330|NCT04956575|593982766|FG011|Overall Study|Withdrawal by Subject|1|||
164441331|NCT06119113|593982769|FG000|Overall Study|Lost to Follow-up|15|||
164441332|NCT06119113|593982770|FG001|Overall Study|Lost to Follow-up|13|||
164703848|NCT03107026|594941799|FG001|Overall Study|Pregnancy|0|||
164703849|NCT03107026|594941800|FG002|Overall Study|Pregnancy|0|||
164389539|NCT01306162|593794316|FG003|Washout 1|Non-compliance to protocol|0|||
164389540|NCT01109992|593794317|FG000|Overall Study|Withdrawal by Subject|0|||
164389541|NCT01109992|593794318|FG001|Overall Study|Withdrawal by Subject|1|||
164389542|NCT01109992|593794317|FG000|Overall Study|Movement during rest scan.|0|||
164389543|NCT01109992|593794318|FG001|Overall Study|Movement during rest scan.|1|||
164389544|NCT00690755|593794319|FG000|Overall Study|Physician Decision|2|||
164389545|NCT00690755|593794320|FG001|Overall Study|Physician Decision|0|||
164389546|NCT00690755|593794321|FG002|Overall Study|Physician Decision|46|||
164389547|NCT00690755|593794322|FG003|Overall Study|Physician Decision|5|||
164389548|NCT00690755|593794323|FG004|Overall Study|Physician Decision|0|||
164389549|NCT00690755|593794324|FG005|Overall Study|Physician Decision|4|||
164389550|NCT00690755|593794325|FG006|Overall Study|Physician Decision|0|||
164389551|NCT04287920|593794329|FG000|Overall Study|Lost to Follow-up|1|||
164389552|NCT04287920|593794330|FG001|Overall Study|Lost to Follow-up|1|||
164389553|NCT04287920|593794329|FG000|Overall Study|Withdrawal by Subject|0|||
164389554|NCT04287920|593794330|FG001|Overall Study|Withdrawal by Subject|3|||
164389555|NCT02952924|593794335|FG000|Overall Study|Protocol Violation|0|||
164389556|NCT02952924|593794336|FG001|Overall Study|Protocol Violation|0|||
164389557|NCT02952924|593794337|FG002|Overall Study|Protocol Violation|0|||
164389558|NCT02952924|593794338|FG003|Overall Study|Protocol Violation|0|||
164389559|NCT02952924|593794339|FG004|Overall Study|Protocol Violation|0|||
164389560|NCT02952924|593794340|FG005|Overall Study|Protocol Violation|0|||
164389561|NCT02952924|593794341|FG006|Overall Study|Protocol Violation|0|||
164389562|NCT02952924|593794342|FG007|Overall Study|Protocol Violation|0|||
164389563|NCT02952924|593794343|FG008|Overall Study|Protocol Violation|0|||
164389564|NCT02952924|593794344|FG009|Overall Study|Protocol Violation|0|||
164389565|NCT02952924|593794345|FG010|Overall Study|Protocol Violation|0|||
164389566|NCT02952924|593794346|FG011|Overall Study|Protocol Violation|0|||
164389567|NCT02952924|593794347|FG012|Overall Study|Protocol Violation|0|||
164389568|NCT02952924|593794348|FG013|Overall Study|Protocol Violation|0|||
164389569|NCT02952924|593794349|FG014|Overall Study|Protocol Violation|0|||
164389570|NCT02952924|593794350|FG015|Overall Study|Protocol Violation|0|||
164389571|NCT02952924|593794351|FG016|Overall Study|Protocol Violation|0|||
164389572|NCT02952924|593794352|FG017|Overall Study|Protocol Violation|0|||
164389573|NCT02952924|593794353|FG018|Overall Study|Protocol Violation|0|||
164389574|NCT02952924|593794354|FG019|Overall Study|Protocol Violation|1|||
164389575|NCT02952924|593794355|FG020|Overall Study|Protocol Violation|0|||
164389576|NCT02952924|593794356|FG021|Overall Study|Protocol Violation|0|||
164389577|NCT02952924|593794335|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
164389578|NCT02952924|593794336|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
164389579|NCT02952924|593794337|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
164389580|NCT02952924|593794338|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
164389581|NCT02952924|593794339|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
164389582|NCT02952924|593794340|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
164389583|NCT02952924|593794341|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
164389584|NCT02952924|593794342|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
164389585|NCT02952924|593794343|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
164389586|NCT02952924|593794344|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
164389587|NCT02952924|593794345|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
164389588|NCT02952924|593794346|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
164389589|NCT02952924|593794347|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
164389590|NCT02952924|593794348|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
164389591|NCT02952924|593794349|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
164389592|NCT02952924|593794350|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
164389593|NCT02952924|593794351|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
164389594|NCT02952924|593794352|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
164389595|NCT02952924|593794353|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
164389596|NCT02952924|593794354|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
164389597|NCT02952924|593794355|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
164389598|NCT02952924|593794356|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
164389599|NCT02952924|593794335|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389600|NCT02952924|593794336|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389601|NCT02952924|593794337|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389602|NCT02952924|593794338|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389603|NCT02952924|593794339|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389604|NCT02952924|593794340|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389605|NCT02952924|593794341|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389606|NCT02952924|593794342|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389607|NCT02952924|593794343|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389608|NCT02952924|593794344|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389609|NCT02952924|593794345|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389610|NCT02952924|593794346|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389611|NCT02952924|593794347|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389612|NCT02952924|593794348|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389613|NCT02952924|593794349|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389614|NCT02952924|593794350|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389615|NCT02952924|593794351|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389616|NCT02952924|593794352|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389617|NCT02952924|593794353|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389618|NCT02952924|593794354|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389619|NCT02952924|593794355|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389620|NCT02952924|593794356|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
164389621|NCT02952924|593794335|FG000|Overall Study|Noncompliance with study drug|0|||
164389622|NCT02952924|593794336|FG001|Overall Study|Noncompliance with study drug|0|||
164389623|NCT02952924|593794337|FG002|Overall Study|Noncompliance with study drug|0|||
164389624|NCT02952924|593794338|FG003|Overall Study|Noncompliance with study drug|0|||
164389625|NCT02952924|593794339|FG004|Overall Study|Noncompliance with study drug|0|||
164389626|NCT02952924|593794340|FG005|Overall Study|Noncompliance with study drug|0|||
164389627|NCT02952924|593794341|FG006|Overall Study|Noncompliance with study drug|0|||
164389628|NCT02952924|593794342|FG007|Overall Study|Noncompliance with study drug|0|||
164389629|NCT02952924|593794343|FG008|Overall Study|Noncompliance with study drug|0|||
164389630|NCT02952924|593794344|FG009|Overall Study|Noncompliance with study drug|0|||
164389631|NCT02952924|593794345|FG010|Overall Study|Noncompliance with study drug|0|||
164389632|NCT02952924|593794346|FG011|Overall Study|Noncompliance with study drug|0|||
164389633|NCT02952924|593794347|FG012|Overall Study|Noncompliance with study drug|0|||
164389634|NCT02952924|593794348|FG013|Overall Study|Noncompliance with study drug|0|||
164389635|NCT02952924|593794349|FG014|Overall Study|Noncompliance with study drug|0|||
164389636|NCT02952924|593794350|FG015|Overall Study|Noncompliance with study drug|0|||
164389637|NCT02952924|593794351|FG016|Overall Study|Noncompliance with study drug|0|||
164389638|NCT02952924|593794352|FG017|Overall Study|Noncompliance with study drug|0|||
164389639|NCT02952924|593794353|FG018|Overall Study|Noncompliance with study drug|0|||
164389640|NCT02952924|593794354|FG019|Overall Study|Noncompliance with study drug|0|||
164389641|NCT02952924|593794355|FG020|Overall Study|Noncompliance with study drug|0|||
164389642|NCT02952924|593794356|FG021|Overall Study|Noncompliance with study drug|1|||
164389643|NCT01435577|593794357|FG000|Overall Study|Adverse Event|10|||
164389644|NCT01435577|593794358|FG001|Overall Study|Adverse Event|0|||
164389645|NCT01435577|593794357|FG000|Overall Study|Lack of Efficacy|7|||
164389646|NCT01435577|593794358|FG001|Overall Study|Lack of Efficacy|51|||
164389647|NCT01435577|593794357|FG000|Overall Study|Alternative treatment started|0|||
164389648|NCT01435577|593794358|FG001|Overall Study|Alternative treatment started|1|||
164389649|NCT01934218|593794360|FG000|Double-blind Phase|Adverse Event|8|||
164389650|NCT01934218|593794361|FG001|Double-blind Phase|Adverse Event|8|||
164389651|NCT01934218|593794360|FG000|Double-blind Phase|Lack of Efficacy|6|||
164389652|NCT01934218|593794361|FG001|Double-blind Phase|Lack of Efficacy|7|||
164389653|NCT01934218|593794360|FG000|Double-blind Phase|Lost to Follow-up|7|||
164389654|NCT01934218|593794361|FG001|Double-blind Phase|Lost to Follow-up|14|||
164389655|NCT01934218|593794360|FG000|Double-blind Phase|Physician Decision|1|||
164389656|NCT01934218|593794361|FG001|Double-blind Phase|Physician Decision|2|||
164389657|NCT01934218|593794360|FG000|Double-blind Phase|Protocol Violation|4|||
164389658|NCT01934218|593794361|FG001|Double-blind Phase|Protocol Violation|0|||
164389659|NCT01934218|593794360|FG000|Double-blind Phase|Withdrawal by Subject|16|||
164389660|NCT01934218|593794361|FG001|Double-blind Phase|Withdrawal by Subject|13|||
164389661|NCT01934218|593794360|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
164389662|NCT01934218|593794361|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
164389663|NCT01934218|593794360|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
164389664|NCT01934218|593794361|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
164389665|NCT01934218|593794360|FG000|Open-Label Phase|Adverse Event|2|||
164389666|NCT01934218|593794361|FG001|Open-Label Phase|Adverse Event|4|||
164389667|NCT01934218|593794360|FG000|Open-Label Phase|Lack of Efficacy|1|||
164389668|NCT01934218|593794361|FG001|Open-Label Phase|Lack of Efficacy|4|||
164389669|NCT01934218|593794360|FG000|Open-Label Phase|Lost to Follow-up|4|||
164389670|NCT01934218|593794361|FG001|Open-Label Phase|Lost to Follow-up|2|||
164389671|NCT01934218|593794360|FG000|Open-Label Phase|Physician Decision|1|||
164389672|NCT01934218|593794361|FG001|Open-Label Phase|Physician Decision|0|||
164389673|NCT01934218|593794360|FG000|Open-Label Phase|Protocol Violation|1|||
164389674|NCT01934218|593794361|FG001|Open-Label Phase|Protocol Violation|0|||
164389675|NCT01934218|593794360|FG000|Open-Label Phase|Withdrawal by Subject|13|||
164389676|NCT01934218|593794361|FG001|Open-Label Phase|Withdrawal by Subject|11|||
164389677|NCT01934218|593794360|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
164389678|NCT01934218|593794361|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
164389679|NCT01934218|593794360|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
164389680|NCT01934218|593794361|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
164389681|NCT03273946|593794365|FG000|Overall Study|Withdrawal by Subject|5|||
164389682|NCT03273946|593794365|FG000|Overall Study|Unwillingness of the guardian|1|||
164389683|NCT03273946|593794365|FG000|Overall Study|Participant refused to use the drug|2|||
164389684|NCT03273946|593794365|FG000|Overall Study|Participant relative refused to use drug|1|||
164389685|NCT01220557|593794366|FG000|Overall Study|Lost to Follow-up|5|||
164389686|NCT01220557|593794367|FG001|Overall Study|Lost to Follow-up|3|||
164389687|NCT01220557|593794366|FG000|Overall Study|attended less than 6 lessons|1|||
164389688|NCT01220557|593794367|FG001|Overall Study|attended less than 6 lessons|2|||
164389689|NCT04323436|593794370|FG000|Overall Study|Adverse Event|7|||
164389690|NCT04323436|593794371|FG001|Overall Study|Adverse Event|0|||
164389691|NCT04323436|593794372|FG002|Overall Study|Adverse Event|0|||
164389692|NCT04323436|593794370|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
164389693|NCT04323436|593794371|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
164389694|NCT04323436|593794372|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
164389695|NCT04323436|593794370|FG000|Overall Study|Death|1|||
164389696|NCT04323436|593794371|FG001|Overall Study|Death|0|||
164389697|NCT04323436|593794372|FG002|Overall Study|Death|0|||
164389698|NCT04323436|593794370|FG000|Overall Study|Physician Decision|2|||
164389699|NCT04323436|593794371|FG001|Overall Study|Physician Decision|0|||
164389700|NCT04323436|593794372|FG002|Overall Study|Physician Decision|0|||
164389701|NCT04323436|593794370|FG000|Overall Study|Progressive disease|10|||
164389702|NCT04323436|593794371|FG001|Overall Study|Progressive disease|0|||
164389703|NCT04323436|593794372|FG002|Overall Study|Progressive disease|0|||
164389704|NCT04323436|593794370|FG000|Overall Study|Subject decision|3|||
164389705|NCT04323436|593794371|FG001|Overall Study|Subject decision|0|||
164389706|NCT04323436|593794372|FG002|Overall Study|Subject decision|0|||
164389707|NCT01682837|593794375|FG000|Baseline|Withdrawal by Subject|5|||
164389708|NCT01664078|593794376|FG000|Overall Study|Death|9|||
164389709|NCT01664078|593794376|FG000|Overall Study|Withdrawal by Subject|4|||
164389710|NCT01664078|593794376|FG000|Overall Study|Lost to Follow-up|2|||
164389711|NCT01664078|593794376|FG000|Overall Study|missed 5 year visit|1|||
164389712|NCT01664078|593794376|FG000|Overall Study|Other|53|||
164389713|NCT04782323|593794377|FG000|Overall Study|Death|1|||
164389714|NCT04782323|593794378|FG001|Overall Study|Death|0|||
164389715|NCT04782323|593794379|FG002|Overall Study|Death|0|||
164389716|NCT04782323|593794380|FG003|Overall Study|Death|0|||
164389717|NCT04782323|593794381|FG004|Overall Study|Death|1|||
164389718|NCT04782323|593794382|FG005|Overall Study|Death|1|||
164389719|NCT04782323|593794383|FG006|Overall Study|Death|1|||
164389720|NCT04782323|593794384|FG007|Overall Study|Death|0|||
164389721|NCT04782323|593794377|FG000|Overall Study|Withdrawal by Subject|0|||
164389722|NCT04782323|593794378|FG001|Overall Study|Withdrawal by Subject|0|||
164389723|NCT04782323|593794379|FG002|Overall Study|Withdrawal by Subject|1|||
164389724|NCT04782323|593794380|FG003|Overall Study|Withdrawal by Subject|0|||
164389725|NCT04782323|593794381|FG004|Overall Study|Withdrawal by Subject|0|||
164389726|NCT04782323|593794382|FG005|Overall Study|Withdrawal by Subject|1|||
164389727|NCT04782323|593794383|FG006|Overall Study|Withdrawal by Subject|0|||
164389728|NCT04782323|593794384|FG007|Overall Study|Withdrawal by Subject|1|||
164389729|NCT04782323|593794377|FG000|Overall Study|Lost to Follow-up|0|||
164389730|NCT04782323|593794378|FG001|Overall Study|Lost to Follow-up|1|||
164594374|NCT02935634|594539175|FG005|Treatment: Track 1|Disease progression|2|||
164594375|NCT02935634|594539170|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
164389731|NCT04782323|593794379|FG002|Overall Study|Lost to Follow-up|1|||
164389732|NCT04782323|593794380|FG003|Overall Study|Lost to Follow-up|0|||
164389733|NCT04782323|593794381|FG004|Overall Study|Lost to Follow-up|0|||
164389734|NCT04782323|593794382|FG005|Overall Study|Lost to Follow-up|1|||
164389735|NCT04782323|593794383|FG006|Overall Study|Lost to Follow-up|1|||
164389736|NCT04782323|593794384|FG007|Overall Study|Lost to Follow-up|2|||
164389737|NCT04782323|593794377|FG000|Overall Study|randomization in error|1|||
164389738|NCT04782323|593794378|FG001|Overall Study|randomization in error|0|||
164389739|NCT04782323|593794379|FG002|Overall Study|randomization in error|0|||
164389740|NCT04782323|593794380|FG003|Overall Study|randomization in error|0|||
164389741|NCT04782323|593794381|FG004|Overall Study|randomization in error|0|||
164389742|NCT04782323|593794382|FG005|Overall Study|randomization in error|0|||
164389743|NCT04782323|593794383|FG006|Overall Study|randomization in error|0|||
164389744|NCT04782323|593794384|FG007|Overall Study|randomization in error|0|||
164389745|NCT04369469|593794387|FG000|Overall Study|Lost to Follow-up|2|||
164389746|NCT04369469|593794388|FG001|Overall Study|Lost to Follow-up|4|||
164389747|NCT04369469|593794387|FG000|Overall Study|Physician Decision|2|||
164389748|NCT04369469|593794388|FG001|Overall Study|Physician Decision|1|||
164389749|NCT04369469|593794387|FG000|Overall Study|Withdrawal by Subject|2|||
164389750|NCT04369469|593794388|FG001|Overall Study|Withdrawal by Subject|3|||
164389751|NCT04369469|593794387|FG000|Overall Study|Adverse Event|1|||
164389752|NCT04369469|593794388|FG001|Overall Study|Adverse Event|0|||
164389753|NCT04369469|593794387|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
164389754|NCT04369469|593794388|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
164389755|NCT04369469|593794387|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
164389756|NCT04369469|593794388|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
164389757|NCT04369469|593794387|FG000|Overall Study|Unable to Provide Consent|0|||
164389758|NCT04369469|593794388|FG001|Overall Study|Unable to Provide Consent|1|||
164389759|NCT03135522|593794389|FG000|Overall Study|Adverse Event|1|||
164389760|NCT03135522|593794390|FG001|Overall Study|Adverse Event|0|||
164389761|NCT03832192|593794393|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
164389762|NCT03832192|593794394|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
164389763|NCT01337245|593794395|FG000|Overall Study|Lost to Follow-up|1|||
164389764|NCT04095858|593794396|FG000|Overall Study|Death|1|||
164389765|NCT04095858|593794397|FG001|Overall Study|Death|0|||
164389766|NCT04095858|593794396|FG000|Overall Study|Study terminated by Sponsor|2|||
164389767|NCT04095858|593794397|FG001|Overall Study|Study terminated by Sponsor|4|||
164389768|NCT01344460|593794398|FG000|Overall Study|Withdrawal by Subject|1|||
164389769|NCT01344460|593794398|FG000|Overall Study|Lost to Follow-up|2|||
164389770|NCT02838017|593794400|FG000|Overall Study|Lost to Follow-up|14|||
164389771|NCT02838017|593794401|FG001|Overall Study|Lost to Follow-up|11|||
164389772|NCT01692197|593794402|FG000|Overall Study|Failed Screening|3|||
164389773|NCT02120924|593794403|FG000|Overall Study|Lack of Efficacy|1|||
164389774|NCT02120924|593794404|FG001|Overall Study|Lack of Efficacy|2|||
164389775|NCT02120924|593794405|FG002|Overall Study|Lack of Efficacy|3|||
164389776|NCT02120924|593794403|FG000|Overall Study|Adverse Event|0|||
164389777|NCT02120924|593794404|FG001|Overall Study|Adverse Event|1|||
164389778|NCT02120924|593794405|FG002|Overall Study|Adverse Event|3|||
164389779|NCT02120924|593794403|FG000|Overall Study|Withdrawal by Subject|16|||
164389780|NCT02120924|593794404|FG001|Overall Study|Withdrawal by Subject|20|||
164389781|NCT02120924|593794405|FG002|Overall Study|Withdrawal by Subject|8|||
164389782|NCT02120924|593794403|FG000|Overall Study|Lost to Follow-up|14|||
164389783|NCT02120924|593794404|FG001|Overall Study|Lost to Follow-up|14|||
164389784|NCT02120924|593794405|FG002|Overall Study|Lost to Follow-up|11|||
164389785|NCT02120924|593794403|FG000|Overall Study|Pregnancy|2|||
164389786|NCT02120924|593794404|FG001|Overall Study|Pregnancy|0|||
164389787|NCT02120924|593794405|FG002|Overall Study|Pregnancy|0|||
164389788|NCT02120924|593794403|FG000|Overall Study|Protocol Violation|3|||
164389789|NCT02120924|593794404|FG001|Overall Study|Protocol Violation|7|||
164389790|NCT02120924|593794405|FG002|Overall Study|Protocol Violation|2|||
164389791|NCT02120924|593794403|FG000|Overall Study|Physician Decision|0|||
164389792|NCT02120924|593794404|FG001|Overall Study|Physician Decision|1|||
164389793|NCT02120924|593794405|FG002|Overall Study|Physician Decision|1|||
164389794|NCT02120924|593794403|FG000|Overall Study|Death|1|||
164389795|NCT02120924|593794404|FG001|Overall Study|Death|0|||
164389796|NCT02120924|593794405|FG002|Overall Study|Death|0|||
164389797|NCT02120924|593794403|FG000|Overall Study|Compliance with IP|5|||
164389798|NCT02120924|593794404|FG001|Overall Study|Compliance with IP|1|||
164389799|NCT02120924|593794405|FG002|Overall Study|Compliance with IP|1|||
164389800|NCT03483623|593794406|FG000|Overall Study|43 complete sets achieved|1|||
164389801|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
164389802|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
164389803|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
164441333|NCT06119113|593982771|FG002|Overall Study|Lost to Follow-up|21|||
164441334|NCT00854906|593982772|FG000|Overall Study|One person had no ocular history|1|||
164441335|NCT05526248|593982773|FG000|Overall Study|Lost to Follow-up|1|||
164389804|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
164389805|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
164389806|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
164389807|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
164389808|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
164389809|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
164389810|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
164389811|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
164389812|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
164389813|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
164389814|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
164389815|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
164389816|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
164389817|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
164389818|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
164389819|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
164389820|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
164389821|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
164441336|NCT05526248|593982773|FG000|Overall Study|Adverse Event|2|||
164389822|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
164389823|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
164389824|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
164389825|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
164389826|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
164389827|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
164389828|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
164389829|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
164389830|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
164389831|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
164389832|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
164389833|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
164389834|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
164389835|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
164389836|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
164389837|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
164389838|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
164389839|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
164389840|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
164389841|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
164389842|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
164389843|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
164389844|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
164389845|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
164389846|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
164389847|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
164389848|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
164389849|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
164389850|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
164389851|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
164389852|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
164389853|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
164389854|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
164389855|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
164389856|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
164389857|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
164389858|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
164389859|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
164389860|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
164389861|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
164389862|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
164389863|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
164703850|NCT03107026|594941798|FG000|Overall Study|Withdrawal by Subject|13|||
164703851|NCT03107026|594941799|FG001|Overall Study|Withdrawal by Subject|5|||
164389864|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
164389865|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
164389866|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
164389867|NCT02730819|593794422|FG000|Overall Study|Lost to Follow-up|9|||
164389868|NCT01308580|593794423|FG000|Overall Study|Lost to Follow-up|12|||
164389869|NCT01308580|593794424|FG001|Overall Study|Lost to Follow-up|7|||
164389870|NCT03403634|593794425|FG000|Overall Study|Disease progression|3|||
164389871|NCT03403634|593794425|FG000|Overall Study|Did not meet eligibility criteria|4|||
164389872|NCT00932893|593794426|FG000|Overall Study|Death|115|||
164389873|NCT00932893|593794427|FG001|Overall Study|Death|24|||
164389874|NCT00932893|593794426|FG000|Overall Study|Lost to Follow-up|8|||
164389875|NCT00932893|593794427|FG001|Overall Study|Lost to Follow-up|0|||
164389876|NCT00932893|593794426|FG000|Overall Study|Withdrawal by Subject|5|||
164389877|NCT00932893|593794427|FG001|Overall Study|Withdrawal by Subject|2|||
164389878|NCT00932893|593794426|FG000|Overall Study|Other|5|||
164389879|NCT00932893|593794427|FG001|Overall Study|Other|144|||
164703852|NCT03107026|594941800|FG002|Overall Study|Withdrawal by Subject|17|||
164703853|NCT03107026|594941798|FG000|Overall Study|non compliance with study visits|1|||
164389880|NCT01850004|593794428|FG000|Overall Study|Poor/Non-compliance|1|||
164389881|NCT01850004|593794428|FG000|Overall Study|Participant Withdrew Consent|9|||
164389882|NCT01850004|593794428|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
164703854|NCT03107026|594941799|FG001|Overall Study|non compliance with study visits|2|||
164389883|NCT01850004|593794428|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
164389884|NCT01850004|593794428|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
164389885|NCT01850004|593794428|FG000|Overall Study|Other Reasons|2|||
164389886|NCT01850004|593794428|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
164389887|NCT01850004|593794428|FG000|Overall Study|Maximum Clinical Benefit|4|||
164417491|NCT01474512|593899505|FG016|Long-Term Extension Period|Protocol Violation|0|||
164417492|NCT01474512|593899506|FG017|Long-Term Extension Period|Protocol Violation|0|||
164417493|NCT01474512|593899489|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
164417494|NCT01474512|593899490|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
164417495|NCT01474512|593899491|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
164417496|NCT01474512|593899492|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
164417497|NCT01474512|593899493|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
164417498|NCT01474512|593899494|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
164417499|NCT01474512|593899495|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
164417500|NCT01474512|593899496|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
164417501|NCT01474512|593899497|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
164417502|NCT01474512|593899498|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
164417503|NCT01474512|593899499|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
164417504|NCT01474512|593899500|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
164417505|NCT01474512|593899501|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
164417506|NCT01474512|593899502|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
164417507|NCT01474512|593899503|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
164417508|NCT01474512|593899504|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
164417509|NCT01474512|593899505|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
164417510|NCT01474512|593899506|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
164417511|NCT01474512|593899489|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
164417512|NCT01474512|593899490|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
164417513|NCT01474512|593899491|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
164417514|NCT01474512|593899492|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
164417515|NCT01474512|593899493|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
164417516|NCT01474512|593899494|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
164417517|NCT01474512|593899495|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
164417518|NCT01474512|593899496|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
164417519|NCT01474512|593899497|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
164417520|NCT01474512|593899498|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
164417521|NCT01474512|593899499|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
164417522|NCT01474512|593899500|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
164417523|NCT01474512|593899501|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
164417524|NCT01474512|593899502|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
164417525|NCT01474512|593899503|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
164417526|NCT01474512|593899504|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
164417527|NCT01474512|593899505|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
164417528|NCT01474512|593899506|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
164417529|NCT01474512|593899489|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
164417530|NCT01474512|593899490|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
164417531|NCT01474512|593899491|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
164417532|NCT01474512|593899492|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
164417533|NCT01474512|593899493|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
164417534|NCT01474512|593899494|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
164417535|NCT01474512|593899495|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
164417536|NCT01474512|593899496|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
164417537|NCT01474512|593899497|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
164417538|NCT01474512|593899498|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
164417539|NCT01474512|593899499|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
164417540|NCT01474512|593899500|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
164417541|NCT01474512|593899501|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
164417542|NCT01474512|593899502|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
164417543|NCT01474512|593899503|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
164417544|NCT01474512|593899504|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
164417545|NCT01474512|593899505|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
164417546|NCT01474512|593899506|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
164417547|NCT01474512|593899489|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
164441337|NCT05526248|593982773|FG000|Overall Study|Withdrawal by Subject|1|||
164441338|NCT01786564|593982778|FG000|Overall Study|Lost to Follow-up|47|||
164441339|NCT01786564|593982778|FG000|Overall Study|Ineligible|17|||
164417548|NCT01474512|593899490|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
164417549|NCT01474512|593899491|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
164417550|NCT01474512|593899492|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
164417551|NCT01474512|593899493|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
164441340|NCT02425111|593982791|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
164441341|NCT02425111|593982791|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
164441342|NCT02425111|593982791|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
164441343|NCT02425111|593982791|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
164441344|NCT02425111|593982791|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
164441345|NCT02425111|593982791|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
164441346|NCT04446117|593982795|FG000|Overall Study|No Study Treatment Given|4|||
164441347|NCT04446117|593982796|FG001|Overall Study|No Study Treatment Given|3|||
164441348|NCT04446117|593982795|FG000|Overall Study|Radiographic Disease Progression|132|||
164441349|NCT04446117|593982796|FG001|Overall Study|Radiographic Disease Progression|158|||
164441350|NCT04446117|593982795|FG000|Overall Study|Adverse Event|79|||
164594376|NCT02935634|594539171|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
164389888|NCT02508311|593796267|FG000|Overall Study|Withdrawal by Subject|1|||
164389889|NCT02508311|593796268|FG001|Overall Study|Withdrawal by Subject|0|||
164389890|NCT04862143|593796269|FG000|Overall Study|Adverse Event|1|||
164389891|NCT04862143|593796269|FG000|Overall Study|Study terminated by sponsor|1|||
164389892|NCT04955639|593796270|FG000|Overall Study|Withdrawal by Subject|2|||
164389893|NCT04955639|593796271|FG001|Overall Study|Withdrawal by Subject|2|||
164389894|NCT04955639|593796270|FG000|Overall Study|Week 26 survey not completed|2|||
164389895|NCT04955639|593796271|FG001|Overall Study|Week 26 survey not completed|2|||
164389896|NCT00413153|593796272|FG000|Overall Study|Withdrawal by Subject|1|||
164389897|NCT00413153|593796273|FG001|Overall Study|Withdrawal by Subject|1|||
164389898|NCT00413153|593796272|FG000|Overall Study|Adverse Event|1|||
164389899|NCT00413153|593796273|FG001|Overall Study|Adverse Event|0|||
164389900|NCT03966157|593796278|FG000|Overall Study|Physician Decision|1|||
164389901|NCT03966157|593796279|FG001|Overall Study|Physician Decision|0|||
164389902|NCT04969250|593796280|FG000|Overall Study|Protocol Violation|0|||
164389903|NCT04969250|593796281|FG001|Overall Study|Protocol Violation|2|||
164389904|NCT04969250|593796282|FG002|Overall Study|Protocol Violation|3|||
164389905|NCT04969250|593796283|FG003|Overall Study|Protocol Violation|8|||
164389906|NCT04969250|593796280|FG000|Overall Study|Withdrawal by Subject|0|||
164389907|NCT04969250|593796281|FG001|Overall Study|Withdrawal by Subject|1|||
164389908|NCT04969250|593796282|FG002|Overall Study|Withdrawal by Subject|0|||
164389909|NCT04969250|593796283|FG003|Overall Study|Withdrawal by Subject|0|||
164389910|NCT00377676|593796284|FG000|Overall Study|Adverse Event|498|||
164389911|NCT00377676|593796285|FG001|Overall Study|Adverse Event|107|||
164389912|NCT00377676|593796284|FG000|Overall Study|Protocol Violation|33|||
164389913|NCT00377676|593796285|FG001|Overall Study|Protocol Violation|27|||
164389914|NCT00377676|593796284|FG000|Overall Study|Death|5|||
164389915|NCT00377676|593796285|FG001|Overall Study|Death|2|||
164441351|NCT04446117|593982796|FG001|Overall Study|Adverse Event|43|||
164441352|NCT04446117|593982795|FG000|Overall Study|Lack of Clinical Benefit|1|||
164441353|NCT04446117|593982796|FG001|Overall Study|Lack of Clinical Benefit|1|||
164441354|NCT04446117|593982795|FG000|Overall Study|Withdrawal by Subject|24|||
164441355|NCT04446117|593982796|FG001|Overall Study|Withdrawal by Subject|22|||
164594377|NCT02935634|594539172|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
164594378|NCT02935634|594539173|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
164594379|NCT02935634|594539174|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
164594380|NCT02935634|594539175|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
164594381|NCT02935634|594539170|FG000|Treatment: Track 1|Lost to Follow-up|1|||
164594382|NCT02935634|594539171|FG001|Treatment: Track 1|Lost to Follow-up|0|||
164594383|NCT02935634|594539172|FG002|Treatment: Track 1|Lost to Follow-up|0|||
164594384|NCT02935634|594539173|FG003|Treatment: Track 1|Lost to Follow-up|0|||
164594385|NCT02935634|594539174|FG004|Treatment: Track 1|Lost to Follow-up|0|||
164594386|NCT02935634|594539175|FG005|Treatment: Track 1|Lost to Follow-up|0|||
164594387|NCT02935634|594539170|FG000|Treatment: Track 1|Study drug toxicity|2|||
164594388|NCT02935634|594539171|FG001|Treatment: Track 1|Study drug toxicity|1|||
164703855|NCT03107026|594941800|FG002|Overall Study|non compliance with study visits|0|||
164703856|NCT03107026|594941798|FG000|Overall Study|non-compliance with study drug|2|||
164703857|NCT03107026|594941799|FG001|Overall Study|non-compliance with study drug|2|||
164703858|NCT03107026|594941800|FG002|Overall Study|non-compliance with study drug|3|||
164441356|NCT04446117|593982795|FG000|Overall Study|Lost to Follow-up|0|||
164441357|NCT04446117|593982796|FG001|Overall Study|Lost to Follow-up|3|||
164441358|NCT04446117|593982795|FG000|Overall Study|Miscellaneous|26|||
164441359|NCT04446117|593982796|FG001|Overall Study|Miscellaneous|36|||
164703859|NCT03107026|594941798|FG000|Overall Study|Physician Decision|0|||
164703860|NCT03107026|594941799|FG001|Overall Study|Physician Decision|1|||
164441360|NCT04446117|593982795|FG000|Overall Study|Missing Data/Data not yet Received|1|||
164703861|NCT03107026|594941800|FG002|Overall Study|Physician Decision|0|||
164389916|NCT00377676|593796284|FG000|Overall Study|Withdrawal by Subject|187|||
164389917|NCT00377676|593796285|FG001|Overall Study|Withdrawal by Subject|72|||
164389918|NCT00377676|593796284|FG000|Overall Study|Lost to Follow-up|120|||
164389919|NCT00377676|593796285|FG001|Overall Study|Lost to Follow-up|56|||
164389920|NCT00377676|593796284|FG000|Overall Study|Other|118|||
164389921|NCT00377676|593796285|FG001|Overall Study|Other|58|||
164703862|NCT00062010|594941801|FG000|Overall Study|Ineligible|3|||
164389922|NCT03834779|593796291|FG000|Overall Study|Death|1|||
164389923|NCT03834779|593796292|FG001|Overall Study|Death|2|||
164389924|NCT03834779|593796291|FG000|Overall Study|Lost to Follow-up|6|||
164389925|NCT03834779|593796292|FG001|Overall Study|Lost to Follow-up|4|||
164389926|NCT03579459|593796293|FG000|Overall Study|Adverse Event|7|||
164389927|NCT03579459|593796294|FG001|Overall Study|Adverse Event|6|||
164389928|NCT03579459|593796295|FG002|Overall Study|Adverse Event|2|||
164389929|NCT03579459|593796296|FG003|Overall Study|Adverse Event|6|||
164389930|NCT03579459|593796293|FG000|Overall Study|Death|1|||
164389931|NCT03579459|593796294|FG001|Overall Study|Death|0|||
164389932|NCT03579459|593796295|FG002|Overall Study|Death|1|||
164389933|NCT03579459|593796296|FG003|Overall Study|Death|2|||
164389934|NCT03579459|593796293|FG000|Overall Study|Lost to Follow-up|6|||
164389935|NCT03579459|593796294|FG001|Overall Study|Lost to Follow-up|2|||
164389936|NCT03579459|593796295|FG002|Overall Study|Lost to Follow-up|4|||
164389937|NCT03579459|593796296|FG003|Overall Study|Lost to Follow-up|1|||
164389938|NCT03579459|593796293|FG000|Overall Study|Physician Decision|0|||
164389939|NCT03579459|593796294|FG001|Overall Study|Physician Decision|1|||
164389940|NCT03579459|593796295|FG002|Overall Study|Physician Decision|0|||
164389941|NCT03579459|593796296|FG003|Overall Study|Physician Decision|1|||
164389942|NCT03579459|593796293|FG000|Overall Study|Protocol Violation|1|||
164389943|NCT03579459|593796294|FG001|Overall Study|Protocol Violation|2|||
164389944|NCT03579459|593796295|FG002|Overall Study|Protocol Violation|3|||
164389945|NCT03579459|593796296|FG003|Overall Study|Protocol Violation|5|||
164389946|NCT03579459|593796293|FG000|Overall Study|Withdrawal by Subject|12|||
164389947|NCT03579459|593796294|FG001|Overall Study|Withdrawal by Subject|8|||
164389948|NCT03579459|593796295|FG002|Overall Study|Withdrawal by Subject|11|||
164389949|NCT03579459|593796296|FG003|Overall Study|Withdrawal by Subject|8|||
164389950|NCT03579459|593796293|FG000|Overall Study|Medication error without associated adverse event|2|||
164389951|NCT03579459|593796294|FG001|Overall Study|Medication error without associated adverse event|1|||
164389952|NCT03579459|593796295|FG002|Overall Study|Medication error without associated adverse event|1|||
164594389|NCT02935634|594539172|FG002|Treatment: Track 1|Study drug toxicity|3|||
164594390|NCT02935634|594539173|FG003|Treatment: Track 1|Study drug toxicity|0|||
164594391|NCT02935634|594539174|FG004|Treatment: Track 1|Study drug toxicity|0|||
164594392|NCT02935634|594539175|FG005|Treatment: Track 1|Study drug toxicity|1|||
164594393|NCT02935634|594539170|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
164594394|NCT02935634|594539171|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
164594395|NCT02935634|594539172|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
164594396|NCT02935634|594539173|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
164594397|NCT02935634|594539174|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
164594398|NCT02935634|594539175|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
164389953|NCT03579459|593796296|FG003|Overall Study|Medication error without associated adverse event|0|||
164389954|NCT03579459|593796293|FG000|Overall Study|Other|0|||
164389955|NCT03579459|593796294|FG001|Overall Study|Other|1|||
164389956|NCT03579459|593796295|FG002|Overall Study|Other|1|||
164389957|NCT03579459|593796296|FG003|Overall Study|Other|0|||
164389958|NCT03579459|593796293|FG000|Overall Study|Randomized not vaccinated|0|||
164389959|NCT03579459|593796294|FG001|Overall Study|Randomized not vaccinated|2|||
164389960|NCT03579459|593796295|FG002|Overall Study|Randomized not vaccinated|0|||
164389961|NCT03579459|593796296|FG003|Overall Study|Randomized not vaccinated|1|||
164389962|NCT02528214|593796297|FG000|Overall Study|Protocol Violation|0|||
164389963|NCT02528214|593796298|FG001|Overall Study|Protocol Violation|1|||
164389964|NCT02528214|593796297|FG000|Overall Study|Adverse Event|0|||
164389965|NCT02528214|593796298|FG001|Overall Study|Adverse Event|1|||
164389966|NCT02528214|593796297|FG000|Overall Study|Other than specified above|0|||
164389967|NCT02528214|593796298|FG001|Overall Study|Other than specified above|1|||
164389968|NCT00407537|593796299|FG000|Overall Study|Death|5|||
164389969|NCT00407537|593796300|FG001|Overall Study|Death|2|||
164389970|NCT00407537|593796299|FG000|Overall Study|Adverse Event|36|||
164389971|NCT00407537|593796300|FG001|Overall Study|Adverse Event|0|||
164389972|NCT00407537|593796299|FG000|Overall Study|Lost to Follow-up|12|||
164389973|NCT00407537|593796300|FG001|Overall Study|Lost to Follow-up|19|||
164389974|NCT00407537|593796299|FG000|Overall Study|Other|6|||
164389975|NCT00407537|593796300|FG001|Overall Study|Other|7|||
164389976|NCT00407537|593796299|FG000|Overall Study|Withdrawal by Subject|34|||
164389977|NCT00407537|593796300|FG001|Overall Study|Withdrawal by Subject|16|||
164389978|NCT03593655|593796302|FG000|First Product Use Period|Withdrawal by Subject|1|||
164389979|NCT03593655|593796303|FG001|First Product Use Period|Withdrawal by Subject|1|||
164389980|NCT03593655|593796302|FG000|First Product Use Period|Lost to Follow-up|1|||
164389981|NCT03593655|593796303|FG001|First Product Use Period|Lost to Follow-up|3|||
164389982|NCT03593655|593796302|FG000|Second Product Use Period|Withdrawal by Subject|1|||
164389983|NCT03593655|593796303|FG001|Second Product Use Period|Withdrawal by Subject|1|||
164389984|NCT03593655|593796302|FG000|Second Product Use Period|Lost to Follow-up|1|||
164389985|NCT03593655|593796303|FG001|Second Product Use Period|Lost to Follow-up|0|||
164389986|NCT03593655|593796302|FG000|Third Product Use Period|Lost to Follow-up|1|||
164389987|NCT03593655|593796303|FG001|Third Product Use Period|Lost to Follow-up|2|||
164703863|NCT01183221|594941802|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
164389988|NCT03593655|593796302|FG000|Third Product Use Period|Physician Decision|0|||
164389989|NCT03593655|593796303|FG001|Third Product Use Period|Physician Decision|1|||
164389990|NCT03593655|593796302|FG000|Third Product Use Period|Withdrawal by Subject|0|||
164389991|NCT03593655|593796303|FG001|Third Product Use Period|Withdrawal by Subject|1|||
164389992|NCT03526250|593796304|FG000|Overall Study|Adverse Event|4|||
164389993|NCT03526250|593796304|FG000|Overall Study|Progressive Disease|16|||
164389994|NCT03526250|593796304|FG000|Overall Study|No Treatment|3|||
164389995|NCT04420221|593796305|FG000|Overall Study|Withdrawal by Subject|0|||
164389996|NCT04420221|593796306|FG001|Overall Study|Withdrawal by Subject|0|||
164389997|NCT04420221|593796307|FG002|Overall Study|Withdrawal by Subject|0|||
164389998|NCT04420221|593796308|FG003|Overall Study|Withdrawal by Subject|0|||
164389999|NCT04420221|593796309|FG004|Overall Study|Withdrawal by Subject|0|||
164390000|NCT04420221|593796310|FG005|Overall Study|Withdrawal by Subject|20|||
164390001|NCT04420221|593796311|FG006|Overall Study|Withdrawal by Subject|5|||
164390002|NCT04420221|593796305|FG000|Overall Study|Other|0|||
164390003|NCT04420221|593796306|FG001|Overall Study|Other|0|||
164390004|NCT04420221|593796307|FG002|Overall Study|Other|0|||
164390005|NCT04420221|593796308|FG003|Overall Study|Other|0|||
164390006|NCT04420221|593796309|FG004|Overall Study|Other|0|||
164390007|NCT04420221|593796310|FG005|Overall Study|Other|1|||
164390008|NCT04420221|593796311|FG006|Overall Study|Other|1|||
164390009|NCT04420221|593796305|FG000|Overall Study|Lost to Follow-up|0|||
164390010|NCT04420221|593796306|FG001|Overall Study|Lost to Follow-up|0|||
164390011|NCT04420221|593796307|FG002|Overall Study|Lost to Follow-up|0|||
164390012|NCT04420221|593796308|FG003|Overall Study|Lost to Follow-up|0|||
164390013|NCT04420221|593796309|FG004|Overall Study|Lost to Follow-up|0|||
164390014|NCT04420221|593796310|FG005|Overall Study|Lost to Follow-up|3|||
164390015|NCT04420221|593796311|FG006|Overall Study|Lost to Follow-up|2|||
164390016|NCT04420221|593796305|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
164390017|NCT04420221|593796306|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
164390018|NCT04420221|593796307|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
164390019|NCT04420221|593796308|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
164390020|NCT04420221|593796309|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
164390021|NCT04420221|593796310|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
164390022|NCT04420221|593796311|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
164390023|NCT05348681|593796312|FG000|Overall Study|Study terminated by Sponsor|8|||
164390024|NCT05348681|593796313|FG001|Overall Study|Study terminated by Sponsor|3|||
164390025|NCT05348681|593796312|FG000|Overall Study|Withdrawal by Subject|1|||
164390026|NCT05348681|593796313|FG001|Overall Study|Withdrawal by Subject|1|||
164390027|NCT05348681|593796312|FG000|Overall Study|Lost to Follow-up|1|||
164390028|NCT05348681|593796313|FG001|Overall Study|Lost to Follow-up|1|||
164390029|NCT05348681|593796312|FG000|Overall Study|Adverse Event|1|||
164390030|NCT05348681|593796313|FG001|Overall Study|Adverse Event|0|||
164390031|NCT05348681|593796312|FG000|Overall Study|Other|2|||
164390032|NCT05348681|593796313|FG001|Overall Study|Other|1|||
164390033|NCT01040130|593796314|FG000|Overall Study|Adverse Event|1|||
164390034|NCT01040130|593796315|FG001|Overall Study|Adverse Event|1|||
164390035|NCT01040130|593796316|FG002|Overall Study|Adverse Event|0|||
164390036|NCT01040130|593796317|FG003|Overall Study|Adverse Event|5|||
164390037|NCT01040130|593796318|FG004|Overall Study|Adverse Event|0|||
164390038|NCT01040130|593796319|FG005|Overall Study|Adverse Event|3|||
164390039|NCT01040130|593796314|FG000|Overall Study|Protocol Violation|0|||
164390040|NCT01040130|593796315|FG001|Overall Study|Protocol Violation|0|||
164390041|NCT01040130|593796316|FG002|Overall Study|Protocol Violation|2|||
164390042|NCT01040130|593796317|FG003|Overall Study|Protocol Violation|0|||
164390043|NCT01040130|593796318|FG004|Overall Study|Protocol Violation|0|||
164390044|NCT01040130|593796319|FG005|Overall Study|Protocol Violation|0|||
164390045|NCT01040130|593796314|FG000|Overall Study|Withdrawal by Subject|0|||
164390046|NCT01040130|593796315|FG001|Overall Study|Withdrawal by Subject|2|||
164390047|NCT01040130|593796316|FG002|Overall Study|Withdrawal by Subject|0|||
164390048|NCT01040130|593796317|FG003|Overall Study|Withdrawal by Subject|0|||
164390049|NCT01040130|593796318|FG004|Overall Study|Withdrawal by Subject|0|||
164390050|NCT01040130|593796319|FG005|Overall Study|Withdrawal by Subject|1|||
164390051|NCT01040130|593796314|FG000|Overall Study|Other reasons not listed above|2|||
164390052|NCT01040130|593796315|FG001|Overall Study|Other reasons not listed above|0|||
164390053|NCT01040130|593796316|FG002|Overall Study|Other reasons not listed above|0|||
164390054|NCT01040130|593796317|FG003|Overall Study|Other reasons not listed above|0|||
164390055|NCT01040130|593796318|FG004|Overall Study|Other reasons not listed above|0|||
164390056|NCT01040130|593796319|FG005|Overall Study|Other reasons not listed above|0|||
164441361|NCT04446117|593982796|FG001|Overall Study|Missing Data/Data not yet Received|0|||
164441362|NCT00324038|593982805|FG000|Overall Study|Adverse Event|38|||
164441363|NCT00324038|593982806|FG001|Overall Study|Adverse Event|23|||
164441364|NCT00324038|593982805|FG000|Overall Study|Lack of Efficacy|5|||
164441365|NCT00324038|593982806|FG001|Overall Study|Lack of Efficacy|13|||
164390057|NCT00553267|593796323|FG000|Overall Study|Adverse Event|8|||
164390058|NCT00553267|593796324|FG001|Overall Study|Adverse Event|10|||
164390059|NCT00553267|593796325|FG002|Overall Study|Adverse Event|5|||
164390060|NCT00553267|593796323|FG000|Overall Study|Non compliant with protocol|3|||
164390061|NCT00553267|593796324|FG001|Overall Study|Non compliant with protocol|3|||
164390062|NCT00553267|593796325|FG002|Overall Study|Non compliant with protocol|2|||
164390063|NCT00553267|593796323|FG000|Overall Study|Lost to Follow-up|0|||
164390064|NCT00553267|593796324|FG001|Overall Study|Lost to Follow-up|0|||
164390065|NCT00553267|593796325|FG002|Overall Study|Lost to Follow-up|1|||
164390066|NCT00553267|593796323|FG000|Overall Study|Consent withdrawn|2|||
164390067|NCT00553267|593796324|FG001|Overall Study|Consent withdrawn|3|||
164390068|NCT00553267|593796325|FG002|Overall Study|Consent withdrawn|1|||
164390069|NCT00553267|593796323|FG000|Overall Study|Specified category|1|||
164390070|NCT00553267|593796324|FG001|Overall Study|Specified category|2|||
164390071|NCT00553267|593796325|FG002|Overall Study|Specified category|1|||
164390072|NCT04389840|593796326|FG000|Overall Study|Adverse Event|0|||
164390073|NCT04389840|593796327|FG001|Overall Study|Adverse Event|0|||
164390074|NCT04389840|593796328|FG002|Overall Study|Adverse Event|0|||
164390075|NCT04389840|593796329|FG003|Overall Study|Adverse Event|1|||
164390076|NCT04389840|593796330|FG004|Overall Study|Adverse Event|0|||
164390077|NCT04389840|593796331|FG005|Overall Study|Adverse Event|0|||
164390078|NCT04389840|593796326|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
164390079|NCT04389840|593796327|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
164390080|NCT04389840|593796328|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
164390081|NCT04389840|593796329|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
164390082|NCT04389840|593796330|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
164390083|NCT04389840|593796331|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
164390084|NCT04389840|593796326|FG000|Overall Study|Death|0|||
164390085|NCT04389840|593796327|FG001|Overall Study|Death|1|||
164390086|NCT04389840|593796328|FG002|Overall Study|Death|0|||
164390087|NCT04389840|593796329|FG003|Overall Study|Death|0|||
164390088|NCT04389840|593796330|FG004|Overall Study|Death|0|||
164390089|NCT04389840|593796331|FG005|Overall Study|Death|0|||
164390090|NCT01618864|593796332|FG000|Overall Study|Withdrawal by Subject|2|||
164390091|NCT01618864|593796332|FG000|Overall Study|Lost to Follow-up|2|||
164390092|NCT03585244|593796333|FG000|Overall Study|Withdrawal by Subject|15|||
164390093|NCT01090453|593796339|FG000|Overall Study|Withdrawal by Subject|1|||
164390094|NCT01090453|593796340|FG001|Overall Study|Withdrawal by Subject|2|||
164390095|NCT01090453|593796339|FG000|Overall Study|Lost to Follow-up|7|||
164390096|NCT01090453|593796340|FG001|Overall Study|Lost to Follow-up|7|||
164390097|NCT01090453|593796339|FG000|Overall Study|Non serious AEs|1|||
164390098|NCT01090453|593796340|FG001|Overall Study|Non serious AEs|0|||
164390099|NCT01090453|593796339|FG000|Overall Study|Protocol Violation|2|||
164390100|NCT01090453|593796340|FG001|Overall Study|Protocol Violation|0|||
164594399|NCT02935634|594539170|FG000|Treatment: Track 1|Participant withdrew consent|2|||
164390101|NCT01090453|593796339|FG000|Overall Study|Other|2|||
164390102|NCT01090453|593796340|FG001|Overall Study|Other|4|||
164390103|NCT01090453|593796339|FG000|Overall Study|Eligibility Criteria|0|||
164390104|NCT01090453|593796340|FG001|Overall Study|Eligibility Criteria|1|||
164390105|NCT00142909|593796346|FG000|Randomization|Various Reasons|7|||
164390106|NCT00142909|593796347|FG001|Randomization|Various Reasons|10|||
164390107|NCT00142909|593796346|FG000|Medications Begin|Protocol Violation|2|||
164390108|NCT00142909|593796347|FG001|Medications Begin|Protocol Violation|0|||
164390109|NCT00142909|593796346|FG000|Medications Begin|Withdrawal by Subject|5|||
164390110|NCT00142909|593796347|FG001|Medications Begin|Withdrawal by Subject|3|||
164390111|NCT00142909|593796346|FG000|Medications Begin|Withdrawal by Subject|2|||
164390112|NCT00142909|593796347|FG001|Medications Begin|Withdrawal by Subject|0|||
164390113|NCT01660763|593796351|FG000|Overall Study|Lack of Efficacy|45|||
164390114|NCT01660763|593796352|FG001|Overall Study|Lack of Efficacy|50|||
164390115|NCT01660763|593796351|FG000|Overall Study|Adverse Event|22|||
164390116|NCT01660763|593796352|FG001|Overall Study|Adverse Event|7|||
164390117|NCT01660763|593796351|FG000|Overall Study|Protocol Violation|1|||
164390118|NCT01660763|593796352|FG001|Overall Study|Protocol Violation|0|||
164390119|NCT01660763|593796351|FG000|Overall Study|Withdrawal by Subject|4|||
164390120|NCT01660763|593796352|FG001|Overall Study|Withdrawal by Subject|0|||
164390121|NCT01660763|593796351|FG000|Overall Study|Patient ready for early discharge|28|||
164390122|NCT01660763|593796352|FG001|Overall Study|Patient ready for early discharge|4|||
164390123|NCT00345397|593796353|FG000|Overall Study|Death|1|||
164390124|NCT01870843|593796354|FG000|Overall Study|Adverse Event|10|||
164390125|NCT01870843|593796354|FG000|Overall Study|Lost to Follow-up|24|||
164390126|NCT01870843|593796354|FG000|Overall Study|Death|1|||
164390127|NCT01870843|593796354|FG000|Overall Study|Withdrawal by Subject|18|||
164390128|NCT01365494|593796359|FG000|Overall Study|Adverse Event|1|||
164390129|NCT01365494|593796360|FG001|Overall Study|Adverse Event|0|||
164390130|NCT01365494|593796359|FG000|Overall Study|Withdrawal by Subject|0|||
164390131|NCT01365494|593796360|FG001|Overall Study|Withdrawal by Subject|1|||
164390132|NCT01365494|593796359|FG000|Overall Study|Lost to Follow-up|1|||
164390133|NCT01365494|593796360|FG001|Overall Study|Lost to Follow-up|2|||
164390134|NCT03021187|593796361|FG000|Overall Study|Death|0|||
164390135|NCT03021187|593796362|FG001|Overall Study|Death|0|||
164390136|NCT03021187|593796363|FG002|Overall Study|Death|3|||
164390137|NCT03021187|593796364|FG003|Overall Study|Death|0|||
164390138|NCT03021187|593796361|FG000|Overall Study|Withdrawal by Subject|0|||
164390139|NCT03021187|593796362|FG001|Overall Study|Withdrawal by Subject|6|||
164390140|NCT03021187|593796363|FG002|Overall Study|Withdrawal by Subject|2|||
164390141|NCT03021187|593796364|FG003|Overall Study|Withdrawal by Subject|5|||
164390142|NCT03021187|593796361|FG000|Overall Study|Lost to Follow-up|10|||
164390143|NCT03021187|593796362|FG001|Overall Study|Lost to Follow-up|3|||
164390144|NCT03021187|593796363|FG002|Overall Study|Lost to Follow-up|1|||
164390145|NCT03021187|593796364|FG003|Overall Study|Lost to Follow-up|4|||
164390146|NCT03351049|593796365|FG000|Overall Study|Withdrawal|26|||
164390147|NCT03351049|593796366|FG001|Overall Study|Withdrawal|22|||
164390148|NCT00718718|593796367|FG000|Prior to Week 12|Adverse Event|0|||
164390149|NCT00718718|593796368|FG001|Prior to Week 12|Adverse Event|0|||
164390150|NCT00718718|593796369|FG002|Prior to Week 12|Adverse Event|0|||
164390151|NCT00718718|593796370|FG003|Prior to Week 12|Adverse Event|0|||
164390152|NCT00718718|593796371|FG004|Prior to Week 12|Adverse Event|0|||
164390153|NCT00718718|593796372|FG005|Prior to Week 12|Adverse Event|0|||
164390154|NCT00718718|593796373|FG006|Prior to Week 12|Adverse Event|0|||
164390155|NCT00718718|593796374|FG007|Prior to Week 12|Adverse Event|1|||
164390156|NCT00718718|593796375|FG008|Prior to Week 12|Adverse Event|1|||
164390157|NCT00718718|593796376|FG009|Prior to Week 12|Adverse Event|0|||
164390158|NCT00718718|593796367|FG000|Prior to Week 12|Withdrawal by Subject|0|||
164390159|NCT00718718|593796368|FG001|Prior to Week 12|Withdrawal by Subject|0|||
164390160|NCT00718718|593796369|FG002|Prior to Week 12|Withdrawal by Subject|0|||
164390161|NCT00718718|593796370|FG003|Prior to Week 12|Withdrawal by Subject|0|||
164390162|NCT00718718|593796371|FG004|Prior to Week 12|Withdrawal by Subject|3|||
164390163|NCT00718718|593796372|FG005|Prior to Week 12|Withdrawal by Subject|0|||
164390164|NCT00718718|593796373|FG006|Prior to Week 12|Withdrawal by Subject|1|||
164390165|NCT00718718|593796374|FG007|Prior to Week 12|Withdrawal by Subject|1|||
164390166|NCT00718718|593796375|FG008|Prior to Week 12|Withdrawal by Subject|1|||
164390167|NCT00718718|593796376|FG009|Prior to Week 12|Withdrawal by Subject|0|||
164390168|NCT00718718|593796367|FG000|Prior to Week 12|Other|1|||
164390169|NCT00718718|593796368|FG001|Prior to Week 12|Other|0|||
164390170|NCT00718718|593796369|FG002|Prior to Week 12|Other|1|||
164390171|NCT00718718|593796370|FG003|Prior to Week 12|Other|0|||
164390172|NCT00718718|593796371|FG004|Prior to Week 12|Other|0|||
164390173|NCT00718718|593796372|FG005|Prior to Week 12|Other|0|||
164390174|NCT00718718|593796373|FG006|Prior to Week 12|Other|0|||
164390175|NCT00718718|593796374|FG007|Prior to Week 12|Other|0|||
164390176|NCT00718718|593796375|FG008|Prior to Week 12|Other|0|||
164390177|NCT00718718|593796376|FG009|Prior to Week 12|Other|0|||
164390178|NCT00718718|593796367|FG000|Week 12 to End of Study|Adverse Event|0|||
164390179|NCT00718718|593796368|FG001|Week 12 to End of Study|Adverse Event|0|||
164390180|NCT00718718|593796369|FG002|Week 12 to End of Study|Adverse Event|0|||
164390181|NCT00718718|593796370|FG003|Week 12 to End of Study|Adverse Event|0|||
164390182|NCT00718718|593796371|FG004|Week 12 to End of Study|Adverse Event|0|||
164390183|NCT00718718|593796372|FG005|Week 12 to End of Study|Adverse Event|0|||
164390184|NCT00718718|593796373|FG006|Week 12 to End of Study|Adverse Event|0|||
164390185|NCT00718718|593796374|FG007|Week 12 to End of Study|Adverse Event|1|||
164390186|NCT00718718|593796375|FG008|Week 12 to End of Study|Adverse Event|0|||
164390187|NCT00718718|593796376|FG009|Week 12 to End of Study|Adverse Event|0|||
164390188|NCT00718718|593796367|FG000|Week 12 to End of Study|Death|0|||
164390189|NCT00718718|593796368|FG001|Week 12 to End of Study|Death|0|||
164390190|NCT00718718|593796369|FG002|Week 12 to End of Study|Death|0|||
164390191|NCT00718718|593796370|FG003|Week 12 to End of Study|Death|0|||
164390192|NCT00718718|593796371|FG004|Week 12 to End of Study|Death|0|||
164390193|NCT00718718|593796372|FG005|Week 12 to End of Study|Death|1|||
164390194|NCT00718718|593796373|FG006|Week 12 to End of Study|Death|0|||
164390195|NCT00718718|593796374|FG007|Week 12 to End of Study|Death|0|||
164390196|NCT00718718|593796375|FG008|Week 12 to End of Study|Death|0|||
164390197|NCT00718718|593796376|FG009|Week 12 to End of Study|Death|0|||
164390198|NCT00718718|593796367|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
164390199|NCT00718718|593796368|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
164390200|NCT00718718|593796369|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
164390201|NCT00718718|593796370|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
164390202|NCT00718718|593796371|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
164390203|NCT00718718|593796372|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
164390204|NCT00718718|593796373|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
164390205|NCT00718718|593796374|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
164390206|NCT00718718|593796375|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
164390207|NCT00718718|593796376|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
164390208|NCT00718718|593796367|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
164390209|NCT00718718|593796368|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
164390210|NCT00718718|593796369|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
164390211|NCT00718718|593796370|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
164390212|NCT00718718|593796371|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
164390213|NCT00718718|593796372|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
164390214|NCT00718718|593796373|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
164390215|NCT00718718|593796374|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
164390216|NCT00718718|593796375|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
164390217|NCT00718718|593796376|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
164390218|NCT00718718|593796367|FG000|Week 12 to End of Study|Other|0|||
164390219|NCT00718718|593796368|FG001|Week 12 to End of Study|Other|1|||
164390220|NCT00718718|593796369|FG002|Week 12 to End of Study|Other|0|||
164390221|NCT00718718|593796370|FG003|Week 12 to End of Study|Other|1|||
164390222|NCT00718718|593796371|FG004|Week 12 to End of Study|Other|0|||
164390223|NCT00718718|593796372|FG005|Week 12 to End of Study|Other|0|||
164390224|NCT00718718|593796373|FG006|Week 12 to End of Study|Other|1|||
164390225|NCT00718718|593796374|FG007|Week 12 to End of Study|Other|0|||
164390226|NCT00718718|593796375|FG008|Week 12 to End of Study|Other|0|||
164390227|NCT00718718|593796376|FG009|Week 12 to End of Study|Other|0|||
164390228|NCT03099382|593796377|FG000|Overall Study|Protocol Violation|2|||
164390229|NCT03099382|593796378|FG001|Overall Study|Protocol Violation|3|||
164390230|NCT01802411|593796381|FG000|Overall Study|Death|2|||
164390231|NCT01802411|593796382|FG001|Overall Study|Death|1|||
164390232|NCT01802411|593796381|FG000|Overall Study|Adverse Event|2|||
164390233|NCT01802411|593796382|FG001|Overall Study|Adverse Event|7|||
164390234|NCT01802411|593796381|FG000|Overall Study|Lack of Efficacy|8|||
164390235|NCT01802411|593796382|FG001|Overall Study|Lack of Efficacy|10|||
164390236|NCT01802411|593796381|FG000|Overall Study|Withdrawal by Subject|0|||
164390237|NCT01802411|593796382|FG001|Overall Study|Withdrawal by Subject|2|||
164390238|NCT01802411|593796381|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
164390239|NCT01802411|593796382|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
164390240|NCT01802411|593796381|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
164390241|NCT01802411|593796382|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
164390242|NCT01802411|593796381|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
164390243|NCT01802411|593796382|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
164390244|NCT03930745|593796388|FG000|Overall Study|Lost to Follow-up|10|||
164390245|NCT03930745|593796389|FG001|Overall Study|Lost to Follow-up|5|||
164390246|NCT03930745|593796388|FG000|Overall Study|Withdrawal by Subject|1|||
164390247|NCT03930745|593796389|FG001|Overall Study|Withdrawal by Subject|2|||
164390248|NCT03930745|593796388|FG000|Overall Study|Protocol Violation|2|||
164390249|NCT03930745|593796389|FG001|Overall Study|Protocol Violation|2|||
164390250|NCT03930745|593796388|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
164390251|NCT03930745|593796389|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
164390252|NCT03930745|593796388|FG000|Overall Study|Adverse Event|0|||
164390253|NCT03930745|593796389|FG001|Overall Study|Adverse Event|1|||
164390254|NCT03930745|593796388|FG000|Overall Study|Pregnancy|0|||
164390255|NCT03930745|593796389|FG001|Overall Study|Pregnancy|1|||
164390256|NCT02715765|593796392|FG000|Overall Study|Study Termination|3|||
164390257|NCT02715765|593796393|FG001|Overall Study|Study Termination|0|||
164390258|NCT02715765|593796394|FG002|Overall Study|Study Termination|0|||
164390259|NCT03588572|593796395|FG000|Visitation 1|Lack of Efficacy|1|||
164390260|NCT03588572|593796396|FG001|Visitation 1|Lack of Efficacy|1|||
164390261|NCT03588572|593796395|FG000|Visitation 2|Lost to Follow-up|1|||
164390262|NCT03588572|593796396|FG001|Visitation 2|Lost to Follow-up|1|||
164390263|NCT03588572|593796395|FG000|Visitation 2|Lack of Efficacy|0|||
164390264|NCT03588572|593796396|FG001|Visitation 2|Lack of Efficacy|1|||
164390265|NCT03588572|593796395|FG000|Visitation 2|Withdrawal by Subject|1|||
164390266|NCT03588572|593796396|FG001|Visitation 2|Withdrawal by Subject|0|||
164390267|NCT03588572|593796395|FG000|Visitation 3|Lost to Follow-up|1|||
164390268|NCT03588572|593796396|FG001|Visitation 3|Lost to Follow-up|1|||
164390269|NCT03588572|593796395|FG000|Visitation 3|Physician Decision|1|||
164390270|NCT03588572|593796396|FG001|Visitation 3|Physician Decision|1|||
164390271|NCT03588572|593796395|FG000|Visitation 3|Withdrawal by Subject|1|||
164703864|NCT01183221|594941803|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
164703865|NCT00852969|594941808|FG000|Overall Study|Adverse Event|0|||
164703866|NCT00852969|594941809|FG001|Overall Study|Adverse Event|1|||
164390272|NCT03588572|593796396|FG001|Visitation 3|Withdrawal by Subject|0|||
164390273|NCT01165281|593796402|FG000|Overall Study|Adverse Event|12|||
164390274|NCT01165281|593796403|FG001|Overall Study|Adverse Event|14|||
164703867|NCT00852969|594941808|FG000|Overall Study|Lost to Follow-up|0|||
164390275|NCT01165281|593796402|FG000|Overall Study|Death|3|||
164390276|NCT01165281|593796403|FG001|Overall Study|Death|4|||
164390277|NCT01165281|593796402|FG000|Overall Study|Lack of Efficacy|4|||
164390278|NCT01165281|593796403|FG001|Overall Study|Lack of Efficacy|1|||
164390279|NCT01165281|593796402|FG000|Overall Study|Lost to Follow-up|0|||
164390280|NCT01165281|593796403|FG001|Overall Study|Lost to Follow-up|1|||
164441366|NCT00324038|593982805|FG000|Overall Study|Lost to Follow-up|0|||
164703868|NCT00852969|594941809|FG001|Overall Study|Lost to Follow-up|1|||
164390281|NCT01165281|593796402|FG000|Overall Study|Physician Decision|8|||
164390282|NCT01165281|593796403|FG001|Overall Study|Physician Decision|1|||
164390283|NCT01165281|593796402|FG000|Overall Study|Protocol Violation|6|||
164390284|NCT01165281|593796403|FG001|Overall Study|Protocol Violation|5|||
164390285|NCT01165281|593796402|FG000|Overall Study|Withdrawal by Subject|8|||
164390286|NCT01165281|593796403|FG001|Overall Study|Withdrawal by Subject|7|||
164390287|NCT01165281|593796402|FG000|Overall Study|Noncompliance with Study Drug|1|||
164390288|NCT01165281|593796403|FG001|Overall Study|Noncompliance with Study Drug|4|||
164390289|NCT01165281|593796402|FG000|Overall Study|Progressive Disease|10|||
164390290|NCT01165281|593796403|FG001|Overall Study|Progressive Disease|14|||
164390291|NCT01165281|593796402|FG000|Overall Study|Other|6|||
164390292|NCT01165281|593796403|FG001|Overall Study|Other|0|||
164390293|NCT02863991|593796406|FG000|Overall Study|Death|0|||
164390294|NCT02863991|593796407|FG001|Overall Study|Death|3|||
164390295|NCT02863991|593796406|FG000|Overall Study|Lack of Efficacy|0|||
164390296|NCT02863991|593796407|FG001|Overall Study|Lack of Efficacy|1|||
164390297|NCT02863991|593796406|FG000|Overall Study|Study Terminated|2|||
164390298|NCT02863991|593796407|FG001|Overall Study|Study Terminated|8|||
164390299|NCT03277313|593796408|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
164390300|NCT03277313|593796409|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
164390301|NCT03277313|593796408|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
164390302|NCT03277313|593796409|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
164390303|NCT03277313|593796408|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
164390304|NCT03277313|593796409|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
164390305|NCT03277313|593796408|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
164390306|NCT03277313|593796409|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
164390307|NCT03277313|593796408|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
164390308|NCT03277313|593796409|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
164390309|NCT00364858|593796410|FG000|Overall Study|Adverse Event|1|||
164390310|NCT00364858|593796411|FG001|Overall Study|Adverse Event|5|||
164390311|NCT00364858|593796410|FG000|Overall Study|Withdrawal by Subject|1|||
164390312|NCT00364858|593796411|FG001|Overall Study|Withdrawal by Subject|1|||
164390313|NCT00364858|593796410|FG000|Overall Study|Pregnancy|1|||
164390314|NCT00364858|593796411|FG001|Overall Study|Pregnancy|1|||
164390315|NCT00364858|593796410|FG000|Overall Study|Clinical failure|2|||
164390316|NCT00364858|593796411|FG001|Overall Study|Clinical failure|13|||
164390317|NCT00364858|593796410|FG000|Overall Study|Discontinuation at baseline|1|||
164390318|NCT00364858|593796411|FG001|Overall Study|Discontinuation at baseline|0|||
164390319|NCT00364858|593796410|FG000|Overall Study|Non-compliant|1|||
164390320|NCT00364858|593796411|FG001|Overall Study|Non-compliant|0|||
164390321|NCT00364858|593796410|FG000|Overall Study|Return to Q2 regimen|0|||
164390322|NCT00364858|593796411|FG001|Overall Study|Return to Q2 regimen|1|||
164390323|NCT00364858|593796410|FG000|Overall Study|Clinical baseline issue|0|||
164390324|NCT00364858|593796411|FG001|Overall Study|Clinical baseline issue|1|||
164390325|NCT00363766|593796412|FG000|Overall Study|Progressive Disease|15|||
164390326|NCT00363766|593796413|FG001|Overall Study|Progressive Disease|9|||
164390327|NCT00363766|593796412|FG000|Overall Study|Adverse Event|10|||
164390328|NCT00363766|593796413|FG001|Overall Study|Adverse Event|2|||
164390329|NCT00363766|593796412|FG000|Overall Study|Disease Related Death|1|||
164390330|NCT00363766|593796413|FG001|Overall Study|Disease Related Death|3|||
164390331|NCT00363766|593796412|FG000|Overall Study|Not Disease Related Death|3|||
164390332|NCT00363766|593796413|FG001|Overall Study|Not Disease Related Death|4|||
164390333|NCT00363766|593796412|FG000|Overall Study|Withdrawal by Subject|2|||
164390334|NCT00363766|593796413|FG001|Overall Study|Withdrawal by Subject|0|||
164390335|NCT00363766|593796412|FG000|Overall Study|Physician Decision|1|||
164390336|NCT00363766|593796413|FG001|Overall Study|Physician Decision|2|||
164390337|NCT00558285|593796414|FG000|Overall Study|Adverse Event|1|||
164441367|NCT00324038|593982806|FG001|Overall Study|Lost to Follow-up|2|||
164441368|NCT00324038|593982805|FG000|Overall Study|Other|6|||
164441369|NCT00324038|593982806|FG001|Overall Study|Other|13|||
164441370|NCT01837641|593982809|FG000|Overall Study|Sponsor decision|1|||
164441371|NCT01837641|593982810|FG001|Overall Study|Sponsor decision|0|||
164441372|NCT01837641|593982811|FG002|Overall Study|Sponsor decision|0|||
164441373|NCT01837641|593982812|FG003|Overall Study|Sponsor decision|0|||
164441374|NCT01837641|593982813|FG004|Overall Study|Sponsor decision|0|||
164441375|NCT01837641|593982814|FG005|Overall Study|Sponsor decision|1|||
164594400|NCT02935634|594539171|FG001|Treatment: Track 1|Participant withdrew consent|0|||
164390338|NCT00558285|593796415|FG001|Overall Study|Adverse Event|1|||
164441376|NCT01837641|593982815|FG006|Overall Study|Sponsor decision|0|||
164390339|NCT00558285|593796416|FG002|Overall Study|Adverse Event|4|||
164441377|NCT01837641|593982816|FG007|Overall Study|Sponsor decision|0|||
164594401|NCT02935634|594539172|FG002|Treatment: Track 1|Participant withdrew consent|1|||
164390340|NCT00558285|593796417|FG003|Overall Study|Adverse Event|1|||
164390341|NCT00558285|593796418|FG004|Overall Study|Adverse Event|2|||
164441378|NCT01837641|593982809|FG000|Overall Study|Adverse Event|0|||
164390342|NCT00558285|593796414|FG000|Overall Study|Abnormal test procedure result(s)|1|||
164390343|NCT00558285|593796415|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164390344|NCT00558285|593796416|FG002|Overall Study|Abnormal test procedure result(s)|0|||
164390345|NCT00558285|593796417|FG003|Overall Study|Abnormal test procedure result(s)|0|||
164441379|NCT01837641|593982810|FG001|Overall Study|Adverse Event|0|||
164441380|NCT01837641|593982811|FG002|Overall Study|Adverse Event|0|||
164441381|NCT01837641|593982812|FG003|Overall Study|Adverse Event|0|||
164390346|NCT00558285|593796418|FG004|Overall Study|Abnormal test procedure result(s)|0|||
164390347|NCT00558285|593796414|FG000|Overall Study|Subject withdrew consent|2|||
164390348|NCT00558285|593796415|FG001|Overall Study|Subject withdrew consent|0|||
164390349|NCT00558285|593796416|FG002|Overall Study|Subject withdrew consent|1|||
164390350|NCT00558285|593796417|FG003|Overall Study|Subject withdrew consent|1|||
164390351|NCT00558285|593796418|FG004|Overall Study|Subject withdrew consent|1|||
164390352|NCT00558285|593796414|FG000|Overall Study|Lost to Follow-up|1|||
164390353|NCT00558285|593796415|FG001|Overall Study|Lost to Follow-up|1|||
164390354|NCT00558285|593796416|FG002|Overall Study|Lost to Follow-up|0|||
164390355|NCT00558285|593796417|FG003|Overall Study|Lost to Follow-up|0|||
164390356|NCT00558285|593796418|FG004|Overall Study|Lost to Follow-up|0|||
164390357|NCT00558285|593796414|FG000|Overall Study|Administrative problems|0|||
164390358|NCT00558285|593796415|FG001|Overall Study|Administrative problems|0|||
164390359|NCT00558285|593796416|FG002|Overall Study|Administrative problems|0|||
164390360|NCT00558285|593796417|FG003|Overall Study|Administrative problems|1|||
164390361|NCT00558285|593796418|FG004|Overall Study|Administrative problems|1|||
164390362|NCT00558285|593796414|FG000|Overall Study|Protocol deviation|1|||
164390363|NCT00558285|593796415|FG001|Overall Study|Protocol deviation|1|||
164390364|NCT00558285|593796416|FG002|Overall Study|Protocol deviation|0|||
164390365|NCT00558285|593796417|FG003|Overall Study|Protocol deviation|1|||
164390366|NCT00558285|593796418|FG004|Overall Study|Protocol deviation|0|||
164390367|NCT02345512|593796419|FG000|Overall Study|Adverse Event|1|||
164390368|NCT02345512|593796419|FG000|Overall Study|Withdrawal by Subject|1|||
164390369|NCT01660906|593796420|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
164390370|NCT02121847|593796421|FG000|Overall Study|Administrative Reasons|1|||
164390371|NCT02121847|593796421|FG000|Overall Study|Adverse Event|2|||
164390372|NCT03478891|593796429|FG000|Overall Study|Enrolled, but product never administered|0|||
164390373|NCT03478891|593796430|FG001|Overall Study|Enrolled, but product never administered|0|||
164390374|NCT03478891|593796431|FG002|Overall Study|Enrolled, but product never administered|1|||
164390375|NCT03478891|593796429|FG000|Overall Study|Moved from area|0|||
164390376|NCT03478891|593796430|FG001|Overall Study|Moved from area|0|||
164390377|NCT03478891|593796431|FG002|Overall Study|Moved from area|1|||
164390378|NCT03478891|593796429|FG000|Overall Study|Lost to Follow-up|1|||
164390379|NCT03478891|593796430|FG001|Overall Study|Lost to Follow-up|0|||
164390380|NCT03478891|593796431|FG002|Overall Study|Lost to Follow-up|1|||
164441382|NCT01837641|593982813|FG004|Overall Study|Adverse Event|0|||
164441383|NCT01837641|593982814|FG005|Overall Study|Adverse Event|1|||
164390381|NCT03823651|593796437|FG000|Overall Study|Death|5|||
164390382|NCT03823651|593796438|FG001|Overall Study|Death|0|||
164390383|NCT03823651|593796437|FG000|Overall Study|Physician Decision|1|||
164390384|NCT03823651|593796438|FG001|Overall Study|Physician Decision|0|||
164390385|NCT03823651|593796437|FG000|Overall Study|Caregiver to patient who died|0|||
164390386|NCT03823651|593796438|FG001|Overall Study|Caregiver to patient who died|5|||
164390387|NCT03823651|593796437|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
164390388|NCT03823651|593796438|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
164390389|NCT03864614|593796442|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
164390390|NCT03864614|593796443|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
164390391|NCT03864614|593796444|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
164390392|NCT03864614|593796445|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
164390393|NCT03864614|593796442|FG000|Overall Study|Withdrawal by Subject|72|||
164390394|NCT03864614|593796443|FG001|Overall Study|Withdrawal by Subject|100|||
164390395|NCT03864614|593796444|FG002|Overall Study|Withdrawal by Subject|1|||
164441384|NCT01837641|593982815|FG006|Overall Study|Adverse Event|0|||
164441385|NCT01837641|593982816|FG007|Overall Study|Adverse Event|0|||
164441386|NCT01837641|593982809|FG000|Overall Study|Withdrawal by Subject|0|||
164441387|NCT01837641|593982810|FG001|Overall Study|Withdrawal by Subject|0|||
164441388|NCT01837641|593982811|FG002|Overall Study|Withdrawal by Subject|0|||
164441389|NCT01837641|593982812|FG003|Overall Study|Withdrawal by Subject|0|||
164441390|NCT01837641|593982813|FG004|Overall Study|Withdrawal by Subject|1|||
164441391|NCT01837641|593982814|FG005|Overall Study|Withdrawal by Subject|0|||
164441392|NCT01837641|593982815|FG006|Overall Study|Withdrawal by Subject|1|||
164441393|NCT01837641|593982816|FG007|Overall Study|Withdrawal by Subject|0|||
164441394|NCT01123083|593982823|FG000|Overall Study|Investigator recommendation|1|||
164441395|NCT01123083|593982824|FG001|Overall Study|Investigator recommendation|1|||
164390396|NCT03864614|593796445|FG003|Overall Study|Withdrawal by Subject|21|||
164390397|NCT03864614|593796442|FG000|Overall Study|Lost to Follow-up|45|||
164390398|NCT03864614|593796443|FG001|Overall Study|Lost to Follow-up|54|||
164390399|NCT03864614|593796444|FG002|Overall Study|Lost to Follow-up|0|||
164441396|NCT01123083|593982823|FG000|Overall Study|Administrative reasons|0|||
164390400|NCT03864614|593796445|FG003|Overall Study|Lost to Follow-up|9|||
164390401|NCT03864614|593796442|FG000|Overall Study|Adverse Event|42|||
164390402|NCT03864614|593796443|FG001|Overall Study|Adverse Event|30|||
164390403|NCT03864614|593796444|FG002|Overall Study|Adverse Event|1|||
164390404|NCT03864614|593796445|FG003|Overall Study|Adverse Event|9|||
164390405|NCT03864614|593796442|FG000|Overall Study|Protocol Deviation|6|||
164390406|NCT03864614|593796443|FG001|Overall Study|Protocol Deviation|26|||
164390407|NCT03864614|593796444|FG002|Overall Study|Protocol Deviation|0|||
164390408|NCT03864614|593796445|FG003|Overall Study|Protocol Deviation|1|||
164390409|NCT03864614|593796442|FG000|Overall Study|Physician Decision|7|||
164390410|NCT03864614|593796443|FG001|Overall Study|Physician Decision|10|||
164594402|NCT02935634|594539173|FG003|Treatment: Track 1|Participant withdrew consent|0|||
164390411|NCT03864614|593796444|FG002|Overall Study|Physician Decision|1|||
164390412|NCT03864614|593796445|FG003|Overall Study|Physician Decision|5|||
164390413|NCT03864614|593796442|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
164390414|NCT03864614|593796443|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
164390415|NCT03864614|593796444|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
164390416|NCT03864614|593796445|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
164390417|NCT03864614|593796442|FG000|Overall Study|Sponsor Decision|1|||
164390418|NCT03864614|593796443|FG001|Overall Study|Sponsor Decision|2|||
164390419|NCT03864614|593796444|FG002|Overall Study|Sponsor Decision|0|||
164390420|NCT03864614|593796445|FG003|Overall Study|Sponsor Decision|0|||
164390421|NCT03864614|593796442|FG000|Overall Study|Pregnancy|0|||
164390422|NCT03864614|593796443|FG001|Overall Study|Pregnancy|1|||
164390423|NCT03864614|593796444|FG002|Overall Study|Pregnancy|0|||
164390424|NCT03864614|593796445|FG003|Overall Study|Pregnancy|0|||
164390425|NCT03864614|593796442|FG000|Overall Study|Other|7|||
164390426|NCT03864614|593796443|FG001|Overall Study|Other|9|||
164390427|NCT03864614|593796444|FG002|Overall Study|Other|1|||
164390428|NCT03864614|593796445|FG003|Overall Study|Other|4|||
164390429|NCT03864614|593796442|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
164390430|NCT03864614|593796443|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
164390431|NCT03864614|593796444|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
164390432|NCT03864614|593796445|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
164390433|NCT01912612|593798875|FG000|Overall Study|Adverse Event|4|||
164390434|NCT01912612|593798876|FG001|Overall Study|Adverse Event|0|||
164390435|NCT01912612|593798877|FG002|Overall Study|Adverse Event|0|||
164390436|NCT01912612|593798875|FG000|Overall Study|Withdrew consent|1|||
164390437|NCT01912612|593798876|FG001|Overall Study|Withdrew consent|0|||
164390438|NCT01912612|593798877|FG002|Overall Study|Withdrew consent|0|||
164390439|NCT01912612|593798875|FG000|Overall Study|Study design change|0|||
164390440|NCT01912612|593798876|FG001|Overall Study|Study design change|0|||
164594403|NCT02935634|594539174|FG004|Treatment: Track 1|Participant withdrew consent|1|||
164594404|NCT02935634|594539175|FG005|Treatment: Track 1|Participant withdrew consent|0|||
164594405|NCT02935634|594539170|FG000|Treatment: Track 1|Other reasons|0|||
164594406|NCT02935634|594539171|FG001|Treatment: Track 1|Other reasons|0|||
164390441|NCT01912612|593798877|FG002|Overall Study|Study design change|3|||
164390442|NCT01588184|593798878|FG000|Overall Study|Death|1|||
164390443|NCT01588184|593798879|FG001|Overall Study|Death|0|||
164390444|NCT01588184|593798880|FG002|Overall Study|Death|0|||
164390445|NCT01588184|593798881|FG003|Overall Study|Death|1|||
164390446|NCT01588184|593798882|FG004|Overall Study|Death|1|||
164390447|NCT01588184|593798883|FG005|Overall Study|Death|1|||
164390448|NCT01588184|593798878|FG000|Overall Study|Withdrawal by Subject|2|||
164390449|NCT01588184|593798879|FG001|Overall Study|Withdrawal by Subject|4|||
164390450|NCT01588184|593798880|FG002|Overall Study|Withdrawal by Subject|0|||
164390451|NCT01588184|593798881|FG003|Overall Study|Withdrawal by Subject|1|||
164390452|NCT01588184|593798882|FG004|Overall Study|Withdrawal by Subject|0|||
164390453|NCT01588184|593798883|FG005|Overall Study|Withdrawal by Subject|0|||
164390454|NCT01588184|593798878|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
164390455|NCT01588184|593798879|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
164390456|NCT01588184|593798880|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
164390457|NCT01588184|593798881|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
164390458|NCT01588184|593798882|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
164390459|NCT01588184|593798883|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
164390460|NCT01588184|593798878|FG000|Overall Study|multiple reasons|0|||
164390461|NCT01588184|593798879|FG001|Overall Study|multiple reasons|3|||
164390462|NCT01588184|593798880|FG002|Overall Study|multiple reasons|0|||
164390463|NCT01588184|593798881|FG003|Overall Study|multiple reasons|1|||
164390464|NCT01588184|593798882|FG004|Overall Study|multiple reasons|0|||
164390465|NCT01588184|593798883|FG005|Overall Study|multiple reasons|0|||
164594407|NCT02935634|594539172|FG002|Treatment: Track 1|Other reasons|2|||
164594408|NCT02935634|594539173|FG003|Treatment: Track 1|Other reasons|0|||
164390466|NCT01983293|593798887|FG000|Overall Study|Withdrawal by Subject|29|||
164390467|NCT01983293|593798888|FG001|Overall Study|Withdrawal by Subject|15|||
164390468|NCT01983293|593798887|FG000|Overall Study|Missing 12-month visit|3|||
164390469|NCT01983293|593798888|FG001|Overall Study|Missing 12-month visit|3|||
164390470|NCT01983293|593798887|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
164390471|NCT01983293|593798888|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
164390472|NCT03147248|593798889|FG000|Overall Study|Adverse Event|0|||
164390473|NCT03147248|593798890|FG001|Overall Study|Adverse Event|2|||
164594409|NCT02935634|594539174|FG004|Treatment: Track 1|Other reasons|0|||
164390474|NCT03147248|593798891|FG002|Overall Study|Adverse Event|2|||
164441397|NCT01123083|593982824|FG001|Overall Study|Administrative reasons|4|||
164441398|NCT01123083|593982823|FG000|Overall Study|Lost to Follow-up|2|||
164441399|NCT01123083|593982824|FG001|Overall Study|Lost to Follow-up|6|||
164441400|NCT01123083|593982823|FG000|Overall Study|Adverse Event|1|||
164441401|NCT01123083|593982824|FG001|Overall Study|Adverse Event|0|||
164441402|NCT01123083|593982823|FG000|Overall Study|Withdrew for another reason not covered|0|||
164441403|NCT01123083|593982824|FG001|Overall Study|Withdrew for another reason not covered|1|||
164441404|NCT01123083|593982823|FG000|Overall Study|Participant/legal representative request|7|||
164441405|NCT01123083|593982824|FG001|Overall Study|Participant/legal representative request|3|||
164390475|NCT03147248|593798892|FG003|Overall Study|Adverse Event|2|||
164390476|NCT03147248|593798893|FG004|Overall Study|Adverse Event|6|||
164390477|NCT03147248|593798894|FG005|Overall Study|Adverse Event|11|||
164390478|NCT03147248|593798889|FG000|Overall Study|Disease progression|1|||
164390479|NCT03147248|593798890|FG001|Overall Study|Disease progression|0|||
164390480|NCT03147248|593798891|FG002|Overall Study|Disease progression|0|||
164390481|NCT03147248|593798892|FG003|Overall Study|Disease progression|0|||
164390482|NCT03147248|593798893|FG004|Overall Study|Disease progression|0|||
164390483|NCT03147248|593798894|FG005|Overall Study|Disease progression|2|||
164390484|NCT03147248|593798889|FG000|Overall Study|Withdrawal by Subject|0|||
164390485|NCT03147248|593798890|FG001|Overall Study|Withdrawal by Subject|0|||
164390486|NCT03147248|593798891|FG002|Overall Study|Withdrawal by Subject|0|||
164390487|NCT03147248|593798892|FG003|Overall Study|Withdrawal by Subject|0|||
164390488|NCT03147248|593798893|FG004|Overall Study|Withdrawal by Subject|12|||
164390489|NCT03147248|593798894|FG005|Overall Study|Withdrawal by Subject|9|||
164390490|NCT03147248|593798889|FG000|Overall Study|Protocol Violation|0|||
164390491|NCT03147248|593798890|FG001|Overall Study|Protocol Violation|0|||
164390492|NCT03147248|593798891|FG002|Overall Study|Protocol Violation|0|||
164390493|NCT03147248|593798892|FG003|Overall Study|Protocol Violation|0|||
164390494|NCT03147248|593798893|FG004|Overall Study|Protocol Violation|2|||
164390495|NCT03147248|593798894|FG005|Overall Study|Protocol Violation|0|||
164390496|NCT03147248|593798889|FG000|Overall Study|Lost to Follow-up|0|||
164390497|NCT03147248|593798890|FG001|Overall Study|Lost to Follow-up|0|||
164390498|NCT03147248|593798891|FG002|Overall Study|Lost to Follow-up|0|||
164390499|NCT03147248|593798892|FG003|Overall Study|Lost to Follow-up|0|||
164390500|NCT03147248|593798893|FG004|Overall Study|Lost to Follow-up|2|||
164390501|NCT03147248|593798894|FG005|Overall Study|Lost to Follow-up|0|||
164390502|NCT03147248|593798889|FG000|Overall Study|Pregnancy|0|||
164390503|NCT03147248|593798890|FG001|Overall Study|Pregnancy|0|||
164390504|NCT03147248|593798891|FG002|Overall Study|Pregnancy|0|||
164390505|NCT03147248|593798892|FG003|Overall Study|Pregnancy|0|||
164390506|NCT03147248|593798893|FG004|Overall Study|Pregnancy|1|||
164390507|NCT03147248|593798894|FG005|Overall Study|Pregnancy|0|||
164390508|NCT03147248|593798889|FG000|Overall Study|Death|0|||
164390509|NCT03147248|593798890|FG001|Overall Study|Death|0|||
164390510|NCT03147248|593798891|FG002|Overall Study|Death|0|||
164390511|NCT03147248|593798892|FG003|Overall Study|Death|0|||
164390512|NCT03147248|593798893|FG004|Overall Study|Death|0|||
164390513|NCT03147248|593798894|FG005|Overall Study|Death|4|||
164390514|NCT03147248|593798889|FG000|Overall Study|Physician Decision|0|||
164703869|NCT00678041|594941810|FG000|Overall Study|Physician Decision|5|||
164703870|NCT00678041|594941811|FG001|Overall Study|Physician Decision|5|||
164703871|NCT03596151|594941814|FG000|Overall Study|Withdrawal by Subject|1|||
164703872|NCT00807248|594941816|FG000|Overall Study|Adverse Event|1|||
164703873|NCT00807248|594941817|FG001|Overall Study|Adverse Event|2|||
164703874|NCT00807248|594941818|FG002|Overall Study|Adverse Event|2|||
164703875|NCT00807248|594941819|FG003|Overall Study|Adverse Event|6|||
164703876|NCT00807248|594941816|FG000|Overall Study|Lack of Efficacy|14|||
164703877|NCT00807248|594941817|FG001|Overall Study|Lack of Efficacy|4|||
164390515|NCT03147248|593798890|FG001|Overall Study|Physician Decision|0|||
164441406|NCT00961636|593982825|FG000|Overall Study|Adverse Event|35|||
164441407|NCT00961636|593982826|FG001|Overall Study|Adverse Event|54|||
164441408|NCT00961636|593982827|FG002|Overall Study|Adverse Event|13|||
164703878|NCT00807248|594941818|FG002|Overall Study|Lack of Efficacy|8|||
164703879|NCT00807248|594941819|FG003|Overall Study|Lack of Efficacy|3|||
164390516|NCT03147248|593798891|FG002|Overall Study|Physician Decision|0|||
164390517|NCT03147248|593798892|FG003|Overall Study|Physician Decision|0|||
164390518|NCT03147248|593798893|FG004|Overall Study|Physician Decision|2|||
164390519|NCT03147248|593798894|FG005|Overall Study|Physician Decision|4|||
164390520|NCT03147248|593798889|FG000|Overall Study|Prolonged Dosing Interval|0|||
164390521|NCT03147248|593798890|FG001|Overall Study|Prolonged Dosing Interval|0|||
164390522|NCT03147248|593798891|FG002|Overall Study|Prolonged Dosing Interval|0|||
164390523|NCT03147248|593798892|FG003|Overall Study|Prolonged Dosing Interval|0|||
164390524|NCT03147248|593798893|FG004|Overall Study|Prolonged Dosing Interval|1|||
164441409|NCT00961636|593982825|FG000|Overall Study|Flushing Symptoms|29|||
164390525|NCT03147248|593798894|FG005|Overall Study|Prolonged Dosing Interval|1|||
164390526|NCT03750552|593798895|FG000|Overall Study|Adverse Event|5|||
164703880|NCT00807248|594941816|FG000|Overall Study|Protocol Violation|0|||
164703881|NCT00807248|594941817|FG001|Overall Study|Protocol Violation|1|||
164390527|NCT03750552|593798896|FG001|Overall Study|Adverse Event|1|||
164390528|NCT03750552|593798895|FG000|Overall Study|Withdrawal by Subject|1|||
164703882|NCT00807248|594941818|FG002|Overall Study|Protocol Violation|1|||
164703883|NCT00807248|594941819|FG003|Overall Study|Protocol Violation|0|||
164703884|NCT00807248|594941816|FG000|Overall Study|Withdrawal of Consent|5|||
164703885|NCT00807248|594941817|FG001|Overall Study|Withdrawal of Consent|5|||
164703886|NCT00807248|594941818|FG002|Overall Study|Withdrawal of Consent|5|||
164703887|NCT00807248|594941819|FG003|Overall Study|Withdrawal of Consent|5|||
164703888|NCT00807248|594941816|FG000|Overall Study|Lost to Follow-up|1|||
164703889|NCT00807248|594941817|FG001|Overall Study|Lost to Follow-up|0|||
164703890|NCT00807248|594941818|FG002|Overall Study|Lost to Follow-up|0|||
164390529|NCT03750552|593798896|FG001|Overall Study|Withdrawal by Subject|1|||
164390530|NCT03750552|593798895|FG000|Overall Study|Other|2|||
164390531|NCT03750552|593798896|FG001|Overall Study|Other|0|||
164390532|NCT02062632|593798897|FG000|Overall Study|No treatment data|1|||
164390533|NCT00773968|593798900|FG000|Overall Study|Adverse Event|2|||
164390534|NCT00773968|593798900|FG000|Overall Study|Death|1|||
164390535|NCT00773968|593798900|FG000|Overall Study|Failure to Return|2|||
164390536|NCT00773968|593798900|FG000|Overall Study|Lack of Efficacy|3|||
164390537|NCT00773968|593798900|FG000|Overall Study|Protocol Violation|1|||
164390538|NCT00773968|593798900|FG000|Overall Study|Withdrawal by Subject|11|||
164390539|NCT00773968|593798900|FG000|Overall Study|Screen Failure|17|||
164390540|NCT00773968|593798900|FG000|Overall Study|Other|8|||
164390541|NCT02008890|593798903|FG000|Period 1|Withdrawal by Subject|7|||
164390542|NCT02008890|593798904|FG001|Period 1|Withdrawal by Subject|7|||
164390543|NCT02008890|593798905|FG002|Period 1|Withdrawal by Subject|5|||
164390544|NCT02008890|593798906|FG003|Period 1|Withdrawal by Subject|0|||
164390545|NCT02008890|593798907|FG004|Period 1|Withdrawal by Subject|0|||
164390546|NCT02008890|593798903|FG000|Period 1|Pregnancy|1|||
164390547|NCT02008890|593798904|FG001|Period 1|Pregnancy|0|||
164390548|NCT02008890|593798905|FG002|Period 1|Pregnancy|0|||
164390549|NCT02008890|593798906|FG003|Period 1|Pregnancy|0|||
164390550|NCT02008890|593798907|FG004|Period 1|Pregnancy|0|||
164390551|NCT02008890|593798903|FG000|Period 1|Physician Decision|1|||
164390552|NCT02008890|593798904|FG001|Period 1|Physician Decision|0|||
164390553|NCT02008890|593798905|FG002|Period 1|Physician Decision|1|||
164390554|NCT02008890|593798906|FG003|Period 1|Physician Decision|0|||
164390555|NCT02008890|593798907|FG004|Period 1|Physician Decision|0|||
164390556|NCT02008890|593798903|FG000|Period 1|Adverse Event|6|||
164390557|NCT02008890|593798904|FG001|Period 1|Adverse Event|8|||
164390558|NCT02008890|593798905|FG002|Period 1|Adverse Event|6|||
164390559|NCT02008890|593798906|FG003|Period 1|Adverse Event|0|||
164390560|NCT02008890|593798907|FG004|Period 1|Adverse Event|0|||
164390561|NCT02008890|593798903|FG000|Period 2|Adverse Event|12|||
164390562|NCT02008890|593798904|FG001|Period 2|Adverse Event|7|||
164390563|NCT02008890|593798905|FG002|Period 2|Adverse Event|0|||
164390564|NCT02008890|593798906|FG003|Period 2|Adverse Event|5|||
164390565|NCT02008890|593798907|FG004|Period 2|Adverse Event|5|||
164390566|NCT02008890|593798903|FG000|Period 2|Withdrawal by Subject|11|||
164390567|NCT02008890|593798904|FG001|Period 2|Withdrawal by Subject|8|||
164390568|NCT02008890|593798905|FG002|Period 2|Withdrawal by Subject|0|||
164390569|NCT02008890|593798906|FG003|Period 2|Withdrawal by Subject|7|||
164390570|NCT02008890|593798907|FG004|Period 2|Withdrawal by Subject|2|||
164390571|NCT02008890|593798903|FG000|Period 2|Physician Decision|4|||
164390572|NCT02008890|593798904|FG001|Period 2|Physician Decision|0|||
164390573|NCT02008890|593798905|FG002|Period 2|Physician Decision|0|||
164390574|NCT02008890|593798906|FG003|Period 2|Physician Decision|2|||
164390575|NCT02008890|593798907|FG004|Period 2|Physician Decision|1|||
164390576|NCT02008890|593798903|FG000|Period 2|Lost to Follow-up|0|||
164390577|NCT02008890|593798904|FG001|Period 2|Lost to Follow-up|0|||
164390578|NCT02008890|593798905|FG002|Period 2|Lost to Follow-up|1|||
164390579|NCT02008890|593798906|FG003|Period 2|Lost to Follow-up|0|||
164390580|NCT02008890|593798907|FG004|Period 2|Lost to Follow-up|0|||
164390581|NCT02008890|593798903|FG000|Extension Period|Withdrawal by Subject|3|||
164390582|NCT02008890|593798904|FG001|Extension Period|Withdrawal by Subject|2|||
164390583|NCT02008890|593798905|FG002|Extension Period|Withdrawal by Subject|0|||
164390584|NCT02008890|593798906|FG003|Extension Period|Withdrawal by Subject|4|||
164441410|NCT00961636|593982826|FG001|Overall Study|Flushing Symptoms|46|||
164703891|NCT00807248|594941819|FG003|Overall Study|Lost to Follow-up|0|||
164441411|NCT00961636|593982827|FG002|Overall Study|Flushing Symptoms|3|||
164441412|NCT00961636|593982825|FG000|Overall Study|Lost to Follow-up|2|||
164703892|NCT00807248|594941816|FG000|Overall Study|Other Reason|0|||
164703893|NCT00807248|594941817|FG001|Overall Study|Other Reason|0|||
164390585|NCT02008890|593798907|FG004|Extension Period|Withdrawal by Subject|2|||
164390586|NCT02008890|593798903|FG000|Extension Period|Lost to Follow-up|1|||
164390587|NCT02008890|593798904|FG001|Extension Period|Lost to Follow-up|0|||
164390588|NCT02008890|593798905|FG002|Extension Period|Lost to Follow-up|0|||
164390589|NCT02008890|593798906|FG003|Extension Period|Lost to Follow-up|0|||
164441413|NCT00961636|593982826|FG001|Overall Study|Lost to Follow-up|3|||
164390590|NCT02008890|593798907|FG004|Extension Period|Lost to Follow-up|0|||
164390591|NCT02008890|593798903|FG000|Extension Period|Adverse Event|1|||
164390592|NCT02008890|593798904|FG001|Extension Period|Adverse Event|3|||
164390593|NCT02008890|593798905|FG002|Extension Period|Adverse Event|0|||
164390594|NCT02008890|593798906|FG003|Extension Period|Adverse Event|0|||
164390595|NCT02008890|593798907|FG004|Extension Period|Adverse Event|2|||
164390596|NCT02207816|593798908|FG000|Overall Study|Serious Adverse Event|0|||
164390597|NCT02207816|593798909|FG001|Overall Study|Serious Adverse Event|5|||
164390598|NCT02207816|593798910|FG002|Overall Study|Serious Adverse Event|2|||
164390599|NCT02207816|593798908|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
164390600|NCT02207816|593798909|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
164390601|NCT02207816|593798910|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
164390602|NCT02207816|593798908|FG000|Overall Study|Withdrawal by Subject|4|||
164390603|NCT02207816|593798909|FG001|Overall Study|Withdrawal by Subject|9|||
164390604|NCT02207816|593798910|FG002|Overall Study|Withdrawal by Subject|7|||
164390605|NCT02207816|593798908|FG000|Overall Study|Migrated/Moved From Study Area|41|||
164390606|NCT02207816|593798909|FG001|Overall Study|Migrated/Moved From Study Area|60|||
164390607|NCT02207816|593798910|FG002|Overall Study|Migrated/Moved From Study Area|51|||
164390608|NCT02207816|593798908|FG000|Overall Study|Lost to Follow-up|3|||
164390609|NCT02207816|593798909|FG001|Overall Study|Lost to Follow-up|9|||
164390610|NCT02207816|593798910|FG002|Overall Study|Lost to Follow-up|1|||
164390611|NCT02207816|593798908|FG000|Overall Study|Other|1|||
164390612|NCT02207816|593798909|FG001|Overall Study|Other|2|||
164390613|NCT02207816|593798910|FG002|Overall Study|Other|4|||
164390614|NCT02522494|593798911|FG000|Overall Study|Lost to Follow-up|6|||
164390615|NCT02522494|593798912|FG001|Overall Study|Lost to Follow-up|2|||
164390616|NCT02522494|593798911|FG000|Overall Study|Withdrawal by Subject|1|||
164390617|NCT02522494|593798912|FG001|Overall Study|Withdrawal by Subject|0|||
164390618|NCT02522494|593798911|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
164390619|NCT02522494|593798912|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
164390620|NCT02522494|593798911|FG000|Overall Study|Participant did not watch the video|1|||
164390621|NCT02522494|593798912|FG001|Overall Study|Participant did not watch the video|0|||
164390622|NCT02522494|593798911|FG000|Overall Study|Death|0|||
164390623|NCT02522494|593798912|FG001|Overall Study|Death|1|||
164390624|NCT02349295|593798915|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
164390625|NCT02349295|593798916|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
164390626|NCT02349295|593798917|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
164390627|NCT02349295|593798918|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
164390628|NCT02349295|593798919|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
164390629|NCT02349295|593798920|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
164390630|NCT02349295|593798921|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
164390631|NCT02349295|593798922|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
164390632|NCT02349295|593798923|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
164390633|NCT02349295|593798924|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
164390634|NCT02349295|593798925|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
164390635|NCT02349295|593798926|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
164390636|NCT02349295|593798927|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
164390637|NCT02349295|593798928|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
164390638|NCT02349295|593798915|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
164390639|NCT02349295|593798916|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
164390640|NCT02349295|593798917|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
164390641|NCT02349295|593798918|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
164390642|NCT02349295|593798919|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
164390643|NCT02349295|593798920|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
164390644|NCT02349295|593798921|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
164390645|NCT02349295|593798922|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
164390646|NCT02349295|593798923|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
164390647|NCT02349295|593798924|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
164390648|NCT02349295|593798925|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
164390649|NCT02349295|593798926|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
164390650|NCT02349295|593798927|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
164390651|NCT02349295|593798928|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
164390652|NCT02349295|593798915|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
164390653|NCT02349295|593798916|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
164390654|NCT02349295|593798917|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
164390655|NCT02349295|593798918|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
164390656|NCT02349295|593798919|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
164390657|NCT02349295|593798920|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
164594410|NCT02935634|594539175|FG005|Treatment: Track 1|Other reasons|0|||
164594411|NCT02935634|594539170|FG000|Treatment: Track 2|Disease progression|13|||
164594412|NCT02935634|594539171|FG001|Treatment: Track 2|Disease progression|26|||
164390658|NCT02349295|593798921|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
164390659|NCT02349295|593798922|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
164390660|NCT02349295|593798923|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
164441414|NCT00961636|593982827|FG002|Overall Study|Lost to Follow-up|1|||
164390661|NCT02349295|593798924|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
164390662|NCT02349295|593798925|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
164390663|NCT02349295|593798926|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
164390664|NCT02349295|593798927|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
164390665|NCT02349295|593798928|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
164390666|NCT02349295|593798915|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
164390667|NCT02349295|593798916|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
164390668|NCT02349295|593798917|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
164390669|NCT02349295|593798918|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
164390670|NCT02349295|593798919|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
164390671|NCT02349295|593798920|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
164390672|NCT02349295|593798921|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
164390673|NCT02349295|593798922|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
164390674|NCT02349295|593798923|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
164390675|NCT02349295|593798924|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
164390676|NCT02349295|593798925|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
164390677|NCT02349295|593798926|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
164390678|NCT02349295|593798927|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
164390679|NCT02349295|593798928|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
164390680|NCT02349295|593798915|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
164390681|NCT02349295|593798916|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
164390682|NCT02349295|593798917|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
164390683|NCT02349295|593798918|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
164390684|NCT02349295|593798919|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
164390685|NCT02349295|593798920|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
164390686|NCT02349295|593798921|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
164390687|NCT02349295|593798922|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
164390688|NCT02349295|593798923|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
164390689|NCT02349295|593798924|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
164390690|NCT02349295|593798925|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
164390691|NCT02349295|593798926|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
164390692|NCT02349295|593798927|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
164390693|NCT02349295|593798928|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
164390694|NCT02349295|593798915|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
164390695|NCT02349295|593798916|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
164390696|NCT02349295|593798917|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
164390697|NCT02349295|593798918|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
164390698|NCT02349295|593798919|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
164390699|NCT02349295|593798920|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
164390700|NCT02349295|593798921|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
164390701|NCT02349295|593798922|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
164390702|NCT02349295|593798923|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
164390703|NCT02349295|593798924|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
164390704|NCT02349295|593798925|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
164390705|NCT02349295|593798926|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
164390706|NCT02349295|593798927|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
164390707|NCT02349295|593798928|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
164390708|NCT02349295|593798915|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
164390709|NCT02349295|593798916|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
164390710|NCT02349295|593798917|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
164390711|NCT02349295|593798918|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
164390712|NCT02349295|593798919|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
164390713|NCT02349295|593798920|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
164390714|NCT02349295|593798921|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
164390715|NCT02349295|593798922|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
164390716|NCT02349295|593798923|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
164390717|NCT02349295|593798924|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
164390718|NCT02349295|593798925|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
164390719|NCT02349295|593798926|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
164390720|NCT02349295|593798927|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
164390721|NCT02349295|593798928|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
164390722|NCT02349295|593798915|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
164390723|NCT02349295|593798916|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
164390724|NCT02349295|593798917|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
164390725|NCT02349295|593798918|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
164390726|NCT02349295|593798919|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
164390727|NCT02349295|593798920|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
164390728|NCT02349295|593798921|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
164390729|NCT02349295|593798922|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
164390730|NCT02349295|593798923|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
164390731|NCT02349295|593798924|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
164390732|NCT02349295|593798925|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
164390733|NCT02349295|593798926|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
164390734|NCT02349295|593798927|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
164390735|NCT02349295|593798928|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
164390736|NCT02349295|593798915|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
164390737|NCT02349295|593798916|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
164390738|NCT02349295|593798917|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
164390739|NCT02349295|593798918|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
164390740|NCT02349295|593798919|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
164390741|NCT02349295|593798920|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
164390742|NCT02349295|593798921|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
164390743|NCT02349295|593798922|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
164390744|NCT02349295|593798923|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
164390745|NCT02349295|593798924|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
164390746|NCT02349295|593798925|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
164390747|NCT02349295|593798926|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
164390748|NCT02349295|593798927|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
164390749|NCT02349295|593798928|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
164390750|NCT02349295|593798915|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
164390751|NCT02349295|593798916|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
164390752|NCT02349295|593798917|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
164390753|NCT02349295|593798918|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
164390754|NCT02349295|593798919|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
164390755|NCT02349295|593798920|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
164390756|NCT02349295|593798921|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
164390757|NCT02349295|593798922|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
164390758|NCT02349295|593798923|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
164390759|NCT02349295|593798924|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
164390760|NCT02349295|593798925|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
164390761|NCT02349295|593798926|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
164390762|NCT02349295|593798927|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
164390763|NCT02349295|593798928|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
164390764|NCT02349295|593798915|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
164390765|NCT02349295|593798916|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
164390766|NCT02349295|593798917|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
164390767|NCT02349295|593798918|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
164390768|NCT02349295|593798919|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
164390769|NCT02349295|593798920|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
164390770|NCT02349295|593798921|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
164390771|NCT02349295|593798922|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
164390772|NCT02349295|593798923|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
164390773|NCT02349295|593798924|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
164390774|NCT02349295|593798925|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
164390775|NCT02349295|593798926|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
164390776|NCT02349295|593798927|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
164390777|NCT02349295|593798928|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
164390778|NCT02349295|593798915|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
164390779|NCT02349295|593798916|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
164390780|NCT02349295|593798917|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
164441415|NCT00961636|593982825|FG000|Overall Study|Physician Decision|3|||
164441416|NCT00961636|593982826|FG001|Overall Study|Physician Decision|1|||
164441417|NCT00961636|593982827|FG002|Overall Study|Physician Decision|1|||
164441418|NCT00961636|593982825|FG000|Overall Study|Protocol Violation|9|||
164441419|NCT00961636|593982826|FG001|Overall Study|Protocol Violation|5|||
164441420|NCT00961636|593982827|FG002|Overall Study|Protocol Violation|1|||
164441421|NCT00961636|593982825|FG000|Overall Study|Withdrawal by Subject|29|||
164441422|NCT00961636|593982826|FG001|Overall Study|Withdrawal by Subject|22|||
164441423|NCT00961636|593982827|FG002|Overall Study|Withdrawal by Subject|13|||
164441424|NCT02551055|593982828|FG000|Overall Study|Death|2|||
164390781|NCT02349295|593798918|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
164390782|NCT02349295|593798919|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
164441425|NCT02551055|593982829|FG001|Overall Study|Death|4|||
164441426|NCT02551055|593982830|FG002|Overall Study|Death|2|||
164441427|NCT02551055|593982831|FG003|Overall Study|Death|2|||
164441428|NCT02551055|593982832|FG004|Overall Study|Death|2|||
164441429|NCT02551055|593982833|FG005|Overall Study|Death|1|||
164441430|NCT02551055|593982834|FG006|Overall Study|Death|2|||
164441431|NCT02551055|593982835|FG007|Overall Study|Death|0|||
164441432|NCT02551055|593982828|FG000|Overall Study|Study Terminated by Sponsor|1|||
164441433|NCT02551055|593982829|FG001|Overall Study|Study Terminated by Sponsor|1|||
164441434|NCT02551055|593982830|FG002|Overall Study|Study Terminated by Sponsor|0|||
164441435|NCT02551055|593982831|FG003|Overall Study|Study Terminated by Sponsor|2|||
164441436|NCT02551055|593982832|FG004|Overall Study|Study Terminated by Sponsor|2|||
164441437|NCT02551055|593982833|FG005|Overall Study|Study Terminated by Sponsor|0|||
164441438|NCT02551055|593982834|FG006|Overall Study|Study Terminated by Sponsor|0|||
164594413|NCT02935634|594539172|FG002|Treatment: Track 2|Disease progression|20|||
164594414|NCT02935634|594539173|FG003|Treatment: Track 2|Disease progression|5|||
164390783|NCT02349295|593798920|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
164390784|NCT02349295|593798921|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
164390785|NCT02349295|593798922|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
164390786|NCT02349295|593798923|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
164390787|NCT02349295|593798924|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
164390788|NCT02349295|593798925|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
164390789|NCT02349295|593798926|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
164390790|NCT02349295|593798927|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
164441439|NCT02551055|593982835|FG007|Overall Study|Study Terminated by Sponsor|0|||
164441440|NCT02551055|593982828|FG000|Overall Study|Withdrawal by Subject|1|||
164441441|NCT02551055|593982829|FG001|Overall Study|Withdrawal by Subject|1|||
164441442|NCT02551055|593982830|FG002|Overall Study|Withdrawal by Subject|0|||
164441443|NCT02551055|593982831|FG003|Overall Study|Withdrawal by Subject|1|||
164441444|NCT02551055|593982832|FG004|Overall Study|Withdrawal by Subject|2|||
164390791|NCT02349295|593798928|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
164390792|NCT02349295|593798915|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
164390793|NCT02349295|593798916|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
164390794|NCT02349295|593798917|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
164390795|NCT02349295|593798918|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
164390796|NCT02349295|593798919|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
164390797|NCT02349295|593798920|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
164390798|NCT02349295|593798921|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
164390799|NCT02349295|593798922|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
164390800|NCT02349295|593798923|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
164390801|NCT02349295|593798924|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
164390802|NCT02349295|593798925|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
164390803|NCT02349295|593798926|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
164390804|NCT02349295|593798927|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
164390805|NCT02349295|593798928|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
164390806|NCT02349295|593798915|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
164390807|NCT02349295|593798916|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
164390808|NCT02349295|593798917|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
164390809|NCT02349295|593798918|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
164390810|NCT02349295|593798919|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
164390811|NCT02349295|593798920|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
164390812|NCT02349295|593798921|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
164390813|NCT02349295|593798922|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
164390814|NCT02349295|593798923|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
164390815|NCT02349295|593798924|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
164390816|NCT02349295|593798925|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
164390817|NCT02349295|593798926|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
164390818|NCT02349295|593798927|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
164390819|NCT02349295|593798928|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
164390820|NCT02349295|593798915|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
164390821|NCT02349295|593798916|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
164390822|NCT02349295|593798917|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
164390823|NCT02349295|593798918|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
164390824|NCT02349295|593798919|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
164390825|NCT02349295|593798920|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
164390826|NCT02349295|593798921|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
164390827|NCT02349295|593798922|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
164390828|NCT02349295|593798923|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
164390829|NCT02349295|593798924|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
164390830|NCT02349295|593798925|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
164390831|NCT02349295|593798926|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
164390832|NCT02349295|593798927|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
164390833|NCT02349295|593798928|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
164390834|NCT02349295|593798915|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
164390835|NCT02349295|593798916|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
164390836|NCT02349295|593798917|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
164390837|NCT02349295|593798918|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
164390838|NCT02349295|593798919|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
164390839|NCT02349295|593798920|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
164390840|NCT02349295|593798921|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
164390841|NCT02349295|593798922|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
164390842|NCT02349295|593798923|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
164390843|NCT02349295|593798924|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
164390844|NCT02349295|593798925|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
164390845|NCT02349295|593798926|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
164390846|NCT02349295|593798927|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
164390847|NCT02349295|593798928|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
164390848|NCT02349295|593798915|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390849|NCT02349295|593798916|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390850|NCT02349295|593798917|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390851|NCT02349295|593798918|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390852|NCT02349295|593798919|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390853|NCT02349295|593798920|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390854|NCT02349295|593798921|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390855|NCT02349295|593798922|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390856|NCT02349295|593798923|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390857|NCT02349295|593798924|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390858|NCT02349295|593798925|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390859|NCT02349295|593798926|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
164390860|NCT02349295|593798927|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390861|NCT02349295|593798928|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390862|NCT02349295|593798915|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390863|NCT02349295|593798916|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390864|NCT02349295|593798917|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390865|NCT02349295|593798918|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390866|NCT02349295|593798919|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390867|NCT02349295|593798920|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390868|NCT02349295|593798921|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390869|NCT02349295|593798922|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390870|NCT02349295|593798923|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390871|NCT02349295|593798924|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390872|NCT02349295|593798925|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390873|NCT02349295|593798926|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
164390874|NCT02349295|593798927|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390875|NCT02349295|593798928|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390876|NCT03240588|593798929|FG000|Overall Study|Death|3|||
164390877|NCT03240588|593798930|FG001|Overall Study|Death|0|||
164390878|NCT03240588|593798931|FG002|Overall Study|Death|0|||
164390879|NCT03240588|593798929|FG000|Overall Study|Adverse Event|5|||
164390880|NCT03240588|593798930|FG001|Overall Study|Adverse Event|4|||
164390881|NCT03240588|593798931|FG002|Overall Study|Adverse Event|0|||
164390882|NCT03240588|593798929|FG000|Overall Study|Lost to Follow-up|9|||
164390883|NCT03240588|593798930|FG001|Overall Study|Lost to Follow-up|4|||
164390884|NCT03240588|593798931|FG002|Overall Study|Lost to Follow-up|0|||
164390885|NCT03240588|593798929|FG000|Overall Study|Physician Decision|3|||
164390886|NCT03240588|593798930|FG001|Overall Study|Physician Decision|2|||
164390887|NCT03240588|593798931|FG002|Overall Study|Physician Decision|0|||
164390888|NCT03240588|593798929|FG000|Overall Study|Did not meet eligibility criteria|0|||
164390889|NCT03240588|593798930|FG001|Overall Study|Did not meet eligibility criteria|6|||
164390890|NCT03240588|593798931|FG002|Overall Study|Did not meet eligibility criteria|0|||
164390891|NCT03240588|593798929|FG000|Overall Study|No longer meets protocol criteria|12|||
164390892|NCT03240588|593798930|FG001|Overall Study|No longer meets protocol criteria|7|||
164390893|NCT03240588|593798931|FG002|Overall Study|No longer meets protocol criteria|0|||
164390894|NCT03240588|593798929|FG000|Overall Study|Withdrawal by Subject|60|||
164390895|NCT03240588|593798930|FG001|Overall Study|Withdrawal by Subject|52|||
164390896|NCT03240588|593798931|FG002|Overall Study|Withdrawal by Subject|7|||
164390897|NCT03240588|593798929|FG000|Overall Study|Other, additional details not available.|0|||
164390898|NCT03240588|593798930|FG001|Overall Study|Other, additional details not available.|12|||
164390899|NCT03240588|593798931|FG002|Overall Study|Other, additional details not available.|1|||
164390900|NCT03240588|593798929|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
164390901|NCT03240588|593798930|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
164390902|NCT03240588|593798931|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
164390903|NCT03240588|593798929|FG000|Overall Study|Closure of study|55|||
164390904|NCT03240588|593798930|FG001|Overall Study|Closure of study|3|||
164390905|NCT03240588|593798931|FG002|Overall Study|Closure of study|0|||
164390906|NCT03240588|593798929|FG000|Overall Study|Subject non-compliance|23|||
164390907|NCT03240588|593798930|FG001|Overall Study|Subject non-compliance|2|||
164390908|NCT03240588|593798931|FG002|Overall Study|Subject non-compliance|1|||
164390909|NCT03240588|593798929|FG000|Overall Study|Device Deficiency|1|||
164390910|NCT03240588|593798930|FG001|Overall Study|Device Deficiency|0|||
164390911|NCT03240588|593798931|FG002|Overall Study|Device Deficiency|0|||
164390912|NCT03240588|593798929|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
164390913|NCT03240588|593798930|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
164390914|NCT03240588|593798931|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
164390915|NCT01259713|593798935|FG000|Overall Study|Adverse Event|54|||
164390916|NCT01259713|593798936|FG001|Overall Study|Adverse Event|23|||
164390917|NCT01259713|593798935|FG000|Overall Study|Death Not Related to IFI|8|||
164390918|NCT01259713|593798936|FG001|Overall Study|Death Not Related to IFI|1|||
164703894|NCT00807248|594941818|FG002|Overall Study|Other Reason|2|||
164390919|NCT01259713|593798935|FG000|Overall Study|Investigators Discretion|14|||
164390920|NCT01259713|593798936|FG001|Overall Study|Investigators Discretion|6|||
164390921|NCT01259713|593798935|FG000|Overall Study|Lack of Efficacy|2|||
164390922|NCT01259713|593798936|FG001|Overall Study|Lack of Efficacy|0|||
164703895|NCT00807248|594941819|FG003|Overall Study|Other Reason|0|||
164390923|NCT01259713|593798935|FG000|Overall Study|Protocol Violation|5|||
164594415|NCT02935634|594539174|FG004|Treatment: Track 2|Disease progression|1|||
164390924|NCT01259713|593798936|FG001|Overall Study|Protocol Violation|4|||
164390925|NCT01259713|593798935|FG000|Overall Study|Subject Withdrew Consent|12|||
164390926|NCT01259713|593798936|FG001|Overall Study|Subject Withdrew Consent|7|||
164390927|NCT02091726|593798937|FG000|Overall Study|Lost to Follow-up|6|||
164390928|NCT06111742|593798944|FG000|Overall Study|Did not receive intervention|1|||
164390929|NCT06111742|593798945|FG001|Overall Study|Did not receive intervention|0|||
164390930|NCT06111742|593798946|FG002|Overall Study|Did not receive intervention|0|||
164390931|NCT06111742|593798944|FG000|Overall Study|Withdrawal by Subject|2|||
164390932|NCT06111742|593798945|FG001|Overall Study|Withdrawal by Subject|0|||
164390933|NCT06111742|593798946|FG002|Overall Study|Withdrawal by Subject|0|||
164390934|NCT03461003|593798947|FG000|Overall Study|Lost to Follow-up|2|||
164390935|NCT03461003|593798948|FG001|Overall Study|Lost to Follow-up|2|||
164390936|NCT03461003|593798947|FG000|Overall Study|Withdrawal by Subject|3|||
164390937|NCT03461003|593798948|FG001|Overall Study|Withdrawal by Subject|1|||
164390938|NCT01914926|593798949|FG000|Overall Study|Adverse Event|1|||
164390939|NCT01914926|593798950|FG001|Overall Study|Adverse Event|0|||
164390940|NCT01914926|593798949|FG000|Overall Study|uncooperative, agitated and removed|0|||
164390941|NCT01914926|593798950|FG001|Overall Study|uncooperative, agitated and removed|1|||
164390942|NCT00620750|593798958|FG000|Overall Study|Lost to Follow-up|25|||
164390943|NCT04477187|593798959|FG000|Overall Study|Lost to Follow-up|2|||
164390944|NCT00856856|593798964|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
164390945|NCT00856856|593798964|FG000|4-year Clinical Follow-up|Missed visit|1|||
164390946|NCT03073603|593798966|FG000|Overall Study|Noncompliance|3|||
164390947|NCT03073603|593798967|FG001|Overall Study|Noncompliance|1|||
164390948|NCT03073603|593798966|FG000|Overall Study|Adverse Event|5|||
164390949|NCT03073603|593798967|FG001|Overall Study|Adverse Event|3|||
164390950|NCT03073603|593798966|FG000|Overall Study|Physician Decision|1|||
164390951|NCT03073603|593798967|FG001|Overall Study|Physician Decision|2|||
164390952|NCT03073603|593798966|FG000|Overall Study|Required treatment not allowed by protocol|1|||
164390953|NCT03073603|593798967|FG001|Overall Study|Required treatment not allowed by protocol|0|||
164390954|NCT03073603|593798966|FG000|Overall Study|Financial or insurance-related|8|||
164390955|NCT03073603|593798967|FG001|Overall Study|Financial or insurance-related|0|||
164390956|NCT03073603|593798966|FG000|Overall Study|Withdrawal by Subject|0|||
164390957|NCT03073603|593798967|FG001|Overall Study|Withdrawal by Subject|1|||
164390958|NCT03073603|593798966|FG000|Overall Study|Discontinued DMT|4|||
164390959|NCT03073603|593798967|FG001|Overall Study|Discontinued DMT|0|||
164390960|NCT03073603|593798966|FG000|Overall Study|Restarted DMT|0|||
164390961|NCT03073603|593798967|FG001|Overall Study|Restarted DMT|1|||
164390962|NCT02473952|593798968|FG000|Overall Study|Adverse Event|2|||
164594416|NCT02935634|594539175|FG005|Treatment: Track 2|Disease progression|4|||
164594417|NCT02935634|594539170|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
164594418|NCT02935634|594539171|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
164594419|NCT02935634|594539172|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
164594420|NCT02935634|594539173|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
164390963|NCT02473952|593798969|FG001|Overall Study|Adverse Event|2|||
164390964|NCT02473952|593798968|FG000|Overall Study|Withdrawal by Subject|0|||
164594421|NCT02935634|594539174|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
164390965|NCT02473952|593798969|FG001|Overall Study|Withdrawal by Subject|6|||
164390966|NCT00922428|593798970|FG000|Overall Study|retrospective/extremely implausible data|2|||
164390967|NCT00922428|593798970|FG000|Overall Study|no medication use or questionable use|13|||
164390968|NCT04757649|593798971|FG000|Overall Study|Withdrawal by Subject|1|||
164390969|NCT04757649|593798971|FG000|Overall Study|Adverse Event|1|||
164390970|NCT02862106|593798972|FG000|Overall Study|Adverse Event|4|||
164390971|NCT02862106|593798973|FG001|Overall Study|Adverse Event|0|||
164390972|NCT02862106|593798972|FG000|Overall Study|Protocol Violation|16|||
164390973|NCT02862106|593798973|FG001|Overall Study|Protocol Violation|1|||
164390974|NCT02862106|593798972|FG000|Overall Study|Lost to Follow-up|15|||
164594422|NCT02935634|594539175|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
164390975|NCT02862106|593798973|FG001|Overall Study|Lost to Follow-up|5|||
164390976|NCT02862106|593798972|FG000|Overall Study|Withdrawal by Subject|2|||
164703896|NCT02444793|594941820|FG000|Overall Study|Lost to Follow-up|2|||
164703897|NCT02444793|594941821|FG001|Overall Study|Lost to Follow-up|2|||
164703898|NCT02444793|594941822|FG002|Overall Study|Lost to Follow-up|0|||
164703899|NCT02444793|594941823|FG003|Overall Study|Lost to Follow-up|0|||
164703900|NCT02444793|594941820|FG000|Overall Study|Death|0|||
164390977|NCT02862106|593798973|FG001|Overall Study|Withdrawal by Subject|0|||
164390978|NCT02862106|593798972|FG000|Overall Study|Subjects moved to other city|1|||
164390979|NCT02862106|593798973|FG001|Overall Study|Subjects moved to other city|0|||
164390980|NCT00096135|593798980|FG000|Overall Study|Physician Decision|20|||
164390981|NCT00096135|593798981|FG001|Overall Study|Physician Decision|4|||
164390982|NCT00096135|593798980|FG000|Overall Study|Refusal of further protocol therapy|4|||
164594423|NCT02935634|594539170|FG000|Treatment: Track 2|Study drug toxicity|7|||
164703901|NCT02444793|594941821|FG001|Overall Study|Death|3|||
164703902|NCT02444793|594941822|FG002|Overall Study|Death|0|||
164390983|NCT00096135|593798981|FG001|Overall Study|Refusal of further protocol therapy|1|||
164390984|NCT00096135|593798980|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
164390985|NCT00096135|593798981|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
164390986|NCT00096135|593798980|FG000|Overall Study|Other, specify|15|||
164390987|NCT00096135|593798981|FG001|Overall Study|Other, specify|3|||
164390988|NCT00096135|593798980|FG000|Overall Study|Ineligible|2|||
164390989|NCT00096135|593798981|FG001|Overall Study|Ineligible|0|||
164390990|NCT00833989|593798990|FG000|Overall Study|Physician Decision|0|||
164390991|NCT00833989|593798991|FG001|Overall Study|Physician Decision|0|||
164390992|NCT00833989|593798992|FG002|Overall Study|Physician Decision|0|||
164390993|NCT00833989|593798993|FG003|Overall Study|Physician Decision|1|||
164390994|NCT00833989|593798990|FG000|Overall Study|Withdrawal by Subject|3|||
164390995|NCT00833989|593798991|FG001|Overall Study|Withdrawal by Subject|0|||
164390996|NCT00833989|593798992|FG002|Overall Study|Withdrawal by Subject|1|||
164390997|NCT00833989|593798993|FG003|Overall Study|Withdrawal by Subject|1|||
164390998|NCT02310750|593798996|FG000|HP Period 1|Lost to Follow-up|0|||
164390999|NCT02310750|593798997|FG001|HP Period 1|Lost to Follow-up|0|||
164391000|NCT02310750|593798998|FG002|HP Period 1|Lost to Follow-up|0|||
164391001|NCT02310750|593798999|FG003|HP Period 1|Lost to Follow-up|0|||
164391002|NCT02310750|593799000|FG004|HP Period 1|Lost to Follow-up|0|||
164391003|NCT02310750|593799001|FG005|HP Period 1|Lost to Follow-up|0|||
164391004|NCT02310750|593799002|FG006|HP Period 1|Lost to Follow-up|1|||
164391005|NCT02310750|593799003|FG007|HP Period 1|Lost to Follow-up|0|||
164391006|NCT02310750|593799004|FG008|HP Period 1|Lost to Follow-up|0|||
164391007|NCT02310750|593799005|FG009|HP Period 1|Lost to Follow-up|0|||
164391008|NCT02310750|593799006|FG010|HP Period 1|Lost to Follow-up|0|||
164391009|NCT02310750|593799007|FG011|HP Period 1|Lost to Follow-up|0|||
164391010|NCT02310750|593799008|FG012|HP Period 1|Lost to Follow-up|0|||
164391011|NCT02310750|593799009|FG013|HP Period 1|Lost to Follow-up|0|||
164391012|NCT02310750|593799010|FG014|HP Period 1|Lost to Follow-up|0|||
164391013|NCT02310750|593799011|FG015|HP Period 1|Lost to Follow-up|0|||
164391014|NCT02310750|593798996|FG000|HP Period 1|Withdrawal by Subject|1|||
164391015|NCT02310750|593798997|FG001|HP Period 1|Withdrawal by Subject|0|||
164391016|NCT02310750|593798998|FG002|HP Period 1|Withdrawal by Subject|0|||
164391017|NCT02310750|593798999|FG003|HP Period 1|Withdrawal by Subject|1|||
164391018|NCT02310750|593799000|FG004|HP Period 1|Withdrawal by Subject|0|||
164391019|NCT02310750|593799001|FG005|HP Period 1|Withdrawal by Subject|0|||
164391020|NCT02310750|593799002|FG006|HP Period 1|Withdrawal by Subject|0|||
164391021|NCT02310750|593799003|FG007|HP Period 1|Withdrawal by Subject|0|||
164391022|NCT02310750|593799004|FG008|HP Period 1|Withdrawal by Subject|0|||
164391023|NCT02310750|593799005|FG009|HP Period 1|Withdrawal by Subject|0|||
164391024|NCT02310750|593799006|FG010|HP Period 1|Withdrawal by Subject|0|||
164391025|NCT02310750|593799007|FG011|HP Period 1|Withdrawal by Subject|0|||
164391026|NCT02310750|593799008|FG012|HP Period 1|Withdrawal by Subject|0|||
164391027|NCT02310750|593799009|FG013|HP Period 1|Withdrawal by Subject|0|||
164391028|NCT02310750|593799010|FG014|HP Period 1|Withdrawal by Subject|0|||
164391029|NCT02310750|593799011|FG015|HP Period 1|Withdrawal by Subject|0|||
164391030|NCT02310750|593798996|FG000|HP Washout 1|Lost to Follow-up|0|||
164391031|NCT02310750|593798997|FG001|HP Washout 1|Lost to Follow-up|0|||
164391032|NCT02310750|593798998|FG002|HP Washout 1|Lost to Follow-up|1|||
164391033|NCT02310750|593798999|FG003|HP Washout 1|Lost to Follow-up|1|||
164391034|NCT02310750|593799000|FG004|HP Washout 1|Lost to Follow-up|2|||
164391035|NCT02310750|593799001|FG005|HP Washout 1|Lost to Follow-up|2|||
164391036|NCT02310750|593799002|FG006|HP Washout 1|Lost to Follow-up|3|||
164391037|NCT02310750|593799003|FG007|HP Washout 1|Lost to Follow-up|0|||
164391038|NCT02310750|593799004|FG008|HP Washout 1|Lost to Follow-up|0|||
164391039|NCT02310750|593799005|FG009|HP Washout 1|Lost to Follow-up|0|||
164391040|NCT02310750|593799006|FG010|HP Washout 1|Lost to Follow-up|0|||
164391041|NCT02310750|593799007|FG011|HP Washout 1|Lost to Follow-up|0|||
164391042|NCT02310750|593799008|FG012|HP Washout 1|Lost to Follow-up|0|||
164391043|NCT02310750|593799009|FG013|HP Washout 1|Lost to Follow-up|0|||
164391044|NCT02310750|593799010|FG014|HP Washout 1|Lost to Follow-up|0|||
164391045|NCT02310750|593799011|FG015|HP Washout 1|Lost to Follow-up|0|||
164391046|NCT02310750|593798996|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
164391047|NCT02310750|593798997|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
164391048|NCT02310750|593798998|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
164391049|NCT02310750|593798999|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
164391050|NCT02310750|593799000|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
164391051|NCT02310750|593799001|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
164391052|NCT02310750|593799002|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
164391053|NCT02310750|593799003|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
164391054|NCT02310750|593799004|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
164391055|NCT02310750|593799005|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
164391056|NCT02310750|593799006|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
164391057|NCT02310750|593799007|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
164391058|NCT02310750|593799008|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
164391059|NCT02310750|593799009|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
164391060|NCT02310750|593799010|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
164391061|NCT02310750|593799011|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
164391062|NCT02310750|593798996|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391063|NCT02310750|593798997|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391064|NCT02310750|593798998|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391065|NCT02310750|593798999|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391066|NCT02310750|593799000|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391067|NCT02310750|593799001|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391068|NCT02310750|593799002|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391069|NCT02310750|593799003|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391070|NCT02310750|593799004|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391071|NCT02310750|593799005|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
164391072|NCT02310750|593799006|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391073|NCT02310750|593799007|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391074|NCT02310750|593799008|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391075|NCT02310750|593799009|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391076|NCT02310750|593799010|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391077|NCT02310750|593799011|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391078|NCT02310750|593798996|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391079|NCT02310750|593798997|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391080|NCT02310750|593798998|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391081|NCT02310750|593798999|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391082|NCT02310750|593799000|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391083|NCT02310750|593799001|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391084|NCT02310750|593799002|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391085|NCT02310750|593799003|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
164391086|NCT02310750|593799004|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
164391087|NCT02310750|593799005|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
164391088|NCT02310750|593799006|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391089|NCT02310750|593799007|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391090|NCT02310750|593799008|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391091|NCT02310750|593799009|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391092|NCT02310750|593799010|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391093|NCT02310750|593799011|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391094|NCT02310750|593798996|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391095|NCT02310750|593798997|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391096|NCT02310750|593798998|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391097|NCT02310750|593798999|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391098|NCT02310750|593799000|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391099|NCT02310750|593799001|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391100|NCT02310750|593799002|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391101|NCT02310750|593799003|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
164391102|NCT02310750|593799004|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
164391103|NCT02310750|593799005|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391104|NCT02310750|593799006|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391105|NCT02310750|593799007|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391106|NCT02310750|593799008|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391107|NCT02310750|593799009|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391108|NCT02310750|593799010|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391109|NCT02310750|593799011|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391110|NCT02310750|593798996|FG000|HP Washout 2|Lost to Follow-up|0|||
164391111|NCT02310750|593798997|FG001|HP Washout 2|Lost to Follow-up|0|||
164391112|NCT02310750|593798998|FG002|HP Washout 2|Lost to Follow-up|0|||
164391113|NCT02310750|593798999|FG003|HP Washout 2|Lost to Follow-up|0|||
164391114|NCT02310750|593799000|FG004|HP Washout 2|Lost to Follow-up|1|||
164391115|NCT02310750|593799001|FG005|HP Washout 2|Lost to Follow-up|0|||
164391116|NCT02310750|593799002|FG006|HP Washout 2|Lost to Follow-up|7|||
164391117|NCT02310750|593799003|FG007|HP Washout 2|Lost to Follow-up|0|||
164391118|NCT02310750|593799004|FG008|HP Washout 2|Lost to Follow-up|0|||
164391119|NCT02310750|593799005|FG009|HP Washout 2|Lost to Follow-up|0|||
164391120|NCT02310750|593799006|FG010|HP Washout 2|Lost to Follow-up|0|||
164391121|NCT02310750|593799007|FG011|HP Washout 2|Lost to Follow-up|0|||
164391122|NCT02310750|593799008|FG012|HP Washout 2|Lost to Follow-up|0|||
164391123|NCT02310750|593799009|FG013|HP Washout 2|Lost to Follow-up|0|||
164391124|NCT02310750|593799010|FG014|HP Washout 2|Lost to Follow-up|0|||
164391125|NCT02310750|593799011|FG015|HP Washout 2|Lost to Follow-up|0|||
164391126|NCT02199028|593799012|FG000|Week 1|Adverse Event|1|||
164391127|NCT02199028|593799013|FG001|Week 1|Adverse Event|0|||
164391128|NCT02199028|593799012|FG000|Week 3|Adverse Event|1|||
164391129|NCT02199028|593799013|FG001|Week 3|Adverse Event|0|||
164391130|NCT01881126|593799016|FG000|Overall Study|Non-compliance|1|||
164391131|NCT01881126|593799017|FG001|Overall Study|Non-compliance|1|||
164391132|NCT01881126|593799016|FG000|Overall Study|Adverse Event|0|||
164391133|NCT01881126|593799017|FG001|Overall Study|Adverse Event|1|||
164391134|NCT05045625|593799018|FG000|Overall Study|Lost to Follow-up|3|||
164391135|NCT03867734|593799019|FG000|Overall Study|Lost to Follow-up|2|||
164391136|NCT01827904|593799020|FG000|Main Study|Withdrawal by Subject|1|||
164391137|NCT01827904|593799021|FG001|Main Study|Withdrawal by Subject|0|||
164391138|NCT01827904|593799022|FG002|Main Study|Withdrawal by Subject|0|||
164391139|NCT01827904|593799020|FG000|Main Study|Adverse Event|1|||
164391140|NCT01827904|593799021|FG001|Main Study|Adverse Event|0|||
164391141|NCT01827904|593799022|FG002|Main Study|Adverse Event|0|||
164391142|NCT01827904|593799020|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
164391143|NCT01827904|593799021|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
164391144|NCT01827904|593799022|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
164391145|NCT01827904|593799020|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
164391146|NCT01827904|593799021|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
164391147|NCT01827904|593799022|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
164391148|NCT01827904|593799020|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
164391149|NCT01827904|593799021|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
164391150|NCT01827904|593799022|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
164391151|NCT01827904|593799020|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
164391152|NCT01827904|593799021|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
164391153|NCT01827904|593799022|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
164391154|NCT01827904|593799020|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
164391155|NCT01827904|593799021|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
164391156|NCT01827904|593799022|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
164391157|NCT01827904|593799020|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
164391158|NCT01827904|593799021|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
164391159|NCT01827904|593799022|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
164391160|NCT01827904|593799020|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
164391161|NCT01827904|593799021|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
164391162|NCT01827904|593799022|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
164391163|NCT01827904|593799020|FG000|Long-term Annual Follow-up|Physician Decision|1|||
164391164|NCT01827904|593799021|FG001|Long-term Annual Follow-up|Physician Decision|0|||
164391165|NCT01827904|593799022|FG002|Long-term Annual Follow-up|Physician Decision|0|||
164391166|NCT01827904|593799020|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
164703903|NCT02444793|594941823|FG003|Overall Study|Death|0|||
164391167|NCT01827904|593799021|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
164391168|NCT01827904|593799022|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
164391169|NCT01827904|593799020|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
164391170|NCT01827904|593799021|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
164391171|NCT01827904|593799022|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
164391172|NCT04266028|593799023|FG000|Overall Study|Adverse Event|0|||
164391173|NCT04266028|593799024|FG001|Overall Study|Adverse Event|0|||
164391174|NCT04266028|593799025|FG002|Overall Study|Adverse Event|1|||
164391175|NCT04266028|593799026|FG003|Overall Study|Adverse Event|0|||
164391176|NCT04266028|593799027|FG004|Overall Study|Adverse Event|1|||
164391177|NCT04266028|593799028|FG005|Overall Study|Adverse Event|0|||
164391178|NCT04266028|593799029|FG006|Overall Study|Adverse Event|2|||
164391179|NCT04266028|593799030|FG007|Overall Study|Adverse Event|0|||
164391180|NCT04266028|593799023|FG000|Overall Study|temporary halt of the study|0|||
164391181|NCT04266028|593799024|FG001|Overall Study|temporary halt of the study|0|||
164391182|NCT04266028|593799025|FG002|Overall Study|temporary halt of the study|0|||
164391183|NCT04266028|593799026|FG003|Overall Study|temporary halt of the study|0|||
164391184|NCT04266028|593799027|FG004|Overall Study|temporary halt of the study|0|||
164391185|NCT04266028|593799028|FG005|Overall Study|temporary halt of the study|0|||
164391186|NCT04266028|593799029|FG006|Overall Study|temporary halt of the study|2|||
164391187|NCT04266028|593799030|FG007|Overall Study|temporary halt of the study|1|||
164391188|NCT04266028|593799023|FG000|Overall Study|Onset of birch pollen season|0|||
164391189|NCT04266028|593799024|FG001|Overall Study|Onset of birch pollen season|0|||
164391190|NCT04266028|593799025|FG002|Overall Study|Onset of birch pollen season|0|||
164391191|NCT04266028|593799026|FG003|Overall Study|Onset of birch pollen season|0|||
164391192|NCT04266028|593799027|FG004|Overall Study|Onset of birch pollen season|1|||
164391193|NCT04266028|593799028|FG005|Overall Study|Onset of birch pollen season|0|||
164391194|NCT04266028|593799029|FG006|Overall Study|Onset of birch pollen season|0|||
164391195|NCT04266028|593799030|FG007|Overall Study|Onset of birch pollen season|0|||
164391196|NCT01458574|593799031|FG000|Overall Study|Adverse Event|5|||
164391197|NCT01458574|593799032|FG001|Overall Study|Adverse Event|9|||
164391198|NCT01458574|593799033|FG002|Overall Study|Adverse Event|7|||
164391199|NCT01458574|593799031|FG000|Overall Study|Lack of Efficacy|70|||
164391200|NCT01458574|593799032|FG001|Overall Study|Lack of Efficacy|53|||
164391201|NCT01458574|593799033|FG002|Overall Study|Lack of Efficacy|132|||
164391202|NCT01458574|593799031|FG000|Overall Study|Lost to Follow-up|3|||
164391203|NCT01458574|593799032|FG001|Overall Study|Lost to Follow-up|2|||
164391204|NCT01458574|593799033|FG002|Overall Study|Lost to Follow-up|1|||
164391205|NCT01458574|593799031|FG000|Overall Study|Pregnancy|1|||
164391206|NCT01458574|593799032|FG001|Overall Study|Pregnancy|1|||
164391207|NCT01458574|593799033|FG002|Overall Study|Pregnancy|0|||
164391208|NCT01458574|593799031|FG000|Overall Study|Protocol Violation|0|||
164391209|NCT01458574|593799032|FG001|Overall Study|Protocol Violation|1|||
164391210|NCT01458574|593799033|FG002|Overall Study|Protocol Violation|0|||
164391211|NCT01458574|593799031|FG000|Overall Study|Withdrawal by Subject|6|||
164391212|NCT01458574|593799032|FG001|Overall Study|Withdrawal by Subject|3|||
164391213|NCT01458574|593799033|FG002|Overall Study|Withdrawal by Subject|5|||
164391214|NCT01458574|593799031|FG000|Overall Study|Other|2|||
164391215|NCT01458574|593799032|FG001|Overall Study|Other|1|||
164391216|NCT01458574|593799033|FG002|Overall Study|Other|0|||
164391217|NCT01458574|593799031|FG000|Overall Study|Randomized but not treated|0|||
164391218|NCT01458574|593799032|FG001|Overall Study|Randomized but not treated|1|||
164391219|NCT01458574|593799033|FG002|Overall Study|Randomized but not treated|0|||
164391220|NCT02125786|593799034|FG000|Overall Study|Still in Follow-up|3|||
164391221|NCT02125786|593799034|FG000|Overall Study|Screen Failure|2|||
164391222|NCT02125786|593799034|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
164391223|NCT02125786|593799034|FG000|Overall Study|Progressive Disease|44|||
164391224|NCT02125786|593799034|FG000|Overall Study|Death|8|||
164391225|NCT02663128|593799037|FG000|Period 2|Physician Decision|0|||
164391226|NCT02663128|593799038|FG001|Period 2|Physician Decision|0|||
164391227|NCT02663128|593799039|FG002|Period 2|Physician Decision|0|||
164391228|NCT02663128|593799040|FG003|Period 2|Physician Decision|0|||
164703904|NCT02444793|594941820|FG000|Overall Study|Other|0|||
164703905|NCT02444793|594941821|FG001|Overall Study|Other|0|||
164391229|NCT02663128|593799041|FG004|Period 2|Physician Decision|1|||
164391230|NCT02663128|593799042|FG005|Period 2|Physician Decision|0|||
164391231|NCT05070897|593799043|FG000|Overall Study|Protocol Violation|123|||
164391232|NCT05070897|593799044|FG001|Overall Study|Protocol Violation|68|||
164391233|NCT01617629|593799047|FG000|Overall Study|Death|2|||
164391234|NCT01617629|593799047|FG000|Overall Study|Investigator's Clinical Judgement|1|||
164703906|NCT02444793|594941822|FG002|Overall Study|Other|2|||
164391235|NCT01617629|593799047|FG000|Overall Study|Reason Not Specified|1|||
164391236|NCT01617629|593799047|FG000|Overall Study|Participant Withdrew Consent|2|||
164391237|NCT01663636|593799048|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
164391238|NCT01663636|593799049|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
164391239|NCT03394924|593799050|FG000|Overall Study|Adverse Event|0|||
164391240|NCT03394924|593799051|FG001|Overall Study|Adverse Event|5|||
164391241|NCT03394924|593799052|FG002|Overall Study|Adverse Event|0|||
164391242|NCT03394924|593799050|FG000|Overall Study|Withdrawal by Subject|2|||
164391243|NCT03394924|593799051|FG001|Overall Study|Withdrawal by Subject|0|||
164391244|NCT03394924|593799052|FG002|Overall Study|Withdrawal by Subject|0|||
164391245|NCT03394924|593799050|FG000|Overall Study|Lost to Follow-up|0|||
164391246|NCT03394924|593799051|FG001|Overall Study|Lost to Follow-up|1|||
164391247|NCT03394924|593799052|FG002|Overall Study|Lost to Follow-up|0|||
164391248|NCT03394924|593799050|FG000|Overall Study|Did not meet all inclusion criteria|1|||
164391249|NCT03394924|593799051|FG001|Overall Study|Did not meet all inclusion criteria|0|||
164391250|NCT03394924|593799052|FG002|Overall Study|Did not meet all inclusion criteria|0|||
164391251|NCT02663817|593799055|FG000|Overall Study|Screen failure|2|||
164391252|NCT05350449|593799056|FG000|Overall Study|Withdrawal by Subject|4|||
164391253|NCT05350449|593799057|FG001|Overall Study|Withdrawal by Subject|8|||
164391254|NCT01949311|593801815|FG000|Overall Study|Lost to Follow-up|73|||
164391255|NCT01949311|593801815|FG000|Overall Study|Terminated by Sponsor|708|||
164391256|NCT01949311|593801815|FG000|Overall Study|Withdrawal by Subject|375|||
164391257|NCT01949311|593801815|FG000|Overall Study|Lack of Efficacy|50|||
164391258|NCT01949311|593801815|FG000|Overall Study|Protocol Deviation|34|||
164391259|NCT01949311|593801815|FG000|Overall Study|Pregnancy|20|||
164391260|NCT01949311|593801815|FG000|Overall Study|Physician Decision|9|||
164391261|NCT01949311|593801815|FG000|Overall Study|Other|4|||
164391262|NCT01949311|593801815|FG000|Overall Study|Adverse Event|107|||
164391263|NCT01925950|593801818|FG000|Part 2|Withdrawal by Subject|1|||
164391264|NCT01925950|593801819|FG001|Part 2|Withdrawal by Subject|0|||
164391265|NCT03508843|593801821|FG000|Overall Study|Withdrawal by Subject|1|||
164391266|NCT03508843|593801821|FG000|Overall Study|technical difficulties|2|||
164391267|NCT04717596|593801822|FG000|Overall Study|Withdrawal by Subject|4|||
164391268|NCT00765843|593801823|FG000|Overall Study|Lost to Follow-up|1|||
164391269|NCT00765843|593801824|FG001|Overall Study|Lost to Follow-up|3|||
164391270|NCT00765843|593801825|FG002|Overall Study|Lost to Follow-up|2|||
164391271|NCT00765843|593801823|FG000|Overall Study|did not return to receive intervention|0|||
164391272|NCT00765843|593801824|FG001|Overall Study|did not return to receive intervention|1|||
164391273|NCT00765843|593801825|FG002|Overall Study|did not return to receive intervention|0|||
164391274|NCT00765843|593801823|FG000|Overall Study|Adverse Event|0|||
164391275|NCT00765843|593801824|FG001|Overall Study|Adverse Event|0|||
164391276|NCT00765843|593801825|FG002|Overall Study|Adverse Event|1|||
164391277|NCT03555396|593801826|FG000|Overall Study|Death|3|||
164391278|NCT03555396|593801827|FG001|Overall Study|Death|1|||
164391279|NCT03555396|593801826|FG000|Overall Study|Lost to Follow-up|0|||
164391280|NCT03555396|593801827|FG001|Overall Study|Lost to Follow-up|2|||
164391281|NCT04066114|593801828|FG000|Overall Study|Adverse Event|1|||
164391282|NCT04066114|593801829|FG001|Overall Study|Adverse Event|0|||
164391283|NCT04066114|593801830|FG002|Overall Study|Adverse Event|0|||
164391284|NCT04066114|593801828|FG000|Overall Study|Withdrawal by Subject|1|||
164391285|NCT04066114|593801829|FG001|Overall Study|Withdrawal by Subject|0|||
164391286|NCT04066114|593801830|FG002|Overall Study|Withdrawal by Subject|0|||
164391287|NCT04066114|593801828|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
164391288|NCT04066114|593801829|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
164391289|NCT04066114|593801830|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
164391290|NCT02460991|593801831|FG000|Overall Study|Withdrawal by Subject|0|||
164391291|NCT02460991|593801832|FG001|Overall Study|Withdrawal by Subject|2|||
164391292|NCT02564523|593801833|FG000|Overall Study|Withdrawal by Subject|3|||
164441445|NCT02551055|593982833|FG005|Overall Study|Withdrawal by Subject|0|||
164441446|NCT02551055|593982834|FG006|Overall Study|Withdrawal by Subject|0|||
164441447|NCT02551055|593982835|FG007|Overall Study|Withdrawal by Subject|0|||
164441448|NCT02551055|593982828|FG000|Overall Study|Reason not specified|0|||
164441449|NCT02551055|593982829|FG001|Overall Study|Reason not specified|0|||
164441450|NCT02551055|593982830|FG002|Overall Study|Reason not specified|0|||
164594424|NCT02935634|594539171|FG001|Treatment: Track 2|Study drug toxicity|3|||
164594425|NCT02935634|594539172|FG002|Treatment: Track 2|Study drug toxicity|0|||
164594426|NCT02935634|594539173|FG003|Treatment: Track 2|Study drug toxicity|0|||
164391293|NCT02564523|593801834|FG001|Overall Study|Withdrawal by Subject|0|||
164391294|NCT02564523|593801835|FG002|Overall Study|Withdrawal by Subject|1|||
164391295|NCT02564523|593801836|FG003|Overall Study|Withdrawal by Subject|0|||
164391296|NCT02564523|593801837|FG004|Overall Study|Withdrawal by Subject|1|||
164391297|NCT02564523|593801838|FG005|Overall Study|Withdrawal by Subject|0|||
164391298|NCT02564523|593801839|FG006|Overall Study|Withdrawal by Subject|1|||
164391299|NCT02564523|593801840|FG007|Overall Study|Withdrawal by Subject|0|||
164391300|NCT02564523|593801841|FG008|Overall Study|Withdrawal by Subject|0|||
164391301|NCT02564523|593801842|FG009|Overall Study|Withdrawal by Subject|0|||
164391302|NCT02564523|593801843|FG010|Overall Study|Withdrawal by Subject|1|||
164391303|NCT02564523|593801844|FG011|Overall Study|Withdrawal by Subject|0|||
164391304|NCT02564523|593801845|FG012|Overall Study|Withdrawal by Subject|1|||
164441451|NCT02551055|593982831|FG003|Overall Study|Reason not specified|0|||
164441452|NCT02551055|593982832|FG004|Overall Study|Reason not specified|1|||
164594427|NCT02935634|594539174|FG004|Treatment: Track 2|Study drug toxicity|0|||
164594428|NCT02935634|594539175|FG005|Treatment: Track 2|Study drug toxicity|0|||
164391305|NCT02564523|593801846|FG013|Overall Study|Withdrawal by Subject|0|||
164391306|NCT02564523|593801847|FG014|Overall Study|Withdrawal by Subject|0|||
164391307|NCT02564523|593801848|FG015|Overall Study|Withdrawal by Subject|0|||
164391308|NCT02564523|593801849|FG016|Overall Study|Withdrawal by Subject|0|||
164391309|NCT02564523|593801850|FG017|Overall Study|Withdrawal by Subject|0|||
164391310|NCT02564523|593801833|FG000|Overall Study|Adverse Event|0|||
164391311|NCT02564523|593801834|FG001|Overall Study|Adverse Event|0|||
164391312|NCT02564523|593801835|FG002|Overall Study|Adverse Event|0|||
164391313|NCT02564523|593801836|FG003|Overall Study|Adverse Event|0|||
164391314|NCT02564523|593801837|FG004|Overall Study|Adverse Event|0|||
164391315|NCT02564523|593801838|FG005|Overall Study|Adverse Event|0|||
164391316|NCT02564523|593801839|FG006|Overall Study|Adverse Event|0|||
164391317|NCT02564523|593801840|FG007|Overall Study|Adverse Event|0|||
164391318|NCT02564523|593801841|FG008|Overall Study|Adverse Event|0|||
164391319|NCT02564523|593801842|FG009|Overall Study|Adverse Event|0|||
164391320|NCT02564523|593801843|FG010|Overall Study|Adverse Event|0|||
164391321|NCT02564523|593801844|FG011|Overall Study|Adverse Event|0|||
164391322|NCT02564523|593801845|FG012|Overall Study|Adverse Event|0|||
164391323|NCT02564523|593801846|FG013|Overall Study|Adverse Event|0|||
164391324|NCT02564523|593801847|FG014|Overall Study|Adverse Event|0|||
164391325|NCT02564523|593801848|FG015|Overall Study|Adverse Event|0|||
164391326|NCT02564523|593801849|FG016|Overall Study|Adverse Event|0|||
164391327|NCT02564523|593801850|FG017|Overall Study|Adverse Event|1|||
164391328|NCT02564523|593801833|FG000|Overall Study|Death|0|||
164391329|NCT02564523|593801834|FG001|Overall Study|Death|0|||
164391330|NCT02564523|593801835|FG002|Overall Study|Death|0|||
164391331|NCT02564523|593801836|FG003|Overall Study|Death|0|||
164391332|NCT02564523|593801837|FG004|Overall Study|Death|0|||
164391333|NCT02564523|593801838|FG005|Overall Study|Death|0|||
164391334|NCT02564523|593801839|FG006|Overall Study|Death|1|||
164391335|NCT02564523|593801840|FG007|Overall Study|Death|0|||
164391336|NCT02564523|593801841|FG008|Overall Study|Death|0|||
164391337|NCT02564523|593801842|FG009|Overall Study|Death|0|||
164391338|NCT02564523|593801843|FG010|Overall Study|Death|1|||
164391339|NCT02564523|593801844|FG011|Overall Study|Death|0|||
164391340|NCT02564523|593801845|FG012|Overall Study|Death|0|||
164391341|NCT02564523|593801846|FG013|Overall Study|Death|0|||
164391342|NCT02564523|593801847|FG014|Overall Study|Death|0|||
164391343|NCT02564523|593801848|FG015|Overall Study|Death|0|||
164391344|NCT02564523|593801849|FG016|Overall Study|Death|0|||
164391345|NCT02564523|593801850|FG017|Overall Study|Death|0|||
164391346|NCT02564523|593801833|FG000|Overall Study|Lost to Follow-up|2|||
164391347|NCT02564523|593801834|FG001|Overall Study|Lost to Follow-up|1|||
164391348|NCT02564523|593801835|FG002|Overall Study|Lost to Follow-up|4|||
164391349|NCT02564523|593801836|FG003|Overall Study|Lost to Follow-up|0|||
164391350|NCT02564523|593801837|FG004|Overall Study|Lost to Follow-up|1|||
164391351|NCT02564523|593801838|FG005|Overall Study|Lost to Follow-up|0|||
164391352|NCT02564523|593801839|FG006|Overall Study|Lost to Follow-up|1|||
164391353|NCT02564523|593801840|FG007|Overall Study|Lost to Follow-up|0|||
164391354|NCT02564523|593801841|FG008|Overall Study|Lost to Follow-up|0|||
164391355|NCT02564523|593801842|FG009|Overall Study|Lost to Follow-up|0|||
164391356|NCT02564523|593801843|FG010|Overall Study|Lost to Follow-up|0|||
164391357|NCT02564523|593801844|FG011|Overall Study|Lost to Follow-up|1|||
164391358|NCT02564523|593801845|FG012|Overall Study|Lost to Follow-up|1|||
164391359|NCT02564523|593801846|FG013|Overall Study|Lost to Follow-up|0|||
164703907|NCT02444793|594941823|FG003|Overall Study|Other|0|||
164391360|NCT02564523|593801847|FG014|Overall Study|Lost to Follow-up|0|||
164391361|NCT02564523|593801848|FG015|Overall Study|Lost to Follow-up|0|||
164391362|NCT02564523|593801849|FG016|Overall Study|Lost to Follow-up|0|||
164391363|NCT02564523|593801850|FG017|Overall Study|Lost to Follow-up|0|||
164391364|NCT02564523|593801833|FG000|Overall Study|Physician Decision|0|||
164391365|NCT02564523|593801834|FG001|Overall Study|Physician Decision|0|||
164391366|NCT02564523|593801835|FG002|Overall Study|Physician Decision|0|||
164703908|NCT02444793|594941820|FG000|Overall Study|Objective progression or relapse|9|||
164703909|NCT02444793|594941821|FG001|Overall Study|Objective progression or relapse|1|||
164703910|NCT02444793|594941822|FG002|Overall Study|Objective progression or relapse|2|||
164391367|NCT02564523|593801836|FG003|Overall Study|Physician Decision|0|||
164391368|NCT02564523|593801837|FG004|Overall Study|Physician Decision|1|||
164703911|NCT02444793|594941823|FG003|Overall Study|Objective progression or relapse|3|||
164391369|NCT02564523|593801838|FG005|Overall Study|Physician Decision|0|||
164391370|NCT02564523|593801839|FG006|Overall Study|Physician Decision|0|||
164391371|NCT02564523|593801840|FG007|Overall Study|Physician Decision|0|||
164391372|NCT02564523|593801841|FG008|Overall Study|Physician Decision|0|||
164391373|NCT02564523|593801842|FG009|Overall Study|Physician Decision|0|||
164391374|NCT02564523|593801843|FG010|Overall Study|Physician Decision|1|||
164391375|NCT02564523|593801844|FG011|Overall Study|Physician Decision|0|||
164391376|NCT02564523|593801845|FG012|Overall Study|Physician Decision|0|||
164703912|NCT02504671|594941826|FG000|Overall Study|Withdrawal by Subject|1|||
164391377|NCT02564523|593801846|FG013|Overall Study|Physician Decision|0|||
164391378|NCT02564523|593801847|FG014|Overall Study|Physician Decision|0|||
164391379|NCT02564523|593801848|FG015|Overall Study|Physician Decision|0|||
164391380|NCT02564523|593801849|FG016|Overall Study|Physician Decision|0|||
164391381|NCT02564523|593801850|FG017|Overall Study|Physician Decision|0|||
164391382|NCT02564523|593801833|FG000|Overall Study|Protocol Violation|2|||
164391383|NCT02564523|593801834|FG001|Overall Study|Protocol Violation|2|||
164391384|NCT02564523|593801835|FG002|Overall Study|Protocol Violation|5|||
164391385|NCT02564523|593801836|FG003|Overall Study|Protocol Violation|0|||
164391386|NCT02564523|593801837|FG004|Overall Study|Protocol Violation|1|||
164391387|NCT02564523|593801838|FG005|Overall Study|Protocol Violation|0|||
164391388|NCT02564523|593801839|FG006|Overall Study|Protocol Violation|0|||
164391389|NCT02564523|593801840|FG007|Overall Study|Protocol Violation|0|||
164391390|NCT02564523|593801841|FG008|Overall Study|Protocol Violation|0|||
164391391|NCT02564523|593801842|FG009|Overall Study|Protocol Violation|0|||
164391392|NCT02564523|593801843|FG010|Overall Study|Protocol Violation|0|||
164391393|NCT02564523|593801844|FG011|Overall Study|Protocol Violation|0|||
164391394|NCT02564523|593801845|FG012|Overall Study|Protocol Violation|0|||
164391395|NCT02564523|593801846|FG013|Overall Study|Protocol Violation|0|||
164391396|NCT02564523|593801847|FG014|Overall Study|Protocol Violation|0|||
164391397|NCT02564523|593801848|FG015|Overall Study|Protocol Violation|0|||
164391398|NCT02564523|593801849|FG016|Overall Study|Protocol Violation|0|||
164391399|NCT02564523|593801850|FG017|Overall Study|Protocol Violation|0|||
164391400|NCT02564523|593801833|FG000|Overall Study|Other|3|||
164391401|NCT02564523|593801834|FG001|Overall Study|Other|0|||
164391402|NCT02564523|593801835|FG002|Overall Study|Other|0|||
164391403|NCT02564523|593801836|FG003|Overall Study|Other|1|||
164391404|NCT02564523|593801837|FG004|Overall Study|Other|0|||
164391405|NCT02564523|593801838|FG005|Overall Study|Other|0|||
164391406|NCT02564523|593801839|FG006|Overall Study|Other|0|||
164391407|NCT02564523|593801840|FG007|Overall Study|Other|0|||
164391408|NCT02564523|593801841|FG008|Overall Study|Other|0|||
164391409|NCT02564523|593801842|FG009|Overall Study|Other|0|||
164391410|NCT02564523|593801843|FG010|Overall Study|Other|0|||
164391411|NCT02564523|593801844|FG011|Overall Study|Other|0|||
164391412|NCT02564523|593801845|FG012|Overall Study|Other|0|||
164391413|NCT02564523|593801846|FG013|Overall Study|Other|0|||
164391414|NCT02564523|593801847|FG014|Overall Study|Other|0|||
164391415|NCT02564523|593801848|FG015|Overall Study|Other|0|||
164391416|NCT02564523|593801849|FG016|Overall Study|Other|0|||
164391417|NCT02564523|593801850|FG017|Overall Study|Other|0|||
164391418|NCT03701555|593801856|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
164391419|NCT03701555|593801857|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
164391420|NCT03701555|593801858|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
164391421|NCT03701555|593801859|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
164391422|NCT03701555|593801860|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
164391423|NCT03701555|593801861|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
164391424|NCT03701555|593801862|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
164391425|NCT03701555|593801863|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
164391426|NCT03701555|593801864|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
164391427|NCT03701555|593801865|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
164391428|NCT03701555|593801866|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
164391429|NCT03701555|593801867|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
164391430|NCT03701555|593801868|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
164391431|NCT03701555|593801869|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
164391432|NCT03701555|593801870|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
164391433|NCT03701555|593801871|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
164391434|NCT03701555|593801872|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
164391435|NCT03701555|593801873|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
164391436|NCT03701555|593801874|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
164391437|NCT03701555|593801875|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
164391438|NCT03701555|593801876|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
164391439|NCT03701555|593801877|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
164391440|NCT03701555|593801878|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
164441453|NCT02551055|593982833|FG005|Overall Study|Reason not specified|0|||
164441454|NCT02551055|593982834|FG006|Overall Study|Reason not specified|1|||
164391441|NCT03701555|593801879|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
164391442|NCT03701555|593801880|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
164391443|NCT03701555|593801881|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
164391444|NCT03701555|593801882|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
164391445|NCT03701555|593801883|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
164391446|NCT03701555|593801884|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
164391447|NCT03701555|593801885|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
164391448|NCT03701555|593801886|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
164391449|NCT03701555|593801887|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
164391450|NCT03701555|593801888|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
164391451|NCT03701555|593801889|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
164391452|NCT03701555|593801890|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
164391453|NCT03701555|593801891|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
164391454|NCT03701555|593801856|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
164391455|NCT03701555|593801857|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
164391456|NCT03701555|593801858|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
164391457|NCT03701555|593801859|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
164391458|NCT03701555|593801860|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
164391459|NCT03701555|593801861|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
164391460|NCT03701555|593801862|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
164391461|NCT03701555|593801863|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
164391462|NCT03701555|593801864|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
164391463|NCT03701555|593801865|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
164391464|NCT03701555|593801866|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
164391465|NCT03701555|593801867|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
164391466|NCT03701555|593801868|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
164391467|NCT03701555|593801869|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
164391468|NCT03701555|593801870|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
164391469|NCT03701555|593801871|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
164391470|NCT03701555|593801872|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
164391471|NCT03701555|593801873|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
164391472|NCT03701555|593801874|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
164391473|NCT03701555|593801875|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
164391474|NCT03701555|593801876|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
164391475|NCT03701555|593801877|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
164391476|NCT03701555|593801878|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
164391477|NCT03701555|593801879|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
164391478|NCT03701555|593801880|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
164391479|NCT03701555|593801881|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
164391480|NCT03701555|593801882|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
164391481|NCT03701555|593801883|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
164391482|NCT03701555|593801884|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
164391483|NCT03701555|593801885|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
164391484|NCT03701555|593801886|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
164391485|NCT03701555|593801887|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
164391486|NCT03701555|593801888|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
164391487|NCT03701555|593801889|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
164391488|NCT03701555|593801890|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
164391489|NCT03701555|593801891|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
164391490|NCT03701555|593801856|FG000|Part 2 (Day 1)|Other|0|||
164391491|NCT03701555|593801857|FG001|Part 2 (Day 1)|Other|0|||
164391492|NCT03701555|593801858|FG002|Part 2 (Day 1)|Other|0|||
164391493|NCT03701555|593801859|FG003|Part 2 (Day 1)|Other|0|||
164391494|NCT03701555|593801860|FG004|Part 2 (Day 1)|Other|0|||
164391495|NCT03701555|593801861|FG005|Part 2 (Day 1)|Other|0|||
164391496|NCT03701555|593801862|FG006|Part 2 (Day 1)|Other|0|||
164391497|NCT03701555|593801863|FG007|Part 2 (Day 1)|Other|0|||
164391498|NCT03701555|593801864|FG008|Part 2 (Day 1)|Other|0|||
164391499|NCT03701555|593801865|FG009|Part 2 (Day 1)|Other|0|||
164391500|NCT03701555|593801866|FG010|Part 2 (Day 1)|Other|3|||
164391501|NCT03701555|593801867|FG011|Part 2 (Day 1)|Other|1|||
164391502|NCT03701555|593801868|FG012|Part 2 (Day 1)|Other|0|||
164391503|NCT03701555|593801869|FG013|Part 2 (Day 1)|Other|1|||
164391504|NCT03701555|593801870|FG014|Part 2 (Day 1)|Other|0|||
164391505|NCT03701555|593801871|FG015|Part 2 (Day 1)|Other|2|||
164391506|NCT03701555|593801872|FG016|Part 2 (Day 1)|Other|2|||
164391507|NCT03701555|593801873|FG017|Part 2 (Day 1)|Other|0|||
164391508|NCT03701555|593801874|FG018|Part 2 (Day 1)|Other|0|||
164391509|NCT03701555|593801875|FG019|Part 2 (Day 1)|Other|0|||
164391510|NCT03701555|593801876|FG020|Part 2 (Day 1)|Other|0|||
164391511|NCT03701555|593801877|FG021|Part 2 (Day 1)|Other|0|||
164391512|NCT03701555|593801878|FG022|Part 2 (Day 1)|Other|0|||
164391513|NCT03701555|593801879|FG023|Part 2 (Day 1)|Other|0|||
164391514|NCT03701555|593801880|FG024|Part 2 (Day 1)|Other|0|||
164391515|NCT03701555|593801881|FG025|Part 2 (Day 1)|Other|0|||
164391516|NCT03701555|593801882|FG026|Part 2 (Day 1)|Other|0|||
164391517|NCT03701555|593801883|FG027|Part 2 (Day 1)|Other|0|||
164391518|NCT03701555|593801884|FG028|Part 2 (Day 1)|Other|0|||
164391519|NCT03701555|593801885|FG029|Part 2 (Day 1)|Other|0|||
164391520|NCT03701555|593801886|FG030|Part 2 (Day 1)|Other|0|||
164391521|NCT03701555|593801887|FG031|Part 2 (Day 1)|Other|0|||
164391522|NCT03701555|593801888|FG032|Part 2 (Day 1)|Other|0|||
164391523|NCT03701555|593801889|FG033|Part 2 (Day 1)|Other|0|||
164391524|NCT03701555|593801890|FG034|Part 2 (Day 1)|Other|0|||
164391525|NCT03701555|593801891|FG035|Part 2 (Day 1)|Other|0|||
164391526|NCT03701555|593801856|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
164391527|NCT03701555|593801857|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
164391528|NCT03701555|593801858|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
164391529|NCT03701555|593801859|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
164391530|NCT03701555|593801860|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
164391531|NCT03701555|593801861|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
164391532|NCT03701555|593801862|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
164391533|NCT03701555|593801863|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
164391534|NCT03701555|593801864|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
164391535|NCT03701555|593801865|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
164391536|NCT03701555|593801866|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
164391537|NCT03701555|593801867|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
164391538|NCT03701555|593801868|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
164391539|NCT03701555|593801869|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
164391540|NCT03701555|593801870|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
164391541|NCT03701555|593801871|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
164391542|NCT03701555|593801872|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
164391543|NCT03701555|593801873|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
164391544|NCT03701555|593801874|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
164391545|NCT03701555|593801875|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
164391546|NCT03701555|593801876|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
164391547|NCT03701555|593801877|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
164391548|NCT03701555|593801878|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
164391549|NCT03701555|593801879|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
164391550|NCT03701555|593801880|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
164391551|NCT03701555|593801881|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
164391552|NCT03701555|593801882|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
164391553|NCT03701555|593801883|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
164391554|NCT03701555|593801884|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
164391555|NCT03701555|593801885|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
164391556|NCT03701555|593801886|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
164391557|NCT03701555|593801887|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
164391558|NCT03701555|593801888|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
164391559|NCT03701555|593801889|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
164391560|NCT03701555|593801890|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
164391561|NCT03701555|593801891|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
164391562|NCT03701555|593801856|FG000|Part 3 (Day 1)|Subject Decision|0|||
164391563|NCT03701555|593801857|FG001|Part 3 (Day 1)|Subject Decision|0|||
164391564|NCT03701555|593801858|FG002|Part 3 (Day 1)|Subject Decision|0|||
164391565|NCT03701555|593801859|FG003|Part 3 (Day 1)|Subject Decision|0|||
164391566|NCT03701555|593801860|FG004|Part 3 (Day 1)|Subject Decision|0|||
164391567|NCT03701555|593801861|FG005|Part 3 (Day 1)|Subject Decision|0|||
164391568|NCT03701555|593801862|FG006|Part 3 (Day 1)|Subject Decision|0|||
164391569|NCT03701555|593801863|FG007|Part 3 (Day 1)|Subject Decision|0|||
164391570|NCT03701555|593801864|FG008|Part 3 (Day 1)|Subject Decision|0|||
164391571|NCT03701555|593801865|FG009|Part 3 (Day 1)|Subject Decision|0|||
164391572|NCT03701555|593801866|FG010|Part 3 (Day 1)|Subject Decision|0|||
164391573|NCT03701555|593801867|FG011|Part 3 (Day 1)|Subject Decision|0|||
164391574|NCT03701555|593801868|FG012|Part 3 (Day 1)|Subject Decision|0|||
164391575|NCT03701555|593801869|FG013|Part 3 (Day 1)|Subject Decision|0|||
164391576|NCT03701555|593801870|FG014|Part 3 (Day 1)|Subject Decision|0|||
164391577|NCT03701555|593801871|FG015|Part 3 (Day 1)|Subject Decision|0|||
164391578|NCT03701555|593801872|FG016|Part 3 (Day 1)|Subject Decision|0|||
164391579|NCT03701555|593801873|FG017|Part 3 (Day 1)|Subject Decision|0|||
164391580|NCT03701555|593801874|FG018|Part 3 (Day 1)|Subject Decision|0|||
164391581|NCT03701555|593801875|FG019|Part 3 (Day 1)|Subject Decision|0|||
164391582|NCT03701555|593801876|FG020|Part 3 (Day 1)|Subject Decision|0|||
164391583|NCT03701555|593801877|FG021|Part 3 (Day 1)|Subject Decision|0|||
164391584|NCT03701555|593801878|FG022|Part 3 (Day 1)|Subject Decision|0|||
164391585|NCT03701555|593801879|FG023|Part 3 (Day 1)|Subject Decision|0|||
164391586|NCT03701555|593801880|FG024|Part 3 (Day 1)|Subject Decision|0|||
164391587|NCT03701555|593801881|FG025|Part 3 (Day 1)|Subject Decision|0|||
164391588|NCT03701555|593801882|FG026|Part 3 (Day 1)|Subject Decision|1|||
164391589|NCT03701555|593801883|FG027|Part 3 (Day 1)|Subject Decision|0|||
164391590|NCT03701555|593801884|FG028|Part 3 (Day 1)|Subject Decision|0|||
164391591|NCT03701555|593801885|FG029|Part 3 (Day 1)|Subject Decision|0|||
164391592|NCT03701555|593801886|FG030|Part 3 (Day 1)|Subject Decision|0|||
164391593|NCT03701555|593801887|FG031|Part 3 (Day 1)|Subject Decision|2|||
164391594|NCT03701555|593801888|FG032|Part 3 (Day 1)|Subject Decision|1|||
164391595|NCT03701555|593801889|FG033|Part 3 (Day 1)|Subject Decision|1|||
164391596|NCT03701555|593801890|FG034|Part 3 (Day 1)|Subject Decision|0|||
164391597|NCT03701555|593801891|FG035|Part 3 (Day 1)|Subject Decision|0|||
164391598|NCT03701555|593801856|FG000|Part 3 (Day 1)|Other|0|||
164391599|NCT03701555|593801857|FG001|Part 3 (Day 1)|Other|0|||
164391600|NCT03701555|593801858|FG002|Part 3 (Day 1)|Other|0|||
164391601|NCT03701555|593801859|FG003|Part 3 (Day 1)|Other|0|||
164391602|NCT03701555|593801860|FG004|Part 3 (Day 1)|Other|0|||
164391603|NCT03701555|593801861|FG005|Part 3 (Day 1)|Other|0|||
164391604|NCT03701555|593801862|FG006|Part 3 (Day 1)|Other|0|||
164391605|NCT03701555|593801863|FG007|Part 3 (Day 1)|Other|0|||
164391606|NCT03701555|593801864|FG008|Part 3 (Day 1)|Other|0|||
164391607|NCT03701555|593801865|FG009|Part 3 (Day 1)|Other|0|||
164441455|NCT02551055|593982835|FG007|Overall Study|Reason not specified|0|||
164391608|NCT03701555|593801866|FG010|Part 3 (Day 1)|Other|0|||
164391609|NCT03701555|593801867|FG011|Part 3 (Day 1)|Other|0|||
164391610|NCT03701555|593801868|FG012|Part 3 (Day 1)|Other|0|||
164391611|NCT03701555|593801869|FG013|Part 3 (Day 1)|Other|0|||
164391612|NCT03701555|593801870|FG014|Part 3 (Day 1)|Other|0|||
164391613|NCT03701555|593801871|FG015|Part 3 (Day 1)|Other|0|||
164391614|NCT03701555|593801872|FG016|Part 3 (Day 1)|Other|0|||
164391615|NCT03701555|593801873|FG017|Part 3 (Day 1)|Other|0|||
164391616|NCT03701555|593801874|FG018|Part 3 (Day 1)|Other|0|||
164391617|NCT03701555|593801875|FG019|Part 3 (Day 1)|Other|0|||
164391618|NCT03701555|593801876|FG020|Part 3 (Day 1)|Other|0|||
164391619|NCT03701555|593801877|FG021|Part 3 (Day 1)|Other|0|||
164391620|NCT03701555|593801878|FG022|Part 3 (Day 1)|Other|0|||
164391621|NCT03701555|593801879|FG023|Part 3 (Day 1)|Other|0|||
164391622|NCT03701555|593801880|FG024|Part 3 (Day 1)|Other|1|||
164391623|NCT03701555|593801881|FG025|Part 3 (Day 1)|Other|1|||
164391624|NCT03701555|593801882|FG026|Part 3 (Day 1)|Other|0|||
164391625|NCT03701555|593801883|FG027|Part 3 (Day 1)|Other|0|||
164391626|NCT03701555|593801884|FG028|Part 3 (Day 1)|Other|0|||
164391627|NCT03701555|593801885|FG029|Part 3 (Day 1)|Other|1|||
164391628|NCT03701555|593801886|FG030|Part 3 (Day 1)|Other|1|||
164391629|NCT03701555|593801887|FG031|Part 3 (Day 1)|Other|0|||
164391630|NCT03701555|593801888|FG032|Part 3 (Day 1)|Other|1|||
164391631|NCT03701555|593801889|FG033|Part 3 (Day 1)|Other|1|||
164391632|NCT03701555|593801890|FG034|Part 3 (Day 1)|Other|0|||
164391633|NCT03701555|593801891|FG035|Part 3 (Day 1)|Other|0|||
164391634|NCT00448539|593801892|FG000|Overall Study|Medication non-compliance|4|||
164391635|NCT00448539|593801893|FG001|Overall Study|Medication non-compliance|1|||
164391636|NCT00448539|593801892|FG000|Overall Study|Protocol Violation|1|||
164391637|NCT00448539|593801893|FG001|Overall Study|Protocol Violation|0|||
164391638|NCT00448539|593801892|FG000|Overall Study|Request of the investigator or sponsor|67|||
164391639|NCT00448539|593801893|FG001|Overall Study|Request of the investigator or sponsor|54|||
164391640|NCT00448539|593801892|FG000|Overall Study|Withdrawal by Subject|20|||
164391641|NCT00448539|593801893|FG001|Overall Study|Withdrawal by Subject|24|||
164391642|NCT00448539|593801892|FG000|Overall Study|Diary non-compliance|1|||
164391643|NCT00448539|593801893|FG001|Overall Study|Diary non-compliance|0|||
164391644|NCT00448539|593801892|FG000|Overall Study|Adverse Event|9|||
164391645|NCT00448539|593801893|FG001|Overall Study|Adverse Event|26|||
164391646|NCT00448539|593801892|FG000|Overall Study|Lack of Efficacy|27|||
164391647|NCT00448539|593801893|FG001|Overall Study|Lack of Efficacy|40|||
164391648|NCT00448539|593801892|FG000|Overall Study|Miscellaneous|2|||
164391649|NCT00448539|593801893|FG001|Overall Study|Miscellaneous|1|||
164391650|NCT00448539|593801892|FG000|Overall Study|Change of meds|2|||
164391651|NCT00448539|593801893|FG001|Overall Study|Change of meds|3|||
164391652|NCT00448539|593801892|FG000|Overall Study|Lost to Follow-up|1|||
164391653|NCT00448539|593801893|FG001|Overall Study|Lost to Follow-up|3|||
164391654|NCT03349710|593801894|FG000|Treatment Period|Death|0|||
164391655|NCT03349710|593801895|FG001|Treatment Period|Death|0|||
164391656|NCT03349710|593801896|FG002|Treatment Period|Death|1|||
164391657|NCT03349710|593801897|FG003|Treatment Period|Death|0|||
164391658|NCT03349710|593801894|FG000|Treatment Period|Disease Progression|0|||
164391659|NCT03349710|593801895|FG001|Treatment Period|Disease Progression|2|||
164391660|NCT03349710|593801896|FG002|Treatment Period|Disease Progression|0|||
164391661|NCT03349710|593801897|FG003|Treatment Period|Disease Progression|1|||
164391662|NCT03349710|593801894|FG000|Treatment Period|Study Drug Toxicity|1|||
164391663|NCT03349710|593801895|FG001|Treatment Period|Study Drug Toxicity|0|||
164391664|NCT03349710|593801896|FG002|Treatment Period|Study Drug Toxicity|1|||
164391665|NCT03349710|593801897|FG003|Treatment Period|Study Drug Toxicity|1|||
164391666|NCT03349710|593801894|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
164391667|NCT03349710|593801895|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
164391668|NCT03349710|593801896|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
164441456|NCT02106442|593982839|FG000|Overall Study|Case Report Forms Uncollected|7|||
164441457|NCT02106442|593982839|FG000|Overall Study|Protocol Deviation|30|||
164441458|NCT06001177|593984395|FG000|Treatment Phase|Adverse Event|1|||
164441459|NCT06001177|593984396|FG001|Treatment Phase|Adverse Event|0|||
164441460|NCT06001177|593984395|FG000|Treatment Phase|Withdrawal by Subject|1|||
164441461|NCT06001177|593984396|FG001|Treatment Phase|Withdrawal by Subject|0|||
164391669|NCT03349710|593801897|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
164391670|NCT03349710|593801894|FG000|Treatment Period|admin reason by sponsor|0|||
164441462|NCT06001177|593984395|FG000|Observation Phase|Adverse Event|1|||
164441463|NCT06001177|593984396|FG001|Observation Phase|Adverse Event|1|||
164441464|NCT06001177|593984395|FG000|Observation Phase|Withdrawal by Subject|0|||
164441465|NCT06001177|593984396|FG001|Observation Phase|Withdrawal by Subject|1|||
164441466|NCT03593876|593984397|FG000|Overall Study|Withdrawal by Subject|1|||
164441467|NCT03593876|593984397|FG000|Overall Study|Discharged home before intervention completion|2|||
164441468|NCT02696707|593984398|FG000|Per Protocol Population|Physician Decision|2|||
164441469|NCT02696707|593984399|FG001|Per Protocol Population|Physician Decision|1|||
164391671|NCT03349710|593801895|FG001|Treatment Period|admin reason by sponsor|7|||
164391672|NCT03349710|593801896|FG002|Treatment Period|admin reason by sponsor|0|||
164391673|NCT03349710|593801897|FG003|Treatment Period|admin reason by sponsor|19|||
164391674|NCT03349710|593801894|FG000|Treatment Period|Other Reason|2|||
164391675|NCT03349710|593801895|FG001|Treatment Period|Other Reason|0|||
164391676|NCT03349710|593801896|FG002|Treatment Period|Other Reason|2|||
164391677|NCT03349710|593801897|FG003|Treatment Period|Other Reason|1|||
164391678|NCT03349710|593801894|FG000|Treatment Period|completed|6|||
164391679|NCT03349710|593801895|FG001|Treatment Period|completed|0|||
164391680|NCT03349710|593801896|FG002|Treatment Period|completed|18|||
164391681|NCT03349710|593801897|FG003|Treatment Period|completed|1|||
164391682|NCT03349710|593801894|FG000|Treatment Period|participant request to discontinue|0|||
164703913|NCT02504671|594941827|FG001|Overall Study|Withdrawal by Subject|5|||
164391683|NCT03349710|593801895|FG001|Treatment Period|participant request to discontinue|0|||
164391684|NCT03349710|593801896|FG002|Treatment Period|participant request to discontinue|4|||
164391685|NCT03349710|593801897|FG003|Treatment Period|participant request to discontinue|0|||
164391686|NCT03349710|593801894|FG000|Treatment Period|participant withdrew consent|1|||
164391687|NCT03349710|593801895|FG001|Treatment Period|participant withdrew consent|0|||
164391688|NCT03349710|593801896|FG002|Treatment Period|participant withdrew consent|0|||
164391689|NCT03349710|593801897|FG003|Treatment Period|participant withdrew consent|0|||
164391690|NCT00695903|593801898|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
164391691|NCT00695903|593801899|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
164391692|NCT00695903|593801898|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
164391693|NCT00695903|593801899|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
164391694|NCT00695903|593801898|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
164391695|NCT00695903|593801899|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
164391696|NCT00695903|593801898|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
164391697|NCT00695903|593801899|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
164391698|NCT00695903|593801898|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
164391699|NCT00695903|593801899|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
164391700|NCT00695903|593801898|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
164391701|NCT00695903|593801899|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
164391702|NCT00695903|593801898|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
164391703|NCT00695903|593801899|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
164391704|NCT00695903|593801898|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
164391705|NCT00695903|593801899|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
164391706|NCT00695903|593801898|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
164391707|NCT00695903|593801899|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
164391708|NCT01296568|593801902|FG000|Continued Access Phase|Lost to Follow-up|1|||
164391709|NCT01296568|593801902|FG000|Continued Access Phase|Withdrawal by Subject|1|||
164391710|NCT01296568|593801902|FG000|Continued Access Phase|Disease Progression|1|||
164391711|NCT01369342|593801908|FG000|Overall Study|Withdrawal by Subject|7|||
164391712|NCT01369342|593801909|FG001|Overall Study|Withdrawal by Subject|7|||
164391713|NCT01369342|593801910|FG002|Overall Study|Withdrawal by Subject|2|||
164391714|NCT01369342|593801908|FG000|Overall Study|Lost to Follow-up|5|||
164391715|NCT01369342|593801909|FG001|Overall Study|Lost to Follow-up|2|||
164391716|NCT01369342|593801910|FG002|Overall Study|Lost to Follow-up|1|||
164391717|NCT01369342|593801908|FG000|Overall Study|Not Treated|1|||
164391718|NCT01369342|593801909|FG001|Overall Study|Not Treated|0|||
164391719|NCT01369342|593801910|FG002|Overall Study|Not Treated|0|||
164391720|NCT00321854|593801911|FG000|Overall Study|Adverse Event|41|||
164391721|NCT00321854|593801912|FG001|Overall Study|Adverse Event|43|||
164391722|NCT00321854|593801911|FG000|Overall Study|Lack of Efficacy|9|||
164391723|NCT00321854|593801912|FG001|Overall Study|Lack of Efficacy|14|||
164391724|NCT00321854|593801911|FG000|Overall Study|Protocol Violation|6|||
164391725|NCT00321854|593801912|FG001|Overall Study|Protocol Violation|5|||
164391726|NCT00321854|593801911|FG000|Overall Study|Lost to Follow-up|0|||
164391727|NCT00321854|593801912|FG001|Overall Study|Lost to Follow-up|2|||
164391728|NCT00321854|593801911|FG000|Overall Study|Withdrawal by Subject|6|||
164391729|NCT00321854|593801912|FG001|Overall Study|Withdrawal by Subject|17|||
164391730|NCT00321854|593801911|FG000|Overall Study|Other|1|||
164391731|NCT00321854|593801912|FG001|Overall Study|Other|1|||
164391732|NCT01816594|593801913|FG000|Overall Study|Local Progress|0|||
164391733|NCT01816594|593801914|FG001|Overall Study|Local Progress|2|||
164391734|NCT01816594|593801913|FG000|Overall Study|Adverse Event|9|||
164391735|NCT01816594|593801914|FG001|Overall Study|Adverse Event|0|||
164391736|NCT01816594|593801913|FG000|Overall Study|Withdrawal by Subject|1|||
164391737|NCT01816594|593801914|FG001|Overall Study|Withdrawal by Subject|0|||
164391738|NCT01816594|593801913|FG000|Overall Study|Physician Decision|1|||
164391739|NCT01816594|593801914|FG001|Overall Study|Physician Decision|0|||
164391740|NCT04723576|593801915|FG000|Overall Study|Withdrawal by Subject|2133|||
164391741|NCT04723576|593801916|FG001|Overall Study|Withdrawal by Subject|3234|||
164391742|NCT03905655|593801917|FG000|Overall Study|Adverse Event|1|||
164391743|NCT03905655|593801918|FG001|Overall Study|Adverse Event|0|||
164391744|NCT03905655|593801919|FG002|Overall Study|Adverse Event|1|||
164391745|NCT03905655|593801920|FG003|Overall Study|Adverse Event|1|||
164703914|NCT02504671|594941828|FG002|Overall Study|Withdrawal by Subject|4|||
164391746|NCT03204279|593801924|FG000|Overall Study|Withdrawal by Subject|0|||
164391747|NCT03204279|593801925|FG001|Overall Study|Withdrawal by Subject|1|||
164391748|NCT01064739|593801926|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
164391749|NCT04827212|593801927|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
164391750|NCT04827212|593801928|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
164391751|NCT04827212|593801927|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
164391752|NCT04827212|593801928|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
164391753|NCT00454051|593801929|FG000|Overall Study|Adverse Event|1|||
164441470|NCT02696707|593984398|FG000|Per Protocol Population|Participant Decision|0|||
164391754|NCT00454051|593801930|FG001|Overall Study|Adverse Event|2|||
164391755|NCT00454051|593801929|FG000|Overall Study|Withdrawal by Subject|1|||
164391756|NCT00454051|593801930|FG001|Overall Study|Withdrawal by Subject|0|||
164391757|NCT00454051|593801929|FG000|Overall Study|Protocol Violation|1|||
164391758|NCT00454051|593801930|FG001|Overall Study|Protocol Violation|1|||
164391759|NCT04258020|593801931|FG000|Overall Study|Withdrawal by Subject|1|||
164391760|NCT04258020|593801932|FG001|Overall Study|Withdrawal by Subject|0|||
164391761|NCT02097472|593801935|FG000|Received Vaccination 2|Adverse Event|0|||
164391762|NCT02097472|593801936|FG001|Received Vaccination 2|Adverse Event|0|||
164391763|NCT02097472|593801937|FG002|Received Vaccination 2|Adverse Event|0|||
164391764|NCT02097472|593801938|FG003|Received Vaccination 2|Adverse Event|0|||
164391765|NCT02097472|593801939|FG004|Received Vaccination 2|Adverse Event|0|||
164391766|NCT02097472|593801940|FG005|Received Vaccination 2|Adverse Event|0|||
164391767|NCT02097472|593801941|FG006|Received Vaccination 2|Adverse Event|1|||
164391768|NCT02097472|593801942|FG007|Received Vaccination 2|Adverse Event|0|||
164391769|NCT01669629|593801943|FG000|Period 1|protocol deviation|1|||
164391770|NCT01669629|593801944|FG001|Period 1|protocol deviation|2|||
164391771|NCT04402866|593801947|FG000|Overall Study|Discontinued Prior to Treatment|0|||
164391772|NCT04402866|593801948|FG001|Overall Study|Discontinued Prior to Treatment|0|||
164391773|NCT04402866|593801949|FG002|Overall Study|Discontinued Prior to Treatment|0|||
164391774|NCT04402866|593801950|FG003|Overall Study|Discontinued Prior to Treatment|0|||
164391775|NCT04402866|593801951|FG004|Overall Study|Discontinued Prior to Treatment|2|||
164391776|NCT04402866|593801952|FG005|Overall Study|Discontinued Prior to Treatment|3|||
164391777|NCT04402866|593801947|FG000|Overall Study|Adverse Event|2|||
164391778|NCT04402866|593801948|FG001|Overall Study|Adverse Event|1|||
164391779|NCT04402866|593801949|FG002|Overall Study|Adverse Event|0|||
164391780|NCT04402866|593801950|FG003|Overall Study|Adverse Event|0|||
164391781|NCT04402866|593801951|FG004|Overall Study|Adverse Event|13|||
164391782|NCT04402866|593801952|FG005|Overall Study|Adverse Event|8|||
164391783|NCT04402866|593801947|FG000|Overall Study|Miscellaneous|0|||
164391784|NCT04402866|593801948|FG001|Overall Study|Miscellaneous|0|||
164391785|NCT04402866|593801949|FG002|Overall Study|Miscellaneous|1|||
164391786|NCT04402866|593801950|FG003|Overall Study|Miscellaneous|0|||
164391787|NCT04402866|593801951|FG004|Overall Study|Miscellaneous|0|||
164391788|NCT04402866|593801952|FG005|Overall Study|Miscellaneous|0|||
164391789|NCT04402866|593801947|FG000|Overall Study|Lost to Follow-up|0|||
164391790|NCT04402866|593801948|FG001|Overall Study|Lost to Follow-up|0|||
164391791|NCT04402866|593801949|FG002|Overall Study|Lost to Follow-up|0|||
164391792|NCT04402866|593801950|FG003|Overall Study|Lost to Follow-up|0|||
164391793|NCT04402866|593801951|FG004|Overall Study|Lost to Follow-up|0|||
164391794|NCT04402866|593801952|FG005|Overall Study|Lost to Follow-up|1|||
164391795|NCT04402866|593801947|FG000|Overall Study|Withdrawal by Subject|0|||
164391796|NCT04402866|593801948|FG001|Overall Study|Withdrawal by Subject|0|||
164391797|NCT04402866|593801949|FG002|Overall Study|Withdrawal by Subject|0|||
164391798|NCT04402866|593801950|FG003|Overall Study|Withdrawal by Subject|0|||
164391799|NCT04402866|593801951|FG004|Overall Study|Withdrawal by Subject|0|||
164391800|NCT04402866|593801952|FG005|Overall Study|Withdrawal by Subject|2|||
164391801|NCT01292928|593801953|FG000|Overall Study|Death|8|||
164391802|NCT01292928|593801953|FG000|Overall Study|Withdrawal by Subject|8|||
164391803|NCT01292928|593801953|FG000|Overall Study|Lost to Follow-up|6|||
164391804|NCT01292928|593801953|FG000|Overall Study|Physician Decision|2|||
164391805|NCT03927950|593801959|FG000|Overall Study|Adverse Event|9|||
164391806|NCT03263429|593801960|FG000|Overall Study|Withdrawal by Subject|0|||
164391807|NCT03263429|593801961|FG001|Overall Study|Withdrawal by Subject|1|||
164391808|NCT03263429|593801962|FG002|Overall Study|Withdrawal by Subject|0|||
164391809|NCT03263429|593801960|FG000|Overall Study|Follow-Up Period Completed|0|||
164391810|NCT03263429|593801961|FG001|Overall Study|Follow-Up Period Completed|2|||
164391811|NCT03263429|593801962|FG002|Overall Study|Follow-Up Period Completed|0|||
164391812|NCT03263429|593801960|FG000|Overall Study|Death|3|||
164391813|NCT03263429|593801961|FG001|Overall Study|Death|5|||
164391814|NCT03263429|593801962|FG002|Overall Study|Death|16|||
164391815|NCT03263429|593801960|FG000|Overall Study|Participant unable to return|0|||
164391816|NCT03263429|593801961|FG001|Overall Study|Participant unable to return|0|||
164391817|NCT03263429|593801962|FG002|Overall Study|Participant unable to return|1|||
164391818|NCT03263429|593801960|FG000|Overall Study|Study Closed|0|||
164391819|NCT03263429|593801961|FG001|Overall Study|Study Closed|0|||
164391820|NCT03263429|593801962|FG002|Overall Study|Study Closed|1|||
164391821|NCT04530448|593801963|FG000|Overall Study|Physician Decision|3|||
164391822|NCT04530448|593801964|FG001|Overall Study|Physician Decision|0|||
164391823|NCT01519206|593801965|FG000|Overall Study|Lost to Follow-up|3|||
164391824|NCT01519206|593801965|FG000|Overall Study|Missed Visit|2|||
164391825|NCT02014116|593801966|FG000|Overall Study|Progressive Disease|3|||
164391826|NCT02014116|593801967|FG001|Overall Study|Progressive Disease|4|||
164391827|NCT02014116|593801968|FG002|Overall Study|Progressive Disease|2|||
164391828|NCT02014116|593801969|FG003|Overall Study|Progressive Disease|6|||
164391829|NCT02014116|593801970|FG004|Overall Study|Progressive Disease|1|||
164391830|NCT02014116|593801971|FG005|Overall Study|Progressive Disease|13|||
164391831|NCT02014116|593801972|FG006|Overall Study|Progressive Disease|1|||
164391832|NCT02014116|593801973|FG007|Overall Study|Progressive Disease|3|||
164391833|NCT02014116|593801974|FG008|Overall Study|Progressive Disease|7|||
164391834|NCT02014116|593801966|FG000|Overall Study|Adverse Event|0|||
164391835|NCT02014116|593801967|FG001|Overall Study|Adverse Event|0|||
164391836|NCT02014116|593801968|FG002|Overall Study|Adverse Event|0|||
164391837|NCT02014116|593801969|FG003|Overall Study|Adverse Event|0|||
164391838|NCT02014116|593801970|FG004|Overall Study|Adverse Event|1|||
164391839|NCT02014116|593801971|FG005|Overall Study|Adverse Event|0|||
164391840|NCT02014116|593801972|FG006|Overall Study|Adverse Event|0|||
164391841|NCT02014116|593801973|FG007|Overall Study|Adverse Event|1|||
164391842|NCT02014116|593801974|FG008|Overall Study|Adverse Event|0|||
164391843|NCT02014116|593801966|FG000|Overall Study|Lost to Follow-up|0|||
164391844|NCT02014116|593801967|FG001|Overall Study|Lost to Follow-up|0|||
164391845|NCT02014116|593801968|FG002|Overall Study|Lost to Follow-up|0|||
164391846|NCT02014116|593801969|FG003|Overall Study|Lost to Follow-up|0|||
164391847|NCT02014116|593801970|FG004|Overall Study|Lost to Follow-up|0|||
164391848|NCT02014116|593801971|FG005|Overall Study|Lost to Follow-up|1|||
164391849|NCT02014116|593801972|FG006|Overall Study|Lost to Follow-up|0|||
164391850|NCT02014116|593801973|FG007|Overall Study|Lost to Follow-up|0|||
164391851|NCT02014116|593801974|FG008|Overall Study|Lost to Follow-up|1|||
164391852|NCT02014116|593801966|FG000|Overall Study|Death|0|||
164391853|NCT02014116|593801967|FG001|Overall Study|Death|0|||
164391854|NCT02014116|593801968|FG002|Overall Study|Death|0|||
164391855|NCT02014116|593801969|FG003|Overall Study|Death|0|||
164391856|NCT02014116|593801970|FG004|Overall Study|Death|0|||
164391857|NCT02014116|593801971|FG005|Overall Study|Death|0|||
164391858|NCT02014116|593801972|FG006|Overall Study|Death|0|||
164391859|NCT02014116|593801973|FG007|Overall Study|Death|1|||
164391860|NCT02014116|593801974|FG008|Overall Study|Death|1|||
164391861|NCT02014116|593801966|FG000|Overall Study|Withdrawal by Subject|0|||
164391862|NCT02014116|593801967|FG001|Overall Study|Withdrawal by Subject|0|||
164391863|NCT02014116|593801968|FG002|Overall Study|Withdrawal by Subject|1|||
164391864|NCT02014116|593801969|FG003|Overall Study|Withdrawal by Subject|1|||
164391865|NCT02014116|593801970|FG004|Overall Study|Withdrawal by Subject|0|||
164391866|NCT02014116|593801971|FG005|Overall Study|Withdrawal by Subject|1|||
164391867|NCT02014116|593801972|FG006|Overall Study|Withdrawal by Subject|0|||
164391868|NCT02014116|593801973|FG007|Overall Study|Withdrawal by Subject|0|||
164391869|NCT02014116|593801974|FG008|Overall Study|Withdrawal by Subject|0|||
164391870|NCT02014116|593801966|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
164391871|NCT02014116|593801967|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
164391872|NCT02014116|593801968|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
164391873|NCT02014116|593801969|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
164391874|NCT02014116|593801970|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
164391875|NCT02014116|593801971|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
164391876|NCT02014116|593801972|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
164391877|NCT02014116|593801973|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
164391878|NCT02014116|593801974|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
164391879|NCT02014116|593801966|FG000|Overall Study|Physician Decision|0|||
164391880|NCT02014116|593801967|FG001|Overall Study|Physician Decision|0|||
164391881|NCT02014116|593801968|FG002|Overall Study|Physician Decision|0|||
164391882|NCT02014116|593801969|FG003|Overall Study|Physician Decision|0|||
164391883|NCT02014116|593801970|FG004|Overall Study|Physician Decision|0|||
164391884|NCT02014116|593801971|FG005|Overall Study|Physician Decision|0|||
164391885|NCT02014116|593801972|FG006|Overall Study|Physician Decision|0|||
164391886|NCT02014116|593801973|FG007|Overall Study|Physician Decision|0|||
164391887|NCT02014116|593801974|FG008|Overall Study|Physician Decision|1|||
164391888|NCT01491854|593801975|FG000|Overall Study|mainly due to premature termination|93|||
164391889|NCT01491854|593801975|FG000|Overall Study|Death|1|||
164391890|NCT01491854|593801975|FG000|Overall Study|Withdrawal by Subject|3|||
164391891|NCT01491854|593801975|FG000|Overall Study|Lost to Follow-up|33|||
164391892|NCT05545072|593801984|FG000|Overall Study|Lost to Follow-up|1|||
164391893|NCT05545072|593801985|FG001|Overall Study|Lost to Follow-up|0|||
164391894|NCT05545072|593801984|FG000|Overall Study|Study ended prematurely due to funding|2|||
164391895|NCT05545072|593801985|FG001|Overall Study|Study ended prematurely due to funding|2|||
164391896|NCT02395042|593801986|FG000|Treatment 1 Period|Adverse Event|1|||
164391897|NCT02395042|593801987|FG001|Treatment 1 Period|Adverse Event|3|||
164391898|NCT02395042|593801988|FG002|Treatment 1 Period|Adverse Event|1|||
164391899|NCT02395042|593801986|FG000|Treatment 1 Period|Lack of Efficacy|1|||
164391900|NCT02395042|593801987|FG001|Treatment 1 Period|Lack of Efficacy|1|||
164391901|NCT02395042|593801988|FG002|Treatment 1 Period|Lack of Efficacy|0|||
164391902|NCT02395042|593801986|FG000|Treatment 1 Period|Lost to Follow-up|1|||
164391903|NCT02395042|593801987|FG001|Treatment 1 Period|Lost to Follow-up|0|||
164391904|NCT02395042|593801988|FG002|Treatment 1 Period|Lost to Follow-up|0|||
164391905|NCT02395042|593801986|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
164391906|NCT02395042|593801987|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
164391907|NCT02395042|593801988|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
164391908|NCT02395042|593801986|FG000|Treatment 2 Period|Lack of Efficacy|1|||
164391909|NCT02395042|593801987|FG001|Treatment 2 Period|Lack of Efficacy|1|||
164391910|NCT02395042|593801988|FG002|Treatment 2 Period|Lack of Efficacy|0|||
164391911|NCT03638141|593801989|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
164391912|NCT03996473|593801990|FG000|Treatment Assignment|Withdrawal by Subject|1|||
164391913|NCT03996473|593801990|FG000|Treatment Assignment|Progressive disease|6|||
164391914|NCT03996473|593801990|FG000|Treatment Assignment|Study drug never administered|1|||
164391915|NCT03996473|593801990|FG000|Active Follow-up|Death|1|||
164391916|NCT03996473|593801990|FG000|Long-term Follow-up|Death|5|||
164391917|NCT03759873|593801991|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
164391918|NCT03759873|593801992|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
164391919|NCT03759873|593801993|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
164391920|NCT03759873|593801994|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
164391921|NCT03759873|593801991|FG000|Overall Study|Moved outside eligible area|0|||
164391922|NCT03759873|593801992|FG001|Overall Study|Moved outside eligible area|2|||
164391923|NCT03759873|593801993|FG002|Overall Study|Moved outside eligible area|0|||
164391924|NCT03759873|593801994|FG003|Overall Study|Moved outside eligible area|0|||
164391925|NCT03759873|593801991|FG000|Overall Study|Withdrawal by Subject|0|||
164391926|NCT03759873|593801992|FG001|Overall Study|Withdrawal by Subject|0|||
164391927|NCT03759873|593801993|FG002|Overall Study|Withdrawal by Subject|1|||
164391928|NCT03759873|593801994|FG003|Overall Study|Withdrawal by Subject|0|||
164391929|NCT03579563|593801997|FG000|Overall Study|Lost to Follow-up|0|||
164391930|NCT03579563|593801998|FG001|Overall Study|Lost to Follow-up|0|||
164391931|NCT03579563|593801999|FG002|Overall Study|Lost to Follow-up|0|||
164391932|NCT03579563|593802000|FG003|Overall Study|Lost to Follow-up|0|||
164391933|NCT03579563|593802001|FG004|Overall Study|Lost to Follow-up|1|||
164391934|NCT03579563|593802002|FG005|Overall Study|Lost to Follow-up|0|||
164391935|NCT03579563|593801997|FG000|Overall Study|Lack of Efficacy|1|||
164391936|NCT03579563|593801998|FG001|Overall Study|Lack of Efficacy|1|||
164391937|NCT03579563|593801999|FG002|Overall Study|Lack of Efficacy|4|||
164391938|NCT03579563|593802000|FG003|Overall Study|Lack of Efficacy|1|||
164391939|NCT03579563|593802001|FG004|Overall Study|Lack of Efficacy|2|||
164391940|NCT03579563|593802002|FG005|Overall Study|Lack of Efficacy|3|||
164391941|NCT03579563|593801997|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
164391942|NCT03579563|593801998|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
164391943|NCT03579563|593801999|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
164391944|NCT03579563|593802000|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
164391945|NCT03579563|593802001|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
164391946|NCT03579563|593802002|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
164391947|NCT03579563|593801997|FG000|Overall Study|Time/distance concern|0|||
164391948|NCT03579563|593801998|FG001|Overall Study|Time/distance concern|0|||
164391949|NCT03579563|593801999|FG002|Overall Study|Time/distance concern|1|||
164391950|NCT03579563|593802000|FG003|Overall Study|Time/distance concern|0|||
164391951|NCT03579563|593802001|FG004|Overall Study|Time/distance concern|0|||
164391952|NCT03579563|593802002|FG005|Overall Study|Time/distance concern|1|||
164391953|NCT03579563|593801997|FG000|Overall Study|COVID shutdown|2|||
164391954|NCT03579563|593801998|FG001|Overall Study|COVID shutdown|3|||
164391955|NCT03579563|593801999|FG002|Overall Study|COVID shutdown|4|||
164391956|NCT03579563|593802000|FG003|Overall Study|COVID shutdown|3|||
164391957|NCT03579563|593802001|FG004|Overall Study|COVID shutdown|1|||
164391958|NCT03579563|593802002|FG005|Overall Study|COVID shutdown|2|||
164391959|NCT03579563|593801997|FG000|Overall Study|Protocol administration error|1|||
164391960|NCT03579563|593801998|FG001|Overall Study|Protocol administration error|0|||
164441471|NCT02696707|593984399|FG001|Per Protocol Population|Participant Decision|2|||
164441472|NCT02696707|593984398|FG000|Completed Study as Planned|Reason = LVEF|2|||
164441473|NCT02696707|593984399|FG001|Completed Study as Planned|Reason = LVEF|2|||
164441474|NCT02696707|593984398|FG000|Completed Study as Planned|Protocol Violation|2|||
164441475|NCT02696707|593984399|FG001|Completed Study as Planned|Protocol Violation|6|||
164703915|NCT02504671|594941829|FG003|Overall Study|Withdrawal by Subject|4|||
164703916|NCT02504671|594941830|FG004|Overall Study|Withdrawal by Subject|5|||
164703917|NCT02504671|594941831|FG005|Overall Study|Withdrawal by Subject|3|||
164703918|NCT02504671|594941826|FG000|Overall Study|Lack of Efficacy|1|||
164703919|NCT02504671|594941827|FG001|Overall Study|Lack of Efficacy|3|||
164391961|NCT03579563|593801999|FG002|Overall Study|Protocol administration error|1|||
164391962|NCT03579563|593802000|FG003|Overall Study|Protocol administration error|0|||
164391963|NCT03579563|593802001|FG004|Overall Study|Protocol administration error|1|||
164391964|NCT03579563|593802002|FG005|Overall Study|Protocol administration error|5|||
164391965|NCT03621696|593802003|FG000|Overall Study|Not eligible|0|||
164391966|NCT03621696|593802004|FG001|Overall Study|Not eligible|0|||
164391967|NCT03621696|593802005|FG002|Overall Study|Not eligible|0|||
164391968|NCT03621696|593802006|FG003|Overall Study|Not eligible|5|||
164391969|NCT03621696|593802003|FG000|Overall Study|Withdrawal by Subject|1|||
164391970|NCT03621696|593802004|FG001|Overall Study|Withdrawal by Subject|1|||
164391971|NCT03621696|593802005|FG002|Overall Study|Withdrawal by Subject|1|||
164391972|NCT03621696|593802006|FG003|Overall Study|Withdrawal by Subject|0|||
164391973|NCT03621696|593802003|FG000|Overall Study|Physician Decision|0|||
164391974|NCT03621696|593802004|FG001|Overall Study|Physician Decision|0|||
164391975|NCT03621696|593802005|FG002|Overall Study|Physician Decision|1|||
164391976|NCT03621696|593802006|FG003|Overall Study|Physician Decision|0|||
164391977|NCT01910519|593802007|FG000|Overall Study|Withdrawal by Subject|2|||
164391978|NCT01910519|593802008|FG001|Overall Study|Withdrawal by Subject|0|||
164391979|NCT01910519|593802007|FG000|Overall Study|Adverse Event|2|||
164391980|NCT01910519|593802008|FG001|Overall Study|Adverse Event|0|||
164391981|NCT02720484|593802011|FG000|Treatment on Study|Adverse Event|1|||
164391982|NCT02720484|593802011|FG000|Treatment on Study|Withdrawal by Subject|1|||
164391983|NCT02720484|593802011|FG000|Treatment on Study|Progressive Disease|4|||
164391984|NCT02720484|593802011|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
164391985|NCT02720484|593802011|FG000|Follow Up for 2 Years|Death|3|||
164391986|NCT02720484|593802011|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
164391987|NCT03832946|593802020|FG000|Overall Study|Adverse Event|3|||
164391988|NCT03832946|593802021|FG001|Overall Study|Adverse Event|1|||
164391989|NCT03832946|593802020|FG000|Overall Study|Lost to Follow-up|1|||
164391990|NCT03832946|593802021|FG001|Overall Study|Lost to Follow-up|0|||
164391991|NCT03832946|593802020|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
164391992|NCT03832946|593802021|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
164391993|NCT03832946|593802020|FG000|Overall Study|Lack of Efficacy|1|||
164391994|NCT03832946|593802021|FG001|Overall Study|Lack of Efficacy|0|||
164391995|NCT03832946|593802020|FG000|Overall Study|Withdrawal by Subject|12|||
164391996|NCT03832946|593802021|FG001|Overall Study|Withdrawal by Subject|9|||
164594429|NCT02935634|594539170|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
164594430|NCT02935634|594539171|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
164594431|NCT02935634|594539172|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
164391997|NCT01003249|593802024|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
164391998|NCT01003249|593802025|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
164391999|NCT01003249|593802024|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
164392000|NCT01003249|593802025|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
164392001|NCT01003249|593802024|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
164392002|NCT01003249|593802025|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
164392003|NCT01003249|593802024|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
164392004|NCT01003249|593802025|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
164392005|NCT02276482|593802028|FG000|Overall Study|Adverse Event|1|||
164392006|NCT02276482|593802029|FG001|Overall Study|Adverse Event|0|||
164392007|NCT02276482|593802028|FG000|Overall Study|Withdrawal by Subject|1|||
164392008|NCT02276482|593802029|FG001|Overall Study|Withdrawal by Subject|0|||
164392009|NCT02276482|593802028|FG000|Overall Study|Gram-negative infection|1|||
164392010|NCT02276482|593802029|FG001|Overall Study|Gram-negative infection|0|||
164392011|NCT02276482|593802028|FG000|Overall Study|Reason not specified|0|||
164392012|NCT02276482|593802029|FG001|Overall Study|Reason not specified|1|||
164392013|NCT02005471|593802036|FG000|Main Study|Adverse Event|0|||
164392014|NCT02005471|593802037|FG001|Main Study|Adverse Event|1|||
164594432|NCT02935634|594539173|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
164392015|NCT02005471|593802038|FG002|Main Study|Adverse Event|0|||
164392016|NCT02005471|593802039|FG003|Main Study|Adverse Event|0|||
164392017|NCT02005471|593802036|FG000|Main Study|Death|83|||
164392018|NCT02005471|593802037|FG001|Main Study|Death|52|||
164392019|NCT02005471|593802038|FG002|Main Study|Death|0|||
164392020|NCT02005471|593802039|FG003|Main Study|Death|0|||
164392021|NCT02005471|593802036|FG000|Main Study|Lost to Follow-up|4|||
164594433|NCT02935634|594539174|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
164392022|NCT02005471|593802037|FG001|Main Study|Lost to Follow-up|5|||
164392023|NCT02005471|593802038|FG002|Main Study|Lost to Follow-up|0|||
164392024|NCT02005471|593802039|FG003|Main Study|Lost to Follow-up|0|||
164392025|NCT02005471|593802036|FG000|Main Study|Physician Decision|3|||
164392026|NCT02005471|593802037|FG001|Main Study|Physician Decision|1|||
164594434|NCT02935634|594539175|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
164392027|NCT02005471|593802038|FG002|Main Study|Physician Decision|0|||
164392028|NCT02005471|593802039|FG003|Main Study|Physician Decision|0|||
164392029|NCT02005471|593802036|FG000|Main Study|Withdrawal by Subject|26|||
164392030|NCT02005471|593802037|FG001|Main Study|Withdrawal by Subject|11|||
164392031|NCT02005471|593802038|FG002|Main Study|Withdrawal by Subject|0|||
164392032|NCT02005471|593802039|FG003|Main Study|Withdrawal by Subject|0|||
164392033|NCT02005471|593802036|FG000|Main Study|Reason not Specified|0|||
164392034|NCT02005471|593802037|FG001|Main Study|Reason not Specified|6|||
164392035|NCT02005471|593802038|FG002|Main Study|Reason not Specified|0|||
164392036|NCT02005471|593802039|FG003|Main Study|Reason not Specified|0|||
164392037|NCT02005471|593802036|FG000|Main Study|Randomized but not Dosed|8|||
164392038|NCT02005471|593802037|FG001|Main Study|Randomized but not Dosed|0|||
164392039|NCT02005471|593802038|FG002|Main Study|Randomized but not Dosed|0|||
164392040|NCT02005471|593802039|FG003|Main Study|Randomized but not Dosed|0|||
164392041|NCT02005471|593802036|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
164392042|NCT02005471|593802037|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
164392043|NCT02005471|593802038|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
164392044|NCT02005471|593802039|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
164392045|NCT02005471|593802036|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
164392046|NCT02005471|593802037|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
164392047|NCT02005471|593802038|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
164392048|NCT02005471|593802039|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
164392049|NCT02005471|593802036|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
164392050|NCT02005471|593802037|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
164392051|NCT02005471|593802038|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
164392052|NCT02005471|593802039|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
164392053|NCT03712917|593802043|FG000|Overall Study|Pregnancy|0|||
164392054|NCT03712917|593802044|FG001|Overall Study|Pregnancy|0|||
164392055|NCT03712917|593802045|FG002|Overall Study|Pregnancy|1|||
164392056|NCT03712917|593802043|FG000|Overall Study|Adverse Event|0|||
164392057|NCT03712917|593802044|FG001|Overall Study|Adverse Event|4|||
164392058|NCT03712917|593802045|FG002|Overall Study|Adverse Event|3|||
164392059|NCT03712917|593802043|FG000|Overall Study|Lost to Follow-up|9|||
164392060|NCT03712917|593802044|FG001|Overall Study|Lost to Follow-up|4|||
164392061|NCT03712917|593802045|FG002|Overall Study|Lost to Follow-up|5|||
164392062|NCT00110617|593802046|FG000|Overall Study|Adverse Event|2|||
164392063|NCT00110617|593802047|FG001|Overall Study|Adverse Event|4|||
164392064|NCT00110617|593802046|FG000|Overall Study|Abnormal Laboratory Value|4|||
164392065|NCT00110617|593802047|FG001|Overall Study|Abnormal Laboratory Value|2|||
164392066|NCT00110617|593802046|FG000|Overall Study|Lack of Efficacy|1|||
164392067|NCT00110617|593802047|FG001|Overall Study|Lack of Efficacy|0|||
164392068|NCT00110617|593802046|FG000|Overall Study|Patient no longer requires study drug|1|||
164392069|NCT00110617|593802047|FG001|Overall Study|Patient no longer requires study drug|0|||
164392070|NCT00110617|593802046|FG000|Overall Study|Protocol Violation|5|||
164392071|NCT00110617|593802047|FG001|Overall Study|Protocol Violation|0|||
164392072|NCT00110617|593802046|FG000|Overall Study|Withdrawal by Subject|10|||
164392073|NCT00110617|593802047|FG001|Overall Study|Withdrawal by Subject|4|||
164392074|NCT00110617|593802046|FG000|Overall Study|Lost to Follow-up|9|||
164392075|NCT00110617|593802047|FG001|Overall Study|Lost to Follow-up|1|||
164392076|NCT00110617|593802046|FG000|Overall Study|Administrative problems|6|||
164392077|NCT00110617|593802047|FG001|Overall Study|Administrative problems|5|||
164392078|NCT00110617|593802046|FG000|Overall Study|Death|1|||
164392079|NCT00110617|593802047|FG001|Overall Study|Death|1|||
164703920|NCT02504671|594941828|FG002|Overall Study|Lack of Efficacy|1|||
164703921|NCT02504671|594941829|FG003|Overall Study|Lack of Efficacy|0|||
164703922|NCT02504671|594941830|FG004|Overall Study|Lack of Efficacy|4|||
164703923|NCT02504671|594941831|FG005|Overall Study|Lack of Efficacy|4|||
164703924|NCT02504671|594941826|FG000|Overall Study|Adverse Event|1|||
164703925|NCT02504671|594941827|FG001|Overall Study|Adverse Event|1|||
164703926|NCT02504671|594941828|FG002|Overall Study|Adverse Event|0|||
164703927|NCT02504671|594941829|FG003|Overall Study|Adverse Event|1|||
164392080|NCT00110617|593802046|FG000|Overall Study|Did not receive study drug|0|||
164392081|NCT00110617|593802047|FG001|Overall Study|Did not receive study drug|12|||
164392082|NCT03230916|593802049|FG000|Overall Study|Withdrawal by Subject|0|||
164392083|NCT03230916|593802050|FG001|Overall Study|Withdrawal by Subject|0|||
164392084|NCT03230916|593802051|FG002|Overall Study|Withdrawal by Subject|0|||
164392085|NCT03230916|593802052|FG003|Overall Study|Withdrawal by Subject|0|||
164392086|NCT03230916|593802053|FG004|Overall Study|Withdrawal by Subject|0|||
164392087|NCT03230916|593802054|FG005|Overall Study|Withdrawal by Subject|1|||
164703928|NCT02504671|594941830|FG004|Overall Study|Adverse Event|0|||
164703929|NCT02504671|594941831|FG005|Overall Study|Adverse Event|2|||
164392088|NCT03230916|593802055|FG006|Overall Study|Withdrawal by Subject|0|||
164392089|NCT03230916|593802056|FG007|Overall Study|Withdrawal by Subject|0|||
164392090|NCT03230916|593802057|FG008|Overall Study|Withdrawal by Subject|0|||
164392091|NCT03230916|593802058|FG009|Overall Study|Withdrawal by Subject|0|||
164392092|NCT03230916|593802059|FG010|Overall Study|Withdrawal by Subject|0|||
164392093|NCT01438541|593802060|FG000|Overall Study|Physician Decision|1|||
164392094|NCT01438541|593802060|FG000|Overall Study|Withdrawal by Subject|1|||
164703930|NCT02504671|594941826|FG000|Overall Study|Protocol Violation|2|||
164392095|NCT01438541|593802060|FG000|Overall Study|discharge from the hospital|5|||
164392096|NCT02091167|593802061|FG000|Overall Study|Lost to Follow-up|0|||
164392097|NCT02091167|593802062|FG001|Overall Study|Lost to Follow-up|2|||
164392098|NCT01559844|593804978|FG000|Overall Study|Consent Withdrawn|7|||
164703931|NCT02504671|594941827|FG001|Overall Study|Protocol Violation|1|||
164703932|NCT02504671|594941828|FG002|Overall Study|Protocol Violation|0|||
164703933|NCT02504671|594941829|FG003|Overall Study|Protocol Violation|0|||
164703934|NCT02504671|594941830|FG004|Overall Study|Protocol Violation|0|||
164703935|NCT02504671|594941831|FG005|Overall Study|Protocol Violation|1|||
164703936|NCT02504671|594941826|FG000|Overall Study|Lost to Follow-up|0|||
164703937|NCT02504671|594941827|FG001|Overall Study|Lost to Follow-up|0|||
164703938|NCT02504671|594941828|FG002|Overall Study|Lost to Follow-up|2|||
164703939|NCT02504671|594941829|FG003|Overall Study|Lost to Follow-up|0|||
164703940|NCT02504671|594941830|FG004|Overall Study|Lost to Follow-up|0|||
164703941|NCT02504671|594941831|FG005|Overall Study|Lost to Follow-up|1|||
164703942|NCT02504671|594941826|FG000|Overall Study|Protocol defined stopping criteria|7|||
164703943|NCT02504671|594941827|FG001|Overall Study|Protocol defined stopping criteria|4|||
164703944|NCT02504671|594941828|FG002|Overall Study|Protocol defined stopping criteria|3|||
164392099|NCT01559844|593804978|FG000|Overall Study|Death|5|||
164392100|NCT01559844|593804978|FG000|Overall Study|Efficacy Failure|10|||
164392101|NCT01559844|593804978|FG000|Overall Study|No Longer A Transplant Candidate|3|||
164392102|NCT02181803|593804979|FG000|Overall Study|Withdrawal by Subject|0|||
164392103|NCT02181803|593804980|FG001|Overall Study|Withdrawal by Subject|2|||
164392104|NCT02181803|593804981|FG002|Overall Study|Withdrawal by Subject|0|||
164392105|NCT02181803|593804982|FG003|Overall Study|Withdrawal by Subject|0|||
164392106|NCT02181803|593804983|FG004|Overall Study|Withdrawal by Subject|0|||
164392107|NCT02181803|593804984|FG005|Overall Study|Withdrawal by Subject|0|||
164392108|NCT02181803|593804985|FG006|Overall Study|Withdrawal by Subject|0|||
164392109|NCT02181803|593804986|FG007|Overall Study|Withdrawal by Subject|0|||
164392110|NCT02181803|593804987|FG008|Overall Study|Withdrawal by Subject|0|||
164392111|NCT02181803|593804979|FG000|Overall Study|Physician Decision|0|||
164392112|NCT02181803|593804980|FG001|Overall Study|Physician Decision|0|||
164392113|NCT02181803|593804981|FG002|Overall Study|Physician Decision|0|||
164392114|NCT02181803|593804982|FG003|Overall Study|Physician Decision|1|||
164392115|NCT02181803|593804983|FG004|Overall Study|Physician Decision|0|||
164392116|NCT02181803|593804984|FG005|Overall Study|Physician Decision|0|||
164392117|NCT02181803|593804985|FG006|Overall Study|Physician Decision|0|||
164392118|NCT02181803|593804986|FG007|Overall Study|Physician Decision|1|||
164392119|NCT02181803|593804987|FG008|Overall Study|Physician Decision|0|||
164392120|NCT02181803|593804979|FG000|Overall Study|Adverse Event|0|||
164392121|NCT02181803|593804980|FG001|Overall Study|Adverse Event|2|||
164392122|NCT02181803|593804981|FG002|Overall Study|Adverse Event|0|||
164392123|NCT02181803|593804982|FG003|Overall Study|Adverse Event|1|||
164392124|NCT02181803|593804983|FG004|Overall Study|Adverse Event|0|||
164392125|NCT02181803|593804984|FG005|Overall Study|Adverse Event|0|||
164392126|NCT02181803|593804985|FG006|Overall Study|Adverse Event|1|||
164392127|NCT02181803|593804986|FG007|Overall Study|Adverse Event|0|||
164392128|NCT02181803|593804987|FG008|Overall Study|Adverse Event|0|||
164392129|NCT00951041|593804988|FG000|Overall Study|Withdrawal by Subject|1|||
164392130|NCT00951041|593804989|FG001|Overall Study|Withdrawal by Subject|1|||
164392131|NCT00951041|593804988|FG000|Overall Study|Lost to Follow-up|1|||
164392132|NCT00951041|593804989|FG001|Overall Study|Lost to Follow-up|0|||
164392133|NCT00951041|593804988|FG000|Overall Study|Other|3|||
164392134|NCT00951041|593804989|FG001|Overall Study|Other|0|||
164392135|NCT02388724|593804993|FG000|Overall Study|Reason not Specified|0|||
164392136|NCT02388724|593804994|FG001|Overall Study|Reason not Specified|1|||
164392137|NCT02388724|593804993|FG000|Overall Study|Major Protocol Deviation|3|||
164392138|NCT02388724|593804994|FG001|Overall Study|Major Protocol Deviation|3|||
164441476|NCT02696707|593984398|FG000|Completed Study as Planned|Metastatic disease|3|||
164441477|NCT02696707|593984399|FG001|Completed Study as Planned|Metastatic disease|0|||
164441478|NCT02696707|593984398|FG000|Completed Study as Planned|Location|1|||
164441479|NCT02696707|593984399|FG001|Completed Study as Planned|Location|1|||
164441480|NCT00071799|593984400|FG000|Overall Study|Adverse Event|19|||
164392139|NCT02388724|593804993|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
164441481|NCT00071799|593984401|FG001|Overall Study|Adverse Event|10|||
164392140|NCT02388724|593804994|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
164441482|NCT00071799|593984400|FG000|Overall Study|Protocol Violation|1|||
164441483|NCT00071799|593984401|FG001|Overall Study|Protocol Violation|7|||
164441484|NCT00071799|593984400|FG000|Overall Study|Lost to Follow-up|1|||
164441485|NCT00071799|593984401|FG001|Overall Study|Lost to Follow-up|1|||
164441486|NCT00071799|593984400|FG000|Overall Study|Withdrawal by Subject|15|||
164441487|NCT00071799|593984401|FG001|Overall Study|Withdrawal by Subject|37|||
164703945|NCT02504671|594941829|FG003|Overall Study|Protocol defined stopping criteria|5|||
164703946|NCT02504671|594941830|FG004|Overall Study|Protocol defined stopping criteria|3|||
164703947|NCT02504671|594941831|FG005|Overall Study|Protocol defined stopping criteria|3|||
164703948|NCT00210249|594941832|FG000|Overall Study|Lost to Follow-up|5|||
164703949|NCT00210249|594941832|FG000|Overall Study|Protocol Violation|11|||
164392141|NCT02388724|593804993|FG000|Overall Study|Voluntary Withdrawal|6|||
164392142|NCT02388724|593804994|FG001|Overall Study|Voluntary Withdrawal|5|||
164392143|NCT02388724|593804993|FG000|Overall Study|Randomized but not Treated|0|||
164392144|NCT02388724|593804994|FG001|Overall Study|Randomized but not Treated|2|||
164703950|NCT03222583|594941833|FG000|Overall Study|Withdrawal by Subject|3|||
164392145|NCT04786444|593804995|FG000|Overall Study|Withdrawal by Subject|4|||
164392146|NCT04786444|593804996|FG001|Overall Study|Withdrawal by Subject|7|||
164392147|NCT04786444|593804997|FG002|Overall Study|Withdrawal by Subject|2|||
164392148|NCT04786444|593804995|FG000|Overall Study|Lost to Follow-up|11|||
164392149|NCT04786444|593804996|FG001|Overall Study|Lost to Follow-up|9|||
164392150|NCT04786444|593804997|FG002|Overall Study|Lost to Follow-up|10|||
164392151|NCT04786444|593804995|FG000|Overall Study|Subject would like to become pregnant|0|||
164392152|NCT04786444|593804996|FG001|Overall Study|Subject would like to become pregnant|1|||
164392153|NCT04786444|593804997|FG002|Overall Study|Subject would like to become pregnant|0|||
164392154|NCT03166618|593804998|FG000|Overall Study|Study was Terminated|0|||
164392155|NCT03166618|593804999|FG001|Overall Study|Study was Terminated|1|||
164392156|NCT03137303|593805001|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
164392157|NCT03137303|593805002|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
164392158|NCT03137303|593805001|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
164392159|NCT03137303|593805002|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
164392160|NCT03137303|593805001|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
164392161|NCT03137303|593805002|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
164392162|NCT03137303|593805001|FG000|T3: 9-month Follow-up|Death|1|||
164392163|NCT03137303|593805002|FG001|T3: 9-month Follow-up|Death|0|||
164392164|NCT03137303|593805001|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
164392165|NCT03137303|593805002|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
164392166|NCT03137303|593805001|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
164392167|NCT03137303|593805002|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
164392168|NCT03137303|593805001|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
164392169|NCT03137303|593805002|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
164392170|NCT01217073|593805003|FG000|Base Period|Adverse Event|1|||
164392171|NCT01217073|593805004|FG001|Base Period|Adverse Event|0|||
164392172|NCT01217073|593805005|FG002|Base Period|Adverse Event|1|||
164392173|NCT01217073|593805006|FG003|Base Period|Adverse Event|0|||
164392174|NCT01217073|593805007|FG004|Base Period|Adverse Event|4|||
164392175|NCT01217073|593805008|FG005|Base Period|Adverse Event|1|||
164392176|NCT01217073|593805009|FG006|Base Period|Adverse Event|0|||
164392177|NCT01217073|593805010|FG007|Base Period|Adverse Event|0|||
164392178|NCT01217073|593805003|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
164392179|NCT01217073|593805004|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
164392180|NCT01217073|593805005|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
164392181|NCT01217073|593805006|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
164392182|NCT01217073|593805007|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
164392183|NCT01217073|593805008|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
164392184|NCT01217073|593805009|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
164441488|NCT00071799|593984400|FG000|Overall Study|Physician Decision|0|||
164703951|NCT03222583|594941834|FG001|Overall Study|Withdrawal by Subject|3|||
164703952|NCT03222583|594941833|FG000|Overall Study|Lost to Follow-up|1|||
164703953|NCT03222583|594941834|FG001|Overall Study|Lost to Follow-up|0|||
164703954|NCT03222583|594941833|FG000|Overall Study|Other|1|||
164703955|NCT03222583|594941834|FG001|Overall Study|Other|3|||
164703956|NCT04280705|594941837|FG000|Overall Study|Enrolled but not treated|4|||
164703957|NCT04280705|594941838|FG001|Overall Study|Enrolled but not treated|10|||
164703958|NCT04280705|594941837|FG000|Overall Study|Physician Decision|1|||
164703959|NCT04280705|594941838|FG001|Overall Study|Physician Decision|0|||
164703960|NCT04280705|594941837|FG000|Overall Study|Withdrawal by Subject|7|||
164703961|NCT04280705|594941838|FG001|Overall Study|Withdrawal by Subject|9|||
164392185|NCT01217073|593805010|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
164392186|NCT01217073|593805003|FG000|Base Period|Excluded medication|0|||
164392187|NCT01217073|593805004|FG001|Base Period|Excluded medication|0|||
164392188|NCT01217073|593805005|FG002|Base Period|Excluded medication|0|||
164392189|NCT01217073|593805006|FG003|Base Period|Excluded medication|0|||
164392190|NCT01217073|593805007|FG004|Base Period|Excluded medication|1|||
164392191|NCT01217073|593805008|FG005|Base Period|Excluded medication|0|||
164392192|NCT01217073|593805009|FG006|Base Period|Excluded medication|0|||
164392193|NCT01217073|593805010|FG007|Base Period|Excluded medication|0|||
164392194|NCT01217073|593805003|FG000|Base Period|Lack of Efficacy|0|||
164392195|NCT01217073|593805004|FG001|Base Period|Lack of Efficacy|0|||
164392196|NCT01217073|593805005|FG002|Base Period|Lack of Efficacy|0|||
164392197|NCT01217073|593805006|FG003|Base Period|Lack of Efficacy|0|||
164392198|NCT01217073|593805007|FG004|Base Period|Lack of Efficacy|0|||
164392199|NCT01217073|593805008|FG005|Base Period|Lack of Efficacy|1|||
164392200|NCT01217073|593805009|FG006|Base Period|Lack of Efficacy|0|||
164392201|NCT01217073|593805010|FG007|Base Period|Lack of Efficacy|0|||
164392202|NCT01217073|593805003|FG000|Base Period|Lost to Follow-up|0|||
164392203|NCT01217073|593805004|FG001|Base Period|Lost to Follow-up|0|||
164703962|NCT04280705|594941837|FG000|Overall Study|Adverse Event|0|||
164703963|NCT04280705|594941838|FG001|Overall Study|Adverse Event|4|||
164703964|NCT04280705|594941837|FG000|Overall Study|Transferred to another hospital|1|||
164703965|NCT04280705|594941838|FG001|Overall Study|Transferred to another hospital|1|||
164392204|NCT01217073|593805005|FG002|Base Period|Lost to Follow-up|1|||
164392205|NCT01217073|593805006|FG003|Base Period|Lost to Follow-up|1|||
164392206|NCT01217073|593805007|FG004|Base Period|Lost to Follow-up|3|||
164392207|NCT01217073|593805008|FG005|Base Period|Lost to Follow-up|0|||
164392208|NCT01217073|593805009|FG006|Base Period|Lost to Follow-up|0|||
164392209|NCT01217073|593805010|FG007|Base Period|Lost to Follow-up|0|||
164392210|NCT01217073|593805003|FG000|Base Period|Physician Decision|0|||
164392211|NCT01217073|593805004|FG001|Base Period|Physician Decision|0|||
164392212|NCT01217073|593805005|FG002|Base Period|Physician Decision|0|||
164392213|NCT01217073|593805006|FG003|Base Period|Physician Decision|0|||
164392214|NCT01217073|593805007|FG004|Base Period|Physician Decision|1|||
164392215|NCT01217073|593805008|FG005|Base Period|Physician Decision|0|||
164392216|NCT01217073|593805009|FG006|Base Period|Physician Decision|0|||
164392217|NCT01217073|593805010|FG007|Base Period|Physician Decision|0|||
164392218|NCT01217073|593805003|FG000|Base Period|Protocol Violation|1|||
164392219|NCT01217073|593805004|FG001|Base Period|Protocol Violation|0|||
164392220|NCT01217073|593805005|FG002|Base Period|Protocol Violation|0|||
164392221|NCT01217073|593805006|FG003|Base Period|Protocol Violation|0|||
164392222|NCT01217073|593805007|FG004|Base Period|Protocol Violation|1|||
164392223|NCT01217073|593805008|FG005|Base Period|Protocol Violation|2|||
164392224|NCT01217073|593805009|FG006|Base Period|Protocol Violation|0|||
164392225|NCT01217073|593805010|FG007|Base Period|Protocol Violation|0|||
164392226|NCT01217073|593805003|FG000|Base Period|Withdrawal by Subject|4|||
164392227|NCT01217073|593805004|FG001|Base Period|Withdrawal by Subject|5|||
164392228|NCT01217073|593805005|FG002|Base Period|Withdrawal by Subject|5|||
164392229|NCT01217073|593805006|FG003|Base Period|Withdrawal by Subject|1|||
164392230|NCT01217073|593805007|FG004|Base Period|Withdrawal by Subject|5|||
164392231|NCT01217073|593805008|FG005|Base Period|Withdrawal by Subject|5|||
164392232|NCT01217073|593805009|FG006|Base Period|Withdrawal by Subject|0|||
164392233|NCT01217073|593805010|FG007|Base Period|Withdrawal by Subject|0|||
164392234|NCT01217073|593805003|FG000|Extension Period|Adverse Event|0|||
164392235|NCT01217073|593805004|FG001|Extension Period|Adverse Event|0|||
164392236|NCT01217073|593805005|FG002|Extension Period|Adverse Event|0|||
164392237|NCT01217073|593805006|FG003|Extension Period|Adverse Event|0|||
164392238|NCT01217073|593805007|FG004|Extension Period|Adverse Event|0|||
164392239|NCT01217073|593805008|FG005|Extension Period|Adverse Event|0|||
164392240|NCT01217073|593805009|FG006|Extension Period|Adverse Event|19|||
164392241|NCT01217073|593805010|FG007|Extension Period|Adverse Event|5|||
164392242|NCT01217073|593805003|FG000|Extension Period|ALT/AST|0|||
164392243|NCT01217073|593805004|FG001|Extension Period|ALT/AST|0|||
164392244|NCT01217073|593805005|FG002|Extension Period|ALT/AST|0|||
164392245|NCT01217073|593805006|FG003|Extension Period|ALT/AST|0|||
164392246|NCT01217073|593805007|FG004|Extension Period|ALT/AST|0|||
164392247|NCT01217073|593805008|FG005|Extension Period|ALT/AST|0|||
164392248|NCT01217073|593805009|FG006|Extension Period|ALT/AST|2|||
164392249|NCT01217073|593805010|FG007|Extension Period|ALT/AST|0|||
164392250|NCT01217073|593805003|FG000|Extension Period|Contraindication to study medication|0|||
164392251|NCT01217073|593805004|FG001|Extension Period|Contraindication to study medication|0|||
164392252|NCT01217073|593805005|FG002|Extension Period|Contraindication to study medication|0|||
164392253|NCT01217073|593805006|FG003|Extension Period|Contraindication to study medication|0|||
164392254|NCT01217073|593805007|FG004|Extension Period|Contraindication to study medication|0|||
164392255|NCT01217073|593805008|FG005|Extension Period|Contraindication to study medication|0|||
164392256|NCT01217073|593805009|FG006|Extension Period|Contraindication to study medication|1|||
164392257|NCT01217073|593805010|FG007|Extension Period|Contraindication to study medication|0|||
164392258|NCT01217073|593805003|FG000|Extension Period|Creatinine/eGFR|0|||
164392259|NCT01217073|593805004|FG001|Extension Period|Creatinine/eGFR|0|||
164703966|NCT01951885|594941839|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
164703967|NCT01951885|594941840|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
164703968|NCT01951885|594941839|FG000|Overall Study|Adverse Event|1|||
164703969|NCT01951885|594941840|FG001|Overall Study|Adverse Event|0|||
164392260|NCT01217073|593805005|FG002|Extension Period|Creatinine/eGFR|0|||
164392261|NCT01217073|593805006|FG003|Extension Period|Creatinine/eGFR|0|||
164392262|NCT01217073|593805007|FG004|Extension Period|Creatinine/eGFR|0|||
164392263|NCT01217073|593805008|FG005|Extension Period|Creatinine/eGFR|0|||
164703970|NCT01951885|594941839|FG000|Overall Study|Withdrawal by Subject|0|||
164392264|NCT01217073|593805009|FG006|Extension Period|Creatinine/eGFR|11|||
164392265|NCT01217073|593805010|FG007|Extension Period|Creatinine/eGFR|1|||
164392266|NCT01217073|593805003|FG000|Extension Period|Death|0|||
164392267|NCT01217073|593805004|FG001|Extension Period|Death|0|||
164392268|NCT01217073|593805005|FG002|Extension Period|Death|0|||
164392269|NCT01217073|593805006|FG003|Extension Period|Death|0|||
164392270|NCT01217073|593805007|FG004|Extension Period|Death|0|||
164392271|NCT01217073|593805008|FG005|Extension Period|Death|0|||
164392272|NCT01217073|593805009|FG006|Extension Period|Death|1|||
164392273|NCT01217073|593805010|FG007|Extension Period|Death|0|||
164392274|NCT01217073|593805003|FG000|Extension Period|Excluded medication|0|||
164392275|NCT01217073|593805004|FG001|Extension Period|Excluded medication|0|||
164703971|NCT01951885|594941840|FG001|Overall Study|Withdrawal by Subject|1|||
164392276|NCT01217073|593805005|FG002|Extension Period|Excluded medication|0|||
164594435|NCT02935634|594539170|FG000|Treatment: Track 2|Participant withdrew consent|0|||
164594436|NCT02935634|594539171|FG001|Treatment: Track 2|Participant withdrew consent|1|||
164594437|NCT02935634|594539172|FG002|Treatment: Track 2|Participant withdrew consent|1|||
164594438|NCT02935634|594539173|FG003|Treatment: Track 2|Participant withdrew consent|0|||
164594439|NCT02935634|594539174|FG004|Treatment: Track 2|Participant withdrew consent|1|||
164594440|NCT02935634|594539175|FG005|Treatment: Track 2|Participant withdrew consent|0|||
164594441|NCT06150573|594539178|FG000|Overall Study|Did not meet study criteria|1|||
164594442|NCT06150573|594539179|FG001|Overall Study|Did not meet study criteria|0|||
164594443|NCT06150573|594539178|FG000|Overall Study|Adverse Event|1|||
164594444|NCT06150573|594539179|FG001|Overall Study|Adverse Event|0|||
164594445|NCT06150573|594539178|FG000|Overall Study|Lost to Follow-up|0|||
164594446|NCT06150573|594539179|FG001|Overall Study|Lost to Follow-up|1|||
164594447|NCT06150573|594539178|FG000|Overall Study|Protocol Violation|0|||
164594448|NCT06150573|594539179|FG001|Overall Study|Protocol Violation|1|||
164594449|NCT06150573|594539178|FG000|Overall Study|Withdrawal by Subject|2|||
164594450|NCT06150573|594539179|FG001|Overall Study|Withdrawal by Subject|0|||
164594451|NCT00210158|594539180|FG000|Overall Study|Protocol Violation|0|||
164703972|NCT01951885|594941839|FG000|Overall Study|ineligible due to a change in donor|0|||
164392277|NCT01217073|593805006|FG003|Extension Period|Excluded medication|0|||
164392278|NCT01217073|593805007|FG004|Extension Period|Excluded medication|0|||
164392279|NCT01217073|593805008|FG005|Extension Period|Excluded medication|0|||
164392280|NCT01217073|593805009|FG006|Extension Period|Excluded medication|2|||
164392281|NCT01217073|593805010|FG007|Extension Period|Excluded medication|0|||
164392282|NCT01217073|593805003|FG000|Extension Period|Lack of Efficacy|0|||
164392283|NCT01217073|593805004|FG001|Extension Period|Lack of Efficacy|0|||
164392284|NCT01217073|593805005|FG002|Extension Period|Lack of Efficacy|0|||
164392285|NCT01217073|593805006|FG003|Extension Period|Lack of Efficacy|0|||
164392286|NCT01217073|593805007|FG004|Extension Period|Lack of Efficacy|0|||
164392287|NCT01217073|593805008|FG005|Extension Period|Lack of Efficacy|0|||
164392288|NCT01217073|593805009|FG006|Extension Period|Lack of Efficacy|3|||
164392289|NCT01217073|593805010|FG007|Extension Period|Lack of Efficacy|0|||
164392290|NCT01217073|593805003|FG000|Extension Period|Lost to Follow-up|0|||
164392291|NCT01217073|593805004|FG001|Extension Period|Lost to Follow-up|0|||
164392292|NCT01217073|593805005|FG002|Extension Period|Lost to Follow-up|0|||
164392293|NCT01217073|593805006|FG003|Extension Period|Lost to Follow-up|0|||
164392294|NCT01217073|593805007|FG004|Extension Period|Lost to Follow-up|0|||
164392295|NCT01217073|593805008|FG005|Extension Period|Lost to Follow-up|0|||
164392296|NCT01217073|593805009|FG006|Extension Period|Lost to Follow-up|9|||
164392297|NCT01217073|593805010|FG007|Extension Period|Lost to Follow-up|1|||
164392298|NCT01217073|593805003|FG000|Extension Period|Non-compliance with study drug|0|||
164392299|NCT01217073|593805004|FG001|Extension Period|Non-compliance with study drug|0|||
164392300|NCT01217073|593805005|FG002|Extension Period|Non-compliance with study drug|0|||
164392301|NCT01217073|593805006|FG003|Extension Period|Non-compliance with study drug|0|||
164392302|NCT01217073|593805007|FG004|Extension Period|Non-compliance with study drug|0|||
164392303|NCT01217073|593805008|FG005|Extension Period|Non-compliance with study drug|0|||
164392304|NCT01217073|593805009|FG006|Extension Period|Non-compliance with study drug|0|||
164392305|NCT01217073|593805010|FG007|Extension Period|Non-compliance with study drug|1|||
164392306|NCT01217073|593805003|FG000|Extension Period|Physician Decision|0|||
164392307|NCT01217073|593805004|FG001|Extension Period|Physician Decision|0|||
164392308|NCT01217073|593805005|FG002|Extension Period|Physician Decision|0|||
164392309|NCT01217073|593805006|FG003|Extension Period|Physician Decision|0|||
164392310|NCT01217073|593805007|FG004|Extension Period|Physician Decision|0|||
164392311|NCT01217073|593805008|FG005|Extension Period|Physician Decision|0|||
164392312|NCT01217073|593805009|FG006|Extension Period|Physician Decision|4|||
164441489|NCT00071799|593984401|FG001|Overall Study|Physician Decision|2|||
164594452|NCT00210158|594539181|FG001|Overall Study|Protocol Violation|2|||
164594453|NCT02284906|594539188|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
164594454|NCT02284906|594539189|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
164594455|NCT02284906|594539190|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
164703973|NCT01951885|594941840|FG001|Overall Study|ineligible due to a change in donor|1|||
164703974|NCT01951885|594941839|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
164703975|NCT01951885|594941840|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
164392313|NCT01217073|593805010|FG007|Extension Period|Physician Decision|1|||
164392314|NCT01217073|593805003|FG000|Extension Period|Protocol Violation|0|||
164392315|NCT01217073|593805004|FG001|Extension Period|Protocol Violation|0|||
164392316|NCT01217073|593805005|FG002|Extension Period|Protocol Violation|0|||
164392317|NCT01217073|593805006|FG003|Extension Period|Protocol Violation|0|||
164392318|NCT01217073|593805007|FG004|Extension Period|Protocol Violation|0|||
164392319|NCT01217073|593805008|FG005|Extension Period|Protocol Violation|0|||
164441490|NCT00071799|593984400|FG000|Overall Study|Lack of Efficacy|11|||
164594456|NCT02284906|594539188|FG000|Overall Study|Major Protocol Deviation|0|||
164594457|NCT02284906|594539189|FG001|Overall Study|Major Protocol Deviation|1|||
164594458|NCT02284906|594539190|FG002|Overall Study|Major Protocol Deviation|0|||
164594459|NCT02284906|594539188|FG000|Overall Study|Voluntary Withdrawal|2|||
164594460|NCT02284906|594539189|FG001|Overall Study|Voluntary Withdrawal|4|||
164392320|NCT01217073|593805009|FG006|Extension Period|Protocol Violation|2|||
164392321|NCT01217073|593805010|FG007|Extension Period|Protocol Violation|1|||
164392322|NCT01217073|593805003|FG000|Extension Period|Site discontinued study participation|0|||
164392323|NCT01217073|593805004|FG001|Extension Period|Site discontinued study participation|0|||
164392324|NCT01217073|593805005|FG002|Extension Period|Site discontinued study participation|0|||
164392325|NCT01217073|593805006|FG003|Extension Period|Site discontinued study participation|0|||
164392326|NCT01217073|593805007|FG004|Extension Period|Site discontinued study participation|0|||
164392327|NCT01217073|593805008|FG005|Extension Period|Site discontinued study participation|0|||
164392328|NCT01217073|593805009|FG006|Extension Period|Site discontinued study participation|7|||
164392329|NCT01217073|593805010|FG007|Extension Period|Site discontinued study participation|2|||
164392330|NCT01217073|593805003|FG000|Extension Period|Withdrawal by Subject|0|||
164392331|NCT01217073|593805004|FG001|Extension Period|Withdrawal by Subject|0|||
164392332|NCT01217073|593805005|FG002|Extension Period|Withdrawal by Subject|0|||
164392333|NCT01217073|593805006|FG003|Extension Period|Withdrawal by Subject|0|||
164392334|NCT01217073|593805007|FG004|Extension Period|Withdrawal by Subject|0|||
164392335|NCT01217073|593805008|FG005|Extension Period|Withdrawal by Subject|0|||
164392336|NCT01217073|593805009|FG006|Extension Period|Withdrawal by Subject|30|||
164392337|NCT01217073|593805010|FG007|Extension Period|Withdrawal by Subject|8|||
164392338|NCT03561090|593805011|FG000|Overall Study|Adverse Event|11|||
164392339|NCT03561090|593805012|FG001|Overall Study|Adverse Event|7|||
164392340|NCT03561090|593805011|FG000|Overall Study|Non-Compliance With Study Drug|2|||
164392341|NCT03561090|593805012|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164392342|NCT03561090|593805011|FG000|Overall Study|Protocol Violation|2|||
164392343|NCT03561090|593805012|FG001|Overall Study|Protocol Violation|2|||
164392344|NCT03561090|593805011|FG000|Overall Study|Withdrawal by Subject|7|||
164392345|NCT03561090|593805012|FG001|Overall Study|Withdrawal by Subject|7|||
164392346|NCT03561090|593805011|FG000|Overall Study|Lost to Follow-up|7|||
164392347|NCT03561090|593805012|FG001|Overall Study|Lost to Follow-up|2|||
164392348|NCT03561090|593805011|FG000|Overall Study|Study Terminated by Sponsor|10|||
164392349|NCT03561090|593805012|FG001|Overall Study|Study Terminated by Sponsor|15|||
164392350|NCT03561090|593805011|FG000|Overall Study|Randomized by Mistake|1|||
164392351|NCT03561090|593805012|FG001|Overall Study|Randomized by Mistake|1|||
164392352|NCT03561090|593805011|FG000|Overall Study|Other Not Specified|0|||
164392353|NCT03561090|593805012|FG001|Overall Study|Other Not Specified|2|||
164392354|NCT00725452|593805019|FG000|Overall Study|Adverse Event|3|||
164392355|NCT00725452|593805019|FG000|Overall Study|Lack of Efficacy|2|||
164392356|NCT00725452|593805019|FG000|Overall Study|Reason not specified|1|||
164392357|NCT00725452|593805019|FG000|Overall Study|Physician Decision|1|||
164392358|NCT00725452|593805019|FG000|Overall Study|Withdrawal by Subject|3|||
164392359|NCT00725452|593805019|FG000|Overall Study|Lost to Follow-up|1|||
164392360|NCT00713648|593805021|FG000|Overall Study|Adverse Event|1|||
164392361|NCT00713648|593805021|FG000|Overall Study|Unclassified|2|||
164392362|NCT00713648|593805021|FG000|Overall Study|According to Protocol|2|||
164392363|NCT00713648|593805021|FG000|Overall Study|Development of antibodies|3|||
164392364|NCT02047045|593805022|FG000|Baseline|Withdrawal by Subject|3|||
164392365|NCT02047045|593805023|FG001|Baseline|Withdrawal by Subject|2|||
164392366|NCT02047045|593805022|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
164392367|NCT02047045|593805023|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
164392368|NCT02047045|593805022|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
164392369|NCT02047045|593805023|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
164392370|NCT02047045|593805022|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
164703976|NCT01687478|594941841|FG000|Overall Study|Adverse Event|3|||
164703977|NCT01687478|594941842|FG001|Overall Study|Adverse Event|10|||
164703978|NCT01687478|594941841|FG000|Overall Study|Lost to Follow-up|1|||
164703979|NCT01687478|594941842|FG001|Overall Study|Lost to Follow-up|3|||
164703980|NCT01687478|594941841|FG000|Overall Study|Protocol Violation|0|||
164703981|NCT01687478|594941842|FG001|Overall Study|Protocol Violation|2|||
164703982|NCT01687478|594941841|FG000|Overall Study|Withdrawal by Subject|21|||
164392371|NCT02047045|593805023|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
164392372|NCT02047045|593805022|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
164392373|NCT02047045|593805023|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
164441491|NCT00071799|593984401|FG001|Overall Study|Lack of Efficacy|18|||
164441492|NCT00071799|593984400|FG000|Overall Study|Disease Progression|23|||
164703983|NCT01687478|594941842|FG001|Overall Study|Withdrawal by Subject|19|||
164392374|NCT02047045|593805022|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
164392375|NCT02047045|593805023|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
164392376|NCT02047045|593805022|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
164392377|NCT02047045|593805023|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
164392378|NCT02047045|593805022|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
164392379|NCT02047045|593805023|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
164392380|NCT02047045|593805022|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
164441493|NCT00071799|593984401|FG001|Overall Study|Disease Progression|20|||
164703984|NCT01687478|594941841|FG000|Overall Study|Physician Decision|1|||
164703985|NCT01687478|594941842|FG001|Overall Study|Physician Decision|3|||
164703986|NCT01687478|594941841|FG000|Overall Study|Entry Criteria Not Met|6|||
164594461|NCT02284906|594539190|FG002|Overall Study|Voluntary Withdrawal|5|||
164594462|NCT02284906|594539188|FG000|Overall Study|Study Termination|0|||
164594463|NCT02284906|594539189|FG001|Overall Study|Study Termination|11|||
164594464|NCT02284906|594539190|FG002|Overall Study|Study Termination|14|||
164392381|NCT02047045|593805023|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
164392382|NCT01343368|593805026|FG000|Overall Study|Death|1|||
164392383|NCT01343368|593805027|FG001|Overall Study|Death|0|||
164392384|NCT01343368|593805026|FG000|Overall Study|Lost to Follow-up|1|||
164392385|NCT01343368|593805027|FG001|Overall Study|Lost to Follow-up|0|||
164392386|NCT02277106|593805028|FG000|Stage 2|Adverse Event|0|||
164392387|NCT02277106|593805029|FG001|Stage 2|Adverse Event|0|||
164392388|NCT02277106|593805030|FG002|Stage 2|Adverse Event|1|||
164392389|NCT02479412|593805031|FG000|Overall Study|Adverse Event|0|||
164392390|NCT02479412|593805032|FG001|Overall Study|Adverse Event|0|||
164392391|NCT02479412|593805033|FG002|Overall Study|Adverse Event|1|||
164392392|NCT02479412|593805034|FG003|Overall Study|Adverse Event|0|||
164392393|NCT02479412|593805035|FG004|Overall Study|Adverse Event|0|||
164392394|NCT02479412|593805036|FG005|Overall Study|Adverse Event|0|||
164392395|NCT02479412|593805037|FG006|Overall Study|Adverse Event|0|||
164392396|NCT02479412|593805038|FG007|Overall Study|Adverse Event|0|||
164392397|NCT02479412|593805039|FG008|Overall Study|Adverse Event|0|||
164392398|NCT02479412|593805031|FG000|Overall Study|Study-specific withdrawal criteria|0|||
164392399|NCT02479412|593805032|FG001|Overall Study|Study-specific withdrawal criteria|0|||
164392400|NCT02479412|593805033|FG002|Overall Study|Study-specific withdrawal criteria|1|||
164392401|NCT02479412|593805034|FG003|Overall Study|Study-specific withdrawal criteria|1|||
164392402|NCT02479412|593805035|FG004|Overall Study|Study-specific withdrawal criteria|0|||
164392403|NCT02479412|593805036|FG005|Overall Study|Study-specific withdrawal criteria|0|||
164392404|NCT02479412|593805037|FG006|Overall Study|Study-specific withdrawal criteria|0|||
164392405|NCT02479412|593805038|FG007|Overall Study|Study-specific withdrawal criteria|1|||
164392406|NCT02479412|593805039|FG008|Overall Study|Study-specific withdrawal criteria|1|||
164392407|NCT02479412|593805031|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
164392408|NCT02479412|593805032|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
164392409|NCT02479412|593805033|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
164441494|NCT00071799|593984400|FG000|Overall Study|Different Central+Local Pathology Review|0|||
164441495|NCT00071799|593984401|FG001|Overall Study|Different Central+Local Pathology Review|1|||
164441496|NCT00071799|593984400|FG000|Overall Study|Not Documented|0|||
164441497|NCT00071799|593984401|FG001|Overall Study|Not Documented|2|||
164441498|NCT00814346|593984402|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
164441499|NCT00814346|593984403|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
164441500|NCT00814346|593984402|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
164441501|NCT00814346|593984403|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
164441502|NCT00814346|593984402|FG000|Open Phase (17 Months)|Adverse Event|5|||
164441503|NCT00814346|593984403|FG001|Open Phase (17 Months)|Adverse Event|0|||
164441504|NCT00814346|593984402|FG000|Open Phase (17 Months)|Consent|2|||
164441505|NCT00814346|593984403|FG001|Open Phase (17 Months)|Consent|0|||
164441506|NCT00814346|593984402|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
164441507|NCT00814346|593984403|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
164441508|NCT00814346|593984402|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
164441509|NCT00814346|593984403|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
164441510|NCT05764161|593984404|FG000|12-week DBVC Period|Lack of Efficacy|2|||
164441511|NCT05764161|593984405|FG001|12-week DBVC Period|Lack of Efficacy|1|||
164441512|NCT05764161|593984404|FG000|12-week DBVC Period|Lost to Follow-up|0|||
164441513|NCT05764161|593984405|FG001|12-week DBVC Period|Lost to Follow-up|2|||
164441514|NCT05764161|593984404|FG000|12-week DBVC Period|Protocol Violation|2|||
164441515|NCT05764161|593984405|FG001|12-week DBVC Period|Protocol Violation|4|||
164441516|NCT05764161|593984404|FG000|12-week DBVC Period|Withdrawal by Subject|7|||
164441517|NCT05764161|593984405|FG001|12-week DBVC Period|Withdrawal by Subject|6|||
164441518|NCT05764161|593984404|FG000|40-week OLE Period|Lack of Efficacy|0|||
164441519|NCT05764161|593984405|FG001|40-week OLE Period|Lack of Efficacy|1|||
164441520|NCT05764161|593984404|FG000|40-week OLE Period|Lost to Follow-up|1|||
164441521|NCT05764161|593984405|FG001|40-week OLE Period|Lost to Follow-up|4|||
164441522|NCT05764161|593984404|FG000|40-week OLE Period|Withdrawal by Subject|2|||
164441523|NCT05764161|593984405|FG001|40-week OLE Period|Withdrawal by Subject|7|||
164441524|NCT05764161|593984404|FG000|40-week OLE Period|Extended Travel|0|||
164441525|NCT05764161|593984405|FG001|40-week OLE Period|Extended Travel|1|||
164441526|NCT05764161|593984404|FG000|40-week OLE Period|Ongoing|66|||
164441527|NCT05764161|593984405|FG001|40-week OLE Period|Ongoing|59|||
164441528|NCT03034915|593984406|FG000|Overall Study|Adverse Event|29|||
164441529|NCT03034915|593984407|FG001|Overall Study|Adverse Event|32|||
164441530|NCT03034915|593984408|FG002|Overall Study|Adverse Event|22|||
164441531|NCT03034915|593984406|FG000|Overall Study|Lost to Follow-up|5|||
164441532|NCT03034915|593984407|FG001|Overall Study|Lost to Follow-up|13|||
164441533|NCT03034915|593984408|FG002|Overall Study|Lost to Follow-up|3|||
164441534|NCT03034915|593984406|FG000|Overall Study|Withdrawal by Subject|29|||
164441535|NCT03034915|593984407|FG001|Overall Study|Withdrawal by Subject|46|||
164441536|NCT03034915|593984408|FG002|Overall Study|Withdrawal by Subject|41|||
164594465|NCT02284906|594539188|FG000|Overall Study|Reason not Specified|1|||
164594466|NCT02284906|594539189|FG001|Overall Study|Reason not Specified|1|||
164594467|NCT02284906|594539190|FG002|Overall Study|Reason not Specified|0|||
164594468|NCT03885726|594539192|FG000|Overall Study|Staffing issues/lost interest|1|||
164594469|NCT03885726|594539192|FG000|Overall Study|Early discharge from hospital|3|||
164392410|NCT02479412|593805034|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
164392411|NCT02479412|593805035|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
164392412|NCT02479412|593805036|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
164392413|NCT02479412|593805037|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
164392414|NCT02479412|593805038|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
164392415|NCT02479412|593805039|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
164392416|NCT01571362|593805040|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
164392417|NCT01571362|593805041|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
164392418|NCT01571362|593805042|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
164392419|NCT01571362|593805040|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
164392420|NCT01571362|593805041|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
164392421|NCT01571362|593805042|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
164392422|NCT01571362|593805040|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
164392423|NCT01571362|593805041|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
164392424|NCT01571362|593805042|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
164392425|NCT01571362|593805040|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
164392426|NCT01571362|593805041|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
164392427|NCT01571362|593805042|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
164392428|NCT01571362|593805040|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
164392429|NCT01571362|593805041|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
164594470|NCT04096326|594539193|FG000|Overall Study|Withdrawal by Subject|0|||
164594471|NCT04096326|594539194|FG001|Overall Study|Withdrawal by Subject|0|||
164703987|NCT01687478|594941842|FG001|Overall Study|Entry Criteria Not Met|2|||
164703988|NCT03084367|594941843|FG000|Overall Study|Lost to Follow-up|32|||
164703989|NCT03084367|594941843|FG000|Overall Study|Withdrawal by Subject|4|||
164703990|NCT03084367|594941843|FG000|Overall Study|Other|1|||
164703991|NCT01206101|594941844|FG000|Overall Study|Adverse Event|1|||
164703992|NCT01206101|594941845|FG001|Overall Study|Adverse Event|0|||
164703993|NCT01206101|594941844|FG000|Overall Study|Physician Decision|0|||
164703994|NCT01206101|594941845|FG001|Overall Study|Physician Decision|1|||
164703995|NCT01206101|594941844|FG000|Overall Study|Unclassified|1|||
164703996|NCT01206101|594941845|FG001|Overall Study|Unclassified|0|||
164703997|NCT01462318|594941848|FG000|Main Study / TP-DI Study|Other|2|||
164703998|NCT01462318|594941849|FG001|Main Study / TP-DI Study|Other|0|||
164703999|NCT01462318|594941850|FG002|Main Study / TP-DI Study|Other|0|||
164704000|NCT01462318|594941848|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
164704001|NCT01462318|594941849|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
164704002|NCT01462318|594941850|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
164704003|NCT01462318|594941848|FG000|Main Study / TP-DI Study|Adverse Event|4|||
164704004|NCT01462318|594941849|FG001|Main Study / TP-DI Study|Adverse Event|0|||
164704005|NCT01462318|594941850|FG002|Main Study / TP-DI Study|Adverse Event|0|||
164704006|NCT01462318|594941848|FG000|Extension Phase|Lost to Follow-up|0|||
164704007|NCT01462318|594941849|FG001|Extension Phase|Lost to Follow-up|0|||
164704008|NCT01462318|594941850|FG002|Extension Phase|Lost to Follow-up|1|||
164704009|NCT01462318|594941848|FG000|Extension Phase|Other|0|||
164704010|NCT01462318|594941849|FG001|Extension Phase|Other|0|||
164704011|NCT01462318|594941850|FG002|Extension Phase|Other|1|||
164704012|NCT01462318|594941848|FG000|Extension Phase|Disease Progression|0|||
164704013|NCT01462318|594941849|FG001|Extension Phase|Disease Progression|0|||
164704014|NCT01462318|594941850|FG002|Extension Phase|Disease Progression|1|||
164704015|NCT01462318|594941848|FG000|Extension Phase|Withdrawal by Subject|0|||
164704016|NCT01462318|594941849|FG001|Extension Phase|Withdrawal by Subject|0|||
164704017|NCT01462318|594941850|FG002|Extension Phase|Withdrawal by Subject|15|||
164704018|NCT01462318|594941848|FG000|Extension Phase|Investigator Decision|0|||
164704019|NCT01462318|594941849|FG001|Extension Phase|Investigator Decision|0|||
164704020|NCT01462318|594941850|FG002|Extension Phase|Investigator Decision|5|||
164392430|NCT01571362|593805042|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
164594472|NCT04096326|594539195|FG002|Overall Study|Withdrawal by Subject|0|||
164594473|NCT04096326|594539196|FG003|Overall Study|Withdrawal by Subject|0|||
164704021|NCT01462318|594941848|FG000|Extension Phase|Adverse Event|0|||
164392431|NCT01571362|593805040|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
164594474|NCT04096326|594539197|FG004|Overall Study|Withdrawal by Subject|0|||
164704022|NCT01462318|594941849|FG001|Extension Phase|Adverse Event|0|||
164704023|NCT01462318|594941850|FG002|Extension Phase|Adverse Event|22|||
164704024|NCT01155024|594941854|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
164704025|NCT01155024|594941855|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
164392432|NCT01571362|593805041|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
164392433|NCT01571362|593805042|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
164392434|NCT01571362|593805040|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164392435|NCT01571362|593805041|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
164392436|NCT01571362|593805042|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
164392437|NCT01571362|593805040|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
164392438|NCT01571362|593805041|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
164392439|NCT01571362|593805042|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
164392440|NCT01571362|593805040|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164392441|NCT01571362|593805041|FG001|Double-Blind Treatment Period|Adverse Event|9|||
164392442|NCT01571362|593805042|FG002|Double-Blind Treatment Period|Adverse Event|14|||
164392443|NCT01571362|593805040|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
164392444|NCT01571362|593805041|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
164392445|NCT01571362|593805042|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
164392446|NCT01571362|593805040|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
164392447|NCT01571362|593805041|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
164392448|NCT01571362|593805042|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
164392449|NCT01571362|593805040|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
164392450|NCT01571362|593805041|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
164392451|NCT01571362|593805042|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
164392452|NCT03667053|593805043|FG000|Overall Study|Withdrawal by Subject|1|||
164392453|NCT03667053|593805044|FG001|Overall Study|Withdrawal by Subject|0|||
164392454|NCT03667053|593805045|FG002|Overall Study|Withdrawal by Subject|0|||
164392455|NCT00130533|593805047|FG000|Overall Study|Withdrawal by Subject|33|||
164392456|NCT00130533|593805048|FG001|Overall Study|Withdrawal by Subject|6|||
164392457|NCT00130533|593805047|FG000|Overall Study|Adverse Event|34|||
164392458|NCT00130533|593805048|FG001|Overall Study|Adverse Event|1|||
164441537|NCT03034915|593984406|FG000|Overall Study|Protocol Deviation|2|||
164441538|NCT03034915|593984407|FG001|Overall Study|Protocol Deviation|14|||
164441539|NCT03034915|593984408|FG002|Overall Study|Protocol Deviation|7|||
164441540|NCT03034915|593984406|FG000|Overall Study|Lack of Efficacy|8|||
164441541|NCT03034915|593984407|FG001|Overall Study|Lack of Efficacy|16|||
164441542|NCT03034915|593984408|FG002|Overall Study|Lack of Efficacy|18|||
164441543|NCT03034915|593984406|FG000|Overall Study|Site closed|2|||
164441544|NCT03034915|593984407|FG001|Overall Study|Site closed|2|||
164441545|NCT03034915|593984408|FG002|Overall Study|Site closed|4|||
164441546|NCT03034915|593984406|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
164441547|NCT03034915|593984407|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
164441548|NCT03034915|593984408|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
164441549|NCT03034915|593984406|FG000|Overall Study|Physician Decision|1|||
164441550|NCT03034915|593984407|FG001|Overall Study|Physician Decision|5|||
164441551|NCT03034915|593984408|FG002|Overall Study|Physician Decision|2|||
164441552|NCT00424762|593984409|FG000|Overall Study|Withdrawal by Subject|18|||
164441553|NCT00424762|593984410|FG001|Overall Study|Withdrawal by Subject|19|||
164441554|NCT00424762|593984409|FG000|Overall Study|Lost to Follow-up|2|||
164441555|NCT00424762|593984410|FG001|Overall Study|Lost to Follow-up|3|||
164441556|NCT00189202|593984411|FG000|Overall Study|Physician Decision|5|||
164441557|NCT02950558|593984415|FG000|Overall Study|Lost to Follow-up|2|||
164441558|NCT02950558|593984416|FG001|Overall Study|Lost to Follow-up|0|||
164441559|NCT01135511|593984421|FG000|Overall Study|Adverse Event|0|||
164441560|NCT01135511|593984422|FG001|Overall Study|Adverse Event|1|||
164441561|NCT01135511|593984423|FG002|Overall Study|Adverse Event|2|||
164441562|NCT01135511|593984424|FG003|Overall Study|Adverse Event|0|||
164441563|NCT01135511|593984425|FG004|Overall Study|Adverse Event|0|||
164441564|NCT01135511|593984426|FG005|Overall Study|Adverse Event|1|||
164441565|NCT01135511|593984427|FG006|Overall Study|Adverse Event|0|||
164441566|NCT01135511|593984428|FG007|Overall Study|Adverse Event|1|||
164441567|NCT01135511|593984429|FG008|Overall Study|Adverse Event|0|||
164594475|NCT04096326|594539198|FG005|Overall Study|Withdrawal by Subject|0|||
164594476|NCT04096326|594539199|FG006|Overall Study|Withdrawal by Subject|1|||
164392459|NCT00130533|593805047|FG000|Overall Study|Disease relapse|9|||
164392460|NCT00130533|593805048|FG001|Overall Study|Disease relapse|13|||
164392461|NCT00130533|593805047|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
164392462|NCT00130533|593805048|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
164392463|NCT00130533|593805047|FG000|Overall Study|Death|4|||
164441568|NCT01135511|593984421|FG000|Overall Study|Lack of Efficacy|0|||
164441569|NCT01135511|593984422|FG001|Overall Study|Lack of Efficacy|1|||
164441570|NCT01135511|593984423|FG002|Overall Study|Lack of Efficacy|1|||
164441571|NCT01135511|593984424|FG003|Overall Study|Lack of Efficacy|2|||
164441572|NCT01135511|593984425|FG004|Overall Study|Lack of Efficacy|0|||
164441573|NCT01135511|593984426|FG005|Overall Study|Lack of Efficacy|0|||
164594477|NCT04096326|594539200|FG007|Overall Study|Withdrawal by Subject|0|||
164594478|NCT04096326|594539201|FG008|Overall Study|Withdrawal by Subject|0|||
164441574|NCT01135511|593984427|FG006|Overall Study|Lack of Efficacy|0|||
164392464|NCT00130533|593805048|FG001|Overall Study|Death|2|||
164392465|NCT00130533|593805047|FG000|Overall Study|Protocol Violation|5|||
164392466|NCT00130533|593805048|FG001|Overall Study|Protocol Violation|1|||
164392467|NCT00130533|593805047|FG000|Overall Study|Lost to Follow-up|1|||
164392468|NCT00130533|593805048|FG001|Overall Study|Lost to Follow-up|1|||
164392469|NCT00130533|593805047|FG000|Overall Study|Sponsor´s decision|2|||
164392470|NCT00130533|593805048|FG001|Overall Study|Sponsor´s decision|0|||
164392471|NCT00130533|593805047|FG000|Overall Study|Second Primary Malignancy|0|||
164392472|NCT00130533|593805048|FG001|Overall Study|Second Primary Malignancy|1|||
164392473|NCT00130533|593805047|FG000|Overall Study|Other|12|||
164392474|NCT00130533|593805048|FG001|Overall Study|Other|5|||
164392475|NCT01059565|593805049|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
164392476|NCT01059565|593805050|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
164392477|NCT01059565|593805049|FG000|24-Week Randomized Phase|Adverse Event|5|||
164392478|NCT01059565|593805050|FG001|24-Week Randomized Phase|Adverse Event|0|||
164392479|NCT01059565|593805049|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
164392480|NCT01059565|593805050|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
164392481|NCT01059565|593805049|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
164392482|NCT01059565|593805050|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
164392483|NCT01059565|593805049|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
164392484|NCT01059565|593805050|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
164392485|NCT01059565|593805049|FG000|24-Week Open-Label Phase|Adverse Event|2|||
164392486|NCT01059565|593805050|FG001|24-Week Open-Label Phase|Adverse Event|0|||
164392487|NCT01059565|593805049|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
164392488|NCT01059565|593805050|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
164392489|NCT01059565|593805049|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
164392490|NCT01059565|593805050|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
164392491|NCT01059565|593805049|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
164392492|NCT01059565|593805050|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
164392493|NCT01059565|593805049|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
164392494|NCT01059565|593805050|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
164392495|NCT01059565|593805049|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
164392496|NCT01059565|593805050|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
164392497|NCT02732938|593805051|FG000|Overall Study|Death|0|||
164392498|NCT02732938|593805052|FG001|Overall Study|Death|11|||
164392499|NCT02732938|593805053|FG002|Overall Study|Death|0|||
164392500|NCT02732938|593805051|FG000|Overall Study|Randomized but did not receive treatment|0|||
164392501|NCT02732938|593805052|FG001|Overall Study|Randomized but did not receive treatment|1|||
164392502|NCT02732938|593805053|FG002|Overall Study|Randomized but did not receive treatment|0|||
164392503|NCT02732938|593805051|FG000|Overall Study|Refused further follow-up|1|||
164392504|NCT02732938|593805052|FG001|Overall Study|Refused further follow-up|0|||
164392505|NCT02732938|593805053|FG002|Overall Study|Refused further follow-up|0|||
164392506|NCT02732938|593805051|FG000|Overall Study|Study terminated by sponsor|3|||
164392507|NCT02732938|593805052|FG001|Overall Study|Study terminated by sponsor|6|||
164392508|NCT02732938|593805053|FG002|Overall Study|Study terminated by sponsor|0|||
164392509|NCT01026974|593805064|FG000|Overall Study|Withdrawal by Subject|0|||
164392510|NCT01026974|593805065|FG001|Overall Study|Withdrawal by Subject|1|||
164392511|NCT01026974|593805066|FG002|Overall Study|Withdrawal by Subject|7|||
164392512|NCT01026974|593805067|FG003|Overall Study|Withdrawal by Subject|2|||
164392513|NCT01026974|593805064|FG000|Overall Study|Lost to Follow-up|1|||
164392514|NCT01026974|593805065|FG001|Overall Study|Lost to Follow-up|1|||
164392515|NCT01026974|593805066|FG002|Overall Study|Lost to Follow-up|4|||
164392516|NCT01026974|593805067|FG003|Overall Study|Lost to Follow-up|0|||
164392517|NCT01026974|593805064|FG000|Overall Study|Adverse Event|0|||
164392518|NCT01026974|593805065|FG001|Overall Study|Adverse Event|0|||
164392519|NCT01026974|593805066|FG002|Overall Study|Adverse Event|0|||
164392520|NCT01026974|593805067|FG003|Overall Study|Adverse Event|1|||
164392521|NCT01026974|593805064|FG000|Overall Study|Inappropriate enrollment|0|||
164392522|NCT01026974|593805065|FG001|Overall Study|Inappropriate enrollment|0|||
164392523|NCT01026974|593805066|FG002|Overall Study|Inappropriate enrollment|1|||
164392524|NCT01026974|593805067|FG003|Overall Study|Inappropriate enrollment|0|||
164392525|NCT02864082|593805074|FG000|Overall Study|Adverse Event|1|||
164392526|NCT02864082|593805075|FG001|Overall Study|Adverse Event|1|||
164594479|NCT04096326|594539202|FG009|Overall Study|Withdrawal by Subject|0|||
164594480|NCT04096326|594539193|FG000|Overall Study|Lost to Follow-up|0|||
164392527|NCT02864082|593805074|FG000|Overall Study|Lost to Follow-up|0|||
164392528|NCT02864082|593805075|FG001|Overall Study|Lost to Follow-up|1|||
164392529|NCT02864082|593805074|FG000|Overall Study|Withdrawal by Subject|2|||
164392530|NCT02864082|593805075|FG001|Overall Study|Withdrawal by Subject|2|||
164392531|NCT04349553|593805076|FG000|Overall Study|Withdrawal by Subject|1|||
164392532|NCT04349553|593805077|FG001|Overall Study|Withdrawal by Subject|0|||
164392533|NCT04349553|593805078|FG002|Overall Study|Withdrawal by Subject|1|||
164392534|NCT04349553|593805079|FG003|Overall Study|Withdrawal by Subject|0|||
164594481|NCT04096326|594539194|FG001|Overall Study|Lost to Follow-up|1|||
164594482|NCT04096326|594539195|FG002|Overall Study|Lost to Follow-up|0|||
164594483|NCT04096326|594539196|FG003|Overall Study|Lost to Follow-up|0|||
164594484|NCT04096326|594539197|FG004|Overall Study|Lost to Follow-up|0|||
164594485|NCT04096326|594539198|FG005|Overall Study|Lost to Follow-up|0|||
164594486|NCT04096326|594539199|FG006|Overall Study|Lost to Follow-up|0|||
164392535|NCT01869491|593805082|FG000|Overall Study|Adverse Event|3|||
164392536|NCT01869491|593805083|FG001|Overall Study|Adverse Event|5|||
164392537|NCT01869491|593805082|FG000|Overall Study|Lack of Efficacy|0|||
164392538|NCT01869491|593805083|FG001|Overall Study|Lack of Efficacy|3|||
164392539|NCT01869491|593805082|FG000|Overall Study|Withdrawal by Subject|6|||
164392540|NCT01869491|593805083|FG001|Overall Study|Withdrawal by Subject|7|||
164392541|NCT01869491|593805082|FG000|Overall Study|Lost to Follow-up|11|||
164392542|NCT01869491|593805083|FG001|Overall Study|Lost to Follow-up|9|||
164392543|NCT01869491|593805082|FG000|Overall Study|No further need of investigational product|1|||
164392544|NCT01869491|593805083|FG001|Overall Study|No further need of investigational product|0|||
164392545|NCT05177770|593805084|FG000|Overall Study|Death|4|||
164392546|NCT05177770|593805084|FG000|Overall Study|Withdrawal by Subject|1|||
164392547|NCT05177770|593805084|FG000|Overall Study|Adverse Event prior to dosing|1|||
164392548|NCT00214136|593805088|FG000|Overall Study|Death|5|||
164392549|NCT01272934|593805089|FG000|Overall Study|Adverse Event|0|||
164392550|NCT01272934|593805090|FG001|Overall Study|Adverse Event|1|||
164392551|NCT01272934|593805089|FG000|Overall Study|Abnormal Laboratory Value|0|||
164392552|NCT01272934|593805090|FG001|Overall Study|Abnormal Laboratory Value|1|||
164392553|NCT04313634|593805091|FG000|Overall Study|Adverse Event|2|||
164392554|NCT04313634|593805092|FG001|Overall Study|Adverse Event|2|||
164392555|NCT04313634|593805093|FG002|Overall Study|Adverse Event|0|||
164392556|NCT04313634|593805091|FG000|Overall Study|Withdrawal by Subject|1|||
164392557|NCT04313634|593805092|FG001|Overall Study|Withdrawal by Subject|0|||
164392558|NCT04313634|593805093|FG002|Overall Study|Withdrawal by Subject|1|||
164392559|NCT04313634|593805091|FG000|Overall Study|Protocol Violation|0|||
164392560|NCT04313634|593805092|FG001|Overall Study|Protocol Violation|0|||
164392561|NCT04313634|593805093|FG002|Overall Study|Protocol Violation|1|||
164392562|NCT00319098|593805096|FG000|Overall Study|Serious adverse event|3|||
164392563|NCT00319098|593805097|FG001|Overall Study|Serious adverse event|0|||
164392564|NCT00319098|593805096|FG000|Overall Study|Adverse Event|20|||
164392565|NCT00319098|593805097|FG001|Overall Study|Adverse Event|1|||
164392566|NCT00319098|593805096|FG000|Overall Study|Withdrawal by Subject|37|||
164392567|NCT00319098|593805097|FG001|Overall Study|Withdrawal by Subject|8|||
164392568|NCT00319098|593805096|FG000|Overall Study|Migrated/moved from study area|2|||
164392569|NCT00319098|593805097|FG001|Overall Study|Migrated/moved from study area|1|||
164392570|NCT00319098|593805096|FG000|Overall Study|Lost to Follow-up|37|||
164392571|NCT00319098|593805097|FG001|Overall Study|Lost to Follow-up|13|||
164392572|NCT00319098|593805096|FG000|Overall Study|Others|33|||
164392573|NCT00319098|593805097|FG001|Overall Study|Others|8|||
164392574|NCT00319098|593805096|FG000|Overall Study|Protocol Violation|3|||
164392575|NCT00319098|593805097|FG001|Overall Study|Protocol Violation|1|||
164392576|NCT02105948|593805098|FG000|Overall Study|Adverse Event|10|||
164392577|NCT02105948|593805099|FG001|Overall Study|Adverse Event|7|||
164392578|NCT02105948|593805100|FG002|Overall Study|Adverse Event|11|||
164392579|NCT02105948|593805101|FG003|Overall Study|Adverse Event|11|||
164392580|NCT02105948|593805098|FG000|Overall Study|Lack of Efficacy|0|||
164392581|NCT02105948|593805099|FG001|Overall Study|Lack of Efficacy|1|||
164392582|NCT02105948|593805100|FG002|Overall Study|Lack of Efficacy|3|||
164392583|NCT02105948|593805101|FG003|Overall Study|Lack of Efficacy|2|||
164392584|NCT02105948|593805098|FG000|Overall Study|Lost to Follow-up|0|||
164392585|NCT02105948|593805099|FG001|Overall Study|Lost to Follow-up|0|||
164392586|NCT02105948|593805100|FG002|Overall Study|Lost to Follow-up|2|||
164392587|NCT02105948|593805101|FG003|Overall Study|Lost to Follow-up|1|||
164392588|NCT02105948|593805098|FG000|Overall Study|Physician Decision|2|||
164392589|NCT02105948|593805099|FG001|Overall Study|Physician Decision|2|||
164392590|NCT02105948|593805100|FG002|Overall Study|Physician Decision|2|||
164392591|NCT02105948|593805101|FG003|Overall Study|Physician Decision|2|||
164392592|NCT02105948|593805098|FG000|Overall Study|Withdrawal by Subject|15|||
164392593|NCT02105948|593805099|FG001|Overall Study|Withdrawal by Subject|10|||
164392594|NCT02105948|593805100|FG002|Overall Study|Withdrawal by Subject|10|||
164392595|NCT02105948|593805101|FG003|Overall Study|Withdrawal by Subject|11|||
164392596|NCT03595904|593805102|FG000|Overall Study|Protocol Violation|3|||
164392597|NCT03595904|593805103|FG001|Overall Study|Protocol Violation|1|||
164392598|NCT03595904|593805102|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
164441575|NCT01135511|593984428|FG007|Overall Study|Lack of Efficacy|0|||
164392599|NCT03595904|593805103|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
164392600|NCT03595904|593805102|FG000|Overall Study|Insurance complications|1|||
164392601|NCT03595904|593805103|FG001|Overall Study|Insurance complications|0|||
164392602|NCT03595904|593805102|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
164594487|NCT04096326|594539200|FG007|Overall Study|Lost to Follow-up|0|||
164594488|NCT04096326|594539201|FG008|Overall Study|Lost to Follow-up|0|||
164594489|NCT04096326|594539202|FG009|Overall Study|Lost to Follow-up|0|||
164392603|NCT03595904|593805103|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
164392604|NCT01358526|593805106|FG000|Open-label Titration Period|Adverse Event|95|||
164392605|NCT01358526|593805107|FG001|Open-label Titration Period|Adverse Event|0|||
164392606|NCT01358526|593805108|FG002|Open-label Titration Period|Adverse Event|0|||
164392607|NCT01358526|593805106|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
164392608|NCT01358526|593805107|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
164392609|NCT01358526|593805108|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
164392610|NCT01358526|593805106|FG000|Open-label Titration Period|Lost to Follow-up|25|||
164392611|NCT01358526|593805107|FG001|Open-label Titration Period|Lost to Follow-up|0|||
164392612|NCT01358526|593805108|FG002|Open-label Titration Period|Lost to Follow-up|0|||
164392613|NCT01358526|593805106|FG000|Open-label Titration Period|Lack of Efficacy|107|||
164392614|NCT01358526|593805107|FG001|Open-label Titration Period|Lack of Efficacy|0|||
164392615|NCT01358526|593805108|FG002|Open-label Titration Period|Lack of Efficacy|0|||
164392616|NCT01358526|593805106|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
164392617|NCT01358526|593805107|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
164392618|NCT01358526|593805108|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
164392619|NCT01358526|593805106|FG000|Open-label Titration Period|Administrative|8|||
164392620|NCT01358526|593805107|FG001|Open-label Titration Period|Administrative|0|||
164392621|NCT01358526|593805108|FG002|Open-label Titration Period|Administrative|0|||
164392622|NCT01358526|593805106|FG000|Open-label Titration Period|Did not qualify|178|||
164392623|NCT01358526|593805107|FG001|Open-label Titration Period|Did not qualify|0|||
164392624|NCT01358526|593805108|FG002|Open-label Titration Period|Did not qualify|0|||
164392625|NCT01358526|593805106|FG000|Double-blind Phase|Adverse Event|0|||
164392626|NCT01358526|593805107|FG001|Double-blind Phase|Adverse Event|24|||
164392627|NCT01358526|593805108|FG002|Double-blind Phase|Adverse Event|23|||
164392628|NCT01358526|593805106|FG000|Double-blind Phase|Withdrawal by Subject|0|||
164392629|NCT01358526|593805107|FG001|Double-blind Phase|Withdrawal by Subject|10|||
164392630|NCT01358526|593805108|FG002|Double-blind Phase|Withdrawal by Subject|8|||
164392631|NCT01358526|593805106|FG000|Double-blind Phase|Lost to Follow-up|0|||
164392632|NCT01358526|593805107|FG001|Double-blind Phase|Lost to Follow-up|4|||
164392633|NCT01358526|593805108|FG002|Double-blind Phase|Lost to Follow-up|1|||
164392634|NCT01358526|593805106|FG000|Double-blind Phase|Lack of Efficacy|0|||
164392635|NCT01358526|593805107|FG001|Double-blind Phase|Lack of Efficacy|31|||
164392636|NCT01358526|593805108|FG002|Double-blind Phase|Lack of Efficacy|73|||
164392637|NCT01358526|593805106|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
164392638|NCT01358526|593805107|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
164392639|NCT01358526|593805108|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
164392640|NCT01358526|593805106|FG000|Double-blind Phase|Administrative|0|||
164392641|NCT01358526|593805107|FG001|Double-blind Phase|Administrative|6|||
164392642|NCT01358526|593805108|FG002|Double-blind Phase|Administrative|10|||
164392643|NCT04558346|593805109|FG000|Overall Study|Withdrawal by Subject|2|||
164392644|NCT04558346|593805110|FG001|Overall Study|Withdrawal by Subject|0|||
164392645|NCT04558346|593805109|FG000|Overall Study|Lost to Follow-up|0|||
164392646|NCT04558346|593805110|FG001|Overall Study|Lost to Follow-up|1|||
164392647|NCT04558346|593805109|FG000|Overall Study|Adverse Event|0|||
164392648|NCT04558346|593805110|FG001|Overall Study|Adverse Event|1|||
164392649|NCT00724971|593805111|FG000|Overall Study|Adverse Event|5|||
164392650|NCT00724971|593805111|FG000|Overall Study|Withdrawal by Subject|1|||
164392651|NCT01962974|593805112|FG000|Overall Study|Study termination|7|||
164392652|NCT00627705|593805114|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
164392653|NCT00627705|593805115|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
164392654|NCT00627705|593805114|FG000|Overall Study|Adverse Event|1|||
164392655|NCT00627705|593805115|FG001|Overall Study|Adverse Event|0|||
164392656|NCT00627705|593805114|FG000|Overall Study|Withdrawal by Subject|0|||
164392657|NCT00627705|593805115|FG001|Overall Study|Withdrawal by Subject|2|||
164392658|NCT00627705|593805114|FG000|Overall Study|Lost to Follow-up|0|||
164392659|NCT00627705|593805115|FG001|Overall Study|Lost to Follow-up|1|||
164392660|NCT01410448|593805119|FG000|Overall Study|No conversion to everolimus|0|||
164392661|NCT01410448|593805120|FG001|Overall Study|No conversion to everolimus|24|||
164392662|NCT01410448|593805119|FG000|Overall Study|Graft loss|4|||
164392663|NCT01410448|593805120|FG001|Overall Study|Graft loss|1|||
164392664|NCT01410448|593805119|FG000|Overall Study|Administrative issues|2|||
164392665|NCT01410448|593805120|FG001|Overall Study|Administrative issues|1|||
164392666|NCT01410448|593805119|FG000|Overall Study|Lost to Follow-up|1|||
164392667|NCT01410448|593805120|FG001|Overall Study|Lost to Follow-up|0|||
164392668|NCT01410448|593805119|FG000|Overall Study|Withdrawal by Subject|3|||
164392669|NCT01410448|593805120|FG001|Overall Study|Withdrawal by Subject|2|||
164392670|NCT01410448|593805119|FG000|Overall Study|Protocol Violation|0|||
164392671|NCT01410448|593805120|FG001|Overall Study|Protocol Violation|4|||
164392672|NCT01410448|593805119|FG000|Overall Study|Death|2|||
164392673|NCT01410448|593805120|FG001|Overall Study|Death|3|||
164392674|NCT02535065|593805121|FG000|Overall Study|Death|13|||
164441576|NCT01135511|593984429|FG008|Overall Study|Lack of Efficacy|0|||
164441577|NCT01135511|593984421|FG000|Overall Study|Protocol Violation|0|||
164392675|NCT02535065|593805121|FG000|Overall Study|Lost to Follow-up|1|||
164392676|NCT02535065|593805121|FG000|Overall Study|Withdrawal by Subject|6|||
164392677|NCT04764396|593805122|FG000|Overall Study|Physician Decision|1|||
164392678|NCT04764396|593805123|FG001|Overall Study|Physician Decision|0|||
164392679|NCT01781572|593805125|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
164392680|NCT01781572|593805126|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
164392681|NCT01781572|593805127|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
164392682|NCT01781572|593805125|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
164392683|NCT01781572|593805126|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
164392684|NCT01781572|593805127|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
164392685|NCT01781572|593805125|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
164392686|NCT01781572|593805126|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
164392687|NCT01781572|593805127|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
164392688|NCT01781572|593805125|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
164392689|NCT01781572|593805126|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
164392690|NCT01781572|593805127|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
164392691|NCT01781572|593805125|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
164392692|NCT01781572|593805126|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
164392693|NCT01781572|593805127|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
164392694|NCT01781572|593805125|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
164392695|NCT01781572|593805126|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
164392696|NCT01781572|593805127|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
164392697|NCT01781572|593805125|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
164392698|NCT01781572|593805126|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
164392699|NCT01781572|593805127|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
164392700|NCT01781572|593805125|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
164392701|NCT01781572|593805126|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
164392702|NCT01781572|593805127|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
164392703|NCT01781572|593805125|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
164392704|NCT01781572|593805126|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
164392705|NCT01781572|593805127|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
164392706|NCT01781572|593805125|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
164392707|NCT01781572|593805126|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
164392708|NCT01781572|593805127|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
164392709|NCT01781572|593805125|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
164392710|NCT01781572|593805126|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
164392711|NCT01781572|593805127|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
164392712|NCT01781572|593805125|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
164392713|NCT01781572|593805126|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
164392714|NCT01781572|593805127|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
164392715|NCT01781572|593805125|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
164392716|NCT01781572|593805126|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
164392717|NCT01781572|593805127|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
164392718|NCT01781572|593805125|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
164392719|NCT01781572|593805126|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
164392720|NCT01781572|593805127|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
164392721|NCT01781572|593805125|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
164392722|NCT01781572|593805126|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
164392723|NCT01781572|593805127|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
164392724|NCT01781572|593805125|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
164392725|NCT01781572|593805126|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
164392726|NCT01781572|593805127|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
164392727|NCT01781572|593805125|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
164392728|NCT01781572|593805126|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
164392729|NCT01781572|593805127|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
164392730|NCT01781572|593805125|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
164392731|NCT01781572|593805126|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
164392732|NCT01781572|593805127|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
164392733|NCT01218438|593805128|FG000|Epoch 1|Physician Decision|2|||
164392734|NCT01218438|593805128|FG000|Epoch 1|Adverse Event|1|||
164392735|NCT01218438|593805128|FG000|Epoch 3|Withdrawal by Subject|3|||
164392736|NCT01218438|593805128|FG000|Epoch 3|Adverse Event|1|||
164392737|NCT01218438|593805128|FG000|Epoch 4|Physician Decision|1|||
164441578|NCT01135511|593984422|FG001|Overall Study|Protocol Violation|0|||
164441579|NCT01135511|593984423|FG002|Overall Study|Protocol Violation|3|||
164392738|NCT01218438|593805128|FG000|Epoch 4|Withdrawal by Subject|2|||
164392739|NCT03762473|593805130|FG000|Overall Study|Death|1|||
164392740|NCT03762473|593805131|FG001|Overall Study|Death|0|||
164392741|NCT00045110|593805133|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
164392742|NCT00045110|593805134|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
164441580|NCT01135511|593984424|FG003|Overall Study|Protocol Violation|0|||
164441581|NCT01135511|593984425|FG004|Overall Study|Protocol Violation|0|||
164441582|NCT01135511|593984426|FG005|Overall Study|Protocol Violation|0|||
164392743|NCT00045110|593805135|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
164392744|NCT00045110|593805133|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
164392745|NCT00045110|593805134|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
164392746|NCT00045110|593805135|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
164392747|NCT00045110|593805133|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
164392748|NCT00045110|593805134|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
164392749|NCT00045110|593805135|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
164392750|NCT01218646|593805138|FG000|Overall Study|Adverse Event|0|||
164392751|NCT01218646|593805139|FG001|Overall Study|Adverse Event|0|||
164392752|NCT01218646|593805140|FG002|Overall Study|Adverse Event|1|||
164392753|NCT01218646|593805141|FG003|Overall Study|Adverse Event|0|||
164392754|NCT01218646|593805138|FG000|Overall Study|Lost to Follow-up|1|||
164392755|NCT01218646|593805139|FG001|Overall Study|Lost to Follow-up|0|||
164392756|NCT01218646|593805140|FG002|Overall Study|Lost to Follow-up|0|||
164392757|NCT01218646|593805141|FG003|Overall Study|Lost to Follow-up|0|||
164392758|NCT01218646|593805138|FG000|Overall Study|Protocol Violation|0|||
164392759|NCT01218646|593805139|FG001|Overall Study|Protocol Violation|0|||
164392760|NCT01218646|593805140|FG002|Overall Study|Protocol Violation|1|||
164392761|NCT01218646|593805141|FG003|Overall Study|Protocol Violation|1|||
164392762|NCT00722761|593805142|FG000|Overall Study|Lost to Follow-up|1|||
164392763|NCT00722761|593805143|FG001|Overall Study|Lost to Follow-up|4|||
164392764|NCT00722761|593805142|FG000|Overall Study|Withdrawal by Subject|5|||
164392765|NCT00722761|593805143|FG001|Overall Study|Withdrawal by Subject|2|||
164392766|NCT02693665|593805148|FG000|Overall Study|Death|3|||
164392767|NCT02693665|593805149|FG001|Overall Study|Death|2|||
164392768|NCT02693665|593805148|FG000|Overall Study|Lost to Follow-up|7|||
164392769|NCT02693665|593805149|FG001|Overall Study|Lost to Follow-up|3|||
164392770|NCT02693665|593805148|FG000|Overall Study|Protocol Violation|1|||
164392771|NCT02693665|593805149|FG001|Overall Study|Protocol Violation|0|||
164392772|NCT02693665|593805148|FG000|Overall Study|Withdrawal by Subject|2|||
164392773|NCT02693665|593805149|FG001|Overall Study|Withdrawal by Subject|0|||
164392774|NCT02693665|593805148|FG000|Overall Study|patient wanted to leave it behind|1|||
164392775|NCT02693665|593805149|FG001|Overall Study|patient wanted to leave it behind|0|||
164392776|NCT02693665|593805148|FG000|Overall Study|anxiety|1|||
164392777|NCT02693665|593805149|FG001|Overall Study|anxiety|0|||
164392778|NCT02693665|593805148|FG000|Overall Study|family issues|1|||
164392779|NCT02693665|593805149|FG001|Overall Study|family issues|0|||
164392780|NCT02693665|593805148|FG000|Overall Study|no reason given|1|||
164392781|NCT02693665|593805149|FG001|Overall Study|no reason given|0|||
164392782|NCT03662750|593805150|FG000|Overall Study|Withdrawal by Subject|1|||
164392783|NCT03096782|593805151|FG000|Overall Study|Death|1|||
164392784|NCT03096782|593805151|FG000|Overall Study|Participant Relapsed|1|||
164392785|NCT02075593|593805152|FG000|Overall Study|Withdrawal by Subject|1|||
164392786|NCT03156023|593805153|FG000|Overall Study|Withdrawal by Subject|1|||
164392787|NCT03156023|593805154|FG001|Overall Study|Withdrawal by Subject|0|||
164392788|NCT03156023|593805155|FG002|Overall Study|Withdrawal by Subject|2|||
164392789|NCT03156023|593805156|FG003|Overall Study|Withdrawal by Subject|1|||
164392790|NCT03156023|593805157|FG004|Overall Study|Withdrawal by Subject|1|||
164392791|NCT03156023|593805153|FG000|Overall Study|Lost to Follow-up|0|||
164392792|NCT03156023|593805154|FG001|Overall Study|Lost to Follow-up|0|||
164392793|NCT03156023|593805155|FG002|Overall Study|Lost to Follow-up|0|||
164392794|NCT03156023|593805156|FG003|Overall Study|Lost to Follow-up|0|||
164392795|NCT03156023|593805157|FG004|Overall Study|Lost to Follow-up|1|||
164392796|NCT02010060|593805162|FG000|Overall Study|Lost to Follow-up|1|||
164392797|NCT02010060|593805163|FG001|Overall Study|Lost to Follow-up|2|||
164392798|NCT02010060|593805164|FG002|Overall Study|Lost to Follow-up|2|||
164392799|NCT02010060|593805162|FG000|Overall Study|Injury|0|||
164392800|NCT02010060|593805163|FG001|Overall Study|Injury|1|||
164392801|NCT02010060|593805164|FG002|Overall Study|Injury|0|||
164392802|NCT05819749|593805165|FG000|Overall Study|Lost to Follow-up|1|||
164392803|NCT00660010|593805166|FG000|Overall Study|Withdrawal by Subject|2|||
164392804|NCT00660010|593805166|FG000|Overall Study|Lost to Follow-up|3|||
164392805|NCT00660010|593805166|FG000|Overall Study|Adverse Event|1|||
164392806|NCT00660010|593805166|FG000|Overall Study|Noncompliance with visit schedule|3|||
164392807|NCT00726752|593805167|FG000|Overall Study|Lack of Efficacy|6|||
164392808|NCT00844857|593807089|FG000|Overall Study|Adverse Event|24|||
164392809|NCT00844857|593807090|FG001|Overall Study|Adverse Event|5|||
164392810|NCT00844857|593807089|FG000|Overall Study|Sponsor Decision|1|||
164392811|NCT00844857|593807090|FG001|Overall Study|Sponsor Decision|1|||
164392812|NCT00844857|593807089|FG000|Overall Study|Physician Decision|2|||
164392813|NCT00844857|593807090|FG001|Overall Study|Physician Decision|0|||
164392814|NCT00844857|593807089|FG000|Overall Study|Parent/Caregiver Decision|6|||
164392815|NCT00844857|593807090|FG001|Overall Study|Parent/Caregiver Decision|2|||
164392816|NCT00844857|593807089|FG000|Overall Study|Withdrawal by Subject|8|||
164392817|NCT00844857|593807090|FG001|Overall Study|Withdrawal by Subject|7|||
164392818|NCT00844857|593807089|FG000|Overall Study|Protocol Violation|6|||
164392819|NCT00844857|593807090|FG001|Overall Study|Protocol Violation|0|||
164392820|NCT00844857|593807089|FG000|Overall Study|Lack of Efficacy|5|||
164392821|NCT00844857|593807090|FG001|Overall Study|Lack of Efficacy|5|||
164392822|NCT00844857|593807089|FG000|Overall Study|Clinical Relapse|0|||
164392823|NCT00844857|593807090|FG001|Overall Study|Clinical Relapse|1|||
164392824|NCT00844857|593807089|FG000|Overall Study|Entry Criteria Not Met|0|||
164392825|NCT00844857|593807090|FG001|Overall Study|Entry Criteria Not Met|1|||
164392826|NCT00844857|593807089|FG000|Overall Study|Lost to Follow-up|2|||
164392827|NCT00844857|593807090|FG001|Overall Study|Lost to Follow-up|3|||
164392828|NCT00844857|593807089|FG000|Overall Study|Did Not Take Study Drug|3|||
164392829|NCT00844857|593807090|FG001|Overall Study|Did Not Take Study Drug|1|||
164392830|NCT00844857|593807089|FG000|Overall Study|Good Clinical Practice Violations|21|||
164392831|NCT00844857|593807090|FG001|Overall Study|Good Clinical Practice Violations|11|||
164392832|NCT00570674|593807091|FG000|Overall Study|Withdrawal by Subject|0|||
164392833|NCT00570674|593807092|FG001|Overall Study|Withdrawal by Subject|0|||
164392834|NCT00570674|593807093|FG002|Overall Study|Withdrawal by Subject|1|||
164392835|NCT00570674|593807094|FG003|Overall Study|Withdrawal by Subject|0|||
164392836|NCT00570674|593807095|FG004|Overall Study|Withdrawal by Subject|0|||
164392837|NCT00570674|593807096|FG005|Overall Study|Withdrawal by Subject|0|||
164392838|NCT00570674|593807097|FG006|Overall Study|Withdrawal by Subject|0|||
164392839|NCT03069482|593807098|FG000|Overall Study|Lost to Follow-up|0|||
164392840|NCT03069482|593807099|FG001|Overall Study|Lost to Follow-up|1|||
164392841|NCT03069482|593807098|FG000|Overall Study|Physician Decision|1|||
164392842|NCT03069482|593807099|FG001|Overall Study|Physician Decision|0|||
164392843|NCT00907153|593807108|FG000|Overall Study|Lost to Follow-up|1|||
164392844|NCT00907153|593807109|FG001|Overall Study|Lost to Follow-up|1|||
164392845|NCT00907153|593807108|FG000|Overall Study|Withdrawal by Subject|1|||
164392846|NCT00907153|593807109|FG001|Overall Study|Withdrawal by Subject|3|||
164392847|NCT02338154|593807116|FG000|Overall Study|Death|46|||
164392848|NCT02338154|593807116|FG000|Overall Study|Valve Implant Failure|17|||
164392849|NCT02338154|593807116|FG000|Overall Study|Valve Explant|11|||
164392850|NCT02338154|593807116|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
164392851|NCT02338154|593807116|FG000|Overall Study|Lost to Follow-up|8|||
164392852|NCT02338154|593807116|FG000|Overall Study|Other Reason|3|||
164392853|NCT02338154|593807116|FG000|Overall Study|Patients Without Exit Form|47|||
164392854|NCT02338154|593807116|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
164392855|NCT03393000|593807119|FG000|Overall Study|Death|11|||
164392856|NCT03393000|593807119|FG000|Overall Study|Withdrawal by Subject|2|||
164392857|NCT03393000|593807119|FG000|Overall Study|Physician Decision|1|||
164392858|NCT01773070|593807120|FG000|Overall Study|Withdrawal by Subject|24|||
164392859|NCT01773070|593807120|FG000|Overall Study|Lost to Follow-up|39|||
164392860|NCT01773070|593807120|FG000|Overall Study|Other|15|||
164392861|NCT01773070|593807120|FG000|Overall Study|Death (unrelated to study procedures)|3|||
164392862|NCT02696317|593807124|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
164392863|NCT02696317|593807125|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
164392864|NCT02696317|593807124|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
164392865|NCT02696317|593807125|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
164392866|NCT00237744|593807126|FG000|Overall Study|Withdrawal by Subject|3|||
164392867|NCT00237744|593807127|FG001|Overall Study|Withdrawal by Subject|1|||
164392868|NCT00237744|593807128|FG002|Overall Study|Withdrawal by Subject|0|||
164392869|NCT02566031|593807129|FG000|Overall Study|Patient/guardian decision|14|||
164392870|NCT02566031|593807130|FG001|Overall Study|Patient/guardian decision|7|||
164392871|NCT02566031|593807129|FG000|Overall Study|Protocol deviation|2|||
164392872|NCT02566031|593807130|FG001|Overall Study|Protocol deviation|3|||
164392873|NCT02566031|593807129|FG000|Overall Study|Adverse Event|3|||
164392874|NCT02566031|593807130|FG001|Overall Study|Adverse Event|1|||
164392875|NCT02566031|593807129|FG000|Overall Study|Lost to Follow-up|1|||
164392876|NCT02566031|593807130|FG001|Overall Study|Lost to Follow-up|1|||
164392877|NCT03031938|593807131|FG000|Overall Study|Death|1|||
164392878|NCT03031938|593807132|FG001|Overall Study|Death|0|||
164392879|NCT03117738|593807139|FG000|Overall Study|Withdrawal by Subject|3|||
164392880|NCT03117738|593807140|FG001|Overall Study|Withdrawal by Subject|1|||
164392881|NCT03117738|593807139|FG000|Overall Study|Lost to Follow-up|1|||
164392882|NCT03117738|593807140|FG001|Overall Study|Lost to Follow-up|4|||
164392883|NCT02015676|593807141|FG000|Overall Study|Adverse Event|2|||
164392884|NCT02015676|593807142|FG001|Overall Study|Adverse Event|18|||
164392885|NCT02015676|593807143|FG002|Overall Study|Adverse Event|0|||
164392886|NCT02015676|593807141|FG000|Overall Study|Lack of Efficacy|2|||
164392887|NCT02015676|593807142|FG001|Overall Study|Lack of Efficacy|4|||
164392888|NCT02015676|593807143|FG002|Overall Study|Lack of Efficacy|0|||
164392889|NCT02015676|593807141|FG000|Overall Study|Protocol Violation|1|||
164392890|NCT02015676|593807142|FG001|Overall Study|Protocol Violation|0|||
164392891|NCT02015676|593807143|FG002|Overall Study|Protocol Violation|0|||
164392892|NCT02015676|593807141|FG000|Overall Study|Withdrawal by Subject|1|||
164392893|NCT02015676|593807142|FG001|Overall Study|Withdrawal by Subject|7|||
164392894|NCT02015676|593807143|FG002|Overall Study|Withdrawal by Subject|1|||
164392895|NCT02015676|593807141|FG000|Overall Study|Administrative reasons|0|||
164392896|NCT02015676|593807142|FG001|Overall Study|Administrative reasons|3|||
164392897|NCT02015676|593807143|FG002|Overall Study|Administrative reasons|1|||
164392898|NCT02015676|593807141|FG000|Overall Study|Death|0|||
164392899|NCT02015676|593807142|FG001|Overall Study|Death|1|||
164392900|NCT02015676|593807143|FG002|Overall Study|Death|0|||
164392901|NCT02015676|593807141|FG000|Overall Study|Disease progression|3|||
164392902|NCT02015676|593807142|FG001|Overall Study|Disease progression|1|||
164392903|NCT02015676|593807143|FG002|Overall Study|Disease progression|1|||
164392904|NCT00476476|593807145|FG000|Overall Study|Adverse Event|2|||
164392905|NCT00476476|593807146|FG001|Overall Study|Adverse Event|7|||
164392906|NCT00476476|593807145|FG000|Overall Study|Progressive Disease|0|||
164392907|NCT00476476|593807146|FG001|Overall Study|Progressive Disease|17|||
164392908|NCT00971048|593807150|FG000|Overall Study|Protocol Violation|1|||
164392909|NCT00971048|593807151|FG001|Overall Study|Protocol Violation|2|||
164392910|NCT00971048|593807152|FG002|Overall Study|Protocol Violation|0|||
164392911|NCT00971048|593807153|FG003|Overall Study|Protocol Violation|1|||
164392912|NCT00971048|593807150|FG000|Overall Study|Adverse Event|0|||
164392913|NCT00971048|593807151|FG001|Overall Study|Adverse Event|0|||
164392914|NCT00971048|593807152|FG002|Overall Study|Adverse Event|1|||
164392915|NCT00971048|593807153|FG003|Overall Study|Adverse Event|0|||
164392916|NCT00971048|593807150|FG000|Overall Study|Physician Decision|0|||
164392917|NCT00971048|593807151|FG001|Overall Study|Physician Decision|0|||
164392918|NCT00971048|593807152|FG002|Overall Study|Physician Decision|0|||
164392919|NCT00971048|593807153|FG003|Overall Study|Physician Decision|1|||
164392920|NCT01715805|593807157|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
164392921|NCT01715805|593807158|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
164392922|NCT01715805|593807159|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
164392923|NCT01715805|593807160|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
164392924|NCT01715805|593807157|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
164392925|NCT01715805|593807158|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
164392926|NCT01715805|593807159|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
164392927|NCT01715805|593807160|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
164392928|NCT01715805|593807157|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
164392929|NCT01715805|593807158|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
164392930|NCT01715805|593807159|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
164392931|NCT01715805|593807160|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
164392932|NCT01715805|593807157|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
164392933|NCT01715805|593807158|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
164392934|NCT01715805|593807159|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
164392935|NCT01715805|593807160|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
164392936|NCT01715805|593807157|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
164392937|NCT01715805|593807158|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
164392938|NCT01715805|593807159|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
164392939|NCT01715805|593807160|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
164392940|NCT01715805|593807157|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
164392941|NCT01715805|593807158|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
164392942|NCT01715805|593807159|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
164392943|NCT01715805|593807160|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
164392944|NCT01715805|593807157|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
164392945|NCT01715805|593807158|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
164392946|NCT01715805|593807159|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
164392947|NCT01715805|593807160|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
164392948|NCT01715805|593807157|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
164392949|NCT01715805|593807158|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
164392950|NCT01715805|593807159|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
164392951|NCT01715805|593807160|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
164392952|NCT01715805|593807157|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
164392953|NCT01715805|593807158|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
164392954|NCT01715805|593807159|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
164392955|NCT01715805|593807160|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
164392956|NCT01715805|593807157|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
164392957|NCT01715805|593807158|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
164392958|NCT01715805|593807159|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
164392959|NCT01715805|593807160|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
164392960|NCT01715805|593807157|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
164392961|NCT01715805|593807158|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
164392962|NCT01715805|593807159|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
164392963|NCT01715805|593807160|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
164392964|NCT01715805|593807157|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
164392965|NCT01715805|593807158|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
164392966|NCT01715805|593807159|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
164392967|NCT01715805|593807160|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
164392968|NCT01715805|593807157|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
164441583|NCT01135511|593984427|FG006|Overall Study|Protocol Violation|0|||
164441584|NCT01135511|593984428|FG007|Overall Study|Protocol Violation|0|||
164441585|NCT01135511|593984429|FG008|Overall Study|Protocol Violation|0|||
164441586|NCT01135511|593984421|FG000|Overall Study|Pregnancy|0|||
164392969|NCT01715805|593807158|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
164392970|NCT01715805|593807159|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
164392971|NCT01715805|593807160|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
164392972|NCT01715805|593807157|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
164392973|NCT01715805|593807158|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
164392974|NCT01715805|593807159|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
164392975|NCT01715805|593807160|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
164392976|NCT02647359|593807163|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
164392977|NCT02647359|593807164|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
164392978|NCT02647359|593807163|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
164392979|NCT02647359|593807164|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
164392980|NCT02647359|593807163|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
164392981|NCT02647359|593807164|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
164392982|NCT02647359|593807163|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
164392983|NCT02647359|593807164|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
164392984|NCT02647359|593807163|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
164392985|NCT02647359|593807164|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
164392986|NCT02647359|593807163|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
164392987|NCT02647359|593807164|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
164392988|NCT00413413|593807165|FG000|Single-Blind|Adverse Event|0|||
164392989|NCT00413413|593807166|FG001|Single-Blind|Adverse Event|9|||
164392990|NCT00413413|593807167|FG002|Single-Blind|Adverse Event|0|||
164392991|NCT00413413|593807165|FG000|Single-Blind|Lack of Efficacy|0|||
164392992|NCT00413413|593807166|FG001|Single-Blind|Lack of Efficacy|5|||
164392993|NCT00413413|593807167|FG002|Single-Blind|Lack of Efficacy|0|||
164392994|NCT00413413|593807165|FG000|Single-Blind|Subject no longer requires study drug|0|||
164392995|NCT00413413|593807166|FG001|Single-Blind|Subject no longer requires study drug|151|||
164392996|NCT00413413|593807167|FG002|Single-Blind|Subject no longer requires study drug|0|||
164392997|NCT00413413|593807165|FG000|Single-Blind|Protocol Violation|0|||
164392998|NCT00413413|593807166|FG001|Single-Blind|Protocol Violation|16|||
164392999|NCT00413413|593807167|FG002|Single-Blind|Protocol Violation|0|||
164393000|NCT00413413|593807165|FG000|Single-Blind|Withdrawal by Subject|0|||
164393001|NCT00413413|593807166|FG001|Single-Blind|Withdrawal by Subject|27|||
164393002|NCT00413413|593807167|FG002|Single-Blind|Withdrawal by Subject|0|||
164393003|NCT00413413|593807165|FG000|Single-Blind|Lost to Follow-up|0|||
164393004|NCT00413413|593807166|FG001|Single-Blind|Lost to Follow-up|8|||
164393005|NCT00413413|593807167|FG002|Single-Blind|Lost to Follow-up|0|||
164393006|NCT00413413|593807165|FG000|Double-Blind|Adverse Event|6|||
164393007|NCT00413413|593807166|FG001|Double-Blind|Adverse Event|0|||
164393008|NCT00413413|593807167|FG002|Double-Blind|Adverse Event|5|||
164393009|NCT00413413|593807165|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
164393010|NCT00413413|593807166|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
164393011|NCT00413413|593807167|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
164393012|NCT00413413|593807165|FG000|Double-Blind|Protocol deviation|1|||
164393013|NCT00413413|593807166|FG001|Double-Blind|Protocol deviation|2|||
164441587|NCT01135511|593984422|FG001|Overall Study|Pregnancy|0|||
164594490|NCT04096326|594539193|FG000|Overall Study|COVID-19-related reasons|0|||
164393014|NCT00413413|593807167|FG002|Double-Blind|Protocol deviation|1|||
164393015|NCT00413413|593807165|FG000|Double-Blind|Subject withdrew consent|4|||
164393016|NCT00413413|593807166|FG001|Double-Blind|Subject withdrew consent|6|||
164393017|NCT00413413|593807167|FG002|Double-Blind|Subject withdrew consent|9|||
164393018|NCT00413413|593807165|FG000|Double-Blind|Lost to Follow-up|3|||
164393019|NCT00413413|593807166|FG001|Double-Blind|Lost to Follow-up|4|||
164393020|NCT00413413|593807167|FG002|Double-Blind|Lost to Follow-up|2|||
164393021|NCT02219932|593807174|FG000|Overall Study|Other|5|||
164393022|NCT02219932|593807175|FG001|Overall Study|Other|11|||
164393023|NCT02219932|593807174|FG000|Overall Study|Death|1|||
164393024|NCT02219932|593807175|FG001|Overall Study|Death|1|||
164393025|NCT02219932|593807174|FG000|Overall Study|Investigator Decision|0|||
164393026|NCT02219932|593807175|FG001|Overall Study|Investigator Decision|1|||
164594491|NCT04096326|594539194|FG001|Overall Study|COVID-19-related reasons|0|||
164393027|NCT02219932|593807174|FG000|Overall Study|Consent Withdrawn|11|||
164393028|NCT02219932|593807175|FG001|Overall Study|Consent Withdrawn|7|||
164393029|NCT02219932|593807174|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
164393030|NCT02219932|593807175|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
164393031|NCT02219932|593807174|FG000|Overall Study|Protocol Violation|10|||
164441588|NCT01135511|593984423|FG002|Overall Study|Pregnancy|0|||
164441589|NCT01135511|593984424|FG003|Overall Study|Pregnancy|1|||
164594492|NCT04096326|594539195|FG002|Overall Study|COVID-19-related reasons|0|||
164393032|NCT02219932|593807175|FG001|Overall Study|Protocol Violation|6|||
164393033|NCT02219932|593807174|FG000|Overall Study|Pregnancy|1|||
164393034|NCT02219932|593807175|FG001|Overall Study|Pregnancy|0|||
164393035|NCT02219932|593807174|FG000|Overall Study|Lost to Follow-up|4|||
164393036|NCT02219932|593807175|FG001|Overall Study|Lost to Follow-up|2|||
164393037|NCT02219932|593807174|FG000|Overall Study|Adverse Event|23|||
164393038|NCT02219932|593807175|FG001|Overall Study|Adverse Event|21|||
164393039|NCT00511004|593807178|FG000|Overall Study|Lost to Follow-up|0|||
164393040|NCT00511004|593807179|FG001|Overall Study|Lost to Follow-up|0|||
164393041|NCT00511004|593807180|FG002|Overall Study|Lost to Follow-up|4|||
164393042|NCT04642638|593807181|FG000|Overall Study|Withdrawal by Subject|23|||
164393043|NCT04642638|593807182|FG001|Overall Study|Withdrawal by Subject|29|||
164393044|NCT04642638|593807183|FG002|Overall Study|Withdrawal by Subject|9|||
164393045|NCT04642638|593807184|FG003|Overall Study|Withdrawal by Subject|7|||
164393046|NCT04642638|593807185|FG004|Overall Study|Withdrawal by Subject|61|||
164393047|NCT04642638|593807186|FG005|Overall Study|Withdrawal by Subject|27|||
164393048|NCT04642638|593807181|FG000|Overall Study|Lost to Follow-up|17|||
164393049|NCT04642638|593807182|FG001|Overall Study|Lost to Follow-up|18|||
164393050|NCT04642638|593807183|FG002|Overall Study|Lost to Follow-up|5|||
164393051|NCT04642638|593807184|FG003|Overall Study|Lost to Follow-up|5|||
164393052|NCT04642638|593807185|FG004|Overall Study|Lost to Follow-up|6|||
164393053|NCT04642638|593807186|FG005|Overall Study|Lost to Follow-up|3|||
164393054|NCT04642638|593807181|FG000|Overall Study|Adverse Event|0|||
164393055|NCT04642638|593807182|FG001|Overall Study|Adverse Event|0|||
164393056|NCT04642638|593807183|FG002|Overall Study|Adverse Event|1|||
164393057|NCT04642638|593807184|FG003|Overall Study|Adverse Event|0|||
164393058|NCT04642638|593807185|FG004|Overall Study|Adverse Event|10|||
164393059|NCT04642638|593807186|FG005|Overall Study|Adverse Event|3|||
164393060|NCT04642638|593807181|FG000|Overall Study|Reason Not Specified|1|||
164393061|NCT04642638|593807182|FG001|Overall Study|Reason Not Specified|4|||
164393062|NCT04642638|593807183|FG002|Overall Study|Reason Not Specified|0|||
164393063|NCT04642638|593807184|FG003|Overall Study|Reason Not Specified|0|||
164393064|NCT04642638|593807185|FG004|Overall Study|Reason Not Specified|38|||
164393065|NCT04642638|593807186|FG005|Overall Study|Reason Not Specified|16|||
164393066|NCT04642638|593807181|FG000|Overall Study|Physician Decision|0|||
164393067|NCT04642638|593807182|FG001|Overall Study|Physician Decision|0|||
164393068|NCT04642638|593807183|FG002|Overall Study|Physician Decision|0|||
164393069|NCT04642638|593807184|FG003|Overall Study|Physician Decision|0|||
164393070|NCT04642638|593807185|FG004|Overall Study|Physician Decision|2|||
164393071|NCT04642638|593807186|FG005|Overall Study|Physician Decision|1|||
164393072|NCT04642638|593807181|FG000|Overall Study|Protocol Deviation|0|||
164393073|NCT04642638|593807182|FG001|Overall Study|Protocol Deviation|0|||
164393074|NCT04642638|593807183|FG002|Overall Study|Protocol Deviation|0|||
164393075|NCT04642638|593807184|FG003|Overall Study|Protocol Deviation|0|||
164393076|NCT04642638|593807185|FG004|Overall Study|Protocol Deviation|1|||
164393077|NCT04642638|593807186|FG005|Overall Study|Protocol Deviation|3|||
164393078|NCT04642638|593807181|FG000|Overall Study|Study Terminated|0|||
164393079|NCT04642638|593807182|FG001|Overall Study|Study Terminated|0|||
164393080|NCT04642638|593807183|FG002|Overall Study|Study Terminated|0|||
164393081|NCT04642638|593807184|FG003|Overall Study|Study Terminated|0|||
164393082|NCT04642638|593807185|FG004|Overall Study|Study Terminated|484|||
164393083|NCT04642638|593807186|FG005|Overall Study|Study Terminated|250|||
164393084|NCT04642638|593807181|FG000|Overall Study|Pregnancy|0|||
164393085|NCT04642638|593807182|FG001|Overall Study|Pregnancy|0|||
164393086|NCT04642638|593807183|FG002|Overall Study|Pregnancy|0|||
164393087|NCT04642638|593807184|FG003|Overall Study|Pregnancy|0|||
164393088|NCT04642638|593807185|FG004|Overall Study|Pregnancy|1|||
164393089|NCT04642638|593807186|FG005|Overall Study|Pregnancy|0|||
164594493|NCT04096326|594539196|FG003|Overall Study|COVID-19-related reasons|0|||
164393090|NCT00990652|593807187|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
164393091|NCT00990652|593807187|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
164393092|NCT01672801|593807189|FG000|Overall Study|Screen Failure|0|||
164393093|NCT01672801|593807190|FG001|Overall Study|Screen Failure|1|||
164393094|NCT06476366|593807191|FG000|Overall Study|Lost to Follow-up|1|||
164393095|NCT06476366|593807192|FG001|Overall Study|Lost to Follow-up|3|||
164393096|NCT06476366|593807191|FG000|Overall Study|Adverse Event|1|||
164393097|NCT06476366|593807192|FG001|Overall Study|Adverse Event|0|||
164393098|NCT04313881|593807197|FG000|Overall Study|Death|138|||
164594494|NCT04096326|594539197|FG004|Overall Study|COVID-19-related reasons|1|||
164393099|NCT04313881|593807198|FG001|Overall Study|Death|126|||
164393100|NCT04313881|593807197|FG000|Overall Study|Study terminated by sponsor|108|||
164441590|NCT01135511|593984425|FG004|Overall Study|Pregnancy|0|||
164594495|NCT04096326|594539198|FG005|Overall Study|COVID-19-related reasons|5|||
164594496|NCT04096326|594539199|FG006|Overall Study|COVID-19-related reasons|0|||
164594497|NCT04096326|594539200|FG007|Overall Study|COVID-19-related reasons|0|||
164594498|NCT04096326|594539201|FG008|Overall Study|COVID-19-related reasons|0|||
164594499|NCT04096326|594539202|FG009|Overall Study|COVID-19-related reasons|0|||
164594500|NCT02496585|594539205|FG000|Overall Study|Death|3|||
164594501|NCT02496585|594539206|FG001|Overall Study|Death|0|||
164594502|NCT02496585|594539205|FG000|Overall Study|Lost to Follow-up|2|||
164393101|NCT04313881|593807198|FG001|Overall Study|Study terminated by sponsor|129|||
164393102|NCT04313881|593807197|FG000|Overall Study|Consent withdrawn|19|||
164393103|NCT04313881|593807198|FG001|Overall Study|Consent withdrawn|15|||
164393104|NCT04313881|593807197|FG000|Overall Study|Reason not Specified|3|||
164393105|NCT04313881|593807198|FG001|Overall Study|Reason not Specified|1|||
164393106|NCT00727272|593807199|FG000|Washout Period A|Adverse Event|0|||
164393107|NCT00727272|593807200|FG001|Washout Period A|Adverse Event|0|||
164393108|NCT00727272|593807201|FG002|Washout Period A|Adverse Event|1|||
164393109|NCT00727272|593807199|FG000|Washout Period B|Withdrawal by Subject|0|||
164393110|NCT00727272|593807200|FG001|Washout Period B|Withdrawal by Subject|0|||
164393111|NCT00727272|593807201|FG002|Washout Period B|Withdrawal by Subject|1|||
164393112|NCT00651664|593807202|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
164393113|NCT00651664|593807203|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
164393114|NCT00651664|593807204|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
164393115|NCT00651664|593807205|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
164393116|NCT00651664|593807206|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
164393117|NCT00651664|593807207|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
164393118|NCT00651664|593807208|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
164393119|NCT00651664|593807209|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
164393120|NCT00651664|593807210|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
164393121|NCT00651664|593807211|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
164393122|NCT00651664|593807202|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
164393123|NCT00651664|593807203|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
164393124|NCT00651664|593807204|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
164393125|NCT00651664|593807205|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
164393126|NCT00651664|593807206|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
164393127|NCT00651664|593807207|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
164393128|NCT00651664|593807208|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
164393129|NCT00651664|593807209|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
164393130|NCT00651664|593807210|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
164393131|NCT00651664|593807211|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
164393132|NCT00651664|593807202|FG000|Overall Study|Progressive Disease|3|||
164393133|NCT00651664|593807203|FG001|Overall Study|Progressive Disease|3|||
164393134|NCT00651664|593807204|FG002|Overall Study|Progressive Disease|3|||
164393135|NCT00651664|593807205|FG003|Overall Study|Progressive Disease|12|||
164393136|NCT00651664|593807206|FG004|Overall Study|Progressive Disease|4|||
164393137|NCT00651664|593807207|FG005|Overall Study|Progressive Disease|1|||
164393138|NCT00651664|593807208|FG006|Overall Study|Progressive Disease|3|||
164393139|NCT00651664|593807209|FG007|Overall Study|Progressive Disease|6|||
164393140|NCT00651664|593807210|FG008|Overall Study|Progressive Disease|5|||
164393141|NCT00651664|593807211|FG009|Overall Study|Progressive Disease|5|||
164393142|NCT00651664|593807202|FG000|Overall Study|Patient Declined Further Treatment|0|||
164393143|NCT00651664|593807203|FG001|Overall Study|Patient Declined Further Treatment|0|||
164393144|NCT00651664|593807204|FG002|Overall Study|Patient Declined Further Treatment|0|||
164393145|NCT00651664|593807205|FG003|Overall Study|Patient Declined Further Treatment|1|||
164393146|NCT00651664|593807206|FG004|Overall Study|Patient Declined Further Treatment|1|||
164393147|NCT00651664|593807207|FG005|Overall Study|Patient Declined Further Treatment|1|||
164393148|NCT00651664|593807208|FG006|Overall Study|Patient Declined Further Treatment|0|||
164393149|NCT00651664|593807209|FG007|Overall Study|Patient Declined Further Treatment|0|||
164393150|NCT00651664|593807210|FG008|Overall Study|Patient Declined Further Treatment|0|||
164393151|NCT00651664|593807211|FG009|Overall Study|Patient Declined Further Treatment|1|||
164393152|NCT00651664|593807202|FG000|Overall Study|Symptomatic Deterioration|0|||
164393153|NCT00651664|593807203|FG001|Overall Study|Symptomatic Deterioration|0|||
164393154|NCT00651664|593807204|FG002|Overall Study|Symptomatic Deterioration|0|||
164393155|NCT00651664|593807205|FG003|Overall Study|Symptomatic Deterioration|1|||
164393156|NCT00651664|593807206|FG004|Overall Study|Symptomatic Deterioration|0|||
164393157|NCT00651664|593807207|FG005|Overall Study|Symptomatic Deterioration|0|||
164393158|NCT00651664|593807208|FG006|Overall Study|Symptomatic Deterioration|1|||
164393159|NCT00651664|593807209|FG007|Overall Study|Symptomatic Deterioration|0|||
164393160|NCT00651664|593807210|FG008|Overall Study|Symptomatic Deterioration|1|||
164393161|NCT00651664|593807211|FG009|Overall Study|Symptomatic Deterioration|0|||
164393162|NCT00651664|593807202|FG000|Overall Study|Reason not Specified|0|||
164393163|NCT00651664|593807203|FG001|Overall Study|Reason not Specified|0|||
164393164|NCT00651664|593807204|FG002|Overall Study|Reason not Specified|0|||
164393165|NCT00651664|593807205|FG003|Overall Study|Reason not Specified|0|||
164393166|NCT00651664|593807206|FG004|Overall Study|Reason not Specified|0|||
164393167|NCT00651664|593807207|FG005|Overall Study|Reason not Specified|0|||
164393168|NCT00651664|593807208|FG006|Overall Study|Reason not Specified|1|||
164441591|NCT01135511|593984426|FG005|Overall Study|Pregnancy|0|||
164393169|NCT00651664|593807209|FG007|Overall Study|Reason not Specified|0|||
164393170|NCT00651664|593807210|FG008|Overall Study|Reason not Specified|0|||
164393171|NCT00651664|593807211|FG009|Overall Study|Reason not Specified|0|||
164393172|NCT03449030|593807212|FG000|Overall Study|Withdrawal by Subject|0|||
164393173|NCT03449030|593807213|FG001|Overall Study|Withdrawal by Subject|0|||
164393174|NCT03449030|593807214|FG002|Overall Study|Withdrawal by Subject|0|||
164393175|NCT03449030|593807215|FG003|Overall Study|Withdrawal by Subject|1|||
164393176|NCT03449030|593807216|FG004|Overall Study|Withdrawal by Subject|1|||
164393177|NCT03449030|593807217|FG005|Overall Study|Withdrawal by Subject|1|||
164393178|NCT03449030|593807218|FG006|Overall Study|Withdrawal by Subject|1|||
164393179|NCT03449030|593807219|FG007|Overall Study|Withdrawal by Subject|2|||
164393180|NCT03449030|593807220|FG008|Overall Study|Withdrawal by Subject|0|||
164393181|NCT03449030|593807221|FG009|Overall Study|Withdrawal by Subject|0|||
164393182|NCT03449030|593807212|FG000|Overall Study|Symptomatic Deterioration|0|||
164393183|NCT03449030|593807213|FG001|Overall Study|Symptomatic Deterioration|1|||
164393184|NCT03449030|593807214|FG002|Overall Study|Symptomatic Deterioration|0|||
164393185|NCT03449030|593807215|FG003|Overall Study|Symptomatic Deterioration|0|||
164393186|NCT03449030|593807216|FG004|Overall Study|Symptomatic Deterioration|0|||
164393187|NCT03449030|593807217|FG005|Overall Study|Symptomatic Deterioration|1|||
164393188|NCT03449030|593807218|FG006|Overall Study|Symptomatic Deterioration|1|||
164393189|NCT03449030|593807219|FG007|Overall Study|Symptomatic Deterioration|0|||
164393190|NCT03449030|593807220|FG008|Overall Study|Symptomatic Deterioration|2|||
164393191|NCT03449030|593807221|FG009|Overall Study|Symptomatic Deterioration|0|||
164393192|NCT03449030|593807212|FG000|Overall Study|Progressive Disease|1|||
164393193|NCT03449030|593807213|FG001|Overall Study|Progressive Disease|0|||
164393194|NCT03449030|593807214|FG002|Overall Study|Progressive Disease|1|||
164393195|NCT03449030|593807215|FG003|Overall Study|Progressive Disease|4|||
164393196|NCT03449030|593807216|FG004|Overall Study|Progressive Disease|5|||
164393197|NCT03449030|593807217|FG005|Overall Study|Progressive Disease|3|||
164393198|NCT03449030|593807218|FG006|Overall Study|Progressive Disease|0|||
164393199|NCT03449030|593807219|FG007|Overall Study|Progressive Disease|1|||
164393200|NCT03449030|593807220|FG008|Overall Study|Progressive Disease|1|||
164393201|NCT03449030|593807221|FG009|Overall Study|Progressive Disease|1|||
164393202|NCT03449030|593807212|FG000|Overall Study|Adverse Event|0|||
164393203|NCT03449030|593807213|FG001|Overall Study|Adverse Event|0|||
164393204|NCT03449030|593807214|FG002|Overall Study|Adverse Event|0|||
164393205|NCT03449030|593807215|FG003|Overall Study|Adverse Event|0|||
164393206|NCT03449030|593807216|FG004|Overall Study|Adverse Event|0|||
164393207|NCT03449030|593807217|FG005|Overall Study|Adverse Event|2|||
164393208|NCT03449030|593807218|FG006|Overall Study|Adverse Event|0|||
164393209|NCT03449030|593807219|FG007|Overall Study|Adverse Event|0|||
164393210|NCT03449030|593807220|FG008|Overall Study|Adverse Event|0|||
164393211|NCT03449030|593807221|FG009|Overall Study|Adverse Event|0|||
164393212|NCT03449030|593807212|FG000|Overall Study|Death|0|||
164393213|NCT03449030|593807213|FG001|Overall Study|Death|0|||
164393214|NCT03449030|593807214|FG002|Overall Study|Death|0|||
164393215|NCT03449030|593807215|FG003|Overall Study|Death|0|||
164393216|NCT03449030|593807216|FG004|Overall Study|Death|1|||
164393217|NCT03449030|593807217|FG005|Overall Study|Death|0|||
164393218|NCT03449030|593807218|FG006|Overall Study|Death|0|||
164393219|NCT03449030|593807219|FG007|Overall Study|Death|0|||
164393220|NCT03449030|593807220|FG008|Overall Study|Death|0|||
164393221|NCT03449030|593807221|FG009|Overall Study|Death|0|||
164393222|NCT02187991|593807224|FG000|Overall Study|Adverse Event|13|||
164393223|NCT02187991|593807225|FG001|Overall Study|Adverse Event|14|||
164393224|NCT02187991|593807226|FG002|Overall Study|Adverse Event|3|||
164393225|NCT02187991|593807227|FG003|Overall Study|Adverse Event|2|||
164393226|NCT02187991|593807224|FG000|Overall Study|Withdrawal by Subject|9|||
164393227|NCT02187991|593807225|FG001|Overall Study|Withdrawal by Subject|6|||
164393228|NCT02187991|593807226|FG002|Overall Study|Withdrawal by Subject|3|||
164393229|NCT02187991|593807227|FG003|Overall Study|Withdrawal by Subject|2|||
164393230|NCT02187991|593807224|FG000|Overall Study|Physician Decision|4|||
164393231|NCT02187991|593807225|FG001|Overall Study|Physician Decision|4|||
164393232|NCT02187991|593807226|FG002|Overall Study|Physician Decision|0|||
164393233|NCT02187991|593807227|FG003|Overall Study|Physician Decision|2|||
164393234|NCT02187991|593807224|FG000|Overall Study|Other, unrelated complication|7|||
164393235|NCT02187991|593807225|FG001|Overall Study|Other, unrelated complication|1|||
164393236|NCT02187991|593807226|FG002|Overall Study|Other, unrelated complication|1|||
164393237|NCT02187991|593807227|FG003|Overall Study|Other, unrelated complication|2|||
164393238|NCT02187991|593807224|FG000|Overall Study|Death|1|||
164393239|NCT02187991|593807225|FG001|Overall Study|Death|3|||
164393240|NCT02187991|593807226|FG002|Overall Study|Death|0|||
164393241|NCT02187991|593807227|FG003|Overall Study|Death|0|||
164393242|NCT01392560|593807228|FG000|Overall Study|Adverse Event|2|||
164393243|NCT01392560|593807228|FG000|Overall Study|not entered|8|||
164393244|NCT01392560|593807228|FG000|Overall Study|discontinued during placebo run-in|2|||
164393245|NCT00522275|593807232|FG000|Overall Study|Adverse Event|35|||
164393246|NCT00522275|593807232|FG000|Overall Study|Lack of Efficacy|80|||
164393247|NCT00522275|593807232|FG000|Overall Study|Subject withdrew consent|16|||
164393248|NCT00522275|593807232|FG000|Overall Study|Protocol deviation|1|||
164393249|NCT00522275|593807232|FG000|Overall Study|Unsatisfactory compliance|11|||
164393250|NCT00522275|593807232|FG000|Overall Study|Lost to Follow-up|8|||
164393251|NCT00522275|593807232|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
164393252|NCT00522275|593807232|FG000|Overall Study|Other: Subject is pregnant|2|||
164393253|NCT00522275|593807232|FG000|Overall Study|Other: Subject relocated|2|||
164393254|NCT00522275|593807232|FG000|Overall Study|Other: Subject arrested|1|||
164393255|NCT00522275|593807232|FG000|Overall Study|Other: Site / clinic closed|4|||
164393256|NCT00522275|593807232|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
164393257|NCT00522275|593807232|FG000|Overall Study|Other: Sponsor request|2|||
164393258|NCT00522275|593807232|FG000|Overall Study|Other: Subject ran out of medication|1|||
164393259|NCT00522275|593807232|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
164393260|NCT04656847|593807234|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
164393261|NCT03301051|593807235|FG000|Overall Study|Adverse Event|0|||
164393262|NCT03301051|593807236|FG001|Overall Study|Adverse Event|4|||
164393263|NCT03301051|593807235|FG000|Overall Study|Withdrawal by Subject|59|||
164393264|NCT03301051|593807236|FG001|Overall Study|Withdrawal by Subject|65|||
164393265|NCT03301051|593807235|FG000|Overall Study|Lost to Follow-up|263|||
164393266|NCT03301051|593807236|FG001|Overall Study|Lost to Follow-up|282|||
164393267|NCT03301051|593807235|FG000|Overall Study|Protocol Violation|1|||
164393268|NCT03301051|593807236|FG001|Overall Study|Protocol Violation|3|||
164393269|NCT03301051|593807235|FG000|Overall Study|Physician Decision|1|||
164393270|NCT03301051|593807236|FG001|Overall Study|Physician Decision|3|||
164393271|NCT03301051|593807235|FG000|Overall Study|Death|1|||
164393272|NCT03301051|593807236|FG001|Overall Study|Death|1|||
164393273|NCT03301051|593807235|FG000|Overall Study|Miscellaneous|8|||
164393274|NCT03301051|593807236|FG001|Overall Study|Miscellaneous|4|||
164393275|NCT03301051|593807235|FG000|Overall Study|Randomized, not vaccinated|13|||
164393276|NCT03301051|593807236|FG001|Overall Study|Randomized, not vaccinated|10|||
164393277|NCT00047879|593807237|FG000|Overall Study|Progressive disease|4|||
164393278|NCT00047879|593807238|FG001|Overall Study|Progressive disease|3|||
164393279|NCT01196975|593807239|FG000|Overall Study|Adverse Event|2|||
164393280|NCT01196975|593807240|FG001|Overall Study|Adverse Event|2|||
164393281|NCT01196975|593807241|FG002|Overall Study|Adverse Event|0|||
164393282|NCT01196975|593807242|FG003|Overall Study|Adverse Event|0|||
164393283|NCT01196975|593807243|FG004|Overall Study|Adverse Event|2|||
164393284|NCT01196975|593807239|FG000|Overall Study|Withdrawal by Subject|2|||
164393285|NCT01196975|593807240|FG001|Overall Study|Withdrawal by Subject|1|||
164393286|NCT01196975|593807241|FG002|Overall Study|Withdrawal by Subject|0|||
164393287|NCT01196975|593807242|FG003|Overall Study|Withdrawal by Subject|1|||
164393288|NCT01196975|593807243|FG004|Overall Study|Withdrawal by Subject|0|||
164393289|NCT01196975|593807239|FG000|Overall Study|Lost to Follow-up|11|||
164393290|NCT01196975|593807240|FG001|Overall Study|Lost to Follow-up|6|||
164393291|NCT01196975|593807241|FG002|Overall Study|Lost to Follow-up|5|||
164393292|NCT01196975|593807242|FG003|Overall Study|Lost to Follow-up|5|||
164393293|NCT01196975|593807243|FG004|Overall Study|Lost to Follow-up|11|||
164393294|NCT01462344|593807247|FG000|Overall Study|Withdrawal by Subject|245|||
164393295|NCT01462344|593807248|FG001|Overall Study|Withdrawal by Subject|226|||
164393296|NCT01462344|593807247|FG000|Overall Study|Adverse Event|24|||
164393297|NCT01462344|593807248|FG001|Overall Study|Adverse Event|23|||
164393298|NCT01462344|593807247|FG000|Overall Study|Asthma Exacerbation|34|||
164393299|NCT01462344|593807248|FG001|Overall Study|Asthma Exacerbation|35|||
164393300|NCT01462344|593807247|FG000|Overall Study|Lack of Efficacy|5|||
164393301|NCT01462344|593807248|FG001|Overall Study|Lack of Efficacy|6|||
164393302|NCT01462344|593807247|FG000|Overall Study|Protocol Violation|68|||
164393303|NCT01462344|593807248|FG001|Overall Study|Protocol Violation|53|||
164393304|NCT01462344|593807247|FG000|Overall Study|Lost to Follow-up|7|||
164393305|NCT01462344|593807248|FG001|Overall Study|Lost to Follow-up|7|||
164393306|NCT00360529|593807249|FG000|Overall Study|Adverse Event|10|||
164393307|NCT00360529|593807250|FG001|Overall Study|Adverse Event|23|||
164441592|NCT01135511|593984427|FG006|Overall Study|Pregnancy|0|||
164441593|NCT01135511|593984428|FG007|Overall Study|Pregnancy|0|||
164441594|NCT01135511|593984429|FG008|Overall Study|Pregnancy|0|||
164441595|NCT01135511|593984421|FG000|Overall Study|could not visit the clinic|0|||
164594503|NCT02496585|594539206|FG001|Overall Study|Lost to Follow-up|0|||
164393308|NCT00360529|593807251|FG002|Overall Study|Adverse Event|33|||
164393309|NCT00360529|593807249|FG000|Overall Study|Protocol Violation|3|||
164441596|NCT01135511|593984422|FG001|Overall Study|could not visit the clinic|1|||
164594504|NCT02496585|594539205|FG000|Overall Study|Withdrawal by Subject|1|||
164393310|NCT00360529|593807250|FG001|Overall Study|Protocol Violation|3|||
164393311|NCT00360529|593807251|FG002|Overall Study|Protocol Violation|11|||
164393312|NCT00360529|593807249|FG000|Overall Study|Lost to Follow-up|14|||
164393313|NCT00360529|593807250|FG001|Overall Study|Lost to Follow-up|10|||
164393314|NCT00360529|593807251|FG002|Overall Study|Lost to Follow-up|13|||
164393315|NCT00360529|593807249|FG000|Overall Study|Withdrawal by Subject|22|||
164393316|NCT00360529|593807250|FG001|Overall Study|Withdrawal by Subject|14|||
164393317|NCT00360529|593807251|FG002|Overall Study|Withdrawal by Subject|18|||
164393318|NCT00360529|593807249|FG000|Overall Study|Lack of Efficacy|8|||
164393319|NCT00360529|593807250|FG001|Overall Study|Lack of Efficacy|6|||
164393320|NCT00360529|593807251|FG002|Overall Study|Lack of Efficacy|5|||
164393321|NCT00360529|593807249|FG000|Overall Study|Reason discontinued not explained above|4|||
164393322|NCT00360529|593807250|FG001|Overall Study|Reason discontinued not explained above|9|||
164393323|NCT00360529|593807251|FG002|Overall Study|Reason discontinued not explained above|11|||
164393324|NCT01453595|593807256|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
164393325|NCT01453595|593807257|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
164393326|NCT01453595|593807258|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
164393327|NCT01128413|593807259|FG000|Overall Study|Withdrawal by Subject|1|||
164393328|NCT01128413|593807260|FG001|Overall Study|Withdrawal by Subject|0|||
164393329|NCT01128413|593807259|FG000|Overall Study|NICOM Monitor Problems|2|||
164393330|NCT01128413|593807260|FG001|Overall Study|NICOM Monitor Problems|1|||
164393331|NCT01128413|593807259|FG000|Overall Study|Pt made DNR|1|||
164393332|NCT01128413|593807260|FG001|Overall Study|Pt made DNR|0|||
164393333|NCT06167031|593807261|FG000|Overall Study|Lost to Follow-up|5|||
164393334|NCT06167031|593807262|FG001|Overall Study|Lost to Follow-up|1|||
164393335|NCT02384954|593809098|FG000|Phase 1|Progressive Disease|2|||
164393336|NCT02384954|593809099|FG001|Phase 1|Progressive Disease|0|||
164393337|NCT02384954|593809100|FG002|Phase 1|Progressive Disease|1|||
164393338|NCT02384954|593809101|FG003|Phase 1|Progressive Disease|1|||
164393339|NCT02384954|593809102|FG004|Phase 1|Progressive Disease|0|||
164393340|NCT02384954|593809103|FG005|Phase 1|Progressive Disease|0|||
164393341|NCT02384954|593809104|FG006|Phase 1|Progressive Disease|0|||
164393342|NCT02384954|593809105|FG007|Phase 1|Progressive Disease|0|||
164393343|NCT02384954|593809106|FG008|Phase 1|Progressive Disease|0|||
164393344|NCT02384954|593809098|FG000|Phase 1|Adverse Event|0|||
164393345|NCT02384954|593809099|FG001|Phase 1|Adverse Event|0|||
164393346|NCT02384954|593809100|FG002|Phase 1|Adverse Event|1|||
164393347|NCT02384954|593809101|FG003|Phase 1|Adverse Event|0|||
164393348|NCT02384954|593809102|FG004|Phase 1|Adverse Event|0|||
164393349|NCT02384954|593809103|FG005|Phase 1|Adverse Event|0|||
164393350|NCT02384954|593809104|FG006|Phase 1|Adverse Event|0|||
164441597|NCT01135511|593984423|FG002|Overall Study|could not visit the clinic|2|||
164441598|NCT01135511|593984424|FG003|Overall Study|could not visit the clinic|0|||
164441599|NCT01135511|593984425|FG004|Overall Study|could not visit the clinic|0|||
164441600|NCT01135511|593984426|FG005|Overall Study|could not visit the clinic|0|||
164441601|NCT01135511|593984427|FG006|Overall Study|could not visit the clinic|0|||
164441602|NCT01135511|593984428|FG007|Overall Study|could not visit the clinic|0|||
164441603|NCT01135511|593984429|FG008|Overall Study|could not visit the clinic|0|||
164441604|NCT01135511|593984421|FG000|Overall Study|noncompliance with study drug taken|0|||
164441605|NCT01135511|593984422|FG001|Overall Study|noncompliance with study drug taken|0|||
164441606|NCT01135511|593984423|FG002|Overall Study|noncompliance with study drug taken|0|||
164441607|NCT01135511|593984424|FG003|Overall Study|noncompliance with study drug taken|0|||
164441608|NCT01135511|593984425|FG004|Overall Study|noncompliance with study drug taken|1|||
164441609|NCT01135511|593984426|FG005|Overall Study|noncompliance with study drug taken|0|||
164441610|NCT01135511|593984427|FG006|Overall Study|noncompliance with study drug taken|0|||
164441611|NCT01135511|593984428|FG007|Overall Study|noncompliance with study drug taken|0|||
164441612|NCT01135511|593984429|FG008|Overall Study|noncompliance with study drug taken|0|||
164441613|NCT01135511|593984421|FG000|Overall Study|Withdrawal by Subject|0|||
164441614|NCT01135511|593984422|FG001|Overall Study|Withdrawal by Subject|0|||
164441615|NCT01135511|593984423|FG002|Overall Study|Withdrawal by Subject|0|||
164441616|NCT01135511|593984424|FG003|Overall Study|Withdrawal by Subject|0|||
164441617|NCT01135511|593984425|FG004|Overall Study|Withdrawal by Subject|0|||
164441618|NCT01135511|593984426|FG005|Overall Study|Withdrawal by Subject|0|||
164441619|NCT01135511|593984427|FG006|Overall Study|Withdrawal by Subject|1|||
164441620|NCT01135511|593984428|FG007|Overall Study|Withdrawal by Subject|0|||
164441621|NCT01135511|593984429|FG008|Overall Study|Withdrawal by Subject|1|||
164441622|NCT03920215|593984433|FG000|Overall Study|Lost to Follow-up|1|||
164441623|NCT03920215|593984434|FG001|Overall Study|Lost to Follow-up|2|||
164441624|NCT03920215|593984435|FG002|Overall Study|Lost to Follow-up|0|||
164704026|NCT01155024|594941854|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
164704027|NCT01155024|594941855|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
164704028|NCT01155024|594941854|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
164704029|NCT01155024|594941855|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
164441625|NCT03920215|593984436|FG003|Overall Study|Lost to Follow-up|0|||
164393351|NCT02384954|593809105|FG007|Phase 1|Adverse Event|0|||
164441626|NCT03920215|593984433|FG000|Overall Study|Death|0|||
164441627|NCT03920215|593984434|FG001|Overall Study|Death|0|||
164441628|NCT03920215|593984435|FG002|Overall Study|Death|0|||
164441629|NCT03920215|593984436|FG003|Overall Study|Death|1|||
164441630|NCT02547922|593984446|FG000|Overall Study|Withdrawal by Subject|9|||
164704030|NCT01936623|594941868|FG000|Overall Study|Lost to Follow-up|0|||
164393352|NCT02384954|593809106|FG008|Phase 1|Adverse Event|0|||
164393353|NCT02384954|593809098|FG000|Phase 2|Progressive Disease|0|||
164393354|NCT02384954|593809099|FG001|Phase 2|Progressive Disease|0|||
164393355|NCT02384954|593809100|FG002|Phase 2|Progressive Disease|0|||
164393356|NCT02384954|593809101|FG003|Phase 2|Progressive Disease|0|||
164393357|NCT02384954|593809102|FG004|Phase 2|Progressive Disease|0|||
164393358|NCT02384954|593809103|FG005|Phase 2|Progressive Disease|0|||
164704031|NCT01936623|594941869|FG001|Overall Study|Lost to Follow-up|5|||
164393359|NCT02384954|593809104|FG006|Phase 2|Progressive Disease|0|||
164393360|NCT02384954|593809105|FG007|Phase 2|Progressive Disease|1|||
164393361|NCT02384954|593809106|FG008|Phase 2|Progressive Disease|2|||
164393362|NCT02384954|593809098|FG000|Phase 2|Adverse Event|0|||
164393363|NCT02384954|593809099|FG001|Phase 2|Adverse Event|0|||
164393364|NCT02384954|593809100|FG002|Phase 2|Adverse Event|0|||
164393365|NCT02384954|593809101|FG003|Phase 2|Adverse Event|0|||
164393366|NCT02384954|593809102|FG004|Phase 2|Adverse Event|0|||
164393367|NCT02384954|593809103|FG005|Phase 2|Adverse Event|0|||
164393368|NCT02384954|593809104|FG006|Phase 2|Adverse Event|0|||
164393369|NCT02384954|593809105|FG007|Phase 2|Adverse Event|1|||
164393370|NCT02384954|593809106|FG008|Phase 2|Adverse Event|1|||
164393371|NCT02384954|593809098|FG000|Phase 2|Failure to meet continuation criteria|0|||
164393372|NCT02384954|593809099|FG001|Phase 2|Failure to meet continuation criteria|0|||
164393373|NCT02384954|593809100|FG002|Phase 2|Failure to meet continuation criteria|0|||
164393374|NCT02384954|593809101|FG003|Phase 2|Failure to meet continuation criteria|0|||
164393375|NCT02384954|593809102|FG004|Phase 2|Failure to meet continuation criteria|0|||
164393376|NCT02384954|593809103|FG005|Phase 2|Failure to meet continuation criteria|0|||
164393377|NCT02384954|593809104|FG006|Phase 2|Failure to meet continuation criteria|0|||
164393378|NCT02384954|593809105|FG007|Phase 2|Failure to meet continuation criteria|1|||
164393379|NCT02384954|593809106|FG008|Phase 2|Failure to meet continuation criteria|0|||
164393380|NCT01474681|593809110|FG000|Overall Study|Death|0|||
164393381|NCT01474681|593809111|FG001|Overall Study|Death|3|||
164393382|NCT01474681|593809112|FG002|Overall Study|Death|2|||
164393383|NCT01474681|593809113|FG003|Overall Study|Death|6|||
164393384|NCT02372396|593809121|FG000|Overall Study|Lost to Follow-up|7|||
164393385|NCT02372396|593809122|FG001|Overall Study|Lost to Follow-up|9|||
164393386|NCT01483924|593809123|FG000|Overall Study|Withdrawal by Subject|2|||
164393387|NCT01483924|593809124|FG001|Overall Study|Withdrawal by Subject|0|||
164393388|NCT01483924|593809125|FG002|Overall Study|Withdrawal by Subject|0|||
164393389|NCT01483924|593809126|FG003|Overall Study|Withdrawal by Subject|1|||
164393390|NCT01483924|593809127|FG004|Overall Study|Withdrawal by Subject|1|||
164393391|NCT01483924|593809123|FG000|Overall Study|Adverse Event|0|||
164393392|NCT01483924|593809124|FG001|Overall Study|Adverse Event|0|||
164393393|NCT01483924|593809125|FG002|Overall Study|Adverse Event|1|||
164393394|NCT01483924|593809126|FG003|Overall Study|Adverse Event|1|||
164393395|NCT01483924|593809127|FG004|Overall Study|Adverse Event|0|||
164393396|NCT01483924|593809123|FG000|Overall Study|Non-compliance|0|||
164393397|NCT01483924|593809124|FG001|Overall Study|Non-compliance|0|||
164393398|NCT01483924|593809125|FG002|Overall Study|Non-compliance|0|||
164393399|NCT01483924|593809126|FG003|Overall Study|Non-compliance|1|||
164393400|NCT01483924|593809127|FG004|Overall Study|Non-compliance|1|||
164393401|NCT01483924|593809123|FG000|Overall Study|Sponsor concern over ECG result|0|||
164393402|NCT01483924|593809124|FG001|Overall Study|Sponsor concern over ECG result|0|||
164393403|NCT01483924|593809125|FG002|Overall Study|Sponsor concern over ECG result|0|||
164393404|NCT01483924|593809126|FG003|Overall Study|Sponsor concern over ECG result|1|||
164393405|NCT01483924|593809127|FG004|Overall Study|Sponsor concern over ECG result|0|||
164393406|NCT00003298|593809130|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
164393407|NCT00003298|593809130|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
164393408|NCT00003298|593809130|FG000|Surgery|Unresectable at surgery|3|||
164393409|NCT00003298|593809130|FG000|Surgery|Progression before surgery|2|||
164393410|NCT00003298|593809130|FG000|Surgery|Unevaluable and off study|2|||
164704032|NCT01383135|594941870|FG000|Overall Study|Not Scanned / Imaged|1|||
164393411|NCT00003298|593809130|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
164393412|NCT00003298|593809130|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
164393413|NCT00003298|593809130|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
164393414|NCT00003298|593809130|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
164393415|NCT00003298|593809130|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
164393416|NCT00003298|593809130|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
164393417|NCT00003298|593809130|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
164393418|NCT00003298|593809130|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
164393419|NCT00003298|593809130|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
164704033|NCT01383135|594941871|FG001|Overall Study|Not Scanned / Imaged|0|||
164393420|NCT00003298|593809130|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
164393421|NCT01910129|593809132|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
164393422|NCT01910129|593809133|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
164393423|NCT01910129|593809134|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
164393424|NCT01910129|593809132|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
164393425|NCT01910129|593809133|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
164441631|NCT02547922|593984447|FG001|Overall Study|Withdrawal by Subject|6|||
164393426|NCT01910129|593809134|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
164393427|NCT00965523|593809137|FG000|Study 221|Progressive Disease|4|||
164704034|NCT01383135|594941872|FG002|Overall Study|Not Scanned / Imaged|1|||
164393428|NCT00965523|593809137|FG000|Study 221|Physician Decision|3|||
164393429|NCT00965523|593809137|FG000|Study 224|Progressive Disease|5|||
164393430|NCT00965523|593809137|FG000|Study 224|Physician Decision|1|||
164393431|NCT02415400|593809140|FG000|Overall Study|Adverse Event|0|||
164393432|NCT02415400|593809141|FG001|Overall Study|Adverse Event|1|||
164393433|NCT02415400|593809142|FG002|Overall Study|Adverse Event|1|||
164393434|NCT02415400|593809143|FG003|Overall Study|Adverse Event|2|||
164393435|NCT02415400|593809140|FG000|Overall Study|Participant request to stop therapy|4|||
164393436|NCT02415400|593809141|FG001|Overall Study|Participant request to stop therapy|3|||
164393437|NCT02415400|593809142|FG002|Overall Study|Participant request to stop therapy|8|||
164393438|NCT02415400|593809143|FG003|Overall Study|Participant request to stop therapy|6|||
164393439|NCT02415400|593809140|FG000|Overall Study|Participant withdrew consent|14|||
164393440|NCT02415400|593809141|FG001|Overall Study|Participant withdrew consent|12|||
164393441|NCT02415400|593809142|FG002|Overall Study|Participant withdrew consent|30|||
164393442|NCT02415400|593809143|FG003|Overall Study|Participant withdrew consent|21|||
164393443|NCT02415400|593809140|FG000|Overall Study|Death|39|||
164393444|NCT02415400|593809141|FG001|Overall Study|Death|41|||
164393445|NCT02415400|593809142|FG002|Overall Study|Death|35|||
164393446|NCT02415400|593809143|FG003|Overall Study|Death|42|||
164393447|NCT02415400|593809140|FG000|Overall Study|Lost to Follow-up|3|||
164393448|NCT02415400|593809141|FG001|Overall Study|Lost to Follow-up|3|||
164393449|NCT02415400|593809142|FG002|Overall Study|Lost to Follow-up|2|||
164393450|NCT02415400|593809143|FG003|Overall Study|Lost to Follow-up|5|||
164393451|NCT02415400|593809140|FG000|Overall Study|Poor/Non-Compliance|0|||
164393452|NCT02415400|593809141|FG001|Overall Study|Poor/Non-Compliance|1|||
164393453|NCT02415400|593809142|FG002|Overall Study|Poor/Non-Compliance|3|||
164393454|NCT02415400|593809143|FG003|Overall Study|Poor/Non-Compliance|4|||
164393455|NCT02415400|593809140|FG000|Overall Study|Participant no longer meets criteria|2|||
164393456|NCT02415400|593809141|FG001|Overall Study|Participant no longer meets criteria|0|||
164393457|NCT02415400|593809142|FG002|Overall Study|Participant no longer meets criteria|0|||
164393458|NCT02415400|593809143|FG003|Overall Study|Participant no longer meets criteria|1|||
164393459|NCT02415400|593809140|FG000|Overall Study|Participant doesn't answer phone|1|||
164393460|NCT02415400|593809141|FG001|Overall Study|Participant doesn't answer phone|0|||
164393461|NCT02415400|593809142|FG002|Overall Study|Participant doesn't answer phone|0|||
164393462|NCT02415400|593809143|FG003|Overall Study|Participant doesn't answer phone|0|||
164393463|NCT02415400|593809140|FG000|Overall Study|Participant wanted home visits|1|||
164393464|NCT02415400|593809141|FG001|Overall Study|Participant wanted home visits|0|||
164393465|NCT02415400|593809142|FG002|Overall Study|Participant wanted home visits|0|||
164393466|NCT02415400|593809143|FG003|Overall Study|Participant wanted home visits|0|||
164393467|NCT02415400|593809140|FG000|Overall Study|Randomized in error|2|||
164393468|NCT02415400|593809141|FG001|Overall Study|Randomized in error|0|||
164393469|NCT02415400|593809142|FG002|Overall Study|Randomized in error|0|||
164393470|NCT02415400|593809143|FG003|Overall Study|Randomized in error|0|||
164393471|NCT02415400|593809140|FG000|Overall Study|No study drug on site|0|||
164393472|NCT02415400|593809141|FG001|Overall Study|No study drug on site|1|||
164393473|NCT02415400|593809142|FG002|Overall Study|No study drug on site|0|||
164393474|NCT02415400|593809143|FG003|Overall Study|No study drug on site|0|||
164393475|NCT02415400|593809140|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
164393476|NCT02415400|593809141|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
164393477|NCT02415400|593809142|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
164393478|NCT02415400|593809143|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
164393479|NCT02415400|593809140|FG000|Overall Study|Coagulation values cannot be set|0|||
164393480|NCT02415400|593809141|FG001|Overall Study|Coagulation values cannot be set|0|||
164393481|NCT02415400|593809142|FG002|Overall Study|Coagulation values cannot be set|1|||
164393482|NCT02415400|593809143|FG003|Overall Study|Coagulation values cannot be set|0|||
164393483|NCT02415400|593809140|FG000|Overall Study|State regulations prevent participation|0|||
164393484|NCT02415400|593809141|FG001|Overall Study|State regulations prevent participation|0|||
164393485|NCT02415400|593809142|FG002|Overall Study|State regulations prevent participation|1|||
164393486|NCT02415400|593809143|FG003|Overall Study|State regulations prevent participation|0|||
164393487|NCT02415400|593809140|FG000|Overall Study|Poor treatment monitoring|0|||
164393488|NCT02415400|593809141|FG001|Overall Study|Poor treatment monitoring|0|||
164441632|NCT02547922|593984448|FG002|Overall Study|Withdrawal by Subject|10|||
164441633|NCT02547922|593984446|FG000|Overall Study|Adverse Event|3|||
164441634|NCT02547922|593984447|FG001|Overall Study|Adverse Event|1|||
164441635|NCT02547922|593984448|FG002|Overall Study|Adverse Event|2|||
164393489|NCT02415400|593809142|FG002|Overall Study|Poor treatment monitoring|1|||
164393490|NCT02415400|593809143|FG003|Overall Study|Poor treatment monitoring|0|||
164704035|NCT01383135|594941873|FG003|Overall Study|Not Scanned / Imaged|0|||
164393491|NCT02415400|593809140|FG000|Overall Study|Participant in jail|0|||
164393492|NCT02415400|593809141|FG001|Overall Study|Participant in jail|0|||
164704036|NCT02455050|594941876|FG000|Treatment Period 1|Lost to Follow-up|1|||
164393493|NCT02415400|593809142|FG002|Overall Study|Participant in jail|1|||
164393494|NCT02415400|593809143|FG003|Overall Study|Participant in jail|0|||
164441636|NCT02547922|593984446|FG000|Overall Study|Lost to Follow-up|1|||
164441637|NCT02547922|593984447|FG001|Overall Study|Lost to Follow-up|0|||
164441638|NCT02547922|593984448|FG002|Overall Study|Lost to Follow-up|0|||
164704037|NCT02455050|594941877|FG001|Treatment Period 1|Lost to Follow-up|1|||
164393495|NCT02415400|593809140|FG000|Overall Study|Investigator decision|0|||
164393496|NCT02415400|593809141|FG001|Overall Study|Investigator decision|0|||
164393497|NCT02415400|593809142|FG002|Overall Study|Investigator decision|1|||
164393498|NCT02415400|593809143|FG003|Overall Study|Investigator decision|1|||
164393499|NCT02415400|593809140|FG000|Overall Study|Site closure; participant won't transfer|0|||
164393500|NCT02415400|593809141|FG001|Overall Study|Site closure; participant won't transfer|0|||
164393501|NCT02415400|593809142|FG002|Overall Study|Site closure; participant won't transfer|0|||
164393502|NCT02415400|593809143|FG003|Overall Study|Site closure; participant won't transfer|1|||
164393503|NCT01226745|593809144|FG000|Overall Study|Did not complete schedule of assessments|8|||
164393504|NCT01226745|593809145|FG001|Overall Study|Did not complete schedule of assessments|3|||
164393505|NCT01226745|593809146|FG002|Overall Study|Did not complete schedule of assessments|6|||
164393506|NCT01226745|593809147|FG003|Overall Study|Did not complete schedule of assessments|0|||
164393507|NCT01226745|593809148|FG004|Overall Study|Did not complete schedule of assessments|0|||
164393508|NCT01226745|593809149|FG005|Overall Study|Did not complete schedule of assessments|1|||
164393509|NCT01226745|593809144|FG000|Overall Study|Lost to Follow-up|2|||
164393510|NCT01226745|593809145|FG001|Overall Study|Lost to Follow-up|6|||
164393511|NCT01226745|593809146|FG002|Overall Study|Lost to Follow-up|6|||
164393512|NCT01226745|593809147|FG003|Overall Study|Lost to Follow-up|1|||
164393513|NCT01226745|593809148|FG004|Overall Study|Lost to Follow-up|1|||
164393514|NCT01226745|593809149|FG005|Overall Study|Lost to Follow-up|2|||
164393515|NCT01226745|593809144|FG000|Overall Study|Death|1|||
164393516|NCT01226745|593809145|FG001|Overall Study|Death|0|||
164393517|NCT01226745|593809146|FG002|Overall Study|Death|0|||
164393518|NCT01226745|593809147|FG003|Overall Study|Death|0|||
164393519|NCT01226745|593809148|FG004|Overall Study|Death|0|||
164393520|NCT01226745|593809149|FG005|Overall Study|Death|1|||
164393521|NCT01226745|593809144|FG000|Overall Study|Other|6|||
164393522|NCT01226745|593809145|FG001|Overall Study|Other|7|||
164393523|NCT01226745|593809146|FG002|Overall Study|Other|8|||
164393524|NCT01226745|593809147|FG003|Overall Study|Other|4|||
164393525|NCT01226745|593809148|FG004|Overall Study|Other|3|||
164393526|NCT01226745|593809149|FG005|Overall Study|Other|1|||
164393527|NCT02270450|593809154|FG000|Overall Study|Refusal unrelated to adverse event|3|||
164393528|NCT02270450|593809155|FG001|Overall Study|Refusal unrelated to adverse event|1|||
164393529|NCT02270450|593809156|FG002|Overall Study|Refusal unrelated to adverse event|5|||
164393530|NCT02270450|593809157|FG003|Overall Study|Refusal unrelated to adverse event|14|||
164393531|NCT02270450|593809154|FG000|Overall Study|Progression/relapse|1|||
164393532|NCT02270450|593809155|FG001|Overall Study|Progression/relapse|2|||
164393533|NCT02270450|593809156|FG002|Overall Study|Progression/relapse|4|||
164393534|NCT02270450|593809157|FG003|Overall Study|Progression/relapse|9|||
164393535|NCT02270450|593809154|FG000|Overall Study|Death|19|||
164393536|NCT02270450|593809155|FG001|Overall Study|Death|19|||
164393537|NCT02270450|593809156|FG002|Overall Study|Death|31|||
164393538|NCT02270450|593809157|FG003|Overall Study|Death|59|||
164441639|NCT02547922|593984446|FG000|Overall Study|Lack of Efficacy|5|||
164441640|NCT02547922|593984447|FG001|Overall Study|Lack of Efficacy|7|||
164441641|NCT02547922|593984448|FG002|Overall Study|Lack of Efficacy|4|||
164704038|NCT02455050|594941878|FG002|Treatment Period 1|Lost to Follow-up|1|||
164704039|NCT02455050|594941879|FG003|Treatment Period 1|Lost to Follow-up|2|||
164704040|NCT02455050|594941876|FG000|Treatment Period 2|Lost to Follow-up|1|||
164704041|NCT02455050|594941877|FG001|Treatment Period 2|Lost to Follow-up|0|||
164704042|NCT02455050|594941878|FG002|Treatment Period 2|Lost to Follow-up|2|||
164704043|NCT02455050|594941879|FG003|Treatment Period 2|Lost to Follow-up|1|||
164704044|NCT02981303|594941880|FG000|Overall Study|Progressive Disease|17|||
164704045|NCT02981303|594941881|FG001|Overall Study|Progressive Disease|37|||
164704046|NCT02981303|594941880|FG000|Overall Study|Adverse Event|1|||
164704047|NCT02981303|594941881|FG001|Overall Study|Adverse Event|4|||
164704048|NCT02981303|594941880|FG000|Overall Study|Withdrawal by Subject|0|||
164704049|NCT02981303|594941881|FG001|Overall Study|Withdrawal by Subject|1|||
164704050|NCT01971970|594941882|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
164704051|NCT01971970|594941883|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
164704052|NCT01971970|594941882|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
164704053|NCT01971970|594941883|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
164704054|NCT01971970|594941882|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
164704055|NCT01971970|594941883|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
164704056|NCT01971970|594941882|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
164393539|NCT02363738|593809158|FG000|Overall Study|Adverse Event|5|||
164441642|NCT02547922|593984446|FG000|Overall Study|Death|1|||
164441643|NCT02547922|593984447|FG001|Overall Study|Death|0|||
164441644|NCT02547922|593984448|FG002|Overall Study|Death|0|||
164704057|NCT01971970|594941883|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
164704058|NCT01971970|594941882|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
164393540|NCT02363738|593809159|FG001|Overall Study|Adverse Event|2|||
164393541|NCT02363738|593809158|FG000|Overall Study|Lack of Efficacy|1|||
164393542|NCT02363738|593809159|FG001|Overall Study|Lack of Efficacy|2|||
164393543|NCT02363738|593809158|FG000|Overall Study|Lost to Follow-up|2|||
164393544|NCT02363738|593809159|FG001|Overall Study|Lost to Follow-up|1|||
164393545|NCT01581281|593809168|FG000|Overall Study|Early Study Closure|15|||
164393546|NCT01581281|593809169|FG001|Overall Study|Early Study Closure|6|||
164393547|NCT01581281|593809170|FG002|Overall Study|Early Study Closure|12|||
164393548|NCT02081846|593809173|FG000|Overall Study|Withdrawal by Subject|1|||
164393549|NCT02081846|593809174|FG001|Overall Study|Withdrawal by Subject|0|||
164393550|NCT02081846|593809173|FG000|Overall Study|invalid consent|1|||
164393551|NCT02081846|593809174|FG001|Overall Study|invalid consent|0|||
164393552|NCT03265600|593809175|FG000|Overall Study|Lost to Follow-up|17|||
164393553|NCT03265600|593809176|FG001|Overall Study|Lost to Follow-up|5|||
164532202|NCT00150969|594320499|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
164393554|NCT03265600|593809175|FG000|Overall Study|Withdrawal by Subject|4|||
164393555|NCT03265600|593809176|FG001|Overall Study|Withdrawal by Subject|2|||
164393556|NCT03265600|593809175|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
164393557|NCT03265600|593809176|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
164393558|NCT00535730|593809177|FG000|Overall Study|Adverse Event|1|||
164393559|NCT00535730|593809178|FG001|Overall Study|Adverse Event|1|||
164393560|NCT00535730|593809177|FG000|Overall Study|Lost to Follow-up|0|||
164393561|NCT00535730|593809178|FG001|Overall Study|Lost to Follow-up|1|||
164393562|NCT00535730|593809177|FG000|Overall Study|Physician Decision|0|||
164393563|NCT00535730|593809178|FG001|Overall Study|Physician Decision|1|||
164393564|NCT00535730|593809177|FG000|Overall Study|Protocol Violation|1|||
164393565|NCT00535730|593809178|FG001|Overall Study|Protocol Violation|0|||
164393566|NCT00535730|593809177|FG000|Overall Study|Withdrawal by Subject|0|||
164393567|NCT00535730|593809178|FG001|Overall Study|Withdrawal by Subject|4|||
164393568|NCT00295750|593809179|FG000|Overall Study|Adverse Event|19|||
164393569|NCT00295750|593809180|FG001|Overall Study|Adverse Event|15|||
164393570|NCT00295750|593809181|FG002|Overall Study|Adverse Event|12|||
164393571|NCT00295750|593809179|FG000|Overall Study|Lack of Efficacy|1|||
164393572|NCT00295750|593809180|FG001|Overall Study|Lack of Efficacy|1|||
164393573|NCT00295750|593809181|FG002|Overall Study|Lack of Efficacy|0|||
164393574|NCT00295750|593809179|FG000|Overall Study|Lost to Follow-up|1|||
164393575|NCT00295750|593809180|FG001|Overall Study|Lost to Follow-up|4|||
164393576|NCT00295750|593809181|FG002|Overall Study|Lost to Follow-up|1|||
164393577|NCT00295750|593809179|FG000|Overall Study|Taking prohibited therapy|2|||
164393578|NCT00295750|593809180|FG001|Overall Study|Taking prohibited therapy|3|||
164393579|NCT00295750|593809181|FG002|Overall Study|Taking prohibited therapy|2|||
164393580|NCT00295750|593809179|FG000|Overall Study|Administrative errors|2|||
164393581|NCT00295750|593809180|FG001|Overall Study|Administrative errors|4|||
164393582|NCT00295750|593809181|FG002|Overall Study|Administrative errors|5|||
164393583|NCT00295750|593809179|FG000|Overall Study|Trial drug errors|1|||
164393584|NCT00295750|593809180|FG001|Overall Study|Trial drug errors|1|||
164393585|NCT00295750|593809181|FG002|Overall Study|Trial drug errors|0|||
164393586|NCT00295750|593809179|FG000|Overall Study|Disease progression|2|||
164393587|NCT00295750|593809180|FG001|Overall Study|Disease progression|1|||
164393588|NCT00295750|593809181|FG002|Overall Study|Disease progression|0|||
164393589|NCT00295750|593809179|FG000|Overall Study|Personal reasons|0|||
164594505|NCT02496585|594539206|FG001|Overall Study|Withdrawal by Subject|2|||
164594506|NCT02496585|594539205|FG000|Overall Study|Progression of Malignancy|4|||
164594507|NCT02496585|594539206|FG001|Overall Study|Progression of Malignancy|1|||
164594508|NCT01276457|594539211|FG000|Core Study|Adverse Event|6|||
164594509|NCT01276457|594539212|FG001|Core Study|Adverse Event|3|||
164594510|NCT01276457|594539211|FG000|Core Study|Lost to Follow-up|1|||
164594511|NCT01276457|594539212|FG001|Core Study|Lost to Follow-up|2|||
164594512|NCT01276457|594539211|FG000|Core Study|Administrative problems|1|||
164594513|NCT01276457|594539212|FG001|Core Study|Administrative problems|1|||
164594514|NCT01276457|594539211|FG000|Core Study|Death|2|||
164594515|NCT01276457|594539212|FG001|Core Study|Death|2|||
164594516|NCT01276457|594539211|FG000|Core Study|Lack of Efficacy|3|||
164594517|NCT01276457|594539212|FG001|Core Study|Lack of Efficacy|12|||
164594518|NCT01276457|594539211|FG000|Extension Study|Lost to Follow-up|3|||
164594519|NCT01276457|594539212|FG001|Extension Study|Lost to Follow-up|0|||
164594520|NCT01276457|594539211|FG000|Extension Study|Death|0|||
164594521|NCT01276457|594539212|FG001|Extension Study|Death|1|||
164594522|NCT01276457|594539211|FG000|Extension Study|Lack of Efficacy|3|||
164594523|NCT01276457|594539212|FG001|Extension Study|Lack of Efficacy|1|||
164594524|NCT05122650|594539213|FG000|Overall Study|Adverse Event|4|||
164594525|NCT05122650|594539214|FG001|Overall Study|Adverse Event|16|||
164393590|NCT00295750|593809180|FG001|Overall Study|Personal reasons|1|||
164393591|NCT00295750|593809181|FG002|Overall Study|Personal reasons|0|||
164532203|NCT00150969|594320500|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
164532204|NCT00150969|594320499|FG000|24-48 Month Extension|Lack of Efficacy|0|||
164532205|NCT00150969|594320500|FG001|24-48 Month Extension|Lack of Efficacy|1|||
164532206|NCT00150969|594320499|FG000|24-48 Month Extension|Adverse Event|1|||
164532207|NCT00150969|594320500|FG001|24-48 Month Extension|Adverse Event|3|||
164532208|NCT00150969|594320499|FG000|24-48 Month Extension|Other Reason|81|||
164532209|NCT00150969|594320500|FG001|24-48 Month Extension|Other Reason|91|||
164532210|NCT00615836|594320501|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
164532211|NCT00615836|594320502|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
164393592|NCT00295750|593809179|FG000|Overall Study|Randomized but never received trial drug|4|||
164393593|NCT00295750|593809180|FG001|Overall Study|Randomized but never received trial drug|3|||
164393594|NCT00295750|593809181|FG002|Overall Study|Randomized but never received trial drug|3|||
164393595|NCT00295750|593809179|FG000|Overall Study|Withdrawal by Subject|9|||
164393596|NCT00295750|593809180|FG001|Overall Study|Withdrawal by Subject|4|||
164393597|NCT00295750|593809181|FG002|Overall Study|Withdrawal by Subject|7|||
164393598|NCT00295750|593809179|FG000|Overall Study|Protocol Violation|2|||
164393599|NCT00295750|593809180|FG001|Overall Study|Protocol Violation|4|||
164393600|NCT00295750|593809181|FG002|Overall Study|Protocol Violation|2|||
164393601|NCT01650259|593809182|FG000|Overall Study|Improvement|105|||
164393602|NCT01650259|593809183|FG001|Overall Study|Improvement|0|||
164594526|NCT05122650|594539215|FG002|Overall Study|Adverse Event|11|||
164594527|NCT05122650|594539216|FG003|Overall Study|Adverse Event|12|||
164594528|NCT05122650|594539213|FG000|Overall Study|Lack of Efficacy|0|||
164594529|NCT05122650|594539214|FG001|Overall Study|Lack of Efficacy|1|||
164594530|NCT05122650|594539215|FG002|Overall Study|Lack of Efficacy|1|||
164594531|NCT05122650|594539216|FG003|Overall Study|Lack of Efficacy|2|||
164594532|NCT05122650|594539213|FG000|Overall Study|Lost to Follow-up|1|||
164594533|NCT05122650|594539214|FG001|Overall Study|Lost to Follow-up|1|||
164594534|NCT05122650|594539215|FG002|Overall Study|Lost to Follow-up|3|||
164594535|NCT05122650|594539216|FG003|Overall Study|Lost to Follow-up|0|||
164594536|NCT05122650|594539213|FG000|Overall Study|Non-compliance with study intervention|0|||
164594537|NCT05122650|594539214|FG001|Overall Study|Non-compliance with study intervention|0|||
164594538|NCT05122650|594539215|FG002|Overall Study|Non-compliance with study intervention|0|||
164594539|NCT05122650|594539216|FG003|Overall Study|Non-compliance with study intervention|2|||
164594540|NCT05122650|594539213|FG000|Overall Study|Protocol Violation|0|||
164594541|NCT05122650|594539214|FG001|Overall Study|Protocol Violation|1|||
164594542|NCT05122650|594539215|FG002|Overall Study|Protocol Violation|0|||
164594543|NCT05122650|594539216|FG003|Overall Study|Protocol Violation|1|||
164594544|NCT05122650|594539213|FG000|Overall Study|Randomized by mistake|0|||
164594545|NCT05122650|594539214|FG001|Overall Study|Randomized by mistake|0|||
164594546|NCT05122650|594539215|FG002|Overall Study|Randomized by mistake|3|||
164594547|NCT05122650|594539216|FG003|Overall Study|Randomized by mistake|2|||
164594548|NCT05122650|594539213|FG000|Overall Study|Sponsor request|0|||
164594549|NCT05122650|594539214|FG001|Overall Study|Sponsor request|1|||
164594550|NCT05122650|594539215|FG002|Overall Study|Sponsor request|1|||
164594551|NCT05122650|594539216|FG003|Overall Study|Sponsor request|2|||
164594552|NCT05122650|594539213|FG000|Overall Study|Withdrawal by Subject|3|||
164594553|NCT05122650|594539214|FG001|Overall Study|Withdrawal by Subject|7|||
164594554|NCT05122650|594539215|FG002|Overall Study|Withdrawal by Subject|4|||
164594555|NCT05122650|594539216|FG003|Overall Study|Withdrawal by Subject|8|||
164594556|NCT05122650|594539213|FG000|Overall Study|Other|5|||
164594557|NCT05122650|594539214|FG001|Overall Study|Other|0|||
164594558|NCT05122650|594539215|FG002|Overall Study|Other|0|||
164594559|NCT05122650|594539216|FG003|Overall Study|Other|0|||
164594560|NCT03280550|594539221|FG000|Overall Study|Withdrawal by Subject|2|||
164594561|NCT03280550|594539222|FG001|Overall Study|Withdrawal by Subject|2|||
164594562|NCT03280550|594539221|FG000|Overall Study|Physician Decision|0|||
164594563|NCT03280550|594539222|FG001|Overall Study|Physician Decision|1|||
164594564|NCT05896761|594539223|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
164594565|NCT05896761|594539224|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
164594566|NCT05896761|594539223|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
164594567|NCT05896761|594539224|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
164594568|NCT01318083|594539225|FG000|Overall Study|Adverse Event|4|||
164594569|NCT01318083|594539226|FG001|Overall Study|Adverse Event|1|||
164594570|NCT01318083|594539227|FG002|Overall Study|Adverse Event|2|||
164594571|NCT01318083|594539225|FG000|Overall Study|Withdrawal by Subject|1|||
164704059|NCT01971970|594941883|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
164393603|NCT01650259|593809182|FG000|Overall Study|Adverse Event|127|||
164393604|NCT01650259|593809183|FG001|Overall Study|Adverse Event|0|||
164393605|NCT01650259|593809182|FG000|Overall Study|Lack of Efficacy|143|||
164393606|NCT01650259|593809183|FG001|Overall Study|Lack of Efficacy|0|||
164393607|NCT01650259|593809182|FG000|Overall Study|Lost to Follow-up|435|||
164393608|NCT01650259|593809183|FG001|Overall Study|Lost to Follow-up|0|||
164393609|NCT01650259|593809182|FG000|Overall Study|Patients had no visit after entry|70|||
164393610|NCT01650259|593809183|FG001|Overall Study|Patients had no visit after entry|0|||
164393611|NCT01650259|593809182|FG000|Overall Study|CRF not collected|98|||
164393612|NCT01650259|593809183|FG001|Overall Study|CRF not collected|82|||
164393613|NCT01650259|593809182|FG000|Overall Study|Not treated|1|||
164393614|NCT01650259|593809183|FG001|Overall Study|Not treated|7|||
164393615|NCT01650259|593809182|FG000|Overall Study|Other than listed|64|||
164393616|NCT01650259|593809183|FG001|Overall Study|Other than listed|146|||
164393617|NCT00936858|593809184|FG000|Overall Study|Death|3|||
164393618|NCT00936858|593809184|FG000|Overall Study|Progression|29|||
164393619|NCT00936858|593809184|FG000|Overall Study|Withdrawal by Subject|5|||
164393620|NCT00936858|593809184|FG000|Overall Study|Adverse Event|1|||
164393621|NCT00936858|593809184|FG000|Overall Study|Physician Decision|7|||
164393622|NCT00936858|593809184|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
164393623|NCT00936858|593809184|FG000|Overall Study|Lost to Follow-up|1|||
164393624|NCT00584727|593809195|FG000|First Intervention|Discontinuation|0|||
164393625|NCT00584727|593809196|FG001|First Intervention|Discontinuation|0|||
164393626|NCT00584727|593809197|FG002|First Intervention|Discontinuation|1|||
164393627|NCT00584727|593809198|FG003|First Intervention|Discontinuation|0|||
164393628|NCT00584727|593809199|FG004|First Intervention|Discontinuation|0|||
164393629|NCT00584727|593809200|FG005|First Intervention|Discontinuation|0|||
164393630|NCT00584727|593809195|FG000|Third Intervention|Protocol Violation|0|||
164393631|NCT00584727|593809196|FG001|Third Intervention|Protocol Violation|0|||
164393632|NCT00584727|593809197|FG002|Third Intervention|Protocol Violation|1|||
164393633|NCT00584727|593809198|FG003|Third Intervention|Protocol Violation|0|||
164393634|NCT00584727|593809199|FG004|Third Intervention|Protocol Violation|4|||
164393635|NCT00584727|593809200|FG005|Third Intervention|Protocol Violation|2|||
164393636|NCT04072159|593809201|FG000|Overall Study|Lost to Follow-up|6|||
164393637|NCT04072159|593809202|FG001|Overall Study|Lost to Follow-up|6|||
164393638|NCT04072159|593809201|FG000|Overall Study|Withdrawal by Subject|2|||
164393639|NCT04072159|593809202|FG001|Overall Study|Withdrawal by Subject|0|||
164393640|NCT00989287|593809206|FG000|Overall Study|Adverse Event|1|||
164393641|NCT00989287|593809207|FG001|Overall Study|Adverse Event|0|||
164393642|NCT00989287|593809206|FG000|Overall Study|Lost to Follow-up|0|||
164393643|NCT00989287|593809207|FG001|Overall Study|Lost to Follow-up|1|||
164393644|NCT00695669|593809208|FG000|Overall Study|Adverse Event|0|||
164393645|NCT00695669|593809209|FG001|Overall Study|Adverse Event|0|||
164393646|NCT00695669|593809210|FG002|Overall Study|Adverse Event|2|||
164393647|NCT00695669|593809211|FG003|Overall Study|Adverse Event|0|||
164393648|NCT00695669|593809208|FG000|Overall Study|Lost to Follow-up|4|||
164393649|NCT00695669|593809209|FG001|Overall Study|Lost to Follow-up|4|||
164393650|NCT00695669|593809210|FG002|Overall Study|Lost to Follow-up|1|||
164393651|NCT00695669|593809211|FG003|Overall Study|Lost to Follow-up|4|||
164393652|NCT00092131|593809212|FG000|Treatment Period I|Adverse Event|1|||
164393653|NCT00092131|593809213|FG001|Treatment Period I|Adverse Event|0|||
164393654|NCT00092131|593809212|FG000|Treatment Period II|Adverse Event|0|||
164393655|NCT00092131|593809213|FG001|Treatment Period II|Adverse Event|1|||
164393656|NCT02341417|593809214|FG000|Overall Study|Withdrawal by Subject|0|||
164393657|NCT02341417|593809215|FG001|Overall Study|Withdrawal by Subject|2|||
164393658|NCT02341417|593809216|FG002|Overall Study|Withdrawal by Subject|0|||
164393659|NCT02341417|593809214|FG000|Overall Study|Decision by sponsor|2|||
164393660|NCT02341417|593809215|FG001|Overall Study|Decision by sponsor|0|||
164393661|NCT02341417|593809216|FG002|Overall Study|Decision by sponsor|0|||
164393662|NCT02341417|593809214|FG000|Overall Study|Death|0|||
164393663|NCT02341417|593809215|FG001|Overall Study|Death|0|||
164393664|NCT02341417|593809216|FG002|Overall Study|Death|1|||
164393665|NCT03570619|593809232|FG000|Overall Study|Adverse Event|2|||
164393666|NCT03570619|593809233|FG001|Overall Study|Adverse Event|0|||
164393667|NCT03570619|593809234|FG002|Overall Study|Adverse Event|1|||
164393668|NCT03570619|593809232|FG000|Overall Study|new diagnosis of new malignancy|1|||
164393669|NCT03570619|593809233|FG001|Overall Study|new diagnosis of new malignancy|0|||
164393670|NCT03570619|593809234|FG002|Overall Study|new diagnosis of new malignancy|0|||
164393671|NCT03570619|593809232|FG000|Overall Study|Physician Decision|1|||
164393672|NCT03570619|593809233|FG001|Overall Study|Physician Decision|1|||
164393673|NCT03570619|593809234|FG002|Overall Study|Physician Decision|0|||
164393674|NCT03570619|593809232|FG000|Overall Study|Withdrawal by Subject|0|||
164393675|NCT03570619|593809233|FG001|Overall Study|Withdrawal by Subject|2|||
164393676|NCT03570619|593809234|FG002|Overall Study|Withdrawal by Subject|0|||
164393677|NCT04773587|593809235|FG000|Overall Study|Lost to Follow-up|11|||
164393678|NCT04773587|593809236|FG001|Overall Study|Lost to Follow-up|3|||
164393679|NCT04773587|593809235|FG000|Overall Study|Adverse Event|6|||
164393680|NCT04773587|593809236|FG001|Overall Study|Adverse Event|3|||
164393681|NCT04773587|593809235|FG000|Overall Study|Lack of Efficacy|5|||
164393682|NCT04773587|593809236|FG001|Overall Study|Lack of Efficacy|2|||
164393683|NCT04773587|593809235|FG000|Overall Study|Withdrawal by Subject|4|||
164393684|NCT04773587|593809236|FG001|Overall Study|Withdrawal by Subject|5|||
164393685|NCT04773587|593809235|FG000|Overall Study|Noncompliance|1|||
164393686|NCT04773587|593809236|FG001|Overall Study|Noncompliance|0|||
164393687|NCT04773587|593809235|FG000|Overall Study|Protocol Violation|1|||
164393688|NCT04773587|593809236|FG001|Overall Study|Protocol Violation|0|||
164393689|NCT04773587|593809235|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
164393690|NCT04773587|593809236|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
164393691|NCT00435370|593809246|FG000|Overall Study|Adverse Event|8|||
164393692|NCT00435370|593809247|FG001|Overall Study|Adverse Event|8|||
164393693|NCT00435370|593809246|FG000|Overall Study|Withdrawal by Subject|10|||
164393694|NCT00435370|593809247|FG001|Overall Study|Withdrawal by Subject|10|||
164393695|NCT00435370|593809246|FG000|Overall Study|Antipsychotic medication changed|4|||
164393696|NCT00435370|593809247|FG001|Overall Study|Antipsychotic medication changed|2|||
164393697|NCT02132611|593809249|FG000|Overall Study|Death|2|||
164594572|NCT01318083|594539226|FG001|Overall Study|Withdrawal by Subject|0|||
164594573|NCT01318083|594539227|FG002|Overall Study|Withdrawal by Subject|2|||
164594574|NCT01318083|594539225|FG000|Overall Study|Lack of Efficacy|0|||
164594575|NCT01318083|594539226|FG001|Overall Study|Lack of Efficacy|0|||
164594576|NCT01318083|594539227|FG002|Overall Study|Lack of Efficacy|1|||
164594577|NCT01318083|594539225|FG000|Overall Study|Treatment Complications|1|||
164393698|NCT01965834|593809251|FG000|Overall Study|Lack of Efficacy|4|||
164393699|NCT03674177|593809254|FG000|Overall Study|Lost to Follow-up|2|||
164393700|NCT03674177|593809255|FG001|Overall Study|Lost to Follow-up|1|||
164393701|NCT03674177|593809256|FG002|Overall Study|Lost to Follow-up|0|||
164393702|NCT03674177|593809257|FG003|Overall Study|Lost to Follow-up|2|||
164393703|NCT02493127|593809258|FG000|Overall Study|Lost to Follow-up|1|||
164393704|NCT02493127|593809259|FG001|Overall Study|Lost to Follow-up|1|||
164393705|NCT00809757|593809265|FG000|Overall Study|Adverse Event|2|||
164393706|NCT00809757|593809266|FG001|Overall Study|Adverse Event|3|||
164393707|NCT00809757|593809267|FG002|Overall Study|Adverse Event|3|||
164393708|NCT00809757|593809265|FG000|Overall Study|Lost to Follow-up|0|||
164393709|NCT00809757|593809266|FG001|Overall Study|Lost to Follow-up|0|||
164393710|NCT00809757|593809267|FG002|Overall Study|Lost to Follow-up|1|||
164393711|NCT00809757|593809265|FG000|Overall Study|Protocol Violation|1|||
164393712|NCT00809757|593809266|FG001|Overall Study|Protocol Violation|1|||
164393713|NCT00809757|593809267|FG002|Overall Study|Protocol Violation|1|||
164393714|NCT00809757|593809265|FG000|Overall Study|Withdrawal by Subject|2|||
164393715|NCT00809757|593809266|FG001|Overall Study|Withdrawal by Subject|1|||
164393716|NCT00809757|593809267|FG002|Overall Study|Withdrawal by Subject|3|||
164393717|NCT00809757|593809265|FG000|Overall Study|Subject Uncooperative|1|||
164393718|NCT00809757|593809266|FG001|Overall Study|Subject Uncooperative|0|||
164393719|NCT00809757|593809267|FG002|Overall Study|Subject Uncooperative|2|||
164393720|NCT00809757|593809265|FG000|Overall Study|Noncompliance with Medication|0|||
164393721|NCT00809757|593809266|FG001|Overall Study|Noncompliance with Medication|0|||
164393722|NCT00809757|593809267|FG002|Overall Study|Noncompliance with Medication|1|||
164393723|NCT00253864|593809268|FG000|Overall Study|Lost to Follow-up|5|||
164393724|NCT00253864|593809269|FG001|Overall Study|Lost to Follow-up|8|||
164393725|NCT00659334|593809270|FG000|Overall Study|Screen Failure|8|||
164393726|NCT00659334|593809271|FG001|Overall Study|Screen Failure|5|||
164393727|NCT00659334|593809272|FG002|Overall Study|Screen Failure|0|||
164393728|NCT00659334|593809273|FG003|Overall Study|Screen Failure|0|||
164393729|NCT00659334|593809274|FG004|Overall Study|Screen Failure|0|||
164393730|NCT00659334|593809275|FG005|Overall Study|Screen Failure|0|||
164393731|NCT00659334|593809276|FG006|Overall Study|Screen Failure|1|||
164393732|NCT03034577|593809277|FG000|Overall Study|Withdrawal by Subject|6|||
164393733|NCT03034577|593809278|FG001|Overall Study|Withdrawal by Subject|9|||
164393734|NCT03034577|593809277|FG000|Overall Study|Lost to Follow-up|25|||
164393735|NCT03034577|593809278|FG001|Overall Study|Lost to Follow-up|26|||
164393736|NCT01174342|593809279|FG000|Overall Study|Conversion to cesarean section|4|||
164393737|NCT02625623|593809280|FG000|Overall Study|Participants randomized but not treated|9|||
164393738|NCT02625623|593809281|FG001|Overall Study|Participants randomized but not treated|1|||
164393739|NCT00744653|593809282|FG000|Overall Study|antineoplastic treatment|11|||
164393740|NCT00744653|593809282|FG000|Overall Study|Death|1|||
164393741|NCT00744653|593809282|FG000|Overall Study|Lost to Follow-up|1|||
164393742|NCT00744653|593809282|FG000|Overall Study|Physician Decision|3|||
164393743|NCT03826667|593809288|FG000|Overall Study|Protocol deviation|21|||
164393744|NCT00808808|593809289|FG000|Overall Study|Vaccinated; survey not completed|131|||
164393745|NCT00808808|593809290|FG001|Overall Study|Vaccinated; survey not completed|169|||
164393746|NCT00808808|593809291|FG002|Overall Study|Vaccinated; survey not completed|302|||
164393747|NCT00808808|593809289|FG000|Overall Study|Employee was not vaccinated.|2686|||
164393748|NCT00808808|593809290|FG001|Overall Study|Employee was not vaccinated.|2268|||
164393749|NCT00808808|593809291|FG002|Overall Study|Employee was not vaccinated.|2255|||
164393750|NCT02298192|593809295|FG000|Overall Study|Unclassified|3|||
164393751|NCT02298192|593809296|FG001|Overall Study|Unclassified|2|||
164393752|NCT02298192|593809295|FG000|Overall Study|Withdrawal criteria|2|||
164594578|NCT01318083|594539226|FG001|Overall Study|Treatment Complications|0|||
164594579|NCT01318083|594539227|FG002|Overall Study|Treatment Complications|0|||
164393753|NCT02298192|593809296|FG001|Overall Study|Withdrawal criteria|0|||
164393754|NCT02298192|593809295|FG000|Overall Study|Withdrawal by Subject|6|||
164594580|NCT01318083|594539225|FG000|Overall Study|Lack of Study Medication Compliance|0|||
164393755|NCT02298192|593809296|FG001|Overall Study|Withdrawal by Subject|1|||
164393756|NCT02298192|593809295|FG000|Overall Study|Lost to Follow-up|2|||
164393757|NCT02298192|593809296|FG001|Overall Study|Lost to Follow-up|1|||
164393758|NCT02298192|593809295|FG000|Overall Study|Adverse Event|6|||
164393759|NCT02298192|593809296|FG001|Overall Study|Adverse Event|2|||
164393760|NCT02352948|593809298|FG000|Overall Study|Death|47|||
164393761|NCT02352948|593809299|FG001|Overall Study|Death|48|||
164393762|NCT02352948|593809300|FG002|Overall Study|Death|114|||
164393763|NCT02352948|593809301|FG003|Overall Study|Death|74|||
164393764|NCT02352948|593809302|FG004|Overall Study|Death|77|||
164594581|NCT01318083|594539226|FG001|Overall Study|Lack of Study Medication Compliance|1|||
164393765|NCT02352948|593809303|FG005|Overall Study|Death|44|||
164393766|NCT02352948|593809298|FG000|Overall Study|Lost to Follow-up|1|||
164393767|NCT02352948|593809299|FG001|Overall Study|Lost to Follow-up|0|||
164393768|NCT02352948|593809300|FG002|Overall Study|Lost to Follow-up|2|||
164393769|NCT02352948|593809301|FG003|Overall Study|Lost to Follow-up|1|||
164393770|NCT02352948|593809302|FG004|Overall Study|Lost to Follow-up|2|||
164393771|NCT02352948|593809303|FG005|Overall Study|Lost to Follow-up|1|||
164393772|NCT02352948|593809298|FG000|Overall Study|Withdrawal by Subject|1|||
164393773|NCT02352948|593809299|FG001|Overall Study|Withdrawal by Subject|10|||
164393774|NCT02352948|593809300|FG002|Overall Study|Withdrawal by Subject|11|||
164393775|NCT02352948|593809301|FG003|Overall Study|Withdrawal by Subject|23|||
164393776|NCT02352948|593809302|FG004|Overall Study|Withdrawal by Subject|9|||
164393777|NCT02352948|593809303|FG005|Overall Study|Withdrawal by Subject|4|||
164393778|NCT02352948|593809298|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164393779|NCT02352948|593809299|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
164393780|NCT02352948|593809300|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
164441645|NCT02547922|593984446|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
164441646|NCT02547922|593984447|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
164441647|NCT02547922|593984448|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
164441648|NCT02547922|593984446|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
164393781|NCT02352948|593809301|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
164393782|NCT02352948|593809302|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
164393783|NCT02352948|593809303|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
164393784|NCT02352948|593809298|FG000|Overall Study|Other|0|||
164393785|NCT02352948|593809299|FG001|Overall Study|Other|0|||
164393786|NCT02352948|593809300|FG002|Overall Study|Other|2|||
164393787|NCT02352948|593809301|FG003|Overall Study|Other|0|||
164393788|NCT02352948|593809302|FG004|Overall Study|Other|0|||
164441649|NCT02547922|593984447|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
164441650|NCT02547922|593984448|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
164441651|NCT02547922|593984446|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
164441652|NCT02547922|593984447|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
164441653|NCT02547922|593984448|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
164441654|NCT02547922|593984446|FG000|Overall Study|Physician Decision|2|||
164441655|NCT02547922|593984447|FG001|Overall Study|Physician Decision|1|||
164441656|NCT02547922|593984448|FG002|Overall Study|Physician Decision|2|||
164441657|NCT02547922|593984446|FG000|Overall Study|Patients did not receive IP|1|||
164441658|NCT02547922|593984447|FG001|Overall Study|Patients did not receive IP|1|||
164441659|NCT02547922|593984448|FG002|Overall Study|Patients did not receive IP|0|||
164441660|NCT02709655|593984449|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
164441661|NCT02709655|593984450|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
164441662|NCT02709655|593984451|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
164441663|NCT02709655|593984452|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
164441664|NCT02709655|593984453|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
164441665|NCT02709655|593984449|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
164441666|NCT02709655|593984450|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
164441667|NCT02709655|593984451|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
164441668|NCT02709655|593984452|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
164441669|NCT02709655|593984453|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
164441670|NCT02709655|593984449|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
164441671|NCT02709655|593984450|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
164441672|NCT02709655|593984451|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
164441673|NCT02709655|593984452|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
164441674|NCT02709655|593984453|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
164441675|NCT02709655|593984449|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
164441676|NCT02709655|593984450|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
164441677|NCT02709655|593984451|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
164594582|NCT01318083|594539227|FG002|Overall Study|Lack of Study Medication Compliance|0|||
164594583|NCT02028338|594539230|FG000|Overall Study|Withdrawal by Subject|3|||
164594584|NCT02028338|594539231|FG001|Overall Study|Withdrawal by Subject|1|||
164594585|NCT02028338|594539230|FG000|Overall Study|Unable to contact participant|1|||
164594586|NCT02028338|594539231|FG001|Overall Study|Unable to contact participant|0|||
164594587|NCT03552549|594539233|FG000|Overall Study|Disease progression|25|||
164594588|NCT03552549|594539234|FG001|Overall Study|Disease progression|17|||
164594589|NCT03552549|594539233|FG000|Overall Study|Adverse event in first 12 months|12|||
164594590|NCT03552549|594539234|FG001|Overall Study|Adverse event in first 12 months|8|||
164594591|NCT03552549|594539233|FG000|Overall Study|Withdrawal by Subject|7|||
164594592|NCT03552549|594539234|FG001|Overall Study|Withdrawal by Subject|7|||
164594593|NCT03552549|594539233|FG000|Overall Study|Unknown (no reason provided)|4|||
164594594|NCT03552549|594539234|FG001|Overall Study|Unknown (no reason provided)|2|||
164594595|NCT03552549|594539233|FG000|Overall Study|Not in participant's best interest|2|||
164704060|NCT01971970|594941882|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
164393789|NCT02352948|593809303|FG005|Overall Study|Other|0|||
164393790|NCT00234065|593809310|FG000|Overall Study|Adverse Event|268|||
164393791|NCT00234065|593809311|FG001|Overall Study|Adverse Event|166|||
164393792|NCT00234065|593809310|FG000|Overall Study|Withdrawal by Subject|73|||
164393793|NCT00234065|593809311|FG001|Overall Study|Withdrawal by Subject|56|||
164393794|NCT00234065|593809310|FG000|Overall Study|Physician Decision|23|||
164393795|NCT00234065|593809311|FG001|Overall Study|Physician Decision|22|||
164393796|NCT00234065|593809310|FG000|Overall Study|Not Classified|111|||
164393797|NCT00234065|593809311|FG001|Overall Study|Not Classified|112|||
164393798|NCT01292603|593811272|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
164393799|NCT01292603|593811273|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
164393800|NCT01292603|593811274|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
164393801|NCT01292603|593811275|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
164393802|NCT01292603|593811276|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
164393803|NCT01292603|593811277|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
164393804|NCT01292603|593811272|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
164393805|NCT01292603|593811273|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
164393806|NCT01292603|593811274|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
164393807|NCT01292603|593811275|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
164393808|NCT01292603|593811276|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
164393809|NCT01292603|593811277|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
164393810|NCT01292603|593811272|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
164393811|NCT01292603|593811273|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
164393812|NCT01292603|593811274|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
164393813|NCT01292603|593811275|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
164393814|NCT01292603|593811276|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
164393815|NCT01292603|593811277|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
164393816|NCT01292603|593811272|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
164393817|NCT01292603|593811273|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
164393818|NCT01292603|593811274|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
164393819|NCT01292603|593811275|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
164393820|NCT01292603|593811276|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
164393821|NCT01292603|593811277|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
164393822|NCT01292603|593811272|FG000|Part 1: Regular Follow-Up Period|Death|3|||
164393823|NCT01292603|593811273|FG001|Part 1: Regular Follow-Up Period|Death|1|||
164393824|NCT01292603|593811274|FG002|Part 1: Regular Follow-Up Period|Death|3|||
164393825|NCT01292603|593811275|FG003|Part 1: Regular Follow-Up Period|Death|1|||
164393826|NCT01292603|593811276|FG004|Part 1: Regular Follow-Up Period|Death|0|||
164393827|NCT01292603|593811277|FG005|Part 1: Regular Follow-Up Period|Death|0|||
164393828|NCT01292603|593811272|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
164393829|NCT01292603|593811273|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
164393830|NCT01292603|593811274|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
164393831|NCT01292603|593811275|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
164393832|NCT01292603|593811276|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
164393833|NCT01292603|593811277|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
164393834|NCT01292603|593811272|FG000|Part 2: Dose Confirmation Period|Death|0|||
164393835|NCT01292603|593811273|FG001|Part 2: Dose Confirmation Period|Death|0|||
164393836|NCT01292603|593811274|FG002|Part 2: Dose Confirmation Period|Death|0|||
164393837|NCT01292603|593811275|FG003|Part 2: Dose Confirmation Period|Death|0|||
164393838|NCT01292603|593811276|FG004|Part 2: Dose Confirmation Period|Death|1|||
164393839|NCT01292603|593811277|FG005|Part 2: Dose Confirmation Period|Death|0|||
164393840|NCT01292603|593811272|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
164393841|NCT01292603|593811273|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
164393842|NCT01292603|593811274|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
164393843|NCT01292603|593811275|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
164393844|NCT01292603|593811276|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
164393845|NCT01292603|593811277|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
164393846|NCT01292603|593811272|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
164393847|NCT01292603|593811273|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
164393848|NCT01292603|593811274|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
164393849|NCT01292603|593811275|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
164393850|NCT01292603|593811276|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
164393851|NCT01292603|593811277|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
164393852|NCT01292603|593811272|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
164393853|NCT01292603|593811273|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
164393854|NCT01292603|593811274|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
164393855|NCT01292603|593811275|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
164393856|NCT01292603|593811276|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
164393857|NCT01292603|593811277|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
164393858|NCT01292603|593811272|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
164393859|NCT01292603|593811273|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
164393860|NCT01292603|593811274|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
164393861|NCT01292603|593811275|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
164393862|NCT01292603|593811276|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
164393863|NCT01292603|593811277|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
164393864|NCT01292603|593811272|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
164393865|NCT01292603|593811273|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
164393866|NCT01292603|593811274|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
164393867|NCT01292603|593811275|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
164393868|NCT01292603|593811276|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
164393869|NCT01292603|593811277|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
164393870|NCT01292603|593811272|FG000|Part 2: Regular Follow-Up|Death|0|||
164393871|NCT01292603|593811273|FG001|Part 2: Regular Follow-Up|Death|0|||
164393872|NCT01292603|593811274|FG002|Part 2: Regular Follow-Up|Death|0|||
164393873|NCT01292603|593811275|FG003|Part 2: Regular Follow-Up|Death|0|||
164393874|NCT01292603|593811276|FG004|Part 2: Regular Follow-Up|Death|6|||
164393875|NCT01292603|593811277|FG005|Part 2: Regular Follow-Up|Death|3|||
164393876|NCT01292603|593811272|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
164393877|NCT01292603|593811273|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
164393878|NCT01292603|593811274|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
164393879|NCT01292603|593811275|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
164393880|NCT01292603|593811276|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
164393881|NCT01292603|593811277|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
164393882|NCT01292603|593811272|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
164393883|NCT01292603|593811273|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
164393884|NCT01292603|593811274|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
164393885|NCT01292603|593811275|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
164393886|NCT01292603|593811276|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
164393887|NCT01292603|593811277|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
164393888|NCT01292603|593811272|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
164393889|NCT01292603|593811273|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
164393890|NCT01292603|593811274|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
164393891|NCT01292603|593811275|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
164393892|NCT01292603|593811276|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
164393893|NCT01292603|593811277|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
164393894|NCT01292603|593811272|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
164393895|NCT01292603|593811273|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
164393896|NCT01292603|593811274|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
164393897|NCT01292603|593811275|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
164393898|NCT01292603|593811276|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
164393899|NCT01292603|593811277|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
164393900|NCT01292603|593811272|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
164393901|NCT01292603|593811273|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
164393902|NCT01292603|593811274|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
164393903|NCT01292603|593811275|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
164393904|NCT01292603|593811276|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
164393905|NCT01292603|593811277|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
164393906|NCT01292603|593811272|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
164393907|NCT01292603|593811273|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
164393908|NCT01292603|593811274|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
164393909|NCT01292603|593811275|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
164393910|NCT01292603|593811276|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
164393911|NCT01292603|593811277|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
164393912|NCT01292603|593811272|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
164393913|NCT01292603|593811273|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
164393914|NCT01292603|593811274|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
164393915|NCT01292603|593811275|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
164393916|NCT01292603|593811276|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
164393917|NCT01292603|593811277|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
164393918|NCT01292603|593811272|FG000|Overall Survival Status|Death|3|||
164393919|NCT01292603|593811273|FG001|Overall Survival Status|Death|1|||
164393920|NCT01292603|593811274|FG002|Overall Survival Status|Death|3|||
164393921|NCT01292603|593811275|FG003|Overall Survival Status|Death|1|||
164393922|NCT01292603|593811276|FG004|Overall Survival Status|Death|16|||
164393923|NCT01292603|593811277|FG005|Overall Survival Status|Death|10|||
164393924|NCT03912259|593811278|FG000|Overall Study|Adverse Event (AE)|2|||
164393925|NCT03912259|593811279|FG001|Overall Study|Adverse Event (AE)|4|||
164393926|NCT03912259|593811278|FG000|Overall Study|Lack of Efficacy|4|||
164393927|NCT03912259|593811279|FG001|Overall Study|Lack of Efficacy|1|||
164393928|NCT03912259|593811278|FG000|Overall Study|Withdrawal by Subject|11|||
164393929|NCT03912259|593811279|FG001|Overall Study|Withdrawal by Subject|1|||
164393930|NCT00381940|593811280|FG000|Overall Study|Lack of Efficacy|3|||
164393931|NCT00381940|593811280|FG000|Overall Study|Protocol Violation|1|||
164393932|NCT00381940|593811280|FG000|Overall Study|Ineligible|1|||
164393933|NCT03162224|593811281|FG000|Overall Study|Death|4|||
164393934|NCT03162224|593811282|FG001|Overall Study|Death|5|||
164393935|NCT03162224|593811283|FG002|Overall Study|Death|8|||
164393936|NCT03162224|593811281|FG000|Overall Study|Withdrawal by Subject|1|||
164393937|NCT03162224|593811282|FG001|Overall Study|Withdrawal by Subject|0|||
164393938|NCT03162224|593811283|FG002|Overall Study|Withdrawal by Subject|1|||
164393939|NCT03162224|593811281|FG000|Overall Study|Lost to Follow-up|0|||
164393940|NCT03162224|593811282|FG001|Overall Study|Lost to Follow-up|1|||
164393941|NCT03162224|593811283|FG002|Overall Study|Lost to Follow-up|0|||
164393942|NCT03162224|593811281|FG000|Overall Study|Other|6|||
164393943|NCT03162224|593811282|FG001|Overall Study|Other|2|||
164393944|NCT03162224|593811283|FG002|Overall Study|Other|1|||
164393945|NCT00082173|593811284|FG000|Overall Study|Withdrawal by Subject|3|||
164393946|NCT00082173|593811285|FG001|Overall Study|Withdrawal by Subject|5|||
164393947|NCT00082173|593811284|FG000|Overall Study|Lost to Follow-up|1|||
164393948|NCT00082173|593811285|FG001|Overall Study|Lost to Follow-up|0|||
164393949|NCT00082173|593811284|FG000|Overall Study|Adverse Event|1|||
164393950|NCT00082173|593811285|FG001|Overall Study|Adverse Event|0|||
164393951|NCT00082173|593811284|FG000|Overall Study|Culture negative or resistant at baselin|5|||
164393952|NCT00082173|593811285|FG001|Overall Study|Culture negative or resistant at baselin|6|||
164393953|NCT02633137|593811294|FG000|Overall Study|Adverse Event|1|||
164393954|NCT02633137|593811294|FG000|Overall Study|Lack of Efficacy|2|||
164393955|NCT02633137|593811294|FG000|Overall Study|Withdrawal by Subject|1|||
164393956|NCT04307004|593811295|FG000|Randomization 1|Withdrawal by Subject|25|||
164594596|NCT03552549|594539234|FG001|Overall Study|Not in participant's best interest|1|||
164594597|NCT03552549|594539233|FG000|Overall Study|Did not complete study treatment|2|||
164594598|NCT03552549|594539234|FG001|Overall Study|Did not complete study treatment|3|||
164393957|NCT04307004|593811296|FG001|Randomization 1|Withdrawal by Subject|26|||
164393958|NCT04307004|593811297|FG002|Randomization 1|Withdrawal by Subject|0|||
164393959|NCT04307004|593811298|FG003|Randomization 1|Withdrawal by Subject|0|||
164393960|NCT04307004|593811295|FG000|Randomization 2|Withdrawal by Subject|0|||
164393961|NCT04307004|593811296|FG001|Randomization 2|Withdrawal by Subject|0|||
164393962|NCT04307004|593811297|FG002|Randomization 2|Withdrawal by Subject|28|||
164393963|NCT04307004|593811298|FG003|Randomization 2|Withdrawal by Subject|23|||
164393964|NCT02807558|593811299|FG000|Overall Study|Consent withdrawn by participant|4|||
164393965|NCT02807558|593811300|FG001|Overall Study|Consent withdrawn by participant|0|||
164393966|NCT02807558|593811301|FG002|Overall Study|Consent withdrawn by participant|4|||
164393967|NCT02807558|593811302|FG003|Overall Study|Consent withdrawn by participant|2|||
164393968|NCT02807558|593811303|FG004|Overall Study|Consent withdrawn by participant|1|||
164393969|NCT02807558|593811304|FG005|Overall Study|Consent withdrawn by participant|0|||
164393970|NCT02807558|593811299|FG000|Overall Study|Non-compliance with Study Drug|0|||
164393971|NCT02807558|593811300|FG001|Overall Study|Non-compliance with Study Drug|0|||
164393972|NCT02807558|593811301|FG002|Overall Study|Non-compliance with Study Drug|1|||
164393973|NCT02807558|593811302|FG003|Overall Study|Non-compliance with Study Drug|0|||
164393974|NCT02807558|593811303|FG004|Overall Study|Non-compliance with Study Drug|0|||
164393975|NCT02807558|593811304|FG005|Overall Study|Non-compliance with Study Drug|0|||
164393976|NCT02807558|593811299|FG000|Overall Study|Adverse Event|0|||
164393977|NCT02807558|593811300|FG001|Overall Study|Adverse Event|0|||
164393978|NCT02807558|593811301|FG002|Overall Study|Adverse Event|9|||
164393979|NCT02807558|593811302|FG003|Overall Study|Adverse Event|0|||
164393980|NCT02807558|593811303|FG004|Overall Study|Adverse Event|0|||
164594599|NCT03552549|594539233|FG000|Overall Study|Did not meet eligibility criteria|1|||
164594600|NCT03552549|594539234|FG001|Overall Study|Did not meet eligibility criteria|0|||
164393981|NCT02807558|593811304|FG005|Overall Study|Adverse Event|0|||
164393982|NCT02807558|593811299|FG000|Overall Study|Death|23|||
164393983|NCT02807558|593811300|FG001|Overall Study|Death|2|||
164393984|NCT02807558|593811301|FG002|Overall Study|Death|3|||
164393985|NCT02807558|593811302|FG003|Overall Study|Death|43|||
164393986|NCT02807558|593811303|FG004|Overall Study|Death|24|||
164393987|NCT02807558|593811304|FG005|Overall Study|Death|15|||
164393988|NCT02807558|593811299|FG000|Overall Study|Progressive Disease|0|||
164393989|NCT02807558|593811300|FG001|Overall Study|Progressive Disease|0|||
164393990|NCT02807558|593811301|FG002|Overall Study|Progressive Disease|1|||
164393991|NCT02807558|593811302|FG003|Overall Study|Progressive Disease|0|||
164393992|NCT02807558|593811303|FG004|Overall Study|Progressive Disease|0|||
164393993|NCT02807558|593811304|FG005|Overall Study|Progressive Disease|0|||
164393994|NCT02807558|593811299|FG000|Overall Study|Other than specified|1|||
164393995|NCT02807558|593811300|FG001|Overall Study|Other than specified|0|||
164393996|NCT02807558|593811301|FG002|Overall Study|Other than specified|2|||
164393997|NCT02807558|593811302|FG003|Overall Study|Other than specified|0|||
164393998|NCT02807558|593811303|FG004|Overall Study|Other than specified|1|||
164393999|NCT02807558|593811304|FG005|Overall Study|Other than specified|1|||
164394000|NCT02807558|593811299|FG000|Overall Study|Lack of Efficacy|0|||
164394001|NCT02807558|593811300|FG001|Overall Study|Lack of Efficacy|0|||
164594601|NCT03552549|594539233|FG000|Overall Study|Administrative|0|||
164594602|NCT03552549|594539234|FG001|Overall Study|Administrative|14|||
164594603|NCT02761993|594539237|FG000|Overall Study|Adverse Event|0|||
164594604|NCT02761993|594539238|FG001|Overall Study|Adverse Event|2|||
164594605|NCT02761993|594539239|FG002|Overall Study|Adverse Event|0|||
164594606|NCT02761993|594539237|FG000|Overall Study|Lost to Follow-up|1|||
164594607|NCT02761993|594539238|FG001|Overall Study|Lost to Follow-up|3|||
164594608|NCT02761993|594539239|FG002|Overall Study|Lost to Follow-up|2|||
164594609|NCT02761993|594539237|FG000|Overall Study|Withdrawal by Subject|1|||
164394002|NCT02807558|593811301|FG002|Overall Study|Lack of Efficacy|9|||
164394003|NCT02807558|593811302|FG003|Overall Study|Lack of Efficacy|0|||
164394004|NCT02807558|593811303|FG004|Overall Study|Lack of Efficacy|0|||
164394005|NCT02807558|593811304|FG005|Overall Study|Lack of Efficacy|0|||
164394006|NCT01972841|593811305|FG000|Overall Study|Randomized but Never Received Treatment|2|||
164394007|NCT01972841|593811306|FG001|Overall Study|Randomized but Never Received Treatment|5|||
164394008|NCT01972841|593811307|FG002|Overall Study|Randomized but Never Received Treatment|4|||
164394009|NCT01972841|593811308|FG003|Overall Study|Randomized but Never Received Treatment|2|||
164394010|NCT01972841|593811309|FG004|Overall Study|Randomized but Never Received Treatment|6|||
164394011|NCT01972841|593811310|FG005|Overall Study|Randomized but Never Received Treatment|13|||
164394012|NCT01972841|593811305|FG000|Overall Study|Adverse Event|13|||
164394013|NCT01972841|593811306|FG001|Overall Study|Adverse Event|8|||
164394014|NCT01972841|593811307|FG002|Overall Study|Adverse Event|12|||
164394015|NCT01972841|593811308|FG003|Overall Study|Adverse Event|9|||
164394016|NCT01972841|593811309|FG004|Overall Study|Adverse Event|21|||
164394017|NCT01972841|593811310|FG005|Overall Study|Adverse Event|26|||
164394018|NCT01972841|593811305|FG000|Overall Study|Lack of Efficacy|1|||
164394019|NCT01972841|593811306|FG001|Overall Study|Lack of Efficacy|0|||
164394020|NCT01972841|593811307|FG002|Overall Study|Lack of Efficacy|0|||
164394021|NCT01972841|593811308|FG003|Overall Study|Lack of Efficacy|2|||
164394022|NCT01972841|593811309|FG004|Overall Study|Lack of Efficacy|4|||
164394023|NCT01972841|593811310|FG005|Overall Study|Lack of Efficacy|1|||
164394024|NCT01972841|593811305|FG000|Overall Study|Lost to Follow-up|4|||
164394025|NCT01972841|593811306|FG001|Overall Study|Lost to Follow-up|2|||
164394026|NCT01972841|593811307|FG002|Overall Study|Lost to Follow-up|4|||
164394027|NCT01972841|593811308|FG003|Overall Study|Lost to Follow-up|2|||
164394028|NCT01972841|593811309|FG004|Overall Study|Lost to Follow-up|9|||
164394029|NCT01972841|593811310|FG005|Overall Study|Lost to Follow-up|3|||
164394030|NCT01972841|593811305|FG000|Overall Study|Protocol Violation|2|||
164394031|NCT01972841|593811306|FG001|Overall Study|Protocol Violation|2|||
164394032|NCT01972841|593811307|FG002|Overall Study|Protocol Violation|3|||
164394033|NCT01972841|593811308|FG003|Overall Study|Protocol Violation|5|||
164394034|NCT01972841|593811309|FG004|Overall Study|Protocol Violation|9|||
164394035|NCT01972841|593811310|FG005|Overall Study|Protocol Violation|4|||
164394036|NCT01972841|593811305|FG000|Overall Study|Withdrawal by participants|21|||
164394037|NCT01972841|593811306|FG001|Overall Study|Withdrawal by participants|27|||
164394038|NCT01972841|593811307|FG002|Overall Study|Withdrawal by participants|23|||
164394039|NCT01972841|593811308|FG003|Overall Study|Withdrawal by participants|16|||
164394040|NCT01972841|593811309|FG004|Overall Study|Withdrawal by participants|33|||
164394041|NCT01972841|593811310|FG005|Overall Study|Withdrawal by participants|34|||
164394042|NCT01972841|593811305|FG000|Overall Study|Miscellaneous|0|||
164394043|NCT01972841|593811306|FG001|Overall Study|Miscellaneous|0|||
164394044|NCT01972841|593811307|FG002|Overall Study|Miscellaneous|4|||
164594610|NCT02761993|594539238|FG001|Overall Study|Withdrawal by Subject|1|||
164394045|NCT01972841|593811308|FG003|Overall Study|Miscellaneous|1|||
164394046|NCT01972841|593811309|FG004|Overall Study|Miscellaneous|0|||
164394047|NCT01972841|593811310|FG005|Overall Study|Miscellaneous|4|||
164394048|NCT01972841|593811305|FG000|Overall Study|Did not have end of treatment page|0|||
164394049|NCT01972841|593811306|FG001|Overall Study|Did not have end of treatment page|0|||
164394050|NCT01972841|593811307|FG002|Overall Study|Did not have end of treatment page|0|||
164394051|NCT01972841|593811308|FG003|Overall Study|Did not have end of treatment page|0|||
164394052|NCT01972841|593811309|FG004|Overall Study|Did not have end of treatment page|1|||
164394053|NCT01972841|593811310|FG005|Overall Study|Did not have end of treatment page|0|||
164394054|NCT04391023|593811313|FG000|Overall Study|Withdrawal by Subject|2|||
164394055|NCT04391023|593811314|FG001|Overall Study|Withdrawal by Subject|2|||
164394056|NCT01270347|593811316|FG000|Core Phase|Adverse Event|1|||
164394057|NCT01270347|593811317|FG001|Core Phase|Adverse Event|6|||
164394058|NCT01270347|593811316|FG000|Core Phase|Withdrawal by Subject|1|||
164394059|NCT01270347|593811317|FG001|Core Phase|Withdrawal by Subject|2|||
164394060|NCT01270347|593811316|FG000|Core Phase|Lost to Follow-up|0|||
164394061|NCT01270347|593811317|FG001|Core Phase|Lost to Follow-up|1|||
164394062|NCT01270347|593811316|FG000|Core Phase|Miscellaneous|8|||
164394063|NCT01270347|593811317|FG001|Core Phase|Miscellaneous|14|||
164394064|NCT01270347|593811316|FG000|Extension Phase|Adverse Event|1|||
164394065|NCT01270347|593811317|FG001|Extension Phase|Adverse Event|3|||
164394066|NCT01270347|593811316|FG000|Extension Phase|Withdrawal by Subject|3|||
164394067|NCT01270347|593811317|FG001|Extension Phase|Withdrawal by Subject|4|||
164394068|NCT01270347|593811316|FG000|Extension Phase|Miscellaneous|2|||
164594611|NCT02761993|594539239|FG002|Overall Study|Withdrawal by Subject|2|||
164594612|NCT04072146|594539244|FG000|Overall Study|Adverse Event|0|||
164394069|NCT01270347|593811317|FG001|Extension Phase|Miscellaneous|2|||
164394070|NCT02085408|593811318|FG000|Step 1: Induction|Disease Progression|19|||
164394071|NCT02085408|593811319|FG001|Step 1: Induction|Disease Progression|19|||
164394072|NCT02085408|593811318|FG000|Step 1: Induction|Adverse Event|18|||
164394073|NCT02085408|593811319|FG001|Step 1: Induction|Adverse Event|17|||
164394074|NCT02085408|593811318|FG000|Step 1: Induction|Death|33|||
164394075|NCT02085408|593811319|FG001|Step 1: Induction|Death|30|||
164594613|NCT04072146|594539245|FG001|Overall Study|Adverse Event|1|||
164594614|NCT03050359|594541008|FG000|Overall Study|Randomized But Not Treated|2|||
164594615|NCT03050359|594541009|FG001|Overall Study|Randomized But Not Treated|0|||
164594616|NCT03050359|594541008|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
164594617|NCT03050359|594541009|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
164594618|NCT03050359|594541008|FG000|Overall Study|Significant Protocol Deviation|2|||
164594619|NCT03050359|594541009|FG001|Overall Study|Significant Protocol Deviation|3|||
164594620|NCT03050359|594541008|FG000|Overall Study|Lost to Follow-up|2|||
164594621|NCT03050359|594541009|FG001|Overall Study|Lost to Follow-up|1|||
164594622|NCT03050359|594541008|FG000|Overall Study|Voluntary Withdrawal|4|||
164594623|NCT03050359|594541009|FG001|Overall Study|Voluntary Withdrawal|6|||
164594624|NCT03050359|594541008|FG000|Overall Study|Pregnancy|1|||
164594625|NCT03050359|594541009|FG001|Overall Study|Pregnancy|0|||
164594626|NCT03050359|594541008|FG000|Overall Study|Reason Not Specified|1|||
164594627|NCT03050359|594541009|FG001|Overall Study|Reason Not Specified|0|||
164594628|NCT02020031|594541010|FG000|Overall Study|Physician Decision|1|||
164594629|NCT02020031|594541011|FG001|Overall Study|Physician Decision|1|||
164594630|NCT00755846|594541014|FG000|Overall Study|Adverse Event|0|||
164394076|NCT02085408|593811318|FG000|Step 1: Induction|Withdrawal by Subject|16|||
164394077|NCT02085408|593811319|FG001|Step 1: Induction|Withdrawal by Subject|8|||
164594631|NCT00755846|594541015|FG001|Overall Study|Adverse Event|0|||
164394078|NCT02085408|593811318|FG000|Step 1: Induction|Alternative Therapy|15|||
164394079|NCT02085408|593811319|FG001|Step 1: Induction|Alternative Therapy|19|||
164394080|NCT02085408|593811318|FG000|Step 1: Induction|Complicating Disease|2|||
164394081|NCT02085408|593811319|FG001|Step 1: Induction|Complicating Disease|3|||
164394082|NCT02085408|593811318|FG000|Step 1: Induction|Other|27|||
164394083|NCT02085408|593811319|FG001|Step 1: Induction|Other|39|||
164394084|NCT02085408|593811318|FG000|Step 1: Induction|Never started treatment|6|||
164394085|NCT02085408|593811319|FG001|Step 1: Induction|Never started treatment|4|||
164394086|NCT02085408|593811318|FG000|Step 2: Consolidation|Disease Progression|5|||
164394087|NCT02085408|593811319|FG001|Step 2: Consolidation|Disease Progression|20|||
164394088|NCT02085408|593811318|FG000|Step 2: Consolidation|Adverse Event|9|||
164394089|NCT02085408|593811319|FG001|Step 2: Consolidation|Adverse Event|8|||
164394090|NCT02085408|593811318|FG000|Step 2: Consolidation|Death|4|||
164394091|NCT02085408|593811319|FG001|Step 2: Consolidation|Death|3|||
164394092|NCT02085408|593811318|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
164394093|NCT02085408|593811319|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
164394094|NCT02085408|593811318|FG000|Step 2: Consolidation|Alternative Therapy|9|||
164394095|NCT02085408|593811319|FG001|Step 2: Consolidation|Alternative Therapy|3|||
164394096|NCT02085408|593811318|FG000|Step 2: Consolidation|Complicating Disease|0|||
164394097|NCT02085408|593811319|FG001|Step 2: Consolidation|Complicating Disease|2|||
164394098|NCT02085408|593811318|FG000|Step 2: Consolidation|Other|6|||
164394099|NCT02085408|593811319|FG001|Step 2: Consolidation|Other|6|||
164394100|NCT02085408|593811318|FG000|Step 2: Consolidation|Never started treatment|4|||
164394101|NCT02085408|593811319|FG001|Step 2: Consolidation|Never started treatment|3|||
164394102|NCT02085408|593811318|FG000|Step 3: Maintenance|Disease Progression|13|||
164394103|NCT02085408|593811319|FG001|Step 3: Maintenance|Disease Progression|11|||
164394104|NCT02085408|593811318|FG000|Step 3: Maintenance|Adverse Event|2|||
164394105|NCT02085408|593811319|FG001|Step 3: Maintenance|Adverse Event|4|||
164394106|NCT02085408|593811318|FG000|Step 3: Maintenance|Death|1|||
164394107|NCT02085408|593811319|FG001|Step 3: Maintenance|Death|2|||
164394108|NCT02085408|593811318|FG000|Step 3: Maintenance|Alternative Therapy|1|||
164394109|NCT02085408|593811319|FG001|Step 3: Maintenance|Alternative Therapy|1|||
164394110|NCT02085408|593811318|FG000|Step 3: Maintenance|Complicating Disease|0|||
164394111|NCT02085408|593811319|FG001|Step 3: Maintenance|Complicating Disease|1|||
164394112|NCT02085408|593811318|FG000|Step 3: Maintenance|Other|3|||
164394113|NCT02085408|593811319|FG001|Step 3: Maintenance|Other|2|||
164394114|NCT02085408|593811318|FG000|Step 3: Maintenance|Never started treatment|5|||
164394115|NCT02085408|593811319|FG001|Step 3: Maintenance|Never started treatment|1|||
164394116|NCT00688636|593811324|FG000|Overall Study|Adverse Event|2|||
164594632|NCT00755846|594541016|FG002|Overall Study|Adverse Event|0|||
164594633|NCT00755846|594541017|FG003|Overall Study|Adverse Event|1|||
164394117|NCT00688636|593811325|FG001|Overall Study|Adverse Event|1|||
164394118|NCT01572727|593811326|FG000|Overall Study|Adverse Event|43|||
164394119|NCT01572727|593811327|FG001|Overall Study|Adverse Event|15|||
164394120|NCT01572727|593811326|FG000|Overall Study|Lost to Follow-up|1|||
164394121|NCT01572727|593811327|FG001|Overall Study|Lost to Follow-up|1|||
164394122|NCT01572727|593811326|FG000|Overall Study|Physician Decision|23|||
164594634|NCT00755846|594541018|FG004|Overall Study|Adverse Event|3|||
164594635|NCT00755846|594541019|FG005|Overall Study|Adverse Event|2|||
164594636|NCT00755846|594541014|FG000|Overall Study|Protocol Violation|1|||
164394123|NCT01572727|593811327|FG001|Overall Study|Physician Decision|9|||
164394124|NCT01572727|593811326|FG000|Overall Study|Progressive disease|59|||
164394125|NCT01572727|593811327|FG001|Overall Study|Progressive disease|82|||
164394126|NCT01572727|593811326|FG000|Overall Study|Protocol Violation|0|||
164394127|NCT01572727|593811327|FG001|Overall Study|Protocol Violation|1|||
164394128|NCT01572727|593811326|FG000|Overall Study|Study terminated by sponsor|61|||
164394129|NCT01572727|593811327|FG001|Overall Study|Study terminated by sponsor|83|||
164394130|NCT01572727|593811326|FG000|Overall Study|Parent/guardian decision|14|||
164394131|NCT01572727|593811327|FG001|Overall Study|Parent/guardian decision|9|||
164394132|NCT01572727|593811326|FG000|Overall Study|Death|2|||
164394133|NCT01572727|593811327|FG001|Overall Study|Death|2|||
164394134|NCT01572727|593811326|FG000|Overall Study|Untreated|4|||
164394135|NCT01572727|593811327|FG001|Overall Study|Untreated|7|||
164394136|NCT04053764|593811328|FG000|Overall Study|Withdrawal by Subject|6|||
164394137|NCT04053764|593811329|FG001|Overall Study|Withdrawal by Subject|2|||
164394138|NCT04053764|593811328|FG000|Overall Study|Physician Decision|2|||
164394139|NCT04053764|593811329|FG001|Overall Study|Physician Decision|1|||
164394140|NCT04053764|593811328|FG000|Overall Study|Adverse Event|1|||
164394141|NCT04053764|593811329|FG001|Overall Study|Adverse Event|0|||
164394142|NCT04053764|593811328|FG000|Overall Study|Pregnancy|1|||
164394143|NCT04053764|593811329|FG001|Overall Study|Pregnancy|0|||
164394144|NCT04732286|593811333|FG000|Overall Study|Progressive Disease|2|||
164394145|NCT04732286|593811333|FG000|Overall Study|Physician Decision|1|||
164394146|NCT04732286|593811333|FG000|Overall Study|Study Terminated by Sponsor|31|||
164394147|NCT04732286|593811333|FG000|Overall Study|Withdrawal by Subject|10|||
164394148|NCT04732286|593811333|FG000|Overall Study|Non-compliance With Study Drug|1|||
164394149|NCT04732286|593811333|FG000|Overall Study|Lost to Follow-up|4|||
164394150|NCT04732286|593811333|FG000|Overall Study|Death|51|||
164394151|NCT00335322|593811335|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
164394152|NCT00335322|593811336|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
164394153|NCT00335322|593811337|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
164394154|NCT02195986|593811340|FG000|Overall Study|Adverse Event|3|||
164394155|NCT02195986|593811341|FG001|Overall Study|Adverse Event|0|||
164394156|NCT02195986|593811342|FG002|Overall Study|Adverse Event|0|||
164394157|NCT02195986|593811340|FG000|Overall Study|Withdrawal by Subject|0|||
164394158|NCT02195986|593811341|FG001|Overall Study|Withdrawal by Subject|3|||
164394159|NCT02195986|593811342|FG002|Overall Study|Withdrawal by Subject|0|||
164394160|NCT02195986|593811340|FG000|Overall Study|Family Emergency|0|||
164394161|NCT02195986|593811341|FG001|Overall Study|Family Emergency|0|||
164394162|NCT02195986|593811342|FG002|Overall Study|Family Emergency|1|||
164394163|NCT02195986|593811340|FG000|Overall Study|Protocol Violation|0|||
164394164|NCT02195986|593811341|FG001|Overall Study|Protocol Violation|1|||
164394165|NCT02195986|593811342|FG002|Overall Study|Protocol Violation|1|||
164394166|NCT02195986|593811340|FG000|Overall Study|Non-compliance|0|||
164394167|NCT02195986|593811341|FG001|Overall Study|Non-compliance|1|||
164394168|NCT02195986|593811342|FG002|Overall Study|Non-compliance|0|||
164394169|NCT02834780|593811343|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
164394170|NCT02834780|593811344|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
164394171|NCT02834780|593811345|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
164394172|NCT02834780|593811346|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
164394173|NCT02834780|593811347|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
164394174|NCT02834780|593811348|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
164394175|NCT02834780|593811349|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
164394176|NCT02834780|593811350|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
164394177|NCT02834780|593811351|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
164394178|NCT02834780|593811352|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
164394179|NCT02834780|593811353|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
164394180|NCT02834780|593811354|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
164394181|NCT02834780|593811355|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
164394182|NCT02834780|593811343|FG000|Overall Study|Withdrawal by Subject|0|||
164394183|NCT02834780|593811344|FG001|Overall Study|Withdrawal by Subject|0|||
164394184|NCT02834780|593811345|FG002|Overall Study|Withdrawal by Subject|1|||
164394185|NCT02834780|593811346|FG003|Overall Study|Withdrawal by Subject|0|||
164394186|NCT02834780|593811347|FG004|Overall Study|Withdrawal by Subject|0|||
164394187|NCT02834780|593811348|FG005|Overall Study|Withdrawal by Subject|0|||
164394188|NCT02834780|593811349|FG006|Overall Study|Withdrawal by Subject|0|||
164394189|NCT02834780|593811350|FG007|Overall Study|Withdrawal by Subject|0|||
164394190|NCT02834780|593811351|FG008|Overall Study|Withdrawal by Subject|0|||
164394191|NCT02834780|593811352|FG009|Overall Study|Withdrawal by Subject|0|||
164394192|NCT02834780|593811353|FG010|Overall Study|Withdrawal by Subject|1|||
164704061|NCT01971970|594941883|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
164704062|NCT01971970|594941882|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
164704063|NCT01971970|594941883|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
164704064|NCT01831765|594941884|FG000|Overall Study|Lack of Efficacy|1|||
164394193|NCT02834780|593811354|FG011|Overall Study|Withdrawal by Subject|0|||
164394194|NCT02834780|593811355|FG012|Overall Study|Withdrawal by Subject|0|||
164394195|NCT02834780|593811343|FG000|Overall Study|Adverse Event|0|||
164394196|NCT02834780|593811344|FG001|Overall Study|Adverse Event|0|||
164394197|NCT02834780|593811345|FG002|Overall Study|Adverse Event|0|||
164394198|NCT02834780|593811346|FG003|Overall Study|Adverse Event|0|||
164394199|NCT02834780|593811347|FG004|Overall Study|Adverse Event|1|||
164394200|NCT02834780|593811348|FG005|Overall Study|Adverse Event|0|||
164394201|NCT02834780|593811349|FG006|Overall Study|Adverse Event|1|||
164394202|NCT02834780|593811350|FG007|Overall Study|Adverse Event|1|||
164394203|NCT02834780|593811351|FG008|Overall Study|Adverse Event|0|||
164394204|NCT02834780|593811352|FG009|Overall Study|Adverse Event|2|||
164394205|NCT02834780|593811353|FG010|Overall Study|Adverse Event|0|||
164394206|NCT02834780|593811354|FG011|Overall Study|Adverse Event|3|||
164394207|NCT02834780|593811355|FG012|Overall Study|Adverse Event|2|||
164394208|NCT02834780|593811343|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
164394209|NCT02834780|593811344|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
164394210|NCT02834780|593811345|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
164394211|NCT02834780|593811346|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
164394212|NCT02834780|593811347|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
164394213|NCT02834780|593811348|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
164394214|NCT02834780|593811349|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
164394215|NCT02834780|593811350|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
164394216|NCT02834780|593811351|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
164394217|NCT02834780|593811352|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
164394218|NCT02834780|593811353|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
164394219|NCT02834780|593811354|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
164394220|NCT02834780|593811355|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
164394221|NCT02834780|593811343|FG000|Overall Study|Other|1|||
164394222|NCT02834780|593811344|FG001|Overall Study|Other|0|||
164394223|NCT02834780|593811345|FG002|Overall Study|Other|1|||
164394224|NCT02834780|593811346|FG003|Overall Study|Other|2|||
164394225|NCT02834780|593811347|FG004|Overall Study|Other|0|||
164394226|NCT02834780|593811348|FG005|Overall Study|Other|0|||
164394227|NCT02834780|593811349|FG006|Overall Study|Other|0|||
164394228|NCT02834780|593811350|FG007|Overall Study|Other|0|||
164394229|NCT02834780|593811351|FG008|Overall Study|Other|0|||
164394230|NCT02834780|593811352|FG009|Overall Study|Other|0|||
164394231|NCT02834780|593811353|FG010|Overall Study|Other|0|||
164394232|NCT02834780|593811354|FG011|Overall Study|Other|0|||
164394233|NCT02834780|593811355|FG012|Overall Study|Other|1|||
164394234|NCT03150056|593811356|FG000|Overall Study|Withdrawal by Subject|0|||
164394235|NCT03150056|593811357|FG001|Overall Study|Withdrawal by Subject|0|||
164394236|NCT03150056|593811358|FG002|Overall Study|Withdrawal by Subject|0|||
164394237|NCT03150056|593811359|FG003|Overall Study|Withdrawal by Subject|0|||
164394238|NCT03150056|593811360|FG004|Overall Study|Withdrawal by Subject|0|||
164394239|NCT03150056|593811361|FG005|Overall Study|Withdrawal by Subject|2|||
164394240|NCT03150056|593811356|FG000|Overall Study|Study terminated by Sponsor|1|||
164394241|NCT03150056|593811357|FG001|Overall Study|Study terminated by Sponsor|3|||
164394242|NCT03150056|593811358|FG002|Overall Study|Study terminated by Sponsor|1|||
164394243|NCT03150056|593811359|FG003|Overall Study|Study terminated by Sponsor|1|||
164394244|NCT03150056|593811360|FG004|Overall Study|Study terminated by Sponsor|5|||
164394245|NCT03150056|593811361|FG005|Overall Study|Study terminated by Sponsor|6|||
164394246|NCT03150056|593811356|FG000|Overall Study|Death|9|||
164394247|NCT03150056|593811357|FG001|Overall Study|Death|2|||
164394248|NCT03150056|593811358|FG002|Overall Study|Death|2|||
164394249|NCT03150056|593811359|FG003|Overall Study|Death|7|||
164394250|NCT03150056|593811360|FG004|Overall Study|Death|8|||
164394251|NCT03150056|593811361|FG005|Overall Study|Death|10|||
164394252|NCT01939028|593811364|FG000|Overall Study|Withdrawal by Subject|5|||
164394253|NCT01939028|593811364|FG000|Overall Study|Physician Decision|7|||
164394254|NCT03282227|593811367|FG000|Overall Study|Exposure Goals Achieved|60|||
164394255|NCT03282227|593811367|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
164394256|NCT03282227|593811367|FG000|Overall Study|Adverse Event|15|||
164394257|NCT03282227|593811367|FG000|Overall Study|Lost to Follow-up|21|||
164394258|NCT03282227|593811367|FG000|Overall Study|Withdrawal by Subject|20|||
164394259|NCT03282227|593811367|FG000|Overall Study|Lack of Efficacy|12|||
164394260|NCT03282227|593811367|FG000|Overall Study|Sponsor decision|3|||
164394261|NCT03282227|593811367|FG000|Overall Study|Physician Decision|2|||
164394262|NCT03282227|593811367|FG000|Overall Study|Pregnancy|2|||
164394263|NCT03282227|593811367|FG000|Overall Study|Other|1|||
164394264|NCT02576678|593811368|FG000|Overall Study|Adverse Event|0|||
164394265|NCT02576678|593811369|FG001|Overall Study|Adverse Event|0|||
164394266|NCT02576678|593811370|FG002|Overall Study|Adverse Event|2|||
164394267|NCT02576678|593811368|FG000|Overall Study|Withdrawal by Subject|3|||
164394268|NCT02576678|593811369|FG001|Overall Study|Withdrawal by Subject|1|||
164394269|NCT02576678|593811370|FG002|Overall Study|Withdrawal by Subject|2|||
164394270|NCT02576678|593811368|FG000|Overall Study|Lost to Follow-up|0|||
164394271|NCT02576678|593811369|FG001|Overall Study|Lost to Follow-up|0|||
164394272|NCT02576678|593811370|FG002|Overall Study|Lost to Follow-up|1|||
164394273|NCT02576678|593811368|FG000|Overall Study|Miscellaneous|2|||
164394274|NCT02576678|593811369|FG001|Overall Study|Miscellaneous|0|||
164394275|NCT02576678|593811370|FG002|Overall Study|Miscellaneous|0|||
164394276|NCT03240692|593811375|FG000|Overall Study|Physician Decision|1|||
164394277|NCT03240692|593811375|FG000|Overall Study|Withdrawal by Subject|1|||
164394278|NCT00683644|593811376|FG000|Overall Study|Withdrawal by Subject|4|||
164394279|NCT00683644|593811377|FG001|Overall Study|Withdrawal by Subject|2|||
164394280|NCT00683644|593811376|FG000|Overall Study|Lost to Follow-up|1|||
164394281|NCT00683644|593811377|FG001|Overall Study|Lost to Follow-up|4|||
164394282|NCT00683644|593811376|FG000|Overall Study|Adverse Event|1|||
164394283|NCT00683644|593811377|FG001|Overall Study|Adverse Event|2|||
164394284|NCT00683644|593811376|FG000|Overall Study|Low copper, other health problems,|7|||
164394285|NCT00683644|593811377|FG001|Overall Study|Low copper, other health problems,|6|||
164394286|NCT00355082|593811378|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
164394287|NCT00355082|593811379|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
164394288|NCT00355082|593811380|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
164394289|NCT00355082|593811378|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
164394290|NCT00355082|593811379|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
164394291|NCT00355082|593811380|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
164394292|NCT00355082|593811378|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
164394293|NCT00355082|593811379|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
164394294|NCT00355082|593811380|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
164394295|NCT00355082|593811378|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
164394296|NCT00355082|593811379|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
164394297|NCT00355082|593811380|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
164394298|NCT00355082|593811378|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
164394299|NCT00355082|593811379|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
164394300|NCT00355082|593811380|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
164394301|NCT00355082|593811378|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
164394302|NCT00355082|593811379|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
164394303|NCT00355082|593811380|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
164394304|NCT00355082|593811378|FG000|Continuation Phase|Adverse Event|2|||
164394305|NCT00355082|593811379|FG001|Continuation Phase|Adverse Event|0|||
164394306|NCT00355082|593811380|FG002|Continuation Phase|Adverse Event|1|||
164394307|NCT00355082|593811378|FG000|Continuation Phase|Lost to Follow-up|2|||
164394308|NCT00355082|593811379|FG001|Continuation Phase|Lost to Follow-up|0|||
164394309|NCT00355082|593811380|FG002|Continuation Phase|Lost to Follow-up|1|||
164394310|NCT00355082|593811378|FG000|Continuation Phase|Protocol Violation|1|||
164394311|NCT00355082|593811379|FG001|Continuation Phase|Protocol Violation|0|||
164394312|NCT00355082|593811380|FG002|Continuation Phase|Protocol Violation|1|||
164394313|NCT00355082|593811378|FG000|Continuation Phase|Withdrawal by Subject|4|||
164394314|NCT00355082|593811379|FG001|Continuation Phase|Withdrawal by Subject|0|||
164394315|NCT00355082|593811380|FG002|Continuation Phase|Withdrawal by Subject|0|||
164394316|NCT00355082|593811378|FG000|Continuation Phase|Lack of Efficacy|5|||
164394317|NCT00355082|593811379|FG001|Continuation Phase|Lack of Efficacy|0|||
164394318|NCT00355082|593811380|FG002|Continuation Phase|Lack of Efficacy|0|||
164394319|NCT00355082|593811378|FG000|Continuation Phase|Site Closed by Sponsor|8|||
164394320|NCT00355082|593811379|FG001|Continuation Phase|Site Closed by Sponsor|0|||
164394321|NCT00355082|593811380|FG002|Continuation Phase|Site Closed by Sponsor|0|||
164394322|NCT00355082|593811378|FG000|Continuation Phase|Scheduling Error|1|||
164394323|NCT00355082|593811379|FG001|Continuation Phase|Scheduling Error|0|||
164394324|NCT00355082|593811380|FG002|Continuation Phase|Scheduling Error|0|||
164394325|NCT00355082|593811378|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
164394326|NCT00355082|593811379|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
164394327|NCT00355082|593811380|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
164394328|NCT02576067|593811381|FG000|Overall Study|Death|0|||
164394329|NCT02576067|593811382|FG001|Overall Study|Death|1|||
164394330|NCT02576067|593811381|FG000|Overall Study|Lack of Efficacy|1|||
164394331|NCT02576067|593811382|FG001|Overall Study|Lack of Efficacy|0|||
164394332|NCT02576067|593811381|FG000|Overall Study|Lost to Follow-up|11|||
164394333|NCT02576067|593811382|FG001|Overall Study|Lost to Follow-up|0|||
164394334|NCT02576067|593811381|FG000|Overall Study|Withdrawal by Subject|11|||
164394335|NCT02576067|593811382|FG001|Overall Study|Withdrawal by Subject|2|||
164394336|NCT02576067|593811381|FG000|Overall Study|study closure of main CIRT trial)|0|||
164441678|NCT02709655|593984452|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
164441679|NCT02709655|593984453|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
164394337|NCT02576067|593811382|FG001|Overall Study|study closure of main CIRT trial)|8|||
164394338|NCT02576067|593811381|FG000|Overall Study|not randomized, failed run-in|7|||
164394339|NCT02576067|593811382|FG001|Overall Study|not randomized, failed run-in|0|||
164394340|NCT02576067|593811381|FG000|Overall Study|screen failure/ re-enrolled|0|||
164394341|NCT02576067|593811382|FG001|Overall Study|screen failure/ re-enrolled|25|||
164394342|NCT02576067|593811381|FG000|Overall Study|Physician Decision|4|||
164441680|NCT02709655|593984449|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
164441681|NCT02709655|593984450|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
164441682|NCT02709655|593984451|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
164441683|NCT02709655|593984452|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
164441684|NCT02709655|593984453|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
164441685|NCT02709655|593984449|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
164594637|NCT00755846|594541015|FG001|Overall Study|Protocol Violation|1|||
164594638|NCT00755846|594541016|FG002|Overall Study|Protocol Violation|1|||
164594639|NCT00755846|594541017|FG003|Overall Study|Protocol Violation|1|||
164394343|NCT02576067|593811382|FG001|Overall Study|Physician Decision|0|||
164394344|NCT02372409|593811383|FG000|Overall Study|Lost to Follow-up|1|||
164394345|NCT02372409|593811384|FG001|Overall Study|Lost to Follow-up|0|||
164394346|NCT02372409|593811383|FG000|Overall Study|Disease progression|1|||
164394347|NCT02372409|593811384|FG001|Overall Study|Disease progression|1|||
164394348|NCT01808313|593811387|FG000|Overall Study|Adverse Event|5|||
164394349|NCT01808313|593811387|FG000|Overall Study|Protocol Violation|2|||
164394350|NCT01808313|593811387|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
164394351|NCT01808313|593811387|FG000|Overall Study|Lost to Follow-up|1|||
164394352|NCT01808313|593811387|FG000|Overall Study|Physician Decision|1|||
164394353|NCT04084314|593811389|FG000|Overall Study|Subject/guardian decision|91|||
164394354|NCT04084314|593811389|FG000|Overall Study|Adverse Event|24|||
164394355|NCT04084314|593811389|FG000|Overall Study|Lost to Follow-up|19|||
164394356|NCT04084314|593811389|FG000|Overall Study|New therapy for study indication|9|||
164394357|NCT04084314|593811389|FG000|Overall Study|Pregnancy|9|||
164394358|NCT04084314|593811389|FG000|Overall Study|Withdrawal of informed consent|8|||
164394359|NCT04084314|593811389|FG000|Overall Study|Physician Decision|4|||
164394360|NCT04084314|593811389|FG000|Overall Study|Protocol Deviation|3|||
164394361|NCT00622167|593811390|FG000|Overall Study|Did not meet angiographic criteria|20|||
164394362|NCT03738150|593811394|FG000|Base Study|Withdrawal by Subject|1|||
164394363|NCT03738150|593811394|FG000|Extension Study|Withdrawal by Subject|1|||
164394364|NCT03086447|593811400|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
164394365|NCT03086447|593811401|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
164394366|NCT03086447|593811400|FG000|Overall Study|Lost Lens|2|||
164394367|NCT03086447|593811401|FG001|Overall Study|Lost Lens|5|||
164394368|NCT03086447|593811400|FG000|Overall Study|Product quality complaint|0|||
164394369|NCT03086447|593811401|FG001|Overall Study|Product quality complaint|1|||
164394370|NCT03086447|593811400|FG000|Overall Study|Lens Damage|1|||
164394371|NCT03086447|593811401|FG001|Overall Study|Lens Damage|6|||
164394372|NCT03086447|593811400|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
164394373|NCT03086447|593811401|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
164394374|NCT03086447|593811400|FG000|Overall Study|Test Article No Longer Available|1|||
164394375|NCT03086447|593811401|FG001|Overall Study|Test Article No Longer Available|0|||
164394376|NCT03086447|593811400|FG000|Overall Study|Protocol Violation|2|||
164394377|NCT03086447|593811401|FG001|Overall Study|Protocol Violation|4|||
164394378|NCT03086447|593811400|FG000|Overall Study|Lost to Follow-up|0|||
164394379|NCT03086447|593811401|FG001|Overall Study|Lost to Follow-up|1|||
164394380|NCT03086447|593811400|FG000|Overall Study|Adverse Event|3|||
164394381|NCT03086447|593811401|FG001|Overall Study|Adverse Event|0|||
164394382|NCT03086447|593811400|FG000|Overall Study|Lens Discomfort|2|||
164394383|NCT03086447|593811401|FG001|Overall Study|Lens Discomfort|1|||
164394384|NCT03387852|593811402|FG000|Overall Study|Adverse event (AE)|3|||
164394385|NCT03387852|593811403|FG001|Overall Study|Adverse event (AE)|0|||
164394386|NCT03387852|593811404|FG002|Overall Study|Adverse event (AE)|2|||
164394387|NCT03387852|593811405|FG003|Overall Study|Adverse event (AE)|0|||
164394388|NCT03387852|593811402|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
164394389|NCT03387852|593811403|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
164394390|NCT03387852|593811404|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
164394391|NCT03387852|593811405|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
164394392|NCT03387852|593811402|FG000|Overall Study|Withdrawal by participant|1|||
164394393|NCT03387852|593811403|FG001|Overall Study|Withdrawal by participant|1|||
164394394|NCT03387852|593811404|FG002|Overall Study|Withdrawal by participant|3|||
164394395|NCT03387852|593811405|FG003|Overall Study|Withdrawal by participant|2|||
164394396|NCT03387852|593811402|FG000|Overall Study|Other- Unspecified|1|||
164394397|NCT03387852|593811403|FG001|Overall Study|Other- Unspecified|1|||
164394398|NCT03387852|593811404|FG002|Overall Study|Other- Unspecified|2|||
164394399|NCT03387852|593811405|FG003|Overall Study|Other- Unspecified|1|||
164394400|NCT03387852|593811402|FG000|Overall Study|Poor compliance to protocol|0|||
164394401|NCT03387852|593811403|FG001|Overall Study|Poor compliance to protocol|0|||
164441686|NCT02709655|593984450|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
164441687|NCT02709655|593984451|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
164594640|NCT00755846|594541018|FG004|Overall Study|Protocol Violation|1|||
164394402|NCT03387852|593811404|FG002|Overall Study|Poor compliance to protocol|0|||
164394403|NCT03387852|593811405|FG003|Overall Study|Poor compliance to protocol|1|||
164394404|NCT03387852|593811402|FG000|Overall Study|Randomized and not treated|0|||
164394405|NCT03387852|593811403|FG001|Overall Study|Randomized and not treated|0|||
164394406|NCT03387852|593811404|FG002|Overall Study|Randomized and not treated|0|||
164394407|NCT03387852|593811405|FG003|Overall Study|Randomized and not treated|1|||
164394408|NCT02194621|593811406|FG000|Overall Study|6 withdrew prior to randomization|2|||
164394409|NCT02194621|593811407|FG001|Overall Study|6 withdrew prior to randomization|2|||
164394410|NCT02194621|593811408|FG002|Overall Study|6 withdrew prior to randomization|2|||
164394411|NCT02194621|593811406|FG000|Overall Study|Withdrawal by Subject|4|||
164394412|NCT02194621|593811407|FG001|Overall Study|Withdrawal by Subject|4|||
164394413|NCT02194621|593811408|FG002|Overall Study|Withdrawal by Subject|7|||
164394414|NCT00714168|593811409|FG000|Overall Study|Pregnancy|5|||
164394415|NCT00714168|593811410|FG001|Overall Study|Pregnancy|4|||
164394416|NCT00714168|593811409|FG000|Overall Study|Lost to Follow-up|32|||
164394417|NCT00714168|593811410|FG001|Overall Study|Lost to Follow-up|50|||
164394418|NCT00714168|593811409|FG000|Overall Study|Relocation|4|||
164394419|NCT00714168|593811410|FG001|Overall Study|Relocation|3|||
164394420|NCT00714168|593811409|FG000|Overall Study|Non-study medical condition|3|||
164394421|NCT00714168|593811410|FG001|Overall Study|Non-study medical condition|2|||
164394422|NCT01864564|593811413|FG000|Overall Study|Lost to Follow-up|17|||
164394423|NCT01864564|593811414|FG001|Overall Study|Lost to Follow-up|23|||
164394424|NCT01864564|593811413|FG000|Overall Study|Withdrawal by Subject|20|||
164394425|NCT01864564|593811414|FG001|Overall Study|Withdrawal by Subject|11|||
164394426|NCT01864564|593811413|FG000|Overall Study|Protocol Violation|0|||
164394427|NCT01864564|593811414|FG001|Overall Study|Protocol Violation|27|||
164394428|NCT01864564|593811413|FG000|Overall Study|not reported|0|||
164394429|NCT01864564|593811414|FG001|Overall Study|not reported|34|||
164441688|NCT02709655|593984452|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
164441689|NCT02709655|593984453|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
164441690|NCT02709655|593984449|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
164441691|NCT02709655|593984450|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
164441692|NCT02709655|593984451|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
164441693|NCT02709655|593984452|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
164441694|NCT02709655|593984453|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
164441695|NCT02709655|593984449|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
164441696|NCT02709655|593984450|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
164441697|NCT02709655|593984451|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
164441698|NCT02709655|593984452|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
164441699|NCT02709655|593984453|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
164441700|NCT02709655|593984449|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
164441701|NCT02709655|593984450|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
164441702|NCT02709655|593984451|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
164441703|NCT02709655|593984452|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
164441704|NCT02709655|593984453|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
164441705|NCT02709655|593984449|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
164441706|NCT02709655|593984450|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
164441707|NCT02709655|593984451|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
164441708|NCT02709655|593984452|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
164441709|NCT02709655|593984453|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
164441710|NCT02709655|593984449|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
164441711|NCT02709655|593984450|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
164441712|NCT02709655|593984451|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
164441713|NCT02709655|593984452|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
164441714|NCT02709655|593984453|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
164441715|NCT02709655|593984449|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
164441716|NCT02709655|593984450|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
164441717|NCT02709655|593984451|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
164594641|NCT00755846|594541019|FG005|Overall Study|Protocol Violation|1|||
164594642|NCT00755846|594541014|FG000|Overall Study|Lost to Follow-up|0|||
164594643|NCT00755846|594541015|FG001|Overall Study|Lost to Follow-up|2|||
164394430|NCT03077724|593811415|FG000|Overall Study|Lost to Follow-up|5|||
164394431|NCT03077724|593811416|FG001|Overall Study|Lost to Follow-up|1|||
164394432|NCT03077724|593811415|FG000|Overall Study|Withdrawal by Subject|3|||
164394433|NCT03077724|593811416|FG001|Overall Study|Withdrawal by Subject|1|||
164441718|NCT02709655|593984452|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
164441719|NCT02709655|593984453|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
164441720|NCT02709655|593984449|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
164594644|NCT00755846|594541016|FG002|Overall Study|Lost to Follow-up|1|||
164594645|NCT00755846|594541017|FG003|Overall Study|Lost to Follow-up|0|||
164594646|NCT00755846|594541018|FG004|Overall Study|Lost to Follow-up|4|||
164394434|NCT02269670|593811417|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
164394435|NCT00126438|593811418|FG000|Overall Study|Withdrawal due to adverse event|1|||
164394436|NCT00126438|593811419|FG001|Overall Study|Withdrawal due to adverse event|0|||
164394437|NCT00126438|593811418|FG000|Overall Study|Lost to Follow-up|22|||
164394438|NCT00126438|593811419|FG001|Overall Study|Lost to Follow-up|0|||
164441721|NCT02709655|593984450|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
164394439|NCT00126438|593811418|FG000|Overall Study|Protocol Violation|8|||
164394440|NCT00126438|593811419|FG001|Overall Study|Protocol Violation|8|||
164394441|NCT00126438|593811418|FG000|Overall Study|Withdrawal by Subject|3|||
164394442|NCT00126438|593811419|FG001|Overall Study|Withdrawal by Subject|2|||
164394443|NCT02313428|593811420|FG000|Overall Study|Lost to Follow-up|1|||
164394444|NCT02313428|593811421|FG001|Overall Study|Lost to Follow-up|1|||
164394445|NCT04414696|593811423|FG000|3-month Follow up|Withdrawal by Subject|1|||
164394446|NCT04414696|593811424|FG001|3-month Follow up|Withdrawal by Subject|0|||
164394447|NCT04414696|593811423|FG000|3-month Follow up|Lost to Follow-up|22|||
164394448|NCT04414696|593811424|FG001|3-month Follow up|Lost to Follow-up|23|||
164394449|NCT04414696|593811423|FG000|6-month Follow up|Withdrawal by Subject|1|||
164394450|NCT04414696|593811424|FG001|6-month Follow up|Withdrawal by Subject|2|||
164394451|NCT04414696|593811423|FG000|6-month Follow up|Lost to Follow-up|5|||
164394452|NCT04414696|593811424|FG001|6-month Follow up|Lost to Follow-up|2|||
164394453|NCT02160314|593813673|FG000|Overall Study|Adverse Event|0|||
164394454|NCT02160314|593813674|FG001|Overall Study|Adverse Event|6|||
164394455|NCT02160314|593813673|FG000|Overall Study|Protocol Violation|0|||
164394456|NCT02160314|593813674|FG001|Overall Study|Protocol Violation|4|||
164394457|NCT02160314|593813673|FG000|Overall Study|Withdrawal by Subject|1|||
164394458|NCT02160314|593813674|FG001|Overall Study|Withdrawal by Subject|2|||
164394459|NCT02160314|593813673|FG000|Overall Study|Lost to Follow-up|0|||
164394460|NCT02160314|593813674|FG001|Overall Study|Lost to Follow-up|1|||
164394461|NCT00593567|593813675|FG000|Overall Study|Adverse Event|2|||
164394462|NCT00593567|593813676|FG001|Overall Study|Adverse Event|0|||
164394463|NCT00593567|593813675|FG000|Overall Study|Physician Decision|2|||
164394464|NCT00593567|593813676|FG001|Overall Study|Physician Decision|0|||
164394465|NCT00593567|593813675|FG000|Overall Study|Protocol Violation|13|||
164394466|NCT00593567|593813676|FG001|Overall Study|Protocol Violation|7|||
164394467|NCT00593567|593813675|FG000|Overall Study|Lack of Efficacy|2|||
164394468|NCT00593567|593813676|FG001|Overall Study|Lack of Efficacy|1|||
164441722|NCT02709655|593984451|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
164441723|NCT02709655|593984452|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
164441724|NCT02709655|593984453|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
164441725|NCT02709655|593984449|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
164441726|NCT02709655|593984450|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
164441727|NCT02709655|593984451|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
164441728|NCT02709655|593984452|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
164441729|NCT02709655|593984453|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
164441730|NCT02709655|593984449|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
164441731|NCT02709655|593984450|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
164441732|NCT02709655|593984451|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
164441733|NCT02709655|593984452|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
164441734|NCT02709655|593984453|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
164441735|NCT02709655|593984449|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
164441736|NCT02709655|593984450|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
164441737|NCT02709655|593984451|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
164441738|NCT02709655|593984452|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
164441739|NCT02709655|593984453|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
164441740|NCT00102063|593984454|FG000|Overall Study|Lack of Efficacy|5|||
164441741|NCT00102063|593984455|FG001|Overall Study|Lack of Efficacy|1|||
164441742|NCT00102063|593984456|FG002|Overall Study|Lack of Efficacy|1|||
164441743|NCT00102063|593984454|FG000|Overall Study|Adverse Event|7|||
164441744|NCT00102063|593984455|FG001|Overall Study|Adverse Event|4|||
164441745|NCT00102063|593984456|FG002|Overall Study|Adverse Event|2|||
164441746|NCT00102063|593984454|FG000|Overall Study|Withdrawal by Subject|4|||
164441747|NCT00102063|593984455|FG001|Overall Study|Withdrawal by Subject|12|||
164594647|NCT00755846|594541019|FG005|Overall Study|Lost to Follow-up|2|||
164594648|NCT00755846|594541014|FG000|Overall Study|Withdrawal by Subject|2|||
164594649|NCT00755846|594541015|FG001|Overall Study|Withdrawal by Subject|3|||
164594650|NCT00755846|594541016|FG002|Overall Study|Withdrawal by Subject|5|||
164594651|NCT00755846|594541017|FG003|Overall Study|Withdrawal by Subject|2|||
164594652|NCT00755846|594541018|FG004|Overall Study|Withdrawal by Subject|0|||
164441748|NCT00102063|593984456|FG002|Overall Study|Withdrawal by Subject|5|||
164594653|NCT00755846|594541019|FG005|Overall Study|Withdrawal by Subject|1|||
164594654|NCT00755846|594541014|FG000|Overall Study|Hyperglycemic Rescue|21|||
164594655|NCT00755846|594541015|FG001|Overall Study|Hyperglycemic Rescue|7|||
164394469|NCT00593567|593813675|FG000|Overall Study|Withdrawal by Subject|1|||
164394470|NCT00593567|593813676|FG001|Overall Study|Withdrawal by Subject|2|||
164394471|NCT00785291|593813681|FG000|Overall Study|Never began treatment|8|||
164394472|NCT00785291|593813682|FG001|Overall Study|Never began treatment|4|||
164394473|NCT00785291|593813683|FG002|Overall Study|Never began treatment|4|||
164394474|NCT00785291|593813681|FG000|Overall Study|Adverse Event|39|||
164394475|NCT00785291|593813682|FG001|Overall Study|Adverse Event|70|||
164394476|NCT00785291|593813683|FG002|Overall Study|Adverse Event|56|||
164704065|NCT01831765|594941885|FG001|Overall Study|Lack of Efficacy|0|||
164394477|NCT00785291|593813681|FG000|Overall Study|Death|7|||
164394478|NCT00785291|593813682|FG001|Overall Study|Death|4|||
164394479|NCT00785291|593813683|FG002|Overall Study|Death|3|||
164394480|NCT00785291|593813681|FG000|Overall Study|Withdrawal by Subject|35|||
164394481|NCT00785291|593813682|FG001|Overall Study|Withdrawal by Subject|36|||
164394482|NCT00785291|593813683|FG002|Overall Study|Withdrawal by Subject|17|||
164394483|NCT00785291|593813681|FG000|Overall Study|Alternative Therapy|12|||
164394484|NCT00785291|593813682|FG001|Overall Study|Alternative Therapy|6|||
164394485|NCT00785291|593813683|FG002|Overall Study|Alternative Therapy|7|||
164394486|NCT00785291|593813681|FG000|Overall Study|Complicating illness|6|||
164394487|NCT00785291|593813682|FG001|Overall Study|Complicating illness|4|||
164394488|NCT00785291|593813683|FG002|Overall Study|Complicating illness|4|||
164394489|NCT00785291|593813681|FG000|Overall Study|Other Medical Reasons|29|||
164394490|NCT00785291|593813682|FG001|Overall Study|Other Medical Reasons|25|||
164394491|NCT00785291|593813683|FG002|Overall Study|Other Medical Reasons|15|||
164394492|NCT02119260|593813684|FG000|Overall Study|Adverse Event|1|||
164394493|NCT02119260|593813685|FG001|Overall Study|Adverse Event|0|||
164394494|NCT02119260|593813686|FG002|Overall Study|Adverse Event|0|||
164394495|NCT02119260|593813687|FG003|Overall Study|Adverse Event|0|||
164394496|NCT02119260|593813688|FG004|Overall Study|Adverse Event|0|||
164394497|NCT02119260|593813689|FG005|Overall Study|Adverse Event|0|||
164394498|NCT02119260|593813690|FG006|Overall Study|Adverse Event|0|||
164394499|NCT02119260|593813684|FG000|Overall Study|Withdrew consent|0|||
164394500|NCT02119260|593813685|FG001|Overall Study|Withdrew consent|1|||
164394501|NCT02119260|593813686|FG002|Overall Study|Withdrew consent|1|||
164394502|NCT02119260|593813687|FG003|Overall Study|Withdrew consent|0|||
164394503|NCT02119260|593813688|FG004|Overall Study|Withdrew consent|0|||
164394504|NCT02119260|593813689|FG005|Overall Study|Withdrew consent|0|||
164394505|NCT02119260|593813690|FG006|Overall Study|Withdrew consent|0|||
164394506|NCT01877408|593813695|FG000|Overall Study|Lost to Follow-up|0|||
164394507|NCT01877408|593813696|FG001|Overall Study|Lost to Follow-up|2|||
164394508|NCT03870763|593813699|FG000|Overall Study|Study terminated by sponsor|0|||
164394509|NCT03870763|593813700|FG001|Overall Study|Study terminated by sponsor|2|||
164394510|NCT03870763|593813701|FG002|Overall Study|Study terminated by sponsor|0|||
164394511|NCT03870763|593813699|FG000|Overall Study|Withdrawal by Subject|0|||
164394512|NCT03870763|593813700|FG001|Overall Study|Withdrawal by Subject|1|||
164394513|NCT03870763|593813701|FG002|Overall Study|Withdrawal by Subject|0|||
164394514|NCT03870763|593813699|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
164394515|NCT03870763|593813700|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
164394516|NCT03870763|593813701|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
164394517|NCT03224182|593813702|FG000|Overall Study|Study Drug Not Instilled|6|||
164394518|NCT03224182|593813703|FG001|Overall Study|Study Drug Not Instilled|1|||
164394519|NCT03224182|593813702|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
164394520|NCT03224182|593813703|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
164394521|NCT03224182|593813702|FG000|Overall Study|Withdrew of Consent|4|||
164394522|NCT03224182|593813703|FG001|Overall Study|Withdrew of Consent|2|||
164394523|NCT03224182|593813702|FG000|Overall Study|Investigator Decision|3|||
164394524|NCT03224182|593813703|FG001|Overall Study|Investigator Decision|1|||
164394525|NCT03224182|593813702|FG000|Overall Study|Sponsor Decision|26|||
164394526|NCT03224182|593813703|FG001|Overall Study|Sponsor Decision|12|||
164394527|NCT03224182|593813702|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
164394528|NCT03224182|593813703|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
164394529|NCT03224182|593813702|FG000|Overall Study|Lost to Follow-up|1|||
164394530|NCT03224182|593813703|FG001|Overall Study|Lost to Follow-up|0|||
164394531|NCT03224182|593813702|FG000|Overall Study|Participant Had Recurrence|11|||
164394532|NCT03224182|593813703|FG001|Overall Study|Participant Had Recurrence|5|||
164394533|NCT03224182|593813702|FG000|Overall Study|Death|0|||
164394534|NCT03224182|593813703|FG001|Overall Study|Death|1|||
164394535|NCT03224182|593813702|FG000|Overall Study|Reason not Specified|3|||
164394536|NCT03224182|593813703|FG001|Overall Study|Reason not Specified|3|||
164441749|NCT00102063|593984454|FG000|Overall Study|Lost to Follow-up|0|||
164394537|NCT03224182|593813702|FG000|Overall Study|Other|1|||
164394538|NCT03224182|593813703|FG001|Overall Study|Other|0|||
164394539|NCT04279314|593813704|FG000|Overall Study|Adverse Event|55|||
164394540|NCT04279314|593813704|FG000|Overall Study|Withdrawal by Subject|5|||
164394541|NCT04279314|593813704|FG000|Overall Study|Lack of Efficacy|5|||
164394542|NCT04279314|593813704|FG000|Overall Study|Protocol Violation|3|||
164394543|NCT04279314|593813704|FG000|Overall Study|Other (not COVID-19 related)|2|||
164394544|NCT02120027|593813705|FG000|Overall Study|Adverse Event|4|||
164394545|NCT02120027|593813706|FG001|Overall Study|Adverse Event|5|||
164394546|NCT02120027|593813705|FG000|Overall Study|Lack of Efficacy|3|||
164394547|NCT02120027|593813706|FG001|Overall Study|Lack of Efficacy|5|||
164394548|NCT02120027|593813705|FG000|Overall Study|Lost to Follow-up|5|||
164394549|NCT02120027|593813706|FG001|Overall Study|Lost to Follow-up|13|||
164394550|NCT02120027|593813705|FG000|Overall Study|Other|4|||
164394551|NCT02120027|593813706|FG001|Overall Study|Other|0|||
164394552|NCT02120027|593813705|FG000|Overall Study|Physician Decision|4|||
164394553|NCT02120027|593813706|FG001|Overall Study|Physician Decision|3|||
164394554|NCT02120027|593813705|FG000|Overall Study|Protocol Violation|18|||
164394555|NCT02120027|593813706|FG001|Overall Study|Protocol Violation|21|||
164394556|NCT02120027|593813705|FG000|Overall Study|Study terminated by Sponsor|45|||
164394557|NCT02120027|593813706|FG001|Overall Study|Study terminated by Sponsor|47|||
164394558|NCT02120027|593813705|FG000|Overall Study|Withdrawal by Subject|33|||
164394559|NCT02120027|593813706|FG001|Overall Study|Withdrawal by Subject|25|||
164394560|NCT01471054|593813714|FG000|Overall Study|Study terminated prematurely|4|||
164394561|NCT01471054|593813715|FG001|Overall Study|Study terminated prematurely|0|||
164394562|NCT00686166|593813716|FG000|Overall Study|Adverse Event|7|||
164394563|NCT00686166|593813716|FG000|Overall Study|Withdrawal by Subject|1|||
164394564|NCT00686166|593813716|FG000|Overall Study|Progression/Relapse|1|||
164394565|NCT00686166|593813716|FG000|Overall Study|Death|1|||
164394566|NCT00686166|593813716|FG000|Overall Study|Not Protocol Specified|1|||
164394567|NCT00686166|593813716|FG000|Overall Study|Ineligible|5|||
164394568|NCT00686166|593813716|FG000|Overall Study|Did not begin protocol therapy|4|||
164394569|NCT00985725|593813717|FG000|Overall Study|Adverse Event|4|||
164394570|NCT00985725|593813718|FG001|Overall Study|Adverse Event|1|||
164394571|NCT00985725|593813717|FG000|Overall Study|Protocol Violation|1|||
164394572|NCT00985725|593813718|FG001|Overall Study|Protocol Violation|3|||
164394573|NCT00985725|593813717|FG000|Overall Study|Withdrawal by Subject|4|||
164394574|NCT00985725|593813718|FG001|Overall Study|Withdrawal by Subject|4|||
164394575|NCT00985725|593813717|FG000|Overall Study|Lost to Follow-up|1|||
164394576|NCT00985725|593813718|FG001|Overall Study|Lost to Follow-up|1|||
164394577|NCT00985725|593813717|FG000|Overall Study|Lack of Efficacy|0|||
164394578|NCT00985725|593813718|FG001|Overall Study|Lack of Efficacy|1|||
164394579|NCT00985725|593813717|FG000|Overall Study|Non-compliance|1|||
164394580|NCT00985725|593813718|FG001|Overall Study|Non-compliance|2|||
164394581|NCT00985725|593813717|FG000|Overall Study|Out-of-window visits|0|||
164394582|NCT00985725|593813718|FG001|Overall Study|Out-of-window visits|1|||
164394583|NCT02314624|593813722|FG000|Overall Study|No participating patient|16|||
164394584|NCT02314624|593813723|FG001|Overall Study|No participating patient|13|||
164594656|NCT00755846|594541016|FG002|Overall Study|Hyperglycemic Rescue|5|||
164594657|NCT00755846|594541017|FG003|Overall Study|Hyperglycemic Rescue|8|||
164594658|NCT00755846|594541018|FG004|Overall Study|Hyperglycemic Rescue|8|||
164594659|NCT00755846|594541019|FG005|Overall Study|Hyperglycemic Rescue|7|||
164594660|NCT00755846|594541014|FG000|Overall Study|Physician Decision|1|||
164594661|NCT00755846|594541015|FG001|Overall Study|Physician Decision|3|||
164594662|NCT00755846|594541016|FG002|Overall Study|Physician Decision|0|||
164594663|NCT00755846|594541017|FG003|Overall Study|Physician Decision|1|||
164594664|NCT00755846|594541018|FG004|Overall Study|Physician Decision|0|||
164594665|NCT00755846|594541019|FG005|Overall Study|Physician Decision|1|||
164594666|NCT00755846|594541014|FG000|Overall Study|Administrative Error|0|||
164594667|NCT00755846|594541015|FG001|Overall Study|Administrative Error|1|||
164594668|NCT00755846|594541016|FG002|Overall Study|Administrative Error|0|||
164594669|NCT00755846|594541017|FG003|Overall Study|Administrative Error|0|||
164594670|NCT00755846|594541018|FG004|Overall Study|Administrative Error|0|||
164594671|NCT00755846|594541019|FG005|Overall Study|Administrative Error|0|||
164594672|NCT00755846|594541014|FG000|Overall Study|Participant Non-compliance|0|||
164594673|NCT00755846|594541015|FG001|Overall Study|Participant Non-compliance|0|||
164594674|NCT00755846|594541016|FG002|Overall Study|Participant Non-compliance|0|||
164594675|NCT00755846|594541017|FG003|Overall Study|Participant Non-compliance|0|||
164594676|NCT00755846|594541018|FG004|Overall Study|Participant Non-compliance|1|||
164594677|NCT00755846|594541019|FG005|Overall Study|Participant Non-compliance|0|||
164594678|NCT02723604|594541030|FG000|Overall Study|ineligible|1|||
164594679|NCT02723604|594541030|FG000|Overall Study|never received treatment|1|||
164594680|NCT01369849|594541032|FG000|Overall Study|Ineligible prior to treatment|0|||
164594681|NCT01369849|594541033|FG001|Overall Study|Ineligible prior to treatment|0|||
164594682|NCT01369849|594541034|FG002|Overall Study|Ineligible prior to treatment|1|||
164594683|NCT01369849|594541032|FG000|Overall Study|Ineligible after receiving treatment|0|||
164594684|NCT01369849|594541033|FG001|Overall Study|Ineligible after receiving treatment|1|||
164594685|NCT01369849|594541034|FG002|Overall Study|Ineligible after receiving treatment|0|||
164394585|NCT02314624|593813722|FG000|Overall Study|Participant withdrew|7|||
164394586|NCT02314624|593813723|FG001|Overall Study|Participant withdrew|2|||
164394587|NCT02314624|593813722|FG000|Overall Study|Lost to Follow-up|2|||
164394588|NCT02314624|593813723|FG001|Overall Study|Lost to Follow-up|5|||
164394589|NCT02314624|593813722|FG000|Overall Study|Dropped/Excluded by PI|6|||
164394590|NCT02314624|593813723|FG001|Overall Study|Dropped/Excluded by PI|6|||
164394591|NCT03151005|593813724|FG000|Overall Study|Lost to Follow-up|5|||
164394592|NCT03151005|593813725|FG001|Overall Study|Lost to Follow-up|5|||
164394593|NCT00360308|593813728|FG000|Overall Study|Adverse Event|15|||
164394594|NCT00360308|593813729|FG001|Overall Study|Adverse Event|14|||
164394595|NCT00360308|593813730|FG002|Overall Study|Adverse Event|25|||
164394596|NCT00360308|593813728|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
164394597|NCT00360308|593813729|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
164394598|NCT00360308|593813730|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
164394599|NCT00360308|593813728|FG000|Overall Study|Protocol Violation|2|||
164394600|NCT00360308|593813729|FG001|Overall Study|Protocol Violation|1|||
164394601|NCT00360308|593813730|FG002|Overall Study|Protocol Violation|2|||
164394602|NCT00360308|593813728|FG000|Overall Study|Withdrawal by Subject|11|||
164394603|NCT00360308|593813729|FG001|Overall Study|Withdrawal by Subject|7|||
164394604|NCT00360308|593813730|FG002|Overall Study|Withdrawal by Subject|14|||
164394605|NCT00360308|593813728|FG000|Overall Study|Lack of Efficacy|3|||
164394606|NCT00360308|593813729|FG001|Overall Study|Lack of Efficacy|0|||
164394607|NCT00360308|593813730|FG002|Overall Study|Lack of Efficacy|2|||
164394608|NCT00360308|593813728|FG000|Overall Study|Other|2|||
164394609|NCT00360308|593813729|FG001|Overall Study|Other|1|||
164394610|NCT00360308|593813730|FG002|Overall Study|Other|1|||
164394611|NCT00360308|593813728|FG000|Overall Study|Study termination by sponsor|43|||
164394612|NCT00360308|593813729|FG001|Overall Study|Study termination by sponsor|55|||
164394613|NCT00360308|593813730|FG002|Overall Study|Study termination by sponsor|44|||
164394614|NCT01549613|593813731|FG000|Overall Study|Lost to Follow-up|11|||
164394615|NCT01549613|593813732|FG001|Overall Study|Lost to Follow-up|11|||
164394616|NCT02131272|593813733|FG000|Overall Study|Withdrawal by parent|0|||
164394617|NCT02131272|593813734|FG001|Overall Study|Withdrawal by parent|1|||
164394618|NCT02131272|593813733|FG000|Overall Study|Withdrawal by Subject|0|||
164394619|NCT02131272|593813734|FG001|Overall Study|Withdrawal by Subject|1|||
164394620|NCT02131272|593813733|FG000|Overall Study|Withdrawal Criteria|1|||
164394621|NCT02131272|593813734|FG001|Overall Study|Withdrawal Criteria|0|||
164144035|NCT00086281|592888574|FG003|Phase 2|Adverse Event|0|||
164394622|NCT04162769|593813735|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
164394623|NCT04162769|593813736|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
164394624|NCT04162769|593813737|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
164394625|NCT04162769|593813738|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
164394626|NCT04162769|593813735|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
164394627|NCT04162769|593813736|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
164394628|NCT04162769|593813737|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
164394629|NCT04162769|593813738|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
164394630|NCT04162769|593813735|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
164394631|NCT04162769|593813736|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
164394632|NCT04162769|593813737|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
164394633|NCT04162769|593813738|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
164394634|NCT04162769|593813735|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
164394635|NCT04162769|593813736|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
164394636|NCT04162769|593813737|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
164394637|NCT04162769|593813738|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
164394638|NCT04162769|593813735|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
164394639|NCT04162769|593813736|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
164394640|NCT04162769|593813737|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
164394641|NCT04162769|593813738|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
164394642|NCT04162769|593813735|FG000|Double-blind Treatment (12-Week)|Other|0|||
164394643|NCT04162769|593813736|FG001|Double-blind Treatment (12-Week)|Other|1|||
164394644|NCT04162769|593813737|FG002|Double-blind Treatment (12-Week)|Other|1|||
164394645|NCT04162769|593813738|FG003|Double-blind Treatment (12-Week)|Other|0|||
164394646|NCT04162769|593813735|FG000|OLE Period (52-Week)|Adverse Event|0|||
164394647|NCT04162769|593813736|FG001|OLE Period (52-Week)|Adverse Event|0|||
164394648|NCT04162769|593813737|FG002|OLE Period (52-Week)|Adverse Event|0|||
164394649|NCT04162769|593813738|FG003|OLE Period (52-Week)|Adverse Event|5|||
164394650|NCT04162769|593813735|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
164394651|NCT04162769|593813736|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
164394652|NCT04162769|593813737|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
164394653|NCT04162769|593813738|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
164394654|NCT04162769|593813735|FG000|OLE Period (52-Week)|Physician Decision|0|||
164394655|NCT04162769|593813736|FG001|OLE Period (52-Week)|Physician Decision|0|||
164394656|NCT04162769|593813737|FG002|OLE Period (52-Week)|Physician Decision|0|||
164394657|NCT04162769|593813738|FG003|OLE Period (52-Week)|Physician Decision|1|||
164394658|NCT04162769|593813735|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
164394659|NCT04162769|593813736|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
164394660|NCT04162769|593813737|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
164394661|NCT04162769|593813738|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
164394662|NCT04162769|593813735|FG000|OLE Period (52-Week)|Protocol deviation|0|||
164394663|NCT04162769|593813736|FG001|OLE Period (52-Week)|Protocol deviation|0|||
164394664|NCT04162769|593813737|FG002|OLE Period (52-Week)|Protocol deviation|0|||
164394665|NCT04162769|593813738|FG003|OLE Period (52-Week)|Protocol deviation|2|||
164394666|NCT01733732|593813739|FG000|Overall Study|Adverse Event|1|||
164394667|NCT01733732|593813740|FG001|Overall Study|Adverse Event|0|||
164394668|NCT01733732|593813739|FG000|Overall Study|Did not attend all study visits|1|||
164394669|NCT01733732|593813740|FG001|Overall Study|Did not attend all study visits|0|||
164394670|NCT00464815|593813741|FG000|Overall Study|Withdrawal by Subject|6|||
164394671|NCT00464815|593813742|FG001|Overall Study|Withdrawal by Subject|3|||
164394672|NCT00515502|593813745|FG000|Treatment Period 1|Adverse Event|0|||
164394673|NCT00515502|593813746|FG001|Treatment Period 1|Adverse Event|0|||
164394674|NCT00515502|593813747|FG002|Treatment Period 1|Adverse Event|0|||
164394675|NCT00515502|593813748|FG003|Treatment Period 1|Adverse Event|0|||
164394676|NCT00515502|593813749|FG004|Treatment Period 1|Adverse Event|0|||
164394677|NCT00515502|593813750|FG005|Treatment Period 1|Adverse Event|0|||
164394678|NCT00515502|593813751|FG006|Treatment Period 1|Adverse Event|1|||
164394679|NCT00515502|593813752|FG007|Treatment Period 1|Adverse Event|0|||
164394680|NCT00515502|593813753|FG008|Treatment Period 1|Adverse Event|1|||
164394681|NCT00515502|593813754|FG009|Treatment Period 1|Adverse Event|0|||
164394682|NCT00515502|593813755|FG010|Treatment Period 1|Adverse Event|0|||
164394683|NCT00515502|593813756|FG011|Treatment Period 1|Adverse Event|1|||
164394684|NCT00515502|593813745|FG000|Treatment Period 2|Adverse Event|0|||
164394685|NCT00515502|593813746|FG001|Treatment Period 2|Adverse Event|1|||
164394686|NCT00515502|593813747|FG002|Treatment Period 2|Adverse Event|0|||
164394687|NCT00515502|593813748|FG003|Treatment Period 2|Adverse Event|0|||
164394688|NCT00515502|593813749|FG004|Treatment Period 2|Adverse Event|0|||
164394689|NCT00515502|593813750|FG005|Treatment Period 2|Adverse Event|0|||
164394690|NCT00515502|593813751|FG006|Treatment Period 2|Adverse Event|0|||
164394691|NCT00515502|593813752|FG007|Treatment Period 2|Adverse Event|0|||
164394692|NCT00515502|593813753|FG008|Treatment Period 2|Adverse Event|0|||
164394693|NCT00515502|593813754|FG009|Treatment Period 2|Adverse Event|0|||
164394694|NCT00515502|593813755|FG010|Treatment Period 2|Adverse Event|0|||
164394695|NCT00515502|593813756|FG011|Treatment Period 2|Adverse Event|0|||
164394696|NCT03252587|593813759|FG000|Overall Study|Adverse Event|3|||
164394697|NCT03252587|593813760|FG001|Overall Study|Adverse Event|8|||
164394698|NCT03252587|593813761|FG002|Overall Study|Adverse Event|6|||
164394699|NCT03252587|593813762|FG003|Overall Study|Adverse Event|12|||
164394700|NCT03252587|593813759|FG000|Overall Study|Lack of Efficacy|7|||
164394701|NCT03252587|593813760|FG001|Overall Study|Lack of Efficacy|2|||
164394702|NCT03252587|593813761|FG002|Overall Study|Lack of Efficacy|2|||
164394703|NCT03252587|593813762|FG003|Overall Study|Lack of Efficacy|4|||
164394704|NCT03252587|593813759|FG000|Overall Study|Lost to Follow-up|2|||
164394705|NCT03252587|593813760|FG001|Overall Study|Lost to Follow-up|0|||
164394706|NCT03252587|593813761|FG002|Overall Study|Lost to Follow-up|0|||
164394707|NCT03252587|593813762|FG003|Overall Study|Lost to Follow-up|2|||
164394708|NCT03252587|593813759|FG000|Overall Study|Pregnancy|2|||
164394709|NCT03252587|593813760|FG001|Overall Study|Pregnancy|1|||
164394710|NCT03252587|593813761|FG002|Overall Study|Pregnancy|0|||
164394711|NCT03252587|593813762|FG003|Overall Study|Pregnancy|1|||
164394712|NCT03252587|593813759|FG000|Overall Study|Withdrawal by Subject|8|||
164394713|NCT03252587|593813760|FG001|Overall Study|Withdrawal by Subject|4|||
164394714|NCT03252587|593813761|FG002|Overall Study|Withdrawal by Subject|4|||
164394715|NCT03252587|593813762|FG003|Overall Study|Withdrawal by Subject|4|||
164394716|NCT03252587|593813759|FG000|Overall Study|Other Reasons|2|||
164394717|NCT03252587|593813760|FG001|Overall Study|Other Reasons|5|||
164441750|NCT00102063|593984455|FG001|Overall Study|Lost to Follow-up|0|||
164394718|NCT03252587|593813761|FG002|Overall Study|Other Reasons|5|||
164394719|NCT03252587|593813762|FG003|Overall Study|Other Reasons|4|||
164394720|NCT04052204|593813763|FG000|Overall Study|Death|1|||
164394721|NCT04052204|593813764|FG001|Overall Study|Death|0|||
164394722|NCT04052204|593813765|FG002|Overall Study|Death|0|||
164394723|NCT04052204|593813763|FG000|Overall Study|Progressive disease|1|||
164394724|NCT04052204|593813764|FG001|Overall Study|Progressive disease|0|||
164394725|NCT04052204|593813765|FG002|Overall Study|Progressive disease|0|||
164394726|NCT04052204|593813763|FG000|Overall Study|Other|1|||
164394727|NCT04052204|593813764|FG001|Overall Study|Other|0|||
164394728|NCT04052204|593813765|FG002|Overall Study|Other|0|||
164394729|NCT03647501|593813766|FG000|Overall Study|Lost to Follow-up|1|||
164394730|NCT03647501|593813767|FG001|Overall Study|Lost to Follow-up|1|||
164394731|NCT03647501|593813766|FG000|Overall Study|Withdrawal by Subject|0|||
164394732|NCT03647501|593813767|FG001|Overall Study|Withdrawal by Subject|1|||
164394733|NCT03945188|593813768|FG000|Overall Study|Protocol Violation|1|||
164394734|NCT03945188|593813769|FG001|Overall Study|Protocol Violation|0|||
164394735|NCT03945188|593813768|FG000|Overall Study|Disease worsening|79|||
164394736|NCT03945188|593813769|FG001|Overall Study|Disease worsening|73|||
164394737|NCT03945188|593813768|FG000|Overall Study|Physician Decision|2|||
164394738|NCT03945188|593813769|FG001|Overall Study|Physician Decision|2|||
164394739|NCT03945188|593813768|FG000|Overall Study|Lack of Efficacy|7|||
164394740|NCT03945188|593813769|FG001|Overall Study|Lack of Efficacy|4|||
164394741|NCT03945188|593813768|FG000|Overall Study|Pregnancy|2|||
164394742|NCT03945188|593813769|FG001|Overall Study|Pregnancy|0|||
164394743|NCT03945188|593813768|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
164394744|NCT03945188|593813769|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
164594686|NCT00115349|594541037|FG000|Overall Study|Study closed due to low enrollment.|11|||
164594687|NCT00115349|594541038|FG001|Overall Study|Study closed due to low enrollment.|9|||
164594688|NCT01028651|594541043|FG000|Overall Study|Death|2|||
164594689|NCT01028651|594541043|FG000|Overall Study|Adverse Event|1|||
164594690|NCT00390416|594541045|FG000|Overall Study|Withdrawal by Subject|1|||
164594691|NCT00390416|594541045|FG000|Overall Study|Not treated|3|||
164594692|NCT01592409|594541046|FG000|Overall Study|Withdrawal by Subject|0|||
164594693|NCT01592409|594541047|FG001|Overall Study|Withdrawal by Subject|1|||
164594694|NCT01728584|594541048|FG000|Overall Study|Adverse Event|1|||
164594695|NCT01728584|594541049|FG001|Overall Study|Adverse Event|0|||
164594696|NCT01728584|594541050|FG002|Overall Study|Adverse Event|0|||
164594697|NCT01728584|594541051|FG003|Overall Study|Adverse Event|0|||
164594698|NCT01728584|594541048|FG000|Overall Study|Physician Decision|4|||
164594699|NCT01728584|594541049|FG001|Overall Study|Physician Decision|0|||
164594700|NCT01728584|594541050|FG002|Overall Study|Physician Decision|1|||
164594701|NCT01728584|594541051|FG003|Overall Study|Physician Decision|0|||
164594702|NCT01728584|594541048|FG000|Overall Study|Withdrawal by Subject|1|||
164594703|NCT01728584|594541049|FG001|Overall Study|Withdrawal by Subject|0|||
164594704|NCT01728584|594541050|FG002|Overall Study|Withdrawal by Subject|0|||
164594705|NCT01728584|594541051|FG003|Overall Study|Withdrawal by Subject|0|||
164594706|NCT01728584|594541048|FG000|Overall Study|Screen failure|1|||
164594707|NCT01728584|594541049|FG001|Overall Study|Screen failure|0|||
164594708|NCT01728584|594541050|FG002|Overall Study|Screen failure|0|||
164594709|NCT01728584|594541051|FG003|Overall Study|Screen failure|0|||
164594710|NCT01728584|594541048|FG000|Overall Study|Other reason (not specified)|1|||
164594711|NCT01728584|594541049|FG001|Overall Study|Other reason (not specified)|0|||
164594712|NCT01728584|594541050|FG002|Overall Study|Other reason (not specified)|0|||
164594713|NCT01728584|594541051|FG003|Overall Study|Other reason (not specified)|1|||
164594714|NCT05132569|594541053|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
164594715|NCT05132569|594541054|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
164594716|NCT05132569|594541053|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
164594717|NCT05132569|594541054|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
164594718|NCT05132569|594541053|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
164594719|NCT05132569|594541054|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
164594720|NCT00471536|594541067|FG000|Overall Study|Withdrawal by Subject|1|||
164594721|NCT01188564|594541070|FG000|Double-blind Phase|randomized not treated|1|||
164594722|NCT01188564|594541071|FG001|Double-blind Phase|randomized not treated|0|||
164594723|NCT01094730|594541074|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
164594724|NCT01094730|594541075|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
164594725|NCT01094730|594541074|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
164594726|NCT01094730|594541075|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
164704066|NCT01831765|594941886|FG002|Overall Study|Lack of Efficacy|0|||
164394745|NCT03945188|593813768|FG000|Overall Study|Adverse Event|10|||
164394746|NCT03945188|593813769|FG001|Overall Study|Adverse Event|5|||
164394747|NCT03945188|593813768|FG000|Overall Study|Other|2|||
164394748|NCT03945188|593813769|FG001|Overall Study|Other|2|||
164394749|NCT03945188|593813768|FG000|Overall Study|Lost to Follow-up|1|||
164394750|NCT03945188|593813769|FG001|Overall Study|Lost to Follow-up|2|||
164394751|NCT01613248|593813770|FG000|Overall Study|Adverse Event|0|||
164394752|NCT01613248|593813771|FG001|Overall Study|Adverse Event|0|||
164394753|NCT01613248|593813772|FG002|Overall Study|Adverse Event|0|||
164594727|NCT01094730|594541074|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
164594728|NCT01094730|594541075|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
164594729|NCT01094730|594541074|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
164594730|NCT01094730|594541075|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
164394754|NCT01613248|593813773|FG003|Overall Study|Adverse Event|1|||
164394755|NCT01613248|593813774|FG004|Overall Study|Adverse Event|0|||
164394756|NCT01613248|593813775|FG005|Overall Study|Adverse Event|0|||
164394757|NCT01613248|593813770|FG000|Overall Study|Withdrawal by Subject|3|||
164394758|NCT01613248|593813771|FG001|Overall Study|Withdrawal by Subject|2|||
164394759|NCT01613248|593813772|FG002|Overall Study|Withdrawal by Subject|2|||
164394760|NCT01613248|593813773|FG003|Overall Study|Withdrawal by Subject|5|||
164394761|NCT01613248|593813774|FG004|Overall Study|Withdrawal by Subject|0|||
164394762|NCT01613248|593813775|FG005|Overall Study|Withdrawal by Subject|1|||
164394763|NCT01613248|593813770|FG000|Overall Study|Lost to Follow-up|5|||
164394764|NCT01613248|593813771|FG001|Overall Study|Lost to Follow-up|7|||
164394765|NCT01613248|593813772|FG002|Overall Study|Lost to Follow-up|4|||
164394766|NCT01613248|593813773|FG003|Overall Study|Lost to Follow-up|8|||
164394767|NCT01613248|593813774|FG004|Overall Study|Lost to Follow-up|4|||
164394768|NCT01613248|593813775|FG005|Overall Study|Lost to Follow-up|2|||
164394769|NCT01613248|593813770|FG000|Overall Study|Study Terminated by Sponsor|4|||
164394770|NCT01613248|593813771|FG001|Overall Study|Study Terminated by Sponsor|6|||
164394771|NCT01613248|593813772|FG002|Overall Study|Study Terminated by Sponsor|8|||
164394772|NCT01613248|593813773|FG003|Overall Study|Study Terminated by Sponsor|8|||
164394773|NCT01613248|593813774|FG004|Overall Study|Study Terminated by Sponsor|9|||
164394774|NCT01613248|593813775|FG005|Overall Study|Study Terminated by Sponsor|11|||
164394775|NCT01613248|593813770|FG000|Overall Study|Physician Decision|8|||
164394776|NCT01613248|593813771|FG001|Overall Study|Physician Decision|8|||
164394777|NCT01613248|593813772|FG002|Overall Study|Physician Decision|9|||
164394778|NCT01613248|593813773|FG003|Overall Study|Physician Decision|4|||
164394779|NCT01613248|593813774|FG004|Overall Study|Physician Decision|7|||
164394780|NCT01613248|593813775|FG005|Overall Study|Physician Decision|6|||
164394781|NCT01613248|593813770|FG000|Overall Study|Lack of Qualifying Event|9|||
164394782|NCT01613248|593813771|FG001|Overall Study|Lack of Qualifying Event|11|||
164394783|NCT01613248|593813772|FG002|Overall Study|Lack of Qualifying Event|10|||
164704067|NCT01831765|594941884|FG000|Overall Study|Other, sponsor withdrew subject|0|||
164704068|NCT01831765|594941885|FG001|Overall Study|Other, sponsor withdrew subject|1|||
164394784|NCT01613248|593813773|FG003|Overall Study|Lack of Qualifying Event|11|||
164394785|NCT01613248|593813774|FG004|Overall Study|Lack of Qualifying Event|15|||
164394786|NCT01613248|593813775|FG005|Overall Study|Lack of Qualifying Event|18|||
164394787|NCT01613248|593813770|FG000|Overall Study|Pregnancy|0|||
164394788|NCT01613248|593813771|FG001|Overall Study|Pregnancy|0|||
164394789|NCT01613248|593813772|FG002|Overall Study|Pregnancy|0|||
164394790|NCT01613248|593813773|FG003|Overall Study|Pregnancy|1|||
164394791|NCT01613248|593813774|FG004|Overall Study|Pregnancy|0|||
164394792|NCT01613248|593813775|FG005|Overall Study|Pregnancy|0|||
164394793|NCT01433354|593813777|FG000|Overall Study|Adverse Event|6|||
164394794|NCT01433354|593813777|FG000|Overall Study|Lost to Follow-up|1|||
164394795|NCT01433354|593813777|FG000|Overall Study|Administrative problems|90|||
164394796|NCT01433354|593813777|FG000|Overall Study|Protocol Violation|2|||
164394797|NCT01433354|593813777|FG000|Overall Study|Lack of Efficacy|17|||
164394798|NCT01433354|593813777|FG000|Overall Study|Subject Withdrew Consent|3|||
164394799|NCT04794803|593813786|FG000|Overall Study|Death|1|||
164394800|NCT04794803|593813787|FG001|Overall Study|Death|3|||
164394801|NCT04794803|593813786|FG000|Overall Study|Lost to Follow-up|2|||
164594731|NCT01094730|594541074|FG000|Period 2 (14 Days)|Protocol Violation|2|||
164704069|NCT01831765|594941886|FG002|Overall Study|Other, sponsor withdrew subject|0|||
164704070|NCT01831765|594941884|FG000|Overall Study|Pregnancy|1|||
164704071|NCT01831765|594941885|FG001|Overall Study|Pregnancy|1|||
164704072|NCT01831765|594941886|FG002|Overall Study|Pregnancy|2|||
164704073|NCT01831765|594941884|FG000|Overall Study|Death|0|||
164704074|NCT01831765|594941885|FG001|Overall Study|Death|1|||
164704075|NCT01831765|594941886|FG002|Overall Study|Death|1|||
164704076|NCT01831765|594941884|FG000|Overall Study|Other, site closed|1|||
164394802|NCT04794803|593813787|FG001|Overall Study|Lost to Follow-up|2|||
164394803|NCT04794803|593813786|FG000|Overall Study|Withdrawal by Subject|1|||
164394804|NCT04794803|593813787|FG001|Overall Study|Withdrawal by Subject|0|||
164394805|NCT04794803|593813786|FG000|Overall Study|Physician Decision|1|||
164394806|NCT04794803|593813787|FG001|Overall Study|Physician Decision|1|||
164394807|NCT04794803|593813786|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
164394808|NCT04794803|593813787|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
164594732|NCT01094730|594541075|FG001|Period 2 (14 Days)|Protocol Violation|0|||
164594733|NCT01094730|594541074|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
164594734|NCT01094730|594541075|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
164594735|NCT01094730|594541074|FG000|Period 2 (14 Days)|Adverse Event|0|||
164594736|NCT01094730|594541075|FG001|Period 2 (14 Days)|Adverse Event|1|||
164594737|NCT01094730|594541074|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
164704077|NCT01831765|594941885|FG001|Overall Study|Other, site closed|1|||
164394809|NCT04794803|593813786|FG000|Overall Study|Refused to continue the treatment|1|||
164394810|NCT04794803|593813787|FG001|Overall Study|Refused to continue the treatment|0|||
164394811|NCT04794803|593813786|FG000|Overall Study|Patient admitted to ICU|0|||
164594738|NCT01094730|594541075|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
164704078|NCT01831765|594941886|FG002|Overall Study|Other, site closed|0|||
164441751|NCT00102063|593984456|FG002|Overall Study|Lost to Follow-up|1|||
164394812|NCT04794803|593813787|FG001|Overall Study|Patient admitted to ICU|1|||
164394813|NCT04124926|593813792|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
164394814|NCT04124926|593813793|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
164394815|NCT04124926|593813794|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
164394816|NCT04124926|593813795|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
164394817|NCT04124926|593813796|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
164394818|NCT04124926|593813792|FG000|Healing Phase|Protocol Violation|0|||
164394819|NCT04124926|593813793|FG001|Healing Phase|Protocol Violation|1|||
164441752|NCT00102063|593984454|FG000|Overall Study|Protocol Violation|0|||
164441753|NCT00102063|593984455|FG001|Overall Study|Protocol Violation|1|||
164441754|NCT00102063|593984456|FG002|Overall Study|Protocol Violation|1|||
164441755|NCT00857649|593984457|FG000|Overall Study|Adverse Event|15|||
164441756|NCT00857649|593984458|FG001|Overall Study|Adverse Event|10|||
164441757|NCT00857649|593984457|FG000|Overall Study|Non-compliance|1|||
164441758|NCT00857649|593984458|FG001|Overall Study|Non-compliance|1|||
164441759|NCT00857649|593984457|FG000|Overall Study|Protocol Violation|2|||
164441760|NCT00857649|593984458|FG001|Overall Study|Protocol Violation|2|||
164594739|NCT04171037|594541076|FG000|Overall Study|Lost to Follow-up|1|||
164594740|NCT04171037|594541077|FG001|Overall Study|Lost to Follow-up|0|||
164594741|NCT04171037|594541076|FG000|Overall Study|Physician Decision|3|||
164394820|NCT04124926|593813794|FG002|Healing Phase|Protocol Violation|0|||
164441761|NCT00857649|593984457|FG000|Overall Study|Withdrawal of Consent|10|||
164441762|NCT00857649|593984458|FG001|Overall Study|Withdrawal of Consent|7|||
164441763|NCT00857649|593984457|FG000|Overall Study|Nursing Home Placement|2|||
164394821|NCT04124926|593813795|FG003|Healing Phase|Protocol Violation|0|||
164394822|NCT04124926|593813796|FG004|Healing Phase|Protocol Violation|0|||
164394823|NCT04124926|593813792|FG000|Healing Phase|Lost to Follow-up|5|||
164394824|NCT04124926|593813793|FG001|Healing Phase|Lost to Follow-up|4|||
164394825|NCT04124926|593813794|FG002|Healing Phase|Lost to Follow-up|0|||
164394826|NCT04124926|593813795|FG003|Healing Phase|Lost to Follow-up|0|||
164394827|NCT04124926|593813796|FG004|Healing Phase|Lost to Follow-up|0|||
164394828|NCT04124926|593813792|FG000|Healing Phase|Voluntary Withdrawal|10|||
164394829|NCT04124926|593813793|FG001|Healing Phase|Voluntary Withdrawal|7|||
164394830|NCT04124926|593813794|FG002|Healing Phase|Voluntary Withdrawal|0|||
164394831|NCT04124926|593813795|FG003|Healing Phase|Voluntary Withdrawal|0|||
164394832|NCT04124926|593813796|FG004|Healing Phase|Voluntary Withdrawal|0|||
164394833|NCT04124926|593813792|FG000|Healing Phase|Withdrawal of Consent|5|||
164394834|NCT04124926|593813793|FG001|Healing Phase|Withdrawal of Consent|3|||
164394835|NCT04124926|593813794|FG002|Healing Phase|Withdrawal of Consent|0|||
164394836|NCT04124926|593813795|FG003|Healing Phase|Withdrawal of Consent|0|||
164394837|NCT04124926|593813796|FG004|Healing Phase|Withdrawal of Consent|0|||
164394838|NCT04124926|593813792|FG000|Healing Phase|Miscellaneous|8|||
164394839|NCT04124926|593813793|FG001|Healing Phase|Miscellaneous|7|||
164394840|NCT04124926|593813794|FG002|Healing Phase|Miscellaneous|0|||
164394841|NCT04124926|593813795|FG003|Healing Phase|Miscellaneous|0|||
164394842|NCT04124926|593813796|FG004|Healing Phase|Miscellaneous|0|||
164394843|NCT04124926|593813792|FG000|Healing Phase|Randomized but not Treated|0|||
164394844|NCT04124926|593813793|FG001|Healing Phase|Randomized but not Treated|3|||
164394845|NCT04124926|593813794|FG002|Healing Phase|Randomized but not Treated|0|||
164394846|NCT04124926|593813795|FG003|Healing Phase|Randomized but not Treated|0|||
164394847|NCT04124926|593813796|FG004|Healing Phase|Randomized but not Treated|0|||
164394848|NCT04124926|593813792|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
164394849|NCT04124926|593813793|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
164394850|NCT04124926|593813794|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
164394851|NCT04124926|593813795|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
164394852|NCT04124926|593813796|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
164394853|NCT04124926|593813792|FG000|Maintenance Phase|Protocol Violation|0|||
164394854|NCT04124926|593813793|FG001|Maintenance Phase|Protocol Violation|0|||
164394855|NCT04124926|593813794|FG002|Maintenance Phase|Protocol Violation|3|||
164394856|NCT04124926|593813795|FG003|Maintenance Phase|Protocol Violation|0|||
164704079|NCT01831765|594941884|FG000|Overall Study|Adverse Event|5|||
164704080|NCT01831765|594941885|FG001|Overall Study|Adverse Event|3|||
164704081|NCT01831765|594941886|FG002|Overall Study|Adverse Event|3|||
164704082|NCT01831765|594941884|FG000|Overall Study|Withdrawal by Subject|22|||
164704083|NCT01831765|594941885|FG001|Overall Study|Withdrawal by Subject|7|||
164704084|NCT01831765|594941886|FG002|Overall Study|Withdrawal by Subject|17|||
164704085|NCT01831765|594941884|FG000|Overall Study|Withdrawal criteria|12|||
164704086|NCT01831765|594941885|FG001|Overall Study|Withdrawal criteria|10|||
164704087|NCT01831765|594941886|FG002|Overall Study|Withdrawal criteria|16|||
164704088|NCT01831765|594941884|FG000|Overall Study|Lost to Follow-up|2|||
164704089|NCT01831765|594941885|FG001|Overall Study|Lost to Follow-up|3|||
164704090|NCT01831765|594941886|FG002|Overall Study|Lost to Follow-up|3|||
164704091|NCT02605993|594941887|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
164704092|NCT02605993|594941888|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
164704093|NCT02605993|594941889|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
164704094|NCT02605993|594941890|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
164704095|NCT03493386|594941893|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
164704096|NCT03493386|594941894|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
164704097|NCT03493386|594941895|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
164704098|NCT03493386|594941896|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
164704099|NCT00988442|594941902|FG000|Overall Study|Death|1|||
164704100|NCT00988442|594941903|FG001|Overall Study|Death|2|||
164704101|NCT00988442|594941902|FG000|Overall Study|Lost to Follow-up|0|||
164704102|NCT00988442|594941903|FG001|Overall Study|Lost to Follow-up|1|||
164704103|NCT00988442|594941902|FG000|Overall Study|Early Study Closure|29|||
164704104|NCT00988442|594941903|FG001|Overall Study|Early Study Closure|25|||
164704105|NCT04620135|594941906|FG000|Study Completion|Adverse Event|2|||
164704106|NCT04620135|594941907|FG001|Study Completion|Adverse Event|3|||
164704107|NCT04620135|594941906|FG000|Study Completion|Withdrawal by Subject|2|||
164704108|NCT04620135|594941907|FG001|Study Completion|Withdrawal by Subject|0|||
164704109|NCT01442688|594941909|FG000|First Intervention|Withdrawal by Subject|1|||
164704110|NCT01442688|594941910|FG001|First Intervention|Withdrawal by Subject|0|||
164704111|NCT01442688|594941909|FG000|First Intervention|subject incarcerated|1|||
164704112|NCT01442688|594941910|FG001|First Intervention|subject incarcerated|0|||
164704113|NCT01442688|594941909|FG000|Second Intervention|Adverse Event|1|||
164704114|NCT01442688|594941910|FG001|Second Intervention|Adverse Event|0|||
164394857|NCT04124926|593813796|FG004|Maintenance Phase|Protocol Violation|0|||
164394858|NCT04124926|593813792|FG000|Maintenance Phase|Lost to Follow-up|0|||
164394859|NCT04124926|593813793|FG001|Maintenance Phase|Lost to Follow-up|0|||
164394860|NCT04124926|593813794|FG002|Maintenance Phase|Lost to Follow-up|7|||
164394861|NCT04124926|593813795|FG003|Maintenance Phase|Lost to Follow-up|8|||
164394862|NCT04124926|593813796|FG004|Maintenance Phase|Lost to Follow-up|9|||
164394863|NCT04124926|593813792|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
164394864|NCT04124926|593813793|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
164394865|NCT04124926|593813794|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
164394866|NCT04124926|593813795|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
164394867|NCT04124926|593813796|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
164394868|NCT04124926|593813792|FG000|Maintenance Phase|Pregnancy|0|||
164394869|NCT04124926|593813793|FG001|Maintenance Phase|Pregnancy|0|||
164394870|NCT04124926|593813794|FG002|Maintenance Phase|Pregnancy|0|||
164394871|NCT04124926|593813795|FG003|Maintenance Phase|Pregnancy|1|||
164394872|NCT04124926|593813796|FG004|Maintenance Phase|Pregnancy|0|||
164394873|NCT04124926|593813792|FG000|Maintenance Phase|Lack of Efficacy|0|||
164394874|NCT04124926|593813793|FG001|Maintenance Phase|Lack of Efficacy|0|||
164394875|NCT04124926|593813794|FG002|Maintenance Phase|Lack of Efficacy|0|||
164394876|NCT04124926|593813795|FG003|Maintenance Phase|Lack of Efficacy|0|||
164394877|NCT04124926|593813796|FG004|Maintenance Phase|Lack of Efficacy|1|||
164394878|NCT04124926|593813792|FG000|Maintenance Phase|Withdrawal of Consent|0|||
164394879|NCT04124926|593813793|FG001|Maintenance Phase|Withdrawal of Consent|0|||
164394880|NCT04124926|593813794|FG002|Maintenance Phase|Withdrawal of Consent|5|||
164394881|NCT04124926|593813795|FG003|Maintenance Phase|Withdrawal of Consent|5|||
164394882|NCT04124926|593813796|FG004|Maintenance Phase|Withdrawal of Consent|5|||
164594742|NCT04171037|594541077|FG001|Overall Study|Physician Decision|3|||
164594743|NCT01934894|594541078|FG000|Overall Study|Adverse Event|1|||
164594744|NCT01934894|594541079|FG001|Overall Study|Adverse Event|2|||
164594745|NCT01934894|594541078|FG000|Overall Study|Death|2|||
164594746|NCT01934894|594541079|FG001|Overall Study|Death|0|||
164594747|NCT01934894|594541078|FG000|Overall Study|Withdrawal by Subject|0|||
164594748|NCT01934894|594541079|FG001|Overall Study|Withdrawal by Subject|1|||
164594749|NCT01934894|594541078|FG000|Overall Study|Progressive Disease|3|||
164704115|NCT04771403|594941911|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
164704116|NCT04771403|594941912|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
164704117|NCT04771403|594941911|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
164704118|NCT04771403|594941912|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
164704119|NCT04771403|594941911|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
164704120|NCT04771403|594941912|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
164704121|NCT04771403|594941911|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
164704122|NCT04771403|594941912|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
164394883|NCT04124926|593813792|FG000|Maintenance Phase|Miscellaneous|0|||
164394884|NCT04124926|593813793|FG001|Maintenance Phase|Miscellaneous|0|||
164394885|NCT04124926|593813794|FG002|Maintenance Phase|Miscellaneous|1|||
164394886|NCT04124926|593813795|FG003|Maintenance Phase|Miscellaneous|2|||
164394887|NCT04124926|593813796|FG004|Maintenance Phase|Miscellaneous|4|||
164394888|NCT04124926|593813792|FG000|Maintenance Phase|Randomized but not Treated|0|||
164394889|NCT04124926|593813793|FG001|Maintenance Phase|Randomized but not Treated|0|||
164394890|NCT04124926|593813794|FG002|Maintenance Phase|Randomized but not Treated|2|||
164394891|NCT04124926|593813795|FG003|Maintenance Phase|Randomized but not Treated|2|||
164394892|NCT04124926|593813796|FG004|Maintenance Phase|Randomized but not Treated|0|||
164394893|NCT03280121|593813803|FG000|Overall Study|Physician Decision|1|||
164394894|NCT03280121|593813803|FG000|Overall Study|Lost to Follow-up|1|||
164394895|NCT03280121|593813803|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
164394896|NCT01324271|593813816|FG000|Overall Study|Lost to Follow-up|3|||
164394897|NCT01324271|593813817|FG001|Overall Study|Lost to Follow-up|0|||
164394898|NCT01324271|593813816|FG000|Overall Study|Physician Decision|1|||
164394899|NCT01324271|593813817|FG001|Overall Study|Physician Decision|0|||
164394900|NCT06116591|593813818|FG000|Overall Study|No longer met eligibility criteria|0|||
164394901|NCT06116591|593813819|FG001|Overall Study|No longer met eligibility criteria|1|||
164394902|NCT06116591|593813818|FG000|Overall Study|Other: Change in life situation|0|||
164394903|NCT06116591|593813819|FG001|Overall Study|Other: Change in life situation|1|||
164394904|NCT05585307|593813820|FG000|Overall Study|Lost to Follow-up|0|||
164394905|NCT05585307|593813821|FG001|Overall Study|Lost to Follow-up|0|||
164394906|NCT05585307|593813822|FG002|Overall Study|Lost to Follow-up|0|||
164394907|NCT05585307|593813823|FG003|Overall Study|Lost to Follow-up|0|||
164394908|NCT05585307|593813824|FG004|Overall Study|Lost to Follow-up|0|||
164394909|NCT05585307|593813825|FG005|Overall Study|Lost to Follow-up|0|||
164594750|NCT01934894|594541079|FG001|Overall Study|Progressive Disease|2|||
164594751|NCT01954251|594541080|FG000|Overall Study|Adverse Event|5|||
164394910|NCT05585307|593813826|FG006|Overall Study|Lost to Follow-up|1|||
164394911|NCT05585307|593813827|FG007|Overall Study|Lost to Follow-up|0|||
164394912|NCT04009291|593813828|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
164394913|NCT04009291|593813829|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
164394914|NCT04009291|593813830|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
164394915|NCT04009291|593813831|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
164394916|NCT04009291|593813832|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
164394917|NCT04009291|593813828|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
164394918|NCT04009291|593813829|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
164394919|NCT04009291|593813830|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
164394920|NCT04009291|593813831|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
164394921|NCT04009291|593813832|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
164394922|NCT00492284|593813835|FG000|Overall Study|Adverse Event|0|||
164394923|NCT00492284|593813836|FG001|Overall Study|Adverse Event|1|||
164394924|NCT00492284|593813837|FG002|Overall Study|Adverse Event|1|||
164394925|NCT00492284|593813838|FG003|Overall Study|Adverse Event|2|||
164394926|NCT00492284|593813835|FG000|Overall Study|Lost to Follow-up|0|||
164394927|NCT00492284|593813836|FG001|Overall Study|Lost to Follow-up|0|||
164394928|NCT00492284|593813837|FG002|Overall Study|Lost to Follow-up|3|||
164394929|NCT00492284|593813838|FG003|Overall Study|Lost to Follow-up|1|||
164394930|NCT00492284|593813835|FG000|Overall Study|Death|0|||
164394931|NCT00492284|593813836|FG001|Overall Study|Death|3|||
164394932|NCT00492284|593813837|FG002|Overall Study|Death|2|||
164394933|NCT00492284|593813838|FG003|Overall Study|Death|5|||
164394934|NCT00492284|593813835|FG000|Overall Study|Withdrawal by Subject|1|||
164394935|NCT00492284|593813836|FG001|Overall Study|Withdrawal by Subject|0|||
164394936|NCT00492284|593813837|FG002|Overall Study|Withdrawal by Subject|0|||
164394937|NCT00492284|593813838|FG003|Overall Study|Withdrawal by Subject|2|||
164394938|NCT02734212|593813839|FG000|Overall Study|Lost to Follow-up|5|||
164394939|NCT02734212|593813840|FG001|Overall Study|Lost to Follow-up|10|||
164394940|NCT00700401|593813851|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
164394941|NCT00700401|593813851|FG000|Overall Study|Adverse Event|5|||
164394942|NCT00700401|593813851|FG000|Overall Study|Refused Treatment|2|||
164394943|NCT00700401|593813851|FG000|Overall Study|Lost to Follow-up|1|||
164394944|NCT00700401|593813851|FG000|Overall Study|Treatment never started|1|||
164394945|NCT00700401|593813851|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
164394946|NCT00700401|593813851|FG000|Overall Study|Withdrawal by Subject|2|||
164394947|NCT02491671|593813852|FG000|Overall Study|Adverse Event|6|||
164394948|NCT02491671|593813853|FG001|Overall Study|Adverse Event|8|||
164394949|NCT02491671|593813852|FG000|Overall Study|Death|0|||
164394950|NCT02491671|593813853|FG001|Overall Study|Death|2|||
164394951|NCT02491671|593813852|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
164394952|NCT02491671|593813853|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
164394953|NCT02251990|593813857|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
164394954|NCT02251990|593813858|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
164394955|NCT02251990|593813857|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
164394956|NCT02251990|593813858|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
164394957|NCT02251990|593813857|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
164394958|NCT02251990|593813858|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
164394959|NCT02251990|593813857|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
164394960|NCT02251990|593813858|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
164394961|NCT02251990|593813857|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
164394962|NCT02251990|593813858|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
164394963|NCT02251990|593813857|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
164394964|NCT02251990|593813858|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
164394965|NCT02293538|593813859|FG000|Overall Study|Adverse Event|0|||
164394966|NCT02293538|593813860|FG001|Overall Study|Adverse Event|1|||
164394967|NCT02293538|593813859|FG000|Overall Study|Lost to Follow-up|1|||
164394968|NCT02293538|593813860|FG001|Overall Study|Lost to Follow-up|0|||
164394969|NCT02293538|593813859|FG000|Overall Study|Withdrawal by Subject|0|||
164394970|NCT02293538|593813860|FG001|Overall Study|Withdrawal by Subject|1|||
164394971|NCT00322348|593813861|FG000|Overall Study|Adverse Event|0|||
164394972|NCT00322348|593813862|FG001|Overall Study|Adverse Event|1|||
164441764|NCT00857649|593984458|FG001|Overall Study|Nursing Home Placement|9|||
164441765|NCT00857649|593984457|FG000|Overall Study|Other Reasons|1|||
164441766|NCT00857649|593984458|FG001|Overall Study|Other Reasons|3|||
164441767|NCT02739035|593984460|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
164441768|NCT02739035|593984461|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
164441769|NCT02739035|593984460|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
164394973|NCT00322348|593813861|FG000|Overall Study|Withdrawal by Subject|1|||
164394974|NCT00322348|593813862|FG001|Overall Study|Withdrawal by Subject|4|||
164394975|NCT00322348|593813861|FG000|Overall Study|Lost to Follow-up|1|||
164394976|NCT00322348|593813862|FG001|Overall Study|Lost to Follow-up|0|||
164394977|NCT00322348|593813861|FG000|Overall Study|Death|0|||
164394978|NCT00322348|593813862|FG001|Overall Study|Death|2|||
164394979|NCT00322348|593813861|FG000|Overall Study|Disease Progression|30|||
164394980|NCT00322348|593813862|FG001|Overall Study|Disease Progression|25|||
164394981|NCT00322348|593813861|FG000|Overall Study|Reasons not specified|5|||
164394982|NCT00322348|593813862|FG001|Overall Study|Reasons not specified|1|||
164394983|NCT01041638|593813864|FG000|Overall Study|Adverse Event|4|||
164394984|NCT01041638|593813864|FG000|Overall Study|Death|1|||
164394985|NCT01041638|593813864|FG000|Overall Study|Lack of Efficacy|7|||
164394986|NCT01041638|593813864|FG000|Overall Study|Physician Decision|4|||
164394987|NCT01041638|593813864|FG000|Overall Study|Withdrawal by Subject|11|||
164394988|NCT03152552|593813865|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
164394989|NCT03152552|593813866|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
164394990|NCT03152552|593813867|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
164394991|NCT03152552|593813868|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
164441770|NCT02739035|593984461|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
164441771|NCT02739035|593984460|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
164441772|NCT02739035|593984461|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
164441773|NCT02739035|593984460|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
164441774|NCT02739035|593984461|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
164441775|NCT02517307|593984469|FG000|Overall Study|Withdrawal by Subject|1|||
164441776|NCT02517307|593984470|FG001|Overall Study|Withdrawal by Subject|0|||
164441777|NCT02517307|593984471|FG002|Overall Study|Withdrawal by Subject|1|||
164441778|NCT02517307|593984472|FG003|Overall Study|Withdrawal by Subject|0|||
164441779|NCT02517307|593984469|FG000|Overall Study|Protocol Violation|0|||
164441780|NCT02517307|593984470|FG001|Overall Study|Protocol Violation|0|||
164441781|NCT02517307|593984471|FG002|Overall Study|Protocol Violation|1|||
164441782|NCT02517307|593984472|FG003|Overall Study|Protocol Violation|1|||
164441783|NCT00843882|593984473|FG000|Step 1|Lack of Efficacy|14|||
164441784|NCT00843882|593984474|FG001|Step 1|Lack of Efficacy|10|||
164441785|NCT00843882|593984475|FG002|Step 1|Lack of Efficacy|21|||
164441786|NCT00843882|593984473|FG000|Step 1|Adverse Event|8|||
164441787|NCT00843882|593984474|FG001|Step 1|Adverse Event|17|||
164441788|NCT00843882|593984475|FG002|Step 1|Adverse Event|20|||
164441789|NCT00843882|593984473|FG000|Step 1|Death|1|||
164441790|NCT00843882|593984474|FG001|Step 1|Death|2|||
164441791|NCT00843882|593984475|FG002|Step 1|Death|4|||
164441792|NCT00843882|593984473|FG000|Step 1|Withdrawal by Subject|6|||
164441793|NCT00843882|593984474|FG001|Step 1|Withdrawal by Subject|12|||
164441794|NCT00843882|593984475|FG002|Step 1|Withdrawal by Subject|9|||
164441795|NCT00843882|593984473|FG000|Step 1|Physician Decision|0|||
164441796|NCT00843882|593984474|FG001|Step 1|Physician Decision|5|||
164441797|NCT00843882|593984475|FG002|Step 1|Physician Decision|1|||
164441798|NCT00843882|593984473|FG000|Step 1|Patient and physician's decision|0|||
164441799|NCT00843882|593984474|FG001|Step 1|Patient and physician's decision|0|||
164441800|NCT00843882|593984475|FG002|Step 1|Patient and physician's decision|1|||
164441801|NCT00843882|593984473|FG000|Step 1|Other complicating disease|1|||
164441802|NCT00843882|593984474|FG001|Step 1|Other complicating disease|3|||
164441803|NCT00843882|593984475|FG002|Step 1|Other complicating disease|4|||
164441804|NCT00843882|593984473|FG000|Step 1|Alternative therapy|0|||
164441805|NCT00843882|593984474|FG001|Step 1|Alternative therapy|1|||
164441806|NCT00843882|593984475|FG002|Step 1|Alternative therapy|1|||
164441807|NCT00843882|593984473|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
164441808|NCT00843882|593984474|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
164704123|NCT04771403|594941911|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
164394992|NCT03152552|593813869|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
164394993|NCT03152552|593813865|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
164394994|NCT03152552|593813866|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
164394995|NCT03152552|593813867|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
164441809|NCT00843882|593984475|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
164441810|NCT00843882|593984473|FG000|Step 1|Off treatment reason unknown|0|||
164441811|NCT00843882|593984474|FG001|Step 1|Off treatment reason unknown|1|||
164441812|NCT00843882|593984475|FG002|Step 1|Off treatment reason unknown|4|||
164394996|NCT03152552|593813868|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
164441813|NCT00843882|593984473|FG000|Step 1|Never started treatment|2|||
164441814|NCT00843882|593984474|FG001|Step 1|Never started treatment|0|||
164441815|NCT00843882|593984475|FG002|Step 1|Never started treatment|0|||
164394997|NCT03152552|593813869|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
164394998|NCT03152552|593813865|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
164394999|NCT03152552|593813866|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
164395000|NCT03152552|593813867|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
164395001|NCT03152552|593813868|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
164395002|NCT03152552|593813869|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
164395003|NCT03152552|593813865|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164395004|NCT03152552|593813866|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164395005|NCT03152552|593813867|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
164395006|NCT03152552|593813868|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164395007|NCT03152552|593813869|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164395008|NCT03152552|593813865|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
164395009|NCT03152552|593813866|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
164395010|NCT03152552|593813867|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
164395011|NCT03152552|593813868|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
164395012|NCT03152552|593813869|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
164395013|NCT03152552|593813865|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
164395014|NCT03152552|593813866|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
164441816|NCT00843882|593984473|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
164441817|NCT00843882|593984474|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
164594752|NCT01954251|594541081|FG001|Overall Study|Adverse Event|7|||
164594753|NCT01954251|594541080|FG000|Overall Study|Lost to Follow-up|6|||
164594754|NCT01954251|594541081|FG001|Overall Study|Lost to Follow-up|6|||
164594755|NCT01954251|594541080|FG000|Overall Study|Withdrawal by Subject|2|||
164594756|NCT01954251|594541081|FG001|Overall Study|Withdrawal by Subject|6|||
164594757|NCT04804033|594541082|FG000|Period 1: DBT Phase|Adverse Event|1|||
164594758|NCT04804033|594541083|FG001|Period 1: DBT Phase|Adverse Event|5|||
164594759|NCT04804033|594541084|FG002|Period 1: DBT Phase|Adverse Event|3|||
164594760|NCT04804033|594541085|FG003|Period 1: DBT Phase|Adverse Event|4|||
164594761|NCT04804033|594541082|FG000|Period 1: DBT Phase|Death|1|||
164594762|NCT04804033|594541083|FG001|Period 1: DBT Phase|Death|0|||
164594763|NCT04804033|594541084|FG002|Period 1: DBT Phase|Death|0|||
164594764|NCT04804033|594541085|FG003|Period 1: DBT Phase|Death|0|||
164594765|NCT04804033|594541082|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
164594766|NCT04804033|594541083|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
164441818|NCT00843882|593984475|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
164594767|NCT04804033|594541084|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
164594768|NCT04804033|594541085|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
164594769|NCT04804033|594541082|FG000|Period 1: DBT Phase|Non-compliance|1|||
164594770|NCT04804033|594541083|FG001|Period 1: DBT Phase|Non-compliance|0|||
164594771|NCT04804033|594541084|FG002|Period 1: DBT Phase|Non-compliance|1|||
164594772|NCT04804033|594541085|FG003|Period 1: DBT Phase|Non-compliance|2|||
164594773|NCT04804033|594541082|FG000|Period 1: DBT Phase|Other|0|||
164594774|NCT04804033|594541083|FG001|Period 1: DBT Phase|Other|1|||
164594775|NCT04804033|594541084|FG002|Period 1: DBT Phase|Other|0|||
164594776|NCT04804033|594541085|FG003|Period 1: DBT Phase|Other|0|||
164594777|NCT04804033|594541082|FG000|Period 1: DBT Phase|Pregnancy|2|||
164594778|NCT04804033|594541083|FG001|Period 1: DBT Phase|Pregnancy|0|||
164594779|NCT04804033|594541084|FG002|Period 1: DBT Phase|Pregnancy|0|||
164594780|NCT04804033|594541085|FG003|Period 1: DBT Phase|Pregnancy|0|||
164594781|NCT04804033|594541082|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
164594782|NCT04804033|594541083|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
164594783|NCT04804033|594541084|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
164594784|NCT04804033|594541085|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
164594785|NCT04804033|594541082|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
164594786|NCT04804033|594541083|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
164594787|NCT04804033|594541084|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
164594788|NCT04804033|594541085|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
164594789|NCT04804033|594541082|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
164594790|NCT04804033|594541083|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
164594791|NCT04804033|594541084|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
164594792|NCT04804033|594541085|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
164594793|NCT04804033|594541082|FG000|Period 2: OLE Phase|Adverse Event|3|||
164594794|NCT04804033|594541083|FG001|Period 2: OLE Phase|Adverse Event|4|||
164594795|NCT04804033|594541084|FG002|Period 2: OLE Phase|Adverse Event|2|||
164594796|NCT04804033|594541085|FG003|Period 2: OLE Phase|Adverse Event|0|||
164594797|NCT04804033|594541082|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
164594798|NCT04804033|594541083|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
164594799|NCT04804033|594541084|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
164594800|NCT04804033|594541085|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
164594801|NCT04804033|594541082|FG000|Period 2: OLE Phase|Non-compliance|2|||
164395015|NCT03152552|593813867|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
164395016|NCT03152552|593813868|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
164395017|NCT03152552|593813869|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
164395018|NCT03152552|593813865|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
164395019|NCT03152552|593813866|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
164395020|NCT03152552|593813867|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
164395021|NCT03152552|593813868|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
164395022|NCT03152552|593813869|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
164395023|NCT01857531|593813871|FG000|Overall Study|Withdrawal by Subject|4|||
164395024|NCT00679939|593813879|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
164704124|NCT04771403|594941912|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
164704125|NCT04771403|594941911|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
164704126|NCT04771403|594941912|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
164704127|NCT04771403|594941911|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
164704128|NCT04771403|594941912|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
164704129|NCT04771403|594941911|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
164704130|NCT04771403|594941912|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
164704131|NCT00857259|594941913|FG000|Overall Study|Protocol Violation|1|||
164704132|NCT00857259|594941914|FG001|Overall Study|Protocol Violation|0|||
164704133|NCT00857259|594941915|FG002|Overall Study|Protocol Violation|1|||
164704134|NCT00546572|594941916|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
164704135|NCT00546572|594941917|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
164395025|NCT00679939|593813880|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
164395026|NCT00679939|593813879|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
164395027|NCT00679939|593813880|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
164395028|NCT00679939|593813879|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
164395029|NCT00679939|593813880|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
164594802|NCT04804033|594541083|FG001|Period 2: OLE Phase|Non-compliance|2|||
164594803|NCT04804033|594541084|FG002|Period 2: OLE Phase|Non-compliance|0|||
164594804|NCT04804033|594541085|FG003|Period 2: OLE Phase|Non-compliance|1|||
164594805|NCT04804033|594541082|FG000|Period 2: OLE Phase|Other|0|||
164594806|NCT04804033|594541083|FG001|Period 2: OLE Phase|Other|2|||
164594807|NCT04804033|594541084|FG002|Period 2: OLE Phase|Other|0|||
164594808|NCT04804033|594541085|FG003|Period 2: OLE Phase|Other|0|||
164594809|NCT04804033|594541082|FG000|Period 2: OLE Phase|Physician Decision|1|||
164594810|NCT04804033|594541083|FG001|Period 2: OLE Phase|Physician Decision|1|||
164395030|NCT00679939|593813879|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
164395031|NCT00679939|593813880|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
164395032|NCT00679939|593813879|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
164395033|NCT00679939|593813880|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
164395034|NCT00679939|593813879|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
164395035|NCT00679939|593813880|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
164395036|NCT00679939|593813879|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
164395037|NCT00679939|593813880|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
164395038|NCT00679939|593813879|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
164395039|NCT00679939|593813880|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
164395040|NCT00679939|593813879|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
164594811|NCT04804033|594541084|FG002|Period 2: OLE Phase|Physician Decision|0|||
164594812|NCT04804033|594541085|FG003|Period 2: OLE Phase|Physician Decision|0|||
164395041|NCT00679939|593813880|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
164395042|NCT00679939|593813879|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
164395043|NCT00679939|593813880|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
164395044|NCT05374421|593813881|FG000|Overall Study|Withdrawal by Subject|3|||
164395045|NCT05374421|593813882|FG001|Overall Study|Withdrawal by Subject|4|||
164395046|NCT02763384|593813883|FG000|Overall Study|Physician Decision|1|||
164395047|NCT02763384|593813883|FG000|Overall Study|Rapid decline - went on hospice|1|||
164395048|NCT04657211|593813884|FG000|Overall Study|Withdrawal by Subject|21|||
164395049|NCT04657211|593813884|FG000|Overall Study|Lost to Follow-up|113|||
164395050|NCT04657211|593813884|FG000|Overall Study|Death|47|||
164395051|NCT04657211|593813884|FG000|Overall Study|Transfer to another institution|21|||
164395052|NCT04657211|593813884|FG000|Overall Study|Other|29|||
164395053|NCT00003508|593815696|FG000|Overall Study|Not evaluable|5|||
164395054|NCT03576768|593815698|FG000|Overall Study|Lost to Follow-up|3|||
164395055|NCT03576768|593815699|FG001|Overall Study|Lost to Follow-up|3|||
164594813|NCT04804033|594541082|FG000|Period 2: OLE Phase|Pregnancy|0|||
164594814|NCT04804033|594541083|FG001|Period 2: OLE Phase|Pregnancy|0|||
164594815|NCT04804033|594541084|FG002|Period 2: OLE Phase|Pregnancy|2|||
164594816|NCT04804033|594541085|FG003|Period 2: OLE Phase|Pregnancy|0|||
164594817|NCT04804033|594541082|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
164594818|NCT04804033|594541083|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
164594819|NCT04804033|594541084|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
164594820|NCT04804033|594541085|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
164594821|NCT04804033|594541082|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
164594822|NCT04804033|594541083|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
164594823|NCT04804033|594541084|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
164594824|NCT04804033|594541085|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
164594825|NCT04804033|594541082|FG000|Period 2: OLE Phase|Not reported|0|||
164594826|NCT04804033|594541083|FG001|Period 2: OLE Phase|Not reported|2|||
164594827|NCT04804033|594541084|FG002|Period 2: OLE Phase|Not reported|0|||
164594828|NCT04804033|594541085|FG003|Period 2: OLE Phase|Not reported|0|||
164594829|NCT04804033|594541082|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
164594830|NCT04804033|594541083|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
164594831|NCT04804033|594541084|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
164594832|NCT04804033|594541085|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
164594833|NCT04804033|594541082|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
164594834|NCT04804033|594541083|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
164594835|NCT04804033|594541084|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
164594836|NCT04804033|594541085|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
164594837|NCT04804033|594541082|FG000|Period 3: Follow-up Phase|Other|0|||
164594838|NCT04804033|594541083|FG001|Period 3: Follow-up Phase|Other|1|||
164594839|NCT04804033|594541084|FG002|Period 3: Follow-up Phase|Other|2|||
164594840|NCT04804033|594541085|FG003|Period 3: Follow-up Phase|Other|1|||
164594841|NCT04804033|594541082|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
164594842|NCT04804033|594541083|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
164594843|NCT04804033|594541084|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
164594844|NCT04804033|594541085|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
164594845|NCT04804033|594541082|FG000|Period 3: Follow-up Phase|Not reported|18|||
164594846|NCT04804033|594541083|FG001|Period 3: Follow-up Phase|Not reported|15|||
164395056|NCT03576768|593815700|FG002|Overall Study|Lost to Follow-up|0|||
164395057|NCT03576768|593815701|FG003|Overall Study|Lost to Follow-up|0|||
164395058|NCT00590902|593815702|FG000|Overall Study|Death|1|||
164395059|NCT02057874|593815703|FG000|Overall Study|participant did not return for scan|1|||
164395060|NCT02979639|593815704|FG000|Overall Study|Withdrawal based on medical judgement|1|||
164395061|NCT02979639|593815704|FG000|Overall Study|Lost to Follow-up|8|||
164395062|NCT02979639|593815704|FG000|Overall Study|Withdrawal by Subject|3|||
164395063|NCT02979639|593815704|FG000|Overall Study|Adverse Event|2|||
164395064|NCT01738984|593815707|FG000|Overall Study|Pregnancy|4|||
164395065|NCT01738984|593815708|FG001|Overall Study|Pregnancy|0|||
164395066|NCT01738984|593815707|FG000|Overall Study|Withdrawal by Subject|1|||
164395067|NCT01738984|593815708|FG001|Overall Study|Withdrawal by Subject|0|||
164395068|NCT01738984|593815707|FG000|Overall Study|Lost to Follow-up|59|||
164395069|NCT01738984|593815708|FG001|Overall Study|Lost to Follow-up|39|||
164395070|NCT02621931|593815713|FG000|Overall Study|Death|0|||
164395071|NCT02621931|593815714|FG001|Overall Study|Death|1|||
164395072|NCT02621931|593815715|FG002|Overall Study|Death|0|||
164395073|NCT02621931|593815713|FG000|Overall Study|Adverse Event|8|||
164395074|NCT02621931|593815714|FG001|Overall Study|Adverse Event|5|||
164395075|NCT02621931|593815715|FG002|Overall Study|Adverse Event|7|||
164395076|NCT02621931|593815713|FG000|Overall Study|Withdrawal by Subject|12|||
164395077|NCT02621931|593815714|FG001|Overall Study|Withdrawal by Subject|10|||
164395078|NCT02621931|593815715|FG002|Overall Study|Withdrawal by Subject|11|||
164395079|NCT02621931|593815713|FG000|Overall Study|Protocol Violation|2|||
164395080|NCT02621931|593815714|FG001|Overall Study|Protocol Violation|2|||
164395081|NCT02621931|593815715|FG002|Overall Study|Protocol Violation|2|||
164395082|NCT02621931|593815713|FG000|Overall Study|Pregnancy|2|||
164395083|NCT02621931|593815714|FG001|Overall Study|Pregnancy|0|||
164395084|NCT02621931|593815715|FG002|Overall Study|Pregnancy|0|||
164395085|NCT02621931|593815713|FG000|Overall Study|Noncompliance to study procedures|0|||
164395086|NCT02621931|593815714|FG001|Overall Study|Noncompliance to study procedures|1|||
164395087|NCT02621931|593815715|FG002|Overall Study|Noncompliance to study procedures|2|||
164395088|NCT02621931|593815713|FG000|Overall Study|Lost to Follow-up|8|||
164395089|NCT02621931|593815714|FG001|Overall Study|Lost to Follow-up|7|||
164395090|NCT02621931|593815715|FG002|Overall Study|Lost to Follow-up|10|||
164395091|NCT02621931|593815713|FG000|Overall Study|Lack of Efficacy|0|||
164395092|NCT02621931|593815714|FG001|Overall Study|Lack of Efficacy|0|||
164395093|NCT02621931|593815715|FG002|Overall Study|Lack of Efficacy|1|||
164395094|NCT02621931|593815713|FG000|Overall Study|Other|1|||
164395095|NCT02621931|593815714|FG001|Overall Study|Other|1|||
164395096|NCT02621931|593815715|FG002|Overall Study|Other|3|||
164395097|NCT00920426|593815716|FG000|ITZ111451|Adverse Event|1|||
164395098|NCT00920426|593815717|FG001|ITZ111451|Adverse Event|0|||
164395099|NCT00920426|593815718|FG002|ITZ111451|Adverse Event|0|||
164395100|NCT00920426|593815719|FG003|ITZ111451|Adverse Event|0|||
164395101|NCT00955357|593815724|FG000|Titration Phase|Adverse Event|9|||
164395102|NCT00955357|593815725|FG001|Titration Phase|Adverse Event|46|||
164395103|NCT00955357|593815724|FG000|Titration Phase|Lack of Efficacy|0|||
164395104|NCT00955357|593815725|FG001|Titration Phase|Lack of Efficacy|2|||
164395105|NCT00955357|593815724|FG000|Titration Phase|Protocol Violation|3|||
164395106|NCT00955357|593815725|FG001|Titration Phase|Protocol Violation|7|||
164395107|NCT00955357|593815724|FG000|Titration Phase|Lost to Follow-up|1|||
164395108|NCT00955357|593815725|FG001|Titration Phase|Lost to Follow-up|3|||
164395109|NCT00955357|593815724|FG000|Titration Phase|Withdrawal by Subject|3|||
164395110|NCT00955357|593815725|FG001|Titration Phase|Withdrawal by Subject|5|||
164395111|NCT00955357|593815724|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
164395112|NCT00955357|593815725|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
164395113|NCT00955357|593815724|FG000|Titration Phase|Study medication not tolerated|0|||
164395114|NCT00955357|593815725|FG001|Titration Phase|Study medication not tolerated|1|||
164395115|NCT00955357|593815724|FG000|Titration Phase|Non compliance to study procedures|0|||
164395116|NCT00955357|593815725|FG001|Titration Phase|Non compliance to study procedures|1|||
164395117|NCT00955357|593815724|FG000|Maintenance Phase|Adverse Event|3|||
164395118|NCT00955357|593815725|FG001|Maintenance Phase|Adverse Event|23|||
164395119|NCT00955357|593815724|FG000|Maintenance Phase|Lack of Efficacy|0|||
164395120|NCT00955357|593815725|FG001|Maintenance Phase|Lack of Efficacy|4|||
164395121|NCT00955357|593815724|FG000|Maintenance Phase|Protocol Violation|2|||
164395122|NCT00955357|593815725|FG001|Maintenance Phase|Protocol Violation|6|||
164395123|NCT00955357|593815724|FG000|Maintenance Phase|Lost to Follow-up|2|||
164395124|NCT00955357|593815725|FG001|Maintenance Phase|Lost to Follow-up|7|||
164395125|NCT00955357|593815724|FG000|Maintenance Phase|Withdrawal by Subject|4|||
164395126|NCT00955357|593815725|FG001|Maintenance Phase|Withdrawal by Subject|4|||
164395127|NCT00955357|593815724|FG000|Maintenance Phase|Patient moving out of area|0|||
164395128|NCT00955357|593815725|FG001|Maintenance Phase|Patient moving out of area|1|||
164395129|NCT00955357|593815724|FG000|Maintenance Phase|Non compliance to study procedures|1|||
164395130|NCT00955357|593815725|FG001|Maintenance Phase|Non compliance to study procedures|0|||
164395131|NCT02943408|593815726|FG000|Overall Study|Lost to Follow-up|7|||
164395132|NCT02943408|593815727|FG001|Overall Study|Lost to Follow-up|1|||
164395133|NCT02943408|593815726|FG000|Overall Study|Withdrawal by Subject|0|||
164395134|NCT02943408|593815727|FG001|Overall Study|Withdrawal by Subject|1|||
164395135|NCT01621126|593815730|FG000|Overall Study|Physician Decision|6|||
164395136|NCT00886340|593815731|FG000|Overall Study|Withdrawal by Subject|0|||
164395137|NCT00886340|593815732|FG001|Overall Study|Withdrawal by Subject|7|||
164395138|NCT02985866|593815733|FG000|Overall Study|Poor CGM data|1|||
164395139|NCT02985866|593815734|FG001|Overall Study|Poor CGM data|1|||
164395140|NCT03751631|593815735|FG000|Overall Study|Withdrawal by Subject|0|||
164395141|NCT03751631|593815736|FG001|Overall Study|Withdrawal by Subject|0|||
164395142|NCT03751631|593815737|FG002|Overall Study|Withdrawal by Subject|1|||
164395143|NCT03751631|593815738|FG003|Overall Study|Withdrawal by Subject|1|||
164395144|NCT03751631|593815739|FG004|Overall Study|Withdrawal by Subject|0|||
164395145|NCT03751631|593815740|FG005|Overall Study|Withdrawal by Subject|0|||
164395146|NCT02481310|593815741|FG000|Follow up|Still in follow up|0|||
164395147|NCT02481310|593815742|FG001|Follow up|Still in follow up|3|||
164395148|NCT02481310|593815743|FG002|Follow up|Still in follow up|0|||
164395149|NCT00643916|593815745|FG000|Overall Study|Protocol Violation|0|||
164395150|NCT00643916|593815746|FG001|Overall Study|Protocol Violation|1|||
164395151|NCT00643916|593815747|FG002|Overall Study|Protocol Violation|1|||
164395152|NCT00643916|593815748|FG003|Overall Study|Protocol Violation|1|||
164395153|NCT00643916|593815749|FG004|Overall Study|Protocol Violation|0|||
164395154|NCT00643916|593815750|FG005|Overall Study|Protocol Violation|0|||
164441819|NCT00843882|593984473|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
164594847|NCT04804033|594541084|FG002|Period 3: Follow-up Phase|Not reported|1|||
164594848|NCT04804033|594541085|FG003|Period 3: Follow-up Phase|Not reported|4|||
164441820|NCT00843882|593984474|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
164594849|NCT01864018|594541086|FG000|Overall Study|Ineligible|3|||
164594850|NCT01864018|594541087|FG001|Overall Study|Ineligible|1|||
164594851|NCT00222729|594541093|FG000|Overall Study|Adverse Event|3|||
164594852|NCT01915849|594541094|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
164594853|NCT01915849|594541095|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
164594854|NCT01915849|594541096|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
164594855|NCT01915849|594541097|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
164594856|NCT01915849|594541094|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
164594857|NCT01915849|594541095|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
164594858|NCT01915849|594541096|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
164594859|NCT01915849|594541097|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
164594860|NCT01798706|594541098|FG000|Overall Study|Adverse Event|15|||
164594861|NCT01798706|594541099|FG001|Overall Study|Adverse Event|10|||
164594862|NCT01798706|594541098|FG000|Overall Study|Lack of Efficacy|0|||
164594863|NCT01798706|594541099|FG001|Overall Study|Lack of Efficacy|2|||
164594864|NCT01798706|594541098|FG000|Overall Study|Poor compliance to protocol|1|||
164594865|NCT01798706|594541099|FG001|Overall Study|Poor compliance to protocol|0|||
164594866|NCT01798706|594541098|FG000|Overall Study|Other than specified above|5|||
164594867|NCT01798706|594541099|FG001|Overall Study|Other than specified above|9|||
164594868|NCT02775864|594541100|FG000|Overall Study|Data ended end of 2010|1764|||
164594869|NCT02775864|594541101|FG001|Overall Study|Data ended end of 2010|2880|||
164594870|NCT02775864|594541102|FG002|Overall Study|Data ended end of 2010|1140|||
164594871|NCT02775864|594541103|FG003|Overall Study|Data ended end of 2010|1194|||
164594872|NCT02775864|594541100|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
164594873|NCT02775864|594541101|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
164594874|NCT02775864|594541102|FG002|Overall Study|Medicaid eligibility discontinued|720|||
164594875|NCT02775864|594541103|FG003|Overall Study|Medicaid eligibility discontinued|890|||
164594876|NCT00256867|594541110|FG000|Overall Study|Adverse Event|0|||
164594877|NCT00256867|594541111|FG001|Overall Study|Adverse Event|1|||
164594878|NCT00256867|594541112|FG002|Overall Study|Adverse Event|1|||
164594879|NCT00256867|594541113|FG003|Overall Study|Adverse Event|1|||
164594880|NCT00256867|594541114|FG004|Overall Study|Adverse Event|2|||
164594881|NCT00256867|594541115|FG005|Overall Study|Adverse Event|2|||
164594882|NCT00256867|594541116|FG006|Overall Study|Adverse Event|1|||
164594883|NCT00256867|594541117|FG007|Overall Study|Adverse Event|4|||
164594884|NCT00256867|594541110|FG000|Overall Study|Lost to Follow-up|2|||
164594885|NCT00256867|594541111|FG001|Overall Study|Lost to Follow-up|2|||
164594886|NCT00256867|594541112|FG002|Overall Study|Lost to Follow-up|2|||
164594887|NCT00256867|594541113|FG003|Overall Study|Lost to Follow-up|3|||
164594888|NCT00256867|594541114|FG004|Overall Study|Lost to Follow-up|2|||
164594889|NCT00256867|594541115|FG005|Overall Study|Lost to Follow-up|0|||
164594890|NCT00256867|594541116|FG006|Overall Study|Lost to Follow-up|1|||
164594891|NCT00256867|594541117|FG007|Overall Study|Lost to Follow-up|2|||
164594892|NCT00256867|594541110|FG000|Overall Study|Protocol Violation|0|||
164594893|NCT00256867|594541111|FG001|Overall Study|Protocol Violation|0|||
164594894|NCT00256867|594541112|FG002|Overall Study|Protocol Violation|0|||
164594895|NCT00256867|594541113|FG003|Overall Study|Protocol Violation|1|||
164594896|NCT00256867|594541114|FG004|Overall Study|Protocol Violation|0|||
164594897|NCT00256867|594541115|FG005|Overall Study|Protocol Violation|1|||
164594898|NCT00256867|594541116|FG006|Overall Study|Protocol Violation|0|||
164594899|NCT00256867|594541117|FG007|Overall Study|Protocol Violation|1|||
164594900|NCT00256867|594541110|FG000|Overall Study|Withdrawal by Subject|0|||
164704136|NCT00546572|594941916|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
164594901|NCT00256867|594541111|FG001|Overall Study|Withdrawal by Subject|0|||
164594902|NCT00256867|594541112|FG002|Overall Study|Withdrawal by Subject|1|||
164704137|NCT00546572|594941917|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
164144036|NCT00086281|592888575|FG004|Phase 2|Adverse Event|0|||
164395155|NCT00643916|593815745|FG000|Overall Study|Lost to Follow-up|0|||
164395156|NCT00643916|593815746|FG001|Overall Study|Lost to Follow-up|1|||
164395157|NCT00643916|593815747|FG002|Overall Study|Lost to Follow-up|0|||
164395158|NCT00643916|593815748|FG003|Overall Study|Lost to Follow-up|0|||
164395159|NCT00643916|593815749|FG004|Overall Study|Lost to Follow-up|0|||
164395160|NCT00643916|593815750|FG005|Overall Study|Lost to Follow-up|0|||
164395161|NCT00643916|593815745|FG000|Overall Study|Withdrawal by Subject|2|||
164395162|NCT00643916|593815746|FG001|Overall Study|Withdrawal by Subject|2|||
164704138|NCT00546572|594941916|FG000|Vax 1 / Year 0|Protocol Violation|3|||
164704139|NCT00546572|594941917|FG001|Vax 1 / Year 0|Protocol Violation|4|||
164704140|NCT00546572|594941916|FG000|Vax 1 / Year 0|Death|2|||
164704141|NCT00546572|594941917|FG001|Vax 1 / Year 0|Death|2|||
164704142|NCT00546572|594941916|FG000|Vax 1 / Year 0|Adverse Event|0|||
164704143|NCT00546572|594941917|FG001|Vax 1 / Year 0|Adverse Event|1|||
164704144|NCT00546572|594941916|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
164704145|NCT00546572|594941917|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
164704146|NCT00546572|594941916|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
164704147|NCT00546572|594941917|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
164704148|NCT00546572|594941916|FG000|Vax 2 / Year 1|Other|1|||
164704149|NCT00546572|594941917|FG001|Vax 2 / Year 1|Other|1|||
164704150|NCT00546572|594941916|FG000|Vax 2 / Year 1|Adverse Event|1|||
164704151|NCT00546572|594941917|FG001|Vax 2 / Year 1|Adverse Event|0|||
164704152|NCT00546572|594941916|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
164704153|NCT00546572|594941917|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
164704154|NCT03979820|594941918|FG000|Overall Study|Protocol Violation|1|||
164704155|NCT03979820|594941919|FG001|Overall Study|Protocol Violation|0|||
164704156|NCT03979820|594941920|FG002|Overall Study|Protocol Violation|0|||
164395163|NCT00643916|593815747|FG002|Overall Study|Withdrawal by Subject|2|||
164395164|NCT00643916|593815748|FG003|Overall Study|Withdrawal by Subject|1|||
164395165|NCT00643916|593815749|FG004|Overall Study|Withdrawal by Subject|0|||
164395166|NCT00643916|593815750|FG005|Overall Study|Withdrawal by Subject|1|||
164395167|NCT00643916|593815745|FG000|Overall Study|Not Vaccinated|2|||
164395168|NCT00643916|593815746|FG001|Overall Study|Not Vaccinated|2|||
164395169|NCT00643916|593815747|FG002|Overall Study|Not Vaccinated|3|||
164395170|NCT00643916|593815748|FG003|Overall Study|Not Vaccinated|0|||
164395171|NCT00643916|593815749|FG004|Overall Study|Not Vaccinated|2|||
164395172|NCT00643916|593815750|FG005|Overall Study|Not Vaccinated|0|||
164395173|NCT02184611|593815752|FG000|Overall Study|Lack of Efficacy|11|||
164395174|NCT02184611|593815753|FG001|Overall Study|Lack of Efficacy|15|||
164395175|NCT02184611|593815752|FG000|Overall Study|Withdrawal by Subject|5|||
164395176|NCT02184611|593815753|FG001|Overall Study|Withdrawal by Subject|6|||
164395177|NCT02184611|593815752|FG000|Overall Study|Adverse Event|4|||
164395178|NCT02184611|593815753|FG001|Overall Study|Adverse Event|5|||
164395179|NCT02184611|593815752|FG000|Overall Study|Protocol Violation|1|||
164395180|NCT02184611|593815753|FG001|Overall Study|Protocol Violation|1|||
164395181|NCT02184611|593815752|FG000|Overall Study|Protocol defined stopping criteria|0|||
164395182|NCT02184611|593815753|FG001|Overall Study|Protocol defined stopping criteria|1|||
164395183|NCT02925455|593815754|FG000|Overall Study|Withdrawal by Subject|2|||
164395184|NCT02925455|593815755|FG001|Overall Study|Withdrawal by Subject|0|||
164395185|NCT01514448|593815759|FG000|Overall Study|Death|7|||
164395186|NCT01514448|593815760|FG001|Overall Study|Death|8|||
164395187|NCT01514448|593815759|FG000|Overall Study|Withdrawal by Subject|2|||
164395188|NCT01514448|593815760|FG001|Overall Study|Withdrawal by Subject|0|||
164395189|NCT01514448|593815759|FG000|Overall Study|Lost to Follow-up|2|||
164704157|NCT03979820|594941921|FG003|Overall Study|Protocol Violation|0|||
164704158|NCT03979820|594941918|FG000|Overall Study|Withdrawal by Subject|0|||
164395190|NCT01514448|593815760|FG001|Overall Study|Lost to Follow-up|0|||
164395191|NCT01514448|593815759|FG000|Overall Study|New Cancer Therapy|1|||
164395192|NCT01514448|593815760|FG001|Overall Study|New Cancer Therapy|0|||
164704159|NCT03979820|594941919|FG001|Overall Study|Withdrawal by Subject|0|||
164704160|NCT03979820|594941920|FG002|Overall Study|Withdrawal by Subject|1|||
164395193|NCT05159622|593815761|FG000|Overall Study|Lost to Follow-up|4|||
164395194|NCT05159622|593815762|FG001|Overall Study|Lost to Follow-up|5|||
164395195|NCT02723864|593815763|FG000|Overall Study|Refused further treatment|1|||
164395196|NCT02723864|593815764|FG001|Overall Study|Refused further treatment|0|||
164395197|NCT02723864|593815765|FG002|Overall Study|Refused further treatment|0|||
164704161|NCT03979820|594941921|FG003|Overall Study|Withdrawal by Subject|0|||
164704162|NCT03979820|594941918|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
164704163|NCT03979820|594941919|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
164704164|NCT03979820|594941920|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
164704165|NCT03979820|594941921|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
164704166|NCT02707861|594941922|FG000|Overall Study|Went onto commercial drug|30|||
164704167|NCT02707861|594941923|FG001|Overall Study|Went onto commercial drug|23|||
164704168|NCT02707861|594941922|FG000|Overall Study|Adverse Event|2|||
164704169|NCT02707861|594941923|FG001|Overall Study|Adverse Event|3|||
164704170|NCT02707861|594941922|FG000|Overall Study|Death|5|||
164704171|NCT02707861|594941923|FG001|Overall Study|Death|2|||
164704172|NCT02707861|594941922|FG000|Overall Study|Lack of Efficacy|0|||
164704173|NCT02707861|594941923|FG001|Overall Study|Lack of Efficacy|2|||
164704174|NCT02707861|594941922|FG000|Overall Study|Physician Decision|1|||
164704175|NCT02707861|594941923|FG001|Overall Study|Physician Decision|4|||
164704176|NCT02707861|594941922|FG000|Overall Study|Withdrawal by Subject|2|||
164704177|NCT02707861|594941923|FG001|Overall Study|Withdrawal by Subject|1|||
164704178|NCT02707861|594941922|FG000|Overall Study|Lost to Follow-up|1|||
164704179|NCT02707861|594941923|FG001|Overall Study|Lost to Follow-up|3|||
164704180|NCT00731549|594941924|FG000|Overall Study|Lost to Follow-up|19|||
164704181|NCT00731549|594941924|FG000|Overall Study|Met withdrawal criteria|24|||
164704182|NCT00731549|594941924|FG000|Overall Study|Physician Decision|16|||
164704183|NCT00731549|594941924|FG000|Overall Study|Withdrawal by Subject|89|||
164704184|NCT00731549|594941924|FG000|Overall Study|Protocol deviation|1|||
164704185|NCT00731549|594941924|FG000|Overall Study|Adverse Event|31|||
164704186|NCT00731549|594941924|FG000|Overall Study|Lack of efficacy with AE|37|||
164704187|NCT00731549|594941924|FG000|Overall Study|Lack of efficacy without AE|6|||
164704188|NCT00507546|594941925|FG000|Overall Study|Withdrawal by Subject|1|||
164704189|NCT00507546|594941926|FG001|Overall Study|Withdrawal by Subject|0|||
164704190|NCT00507546|594941925|FG000|Overall Study|Protocol Violation|1|||
164704191|NCT00507546|594941926|FG001|Overall Study|Protocol Violation|0|||
164704192|NCT00507546|594941925|FG000|Overall Study|Physician Decision|0|||
164704193|NCT00507546|594941926|FG001|Overall Study|Physician Decision|1|||
164704194|NCT00609466|594941929|FG000|Overall Study|Withdrawal by Subject|0|||
164704195|NCT00609466|594941930|FG001|Overall Study|Withdrawal by Subject|1|||
164704196|NCT00609466|594941931|FG002|Overall Study|Withdrawal by Subject|1|||
164704197|NCT00609466|594941929|FG000|Overall Study|Adverse Event|2|||
164704198|NCT00609466|594941930|FG001|Overall Study|Adverse Event|3|||
164704199|NCT00609466|594941931|FG002|Overall Study|Adverse Event|1|||
164704200|NCT00609466|594941929|FG000|Overall Study|Lack of Efficacy|0|||
164704201|NCT00609466|594941930|FG001|Overall Study|Lack of Efficacy|2|||
164704202|NCT00609466|594941931|FG002|Overall Study|Lack of Efficacy|2|||
164704203|NCT01299805|594941934|FG000|Overall Study|Adverse Event|2|||
164704204|NCT01299805|594941935|FG001|Overall Study|Adverse Event|0|||
164704205|NCT02518919|594944490|FG000|Overall Study|Protocol Violation|1|||
164704206|NCT02518919|594944491|FG001|Overall Study|Protocol Violation|1|||
164704207|NCT02518919|594944492|FG002|Overall Study|Protocol Violation|2|||
164704208|NCT04498403|594944493|FG000|Overall Study|Adverse Event|1|||
164704209|NCT04498403|594944494|FG001|Overall Study|Adverse Event|0|||
164704210|NCT04498403|594944493|FG000|Overall Study|Study Terminated By Sponsor|29|||
164704211|NCT04498403|594944494|FG001|Overall Study|Study Terminated By Sponsor|10|||
164704212|NCT03986138|594944495|FG000|First MRI Examination|Physician Decision|0|||
164704213|NCT03986138|594944496|FG001|First MRI Examination|Physician Decision|1|||
164704214|NCT03986138|594944495|FG000|First MRI Examination|Other reason (mainly technical issues with MRI machine)|1|||
164704215|NCT03986138|594944496|FG001|First MRI Examination|Other reason (mainly technical issues with MRI machine)|2|||
164704216|NCT03986138|594944495|FG000|Washout|Withdrawal by Subject|4|||
164704217|NCT03986138|594944496|FG001|Washout|Withdrawal by Subject|5|||
164395198|NCT02723864|593815766|FG003|Overall Study|Refused further treatment|0|||
164704218|NCT03986138|594944495|FG000|Washout|Lost to Follow-up|0|||
164704219|NCT03986138|594944496|FG001|Washout|Lost to Follow-up|2|||
164704220|NCT03986138|594944495|FG000|Washout|Adverse Event|1|||
164704221|NCT03986138|594944496|FG001|Washout|Adverse Event|1|||
164704222|NCT03986138|594944495|FG000|Washout|Other reason|5|||
164704223|NCT03986138|594944496|FG001|Washout|Other reason|5|||
164704224|NCT03986138|594944495|FG000|Second MRI Examination|Withdrawal by Subject|0|||
164704225|NCT03986138|594944496|FG001|Second MRI Examination|Withdrawal by Subject|2|||
164704226|NCT02031458|594944498|FG000|May 8, 2015 to January 11, 2019|Death|89|||
164704227|NCT02031458|594944499|FG001|May 8, 2015 to January 11, 2019|Death|193|||
164704228|NCT02031458|594944500|FG002|May 8, 2015 to January 11, 2019|Death|198|||
164395199|NCT02723864|593815767|FG004|Overall Study|Refused further treatment|1|||
164395200|NCT02723864|593815768|FG005|Overall Study|Refused further treatment|2|||
164395201|NCT02723864|593815769|FG006|Overall Study|Refused further treatment|0|||
164395202|NCT02723864|593815763|FG000|Overall Study|Exceed treatment hold time|0|||
164395203|NCT02723864|593815764|FG001|Overall Study|Exceed treatment hold time|1|||
164395204|NCT02723864|593815765|FG002|Overall Study|Exceed treatment hold time|0|||
164395205|NCT02723864|593815766|FG003|Overall Study|Exceed treatment hold time|0|||
164395206|NCT02723864|593815767|FG004|Overall Study|Exceed treatment hold time|0|||
164395207|NCT02723864|593815768|FG005|Overall Study|Exceed treatment hold time|0|||
164395208|NCT02723864|593815769|FG006|Overall Study|Exceed treatment hold time|0|||
164395209|NCT02723864|593815763|FG000|Overall Study|Clinical progression|0|||
164395210|NCT02723864|593815764|FG001|Overall Study|Clinical progression|0|||
164395211|NCT02723864|593815765|FG002|Overall Study|Clinical progression|1|||
164395212|NCT02723864|593815766|FG003|Overall Study|Clinical progression|0|||
164395213|NCT02723864|593815767|FG004|Overall Study|Clinical progression|0|||
164395214|NCT02723864|593815768|FG005|Overall Study|Clinical progression|3|||
164395215|NCT02723864|593815769|FG006|Overall Study|Clinical progression|1|||
164395216|NCT02723864|593815763|FG000|Overall Study|Physician Decision|0|||
164395217|NCT02723864|593815764|FG001|Overall Study|Physician Decision|0|||
164395218|NCT02723864|593815765|FG002|Overall Study|Physician Decision|0|||
164395219|NCT02723864|593815766|FG003|Overall Study|Physician Decision|0|||
164395220|NCT02723864|593815767|FG004|Overall Study|Physician Decision|0|||
164395221|NCT02723864|593815768|FG005|Overall Study|Physician Decision|0|||
164395222|NCT02723864|593815769|FG006|Overall Study|Physician Decision|1|||
164395223|NCT02723864|593815763|FG000|Overall Study|Changes in patient condition|0|||
164395224|NCT02723864|593815764|FG001|Overall Study|Changes in patient condition|0|||
164395225|NCT02723864|593815765|FG002|Overall Study|Changes in patient condition|0|||
164395226|NCT02723864|593815766|FG003|Overall Study|Changes in patient condition|0|||
164395227|NCT02723864|593815767|FG004|Overall Study|Changes in patient condition|0|||
164395228|NCT02723864|593815768|FG005|Overall Study|Changes in patient condition|1|||
164395229|NCT02723864|593815769|FG006|Overall Study|Changes in patient condition|0|||
164395230|NCT02723864|593815763|FG000|Overall Study|Patient choice|0|||
164395231|NCT02723864|593815764|FG001|Overall Study|Patient choice|0|||
164395232|NCT02723864|593815765|FG002|Overall Study|Patient choice|0|||
164395233|NCT02723864|593815766|FG003|Overall Study|Patient choice|0|||
164395234|NCT02723864|593815767|FG004|Overall Study|Patient choice|0|||
164395235|NCT02723864|593815768|FG005|Overall Study|Patient choice|1|||
164395236|NCT02723864|593815769|FG006|Overall Study|Patient choice|0|||
164395237|NCT02723864|593815763|FG000|Overall Study|Adverse Event|0|||
164395238|NCT02723864|593815764|FG001|Overall Study|Adverse Event|0|||
164395239|NCT02723864|593815765|FG002|Overall Study|Adverse Event|0|||
164395240|NCT02723864|593815766|FG003|Overall Study|Adverse Event|0|||
164395241|NCT02723864|593815767|FG004|Overall Study|Adverse Event|0|||
164395242|NCT02723864|593815768|FG005|Overall Study|Adverse Event|1|||
164395243|NCT02723864|593815769|FG006|Overall Study|Adverse Event|0|||
164395244|NCT02723864|593815763|FG000|Overall Study|Started new treatment|0|||
164395245|NCT02723864|593815764|FG001|Overall Study|Started new treatment|0|||
164395246|NCT02723864|593815765|FG002|Overall Study|Started new treatment|0|||
164594903|NCT00256867|594541113|FG003|Overall Study|Withdrawal by Subject|1|||
164594904|NCT00256867|594541114|FG004|Overall Study|Withdrawal by Subject|2|||
164594905|NCT00256867|594541115|FG005|Overall Study|Withdrawal by Subject|2|||
164594906|NCT00256867|594541116|FG006|Overall Study|Withdrawal by Subject|3|||
164594907|NCT00256867|594541117|FG007|Overall Study|Withdrawal by Subject|2|||
164704229|NCT02031458|594944498|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
164704230|NCT02031458|594944499|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
164395247|NCT02723864|593815766|FG003|Overall Study|Started new treatment|0|||
164395248|NCT02723864|593815767|FG004|Overall Study|Started new treatment|0|||
164395249|NCT02723864|593815768|FG005|Overall Study|Started new treatment|1|||
164594908|NCT00256867|594541110|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
164594909|NCT00256867|594541111|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
164594910|NCT00256867|594541112|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
164594911|NCT00256867|594541113|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
164594912|NCT00256867|594541114|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
164594913|NCT00256867|594541115|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
164594914|NCT00256867|594541116|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
164594915|NCT00256867|594541117|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
164594916|NCT00256867|594541110|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
164594917|NCT00256867|594541111|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
164594918|NCT00256867|594541112|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
164594919|NCT00256867|594541113|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
164594920|NCT00256867|594541114|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
164594921|NCT00256867|594541115|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
164594922|NCT00256867|594541116|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
164594923|NCT00256867|594541117|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
164395250|NCT02723864|593815769|FG006|Overall Study|Started new treatment|0|||
164395251|NCT02723864|593815763|FG000|Overall Study|Switched to alternative treatment|0|||
164395252|NCT02723864|593815764|FG001|Overall Study|Switched to alternative treatment|0|||
164395253|NCT02723864|593815765|FG002|Overall Study|Switched to alternative treatment|0|||
164395254|NCT02723864|593815766|FG003|Overall Study|Switched to alternative treatment|0|||
164395255|NCT02723864|593815767|FG004|Overall Study|Switched to alternative treatment|0|||
164395256|NCT02723864|593815768|FG005|Overall Study|Switched to alternative treatment|1|||
164395257|NCT02723864|593815769|FG006|Overall Study|Switched to alternative treatment|0|||
164395258|NCT02723864|593815763|FG000|Overall Study|Late determination of ineligibility|0|||
164395259|NCT02723864|593815764|FG001|Overall Study|Late determination of ineligibility|0|||
164395260|NCT02723864|593815765|FG002|Overall Study|Late determination of ineligibility|0|||
164395261|NCT02723864|593815766|FG003|Overall Study|Late determination of ineligibility|0|||
164395262|NCT02723864|593815767|FG004|Overall Study|Late determination of ineligibility|0|||
164395263|NCT02723864|593815768|FG005|Overall Study|Late determination of ineligibility|1|||
164395264|NCT02723864|593815769|FG006|Overall Study|Late determination of ineligibility|0|||
164395265|NCT03232983|593815770|FG000|Period 1|Physician Decision|0|||
164395266|NCT03232983|593815771|FG001|Period 1|Physician Decision|0|||
164395267|NCT03232983|593815772|FG002|Period 1|Physician Decision|1|||
164395268|NCT03232983|593815773|FG003|Period 1|Physician Decision|0|||
164395269|NCT03232983|593815770|FG000|Washout Period 2|Physician Decision|0|||
164395270|NCT03232983|593815771|FG001|Washout Period 2|Physician Decision|0|||
164395271|NCT03232983|593815772|FG002|Washout Period 2|Physician Decision|1|||
164395272|NCT03232983|593815773|FG003|Washout Period 2|Physician Decision|0|||
164395273|NCT03232983|593815770|FG000|Washout Period 2|Withdrawal by Subject|0|||
164395274|NCT03232983|593815771|FG001|Washout Period 2|Withdrawal by Subject|0|||
164395275|NCT03232983|593815772|FG002|Washout Period 2|Withdrawal by Subject|0|||
164395276|NCT03232983|593815773|FG003|Washout Period 2|Withdrawal by Subject|1|||
164395277|NCT03232983|593815770|FG000|Period 4|Withdrawal by Subject|1|||
164395278|NCT03232983|593815771|FG001|Period 4|Withdrawal by Subject|0|||
164395279|NCT03232983|593815772|FG002|Period 4|Withdrawal by Subject|0|||
164395280|NCT03232983|593815773|FG003|Period 4|Withdrawal by Subject|0|||
164441821|NCT00843882|593984475|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
164441822|NCT00843882|593984473|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
164441823|NCT00843882|593984474|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
164441824|NCT00843882|593984475|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
164441825|NCT00843882|593984473|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
164395281|NCT00746590|593815774|FG000|Overall Study|Death|1|||
164395282|NCT03643952|593815779|FG000|Overall Study|Lack of Efficacy|1|||
164395283|NCT01358968|593815780|FG000|Period 2|Adverse Event|0|||
164441826|NCT00843882|593984474|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
164395284|NCT01358968|593815781|FG001|Period 2|Adverse Event|1|||
164395285|NCT01358968|593815782|FG002|Period 2|Adverse Event|0|||
164441827|NCT00843882|593984475|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
164441828|NCT00843882|593984473|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
164441829|NCT00843882|593984474|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
164441830|NCT00843882|593984475|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
164441831|NCT00843882|593984473|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
164441832|NCT00843882|593984474|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
164441833|NCT00843882|593984475|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
164441834|NCT00843882|593984473|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
164441835|NCT00843882|593984474|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
164441836|NCT00843882|593984475|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
164441837|NCT02248480|593984476|FG000|Overall Study|Lack of Efficacy|4|||
164441838|NCT02248480|593984477|FG001|Overall Study|Lack of Efficacy|6|||
164704231|NCT02031458|594944500|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
164704232|NCT02031458|594944498|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
164704233|NCT02031458|594944499|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
164704234|NCT02031458|594944500|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
164704235|NCT02031458|594944498|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
164704236|NCT02031458|594944499|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
164704237|NCT02031458|594944500|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
164704238|NCT02031458|594944498|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
164704239|NCT02031458|594944499|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
164704240|NCT02031458|594944500|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
164704241|NCT02031458|594944498|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
164704242|NCT02031458|594944499|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
164704243|NCT02031458|594944500|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
164704244|NCT02031458|594944498|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
164704245|NCT02031458|594944499|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
164704246|NCT02031458|594944500|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
164704247|NCT02031458|594944498|FG000|Baseline to May 8, 2015|Death|36|||
164704248|NCT02031458|594944499|FG001|Baseline to May 8, 2015|Death|87|||
164704249|NCT02031458|594944500|FG002|Baseline to May 8, 2015|Death|100|||
164704250|NCT02031458|594944498|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
164704251|NCT02031458|594944499|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
164704252|NCT02031458|594944500|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
164704253|NCT02031458|594944498|FG000|Baseline to May 8, 2015|Physician Decision|0|||
164704254|NCT02031458|594944499|FG001|Baseline to May 8, 2015|Physician Decision|1|||
164704255|NCT02031458|594944500|FG002|Baseline to May 8, 2015|Physician Decision|0|||
164704256|NCT02031458|594944498|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
164704257|NCT02031458|594944499|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
164704258|NCT02031458|594944500|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
164704259|NCT02031458|594944498|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
164704260|NCT02031458|594944499|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
164704261|NCT02031458|594944500|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
164704262|NCT02031458|594944498|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
164704263|NCT02031458|594944499|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
164704264|NCT02031458|594944500|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
164704265|NCT02031458|594944498|FG000|Baseline to May 8, 2015|On Treatment|43|||
164704266|NCT02031458|594944499|FG001|Baseline to May 8, 2015|On Treatment|81|||
164704267|NCT02031458|594944500|FG002|Baseline to May 8, 2015|On Treatment|73|||
164704268|NCT02031458|594944498|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
164704269|NCT02031458|594944499|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
164704270|NCT02031458|594944500|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
164704271|NCT03182244|594944503|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
164704272|NCT03182244|594944504|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
164704273|NCT03182244|594944503|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
164704274|NCT03182244|594944504|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
164704275|NCT03182244|594944503|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
164704276|NCT03182244|594944504|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
164704277|NCT03182244|594944503|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
164704278|NCT03182244|594944504|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
164704279|NCT03182244|594944503|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
164704280|NCT03182244|594944504|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
164704281|NCT03182244|594944503|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
164704282|NCT03182244|594944504|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
164704283|NCT03182244|594944503|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
164704284|NCT03182244|594944504|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
164704285|NCT03182244|594944503|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
164704286|NCT03182244|594944504|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
164704287|NCT03182244|594944503|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
164441839|NCT02248480|593984476|FG000|Overall Study|Adverse Event|11|||
164441840|NCT02248480|593984477|FG001|Overall Study|Adverse Event|2|||
164441841|NCT02248480|593984476|FG000|Overall Study|Withdrawal by Subject|2|||
164441842|NCT02248480|593984477|FG001|Overall Study|Withdrawal by Subject|4|||
164704288|NCT03182244|594944504|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
164704289|NCT03182244|594944503|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
164704290|NCT03182244|594944504|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
164704291|NCT03182244|594944503|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
164704292|NCT03182244|594944504|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
164704293|NCT03182244|594944503|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
164704294|NCT03182244|594944504|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
164704295|NCT03182244|594944503|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
164704296|NCT03182244|594944504|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
164704297|NCT03188718|594944505|FG000|Overall Study|Participant noncompliance|4|||
164704298|NCT03188718|594944505|FG000|Overall Study|Withdrawal by Subject|1|||
164704299|NCT03188718|594944505|FG000|Overall Study|Device failure|3|||
164704300|NCT02049450|594944506|FG000|Overall Study|Adverse Event|2|||
164704301|NCT02049450|594944506|FG000|Overall Study|Withdrawal by Subject|1|||
164704302|NCT02049450|594944506|FG000|Overall Study|Patients/guardian decision|1|||
164704303|NCT02492880|594944507|FG000|Overall Study|Lost to Follow-up|1|||
164704304|NCT02492880|594944507|FG000|Overall Study|Protocol Violation|1|||
164704305|NCT03186781|594944513|FG000|Overall Study|Lost to Follow-up|0|||
164704306|NCT03186781|594944514|FG001|Overall Study|Lost to Follow-up|0|||
164704307|NCT03186781|594944515|FG002|Overall Study|Lost to Follow-up|1|||
164704308|NCT03186781|594944516|FG003|Overall Study|Lost to Follow-up|0|||
164704309|NCT03186781|594944517|FG004|Overall Study|Lost to Follow-up|1|||
164704310|NCT03186781|594944518|FG005|Overall Study|Lost to Follow-up|0|||
164704311|NCT03186781|594944513|FG000|Overall Study|Moved from Area|0|||
164704312|NCT03186781|594944514|FG001|Overall Study|Moved from Area|0|||
164704313|NCT03186781|594944515|FG002|Overall Study|Moved from Area|0|||
164704314|NCT03186781|594944516|FG003|Overall Study|Moved from Area|0|||
164704315|NCT03186781|594944517|FG004|Overall Study|Moved from Area|1|||
164704316|NCT03186781|594944518|FG005|Overall Study|Moved from Area|0|||
164704317|NCT03186781|594944513|FG000|Overall Study|Withdrawal by Subject|0|||
164704318|NCT03186781|594944514|FG001|Overall Study|Withdrawal by Subject|0|||
164704319|NCT03186781|594944515|FG002|Overall Study|Withdrawal by Subject|0|||
164704320|NCT03186781|594944516|FG003|Overall Study|Withdrawal by Subject|0|||
164704321|NCT03186781|594944517|FG004|Overall Study|Withdrawal by Subject|1|||
164704322|NCT03186781|594944518|FG005|Overall Study|Withdrawal by Subject|0|||
164704323|NCT04709835|594944519|FG000|Overall Study|Withdrawal by Subject|0|||
164704324|NCT04709835|594944520|FG001|Overall Study|Withdrawal by Subject|1|||
164704325|NCT04709835|594944521|FG002|Overall Study|Withdrawal by Subject|0|||
164704326|NCT00372411|594944524|FG000|Overall Study|Withdrawal by Subject|3|||
164704327|NCT00372411|594944525|FG001|Overall Study|Withdrawal by Subject|4|||
164704328|NCT00372411|594944526|FG002|Overall Study|Withdrawal by Subject|1|||
164704329|NCT00372411|594944524|FG000|Overall Study|Death|0|||
164704330|NCT00372411|594944525|FG001|Overall Study|Death|2|||
164704331|NCT00372411|594944526|FG002|Overall Study|Death|1|||
164704332|NCT00372411|594944524|FG000|Overall Study|Lost to Follow-up|1|||
164704333|NCT00372411|594944525|FG001|Overall Study|Lost to Follow-up|1|||
164704334|NCT00372411|594944526|FG002|Overall Study|Lost to Follow-up|1|||
164704335|NCT00372411|594944524|FG000|Overall Study|Adverse Event|1|||
164704336|NCT00372411|594944525|FG001|Overall Study|Adverse Event|1|||
164704337|NCT00372411|594944526|FG002|Overall Study|Adverse Event|0|||
164704338|NCT00667810|594944529|FG000|Overall Study|Adverse Event|13|||
164704339|NCT00667810|594944530|FG001|Overall Study|Adverse Event|14|||
164704340|NCT00667810|594944531|FG002|Overall Study|Adverse Event|19|||
164704341|NCT00667810|594944532|FG003|Overall Study|Adverse Event|1|||
164704342|NCT00667810|594944529|FG000|Overall Study|Death|1|||
164704343|NCT00667810|594944530|FG001|Overall Study|Death|1|||
164704344|NCT00667810|594944531|FG002|Overall Study|Death|3|||
164704345|NCT00667810|594944532|FG003|Overall Study|Death|0|||
164704346|NCT00667810|594944529|FG000|Overall Study|Lack of Efficacy|1|||
164704347|NCT00667810|594944530|FG001|Overall Study|Lack of Efficacy|0|||
164704348|NCT00667810|594944531|FG002|Overall Study|Lack of Efficacy|2|||
164704349|NCT00667810|594944532|FG003|Overall Study|Lack of Efficacy|0|||
164704350|NCT00667810|594944529|FG000|Overall Study|Lost to Follow-up|1|||
164704351|NCT00667810|594944530|FG001|Overall Study|Lost to Follow-up|4|||
164704352|NCT00667810|594944531|FG002|Overall Study|Lost to Follow-up|2|||
164704353|NCT00667810|594944532|FG003|Overall Study|Lost to Follow-up|0|||
164704354|NCT00667810|594944529|FG000|Overall Study|Physician Decision|1|||
164704355|NCT00667810|594944530|FG001|Overall Study|Physician Decision|1|||
164704356|NCT00667810|594944531|FG002|Overall Study|Physician Decision|2|||
164704357|NCT00667810|594944532|FG003|Overall Study|Physician Decision|0|||
164441843|NCT02248480|593984476|FG000|Overall Study|Entry Criteria Not Met|0|||
164441844|NCT02248480|593984477|FG001|Overall Study|Entry Criteria Not Met|1|||
164441845|NCT02248480|593984476|FG000|Overall Study|Other:Physician Decision|0|||
164441846|NCT02248480|593984477|FG001|Overall Study|Other:Physician Decision|1|||
164441847|NCT00630786|593984478|FG000|Overall Study|Physician Decision|0|||
164441848|NCT00630786|593984479|FG001|Overall Study|Physician Decision|0|||
164441849|NCT00630786|593984480|FG002|Overall Study|Physician Decision|1|||
164441850|NCT00630786|593984478|FG000|Overall Study|Withdrawal by Subject|0|||
164395286|NCT01358968|593815783|FG003|Period 2|Adverse Event|0|||
164395287|NCT01358968|593815780|FG000|Continued Access Phase|Progression of Disease|0|||
164395288|NCT01358968|593815781|FG001|Continued Access Phase|Progression of Disease|0|||
164395289|NCT01358968|593815782|FG002|Continued Access Phase|Progression of Disease|8|||
164395290|NCT01358968|593815783|FG003|Continued Access Phase|Progression of Disease|4|||
164395291|NCT01358968|593815780|FG000|Continued Access Phase|Protocol Violation|0|||
164395292|NCT01358968|593815781|FG001|Continued Access Phase|Protocol Violation|0|||
164395293|NCT01358968|593815782|FG002|Continued Access Phase|Protocol Violation|0|||
164395294|NCT01358968|593815783|FG003|Continued Access Phase|Protocol Violation|2|||
164395295|NCT01358968|593815780|FG000|Continued Access Phase|Withdrawal by Subject|0|||
164395296|NCT01358968|593815781|FG001|Continued Access Phase|Withdrawal by Subject|0|||
164441851|NCT00630786|593984479|FG001|Overall Study|Withdrawal by Subject|1|||
164395297|NCT01358968|593815782|FG002|Continued Access Phase|Withdrawal by Subject|3|||
164395298|NCT01358968|593815783|FG003|Continued Access Phase|Withdrawal by Subject|0|||
164395299|NCT01358968|593815780|FG000|Continued Access Phase|Death|0|||
164395300|NCT01358968|593815781|FG001|Continued Access Phase|Death|0|||
164395301|NCT01358968|593815782|FG002|Continued Access Phase|Death|1|||
164395302|NCT01358968|593815783|FG003|Continued Access Phase|Death|1|||
164395303|NCT01597050|593815784|FG000|Overall Study|Withdrawal by Subject|1|||
164395304|NCT01597050|593815785|FG001|Overall Study|Withdrawal by Subject|0|||
164395305|NCT00483184|593815786|FG000|Overall Study|Withdrawal by Subject|2|||
164395306|NCT00483184|593815787|FG001|Overall Study|Withdrawal by Subject|2|||
164395307|NCT00483184|593815788|FG002|Overall Study|Withdrawal by Subject|0|||
164395308|NCT00483184|593815786|FG000|Overall Study|Lost to Follow-up|1|||
164395309|NCT00483184|593815787|FG001|Overall Study|Lost to Follow-up|0|||
164395310|NCT00483184|593815788|FG002|Overall Study|Lost to Follow-up|0|||
164395311|NCT00483184|593815786|FG000|Overall Study|Adverse Event|1|||
164395312|NCT00483184|593815787|FG001|Overall Study|Adverse Event|2|||
164395313|NCT00483184|593815788|FG002|Overall Study|Adverse Event|2|||
164395314|NCT00483184|593815786|FG000|Overall Study|Protocol Violation|1|||
164395315|NCT00483184|593815787|FG001|Overall Study|Protocol Violation|0|||
164395316|NCT00483184|593815788|FG002|Overall Study|Protocol Violation|1|||
164395317|NCT00815295|593815794|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
164395318|NCT00815295|593815795|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
164395319|NCT00815295|593815796|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
164395320|NCT01618162|593815799|FG000|Overall Study|Protocol Violation|13|||
164395321|NCT01618162|593815800|FG001|Overall Study|Protocol Violation|10|||
164395322|NCT01618162|593815799|FG000|Overall Study|Adverse Event|9|||
164395323|NCT01618162|593815800|FG001|Overall Study|Adverse Event|2|||
164395324|NCT01618162|593815799|FG000|Overall Study|Withdrawal Criteria|2|||
164395325|NCT01618162|593815800|FG001|Overall Study|Withdrawal Criteria|10|||
164395326|NCT01618162|593815799|FG000|Overall Study|Unclassified|14|||
164395327|NCT01618162|593815800|FG001|Overall Study|Unclassified|13|||
164395328|NCT03321396|593815801|FG000|Overall Study|Physician Decision|1|||
164395329|NCT00937924|593815803|FG000|Overall Study|Lost to Follow-up|44|||
164594924|NCT00256867|594541110|FG000|Overall Study|Investigator's Decision|0|||
164594925|NCT00256867|594541111|FG001|Overall Study|Investigator's Decision|0|||
164594926|NCT00256867|594541112|FG002|Overall Study|Investigator's Decision|0|||
164594927|NCT00256867|594541113|FG003|Overall Study|Investigator's Decision|0|||
164594928|NCT00256867|594541114|FG004|Overall Study|Investigator's Decision|1|||
164594929|NCT00256867|594541115|FG005|Overall Study|Investigator's Decision|0|||
164594930|NCT00256867|594541116|FG006|Overall Study|Investigator's Decision|0|||
164594931|NCT00256867|594541117|FG007|Overall Study|Investigator's Decision|0|||
164594932|NCT00256867|594541110|FG000|Overall Study|Non-compliance with study medication|0|||
164594933|NCT00256867|594541111|FG001|Overall Study|Non-compliance with study medication|0|||
164594934|NCT00256867|594541112|FG002|Overall Study|Non-compliance with study medication|0|||
164594935|NCT00256867|594541113|FG003|Overall Study|Non-compliance with study medication|0|||
164594936|NCT00256867|594541114|FG004|Overall Study|Non-compliance with study medication|0|||
164594937|NCT00256867|594541115|FG005|Overall Study|Non-compliance with study medication|0|||
164594938|NCT00256867|594541116|FG006|Overall Study|Non-compliance with study medication|0|||
164594939|NCT00256867|594541117|FG007|Overall Study|Non-compliance with study medication|1|||
164594940|NCT00256867|594541110|FG000|Overall Study|Participant travelled Overseas|0|||
164594941|NCT00256867|594541111|FG001|Overall Study|Participant travelled Overseas|1|||
164594942|NCT00256867|594541112|FG002|Overall Study|Participant travelled Overseas|0|||
164594943|NCT00256867|594541113|FG003|Overall Study|Participant travelled Overseas|0|||
164594944|NCT00256867|594541114|FG004|Overall Study|Participant travelled Overseas|0|||
164594945|NCT00256867|594541115|FG005|Overall Study|Participant travelled Overseas|0|||
164594946|NCT00256867|594541116|FG006|Overall Study|Participant travelled Overseas|0|||
164594947|NCT00256867|594541117|FG007|Overall Study|Participant travelled Overseas|0|||
164594948|NCT00256867|594541110|FG000|Overall Study|Participant out of assessment window|0|||
164594949|NCT00256867|594541111|FG001|Overall Study|Participant out of assessment window|0|||
164594950|NCT00256867|594541112|FG002|Overall Study|Participant out of assessment window|1|||
164594951|NCT00256867|594541113|FG003|Overall Study|Participant out of assessment window|0|||
164704358|NCT00667810|594944529|FG000|Overall Study|Protocol Violation|0|||
164704359|NCT00667810|594944530|FG001|Overall Study|Protocol Violation|2|||
164704360|NCT00667810|594944531|FG002|Overall Study|Protocol Violation|0|||
164704361|NCT00667810|594944532|FG003|Overall Study|Protocol Violation|0|||
164704362|NCT00667810|594944529|FG000|Overall Study|Withdrawal by Subject|14|||
164704363|NCT00667810|594944530|FG001|Overall Study|Withdrawal by Subject|20|||
164704364|NCT00667810|594944531|FG002|Overall Study|Withdrawal by Subject|29|||
164704365|NCT00667810|594944532|FG003|Overall Study|Withdrawal by Subject|1|||
164704366|NCT00667810|594944529|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
164704367|NCT00667810|594944530|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
164704368|NCT00667810|594944531|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
164704369|NCT00667810|594944532|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
164704370|NCT00667810|594944529|FG000|Overall Study|Failed to Return|0|||
164704371|NCT00667810|594944530|FG001|Overall Study|Failed to Return|0|||
164704372|NCT00667810|594944531|FG002|Overall Study|Failed to Return|2|||
164704373|NCT00667810|594944532|FG003|Overall Study|Failed to Return|0|||
164704374|NCT00667810|594944529|FG000|Overall Study|Loss of Caregiver|0|||
164704375|NCT00667810|594944530|FG001|Overall Study|Loss of Caregiver|1|||
164704376|NCT00667810|594944531|FG002|Overall Study|Loss of Caregiver|3|||
164704377|NCT00667810|594944532|FG003|Overall Study|Loss of Caregiver|0|||
164704378|NCT00667810|594944529|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
164704379|NCT00667810|594944530|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
164704380|NCT00667810|594944531|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
164704381|NCT00667810|594944532|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
164704382|NCT00667810|594944529|FG000|Overall Study|Other|6|||
164704383|NCT00667810|594944530|FG001|Overall Study|Other|6|||
164704384|NCT00667810|594944531|FG002|Overall Study|Other|5|||
164395330|NCT00937924|593815804|FG001|Overall Study|Lost to Follow-up|44|||
164395331|NCT00937924|593815805|FG002|Overall Study|Lost to Follow-up|41|||
164395332|NCT00224874|593815806|FG000|Overall Study|Withdrawal by Subject|0|||
164594952|NCT00256867|594541114|FG004|Overall Study|Participant out of assessment window|0|||
164594953|NCT00256867|594541115|FG005|Overall Study|Participant out of assessment window|0|||
164594954|NCT00256867|594541116|FG006|Overall Study|Participant out of assessment window|0|||
164704385|NCT00667810|594944532|FG003|Overall Study|Other|0|||
164704386|NCT01570686|594944535|FG000|Overall Study|Abnormal test procedure result(s)|1|||
164704387|NCT01570686|594944536|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164704388|NCT01570686|594944535|FG000|Overall Study|Administrative problems|0|||
164704389|NCT01570686|594944536|FG001|Overall Study|Administrative problems|1|||
164704390|NCT01570686|594944535|FG000|Overall Study|Adverse Event|8|||
164704391|NCT01570686|594944536|FG001|Overall Study|Adverse Event|6|||
164395333|NCT00224874|593815807|FG001|Overall Study|Withdrawal by Subject|0|||
164395334|NCT00224874|593815808|FG002|Overall Study|Withdrawal by Subject|1|||
164395335|NCT00224874|593815809|FG003|Overall Study|Withdrawal by Subject|0|||
164395336|NCT02355002|593815810|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
164395337|NCT02355002|593815811|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
164395338|NCT02355002|593815810|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
164395339|NCT02355002|593815811|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
164395340|NCT02355002|593815810|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
164395341|NCT02355002|593815811|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
164395342|NCT02355002|593815810|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
164395343|NCT02355002|593815811|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
164395344|NCT02355002|593815810|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
164395345|NCT02355002|593815811|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
164395346|NCT02355002|593815810|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
164395347|NCT02355002|593815811|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
164395348|NCT02355002|593815810|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
164395349|NCT02355002|593815811|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
164395350|NCT05554237|593815812|FG000|Part 2 (7 Days)|Adverse Event|0|||
164395351|NCT05554237|593815813|FG001|Part 2 (7 Days)|Adverse Event|0|||
164395352|NCT05554237|593815814|FG002|Part 2 (7 Days)|Adverse Event|0|||
164395353|NCT05554237|593815815|FG003|Part 2 (7 Days)|Adverse Event|0|||
164395354|NCT05554237|593815816|FG004|Part 2 (7 Days)|Adverse Event|2|||
164395355|NCT05554237|593815817|FG005|Part 2 (7 Days)|Adverse Event|0|||
164395356|NCT05554237|593815818|FG006|Part 2 (7 Days)|Adverse Event|0|||
164395357|NCT05554237|593815819|FG007|Part 2 (7 Days)|Adverse Event|0|||
164395358|NCT05554237|593815820|FG008|Part 2 (7 Days)|Adverse Event|0|||
164594955|NCT00256867|594541117|FG007|Overall Study|Participant out of assessment window|0|||
164594956|NCT00256867|594541110|FG000|Overall Study|Withdrawal by participant|0|||
164594957|NCT00256867|594541111|FG001|Overall Study|Withdrawal by participant|0|||
164594958|NCT00256867|594541112|FG002|Overall Study|Withdrawal by participant|0|||
164594959|NCT00256867|594541113|FG003|Overall Study|Withdrawal by participant|0|||
164594960|NCT00256867|594541114|FG004|Overall Study|Withdrawal by participant|0|||
164594961|NCT00256867|594541115|FG005|Overall Study|Withdrawal by participant|1|||
164594962|NCT00256867|594541116|FG006|Overall Study|Withdrawal by participant|0|||
164704392|NCT01570686|594944535|FG000|Overall Study|Lost to Follow-up|4|||
164704393|NCT01570686|594944536|FG001|Overall Study|Lost to Follow-up|3|||
164704394|NCT01570686|594944535|FG000|Overall Study|Protocol Deviation|3|||
164704395|NCT01570686|594944536|FG001|Overall Study|Protocol Deviation|0|||
164395359|NCT05554237|593815821|FG009|Part 2 (7 Days)|Adverse Event|1|||
164395360|NCT05554237|593815822|FG010|Part 2 (7 Days)|Adverse Event|0|||
164395361|NCT05554237|593815823|FG011|Part 2 (7 Days)|Adverse Event|0|||
164395362|NCT05554237|593815824|FG012|Part 2 (7 Days)|Adverse Event|1|||
164395363|NCT05554237|593815825|FG013|Part 2 (7 Days)|Adverse Event|0|||
164395364|NCT03644186|593815826|FG000|Overall Study|Withdrawal by Subject|1|||
164395365|NCT03644186|593815827|FG001|Overall Study|Withdrawal by Subject|1|||
164395366|NCT02192502|593815829|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
164395367|NCT02192502|593815830|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
164395368|NCT02192502|593815829|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
164395369|NCT02192502|593815830|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
164395370|NCT02192502|593815829|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
164395371|NCT02192502|593815830|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
164395372|NCT04818346|593815834|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
164395373|NCT04818346|593815835|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
164395374|NCT04818346|593815836|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
164704396|NCT01570686|594944535|FG000|Overall Study|Withdrawal by Subject|4|||
164704397|NCT01570686|594944536|FG001|Overall Study|Withdrawal by Subject|4|||
164395375|NCT04818346|593815837|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
164395376|NCT04818346|593815834|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
164395377|NCT04818346|593815835|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
164395378|NCT04818346|593815836|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
164395379|NCT04818346|593815837|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
164395380|NCT04818346|593815834|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
164395381|NCT04818346|593815835|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
164395382|NCT04818346|593815836|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
164395383|NCT04818346|593815837|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
164395384|NCT04818346|593815834|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
164395385|NCT04818346|593815835|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
164395386|NCT04818346|593815836|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
164395387|NCT04818346|593815837|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
164395388|NCT04818346|593815834|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
164395389|NCT04818346|593815835|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
164395390|NCT04818346|593815836|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
164395391|NCT04818346|593815837|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
164395392|NCT04818346|593815834|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
164395393|NCT04818346|593815835|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
164395394|NCT04818346|593815836|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
164395395|NCT04818346|593815837|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
164395396|NCT04818346|593815834|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
164395397|NCT04818346|593815835|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
164395398|NCT04818346|593815836|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
164395399|NCT04818346|593815837|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
164395400|NCT04818346|593815834|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
164395401|NCT04818346|593815835|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
164395402|NCT04818346|593815836|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
164441852|NCT00630786|593984480|FG002|Overall Study|Withdrawal by Subject|1|||
164594963|NCT00256867|594541117|FG007|Overall Study|Withdrawal by participant|0|||
164594964|NCT01465178|594541118|FG000|Overall Study|Withdrawal by Subject|1|||
164594965|NCT01465178|594541119|FG001|Overall Study|Withdrawal by Subject|0|||
164704398|NCT01570686|594944535|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164704399|NCT01570686|594944536|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
164704400|NCT02372071|594944539|FG000|Overall Study|Protocol Violation|18|||
164704401|NCT02227147|594944540|FG000|Controlled Treatment Period|Adverse Event|4|||
164704402|NCT02227147|594944541|FG001|Controlled Treatment Period|Adverse Event|3|||
164395403|NCT04818346|593815837|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
164395404|NCT04818346|593815834|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
164395405|NCT04818346|593815835|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
164395406|NCT04818346|593815836|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
164395407|NCT04818346|593815837|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
164395408|NCT04818346|593815834|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
164395409|NCT04818346|593815835|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
164395410|NCT04818346|593815836|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
164395411|NCT04818346|593815837|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
164395412|NCT04818346|593815834|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
164395413|NCT04818346|593815835|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
164395414|NCT04818346|593815836|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
164395415|NCT04818346|593815837|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
164395416|NCT04818346|593815834|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
164395417|NCT04818346|593815835|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
164395418|NCT04818346|593815836|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
164395419|NCT04818346|593815837|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
164395420|NCT04818346|593815834|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
164395421|NCT04818346|593815835|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
164395422|NCT04818346|593815836|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
164395423|NCT04818346|593815837|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
164395424|NCT04818346|593815834|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
164395425|NCT04818346|593815835|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
164395426|NCT04818346|593815836|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
164395427|NCT04818346|593815837|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
164395428|NCT04818346|593815834|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
164395429|NCT04818346|593815835|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
164395430|NCT04818346|593815836|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
164395431|NCT04818346|593815837|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
164395432|NCT05553808|593815838|FG000|Overall Study|Death|25|||
164395433|NCT05553808|593815839|FG001|Overall Study|Death|62|||
164395434|NCT05553808|593815838|FG000|Overall Study|Site Closed|6|||
164395435|NCT05553808|593815839|FG001|Overall Study|Site Closed|6|||
164395436|NCT05553808|593815838|FG000|Overall Study|Lost to Follow-up|1|||
164395437|NCT05553808|593815839|FG001|Overall Study|Lost to Follow-up|0|||
164395438|NCT05553808|593815838|FG000|Overall Study|Withdrawal by Subject|3|||
164395439|NCT05553808|593815839|FG001|Overall Study|Withdrawal by Subject|2|||
164395440|NCT02273141|593815840|FG000|Overall Study|Adverse Event|0|||
164395441|NCT02273141|593815841|FG001|Overall Study|Adverse Event|1|||
164395442|NCT02273141|593815840|FG000|Overall Study|Lost to Follow-up|1|||
164395443|NCT02273141|593815841|FG001|Overall Study|Lost to Follow-up|3|||
164395444|NCT02273141|593815840|FG000|Overall Study|Withdrawal by Subject|10|||
164395445|NCT02273141|593815841|FG001|Overall Study|Withdrawal by Subject|15|||
164395446|NCT02273141|593815840|FG000|Overall Study|Various|6|||
164395447|NCT02273141|593815841|FG001|Overall Study|Various|6|||
164395448|NCT04575467|593815845|FG000|Overall Study|Adverse Event|0|||
164395449|NCT04575467|593815846|FG001|Overall Study|Adverse Event|1|||
164395450|NCT04575467|593815847|FG002|Overall Study|Adverse Event|0|||
164395451|NCT04575467|593815848|FG003|Overall Study|Adverse Event|0|||
164395452|NCT01328574|593815849|FG000|Overall Study|Refused further treatment|1|||
164395453|NCT00729833|593815852|FG000|Overall Study|Death|5|||
164395454|NCT00729833|593815853|FG001|Overall Study|Death|1|||
164395455|NCT00729833|593815854|FG002|Overall Study|Death|3|||
164395456|NCT00729833|593815855|FG003|Overall Study|Death|5|||
164395457|NCT00729833|593815852|FG000|Overall Study|Study Terminated by Sponsor|0|||
164395458|NCT00729833|593815853|FG001|Overall Study|Study Terminated by Sponsor|0|||
164395459|NCT00729833|593815854|FG002|Overall Study|Study Terminated by Sponsor|1|||
164594966|NCT00527111|594541120|FG000|Overall Study|Adverse Event|14|||
164594967|NCT00527111|594541121|FG001|Overall Study|Adverse Event|13|||
164594968|NCT00527111|594541120|FG000|Overall Study|Death|0|||
164594969|NCT00527111|594541121|FG001|Overall Study|Death|1|||
164594970|NCT00527111|594541120|FG000|Overall Study|Investigator Request|2|||
164594971|NCT00527111|594541121|FG001|Overall Study|Investigator Request|1|||
164594972|NCT00527111|594541120|FG000|Overall Study|Patient Request|2|||
164594973|NCT00527111|594541121|FG001|Overall Study|Patient Request|5|||
164594974|NCT00527111|594541120|FG000|Overall Study|Other|2|||
164594975|NCT00527111|594541121|FG001|Overall Study|Other|2|||
164594976|NCT01617434|594541122|FG000|Overall Study|Adverse Event|12|||
164594977|NCT01617434|594541123|FG001|Overall Study|Adverse Event|3|||
164594978|NCT01617434|594541122|FG000|Overall Study|Protocol Violation|8|||
164594979|NCT01617434|594541123|FG001|Overall Study|Protocol Violation|7|||
164395460|NCT00729833|593815855|FG003|Overall Study|Study Terminated by Sponsor|0|||
164395461|NCT00729833|593815852|FG000|Overall Study|Lost to Follow-up|1|||
164395462|NCT00729833|593815853|FG001|Overall Study|Lost to Follow-up|0|||
164395463|NCT00729833|593815854|FG002|Overall Study|Lost to Follow-up|0|||
164395464|NCT00729833|593815855|FG003|Overall Study|Lost to Follow-up|0|||
164395465|NCT00729833|593815852|FG000|Overall Study|Withdrawal by Subject|3|||
164395466|NCT00729833|593815853|FG001|Overall Study|Withdrawal by Subject|1|||
164395467|NCT00729833|593815854|FG002|Overall Study|Withdrawal by Subject|3|||
164395468|NCT00729833|593815855|FG003|Overall Study|Withdrawal by Subject|0|||
164441853|NCT00630786|593984478|FG000|Overall Study|Lost to Follow-up|0|||
164441854|NCT00630786|593984479|FG001|Overall Study|Lost to Follow-up|1|||
164441855|NCT00630786|593984480|FG002|Overall Study|Lost to Follow-up|0|||
164441856|NCT00630786|593984478|FG000|Overall Study|Other|1|||
164441857|NCT00630786|593984479|FG001|Overall Study|Other|0|||
164441858|NCT00630786|593984480|FG002|Overall Study|Other|0|||
164441859|NCT02770248|593984481|FG000|Overall Study|Adverse Event|0|||
164441860|NCT02770248|593984482|FG001|Overall Study|Adverse Event|1|||
164441861|NCT02770248|593984481|FG000|Overall Study|Randomized in error, prior to treatment|0|||
164441862|NCT02770248|593984482|FG001|Overall Study|Randomized in error, prior to treatment|1|||
164441863|NCT01579916|593984483|FG000|Overall Study|Lost to Follow-up|6|||
164441864|NCT01579916|593984484|FG001|Overall Study|Lost to Follow-up|1|||
164441865|NCT01579916|593984483|FG000|Overall Study|Withdrawal by Subject|1|||
164441866|NCT01579916|593984484|FG001|Overall Study|Withdrawal by Subject|1|||
164441867|NCT01579916|593984483|FG000|Overall Study|Death|1|||
164441868|NCT01579916|593984484|FG001|Overall Study|Death|0|||
164441869|NCT03264456|593984485|FG000|Overall Study|Withdrawal by Subject|3|||
164441870|NCT03264456|593984485|FG000|Overall Study|Lost to Follow-up|1|||
164441871|NCT02486588|593984490|FG000|Overall Study|Randomized in error- ineligible|738|||
164441872|NCT02486588|593984491|FG001|Overall Study|Randomized in error- ineligible|750|||
164441873|NCT02486588|593984492|FG002|Overall Study|Randomized in error- ineligible|755|||
164441874|NCT02486588|593984493|FG003|Overall Study|Randomized in error- ineligible|738|||
164441875|NCT02486588|593984494|FG004|Overall Study|Randomized in error- ineligible|746|||
164441876|NCT02486588|593984495|FG005|Overall Study|Randomized in error- ineligible|746|||
164441877|NCT00546871|593984496|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
164441878|NCT00546871|593984497|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
164441879|NCT00546871|593984496|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
164441880|NCT00546871|593984497|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
164441881|NCT00546871|593984496|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
164441882|NCT00546871|593984497|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
164441883|NCT00546871|593984496|FG000|Study Extension Period|Protocol Violation|1|||
164441884|NCT00546871|593984497|FG001|Study Extension Period|Protocol Violation|0|||
164441885|NCT00546871|593984496|FG000|Study Extension Period|Withdrawal by Subject|0|||
164441886|NCT00546871|593984497|FG001|Study Extension Period|Withdrawal by Subject|1|||
164441887|NCT01713946|593984498|FG000|Overall Study|Death|0|||
164441888|NCT01713946|593984499|FG001|Overall Study|Death|2|||
164441889|NCT01713946|593984500|FG002|Overall Study|Death|2|||
164441890|NCT01713946|593984498|FG000|Overall Study|Adverse Event|19|||
164441891|NCT01713946|593984499|FG001|Overall Study|Adverse Event|14|||
164441892|NCT01713946|593984500|FG002|Overall Study|Adverse Event|13|||
164441893|NCT01713946|593984498|FG000|Overall Study|Withdrawal by Subject|12|||
164441894|NCT01713946|593984499|FG001|Overall Study|Withdrawal by Subject|12|||
164441895|NCT01713946|593984500|FG002|Overall Study|Withdrawal by Subject|8|||
164441896|NCT01713946|593984498|FG000|Overall Study|Lack of Efficacy|8|||
164441897|NCT01713946|593984499|FG001|Overall Study|Lack of Efficacy|8|||
164441898|NCT01713946|593984500|FG002|Overall Study|Lack of Efficacy|14|||
164441899|NCT01713946|593984498|FG000|Overall Study|Protocol Violation|2|||
164441900|NCT01713946|593984499|FG001|Overall Study|Protocol Violation|4|||
164594980|NCT01617434|594541122|FG000|Overall Study|Withdrawal Criteria|12|||
164594981|NCT01617434|594541123|FG001|Overall Study|Withdrawal Criteria|37|||
164594982|NCT01617434|594541122|FG000|Overall Study|Unclassified|3|||
164594983|NCT01617434|594541123|FG001|Overall Study|Unclassified|4|||
164594984|NCT02993224|594541124|FG000|Core Phase - Period 1|Adverse Event|4|||
164594985|NCT02993224|594541124|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
164594986|NCT02993224|594541124|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
164441901|NCT01713946|593984500|FG002|Overall Study|Protocol Violation|1|||
164594987|NCT02993224|594541124|FG000|Core Phase- Period 2|Adverse Event|1|||
164594988|NCT02993224|594541124|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
164395469|NCT00729833|593815852|FG000|Overall Study|Unspecified Reasons|11|||
164395470|NCT00729833|593815853|FG001|Overall Study|Unspecified Reasons|5|||
164395471|NCT00729833|593815854|FG002|Overall Study|Unspecified Reasons|5|||
164441902|NCT01713946|593984498|FG000|Overall Study|Lost to Follow-up|0|||
164441903|NCT01713946|593984499|FG001|Overall Study|Lost to Follow-up|0|||
164441904|NCT01713946|593984500|FG002|Overall Study|Lost to Follow-up|1|||
164441905|NCT01713946|593984498|FG000|Overall Study|Administrative problems|1|||
164441906|NCT01713946|593984499|FG001|Overall Study|Administrative problems|0|||
164441907|NCT01713946|593984500|FG002|Overall Study|Administrative problems|0|||
164395472|NCT00729833|593815855|FG003|Overall Study|Unspecified Reasons|1|||
164395473|NCT01922076|593815857|FG000|Overall Study|Adverse Event|0|||
164395474|NCT01922076|593815858|FG001|Overall Study|Adverse Event|0|||
164395475|NCT01922076|593815859|FG002|Overall Study|Adverse Event|0|||
164395476|NCT01922076|593815860|FG003|Overall Study|Adverse Event|0|||
164395477|NCT01922076|593815861|FG004|Overall Study|Adverse Event|1|||
164395478|NCT01922076|593815862|FG005|Overall Study|Adverse Event|0|||
164395479|NCT01922076|593815863|FG006|Overall Study|Adverse Event|0|||
164395480|NCT01922076|593815857|FG000|Overall Study|Physician Decision|0|||
164395481|NCT01922076|593815858|FG001|Overall Study|Physician Decision|0|||
164395482|NCT01922076|593815859|FG002|Overall Study|Physician Decision|1|||
164395483|NCT01922076|593815860|FG003|Overall Study|Physician Decision|0|||
164395484|NCT01922076|593815861|FG004|Overall Study|Physician Decision|0|||
164395485|NCT01922076|593815862|FG005|Overall Study|Physician Decision|0|||
164395486|NCT01922076|593815863|FG006|Overall Study|Physician Decision|0|||
164395487|NCT01922076|593815857|FG000|Overall Study|Withdrawal by Subject|0|||
164395488|NCT01922076|593815858|FG001|Overall Study|Withdrawal by Subject|0|||
164395489|NCT01922076|593815859|FG002|Overall Study|Withdrawal by Subject|0|||
164395490|NCT01922076|593815860|FG003|Overall Study|Withdrawal by Subject|1|||
164395491|NCT01922076|593815861|FG004|Overall Study|Withdrawal by Subject|0|||
164395492|NCT01922076|593815862|FG005|Overall Study|Withdrawal by Subject|1|||
164395493|NCT01922076|593815863|FG006|Overall Study|Withdrawal by Subject|1|||
164395494|NCT04598152|593815872|FG000|Overall Study|Lost to Follow-up|0|||
164395495|NCT04598152|593815873|FG001|Overall Study|Lost to Follow-up|1|||
164395496|NCT03346759|593815878|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
164395497|NCT03346759|593815879|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
164395498|NCT03346759|593815878|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
164395499|NCT03346759|593815879|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
164395500|NCT03346759|593815878|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
164395501|NCT03346759|593815879|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
164395502|NCT03943095|593815880|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
164395503|NCT03943095|593815881|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
164395504|NCT03943095|593815880|FG000|Overall Study|Withdrawal by Subject|1|||
164395505|NCT03943095|593815881|FG001|Overall Study|Withdrawal by Subject|0|||
164395506|NCT04988308|593815882|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
164395507|NCT04988308|593815883|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
164395508|NCT04988308|593815884|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
164395509|NCT04988308|593815885|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
164395510|NCT04988308|593815886|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
164395511|NCT04988308|593815887|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
164395512|NCT04988308|593815882|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
164395513|NCT04988308|593815883|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
164395514|NCT04988308|593815884|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
164395515|NCT04988308|593815885|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
164395516|NCT04988308|593815886|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
164395517|NCT04988308|593815887|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
164395518|NCT04988308|593815882|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
164395519|NCT04988308|593815883|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
164395520|NCT04988308|593815884|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
164395521|NCT04988308|593815885|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
164395522|NCT04988308|593815886|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
164395523|NCT04988308|593815887|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
164395524|NCT04988308|593815882|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
164395525|NCT04988308|593815883|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
164395526|NCT04988308|593815884|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
164395527|NCT04988308|593815885|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
164395528|NCT04988308|593815886|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
164395529|NCT04988308|593815887|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
164395530|NCT04988308|593815882|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
164395531|NCT04988308|593815883|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
164395532|NCT04988308|593815884|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
164395533|NCT04988308|593815885|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
164395534|NCT04988308|593815886|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
164395535|NCT04988308|593815887|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
164395536|NCT04988308|593815882|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
164395537|NCT04988308|593815883|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
164395538|NCT04988308|593815884|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
164395539|NCT04988308|593815885|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
164395540|NCT04988308|593815886|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
164395541|NCT04988308|593815887|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
164395542|NCT04988308|593815882|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
164395543|NCT04988308|593815883|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
164395544|NCT04988308|593815884|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
164395545|NCT04988308|593815885|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
164395546|NCT04988308|593815886|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
164395547|NCT04988308|593815887|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
164395548|NCT04988308|593815882|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
164395549|NCT04988308|593815883|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
164395550|NCT04988308|593815884|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
164395551|NCT04988308|593815885|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
164395552|NCT04988308|593815886|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
164395553|NCT04988308|593815887|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
164395554|NCT04988308|593815882|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
164395555|NCT04988308|593815883|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
164395556|NCT04988308|593815884|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
164395557|NCT04988308|593815885|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
164395558|NCT04988308|593815886|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
164395559|NCT04988308|593815887|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
164395560|NCT04177758|593815897|FG000|Overall Study|Lost to Follow-up|19|||
164395561|NCT04177758|593815898|FG001|Overall Study|Lost to Follow-up|11|||
164395562|NCT04918784|593817862|FG000|Overall Study|Amputation - no longer eligible|1|||
164395563|NCT04918784|593817863|FG001|Overall Study|Amputation - no longer eligible|2|||
164395564|NCT04918784|593817862|FG000|Overall Study|Death|1|||
164395565|NCT04918784|593817863|FG001|Overall Study|Death|0|||
164395566|NCT04918784|593817862|FG000|Overall Study|patient non-compliance|3|||
164395567|NCT04918784|593817863|FG001|Overall Study|patient non-compliance|1|||
164395568|NCT04918784|593817862|FG000|Overall Study|Adverse Event|1|||
164395569|NCT04918784|593817863|FG001|Overall Study|Adverse Event|0|||
164395570|NCT01712009|593817864|FG000|Overall Study|Withdrawal by Subject|24|||
164395571|NCT01712009|593817865|FG001|Overall Study|Withdrawal by Subject|15|||
164395572|NCT01712009|593817866|FG002|Overall Study|Withdrawal by Subject|8|||
164395573|NCT01712009|593817864|FG000|Overall Study|Lost to Follow-up|2|||
164395574|NCT01712009|593817865|FG001|Overall Study|Lost to Follow-up|0|||
164395575|NCT01712009|593817866|FG002|Overall Study|Lost to Follow-up|1|||
164395576|NCT01712009|593817864|FG000|Overall Study|Decision by Sponsor|12|||
164395577|NCT01712009|593817865|FG001|Overall Study|Decision by Sponsor|14|||
164395578|NCT01712009|593817866|FG002|Overall Study|Decision by Sponsor|12|||
164395579|NCT01111123|593817868|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
164395580|NCT01111123|593817869|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
164395581|NCT01111123|593817868|FG000|Maintenance Phase|Lost to Follow-up|0|||
164395582|NCT01111123|593817869|FG001|Maintenance Phase|Lost to Follow-up|2|||
164395583|NCT01986881|593817870|FG000|Overall Study|Death|228|||
164395584|NCT01986881|593817871|FG001|Overall Study|Death|233|||
164395585|NCT01986881|593817872|FG002|Overall Study|Death|247|||
164395586|NCT01986881|593817870|FG000|Overall Study|Lost to Follow-up|51|||
164395587|NCT01986881|593817871|FG001|Overall Study|Lost to Follow-up|44|||
164395588|NCT01986881|593817872|FG002|Overall Study|Lost to Follow-up|55|||
164395589|NCT01986881|593817870|FG000|Overall Study|Physician Decision|7|||
164395590|NCT01986881|593817871|FG001|Overall Study|Physician Decision|4|||
164395591|NCT01986881|593817872|FG002|Overall Study|Physician Decision|6|||
164395592|NCT01986881|593817870|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
164395593|NCT01986881|593817871|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
164395594|NCT01986881|593817872|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
164395595|NCT01986881|593817870|FG000|Overall Study|Withdrawal by Subject|41|||
164395596|NCT01986881|593817871|FG001|Overall Study|Withdrawal by Subject|60|||
164441908|NCT01713946|593984498|FG000|Overall Study|Did not continue in Ext|0|||
164441909|NCT01713946|593984499|FG001|Overall Study|Did not continue in Ext|3|||
164594989|NCT02993224|594541124|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
164594990|NCT02993224|594541124|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
164594991|NCT02993224|594541124|FG000|Extension Phase|Adverse Event|3|||
164395597|NCT01986881|593817872|FG002|Overall Study|Withdrawal by Subject|45|||
164395598|NCT01986881|593817870|FG000|Overall Study|Subject Moved|0|||
164395599|NCT01986881|593817871|FG001|Overall Study|Subject Moved|1|||
164441910|NCT01713946|593984500|FG002|Overall Study|Did not continue in Ext|0|||
164441911|NCT01713946|593984498|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
164395600|NCT01986881|593817872|FG002|Overall Study|Subject Moved|0|||
164594992|NCT02993224|594541124|FG000|Extension Phase|Withdrawal by Subject|3|||
164395601|NCT01986881|593817870|FG000|Overall Study|Other|1|||
164395602|NCT01986881|593817871|FG001|Overall Study|Other|2|||
164395603|NCT01986881|593817872|FG002|Overall Study|Other|2|||
164395604|NCT00677833|593817877|FG000|Overall Study|Withdrawal by Subject|4|||
164395605|NCT00677833|593817878|FG001|Overall Study|Withdrawal by Subject|0|||
164441912|NCT01713946|593984499|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
164441913|NCT01713946|593984500|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
164441914|NCT01713946|593984498|FG000|Overall Study|Patients never switched to everolimus|0|||
164441915|NCT01713946|593984499|FG001|Overall Study|Patients never switched to everolimus|0|||
164441916|NCT01713946|593984500|FG002|Overall Study|Patients never switched to everolimus|5|||
164441917|NCT05309668|593985562|FG000|Overall Study|Ongoing at data cut-off|14|||
164441918|NCT05309668|593985563|FG001|Overall Study|Ongoing at data cut-off|17|||
164441919|NCT05309668|593985564|FG002|Overall Study|Ongoing at data cut-off|4|||
164441920|NCT05136443|593985565|FG000|Overall Study|Lost to Follow-up|2|||
164441921|NCT05136443|593985565|FG000|Overall Study|Adverse Event|2|||
164441922|NCT00507689|593985574|FG000|Pre-Randomization Period|Adverse Event|1|||
164441923|NCT00507689|593985575|FG001|Pre-Randomization Period|Adverse Event|0|||
164441924|NCT00507689|593985574|FG000|Pre-Randomization Period|Physician Decision|1|||
164441925|NCT00507689|593985575|FG001|Pre-Randomization Period|Physician Decision|0|||
164441926|NCT00507689|593985574|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
164441927|NCT00507689|593985575|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
164441928|NCT00507689|593985574|FG000|Randomized Period|Adverse Event|1|||
164441929|NCT00507689|593985575|FG001|Randomized Period|Adverse Event|1|||
164441930|NCT00507689|593985574|FG000|Randomized Period|Withdrawal by Subject|0|||
164441931|NCT00507689|593985575|FG001|Randomized Period|Withdrawal by Subject|1|||
164441932|NCT01241292|593985576|FG000|Overall Study|Administrative Reason by Sponsor|1|||
164441933|NCT01241292|593985577|FG001|Overall Study|Administrative Reason by Sponsor|0|||
164441934|NCT01241292|593985576|FG000|Overall Study|Disease Progression|2|||
164441935|NCT01241292|593985577|FG001|Overall Study|Disease Progression|0|||
164441936|NCT01241292|593985576|FG000|Overall Study|Study Drug Toxicity|0|||
164441937|NCT01241292|593985577|FG001|Overall Study|Study Drug Toxicity|1|||
164441938|NCT01241292|593985576|FG000|Overall Study|Participant Discontinued Treatment|0|||
164441939|NCT01241292|593985577|FG001|Overall Study|Participant Discontinued Treatment|2|||
164441940|NCT03861767|593985578|FG000|Overall Study|Withdrawal by Subject|2|||
164441941|NCT03861767|593985579|FG001|Overall Study|Withdrawal by Subject|1|||
164441942|NCT03861767|593985580|FG002|Overall Study|Withdrawal by Subject|0|||
164441943|NCT03861767|593985581|FG003|Overall Study|Withdrawal by Subject|5|||
164441944|NCT03861767|593985582|FG004|Overall Study|Withdrawal by Subject|2|||
164441945|NCT03861767|593985583|FG005|Overall Study|Withdrawal by Subject|1|||
164441946|NCT03861767|593985584|FG006|Overall Study|Withdrawal by Subject|3|||
164441947|NCT03861767|593985585|FG007|Overall Study|Withdrawal by Subject|1|||
164441948|NCT03861767|593985586|FG008|Overall Study|Withdrawal by Subject|0|||
164594993|NCT02993224|594541124|FG000|Extension Phase|Lost to Follow-up|2|||
164594994|NCT02993224|594541124|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
164594995|NCT02689219|594541132|FG000|Overall Study|Death|1|||
164594996|NCT02689219|594541133|FG001|Overall Study|Death|1|||
164594997|NCT02689219|594541132|FG000|Overall Study|Disease Progression|10|||
164594998|NCT02689219|594541133|FG001|Overall Study|Disease Progression|6|||
164594999|NCT01921257|594541139|FG000|Overall Study|Adverse Event|1|||
164595000|NCT01921257|594541139|FG000|Overall Study|Protocol Violation|1|||
164595001|NCT01921257|594541139|FG000|Overall Study|Withdrawal by Subject|1|||
164595002|NCT01912768|594541140|FG000|Overall Study|Adverse Event|2|||
164395606|NCT00677833|593817879|FG002|Overall Study|Withdrawal by Subject|1|||
164395607|NCT00677833|593817880|FG003|Overall Study|Withdrawal by Subject|3|||
164395608|NCT00677833|593817877|FG000|Overall Study|Lost to Follow-up|0|||
164395609|NCT00677833|593817878|FG001|Overall Study|Lost to Follow-up|0|||
164395610|NCT00677833|593817879|FG002|Overall Study|Lost to Follow-up|1|||
164395611|NCT00677833|593817880|FG003|Overall Study|Lost to Follow-up|0|||
164395612|NCT02606279|593817881|FG000|Overall Study|Lost to Follow-up|0|||
164395613|NCT02606279|593817882|FG001|Overall Study|Lost to Follow-up|1|||
164395614|NCT01690130|593817885|FG000|Overall Study|Subject have cancelled visit.|1|||
164441949|NCT03861767|593985587|FG009|Overall Study|Withdrawal by Subject|5|||
164441950|NCT01145885|593985588|FG000|Overall Study|Progressive Disease|7|||
164441951|NCT05299606|593985589|FG000|Overall Study|Death|1|||
164441952|NCT03460756|593985591|FG000|Overall Study|Adverse Event|0|||
164595003|NCT01912768|594541141|FG001|Overall Study|Adverse Event|0|||
164595004|NCT01912768|594541140|FG000|Overall Study|Lost to Follow-up|2|||
164595005|NCT01912768|594541141|FG001|Overall Study|Lost to Follow-up|1|||
164595006|NCT01912768|594541140|FG000|Overall Study|Withdrawal by Subject|5|||
164595007|NCT01912768|594541141|FG001|Overall Study|Withdrawal by Subject|3|||
164595008|NCT01912768|594541140|FG000|Overall Study|Randomized in error|1|||
164595009|NCT01912768|594541141|FG001|Overall Study|Randomized in error|0|||
164595010|NCT02426658|594541142|FG000|Overall Study|Withdrawal by Subject|1|||
164595011|NCT02426658|594541142|FG000|Overall Study|Patient expired before treatment|2|||
164595012|NCT03255291|594541143|FG000|Overall Study|Determined to be ineligible|10|||
164395615|NCT01690130|593817886|FG001|Overall Study|Subject have cancelled visit.|0|||
164395616|NCT02633800|593817887|FG000|Overall Study|Death|3|||
164395617|NCT02633800|593817888|FG001|Overall Study|Death|3|||
164441953|NCT03460756|593985592|FG001|Overall Study|Adverse Event|0|||
164441954|NCT03460756|593985593|FG002|Overall Study|Adverse Event|0|||
164441955|NCT03460756|593985594|FG003|Overall Study|Adverse Event|1|||
164441956|NCT03460756|593985591|FG000|Overall Study|Lack of Efficacy|0|||
164595013|NCT03255291|594541144|FG001|Overall Study|Determined to be ineligible|12|||
164395618|NCT02633800|593817887|FG000|Overall Study|Reason not provided|1|||
164395619|NCT02633800|593817888|FG001|Overall Study|Reason not provided|0|||
164395620|NCT02633800|593817887|FG000|Overall Study|Radiologic(al) progression|23|||
164395621|NCT02633800|593817888|FG001|Overall Study|Radiologic(al) progression|23|||
164395622|NCT02633800|593817887|FG000|Overall Study|Clinical progression|3|||
164395623|NCT02633800|593817888|FG001|Overall Study|Clinical progression|6|||
164395624|NCT02633800|593817887|FG000|Overall Study|Study terminated by sponsor|6|||
164395625|NCT02633800|593817888|FG001|Overall Study|Study terminated by sponsor|5|||
164395626|NCT02633800|593817887|FG000|Overall Study|Adverse event, non-fatal|7|||
164395627|NCT02633800|593817888|FG001|Overall Study|Adverse event, non-fatal|2|||
164395628|NCT02633800|593817887|FG000|Overall Study|Withdrawal by Subject|0|||
164395629|NCT02633800|593817888|FG001|Overall Study|Withdrawal by Subject|3|||
164395630|NCT02633800|593817887|FG000|Overall Study|Patient Request|1|||
164395631|NCT02633800|593817888|FG001|Overall Study|Patient Request|1|||
164395632|NCT02013622|593817889|FG000|Overall Study|Lost to Follow-up|10|||
164395633|NCT02013622|593817889|FG000|Overall Study|Adverse Event|3|||
164395634|NCT02013622|593817889|FG000|Overall Study|Met Withdrawal Criteria|3|||
164395635|NCT02013622|593817889|FG000|Overall Study|Withdrawal by Subject|6|||
164395636|NCT02013622|593817889|FG000|Overall Study|Protocol Deviation|1|||
164395637|NCT02013622|593817889|FG000|Overall Study|Lack of Efficacy|1|||
164395638|NCT04969198|593817892|FG000|Overall Study|Withdrawal by Subject|20|||
164395639|NCT04969198|593817892|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
164395640|NCT04969198|593817892|FG000|Overall Study|Lost to Follow-up|20|||
164395641|NCT01640808|593817893|FG000|Overall Study|Unable to continue dynamic CT|14|||
164395642|NCT01640808|593817894|FG001|Overall Study|Unable to continue dynamic CT|4|||
164395643|NCT01640808|593817893|FG000|Overall Study|Withdrawal by Subject|12|||
164395644|NCT01640808|593817894|FG001|Overall Study|Withdrawal by Subject|4|||
164395645|NCT01640808|593817893|FG000|Overall Study|Lost to Follow-up|4|||
164395646|NCT01640808|593817894|FG001|Overall Study|Lost to Follow-up|0|||
164395647|NCT01640808|593817893|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
164395648|NCT01640808|593817894|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
164395649|NCT01640808|593817893|FG000|Overall Study|Administration of anticancer drugs|2|||
164395650|NCT01640808|593817894|FG001|Overall Study|Administration of anticancer drugs|1|||
164395651|NCT01640808|593817893|FG000|Overall Study|Physician Decision|19|||
164395652|NCT01640808|593817894|FG001|Overall Study|Physician Decision|5|||
164395653|NCT01640808|593817893|FG000|Overall Study|Randomized but not treated|4|||
164395654|NCT01640808|593817894|FG001|Overall Study|Randomized but not treated|2|||
164395655|NCT02477111|593817895|FG000|Overall Study|Death|28|||
164395656|NCT02477111|593817895|FG000|Overall Study|Withdrawal by Subject|19|||
164395657|NCT02477111|593817895|FG000|Overall Study|Lost to Follow-up|4|||
164395658|NCT01381692|593817896|FG000|Overall Study|Adverse Event|1|||
164395659|NCT01381692|593817897|FG001|Overall Study|Adverse Event|0|||
164395660|NCT01381692|593817898|FG002|Overall Study|Adverse Event|0|||
164395661|NCT01381692|593817899|FG003|Overall Study|Adverse Event|0|||
164395662|NCT01381692|593817900|FG004|Overall Study|Adverse Event|0|||
164395663|NCT01381692|593817901|FG005|Overall Study|Adverse Event|0|||
164395664|NCT02189798|593817902|FG000|Extended Use Phase|Withdrawal by Subject|0|||
164395665|NCT02189798|593817903|FG001|Extended Use Phase|Withdrawal by Subject|4|||
164395666|NCT02189798|593817902|FG000|Extended Use Phase|Physician Decision|1|||
164395667|NCT02189798|593817903|FG001|Extended Use Phase|Physician Decision|0|||
164395668|NCT02189798|593817902|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
164395669|NCT02189798|593817903|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
164395670|NCT02189798|593817902|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
164395671|NCT02189798|593817903|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
164395672|NCT02189798|593817902|FG000|Extended Use Phase|Travel Issues|2|||
164395673|NCT02189798|593817903|FG001|Extended Use Phase|Travel Issues|1|||
164395674|NCT02189798|593817902|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
164395675|NCT02189798|593817903|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
164395676|NCT00529399|593817906|FG000|Overall Study|Lost to Follow-up|1|||
164395677|NCT00529399|593817907|FG001|Overall Study|Lost to Follow-up|0|||
164395678|NCT00529399|593817908|FG002|Overall Study|Lost to Follow-up|1|||
164395679|NCT00529399|593817906|FG000|Overall Study|Withdrawal by Subject|1|||
164395680|NCT00529399|593817907|FG001|Overall Study|Withdrawal by Subject|0|||
164395681|NCT00529399|593817908|FG002|Overall Study|Withdrawal by Subject|1|||
164395682|NCT00529399|593817906|FG000|Overall Study|Non-compliant|0|||
164395683|NCT00529399|593817907|FG001|Overall Study|Non-compliant|1|||
164395684|NCT00529399|593817908|FG002|Overall Study|Non-compliant|0|||
164395685|NCT03695172|593817909|FG000|Overall Study|Withdrawal by Subject|1|||
164395686|NCT03695172|593817910|FG001|Overall Study|Withdrawal by Subject|1|||
164595014|NCT03255291|594541145|FG002|Overall Study|Determined to be ineligible|6|||
164595015|NCT03255291|594541146|FG003|Overall Study|Determined to be ineligible|6|||
164595016|NCT03255291|594541147|FG004|Overall Study|Determined to be ineligible|5|||
164595017|NCT03255291|594541148|FG005|Overall Study|Determined to be ineligible|10|||
164595018|NCT03255291|594541143|FG000|Overall Study|Baseline data collection issues|3|||
164595019|NCT03255291|594541144|FG001|Overall Study|Baseline data collection issues|0|||
164395687|NCT03695172|593817911|FG002|Overall Study|Withdrawal by Subject|0|||
164395688|NCT01506193|593817912|FG000|Overall Study|Protocol Violation|1|||
164395689|NCT01506193|593817913|FG001|Overall Study|Protocol Violation|0|||
164395690|NCT01506193|593817914|FG002|Overall Study|Protocol Violation|1|||
164395691|NCT01506193|593817912|FG000|Overall Study|Migrated/moved from study area|0|||
164395692|NCT01506193|593817913|FG001|Overall Study|Migrated/moved from study area|0|||
164395693|NCT01506193|593817914|FG002|Overall Study|Migrated/moved from study area|1|||
164395694|NCT01506193|593817912|FG000|Overall Study|Adverse event, non-fatal|0|||
164395695|NCT01506193|593817913|FG001|Overall Study|Adverse event, non-fatal|0|||
164395696|NCT01506193|593817914|FG002|Overall Study|Adverse event, non-fatal|1|||
164395697|NCT01506193|593817912|FG000|Overall Study|Withdrawal by Subject|5|||
164395698|NCT01506193|593817913|FG001|Overall Study|Withdrawal by Subject|1|||
164395699|NCT01506193|593817914|FG002|Overall Study|Withdrawal by Subject|8|||
164395700|NCT01506193|593817912|FG000|Overall Study|Lost to Follow-up|8|||
164395701|NCT01506193|593817913|FG001|Overall Study|Lost to Follow-up|3|||
164395702|NCT01506193|593817914|FG002|Overall Study|Lost to Follow-up|3|||
164395703|NCT03206203|593817928|FG000|Treatment|Death|38|||
164395704|NCT03206203|593817929|FG001|Treatment|Death|26|||
164395705|NCT03206203|593817930|FG002|Treatment|Death|0|||
164395706|NCT03206203|593817928|FG000|Treatment|Withdrawal by Subject|1|||
164395707|NCT03206203|593817929|FG001|Treatment|Withdrawal by Subject|0|||
164395708|NCT03206203|593817930|FG002|Treatment|Withdrawal by Subject|0|||
164395709|NCT03206203|593817928|FG000|Treatment|Lost to Follow-up|4|||
164395710|NCT03206203|593817929|FG001|Treatment|Lost to Follow-up|0|||
164395711|NCT03206203|593817930|FG002|Treatment|Lost to Follow-up|0|||
164395712|NCT03206203|593817928|FG000|Treatment|N/A in Follow-Up|8|||
164395713|NCT03206203|593817929|FG001|Treatment|N/A in Follow-Up|1|||
164395714|NCT03206203|593817930|FG002|Treatment|N/A in Follow-Up|0|||
164395715|NCT03206203|593817928|FG000|Treatment|Disease progression|0|||
164395716|NCT03206203|593817929|FG001|Treatment|Disease progression|1|||
164395717|NCT03206203|593817930|FG002|Treatment|Disease progression|0|||
164395718|NCT03206203|593817928|FG000|Treatment|Refused follow-up|0|||
164395719|NCT03206203|593817929|FG001|Treatment|Refused follow-up|1|||
164395720|NCT03206203|593817930|FG002|Treatment|Refused follow-up|0|||
164395721|NCT03206203|593817928|FG000|Treatment|Cross over to Arm 1|0|||
164395722|NCT03206203|593817929|FG001|Treatment|Cross over to Arm 1|19|||
164395723|NCT03206203|593817930|FG002|Treatment|Cross over to Arm 1|0|||
164395724|NCT03206203|593817928|FG000|Optional Cross-Over|Death|0|||
164395725|NCT03206203|593817929|FG001|Optional Cross-Over|Death|0|||
164395726|NCT03206203|593817930|FG002|Optional Cross-Over|Death|14|||
164395727|NCT03206203|593817928|FG000|Optional Cross-Over|Refused follow-up|0|||
164395728|NCT03206203|593817929|FG001|Optional Cross-Over|Refused follow-up|0|||
164395729|NCT03206203|593817930|FG002|Optional Cross-Over|Refused follow-up|2|||
164395730|NCT01454583|593817939|FG000|1st Year|Lost to Follow-up|1057|||
164395731|NCT01454583|593817940|FG001|1st Year|Lost to Follow-up|318|||
164395732|NCT01454583|593817941|FG002|1st Year|Lost to Follow-up|180|||
164395733|NCT01454583|593817939|FG000|2nd Year|Lost to Follow-up|3965|||
164395734|NCT01454583|593817940|FG001|2nd Year|Lost to Follow-up|1049|||
164395735|NCT01454583|593817941|FG002|2nd Year|Lost to Follow-up|737|||
164395736|NCT01454583|593817939|FG000|3rd Year|Lost to Follow-up|1959|||
164395737|NCT01454583|593817940|FG001|3rd Year|Lost to Follow-up|512|||
164395738|NCT01454583|593817941|FG002|3rd Year|Lost to Follow-up|297|||
164395739|NCT04330638|593817942|FG000|Overall Study|Adverse Event|9|||
164395740|NCT04330638|593817943|FG001|Overall Study|Adverse Event|10|||
164395741|NCT04330638|593817944|FG002|Overall Study|Adverse Event|15|||
164395742|NCT04330638|593817945|FG003|Overall Study|Adverse Event|6|||
164395743|NCT04330638|593817946|FG004|Overall Study|Adverse Event|10|||
164395744|NCT04330638|593817947|FG005|Overall Study|Adverse Event|5|||
164395745|NCT04330638|593817942|FG000|Overall Study|Other|2|||
164395746|NCT04330638|593817943|FG001|Overall Study|Other|2|||
164395747|NCT04330638|593817944|FG002|Overall Study|Other|5|||
164395748|NCT04330638|593817945|FG003|Overall Study|Other|1|||
164395749|NCT04330638|593817946|FG004|Overall Study|Other|3|||
164395750|NCT04330638|593817947|FG005|Overall Study|Other|2|||
164395751|NCT04330638|593817942|FG000|Overall Study|Withdrawal by Subject|4|||
164395752|NCT04330638|593817943|FG001|Overall Study|Withdrawal by Subject|0|||
164395753|NCT04330638|593817944|FG002|Overall Study|Withdrawal by Subject|0|||
164395754|NCT04330638|593817945|FG003|Overall Study|Withdrawal by Subject|0|||
164395755|NCT04330638|593817946|FG004|Overall Study|Withdrawal by Subject|0|||
164395756|NCT04330638|593817947|FG005|Overall Study|Withdrawal by Subject|0|||
164395757|NCT04330638|593817942|FG000|Overall Study|Lost to Follow-up|3|||
164395758|NCT04330638|593817943|FG001|Overall Study|Lost to Follow-up|2|||
164395759|NCT04330638|593817944|FG002|Overall Study|Lost to Follow-up|3|||
164395760|NCT04330638|593817945|FG003|Overall Study|Lost to Follow-up|2|||
164395761|NCT04330638|593817946|FG004|Overall Study|Lost to Follow-up|3|||
164395762|NCT04330638|593817947|FG005|Overall Study|Lost to Follow-up|0|||
164395763|NCT01988779|593817951|FG000|Overall Study|Withdrawal by Subject|2|||
164395764|NCT01988779|593817952|FG001|Overall Study|Withdrawal by Subject|2|||
164395765|NCT01988779|593817951|FG000|Overall Study|Protocol Violation|1|||
164395766|NCT01988779|593817952|FG001|Overall Study|Protocol Violation|0|||
164395767|NCT00377403|593817955|FG000|Overall Study|Unable to contact for telephone intervie|4|||
164395768|NCT00377403|593817956|FG001|Overall Study|Unable to contact for telephone intervie|7|||
164395769|NCT02275065|593817957|FG000|Overall Study|Randomized but not treated|1|||
164395770|NCT02275065|593817958|FG001|Overall Study|Randomized but not treated|0|||
164395771|NCT02275065|593817959|FG002|Overall Study|Randomized but not treated|1|||
164395772|NCT02275065|593817960|FG003|Overall Study|Randomized but not treated|1|||
164395773|NCT02275065|593817961|FG004|Overall Study|Randomized but not treated|0|||
164395774|NCT00417079|593817963|FG000|Overall Study|Disease progression|267|||
164395775|NCT00417079|593817964|FG001|Overall Study|Disease progression|180|||
164395776|NCT00417079|593817963|FG000|Overall Study|Adverse Event|32|||
164395777|NCT00417079|593817964|FG001|Overall Study|Adverse Event|67|||
164395778|NCT00417079|593817963|FG000|Overall Study|Non-compliance to protocol|0|||
164395779|NCT00417079|593817964|FG001|Overall Study|Non-compliance to protocol|1|||
164395780|NCT00417079|593817963|FG000|Overall Study|Lost to Follow-up|2|||
164395781|NCT00417079|593817964|FG001|Overall Study|Lost to Follow-up|0|||
164395782|NCT00417079|593817963|FG000|Overall Study|Withdrawal by Subject|17|||
164395783|NCT00417079|593817964|FG001|Overall Study|Withdrawal by Subject|8|||
164395784|NCT00417079|593817963|FG000|Overall Study|Not treated|6|||
164395785|NCT00417079|593817964|FG001|Overall Study|Not treated|7|||
164395786|NCT00417079|593817963|FG000|Overall Study|Screened failure|2|||
164395787|NCT00417079|593817964|FG001|Overall Study|Screened failure|1|||
164395788|NCT00417079|593817963|FG000|Overall Study|Investigator's decision|1|||
164395789|NCT00417079|593817964|FG001|Overall Study|Investigator's decision|4|||
164395790|NCT00417079|593817963|FG000|Overall Study|Non-confirmed Disease progression|1|||
164395791|NCT00417079|593817964|FG001|Overall Study|Non-confirmed Disease progression|1|||
164395792|NCT00417079|593817963|FG000|Overall Study|Clinical deterioration|1|||
164395793|NCT00417079|593817964|FG001|Overall Study|Clinical deterioration|0|||
164395794|NCT00417079|593817963|FG000|Overall Study|Screening error|2|||
164395795|NCT00417079|593817964|FG001|Overall Study|Screening error|1|||
164395796|NCT00417079|593817963|FG000|Overall Study|Withdrawal by subject's family|0|||
164395797|NCT00417079|593817964|FG001|Overall Study|Withdrawal by subject's family|1|||
164395798|NCT00417079|593817963|FG000|Overall Study|Patient unable to come to the clinic|0|||
164395799|NCT00417079|593817964|FG001|Overall Study|Patient unable to come to the clinic|1|||
164395800|NCT00417079|593817963|FG000|Overall Study|abnormal liver function tests|0|||
164395801|NCT00417079|593817964|FG001|Overall Study|abnormal liver function tests|1|||
164395802|NCT01687257|593817965|FG000|Overall Study|Efficacy Failure|6|||
164395803|NCT01687257|593817966|FG001|Overall Study|Efficacy Failure|0|||
164395804|NCT01687257|593817967|FG002|Overall Study|Efficacy Failure|5|||
164395805|NCT01687257|593817965|FG000|Overall Study|Subject Withdrew Consent|1|||
164395806|NCT01687257|593817966|FG001|Overall Study|Subject Withdrew Consent|1|||
164395807|NCT01687257|593817967|FG002|Overall Study|Subject Withdrew Consent|1|||
164395808|NCT01687257|593817965|FG000|Overall Study|Adverse Event|1|||
164395809|NCT01687257|593817966|FG001|Overall Study|Adverse Event|0|||
164395810|NCT01687257|593817967|FG002|Overall Study|Adverse Event|0|||
164395811|NCT01687257|593817965|FG000|Overall Study|Investigator's Discretion|0|||
164395812|NCT01687257|593817966|FG001|Overall Study|Investigator's Discretion|3|||
164395813|NCT01687257|593817967|FG002|Overall Study|Investigator's Discretion|0|||
164395814|NCT04899349|593817968|FG000|Overall Study|Study terminated by Sponsor|2|||
164395815|NCT04899349|593817969|FG001|Overall Study|Study terminated by Sponsor|0|||
164395816|NCT03336619|593817971|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
164395817|NCT03336619|593817972|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
164395818|NCT03336619|593817971|FG000|Overall Study|Withdrawal by Subject|17|||
164395819|NCT03336619|593817972|FG001|Overall Study|Withdrawal by Subject|16|||
164395820|NCT03336619|593817971|FG000|Overall Study|Adverse Event|2|||
164395821|NCT03336619|593817972|FG001|Overall Study|Adverse Event|5|||
164395822|NCT03336619|593817971|FG000|Overall Study|Physician Decision|3|||
164395823|NCT03336619|593817972|FG001|Overall Study|Physician Decision|0|||
164395824|NCT01300546|593817973|FG000|Overall Study|Withdrawal by Subject|1|||
164395825|NCT01300546|593817974|FG001|Overall Study|Withdrawal by Subject|0|||
164395826|NCT01300546|593817973|FG000|Overall Study|Lost to Follow-up|0|||
164395827|NCT01300546|593817974|FG001|Overall Study|Lost to Follow-up|2|||
164395828|NCT01300546|593817973|FG000|Overall Study|Lack of Efficacy|0|||
164395829|NCT01300546|593817974|FG001|Overall Study|Lack of Efficacy|3|||
164395830|NCT01300546|593817973|FG000|Overall Study|Adverse Event|0|||
164395831|NCT01300546|593817974|FG001|Overall Study|Adverse Event|1|||
164395832|NCT02820623|593817975|FG000|Overall Study|Withdrawal by Subject|1|||
164395833|NCT02820623|593817976|FG001|Overall Study|Withdrawal by Subject|3|||
164395834|NCT02820623|593817977|FG002|Overall Study|Withdrawal by Subject|3|||
164395835|NCT02820623|593817975|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
164395836|NCT02820623|593817976|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
164395837|NCT02820623|593817977|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
164395838|NCT02820623|593817975|FG000|Overall Study|Therapist unable to enroll clients|1|||
164395839|NCT02820623|593817976|FG001|Overall Study|Therapist unable to enroll clients|1|||
164395840|NCT02820623|593817977|FG002|Overall Study|Therapist unable to enroll clients|3|||
164395841|NCT02820623|593817975|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
164395842|NCT02820623|593817976|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
164395843|NCT02820623|593817977|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
164395844|NCT05207813|593817980|FG000|Overall Study|Lost to Follow-up|2|||
164395845|NCT01954017|593817981|FG000|Overall Study|Adverse Event|0|||
164395846|NCT01954017|593817982|FG001|Overall Study|Adverse Event|0|||
164395847|NCT01954017|593817983|FG002|Overall Study|Adverse Event|1|||
164395848|NCT01954017|593817981|FG000|Overall Study|Death|2|||
164395849|NCT01954017|593817982|FG001|Overall Study|Death|1|||
164395850|NCT01954017|593817983|FG002|Overall Study|Death|1|||
164395851|NCT01954017|593817981|FG000|Overall Study|Withdrawal by Subject|0|||
164395852|NCT01954017|593817982|FG001|Overall Study|Withdrawal by Subject|1|||
164395853|NCT01954017|593817983|FG002|Overall Study|Withdrawal by Subject|0|||
164395854|NCT01954017|593817981|FG000|Overall Study|Protocol Violation|0|||
164395855|NCT01954017|593817982|FG001|Overall Study|Protocol Violation|3|||
164395856|NCT01954017|593817983|FG002|Overall Study|Protocol Violation|2|||
164395857|NCT01954017|593817981|FG000|Overall Study|Necrotizing enterocolitis|1|||
164395858|NCT01954017|593817982|FG001|Overall Study|Necrotizing enterocolitis|0|||
164395859|NCT01954017|593817983|FG002|Overall Study|Necrotizing enterocolitis|1|||
164395860|NCT01954017|593817981|FG000|Overall Study|Enteral intake stopped >7 days|0|||
164395861|NCT01954017|593817982|FG001|Overall Study|Enteral intake stopped >7 days|1|||
164395862|NCT01954017|593817983|FG002|Overall Study|Enteral intake stopped >7 days|1|||
164395863|NCT01954017|593817981|FG000|Overall Study|All other reasons|2|||
164395864|NCT01954017|593817982|FG001|Overall Study|All other reasons|2|||
164395865|NCT01954017|593817983|FG002|Overall Study|All other reasons|7|||
164395866|NCT02653482|593817986|FG000|Overall Study|Death|1|||
164395867|NCT02653482|593817987|FG001|Overall Study|Death|1|||
164395868|NCT01669122|593817988|FG000|Period I|Lost to Follow-up|1|||
164395869|NCT01669122|593817988|FG000|Washout Period II|Protocol Violation|2|||
164395870|NCT05132699|593817990|FG000|Overall Study|Withdrawal by Subject|3|||
164395871|NCT05132699|593817991|FG001|Overall Study|Withdrawal by Subject|0|||
164395872|NCT04370054|593817992|FG000|Treatment Phase|Lost to Follow-up|1|||
164395873|NCT04370054|593817992|FG000|Treatment Phase|Withdrawal by Subject|1|||
164395874|NCT04370054|593817992|FG000|Follow-Up Phase|Ongoing|75|||
164395875|NCT02096900|593817993|FG000|Overall Study|Did not receive medication|3|||
164395876|NCT02096900|593817994|FG001|Overall Study|Did not receive medication|1|||
164395877|NCT02096900|593817993|FG000|Overall Study|Surgery cancelled- medication received|1|||
164395878|NCT02096900|593817994|FG001|Overall Study|Surgery cancelled- medication received|1|||
164395879|NCT05557942|593817995|FG000|Overall Study|Death|0|||
164395880|NCT05557942|593817996|FG001|Overall Study|Death|0|||
164395881|NCT05557942|593817997|FG002|Overall Study|Death|0|||
164395882|NCT05557942|593817998|FG003|Overall Study|Death|2|||
164395883|NCT05557942|593817999|FG004|Overall Study|Death|1|||
164395884|NCT05557942|593818000|FG005|Overall Study|Death|1|||
164395885|NCT05557942|593817995|FG000|Overall Study|Physician Decision|1|||
164395886|NCT05557942|593817996|FG001|Overall Study|Physician Decision|1|||
164395887|NCT05557942|593817997|FG002|Overall Study|Physician Decision|2|||
164395888|NCT05557942|593817998|FG003|Overall Study|Physician Decision|3|||
164395889|NCT05557942|593817999|FG004|Overall Study|Physician Decision|0|||
164395890|NCT05557942|593818000|FG005|Overall Study|Physician Decision|2|||
164395891|NCT05557942|593817995|FG000|Overall Study|Study terminated by sponsor|17|||
164395892|NCT05557942|593817996|FG001|Overall Study|Study terminated by sponsor|17|||
164395893|NCT05557942|593817997|FG002|Overall Study|Study terminated by sponsor|14|||
164395894|NCT05557942|593817998|FG003|Overall Study|Study terminated by sponsor|40|||
164395895|NCT05557942|593817999|FG004|Overall Study|Study terminated by sponsor|45|||
164441957|NCT03460756|593985592|FG001|Overall Study|Lack of Efficacy|0|||
164441958|NCT03460756|593985593|FG002|Overall Study|Lack of Efficacy|0|||
164441959|NCT03460756|593985594|FG003|Overall Study|Lack of Efficacy|2|||
164441960|NCT03460756|593985591|FG000|Overall Study|Lost to Follow-up|0|||
164704403|NCT02227147|594944540|FG000|Controlled Treatment Period|Other|2|||
164395896|NCT05557942|593818000|FG005|Overall Study|Study terminated by sponsor|37|||
164395897|NCT05557942|593817995|FG000|Overall Study|Protocol Violation|0|||
164395898|NCT05557942|593817996|FG001|Overall Study|Protocol Violation|0|||
164395899|NCT05557942|593817997|FG002|Overall Study|Protocol Violation|0|||
164395900|NCT05557942|593817998|FG003|Overall Study|Protocol Violation|0|||
164395901|NCT05557942|593817999|FG004|Overall Study|Protocol Violation|0|||
164395902|NCT05557942|593818000|FG005|Overall Study|Protocol Violation|1|||
164395903|NCT05557942|593817995|FG000|Overall Study|Withdrawal by Subject|0|||
164395904|NCT05557942|593817996|FG001|Overall Study|Withdrawal by Subject|0|||
164395905|NCT05557942|593817997|FG002|Overall Study|Withdrawal by Subject|0|||
164395906|NCT05557942|593817998|FG003|Overall Study|Withdrawal by Subject|0|||
164441961|NCT03460756|593985592|FG001|Overall Study|Lost to Follow-up|1|||
164441962|NCT03460756|593985593|FG002|Overall Study|Lost to Follow-up|2|||
164395907|NCT05557942|593817999|FG004|Overall Study|Withdrawal by Subject|2|||
164395908|NCT05557942|593818000|FG005|Overall Study|Withdrawal by Subject|0|||
164395909|NCT00710424|593818003|FG000|Overall Study|Adverse Event|30|||
164395910|NCT00710424|593818004|FG001|Overall Study|Adverse Event|12|||
164395911|NCT00710424|593818003|FG000|Overall Study|Lack of Efficacy|4|||
164395912|NCT00710424|593818004|FG001|Overall Study|Lack of Efficacy|5|||
164395913|NCT00710424|593818003|FG000|Overall Study|Withdrawal by Subject|5|||
164395914|NCT00710424|593818004|FG001|Overall Study|Withdrawal by Subject|3|||
164395915|NCT00710424|593818003|FG000|Overall Study|Lost to Follow-up|0|||
164395916|NCT00710424|593818004|FG001|Overall Study|Lost to Follow-up|1|||
164395917|NCT00710424|593818003|FG000|Overall Study|Refused medication, no side effects|1|||
164395918|NCT00710424|593818004|FG001|Overall Study|Refused medication, no side effects|0|||
164395919|NCT00710424|593818003|FG000|Overall Study|Non-compliance with stable analgesia|1|||
164395920|NCT00710424|593818004|FG001|Overall Study|Non-compliance with stable analgesia|0|||
164395921|NCT00710424|593818003|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
164395922|NCT00710424|593818004|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
164395923|NCT00710424|593818003|FG000|Overall Study|Subject thought medication changed|1|||
164395924|NCT00710424|593818004|FG001|Overall Study|Subject thought medication changed|0|||
164395925|NCT00710424|593818003|FG000|Overall Study|Ceased treatment due to travel|1|||
164395926|NCT00710424|593818004|FG001|Overall Study|Ceased treatment due to travel|0|||
164395927|NCT00710424|593818003|FG000|Overall Study|Subject preferred paracetamol|0|||
164395928|NCT00710424|593818004|FG001|Overall Study|Subject preferred paracetamol|1|||
164395929|NCT00710424|593818003|FG000|Overall Study|Felt good so stopped treatment|0|||
164395930|NCT00710424|593818004|FG001|Overall Study|Felt good so stopped treatment|1|||
164395931|NCT06273774|593818005|FG000|Overall Study|Participant was out of state.|0|||
164395932|NCT06273774|593818006|FG001|Overall Study|Participant was out of state.|0|||
164395933|NCT06273774|593818007|FG002|Overall Study|Participant was out of state.|0|||
164395934|NCT06273774|593818008|FG003|Overall Study|Participant was out of state.|0|||
164395935|NCT06273774|593818009|FG004|Overall Study|Participant was out of state.|0|||
164395936|NCT06273774|593818010|FG005|Overall Study|Participant was out of state.|1|||
164395937|NCT06273774|593818005|FG000|Overall Study|Lost to Follow-up|0|||
164395938|NCT06273774|593818006|FG001|Overall Study|Lost to Follow-up|0|||
164395939|NCT06273774|593818007|FG002|Overall Study|Lost to Follow-up|0|||
164395940|NCT06273774|593818008|FG003|Overall Study|Lost to Follow-up|0|||
164395941|NCT06273774|593818009|FG004|Overall Study|Lost to Follow-up|1|||
164395942|NCT06273774|593818010|FG005|Overall Study|Lost to Follow-up|0|||
164395943|NCT02097108|593818011|FG000|Overall Study|Adverse Event|1|||
164395944|NCT02097108|593818011|FG000|Overall Study|patient was abroad for 6 months|1|||
164395945|NCT00127608|593818014|FG000|Overall Study|VZV DNA negative|1|||
164395946|NCT04050865|593819600|FG000|Overall Study|Adverse Event|1|||
164395947|NCT04050865|593819601|FG001|Overall Study|Adverse Event|0|||
164395948|NCT04050865|593819600|FG000|Overall Study|no insert|1|||
164395949|NCT04050865|593819601|FG001|Overall Study|no insert|0|||
164395950|NCT04050865|593819600|FG000|Overall Study|Only 1 insert|2|||
164395951|NCT04050865|593819601|FG001|Overall Study|Only 1 insert|3|||
164395952|NCT04050865|593819600|FG000|Overall Study|Physician Decision|0|||
164395953|NCT04050865|593819601|FG001|Overall Study|Physician Decision|1|||
164395954|NCT04050865|593819600|FG000|Overall Study|Withdrawal by Subject|0|||
164395955|NCT04050865|593819601|FG001|Overall Study|Withdrawal by Subject|1|||
164395956|NCT02035332|593819603|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
164395957|NCT01258608|593819605|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
164395958|NCT01258608|593819606|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
164395959|NCT01258608|593819605|FG000|Overall Study|Clinical progression|1|||
164395960|NCT01258608|593819606|FG001|Overall Study|Clinical progression|0|||
164395961|NCT01258608|593819605|FG000|Overall Study|Sponsor decision|0|||
164395962|NCT01258608|593819606|FG001|Overall Study|Sponsor decision|1|||
164395963|NCT01258608|593819605|FG000|Overall Study|Physician Decision|6|||
164395964|NCT01258608|593819606|FG001|Overall Study|Physician Decision|1|||
164395965|NCT01258608|593819605|FG000|Overall Study|Lost to Follow-up|0|||
164395966|NCT01258608|593819606|FG001|Overall Study|Lost to Follow-up|1|||
164395967|NCT01258608|593819605|FG000|Overall Study|Lack of compliance|1|||
164395968|NCT01258608|593819606|FG001|Overall Study|Lack of compliance|0|||
164395969|NCT01258608|593819605|FG000|Overall Study|Lack of Efficacy|0|||
164395970|NCT01258608|593819606|FG001|Overall Study|Lack of Efficacy|1|||
164395971|NCT01258608|593819605|FG000|Overall Study|Adverse Event|6|||
164395972|NCT01258608|593819606|FG001|Overall Study|Adverse Event|10|||
164441963|NCT03460756|593985594|FG003|Overall Study|Lost to Follow-up|1|||
164441964|NCT03460756|593985591|FG000|Overall Study|Pregnancy|0|||
164395973|NCT01258608|593819605|FG000|Overall Study|Withdrawal by Subject|6|||
164395974|NCT01258608|593819606|FG001|Overall Study|Withdrawal by Subject|5|||
164395975|NCT04205630|593819607|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
164441965|NCT03460756|593985592|FG001|Overall Study|Pregnancy|0|||
164395976|NCT04205630|593819607|FG000|Overall Study|Disease clinical progression|7|||
164395977|NCT04205630|593819607|FG000|Overall Study|Withdrawal by Subject|2|||
164395978|NCT04205630|593819607|FG000|Overall Study|Adverse Event|17|||
164441966|NCT03460756|593985593|FG002|Overall Study|Pregnancy|0|||
164395979|NCT04205630|593819607|FG000|Overall Study|Other|1|||
164395980|NCT00440531|593819615|FG000|Overall Study|Adverse Event|1|||
164395981|NCT00440531|593819616|FG001|Overall Study|Adverse Event|0|||
164395982|NCT00440531|593819617|FG002|Overall Study|Adverse Event|2|||
164395983|NCT00440531|593819615|FG000|Overall Study|Withdrawal by Subject|2|||
164395984|NCT00440531|593819616|FG001|Overall Study|Withdrawal by Subject|0|||
164395985|NCT00440531|593819617|FG002|Overall Study|Withdrawal by Subject|0|||
164395986|NCT00440531|593819615|FG000|Overall Study|Protocol Violation|1|||
164395987|NCT00440531|593819616|FG001|Overall Study|Protocol Violation|2|||
164395988|NCT00440531|593819617|FG002|Overall Study|Protocol Violation|0|||
164395989|NCT00440531|593819615|FG000|Overall Study|Lost to Follow-up|4|||
164395990|NCT00440531|593819616|FG001|Overall Study|Lost to Follow-up|3|||
164395991|NCT00440531|593819617|FG002|Overall Study|Lost to Follow-up|5|||
164395992|NCT00440531|593819615|FG000|Overall Study|see pre-assignment details|2|||
164395993|NCT00440531|593819616|FG001|Overall Study|see pre-assignment details|0|||
164395994|NCT00440531|593819617|FG002|Overall Study|see pre-assignment details|0|||
164395995|NCT00447057|593819618|FG000|Overall Study|Adverse Event|4|||
164395996|NCT00447057|593819619|FG001|Overall Study|Adverse Event|10|||
164395997|NCT00447057|593819620|FG002|Overall Study|Adverse Event|0|||
164395998|NCT00447057|593819621|FG003|Overall Study|Adverse Event|3|||
164395999|NCT00447057|593819618|FG000|Overall Study|Death due to study disease|6|||
164396000|NCT00447057|593819619|FG001|Overall Study|Death due to study disease|4|||
164396001|NCT00447057|593819620|FG002|Overall Study|Death due to study disease|1|||
164396002|NCT00447057|593819621|FG003|Overall Study|Death due to study disease|1|||
164396003|NCT00447057|593819618|FG000|Overall Study|Lost to Follow-up|0|||
164396004|NCT00447057|593819619|FG001|Overall Study|Lost to Follow-up|1|||
164396005|NCT00447057|593819620|FG002|Overall Study|Lost to Follow-up|0|||
164396006|NCT00447057|593819621|FG003|Overall Study|Lost to Follow-up|0|||
164396007|NCT00447057|593819618|FG000|Overall Study|Entry criteria not met|1|||
164396008|NCT00447057|593819619|FG001|Overall Study|Entry criteria not met|1|||
164396009|NCT00447057|593819620|FG002|Overall Study|Entry criteria not met|0|||
164396010|NCT00447057|593819621|FG003|Overall Study|Entry criteria not met|0|||
164396011|NCT00447057|593819618|FG000|Overall Study|Protocol Violation|0|||
164396012|NCT00447057|593819619|FG001|Overall Study|Protocol Violation|1|||
164396013|NCT00447057|593819620|FG002|Overall Study|Protocol Violation|0|||
164396014|NCT00447057|593819621|FG003|Overall Study|Protocol Violation|0|||
164396015|NCT00447057|593819618|FG000|Overall Study|Withdrawal by Subject|4|||
164396016|NCT00447057|593819619|FG001|Overall Study|Withdrawal by Subject|5|||
164396017|NCT00447057|593819620|FG002|Overall Study|Withdrawal by Subject|1|||
164396018|NCT00447057|593819621|FG003|Overall Study|Withdrawal by Subject|1|||
164396019|NCT00447057|593819618|FG000|Overall Study|Physician Decision|9|||
164396020|NCT00447057|593819619|FG001|Overall Study|Physician Decision|6|||
164396021|NCT00447057|593819620|FG002|Overall Study|Physician Decision|3|||
164396022|NCT00447057|593819621|FG003|Overall Study|Physician Decision|1|||
164396023|NCT00447057|593819618|FG000|Overall Study|Sponsor decision|1|||
164396024|NCT00447057|593819619|FG001|Overall Study|Sponsor decision|1|||
164396025|NCT00447057|593819620|FG002|Overall Study|Sponsor decision|0|||
164396026|NCT00447057|593819621|FG003|Overall Study|Sponsor decision|0|||
164396027|NCT00447057|593819618|FG000|Overall Study|Progressive disease|58|||
164396028|NCT00447057|593819619|FG001|Overall Study|Progressive disease|43|||
164396029|NCT00447057|593819620|FG002|Overall Study|Progressive disease|13|||
164396030|NCT00447057|593819621|FG003|Overall Study|Progressive disease|18|||
164396031|NCT00447057|593819618|FG000|Overall Study|Death due to adverse event|0|||
164396032|NCT00447057|593819619|FG001|Overall Study|Death due to adverse event|0|||
164396033|NCT00447057|593819620|FG002|Overall Study|Death due to adverse event|1|||
164396034|NCT00447057|593819621|FG003|Overall Study|Death due to adverse event|2|||
164396035|NCT00447057|593819618|FG000|Overall Study|Death, study drug related|0|||
164396036|NCT00447057|593819619|FG001|Overall Study|Death, study drug related|1|||
164396037|NCT00447057|593819620|FG002|Overall Study|Death, study drug related|0|||
164396038|NCT00447057|593819621|FG003|Overall Study|Death, study drug related|0|||
164441967|NCT03460756|593985594|FG003|Overall Study|Pregnancy|1|||
164441968|NCT03460756|593985591|FG000|Overall Study|Protocol Violation|0|||
164396039|NCT00512148|593819622|FG000|Primay Study Period|Withdrawal by Subject|1|||
164396040|NCT00160680|593819629|FG000|Overall Study|Adverse Event|0|||
164396041|NCT00160680|593819630|FG001|Overall Study|Adverse Event|1|||
164396042|NCT00160680|593819629|FG000|Overall Study|Lack of Efficacy|2|||
164396043|NCT00160680|593819630|FG001|Overall Study|Lack of Efficacy|1|||
164396044|NCT00160680|593819629|FG000|Overall Study|Lost to Follow-up|3|||
164441969|NCT03460756|593985592|FG001|Overall Study|Protocol Violation|0|||
164704404|NCT02227147|594944541|FG001|Controlled Treatment Period|Other|0|||
164396045|NCT00160680|593819630|FG001|Overall Study|Lost to Follow-up|2|||
164396046|NCT00160680|593819629|FG000|Overall Study|Withdrawal by Subject|4|||
164396047|NCT00160680|593819630|FG001|Overall Study|Withdrawal by Subject|9|||
164396048|NCT04493216|593819631|FG000|Overall Study|Study terminated by sponsor|30|||
164396049|NCT04493216|593819632|FG001|Overall Study|Study terminated by sponsor|33|||
164396050|NCT04493216|593819633|FG002|Overall Study|Study terminated by sponsor|28|||
164396051|NCT04493216|593819634|FG003|Overall Study|Study terminated by sponsor|27|||
164396052|NCT04493216|593819631|FG000|Overall Study|Withdrawal by Subject|2|||
164441970|NCT03460756|593985593|FG002|Overall Study|Protocol Violation|0|||
164396053|NCT04493216|593819632|FG001|Overall Study|Withdrawal by Subject|1|||
164396054|NCT04493216|593819633|FG002|Overall Study|Withdrawal by Subject|1|||
164396055|NCT04493216|593819634|FG003|Overall Study|Withdrawal by Subject|2|||
164396056|NCT04493216|593819631|FG000|Overall Study|Protocol Violation|1|||
164396057|NCT04493216|593819632|FG001|Overall Study|Protocol Violation|2|||
164396058|NCT04493216|593819633|FG002|Overall Study|Protocol Violation|0|||
164396059|NCT04493216|593819634|FG003|Overall Study|Protocol Violation|2|||
164396060|NCT04493216|593819631|FG000|Overall Study|Physician Decision|0|||
164396061|NCT04493216|593819632|FG001|Overall Study|Physician Decision|0|||
164396062|NCT04493216|593819633|FG002|Overall Study|Physician Decision|1|||
164396063|NCT04493216|593819634|FG003|Overall Study|Physician Decision|0|||
164396064|NCT04493216|593819631|FG000|Overall Study|Lost to Follow-up|2|||
164396065|NCT04493216|593819632|FG001|Overall Study|Lost to Follow-up|1|||
164396066|NCT04493216|593819633|FG002|Overall Study|Lost to Follow-up|0|||
164396067|NCT04493216|593819634|FG003|Overall Study|Lost to Follow-up|1|||
164396068|NCT04493216|593819631|FG000|Overall Study|Adverse Event|1|||
164396069|NCT04493216|593819632|FG001|Overall Study|Adverse Event|4|||
164396070|NCT04493216|593819633|FG002|Overall Study|Adverse Event|5|||
164396071|NCT04493216|593819634|FG003|Overall Study|Adverse Event|2|||
164396072|NCT04493216|593819631|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
164396073|NCT04493216|593819632|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
164396074|NCT04493216|593819633|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
164396075|NCT04493216|593819634|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
164396076|NCT04605978|593819647|FG000|Overall Study|Adverse Event|2|||
164396077|NCT04605978|593819648|FG001|Overall Study|Adverse Event|1|||
164396078|NCT04605978|593819647|FG000|Overall Study|Withdrawal nonmedical reason|1|||
164704405|NCT02227147|594944540|FG000|Follow-up Period|Other|3|||
164396079|NCT04605978|593819648|FG001|Overall Study|Withdrawal nonmedical reason|1|||
164396080|NCT02583425|593819649|FG000|Screening|Did not meet entry criteria|12|||
164396081|NCT02583425|593819649|FG000|Baseline|Did not meet continued criteria|5|||
164396082|NCT02583425|593819649|FG000|Treatment Period|Adverse Event|1|||
164396083|NCT01644734|593819650|FG000|Overall Study|Adverse Event|4|||
164396084|NCT01644734|593819650|FG000|Overall Study|Lost to Follow-up|17|||
164396085|NCT01644734|593819650|FG000|Overall Study|Reasons other than stated above|7|||
164396086|NCT01644734|593819650|FG000|Overall Study|Missing documentation|238|||
164396087|NCT02216123|593819651|FG000|Overall Study|Lost to Follow-up|4|||
164396088|NCT02216123|593819652|FG001|Overall Study|Lost to Follow-up|2|||
164396089|NCT02216123|593819651|FG000|Overall Study|Withdrawal by Subject|2|||
164396090|NCT02216123|593819652|FG001|Overall Study|Withdrawal by Subject|0|||
164396091|NCT03318523|593819657|FG000|PC Period: Up to Year 1|Adverse Event|1|||
164396092|NCT03318523|593819658|FG001|PC Period: Up to Year 1|Adverse Event|0|||
164396093|NCT03318523|593819659|FG002|PC Period: Up to Year 1|Adverse Event|2|||
164396094|NCT03318523|593819660|FG003|PC Period: Up to Year 1|Adverse Event|0|||
164396095|NCT03318523|593819661|FG004|PC Period: Up to Year 1|Adverse Event|0|||
164441971|NCT03460756|593985594|FG003|Overall Study|Protocol Violation|1|||
164441972|NCT03460756|593985591|FG000|Overall Study|Withdrawal by Subject|0|||
164441973|NCT03460756|593985592|FG001|Overall Study|Withdrawal by Subject|4|||
164441974|NCT03460756|593985593|FG002|Overall Study|Withdrawal by Subject|7|||
164441975|NCT03460756|593985594|FG003|Overall Study|Withdrawal by Subject|3|||
164441976|NCT00723450|593985596|FG000|Open-Label Phase|Adverse Event|26|||
164441977|NCT00723450|593985597|FG001|Open-Label Phase|Adverse Event|0|||
164441978|NCT00723450|593985598|FG002|Open-Label Phase|Adverse Event|0|||
164441979|NCT00723450|593985596|FG000|Open-Label Phase|Lack of Efficacy|18|||
164704406|NCT02227147|594944541|FG001|Follow-up Period|Other|5|||
164704407|NCT03514641|594944544|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
164396096|NCT03318523|593819662|FG005|PC Period: Up to Year 1|Adverse Event|0|||
164396097|NCT03318523|593819663|FG006|PC Period: Up to Year 1|Adverse Event|0|||
164396098|NCT03318523|593819664|FG007|PC Period: Up to Year 1|Adverse Event|0|||
164396099|NCT03318523|593819665|FG008|PC Period: Up to Year 1|Adverse Event|0|||
164396100|NCT03318523|593819666|FG009|PC Period: Up to Year 1|Adverse Event|0|||
164396101|NCT03318523|593819657|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
164396102|NCT03318523|593819658|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
164396103|NCT03318523|593819659|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
164396104|NCT03318523|593819660|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
164396105|NCT03318523|593819661|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
164396106|NCT03318523|593819662|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
164396107|NCT03318523|593819663|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
164396108|NCT03318523|593819664|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
164396109|NCT03318523|593819665|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
164396110|NCT03318523|593819666|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
164396111|NCT03318523|593819657|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
164396112|NCT03318523|593819658|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
164704408|NCT03514641|594944545|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
164396113|NCT03318523|593819659|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
164441980|NCT00723450|593985597|FG001|Open-Label Phase|Lack of Efficacy|0|||
164441981|NCT00723450|593985598|FG002|Open-Label Phase|Lack of Efficacy|0|||
164396114|NCT03318523|593819660|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
164396115|NCT03318523|593819661|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
164396116|NCT03318523|593819662|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
164396117|NCT03318523|593819663|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
164396118|NCT03318523|593819664|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
164396119|NCT03318523|593819665|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
164396120|NCT03318523|593819666|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
164396121|NCT03318523|593819657|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
164396122|NCT03318523|593819658|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
164396123|NCT03318523|593819659|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
164396124|NCT03318523|593819660|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
164396125|NCT03318523|593819661|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
164396126|NCT03318523|593819662|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
164396127|NCT03318523|593819663|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
164396128|NCT03318523|593819664|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
164396129|NCT03318523|593819665|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
164396130|NCT03318523|593819666|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
164396131|NCT03318523|593819657|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
164396132|NCT03318523|593819658|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
164396133|NCT03318523|593819659|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
164396134|NCT03318523|593819660|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
164396135|NCT03318523|593819661|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
164396136|NCT03318523|593819662|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
164396137|NCT03318523|593819663|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
164396138|NCT03318523|593819664|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
164396139|NCT03318523|593819665|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
164396140|NCT03318523|593819666|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
164396141|NCT03318523|593819657|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
164396142|NCT03318523|593819658|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
164396143|NCT03318523|593819659|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
164396144|NCT03318523|593819660|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
164396145|NCT03318523|593819661|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
164396146|NCT03318523|593819662|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
164396147|NCT03318523|593819663|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
164396148|NCT03318523|593819664|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
164396149|NCT03318523|593819665|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
164396150|NCT03318523|593819666|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
164396151|NCT03318523|593819657|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
164396152|NCT03318523|593819658|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
164396153|NCT03318523|593819659|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
164396154|NCT03318523|593819660|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
164396155|NCT03318523|593819661|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
164396156|NCT03318523|593819662|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
164396157|NCT03318523|593819663|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
164396158|NCT03318523|593819664|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
164396159|NCT03318523|593819665|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
164396160|NCT03318523|593819666|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
164396161|NCT03318523|593819657|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
164396162|NCT03318523|593819658|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
164396163|NCT03318523|593819659|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
164396164|NCT03318523|593819660|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
164396165|NCT03318523|593819661|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
164396166|NCT03318523|593819662|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
164396167|NCT03318523|593819663|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
164396168|NCT03318523|593819664|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
164441982|NCT00723450|593985596|FG000|Open-Label Phase|Protocol Violation|35|||
164441983|NCT00723450|593985597|FG001|Open-Label Phase|Protocol Violation|0|||
164441984|NCT00723450|593985598|FG002|Open-Label Phase|Protocol Violation|0|||
164441985|NCT00723450|593985596|FG000|Open-Label Phase|Lost to Follow-up|7|||
164441986|NCT00723450|593985597|FG001|Open-Label Phase|Lost to Follow-up|0|||
164441987|NCT00723450|593985598|FG002|Open-Label Phase|Lost to Follow-up|0|||
164441988|NCT00723450|593985596|FG000|Open-Label Phase|Physician Decision|2|||
164396169|NCT03318523|593819665|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
164396170|NCT03318523|593819666|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
164441989|NCT00723450|593985597|FG001|Open-Label Phase|Physician Decision|0|||
164595020|NCT03255291|594541145|FG002|Overall Study|Baseline data collection issues|0|||
164595021|NCT03255291|594541146|FG003|Overall Study|Baseline data collection issues|0|||
164595022|NCT03255291|594541147|FG004|Overall Study|Baseline data collection issues|2|||
164595023|NCT03255291|594541148|FG005|Overall Study|Baseline data collection issues|0|||
164595024|NCT00634244|594541149|FG000|Overall Study|Never started treatment|0|||
164595025|NCT00634244|594541150|FG001|Overall Study|Never started treatment|1|||
164595026|NCT00634244|594541151|FG002|Overall Study|Never started treatment|0|||
164595027|NCT00634244|594541149|FG000|Overall Study|Death|1|||
164595028|NCT00634244|594541150|FG001|Overall Study|Death|6|||
164595029|NCT00634244|594541151|FG002|Overall Study|Death|0|||
164595030|NCT00634244|594541149|FG000|Overall Study|Adverse Event|0|||
164595031|NCT00634244|594541150|FG001|Overall Study|Adverse Event|2|||
164595032|NCT00634244|594541151|FG002|Overall Study|Adverse Event|0|||
164595033|NCT00634244|594541149|FG000|Overall Study|Withdrawal by Subject|0|||
164595034|NCT00634244|594541150|FG001|Overall Study|Withdrawal by Subject|1|||
164595035|NCT00634244|594541151|FG002|Overall Study|Withdrawal by Subject|0|||
164595036|NCT00634244|594541149|FG000|Overall Study|Physician Decision|0|||
164595037|NCT00634244|594541150|FG001|Overall Study|Physician Decision|1|||
164595038|NCT00634244|594541151|FG002|Overall Study|Physician Decision|0|||
164595039|NCT00634244|594541149|FG000|Overall Study|Disease progression/relapse|0|||
164595040|NCT00634244|594541150|FG001|Overall Study|Disease progression/relapse|1|||
164595041|NCT00634244|594541151|FG002|Overall Study|Disease progression/relapse|0|||
164595042|NCT00634244|594541149|FG000|Overall Study|Other complicating disease|0|||
164595043|NCT00634244|594541150|FG001|Overall Study|Other complicating disease|1|||
164595044|NCT00634244|594541151|FG002|Overall Study|Other complicating disease|0|||
164595045|NCT04369430|594541157|FG000|Overall Study|Adverse Event|2|||
164595046|NCT04369430|594541158|FG001|Overall Study|Adverse Event|3|||
164595047|NCT04369430|594541157|FG000|Overall Study|Death|1|||
164595048|NCT04369430|594541158|FG001|Overall Study|Death|0|||
164595049|NCT04369430|594541157|FG000|Overall Study|Withdrawal by Subject|4|||
164595050|NCT04369430|594541158|FG001|Overall Study|Withdrawal by Subject|3|||
164595051|NCT04369430|594541157|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
164595052|NCT04369430|594541158|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
164595053|NCT04369430|594541157|FG000|Overall Study|Lost to Follow-up|0|||
164595054|NCT04369430|594541158|FG001|Overall Study|Lost to Follow-up|1|||
164595055|NCT03453151|594541159|FG000|Overall Study|Withdrawal by Subject|1|||
164595056|NCT03453151|594541159|FG000|Overall Study|Physician Decision|3|||
164595057|NCT01468909|594541160|FG000|Overall Study|Never Treated|2|||
164595058|NCT01468909|594541161|FG001|Overall Study|Never Treated|2|||
164595059|NCT01204658|594541162|FG000|Primary Phase|Adverse Event|0|||
164595060|NCT01204658|594541163|FG001|Primary Phase|Adverse Event|0|||
164595061|NCT01204658|594541164|FG002|Primary Phase|Adverse Event|1|||
164595062|NCT01204658|594541165|FG003|Primary Phase|Adverse Event|0|||
164595063|NCT04594239|594541170|FG000|Overall Study|Withdrawal by Subject|3|||
164396171|NCT02163733|593819672|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
164396172|NCT02163733|593819673|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
164396173|NCT02163733|593819674|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
164396174|NCT02163733|593819672|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
164396175|NCT02163733|593819673|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
164396176|NCT02163733|593819674|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
164396177|NCT01615328|593819677|FG000|Overall Study|Lost to Follow-up|3|||
164396178|NCT01615328|593819678|FG001|Overall Study|Lost to Follow-up|5|||
164396179|NCT02157779|593819679|FG000|Overall Study|Logistical|9|||
164396180|NCT02157779|593819680|FG001|Overall Study|Logistical|3|||
164396181|NCT02157779|593819679|FG000|Overall Study|Stopped attending, reason unknown|11|||
164396182|NCT02157779|593819680|FG001|Overall Study|Stopped attending, reason unknown|7|||
164396183|NCT02157779|593819679|FG000|Overall Study|No response to outreach after Baseline|1|||
164396184|NCT02157779|593819680|FG001|Overall Study|No response to outreach after Baseline|1|||
164396185|NCT02157779|593819679|FG000|Overall Study|Moved|1|||
164396186|NCT02157779|593819680|FG001|Overall Study|Moved|0|||
164595064|NCT04594239|594541171|FG001|Overall Study|Withdrawal by Subject|4|||
164595065|NCT04594239|594541172|FG002|Overall Study|Withdrawal by Subject|2|||
164595066|NCT04594239|594541173|FG003|Overall Study|Withdrawal by Subject|4|||
164595067|NCT04594239|594541170|FG000|Overall Study|Lost to Follow-up|8|||
164595068|NCT04594239|594541171|FG001|Overall Study|Lost to Follow-up|5|||
164595069|NCT04594239|594541172|FG002|Overall Study|Lost to Follow-up|4|||
164595070|NCT04594239|594541173|FG003|Overall Study|Lost to Follow-up|6|||
164595071|NCT04594239|594541170|FG000|Overall Study|Subject relocated|0|||
164595072|NCT04594239|594541171|FG001|Overall Study|Subject relocated|0|||
164595073|NCT04594239|594541172|FG002|Overall Study|Subject relocated|0|||
164396187|NCT02157779|593819679|FG000|Overall Study|Medical|1|||
164595074|NCT04594239|594541173|FG003|Overall Study|Subject relocated|1|||
164595075|NCT03229759|594541174|FG000|Overall Study|Screen Failure|30|||
164595076|NCT00818207|594543041|FG000|Overall Study|Adverse Event|6|||
164595077|NCT00818207|594543042|FG001|Overall Study|Adverse Event|0|||
164595078|NCT00818207|594543041|FG000|Overall Study|Lost to Follow-up|160|||
164595079|NCT00818207|594543042|FG001|Overall Study|Lost to Follow-up|146|||
164396188|NCT02157779|593819680|FG001|Overall Study|Medical|0|||
164396189|NCT02157779|593819679|FG000|Overall Study|Legal issue|1|||
164396190|NCT02157779|593819680|FG001|Overall Study|Legal issue|0|||
164396191|NCT00487162|593819684|FG000|Overall Study|Adverse Event|0|||
164396192|NCT00487162|593819685|FG001|Overall Study|Adverse Event|1|||
164396193|NCT00487162|593819684|FG000|Overall Study|Physician Decision|0|||
164396194|NCT00487162|593819685|FG001|Overall Study|Physician Decision|1|||
164396195|NCT00487162|593819684|FG000|Overall Study|Withdrawal by Subject|2|||
164396196|NCT00487162|593819685|FG001|Overall Study|Withdrawal by Subject|3|||
164396197|NCT00530855|593819686|FG000|Overall Study|Lack of Efficacy|20|||
164396198|NCT00530855|593819686|FG000|Overall Study|Withdrawal by Subject|30|||
164396199|NCT00530855|593819686|FG000|Overall Study|Fatal Serious AE|3|||
164396200|NCT00530855|593819686|FG000|Overall Study|Non Fatal Serious AE|7|||
164396201|NCT00530855|593819686|FG000|Overall Study|Non Fatal Non Serious AE|12|||
164396202|NCT00530855|593819686|FG000|Overall Study|Protocol Violation|3|||
164396203|NCT00530855|593819686|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
164396204|NCT00530855|593819686|FG000|Overall Study|Lost to Follow-up|9|||
164396205|NCT00530855|593819686|FG000|Overall Study|Other reason for premature termination|17|||
164396206|NCT01654549|593819705|FG000|Overall Study|H.pylori eradication not successful|0|||
164396207|NCT01654549|593819706|FG001|Overall Study|H.pylori eradication not successful|1|||
164396208|NCT03152526|593819707|FG000|Overall Study|Withdrawal by Subject|0|||
164396209|NCT03152526|593819708|FG001|Overall Study|Withdrawal by Subject|1|||
164396210|NCT05130970|593819709|FG000|Overall Study|Adverse Event|1|||
164396211|NCT05130970|593819710|FG001|Overall Study|Adverse Event|1|||
164396212|NCT05130970|593819709|FG000|Overall Study|Death|0|||
164396213|NCT05130970|593819710|FG001|Overall Study|Death|1|||
164396214|NCT05130970|593819709|FG000|Overall Study|Lost to Follow-up|0|||
164396215|NCT05130970|593819710|FG001|Overall Study|Lost to Follow-up|1|||
164396216|NCT05130970|593819709|FG000|Overall Study|Physician Decision|0|||
164396217|NCT05130970|593819710|FG001|Overall Study|Physician Decision|1|||
164396218|NCT05130970|593819709|FG000|Overall Study|Withdrawal by Subject|1|||
164396219|NCT05130970|593819710|FG001|Overall Study|Withdrawal by Subject|1|||
164396220|NCT02701985|593819711|FG000|Overall Study|Withdrawal by Subject|1|||
164396221|NCT02701985|593819712|FG001|Overall Study|Withdrawal by Subject|1|||
164396222|NCT02701985|593819711|FG000|Overall Study|Lost to Follow-up|1|||
164396223|NCT02701985|593819712|FG001|Overall Study|Lost to Follow-up|0|||
164396224|NCT02701985|593819711|FG000|Overall Study|Death|1|||
164396225|NCT02701985|593819712|FG001|Overall Study|Death|0|||
164396226|NCT02701985|593819711|FG000|Overall Study|Adverse Event|0|||
164396227|NCT02701985|593819712|FG001|Overall Study|Adverse Event|5|||
164396228|NCT01362140|593819714|FG000|Overall Study|Noncompliance|1|||
164396229|NCT01362140|593819715|FG001|Overall Study|Noncompliance|0|||
164396230|NCT01362140|593819714|FG000|Overall Study|Adverse Event|2|||
164396231|NCT01362140|593819715|FG001|Overall Study|Adverse Event|2|||
164396232|NCT01362140|593819714|FG000|Overall Study|Withdrawal by Subject|3|||
164396233|NCT01362140|593819715|FG001|Overall Study|Withdrawal by Subject|3|||
164396234|NCT01362140|593819714|FG000|Overall Study|Administrative Decision|0|||
164396235|NCT01362140|593819715|FG001|Overall Study|Administrative Decision|1|||
164396236|NCT01362140|593819714|FG000|Overall Study|Death|2|||
164396237|NCT01362140|593819715|FG001|Overall Study|Death|1|||
164396238|NCT01362140|593819714|FG000|Overall Study|Other|1|||
164396239|NCT01362140|593819715|FG001|Overall Study|Other|1|||
164396240|NCT01362140|593819714|FG000|Overall Study|Protocol-specified Criteria|1|||
164396241|NCT01362140|593819715|FG001|Overall Study|Protocol-specified Criteria|2|||
164396242|NCT01362140|593819714|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
164396243|NCT01362140|593819715|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
164396244|NCT01556438|593819716|FG000|Overall Study|Adverse Event|4|||
164396245|NCT01556438|593819717|FG001|Overall Study|Adverse Event|2|||
164396246|NCT01556438|593819716|FG000|Overall Study|Sponsor Decision|0|||
164396247|NCT01556438|593819717|FG001|Overall Study|Sponsor Decision|2|||
164396248|NCT01556438|593819716|FG000|Overall Study|Progressive Disease|0|||
164396249|NCT01556438|593819717|FG001|Overall Study|Progressive Disease|6|||
164396250|NCT01556438|593819716|FG000|Overall Study|Death|0|||
164396251|NCT01556438|593819717|FG001|Overall Study|Death|1|||
164396252|NCT01388816|593819718|FG000|Overall Study|Adverse Event|0|||
164396253|NCT01388816|593819719|FG001|Overall Study|Adverse Event|2|||
164396254|NCT01388816|593819720|FG002|Overall Study|Adverse Event|0|||
164396255|NCT01388816|593819721|FG003|Overall Study|Adverse Event|0|||
164396256|NCT01388816|593819718|FG000|Overall Study|Lost to Follow-up|0|||
164396257|NCT01388816|593819719|FG001|Overall Study|Lost to Follow-up|1|||
164396258|NCT01388816|593819720|FG002|Overall Study|Lost to Follow-up|0|||
164396259|NCT01388816|593819721|FG003|Overall Study|Lost to Follow-up|0|||
164396260|NCT01388816|593819718|FG000|Overall Study|Withdrawal by Subject|2|||
164396261|NCT01388816|593819719|FG001|Overall Study|Withdrawal by Subject|1|||
164396262|NCT01388816|593819720|FG002|Overall Study|Withdrawal by Subject|1|||
164396263|NCT01388816|593819721|FG003|Overall Study|Withdrawal by Subject|0|||
164396264|NCT01388816|593819718|FG000|Overall Study|Protocol Violation|0|||
164396265|NCT01388816|593819719|FG001|Overall Study|Protocol Violation|0|||
164396266|NCT01388816|593819720|FG002|Overall Study|Protocol Violation|2|||
164396267|NCT01388816|593819721|FG003|Overall Study|Protocol Violation|0|||
164396268|NCT00743366|593819722|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
164396269|NCT00743366|593819723|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
164396270|NCT03998618|593819724|FG000|Overall Study|Death|7|||
164396271|NCT03998618|593819725|FG001|Overall Study|Death|11|||
164396272|NCT03998618|593819724|FG000|Overall Study|hospice enrollment|3|||
164396273|NCT03998618|593819725|FG001|Overall Study|hospice enrollment|3|||
164396274|NCT03998618|593819724|FG000|Overall Study|Not feeling well/health problems|3|||
164396275|NCT03998618|593819725|FG001|Overall Study|Not feeling well/health problems|5|||
164396276|NCT03998618|593819724|FG000|Overall Study|Lost to Follow-up|6|||
164396277|NCT03998618|593819725|FG001|Overall Study|Lost to Follow-up|6|||
164396278|NCT03998618|593819724|FG000|Overall Study|Withdrawal by Subject|0|||
164396279|NCT03998618|593819725|FG001|Overall Study|Withdrawal by Subject|4|||
164396280|NCT02308748|593819726|FG000|Period 1|Withdrawal by Subject|0|||
164396281|NCT02308748|593819727|FG001|Period 1|Withdrawal by Subject|0|||
164396282|NCT02308748|593819728|FG002|Period 1|Withdrawal by Subject|1|||
164396283|NCT02308748|593819729|FG003|Period 1|Withdrawal by Subject|0|||
164396284|NCT02308748|593819730|FG004|Period 1|Withdrawal by Subject|0|||
164396285|NCT02308748|593819731|FG005|Period 1|Withdrawal by Subject|0|||
164396286|NCT02308748|593819732|FG006|Period 1|Withdrawal by Subject|0|||
164396287|NCT02308748|593819733|FG007|Period 1|Withdrawal by Subject|0|||
164396288|NCT02308748|593819734|FG008|Period 1|Withdrawal by Subject|0|||
164396289|NCT02308748|593819735|FG009|Period 1|Withdrawal by Subject|0|||
164396290|NCT02308748|593819726|FG000|Period 2|Adverse Event|0|||
164396291|NCT02308748|593819727|FG001|Period 2|Adverse Event|0|||
164396292|NCT02308748|593819728|FG002|Period 2|Adverse Event|0|||
164396293|NCT02308748|593819729|FG003|Period 2|Adverse Event|0|||
164396294|NCT02308748|593819730|FG004|Period 2|Adverse Event|0|||
164396295|NCT02308748|593819731|FG005|Period 2|Adverse Event|0|||
164396296|NCT02308748|593819732|FG006|Period 2|Adverse Event|0|||
164396297|NCT02308748|593819733|FG007|Period 2|Adverse Event|1|||
164396298|NCT02308748|593819734|FG008|Period 2|Adverse Event|0|||
164396299|NCT02308748|593819735|FG009|Period 2|Adverse Event|0|||
164396300|NCT02308748|593819726|FG000|Period 3|Protocol Violation|0|||
164396301|NCT02308748|593819727|FG001|Period 3|Protocol Violation|0|||
164396302|NCT02308748|593819728|FG002|Period 3|Protocol Violation|0|||
164396303|NCT02308748|593819729|FG003|Period 3|Protocol Violation|0|||
164396304|NCT02308748|593819730|FG004|Period 3|Protocol Violation|0|||
164396305|NCT02308748|593819731|FG005|Period 3|Protocol Violation|0|||
164396306|NCT02308748|593819732|FG006|Period 3|Protocol Violation|0|||
164396307|NCT02308748|593819733|FG007|Period 3|Protocol Violation|0|||
164396308|NCT02308748|593819734|FG008|Period 3|Protocol Violation|0|||
164396309|NCT02308748|593819735|FG009|Period 3|Protocol Violation|1|||
164396310|NCT02308748|593819726|FG000|Period 5|Adverse Event|1|||
164396311|NCT02308748|593819727|FG001|Period 5|Adverse Event|0|||
164396312|NCT02308748|593819728|FG002|Period 5|Adverse Event|0|||
164396313|NCT02308748|593819729|FG003|Period 5|Adverse Event|0|||
164396314|NCT02308748|593819730|FG004|Period 5|Adverse Event|0|||
164396315|NCT02308748|593819731|FG005|Period 5|Adverse Event|0|||
164396316|NCT02308748|593819732|FG006|Period 5|Adverse Event|0|||
164595080|NCT00818207|594543041|FG000|Overall Study|Multiple reasons|11|||
164595081|NCT00818207|594543042|FG001|Overall Study|Multiple reasons|12|||
164396317|NCT02308748|593819733|FG007|Period 5|Adverse Event|0|||
164396318|NCT02308748|593819734|FG008|Period 5|Adverse Event|1|||
164396319|NCT02308748|593819735|FG009|Period 5|Adverse Event|0|||
164396320|NCT01152580|593819736|FG000|Overall Study|Withdrawal by Subject|0|||
164396321|NCT01152580|593819737|FG001|Overall Study|Withdrawal by Subject|1|||
164396322|NCT01994954|593819739|FG000|Overall Study|Death|1|||
164396323|NCT01994954|593819740|FG001|Overall Study|Death|0|||
164396324|NCT01994954|593819739|FG000|Overall Study|Withdrawal by Subject|9|||
164396325|NCT01994954|593819740|FG001|Overall Study|Withdrawal by Subject|14|||
164396326|NCT01994954|593819739|FG000|Overall Study|Physician Decision|2|||
164396327|NCT01994954|593819740|FG001|Overall Study|Physician Decision|2|||
164441990|NCT00723450|593985598|FG002|Open-Label Phase|Physician Decision|0|||
164441991|NCT00723450|593985596|FG000|Open-Label Phase|Withdrawal by Subject|37|||
164595082|NCT00818207|594543041|FG000|Overall Study|Withdrawal by Subject|42|||
164595083|NCT00818207|594543042|FG001|Overall Study|Withdrawal by Subject|104|||
164595084|NCT00818207|594543041|FG000|Overall Study|Death|3|||
164595085|NCT00818207|594543042|FG001|Overall Study|Death|5|||
164704409|NCT03514641|594944546|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
164396328|NCT01994954|593819739|FG000|Overall Study|Lost to Follow-up|8|||
164396329|NCT01994954|593819740|FG001|Overall Study|Lost to Follow-up|10|||
164396330|NCT01994954|593819739|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
164396331|NCT01994954|593819740|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
164396332|NCT00449176|593819741|FG000|Overall Study|Withdrawal by Subject|39|||
164396333|NCT00449176|593819742|FG001|Overall Study|Withdrawal by Subject|43|||
164396334|NCT00449176|593819743|FG002|Overall Study|Withdrawal by Subject|59|||
164396335|NCT00449176|593819741|FG000|Overall Study|Lost to Follow-up|13|||
164396336|NCT00449176|593819742|FG001|Overall Study|Lost to Follow-up|8|||
164595086|NCT02616185|594543043|FG000|Overall Study|Death|0|||
164396337|NCT00449176|593819743|FG002|Overall Study|Lost to Follow-up|12|||
164396338|NCT00449176|593819741|FG000|Overall Study|Adverse Event|51|||
164396339|NCT00449176|593819742|FG001|Overall Study|Adverse Event|107|||
164396340|NCT00449176|593819743|FG002|Overall Study|Adverse Event|15|||
164396341|NCT00449176|593819741|FG000|Overall Study|Lack of Efficacy|13|||
164396342|NCT00449176|593819742|FG001|Overall Study|Lack of Efficacy|7|||
164396343|NCT00449176|593819743|FG002|Overall Study|Lack of Efficacy|50|||
164396344|NCT00449176|593819741|FG000|Overall Study|Study drug non-compliant|14|||
164396345|NCT00449176|593819742|FG001|Overall Study|Study drug non-compliant|11|||
164396346|NCT00449176|593819743|FG002|Overall Study|Study drug non-compliant|11|||
164396347|NCT00449176|593819741|FG000|Overall Study|all other|22|||
164396348|NCT00449176|593819742|FG001|Overall Study|all other|19|||
164396349|NCT00449176|593819743|FG002|Overall Study|all other|20|||
164396350|NCT02472964|593819744|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
164396351|NCT02472964|593819745|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
164396352|NCT02472964|593819744|FG000|Part 1 (up to Week 24)|disease progression|58|||
164396353|NCT02472964|593819745|FG001|Part 1 (up to Week 24)|disease progression|47|||
164396354|NCT02472964|593819744|FG000|Part 1 (up to Week 24)|Death|3|||
164396355|NCT02472964|593819745|FG001|Part 1 (up to Week 24)|Death|6|||
164396356|NCT02472964|593819744|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
164396357|NCT02472964|593819745|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
164396358|NCT02472964|593819744|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
164396359|NCT02472964|593819745|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
164396360|NCT02472964|593819744|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
164396361|NCT02472964|593819745|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
164396362|NCT02472964|593819744|FG000|Part 1 (up to Week 24)|Other|2|||
164396363|NCT02472964|593819745|FG001|Part 1 (up to Week 24)|Other|1|||
164396364|NCT02472964|593819744|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
164396365|NCT02472964|593819745|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
164396366|NCT02472964|593819744|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
164396367|NCT02472964|593819745|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
164396368|NCT02472964|593819744|FG000|Part 2 (Week 24-week 48)|Death|0|||
164396369|NCT02472964|593819745|FG001|Part 2 (Week 24-week 48)|Death|1|||
164396370|NCT02472964|593819744|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
164396371|NCT02472964|593819745|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
164396372|NCT02472964|593819744|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
164396373|NCT02472964|593819745|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
164396374|NCT02472964|593819744|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
164396375|NCT02472964|593819745|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
164396376|NCT02472964|593819744|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
164396377|NCT02472964|593819745|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
164396378|NCT01967732|593819748|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
164396379|NCT01967732|593819749|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
164396380|NCT01967732|593819750|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
164396381|NCT01967732|593819751|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
164396382|NCT01967732|593819748|FG000|First Intervention (Day 1)|Poor venous access|0|||
164396383|NCT01967732|593819749|FG001|First Intervention (Day 1)|Poor venous access|1|||
164396384|NCT01967732|593819750|FG002|First Intervention (Day 1)|Poor venous access|0|||
164396385|NCT01967732|593819751|FG003|First Intervention (Day 1)|Poor venous access|0|||
164396386|NCT00833638|593819759|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
164396387|NCT00833638|593819760|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
164396388|NCT00833638|593819761|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
164396389|NCT00833638|593819759|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
164396390|NCT00833638|593819760|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
164396391|NCT00833638|593819761|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
164396392|NCT00833638|593819759|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
164396393|NCT00833638|593819760|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
164396394|NCT00833638|593819761|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
164396395|NCT00833638|593819759|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
164396396|NCT00833638|593819760|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
164396397|NCT00833638|593819761|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
164396398|NCT00833638|593819759|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
164396399|NCT00833638|593819760|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
164396400|NCT00833638|593819761|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
164396401|NCT00833638|593819759|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
164396402|NCT00833638|593819760|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
164396403|NCT00833638|593819761|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
164396404|NCT00833638|593819759|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
164396405|NCT00833638|593819760|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
164396406|NCT00833638|593819761|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
164396407|NCT00833638|593819759|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
164396408|NCT00833638|593819760|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
164396409|NCT00833638|593819761|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
164396410|NCT00833638|593819759|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
164396411|NCT00833638|593819760|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
164396412|NCT00833638|593819761|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
164396413|NCT01178086|593819762|FG000|Overall Study|Participant refusal|7|||
164396414|NCT01178086|593819762|FG000|Overall Study|Physician Decision|44|||
164396415|NCT01178086|593819762|FG000|Overall Study|Switch to other CLL therapy|113|||
164396416|NCT01178086|593819762|FG000|Overall Study|Death|59|||
164396417|NCT01178086|593819762|FG000|Overall Study|Other unspecified|89|||
164396418|NCT01178086|593819762|FG000|Overall Study|Excluded from EAS|20|||
164396419|NCT01400503|593819763|FG000|Overall Study|Withdrawal by Subject|1|||
164396420|NCT01400503|593819763|FG000|Overall Study|Study Terminated by Sponsor|58|||
164396421|NCT01400503|593819763|FG000|Overall Study|Other|1|||
164396422|NCT01261338|593819764|FG000|Overall Study|Withdrawal by Subject|3|||
164396423|NCT01261338|593819765|FG001|Overall Study|Withdrawal by Subject|2|||
164441992|NCT00723450|593985597|FG001|Open-Label Phase|Withdrawal by Subject|0|||
164595087|NCT02616185|594543044|FG001|Overall Study|Death|0|||
164595088|NCT02616185|594543045|FG002|Overall Study|Death|0|||
164595089|NCT02616185|594543046|FG003|Overall Study|Death|1|||
164595090|NCT02616185|594543047|FG004|Overall Study|Death|2|||
164595091|NCT02616185|594543048|FG005|Overall Study|Death|0|||
164595092|NCT02616185|594543049|FG006|Overall Study|Death|0|||
164595093|NCT02616185|594543050|FG007|Overall Study|Death|2|||
164595094|NCT02616185|594543051|FG008|Overall Study|Death|1|||
164595095|NCT02616185|594543043|FG000|Overall Study|Study terminated by sponsor|0|||
164595096|NCT02616185|594543044|FG001|Overall Study|Study terminated by sponsor|0|||
164595097|NCT02616185|594543045|FG002|Overall Study|Study terminated by sponsor|1|||
164595098|NCT02616185|594543046|FG003|Overall Study|Study terminated by sponsor|0|||
164704410|NCT03514641|594944547|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
164595099|NCT02616185|594543047|FG004|Overall Study|Study terminated by sponsor|0|||
164595100|NCT02616185|594543048|FG005|Overall Study|Study terminated by sponsor|0|||
164441993|NCT00723450|593985598|FG002|Open-Label Phase|Withdrawal by Subject|0|||
164595101|NCT02616185|594543049|FG006|Overall Study|Study terminated by sponsor|5|||
164396622|NCT03563716|593820999|FG000|Overall Study|Death|20|||
164396623|NCT03563716|593821000|FG001|Overall Study|Death|14|||
164396624|NCT03563716|593820999|FG000|Overall Study|Withdrawal by Subject|3|||
164396625|NCT03563716|593821000|FG001|Overall Study|Withdrawal by Subject|3|||
164396626|NCT03563716|593820999|FG000|Overall Study|Still on Study|45|||
164396627|NCT03563716|593821000|FG001|Overall Study|Still on Study|50|||
164396650|NCT00364286|593821038|FG000|Overall Study|Withdrawal by Subject|1|||
164441994|NCT00723450|593985596|FG000|Randomized Phase|Adverse Event|0|||
164441995|NCT00723450|593985597|FG001|Randomized Phase|Adverse Event|26|||
164441996|NCT00723450|593985598|FG002|Randomized Phase|Adverse Event|17|||
164441997|NCT00723450|593985596|FG000|Randomized Phase|Lack of Efficacy|0|||
164441998|NCT00723450|593985597|FG001|Randomized Phase|Lack of Efficacy|11|||
164441999|NCT00723450|593985598|FG002|Randomized Phase|Lack of Efficacy|11|||
164442000|NCT00723450|593985596|FG000|Randomized Phase|Protocol Violation|0|||
164442001|NCT00723450|593985597|FG001|Randomized Phase|Protocol Violation|9|||
164442002|NCT00723450|593985598|FG002|Randomized Phase|Protocol Violation|13|||
164442003|NCT00723450|593985596|FG000|Randomized Phase|Lost to Follow-up|0|||
164442004|NCT00723450|593985597|FG001|Randomized Phase|Lost to Follow-up|2|||
164442005|NCT00723450|593985598|FG002|Randomized Phase|Lost to Follow-up|3|||
164442006|NCT00723450|593985596|FG000|Randomized Phase|Physician Decision|0|||
164442007|NCT00723450|593985597|FG001|Randomized Phase|Physician Decision|3|||
164442008|NCT00723450|593985598|FG002|Randomized Phase|Physician Decision|1|||
164442009|NCT00723450|593985596|FG000|Randomized Phase|Withdrawal by Subject|0|||
164442010|NCT00723450|593985597|FG001|Randomized Phase|Withdrawal by Subject|14|||
164442011|NCT00723450|593985598|FG002|Randomized Phase|Withdrawal by Subject|22|||
164442012|NCT00117286|593985599|FG000|Overall Study|Adverse Event|12|||
164442013|NCT00117286|593985600|FG001|Overall Study|Adverse Event|6|||
164442014|NCT00117286|593985599|FG000|Overall Study|Lost to Follow-up|2|||
164442015|NCT00117286|593985600|FG001|Overall Study|Lost to Follow-up|0|||
164442016|NCT00117286|593985599|FG000|Overall Study|Protocol Violation|3|||
164442017|NCT00117286|593985600|FG001|Overall Study|Protocol Violation|3|||
164442018|NCT00117286|593985599|FG000|Overall Study|Withdrawal by Subject|6|||
164442019|NCT00117286|593985600|FG001|Overall Study|Withdrawal by Subject|2|||
164442020|NCT00117286|593985599|FG000|Overall Study|Physician Decision|3|||
164442021|NCT00117286|593985600|FG001|Overall Study|Physician Decision|7|||
164442022|NCT00117286|593985599|FG000|Overall Study|Lack of Efficacy|2|||
164442023|NCT00117286|593985600|FG001|Overall Study|Lack of Efficacy|1|||
164442024|NCT00117286|593985599|FG000|Overall Study|Research site closing|0|||
164442025|NCT00117286|593985600|FG001|Overall Study|Research site closing|2|||
164442026|NCT02537522|593985608|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
164442027|NCT02537522|593985609|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
164442028|NCT02537522|593985610|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
164442029|NCT02537522|593985611|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
164442030|NCT02537522|593985608|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
164442031|NCT02537522|593985609|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
164442032|NCT02537522|593985610|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
164442033|NCT02537522|593985611|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
164595102|NCT02616185|594543050|FG007|Overall Study|Study terminated by sponsor|2|||
164595103|NCT02616185|594543051|FG008|Overall Study|Study terminated by sponsor|0|||
164595104|NCT02616185|594543043|FG000|Overall Study|Participant refused further follow-up|1|||
164595105|NCT02616185|594543044|FG001|Overall Study|Participant refused further follow-up|1|||
164595106|NCT02616185|594543045|FG002|Overall Study|Participant refused further follow-up|2|||
164442034|NCT02537522|593985608|FG000|Phase I - Contralateral|incorrect randomization|0|||
164396651|NCT00364286|593821038|FG000|Overall Study|Adverse Event|2|||
164442035|NCT02537522|593985609|FG001|Phase I - Contralateral|incorrect randomization|1|||
164396672|NCT00430989|593821042|FG000|Overall Study|Lost to Follow-up|2|||
164396673|NCT00430989|593821043|FG001|Overall Study|Lost to Follow-up|3|||
164396674|NCT00430989|593821042|FG000|Overall Study|Withdrawal by Subject|15|||
164396675|NCT00430989|593821043|FG001|Overall Study|Withdrawal by Subject|14|||
164396676|NCT00430989|593821042|FG000|Overall Study|Protocol Violation|30|||
164396677|NCT00430989|593821043|FG001|Overall Study|Protocol Violation|37|||
164396678|NCT00430989|593821042|FG000|Overall Study|Not eligible|13|||
164396679|NCT00430989|593821043|FG001|Overall Study|Not eligible|6|||
164396711|NCT05297786|593821073|FG000|Overall Study|Withdrawal by Subject|3|||
164396712|NCT05297786|593821074|FG001|Overall Study|Withdrawal by Subject|0|||
164396713|NCT05297786|593821073|FG000|Overall Study|Renal transplantation|1|||
164396714|NCT05297786|593821074|FG001|Overall Study|Renal transplantation|0|||
164396715|NCT05297786|593821073|FG000|Overall Study|Physician Decision|1|||
164396716|NCT05297786|593821074|FG001|Overall Study|Physician Decision|0|||
164396717|NCT05297786|593821073|FG000|Overall Study|Adverse Event|0|||
164396718|NCT05297786|593821074|FG001|Overall Study|Adverse Event|1|||
164595107|NCT02616185|594543046|FG003|Overall Study|Participant refused further follow-up|3|||
164595108|NCT02616185|594543047|FG004|Overall Study|Participant refused further follow-up|4|||
164595109|NCT02616185|594543048|FG005|Overall Study|Participant refused further follow-up|0|||
164396719|NCT05297786|593821073|FG000|Overall Study|Withdrawal by Subject|0|||
164595110|NCT02616185|594543049|FG006|Overall Study|Participant refused further follow-up|3|||
164595111|NCT02616185|594543050|FG007|Overall Study|Participant refused further follow-up|4|||
164396720|NCT05297786|593821074|FG001|Overall Study|Withdrawal by Subject|1|||
164396728|NCT05402137|593821080|FG000|Overall Study|Lost to Follow-up|42|||
164396729|NCT05402137|593821081|FG001|Overall Study|Lost to Follow-up|40|||
164396755|NCT06269484|593823353|FG000|Overall Study|Withdrawal by Subject|3|||
164396756|NCT06269484|593823354|FG001|Overall Study|Withdrawal by Subject|0|||
164396757|NCT06269484|593823355|FG002|Overall Study|Withdrawal by Subject|2|||
164396758|NCT06269484|593823353|FG000|Overall Study|All other reasons apart from specified|1|||
164396759|NCT06269484|593823354|FG001|Overall Study|All other reasons apart from specified|0|||
164396760|NCT06269484|593823355|FG002|Overall Study|All other reasons apart from specified|0|||
164396761|NCT06269484|593823353|FG000|Overall Study|Randomised but not started treatment|0|||
164396762|NCT06269484|593823354|FG001|Overall Study|Randomised but not started treatment|1|||
164396763|NCT06269484|593823355|FG002|Overall Study|Randomised but not started treatment|0|||
164442036|NCT02537522|593985610|FG002|Phase I - Contralateral|incorrect randomization|0|||
164442037|NCT02537522|593985611|FG003|Phase I - Contralateral|incorrect randomization|0|||
164595112|NCT02616185|594543051|FG008|Overall Study|Participant refused further follow-up|3|||
164595113|NCT02616185|594543043|FG000|Overall Study|Not reported|0|||
164595114|NCT02616185|594543044|FG001|Overall Study|Not reported|0|||
164595115|NCT02616185|594543045|FG002|Overall Study|Not reported|0|||
164396815|NCT03994601|593823390|FG000|Overall Study|Adverse Event|0|||
164396816|NCT03994601|593823391|FG001|Overall Study|Adverse Event|0|||
164396817|NCT03994601|593823392|FG002|Overall Study|Adverse Event|0|||
164396818|NCT03994601|593823393|FG003|Overall Study|Adverse Event|0|||
164396819|NCT03994601|593823394|FG004|Overall Study|Adverse Event|0|||
164396820|NCT03994601|593823395|FG005|Overall Study|Adverse Event|0|||
164396821|NCT03994601|593823396|FG006|Overall Study|Adverse Event|0|||
164396822|NCT03994601|593823397|FG007|Overall Study|Adverse Event|2|||
164396823|NCT03994601|593823398|FG008|Overall Study|Adverse Event|2|||
164396824|NCT03994601|593823399|FG009|Overall Study|Adverse Event|7|||
164396825|NCT03994601|593823400|FG010|Overall Study|Adverse Event|4|||
164396826|NCT03994601|593823401|FG011|Overall Study|Adverse Event|1|||
164396827|NCT03994601|593823402|FG012|Overall Study|Adverse Event|0|||
164396828|NCT03994601|593823390|FG000|Overall Study|Withdrew Consent|0|||
164396829|NCT03994601|593823391|FG001|Overall Study|Withdrew Consent|0|||
164396830|NCT03994601|593823392|FG002|Overall Study|Withdrew Consent|0|||
164396831|NCT03994601|593823393|FG003|Overall Study|Withdrew Consent|0|||
164396832|NCT03994601|593823394|FG004|Overall Study|Withdrew Consent|0|||
164396833|NCT03994601|593823395|FG005|Overall Study|Withdrew Consent|0|||
164396834|NCT03994601|593823396|FG006|Overall Study|Withdrew Consent|1|||
164396835|NCT03994601|593823397|FG007|Overall Study|Withdrew Consent|2|||
164396836|NCT03994601|593823398|FG008|Overall Study|Withdrew Consent|0|||
164396837|NCT03994601|593823399|FG009|Overall Study|Withdrew Consent|3|||
164396838|NCT03994601|593823400|FG010|Overall Study|Withdrew Consent|0|||
164396839|NCT03994601|593823401|FG011|Overall Study|Withdrew Consent|0|||
164396840|NCT03994601|593823402|FG012|Overall Study|Withdrew Consent|0|||
164396841|NCT03994601|593823390|FG000|Overall Study|Death|1|||
164595116|NCT02616185|594543046|FG003|Overall Study|Not reported|1|||
164595117|NCT02616185|594543047|FG004|Overall Study|Not reported|3|||
164595118|NCT02616185|594543048|FG005|Overall Study|Not reported|1|||
164595119|NCT02616185|594543049|FG006|Overall Study|Not reported|0|||
164595120|NCT02616185|594543050|FG007|Overall Study|Not reported|5|||
164595121|NCT02616185|594543051|FG008|Overall Study|Not reported|2|||
164595122|NCT01303380|594543052|FG000|Overall Study|Lack of compliance to study procedures|1|||
164595123|NCT00967226|594543053|FG000|Overall Study|Adverse Event|0|||
164595124|NCT00967226|594543054|FG001|Overall Study|Adverse Event|5|||
164595125|NCT00967226|594543053|FG000|Overall Study|Protocol Violation|2|||
164396842|NCT03994601|593823391|FG001|Overall Study|Death|0|||
164396843|NCT03994601|593823392|FG002|Overall Study|Death|0|||
164396844|NCT03994601|593823393|FG003|Overall Study|Death|0|||
164396845|NCT03994601|593823394|FG004|Overall Study|Death|0|||
164396846|NCT03994601|593823395|FG005|Overall Study|Death|0|||
164396847|NCT03994601|593823396|FG006|Overall Study|Death|1|||
164396848|NCT03994601|593823397|FG007|Overall Study|Death|2|||
164396849|NCT03994601|593823398|FG008|Overall Study|Death|0|||
164396850|NCT03994601|593823399|FG009|Overall Study|Death|5|||
164442038|NCT02537522|593985608|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
164442039|NCT02537522|593985609|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
164396851|NCT03994601|593823400|FG010|Overall Study|Death|4|||
164595126|NCT00967226|594543054|FG001|Overall Study|Protocol Violation|0|||
164396852|NCT03994601|593823401|FG011|Overall Study|Death|1|||
164396853|NCT03994601|593823402|FG012|Overall Study|Death|3|||
164396854|NCT03994601|593823390|FG000|Overall Study|Other Reasons|0|||
164396855|NCT03994601|593823391|FG001|Overall Study|Other Reasons|1|||
164396856|NCT03994601|593823392|FG002|Overall Study|Other Reasons|0|||
164396857|NCT03994601|593823393|FG003|Overall Study|Other Reasons|0|||
164396858|NCT03994601|593823394|FG004|Overall Study|Other Reasons|1|||
164396859|NCT03994601|593823395|FG005|Overall Study|Other Reasons|0|||
164396860|NCT03994601|593823396|FG006|Overall Study|Other Reasons|0|||
164396861|NCT03994601|593823397|FG007|Overall Study|Other Reasons|4|||
164595127|NCT00967226|594543053|FG000|Overall Study|Physician Decision|0|||
164396862|NCT03994601|593823398|FG008|Overall Study|Other Reasons|0|||
164396863|NCT03994601|593823399|FG009|Overall Study|Other Reasons|4|||
164396864|NCT03994601|593823400|FG010|Overall Study|Other Reasons|3|||
164396865|NCT03994601|593823401|FG011|Overall Study|Other Reasons|4|||
164396866|NCT03994601|593823402|FG012|Overall Study|Other Reasons|2|||
164396867|NCT03994601|593823390|FG000|Overall Study|Disease Progression|3|||
164396868|NCT03994601|593823391|FG001|Overall Study|Disease Progression|3|||
164396869|NCT03994601|593823392|FG002|Overall Study|Disease Progression|4|||
164396870|NCT03994601|593823393|FG003|Overall Study|Disease Progression|6|||
164396871|NCT03994601|593823394|FG004|Overall Study|Disease Progression|3|||
164396872|NCT03994601|593823395|FG005|Overall Study|Disease Progression|5|||
164396873|NCT03994601|593823396|FG006|Overall Study|Disease Progression|7|||
164396874|NCT03994601|593823397|FG007|Overall Study|Disease Progression|25|||
164396875|NCT03994601|593823398|FG008|Overall Study|Disease Progression|1|||
164396876|NCT03994601|593823399|FG009|Overall Study|Disease Progression|24|||
164396877|NCT03994601|593823400|FG010|Overall Study|Disease Progression|20|||
164396878|NCT03994601|593823401|FG011|Overall Study|Disease Progression|24|||
164396879|NCT03994601|593823402|FG012|Overall Study|Disease Progression|7|||
164396880|NCT03994601|593823390|FG000|Overall Study|Study Drug Toxicity|0|||
164396881|NCT03994601|593823391|FG001|Overall Study|Study Drug Toxicity|0|||
164396882|NCT03994601|593823392|FG002|Overall Study|Study Drug Toxicity|0|||
164396883|NCT03994601|593823393|FG003|Overall Study|Study Drug Toxicity|0|||
164396884|NCT03994601|593823394|FG004|Overall Study|Study Drug Toxicity|1|||
164396885|NCT03994601|593823395|FG005|Overall Study|Study Drug Toxicity|0|||
164396886|NCT03994601|593823396|FG006|Overall Study|Study Drug Toxicity|0|||
164396887|NCT03994601|593823397|FG007|Overall Study|Study Drug Toxicity|3|||
164396888|NCT03994601|593823398|FG008|Overall Study|Study Drug Toxicity|0|||
164396889|NCT03994601|593823399|FG009|Overall Study|Study Drug Toxicity|0|||
164396890|NCT03994601|593823400|FG010|Overall Study|Study Drug Toxicity|3|||
164396891|NCT03994601|593823401|FG011|Overall Study|Study Drug Toxicity|3|||
164396892|NCT03994601|593823402|FG012|Overall Study|Study Drug Toxicity|0|||
164396893|NCT03994601|593823390|FG000|Overall Study|AE Unrelated to Study Drug|0|||
164396894|NCT03994601|593823391|FG001|Overall Study|AE Unrelated to Study Drug|0|||
164396895|NCT03994601|593823392|FG002|Overall Study|AE Unrelated to Study Drug|1|||
164396896|NCT03994601|593823393|FG003|Overall Study|AE Unrelated to Study Drug|0|||
164396897|NCT03994601|593823394|FG004|Overall Study|AE Unrelated to Study Drug|0|||
164396898|NCT03994601|593823395|FG005|Overall Study|AE Unrelated to Study Drug|0|||
164396899|NCT03994601|593823396|FG006|Overall Study|AE Unrelated to Study Drug|0|||
164396900|NCT03994601|593823397|FG007|Overall Study|AE Unrelated to Study Drug|1|||
164396901|NCT03994601|593823398|FG008|Overall Study|AE Unrelated to Study Drug|0|||
164396902|NCT03994601|593823399|FG009|Overall Study|AE Unrelated to Study Drug|4|||
164396903|NCT03994601|593823400|FG010|Overall Study|AE Unrelated to Study Drug|5|||
164396904|NCT03994601|593823401|FG011|Overall Study|AE Unrelated to Study Drug|0|||
164396905|NCT03994601|593823402|FG012|Overall Study|AE Unrelated to Study Drug|0|||
164396906|NCT03994601|593823390|FG000|Overall Study|Request to Discontinue|0|||
164396907|NCT03994601|593823391|FG001|Overall Study|Request to Discontinue|0|||
164396908|NCT03994601|593823392|FG002|Overall Study|Request to Discontinue|0|||
164396909|NCT03994601|593823393|FG003|Overall Study|Request to Discontinue|0|||
164396910|NCT03994601|593823394|FG004|Overall Study|Request to Discontinue|0|||
164396911|NCT03994601|593823395|FG005|Overall Study|Request to Discontinue|0|||
164396912|NCT03994601|593823396|FG006|Overall Study|Request to Discontinue|0|||
164396913|NCT03994601|593823397|FG007|Overall Study|Request to Discontinue|1|||
164396914|NCT03994601|593823398|FG008|Overall Study|Request to Discontinue|0|||
164396915|NCT03994601|593823399|FG009|Overall Study|Request to Discontinue|0|||
164396916|NCT03994601|593823400|FG010|Overall Study|Request to Discontinue|0|||
164396917|NCT03994601|593823401|FG011|Overall Study|Request to Discontinue|0|||
164396918|NCT03994601|593823402|FG012|Overall Study|Request to Discontinue|0|||
164396919|NCT04221438|593823403|FG000|Overall Study|Adverse Event|1|||
164396920|NCT04221438|593823403|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
164396934|NCT06379893|593823427|FG000|Overall Study|Withdrawal by Subject|1|||
164396935|NCT06379893|593823427|FG000|Overall Study|Sponsors' decision|1|||
164595128|NCT00967226|594543054|FG001|Overall Study|Physician Decision|1|||
164595129|NCT01670656|594543055|FG000|Overall Study|Non-compliance with study drug|0|||
164595130|NCT01670656|594543056|FG001|Overall Study|Non-compliance with study drug|0|||
164595131|NCT01670656|594543057|FG002|Overall Study|Non-compliance with study drug|3|||
164595132|NCT01670656|594543058|FG003|Overall Study|Non-compliance with study drug|0|||
164595133|NCT01670656|594543059|FG004|Overall Study|Non-compliance with study drug|1|||
164442040|NCT02537522|593985610|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
164442041|NCT02537522|593985611|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
164442042|NCT02537522|593985608|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
164442043|NCT02537522|593985609|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
164442044|NCT02537522|593985610|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
164442045|NCT02537522|593985611|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
164442046|NCT03024606|593985613|FG000|Overall Study|Withdrawal by Subject|9|||
164442047|NCT03024606|593985614|FG001|Overall Study|Withdrawal by Subject|10|||
164442048|NCT01595061|593985615|FG000|Overall Study|Never Treated|3|||
164442049|NCT01595061|593985615|FG000|Overall Study|Inadequate Pathology|1|||
164442050|NCT00356265|593985616|FG000|Overall Study|Withdrawal by Subject|0|||
164442051|NCT00356265|593985617|FG001|Overall Study|Withdrawal by Subject|0|||
164595134|NCT01670656|594543055|FG000|Overall Study|Pregnancy|0|||
164595135|NCT01670656|594543056|FG001|Overall Study|Pregnancy|0|||
164595136|NCT01670656|594543057|FG002|Overall Study|Pregnancy|0|||
164595137|NCT01670656|594543058|FG003|Overall Study|Pregnancy|0|||
164595138|NCT01670656|594543059|FG004|Overall Study|Pregnancy|1|||
164595139|NCT01670656|594543055|FG000|Overall Study|Withdrawal by Subject|1|||
164595140|NCT01670656|594543056|FG001|Overall Study|Withdrawal by Subject|1|||
164595141|NCT01670656|594543057|FG002|Overall Study|Withdrawal by Subject|0|||
164595142|NCT01670656|594543058|FG003|Overall Study|Withdrawal by Subject|0|||
164595143|NCT01670656|594543059|FG004|Overall Study|Withdrawal by Subject|0|||
164595144|NCT01670656|594543055|FG000|Overall Study|Non-compliance with protocol|0|||
164595145|NCT01670656|594543056|FG001|Overall Study|Non-compliance with protocol|3|||
164595146|NCT01670656|594543057|FG002|Overall Study|Non-compliance with protocol|1|||
164595147|NCT01670656|594543058|FG003|Overall Study|Non-compliance with protocol|1|||
164595148|NCT01670656|594543059|FG004|Overall Study|Non-compliance with protocol|2|||
164595149|NCT01670656|594543055|FG000|Overall Study|Adverse Event|2|||
164442052|NCT00356265|593985618|FG002|Overall Study|Withdrawal by Subject|1|||
164595150|NCT01670656|594543056|FG001|Overall Study|Adverse Event|2|||
164595151|NCT01670656|594543057|FG002|Overall Study|Adverse Event|2|||
164595152|NCT01670656|594543058|FG003|Overall Study|Adverse Event|3|||
164595153|NCT01670656|594543059|FG004|Overall Study|Adverse Event|3|||
164595154|NCT01670656|594543055|FG000|Overall Study|Subject withdrew consent|0|||
164595155|NCT01670656|594543056|FG001|Overall Study|Subject withdrew consent|1|||
164595156|NCT01670656|594543057|FG002|Overall Study|Subject withdrew consent|2|||
164595157|NCT01670656|594543058|FG003|Overall Study|Subject withdrew consent|1|||
164704411|NCT03514641|594944544|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
164595158|NCT01670656|594543059|FG004|Overall Study|Subject withdrew consent|1|||
164595159|NCT01670656|594543055|FG000|Overall Study|Lost to Follow-up|0|||
164595160|NCT01670656|594543056|FG001|Overall Study|Lost to Follow-up|0|||
164595161|NCT01670656|594543057|FG002|Overall Study|Lost to Follow-up|0|||
164595162|NCT01670656|594543058|FG003|Overall Study|Lost to Follow-up|0|||
164595163|NCT01670656|594543059|FG004|Overall Study|Lost to Follow-up|3|||
164595164|NCT01670656|594543055|FG000|Overall Study|Subject moved|0|||
164595165|NCT01670656|594543056|FG001|Overall Study|Subject moved|0|||
164595166|NCT01670656|594543057|FG002|Overall Study|Subject moved|0|||
164595167|NCT01670656|594543058|FG003|Overall Study|Subject moved|1|||
164595168|NCT01670656|594543059|FG004|Overall Study|Subject moved|0|||
164595169|NCT00789958|594543060|FG000|Overall Study|Adverse Event|3|||
164595170|NCT00789958|594543060|FG000|Overall Study|Withdrawal by Subject|4|||
164595171|NCT00789958|594543060|FG000|Overall Study|Progression|3|||
164704412|NCT03514641|594944545|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
164704413|NCT03514641|594944546|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
164704414|NCT03514641|594944547|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
164704415|NCT03514641|594944544|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
164704416|NCT03514641|594944545|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
164704417|NCT03514641|594944546|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
164704418|NCT03514641|594944547|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
164397091|NCT03575793|593823495|FG000|Overall Study|Withdrawal by Subject|0|||
164397092|NCT03575793|593823496|FG001|Overall Study|Withdrawal by Subject|1|||
164397093|NCT03575793|593823495|FG000|Overall Study|Never Treated|0|||
164397094|NCT03575793|593823496|FG001|Overall Study|Never Treated|2|||
164595172|NCT00789958|594543060|FG000|Overall Study|not protocol specified|1|||
164595173|NCT00789958|594543060|FG000|Overall Study|Not eligible/not analyzable|26|||
164704419|NCT03514641|594944544|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
164595174|NCT00487084|594543061|FG000|Overall Study|Did not receive intervention|4|||
164397117|NCT03659916|593823505|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
164397118|NCT03659916|593823506|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
164397119|NCT03659916|593823507|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
164397120|NCT03659916|593823505|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
164397121|NCT03659916|593823506|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
164397122|NCT03659916|593823507|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
164397123|NCT03659916|593823505|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
164397124|NCT03659916|593823506|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
164397125|NCT03659916|593823507|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
164595175|NCT00487084|594543062|FG001|Overall Study|Did not receive intervention|3|||
164595176|NCT00487084|594543063|FG002|Overall Study|Did not receive intervention|5|||
164595177|NCT00111475|594543064|FG000|Overall Study|Lost to Follow-up|0|||
164595178|NCT00111475|594543065|FG001|Overall Study|Lost to Follow-up|0|||
164595179|NCT00111475|594543066|FG002|Overall Study|Lost to Follow-up|0|||
164595180|NCT00111475|594543067|FG003|Overall Study|Lost to Follow-up|0|||
164595181|NCT00111475|594543068|FG004|Overall Study|Lost to Follow-up|0|||
164595182|NCT00111475|594543069|FG005|Overall Study|Lost to Follow-up|1|||
164595183|NCT00111475|594543070|FG006|Overall Study|Lost to Follow-up|0|||
164595184|NCT00111475|594543071|FG007|Overall Study|Lost to Follow-up|0|||
164595185|NCT00111475|594543072|FG008|Overall Study|Lost to Follow-up|0|||
164595186|NCT00111475|594543073|FG009|Overall Study|Lost to Follow-up|0|||
164595187|NCT03303092|594543074|FG000|Overall Study|Adverse Event|1|||
164595188|NCT03303092|594543075|FG001|Overall Study|Adverse Event|0|||
164595189|NCT03303092|594543076|FG002|Overall Study|Adverse Event|1|||
164595190|NCT03303092|594543074|FG000|Overall Study|Protocol Violation|1|||
164595191|NCT03303092|594543075|FG001|Overall Study|Protocol Violation|5|||
164595192|NCT03303092|594543076|FG002|Overall Study|Protocol Violation|1|||
164595193|NCT03303092|594543074|FG000|Overall Study|Withdrawal by Subject|1|||
164595194|NCT03303092|594543075|FG001|Overall Study|Withdrawal by Subject|1|||
164595195|NCT03303092|594543076|FG002|Overall Study|Withdrawal by Subject|3|||
164595196|NCT01697267|594543080|FG000|Overall Study|Death|3|||
164595197|NCT01697267|594543081|FG001|Overall Study|Death|1|||
164595198|NCT01697267|594543080|FG000|Overall Study|Withdrawal by Subject|5|||
164595199|NCT01697267|594543081|FG001|Overall Study|Withdrawal by Subject|5|||
164595200|NCT01697267|594543080|FG000|Overall Study|Adverse Event|2|||
164595201|NCT01697267|594543081|FG001|Overall Study|Adverse Event|1|||
164595202|NCT01697267|594543080|FG000|Overall Study|Lost to Follow-up|2|||
164595203|NCT01697267|594543081|FG001|Overall Study|Lost to Follow-up|4|||
164595204|NCT01697267|594543080|FG000|Overall Study|Physician Decision|2|||
164595205|NCT01697267|594543081|FG001|Overall Study|Physician Decision|4|||
164595206|NCT00833248|594543084|FG000|Overall Study|Adverse Event|3|||
164595207|NCT00833248|594543085|FG001|Overall Study|Adverse Event|0|||
164595208|NCT00833248|594543084|FG000|Overall Study|Protocol Violation|1|||
164595209|NCT00833248|594543085|FG001|Overall Study|Protocol Violation|2|||
164595210|NCT00833248|594543084|FG000|Overall Study|Withdrawal by Subject|0|||
164595211|NCT00833248|594543085|FG001|Overall Study|Withdrawal by Subject|1|||
164595212|NCT01830543|594543086|FG000|Overall Study|Subject Decision|19|||
164595213|NCT01830543|594543087|FG001|Overall Study|Subject Decision|21|||
164595214|NCT01830543|594543088|FG002|Overall Study|Subject Decision|57|||
164595215|NCT01830543|594543086|FG000|Overall Study|Adverse Event|91|||
164595216|NCT01830543|594543087|FG001|Overall Study|Adverse Event|77|||
164595217|NCT01830543|594543088|FG002|Overall Study|Adverse Event|76|||
164595218|NCT01830543|594543086|FG000|Overall Study|Death|20|||
164595219|NCT01830543|594543087|FG001|Overall Study|Death|22|||
164595220|NCT01830543|594543088|FG002|Overall Study|Death|22|||
164595221|NCT01830543|594543086|FG000|Overall Study|Protocol Violation|3|||
164595222|NCT01830543|594543087|FG001|Overall Study|Protocol Violation|7|||
164595223|NCT01830543|594543088|FG002|Overall Study|Protocol Violation|7|||
164595224|NCT01830543|594543086|FG000|Overall Study|Physician Decision|11|||
164595225|NCT01830543|594543087|FG001|Overall Study|Physician Decision|5|||
164397126|NCT03659916|593823505|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
164397127|NCT03659916|593823506|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
164397128|NCT03659916|593823507|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
164397129|NCT03659916|593823505|FG000|Treatment Period (72 Weeks)|Other|1|||
164397130|NCT03659916|593823506|FG001|Treatment Period (72 Weeks)|Other|3|||
164397131|NCT03659916|593823507|FG002|Treatment Period (72 Weeks)|Other|9|||
164397132|NCT03659916|593823505|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
164397133|NCT03659916|593823506|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
164704420|NCT03514641|594944545|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
164704421|NCT03514641|594944546|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
164704422|NCT03514641|594944547|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
164704423|NCT03514641|594944544|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
164704424|NCT03514641|594944545|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
164704425|NCT03514641|594944546|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
164704426|NCT03514641|594944547|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
164704427|NCT03514641|594944544|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
164704428|NCT03514641|594944545|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
164704429|NCT03514641|594944546|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
164704430|NCT03514641|594944547|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
164704431|NCT03514641|594944544|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
164704432|NCT03514641|594944545|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
164704433|NCT03514641|594944546|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
164704434|NCT03514641|594944547|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
164704435|NCT03514641|594944544|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
164704436|NCT03514641|594944545|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
164704437|NCT03514641|594944546|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
164704438|NCT03514641|594944547|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
164704439|NCT03514641|594944544|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
164704440|NCT03514641|594944545|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
164704441|NCT03514641|594944546|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
164704442|NCT03514641|594944547|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
164704443|NCT03514641|594944544|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
164704444|NCT03514641|594944545|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
164704445|NCT03514641|594944546|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
164704446|NCT03514641|594944547|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
164704447|NCT03514641|594944544|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
164704448|NCT03514641|594944545|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
164704449|NCT03514641|594944546|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
164704450|NCT03514641|594944547|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
164704451|NCT03514641|594944544|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
164704452|NCT03514641|594944545|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
164704453|NCT03514641|594944546|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
164704454|NCT03514641|594944547|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
164704455|NCT01345175|594944548|FG000|Overall Study|Physician Decision|0|||
164704456|NCT01345175|594944549|FG001|Overall Study|Physician Decision|1|||
164704457|NCT01345175|594944548|FG000|Overall Study|Withdrawal by Subject|1|||
164704458|NCT01345175|594944549|FG001|Overall Study|Withdrawal by Subject|1|||
164704459|NCT01345175|594944548|FG000|Overall Study|Failed to complete BFI|3|||
164704460|NCT01345175|594944549|FG001|Overall Study|Failed to complete BFI|2|||
164704461|NCT01345175|594944548|FG000|Overall Study|Stopped taking medication|2|||
164704462|NCT01345175|594944549|FG001|Overall Study|Stopped taking medication|2|||
164704463|NCT01561430|594944553|FG000|Overall Study|Adverse Event|0|||
164704464|NCT01561430|594944554|FG001|Overall Study|Adverse Event|0|||
164704465|NCT01561430|594944555|FG002|Overall Study|Adverse Event|3|||
164704466|NCT01561430|594944556|FG003|Overall Study|Adverse Event|1|||
164704467|NCT01561430|594944553|FG000|Overall Study|Withdrawal by Subject|0|||
164704468|NCT01561430|594944554|FG001|Overall Study|Withdrawal by Subject|0|||
164704469|NCT01561430|594944555|FG002|Overall Study|Withdrawal by Subject|1|||
164397134|NCT03659916|593823507|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
164397135|NCT03659916|593823505|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
164397136|NCT03659916|593823506|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
164397137|NCT03659916|593823507|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
164397138|NCT03659916|593823505|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
164397139|NCT03659916|593823506|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
164397140|NCT03659916|593823507|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
164397141|NCT03659916|593823505|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
164704470|NCT01561430|594944556|FG003|Overall Study|Withdrawal by Subject|0|||
164704471|NCT01561430|594944553|FG000|Overall Study|Physician Decision|0|||
164397142|NCT03659916|593823506|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
164397143|NCT03659916|593823507|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
164397144|NCT03659916|593823505|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
164397145|NCT03659916|593823506|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
164397146|NCT03659916|593823507|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
164397147|NCT03659916|593823505|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
164397148|NCT03659916|593823506|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
164397149|NCT03659916|593823507|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
164595226|NCT01830543|594543088|FG002|Overall Study|Physician Decision|12|||
164595227|NCT01830543|594543086|FG000|Overall Study|Withdrawal by consent|3|||
164595228|NCT01830543|594543087|FG001|Overall Study|Withdrawal by consent|3|||
164595229|NCT01830543|594543088|FG002|Overall Study|Withdrawal by consent|3|||
164595230|NCT01830543|594543086|FG000|Overall Study|Other|12|||
164595231|NCT01830543|594543087|FG001|Overall Study|Other|17|||
164595232|NCT01830543|594543088|FG002|Overall Study|Other|37|||
164595233|NCT02681055|594543091|FG000|Weeks 5-12|Adverse Event|1|||
164595234|NCT00377611|594543096|FG000|Overall Study|Adverse Event|2|||
164595235|NCT00377611|594543097|FG001|Overall Study|Adverse Event|9|||
164595236|NCT00377611|594543096|FG000|Overall Study|Protocol Violation|2|||
164595237|NCT00377611|594543097|FG001|Overall Study|Protocol Violation|0|||
164595238|NCT00377611|594543096|FG000|Overall Study|Withdrawal by Subject|0|||
164595239|NCT00377611|594543097|FG001|Overall Study|Withdrawal by Subject|5|||
164595240|NCT00377611|594543096|FG000|Overall Study|Lost to Follow-up|18|||
164595241|NCT00377611|594543097|FG001|Overall Study|Lost to Follow-up|16|||
164595242|NCT00377611|594543096|FG000|Overall Study|Other|0|||
164595243|NCT00377611|594543097|FG001|Overall Study|Other|3|||
164595244|NCT02116660|594543100|FG000|Overall Study|Deteriorating renal function|0|||
164595245|NCT02116660|594543101|FG001|Overall Study|Deteriorating renal function|1|||
164595246|NCT02116660|594543100|FG000|Overall Study|Adverse Event|1|||
164595247|NCT02116660|594543101|FG001|Overall Study|Adverse Event|1|||
164595248|NCT02116660|594543100|FG000|Overall Study|Withdrawal by Subject|0|||
164595249|NCT02116660|594543101|FG001|Overall Study|Withdrawal by Subject|2|||
164595250|NCT02116660|594543100|FG000|Overall Study|Organization reason|1|||
164595251|NCT02116660|594543101|FG001|Overall Study|Organization reason|0|||
164595252|NCT02561299|594543104|FG000|Overall Study|Death|2|||
164595253|NCT02561299|594543105|FG001|Overall Study|Death|4|||
164595254|NCT02561299|594543104|FG000|Overall Study|Lost to Follow-up|1|||
164595255|NCT02561299|594543105|FG001|Overall Study|Lost to Follow-up|0|||
164595256|NCT02561299|594543104|FG000|Overall Study|Withdrawal by Subject|2|||
164595257|NCT02561299|594543105|FG001|Overall Study|Withdrawal by Subject|2|||
164595258|NCT02345252|594543112|FG000|Double-Blind Phase|Adverse Event|2|||
164595259|NCT02345252|594543113|FG001|Double-Blind Phase|Adverse Event|3|||
164595260|NCT02345252|594543112|FG000|Double-Blind Phase|Death|1|||
164595261|NCT02345252|594543113|FG001|Double-Blind Phase|Death|2|||
164595262|NCT02345252|594543112|FG000|Double-Blind Phase|Lack of Efficacy|1|||
164595263|NCT02345252|594543113|FG001|Double-Blind Phase|Lack of Efficacy|0|||
164595264|NCT02345252|594543112|FG000|Double-Blind Phase|Investigator's Discretion|4|||
164595265|NCT02345252|594543113|FG001|Double-Blind Phase|Investigator's Discretion|6|||
164595266|NCT02345252|594543112|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
164595267|NCT02345252|594543113|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
164595268|NCT02345252|594543112|FG000|Double-Blind Phase|Protocol Violation|2|||
164595269|NCT02345252|594543113|FG001|Double-Blind Phase|Protocol Violation|1|||
164595270|NCT02345252|594543112|FG000|Double-Blind Phase|Withdrew Consent|21|||
164595271|NCT02345252|594543113|FG001|Double-Blind Phase|Withdrew Consent|23|||
164595272|NCT02345252|594543112|FG000|Double-Blind Phase|Lost to Follow-up|8|||
164595273|NCT02345252|594543113|FG001|Double-Blind Phase|Lost to Follow-up|10|||
164595274|NCT02345252|594543112|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
164595275|NCT02345252|594543113|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
164595276|NCT02864940|594543120|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
164595277|NCT02864940|594543121|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
164595278|NCT02702193|594543122|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
164595279|NCT02702193|594543123|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
164595280|NCT02702193|594543122|FG000|4 Month Follow up|Withdrawal by Subject|1|||
164595281|NCT02702193|594543123|FG001|4 Month Follow up|Withdrawal by Subject|0|||
164595282|NCT02702193|594543122|FG000|4 Month Follow up|Lost to Follow-up|17|||
164595283|NCT02702193|594543123|FG001|4 Month Follow up|Lost to Follow-up|18|||
164595284|NCT02702193|594543122|FG000|8 Month Follow up|Withdrawal by Subject|1|||
164595285|NCT02702193|594543123|FG001|8 Month Follow up|Withdrawal by Subject|0|||
164595286|NCT02702193|594543122|FG000|8 Month Follow up|Lost to Follow-up|14|||
164595287|NCT02702193|594543123|FG001|8 Month Follow up|Lost to Follow-up|18|||
164595288|NCT02702193|594543122|FG000|12 Month Follow up|Withdrawal by Subject|1|||
164595289|NCT02702193|594543123|FG001|12 Month Follow up|Withdrawal by Subject|0|||
164595290|NCT02702193|594543122|FG000|12 Month Follow up|Lost to Follow-up|16|||
164595291|NCT02702193|594543123|FG001|12 Month Follow up|Lost to Follow-up|18|||
164595292|NCT04285346|594543126|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
164595293|NCT04285346|594543127|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
164595294|NCT04285346|594543126|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
164595295|NCT04285346|594543127|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
164595296|NCT04285346|594543126|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
164595297|NCT04285346|594543127|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
164595298|NCT00610935|594543128|FG000|Overall Study|Lost to Follow-up|0|||
164595299|NCT00610935|594543129|FG001|Overall Study|Lost to Follow-up|1|||
164595300|NCT00610935|594543128|FG000|Overall Study|Withdrawal by Subject|0|||
164595301|NCT00610935|594543129|FG001|Overall Study|Withdrawal by Subject|2|||
164595302|NCT00610935|594543128|FG000|Overall Study|Sponsor Discontinuation|1|||
164595303|NCT00610935|594543129|FG001|Overall Study|Sponsor Discontinuation|0|||
164595304|NCT04360187|594543130|FG000|Double-Blind Treatment|Adverse Event|9|||
164595305|NCT04360187|594543131|FG001|Double-Blind Treatment|Adverse Event|11|||
164595306|NCT04360187|594543130|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
164595307|NCT04360187|594543131|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
164595308|NCT04360187|594543130|FG000|Double-Blind Treatment|Physician Decision|1|||
164595309|NCT04360187|594543131|FG001|Double-Blind Treatment|Physician Decision|0|||
164595310|NCT04360187|594543130|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
164595311|NCT04360187|594543131|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
164595312|NCT04360187|594543130|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
164595313|NCT04360187|594543131|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
164595314|NCT04360187|594543130|FG000|Follow-Up|Lost to Follow-up|1|||
164595315|NCT04360187|594543131|FG001|Follow-Up|Lost to Follow-up|0|||
164595316|NCT02399813|594543132|FG000|Overall Study|Progressive Disease-Radiographic|2|||
164595317|NCT02399813|594543132|FG000|Overall Study|Death|20|||
164595318|NCT02399813|594543132|FG000|Overall Study|Withdrawal by Subject|3|||
164595319|NCT02399813|594543132|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
164595320|NCT02399813|594543132|FG000|Overall Study|Lost to Follow-up|2|||
164595321|NCT02399813|594543132|FG000|Overall Study|Other than specified|5|||
164595322|NCT05372575|594543133|FG000|Overall Study|Protocol Violation|7|||
164595323|NCT05372575|594543134|FG001|Overall Study|Protocol Violation|16|||
164595324|NCT02203838|594543137|FG000|Overall Study|Lack of Efficacy|7|||
164595325|NCT02203838|594543138|FG001|Overall Study|Lack of Efficacy|0|||
164595326|NCT02203838|594543139|FG002|Overall Study|Lack of Efficacy|1|||
164595327|NCT02203838|594543140|FG003|Overall Study|Lack of Efficacy|1|||
164595328|NCT02203838|594543137|FG000|Overall Study|Adverse Event|46|||
164595329|NCT02203838|594543138|FG001|Overall Study|Adverse Event|6|||
164595330|NCT02203838|594543139|FG002|Overall Study|Adverse Event|3|||
164595331|NCT02203838|594543140|FG003|Overall Study|Adverse Event|2|||
164595332|NCT02203838|594543137|FG000|Overall Study|Lost to Follow-up|39|||
164595333|NCT02203838|594543138|FG001|Overall Study|Lost to Follow-up|3|||
164595334|NCT02203838|594543139|FG002|Overall Study|Lost to Follow-up|2|||
164704472|NCT01561430|594944554|FG001|Overall Study|Physician Decision|1|||
164704473|NCT01561430|594944555|FG002|Overall Study|Physician Decision|0|||
164704474|NCT01561430|594944556|FG003|Overall Study|Physician Decision|0|||
164704475|NCT01561430|594944553|FG000|Overall Study|Sponsor Decision|1|||
164704476|NCT01561430|594944554|FG001|Overall Study|Sponsor Decision|14|||
164704477|NCT01561430|594944555|FG002|Overall Study|Sponsor Decision|13|||
164704478|NCT01561430|594944556|FG003|Overall Study|Sponsor Decision|12|||
164704479|NCT04112173|594944557|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
164704480|NCT03347422|594944558|FG000|Part A (26 Weeks)|Adverse Event|3|||
164704481|NCT03347422|594944559|FG001|Part A (26 Weeks)|Adverse Event|0|||
164704482|NCT03347422|594944558|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
164704483|NCT03347422|594944559|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
164704484|NCT03347422|594944558|FG000|Part B (149 Weeks)|Adverse Event|0|||
164704485|NCT03347422|594944559|FG001|Part B (149 Weeks)|Adverse Event|1|||
164704486|NCT03347422|594944558|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
164704487|NCT03347422|594944559|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
164704488|NCT03347422|594944558|FG000|Part B (149 Weeks)|Other|1|||
164704489|NCT03347422|594944559|FG001|Part B (149 Weeks)|Other|0|||
164704490|NCT04234984|594944571|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
164704491|NCT04234984|594944571|FG000|Follow-up at the Second Time Point|Death|1|||
164704492|NCT04234984|594944571|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
164704493|NCT01055132|594944572|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
164704494|NCT01055132|594944573|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
164704495|NCT01055132|594944572|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
164704496|NCT01055132|594944573|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
164704497|NCT00158600|594944574|FG000|Overall Study|unable to commit time to study|0|||
164704498|NCT00158600|594944575|FG001|Overall Study|unable to commit time to study|1|||
164704499|NCT00158600|594944574|FG000|Overall Study|Adverse Event|2|||
164704500|NCT00158600|594944575|FG001|Overall Study|Adverse Event|1|||
164704501|NCT00158600|594944574|FG000|Overall Study|Death|1|||
164704502|NCT00158600|594944575|FG001|Overall Study|Death|0|||
164704503|NCT00158600|594944574|FG000|Overall Study|Withdrawal by Subject|2|||
164704504|NCT00158600|594944575|FG001|Overall Study|Withdrawal by Subject|2|||
164704505|NCT02570113|594944576|FG000|Overall Study|Withdrawal by Subject|3|||
164704506|NCT02038907|594944577|FG000|Overall Study|Protocol Violation|0|||
164704507|NCT02038907|594944578|FG001|Overall Study|Protocol Violation|0|||
164704508|NCT02038907|594944579|FG002|Overall Study|Protocol Violation|0|||
164704509|NCT02038907|594944580|FG003|Overall Study|Protocol Violation|0|||
164704510|NCT02038907|594944581|FG004|Overall Study|Protocol Violation|0|||
164704511|NCT02038907|594944582|FG005|Overall Study|Protocol Violation|0|||
164704512|NCT02038907|594944583|FG006|Overall Study|Protocol Violation|0|||
164704513|NCT02038907|594944584|FG007|Overall Study|Protocol Violation|0|||
164704514|NCT02038907|594944585|FG008|Overall Study|Protocol Violation|0|||
164704515|NCT02038907|594944586|FG009|Overall Study|Protocol Violation|0|||
164704516|NCT02038907|594944587|FG010|Overall Study|Protocol Violation|1|||
164704517|NCT02038907|594944588|FG011|Overall Study|Protocol Violation|0|||
164704518|NCT02038907|594944589|FG012|Overall Study|Protocol Violation|0|||
164704519|NCT02038907|594944590|FG013|Overall Study|Protocol Violation|0|||
164704520|NCT02038907|594944577|FG000|Overall Study|Withdrawal by Subject|0|||
164704521|NCT02038907|594944578|FG001|Overall Study|Withdrawal by Subject|0|||
164704522|NCT02038907|594944579|FG002|Overall Study|Withdrawal by Subject|0|||
164704523|NCT02038907|594944580|FG003|Overall Study|Withdrawal by Subject|0|||
164704524|NCT02038907|594944581|FG004|Overall Study|Withdrawal by Subject|0|||
164704525|NCT02038907|594944582|FG005|Overall Study|Withdrawal by Subject|0|||
164704526|NCT02038907|594944583|FG006|Overall Study|Withdrawal by Subject|0|||
164704527|NCT02038907|594944584|FG007|Overall Study|Withdrawal by Subject|0|||
164704528|NCT02038907|594944585|FG008|Overall Study|Withdrawal by Subject|0|||
164704529|NCT02038907|594944586|FG009|Overall Study|Withdrawal by Subject|0|||
164704530|NCT02038907|594944587|FG010|Overall Study|Withdrawal by Subject|1|||
164704531|NCT02038907|594944588|FG011|Overall Study|Withdrawal by Subject|0|||
164704532|NCT02038907|594944589|FG012|Overall Study|Withdrawal by Subject|0|||
164704533|NCT02038907|594944590|FG013|Overall Study|Withdrawal by Subject|0|||
164704534|NCT02746471|594944591|FG000|Overall Study|Death|43|||
164704535|NCT02746471|594944591|FG000|Overall Study|Exited before 36 months|1119|||
164704536|NCT02564211|594944592|FG000|Overall Study|Adverse Event|4|||
164704537|NCT00910091|594944594|FG000|Pre-assignment|Withdrawal by Subject|0|||
164704538|NCT00910091|594944595|FG001|Pre-assignment|Withdrawal by Subject|2|||
164704539|NCT00910091|594944594|FG000|Treatment and Survival|Withdrawal by Subject|3|||
164704540|NCT00910091|594944595|FG001|Treatment and Survival|Withdrawal by Subject|4|||
164704541|NCT00910091|594944594|FG000|Treatment and Survival|Adverse Event|1|||
164704542|NCT00910091|594944595|FG001|Treatment and Survival|Adverse Event|0|||
164704543|NCT00622466|594944600|FG000|Overall Study|Death|1|||
164704544|NCT00622466|594944600|FG000|Overall Study|Adverse Event|1|||
164704545|NCT00622466|594944600|FG000|Overall Study|Withdrawal by Subject|2|||
164704546|NCT01908816|594944603|FG000|Overall Study|Subject's no longer requires study drug|0|||
164704547|NCT01908816|594944604|FG001|Overall Study|Subject's no longer requires study drug|0|||
164704548|NCT01908816|594944605|FG002|Overall Study|Subject's no longer requires study drug|0|||
164704549|NCT01908816|594944606|FG003|Overall Study|Subject's no longer requires study drug|1|||
164704550|NCT01908816|594944603|FG000|Overall Study|Protocol deviation|1|||
164704551|NCT01908816|594944604|FG001|Overall Study|Protocol deviation|2|||
164704552|NCT01908816|594944605|FG002|Overall Study|Protocol deviation|1|||
164704553|NCT01908816|594944606|FG003|Overall Study|Protocol deviation|1|||
164704554|NCT01908816|594944603|FG000|Overall Study|Withdrawal by Subject|0|||
164704555|NCT01908816|594944604|FG001|Overall Study|Withdrawal by Subject|4|||
164704556|NCT01908816|594944605|FG002|Overall Study|Withdrawal by Subject|2|||
164704557|NCT01908816|594944606|FG003|Overall Study|Withdrawal by Subject|2|||
164704558|NCT01908816|594944603|FG000|Overall Study|Lost to Follow-up|3|||
164442053|NCT00588770|593985624|FG000|Overall Study|Disease progression|85|||
164442054|NCT00588770|593985625|FG001|Overall Study|Disease progression|68|||
164704559|NCT01908816|594944604|FG001|Overall Study|Lost to Follow-up|5|||
164704560|NCT01908816|594944605|FG002|Overall Study|Lost to Follow-up|4|||
164704561|NCT01908816|594944606|FG003|Overall Study|Lost to Follow-up|2|||
164704562|NCT01908816|594944603|FG000|Overall Study|Death|1|||
164704563|NCT01908816|594944604|FG001|Overall Study|Death|0|||
164704564|NCT01908816|594944605|FG002|Overall Study|Death|7|||
164442055|NCT00588770|593985624|FG000|Overall Study|Adverse Event|29|||
164442056|NCT00588770|593985625|FG001|Overall Study|Adverse Event|58|||
164704565|NCT01908816|594944606|FG003|Overall Study|Death|1|||
164704566|NCT01908816|594944603|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164704567|NCT01908816|594944604|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
164704568|NCT01908816|594944605|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
164704569|NCT01908816|594944606|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
164704570|NCT01908816|594944603|FG000|Overall Study|Early termination|87|||
164704571|NCT01908816|594944604|FG001|Overall Study|Early termination|60|||
164704572|NCT01908816|594944605|FG002|Overall Study|Early termination|43|||
164704573|NCT01908816|594944606|FG003|Overall Study|Early termination|28|||
164704574|NCT02618408|594944608|FG000|Overall Study|Withdrawal by Subject|1|||
164704575|NCT02618408|594944609|FG001|Overall Study|Withdrawal by Subject|0|||
164704576|NCT02618408|594944610|FG002|Overall Study|Withdrawal by Subject|4|||
164595335|NCT02203838|594543140|FG003|Overall Study|Lost to Follow-up|1|||
164595336|NCT02203838|594543137|FG000|Overall Study|Protocol Violation|7|||
164595337|NCT02203838|594543138|FG001|Overall Study|Protocol Violation|3|||
164595338|NCT02203838|594543139|FG002|Overall Study|Protocol Violation|0|||
164704577|NCT02618408|594944608|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
164704578|NCT02618408|594944609|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
164704579|NCT02618408|594944610|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
164704580|NCT02618408|594944608|FG000|Overall Study|Lost to Follow-up|4|||
164704581|NCT02618408|594944609|FG001|Overall Study|Lost to Follow-up|2|||
164704582|NCT02618408|594944610|FG002|Overall Study|Lost to Follow-up|6|||
164704583|NCT02618408|594944608|FG000|Overall Study|Adverse Event|4|||
164704584|NCT02618408|594944609|FG001|Overall Study|Adverse Event|0|||
164704585|NCT02618408|594944610|FG002|Overall Study|Adverse Event|10|||
164704586|NCT02618408|594944608|FG000|Overall Study|Physician Decision|1|||
164704587|NCT02618408|594944609|FG001|Overall Study|Physician Decision|1|||
164704588|NCT02618408|594944610|FG002|Overall Study|Physician Decision|2|||
164704589|NCT02618408|594944608|FG000|Overall Study|Protocol Violation|1|||
164704590|NCT02618408|594944609|FG001|Overall Study|Protocol Violation|1|||
164704591|NCT02618408|594944610|FG002|Overall Study|Protocol Violation|2|||
164704592|NCT02618408|594944608|FG000|Overall Study|Other, Multiple Categories|0|||
164704593|NCT02618408|594944609|FG001|Overall Study|Other, Multiple Categories|0|||
164704594|NCT02618408|594944610|FG002|Overall Study|Other, Multiple Categories|4|||
164704595|NCT05183217|594944614|FG000|Overall Study|Withdrawal by Subject|1|||
164704596|NCT05183217|594944615|FG001|Overall Study|Withdrawal by Subject|1|||
164704597|NCT03914950|594944617|FG000|Overall Study|Physician Decision|54|||
164704598|NCT03397771|594944620|FG000|Overall Study|2 erroneously randomized, never treated|3|||
164704599|NCT03397771|594944621|FG001|Overall Study|2 erroneously randomized, never treated|1|||
164704600|NCT03397771|594944620|FG000|Overall Study|Withdrawal by Subject|1|||
164595339|NCT02203838|594543140|FG003|Overall Study|Protocol Violation|0|||
164595340|NCT02203838|594543137|FG000|Overall Study|Withdrawal by Subject|83|||
164595341|NCT02203838|594543138|FG001|Overall Study|Withdrawal by Subject|10|||
164595342|NCT02203838|594543139|FG002|Overall Study|Withdrawal by Subject|8|||
164595343|NCT02203838|594543140|FG003|Overall Study|Withdrawal by Subject|11|||
164595344|NCT02203838|594543137|FG000|Overall Study|Physician Decision|27|||
164595345|NCT02203838|594543138|FG001|Overall Study|Physician Decision|0|||
164595346|NCT02203838|594543139|FG002|Overall Study|Physician Decision|2|||
164595347|NCT02203838|594543140|FG003|Overall Study|Physician Decision|3|||
164595348|NCT02203838|594543137|FG000|Overall Study|Other|1|||
164595349|NCT02203838|594543138|FG001|Overall Study|Other|0|||
164595350|NCT02203838|594543139|FG002|Overall Study|Other|0|||
164595351|NCT02203838|594543140|FG003|Overall Study|Other|0|||
164595352|NCT03345836|594543143|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
164704601|NCT03397771|594944621|FG001|Overall Study|Withdrawal by Subject|3|||
164704602|NCT03397771|594944620|FG000|Overall Study|Protocol Violation|2|||
164704603|NCT03397771|594944621|FG001|Overall Study|Protocol Violation|2|||
164595353|NCT03345836|594543144|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
164595354|NCT03345836|594543145|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
164595355|NCT03345836|594543146|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
164595356|NCT03345836|594543147|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
164595357|NCT03345836|594543148|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
164595358|NCT03345836|594543143|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
164595359|NCT03345836|594543144|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
164595360|NCT03345836|594543145|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
164595361|NCT03345836|594543146|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
164595362|NCT03345836|594543147|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
164595363|NCT03345836|594543148|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
164595364|NCT03345836|594543143|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
164595365|NCT03345836|594543144|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
164595366|NCT03345836|594543145|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
164595367|NCT03345836|594543146|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
164704604|NCT03397771|594944620|FG000|Overall Study|Adverse Event|2|||
164704605|NCT03397771|594944621|FG001|Overall Study|Adverse Event|1|||
164595368|NCT03345836|594543147|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
164595369|NCT03345836|594543148|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
164595370|NCT03345836|594543143|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
164595371|NCT03345836|594543144|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
164704606|NCT02669758|594944622|FG000|Overall Study|Withdrawal by Subject|43|||
164704607|NCT02669758|594944622|FG000|Overall Study|Lost to Follow-up|19|||
164704608|NCT02669758|594944622|FG000|Overall Study|Adverse Event|16|||
164704609|NCT02669758|594944622|FG000|Overall Study|Non-Compliance with Study Drug|8|||
164704610|NCT02669758|594944622|FG000|Overall Study|Lack of Efficacy|5|||
164704611|NCT02669758|594944622|FG000|Overall Study|Pregnancy|1|||
164704612|NCT02669758|594944622|FG000|Overall Study|Study noncompliance|1|||
164704613|NCT02669758|594944622|FG000|Overall Study|Protocol Violation|1|||
164397227|NCT03003468|593823546|FG000|Overall Study|Withdrawal by Subject|0|||
164397228|NCT03003468|593823547|FG001|Overall Study|Withdrawal by Subject|0|||
164397229|NCT03003468|593823548|FG002|Overall Study|Withdrawal by Subject|1|||
164397230|NCT03003468|593823546|FG000|Overall Study|No measurable lesions|0|||
164397231|NCT03003468|593823547|FG001|Overall Study|No measurable lesions|0|||
164397232|NCT03003468|593823548|FG002|Overall Study|No measurable lesions|1|||
164397267|NCT06286332|593823559|FG000|Overall Study|Death|1|||
164397268|NCT06286332|593823560|FG001|Overall Study|Death|2|||
164397269|NCT06286332|593823559|FG000|Overall Study|Transfer to ICU|2|||
164397270|NCT06286332|593823560|FG001|Overall Study|Transfer to ICU|0|||
164397281|NCT06070987|593823564|FG000|first treatment|Withdrawal by Subject|1|||
164397282|NCT06070987|593823565|FG001|first treatment|Withdrawal by Subject|0|||
164397283|NCT06070987|593823564|FG000|first treatment|Lost to Follow-up|1|||
164397284|NCT06070987|593823565|FG001|first treatment|Lost to Follow-up|1|||
164397285|NCT06070987|593823564|FG000|first treatment|Protocol Violation|1|||
164397286|NCT06070987|593823565|FG001|first treatment|Protocol Violation|1|||
164704614|NCT03393806|594944623|FG000|Overall Study|Physician Decision|1|||
164704615|NCT03393806|594944624|FG001|Overall Study|Physician Decision|0|||
164704616|NCT01259115|594944625|FG000|Period 1|Adverse Event|1|||
164397287|NCT06070987|593823564|FG000|wash out|did not participate in second treatment|2|||
164397288|NCT06070987|593823565|FG001|wash out|did not participate in second treatment|2|||
164397289|NCT06070987|593823564|FG000|second treatment|Withdrawal by Subject|1|||
164397290|NCT06070987|593823565|FG001|second treatment|Withdrawal by Subject|0|||
164397291|NCT06070987|593823564|FG000|second treatment|Lost to Follow-up|1|||
164704617|NCT01259115|594944626|FG001|Period 1|Adverse Event|0|||
164704618|NCT01259115|594944625|FG000|Period 1|Protocol Violation|2|||
164704619|NCT01259115|594944626|FG001|Period 1|Protocol Violation|0|||
164704620|NCT01259115|594944625|FG000|Period 1|Lost to Follow-up|0|||
164442057|NCT00588770|593985624|FG000|Overall Study|Death|13|||
164442058|NCT00588770|593985625|FG001|Overall Study|Death|22|||
164442059|NCT00588770|593985624|FG000|Overall Study|Withdrawal by Subject|15|||
164442060|NCT00588770|593985625|FG001|Overall Study|Withdrawal by Subject|25|||
164442061|NCT00588770|593985624|FG000|Overall Study|Alternative therapy|2|||
164442062|NCT00588770|593985625|FG001|Overall Study|Alternative therapy|4|||
164442063|NCT00588770|593985624|FG000|Overall Study|Other complicating disease|3|||
164442064|NCT00588770|593985625|FG001|Overall Study|Other complicating disease|2|||
164442065|NCT00588770|593985624|FG000|Overall Study|Not start protocol therapy|0|||
164442066|NCT00588770|593985625|FG001|Overall Study|Not start protocol therapy|9|||
164442067|NCT00588770|593985624|FG000|Overall Study|Lack of Efficacy|8|||
164442068|NCT00588770|593985625|FG001|Overall Study|Lack of Efficacy|10|||
164442069|NCT00588770|593985624|FG000|Overall Study|Physician discretion|2|||
164442070|NCT00588770|593985625|FG001|Overall Study|Physician discretion|0|||
164442071|NCT00588770|593985624|FG000|Overall Study|Patient non-compliance|2|||
164442072|NCT00588770|593985625|FG001|Overall Study|Patient non-compliance|2|||
164442073|NCT04697628|593985626|FG000|Overall Study|Withdrawal by Subject|17|||
164442074|NCT04697628|593985627|FG001|Overall Study|Withdrawal by Subject|23|||
164442075|NCT04697628|593985626|FG000|Overall Study|Lost to Follow-up|0|||
164442076|NCT04697628|593985627|FG001|Overall Study|Lost to Follow-up|4|||
164442077|NCT04697628|593985626|FG000|Overall Study|On-going in study|122|||
164442078|NCT04697628|593985627|FG001|Overall Study|On-going in study|91|||
164442079|NCT01582269|593985628|FG000|Overall Study|Withdrawal by Subject|1|||
164442080|NCT01582269|593985629|FG001|Overall Study|Withdrawal by Subject|0|||
164442081|NCT01582269|593985630|FG002|Overall Study|Withdrawal by Subject|0|||
164442082|NCT00617201|593985635|FG000|Overall Study|Lost to Follow-up|9|||
164442083|NCT00617201|593985636|FG001|Overall Study|Lost to Follow-up|13|||
164442084|NCT05644444|593986414|FG000|Tolerance Phase|Adverse Event|0|||
164442085|NCT05644444|593986415|FG001|Tolerance Phase|Adverse Event|2|||
164442086|NCT05644444|593986414|FG000|Treatment Phase|Adverse Event|0|||
164442087|NCT05644444|593986415|FG001|Treatment Phase|Adverse Event|2|||
164442088|NCT03723616|593986417|FG000|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|17|||
164442089|NCT03723616|593986418|FG001|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|16|||
164442090|NCT03723616|593986419|FG002|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|20|||
164442091|NCT03723616|593986420|FG003|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|6|||
164442092|NCT03723616|593986421|FG004|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
164397292|NCT06070987|593823565|FG001|second treatment|Lost to Follow-up|1|||
164704621|NCT01259115|594944626|FG001|Period 1|Lost to Follow-up|1|||
164704622|NCT01259115|594944625|FG000|Period 2|Adverse Event|1|||
164704623|NCT01259115|594944626|FG001|Period 2|Adverse Event|0|||
164704624|NCT00762437|594944629|FG000|Overall Study|Lost to Follow-up|7|||
164704625|NCT00762437|594944629|FG000|Overall Study|Missed final study visit|11|||
164704626|NCT00762437|594944629|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
164704627|NCT04480021|594944633|FG000|Overall Study|Lost to Follow-up|3|||
164704628|NCT04480021|594944634|FG001|Overall Study|Lost to Follow-up|4|||
164704629|NCT01229735|594944635|FG000|Overall Study|Lack of Efficacy|8|||
164704630|NCT01229735|594944636|FG001|Overall Study|Lack of Efficacy|8|||
164704631|NCT01229735|594944635|FG000|Overall Study|Protocol Violation|13|||
164704632|NCT01229735|594944636|FG001|Overall Study|Protocol Violation|8|||
164704633|NCT01229735|594944635|FG000|Overall Study|Lost to Follow-up|0|||
164704634|NCT01229735|594944636|FG001|Overall Study|Lost to Follow-up|2|||
164704635|NCT01229735|594944635|FG000|Overall Study|Withdrawal by Subject|18|||
164704636|NCT01229735|594944636|FG001|Overall Study|Withdrawal by Subject|17|||
164704637|NCT01229735|594944635|FG000|Overall Study|Other Reason|13|||
164704638|NCT01229735|594944636|FG001|Overall Study|Other Reason|10|||
164704639|NCT01229735|594944635|FG000|Overall Study|SAE, non-fatal|0|||
164704640|NCT01229735|594944636|FG001|Overall Study|SAE, non-fatal|4|||
164704641|NCT01229735|594944635|FG000|Overall Study|AE, non-serious non-fatal|13|||
164704642|NCT01229735|594944636|FG001|Overall Study|AE, non-serious non-fatal|17|||
164704643|NCT01229735|594944635|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
164704644|NCT01229735|594944636|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
164704645|NCT02685202|594944637|FG000|Overall Study|Lost to Follow-up|9|||
164704646|NCT02130882|594944638|FG000|Overall Study|Withdrawal by Subject|0|||
164704647|NCT02130882|594944639|FG001|Overall Study|Withdrawal by Subject|1|||
164704648|NCT02987959|594944644|FG000|Overall Study|Grantor stopped supply of drugs|6|||
164704649|NCT04453202|594944645|FG000|Overall Study|Adverse Event|0|||
164704650|NCT04453202|594944646|FG001|Overall Study|Adverse Event|0|||
164704651|NCT04453202|594944647|FG002|Overall Study|Adverse Event|0|||
164704652|NCT04453202|594944648|FG003|Overall Study|Adverse Event|0|||
164704653|NCT04453202|594944649|FG004|Overall Study|Adverse Event|0|||
164704654|NCT04453202|594944650|FG005|Overall Study|Adverse Event|0|||
164704655|NCT04453202|594944651|FG006|Overall Study|Adverse Event|1|||
164704656|NCT04453202|594944652|FG007|Overall Study|Adverse Event|0|||
164704657|NCT04453202|594944653|FG008|Overall Study|Adverse Event|0|||
164704658|NCT04453202|594944654|FG009|Overall Study|Adverse Event|0|||
164704659|NCT04453202|594944655|FG010|Overall Study|Adverse Event|0|||
164704660|NCT04453202|594944645|FG000|Overall Study|Death|0|||
164704661|NCT04453202|594944646|FG001|Overall Study|Death|0|||
164704662|NCT04453202|594944647|FG002|Overall Study|Death|0|||
164704663|NCT04453202|594944648|FG003|Overall Study|Death|0|||
164704664|NCT04453202|594944649|FG004|Overall Study|Death|0|||
164704665|NCT04453202|594944650|FG005|Overall Study|Death|0|||
164704666|NCT04453202|594944651|FG006|Overall Study|Death|0|||
164704667|NCT04453202|594944652|FG007|Overall Study|Death|0|||
164704668|NCT04453202|594944653|FG008|Overall Study|Death|0|||
164704669|NCT04453202|594944654|FG009|Overall Study|Death|1|||
164704670|NCT04453202|594944655|FG010|Overall Study|Death|0|||
164704671|NCT04453202|594944645|FG000|Overall Study|Lost to Follow-up|0|||
164704672|NCT04453202|594944646|FG001|Overall Study|Lost to Follow-up|1|||
164704673|NCT04453202|594944647|FG002|Overall Study|Lost to Follow-up|0|||
164704674|NCT04453202|594944648|FG003|Overall Study|Lost to Follow-up|1|||
164704675|NCT04453202|594944649|FG004|Overall Study|Lost to Follow-up|0|||
164704676|NCT04453202|594944650|FG005|Overall Study|Lost to Follow-up|0|||
164704677|NCT04453202|594944651|FG006|Overall Study|Lost to Follow-up|0|||
164704678|NCT04453202|594944652|FG007|Overall Study|Lost to Follow-up|0|||
164704679|NCT04453202|594944653|FG008|Overall Study|Lost to Follow-up|0|||
164704680|NCT04453202|594944654|FG009|Overall Study|Lost to Follow-up|1|||
164704681|NCT04453202|594944655|FG010|Overall Study|Lost to Follow-up|1|||
164704682|NCT04453202|594944645|FG000|Overall Study|Withdrawal by Subject|1|||
164704683|NCT04453202|594944646|FG001|Overall Study|Withdrawal by Subject|2|||
164442093|NCT03723616|593986422|FG005|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
164442094|NCT00493649|593986425|FG000|Overall Study|Adverse Event|44|||
164442095|NCT00493649|593986425|FG000|Overall Study|Patient Request|21|||
164442096|NCT00493649|593986425|FG000|Overall Study|Investigator Request|2|||
164442097|NCT00493649|593986425|FG000|Overall Study|Disease Progression|1|||
164442098|NCT00493649|593986425|FG000|Overall Study|Lost to Follow-up|1|||
164442099|NCT00493649|593986425|FG000|Overall Study|Other|13|||
164442100|NCT00683696|593986426|FG000|Overall Study|Withdrawn due to study closure|337|||
164442101|NCT00683696|593986427|FG001|Overall Study|Withdrawn due to study closure|338|||
164442102|NCT00683696|593986426|FG000|Overall Study|Withdrawn prior to study closure|13|||
164442103|NCT00683696|593986427|FG001|Overall Study|Withdrawn prior to study closure|28|||
164442104|NCT00683696|593986426|FG000|Overall Study|Lost to Follow-up|5|||
164442105|NCT00683696|593986427|FG001|Overall Study|Lost to Follow-up|6|||
164442106|NCT00683696|593986426|FG000|Overall Study|Vital status follow-up only|3|||
164442107|NCT00683696|593986427|FG001|Overall Study|Vital status follow-up only|3|||
164442108|NCT00683696|593986426|FG000|Overall Study|Death|46|||
164442109|NCT00683696|593986427|FG001|Overall Study|Death|30|||
164442110|NCT00818454|593986439|FG000|Treatment Period 1|Adverse Event|0|||
164442111|NCT00818454|593986440|FG001|Treatment Period 1|Adverse Event|1|||
164442112|NCT00818454|593986441|FG002|Treatment Period 1|Adverse Event|0|||
164442113|NCT00818454|593986442|FG003|Treatment Period 1|Adverse Event|0|||
164442114|NCT00818454|593986439|FG000|Treatment Period 1|Other|3|||
164442115|NCT00818454|593986440|FG001|Treatment Period 1|Other|0|||
164442116|NCT00818454|593986441|FG002|Treatment Period 1|Other|0|||
164442117|NCT00818454|593986442|FG003|Treatment Period 1|Other|0|||
164442118|NCT00818454|593986439|FG000|Washout Period of 1 Week|Adverse Event|1|||
164442119|NCT00818454|593986440|FG001|Washout Period of 1 Week|Adverse Event|1|||
164442120|NCT00818454|593986441|FG002|Washout Period of 1 Week|Adverse Event|0|||
164442121|NCT00818454|593986442|FG003|Washout Period of 1 Week|Adverse Event|0|||
164442122|NCT00818454|593986439|FG000|Washout Period of 1 Week|Protocol Violation|2|||
164442123|NCT00818454|593986440|FG001|Washout Period of 1 Week|Protocol Violation|0|||
164442124|NCT00818454|593986441|FG002|Washout Period of 1 Week|Protocol Violation|0|||
164442125|NCT00818454|593986442|FG003|Washout Period of 1 Week|Protocol Violation|0|||
164442126|NCT00818454|593986439|FG000|Washout Period of 1 Week|Other|1|||
164442127|NCT00818454|593986440|FG001|Washout Period of 1 Week|Other|2|||
164442128|NCT00818454|593986441|FG002|Washout Period of 1 Week|Other|0|||
164442129|NCT00818454|593986442|FG003|Washout Period of 1 Week|Other|0|||
164442130|NCT00818454|593986439|FG000|Treatment Period 2|Other|2|||
164442131|NCT00818454|593986440|FG001|Treatment Period 2|Other|1|||
164442132|NCT00818454|593986441|FG002|Treatment Period 2|Other|0|||
164442133|NCT00818454|593986442|FG003|Treatment Period 2|Other|0|||
164442134|NCT00818454|593986439|FG000|Treatment Period 3|Adverse Event|0|||
164442135|NCT00818454|593986440|FG001|Treatment Period 3|Adverse Event|0|||
164442136|NCT00818454|593986441|FG002|Treatment Period 3|Adverse Event|0|||
164442137|NCT00818454|593986442|FG003|Treatment Period 3|Adverse Event|1|||
164442138|NCT03454529|593986447|FG000|Overall Study|Did not receive treatment|6|||
164442139|NCT03454529|593986447|FG000|Overall Study|Received < 80% doses|1|||
164442140|NCT01040689|593986449|FG000|Overall Study|Adverse Event|0|||
164442141|NCT01040689|593986450|FG001|Overall Study|Adverse Event|0|||
164442142|NCT01040689|593986451|FG002|Overall Study|Adverse Event|2|||
164442143|NCT01040689|593986452|FG003|Overall Study|Adverse Event|4|||
164442144|NCT01040689|593986449|FG000|Overall Study|Lack of Efficacy|0|||
164442145|NCT01040689|593986450|FG001|Overall Study|Lack of Efficacy|0|||
164442146|NCT01040689|593986451|FG002|Overall Study|Lack of Efficacy|1|||
164442147|NCT01040689|593986452|FG003|Overall Study|Lack of Efficacy|0|||
164442148|NCT01040689|593986449|FG000|Overall Study|Lost to Follow-up|1|||
164442149|NCT01040689|593986450|FG001|Overall Study|Lost to Follow-up|0|||
164442150|NCT01040689|593986451|FG002|Overall Study|Lost to Follow-up|0|||
164442151|NCT01040689|593986452|FG003|Overall Study|Lost to Follow-up|0|||
164595372|NCT03345836|594543145|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
164595373|NCT03345836|594543146|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
164595374|NCT03345836|594543147|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
164595375|NCT03345836|594543148|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
164595376|NCT03345836|594543143|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
164595377|NCT03345836|594543144|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
164595378|NCT03345836|594543145|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
164595379|NCT03345836|594543146|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
164595380|NCT03345836|594543147|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
164595381|NCT03345836|594543148|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
164595382|NCT03345836|594543143|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
164595383|NCT03345836|594543144|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
164595384|NCT03345836|594543145|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
164442152|NCT01040689|593986449|FG000|Overall Study|Withdrawal by Subject|2|||
164442153|NCT01040689|593986450|FG001|Overall Study|Withdrawal by Subject|1|||
164442154|NCT01040689|593986451|FG002|Overall Study|Withdrawal by Subject|1|||
164442155|NCT01040689|593986452|FG003|Overall Study|Withdrawal by Subject|0|||
164442156|NCT01040689|593986449|FG000|Overall Study|Other reasons not listed above|0|||
164442157|NCT01040689|593986450|FG001|Overall Study|Other reasons not listed above|1|||
164442158|NCT01040689|593986451|FG002|Overall Study|Other reasons not listed above|0|||
164704684|NCT04453202|594944647|FG002|Overall Study|Withdrawal by Subject|1|||
164704685|NCT04453202|594944648|FG003|Overall Study|Withdrawal by Subject|2|||
164704686|NCT04453202|594944649|FG004|Overall Study|Withdrawal by Subject|1|||
164704687|NCT04453202|594944650|FG005|Overall Study|Withdrawal by Subject|1|||
164704688|NCT04453202|594944651|FG006|Overall Study|Withdrawal by Subject|0|||
164704689|NCT04453202|594944652|FG007|Overall Study|Withdrawal by Subject|0|||
164704690|NCT04453202|594944653|FG008|Overall Study|Withdrawal by Subject|0|||
164704691|NCT04453202|594944654|FG009|Overall Study|Withdrawal by Subject|1|||
164704692|NCT04453202|594944655|FG010|Overall Study|Withdrawal by Subject|0|||
164704693|NCT04453202|594944645|FG000|Overall Study|Adverse Event|0|||
164704694|NCT04453202|594944646|FG001|Overall Study|Adverse Event|0|||
164704695|NCT04453202|594944647|FG002|Overall Study|Adverse Event|0|||
164704696|NCT04453202|594944648|FG003|Overall Study|Adverse Event|0|||
164704697|NCT04453202|594944649|FG004|Overall Study|Adverse Event|0|||
164704698|NCT04453202|594944650|FG005|Overall Study|Adverse Event|1|||
164704699|NCT04453202|594944651|FG006|Overall Study|Adverse Event|0|||
164704700|NCT04453202|594944652|FG007|Overall Study|Adverse Event|0|||
164704701|NCT04453202|594944653|FG008|Overall Study|Adverse Event|0|||
164704702|NCT04453202|594944654|FG009|Overall Study|Adverse Event|0|||
164704703|NCT04453202|594944655|FG010|Overall Study|Adverse Event|0|||
164704704|NCT01355159|594944660|FG000|Overall Study|Withdrew consent|39|||
164704705|NCT01355159|594944661|FG001|Overall Study|Withdrew consent|47|||
164704706|NCT01355159|594944660|FG000|Overall Study|No primary outcome data|17|||
164704707|NCT01355159|594944661|FG001|Overall Study|No primary outcome data|11|||
164704708|NCT01355159|594944660|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
164704709|NCT01355159|594944661|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
164704710|NCT01355159|594944660|FG000|Overall Study|Early intrauterine fetal death|6|||
164704711|NCT01355159|594944661|FG001|Overall Study|Early intrauterine fetal death|6|||
164704712|NCT03276221|594944662|FG000|Overall Study|Lost to Follow-up|6|||
164704713|NCT03276221|594944663|FG001|Overall Study|Lost to Follow-up|2|||
164704714|NCT03276221|594944664|FG002|Overall Study|Lost to Follow-up|0|||
164704715|NCT03276221|594944662|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
164704716|NCT03276221|594944663|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
164704717|NCT03276221|594944664|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
164704718|NCT00424775|594944665|FG000|Overall Study|Adverse Event|2|||
164704719|NCT00424775|594944666|FG001|Overall Study|Adverse Event|0|||
164704720|NCT00424775|594944665|FG000|Overall Study|Lack of Efficacy|1|||
164704721|NCT00424775|594944666|FG001|Overall Study|Lack of Efficacy|0|||
164704722|NCT02615171|594944667|FG000|Overall Study|Lost to Follow-up|2|||
164704723|NCT02615171|594944668|FG001|Overall Study|Lost to Follow-up|1|||
164704724|NCT01300923|594944669|FG000|Overall Study|Physician Decision|0|||
164704725|NCT01300923|594944670|FG001|Overall Study|Physician Decision|2|||
164704726|NCT02384850|594944676|FG000|Overall Study|Withdrawal by Subject|2|||
164704727|NCT02384850|594944677|FG001|Overall Study|Withdrawal by Subject|2|||
164704728|NCT00446199|594944679|FG000|Overall Study|Adverse Event|7|||
164704729|NCT00446199|594944680|FG001|Overall Study|Adverse Event|4|||
164704730|NCT00446199|594944681|FG002|Overall Study|Adverse Event|6|||
164704731|NCT00446199|594944682|FG003|Overall Study|Adverse Event|4|||
164442159|NCT01040689|593986452|FG003|Overall Study|Other reasons not listed above|0|||
164442160|NCT00346333|593986456|FG000|Overall Study|Death|1|||
164704732|NCT00446199|594944679|FG000|Overall Study|Lost to Follow-up|4|||
164704733|NCT00446199|594944680|FG001|Overall Study|Lost to Follow-up|5|||
164704734|NCT00446199|594944681|FG002|Overall Study|Lost to Follow-up|2|||
164704735|NCT00446199|594944682|FG003|Overall Study|Lost to Follow-up|6|||
164704736|NCT00446199|594944679|FG000|Overall Study|Protocol Violation|1|||
164704737|NCT00446199|594944680|FG001|Overall Study|Protocol Violation|2|||
164442161|NCT00346333|593986457|FG001|Overall Study|Death|0|||
164442162|NCT00346333|593986456|FG000|Overall Study|unwilling or unable to continue|4|||
164704738|NCT00446199|594944681|FG002|Overall Study|Protocol Violation|1|||
164704739|NCT00446199|594944682|FG003|Overall Study|Protocol Violation|3|||
164704740|NCT00446199|594944679|FG000|Overall Study|Withdrawal by Subject|2|||
164704741|NCT00446199|594944680|FG001|Overall Study|Withdrawal by Subject|5|||
164704742|NCT00446199|594944681|FG002|Overall Study|Withdrawal by Subject|9|||
164704743|NCT00446199|594944682|FG003|Overall Study|Withdrawal by Subject|10|||
164704744|NCT00446199|594944679|FG000|Overall Study|Site termination|2|||
164704745|NCT00446199|594944680|FG001|Overall Study|Site termination|0|||
164704746|NCT00446199|594944681|FG002|Overall Study|Site termination|0|||
164442163|NCT00346333|593986457|FG001|Overall Study|unwilling or unable to continue|8|||
164442164|NCT02798835|593986460|FG000|Overall Study|Protocol Violation|0|||
164442165|NCT02798835|593986461|FG001|Overall Study|Protocol Violation|0|||
164442166|NCT02798835|593986462|FG002|Overall Study|Protocol Violation|3|||
164442167|NCT03194958|593986470|FG000|Overall Study|Death|0|||
164442168|NCT03194958|593986471|FG001|Overall Study|Death|1|||
164442169|NCT03194958|593986472|FG002|Overall Study|Death|1|||
164442170|NCT03194958|593986473|FG003|Overall Study|Death|1|||
164442171|NCT03194958|593986470|FG000|Overall Study|Withdrawal by Subject|24|||
164442172|NCT03194958|593986471|FG001|Overall Study|Withdrawal by Subject|27|||
164442173|NCT03194958|593986472|FG002|Overall Study|Withdrawal by Subject|7|||
164442174|NCT03194958|593986473|FG003|Overall Study|Withdrawal by Subject|22|||
164442175|NCT03194958|593986470|FG000|Overall Study|Lost to Follow-up|168|||
164442176|NCT03194958|593986471|FG001|Overall Study|Lost to Follow-up|196|||
164442177|NCT03194958|593986472|FG002|Overall Study|Lost to Follow-up|174|||
164442178|NCT03194958|593986473|FG003|Overall Study|Lost to Follow-up|186|||
164442179|NCT03388632|593986476|FG000|Triplet C|Clinical progression|0|||
164442180|NCT03388632|593986477|FG001|Triplet C|Clinical progression|0|||
164442181|NCT03388632|593986478|FG002|Triplet C|Clinical progression|0|||
164442182|NCT03388632|593986479|FG003|Triplet C|Clinical progression|0|||
164442183|NCT03388632|593986480|FG004|Triplet C|Clinical progression|1|||
164442184|NCT03388632|593986481|FG005|Triplet C|Clinical progression|0|||
164442185|NCT03388632|593986482|FG006|Triplet C|Clinical progression|0|||
164442186|NCT03388632|593986483|FG007|Triplet C|Clinical progression|0|||
164442187|NCT03388632|593986484|FG008|Triplet C|Clinical progression|0|||
164442188|NCT03388632|593986476|FG000|Triplet C|42-day lapse in tx|0|||
164442189|NCT03388632|593986477|FG001|Triplet C|42-day lapse in tx|0|||
164442190|NCT03388632|593986478|FG002|Triplet C|42-day lapse in tx|0|||
164442191|NCT03388632|593986479|FG003|Triplet C|42-day lapse in tx|0|||
164442192|NCT03388632|593986480|FG004|Triplet C|42-day lapse in tx|1|||
164442193|NCT03388632|593986481|FG005|Triplet C|42-day lapse in tx|0|||
164442194|NCT03388632|593986482|FG006|Triplet C|42-day lapse in tx|0|||
164442195|NCT03388632|593986483|FG007|Triplet C|42-day lapse in tx|0|||
164442196|NCT03388632|593986484|FG008|Triplet C|42-day lapse in tx|0|||
164442197|NCT03388632|593986476|FG000|Triplet C|Adverse Event|0|||
164442198|NCT03388632|593986477|FG001|Triplet C|Adverse Event|0|||
164442199|NCT03388632|593986478|FG002|Triplet C|Adverse Event|0|||
164442200|NCT03388632|593986479|FG003|Triplet C|Adverse Event|0|||
164442201|NCT03388632|593986480|FG004|Triplet C|Adverse Event|0|||
164442202|NCT03388632|593986481|FG005|Triplet C|Adverse Event|0|||
164442203|NCT03388632|593986482|FG006|Triplet C|Adverse Event|0|||
164442204|NCT03388632|593986483|FG007|Triplet C|Adverse Event|0|||
164442205|NCT03388632|593986484|FG008|Triplet C|Adverse Event|1|||
164442206|NCT03388632|593986476|FG000|Triplet C|Switched to alternative treatment|0|||
164442207|NCT03388632|593986477|FG001|Triplet C|Switched to alternative treatment|0|||
164442208|NCT03388632|593986478|FG002|Triplet C|Switched to alternative treatment|0|||
164704747|NCT00446199|594944682|FG003|Overall Study|Site termination|1|||
164704748|NCT00446199|594944679|FG000|Overall Study|Randomization in Error|2|||
164704749|NCT00446199|594944680|FG001|Overall Study|Randomization in Error|0|||
164704750|NCT00446199|594944681|FG002|Overall Study|Randomization in Error|1|||
164704751|NCT00446199|594944682|FG003|Overall Study|Randomization in Error|1|||
164442209|NCT03388632|593986479|FG003|Triplet C|Switched to alternative treatment|0|||
164442210|NCT03388632|593986480|FG004|Triplet C|Switched to alternative treatment|0|||
164442211|NCT03388632|593986481|FG005|Triplet C|Switched to alternative treatment|0|||
164442212|NCT03388632|593986482|FG006|Triplet C|Switched to alternative treatment|0|||
164442213|NCT03388632|593986483|FG007|Triplet C|Switched to alternative treatment|1|||
164442214|NCT03388632|593986484|FG008|Triplet C|Switched to alternative treatment|0|||
164442215|NCT03388632|593986476|FG000|Triplet C|Participant choice|0|||
164442216|NCT03388632|593986477|FG001|Triplet C|Participant choice|0|||
164442217|NCT03388632|593986478|FG002|Triplet C|Participant choice|0|||
164442218|NCT03388632|593986479|FG003|Triplet C|Participant choice|0|||
164442219|NCT03388632|593986480|FG004|Triplet C|Participant choice|0|||
164442220|NCT03388632|593986481|FG005|Triplet C|Participant choice|1|||
164704752|NCT00446199|594944679|FG000|Overall Study|Lack of Efficacy|1|||
164442221|NCT03388632|593986482|FG006|Triplet C|Participant choice|0|||
164442222|NCT03388632|593986483|FG007|Triplet C|Participant choice|0|||
164442223|NCT03388632|593986484|FG008|Triplet C|Participant choice|0|||
164442224|NCT04177394|593986485|FG000|Overall Study|Death|16|||
164442225|NCT04177394|593986485|FG000|Overall Study|Withdrawal by Subject|19|||
164442226|NCT04177394|593986485|FG000|Overall Study|Missed visits|61|||
164442227|NCT04177394|593986485|FG000|Overall Study|Expected Visits|15|||
164442228|NCT02115282|593986486|FG000|Overall Study|Disease progression during treatment|216|||
164442229|NCT02115282|593986487|FG001|Overall Study|Disease progression during treatment|229|||
164704753|NCT00446199|594944680|FG001|Overall Study|Lack of Efficacy|0|||
164704754|NCT00446199|594944681|FG002|Overall Study|Lack of Efficacy|0|||
164704755|NCT00446199|594944682|FG003|Overall Study|Lack of Efficacy|1|||
164704756|NCT00446199|594944679|FG000|Overall Study|Non-compliant with study drug|1|||
164704757|NCT00446199|594944680|FG001|Overall Study|Non-compliant with study drug|0|||
164704758|NCT00446199|594944681|FG002|Overall Study|Non-compliant with study drug|5|||
164704759|NCT00446199|594944682|FG003|Overall Study|Non-compliant with study drug|0|||
164704760|NCT00446199|594944679|FG000|Overall Study|Non-compliant with visit schedule|1|||
164704761|NCT00446199|594944680|FG001|Overall Study|Non-compliant with visit schedule|1|||
164704762|NCT00446199|594944681|FG002|Overall Study|Non-compliant with visit schedule|1|||
164704763|NCT00446199|594944682|FG003|Overall Study|Non-compliant with visit schedule|2|||
164704764|NCT00446199|594944679|FG000|Overall Study|Hormone fear|0|||
164704765|NCT00446199|594944680|FG001|Overall Study|Hormone fear|0|||
164704766|NCT00446199|594944681|FG002|Overall Study|Hormone fear|0|||
164704767|NCT00446199|594944682|FG003|Overall Study|Hormone fear|1|||
164704768|NCT00446199|594944679|FG000|Overall Study|Lost interest in study participation|0|||
164704769|NCT00446199|594944680|FG001|Overall Study|Lost interest in study participation|1|||
164704770|NCT00446199|594944681|FG002|Overall Study|Lost interest in study participation|0|||
164704771|NCT00446199|594944682|FG003|Overall Study|Lost interest in study participation|0|||
164704772|NCT00446199|594944679|FG000|Overall Study|In-/Exclusion criterion violated|2|||
164704773|NCT00446199|594944680|FG001|Overall Study|In-/Exclusion criterion violated|1|||
164704774|NCT00446199|594944681|FG002|Overall Study|In-/Exclusion criterion violated|2|||
164704775|NCT00446199|594944682|FG003|Overall Study|In-/Exclusion criterion violated|1|||
164704776|NCT00446199|594944679|FG000|Overall Study|Move|0|||
164704777|NCT00446199|594944680|FG001|Overall Study|Move|1|||
164704778|NCT00446199|594944681|FG002|Overall Study|Move|0|||
164704779|NCT00446199|594944682|FG003|Overall Study|Move|0|||
164704780|NCT01079832|594944685|FG000|Overall Study|Withdrawal by Subject|1|||
164704781|NCT01195272|594944688|FG000|Overall Study|Adverse Event|1|||
164704782|NCT01195272|594944688|FG000|Overall Study|Lack of Efficacy|3|||
164704783|NCT01769339|594944689|FG000|Overall Study|Lost to Follow-up|42|||
164704784|NCT01769339|594944689|FG000|Overall Study|Adverse Event|1|||
164704785|NCT04969861|594944690|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
164704786|NCT04969861|594944691|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
164704787|NCT00290251|594944692|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
164704788|NCT00290251|594944693|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
164704789|NCT00290251|594944694|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
164704790|NCT00290251|594944695|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
164704791|NCT00290251|594944696|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
164704792|NCT00290251|594944697|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
164704793|NCT00290251|594944692|FG000|Treatment 1 (Months 2-4)|headache|0|||
164704794|NCT00290251|594944693|FG001|Treatment 1 (Months 2-4)|headache|0|||
164704795|NCT00290251|594944694|FG002|Treatment 1 (Months 2-4)|headache|0|||
164704796|NCT00290251|594944695|FG003|Treatment 1 (Months 2-4)|headache|0|||
164704797|NCT00290251|594944696|FG004|Treatment 1 (Months 2-4)|headache|1|||
164704798|NCT00290251|594944697|FG005|Treatment 1 (Months 2-4)|headache|0|||
164704799|NCT00290251|594944692|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
164704800|NCT00290251|594944693|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
164704801|NCT00290251|594944694|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
164704802|NCT00290251|594944695|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
164704803|NCT00290251|594944696|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
164704804|NCT00290251|594944697|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
164704805|NCT03548064|594946604|FG000|Overall Study|Withdrawal by Subject|0|||
164704806|NCT03548064|594946605|FG001|Overall Study|Withdrawal by Subject|0|||
164704807|NCT03548064|594946606|FG002|Overall Study|Withdrawal by Subject|0|||
164704808|NCT03548064|594946607|FG003|Overall Study|Withdrawal by Subject|1|||
164704809|NCT03548064|594946608|FG004|Overall Study|Withdrawal by Subject|0|||
164704810|NCT03548064|594946609|FG005|Overall Study|Withdrawal by Subject|0|||
164704811|NCT03548064|594946610|FG006|Overall Study|Withdrawal by Subject|0|||
164704812|NCT03548064|594946611|FG007|Overall Study|Withdrawal by Subject|0|||
164704813|NCT03548064|594946604|FG000|Overall Study|Lost to Follow-up|0|||
164704814|NCT03548064|594946605|FG001|Overall Study|Lost to Follow-up|0|||
164704815|NCT03548064|594946606|FG002|Overall Study|Lost to Follow-up|0|||
164704816|NCT03548064|594946607|FG003|Overall Study|Lost to Follow-up|0|||
164704817|NCT03548064|594946608|FG004|Overall Study|Lost to Follow-up|2|||
164704818|NCT03548064|594946609|FG005|Overall Study|Lost to Follow-up|0|||
164704819|NCT03548064|594946610|FG006|Overall Study|Lost to Follow-up|0|||
164704820|NCT03548064|594946611|FG007|Overall Study|Lost to Follow-up|0|||
164704821|NCT03548064|594946604|FG000|Overall Study|Covid-19 Pandemic|0|||
164704822|NCT03548064|594946605|FG001|Overall Study|Covid-19 Pandemic|0|||
164704823|NCT03548064|594946606|FG002|Overall Study|Covid-19 Pandemic|0|||
164704824|NCT03548064|594946607|FG003|Overall Study|Covid-19 Pandemic|0|||
164595385|NCT03345836|594543146|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
164595386|NCT03345836|594543147|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
164595387|NCT03345836|594543148|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
164595388|NCT03345836|594543143|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
164595389|NCT03345836|594543144|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
164595390|NCT03345836|594543145|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
164595391|NCT03345836|594543146|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
164595392|NCT03345836|594543147|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
164595393|NCT03345836|594543148|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
164595394|NCT03345836|594543143|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
164595395|NCT03345836|594543144|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
164595396|NCT03345836|594543145|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
164595397|NCT03345836|594543146|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
164595398|NCT03345836|594543147|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
164595399|NCT03345836|594543148|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
164595400|NCT03345836|594543143|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
164595401|NCT03345836|594543144|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
164595402|NCT03345836|594543145|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
164595403|NCT03345836|594543146|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
164595404|NCT03345836|594543147|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
164595405|NCT03345836|594543148|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
164595406|NCT03345836|594543143|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
164595407|NCT03345836|594543144|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
164595408|NCT03345836|594543145|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
164595409|NCT03345836|594543146|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
164595410|NCT03345836|594543147|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
164595411|NCT03345836|594543148|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
164595412|NCT03345836|594543143|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
164595413|NCT03345836|594543144|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
164595414|NCT03345836|594543145|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
164704825|NCT03548064|594946608|FG004|Overall Study|Covid-19 Pandemic|10|||
164704826|NCT03548064|594946609|FG005|Overall Study|Covid-19 Pandemic|3|||
164704827|NCT03548064|594946610|FG006|Overall Study|Covid-19 Pandemic|0|||
164397482|NCT04814654|593824542|FG000|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|170|||
164397483|NCT04814654|593824543|FG001|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|167|||
164397484|NCT04814654|593824544|FG002|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|157|||
164397487|NCT00826540|593824549|FG000|Overall Study|ineligible|3|||
164397488|NCT00826540|593824549|FG000|Overall Study|Withdrawal by Subject|1|||
164595415|NCT03345836|594543146|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
164595416|NCT03345836|594543147|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
164595417|NCT03345836|594543148|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
164595418|NCT03510663|594543149|FG000|Overall Study|Withdrawal by Subject|0|||
164595419|NCT03510663|594543150|FG001|Overall Study|Withdrawal by Subject|1|||
164595420|NCT03510663|594543151|FG002|Overall Study|Withdrawal by Subject|0|||
164595421|NCT03510663|594543152|FG003|Overall Study|Withdrawal by Subject|0|||
164595422|NCT03510663|594543153|FG004|Overall Study|Withdrawal by Subject|0|||
164595423|NCT03510663|594543154|FG005|Overall Study|Withdrawal by Subject|0|||
164595424|NCT03510663|594543155|FG006|Overall Study|Withdrawal by Subject|0|||
164595425|NCT03510663|594543156|FG007|Overall Study|Withdrawal by Subject|0|||
164595426|NCT05091060|594543159|FG000|Overall Study|Lost to Follow-up|1|||
164595427|NCT02739594|594543160|FG000|Overall Study|Undesired Event|3|||
164595428|NCT02739594|594543161|FG001|Overall Study|Undesired Event|4|||
164595429|NCT02739594|594543160|FG000|Overall Study|Violation of Eligibility Criteria|1|||
164595430|NCT02739594|594543161|FG001|Overall Study|Violation of Eligibility Criteria|2|||
164595431|NCT02739594|594543160|FG000|Overall Study|Protocol Violation|5|||
164595432|NCT02739594|594543161|FG001|Overall Study|Protocol Violation|6|||
164595433|NCT02739594|594543160|FG000|Overall Study|Death|4|||
164595434|NCT02739594|594543161|FG001|Overall Study|Death|2|||
164595435|NCT02739594|594543160|FG000|Overall Study|Renal Insufficiency|4|||
164595436|NCT02739594|594543161|FG001|Overall Study|Renal Insufficiency|6|||
164595437|NCT02739594|594543160|FG000|Overall Study|Administrative Reasons|1|||
164595438|NCT02739594|594543161|FG001|Overall Study|Administrative Reasons|3|||
164595439|NCT02739594|594543160|FG000|Overall Study|Withdrawal by Subject|1|||
164595440|NCT02739594|594543161|FG001|Overall Study|Withdrawal by Subject|1|||
164595441|NCT02739594|594543160|FG000|Overall Study|Lost to Follow-up|0|||
164595442|NCT02739594|594543161|FG001|Overall Study|Lost to Follow-up|1|||
164595443|NCT02739594|594543160|FG000|Overall Study|Elevated Serum Creatinine|0|||
164595444|NCT02739594|594543161|FG001|Overall Study|Elevated Serum Creatinine|1|||
164704828|NCT03548064|594946611|FG007|Overall Study|Covid-19 Pandemic|0|||
164704829|NCT06218823|594946614|FG000|Overall Study|Death|3|||
164704830|NCT06218823|594946615|FG001|Overall Study|Death|0|||
164704831|NCT06218823|594946614|FG000|Overall Study|Lost to Follow-up|0|||
164704832|NCT06218823|594946615|FG001|Overall Study|Lost to Follow-up|2|||
164704833|NCT03611543|594946616|FG000|Overall Study|Withdrawal by Subject|4|||
164704834|NCT03611543|594946617|FG001|Overall Study|Withdrawal by Subject|4|||
164704835|NCT03611543|594946616|FG000|Overall Study|Physician Decision|1|||
164704836|NCT03611543|594946617|FG001|Overall Study|Physician Decision|1|||
164704837|NCT03611543|594946616|FG000|Overall Study|Protocol Violation|2|||
164704838|NCT03611543|594946617|FG001|Overall Study|Protocol Violation|2|||
164704839|NCT03611543|594946616|FG000|Overall Study|Device failure|2|||
164704840|NCT03611543|594946617|FG001|Overall Study|Device failure|2|||
164704841|NCT03611543|594946616|FG000|Overall Study|Missing information|5|||
164704842|NCT03611543|594946617|FG001|Overall Study|Missing information|5|||
164704843|NCT06077487|594946618|FG000|Overall Study|Withdrawal by Subject|0|||
164704844|NCT06077487|594946619|FG001|Overall Study|Withdrawal by Subject|1|||
164704845|NCT05101486|594946620|FG000|Overall Study|Death|1|||
164704846|NCT05101486|594946621|FG001|Overall Study|Death|0|||
164704847|NCT05101486|594946622|FG002|Overall Study|Death|1|||
164704848|NCT05101486|594946620|FG000|Overall Study|Lost to Follow-up|12|||
164704849|NCT05101486|594946621|FG001|Overall Study|Lost to Follow-up|8|||
164704850|NCT05101486|594946622|FG002|Overall Study|Lost to Follow-up|17|||
164704851|NCT05101486|594946620|FG000|Overall Study|Physician Decision|1|||
164704852|NCT05101486|594946621|FG001|Overall Study|Physician Decision|0|||
164704853|NCT05101486|594946622|FG002|Overall Study|Physician Decision|0|||
164704854|NCT05101486|594946620|FG000|Overall Study|Protocol Violation|0|||
164595445|NCT02739594|594543160|FG000|Overall Study|Other|6|||
164704855|NCT05101486|594946621|FG001|Overall Study|Protocol Violation|0|||
164704856|NCT05101486|594946622|FG002|Overall Study|Protocol Violation|1|||
164704857|NCT05101486|594946620|FG000|Overall Study|Withdrawal by Subject|5|||
164397497|NCT03222609|593824791|FG000|Overall Study|Withdrew consent|3|||
164397498|NCT03222609|593824792|FG001|Overall Study|Withdrew consent|9|||
164397499|NCT03222609|593824793|FG002|Overall Study|Withdrew consent|4|||
164397500|NCT03222609|593824794|FG003|Overall Study|Withdrew consent|2|||
164397501|NCT03222609|593824791|FG000|Overall Study|Lost to Follow-up|2|||
164397502|NCT03222609|593824792|FG001|Overall Study|Lost to Follow-up|2|||
164397503|NCT03222609|593824793|FG002|Overall Study|Lost to Follow-up|1|||
164397504|NCT03222609|593824794|FG003|Overall Study|Lost to Follow-up|0|||
164397505|NCT03222609|593824791|FG000|Overall Study|Death|20|||
164397506|NCT03222609|593824792|FG001|Overall Study|Death|38|||
164397507|NCT03222609|593824793|FG002|Overall Study|Death|18|||
164397508|NCT03222609|593824794|FG003|Overall Study|Death|10|||
164595446|NCT02739594|594543161|FG001|Overall Study|Other|2|||
164595447|NCT01930799|594543164|FG000|Overall Study|Withdrawal by Subject|3|||
164595448|NCT01930799|594543164|FG000|Overall Study|Lost to Follow-up|5|||
164595449|NCT00952289|594543165|FG000|All Participants|Death|9|||
164595450|NCT00952289|594543166|FG001|All Participants|Death|9|||
164595451|NCT00952289|594543165|FG000|All Participants|Adverse Event|8|||
164595452|NCT00952289|594543166|FG001|All Participants|Adverse Event|8|||
164595453|NCT00952289|594543165|FG000|All Participants|Disease progression|3|||
164595454|NCT00952289|594543166|FG001|All Participants|Disease progression|12|||
164595455|NCT00952289|594543165|FG000|All Participants|Withdrawal by Subject|1|||
164595456|NCT00952289|594543166|FG001|All Participants|Withdrawal by Subject|10|||
164595457|NCT00952289|594543165|FG000|All Participants|Data lost during site relocation|0|||
164595458|NCT00952289|594543166|FG001|All Participants|Data lost during site relocation|1|||
164595459|NCT00952289|594543165|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
164595460|NCT00952289|594543166|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
164595461|NCT00952289|594543165|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
164595462|NCT00952289|594543166|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
164595463|NCT00952289|594543165|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
164595464|NCT00952289|594543166|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
164595465|NCT00952289|594543165|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
164595466|NCT00952289|594543166|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
164595467|NCT00952289|594543165|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
164595468|NCT00952289|594543166|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
164595469|NCT00875017|594543167|FG000|First Intervention|Withdrawal by Subject|1|||
164595470|NCT00875017|594543168|FG001|First Intervention|Withdrawal by Subject|0|||
164595471|NCT00875017|594543169|FG002|First Intervention|Withdrawal by Subject|1|||
164595472|NCT00875017|594543170|FG003|First Intervention|Withdrawal by Subject|0|||
164595473|NCT00875017|594543171|FG004|First Intervention|Withdrawal by Subject|0|||
164595474|NCT00875017|594543172|FG005|First Intervention|Withdrawal by Subject|0|||
164595475|NCT00875017|594543167|FG000|First Intervention|Adverse Event|0|||
164595476|NCT00875017|594543168|FG001|First Intervention|Adverse Event|0|||
164595477|NCT00875017|594543169|FG002|First Intervention|Adverse Event|0|||
164595478|NCT00875017|594543170|FG003|First Intervention|Adverse Event|1|||
164595479|NCT00875017|594543171|FG004|First Intervention|Adverse Event|0|||
164595480|NCT00875017|594543172|FG005|First Intervention|Adverse Event|0|||
164595481|NCT00875017|594543167|FG000|First Intervention|Problems collecting rectal effluent|1|||
164595482|NCT00875017|594543168|FG001|First Intervention|Problems collecting rectal effluent|0|||
164595483|NCT00875017|594543169|FG002|First Intervention|Problems collecting rectal effluent|0|||
164595484|NCT00875017|594543170|FG003|First Intervention|Problems collecting rectal effluent|0|||
164595485|NCT00875017|594543171|FG004|First Intervention|Problems collecting rectal effluent|0|||
164595486|NCT00875017|594543172|FG005|First Intervention|Problems collecting rectal effluent|0|||
164595487|NCT00875017|594543167|FG000|First Intervention|Intolerance to nasogastric tube|0|||
164595488|NCT00875017|594543168|FG001|First Intervention|Intolerance to nasogastric tube|0|||
164595489|NCT00875017|594543169|FG002|First Intervention|Intolerance to nasogastric tube|0|||
164595490|NCT00875017|594543170|FG003|First Intervention|Intolerance to nasogastric tube|0|||
164595491|NCT00875017|594543171|FG004|First Intervention|Intolerance to nasogastric tube|1|||
164595492|NCT00875017|594543172|FG005|First Intervention|Intolerance to nasogastric tube|0|||
164595493|NCT00875017|594543167|FG000|Washout|Problem collecting rectal effluent|0|||
164595494|NCT00875017|594543168|FG001|Washout|Problem collecting rectal effluent|0|||
164595495|NCT00875017|594543169|FG002|Washout|Problem collecting rectal effluent|1|||
164595496|NCT00875017|594543170|FG003|Washout|Problem collecting rectal effluent|0|||
164595497|NCT00875017|594543171|FG004|Washout|Problem collecting rectal effluent|0|||
164595498|NCT00875017|594543172|FG005|Washout|Problem collecting rectal effluent|0|||
164595499|NCT00875017|594543167|FG000|Second Intervention|Adverse Event|0|||
164397509|NCT03222609|593824791|FG000|Overall Study|Other, not specified|9|||
164397510|NCT03222609|593824792|FG001|Overall Study|Other, not specified|42|||
164397511|NCT03222609|593824793|FG002|Overall Study|Other, not specified|11|||
164397512|NCT03222609|593824794|FG003|Overall Study|Other, not specified|20|||
164442230|NCT02115282|593986486|FG000|Overall Study|Adverse Event|49|||
164442231|NCT02115282|593986487|FG001|Overall Study|Adverse Event|23|||
164442232|NCT02115282|593986486|FG000|Overall Study|Death|1|||
164442233|NCT02115282|593986487|FG001|Overall Study|Death|3|||
164442234|NCT02115282|593986486|FG000|Overall Study|Alternative therapy|1|||
164442235|NCT02115282|593986487|FG001|Overall Study|Alternative therapy|1|||
164442236|NCT02115282|593986486|FG000|Overall Study|Complicating disease|0|||
164442237|NCT02115282|593986487|FG001|Overall Study|Complicating disease|3|||
164595500|NCT00875017|594543168|FG001|Second Intervention|Adverse Event|0|||
164595501|NCT00875017|594543169|FG002|Second Intervention|Adverse Event|0|||
164595502|NCT00875017|594543170|FG003|Second Intervention|Adverse Event|1|||
164704858|NCT05101486|594946621|FG001|Overall Study|Withdrawal by Subject|2|||
164704859|NCT05101486|594946622|FG002|Overall Study|Withdrawal by Subject|4|||
164442238|NCT02115282|593986486|FG000|Overall Study|Withdrawal by Subject|12|||
164442239|NCT02115282|593986487|FG001|Overall Study|Withdrawal by Subject|10|||
164442240|NCT02115282|593986486|FG000|Overall Study|Symptomatic progression/deterioration|7|||
164442241|NCT02115282|593986487|FG001|Overall Study|Symptomatic progression/deterioration|18|||
164442242|NCT02115282|593986486|FG000|Overall Study|Non-compliance|5|||
164442243|NCT02115282|593986487|FG001|Overall Study|Non-compliance|1|||
164442244|NCT02115282|593986486|FG000|Overall Study|Protocol Violation|2|||
164442245|NCT02115282|593986487|FG001|Overall Study|Protocol Violation|2|||
164442246|NCT02115282|593986486|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
164442247|NCT02115282|593986487|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
164442248|NCT02115282|593986486|FG000|Overall Study|Not start protocol therapy|9|||
164442249|NCT02115282|593986487|FG001|Overall Study|Not start protocol therapy|10|||
164442250|NCT00256243|593986488|FG000|Overall Study|Lost to Follow-up|2|||
164442251|NCT00256243|593986488|FG000|Overall Study|Death|7|||
164442252|NCT00256243|593986488|FG000|Overall Study|Not treated|1|||
164442253|NCT06218251|593986491|FG000|Overall Study|Lost to Follow-up|4|||
164442254|NCT00997386|593986494|FG000|Overall Study|Death|7|||
164442255|NCT03492177|593986496|FG000|Overall Study|Adverse Event|1|||
164442256|NCT03492177|593986497|FG001|Overall Study|Adverse Event|0|||
164442257|NCT03492177|593986498|FG002|Overall Study|Adverse Event|0|||
164442258|NCT03492177|593986496|FG000|Overall Study|Death|3|||
164442259|NCT03492177|593986497|FG001|Overall Study|Death|0|||
164442260|NCT03492177|593986498|FG002|Overall Study|Death|3|||
164442261|NCT03492177|593986496|FG000|Overall Study|Lack of Efficacy|1|||
164442262|NCT03492177|593986497|FG001|Overall Study|Lack of Efficacy|2|||
164442263|NCT03492177|593986498|FG002|Overall Study|Lack of Efficacy|0|||
164442264|NCT03492177|593986496|FG000|Overall Study|Other|1|||
164442265|NCT03492177|593986497|FG001|Overall Study|Other|0|||
164442266|NCT03492177|593986498|FG002|Overall Study|Other|0|||
164442267|NCT03492177|593986496|FG000|Overall Study|Ongoing|16|||
164595503|NCT00875017|594543171|FG004|Second Intervention|Adverse Event|0|||
164595504|NCT00875017|594543172|FG005|Second Intervention|Adverse Event|0|||
164595505|NCT00875017|594543167|FG000|Washout|Problems collecting rectal effluent|0|||
164595506|NCT00875017|594543168|FG001|Washout|Problems collecting rectal effluent|1|||
164595507|NCT00875017|594543169|FG002|Washout|Problems collecting rectal effluent|0|||
164595508|NCT00875017|594543170|FG003|Washout|Problems collecting rectal effluent|0|||
164595509|NCT00875017|594543171|FG004|Washout|Problems collecting rectal effluent|0|||
164595510|NCT00875017|594543172|FG005|Washout|Problems collecting rectal effluent|0|||
164595511|NCT00875017|594543167|FG000|Third Intervention|Adverse Event|0|||
164595512|NCT00875017|594543168|FG001|Third Intervention|Adverse Event|1|||
164595513|NCT00875017|594543169|FG002|Third Intervention|Adverse Event|1|||
164595514|NCT00875017|594543170|FG003|Third Intervention|Adverse Event|0|||
164595515|NCT00875017|594543171|FG004|Third Intervention|Adverse Event|0|||
164595516|NCT00875017|594543172|FG005|Third Intervention|Adverse Event|0|||
164595517|NCT00875017|594543167|FG000|Washout|Withdrawal by Subject|0|||
164595518|NCT00875017|594543168|FG001|Washout|Withdrawal by Subject|0|||
164595519|NCT00875017|594543169|FG002|Washout|Withdrawal by Subject|0|||
164595520|NCT00875017|594543170|FG003|Washout|Withdrawal by Subject|0|||
164595521|NCT00875017|594543171|FG004|Washout|Withdrawal by Subject|1|||
164595522|NCT00875017|594543172|FG005|Washout|Withdrawal by Subject|0|||
164595523|NCT00875017|594543167|FG000|Fourth Intervention|Inability to comply with fasting|0|||
164595524|NCT00875017|594543168|FG001|Fourth Intervention|Inability to comply with fasting|0|||
164595525|NCT00875017|594543169|FG002|Fourth Intervention|Inability to comply with fasting|0|||
164595526|NCT00875017|594543170|FG003|Fourth Intervention|Inability to comply with fasting|0|||
164595527|NCT00875017|594543171|FG004|Fourth Intervention|Inability to comply with fasting|0|||
164595528|NCT00875017|594543172|FG005|Fourth Intervention|Inability to comply with fasting|1|||
164595529|NCT01477892|594543173|FG000|Overall Study|Withdrawal by Subject|0|||
164595530|NCT01477892|594543174|FG001|Overall Study|Withdrawal by Subject|2|||
164595531|NCT03259334|594543175|FG000|Overall Study|Adverse Event|3|||
164595532|NCT03259334|594543176|FG001|Overall Study|Adverse Event|8|||
164595533|NCT03259334|594543177|FG002|Overall Study|Adverse Event|5|||
164595534|NCT03259334|594543175|FG000|Overall Study|Withdrawal by Subject|4|||
164595535|NCT03259334|594543176|FG001|Overall Study|Withdrawal by Subject|2|||
164595536|NCT03259334|594543177|FG002|Overall Study|Withdrawal by Subject|4|||
164595537|NCT03259334|594543175|FG000|Overall Study|Physician Decision|1|||
164595538|NCT03259334|594543176|FG001|Overall Study|Physician Decision|0|||
164595539|NCT03259334|594543177|FG002|Overall Study|Physician Decision|0|||
164595540|NCT03259334|594543175|FG000|Overall Study|Lost to Follow-up|0|||
164595541|NCT03259334|594543176|FG001|Overall Study|Lost to Follow-up|2|||
164595542|NCT03259334|594543177|FG002|Overall Study|Lost to Follow-up|1|||
164595543|NCT03259334|594543175|FG000|Overall Study|Protocol Deviation|0|||
164595544|NCT03259334|594543176|FG001|Overall Study|Protocol Deviation|3|||
164595545|NCT03259334|594543177|FG002|Overall Study|Protocol Deviation|2|||
164595546|NCT03259334|594543175|FG000|Overall Study|Lack of Efficacy|2|||
164595547|NCT03259334|594543176|FG001|Overall Study|Lack of Efficacy|0|||
164595548|NCT03259334|594543177|FG002|Overall Study|Lack of Efficacy|1|||
164595549|NCT03259334|594543175|FG000|Overall Study|Randomized but never treated|0|||
164595550|NCT03259334|594543176|FG001|Overall Study|Randomized but never treated|2|||
164595551|NCT03259334|594543177|FG002|Overall Study|Randomized but never treated|0|||
164595552|NCT03375112|594543178|FG000|Overall Study|Withdrawal by Subject|3|||
164595553|NCT03375112|594543179|FG001|Overall Study|Withdrawal by Subject|0|||
164595554|NCT03599141|594543180|FG000|Overall Study|Lost to Follow-up|3|||
164595555|NCT03599141|594543181|FG001|Overall Study|Lost to Follow-up|1|||
164595556|NCT00777491|594543182|FG000|Overall Study|Protocol Violation|0|||
164595557|NCT00777491|594543183|FG001|Overall Study|Protocol Violation|2|||
164595558|NCT00777491|594543182|FG000|Overall Study|Did not receive any protocol treatment|2|||
164595559|NCT00777491|594543183|FG001|Overall Study|Did not receive any protocol treatment|0|||
164595560|NCT01689207|594543184|FG000|Overall Study|Adverse Event|0|||
164595561|NCT01689207|594543185|FG001|Overall Study|Adverse Event|1|||
164595562|NCT01689207|594543186|FG002|Overall Study|Adverse Event|0|||
164704860|NCT05101486|594946620|FG000|Overall Study|Randomized but not vaccinated|1|||
164704861|NCT05101486|594946621|FG001|Overall Study|Randomized but not vaccinated|1|||
164704862|NCT05101486|594946622|FG002|Overall Study|Randomized but not vaccinated|1|||
164704863|NCT02788045|594946623|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
164704864|NCT02788045|594946624|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
164704865|NCT02788045|594946625|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
164704866|NCT02788045|594946623|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
164704867|NCT02788045|594946624|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
164704868|NCT02788045|594946625|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
164704869|NCT02788045|594946623|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
164704870|NCT02788045|594946624|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
164704871|NCT02788045|594946625|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
164704872|NCT02788045|594946623|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
164704873|NCT02788045|594946624|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
164704874|NCT02788045|594946625|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
164704875|NCT02788045|594946623|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
164704876|NCT02788045|594946624|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
164704877|NCT02788045|594946625|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
164704878|NCT02788045|594946623|FG000|Main Study (Up to Week 72)|Other|3|||
164704879|NCT02788045|594946624|FG001|Main Study (Up to Week 72)|Other|0|||
164704880|NCT02788045|594946625|FG002|Main Study (Up to Week 72)|Other|0|||
164704881|NCT02788045|594946623|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
164704882|NCT02788045|594946624|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
164704883|NCT02788045|594946625|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
164704884|NCT02788045|594946623|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
164704885|NCT02788045|594946624|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
164704886|NCT02788045|594946625|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
164704887|NCT02788045|594946623|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
164704888|NCT02788045|594946624|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
164704889|NCT02788045|594946625|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
164442268|NCT03492177|593986497|FG001|Overall Study|Ongoing|19|||
164442269|NCT03492177|593986498|FG002|Overall Study|Ongoing|17|||
164442270|NCT05850520|593986499|FG000|Overall Study|Withdrawal by Subject|8|||
164442271|NCT05850520|593986500|FG001|Overall Study|Withdrawal by Subject|8|||
164442272|NCT05850520|593986501|FG002|Overall Study|Withdrawal by Subject|16|||
164442273|NCT05850520|593986499|FG000|Overall Study|Lost to Follow-up|2|||
164442274|NCT05850520|593986500|FG001|Overall Study|Lost to Follow-up|2|||
164442275|NCT05850520|593986501|FG002|Overall Study|Lost to Follow-up|2|||
164442276|NCT05850520|593986499|FG000|Overall Study|Death|2|||
164442277|NCT05850520|593986500|FG001|Overall Study|Death|2|||
164442278|NCT05850520|593986501|FG002|Overall Study|Death|3|||
164442279|NCT05850520|593986499|FG000|Overall Study|Adverse Event|2|||
164442280|NCT05850520|593986500|FG001|Overall Study|Adverse Event|0|||
164442281|NCT05850520|593986501|FG002|Overall Study|Adverse Event|1|||
164442282|NCT05850520|593986499|FG000|Overall Study|Physician Decision|0|||
164442283|NCT05850520|593986500|FG001|Overall Study|Physician Decision|1|||
164704890|NCT03047473|594946629|FG000|Overall Study|Lost to Follow-up|2|||
164704891|NCT00292188|594946630|FG000|Single-Blind|Adverse Event|14|||
164704892|NCT00292188|594946631|FG001|Single-Blind|Adverse Event|0|||
164704893|NCT00292188|594946632|FG002|Single-Blind|Adverse Event|0|||
164704894|NCT00292188|594946630|FG000|Single-Blind|Lack of Efficacy|2|||
164442284|NCT05850520|593986501|FG002|Overall Study|Physician Decision|0|||
164442285|NCT05850520|593986499|FG000|Overall Study|Protocol deviation|0|||
164704895|NCT00292188|594946631|FG001|Single-Blind|Lack of Efficacy|0|||
164704896|NCT00292188|594946632|FG002|Single-Blind|Lack of Efficacy|0|||
164704897|NCT00292188|594946630|FG000|Single-Blind|Laboratory Abnormality|5|||
164704898|NCT00292188|594946631|FG001|Single-Blind|Laboratory Abnormality|0|||
164704899|NCT00292188|594946632|FG002|Single-Blind|Laboratory Abnormality|0|||
164704900|NCT00292188|594946630|FG000|Single-Blind|Lost to Follow-up|3|||
164704901|NCT00292188|594946631|FG001|Single-Blind|Lost to Follow-up|0|||
164704902|NCT00292188|594946632|FG002|Single-Blind|Lost to Follow-up|0|||
164704903|NCT00292188|594946630|FG000|Single-Blind|Other|77|||
164704904|NCT00292188|594946631|FG001|Single-Blind|Other|0|||
164704905|NCT00292188|594946632|FG002|Single-Blind|Other|0|||
164704906|NCT00292188|594946630|FG000|Single-Blind|Withdrawal by Subject|12|||
164704907|NCT00292188|594946631|FG001|Single-Blind|Withdrawal by Subject|0|||
164704908|NCT00292188|594946632|FG002|Single-Blind|Withdrawal by Subject|0|||
164704909|NCT00292188|594946630|FG000|Single-Blind|Did not receive treatment|1|||
164704910|NCT00292188|594946631|FG001|Single-Blind|Did not receive treatment|0|||
164704911|NCT00292188|594946632|FG002|Single-Blind|Did not receive treatment|0|||
164704912|NCT00292188|594946630|FG000|Double-Blind|Adverse Event|0|||
164704913|NCT00292188|594946631|FG001|Double-Blind|Adverse Event|25|||
164704914|NCT00292188|594946632|FG002|Double-Blind|Adverse Event|9|||
164704915|NCT00292188|594946630|FG000|Double-Blind|Lack of Efficacy|0|||
164704916|NCT00292188|594946631|FG001|Double-Blind|Lack of Efficacy|2|||
164704917|NCT00292188|594946632|FG002|Double-Blind|Lack of Efficacy|12|||
164704918|NCT00292188|594946630|FG000|Double-Blind|Lost to Follow-up|0|||
164704919|NCT00292188|594946631|FG001|Double-Blind|Lost to Follow-up|1|||
164704920|NCT00292188|594946632|FG002|Double-Blind|Lost to Follow-up|0|||
164704921|NCT00292188|594946630|FG000|Double-Blind|Other|0|||
164704922|NCT00292188|594946631|FG001|Double-Blind|Other|3|||
164704923|NCT00292188|594946632|FG002|Double-Blind|Other|4|||
164704924|NCT00292188|594946630|FG000|Double-Blind|Withdrawal by Subject|0|||
164704925|NCT00292188|594946631|FG001|Double-Blind|Withdrawal by Subject|0|||
164704926|NCT00292188|594946632|FG002|Double-Blind|Withdrawal by Subject|3|||
164704927|NCT00292188|594946630|FG000|Double-Blind|Laboratory Abnormality|0|||
164704928|NCT00292188|594946631|FG001|Double-Blind|Laboratory Abnormality|0|||
164704929|NCT00292188|594946632|FG002|Double-Blind|Laboratory Abnormality|1|||
164704930|NCT00721630|594946633|FG000|Overall Study|Participant found to be ineligible|1|||
164704931|NCT04711902|594946636|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
164704932|NCT04711902|594946637|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
164704933|NCT04711902|594946638|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
164704934|NCT04711902|594946639|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
164704935|NCT04711902|594946640|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
164704936|NCT04711902|594946641|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
164704937|NCT03786718|594946642|FG000|Overall Study|Lost to Follow-up|3|||
164704938|NCT03786718|594946642|FG000|Overall Study|Withdrawal by Subject|1|||
164704939|NCT03786718|594946642|FG000|Overall Study|Did not use the intervention|2|||
164704940|NCT03786718|594946642|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
164704941|NCT01398514|594946645|FG000|Overall Study|Adverse Event|1|||
164704942|NCT01398514|594946646|FG001|Overall Study|Adverse Event|0|||
164704943|NCT01398514|594946645|FG000|Overall Study|Non-compliance with study procedures|2|||
164704944|NCT01398514|594946646|FG001|Overall Study|Non-compliance with study procedures|0|||
164704945|NCT01398514|594946645|FG000|Overall Study|Physiologic non-responsiveness|1|||
164704946|NCT01398514|594946646|FG001|Overall Study|Physiologic non-responsiveness|3|||
164704947|NCT01398514|594946645|FG000|Overall Study|Failure to show a conditioned response|4|||
164704948|NCT01398514|594946646|FG001|Overall Study|Failure to show a conditioned response|3|||
164704949|NCT00754650|594946648|FG000|Overall Study|Disease Progression|2|||
164704950|NCT03167723|594946654|FG000|Overall Study|Protocol Violation|4|||
164704951|NCT03167723|594946655|FG001|Overall Study|Protocol Violation|6|||
164704952|NCT00507130|594946660|FG000|Overall Study|Lost to Follow-up|0|||
164442286|NCT05850520|593986500|FG001|Overall Study|Protocol deviation|0|||
164704953|NCT00507130|594946661|FG001|Overall Study|Lost to Follow-up|0|||
164704954|NCT00507130|594946662|FG002|Overall Study|Lost to Follow-up|1|||
164704955|NCT00507130|594946663|FG003|Overall Study|Lost to Follow-up|1|||
164704956|NCT00507130|594946660|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
164704957|NCT00507130|594946661|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
164704958|NCT00507130|594946662|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
164704959|NCT00507130|594946663|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
164704960|NCT02524730|594946664|FG000|Overall Study|Lost to Follow-up|5|||
164397751|NCT00756509|593825251|FG000|Core Phase|Adverse Event|2|||
164397752|NCT00756509|593825251|FG000|Core Phase|Lack of Efficacy|2|||
164397753|NCT00756509|593825251|FG000|Core Phase|Disease progression|6|||
164397754|NCT00756509|593825251|FG000|Follow-Up Phase|Missing values|2|||
164397755|NCT00756509|593825251|FG000|Follow-Up Phase|Disease progression|9|||
164595563|NCT01689207|594543187|FG003|Overall Study|Adverse Event|0|||
164595564|NCT01689207|594543188|FG004|Overall Study|Adverse Event|2|||
164595565|NCT01689207|594543189|FG005|Overall Study|Adverse Event|1|||
164595566|NCT01689207|594543190|FG006|Overall Study|Adverse Event|0|||
164595567|NCT01689207|594543191|FG007|Overall Study|Adverse Event|0|||
164595568|NCT01689207|594543192|FG008|Overall Study|Adverse Event|1|||
164595569|NCT01689207|594543193|FG009|Overall Study|Adverse Event|0|||
164595570|NCT01689207|594543194|FG010|Overall Study|Adverse Event|0|||
164595571|NCT00364845|594543195|FG000|Overall Study|Adverse Event|1|||
164595572|NCT00364845|594543196|FG001|Overall Study|Adverse Event|0|||
164595573|NCT00364845|594543195|FG000|Overall Study|Withdrawal by Subject|2|||
164595574|NCT00364845|594543196|FG001|Overall Study|Withdrawal by Subject|1|||
164595575|NCT00364845|594543195|FG000|Overall Study|Physician Decision|8|||
164595576|NCT00364845|594543196|FG001|Overall Study|Physician Decision|8|||
164595577|NCT00364845|594543195|FG000|Overall Study|Lost to Follow-up|0|||
164595578|NCT00364845|594543196|FG001|Overall Study|Lost to Follow-up|1|||
164595579|NCT00364845|594543195|FG000|Overall Study|Death|0|||
164397756|NCT00756509|593825251|FG000|Follow-Up Phase|Administrative problems|3|||
164397757|NCT00756509|593825251|FG000|Follow-Up Phase|Lost to Follow-up|1|||
164397758|NCT00756509|593825251|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
164397759|NCT00756509|593825251|FG000|Follow-Up Phase|Subject's condition no longer requires study drug|1|||
164397760|NCT00756509|593825251|FG000|Follow-Up Phase|Adverse Event|7|||
164595580|NCT00364845|594543196|FG001|Overall Study|Death|1|||
164595581|NCT01423617|594543197|FG000|Overall Study|Lost to Follow-up|0|||
164595582|NCT01423617|594543198|FG001|Overall Study|Lost to Follow-up|1|||
164595583|NCT03591146|594543202|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
164595584|NCT03591146|594543203|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
164595585|NCT03591146|594543204|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
164595586|NCT03591146|594543205|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
164595587|NCT03591146|594543206|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
164417552|NCT01474512|593899494|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
164417553|NCT01474512|593899495|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
164417554|NCT01474512|593899496|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
164417555|NCT01474512|593899497|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
164417556|NCT01474512|593899498|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
164417557|NCT01474512|593899499|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
164417558|NCT01474512|593899500|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
164417559|NCT01474512|593899501|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
164417560|NCT01474512|593899502|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
164417561|NCT01474512|593899503|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
164417562|NCT01474512|593899504|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
164417563|NCT01474512|593899505|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
164417564|NCT01474512|593899506|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
164417565|NCT01474512|593899489|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
164417566|NCT01474512|593899490|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
164417567|NCT01474512|593899491|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
164417568|NCT01474512|593899492|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
164417569|NCT01474512|593899493|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
164417570|NCT01474512|593899494|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
164417571|NCT01474512|593899495|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
164417572|NCT01474512|593899496|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
164417573|NCT01474512|593899497|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
164417574|NCT01474512|593899498|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
164417575|NCT01474512|593899499|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
164417576|NCT01474512|593899500|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
164417577|NCT01474512|593899501|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
164417578|NCT01474512|593899502|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
164417579|NCT01474512|593899503|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
164417580|NCT01474512|593899504|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
164417581|NCT01474512|593899505|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
164417582|NCT01474512|593899506|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
164417583|NCT01474512|593899489|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
164417584|NCT01474512|593899490|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
164417585|NCT01474512|593899491|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
164417586|NCT01474512|593899492|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
164417587|NCT01474512|593899493|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
164417588|NCT01474512|593899494|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
164417589|NCT01474512|593899495|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
164417590|NCT01474512|593899496|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
164417591|NCT01474512|593899497|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
164417592|NCT01474512|593899498|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
164397780|NCT02822222|593826343|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
164397781|NCT02822222|593826344|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
164397782|NCT00833560|593826345|FG000|Overall Study|Toxicity|13|||
164397783|NCT00833560|593826345|FG000|Overall Study|Adverse Event|11|||
164397784|NCT00833560|593826345|FG000|Overall Study|Protocol Violation|6|||
164397785|NCT00833560|593826345|FG000|Overall Study|Lack of Efficacy|4|||
164397786|NCT00833560|593826345|FG000|Overall Study|Death|2|||
164397787|NCT00833560|593826345|FG000|Overall Study|Pregression of other disease|1|||
164397788|NCT00833560|593826345|FG000|Overall Study|Other|5|||
164397789|NCT03382782|593826348|FG000|Cohort 1|Withdrawal by Subject|11|||
164397790|NCT03382782|593826349|FG001|Cohort 1|Withdrawal by Subject|5|||
164397791|NCT03382782|593826350|FG002|Cohort 1|Withdrawal by Subject|0|||
164397792|NCT03382782|593826348|FG000|Cohort 2|Withdrawal by Subject|1|||
164397793|NCT03382782|593826349|FG001|Cohort 2|Withdrawal by Subject|1|||
164397794|NCT03382782|593826350|FG002|Cohort 2|Withdrawal by Subject|0|||
164397795|NCT03382782|593826348|FG000|Cohort 3|Withdrawal by Subject|1|||
164397796|NCT03382782|593826349|FG001|Cohort 3|Withdrawal by Subject|2|||
164397797|NCT03382782|593826350|FG002|Cohort 3|Withdrawal by Subject|0|||
164397798|NCT01791725|593826352|FG000|Overall Study|Withdrawal by Subject|0|||
164397799|NCT01791725|593826353|FG001|Overall Study|Withdrawal by Subject|1|||
164397800|NCT01791725|593826354|FG002|Overall Study|Withdrawal by Subject|0|||
164397801|NCT02690974|593826357|FG000|Overall Study|Adverse Event|16|||
164397802|NCT02690974|593826357|FG000|Overall Study|Death|9|||
164397803|NCT02690974|593826357|FG000|Overall Study|Subject/guardian decision|4|||
164397804|NCT02690974|593826357|FG000|Overall Study|Lost to Follow-up|3|||
164442287|NCT05850520|593986501|FG002|Overall Study|Protocol deviation|1|||
164442288|NCT05850520|593986499|FG000|Overall Study|No information was available on whether follow-up was completed or not|0|||
164704961|NCT02524730|594946664|FG000|Overall Study|Withdrawal by Subject|18|||
164704962|NCT02524730|594946664|FG000|Overall Study|Death|10|||
164442289|NCT05850520|593986500|FG001|Overall Study|No information was available on whether follow-up was completed or not|2|||
164442290|NCT05850520|593986501|FG002|Overall Study|No information was available on whether follow-up was completed or not|2|||
164442291|NCT03785782|593987464|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
164442292|NCT03785782|593987465|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
164442293|NCT03785782|593987464|FG000|Overall Study|Withdrawal by Subject|1|||
164442294|NCT03785782|593987465|FG001|Overall Study|Withdrawal by Subject|1|||
164442295|NCT03785782|593987464|FG000|Overall Study|insufficient image quality.|3|||
164442296|NCT03785782|593987465|FG001|Overall Study|insufficient image quality.|0|||
164442297|NCT05777785|593987466|FG000|Overall Study|Withdrawal by Subject|5|||
164442298|NCT05777785|593987466|FG000|Overall Study|Lost to Follow-up|1|||
164442299|NCT04817670|593987467|FG000|Overall Study|Withdrawal by Subject|1|||
164442300|NCT04817670|593987468|FG001|Overall Study|Withdrawal by Subject|0|||
164442301|NCT04817670|593987469|FG002|Overall Study|Withdrawal by Subject|0|||
164442302|NCT04817670|593987470|FG003|Overall Study|Withdrawal by Subject|0|||
164442303|NCT04817670|593987471|FG004|Overall Study|Withdrawal by Subject|0|||
164442304|NCT04817670|593987467|FG000|Overall Study|Lost to Follow-up|0|||
164442305|NCT04817670|593987468|FG001|Overall Study|Lost to Follow-up|0|||
164442306|NCT04817670|593987469|FG002|Overall Study|Lost to Follow-up|1|||
164442307|NCT04817670|593987470|FG003|Overall Study|Lost to Follow-up|0|||
164442308|NCT04817670|593987471|FG004|Overall Study|Lost to Follow-up|0|||
164704963|NCT02524730|594946664|FG000|Overall Study|Adverse Event|8|||
164704964|NCT02524730|594946664|FG000|Overall Study|Protocol Violation|1|||
164704965|NCT02524730|594946664|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
164442309|NCT00304031|593987472|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
164442310|NCT00304031|593987473|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
164442311|NCT00304031|593987474|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
164442312|NCT00304031|593987472|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
164442313|NCT00304031|593987473|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
164442314|NCT00304031|593987474|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
164442315|NCT00304031|593987472|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
164442316|NCT00304031|593987473|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
164442317|NCT00304031|593987474|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
164442318|NCT00304031|593987472|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
164704966|NCT00699374|594946672|FG000|Overall Study|Death|93|||
164704967|NCT00699374|594946673|FG001|Overall Study|Death|83|||
164704968|NCT00699374|594946672|FG000|Overall Study|Adverse Event|70|||
164704969|NCT00699374|594946673|FG001|Overall Study|Adverse Event|67|||
164397805|NCT02690974|593826357|FG000|Overall Study|Withdrawal of Informed Consent|3|||
164397806|NCT02690974|593826357|FG000|Overall Study|Physician Decision|2|||
164397807|NCT02690974|593826357|FG000|Overall Study|Non-compliance with study treatment|1|||
164442319|NCT00304031|593987473|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
164442320|NCT00304031|593987474|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
164397808|NCT02690974|593826357|FG000|Overall Study|Protocol-defined stopping criteria|1|||
164397809|NCT02690974|593826357|FG000|Overall Study|Protocol Deviation|1|||
164397810|NCT01666951|593826358|FG000|Overall Study|Not dosed|1|||
164397811|NCT01666951|593826359|FG001|Overall Study|Not dosed|1|||
164397812|NCT03338894|593826362|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
164397813|NCT02548455|593826363|FG000|Overall Study|Withdrawal by Subject|27|||
164397814|NCT02548455|593826363|FG000|Overall Study|Death|26|||
164397815|NCT02548455|593826363|FG000|Overall Study|Lost to Follow-up|14|||
164397816|NCT02548455|593826363|FG000|Overall Study|Visit not completed|173|||
164397817|NCT02525874|593826368|FG000|Overall Study|Other|1|||
164397818|NCT02525874|593826368|FG000|Overall Study|Investigator Decision|1|||
164397819|NCT02525874|593826368|FG000|Overall Study|Consent withdrawn|22|||
164397820|NCT02525874|593826368|FG000|Overall Study|Non-compliance with study drug|3|||
164397821|NCT02525874|593826368|FG000|Overall Study|Adverse Event|17|||
164397822|NCT02525874|593826368|FG000|Overall Study|Lost to Follow-up|7|||
164397823|NCT02525874|593826368|FG000|Overall Study|Disease progression, defined by protocol|2|||
164397824|NCT02525874|593826368|FG000|Overall Study|Disease relapse|4|||
164397825|NCT02525874|593826368|FG000|Overall Study|Alternative Treatment for MS|2|||
164397826|NCT02525874|593826368|FG000|Overall Study|New lesions in Brain|1|||
164397827|NCT02794285|593826371|FG000|Overall Study|Adverse Event|11|||
164397828|NCT02794285|593826372|FG001|Overall Study|Adverse Event|4|||
164397829|NCT02794285|593826373|FG002|Overall Study|Adverse Event|5|||
164397830|NCT02794285|593826374|FG003|Overall Study|Adverse Event|8|||
164397831|NCT02794285|593826371|FG000|Overall Study|Condition Under Investigation Improved|1|||
164397832|NCT02794285|593826372|FG001|Overall Study|Condition Under Investigation Improved|0|||
164397833|NCT02794285|593826373|FG002|Overall Study|Condition Under Investigation Improved|0|||
164397834|NCT02794285|593826374|FG003|Overall Study|Condition Under Investigation Improved|0|||
164397835|NCT02794285|593826371|FG000|Overall Study|Condition Under Investigation Worsened|0|||
164397836|NCT02794285|593826372|FG001|Overall Study|Condition Under Investigation Worsened|2|||
164397837|NCT02794285|593826373|FG002|Overall Study|Condition Under Investigation Worsened|1|||
164397838|NCT02794285|593826374|FG003|Overall Study|Condition Under Investigation Worsened|0|||
164397839|NCT02794285|593826371|FG000|Overall Study|Death|2|||
164397840|NCT02794285|593826372|FG001|Overall Study|Death|1|||
164397841|NCT02794285|593826373|FG002|Overall Study|Death|2|||
164397842|NCT02794285|593826374|FG003|Overall Study|Death|0|||
164397843|NCT02794285|593826371|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
164397844|NCT02794285|593826372|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
164397845|NCT02794285|593826373|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
164397846|NCT02794285|593826374|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
164397847|NCT02794285|593826371|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
164397848|NCT02794285|593826372|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
164397849|NCT02794285|593826373|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
164397850|NCT02794285|593826374|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
164397851|NCT02794285|593826371|FG000|Overall Study|Lack of Efficacy|10|||
164397852|NCT02794285|593826372|FG001|Overall Study|Lack of Efficacy|6|||
164397853|NCT02794285|593826373|FG002|Overall Study|Lack of Efficacy|3|||
164397854|NCT02794285|593826374|FG003|Overall Study|Lack of Efficacy|3|||
164397855|NCT02794285|593826371|FG000|Overall Study|Lost to Follow-up|5|||
164397856|NCT02794285|593826372|FG001|Overall Study|Lost to Follow-up|6|||
164397857|NCT02794285|593826373|FG002|Overall Study|Lost to Follow-up|3|||
164397858|NCT02794285|593826374|FG003|Overall Study|Lost to Follow-up|1|||
164397859|NCT02794285|593826371|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
164397860|NCT02794285|593826372|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
164397861|NCT02794285|593826373|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
164397862|NCT02794285|593826374|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
164397863|NCT02794285|593826371|FG000|Overall Study|Withdrawal by Subject|38|||
164397864|NCT02794285|593826372|FG001|Overall Study|Withdrawal by Subject|29|||
164397865|NCT02794285|593826373|FG002|Overall Study|Withdrawal by Subject|20|||
164397866|NCT02794285|593826374|FG003|Overall Study|Withdrawal by Subject|12|||
164397867|NCT02794285|593826371|FG000|Overall Study|Missing|1|||
164704970|NCT00699374|594946672|FG000|Overall Study|Global deterioration of health status|7|||
164704971|NCT00699374|594946673|FG001|Overall Study|Global deterioration of health status|8|||
164704972|NCT00699374|594946672|FG000|Overall Study|Lost to Follow-up|3|||
164704973|NCT00699374|594946673|FG001|Overall Study|Lost to Follow-up|5|||
164704974|NCT00699374|594946672|FG000|Overall Study|Withdrawal by Subject|34|||
164704975|NCT00699374|594946673|FG001|Overall Study|Withdrawal by Subject|44|||
164397868|NCT02794285|593826372|FG001|Overall Study|Missing|0|||
164397869|NCT02794285|593826373|FG002|Overall Study|Missing|0|||
164397870|NCT02794285|593826374|FG003|Overall Study|Missing|0|||
164397871|NCT02794285|593826371|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
164397872|NCT02794285|593826372|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
164397873|NCT02794285|593826373|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
164397874|NCT02794285|593826374|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
164397875|NCT02794285|593826371|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
164397876|NCT02794285|593826372|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
164397877|NCT02794285|593826373|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
164397878|NCT02794285|593826374|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
164397879|NCT00423176|593826375|FG000|Overall Study|Adverse Event|4|||
164397880|NCT00423176|593826376|FG001|Overall Study|Adverse Event|6|||
164397881|NCT00423176|593826375|FG000|Overall Study|Treatment Failure|1|||
164397882|NCT00423176|593826376|FG001|Overall Study|Treatment Failure|6|||
164397883|NCT00423176|593826375|FG000|Overall Study|Lost to Follow-up|4|||
164397884|NCT00423176|593826376|FG001|Overall Study|Lost to Follow-up|7|||
164397885|NCT00423176|593826375|FG000|Overall Study|Withdrawal by Subject|4|||
164397886|NCT00423176|593826376|FG001|Overall Study|Withdrawal by Subject|3|||
164397887|NCT00423176|593826375|FG000|Overall Study|Protocol Violation|1|||
164397888|NCT00423176|593826376|FG001|Overall Study|Protocol Violation|3|||
164397889|NCT00423176|593826375|FG000|Overall Study|Did not meet protocol eligibility|2|||
164397890|NCT00423176|593826376|FG001|Overall Study|Did not meet protocol eligibility|4|||
164397891|NCT04535947|593826377|FG000|Overall Study|Adverse Event|1|||
164397892|NCT04535947|593826378|FG001|Overall Study|Adverse Event|4|||
164397893|NCT04535947|593826377|FG000|Overall Study|Other reasons not specified|2|||
164397894|NCT04535947|593826378|FG001|Overall Study|Other reasons not specified|0|||
164397895|NCT04535947|593826377|FG000|Overall Study|Withdrawal by Subject|1|||
164397896|NCT04535947|593826378|FG001|Overall Study|Withdrawal by Subject|1|||
164397897|NCT04867369|593826384|FG000|Overall Study|Withdrawal by Subject|1|||
164397898|NCT04867369|593826385|FG001|Overall Study|Withdrawal by Subject|0|||
164397899|NCT03896035|593826391|FG000|Overall Study|Lost to Follow-up|2|||
164397900|NCT03896035|593826392|FG001|Overall Study|Lost to Follow-up|6|||
164397901|NCT03896035|593826391|FG000|Overall Study|Withdrawal by Subject|0|||
164397902|NCT03896035|593826392|FG001|Overall Study|Withdrawal by Subject|1|||
164397903|NCT03896035|593826391|FG000|Overall Study|Health/family health issues during COVID|0|||
164397904|NCT03896035|593826392|FG001|Overall Study|Health/family health issues during COVID|4|||
164397905|NCT00675766|593826402|FG000|Overall Study|Lost to Follow-up|6|||
164397906|NCT00675766|593826403|FG001|Overall Study|Lost to Follow-up|5|||
164397907|NCT00675766|593826404|FG002|Overall Study|Lost to Follow-up|21|||
164397908|NCT00675766|593826405|FG003|Overall Study|Lost to Follow-up|26|||
164397909|NCT01749982|593826406|FG000|Overall Study|Physician Decision|0|||
164397910|NCT01749982|593826407|FG001|Overall Study|Physician Decision|0|||
164397911|NCT01749982|593826408|FG002|Overall Study|Physician Decision|0|||
164397912|NCT01749982|593826409|FG003|Overall Study|Physician Decision|1|||
164397913|NCT01749982|593826406|FG000|Overall Study|Lost to Follow-up|0|||
164397914|NCT01749982|593826407|FG001|Overall Study|Lost to Follow-up|0|||
164397915|NCT01749982|593826408|FG002|Overall Study|Lost to Follow-up|0|||
164397916|NCT01749982|593826409|FG003|Overall Study|Lost to Follow-up|1|||
164397917|NCT01749982|593826406|FG000|Overall Study|Withdrawal by Subject|0|||
164397918|NCT01749982|593826407|FG001|Overall Study|Withdrawal by Subject|0|||
164397919|NCT01749982|593826408|FG002|Overall Study|Withdrawal by Subject|0|||
164397920|NCT01749982|593826409|FG003|Overall Study|Withdrawal by Subject|1|||
164397921|NCT02677116|593826410|FG000|Overall Study|Adverse Event|0|||
164442321|NCT00304031|593987472|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
164442322|NCT00304031|593987473|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
164442323|NCT00304031|593987474|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
164442324|NCT00304031|593987472|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
164442325|NCT00304031|593987473|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
164442326|NCT00304031|593987474|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
164442327|NCT00304031|593987472|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
164442328|NCT00304031|593987473|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
164442329|NCT00304031|593987474|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
164442330|NCT00304031|593987472|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
164442331|NCT00304031|593987473|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
164442332|NCT00304031|593987474|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
164442333|NCT00304031|593987472|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
164442334|NCT00304031|593987473|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
164397922|NCT02677116|593826411|FG001|Overall Study|Adverse Event|1|||
164397923|NCT02677116|593826412|FG002|Overall Study|Adverse Event|0|||
164397924|NCT02677116|593826413|FG003|Overall Study|Adverse Event|0|||
164397925|NCT02677116|593826414|FG004|Overall Study|Adverse Event|0|||
164397926|NCT02677116|593826415|FG005|Overall Study|Adverse Event|1|||
164397927|NCT02677116|593826416|FG006|Overall Study|Adverse Event|1|||
164397928|NCT02677116|593826417|FG007|Overall Study|Adverse Event|0|||
164397929|NCT02677116|593826418|FG008|Overall Study|Adverse Event|0|||
164397930|NCT02677116|593826410|FG000|Overall Study|Physician Decision|0|||
164397931|NCT02677116|593826411|FG001|Overall Study|Physician Decision|2|||
164397932|NCT02677116|593826412|FG002|Overall Study|Physician Decision|3|||
164442335|NCT00304031|593987474|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
164442336|NCT01188655|593987475|FG000|Overall Study|Lack of Efficacy|1|||
164397933|NCT02677116|593826413|FG003|Overall Study|Physician Decision|2|||
164397934|NCT02677116|593826414|FG004|Overall Study|Physician Decision|1|||
164397935|NCT02677116|593826415|FG005|Overall Study|Physician Decision|3|||
164397936|NCT02677116|593826416|FG006|Overall Study|Physician Decision|1|||
164397937|NCT02677116|593826417|FG007|Overall Study|Physician Decision|1|||
164397938|NCT02677116|593826418|FG008|Overall Study|Physician Decision|2|||
164397939|NCT02677116|593826410|FG000|Overall Study|Withdrawal by parent or guardian|2|||
164397940|NCT02677116|593826411|FG001|Overall Study|Withdrawal by parent or guardian|1|||
164397941|NCT02677116|593826412|FG002|Overall Study|Withdrawal by parent or guardian|0|||
164397942|NCT02677116|593826413|FG003|Overall Study|Withdrawal by parent or guardian|1|||
164397943|NCT02677116|593826414|FG004|Overall Study|Withdrawal by parent or guardian|0|||
164397944|NCT02677116|593826415|FG005|Overall Study|Withdrawal by parent or guardian|0|||
164397945|NCT02677116|593826416|FG006|Overall Study|Withdrawal by parent or guardian|2|||
164397946|NCT02677116|593826417|FG007|Overall Study|Withdrawal by parent or guardian|1|||
164397947|NCT02677116|593826418|FG008|Overall Study|Withdrawal by parent or guardian|0|||
164397948|NCT02677116|593826410|FG000|Overall Study|Withdrawal by Subject|1|||
164397949|NCT02677116|593826411|FG001|Overall Study|Withdrawal by Subject|0|||
164397950|NCT02677116|593826412|FG002|Overall Study|Withdrawal by Subject|0|||
164397951|NCT02677116|593826413|FG003|Overall Study|Withdrawal by Subject|0|||
164397952|NCT02677116|593826414|FG004|Overall Study|Withdrawal by Subject|0|||
164397953|NCT02677116|593826415|FG005|Overall Study|Withdrawal by Subject|0|||
164397954|NCT02677116|593826416|FG006|Overall Study|Withdrawal by Subject|0|||
164397955|NCT02677116|593826417|FG007|Overall Study|Withdrawal by Subject|0|||
164397956|NCT02677116|593826418|FG008|Overall Study|Withdrawal by Subject|0|||
164397957|NCT01207102|593826423|FG000|Overall Study|Withdrawal by Subject|5|||
164397958|NCT01207102|593826423|FG000|Overall Study|Adverse Event|2|||
164397959|NCT01207102|593826423|FG000|Overall Study|progression|2|||
164397960|NCT01207102|593826423|FG000|Overall Study|Withdrawal by Treating Physician|1|||
164397961|NCT01018394|593826424|FG000|Overall Study|Withdrawal by Subject|5|||
164397962|NCT01018394|593826425|FG001|Overall Study|Withdrawal by Subject|5|||
164397963|NCT01018394|593826424|FG000|Overall Study|Lost to Follow-up|4|||
164397964|NCT01018394|593826425|FG001|Overall Study|Lost to Follow-up|3|||
164397965|NCT03792126|593826426|FG000|Overall Study|Adverse Event|1|||
164397966|NCT03792126|593826427|FG001|Overall Study|Adverse Event|2|||
164397967|NCT03792126|593826426|FG000|Overall Study|Death|0|||
164397968|NCT03792126|593826427|FG001|Overall Study|Death|1|||
164397969|NCT03792126|593826426|FG000|Overall Study|Lost to Follow-up|1|||
164397970|NCT03792126|593826427|FG001|Overall Study|Lost to Follow-up|0|||
164397971|NCT03792126|593826426|FG000|Overall Study|Withdrawal by Subject|0|||
164397972|NCT03792126|593826427|FG001|Overall Study|Withdrawal by Subject|1|||
164397973|NCT03792126|593826426|FG000|Overall Study|COVID-19 Restrictions|1|||
164397974|NCT03792126|593826427|FG001|Overall Study|COVID-19 Restrictions|3|||
164397975|NCT03792126|593826426|FG000|Overall Study|Symptoms resolved|0|||
164397976|NCT03792126|593826427|FG001|Overall Study|Symptoms resolved|3|||
164397977|NCT04302350|593826428|FG000|Overall Study|Physician Decision|1|||
164397978|NCT04302350|593826429|FG001|Overall Study|Physician Decision|1|||
164397979|NCT04302350|593826430|FG002|Overall Study|Physician Decision|2|||
164397980|NCT04302350|593826428|FG000|Overall Study|Lack of Efficacy|1|||
164397981|NCT04302350|593826429|FG001|Overall Study|Lack of Efficacy|1|||
164397982|NCT04302350|593826430|FG002|Overall Study|Lack of Efficacy|4|||
164397983|NCT04302350|593826428|FG000|Overall Study|Adverse Event|0|||
164397984|NCT04302350|593826429|FG001|Overall Study|Adverse Event|1|||
164397985|NCT04302350|593826430|FG002|Overall Study|Adverse Event|2|||
164397986|NCT00490646|593826431|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
164442337|NCT01188655|593987475|FG000|Overall Study|Lost to Follow-up|1|||
164442338|NCT01188655|593987475|FG000|Overall Study|Other|11|||
164442339|NCT00925899|593987478|FG000|Part 1|Death|1|||
164442340|NCT00925899|593987479|FG001|Part 1|Death|2|||
164442341|NCT00925899|593987478|FG000|Part 1|Withdrawal by Subject|10|||
164442342|NCT00925899|593987479|FG001|Part 1|Withdrawal by Subject|9|||
164442343|NCT00089544|593987480|FG000|Overall Study|Ineligible|1|||
164442344|NCT00089544|593987481|FG001|Overall Study|Ineligible|0|||
164595588|NCT03591146|594543202|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
164595589|NCT03591146|594543203|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
164595590|NCT03591146|594543204|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
164595591|NCT03591146|594543205|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
164595592|NCT03591146|594543206|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
164595593|NCT03591146|594543202|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
164595594|NCT03591146|594543203|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
164595595|NCT03591146|594543204|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
164595596|NCT03591146|594543205|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
164595597|NCT03591146|594543206|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
164595598|NCT03591146|594543202|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
164595599|NCT03591146|594543203|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
164595600|NCT03591146|594543204|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
164595601|NCT03591146|594543205|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
164595602|NCT03591146|594543206|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
164595603|NCT04737031|594543207|FG000|Overall Study|Patients who did not have a treatment visit|0|||
164595604|NCT04737031|594543208|FG001|Overall Study|Patients who did not have a treatment visit|31|||
164704976|NCT00699374|594946672|FG000|Overall Study|Objective progression or relapse|281|||
164397987|NCT00490646|593826432|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
164397988|NCT00490646|593826431|FG000|Overall Study|Never Treated (had an adverse event)|1|||
164397989|NCT00490646|593826432|FG001|Overall Study|Never Treated (had an adverse event)|0|||
164397990|NCT00490646|593826431|FG000|Overall Study|Never Treated (withdrew consent)|0|||
164397991|NCT00490646|593826432|FG001|Overall Study|Never Treated (withdrew consent)|1|||
164397992|NCT00983073|593826434|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
164397993|NCT00983073|593826434|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
164397994|NCT00983073|593826434|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
164397995|NCT00983073|593826434|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
164397996|NCT00983073|593826434|FG000|Titration and Optimal Dose Period|Other reason|4|||
164397997|NCT00983073|593826434|FG000|Maintenance Period|Adverse Event|5|||
164397998|NCT00983073|593826434|FG000|Maintenance Period|Withdrawal by Subject|2|||
164397999|NCT00983073|593826434|FG000|Maintenance Period|Lack of Efficacy|2|||
164398000|NCT00983073|593826434|FG000|Maintenance Period|Other Reason|7|||
164398001|NCT02962908|593826437|FG000|Overall Study|Lost to Follow-up|0|||
164398002|NCT02962908|593826438|FG001|Overall Study|Lost to Follow-up|3|||
164398003|NCT02962908|593826439|FG002|Overall Study|Lost to Follow-up|0|||
164398004|NCT02962908|593826440|FG003|Overall Study|Lost to Follow-up|1|||
164398005|NCT02962908|593826437|FG000|Overall Study|Withdrawal by Subject|0|||
164398006|NCT02962908|593826438|FG001|Overall Study|Withdrawal by Subject|3|||
164398007|NCT02962908|593826439|FG002|Overall Study|Withdrawal by Subject|0|||
164398008|NCT02962908|593826440|FG003|Overall Study|Withdrawal by Subject|2|||
164398009|NCT02962908|593826437|FG000|Overall Study|Protocol Violation|0|||
164398010|NCT02962908|593826438|FG001|Overall Study|Protocol Violation|1|||
164398011|NCT02962908|593826439|FG002|Overall Study|Protocol Violation|0|||
164398012|NCT02962908|593826440|FG003|Overall Study|Protocol Violation|0|||
164398013|NCT02962908|593826437|FG000|Overall Study|Physician Decision|0|||
164398014|NCT02962908|593826438|FG001|Overall Study|Physician Decision|1|||
164398015|NCT02962908|593826439|FG002|Overall Study|Physician Decision|0|||
164398016|NCT02962908|593826440|FG003|Overall Study|Physician Decision|0|||
164398017|NCT03543254|593826441|FG000|Overall Study|Lost to Follow-up|1|||
164398018|NCT02077166|593826442|FG000|Overall Study|Death|6|||
164398019|NCT02077166|593826443|FG001|Overall Study|Death|7|||
164398020|NCT02077166|593826444|FG002|Overall Study|Death|5|||
164398021|NCT02077166|593826445|FG003|Overall Study|Death|6|||
164398022|NCT02077166|593826446|FG004|Overall Study|Death|4|||
164398023|NCT02077166|593826447|FG005|Overall Study|Death|32|||
164398024|NCT02077166|593826448|FG006|Overall Study|Death|22|||
164398025|NCT02077166|593826442|FG000|Overall Study|Study Closure by Sponsor|3|||
164398026|NCT02077166|593826443|FG001|Overall Study|Study Closure by Sponsor|0|||
164398027|NCT02077166|593826444|FG002|Overall Study|Study Closure by Sponsor|2|||
164398028|NCT02077166|593826445|FG003|Overall Study|Study Closure by Sponsor|2|||
164398029|NCT02077166|593826446|FG004|Overall Study|Study Closure by Sponsor|2|||
164398030|NCT02077166|593826447|FG005|Overall Study|Study Closure by Sponsor|12|||
164398031|NCT02077166|593826448|FG006|Overall Study|Study Closure by Sponsor|4|||
164398032|NCT02077166|593826442|FG000|Overall Study|Lost to Follow-up|0|||
164398033|NCT02077166|593826443|FG001|Overall Study|Lost to Follow-up|0|||
164398034|NCT02077166|593826444|FG002|Overall Study|Lost to Follow-up|0|||
164398035|NCT02077166|593826445|FG003|Overall Study|Lost to Follow-up|0|||
164398036|NCT02077166|593826446|FG004|Overall Study|Lost to Follow-up|0|||
164398037|NCT02077166|593826447|FG005|Overall Study|Lost to Follow-up|1|||
164704977|NCT00699374|594946673|FG001|Overall Study|Objective progression or relapse|277|||
164704978|NCT00699374|594946672|FG000|Overall Study|Other|18|||
164704979|NCT00699374|594946673|FG001|Overall Study|Other|15|||
164704980|NCT00699374|594946672|FG000|Overall Study|Protocol Violation|2|||
164704981|NCT00699374|594946673|FG001|Overall Study|Protocol Violation|6|||
164704982|NCT00699374|594946672|FG000|Overall Study|Study terminated by sponsor|13|||
164398038|NCT02077166|593826448|FG006|Overall Study|Lost to Follow-up|0|||
164398039|NCT02077166|593826442|FG000|Overall Study|Withdrawal by Subject|3|||
164398040|NCT02077166|593826443|FG001|Overall Study|Withdrawal by Subject|0|||
164398041|NCT02077166|593826444|FG002|Overall Study|Withdrawal by Subject|1|||
164398042|NCT02077166|593826445|FG003|Overall Study|Withdrawal by Subject|1|||
164398043|NCT02077166|593826446|FG004|Overall Study|Withdrawal by Subject|1|||
164398044|NCT02077166|593826447|FG005|Overall Study|Withdrawal by Subject|3|||
164398045|NCT02077166|593826448|FG006|Overall Study|Withdrawal by Subject|0|||
164398046|NCT02077166|593826442|FG000|Overall Study|Other, Not Specified|0|||
164398047|NCT02077166|593826443|FG001|Overall Study|Other, Not Specified|0|||
164704983|NCT00699374|594946673|FG001|Overall Study|Study terminated by sponsor|28|||
164704984|NCT00699374|594946672|FG000|Overall Study|Randomized but not treated|4|||
164398048|NCT02077166|593826444|FG002|Overall Study|Other, Not Specified|1|||
164398049|NCT02077166|593826445|FG003|Overall Study|Other, Not Specified|0|||
164398050|NCT02077166|593826446|FG004|Overall Study|Other, Not Specified|1|||
164398051|NCT02077166|593826447|FG005|Overall Study|Other, Not Specified|7|||
164398052|NCT02077166|593826448|FG006|Overall Study|Other, Not Specified|8|||
164398053|NCT02899728|593826449|FG000|Overall Study|Withdrawal by Subject|1|||
164704985|NCT00699374|594946673|FG001|Overall Study|Randomized but not treated|2|||
164442345|NCT02396316|593987482|FG000|Overall Study|Physician Decision|1|||
164442346|NCT02396316|593987483|FG001|Overall Study|Physician Decision|0|||
164442347|NCT02396316|593987482|FG000|Overall Study|Progressive disease|6|||
164442348|NCT02396316|593987483|FG001|Overall Study|Progressive disease|3|||
164442349|NCT02396316|593987482|FG000|Overall Study|Protocol Violation|0|||
164442350|NCT02396316|593987483|FG001|Overall Study|Protocol Violation|1|||
164595605|NCT04737031|594543209|FG002|Overall Study|Patients who did not have a treatment visit|93|||
164595606|NCT04737031|594543210|FG003|Overall Study|Patients who did not have a treatment visit|227|||
164595607|NCT00142519|594543213|FG000|Overall Study|Not Treated|7|||
164595608|NCT00142519|594543214|FG001|Overall Study|Not Treated|9|||
164595609|NCT00142519|594543213|FG000|Overall Study|Protocol Violation|1|||
164595610|NCT00142519|594543214|FG001|Overall Study|Protocol Violation|0|||
164595611|NCT00142519|594543213|FG000|Overall Study|Withdrawal by Subject|10|||
164595612|NCT00142519|594543214|FG001|Overall Study|Withdrawal by Subject|7|||
164595613|NCT01511419|594543220|FG000|Dose 2|Physician Decision|1|||
164595614|NCT01511419|594543221|FG001|Dose 2|Physician Decision|0|||
164595615|NCT00937768|594543222|FG000|Overall Study|Refused Further Treatment|3|||
164595616|NCT00937768|594543223|FG001|Overall Study|Refused Further Treatment|2|||
164595617|NCT00937768|594543222|FG000|Overall Study|Disease Progression|1|||
164595618|NCT00937768|594543223|FG001|Overall Study|Disease Progression|1|||
164595619|NCT00937768|594543222|FG000|Overall Study|Alternate Treatment|0|||
164595620|NCT00937768|594543223|FG001|Overall Study|Alternate Treatment|1|||
164595621|NCT00937768|594543222|FG000|Overall Study|No Further Funding|4|||
164595622|NCT00937768|594543223|FG001|Overall Study|No Further Funding|4|||
164595623|NCT00762372|594544974|FG000|Overall Study|Adverse Event|1|||
164595624|NCT00762372|594544975|FG001|Overall Study|Adverse Event|0|||
164595625|NCT00762372|594544976|FG002|Overall Study|Adverse Event|0|||
164595626|NCT01194804|594544977|FG000|Overall Study|Withdrawal by Subject|1|||
164595627|NCT02670915|594544978|FG000|Overall Study|Withdrawal by Subject|0|||
164595628|NCT02670915|594544979|FG001|Overall Study|Withdrawal by Subject|1|||
164595629|NCT02670915|594544980|FG002|Overall Study|Withdrawal by Subject|4|||
164595630|NCT02670915|594544978|FG000|Overall Study|Withdrawal by parent/guardian|4|||
164595631|NCT02670915|594544979|FG001|Overall Study|Withdrawal by parent/guardian|4|||
164595632|NCT02670915|594544980|FG002|Overall Study|Withdrawal by parent/guardian|1|||
164595633|NCT02670915|594544978|FG000|Overall Study|Unclassified|0|||
164595634|NCT02670915|594544979|FG001|Overall Study|Unclassified|3|||
164595635|NCT02670915|594544980|FG002|Overall Study|Unclassified|0|||
164595636|NCT00165841|594544981|FG000|Overall Study|Adverse Event|2|||
164595637|NCT00165841|594544982|FG001|Overall Study|Adverse Event|3|||
164595638|NCT00165841|594544981|FG000|Overall Study|Lack of Efficacy|6|||
164595639|NCT00165841|594544982|FG001|Overall Study|Lack of Efficacy|33|||
164595640|NCT00165841|594544981|FG000|Overall Study|Lost to Follow-up|4|||
164595641|NCT00165841|594544982|FG001|Overall Study|Lost to Follow-up|4|||
164595642|NCT00165841|594544981|FG000|Overall Study|Withdrawal by Subject|7|||
164595643|NCT00165841|594544982|FG001|Overall Study|Withdrawal by Subject|8|||
164595644|NCT00165841|594544981|FG000|Overall Study|Physician Decision|1|||
164595645|NCT00165841|594544982|FG001|Overall Study|Physician Decision|0|||
164595646|NCT00165841|594544981|FG000|Overall Study|Protocol Violation|6|||
164595647|NCT00165841|594544982|FG001|Overall Study|Protocol Violation|8|||
164595648|NCT00165841|594544981|FG000|Overall Study|Other|3|||
164595649|NCT00165841|594544982|FG001|Overall Study|Other|5|||
164595650|NCT00165841|594544981|FG000|Overall Study|Medication Noncompliance|1|||
164595651|NCT00165841|594544982|FG001|Overall Study|Medication Noncompliance|1|||
164595652|NCT01000727|594544983|FG000|Overall Study|Lost to Follow-up|41|||
164595653|NCT01000727|594544984|FG001|Overall Study|Lost to Follow-up|43|||
164595654|NCT01000727|594544983|FG000|Overall Study|Withdrawal by Subject|111|||
164595655|NCT01000727|594544984|FG001|Overall Study|Withdrawal by Subject|109|||
164595656|NCT01000727|594544983|FG000|Overall Study|Study closed/terminated|23|||
164595657|NCT01000727|594544984|FG001|Overall Study|Study closed/terminated|24|||
164595658|NCT01026389|594544987|FG000|Overall Study|Withdrawal by Subject|1|||
164595659|NCT01026389|594544988|FG001|Overall Study|Withdrawal by Subject|3|||
164595660|NCT01026389|594544987|FG000|Overall Study|change of treatment, patient moved|4|||
164595661|NCT01026389|594544988|FG001|Overall Study|change of treatment, patient moved|2|||
164595662|NCT01995136|594544989|FG000|Overall Study|Change in residence|1|||
164442351|NCT02396316|593987482|FG000|Overall Study|Treatment unblinded|0|||
164595663|NCT01626352|594544993|FG000|Overall Study|Disease Progression|3|||
164595664|NCT01626352|594544993|FG000|Overall Study|Intercurrent Illness|2|||
164595665|NCT01626352|594544993|FG000|Overall Study|Death|2|||
164595666|NCT01626352|594544993|FG000|Overall Study|Withdrawal by Subject|1|||
164595667|NCT01626352|594544993|FG000|Overall Study|Non-Compliance|1|||
164595668|NCT01626352|594544993|FG000|Overall Study|Never Treated|1|||
164595669|NCT01030458|594544998|FG000|Overall Study|Lost to Follow-up|9|||
164595670|NCT01030458|594544999|FG001|Overall Study|Lost to Follow-up|10|||
164595671|NCT01030458|594544998|FG000|Overall Study|Withdrawal by Subject|2|||
164595672|NCT01030458|594544999|FG001|Overall Study|Withdrawal by Subject|3|||
164595673|NCT01030458|594544998|FG000|Overall Study|Logistical reasons|9|||
164595674|NCT01030458|594544999|FG001|Overall Study|Logistical reasons|5|||
164595675|NCT01030458|594544998|FG000|Overall Study|Moved or changed job|6|||
164442352|NCT02396316|593987483|FG001|Overall Study|Treatment unblinded|1|||
164704986|NCT00699374|594946672|FG000|Overall Study|Died 28 days after last dose|5|||
164704987|NCT00699374|594946673|FG001|Overall Study|Died 28 days after last dose|9|||
164704988|NCT03678285|594946678|FG000|Overall Study|Adverse Event|2|||
164704989|NCT03678285|594946678|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
164704990|NCT03678285|594946678|FG000|Overall Study|Dehydrated prior to start of workout|1|||
164704991|NCT00123474|594946679|FG000|Randomized to Treatment|Randomized, never treated|1|||
164704992|NCT00123474|594946680|FG001|Randomized to Treatment|Randomized, never treated|4|||
164704993|NCT00123474|594946681|FG002|Randomized to Treatment|Randomized, never treated|2|||
164704994|NCT00123474|594946682|FG003|Randomized to Treatment|Randomized, never treated|1|||
164704995|NCT00123474|594946679|FG000|As Treated at Study Closure|not reported when site closed|1|||
164595676|NCT01030458|594544999|FG001|Overall Study|Moved or changed job|13|||
164595677|NCT01030458|594544998|FG000|Overall Study|Side effect of medication|1|||
164595678|NCT01030458|594544999|FG001|Overall Study|Side effect of medication|1|||
164595679|NCT00839423|594545002|FG000|Overall Study|Adverse Event|4|||
164595680|NCT00839423|594545003|FG001|Overall Study|Adverse Event|3|||
164595681|NCT00839423|594545004|FG002|Overall Study|Adverse Event|7|||
164595682|NCT00839423|594545005|FG003|Overall Study|Adverse Event|16|||
164595683|NCT00839423|594545002|FG000|Overall Study|Lack of Efficacy|6|||
164595684|NCT00839423|594545003|FG001|Overall Study|Lack of Efficacy|6|||
164595685|NCT00839423|594545004|FG002|Overall Study|Lack of Efficacy|3|||
164595686|NCT00839423|594545005|FG003|Overall Study|Lack of Efficacy|2|||
164595687|NCT00839423|594545002|FG000|Overall Study|Non-compliance|0|||
164595688|NCT00839423|594545003|FG001|Overall Study|Non-compliance|0|||
164595689|NCT00839423|594545004|FG002|Overall Study|Non-compliance|0|||
164595690|NCT00839423|594545005|FG003|Overall Study|Non-compliance|1|||
164595691|NCT00839423|594545002|FG000|Overall Study|Protocol Violation|0|||
164595692|NCT00839423|594545003|FG001|Overall Study|Protocol Violation|1|||
164595693|NCT00839423|594545004|FG002|Overall Study|Protocol Violation|2|||
164595694|NCT00839423|594545005|FG003|Overall Study|Protocol Violation|0|||
164595695|NCT00839423|594545002|FG000|Overall Study|Withdrawal of consent|4|||
164595696|NCT00839423|594545003|FG001|Overall Study|Withdrawal of consent|0|||
164595697|NCT00839423|594545004|FG002|Overall Study|Withdrawal of consent|4|||
164595698|NCT00839423|594545005|FG003|Overall Study|Withdrawal of consent|1|||
164595699|NCT00839423|594545002|FG000|Overall Study|Lost to Follow-up|1|||
164595700|NCT00839423|594545003|FG001|Overall Study|Lost to Follow-up|0|||
164595701|NCT00839423|594545004|FG002|Overall Study|Lost to Follow-up|1|||
164595702|NCT00839423|594545005|FG003|Overall Study|Lost to Follow-up|0|||
164595703|NCT00839423|594545002|FG000|Overall Study|Administrative or other reasons|3|||
164595704|NCT00839423|594545003|FG001|Overall Study|Administrative or other reasons|0|||
164595705|NCT00839423|594545004|FG002|Overall Study|Administrative or other reasons|1|||
164595706|NCT00839423|594545005|FG003|Overall Study|Administrative or other reasons|0|||
164595707|NCT01071096|594545006|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
164595708|NCT01071096|594545007|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
164595709|NCT02585999|594545008|FG000|Overall Study|Lost to Follow-up|1|||
164595710|NCT02585999|594545008|FG000|Overall Study|Protocol Violation|1|||
164595711|NCT00756886|594545011|FG000|Overall Study|Lost to Follow-up|1|||
164595712|NCT00756886|594545012|FG001|Overall Study|Lost to Follow-up|0|||
164595713|NCT00756886|594545011|FG000|Overall Study|Adverse Event|0|||
164595714|NCT00756886|594545012|FG001|Overall Study|Adverse Event|3|||
164595715|NCT00756886|594545011|FG000|Overall Study|Lack of Efficacy|1|||
164595716|NCT00756886|594545012|FG001|Overall Study|Lack of Efficacy|0|||
164595717|NCT00756886|594545011|FG000|Overall Study|Ineligible|9|||
164595718|NCT00756886|594545012|FG001|Overall Study|Ineligible|4|||
164595719|NCT00871377|594545016|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
164595720|NCT00871377|594545017|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
164595721|NCT00871377|594545018|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
164595722|NCT00871377|594545019|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
164595723|NCT00871377|594545020|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
164595724|NCT00871377|594545021|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
164595725|NCT00871377|594545016|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
164595726|NCT00871377|594545017|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
164595727|NCT00871377|594545018|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
164595728|NCT00871377|594545019|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
164595729|NCT00871377|594545020|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
164595730|NCT00871377|594545021|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
164595731|NCT00871377|594545016|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
164595732|NCT00871377|594545017|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
164595733|NCT00871377|594545018|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
164595734|NCT00871377|594545019|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
164595735|NCT00871377|594545020|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
164595736|NCT00871377|594545021|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
164595737|NCT00871377|594545016|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
164595738|NCT00871377|594545017|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
164595739|NCT00871377|594545018|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
164595740|NCT00871377|594545019|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
164442353|NCT03648762|593987484|FG000|Overall Study|Lost to Follow-up|1|||
164442354|NCT03648762|593987485|FG001|Overall Study|Lost to Follow-up|2|||
164442355|NCT03648762|593987486|FG002|Overall Study|Lost to Follow-up|0|||
164442356|NCT03648762|593987484|FG000|Overall Study|Withdrawal by Subject|5|||
164442357|NCT03648762|593987485|FG001|Overall Study|Withdrawal by Subject|2|||
164442358|NCT03648762|593987486|FG002|Overall Study|Withdrawal by Subject|1|||
164442359|NCT01662336|593987492|FG000|Overall Study|Adverse Event|1|||
164442360|NCT01662336|593987492|FG000|Overall Study|No longer on LPV/r|30|||
164595741|NCT00871377|594545020|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
164595742|NCT00871377|594545021|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
164595743|NCT00871377|594545016|FG000|Third Intervention (10 Weeks)|Death|0|||
164595744|NCT00871377|594545017|FG001|Third Intervention (10 Weeks)|Death|0|||
164595745|NCT00871377|594545018|FG002|Third Intervention (10 Weeks)|Death|0|||
164595746|NCT00871377|594545019|FG003|Third Intervention (10 Weeks)|Death|1|||
164595747|NCT00871377|594545020|FG004|Third Intervention (10 Weeks)|Death|0|||
164595748|NCT00871377|594545021|FG005|Third Intervention (10 Weeks)|Death|0|||
164595749|NCT04348656|594545022|FG000|Overall Study|Withdrawal by Subject|2|||
164595750|NCT04348656|594545023|FG001|Overall Study|Withdrawal by Subject|0|||
164595751|NCT04348656|594545022|FG000|Overall Study|Lost to Follow-up|11|||
164595752|NCT04348656|594545023|FG001|Overall Study|Lost to Follow-up|6|||
164595753|NCT01395368|594545024|FG000|Overall Study|Physician Decision|14|||
164595754|NCT01395368|594545024|FG000|Overall Study|Withdrawal by Subject|2|||
164595755|NCT00288860|594545030|FG000|Overall Study|Did not complete intake|4|||
164595756|NCT00288860|594545031|FG001|Overall Study|Did not complete intake|8|||
164595757|NCT00288860|594545030|FG000|Overall Study|Death|4|||
164595758|NCT00288860|594545031|FG001|Overall Study|Death|3|||
164595759|NCT00288860|594545030|FG000|Overall Study|Withdrawal by Subject|20|||
164595760|NCT00288860|594545031|FG001|Overall Study|Withdrawal by Subject|15|||
164595761|NCT00288860|594545030|FG000|Overall Study|Lost to Follow-up|74|||
164595762|NCT00288860|594545031|FG001|Overall Study|Lost to Follow-up|71|||
164595763|NCT05142332|594545036|FG000|Overall Study|Withdrawal by Subject|0|||
164595764|NCT05142332|594545037|FG001|Overall Study|Withdrawal by Subject|1|||
164595765|NCT05142332|594545038|FG002|Overall Study|Withdrawal by Subject|2|||
164595766|NCT05142332|594545039|FG003|Overall Study|Withdrawal by Subject|0|||
164595767|NCT05142332|594545040|FG004|Overall Study|Withdrawal by Subject|0|||
164595768|NCT05142332|594545041|FG005|Overall Study|Withdrawal by Subject|2|||
164595769|NCT05142332|594545042|FG006|Overall Study|Withdrawal by Subject|6|||
164595770|NCT05142332|594545036|FG000|Overall Study|Left ED|3|||
164595771|NCT05142332|594545037|FG001|Overall Study|Left ED|0|||
164595772|NCT05142332|594545038|FG002|Overall Study|Left ED|4|||
164595773|NCT05142332|594545039|FG003|Overall Study|Left ED|6|||
164595774|NCT05142332|594545040|FG004|Overall Study|Left ED|1|||
164595775|NCT05142332|594545041|FG005|Overall Study|Left ED|2|||
164595776|NCT05142332|594545042|FG006|Overall Study|Left ED|6|||
164595777|NCT05142332|594545036|FG000|Overall Study|Physician Decision|0|||
164595778|NCT05142332|594545037|FG001|Overall Study|Physician Decision|0|||
164595779|NCT05142332|594545038|FG002|Overall Study|Physician Decision|2|||
164595780|NCT05142332|594545039|FG003|Overall Study|Physician Decision|1|||
164595781|NCT05142332|594545040|FG004|Overall Study|Physician Decision|0|||
164595782|NCT05142332|594545041|FG005|Overall Study|Physician Decision|0|||
164595783|NCT05142332|594545042|FG006|Overall Study|Physician Decision|3|||
164595784|NCT05142332|594545036|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
164595785|NCT05142332|594545037|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
164595786|NCT05142332|594545038|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
164595787|NCT05142332|594545039|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
164595788|NCT05142332|594545040|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
164595789|NCT05142332|594545041|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
164595790|NCT05142332|594545042|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
164595791|NCT00882999|594545045|FG000|Overall Study|Adverse Event|0|||
164595792|NCT00882999|594545046|FG001|Overall Study|Adverse Event|0|||
164595793|NCT00882999|594545047|FG002|Overall Study|Adverse Event|0|||
164595794|NCT00882999|594545048|FG003|Overall Study|Adverse Event|0|||
164595795|NCT00882999|594545049|FG004|Overall Study|Adverse Event|1|||
164595796|NCT00882999|594545050|FG005|Overall Study|Adverse Event|0|||
164595797|NCT00882999|594545051|FG006|Overall Study|Adverse Event|0|||
164595798|NCT00882999|594545045|FG000|Overall Study|Death|0|||
164595799|NCT00882999|594545046|FG001|Overall Study|Death|1|||
164595800|NCT00882999|594545047|FG002|Overall Study|Death|0|||
164595801|NCT00882999|594545048|FG003|Overall Study|Death|0|||
164595802|NCT00882999|594545049|FG004|Overall Study|Death|0|||
164595803|NCT00882999|594545050|FG005|Overall Study|Death|0|||
164442361|NCT01662336|593987492|FG000|Overall Study|Other|29|||
164595804|NCT00882999|594545051|FG006|Overall Study|Death|0|||
164595805|NCT00882999|594545045|FG000|Overall Study|Withdrawal by Subject|7|||
164595806|NCT00882999|594545046|FG001|Overall Study|Withdrawal by Subject|6|||
164595807|NCT00882999|594545047|FG002|Overall Study|Withdrawal by Subject|3|||
164595808|NCT00882999|594545048|FG003|Overall Study|Withdrawal by Subject|3|||
164704996|NCT00123474|594946680|FG001|As Treated at Study Closure|not reported when site closed|0|||
164704997|NCT00123474|594946681|FG002|As Treated at Study Closure|not reported when site closed|1|||
164704998|NCT00123474|594946682|FG003|As Treated at Study Closure|not reported when site closed|0|||
164704999|NCT00123474|594946679|FG000|As Treated at Study Closure|Adverse Event|10|||
164705000|NCT00123474|594946680|FG001|As Treated at Study Closure|Adverse Event|4|||
164705001|NCT00123474|594946681|FG002|As Treated at Study Closure|Adverse Event|10|||
164705002|NCT00123474|594946682|FG003|As Treated at Study Closure|Adverse Event|8|||
164705003|NCT00123474|594946679|FG000|As Treated at Study Closure|Disease Progression|35|||
164705004|NCT00123474|594946680|FG001|As Treated at Study Closure|Disease Progression|42|||
164705005|NCT00123474|594946681|FG002|As Treated at Study Closure|Disease Progression|29|||
164705006|NCT00123474|594946682|FG003|As Treated at Study Closure|Disease Progression|27|||
164705007|NCT00123474|594946679|FG000|As Treated at Study Closure|Investigator Request|12|||
164705008|NCT00123474|594946680|FG001|As Treated at Study Closure|Investigator Request|6|||
164705009|NCT00123474|594946681|FG002|As Treated at Study Closure|Investigator Request|7|||
164705010|NCT00123474|594946682|FG003|As Treated at Study Closure|Investigator Request|5|||
164705011|NCT00123474|594946679|FG000|As Treated at Study Closure|non-specified|54|||
164705012|NCT00123474|594946680|FG001|As Treated at Study Closure|non-specified|47|||
164705013|NCT00123474|594946681|FG002|As Treated at Study Closure|non-specified|57|||
164705014|NCT00123474|594946682|FG003|As Treated at Study Closure|non-specified|60|||
164705015|NCT00123474|594946679|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
164705016|NCT00123474|594946680|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
164705017|NCT00123474|594946681|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
164705018|NCT00123474|594946682|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
164705019|NCT00123474|594946679|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
164705020|NCT00123474|594946680|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
164705021|NCT00123474|594946681|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
164705022|NCT00123474|594946682|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
164398054|NCT02899728|593826450|FG001|Overall Study|Withdrawal by Subject|1|||
164398055|NCT01962493|593826451|FG000|Overall Study|Adverse Event|1|||
164398056|NCT01962493|593826452|FG001|Overall Study|Adverse Event|2|||
164398057|NCT01962493|593826451|FG000|Overall Study|Protocol Violation|0|||
164398058|NCT01962493|593826452|FG001|Overall Study|Protocol Violation|1|||
164398059|NCT01962493|593826451|FG000|Overall Study|Withdrawal by Subject|4|||
164398060|NCT01962493|593826452|FG001|Overall Study|Withdrawal by Subject|2|||
164398061|NCT01951625|593826453|FG000|Treatment Period|Protocol Violation|2|||
164398062|NCT01951625|593826454|FG001|Treatment Period|Protocol Violation|0|||
164398063|NCT01951625|593826455|FG002|Treatment Period|Protocol Violation|1|||
164398064|NCT01951625|593826456|FG003|Treatment Period|Protocol Violation|3|||
164398065|NCT01951625|593826457|FG004|Treatment Period|Protocol Violation|2|||
164398066|NCT01951625|593826453|FG000|Treatment Period|Physician Decision|0|||
164398067|NCT01951625|593826454|FG001|Treatment Period|Physician Decision|0|||
164398068|NCT01951625|593826455|FG002|Treatment Period|Physician Decision|0|||
164398069|NCT01951625|593826456|FG003|Treatment Period|Physician Decision|0|||
164398070|NCT01951625|593826457|FG004|Treatment Period|Physician Decision|1|||
164398071|NCT01951625|593826453|FG000|Treatment Period|Protocol driven decision point|0|||
164398072|NCT01951625|593826454|FG001|Treatment Period|Protocol driven decision point|5|||
164398073|NCT01951625|593826455|FG002|Treatment Period|Protocol driven decision point|0|||
164398074|NCT01951625|593826456|FG003|Treatment Period|Protocol driven decision point|2|||
164705023|NCT01059344|594946683|FG000|Overall Study|Adverse Event|12|||
164705024|NCT01059344|594946684|FG001|Overall Study|Adverse Event|30|||
164398075|NCT01951625|593826457|FG004|Treatment Period|Protocol driven decision point|1|||
164398076|NCT01951625|593826453|FG000|Treatment Period|Non compliance with study drug|1|||
164398077|NCT01951625|593826454|FG001|Treatment Period|Non compliance with study drug|2|||
164398078|NCT01951625|593826455|FG002|Treatment Period|Non compliance with study drug|2|||
164398079|NCT01951625|593826456|FG003|Treatment Period|Non compliance with study drug|0|||
164398080|NCT01951625|593826457|FG004|Treatment Period|Non compliance with study drug|0|||
164398081|NCT01951625|593826453|FG000|Treatment Period|Death|3|||
164398082|NCT01951625|593826454|FG001|Treatment Period|Death|2|||
164398083|NCT01951625|593826455|FG002|Treatment Period|Death|2|||
164398084|NCT01951625|593826456|FG003|Treatment Period|Death|1|||
164398085|NCT01951625|593826457|FG004|Treatment Period|Death|2|||
164398086|NCT01951625|593826453|FG000|Treatment Period|Adverse Event|7|||
164398087|NCT01951625|593826454|FG001|Treatment Period|Adverse Event|10|||
164705025|NCT01059344|594946683|FG000|Overall Study|Withdrawal by Subject|6|||
164705026|NCT01059344|594946684|FG001|Overall Study|Withdrawal by Subject|9|||
164705027|NCT01059344|594946683|FG000|Overall Study|Lost to Follow-up|1|||
164705028|NCT01059344|594946684|FG001|Overall Study|Lost to Follow-up|1|||
164705029|NCT01059344|594946683|FG000|Overall Study|Other|3|||
164705030|NCT01059344|594946684|FG001|Overall Study|Other|6|||
164705031|NCT02731326|594946689|FG000|Overall Study|Withdrawal by Subject|4|||
164398088|NCT01951625|593826455|FG002|Treatment Period|Adverse Event|9|||
164398089|NCT01951625|593826456|FG003|Treatment Period|Adverse Event|8|||
164398090|NCT01951625|593826457|FG004|Treatment Period|Adverse Event|8|||
164398091|NCT01951625|593826453|FG000|Treatment Period|Withdrawal by Subject|5|||
164398092|NCT01951625|593826454|FG001|Treatment Period|Withdrawal by Subject|2|||
164705032|NCT02731326|594946690|FG001|Overall Study|Withdrawal by Subject|1|||
164705033|NCT02731326|594946689|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
164705034|NCT02731326|594946690|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
164705035|NCT02731326|594946689|FG000|Overall Study|Discharged without AliveCor|10|||
164705036|NCT02731326|594946690|FG001|Overall Study|Discharged without AliveCor|0|||
164705037|NCT02731326|594946689|FG000|Overall Study|Duplicate Participant|1|||
164705038|NCT02731326|594946690|FG001|Overall Study|Duplicate Participant|1|||
164705039|NCT01085201|594946691|FG000|Overall Study|Scheduling conflict|1|||
164705040|NCT01085201|594946692|FG001|Overall Study|Scheduling conflict|0|||
164705041|NCT01085201|594946693|FG002|Overall Study|Scheduling conflict|1|||
164705042|NCT01085201|594946694|FG003|Overall Study|Scheduling conflict|0|||
164705043|NCT01085201|594946695|FG004|Overall Study|Scheduling conflict|0|||
164705044|NCT01085201|594946691|FG000|Overall Study|Unknown- no study drug|2|||
164705045|NCT01085201|594946692|FG001|Overall Study|Unknown- no study drug|0|||
164705046|NCT01085201|594946693|FG002|Overall Study|Unknown- no study drug|0|||
164705047|NCT01085201|594946694|FG003|Overall Study|Unknown- no study drug|0|||
164705048|NCT01085201|594946695|FG004|Overall Study|Unknown- no study drug|0|||
164705049|NCT01085201|594946691|FG000|Overall Study|Fond ineligible after consent|0|||
164705050|NCT01085201|594946692|FG001|Overall Study|Fond ineligible after consent|1|||
164705051|NCT01085201|594946693|FG002|Overall Study|Fond ineligible after consent|1|||
164705052|NCT01085201|594946694|FG003|Overall Study|Fond ineligible after consent|0|||
164705053|NCT01085201|594946695|FG004|Overall Study|Fond ineligible after consent|0|||
164705054|NCT03893565|594946696|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
164705055|NCT03893565|594946697|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
164705056|NCT03893565|594946698|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
164705057|NCT03893565|594946699|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
164705058|NCT03893565|594946700|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
164705059|NCT03893565|594946701|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
164705060|NCT03893565|594946702|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
164705061|NCT03893565|594946703|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
164705062|NCT03893565|594946704|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
164705063|NCT03893565|594946696|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
164705064|NCT03893565|594946697|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
164705065|NCT03893565|594946698|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
164705066|NCT03893565|594946699|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
164705067|NCT03893565|594946700|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
164705068|NCT03893565|594946701|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
164705069|NCT03893565|594946702|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
164705070|NCT03893565|594946703|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
164705071|NCT03893565|594946704|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
164705072|NCT03893565|594946696|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164705073|NCT03893565|594946697|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
164705074|NCT03893565|594946698|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164705075|NCT03893565|594946699|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
164705076|NCT03893565|594946700|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164705077|NCT03893565|594946701|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164705078|NCT03893565|594946702|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164705079|NCT03893565|594946703|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164705080|NCT03893565|594946704|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164705081|NCT03893565|594946696|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
164705082|NCT03893565|594946697|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
164705083|NCT03893565|594946698|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
164705084|NCT03893565|594946699|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
164705085|NCT03893565|594946700|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
164705086|NCT03893565|594946701|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
164705087|NCT03893565|594946702|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
164705088|NCT03893565|594946703|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
164705089|NCT03893565|594946704|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
164705090|NCT03893565|594946696|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
164398093|NCT01951625|593826455|FG002|Treatment Period|Withdrawal by Subject|1|||
164398094|NCT01951625|593826456|FG003|Treatment Period|Withdrawal by Subject|7|||
164705091|NCT03893565|594946697|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
164705092|NCT03893565|594946698|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
164705093|NCT03893565|594946699|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164705094|NCT03893565|594946700|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
164398095|NCT01951625|593826457|FG004|Treatment Period|Withdrawal by Subject|3|||
164705095|NCT03893565|594946701|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164398096|NCT01951625|593826453|FG000|Treatment Period|Lost to Follow-up|1|||
164398097|NCT01951625|593826454|FG001|Treatment Period|Lost to Follow-up|0|||
164398098|NCT01951625|593826455|FG002|Treatment Period|Lost to Follow-up|0|||
164398099|NCT01951625|593826456|FG003|Treatment Period|Lost to Follow-up|1|||
164398100|NCT01951625|593826457|FG004|Treatment Period|Lost to Follow-up|0|||
164398101|NCT01951625|593826453|FG000|Follow Up Period|Non-compliance with study drug|1|||
164398102|NCT01951625|593826454|FG001|Follow Up Period|Non-compliance with study drug|0|||
164398103|NCT01951625|593826455|FG002|Follow Up Period|Non-compliance with study drug|0|||
164398104|NCT01951625|593826456|FG003|Follow Up Period|Non-compliance with study drug|0|||
164398105|NCT01951625|593826457|FG004|Follow Up Period|Non-compliance with study drug|0|||
164398106|NCT01951625|593826453|FG000|Follow Up Period|Death|1|||
164398107|NCT01951625|593826454|FG001|Follow Up Period|Death|3|||
164398108|NCT01951625|593826455|FG002|Follow Up Period|Death|2|||
164398109|NCT01951625|593826456|FG003|Follow Up Period|Death|2|||
164398110|NCT01951625|593826457|FG004|Follow Up Period|Death|1|||
164398111|NCT01951625|593826453|FG000|Follow Up Period|Logistical difficulties|1|||
164398112|NCT01951625|593826454|FG001|Follow Up Period|Logistical difficulties|2|||
164398113|NCT01951625|593826455|FG002|Follow Up Period|Logistical difficulties|0|||
164398114|NCT01951625|593826456|FG003|Follow Up Period|Logistical difficulties|0|||
164398115|NCT01951625|593826457|FG004|Follow Up Period|Logistical difficulties|0|||
164398116|NCT01951625|593826453|FG000|Follow Up Period|Adverse Event|0|||
164398117|NCT01951625|593826454|FG001|Follow Up Period|Adverse Event|3|||
164398118|NCT01951625|593826455|FG002|Follow Up Period|Adverse Event|2|||
164398119|NCT01951625|593826456|FG003|Follow Up Period|Adverse Event|3|||
164398120|NCT01951625|593826457|FG004|Follow Up Period|Adverse Event|5|||
164398121|NCT01951625|593826453|FG000|Follow Up Period|Withdrawal by Subject|4|||
164398122|NCT01951625|593826454|FG001|Follow Up Period|Withdrawal by Subject|1|||
164398123|NCT01951625|593826455|FG002|Follow Up Period|Withdrawal by Subject|0|||
164398124|NCT01951625|593826456|FG003|Follow Up Period|Withdrawal by Subject|5|||
164398125|NCT01951625|593826457|FG004|Follow Up Period|Withdrawal by Subject|3|||
164398126|NCT01951625|593826453|FG000|Follow Up Period|Lost to Follow-up|1|||
164398127|NCT01951625|593826454|FG001|Follow Up Period|Lost to Follow-up|0|||
164398128|NCT01951625|593826455|FG002|Follow Up Period|Lost to Follow-up|0|||
164398129|NCT01951625|593826456|FG003|Follow Up Period|Lost to Follow-up|1|||
164398130|NCT01951625|593826457|FG004|Follow Up Period|Lost to Follow-up|1|||
164398131|NCT03754803|593826460|FG000|Overall Study|Withdrawal by Subject|2|||
164398132|NCT05338333|593826461|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
164398133|NCT05338333|593826462|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
164398134|NCT04348604|593826465|FG000|Week 8|Withdrawal by Subject|1|||
164705096|NCT03893565|594946702|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164705097|NCT03893565|594946703|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164705098|NCT03893565|594946704|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164705099|NCT03893565|594946696|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
164705100|NCT03893565|594946697|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
164705101|NCT03893565|594946698|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
164705102|NCT03893565|594946699|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
164705103|NCT03893565|594946700|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
164705104|NCT03893565|594946701|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
164705105|NCT03893565|594946702|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
164705106|NCT03893565|594946703|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
164705107|NCT03893565|594946704|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
164705108|NCT03893565|594946696|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164705109|NCT03893565|594946697|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164398135|NCT04348604|593826466|FG001|Week 8|Withdrawal by Subject|1|||
164398136|NCT04348604|593826465|FG000|Week 8|Lost to Follow-up|1|||
164398137|NCT04348604|593826466|FG001|Week 8|Lost to Follow-up|2|||
164442362|NCT01662336|593987492|FG000|Overall Study|Withdrawal by Subject|6|||
164442363|NCT02189252|593987493|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
164442364|NCT02189252|593987494|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
164442365|NCT02189252|593987495|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
164442366|NCT02189252|593987496|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
164398138|NCT04348604|593826465|FG000|Week 8|Suspended|0|||
164398139|NCT04348604|593826466|FG001|Week 8|Suspended|1|||
164398140|NCT04348604|593826465|FG000|Week 12|Lost to Follow-up|1|||
164398141|NCT04348604|593826466|FG001|Week 12|Lost to Follow-up|2|||
164398142|NCT04348604|593826465|FG000|Week 12|Withdrawal by Subject|1|||
164398143|NCT04348604|593826466|FG001|Week 12|Withdrawal by Subject|0|||
164398144|NCT04348604|593826465|FG000|Week 24|Lost to Follow-up|2|||
164398145|NCT04348604|593826466|FG001|Week 24|Lost to Follow-up|1|||
164398146|NCT01377480|593827985|FG000|Overall Study|Protocol Violation|0|||
164398147|NCT01377480|593827986|FG001|Overall Study|Protocol Violation|0|||
164398148|NCT01377480|593827987|FG002|Overall Study|Protocol Violation|0|||
164398149|NCT01377480|593827988|FG003|Overall Study|Protocol Violation|4|||
164398150|NCT01377480|593827985|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
164398151|NCT01377480|593827986|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
164398152|NCT01377480|593827987|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
164398153|NCT01377480|593827988|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
164398154|NCT01377480|593827985|FG000|Overall Study|Withdrawal by Subject|0|||
164398155|NCT01377480|593827986|FG001|Overall Study|Withdrawal by Subject|0|||
164398156|NCT01377480|593827987|FG002|Overall Study|Withdrawal by Subject|1|||
164398157|NCT01377480|593827988|FG003|Overall Study|Withdrawal by Subject|0|||
164398158|NCT01377480|593827985|FG000|Overall Study|Serious adverse event|0|||
164398159|NCT01377480|593827986|FG001|Overall Study|Serious adverse event|0|||
164398160|NCT01377480|593827987|FG002|Overall Study|Serious adverse event|1|||
164398161|NCT01377480|593827988|FG003|Overall Study|Serious adverse event|1|||
164398162|NCT01377480|593827985|FG000|Overall Study|Other|0|||
164398163|NCT01377480|593827986|FG001|Overall Study|Other|0|||
164398164|NCT01377480|593827987|FG002|Overall Study|Other|7|||
164398165|NCT01377480|593827988|FG003|Overall Study|Other|6|||
164398166|NCT01735201|593827995|FG000|Overall Study|Adverse Event|1|||
164398167|NCT01735201|593827996|FG001|Overall Study|Adverse Event|1|||
164398168|NCT01735201|593827997|FG002|Overall Study|Adverse Event|0|||
164398169|NCT01735201|593827998|FG003|Overall Study|Adverse Event|1|||
164398170|NCT01735201|593827999|FG004|Overall Study|Adverse Event|1|||
164398171|NCT01735201|593828000|FG005|Overall Study|Adverse Event|3|||
164398172|NCT01735201|593828001|FG006|Overall Study|Adverse Event|2|||
164398173|NCT01735201|593828002|FG007|Overall Study|Adverse Event|1|||
164398174|NCT01735201|593827995|FG000|Overall Study|Personal Reasons|1|||
164398175|NCT01735201|593827996|FG001|Overall Study|Personal Reasons|0|||
164398176|NCT01735201|593827997|FG002|Overall Study|Personal Reasons|0|||
164398177|NCT01735201|593827998|FG003|Overall Study|Personal Reasons|0|||
164398178|NCT01735201|593827999|FG004|Overall Study|Personal Reasons|0|||
164398179|NCT01735201|593828000|FG005|Overall Study|Personal Reasons|0|||
164398180|NCT01735201|593828001|FG006|Overall Study|Personal Reasons|0|||
164398181|NCT01735201|593828002|FG007|Overall Study|Personal Reasons|0|||
164398182|NCT01735201|593827995|FG000|Overall Study|Protocol Violation|1|||
164398183|NCT01735201|593827996|FG001|Overall Study|Protocol Violation|0|||
164398184|NCT01735201|593827997|FG002|Overall Study|Protocol Violation|0|||
164398185|NCT01735201|593827998|FG003|Overall Study|Protocol Violation|0|||
164398186|NCT01735201|593827999|FG004|Overall Study|Protocol Violation|0|||
164398187|NCT01735201|593828000|FG005|Overall Study|Protocol Violation|0|||
164398188|NCT01735201|593828001|FG006|Overall Study|Protocol Violation|0|||
164595809|NCT00882999|594545049|FG004|Overall Study|Withdrawal by Subject|6|||
164595810|NCT00882999|594545050|FG005|Overall Study|Withdrawal by Subject|5|||
164595811|NCT00882999|594545051|FG006|Overall Study|Withdrawal by Subject|5|||
164595812|NCT00882999|594545045|FG000|Overall Study|Lost to Follow-up|0|||
164595813|NCT00882999|594545046|FG001|Overall Study|Lost to Follow-up|1|||
164595814|NCT00882999|594545047|FG002|Overall Study|Lost to Follow-up|1|||
164595815|NCT00882999|594545048|FG003|Overall Study|Lost to Follow-up|2|||
164595816|NCT00882999|594545049|FG004|Overall Study|Lost to Follow-up|1|||
164595817|NCT00882999|594545050|FG005|Overall Study|Lost to Follow-up|1|||
164595818|NCT00882999|594545051|FG006|Overall Study|Lost to Follow-up|2|||
164595819|NCT00882999|594545045|FG000|Overall Study|Physician Decision|1|||
164595820|NCT00882999|594545046|FG001|Overall Study|Physician Decision|0|||
164595821|NCT00882999|594545047|FG002|Overall Study|Physician Decision|0|||
164595822|NCT00882999|594545048|FG003|Overall Study|Physician Decision|0|||
164595823|NCT00882999|594545049|FG004|Overall Study|Physician Decision|0|||
164595824|NCT00882999|594545050|FG005|Overall Study|Physician Decision|1|||
164595825|NCT00882999|594545051|FG006|Overall Study|Physician Decision|1|||
164595826|NCT00082758|594545053|FG000|Overall Study|Adverse Event|0|||
164595827|NCT00082758|594545054|FG001|Overall Study|Adverse Event|2|||
164595828|NCT00082758|594545055|FG002|Overall Study|Adverse Event|0|||
164595829|NCT00082758|594545053|FG000|Overall Study|Lack of Efficacy|12|||
164595830|NCT00082758|594545054|FG001|Overall Study|Lack of Efficacy|13|||
164595831|NCT00082758|594545055|FG002|Overall Study|Lack of Efficacy|0|||
164595832|NCT00082758|594545053|FG000|Overall Study|Physician Decision|0|||
164595833|NCT00082758|594545054|FG001|Overall Study|Physician Decision|1|||
164595834|NCT00082758|594545055|FG002|Overall Study|Physician Decision|0|||
164595835|NCT00082758|594545053|FG000|Overall Study|Withdrawal by Subject|3|||
164595836|NCT00082758|594545054|FG001|Overall Study|Withdrawal by Subject|0|||
164398189|NCT01735201|593828002|FG007|Overall Study|Protocol Violation|0|||
164398190|NCT01735201|593827995|FG000|Overall Study|Other Miscellaneous Reasons|0|||
164398191|NCT01735201|593827996|FG001|Overall Study|Other Miscellaneous Reasons|0|||
164595837|NCT00082758|594545055|FG002|Overall Study|Withdrawal by Subject|0|||
164398192|NCT01735201|593827997|FG002|Overall Study|Other Miscellaneous Reasons|0|||
164398193|NCT01735201|593827998|FG003|Overall Study|Other Miscellaneous Reasons|1|||
164595838|NCT00082758|594545053|FG000|Overall Study|Protocol Violation|0|||
164398194|NCT01735201|593827999|FG004|Overall Study|Other Miscellaneous Reasons|0|||
164398195|NCT01735201|593828000|FG005|Overall Study|Other Miscellaneous Reasons|2|||
164398196|NCT01735201|593828001|FG006|Overall Study|Other Miscellaneous Reasons|1|||
164398197|NCT01735201|593828002|FG007|Overall Study|Other Miscellaneous Reasons|1|||
164398198|NCT01203930|593828008|FG000|Overall Study|Disease Progression|0|||
164398199|NCT01203930|593828009|FG001|Overall Study|Disease Progression|4|||
164398200|NCT01203930|593828008|FG000|Overall Study|Death|3|||
164398201|NCT01203930|593828009|FG001|Overall Study|Death|1|||
164398202|NCT01203930|593828008|FG000|Overall Study|Withdrew Consent|1|||
164398203|NCT01203930|593828009|FG001|Overall Study|Withdrew Consent|10|||
164398204|NCT01203930|593828008|FG000|Overall Study|Investigator Request|0|||
164398205|NCT01203930|593828009|FG001|Overall Study|Investigator Request|8|||
164398206|NCT01203930|593828008|FG000|Overall Study|Study Terminated by Sponsor|0|||
164398207|NCT01203930|593828009|FG001|Overall Study|Study Terminated by Sponsor|12|||
164398208|NCT01203930|593828008|FG000|Overall Study|Poor tolerance of study drug|0|||
164398209|NCT01203930|593828009|FG001|Overall Study|Poor tolerance of study drug|1|||
164398210|NCT01203930|593828008|FG000|Overall Study|Adverse Event|17|||
164398211|NCT01203930|593828009|FG001|Overall Study|Adverse Event|5|||
164398212|NCT02178059|593828010|FG000|Washout|Physician Decision|1|||
164398213|NCT02178059|593828011|FG001|Washout|Physician Decision|0|||
164398214|NCT01266850|593828014|FG000|Overall Study|Lost to Follow-up|19|||
164398215|NCT01266850|593828015|FG001|Overall Study|Lost to Follow-up|19|||
164398216|NCT01266850|593828016|FG002|Overall Study|Lost to Follow-up|13|||
164398217|NCT01266850|593828017|FG003|Overall Study|Lost to Follow-up|13|||
164398218|NCT01266850|593828018|FG004|Overall Study|Lost to Follow-up|12|||
164398219|NCT01266850|593828014|FG000|Overall Study|Withdrawal by Subject|8|||
164398220|NCT01266850|593828015|FG001|Overall Study|Withdrawal by Subject|9|||
164398221|NCT01266850|593828016|FG002|Overall Study|Withdrawal by Subject|6|||
164398222|NCT01266850|593828017|FG003|Overall Study|Withdrawal by Subject|9|||
164398223|NCT01266850|593828018|FG004|Overall Study|Withdrawal by Subject|12|||
164398224|NCT01266850|593828014|FG000|Overall Study|Physician Decision|3|||
164398225|NCT01266850|593828015|FG001|Overall Study|Physician Decision|6|||
164398226|NCT01266850|593828016|FG002|Overall Study|Physician Decision|4|||
164595839|NCT00082758|594545054|FG001|Overall Study|Protocol Violation|1|||
164595840|NCT00082758|594545055|FG002|Overall Study|Protocol Violation|0|||
164595841|NCT00937560|594545056|FG000|Initial Treatment|Death|6|||
164595842|NCT00937560|594545056|FG000|Initial Treatment|Withdraw consent|3|||
164595843|NCT00937560|594545056|FG000|Initial Treatment|Adverse Event|1|||
164595844|NCT00937560|594545056|FG000|Initial Treatment|Lost to Follow-up|1|||
164595845|NCT00937560|594545056|FG000|Initial Treatment|No end of study page|10|||
164595846|NCT00937560|594545056|FG000|Maintenance Treatment|Death|12|||
164595847|NCT00937560|594545056|FG000|Maintenance Treatment|Withdraw consent|5|||
164595848|NCT00937560|594545056|FG000|Maintenance Treatment|According to protocol|1|||
164595849|NCT00411788|594545057|FG000|Overall Study|Protocol Violation|1|||
164595850|NCT00411788|594545057|FG000|Overall Study|Adverse Event|1|||
164595851|NCT00848549|594545058|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
164595852|NCT00848549|594545059|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
164595853|NCT00848549|594545058|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
164595854|NCT00848549|594545059|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
164595855|NCT00848549|594545058|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
164595856|NCT00848549|594545059|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
164595857|NCT00848549|594545058|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
164595858|NCT00848549|594545059|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
164595859|NCT00848549|594545058|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
164595860|NCT00848549|594545059|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
164595861|NCT00848549|594545058|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
164595862|NCT00848549|594545059|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
164595863|NCT00848549|594545058|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
164595864|NCT00848549|594545059|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
164595865|NCT00848549|594545058|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
164595866|NCT00848549|594545059|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
164595867|NCT00848549|594545058|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
164595868|NCT00848549|594545059|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
164595869|NCT00848549|594545058|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
164595870|NCT00848549|594545059|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
164595871|NCT00848549|594545058|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
164595872|NCT00848549|594545059|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
164595873|NCT00848549|594545058|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
164595874|NCT00848549|594545059|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
164595875|NCT00848549|594545058|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
164705110|NCT03893565|594946698|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164705111|NCT03893565|594946699|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
164705112|NCT03893565|594946700|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164705113|NCT03893565|594946701|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164705114|NCT03893565|594946702|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164705115|NCT03893565|594946703|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164705116|NCT03893565|594946704|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164705117|NCT03893565|594946696|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
164705118|NCT03893565|594946697|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
164705119|NCT03893565|594946698|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
164705120|NCT03893565|594946699|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
164705121|NCT03893565|594946700|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
164705122|NCT03893565|594946701|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
164705123|NCT03893565|594946702|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
164705124|NCT03893565|594946703|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
164705125|NCT03893565|594946704|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
164705126|NCT03893565|594946696|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
164705127|NCT03893565|594946697|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
164705128|NCT03893565|594946698|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
164705129|NCT03893565|594946699|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
164705130|NCT03893565|594946700|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
164705131|NCT03893565|594946701|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
164705132|NCT03893565|594946702|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
164705133|NCT03893565|594946703|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
164705134|NCT03893565|594946704|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
164705135|NCT03893565|594946696|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
164705136|NCT03893565|594946697|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
164705137|NCT03893565|594946698|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
164595876|NCT00848549|594545059|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
164595877|NCT00848549|594545058|FG000|E2090-E044-314 (Extension Study)|Other|5|||
164595878|NCT00848549|594545059|FG001|E2090-E044-314 (Extension Study)|Other|6|||
164595879|NCT05631548|594545060|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
164595880|NCT05631548|594545061|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
164705138|NCT03893565|594946699|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
164705139|NCT03893565|594946700|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
164705140|NCT03893565|594946701|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
164705141|NCT03893565|594946702|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
164705142|NCT03893565|594946703|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
164705143|NCT03893565|594946704|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
164398227|NCT01266850|593828017|FG003|Overall Study|Physician Decision|4|||
164398228|NCT01266850|593828018|FG004|Overall Study|Physician Decision|3|||
164398229|NCT01266850|593828014|FG000|Overall Study|Protocol Violation|0|||
164398230|NCT01266850|593828015|FG001|Overall Study|Protocol Violation|1|||
164398231|NCT01266850|593828016|FG002|Overall Study|Protocol Violation|0|||
164398232|NCT01266850|593828017|FG003|Overall Study|Protocol Violation|1|||
164398233|NCT01266850|593828018|FG004|Overall Study|Protocol Violation|2|||
164398234|NCT01266850|593828014|FG000|Overall Study|Adverse Event|0|||
164398235|NCT01266850|593828015|FG001|Overall Study|Adverse Event|0|||
164398236|NCT01266850|593828016|FG002|Overall Study|Adverse Event|0|||
164398237|NCT01266850|593828017|FG003|Overall Study|Adverse Event|0|||
164398238|NCT01266850|593828018|FG004|Overall Study|Adverse Event|1|||
164398239|NCT01266850|593828014|FG000|Overall Study|Site Closure|0|||
164398240|NCT01266850|593828015|FG001|Overall Study|Site Closure|1|||
164398241|NCT01266850|593828016|FG002|Overall Study|Site Closure|1|||
164398242|NCT01266850|593828017|FG003|Overall Study|Site Closure|1|||
164398243|NCT01266850|593828018|FG004|Overall Study|Site Closure|0|||
164595881|NCT01219959|594545062|FG000|Overall Study|Adverse Event|6|||
164595882|NCT01219959|594545063|FG001|Overall Study|Adverse Event|14|||
164595883|NCT01219959|594545062|FG000|Overall Study|Physician Decision|0|||
164595884|NCT01219959|594545063|FG001|Overall Study|Physician Decision|4|||
164595885|NCT01219959|594545062|FG000|Overall Study|Withdrawal by Subject|0|||
164595886|NCT01219959|594545063|FG001|Overall Study|Withdrawal by Subject|2|||
164595887|NCT01219959|594545062|FG000|Overall Study|Renal Transplantation|0|||
164595888|NCT01219959|594545063|FG001|Overall Study|Renal Transplantation|3|||
164595889|NCT01219959|594545062|FG000|Overall Study|Other|1|||
164595890|NCT01219959|594545063|FG001|Overall Study|Other|0|||
164595891|NCT00436566|594545064|FG000|Overall Study|Withdrawal by Subject|2|||
164595892|NCT00436566|594545064|FG000|Overall Study|Protocol Violation|1|||
164595893|NCT02651194|594545065|FG000|Overall Study|Lost to Follow-up|3|||
164595894|NCT02651194|594545065|FG000|Overall Study|Other|2|||
164595895|NCT01980706|594545066|FG000|Overall Study|Withdrawal by Subject|9|||
164442367|NCT02189252|593987493|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
164442368|NCT02189252|593987494|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
164442369|NCT02189252|593987495|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
164442370|NCT02189252|593987496|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
164442371|NCT04603924|593987497|FG000|Overall Study|Not Dosed|2|||
164442372|NCT04603924|593987498|FG001|Overall Study|Not Dosed|1|||
164442373|NCT04603924|593987497|FG000|Overall Study|Withdrawal by Subject|6|||
164442374|NCT04603924|593987498|FG001|Overall Study|Withdrawal by Subject|6|||
164442375|NCT04603924|593987497|FG000|Overall Study|Adverse Event|2|||
164442376|NCT04603924|593987498|FG001|Overall Study|Adverse Event|2|||
164442377|NCT00768664|593987501|FG000|Overall Study|Death|57|||
164442378|NCT00768664|593987501|FG000|Overall Study|Lost to Follow-up|2|||
164442379|NCT00768664|593987501|FG000|Overall Study|Other|9|||
164442380|NCT00768664|593987501|FG000|Overall Study|Participant refused|1|||
164442381|NCT02544152|593987502|FG000|Overall Study|Adverse Event|0|||
164442382|NCT02544152|593987503|FG001|Overall Study|Adverse Event|4|||
164442383|NCT02544152|593987502|FG000|Overall Study|Withdrawal by Subject|0|||
164442384|NCT02544152|593987503|FG001|Overall Study|Withdrawal by Subject|3|||
164442385|NCT02544152|593987502|FG000|Overall Study|Other|1|||
164442386|NCT02544152|593987503|FG001|Overall Study|Other|0|||
164442387|NCT00686855|593987504|FG000|Overall Study|Lost to Follow-up|1|||
164442388|NCT00686855|593987505|FG001|Overall Study|Lost to Follow-up|0|||
164442389|NCT00686855|593987504|FG000|Overall Study|Progressive GVHD|0|||
164442390|NCT00686855|593987505|FG001|Overall Study|Progressive GVHD|1|||
164442391|NCT02320123|593987508|FG000|Overall Study|Lost to Follow-up|4|||
164442392|NCT02320123|593987509|FG001|Overall Study|Lost to Follow-up|6|||
164442393|NCT02320123|593987508|FG000|Overall Study|Death|6|||
164442394|NCT02320123|593987509|FG001|Overall Study|Death|5|||
164442395|NCT00465816|593987510|FG000|Overall Study|Lost to Follow-up|0|||
164442396|NCT00465816|593987511|FG001|Overall Study|Lost to Follow-up|0|||
164442397|NCT00465816|593987512|FG002|Overall Study|Lost to Follow-up|2|||
164442398|NCT02139046|593987513|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
164442399|NCT02139046|593987514|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
164442400|NCT02139046|593987515|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
164442401|NCT02139046|593987516|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
164442402|NCT02139046|593987517|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
164442403|NCT02139046|593987513|FG000|Overall Study|Major Protocol Deviation|9|||
164442404|NCT02139046|593987514|FG001|Overall Study|Major Protocol Deviation|10|||
164442405|NCT02139046|593987515|FG002|Overall Study|Major Protocol Deviation|16|||
164442406|NCT02139046|593987516|FG003|Overall Study|Major Protocol Deviation|12|||
164442407|NCT02139046|593987517|FG004|Overall Study|Major Protocol Deviation|6|||
164442408|NCT02139046|593987513|FG000|Overall Study|Lost to Follow-up|13|||
164442409|NCT02139046|593987514|FG001|Overall Study|Lost to Follow-up|16|||
164442410|NCT02139046|593987515|FG002|Overall Study|Lost to Follow-up|16|||
164442411|NCT02139046|593987516|FG003|Overall Study|Lost to Follow-up|18|||
164442412|NCT02139046|593987517|FG004|Overall Study|Lost to Follow-up|13|||
164595896|NCT01980706|594545067|FG001|Overall Study|Withdrawal by Subject|6|||
164595897|NCT01980706|594545068|FG002|Overall Study|Withdrawal by Subject|2|||
164595898|NCT01980706|594545066|FG000|Overall Study|Adverse Event|1|||
164595899|NCT01980706|594545067|FG001|Overall Study|Adverse Event|2|||
164595900|NCT01980706|594545068|FG002|Overall Study|Adverse Event|5|||
164595901|NCT01980706|594545066|FG000|Overall Study|Lost to Follow-up|3|||
164595902|NCT01980706|594545067|FG001|Overall Study|Lost to Follow-up|4|||
164595903|NCT01980706|594545068|FG002|Overall Study|Lost to Follow-up|3|||
164595904|NCT01980706|594545066|FG000|Overall Study|miscellaneous|4|||
164595905|NCT01980706|594545067|FG001|Overall Study|miscellaneous|5|||
164595906|NCT01980706|594545068|FG002|Overall Study|miscellaneous|3|||
164595907|NCT02546674|594545069|FG000|Overall Study|Adverse Event|19|||
164595908|NCT02546674|594545069|FG000|Overall Study|Death|1|||
164595909|NCT02546674|594545069|FG000|Overall Study|Lost to Follow-up|1|||
164595910|NCT02546674|594545069|FG000|Overall Study|Physician Decision|13|||
164595911|NCT02546674|594545069|FG000|Overall Study|Pregnancy|1|||
164595912|NCT02546674|594545069|FG000|Overall Study|Progressive Disease|2|||
164595913|NCT02546674|594545069|FG000|Overall Study|Protocol Deviation|2|||
164595914|NCT02546674|594545069|FG000|Overall Study|Subject/Guardian Decision|6|||
164595915|NCT02546674|594545069|FG000|Overall Study|Withdrawal of Informed Consent|3|||
164595916|NCT02232087|594545070|FG000|Overall Study|Withdrawal by Subject|2|||
164595917|NCT02232087|594545071|FG001|Overall Study|Withdrawal by Subject|0|||
164595918|NCT02232087|594545072|FG002|Overall Study|Withdrawal by Subject|0|||
164442413|NCT02139046|593987513|FG000|Overall Study|Voluntary Withdrawal|20|||
164442414|NCT02139046|593987514|FG001|Overall Study|Voluntary Withdrawal|8|||
164442415|NCT02139046|593987515|FG002|Overall Study|Voluntary Withdrawal|10|||
164442416|NCT02139046|593987516|FG003|Overall Study|Voluntary Withdrawal|15|||
164442417|NCT02139046|593987517|FG004|Overall Study|Voluntary Withdrawal|16|||
164442418|NCT02139046|593987513|FG000|Overall Study|Lack of Efficacy|0|||
164442419|NCT02139046|593987514|FG001|Overall Study|Lack of Efficacy|1|||
164442420|NCT02139046|593987515|FG002|Overall Study|Lack of Efficacy|2|||
164595919|NCT02232087|594545073|FG003|Overall Study|Withdrawal by Subject|0|||
164595920|NCT02232087|594545074|FG004|Overall Study|Withdrawal by Subject|0|||
164705144|NCT03893565|594946696|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
164705145|NCT03893565|594946697|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
164705146|NCT03893565|594946698|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
164705147|NCT03893565|594946699|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
164705148|NCT03893565|594946700|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
164705149|NCT03893565|594946701|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
164705150|NCT03893565|594946702|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
164705151|NCT03893565|594946703|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
164705152|NCT03893565|594946704|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
164705153|NCT03893565|594946696|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
164705154|NCT03893565|594946697|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
164705155|NCT03893565|594946698|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
164705156|NCT03893565|594946699|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
164705157|NCT03893565|594946700|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
164705158|NCT03893565|594946701|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
164705159|NCT03893565|594946702|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
164705160|NCT03893565|594946703|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
164705161|NCT03893565|594946704|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
164705162|NCT03893565|594946696|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164705163|NCT03893565|594946697|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164705164|NCT03893565|594946698|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164705165|NCT03893565|594946699|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164705166|NCT03893565|594946700|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164705167|NCT03893565|594946701|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164705168|NCT03893565|594946702|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164705169|NCT03893565|594946703|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
164705170|NCT03893565|594946704|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164705171|NCT03893565|594946696|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164705172|NCT03893565|594946697|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164705173|NCT03893565|594946698|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164705174|NCT03893565|594946699|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164705175|NCT03893565|594946700|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164705176|NCT03893565|594946701|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164705177|NCT03893565|594946702|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164705178|NCT03893565|594946703|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
164705179|NCT03893565|594946704|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164705180|NCT03893565|594946696|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164705181|NCT03893565|594946697|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164705182|NCT03893565|594946698|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164705183|NCT03893565|594946699|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164705184|NCT03893565|594946700|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164705185|NCT03893565|594946701|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164705186|NCT03893565|594946702|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164705187|NCT03893565|594946703|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
164705188|NCT03893565|594946704|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164705189|NCT03893565|594946696|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
164705190|NCT03893565|594946697|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
164705191|NCT03893565|594946698|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
164705192|NCT03893565|594946699|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
164398244|NCT00857207|593828022|FG000|Overall Study|Withdrawal by Subject|13|||
164398245|NCT00857207|593828023|FG001|Overall Study|Withdrawal by Subject|0|||
164398246|NCT00857207|593828022|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
164398247|NCT00857207|593828023|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
164398248|NCT00857207|593828022|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
164398249|NCT00857207|593828023|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
164398250|NCT02030015|593828024|FG000|Overall Study|Withdrawal by Subject|3|||
164398251|NCT02030015|593828024|FG000|Overall Study|Death|13|||
164398252|NCT03014674|593828025|FG000|Overall Study|Withdrawal by Subject|1|||
164398253|NCT03014674|593828026|FG001|Overall Study|Withdrawal by Subject|0|||
164398254|NCT03014674|593828027|FG002|Overall Study|Withdrawal by Subject|0|||
164398255|NCT01332227|593828028|FG000|Overall Study|Adverse Event|4|||
164398256|NCT01332227|593828029|FG001|Overall Study|Adverse Event|1|||
164442421|NCT02139046|593987516|FG003|Overall Study|Lack of Efficacy|1|||
164442422|NCT02139046|593987517|FG004|Overall Study|Lack of Efficacy|2|||
164705193|NCT03893565|594946700|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
164705194|NCT03893565|594946701|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
164705195|NCT03893565|594946702|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
164705196|NCT03893565|594946703|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
164705197|NCT03893565|594946704|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
164705198|NCT03870477|594946709|FG000|Overall Study|Early Study Termination|1|||
164705199|NCT02256436|594946712|FG000|Overall Study|Adverse Event|9|||
164705200|NCT02256436|594946713|FG001|Overall Study|Adverse Event|14|||
164705201|NCT02256436|594946712|FG000|Overall Study|Death|216|||
164705202|NCT02256436|594946713|FG001|Overall Study|Death|208|||
164705203|NCT02256436|594946712|FG000|Overall Study|Lost to Follow-up|1|||
164705204|NCT02256436|594946713|FG001|Overall Study|Lost to Follow-up|2|||
164705205|NCT02256436|594946712|FG000|Overall Study|Physician Decision|1|||
164705206|NCT02256436|594946713|FG001|Overall Study|Physician Decision|0|||
164705207|NCT02256436|594946712|FG000|Overall Study|Protocol Violation|0|||
164705208|NCT02256436|594946713|FG001|Overall Study|Protocol Violation|1|||
164705209|NCT02256436|594946712|FG000|Overall Study|Withdrawal by Subject|26|||
164705210|NCT02256436|594946713|FG001|Overall Study|Withdrawal by Subject|10|||
164705211|NCT02256436|594946712|FG000|Overall Study|Transferred to Extension Study|11|||
164705212|NCT02256436|594946713|FG001|Overall Study|Transferred to Extension Study|23|||
164705213|NCT02256436|594946712|FG000|Overall Study|Did Not Continue on Extension Study|8|||
164705214|NCT02256436|594946713|FG001|Overall Study|Did Not Continue on Extension Study|12|||
164705215|NCT05961215|594946714|FG000|Overall Study|Withdrawal by Subject|1|||
164705216|NCT04480710|594946715|FG000|Overall Study|Adverse Event|0|||
164705217|NCT04480710|594946716|FG001|Overall Study|Adverse Event|2|||
164705218|NCT04480710|594946717|FG002|Overall Study|Adverse Event|0|||
164705219|NCT04480710|594946718|FG003|Overall Study|Adverse Event|0|||
164705220|NCT04480710|594946715|FG000|Overall Study|Withdrawal by Subject|0|||
164705221|NCT04480710|594946716|FG001|Overall Study|Withdrawal by Subject|1|||
164705222|NCT04480710|594946717|FG002|Overall Study|Withdrawal by Subject|0|||
164705223|NCT04480710|594946718|FG003|Overall Study|Withdrawal by Subject|0|||
164705224|NCT04480710|594946715|FG000|Overall Study|Physician Decision|0|||
164705225|NCT04480710|594946716|FG001|Overall Study|Physician Decision|0|||
164705226|NCT04480710|594946717|FG002|Overall Study|Physician Decision|1|||
164705227|NCT04480710|594946718|FG003|Overall Study|Physician Decision|0|||
164705228|NCT01986010|594946719|FG000|Overall Study|Adverse Event|0|||
164705229|NCT01986010|594946720|FG001|Overall Study|Adverse Event|1|||
164705230|NCT01986010|594946721|FG002|Overall Study|Adverse Event|0|||
164705231|NCT01986010|594946722|FG003|Overall Study|Adverse Event|0|||
164705232|NCT01986010|594946723|FG004|Overall Study|Adverse Event|0|||
164705233|NCT01986010|594946724|FG005|Overall Study|Adverse Event|0|||
164705234|NCT01986010|594946725|FG006|Overall Study|Adverse Event|0|||
164705235|NCT01986010|594946726|FG007|Overall Study|Adverse Event|0|||
164705236|NCT01986010|594946727|FG008|Overall Study|Adverse Event|0|||
164705237|NCT01986010|594946728|FG009|Overall Study|Adverse Event|0|||
164705238|NCT01986010|594946729|FG010|Overall Study|Adverse Event|0|||
164705239|NCT01986010|594946730|FG011|Overall Study|Adverse Event|0|||
164705240|NCT01986010|594946731|FG012|Overall Study|Adverse Event|0|||
164705241|NCT01986010|594946732|FG013|Overall Study|Adverse Event|0|||
164705242|NCT01986010|594946733|FG014|Overall Study|Adverse Event|0|||
164705243|NCT01986010|594946734|FG015|Overall Study|Adverse Event|1|||
164705244|NCT01986010|594946735|FG016|Overall Study|Adverse Event|0|||
164705245|NCT01986010|594946719|FG000|Overall Study|Lost to Follow-up|2|||
164705246|NCT01986010|594946720|FG001|Overall Study|Lost to Follow-up|1|||
164705247|NCT01986010|594946721|FG002|Overall Study|Lost to Follow-up|2|||
164705248|NCT01986010|594946722|FG003|Overall Study|Lost to Follow-up|2|||
164705249|NCT01986010|594946723|FG004|Overall Study|Lost to Follow-up|2|||
164705250|NCT01986010|594946724|FG005|Overall Study|Lost to Follow-up|2|||
164705251|NCT01986010|594946725|FG006|Overall Study|Lost to Follow-up|0|||
164705252|NCT01986010|594946726|FG007|Overall Study|Lost to Follow-up|0|||
164705253|NCT01986010|594946727|FG008|Overall Study|Lost to Follow-up|4|||
164398257|NCT01332227|593828028|FG000|Overall Study|Withdrawal by Subject|5|||
164398258|NCT01332227|593828029|FG001|Overall Study|Withdrawal by Subject|1|||
164398259|NCT01332227|593828028|FG000|Overall Study|Lost to Follow-up|2|||
164705254|NCT01986010|594946728|FG009|Overall Study|Lost to Follow-up|2|||
164705255|NCT01986010|594946729|FG010|Overall Study|Lost to Follow-up|0|||
164705256|NCT01986010|594946730|FG011|Overall Study|Lost to Follow-up|1|||
164705257|NCT01986010|594946731|FG012|Overall Study|Lost to Follow-up|1|||
164705258|NCT01986010|594946732|FG013|Overall Study|Lost to Follow-up|1|||
164705259|NCT01986010|594946733|FG014|Overall Study|Lost to Follow-up|2|||
164705260|NCT01986010|594946734|FG015|Overall Study|Lost to Follow-up|0|||
164705261|NCT01986010|594946735|FG016|Overall Study|Lost to Follow-up|0|||
164705262|NCT01986010|594946719|FG000|Overall Study|Physician Decision|0|||
164705263|NCT01986010|594946720|FG001|Overall Study|Physician Decision|0|||
164705264|NCT01986010|594946721|FG002|Overall Study|Physician Decision|0|||
164705265|NCT01986010|594946722|FG003|Overall Study|Physician Decision|0|||
164705266|NCT01986010|594946723|FG004|Overall Study|Physician Decision|0|||
164705267|NCT01986010|594946724|FG005|Overall Study|Physician Decision|0|||
164705268|NCT01986010|594946725|FG006|Overall Study|Physician Decision|0|||
164705269|NCT01986010|594946726|FG007|Overall Study|Physician Decision|0|||
164705270|NCT01986010|594946727|FG008|Overall Study|Physician Decision|0|||
164705271|NCT01986010|594946728|FG009|Overall Study|Physician Decision|0|||
164705272|NCT01986010|594946729|FG010|Overall Study|Physician Decision|0|||
164705273|NCT01986010|594946730|FG011|Overall Study|Physician Decision|0|||
164705274|NCT01986010|594946731|FG012|Overall Study|Physician Decision|0|||
164705275|NCT01986010|594946732|FG013|Overall Study|Physician Decision|0|||
164705276|NCT01986010|594946733|FG014|Overall Study|Physician Decision|1|||
164705277|NCT01986010|594946734|FG015|Overall Study|Physician Decision|0|||
164705278|NCT01986010|594946735|FG016|Overall Study|Physician Decision|0|||
164705279|NCT01986010|594946719|FG000|Overall Study|Withdrawal by Subject|2|||
164705280|NCT01986010|594946720|FG001|Overall Study|Withdrawal by Subject|2|||
164705281|NCT01986010|594946721|FG002|Overall Study|Withdrawal by Subject|3|||
164705282|NCT01986010|594946722|FG003|Overall Study|Withdrawal by Subject|0|||
164705283|NCT01986010|594946723|FG004|Overall Study|Withdrawal by Subject|2|||
164705284|NCT01986010|594946724|FG005|Overall Study|Withdrawal by Subject|4|||
164705285|NCT01986010|594946725|FG006|Overall Study|Withdrawal by Subject|0|||
164705286|NCT01986010|594946726|FG007|Overall Study|Withdrawal by Subject|0|||
164705287|NCT01986010|594946727|FG008|Overall Study|Withdrawal by Subject|0|||
164705288|NCT01986010|594946728|FG009|Overall Study|Withdrawal by Subject|0|||
164705289|NCT01986010|594946729|FG010|Overall Study|Withdrawal by Subject|0|||
164705290|NCT01986010|594946730|FG011|Overall Study|Withdrawal by Subject|2|||
164705291|NCT01986010|594946731|FG012|Overall Study|Withdrawal by Subject|0|||
164398260|NCT01332227|593828029|FG001|Overall Study|Lost to Follow-up|0|||
164398261|NCT01332227|593828028|FG000|Overall Study|Lack of Efficacy|3|||
164398262|NCT01332227|593828029|FG001|Overall Study|Lack of Efficacy|1|||
164398263|NCT01332227|593828028|FG000|Overall Study|Poor compliance/noncompliance|1|||
164398264|NCT01332227|593828029|FG001|Overall Study|Poor compliance/noncompliance|1|||
164398265|NCT01332227|593828028|FG000|Overall Study|Patient moved from area|1|||
164398266|NCT01332227|593828029|FG001|Overall Study|Patient moved from area|0|||
164442423|NCT02139046|593987513|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
164705292|NCT01986010|594946732|FG013|Overall Study|Withdrawal by Subject|1|||
164705293|NCT01986010|594946733|FG014|Overall Study|Withdrawal by Subject|2|||
164705294|NCT01986010|594946734|FG015|Overall Study|Withdrawal by Subject|0|||
164705295|NCT01986010|594946735|FG016|Overall Study|Withdrawal by Subject|0|||
164705296|NCT01986010|594946719|FG000|Overall Study|Status Not Recorded|2|||
164705297|NCT01986010|594946720|FG001|Overall Study|Status Not Recorded|4|||
164705298|NCT01986010|594946721|FG002|Overall Study|Status Not Recorded|2|||
164705299|NCT01986010|594946722|FG003|Overall Study|Status Not Recorded|0|||
164705300|NCT01986010|594946723|FG004|Overall Study|Status Not Recorded|1|||
164705301|NCT01986010|594946724|FG005|Overall Study|Status Not Recorded|2|||
164705302|NCT01986010|594946725|FG006|Overall Study|Status Not Recorded|0|||
164705303|NCT01986010|594946726|FG007|Overall Study|Status Not Recorded|0|||
164705304|NCT01986010|594946727|FG008|Overall Study|Status Not Recorded|2|||
164705305|NCT01986010|594946728|FG009|Overall Study|Status Not Recorded|1|||
164705306|NCT01986010|594946729|FG010|Overall Study|Status Not Recorded|7|||
164705307|NCT01986010|594946730|FG011|Overall Study|Status Not Recorded|7|||
164705308|NCT01986010|594946731|FG012|Overall Study|Status Not Recorded|9|||
164705309|NCT01986010|594946732|FG013|Overall Study|Status Not Recorded|9|||
164705310|NCT01986010|594946733|FG014|Overall Study|Status Not Recorded|5|||
164398267|NCT01332227|593828028|FG000|Overall Study|Patient began prohibited medication|0|||
164398268|NCT01332227|593828029|FG001|Overall Study|Patient began prohibited medication|1|||
164398269|NCT00254982|593828046|FG000|Overall Study|Other|2|||
164398270|NCT00254982|593828047|FG001|Overall Study|Other|1|||
164398271|NCT00254982|593828046|FG000|Overall Study|Lack of Efficacy|5|||
164398272|NCT00254982|593828047|FG001|Overall Study|Lack of Efficacy|3|||
164398273|NCT00254982|593828046|FG000|Overall Study|Lost to Follow-up|5|||
164442424|NCT02139046|593987514|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
164705311|NCT01986010|594946734|FG015|Overall Study|Status Not Recorded|10|||
164705312|NCT01986010|594946735|FG016|Overall Study|Status Not Recorded|4|||
164705313|NCT01394952|594946736|FG000|Overall Study|Lost to Follow-up|0|||
164705314|NCT01394952|594946737|FG001|Overall Study|Lost to Follow-up|5|||
164705315|NCT01394952|594946736|FG000|Overall Study|Withdrawal by Subject|10|||
164705316|NCT01394952|594946737|FG001|Overall Study|Withdrawal by Subject|5|||
164705317|NCT01394952|594946736|FG000|Overall Study|Physician Decision|2|||
164705318|NCT01394952|594946737|FG001|Overall Study|Physician Decision|0|||
164705319|NCT01394952|594946736|FG000|Overall Study|Sponsor Decision|5|||
164705320|NCT01394952|594946737|FG001|Overall Study|Sponsor Decision|7|||
164705321|NCT01335997|594946738|FG000|Period I and II|Adverse Event|63|||
164705322|NCT01335997|594946739|FG001|Period I and II|Adverse Event|43|||
164705323|NCT01335997|594946738|FG000|Period I and II|Noncompliance with Study Drug|1|||
164398274|NCT00254982|593828047|FG001|Overall Study|Lost to Follow-up|3|||
164398275|NCT00254982|593828046|FG000|Overall Study|Adverse Event|18|||
164705324|NCT01335997|594946739|FG001|Period I and II|Noncompliance with Study Drug|1|||
164705325|NCT01335997|594946738|FG000|Period I and II|Lost to Follow-up|3|||
164705326|NCT01335997|594946739|FG001|Period I and II|Lost to Follow-up|5|||
164705327|NCT01335997|594946738|FG000|Period I and II|Withdrawal by Subject|9|||
164705328|NCT01335997|594946739|FG001|Period I and II|Withdrawal by Subject|4|||
164705329|NCT01335997|594946738|FG000|Period I and II|Study Terminated by Sponsor|406|||
164705330|NCT01335997|594946739|FG001|Period I and II|Study Terminated by Sponsor|415|||
164705331|NCT01335997|594946738|FG000|Period I and II|Protocol Violation|9|||
164705332|NCT01335997|594946739|FG001|Period I and II|Protocol Violation|10|||
164705333|NCT01335997|594946738|FG000|Period I and II|Physician Decision|2|||
164705334|NCT01335997|594946739|FG001|Period I and II|Physician Decision|1|||
164705335|NCT01335997|594946738|FG000|Period III|Adverse Event|0|||
164705336|NCT01335997|594946739|FG001|Period III|Adverse Event|2|||
164705337|NCT01335997|594946738|FG000|Period III|Study Terminated by Sponsor|77|||
164705338|NCT01335997|594946739|FG001|Period III|Study Terminated by Sponsor|76|||
164705339|NCT01335997|594946738|FG000|Period III|Protocol Violation|0|||
164705340|NCT01335997|594946739|FG001|Period III|Protocol Violation|1|||
164705341|NCT01335997|594946738|FG000|Period III|Lost to Follow-up|1|||
164705342|NCT01335997|594946739|FG001|Period III|Lost to Follow-up|0|||
164442425|NCT02139046|593987515|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
164442426|NCT02139046|593987516|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
164442427|NCT02139046|593987517|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
164442428|NCT02139046|593987513|FG000|Overall Study|Other Miscellaneous Reasons|10|||
164442429|NCT02139046|593987514|FG001|Overall Study|Other Miscellaneous Reasons|9|||
164442430|NCT02139046|593987515|FG002|Overall Study|Other Miscellaneous Reasons|4|||
164442431|NCT02139046|593987516|FG003|Overall Study|Other Miscellaneous Reasons|9|||
164442432|NCT02139046|593987517|FG004|Overall Study|Other Miscellaneous Reasons|12|||
164442433|NCT01765543|593987522|FG000|Overall Study|Death|1|||
164442434|NCT01765543|593987522|FG000|Overall Study|Withdrawal by Subject|2|||
164442435|NCT03718767|593987533|FG000|Overall Study|Declined to participate (before treatment started)|0|||
164705343|NCT00085423|594946742|FG000|Overall Study|Withdrawal by Subject|1|||
164705344|NCT00085423|594946742|FG000|Overall Study|screen failure|1|||
164705345|NCT04740814|594946743|FG000|Overall Study|Adverse Event|3|||
164705346|NCT04740814|594946743|FG000|Overall Study|Protocol Violation|2|||
164705347|NCT04740814|594946743|FG000|Overall Study|Lost to Follow-up|2|||
164705348|NCT04740814|594946743|FG000|Overall Study|Withdrawal by Subject|3|||
164705349|NCT02994940|594946744|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
164705350|NCT02994940|594946745|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
164705351|NCT02994940|594946744|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
164705352|NCT02994940|594946745|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
164705353|NCT02994940|594946744|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
164705354|NCT02994940|594946745|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
164705355|NCT01103466|594946746|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
164705356|NCT01103466|594946747|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
164705357|NCT01103466|594946748|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
164705358|NCT01103466|594946746|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
164705359|NCT01103466|594946747|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
164705360|NCT01103466|594946748|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
164705361|NCT01103466|594946746|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
164705362|NCT01103466|594946747|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
164705363|NCT01103466|594946748|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
164442436|NCT03718767|593987534|FG001|Overall Study|Declined to participate (before treatment started)|0|||
164442437|NCT03718767|593987535|FG002|Overall Study|Declined to participate (before treatment started)|7|||
164442438|NCT03718767|593987533|FG000|Overall Study|Ineligible|0|||
164705364|NCT01103466|594946746|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
164705365|NCT01103466|594946747|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
164705366|NCT01103466|594946748|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
164705367|NCT01103466|594946746|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
164705368|NCT01103466|594946747|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
164705369|NCT01103466|594946748|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
164705370|NCT01103466|594946746|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
164705371|NCT01103466|594946747|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
164705372|NCT01103466|594946748|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
164705373|NCT02331368|594946755|FG000|Overall Study|Withdrawal by Subject|3|||
164705374|NCT02302859|594946756|FG000|Overall Study|Lost Phone|1|||
164705375|NCT02302859|594946757|FG001|Overall Study|Lost Phone|1|||
164442439|NCT03718767|593987534|FG001|Overall Study|Ineligible|0|||
164705376|NCT02302859|594946756|FG000|Overall Study|Withdrawal by Subject|0|||
164705377|NCT02302859|594946757|FG001|Overall Study|Withdrawal by Subject|1|||
164705378|NCT02989168|594946768|FG000|Overall Study|Withdrawal by Subject|2|||
164442440|NCT03718767|593987535|FG002|Overall Study|Ineligible|17|||
164442441|NCT06129045|593987538|FG000|Overall Study|Lost to Follow-up|1|||
164442442|NCT06129045|593987539|FG001|Overall Study|Lost to Follow-up|1|||
164398276|NCT00254982|593828047|FG001|Overall Study|Adverse Event|16|||
164398277|NCT00254982|593828046|FG000|Overall Study|Withdrawal by Subject|1|||
164398278|NCT00254982|593828047|FG001|Overall Study|Withdrawal by Subject|1|||
164398279|NCT00254982|593828046|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
164398280|NCT00254982|593828047|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
164398281|NCT00254982|593828046|FG000|Overall Study|Protocol deviation|1|||
164398282|NCT00254982|593828047|FG001|Overall Study|Protocol deviation|1|||
164398283|NCT00254982|593828046|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
164398284|NCT00254982|593828047|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
164398285|NCT00254982|593828046|FG000|Overall Study|Malignancy|0|||
164398286|NCT00254982|593828047|FG001|Overall Study|Malignancy|2|||
164398287|NCT00254982|593828046|FG000|Overall Study|Opportunistic infection|1|||
164398288|NCT00254982|593828047|FG001|Overall Study|Opportunistic infection|0|||
164398289|NCT00254982|593828046|FG000|Overall Study|Abnormal liver function tests|2|||
164398290|NCT00254982|593828047|FG001|Overall Study|Abnormal liver function tests|1|||
164398291|NCT02261493|593828048|FG000|Overall Study|Noncompliance|0|||
164398292|NCT02261493|593828049|FG001|Overall Study|Noncompliance|0|||
164398293|NCT02261493|593828050|FG002|Overall Study|Noncompliance|2|||
164398294|NCT02261493|593828048|FG000|Overall Study|Physician Decision|0|||
164398295|NCT02261493|593828049|FG001|Overall Study|Physician Decision|1|||
164398296|NCT02261493|593828050|FG002|Overall Study|Physician Decision|0|||
164398297|NCT02261493|593828048|FG000|Overall Study|Undisclosed alcohol abuse|0|||
164398298|NCT02261493|593828049|FG001|Overall Study|Undisclosed alcohol abuse|1|||
164398299|NCT02261493|593828050|FG002|Overall Study|Undisclosed alcohol abuse|0|||
164398300|NCT02261493|593828048|FG000|Overall Study|Protocol Violation|1|||
164398301|NCT02261493|593828049|FG001|Overall Study|Protocol Violation|0|||
164398302|NCT02261493|593828050|FG002|Overall Study|Protocol Violation|0|||
164398303|NCT02261493|593828048|FG000|Overall Study|Personal Reasons|14|||
164398304|NCT02261493|593828049|FG001|Overall Study|Personal Reasons|14|||
164398305|NCT02261493|593828050|FG002|Overall Study|Personal Reasons|16|||
164398306|NCT02261493|593828048|FG000|Overall Study|Lost to Follow-up|14|||
164398307|NCT02261493|593828049|FG001|Overall Study|Lost to Follow-up|27|||
164398308|NCT02261493|593828050|FG002|Overall Study|Lost to Follow-up|8|||
164398309|NCT02261493|593828048|FG000|Overall Study|Pregnancy|1|||
164398310|NCT02261493|593828049|FG001|Overall Study|Pregnancy|2|||
164398311|NCT02261493|593828050|FG002|Overall Study|Pregnancy|0|||
164398312|NCT02261493|593828048|FG000|Overall Study|Lack of Efficacy|0|||
164398313|NCT02261493|593828049|FG001|Overall Study|Lack of Efficacy|1|||
164398314|NCT02261493|593828050|FG002|Overall Study|Lack of Efficacy|0|||
164398315|NCT02261493|593828048|FG000|Overall Study|Adverse Event|0|||
164398316|NCT02261493|593828049|FG001|Overall Study|Adverse Event|1|||
164398317|NCT02261493|593828050|FG002|Overall Study|Adverse Event|0|||
164398318|NCT00558428|593828051|FG000|Overall Study|Adverse Event|6|||
164398319|NCT00558428|593828052|FG001|Overall Study|Adverse Event|22|||
164398320|NCT00558428|593828053|FG002|Overall Study|Adverse Event|3|||
164398321|NCT00558428|593828054|FG003|Overall Study|Adverse Event|4|||
164398322|NCT00558428|593828051|FG000|Overall Study|Lost to Follow-up|0|||
164398323|NCT00558428|593828052|FG001|Overall Study|Lost to Follow-up|1|||
164398324|NCT00558428|593828053|FG002|Overall Study|Lost to Follow-up|0|||
164398325|NCT00558428|593828054|FG003|Overall Study|Lost to Follow-up|0|||
164398326|NCT00558428|593828051|FG000|Overall Study|Lack of Efficacy|0|||
164398327|NCT00558428|593828052|FG001|Overall Study|Lack of Efficacy|0|||
164398328|NCT00558428|593828053|FG002|Overall Study|Lack of Efficacy|1|||
164398329|NCT00558428|593828054|FG003|Overall Study|Lack of Efficacy|2|||
164398330|NCT00558428|593828051|FG000|Overall Study|Non compliant with protocol|1|||
164398331|NCT00558428|593828052|FG001|Overall Study|Non compliant with protocol|0|||
164595921|NCT02232087|594545075|FG005|Overall Study|Withdrawal by Subject|1|||
164595922|NCT02232087|594545070|FG000|Overall Study|poor inhalation technique|0|||
164595923|NCT02232087|594545071|FG001|Overall Study|poor inhalation technique|1|||
164595924|NCT02232087|594545072|FG002|Overall Study|poor inhalation technique|0|||
164595925|NCT02232087|594545073|FG003|Overall Study|poor inhalation technique|0|||
164595926|NCT02232087|594545074|FG004|Overall Study|poor inhalation technique|0|||
164595927|NCT02232087|594545075|FG005|Overall Study|poor inhalation technique|2|||
164595928|NCT02232087|594545070|FG000|Overall Study|protocol stop criteria|0|||
164595929|NCT02232087|594545071|FG001|Overall Study|protocol stop criteria|1|||
164595930|NCT02232087|594545072|FG002|Overall Study|protocol stop criteria|0|||
164595931|NCT02232087|594545073|FG003|Overall Study|protocol stop criteria|1|||
164705379|NCT02989168|594946769|FG001|Overall Study|Withdrawal by Subject|0|||
164398332|NCT00558428|593828053|FG002|Overall Study|Non compliant with protocol|0|||
164398333|NCT00558428|593828054|FG003|Overall Study|Non compliant with protocol|3|||
164398334|NCT00558428|593828051|FG000|Overall Study|Consent withdrawn|2|||
164398335|NCT00558428|593828052|FG001|Overall Study|Consent withdrawn|1|||
164398336|NCT00558428|593828053|FG002|Overall Study|Consent withdrawn|0|||
164398337|NCT00558428|593828054|FG003|Overall Study|Consent withdrawn|1|||
164398338|NCT00558428|593828051|FG000|Overall Study|Other|3|||
164398339|NCT00558428|593828052|FG001|Overall Study|Other|0|||
164398340|NCT00558428|593828053|FG002|Overall Study|Other|0|||
164398341|NCT00558428|593828054|FG003|Overall Study|Other|1|||
164595932|NCT02232087|594545074|FG004|Overall Study|protocol stop criteria|0|||
164398342|NCT02570126|593828055|FG000|Overall Study|Lost to Follow-up|2|||
164398343|NCT02570126|593828056|FG001|Overall Study|Lost to Follow-up|0|||
164398344|NCT02570126|593828055|FG000|Overall Study|Unable To Arrange Visit 3|1|||
164398345|NCT02570126|593828056|FG001|Overall Study|Unable To Arrange Visit 3|0|||
164398346|NCT02570126|593828055|FG000|Overall Study|Violation Of Procedures GSK|0|||
164398347|NCT02570126|593828056|FG001|Overall Study|Violation Of Procedures GSK|1|||
164398348|NCT02570126|593828055|FG000|Overall Study|Protocol Violation|0|||
164398349|NCT02570126|593828056|FG001|Overall Study|Protocol Violation|1|||
164398350|NCT02570126|593828055|FG000|Overall Study|Withdrawal by Subject|3|||
164398351|NCT02570126|593828056|FG001|Overall Study|Withdrawal by Subject|7|||
164398352|NCT00626028|593828057|FG000|Overall Study|Adverse Event|1|||
164398353|NCT00626028|593828058|FG001|Overall Study|Adverse Event|1|||
164398354|NCT00626028|593828057|FG000|Overall Study|Device Failure|0|||
164398355|NCT00626028|593828058|FG001|Overall Study|Device Failure|1|||
164398356|NCT00626028|593828057|FG000|Overall Study|Physician Decision|2|||
164398357|NCT00626028|593828058|FG001|Overall Study|Physician Decision|1|||
164398358|NCT00626028|593828057|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
164398359|NCT00626028|593828058|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
164398360|NCT05224050|593828060|FG000|Overall Study|Withdrawal by Subject|9|||
164398361|NCT05224050|593828060|FG000|Overall Study|Lost to Follow-up|3|||
164398362|NCT01292876|593828061|FG000|Overall Study|Physician Decision|4|||
164398363|NCT00917579|593828062|FG000|Washout >= 2 Weeks|Adverse Event|1|||
164398364|NCT00917579|593828063|FG001|Washout >= 2 Weeks|Adverse Event|0|||
164398365|NCT00917579|593828062|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
164398366|NCT00917579|593828063|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
164398367|NCT01627327|593828064|FG000|Overall Study|Adverse Event|6|||
164398368|NCT01627327|593828065|FG001|Overall Study|Adverse Event|12|||
164398369|NCT01627327|593828064|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
164398370|NCT01627327|593828065|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
164398371|NCT01627327|593828064|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
164398372|NCT01627327|593828065|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
164398373|NCT01627327|593828064|FG000|Overall Study|Protocol Violation|4|||
164398374|NCT01627327|593828065|FG001|Overall Study|Protocol Violation|10|||
164398375|NCT01627327|593828064|FG000|Overall Study|Lost to Follow-up|1|||
164398376|NCT01627327|593828065|FG001|Overall Study|Lost to Follow-up|3|||
164398377|NCT01627327|593828064|FG000|Overall Study|Physician Decision|1|||
164398378|NCT01627327|593828065|FG001|Overall Study|Physician Decision|0|||
164398379|NCT01627327|593828064|FG000|Overall Study|Withdrawal by Subject|3|||
164398380|NCT01627327|593828065|FG001|Overall Study|Withdrawal by Subject|3|||
164398381|NCT05763628|593828073|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
164398382|NCT05763628|593828074|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
164398383|NCT05763628|593828073|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
164398384|NCT05763628|593828074|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
164398385|NCT05763628|593828073|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
164398386|NCT05763628|593828074|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
164398387|NCT01137474|593828075|FG000|Overall Study|Adverse Event|3|||
164398388|NCT01137474|593828076|FG001|Overall Study|Adverse Event|5|||
164398389|NCT01137474|593828077|FG002|Overall Study|Adverse Event|1|||
164398390|NCT01137474|593828078|FG003|Overall Study|Adverse Event|3|||
164398391|NCT01137474|593828075|FG000|Overall Study|Withdrawal by Subject|7|||
164398392|NCT01137474|593828076|FG001|Overall Study|Withdrawal by Subject|2|||
164398393|NCT01137474|593828077|FG002|Overall Study|Withdrawal by Subject|6|||
164398394|NCT01137474|593828078|FG003|Overall Study|Withdrawal by Subject|9|||
164398395|NCT01137474|593828075|FG000|Overall Study|No longer met study criteria|6|||
164398396|NCT01137474|593828076|FG001|Overall Study|No longer met study criteria|1|||
164398397|NCT01137474|593828077|FG002|Overall Study|No longer met study criteria|0|||
164398398|NCT01137474|593828078|FG003|Overall Study|No longer met study criteria|5|||
164398399|NCT01137474|593828075|FG000|Overall Study|Lost to Follow-up|5|||
164398400|NCT01137474|593828076|FG001|Overall Study|Lost to Follow-up|1|||
164398401|NCT01137474|593828077|FG002|Overall Study|Lost to Follow-up|0|||
164398402|NCT01137474|593828078|FG003|Overall Study|Lost to Follow-up|2|||
164398403|NCT01137474|593828075|FG000|Overall Study|Lack of Efficacy|0|||
164398404|NCT01137474|593828076|FG001|Overall Study|Lack of Efficacy|0|||
164398405|NCT01137474|593828077|FG002|Overall Study|Lack of Efficacy|0|||
164398406|NCT01137474|593828078|FG003|Overall Study|Lack of Efficacy|2|||
164398407|NCT01137474|593828075|FG000|Overall Study|Other|3|||
164398408|NCT01137474|593828076|FG001|Overall Study|Other|1|||
164398409|NCT01137474|593828077|FG002|Overall Study|Other|0|||
164398410|NCT01137474|593828078|FG003|Overall Study|Other|0|||
164398411|NCT01137474|593828075|FG000|Overall Study|Pregnancy|0|||
164398412|NCT01137474|593828076|FG001|Overall Study|Pregnancy|1|||
164398413|NCT01137474|593828077|FG002|Overall Study|Pregnancy|0|||
164398414|NCT01137474|593828078|FG003|Overall Study|Pregnancy|0|||
164398415|NCT01137474|593828075|FG000|Overall Study|Administrative reason by sponsor|0|||
164398416|NCT01137474|593828076|FG001|Overall Study|Administrative reason by sponsor|1|||
164398417|NCT01137474|593828077|FG002|Overall Study|Administrative reason by sponsor|0|||
164398418|NCT01137474|593828078|FG003|Overall Study|Administrative reason by sponsor|0|||
164705380|NCT02989168|594946768|FG000|Overall Study|Physician Decision|0|||
164705381|NCT02989168|594946769|FG001|Overall Study|Physician Decision|1|||
164705382|NCT02989168|594946768|FG000|Overall Study|Adverse Event|1|||
164705383|NCT02989168|594946769|FG001|Overall Study|Adverse Event|2|||
164398419|NCT00868439|593828084|FG000|Overall Study|Adverse Event|4|||
164398420|NCT00868439|593828085|FG001|Overall Study|Adverse Event|3|||
164705384|NCT02989168|594946768|FG000|Overall Study|Sponsor stopped study.|1|||
164398421|NCT00868439|593828084|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
164398422|NCT00868439|593828085|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
164398423|NCT00868439|593828084|FG000|Overall Study|Death|0|||
164398424|NCT00868439|593828085|FG001|Overall Study|Death|1|||
164398425|NCT00868439|593828084|FG000|Overall Study|Protocol Violation|1|||
164398426|NCT00868439|593828085|FG001|Overall Study|Protocol Violation|1|||
164398427|NCT00868439|593828084|FG000|Overall Study|Physician Decision|1|||
164398428|NCT00868439|593828085|FG001|Overall Study|Physician Decision|0|||
164398429|NCT00868439|593828084|FG000|Overall Study|Withdrawal by Subject|0|||
164398430|NCT00868439|593828085|FG001|Overall Study|Withdrawal by Subject|1|||
164398431|NCT01132326|593828086|FG000|Overall Study|Lack of Efficacy|25|||
164398432|NCT01132326|593828086|FG000|Overall Study|Adverse Event|37|||
164398433|NCT01132326|593828086|FG000|Overall Study|Protocol Violation|1|||
164398434|NCT01132326|593828086|FG000|Overall Study|Lost to Follow-up|16|||
164398435|NCT01132326|593828086|FG000|Overall Study|Withdrawal by Subject|40|||
164398436|NCT01132326|593828086|FG000|Overall Study|Physician Decision|10|||
164398437|NCT01132326|593828086|FG000|Overall Study|Study Termination|80|||
164398438|NCT01132326|593828086|FG000|Overall Study|Declining Health|1|||
164398439|NCT01132326|593828086|FG000|Overall Study|Pregnancy|1|||
164398440|NCT01132326|593828086|FG000|Overall Study|Caregiver Withdrew Consent|1|||
164398441|NCT01132326|593828086|FG000|Overall Study|Death|5|||
164398442|NCT01132326|593828086|FG000|Overall Study|Subject Unable to Come To Visits|1|||
164398443|NCT00338884|593828089|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
164398444|NCT00338884|593828089|FG000|Overall Study|Adverse Event|14|||
164398445|NCT00338884|593828089|FG000|Overall Study|Death|8|||
164398446|NCT00338884|593828089|FG000|Overall Study|Other|4|||
164398447|NCT00338884|593828089|FG000|Overall Study|Global Deterioration of Health Status|3|||
164398448|NCT00338884|593828089|FG000|Overall Study|Withdrawal by Subject|3|||
164398449|NCT00338884|593828089|FG000|Overall Study|Lost to Follow-up|1|||
164398450|NCT00338884|593828089|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
164398451|NCT00911534|593828090|FG000|Overall Study|Adverse Event|4|||
164398452|NCT00911534|593828091|FG001|Overall Study|Adverse Event|4|||
164398453|NCT00911534|593828090|FG000|Overall Study|Lost to Follow-up|2|||
164398454|NCT00911534|593828091|FG001|Overall Study|Lost to Follow-up|4|||
164398455|NCT00911534|593828090|FG000|Overall Study|Withdrawal by Subject|2|||
164398456|NCT00911534|593828091|FG001|Overall Study|Withdrawal by Subject|1|||
164398457|NCT00911534|593828090|FG000|Overall Study|Lack of Efficacy|4|||
164398458|NCT00911534|593828091|FG001|Overall Study|Lack of Efficacy|1|||
164398459|NCT00911534|593828090|FG000|Overall Study|Withdrawal of consent|1|||
164398460|NCT00911534|593828091|FG001|Overall Study|Withdrawal of consent|4|||
164398461|NCT00911534|593828090|FG000|Overall Study|Other|2|||
164398462|NCT00911534|593828091|FG001|Overall Study|Other|2|||
164398463|NCT05072080|593828093|FG000|Overall Study|Death|0|||
164398464|NCT05072080|593828094|FG001|Overall Study|Death|0|||
164398465|NCT05072080|593828095|FG002|Overall Study|Death|1|||
164398466|NCT05072080|593828096|FG003|Overall Study|Death|0|||
164398467|NCT05072080|593828093|FG000|Overall Study|Lost to Follow-up|65|||
164398468|NCT05072080|593828094|FG001|Overall Study|Lost to Follow-up|70|||
164398469|NCT05072080|593828095|FG002|Overall Study|Lost to Follow-up|58|||
164398470|NCT05072080|593828096|FG003|Overall Study|Lost to Follow-up|23|||
164398471|NCT05072080|593828093|FG000|Overall Study|Physician Decision|2|||
164398472|NCT05072080|593828094|FG001|Overall Study|Physician Decision|1|||
164398473|NCT05072080|593828095|FG002|Overall Study|Physician Decision|1|||
164398474|NCT05072080|593828096|FG003|Overall Study|Physician Decision|0|||
164398475|NCT05072080|593828093|FG000|Overall Study|Withdrawal by Subject|45|||
164398476|NCT05072080|593828094|FG001|Overall Study|Withdrawal by Subject|30|||
164705385|NCT02989168|594946769|FG001|Overall Study|Sponsor stopped study.|0|||
164705386|NCT01940497|594946770|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
164705387|NCT01940497|594946771|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
164705388|NCT01940497|594946770|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
164705389|NCT01940497|594946771|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
164398477|NCT05072080|593828095|FG002|Overall Study|Withdrawal by Subject|27|||
164398478|NCT05072080|593828096|FG003|Overall Study|Withdrawal by Subject|7|||
164398479|NCT05072080|593828093|FG000|Overall Study|Sponsor Decision|0|||
164398480|NCT05072080|593828094|FG001|Overall Study|Sponsor Decision|1|||
164398481|NCT05072080|593828095|FG002|Overall Study|Sponsor Decision|0|||
164398482|NCT05072080|593828096|FG003|Overall Study|Sponsor Decision|0|||
164398483|NCT05072080|593828093|FG000|Overall Study|Subject moved|1|||
164398484|NCT05072080|593828094|FG001|Overall Study|Subject moved|3|||
164398485|NCT05072080|593828095|FG002|Overall Study|Subject moved|5|||
164398486|NCT05072080|593828096|FG003|Overall Study|Subject moved|2|||
164705390|NCT01940497|594946770|FG000|Overall Study|Violation of Entry Criteria|1|||
164398487|NCT05072080|593828093|FG000|Overall Study|Withdrawal by parent|0|||
164398488|NCT05072080|593828094|FG001|Overall Study|Withdrawal by parent|0|||
164398489|NCT05072080|593828095|FG002|Overall Study|Withdrawal by parent|1|||
164398490|NCT05072080|593828096|FG003|Overall Study|Withdrawal by parent|0|||
164705391|NCT01940497|594946771|FG001|Overall Study|Violation of Entry Criteria|1|||
164705392|NCT01940497|594946770|FG000|Overall Study|Refused Treatment|1|||
164705393|NCT01940497|594946771|FG001|Overall Study|Refused Treatment|3|||
164705394|NCT01940497|594946770|FG000|Overall Study|Withdrew Consent|6|||
164705395|NCT01940497|594946771|FG001|Overall Study|Withdrew Consent|2|||
164705396|NCT01940497|594946770|FG000|Overall Study|Administrative/Other|1|||
164705397|NCT01940497|594946771|FG001|Overall Study|Administrative/Other|1|||
164705398|NCT02435836|594946773|FG000|Overall Study|Lost to Follow-up|21|||
164705399|NCT02435836|594946773|FG000|Overall Study|Lack of Efficacy|1|||
164705400|NCT02435836|594946773|FG000|Overall Study|Withdrawal by Subject|236|||
164705401|NCT02435836|594946773|FG000|Overall Study|Insufficient Clinical Response|26|||
164705402|NCT02435836|594946773|FG000|Overall Study|Adverse Event|44|||
164705403|NCT02435836|594946773|FG000|Overall Study|Sponsor discontinued trial|167|||
164705404|NCT02435836|594946773|FG000|Overall Study|Noncompliance|27|||
164705405|NCT02435836|594946773|FG000|Overall Study|Protocol Violation|6|||
164705406|NCT02435836|594946773|FG000|Overall Study|Met Withdrawal Criteria|7|||
164705407|NCT02435836|594946773|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
164705408|NCT01661179|594946776|FG000|Overall Study|Death|1|||
164705409|NCT01661179|594946776|FG000|Overall Study|Withdrawal by Subject|1|||
164705410|NCT01661179|594946776|FG000|Overall Study|Other Eligibility criteria|4|||
164705411|NCT01946191|594946777|FG000|Allocation|Did not complete orientation|1|||
164705412|NCT01946191|594946778|FG001|Allocation|Did not complete orientation|1|||
164705413|NCT01946191|594946777|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
164705414|NCT01946191|594946778|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
164705415|NCT01946191|594946777|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
164705416|NCT01946191|594946778|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
164705417|NCT01946191|594946777|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
164705418|NCT01946191|594946778|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
164705419|NCT03071094|594946781|FG000|Overall Study|Death|1|||
164705420|NCT03071094|594946782|FG001|Overall Study|Death|1|||
164705421|NCT03071094|594946781|FG000|Overall Study|Adverse Event|1|||
164705422|NCT03071094|594946782|FG001|Overall Study|Adverse Event|0|||
164705423|NCT02312063|594946783|FG000|Overall Study|Withdrawal by Subject|0|||
164705424|NCT02312063|594946784|FG001|Overall Study|Withdrawal by Subject|1|||
164398491|NCT05072080|593828093|FG000|Overall Study|Subject was deployed|0|||
164705425|NCT04732221|594948650|FG000|Base Period|Death|2|||
164705426|NCT04732221|594948651|FG001|Base Period|Death|0|||
164705427|NCT04732221|594948652|FG002|Base Period|Death|0|||
164705428|NCT04732221|594948653|FG003|Base Period|Death|0|||
164705429|NCT04732221|594948654|FG004|Base Period|Death|0|||
164705430|NCT04732221|594948655|FG005|Base Period|Death|0|||
164705431|NCT04732221|594948656|FG006|Base Period|Death|0|||
164705432|NCT04732221|594948650|FG000|Base Period|Withdrawal by Subject|0|||
164705433|NCT04732221|594948651|FG001|Base Period|Withdrawal by Subject|1|||
164705434|NCT04732221|594948652|FG002|Base Period|Withdrawal by Subject|1|||
164705435|NCT04732221|594948653|FG003|Base Period|Withdrawal by Subject|0|||
164705436|NCT04732221|594948654|FG004|Base Period|Withdrawal by Subject|0|||
164705437|NCT04732221|594948655|FG005|Base Period|Withdrawal by Subject|0|||
164705438|NCT04732221|594948656|FG006|Base Period|Withdrawal by Subject|0|||
164705439|NCT04732221|594948650|FG000|Extension Period|Adverse Event|0|||
164705440|NCT04732221|594948651|FG001|Extension Period|Adverse Event|0|||
164705441|NCT04732221|594948652|FG002|Extension Period|Adverse Event|0|||
164705442|NCT04732221|594948653|FG003|Extension Period|Adverse Event|0|||
164705443|NCT04732221|594948654|FG004|Extension Period|Adverse Event|0|||
164705444|NCT04732221|594948655|FG005|Extension Period|Adverse Event|1|||
164705445|NCT04732221|594948656|FG006|Extension Period|Adverse Event|0|||
164705446|NCT04732221|594948650|FG000|Extension Period|Death|0|||
164705447|NCT04732221|594948651|FG001|Extension Period|Death|0|||
164705448|NCT04732221|594948652|FG002|Extension Period|Death|0|||
164705449|NCT04732221|594948653|FG003|Extension Period|Death|0|||
164705450|NCT04732221|594948654|FG004|Extension Period|Death|1|||
164705451|NCT04732221|594948655|FG005|Extension Period|Death|0|||
164705452|NCT04732221|594948656|FG006|Extension Period|Death|2|||
164705453|NCT04732221|594948650|FG000|Extension Period|Pregnancy|0|||
164705454|NCT04732221|594948651|FG001|Extension Period|Pregnancy|0|||
164705455|NCT04732221|594948652|FG002|Extension Period|Pregnancy|0|||
164705456|NCT04732221|594948653|FG003|Extension Period|Pregnancy|0|||
164705457|NCT04732221|594948654|FG004|Extension Period|Pregnancy|1|||
164705458|NCT04732221|594948655|FG005|Extension Period|Pregnancy|0|||
164705459|NCT04732221|594948656|FG006|Extension Period|Pregnancy|0|||
164705460|NCT04732221|594948650|FG000|Extension Period|Sponsors Decision|0|||
164705461|NCT04732221|594948651|FG001|Extension Period|Sponsors Decision|0|||
164705462|NCT04732221|594948652|FG002|Extension Period|Sponsors Decision|0|||
164705463|NCT04732221|594948653|FG003|Extension Period|Sponsors Decision|0|||
164705464|NCT04732221|594948654|FG004|Extension Period|Sponsors Decision|41|||
164705465|NCT04732221|594948655|FG005|Extension Period|Sponsors Decision|40|||
164705466|NCT04732221|594948656|FG006|Extension Period|Sponsors Decision|40|||
164705467|NCT04732221|594948650|FG000|Extension Period|Withdrawal by Subject|0|||
164705468|NCT04732221|594948651|FG001|Extension Period|Withdrawal by Subject|0|||
164705469|NCT04732221|594948652|FG002|Extension Period|Withdrawal by Subject|0|||
164705470|NCT04732221|594948653|FG003|Extension Period|Withdrawal by Subject|0|||
164705471|NCT04732221|594948654|FG004|Extension Period|Withdrawal by Subject|1|||
164705472|NCT04732221|594948655|FG005|Extension Period|Withdrawal by Subject|5|||
164705473|NCT04732221|594948656|FG006|Extension Period|Withdrawal by Subject|2|||
164705474|NCT04305587|594948659|FG000|Overall Study|Withdrawal by Subject|0|||
164705475|NCT04305587|594948660|FG001|Overall Study|Withdrawal by Subject|0|||
164705476|NCT04305587|594948661|FG002|Overall Study|Withdrawal by Subject|0|||
164705477|NCT04305587|594948662|FG003|Overall Study|Withdrawal by Subject|1|||
164705478|NCT04305587|594948663|FG004|Overall Study|Withdrawal by Subject|0|||
164705479|NCT04305587|594948664|FG005|Overall Study|Withdrawal by Subject|0|||
164705480|NCT04305587|594948665|FG006|Overall Study|Withdrawal by Subject|0|||
164705481|NCT04305587|594948666|FG007|Overall Study|Withdrawal by Subject|0|||
164705482|NCT04305587|594948667|FG008|Overall Study|Withdrawal by Subject|0|||
164398492|NCT05072080|593828094|FG001|Overall Study|Subject was deployed|1|||
164398493|NCT05072080|593828095|FG002|Overall Study|Subject was deployed|0|||
164398494|NCT05072080|593828096|FG003|Overall Study|Subject was deployed|0|||
164705483|NCT00824616|594948668|FG000|Overall Study|Adverse Event|2|||
164705484|NCT00824616|594948669|FG001|Overall Study|Adverse Event|1|||
164705485|NCT00824616|594948668|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
164705486|NCT00824616|594948669|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
164705487|NCT00824616|594948668|FG000|Overall Study|Hyperglycemia|1|||
164705488|NCT00824616|594948669|FG001|Overall Study|Hyperglycemia|1|||
164705489|NCT00824616|594948668|FG000|Overall Study|Lack of Efficacy|2|||
164705490|NCT00824616|594948669|FG001|Overall Study|Lack of Efficacy|1|||
164705491|NCT00824616|594948668|FG000|Overall Study|Lost to Follow-up|0|||
164705492|NCT00824616|594948669|FG001|Overall Study|Lost to Follow-up|1|||
164705493|NCT00824616|594948668|FG000|Overall Study|Withdrawal by Subject|1|||
164705494|NCT00824616|594948669|FG001|Overall Study|Withdrawal by Subject|1|||
164705495|NCT01200992|594948670|FG000|Overall Study|Study terminated early|35|||
164705496|NCT01200992|594948671|FG001|Overall Study|Study terminated early|41|||
164705497|NCT01200992|594948670|FG000|Overall Study|Randomized but not treated|2|||
164705498|NCT01200992|594948671|FG001|Overall Study|Randomized but not treated|0|||
164705499|NCT01783548|594948679|FG000|Overall Study|Adverse Event|8|||
164705500|NCT01783548|594948680|FG001|Overall Study|Adverse Event|4|||
164705501|NCT01783548|594948679|FG000|Overall Study|Withdrawal by Subject|11|||
164398495|NCT05072080|593828093|FG000|Overall Study|Subject left site without receiving dose|0|||
164398496|NCT05072080|593828094|FG001|Overall Study|Subject left site without receiving dose|1|||
164398497|NCT05072080|593828095|FG002|Overall Study|Subject left site without receiving dose|0|||
164398498|NCT05072080|593828096|FG003|Overall Study|Subject left site without receiving dose|0|||
164398499|NCT05072080|593828093|FG000|Overall Study|Subject incarcerated|0|||
164398500|NCT05072080|593828094|FG001|Overall Study|Subject incarcerated|1|||
164398501|NCT05072080|593828095|FG002|Overall Study|Subject incarcerated|0|||
164398502|NCT05072080|593828096|FG003|Overall Study|Subject incarcerated|1|||
164398503|NCT05072080|593828093|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
164398504|NCT05072080|593828094|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
164398505|NCT05072080|593828095|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
164398506|NCT05072080|593828096|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
164398507|NCT05072080|593828093|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
164398508|NCT05072080|593828094|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
164398509|NCT05072080|593828095|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
164398510|NCT05072080|593828096|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
164398511|NCT03492281|593828097|FG000|Overall Study|Withdrawal by Subject|21|||
164398512|NCT03492281|593828098|FG001|Overall Study|Withdrawal by Subject|14|||
164398513|NCT03492281|593828099|FG002|Overall Study|Withdrawal by Subject|13|||
164398514|NCT03492281|593828097|FG000|Overall Study|Lost to Follow-up|14|||
164398515|NCT03492281|593828098|FG001|Overall Study|Lost to Follow-up|15|||
164398516|NCT03492281|593828099|FG002|Overall Study|Lost to Follow-up|10|||
164398517|NCT03492281|593828097|FG000|Overall Study|Adverse Event|6|||
164398518|NCT03492281|593828098|FG001|Overall Study|Adverse Event|8|||
164398519|NCT03492281|593828099|FG002|Overall Study|Adverse Event|13|||
164398520|NCT03492281|593828097|FG000|Overall Study|Lack of Efficacy|3|||
164398521|NCT03492281|593828098|FG001|Overall Study|Lack of Efficacy|0|||
164398522|NCT03492281|593828099|FG002|Overall Study|Lack of Efficacy|1|||
164398523|NCT03492281|593828097|FG000|Overall Study|Physician Decision|1|||
164398524|NCT03492281|593828098|FG001|Overall Study|Physician Decision|0|||
164398525|NCT03492281|593828099|FG002|Overall Study|Physician Decision|3|||
164398526|NCT03492281|593828097|FG000|Overall Study|Protocol Violation|0|||
164398527|NCT03492281|593828098|FG001|Overall Study|Protocol Violation|2|||
164398528|NCT03492281|593828099|FG002|Overall Study|Protocol Violation|1|||
164398529|NCT03492281|593828097|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
164398530|NCT03492281|593828098|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
164398531|NCT03492281|593828099|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
164398532|NCT03492281|593828097|FG000|Overall Study|Death|0|||
164398533|NCT03492281|593828098|FG001|Overall Study|Death|0|||
164398534|NCT03492281|593828099|FG002|Overall Study|Death|1|||
164398535|NCT03492281|593828097|FG000|Overall Study|Captured as Other in Database|8|||
164398536|NCT03492281|593828098|FG001|Overall Study|Captured as Other in Database|6|||
164595933|NCT02232087|594545075|FG005|Overall Study|protocol stop criteria|0|||
164595934|NCT02232087|594545070|FG000|Overall Study|Adverse Event|0|||
164595935|NCT02232087|594545071|FG001|Overall Study|Adverse Event|0|||
164595936|NCT02232087|594545072|FG002|Overall Study|Adverse Event|0|||
164595937|NCT02232087|594545073|FG003|Overall Study|Adverse Event|0|||
164595938|NCT02232087|594545074|FG004|Overall Study|Adverse Event|1|||
164595939|NCT02232087|594545075|FG005|Overall Study|Adverse Event|0|||
164595940|NCT02208024|594545076|FG000|Overall Study|Withdrawal by Subject|1|||
164595941|NCT01958125|594545077|FG000|Overall Study|Missing diary data|2|||
164595942|NCT01958125|594545078|FG001|Overall Study|Missing diary data|6|||
164595943|NCT01958125|594545077|FG000|Overall Study|No headache attacks|0|||
164595944|NCT01958125|594545078|FG001|Overall Study|No headache attacks|2|||
164595945|NCT01106625|594545085|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
164595946|NCT01106625|594545086|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
164595947|NCT01106625|594545087|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
164595948|NCT01106625|594545085|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
164595949|NCT01106625|594545086|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
164595950|NCT01106625|594545087|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
164595951|NCT01106625|594545085|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
164595952|NCT01106625|594545086|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
164595953|NCT01106625|594545087|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
164595954|NCT01106625|594545085|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
164595955|NCT01106625|594545086|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
164595956|NCT01106625|594545087|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
164595957|NCT01106625|594545085|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
164595958|NCT01106625|594545086|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
164595959|NCT01106625|594545087|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
164398537|NCT03492281|593828099|FG002|Overall Study|Captured as Other in Database|3|||
164398538|NCT03342638|593828100|FG000|Overall Study|Withdrawal by Subject|1|||
164398539|NCT03342638|593828101|FG001|Overall Study|Withdrawal by Subject|0|||
164398540|NCT03342638|593828100|FG000|Overall Study|Physician Decision|0|||
164398541|NCT03342638|593828101|FG001|Overall Study|Physician Decision|1|||
164398542|NCT00113568|593828117|FG000|Overall Study|Adverse Event|97|||
164398543|NCT00113568|593828117|FG000|Overall Study|Death|1|||
164398544|NCT00113568|593828117|FG000|Overall Study|Lack of Efficacy|30|||
164398545|NCT00113568|593828117|FG000|Overall Study|Lost to Follow-up|156|||
164398546|NCT00113568|593828117|FG000|Overall Study|Protocol Violation|32|||
164398547|NCT00113568|593828117|FG000|Overall Study|Withdrawal by Subject|117|||
164398548|NCT00113568|593828117|FG000|Overall Study|Other|112|||
164398549|NCT02191267|593828119|FG000|Overall Study|Withdrawal by Subject|1|||
164398550|NCT02191267|593828120|FG001|Overall Study|Withdrawal by Subject|0|||
164398551|NCT02191267|593828121|FG002|Overall Study|Withdrawal by Subject|0|||
164398552|NCT03213158|593828124|FG000|Overall Study|Withdrawal by Subject|1|||
164398553|NCT03213158|593828124|FG000|Overall Study|Physician Decision|2|||
164398554|NCT00587964|593828125|FG000|Overall Study|Withdrawal by Subject|1|||
164398555|NCT00587964|593828125|FG000|Overall Study|Lost to Follow-up|1|||
164398556|NCT00587964|593828125|FG000|Overall Study|Patient found to be ineligible|1|||
164398557|NCT00587964|593828125|FG000|Overall Study|Patient did not receive intervention|5|||
164398558|NCT00587964|593828125|FG000|Overall Study|Progression of Disease|4|||
164398559|NCT01569438|593828127|FG000|Overall Study|Lack of Efficacy|1|||
164398560|NCT01569438|593828128|FG001|Overall Study|Lack of Efficacy|2|||
164398561|NCT01569438|593828127|FG000|Overall Study|Withdrawal by Subject|0|||
164398562|NCT01569438|593828128|FG001|Overall Study|Withdrawal by Subject|3|||
164398563|NCT01569438|593828127|FG000|Overall Study|Adverse Event|2|||
164398564|NCT01569438|593828128|FG001|Overall Study|Adverse Event|15|||
164398565|NCT01569438|593828127|FG000|Overall Study|Protocol Violation|2|||
164398566|NCT01569438|593828128|FG001|Overall Study|Protocol Violation|0|||
164398567|NCT01569438|593828127|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
164398568|NCT01569438|593828128|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
164398569|NCT01569438|593828127|FG000|Overall Study|Sponsor/Physician decision|1|||
164398570|NCT01569438|593828128|FG001|Overall Study|Sponsor/Physician decision|1|||
164398571|NCT01569438|593828127|FG000|Overall Study|Unable to adhere to study schedule|0|||
164398572|NCT01569438|593828128|FG001|Overall Study|Unable to adhere to study schedule|1|||
164398573|NCT03649230|593828130|FG000|Overall Study|Adverse Event|12|||
164398574|NCT03649230|593828130|FG000|Overall Study|Death|8|||
164398575|NCT03649230|593828130|FG000|Overall Study|Withdrawal by Subject|6|||
164398576|NCT03649230|593828130|FG000|Overall Study|Physician Decision|5|||
164398577|NCT03649230|593828130|FG000|Overall Study|Disease progression|5|||
164398578|NCT03649230|593828130|FG000|Overall Study|Switched to non-HEC|5|||
164398579|NCT03649230|593828130|FG000|Overall Study|Chemotherapy discontinued|4|||
164398580|NCT03649230|593828130|FG000|Overall Study|Received only 3 HEC cycles|4|||
164398581|NCT03649230|593828130|FG000|Overall Study|Screen Failure|3|||
164398582|NCT03649230|593828130|FG000|Overall Study|Patient stopped treatment|2|||
164398583|NCT03649230|593828130|FG000|Overall Study|Protocol Violation|1|||
164398584|NCT03649230|593828130|FG000|Overall Study|Non-compliance|1|||
164398585|NCT03649230|593828130|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
164398586|NCT01693068|593828131|FG000|Randomization Period|On-study|2|||
164398587|NCT01693068|593828132|FG001|Randomization Period|On-study|5|||
164398588|NCT01693068|593828133|FG002|Randomization Period|On-study|0|||
164398589|NCT01693068|593828131|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
164398590|NCT01693068|593828132|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
164398591|NCT01693068|593828133|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
164398592|NCT00617344|593828140|FG000|Overall Study|Serious adverse event|1|||
164398593|NCT00617344|593828141|FG001|Overall Study|Serious adverse event|0|||
164398594|NCT00617344|593828142|FG002|Overall Study|Serious adverse event|0|||
164398595|NCT00617344|593828140|FG000|Overall Study|Other Adverse Event|1|||
164398596|NCT00617344|593828141|FG001|Overall Study|Other Adverse Event|1|||
164398597|NCT00617344|593828142|FG002|Overall Study|Other Adverse Event|0|||
164398598|NCT00617344|593828140|FG000|Overall Study|Protocol Violation|10|||
164398599|NCT00617344|593828141|FG001|Overall Study|Protocol Violation|8|||
164398600|NCT00617344|593828142|FG002|Overall Study|Protocol Violation|5|||
164398601|NCT00617344|593828140|FG000|Overall Study|Lost to Follow-up|5|||
164398602|NCT00617344|593828141|FG001|Overall Study|Lost to Follow-up|4|||
164398603|NCT00617344|593828142|FG002|Overall Study|Lost to Follow-up|1|||
164398604|NCT00617344|593828140|FG000|Overall Study|Withdrawal by Subject|8|||
164398605|NCT00617344|593828141|FG001|Overall Study|Withdrawal by Subject|9|||
164398606|NCT00617344|593828142|FG002|Overall Study|Withdrawal by Subject|2|||
164398607|NCT02747238|593828143|FG000|Overall Study|Lack of Efficacy|0|||
164398608|NCT02747238|593828144|FG001|Overall Study|Lack of Efficacy|1|||
164398609|NCT02747238|593828143|FG000|Overall Study|Data lost|3|||
164398610|NCT02747238|593828144|FG001|Overall Study|Data lost|5|||
164398611|NCT05245864|593828152|FG000|Overall Study|Withdrawal by Subject|1|||
164398612|NCT05245864|593828153|FG001|Overall Study|Withdrawal by Subject|1|||
164398613|NCT01475136|593828154|FG000|Overall Study|Sponsor Decision|0|||
164398614|NCT01475136|593828155|FG001|Overall Study|Sponsor Decision|1|||
164398615|NCT01475136|593828156|FG002|Overall Study|Sponsor Decision|0|||
164398616|NCT01475136|593828157|FG003|Overall Study|Sponsor Decision|0|||
164398617|NCT01475136|593828154|FG000|Overall Study|Entry Criteria Not Met|0|||
164398618|NCT01475136|593828155|FG001|Overall Study|Entry Criteria Not Met|2|||
164398619|NCT01475136|593828156|FG002|Overall Study|Entry Criteria Not Met|3|||
164398620|NCT01475136|593828157|FG003|Overall Study|Entry Criteria Not Met|1|||
164398621|NCT01475136|593828154|FG000|Overall Study|Withdrawal by Subject|0|||
164398622|NCT01475136|593828155|FG001|Overall Study|Withdrawal by Subject|0|||
164398623|NCT01475136|593828156|FG002|Overall Study|Withdrawal by Subject|0|||
164398624|NCT01475136|593828157|FG003|Overall Study|Withdrawal by Subject|2|||
164398625|NCT01475136|593828154|FG000|Overall Study|Adverse Event|1|||
164398626|NCT01475136|593828155|FG001|Overall Study|Adverse Event|0|||
164398627|NCT01475136|593828156|FG002|Overall Study|Adverse Event|0|||
164398628|NCT01475136|593828157|FG003|Overall Study|Adverse Event|1|||
164398629|NCT01475136|593828154|FG000|Overall Study|Death|0|||
164398630|NCT01475136|593828155|FG001|Overall Study|Death|0|||
164398631|NCT01475136|593828156|FG002|Overall Study|Death|0|||
164398632|NCT01475136|593828157|FG003|Overall Study|Death|1|||
164398633|NCT01329029|593828158|FG000|Overall Study|Withdrawal by Subject|117|||
164398634|NCT01329029|593828159|FG001|Overall Study|Withdrawal by Subject|87|||
164398635|NCT01329029|593828158|FG000|Overall Study|Adverse Event|82|||
164398636|NCT01329029|593828159|FG001|Overall Study|Adverse Event|29|||
164398637|NCT01329029|593828158|FG000|Overall Study|Death|16|||
164398638|NCT01329029|593828159|FG001|Overall Study|Death|19|||
164398639|NCT01329029|593828158|FG000|Overall Study|Other|14|||
164398640|NCT01329029|593828159|FG001|Overall Study|Other|20|||
164398641|NCT01329029|593828158|FG000|Overall Study|COPD Exacerbation|11|||
164398642|NCT01329029|593828159|FG001|Overall Study|COPD Exacerbation|18|||
164398643|NCT01329029|593828158|FG000|Overall Study|Physician Decision|16|||
164398644|NCT01329029|593828159|FG001|Overall Study|Physician Decision|13|||
164398645|NCT01329029|593828158|FG000|Overall Study|Lost to Follow-up|8|||
164398646|NCT01329029|593828159|FG001|Overall Study|Lost to Follow-up|5|||
164398647|NCT01329029|593828158|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
164398648|NCT01329029|593828159|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
164398649|NCT01323530|593830612|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
164398650|NCT01323530|593830613|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
164398651|NCT01323530|593830614|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
164398652|NCT01323530|593830615|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
164398653|NCT01323530|593830616|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
164398654|NCT01323530|593830617|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
164398655|NCT01323530|593830618|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
164398656|NCT01323530|593830612|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
164398657|NCT01323530|593830613|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
164398658|NCT01323530|593830614|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
164398659|NCT01323530|593830615|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
164398660|NCT01323530|593830616|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
164398661|NCT01323530|593830617|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
164398662|NCT01323530|593830618|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
164398663|NCT01323530|593830612|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
164398664|NCT01323530|593830613|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
164398665|NCT01323530|593830614|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
164398666|NCT01323530|593830615|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
164398667|NCT01323530|593830616|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
164398668|NCT01323530|593830617|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
164398669|NCT01323530|593830618|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
164398670|NCT01323530|593830612|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
164398671|NCT01323530|593830613|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
164398672|NCT01323530|593830614|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
164398673|NCT01323530|593830615|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
164398674|NCT01323530|593830616|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
164398675|NCT01323530|593830617|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
164398676|NCT01323530|593830618|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
164398677|NCT01323530|593830612|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
164398678|NCT01323530|593830613|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
164398679|NCT01323530|593830614|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
164398680|NCT01323530|593830615|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
164398681|NCT01323530|593830616|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
164398682|NCT01323530|593830617|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
164398683|NCT01323530|593830618|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
164398684|NCT01323530|593830612|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
164398685|NCT01323530|593830613|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
164398686|NCT01323530|593830614|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
164398687|NCT01323530|593830615|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
164398688|NCT01323530|593830616|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
164398689|NCT01323530|593830617|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
164398690|NCT01323530|593830618|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
164398691|NCT01323530|593830612|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
164398692|NCT01323530|593830613|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
164398693|NCT01323530|593830614|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
164398694|NCT01323530|593830615|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
164398695|NCT01323530|593830616|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
164398696|NCT01323530|593830617|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
164398697|NCT01323530|593830618|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
164398698|NCT01323530|593830612|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
164398699|NCT01323530|593830613|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
164398700|NCT01323530|593830614|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
164398701|NCT01323530|593830615|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
164398702|NCT01323530|593830616|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
164398703|NCT01323530|593830617|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
164398704|NCT01323530|593830618|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
164398705|NCT01194570|593830621|FG000|Overall Study|Adverse Event|22|||
164398706|NCT01194570|593830622|FG001|Overall Study|Adverse Event|40|||
164398707|NCT01194570|593830621|FG000|Overall Study|Death|6|||
164398708|NCT01194570|593830622|FG001|Overall Study|Death|20|||
164398709|NCT01194570|593830621|FG000|Overall Study|Lack of Efficacy|32|||
164398710|NCT01194570|593830622|FG001|Overall Study|Lack of Efficacy|33|||
164398711|NCT01194570|593830621|FG000|Overall Study|Lost to Follow-up|4|||
164398712|NCT01194570|593830622|FG001|Overall Study|Lost to Follow-up|15|||
164398713|NCT01194570|593830621|FG000|Overall Study|Non-Compliance|2|||
164398714|NCT01194570|593830622|FG001|Overall Study|Non-Compliance|2|||
164398715|NCT01194570|593830621|FG000|Overall Study|Non-Compliance With Study Drug|2|||
164398716|NCT01194570|593830622|FG001|Overall Study|Non-Compliance With Study Drug|2|||
164398717|NCT01194570|593830621|FG000|Overall Study|Other|18|||
164398718|NCT01194570|593830622|FG001|Overall Study|Other|47|||
164398719|NCT01194570|593830621|FG000|Overall Study|Physician Decision|10|||
164398720|NCT01194570|593830622|FG001|Overall Study|Physician Decision|25|||
164398721|NCT01194570|593830621|FG000|Overall Study|Protocol Violation|1|||
164398722|NCT01194570|593830622|FG001|Overall Study|Protocol Violation|2|||
164398723|NCT01194570|593830621|FG000|Overall Study|Study Terminated By Sponsor|0|||
164398724|NCT01194570|593830622|FG001|Overall Study|Study Terminated By Sponsor|1|||
164398725|NCT01194570|593830621|FG000|Overall Study|Withdrawal by Subject|57|||
164398726|NCT01194570|593830622|FG001|Overall Study|Withdrawal by Subject|82|||
164398727|NCT01194570|593830621|FG000|Overall Study|Pregnancy|1|||
164398728|NCT01194570|593830622|FG001|Overall Study|Pregnancy|1|||
164398729|NCT04098406|593830626|FG000|Overall Study|Adverse Event|2|||
164398730|NCT04098406|593830627|FG001|Overall Study|Adverse Event|1|||
164398731|NCT04098406|593830626|FG000|Overall Study|Withdrawal by Subject|1|||
164398732|NCT04098406|593830627|FG001|Overall Study|Withdrawal by Subject|0|||
164398733|NCT00499031|593830628|FG000|Overall Study|Improper pre-protocol treatment|1|||
164398734|NCT00499031|593830628|FG000|Overall Study|Required test not done|1|||
164398735|NCT00499031|593830628|FG000|Overall Study|Never treated|1|||
164398736|NCT00428090|593830629|FG000|Overall Study|Adverse Event|10|||
164398737|NCT00428090|593830630|FG001|Overall Study|Adverse Event|8|||
164398738|NCT00428090|593830631|FG002|Overall Study|Adverse Event|10|||
164398739|NCT00428090|593830632|FG003|Overall Study|Adverse Event|11|||
164398740|NCT00428090|593830629|FG000|Overall Study|Lost to Follow-up|3|||
164398741|NCT00428090|593830630|FG001|Overall Study|Lost to Follow-up|6|||
164398742|NCT00428090|593830631|FG002|Overall Study|Lost to Follow-up|1|||
164398743|NCT00428090|593830632|FG003|Overall Study|Lost to Follow-up|4|||
164398744|NCT00428090|593830629|FG000|Overall Study|Protocol Violation|3|||
164398745|NCT00428090|593830630|FG001|Overall Study|Protocol Violation|1|||
164398746|NCT00428090|593830631|FG002|Overall Study|Protocol Violation|3|||
164398747|NCT00428090|593830632|FG003|Overall Study|Protocol Violation|3|||
164398748|NCT00428090|593830629|FG000|Overall Study|Withdrawal by Subject|10|||
164398749|NCT00428090|593830630|FG001|Overall Study|Withdrawal by Subject|12|||
164398750|NCT00428090|593830631|FG002|Overall Study|Withdrawal by Subject|15|||
164398751|NCT00428090|593830632|FG003|Overall Study|Withdrawal by Subject|5|||
164398752|NCT00428090|593830629|FG000|Overall Study|Sponsor terminated study|0|||
164398753|NCT00428090|593830630|FG001|Overall Study|Sponsor terminated study|1|||
164398754|NCT00428090|593830631|FG002|Overall Study|Sponsor terminated study|0|||
164398755|NCT00428090|593830632|FG003|Overall Study|Sponsor terminated study|0|||
164398756|NCT00428090|593830629|FG000|Overall Study|Non-compliance|4|||
164398757|NCT00428090|593830630|FG001|Overall Study|Non-compliance|0|||
164398758|NCT00428090|593830631|FG002|Overall Study|Non-compliance|1|||
164398759|NCT00428090|593830632|FG003|Overall Study|Non-compliance|3|||
164398760|NCT00428090|593830629|FG000|Overall Study|Par. did not returned to visit|1|||
164442443|NCT06129045|593987540|FG002|Overall Study|Lost to Follow-up|4|||
164398761|NCT00428090|593830630|FG001|Overall Study|Par. did not returned to visit|0|||
164398762|NCT00428090|593830631|FG002|Overall Study|Par. did not returned to visit|0|||
164398763|NCT00428090|593830632|FG003|Overall Study|Par. did not returned to visit|1|||
164398764|NCT00428090|593830629|FG000|Overall Study|Follow-Up visit not possible|1|||
164398765|NCT00428090|593830630|FG001|Overall Study|Follow-Up visit not possible|0|||
164398766|NCT00428090|593830631|FG002|Overall Study|Follow-Up visit not possible|0|||
164398767|NCT00428090|593830632|FG003|Overall Study|Follow-Up visit not possible|0|||
164398768|NCT00428090|593830629|FG000|Overall Study|Prohibited medication used for SAE|1|||
164398769|NCT00428090|593830630|FG001|Overall Study|Prohibited medication used for SAE|0|||
164398770|NCT00428090|593830631|FG002|Overall Study|Prohibited medication used for SAE|0|||
164398771|NCT00428090|593830632|FG003|Overall Study|Prohibited medication used for SAE|0|||
164398772|NCT00428090|593830629|FG000|Overall Study|Death of par.|1|||
164398773|NCT00428090|593830630|FG001|Overall Study|Death of par.|0|||
164398774|NCT00428090|593830631|FG002|Overall Study|Death of par.|1|||
164398775|NCT00428090|593830632|FG003|Overall Study|Death of par.|0|||
164398776|NCT00428090|593830629|FG000|Overall Study|Visit 7 exceed the visit window|0|||
164398777|NCT00428090|593830630|FG001|Overall Study|Visit 7 exceed the visit window|1|||
164398778|NCT00428090|593830631|FG002|Overall Study|Visit 7 exceed the visit window|0|||
164398779|NCT00428090|593830632|FG003|Overall Study|Visit 7 exceed the visit window|0|||
164398780|NCT00428090|593830629|FG000|Overall Study|Medical monitor terminated par.|0|||
164398781|NCT00428090|593830630|FG001|Overall Study|Medical monitor terminated par.|1|||
164398782|NCT00428090|593830631|FG002|Overall Study|Medical monitor terminated par.|0|||
164398783|NCT00428090|593830632|FG003|Overall Study|Medical monitor terminated par.|0|||
164398784|NCT00428090|593830629|FG000|Overall Study|Mental status of par. was|0|||
164398785|NCT00428090|593830630|FG001|Overall Study|Mental status of par. was|1|||
164398786|NCT00428090|593830631|FG002|Overall Study|Mental status of par. was|0|||
164398787|NCT00428090|593830632|FG003|Overall Study|Mental status of par. was|0|||
164398788|NCT00428090|593830629|FG000|Overall Study|Worsening of AD|0|||
164398789|NCT00428090|593830630|FG001|Overall Study|Worsening of AD|0|||
164398790|NCT00428090|593830631|FG002|Overall Study|Worsening of AD|1|||
164398791|NCT00428090|593830632|FG003|Overall Study|Worsening of AD|0|||
164398792|NCT00428090|593830629|FG000|Overall Study|Excluded for concerning QTc value|0|||
164398793|NCT00428090|593830630|FG001|Overall Study|Excluded for concerning QTc value|0|||
164398794|NCT00428090|593830631|FG002|Overall Study|Excluded for concerning QTc value|1|||
164398795|NCT00428090|593830632|FG003|Overall Study|Excluded for concerning QTc value|0|||
164398796|NCT00428090|593830629|FG000|Overall Study|Insufficient AD documentation|0|||
164398797|NCT00428090|593830630|FG001|Overall Study|Insufficient AD documentation|0|||
164398798|NCT00428090|593830631|FG002|Overall Study|Insufficient AD documentation|1|||
164398799|NCT00428090|593830632|FG003|Overall Study|Insufficient AD documentation|0|||
164398800|NCT00428090|593830629|FG000|Overall Study|High MMSE scores|0|||
164398801|NCT00428090|593830630|FG001|Overall Study|High MMSE scores|0|||
164398802|NCT00428090|593830631|FG002|Overall Study|High MMSE scores|1|||
164398803|NCT00428090|593830632|FG003|Overall Study|High MMSE scores|0|||
164398804|NCT00428090|593830629|FG000|Overall Study|Deterioration of cognitive status|0|||
164398805|NCT00428090|593830630|FG001|Overall Study|Deterioration of cognitive status|0|||
164398806|NCT00428090|593830631|FG002|Overall Study|Deterioration of cognitive status|1|||
164398807|NCT00428090|593830632|FG003|Overall Study|Deterioration of cognitive status|0|||
164398808|NCT00428090|593830629|FG000|Overall Study|Serious adverse event|0|||
164398809|NCT00428090|593830630|FG001|Overall Study|Serious adverse event|0|||
164398810|NCT00428090|593830631|FG002|Overall Study|Serious adverse event|1|||
164398811|NCT00428090|593830632|FG003|Overall Study|Serious adverse event|0|||
164398812|NCT00428090|593830629|FG000|Overall Study|Excluded for heart insufficiency|0|||
164398813|NCT00428090|593830630|FG001|Overall Study|Excluded for heart insufficiency|0|||
164398814|NCT00428090|593830631|FG002|Overall Study|Excluded for heart insufficiency|1|||
164398815|NCT00428090|593830632|FG003|Overall Study|Excluded for heart insufficiency|0|||
164398816|NCT00428090|593830629|FG000|Overall Study|Raised Creatinine Value|0|||
164398817|NCT00428090|593830630|FG001|Overall Study|Raised Creatinine Value|0|||
164442444|NCT02031471|593987541|FG000|24 Week Treatment Period|Adverse Event|6|||
164442445|NCT02031471|593987541|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
164442446|NCT02031471|593987541|FG000|24 Week Treatment Period|Protocol Violation|1|||
164398818|NCT00428090|593830631|FG002|Overall Study|Raised Creatinine Value|0|||
164398819|NCT00428090|593830632|FG003|Overall Study|Raised Creatinine Value|1|||
164398820|NCT03409666|593830633|FG000|Overall Study|Physician Decision|0|||
164398821|NCT03409666|593830634|FG001|Overall Study|Physician Decision|1|||
164398822|NCT03409666|593830633|FG000|Overall Study|Protocol Violation|0|||
164398823|NCT03409666|593830634|FG001|Overall Study|Protocol Violation|3|||
164398824|NCT02366910|593830638|FG000|Overall Study|Withdrawal by Subject|2|||
164398825|NCT02366910|593830638|FG000|Overall Study|Screen Failure|3|||
164398826|NCT02623322|593830639|FG000|Overall Study|Lost to Follow-up|2|||
164398827|NCT02623322|593830640|FG001|Overall Study|Lost to Follow-up|1|||
164398828|NCT02623322|593830641|FG002|Overall Study|Lost to Follow-up|0|||
164398829|NCT03104699|593830642|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
164398830|NCT03104699|593830643|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
164398831|NCT03104699|593830644|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
164705502|NCT01783548|594948680|FG001|Overall Study|Withdrawal by Subject|8|||
164705503|NCT01783548|594948679|FG000|Overall Study|Non-compliance|4|||
164705504|NCT01783548|594948680|FG001|Overall Study|Non-compliance|0|||
164705505|NCT01783548|594948679|FG000|Overall Study|Protocol Violation|2|||
164705506|NCT01783548|594948680|FG001|Overall Study|Protocol Violation|2|||
164705507|NCT01783548|594948679|FG000|Overall Study|Lost to Follow-up|8|||
164398832|NCT03104699|593830645|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
164398833|NCT03104699|593830646|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
164398834|NCT03104699|593830647|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
164398835|NCT03104699|593830642|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
164398836|NCT03104699|593830643|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
164398837|NCT03104699|593830644|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
164398838|NCT03104699|593830645|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
164398839|NCT03104699|593830646|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
164398840|NCT03104699|593830647|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
164398841|NCT03104699|593830642|FG000|Phase 1: Dose Escalation|Death|6|||
164398842|NCT03104699|593830643|FG001|Phase 1: Dose Escalation|Death|3|||
164398843|NCT03104699|593830644|FG002|Phase 1: Dose Escalation|Death|0|||
164398844|NCT03104699|593830645|FG003|Phase 1: Dose Escalation|Death|1|||
164398845|NCT03104699|593830646|FG004|Phase 1: Dose Escalation|Death|1|||
164398846|NCT03104699|593830647|FG005|Phase 1: Dose Escalation|Death|0|||
164398847|NCT03104699|593830642|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
164398848|NCT03104699|593830643|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
164398849|NCT03104699|593830644|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
164398850|NCT03104699|593830645|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
164398851|NCT03104699|593830646|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
164398852|NCT03104699|593830647|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
164398853|NCT03104699|593830642|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
164398854|NCT03104699|593830643|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
164398855|NCT03104699|593830644|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
164398856|NCT03104699|593830645|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
164398857|NCT03104699|593830646|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
164398858|NCT03104699|593830647|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
164398859|NCT03104699|593830642|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
164398860|NCT03104699|593830643|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
164398861|NCT03104699|593830644|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
164398862|NCT03104699|593830645|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
164398863|NCT03104699|593830646|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
164398864|NCT03104699|593830647|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
164398865|NCT03104699|593830642|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
164398866|NCT03104699|593830643|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
164398867|NCT03104699|593830644|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
164398868|NCT03104699|593830645|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
164398869|NCT03104699|593830646|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
164398870|NCT03104699|593830647|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
164398871|NCT03104699|593830642|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
164398872|NCT03104699|593830643|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
164398873|NCT03104699|593830644|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
164705508|NCT01783548|594948680|FG001|Overall Study|Lost to Follow-up|3|||
164705509|NCT01783548|594948679|FG000|Overall Study|Lack of Efficacy|1|||
164705510|NCT01783548|594948680|FG001|Overall Study|Lack of Efficacy|1|||
164705511|NCT04645966|594948681|FG000|Vaccination Phase|Adverse Event|1|||
164705512|NCT04645966|594948682|FG001|Vaccination Phase|Adverse Event|0|||
164398874|NCT03104699|593830645|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
164398875|NCT03104699|593830646|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
164398876|NCT03104699|593830647|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
164398877|NCT03104699|593830642|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
164398878|NCT03104699|593830643|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
164398879|NCT03104699|593830644|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
164398880|NCT03104699|593830645|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
164398881|NCT03104699|593830646|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
164398882|NCT03104699|593830647|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
164398883|NCT03104699|593830642|FG000|Phase 2: Dose Expansion|Death|0|||
164398884|NCT03104699|593830643|FG001|Phase 2: Dose Expansion|Death|0|||
164398885|NCT03104699|593830644|FG002|Phase 2: Dose Expansion|Death|0|||
164398886|NCT03104699|593830645|FG003|Phase 2: Dose Expansion|Death|0|||
164398887|NCT03104699|593830646|FG004|Phase 2: Dose Expansion|Death|0|||
164705513|NCT04645966|594948683|FG002|Vaccination Phase|Adverse Event|0|||
164705514|NCT04645966|594948684|FG003|Vaccination Phase|Adverse Event|0|||
164705515|NCT04645966|594948685|FG004|Vaccination Phase|Adverse Event|0|||
164398888|NCT03104699|593830647|FG005|Phase 2: Dose Expansion|Death|107|||
164398889|NCT03104699|593830642|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
164398890|NCT03104699|593830643|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
164398891|NCT03104699|593830644|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
164398892|NCT03104699|593830645|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
164398893|NCT03104699|593830646|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
164398894|NCT03104699|593830647|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
164398895|NCT03104699|593830642|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
164398896|NCT03104699|593830643|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
164398897|NCT03104699|593830644|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
164398898|NCT03104699|593830645|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
164398899|NCT03104699|593830646|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
164398900|NCT03104699|593830647|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
164398901|NCT03104699|593830642|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164398902|NCT03104699|593830643|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164398903|NCT03104699|593830644|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164398904|NCT03104699|593830645|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164398905|NCT03104699|593830646|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164398906|NCT03104699|593830647|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
164398907|NCT03104699|593830642|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
164398908|NCT03104699|593830643|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
164398909|NCT03104699|593830644|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
164398910|NCT03104699|593830645|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
164398911|NCT03104699|593830646|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
164398912|NCT03104699|593830647|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
164398913|NCT02462876|593830648|FG000|Overall Study|Death|3|||
164398914|NCT02462876|593830648|FG000|Overall Study|Lost to Follow-up|7|||
164398915|NCT02462876|593830648|FG000|Overall Study|Surgical Bypass|9|||
164398916|NCT02462876|593830648|FG000|Overall Study|Amputation Above the Metatarsals|1|||
164398917|NCT02462876|593830648|FG000|Overall Study|36 months follow-up visit missed|1|||
164398918|NCT02462876|593830648|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
164398919|NCT02462876|593830648|FG000|Overall Study|Patient did not come back to the vascular department|1|||
164398920|NCT02462876|593830648|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
164398921|NCT02462876|593830648|FG000|Overall Study|Patient refused to come back|1|||
164398922|NCT02462876|593830648|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
164398923|NCT02462876|593830648|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
164398924|NCT01786512|593830649|FG000|Overall Study|Lost to Follow-up|0|||
164398925|NCT01786512|593830650|FG001|Overall Study|Lost to Follow-up|0|||
164398926|NCT01786512|593830651|FG002|Overall Study|Lost to Follow-up|0|||
164398927|NCT01786512|593830652|FG003|Overall Study|Lost to Follow-up|0|||
164398928|NCT01786512|593830653|FG004|Overall Study|Lost to Follow-up|0|||
164398929|NCT01786512|593830654|FG005|Overall Study|Lost to Follow-up|0|||
164398930|NCT01786512|593830655|FG006|Overall Study|Lost to Follow-up|0|||
164398931|NCT01786512|593830656|FG007|Overall Study|Lost to Follow-up|0|||
164398932|NCT01786512|593830657|FG008|Overall Study|Lost to Follow-up|0|||
164398933|NCT01786512|593830658|FG009|Overall Study|Lost to Follow-up|1|||
164398934|NCT01786512|593830659|FG010|Overall Study|Lost to Follow-up|0|||
164398935|NCT01786512|593830649|FG000|Overall Study|Decision by sponsor|0|||
164398936|NCT01786512|593830650|FG001|Overall Study|Decision by sponsor|0|||
164398937|NCT01786512|593830651|FG002|Overall Study|Decision by sponsor|0|||
164398938|NCT01786512|593830652|FG003|Overall Study|Decision by sponsor|0|||
164398939|NCT01786512|593830653|FG004|Overall Study|Decision by sponsor|0|||
164398940|NCT01786512|593830654|FG005|Overall Study|Decision by sponsor|0|||
164398941|NCT01786512|593830655|FG006|Overall Study|Decision by sponsor|0|||
164398942|NCT01786512|593830656|FG007|Overall Study|Decision by sponsor|0|||
164398943|NCT01786512|593830657|FG008|Overall Study|Decision by sponsor|0|||
164398944|NCT01786512|593830658|FG009|Overall Study|Decision by sponsor|0|||
164398945|NCT01786512|593830659|FG010|Overall Study|Decision by sponsor|2|||
164398946|NCT01786512|593830649|FG000|Overall Study|Withdrawal by Subject|0|||
164398947|NCT01786512|593830650|FG001|Overall Study|Withdrawal by Subject|1|||
164442447|NCT02031471|593987541|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
164442448|NCT02031471|593987541|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
164442449|NCT02031471|593987541|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
164442450|NCT02031471|593987541|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
164442451|NCT05797155|593987548|FG000|Overall Study|Lost to Follow-up|33|||
164442452|NCT05797155|593987549|FG001|Overall Study|Lost to Follow-up|12|||
164398948|NCT01786512|593830651|FG002|Overall Study|Withdrawal by Subject|0|||
164398949|NCT01786512|593830652|FG003|Overall Study|Withdrawal by Subject|0|||
164398950|NCT01786512|593830653|FG004|Overall Study|Withdrawal by Subject|0|||
164398951|NCT01786512|593830654|FG005|Overall Study|Withdrawal by Subject|0|||
164398952|NCT01786512|593830655|FG006|Overall Study|Withdrawal by Subject|1|||
164398953|NCT01786512|593830656|FG007|Overall Study|Withdrawal by Subject|0|||
164398954|NCT01786512|593830657|FG008|Overall Study|Withdrawal by Subject|0|||
164398955|NCT01786512|593830658|FG009|Overall Study|Withdrawal by Subject|3|||
164398956|NCT01786512|593830659|FG010|Overall Study|Withdrawal by Subject|7|||
164398957|NCT01786512|593830649|FG000|Overall Study|Death|0|||
164398958|NCT01786512|593830650|FG001|Overall Study|Death|0|||
164398959|NCT01786512|593830651|FG002|Overall Study|Death|0|||
164398960|NCT01786512|593830652|FG003|Overall Study|Death|0|||
164398961|NCT01786512|593830653|FG004|Overall Study|Death|0|||
164398962|NCT01786512|593830654|FG005|Overall Study|Death|0|||
164398963|NCT01786512|593830655|FG006|Overall Study|Death|0|||
164398964|NCT01786512|593830656|FG007|Overall Study|Death|0|||
164398965|NCT01786512|593830657|FG008|Overall Study|Death|4|||
164398966|NCT01786512|593830658|FG009|Overall Study|Death|1|||
164398967|NCT01786512|593830659|FG010|Overall Study|Death|3|||
164398968|NCT02450331|593830660|FG000|Overall Study|Death|162|||
164398969|NCT02450331|593830661|FG001|Overall Study|Death|171|||
164398970|NCT02450331|593830660|FG000|Overall Study|Lost to Follow-up|14|||
164398971|NCT02450331|593830661|FG001|Overall Study|Lost to Follow-up|12|||
164398972|NCT02450331|593830660|FG000|Overall Study|Withdrawal by Subject|55|||
164398973|NCT02450331|593830661|FG001|Overall Study|Withdrawal by Subject|44|||
164398974|NCT02450331|593830660|FG000|Overall Study|Non-specified other|1|||
164398975|NCT02450331|593830661|FG001|Overall Study|Non-specified other|1|||
164398976|NCT02080871|593830662|FG000|Overall Study|Death|1|||
164398977|NCT02080871|593830662|FG000|Overall Study|Lost to Follow-up|1|||
164398978|NCT00234052|593830663|FG000|Treatment|Withdrawal by Subject|3|||
164398979|NCT00234052|593830663|FG000|Treatment|Adverse Event|5|||
164398980|NCT00234052|593830663|FG000|Treatment|Death|2|||
164398981|NCT00234052|593830663|FG000|Treatment|Progressive Disease|11|||
164398982|NCT00234052|593830663|FG000|Follow-up for 5 Years|Death|41|||
164398983|NCT00234052|593830663|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
164398984|NCT00234052|593830663|FG000|Follow-up for 5 Years|Other|7|||
164398985|NCT01410474|593830664|FG000|Overall Study|Withdrawal by Subject|0|||
164398986|NCT01410474|593830665|FG001|Overall Study|Withdrawal by Subject|1|||
164398987|NCT02428296|593830666|FG000|Overall Study|Adverse Event|7|||
164398988|NCT02428296|593830666|FG000|Overall Study|Withdrawal by Subject|2|||
164398989|NCT04493931|593830668|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
164398990|NCT04493931|593830669|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
164398991|NCT04493931|593830670|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
164398992|NCT04493931|593830671|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
164398993|NCT04493931|593830672|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
164398994|NCT04493931|593830673|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
164398995|NCT04493931|593830674|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
164398996|NCT04493931|593830668|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
164398997|NCT04493931|593830669|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
164398998|NCT04493931|593830670|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
164398999|NCT04493931|593830671|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
164399000|NCT04493931|593830672|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
164399001|NCT04493931|593830673|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
164399002|NCT04493931|593830674|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
164399003|NCT04493931|593830668|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
164399004|NCT04493931|593830669|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
164399005|NCT04493931|593830670|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
164399006|NCT04493931|593830671|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
164399007|NCT04493931|593830672|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
164399008|NCT04493931|593830673|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
164399009|NCT04493931|593830674|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
164705516|NCT04645966|594948686|FG005|Vaccination Phase|Adverse Event|0|||
164705517|NCT04645966|594948687|FG006|Vaccination Phase|Adverse Event|1|||
164399010|NCT04493931|593830668|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
164399011|NCT04493931|593830669|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
164399012|NCT04493931|593830670|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
164399013|NCT04493931|593830671|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
164399014|NCT04493931|593830672|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
164399015|NCT04493931|593830673|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
164399016|NCT04493931|593830674|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
164399017|NCT00420199|593830676|FG000|Overall Study|Participant no longer met study criteria|1|||
164399018|NCT00420199|593830677|FG001|Overall Study|Participant no longer met study criteria|0|||
164399019|NCT00754338|593830678|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
164399020|NCT00754338|593830679|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
164399021|NCT00754338|593830680|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
164442453|NCT01350804|593987550|FG000|Core Study|Withdrawal by Subject|11|||
164442454|NCT01350804|593987551|FG001|Core Study|Withdrawal by Subject|17|||
164442455|NCT01350804|593987552|FG002|Core Study|Withdrawal by Subject|16|||
164705518|NCT04645966|594948688|FG007|Vaccination Phase|Adverse Event|0|||
164399022|NCT00754338|593830681|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
164399023|NCT00754338|593830678|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
164399024|NCT00754338|593830679|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
164399025|NCT00754338|593830680|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
164399026|NCT00754338|593830681|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
164399027|NCT00831779|593830682|FG000|Overall Study|Lost to Follow-up|1|||
164399028|NCT00831779|593830683|FG001|Overall Study|Lost to Follow-up|0|||
164399029|NCT00831779|593830682|FG000|Overall Study|No longer met criteria|0|||
164399030|NCT00831779|593830683|FG001|Overall Study|No longer met criteria|1|||
164399031|NCT04020341|593830684|FG000|Overall Study|Adverse Event|8|||
164399032|NCT04020341|593830685|FG001|Overall Study|Adverse Event|6|||
164399033|NCT04020341|593830684|FG000|Overall Study|Lost to Follow-up|8|||
164399034|NCT04020341|593830685|FG001|Overall Study|Lost to Follow-up|2|||
164399035|NCT04020341|593830684|FG000|Overall Study|Withdrawal by Subject|16|||
164399036|NCT04020341|593830685|FG001|Overall Study|Withdrawal by Subject|16|||
164399037|NCT04020341|593830684|FG000|Overall Study|Participant not able to swallow the tablet|1|||
164399038|NCT04020341|593830685|FG001|Overall Study|Participant not able to swallow the tablet|0|||
164399039|NCT04020341|593830684|FG000|Overall Study|Physician Decision|0|||
164399040|NCT04020341|593830685|FG001|Overall Study|Physician Decision|2|||
164399041|NCT04020341|593830684|FG000|Overall Study|Protocol Deviation|0|||
164399042|NCT04020341|593830685|FG001|Overall Study|Protocol Deviation|2|||
164399043|NCT04528069|593830686|FG000|Overall Study|Adverse Event|1|||
164399044|NCT04528069|593830686|FG000|Overall Study|Lost to Follow-up|1|||
164399045|NCT04528069|593830686|FG000|Overall Study|Patient Unable to Come|1|||
164399046|NCT04528069|593830686|FG000|Overall Study|Patient Unable to Attend|1|||
164399047|NCT01814371|593830688|FG000|Overall Study|Lost to Follow-up|30|||
164399048|NCT01814371|593830689|FG001|Overall Study|Lost to Follow-up|27|||
164399049|NCT04683926|593830690|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
164399050|NCT04683926|593830691|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
164399051|NCT04683926|593830692|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
164399052|NCT04683926|593830693|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
164399053|NCT01692782|593830695|FG000|Overall Study|Adverse Event|12|||
164399054|NCT01692782|593830696|FG001|Overall Study|Adverse Event|32|||
164399055|NCT01692782|593830697|FG002|Overall Study|Adverse Event|2|||
164399056|NCT01692782|593830695|FG000|Overall Study|Lack of Efficacy|1|||
164399057|NCT01692782|593830696|FG001|Overall Study|Lack of Efficacy|2|||
164399058|NCT01692782|593830697|FG002|Overall Study|Lack of Efficacy|0|||
164399059|NCT01692782|593830695|FG000|Overall Study|Lost to Follow-up|2|||
164399060|NCT01692782|593830696|FG001|Overall Study|Lost to Follow-up|7|||
164399061|NCT01692782|593830697|FG002|Overall Study|Lost to Follow-up|1|||
164399062|NCT01692782|593830695|FG000|Overall Study|Pregnancy|1|||
164399063|NCT01692782|593830696|FG001|Overall Study|Pregnancy|0|||
164399064|NCT01692782|593830697|FG002|Overall Study|Pregnancy|0|||
164399065|NCT01692782|593830695|FG000|Overall Study|Protocol Violation|1|||
164399066|NCT01692782|593830696|FG001|Overall Study|Protocol Violation|0|||
164399067|NCT01692782|593830697|FG002|Overall Study|Protocol Violation|2|||
164399068|NCT01692782|593830695|FG000|Overall Study|Non-complance with study drug|0|||
164399069|NCT01692782|593830696|FG001|Overall Study|Non-complance with study drug|4|||
164399070|NCT01692782|593830697|FG002|Overall Study|Non-complance with study drug|1|||
164399071|NCT01692782|593830695|FG000|Overall Study|Non-compliant with study visits|0|||
164399072|NCT01692782|593830696|FG001|Overall Study|Non-compliant with study visits|0|||
164399073|NCT01692782|593830697|FG002|Overall Study|Non-compliant with study visits|1|||
164399074|NCT01692782|593830695|FG000|Overall Study|SAE not related to study drug|0|||
164399075|NCT01692782|593830696|FG001|Overall Study|SAE not related to study drug|1|||
164399076|NCT01692782|593830697|FG002|Overall Study|SAE not related to study drug|0|||
164399077|NCT01692782|593830695|FG000|Overall Study|Withdrawal by Subject|3|||
164399078|NCT01692782|593830696|FG001|Overall Study|Withdrawal by Subject|10|||
164399079|NCT01692782|593830697|FG002|Overall Study|Withdrawal by Subject|3|||
164399080|NCT00952367|593830706|FG000|Overall Study|Withdrawal by Subject|2|||
164399081|NCT00952367|593830706|FG000|Overall Study|Noncoordination|1|||
164399082|NCT00952367|593830706|FG000|Overall Study|Protocol Violation|3|||
164399083|NCT03205371|593830713|FG000|Overall Study|Withdrawal by Subject|4|||
164442456|NCT01350804|593987553|FG003|Core Study|Withdrawal by Subject|7|||
164442457|NCT01350804|593987550|FG000|Core Study|Study terminated by Sponsor|0|||
164399084|NCT03205371|593830714|FG001|Overall Study|Withdrawal by Subject|1|||
164399085|NCT03205371|593830715|FG002|Overall Study|Withdrawal by Subject|0|||
164399086|NCT03205371|593830716|FG003|Overall Study|Withdrawal by Subject|0|||
164399087|NCT03205371|593830717|FG004|Overall Study|Withdrawal by Subject|0|||
164399088|NCT03205371|593830718|FG005|Overall Study|Withdrawal by Subject|0|||
164399089|NCT03205371|593830719|FG006|Overall Study|Withdrawal by Subject|4|||
164399090|NCT03205371|593830720|FG007|Overall Study|Withdrawal by Subject|0|||
164399091|NCT03205371|593830721|FG008|Overall Study|Withdrawal by Subject|2|||
164399092|NCT03205371|593830722|FG009|Overall Study|Withdrawal by Subject|0|||
164399093|NCT03205371|593830723|FG010|Overall Study|Withdrawal by Subject|0|||
164399094|NCT03205371|593830724|FG011|Overall Study|Withdrawal by Subject|1|||
164442458|NCT01350804|593987551|FG001|Core Study|Study terminated by Sponsor|0|||
164399095|NCT03205371|593830713|FG000|Overall Study|Lost to Follow-up|0|||
164399096|NCT03205371|593830714|FG001|Overall Study|Lost to Follow-up|0|||
164399097|NCT03205371|593830715|FG002|Overall Study|Lost to Follow-up|0|||
164399098|NCT03205371|593830716|FG003|Overall Study|Lost to Follow-up|0|||
164399099|NCT03205371|593830717|FG004|Overall Study|Lost to Follow-up|0|||
164399100|NCT03205371|593830718|FG005|Overall Study|Lost to Follow-up|0|||
164399101|NCT03205371|593830719|FG006|Overall Study|Lost to Follow-up|5|||
164399102|NCT03205371|593830720|FG007|Overall Study|Lost to Follow-up|2|||
164399103|NCT03205371|593830721|FG008|Overall Study|Lost to Follow-up|3|||
164399104|NCT03205371|593830722|FG009|Overall Study|Lost to Follow-up|0|||
164399105|NCT03205371|593830723|FG010|Overall Study|Lost to Follow-up|0|||
164399106|NCT03205371|593830724|FG011|Overall Study|Lost to Follow-up|0|||
164399107|NCT03205371|593830713|FG000|Overall Study|Protocol Violation|0|||
164399108|NCT03205371|593830714|FG001|Overall Study|Protocol Violation|0|||
164399109|NCT03205371|593830715|FG002|Overall Study|Protocol Violation|0|||
164399110|NCT03205371|593830716|FG003|Overall Study|Protocol Violation|0|||
164399111|NCT03205371|593830717|FG004|Overall Study|Protocol Violation|0|||
164399112|NCT03205371|593830718|FG005|Overall Study|Protocol Violation|0|||
164399113|NCT03205371|593830719|FG006|Overall Study|Protocol Violation|1|||
164399114|NCT03205371|593830720|FG007|Overall Study|Protocol Violation|0|||
164399115|NCT03205371|593830721|FG008|Overall Study|Protocol Violation|0|||
164399116|NCT03205371|593830722|FG009|Overall Study|Protocol Violation|0|||
164399117|NCT03205371|593830723|FG010|Overall Study|Protocol Violation|0|||
164399118|NCT03205371|593830724|FG011|Overall Study|Protocol Violation|0|||
164399119|NCT03205371|593830713|FG000|Overall Study|Adverse Event|0|||
164399120|NCT03205371|593830714|FG001|Overall Study|Adverse Event|0|||
164399121|NCT03205371|593830715|FG002|Overall Study|Adverse Event|0|||
164399122|NCT03205371|593830716|FG003|Overall Study|Adverse Event|0|||
164399123|NCT03205371|593830717|FG004|Overall Study|Adverse Event|0|||
164399124|NCT03205371|593830718|FG005|Overall Study|Adverse Event|0|||
164399125|NCT03205371|593830719|FG006|Overall Study|Adverse Event|0|||
164399126|NCT03205371|593830720|FG007|Overall Study|Adverse Event|1|||
164399127|NCT03205371|593830721|FG008|Overall Study|Adverse Event|0|||
164399128|NCT03205371|593830722|FG009|Overall Study|Adverse Event|0|||
164399129|NCT03205371|593830723|FG010|Overall Study|Adverse Event|0|||
164399130|NCT03205371|593830724|FG011|Overall Study|Adverse Event|0|||
164399131|NCT02835339|593830725|FG000|Overall Study|Did not receive allocated intervention|13|||
164399132|NCT02835339|593830726|FG001|Overall Study|Did not receive allocated intervention|16|||
164399133|NCT00736645|593830732|FG000|Overall Study|Adverse Event|0|||
164399134|NCT00736645|593830733|FG001|Overall Study|Adverse Event|2|||
164399135|NCT00736645|593830734|FG002|Overall Study|Adverse Event|0|||
164399136|NCT00736645|593830735|FG003|Overall Study|Adverse Event|0|||
164399137|NCT01239030|593830736|FG000|Double Blind|Adverse Event|0|||
164399138|NCT01239030|593830737|FG001|Double Blind|Adverse Event|1|||
164442459|NCT01350804|593987552|FG002|Core Study|Study terminated by Sponsor|0|||
164442460|NCT01350804|593987553|FG003|Core Study|Study terminated by Sponsor|2|||
164442461|NCT01350804|593987550|FG000|Core Study|Protocol deviation|1|||
164442462|NCT01350804|593987551|FG001|Core Study|Protocol deviation|0|||
164442463|NCT01350804|593987552|FG002|Core Study|Protocol deviation|1|||
164442464|NCT01350804|593987553|FG003|Core Study|Protocol deviation|0|||
164442465|NCT01350804|593987550|FG000|Core Study|Physician Decision|1|||
164442466|NCT01350804|593987551|FG001|Core Study|Physician Decision|0|||
164442467|NCT01350804|593987552|FG002|Core Study|Physician Decision|1|||
164442468|NCT01350804|593987553|FG003|Core Study|Physician Decision|3|||
164442469|NCT01350804|593987550|FG000|Core Study|Lost to Follow-up|3|||
164442470|NCT01350804|593987551|FG001|Core Study|Lost to Follow-up|0|||
164705519|NCT04645966|594948689|FG008|Vaccination Phase|Adverse Event|0|||
164705520|NCT04645966|594948681|FG000|Vaccination Phase|Death|0|||
164705521|NCT04645966|594948682|FG001|Vaccination Phase|Death|0|||
164705522|NCT04645966|594948683|FG002|Vaccination Phase|Death|0|||
164705523|NCT04645966|594948684|FG003|Vaccination Phase|Death|0|||
164399139|NCT01239030|593830738|FG002|Double Blind|Adverse Event|0|||
164399140|NCT01239030|593830739|FG003|Double Blind|Adverse Event|2|||
164399141|NCT01239030|593830740|FG004|Double Blind|Adverse Event|0|||
164442471|NCT01350804|593987552|FG002|Core Study|Lost to Follow-up|2|||
164442472|NCT01350804|593987553|FG003|Core Study|Lost to Follow-up|1|||
164442473|NCT01350804|593987550|FG000|Core Study|Lack of Efficacy|16|||
164442474|NCT01350804|593987551|FG001|Core Study|Lack of Efficacy|19|||
164399142|NCT01239030|593830736|FG000|Double Blind|Withdrawal by Subject|0|||
164399143|NCT01239030|593830737|FG001|Double Blind|Withdrawal by Subject|1|||
164442475|NCT01350804|593987552|FG002|Core Study|Lack of Efficacy|18|||
164442476|NCT01350804|593987553|FG003|Core Study|Lack of Efficacy|5|||
164705524|NCT04645966|594948685|FG004|Vaccination Phase|Death|0|||
164399144|NCT01239030|593830738|FG002|Double Blind|Withdrawal by Subject|1|||
164399145|NCT01239030|593830739|FG003|Double Blind|Withdrawal by Subject|0|||
164399146|NCT01239030|593830740|FG004|Double Blind|Withdrawal by Subject|1|||
164399147|NCT01239030|593830736|FG000|Double Blind|Lost to Follow-up|1|||
164399148|NCT01239030|593830737|FG001|Double Blind|Lost to Follow-up|1|||
164442477|NCT01350804|593987550|FG000|Core Study|Death|1|||
164442478|NCT01350804|593987551|FG001|Core Study|Death|1|||
164705525|NCT04645966|594948686|FG005|Vaccination Phase|Death|1|||
164595960|NCT01106625|594545085|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
164595961|NCT01106625|594545086|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
164399149|NCT01239030|593830738|FG002|Double Blind|Lost to Follow-up|0|||
164399150|NCT01239030|593830739|FG003|Double Blind|Lost to Follow-up|0|||
164399151|NCT01239030|593830740|FG004|Double Blind|Lost to Follow-up|0|||
164399152|NCT01239030|593830736|FG000|Double Blind|Physician Decision|0|||
164399153|NCT01239030|593830737|FG001|Double Blind|Physician Decision|1|||
164399154|NCT01239030|593830738|FG002|Double Blind|Physician Decision|0|||
164399155|NCT01239030|593830739|FG003|Double Blind|Physician Decision|0|||
164399156|NCT01239030|593830740|FG004|Double Blind|Physician Decision|0|||
164399157|NCT01239030|593830736|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
164399158|NCT01239030|593830737|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
164399159|NCT01239030|593830738|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
164399160|NCT01239030|593830739|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
164399161|NCT01239030|593830740|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
164399162|NCT01239030|593830736|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
164399163|NCT01239030|593830737|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
164399164|NCT01239030|593830738|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
164399165|NCT01239030|593830739|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
164399166|NCT01239030|593830740|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
164399167|NCT01239030|593830736|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
164399168|NCT01239030|593830737|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
164399169|NCT01239030|593830738|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
164399170|NCT01239030|593830739|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
164399171|NCT01239030|593830740|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
164399172|NCT01239030|593830736|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
164399173|NCT01239030|593830737|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
164399174|NCT01239030|593830738|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
164399175|NCT01239030|593830739|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
164399176|NCT01239030|593830740|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
164399177|NCT04403698|593830741|FG000|Overall Study|Adverse Event|1|||
164399178|NCT04403698|593830742|FG001|Overall Study|Adverse Event|1|||
164399179|NCT04403698|593830741|FG000|Overall Study|Lost to Follow-up|1|||
164399180|NCT04403698|593830742|FG001|Overall Study|Lost to Follow-up|0|||
164399181|NCT04403698|593830741|FG000|Overall Study|Protocol Violation|0|||
164399182|NCT04403698|593830742|FG001|Overall Study|Protocol Violation|1|||
164399183|NCT00977665|593830743|FG000|Overall Study|Withdrawal by Subject|1|||
164399184|NCT00977665|593830744|FG001|Overall Study|Withdrawal by Subject|3|||
164399185|NCT00977665|593830743|FG000|Overall Study|Physician Decision|2|||
164399186|NCT00977665|593830744|FG001|Overall Study|Physician Decision|1|||
164399187|NCT00977665|593830743|FG000|Overall Study|Sponsor requested withdrawal|0|||
164399188|NCT00977665|593830744|FG001|Overall Study|Sponsor requested withdrawal|1|||
164399189|NCT00977665|593830743|FG000|Overall Study|Lost to Follow-up|1|||
164399190|NCT00977665|593830744|FG001|Overall Study|Lost to Follow-up|0|||
164399191|NCT00977665|593830743|FG000|Overall Study|Death|3|||
164595962|NCT01106625|594545087|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
164595963|NCT01106625|594545085|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
164595964|NCT01106625|594545086|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
164705526|NCT04645966|594948687|FG006|Vaccination Phase|Death|0|||
164705527|NCT04645966|594948688|FG007|Vaccination Phase|Death|0|||
164705528|NCT04645966|594948689|FG008|Vaccination Phase|Death|0|||
164705529|NCT04645966|594948681|FG000|Vaccination Phase|Protocol Violation|0|||
164705530|NCT04645966|594948682|FG001|Vaccination Phase|Protocol Violation|0|||
164705531|NCT04645966|594948683|FG002|Vaccination Phase|Protocol Violation|0|||
164705532|NCT04645966|594948684|FG003|Vaccination Phase|Protocol Violation|0|||
164705533|NCT04645966|594948685|FG004|Vaccination Phase|Protocol Violation|1|||
164705534|NCT04645966|594948686|FG005|Vaccination Phase|Protocol Violation|0|||
164705535|NCT04645966|594948687|FG006|Vaccination Phase|Protocol Violation|0|||
164705536|NCT04645966|594948688|FG007|Vaccination Phase|Protocol Violation|0|||
164399192|NCT00977665|593830744|FG001|Overall Study|Death|2|||
164399193|NCT00977665|593830743|FG000|Overall Study|Adverse Event|14|||
164399194|NCT00977665|593830744|FG001|Overall Study|Adverse Event|7|||
164399195|NCT00977665|593830743|FG000|Overall Study|Treatment failure|0|||
164595965|NCT01106625|594545087|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
164705537|NCT04645966|594948689|FG008|Vaccination Phase|Protocol Violation|0|||
164705538|NCT04645966|594948681|FG000|Vaccination Phase|Study terminated by sponsor|0|||
164705539|NCT04645966|594948682|FG001|Vaccination Phase|Study terminated by sponsor|0|||
164705540|NCT04645966|594948683|FG002|Vaccination Phase|Study terminated by sponsor|14|||
164399196|NCT00977665|593830744|FG001|Overall Study|Treatment failure|1|||
164399197|NCT01330433|593830745|FG000|Overall Study|Death|1|||
164705541|NCT04645966|594948684|FG003|Vaccination Phase|Study terminated by sponsor|15|||
164705542|NCT04645966|594948685|FG004|Vaccination Phase|Study terminated by sponsor|47|||
164705543|NCT04645966|594948686|FG005|Vaccination Phase|Study terminated by sponsor|43|||
164705544|NCT04645966|594948687|FG006|Vaccination Phase|Study terminated by sponsor|29|||
164399198|NCT01330433|593830746|FG001|Overall Study|Death|3|||
164399199|NCT01330433|593830745|FG000|Overall Study|Lost to Follow-up|1|||
164399200|NCT01330433|593830746|FG001|Overall Study|Lost to Follow-up|0|||
164399201|NCT02300220|593830752|FG000|Overall Study|Lost to Follow-up|1|||
164399202|NCT02300220|593830753|FG001|Overall Study|Lost to Follow-up|2|||
164399203|NCT02300220|593830752|FG000|Overall Study|Death|1|||
164399204|NCT02300220|593830753|FG001|Overall Study|Death|1|||
164399205|NCT02300220|593830752|FG000|Overall Study|Adverse Event|1|||
164399206|NCT02300220|593830753|FG001|Overall Study|Adverse Event|1|||
164399207|NCT02300220|593830752|FG000|Overall Study|Protocol Violation|1|||
164399208|NCT02300220|593830753|FG001|Overall Study|Protocol Violation|0|||
164399209|NCT02300220|593830752|FG000|Overall Study|Withdrawal by Subject|0|||
164399210|NCT02300220|593830753|FG001|Overall Study|Withdrawal by Subject|2|||
164399211|NCT02300220|593830752|FG000|Overall Study|Did not tolerate IMP|0|||
164399212|NCT02300220|593830753|FG001|Overall Study|Did not tolerate IMP|1|||
164399213|NCT04322682|593830754|FG000|Overall Study|Withdrawal by Subject|33|||
164399214|NCT04322682|593830755|FG001|Overall Study|Withdrawal by Subject|47|||
164399215|NCT04322682|593830754|FG000|Overall Study|Death|5|||
164399216|NCT04322682|593830755|FG001|Overall Study|Death|9|||
164399217|NCT04322682|593830754|FG000|Overall Study|Lost to Follow-up|4|||
164399218|NCT04322682|593830755|FG001|Overall Study|Lost to Follow-up|8|||
164399219|NCT04322682|593830754|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
164399220|NCT04322682|593830755|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
164399221|NCT02238379|593830756|FG000|Overall Study|Lost to Follow-up|1|||
164399222|NCT02238379|593830757|FG001|Overall Study|Lost to Follow-up|0|||
164399223|NCT04123067|593830758|FG000|Overall Study|Lost to Follow-up|0|||
164399224|NCT04123067|593830759|FG001|Overall Study|Lost to Follow-up|1|||
164399225|NCT00441090|593830760|FG000|Overall Study|Adverse Event|0|||
164399226|NCT00441090|593830761|FG001|Overall Study|Adverse Event|1|||
164399227|NCT00441090|593830762|FG002|Overall Study|Adverse Event|1|||
164399228|NCT00441090|593830763|FG003|Overall Study|Adverse Event|0|||
164399229|NCT00441090|593830764|FG004|Overall Study|Adverse Event|0|||
164399230|NCT00441090|593830760|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
164399231|NCT00441090|593830761|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
164399232|NCT00441090|593830762|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
164399233|NCT00441090|593830763|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
164399234|NCT00441090|593830764|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
164399235|NCT00441090|593830760|FG000|Overall Study|Withdrawal by Subject|1|||
164399236|NCT00441090|593830761|FG001|Overall Study|Withdrawal by Subject|0|||
164399237|NCT00441090|593830762|FG002|Overall Study|Withdrawal by Subject|1|||
164399238|NCT00441090|593830763|FG003|Overall Study|Withdrawal by Subject|0|||
164399239|NCT00441090|593830764|FG004|Overall Study|Withdrawal by Subject|0|||
164399240|NCT00441090|593830760|FG000|Overall Study|Lack of Efficacy|1|||
164705545|NCT04645966|594948688|FG007|Vaccination Phase|Study terminated by sponsor|29|||
164705546|NCT04645966|594948689|FG008|Vaccination Phase|Study terminated by sponsor|12|||
164705547|NCT04645966|594948681|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
164705548|NCT04645966|594948682|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
164705549|NCT04645966|594948683|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
164705550|NCT04645966|594948684|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
164705551|NCT04645966|594948685|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
164705552|NCT04645966|594948686|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
164705553|NCT04645966|594948687|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
164705554|NCT04645966|594948688|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
164705555|NCT04645966|594948689|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
164705556|NCT04645966|594948681|FG000|Vaccination Phase|Other|0|||
164705557|NCT04645966|594948682|FG001|Vaccination Phase|Other|0|||
164705558|NCT04645966|594948683|FG002|Vaccination Phase|Other|0|||
164399241|NCT00441090|593830761|FG001|Overall Study|Lack of Efficacy|0|||
164399242|NCT00441090|593830762|FG002|Overall Study|Lack of Efficacy|0|||
164399243|NCT00441090|593830763|FG003|Overall Study|Lack of Efficacy|0|||
164399244|NCT00441090|593830764|FG004|Overall Study|Lack of Efficacy|0|||
164399245|NCT01441102|593830765|FG000|Overall Study|Adverse Event|1|||
164399246|NCT01441102|593830765|FG000|Overall Study|Withdrawal by Subject|2|||
164399247|NCT03085485|593830766|FG000|Overall Study|Death|1|||
164399248|NCT03085485|593830767|FG001|Overall Study|Death|0|||
164399249|NCT03085485|593830766|FG000|Overall Study|Lost to Follow-up|1|||
164399250|NCT03085485|593830767|FG001|Overall Study|Lost to Follow-up|0|||
164399251|NCT00605280|593830768|FG000|Year 1|Protocol Violation|0|||
164399252|NCT00605280|593830769|FG001|Year 1|Protocol Violation|0|||
164705559|NCT04645966|594948684|FG003|Vaccination Phase|Other|0|||
164399253|NCT00605280|593830770|FG002|Year 1|Protocol Violation|0|||
164399254|NCT00605280|593830771|FG003|Year 1|Protocol Violation|1|||
164399255|NCT00605280|593830768|FG000|Year 1|Adverse Event|3|||
164399256|NCT00605280|593830769|FG001|Year 1|Adverse Event|1|||
164399257|NCT00605280|593830770|FG002|Year 1|Adverse Event|1|||
164399258|NCT00605280|593830771|FG003|Year 1|Adverse Event|5|||
164705560|NCT04645966|594948685|FG004|Vaccination Phase|Other|0|||
164705561|NCT04645966|594948686|FG005|Vaccination Phase|Other|2|||
164705562|NCT04645966|594948687|FG006|Vaccination Phase|Other|0|||
164399259|NCT00605280|593830768|FG000|Year 1|Physician Decision|7|||
164399260|NCT00605280|593830769|FG001|Year 1|Physician Decision|4|||
164399261|NCT00605280|593830770|FG002|Year 1|Physician Decision|0|||
164399262|NCT00605280|593830771|FG003|Year 1|Physician Decision|6|||
164399263|NCT00605280|593830768|FG000|Year 1|Withdrawal by Subject|2|||
164399264|NCT00605280|593830769|FG001|Year 1|Withdrawal by Subject|4|||
164399265|NCT00605280|593830770|FG002|Year 1|Withdrawal by Subject|0|||
164399266|NCT00605280|593830771|FG003|Year 1|Withdrawal by Subject|4|||
164399267|NCT00605280|593830768|FG000|Year 1|Other|2|||
164399268|NCT00605280|593830769|FG001|Year 1|Other|1|||
164399269|NCT00605280|593830770|FG002|Year 1|Other|0|||
164399270|NCT00605280|593830771|FG003|Year 1|Other|1|||
164399271|NCT00605280|593830768|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
164399272|NCT00605280|593830769|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
164399273|NCT00605280|593830770|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
164399274|NCT00605280|593830771|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
164399275|NCT00605280|593830768|FG000|Year 2|Adverse Event|4|||
164399276|NCT00605280|593830769|FG001|Year 2|Adverse Event|0|||
164399277|NCT00605280|593830770|FG002|Year 2|Adverse Event|2|||
164399278|NCT00605280|593830771|FG003|Year 2|Adverse Event|4|||
164399279|NCT00605280|593830768|FG000|Year 2|Physician Decision|11|||
164399280|NCT00605280|593830769|FG001|Year 2|Physician Decision|6|||
164399281|NCT00605280|593830770|FG002|Year 2|Physician Decision|4|||
164399282|NCT00605280|593830771|FG003|Year 2|Physician Decision|11|||
164399283|NCT00605280|593830768|FG000|Year 2|Withdrawal by Subject|4|||
164399284|NCT00605280|593830769|FG001|Year 2|Withdrawal by Subject|0|||
164399285|NCT00605280|593830770|FG002|Year 2|Withdrawal by Subject|0|||
164399286|NCT00605280|593830771|FG003|Year 2|Withdrawal by Subject|4|||
164399287|NCT00605280|593830768|FG000|Year 2|Other|1|||
164399288|NCT00605280|593830769|FG001|Year 2|Other|0|||
164399289|NCT00605280|593830770|FG002|Year 2|Other|0|||
164399290|NCT00605280|593830771|FG003|Year 2|Other|1|||
164399291|NCT00605280|593830768|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
164399292|NCT00605280|593830769|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
164399293|NCT00605280|593830770|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
164399294|NCT00605280|593830771|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
164399295|NCT00605280|593830768|FG000|Year 3 Extension|Adverse Event|2|||
164399296|NCT00605280|593830769|FG001|Year 3 Extension|Adverse Event|0|||
164399297|NCT00605280|593830770|FG002|Year 3 Extension|Adverse Event|0|||
164399298|NCT00605280|593830771|FG003|Year 3 Extension|Adverse Event|2|||
164399299|NCT00605280|593830768|FG000|Year 3 Extension|Physician Decision|0|||
164399300|NCT00605280|593830769|FG001|Year 3 Extension|Physician Decision|0|||
164399301|NCT00605280|593830770|FG002|Year 3 Extension|Physician Decision|0|||
164399302|NCT00605280|593830771|FG003|Year 3 Extension|Physician Decision|2|||
164399303|NCT00605280|593830768|FG000|Year 3 Extension|Withdrawal by Subject|2|||
164399304|NCT00605280|593830769|FG001|Year 3 Extension|Withdrawal by Subject|0|||
164399305|NCT00605280|593830770|FG002|Year 3 Extension|Withdrawal by Subject|0|||
164399306|NCT00605280|593830771|FG003|Year 3 Extension|Withdrawal by Subject|5|||
164399307|NCT00605280|593830768|FG000|Year 3 Extension|Other|2|||
164399308|NCT00605280|593830769|FG001|Year 3 Extension|Other|0|||
164399309|NCT00605280|593830770|FG002|Year 3 Extension|Other|0|||
164399310|NCT00605280|593830771|FG003|Year 3 Extension|Other|0|||
164399311|NCT00605280|593830768|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
164399312|NCT00605280|593830769|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
164399313|NCT00605280|593830770|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
164399314|NCT00605280|593830771|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
164399315|NCT00518115|593830775|FG000|Overall Study|Adverse Event|6|||
164399316|NCT00518115|593830776|FG001|Overall Study|Adverse Event|1|||
164399317|NCT00518115|593830777|FG002|Overall Study|Adverse Event|5|||
164399318|NCT00518115|593830778|FG003|Overall Study|Adverse Event|6|||
164399319|NCT00518115|593830779|FG004|Overall Study|Adverse Event|5|||
164399320|NCT00518115|593830780|FG005|Overall Study|Adverse Event|5|||
164399321|NCT00518115|593830781|FG006|Overall Study|Adverse Event|5|||
164399322|NCT00518115|593830782|FG007|Overall Study|Adverse Event|10|||
164399323|NCT00518115|593830783|FG008|Overall Study|Adverse Event|2|||
164399324|NCT00518115|593830784|FG009|Overall Study|Adverse Event|9|||
164399325|NCT00518115|593830775|FG000|Overall Study|Lost to Follow-up|0|||
164705563|NCT04645966|594948688|FG007|Vaccination Phase|Other|0|||
164399326|NCT00518115|593830776|FG001|Overall Study|Lost to Follow-up|0|||
164399327|NCT00518115|593830777|FG002|Overall Study|Lost to Follow-up|2|||
164399328|NCT00518115|593830778|FG003|Overall Study|Lost to Follow-up|3|||
164399329|NCT00518115|593830779|FG004|Overall Study|Lost to Follow-up|1|||
164399330|NCT00518115|593830780|FG005|Overall Study|Lost to Follow-up|3|||
164399331|NCT00518115|593830781|FG006|Overall Study|Lost to Follow-up|0|||
164399332|NCT00518115|593830782|FG007|Overall Study|Lost to Follow-up|1|||
164399333|NCT00518115|593830783|FG008|Overall Study|Lost to Follow-up|1|||
164399334|NCT00518115|593830784|FG009|Overall Study|Lost to Follow-up|1|||
164399335|NCT00518115|593830775|FG000|Overall Study|Protocol Violation|1|||
164399336|NCT00518115|593830776|FG001|Overall Study|Protocol Violation|3|||
164399337|NCT00518115|593830777|FG002|Overall Study|Protocol Violation|1|||
164399338|NCT00518115|593830778|FG003|Overall Study|Protocol Violation|0|||
164399339|NCT00518115|593830779|FG004|Overall Study|Protocol Violation|0|||
164399340|NCT00518115|593830780|FG005|Overall Study|Protocol Violation|0|||
164399341|NCT00518115|593830781|FG006|Overall Study|Protocol Violation|0|||
164399342|NCT00518115|593830782|FG007|Overall Study|Protocol Violation|0|||
164399343|NCT00518115|593830783|FG008|Overall Study|Protocol Violation|0|||
164399344|NCT00518115|593830784|FG009|Overall Study|Protocol Violation|0|||
164399345|NCT00518115|593830775|FG000|Overall Study|Withdrawal by Subject|1|||
164399346|NCT00518115|593830776|FG001|Overall Study|Withdrawal by Subject|1|||
164399347|NCT00518115|593830777|FG002|Overall Study|Withdrawal by Subject|5|||
164399348|NCT00518115|593830778|FG003|Overall Study|Withdrawal by Subject|0|||
164399349|NCT00518115|593830779|FG004|Overall Study|Withdrawal by Subject|2|||
164399350|NCT00518115|593830780|FG005|Overall Study|Withdrawal by Subject|1|||
164399351|NCT00518115|593830781|FG006|Overall Study|Withdrawal by Subject|0|||
164399352|NCT00518115|593830782|FG007|Overall Study|Withdrawal by Subject|2|||
164399353|NCT00518115|593830783|FG008|Overall Study|Withdrawal by Subject|1|||
164399354|NCT00518115|593830784|FG009|Overall Study|Withdrawal by Subject|3|||
164399355|NCT00518115|593830775|FG000|Overall Study|Lack of Efficacy|1|||
164399356|NCT00518115|593830776|FG001|Overall Study|Lack of Efficacy|0|||
164399357|NCT00518115|593830777|FG002|Overall Study|Lack of Efficacy|1|||
164399358|NCT00518115|593830778|FG003|Overall Study|Lack of Efficacy|1|||
164399359|NCT00518115|593830779|FG004|Overall Study|Lack of Efficacy|0|||
164399360|NCT00518115|593830780|FG005|Overall Study|Lack of Efficacy|0|||
164399361|NCT00518115|593830781|FG006|Overall Study|Lack of Efficacy|0|||
164399362|NCT00518115|593830782|FG007|Overall Study|Lack of Efficacy|1|||
164399363|NCT00518115|593830783|FG008|Overall Study|Lack of Efficacy|0|||
164399364|NCT00518115|593830784|FG009|Overall Study|Lack of Efficacy|0|||
164399365|NCT00518115|593830775|FG000|Overall Study|Non-Compliance|1|||
164399366|NCT00518115|593830776|FG001|Overall Study|Non-Compliance|0|||
164399367|NCT00518115|593830777|FG002|Overall Study|Non-Compliance|1|||
164399368|NCT00518115|593830778|FG003|Overall Study|Non-Compliance|0|||
164399369|NCT00518115|593830779|FG004|Overall Study|Non-Compliance|1|||
164399370|NCT00518115|593830780|FG005|Overall Study|Non-Compliance|1|||
164399371|NCT00518115|593830781|FG006|Overall Study|Non-Compliance|1|||
164399372|NCT00518115|593830782|FG007|Overall Study|Non-Compliance|1|||
164399373|NCT00518115|593830783|FG008|Overall Study|Non-Compliance|0|||
164399374|NCT00518115|593830784|FG009|Overall Study|Non-Compliance|1|||
164399375|NCT00518115|593830775|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
164399376|NCT00518115|593830776|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
164399377|NCT00518115|593830777|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
164399378|NCT00518115|593830778|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
164399379|NCT00518115|593830779|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
164399380|NCT00518115|593830780|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
164399381|NCT00518115|593830781|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
164399382|NCT00518115|593830782|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
164399383|NCT00518115|593830783|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
164399384|NCT00518115|593830784|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
164399385|NCT00518115|593830775|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
164399386|NCT00518115|593830776|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
164399387|NCT00518115|593830777|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
164442479|NCT01350804|593987552|FG002|Core Study|Death|1|||
164442480|NCT01350804|593987553|FG003|Core Study|Death|0|||
164595966|NCT01106625|594545085|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
164595967|NCT01106625|594545086|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
164595968|NCT01106625|594545087|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
164595969|NCT01106625|594545085|FG000|Core Period: Baseline to Week 26|Other|8|||
164595970|NCT01106625|594545086|FG001|Core Period: Baseline to Week 26|Other|7|||
164595971|NCT01106625|594545087|FG002|Core Period: Baseline to Week 26|Other|4|||
164595972|NCT01106625|594545085|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
164595973|NCT01106625|594545086|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
164595974|NCT01106625|594545087|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
164595975|NCT01106625|594545085|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
164595976|NCT01106625|594545086|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
164595977|NCT01106625|594545087|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
164399388|NCT00518115|593830778|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
164399389|NCT00518115|593830779|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
164399390|NCT00518115|593830780|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
164399391|NCT00518115|593830781|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
164399392|NCT00518115|593830782|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
164399393|NCT00518115|593830783|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
164399394|NCT00518115|593830784|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
164399395|NCT00518115|593830775|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
164399396|NCT00518115|593830776|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
164442481|NCT01350804|593987550|FG000|Core Study|Adverse Event|8|||
164399397|NCT00518115|593830777|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
164399398|NCT00518115|593830778|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
164399399|NCT00518115|593830779|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
164399400|NCT00518115|593830780|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
164399401|NCT00518115|593830781|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
164399402|NCT00518115|593830782|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
164399403|NCT00518115|593830783|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
164399404|NCT00518115|593830784|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
164399405|NCT00518115|593830775|FG000|Overall Study|Wrong Monotherapy Administered|0|||
164399406|NCT00518115|593830776|FG001|Overall Study|Wrong Monotherapy Administered|0|||
164399407|NCT00518115|593830777|FG002|Overall Study|Wrong Monotherapy Administered|1|||
164399408|NCT00518115|593830778|FG003|Overall Study|Wrong Monotherapy Administered|0|||
164399409|NCT00518115|593830779|FG004|Overall Study|Wrong Monotherapy Administered|0|||
164399410|NCT00518115|593830780|FG005|Overall Study|Wrong Monotherapy Administered|0|||
164399411|NCT00518115|593830781|FG006|Overall Study|Wrong Monotherapy Administered|1|||
164399412|NCT00518115|593830782|FG007|Overall Study|Wrong Monotherapy Administered|0|||
164399413|NCT00518115|593830783|FG008|Overall Study|Wrong Monotherapy Administered|0|||
164399414|NCT00518115|593830784|FG009|Overall Study|Wrong Monotherapy Administered|0|||
164399415|NCT00518115|593830775|FG000|Overall Study|Violation of Exclusion Criteria|0|||
164399416|NCT00518115|593830776|FG001|Overall Study|Violation of Exclusion Criteria|0|||
164399417|NCT00518115|593830777|FG002|Overall Study|Violation of Exclusion Criteria|0|||
164399418|NCT00518115|593830778|FG003|Overall Study|Violation of Exclusion Criteria|1|||
164399419|NCT00518115|593830779|FG004|Overall Study|Violation of Exclusion Criteria|0|||
164399420|NCT00518115|593830780|FG005|Overall Study|Violation of Exclusion Criteria|0|||
164399421|NCT00518115|593830781|FG006|Overall Study|Violation of Exclusion Criteria|1|||
164399422|NCT00518115|593830782|FG007|Overall Study|Violation of Exclusion Criteria|0|||
164399423|NCT00518115|593830783|FG008|Overall Study|Violation of Exclusion Criteria|0|||
164399424|NCT00518115|593830784|FG009|Overall Study|Violation of Exclusion Criteria|0|||
164399425|NCT00518115|593830775|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
164399426|NCT00518115|593830776|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
164399427|NCT00518115|593830777|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
164399428|NCT00518115|593830778|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
164399429|NCT00518115|593830779|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
164399430|NCT00518115|593830780|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
164399431|NCT00518115|593830781|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
164399432|NCT00518115|593830782|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
164399433|NCT00518115|593830783|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
164399434|NCT00518115|593830784|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
164399435|NCT00518115|593830775|FG000|Overall Study|Withdrew Consent|0|||
164399436|NCT00518115|593830776|FG001|Overall Study|Withdrew Consent|0|||
164399437|NCT00518115|593830777|FG002|Overall Study|Withdrew Consent|0|||
164399438|NCT00518115|593830778|FG003|Overall Study|Withdrew Consent|0|||
164399439|NCT00518115|593830779|FG004|Overall Study|Withdrew Consent|0|||
164399440|NCT00518115|593830780|FG005|Overall Study|Withdrew Consent|1|||
164399441|NCT00518115|593830781|FG006|Overall Study|Withdrew Consent|0|||
164399442|NCT00518115|593830782|FG007|Overall Study|Withdrew Consent|0|||
164399443|NCT00518115|593830783|FG008|Overall Study|Withdrew Consent|0|||
164399444|NCT00518115|593830784|FG009|Overall Study|Withdrew Consent|0|||
164399445|NCT00518115|593830775|FG000|Overall Study|Moved Out of State|0|||
164399446|NCT00518115|593830776|FG001|Overall Study|Moved Out of State|0|||
164399447|NCT00518115|593830777|FG002|Overall Study|Moved Out of State|0|||
164399448|NCT00518115|593830778|FG003|Overall Study|Moved Out of State|0|||
164399449|NCT00518115|593830779|FG004|Overall Study|Moved Out of State|0|||
164399450|NCT00518115|593830780|FG005|Overall Study|Moved Out of State|0|||
164399451|NCT00518115|593830781|FG006|Overall Study|Moved Out of State|0|||
164399452|NCT00518115|593830782|FG007|Overall Study|Moved Out of State|0|||
164399453|NCT00518115|593830783|FG008|Overall Study|Moved Out of State|0|||
164399454|NCT00518115|593830784|FG009|Overall Study|Moved Out of State|1|||
164399455|NCT04891419|593830785|FG000|Overall Study|Withdrawal by Subject|4|||
164399456|NCT04891419|593830786|FG001|Overall Study|Withdrawal by Subject|0|||
164399457|NCT04891419|593830785|FG000|Overall Study|Lost to Follow-up|1|||
164399458|NCT04891419|593830786|FG001|Overall Study|Lost to Follow-up|3|||
164399459|NCT00827918|593830790|FG000|Overall Study|Adverse Event|4|||
164399460|NCT00827918|593830791|FG001|Overall Study|Adverse Event|0|||
164399461|NCT00827918|593830792|FG002|Overall Study|Adverse Event|0|||
164399462|NCT00827918|593830790|FG000|Overall Study|Lack of Efficacy|16|||
164399463|NCT00827918|593830791|FG001|Overall Study|Lack of Efficacy|4|||
164399464|NCT00827918|593830792|FG002|Overall Study|Lack of Efficacy|15|||
164399465|NCT00827918|593830790|FG000|Overall Study|Physician Decision|1|||
164399466|NCT00827918|593830791|FG001|Overall Study|Physician Decision|0|||
164399467|NCT00827918|593830792|FG002|Overall Study|Physician Decision|0|||
164399468|NCT00827918|593830790|FG000|Overall Study|Pregnancy|0|||
164399469|NCT00827918|593830791|FG001|Overall Study|Pregnancy|1|||
164399470|NCT00827918|593830792|FG002|Overall Study|Pregnancy|0|||
164399471|NCT00827918|593830790|FG000|Overall Study|Progressive Disease|1|||
164399472|NCT00827918|593830791|FG001|Overall Study|Progressive Disease|1|||
164399473|NCT00827918|593830792|FG002|Overall Study|Progressive Disease|0|||
164399474|NCT00827918|593830790|FG000|Overall Study|Protocol Violation|0|||
164399475|NCT00827918|593830791|FG001|Overall Study|Protocol Violation|1|||
164399476|NCT00827918|593830792|FG002|Overall Study|Protocol Violation|0|||
164399477|NCT00827918|593830790|FG000|Overall Study|Withdrawal by Subject|6|||
164399478|NCT00827918|593830791|FG001|Overall Study|Withdrawal by Subject|2|||
164399479|NCT00827918|593830792|FG002|Overall Study|Withdrawal by Subject|6|||
164399480|NCT00802074|593830793|FG000|Overall Study|Adverse Event|1|||
164399481|NCT00802074|593830794|FG001|Overall Study|Adverse Event|1|||
164399482|NCT00802074|593830795|FG002|Overall Study|Adverse Event|1|||
164399483|NCT00802074|593830796|FG003|Overall Study|Adverse Event|0|||
164399484|NCT00802074|593830797|FG004|Overall Study|Adverse Event|0|||
164399485|NCT00802074|593830798|FG005|Overall Study|Adverse Event|0|||
164399486|NCT00802074|593830793|FG000|Overall Study|Withdrawal by Subject|1|||
164399487|NCT00802074|593830794|FG001|Overall Study|Withdrawal by Subject|0|||
164399488|NCT00802074|593830795|FG002|Overall Study|Withdrawal by Subject|0|||
164399489|NCT00802074|593830796|FG003|Overall Study|Withdrawal by Subject|0|||
164399490|NCT00802074|593830797|FG004|Overall Study|Withdrawal by Subject|0|||
164399491|NCT00802074|593830798|FG005|Overall Study|Withdrawal by Subject|0|||
164399492|NCT02291614|593830801|FG000|Overall Study|Lost to Follow-up|0|||
164399493|NCT02291614|593830802|FG001|Overall Study|Lost to Follow-up|0|||
164399494|NCT02291614|593830803|FG002|Overall Study|Lost to Follow-up|0|||
164399495|NCT02291614|593830804|FG003|Overall Study|Lost to Follow-up|0|||
164399496|NCT02291614|593830805|FG004|Overall Study|Lost to Follow-up|0|||
164399497|NCT02291614|593830806|FG005|Overall Study|Lost to Follow-up|0|||
164399498|NCT02291614|593830807|FG006|Overall Study|Lost to Follow-up|0|||
164399499|NCT02291614|593830808|FG007|Overall Study|Lost to Follow-up|1|||
164399500|NCT02291614|593830809|FG008|Overall Study|Lost to Follow-up|0|||
164399501|NCT02291614|593830810|FG009|Overall Study|Lost to Follow-up|0|||
164399502|NCT02291614|593830811|FG010|Overall Study|Lost to Follow-up|0|||
164399503|NCT02291614|593830801|FG000|Overall Study|Withdrawal by Subject|0|||
164399504|NCT02291614|593830802|FG001|Overall Study|Withdrawal by Subject|1|||
164399505|NCT02291614|593830803|FG002|Overall Study|Withdrawal by Subject|0|||
164399506|NCT02291614|593830804|FG003|Overall Study|Withdrawal by Subject|0|||
164399507|NCT02291614|593830805|FG004|Overall Study|Withdrawal by Subject|0|||
164399508|NCT02291614|593830806|FG005|Overall Study|Withdrawal by Subject|0|||
164399509|NCT02291614|593830807|FG006|Overall Study|Withdrawal by Subject|0|||
164399510|NCT02291614|593830808|FG007|Overall Study|Withdrawal by Subject|0|||
164399511|NCT02291614|593830809|FG008|Overall Study|Withdrawal by Subject|0|||
164399512|NCT02291614|593830810|FG009|Overall Study|Withdrawal by Subject|2|||
164399513|NCT02291614|593830811|FG010|Overall Study|Withdrawal by Subject|2|||
164399514|NCT02291614|593830801|FG000|Overall Study|Decision by sponsor|0|||
164399515|NCT02291614|593830802|FG001|Overall Study|Decision by sponsor|0|||
164399516|NCT02291614|593830803|FG002|Overall Study|Decision by sponsor|0|||
164399517|NCT02291614|593830804|FG003|Overall Study|Decision by sponsor|1|||
164399518|NCT02291614|593830805|FG004|Overall Study|Decision by sponsor|0|||
164399519|NCT02291614|593830806|FG005|Overall Study|Decision by sponsor|0|||
164399520|NCT02291614|593830807|FG006|Overall Study|Decision by sponsor|0|||
164399521|NCT02291614|593830808|FG007|Overall Study|Decision by sponsor|0|||
164399522|NCT02291614|593830809|FG008|Overall Study|Decision by sponsor|0|||
164399523|NCT02291614|593830810|FG009|Overall Study|Decision by sponsor|0|||
164399524|NCT02291614|593830811|FG010|Overall Study|Decision by sponsor|0|||
164399525|NCT02291614|593830801|FG000|Overall Study|Death|0|||
164399526|NCT02291614|593830802|FG001|Overall Study|Death|0|||
164399527|NCT02291614|593830803|FG002|Overall Study|Death|1|||
164399528|NCT02291614|593830804|FG003|Overall Study|Death|0|||
164399529|NCT02291614|593830805|FG004|Overall Study|Death|1|||
164399530|NCT02291614|593830806|FG005|Overall Study|Death|1|||
164399531|NCT02291614|593830807|FG006|Overall Study|Death|1|||
164399532|NCT02291614|593830808|FG007|Overall Study|Death|0|||
164399533|NCT02291614|593830809|FG008|Overall Study|Death|0|||
164399534|NCT02291614|593830810|FG009|Overall Study|Death|0|||
164399535|NCT02291614|593830811|FG010|Overall Study|Death|0|||
164399536|NCT00127101|593830812|FG000|Base Protocol|Adverse Event|0|||
164399537|NCT00127101|593830813|FG001|Base Protocol|Adverse Event|2|||
164399538|NCT00127101|593830814|FG002|Base Protocol|Adverse Event|1|||
164399539|NCT00127101|593830815|FG003|Base Protocol|Adverse Event|0|||
164399540|NCT00127101|593830816|FG004|Base Protocol|Adverse Event|0|||
164399541|NCT00127101|593830817|FG005|Base Protocol|Adverse Event|0|||
164399542|NCT00127101|593830812|FG000|Base Protocol|Lack of Efficacy|1|||
164399543|NCT00127101|593830813|FG001|Base Protocol|Lack of Efficacy|0|||
164399544|NCT00127101|593830814|FG002|Base Protocol|Lack of Efficacy|0|||
164399545|NCT00127101|593830815|FG003|Base Protocol|Lack of Efficacy|0|||
164399546|NCT00127101|593830816|FG004|Base Protocol|Lack of Efficacy|2|||
164399547|NCT00127101|593830817|FG005|Base Protocol|Lack of Efficacy|0|||
164399548|NCT00127101|593830812|FG000|Base Protocol|Withdrawal by Subject|1|||
164399549|NCT00127101|593830813|FG001|Base Protocol|Withdrawal by Subject|2|||
164399550|NCT00127101|593830814|FG002|Base Protocol|Withdrawal by Subject|1|||
164399551|NCT00127101|593830815|FG003|Base Protocol|Withdrawal by Subject|0|||
164399552|NCT00127101|593830816|FG004|Base Protocol|Withdrawal by Subject|0|||
164399553|NCT00127101|593830817|FG005|Base Protocol|Withdrawal by Subject|1|||
164399554|NCT00127101|593830812|FG000|Continuation Phase|Adverse Event|0|||
164399555|NCT00127101|593830813|FG001|Continuation Phase|Adverse Event|0|||
164399556|NCT00127101|593830814|FG002|Continuation Phase|Adverse Event|0|||
164399557|NCT00127101|593830815|FG003|Continuation Phase|Adverse Event|0|||
164399558|NCT00127101|593830816|FG004|Continuation Phase|Adverse Event|1|||
164399559|NCT00127101|593830817|FG005|Continuation Phase|Adverse Event|1|||
164399560|NCT00127101|593830812|FG000|Continuation Phase|Lack of Efficacy|0|||
164399561|NCT00127101|593830813|FG001|Continuation Phase|Lack of Efficacy|0|||
164399562|NCT00127101|593830814|FG002|Continuation Phase|Lack of Efficacy|0|||
164399563|NCT00127101|593830815|FG003|Continuation Phase|Lack of Efficacy|0|||
164399564|NCT00127101|593830816|FG004|Continuation Phase|Lack of Efficacy|0|||
164399565|NCT00127101|593830817|FG005|Continuation Phase|Lack of Efficacy|1|||
164399566|NCT00127101|593830812|FG000|Continuation Phase|Withdrawal by Subject|0|||
164399567|NCT00127101|593830813|FG001|Continuation Phase|Withdrawal by Subject|0|||
164399568|NCT00127101|593830814|FG002|Continuation Phase|Withdrawal by Subject|1|||
164399569|NCT00127101|593830815|FG003|Continuation Phase|Withdrawal by Subject|0|||
164399570|NCT00127101|593830816|FG004|Continuation Phase|Withdrawal by Subject|2|||
164399571|NCT00127101|593830817|FG005|Continuation Phase|Withdrawal by Subject|1|||
164399572|NCT00843167|593830818|FG000|Treatment Period|Adverse Event|1|||
164399573|NCT00843167|593830819|FG001|Treatment Period|Adverse Event|5|||
164399574|NCT00843167|593830818|FG000|Treatment Period|Withdrawal by Subject|2|||
164399575|NCT00843167|593830819|FG001|Treatment Period|Withdrawal by Subject|3|||
164399576|NCT03743038|593830820|FG000|Overall Study|Physician Decision|1|||
164399577|NCT01830127|593830821|FG000|Overall Study|Adverse Event|1|||
164399578|NCT01830127|593830822|FG001|Overall Study|Adverse Event|6|||
164399579|NCT01830127|593830821|FG000|Overall Study|Lack of Efficacy|3|||
164399580|NCT01830127|593830822|FG001|Overall Study|Lack of Efficacy|0|||
164399581|NCT01830127|593830821|FG000|Overall Study|Withdrawal by Subject|1|||
164399582|NCT01830127|593830822|FG001|Overall Study|Withdrawal by Subject|1|||
164399583|NCT01830127|593830821|FG000|Overall Study|Other reason not defined above|0|||
164399584|NCT01830127|593830822|FG001|Overall Study|Other reason not defined above|2|||
164399585|NCT02137369|593830829|FG000|Overall Study|Withdrawal by Subject|3|||
164399586|NCT02137369|593830830|FG001|Overall Study|Withdrawal by Subject|2|||
164399587|NCT02137369|593830829|FG000|Overall Study|Adverse Event|2|||
164399588|NCT02137369|593830830|FG001|Overall Study|Adverse Event|0|||
164399589|NCT02137369|593830829|FG000|Overall Study|Lost to Follow-up|1|||
164399590|NCT02137369|593830830|FG001|Overall Study|Lost to Follow-up|0|||
164399591|NCT02137369|593830829|FG000|Overall Study|Moved away|2|||
164399592|NCT02137369|593830830|FG001|Overall Study|Moved away|0|||
164399593|NCT00680407|593830840|FG000|Overall Study|Lost to Follow-up|3|||
164399594|NCT00680407|593830841|FG001|Overall Study|Lost to Follow-up|3|||
164399595|NCT00680407|593830842|FG002|Overall Study|Lost to Follow-up|1|||
164399596|NCT00680407|593830840|FG000|Overall Study|Withdrawal by Subject|5|||
164399597|NCT00680407|593830841|FG001|Overall Study|Withdrawal by Subject|2|||
164442482|NCT01350804|593987551|FG001|Core Study|Adverse Event|10|||
164442483|NCT01350804|593987552|FG002|Core Study|Adverse Event|8|||
164442484|NCT01350804|593987553|FG003|Core Study|Adverse Event|8|||
164442485|NCT01350804|593987550|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
164442486|NCT01350804|593987551|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
164442487|NCT01350804|593987552|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
164442488|NCT01350804|593987553|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
164442489|NCT01350804|593987550|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
164442490|NCT01350804|593987551|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
164442491|NCT01350804|593987552|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
164442492|NCT01350804|593987553|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
164442493|NCT01350804|593987550|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
164442494|NCT01350804|593987551|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
164442495|NCT01350804|593987552|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
164442496|NCT01350804|593987553|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
164442497|NCT01350804|593987550|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
164442498|NCT01350804|593987551|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
164442499|NCT01350804|593987552|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
164442500|NCT01350804|593987553|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
164442501|NCT01350804|593987550|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
164442502|NCT01350804|593987551|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
164442503|NCT01350804|593987552|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
164442504|NCT01350804|593987553|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
164442505|NCT01350804|593987550|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
164442506|NCT01350804|593987551|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
164442507|NCT01350804|593987552|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
164442508|NCT01350804|593987553|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
164442509|NCT00026312|593987554|FG000|Overall Study|Adverse Event|0|||
164442510|NCT00026312|593987555|FG001|Overall Study|Adverse Event|32|||
164442511|NCT00026312|593987554|FG000|Overall Study|Death|1|||
164442512|NCT00026312|593987555|FG001|Overall Study|Death|7|||
164442513|NCT00026312|593987554|FG000|Overall Study|Lack of Efficacy|19|||
164442514|NCT00026312|593987555|FG001|Overall Study|Lack of Efficacy|114|||
164442515|NCT00026312|593987554|FG000|Overall Study|Lost to Follow-up|0|||
164442516|NCT00026312|593987555|FG001|Overall Study|Lost to Follow-up|5|||
164442517|NCT00026312|593987554|FG000|Overall Study|Physician Decision|1|||
164442518|NCT00026312|593987555|FG001|Overall Study|Physician Decision|37|||
164442519|NCT00026312|593987554|FG000|Overall Study|Protocol Violation|0|||
164442520|NCT00026312|593987555|FG001|Overall Study|Protocol Violation|3|||
164442521|NCT00026312|593987554|FG000|Overall Study|Withdrawal by Subject|1|||
164442522|NCT00026312|593987555|FG001|Overall Study|Withdrawal by Subject|6|||
164442523|NCT00026312|593987554|FG000|Overall Study|Ineligible|4|||
164442524|NCT00026312|593987555|FG001|Overall Study|Ineligible|5|||
164442525|NCT00026312|593987554|FG000|Overall Study|Entry onto another COG study|0|||
164595978|NCT01106625|594545085|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
164595979|NCT01106625|594545086|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
164595980|NCT01106625|594545087|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
164595981|NCT01106625|594545085|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
164595982|NCT01106625|594545086|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
164595983|NCT01106625|594545087|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
164595984|NCT01106625|594545085|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
164595985|NCT01106625|594545086|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
164595986|NCT01106625|594545087|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
164595987|NCT01106625|594545085|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
164595988|NCT01106625|594545086|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
164595989|NCT01106625|594545087|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
164705564|NCT04645966|594948689|FG008|Vaccination Phase|Other|0|||
164705565|NCT04645966|594948681|FG000|Vaccination Phase|Lost to Follow-up|0|||
164705566|NCT04645966|594948682|FG001|Vaccination Phase|Lost to Follow-up|0|||
164705567|NCT04645966|594948683|FG002|Vaccination Phase|Lost to Follow-up|0|||
164705568|NCT04645966|594948684|FG003|Vaccination Phase|Lost to Follow-up|0|||
164705569|NCT04645966|594948685|FG004|Vaccination Phase|Lost to Follow-up|0|||
164705570|NCT04645966|594948686|FG005|Vaccination Phase|Lost to Follow-up|0|||
164705571|NCT04645966|594948687|FG006|Vaccination Phase|Lost to Follow-up|0|||
164705572|NCT04645966|594948688|FG007|Vaccination Phase|Lost to Follow-up|1|||
164705573|NCT04645966|594948689|FG008|Vaccination Phase|Lost to Follow-up|0|||
164705574|NCT04645966|594948681|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
164705575|NCT04645966|594948682|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
164705576|NCT04645966|594948683|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
164705577|NCT04645966|594948684|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
164705578|NCT04645966|594948685|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
164705579|NCT04645966|594948686|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
164705580|NCT04645966|594948687|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
164705581|NCT04645966|594948688|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
164705582|NCT04645966|594948689|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
164705583|NCT04645966|594948681|FG000|Follow-up Phase|Lost to Follow-up|0|||
164705584|NCT04645966|594948682|FG001|Follow-up Phase|Lost to Follow-up|0|||
164399598|NCT00680407|593830842|FG002|Overall Study|Withdrawal by Subject|2|||
164399599|NCT02543658|593833070|FG000|Overall Study|Lack of Efficacy|0|||
164399600|NCT02543658|593833071|FG001|Overall Study|Lack of Efficacy|4|||
164399601|NCT00789815|593833072|FG000|Overall Study|Protocol Violation|6|||
164399602|NCT00789815|593833073|FG001|Overall Study|Protocol Violation|1|||
164399603|NCT00789815|593833072|FG000|Overall Study|Intubation due to massive bleeding|1|||
164399604|NCT00789815|593833073|FG001|Overall Study|Intubation due to massive bleeding|0|||
164399605|NCT04128293|593833082|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
164399606|NCT04128293|593833083|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
164399607|NCT04128293|593833084|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
164399608|NCT04128293|593833085|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
164399609|NCT00514943|593833088|FG000|Stage 1|Progressive disease|4|||
164399610|NCT00514943|593833089|FG001|Stage 1|Progressive disease|8|||
164399611|NCT00514943|593833088|FG000|Stage 1|Other Adverse Event|16|||
164399612|NCT00514943|593833089|FG001|Stage 1|Other Adverse Event|6|||
164399613|NCT00514943|593833088|FG000|Stage 1|Not treated|1|||
164399614|NCT00514943|593833089|FG001|Stage 1|Not treated|2|||
164399615|NCT00514943|593833088|FG000|Stage 1|Patient refused to continue study meds|8|||
164399616|NCT00514943|593833089|FG001|Stage 1|Patient refused to continue study meds|3|||
164399617|NCT00514943|593833088|FG000|Stage 1|Other than stated above|1|||
164399618|NCT00514943|593833089|FG001|Stage 1|Other than stated above|7|||
164399619|NCT00514943|593833088|FG000|Stage 2|Progressive disease|27|||
164399620|NCT00514943|593833089|FG001|Stage 2|Progressive disease|24|||
164399621|NCT00514943|593833088|FG000|Stage 2|Other Adverse Event|3|||
164399622|NCT00514943|593833089|FG001|Stage 2|Other Adverse Event|10|||
164399623|NCT00514943|593833088|FG000|Stage 2|Patient refused to continue study meds|2|||
164399624|NCT00514943|593833089|FG001|Stage 2|Patient refused to continue study meds|0|||
164399625|NCT00514943|593833088|FG000|Stage 2|Other than stated above|0|||
164399626|NCT00514943|593833089|FG001|Stage 2|Other than stated above|2|||
164399627|NCT03255824|593833095|FG000|Overall Study|Under-sedation|2|||
164399628|NCT03255824|593833096|FG001|Overall Study|Under-sedation|1|||
164399629|NCT02001194|593833099|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
164399630|NCT02001194|593833100|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
164399631|NCT02001194|593833101|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
164399632|NCT02001194|593833102|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
164399633|NCT02001194|593833099|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
164399634|NCT02001194|593833100|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
164399635|NCT02001194|593833101|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
164442526|NCT00026312|593987555|FG001|Overall Study|Entry onto another COG study|1|||
164442527|NCT00026312|593987554|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
164442528|NCT00026312|593987555|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
164442529|NCT02611037|593987556|FG000|Overall Study|Withdrawal prior to treatment|2|||
164595990|NCT01106625|594545085|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
164595991|NCT01106625|594545086|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
164595992|NCT01106625|594545087|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
164595993|NCT01106625|594545085|FG000|Extension Period: Week 26 to Week 52|Other|5|||
164595994|NCT01106625|594545086|FG001|Extension Period: Week 26 to Week 52|Other|5|||
164595995|NCT01106625|594545087|FG002|Extension Period: Week 26 to Week 52|Other|4|||
164595996|NCT04056455|594545091|FG000|Overall Study|Adverse Event|1|||
164595997|NCT04056455|594545092|FG001|Overall Study|Adverse Event|0|||
164595998|NCT02512068|594545093|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
164595999|NCT02512068|594545094|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
164596000|NCT02512068|594545093|FG000|Overall Study|Major Protocol Deviation|1|||
164596001|NCT02512068|594545094|FG001|Overall Study|Major Protocol Deviation|0|||
164596002|NCT02512068|594545093|FG000|Overall Study|Voluntary Withdrawal|0|||
164596003|NCT02512068|594545094|FG001|Overall Study|Voluntary Withdrawal|1|||
164596004|NCT02512068|594545093|FG000|Overall Study|Lack of Efficacy|0|||
164596005|NCT02512068|594545094|FG001|Overall Study|Lack of Efficacy|1|||
164596006|NCT02512068|594545093|FG000|Overall Study|Reason Not Specified|3|||
164596007|NCT02512068|594545094|FG001|Overall Study|Reason Not Specified|5|||
164596008|NCT00830037|594545101|FG000|Overall Study|Withdrawal by Subject|2|||
164596009|NCT00830037|594545102|FG001|Overall Study|Withdrawal by Subject|3|||
164596010|NCT00830037|594545101|FG000|Overall Study|Lost to Follow-up|1|||
164596011|NCT00830037|594545102|FG001|Overall Study|Lost to Follow-up|2|||
164596012|NCT00830037|594545101|FG000|Overall Study|Active when terminated by DSMB|15|||
164596013|NCT00830037|594545102|FG001|Overall Study|Active when terminated by DSMB|14|||
164596014|NCT01401010|594545105|FG000|Overall Study|Could not interpret assay results|1|||
164596015|NCT01401010|594545106|FG001|Overall Study|Could not interpret assay results|0|||
164596016|NCT02841787|594545107|FG000|Overall Study|Lost to Follow-up|1|||
164596017|NCT02841787|594545108|FG001|Overall Study|Lost to Follow-up|0|||
164596018|NCT02841787|594545109|FG002|Overall Study|Lost to Follow-up|0|||
164596019|NCT02841787|594545107|FG000|Overall Study|Symptoms dropped below threshold|1|||
164596020|NCT02841787|594545108|FG001|Overall Study|Symptoms dropped below threshold|0|||
164596021|NCT02841787|594545109|FG002|Overall Study|Symptoms dropped below threshold|0|||
164596022|NCT02841787|594545107|FG000|Overall Study|Withdrawal by Subject|1|||
164596023|NCT02841787|594545108|FG001|Overall Study|Withdrawal by Subject|4|||
164596024|NCT02841787|594545109|FG002|Overall Study|Withdrawal by Subject|0|||
164596025|NCT01474746|594545110|FG000|Overall Study|Lost to Follow-up|1|||
164596026|NCT01474746|594545111|FG001|Overall Study|Lost to Follow-up|1|||
164596027|NCT01474746|594545110|FG000|Overall Study|Withdrawal by Subject|2|||
164596028|NCT01474746|594545111|FG001|Overall Study|Withdrawal by Subject|1|||
164596029|NCT00524316|594545115|FG000|Overall Study|Withdrawal by Subject|2|||
164596030|NCT00524316|594545115|FG000|Overall Study|Adverse Event|7|||
164596031|NCT00524316|594545115|FG000|Overall Study|Disease Progression|7|||
164596032|NCT01199263|594545116|FG000|Overall Study|Ineligible|0|||
164596033|NCT01199263|594545117|FG001|Overall Study|Ineligible|2|||
164596034|NCT01199263|594545116|FG000|Overall Study|Never Treated|6|||
164596035|NCT01199263|594545117|FG001|Overall Study|Never Treated|0|||
164596036|NCT01687413|594545122|FG000|Overall Study|Withdrawal by Subject|0|||
164596037|NCT01687413|594545123|FG001|Overall Study|Withdrawal by Subject|2|||
164596038|NCT01687413|594545122|FG000|Overall Study|Not eligible|0|||
164596039|NCT01687413|594545123|FG001|Overall Study|Not eligible|2|||
164596040|NCT01687413|594545122|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
164596041|NCT01687413|594545123|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
164596042|NCT00091390|594545125|FG000|Overall Study|Protocol Violation|1|||
164596043|NCT00091390|594545125|FG000|Overall Study|No protocol treatment|3|||
164596044|NCT02349789|594546566|FG000|Overall Study|Withdrawal by Subject|2|||
164596045|NCT00311181|594546567|FG000|Overall Study|Final DFTs were not obtained|96|||
164596046|NCT02669862|594546568|FG000|Overall Study|Lost to Follow-up|0|||
164596047|NCT02669862|594546569|FG001|Overall Study|Lost to Follow-up|2|||
164596048|NCT02669862|594546570|FG002|Overall Study|Lost to Follow-up|1|||
164596049|NCT02669862|594546568|FG000|Overall Study|Withdrawal by Subject|2|||
164596050|NCT02669862|594546569|FG001|Overall Study|Withdrawal by Subject|2|||
164596051|NCT02669862|594546570|FG002|Overall Study|Withdrawal by Subject|3|||
164596052|NCT02669862|594546568|FG000|Overall Study|moved|0|||
164596053|NCT02669862|594546569|FG001|Overall Study|moved|1|||
164596054|NCT02669862|594546570|FG002|Overall Study|moved|0|||
164596055|NCT02669862|594546568|FG000|Overall Study|Protocol Violation|0|||
164596056|NCT02669862|594546569|FG001|Overall Study|Protocol Violation|0|||
164596057|NCT02669862|594546570|FG002|Overall Study|Protocol Violation|1|||
164596058|NCT02294318|594546571|FG000|Overall Study|Worsening of drinking|3|||
164596059|NCT02294318|594546572|FG001|Overall Study|Worsening of drinking|0|||
164596060|NCT02294318|594546571|FG000|Overall Study|Not exposed to intervention|0|||
164442530|NCT02611037|593987557|FG001|Overall Study|Withdrawal prior to treatment|0|||
164442531|NCT01170026|593988563|FG000|Overall Study|Lost to Follow-up|4|||
164442532|NCT01170026|593988564|FG001|Overall Study|Lost to Follow-up|2|||
164442533|NCT03889925|593988565|FG000|Overall Study|Lost to Follow-up|11|||
164442534|NCT03889925|593988566|FG001|Overall Study|Lost to Follow-up|10|||
164442535|NCT01823536|593988570|FG000|Overall Study|Lost to Follow-up|1|||
164442536|NCT01823536|593988571|FG001|Overall Study|Lost to Follow-up|0|||
164442537|NCT01823536|593988572|FG002|Overall Study|Lost to Follow-up|0|||
164442538|NCT01823536|593988573|FG003|Overall Study|Lost to Follow-up|1|||
164442539|NCT01823536|593988574|FG004|Overall Study|Lost to Follow-up|1|||
164442540|NCT01823536|593988575|FG005|Overall Study|Lost to Follow-up|0|||
164442541|NCT01823536|593988570|FG000|Overall Study|Protocol Violation|0|||
164442542|NCT01823536|593988571|FG001|Overall Study|Protocol Violation|1|||
164442543|NCT01823536|593988572|FG002|Overall Study|Protocol Violation|0|||
164442544|NCT01823536|593988573|FG003|Overall Study|Protocol Violation|0|||
164442545|NCT01823536|593988574|FG004|Overall Study|Protocol Violation|0|||
164442546|NCT01823536|593988575|FG005|Overall Study|Protocol Violation|0|||
164442547|NCT01823536|593988570|FG000|Overall Study|Withdrawal by Subject|1|||
164442548|NCT01823536|593988571|FG001|Overall Study|Withdrawal by Subject|1|||
164442549|NCT01823536|593988572|FG002|Overall Study|Withdrawal by Subject|0|||
164442550|NCT01823536|593988573|FG003|Overall Study|Withdrawal by Subject|0|||
164442551|NCT01823536|593988574|FG004|Overall Study|Withdrawal by Subject|0|||
164596061|NCT02294318|594546572|FG001|Overall Study|Not exposed to intervention|2|||
164596062|NCT01116687|594546574|FG000|Overall Study|Withdrawal by Subject|4|||
164596063|NCT01694420|594546575|FG000|Overall Study|Lost to Follow-up|3|||
164442552|NCT01823536|593988575|FG005|Overall Study|Withdrawal by Subject|0|||
164442553|NCT01823536|593988570|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
164442554|NCT01823536|593988571|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
164442555|NCT01823536|593988572|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
164596064|NCT03497429|594546577|FG000|Overall Study|Progressive disease|3|||
164442556|NCT01823536|593988573|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
164442557|NCT01823536|593988574|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
164442558|NCT01823536|593988575|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
164442559|NCT01823536|593988570|FG000|Overall Study|Met exclusion criterion No 6|0|||
164442560|NCT01823536|593988571|FG001|Overall Study|Met exclusion criterion No 6|0|||
164442561|NCT01823536|593988572|FG002|Overall Study|Met exclusion criterion No 6|0|||
164442562|NCT01823536|593988573|FG003|Overall Study|Met exclusion criterion No 6|1|||
164442563|NCT01823536|593988574|FG004|Overall Study|Met exclusion criterion No 6|0|||
164442564|NCT01823536|593988575|FG005|Overall Study|Met exclusion criterion No 6|0|||
164442565|NCT01823536|593988570|FG000|Overall Study|Subject moved out of the state|0|||
164442566|NCT01823536|593988571|FG001|Overall Study|Subject moved out of the state|0|||
164442567|NCT01823536|593988572|FG002|Overall Study|Subject moved out of the state|0|||
164705585|NCT04645966|594948683|FG002|Follow-up Phase|Lost to Follow-up|0|||
164705586|NCT04645966|594948684|FG003|Follow-up Phase|Lost to Follow-up|0|||
164705587|NCT04645966|594948685|FG004|Follow-up Phase|Lost to Follow-up|0|||
164705588|NCT04645966|594948686|FG005|Follow-up Phase|Lost to Follow-up|0|||
164705589|NCT04645966|594948687|FG006|Follow-up Phase|Lost to Follow-up|0|||
164705590|NCT04645966|594948688|FG007|Follow-up Phase|Lost to Follow-up|1|||
164705591|NCT04645966|594948689|FG008|Follow-up Phase|Lost to Follow-up|0|||
164705592|NCT00552578|594948693|FG000|Overall Study|Lost to Follow-up|1|||
164705593|NCT00552578|594948694|FG001|Overall Study|Lost to Follow-up|1|||
164705594|NCT01059539|594948697|FG000|Overall Study|Adverse Event|66|||
164705595|NCT01059539|594948697|FG000|Overall Study|Insufficient Therapeutic Response|26|||
164705596|NCT01059539|594948697|FG000|Overall Study|Protocol Violation|55|||
164705597|NCT01059539|594948697|FG000|Overall Study|Withdrawal of Consent|80|||
164705598|NCT01059539|594948697|FG000|Overall Study|Lost to Follow-up|42|||
164705599|NCT01059539|594948697|FG000|Overall Study|Reason Not Specified|2|||
164705600|NCT04091659|594948701|FG000|Overall Study|Protocol Violation|3|||
164705601|NCT04091659|594948702|FG001|Overall Study|Protocol Violation|0|||
164705602|NCT04091659|594948701|FG000|Overall Study|Lost to Follow-up|0|||
164705603|NCT04091659|594948702|FG001|Overall Study|Lost to Follow-up|1|||
164705604|NCT04015908|594948710|FG000|Overall Study|Lost to Follow-up|0|||
164705605|NCT04015908|594948711|FG001|Overall Study|Lost to Follow-up|1|||
164705606|NCT01715571|594948712|FG000|Overall Study|Lost to Follow-up|8|||
164705607|NCT03569228|594948718|FG000|Overall Study|Withdrawal by PI|0|||
164705608|NCT03569228|594948719|FG001|Overall Study|Withdrawal by PI|0|||
164705609|NCT03569228|594948720|FG002|Overall Study|Withdrawal by PI|2|||
164705610|NCT03569228|594948721|FG003|Overall Study|Withdrawal by PI|2|||
164705611|NCT03569228|594948722|FG004|Overall Study|Withdrawal by PI|1|||
164705612|NCT03569228|594948723|FG005|Overall Study|Withdrawal by PI|0|||
164705613|NCT03569228|594948724|FG006|Overall Study|Withdrawal by PI|0|||
164705614|NCT03569228|594948725|FG007|Overall Study|Withdrawal by PI|0|||
164705615|NCT03569228|594948726|FG008|Overall Study|Withdrawal by PI|0|||
164705616|NCT03569228|594948718|FG000|Overall Study|Lost to Follow-up|0|||
164705617|NCT03569228|594948719|FG001|Overall Study|Lost to Follow-up|0|||
164705618|NCT03569228|594948720|FG002|Overall Study|Lost to Follow-up|0|||
164705619|NCT03569228|594948721|FG003|Overall Study|Lost to Follow-up|0|||
164705620|NCT03569228|594948722|FG004|Overall Study|Lost to Follow-up|0|||
164705621|NCT03569228|594948723|FG005|Overall Study|Lost to Follow-up|0|||
164705622|NCT03569228|594948724|FG006|Overall Study|Lost to Follow-up|0|||
164705623|NCT03569228|594948725|FG007|Overall Study|Lost to Follow-up|0|||
164705624|NCT03569228|594948726|FG008|Overall Study|Lost to Follow-up|1|||
164705625|NCT03569228|594948718|FG000|Overall Study|Screen Fail|2|||
164705626|NCT03569228|594948719|FG001|Overall Study|Screen Fail|2|||
164705627|NCT03569228|594948720|FG002|Overall Study|Screen Fail|1|||
164705628|NCT03569228|594948721|FG003|Overall Study|Screen Fail|1|||
164705629|NCT03569228|594948722|FG004|Overall Study|Screen Fail|1|||
164705630|NCT03569228|594948723|FG005|Overall Study|Screen Fail|3|||
164705631|NCT03569228|594948724|FG006|Overall Study|Screen Fail|1|||
164705632|NCT03569228|594948725|FG007|Overall Study|Screen Fail|5|||
164705633|NCT03569228|594948726|FG008|Overall Study|Screen Fail|2|||
164705634|NCT05442866|594948727|FG000|Overall Study|Death|1|||
164705635|NCT05442866|594948727|FG000|Overall Study|Lost to Follow-up|9|||
164705636|NCT05442866|594948727|FG000|Overall Study|Protocol Violation|1|||
164705637|NCT01584843|594948740|FG000|First Treatment Period|Adverse Event|0|||
164705638|NCT01584843|594948741|FG001|First Treatment Period|Adverse Event|0|||
164705639|NCT01584843|594948742|FG002|First Treatment Period|Adverse Event|1|||
164705640|NCT01584843|594948743|FG003|First Treatment Period|Adverse Event|0|||
164705641|NCT01584843|594948744|FG004|First Treatment Period|Adverse Event|0|||
164705642|NCT01584843|594948745|FG005|First Treatment Period|Adverse Event|0|||
164705643|NCT01584843|594948740|FG000|First Treatment Period|Protocol Violation|0|||
164705644|NCT01584843|594948741|FG001|First Treatment Period|Protocol Violation|0|||
164705645|NCT01584843|594948742|FG002|First Treatment Period|Protocol Violation|0|||
164705646|NCT01584843|594948743|FG003|First Treatment Period|Protocol Violation|0|||
164705647|NCT01584843|594948744|FG004|First Treatment Period|Protocol Violation|0|||
164705648|NCT01584843|594948745|FG005|First Treatment Period|Protocol Violation|1|||
164705649|NCT01584843|594948740|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
164705650|NCT01584843|594948741|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
164705651|NCT01584843|594948742|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
164705652|NCT01584843|594948743|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
164705653|NCT01584843|594948744|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
164705654|NCT01584843|594948745|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
164705655|NCT01584843|594948740|FG000|Second Treatment Period|Withdrawal by Subject|0|||
164705656|NCT01584843|594948741|FG001|Second Treatment Period|Withdrawal by Subject|0|||
164705657|NCT01584843|594948742|FG002|Second Treatment Period|Withdrawal by Subject|0|||
164705658|NCT01584843|594948743|FG003|Second Treatment Period|Withdrawal by Subject|0|||
164705659|NCT01584843|594948744|FG004|Second Treatment Period|Withdrawal by Subject|0|||
164705660|NCT01584843|594948745|FG005|Second Treatment Period|Withdrawal by Subject|1|||
164705661|NCT04126213|594948748|FG000|Overall Study|Lost to Follow-up|9|||
164705662|NCT04126213|594948749|FG001|Overall Study|Lost to Follow-up|1|||
164705663|NCT04126213|594948750|FG002|Overall Study|Lost to Follow-up|5|||
164705664|NCT04126213|594948751|FG003|Overall Study|Lost to Follow-up|10|||
164705665|NCT04126213|594948752|FG004|Overall Study|Lost to Follow-up|4|||
164705666|NCT04126213|594948753|FG005|Overall Study|Lost to Follow-up|7|||
164705667|NCT04126213|594948748|FG000|Overall Study|Withdrawal by Subject|3|||
164705668|NCT04126213|594948749|FG001|Overall Study|Withdrawal by Subject|2|||
164596065|NCT03497429|594546578|FG001|Overall Study|Progressive disease|4|||
164596066|NCT03497429|594546577|FG000|Overall Study|Adverse Event|0|||
164596067|NCT03497429|594546578|FG001|Overall Study|Adverse Event|2|||
164596068|NCT00506948|594546579|FG000|Overall Study|Death|4|||
164596069|NCT00506948|594546579|FG000|Overall Study|Adverse Event|5|||
164596070|NCT00506948|594546579|FG000|Overall Study|Physician Decision|1|||
164596071|NCT02395653|594546580|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
164596072|NCT02395653|594546580|FG000|Overall Study|Consent Withdrawn at Screening|1|||
164596073|NCT02395653|594546580|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
164399636|NCT02001194|593833102|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
164399637|NCT03432364|593833110|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
164399638|NCT00522301|593833111|FG000|Overall Study|Withdrawal by Subject|1|||
164399639|NCT00522301|593833111|FG000|Overall Study|Adverse Event|5|||
164399640|NCT03040713|593833112|FG000|Overall Study|Positive amyloid scan|3|||
164399641|NCT01699022|593833115|FG000|Overall Study|Early discontinuation from the study|3|||
164399642|NCT03284788|593833116|FG000|Overall Study|Withdrawal by Subject|2|||
164399643|NCT04539821|593833117|FG000|Overall Study|Withdrawal by Subject|2|||
164399644|NCT04539821|593833117|FG000|Overall Study|continued care with their physician|20|||
164399645|NCT04539821|593833117|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
164399646|NCT00605293|593833118|FG000|Overall Study|Death|2|||
164596074|NCT02395653|594546580|FG000|Overall Study|Investigator Decision at Screening|1|||
164596075|NCT02395653|594546580|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
164596076|NCT02395653|594546580|FG000|Overall Study|Withdrawal by Subject|1|||
164596077|NCT02395653|594546580|FG000|Overall Study|Lost to Follow-up|1|||
164596078|NCT02494778|594546581|FG000|Overall Study|Death|3|||
164596079|NCT02494778|594546581|FG000|Overall Study|Other|173|||
164596080|NCT02494778|594546581|FG000|Overall Study|Lack of Efficacy|4|||
164596081|NCT02494778|594546581|FG000|Overall Study|Adverse Event|18|||
164596082|NCT02494778|594546581|FG000|Overall Study|Withdrawal by Subject|20|||
164596083|NCT02494778|594546581|FG000|Overall Study|Lost to Follow-up|2|||
164596084|NCT02494778|594546581|FG000|Overall Study|Noncompliant with study drug admin.|1|||
164596085|NCT03621943|594546582|FG000|First Randomized Intervention|Lost to Follow-up|51|||
164596086|NCT03621943|594546583|FG001|First Randomized Intervention|Lost to Follow-up|54|||
164596087|NCT03621943|594546582|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
164596088|NCT03621943|594546583|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
164596089|NCT03621943|594546582|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
164596090|NCT03621943|594546583|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
164596091|NCT03621943|594546582|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
164596092|NCT03621943|594546583|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
164596093|NCT02174861|594546584|FG000|Overall Study|Decision by sponsor|8|||
164596094|NCT02174861|594546584|FG000|Overall Study|Withdrawal by Subject|124|||
164596095|NCT02174861|594546584|FG000|Overall Study|Lost to Follow-up|26|||
164596096|NCT01215734|594546585|FG000|Overall Study|Death|0|||
164596097|NCT01215734|594546586|FG001|Overall Study|Death|1|||
164596098|NCT00315705|594546587|FG000|Phase 1|Refused further treatment|1|||
164596099|NCT00315705|594546587|FG000|Phase 1|Failure to achieve response|8|||
164596100|NCT00315705|594546587|FG000|Phase 1|Disease relapse|4|||
164596101|NCT00315705|594546587|FG000|Phase 1|Scheduled for transplant|9|||
164596102|NCT00315705|594546587|FG000|Phase 1|Death|3|||
164596103|NCT00315705|594546587|FG000|Phase 2|Physician Decision|4|||
164596104|NCT00315705|594546587|FG000|Phase 2|Adverse Event|1|||
164596105|NCT00315705|594546587|FG000|Phase 2|Failure to achieve response|3|||
164596106|NCT00315705|594546587|FG000|Phase 2|Disease relapse|1|||
164596107|NCT00315705|594546587|FG000|Phase 2|Scheduled for transplant|8|||
164596108|NCT00315705|594546587|FG000|Phase 2|Other|1|||
164596109|NCT00315705|594546587|FG000|Phase 2|Death|7|||
164596110|NCT01346371|594546588|FG000|Overall Study|Lost to Follow-up|2|||
164596111|NCT01346371|594546589|FG001|Overall Study|Lost to Follow-up|0|||
164596112|NCT01716533|594546590|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
164596113|NCT01716533|594546591|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
164596114|NCT01716533|594546592|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
164596115|NCT01716533|594546593|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
164596116|NCT01716533|594546590|FG000|Overall Study|Withdrawal by Subject|0|||
164596117|NCT01716533|594546591|FG001|Overall Study|Withdrawal by Subject|0|||
164596118|NCT01716533|594546592|FG002|Overall Study|Withdrawal by Subject|0|||
164596119|NCT01716533|594546593|FG003|Overall Study|Withdrawal by Subject|5|||
164596120|NCT01716533|594546590|FG000|Overall Study|Death|0|||
164596121|NCT01716533|594546591|FG001|Overall Study|Death|0|||
164596122|NCT01716533|594546592|FG002|Overall Study|Death|0|||
164596123|NCT01716533|594546593|FG003|Overall Study|Death|2|||
164596124|NCT01716533|594546590|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
164596125|NCT01716533|594546591|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
164596126|NCT01716533|594546592|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
164596127|NCT01716533|594546593|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
164596128|NCT02622724|594546603|FG000|Overall Study|Death|51|||
164596129|NCT02622724|594546604|FG001|Overall Study|Death|53|||
164442568|NCT01823536|593988573|FG003|Overall Study|Subject moved out of the state|0|||
164442569|NCT01823536|593988574|FG004|Overall Study|Subject moved out of the state|1|||
164442570|NCT01823536|593988575|FG005|Overall Study|Subject moved out of the state|0|||
164442571|NCT00566735|593988576|FG000|Overall Study|Withdrawal by Subject|0|||
164442572|NCT00566735|593988577|FG001|Overall Study|Withdrawal by Subject|1|||
164442573|NCT00566735|593988576|FG000|Overall Study|Refused neuropsychological testing|2|||
164442574|NCT00566735|593988577|FG001|Overall Study|Refused neuropsychological testing|5|||
164442575|NCT00566735|593988576|FG000|Overall Study|Switched into a manic episode|0|||
164442576|NCT00566735|593988577|FG001|Overall Study|Switched into a manic episode|1|||
164442577|NCT03762668|593988578|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
164442578|NCT03762668|593988579|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
164442579|NCT02731755|593988583|FG000|First Intervention|Withdrawal by Subject|0|||
164442580|NCT02731755|593988584|FG001|First Intervention|Withdrawal by Subject|2|||
164442581|NCT04480827|593988585|FG000|Overall Study|Adverse Event|0|||
164442582|NCT04480827|593988586|FG001|Overall Study|Adverse Event|0|||
164442583|NCT04480827|593988587|FG002|Overall Study|Adverse Event|0|||
164442584|NCT04480827|593988588|FG003|Overall Study|Adverse Event|0|||
164442585|NCT04480827|593988589|FG004|Overall Study|Adverse Event|0|||
164442586|NCT04480827|593988590|FG005|Overall Study|Adverse Event|1|||
164442587|NCT04480827|593988591|FG006|Overall Study|Adverse Event|0|||
164442588|NCT01185561|593988592|FG000|Overall Study|Lost to Follow-up|0|||
164442589|NCT01185561|593988593|FG001|Overall Study|Lost to Follow-up|4|||
164442590|NCT01185561|593988592|FG000|Overall Study|Withdrawal by Subject|2|||
164442591|NCT01185561|593988593|FG001|Overall Study|Withdrawal by Subject|8|||
164596130|NCT02622724|594546603|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
164596131|NCT02622724|594546604|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
164442592|NCT05876949|593988596|FG000|Overall Study|Withdrawal by Subject|1|||
164442593|NCT05876949|593988597|FG001|Overall Study|Withdrawal by Subject|3|||
164442594|NCT05876949|593988596|FG000|Overall Study|Physician Decision|0|||
164442595|NCT05876949|593988597|FG001|Overall Study|Physician Decision|2|||
164442596|NCT05876949|593988596|FG000|Overall Study|Death|0|||
164442597|NCT05876949|593988597|FG001|Overall Study|Death|1|||
164442598|NCT02755805|593988598|FG000|Overall Study|Lost to Follow-up|1|||
164442599|NCT02755805|593988599|FG001|Overall Study|Lost to Follow-up|2|||
164442600|NCT02755805|593988598|FG000|Overall Study|Refused assessments|1|||
164442601|NCT02755805|593988599|FG001|Overall Study|Refused assessments|0|||
164442602|NCT02755805|593988598|FG000|Overall Study|Withdrawal by Subject|0|||
164442603|NCT02755805|593988599|FG001|Overall Study|Withdrawal by Subject|2|||
164442604|NCT00494442|593988604|FG000|Overall Study|Death|1|||
164442605|NCT00494442|593988605|FG001|Overall Study|Death|1|||
164596132|NCT02622724|594546603|FG000|Overall Study|Early termination of study|38|||
164596133|NCT02622724|594546604|FG001|Overall Study|Early termination of study|43|||
164442606|NCT00494442|593988604|FG000|Overall Study|Lack of Efficacy|16|||
164442607|NCT00494442|593988605|FG001|Overall Study|Lack of Efficacy|10|||
164596134|NCT00254293|594546605|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
164596135|NCT00254293|594546606|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
164596136|NCT00254293|594546607|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
164442608|NCT00494442|593988604|FG000|Overall Study|Adverse Event|0|||
164442609|NCT00494442|593988605|FG001|Overall Study|Adverse Event|2|||
164442610|NCT00494442|593988604|FG000|Overall Study|Physician Decision|0|||
164596137|NCT00254293|594546608|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
164596138|NCT00254293|594546609|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
164596139|NCT00254293|594546610|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
164596140|NCT00254293|594546611|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
164442611|NCT00494442|593988605|FG001|Overall Study|Physician Decision|1|||
164442612|NCT00494442|593988604|FG000|Overall Study|Non-compliance|0|||
164442613|NCT00494442|593988605|FG001|Overall Study|Non-compliance|1|||
164442614|NCT00494442|593988604|FG000|Overall Study|Intercurrent illness|0|||
164442615|NCT00494442|593988605|FG001|Overall Study|Intercurrent illness|1|||
164442616|NCT03593213|593988606|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
164442617|NCT03593213|593988607|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
164442618|NCT03593213|593988608|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
164442619|NCT03593213|593988609|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
164442620|NCT03593213|593988606|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
164442621|NCT03593213|593988607|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
164442622|NCT03593213|593988608|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
164442623|NCT03593213|593988609|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
164442624|NCT03593213|593988606|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
164442625|NCT03593213|593988607|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
164442626|NCT03593213|593988608|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
164442627|NCT03593213|593988609|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
164442628|NCT03593213|593988606|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
164442629|NCT03593213|593988607|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
164442630|NCT03593213|593988608|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
164442631|NCT03593213|593988609|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
164442632|NCT03593213|593988606|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
164442633|NCT03593213|593988607|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
164442634|NCT03593213|593988608|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
164442635|NCT03593213|593988609|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
164442636|NCT03593213|593988606|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
164442637|NCT03593213|593988607|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
164442638|NCT03593213|593988608|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
164442639|NCT03593213|593988609|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
164442640|NCT03593213|593988606|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
164442641|NCT03593213|593988607|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
164442642|NCT03593213|593988608|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
164442643|NCT03593213|593988609|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
164442644|NCT03593213|593988606|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
164442645|NCT03593213|593988607|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
164442646|NCT03593213|593988608|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
164442647|NCT03593213|593988609|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
164442648|NCT03593213|593988606|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
164442649|NCT03593213|593988607|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
164442650|NCT03593213|593988608|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
164442651|NCT03593213|593988609|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
164442652|NCT03593213|593988606|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
164442653|NCT03593213|593988607|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
164442654|NCT03593213|593988608|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
164442655|NCT03593213|593988609|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
164442656|NCT03593213|593988606|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
164442657|NCT03593213|593988607|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
164442658|NCT03593213|593988608|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
164442659|NCT03593213|593988609|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
164442660|NCT03593213|593988606|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
164442661|NCT03593213|593988607|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
164442662|NCT03593213|593988608|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
164442663|NCT03593213|593988609|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
164442664|NCT03593213|593988606|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
164442665|NCT03593213|593988607|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
164442666|NCT03593213|593988608|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
164442667|NCT03593213|593988609|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
164442668|NCT03593213|593988606|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
164442669|NCT03593213|593988607|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
164442670|NCT03593213|593988608|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
164442671|NCT03593213|593988609|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
164442672|NCT03593213|593988606|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
164596141|NCT00254293|594546605|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
164596142|NCT00254293|594546606|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
164596143|NCT00254293|594546607|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
164596144|NCT00254293|594546608|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
164596145|NCT00254293|594546609|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
164596146|NCT00254293|594546610|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
164596147|NCT00254293|594546611|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
164705669|NCT04126213|594948750|FG002|Overall Study|Withdrawal by Subject|1|||
164705670|NCT04126213|594948751|FG003|Overall Study|Withdrawal by Subject|1|||
164705671|NCT04126213|594948752|FG004|Overall Study|Withdrawal by Subject|1|||
164705672|NCT04126213|594948753|FG005|Overall Study|Withdrawal by Subject|1|||
164705673|NCT04126213|594948748|FG000|Overall Study|Other|0|||
164705674|NCT04126213|594948749|FG001|Overall Study|Other|0|||
164705675|NCT04126213|594948750|FG002|Overall Study|Other|2|||
164705676|NCT04126213|594948751|FG003|Overall Study|Other|2|||
164705677|NCT04126213|594948752|FG004|Overall Study|Other|0|||
164705678|NCT04126213|594948753|FG005|Overall Study|Other|1|||
164705679|NCT04126213|594948748|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164705680|NCT04126213|594948749|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
164705681|NCT04126213|594948750|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164705682|NCT04126213|594948751|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164705683|NCT04126213|594948752|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164705684|NCT04126213|594948753|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
164705685|NCT02853370|594948755|FG000|Overall Study|Physician Decision|1|||
164705686|NCT02853370|594948755|FG000|Overall Study|Lack of Efficacy|2|||
164705687|NCT02853370|594948755|FG000|Overall Study|Death|1|||
164705688|NCT02853370|594948755|FG000|Overall Study|Adverse Event|4|||
164705689|NCT02853370|594948755|FG000|Overall Study|Withdrawal by Subject|3|||
164705690|NCT00643565|594948757|FG000|Overall Study|Death|12|||
164705691|NCT00643565|594948758|FG001|Overall Study|Death|11|||
164705692|NCT00643565|594948757|FG000|Overall Study|Withdrawal by Subject|4|||
164705693|NCT00643565|594948758|FG001|Overall Study|Withdrawal by Subject|1|||
164705694|NCT00643565|594948757|FG000|Overall Study|Lost to Follow-up|0|||
164705695|NCT00643565|594948758|FG001|Overall Study|Lost to Follow-up|6|||
164705696|NCT00643565|594948757|FG000|Overall Study|Other|7|||
164705697|NCT00643565|594948758|FG001|Overall Study|Other|8|||
164705698|NCT00643565|594948757|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
164705699|NCT00643565|594948758|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
164705700|NCT00643565|594948757|FG000|Overall Study|Recurrence of Disease|2|||
164705701|NCT00643565|594948758|FG001|Overall Study|Recurrence of Disease|1|||
164705702|NCT00643565|594948757|FG000|Overall Study|Progression of Disease|18|||
164705703|NCT00643565|594948758|FG001|Overall Study|Progression of Disease|14|||
164705704|NCT00643565|594948757|FG000|Overall Study|Protocol Violation|3|||
164705705|NCT00643565|594948758|FG001|Overall Study|Protocol Violation|0|||
164705706|NCT00643565|594948757|FG000|Overall Study|Did Not Cooperate|0|||
164705707|NCT00643565|594948758|FG001|Overall Study|Did Not Cooperate|1|||
164705708|NCT00643565|594948757|FG000|Overall Study|Administrative|22|||
164705709|NCT00643565|594948758|FG001|Overall Study|Administrative|16|||
164705710|NCT00643565|594948757|FG000|Overall Study|Adverse Event|5|||
164705711|NCT00643565|594948758|FG001|Overall Study|Adverse Event|8|||
164705712|NCT02317614|594948759|FG000|Overall Study|Lost to Follow-up|1|||
164705713|NCT02317614|594948760|FG001|Overall Study|Lost to Follow-up|1|||
164705714|NCT02317614|594948759|FG000|Overall Study|Withdrawal by Subject|1|||
164705715|NCT02317614|594948760|FG001|Overall Study|Withdrawal by Subject|0|||
164705716|NCT02317614|594948759|FG000|Overall Study|Death|1|||
164705717|NCT02317614|594948760|FG001|Overall Study|Death|1|||
164705718|NCT03285308|594948763|FG000|Overall Study|Adverse Event|3|||
164705719|NCT03285308|594948764|FG001|Overall Study|Adverse Event|7|||
164705720|NCT03285308|594948763|FG000|Overall Study|Withdrawal by Subject|8|||
164705721|NCT03285308|594948764|FG001|Overall Study|Withdrawal by Subject|9|||
164705722|NCT03285308|594948763|FG000|Overall Study|Lost to Follow-up|3|||
164705723|NCT03285308|594948764|FG001|Overall Study|Lost to Follow-up|1|||
164705724|NCT03285308|594948763|FG000|Overall Study|Protocol Deviation|6|||
164705725|NCT03285308|594948764|FG001|Overall Study|Protocol Deviation|5|||
164705726|NCT03285308|594948763|FG000|Overall Study|Reason not Specified|0|||
164705727|NCT03285308|594948764|FG001|Overall Study|Reason not Specified|1|||
164705728|NCT02283983|594948765|FG000|Overall Study|Inclusion criteria not met|0|||
164705729|NCT02283983|594948766|FG001|Overall Study|Inclusion criteria not met|1|||
164705730|NCT02283983|594948765|FG000|Overall Study|Withdrawal by Subject|4|||
164705731|NCT02283983|594948766|FG001|Overall Study|Withdrawal by Subject|2|||
164705732|NCT02283983|594948765|FG000|Overall Study|Protocol Violation|0|||
164705733|NCT02283983|594948766|FG001|Overall Study|Protocol Violation|4|||
164705734|NCT02283983|594948765|FG000|Overall Study|Physician Decision|2|||
164705735|NCT02283983|594948766|FG001|Overall Study|Physician Decision|4|||
164705736|NCT02283983|594948765|FG000|Overall Study|Death|1|||
164705737|NCT02283983|594948766|FG001|Overall Study|Death|0|||
164705738|NCT02283983|594948765|FG000|Overall Study|Adverse Event|1|||
164705739|NCT02283983|594948766|FG001|Overall Study|Adverse Event|0|||
164705740|NCT02283983|594948765|FG000|Overall Study|Lost to Follow-up|9|||
164705741|NCT02283983|594948766|FG001|Overall Study|Lost to Follow-up|8|||
164705742|NCT02283983|594948765|FG000|Overall Study|Relapse|1|||
164705743|NCT02283983|594948766|FG001|Overall Study|Relapse|0|||
164705744|NCT00669071|594948770|FG000|Overall Study|Lost to Follow-up|3|||
164705745|NCT00669071|594948770|FG000|Overall Study|Final visit 40 days out of window|1|||
164705746|NCT04305496|594948771|FG000|Global Cohort|Withdrawal by Subject|13|||
164705747|NCT04305496|594948772|FG001|Global Cohort|Withdrawal by Subject|6|||
164596148|NCT00254293|594546605|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
164596149|NCT00254293|594546606|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
164596150|NCT00254293|594546607|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
164596151|NCT00254293|594546608|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
164596152|NCT00254293|594546609|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
164596153|NCT00254293|594546610|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
164596154|NCT00254293|594546611|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
164596155|NCT00254293|594546605|FG000|LTE Open Label Variable SC Dosing|Death|0|||
164596156|NCT00254293|594546606|FG001|LTE Open Label Variable SC Dosing|Death|0|||
164596157|NCT00254293|594546607|FG002|LTE Open Label Variable SC Dosing|Death|1|||
164596158|NCT00254293|594546608|FG003|LTE Open Label Variable SC Dosing|Death|0|||
164596159|NCT00254293|594546609|FG004|LTE Open Label Variable SC Dosing|Death|0|||
164596160|NCT00254293|594546610|FG005|LTE Open Label Variable SC Dosing|Death|0|||
164596161|NCT00254293|594546611|FG006|LTE Open Label Variable SC Dosing|Death|0|||
164596162|NCT00254293|594546605|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
164596163|NCT00254293|594546606|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
164596164|NCT00254293|594546607|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
164596165|NCT00254293|594546608|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
164596166|NCT00254293|594546609|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
164596167|NCT00254293|594546610|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
164596168|NCT00254293|594546611|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
164596169|NCT00254293|594546605|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
164596170|NCT00254293|594546606|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
164596171|NCT00254293|594546607|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
164596172|NCT00254293|594546608|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
164596173|NCT00254293|594546609|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
164596174|NCT00254293|594546610|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
164596175|NCT00254293|594546611|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
164596176|NCT00254293|594546605|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
164596177|NCT00254293|594546606|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
164596178|NCT00254293|594546607|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
164596179|NCT00254293|594546608|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
164596180|NCT00254293|594546609|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
164596181|NCT00254293|594546610|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
164596182|NCT00254293|594546611|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
164596183|NCT00254293|594546605|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
164596184|NCT00254293|594546606|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
164596185|NCT00254293|594546607|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
164596186|NCT00254293|594546608|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
164596187|NCT00254293|594546609|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
164596188|NCT00254293|594546610|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
164596189|NCT00254293|594546611|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
164596190|NCT00254293|594546605|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
164596191|NCT00254293|594546606|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
164596192|NCT00254293|594546607|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
164596193|NCT00254293|594546608|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
164596194|NCT00254293|594546609|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
164596195|NCT00254293|594546610|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
164596196|NCT00254293|594546611|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
164596197|NCT00254293|594546605|FG000|LTE Open Label Variable SC Dosing|Other|0|||
164596198|NCT00254293|594546606|FG001|LTE Open Label Variable SC Dosing|Other|0|||
164596199|NCT00254293|594546607|FG002|LTE Open Label Variable SC Dosing|Other|2|||
164596200|NCT00254293|594546608|FG003|LTE Open Label Variable SC Dosing|Other|0|||
164596201|NCT00254293|594546609|FG004|LTE Open Label Variable SC Dosing|Other|0|||
164596202|NCT00254293|594546610|FG005|LTE Open Label Variable SC Dosing|Other|0|||
164596203|NCT00254293|594546611|FG006|LTE Open Label Variable SC Dosing|Other|0|||
164596204|NCT00254293|594546605|FG000|LTE Open Label Fixed Dosing|Death|0|||
164596205|NCT00254293|594546606|FG001|LTE Open Label Fixed Dosing|Death|0|||
164596206|NCT00254293|594546607|FG002|LTE Open Label Fixed Dosing|Death|0|||
164596207|NCT00254293|594546608|FG003|LTE Open Label Fixed Dosing|Death|0|||
164596208|NCT00254293|594546609|FG004|LTE Open Label Fixed Dosing|Death|0|||
164596209|NCT00254293|594546610|FG005|LTE Open Label Fixed Dosing|Death|0|||
164596210|NCT00254293|594546611|FG006|LTE Open Label Fixed Dosing|Death|3|||
164596211|NCT00254293|594546605|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
164596212|NCT00254293|594546606|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
164596213|NCT00254293|594546607|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
164596214|NCT00254293|594546608|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
164596215|NCT00254293|594546609|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
164596216|NCT00254293|594546610|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
164442673|NCT03593213|593988607|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
164596217|NCT00254293|594546611|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
164596218|NCT00254293|594546605|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
164596219|NCT00254293|594546606|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
164596220|NCT00254293|594546607|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
164596221|NCT00254293|594546608|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
164596222|NCT00254293|594546609|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
164596223|NCT00254293|594546610|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
164596224|NCT00254293|594546611|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
164596225|NCT00254293|594546605|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
164596226|NCT00254293|594546606|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
164596227|NCT00254293|594546607|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
164596228|NCT00254293|594546608|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
164596229|NCT00254293|594546609|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
164596230|NCT00254293|594546610|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
164596231|NCT00254293|594546611|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
164596232|NCT00254293|594546605|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
164596233|NCT00254293|594546606|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
164596234|NCT00254293|594546607|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
164596235|NCT00254293|594546608|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
164596236|NCT00254293|594546609|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
164596237|NCT00254293|594546610|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
164596238|NCT00254293|594546611|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
164596239|NCT00254293|594546605|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
164596240|NCT00254293|594546606|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
164596241|NCT00254293|594546607|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
164596242|NCT00254293|594546608|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
164596243|NCT00254293|594546609|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
164596244|NCT00254293|594546610|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
164596245|NCT00254293|594546611|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
164596246|NCT00254293|594546605|FG000|LTE Open Label Fixed Dosing|Other|0|||
164596247|NCT00254293|594546606|FG001|LTE Open Label Fixed Dosing|Other|0|||
164596248|NCT00254293|594546607|FG002|LTE Open Label Fixed Dosing|Other|0|||
164596249|NCT00254293|594546608|FG003|LTE Open Label Fixed Dosing|Other|0|||
164596250|NCT00254293|594546609|FG004|LTE Open Label Fixed Dosing|Other|0|||
164596251|NCT00254293|594546610|FG005|LTE Open Label Fixed Dosing|Other|0|||
164596252|NCT00254293|594546611|FG006|LTE Open Label Fixed Dosing|Other|1|||
164596253|NCT01575197|594546612|FG000|Overall Study|Migration out of study area|1|||
164596254|NCT01575197|594546613|FG001|Overall Study|Migration out of study area|5|||
164596255|NCT01575197|594546614|FG002|Overall Study|Migration out of study area|4|||
164596256|NCT01575197|594546612|FG000|Overall Study|SAE|0|||
164596257|NCT01575197|594546613|FG001|Overall Study|SAE|1|||
164596258|NCT01575197|594546614|FG002|Overall Study|SAE|0|||
164596259|NCT01575197|594546612|FG000|Overall Study|Lost to Follow-up|0|||
164596260|NCT01575197|594546613|FG001|Overall Study|Lost to Follow-up|1|||
164596261|NCT01575197|594546614|FG002|Overall Study|Lost to Follow-up|0|||
164596262|NCT01575197|594546612|FG000|Overall Study|Withdrawal by Subject|0|||
164596263|NCT01575197|594546613|FG001|Overall Study|Withdrawal by Subject|1|||
164596264|NCT01575197|594546614|FG002|Overall Study|Withdrawal by Subject|1|||
164596265|NCT01575197|594546612|FG000|Overall Study|Protocol Violation|2|||
164596266|NCT01575197|594546613|FG001|Overall Study|Protocol Violation|1|||
164596267|NCT01575197|594546614|FG002|Overall Study|Protocol Violation|1|||
164596268|NCT03196193|594546615|FG000|Overall Study|Adverse Event|1|||
164596269|NCT03196193|594546616|FG001|Overall Study|Adverse Event|0|||
164596270|NCT03196193|594546615|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
164596271|NCT03196193|594546616|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
164596272|NCT03446651|594546619|FG000|Overall Study|Lost to Follow-up|4|||
164596273|NCT03446651|594546620|FG001|Overall Study|Lost to Follow-up|0|||
164596274|NCT03446651|594546619|FG000|Overall Study|Open Label Participants|5|||
164596275|NCT03446651|594546620|FG001|Overall Study|Open Label Participants|0|||
164596276|NCT00343291|594546621|FG000|Overall Study|Adverse Event|13|||
164596277|NCT00343291|594546622|FG001|Overall Study|Adverse Event|13|||
164596278|NCT00343291|594546621|FG000|Overall Study|Death|3|||
164596279|NCT00343291|594546622|FG001|Overall Study|Death|2|||
164596280|NCT00343291|594546621|FG000|Overall Study|Progressive disease|33|||
164596281|NCT00343291|594546622|FG001|Overall Study|Progressive disease|34|||
164596282|NCT00343291|594546621|FG000|Overall Study|Withdrawal by Subject|0|||
164596283|NCT00343291|594546622|FG001|Overall Study|Withdrawal by Subject|2|||
164596284|NCT00343291|594546621|FG000|Overall Study|Other|8|||
164596285|NCT00343291|594546622|FG001|Overall Study|Other|5|||
164596286|NCT02338492|594546623|FG000|Overall Study|Death|32|||
164596287|NCT02338492|594546623|FG000|Overall Study|Adverse Event|3|||
164596288|NCT02338492|594546623|FG000|Overall Study|Lost to Follow-up|4|||
164596289|NCT02338492|594546623|FG000|Overall Study|Reason not captured above|6|||
164596290|NCT01332019|594546624|FG000|Overall Study|Was Not Dosed|1|||
164596291|NCT01332019|594546625|FG001|Overall Study|Was Not Dosed|0|||
164596292|NCT01332019|594546624|FG000|Overall Study|Other|16|||
164144037|NCT00086281|592888576|FG005|Phase 2|Adverse Event|0|||
164596293|NCT01332019|594546625|FG001|Overall Study|Other|18|||
164596294|NCT01332019|594546624|FG000|Overall Study|Death|2|||
164596295|NCT01332019|594546625|FG001|Overall Study|Death|1|||
164596296|NCT01332019|594546624|FG000|Overall Study|Physician Decision|4|||
164596297|NCT01332019|594546625|FG001|Overall Study|Physician Decision|3|||
164596298|NCT01332019|594546624|FG000|Overall Study|Withdrawal by Subject|73|||
164596299|NCT01332019|594546625|FG001|Overall Study|Withdrawal by Subject|71|||
164596300|NCT01332019|594546624|FG000|Overall Study|Lost to Follow-up|4|||
164596301|NCT01332019|594546625|FG001|Overall Study|Lost to Follow-up|7|||
164596302|NCT01332019|594546624|FG000|Overall Study|Adverse Event|13|||
164596303|NCT01332019|594546625|FG001|Overall Study|Adverse Event|22|||
164596304|NCT04281030|594546626|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
164596305|NCT04281030|594546627|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
164596306|NCT04281030|594546626|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
164705748|NCT04305496|594948771|FG000|Global Cohort|Physician Decision|1|||
164705749|NCT04305496|594948772|FG001|Global Cohort|Physician Decision|1|||
164705750|NCT04305496|594948771|FG000|Global Cohort|Subjective disease progression|16|||
164596307|NCT04281030|594546627|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
164596308|NCT00310388|594546628|FG000|Primary Reporting Phase|Adverse Event|101|||
164596309|NCT00310388|594546629|FG001|Primary Reporting Phase|Adverse Event|0|||
164596310|NCT00310388|594546628|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
164596311|NCT00310388|594546629|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
164596312|NCT00310388|594546628|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
164596313|NCT00310388|594546629|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
164596314|NCT00310388|594546628|FG000|Primary Reporting Phase|Protocol Violation|10|||
164596315|NCT00310388|594546629|FG001|Primary Reporting Phase|Protocol Violation|0|||
164596316|NCT00310388|594546628|FG000|Primary Reporting Phase|Pregnancy|3|||
164596317|NCT00310388|594546629|FG001|Primary Reporting Phase|Pregnancy|0|||
164596318|NCT00310388|594546628|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
164596319|NCT00310388|594546629|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
164596320|NCT00310388|594546628|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
164596321|NCT00310388|594546629|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
164596322|NCT00310388|594546628|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
164596323|NCT00310388|594546629|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
164596324|NCT00310388|594546628|FG000|Primary Reporting Phase|Physician Decision|2|||
164596325|NCT00310388|594546629|FG001|Primary Reporting Phase|Physician Decision|0|||
164596326|NCT00310388|594546628|FG000|Primary Reporting Phase|Request of the sponsor|19|||
164596327|NCT00310388|594546629|FG001|Primary Reporting Phase|Request of the sponsor|0|||
164596328|NCT00310388|594546628|FG000|Primary Reporting Phase|Failed to return|8|||
164596329|NCT00310388|594546629|FG001|Primary Reporting Phase|Failed to return|0|||
164596330|NCT00310388|594546628|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
164596331|NCT00310388|594546629|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
164596332|NCT00310388|594546628|FG000|Primary Reporting Phase|Participant request|2|||
164596333|NCT00310388|594546629|FG001|Primary Reporting Phase|Participant request|0|||
164596334|NCT00310388|594546628|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
164596335|NCT00310388|594546629|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
164596336|NCT00310388|594546628|FG000|Primary Reporting Phase|Discontinuation of study|1|||
164596337|NCT00310388|594546629|FG001|Primary Reporting Phase|Discontinuation of study|0|||
164596338|NCT00310388|594546628|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
164596339|NCT00310388|594546629|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
164596340|NCT00310388|594546628|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
164596341|NCT00310388|594546629|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
164596342|NCT00310388|594546628|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
164596343|NCT00310388|594546629|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
164596344|NCT00310388|594546628|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
164596345|NCT00310388|594546629|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
164596346|NCT00310388|594546628|FG000|Primary Reporting Phase|Participant passed away|1|||
164596347|NCT00310388|594546629|FG001|Primary Reporting Phase|Participant passed away|0|||
164596348|NCT00310388|594546628|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
164596349|NCT00310388|594546629|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
164596350|NCT00310388|594546628|FG000|Primary Reporting Phase|Missing|1|||
164596351|NCT00310388|594546629|FG001|Primary Reporting Phase|Missing|0|||
164596352|NCT00310388|594546628|FG000|Primary Reporting Phase|Other|1|||
164596353|NCT00310388|594546629|FG001|Primary Reporting Phase|Other|0|||
164596354|NCT00310388|594546628|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
164596355|NCT00310388|594546629|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
164596356|NCT00310388|594546628|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
164596357|NCT00310388|594546629|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
164596358|NCT00310388|594546628|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
164596359|NCT00310388|594546629|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
164596360|NCT00310388|594546628|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
164596361|NCT00310388|594546629|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
164596362|NCT01757405|594546632|FG000|Overall Study|Lost to Follow-up|1|||
164596363|NCT01757405|594546633|FG001|Overall Study|Lost to Follow-up|1|||
164596364|NCT01757405|594546632|FG000|Overall Study|Withdrawal by Subject|0|||
164596365|NCT01757405|594546633|FG001|Overall Study|Withdrawal by Subject|1|||
164705751|NCT04305496|594948772|FG001|Global Cohort|Subjective disease progression|17|||
164705752|NCT04305496|594948771|FG000|Global Cohort|Condition under investigation worsened|209|||
164705753|NCT04305496|594948772|FG001|Global Cohort|Condition under investigation worsened|273|||
164705754|NCT04305496|594948771|FG000|Global Cohort|Protocol Violation|2|||
164705755|NCT04305496|594948772|FG001|Global Cohort|Protocol Violation|0|||
164705756|NCT04305496|594948771|FG000|Global Cohort|Adverse Event|44|||
164705757|NCT04305496|594948772|FG001|Global Cohort|Adverse Event|6|||
164705758|NCT04305496|594948771|FG000|Global Cohort|Death|3|||
164705759|NCT04305496|594948772|FG001|Global Cohort|Death|2|||
164705760|NCT04305496|594948771|FG000|Global Cohort|Any reason not specifically recorded|4|||
164705761|NCT04305496|594948772|FG001|Global Cohort|Any reason not specifically recorded|5|||
164705762|NCT04305496|594948771|FG000|China Cohort|Any reason not specifically recorded|1|||
164705763|NCT04305496|594948772|FG001|China Cohort|Any reason not specifically recorded|1|||
164705764|NCT04305496|594948771|FG000|China Cohort|Adverse Event|8|||
164705765|NCT04305496|594948772|FG001|China Cohort|Adverse Event|2|||
164705766|NCT04305496|594948771|FG000|China Cohort|Condition under investigation worsened|40|||
164705767|NCT04305496|594948772|FG001|China Cohort|Condition under investigation worsened|47|||
164705768|NCT04305496|594948771|FG000|China Cohort|Subjective disease progression|2|||
164705769|NCT04305496|594948772|FG001|China Cohort|Subjective disease progression|2|||
164705770|NCT04305496|594948771|FG000|China Cohort|Withdrawal by Subject|2|||
164705771|NCT04305496|594948772|FG001|China Cohort|Withdrawal by Subject|1|||
164705772|NCT01910389|594948774|FG000|Overall Study|Withdrawal by Subject|2|||
164705773|NCT01910389|594948775|FG001|Overall Study|Withdrawal by Subject|0|||
164705774|NCT01910389|594948774|FG000|Overall Study|Study Closed|13|||
164705775|NCT01910389|594948775|FG001|Overall Study|Study Closed|8|||
164705776|NCT02912650|594948776|FG000|Overall Study|Withdrawal by Subject|1|||
164705777|NCT02912650|594948777|FG001|Overall Study|Withdrawal by Subject|0|||
164705778|NCT02912650|594948778|FG002|Overall Study|Withdrawal by Subject|1|||
164705779|NCT02912650|594948779|FG003|Overall Study|Withdrawal by Subject|5|||
164705780|NCT02912650|594948776|FG000|Overall Study|Adverse Event|0|||
164705781|NCT02912650|594948777|FG001|Overall Study|Adverse Event|0|||
164705782|NCT02912650|594948778|FG002|Overall Study|Adverse Event|1|||
164705783|NCT02912650|594948779|FG003|Overall Study|Adverse Event|0|||
164705784|NCT01898650|594948780|FG000|Overall Study|the subject would not lie still for imaging|1|||
164705785|NCT05896202|594948784|FG000|Overall Study|Lost to Follow-up|2|||
164705786|NCT05896202|594948785|FG001|Overall Study|Lost to Follow-up|2|||
164705787|NCT02357342|594948788|FG000|First 6 Months|Death|2|||
164705788|NCT02357342|594948789|FG001|First 6 Months|Death|0|||
164705789|NCT01674647|594948790|FG000|Treatment Period|Death|4|||
164705790|NCT01674647|594948791|FG001|Treatment Period|Death|1|||
164705791|NCT01674647|594948790|FG000|Treatment Period|Efficacy outcome reached|0|||
164705792|NCT01674647|594948791|FG001|Treatment Period|Efficacy outcome reached|1|||
164705793|NCT01674647|594948790|FG000|Treatment Period|Physician Decision|3|||
164705794|NCT01674647|594948791|FG001|Treatment Period|Physician Decision|1|||
164705795|NCT01674647|594948790|FG000|Treatment Period|Adverse Event|60|||
164705796|NCT01674647|594948791|FG001|Treatment Period|Adverse Event|22|||
164705797|NCT01674647|594948790|FG000|Treatment Period|Non-compliance with study drug|3|||
164705798|NCT01674647|594948791|FG001|Treatment Period|Non-compliance with study drug|0|||
164705799|NCT01674647|594948790|FG000|Treatment Period|Lost to Follow-up|1|||
164705800|NCT01674647|594948791|FG001|Treatment Period|Lost to Follow-up|1|||
164705801|NCT01674647|594948790|FG000|Treatment Period|Withdrawal by Subject|19|||
164705802|NCT01674647|594948791|FG001|Treatment Period|Withdrawal by Subject|16|||
164705803|NCT01674647|594948790|FG000|Treatment Period|Switching to other therapy|5|||
164705804|NCT01674647|594948791|FG001|Treatment Period|Switching to other therapy|2|||
164705805|NCT01674647|594948790|FG000|Treatment Period|Logistical difficulties|5|||
164705806|NCT01674647|594948791|FG001|Treatment Period|Logistical difficulties|8|||
164705807|NCT01674647|594948790|FG000|Treatment Period|Treatment failure|0|||
164705808|NCT01674647|594948791|FG001|Treatment Period|Treatment failure|14|||
164705809|NCT01674647|594948790|FG000|Treatment Period|Protocol Violation|56|||
164705810|NCT01674647|594948791|FG001|Treatment Period|Protocol Violation|36|||
164705811|NCT01674647|594948790|FG000|30-day Safety Follow-up Period|Death|3|||
164705812|NCT01674647|594948791|FG001|30-day Safety Follow-up Period|Death|2|||
164705813|NCT01674647|594948790|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
164705814|NCT01674647|594948791|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
164705815|NCT01674647|594948790|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
164705816|NCT01674647|594948791|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
164705817|NCT01674647|594948790|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
164705818|NCT01674647|594948791|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
164705819|NCT01674647|594948790|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
164705820|NCT01674647|594948791|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
164705821|NCT01674647|594948790|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
164705822|NCT01674647|594948791|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
164705823|NCT01490866|594948794|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
164705824|NCT01490866|594948794|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
164705825|NCT01490866|594948794|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
164442674|NCT03593213|593988608|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
164442675|NCT03593213|593988609|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
164442676|NCT03593213|593988606|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
164442677|NCT03593213|593988607|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
164596366|NCT00238303|594546634|FG000|Overall Study|Withdrawal by Subject|11|||
164596367|NCT00238303|594546635|FG001|Overall Study|Withdrawal by Subject|1|||
164442678|NCT03593213|593988608|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
164705826|NCT01490866|594948794|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
164705827|NCT01490866|594948794|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
164705828|NCT01490866|594948794|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
164705829|NCT01490866|594948794|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
164705830|NCT01490866|594948794|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
164705831|NCT01490866|594948794|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
164705832|NCT01490866|594948794|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
164705833|NCT01490866|594948794|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
164705834|NCT03923530|594948795|FG000|Overall Study|Withdrawal by Subject|1|||
164705835|NCT03923530|594948795|FG000|Overall Study|screen failure|3|||
164705836|NCT00741936|594948796|FG000|Overall Study|Lost to Follow-up|1|||
164705837|NCT00741936|594948797|FG001|Overall Study|Lost to Follow-up|1|||
164705838|NCT00741936|594948796|FG000|Overall Study|Adverse Event|3|||
164705839|NCT00741936|594948797|FG001|Overall Study|Adverse Event|4|||
164705840|NCT00741936|594948796|FG000|Overall Study|Pregnancy|0|||
164705841|NCT00741936|594948797|FG001|Overall Study|Pregnancy|1|||
164705842|NCT00741936|594948796|FG000|Overall Study|Protocol Violation|2|||
164705843|NCT00741936|594948797|FG001|Overall Study|Protocol Violation|0|||
164705844|NCT00741936|594948796|FG000|Overall Study|Lack of Efficacy|0|||
164705845|NCT00741936|594948797|FG001|Overall Study|Lack of Efficacy|2|||
164705846|NCT00741936|594948796|FG000|Overall Study|Low compliance|3|||
164705847|NCT00741936|594948797|FG001|Overall Study|Low compliance|0|||
164705848|NCT03456960|594948798|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
164705849|NCT03456960|594948799|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
164705850|NCT03456960|594948800|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
164705851|NCT03456960|594948801|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
164705852|NCT03456960|594948802|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
164705853|NCT03456960|594948803|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
164705854|NCT03456960|594948798|FG000|Period 2 (1 Day)|Adverse Event|1|||
164705855|NCT03456960|594948799|FG001|Period 2 (1 Day)|Adverse Event|0|||
164705856|NCT03456960|594948800|FG002|Period 2 (1 Day)|Adverse Event|0|||
164705857|NCT03456960|594948801|FG003|Period 2 (1 Day)|Adverse Event|1|||
164705858|NCT03456960|594948802|FG004|Period 2 (1 Day)|Adverse Event|0|||
164705859|NCT03456960|594948803|FG005|Period 2 (1 Day)|Adverse Event|0|||
164705860|NCT01941940|594948804|FG000|Overall Study|Adverse Event|11|||
164705861|NCT01941940|594948804|FG000|Overall Study|Lost to Follow-up|2|||
164705862|NCT01941940|594948804|FG000|Overall Study|Physician Decision|2|||
164705863|NCT01941940|594948804|FG000|Overall Study|Withdrawal by Subject|15|||
164705864|NCT01941940|594948804|FG000|Overall Study|Death|1|||
164705865|NCT01941940|594948804|FG000|Overall Study|Other|1|||
164705866|NCT01941940|594948804|FG000|Overall Study|Other|1|||
164705867|NCT00532935|594948805|FG000|Overall Study|Adverse Event|11|||
164705868|NCT00532935|594948806|FG001|Overall Study|Adverse Event|12|||
164705869|NCT00532935|594948805|FG000|Overall Study|Lack of Efficacy|0|||
164705870|NCT00532935|594948806|FG001|Overall Study|Lack of Efficacy|3|||
164705871|NCT00532935|594948805|FG000|Overall Study|Lost to Follow-up|10|||
164705872|NCT00532935|594948806|FG001|Overall Study|Lost to Follow-up|6|||
164705873|NCT00532935|594948805|FG000|Overall Study|Physician Decision|4|||
164705874|NCT00532935|594948806|FG001|Overall Study|Physician Decision|5|||
164705875|NCT00532935|594948805|FG000|Overall Study|Pregnancy|1|||
164705876|NCT00532935|594948806|FG001|Overall Study|Pregnancy|0|||
164705877|NCT00532935|594948805|FG000|Overall Study|Protocol Violation|4|||
164705878|NCT00532935|594948806|FG001|Overall Study|Protocol Violation|2|||
164705879|NCT00532935|594948805|FG000|Overall Study|Withdrawal by Subject|10|||
164705880|NCT00532935|594948806|FG001|Overall Study|Withdrawal by Subject|9|||
164705881|NCT00532935|594948805|FG000|Overall Study|Protocol Specific Criteria|11|||
164705882|NCT00532935|594948806|FG001|Overall Study|Protocol Specific Criteria|15|||
164705883|NCT00502801|594948807|FG000|Treatment Period|Withdrawal by Subject|3|||
164705884|NCT00502801|594948807|FG000|Treatment Period|Adverse Event|7|||
164705885|NCT00502801|594948807|FG000|Treatment Period|Death|14|||
164705886|NCT00502801|594948807|FG000|Treatment Period|OTHER|30|||
164705887|NCT00502801|594948807|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
164705888|NCT00502801|594948807|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
164705889|NCT00502801|594948807|FG000|End of Therapy to Test of Cure|Death|3|||
164705890|NCT00502801|594948807|FG000|End of Therapy to Test of Cure|OTHER|2|||
164705891|NCT04135196|594948808|FG000|Overall Study|Lost to Follow-up|8|||
164705892|NCT04135196|594948809|FG001|Overall Study|Lost to Follow-up|7|||
164705893|NCT04135196|594948810|FG002|Overall Study|Lost to Follow-up|8|||
164705894|NCT04135196|594948811|FG003|Overall Study|Lost to Follow-up|9|||
164705895|NCT04135196|594948812|FG004|Overall Study|Lost to Follow-up|1|||
164705896|NCT04135196|594948808|FG000|Overall Study|Pregnancy|0|||
164705897|NCT04135196|594948809|FG001|Overall Study|Pregnancy|0|||
164705898|NCT04135196|594948810|FG002|Overall Study|Pregnancy|1|||
164705899|NCT04135196|594948811|FG003|Overall Study|Pregnancy|0|||
164705900|NCT04135196|594948812|FG004|Overall Study|Pregnancy|0|||
164705901|NCT04135196|594948808|FG000|Overall Study|Withdrawal by Subject|0|||
164705902|NCT04135196|594948809|FG001|Overall Study|Withdrawal by Subject|0|||
164705903|NCT04135196|594948810|FG002|Overall Study|Withdrawal by Subject|0|||
164442679|NCT03593213|593988609|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
164442680|NCT03593213|593988606|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
164442681|NCT03593213|593988607|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
164596368|NCT00238303|594546636|FG002|Overall Study|Withdrawal by Subject|2|||
164596369|NCT00238303|594546634|FG000|Overall Study|Death|1|||
164596370|NCT00238303|594546635|FG001|Overall Study|Death|0|||
164442682|NCT03593213|593988608|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
164442683|NCT03593213|593988609|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
164442684|NCT03593213|593988606|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
164442685|NCT03593213|593988607|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
164442686|NCT03593213|593988608|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
164442687|NCT03593213|593988609|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
164442688|NCT03593213|593988606|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
164442689|NCT03593213|593988607|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
164596371|NCT00238303|594546636|FG002|Overall Study|Death|1|||
164596372|NCT00238303|594546634|FG000|Overall Study|Other Medical Problems|2|||
164596373|NCT00238303|594546635|FG001|Overall Study|Other Medical Problems|0|||
164596374|NCT00238303|594546636|FG002|Overall Study|Other Medical Problems|2|||
164596375|NCT00238303|594546634|FG000|Overall Study|Poor tolerance of study treatment|1|||
164596376|NCT00238303|594546635|FG001|Overall Study|Poor tolerance of study treatment|0|||
164596377|NCT00238303|594546636|FG002|Overall Study|Poor tolerance of study treatment|1|||
164596378|NCT00238303|594546634|FG000|Overall Study|Adverse Event|0|||
164705904|NCT04135196|594948811|FG003|Overall Study|Withdrawal by Subject|0|||
164705905|NCT04135196|594948812|FG004|Overall Study|Withdrawal by Subject|1|||
164705906|NCT03212521|594948815|FG000|Overall Study|Adverse Event|1|||
164705907|NCT03212521|594948815|FG000|Overall Study|Lost to Follow-up|4|||
164705908|NCT03212521|594948815|FG000|Overall Study|Withdrawal by Subject|1|||
164705909|NCT03212521|594948815|FG000|Overall Study|Other|1|||
164705910|NCT00914459|594948816|FG000|Overall Study|Protocol Violation|0|||
164705911|NCT00914459|594948817|FG001|Overall Study|Protocol Violation|1|||
164705912|NCT00914459|594948816|FG000|Overall Study|Parent/Legal guardian request|1|||
164705913|NCT00914459|594948817|FG001|Overall Study|Parent/Legal guardian request|0|||
164705914|NCT03176459|594948818|FG000|Overall Study|Lost to Follow-up|5|||
164705915|NCT03176459|594948819|FG001|Overall Study|Lost to Follow-up|7|||
164705916|NCT01083810|594948820|FG000|Overall Study|Lost to Follow-up|23|||
164705917|NCT01083810|594948821|FG001|Overall Study|Lost to Follow-up|11|||
164596379|NCT00238303|594546635|FG001|Overall Study|Adverse Event|1|||
164596380|NCT00238303|594546636|FG002|Overall Study|Adverse Event|3|||
164596381|NCT05906732|594546638|FG000|Overall Study|Withdrawal by Subject|1|||
164596382|NCT05906732|594546639|FG001|Overall Study|Withdrawal by Subject|0|||
164596383|NCT05906732|594546640|FG002|Overall Study|Withdrawal by Subject|0|||
164705918|NCT01083810|594948822|FG002|Overall Study|Lost to Follow-up|4|||
164399647|NCT00605293|593833119|FG001|Overall Study|Death|1|||
164399648|NCT00605293|593833118|FG000|Overall Study|Insufficient Therapeutic Response|2|||
164399649|NCT00605293|593833119|FG001|Overall Study|Insufficient Therapeutic Response|0|||
164399650|NCT00605293|593833118|FG000|Overall Study|Adverse Event|1|||
164399651|NCT00605293|593833119|FG001|Overall Study|Adverse Event|0|||
164399652|NCT00605293|593833118|FG000|Overall Study|Holidays Dialysis Out|1|||
164399653|NCT00605293|593833119|FG001|Overall Study|Holidays Dialysis Out|0|||
164399654|NCT00605293|593833118|FG000|Overall Study|Blood Transfusion|7|||
164399655|NCT00605293|593833119|FG001|Overall Study|Blood Transfusion|1|||
164399656|NCT00605293|593833118|FG000|Overall Study|Renal Transplantation|3|||
164399657|NCT00605293|593833119|FG001|Overall Study|Renal Transplantation|1|||
164399658|NCT00605293|593833118|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
164399659|NCT00605293|593833119|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
164399660|NCT00605293|593833118|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
164399661|NCT00605293|593833119|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
164399662|NCT00605293|593833118|FG000|Overall Study|Principal Investigator Decision|0|||
164399663|NCT00605293|593833119|FG001|Overall Study|Principal Investigator Decision|1|||
164399664|NCT03581981|593833120|FG000|Overall Study|Withdrawal by Subject|12|||
164399665|NCT03581981|593833121|FG001|Overall Study|Withdrawal by Subject|13|||
164399666|NCT03581981|593833120|FG000|Overall Study|Physician Decision|1|||
164399667|NCT03581981|593833121|FG001|Overall Study|Physician Decision|2|||
164399668|NCT03581981|593833120|FG000|Overall Study|Lost to Follow-up|0|||
164399669|NCT03581981|593833121|FG001|Overall Study|Lost to Follow-up|4|||
164399670|NCT00781391|593833122|FG000|Overall Study|never received study drug|24|||
164399671|NCT00781391|593833123|FG001|Overall Study|never received study drug|23|||
164399672|NCT00781391|593833124|FG002|Overall Study|never received study drug|32|||
164399673|NCT00781391|593833122|FG000|Overall Study|Protocol Violation|19|||
164399674|NCT00781391|593833123|FG001|Overall Study|Protocol Violation|17|||
164399675|NCT00781391|593833124|FG002|Overall Study|Protocol Violation|20|||
164399676|NCT00781391|593833122|FG000|Overall Study|Death|789|||
164399677|NCT00781391|593833123|FG001|Overall Study|Death|730|||
164399678|NCT00781391|593833124|FG002|Overall Study|Death|706|||
164399679|NCT00781391|593833122|FG000|Overall Study|Withdrawal by Subject|47|||
164399680|NCT00781391|593833123|FG001|Overall Study|Withdrawal by Subject|37|||
164399681|NCT00781391|593833124|FG002|Overall Study|Withdrawal by Subject|25|||
164399682|NCT00781391|593833122|FG000|Overall Study|Lost to Follow-up|0|||
164399683|NCT00781391|593833123|FG001|Overall Study|Lost to Follow-up|0|||
164399684|NCT00781391|593833124|FG002|Overall Study|Lost to Follow-up|1|||
164399685|NCT01984684|593833125|FG000|Overall Study|Lost to Follow-up|25|||
164399686|NCT01984684|593833126|FG001|Overall Study|Lost to Follow-up|24|||
164399687|NCT01984684|593833125|FG000|Overall Study|Adverse Event|8|||
164399688|NCT01984684|593833126|FG001|Overall Study|Adverse Event|12|||
164399689|NCT01984684|593833125|FG000|Overall Study|Withdrawal by Subject|9|||
164399690|NCT01984684|593833126|FG001|Overall Study|Withdrawal by Subject|9|||
164399691|NCT01984684|593833125|FG000|Overall Study|Lack of Efficacy|3|||
164399692|NCT01984684|593833126|FG001|Overall Study|Lack of Efficacy|6|||
164399693|NCT01984684|593833125|FG000|Overall Study|Physician Decision|4|||
164399694|NCT01984684|593833126|FG001|Overall Study|Physician Decision|2|||
164399695|NCT01984684|593833125|FG000|Overall Study|Protocol Violation|4|||
164399696|NCT01984684|593833126|FG001|Overall Study|Protocol Violation|2|||
164399697|NCT01984684|593833125|FG000|Overall Study|Death|0|||
164399698|NCT01984684|593833126|FG001|Overall Study|Death|1|||
164399699|NCT01984684|593833125|FG000|Overall Study|Noncompliance with study drug|2|||
164399700|NCT01984684|593833126|FG001|Overall Study|Noncompliance with study drug|1|||
164399701|NCT01984684|593833125|FG000|Overall Study|Subject incarcerated|1|||
164399702|NCT01984684|593833126|FG001|Overall Study|Subject incarcerated|0|||
164399703|NCT01984684|593833125|FG000|Overall Study|Study drug not available at site|1|||
164399704|NCT01984684|593833126|FG001|Overall Study|Study drug not available at site|1|||
164399705|NCT01984684|593833125|FG000|Overall Study|Subject had inadequate IV access|0|||
164399706|NCT01984684|593833126|FG001|Overall Study|Subject had inadequate IV access|1|||
164399707|NCT01077544|593833134|FG000|Overall Study|New Cancer Therapy|3|||
164399708|NCT01077544|593833135|FG001|Overall Study|New Cancer Therapy|3|||
164705919|NCT01083810|594948820|FG000|Overall Study|Adverse Event|15|||
164399709|NCT01077544|593833134|FG000|Overall Study|Adverse Event|0|||
164399710|NCT01077544|593833135|FG001|Overall Study|Adverse Event|1|||
164399711|NCT01077544|593833134|FG000|Overall Study|Disease Progression|0|||
164399712|NCT01077544|593833135|FG001|Overall Study|Disease Progression|1|||
164399713|NCT00689221|593833136|FG000|Overall Study|Ongoing at cut-off date|39|||
164399714|NCT00689221|593833137|FG001|Overall Study|Ongoing at cut-off date|36|||
164399715|NCT03182868|593833138|FG000|Overall Study|Protocol Violation|3|||
164399716|NCT03182868|593833139|FG001|Overall Study|Protocol Violation|0|||
164399717|NCT03182868|593833140|FG002|Overall Study|Protocol Violation|4|||
164399718|NCT03182868|593833141|FG003|Overall Study|Protocol Violation|1|||
164399719|NCT03182868|593833142|FG004|Overall Study|Protocol Violation|8|||
164399720|NCT01292239|593833143|FG000|Overall Study|Other|1|||
164399721|NCT01292239|593833144|FG001|Overall Study|Other|1|||
164399722|NCT01292239|593833143|FG000|Overall Study|Withdrawal by Subject|3|||
164399723|NCT01292239|593833144|FG001|Overall Study|Withdrawal by Subject|6|||
164399724|NCT00262821|593833145|FG000|Overall Study|Ineligible - wrong stage|0|||
164399725|NCT00262821|593833146|FG001|Overall Study|Ineligible - wrong stage|3|||
164399726|NCT00262821|593833145|FG000|Overall Study|Ineligible - wrong cell type|2|||
164399727|NCT00262821|593833146|FG001|Overall Study|Ineligible - wrong cell type|2|||
164399728|NCT00262821|593833145|FG000|Overall Study|Ineligible - wrong primary|0|||
164399729|NCT00262821|593833146|FG001|Overall Study|Ineligible - wrong primary|1|||
164399730|NCT00262821|593833145|FG000|Overall Study|Ineligible - inadequate pathology|1|||
164399731|NCT00262821|593833146|FG001|Overall Study|Ineligible - inadequate pathology|3|||
164399732|NCT00262821|593833145|FG000|Overall Study|Ineligible - elevated creatinine|0|||
164399733|NCT00262821|593833146|FG001|Overall Study|Ineligible - elevated creatinine|2|||
164399734|NCT00262821|593833145|FG000|Overall Study|Ineligible - required test not done|1|||
164399735|NCT00262821|593833146|FG001|Overall Study|Ineligible - required test not done|4|||
164399736|NCT00262821|593833145|FG000|Overall Study|Inevaluable - inadequate data|0|||
164399737|NCT00262821|593833146|FG001|Overall Study|Inevaluable - inadequate data|4|||
164399738|NCT03923933|593833147|FG000|Overall Study|Lost to Follow-up|1|||
164399739|NCT03923933|593833148|FG001|Overall Study|Lost to Follow-up|0|||
164399740|NCT03923933|593833147|FG000|Overall Study|Withdrawal by Subject|0|||
164399741|NCT03923933|593833148|FG001|Overall Study|Withdrawal by Subject|1|||
164399742|NCT01995461|593833149|FG000|Overall Study|Death|1|||
164399743|NCT01995461|593833149|FG000|Overall Study|Lost to Follow-up|2|||
164399744|NCT01995461|593833149|FG000|Overall Study|Withdrawal by Subject|2|||
164399745|NCT01777854|593833150|FG000|Overall Study|Physician Decision|3|||
164399746|NCT01777854|593833151|FG001|Overall Study|Physician Decision|3|||
164399747|NCT03311373|593833152|FG000|Overall Study|Adverse Event|1|||
164399748|NCT03311373|593833152|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
164399749|NCT03311373|593833152|FG000|Overall Study|Lost to Follow-up|1|||
164399750|NCT03311373|593833152|FG000|Overall Study|Physician Decision|1|||
164399751|NCT03311373|593833152|FG000|Overall Study|Withdrawal by Subject|3|||
164399752|NCT00295022|593833153|FG000|Overall Study|Adverse Event|1|||
164399753|NCT00295022|593833154|FG001|Overall Study|Adverse Event|1|||
164399754|NCT00295022|593833155|FG002|Overall Study|Adverse Event|2|||
164399755|NCT00295022|593833153|FG000|Overall Study|Lost to Follow-up|0|||
164399756|NCT00295022|593833154|FG001|Overall Study|Lost to Follow-up|0|||
164399757|NCT00295022|593833155|FG002|Overall Study|Lost to Follow-up|1|||
164399758|NCT00295022|593833153|FG000|Overall Study|Withdrawal by Subject|0|||
164399759|NCT00295022|593833154|FG001|Overall Study|Withdrawal by Subject|0|||
164399760|NCT00295022|593833155|FG002|Overall Study|Withdrawal by Subject|2|||
164399761|NCT00734630|593833157|FG000|Overall Study|Lack of Efficacy|4|||
164399762|NCT00734630|593833158|FG001|Overall Study|Lack of Efficacy|4|||
164399763|NCT00734630|593833157|FG000|Overall Study|Withdrawal by Subject|7|||
164399764|NCT00734630|593833158|FG001|Overall Study|Withdrawal by Subject|9|||
164399765|NCT00734630|593833157|FG000|Overall Study|Lost to Follow-up|13|||
164399766|NCT00734630|593833158|FG001|Overall Study|Lost to Follow-up|7|||
164399767|NCT00734630|593833157|FG000|Overall Study|Protocol Violation|0|||
164399768|NCT00734630|593833158|FG001|Overall Study|Protocol Violation|3|||
164399769|NCT00734630|593833157|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
164399770|NCT00734630|593833158|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
164399771|NCT00734630|593833157|FG000|Overall Study|Adverse Event|3|||
164399772|NCT00734630|593833158|FG001|Overall Study|Adverse Event|6|||
164399773|NCT00734630|593833157|FG000|Overall Study|Randomized in Error|0|||
164399774|NCT00734630|593833158|FG001|Overall Study|Randomized in Error|1|||
164399775|NCT00734630|593833157|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
164399776|NCT00734630|593833158|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
164399777|NCT00734630|593833157|FG000|Overall Study|Poor Compliance|1|||
164399778|NCT00734630|593833158|FG001|Overall Study|Poor Compliance|1|||
164399779|NCT01302847|593833163|FG000|Overall Study|Death|0|||
164596384|NCT05906732|594546641|FG003|Overall Study|Withdrawal by Subject|0|||
164596385|NCT05906732|594546638|FG000|Overall Study|Physician Decision|2|||
164596386|NCT05906732|594546639|FG001|Overall Study|Physician Decision|4|||
164596387|NCT05906732|594546640|FG002|Overall Study|Physician Decision|0|||
164596388|NCT05906732|594546641|FG003|Overall Study|Physician Decision|0|||
164596389|NCT01248130|594546642|FG000|Overall Study|Protocol Violation|1|||
164596390|NCT01248130|594546643|FG001|Overall Study|Protocol Violation|0|||
164399780|NCT01302847|593833164|FG001|Overall Study|Death|1|||
164399781|NCT01302847|593833165|FG002|Overall Study|Death|0|||
164399782|NCT01302847|593833166|FG003|Overall Study|Death|0|||
164399783|NCT01302847|593833167|FG004|Overall Study|Death|0|||
164399784|NCT01302847|593833168|FG005|Overall Study|Death|1|||
164399785|NCT01302847|593833169|FG006|Overall Study|Death|1|||
164399786|NCT01302847|593833170|FG007|Overall Study|Death|0|||
164399787|NCT01302847|593833163|FG000|Overall Study|Pregnancy|2|||
164399788|NCT01302847|593833164|FG001|Overall Study|Pregnancy|0|||
164399789|NCT01302847|593833165|FG002|Overall Study|Pregnancy|0|||
164705920|NCT01083810|594948821|FG001|Overall Study|Adverse Event|11|||
164399790|NCT01302847|593833166|FG003|Overall Study|Pregnancy|0|||
164596391|NCT01248130|594546642|FG000|Overall Study|Ineligible|1|||
164596392|NCT01248130|594546643|FG001|Overall Study|Ineligible|0|||
164399791|NCT01302847|593833167|FG004|Overall Study|Pregnancy|0|||
164399792|NCT01302847|593833168|FG005|Overall Study|Pregnancy|0|||
164399793|NCT01302847|593833169|FG006|Overall Study|Pregnancy|0|||
164399794|NCT01302847|593833170|FG007|Overall Study|Pregnancy|0|||
164399795|NCT01302847|593833163|FG000|Overall Study|Virologic failure|0|||
164399796|NCT01302847|593833164|FG001|Overall Study|Virologic failure|2|||
164399797|NCT01302847|593833165|FG002|Overall Study|Virologic failure|0|||
164399798|NCT01302847|593833166|FG003|Overall Study|Virologic failure|2|||
164399799|NCT01302847|593833167|FG004|Overall Study|Virologic failure|1|||
164399800|NCT01302847|593833168|FG005|Overall Study|Virologic failure|3|||
164399801|NCT01302847|593833169|FG006|Overall Study|Virologic failure|1|||
164399802|NCT01302847|593833170|FG007|Overall Study|Virologic failure|2|||
164399803|NCT01302847|593833163|FG000|Overall Study|Severe debilitation, unable to continue|0|||
164399804|NCT01302847|593833164|FG001|Overall Study|Severe debilitation, unable to continue|0|||
164399805|NCT01302847|593833165|FG002|Overall Study|Severe debilitation, unable to continue|0|||
164399806|NCT01302847|593833166|FG003|Overall Study|Severe debilitation, unable to continue|0|||
164399807|NCT01302847|593833167|FG004|Overall Study|Severe debilitation, unable to continue|0|||
164399808|NCT01302847|593833168|FG005|Overall Study|Severe debilitation, unable to continue|1|||
164399809|NCT01302847|593833169|FG006|Overall Study|Severe debilitation, unable to continue|1|||
164399810|NCT01302847|593833170|FG007|Overall Study|Severe debilitation, unable to continue|0|||
164399811|NCT01302847|593833163|FG000|Overall Study|Not able to get to clinic|1|||
164399812|NCT01302847|593833164|FG001|Overall Study|Not able to get to clinic|1|||
164399813|NCT01302847|593833165|FG002|Overall Study|Not able to get to clinic|0|||
164399814|NCT01302847|593833166|FG003|Overall Study|Not able to get to clinic|0|||
164399815|NCT01302847|593833167|FG004|Overall Study|Not able to get to clinic|0|||
164399816|NCT01302847|593833168|FG005|Overall Study|Not able to get to clinic|0|||
164399817|NCT01302847|593833169|FG006|Overall Study|Not able to get to clinic|0|||
164399818|NCT01302847|593833170|FG007|Overall Study|Not able to get to clinic|0|||
164399819|NCT01302847|593833163|FG000|Overall Study|Site closing|2|||
164399820|NCT01302847|593833164|FG001|Overall Study|Site closing|2|||
164399821|NCT01302847|593833165|FG002|Overall Study|Site closing|0|||
164399822|NCT01302847|593833166|FG003|Overall Study|Site closing|0|||
164399823|NCT01302847|593833167|FG004|Overall Study|Site closing|0|||
164399824|NCT01302847|593833168|FG005|Overall Study|Site closing|0|||
164399825|NCT01302847|593833169|FG006|Overall Study|Site closing|0|||
164399826|NCT01302847|593833170|FG007|Overall Study|Site closing|0|||
164399827|NCT01302847|593833163|FG000|Overall Study|Withdrawal by Subject|1|||
164399828|NCT01302847|593833164|FG001|Overall Study|Withdrawal by Subject|0|||
164399829|NCT01302847|593833165|FG002|Overall Study|Withdrawal by Subject|0|||
164399830|NCT01302847|593833166|FG003|Overall Study|Withdrawal by Subject|0|||
164399831|NCT01302847|593833167|FG004|Overall Study|Withdrawal by Subject|1|||
164399832|NCT01302847|593833168|FG005|Overall Study|Withdrawal by Subject|0|||
164399833|NCT01302847|593833169|FG006|Overall Study|Withdrawal by Subject|0|||
164399834|NCT01302847|593833170|FG007|Overall Study|Withdrawal by Subject|1|||
164399835|NCT01302847|593833163|FG000|Overall Study|Not willing to adhere to requirements|5|||
164399836|NCT01302847|593833164|FG001|Overall Study|Not willing to adhere to requirements|0|||
164399837|NCT01302847|593833165|FG002|Overall Study|Not willing to adhere to requirements|1|||
164399838|NCT01302847|593833166|FG003|Overall Study|Not willing to adhere to requirements|0|||
164399839|NCT01302847|593833167|FG004|Overall Study|Not willing to adhere to requirements|0|||
164399840|NCT01302847|593833168|FG005|Overall Study|Not willing to adhere to requirements|0|||
164399841|NCT01302847|593833169|FG006|Overall Study|Not willing to adhere to requirements|0|||
164399842|NCT01302847|593833170|FG007|Overall Study|Not willing to adhere to requirements|2|||
164399843|NCT01302847|593833163|FG000|Overall Study|Site unable to contact participant|2|||
164399844|NCT01302847|593833164|FG001|Overall Study|Site unable to contact participant|1|||
164399845|NCT01302847|593833165|FG002|Overall Study|Site unable to contact participant|0|||
164399846|NCT01302847|593833166|FG003|Overall Study|Site unable to contact participant|0|||
164399847|NCT01302847|593833167|FG004|Overall Study|Site unable to contact participant|0|||
164399848|NCT01302847|593833168|FG005|Overall Study|Site unable to contact participant|0|||
164399849|NCT01302847|593833169|FG006|Overall Study|Site unable to contact participant|2|||
164399850|NCT01302847|593833170|FG007|Overall Study|Site unable to contact participant|0|||
164399851|NCT01565707|593833171|FG000|Overall Study|Adverse Event|1|||
164399852|NCT01565707|593833172|FG001|Overall Study|Adverse Event|6|||
164399853|NCT01565707|593833173|FG002|Overall Study|Adverse Event|2|||
164399854|NCT01565707|593833174|FG003|Overall Study|Adverse Event|1|||
164399855|NCT01565707|593833171|FG000|Overall Study|Lost to Follow-up|1|||
164596393|NCT01994226|594546650|FG000|Overall Study|Protocol Violation|13|||
164399856|NCT01565707|593833172|FG001|Overall Study|Lost to Follow-up|0|||
164399857|NCT01565707|593833173|FG002|Overall Study|Lost to Follow-up|0|||
164399858|NCT01565707|593833174|FG003|Overall Study|Lost to Follow-up|0|||
164399859|NCT01565707|593833171|FG000|Overall Study|Protocol Violation|1|||
164596394|NCT01994226|594546651|FG001|Overall Study|Protocol Violation|10|||
164596395|NCT01994226|594546650|FG000|Overall Study|Early Cessation of treatment|6|||
164596396|NCT01994226|594546651|FG001|Overall Study|Early Cessation of treatment|11|||
164596397|NCT02488551|594546652|FG000|Overall Study|Lost to Follow-up|4|||
164596398|NCT02488551|594546653|FG001|Overall Study|Lost to Follow-up|7|||
164596399|NCT02488551|594546654|FG002|Overall Study|Lost to Follow-up|0|||
164596400|NCT02488551|594546655|FG003|Overall Study|Lost to Follow-up|0|||
164399860|NCT01565707|593833172|FG001|Overall Study|Protocol Violation|0|||
164399861|NCT01565707|593833173|FG002|Overall Study|Protocol Violation|0|||
164399862|NCT01565707|593833174|FG003|Overall Study|Protocol Violation|1|||
164399863|NCT01565707|593833171|FG000|Overall Study|Withdrawal by Subject|3|||
164399864|NCT01565707|593833172|FG001|Overall Study|Withdrawal by Subject|1|||
164399865|NCT01565707|593833173|FG002|Overall Study|Withdrawal by Subject|1|||
164399866|NCT01565707|593833174|FG003|Overall Study|Withdrawal by Subject|1|||
164399867|NCT01565707|593833171|FG000|Overall Study|Randomized but not evaluable|2|||
164399868|NCT01565707|593833172|FG001|Overall Study|Randomized but not evaluable|0|||
164399869|NCT01565707|593833173|FG002|Overall Study|Randomized but not evaluable|0|||
164399870|NCT01565707|593833174|FG003|Overall Study|Randomized but not evaluable|0|||
164399871|NCT01565707|593833171|FG000|Overall Study|Miscellaneous|1|||
164399872|NCT01565707|593833172|FG001|Overall Study|Miscellaneous|1|||
164399873|NCT01565707|593833173|FG002|Overall Study|Miscellaneous|0|||
164399874|NCT01565707|593833174|FG003|Overall Study|Miscellaneous|2|||
164399875|NCT01371851|593833175|FG000|Overall Study|Lost to Follow-up|5|||
164399876|NCT01371851|593833176|FG001|Overall Study|Lost to Follow-up|8|||
164399877|NCT01371851|593833175|FG000|Overall Study|was arrested and put in jail|0|||
164399878|NCT01371851|593833176|FG001|Overall Study|was arrested and put in jail|1|||
164399879|NCT01371851|593833175|FG000|Overall Study|non study related adverse event|1|||
164399880|NCT01371851|593833176|FG001|Overall Study|non study related adverse event|0|||
164399881|NCT01371851|593833175|FG000|Overall Study|Blood Pressure outside study parameters|2|||
164399882|NCT01371851|593833176|FG001|Overall Study|Blood Pressure outside study parameters|0|||
164399883|NCT00450411|593833177|FG000|Overall Study|Protocol Violation|6|||
164399884|NCT00450411|593833177|FG000|Overall Study|No protocol treatment|2|||
164399885|NCT03969719|593833188|FG000|Overall Study|Other reasons not specified|1|||
164399886|NCT03969719|593833189|FG001|Overall Study|Other reasons not specified|1|||
164399887|NCT03969719|593833190|FG002|Overall Study|Other reasons not specified|3|||
164399888|NCT03969719|593833188|FG000|Overall Study|Withdrawal by Subject|2|||
164399889|NCT03969719|593833189|FG001|Overall Study|Withdrawal by Subject|3|||
164399890|NCT03969719|593833190|FG002|Overall Study|Withdrawal by Subject|2|||
164399891|NCT03969719|593833188|FG000|Overall Study|Protocol Violation|1|||
164399892|NCT03969719|593833189|FG001|Overall Study|Protocol Violation|2|||
164399893|NCT03969719|593833190|FG002|Overall Study|Protocol Violation|0|||
164399894|NCT03969719|593833188|FG000|Overall Study|Adverse Event|0|||
164399895|NCT03969719|593833189|FG001|Overall Study|Adverse Event|2|||
164399896|NCT03969719|593833190|FG002|Overall Study|Adverse Event|0|||
164399897|NCT03969719|593833188|FG000|Overall Study|Lost to Follow-up|0|||
164399898|NCT03969719|593833189|FG001|Overall Study|Lost to Follow-up|1|||
164399899|NCT03969719|593833190|FG002|Overall Study|Lost to Follow-up|0|||
164399900|NCT05608629|593833191|FG000|Overall Study|Lost to Follow-up|2|||
164399901|NCT02130193|593833192|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
164399902|NCT02130193|593833193|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
164399903|NCT02130193|593833194|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
164399904|NCT02130193|593833192|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
164399905|NCT02130193|593833193|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
164399906|NCT02130193|593833194|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
164399907|NCT02130193|593833192|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
164399908|NCT02130193|593833193|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
164399909|NCT02130193|593833194|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
164399910|NCT02130193|593833192|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
164399911|NCT02130193|593833193|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
164399912|NCT02130193|593833194|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
164399913|NCT01212770|593833195|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
164399914|NCT01212770|593833196|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
164399915|NCT01212770|593833197|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
164399916|NCT01212770|593833198|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
164399917|NCT01212770|593833199|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
164399918|NCT01212770|593833200|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
164399919|NCT01212770|593833201|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
164399920|NCT01212770|593833202|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
164596401|NCT02488551|594546652|FG000|Overall Study|Military Deployment|1|||
164596402|NCT02488551|594546653|FG001|Overall Study|Military Deployment|1|||
164596403|NCT02488551|594546654|FG002|Overall Study|Military Deployment|0|||
164596404|NCT02488551|594546655|FG003|Overall Study|Military Deployment|0|||
164596405|NCT01860534|594546656|FG000|ROP #1|Needed treatment for ROP|0|||
164596406|NCT01860534|594546657|FG001|ROP #1|Needed treatment for ROP|1|||
164596407|NCT01860534|594546656|FG000|ROP #2|discharged prior to ROP #2|1|||
164596408|NCT01860534|594546657|FG001|ROP #2|discharged prior to ROP #2|0|||
164596409|NCT03364673|594546663|FG000|Overall Study|Withdrawal by Subject|2|||
164596410|NCT03364673|594546663|FG000|Overall Study|Injury unrelated to study|3|||
164596411|NCT00779324|594546664|FG000|Overall Study|Lost to Follow-up|2|||
164399921|NCT01212770|593833203|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
164399922|NCT01212770|593833195|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
164399923|NCT01212770|593833196|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
164399924|NCT01212770|593833197|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
164399925|NCT01212770|593833198|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
164399926|NCT01212770|593833199|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
164399927|NCT01212770|593833200|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
164399928|NCT01212770|593833201|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
164399929|NCT01212770|593833202|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
164399930|NCT01212770|593833203|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
164399931|NCT01212770|593833195|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
164399932|NCT01212770|593833196|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
164399933|NCT01212770|593833197|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
164399934|NCT01212770|593833198|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
164399935|NCT01212770|593833199|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
164399936|NCT01212770|593833200|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
164399937|NCT01212770|593833201|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
164399938|NCT01212770|593833202|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
164399939|NCT01212770|593833203|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
164399940|NCT01212770|593833195|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
164399941|NCT01212770|593833196|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
164399942|NCT01212770|593833197|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
164399943|NCT01212770|593833198|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
164399944|NCT01212770|593833199|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
164399945|NCT01212770|593833200|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
164399946|NCT01212770|593833201|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
164399947|NCT01212770|593833202|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
164399948|NCT01212770|593833203|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
164399949|NCT01212770|593833195|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
164399950|NCT01212770|593833196|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
164399951|NCT01212770|593833197|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
164399952|NCT01212770|593833198|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
164399953|NCT01212770|593833199|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
164399954|NCT01212770|593833200|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
164399955|NCT01212770|593833201|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
164399956|NCT01212770|593833202|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
164399957|NCT01212770|593833203|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
164399958|NCT01212770|593833195|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
164399959|NCT01212770|593833196|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
164399960|NCT01212770|593833197|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
164399961|NCT01212770|593833198|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
164399962|NCT01212770|593833199|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
164399963|NCT01212770|593833200|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
164399964|NCT01212770|593833201|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
164399965|NCT01212770|593833202|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
164399966|NCT01212770|593833203|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
164399967|NCT01212770|593833195|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
164399968|NCT01212770|593833196|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
164399969|NCT01212770|593833197|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
164399970|NCT01212770|593833198|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
164399971|NCT01212770|593833199|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
164399972|NCT01212770|593833200|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
164399973|NCT01212770|593833201|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
164399974|NCT01212770|593833202|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
164399975|NCT01212770|593833203|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
164399976|NCT01212770|593833195|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
164399977|NCT01212770|593833196|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
164399978|NCT01212770|593833197|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
164399979|NCT01212770|593833198|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
164442690|NCT03593213|593988608|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
164596412|NCT00779324|594546665|FG001|Overall Study|Lost to Follow-up|1|||
164596413|NCT00779324|594546664|FG000|Overall Study|Withdrawal by Subject|4|||
164596414|NCT00779324|594546665|FG001|Overall Study|Withdrawal by Subject|2|||
164596415|NCT00779324|594546664|FG000|Overall Study|Missed visit|1|||
164596416|NCT00779324|594546665|FG001|Overall Study|Missed visit|1|||
164596417|NCT02207556|594546666|FG000|Overall Study|Physician Decision|1|||
164399980|NCT01212770|593833199|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
164399981|NCT01212770|593833200|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
164399982|NCT01212770|593833201|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
164399983|NCT01212770|593833202|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
164399984|NCT01212770|593833203|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
164399985|NCT01212770|593833195|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
164399986|NCT01212770|593833196|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
164399987|NCT01212770|593833197|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
164399988|NCT01212770|593833198|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
164399989|NCT01212770|593833199|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
164399990|NCT01212770|593833200|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
164399991|NCT01212770|593833201|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
164399992|NCT01212770|593833202|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
164399993|NCT01212770|593833203|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
164399994|NCT01212770|593833195|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
164399995|NCT01212770|593833196|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
164399996|NCT01212770|593833197|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
164399997|NCT01212770|593833198|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
164399998|NCT01212770|593833199|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
164399999|NCT01212770|593833200|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
164400000|NCT01212770|593833201|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
164400001|NCT01212770|593833202|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
164400002|NCT01212770|593833203|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
164400003|NCT01212770|593833195|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
164400004|NCT01212770|593833196|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
164400005|NCT01212770|593833197|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
164400006|NCT01212770|593833198|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
164400007|NCT01212770|593833199|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
164400008|NCT01212770|593833200|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
164400009|NCT01212770|593833201|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
164400010|NCT01212770|593833202|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
164400011|NCT01212770|593833203|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
164400012|NCT01212770|593833195|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
164400013|NCT01212770|593833196|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
164400014|NCT01212770|593833197|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
164400015|NCT01212770|593833198|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
164400016|NCT01212770|593833199|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
164400017|NCT01212770|593833200|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
164400018|NCT01212770|593833201|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
164400019|NCT01212770|593833202|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
164400020|NCT01212770|593833203|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
164400021|NCT01212770|593833195|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
164400022|NCT01212770|593833196|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
164400023|NCT01212770|593833197|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
164400024|NCT01212770|593833198|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
164400025|NCT01212770|593833199|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
164400026|NCT01212770|593833200|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
164400027|NCT01212770|593833201|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
164400028|NCT01212770|593833202|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
164400029|NCT01212770|593833203|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
164400030|NCT01212770|593833195|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
164442691|NCT03593213|593988609|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
164442692|NCT03184558|593988612|FG000|Overall Study|Withdrawal by Subject|2|||
164442693|NCT03184558|593988612|FG000|Overall Study|Death|16|||
164442694|NCT03184558|593988612|FG000|Overall Study|Lost to Follow-up|2|||
164442695|NCT03184558|593988612|FG000|Overall Study|Other|9|||
164596418|NCT02207556|594546667|FG001|Overall Study|Physician Decision|0|||
164596419|NCT02207556|594546666|FG000|Overall Study|Withdrawal by Subject|1|||
164596420|NCT02207556|594546667|FG001|Overall Study|Withdrawal by Subject|0|||
164596421|NCT02207556|594546666|FG000|Overall Study|Death|0|||
164400031|NCT01212770|593833196|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
164400032|NCT01212770|593833197|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
164400033|NCT01212770|593833198|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
164400034|NCT01212770|593833199|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
164400035|NCT01212770|593833200|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
164400036|NCT01212770|593833201|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
164442696|NCT01831791|593988613|FG000|Overall Study|Withdrawal by Subject|10|||
164596422|NCT02207556|594546667|FG001|Overall Study|Death|5|||
164400037|NCT01212770|593833202|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
164400038|NCT01212770|593833203|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
164400039|NCT01212770|593833195|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
164400040|NCT01212770|593833196|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
164400041|NCT01212770|593833197|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
164400042|NCT01212770|593833198|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
164400043|NCT01212770|593833199|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
164400044|NCT01212770|593833200|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
164400045|NCT01212770|593833201|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
164400046|NCT01212770|593833202|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
164400047|NCT01212770|593833203|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
164400048|NCT01212770|593833195|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
164400049|NCT01212770|593833196|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
164400050|NCT01212770|593833197|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
164400051|NCT01212770|593833198|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
164400052|NCT01212770|593833199|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
164400053|NCT01212770|593833200|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
164400054|NCT01212770|593833201|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
164400055|NCT01212770|593833202|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
164400056|NCT01212770|593833203|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
164400057|NCT01212770|593833195|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
164400058|NCT01212770|593833196|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
164400059|NCT01212770|593833197|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
164400060|NCT01212770|593833198|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
164400061|NCT01212770|593833199|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
164400062|NCT01212770|593833200|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
164400063|NCT01212770|593833201|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
164400064|NCT01212770|593833202|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
164400065|NCT01212770|593833203|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
164400066|NCT01212770|593833195|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
164400067|NCT01212770|593833196|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
164400068|NCT01212770|593833197|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
164400069|NCT01212770|593833198|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
164400070|NCT01212770|593833199|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
164400071|NCT01212770|593833200|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
164400072|NCT01212770|593833201|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
164400073|NCT01212770|593833202|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
164400074|NCT01212770|593833203|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
164596423|NCT03558555|594546668|FG000|Overall Study|Lost to Follow-up|2|||
164596424|NCT03558555|594546669|FG001|Overall Study|Lost to Follow-up|1|||
164596425|NCT00194025|594546670|FG000|Overall Study|Adverse Event|1|||
164400075|NCT01212770|593833195|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
164400076|NCT01212770|593833196|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
164400077|NCT01212770|593833197|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
164400078|NCT01212770|593833198|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
164400079|NCT01212770|593833199|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
164400080|NCT01212770|593833200|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
164400081|NCT01212770|593833201|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
164400082|NCT01212770|593833202|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
164400083|NCT01212770|593833203|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
164400084|NCT01212770|593833195|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
164400085|NCT01212770|593833196|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
164400086|NCT01212770|593833197|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
164400087|NCT01212770|593833198|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
164400088|NCT01212770|593833199|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
164400089|NCT01212770|593833200|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
164400090|NCT01212770|593833201|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
164400091|NCT01212770|593833202|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
164400092|NCT01212770|593833203|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
164400093|NCT01212770|593833195|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
164400094|NCT01212770|593833196|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
164400095|NCT01212770|593833197|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
164596426|NCT00194025|594546670|FG000|Overall Study|non-adherence with study medication|4|||
164596427|NCT01199055|594546680|FG000|Overall Study|Death|0|||
164400096|NCT01212770|593833198|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
164596428|NCT01199055|594546681|FG001|Overall Study|Death|1|||
164596429|NCT01199055|594546682|FG002|Overall Study|Death|0|||
164400097|NCT01212770|593833199|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
164400098|NCT01212770|593833200|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
164400099|NCT01212770|593833201|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
164400100|NCT01212770|593833202|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
164400101|NCT01212770|593833203|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
164400102|NCT01212770|593833195|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
164400103|NCT01212770|593833196|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
164400104|NCT01212770|593833197|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
164400105|NCT01212770|593833198|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
164400106|NCT01212770|593833199|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
164400107|NCT01212770|593833200|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
164400108|NCT01212770|593833201|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
164400109|NCT01212770|593833202|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
164400110|NCT01212770|593833203|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
164400111|NCT01212770|593833195|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
164400112|NCT01212770|593833196|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
164400113|NCT01212770|593833197|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
164400114|NCT01212770|593833198|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
164400115|NCT01212770|593833199|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
164400116|NCT01212770|593833200|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
164400117|NCT01212770|593833201|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
164400118|NCT01212770|593833202|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
164400119|NCT01212770|593833203|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
164400120|NCT01212770|593833195|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
164400121|NCT01212770|593833196|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
164400122|NCT01212770|593833197|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
164400123|NCT01212770|593833198|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
164400124|NCT01212770|593833199|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
164400125|NCT01212770|593833200|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
164400126|NCT01212770|593833201|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
164400127|NCT01212770|593833202|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
164400128|NCT01212770|593833203|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
164400129|NCT01212770|593833195|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
164400130|NCT01212770|593833196|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
164400131|NCT01212770|593833197|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
164400132|NCT01212770|593833198|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
164400133|NCT01212770|593833199|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
164400134|NCT01212770|593833200|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
164400135|NCT01212770|593833201|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
164400136|NCT01212770|593833202|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
164400137|NCT01212770|593833203|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
164400138|NCT01212770|593833195|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
164400139|NCT01212770|593833196|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
164400140|NCT01212770|593833197|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
164400141|NCT01212770|593833198|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
164400142|NCT01212770|593833199|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
164400143|NCT01212770|593833200|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
164400144|NCT01212770|593833201|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
164400145|NCT01212770|593833202|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
164400146|NCT01212770|593833203|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
164400147|NCT01212770|593833195|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
164400148|NCT01212770|593833196|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
164400149|NCT01212770|593833197|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
164400150|NCT01212770|593833198|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
164400151|NCT01212770|593833199|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
164400152|NCT01212770|593833200|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
164400153|NCT01212770|593833201|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
164400154|NCT01212770|593833202|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
164400155|NCT01212770|593833203|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
164400156|NCT01212770|593833195|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
164400157|NCT01212770|593833196|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
164400158|NCT01212770|593833197|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
164400159|NCT01212770|593833198|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
164400160|NCT01212770|593833199|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
164400161|NCT01212770|593833200|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
164400162|NCT01212770|593833201|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
164400163|NCT01212770|593833202|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
164400164|NCT01212770|593833203|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
164400165|NCT01212770|593833195|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
164400166|NCT01212770|593833196|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
164400167|NCT01212770|593833197|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
164400168|NCT01212770|593833198|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
164400169|NCT01212770|593833199|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
164400170|NCT01212770|593833200|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
164400171|NCT01212770|593833201|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
164400172|NCT01212770|593833202|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
164400173|NCT01212770|593833203|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
164400174|NCT01212770|593833195|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
164400175|NCT01212770|593833196|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
164400176|NCT01212770|593833197|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
164400177|NCT01212770|593833198|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
164400178|NCT01212770|593833199|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
164400179|NCT01212770|593833200|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
164400180|NCT01212770|593833201|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
164400181|NCT01212770|593833202|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
164400182|NCT01212770|593833203|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
164400183|NCT01212770|593833195|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
164400184|NCT01212770|593833196|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
164400185|NCT01212770|593833197|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
164400186|NCT01212770|593833198|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
164400187|NCT01212770|593833199|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
164400188|NCT01212770|593833200|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
164400189|NCT01212770|593833201|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
164400190|NCT01212770|593833202|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
164400191|NCT01212770|593833203|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
164400192|NCT01212770|593833195|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
164400193|NCT01212770|593833196|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
164400194|NCT01212770|593833197|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
164400195|NCT01212770|593833198|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
164400196|NCT01212770|593833199|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
164400197|NCT01212770|593833200|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
164400198|NCT01212770|593833201|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
164400199|NCT01212770|593833202|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
164400200|NCT01212770|593833203|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
164400201|NCT01212770|593833195|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
164400202|NCT01212770|593833196|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
164400203|NCT01212770|593833197|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
164400204|NCT01212770|593833198|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
164400205|NCT01212770|593833199|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
164400206|NCT01212770|593833200|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
164400207|NCT01212770|593833201|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
164400208|NCT01212770|593833202|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
164400209|NCT01212770|593833203|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
164400210|NCT01212770|593833195|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
164400211|NCT01212770|593833196|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
164400212|NCT01212770|593833197|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
164400213|NCT01212770|593833198|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
164400214|NCT01212770|593833199|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
164400215|NCT01212770|593833200|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
164400216|NCT01212770|593833201|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
164400217|NCT01212770|593833202|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
164400218|NCT01212770|593833203|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
164400219|NCT01212770|593833195|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
164400220|NCT01212770|593833196|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
164400221|NCT01212770|593833197|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
164400222|NCT01212770|593833198|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
164400223|NCT01212770|593833199|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
164400224|NCT01212770|593833200|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
164442697|NCT01254019|593988614|FG000|Overall Study|Adverse Event|0|||
164442698|NCT01254019|593988615|FG001|Overall Study|Adverse Event|2|||
164442699|NCT01254019|593988614|FG000|Overall Study|Protocol Violation|1|||
164442700|NCT01254019|593988615|FG001|Overall Study|Protocol Violation|0|||
164400225|NCT01212770|593833201|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
164400226|NCT01212770|593833202|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
164596430|NCT01199055|594546680|FG000|Overall Study|Physician Decision|0|||
164596431|NCT01199055|594546681|FG001|Overall Study|Physician Decision|1|||
164596432|NCT01199055|594546682|FG002|Overall Study|Physician Decision|1|||
164596433|NCT01199055|594546680|FG000|Overall Study|Progressive disease|2|||
164442701|NCT01254019|593988614|FG000|Overall Study|Withdrawal by Subject|0|||
164442702|NCT01254019|593988615|FG001|Overall Study|Withdrawal by Subject|2|||
164442703|NCT03061474|593988616|FG000|Overall Study|Adverse Event|2|||
164442704|NCT03061474|593988617|FG001|Overall Study|Adverse Event|0|||
164442705|NCT03061474|593988616|FG000|Overall Study|Safety Risk|0|||
164400227|NCT01212770|593833203|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
164400228|NCT01212770|593833195|FG000|Long-term Safety Phase (Year 5)|Death|0|||
164400229|NCT01212770|593833196|FG001|Long-term Safety Phase (Year 5)|Death|0|||
164400230|NCT01212770|593833197|FG002|Long-term Safety Phase (Year 5)|Death|0|||
164400231|NCT01212770|593833198|FG003|Long-term Safety Phase (Year 5)|Death|0|||
164400232|NCT01212770|593833199|FG004|Long-term Safety Phase (Year 5)|Death|0|||
164400233|NCT01212770|593833200|FG005|Long-term Safety Phase (Year 5)|Death|0|||
164400234|NCT01212770|593833201|FG006|Long-term Safety Phase (Year 5)|Death|0|||
164400235|NCT01212770|593833202|FG007|Long-term Safety Phase (Year 5)|Death|1|||
164400236|NCT01212770|593833203|FG008|Long-term Safety Phase (Year 5)|Death|0|||
164400237|NCT01297959|593833204|FG000|Overall Study|Adverse Event|0|||
164400238|NCT01297959|593833205|FG001|Overall Study|Adverse Event|1|||
164400239|NCT01297959|593833204|FG000|Overall Study|Protocol Violation|2|||
164400240|NCT01297959|593833205|FG001|Overall Study|Protocol Violation|1|||
164400241|NCT01297959|593833204|FG000|Overall Study|Withdrawal by Subject|5|||
164400242|NCT01297959|593833205|FG001|Overall Study|Withdrawal by Subject|4|||
164400243|NCT01297959|593833204|FG000|Overall Study|Physician Decision|0|||
164400244|NCT01297959|593833205|FG001|Overall Study|Physician Decision|1|||
164400245|NCT01297959|593833204|FG000|Overall Study|Unrelated medical illness / complication|0|||
164400246|NCT01297959|593833205|FG001|Overall Study|Unrelated medical illness / complication|2|||
164400247|NCT01297959|593833204|FG000|Overall Study|Other|13|||
164400248|NCT01297959|593833205|FG001|Overall Study|Other|7|||
164400249|NCT00707031|593833208|FG000|Overall Study|Adverse Event|45|||
164400250|NCT00707031|593833209|FG001|Overall Study|Adverse Event|45|||
164400251|NCT00707031|593833208|FG000|Overall Study|Lack of Efficacy|19|||
164400252|NCT00707031|593833209|FG001|Overall Study|Lack of Efficacy|6|||
164400253|NCT00707031|593833208|FG000|Overall Study|Lost to Follow-up|2|||
164400254|NCT00707031|593833209|FG001|Overall Study|Lost to Follow-up|1|||
164400255|NCT00707031|593833208|FG000|Overall Study|Protocol Violation|1|||
164400256|NCT00707031|593833209|FG001|Overall Study|Protocol Violation|0|||
164400257|NCT00707031|593833208|FG000|Overall Study|Withdrawal by Subject|7|||
164400258|NCT00707031|593833209|FG001|Overall Study|Withdrawal by Subject|8|||
164400259|NCT00707031|593833208|FG000|Overall Study|Poor Compliance to Protocol|7|||
164400260|NCT00707031|593833209|FG001|Overall Study|Poor Compliance to Protocol|13|||
164442706|NCT03061474|593988617|FG001|Overall Study|Safety Risk|1|||
164442707|NCT03061474|593988616|FG000|Overall Study|Participant unwilling or unable to participate|0|||
164442708|NCT03061474|593988617|FG001|Overall Study|Participant unwilling or unable to participate|2|||
164442709|NCT03061474|593988616|FG000|Overall Study|Lost to Follow-up|0|||
164442710|NCT03061474|593988617|FG001|Overall Study|Lost to Follow-up|1|||
164442711|NCT01391130|593988620|FG000|Overall Study|Withdrawal by Subject|3|||
164442712|NCT01391130|593988621|FG001|Overall Study|Withdrawal by Subject|2|||
164442713|NCT01391130|593988620|FG000|Overall Study|Physician Decision|2|||
164442714|NCT01391130|593988621|FG001|Overall Study|Physician Decision|3|||
164442715|NCT01391130|593988620|FG000|Overall Study|Did not Receive Drug|1|||
164442716|NCT01391130|593988621|FG001|Overall Study|Did not Receive Drug|1|||
164442717|NCT03520413|593988624|FG000|Overall Study|Lost to Follow-up|1|||
164442718|NCT03520413|593988625|FG001|Overall Study|Lost to Follow-up|1|||
164442719|NCT03520413|593988624|FG000|Overall Study|Withdrawal by Subject|1|||
164442720|NCT03520413|593988625|FG001|Overall Study|Withdrawal by Subject|2|||
164442721|NCT03520413|593988624|FG000|Overall Study|Death|0|||
164442722|NCT03520413|593988625|FG001|Overall Study|Death|1|||
164596434|NCT01199055|594546681|FG001|Overall Study|Progressive disease|1|||
164400261|NCT00707031|593833208|FG000|Overall Study|Familial or Personal Reasons|12|||
164400262|NCT00707031|593833209|FG001|Overall Study|Familial or Personal Reasons|15|||
164400263|NCT00707031|593833208|FG000|Overall Study|Serious Noncompliance|2|||
164400264|NCT00707031|593833209|FG001|Overall Study|Serious Noncompliance|3|||
164400265|NCT00707031|593833208|FG000|Overall Study|Sponsor Decision|9|||
164400266|NCT00707031|593833209|FG001|Overall Study|Sponsor Decision|8|||
164442723|NCT03520413|593988624|FG000|Overall Study|Physician Decision|3|||
164442724|NCT03520413|593988625|FG001|Overall Study|Physician Decision|3|||
164442725|NCT03520413|593988624|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
164442726|NCT03520413|593988625|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
164442727|NCT00869323|593988626|FG000|Maintenance Therapy|concurrent illness|1|||
164596435|NCT01199055|594546682|FG002|Overall Study|Progressive disease|2|||
164596436|NCT01199055|594546680|FG000|Overall Study|Withdrawal by Subject|0|||
164596437|NCT01199055|594546681|FG001|Overall Study|Withdrawal by Subject|0|||
164596438|NCT01199055|594546682|FG002|Overall Study|Withdrawal by Subject|1|||
164596439|NCT00511342|594546683|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
164596440|NCT00511342|594546684|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
164596441|NCT00511342|594546683|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
164400267|NCT03519854|593833210|FG000|Overall Study|Technical Error|0|||
164705921|NCT01083810|594948822|FG002|Overall Study|Adverse Event|4|||
164705922|NCT01083810|594948820|FG000|Overall Study|Withdrawal by Subject|7|||
164705923|NCT01083810|594948821|FG001|Overall Study|Withdrawal by Subject|2|||
164705924|NCT01083810|594948822|FG002|Overall Study|Withdrawal by Subject|4|||
164400268|NCT03519854|593833211|FG001|Overall Study|Technical Error|0|||
164400269|NCT03519854|593833212|FG002|Overall Study|Technical Error|1|||
164400270|NCT03519854|593833213|FG003|Overall Study|Technical Error|0|||
164400271|NCT03519854|593833214|FG004|Overall Study|Technical Error|0|||
164400272|NCT03519854|593833215|FG005|Overall Study|Technical Error|0|||
164400273|NCT03519854|593833216|FG006|Overall Study|Technical Error|0|||
164400274|NCT03519854|593833217|FG007|Overall Study|Technical Error|0|||
164400275|NCT03519854|593833218|FG008|Overall Study|Technical Error|0|||
164400276|NCT03519854|593833219|FG009|Overall Study|Technical Error|0|||
164400277|NCT03519854|593833220|FG010|Overall Study|Technical Error|0|||
164400278|NCT03519854|593833221|FG011|Overall Study|Technical Error|0|||
164400279|NCT03519854|593833222|FG012|Overall Study|Technical Error|0|||
164400280|NCT03519854|593833223|FG013|Overall Study|Technical Error|0|||
164400281|NCT03519854|593833224|FG014|Overall Study|Technical Error|0|||
164400282|NCT03519854|593833225|FG015|Overall Study|Technical Error|0|||
164400283|NCT03519854|593833226|FG016|Overall Study|Technical Error|0|||
164400284|NCT03519854|593833227|FG017|Overall Study|Technical Error|0|||
164400285|NCT00951275|593833229|FG000|Overall Study|Administrative Reason|1|||
164400286|NCT00951275|593833229|FG000|Overall Study|Adverse Event|7|||
164400287|NCT00951275|593833229|FG000|Overall Study|Withdrawal by Subject|4|||
164400288|NCT00951275|593833229|FG000|Overall Study|Protocol Violation|1|||
164400289|NCT02925676|593833233|FG000|Overall Study|Withdrawal by Subject|1|||
164400290|NCT02048072|593833234|FG000|Overall Study|Adverse Event|3|||
164400291|NCT02048072|593833234|FG000|Overall Study|Lost to Follow-up|1|||
164400292|NCT04304833|593833235|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
164400293|NCT04304833|593833236|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
164400294|NCT03776136|593833237|FG000|Overall Study|Death|85|||
164400295|NCT03776136|593833237|FG000|Overall Study|Withdrawal by Subject|3|||
164400296|NCT03776136|593833237|FG000|Overall Study|Sponsor Decision|15|||
164400297|NCT02858895|593833238|FG000|Overall Study|Disease progression|31|||
164400298|NCT02858895|593833238|FG000|Overall Study|Death|2|||
164400299|NCT02858895|593833238|FG000|Overall Study|Adverse Event|1|||
164400300|NCT02858895|593833238|FG000|Overall Study|Withdrawal by Subject|3|||
164400301|NCT02858895|593833238|FG000|Overall Study|hospice,|1|||
164400302|NCT02858895|593833238|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
164400303|NCT00251745|593833242|FG000|Overall Study|Adverse Event|7|||
164400304|NCT00251745|593833243|FG001|Overall Study|Adverse Event|9|||
164400305|NCT00251745|593833244|FG002|Overall Study|Adverse Event|11|||
164400306|NCT00251745|593833242|FG000|Overall Study|Lost to Follow-up|4|||
164400307|NCT00251745|593833243|FG001|Overall Study|Lost to Follow-up|2|||
164400308|NCT00251745|593833244|FG002|Overall Study|Lost to Follow-up|5|||
164400309|NCT00251745|593833242|FG000|Overall Study|Withdrawal by Subject|13|||
164400310|NCT00251745|593833243|FG001|Overall Study|Withdrawal by Subject|7|||
164400311|NCT00251745|593833244|FG002|Overall Study|Withdrawal by Subject|3|||
164400312|NCT00251745|593833242|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
164400313|NCT00251745|593833243|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
164400314|NCT00251745|593833244|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
164400315|NCT00251745|593833242|FG000|Overall Study|Lack of Efficacy|3|||
164400316|NCT00251745|593833243|FG001|Overall Study|Lack of Efficacy|0|||
164400317|NCT00251745|593833244|FG002|Overall Study|Lack of Efficacy|0|||
164400318|NCT00251745|593833242|FG000|Overall Study|Noncompliant|0|||
164400319|NCT00251745|593833243|FG001|Overall Study|Noncompliant|2|||
164400320|NCT00251745|593833244|FG002|Overall Study|Noncompliant|2|||
164400321|NCT00251745|593833242|FG000|Overall Study|Pregnancy|0|||
164400322|NCT00251745|593833243|FG001|Overall Study|Pregnancy|1|||
164400323|NCT00251745|593833244|FG002|Overall Study|Pregnancy|0|||
164705925|NCT01083810|594948820|FG000|Overall Study|Reason not reported|6|||
164705926|NCT01083810|594948821|FG001|Overall Study|Reason not reported|1|||
164705927|NCT01083810|594948822|FG002|Overall Study|Reason not reported|1|||
164400324|NCT00251745|593833242|FG000|Overall Study|Per Subject Request|0|||
164400325|NCT00251745|593833243|FG001|Overall Study|Per Subject Request|0|||
164705928|NCT01083810|594948820|FG000|Overall Study|Non-compliance|4|||
164705929|NCT01083810|594948821|FG001|Overall Study|Non-compliance|7|||
164400326|NCT00251745|593833244|FG002|Overall Study|Per Subject Request|1|||
164400327|NCT00251745|593833242|FG000|Overall Study|Per Investigator Request|1|||
164400328|NCT00251745|593833243|FG001|Overall Study|Per Investigator Request|0|||
164400329|NCT00251745|593833244|FG002|Overall Study|Per Investigator Request|0|||
164400330|NCT02586025|593835156|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
164400331|NCT02586025|593835157|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
164400332|NCT02586025|593835156|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
164400333|NCT02586025|593835157|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
164400334|NCT02586025|593835156|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
164400335|NCT02586025|593835157|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
164400336|NCT02586025|593835156|FG000|Neoadjuvant Treatment|Death|1|||
164400337|NCT02586025|593835157|FG001|Neoadjuvant Treatment|Death|0|||
164400338|NCT02586025|593835156|FG000|Neoadjuvant Treatment|Adverse Event|1|||
164400339|NCT02586025|593835157|FG001|Neoadjuvant Treatment|Adverse Event|0|||
164400340|NCT02586025|593835156|FG000|Neoadjuvant Treatment|Physician Decision|2|||
164596442|NCT00511342|594546684|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
164596443|NCT00511342|594546683|FG000|Overall Study|Pregnancy|0|||
164596444|NCT00511342|594546684|FG001|Overall Study|Pregnancy|1|||
164596445|NCT00511342|594546683|FG000|Overall Study|Pregnancy wish|0|||
164596446|NCT00511342|594546684|FG001|Overall Study|Pregnancy wish|1|||
164596447|NCT00511342|594546683|FG000|Overall Study|Lost to Follow-up|1|||
164596448|NCT00511342|594546684|FG001|Overall Study|Lost to Follow-up|5|||
164596449|NCT00511342|594546683|FG000|Overall Study|Other Reason|2|||
164596450|NCT00511342|594546684|FG001|Overall Study|Other Reason|2|||
164596451|NCT00369668|594546685|FG000|Overall Study|Lack of Efficacy|4|||
164596452|NCT00369668|594546686|FG001|Overall Study|Lack of Efficacy|5|||
164596453|NCT00369668|594546687|FG002|Overall Study|Lack of Efficacy|7|||
164596454|NCT00303108|594546688|FG000|Overall Study|Adverse Event|5|||
164596455|NCT00303108|594546689|FG001|Overall Study|Adverse Event|6|||
164596456|NCT00303108|594546690|FG002|Overall Study|Adverse Event|7|||
164596457|NCT00303108|594546688|FG000|Overall Study|Patient Request|4|||
164596458|NCT00303108|594546689|FG001|Overall Study|Patient Request|2|||
164596459|NCT00303108|594546690|FG002|Overall Study|Patient Request|8|||
164596460|NCT00303108|594546688|FG000|Overall Study|Failed Entry|1|||
164596461|NCT00303108|594546689|FG001|Overall Study|Failed Entry|0|||
164596462|NCT00303108|594546690|FG002|Overall Study|Failed Entry|1|||
164596463|NCT00303108|594546688|FG000|Overall Study|ineligible|2|||
164596464|NCT00303108|594546689|FG001|Overall Study|ineligible|1|||
164596465|NCT00303108|594546690|FG002|Overall Study|ineligible|0|||
164596466|NCT02427477|594546691|FG000|Period 1|Adverse Event|1|||
164596467|NCT02427477|594546692|FG001|Period 1|Adverse Event|0|||
164596468|NCT02435277|594546693|FG000|Overall Study|Adverse Event|1|||
164596469|NCT02435277|594546694|FG001|Overall Study|Adverse Event|1|||
164596470|NCT02435277|594546695|FG002|Overall Study|Adverse Event|0|||
164400341|NCT02586025|593835157|FG001|Neoadjuvant Treatment|Physician Decision|1|||
164400342|NCT02586025|593835156|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
164400343|NCT02586025|593835157|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
164400344|NCT02586025|593835156|FG000|Adjuvant Treatment|Recurrent Disease|4|||
164400345|NCT02586025|593835157|FG001|Adjuvant Treatment|Recurrent Disease|5|||
164400346|NCT02586025|593835156|FG000|Adjuvant Treatment|Physician Decision|0|||
164400347|NCT02586025|593835157|FG001|Adjuvant Treatment|Physician Decision|1|||
164400348|NCT02586025|593835156|FG000|Adjuvant Treatment|Pregnancy|1|||
164400349|NCT02586025|593835157|FG001|Adjuvant Treatment|Pregnancy|0|||
164400350|NCT02586025|593835156|FG000|Treatment-Free Follow-Up|Death|11|||
164400351|NCT02586025|593835157|FG001|Treatment-Free Follow-Up|Death|11|||
164400352|NCT02586025|593835156|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
164400353|NCT02586025|593835157|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
164400354|NCT02586025|593835156|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
164400355|NCT02586025|593835157|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
164400356|NCT02586025|593835156|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
164400357|NCT02586025|593835157|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
164400358|NCT02586025|593835156|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
164400359|NCT02586025|593835157|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
164400360|NCT03822117|593835158|FG000|Overall Study|Death|18|||
164400361|NCT03822117|593835159|FG001|Overall Study|Death|17|||
164400362|NCT03822117|593835160|FG002|Overall Study|Death|12|||
164400363|NCT03822117|593835161|FG003|Overall Study|Death|4|||
164400364|NCT03822117|593835158|FG000|Overall Study|Lost to Follow-up|1|||
164400365|NCT03822117|593835159|FG001|Overall Study|Lost to Follow-up|2|||
164400366|NCT03822117|593835160|FG002|Overall Study|Lost to Follow-up|3|||
164400367|NCT03822117|593835161|FG003|Overall Study|Lost to Follow-up|0|||
164400368|NCT03822117|593835158|FG000|Overall Study|Study Terminated by Sponsor|25|||
164400369|NCT03822117|593835159|FG001|Overall Study|Study Terminated by Sponsor|11|||
164400370|NCT03822117|593835160|FG002|Overall Study|Study Terminated by Sponsor|6|||
164400371|NCT03822117|593835161|FG003|Overall Study|Study Terminated by Sponsor|0|||
164400372|NCT03822117|593835158|FG000|Overall Study|Withdrawal by Subject|4|||
164400373|NCT03822117|593835159|FG001|Overall Study|Withdrawal by Subject|0|||
164400374|NCT03822117|593835160|FG002|Overall Study|Withdrawal by Subject|3|||
164596471|NCT02435277|594546696|FG003|Overall Study|Adverse Event|0|||
164596472|NCT02435277|594546693|FG000|Overall Study|Withdrawal by Subject|1|||
164596473|NCT02435277|594546694|FG001|Overall Study|Withdrawal by Subject|0|||
164596474|NCT02435277|594546695|FG002|Overall Study|Withdrawal by Subject|0|||
164705930|NCT01083810|594948822|FG002|Overall Study|Non-compliance|2|||
164596475|NCT02435277|594546696|FG003|Overall Study|Withdrawal by Subject|0|||
164400375|NCT03822117|593835161|FG003|Overall Study|Withdrawal by Subject|0|||
164400376|NCT03822117|593835158|FG000|Overall Study|Disease Progression|1|||
164596476|NCT00444626|594546697|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
164596477|NCT00444626|594546697|FG000|Initial Treatment Period|Adverse Event|1|||
164596478|NCT00444626|594546697|FG000|Initial Treatment Period|Lost to Follow-up|9|||
164705931|NCT01083810|594948820|FG000|Overall Study|Simplification|4|||
164705932|NCT01083810|594948821|FG001|Overall Study|Simplification|1|||
164705933|NCT01083810|594948822|FG002|Overall Study|Simplification|0|||
164705934|NCT01083810|594948820|FG000|Overall Study|Death|2|||
164705935|NCT01083810|594948821|FG001|Overall Study|Death|2|||
164400377|NCT03822117|593835159|FG001|Overall Study|Disease Progression|2|||
164400378|NCT03822117|593835160|FG002|Overall Study|Disease Progression|1|||
164400379|NCT03822117|593835161|FG003|Overall Study|Disease Progression|0|||
164400380|NCT03822117|593835158|FG000|Overall Study|Never Returned to Hospital|0|||
164400381|NCT03822117|593835159|FG001|Overall Study|Never Returned to Hospital|0|||
164400382|NCT03822117|593835160|FG002|Overall Study|Never Returned to Hospital|1|||
164400383|NCT03822117|593835161|FG003|Overall Study|Never Returned to Hospital|0|||
164400384|NCT00415610|593835163|FG000|Overall Study|Death|3|||
164400385|NCT00415610|593835164|FG001|Overall Study|Death|2|||
164400386|NCT00415610|593835165|FG002|Overall Study|Death|5|||
164400387|NCT01357616|593835169|FG000|Overall Study|Adverse Event|1|||
164400388|NCT01357616|593835170|FG001|Overall Study|Adverse Event|1|||
164400389|NCT01357616|593835169|FG000|Overall Study|Lost to Follow-up|4|||
164400390|NCT01357616|593835170|FG001|Overall Study|Lost to Follow-up|3|||
164400391|NCT01357616|593835169|FG000|Overall Study|Protocol Violation|0|||
164400392|NCT01357616|593835170|FG001|Overall Study|Protocol Violation|2|||
164400393|NCT01357616|593835169|FG000|Overall Study|Inadequate Control of IOP|1|||
164400394|NCT01357616|593835170|FG001|Overall Study|Inadequate Control of IOP|2|||
164400395|NCT01357616|593835169|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
164400396|NCT01357616|593835170|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
164400397|NCT01357616|593835169|FG000|Overall Study|Withdrawal by Subject|1|||
164400398|NCT01357616|593835170|FG001|Overall Study|Withdrawal by Subject|0|||
164400399|NCT03813238|593835180|FG000|Overall Study|Adverse Event|0|||
164400400|NCT03813238|593835181|FG001|Overall Study|Adverse Event|6|||
164400401|NCT03813238|593835180|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164400402|NCT03813238|593835181|FG001|Overall Study|Withdrawal by parent/guardian|2|||
164400403|NCT03813238|593835180|FG000|Overall Study|Lost to Follow-up|0|||
164400404|NCT03813238|593835181|FG001|Overall Study|Lost to Follow-up|1|||
164400405|NCT03813238|593835180|FG000|Overall Study|Other than specified|1|||
164400406|NCT03813238|593835181|FG001|Overall Study|Other than specified|2|||
164400407|NCT02066402|593835182|FG000|Overall Study|Adverse Event|1|||
164400408|NCT02066402|593835183|FG001|Overall Study|Adverse Event|2|||
164400409|NCT02066402|593835182|FG000|Overall Study|Lost to Follow-up|11|||
164400410|NCT02066402|593835183|FG001|Overall Study|Lost to Follow-up|8|||
164400411|NCT02066402|593835182|FG000|Overall Study|Withdrawal by Subject|14|||
164400412|NCT02066402|593835183|FG001|Overall Study|Withdrawal by Subject|11|||
164400413|NCT02066402|593835182|FG000|Overall Study|Progressive disease-clinical progression|0|||
164400414|NCT02066402|593835183|FG001|Overall Study|Progressive disease-clinical progression|1|||
164400415|NCT02066402|593835182|FG000|Overall Study|Protocol driven decision point|0|||
164400416|NCT02066402|593835183|FG001|Overall Study|Protocol driven decision point|1|||
164400417|NCT00152464|593835184|FG000|Overall Study|Adverse Event|3|||
164400418|NCT00152464|593835185|FG001|Overall Study|Adverse Event|6|||
164400419|NCT00152464|593835184|FG000|Overall Study|Lost to Follow-up|8|||
164400420|NCT00152464|593835185|FG001|Overall Study|Lost to Follow-up|4|||
164400421|NCT00152464|593835184|FG000|Overall Study|Protocol Violation|3|||
164400422|NCT00152464|593835185|FG001|Overall Study|Protocol Violation|1|||
164400423|NCT00152464|593835184|FG000|Overall Study|Withdrawal by Subject|21|||
164400424|NCT00152464|593835185|FG001|Overall Study|Withdrawal by Subject|22|||
164400425|NCT00152464|593835184|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
164400426|NCT00152464|593835185|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
164400427|NCT00152464|593835184|FG000|Overall Study|Eczema deterioration|0|||
164400428|NCT00152464|593835185|FG001|Overall Study|Eczema deterioration|1|||
164400429|NCT00152464|593835184|FG000|Overall Study|Parent decision|1|||
164400430|NCT00152464|593835185|FG001|Overall Study|Parent decision|1|||
164400431|NCT00152464|593835184|FG000|Overall Study|Investigator decision|1|||
164400432|NCT00152464|593835185|FG001|Overall Study|Investigator decision|0|||
164400433|NCT00152464|593835184|FG000|Overall Study|Lack of Efficacy|1|||
164400434|NCT00152464|593835185|FG001|Overall Study|Lack of Efficacy|0|||
164400435|NCT00152464|593835184|FG000|Overall Study|Eczema poorly controlled|1|||
164400436|NCT00152464|593835185|FG001|Overall Study|Eczema poorly controlled|0|||
164400437|NCT00152464|593835184|FG000|Overall Study|Patient relocated|1|||
164400438|NCT00152464|593835185|FG001|Overall Study|Patient relocated|0|||
164400439|NCT02565914|593835186|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
164400440|NCT02565914|593835186|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
164400441|NCT02565914|593835186|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
164705936|NCT01083810|594948822|FG002|Overall Study|Death|3|||
164705937|NCT01083810|594948820|FG000|Overall Study|Co-morbidities|1|||
164400442|NCT02565914|593835186|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
164400443|NCT02565914|593835186|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
164400444|NCT02565914|593835186|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
164400445|NCT02565914|593835186|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
164705938|NCT01083810|594948821|FG001|Overall Study|Co-morbidities|0|||
164705939|NCT01083810|594948822|FG002|Overall Study|Co-morbidities|0|||
164400446|NCT02565914|593835186|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
164400447|NCT02565914|593835186|FG000|Part A (Up to 96 Weeks)|Other|18|||
164400448|NCT02565914|593835186|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
164400449|NCT02565914|593835186|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
164400450|NCT02565914|593835186|FG000|Part B (Up to 96 Weeks)|Other|1|||
164400451|NCT02565914|593835186|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
164400452|NCT02565914|593835186|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
164400453|NCT02565914|593835186|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
164400454|NCT02565914|593835186|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
164400455|NCT02565914|593835186|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
164400456|NCT02565914|593835186|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
164400457|NCT02565914|593835186|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
164400458|NCT02565914|593835186|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
164400459|NCT02565914|593835186|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
164400460|NCT02565914|593835186|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
164400461|NCT02565914|593835186|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
164400462|NCT02565914|593835186|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
164400463|NCT00828984|593835187|FG000|Overall Study|Adverse Event|2|||
164400464|NCT00828984|593835188|FG001|Overall Study|Adverse Event|3|||
164400465|NCT00828984|593835189|FG002|Overall Study|Adverse Event|0|||
164400466|NCT00828984|593835187|FG000|Overall Study|Lost to Follow-up|5|||
164400467|NCT00828984|593835188|FG001|Overall Study|Lost to Follow-up|3|||
164400468|NCT00828984|593835189|FG002|Overall Study|Lost to Follow-up|1|||
164400469|NCT00828984|593835187|FG000|Overall Study|Withdrawal by Subject|4|||
164400470|NCT00828984|593835188|FG001|Overall Study|Withdrawal by Subject|4|||
164400471|NCT00828984|593835189|FG002|Overall Study|Withdrawal by Subject|4|||
164400472|NCT00828984|593835187|FG000|Overall Study|Ineligable|1|||
164400473|NCT00828984|593835188|FG001|Overall Study|Ineligable|2|||
164400474|NCT00828984|593835189|FG002|Overall Study|Ineligable|0|||
164400475|NCT00828984|593835187|FG000|Overall Study|Medical Contraindication|0|||
164400476|NCT00828984|593835188|FG001|Overall Study|Medical Contraindication|1|||
164400477|NCT00828984|593835189|FG002|Overall Study|Medical Contraindication|0|||
164400478|NCT00828984|593835187|FG000|Overall Study|Noncompliant|1|||
164400479|NCT00828984|593835188|FG001|Overall Study|Noncompliant|2|||
164400480|NCT00828984|593835189|FG002|Overall Study|Noncompliant|3|||
164400481|NCT00828984|593835187|FG000|Overall Study|ConMed|1|||
164400482|NCT00828984|593835188|FG001|Overall Study|ConMed|1|||
164400483|NCT00828984|593835189|FG002|Overall Study|ConMed|1|||
164400484|NCT00863655|593835192|FG000|Overall Study|Protocol Violation|4|||
164400485|NCT00863655|593835193|FG001|Overall Study|Protocol Violation|0|||
164400486|NCT00863655|593835192|FG000|Overall Study|Adverse Event|52|||
164400487|NCT00863655|593835193|FG001|Overall Study|Adverse Event|8|||
164400488|NCT00863655|593835192|FG000|Overall Study|Withdrawal by Subject|47|||
164400489|NCT00863655|593835193|FG001|Overall Study|Withdrawal by Subject|7|||
164400490|NCT00863655|593835192|FG000|Overall Study|Administrative problems|1|||
164400491|NCT00863655|593835193|FG001|Overall Study|Administrative problems|0|||
164400492|NCT00863655|593835192|FG000|Overall Study|Death|7|||
164400493|NCT00863655|593835193|FG001|Overall Study|Death|1|||
164400494|NCT00863655|593835192|FG000|Overall Study|New cancer therapy|5|||
164400495|NCT00863655|593835193|FG001|Overall Study|New cancer therapy|1|||
164400496|NCT00863655|593835192|FG000|Overall Study|Disease progression|364|||
164400497|NCT00863655|593835193|FG001|Overall Study|Disease progression|221|||
164400498|NCT00863655|593835192|FG000|Overall Study|Treatment completed as per protocol|5|||
164400499|NCT00863655|593835193|FG001|Overall Study|Treatment completed as per protocol|1|||
164400500|NCT04465357|593835194|FG000|Overall Study|Adverse Event|2|||
164400501|NCT04465357|593835194|FG000|Overall Study|Lack of Efficacy|1|||
164400502|NCT04465357|593835194|FG000|Overall Study|Lost to Follow-up|2|||
164400503|NCT04465357|593835194|FG000|Overall Study|Withdrawal by Subject|6|||
164400504|NCT04465357|593835194|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
164400505|NCT00430248|593835205|FG000|Overall Study|Adverse Event|49|||
164400506|NCT00430248|593835206|FG001|Overall Study|Adverse Event|61|||
164400507|NCT00430248|593835207|FG002|Overall Study|Adverse Event|64|||
164400508|NCT00430248|593835205|FG000|Overall Study|Protocol Violation|10|||
164705940|NCT01083810|594948820|FG000|Overall Study|Participation in study|1|||
164400509|NCT00430248|593835206|FG001|Overall Study|Protocol Violation|2|||
164400510|NCT00430248|593835207|FG002|Overall Study|Protocol Violation|4|||
164400511|NCT00430248|593835205|FG000|Overall Study|Personal Reasons|12|||
164400512|NCT00430248|593835206|FG001|Overall Study|Personal Reasons|24|||
164400513|NCT00430248|593835207|FG002|Overall Study|Personal Reasons|9|||
164400514|NCT00430248|593835205|FG000|Overall Study|Lost to Follow-up|28|||
164400515|NCT00430248|593835206|FG001|Overall Study|Lost to Follow-up|33|||
164400516|NCT00430248|593835207|FG002|Overall Study|Lost to Follow-up|28|||
164400517|NCT00430248|593835205|FG000|Overall Study|Therapeutic Failure|1|||
164400518|NCT00430248|593835206|FG001|Overall Study|Therapeutic Failure|1|||
164400519|NCT00430248|593835207|FG002|Overall Study|Therapeutic Failure|1|||
164400520|NCT00430248|593835205|FG000|Overall Study|Withdrawal by Subject|14|||
164705941|NCT01083810|594948821|FG001|Overall Study|Participation in study|0|||
164400521|NCT00430248|593835206|FG001|Overall Study|Withdrawal by Subject|20|||
164400522|NCT00430248|593835207|FG002|Overall Study|Withdrawal by Subject|16|||
164400523|NCT00430248|593835205|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
164400524|NCT00430248|593835206|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
164400525|NCT00430248|593835207|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
164400526|NCT00430248|593835205|FG000|Overall Study|Gout Flare|3|||
164400527|NCT00430248|593835206|FG001|Overall Study|Gout Flare|7|||
164400528|NCT00430248|593835207|FG002|Overall Study|Gout Flare|2|||
164400529|NCT00430248|593835205|FG000|Overall Study|Reason Not Specified|8|||
164400530|NCT00430248|593835206|FG001|Overall Study|Reason Not Specified|8|||
164400531|NCT00430248|593835207|FG002|Overall Study|Reason Not Specified|11|||
164400532|NCT00002558|593835210|FG000|Overall Study|Withdrawal by Subject|0|||
164400533|NCT00002558|593835211|FG001|Overall Study|Withdrawal by Subject|1|||
164400534|NCT01260350|593835215|FG000|Overall Study|Lack of Efficacy|0|||
164400535|NCT01260350|593835216|FG001|Overall Study|Lack of Efficacy|0|||
164400536|NCT01260350|593835217|FG002|Overall Study|Lack of Efficacy|0|||
164400537|NCT01260350|593835218|FG003|Overall Study|Lack of Efficacy|0|||
164400538|NCT01260350|593835219|FG004|Overall Study|Lack of Efficacy|0|||
164400539|NCT01260350|593835220|FG005|Overall Study|Lack of Efficacy|0|||
164400540|NCT01260350|593835221|FG006|Overall Study|Lack of Efficacy|0|||
164400541|NCT01260350|593835222|FG007|Overall Study|Lack of Efficacy|0|||
164400542|NCT01260350|593835223|FG008|Overall Study|Lack of Efficacy|0|||
164400543|NCT01260350|593835224|FG009|Overall Study|Lack of Efficacy|0|||
164400544|NCT01260350|593835225|FG010|Overall Study|Lack of Efficacy|0|||
164400545|NCT01260350|593835226|FG011|Overall Study|Lack of Efficacy|0|||
164400546|NCT01260350|593835227|FG012|Overall Study|Lack of Efficacy|0|||
164400547|NCT01260350|593835228|FG013|Overall Study|Lack of Efficacy|0|||
164400548|NCT01260350|593835229|FG014|Overall Study|Lack of Efficacy|0|||
164400549|NCT01260350|593835230|FG015|Overall Study|Lack of Efficacy|0|||
164400550|NCT01260350|593835231|FG016|Overall Study|Lack of Efficacy|0|||
164400551|NCT01260350|593835232|FG017|Overall Study|Lack of Efficacy|1|||
164400552|NCT01260350|593835233|FG018|Overall Study|Lack of Efficacy|0|||
164400553|NCT01260350|593835234|FG019|Overall Study|Lack of Efficacy|0|||
164400554|NCT01260350|593835235|FG020|Overall Study|Lack of Efficacy|3|||
164400555|NCT01260350|593835236|FG021|Overall Study|Lack of Efficacy|0|||
164400556|NCT01260350|593835215|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
164400557|NCT01260350|593835216|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
164400558|NCT01260350|593835217|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
164400559|NCT01260350|593835218|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
164400560|NCT01260350|593835219|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
164400561|NCT01260350|593835220|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
164400562|NCT01260350|593835221|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
164400563|NCT01260350|593835222|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
164400564|NCT01260350|593835223|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
164400565|NCT01260350|593835224|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
164400566|NCT01260350|593835225|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
164400567|NCT01260350|593835226|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
164400568|NCT01260350|593835227|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
164400569|NCT01260350|593835228|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
164400570|NCT01260350|593835229|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
164400571|NCT01260350|593835230|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
164400572|NCT01260350|593835231|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
164400573|NCT01260350|593835232|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
164400574|NCT01260350|593835233|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
164400575|NCT01260350|593835234|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
164400576|NCT01260350|593835235|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
164400577|NCT01260350|593835236|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
164400578|NCT00716092|593835247|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
164400579|NCT00716092|593835248|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
164400580|NCT00716092|593835249|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
164400581|NCT02436330|593835250|FG000|Cohort 1|Lost to Follow-up|5|||
164400582|NCT02436330|593835251|FG001|Cohort 1|Lost to Follow-up|2|||
164596479|NCT00008138|594546700|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
164400583|NCT02436330|593835250|FG000|Cohort 1|Withdrawal by Subject|0|||
164400584|NCT02436330|593835251|FG001|Cohort 1|Withdrawal by Subject|1|||
164400585|NCT02436330|593835250|FG000|Cohort 2|Lost to Follow-up|2|||
164400586|NCT02436330|593835251|FG001|Cohort 2|Lost to Follow-up|0|||
164400587|NCT02436330|593835250|FG000|Cohort 2|Withdrawal by Subject|2|||
164400588|NCT02436330|593835251|FG001|Cohort 2|Withdrawal by Subject|3|||
164400589|NCT02436330|593835250|FG000|Cohort 3|Lost to Follow-up|1|||
164596480|NCT00008138|594546700|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
164596481|NCT00008138|594546700|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
164596482|NCT00008138|594546700|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
164596483|NCT00008138|594546700|FG000|Interval Debulking|Withdrawal by Subject|2|||
164596484|NCT00008138|594546700|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
164400590|NCT02436330|593835251|FG001|Cohort 3|Lost to Follow-up|0|||
164400591|NCT02436330|593835250|FG000|Cohort 3|Withdrawal by Subject|4|||
164400592|NCT02436330|593835251|FG001|Cohort 3|Withdrawal by Subject|0|||
164400593|NCT02436330|593835250|FG000|Cohort 4|Lost to Follow-up|1|||
164400594|NCT02436330|593835251|FG001|Cohort 4|Lost to Follow-up|0|||
164400595|NCT02436330|593835250|FG000|Cohort 4|Withdrawal by Subject|1|||
164400596|NCT02436330|593835251|FG001|Cohort 4|Withdrawal by Subject|0|||
164400597|NCT02436330|593835250|FG000|Cohort 5|Lost to Follow-up|3|||
164400598|NCT02436330|593835251|FG001|Cohort 5|Lost to Follow-up|2|||
164400599|NCT02436330|593835250|FG000|Cohort 5|Withdrawal by Subject|3|||
164400600|NCT02436330|593835251|FG001|Cohort 5|Withdrawal by Subject|2|||
164400601|NCT02436330|593835250|FG000|Cohort 6|Lost to Follow-up|2|||
164400602|NCT02436330|593835251|FG001|Cohort 6|Lost to Follow-up|0|||
164400603|NCT02436330|593835250|FG000|Cohort 6|Withdrawal by Subject|1|||
164400604|NCT02436330|593835251|FG001|Cohort 6|Withdrawal by Subject|1|||
164400605|NCT02054806|593835252|FG000|Overall Study|Sponsor Decision|31|||
164705942|NCT01083810|594948822|FG002|Overall Study|Participation in study|0|||
164705943|NCT01083810|594948820|FG000|Overall Study|Therapy break|1|||
164705944|NCT01083810|594948821|FG001|Overall Study|Therapy break|2|||
164400606|NCT02054806|593835252|FG000|Overall Study|Withdrawal by Subject|43|||
164400607|NCT02054806|593835252|FG000|Overall Study|Protocol Violation|2|||
164400608|NCT02054806|593835252|FG000|Overall Study|Lost to Follow-up|10|||
164400609|NCT02054806|593835252|FG000|Overall Study|Death|391|||
164400610|NCT00677235|593835253|FG000|Overall Study|Withdrawal by Subject|1|||
164400611|NCT00677235|593835254|FG001|Overall Study|Withdrawal by Subject|1|||
164400612|NCT00677235|593835253|FG000|Overall Study|Lost to Follow-up|2|||
164400613|NCT00677235|593835254|FG001|Overall Study|Lost to Follow-up|1|||
164400614|NCT00677235|593835253|FG000|Overall Study|Death|37|||
164400615|NCT00677235|593835254|FG001|Overall Study|Death|36|||
164400616|NCT00677235|593835253|FG000|Overall Study|Adverse Experience|1|||
164400617|NCT00677235|593835254|FG001|Overall Study|Adverse Experience|0|||
164400618|NCT01040260|593835255|FG000|Overall Study|Withdrawal by Subject|12|||
164400619|NCT01040260|593835256|FG001|Overall Study|Withdrawal by Subject|6|||
164400620|NCT01040260|593835255|FG000|Overall Study|Lost to Follow-up|3|||
164400621|NCT01040260|593835256|FG001|Overall Study|Lost to Follow-up|5|||
164400622|NCT00708916|593835261|FG000|Overall Study|Subject Noncompliance|2|||
164400623|NCT00708916|593835261|FG000|Overall Study|Adverse Event|2|||
164400624|NCT03923959|593835264|FG000|Overall Study|Death|16|||
164400625|NCT03923959|593835265|FG001|Overall Study|Death|12|||
164400626|NCT03923959|593835264|FG000|Overall Study|Lost to Follow-up|56|||
164400627|NCT03923959|593835265|FG001|Overall Study|Lost to Follow-up|56|||
164400628|NCT03923959|593835264|FG000|Overall Study|Withdrawal by Subject|1|||
164400629|NCT03923959|593835265|FG001|Overall Study|Withdrawal by Subject|1|||
164400630|NCT03923959|593835264|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
164400631|NCT03923959|593835265|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
164400632|NCT04212091|593835266|FG000|Overall Study|Lost to Follow-up|0|||
164400633|NCT04212091|593835267|FG001|Overall Study|Lost to Follow-up|0|||
164400634|NCT04212091|593835268|FG002|Overall Study|Lost to Follow-up|0|||
164400635|NCT04212091|593835269|FG003|Overall Study|Lost to Follow-up|0|||
164442728|NCT02880241|593988627|FG000|Overall Study|Lack of Efficacy|1|||
164442729|NCT02880241|593988628|FG001|Overall Study|Lack of Efficacy|0|||
164442730|NCT02880241|593988629|FG002|Overall Study|Lack of Efficacy|0|||
164442731|NCT02880241|593988630|FG003|Overall Study|Lack of Efficacy|0|||
164442732|NCT02880241|593988631|FG004|Overall Study|Lack of Efficacy|0|||
164442733|NCT02880241|593988632|FG005|Overall Study|Lack of Efficacy|0|||
164442734|NCT00638963|593988633|FG000|Overall Study|Withdrawal by Subject|1|||
164705945|NCT01083810|594948822|FG002|Overall Study|Therapy break|2|||
164705946|NCT01083810|594948820|FG000|Overall Study|Virologic failure|1|||
164400636|NCT04212091|593835270|FG004|Overall Study|Lost to Follow-up|1|||
164400637|NCT04212091|593835271|FG005|Overall Study|Lost to Follow-up|1|||
164400638|NCT04212091|593835266|FG000|Overall Study|Participant unable to adhere to visit|0|||
164400639|NCT04212091|593835267|FG001|Overall Study|Participant unable to adhere to visit|0|||
164442735|NCT00638963|593988634|FG001|Overall Study|Withdrawal by Subject|0|||
164442736|NCT00712335|593988635|FG000|Overall Study|Withdrawal by Subject|0|||
164400640|NCT04212091|593835268|FG002|Overall Study|Participant unable to adhere to visit|0|||
164442737|NCT00712335|593988636|FG001|Overall Study|Withdrawal by Subject|7|||
164442738|NCT00712335|593988637|FG002|Overall Study|Withdrawal by Subject|2|||
164442739|NCT00712335|593988638|FG003|Overall Study|Withdrawal by Subject|3|||
164705947|NCT01083810|594948821|FG001|Overall Study|Virologic failure|8|||
164400641|NCT04212091|593835269|FG003|Overall Study|Participant unable to adhere to visit|0|||
164442740|NCT00712335|593988639|FG004|Overall Study|Withdrawal by Subject|0|||
164705948|NCT01083810|594948822|FG002|Overall Study|Virologic failure|0|||
164705949|NCT01602965|594948824|FG000|Overall Study|Lost to Follow-up|4|||
164400642|NCT04212091|593835270|FG004|Overall Study|Participant unable to adhere to visit|1|||
164400643|NCT04212091|593835271|FG005|Overall Study|Participant unable to adhere to visit|0|||
164400644|NCT04575051|593835272|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
164442741|NCT00712335|593988635|FG000|Overall Study|Lost to Follow-up|2|||
164400645|NCT04575051|593835273|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
164400646|NCT04575051|593835274|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
164400647|NCT04575051|593835275|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
164400648|NCT04575051|593835276|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
164400649|NCT04575051|593835272|FG000|Time Period 1|Missing follow up|1|||
164400650|NCT04575051|593835273|FG001|Time Period 1|Missing follow up|3|||
164400651|NCT04575051|593835274|FG002|Time Period 1|Missing follow up|1|||
164400652|NCT04575051|593835275|FG003|Time Period 1|Missing follow up|3|||
164400653|NCT04575051|593835276|FG004|Time Period 1|Missing follow up|2|||
164400654|NCT04575051|593835272|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
164400655|NCT04575051|593835273|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
164400656|NCT04575051|593835274|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
164400657|NCT04575051|593835275|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
164400658|NCT04575051|593835276|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
164400659|NCT04575051|593835272|FG000|Time Period 2|Missing follow up|1|||
164400660|NCT04575051|593835273|FG001|Time Period 2|Missing follow up|8|||
164400661|NCT04575051|593835274|FG002|Time Period 2|Missing follow up|7|||
164400662|NCT04575051|593835275|FG003|Time Period 2|Missing follow up|0|||
164400663|NCT04575051|593835276|FG004|Time Period 2|Missing follow up|1|||
164400664|NCT04575051|593835272|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
164400665|NCT04575051|593835273|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
164400666|NCT04575051|593835274|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
164400667|NCT04575051|593835275|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
164400668|NCT04575051|593835276|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
164400669|NCT04575051|593835272|FG000|Time Period 3|Missing follow up|8|||
164400670|NCT04575051|593835273|FG001|Time Period 3|Missing follow up|6|||
164400671|NCT04575051|593835274|FG002|Time Period 3|Missing follow up|4|||
164400672|NCT04575051|593835275|FG003|Time Period 3|Missing follow up|3|||
164400673|NCT04575051|593835276|FG004|Time Period 3|Missing follow up|0|||
164400674|NCT04575051|593835272|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
164400675|NCT04575051|593835273|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
164400676|NCT04575051|593835274|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
164400677|NCT04575051|593835275|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
164400678|NCT04575051|593835276|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
164400679|NCT04575051|593835272|FG000|Time Period 4|Missing follow up|17|||
164400680|NCT04575051|593835273|FG001|Time Period 4|Missing follow up|3|||
164400681|NCT04575051|593835274|FG002|Time Period 4|Missing follow up|4|||
164400682|NCT04575051|593835275|FG003|Time Period 4|Missing follow up|2|||
164400683|NCT04575051|593835276|FG004|Time Period 4|Missing follow up|1|||
164400684|NCT04575051|593835272|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
164400685|NCT04575051|593835273|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
164400686|NCT04575051|593835274|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
164400687|NCT04575051|593835275|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
164400688|NCT04575051|593835276|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
164400689|NCT04575051|593835272|FG000|Time Period 5|Missing follow up|11|||
164400690|NCT04575051|593835273|FG001|Time Period 5|Missing follow up|8|||
164400691|NCT04575051|593835274|FG002|Time Period 5|Missing follow up|12|||
164400692|NCT04575051|593835275|FG003|Time Period 5|Missing follow up|3|||
164400693|NCT04575051|593835276|FG004|Time Period 5|Missing follow up|11|||
164400694|NCT00951483|593835277|FG000|Overall Study|Physician Decision|4|||
164400695|NCT00951483|593835278|FG001|Overall Study|Physician Decision|0|||
164400696|NCT00951483|593835277|FG000|Overall Study|Withdrawal by Subject|15|||
164400697|NCT00951483|593835278|FG001|Overall Study|Withdrawal by Subject|0|||
164400698|NCT03565887|593835279|FG000|Overall Study|Adverse Event|1|||
164400699|NCT03565887|593835280|FG001|Overall Study|Adverse Event|0|||
164400700|NCT03565887|593835279|FG000|Overall Study|Withdrawal by Subject|0|||
164400701|NCT03565887|593835280|FG001|Overall Study|Withdrawal by Subject|2|||
164400702|NCT00765388|593835281|FG000|Period 1|Lack of Efficacy|1|||
164400703|NCT00765388|593835282|FG001|Period 1|Lack of Efficacy|2|||
164400704|NCT00765388|593835281|FG000|Period 1|Lost to Follow-up|0|||
164705950|NCT01602965|594948825|FG001|Overall Study|Lost to Follow-up|2|||
164400705|NCT00765388|593835282|FG001|Period 1|Lost to Follow-up|1|||
164400706|NCT00765388|593835281|FG000|Period 1|Herpes Zoster|0|||
164400707|NCT00765388|593835282|FG001|Period 1|Herpes Zoster|1|||
164705951|NCT04941729|594953330|FG000|Overall Study|Death|0|||
164400708|NCT00765388|593835281|FG000|Period 1|Hip operation|0|||
164400709|NCT00765388|593835282|FG001|Period 1|Hip operation|1|||
164400710|NCT01939548|593835284|FG000|Overall Study|Non compliance|0|||
164400711|NCT01939548|593835285|FG001|Overall Study|Non compliance|2|||
164400712|NCT01939548|593835286|FG002|Overall Study|Non compliance|0|||
164400713|NCT01939548|593835284|FG000|Overall Study|Study Terminated by Sponsor|17|||
164400714|NCT01939548|593835285|FG001|Overall Study|Study Terminated by Sponsor|19|||
164705952|NCT04941729|594953331|FG001|Overall Study|Death|1|||
164705953|NCT04941729|594953330|FG000|Overall Study|Study terminated by sponsor|11|||
164705954|NCT04941729|594953331|FG001|Overall Study|Study terminated by sponsor|10|||
164705955|NCT00006721|594953332|FG000|Overall Study|Adverse Event|0|||
164400715|NCT01939548|593835286|FG002|Overall Study|Study Terminated by Sponsor|12|||
164400716|NCT01939548|593835284|FG000|Overall Study|Insufficient Clinical Response|1|||
164400717|NCT01939548|593835285|FG001|Overall Study|Insufficient Clinical Response|0|||
164400718|NCT01939548|593835286|FG002|Overall Study|Insufficient Clinical Response|0|||
164400719|NCT01939548|593835284|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
164400720|NCT01939548|593835285|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
164400721|NCT01939548|593835286|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
164400722|NCT01939548|593835284|FG000|Overall Study|Withdrawal by Subject|4|||
164400723|NCT01939548|593835285|FG001|Overall Study|Withdrawal by Subject|4|||
164400724|NCT01939548|593835286|FG002|Overall Study|Withdrawal by Subject|1|||
164400725|NCT01939548|593835284|FG000|Overall Study|Protocol Violation|7|||
164400726|NCT01939548|593835285|FG001|Overall Study|Protocol Violation|6|||
164400727|NCT01939548|593835286|FG002|Overall Study|Protocol Violation|5|||
164400728|NCT01939548|593835284|FG000|Overall Study|Lost to Follow-up|5|||
164400729|NCT01939548|593835285|FG001|Overall Study|Lost to Follow-up|5|||
164400730|NCT01939548|593835286|FG002|Overall Study|Lost to Follow-up|3|||
164400731|NCT01939548|593835284|FG000|Overall Study|Adverse Event|2|||
164400732|NCT01939548|593835285|FG001|Overall Study|Adverse Event|9|||
164400733|NCT01939548|593835286|FG002|Overall Study|Adverse Event|7|||
164400734|NCT01939548|593835284|FG000|Overall Study|Death|0|||
164400735|NCT01939548|593835285|FG001|Overall Study|Death|0|||
164400736|NCT01939548|593835286|FG002|Overall Study|Death|1|||
164400737|NCT01939548|593835284|FG000|Overall Study|Participant dropped|0|||
164400738|NCT01939548|593835285|FG001|Overall Study|Participant dropped|0|||
164400739|NCT01939548|593835286|FG002|Overall Study|Participant dropped|1|||
164400740|NCT01939548|593835284|FG000|Overall Study|Participant unwilling to continue|0|||
164400741|NCT01939548|593835285|FG001|Overall Study|Participant unwilling to continue|1|||
164400742|NCT01939548|593835286|FG002|Overall Study|Participant unwilling to continue|0|||
164400743|NCT01939548|593835284|FG000|Overall Study|Participant withdrew consent|0|||
164400744|NCT01939548|593835285|FG001|Overall Study|Participant withdrew consent|2|||
164400745|NCT01939548|593835286|FG002|Overall Study|Participant withdrew consent|0|||
164400746|NCT01939548|593835284|FG000|Overall Study|Did not complete follow-up|0|||
164400747|NCT01939548|593835285|FG001|Overall Study|Did not complete follow-up|1|||
164400748|NCT01939548|593835286|FG002|Overall Study|Did not complete follow-up|0|||
164400749|NCT01022762|593835289|FG000|Overall Study|Adverse Event|3|||
164400750|NCT01022762|593835290|FG001|Overall Study|Adverse Event|1|||
164400751|NCT01022762|593835289|FG000|Overall Study|Lack of Efficacy|0|||
164400752|NCT01022762|593835290|FG001|Overall Study|Lack of Efficacy|1|||
164400753|NCT01022762|593835289|FG000|Overall Study|Protocol Violation|7|||
164400754|NCT01022762|593835290|FG001|Overall Study|Protocol Violation|6|||
164400755|NCT01022762|593835289|FG000|Overall Study|Unclassified|12|||
164400756|NCT01022762|593835290|FG001|Overall Study|Unclassified|20|||
164400757|NCT01302119|593835291|FG000|Overall Study|Withdrawal by Subject|30|||
164400758|NCT01302119|593835292|FG001|Overall Study|Withdrawal by Subject|20|||
164400759|NCT01302119|593835291|FG000|Overall Study|Lost to Follow-up|10|||
164400760|NCT01302119|593835292|FG001|Overall Study|Lost to Follow-up|4|||
164400761|NCT01302119|593835291|FG000|Overall Study|Adverse Event|2|||
164705956|NCT00006721|594953333|FG001|Overall Study|Adverse Event|4|||
164400762|NCT01302119|593835292|FG001|Overall Study|Adverse Event|1|||
164400763|NCT01302119|593835291|FG000|Overall Study|Non-compliance|4|||
164400764|NCT01302119|593835292|FG001|Overall Study|Non-compliance|2|||
164400765|NCT01302119|593835291|FG000|Overall Study|Non-specific|4|||
164400766|NCT01302119|593835292|FG001|Overall Study|Non-specific|1|||
164400767|NCT01775904|593835293|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
164400768|NCT01775904|593835293|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
164400769|NCT01662310|593835296|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
164705957|NCT00006721|594953334|FG002|Overall Study|Adverse Event|4|||
164705958|NCT00006721|594953332|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
164705959|NCT00006721|594953333|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
164705960|NCT00006721|594953334|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
164400770|NCT01662310|593835297|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
164400771|NCT01662310|593835298|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
164400772|NCT01662310|593835299|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
164400773|NCT01662310|593835300|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
164400774|NCT01662310|593835296|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
164400775|NCT01662310|593835297|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
164400776|NCT01662310|593835298|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
164400777|NCT01662310|593835299|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
164400778|NCT01662310|593835300|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
164400779|NCT01662310|593835296|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
164400780|NCT01662310|593835297|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
164400781|NCT01662310|593835298|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
164400782|NCT01662310|593835299|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
164400783|NCT01662310|593835300|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
164400784|NCT01662310|593835296|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
164400785|NCT01662310|593835297|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
164596485|NCT00008138|594546700|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
164596486|NCT00008138|594546700|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
164596487|NCT03213626|594546701|FG000|Overall Study|Adverse Event|1|||
164596488|NCT03213626|594546701|FG000|Overall Study|Progressive Disease|6|||
164400786|NCT01662310|593835298|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
164400787|NCT01662310|593835299|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
164400788|NCT01662310|593835300|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
164400789|NCT01662310|593835296|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
164400790|NCT01662310|593835297|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
164400791|NCT01662310|593835298|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
164400792|NCT01662310|593835299|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
164400793|NCT01662310|593835300|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
164400794|NCT01662310|593835296|FG000|Run-In or Stabilization Phase|Other|1|||
164400795|NCT01662310|593835297|FG001|Run-In or Stabilization Phase|Other|0|||
164400796|NCT01662310|593835298|FG002|Run-In or Stabilization Phase|Other|0|||
164400797|NCT01662310|593835299|FG003|Run-In or Stabilization Phase|Other|0|||
164400798|NCT01662310|593835300|FG004|Run-In or Stabilization Phase|Other|0|||
164400799|NCT01662310|593835296|FG000|Double-Blind Phase|Adverse Event|0|||
164400800|NCT01662310|593835297|FG001|Double-Blind Phase|Adverse Event|0|||
164400801|NCT01662310|593835298|FG002|Double-Blind Phase|Adverse Event|1|||
164400802|NCT01662310|593835299|FG003|Double-Blind Phase|Adverse Event|0|||
164400803|NCT01662310|593835300|FG004|Double-Blind Phase|Adverse Event|0|||
164400804|NCT01662310|593835296|FG000|Double-Blind Phase|Lost to Follow-up|0|||
164400805|NCT01662310|593835297|FG001|Double-Blind Phase|Lost to Follow-up|3|||
164400806|NCT01662310|593835298|FG002|Double-Blind Phase|Lost to Follow-up|0|||
164400807|NCT01662310|593835299|FG003|Double-Blind Phase|Lost to Follow-up|0|||
164400808|NCT01662310|593835300|FG004|Double-Blind Phase|Lost to Follow-up|0|||
164400809|NCT01662310|593835296|FG000|Double-Blind Phase|Pregnancy|0|||
164400810|NCT01662310|593835297|FG001|Double-Blind Phase|Pregnancy|2|||
164400811|NCT01662310|593835298|FG002|Double-Blind Phase|Pregnancy|0|||
164400812|NCT01662310|593835299|FG003|Double-Blind Phase|Pregnancy|0|||
164400813|NCT01662310|593835300|FG004|Double-Blind Phase|Pregnancy|0|||
164400814|NCT01662310|593835296|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
164400815|NCT01662310|593835297|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
164400816|NCT01662310|593835298|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
164400817|NCT01662310|593835299|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
164400818|NCT01662310|593835300|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
164400819|NCT01662310|593835296|FG000|Double-Blind Phase|Other|0|||
164400820|NCT01662310|593835297|FG001|Double-Blind Phase|Other|0|||
164400821|NCT01662310|593835298|FG002|Double-Blind Phase|Other|1|||
164400822|NCT01662310|593835299|FG003|Double-Blind Phase|Other|0|||
164400823|NCT01662310|593835300|FG004|Double-Blind Phase|Other|0|||
164400824|NCT01662310|593835296|FG000|Double-Blind Phase|Randomized but not treated|0|||
164400825|NCT01662310|593835297|FG001|Double-Blind Phase|Randomized but not treated|1|||
164400826|NCT01662310|593835298|FG002|Double-Blind Phase|Randomized but not treated|0|||
164400827|NCT01662310|593835299|FG003|Double-Blind Phase|Randomized but not treated|0|||
164400828|NCT01662310|593835300|FG004|Double-Blind Phase|Randomized but not treated|0|||
164400829|NCT01662310|593835296|FG000|Open-Label Extension Phase|Adverse Event|0|||
164400830|NCT01662310|593835297|FG001|Open-Label Extension Phase|Adverse Event|0|||
164400831|NCT01662310|593835298|FG002|Open-Label Extension Phase|Adverse Event|0|||
164400832|NCT01662310|593835299|FG003|Open-Label Extension Phase|Adverse Event|3|||
164400833|NCT01662310|593835300|FG004|Open-Label Extension Phase|Adverse Event|0|||
164400834|NCT01662310|593835296|FG000|Open-Label Extension Phase|Death|0|||
164442742|NCT00712335|593988636|FG001|Overall Study|Lost to Follow-up|5|||
164442743|NCT00712335|593988637|FG002|Overall Study|Lost to Follow-up|0|||
164400835|NCT01662310|593835297|FG001|Open-Label Extension Phase|Death|0|||
164400836|NCT01662310|593835298|FG002|Open-Label Extension Phase|Death|0|||
164400837|NCT01662310|593835299|FG003|Open-Label Extension Phase|Death|1|||
164400838|NCT01662310|593835300|FG004|Open-Label Extension Phase|Death|0|||
164400839|NCT01662310|593835296|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
164442744|NCT00712335|593988638|FG003|Overall Study|Lost to Follow-up|1|||
164400840|NCT01662310|593835297|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
164400841|NCT01662310|593835298|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
164400842|NCT01662310|593835299|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
164400843|NCT01662310|593835300|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
164400844|NCT01662310|593835296|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
164400845|NCT01662310|593835297|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
164400846|NCT01662310|593835298|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
164400847|NCT01662310|593835299|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
164596489|NCT01005732|594546702|FG000|Overall Study|Lost to Follow-up|10|||
164596490|NCT01005732|594546702|FG000|Overall Study|Death|1|||
164400848|NCT01662310|593835300|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
164400849|NCT01662310|593835296|FG000|Open-Label Extension Phase|Pregnancy|0|||
164400850|NCT01662310|593835297|FG001|Open-Label Extension Phase|Pregnancy|0|||
164400851|NCT01662310|593835298|FG002|Open-Label Extension Phase|Pregnancy|0|||
164400852|NCT01662310|593835299|FG003|Open-Label Extension Phase|Pregnancy|1|||
164400853|NCT01662310|593835300|FG004|Open-Label Extension Phase|Pregnancy|0|||
164400854|NCT01662310|593835296|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
164400855|NCT01662310|593835297|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
164400856|NCT01662310|593835298|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
164400857|NCT01662310|593835299|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
164400858|NCT01662310|593835300|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
164400859|NCT02432105|593835301|FG000|Overall Study|Lost to Follow-up|1|||
164400860|NCT02432105|593835302|FG001|Overall Study|Lost to Follow-up|1|||
164400861|NCT02432105|593835303|FG002|Overall Study|Lost to Follow-up|0|||
164400862|NCT02432105|593835301|FG000|Overall Study|Withdrawal by Subject|1|||
164400863|NCT02432105|593835302|FG001|Overall Study|Withdrawal by Subject|0|||
164400864|NCT02432105|593835303|FG002|Overall Study|Withdrawal by Subject|1|||
164400865|NCT02432105|593835301|FG000|Overall Study|Culture positive for yeast|0|||
164400866|NCT02432105|593835302|FG001|Overall Study|Culture positive for yeast|1|||
164400867|NCT02432105|593835303|FG002|Overall Study|Culture positive for yeast|0|||
164400868|NCT02432105|593835301|FG000|Overall Study|Randomized in error|0|||
164400869|NCT02432105|593835302|FG001|Overall Study|Randomized in error|0|||
164400870|NCT02432105|593835303|FG002|Overall Study|Randomized in error|2|||
164400871|NCT00829387|593835307|FG000|Overall Study|Withdrawal by Subject|2|||
164400872|NCT00829387|593835308|FG001|Overall Study|Withdrawal by Subject|3|||
164400873|NCT00829387|593835307|FG000|Overall Study|Disqualified by PI|1|||
164596491|NCT02198651|594548878|FG000|Lead-in Period|Withdrew consent|13|||
164400874|NCT00829387|593835308|FG001|Overall Study|Disqualified by PI|0|||
164400875|NCT02085252|593835309|FG000|Overall Study|Withdrawal of Consent|1|||
164400876|NCT02085252|593835310|FG001|Overall Study|Withdrawal of Consent|0|||
164400877|NCT02085252|593835309|FG000|Overall Study|Adverse Event|0|||
164400878|NCT02085252|593835310|FG001|Overall Study|Adverse Event|1|||
164400879|NCT02085252|593835309|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
164400880|NCT02085252|593835310|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
164400881|NCT02085252|593835309|FG000|Overall Study|Reason Not Specified|0|||
164400882|NCT02085252|593835310|FG001|Overall Study|Reason Not Specified|1|||
164400883|NCT02085252|593835309|FG000|Overall Study|Reason Unknown|0|||
164400884|NCT02085252|593835310|FG001|Overall Study|Reason Unknown|1|||
164400885|NCT03260868|593835311|FG000|Overall Study|Poor Compliance to Protocol|0|||
164400886|NCT03260868|593835312|FG001|Overall Study|Poor Compliance to Protocol|2|||
164400887|NCT03260868|593835311|FG000|Overall Study|Study Terminated By Sponsor|2|||
164400888|NCT03260868|593835312|FG001|Overall Study|Study Terminated By Sponsor|1|||
164400889|NCT03260868|593835311|FG000|Overall Study|Other than specified above|1|||
164400890|NCT03260868|593835312|FG001|Overall Study|Other than specified above|0|||
164400891|NCT03645759|593835316|FG000|Overall Study|Lost to Follow-up|3|||
164400892|NCT03645759|593835317|FG001|Overall Study|Lost to Follow-up|2|||
164400893|NCT02693743|593835320|FG000|Overall Study|Physician Decision|1|||
164400894|NCT02693743|593835321|FG001|Overall Study|Physician Decision|0|||
164400895|NCT02626780|593835322|FG000|Overall Study|Withdrawal by Subject|3|||
164400896|NCT05540522|593835323|FG000|Overall Study|Adverse Event|1|||
164400897|NCT05540522|593835324|FG001|Overall Study|Adverse Event|0|||
164400898|NCT05540522|593835325|FG002|Overall Study|Adverse Event|2|||
164400899|NCT05540522|593835326|FG003|Overall Study|Adverse Event|5|||
164400900|NCT05540522|593835323|FG000|Overall Study|Lost to Follow-up|487|||
164400901|NCT05540522|593835324|FG001|Overall Study|Lost to Follow-up|427|||
164400902|NCT05540522|593835325|FG002|Overall Study|Lost to Follow-up|146|||
164596492|NCT02198651|594548879|FG001|Lead-in Period|Withdrew consent|0|||
164596493|NCT02198651|594548880|FG002|Lead-in Period|Withdrew consent|0|||
164400903|NCT05540522|593835326|FG003|Overall Study|Lost to Follow-up|166|||
164400904|NCT05540522|593835323|FG000|Overall Study|Physician Decision|11|||
164400905|NCT05540522|593835324|FG001|Overall Study|Physician Decision|19|||
164400906|NCT05540522|593835325|FG002|Overall Study|Physician Decision|8|||
164596494|NCT02198651|594548881|FG003|Lead-in Period|Withdrew consent|0|||
164596495|NCT02198651|594548882|FG004|Lead-in Period|Withdrew consent|0|||
164596496|NCT02198651|594548878|FG000|Lead-in Period|Adverse Event|2|||
164596497|NCT02198651|594548879|FG001|Lead-in Period|Adverse Event|0|||
164596498|NCT02198651|594548880|FG002|Lead-in Period|Adverse Event|0|||
164596499|NCT02198651|594548881|FG003|Lead-in Period|Adverse Event|0|||
164596500|NCT02198651|594548882|FG004|Lead-in Period|Adverse Event|0|||
164596501|NCT02198651|594548878|FG000|Lead-in Period|Other, not specified|22|||
164596502|NCT02198651|594548879|FG001|Lead-in Period|Other, not specified|0|||
164596503|NCT02198651|594548880|FG002|Lead-in Period|Other, not specified|0|||
164596504|NCT02198651|594548881|FG003|Lead-in Period|Other, not specified|0|||
164596505|NCT02198651|594548882|FG004|Lead-in Period|Other, not specified|0|||
164596506|NCT02198651|594548878|FG000|Double-blind Period|Withdrew consent|0|||
164596507|NCT02198651|594548879|FG001|Double-blind Period|Withdrew consent|4|||
164596508|NCT02198651|594548880|FG002|Double-blind Period|Withdrew consent|0|||
164400907|NCT05540522|593835326|FG003|Overall Study|Physician Decision|13|||
164400908|NCT05540522|593835323|FG000|Overall Study|Pregnancy|1|||
164400909|NCT05540522|593835324|FG001|Overall Study|Pregnancy|0|||
164400910|NCT05540522|593835325|FG002|Overall Study|Pregnancy|0|||
164400911|NCT05540522|593835326|FG003|Overall Study|Pregnancy|0|||
164400912|NCT05540522|593835323|FG000|Overall Study|Protocol Violation|3|||
164400913|NCT05540522|593835324|FG001|Overall Study|Protocol Violation|1|||
164400914|NCT05540522|593835325|FG002|Overall Study|Protocol Violation|9|||
164400915|NCT05540522|593835326|FG003|Overall Study|Protocol Violation|7|||
164400916|NCT05540522|593835323|FG000|Overall Study|Withdrawal by Subject|168|||
164400917|NCT05540522|593835324|FG001|Overall Study|Withdrawal by Subject|134|||
164400918|NCT05540522|593835325|FG002|Overall Study|Withdrawal by Subject|331|||
164400919|NCT05540522|593835326|FG003|Overall Study|Withdrawal by Subject|322|||
164400920|NCT05540522|593835323|FG000|Overall Study|Death|7|||
164400921|NCT05540522|593835324|FG001|Overall Study|Death|9|||
164400922|NCT05540522|593835325|FG002|Overall Study|Death|49|||
164400923|NCT05540522|593835326|FG003|Overall Study|Death|46|||
164400924|NCT05540522|593835323|FG000|Overall Study|Not vaccinated|34|||
164400925|NCT05540522|593835324|FG001|Overall Study|Not vaccinated|53|||
164400926|NCT05540522|593835325|FG002|Overall Study|Not vaccinated|57|||
164400927|NCT05540522|593835326|FG003|Overall Study|Not vaccinated|50|||
164400928|NCT05540522|593835323|FG000|Overall Study|No longer meets eligibility criteria|0|||
164400929|NCT05540522|593835324|FG001|Overall Study|No longer meets eligibility criteria|0|||
164400930|NCT05540522|593835325|FG002|Overall Study|No longer meets eligibility criteria|3|||
164400931|NCT05540522|593835326|FG003|Overall Study|No longer meets eligibility criteria|2|||
164400932|NCT05540522|593835323|FG000|Overall Study|Other (Unspecified)|8|||
164400933|NCT05540522|593835324|FG001|Overall Study|Other (Unspecified)|10|||
164400934|NCT05540522|593835325|FG002|Overall Study|Other (Unspecified)|4|||
164400935|NCT05540522|593835326|FG003|Overall Study|Other (Unspecified)|2|||
164400936|NCT02459574|593835327|FG000|Overall Study|Withdrawal by Subject|6|||
164400937|NCT02459574|593835328|FG001|Overall Study|Withdrawal by Subject|6|||
164400938|NCT02459574|593835329|FG002|Overall Study|Withdrawal by Subject|2|||
164400939|NCT02459574|593835327|FG000|Overall Study|Lost to Follow-up|1|||
164400940|NCT02459574|593835328|FG001|Overall Study|Lost to Follow-up|1|||
164400941|NCT02459574|593835329|FG002|Overall Study|Lost to Follow-up|0|||
164400942|NCT02459574|593835327|FG000|Overall Study|Death|0|||
164400943|NCT02459574|593835328|FG001|Overall Study|Death|1|||
164400944|NCT02459574|593835329|FG002|Overall Study|Death|0|||
164400945|NCT04508699|593835332|FG000|Overall Study|Lack of Efficacy|2|||
164400946|NCT04508699|593835333|FG001|Overall Study|Lack of Efficacy|15|||
164400947|NCT04508699|593835332|FG000|Overall Study|Withdrawal by Subject|0|||
164400948|NCT04508699|593835333|FG001|Overall Study|Withdrawal by Subject|2|||
164400949|NCT01337674|593836784|FG000|Treatment Period 1|Adverse Event|0|||
164400950|NCT01337674|593836785|FG001|Treatment Period 1|Adverse Event|1|||
164400951|NCT01337674|593836786|FG002|Treatment Period 1|Adverse Event|0|||
164400952|NCT01337674|593836787|FG003|Treatment Period 1|Adverse Event|0|||
164400953|NCT01337674|593836784|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
164400954|NCT01337674|593836785|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
164400955|NCT01337674|593836786|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
164400956|NCT01337674|593836787|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
164400957|NCT01337674|593836784|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164400958|NCT01337674|593836785|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164400959|NCT01337674|593836786|FG002|Treatment Period 2|Withdrawal by Subject|1|||
164400960|NCT01337674|593836787|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164400961|NCT01553318|593836790|FG000|Overall Study|Protocol Violation|3|||
164400962|NCT01553318|593836791|FG001|Overall Study|Protocol Violation|2|||
164400963|NCT00695786|593836792|FG000|Overall Study|Adverse Event|0|||
164400964|NCT00695786|593836793|FG001|Overall Study|Adverse Event|3|||
164400965|NCT00695786|593836794|FG002|Overall Study|Adverse Event|4|||
164400966|NCT00695786|593836795|FG003|Overall Study|Adverse Event|2|||
164400967|NCT00695786|593836792|FG000|Overall Study|Lost to Follow-up|0|||
164400968|NCT00695786|593836793|FG001|Overall Study|Lost to Follow-up|5|||
164400969|NCT00695786|593836794|FG002|Overall Study|Lost to Follow-up|1|||
164400970|NCT00695786|593836795|FG003|Overall Study|Lost to Follow-up|1|||
164400971|NCT00695786|593836792|FG000|Overall Study|Withdrawal by Subject|0|||
164400972|NCT00695786|593836793|FG001|Overall Study|Withdrawal by Subject|4|||
164400973|NCT00695786|593836794|FG002|Overall Study|Withdrawal by Subject|3|||
164400974|NCT00695786|593836795|FG003|Overall Study|Withdrawal by Subject|1|||
164400975|NCT00695786|593836792|FG000|Overall Study|Deemed Ineligible|1|||
164400976|NCT00695786|593836793|FG001|Overall Study|Deemed Ineligible|0|||
164400977|NCT00695786|593836794|FG002|Overall Study|Deemed Ineligible|0|||
164400978|NCT00695786|593836795|FG003|Overall Study|Deemed Ineligible|0|||
164400979|NCT00695786|593836792|FG000|Overall Study|Lack of Efficacy|0|||
164400980|NCT00695786|593836793|FG001|Overall Study|Lack of Efficacy|0|||
164400981|NCT00695786|593836794|FG002|Overall Study|Lack of Efficacy|0|||
164400982|NCT00695786|593836795|FG003|Overall Study|Lack of Efficacy|4|||
164400983|NCT04244396|593836799|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
164400984|NCT04244396|593836799|FG000|Overall Study|Withdrawal by Subject|2|||
164596509|NCT02198651|594548881|FG003|Double-blind Period|Withdrew consent|0|||
164596510|NCT02198651|594548882|FG004|Double-blind Period|Withdrew consent|0|||
164596511|NCT02198651|594548878|FG000|Double-blind Period|Adverse Event|0|||
164596512|NCT02198651|594548879|FG001|Double-blind Period|Adverse Event|1|||
164400985|NCT04244396|593836799|FG000|Overall Study|Study termination|37|||
164400986|NCT01787097|593836800|FG000|Overall Study|Withdrawal by Subject|1|||
164400987|NCT01787097|593836801|FG001|Overall Study|Withdrawal by Subject|0|||
164400988|NCT01787097|593836802|FG002|Overall Study|Withdrawal by Subject|0|||
164400989|NCT01787097|593836803|FG003|Overall Study|Withdrawal by Subject|0|||
164400990|NCT00245102|593836804|FG000|Overall Study|Not Treated|1|||
164400991|NCT00245102|593836805|FG001|Overall Study|Not Treated|0|||
164400992|NCT00245102|593836806|FG002|Overall Study|Not Treated|1|||
164400993|NCT00245102|593836807|FG003|Overall Study|Not Treated|0|||
164400994|NCT00245102|593836808|FG004|Overall Study|Not Treated|0|||
164400995|NCT00245102|593836809|FG005|Overall Study|Not Treated|0|||
164400996|NCT00245102|593836804|FG000|Overall Study|Protocol Violation|1|||
164400997|NCT00245102|593836805|FG001|Overall Study|Protocol Violation|0|||
164400998|NCT00245102|593836806|FG002|Overall Study|Protocol Violation|0|||
164400999|NCT00245102|593836807|FG003|Overall Study|Protocol Violation|0|||
164401000|NCT00245102|593836808|FG004|Overall Study|Protocol Violation|0|||
164401001|NCT00245102|593836809|FG005|Overall Study|Protocol Violation|0|||
164401002|NCT00245102|593836804|FG000|Overall Study|Death|0|||
164401003|NCT00245102|593836805|FG001|Overall Study|Death|0|||
164401004|NCT00245102|593836806|FG002|Overall Study|Death|0|||
164401005|NCT00245102|593836807|FG003|Overall Study|Death|1|||
164401006|NCT00245102|593836808|FG004|Overall Study|Death|0|||
164401007|NCT00245102|593836809|FG005|Overall Study|Death|0|||
164401008|NCT00245102|593836804|FG000|Overall Study|Adverse Event|4|||
164401009|NCT00245102|593836805|FG001|Overall Study|Adverse Event|2|||
164401010|NCT00245102|593836806|FG002|Overall Study|Adverse Event|5|||
164401011|NCT00245102|593836807|FG003|Overall Study|Adverse Event|1|||
164401012|NCT00245102|593836808|FG004|Overall Study|Adverse Event|0|||
164401013|NCT00245102|593836809|FG005|Overall Study|Adverse Event|2|||
164401014|NCT00245102|593836804|FG000|Overall Study|Decline in performance|0|||
164401015|NCT00245102|593836805|FG001|Overall Study|Decline in performance|2|||
164401016|NCT00245102|593836806|FG002|Overall Study|Decline in performance|0|||
164401017|NCT00245102|593836807|FG003|Overall Study|Decline in performance|1|||
164401018|NCT00245102|593836808|FG004|Overall Study|Decline in performance|0|||
164401019|NCT00245102|593836809|FG005|Overall Study|Decline in performance|2|||
164401020|NCT00245102|593836804|FG000|Overall Study|Participant needed surgery|0|||
164596513|NCT02198651|594548880|FG002|Double-blind Period|Adverse Event|0|||
164401021|NCT00245102|593836805|FG001|Overall Study|Participant needed surgery|0|||
164401022|NCT00245102|593836806|FG002|Overall Study|Participant needed surgery|1|||
164401023|NCT00245102|593836807|FG003|Overall Study|Participant needed surgery|0|||
164401024|NCT00245102|593836808|FG004|Overall Study|Participant needed surgery|0|||
164401025|NCT00245102|593836809|FG005|Overall Study|Participant needed surgery|0|||
164401026|NCT00245102|593836804|FG000|Overall Study|Clinical progression|1|||
164401027|NCT00245102|593836805|FG001|Overall Study|Clinical progression|0|||
164401028|NCT00245102|593836806|FG002|Overall Study|Clinical progression|0|||
164401029|NCT00245102|593836807|FG003|Overall Study|Clinical progression|0|||
164401030|NCT00245102|593836808|FG004|Overall Study|Clinical progression|0|||
164401031|NCT00245102|593836809|FG005|Overall Study|Clinical progression|0|||
164401032|NCT00289887|593836810|FG000|Overall Study|Adverse Event|3|||
164401033|NCT00289887|593836811|FG001|Overall Study|Adverse Event|3|||
164401034|NCT00289887|593836810|FG000|Overall Study|Lack of Efficacy|3|||
164401035|NCT00289887|593836811|FG001|Overall Study|Lack of Efficacy|11|||
164401036|NCT00289887|593836810|FG000|Overall Study|Lost to Follow-up|3|||
164401037|NCT00289887|593836811|FG001|Overall Study|Lost to Follow-up|3|||
164401038|NCT00289887|593836810|FG000|Overall Study|Protocol Violation|3|||
164401039|NCT00289887|593836811|FG001|Overall Study|Protocol Violation|1|||
164596514|NCT02198651|594548881|FG003|Double-blind Period|Adverse Event|0|||
164596515|NCT02198651|594548882|FG004|Double-blind Period|Adverse Event|0|||
164596516|NCT02198651|594548878|FG000|Double-blind Period|Other, not specified|0|||
164401040|NCT00289887|593836810|FG000|Overall Study|Withdrawal by Subject|3|||
164401041|NCT00289887|593836811|FG001|Overall Study|Withdrawal by Subject|8|||
164401042|NCT00289887|593836810|FG000|Overall Study|Other|7|||
164401043|NCT00289887|593836811|FG001|Overall Study|Other|3|||
164596517|NCT02198651|594548879|FG001|Double-blind Period|Other, not specified|4|||
164596518|NCT02198651|594548880|FG002|Double-blind Period|Other, not specified|1|||
164596519|NCT02198651|594548881|FG003|Double-blind Period|Other, not specified|0|||
164401044|NCT02293395|593836814|FG000|Overall Study|Lost to Follow-up|1|||
164401045|NCT02293395|593836815|FG001|Overall Study|Lost to Follow-up|0|||
164401046|NCT02293395|593836814|FG000|Overall Study|Withdrawal by Subject|8|||
164596520|NCT02198651|594548882|FG004|Double-blind Period|Other, not specified|0|||
164401047|NCT02293395|593836815|FG001|Overall Study|Withdrawal by Subject|7|||
164401048|NCT01464021|593836816|FG000|Overall Study|Withdrawal by Subject|13|||
164401049|NCT01464021|593836816|FG000|Overall Study|Lost to Follow-up|1|||
164401050|NCT01464021|593836816|FG000|Overall Study|Lack of Efficacy|1|||
164401051|NCT01464021|593836816|FG000|Overall Study|various|11|||
164596521|NCT02198651|594548878|FG000|Open-label Rescue Period|Withdrew consent|0|||
164401052|NCT00224770|593836822|FG000|Overall Study|Lost to Follow-up|4|||
164401053|NCT00224770|593836823|FG001|Overall Study|Lost to Follow-up|2|||
164401054|NCT00224770|593836824|FG002|Overall Study|Lost to Follow-up|0|||
164401055|NCT01106430|593836825|FG000|Overall Study|Adverse Event|8|||
164401056|NCT01106430|593836826|FG001|Overall Study|Adverse Event|10|||
164401057|NCT01106430|593836825|FG000|Overall Study|Lack of Efficacy|2|||
164401058|NCT01106430|593836826|FG001|Overall Study|Lack of Efficacy|13|||
164401059|NCT01106430|593836825|FG000|Overall Study|Lost to Follow-up|5|||
164401060|NCT01106430|593836826|FG001|Overall Study|Lost to Follow-up|1|||
164401061|NCT01106430|593836825|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
164401062|NCT01106430|593836826|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
164401063|NCT01106430|593836825|FG000|Overall Study|Moved Out Of State|0|||
164401064|NCT01106430|593836826|FG001|Overall Study|Moved Out Of State|1|||
164401065|NCT01106430|593836825|FG000|Overall Study|Refused To Take Medication|0|||
164401066|NCT01106430|593836826|FG001|Overall Study|Refused To Take Medication|1|||
164401067|NCT01106430|593836825|FG000|Overall Study|Noncompliance|0|||
164401068|NCT01106430|593836826|FG001|Overall Study|Noncompliance|1|||
164401069|NCT01106430|593836825|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
164401070|NCT01106430|593836826|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
164401071|NCT01106430|593836825|FG000|Overall Study|Previous Use Of Marijuana|1|||
164401072|NCT01106430|593836826|FG001|Overall Study|Previous Use Of Marijuana|0|||
164401073|NCT01106430|593836825|FG000|Overall Study|Protocol Violation|7|||
164401074|NCT01106430|593836826|FG001|Overall Study|Protocol Violation|2|||
164401075|NCT01106430|593836825|FG000|Overall Study|Withdrawal by Subject|8|||
164401076|NCT01106430|593836826|FG001|Overall Study|Withdrawal by Subject|4|||
164401077|NCT00437645|593836827|FG000|Overall Study|Adverse Event|15|||
164401078|NCT00437645|593836828|FG001|Overall Study|Adverse Event|84|||
164401079|NCT00437645|593836827|FG000|Overall Study|Withdrawal by Subject|10|||
164401080|NCT00437645|593836828|FG001|Overall Study|Withdrawal by Subject|22|||
164401081|NCT00437645|593836827|FG000|Overall Study|Protocol Violation|3|||
164401082|NCT00437645|593836828|FG001|Overall Study|Protocol Violation|3|||
164401083|NCT00437645|593836827|FG000|Overall Study|Lost to Follow-up|2|||
164401084|NCT00437645|593836828|FG001|Overall Study|Lost to Follow-up|3|||
164401085|NCT00437645|593836827|FG000|Overall Study|Administrative problems|2|||
164401086|NCT00437645|593836828|FG001|Overall Study|Administrative problems|1|||
164401087|NCT00437645|593836827|FG000|Overall Study|Lack of Efficacy|2|||
164401088|NCT00437645|593836828|FG001|Overall Study|Lack of Efficacy|1|||
164401089|NCT00437645|593836827|FG000|Overall Study|Condition no longer requires study drug|1|||
164401090|NCT00437645|593836828|FG001|Overall Study|Condition no longer requires study drug|1|||
164401091|NCT00175825|593836833|FG000|Overall Study|Adverse Event|3|||
164401092|NCT00175825|593836834|FG001|Overall Study|Adverse Event|2|||
164401093|NCT00175825|593836835|FG002|Overall Study|Adverse Event|1|||
164401094|NCT00175825|593836836|FG003|Overall Study|Adverse Event|1|||
164401095|NCT00175825|593836833|FG000|Overall Study|Lost to Follow-up|1|||
164401096|NCT00175825|593836834|FG001|Overall Study|Lost to Follow-up|2|||
164401097|NCT00175825|593836835|FG002|Overall Study|Lost to Follow-up|0|||
164401098|NCT00175825|593836836|FG003|Overall Study|Lost to Follow-up|0|||
164401099|NCT00175825|593836833|FG000|Overall Study|Withdrawal by Subject|1|||
164401100|NCT00175825|593836834|FG001|Overall Study|Withdrawal by Subject|0|||
164401101|NCT00175825|593836835|FG002|Overall Study|Withdrawal by Subject|0|||
164401102|NCT00175825|593836836|FG003|Overall Study|Withdrawal by Subject|0|||
164401103|NCT03704584|593836837|FG000|Overall Study|Withdrawal by Subject|1|||
164401104|NCT03704584|593836838|FG001|Overall Study|Withdrawal by Subject|0|||
164401105|NCT04385368|593836839|FG000|Overall Study|Death|5|||
164442745|NCT00712335|593988639|FG004|Overall Study|Lost to Follow-up|0|||
164442746|NCT00712335|593988635|FG000|Overall Study|Protocol Violation|1|||
164442747|NCT00712335|593988636|FG001|Overall Study|Protocol Violation|2|||
164442748|NCT00712335|593988637|FG002|Overall Study|Protocol Violation|1|||
164442749|NCT00712335|593988638|FG003|Overall Study|Protocol Violation|0|||
164442750|NCT00712335|593988639|FG004|Overall Study|Protocol Violation|0|||
164442751|NCT00712335|593988635|FG000|Overall Study|Lack of Efficacy|0|||
164442752|NCT00712335|593988636|FG001|Overall Study|Lack of Efficacy|0|||
164442753|NCT00712335|593988637|FG002|Overall Study|Lack of Efficacy|1|||
164442754|NCT00712335|593988638|FG003|Overall Study|Lack of Efficacy|1|||
164442755|NCT00712335|593988639|FG004|Overall Study|Lack of Efficacy|0|||
164442756|NCT00712335|593988635|FG000|Overall Study|Other Reason|0|||
164401106|NCT04385368|593836840|FG001|Overall Study|Death|5|||
164401107|NCT04385368|593836839|FG000|Overall Study|Physician Decision|3|||
164401108|NCT04385368|593836840|FG001|Overall Study|Physician Decision|0|||
164442757|NCT00712335|593988636|FG001|Overall Study|Other Reason|3|||
164401109|NCT04385368|593836839|FG000|Overall Study|Withdrawal by Subject|4|||
164401110|NCT04385368|593836840|FG001|Overall Study|Withdrawal by Subject|3|||
164401111|NCT02123108|593836844|FG000|Overall Study|Death|2|||
164401112|NCT02123108|593836845|FG001|Overall Study|Death|3|||
164401113|NCT02219048|593836846|FG000|Overall Study|Adverse Event|2|||
164401114|NCT02219048|593836847|FG001|Overall Study|Adverse Event|5|||
164401115|NCT02219048|593836846|FG000|Overall Study|No longer meets eligibility criteria|1|||
164442758|NCT00712335|593988637|FG002|Overall Study|Other Reason|1|||
164442759|NCT00712335|593988638|FG003|Overall Study|Other Reason|0|||
164401116|NCT02219048|593836847|FG001|Overall Study|No longer meets eligibility criteria|0|||
164401117|NCT02219048|593836846|FG000|Overall Study|Study terminated by sponsor|16|||
164401118|NCT02219048|593836847|FG001|Overall Study|Study terminated by sponsor|15|||
164401119|NCT02219048|593836846|FG000|Overall Study|Withdrawal by Subject|2|||
164401120|NCT02219048|593836847|FG001|Overall Study|Withdrawal by Subject|0|||
164401121|NCT02219048|593836846|FG000|Overall Study|Other|0|||
164401122|NCT02219048|593836847|FG001|Overall Study|Other|1|||
164401123|NCT04721925|593836848|FG000|2-Month Assessment|Lost to Follow-up|5|||
164401124|NCT04721925|593836849|FG001|2-Month Assessment|Lost to Follow-up|3|||
164401125|NCT04721925|593836848|FG000|4-Month Assessment|Lost to Follow-up|3|||
164401126|NCT04721925|593836849|FG001|4-Month Assessment|Lost to Follow-up|6|||
164401127|NCT03802123|593836858|FG000|Overall Study|Withdrawal by Subject|3|||
164401128|NCT03802123|593836858|FG000|Overall Study|Physician Decision|1|||
164401129|NCT03802123|593836858|FG000|Overall Study|Subject moved to hospice care|1|||
164401130|NCT03802123|593836858|FG000|Overall Study|technician error|1|||
164401131|NCT03802123|593836858|FG000|Overall Study|Death|3|||
164401132|NCT01274182|593836859|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
164401133|NCT01274182|593836860|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
164401134|NCT01274182|593836861|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
164401135|NCT01274182|593836859|FG000|Overall Study|Adverse Event|4|||
164401136|NCT01274182|593836860|FG001|Overall Study|Adverse Event|5|||
164401137|NCT01274182|593836861|FG002|Overall Study|Adverse Event|3|||
164401138|NCT01274182|593836859|FG000|Overall Study|Withdrawal by Subject|5|||
164401139|NCT01274182|593836860|FG001|Overall Study|Withdrawal by Subject|5|||
164401140|NCT01274182|593836861|FG002|Overall Study|Withdrawal by Subject|3|||
164401141|NCT01274182|593836859|FG000|Overall Study|Lost to Follow-up|2|||
164401142|NCT01274182|593836860|FG001|Overall Study|Lost to Follow-up|3|||
164401143|NCT01274182|593836861|FG002|Overall Study|Lost to Follow-up|1|||
164401144|NCT01274182|593836859|FG000|Overall Study|Protocol Violation|3|||
164401145|NCT01274182|593836860|FG001|Overall Study|Protocol Violation|2|||
164401146|NCT01274182|593836861|FG002|Overall Study|Protocol Violation|0|||
164401147|NCT01274182|593836859|FG000|Overall Study|Death|1|||
164401148|NCT01274182|593836860|FG001|Overall Study|Death|0|||
164401149|NCT01274182|593836861|FG002|Overall Study|Death|1|||
164401150|NCT01970982|593836862|FG000|Overall Study|Withdrawal by Subject|0|||
164401151|NCT01970982|593836863|FG001|Overall Study|Withdrawal by Subject|0|||
164401152|NCT01970982|593836864|FG002|Overall Study|Withdrawal by Subject|2|||
164401153|NCT04555096|593836870|FG000|Overall Study|Death|4|||
164401154|NCT04555096|593836871|FG001|Overall Study|Death|4|||
164401155|NCT04555096|593836870|FG000|Overall Study|Withdrawal by Subject|1|||
164401156|NCT04555096|593836871|FG001|Overall Study|Withdrawal by Subject|0|||
164401157|NCT04555096|593836870|FG000|Overall Study|Other|0|||
164401158|NCT04555096|593836871|FG001|Overall Study|Other|1|||
164401159|NCT04040751|593836874|FG000|Overall Study|Withdrawal by Subject|2|||
164401160|NCT04040751|593836875|FG001|Overall Study|Withdrawal by Subject|0|||
164401161|NCT04040751|593836876|FG002|Overall Study|Withdrawal by Subject|2|||
164401162|NCT04040751|593836877|FG003|Overall Study|Withdrawal by Subject|0|||
164401163|NCT02862457|593836878|FG000|Overall Study|Death|1|||
164401164|NCT02862457|593836879|FG001|Overall Study|Death|3|||
164401165|NCT02862457|593836880|FG002|Overall Study|Death|2|||
164401166|NCT02862457|593836881|FG003|Overall Study|Death|3|||
164401167|NCT02862457|593836882|FG004|Overall Study|Death|0|||
164401168|NCT02862457|593836883|FG005|Overall Study|Death|2|||
164401169|NCT02862457|593836884|FG006|Overall Study|Death|1|||
164401170|NCT02862457|593836878|FG000|Overall Study|Lost to Follow-up|1|||
164401171|NCT02862457|593836879|FG001|Overall Study|Lost to Follow-up|0|||
164401172|NCT02862457|593836880|FG002|Overall Study|Lost to Follow-up|0|||
164401173|NCT02862457|593836881|FG003|Overall Study|Lost to Follow-up|1|||
164401174|NCT02862457|593836882|FG004|Overall Study|Lost to Follow-up|0|||
164401175|NCT02862457|593836883|FG005|Overall Study|Lost to Follow-up|0|||
164401176|NCT02862457|593836884|FG006|Overall Study|Lost to Follow-up|0|||
164401177|NCT02862457|593836878|FG000|Overall Study|Withdrawal by Subject|0|||
164401178|NCT02862457|593836879|FG001|Overall Study|Withdrawal by Subject|0|||
164442760|NCT00712335|593988639|FG004|Overall Study|Other Reason|0|||
164442761|NCT03401112|593988640|FG000|Overall Study|Adverse Event|1|||
164705961|NCT00006721|594953332|FG000|Overall Study|Progression/Relapse|0|||
164401179|NCT02862457|593836880|FG002|Overall Study|Withdrawal by Subject|1|||
164401180|NCT02862457|593836881|FG003|Overall Study|Withdrawal by Subject|0|||
164401181|NCT02862457|593836882|FG004|Overall Study|Withdrawal by Subject|0|||
164401182|NCT02862457|593836883|FG005|Overall Study|Withdrawal by Subject|1|||
164401183|NCT02862457|593836884|FG006|Overall Study|Withdrawal by Subject|0|||
164401184|NCT03364751|593836885|FG000|Overall Study|Withdrawal by Subject|1|||
164401185|NCT03364751|593836886|FG001|Overall Study|Withdrawal by Subject|0|||
164401186|NCT03364751|593836887|FG002|Overall Study|Withdrawal by Subject|0|||
164401187|NCT03364751|593836888|FG003|Overall Study|Withdrawal by Subject|0|||
164401188|NCT03364751|593836885|FG000|Overall Study|Lost to Follow-up|0|||
164401189|NCT03364751|593836886|FG001|Overall Study|Lost to Follow-up|1|||
164401190|NCT03364751|593836887|FG002|Overall Study|Lost to Follow-up|0|||
164401191|NCT03364751|593836888|FG003|Overall Study|Lost to Follow-up|0|||
164401192|NCT02342886|593836890|FG000|Overall Study|Treatment non-compliance|1|||
164401193|NCT02342886|593836891|FG001|Overall Study|Treatment non-compliance|0|||
164401194|NCT02342886|593836892|FG002|Overall Study|Treatment non-compliance|0|||
164401195|NCT02342886|593836893|FG003|Overall Study|Treatment non-compliance|1|||
164401196|NCT02342886|593836894|FG004|Overall Study|Treatment non-compliance|0|||
164401197|NCT02342886|593836890|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
164401198|NCT02342886|593836891|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
164401199|NCT02342886|593836892|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
164401200|NCT02342886|593836893|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
164401201|NCT02342886|593836894|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
164401202|NCT02342886|593836890|FG000|Overall Study|Adverse event/specific toxicity|4|||
164401203|NCT02342886|593836891|FG001|Overall Study|Adverse event/specific toxicity|3|||
164401204|NCT02342886|593836892|FG002|Overall Study|Adverse event/specific toxicity|11|||
164401205|NCT02342886|593836893|FG003|Overall Study|Adverse event/specific toxicity|2|||
164401206|NCT02342886|593836894|FG004|Overall Study|Adverse event/specific toxicity|1|||
164401207|NCT02342886|593836890|FG000|Overall Study|Lost to Follow-up|1|||
164401208|NCT02342886|593836891|FG001|Overall Study|Lost to Follow-up|0|||
164401209|NCT02342886|593836892|FG002|Overall Study|Lost to Follow-up|0|||
164401210|NCT02342886|593836893|FG003|Overall Study|Lost to Follow-up|0|||
164401211|NCT02342886|593836894|FG004|Overall Study|Lost to Follow-up|0|||
164401212|NCT02342886|593836890|FG000|Overall Study|Death|1|||
164401213|NCT02342886|593836891|FG001|Overall Study|Death|2|||
164401214|NCT02342886|593836892|FG002|Overall Study|Death|1|||
164401215|NCT02342886|593836893|FG003|Overall Study|Death|0|||
164401216|NCT02342886|593836894|FG004|Overall Study|Death|1|||
164401217|NCT02342886|593836890|FG000|Overall Study|Withdrawal by Subject|0|||
164401218|NCT02342886|593836891|FG001|Overall Study|Withdrawal by Subject|1|||
164401219|NCT02342886|593836892|FG002|Overall Study|Withdrawal by Subject|0|||
164401220|NCT02342886|593836893|FG003|Overall Study|Withdrawal by Subject|1|||
164401221|NCT02342886|593836894|FG004|Overall Study|Withdrawal by Subject|0|||
164401222|NCT02342886|593836890|FG000|Overall Study|Investigator/sponsor decision|0|||
164401223|NCT02342886|593836891|FG001|Overall Study|Investigator/sponsor decision|2|||
164401224|NCT02342886|593836892|FG002|Overall Study|Investigator/sponsor decision|0|||
164401225|NCT02342886|593836893|FG003|Overall Study|Investigator/sponsor decision|3|||
164401226|NCT02342886|593836894|FG004|Overall Study|Investigator/sponsor decision|1|||
164401227|NCT02342886|593836890|FG000|Overall Study|Pregnancy|0|||
164401228|NCT02342886|593836891|FG001|Overall Study|Pregnancy|0|||
164401229|NCT02342886|593836892|FG002|Overall Study|Pregnancy|2|||
164401230|NCT02342886|593836893|FG003|Overall Study|Pregnancy|0|||
164401231|NCT02342886|593836894|FG004|Overall Study|Pregnancy|0|||
164401232|NCT02342886|593836890|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
164401233|NCT02342886|593836891|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
164401234|NCT02342886|593836892|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
164401235|NCT02342886|593836893|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
164401236|NCT02342886|593836894|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
164401237|NCT02342886|593836890|FG000|Overall Study|Protocol Violation|0|||
164401238|NCT02342886|593836891|FG001|Overall Study|Protocol Violation|0|||
164401239|NCT02342886|593836892|FG002|Overall Study|Protocol Violation|0|||
164401240|NCT02342886|593836893|FG003|Overall Study|Protocol Violation|2|||
164401241|NCT02342886|593836894|FG004|Overall Study|Protocol Violation|0|||
164401242|NCT00862134|593836895|FG000|Overall Study|Death|1|||
164401243|NCT00862134|593836896|FG001|Overall Study|Death|0|||
164401244|NCT00862134|593836895|FG000|Overall Study|Physician Decision|0|||
164401245|NCT00862134|593836896|FG001|Overall Study|Physician Decision|1|||
164401246|NCT00862134|593836895|FG000|Overall Study|Withdrawal by Subject|1|||
164401247|NCT00862134|593836896|FG001|Overall Study|Withdrawal by Subject|2|||
164401248|NCT00862134|593836895|FG000|Overall Study|Sponsor terminated study|5|||
164401249|NCT00862134|593836896|FG001|Overall Study|Sponsor terminated study|7|||
164401250|NCT00862134|593836895|FG000|Overall Study|Adverse Event|2|||
164401251|NCT00862134|593836896|FG001|Overall Study|Adverse Event|2|||
164401252|NCT00862134|593836895|FG000|Overall Study|Withdrew prior to dosing|2|||
164401253|NCT00862134|593836896|FG001|Overall Study|Withdrew prior to dosing|0|||
164401254|NCT00765674|593836897|FG000|Overall Study|Adverse Event|7|||
164401255|NCT00765674|593836898|FG001|Overall Study|Adverse Event|2|||
164401256|NCT00765674|593836899|FG002|Overall Study|Adverse Event|8|||
164401257|NCT00765674|593836900|FG003|Overall Study|Adverse Event|11|||
164705962|NCT00006721|594953333|FG001|Overall Study|Progression/Relapse|1|||
164401258|NCT00765674|593836897|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
164401259|NCT00765674|593836898|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
164401260|NCT00765674|593836899|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
164401261|NCT00765674|593836900|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
164401262|NCT00765674|593836897|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
164401263|NCT00765674|593836898|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
164401264|NCT00765674|593836899|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
164401265|NCT00765674|593836900|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
164401266|NCT00765674|593836897|FG000|Overall Study|Lack of Efficacy|2|||
164442762|NCT03401112|593988641|FG001|Overall Study|Adverse Event|2|||
164442763|NCT03401112|593988642|FG002|Overall Study|Adverse Event|3|||
164442764|NCT03401112|593988643|FG003|Overall Study|Adverse Event|2|||
164442765|NCT03401112|593988644|FG004|Overall Study|Adverse Event|0|||
164442766|NCT03401112|593988640|FG000|Overall Study|Lost to Follow-up|1|||
164442767|NCT03401112|593988641|FG001|Overall Study|Lost to Follow-up|0|||
164442768|NCT03401112|593988642|FG002|Overall Study|Lost to Follow-up|0|||
164442769|NCT03401112|593988643|FG003|Overall Study|Lost to Follow-up|0|||
164442770|NCT03401112|593988644|FG004|Overall Study|Lost to Follow-up|0|||
164442771|NCT03401112|593988640|FG000|Overall Study|Noncompliance|1|||
164442772|NCT03401112|593988641|FG001|Overall Study|Noncompliance|2|||
164442773|NCT03401112|593988642|FG002|Overall Study|Noncompliance|3|||
164442774|NCT03401112|593988643|FG003|Overall Study|Noncompliance|0|||
164442775|NCT03401112|593988644|FG004|Overall Study|Noncompliance|0|||
164442776|NCT03401112|593988640|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
164442777|NCT03401112|593988641|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
164442778|NCT03401112|593988642|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
164442779|NCT03401112|593988643|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
164442780|NCT03401112|593988644|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
164442781|NCT03401112|593988640|FG000|Overall Study|Withdrawal by Subject|0|||
164442782|NCT03401112|593988641|FG001|Overall Study|Withdrawal by Subject|3|||
164442783|NCT03401112|593988642|FG002|Overall Study|Withdrawal by Subject|2|||
164442784|NCT03401112|593988643|FG003|Overall Study|Withdrawal by Subject|1|||
164442785|NCT03401112|593988644|FG004|Overall Study|Withdrawal by Subject|0|||
164442786|NCT03401112|593988640|FG000|Overall Study|Physician Decision|0|||
164442787|NCT03401112|593988641|FG001|Overall Study|Physician Decision|0|||
164442788|NCT03401112|593988642|FG002|Overall Study|Physician Decision|0|||
164442789|NCT03401112|593988643|FG003|Overall Study|Physician Decision|2|||
164401267|NCT00765674|593836898|FG001|Overall Study|Lack of Efficacy|3|||
164401268|NCT00765674|593836899|FG002|Overall Study|Lack of Efficacy|1|||
164401269|NCT00765674|593836900|FG003|Overall Study|Lack of Efficacy|2|||
164401270|NCT00765674|593836897|FG000|Overall Study|Protocol Violation|2|||
164401271|NCT00765674|593836898|FG001|Overall Study|Protocol Violation|0|||
164401272|NCT00765674|593836899|FG002|Overall Study|Protocol Violation|1|||
164401273|NCT00765674|593836900|FG003|Overall Study|Protocol Violation|0|||
164401274|NCT00765674|593836897|FG000|Overall Study|Withdrawal by Subject|5|||
164401275|NCT00765674|593836898|FG001|Overall Study|Withdrawal by Subject|7|||
164401276|NCT00765674|593836899|FG002|Overall Study|Withdrawal by Subject|3|||
164401277|NCT00765674|593836900|FG003|Overall Study|Withdrawal by Subject|8|||
164401278|NCT00765674|593836897|FG000|Overall Study|Lost to Follow-up|4|||
164401279|NCT00765674|593836898|FG001|Overall Study|Lost to Follow-up|6|||
164401280|NCT00765674|593836899|FG002|Overall Study|Lost to Follow-up|2|||
164401281|NCT00765674|593836900|FG003|Overall Study|Lost to Follow-up|1|||
164401282|NCT00765674|593836897|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
164401283|NCT00765674|593836898|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
164401284|NCT00765674|593836899|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
164401285|NCT00765674|593836900|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
164401286|NCT03015402|593836901|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
164401287|NCT03015402|593836902|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
164401288|NCT03015402|593836901|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
164401289|NCT03015402|593836902|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
164401290|NCT01813474|593836908|FG000|Overall Study|Withdrawal by Subject|0|||
164401291|NCT01813474|593836909|FG001|Overall Study|Withdrawal by Subject|0|||
164401292|NCT01813474|593836910|FG002|Overall Study|Withdrawal by Subject|1|||
164442790|NCT03401112|593988644|FG004|Overall Study|Physician Decision|0|||
164442791|NCT03401112|593988640|FG000|Overall Study|Study was Terminated by Sponsor|0|||
164442792|NCT03401112|593988641|FG001|Overall Study|Study was Terminated by Sponsor|0|||
164442793|NCT03401112|593988642|FG002|Overall Study|Study was Terminated by Sponsor|0|||
164442794|NCT03401112|593988643|FG003|Overall Study|Study was Terminated by Sponsor|1|||
164442795|NCT03401112|593988644|FG004|Overall Study|Study was Terminated by Sponsor|0|||
164442796|NCT03401112|593988640|FG000|Overall Study|Day 1 Assessment not Done|1|||
164442797|NCT03401112|593988641|FG001|Overall Study|Day 1 Assessment not Done|0|||
164442798|NCT03401112|593988642|FG002|Overall Study|Day 1 Assessment not Done|0|||
164442799|NCT03401112|593988643|FG003|Overall Study|Day 1 Assessment not Done|0|||
164401293|NCT01813474|593836908|FG000|Overall Study|Adverse Event|1|||
164401294|NCT01813474|593836909|FG001|Overall Study|Adverse Event|1|||
164401295|NCT01813474|593836910|FG002|Overall Study|Adverse Event|0|||
164401296|NCT01813474|593836908|FG000|Overall Study|Lack of Efficacy|2|||
164401297|NCT01813474|593836909|FG001|Overall Study|Lack of Efficacy|6|||
164401298|NCT01813474|593836910|FG002|Overall Study|Lack of Efficacy|9|||
164401299|NCT01813474|593836908|FG000|Overall Study|Death|0|||
164401300|NCT01813474|593836909|FG001|Overall Study|Death|0|||
164401301|NCT01813474|593836910|FG002|Overall Study|Death|1|||
164401302|NCT00316082|593836911|FG000|Overall Study|Lack of Efficacy|2|||
164401303|NCT00316082|593836912|FG001|Overall Study|Lack of Efficacy|3|||
164401304|NCT00316082|593836913|FG002|Overall Study|Lack of Efficacy|3|||
164401305|NCT00316082|593836914|FG003|Overall Study|Lack of Efficacy|4|||
164596522|NCT02198651|594548879|FG001|Open-label Rescue Period|Withdrew consent|0|||
164596523|NCT02198651|594548880|FG002|Open-label Rescue Period|Withdrew consent|0|||
164596524|NCT02198651|594548881|FG003|Open-label Rescue Period|Withdrew consent|2|||
164596525|NCT02198651|594548882|FG004|Open-label Rescue Period|Withdrew consent|0|||
164596526|NCT02198651|594548878|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
164596527|NCT02198651|594548879|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
164401306|NCT00316082|593836915|FG004|Overall Study|Lack of Efficacy|6|||
164401307|NCT00316082|593836911|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
164401308|NCT00316082|593836912|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
164401309|NCT00316082|593836913|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
164401310|NCT00316082|593836914|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
164401311|NCT00316082|593836915|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
164401312|NCT00316082|593836911|FG000|Overall Study|Lost to Follow-up|7|||
164401313|NCT00316082|593836912|FG001|Overall Study|Lost to Follow-up|6|||
164401314|NCT00316082|593836913|FG002|Overall Study|Lost to Follow-up|7|||
164401315|NCT00316082|593836914|FG003|Overall Study|Lost to Follow-up|8|||
164401316|NCT00316082|593836915|FG004|Overall Study|Lost to Follow-up|6|||
164401317|NCT00316082|593836911|FG000|Overall Study|Poor/noncompliance|6|||
164401318|NCT00316082|593836912|FG001|Overall Study|Poor/noncompliance|1|||
164401319|NCT00316082|593836913|FG002|Overall Study|Poor/noncompliance|4|||
164401320|NCT00316082|593836914|FG003|Overall Study|Poor/noncompliance|1|||
164401321|NCT00316082|593836915|FG004|Overall Study|Poor/noncompliance|4|||
164401322|NCT00316082|593836911|FG000|Overall Study|Adverse Event|4|||
164401323|NCT00316082|593836912|FG001|Overall Study|Adverse Event|2|||
164401324|NCT00316082|593836913|FG002|Overall Study|Adverse Event|5|||
164401325|NCT00316082|593836914|FG003|Overall Study|Adverse Event|1|||
164401326|NCT00316082|593836915|FG004|Overall Study|Adverse Event|3|||
164401327|NCT00316082|593836911|FG000|Overall Study|Subject no longer meets study criteria|3|||
164401328|NCT00316082|593836912|FG001|Overall Study|Subject no longer meets study criteria|1|||
164401329|NCT00316082|593836913|FG002|Overall Study|Subject no longer meets study criteria|2|||
164401330|NCT00316082|593836914|FG003|Overall Study|Subject no longer meets study criteria|2|||
164401331|NCT00316082|593836915|FG004|Overall Study|Subject no longer meets study criteria|1|||
164401332|NCT00316082|593836911|FG000|Overall Study|Physician Decision|1|||
164401333|NCT00316082|593836912|FG001|Overall Study|Physician Decision|1|||
164401334|NCT00316082|593836913|FG002|Overall Study|Physician Decision|2|||
164401335|NCT00316082|593836914|FG003|Overall Study|Physician Decision|1|||
164401336|NCT00316082|593836915|FG004|Overall Study|Physician Decision|1|||
164401337|NCT00316082|593836911|FG000|Overall Study|Death|0|||
164401338|NCT00316082|593836912|FG001|Overall Study|Death|0|||
164401339|NCT00316082|593836913|FG002|Overall Study|Death|1|||
164401340|NCT00316082|593836914|FG003|Overall Study|Death|0|||
164401341|NCT00316082|593836915|FG004|Overall Study|Death|0|||
164401342|NCT00316082|593836911|FG000|Overall Study|Administrative reason by sponsor|0|||
164401343|NCT00316082|593836912|FG001|Overall Study|Administrative reason by sponsor|0|||
164401344|NCT00316082|593836913|FG002|Overall Study|Administrative reason by sponsor|1|||
164401345|NCT00316082|593836914|FG003|Overall Study|Administrative reason by sponsor|0|||
164401346|NCT00316082|593836915|FG004|Overall Study|Administrative reason by sponsor|0|||
164401347|NCT00528775|593836918|FG000|Overall Study|Other not specified|1|||
164401348|NCT02216773|593836919|FG000|Overall Study|Disease progression|4|||
164401349|NCT02216773|593836920|FG001|Overall Study|Disease progression|2|||
164401350|NCT02216773|593836919|FG000|Overall Study|Insufficient FLRV|4|||
164401351|NCT02216773|593836920|FG001|Overall Study|Insufficient FLRV|0|||
164401352|NCT02216773|593836919|FG000|Overall Study|Abandoned|4|||
164401353|NCT02216773|593836920|FG001|Overall Study|Abandoned|3|||
164401354|NCT00941330|593836938|FG000|Overall Study|Other|1|||
164401355|NCT00941330|593836939|FG001|Overall Study|Other|0|||
164401356|NCT00941330|593836938|FG000|Overall Study|Physician Decision|0|||
164401357|NCT00941330|593836939|FG001|Overall Study|Physician Decision|2|||
164401358|NCT00541450|593836940|FG000|Phase A|Adverse Event|3|||
164401359|NCT00541450|593836941|FG001|Phase A|Adverse Event|0|||
164401360|NCT00541450|593836940|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
164401361|NCT00541450|593836941|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
164596528|NCT02198651|594548880|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
164596529|NCT02198651|594548881|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
164596530|NCT02198651|594548882|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
164596531|NCT00786032|594548887|FG000|Overall Study|Death|4|||
164596532|NCT00786032|594548887|FG000|Overall Study|Withdrawal by Subject|14|||
164596533|NCT00786032|594548887|FG000|Overall Study|Did not complete in the timeframe|6|||
164596534|NCT02922634|594548888|FG000|Overall Study|Withdrawal by Subject|5|||
164705963|NCT00006721|594953334|FG002|Overall Study|Progression/Relapse|2|||
164401362|NCT00541450|593836940|FG000|Phase A|Hyperglycemia|0|||
164401363|NCT00541450|593836941|FG001|Phase A|Hyperglycemia|1|||
164401364|NCT00541450|593836940|FG000|Phase A|Lost to Follow-up|6|||
164401365|NCT00541450|593836941|FG001|Phase A|Lost to Follow-up|4|||
164401366|NCT00541450|593836940|FG000|Phase A|Physician Decision|2|||
164401367|NCT00541450|593836941|FG001|Phase A|Physician Decision|0|||
164442800|NCT03401112|593988644|FG004|Overall Study|Day 1 Assessment not Done|0|||
164705964|NCT00006721|594953332|FG000|Overall Study|Death|0|||
164401368|NCT00541450|593836940|FG000|Phase A|Protocol Violation|2|||
164401369|NCT00541450|593836941|FG001|Phase A|Protocol Violation|3|||
164401370|NCT00541450|593836940|FG000|Phase A|Withdrawal by Subject|7|||
164401371|NCT00541450|593836941|FG001|Phase A|Withdrawal by Subject|7|||
164401372|NCT00541450|593836940|FG000|Phase B|Adverse Event|6|||
164401373|NCT00541450|593836941|FG001|Phase B|Adverse Event|6|||
164401374|NCT00541450|593836940|FG000|Phase B|Hyperglycemia|10|||
164401375|NCT00541450|593836941|FG001|Phase B|Hyperglycemia|9|||
164401376|NCT00541450|593836940|FG000|Phase B|Lost to Follow-up|6|||
164401377|NCT00541450|593836941|FG001|Phase B|Lost to Follow-up|4|||
164401378|NCT00541450|593836940|FG000|Phase B|Physician Decision|4|||
164401379|NCT00541450|593836941|FG001|Phase B|Physician Decision|2|||
164401380|NCT00541450|593836940|FG000|Phase B|Pregnancy|0|||
164401381|NCT00541450|593836941|FG001|Phase B|Pregnancy|1|||
164401382|NCT00541450|593836940|FG000|Phase B|Protocol Violation|3|||
164401383|NCT00541450|593836941|FG001|Phase B|Protocol Violation|3|||
164401384|NCT00541450|593836940|FG000|Phase B|Withdrawal by Subject|8|||
164401385|NCT00541450|593836941|FG001|Phase B|Withdrawal by Subject|6|||
164401386|NCT00981084|593836942|FG000|Post Intervention (Data Analysis)|poor effort|1|||
164401387|NCT00981084|593836943|FG001|Post Intervention (Data Analysis)|poor effort|1|||
164401388|NCT00981084|593836942|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
164401389|NCT00981084|593836943|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
164401390|NCT01112579|593836944|FG000|Overall Study|Missed Visit|1|||
164401391|NCT01112579|593836945|FG001|Overall Study|Missed Visit|1|||
164401392|NCT01112579|593836944|FG000|Overall Study|Death|0|||
164401393|NCT01112579|593836945|FG001|Overall Study|Death|2|||
164401394|NCT01648270|593836946|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
164401395|NCT04969263|593836947|FG000|Overall Study|Death|1|||
164401396|NCT04969263|593836947|FG000|Overall Study|Lost to Follow-up|2|||
164401397|NCT04969263|593836947|FG000|Overall Study|Withdrawal by Subject|5|||
164401398|NCT04969263|593836947|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
164401399|NCT01389973|593836948|FG000|Overall Study|Lost to Follow-up|1|||
164401400|NCT01389973|593836948|FG000|Overall Study|Trial Stopped by Sponsor|9|||
164401401|NCT01389973|593836948|FG000|Overall Study|Other|10|||
164401402|NCT00725296|593836949|FG000|Overall Study|Adverse Event|11|||
164401403|NCT00725296|593836949|FG000|Overall Study|Lack of Efficacy|7|||
164401404|NCT00725296|593836949|FG000|Overall Study|Withdrawal by Subject|3|||
164401405|NCT00725296|593836949|FG000|Overall Study|Non-Compliance|2|||
164401406|NCT00725296|593836949|FG000|Overall Study|Lost to Follow-up|1|||
164401407|NCT00725296|593836949|FG000|Overall Study|Other|38|||
164401408|NCT03360942|593836950|FG000|Overall Study|Device explanted|2|||
164401409|NCT03360942|593836950|FG000|Overall Study|Study closure|1|||
164401410|NCT03360942|593836950|FG000|Overall Study|Withdrawal by Subject|2|||
164401411|NCT03456700|593836951|FG000|Overall Study|Withdrawal by Subject|1|||
164401412|NCT00613951|593836952|FG000|Overall Study|Adverse Event|1|||
164401413|NCT00613951|593836953|FG001|Overall Study|Adverse Event|0|||
164401414|NCT00613951|593836954|FG002|Overall Study|Adverse Event|1|||
164401415|NCT00613951|593836952|FG000|Overall Study|Lack of Efficacy|0|||
164401416|NCT00613951|593836953|FG001|Overall Study|Lack of Efficacy|1|||
164401417|NCT00613951|593836954|FG002|Overall Study|Lack of Efficacy|1|||
164401418|NCT00613951|593836952|FG000|Overall Study|Protocol Violation|1|||
164401419|NCT00613951|593836953|FG001|Overall Study|Protocol Violation|1|||
164401420|NCT00613951|593836954|FG002|Overall Study|Protocol Violation|1|||
164401421|NCT00613951|593836952|FG000|Overall Study|Unclassified|5|||
164401422|NCT00613951|593836953|FG001|Overall Study|Unclassified|3|||
164401423|NCT00613951|593836954|FG002|Overall Study|Unclassified|2|||
164401424|NCT03053050|593836955|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
164401425|NCT03053050|593836956|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
164401426|NCT03053050|593836957|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
164401427|NCT03053050|593836958|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
164401428|NCT03053050|593836955|FG000|Randomized Phase|Withdrew Consent|16|||
164401429|NCT03053050|593836956|FG001|Randomized Phase|Withdrew Consent|8|||
164401430|NCT03053050|593836957|FG002|Randomized Phase|Withdrew Consent|9|||
164401431|NCT03053050|593836958|FG003|Randomized Phase|Withdrew Consent|0|||
164401432|NCT03053050|593836955|FG000|Randomized Phase|Investigator's Discretion|6|||
164401433|NCT03053050|593836956|FG001|Randomized Phase|Investigator's Discretion|6|||
164401434|NCT03053050|593836957|FG002|Randomized Phase|Investigator's Discretion|3|||
164401435|NCT03053050|593836958|FG003|Randomized Phase|Investigator's Discretion|0|||
164401436|NCT03053050|593836955|FG000|Randomized Phase|Lost to Follow-up|5|||
164401437|NCT03053050|593836956|FG001|Randomized Phase|Lost to Follow-up|1|||
164401438|NCT03053050|593836957|FG002|Randomized Phase|Lost to Follow-up|1|||
164401439|NCT03053050|593836958|FG003|Randomized Phase|Lost to Follow-up|0|||
164401440|NCT03053050|593836955|FG000|Randomized Phase|Adverse Event|0|||
164401441|NCT03053050|593836956|FG001|Randomized Phase|Adverse Event|1|||
164401442|NCT03053050|593836957|FG002|Randomized Phase|Adverse Event|0|||
164401443|NCT03053050|593836958|FG003|Randomized Phase|Adverse Event|0|||
164401444|NCT03053050|593836955|FG000|Randomized Phase|Randomized but Never Treated|2|||
164705965|NCT00006721|594953333|FG001|Overall Study|Death|1|||
164401445|NCT03053050|593836956|FG001|Randomized Phase|Randomized but Never Treated|2|||
164401446|NCT03053050|593836957|FG002|Randomized Phase|Randomized but Never Treated|2|||
164401447|NCT03053050|593836958|FG003|Randomized Phase|Randomized but Never Treated|0|||
164401448|NCT03053050|593836955|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
164401449|NCT03053050|593836956|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
164401450|NCT03053050|593836957|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
164401451|NCT03053050|593836958|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
164401452|NCT03053050|593836955|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
164401453|NCT03053050|593836956|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
164401454|NCT03053050|593836957|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
164401455|NCT03053050|593836958|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
164401456|NCT03053050|593836955|FG000|Open-label Phase|Withdrew Consent|0|||
164401457|NCT03053050|593836956|FG001|Open-label Phase|Withdrew Consent|0|||
164401458|NCT03053050|593836957|FG002|Open-label Phase|Withdrew Consent|0|||
164401459|NCT03053050|593836958|FG003|Open-label Phase|Withdrew Consent|6|||
164401460|NCT03053050|593836955|FG000|Open-label Phase|Investigator's Discretion|0|||
164401461|NCT03053050|593836956|FG001|Open-label Phase|Investigator's Discretion|0|||
164401462|NCT03053050|593836957|FG002|Open-label Phase|Investigator's Discretion|0|||
164401463|NCT03053050|593836958|FG003|Open-label Phase|Investigator's Discretion|4|||
164401464|NCT00655980|593836959|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
164401465|NCT00655980|593836960|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
164401466|NCT00655980|593836961|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
164401467|NCT04866017|593836968|FG000|Overall Study|Study Terminated by Sponsor|13|||
164401468|NCT04866017|593836969|FG001|Overall Study|Study Terminated by Sponsor|14|||
164401469|NCT04866017|593836970|FG002|Overall Study|Study Terminated by Sponsor|13|||
164401470|NCT04866017|593836968|FG000|Overall Study|Death|8|||
164401471|NCT04866017|593836969|FG001|Overall Study|Death|4|||
164401472|NCT04866017|593836970|FG002|Overall Study|Death|8|||
164401473|NCT04866017|593836968|FG000|Overall Study|Withdrawal by Subject|1|||
164401474|NCT04866017|593836969|FG001|Overall Study|Withdrawal by Subject|0|||
164401475|NCT04866017|593836970|FG002|Overall Study|Withdrawal by Subject|1|||
164401476|NCT04866017|593836968|FG000|Overall Study|Physician Decision|0|||
164401477|NCT04866017|593836969|FG001|Overall Study|Physician Decision|1|||
164401478|NCT04866017|593836970|FG002|Overall Study|Physician Decision|0|||
164401479|NCT01266642|593836971|FG000|Overall Study|Protocol Violation|0|||
164401480|NCT01266642|593836972|FG001|Overall Study|Protocol Violation|1|||
164401481|NCT03412812|593838538|FG000|Level 1|Death|3|||
164401482|NCT03412812|593838539|FG001|Level 1|Death|0|||
164401483|NCT03412812|593838538|FG000|Level 1|Adverse Event|0|||
164401484|NCT03412812|593838539|FG001|Level 1|Adverse Event|1|||
164401485|NCT02127372|593838540|FG000|Overall Study|Withdrawal by Subject|1|||
164401486|NCT02127372|593838541|FG001|Overall Study|Withdrawal by Subject|0|||
164401487|NCT03548207|593838544|FG000|Overall Study|Death|10|||
164401488|NCT03548207|593838545|FG001|Overall Study|Death|23|||
164401489|NCT03548207|593838546|FG002|Overall Study|Death|3|||
164401490|NCT03548207|593838544|FG000|Overall Study|Lost to Follow-up|0|||
164401491|NCT03548207|593838545|FG001|Overall Study|Lost to Follow-up|2|||
164401492|NCT03548207|593838546|FG002|Overall Study|Lost to Follow-up|0|||
164401493|NCT03548207|593838544|FG000|Overall Study|Withdrawal by Subject|0|||
164401494|NCT03548207|593838545|FG001|Overall Study|Withdrawal by Subject|3|||
164401495|NCT03548207|593838546|FG002|Overall Study|Withdrawal by Subject|0|||
164401496|NCT03548207|593838544|FG000|Overall Study|Sponsor decision|19|||
164401497|NCT03548207|593838545|FG001|Overall Study|Sponsor decision|40|||
164401498|NCT03548207|593838546|FG002|Overall Study|Sponsor decision|6|||
164401499|NCT03548207|593838544|FG000|Overall Study|Randomized but not treated|6|||
164401500|NCT03548207|593838545|FG001|Overall Study|Randomized but not treated|10|||
164401501|NCT03548207|593838546|FG002|Overall Study|Randomized but not treated|4|||
164401502|NCT01756352|593838547|FG000|Overall Study|moved away and lost to followup|1|||
164401503|NCT02641392|593838550|FG000|Overall Study|Lost to Follow-up|0|||
164401504|NCT02641392|593838551|FG001|Overall Study|Lost to Follow-up|0|||
164401505|NCT02641392|593838552|FG002|Overall Study|Lost to Follow-up|2|||
164401506|NCT02641392|593838550|FG000|Overall Study|Withdrawal by Subject|0|||
164401507|NCT02641392|593838551|FG001|Overall Study|Withdrawal by Subject|0|||
164401508|NCT02641392|593838552|FG002|Overall Study|Withdrawal by Subject|17|||
164401509|NCT02641392|593838550|FG000|Overall Study|Adverse Event|0|||
164401510|NCT02641392|593838551|FG001|Overall Study|Adverse Event|1|||
164401511|NCT02641392|593838552|FG002|Overall Study|Adverse Event|25|||
164401512|NCT02641392|593838550|FG000|Overall Study|Study Terminated by Sponsor|4|||
164401513|NCT02641392|593838551|FG001|Overall Study|Study Terminated by Sponsor|12|||
164401514|NCT02641392|593838552|FG002|Overall Study|Study Terminated by Sponsor|144|||
164401515|NCT02641392|593838550|FG000|Overall Study|Lack of Efficacy|0|||
164401516|NCT02641392|593838551|FG001|Overall Study|Lack of Efficacy|0|||
164401517|NCT02641392|593838552|FG002|Overall Study|Lack of Efficacy|101|||
164401518|NCT02641392|593838550|FG000|Overall Study|Miscellaneous|0|||
164401519|NCT02641392|593838551|FG001|Overall Study|Miscellaneous|0|||
164401520|NCT02641392|593838552|FG002|Overall Study|Miscellaneous|3|||
164401521|NCT02641392|593838550|FG000|Overall Study|Death|0|||
164442801|NCT03401112|593988640|FG000|Overall Study|Not Dosed|0|||
164442802|NCT03401112|593988641|FG001|Overall Study|Not Dosed|0|||
164442803|NCT03401112|593988642|FG002|Overall Study|Not Dosed|1|||
164442804|NCT03401112|593988643|FG003|Overall Study|Not Dosed|0|||
164442805|NCT03401112|593988644|FG004|Overall Study|Not Dosed|0|||
164442806|NCT03401112|593988640|FG000|Overall Study|Missed Clinical Visit|0|||
164442807|NCT03401112|593988641|FG001|Overall Study|Missed Clinical Visit|0|||
164442808|NCT03401112|593988642|FG002|Overall Study|Missed Clinical Visit|1|||
164442809|NCT03401112|593988643|FG003|Overall Study|Missed Clinical Visit|0|||
164442810|NCT03401112|593988644|FG004|Overall Study|Missed Clinical Visit|0|||
164442811|NCT03401112|593988640|FG000|Overall Study|Missed Doses|0|||
164442812|NCT03401112|593988641|FG001|Overall Study|Missed Doses|0|||
164442813|NCT03401112|593988642|FG002|Overall Study|Missed Doses|1|||
164442814|NCT03401112|593988643|FG003|Overall Study|Missed Doses|0|||
164442815|NCT03401112|593988644|FG004|Overall Study|Missed Doses|0|||
164442816|NCT01264679|593988645|FG000|Overall Study|Participation in Another Clinical Trial|1|||
164442817|NCT01264679|593988645|FG000|Overall Study|Physician Decision|1|||
164401522|NCT02641392|593838551|FG001|Overall Study|Death|0|||
164401523|NCT02641392|593838552|FG002|Overall Study|Death|1|||
164401524|NCT03466086|593838555|FG000|Period 1|Sponsor decision due to study timeline|1|||
164401525|NCT03466086|593838556|FG001|Period 1|Sponsor decision due to study timeline|0|||
164401526|NCT03466086|593838555|FG000|Period 1|Withdrawal by Subject|1|||
164401527|NCT03466086|593838556|FG001|Period 1|Withdrawal by Subject|0|||
164401528|NCT01256411|593838562|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
164401529|NCT01256411|593838563|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
164401530|NCT01256411|593838564|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
164401531|NCT01256411|593838565|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
164401532|NCT01256411|593838566|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
164401533|NCT01256411|593838567|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
164401534|NCT01256411|593838562|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
164401535|NCT01256411|593838563|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
164401536|NCT01256411|593838564|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
164401537|NCT01256411|593838565|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
164401538|NCT01256411|593838566|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
164401539|NCT01256411|593838567|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
164401540|NCT01256411|593838562|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
164401541|NCT01256411|593838563|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
164401542|NCT01256411|593838564|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
164401543|NCT01256411|593838565|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
164401544|NCT01256411|593838566|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
164401545|NCT01256411|593838567|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
164401546|NCT01256411|593838562|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
164401547|NCT01256411|593838563|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
164401548|NCT01256411|593838564|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
164401549|NCT01256411|593838565|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
164401550|NCT01256411|593838566|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
164401551|NCT01256411|593838567|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
164401552|NCT01256411|593838562|FG000|Extension by Maximum Treatment|Adverse Event|4|||
164401553|NCT01256411|593838563|FG001|Extension by Maximum Treatment|Adverse Event|2|||
164401554|NCT01256411|593838564|FG002|Extension by Maximum Treatment|Adverse Event|1|||
164401555|NCT01256411|593838565|FG003|Extension by Maximum Treatment|Adverse Event|0|||
164401556|NCT01256411|593838566|FG004|Extension by Maximum Treatment|Adverse Event|0|||
164401557|NCT01256411|593838567|FG005|Extension by Maximum Treatment|Adverse Event|0|||
164401558|NCT01256411|593838562|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
164401559|NCT01256411|593838563|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
164401560|NCT01256411|593838564|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
164401561|NCT01256411|593838565|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
164401562|NCT01256411|593838566|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
164401563|NCT01256411|593838567|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
164442818|NCT01264679|593988645|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
164442819|NCT01264679|593988645|FG000|Overall Study|Withdrawal by Subject|1|||
164705966|NCT00006721|594953334|FG002|Overall Study|Death|2|||
164401564|NCT01256411|593838562|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
164401565|NCT01256411|593838563|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
164401566|NCT01256411|593838564|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
164705967|NCT00006721|594953332|FG000|Overall Study|Other - Not Protocol Specified|0|||
164401567|NCT01256411|593838565|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
164401568|NCT01256411|593838566|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
164442820|NCT03475316|593988646|FG000|6 Month Intervention|Adverse Event|2|||
164442821|NCT03475316|593988647|FG001|6 Month Intervention|Adverse Event|1|||
164442822|NCT03475316|593988646|FG000|6 Month Intervention|Withdrawal by Subject|2|||
164442823|NCT03475316|593988647|FG001|6 Month Intervention|Withdrawal by Subject|0|||
164442824|NCT03475316|593988646|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
164442825|NCT03475316|593988647|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
164442826|NCT03475316|593988646|FG000|9 Months|Study stopped due to COVID pandemic|3|||
164442827|NCT03475316|593988647|FG001|9 Months|Study stopped due to COVID pandemic|4|||
164442828|NCT00566527|593988654|FG000|Overall Study|Reason not provided|3|||
164442829|NCT00566527|593988655|FG001|Overall Study|Reason not provided|11|||
164442830|NCT00566527|593988656|FG002|Overall Study|Reason not provided|10|||
164442831|NCT00566527|593988654|FG000|Overall Study|Adverse Event|2|||
164442832|NCT00566527|593988655|FG001|Overall Study|Adverse Event|0|||
164442833|NCT00566527|593988656|FG002|Overall Study|Adverse Event|1|||
164442834|NCT00566527|593988654|FG000|Overall Study|Physician Decision|3|||
164442835|NCT00566527|593988655|FG001|Overall Study|Physician Decision|8|||
164442836|NCT00566527|593988656|FG002|Overall Study|Physician Decision|20|||
164442837|NCT00566527|593988654|FG000|Overall Study|Lost to Follow-up|3|||
164442838|NCT00566527|593988655|FG001|Overall Study|Lost to Follow-up|4|||
164442839|NCT00566527|593988656|FG002|Overall Study|Lost to Follow-up|4|||
164442840|NCT00566527|593988654|FG000|Overall Study|Withdrawal by Subject|6|||
164442841|NCT00566527|593988655|FG001|Overall Study|Withdrawal by Subject|43|||
164442842|NCT00566527|593988656|FG002|Overall Study|Withdrawal by Subject|43|||
164442843|NCT01837966|593988660|FG000|Overall Study|Withdrawal by Subject|2|||
164442844|NCT01837966|593988661|FG001|Overall Study|Withdrawal by Subject|1|||
164442845|NCT04975308|593988665|FG000|Overall Study|Withdrawal by Subject|6|||
164442846|NCT04975308|593988666|FG001|Overall Study|Withdrawal by Subject|16|||
164442847|NCT04975308|593988667|FG002|Overall Study|Withdrawal by Subject|6|||
164442848|NCT04975308|593988665|FG000|Overall Study|Physician Decision|0|||
164442849|NCT04975308|593988666|FG001|Overall Study|Physician Decision|3|||
164442850|NCT04975308|593988667|FG002|Overall Study|Physician Decision|1|||
164442851|NCT04975308|593988665|FG000|Overall Study|Adverse Event|10|||
164442852|NCT04975308|593988666|FG001|Overall Study|Adverse Event|1|||
164442853|NCT04975308|593988667|FG002|Overall Study|Adverse Event|12|||
164442854|NCT04975308|593988665|FG000|Overall Study|On study treatment (Ongoing)|65|||
164442855|NCT04975308|593988666|FG001|Overall Study|On study treatment (Ongoing)|43|||
164442856|NCT04975308|593988667|FG002|Overall Study|On study treatment (Ongoing)|75|||
164442857|NCT04975308|593988665|FG000|Overall Study|Protocol Deviation|4|||
164442858|NCT04975308|593988666|FG001|Overall Study|Protocol Deviation|3|||
164442859|NCT04975308|593988667|FG002|Overall Study|Protocol Deviation|2|||
164442860|NCT01179334|593988670|FG000|Treatment Period|Adverse Event|1|||
164442861|NCT01179334|593988671|FG001|Treatment Period|Adverse Event|0|||
164442862|NCT01179334|593988670|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
164442863|NCT01179334|593988671|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
164442864|NCT01179334|593988670|FG000|Long-term Extension (LTE) Period|Death|3|||
164442865|NCT01179334|593988671|FG001|Long-term Extension (LTE) Period|Death|0|||
164442866|NCT01179334|593988670|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
164442867|NCT01179334|593988671|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
164401569|NCT01256411|593838567|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
164401570|NCT01256411|593838562|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
164401571|NCT01256411|593838563|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
164401572|NCT01256411|593838564|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
164401573|NCT01256411|593838565|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
164401574|NCT01256411|593838566|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
164401575|NCT01256411|593838567|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
164401576|NCT01256411|593838562|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
164401577|NCT01256411|593838563|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
164401578|NCT01256411|593838564|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
164401579|NCT01256411|593838565|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
164401580|NCT01256411|593838566|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
164401581|NCT01256411|593838567|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
164401582|NCT01256411|593838562|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
164401583|NCT01256411|593838563|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
164401584|NCT01256411|593838564|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
164401585|NCT01256411|593838565|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
164401586|NCT01256411|593838566|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
164401587|NCT01256411|593838567|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
164401588|NCT02274857|593838568|FG000|Overall Study|Adverse Event|1|||
164401589|NCT02274857|593838569|FG001|Overall Study|Adverse Event|0|||
164442868|NCT01152190|593988673|FG000|Overall Study|Adverse Event|2|||
164442869|NCT01152190|593988674|FG001|Overall Study|Adverse Event|4|||
164442870|NCT01152190|593988673|FG000|Overall Study|Death|1|||
164442871|NCT01152190|593988674|FG001|Overall Study|Death|0|||
164442872|NCT01152190|593988673|FG000|Overall Study|Protocol Violation|1|||
164442873|NCT01152190|593988674|FG001|Overall Study|Protocol Violation|1|||
164442874|NCT01152190|593988673|FG000|Overall Study|Withdrawal by Subject|1|||
164442875|NCT01152190|593988674|FG001|Overall Study|Withdrawal by Subject|3|||
164401590|NCT02274857|593838568|FG000|Overall Study|Death|1|||
164401591|NCT02274857|593838569|FG001|Overall Study|Death|2|||
164401592|NCT02274857|593838568|FG000|Overall Study|Lost to Follow-up|3|||
164401593|NCT02274857|593838569|FG001|Overall Study|Lost to Follow-up|0|||
164401594|NCT02274857|593838568|FG000|Overall Study|Physician Decision|2|||
164401595|NCT02274857|593838569|FG001|Overall Study|Physician Decision|0|||
164401596|NCT02274857|593838568|FG000|Overall Study|Trial screen failure|0|||
164401597|NCT02274857|593838569|FG001|Overall Study|Trial screen failure|2|||
164401598|NCT02274857|593838568|FG000|Overall Study|Withdrawal by Subject|11|||
164401599|NCT02274857|593838569|FG001|Overall Study|Withdrawal by Subject|2|||
164401600|NCT02274857|593838568|FG000|Overall Study|Other|2|||
164401601|NCT02274857|593838569|FG001|Overall Study|Other|0|||
164401602|NCT02403180|593838570|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
164401603|NCT02403180|593838571|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
164401604|NCT02403180|593838570|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
164401605|NCT02403180|593838571|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
164401606|NCT01113502|593838572|FG000|Overall Study|Withdrawal by Subject|1|||
164401607|NCT01113502|593838573|FG001|Overall Study|Withdrawal by Subject|0|||
164401608|NCT01113502|593838574|FG002|Overall Study|Withdrawal by Subject|1|||
164401609|NCT01113502|593838575|FG003|Overall Study|Withdrawal by Subject|1|||
164401610|NCT01113502|593838576|FG004|Overall Study|Withdrawal by Subject|0|||
164401611|NCT01113502|593838572|FG000|Overall Study|Adverse Event|0|||
164401612|NCT01113502|593838573|FG001|Overall Study|Adverse Event|0|||
164401613|NCT01113502|593838574|FG002|Overall Study|Adverse Event|3|||
164401614|NCT01113502|593838575|FG003|Overall Study|Adverse Event|2|||
164401615|NCT01113502|593838576|FG004|Overall Study|Adverse Event|0|||
164401616|NCT00117676|593838579|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
164401617|NCT00117676|593838580|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
164401618|NCT00117676|593838579|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
164401619|NCT00117676|593838580|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
164401620|NCT00117676|593838579|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
164401621|NCT00117676|593838580|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
164401622|NCT00117676|593838579|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
164401623|NCT00117676|593838580|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
164401624|NCT00117676|593838579|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
164401625|NCT00117676|593838580|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
164401626|NCT00117676|593838579|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
164401627|NCT00117676|593838580|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
164401628|NCT00117676|593838579|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
164401629|NCT00117676|593838580|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
164401630|NCT00117676|593838579|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
164401631|NCT00117676|593838580|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
164401632|NCT00117676|593838579|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
164401633|NCT00117676|593838580|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
164401634|NCT00117676|593838579|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
164401635|NCT00117676|593838580|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
164401636|NCT00117676|593838579|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
164401637|NCT00117676|593838580|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
164401638|NCT00117676|593838579|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
164401639|NCT00117676|593838580|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
164401640|NCT00117676|593838579|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
164401641|NCT00117676|593838580|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
164401642|NCT00117676|593838579|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
164401643|NCT00117676|593838580|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
164401644|NCT00117676|593838579|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
164401645|NCT00117676|593838580|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
164401646|NCT00117676|593838579|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
164401647|NCT00117676|593838580|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
164401648|NCT00117676|593838579|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
164401649|NCT00117676|593838580|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
164401650|NCT00117676|593838579|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
164401651|NCT00117676|593838580|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
164401652|NCT00117676|593838579|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
164401653|NCT00117676|593838580|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
164401654|NCT00117676|593838579|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
164596535|NCT02922634|594548888|FG000|Overall Study|Did not have their surgery|5|||
164596536|NCT02625324|594548889|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
164596537|NCT02625324|594548889|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
164442876|NCT00547118|593988677|FG000|Overall Study|Did not qualify prior to starting drug|1|||
164442877|NCT00547118|593988678|FG001|Overall Study|Did not qualify prior to starting drug|1|||
164442878|NCT00547118|593988677|FG000|Overall Study|Study suspended|7|||
164442879|NCT00547118|593988678|FG001|Overall Study|Study suspended|8|||
164596538|NCT02625324|594548889|FG000|6-Month Follow-up Subject Accountability|Death|5|||
164596539|NCT02625324|594548889|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
164596540|NCT02625324|594548889|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
164596541|NCT02625324|594548889|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
164596542|NCT02625324|594548889|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
164596543|NCT02625324|594548889|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
164596544|NCT02625324|594548889|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
164596545|NCT02625324|594548889|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
164596546|NCT02625324|594548889|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
164596547|NCT02625324|594548889|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
164596548|NCT02625324|594548889|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
164596549|NCT02625324|594548889|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
164596550|NCT02625324|594548889|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
164596551|NCT02625324|594548889|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
164596552|NCT02625324|594548889|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
164596553|NCT02457182|594548890|FG000|Overall Study|Lost to Follow-up|1|||
164596554|NCT02457182|594548891|FG001|Overall Study|Lost to Follow-up|0|||
164596555|NCT00352755|594548894|FG000|Overall Study|Physician Decision|1|||
164596556|NCT00352755|594548894|FG000|Overall Study|Adverse Event|1|||
164596557|NCT02397694|594548899|FG000|Double-Blinded Phase|Adverse Event|1|||
164596558|NCT02397694|594548900|FG001|Double-Blinded Phase|Adverse Event|0|||
164596559|NCT02397694|594548899|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
164596560|NCT02397694|594548900|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
164596561|NCT02397694|594548899|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
164596562|NCT02397694|594548900|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
164705968|NCT00006721|594953333|FG001|Overall Study|Other - Not Protocol Specified|7|||
164705969|NCT00006721|594953334|FG002|Overall Study|Other - Not Protocol Specified|7|||
164705970|NCT00006721|594953332|FG000|Overall Study|Ineligible|2|||
164705971|NCT00006721|594953333|FG001|Overall Study|Ineligible|12|||
164705972|NCT00006721|594953334|FG002|Overall Study|Ineligible|10|||
164705973|NCT00006721|594953332|FG000|Overall Study|Eligible but no Treatment Received|1|||
164705974|NCT00006721|594953333|FG001|Overall Study|Eligible but no Treatment Received|0|||
164401655|NCT00117676|593838580|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
164401656|NCT00117676|593838579|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
164401657|NCT00117676|593838580|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
164401658|NCT00117676|593838579|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
164401659|NCT00117676|593838580|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
164401660|NCT00117676|593838579|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
164401661|NCT00117676|593838580|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
164401662|NCT00117676|593838579|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
164401663|NCT00117676|593838580|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
164401664|NCT00117676|593838579|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
164401665|NCT00117676|593838580|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
164401666|NCT00117676|593838579|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
164401667|NCT00117676|593838580|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
164401668|NCT00117676|593838579|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
164401669|NCT00117676|593838580|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
164401670|NCT00117676|593838579|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
164401671|NCT00117676|593838580|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
164401672|NCT00117676|593838579|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
164401673|NCT00117676|593838580|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
164401674|NCT00117676|593838579|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
164401675|NCT00117676|593838580|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
164401676|NCT00117676|593838579|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
164401677|NCT00117676|593838580|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
164401678|NCT00117676|593838579|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
164401679|NCT00117676|593838580|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
164401680|NCT00117676|593838579|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
164401681|NCT00117676|593838580|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
164596563|NCT02397694|594548899|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
164596564|NCT02397694|594548900|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
164596565|NCT02397694|594548899|FG000|Open Label Extension Phase|Protocol Violation|1|||
164705975|NCT00006721|594953334|FG002|Overall Study|Eligible but no Treatment Received|0|||
164705976|NCT03845296|594953335|FG000|Overall Study|On Treatment|2|||
164705977|NCT03845296|594953336|FG001|Overall Study|On Treatment|1|||
164705978|NCT03845296|594953335|FG000|Overall Study|Adverse Event|4|||
164705979|NCT03845296|594953336|FG001|Overall Study|Adverse Event|11|||
164705980|NCT03845296|594953335|FG000|Overall Study|Refusal unrelated to adverse event|0|||
164705981|NCT03845296|594953336|FG001|Overall Study|Refusal unrelated to adverse event|1|||
164401682|NCT00117676|593838579|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
164401683|NCT00117676|593838580|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
164401684|NCT00117676|593838579|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
164401685|NCT00117676|593838580|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
164401686|NCT00952822|593838581|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
164401687|NCT00952822|593838582|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
164401688|NCT00952822|593838583|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
164401689|NCT00952822|593838584|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
164401690|NCT00952822|593838581|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
164401691|NCT00952822|593838582|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
164401692|NCT00952822|593838583|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
164401693|NCT00952822|593838584|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
164401694|NCT00691938|593838585|FG000|Overall Study|QTc prolongation|1|||
164401695|NCT00691938|593838586|FG001|Overall Study|QTc prolongation|0|||
164401696|NCT00691938|593838587|FG002|Overall Study|QTc prolongation|0|||
164401697|NCT00691938|593838588|FG003|Overall Study|QTc prolongation|0|||
164401698|NCT00691938|593838589|FG004|Overall Study|QTc prolongation|0|||
164401699|NCT00691938|593838590|FG005|Overall Study|QTc prolongation|0|||
164401700|NCT00691938|593838591|FG006|Overall Study|QTc prolongation|0|||
164401701|NCT00594854|593838593|FG000|Overall Study|Study terminated|7|||
164401702|NCT00594854|593838594|FG001|Overall Study|Study terminated|10|||
164401703|NCT04918147|593838605|FG000|Overall Study|Disease flare as defined in protocol|0|||
164401704|NCT04918147|593838606|FG001|Overall Study|Disease flare as defined in protocol|2|||
164401705|NCT03292146|593838607|FG000|Baseline to 12 months|Relocation|1|||
164401706|NCT03292146|593838608|FG001|Baseline to 12 months|Relocation|0|||
164401707|NCT03292146|593838607|FG000|Baseline to 12 months|Seeking higher level of care for eating disorder|1|||
164401708|NCT03292146|593838608|FG001|Baseline to 12 months|Seeking higher level of care for eating disorder|0|||
164401709|NCT03292146|593838607|FG000|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|0|||
164401710|NCT03292146|593838608|FG001|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|1|||
164401711|NCT03292146|593838607|FG000|12 months to 24 months|Planning pregnancy|2|||
164401712|NCT03292146|593838608|FG001|12 months to 24 months|Planning pregnancy|2|||
164401713|NCT03292146|593838607|FG000|12 months to 24 months|Personal reasons|1|||
164401714|NCT03292146|593838608|FG001|12 months to 24 months|Personal reasons|0|||
164401715|NCT03292146|593838607|FG000|12 months to 24 months|Lost to Follow-up|0|||
164401716|NCT03292146|593838608|FG001|12 months to 24 months|Lost to Follow-up|1|||
164401717|NCT03575325|593838611|FG000|Overall Study|Death|1|||
164401718|NCT03440372|593838612|FG000|Treatment|Adverse Event|16|||
164401719|NCT03440372|593838613|FG001|Treatment|Adverse Event|8|||
164401720|NCT03440372|593838612|FG000|Treatment|Lack of Efficacy|4|||
164401721|NCT03440372|593838613|FG001|Treatment|Lack of Efficacy|2|||
164401722|NCT03440372|593838612|FG000|Treatment|Withdrawal by Subject|12|||
164401723|NCT03440372|593838613|FG001|Treatment|Withdrawal by Subject|8|||
164401724|NCT03440372|593838612|FG000|Treatment|Lost to Follow-up|1|||
164401725|NCT03440372|593838613|FG001|Treatment|Lost to Follow-up|0|||
164401726|NCT03440372|593838612|FG000|Treatment|Pregnancy|1|||
164401727|NCT03440372|593838613|FG001|Treatment|Pregnancy|0|||
164401728|NCT03440372|593838612|FG000|Treatment|Study Terminated by Sponsor|2|||
164401729|NCT03440372|593838613|FG001|Treatment|Study Terminated by Sponsor|1|||
164401730|NCT03440372|593838612|FG000|Treatment|Other Reason|2|||
164401731|NCT03440372|593838613|FG001|Treatment|Other Reason|3|||
164401732|NCT05711641|593838614|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
164401733|NCT05711641|593838615|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
164401734|NCT05711641|593838614|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
164401735|NCT05711641|593838615|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
164401736|NCT03574597|593838616|FG000|Overall Study|Withdrawal by Subject|67|||
164401737|NCT03574597|593838617|FG001|Overall Study|Withdrawal by Subject|96|||
164401738|NCT03574597|593838616|FG000|Overall Study|Lost to Follow-up|192|||
164401739|NCT03574597|593838617|FG001|Overall Study|Lost to Follow-up|188|||
164401740|NCT03804710|593838618|FG000|Overall Study|Adverse Event|0|||
164401741|NCT03804710|593838619|FG001|Overall Study|Adverse Event|3|||
164401742|NCT03804710|593838618|FG000|Overall Study|Withdrawal by Subject|2|||
164401743|NCT03804710|593838619|FG001|Overall Study|Withdrawal by Subject|1|||
164442880|NCT00834834|593988680|FG000|Overall Study|Withdrawal by Subject|4|||
164401744|NCT03804710|593838618|FG000|Overall Study|Other|0|||
164442881|NCT00834834|593988681|FG001|Overall Study|Withdrawal by Subject|3|||
164705982|NCT03845296|594953335|FG000|Overall Study|Progression/relapse|14|||
164401745|NCT03804710|593838619|FG001|Overall Study|Other|1|||
164401746|NCT04542018|593838620|FG000|Overall Study|Withdrawal by Subject|0|||
164596566|NCT02397694|594548900|FG001|Open Label Extension Phase|Protocol Violation|0|||
164596567|NCT02397694|594548899|FG000|Open Label Extension Phase|Withdrew Consent|3|||
164596568|NCT02397694|594548900|FG001|Open Label Extension Phase|Withdrew Consent|1|||
164596569|NCT02397694|594548899|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
164401747|NCT04542018|593838621|FG001|Overall Study|Withdrawal by Subject|0|||
164401748|NCT04542018|593838622|FG002|Overall Study|Withdrawal by Subject|4|||
164401749|NCT04542018|593838620|FG000|Overall Study|Protocol Violation|0|||
164401750|NCT04542018|593838621|FG001|Overall Study|Protocol Violation|0|||
164401751|NCT04542018|593838622|FG002|Overall Study|Protocol Violation|2|||
164401752|NCT03583554|593838623|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
164401753|NCT03583554|593838624|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
164401754|NCT03583554|593838625|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
164401755|NCT03178266|593838626|FG000|Overall Study|Death|0|||
164401756|NCT03178266|593838627|FG001|Overall Study|Death|1|||
164401757|NCT03178266|593838626|FG000|Overall Study|Disont. Early|0|||
164401758|NCT03178266|593838627|FG001|Overall Study|Disont. Early|1|||
164401759|NCT03178266|593838626|FG000|Overall Study|Withdrawal by Subject|0|||
164401760|NCT03178266|593838627|FG001|Overall Study|Withdrawal by Subject|2|||
164401761|NCT01596582|593838639|FG000|Overall Study|Deemed ineligible after study visit|3|||
164401762|NCT01596582|593838640|FG001|Overall Study|Deemed ineligible after study visit|6|||
164401763|NCT01596582|593838639|FG000|Overall Study|Missing all outcome data|1|||
164401764|NCT01596582|593838640|FG001|Overall Study|Missing all outcome data|1|||
164401765|NCT02012491|593838645|FG000|Overall Study|Lost to Follow-up|1|||
164401766|NCT02012491|593838646|FG001|Overall Study|Lost to Follow-up|0|||
164401767|NCT02012491|593838645|FG000|Overall Study|Protocol Violation|0|||
164401768|NCT02012491|593838646|FG001|Overall Study|Protocol Violation|1|||
164401769|NCT02012491|593838645|FG000|Overall Study|Withdrawal by Subject|1|||
164401770|NCT02012491|593838646|FG001|Overall Study|Withdrawal by Subject|0|||
164401771|NCT01667432|593838647|FG000|Overall Study|Premature Study Termination|26|||
164401772|NCT01667432|593838647|FG000|Overall Study|Failure to Return|10|||
164401773|NCT01667432|593838647|FG000|Overall Study|Moved to Another Center|3|||
164401774|NCT01667432|593838647|FG000|Overall Study|Lost to Follow-up|3|||
164401775|NCT01667432|593838647|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
164401776|NCT01667432|593838647|FG000|Overall Study|Insufficient Therapeutic Response|4|||
164401777|NCT01667432|593838647|FG000|Overall Study|Adverse Event|1|||
164401778|NCT01667432|593838647|FG000|Overall Study|Protocol Deviation|2|||
164401779|NCT01667432|593838647|FG000|Overall Study|Principal Investigator Decision|1|||
164401780|NCT01667432|593838647|FG000|Overall Study|Reason Not Specified|2|||
164401781|NCT01667432|593838647|FG000|Overall Study|Missing Information|4|||
164401782|NCT00553696|593838652|FG000|Overall Study|Adverse Event|2|||
164401783|NCT00553696|593838653|FG001|Overall Study|Adverse Event|4|||
164401784|NCT00553696|593838654|FG002|Overall Study|Adverse Event|0|||
164401785|NCT00553696|593838655|FG003|Overall Study|Adverse Event|1|||
164401786|NCT00553696|593838652|FG000|Overall Study|Global deterioration of health status|0|||
164401787|NCT00553696|593838653|FG001|Overall Study|Global deterioration of health status|2|||
164401788|NCT00553696|593838654|FG002|Overall Study|Global deterioration of health status|0|||
164401789|NCT00553696|593838655|FG003|Overall Study|Global deterioration of health status|0|||
164401790|NCT00553696|593838652|FG000|Overall Study|Objective progression or relapse|2|||
164401791|NCT00553696|593838653|FG001|Overall Study|Objective progression or relapse|9|||
164401792|NCT00553696|593838654|FG002|Overall Study|Objective progression or relapse|6|||
164401793|NCT00553696|593838655|FG003|Overall Study|Objective progression or relapse|0|||
164401794|NCT00553696|593838652|FG000|Overall Study|Withdrawal by Subject|0|||
164401795|NCT00553696|593838653|FG001|Overall Study|Withdrawal by Subject|1|||
164401796|NCT00553696|593838654|FG002|Overall Study|Withdrawal by Subject|0|||
164401797|NCT00553696|593838655|FG003|Overall Study|Withdrawal by Subject|0|||
164401798|NCT00686881|593838656|FG000|Overall Study|Withdrawal by Subject|11|||
164401799|NCT00686881|593838657|FG001|Overall Study|Withdrawal by Subject|18|||
164401800|NCT00686881|593838656|FG000|Overall Study|Lost to Follow-up|0|||
164401801|NCT00686881|593838657|FG001|Overall Study|Lost to Follow-up|1|||
164401802|NCT00686881|593838656|FG000|Overall Study|Treatment-related adverse event|10|||
164401803|NCT00686881|593838657|FG001|Overall Study|Treatment-related adverse event|9|||
164401804|NCT00686881|593838656|FG000|Overall Study|Met discontinuation criteria|5|||
164401805|NCT00686881|593838657|FG001|Overall Study|Met discontinuation criteria|0|||
164596570|NCT02397694|594548900|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
164401806|NCT00686881|593838656|FG000|Overall Study|Onset of malignant tumor|11|||
164401807|NCT00686881|593838657|FG001|Overall Study|Onset of malignant tumor|11|||
164401808|NCT00686881|593838656|FG000|Overall Study|Lack of Efficacy|4|||
164401809|NCT00686881|593838657|FG001|Overall Study|Lack of Efficacy|3|||
164401810|NCT00686881|593838656|FG000|Overall Study|Physician Decision|1|||
164401811|NCT00686881|593838657|FG001|Overall Study|Physician Decision|0|||
164596571|NCT00424528|594548901|FG000|Overall Study|Adverse Event|2|||
164596572|NCT00424528|594548902|FG001|Overall Study|Adverse Event|1|||
164596573|NCT00424528|594548903|FG002|Overall Study|Adverse Event|2|||
164401812|NCT00686881|593838656|FG000|Overall Study|Circumstances of site|1|||
164442882|NCT00373529|593988682|FG000|Overall Study|Physician Decision|19|||
164401813|NCT00686881|593838657|FG001|Overall Study|Circumstances of site|1|||
164401814|NCT00686881|593838656|FG000|Overall Study|Did not meet protocol eligibility|1|||
164401815|NCT00686881|593838657|FG001|Overall Study|Did not meet protocol eligibility|0|||
164401816|NCT00686881|593838656|FG000|Overall Study|Irregular visits|1|||
164401817|NCT00686881|593838657|FG001|Overall Study|Irregular visits|0|||
164401818|NCT00686881|593838656|FG000|Overall Study|Study discontinuation|35|||
164401819|NCT00686881|593838657|FG001|Overall Study|Study discontinuation|32|||
164401820|NCT00686881|593838656|FG000|Overall Study|Never received study drug|2|||
164401821|NCT00686881|593838657|FG001|Overall Study|Never received study drug|6|||
164401822|NCT00671931|593838660|FG000|Overall Study|Physician Decision|1|||
164401823|NCT00671931|593838661|FG001|Overall Study|Physician Decision|0|||
164401824|NCT00671931|593838662|FG002|Overall Study|Physician Decision|0|||
164401825|NCT00671931|593838663|FG003|Overall Study|Physician Decision|2|||
164401826|NCT00671931|593838664|FG004|Overall Study|Physician Decision|1|||
164401827|NCT01298999|593838665|FG000|Overall Study|Physician Decision|0|||
164401828|NCT01298999|593838666|FG001|Overall Study|Physician Decision|1|||
164401829|NCT01298999|593838665|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
164401830|NCT01298999|593838666|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
164401831|NCT02816138|593838667|FG000|Overall Study|Adverse Event|1|||
164401832|NCT00818753|593838668|FG000|Overall Study|Protocol Violation|1|||
164401833|NCT00818753|593838669|FG001|Overall Study|Protocol Violation|0|||
164401834|NCT00818753|593838670|FG002|Overall Study|Protocol Violation|0|||
164401835|NCT00818753|593838668|FG000|Overall Study|Other reason (not specified)|0|||
164401836|NCT00818753|593838669|FG001|Overall Study|Other reason (not specified)|0|||
164401837|NCT00818753|593838670|FG002|Overall Study|Other reason (not specified)|1|||
164401838|NCT00818753|593838668|FG000|Overall Study|Randomised and not treated|2|||
164401839|NCT00818753|593838669|FG001|Overall Study|Randomised and not treated|0|||
164401840|NCT00818753|593838670|FG002|Overall Study|Randomised and not treated|0|||
164401841|NCT00902694|593838671|FG000|Overall Study|Death|1|||
164401842|NCT00902694|593838672|FG001|Overall Study|Death|3|||
164401843|NCT00902694|593838671|FG000|Overall Study|Lost to Follow-up|1|||
164401844|NCT00902694|593838672|FG001|Overall Study|Lost to Follow-up|0|||
164401845|NCT00902694|593838671|FG000|Overall Study|Censored per protocol|3|||
164401846|NCT00902694|593838672|FG001|Overall Study|Censored per protocol|1|||
164401847|NCT00902694|593838671|FG000|Overall Study|Pregnancy|1|||
164401848|NCT00902694|593838672|FG001|Overall Study|Pregnancy|1|||
164401849|NCT00902694|593838671|FG000|Overall Study|Incarceration|1|||
164401850|NCT00902694|593838672|FG001|Overall Study|Incarceration|0|||
164596574|NCT00424528|594548901|FG000|Overall Study|Protocol Violation|1|||
164596575|NCT00424528|594548902|FG001|Overall Study|Protocol Violation|1|||
164596576|NCT00424528|594548903|FG002|Overall Study|Protocol Violation|0|||
164596577|NCT00424528|594548901|FG000|Overall Study|Lost to Follow-up|0|||
164596578|NCT00424528|594548902|FG001|Overall Study|Lost to Follow-up|1|||
164596579|NCT00424528|594548903|FG002|Overall Study|Lost to Follow-up|0|||
164596580|NCT00424528|594548901|FG000|Overall Study|noncompliance with study requirements|2|||
164596581|NCT00424528|594548902|FG001|Overall Study|noncompliance with study requirements|1|||
164596582|NCT00424528|594548903|FG002|Overall Study|noncompliance with study requirements|2|||
164596583|NCT02115113|594548904|FG000|Participants in Run-in Period|Death|0|||
164596584|NCT02115113|594548905|FG001|Participants in Run-in Period|Death|0|||
164596585|NCT02115113|594548906|FG002|Participants in Run-in Period|Death|1|||
164596586|NCT02115113|594548904|FG000|Participants in Run-in Period|Administrative problems|0|||
164596587|NCT02115113|594548905|FG001|Participants in Run-in Period|Administrative problems|0|||
164596588|NCT02115113|594548906|FG002|Participants in Run-in Period|Administrative problems|1|||
164596589|NCT02115113|594548904|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
164596590|NCT02115113|594548905|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
164596591|NCT02115113|594548906|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
164596592|NCT02115113|594548904|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
164596593|NCT02115113|594548905|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
164596594|NCT02115113|594548906|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
164596595|NCT02115113|594548904|FG000|Participants Randomized|Lost to Follow-up|1|||
164596596|NCT02115113|594548905|FG001|Participants Randomized|Lost to Follow-up|0|||
164596597|NCT02115113|594548906|FG002|Participants Randomized|Lost to Follow-up|0|||
164596598|NCT02115113|594548904|FG000|Participants Randomized|Death|1|||
164596599|NCT02115113|594548905|FG001|Participants Randomized|Death|0|||
164596600|NCT02115113|594548906|FG002|Participants Randomized|Death|0|||
164596601|NCT01009983|594548909|FG000|Overall Study|necessary scans not completed|1|||
164596602|NCT03137121|594548912|FG000|Overall Study|Withdrawal by Subject|0|||
164401851|NCT04154787|593838673|FG000|Overall Study|Adverse Event|0|||
164596603|NCT03137121|594548913|FG001|Overall Study|Withdrawal by Subject|1|||
164596604|NCT02709083|594548917|FG000|Overall Study|Original PI left institution|7|||
164596605|NCT03544268|594548918|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
164596606|NCT03544268|594548919|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
164401852|NCT04154787|593838674|FG001|Overall Study|Adverse Event|1|||
164596607|NCT04410198|594548920|FG000|Overall Study|Death|10|||
164401853|NCT04154787|593838675|FG002|Overall Study|Adverse Event|0|||
164401854|NCT04154787|593838673|FG000|Overall Study|Patient Requires Other Treatment|0|||
164401855|NCT04154787|593838674|FG001|Overall Study|Patient Requires Other Treatment|1|||
164401856|NCT04154787|593838675|FG002|Overall Study|Patient Requires Other Treatment|0|||
164401857|NCT04154787|593838673|FG000|Overall Study|Study Terminated By Sponsor|0|||
164401858|NCT04154787|593838674|FG001|Overall Study|Study Terminated By Sponsor|6|||
164401859|NCT04154787|593838675|FG002|Overall Study|Study Terminated By Sponsor|1|||
164401860|NCT04154787|593838673|FG000|Overall Study|Subject Decision|0|||
164401861|NCT04154787|593838674|FG001|Overall Study|Subject Decision|1|||
164401862|NCT04154787|593838675|FG002|Overall Study|Subject Decision|0|||
164401863|NCT04154787|593838673|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
164401864|NCT04154787|593838674|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
164401865|NCT04154787|593838675|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
164401866|NCT02532179|593840026|FG000|Overall Study|Lost to Follow-up|1|||
164401867|NCT02532179|593840026|FG000|Overall Study|Pregnancy|1|||
164401868|NCT02532179|593840026|FG000|Overall Study|Subject received depot steroid injection|1|||
164401869|NCT02240108|593840027|FG000|Overall Study|Other than specified|8|||
164401870|NCT02240108|593840028|FG001|Overall Study|Other than specified|6|||
164401871|NCT02240108|593840027|FG000|Overall Study|Adverse Event|1|||
164401872|NCT02240108|593840028|FG001|Overall Study|Adverse Event|9|||
164401873|NCT02240108|593840027|FG000|Overall Study|Pregnancy|1|||
164401874|NCT02240108|593840028|FG001|Overall Study|Pregnancy|0|||
164401875|NCT02240108|593840027|FG000|Overall Study|Withdrawal by Subject|4|||
164401876|NCT02240108|593840028|FG001|Overall Study|Withdrawal by Subject|9|||
164401877|NCT02240108|593840027|FG000|Overall Study|StudyTerminated by Sponsor|0|||
164401878|NCT02240108|593840028|FG001|Overall Study|StudyTerminated by Sponsor|1|||
164401879|NCT00119405|593840029|FG000|Overall Study|Withdrawal by Subject|1|||
164401880|NCT01090310|593840030|FG000|Core Study|Adverse Event|2|||
164401881|NCT01090310|593840031|FG001|Core Study|Adverse Event|2|||
164401882|NCT01090310|593840032|FG002|Core Study|Adverse Event|1|||
164401883|NCT01090310|593840033|FG003|Core Study|Adverse Event|1|||
164401884|NCT01090310|593840030|FG000|Core Study|Subject withdrew consent|0|||
164401885|NCT01090310|593840031|FG001|Core Study|Subject withdrew consent|3|||
164401886|NCT01090310|593840032|FG002|Core Study|Subject withdrew consent|1|||
164401887|NCT01090310|593840033|FG003|Core Study|Subject withdrew consent|1|||
164401888|NCT01090310|593840030|FG000|Core Study|Abnormal test procedure result|0|||
164401889|NCT01090310|593840031|FG001|Core Study|Abnormal test procedure result|0|||
164401890|NCT01090310|593840032|FG002|Core Study|Abnormal test procedure result|1|||
164401891|NCT01090310|593840033|FG003|Core Study|Abnormal test procedure result|0|||
164401892|NCT01090310|593840030|FG000|Core Study|Administrative reasons|5|||
164401893|NCT01090310|593840031|FG001|Core Study|Administrative reasons|6|||
164401894|NCT01090310|593840032|FG002|Core Study|Administrative reasons|4|||
164401895|NCT01090310|593840033|FG003|Core Study|Administrative reasons|4|||
164401896|NCT01090310|593840030|FG000|Core Study|Protocol deviation|1|||
164401897|NCT01090310|593840031|FG001|Core Study|Protocol deviation|0|||
164401898|NCT01090310|593840032|FG002|Core Study|Protocol deviation|0|||
164401899|NCT01090310|593840033|FG003|Core Study|Protocol deviation|1|||
164401900|NCT01090310|593840030|FG000|Extension Study|Aministrative problems|13|||
164401901|NCT01090310|593840031|FG001|Extension Study|Aministrative problems|15|||
164401902|NCT01090310|593840032|FG002|Extension Study|Aministrative problems|14|||
164401903|NCT01090310|593840033|FG003|Extension Study|Aministrative problems|18|||
164401904|NCT01090310|593840030|FG000|Extension Study|Adverse Event|0|||
164401905|NCT01090310|593840031|FG001|Extension Study|Adverse Event|0|||
164401906|NCT01090310|593840032|FG002|Extension Study|Adverse Event|0|||
164401907|NCT01090310|593840033|FG003|Extension Study|Adverse Event|1|||
164401908|NCT01090310|593840030|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
164401909|NCT01090310|593840031|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
164401910|NCT01090310|593840032|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
164401911|NCT01090310|593840033|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
164401912|NCT01090310|593840030|FG000|Extension Study|Subject withdrew consent|0|||
164401913|NCT01090310|593840031|FG001|Extension Study|Subject withdrew consent|1|||
164401914|NCT01090310|593840032|FG002|Extension Study|Subject withdrew consent|0|||
164705983|NCT03845296|594953336|FG001|Overall Study|Progression/relapse|18|||
164705984|NCT03845296|594953335|FG000|Overall Study|Death|4|||
164401915|NCT01090310|593840033|FG003|Extension Study|Subject withdrew consent|0|||
164401916|NCT00989092|593840034|FG000|Overall Study|Physician Decision|9|||
164401917|NCT00989092|593840035|FG001|Overall Study|Physician Decision|6|||
164401918|NCT00989092|593840034|FG000|Overall Study|Adverse Event|20|||
164401919|NCT00989092|593840035|FG001|Overall Study|Adverse Event|1|||
164401920|NCT00989092|593840034|FG000|Overall Study|Chemotherapy initiated|12|||
164401921|NCT00989092|593840035|FG001|Overall Study|Chemotherapy initiated|4|||
164705985|NCT03845296|594953336|FG001|Overall Study|Death|0|||
164401922|NCT00989092|593840034|FG000|Overall Study|Withdrawal by Subject|17|||
164401923|NCT00989092|593840035|FG001|Overall Study|Withdrawal by Subject|9|||
164401924|NCT00989092|593840034|FG000|Overall Study|Death|14|||
164401925|NCT00989092|593840035|FG001|Overall Study|Death|2|||
164401926|NCT00989092|593840034|FG000|Overall Study|Ineligibility determined|3|||
164705986|NCT03845296|594953335|FG000|Overall Study|Other - not protocol specified|1|||
164442883|NCT00373529|593988682|FG000|Overall Study|Withdrawal by Subject|7|||
164442884|NCT00373529|593988682|FG000|Overall Study|Adverse Event|7|||
164442885|NCT00373529|593988682|FG000|Overall Study|Treatment failure|36|||
164442886|NCT00373529|593988682|FG000|Overall Study|Disease recurrence|10|||
164442887|NCT00373529|593988682|FG000|Overall Study|Death|16|||
164442888|NCT00373529|593988682|FG000|Overall Study|Need for treatment prohibited by study|1|||
164442889|NCT00373529|593988682|FG000|Overall Study|Other|8|||
164442890|NCT00373529|593988682|FG000|Overall Study|Failed independent confirmation of AML|3|||
164442891|NCT00373529|593988682|FG000|Overall Study|Consent violation|1|||
164442892|NCT03070483|593988683|FG000|Overall Study|Lost to Follow-up|2|||
164442893|NCT00732381|593988686|FG000|Overall Study|Adverse Event|1|||
164442894|NCT00732381|593988687|FG001|Overall Study|Adverse Event|0|||
164442895|NCT00732381|593988686|FG000|Overall Study|Treatment Failure|1|||
164442896|NCT00732381|593988687|FG001|Overall Study|Treatment Failure|1|||
164442897|NCT01390402|593988688|FG000|Overall Study|Death|1|||
164442898|NCT01390402|593988688|FG000|Overall Study|Disease Progression|4|||
164442899|NCT00414544|593989857|FG000|Overall Study|Lost to Follow-up|14|||
164442900|NCT01599104|593989858|FG000|Overall Study|Withdrawal by Subject|1|||
164442901|NCT01599104|593989859|FG001|Overall Study|Withdrawal by Subject|1|||
164442902|NCT01599104|593989860|FG002|Overall Study|Withdrawal by Subject|2|||
164442903|NCT01599104|593989858|FG000|Overall Study|Technical Problems|1|||
164442904|NCT01599104|593989859|FG001|Overall Study|Technical Problems|0|||
164442905|NCT01599104|593989860|FG002|Overall Study|Technical Problems|0|||
164442906|NCT01599104|593989858|FG000|Overall Study|Physician Decision|3|||
164442907|NCT01599104|593989859|FG001|Overall Study|Physician Decision|2|||
164442908|NCT01599104|593989860|FG002|Overall Study|Physician Decision|2|||
164442909|NCT01599104|593989858|FG000|Overall Study|Non-compliance with study treatment|0|||
164442910|NCT01599104|593989859|FG001|Overall Study|Non-compliance with study treatment|1|||
164442911|NCT01599104|593989860|FG002|Overall Study|Non-compliance with study treatment|0|||
164442912|NCT01599104|593989858|FG000|Overall Study|Lack of Efficacy|4|||
164442913|NCT01599104|593989859|FG001|Overall Study|Lack of Efficacy|4|||
164442914|NCT01599104|593989860|FG002|Overall Study|Lack of Efficacy|10|||
164442915|NCT01599104|593989858|FG000|Overall Study|Adverse Event|7|||
164442916|NCT01599104|593989859|FG001|Overall Study|Adverse Event|6|||
164442917|NCT01599104|593989860|FG002|Overall Study|Adverse Event|12|||
164442918|NCT00714714|593989861|FG000|Overall Study|Adverse Event|1|||
164442919|NCT00585052|593989864|FG000|Overall Study|Withdrawal by Subject|1|||
164442920|NCT02616900|593989865|FG000|Overall Study|Lack of Efficacy|7|||
164442921|NCT02616900|593989865|FG000|Overall Study|Lost to Follow-up|2|||
164442922|NCT02616900|593989865|FG000|Overall Study|Protocol Violation|5|||
164442923|NCT02616900|593989865|FG000|Overall Study|Withdrawal by Subject|3|||
164442924|NCT02616900|593989865|FG000|Overall Study|Incomplete data|6|||
164442925|NCT04425863|593989866|FG000|Overall Study|Death|0|||
164442926|NCT04425863|593989867|FG001|Overall Study|Death|0|||
164442927|NCT04425863|593989868|FG002|Overall Study|Death|1|||
164442928|NCT03691428|593989869|FG000|Overall Study|Withdrawal by Subject|6|||
164442929|NCT03691428|593989870|FG001|Overall Study|Withdrawal by Subject|8|||
164442930|NCT01460290|593989871|FG000|Overall Study|Adverse Event|3|||
164442931|NCT01460290|593989871|FG000|Overall Study|Elevated liver function|1|||
164442932|NCT01190007|593989872|FG000|Overall Study|Withdrawal by Subject|4|||
164442933|NCT01190007|593989872|FG000|Overall Study|Adverse Event|8|||
164442934|NCT01190007|593989872|FG000|Overall Study|Difficulty of visit for complications|1|||
164442935|NCT01190007|593989872|FG000|Overall Study|Participant was arrested|1|||
164442936|NCT00845832|593989880|FG000|Treatment Period|Adverse Event|0|||
164442937|NCT00845832|593989881|FG001|Treatment Period|Adverse Event|2|||
164442938|NCT00845832|593989882|FG002|Treatment Period|Adverse Event|0|||
164442939|NCT00845832|593989880|FG000|Treatment Period|Protocol Violation|1|||
164442940|NCT00845832|593989881|FG001|Treatment Period|Protocol Violation|1|||
164442941|NCT00845832|593989882|FG002|Treatment Period|Protocol Violation|0|||
164442942|NCT00845832|593989880|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
164442943|NCT00845832|593989881|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
164442944|NCT00845832|593989882|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
164442945|NCT00845832|593989880|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
164442946|NCT00845832|593989881|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
164442947|NCT00845832|593989882|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
164442948|NCT03260140|593989888|FG000|Overall Study|Death|4|||
164442949|NCT03260140|593989889|FG001|Overall Study|Death|1|||
164442950|NCT03260140|593989888|FG000|Overall Study|Withdrawal by Subject|1|||
164442951|NCT03260140|593989889|FG001|Overall Study|Withdrawal by Subject|4|||
164442952|NCT00463788|593989890|FG000|Overall Study|Progressive Disease|86|||
164442953|NCT00463788|593989891|FG001|Overall Study|Progressive Disease|42|||
164442954|NCT00463788|593989890|FG000|Overall Study|Adverse Event|6|||
164442955|NCT00463788|593989891|FG001|Overall Study|Adverse Event|2|||
164442956|NCT00463788|593989890|FG000|Overall Study|Withdrawal by Subject|6|||
164442957|NCT00463788|593989891|FG001|Overall Study|Withdrawal by Subject|2|||
164442958|NCT00463788|593989890|FG000|Overall Study|Death|4|||
164442959|NCT00463788|593989891|FG001|Overall Study|Death|3|||
164442960|NCT00463788|593989890|FG000|Overall Study|Symptomatic Deterioration|2|||
164401927|NCT00989092|593840035|FG001|Overall Study|Ineligibility determined|3|||
164401928|NCT00989092|593840034|FG000|Overall Study|Lost to Follow-up|6|||
164401929|NCT00989092|593840035|FG001|Overall Study|Lost to Follow-up|2|||
164401930|NCT00989092|593840034|FG000|Overall Study|Other|3|||
164401931|NCT00989092|593840035|FG001|Overall Study|Other|1|||
164401932|NCT00989092|593840034|FG000|Overall Study|Protocol deviation|2|||
164401933|NCT00989092|593840035|FG001|Overall Study|Protocol deviation|0|||
164401934|NCT00989092|593840034|FG000|Overall Study|Erythropoietin therapy initiated|2|||
164401935|NCT00989092|593840035|FG001|Overall Study|Erythropoietin therapy initiated|0|||
164401936|NCT00989092|593840034|FG000|Overall Study|Did not receive study drug|2|||
164401937|NCT00989092|593840035|FG001|Overall Study|Did not receive study drug|0|||
164401938|NCT03837509|593840040|FG000|Phase 1|Death|5|||
164401939|NCT03837509|593840041|FG001|Phase 1|Death|2|||
164401940|NCT03837509|593840042|FG002|Phase 1|Death|0|||
164401941|NCT03837509|593840043|FG003|Phase 1|Death|0|||
164401942|NCT03837509|593840044|FG004|Phase 1|Death|0|||
164401943|NCT03837509|593840040|FG000|Phase 2|Death|0|||
164401944|NCT03837509|593840041|FG001|Phase 2|Death|0|||
164401945|NCT03837509|593840042|FG002|Phase 2|Death|0|||
164401946|NCT03837509|593840043|FG003|Phase 2|Death|1|||
164401947|NCT03837509|593840044|FG004|Phase 2|Death|1|||
164401948|NCT03320018|593840051|FG000|Treatment Period|Withdrawal by Subject|1|||
164401949|NCT03320018|593840052|FG001|Treatment Period|Withdrawal by Subject|0|||
164401950|NCT03320018|593840051|FG000|Day 90 Follow up|Death|0|||
164401951|NCT03320018|593840052|FG001|Day 90 Follow up|Death|1|||
164401952|NCT00549757|593840053|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
164401953|NCT00549757|593840054|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
164401954|NCT00549757|593840053|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
164401955|NCT00549757|593840054|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
164401956|NCT00549757|593840053|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
164401957|NCT00549757|593840054|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
164401958|NCT00549757|593840053|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
164401959|NCT00549757|593840054|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
164401960|NCT00549757|593840053|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
164401961|NCT00549757|593840054|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
164401962|NCT00549757|593840053|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
164401963|NCT00549757|593840054|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
164401964|NCT00549757|593840053|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
164401965|NCT00549757|593840054|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
164401966|NCT00549757|593840053|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
164401967|NCT00549757|593840054|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
164401968|NCT00549757|593840053|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
164401969|NCT00549757|593840054|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
164401970|NCT00549757|593840053|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
164401971|NCT00549757|593840054|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
164401972|NCT00549757|593840053|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
164401973|NCT00549757|593840054|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
164401974|NCT00549757|593840053|FG000|Extension Period (in Average 9 Months)|Death|143|||
164401975|NCT00549757|593840054|FG001|Extension Period (in Average 9 Months)|Death|136|||
164401976|NCT00549757|593840053|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
164401977|NCT00549757|593840054|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
164401978|NCT00549757|593840053|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
164401979|NCT00549757|593840054|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
164401980|NCT00549757|593840053|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
164401981|NCT00549757|593840054|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
164401982|NCT01123382|593840065|FG000|Overall Study|Withdrawal by Subject|1|||
164401983|NCT01123382|593840066|FG001|Overall Study|Withdrawal by Subject|4|||
164401984|NCT01123382|593840065|FG000|Overall Study|Lost to Follow-up|1|||
164401985|NCT01123382|593840066|FG001|Overall Study|Lost to Follow-up|2|||
164401986|NCT00330174|593840067|FG000|Overall Study|Withdrawal by Subject|7|||
164705987|NCT03845296|594953336|FG001|Overall Study|Other - not protocol specified|3|||
164705988|NCT05424042|594953337|FG000|Overall Study|Withdrawal by Subject|2|||
164705989|NCT05424042|594953338|FG001|Overall Study|Withdrawal by Subject|0|||
164401987|NCT00330174|593840068|FG001|Overall Study|Withdrawal by Subject|7|||
164401988|NCT00330174|593840067|FG000|Overall Study|Lost to Follow-up|4|||
164401989|NCT00330174|593840068|FG001|Overall Study|Lost to Follow-up|1|||
164401990|NCT00330174|593840067|FG000|Overall Study|Clinical deterioration|1|||
164401991|NCT00330174|593840068|FG001|Overall Study|Clinical deterioration|2|||
164705990|NCT05424042|594953339|FG002|Overall Study|Withdrawal by Subject|4|||
164705991|NCT05424042|594953337|FG000|Overall Study|Lost to Follow-up|0|||
164401992|NCT00330174|593840067|FG000|Overall Study|Excessive missed visits|3|||
164401993|NCT00330174|593840068|FG001|Overall Study|Excessive missed visits|8|||
164401994|NCT00330174|593840067|FG000|Overall Study|Miscellaneous reasons|7|||
164442961|NCT00463788|593989891|FG001|Overall Study|Symptomatic Deterioration|3|||
164442962|NCT00463788|593989890|FG000|Overall Study|Lost to Follow-up|1|||
164442963|NCT00463788|593989891|FG001|Overall Study|Lost to Follow-up|0|||
164442964|NCT00463788|593989890|FG000|Overall Study|Protocol Violation|0|||
164442965|NCT00463788|593989891|FG001|Overall Study|Protocol Violation|1|||
164442966|NCT00463788|593989890|FG000|Overall Study|Other|3|||
164442967|NCT00463788|593989891|FG001|Overall Study|Other|0|||
164442968|NCT00463788|593989890|FG000|Overall Study|Randomized but not treated|1|||
164442969|NCT00463788|593989891|FG001|Overall Study|Randomized but not treated|1|||
164442970|NCT00360698|593989892|FG000|Run-In|Physician Decision|0|||
164442971|NCT00360698|593989893|FG001|Run-In|Physician Decision|1|||
164442972|NCT00360698|593989892|FG000|Run-In|Withdrawal by Subject|0|||
164442973|NCT00360698|593989893|FG001|Run-In|Withdrawal by Subject|2|||
164442974|NCT00360698|593989892|FG000|Run-In|Non compliance with treatment procedure|0|||
164442975|NCT00360698|593989893|FG001|Run-In|Non compliance with treatment procedure|1|||
164442976|NCT00360698|593989892|FG000|Run-In|Sponsor request|0|||
164442977|NCT00360698|593989893|FG001|Run-In|Sponsor request|2|||
164442978|NCT00360698|593989892|FG000|Run-In|Patient did not meet inclusion criteria|0|||
164442979|NCT00360698|593989893|FG001|Run-In|Patient did not meet inclusion criteria|1|||
164442980|NCT00360698|593989892|FG000|Run-In|Patient personal reasons|0|||
164442981|NCT00360698|593989893|FG001|Run-In|Patient personal reasons|2|||
164442982|NCT00360698|593989892|FG000|Run-In|Need of insulin with meals|0|||
164442983|NCT00360698|593989893|FG001|Run-In|Need of insulin with meals|1|||
164442984|NCT00360698|593989892|FG000|Treatment Period|Non compliance with treatment procedure|1|||
164442985|NCT00360698|593989893|FG001|Treatment Period|Non compliance with treatment procedure|0|||
164442986|NCT00360698|593989892|FG000|Treatment Period|Early termination by error|0|||
164442987|NCT00360698|593989893|FG001|Treatment Period|Early termination by error|1|||
164442988|NCT01692938|593989904|FG000|Overall Study|Protocol Deviation|1|||
164442989|NCT01692938|593989905|FG001|Overall Study|Protocol Deviation|1|||
164442990|NCT01692938|593989904|FG000|Overall Study|Study completed prior to site completion|3|||
164442991|NCT01692938|593989905|FG001|Overall Study|Study completed prior to site completion|3|||
164442992|NCT02957136|593989908|FG000|Overall Study|Withdrawal by Subject|2|||
164442993|NCT02957136|593989909|FG001|Overall Study|Withdrawal by Subject|1|||
164442994|NCT02200770|593989913|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
164442995|NCT02200770|593989914|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
164442996|NCT02200770|593989913|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
164442997|NCT02200770|593989914|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
164442998|NCT02200770|593989913|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
164442999|NCT02200770|593989914|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
164443000|NCT02200770|593989913|FG000|Randomized-controlled Period (RCP)|Other|1|||
164443001|NCT02200770|593989914|FG001|Randomized-controlled Period (RCP)|Other|2|||
164443002|NCT02200770|593989913|FG000|Open-label Period (OLP)|Adverse Event|1|||
164443003|NCT02200770|593989914|FG001|Open-label Period (OLP)|Adverse Event|2|||
164443004|NCT02200770|593989913|FG000|Open-label Period (OLP)|Death|1|||
164443005|NCT02200770|593989914|FG001|Open-label Period (OLP)|Death|2|||
164443006|NCT02200770|593989913|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
164443007|NCT02200770|593989914|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
164443008|NCT02200770|593989913|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
164443009|NCT02200770|593989914|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
164443010|NCT02200770|593989913|FG000|Open-label Period (OLP)|Other|6|||
164443011|NCT02200770|593989914|FG001|Open-label Period (OLP)|Other|15|||
164443012|NCT05283395|593989916|FG000|Overall Study|Adverse Event|4|||
164443013|NCT05283395|593989917|FG001|Overall Study|Adverse Event|4|||
164443014|NCT05283395|593989918|FG002|Overall Study|Adverse Event|0|||
164443015|NCT05283395|593989916|FG000|Overall Study|Patient Lost to Follow-Up|0|||
164443016|NCT05283395|593989917|FG001|Overall Study|Patient Lost to Follow-Up|0|||
164443017|NCT05283395|593989918|FG002|Overall Study|Patient Lost to Follow-Up|1|||
164443018|NCT05283395|593989916|FG000|Overall Study|Patient Withdrawal|2|||
164443019|NCT05283395|593989917|FG001|Overall Study|Patient Withdrawal|4|||
164443020|NCT05283395|593989918|FG002|Overall Study|Patient Withdrawal|2|||
164443021|NCT05283395|593989916|FG000|Overall Study|Investigator Decision|1|||
164443022|NCT05283395|593989917|FG001|Overall Study|Investigator Decision|0|||
164443023|NCT05283395|593989918|FG002|Overall Study|Investigator Decision|1|||
164443024|NCT05283395|593989916|FG000|Overall Study|Enrolled in error|0|||
164443025|NCT05283395|593989917|FG001|Overall Study|Enrolled in error|0|||
164443026|NCT05283395|593989918|FG002|Overall Study|Enrolled in error|1|||
164443027|NCT00424645|593989919|FG000|Overall Study|Death|1|||
164443028|NCT00424645|593989920|FG001|Overall Study|Death|0|||
164443029|NCT02555215|593989921|FG000|Overall Study|Other|1|||
164443030|NCT02555215|593989921|FG000|Overall Study|Investigator Decision|2|||
164443031|NCT00529789|593989922|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
164443032|NCT00529789|593989922|FG000|Study Period II/III|Adverse Event|3|||
164443033|NCT00529789|593989922|FG000|Study Period II/III|Lack of Efficacy|2|||
164443034|NCT00529789|593989922|FG000|Study Period II/III|Withdrawal by Subject|1|||
164443035|NCT00529789|593989922|FG000|Study Period II/III|Protocol Violation|3|||
164443036|NCT00529789|593989922|FG000|Study Period II/III|Physician Decision|3|||
164705992|NCT05424042|594953338|FG001|Overall Study|Lost to Follow-up|0|||
164705993|NCT05424042|594953339|FG002|Overall Study|Lost to Follow-up|1|||
164705994|NCT05091307|594953340|FG000|Overall Study|Death|0|||
164705995|NCT05091307|594953341|FG001|Overall Study|Death|0|||
164705996|NCT05091307|594953342|FG002|Overall Study|Death|1|||
164705997|NCT05091307|594953343|FG003|Overall Study|Death|0|||
164705998|NCT05091307|594953340|FG000|Overall Study|Lost to Follow-up|33|||
164705999|NCT05091307|594953341|FG001|Overall Study|Lost to Follow-up|33|||
164706000|NCT05091307|594953342|FG002|Overall Study|Lost to Follow-up|2|||
164706001|NCT05091307|594953343|FG003|Overall Study|Lost to Follow-up|0|||
164706002|NCT05091307|594953340|FG000|Overall Study|Physician Decision|1|||
164706003|NCT05091307|594953341|FG001|Overall Study|Physician Decision|0|||
164706004|NCT05091307|594953342|FG002|Overall Study|Physician Decision|0|||
164401995|NCT00330174|593840068|FG001|Overall Study|Miscellaneous reasons|1|||
164401996|NCT06134180|593840071|FG000|Overall Study|Lost to Follow-up|4|||
164401997|NCT01362439|593840072|FG000|Overall Study|Adverse Event|1|||
164401998|NCT01362439|593840072|FG000|Overall Study|Lack of Efficacy|3|||
164401999|NCT01362439|593840072|FG000|Overall Study|Lost to Follow-up|2|||
164402000|NCT01362439|593840072|FG000|Overall Study|Study medication non-compliant|1|||
164402001|NCT01362439|593840072|FG000|Overall Study|Participant who withdrew consent|8|||
164402002|NCT02712905|593840075|FG000|Monotherapy|Death|2|||
164402003|NCT02712905|593840076|FG001|Monotherapy|Death|5|||
164402004|NCT02712905|593840077|FG002|Monotherapy|Death|0|||
164402005|NCT02712905|593840078|FG003|Monotherapy|Death|3|||
164402006|NCT02712905|593840079|FG004|Monotherapy|Death|15|||
164402007|NCT02712905|593840080|FG005|Monotherapy|Death|1|||
164402008|NCT02712905|593840081|FG006|Monotherapy|Death|3|||
164402009|NCT02712905|593840082|FG007|Monotherapy|Death|3|||
164402010|NCT02712905|593840083|FG008|Monotherapy|Death|0|||
164402011|NCT02712905|593840084|FG009|Monotherapy|Death|27|||
164402012|NCT02712905|593840085|FG010|Monotherapy|Death|2|||
164402013|NCT02712905|593840086|FG011|Monotherapy|Death|5|||
164402014|NCT02712905|593840087|FG012|Monotherapy|Death|0|||
164402015|NCT02712905|593840088|FG013|Monotherapy|Death|0|||
164402016|NCT02712905|593840089|FG014|Monotherapy|Death|0|||
164402017|NCT02712905|593840090|FG015|Monotherapy|Death|0|||
164402018|NCT02712905|593840091|FG016|Monotherapy|Death|0|||
164402019|NCT02712905|593840092|FG017|Monotherapy|Death|0|||
164402020|NCT02712905|593840075|FG000|Monotherapy|Lost to Follow-up|0|||
164402021|NCT02712905|593840076|FG001|Monotherapy|Lost to Follow-up|1|||
164402022|NCT02712905|593840077|FG002|Monotherapy|Lost to Follow-up|0|||
164402023|NCT02712905|593840078|FG003|Monotherapy|Lost to Follow-up|1|||
164402024|NCT02712905|593840079|FG004|Monotherapy|Lost to Follow-up|0|||
164402025|NCT02712905|593840080|FG005|Monotherapy|Lost to Follow-up|0|||
164402026|NCT02712905|593840081|FG006|Monotherapy|Lost to Follow-up|0|||
164402027|NCT02712905|593840082|FG007|Monotherapy|Lost to Follow-up|0|||
164402028|NCT02712905|593840083|FG008|Monotherapy|Lost to Follow-up|0|||
164402029|NCT02712905|593840084|FG009|Monotherapy|Lost to Follow-up|2|||
164402030|NCT02712905|593840085|FG010|Monotherapy|Lost to Follow-up|0|||
164402031|NCT02712905|593840086|FG011|Monotherapy|Lost to Follow-up|0|||
164402032|NCT02712905|593840087|FG012|Monotherapy|Lost to Follow-up|0|||
164402033|NCT02712905|593840088|FG013|Monotherapy|Lost to Follow-up|0|||
164402034|NCT02712905|593840089|FG014|Monotherapy|Lost to Follow-up|0|||
164402035|NCT02712905|593840090|FG015|Monotherapy|Lost to Follow-up|0|||
164402036|NCT02712905|593840091|FG016|Monotherapy|Lost to Follow-up|0|||
164402037|NCT02712905|593840092|FG017|Monotherapy|Lost to Follow-up|0|||
164402038|NCT02712905|593840075|FG000|Monotherapy|Physician Decision|1|||
164402039|NCT02712905|593840076|FG001|Monotherapy|Physician Decision|0|||
164402040|NCT02712905|593840077|FG002|Monotherapy|Physician Decision|0|||
164402041|NCT02712905|593840078|FG003|Monotherapy|Physician Decision|1|||
164402042|NCT02712905|593840079|FG004|Monotherapy|Physician Decision|0|||
164402043|NCT02712905|593840080|FG005|Monotherapy|Physician Decision|0|||
164402044|NCT02712905|593840081|FG006|Monotherapy|Physician Decision|0|||
164402045|NCT02712905|593840082|FG007|Monotherapy|Physician Decision|0|||
164402046|NCT02712905|593840083|FG008|Monotherapy|Physician Decision|0|||
164402047|NCT02712905|593840084|FG009|Monotherapy|Physician Decision|1|||
164402048|NCT02712905|593840085|FG010|Monotherapy|Physician Decision|0|||
164402049|NCT02712905|593840086|FG011|Monotherapy|Physician Decision|0|||
164402050|NCT02712905|593840087|FG012|Monotherapy|Physician Decision|0|||
164402051|NCT02712905|593840088|FG013|Monotherapy|Physician Decision|0|||
164402052|NCT02712905|593840089|FG014|Monotherapy|Physician Decision|0|||
164402053|NCT02712905|593840090|FG015|Monotherapy|Physician Decision|0|||
164402054|NCT02712905|593840091|FG016|Monotherapy|Physician Decision|0|||
164402055|NCT02712905|593840092|FG017|Monotherapy|Physician Decision|0|||
164402056|NCT02712905|593840075|FG000|Monotherapy|Study Terminated by Sponsor|0|||
164402057|NCT02712905|593840076|FG001|Monotherapy|Study Terminated by Sponsor|0|||
164402058|NCT02712905|593840077|FG002|Monotherapy|Study Terminated by Sponsor|0|||
164402059|NCT02712905|593840078|FG003|Monotherapy|Study Terminated by Sponsor|0|||
164402060|NCT02712905|593840079|FG004|Monotherapy|Study Terminated by Sponsor|1|||
164402061|NCT02712905|593840080|FG005|Monotherapy|Study Terminated by Sponsor|0|||
164402062|NCT02712905|593840081|FG006|Monotherapy|Study Terminated by Sponsor|0|||
164402063|NCT02712905|593840082|FG007|Monotherapy|Study Terminated by Sponsor|0|||
164706005|NCT05091307|594953343|FG003|Overall Study|Physician Decision|0|||
164443037|NCT00529789|593989922|FG000|Study Period II/III|Lost to Follow-up|3|||
164443038|NCT00529789|593989922|FG000|Study Period IV|Parent/Caregiver Decision|1|||
164443039|NCT00529789|593989922|FG000|Study Period IV|Adverse Event|1|||
164706006|NCT05091307|594953340|FG000|Overall Study|Protocol Violation|1|||
164706007|NCT05091307|594953341|FG001|Overall Study|Protocol Violation|0|||
164706008|NCT05091307|594953342|FG002|Overall Study|Protocol Violation|0|||
164706009|NCT05091307|594953343|FG003|Overall Study|Protocol Violation|0|||
164443040|NCT00529789|593989922|FG000|Study Period IV|Lack of Efficacy|1|||
164443041|NCT00529789|593989922|FG000|Study Period IV|Lost to Follow-up|3|||
164443042|NCT02204982|593989923|FG000|Overall Study|Patient ineligible-medical monitor|1|||
164443043|NCT02204982|593989924|FG001|Overall Study|Patient ineligible-medical monitor|0|||
164443044|NCT02204982|593989923|FG000|Overall Study|Withdrawal by Subject|1|||
164443045|NCT02204982|593989924|FG001|Overall Study|Withdrawal by Subject|0|||
164443046|NCT02204982|593989923|FG000|Overall Study|Adverse Event|1|||
164443047|NCT02204982|593989924|FG001|Overall Study|Adverse Event|0|||
164443048|NCT02204982|593989923|FG000|Overall Study|Adverse Event and Investigator decision|1|||
164443049|NCT02204982|593989924|FG001|Overall Study|Adverse Event and Investigator decision|0|||
164443050|NCT02204982|593989923|FG000|Overall Study|Physician Decision|0|||
164443051|NCT02204982|593989924|FG001|Overall Study|Physician Decision|2|||
164443052|NCT02204982|593989923|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
164443053|NCT02204982|593989924|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
164443054|NCT02204982|593989923|FG000|Overall Study|Termination of Study bySponsor|0|||
164443055|NCT02204982|593989924|FG001|Overall Study|Termination of Study bySponsor|1|||
164443056|NCT00468910|593989927|FG000|Overall Study|Lost to Follow-up|2|||
164443057|NCT00468910|593989928|FG001|Overall Study|Lost to Follow-up|1|||
164443058|NCT00468910|593989927|FG000|Overall Study|Withdrawal by Subject|2|||
164443059|NCT00468910|593989928|FG001|Overall Study|Withdrawal by Subject|1|||
164443060|NCT00468910|593989927|FG000|Overall Study|Medical Contraindication|0|||
164443061|NCT00468910|593989928|FG001|Overall Study|Medical Contraindication|1|||
164443062|NCT01909778|593989929|FG000|Overall Study|failed screening|1|||
164443063|NCT01943916|593989930|FG000|Overall Study|Technically invalid images|10|||
164443064|NCT01943916|593989930|FG000|Overall Study|Enrollment Failure|23|||
164443065|NCT01943916|593989930|FG000|Overall Study|Pilot Phase exclusion|100|||
164443066|NCT01943916|593989930|FG000|Overall Study|Quality Assurance Reader Fail|130|||
164443067|NCT01943916|593989930|FG000|Overall Study|Technical Failure|39|||
164443068|NCT01943916|593989930|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
164443069|NCT01943916|593989930|FG000|Overall Study|No Truth Panel Review|38|||
164443070|NCT01943916|593989930|FG000|Overall Study|Protocol Deviation|1|||
164443071|NCT00919763|593989931|FG000|Overall Study|Adverse Event|7|||
164443072|NCT00919763|593989932|FG001|Overall Study|Adverse Event|1|||
164443073|NCT00919763|593989931|FG000|Overall Study|Lost to Follow-up|1|||
164443074|NCT00919763|593989932|FG001|Overall Study|Lost to Follow-up|0|||
164443075|NCT00919763|593989931|FG000|Overall Study|Protocol Violation|1|||
164443076|NCT00919763|593989932|FG001|Overall Study|Protocol Violation|1|||
164443077|NCT00919763|593989931|FG000|Overall Study|Withdrawal by Subject|3|||
164443078|NCT00919763|593989932|FG001|Overall Study|Withdrawal by Subject|1|||
164443079|NCT00919763|593989931|FG000|Overall Study|Non-compliance|0|||
164443080|NCT00919763|593989932|FG001|Overall Study|Non-compliance|1|||
164443081|NCT03654768|593989933|FG000|Overall Study|Adverse Event|1|||
164443082|NCT03654768|593989934|FG001|Overall Study|Adverse Event|6|||
164443083|NCT03654768|593989933|FG000|Overall Study|Loss of response|2|||
164443084|NCT03654768|593989934|FG001|Overall Study|Loss of response|2|||
164443085|NCT03654768|593989933|FG000|Overall Study|Non-compliance|0|||
164443086|NCT03654768|593989934|FG001|Overall Study|Non-compliance|1|||
164443087|NCT03654768|593989933|FG000|Overall Study|Refusal not related to toxicity|1|||
164443088|NCT03654768|593989934|FG001|Overall Study|Refusal not related to toxicity|5|||
164706010|NCT05091307|594953340|FG000|Overall Study|Withdrawal by Subject|16|||
164443089|NCT03654768|593989933|FG000|Overall Study|Did not receive protocol therapy|1|||
164443090|NCT03654768|593989934|FG001|Overall Study|Did not receive protocol therapy|1|||
164443091|NCT05323734|593989935|FG000|Overall Study|Adverse Event|5|||
164443092|NCT05323734|593989936|FG001|Overall Study|Adverse Event|2|||
164443093|NCT05323734|593989935|FG000|Overall Study|Physician Decision|1|||
164443094|NCT05323734|593989936|FG001|Overall Study|Physician Decision|0|||
164443095|NCT05323734|593989935|FG000|Overall Study|Lack of Efficacy|1|||
164443096|NCT05323734|593989936|FG001|Overall Study|Lack of Efficacy|2|||
164443097|NCT05323734|593989935|FG000|Overall Study|Withdrawal by Subject|2|||
164443098|NCT05323734|593989936|FG001|Overall Study|Withdrawal by Subject|0|||
164443099|NCT05323734|593989935|FG000|Overall Study|Participant Withdrawn Due|0|||
164443100|NCT05323734|593989936|FG001|Overall Study|Participant Withdrawn Due|1|||
164443101|NCT01595321|593989937|FG000|Overall Study|Adverse Event|1|||
164443102|NCT01595321|593989938|FG001|Overall Study|Adverse Event|1|||
164706011|NCT05091307|594953341|FG001|Overall Study|Withdrawal by Subject|16|||
164443103|NCT01595321|593989939|FG002|Overall Study|Adverse Event|1|||
164706012|NCT05091307|594953342|FG002|Overall Study|Withdrawal by Subject|0|||
164443104|NCT01595321|593989937|FG000|Overall Study|Lack of Efficacy|0|||
164443105|NCT01595321|593989938|FG001|Overall Study|Lack of Efficacy|0|||
164706013|NCT05091307|594953343|FG003|Overall Study|Withdrawal by Subject|1|||
164596608|NCT04410198|594548920|FG000|Overall Study|Withdrawal by Subject|7|||
164402064|NCT02712905|593840083|FG008|Monotherapy|Study Terminated by Sponsor|0|||
164402065|NCT02712905|593840084|FG009|Monotherapy|Study Terminated by Sponsor|2|||
164402066|NCT02712905|593840085|FG010|Monotherapy|Study Terminated by Sponsor|0|||
164402067|NCT02712905|593840086|FG011|Monotherapy|Study Terminated by Sponsor|0|||
164402068|NCT02712905|593840087|FG012|Monotherapy|Study Terminated by Sponsor|0|||
164402069|NCT02712905|593840088|FG013|Monotherapy|Study Terminated by Sponsor|0|||
164402070|NCT02712905|593840089|FG014|Monotherapy|Study Terminated by Sponsor|0|||
164402071|NCT02712905|593840090|FG015|Monotherapy|Study Terminated by Sponsor|0|||
164402072|NCT02712905|593840091|FG016|Monotherapy|Study Terminated by Sponsor|0|||
164402073|NCT02712905|593840092|FG017|Monotherapy|Study Terminated by Sponsor|0|||
164402074|NCT02712905|593840075|FG000|Monotherapy|Withdrawal by Subject|0|||
164402075|NCT02712905|593840076|FG001|Monotherapy|Withdrawal by Subject|0|||
164402076|NCT02712905|593840077|FG002|Monotherapy|Withdrawal by Subject|1|||
164402077|NCT02712905|593840078|FG003|Monotherapy|Withdrawal by Subject|0|||
164402078|NCT02712905|593840079|FG004|Monotherapy|Withdrawal by Subject|2|||
164402079|NCT02712905|593840080|FG005|Monotherapy|Withdrawal by Subject|0|||
164402080|NCT02712905|593840081|FG006|Monotherapy|Withdrawal by Subject|0|||
164402081|NCT02712905|593840082|FG007|Monotherapy|Withdrawal by Subject|0|||
164402082|NCT02712905|593840083|FG008|Monotherapy|Withdrawal by Subject|0|||
164402083|NCT02712905|593840084|FG009|Monotherapy|Withdrawal by Subject|4|||
164402084|NCT02712905|593840085|FG010|Monotherapy|Withdrawal by Subject|1|||
164402085|NCT02712905|593840086|FG011|Monotherapy|Withdrawal by Subject|2|||
164402086|NCT02712905|593840087|FG012|Monotherapy|Withdrawal by Subject|0|||
164402087|NCT02712905|593840088|FG013|Monotherapy|Withdrawal by Subject|0|||
164402088|NCT02712905|593840089|FG014|Monotherapy|Withdrawal by Subject|0|||
164402089|NCT02712905|593840090|FG015|Monotherapy|Withdrawal by Subject|0|||
164402090|NCT02712905|593840091|FG016|Monotherapy|Withdrawal by Subject|0|||
164402091|NCT02712905|593840092|FG017|Monotherapy|Withdrawal by Subject|0|||
164402092|NCT02712905|593840075|FG000|Monotherapy|Started New Cancer Drug|0|||
164402093|NCT02712905|593840076|FG001|Monotherapy|Started New Cancer Drug|0|||
164402094|NCT02712905|593840077|FG002|Monotherapy|Started New Cancer Drug|0|||
164402095|NCT02712905|593840078|FG003|Monotherapy|Started New Cancer Drug|0|||
164402096|NCT02712905|593840079|FG004|Monotherapy|Started New Cancer Drug|0|||
164402097|NCT02712905|593840080|FG005|Monotherapy|Started New Cancer Drug|1|||
164402098|NCT02712905|593840081|FG006|Monotherapy|Started New Cancer Drug|0|||
164402099|NCT02712905|593840082|FG007|Monotherapy|Started New Cancer Drug|0|||
164402100|NCT02712905|593840083|FG008|Monotherapy|Started New Cancer Drug|0|||
164402101|NCT02712905|593840084|FG009|Monotherapy|Started New Cancer Drug|0|||
164402102|NCT02712905|593840085|FG010|Monotherapy|Started New Cancer Drug|0|||
164402103|NCT02712905|593840086|FG011|Monotherapy|Started New Cancer Drug|0|||
164402104|NCT02712905|593840087|FG012|Monotherapy|Started New Cancer Drug|0|||
164402105|NCT02712905|593840088|FG013|Monotherapy|Started New Cancer Drug|0|||
164402106|NCT02712905|593840089|FG014|Monotherapy|Started New Cancer Drug|0|||
164402107|NCT02712905|593840090|FG015|Monotherapy|Started New Cancer Drug|0|||
164402108|NCT02712905|593840091|FG016|Monotherapy|Started New Cancer Drug|0|||
164596609|NCT04410198|594548920|FG000|Overall Study|Transferred/Relocation|4|||
164596610|NCT04410198|594548920|FG000|Overall Study|Kidney Transplant|9|||
164596611|NCT04410198|594548920|FG000|Overall Study|Adverse Event|4|||
164402109|NCT02712905|593840092|FG017|Monotherapy|Started New Cancer Drug|0|||
164402110|NCT02712905|593840075|FG000|Monotherapy|Adverse Event|0|||
164402111|NCT02712905|593840076|FG001|Monotherapy|Adverse Event|0|||
164402112|NCT02712905|593840077|FG002|Monotherapy|Adverse Event|0|||
164402113|NCT02712905|593840078|FG003|Monotherapy|Adverse Event|0|||
164402114|NCT02712905|593840079|FG004|Monotherapy|Adverse Event|0|||
164402115|NCT02712905|593840080|FG005|Monotherapy|Adverse Event|0|||
164402116|NCT02712905|593840081|FG006|Monotherapy|Adverse Event|0|||
164402117|NCT02712905|593840082|FG007|Monotherapy|Adverse Event|0|||
164596612|NCT04410198|594548920|FG000|Overall Study|Physician Decision|2|||
164596613|NCT04410198|594548920|FG000|Overall Study|Other than specified|1|||
164596614|NCT02871401|594548921|FG000|Overall Study|Adverse Event|1|||
164596615|NCT02871401|594548922|FG001|Overall Study|Adverse Event|0|||
164596616|NCT02282982|594548923|FG000|Overall Study|Lost to Follow-up|15|||
164596617|NCT02282982|594548923|FG000|Overall Study|Withdrew consent|2|||
164596618|NCT02282982|594548923|FG000|Overall Study|Death|4|||
164596619|NCT02282982|594548923|FG000|Overall Study|Lack of product|156|||
164596620|NCT02282982|594548923|FG000|Overall Study|Palivizumab is ended|11|||
164596621|NCT02282982|594548923|FG000|Overall Study|Other, not specified|18|||
164596622|NCT02006667|594548924|FG000|Overall Study|Adverse Event|3|||
164596623|NCT02006667|594548924|FG000|Overall Study|Death|2|||
164596624|NCT02006667|594548924|FG000|Overall Study|Withdrawal by Subject|1|||
164596625|NCT02939937|594548925|FG000|Overall Study|Adverse Event|5|||
164596626|NCT02939937|594548926|FG001|Overall Study|Adverse Event|0|||
164596627|NCT02939937|594548925|FG000|Overall Study|Lost to Follow-up|1|||
164596628|NCT02939937|594548926|FG001|Overall Study|Lost to Follow-up|3|||
164402118|NCT02712905|593840083|FG008|Monotherapy|Adverse Event|1|||
164402119|NCT02712905|593840084|FG009|Monotherapy|Adverse Event|0|||
164402120|NCT02712905|593840085|FG010|Monotherapy|Adverse Event|0|||
164596629|NCT00568958|594548928|FG000|Allocation|Withdrawal by Subject|7|||
164596630|NCT00568958|594548929|FG001|Allocation|Withdrawal by Subject|3|||
164596631|NCT00568958|594548928|FG000|Allocation|Physician Decision|2|||
164706014|NCT05091307|594953340|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
164402121|NCT02712905|593840086|FG011|Monotherapy|Adverse Event|0|||
164402122|NCT02712905|593840087|FG012|Monotherapy|Adverse Event|0|||
164402123|NCT02712905|593840088|FG013|Monotherapy|Adverse Event|0|||
164402124|NCT02712905|593840089|FG014|Monotherapy|Adverse Event|0|||
164402125|NCT02712905|593840090|FG015|Monotherapy|Adverse Event|0|||
164402126|NCT02712905|593840091|FG016|Monotherapy|Adverse Event|0|||
164402127|NCT02712905|593840092|FG017|Monotherapy|Adverse Event|0|||
164402128|NCT02712905|593840075|FG000|Combination Therapy|Death|0|||
164402129|NCT02712905|593840076|FG001|Combination Therapy|Death|0|||
164402130|NCT02712905|593840077|FG002|Combination Therapy|Death|0|||
164402131|NCT02712905|593840078|FG003|Combination Therapy|Death|0|||
164402132|NCT02712905|593840079|FG004|Combination Therapy|Death|0|||
164402133|NCT02712905|593840080|FG005|Combination Therapy|Death|0|||
164402134|NCT02712905|593840081|FG006|Combination Therapy|Death|0|||
164402135|NCT02712905|593840082|FG007|Combination Therapy|Death|0|||
164402136|NCT02712905|593840083|FG008|Combination Therapy|Death|0|||
164402137|NCT02712905|593840084|FG009|Combination Therapy|Death|0|||
164402138|NCT02712905|593840085|FG010|Combination Therapy|Death|0|||
164402139|NCT02712905|593840086|FG011|Combination Therapy|Death|0|||
164402140|NCT02712905|593840087|FG012|Combination Therapy|Death|5|||
164402141|NCT02712905|593840088|FG013|Combination Therapy|Death|6|||
164402142|NCT02712905|593840089|FG014|Combination Therapy|Death|1|||
164402143|NCT02712905|593840090|FG015|Combination Therapy|Death|3|||
164402144|NCT02712905|593840091|FG016|Combination Therapy|Death|1|||
164402145|NCT02712905|593840092|FG017|Combination Therapy|Death|3|||
164402146|NCT02712905|593840075|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
164402147|NCT02712905|593840076|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
164402148|NCT02712905|593840077|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
164402149|NCT02712905|593840078|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
164402150|NCT02712905|593840079|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
164402151|NCT02712905|593840080|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
164402152|NCT02712905|593840081|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
164402153|NCT02712905|593840082|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
164402154|NCT02712905|593840083|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
164402155|NCT02712905|593840084|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
164402156|NCT02712905|593840085|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
164402157|NCT02712905|593840086|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
164402158|NCT02712905|593840087|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
164402159|NCT02712905|593840088|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
164402160|NCT02712905|593840089|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
164402161|NCT02712905|593840090|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
164402162|NCT02712905|593840091|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
164402163|NCT02712905|593840092|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
164402164|NCT02712905|593840075|FG000|Combination Therapy|Withdrawal by Subject|0|||
164402165|NCT02712905|593840076|FG001|Combination Therapy|Withdrawal by Subject|0|||
164402166|NCT02712905|593840077|FG002|Combination Therapy|Withdrawal by Subject|0|||
164402167|NCT02712905|593840078|FG003|Combination Therapy|Withdrawal by Subject|0|||
164402168|NCT02712905|593840079|FG004|Combination Therapy|Withdrawal by Subject|0|||
164402169|NCT02712905|593840080|FG005|Combination Therapy|Withdrawal by Subject|0|||
164402170|NCT02712905|593840081|FG006|Combination Therapy|Withdrawal by Subject|0|||
164402171|NCT02712905|593840082|FG007|Combination Therapy|Withdrawal by Subject|0|||
164402172|NCT02712905|593840083|FG008|Combination Therapy|Withdrawal by Subject|0|||
164402173|NCT02712905|593840084|FG009|Combination Therapy|Withdrawal by Subject|0|||
164402174|NCT02712905|593840085|FG010|Combination Therapy|Withdrawal by Subject|0|||
164402175|NCT02712905|593840086|FG011|Combination Therapy|Withdrawal by Subject|0|||
164402176|NCT02712905|593840087|FG012|Combination Therapy|Withdrawal by Subject|0|||
164402177|NCT02712905|593840088|FG013|Combination Therapy|Withdrawal by Subject|0|||
164402178|NCT02712905|593840089|FG014|Combination Therapy|Withdrawal by Subject|0|||
164402179|NCT02712905|593840090|FG015|Combination Therapy|Withdrawal by Subject|1|||
164402180|NCT02712905|593840091|FG016|Combination Therapy|Withdrawal by Subject|0|||
164402181|NCT02712905|593840092|FG017|Combination Therapy|Withdrawal by Subject|2|||
164402182|NCT02712905|593840075|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
164402183|NCT02712905|593840076|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
164402184|NCT02712905|593840077|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
164402185|NCT02712905|593840078|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
164402186|NCT02712905|593840079|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
164402187|NCT02712905|593840080|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
164402188|NCT02712905|593840081|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
164402189|NCT02712905|593840082|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
164402190|NCT02712905|593840083|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
164417593|NCT01474512|593899499|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
164443106|NCT01595321|593989939|FG002|Overall Study|Lack of Efficacy|4|||
164443107|NCT04795752|593989940|FG000|Primary Endpoint Phase|Withdrawal by Subject|7|||
164443108|NCT04795752|593989941|FG001|Primary Endpoint Phase|Withdrawal by Subject|7|||
164443109|NCT04795752|593989940|FG000|Primary Endpoint Phase|Lost to Follow-up|3|||
164443110|NCT04795752|593989941|FG001|Primary Endpoint Phase|Lost to Follow-up|2|||
164443111|NCT04795752|593989940|FG000|Primary Endpoint Phase|Physician Decision|2|||
164443112|NCT04795752|593989941|FG001|Primary Endpoint Phase|Physician Decision|0|||
164443113|NCT04795752|593989940|FG000|Primary Endpoint Phase|Other|4|||
164443114|NCT04795752|593989941|FG001|Primary Endpoint Phase|Other|1|||
164443115|NCT04795752|593989940|FG000|Primary Endpoint Phase|Protocol Violation|1|||
164443116|NCT04795752|593989941|FG001|Primary Endpoint Phase|Protocol Violation|0|||
164443117|NCT04795752|593989940|FG000|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|7|||
164443118|NCT04795752|593989941|FG001|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|0|||
164443119|NCT04795752|593989940|FG000|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
164443120|NCT04795752|593989941|FG001|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
164443121|NCT04795752|593989940|FG000|X-over-Restasis arm; Durability-TC arm|Physician Decision|1|||
164443122|NCT04795752|593989941|FG001|X-over-Restasis arm; Durability-TC arm|Physician Decision|0|||
164443123|NCT04795752|593989940|FG000|X-over-Restasis arm; Durability-TC arm|Death|1|||
164443124|NCT04795752|593989941|FG001|X-over-Restasis arm; Durability-TC arm|Death|0|||
164443125|NCT04795752|593989940|FG000|X-over-Restasis arm; Durability-TC arm|Other|3|||
164443126|NCT04795752|593989941|FG001|X-over-Restasis arm; Durability-TC arm|Other|1|||
164443127|NCT00792948|593989942|FG000|Overall Study|Adverse Event|6|||
164443128|NCT00792948|593989942|FG000|Overall Study|Death|4|||
164443129|NCT00792948|593989942|FG000|Overall Study|Withdrawal by Subject|3|||
164443130|NCT00792948|593989942|FG000|Overall Study|Ineligible|2|||
164443131|NCT00792948|593989942|FG000|Overall Study|Insurance denial - not treated|1|||
164443132|NCT00792948|593989942|FG000|Overall Study|Physician Decision|11|||
164443133|NCT00792948|593989942|FG000|Overall Study|Protocol Violation|1|||
164443134|NCT01585558|593989953|FG000|Overall Study|Withdrawal by Subject|4|||
164443135|NCT01585558|593989954|FG001|Overall Study|Withdrawal by Subject|5|||
164443136|NCT01585558|593989955|FG002|Overall Study|Withdrawal by Subject|8|||
164443137|NCT01585558|593989953|FG000|Overall Study|Lost to Follow-up|2|||
164443138|NCT01585558|593989954|FG001|Overall Study|Lost to Follow-up|0|||
164443139|NCT01585558|593989955|FG002|Overall Study|Lost to Follow-up|3|||
164443140|NCT01585558|593989953|FG000|Overall Study|Adverse Event|3|||
164443141|NCT01585558|593989954|FG001|Overall Study|Adverse Event|4|||
164443142|NCT01585558|593989955|FG002|Overall Study|Adverse Event|1|||
164402191|NCT02712905|593840084|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
164402192|NCT02712905|593840085|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
164402193|NCT02712905|593840086|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
164402194|NCT02712905|593840087|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
164402195|NCT02712905|593840088|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
164402196|NCT02712905|593840089|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
164402197|NCT02712905|593840090|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
164402198|NCT02712905|593840091|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
164402199|NCT02712905|593840092|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
164402200|NCT03624504|593840093|FG000|Overall Study|Unsuccessful Implant|1|||
164402201|NCT02975973|593840094|FG000|Overall Study|Adverse Event|1|||
164443143|NCT01585558|593989953|FG000|Overall Study|Protocol Violation|4|||
164443144|NCT01585558|593989954|FG001|Overall Study|Protocol Violation|3|||
164443145|NCT01585558|593989955|FG002|Overall Study|Protocol Violation|2|||
164443146|NCT01585558|593989953|FG000|Overall Study|Lack of Efficacy|0|||
164443147|NCT01585558|593989954|FG001|Overall Study|Lack of Efficacy|0|||
164443148|NCT01585558|593989955|FG002|Overall Study|Lack of Efficacy|1|||
164443149|NCT02994654|593989958|FG000|Overall Study|Lost to Follow-up|1|||
164443150|NCT00840177|593991492|FG000|Overall Study|Adverse Event|5|||
164443151|NCT00840177|593991493|FG001|Overall Study|Adverse Event|1|||
164443152|NCT00840177|593991494|FG002|Overall Study|Adverse Event|1|||
164443153|NCT00840177|593991492|FG000|Overall Study|Refusal unrelated to adverse events|1|||
164443154|NCT00840177|593991493|FG001|Overall Study|Refusal unrelated to adverse events|0|||
164443155|NCT00840177|593991494|FG002|Overall Study|Refusal unrelated to adverse events|1|||
164443156|NCT00840177|593991492|FG000|Overall Study|Progression/relapse|2|||
164443157|NCT00840177|593991493|FG001|Overall Study|Progression/relapse|0|||
164596632|NCT00568958|594548929|FG001|Allocation|Physician Decision|0|||
164596633|NCT00568958|594548928|FG000|Follow-Up|Withdrawal by Subject|6|||
164596634|NCT00568958|594548929|FG001|Follow-Up|Withdrawal by Subject|6|||
164596635|NCT00568958|594548928|FG000|Follow-Up|Physician Decision|1|||
164596636|NCT00568958|594548929|FG001|Follow-Up|Physician Decision|1|||
164596637|NCT00568958|594548928|FG000|Follow-Up|Family Emergency|1|||
164596638|NCT00568958|594548929|FG001|Follow-Up|Family Emergency|0|||
164596639|NCT00568958|594548928|FG000|Follow-Up|Adverse Event|1|||
164596640|NCT00568958|594548929|FG001|Follow-Up|Adverse Event|0|||
164443158|NCT00840177|593991494|FG002|Overall Study|Progression/relapse|0|||
164443159|NCT00840177|593991492|FG000|Overall Study|Death|4|||
164443160|NCT00840177|593991493|FG001|Overall Study|Death|5|||
164443161|NCT00840177|593991494|FG002|Overall Study|Death|5|||
164443162|NCT00840177|593991492|FG000|Overall Study|not protocol specified|6|||
164443163|NCT00840177|593991493|FG001|Overall Study|not protocol specified|3|||
164443164|NCT00840177|593991494|FG002|Overall Study|not protocol specified|0|||
164443165|NCT00840177|593991492|FG000|Overall Study|Ineligible|0|||
164443166|NCT00840177|593991493|FG001|Overall Study|Ineligible|0|||
164443167|NCT00840177|593991494|FG002|Overall Study|Ineligible|3|||
164443168|NCT00840177|593991492|FG000|Overall Study|Did not start treatment|0|||
164443169|NCT00840177|593991493|FG001|Overall Study|Did not start treatment|0|||
164443170|NCT00840177|593991494|FG002|Overall Study|Did not start treatment|1|||
164443171|NCT00722046|593991495|FG000|Overall Study|Adverse Event|0|||
164443172|NCT00722046|593991496|FG001|Overall Study|Adverse Event|1|||
164443173|NCT00722046|593991497|FG002|Overall Study|Adverse Event|2|||
164443174|NCT00722046|593991498|FG003|Overall Study|Adverse Event|1|||
164443175|NCT00722046|593991499|FG004|Overall Study|Adverse Event|2|||
164443176|NCT00722046|593991500|FG005|Overall Study|Adverse Event|1|||
164443177|NCT00722046|593991501|FG006|Overall Study|Adverse Event|0|||
164443178|NCT00722046|593991495|FG000|Overall Study|Death|0|||
164443179|NCT00722046|593991496|FG001|Overall Study|Death|1|||
164443180|NCT00722046|593991497|FG002|Overall Study|Death|0|||
164443181|NCT00722046|593991498|FG003|Overall Study|Death|0|||
164443182|NCT00722046|593991499|FG004|Overall Study|Death|0|||
164443183|NCT00722046|593991500|FG005|Overall Study|Death|0|||
164443184|NCT00722046|593991501|FG006|Overall Study|Death|2|||
164443185|NCT00722046|593991495|FG000|Overall Study|Protocol Violation|1|||
164443186|NCT00722046|593991496|FG001|Overall Study|Protocol Violation|0|||
164443187|NCT00722046|593991497|FG002|Overall Study|Protocol Violation|0|||
164443188|NCT00722046|593991498|FG003|Overall Study|Protocol Violation|0|||
164443189|NCT00722046|593991499|FG004|Overall Study|Protocol Violation|0|||
164443190|NCT00722046|593991500|FG005|Overall Study|Protocol Violation|1|||
164443191|NCT00722046|593991501|FG006|Overall Study|Protocol Violation|0|||
164443192|NCT00722046|593991495|FG000|Overall Study|Withdrawal by Subject|3|||
164443193|NCT00722046|593991496|FG001|Overall Study|Withdrawal by Subject|3|||
164443194|NCT00722046|593991497|FG002|Overall Study|Withdrawal by Subject|4|||
164443195|NCT00722046|593991498|FG003|Overall Study|Withdrawal by Subject|4|||
164443196|NCT00722046|593991499|FG004|Overall Study|Withdrawal by Subject|4|||
164443197|NCT00722046|593991500|FG005|Overall Study|Withdrawal by Subject|7|||
164443198|NCT00722046|593991501|FG006|Overall Study|Withdrawal by Subject|3|||
164443199|NCT00722046|593991495|FG000|Overall Study|Randomized, but not treated|1|||
164443200|NCT00722046|593991496|FG001|Overall Study|Randomized, but not treated|1|||
164443201|NCT00722046|593991497|FG002|Overall Study|Randomized, but not treated|0|||
164443202|NCT00722046|593991498|FG003|Overall Study|Randomized, but not treated|2|||
164443203|NCT00722046|593991499|FG004|Overall Study|Randomized, but not treated|0|||
164443204|NCT00722046|593991500|FG005|Overall Study|Randomized, but not treated|0|||
164443205|NCT00722046|593991501|FG006|Overall Study|Randomized, but not treated|0|||
164443206|NCT00722046|593991495|FG000|Overall Study|Other|0|||
164443207|NCT00722046|593991496|FG001|Overall Study|Other|0|||
164443208|NCT00722046|593991497|FG002|Overall Study|Other|1|||
164443209|NCT00722046|593991498|FG003|Overall Study|Other|1|||
164443210|NCT00722046|593991499|FG004|Overall Study|Other|3|||
164443211|NCT00722046|593991500|FG005|Overall Study|Other|2|||
164443212|NCT00722046|593991501|FG006|Overall Study|Other|1|||
164443213|NCT01318382|593991502|FG000|Overall Study|Physician Decision|2|||
164443214|NCT01318382|593991502|FG000|Overall Study|Device Malfunction|10|||
164706015|NCT05091307|594953341|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
164706016|NCT05091307|594953342|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
164706017|NCT05091307|594953343|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
164706018|NCT05091307|594953340|FG000|Overall Study|Initiated Prohibited Medication|1|||
164443215|NCT01318382|593991502|FG000|Overall Study|Protocol Violation|1|||
164443216|NCT01582100|593991503|FG000|Overall Study|Adverse Event|1|||
164443217|NCT01582100|593991503|FG000|Overall Study|Withdrawal by Subject|1|||
164443218|NCT02613871|593991505|FG000|Overall Study|Death|2|||
164443219|NCT02613871|593991505|FG000|Overall Study|Withdrew Consent|1|||
164443220|NCT02527148|593991506|FG000|Overall Study|Did not receive study intervention|1|||
164443221|NCT02527148|593991507|FG001|Overall Study|Did not receive study intervention|0|||
164443222|NCT02918279|593991508|FG000|Overall Study|Lost to Follow-up|3|||
164443223|NCT02918279|593991509|FG001|Overall Study|Lost to Follow-up|6|||
164443224|NCT02918279|593991508|FG000|Overall Study|Withdrawal by Subject|5|||
164443225|NCT02918279|593991509|FG001|Overall Study|Withdrawal by Subject|15|||
164443226|NCT02918279|593991508|FG000|Overall Study|Withdrawal by parent/guardian|2|||
164443227|NCT02918279|593991509|FG001|Overall Study|Withdrawal by parent/guardian|1|||
164706019|NCT05091307|594953341|FG001|Overall Study|Initiated Prohibited Medication|0|||
164443228|NCT02918279|593991508|FG000|Overall Study|Other|3|||
164443229|NCT02918279|593991509|FG001|Overall Study|Other|1|||
164443230|NCT00309907|593991510|FG000|Overall Study|Death|4|||
164443231|NCT00309907|593991510|FG000|Overall Study|Physician Decision|1|||
164443232|NCT00309907|593991510|FG000|Overall Study|Ineligible|11|||
164402202|NCT02975973|593840095|FG001|Overall Study|Adverse Event|1|||
164402203|NCT02975973|593840096|FG002|Overall Study|Adverse Event|1|||
164402204|NCT02975973|593840097|FG003|Overall Study|Adverse Event|0|||
164402205|NCT01812655|593840098|FG000|Overall Study|Protocol Violation|1|||
164402206|NCT01812655|593840099|FG001|Overall Study|Protocol Violation|1|||
164402207|NCT01812655|593840100|FG002|Overall Study|Protocol Violation|0|||
164402208|NCT01428076|593840101|FG000|Overall Study|Adverse Event|0|||
164443233|NCT00309907|593991510|FG000|Overall Study|Major infectious event|4|||
164443234|NCT00494780|593991511|FG000|Overall Study|Adverse Event|1|||
164443235|NCT00494780|593991512|FG001|Overall Study|Adverse Event|0|||
164443236|NCT00494780|593991511|FG000|Overall Study|Withdrew before Dosed|0|||
164443237|NCT00494780|593991512|FG001|Overall Study|Withdrew before Dosed|1|||
164443238|NCT00494780|593991511|FG000|Overall Study|Progression of Study Disease|7|||
164443239|NCT00494780|593991512|FG001|Overall Study|Progression of Study Disease|8|||
164443240|NCT00494780|593991511|FG000|Overall Study|New Treatment|2|||
164443241|NCT00494780|593991512|FG001|Overall Study|New Treatment|2|||
164443242|NCT00494780|593991511|FG000|Overall Study|Non-compliance|1|||
164443243|NCT00494780|593991512|FG001|Overall Study|Non-compliance|0|||
164443244|NCT00494780|593991511|FG000|Overall Study|Residual Tumour Mass|0|||
164443245|NCT00494780|593991512|FG001|Overall Study|Residual Tumour Mass|1|||
164443246|NCT00494780|593991511|FG000|Overall Study|Insurance Issues|0|||
164443247|NCT00494780|593991512|FG001|Overall Study|Insurance Issues|1|||
164443248|NCT00869258|593991513|FG000|Overall Study|Physician Decision|1|||
164443249|NCT01641198|593991514|FG000|After 12 Months of Function|Lost to Follow-up|3|||
164443250|NCT01641198|593991515|FG001|After 12 Months of Function|Lost to Follow-up|2|||
164443251|NCT01641198|593991516|FG002|After 12 Months of Function|Lost to Follow-up|2|||
164596641|NCT03583372|594548933|FG000|Overall Study|Withdrawal by Subject|6|||
164596642|NCT03583372|594548934|FG001|Overall Study|Withdrawal by Subject|11|||
164596643|NCT03583372|594548935|FG002|Overall Study|Withdrawal by Subject|7|||
164596644|NCT03583372|594548936|FG003|Overall Study|Withdrawal by Subject|8|||
164596645|NCT03583372|594548933|FG000|Overall Study|Lost to Follow-up|4|||
164596646|NCT03583372|594548934|FG001|Overall Study|Lost to Follow-up|6|||
164596647|NCT03583372|594548935|FG002|Overall Study|Lost to Follow-up|3|||
164596648|NCT03583372|594548936|FG003|Overall Study|Lost to Follow-up|2|||
164596649|NCT03583372|594548933|FG000|Overall Study|Adverse Event|1|||
164596650|NCT03583372|594548934|FG001|Overall Study|Adverse Event|3|||
164596651|NCT03583372|594548935|FG002|Overall Study|Adverse Event|4|||
164596652|NCT03583372|594548936|FG003|Overall Study|Adverse Event|4|||
164596653|NCT03583372|594548933|FG000|Overall Study|Physician Decision|0|||
164596654|NCT03583372|594548934|FG001|Overall Study|Physician Decision|1|||
164596655|NCT03583372|594548935|FG002|Overall Study|Physician Decision|1|||
164596656|NCT03583372|594548936|FG003|Overall Study|Physician Decision|1|||
164402209|NCT01428076|593840102|FG001|Overall Study|Adverse Event|1|||
164402210|NCT04435665|593840103|FG000|Overall Study|Lost to Follow-up|0|||
164402211|NCT04435665|593840104|FG001|Overall Study|Lost to Follow-up|0|||
164402212|NCT04435665|593840105|FG002|Overall Study|Lost to Follow-up|0|||
164402213|NCT04435665|593840106|FG003|Overall Study|Lost to Follow-up|1|||
164402214|NCT02454101|593840107|FG000|Overall Study|Adverse Event|2|||
164402215|NCT02454101|593840108|FG001|Overall Study|Adverse Event|3|||
164402216|NCT02454101|593840107|FG000|Overall Study|Lost to Follow-up|3|||
164402217|NCT02454101|593840108|FG001|Overall Study|Lost to Follow-up|4|||
164402218|NCT00419263|593840109|FG000|Overall Study|Lost to Follow-up|2|||
164402219|NCT00419263|593840110|FG001|Overall Study|Lost to Follow-up|1|||
164402220|NCT00419263|593840111|FG002|Overall Study|Lost to Follow-up|1|||
164402221|NCT00419263|593840109|FG000|Overall Study|Randomized in Error, Not Treated|1|||
164402222|NCT00419263|593840110|FG001|Overall Study|Randomized in Error, Not Treated|1|||
164402223|NCT00419263|593840111|FG002|Overall Study|Randomized in Error, Not Treated|0|||
164402224|NCT00419263|593840109|FG000|Overall Study|Adverse Event|0|||
164402225|NCT00419263|593840110|FG001|Overall Study|Adverse Event|0|||
164402226|NCT00419263|593840111|FG002|Overall Study|Adverse Event|1|||
164402227|NCT00419263|593840109|FG000|Overall Study|Withdrawal by Subject|0|||
164402228|NCT00419263|593840110|FG001|Overall Study|Withdrawal by Subject|0|||
164402229|NCT00419263|593840111|FG002|Overall Study|Withdrawal by Subject|1|||
164402230|NCT00540124|593840115|FG000|Overall Study|Adverse Event|0|||
164402231|NCT00540124|593840116|FG001|Overall Study|Adverse Event|2|||
164402232|NCT00540124|593840117|FG002|Overall Study|Adverse Event|1|||
164402233|NCT00540124|593840115|FG000|Overall Study|Entry Criteria Not Met|2|||
164402234|NCT00540124|593840116|FG001|Overall Study|Entry Criteria Not Met|0|||
164402235|NCT00540124|593840117|FG002|Overall Study|Entry Criteria Not Met|0|||
164402236|NCT00540124|593840115|FG000|Overall Study|Lack of Efficacy|1|||
164402237|NCT00540124|593840116|FG001|Overall Study|Lack of Efficacy|0|||
164402238|NCT00540124|593840117|FG002|Overall Study|Lack of Efficacy|0|||
164402239|NCT00540124|593840115|FG000|Overall Study|Withdrawal by Subject|1|||
164402240|NCT00540124|593840116|FG001|Overall Study|Withdrawal by Subject|1|||
164402241|NCT00540124|593840117|FG002|Overall Study|Withdrawal by Subject|0|||
164402242|NCT02124265|593840118|FG000|Overall Study|Adverse Event|1|||
164402243|NCT00058123|593840119|FG000|Overall Study|Wrong histology|9|||
164402244|NCT00058123|593840119|FG000|Overall Study|Received >3 prior treatments|1|||
164706020|NCT05091307|594953342|FG002|Overall Study|Initiated Prohibited Medication|0|||
164706021|NCT05091307|594953343|FG003|Overall Study|Initiated Prohibited Medication|0|||
164402245|NCT00344461|593840122|FG000|Overall Study|Adverse Event|6|||
164402246|NCT00344461|593840122|FG000|Overall Study|Death|1|||
164402247|NCT00344461|593840122|FG000|Overall Study|Lack of Efficacy|2|||
164402248|NCT00344461|593840122|FG000|Overall Study|Lost to Follow-up|2|||
164402249|NCT00344461|593840122|FG000|Overall Study|Physician Decision|2|||
164402250|NCT00344461|593840122|FG000|Overall Study|Protocol Violation|6|||
164402251|NCT00344461|593840122|FG000|Overall Study|Withdrawal by Subject|2|||
164402252|NCT02151266|593840125|FG000|Overall Study|Lost to Follow-up|1|||
164402253|NCT02151266|593840126|FG001|Overall Study|Lost to Follow-up|4|||
164402254|NCT02151266|593840127|FG002|Overall Study|Lost to Follow-up|1|||
164402255|NCT02151266|593840125|FG000|Overall Study|Did NOT receive intervention|3|||
164402256|NCT02151266|593840126|FG001|Overall Study|Did NOT receive intervention|6|||
164402257|NCT02151266|593840127|FG002|Overall Study|Did NOT receive intervention|2|||
164402258|NCT02151266|593840125|FG000|Overall Study|Not able to exercise|4|||
164402259|NCT02151266|593840126|FG001|Overall Study|Not able to exercise|5|||
164402260|NCT02151266|593840127|FG002|Overall Study|Not able to exercise|4|||
164402261|NCT04839965|593840132|FG000|Overall Study|Death|6|||
164402262|NCT04839965|593840133|FG001|Overall Study|Death|6|||
164402263|NCT04839965|593840132|FG000|Overall Study|Lost to Follow-up|1|||
164402264|NCT04839965|593840133|FG001|Overall Study|Lost to Follow-up|0|||
164402265|NCT02291679|593840134|FG000|Overall Study|Adverse Event|2|||
164402266|NCT02291679|593840135|FG001|Overall Study|Adverse Event|12|||
164402267|NCT02291679|593840136|FG002|Overall Study|Adverse Event|19|||
164402268|NCT02291679|593840134|FG000|Overall Study|Protocol Violation|5|||
164402269|NCT02291679|593840135|FG001|Overall Study|Protocol Violation|1|||
164402270|NCT02291679|593840136|FG002|Overall Study|Protocol Violation|7|||
164402271|NCT02291679|593840134|FG000|Overall Study|Withdrew Consent|18|||
164402272|NCT02291679|593840135|FG001|Overall Study|Withdrew Consent|10|||
164402273|NCT02291679|593840136|FG002|Overall Study|Withdrew Consent|15|||
164402274|NCT02291679|593840134|FG000|Overall Study|Lost to Follow-up|12|||
164402275|NCT02291679|593840135|FG001|Overall Study|Lost to Follow-up|10|||
164402276|NCT02291679|593840136|FG002|Overall Study|Lost to Follow-up|9|||
164402277|NCT02291679|593840134|FG000|Overall Study|Insufficient Therapeutic Response|5|||
164402278|NCT02291679|593840135|FG001|Overall Study|Insufficient Therapeutic Response|5|||
164402279|NCT02291679|593840136|FG002|Overall Study|Insufficient Therapeutic Response|7|||
164402280|NCT02291679|593840134|FG000|Overall Study|Other|2|||
164402281|NCT02291679|593840135|FG001|Overall Study|Other|4|||
164402282|NCT02291679|593840136|FG002|Overall Study|Other|2|||
164402283|NCT02355028|593840137|FG000|Overall Study|Adverse Event|2|||
164402284|NCT02355028|593840138|FG001|Overall Study|Adverse Event|0|||
164402285|NCT02355028|593840137|FG000|Overall Study|Withdrawal by Subject|1|||
164402286|NCT02355028|593840138|FG001|Overall Study|Withdrawal by Subject|1|||
164402287|NCT02355028|593840137|FG000|Overall Study|Deemed ineligible after randomization|8|||
164402288|NCT02355028|593840138|FG001|Overall Study|Deemed ineligible after randomization|4|||
164402289|NCT02276222|593840139|FG000|Overall Study|Adverse Event|62|||
164402290|NCT02276222|593840140|FG001|Overall Study|Adverse Event|11|||
164402291|NCT02276222|593840139|FG000|Overall Study|Death|3|||
164402292|NCT02276222|593840140|FG001|Overall Study|Death|4|||
164402293|NCT02276222|593840139|FG000|Overall Study|Lack of Efficacy|13|||
164402294|NCT02276222|593840140|FG001|Overall Study|Lack of Efficacy|3|||
164402295|NCT02276222|593840139|FG000|Overall Study|Protocol Violation|3|||
164402296|NCT02276222|593840140|FG001|Overall Study|Protocol Violation|2|||
164402297|NCT02276222|593840139|FG000|Overall Study|Withdrawal by Subject|79|||
164402298|NCT02276222|593840140|FG001|Overall Study|Withdrawal by Subject|33|||
164402299|NCT02276222|593840139|FG000|Overall Study|non compliance with study medication|6|||
164402300|NCT02276222|593840140|FG001|Overall Study|non compliance with study medication|2|||
164402301|NCT02276222|593840139|FG000|Overall Study|sponsor decision|0|||
164402302|NCT02276222|593840140|FG001|Overall Study|sponsor decision|3|||
164402303|NCT02276222|593840139|FG000|Overall Study|Lost to Follow-up|15|||
164402304|NCT02276222|593840140|FG001|Overall Study|Lost to Follow-up|5|||
164402305|NCT02276222|593840139|FG000|Overall Study|Physician Decision|2|||
164402306|NCT02276222|593840140|FG001|Overall Study|Physician Decision|1|||
164402307|NCT02276222|593840139|FG000|Overall Study|sheduling conflict|1|||
164402308|NCT02276222|593840140|FG001|Overall Study|sheduling conflict|0|||
164706022|NCT05091307|594953340|FG000|Overall Study|Other|4|||
164402309|NCT02276222|593840139|FG000|Overall Study|subject withdrew after randomization|1|||
164402310|NCT02276222|593840140|FG001|Overall Study|subject withdrew after randomization|0|||
164402311|NCT05899686|593840141|FG000|Overall Study|Protocol Violation|1|||
164402312|NCT02170025|593840142|FG000|Overall Study|Adverse Event|2|||
164402313|NCT02170025|593840143|FG001|Overall Study|Adverse Event|0|||
164402314|NCT01525602|593840144|FG000|Overall Study|Adverse Event|1|||
164402315|NCT01525602|593840145|FG001|Overall Study|Adverse Event|0|||
164402316|NCT01525602|593840146|FG002|Overall Study|Adverse Event|1|||
164402317|NCT01525602|593840147|FG003|Overall Study|Adverse Event|1|||
164402318|NCT01525602|593840148|FG004|Overall Study|Adverse Event|3|||
164402319|NCT01525602|593840149|FG005|Overall Study|Adverse Event|3|||
164706023|NCT05091307|594953341|FG001|Overall Study|Other|4|||
164596657|NCT03583372|594548933|FG000|Overall Study|Lack of Efficacy|0|||
164596658|NCT03583372|594548934|FG001|Overall Study|Lack of Efficacy|1|||
164443252|NCT01641198|593991514|FG000|After 12 Months of Function|Protocol Violation|1|||
164443253|NCT01641198|593991515|FG001|After 12 Months of Function|Protocol Violation|0|||
164443254|NCT01641198|593991516|FG002|After 12 Months of Function|Protocol Violation|0|||
164443255|NCT01641198|593991514|FG000|After 12 Months of Function|Adverse Event|0|||
164443256|NCT01641198|593991515|FG001|After 12 Months of Function|Adverse Event|1|||
164443257|NCT01641198|593991516|FG002|After 12 Months of Function|Adverse Event|0|||
164443258|NCT01641198|593991514|FG000|After 24 Months of Function|Lost to Follow-up|4|||
164443259|NCT01641198|593991515|FG001|After 24 Months of Function|Lost to Follow-up|9|||
164443260|NCT01641198|593991516|FG002|After 24 Months of Function|Lost to Follow-up|6|||
164443261|NCT01641198|593991514|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
164443262|NCT01641198|593991515|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
164443263|NCT01641198|593991516|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
164443264|NCT01641198|593991514|FG000|At 15-20 Years of Function|Death|1|||
164443265|NCT01641198|593991515|FG001|At 15-20 Years of Function|Death|0|||
164443266|NCT01641198|593991516|FG002|At 15-20 Years of Function|Death|1|||
164443267|NCT00980330|593991518|FG000|Overall Study|Adverse Event|0|||
164443268|NCT00980330|593991519|FG001|Overall Study|Adverse Event|0|||
164443269|NCT00980330|593991520|FG002|Overall Study|Adverse Event|0|||
164443270|NCT00980330|593991521|FG003|Overall Study|Adverse Event|1|||
164443271|NCT00980330|593991522|FG004|Overall Study|Adverse Event|0|||
164443272|NCT00980330|593991523|FG005|Overall Study|Adverse Event|0|||
164443273|NCT00980330|593991524|FG006|Overall Study|Adverse Event|0|||
164443274|NCT00980330|593991518|FG000|Overall Study|Lost to Follow-up|1|||
164443275|NCT00980330|593991519|FG001|Overall Study|Lost to Follow-up|1|||
164443276|NCT00980330|593991520|FG002|Overall Study|Lost to Follow-up|4|||
164443277|NCT00980330|593991521|FG003|Overall Study|Lost to Follow-up|2|||
164443278|NCT00980330|593991522|FG004|Overall Study|Lost to Follow-up|1|||
164443279|NCT00980330|593991523|FG005|Overall Study|Lost to Follow-up|1|||
164443280|NCT00980330|593991524|FG006|Overall Study|Lost to Follow-up|2|||
164443281|NCT00980330|593991518|FG000|Overall Study|Withdrawal by Subject|2|||
164443282|NCT00980330|593991519|FG001|Overall Study|Withdrawal by Subject|4|||
164443283|NCT00980330|593991520|FG002|Overall Study|Withdrawal by Subject|4|||
164443284|NCT00980330|593991521|FG003|Overall Study|Withdrawal by Subject|1|||
164443285|NCT00980330|593991522|FG004|Overall Study|Withdrawal by Subject|3|||
164443286|NCT00980330|593991523|FG005|Overall Study|Withdrawal by Subject|2|||
164443287|NCT00980330|593991524|FG006|Overall Study|Withdrawal by Subject|5|||
164443288|NCT00980330|593991518|FG000|Overall Study|(not specified)|2|||
164443289|NCT00980330|593991519|FG001|Overall Study|(not specified)|0|||
164443290|NCT00980330|593991520|FG002|Overall Study|(not specified)|0|||
164443291|NCT00980330|593991521|FG003|Overall Study|(not specified)|1|||
164443292|NCT00980330|593991522|FG004|Overall Study|(not specified)|1|||
164443293|NCT00980330|593991523|FG005|Overall Study|(not specified)|1|||
164443294|NCT00980330|593991524|FG006|Overall Study|(not specified)|0|||
164443295|NCT00346151|593991525|FG000|Overall Study|Withdrawal by Subject|3|||
164443296|NCT01075217|593991526|FG000|Overall Study|Adverse Event|1|||
164443297|NCT01075217|593991527|FG001|Overall Study|Adverse Event|1|||
164443298|NCT01075217|593991526|FG000|Overall Study|Physician Decision|1|||
164443299|NCT01075217|593991527|FG001|Overall Study|Physician Decision|0|||
164443300|NCT02448446|593991528|FG000|Overall Study|Withdrawal by Subject|1|||
164443301|NCT02448446|593991529|FG001|Overall Study|Withdrawal by Subject|0|||
164443302|NCT01369498|593991530|FG000|Overall Study|Lack of Efficacy|9|||
164443303|NCT01369498|593991531|FG001|Overall Study|Lack of Efficacy|9|||
164443304|NCT01369498|593991532|FG002|Overall Study|Lack of Efficacy|1|||
164443305|NCT01369498|593991533|FG003|Overall Study|Lack of Efficacy|3|||
164443306|NCT01369498|593991530|FG000|Overall Study|Adverse Event|1|||
164443307|NCT01369498|593991531|FG001|Overall Study|Adverse Event|2|||
164443308|NCT01369498|593991532|FG002|Overall Study|Adverse Event|0|||
164443309|NCT01369498|593991533|FG003|Overall Study|Adverse Event|1|||
164443310|NCT01369498|593991530|FG000|Overall Study|Withdrawal of Consent|0|||
164443311|NCT01369498|593991531|FG001|Overall Study|Withdrawal of Consent|1|||
164443312|NCT01369498|593991532|FG002|Overall Study|Withdrawal of Consent|1|||
164443313|NCT01369498|593991533|FG003|Overall Study|Withdrawal of Consent|1|||
164443314|NCT01369498|593991530|FG000|Overall Study|Death|0|||
164443315|NCT01369498|593991531|FG001|Overall Study|Death|0|||
164596659|NCT03583372|594548935|FG002|Overall Study|Lack of Efficacy|0|||
164443316|NCT01369498|593991532|FG002|Overall Study|Death|1|||
164443317|NCT01369498|593991533|FG003|Overall Study|Death|0|||
164443318|NCT01369498|593991530|FG000|Overall Study|Investigator's Discretion|1|||
164596660|NCT03583372|594548936|FG003|Overall Study|Lack of Efficacy|1|||
164596661|NCT03583372|594548933|FG000|Overall Study|Death|1|||
164596662|NCT03583372|594548934|FG001|Overall Study|Death|0|||
164596663|NCT03583372|594548935|FG002|Overall Study|Death|0|||
164596664|NCT03583372|594548936|FG003|Overall Study|Death|0|||
164596665|NCT03583372|594548933|FG000|Overall Study|Protocol Violation|0|||
164596666|NCT03583372|594548934|FG001|Overall Study|Protocol Violation|1|||
164596667|NCT03583372|594548935|FG002|Overall Study|Protocol Violation|0|||
164596668|NCT03583372|594548936|FG003|Overall Study|Protocol Violation|0|||
164443319|NCT01369498|593991531|FG001|Overall Study|Investigator's Discretion|0|||
164443320|NCT01369498|593991532|FG002|Overall Study|Investigator's Discretion|1|||
164443321|NCT01369498|593991533|FG003|Overall Study|Investigator's Discretion|3|||
164443322|NCT01369498|593991530|FG000|Overall Study|Unknown Reason|1|||
164443323|NCT01369498|593991531|FG001|Overall Study|Unknown Reason|0|||
164443324|NCT01369498|593991532|FG002|Overall Study|Unknown Reason|11|||
164443325|NCT01369498|593991533|FG003|Overall Study|Unknown Reason|6|||
164443326|NCT01369498|593991530|FG000|Overall Study|Disease Progression|0|||
164443327|NCT01369498|593991531|FG001|Overall Study|Disease Progression|0|||
164443328|NCT01369498|593991532|FG002|Overall Study|Disease Progression|0|||
164443329|NCT01369498|593991533|FG003|Overall Study|Disease Progression|1|||
164443330|NCT00439569|593991538|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
164443331|NCT00439569|593991538|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
164443332|NCT00439569|593991538|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
164443333|NCT01444417|593991540|FG000|Overall Study|Ineligibility Determined|0|||
164443334|NCT01444417|593991541|FG001|Overall Study|Ineligibility Determined|1|||
164443335|NCT01444417|593991540|FG000|Overall Study|Withdrawal by Subject|2|||
164443336|NCT01444417|593991541|FG001|Overall Study|Withdrawal by Subject|0|||
164443337|NCT02755116|593991542|FG000|Overall Study|surgery converted to open, pt admitted|3|||
164443338|NCT02755116|593991543|FG001|Overall Study|surgery converted to open, pt admitted|1|||
164443339|NCT02214160|593991548|FG000|Overall Study|Withdrawal by Subject|1|||
164443340|NCT02214160|593991549|FG001|Overall Study|Withdrawal by Subject|0|||
164443341|NCT02214160|593991550|FG002|Overall Study|Withdrawal by Subject|6|||
164443342|NCT02214160|593991548|FG000|Overall Study|Death|2|||
164443343|NCT02214160|593991549|FG001|Overall Study|Death|2|||
164443344|NCT02214160|593991550|FG002|Overall Study|Death|1|||
164443345|NCT02214160|593991548|FG000|Overall Study|Subject Non-Compliance|0|||
164443346|NCT02214160|593991549|FG001|Overall Study|Subject Non-Compliance|3|||
164443347|NCT02214160|593991550|FG002|Overall Study|Subject Non-Compliance|1|||
164443348|NCT02214160|593991548|FG000|Overall Study|Adverse Event|0|||
164443349|NCT02214160|593991549|FG001|Overall Study|Adverse Event|1|||
164443350|NCT02214160|593991550|FG002|Overall Study|Adverse Event|1|||
164443351|NCT02214160|593991548|FG000|Overall Study|Sponsor Decision|0|||
164443352|NCT02214160|593991549|FG001|Overall Study|Sponsor Decision|2|||
164443353|NCT02214160|593991550|FG002|Overall Study|Sponsor Decision|0|||
164596669|NCT03583372|594548933|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
164596670|NCT03583372|594548934|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
164596671|NCT03583372|594548935|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
164443354|NCT02214160|593991548|FG000|Overall Study|Protocol Violation|1|||
164443355|NCT02214160|593991549|FG001|Overall Study|Protocol Violation|0|||
164443356|NCT02214160|593991550|FG002|Overall Study|Protocol Violation|0|||
164443357|NCT02214160|593991548|FG000|Overall Study|Physician Decision|0|||
164443358|NCT02214160|593991549|FG001|Overall Study|Physician Decision|0|||
164443359|NCT02214160|593991550|FG002|Overall Study|Physician Decision|1|||
164443360|NCT02423798|593991551|FG000|Overall Study|Withdrawal by Subject|3|||
164443361|NCT01063972|593991552|FG000|Overall Study|Death|12|||
164443362|NCT01063972|593991553|FG001|Overall Study|Death|11|||
164443363|NCT01063972|593991552|FG000|Overall Study|Incarcerated|2|||
164443364|NCT01063972|593991553|FG001|Overall Study|Incarcerated|1|||
164443365|NCT01510717|593991555|FG000|Overall Study|Adverse Event|1|||
164443366|NCT01510717|593991556|FG001|Overall Study|Adverse Event|2|||
164443367|NCT01510717|593991555|FG000|Overall Study|Death|1|||
164443368|NCT01510717|593991556|FG001|Overall Study|Death|0|||
164443369|NCT01510717|593991555|FG000|Overall Study|Lost to Follow-up|0|||
164443370|NCT01510717|593991556|FG001|Overall Study|Lost to Follow-up|1|||
164443371|NCT01510717|593991555|FG000|Overall Study|Withdrawal by Subject|0|||
164443372|NCT01510717|593991556|FG001|Overall Study|Withdrawal by Subject|2|||
164443373|NCT01968226|593991557|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
164443374|NCT00457743|593991558|FG000|Overall Study|Adverse Event|0|||
164443375|NCT00457743|593991559|FG001|Overall Study|Adverse Event|4|||
164596672|NCT03583372|594548936|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
164443376|NCT00457743|593991560|FG002|Overall Study|Adverse Event|0|||
164443377|NCT00457743|593991558|FG000|Overall Study|Lack of Efficacy|3|||
164443378|NCT00457743|593991559|FG001|Overall Study|Lack of Efficacy|23|||
164443379|NCT00457743|593991560|FG002|Overall Study|Lack of Efficacy|3|||
164443380|NCT00959946|593991561|FG000|Overall Study|Adverse Event|0|||
164443381|NCT00959946|593991562|FG001|Overall Study|Adverse Event|0|||
164443382|NCT00959946|593991563|FG002|Overall Study|Adverse Event|2|||
164443383|NCT00959946|593991564|FG003|Overall Study|Adverse Event|1|||
164443384|NCT00959946|593991565|FG004|Overall Study|Adverse Event|0|||
164443385|NCT00959946|593991566|FG005|Overall Study|Adverse Event|1|||
164596673|NCT03583372|594548933|FG000|Overall Study|Did Not Receive Study Drug|0|||
164596674|NCT03583372|594548934|FG001|Overall Study|Did Not Receive Study Drug|1|||
164596675|NCT03583372|594548935|FG002|Overall Study|Did Not Receive Study Drug|0|||
164596676|NCT03583372|594548936|FG003|Overall Study|Did Not Receive Study Drug|0|||
164596677|NCT03583372|594548933|FG000|Overall Study|Captured as Other in the Database|1|||
164443386|NCT00959946|593991567|FG006|Overall Study|Adverse Event|0|||
164443387|NCT00959946|593991568|FG007|Overall Study|Adverse Event|0|||
164402320|NCT01525602|593840150|FG006|Overall Study|Adverse Event|0|||
164402321|NCT01525602|593840151|FG007|Overall Study|Adverse Event|1|||
164402322|NCT01525602|593840144|FG000|Overall Study|Disease progression|6|||
164402323|NCT01525602|593840145|FG001|Overall Study|Disease progression|3|||
164402324|NCT01525602|593840146|FG002|Overall Study|Disease progression|2|||
164402325|NCT01525602|593840147|FG003|Overall Study|Disease progression|5|||
164402326|NCT01525602|593840148|FG004|Overall Study|Disease progression|22|||
164402327|NCT01525602|593840149|FG005|Overall Study|Disease progression|2|||
164402328|NCT01525602|593840150|FG006|Overall Study|Disease progression|3|||
164402329|NCT01525602|593840151|FG007|Overall Study|Disease progression|3|||
164402330|NCT01525602|593840144|FG000|Overall Study|Clinical progression|2|||
164402331|NCT01525602|593840145|FG001|Overall Study|Clinical progression|0|||
164402332|NCT01525602|593840146|FG002|Overall Study|Clinical progression|0|||
164402333|NCT01525602|593840147|FG003|Overall Study|Clinical progression|0|||
164402334|NCT01525602|593840148|FG004|Overall Study|Clinical progression|0|||
164402335|NCT01525602|593840149|FG005|Overall Study|Clinical progression|0|||
164402336|NCT01525602|593840150|FG006|Overall Study|Clinical progression|1|||
164402337|NCT01525602|593840151|FG007|Overall Study|Clinical progression|1|||
164402338|NCT01525602|593840144|FG000|Overall Study|Non-compliance|0|||
164402339|NCT01525602|593840145|FG001|Overall Study|Non-compliance|0|||
164402340|NCT01525602|593840146|FG002|Overall Study|Non-compliance|0|||
164402341|NCT01525602|593840147|FG003|Overall Study|Non-compliance|0|||
164402342|NCT01525602|593840148|FG004|Overall Study|Non-compliance|1|||
164402343|NCT01525602|593840149|FG005|Overall Study|Non-compliance|0|||
164402344|NCT01525602|593840150|FG006|Overall Study|Non-compliance|0|||
164402345|NCT01525602|593840151|FG007|Overall Study|Non-compliance|0|||
164402346|NCT01525602|593840144|FG000|Overall Study|Withdrawal by Subject|0|||
164402347|NCT01525602|593840145|FG001|Overall Study|Withdrawal by Subject|0|||
164402348|NCT01525602|593840146|FG002|Overall Study|Withdrawal by Subject|0|||
164402349|NCT01525602|593840147|FG003|Overall Study|Withdrawal by Subject|0|||
164402350|NCT01525602|593840148|FG004|Overall Study|Withdrawal by Subject|3|||
164402351|NCT01525602|593840149|FG005|Overall Study|Withdrawal by Subject|1|||
164402352|NCT01525602|593840150|FG006|Overall Study|Withdrawal by Subject|0|||
164402353|NCT01525602|593840151|FG007|Overall Study|Withdrawal by Subject|1|||
164402354|NCT01525602|593840144|FG000|Overall Study|Physician Decision|0|||
164402355|NCT01525602|593840145|FG001|Overall Study|Physician Decision|0|||
164402356|NCT01525602|593840146|FG002|Overall Study|Physician Decision|0|||
164402357|NCT01525602|593840147|FG003|Overall Study|Physician Decision|0|||
164402358|NCT01525602|593840148|FG004|Overall Study|Physician Decision|3|||
164402359|NCT01525602|593840149|FG005|Overall Study|Physician Decision|0|||
164402360|NCT01525602|593840150|FG006|Overall Study|Physician Decision|1|||
164402361|NCT01525602|593840151|FG007|Overall Study|Physician Decision|0|||
164402362|NCT01525602|593840144|FG000|Overall Study|Death|0|||
164402363|NCT01525602|593840145|FG001|Overall Study|Death|0|||
164402364|NCT01525602|593840146|FG002|Overall Study|Death|0|||
164402365|NCT01525602|593840147|FG003|Overall Study|Death|0|||
164402366|NCT01525602|593840148|FG004|Overall Study|Death|1|||
164402367|NCT01525602|593840149|FG005|Overall Study|Death|1|||
164402368|NCT01525602|593840150|FG006|Overall Study|Death|0|||
164402369|NCT01525602|593840151|FG007|Overall Study|Death|0|||
164402370|NCT01525602|593840144|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
164402371|NCT01525602|593840145|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
164402372|NCT01525602|593840146|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
164402373|NCT01525602|593840147|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
164402374|NCT01525602|593840148|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
164402375|NCT01525602|593840149|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
164402376|NCT01525602|593840150|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
164402377|NCT01525602|593840151|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
164402378|NCT03703466|593840157|FG000|Overall Study|Death|2|||
164402379|NCT03703466|593840158|FG001|Overall Study|Death|1|||
164402380|NCT03703466|593840159|FG002|Overall Study|Death|0|||
164402381|NCT03703466|593840157|FG000|Overall Study|Withdrawal by Subject|0|||
164402382|NCT03703466|593840158|FG001|Overall Study|Withdrawal by Subject|3|||
164596678|NCT03583372|594548934|FG001|Overall Study|Captured as Other in the Database|2|||
164402383|NCT03703466|593840159|FG002|Overall Study|Withdrawal by Subject|0|||
164402384|NCT03703466|593840157|FG000|Overall Study|Completed < 3 Cycles|2|||
164402385|NCT03703466|593840158|FG001|Overall Study|Completed < 3 Cycles|2|||
164402386|NCT03703466|593840159|FG002|Overall Study|Completed < 3 Cycles|2|||
164596679|NCT03583372|594548935|FG002|Overall Study|Captured as Other in the Database|4|||
164596680|NCT03583372|594548936|FG003|Overall Study|Captured as Other in the Database|1|||
164402387|NCT02412137|593840160|FG000|Overall Study|Withdrawal by Subject|2|||
164402388|NCT02412137|593840161|FG001|Overall Study|Withdrawal by Subject|0|||
164402389|NCT02412137|593840160|FG000|Overall Study|Lost to Follow-up|21|||
164402390|NCT02412137|593840161|FG001|Overall Study|Lost to Follow-up|14|||
164402391|NCT02412137|593840160|FG000|Overall Study|Physician Decision|28|||
164402392|NCT02412137|593840161|FG001|Overall Study|Physician Decision|9|||
164402393|NCT00506493|593840164|FG000|Overall Study|Death|6|||
164402394|NCT00506493|593840164|FG000|Overall Study|Withdrawal by Subject|5|||
164443388|NCT00959946|593991561|FG000|Overall Study|Death|0|||
164443389|NCT00959946|593991562|FG001|Overall Study|Death|0|||
164443390|NCT00959946|593991563|FG002|Overall Study|Death|0|||
164443391|NCT00959946|593991564|FG003|Overall Study|Death|0|||
164443392|NCT00959946|593991565|FG004|Overall Study|Death|0|||
164443393|NCT00959946|593991566|FG005|Overall Study|Death|1|||
164443394|NCT00959946|593991567|FG006|Overall Study|Death|0|||
164443395|NCT00959946|593991568|FG007|Overall Study|Death|0|||
164443396|NCT00959946|593991561|FG000|Overall Study|Disease Progression|2|||
164443397|NCT00959946|593991562|FG001|Overall Study|Disease Progression|4|||
164443398|NCT00959946|593991563|FG002|Overall Study|Disease Progression|2|||
164443399|NCT00959946|593991564|FG003|Overall Study|Disease Progression|4|||
164443400|NCT00959946|593991565|FG004|Overall Study|Disease Progression|4|||
164443401|NCT00959946|593991566|FG005|Overall Study|Disease Progression|6|||
164443402|NCT00959946|593991567|FG006|Overall Study|Disease Progression|2|||
164443403|NCT00959946|593991568|FG007|Overall Study|Disease Progression|2|||
164443404|NCT00959946|593991561|FG000|Overall Study|Withdrawal by Subject|0|||
164443405|NCT00959946|593991562|FG001|Overall Study|Withdrawal by Subject|0|||
164443406|NCT00959946|593991563|FG002|Overall Study|Withdrawal by Subject|0|||
164443407|NCT00959946|593991564|FG003|Overall Study|Withdrawal by Subject|0|||
164443408|NCT00959946|593991565|FG004|Overall Study|Withdrawal by Subject|0|||
164443409|NCT00959946|593991566|FG005|Overall Study|Withdrawal by Subject|1|||
164443410|NCT00959946|593991567|FG006|Overall Study|Withdrawal by Subject|0|||
164443411|NCT00959946|593991568|FG007|Overall Study|Withdrawal by Subject|0|||
164443412|NCT01202955|593991569|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
164443413|NCT01202955|593991570|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
164443414|NCT00159783|593991575|FG000|Overall Study|Adverse Event|5|||
164443415|NCT00159783|593991576|FG001|Overall Study|Adverse Event|7|||
164443416|NCT00159783|593991577|FG002|Overall Study|Adverse Event|9|||
164443417|NCT00159783|593991575|FG000|Overall Study|Lack of Efficacy|1|||
164443418|NCT00159783|593991576|FG001|Overall Study|Lack of Efficacy|2|||
164443419|NCT00159783|593991577|FG002|Overall Study|Lack of Efficacy|3|||
164443420|NCT00159783|593991575|FG000|Overall Study|Withdrawal by Subject|7|||
164443421|NCT00159783|593991576|FG001|Overall Study|Withdrawal by Subject|11|||
164443422|NCT00159783|593991577|FG002|Overall Study|Withdrawal by Subject|12|||
164443423|NCT00159783|593991575|FG000|Overall Study|Lost to Follow-up|6|||
164443424|NCT00159783|593991576|FG001|Overall Study|Lost to Follow-up|5|||
164443425|NCT00159783|593991577|FG002|Overall Study|Lost to Follow-up|11|||
164443426|NCT00159783|593991575|FG000|Overall Study|Other|0|||
164443427|NCT00159783|593991576|FG001|Overall Study|Other|2|||
164443428|NCT00159783|593991577|FG002|Overall Study|Other|4|||
164443429|NCT00841035|593991578|FG000|Phase 1 Overall Study|Physician Decision|13|||
164443430|NCT00433199|593991583|FG000|Double-Blind Period|Adverse Event|0|||
164443431|NCT00433199|593991584|FG001|Double-Blind Period|Adverse Event|25|||
164443432|NCT00433199|593991583|FG000|Double-Blind Period|Lack of Efficacy|0|||
164443433|NCT00433199|593991584|FG001|Double-Blind Period|Lack of Efficacy|2|||
164443434|NCT00433199|593991583|FG000|Double-Blind Period|Lost to Follow-up|2|||
164443435|NCT00433199|593991584|FG001|Double-Blind Period|Lost to Follow-up|5|||
164443436|NCT00433199|593991583|FG000|Double-Blind Period|Withdrawal by Subject|8|||
164443437|NCT00433199|593991584|FG001|Double-Blind Period|Withdrawal by Subject|19|||
164443438|NCT00433199|593991583|FG000|Double-Blind Period|Protocol Violation|1|||
164443439|NCT00433199|593991584|FG001|Double-Blind Period|Protocol Violation|10|||
164443440|NCT00433199|593991583|FG000|Double-Blind Period|Administrative|1|||
164443441|NCT00433199|593991584|FG001|Double-Blind Period|Administrative|5|||
164443442|NCT00433199|593991583|FG000|Open-Label Period|Adverse Event|0|||
164443443|NCT00433199|593991584|FG001|Open-Label Period|Adverse Event|19|||
164443444|NCT00433199|593991583|FG000|Open-Label Period|Lack of Efficacy|0|||
164443445|NCT00433199|593991584|FG001|Open-Label Period|Lack of Efficacy|2|||
164443446|NCT00433199|593991583|FG000|Open-Label Period|Lost to Follow-up|0|||
164443447|NCT00433199|593991584|FG001|Open-Label Period|Lost to Follow-up|3|||
164443448|NCT00433199|593991583|FG000|Open-Label Period|Withdrawal by Subject|0|||
164443449|NCT00433199|593991584|FG001|Open-Label Period|Withdrawal by Subject|7|||
164443450|NCT00433199|593991583|FG000|Open-Label Period|Protocol Violation|0|||
164706024|NCT05091307|594953342|FG002|Overall Study|Other|0|||
164706025|NCT05091307|594953343|FG003|Overall Study|Other|0|||
164443451|NCT00433199|593991584|FG001|Open-Label Period|Protocol Violation|2|||
164443452|NCT00433199|593991583|FG000|Open-Label Period|Administrative|0|||
164443453|NCT00433199|593991584|FG001|Open-Label Period|Administrative|1|||
164443454|NCT00357097|593991585|FG000|Overall Study|Did not meet inclusion criteria|5|||
164443455|NCT00357097|593991586|FG001|Overall Study|Did not meet inclusion criteria|3|||
164706026|NCT05091307|594953340|FG000|Overall Study|Randomized but not vaccinated|0|||
164706027|NCT05091307|594953341|FG001|Overall Study|Randomized but not vaccinated|2|||
164443456|NCT00357097|593991585|FG000|Overall Study|Adverse Event|34|||
164443457|NCT00357097|593991586|FG001|Overall Study|Adverse Event|6|||
164443458|NCT00357097|593991585|FG000|Overall Study|Withdrawal by Subject|8|||
164443459|NCT00357097|593991586|FG001|Overall Study|Withdrawal by Subject|7|||
164443460|NCT00357097|593991585|FG000|Overall Study|Non-compliance|1|||
164443461|NCT00357097|593991586|FG001|Overall Study|Non-compliance|2|||
164706028|NCT05091307|594953342|FG002|Overall Study|Randomized but not vaccinated|0|||
164443462|NCT00357097|593991585|FG000|Overall Study|Lack of Efficacy|2|||
164443463|NCT00357097|593991586|FG001|Overall Study|Lack of Efficacy|8|||
164443464|NCT00357097|593991585|FG000|Overall Study|Met Exclusion Criteria|3|||
164443465|NCT00357097|593991586|FG001|Overall Study|Met Exclusion Criteria|1|||
164443466|NCT00357097|593991585|FG000|Overall Study|Other|1|||
164443467|NCT00357097|593991586|FG001|Overall Study|Other|1|||
164443468|NCT00357097|593991585|FG000|Overall Study|Increase of RLS Symptoms|0|||
164443469|NCT00357097|593991586|FG001|Overall Study|Increase of RLS Symptoms|1|||
164443470|NCT00658996|593991587|FG000|First Intervention|Positive slit lamp finding|1|||
164443471|NCT00658996|593991588|FG001|First Intervention|Positive slit lamp finding|0|||
164443472|NCT00658996|593991587|FG000|First Intervention|Lack of lenses|0|||
164443473|NCT00658996|593991588|FG001|First Intervention|Lack of lenses|1|||
164443474|NCT00658996|593991587|FG000|Crossover Period|Physician Decision|1|||
164443475|NCT00658996|593991588|FG001|Crossover Period|Physician Decision|0|||
164443476|NCT00658996|593991587|FG000|Crossover Period|Ineligible|1|||
164443477|NCT00658996|593991588|FG001|Crossover Period|Ineligible|1|||
164443478|NCT00658996|593991587|FG000|Second Intervention|Developed a stye on upper lid|1|||
164443479|NCT00658996|593991588|FG001|Second Intervention|Developed a stye on upper lid|0|||
164443480|NCT00658996|593991587|FG000|Second Intervention|Positive slit lamp finding|0|||
164443481|NCT00658996|593991588|FG001|Second Intervention|Positive slit lamp finding|1|||
164443482|NCT03603717|593991595|FG000|Overall Study|Lost to Follow-up|20|||
164443483|NCT03603717|593991596|FG001|Overall Study|Lost to Follow-up|20|||
164443484|NCT03603717|593991595|FG000|Overall Study|Withdrawal by Subject|16|||
164443485|NCT03603717|593991596|FG001|Overall Study|Withdrawal by Subject|10|||
164443486|NCT01810263|593991597|FG000|Overall Study|Lost to Follow-up|8|||
164443487|NCT01810263|593991598|FG001|Overall Study|Lost to Follow-up|7|||
164443488|NCT00457691|593991599|FG000|Overall Study|Adverse Event|4|||
164443489|NCT00457691|593991600|FG001|Overall Study|Adverse Event|1|||
164443490|NCT00457691|593991599|FG000|Overall Study|Death|163|||
164443491|NCT00457691|593991600|FG001|Overall Study|Death|148|||
164443492|NCT00457691|593991599|FG000|Overall Study|Protocol Violation|1|||
164443493|NCT00457691|593991600|FG001|Overall Study|Protocol Violation|3|||
164443494|NCT00457691|593991599|FG000|Overall Study|Lost to Follow-up|23|||
164443495|NCT00457691|593991600|FG001|Overall Study|Lost to Follow-up|14|||
164443496|NCT00457691|593991599|FG000|Overall Study|Study terminated by Sponsor|1|||
164443497|NCT00457691|593991600|FG001|Overall Study|Study terminated by Sponsor|1|||
164443498|NCT00457691|593991599|FG000|Overall Study|Subject refused (reason other than AE)|14|||
164443499|NCT00457691|593991600|FG001|Overall Study|Subject refused (reason other than AE)|19|||
164443500|NCT00457691|593991599|FG000|Overall Study|Disease progression, study terminated|180|||
164443501|NCT00457691|593991600|FG001|Overall Study|Disease progression, study terminated|196|||
164443502|NCT03073941|593992638|FG000|Overall Study|Received non-study device intraoperatively|0|||
164443503|NCT03073941|593992639|FG001|Overall Study|Received non-study device intraoperatively|2|||
164443504|NCT03073941|593992638|FG000|Overall Study|Death|1|||
164443505|NCT03073941|593992639|FG001|Overall Study|Death|0|||
164443506|NCT03073941|593992638|FG000|Overall Study|Withdrawal by Subject|1|||
164443507|NCT03073941|593992639|FG001|Overall Study|Withdrawal by Subject|3|||
164443508|NCT03073941|593992638|FG000|Overall Study|Lost to Follow-up|5|||
164443509|NCT03073941|593992639|FG001|Overall Study|Lost to Follow-up|4|||
164443510|NCT03073941|593992638|FG000|Overall Study|Adverse Event|4|||
164443511|NCT03073941|593992639|FG001|Overall Study|Adverse Event|2|||
164443512|NCT03073941|593992638|FG000|Overall Study|Met an exclusion criterion|0|||
164443513|NCT03073941|593992639|FG001|Overall Study|Met an exclusion criterion|1|||
164443514|NCT04250883|593992640|FG000|Overall Study|Lost to Follow-up|1|||
164443515|NCT04250883|593992641|FG001|Overall Study|Lost to Follow-up|0|||
164443516|NCT02763319|593992642|FG000|Overall Study|Adverse Event|12|||
164443517|NCT02763319|593992643|FG001|Overall Study|Adverse Event|3|||
164443518|NCT02763319|593992642|FG000|Overall Study|Death|123|||
164443519|NCT02763319|593992643|FG001|Overall Study|Death|123|||
164443520|NCT02763319|593992642|FG000|Overall Study|Lost to Follow-up|6|||
164443521|NCT02763319|593992643|FG001|Overall Study|Lost to Follow-up|7|||
164443522|NCT02763319|593992642|FG000|Overall Study|Noncompliance with Study Drug|2|||
164443523|NCT02763319|593992643|FG001|Overall Study|Noncompliance with Study Drug|0|||
164443524|NCT02763319|593992642|FG000|Overall Study|"Captured as Other in Database"|29|||
164443525|NCT02763319|593992643|FG001|Overall Study|"Captured as Other in Database"|34|||
164443526|NCT02763319|593992642|FG000|Overall Study|Physician Decision|1|||
164443527|NCT02763319|593992643|FG001|Overall Study|Physician Decision|7|||
164443528|NCT02763319|593992642|FG000|Overall Study|Progressive Disease|24|||
164443529|NCT02763319|593992643|FG001|Overall Study|Progressive Disease|27|||
164443530|NCT02763319|593992642|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
164443531|NCT02763319|593992643|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
164443532|NCT02763319|593992642|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
164443533|NCT02763319|593992643|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
164443534|NCT02763319|593992642|FG000|Overall Study|Withdrawal by Subject|26|||
164443535|NCT02763319|593992643|FG001|Overall Study|Withdrawal by Subject|25|||
164443536|NCT03936660|593992644|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
164596681|NCT02796391|594548937|FG000|Overall Study|Lost to Follow-up|2|||
164596682|NCT02796391|594548938|FG001|Overall Study|Lost to Follow-up|2|||
164596683|NCT02796391|594548939|FG002|Overall Study|Lost to Follow-up|13|||
164596684|NCT02796391|594548940|FG003|Overall Study|Lost to Follow-up|8|||
164596685|NCT02796391|594548941|FG004|Overall Study|Lost to Follow-up|14|||
164402395|NCT03076970|593841997|FG000|Washout Period 2|Adverse Event|0|||
164402396|NCT03076970|593841998|FG001|Washout Period 2|Adverse Event|0|||
164402397|NCT03076970|593841999|FG002|Washout Period 2|Adverse Event|0|||
164402398|NCT03076970|593842000|FG003|Washout Period 2|Adverse Event|0|||
164402399|NCT03076970|593842001|FG004|Washout Period 2|Adverse Event|1|||
164402400|NCT03076970|593842002|FG005|Washout Period 2|Adverse Event|0|||
164402401|NCT03076970|593841997|FG000|Period 3|Withdrawal by Subject|0|||
164402402|NCT03076970|593841998|FG001|Period 3|Withdrawal by Subject|0|||
164402403|NCT03076970|593841999|FG002|Period 3|Withdrawal by Subject|0|||
164402404|NCT03076970|593842000|FG003|Period 3|Withdrawal by Subject|0|||
164402405|NCT03076970|593842001|FG004|Period 3|Withdrawal by Subject|0|||
164402406|NCT03076970|593842002|FG005|Period 3|Withdrawal by Subject|1|||
164402407|NCT03076970|593841997|FG000|Period 3|Failure to meet I/E criteria|0|||
164402408|NCT03076970|593841998|FG001|Period 3|Failure to meet I/E criteria|0|||
164402409|NCT03076970|593841999|FG002|Period 3|Failure to meet I/E criteria|0|||
164402410|NCT03076970|593842000|FG003|Period 3|Failure to meet I/E criteria|0|||
164402411|NCT03076970|593842001|FG004|Period 3|Failure to meet I/E criteria|1|||
164402412|NCT03076970|593842002|FG005|Period 3|Failure to meet I/E criteria|0|||
164402413|NCT00939484|593842004|FG000|Overall Study|Progression/Relapse|8|||
164402414|NCT00939484|593842005|FG001|Overall Study|Progression/Relapse|20|||
164402415|NCT00939484|593842006|FG002|Overall Study|Progression/Relapse|3|||
164402416|NCT04233372|593842007|FG000|Overall Study|Lost to Follow-up|104|||
164402417|NCT04233372|593842007|FG000|Overall Study|Adverse Event|8|||
164402418|NCT04233372|593842007|FG000|Overall Study|Withdrawal by Subject|2|||
164402419|NCT04958785|593842008|FG000|Overall Study|Study Terminated by Sponsor|4|||
164402420|NCT04958785|593842009|FG001|Overall Study|Study Terminated by Sponsor|10|||
164402421|NCT04958785|593842010|FG002|Overall Study|Study Terminated by Sponsor|7|||
164402422|NCT04958785|593842011|FG003|Overall Study|Study Terminated by Sponsor|6|||
164402423|NCT04958785|593842012|FG004|Overall Study|Study Terminated by Sponsor|34|||
164402424|NCT04958785|593842008|FG000|Overall Study|Death|2|||
164402425|NCT04958785|593842009|FG001|Overall Study|Death|3|||
164402426|NCT04958785|593842010|FG002|Overall Study|Death|4|||
164402427|NCT04958785|593842011|FG003|Overall Study|Death|5|||
164402428|NCT04958785|593842012|FG004|Overall Study|Death|5|||
164402429|NCT04958785|593842008|FG000|Overall Study|Withdrew consent|2|||
164402430|NCT04958785|593842009|FG001|Overall Study|Withdrew consent|0|||
164402431|NCT04958785|593842010|FG002|Overall Study|Withdrew consent|3|||
164402432|NCT04958785|593842011|FG003|Overall Study|Withdrew consent|1|||
164402433|NCT04958785|593842012|FG004|Overall Study|Withdrew consent|0|||
164402434|NCT04958785|593842008|FG000|Overall Study|Investigator's discretion|0|||
164402435|NCT04958785|593842009|FG001|Overall Study|Investigator's discretion|1|||
164402436|NCT04958785|593842010|FG002|Overall Study|Investigator's discretion|0|||
164402437|NCT04958785|593842011|FG003|Overall Study|Investigator's discretion|1|||
164402438|NCT04958785|593842012|FG004|Overall Study|Investigator's discretion|2|||
164402439|NCT04958785|593842008|FG000|Overall Study|Adverse Event|0|||
164402440|NCT04958785|593842009|FG001|Overall Study|Adverse Event|0|||
164402441|NCT04958785|593842010|FG002|Overall Study|Adverse Event|0|||
164402442|NCT04958785|593842011|FG003|Overall Study|Adverse Event|0|||
164402443|NCT04958785|593842012|FG004|Overall Study|Adverse Event|1|||
164402444|NCT04958785|593842008|FG000|Overall Study|Lost to Follow-up|0|||
164402445|NCT04958785|593842009|FG001|Overall Study|Lost to Follow-up|0|||
164402446|NCT04958785|593842010|FG002|Overall Study|Lost to Follow-up|0|||
164402447|NCT04958785|593842011|FG003|Overall Study|Lost to Follow-up|0|||
164402448|NCT04958785|593842012|FG004|Overall Study|Lost to Follow-up|1|||
164402449|NCT01224925|593842013|FG000|Overall Study|Lost to Follow-up|3|||
164402450|NCT01224925|593842014|FG001|Overall Study|Lost to Follow-up|2|||
164402451|NCT02472652|593842019|FG000|Overall Study|Lost to Follow-up|1|||
164402452|NCT04586569|593842020|FG000|Overall Study|Withdrawal by Subject|0|||
164402453|NCT04586569|593842021|FG001|Overall Study|Withdrawal by Subject|2|||
164596686|NCT02796391|594548942|FG005|Overall Study|Lost to Follow-up|13|||
164596687|NCT02796391|594548937|FG000|Overall Study|COVID|0|||
164596688|NCT02796391|594548938|FG001|Overall Study|COVID|0|||
164596689|NCT02796391|594548939|FG002|Overall Study|COVID|5|||
164402454|NCT04586569|593842020|FG000|Overall Study|No longer eligible|2|||
164402455|NCT04586569|593842021|FG001|Overall Study|No longer eligible|3|||
164402456|NCT04586569|593842020|FG000|Overall Study|Physician Decision|1|||
164402457|NCT04586569|593842021|FG001|Overall Study|Physician Decision|0|||
164402458|NCT03185832|593842022|FG000|Overall Study|Death|9|||
164402459|NCT03185832|593842023|FG001|Overall Study|Death|14|||
164402460|NCT03185832|593842024|FG002|Overall Study|Death|9|||
164402461|NCT03185832|593842025|FG003|Overall Study|Death|7|||
164402462|NCT03185832|593842022|FG000|Overall Study|Withdrawn - vital status available|0|||
164402463|NCT03185832|593842023|FG001|Overall Study|Withdrawn - vital status available|1|||
164402464|NCT03185832|593842024|FG002|Overall Study|Withdrawn - vital status available|1|||
164596690|NCT02796391|594548940|FG003|Overall Study|COVID|5|||
164596691|NCT02796391|594548941|FG004|Overall Study|COVID|2|||
164443537|NCT03936660|593992645|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
164443538|NCT00925587|593992648|FG000|Overall Study|Protocol Specified Criteria|6|||
164443539|NCT00925587|593992649|FG001|Overall Study|Protocol Specified Criteria|6|||
164443540|NCT00925587|593992648|FG000|Overall Study|Physician Decision|4|||
164443541|NCT00925587|593992649|FG001|Overall Study|Physician Decision|1|||
164443542|NCT00925587|593992648|FG000|Overall Study|Protocol Violation|6|||
164443543|NCT00925587|593992649|FG001|Overall Study|Protocol Violation|4|||
164443544|NCT00925587|593992648|FG000|Overall Study|Withdrawal by Subject|9|||
164443545|NCT00925587|593992649|FG001|Overall Study|Withdrawal by Subject|6|||
164443546|NCT00925587|593992648|FG000|Overall Study|Death|5|||
164443547|NCT00925587|593992649|FG001|Overall Study|Death|5|||
164443548|NCT00925587|593992648|FG000|Overall Study|Adverse Event|6|||
164443549|NCT00925587|593992649|FG001|Overall Study|Adverse Event|2|||
164443550|NCT00925587|593992648|FG000|Overall Study|Lost to Follow-up|0|||
164443551|NCT00925587|593992649|FG001|Overall Study|Lost to Follow-up|1|||
164443552|NCT01460446|593992657|FG000|Overall Study|Non-compliance|2|||
164443553|NCT01460446|593992658|FG001|Overall Study|Non-compliance|9|||
164443554|NCT01460446|593992657|FG000|Overall Study|Consent Withdrawn|0|||
164443555|NCT01460446|593992658|FG001|Overall Study|Consent Withdrawn|4|||
164443556|NCT01460446|593992657|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
164443557|NCT01460446|593992658|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
164443558|NCT01460446|593992657|FG000|Overall Study|Surgery/Illness|1|||
164443559|NCT01460446|593992658|FG001|Overall Study|Surgery/Illness|1|||
164443560|NCT01460446|593992657|FG000|Overall Study|Pregnancy|1|||
164443561|NCT01460446|593992658|FG001|Overall Study|Pregnancy|0|||
164443562|NCT01460446|593992657|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
164443563|NCT01460446|593992658|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
164443564|NCT00516321|593992659|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
164443565|NCT00516321|593992660|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
164443566|NCT00516321|593992661|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
164443567|NCT00516321|593992659|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
164443568|NCT00516321|593992660|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
164443569|NCT00516321|593992661|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
164443570|NCT00516321|593992659|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
164443571|NCT00516321|593992660|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
164443572|NCT00516321|593992661|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
164443573|NCT00516321|593992659|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
164443574|NCT00516321|593992660|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
164443575|NCT00516321|593992661|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
164443576|NCT00516321|593992659|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
164443577|NCT00516321|593992660|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
164443578|NCT00516321|593992661|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
164443579|NCT00516321|593992659|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
164443580|NCT00516321|593992660|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
164443581|NCT00516321|593992661|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
164443582|NCT00516321|593992659|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
164443583|NCT00516321|593992660|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
164443584|NCT00516321|593992661|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
164443585|NCT00516321|593992659|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
164443586|NCT00516321|593992660|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
164443587|NCT00516321|593992661|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
164443588|NCT00516321|593992659|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
164443589|NCT00516321|593992660|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
164443590|NCT00516321|593992661|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
164443591|NCT00516321|593992659|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
164443592|NCT00516321|593992660|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
164443593|NCT00516321|593992661|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
164443594|NCT00516321|593992659|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
164443595|NCT00516321|593992660|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
164443596|NCT00516321|593992661|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
164443597|NCT02271854|593992667|FG000|Overall Study|Withdrawal by Subject|2|||
164443598|NCT02271854|593992667|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
164443599|NCT02271854|593992667|FG000|Overall Study|Lost to Follow-up|1|||
164443600|NCT01308567|593992668|FG000|Overall Study|Lost to Follow-up|2|||
164443601|NCT01308567|593992669|FG001|Overall Study|Lost to Follow-up|4|||
164443602|NCT01308567|593992670|FG002|Overall Study|Lost to Follow-up|4|||
164706029|NCT05091307|594953343|FG003|Overall Study|Randomized but not vaccinated|0|||
164706030|NCT00379340|594953346|FG000|Overall Study|Death|0|||
164706031|NCT00379340|594953347|FG001|Overall Study|Death|0|||
164706032|NCT00379340|594953348|FG002|Overall Study|Death|0|||
164706033|NCT00379340|594953349|FG003|Overall Study|Death|2|||
164443603|NCT01571596|593992673|FG000|Overall Study|Adverse Event|2|||
164443604|NCT01571596|593992674|FG001|Overall Study|Adverse Event|0|||
164443605|NCT01571596|593992675|FG002|Overall Study|Adverse Event|0|||
164443606|NCT01571596|593992673|FG000|Overall Study|Study Terminated by the Sponsor|0|||
164443607|NCT01571596|593992674|FG001|Overall Study|Study Terminated by the Sponsor|1|||
164443608|NCT01571596|593992675|FG002|Overall Study|Study Terminated by the Sponsor|1|||
164443609|NCT01078116|593992684|FG000|Overall Study|Lost to Follow-up|17|||
164443610|NCT01078116|593992684|FG000|Overall Study|Adverse Event|5|||
164443611|NCT01078116|593992684|FG000|Overall Study|Withdrawal by Subject|8|||
164443612|NCT01078116|593992684|FG000|Overall Study|Lack of effectiveness|15|||
164443613|NCT01078116|593992684|FG000|Overall Study|Case report form not completed|3|||
164443614|NCT02242487|593992685|FG000|Overall Study|Adverse Event|13|||
164443615|NCT02242487|593992686|FG001|Overall Study|Adverse Event|15|||
164443616|NCT02242487|593992685|FG000|Overall Study|Lack of Efficacy|4|||
164443617|NCT02242487|593992686|FG001|Overall Study|Lack of Efficacy|6|||
164443618|NCT02242487|593992685|FG000|Overall Study|Protocol Violation|2|||
164443619|NCT02242487|593992686|FG001|Overall Study|Protocol Violation|0|||
164443620|NCT02242487|593992685|FG000|Overall Study|Lost to Follow-up|2|||
164443621|NCT02242487|593992686|FG001|Overall Study|Lost to Follow-up|1|||
164443622|NCT02242487|593992685|FG000|Overall Study|Other - Miscellaneous|4|||
164443623|NCT02242487|593992686|FG001|Overall Study|Other - Miscellaneous|6|||
164443624|NCT02242487|593992685|FG000|Overall Study|Withdrawal by Subject|37|||
164443625|NCT02242487|593992686|FG001|Overall Study|Withdrawal by Subject|19|||
164443626|NCT03644849|593992687|FG000|Overall Study|Lost to Follow-up|1|||
164443627|NCT03644849|593992688|FG001|Overall Study|Lost to Follow-up|3|||
164443628|NCT03737240|593992697|FG000|Overall Study|Lost to Follow-up|16|||
164443629|NCT03737240|593992698|FG001|Overall Study|Lost to Follow-up|15|||
164443630|NCT02512965|593992701|FG000|Overall Study|Withdrawal by Subject|0|||
164443631|NCT02512965|593992702|FG001|Overall Study|Withdrawal by Subject|4|||
164443632|NCT02570711|593992706|FG000|Overall Study|Death|1|||
164443633|NCT02570711|593992707|FG001|Overall Study|Death|0|||
164443634|NCT02570711|593992706|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
164443635|NCT02570711|593992707|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
164443636|NCT05001945|593992708|FG000|Overall Study|Adverse Event|0|||
164443637|NCT05001945|593992709|FG001|Overall Study|Adverse Event|0|||
164443638|NCT05001945|593992710|FG002|Overall Study|Adverse Event|0|||
164443639|NCT05001945|593992711|FG003|Overall Study|Adverse Event|1|||
164443640|NCT05001945|593992712|FG004|Overall Study|Adverse Event|0|||
164443641|NCT05001945|593992713|FG005|Overall Study|Adverse Event|0|||
164443642|NCT05001945|593992714|FG006|Overall Study|Adverse Event|0|||
164443643|NCT05001945|593992715|FG007|Overall Study|Adverse Event|0|||
164443644|NCT05001945|593992708|FG000|Overall Study|Lost to Follow-up|0|||
164443645|NCT05001945|593992709|FG001|Overall Study|Lost to Follow-up|1|||
164443646|NCT05001945|593992710|FG002|Overall Study|Lost to Follow-up|1|||
164443647|NCT05001945|593992711|FG003|Overall Study|Lost to Follow-up|2|||
164443648|NCT05001945|593992712|FG004|Overall Study|Lost to Follow-up|0|||
164443649|NCT05001945|593992713|FG005|Overall Study|Lost to Follow-up|1|||
164443650|NCT05001945|593992714|FG006|Overall Study|Lost to Follow-up|0|||
164443651|NCT05001945|593992715|FG007|Overall Study|Lost to Follow-up|0|||
164443652|NCT05001945|593992708|FG000|Overall Study|Protocol Violation|1|||
164443653|NCT05001945|593992709|FG001|Overall Study|Protocol Violation|0|||
164443654|NCT05001945|593992710|FG002|Overall Study|Protocol Violation|1|||
164443655|NCT05001945|593992711|FG003|Overall Study|Protocol Violation|1|||
164443656|NCT05001945|593992712|FG004|Overall Study|Protocol Violation|0|||
164443657|NCT05001945|593992713|FG005|Overall Study|Protocol Violation|1|||
164443658|NCT05001945|593992714|FG006|Overall Study|Protocol Violation|0|||
164443659|NCT05001945|593992715|FG007|Overall Study|Protocol Violation|0|||
164443660|NCT05001945|593992708|FG000|Overall Study|Withdrawal by Subject|0|||
164443661|NCT05001945|593992709|FG001|Overall Study|Withdrawal by Subject|0|||
164443662|NCT05001945|593992710|FG002|Overall Study|Withdrawal by Subject|0|||
164443663|NCT05001945|593992711|FG003|Overall Study|Withdrawal by Subject|1|||
164443664|NCT05001945|593992712|FG004|Overall Study|Withdrawal by Subject|1|||
164443665|NCT05001945|593992713|FG005|Overall Study|Withdrawal by Subject|1|||
164443666|NCT05001945|593992714|FG006|Overall Study|Withdrawal by Subject|0|||
164443667|NCT05001945|593992715|FG007|Overall Study|Withdrawal by Subject|1|||
164443668|NCT05001945|593992708|FG000|Overall Study|Not specified by Investigator|0|||
164443669|NCT05001945|593992709|FG001|Overall Study|Not specified by Investigator|3|||
164443670|NCT05001945|593992710|FG002|Overall Study|Not specified by Investigator|0|||
164443671|NCT05001945|593992711|FG003|Overall Study|Not specified by Investigator|0|||
164443672|NCT05001945|593992712|FG004|Overall Study|Not specified by Investigator|1|||
164443673|NCT05001945|593992713|FG005|Overall Study|Not specified by Investigator|0|||
164443674|NCT05001945|593992714|FG006|Overall Study|Not specified by Investigator|0|||
164443675|NCT05001945|593992715|FG007|Overall Study|Not specified by Investigator|0|||
164443676|NCT00545077|593992716|FG000|Overall Study|Treatment not received|5|||
164596692|NCT02796391|594548942|FG005|Overall Study|COVID|4|||
164596693|NCT02796391|594548937|FG000|Overall Study|Participant did not like study cigarettes|0|||
164596694|NCT02796391|594548938|FG001|Overall Study|Participant did not like study cigarettes|0|||
164706034|NCT00379340|594953350|FG004|Overall Study|Death|0|||
164706035|NCT00379340|594953346|FG000|Overall Study|Lack of Efficacy|6|||
164706036|NCT00379340|594953347|FG001|Overall Study|Lack of Efficacy|1|||
164706037|NCT00379340|594953348|FG002|Overall Study|Lack of Efficacy|0|||
164706038|NCT00379340|594953349|FG003|Overall Study|Lack of Efficacy|4|||
164706039|NCT00379340|594953350|FG004|Overall Study|Lack of Efficacy|3|||
164706040|NCT00379340|594953346|FG000|Overall Study|Physician Decision|6|||
164706041|NCT00379340|594953347|FG001|Overall Study|Physician Decision|2|||
164706042|NCT00379340|594953348|FG002|Overall Study|Physician Decision|1|||
164706043|NCT00379340|594953349|FG003|Overall Study|Physician Decision|2|||
164706044|NCT00379340|594953350|FG004|Overall Study|Physician Decision|3|||
164706045|NCT00379340|594953346|FG000|Overall Study|Withdrawal by Subject|0|||
164706046|NCT00379340|594953347|FG001|Overall Study|Withdrawal by Subject|0|||
164706047|NCT00379340|594953348|FG002|Overall Study|Withdrawal by Subject|0|||
164706048|NCT00379340|594953349|FG003|Overall Study|Withdrawal by Subject|1|||
164706049|NCT00379340|594953350|FG004|Overall Study|Withdrawal by Subject|0|||
164706050|NCT00379340|594953346|FG000|Overall Study|Refusal of further protocol therapy|1|||
164706051|NCT00379340|594953347|FG001|Overall Study|Refusal of further protocol therapy|0|||
164402465|NCT03185832|593842025|FG003|Overall Study|Withdrawn - vital status available|4|||
164402466|NCT01083641|593842027|FG000|Overall Study|Withdrawal by Subject|2|||
164402467|NCT03439189|593842028|FG000|Overall Study|Protocol Violation|19|||
164402468|NCT03439189|593842028|FG000|Overall Study|Lack of Efficacy|63|||
164402469|NCT01777321|593842029|FG000|Overall Study|Withdrawal by Subject|0|||
164402470|NCT01777321|593842030|FG001|Overall Study|Withdrawal by Subject|1|||
164402471|NCT02173548|593842031|FG000|Overall Study|Lost to Follow-up|0|||
164402472|NCT02173548|593842032|FG001|Overall Study|Lost to Follow-up|2|||
164402473|NCT02173548|593842031|FG000|Overall Study|Withdrawal by Subject|1|||
164402474|NCT02173548|593842032|FG001|Overall Study|Withdrawal by Subject|0|||
164402475|NCT03597568|593842033|FG000|Overall Study|Withdrawal by Subject|1|||
164402476|NCT03597568|593842034|FG001|Overall Study|Withdrawal by Subject|1|||
164402477|NCT03597568|593842033|FG000|Overall Study|Unable to analyze vascular data|1|||
164402478|NCT03597568|593842034|FG001|Overall Study|Unable to analyze vascular data|1|||
164402479|NCT00999466|593842037|FG000|Main Part|Withdrawal by Subject|0|||
164402480|NCT00999466|593842038|FG001|Main Part|Withdrawal by Subject|0|||
164402481|NCT00999466|593842039|FG002|Main Part|Withdrawal by Subject|2|||
164402482|NCT00999466|593842037|FG000|Main Part|Adverse Event|0|||
164402483|NCT00999466|593842038|FG001|Main Part|Adverse Event|4|||
164402484|NCT00999466|593842039|FG002|Main Part|Adverse Event|2|||
164402485|NCT05131165|593842040|FG000|Overall Study|Death|1|||
164402486|NCT05131165|593842041|FG001|Overall Study|Death|1|||
164402487|NCT05131165|593842042|FG002|Overall Study|Death|0|||
164402488|NCT05131165|593842040|FG000|Overall Study|Lost to Follow-up|2|||
164402489|NCT05131165|593842041|FG001|Overall Study|Lost to Follow-up|2|||
164402490|NCT05131165|593842042|FG002|Overall Study|Lost to Follow-up|5|||
164402491|NCT05131165|593842040|FG000|Overall Study|Transferred out of clinic|1|||
164402492|NCT05131165|593842041|FG001|Overall Study|Transferred out of clinic|0|||
164402493|NCT05131165|593842042|FG002|Overall Study|Transferred out of clinic|3|||
164402494|NCT05131165|593842040|FG000|Overall Study|Dropped out|1|||
164402495|NCT05131165|593842041|FG001|Overall Study|Dropped out|2|||
164402496|NCT05131165|593842042|FG002|Overall Study|Dropped out|0|||
164402497|NCT00526630|593842043|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
164402498|NCT00526630|593842044|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
164402499|NCT00526630|593842043|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
164402500|NCT00526630|593842044|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
164402501|NCT00337272|593842047|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
164402502|NCT00337272|593842048|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
164402503|NCT00337272|593842047|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
164402504|NCT00337272|593842048|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
164402505|NCT00337272|593842047|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
164402506|NCT00337272|593842048|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
164402507|NCT00337272|593842047|FG000|Treatment Period|Non-compliance|1|||
164402508|NCT00337272|593842048|FG001|Treatment Period|Non-compliance|1|||
164402509|NCT00337272|593842047|FG000|Treatment Period|Withdrawal by Subject|0|||
164402510|NCT00337272|593842048|FG001|Treatment Period|Withdrawal by Subject|1|||
164443677|NCT00545077|593992717|FG001|Overall Study|Treatment not received|1|||
164402511|NCT00337272|593842047|FG000|Withdrawal Period|Non-compliance|0|||
164443678|NCT00545077|593992716|FG000|Overall Study|Disease Progression|131|||
164443679|NCT00545077|593992717|FG001|Overall Study|Disease Progression|98|||
164706052|NCT00379340|594953348|FG002|Overall Study|Refusal of further protocol therapy|1|||
164706053|NCT00379340|594953349|FG003|Overall Study|Refusal of further protocol therapy|1|||
164402512|NCT00337272|593842048|FG001|Withdrawal Period|Non-compliance|1|||
164402513|NCT05674890|593842054|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
164402514|NCT05674890|593842055|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
164402515|NCT05674890|593842054|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
164706054|NCT00379340|594953350|FG004|Overall Study|Refusal of further protocol therapy|7|||
164402516|NCT05674890|593842055|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
164402517|NCT05674890|593842054|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
164402518|NCT05674890|593842055|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
164402519|NCT02093663|593842062|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
164402520|NCT02093663|593842063|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
164402521|NCT02093663|593842064|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
164402522|NCT02093663|593842065|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
164402523|NCT02093663|593842066|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
164402524|NCT02093663|593842062|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
164402525|NCT02093663|593842063|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
164402526|NCT02093663|593842064|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
164402527|NCT02093663|593842065|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
164402528|NCT02093663|593842066|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
164402529|NCT02093663|593842062|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
164402530|NCT02093663|593842063|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
164402531|NCT02093663|593842064|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
164402532|NCT02093663|593842065|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
164402533|NCT02093663|593842066|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
164402534|NCT02093663|593842062|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
164402535|NCT02093663|593842063|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
164402536|NCT02093663|593842064|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
164402537|NCT02093663|593842065|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
164402538|NCT02093663|593842066|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
164402539|NCT02093663|593842062|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
164402540|NCT02093663|593842063|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
164402541|NCT02093663|593842064|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
164402542|NCT02093663|593842065|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
164402543|NCT02093663|593842066|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
164402544|NCT02093663|593842062|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
164402545|NCT02093663|593842063|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
164402546|NCT02093663|593842064|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
164402547|NCT02093663|593842065|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
164402548|NCT02093663|593842066|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
164402549|NCT02093663|593842062|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
164402550|NCT02093663|593842063|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
164402551|NCT02093663|593842064|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
164402552|NCT02093663|593842065|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
164402553|NCT02093663|593842066|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
164402554|NCT02093663|593842062|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
164402555|NCT02093663|593842063|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
164402556|NCT02093663|593842064|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
164402557|NCT02093663|593842065|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
164402558|NCT02093663|593842066|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
164402559|NCT02093663|593842062|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
164402560|NCT02093663|593842063|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
164402561|NCT02093663|593842064|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
164402562|NCT02093663|593842065|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
164402563|NCT02093663|593842066|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
164402564|NCT05453110|593842069|FG000|Overall Study|Received intervention but did not complete primary outcome measure|5|||
164402565|NCT05453110|593842070|FG001|Overall Study|Received intervention but did not complete primary outcome measure|5|||
164402566|NCT05453110|593842071|FG002|Overall Study|Received intervention but did not complete primary outcome measure|6|||
164402567|NCT05906368|593842072|FG000|Overall Study|Withdrawal by Subject|1|||
164402568|NCT05906368|593842073|FG001|Overall Study|Withdrawal by Subject|1|||
164402569|NCT05906368|593842072|FG000|Overall Study|Ineligibility criteria identified|2|||
164402570|NCT05906368|593842073|FG001|Overall Study|Ineligibility criteria identified|0|||
164402571|NCT01505387|593842074|FG000|Overall Study|Protocol Violation|1|||
164402572|NCT01505387|593842075|FG001|Overall Study|Protocol Violation|0|||
164402573|NCT01505387|593842074|FG000|Overall Study|Withdrawal by Subject|1|||
164402574|NCT01505387|593842075|FG001|Overall Study|Withdrawal by Subject|1|||
164402575|NCT01197508|593842076|FG000|Overall Study|Withdrawal by Subject|8|||
164402576|NCT01197508|593842077|FG001|Overall Study|Withdrawal by Subject|7|||
164402577|NCT01197508|593842078|FG002|Overall Study|Withdrawal by Subject|15|||
164402578|NCT01197508|593842079|FG003|Overall Study|Withdrawal by Subject|4|||
164402579|NCT01197508|593842076|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
164402580|NCT01197508|593842077|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
164402581|NCT01197508|593842078|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
164402582|NCT01197508|593842079|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
164402583|NCT01197508|593842076|FG000|Overall Study|Adverse Event|10|||
164402584|NCT01197508|593842077|FG001|Overall Study|Adverse Event|13|||
164402585|NCT01197508|593842078|FG002|Overall Study|Adverse Event|23|||
164402586|NCT01197508|593842079|FG003|Overall Study|Adverse Event|3|||
164402587|NCT01197508|593842076|FG000|Overall Study|Severe non-compliance to protocol|0|||
164402588|NCT01197508|593842077|FG001|Overall Study|Severe non-compliance to protocol|3|||
164402589|NCT01197508|593842078|FG002|Overall Study|Severe non-compliance to protocol|1|||
164402590|NCT01197508|593842079|FG003|Overall Study|Severe non-compliance to protocol|3|||
164402591|NCT01197508|593842076|FG000|Overall Study|Condition under investigation worsened|1|||
164402592|NCT01197508|593842077|FG001|Overall Study|Condition under investigation worsened|1|||
164402593|NCT01197508|593842078|FG002|Overall Study|Condition under investigation worsened|1|||
164402594|NCT01197508|593842079|FG003|Overall Study|Condition under investigation worsened|1|||
164402595|NCT01197508|593842076|FG000|Overall Study|Lack of Efficacy|1|||
164402596|NCT01197508|593842077|FG001|Overall Study|Lack of Efficacy|2|||
164402597|NCT01197508|593842078|FG002|Overall Study|Lack of Efficacy|2|||
164402598|NCT01197508|593842079|FG003|Overall Study|Lack of Efficacy|1|||
164402599|NCT01197508|593842076|FG000|Overall Study|Study-specific withdrawal criteria|0|||
164402600|NCT01197508|593842077|FG001|Overall Study|Study-specific withdrawal criteria|0|||
164402601|NCT01197508|593842078|FG002|Overall Study|Study-specific withdrawal criteria|1|||
164402602|NCT01197508|593842079|FG003|Overall Study|Study-specific withdrawal criteria|2|||
164402603|NCT01197508|593842076|FG000|Overall Study|Lost to Follow-up|1|||
164402604|NCT01197508|593842077|FG001|Overall Study|Lost to Follow-up|1|||
164402605|NCT01197508|593842078|FG002|Overall Study|Lost to Follow-up|2|||
164402606|NCT01197508|593842079|FG003|Overall Study|Lost to Follow-up|0|||
164402607|NCT01197508|593842076|FG000|Overall Study|Other|2|||
164402608|NCT01197508|593842077|FG001|Overall Study|Other|3|||
164402609|NCT01197508|593842078|FG002|Overall Study|Other|2|||
164402610|NCT01197508|593842079|FG003|Overall Study|Other|2|||
164402611|NCT00266825|593842080|FG000|Completed Follow-Up|Lost to Follow-up|14|||
164402612|NCT00266825|593842081|FG001|Completed Follow-Up|Lost to Follow-up|19|||
164402613|NCT00266825|593842080|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
164402614|NCT00266825|593842081|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
164402615|NCT02799784|593842084|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
164402616|NCT02799784|593842085|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
164402617|NCT02799784|593842084|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
164402618|NCT02799784|593842085|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
164402619|NCT02799784|593842084|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
164402620|NCT02799784|593842085|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
164402621|NCT02799784|593842084|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
164402622|NCT02799784|593842085|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
164402623|NCT02799784|593842084|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
164402624|NCT02799784|593842085|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
164402625|NCT02799784|593842084|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
164402626|NCT02799784|593842085|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
164402627|NCT01127646|593842086|FG000|Overall Study|Entry Criteria Not Met|1|||
164402628|NCT01127646|593842087|FG001|Overall Study|Entry Criteria Not Met|0|||
164402629|NCT01127646|593842086|FG000|Overall Study|Protocol Violation|0|||
164402630|NCT01127646|593842087|FG001|Overall Study|Protocol Violation|1|||
164402631|NCT00595504|593842091|FG000|Overall Study|Withdrawal by Subject|1|||
164402632|NCT00595504|593842092|FG001|Overall Study|Withdrawal by Subject|3|||
164402633|NCT00595504|593842091|FG000|Overall Study|Physician Decision|1|||
164402634|NCT00595504|593842092|FG001|Overall Study|Physician Decision|0|||
164402635|NCT00293267|593842093|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
164402636|NCT00293267|593842094|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
164402637|NCT00293267|593842093|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
164402638|NCT00293267|593842094|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
164402639|NCT00293267|593842093|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
164402640|NCT00293267|593842094|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
164402641|NCT00293267|593842093|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
164596695|NCT02796391|594548939|FG002|Overall Study|Participant did not like study cigarettes|3|||
164596696|NCT02796391|594548940|FG003|Overall Study|Participant did not like study cigarettes|0|||
164596697|NCT02796391|594548941|FG004|Overall Study|Participant did not like study cigarettes|0|||
164596698|NCT02796391|594548942|FG005|Overall Study|Participant did not like study cigarettes|0|||
164596699|NCT02796391|594548937|FG000|Overall Study|Withdrawal by Subject|1|||
164596700|NCT02796391|594548938|FG001|Overall Study|Withdrawal by Subject|1|||
164596701|NCT02796391|594548939|FG002|Overall Study|Withdrawal by Subject|4|||
164596702|NCT02796391|594548940|FG003|Overall Study|Withdrawal by Subject|3|||
164706055|NCT00379340|594953346|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
164706056|NCT00379340|594953347|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
164706057|NCT00379340|594953348|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
164706058|NCT00379340|594953349|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
164706059|NCT00379340|594953350|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
164706060|NCT00379340|594953346|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
164706061|NCT00379340|594953347|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
164706062|NCT00379340|594953348|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
164706063|NCT00379340|594953349|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
164706064|NCT00379340|594953350|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
164706065|NCT05327816|594953351|FG000|Overall Study|Lost to Follow-up|1|||
164706066|NCT05327816|594953352|FG001|Overall Study|Lost to Follow-up|0|||
164706067|NCT05327816|594953353|FG002|Overall Study|Lost to Follow-up|0|||
164706068|NCT05327816|594953354|FG003|Overall Study|Lost to Follow-up|0|||
164706069|NCT05327816|594953355|FG004|Overall Study|Lost to Follow-up|0|||
164706070|NCT05327816|594953356|FG005|Overall Study|Lost to Follow-up|0|||
164706071|NCT05327816|594953357|FG006|Overall Study|Lost to Follow-up|0|||
164706072|NCT05327816|594953358|FG007|Overall Study|Lost to Follow-up|0|||
164402642|NCT00293267|593842094|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
164402643|NCT00293267|593842093|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
164402644|NCT00293267|593842094|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
164402645|NCT00293267|593842093|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
164402646|NCT00293267|593842094|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
164402647|NCT00293267|593842093|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
164402648|NCT00293267|593842094|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
164402649|NCT00293267|593842093|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
164402650|NCT00293267|593842094|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
164402651|NCT00293267|593842093|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
164402652|NCT00293267|593842094|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
164402653|NCT00293267|593842093|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
164402654|NCT00293267|593842094|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
164402655|NCT00293267|593842093|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
164402656|NCT00293267|593842094|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
164402657|NCT00293267|593842093|FG000|Extension - Double-Blind Week 49-156|Death|3|||
164402658|NCT00293267|593842094|FG001|Extension - Double-Blind Week 49-156|Death|0|||
164402659|NCT00293267|593842093|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
164402660|NCT00293267|593842094|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
164402661|NCT00293267|593842093|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
164402662|NCT00293267|593842094|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
164402663|NCT00293267|593842093|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
164402664|NCT00293267|593842094|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
164402665|NCT00293267|593842093|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
164402666|NCT00293267|593842094|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
164402667|NCT00293267|593842093|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
164402668|NCT00293267|593842094|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
164402669|NCT00293267|593842093|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
164402670|NCT00293267|593842094|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
164402671|NCT00293267|593842093|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
164402672|NCT00293267|593842094|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
164402673|NCT00293267|593842093|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
164402674|NCT00293267|593842094|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
164402675|NCT00293267|593842093|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
164402676|NCT00293267|593842094|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
164402677|NCT00293267|593842093|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
164402678|NCT00293267|593842094|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
164402679|NCT00293267|593842093|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
164402680|NCT00293267|593842094|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
164402681|NCT00293267|593842093|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
164402682|NCT00293267|593842094|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
164402683|NCT00293267|593842093|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
164402684|NCT00293267|593842094|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
164402685|NCT00293267|593842093|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
164402686|NCT00293267|593842094|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
164706073|NCT05327816|594953359|FG008|Overall Study|Lost to Follow-up|0|||
164706074|NCT05327816|594953360|FG009|Overall Study|Lost to Follow-up|1|||
164706075|NCT05327816|594953361|FG010|Overall Study|Lost to Follow-up|0|||
164706076|NCT05327816|594953351|FG000|Overall Study|Withdrawal by Subject|0|||
164443680|NCT00545077|593992716|FG000|Overall Study|Withdrawal by Subject|3|||
164443681|NCT00545077|593992717|FG001|Overall Study|Withdrawal by Subject|14|||
164443682|NCT00545077|593992716|FG000|Overall Study|Physician Decision|6|||
164443683|NCT00545077|593992717|FG001|Overall Study|Physician Decision|3|||
164443684|NCT00545077|593992716|FG000|Overall Study|Lost to Follow-up|2|||
164596703|NCT02796391|594548941|FG004|Overall Study|Withdrawal by Subject|4|||
164596704|NCT02796391|594548942|FG005|Overall Study|Withdrawal by Subject|3|||
164596705|NCT02796391|594548937|FG000|Overall Study|Adverse Event|0|||
164596706|NCT02796391|594548938|FG001|Overall Study|Adverse Event|0|||
164596707|NCT02796391|594548939|FG002|Overall Study|Adverse Event|0|||
164596708|NCT02796391|594548940|FG003|Overall Study|Adverse Event|1|||
164596709|NCT02796391|594548941|FG004|Overall Study|Adverse Event|0|||
164596710|NCT02796391|594548942|FG005|Overall Study|Adverse Event|0|||
164596711|NCT02796391|594548937|FG000|Overall Study|Protocol Violation|0|||
164596712|NCT02796391|594548938|FG001|Overall Study|Protocol Violation|0|||
164596713|NCT02796391|594548939|FG002|Overall Study|Protocol Violation|0|||
164596714|NCT02796391|594548940|FG003|Overall Study|Protocol Violation|1|||
164596715|NCT02796391|594548941|FG004|Overall Study|Protocol Violation|0|||
164596716|NCT02796391|594548942|FG005|Overall Study|Protocol Violation|0|||
164596717|NCT02695524|594548943|FG000|Overall Study|Lost to Follow-up|3|||
164596718|NCT02695524|594548944|FG001|Overall Study|Lost to Follow-up|2|||
164596719|NCT02695524|594548943|FG000|Overall Study|Death|0|||
164596720|NCT02695524|594548944|FG001|Overall Study|Death|1|||
164596721|NCT00798655|594548950|FG000|Overall Study|Did not receive at least one dose of pan|2|||
164596722|NCT04831515|594548951|FG000|First Intervention|Adverse Event|0|||
164596723|NCT04831515|594548952|FG001|First Intervention|Adverse Event|1|||
164596724|NCT03712345|594548953|FG000|Overall Study|Failure to meet randomization criteria|0|||
164596725|NCT03712345|594548954|FG001|Overall Study|Failure to meet randomization criteria|0|||
164596726|NCT03712345|594548955|FG002|Overall Study|Failure to meet randomization criteria|1|||
164596727|NCT00960934|594548958|FG000|Overall Study|Adverse Event|2|||
164596728|NCT00960934|594548959|FG001|Overall Study|Adverse Event|3|||
164596729|NCT00960934|594548960|FG002|Overall Study|Adverse Event|3|||
164596730|NCT00960934|594548961|FG003|Overall Study|Adverse Event|2|||
164596731|NCT00960934|594548962|FG004|Overall Study|Adverse Event|4|||
164402687|NCT00293267|593842093|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
164402688|NCT00293267|593842094|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
164402689|NCT00293267|593842093|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
164402690|NCT00293267|593842094|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
164402691|NCT01804816|593842095|FG000|No acupuncture (initial 5 weeks)|Withdrawal by Subject|3|||
164402692|NCT01804816|593842095|FG000|Acupuncture (second 5 weeks)|Physician Decision|1|||
164443685|NCT00545077|593992717|FG001|Overall Study|Lost to Follow-up|0|||
164443686|NCT00545077|593992716|FG000|Overall Study|Protocol Violation|1|||
164443687|NCT00545077|593992717|FG001|Overall Study|Protocol Violation|0|||
164443688|NCT00545077|593992716|FG000|Overall Study|Adverse Event|0|||
164443689|NCT00545077|593992717|FG001|Overall Study|Adverse Event|31|||
164443690|NCT00545077|593992716|FG000|Overall Study|Death|0|||
164443691|NCT00545077|593992717|FG001|Overall Study|Death|8|||
164443692|NCT02423291|593992718|FG000|Overall Study|Lack of Efficacy|14|||
164443693|NCT02423291|593992718|FG000|Overall Study|Adverse Event|1|||
164443694|NCT01124734|593992719|FG000|Overall Study|Disease progression|13|||
164443695|NCT01124734|593992719|FG000|Overall Study|Adverse Event|1|||
164596732|NCT00960934|594548963|FG005|Overall Study|Adverse Event|3|||
164596733|NCT00960934|594548958|FG000|Overall Study|Lack of Efficacy|1|||
164402693|NCT01050816|593842096|FG000|Overall Study|Lost to Follow-up|2|||
164402694|NCT01050816|593842096|FG000|Overall Study|patient's refusal|2|||
164402695|NCT01754467|593842097|FG000|Overall Study|Lost to Follow-up|1|||
164402696|NCT01235546|593842098|FG000|Overall Study|Staff error, medication not administered|1|||
164402697|NCT01235546|593842099|FG001|Overall Study|Staff error, medication not administered|0|||
164443696|NCT01124734|593992719|FG000|Overall Study|Withdrawal by Subject|1|||
164443697|NCT01124734|593992719|FG000|Overall Study|Elected for alternative treatment|2|||
164443698|NCT01430611|593992721|FG000|Overall Study|Adverse Event|0|||
164443699|NCT01430611|593992722|FG001|Overall Study|Adverse Event|1|||
164596734|NCT00960934|594548959|FG001|Overall Study|Lack of Efficacy|0|||
164596735|NCT00960934|594548960|FG002|Overall Study|Lack of Efficacy|0|||
164596736|NCT00960934|594548961|FG003|Overall Study|Lack of Efficacy|0|||
164596737|NCT00960934|594548962|FG004|Overall Study|Lack of Efficacy|0|||
164596738|NCT00960934|594548963|FG005|Overall Study|Lack of Efficacy|0|||
164596739|NCT00960934|594548958|FG000|Overall Study|Lost to Follow-up|0|||
164596740|NCT00960934|594548959|FG001|Overall Study|Lost to Follow-up|1|||
164596741|NCT00960934|594548960|FG002|Overall Study|Lost to Follow-up|0|||
164596742|NCT00960934|594548961|FG003|Overall Study|Lost to Follow-up|0|||
164596743|NCT00960934|594548962|FG004|Overall Study|Lost to Follow-up|0|||
164596744|NCT00960934|594548963|FG005|Overall Study|Lost to Follow-up|0|||
164596745|NCT00960934|594548958|FG000|Overall Study|Other|2|||
164596746|NCT00960934|594548959|FG001|Overall Study|Other|1|||
164596747|NCT00960934|594548960|FG002|Overall Study|Other|5|||
164596748|NCT00960934|594548961|FG003|Overall Study|Other|4|||
164596749|NCT00960934|594548962|FG004|Overall Study|Other|2|||
164596750|NCT00960934|594548963|FG005|Overall Study|Other|2|||
164596751|NCT00960934|594548958|FG000|Overall Study|Physician Decision|0|||
164596752|NCT00960934|594548959|FG001|Overall Study|Physician Decision|1|||
164596753|NCT00960934|594548960|FG002|Overall Study|Physician Decision|0|||
164596754|NCT00960934|594548961|FG003|Overall Study|Physician Decision|0|||
164596755|NCT00960934|594548962|FG004|Overall Study|Physician Decision|0|||
164596756|NCT00960934|594548963|FG005|Overall Study|Physician Decision|0|||
164402698|NCT01235546|593842098|FG000|Overall Study|Protocol Violation|1|||
164402699|NCT01235546|593842099|FG001|Overall Study|Protocol Violation|1|||
164402700|NCT02230956|593842102|FG000|Overall Study|Adverse Event|1|||
164402701|NCT02230956|593842103|FG001|Overall Study|Adverse Event|1|||
164402702|NCT02230956|593842104|FG002|Overall Study|Adverse Event|0|||
164402703|NCT02230956|593842102|FG000|Overall Study|Lack of Efficacy|1|||
164402704|NCT02230956|593842103|FG001|Overall Study|Lack of Efficacy|1|||
164402705|NCT02230956|593842104|FG002|Overall Study|Lack of Efficacy|1|||
164402706|NCT02230956|593842102|FG000|Overall Study|Lost to Follow-up|1|||
164402707|NCT02230956|593842103|FG001|Overall Study|Lost to Follow-up|1|||
164402708|NCT02230956|593842104|FG002|Overall Study|Lost to Follow-up|2|||
164402709|NCT02230956|593842102|FG000|Overall Study|Personal Reasons|2|||
164402710|NCT02230956|593842103|FG001|Overall Study|Personal Reasons|1|||
164402711|NCT02230956|593842104|FG002|Overall Study|Personal Reasons|1|||
164402712|NCT02230956|593842102|FG000|Overall Study|Protocol Violation|0|||
164402713|NCT02230956|593842103|FG001|Overall Study|Protocol Violation|1|||
164402714|NCT02230956|593842104|FG002|Overall Study|Protocol Violation|1|||
164402715|NCT02230956|593842102|FG000|Overall Study|Other Miscellaneous Reason|0|||
164402716|NCT02230956|593842103|FG001|Overall Study|Other Miscellaneous Reason|1|||
164402717|NCT02230956|593842104|FG002|Overall Study|Other Miscellaneous Reason|2|||
164402718|NCT01445652|593842105|FG000|Overall Study|Not comfortable in lenses|5|||
164402719|NCT01445652|593842106|FG001|Overall Study|Not comfortable in lenses|0|||
164402720|NCT01445652|593842105|FG000|Overall Study|Failed to attend scheduled visit|2|||
164402721|NCT01445652|593842106|FG001|Overall Study|Failed to attend scheduled visit|3|||
164402722|NCT01445652|593842105|FG000|Overall Study|Failed teach session|2|||
164402723|NCT01445652|593842106|FG001|Overall Study|Failed teach session|0|||
164402724|NCT01445652|593842105|FG000|Overall Study|Adverse Event|1|||
164402725|NCT01445652|593842106|FG001|Overall Study|Adverse Event|0|||
164402726|NCT03002610|593842107|FG000|Overall Study|Withdrawal by Subject|6|||
164402727|NCT03002610|593842108|FG001|Overall Study|Withdrawal by Subject|25|||
164402728|NCT03002610|593842109|FG002|Overall Study|Withdrawal by Subject|13|||
164402729|NCT00929162|593842110|FG000|Overall Study|Adverse Event|8|||
164402730|NCT00929162|593842111|FG001|Overall Study|Adverse Event|5|||
164402731|NCT00929162|593842110|FG000|Overall Study|Withdrawal by Subject|3|||
164402732|NCT00929162|593842111|FG001|Overall Study|Withdrawal by Subject|1|||
164402733|NCT00929162|593842110|FG000|Overall Study|Protocol Violation|32|||
164402734|NCT00929162|593842111|FG001|Overall Study|Protocol Violation|30|||
164402735|NCT00929162|593842110|FG000|Overall Study|Other termination reason|5|||
164402736|NCT00929162|593842111|FG001|Overall Study|Other termination reason|6|||
164402737|NCT01822587|593842112|FG000|Overall Study|Lost to Follow-up|7|||
164402738|NCT01822587|593842113|FG001|Overall Study|Lost to Follow-up|9|||
164402739|NCT01822587|593842114|FG002|Overall Study|Lost to Follow-up|12|||
164402740|NCT01822587|593842112|FG000|Overall Study|Physician Decision|9|||
164402741|NCT01822587|593842113|FG001|Overall Study|Physician Decision|6|||
164402742|NCT01822587|593842114|FG002|Overall Study|Physician Decision|6|||
164402743|NCT00658567|593842116|FG000|Overall Study|Adverse Event|5|||
164402744|NCT00658567|593842117|FG001|Overall Study|Adverse Event|2|||
164402745|NCT00658567|593842118|FG002|Overall Study|Adverse Event|3|||
164402746|NCT00658567|593842116|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
164402747|NCT00658567|593842117|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
164402748|NCT00658567|593842118|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
164402749|NCT00658567|593842116|FG000|Overall Study|Physician Decision|0|||
164402750|NCT00658567|593842117|FG001|Overall Study|Physician Decision|1|||
164402751|NCT00658567|593842118|FG002|Overall Study|Physician Decision|0|||
164402752|NCT00658567|593842116|FG000|Overall Study|At Discretion of Sponsor|1|||
164402753|NCT00658567|593842117|FG001|Overall Study|At Discretion of Sponsor|1|||
164402754|NCT00658567|593842118|FG002|Overall Study|At Discretion of Sponsor|1|||
164402755|NCT01755702|593842119|FG000|Wash Out Period I|Other Reason|3|||
164402756|NCT01755702|593842119|FG000|Washout Period II|Other Reason|5|||
164402757|NCT04860518|593842121|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
164443700|NCT01430611|593992721|FG000|Overall Study|Protocol Violation|1|||
164443701|NCT01430611|593992722|FG001|Overall Study|Protocol Violation|0|||
164596757|NCT00960934|594548958|FG000|Overall Study|Progressive Disease|1|||
164596758|NCT00960934|594548959|FG001|Overall Study|Progressive Disease|1|||
164402758|NCT04860518|593842122|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
164402759|NCT02355743|593842125|FG000|Overall Study|Withdrawal by Subject|1|||
164402760|NCT02355743|593842125|FG000|Overall Study|Lost to Follow-up|1|||
164402761|NCT02279043|593842129|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
164402762|NCT02279043|593842130|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
164596759|NCT00960934|594548960|FG002|Overall Study|Progressive Disease|0|||
164443702|NCT01430611|593992721|FG000|Overall Study|Lost to Follow-up|1|||
164443703|NCT01430611|593992722|FG001|Overall Study|Lost to Follow-up|0|||
164443704|NCT01430611|593992721|FG000|Overall Study|Withdrawal by Subject|15|||
164443705|NCT01430611|593992722|FG001|Overall Study|Withdrawal by Subject|14|||
164443706|NCT00939510|593992723|FG000|Overall Study|Withdrawal by Subject|1|||
164443707|NCT02115139|593992724|FG000|Overall Study|Protocol Violation|1|||
164443708|NCT02115139|593992724|FG000|Overall Study|treatment discontinuation|6|||
164443709|NCT04740164|593992725|FG000|Overall Study|Lack of Efficacy|4|||
164443710|NCT04740164|593992726|FG001|Overall Study|Lack of Efficacy|0|||
164443711|NCT04740164|593992725|FG000|Overall Study|Physician Decision|3|||
164443712|NCT04740164|593992726|FG001|Overall Study|Physician Decision|3|||
164443713|NCT00258895|593992732|FG000|Overall Study|Lost to Follow-up|3|||
164443714|NCT00258895|593992733|FG001|Overall Study|Lost to Follow-up|1|||
164443715|NCT00258895|593992732|FG000|Overall Study|Protocol Violation|6|||
164443716|NCT00258895|593992733|FG001|Overall Study|Protocol Violation|2|||
164443717|NCT00258895|593992732|FG000|Overall Study|Withdrawal by Subject|1|||
164443718|NCT00258895|593992733|FG001|Overall Study|Withdrawal by Subject|0|||
164443719|NCT00442117|593992734|FG000|Overall Study|Adverse Event|3|||
164443720|NCT00442117|593992735|FG001|Overall Study|Adverse Event|2|||
164443721|NCT00442117|593992734|FG000|Overall Study|Lack of Efficacy|2|||
164443722|NCT00442117|593992735|FG001|Overall Study|Lack of Efficacy|6|||
164443723|NCT00442117|593992734|FG000|Overall Study|Lost to Follow-up|1|||
164443724|NCT00442117|593992735|FG001|Overall Study|Lost to Follow-up|2|||
164443725|NCT00442117|593992734|FG000|Overall Study|Withdrawal by Subject|2|||
164443726|NCT00442117|593992735|FG001|Overall Study|Withdrawal by Subject|2|||
164443727|NCT00442117|593992734|FG000|Overall Study|Major Deviation|25|||
164443728|NCT00442117|593992735|FG001|Overall Study|Major Deviation|20|||
164443729|NCT00442117|593992734|FG000|Overall Study|Non compliance with protocol|3|||
164443730|NCT00442117|593992735|FG001|Overall Study|Non compliance with protocol|5|||
164443731|NCT00442117|593992734|FG000|Overall Study|Met Withdrawal Criteria|2|||
164443732|NCT00442117|593992735|FG001|Overall Study|Met Withdrawal Criteria|1|||
164443733|NCT00305695|593992744|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
164443734|NCT00305695|593992745|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
164443735|NCT00305695|593992744|FG000|Overall Study|Did not have baseline scan|1|||
164443736|NCT00305695|593992745|FG001|Overall Study|Did not have baseline scan|1|||
164443737|NCT01121549|593992747|FG000|Overall Study|Adverse Event|10|||
164443738|NCT01121549|593992747|FG000|Overall Study|Lack of Efficacy|11|||
164443739|NCT01121549|593992747|FG000|Overall Study|Lost to Follow-up|12|||
164443740|NCT01121549|593992747|FG000|Overall Study|Did not meet entrance criteria|9|||
164443741|NCT01121549|593992747|FG000|Overall Study|Study terminated by sponsor|197|||
164443742|NCT01121549|593992747|FG000|Overall Study|Pregnancy|1|||
164443743|NCT01121549|593992747|FG000|Overall Study|Protocol Violation|33|||
164443744|NCT01121549|593992747|FG000|Overall Study|Withdrawal by Subject|16|||
164443745|NCT01121549|593992747|FG000|Overall Study|Other|58|||
164443746|NCT04411056|593994531|FG000|Overall Study|surgery cancelled|1|||
164443747|NCT04411056|593994532|FG001|Overall Study|surgery cancelled|0|||
164443748|NCT04411056|593994531|FG000|Overall Study|Equipment problem during intubation|0|||
164443749|NCT04411056|593994532|FG001|Overall Study|Equipment problem during intubation|1|||
164443750|NCT04623008|593994533|FG000|Baseline to T2|Withdrawal by Subject|4|||
164443751|NCT04623008|593994534|FG001|Baseline to T2|Withdrawal by Subject|2|||
164443752|NCT04623008|593994533|FG000|Baseline to T3|Withdrawal by Subject|4|||
164443753|NCT04623008|593994534|FG001|Baseline to T3|Withdrawal by Subject|2|||
164443754|NCT03122886|593994546|FG000|Overall Study|Withdrawal by Subject|1|||
164443755|NCT03122886|593994547|FG001|Overall Study|Withdrawal by Subject|2|||
164443756|NCT05985044|593994552|FG000|Overall Study|Death|6|||
164443757|NCT05985044|593994552|FG000|Overall Study|Lost to Follow-up|4|||
164443758|NCT05985044|593994552|FG000|Overall Study|Incapacitation|3|||
164443759|NCT05985044|593994552|FG000|Overall Study|Withdrawal by Subject|2|||
164443760|NCT02279095|593994556|FG000|Overall Study|Non-Compliance|1|||
164443761|NCT02279095|593994556|FG000|Overall Study|Withdrawal by Subject|8|||
164443762|NCT02279095|593994556|FG000|Overall Study|Adverse Event|2|||
164443763|NCT02279095|593994556|FG000|Overall Study|Other|7|||
164596760|NCT00960934|594548961|FG003|Overall Study|Progressive Disease|0|||
164596761|NCT00960934|594548962|FG004|Overall Study|Progressive Disease|1|||
164596762|NCT00960934|594548963|FG005|Overall Study|Progressive Disease|1|||
164596763|NCT00960934|594548958|FG000|Overall Study|Protocol Violation|3|||
164596764|NCT00960934|594548959|FG001|Overall Study|Protocol Violation|4|||
164443764|NCT02279095|593994556|FG000|Overall Study|Lost to Follow-up|1|||
164443765|NCT05938413|593994557|FG000|Overall Study|Lost to Follow-up|1|||
164443766|NCT05938413|593994558|FG001|Overall Study|Lost to Follow-up|7|||
164443767|NCT05938413|593994557|FG000|Overall Study|Withdrawal by Subject|1|||
164443768|NCT05938413|593994558|FG001|Overall Study|Withdrawal by Subject|1|||
164443769|NCT03312907|593994559|FG000|Overall Study|Adverse Event|1|||
164443770|NCT03312907|593994560|FG001|Overall Study|Adverse Event|6|||
164443771|NCT03312907|593994561|FG002|Overall Study|Adverse Event|1|||
164443772|NCT03312907|593994559|FG000|Overall Study|Protocol Violation|2|||
164402763|NCT02279043|593842131|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
164402764|NCT02279043|593842129|FG000|Overall Study|Lost to Follow-up|46|||
164402765|NCT02279043|593842130|FG001|Overall Study|Lost to Follow-up|88|||
164402766|NCT02279043|593842131|FG002|Overall Study|Lost to Follow-up|0|||
164402767|NCT00490282|593842132|FG000|Overall Study|Withdrawal by Subject|3|||
164402768|NCT01860703|593842137|FG000|Overall Study|Adverse Event|1|||
164402769|NCT01860703|593842138|FG001|Overall Study|Adverse Event|4|||
164402770|NCT01860703|593842139|FG002|Overall Study|Adverse Event|0|||
164402771|NCT01860703|593842140|FG003|Overall Study|Adverse Event|2|||
164402772|NCT01860703|593842137|FG000|Overall Study|Withdrawal by Subject|0|||
164402773|NCT01860703|593842138|FG001|Overall Study|Withdrawal by Subject|1|||
164402774|NCT01860703|593842139|FG002|Overall Study|Withdrawal by Subject|0|||
164402775|NCT01860703|593842140|FG003|Overall Study|Withdrawal by Subject|0|||
164402776|NCT01860703|593842137|FG000|Overall Study|Personal reason|1|||
164402777|NCT01860703|593842138|FG001|Overall Study|Personal reason|0|||
164402778|NCT01860703|593842139|FG002|Overall Study|Personal reason|1|||
164402779|NCT01860703|593842140|FG003|Overall Study|Personal reason|0|||
164402780|NCT06213701|593842142|FG000|Overall Study|Withdrawal by Subject|2|||
164402781|NCT06213701|593842143|FG001|Overall Study|Withdrawal by Subject|1|||
164402782|NCT06213701|593842144|FG002|Overall Study|Withdrawal by Subject|0|||
164402783|NCT00538590|593842145|FG000|Overall Study|Death|1|||
164402784|NCT00538590|593842146|FG001|Overall Study|Death|0|||
164402785|NCT00374322|593842150|FG000|Overall Study|Lost to Follow-up|92|||
164402786|NCT00374322|593842151|FG001|Overall Study|Lost to Follow-up|90|||
164402787|NCT00374322|593842150|FG000|Overall Study|Protocol Violation|8|||
164402788|NCT00374322|593842151|FG001|Overall Study|Protocol Violation|3|||
164402789|NCT00374322|593842150|FG000|Overall Study|Withdrawal by Subject|235|||
164402790|NCT00374322|593842151|FG001|Overall Study|Withdrawal by Subject|167|||
164402791|NCT00374322|593842150|FG000|Overall Study|Sponsor Terminated Study|866|||
164402792|NCT00374322|593842151|FG001|Overall Study|Sponsor Terminated Study|990|||
164402793|NCT00374322|593842150|FG000|Overall Study|Physician Decision|36|||
164402794|NCT00374322|593842151|FG001|Overall Study|Physician Decision|32|||
164402795|NCT00374322|593842150|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
164402796|NCT00374322|593842151|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
164402797|NCT00374322|593842150|FG000|Overall Study|Sponsor Decision|2|||
164402798|NCT00374322|593842151|FG001|Overall Study|Sponsor Decision|3|||
164402799|NCT00374322|593842150|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
164402800|NCT00374322|593842151|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
164402801|NCT00374322|593842150|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
164402802|NCT00374322|593842151|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
164402803|NCT00374322|593842150|FG000|Overall Study|Severe Toxicity|1|||
164402804|NCT00374322|593842151|FG001|Overall Study|Severe Toxicity|0|||
164402805|NCT00374322|593842150|FG000|Overall Study|Site Closed|2|||
164402806|NCT00374322|593842151|FG001|Overall Study|Site Closed|2|||
164402807|NCT00374322|593842150|FG000|Overall Study|Participant Changed Physician|1|||
164402808|NCT00374322|593842151|FG001|Overall Study|Participant Changed Physician|0|||
164402809|NCT00374322|593842150|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
164402810|NCT00374322|593842151|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
164402811|NCT00374322|593842150|FG000|Overall Study|Noncompliance with Study Requirements|0|||
164402812|NCT00374322|593842151|FG001|Overall Study|Noncompliance with Study Requirements|1|||
164402813|NCT00374322|593842150|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
164402814|NCT00374322|593842151|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
164402815|NCT00374322|593842150|FG000|Overall Study|Did Not Receive Study Medication|8|||
164402816|NCT00374322|593842151|FG001|Overall Study|Did Not Receive Study Medication|6|||
164402817|NCT00636610|593842155|FG000|Overall Study|Adverse Event|4|||
164402818|NCT00636610|593842156|FG001|Overall Study|Adverse Event|4|||
164402819|NCT00636610|593842155|FG000|Overall Study|Death|6|||
164402820|NCT00636610|593842156|FG001|Overall Study|Death|3|||
164402821|NCT00636610|593842155|FG000|Overall Study|Physician decision to withdraw patient|15|||
164402822|NCT00636610|593842156|FG001|Overall Study|Physician decision to withdraw patient|9|||
164402823|NCT00636610|593842155|FG000|Overall Study|Subject decision to withdraw|15|||
164402824|NCT00636610|593842156|FG001|Overall Study|Subject decision to withdraw|11|||
164402825|NCT00636610|593842155|FG000|Overall Study|Disease progression - radiographic|41|||
164402826|NCT00636610|593842156|FG001|Overall Study|Disease progression - radiographic|51|||
164402827|NCT00636610|593842155|FG000|Overall Study|Disease progression - clinical|8|||
164402828|NCT00636610|593842156|FG001|Overall Study|Disease progression - clinical|3|||
164402829|NCT00636610|593842155|FG000|Overall Study|Reason for discontinuation not available|3|||
164402830|NCT00636610|593842156|FG001|Overall Study|Reason for discontinuation not available|2|||
164402831|NCT02495025|593842157|FG000|Overall Study|Lost to Follow-up|21|||
164402832|NCT02495025|593842158|FG001|Overall Study|Lost to Follow-up|14|||
164402833|NCT02495025|593842157|FG000|Overall Study|Withdrawal by Subject|5|||
164402834|NCT02495025|593842158|FG001|Overall Study|Withdrawal by Subject|0|||
164402835|NCT00313820|593842159|FG000|Assigned to Treatment|Other|1|||
164402836|NCT00313820|593842160|FG001|Assigned to Treatment|Other|0|||
164402837|NCT00313820|593842159|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
164402838|NCT00313820|593842160|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
164402839|NCT00313820|593842159|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
164402840|NCT00313820|593842160|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
164402841|NCT00313820|593842159|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
164402842|NCT00313820|593842160|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
164402843|NCT00313820|593842159|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
164402844|NCT00313820|593842160|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
164402845|NCT00313820|593842159|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
164402846|NCT00313820|593842160|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
164402847|NCT01169675|593842165|FG000|Overall Study|Progressive disease|13|||
164402848|NCT01169675|593842166|FG001|Overall Study|Progressive disease|2|||
164402849|NCT01169675|593842167|FG002|Overall Study|Progressive disease|5|||
164402850|NCT01169675|593842168|FG003|Overall Study|Progressive disease|15|||
164402851|NCT01169675|593842169|FG004|Overall Study|Progressive disease|1|||
164402852|NCT01169675|593842165|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
164402853|NCT01169675|593842166|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164402854|NCT01169675|593842167|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164402855|NCT01169675|593842168|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164402856|NCT01169675|593842169|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
164402857|NCT01169675|593842165|FG000|Overall Study|Adverse Event|5|||
164402858|NCT01169675|593842166|FG001|Overall Study|Adverse Event|1|||
164402859|NCT01169675|593842167|FG002|Overall Study|Adverse Event|2|||
164402860|NCT01169675|593842168|FG003|Overall Study|Adverse Event|0|||
164402861|NCT01169675|593842169|FG004|Overall Study|Adverse Event|0|||
164402862|NCT01169675|593842165|FG000|Overall Study|Withdrawal by Subject|1|||
164402863|NCT01169675|593842166|FG001|Overall Study|Withdrawal by Subject|0|||
164402864|NCT01169675|593842167|FG002|Overall Study|Withdrawal by Subject|0|||
164402865|NCT01169675|593842168|FG003|Overall Study|Withdrawal by Subject|1|||
164402866|NCT01169675|593842169|FG004|Overall Study|Withdrawal by Subject|2|||
164402867|NCT01169675|593842165|FG000|Overall Study|Other Reason Not Defined Above|0|||
164402868|NCT01169675|593842166|FG001|Overall Study|Other Reason Not Defined Above|0|||
164402869|NCT01169675|593842167|FG002|Overall Study|Other Reason Not Defined Above|0|||
164402870|NCT01169675|593842168|FG003|Overall Study|Other Reason Not Defined Above|1|||
164402871|NCT01169675|593842169|FG004|Overall Study|Other Reason Not Defined Above|1|||
164402872|NCT04102579|593842170|FG000|Overall Study|Withdrawal by Subject|3|||
164402873|NCT04102579|593842171|FG001|Overall Study|Withdrawal by Subject|4|||
164402874|NCT04102579|593842170|FG000|Overall Study|Lost to Follow-up|0|||
164402875|NCT04102579|593842171|FG001|Overall Study|Lost to Follow-up|1|||
164402876|NCT04102579|593842170|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
164402877|NCT04102579|593842171|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
164402878|NCT04102579|593842170|FG000|Overall Study|Other than Specified|1|||
164402879|NCT04102579|593842171|FG001|Overall Study|Other than Specified|0|||
164402880|NCT04102579|593842170|FG000|Overall Study|Not Dosed with Study Drug|0|||
164402881|NCT04102579|593842171|FG001|Overall Study|Not Dosed with Study Drug|1|||
164402882|NCT00572195|593842172|FG000|Overall Study|Withdrawal by Subject|50|||
164402883|NCT00572195|593842172|FG000|Overall Study|Death|9|||
164402884|NCT00572195|593842172|FG000|Overall Study|Adverse Event|4|||
164402885|NCT00572195|593842172|FG000|Overall Study|Lost to Follow-up|5|||
164402886|NCT04120233|593842173|FG000|Overall Study|Adverse Event|0|||
164402887|NCT04120233|593842174|FG001|Overall Study|Adverse Event|0|||
164402888|NCT04120233|593842175|FG002|Overall Study|Adverse Event|0|||
164402889|NCT04120233|593842176|FG003|Overall Study|Adverse Event|0|||
164402890|NCT04120233|593842177|FG004|Overall Study|Adverse Event|1|||
164402891|NCT04120233|593842178|FG005|Overall Study|Adverse Event|0|||
164402892|NCT05178121|593844200|FG000|Overall Study|Other|4|||
164402893|NCT05178121|593844200|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
164402894|NCT00949884|593844201|FG000|Overall Study|Adverse Event|14|||
164402895|NCT00949884|593844202|FG001|Overall Study|Adverse Event|3|||
164402896|NCT00949884|593844203|FG002|Overall Study|Adverse Event|12|||
164402897|NCT00949884|593844201|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
164402898|NCT00949884|593844202|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
164402899|NCT00949884|593844203|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
164402900|NCT00949884|593844201|FG000|Overall Study|Lost to Follow-up|7|||
164402901|NCT00949884|593844202|FG001|Overall Study|Lost to Follow-up|5|||
164402902|NCT00949884|593844203|FG002|Overall Study|Lost to Follow-up|5|||
164402903|NCT00949884|593844201|FG000|Overall Study|Physician Decision|5|||
164402904|NCT00949884|593844202|FG001|Overall Study|Physician Decision|0|||
164402905|NCT00949884|593844203|FG002|Overall Study|Physician Decision|6|||
164402906|NCT00949884|593844201|FG000|Overall Study|Treatment non-compliance|5|||
164402907|NCT00949884|593844202|FG001|Overall Study|Treatment non-compliance|0|||
164402908|NCT00949884|593844203|FG002|Overall Study|Treatment non-compliance|8|||
164443773|NCT03312907|593994560|FG001|Overall Study|Protocol Violation|3|||
164443774|NCT03312907|593994561|FG002|Overall Study|Protocol Violation|4|||
164706077|NCT05327816|594953352|FG001|Overall Study|Withdrawal by Subject|0|||
164706078|NCT05327816|594953353|FG002|Overall Study|Withdrawal by Subject|0|||
164706079|NCT05327816|594953354|FG003|Overall Study|Withdrawal by Subject|0|||
164706080|NCT05327816|594953355|FG004|Overall Study|Withdrawal by Subject|1|||
164706081|NCT05327816|594953356|FG005|Overall Study|Withdrawal by Subject|1|||
164706082|NCT05327816|594953357|FG006|Overall Study|Withdrawal by Subject|0|||
164706083|NCT05327816|594953358|FG007|Overall Study|Withdrawal by Subject|0|||
164402909|NCT00949884|593844201|FG000|Overall Study|Withdrawal by Subject|13|||
164402910|NCT00949884|593844202|FG001|Overall Study|Withdrawal by Subject|4|||
164402911|NCT00949884|593844203|FG002|Overall Study|Withdrawal by Subject|16|||
164402912|NCT00949884|593844201|FG000|Overall Study|Lack of Efficacy|4|||
164402913|NCT00949884|593844202|FG001|Overall Study|Lack of Efficacy|2|||
164402914|NCT00949884|593844203|FG002|Overall Study|Lack of Efficacy|7|||
164402915|NCT00949884|593844201|FG000|Overall Study|Study terminated by sponsor|0|||
164402916|NCT00949884|593844202|FG001|Overall Study|Study terminated by sponsor|0|||
164402917|NCT00949884|593844203|FG002|Overall Study|Study terminated by sponsor|1|||
164402918|NCT01953003|593844204|FG000|Overall Study|Not treated|0|||
164402919|NCT01953003|593844205|FG001|Overall Study|Not treated|1|||
164402920|NCT01953003|593844204|FG000|Overall Study|Progressive disease|35|||
164402921|NCT01953003|593844205|FG001|Overall Study|Progressive disease|45|||
164402922|NCT01953003|593844204|FG000|Overall Study|Related Adverse events|7|||
164402923|NCT01953003|593844205|FG001|Overall Study|Related Adverse events|2|||
164402924|NCT01953003|593844204|FG000|Overall Study|Non-related adverse events|0|||
164402925|NCT01953003|593844205|FG001|Overall Study|Non-related adverse events|2|||
164402926|NCT01953003|593844204|FG000|Overall Study|Protocol Violation|0|||
164402927|NCT01953003|593844205|FG001|Overall Study|Protocol Violation|1|||
164402928|NCT01953003|593844204|FG000|Overall Study|Withdrawal by Subject|14|||
164402929|NCT01953003|593844205|FG001|Overall Study|Withdrawal by Subject|4|||
164402930|NCT00553501|593844212|FG000|Overall Study|Adverse Event|2|||
164402931|NCT00553501|593844212|FG000|Overall Study|Death|1|||
164402932|NCT00553501|593844212|FG000|Overall Study|Progression|1|||
164402933|NCT00949715|593844216|FG000|Overall Study|Physician Decision|1|||
164402934|NCT00949715|593844217|FG001|Overall Study|Physician Decision|0|||
164402935|NCT00949715|593844216|FG000|Overall Study|Lost to Follow-up|1|||
164402936|NCT00949715|593844217|FG001|Overall Study|Lost to Follow-up|0|||
164402937|NCT00949715|593844216|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
164402938|NCT00949715|593844217|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
164402939|NCT03391765|593844220|FG000|Overall Study|Adverse Event|2|||
164402940|NCT03391765|593844221|FG001|Overall Study|Adverse Event|0|||
164402941|NCT03391765|593844222|FG002|Overall Study|Adverse Event|0|||
164402942|NCT03391765|593844223|FG003|Overall Study|Adverse Event|2|||
164402943|NCT03391765|593844220|FG000|Overall Study|Withdrew consent|5|||
164402944|NCT03391765|593844221|FG001|Overall Study|Withdrew consent|7|||
164402945|NCT03391765|593844222|FG002|Overall Study|Withdrew consent|2|||
164402946|NCT03391765|593844223|FG003|Overall Study|Withdrew consent|5|||
164402947|NCT03391765|593844220|FG000|Overall Study|Other, not specified|44|||
164402948|NCT03391765|593844221|FG001|Overall Study|Other, not specified|38|||
164402949|NCT03391765|593844222|FG002|Overall Study|Other, not specified|21|||
164402950|NCT03391765|593844223|FG003|Overall Study|Other, not specified|16|||
164402951|NCT00662857|593844228|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
164402952|NCT00662857|593844229|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
164402953|NCT00662857|593844228|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
164402954|NCT00662857|593844229|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
164402955|NCT00662857|593844228|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
164402956|NCT00662857|593844229|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
164402957|NCT03966053|593844232|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
164402958|NCT02832622|593844234|FG000|Overall Study|MPP not programmed|1259|||
164402959|NCT02832622|593844234|FG000|Overall Study|Withdrawal by Subject|123|||
164402960|NCT02832622|593844234|FG000|Overall Study|Death|119|||
164402961|NCT02832622|593844234|FG000|Overall Study|Unsuccessful CRT implant|93|||
164402962|NCT02832622|593844234|FG000|Overall Study|Lost to Follow-up|45|||
164402963|NCT02832622|593844234|FG000|Overall Study|Patient non-compliance|42|||
164402964|NCT02832622|593844234|FG000|Overall Study|Withdrawal by other reasons|25|||
164402965|NCT02832622|593844234|FG000|Overall Study|System explant|24|||
164402966|NCT02832622|593844234|FG000|Overall Study|Physician Decision|6|||
164706084|NCT05327816|594953359|FG008|Overall Study|Withdrawal by Subject|0|||
164402967|NCT00998400|593844235|FG000|Overall Study|Lack of interest/motivation|1|||
164402968|NCT00998400|593844236|FG001|Overall Study|Lack of interest/motivation|2|||
164402969|NCT00998400|593844235|FG000|Overall Study|Logistical problems|1|||
164402970|NCT00998400|593844236|FG001|Overall Study|Logistical problems|0|||
164402971|NCT00800202|593844238|FG000|Overall Study|Adverse Event|7|||
164402972|NCT00800202|593844239|FG001|Overall Study|Adverse Event|6|||
164402973|NCT00800202|593844238|FG000|Overall Study|Death|1|||
164402974|NCT00800202|593844239|FG001|Overall Study|Death|0|||
164402975|NCT00800202|593844238|FG000|Overall Study|Other|5|||
164402976|NCT00800202|593844239|FG001|Overall Study|Other|0|||
164402977|NCT00800202|593844238|FG000|Overall Study|Disease Progression|54|||
164402978|NCT00800202|593844239|FG001|Overall Study|Disease Progression|18|||
164402979|NCT02364180|593844240|FG000|Overall Study|Screen Fail|1|||
164402980|NCT01783418|593844241|FG000|Overall Study|Withdrawal by Subject|1|||
164402981|NCT01783418|593844242|FG001|Overall Study|Withdrawal by Subject|0|||
164402982|NCT02691182|593844243|FG000|Overall Study|Withdrawal by Subject|4|||
164402983|NCT02691182|593844244|FG001|Overall Study|Withdrawal by Subject|7|||
164402984|NCT02691182|593844245|FG002|Overall Study|Withdrawal by Subject|6|||
164402985|NCT02691182|593844246|FG003|Overall Study|Withdrawal by Subject|8|||
164402986|NCT02691182|593844243|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
164402987|NCT02691182|593844244|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
164402988|NCT02691182|593844245|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
164402989|NCT02691182|593844246|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
164402990|NCT02691182|593844243|FG000|Overall Study|Lost to Follow-up|8|||
164402991|NCT02691182|593844244|FG001|Overall Study|Lost to Follow-up|33|||
164402992|NCT02691182|593844245|FG002|Overall Study|Lost to Follow-up|19|||
164402993|NCT02691182|593844246|FG003|Overall Study|Lost to Follow-up|22|||
164402994|NCT02691182|593844243|FG000|Overall Study|Adverse Event|3|||
164402995|NCT02691182|593844244|FG001|Overall Study|Adverse Event|10|||
164402996|NCT02691182|593844245|FG002|Overall Study|Adverse Event|10|||
164402997|NCT02691182|593844246|FG003|Overall Study|Adverse Event|11|||
164402998|NCT02691182|593844243|FG000|Overall Study|Physician Decision|3|||
164402999|NCT02691182|593844244|FG001|Overall Study|Physician Decision|7|||
164403000|NCT02691182|593844245|FG002|Overall Study|Physician Decision|14|||
164403001|NCT02691182|593844246|FG003|Overall Study|Physician Decision|8|||
164403002|NCT02691182|593844243|FG000|Overall Study|Lack of Efficacy|0|||
164403003|NCT02691182|593844244|FG001|Overall Study|Lack of Efficacy|0|||
164403004|NCT02691182|593844245|FG002|Overall Study|Lack of Efficacy|0|||
164403005|NCT02691182|593844246|FG003|Overall Study|Lack of Efficacy|4|||
164403006|NCT02691182|593844243|FG000|Overall Study|Protocol Violation|2|||
164403007|NCT02691182|593844244|FG001|Overall Study|Protocol Violation|6|||
164403008|NCT02691182|593844245|FG002|Overall Study|Protocol Violation|6|||
164403009|NCT02691182|593844246|FG003|Overall Study|Protocol Violation|8|||
164403010|NCT02691182|593844243|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
164403011|NCT02691182|593844244|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
164403012|NCT02691182|593844245|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
164403013|NCT02691182|593844246|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
164403014|NCT02691182|593844243|FG000|Overall Study|Missing|0|||
164403015|NCT02691182|593844244|FG001|Overall Study|Missing|5|||
164403016|NCT02691182|593844245|FG002|Overall Study|Missing|1|||
164403017|NCT02691182|593844246|FG003|Overall Study|Missing|5|||
164403018|NCT00105235|593844247|FG000|Overall Study|Death|4|||
164403019|NCT00105235|593844247|FG000|Overall Study|Physician Decision|1|||
164403020|NCT00105235|593844247|FG000|Overall Study|Withdrawal by Subject|2|||
164403021|NCT02052310|593844248|FG000|Overall Study|Death|64|||
164403022|NCT02052310|593844249|FG001|Overall Study|Death|54|||
164403023|NCT02052310|593844248|FG000|Overall Study|Withdrawal by Subject|37|||
164403024|NCT02052310|593844249|FG001|Overall Study|Withdrawal by Subject|49|||
164403025|NCT02052310|593844248|FG000|Overall Study|Other than specified|32|||
164403026|NCT02052310|593844249|FG001|Overall Study|Other than specified|29|||
164403027|NCT02052310|593844248|FG000|Overall Study|Adverse Event|29|||
164403028|NCT02052310|593844249|FG001|Overall Study|Adverse Event|22|||
164403029|NCT02052310|593844248|FG000|Overall Study|Kidney Transplant|23|||
164403030|NCT02052310|593844249|FG001|Overall Study|Kidney Transplant|29|||
164403031|NCT02052310|593844248|FG000|Overall Study|Physician Decision|14|||
164403032|NCT02052310|593844249|FG001|Overall Study|Physician Decision|7|||
164403033|NCT02052310|593844248|FG000|Overall Study|Lack of Efficacy|6|||
164403034|NCT02052310|593844249|FG001|Overall Study|Lack of Efficacy|1|||
164403035|NCT02052310|593844248|FG000|Overall Study|Site Terminated by Sponsor|5|||
164403036|NCT02052310|593844249|FG001|Overall Study|Site Terminated by Sponsor|13|||
164403037|NCT02052310|593844248|FG000|Overall Study|Lost to Follow-up|4|||
164403038|NCT02052310|593844249|FG001|Overall Study|Lost to Follow-up|2|||
164403039|NCT02052310|593844248|FG000|Overall Study|Protocol Violation|1|||
164403040|NCT02052310|593844249|FG001|Overall Study|Protocol Violation|6|||
164403041|NCT01964326|593844250|FG000|Overall Study|Adverse Event|48|||
164403042|NCT01964326|593844250|FG000|Overall Study|Death|2|||
164403043|NCT01964326|593844250|FG000|Overall Study|Protocol Violation|4|||
164403044|NCT01964326|593844250|FG000|Overall Study|Lost to Follow-up|88|||
164403045|NCT01964326|593844250|FG000|Overall Study|Withdrawal by Subject|87|||
164403046|NCT01964326|593844250|FG000|Overall Study|Pregnancy|1|||
164403047|NCT01964326|593844250|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
164403048|NCT01964326|593844250|FG000|Overall Study|Physician Decision|55|||
164403049|NCT01964326|593844250|FG000|Overall Study|Investigator Discretion|1|||
164443775|NCT03312907|593994559|FG000|Overall Study|Lost to Follow-up|2|||
164443776|NCT03312907|593994560|FG001|Overall Study|Lost to Follow-up|3|||
164443777|NCT03312907|593994561|FG002|Overall Study|Lost to Follow-up|2|||
164443778|NCT03312907|593994559|FG000|Overall Study|Physician Decision|3|||
164443779|NCT03312907|593994560|FG001|Overall Study|Physician Decision|4|||
164443780|NCT03312907|593994561|FG002|Overall Study|Physician Decision|2|||
164443781|NCT03312907|593994559|FG000|Overall Study|Withdrawal by Subject|9|||
164443782|NCT03312907|593994560|FG001|Overall Study|Withdrawal by Subject|14|||
164443783|NCT03312907|593994561|FG002|Overall Study|Withdrawal by Subject|10|||
164443784|NCT04688450|593994562|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
164443785|NCT04688450|593994562|FG000|Overall Study|Withdrawal by Subject|1|||
164443786|NCT03481777|593994567|FG000|Overall Study|Withdrawal by Subject|36|||
164443787|NCT03481777|593994568|FG001|Overall Study|Withdrawal by Subject|31|||
164443788|NCT03481777|593994567|FG000|Overall Study|Non stroke = non target population|277|||
164443789|NCT03481777|593994568|FG001|Overall Study|Non stroke = non target population|254|||
164443790|NCT03189524|593994569|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
164443791|NCT03189524|593994570|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
164443792|NCT03189524|593994571|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
164443793|NCT03189524|593994569|FG000|Overall Study|Death|2|||
164443794|NCT03189524|593994570|FG001|Overall Study|Death|2|||
164443795|NCT03189524|593994571|FG002|Overall Study|Death|1|||
164443796|NCT03189524|593994569|FG000|Overall Study|Lost to Follow-up|1|||
164443797|NCT03189524|593994570|FG001|Overall Study|Lost to Follow-up|0|||
164443798|NCT03189524|593994571|FG002|Overall Study|Lost to Follow-up|8|||
164443799|NCT03189524|593994569|FG000|Overall Study|Withdrawal by Subject|1|||
164443800|NCT03189524|593994570|FG001|Overall Study|Withdrawal by Subject|1|||
164443801|NCT03189524|593994571|FG002|Overall Study|Withdrawal by Subject|3|||
164443802|NCT03189524|593994569|FG000|Overall Study|Progressive Disease|0|||
164443803|NCT03189524|593994570|FG001|Overall Study|Progressive Disease|2|||
164443804|NCT03189524|593994571|FG002|Overall Study|Progressive Disease|0|||
164443805|NCT01780298|593994573|FG000|Overall Study|Physician Decision|1|||
164443806|NCT01780298|593994574|FG001|Overall Study|Physician Decision|5|||
164443807|NCT01780298|593994575|FG002|Overall Study|Physician Decision|1|||
164443808|NCT01780298|593994576|FG003|Overall Study|Physician Decision|1|||
164443809|NCT01780298|593994573|FG000|Overall Study|Subject not matched|1|||
164443810|NCT01780298|593994574|FG001|Overall Study|Subject not matched|0|||
164443811|NCT01780298|593994575|FG002|Overall Study|Subject not matched|1|||
164443812|NCT01780298|593994576|FG003|Overall Study|Subject not matched|0|||
164443813|NCT01780298|593994573|FG000|Overall Study|Adverse Event|0|||
164443814|NCT01780298|593994574|FG001|Overall Study|Adverse Event|0|||
164443815|NCT01780298|593994575|FG002|Overall Study|Adverse Event|2|||
164443816|NCT01780298|593994576|FG003|Overall Study|Adverse Event|0|||
164443817|NCT03613740|593994592|FG000|Overall Study|Lost to Follow-up|1|||
164443818|NCT03613740|593994593|FG001|Overall Study|Lost to Follow-up|1|||
164443819|NCT01693120|593994594|FG000|Enrollment|Lost to Follow-up|1|||
164443820|NCT01693120|593994594|FG000|Enrollment|Withdrawal by Subject|10|||
164443821|NCT01693120|593994594|FG000|Enrollment|Protocol Violation|46|||
164443822|NCT01693120|593994594|FG000|Enrollment|Physician Decision|3|||
164443823|NCT01693120|593994594|FG000|Enrollment|Adverse Event|1|||
164443824|NCT01693120|593994594|FG000|Enrollment|Study closed|8|||
164443825|NCT01693120|593994594|FG000|Enrollment|Other|1|||
164443826|NCT01693120|593994594|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
164443827|NCT01693120|593994594|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
164443828|NCT01693120|593994594|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
164443829|NCT01693120|593994594|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
164443830|NCT01693120|593994594|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
164443831|NCT02499159|593994601|FG000|Randomization|Protocol Violation|1|||
164443832|NCT02499159|593994602|FG001|Randomization|Protocol Violation|1|||
164443833|NCT02499159|593994601|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
164443834|NCT02499159|593994602|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
164443835|NCT02499159|593994601|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
164443836|NCT02499159|593994602|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
164443837|NCT02499159|593994601|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
164443838|NCT02499159|593994602|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
164443839|NCT02499159|593994601|FG000|30-Day Follow-Up Phone Call|Other|1|||
164443840|NCT02499159|593994602|FG001|30-Day Follow-Up Phone Call|Other|0|||
164443841|NCT01599793|593994603|FG000|Overall Study|Adverse Event|2|||
164443842|NCT02564744|593994604|FG000|Overall Study|Investigator decision|0|||
164443843|NCT02564744|593994605|FG001|Overall Study|Investigator decision|0|||
164443844|NCT02564744|593994606|FG002|Overall Study|Investigator decision|0|||
164443845|NCT02564744|593994607|FG003|Overall Study|Investigator decision|0|||
164443846|NCT02564744|593994608|FG004|Overall Study|Investigator decision|1|||
164443847|NCT02564744|593994604|FG000|Overall Study|Death|10|||
164443848|NCT02564744|593994605|FG001|Overall Study|Death|5|||
164443849|NCT02564744|593994606|FG002|Overall Study|Death|4|||
164443850|NCT02564744|593994607|FG003|Overall Study|Death|16|||
164443851|NCT02564744|593994608|FG004|Overall Study|Death|16|||
164443852|NCT02564744|593994604|FG000|Overall Study|End of study Page Missing|0|||
164443853|NCT02564744|593994605|FG001|Overall Study|End of study Page Missing|0|||
164443854|NCT02564744|593994606|FG002|Overall Study|End of study Page Missing|3|||
164443855|NCT02564744|593994607|FG003|Overall Study|End of study Page Missing|3|||
164443856|NCT02564744|593994608|FG004|Overall Study|End of study Page Missing|0|||
164443857|NCT02564744|593994604|FG000|Overall Study|Subject Withdrew Consent|1|||
164443858|NCT02564744|593994605|FG001|Overall Study|Subject Withdrew Consent|1|||
164443859|NCT02564744|593994606|FG002|Overall Study|Subject Withdrew Consent|1|||
164443860|NCT02564744|593994607|FG003|Overall Study|Subject Withdrew Consent|0|||
164443861|NCT02564744|593994608|FG004|Overall Study|Subject Withdrew Consent|2|||
164443862|NCT02564744|593994604|FG000|Overall Study|Lost to Follow-up|0|||
164443863|NCT02564744|593994605|FG001|Overall Study|Lost to Follow-up|1|||
164443864|NCT02564744|593994606|FG002|Overall Study|Lost to Follow-up|0|||
164443865|NCT02564744|593994607|FG003|Overall Study|Lost to Follow-up|0|||
164443866|NCT02564744|593994608|FG004|Overall Study|Lost to Follow-up|1|||
164443867|NCT02564744|593994604|FG000|Overall Study|Reason not specified|1|||
164443868|NCT02564744|593994605|FG001|Overall Study|Reason not specified|0|||
164443869|NCT02564744|593994606|FG002|Overall Study|Reason not specified|0|||
164443870|NCT02564744|593994607|FG003|Overall Study|Reason not specified|0|||
164443871|NCT02564744|593994608|FG004|Overall Study|Reason not specified|0|||
164443872|NCT02675244|593994618|FG000|Overall Study|Death|9|||
164443873|NCT02675244|593994619|FG001|Overall Study|Death|6|||
164443874|NCT02675244|593994618|FG000|Overall Study|Withdrawal by Subject|3|||
164443875|NCT02675244|593994619|FG001|Overall Study|Withdrawal by Subject|6|||
164443876|NCT02675244|593994618|FG000|Overall Study|Lost to Follow-up|1|||
164443877|NCT02675244|593994619|FG001|Overall Study|Lost to Follow-up|1|||
164443878|NCT02675244|593994618|FG000|Overall Study|Ongoing at 2 Years|190|||
164443879|NCT02675244|593994619|FG001|Overall Study|Ongoing at 2 Years|185|||
164443880|NCT02652442|593994623|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
164443881|NCT02252042|593994624|FG000|Overall Study|Adverse Event|9|||
164443882|NCT02252042|593994625|FG001|Overall Study|Adverse Event|6|||
164443883|NCT02252042|593994624|FG000|Overall Study|Death|209|||
164443884|NCT02252042|593994625|FG001|Overall Study|Death|217|||
164443885|NCT02252042|593994624|FG000|Overall Study|Physician Decision|0|||
164443886|NCT02252042|593994625|FG001|Overall Study|Physician Decision|2|||
164443887|NCT02252042|593994624|FG000|Overall Study|Transferred to Extension Study|7|||
164443888|NCT02252042|593994625|FG001|Overall Study|Transferred to Extension Study|1|||
164443889|NCT02252042|593994624|FG000|Overall Study|Did Not Continue on Extension Study|7|||
164443890|NCT02252042|593994625|FG001|Overall Study|Did Not Continue on Extension Study|2|||
164443891|NCT02252042|593994624|FG000|Overall Study|Withdrawal by Subject|15|||
164443892|NCT02252042|593994625|FG001|Overall Study|Withdrawal by Subject|20|||
164443893|NCT02593149|593994628|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
164443894|NCT02593149|593994629|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
164443895|NCT02593149|593994628|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
164443896|NCT02593149|593994629|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
164443897|NCT01177670|593994631|FG000|Overall Study|Study Terminated|115|||
164443898|NCT01177670|593994631|FG000|Overall Study|Physician Decision|50|||
164443899|NCT01177670|593994631|FG000|Overall Study|Withdrawal by Subject|4|||
164443900|NCT00979992|593994632|FG000|Overall Study|Ineligible - inadequate pathology|1|||
164443901|NCT00979992|593994632|FG000|Overall Study|Ineligible - wrong cell type|2|||
164443902|NCT00979992|593994632|FG000|Overall Study|Refused - Never Treated|2|||
164443903|NCT01140048|593994634|FG000|Overall Study|Physician Decision|1|||
164443904|NCT01140048|593994634|FG000|Overall Study|Withdrawal by Subject|13|||
164443905|NCT01140048|593994634|FG000|Overall Study|Lost to Follow-up|31|||
164443906|NCT02888080|593994635|FG000|Overall Study|Subject / Guardian decision|1|||
164443907|NCT02888080|593994636|FG001|Overall Study|Subject / Guardian decision|3|||
164443908|NCT02888080|593994635|FG000|Overall Study|New Therapy for study indication|1|||
164443909|NCT02888080|593994636|FG001|Overall Study|New Therapy for study indication|0|||
164443910|NCT02888080|593994635|FG000|Overall Study|Lack of Efficacy|0|||
164443911|NCT02888080|593994636|FG001|Overall Study|Lack of Efficacy|1|||
164443912|NCT02888080|593994635|FG000|Overall Study|Adverse Event|0|||
164443913|NCT02888080|593994636|FG001|Overall Study|Adverse Event|1|||
164443914|NCT04530747|593994638|FG000|Overall Study|Withdrawal by Subject|1|||
164443915|NCT04530747|593994639|FG001|Overall Study|Withdrawal by Subject|0|||
164443916|NCT03292913|593994640|FG000|Overall Study|Death|9|||
164443917|NCT03292913|593994641|FG001|Overall Study|Death|3|||
164443918|NCT03292913|593994640|FG000|Overall Study|Lost to Follow-up|49|||
164443919|NCT03292913|593994641|FG001|Overall Study|Lost to Follow-up|49|||
164443920|NCT03292913|593994640|FG000|Overall Study|Withdrawal by Subject|2|||
164443921|NCT03292913|593994641|FG001|Overall Study|Withdrawal by Subject|0|||
164443922|NCT03292913|593994640|FG000|Overall Study|Clinic closed due to COVID|22|||
164443923|NCT03292913|593994641|FG001|Overall Study|Clinic closed due to COVID|36|||
164443924|NCT03950622|593994642|FG000|Overall Study|Withdrawal by Subject|1|||
164443925|NCT03950622|593994643|FG001|Overall Study|Withdrawal by Subject|0|||
164443926|NCT03950622|593994642|FG000|Overall Study|Protocol Deviation|0|||
164443927|NCT03950622|593994643|FG001|Overall Study|Protocol Deviation|1|||
164443928|NCT03950622|593994642|FG000|Overall Study|Physician Decision|1|||
164443929|NCT03950622|593994643|FG001|Overall Study|Physician Decision|0|||
164443930|NCT03950622|593994642|FG000|Overall Study|Lost to Follow-up|5|||
164443931|NCT03950622|593994643|FG001|Overall Study|Lost to Follow-up|5|||
164443932|NCT03950622|593994642|FG000|Overall Study|Death|1|||
164443933|NCT03950622|593994643|FG001|Overall Study|Death|1|||
164443934|NCT03531840|593994650|FG000|Overall Study|Death on study|3|||
164443935|NCT03531840|593994651|FG001|Overall Study|Death on study|2|||
164443936|NCT03531840|593994652|FG002|Overall Study|Death on study|1|||
164443937|NCT03531840|593994653|FG003|Overall Study|Death on study|2|||
164443938|NCT03531840|593994650|FG000|Overall Study|Death during follow up|2|||
164443939|NCT03531840|593994651|FG001|Overall Study|Death during follow up|3|||
164443940|NCT03531840|593994652|FG002|Overall Study|Death during follow up|4|||
164443941|NCT03531840|593994653|FG003|Overall Study|Death during follow up|1|||
164443942|NCT02267824|593994655|FG000|Overall Study|Pregnancy|1|||
164443943|NCT02267824|593994656|FG001|Overall Study|Pregnancy|1|||
164443944|NCT02267824|593994655|FG000|Overall Study|Lost to Follow-up|4|||
164443945|NCT02267824|593994656|FG001|Overall Study|Lost to Follow-up|0|||
164443946|NCT02267824|593994655|FG000|Overall Study|Protocol Violation|3|||
164443947|NCT02267824|593994656|FG001|Overall Study|Protocol Violation|0|||
164443948|NCT02267824|593994655|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
164443949|NCT02267824|593994656|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
164443950|NCT02928224|593994657|FG000|Overall Study|Lost to Follow-up|1|||
164443951|NCT02928224|593994658|FG001|Overall Study|Lost to Follow-up|1|||
164443952|NCT02928224|593994659|FG002|Overall Study|Lost to Follow-up|3|||
164443953|NCT02928224|593994660|FG003|Overall Study|Lost to Follow-up|0|||
164443954|NCT02928224|593994657|FG000|Overall Study|Death|30|||
164443955|NCT02928224|593994658|FG001|Overall Study|Death|209|||
164443956|NCT02928224|593994659|FG002|Overall Study|Death|193|||
164443957|NCT02928224|593994660|FG003|Overall Study|Death|198|||
164443958|NCT02928224|593994657|FG000|Overall Study|Withdrawal by Subject|0|||
164443959|NCT02928224|593994658|FG001|Overall Study|Withdrawal by Subject|3|||
164443960|NCT02928224|593994659|FG002|Overall Study|Withdrawal by Subject|7|||
164443961|NCT02928224|593994660|FG003|Overall Study|Withdrawal by Subject|20|||
164443962|NCT02928224|593994657|FG000|Overall Study|Study participation terminated by sponsor|3|||
164443963|NCT02928224|593994658|FG001|Overall Study|Study participation terminated by sponsor|8|||
164443964|NCT02928224|593994659|FG002|Overall Study|Study participation terminated by sponsor|12|||
164443965|NCT02928224|593994660|FG003|Overall Study|Study participation terminated by sponsor|3|||
164443966|NCT02928224|593994657|FG000|Overall Study|Other|3|||
164443967|NCT02928224|593994658|FG001|Overall Study|Other|3|||
164443968|NCT02928224|593994659|FG002|Overall Study|Other|5|||
164443969|NCT02928224|593994660|FG003|Overall Study|Other|0|||
164443970|NCT02538107|593994661|FG000|Overall Study|Did not receive any Mircera dose|11|||
164443971|NCT02538107|593994661|FG000|Overall Study|Missing|5|||
164596765|NCT00960934|594548960|FG002|Overall Study|Protocol Violation|0|||
164596766|NCT00960934|594548961|FG003|Overall Study|Protocol Violation|3|||
164596767|NCT00960934|594548962|FG004|Overall Study|Protocol Violation|3|||
164596768|NCT00960934|594548963|FG005|Overall Study|Protocol Violation|2|||
164596769|NCT00960934|594548958|FG000|Overall Study|Withdrawal by Subject|5|||
164443972|NCT02538107|593994661|FG000|Overall Study|Necessity of dialysis|20|||
164443973|NCT02538107|593994661|FG000|Overall Study|Administration of other ESA|11|||
164443974|NCT02538107|593994661|FG000|Overall Study|No further treatment necessary|18|||
164443975|NCT02538107|593994661|FG000|Overall Study|Withdrawal by Subject|17|||
164443976|NCT02538107|593994661|FG000|Overall Study|Death|4|||
164443977|NCT02538107|593994661|FG000|Overall Study|Administrative reason|5|||
164443978|NCT02538107|593994661|FG000|Overall Study|Adverse Event|4|||
164443979|NCT02538107|593994661|FG000|Overall Study|Surgery|1|||
164443980|NCT02538107|593994661|FG000|Overall Study|Other|7|||
164443981|NCT02538107|593994661|FG000|Overall Study|Not recorded|7|||
164443982|NCT01278394|593994662|FG000|Overall Study|Lost to Follow-up|1|||
164443983|NCT02471755|593994663|FG000|Overall Study|Withdrawal by Subject|1|||
164443984|NCT02471755|593994664|FG001|Overall Study|Withdrawal by Subject|0|||
164443985|NCT02471755|593994663|FG000|Overall Study|Lost to Follow-up|0|||
164443986|NCT02471755|593994664|FG001|Overall Study|Lost to Follow-up|1|||
164443987|NCT00958633|593994667|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
164443988|NCT00958633|593994668|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
164443989|NCT00958633|593994669|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
164443990|NCT00958633|593994667|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
164596770|NCT00960934|594548959|FG001|Overall Study|Withdrawal by Subject|6|||
164596771|NCT00960934|594548960|FG002|Overall Study|Withdrawal by Subject|4|||
164596772|NCT00960934|594548961|FG003|Overall Study|Withdrawal by Subject|5|||
164144038|NCT00086281|592888577|FG006|Phase 2|Adverse Event|0|||
164443991|NCT00958633|593994668|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
164443992|NCT00958633|593994669|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
164443993|NCT00958633|593994667|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
164443994|NCT00958633|593994668|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
164596773|NCT00960934|594548962|FG004|Overall Study|Withdrawal by Subject|5|||
164443995|NCT00958633|593994669|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
164443996|NCT00958633|593994667|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
164443997|NCT00958633|593994668|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
164443998|NCT00958633|593994669|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
164443999|NCT00958633|593994667|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
164444000|NCT00958633|593994668|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
164444001|NCT00958633|593994669|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
164444002|NCT00958633|593994667|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
164444003|NCT00958633|593994668|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
164444004|NCT00958633|593994669|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
164444005|NCT00958633|593994667|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
164444006|NCT00958633|593994668|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
164444007|NCT00958633|593994669|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
164444008|NCT00094575|593994673|FG000|Overall Study|Death|146|||
164444009|NCT00094575|593994674|FG001|Overall Study|Death|146|||
164444010|NCT00794118|593994675|FG000|Overall Study|Lost to Follow-up|16|||
164444011|NCT00794118|593994675|FG000|Overall Study|Withdrawal by Subject|9|||
164444012|NCT00794118|593994675|FG000|Overall Study|Changed hospital center|2|||
164444013|NCT01597258|593994678|FG000|Overall Study|No Drug Administration|1|||
164444014|NCT04789408|593994679|FG000|Overall Study|Death|4|||
164444015|NCT04789408|593994680|FG001|Overall Study|Death|3|||
164444016|NCT04789408|593994681|FG002|Overall Study|Death|6|||
164444017|NCT04789408|593994679|FG000|Overall Study|Did not meet eligibility criteria|1|||
164444018|NCT04789408|593994680|FG001|Overall Study|Did not meet eligibility criteria|0|||
164444019|NCT04789408|593994681|FG002|Overall Study|Did not meet eligibility criteria|0|||
164444020|NCT04789408|593994679|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
164444021|NCT04789408|593994680|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
164444022|NCT04789408|593994681|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
164444023|NCT02544074|593996426|FG000|Overall Study|Withdrawal by Subject|0|||
164444024|NCT02544074|593996427|FG001|Overall Study|Withdrawal by Subject|1|||
164444025|NCT02544074|593996428|FG002|Overall Study|Withdrawal by Subject|0|||
164444026|NCT02544074|593996429|FG003|Overall Study|Withdrawal by Subject|0|||
164444027|NCT02544074|593996430|FG004|Overall Study|Withdrawal by Subject|0|||
164444028|NCT02544074|593996431|FG005|Overall Study|Withdrawal by Subject|0|||
164444029|NCT02544074|593996432|FG006|Overall Study|Withdrawal by Subject|0|||
164444030|NCT02544074|593996433|FG007|Overall Study|Withdrawal by Subject|0|||
164444031|NCT02544074|593996434|FG008|Overall Study|Withdrawal by Subject|0|||
164444032|NCT02544074|593996435|FG009|Overall Study|Withdrawal by Subject|0|||
164444033|NCT02544074|593996436|FG010|Overall Study|Withdrawal by Subject|0|||
164444034|NCT02544074|593996437|FG011|Overall Study|Withdrawal by Subject|0|||
164444035|NCT02544074|593996438|FG012|Overall Study|Withdrawal by Subject|0|||
164444036|NCT02544074|593996439|FG013|Overall Study|Withdrawal by Subject|0|||
164444037|NCT02544074|593996440|FG014|Overall Study|Withdrawal by Subject|0|||
164444038|NCT02544074|593996441|FG015|Overall Study|Withdrawal by Subject|0|||
164444039|NCT02544074|593996442|FG016|Overall Study|Withdrawal by Subject|0|||
164444040|NCT02544074|593996443|FG017|Overall Study|Withdrawal by Subject|0|||
164444041|NCT02544074|593996444|FG018|Overall Study|Withdrawal by Subject|0|||
164444042|NCT02544074|593996445|FG019|Overall Study|Withdrawal by Subject|0|||
164444043|NCT02544074|593996446|FG020|Overall Study|Withdrawal by Subject|0|||
164444044|NCT02544074|593996426|FG000|Overall Study|Tablet error|0|||
164444045|NCT02544074|593996427|FG001|Overall Study|Tablet error|0|||
164444046|NCT02544074|593996428|FG002|Overall Study|Tablet error|0|||
164444047|NCT02544074|593996429|FG003|Overall Study|Tablet error|0|||
164444048|NCT02544074|593996430|FG004|Overall Study|Tablet error|0|||
164444049|NCT02544074|593996431|FG005|Overall Study|Tablet error|1|||
164444050|NCT02544074|593996432|FG006|Overall Study|Tablet error|0|||
164444051|NCT02544074|593996433|FG007|Overall Study|Tablet error|0|||
164444052|NCT02544074|593996434|FG008|Overall Study|Tablet error|0|||
164444053|NCT02544074|593996435|FG009|Overall Study|Tablet error|1|||
164444054|NCT02544074|593996436|FG010|Overall Study|Tablet error|0|||
164444055|NCT02544074|593996437|FG011|Overall Study|Tablet error|0|||
164444056|NCT02544074|593996438|FG012|Overall Study|Tablet error|0|||
164444057|NCT02544074|593996439|FG013|Overall Study|Tablet error|0|||
164596774|NCT00960934|594548963|FG005|Overall Study|Withdrawal by Subject|7|||
164596775|NCT00960934|594548958|FG000|Overall Study|Study Terminated by Sponsor|50|||
164596776|NCT00960934|594548959|FG001|Overall Study|Study Terminated by Sponsor|46|||
164444058|NCT02544074|593996440|FG014|Overall Study|Tablet error|0|||
164444059|NCT02544074|593996441|FG015|Overall Study|Tablet error|0|||
164444060|NCT02544074|593996442|FG016|Overall Study|Tablet error|0|||
164596777|NCT00960934|594548960|FG002|Overall Study|Study Terminated by Sponsor|52|||
164444061|NCT02544074|593996443|FG017|Overall Study|Tablet error|0|||
164596778|NCT00960934|594548961|FG003|Overall Study|Study Terminated by Sponsor|50|||
164444062|NCT02544074|593996444|FG018|Overall Study|Tablet error|0|||
164444063|NCT02544074|593996445|FG019|Overall Study|Tablet error|0|||
164444064|NCT02544074|593996446|FG020|Overall Study|Tablet error|0|||
164444065|NCT05672667|593996447|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
164444066|NCT03873779|593996448|FG000|Overall Study|Withdrawal by Subject|1|||
164444067|NCT02581215|593996449|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
164444068|NCT02581215|593996450|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
164444069|NCT02581215|593996449|FG000|Overall Study|Eligibility Criteria Not Met|0|||
164444070|NCT02581215|593996450|FG001|Overall Study|Eligibility Criteria Not Met|1|||
164444071|NCT02300298|593996452|FG000|Disposition for Nintedanib|Progressive disease|10|||
164444072|NCT02300298|593996453|FG001|Disposition for Nintedanib|Progressive disease|0|||
164444073|NCT02300298|593996452|FG000|Disposition for Docetaxel|Progressive disease|0|||
164444074|NCT02300298|593996453|FG001|Disposition for Docetaxel|Progressive disease|6|||
164444075|NCT02300298|593996452|FG000|Disposition for Docetaxel|other adverse event|0|||
164444076|NCT02300298|593996453|FG001|Disposition for Docetaxel|other adverse event|4|||
164444077|NCT00774397|593996454|FG000|Overall Study|Adverse Event|1|||
164444078|NCT00774397|593996455|FG001|Overall Study|Adverse Event|3|||
164444079|NCT00774397|593996456|FG002|Overall Study|Adverse Event|16|||
164444080|NCT00774397|593996457|FG003|Overall Study|Adverse Event|8|||
164444081|NCT00774397|593996458|FG004|Overall Study|Adverse Event|8|||
164444082|NCT00774397|593996459|FG005|Overall Study|Adverse Event|3|||
164444083|NCT00774397|593996460|FG006|Overall Study|Adverse Event|16|||
164444084|NCT00774397|593996454|FG000|Overall Study|Lack of Efficacy|11|||
164444085|NCT00774397|593996455|FG001|Overall Study|Lack of Efficacy|4|||
164444086|NCT00774397|593996456|FG002|Overall Study|Lack of Efficacy|5|||
164444087|NCT00774397|593996457|FG003|Overall Study|Lack of Efficacy|3|||
164444088|NCT00774397|593996458|FG004|Overall Study|Lack of Efficacy|27|||
164444089|NCT00774397|593996459|FG005|Overall Study|Lack of Efficacy|15|||
164444090|NCT00774397|593996460|FG006|Overall Study|Lack of Efficacy|9|||
164444091|NCT00774397|593996454|FG000|Overall Study|Protocol Violation|0|||
164444092|NCT00774397|593996455|FG001|Overall Study|Protocol Violation|1|||
164444093|NCT00774397|593996456|FG002|Overall Study|Protocol Violation|3|||
164444094|NCT00774397|593996457|FG003|Overall Study|Protocol Violation|1|||
164444095|NCT00774397|593996458|FG004|Overall Study|Protocol Violation|2|||
164444096|NCT00774397|593996459|FG005|Overall Study|Protocol Violation|1|||
164444097|NCT00774397|593996460|FG006|Overall Study|Protocol Violation|0|||
164444098|NCT00774397|593996454|FG000|Overall Study|Lost to Follow-up|0|||
164444099|NCT00774397|593996455|FG001|Overall Study|Lost to Follow-up|1|||
164444100|NCT00774397|593996456|FG002|Overall Study|Lost to Follow-up|1|||
164444101|NCT00774397|593996457|FG003|Overall Study|Lost to Follow-up|1|||
164444102|NCT00774397|593996458|FG004|Overall Study|Lost to Follow-up|0|||
164444103|NCT00774397|593996459|FG005|Overall Study|Lost to Follow-up|1|||
164444104|NCT00774397|593996460|FG006|Overall Study|Lost to Follow-up|0|||
164444105|NCT00774397|593996454|FG000|Overall Study|Refused to continue trial medication|1|||
164444106|NCT00774397|593996455|FG001|Overall Study|Refused to continue trial medication|3|||
164444107|NCT00774397|593996456|FG002|Overall Study|Refused to continue trial medication|2|||
164444108|NCT00774397|593996457|FG003|Overall Study|Refused to continue trial medication|2|||
164444109|NCT00774397|593996458|FG004|Overall Study|Refused to continue trial medication|6|||
164444110|NCT00774397|593996459|FG005|Overall Study|Refused to continue trial medication|2|||
164444111|NCT00774397|593996460|FG006|Overall Study|Refused to continue trial medication|3|||
164444112|NCT00774397|593996454|FG000|Overall Study|Not treated|0|||
164444113|NCT00774397|593996455|FG001|Overall Study|Not treated|0|||
164444114|NCT00774397|593996456|FG002|Overall Study|Not treated|0|||
164444115|NCT00774397|593996457|FG003|Overall Study|Not treated|0|||
164444116|NCT00774397|593996458|FG004|Overall Study|Not treated|1|||
164444117|NCT00774397|593996459|FG005|Overall Study|Not treated|0|||
164444118|NCT00774397|593996460|FG006|Overall Study|Not treated|1|||
164444119|NCT00774397|593996454|FG000|Overall Study|Other than those stated above|1|||
164444120|NCT00774397|593996455|FG001|Overall Study|Other than those stated above|1|||
164444121|NCT00774397|593996456|FG002|Overall Study|Other than those stated above|3|||
164444122|NCT00774397|593996457|FG003|Overall Study|Other than those stated above|2|||
164444123|NCT00774397|593996458|FG004|Overall Study|Other than those stated above|2|||
164444124|NCT00774397|593996459|FG005|Overall Study|Other than those stated above|0|||
164444125|NCT00774397|593996460|FG006|Overall Study|Other than those stated above|1|||
164444126|NCT01636687|593996466|FG000|Induction Period|Withdrawal by Subject|1|||
164444127|NCT01636687|593996467|FG001|Induction Period|Withdrawal by Subject|0|||
164444128|NCT01636687|593996468|FG002|Induction Period|Withdrawal by Subject|0|||
164706085|NCT05327816|594953360|FG009|Overall Study|Withdrawal by Subject|0|||
164444129|NCT01636687|593996469|FG003|Induction Period|Withdrawal by Subject|0|||
164444130|NCT01636687|593996470|FG004|Induction Period|Withdrawal by Subject|0|||
164444131|NCT01636687|593996466|FG000|Induction Period|Adverse Event|1|||
164444132|NCT01636687|593996467|FG001|Induction Period|Adverse Event|0|||
164444133|NCT01636687|593996468|FG002|Induction Period|Adverse Event|0|||
164444134|NCT01636687|593996469|FG003|Induction Period|Adverse Event|0|||
164444135|NCT01636687|593996470|FG004|Induction Period|Adverse Event|1|||
164444136|NCT01636687|593996466|FG000|Induction Period|Lack of Efficacy|0|||
164444137|NCT01636687|593996467|FG001|Induction Period|Lack of Efficacy|0|||
164444138|NCT01636687|593996468|FG002|Induction Period|Lack of Efficacy|0|||
164444139|NCT01636687|593996469|FG003|Induction Period|Lack of Efficacy|0|||
164444140|NCT01636687|593996470|FG004|Induction Period|Lack of Efficacy|1|||
164444141|NCT01636687|593996466|FG000|Induction Period|Physician Decision|1|||
164444142|NCT01636687|593996467|FG001|Induction Period|Physician Decision|0|||
164444143|NCT01636687|593996468|FG002|Induction Period|Physician Decision|0|||
164444144|NCT01636687|593996469|FG003|Induction Period|Physician Decision|0|||
164444145|NCT01636687|593996470|FG004|Induction Period|Physician Decision|0|||
164444146|NCT01636687|593996466|FG000|Maintenance Period|Withdrawal by Subject|2|||
164444147|NCT01636687|593996467|FG001|Maintenance Period|Withdrawal by Subject|0|||
164444148|NCT01636687|593996468|FG002|Maintenance Period|Withdrawal by Subject|2|||
164444149|NCT01636687|593996469|FG003|Maintenance Period|Withdrawal by Subject|0|||
164444150|NCT01636687|593996470|FG004|Maintenance Period|Withdrawal by Subject|0|||
164444151|NCT01636687|593996466|FG000|Maintenance Period|Adverse Event|1|||
164444152|NCT01636687|593996467|FG001|Maintenance Period|Adverse Event|0|||
164444153|NCT01636687|593996468|FG002|Maintenance Period|Adverse Event|0|||
164444154|NCT01636687|593996469|FG003|Maintenance Period|Adverse Event|0|||
164444155|NCT01636687|593996470|FG004|Maintenance Period|Adverse Event|0|||
164444156|NCT01636687|593996466|FG000|Maintenance Period|Lack of Efficacy|4|||
164444157|NCT01636687|593996467|FG001|Maintenance Period|Lack of Efficacy|1|||
164444158|NCT01636687|593996468|FG002|Maintenance Period|Lack of Efficacy|0|||
164444159|NCT01636687|593996469|FG003|Maintenance Period|Lack of Efficacy|0|||
164444160|NCT01636687|593996470|FG004|Maintenance Period|Lack of Efficacy|0|||
164444161|NCT01636687|593996466|FG000|Maintenance Period|Lost to Follow-up|1|||
164444162|NCT01636687|593996467|FG001|Maintenance Period|Lost to Follow-up|1|||
164444163|NCT01636687|593996468|FG002|Maintenance Period|Lost to Follow-up|0|||
164444164|NCT01636687|593996469|FG003|Maintenance Period|Lost to Follow-up|0|||
164444165|NCT01636687|593996470|FG004|Maintenance Period|Lost to Follow-up|1|||
164444166|NCT01636687|593996466|FG000|Maintenance Period|Physician Decision|0|||
164444167|NCT01636687|593996467|FG001|Maintenance Period|Physician Decision|0|||
164444168|NCT01636687|593996468|FG002|Maintenance Period|Physician Decision|0|||
164444169|NCT01636687|593996469|FG003|Maintenance Period|Physician Decision|0|||
164444170|NCT01636687|593996470|FG004|Maintenance Period|Physician Decision|1|||
164444171|NCT01636687|593996466|FG000|Extension Period|technical problems|0|||
164444172|NCT01636687|593996467|FG001|Extension Period|technical problems|1|||
164444173|NCT01636687|593996468|FG002|Extension Period|technical problems|2|||
164444174|NCT01636687|593996469|FG003|Extension Period|technical problems|1|||
164444175|NCT01636687|593996470|FG004|Extension Period|technical problems|0|||
164444176|NCT01636687|593996466|FG000|Extension Period|Adverse Event|4|||
164444177|NCT01636687|593996467|FG001|Extension Period|Adverse Event|3|||
164444178|NCT01636687|593996468|FG002|Extension Period|Adverse Event|2|||
164444179|NCT01636687|593996469|FG003|Extension Period|Adverse Event|1|||
164444180|NCT01636687|593996470|FG004|Extension Period|Adverse Event|0|||
164444181|NCT01636687|593996466|FG000|Extension Period|Lack of Efficacy|7|||
164444182|NCT01636687|593996467|FG001|Extension Period|Lack of Efficacy|0|||
164444183|NCT01636687|593996468|FG002|Extension Period|Lack of Efficacy|2|||
164444184|NCT01636687|593996469|FG003|Extension Period|Lack of Efficacy|1|||
164444185|NCT01636687|593996470|FG004|Extension Period|Lack of Efficacy|0|||
164444186|NCT01636687|593996466|FG000|Extension Period|Lost to Follow-up|1|||
164444187|NCT01636687|593996467|FG001|Extension Period|Lost to Follow-up|0|||
164444188|NCT01636687|593996468|FG002|Extension Period|Lost to Follow-up|1|||
164444189|NCT01636687|593996469|FG003|Extension Period|Lost to Follow-up|0|||
164444190|NCT01636687|593996470|FG004|Extension Period|Lost to Follow-up|0|||
164444191|NCT01636687|593996466|FG000|Extension Period|Physician Decision|1|||
164444192|NCT01636687|593996467|FG001|Extension Period|Physician Decision|0|||
164444193|NCT01636687|593996468|FG002|Extension Period|Physician Decision|0|||
164444194|NCT01636687|593996469|FG003|Extension Period|Physician Decision|1|||
164444195|NCT01636687|593996470|FG004|Extension Period|Physician Decision|0|||
164444196|NCT01636687|593996466|FG000|Extension Period|study terminated by sponsor|33|||
164444197|NCT01636687|593996467|FG001|Extension Period|study terminated by sponsor|50|||
164706086|NCT05327816|594953361|FG010|Overall Study|Withdrawal by Subject|0|||
164706087|NCT05327816|594953351|FG000|Overall Study|Study Terminated by Sponsor|11|||
164706088|NCT05327816|594953352|FG001|Overall Study|Study Terminated by Sponsor|12|||
164706089|NCT05327816|594953353|FG002|Overall Study|Study Terminated by Sponsor|12|||
164444198|NCT01636687|593996468|FG002|Extension Period|study terminated by sponsor|17|||
164706090|NCT05327816|594953354|FG003|Overall Study|Study Terminated by Sponsor|12|||
164444199|NCT01636687|593996469|FG003|Extension Period|study terminated by sponsor|23|||
164706091|NCT05327816|594953355|FG004|Overall Study|Study Terminated by Sponsor|11|||
164444200|NCT01636687|593996470|FG004|Extension Period|study terminated by sponsor|0|||
164444201|NCT01636687|593996466|FG000|Extension Period|Withdrawal by Subject|1|||
164706092|NCT05327816|594953356|FG005|Overall Study|Study Terminated by Sponsor|11|||
164706093|NCT05327816|594953357|FG006|Overall Study|Study Terminated by Sponsor|11|||
164444202|NCT01636687|593996467|FG001|Extension Period|Withdrawal by Subject|0|||
164444203|NCT01636687|593996468|FG002|Extension Period|Withdrawal by Subject|1|||
164444204|NCT01636687|593996469|FG003|Extension Period|Withdrawal by Subject|1|||
164444205|NCT01636687|593996470|FG004|Extension Period|Withdrawal by Subject|0|||
164444206|NCT01636687|593996466|FG000|Follow-up Period|Withdrawal by Subject|1|||
164444207|NCT01636687|593996467|FG001|Follow-up Period|Withdrawal by Subject|0|||
164444208|NCT01636687|593996468|FG002|Follow-up Period|Withdrawal by Subject|0|||
164706094|NCT05327816|594953358|FG007|Overall Study|Study Terminated by Sponsor|11|||
164706095|NCT05327816|594953359|FG008|Overall Study|Study Terminated by Sponsor|11|||
164444209|NCT01636687|593996469|FG003|Follow-up Period|Withdrawal by Subject|0|||
164444210|NCT01636687|593996470|FG004|Follow-up Period|Withdrawal by Subject|1|||
164444211|NCT00636207|593996473|FG000|Overall Study|Adverse Event|1|||
164444212|NCT00636207|593996474|FG001|Overall Study|Adverse Event|0|||
164444213|NCT00636207|593996475|FG002|Overall Study|Adverse Event|0|||
164444214|NCT00636207|593996476|FG003|Overall Study|Adverse Event|0|||
164444215|NCT00636207|593996477|FG004|Overall Study|Adverse Event|0|||
164444216|NCT00636207|593996478|FG005|Overall Study|Adverse Event|0|||
164444217|NCT00636207|593996479|FG006|Overall Study|Adverse Event|0|||
164444218|NCT00636207|593996473|FG000|Overall Study|Withdrawal by Subject|0|||
164444219|NCT00636207|593996474|FG001|Overall Study|Withdrawal by Subject|1|||
164444220|NCT00636207|593996475|FG002|Overall Study|Withdrawal by Subject|0|||
164444221|NCT00636207|593996476|FG003|Overall Study|Withdrawal by Subject|0|||
164444222|NCT00636207|593996477|FG004|Overall Study|Withdrawal by Subject|1|||
164444223|NCT00636207|593996478|FG005|Overall Study|Withdrawal by Subject|0|||
164444224|NCT00636207|593996479|FG006|Overall Study|Withdrawal by Subject|0|||
164444225|NCT00666276|593996482|FG000|Overall Study|Protocol Violation|34|||
164444226|NCT01039688|593996483|FG000|Overall Study|Adverse Event|38|||
164444227|NCT01039688|593996484|FG001|Overall Study|Adverse Event|39|||
164444228|NCT01039688|593996485|FG002|Overall Study|Adverse Event|24|||
164444229|NCT01039688|593996483|FG000|Overall Study|Lack of Efficacy|20|||
164444230|NCT01039688|593996484|FG001|Overall Study|Lack of Efficacy|11|||
164444231|NCT01039688|593996485|FG002|Overall Study|Lack of Efficacy|26|||
164444232|NCT01039688|593996483|FG000|Overall Study|Lost to Follow-up|11|||
164444233|NCT01039688|593996484|FG001|Overall Study|Lost to Follow-up|9|||
164444234|NCT01039688|593996485|FG002|Overall Study|Lost to Follow-up|5|||
164444235|NCT01039688|593996483|FG000|Overall Study|Other|13|||
164444236|NCT01039688|593996484|FG001|Overall Study|Other|25|||
164444237|NCT01039688|593996485|FG002|Overall Study|Other|12|||
164444238|NCT01039688|593996483|FG000|Overall Study|Withdrawal by Subject|23|||
164444239|NCT01039688|593996484|FG001|Overall Study|Withdrawal by Subject|27|||
164444240|NCT01039688|593996485|FG002|Overall Study|Withdrawal by Subject|13|||
164444241|NCT01039688|593996483|FG000|Overall Study|Death|2|||
164444242|NCT01039688|593996484|FG001|Overall Study|Death|0|||
164444243|NCT01039688|593996485|FG002|Overall Study|Death|0|||
164444244|NCT02594735|593996486|FG000|Overall Study|Adverse Event|1|||
164444245|NCT03844269|593996488|FG000|Overall Study|Withdrawal pre-intervention|1|||
164444246|NCT03844269|593996488|FG000|Overall Study|Did not complete the intervention|2|||
164444247|NCT00101010|593996494|FG000|Overall Study|Physician Decision|1|||
164444248|NCT04054635|593996503|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
164444249|NCT04054635|593996504|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
164444250|NCT04054635|593996505|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
164444251|NCT04054635|593996503|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
164444252|NCT04054635|593996504|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
164444253|NCT04054635|593996505|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
164444254|NCT00364013|593996506|FG000|Overall Study|Ineligibility determined|4|||
164444255|NCT00364013|593996507|FG001|Overall Study|Ineligibility determined|2|||
164444256|NCT00364013|593996506|FG000|Overall Study|Adverse Event|4|||
164444257|NCT00364013|593996507|FG001|Overall Study|Adverse Event|3|||
164444258|NCT00364013|593996506|FG000|Overall Study|Withdrawal by Subject|13|||
164444259|NCT00364013|593996507|FG001|Overall Study|Withdrawal by Subject|18|||
164444260|NCT00364013|593996506|FG000|Overall Study|Physician Decision|3|||
164444261|NCT00364013|593996507|FG001|Overall Study|Physician Decision|3|||
164444262|NCT00364013|593996506|FG000|Overall Study|Lost to Follow-up|10|||
164706096|NCT05327816|594953360|FG009|Overall Study|Study Terminated by Sponsor|11|||
164706097|NCT05327816|594953361|FG010|Overall Study|Study Terminated by Sponsor|12|||
164706098|NCT05327816|594953351|FG000|Overall Study|Randomized but not treated|0|||
164706099|NCT05327816|594953352|FG001|Overall Study|Randomized but not treated|0|||
164706100|NCT05327816|594953353|FG002|Overall Study|Randomized but not treated|0|||
164444263|NCT00364013|593996507|FG001|Overall Study|Lost to Follow-up|3|||
164444264|NCT00364013|593996506|FG000|Overall Study|Protocol-specified criteria|6|||
164444265|NCT00364013|593996507|FG001|Overall Study|Protocol-specified criteria|6|||
164444266|NCT00364013|593996506|FG000|Overall Study|Other|41|||
164444267|NCT00364013|593996507|FG001|Overall Study|Other|47|||
164444268|NCT00364013|593996506|FG000|Overall Study|Ongoing|20|||
164444269|NCT00364013|593996507|FG001|Overall Study|Ongoing|13|||
164706101|NCT05327816|594953354|FG003|Overall Study|Randomized but not treated|0|||
164706102|NCT05327816|594953355|FG004|Overall Study|Randomized but not treated|0|||
164706103|NCT05327816|594953356|FG005|Overall Study|Randomized but not treated|0|||
164706104|NCT05327816|594953357|FG006|Overall Study|Randomized but not treated|1|||
164444270|NCT00891930|593996508|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
164444271|NCT00891930|593996508|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
164444272|NCT00891930|593996508|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
164706105|NCT05327816|594953358|FG007|Overall Study|Randomized but not treated|1|||
164444273|NCT00891930|593996508|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
164444274|NCT00891930|593996508|FG000|Part 2 Panitumumab + AMG479|Death|30|||
164444275|NCT00835770|593996515|FG000|Overall Study|MS Relapse|17|||
164444276|NCT00835770|593996516|FG001|Overall Study|MS Relapse|23|||
164444277|NCT00835770|593996515|FG000|Overall Study|MS Progression|14|||
164444278|NCT00835770|593996516|FG001|Overall Study|MS Progression|9|||
164444279|NCT00835770|593996515|FG000|Overall Study|Adverse Event|113|||
164444280|NCT00835770|593996516|FG001|Overall Study|Adverse Event|124|||
164444281|NCT00835770|593996515|FG000|Overall Study|Lost to Follow-up|22|||
164444282|NCT00835770|593996516|FG001|Overall Study|Lost to Follow-up|19|||
164444283|NCT00835770|593996515|FG000|Overall Study|Consent Withdrawn|144|||
164444284|NCT00835770|593996516|FG001|Overall Study|Consent Withdrawn|156|||
164444285|NCT00835770|593996515|FG000|Overall Study|Investigator Decision|42|||
164444286|NCT00835770|593996516|FG001|Overall Study|Investigator Decision|42|||
164444287|NCT00835770|593996515|FG000|Overall Study|Participant Non-Compliance|11|||
164596779|NCT00960934|594548962|FG004|Overall Study|Study Terminated by Sponsor|49|||
164596780|NCT00960934|594548963|FG005|Overall Study|Study Terminated by Sponsor|49|||
164596781|NCT00174785|594548974|FG000|Overall Study|Adverse Event|293|||
164596782|NCT00174785|594548975|FG001|Overall Study|Adverse Event|191|||
164596783|NCT00174785|594548974|FG000|Overall Study|Protocol Violation|14|||
164596784|NCT00174785|594548975|FG001|Overall Study|Protocol Violation|14|||
164596785|NCT00174785|594548974|FG000|Overall Study|Withdrawal by Subject|173|||
164596786|NCT00174785|594548975|FG001|Overall Study|Withdrawal by Subject|175|||
164596787|NCT00174785|594548974|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
164596788|NCT00174785|594548975|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
164596789|NCT00174785|594548974|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
164596790|NCT00174785|594548975|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
164596791|NCT00174785|594548974|FG000|Overall Study|Other prohibited medication|5|||
164596792|NCT00174785|594548975|FG001|Overall Study|Other prohibited medication|3|||
164596793|NCT00174785|594548974|FG000|Overall Study|Family request|6|||
164596794|NCT00174785|594548975|FG001|Overall Study|Family request|8|||
164596795|NCT00174785|594548974|FG000|Overall Study|Not pre-specified/Not coded|56|||
164596796|NCT00174785|594548975|FG001|Overall Study|Not pre-specified/Not coded|70|||
164596797|NCT00120289|594548976|FG000|Overall Study|Death|96|||
164596798|NCT00120289|594548977|FG001|Overall Study|Death|82|||
164596799|NCT00120289|594548976|FG000|Overall Study|Lost to Follow-up|11|||
164596800|NCT00120289|594548977|FG001|Overall Study|Lost to Follow-up|14|||
164596801|NCT00120289|594548976|FG000|Overall Study|Withdrawal by Subject|14|||
164596802|NCT00120289|594548977|FG001|Overall Study|Withdrawal by Subject|13|||
164596803|NCT02179515|594548981|FG000|Overall Study|switched to alternative treatment|0|||
164596804|NCT02179515|594548982|FG001|Overall Study|switched to alternative treatment|1|||
164596805|NCT02179515|594548983|FG002|Overall Study|switched to alternative treatment|1|||
164596806|NCT02179515|594548981|FG000|Overall Study|Death|0|||
164596807|NCT02179515|594548982|FG001|Overall Study|Death|1|||
164596808|NCT02179515|594548983|FG002|Overall Study|Death|1|||
164596809|NCT02179515|594548981|FG000|Overall Study|refused further treatment|0|||
164596810|NCT02179515|594548982|FG001|Overall Study|refused further treatment|3|||
164596811|NCT02179515|594548983|FG002|Overall Study|refused further treatment|4|||
164596812|NCT02179515|594548981|FG000|Overall Study|Disease progression on study|2|||
164596813|NCT02179515|594548982|FG001|Overall Study|Disease progression on study|11|||
164596814|NCT02179515|594548983|FG002|Overall Study|Disease progression on study|8|||
164596815|NCT00782418|594548984|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
164596816|NCT00782418|594548985|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
164596817|NCT00782418|594548986|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
164596818|NCT00782418|594548987|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
164596819|NCT00782418|594548988|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
164596820|NCT00782418|594548989|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
164596821|NCT00782418|594548990|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
164596822|NCT00782418|594548984|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
164596823|NCT00782418|594548985|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
164444288|NCT00835770|593996516|FG001|Overall Study|Participant Non-Compliance|9|||
164444289|NCT00835770|593996515|FG000|Overall Study|Death|4|||
164444290|NCT00835770|593996516|FG001|Overall Study|Death|6|||
164444291|NCT00835770|593996515|FG000|Overall Study|Other|115|||
164444292|NCT00835770|593996516|FG001|Overall Study|Other|104|||
164444293|NCT00835770|593996515|FG000|Overall Study|Other|2|||
164444294|NCT00835770|593996516|FG001|Overall Study|Other|1|||
164444295|NCT01185782|593996517|FG000|Overall Study|Adverse Event|0|||
164596824|NCT00782418|594548986|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
164596825|NCT00782418|594548987|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
164596826|NCT00782418|594548988|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
164596827|NCT00782418|594548989|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
164596828|NCT00782418|594548990|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
164444296|NCT01185782|593996518|FG001|Overall Study|Adverse Event|1|||
164444297|NCT01185782|593996517|FG000|Overall Study|Protocol Violation|1|||
164444298|NCT01185782|593996518|FG001|Overall Study|Protocol Violation|0|||
164444299|NCT01185782|593996517|FG000|Overall Study|Poor Response to Treatment|3|||
164444300|NCT01185782|593996518|FG001|Overall Study|Poor Response to Treatment|1|||
164444301|NCT01185782|593996517|FG000|Overall Study|Other|2|||
164444302|NCT01185782|593996518|FG001|Overall Study|Other|5|||
164444303|NCT01185782|593996517|FG000|Overall Study|Randomized but not treated|0|||
164444304|NCT01185782|593996518|FG001|Overall Study|Randomized but not treated|4|||
164444305|NCT02507752|593996519|FG000|Overall Study|Adverse Event|1|||
164444306|NCT02507752|593996519|FG000|Overall Study|Protocol Violation|6|||
164444307|NCT02507752|593996519|FG000|Overall Study|Lost to Follow-up|7|||
164444308|NCT02507752|593996519|FG000|Overall Study|Infusion reaction at first infusion|1|||
164444309|NCT02507752|593996519|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
164444310|NCT02507752|593996519|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
164444311|NCT01254188|593996525|FG000|Overall Study|Disease Progression|6|||
164444312|NCT01254188|593996525|FG000|Overall Study|Protocol Violation|6|||
164444313|NCT01254188|593996525|FG000|Overall Study|Pregnancy|2|||
164444314|NCT01254188|593996525|FG000|Overall Study|Death|4|||
164444315|NCT01254188|593996525|FG000|Overall Study|Lost to Follow-up|5|||
164444316|NCT01254188|593996525|FG000|Overall Study|Withdrawal by Subject|7|||
164444317|NCT01254188|593996525|FG000|Overall Study|Adverse Event|43|||
164444318|NCT01254188|593996525|FG000|Overall Study|per investigator discretion|20|||
164444319|NCT02202499|593996529|FG000|Overall Study|Cancer diagnosis|0|||
164444320|NCT02202499|593996530|FG001|Overall Study|Cancer diagnosis|0|||
164444321|NCT02202499|593996531|FG002|Overall Study|Cancer diagnosis|1|||
164444322|NCT02202499|593996529|FG000|Overall Study|Moved from area|0|||
164444323|NCT02202499|593996530|FG001|Overall Study|Moved from area|0|||
164444324|NCT02202499|593996531|FG002|Overall Study|Moved from area|1|||
164444325|NCT02202499|593996529|FG000|Overall Study|Declined before randomization|1|||
164444326|NCT02202499|593996530|FG001|Overall Study|Declined before randomization|0|||
164444327|NCT02202499|593996531|FG002|Overall Study|Declined before randomization|0|||
164444328|NCT02202499|593996529|FG000|Overall Study|Auto accident|1|||
164444329|NCT02202499|593996530|FG001|Overall Study|Auto accident|0|||
164444330|NCT02202499|593996531|FG002|Overall Study|Auto accident|0|||
164444331|NCT00535145|593996533|FG000|Phase I|Adverse Event|3|||
164444332|NCT00535145|593996533|FG000|Phase I|Lost to Follow-up|7|||
164444333|NCT00535145|593996533|FG000|Phase I|Withdrawal by Subject|6|||
164444334|NCT00535145|593996533|FG000|Phase I|(eligibility)|8|||
164444335|NCT00535145|593996533|FG000|Phase I|(protocol violation)|1|||
164444336|NCT00535145|593996533|FG000|Phase I|(PI decision)|1|||
164444337|NCT00535145|593996533|FG000|Phase I|(diagnosis)|3|||
164444338|NCT00535145|593996533|FG000|Phase II|Adverse Event|2|||
164444339|NCT00535145|593996533|FG000|Phase II|Lack of Efficacy|1|||
164444340|NCT00535145|593996533|FG000|Phase II|Lost to Follow-up|5|||
164444341|NCT00535145|593996533|FG000|Phase II|Withdrawal by Subject|5|||
164444342|NCT00535145|593996533|FG000|Phase II|Subject non-compliance|2|||
164444343|NCT05082935|593996536|FG000|Overall Study|Lost to Follow-up|549|||
164444344|NCT05082935|593996537|FG001|Overall Study|Lost to Follow-up|631|||
164444345|NCT05082935|593996536|FG000|Overall Study|Withdrawal by Subject|27|||
164444346|NCT05082935|593996537|FG001|Overall Study|Withdrawal by Subject|58|||
164444347|NCT00546754|593996539|FG000|Overall Study|Serious Adverse Event|1|||
164444348|NCT00546754|593996540|FG001|Overall Study|Serious Adverse Event|1|||
164444349|NCT00546754|593996539|FG000|Overall Study|Adverse Event|11|||
164444350|NCT00546754|593996540|FG001|Overall Study|Adverse Event|16|||
164444351|NCT00546754|593996539|FG000|Overall Study|Lack of Efficacy|1|||
164444352|NCT00546754|593996540|FG001|Overall Study|Lack of Efficacy|1|||
164444353|NCT00546754|593996539|FG000|Overall Study|Lost to Follow-up|9|||
164444354|NCT00546754|593996540|FG001|Overall Study|Lost to Follow-up|15|||
164444355|NCT00546754|593996539|FG000|Overall Study|Protocol Violation|3|||
164444356|NCT00546754|593996540|FG001|Overall Study|Protocol Violation|0|||
164706106|NCT05327816|594953359|FG008|Overall Study|Randomized but not treated|1|||
164444357|NCT00546754|593996539|FG000|Overall Study|Withdrawal by Subject|6|||
164444358|NCT00546754|593996540|FG001|Overall Study|Withdrawal by Subject|7|||
164444359|NCT00546754|593996539|FG000|Overall Study|Dyspnea|1|||
164444360|NCT00546754|593996540|FG001|Overall Study|Dyspnea|0|||
164444361|NCT00546754|593996539|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
164444362|NCT00546754|593996540|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
164444363|NCT00546754|593996539|FG000|Overall Study|Hip Replacement|1|||
164706107|NCT05327816|594953360|FG009|Overall Study|Randomized but not treated|0|||
164706108|NCT05327816|594953361|FG010|Overall Study|Randomized but not treated|0|||
164444364|NCT00546754|593996540|FG001|Overall Study|Hip Replacement|0|||
164444365|NCT00546754|593996539|FG000|Overall Study|Suicide|1|||
164444366|NCT00546754|593996540|FG001|Overall Study|Suicide|0|||
164444367|NCT00546754|593996539|FG000|Overall Study|Missing Cooperation|1|||
164444368|NCT00546754|593996540|FG001|Overall Study|Missing Cooperation|0|||
164444369|NCT00546754|593996539|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
164444370|NCT00546754|593996540|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
164444371|NCT00546754|593996539|FG000|Overall Study|Patient's Decision|0|||
164444372|NCT00546754|593996540|FG001|Overall Study|Patient's Decision|1|||
164444373|NCT00546754|593996539|FG000|Overall Study|Missing|14|||
164444374|NCT00546754|593996540|FG001|Overall Study|Missing|7|||
164444375|NCT01576484|593996541|FG000|Overall Study|Adverse Event|1|||
164444376|NCT01576484|593996542|FG001|Overall Study|Adverse Event|1|||
164444377|NCT01576484|593996541|FG000|Overall Study|Protocol Violation|0|||
164444378|NCT01576484|593996542|FG001|Overall Study|Protocol Violation|2|||
164444379|NCT01576484|593996541|FG000|Overall Study|Sponsor Decision|2|||
164444380|NCT01576484|593996542|FG001|Overall Study|Sponsor Decision|8|||
164444381|NCT01576484|593996541|FG000|Overall Study|Withdrawal by Subject|0|||
164444382|NCT01576484|593996542|FG001|Overall Study|Withdrawal by Subject|3|||
164444383|NCT01576484|593996541|FG000|Overall Study|Other|2|||
164444384|NCT01576484|593996542|FG001|Overall Study|Other|5|||
164444385|NCT00837616|593996547|FG000|Overall Study|Withdrawal by Subject|0|||
164444386|NCT00837616|593996548|FG001|Overall Study|Withdrawal by Subject|1|||
164444387|NCT03512756|593996554|FG000|Part 1|Death|23|||
164444388|NCT03512756|593996555|FG001|Part 1|Death|18|||
164444389|NCT03512756|593996556|FG002|Part 1|Death|0|||
164444390|NCT03512756|593996557|FG003|Part 1|Death|0|||
164444391|NCT03512756|593996554|FG000|Part 1|Lost to Follow-up|0|||
164444392|NCT03512756|593996555|FG001|Part 1|Lost to Follow-up|3|||
164444393|NCT03512756|593996556|FG002|Part 1|Lost to Follow-up|0|||
164444394|NCT03512756|593996557|FG003|Part 1|Lost to Follow-up|0|||
164444395|NCT03512756|593996554|FG000|Part 1|Physician Decision|0|||
164444396|NCT03512756|593996555|FG001|Part 1|Physician Decision|1|||
164444397|NCT03512756|593996556|FG002|Part 1|Physician Decision|0|||
164444398|NCT03512756|593996557|FG003|Part 1|Physician Decision|0|||
164444399|NCT03512756|593996554|FG000|Part 1|Withdrawal by Subject|2|||
164444400|NCT03512756|593996555|FG001|Part 1|Withdrawal by Subject|2|||
164444401|NCT03512756|593996556|FG002|Part 1|Withdrawal by Subject|0|||
164444402|NCT03512756|593996557|FG003|Part 1|Withdrawal by Subject|0|||
164444403|NCT03512756|593996554|FG000|Part 2|Death|0|||
164444404|NCT03512756|593996555|FG001|Part 2|Death|0|||
164444405|NCT03512756|593996556|FG002|Part 2|Death|32|||
164444406|NCT03512756|593996557|FG003|Part 2|Death|21|||
164444407|NCT03512756|593996554|FG000|Part 2|Lost to Follow-up|0|||
164444408|NCT03512756|593996555|FG001|Part 2|Lost to Follow-up|0|||
164444409|NCT03512756|593996556|FG002|Part 2|Lost to Follow-up|1|||
164444410|NCT03512756|593996557|FG003|Part 2|Lost to Follow-up|0|||
164444411|NCT03512756|593996554|FG000|Part 2|Physician Decision|0|||
164444412|NCT03512756|593996555|FG001|Part 2|Physician Decision|0|||
164444413|NCT03512756|593996556|FG002|Part 2|Physician Decision|2|||
164444414|NCT03512756|593996557|FG003|Part 2|Physician Decision|4|||
164444415|NCT03512756|593996554|FG000|Part 2|Study Terminated by Sponsor|0|||
164444416|NCT03512756|593996555|FG001|Part 2|Study Terminated by Sponsor|0|||
164444417|NCT03512756|593996556|FG002|Part 2|Study Terminated by Sponsor|2|||
164444418|NCT03512756|593996557|FG003|Part 2|Study Terminated by Sponsor|6|||
164444419|NCT03512756|593996554|FG000|Part 2|Protocol Violation|0|||
164444420|NCT03512756|593996555|FG001|Part 2|Protocol Violation|0|||
164444421|NCT03512756|593996556|FG002|Part 2|Protocol Violation|1|||
164444422|NCT03512756|593996557|FG003|Part 2|Protocol Violation|0|||
164444423|NCT03512756|593996554|FG000|Part 2|Withdrawal by Subject|0|||
164444424|NCT03512756|593996555|FG001|Part 2|Withdrawal by Subject|0|||
164444425|NCT03512756|593996556|FG002|Part 2|Withdrawal by Subject|3|||
164444426|NCT03512756|593996557|FG003|Part 2|Withdrawal by Subject|9|||
164444427|NCT03473340|593996558|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
164444428|NCT03473340|593996559|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
164444429|NCT03473340|593996558|FG000|Overall Study|Withdrawal by Subject|1|||
164444430|NCT03473340|593996559|FG001|Overall Study|Withdrawal by Subject|0|||
164444431|NCT03473340|593996558|FG000|Overall Study|Lost to Follow-up|1|||
164444432|NCT03473340|593996559|FG001|Overall Study|Lost to Follow-up|2|||
164444433|NCT02079844|593996560|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
164444434|NCT02079844|593996561|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
164444435|NCT02079844|593996562|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
164444436|NCT02079844|593996560|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
164444437|NCT02079844|593996561|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
164444438|NCT02079844|593996562|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
164444439|NCT01420549|593996563|FG000|Overall Study|Adverse Event|1|||
164444440|NCT01420549|593996564|FG001|Overall Study|Adverse Event|1|||
164444441|NCT01420549|593996563|FG000|Overall Study|Lost to Follow-up|2|||
164444442|NCT01420549|593996564|FG001|Overall Study|Lost to Follow-up|2|||
164444443|NCT01420549|593996563|FG000|Overall Study|Protocol Violation|0|||
164444444|NCT01420549|593996564|FG001|Overall Study|Protocol Violation|1|||
164444445|NCT01420549|593996563|FG000|Overall Study|Non-adherence to medication|4|||
164706109|NCT01367665|594953362|FG000|Overall Study|Death|102|||
164444446|NCT01420549|593996564|FG001|Overall Study|Non-adherence to medication|1|||
164444447|NCT03394885|593996565|FG000|Overall Study|Adverse Event|4|||
164444448|NCT03394885|593996565|FG000|Overall Study|Lack of Efficacy|1|||
164444449|NCT03394885|593996565|FG000|Overall Study|Physician Decision|1|||
164444450|NCT03394885|593996565|FG000|Overall Study|Withdrawal by Subject|8|||
164444451|NCT03394885|593996565|FG000|Overall Study|Alternative Therapy|1|||
164444452|NCT00203411|593996566|FG000|Follow-up|Progressive Disease|4|||
164706110|NCT01367665|594953363|FG001|Overall Study|Death|19|||
164706111|NCT01367665|594953362|FG000|Overall Study|Lost to Follow-up|222|||
164706112|NCT01367665|594953363|FG001|Overall Study|Lost to Follow-up|22|||
164706113|NCT01367665|594953362|FG000|Overall Study|Not Done|118|||
164706114|NCT01367665|594953363|FG001|Overall Study|Not Done|14|||
164706115|NCT02752906|594953364|FG000|Overall Study|Protocol Violation|2|||
164706116|NCT02752906|594953365|FG001|Overall Study|Protocol Violation|1|||
164706117|NCT02752906|594953364|FG000|Overall Study|Withdrawal by Subject|2|||
164444453|NCT04980755|593996567|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
164444454|NCT04980755|593996567|FG000|Body Reprogramming Courses|Work commitment|2|||
164444455|NCT04980755|593996567|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
164444456|NCT04980755|593996567|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
164444457|NCT01212991|593996568|FG000|Double-blind|Lost to Follow-up|8|||
164444458|NCT01212991|593996569|FG001|Double-blind|Lost to Follow-up|4|||
164444459|NCT01212991|593996570|FG002|Double-blind|Lost to Follow-up|0|||
164444460|NCT01212991|593996568|FG000|Double-blind|Death|699|||
164444461|NCT01212991|593996569|FG001|Double-blind|Death|550|||
164444462|NCT01212991|593996570|FG002|Double-blind|Death|0|||
164444463|NCT01212991|593996568|FG000|Double-blind|Withdrawal by Subject|16|||
164444464|NCT01212991|593996569|FG001|Double-blind|Withdrawal by Subject|19|||
164444465|NCT01212991|593996570|FG002|Double-blind|Withdrawal by Subject|0|||
164444466|NCT01212991|593996568|FG000|Double-blind|Other|7|||
164444467|NCT01212991|593996569|FG001|Double-blind|Other|0|||
164444468|NCT01212991|593996570|FG002|Double-blind|Other|0|||
164444469|NCT01212991|593996568|FG000|Double-blind|Sponsor decision|142|||
164444470|NCT01212991|593996569|FG001|Double-blind|Sponsor decision|38|||
164444471|NCT01212991|593996570|FG002|Double-blind|Sponsor decision|0|||
164444472|NCT01212991|593996568|FG000|Open-label|Death|0|||
164444473|NCT01212991|593996569|FG001|Open-label|Death|0|||
164444474|NCT01212991|593996570|FG002|Open-label|Death|166|||
164444475|NCT01212991|593996568|FG000|Open-label|Lost to Follow-up|0|||
164444476|NCT01212991|593996569|FG001|Open-label|Lost to Follow-up|0|||
164444477|NCT01212991|593996570|FG002|Open-label|Lost to Follow-up|5|||
164444478|NCT01212991|593996568|FG000|Open-label|Withdrawal by Subject|0|||
164444479|NCT01212991|593996569|FG001|Open-label|Withdrawal by Subject|0|||
164444480|NCT01212991|593996570|FG002|Open-label|Withdrawal by Subject|7|||
164444481|NCT01212991|593996568|FG000|Open-label|Sponsor decision|0|||
164444482|NCT01212991|593996569|FG001|Open-label|Sponsor decision|0|||
164444483|NCT01212991|593996570|FG002|Open-label|Sponsor decision|53|||
164444484|NCT01212991|593996568|FG000|Open-label|Other|0|||
164444485|NCT01212991|593996569|FG001|Open-label|Other|0|||
164444486|NCT01212991|593996570|FG002|Open-label|Other|3|||
164444487|NCT04279574|593997713|FG000|Overall Study|Death|1|||
164444488|NCT04279574|593997714|FG001|Overall Study|Death|0|||
164444489|NCT04279574|593997713|FG000|Overall Study|lost restoration, tooth fracture|1|||
164444490|NCT04279574|593997714|FG001|Overall Study|lost restoration, tooth fracture|0|||
164444491|NCT04279574|593997713|FG000|Overall Study|Lost to Follow-up|0|||
164444492|NCT04279574|593997714|FG001|Overall Study|Lost to Follow-up|1|||
164444493|NCT02407249|593997717|FG000|Overall Study|Did not complete 12-month follow-up|13|||
164444494|NCT02407249|593997717|FG000|Overall Study|Not treated|13|||
164444495|NCT01391832|593997718|FG000|Overall Study|Withdrawal by Subject|21|||
164444496|NCT01391832|593997719|FG001|Overall Study|Withdrawal by Subject|22|||
164444497|NCT01391832|593997718|FG000|Overall Study|Lost to Follow-up|0|||
164444498|NCT01391832|593997719|FG001|Overall Study|Lost to Follow-up|1|||
164444499|NCT03345901|593997723|FG000|Overall Study|The study was terminated|18|||
164444500|NCT04252586|593997724|FG000|Overall Study|Withdrawal by parent/guardian|3|||
164444501|NCT04252586|593997724|FG000|Overall Study|Adverse Event|1|||
164444502|NCT04252586|593997724|FG000|Overall Study|Death|2|||
164444503|NCT04252586|593997724|FG000|Overall Study|Study terminated by sponsor|4|||
164444504|NCT04252586|593997724|FG000|Overall Study|Sponsor request|10|||
164444505|NCT04252586|593997724|FG000|Overall Study|Did not complete treatment period|1|||
164444506|NCT00232180|593997725|FG000|Double-blind (DB) Phase|Death|186|||
164444507|NCT00232180|593997726|FG001|Double-blind (DB) Phase|Death|222|||
164444508|NCT00232180|593997727|FG002|Double-blind (DB) Phase|Death|0|||
164444509|NCT00232180|593997725|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
164444510|NCT00232180|593997726|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
164444511|NCT00232180|593997727|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
164706118|NCT02752906|594953365|FG001|Overall Study|Withdrawal by Subject|2|||
164706119|NCT02752906|594953364|FG000|Overall Study|Lost to Follow-up|3|||
164403050|NCT01964326|593844250|FG000|Overall Study|Other|9|||
164403051|NCT01964326|593844250|FG000|Overall Study|Did not meet eligibility criteria|1|||
164403052|NCT02563002|593844253|FG000|Overall Study|Death|72|||
164403053|NCT02563002|593844254|FG001|Overall Study|Death|87|||
164403054|NCT02563002|593844253|FG000|Overall Study|Lost to Follow-up|5|||
164403055|NCT02563002|593844254|FG001|Overall Study|Lost to Follow-up|0|||
164403056|NCT02563002|593844253|FG000|Overall Study|Physician Decision|0|||
164403057|NCT02563002|593844254|FG001|Overall Study|Physician Decision|2|||
164403058|NCT02563002|593844253|FG000|Overall Study|Withdrawal by Subject|2|||
164403059|NCT02563002|593844254|FG001|Overall Study|Withdrawal by Subject|10|||
164444512|NCT00232180|593997725|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
164444513|NCT00232180|593997726|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
164444514|NCT00232180|593997727|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
164444515|NCT00232180|593997725|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
164444516|NCT00232180|593997726|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
164444517|NCT00232180|593997727|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
164444518|NCT00232180|593997725|FG000|Double-blind (DB) Phase|Adverse Event|83|||
164444519|NCT00232180|593997726|FG001|Double-blind (DB) Phase|Adverse Event|100|||
164444520|NCT00232180|593997727|FG002|Double-blind (DB) Phase|Adverse Event|0|||
164444521|NCT00232180|593997725|FG000|Double-blind (DB) Phase|Other|70|||
164444522|NCT00232180|593997726|FG001|Double-blind (DB) Phase|Other|75|||
164444523|NCT00232180|593997727|FG002|Double-blind (DB) Phase|Other|0|||
164444524|NCT00232180|593997725|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
164444525|NCT00232180|593997726|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
164444526|NCT00232180|593997727|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
164444527|NCT00232180|593997725|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
164444528|NCT00232180|593997726|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
164444529|NCT00232180|593997727|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
164444530|NCT00232180|593997725|FG000|Open Label Phase|Death|0|||
164444531|NCT00232180|593997726|FG001|Open Label Phase|Death|0|||
164444532|NCT00232180|593997727|FG002|Open Label Phase|Death|48|||
164444533|NCT00232180|593997725|FG000|Open Label Phase|Lost to Follow-up|0|||
164444534|NCT00232180|593997726|FG001|Open Label Phase|Lost to Follow-up|0|||
164444535|NCT00232180|593997727|FG002|Open Label Phase|Lost to Follow-up|5|||
164444536|NCT00232180|593997725|FG000|Open Label Phase|Protocol Violation|0|||
164403060|NCT02563002|593844253|FG000|Overall Study|Sponsor decision|74|||
164444537|NCT00232180|593997726|FG001|Open Label Phase|Protocol Violation|0|||
164444538|NCT00232180|593997727|FG002|Open Label Phase|Protocol Violation|3|||
164596829|NCT01718509|594548991|FG000|Overall Study|Lost to Follow-up|18|||
164596830|NCT01718509|594548992|FG001|Overall Study|Lost to Follow-up|15|||
164403061|NCT02563002|593844254|FG001|Overall Study|Sponsor decision|55|||
164403062|NCT03518125|593844255|FG000|Overall Study|Lost to Follow-up|0|||
164403063|NCT03518125|593844256|FG001|Overall Study|Lost to Follow-up|2|||
164403064|NCT03518125|593844257|FG002|Overall Study|Lost to Follow-up|0|||
164403065|NCT03518125|593844258|FG003|Overall Study|Lost to Follow-up|0|||
164403066|NCT03518125|593844259|FG004|Overall Study|Lost to Follow-up|3|||
164403067|NCT03518125|593844260|FG005|Overall Study|Lost to Follow-up|5|||
164403068|NCT03518125|593844255|FG000|Overall Study|Physician Decision|0|||
164403069|NCT03518125|593844256|FG001|Overall Study|Physician Decision|1|||
164403070|NCT03518125|593844257|FG002|Overall Study|Physician Decision|0|||
164403071|NCT03518125|593844258|FG003|Overall Study|Physician Decision|0|||
164403072|NCT03518125|593844259|FG004|Overall Study|Physician Decision|0|||
164403073|NCT03518125|593844260|FG005|Overall Study|Physician Decision|0|||
164403074|NCT03518125|593844255|FG000|Overall Study|Withdrawal by Subject|1|||
164403075|NCT03518125|593844256|FG001|Overall Study|Withdrawal by Subject|1|||
164403076|NCT03518125|593844257|FG002|Overall Study|Withdrawal by Subject|0|||
164403077|NCT03518125|593844258|FG003|Overall Study|Withdrawal by Subject|1|||
164403078|NCT03518125|593844259|FG004|Overall Study|Withdrawal by Subject|1|||
164403079|NCT03518125|593844260|FG005|Overall Study|Withdrawal by Subject|3|||
164403080|NCT03518125|593844255|FG000|Overall Study|Missed Day 394 Visit|1|||
164403081|NCT03518125|593844256|FG001|Overall Study|Missed Day 394 Visit|0|||
164403082|NCT03518125|593844257|FG002|Overall Study|Missed Day 394 Visit|0|||
164403083|NCT03518125|593844258|FG003|Overall Study|Missed Day 394 Visit|0|||
164403084|NCT03518125|593844259|FG004|Overall Study|Missed Day 394 Visit|0|||
164403085|NCT03518125|593844260|FG005|Overall Study|Missed Day 394 Visit|0|||
164403086|NCT00508404|593844261|FG000|Overall Study|Ongoing at Data Cut-off|12|||
164403087|NCT00508404|593844261|FG000|Overall Study|Adverse Event|2|||
164403088|NCT00508404|593844261|FG000|Overall Study|Death|16|||
164403089|NCT00508404|593844261|FG000|Overall Study|Physician Decision|2|||
164403090|NCT00508404|593844261|FG000|Overall Study|Withdrawal by Subject|3|||
164403091|NCT00508404|593844261|FG000|Overall Study|Protocol-specified Criteria|2|||
164403092|NCT00508404|593844261|FG000|Overall Study|Lost to Follow-up|2|||
164403093|NCT00508404|593844261|FG000|Overall Study|Other - Not Specified|3|||
164403094|NCT01662063|593844262|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
164403095|NCT01662063|593844263|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
164403096|NCT01662063|593844264|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
164403097|NCT01662063|593844262|FG000|Overall Study|Lack of Efficacy|1|||
164403098|NCT01662063|593844263|FG001|Overall Study|Lack of Efficacy|6|||
164403099|NCT01662063|593844264|FG002|Overall Study|Lack of Efficacy|0|||
164403100|NCT01662063|593844262|FG000|Overall Study|Lost to Follow-up|0|||
164403101|NCT01662063|593844263|FG001|Overall Study|Lost to Follow-up|4|||
164403102|NCT01662063|593844264|FG002|Overall Study|Lost to Follow-up|0|||
164596831|NCT01718509|594548991|FG000|Overall Study|Withdrawal by Subject|7|||
164596832|NCT01718509|594548992|FG001|Overall Study|Withdrawal by Subject|13|||
164596833|NCT01718509|594548991|FG000|Overall Study|Adverse Event|5|||
164596834|NCT01718509|594548992|FG001|Overall Study|Adverse Event|7|||
164596835|NCT01718509|594548991|FG000|Overall Study|Other|13|||
164596836|NCT01718509|594548992|FG001|Overall Study|Other|11|||
164444539|NCT00232180|593997725|FG000|Open Label Phase|Study terminated by sponsor|0|||
164444540|NCT00232180|593997726|FG001|Open Label Phase|Study terminated by sponsor|0|||
164444541|NCT00232180|593997727|FG002|Open Label Phase|Study terminated by sponsor|3|||
164444542|NCT00232180|593997725|FG000|Open Label Phase|Withdrawal by Subject|0|||
164444543|NCT00232180|593997726|FG001|Open Label Phase|Withdrawal by Subject|0|||
164444544|NCT00232180|593997727|FG002|Open Label Phase|Withdrawal by Subject|37|||
164444545|NCT00232180|593997725|FG000|Open Label Phase|Other|0|||
164444546|NCT00232180|593997726|FG001|Open Label Phase|Other|0|||
164444547|NCT00232180|593997727|FG002|Open Label Phase|Other|16|||
164444548|NCT00232180|593997725|FG000|Open Label Phase|Adverse Event|0|||
164444549|NCT00232180|593997726|FG001|Open Label Phase|Adverse Event|0|||
164444550|NCT00232180|593997727|FG002|Open Label Phase|Adverse Event|25|||
164444551|NCT00232180|593997725|FG000|Open Label Phase|Laboratory abnormality|0|||
164444552|NCT00232180|593997726|FG001|Open Label Phase|Laboratory abnormality|0|||
164444553|NCT00232180|593997727|FG002|Open Label Phase|Laboratory abnormality|10|||
164444554|NCT00232180|593997725|FG000|Open Label Phase|Randomized but not treated|0|||
164444555|NCT00232180|593997726|FG001|Open Label Phase|Randomized but not treated|0|||
164444556|NCT00232180|593997727|FG002|Open Label Phase|Randomized but not treated|1|||
164444557|NCT02748317|593997728|FG000|Overall Study|Withdrawal by Subject|14|||
164444558|NCT02748317|593997728|FG000|Overall Study|Lost to Follow-up|8|||
164444559|NCT02748317|593997728|FG000|Overall Study|Death|1|||
164444560|NCT03452189|593997729|FG000|First Intervention (3 Months)|Adverse Event|1|||
164444561|NCT03452189|593997730|FG001|First Intervention (3 Months)|Adverse Event|0|||
164444562|NCT03452189|593997729|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
164444563|NCT03452189|593997730|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
164444564|NCT02724592|593997731|FG000|Overall Study|Lost to Follow-up|4|||
164444565|NCT02724592|593997732|FG001|Overall Study|Lost to Follow-up|1|||
164444566|NCT00434304|593997733|FG000|Overall Study|Adverse Event|14|||
164444567|NCT00434304|593997733|FG000|Overall Study|Lack of Efficacy|2|||
164444568|NCT00434304|593997733|FG000|Overall Study|Withdrawal by Subject|4|||
164444569|NCT05262738|593997734|FG000|Overall Study|Withdrawal by Subject|1|||
164444570|NCT05262738|593997735|FG001|Overall Study|Withdrawal by Subject|0|||
164444571|NCT01424397|593997739|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
164444572|NCT01424397|593997740|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
164444573|NCT01424397|593997741|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
164444574|NCT01424397|593997742|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
164444575|NCT01424397|593997743|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
164444576|NCT01424397|593997744|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
164444577|NCT01424397|593997745|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
164706120|NCT02752906|594953365|FG001|Overall Study|Lost to Follow-up|2|||
164706121|NCT03283319|594953367|FG000|Overall Study|Lost to Follow-up|5|||
164706122|NCT03283319|594953368|FG001|Overall Study|Lost to Follow-up|4|||
164706123|NCT03283319|594953369|FG002|Overall Study|Lost to Follow-up|5|||
164706124|NCT03283319|594953370|FG003|Overall Study|Lost to Follow-up|5|||
164706125|NCT03283319|594953371|FG004|Overall Study|Lost to Follow-up|4|||
164706126|NCT03283319|594953372|FG005|Overall Study|Lost to Follow-up|3|||
164706127|NCT03283319|594953367|FG000|Overall Study|Withdrawal by Subject|2|||
164444578|NCT01424397|593997746|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
164444579|NCT01424397|593997747|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
164444580|NCT01424397|593997748|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
164444581|NCT01424397|593997749|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
164444582|NCT01424397|593997750|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
164444583|NCT01149369|593997751|FG000|Overall Study|Adverse Event|6|||
164444584|NCT01149369|593997752|FG001|Overall Study|Adverse Event|3|||
164444585|NCT02767765|593997753|FG000|Overall Study|Adverse Event|4|||
164444586|NCT02767765|593997753|FG000|Overall Study|Death|1|||
164444587|NCT02767765|593997753|FG000|Overall Study|Insufficient response|1|||
164444588|NCT02767765|593997753|FG000|Overall Study|Lost to Follow-up|2|||
164444589|NCT02767765|593997753|FG000|Overall Study|Investigator decision|1|||
164444590|NCT02767765|593997753|FG000|Overall Study|Non-Compliance|1|||
164444591|NCT02767765|593997753|FG000|Overall Study|Withdrawal by Subject|1|||
164706128|NCT03283319|594953368|FG001|Overall Study|Withdrawal by Subject|2|||
164706129|NCT03283319|594953369|FG002|Overall Study|Withdrawal by Subject|2|||
164444592|NCT01951170|593997754|FG000|Overall Study|Investigator decision|1|||
164444593|NCT01972724|593997762|FG000|Double-Blind|Rescue Criteria Met|1|||
164444594|NCT01972724|593997763|FG001|Double-Blind|Rescue Criteria Met|0|||
164444595|NCT01972724|593997764|FG002|Double-Blind|Rescue Criteria Met|0|||
164444596|NCT01972724|593997762|FG000|Double-Blind|Adverse Event|1|||
164444597|NCT01972724|593997763|FG001|Double-Blind|Adverse Event|0|||
164444598|NCT01972724|593997764|FG002|Double-Blind|Adverse Event|0|||
164444599|NCT01972724|593997762|FG000|Double-Blind|Withdrawal of Consent|2|||
164444600|NCT01972724|593997763|FG001|Double-Blind|Withdrawal of Consent|1|||
164444601|NCT01972724|593997764|FG002|Double-Blind|Withdrawal of Consent|0|||
164444602|NCT01972724|593997762|FG000|Double-Blind|Significant Protocol Deviation|5|||
164144039|NCT00086281|592888578|FG007|Phase 2|Adverse Event|0|||
164444603|NCT01972724|593997763|FG001|Double-Blind|Significant Protocol Deviation|8|||
164444604|NCT01972724|593997764|FG002|Double-Blind|Significant Protocol Deviation|0|||
164444605|NCT01972724|593997762|FG000|Open-Label|Withdrew Consent|0|||
164444606|NCT01972724|593997763|FG001|Open-Label|Withdrew Consent|0|||
164444607|NCT01972724|593997764|FG002|Open-Label|Withdrew Consent|3|||
164444608|NCT01972724|593997762|FG000|Open-Label|Significant Protocol Deviation|0|||
164444609|NCT01972724|593997763|FG001|Open-Label|Significant Protocol Deviation|0|||
164444610|NCT01972724|593997764|FG002|Open-Label|Significant Protocol Deviation|2|||
164444611|NCT00277355|593997765|FG000|Overall Study|Withdrawal by Subject|3|||
164444612|NCT00277355|593997766|FG001|Overall Study|Withdrawal by Subject|3|||
164444613|NCT00277355|593997765|FG000|Overall Study|Lost to Follow-up|2|||
164444614|NCT00277355|593997766|FG001|Overall Study|Lost to Follow-up|2|||
164444615|NCT00277355|593997765|FG000|Overall Study|Adverse Event|5|||
164444616|NCT00277355|593997766|FG001|Overall Study|Adverse Event|0|||
164444617|NCT00277355|593997765|FG000|Overall Study|Death|3|||
164444618|NCT00277355|593997766|FG001|Overall Study|Death|0|||
164444619|NCT00277355|593997765|FG000|Overall Study|Physician Decision|1|||
164444620|NCT00277355|593997766|FG001|Overall Study|Physician Decision|0|||
164444621|NCT00668863|593997769|FG000|Overall Study|Objective Progression or Relapse|42|||
164444622|NCT00668863|593997769|FG000|Overall Study|Adverse Event|13|||
164444623|NCT00668863|593997769|FG000|Overall Study|Study Terminated by Sponsor|8|||
164444624|NCT00668863|593997769|FG000|Overall Study|Global Deterioration of Health Status|4|||
164444625|NCT00668863|593997769|FG000|Overall Study|Withdrawal by Subject|1|||
164444626|NCT00668863|593997769|FG000|Overall Study|Surgery|1|||
164444627|NCT00668863|593997769|FG000|Overall Study|Subject's work scheduling problem|1|||
164444628|NCT00668863|593997769|FG000|Overall Study|Physician Decision|1|||
164444629|NCT00665444|593997770|FG000|Overall Study|Physician Decision|1|||
164444630|NCT00665444|593997770|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
164444631|NCT01061151|593997773|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
164444632|NCT01061151|593997774|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
164444633|NCT01061151|593997775|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
164444634|NCT01061151|593997776|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
164444635|NCT01061151|593997773|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
164444636|NCT01061151|593997774|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
164444637|NCT01061151|593997775|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
164444638|NCT01061151|593997776|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
164444639|NCT01061151|593997773|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
164444640|NCT01061151|593997774|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
164444641|NCT01061151|593997775|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
164444642|NCT01061151|593997776|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
164444643|NCT01061151|593997773|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
164444644|NCT01061151|593997774|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
164444645|NCT01061151|593997775|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
164444646|NCT01061151|593997776|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
164444647|NCT01061151|593997773|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
164444648|NCT01061151|593997774|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
164444649|NCT01061151|593997775|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
164444650|NCT01061151|593997776|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
164444651|NCT01061151|593997773|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
164444652|NCT01061151|593997774|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
164444653|NCT01061151|593997775|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
164444654|NCT01061151|593997776|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
164444655|NCT01061151|593997773|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
164444656|NCT01061151|593997774|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
164444657|NCT01061151|593997775|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
164444658|NCT01061151|593997776|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
164444659|NCT01061151|593997773|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
164444660|NCT01061151|593997774|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
164444661|NCT01061151|593997775|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
164444662|NCT01061151|593997776|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
164444663|NCT01061151|593997773|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
164444664|NCT01061151|593997774|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
164444665|NCT01061151|593997775|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
164444666|NCT01061151|593997776|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
164706130|NCT03283319|594953370|FG003|Overall Study|Withdrawal by Subject|1|||
164706131|NCT03283319|594953371|FG004|Overall Study|Withdrawal by Subject|0|||
164444667|NCT01061151|593997773|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
164706132|NCT03283319|594953372|FG005|Overall Study|Withdrawal by Subject|1|||
164444668|NCT01061151|593997774|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
164706133|NCT03283319|594953367|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
164444669|NCT01061151|593997775|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
164444670|NCT01061151|593997776|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
164444671|NCT01061151|593997773|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
164444672|NCT01061151|593997774|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
164444673|NCT01061151|593997775|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
164444674|NCT01061151|593997776|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
164444675|NCT01061151|593997773|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
164444676|NCT01061151|593997774|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
164444677|NCT01061151|593997775|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
164444678|NCT01061151|593997776|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
164444679|NCT01061151|593997773|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
164444680|NCT01061151|593997774|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
164444681|NCT01061151|593997775|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
164444682|NCT01061151|593997776|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
164444683|NCT01061151|593997773|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
164444684|NCT01061151|593997774|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
164444685|NCT01061151|593997775|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
164444686|NCT01061151|593997776|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
164444687|NCT01061151|593997773|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
164444688|NCT01061151|593997774|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
164444689|NCT01061151|593997775|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
164444690|NCT01061151|593997776|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
164444691|NCT03756571|593997786|FG000|Overall Study|Lost to Follow-up|1|||
164444692|NCT03756571|593997787|FG001|Overall Study|Lost to Follow-up|1|||
164444693|NCT02379819|593997788|FG000|Overall Study|Withdrawal by Subject|10|||
164444694|NCT02379819|593997788|FG000|Overall Study|Death|2|||
164444695|NCT02379819|593997788|FG000|Overall Study|Lack of Efficacy|1|||
164444696|NCT02379819|593997788|FG000|Overall Study|Lost to Follow-up|1|||
164444697|NCT00529516|593997789|FG000|Overall Study|Adverse Event|2|||
164444698|NCT00529516|593997790|FG001|Overall Study|Adverse Event|1|||
164444699|NCT00529516|593997791|FG002|Overall Study|Adverse Event|0|||
164444700|NCT00529516|593997789|FG000|Overall Study|Withdrawal by Subject|1|||
164444701|NCT00529516|593997790|FG001|Overall Study|Withdrawal by Subject|1|||
164444702|NCT00529516|593997791|FG002|Overall Study|Withdrawal by Subject|0|||
164444703|NCT00529516|593997789|FG000|Overall Study|Lost to Follow-up|0|||
164444704|NCT00529516|593997790|FG001|Overall Study|Lost to Follow-up|0|||
164444705|NCT00529516|593997791|FG002|Overall Study|Lost to Follow-up|1|||
164444706|NCT03752151|593997792|FG000|Overall Study|Withdrawal by Subject|1|||
164444707|NCT03752151|593997792|FG000|Overall Study|Protocol Violation|1|||
164444708|NCT04056624|593997793|FG000|Overall Study|Withdrawal by Subject|0|||
164444709|NCT04056624|593997794|FG001|Overall Study|Withdrawal by Subject|0|||
164444710|NCT04056624|593997795|FG002|Overall Study|Withdrawal by Subject|1|||
164444711|NCT04056624|593997793|FG000|Overall Study|Protocol Violation|1|||
164444712|NCT04056624|593997794|FG001|Overall Study|Protocol Violation|2|||
164444713|NCT04056624|593997795|FG002|Overall Study|Protocol Violation|0|||
164444714|NCT00703820|593997799|FG000|Overall Study|Adverse Event|12|||
164444715|NCT00703820|593997800|FG001|Overall Study|Adverse Event|17|||
164444716|NCT00703820|593997799|FG000|Overall Study|Death|5|||
164444717|NCT00703820|593997800|FG001|Overall Study|Death|0|||
164444718|NCT00703820|593997799|FG000|Overall Study|Lack of Efficacy|11|||
164444719|NCT00703820|593997800|FG001|Overall Study|Lack of Efficacy|11|||
164444720|NCT00703820|593997799|FG000|Overall Study|Received non-protocol therapy|1|||
164444721|NCT00703820|593997800|FG001|Overall Study|Received non-protocol therapy|0|||
164444722|NCT00703820|593997799|FG000|Overall Study|Physician Decision|4|||
164444723|NCT00703820|593997800|FG001|Overall Study|Physician Decision|5|||
164444724|NCT00703820|593997799|FG000|Overall Study|Withdrawal by Subject|2|||
164444725|NCT00703820|593997800|FG001|Overall Study|Withdrawal by Subject|1|||
164444726|NCT03451721|593997803|FG000|Overall Study|Death|1|||
164444727|NCT01546753|593997806|FG000|Overall Study|anxiety|1|||
164444728|NCT01546753|593997807|FG001|Overall Study|anxiety|1|||
164444729|NCT01546753|593997806|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
164444730|NCT01546753|593997807|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
164444731|NCT00960141|593997808|FG000|Overall Study|Adverse Event|4|||
164444732|NCT00960141|593997809|FG001|Overall Study|Adverse Event|8|||
164444733|NCT00960141|593997810|FG002|Overall Study|Adverse Event|2|||
164444734|NCT00960141|593997808|FG000|Overall Study|Lack of Efficacy|3|||
164444735|NCT00960141|593997809|FG001|Overall Study|Lack of Efficacy|4|||
164444736|NCT00960141|593997810|FG002|Overall Study|Lack of Efficacy|2|||
164444737|NCT00960141|593997808|FG000|Overall Study|Lost to Follow-up|1|||
164444738|NCT00960141|593997809|FG001|Overall Study|Lost to Follow-up|0|||
164444739|NCT00960141|593997810|FG002|Overall Study|Lost to Follow-up|0|||
164596837|NCT01718509|594548991|FG000|Overall Study|Protocol Violation|4|||
164596838|NCT01718509|594548992|FG001|Overall Study|Protocol Violation|2|||
164596839|NCT01718509|594548991|FG000|Overall Study|Lack of Efficacy|1|||
164444740|NCT00960141|593997808|FG000|Overall Study|Protocol Violation|1|||
164444741|NCT00960141|593997809|FG001|Overall Study|Protocol Violation|3|||
164444742|NCT00960141|593997810|FG002|Overall Study|Protocol Violation|2|||
164444743|NCT00960141|593997808|FG000|Overall Study|Withdrawal by Subject|1|||
164444744|NCT00960141|593997809|FG001|Overall Study|Withdrawal by Subject|2|||
164444745|NCT00960141|593997810|FG002|Overall Study|Withdrawal by Subject|1|||
164444746|NCT03036813|593997812|FG000|Overall Study|Adverse Event|6|||
164444747|NCT03036813|593997813|FG001|Overall Study|Adverse Event|11|||
164444748|NCT03036813|593997814|FG002|Overall Study|Adverse Event|6|||
164444749|NCT03036813|593997812|FG000|Overall Study|Withdrawal by Subject|12|||
164444750|NCT03036813|593997813|FG001|Overall Study|Withdrawal by Subject|6|||
164444751|NCT03036813|593997814|FG002|Overall Study|Withdrawal by Subject|10|||
164444752|NCT03036813|593997812|FG000|Overall Study|Lost to Follow-up|1|||
164444753|NCT03036813|593997813|FG001|Overall Study|Lost to Follow-up|1|||
164444754|NCT03036813|593997814|FG002|Overall Study|Lost to Follow-up|0|||
164444755|NCT03036813|593997812|FG000|Overall Study|Physician Decision|2|||
164444756|NCT03036813|593997813|FG001|Overall Study|Physician Decision|1|||
164444757|NCT03036813|593997814|FG002|Overall Study|Physician Decision|1|||
164444758|NCT03036813|593997812|FG000|Overall Study|Non-Compliance|1|||
164444759|NCT03036813|593997813|FG001|Overall Study|Non-Compliance|5|||
164444760|NCT03036813|593997814|FG002|Overall Study|Non-Compliance|3|||
164444761|NCT03036813|593997812|FG000|Overall Study|Pregnancy|0|||
164444762|NCT03036813|593997813|FG001|Overall Study|Pregnancy|0|||
164444763|NCT03036813|593997814|FG002|Overall Study|Pregnancy|1|||
164444764|NCT03036813|593997812|FG000|Overall Study|Other|0|||
164444765|NCT03036813|593997813|FG001|Overall Study|Other|3|||
164444766|NCT03036813|593997814|FG002|Overall Study|Other|5|||
164444767|NCT01102231|593997815|FG000|Overall Study|Protocol Violation|3|||
164444768|NCT01102231|593997815|FG000|Overall Study|Lack of Efficacy|2|||
164444769|NCT01102231|593997815|FG000|Overall Study|Death|2|||
164444770|NCT01102231|593997815|FG000|Overall Study|Adverse Event|3|||
164444771|NCT01102231|593997815|FG000|Overall Study|Withdrawal by Subject|1|||
164444772|NCT01102231|593997815|FG000|Overall Study|Did not received the treatment|4|||
164444773|NCT01236560|593997822|FG000|Overall Study|Adverse Event|0|||
164444774|NCT01236560|593997823|FG001|Overall Study|Adverse Event|2|||
164444775|NCT01236560|593997824|FG002|Overall Study|Adverse Event|1|||
164444776|NCT01236560|593997825|FG003|Overall Study|Adverse Event|3|||
164444777|NCT01236560|593997826|FG004|Overall Study|Adverse Event|0|||
164444778|NCT01236560|593997827|FG005|Overall Study|Adverse Event|0|||
164444779|NCT01236560|593997822|FG000|Overall Study|Death|0|||
164444780|NCT01236560|593997823|FG001|Overall Study|Death|1|||
164444781|NCT01236560|593997824|FG002|Overall Study|Death|0|||
164444782|NCT01236560|593997825|FG003|Overall Study|Death|1|||
164444783|NCT01236560|593997826|FG004|Overall Study|Death|0|||
164444784|NCT01236560|593997827|FG005|Overall Study|Death|0|||
164444785|NCT01236560|593997822|FG000|Overall Study|Lost to Follow-up|0|||
164444786|NCT01236560|593997823|FG001|Overall Study|Lost to Follow-up|1|||
164444787|NCT01236560|593997824|FG002|Overall Study|Lost to Follow-up|1|||
164444788|NCT01236560|593997825|FG003|Overall Study|Lost to Follow-up|0|||
164444789|NCT01236560|593997826|FG004|Overall Study|Lost to Follow-up|0|||
164444790|NCT01236560|593997827|FG005|Overall Study|Lost to Follow-up|0|||
164444791|NCT01236560|593997822|FG000|Overall Study|Physician Decision|0|||
164444792|NCT01236560|593997823|FG001|Overall Study|Physician Decision|1|||
164444793|NCT01236560|593997824|FG002|Overall Study|Physician Decision|8|||
164444794|NCT01236560|593997825|FG003|Overall Study|Physician Decision|0|||
164444795|NCT01236560|593997826|FG004|Overall Study|Physician Decision|0|||
164444796|NCT01236560|593997827|FG005|Overall Study|Physician Decision|0|||
164444797|NCT01236560|593997822|FG000|Overall Study|Withdrawal by Subject|0|||
164444798|NCT01236560|593997823|FG001|Overall Study|Withdrawal by Subject|0|||
164444799|NCT01236560|593997824|FG002|Overall Study|Withdrawal by Subject|1|||
164444800|NCT01236560|593997825|FG003|Overall Study|Withdrawal by Subject|2|||
164444801|NCT01236560|593997826|FG004|Overall Study|Withdrawal by Subject|0|||
164706134|NCT03283319|594953368|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
164444802|NCT01236560|593997827|FG005|Overall Study|Withdrawal by Subject|0|||
164444803|NCT01236560|593997822|FG000|Overall Study|Progressive disease|5|||
164706135|NCT03283319|594953369|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
164706136|NCT03283319|594953370|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
164444804|NCT01236560|593997823|FG001|Overall Study|Progressive disease|19|||
164444805|NCT01236560|593997824|FG002|Overall Study|Progressive disease|9|||
164444806|NCT01236560|593997825|FG003|Overall Study|Progressive disease|16|||
164444807|NCT01236560|593997826|FG004|Overall Study|Progressive disease|0|||
164444808|NCT01236560|593997827|FG005|Overall Study|Progressive disease|0|||
164444809|NCT04714320|593999732|FG000|Overall Study|Voluntary Withdrawal|4|||
164444810|NCT04714320|593999733|FG001|Overall Study|Voluntary Withdrawal|1|||
164444811|NCT04714320|593999734|FG002|Overall Study|Voluntary Withdrawal|2|||
164444812|NCT04714320|593999732|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
164444813|NCT04714320|593999733|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
164444814|NCT04714320|593999734|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
164444815|NCT04714320|593999732|FG000|Overall Study|Reason Not Specified|1|||
164706137|NCT03283319|594953371|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
164706138|NCT03283319|594953372|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
164706139|NCT04663295|594953373|FG000|Run-in Period|Withdrawal by Subject|3|||
164706140|NCT04663295|594953373|FG000|Overall Study Period|Pregnancy|1|||
164706141|NCT04663295|594953373|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
164403103|NCT01662063|593844262|FG000|Overall Study|Protocol Violation|1|||
164403104|NCT01662063|593844263|FG001|Overall Study|Protocol Violation|0|||
164403105|NCT01662063|593844264|FG002|Overall Study|Protocol Violation|0|||
164403106|NCT01662063|593844262|FG000|Overall Study|Withdrawal by Subject|2|||
164403107|NCT01662063|593844263|FG001|Overall Study|Withdrawal by Subject|4|||
164403108|NCT01662063|593844264|FG002|Overall Study|Withdrawal by Subject|1|||
164403109|NCT01662063|593844262|FG000|Overall Study|Physician Decision|0|||
164403110|NCT01662063|593844263|FG001|Overall Study|Physician Decision|2|||
164403111|NCT01662063|593844264|FG002|Overall Study|Physician Decision|0|||
164403112|NCT01662063|593844262|FG000|Overall Study|Other|0|||
164403113|NCT01662063|593844263|FG001|Overall Study|Other|1|||
164403114|NCT01662063|593844264|FG002|Overall Study|Other|0|||
164403115|NCT01949870|593844265|FG000|Overall Study|Lack of Efficacy|2|||
164403116|NCT01949870|593844265|FG000|Overall Study|Adverse Event|1|||
164403117|NCT01949870|593844265|FG000|Overall Study|Study termination|1|||
164403118|NCT01949870|593844265|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
164403119|NCT01477853|593844266|FG000|Phase A|Adverse Event|1|||
164403120|NCT01477853|593844267|FG001|Phase A|Adverse Event|2|||
164403121|NCT01477853|593844268|FG002|Phase A|Adverse Event|2|||
164403122|NCT01477853|593844266|FG000|Phase A|Lost to Follow-up|4|||
164403123|NCT01477853|593844267|FG001|Phase A|Lost to Follow-up|3|||
164403124|NCT01477853|593844268|FG002|Phase A|Lost to Follow-up|2|||
164403125|NCT01477853|593844266|FG000|Phase A|Physician Decision|1|||
164403126|NCT01477853|593844267|FG001|Phase A|Physician Decision|0|||
164403127|NCT01477853|593844268|FG002|Phase A|Physician Decision|1|||
164403128|NCT01477853|593844266|FG000|Phase A|Study terminated by sponsor|37|||
164403129|NCT01477853|593844267|FG001|Phase A|Study terminated by sponsor|40|||
164403130|NCT01477853|593844268|FG002|Phase A|Study terminated by sponsor|39|||
164403131|NCT01477853|593844266|FG000|Phase B|Lost to Follow-up|0|||
164403132|NCT01477853|593844267|FG001|Phase B|Lost to Follow-up|1|||
164403133|NCT01477853|593844268|FG002|Phase B|Lost to Follow-up|0|||
164403134|NCT01477853|593844266|FG000|Phase B|Study terminated by sponsor|12|||
164403135|NCT01477853|593844267|FG001|Phase B|Study terminated by sponsor|10|||
164403136|NCT01477853|593844268|FG002|Phase B|Study terminated by sponsor|11|||
164403137|NCT03086330|593844269|FG000|Overall Study|Withdrawal by Subject|3|||
164403138|NCT03086330|593844270|FG001|Overall Study|Withdrawal by Subject|2|||
164403139|NCT03086330|593844269|FG000|Overall Study|Lost to Follow-up|1|||
164403140|NCT03086330|593844270|FG001|Overall Study|Lost to Follow-up|2|||
164403141|NCT01970462|593844271|FG000|Overall Study|Lost to Follow-up|0|||
164403142|NCT01970462|593844272|FG001|Overall Study|Lost to Follow-up|2|||
164403143|NCT02740049|593844273|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
164403144|NCT04570436|593844277|FG000|Overall Study|Adverse Event|0|||
164403145|NCT04570436|593844278|FG001|Overall Study|Adverse Event|0|||
164403146|NCT04570436|593844279|FG002|Overall Study|Adverse Event|1|||
164403147|NCT04570436|593844280|FG003|Overall Study|Adverse Event|0|||
164403148|NCT04570436|593844281|FG004|Overall Study|Adverse Event|0|||
164403149|NCT04570436|593844282|FG005|Overall Study|Adverse Event|0|||
164403150|NCT04570436|593844283|FG006|Overall Study|Adverse Event|0|||
164403151|NCT04570436|593844284|FG007|Overall Study|Adverse Event|0|||
164403152|NCT04570436|593844285|FG008|Overall Study|Adverse Event|0|||
164403153|NCT04570436|593844286|FG009|Overall Study|Adverse Event|0|||
164403154|NCT04570436|593844277|FG000|Overall Study|Physician Decision|1|||
164403155|NCT04570436|593844278|FG001|Overall Study|Physician Decision|0|||
164403156|NCT04570436|593844279|FG002|Overall Study|Physician Decision|0|||
164403157|NCT04570436|593844280|FG003|Overall Study|Physician Decision|0|||
164403158|NCT04570436|593844281|FG004|Overall Study|Physician Decision|0|||
164403159|NCT04570436|593844282|FG005|Overall Study|Physician Decision|0|||
164403160|NCT04570436|593844283|FG006|Overall Study|Physician Decision|0|||
164403161|NCT04570436|593844284|FG007|Overall Study|Physician Decision|0|||
164403162|NCT04570436|593844285|FG008|Overall Study|Physician Decision|0|||
164403163|NCT04570436|593844286|FG009|Overall Study|Physician Decision|0|||
164403164|NCT00645164|593844287|FG000|Overall Study|Lost to Follow-up|2|||
164403165|NCT00645164|593844287|FG000|Overall Study|Withdrawal by Subject|4|||
164403166|NCT00645164|593844287|FG000|Overall Study|Protocol Violation|1|||
164403167|NCT03172702|593844288|FG000|Overall Study|Adverse Event|9|||
164403168|NCT03172702|593844288|FG000|Overall Study|Death|2|||
164403169|NCT03172702|593844288|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
164403170|NCT03172702|593844288|FG000|Overall Study|Withdrawal by Subject|5|||
164403171|NCT03172702|593844288|FG000|Overall Study|Other|2|||
164403172|NCT04280562|593844291|FG000|Study|Adverse Event|2|||
164403173|NCT04280562|593844292|FG001|Study|Adverse Event|0|||
164403174|NCT04280562|593844291|FG000|Study|Lost to Follow-up|3|||
164403175|NCT04280562|593844292|FG001|Study|Lost to Follow-up|3|||
164403176|NCT02061202|593844293|FG000|Overall Study|Lost to Follow-up|1|||
164403177|NCT02061202|593844294|FG001|Overall Study|Lost to Follow-up|1|||
164444816|NCT04714320|593999733|FG001|Overall Study|Reason Not Specified|3|||
164444817|NCT04714320|593999734|FG002|Overall Study|Reason Not Specified|3|||
164444818|NCT04755660|593999739|FG000|Overall Study|Lost to Follow-up|1|||
164444819|NCT04755660|593999740|FG001|Overall Study|Lost to Follow-up|1|||
164444820|NCT04755660|593999741|FG002|Overall Study|Lost to Follow-up|0|||
164444821|NCT04755660|593999739|FG000|Overall Study|Withdrawal by Subject|0|||
164444822|NCT04755660|593999740|FG001|Overall Study|Withdrawal by Subject|1|||
164444823|NCT04755660|593999741|FG002|Overall Study|Withdrawal by Subject|1|||
164444824|NCT04755660|593999739|FG000|Overall Study|Physician Decision|0|||
164444825|NCT04755660|593999740|FG001|Overall Study|Physician Decision|0|||
164444826|NCT04755660|593999741|FG002|Overall Study|Physician Decision|1|||
164444827|NCT04524390|593999743|FG000|Double Blind|Consent Withdrawal by subject|2|||
164444828|NCT04524390|593999744|FG001|Double Blind|Consent Withdrawal by subject|1|||
164444829|NCT04524390|593999745|FG002|Double Blind|Consent Withdrawal by subject|0|||
164444830|NCT04524390|593999743|FG000|Double Blind|Adverse Event|5|||
164444831|NCT04524390|593999744|FG001|Double Blind|Adverse Event|3|||
164444832|NCT04524390|593999745|FG002|Double Blind|Adverse Event|0|||
164444833|NCT04524390|593999743|FG000|Double Blind|Liver Transplant|5|||
164444834|NCT04524390|593999744|FG001|Double Blind|Liver Transplant|6|||
164444835|NCT04524390|593999745|FG002|Double Blind|Liver Transplant|0|||
164444836|NCT04524390|593999743|FG000|Double Blind|Disease Progression|0|||
164444837|NCT04524390|593999744|FG001|Double Blind|Disease Progression|1|||
164444838|NCT04524390|593999745|FG002|Double Blind|Disease Progression|0|||
164444839|NCT04524390|593999743|FG000|Open-Label|Drug interruption criteria|0|||
164444840|NCT04524390|593999744|FG001|Open-Label|Drug interruption criteria|0|||
164444841|NCT04524390|593999745|FG002|Open-Label|Drug interruption criteria|1|||
164444842|NCT04524390|593999743|FG000|Open-Label|Liver Transplant|0|||
164444843|NCT04524390|593999744|FG001|Open-Label|Liver Transplant|0|||
164444844|NCT04524390|593999745|FG002|Open-Label|Liver Transplant|1|||
164444845|NCT04524390|593999743|FG000|Open-Label|Disease Progression|0|||
164444846|NCT04524390|593999744|FG001|Open-Label|Disease Progression|0|||
164444847|NCT04524390|593999745|FG002|Open-Label|Disease Progression|1|||
164444848|NCT04524390|593999743|FG000|Open-Label|Adverse Event|0|||
164444849|NCT04524390|593999744|FG001|Open-Label|Adverse Event|0|||
164444850|NCT04524390|593999745|FG002|Open-Label|Adverse Event|3|||
164444851|NCT04524390|593999743|FG000|Open-Label|Study Termination by sponsor|0|||
164444852|NCT04524390|593999744|FG001|Open-Label|Study Termination by sponsor|0|||
164444853|NCT04524390|593999745|FG002|Open-Label|Study Termination by sponsor|45|||
164444854|NCT02765100|593999746|FG000|Overall Study|subject found ineligible after baseline|1|||
164444855|NCT02765100|593999747|FG001|Overall Study|subject found ineligible after baseline|1|||
164444856|NCT02765100|593999746|FG000|Overall Study|Lost to Follow-up|0|||
164444857|NCT02765100|593999747|FG001|Overall Study|Lost to Follow-up|1|||
164444858|NCT02597920|593999748|FG000|Overall Study|Worsening of other pre-existing disease|0|||
164444859|NCT02597920|593999749|FG001|Overall Study|Worsening of other pre-existing disease|1|||
164444860|NCT02597920|593999750|FG002|Overall Study|Worsening of other pre-existing disease|0|||
164444861|NCT02597920|593999748|FG000|Overall Study|Other adverse event|20|||
164444862|NCT02597920|593999749|FG001|Overall Study|Other adverse event|30|||
164444863|NCT02597920|593999750|FG002|Overall Study|Other adverse event|0|||
164444864|NCT02597920|593999748|FG000|Overall Study|Lost to Follow-up|7|||
164444865|NCT02597920|593999749|FG001|Overall Study|Lost to Follow-up|9|||
164444866|NCT02597920|593999750|FG002|Overall Study|Lost to Follow-up|0|||
164444867|NCT02597920|593999748|FG000|Overall Study|Refuse to continue in the study|3|||
164444868|NCT02597920|593999749|FG001|Overall Study|Refuse to continue in the study|13|||
164444869|NCT02597920|593999750|FG002|Overall Study|Refuse to continue in the study|1|||
164444870|NCT02597920|593999748|FG000|Overall Study|Other than specified|10|||
164444871|NCT02597920|593999749|FG001|Overall Study|Other than specified|31|||
164444872|NCT02597920|593999750|FG002|Overall Study|Other than specified|5|||
164444873|NCT02597920|593999748|FG000|Overall Study|Other|1|||
164444874|NCT02597920|593999749|FG001|Overall Study|Other|0|||
164444875|NCT02597920|593999750|FG002|Overall Study|Other|0|||
164444876|NCT04532528|593999756|FG000|Overall Study|Adverse Event|12|||
164444877|NCT04532528|593999757|FG001|Overall Study|Adverse Event|17|||
164444878|NCT04532528|593999756|FG000|Overall Study|Withdrawal of consent|16|||
164444879|NCT04532528|593999757|FG001|Overall Study|Withdrawal of consent|17|||
164444880|NCT04532528|593999756|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
164444881|NCT04532528|593999757|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
164444882|NCT04532528|593999756|FG000|Overall Study|Lost to Follow-up|69|||
164596840|NCT01718509|594548992|FG001|Overall Study|Lack of Efficacy|0|||
164596841|NCT02052778|594548993|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
164596842|NCT02052778|594548994|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
164596843|NCT02052778|594548995|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
164596844|NCT02052778|594548996|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
164444883|NCT04532528|593999757|FG001|Overall Study|Lost to Follow-up|68|||
164444884|NCT04532528|593999756|FG000|Overall Study|Administrative problems|12|||
164444885|NCT04532528|593999757|FG001|Overall Study|Administrative problems|14|||
164444886|NCT04532528|593999756|FG000|Overall Study|Death|3|||
164706142|NCT00554190|594953374|FG000|Overall Study|Termination forms not completed|10|||
164706143|NCT01502410|594953376|FG000|Overall Study|Adverse Event|1|||
164403178|NCT00162370|593844295|FG000|Efficacy Population|Lost to Follow-up|51|||
164403179|NCT04559568|593844296|FG000|Overall Study|Physician Decision|0|||
164403180|NCT04559568|593844297|FG001|Overall Study|Physician Decision|0|||
164403181|NCT04559568|593844298|FG002|Overall Study|Physician Decision|0|||
164403182|NCT04559568|593844299|FG003|Overall Study|Physician Decision|0|||
164403183|NCT04559568|593844300|FG004|Overall Study|Physician Decision|0|||
164403184|NCT04559568|593844301|FG005|Overall Study|Physician Decision|0|||
164403185|NCT04559568|593844302|FG006|Overall Study|Physician Decision|0|||
164403186|NCT04559568|593844303|FG007|Overall Study|Physician Decision|0|||
164403187|NCT04559568|593844304|FG008|Overall Study|Physician Decision|0|||
164403188|NCT04559568|593844305|FG009|Overall Study|Physician Decision|1|||
164403189|NCT04559568|593844306|FG010|Overall Study|Physician Decision|0|||
164403190|NCT04559568|593844296|FG000|Overall Study|Withdrawal by Subject|0|||
164403191|NCT04559568|593844297|FG001|Overall Study|Withdrawal by Subject|0|||
164403192|NCT04559568|593844298|FG002|Overall Study|Withdrawal by Subject|0|||
164403193|NCT04559568|593844299|FG003|Overall Study|Withdrawal by Subject|0|||
164403194|NCT04559568|593844300|FG004|Overall Study|Withdrawal by Subject|0|||
164403195|NCT04559568|593844301|FG005|Overall Study|Withdrawal by Subject|0|||
164403196|NCT04559568|593844302|FG006|Overall Study|Withdrawal by Subject|0|||
164403197|NCT04559568|593844303|FG007|Overall Study|Withdrawal by Subject|0|||
164403198|NCT04559568|593844304|FG008|Overall Study|Withdrawal by Subject|0|||
164403199|NCT04559568|593844305|FG009|Overall Study|Withdrawal by Subject|0|||
164403200|NCT04559568|593844306|FG010|Overall Study|Withdrawal by Subject|1|||
164403201|NCT03721965|593844311|FG000|Overall Study|Death|1|||
164403202|NCT03721965|593844311|FG000|Overall Study|Study Terminated by Sponsor|1|||
164403203|NCT01494584|593844319|FG000|Overall Study|Study Closed/Terminated|1|||
164403204|NCT01218126|593844322|FG000|Overall Study|Adverse Event|8|||
164403205|NCT01218126|593844323|FG001|Overall Study|Adverse Event|10|||
164403206|NCT01218126|593844324|FG002|Overall Study|Adverse Event|12|||
164403207|NCT01218126|593844325|FG003|Overall Study|Adverse Event|16|||
164403208|NCT01218126|593844322|FG000|Overall Study|Lack of Efficacy|7|||
164403209|NCT01218126|593844323|FG001|Overall Study|Lack of Efficacy|2|||
164403210|NCT01218126|593844324|FG002|Overall Study|Lack of Efficacy|2|||
164403211|NCT01218126|593844325|FG003|Overall Study|Lack of Efficacy|6|||
164403212|NCT01218126|593844322|FG000|Overall Study|Protocol Violation|5|||
164403213|NCT01218126|593844323|FG001|Overall Study|Protocol Violation|2|||
164403214|NCT01218126|593844324|FG002|Overall Study|Protocol Violation|2|||
164403215|NCT01218126|593844325|FG003|Overall Study|Protocol Violation|3|||
164403216|NCT01218126|593844322|FG000|Overall Study|Protocol-defined stopping criteria|1|||
164403217|NCT01218126|593844323|FG001|Overall Study|Protocol-defined stopping criteria|1|||
164403218|NCT01218126|593844324|FG002|Overall Study|Protocol-defined stopping criteria|0|||
164403219|NCT01218126|593844325|FG003|Overall Study|Protocol-defined stopping criteria|0|||
164403220|NCT01218126|593844322|FG000|Overall Study|Lost to Follow-up|0|||
164403221|NCT01218126|593844323|FG001|Overall Study|Lost to Follow-up|0|||
164403222|NCT01218126|593844324|FG002|Overall Study|Lost to Follow-up|0|||
164403223|NCT01218126|593844325|FG003|Overall Study|Lost to Follow-up|2|||
164403224|NCT01218126|593844322|FG000|Overall Study|Physician Decision|1|||
164403225|NCT01218126|593844323|FG001|Overall Study|Physician Decision|2|||
164403226|NCT01218126|593844324|FG002|Overall Study|Physician Decision|4|||
164403227|NCT01218126|593844325|FG003|Overall Study|Physician Decision|2|||
164403228|NCT01218126|593844322|FG000|Overall Study|Withdrawal by Subject|2|||
164403229|NCT01218126|593844323|FG001|Overall Study|Withdrawal by Subject|5|||
164403230|NCT01218126|593844324|FG002|Overall Study|Withdrawal by Subject|4|||
164403231|NCT01218126|593844325|FG003|Overall Study|Withdrawal by Subject|6|||
164444887|NCT04532528|593999757|FG001|Overall Study|Death|3|||
164706144|NCT01502410|594953377|FG001|Overall Study|Adverse Event|2|||
164706145|NCT01502410|594953378|FG002|Overall Study|Adverse Event|0|||
164706146|NCT01502410|594953379|FG003|Overall Study|Adverse Event|0|||
164706147|NCT01502410|594953376|FG000|Overall Study|Lack of Efficacy|7|||
164706148|NCT01502410|594953377|FG001|Overall Study|Lack of Efficacy|7|||
164706149|NCT01502410|594953378|FG002|Overall Study|Lack of Efficacy|0|||
164706150|NCT01502410|594953379|FG003|Overall Study|Lack of Efficacy|0|||
164403232|NCT05380947|593844332|FG000|Washout Period 1|Not attend visit|1|||
164403233|NCT05380947|593844333|FG001|Washout Period 1|Not attend visit|0|||
164403234|NCT05380947|593844334|FG002|Washout Period 1|Not attend visit|0|||
164403235|NCT05380947|593844335|FG003|Washout Period 1|Not attend visit|0|||
164403236|NCT05380947|593844332|FG000|Washout Period 2|Adverse Event|1|||
164403237|NCT05380947|593844333|FG001|Washout Period 2|Adverse Event|0|||
164403238|NCT05380947|593844334|FG002|Washout Period 2|Adverse Event|0|||
164403239|NCT05380947|593844335|FG003|Washout Period 2|Adverse Event|0|||
164403240|NCT05380947|593844332|FG000|Washout Period 3|Adverse Event|0|||
164403241|NCT05380947|593844333|FG001|Washout Period 3|Adverse Event|1|||
164403242|NCT05380947|593844334|FG002|Washout Period 3|Adverse Event|0|||
164403243|NCT05380947|593844335|FG003|Washout Period 3|Adverse Event|0|||
164403244|NCT05380947|593844332|FG000|Washout Period 3|Not attend visit|0|||
164403245|NCT05380947|593844333|FG001|Washout Period 3|Not attend visit|1|||
164444888|NCT04532528|593999756|FG000|Overall Study|Other|38|||
164444889|NCT04532528|593999757|FG001|Overall Study|Other|46|||
164444890|NCT00244855|593999762|FG000|Overall Study|Withdrawal by Subject|0|||
164444891|NCT00244855|593999763|FG001|Overall Study|Withdrawal by Subject|1|||
164444892|NCT01068743|593999764|FG000|Period 3|Adverse Event|0|||
164444893|NCT01068743|593999765|FG001|Period 3|Adverse Event|1|||
164444894|NCT01068743|593999766|FG002|Period 3|Adverse Event|0|||
164444895|NCT01068743|593999767|FG003|Period 3|Adverse Event|0|||
164444896|NCT00293293|593999768|FG000|Overall Study|Withdrawal by Subject|1|||
164444897|NCT00293293|593999769|FG001|Overall Study|Withdrawal by Subject|1|||
164444898|NCT00293293|593999768|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
164444899|NCT00293293|593999769|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
164444900|NCT00293293|593999768|FG000|Overall Study|Patient discontinued chemotherapy|0|||
164444901|NCT00293293|593999769|FG001|Overall Study|Patient discontinued chemotherapy|1|||
164444902|NCT03740009|593999773|FG000|Overall Study|Physician Decision|9|||
164444903|NCT03740009|593999773|FG000|Overall Study|Lost to Follow-up|1|||
164444904|NCT01007396|593999774|FG000|Overall Study|Lost to Follow-up|47|||
164444905|NCT00174382|593999775|FG000|Overall Study|Death|2|||
164444906|NCT00174382|593999775|FG000|Overall Study|Adverse Event|19|||
164444907|NCT00174382|593999775|FG000|Overall Study|Withdrawal by Subject|6|||
164444908|NCT00174382|593999775|FG000|Overall Study|Protocol Violation|3|||
164444909|NCT00174382|593999775|FG000|Overall Study|Arrived early for last visit in error|1|||
164444910|NCT00174382|593999775|FG000|Overall Study|Subject felt pill not effective enough|1|||
164444911|NCT00174382|593999775|FG000|Overall Study|Lost to Follow-up|1|||
164444912|NCT03903822|593999776|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
164444913|NCT03903822|593999777|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
164444914|NCT03903822|593999778|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
164444915|NCT03903822|593999779|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
164444916|NCT03903822|593999780|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
164444917|NCT03903822|593999781|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
164444918|NCT03903822|593999782|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
164444919|NCT03903822|593999783|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
164444920|NCT03903822|593999776|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
164444921|NCT03903822|593999777|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
164444922|NCT03903822|593999778|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
164444923|NCT03903822|593999779|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
164444924|NCT03903822|593999780|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
164444925|NCT03903822|593999781|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
164444926|NCT03903822|593999782|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
164444927|NCT03903822|593999783|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
164444928|NCT03903822|593999776|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
164444929|NCT03903822|593999777|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
164444930|NCT03903822|593999778|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
164444931|NCT03903822|593999779|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
164444932|NCT03903822|593999780|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
164444933|NCT03903822|593999781|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
164444934|NCT03903822|593999782|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
164444935|NCT03903822|593999783|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
164444936|NCT03903822|593999776|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
164444937|NCT03903822|593999777|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
164444938|NCT03903822|593999778|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
164444939|NCT03903822|593999779|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
164444940|NCT03903822|593999780|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
164444941|NCT03903822|593999781|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
164444942|NCT03903822|593999782|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
164444943|NCT03903822|593999783|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
164444944|NCT03903822|593999776|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
164444945|NCT03903822|593999777|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
164444946|NCT03903822|593999778|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
164444947|NCT03903822|593999779|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
164444948|NCT03903822|593999780|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
164444949|NCT03903822|593999781|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
164444950|NCT03903822|593999782|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
164444951|NCT03903822|593999783|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
164444952|NCT03903822|593999776|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
164444953|NCT03903822|593999777|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
164444954|NCT03903822|593999778|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
164444955|NCT03903822|593999779|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
164444956|NCT03903822|593999780|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
164706151|NCT01502410|594953376|FG000|Overall Study|Physician Decision|0|||
164444957|NCT03903822|593999781|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
164444958|NCT03903822|593999782|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
164444959|NCT03903822|593999783|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
164444960|NCT03903822|593999776|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
164444961|NCT03903822|593999777|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
164444962|NCT03903822|593999778|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
164444963|NCT03903822|593999779|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
164444964|NCT03903822|593999780|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
164444965|NCT03903822|593999781|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
164444966|NCT03903822|593999782|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
164444967|NCT03903822|593999783|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
164444968|NCT03903822|593999776|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
164444969|NCT03903822|593999777|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
164444970|NCT03903822|593999778|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
164444971|NCT03903822|593999779|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
164444972|NCT03903822|593999780|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
164444973|NCT03903822|593999781|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
164444974|NCT03903822|593999782|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
164444975|NCT03903822|593999783|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
164444976|NCT03903822|593999776|FG000|Treatment Phase (6 Weeks)|Other|2|||
164444977|NCT03903822|593999777|FG001|Treatment Phase (6 Weeks)|Other|1|||
164444978|NCT03903822|593999778|FG002|Treatment Phase (6 Weeks)|Other|0|||
164444979|NCT03903822|593999779|FG003|Treatment Phase (6 Weeks)|Other|0|||
164444980|NCT03903822|593999780|FG004|Treatment Phase (6 Weeks)|Other|1|||
164444981|NCT03903822|593999781|FG005|Treatment Phase (6 Weeks)|Other|1|||
164444982|NCT03903822|593999782|FG006|Treatment Phase (6 Weeks)|Other|0|||
164444983|NCT03903822|593999783|FG007|Treatment Phase (6 Weeks)|Other|0|||
164444984|NCT03903822|593999776|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
164444985|NCT03903822|593999777|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
164444986|NCT03903822|593999778|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
164444987|NCT03903822|593999779|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
164444988|NCT03903822|593999780|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
164444989|NCT03903822|593999781|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
164444990|NCT03903822|593999782|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
164444991|NCT03903822|593999783|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
164444992|NCT03903822|593999776|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
164444993|NCT03903822|593999777|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
164444994|NCT03903822|593999778|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
164444995|NCT03903822|593999779|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
164444996|NCT03903822|593999780|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
164444997|NCT03903822|593999781|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
164444998|NCT03903822|593999782|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
164444999|NCT03903822|593999783|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
164445000|NCT03903822|593999776|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
164445001|NCT03903822|593999777|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
164445002|NCT03903822|593999778|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
164445003|NCT03903822|593999779|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
164445004|NCT03903822|593999780|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
164445005|NCT03903822|593999781|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
164445006|NCT03903822|593999782|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
164445007|NCT03903822|593999783|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
164445008|NCT03903822|593999776|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
164445009|NCT03903822|593999777|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
164445010|NCT03903822|593999778|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
164445011|NCT03903822|593999779|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
164445012|NCT03903822|593999780|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
164445013|NCT03903822|593999781|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
164445014|NCT03903822|593999782|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
164445015|NCT03903822|593999783|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
164445016|NCT03903822|593999776|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
164445017|NCT03903822|593999777|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
164445018|NCT03903822|593999778|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
164445019|NCT03903822|593999779|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
164445020|NCT03903822|593999780|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
164445021|NCT03903822|593999781|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
164445022|NCT03903822|593999782|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
164706152|NCT01502410|594953377|FG001|Overall Study|Physician Decision|1|||
164706153|NCT01502410|594953378|FG002|Overall Study|Physician Decision|0|||
164445023|NCT03903822|593999783|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
164445024|NCT03903822|593999776|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
164706154|NCT01502410|594953379|FG003|Overall Study|Physician Decision|0|||
164445025|NCT03903822|593999777|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
164445026|NCT03903822|593999778|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
164445027|NCT03903822|593999779|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
164445028|NCT03903822|593999780|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
164445029|NCT03903822|593999781|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
164445030|NCT03903822|593999782|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
164445031|NCT03903822|593999783|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
164445032|NCT03903822|593999776|FG000|Follow up Phase (4 Weeks)|Other|1|||
164445033|NCT03903822|593999777|FG001|Follow up Phase (4 Weeks)|Other|1|||
164445034|NCT03903822|593999778|FG002|Follow up Phase (4 Weeks)|Other|0|||
164445035|NCT03903822|593999779|FG003|Follow up Phase (4 Weeks)|Other|0|||
164445036|NCT03903822|593999780|FG004|Follow up Phase (4 Weeks)|Other|0|||
164445037|NCT03903822|593999781|FG005|Follow up Phase (4 Weeks)|Other|0|||
164445038|NCT03903822|593999782|FG006|Follow up Phase (4 Weeks)|Other|0|||
164445039|NCT03903822|593999783|FG007|Follow up Phase (4 Weeks)|Other|0|||
164445040|NCT00296036|593999784|FG000|Overall Study|Withdrawal by Subject|1|||
164445041|NCT00296036|593999785|FG001|Overall Study|Withdrawal by Subject|0|||
164445042|NCT00296036|593999786|FG002|Overall Study|Withdrawal by Subject|2|||
164445043|NCT00296036|593999787|FG003|Overall Study|Withdrawal by Subject|1|||
164445044|NCT00296036|593999788|FG004|Overall Study|Withdrawal by Subject|2|||
164445045|NCT00296036|593999789|FG005|Overall Study|Withdrawal by Subject|1|||
164445046|NCT00296036|593999784|FG000|Overall Study|Protocol Violation|0|||
164445047|NCT00296036|593999785|FG001|Overall Study|Protocol Violation|0|||
164445048|NCT00296036|593999786|FG002|Overall Study|Protocol Violation|0|||
164445049|NCT00296036|593999787|FG003|Overall Study|Protocol Violation|0|||
164445050|NCT00296036|593999788|FG004|Overall Study|Protocol Violation|0|||
164445051|NCT00296036|593999789|FG005|Overall Study|Protocol Violation|3|||
164445052|NCT00785512|593999792|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
164445053|NCT00785512|593999793|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
164445054|NCT00785512|593999792|FG000|Overall Study|Adverse Event|0|||
164445055|NCT00785512|593999793|FG001|Overall Study|Adverse Event|0|||
164445056|NCT00785512|593999792|FG000|Overall Study|Lack of Efficacy|0|||
164445057|NCT00785512|593999793|FG001|Overall Study|Lack of Efficacy|2|||
164445058|NCT00785512|593999792|FG000|Overall Study|Withdrawal by Subject|0|||
164445059|NCT00785512|593999793|FG001|Overall Study|Withdrawal by Subject|1|||
164445060|NCT00785512|593999792|FG000|Overall Study|Lost to Follow-up|3|||
164445061|NCT00785512|593999793|FG001|Overall Study|Lost to Follow-up|0|||
164445062|NCT00785512|593999792|FG000|Overall Study|Precedure Refused|0|||
164445063|NCT00785512|593999793|FG001|Overall Study|Precedure Refused|0|||
164445064|NCT00785512|593999792|FG000|Overall Study|IVRS Programing Error|0|||
164445065|NCT00785512|593999793|FG001|Overall Study|IVRS Programing Error|0|||
164445066|NCT00785512|593999792|FG000|Overall Study|Physician Decision|0|||
164445067|NCT00785512|593999793|FG001|Overall Study|Physician Decision|0|||
164445068|NCT00785512|593999792|FG000|Overall Study|Lack of compliance|0|||
164445069|NCT00785512|593999793|FG001|Overall Study|Lack of compliance|1|||
164445070|NCT05061693|593999796|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
164445071|NCT05061693|593999797|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
164445072|NCT05061693|593999798|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
164445073|NCT05061693|593999799|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
164445074|NCT05061693|593999800|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
164445075|NCT05061693|593999801|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
164445076|NCT05061693|593999802|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
164445077|NCT05061693|593999803|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
164445078|NCT05061693|593999804|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
164445079|NCT05061693|593999805|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
164445080|NCT05061693|593999806|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
164445081|NCT05061693|593999807|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
164445082|NCT05061693|593999796|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
164445083|NCT05061693|593999797|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
164445084|NCT05061693|593999798|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
164445085|NCT05061693|593999799|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
164445086|NCT05061693|593999800|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
164445087|NCT05061693|593999801|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
164445088|NCT05061693|593999802|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
164445089|NCT05061693|593999803|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
164445090|NCT05061693|593999804|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
164445091|NCT05061693|593999805|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
164445092|NCT05061693|593999806|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
164445093|NCT05061693|593999807|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
164445094|NCT05061693|593999796|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
164445095|NCT05061693|593999797|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
164445096|NCT05061693|593999798|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
164445097|NCT05061693|593999799|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
164445098|NCT05061693|593999800|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
164445099|NCT05061693|593999801|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
164445100|NCT05061693|593999802|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
164706155|NCT01502410|594953376|FG000|Overall Study|Withdrawal by Subject|2|||
164706156|NCT01502410|594953377|FG001|Overall Study|Withdrawal by Subject|0|||
164706157|NCT01502410|594953378|FG002|Overall Study|Withdrawal by Subject|0|||
164445101|NCT05061693|593999803|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
164445102|NCT05061693|593999804|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
164445103|NCT05061693|593999805|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
164445104|NCT05061693|593999806|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
164445105|NCT05061693|593999807|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
164445106|NCT05061693|593999796|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
164445107|NCT05061693|593999797|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
164445108|NCT05061693|593999798|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
164445109|NCT05061693|593999799|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
164445110|NCT05061693|593999800|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
164445111|NCT05061693|593999801|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
164445112|NCT05061693|593999802|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
164445113|NCT05061693|593999803|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
164445114|NCT05061693|593999804|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
164445115|NCT05061693|593999805|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
164445116|NCT05061693|593999806|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
164445117|NCT05061693|593999807|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
164445118|NCT05061693|593999796|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
164445119|NCT05061693|593999797|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
164445120|NCT05061693|593999798|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
164445121|NCT05061693|593999799|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
164445122|NCT05061693|593999800|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
164445123|NCT05061693|593999801|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
164445124|NCT05061693|593999802|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
164445125|NCT05061693|593999803|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
164445126|NCT05061693|593999804|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
164445127|NCT05061693|593999805|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
164445128|NCT05061693|593999806|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
164445129|NCT05061693|593999807|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
164445130|NCT05061693|593999796|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
164445131|NCT05061693|593999797|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
164445132|NCT05061693|593999798|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
164445133|NCT05061693|593999799|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
164445134|NCT05061693|593999800|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
164445135|NCT05061693|593999801|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
164445136|NCT05061693|593999802|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
164445137|NCT05061693|593999803|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
164445138|NCT05061693|593999804|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
164445139|NCT05061693|593999805|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
164445140|NCT05061693|593999806|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
164445141|NCT05061693|593999807|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
164445142|NCT05061693|593999796|FG000|24-week Extension Period|Adverse Event|0|||
164445143|NCT05061693|593999797|FG001|24-week Extension Period|Adverse Event|0|||
164445144|NCT05061693|593999798|FG002|24-week Extension Period|Adverse Event|0|||
164445145|NCT05061693|593999799|FG003|24-week Extension Period|Adverse Event|0|||
164445146|NCT05061693|593999800|FG004|24-week Extension Period|Adverse Event|0|||
164445147|NCT05061693|593999801|FG005|24-week Extension Period|Adverse Event|0|||
164445148|NCT05061693|593999802|FG006|24-week Extension Period|Adverse Event|0|||
164445149|NCT05061693|593999803|FG007|24-week Extension Period|Adverse Event|2|||
164445150|NCT05061693|593999804|FG008|24-week Extension Period|Adverse Event|2|||
164445151|NCT05061693|593999805|FG009|24-week Extension Period|Adverse Event|0|||
164445152|NCT05061693|593999806|FG010|24-week Extension Period|Adverse Event|1|||
164445153|NCT05061693|593999807|FG011|24-week Extension Period|Adverse Event|3|||
164445154|NCT05061693|593999796|FG000|24-week Extension Period|Lack of Efficacy|0|||
164445155|NCT05061693|593999797|FG001|24-week Extension Period|Lack of Efficacy|0|||
164445156|NCT05061693|593999798|FG002|24-week Extension Period|Lack of Efficacy|0|||
164445157|NCT05061693|593999799|FG003|24-week Extension Period|Lack of Efficacy|0|||
164445158|NCT05061693|593999800|FG004|24-week Extension Period|Lack of Efficacy|0|||
164445159|NCT05061693|593999801|FG005|24-week Extension Period|Lack of Efficacy|0|||
164445160|NCT05061693|593999802|FG006|24-week Extension Period|Lack of Efficacy|0|||
164706158|NCT01502410|594953379|FG003|Overall Study|Withdrawal by Subject|0|||
164706159|NCT01007942|594953390|FG000|Overall Study|Adverse Event|29|||
164445161|NCT05061693|593999803|FG007|24-week Extension Period|Lack of Efficacy|0|||
164445162|NCT05061693|593999804|FG008|24-week Extension Period|Lack of Efficacy|0|||
164445163|NCT05061693|593999805|FG009|24-week Extension Period|Lack of Efficacy|0|||
164445164|NCT05061693|593999806|FG010|24-week Extension Period|Lack of Efficacy|2|||
164445165|NCT05061693|593999807|FG011|24-week Extension Period|Lack of Efficacy|0|||
164445166|NCT05061693|593999796|FG000|24-week Extension Period|Lost to Follow-up|0|||
164445167|NCT05061693|593999797|FG001|24-week Extension Period|Lost to Follow-up|0|||
164445168|NCT05061693|593999798|FG002|24-week Extension Period|Lost to Follow-up|0|||
164445169|NCT05061693|593999799|FG003|24-week Extension Period|Lost to Follow-up|0|||
164445170|NCT05061693|593999800|FG004|24-week Extension Period|Lost to Follow-up|0|||
164445171|NCT05061693|593999801|FG005|24-week Extension Period|Lost to Follow-up|0|||
164445172|NCT05061693|593999802|FG006|24-week Extension Period|Lost to Follow-up|1|||
164445173|NCT05061693|593999803|FG007|24-week Extension Period|Lost to Follow-up|0|||
164445174|NCT05061693|593999804|FG008|24-week Extension Period|Lost to Follow-up|1|||
164445175|NCT05061693|593999805|FG009|24-week Extension Period|Lost to Follow-up|1|||
164445176|NCT05061693|593999806|FG010|24-week Extension Period|Lost to Follow-up|0|||
164445177|NCT05061693|593999807|FG011|24-week Extension Period|Lost to Follow-up|0|||
164445178|NCT05061693|593999796|FG000|24-week Extension Period|Withdrawal by Subject|0|||
164445179|NCT05061693|593999797|FG001|24-week Extension Period|Withdrawal by Subject|0|||
164445180|NCT05061693|593999798|FG002|24-week Extension Period|Withdrawal by Subject|0|||
164445181|NCT05061693|593999799|FG003|24-week Extension Period|Withdrawal by Subject|0|||
164445182|NCT05061693|593999800|FG004|24-week Extension Period|Withdrawal by Subject|0|||
164445183|NCT05061693|593999801|FG005|24-week Extension Period|Withdrawal by Subject|0|||
164445184|NCT05061693|593999802|FG006|24-week Extension Period|Withdrawal by Subject|0|||
164706160|NCT01007942|594953391|FG001|Overall Study|Adverse Event|14|||
164403246|NCT05380947|593844334|FG002|Washout Period 3|Not attend visit|0|||
164403247|NCT05380947|593844335|FG003|Washout Period 3|Not attend visit|1|||
164403248|NCT01563536|593844336|FG000|Overall Study|Withdrawal by Subject|0|||
164403249|NCT01563536|593844337|FG001|Overall Study|Withdrawal by Subject|2|||
164403250|NCT01563536|593844336|FG000|Overall Study|Lost to Follow-up|1|||
164403251|NCT01563536|593844337|FG001|Overall Study|Lost to Follow-up|0|||
164403252|NCT01256567|593844340|FG000|Overall Study|Withdrawal by Subject|1|||
164403253|NCT00567190|593844346|FG000|Overall Study|Death|235|||
164403254|NCT00567190|593844347|FG001|Overall Study|Death|280|||
164403255|NCT00567190|593844346|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
164403256|NCT00567190|593844347|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
164403257|NCT03184792|593844352|FG000|Overall Study|Pandemic|2|||
164403258|NCT03184792|593844353|FG001|Overall Study|Pandemic|2|||
164403259|NCT02453685|593844357|FG000|Overall Study|Adverse Event|0|||
164403260|NCT02453685|593844358|FG001|Overall Study|Adverse Event|1|||
164403261|NCT02453685|593844357|FG000|Overall Study|Protocol Violation|7|||
164403262|NCT02453685|593844358|FG001|Overall Study|Protocol Violation|4|||
164403263|NCT02453685|593844357|FG000|Overall Study|Lost to Follow-up|0|||
164403264|NCT02453685|593844358|FG001|Overall Study|Lost to Follow-up|1|||
164403265|NCT02453685|593844357|FG000|Overall Study|Withdrawal by Subject|8|||
164403266|NCT02453685|593844358|FG001|Overall Study|Withdrawal by Subject|4|||
164403267|NCT02453685|593844357|FG000|Overall Study|Unclassified|4|||
164403268|NCT02453685|593844358|FG001|Overall Study|Unclassified|2|||
164403269|NCT02778100|593844361|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
164403270|NCT02778100|593844362|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
164403271|NCT01515748|593844366|FG000|Overall Study|Withdrawal by Subject|32|||
164403272|NCT01515748|593844367|FG001|Overall Study|Withdrawal by Subject|41|||
164403273|NCT01515748|593844366|FG000|Overall Study|Lost to Follow-up|2|||
164403274|NCT01515748|593844367|FG001|Overall Study|Lost to Follow-up|4|||
164403275|NCT01515748|593844366|FG000|Overall Study|Other than specified above|5|||
164403276|NCT01515748|593844367|FG001|Overall Study|Other than specified above|10|||
164403277|NCT03221387|593844368|FG000|Overall Study|Lost to Follow-up|1|||
164403278|NCT03221387|593844368|FG000|Overall Study|Lung transplant|1|||
164403279|NCT00522626|593844369|FG000|Overall Study|Lost to Follow-up|7|||
164403280|NCT02365519|593844370|FG000|Randomized and Treated|Adverse Event|0|||
164403281|NCT02365519|593844371|FG001|Randomized and Treated|Adverse Event|1|||
164403282|NCT02365519|593844372|FG002|Randomized and Treated|Adverse Event|0|||
164403283|NCT02365519|593844370|FG000|Randomized and Treated|Withdrawal by Subject|0|||
164445185|NCT05061693|593999803|FG007|24-week Extension Period|Withdrawal by Subject|0|||
164445186|NCT05061693|593999804|FG008|24-week Extension Period|Withdrawal by Subject|1|||
164445187|NCT05061693|593999805|FG009|24-week Extension Period|Withdrawal by Subject|2|||
164445188|NCT05061693|593999806|FG010|24-week Extension Period|Withdrawal by Subject|2|||
164445189|NCT05061693|593999807|FG011|24-week Extension Period|Withdrawal by Subject|1|||
164706161|NCT01007942|594953390|FG000|Overall Study|Abnormal test procedure|0|||
164706162|NCT01007942|594953391|FG001|Overall Study|Abnormal test procedure|1|||
164706163|NCT01007942|594953390|FG000|Overall Study|Disease progression|217|||
164403284|NCT02365519|593844371|FG001|Randomized and Treated|Withdrawal by Subject|1|||
164403285|NCT02365519|593844372|FG002|Randomized and Treated|Withdrawal by Subject|1|||
164403286|NCT05809596|593844373|FG000|Overall Study|Death|16|||
164403287|NCT05809596|593844373|FG000|Overall Study|Withdrawal by Subject|4|||
164403288|NCT05809596|593844373|FG000|Overall Study|Physician Decision|1|||
164403289|NCT05809596|593844373|FG000|Overall Study|Missed Visit|2|||
164403290|NCT05809596|593844373|FG000|Overall Study|Other|3|||
164445190|NCT05061693|593999796|FG000|24-week Extension Period|Sponsor Decision|0|||
164445191|NCT05061693|593999797|FG001|24-week Extension Period|Sponsor Decision|0|||
164445192|NCT05061693|593999798|FG002|24-week Extension Period|Sponsor Decision|0|||
164445193|NCT05061693|593999799|FG003|24-week Extension Period|Sponsor Decision|0|||
164445194|NCT05061693|593999800|FG004|24-week Extension Period|Sponsor Decision|0|||
164445195|NCT05061693|593999801|FG005|24-week Extension Period|Sponsor Decision|0|||
164445196|NCT05061693|593999802|FG006|24-week Extension Period|Sponsor Decision|0|||
164445197|NCT05061693|593999803|FG007|24-week Extension Period|Sponsor Decision|1|||
164445198|NCT05061693|593999804|FG008|24-week Extension Period|Sponsor Decision|0|||
164445199|NCT05061693|593999805|FG009|24-week Extension Period|Sponsor Decision|0|||
164445200|NCT05061693|593999806|FG010|24-week Extension Period|Sponsor Decision|0|||
164445201|NCT05061693|593999807|FG011|24-week Extension Period|Sponsor Decision|0|||
164445202|NCT05061693|593999796|FG000|24-week Extension Period|Site Closure|0|||
164445203|NCT05061693|593999797|FG001|24-week Extension Period|Site Closure|0|||
164445204|NCT05061693|593999798|FG002|24-week Extension Period|Site Closure|0|||
164445205|NCT05061693|593999799|FG003|24-week Extension Period|Site Closure|0|||
164445206|NCT05061693|593999800|FG004|24-week Extension Period|Site Closure|0|||
164445207|NCT05061693|593999801|FG005|24-week Extension Period|Site Closure|0|||
164445208|NCT05061693|593999802|FG006|24-week Extension Period|Site Closure|0|||
164445209|NCT05061693|593999803|FG007|24-week Extension Period|Site Closure|0|||
164445210|NCT05061693|593999804|FG008|24-week Extension Period|Site Closure|1|||
164445211|NCT05061693|593999805|FG009|24-week Extension Period|Site Closure|0|||
164445212|NCT05061693|593999806|FG010|24-week Extension Period|Site Closure|0|||
164445213|NCT05061693|593999807|FG011|24-week Extension Period|Site Closure|1|||
164445214|NCT03823911|593999808|FG000|Overall Study|Lost to Follow-up|1|||
164445215|NCT03823911|593999809|FG001|Overall Study|Lost to Follow-up|5|||
164445216|NCT03823911|593999810|FG002|Overall Study|Lost to Follow-up|2|||
164445217|NCT03823911|593999808|FG000|Overall Study|Did not meet eligibility criteria|13|||
164445218|NCT03823911|593999809|FG001|Overall Study|Did not meet eligibility criteria|7|||
164445219|NCT03823911|593999810|FG002|Overall Study|Did not meet eligibility criteria|4|||
164445220|NCT03823911|593999808|FG000|Overall Study|Death|0|||
164445221|NCT03823911|593999809|FG001|Overall Study|Death|1|||
164445222|NCT03823911|593999810|FG002|Overall Study|Death|0|||
164445223|NCT01792830|593999811|FG000|Overall Study|Withdrawal by Subject|22|||
164445224|NCT01792830|593999812|FG001|Overall Study|Withdrawal by Subject|0|||
164445225|NCT01792830|593999813|FG002|Overall Study|Withdrawal by Subject|0|||
164445226|NCT01792830|593999814|FG003|Overall Study|Withdrawal by Subject|2|||
164445227|NCT01792830|593999815|FG004|Overall Study|Withdrawal by Subject|1|||
164445228|NCT01792830|593999816|FG005|Overall Study|Withdrawal by Subject|1|||
164445229|NCT01792830|593999817|FG006|Overall Study|Withdrawal by Subject|1|||
164445230|NCT01792830|593999818|FG007|Overall Study|Withdrawal by Subject|1|||
164445231|NCT01792830|593999819|FG008|Overall Study|Withdrawal by Subject|7|||
164445232|NCT01792830|593999820|FG009|Overall Study|Withdrawal by Subject|0|||
164445233|NCT01792830|593999821|FG010|Overall Study|Withdrawal by Subject|2|||
164445234|NCT01792830|593999811|FG000|Overall Study|Death|3|||
164445235|NCT01792830|593999812|FG001|Overall Study|Death|0|||
164445236|NCT01792830|593999813|FG002|Overall Study|Death|0|||
164445237|NCT01792830|593999814|FG003|Overall Study|Death|1|||
164445238|NCT01792830|593999815|FG004|Overall Study|Death|0|||
164445239|NCT01792830|593999816|FG005|Overall Study|Death|0|||
164445240|NCT01792830|593999817|FG006|Overall Study|Death|1|||
164445241|NCT01792830|593999818|FG007|Overall Study|Death|0|||
164445242|NCT01792830|593999819|FG008|Overall Study|Death|1|||
164445243|NCT01792830|593999820|FG009|Overall Study|Death|0|||
164445244|NCT01792830|593999821|FG010|Overall Study|Death|1|||
164445245|NCT01792830|593999811|FG000|Overall Study|Adverse Event|0|||
164445246|NCT01792830|593999812|FG001|Overall Study|Adverse Event|0|||
164445247|NCT01792830|593999813|FG002|Overall Study|Adverse Event|0|||
164445248|NCT01792830|593999814|FG003|Overall Study|Adverse Event|0|||
164445249|NCT01792830|593999815|FG004|Overall Study|Adverse Event|0|||
164445250|NCT01792830|593999816|FG005|Overall Study|Adverse Event|0|||
164445251|NCT01792830|593999817|FG006|Overall Study|Adverse Event|0|||
164445252|NCT01792830|593999818|FG007|Overall Study|Adverse Event|0|||
164445253|NCT01792830|593999819|FG008|Overall Study|Adverse Event|1|||
164706164|NCT01007942|594953391|FG001|Overall Study|Disease progression|242|||
164445254|NCT01792830|593999820|FG009|Overall Study|Adverse Event|0|||
164445255|NCT01792830|593999821|FG010|Overall Study|Adverse Event|0|||
164445256|NCT01943799|593999837|FG000|Overall Study|Lost to Follow-up|0|||
164445257|NCT01943799|593999838|FG001|Overall Study|Lost to Follow-up|1|||
164445258|NCT01943799|593999839|FG002|Overall Study|Lost to Follow-up|1|||
164445259|NCT01943799|593999840|FG003|Overall Study|Lost to Follow-up|0|||
164445260|NCT01943799|593999837|FG000|Overall Study|Protocol Violation|1|||
164445261|NCT01943799|593999838|FG001|Overall Study|Protocol Violation|0|||
164445262|NCT01943799|593999839|FG002|Overall Study|Protocol Violation|0|||
164445263|NCT01943799|593999840|FG003|Overall Study|Protocol Violation|0|||
164445264|NCT01943799|593999837|FG000|Overall Study|Withdrawal by Subject|4|||
164445265|NCT01943799|593999838|FG001|Overall Study|Withdrawal by Subject|2|||
164445266|NCT01943799|593999839|FG002|Overall Study|Withdrawal by Subject|1|||
164445267|NCT01943799|593999840|FG003|Overall Study|Withdrawal by Subject|0|||
164445268|NCT05274217|593999841|FG000|Overall Study|Study terminated.|11|||
164445269|NCT05274217|593999842|FG001|Overall Study|Study terminated.|0|||
164445270|NCT00396084|593999843|FG000|Overall Study|Adverse Event|0|||
164445271|NCT00396084|593999844|FG001|Overall Study|Adverse Event|0|||
164445272|NCT00396084|593999845|FG002|Overall Study|Adverse Event|0|||
164445273|NCT00396084|593999846|FG003|Overall Study|Adverse Event|0|||
164445274|NCT00396084|593999847|FG004|Overall Study|Adverse Event|1|||
164445275|NCT00396084|593999848|FG005|Overall Study|Adverse Event|2|||
164445276|NCT00396084|593999843|FG000|Overall Study|Withdrawal by Subject|0|||
164445277|NCT00396084|593999844|FG001|Overall Study|Withdrawal by Subject|0|||
164445278|NCT00396084|593999845|FG002|Overall Study|Withdrawal by Subject|0|||
164445279|NCT00396084|593999846|FG003|Overall Study|Withdrawal by Subject|1|||
164445280|NCT00396084|593999847|FG004|Overall Study|Withdrawal by Subject|0|||
164445281|NCT00396084|593999848|FG005|Overall Study|Withdrawal by Subject|0|||
164445282|NCT00311363|593999851|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
164445283|NCT00311363|593999852|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
164445284|NCT00311363|593999853|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
164445285|NCT00311363|593999851|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
164445286|NCT00311363|593999852|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
164445287|NCT00311363|593999853|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
164445288|NCT00311363|593999851|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
164445289|NCT00311363|593999852|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
164445290|NCT00311363|593999853|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
164445291|NCT00311363|593999851|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
164445292|NCT00311363|593999852|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
164445293|NCT00311363|593999853|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
164445294|NCT00311363|593999851|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
164445295|NCT00311363|593999852|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
164445296|NCT00311363|593999853|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
164445297|NCT00311363|593999851|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
164445298|NCT00311363|593999852|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
164445299|NCT00311363|593999853|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
164445300|NCT00311363|593999851|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
164445301|NCT00311363|593999852|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
164445302|NCT00311363|593999853|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
164445303|NCT00311363|593999851|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
164445304|NCT00311363|593999852|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
164445305|NCT00311363|593999853|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
164445306|NCT00311363|593999851|FG000|24-Week Single-Blind Treatment Period|Death|1|||
164445307|NCT00311363|593999852|FG001|24-Week Single-Blind Treatment Period|Death|0|||
164445308|NCT00311363|593999853|FG002|24-Week Single-Blind Treatment Period|Death|0|||
164445309|NCT00311363|593999851|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
164445310|NCT00311363|593999852|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
164445311|NCT00311363|593999853|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
164445312|NCT00311363|593999851|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
164445313|NCT00311363|593999852|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
164445314|NCT00311363|593999853|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
164403291|NCT03770494|593844374|FG000|Overall Study|Lost to Follow-up|0|||
164403292|NCT03770494|593844375|FG001|Overall Study|Lost to Follow-up|0|||
164403293|NCT03770494|593844376|FG002|Overall Study|Lost to Follow-up|1|||
164403294|NCT03770494|593844377|FG003|Overall Study|Lost to Follow-up|1|||
164403295|NCT03770494|593844378|FG004|Overall Study|Lost to Follow-up|1|||
164403296|NCT03770494|593844379|FG005|Overall Study|Lost to Follow-up|0|||
164403297|NCT03770494|593844380|FG006|Overall Study|Lost to Follow-up|0|||
164403298|NCT03770494|593844381|FG007|Overall Study|Lost to Follow-up|0|||
164403299|NCT03770494|593844382|FG008|Overall Study|Lost to Follow-up|0|||
164403300|NCT03770494|593844383|FG009|Overall Study|Lost to Follow-up|0|||
164403301|NCT03770494|593844384|FG010|Overall Study|Lost to Follow-up|0|||
164403302|NCT03770494|593844385|FG011|Overall Study|Lost to Follow-up|0|||
164403303|NCT03770494|593844386|FG012|Overall Study|Lost to Follow-up|0|||
164403304|NCT03770494|593844387|FG013|Overall Study|Lost to Follow-up|0|||
164403305|NCT03770494|593844374|FG000|Overall Study|Study terminated by sponsor|1|||
164403306|NCT03770494|593844375|FG001|Overall Study|Study terminated by sponsor|2|||
164403307|NCT03770494|593844376|FG002|Overall Study|Study terminated by sponsor|1|||
164403308|NCT03770494|593844377|FG003|Overall Study|Study terminated by sponsor|1|||
164403309|NCT03770494|593844378|FG004|Overall Study|Study terminated by sponsor|1|||
164403310|NCT03770494|593844379|FG005|Overall Study|Study terminated by sponsor|2|||
164403311|NCT03770494|593844380|FG006|Overall Study|Study terminated by sponsor|1|||
164445315|NCT00311363|593999851|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
164445316|NCT00311363|593999852|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
164403312|NCT03770494|593844381|FG007|Overall Study|Study terminated by sponsor|2|||
164445317|NCT00311363|593999853|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
164445318|NCT00311363|593999851|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
164445319|NCT00311363|593999852|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
164445320|NCT00311363|593999853|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
164445321|NCT00311363|593999851|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
164445322|NCT00311363|593999852|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
164445323|NCT00311363|593999853|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
164445324|NCT00311363|593999851|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
164445325|NCT00311363|593999852|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
164445326|NCT00311363|593999853|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
164445327|NCT04009577|593999854|FG000|Core Study|Adverse Event|1|||
164445328|NCT04009577|593999855|FG001|Core Study|Adverse Event|0|||
164445329|NCT04009577|593999856|FG002|Core Study|Adverse Event|2|||
164445330|NCT04009577|593999857|FG003|Core Study|Adverse Event|4|||
164445331|NCT04009577|593999854|FG000|Core Study|Withdrawal by Subject|0|||
164445332|NCT04009577|593999855|FG001|Core Study|Withdrawal by Subject|0|||
164445333|NCT04009577|593999856|FG002|Core Study|Withdrawal by Subject|2|||
164445334|NCT04009577|593999857|FG003|Core Study|Withdrawal by Subject|0|||
164445335|NCT04009577|593999854|FG000|Core Study|Other|0|||
164445336|NCT04009577|593999855|FG001|Core Study|Other|0|||
164445337|NCT04009577|593999856|FG002|Core Study|Other|0|||
164445338|NCT04009577|593999857|FG003|Core Study|Other|1|||
164445339|NCT04009577|593999854|FG000|Extension Phase|Adverse Event|0|||
164445340|NCT04009577|593999855|FG001|Extension Phase|Adverse Event|0|||
164445341|NCT04009577|593999856|FG002|Extension Phase|Adverse Event|0|||
164445342|NCT04009577|593999857|FG003|Extension Phase|Adverse Event|1|||
164445343|NCT04009577|593999854|FG000|Extension Phase|Inadequate therapeutic effect|0|||
164445344|NCT04009577|593999855|FG001|Extension Phase|Inadequate therapeutic effect|0|||
164445345|NCT04009577|593999856|FG002|Extension Phase|Inadequate therapeutic effect|1|||
164445346|NCT04009577|593999857|FG003|Extension Phase|Inadequate therapeutic effect|0|||
164445347|NCT04009577|593999854|FG000|Extension Phase|Withdrawal by Subject|0|||
164445348|NCT04009577|593999855|FG001|Extension Phase|Withdrawal by Subject|0|||
164445349|NCT04009577|593999856|FG002|Extension Phase|Withdrawal by Subject|1|||
164445350|NCT04009577|593999857|FG003|Extension Phase|Withdrawal by Subject|0|||
164445351|NCT04009577|593999854|FG000|Extension Phase|Not Treated|0|||
164445352|NCT04009577|593999855|FG001|Extension Phase|Not Treated|0|||
164445353|NCT04009577|593999856|FG002|Extension Phase|Not Treated|2|||
164445354|NCT04009577|593999857|FG003|Extension Phase|Not Treated|0|||
164445355|NCT01832480|593999858|FG000|Overall Study|Lost to Follow-up|33|||
164445356|NCT01832480|593999859|FG001|Overall Study|Lost to Follow-up|30|||
164445357|NCT01832480|593999858|FG000|Overall Study|Withdrawal by Subject|0|||
164445358|NCT01832480|593999859|FG001|Overall Study|Withdrawal by Subject|2|||
164445359|NCT01832480|593999858|FG000|Overall Study|post randomization ineligible|8|||
164445360|NCT01832480|593999859|FG001|Overall Study|post randomization ineligible|10|||
164445361|NCT03764475|593999861|FG000|Overall Study|Adverse Event|11|||
164445362|NCT03764475|593999862|FG001|Overall Study|Adverse Event|2|||
164445363|NCT03764475|593999861|FG000|Overall Study|Lost to Follow-up|24|||
164445364|NCT03764475|593999862|FG001|Overall Study|Lost to Follow-up|10|||
164445365|NCT03764475|593999861|FG000|Overall Study|Withdrawal by Subject|26|||
164445366|NCT03764475|593999862|FG001|Overall Study|Withdrawal by Subject|10|||
164445367|NCT03764475|593999861|FG000|Overall Study|Lack of Efficacy|3|||
164445368|NCT03764475|593999862|FG001|Overall Study|Lack of Efficacy|0|||
164445369|NCT03764475|593999861|FG000|Overall Study|COVID-19 Disruption|2|||
164445370|NCT03764475|593999862|FG001|Overall Study|COVID-19 Disruption|0|||
164445371|NCT02261467|593999863|FG000|Overall Study|Enrolled in Error|1|||
164445372|NCT02261467|593999864|FG001|Overall Study|Enrolled in Error|0|||
164445373|NCT02261467|593999863|FG000|Overall Study|Protocol Violation|0|||
164445374|NCT02261467|593999864|FG001|Overall Study|Protocol Violation|1|||
164445375|NCT02261467|593999863|FG000|Overall Study|Personal Reasons|17|||
164445376|NCT02261467|593999864|FG001|Overall Study|Personal Reasons|22|||
164445377|NCT02261467|593999863|FG000|Overall Study|Lost to Follow-up|2|||
164445378|NCT02261467|593999864|FG001|Overall Study|Lost to Follow-up|13|||
164445379|NCT02261467|593999863|FG000|Overall Study|Adverse Event|1|||
164596845|NCT02052778|594548997|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
164445380|NCT02261467|593999864|FG001|Overall Study|Adverse Event|1|||
164445381|NCT05510245|593999865|FG000|Overall Study|Withdrawal by Subject|1|||
164445382|NCT05510245|593999866|FG001|Overall Study|Withdrawal by Subject|0|||
164596846|NCT02052778|594548998|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
164445383|NCT05510245|593999867|FG002|Overall Study|Withdrawal by Subject|0|||
164596847|NCT02052778|594548999|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
164596848|NCT02052778|594549000|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
164445384|NCT01373346|593999870|FG000|Overall Study|Death|1|||
164445385|NCT01395758|593999874|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
164445386|NCT01395758|593999875|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
164445387|NCT01395758|593999876|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
164445388|NCT04305405|593999877|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164445389|NCT04305405|593999878|FG001|Overall Study|Withdrawal by parent/guardian|1|||
164445390|NCT00206375|593999879|FG000|Overall Study|Lost to Follow-up|1|||
164445391|NCT00206375|593999880|FG001|Overall Study|Lost to Follow-up|0|||
164445392|NCT00206375|593999881|FG002|Overall Study|Lost to Follow-up|0|||
164445393|NCT00206375|593999879|FG000|Overall Study|Withdrawal by Subject|2|||
164445394|NCT00206375|593999880|FG001|Overall Study|Withdrawal by Subject|1|||
164445395|NCT00206375|593999881|FG002|Overall Study|Withdrawal by Subject|3|||
164445396|NCT00206375|593999879|FG000|Overall Study|Study terminated due to lack of funds|0|||
164445397|NCT00206375|593999880|FG001|Overall Study|Study terminated due to lack of funds|1|||
164445398|NCT00206375|593999881|FG002|Overall Study|Study terminated due to lack of funds|1|||
164445399|NCT02674750|593999888|FG000|Overall Study|Death|4|||
164445400|NCT02674750|593999889|FG001|Overall Study|Death|5|||
164445401|NCT02674750|593999890|FG002|Overall Study|Death|8|||
164445402|NCT02674750|593999888|FG000|Overall Study|Lost to Follow-up|0|||
164445403|NCT02674750|593999889|FG001|Overall Study|Lost to Follow-up|8|||
164445404|NCT02674750|593999890|FG002|Overall Study|Lost to Follow-up|0|||
164445405|NCT02674750|593999888|FG000|Overall Study|Lack of Efficacy|1|||
164445406|NCT02674750|593999889|FG001|Overall Study|Lack of Efficacy|17|||
164445407|NCT02674750|593999890|FG002|Overall Study|Lack of Efficacy|3|||
164445408|NCT02674750|593999888|FG000|Overall Study|Withdrawal by Subject|0|||
164445409|NCT02674750|593999889|FG001|Overall Study|Withdrawal by Subject|7|||
164445410|NCT02674750|593999890|FG002|Overall Study|Withdrawal by Subject|1|||
164445411|NCT02674750|593999888|FG000|Overall Study|Other|0|||
164445412|NCT02674750|593999889|FG001|Overall Study|Other|8|||
164445413|NCT02674750|593999890|FG002|Overall Study|Other|0|||
164445414|NCT01685606|593999893|FG000|Overall Study|Withdrawal by Subject|1|||
164445415|NCT01787760|593999894|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
164445416|NCT01787760|593999895|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
164445417|NCT01787760|593999896|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
164445418|NCT01787760|593999894|FG000|Overall Study|Decompensated on left exotropia|0|||
164445419|NCT01787760|593999895|FG001|Overall Study|Decompensated on left exotropia|0|||
164445420|NCT01787760|593999896|FG002|Overall Study|Decompensated on left exotropia|1|||
164445421|NCT01787760|593999894|FG000|Overall Study|Dryness|0|||
164445422|NCT01787760|593999895|FG001|Overall Study|Dryness|1|||
164445423|NCT01787760|593999896|FG002|Overall Study|Dryness|0|||
164445424|NCT01787760|593999894|FG000|Overall Study|Relocation|1|||
164445425|NCT01787760|593999895|FG001|Overall Study|Relocation|1|||
164445426|NCT01787760|593999896|FG002|Overall Study|Relocation|0|||
164445427|NCT01787760|593999894|FG000|Overall Study|Lens discomfort|3|||
164445428|NCT01787760|593999895|FG001|Overall Study|Lens discomfort|0|||
164445429|NCT01787760|593999896|FG002|Overall Study|Lens discomfort|0|||
164445430|NCT01787760|593999894|FG000|Overall Study|Lens handling difficulty|1|||
164445431|NCT01787760|593999895|FG001|Overall Study|Lens handling difficulty|2|||
164445432|NCT01787760|593999896|FG002|Overall Study|Lens handling difficulty|0|||
164445433|NCT01787760|593999894|FG000|Overall Study|Protocol Violation|6|||
164445434|NCT01787760|593999895|FG001|Overall Study|Protocol Violation|0|||
164445435|NCT01787760|593999896|FG002|Overall Study|Protocol Violation|1|||
164445436|NCT01787760|593999894|FG000|Overall Study|Withdrawal by Subject|5|||
164445437|NCT01787760|593999895|FG001|Overall Study|Withdrawal by Subject|1|||
164445438|NCT01787760|593999896|FG002|Overall Study|Withdrawal by Subject|2|||
164445439|NCT01787760|593999894|FG000|Overall Study|Lost to Follow-up|1|||
164445440|NCT01787760|593999895|FG001|Overall Study|Lost to Follow-up|0|||
164445441|NCT01787760|593999896|FG002|Overall Study|Lost to Follow-up|1|||
164445442|NCT01787760|593999894|FG000|Overall Study|Stroke|1|||
164445443|NCT01787760|593999895|FG001|Overall Study|Stroke|0|||
164445444|NCT01787760|593999896|FG002|Overall Study|Stroke|0|||
164445445|NCT01787760|593999894|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
164445446|NCT01787760|593999895|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
164445447|NCT01787760|593999896|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
164445448|NCT01787760|593999894|FG000|Overall Study|Unsatisfactory physiological response|2|||
164445449|NCT01787760|593999895|FG001|Overall Study|Unsatisfactory physiological response|4|||
164445450|NCT01787760|593999896|FG002|Overall Study|Unsatisfactory physiological response|0|||
164445451|NCT01787760|593999894|FG000|Overall Study|Unsatisfactory visual response|1|||
164445452|NCT01787760|593999895|FG001|Overall Study|Unsatisfactory visual response|1|||
164445453|NCT01787760|593999896|FG002|Overall Study|Unsatisfactory visual response|0|||
164445454|NCT01787760|593999894|FG000|Overall Study|Near vision blur|1|||
164445455|NCT01787760|593999895|FG001|Overall Study|Near vision blur|0|||
164445456|NCT01787760|593999896|FG002|Overall Study|Near vision blur|0|||
164445457|NCT00736853|593999897|FG000|Open-Label Period|Physician Decision|2|||
164445458|NCT00736853|593999898|FG001|Open-Label Period|Physician Decision|0|||
164445459|NCT00736853|593999899|FG002|Open-Label Period|Physician Decision|0|||
164445460|NCT00736853|593999897|FG000|Open-Label Period|Adverse Event|31|||
164445461|NCT00736853|593999898|FG001|Open-Label Period|Adverse Event|0|||
164445462|NCT00736853|593999899|FG002|Open-Label Period|Adverse Event|0|||
164445463|NCT00736853|593999897|FG000|Open-Label Period|Withdrawal by Subject|16|||
164445464|NCT00736853|593999898|FG001|Open-Label Period|Withdrawal by Subject|0|||
164445465|NCT00736853|593999899|FG002|Open-Label Period|Withdrawal by Subject|0|||
164445466|NCT00736853|593999897|FG000|Open-Label Period|Started but not treated|42|||
164445467|NCT00736853|593999898|FG001|Open-Label Period|Started but not treated|0|||
164445468|NCT00736853|593999899|FG002|Open-Label Period|Started but not treated|0|||
164445469|NCT00736853|593999897|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
164445470|NCT00736853|593999898|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
164445471|NCT00736853|593999899|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
164445472|NCT00736853|593999897|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
164445473|NCT00736853|593999898|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
164445474|NCT00736853|593999899|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
164445475|NCT00736853|593999897|FG000|Double-Blind Period|Lack of Efficacy|0|||
164445476|NCT00736853|593999898|FG001|Double-Blind Period|Lack of Efficacy|19|||
164445477|NCT00736853|593999899|FG002|Double-Blind Period|Lack of Efficacy|42|||
164445478|NCT00736853|593999897|FG000|Double-Blind Period|Adverse Event|0|||
164445479|NCT00736853|593999898|FG001|Double-Blind Period|Adverse Event|3|||
164445480|NCT00736853|593999899|FG002|Double-Blind Period|Adverse Event|2|||
164445481|NCT00736853|593999897|FG000|Double-Blind Period|Withdrawal by Subject|0|||
164445482|NCT00736853|593999898|FG001|Double-Blind Period|Withdrawal by Subject|1|||
164445483|NCT00736853|593999899|FG002|Double-Blind Period|Withdrawal by Subject|4|||
164445484|NCT00736853|593999897|FG000|Double-Blind Period|Ineligible to participate the study|0|||
164445485|NCT00736853|593999898|FG001|Double-Blind Period|Ineligible to participate the study|1|||
164445486|NCT00736853|593999899|FG002|Double-Blind Period|Ineligible to participate the study|0|||
164445487|NCT01353963|593999900|FG000|Overall Study|Adverse Event|2|||
164445488|NCT01415349|593999901|FG000|Treatment Period 1|Adverse Event|0|||
164445489|NCT01415349|593999902|FG001|Treatment Period 1|Adverse Event|1|||
164445490|NCT01415349|593999901|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164445491|NCT01415349|593999902|FG001|Treatment Period 1|Withdrawal by Subject|1|||
164445492|NCT02139943|593999903|FG000|Overall Study|Adverse Event|0|||
164445493|NCT02139943|593999904|FG001|Overall Study|Adverse Event|1|||
164445494|NCT02139943|593999905|FG002|Overall Study|Adverse Event|2|||
164445495|NCT02139943|593999903|FG000|Overall Study|Lost to Follow-up|3|||
164445496|NCT02139943|593999904|FG001|Overall Study|Lost to Follow-up|2|||
164445497|NCT02139943|593999905|FG002|Overall Study|Lost to Follow-up|2|||
164445498|NCT02139943|593999903|FG000|Overall Study|Withdrawal by Subject|4|||
164445499|NCT02139943|593999904|FG001|Overall Study|Withdrawal by Subject|3|||
164445500|NCT02139943|593999905|FG002|Overall Study|Withdrawal by Subject|0|||
164445501|NCT02139943|593999903|FG000|Overall Study|Other|0|||
164445502|NCT02139943|593999904|FG001|Overall Study|Other|0|||
164445503|NCT02139943|593999905|FG002|Overall Study|Other|1|||
164445504|NCT02139943|593999903|FG000|Overall Study|Participant wishes to discontinue|2|||
164445505|NCT02139943|593999904|FG001|Overall Study|Participant wishes to discontinue|0|||
164445506|NCT02139943|593999905|FG002|Overall Study|Participant wishes to discontinue|0|||
164445507|NCT02139943|593999903|FG000|Overall Study|Participant in Poor Compliance|1|||
164445508|NCT02139943|593999904|FG001|Overall Study|Participant in Poor Compliance|0|||
164445509|NCT02139943|593999905|FG002|Overall Study|Participant in Poor Compliance|1|||
164445510|NCT02139943|593999903|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
164445511|NCT02139943|593999904|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
164445512|NCT02139943|593999905|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
164445513|NCT01764464|593999906|FG000|First Intervention|Withdrawal by Subject|1|||
164445514|NCT01764464|593999907|FG001|First Intervention|Withdrawal by Subject|0|||
164445515|NCT01764464|593999906|FG000|First Intervention|Lost to Follow-up|1|||
164445516|NCT01764464|593999907|FG001|First Intervention|Lost to Follow-up|0|||
164445517|NCT01764464|593999906|FG000|First Intervention|Adverse Event|0|||
164445518|NCT01764464|593999907|FG001|First Intervention|Adverse Event|2|||
164445519|NCT01764464|593999906|FG000|First Intervention|did not receive study drug|0|||
164445520|NCT01764464|593999907|FG001|First Intervention|did not receive study drug|1|||
164445521|NCT01764464|593999906|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
164445522|NCT01764464|593999907|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
164445523|NCT02531113|593999917|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
164445524|NCT02531113|593999917|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
164445525|NCT02531113|593999917|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
164445526|NCT02531113|593999917|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
164445527|NCT02531113|593999917|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
164445528|NCT02531113|593999917|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
164445529|NCT02531113|593999917|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
164445530|NCT02531113|593999917|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
164445531|NCT00632424|593999918|FG000|Overall Study|Disease Progression|17|||
164445532|NCT00632424|593999918|FG000|Overall Study|Study Drug Toxicity|1|||
164445533|NCT00801983|593999919|FG000|Period 1|Lost to Follow-up|2|||
164445534|NCT00801983|593999920|FG001|Period 1|Lost to Follow-up|0|||
164445535|NCT00801983|593999919|FG000|Period 1|Withdrawal by Subject|2|||
164445536|NCT00801983|593999920|FG001|Period 1|Withdrawal by Subject|8|||
164445537|NCT00801983|593999919|FG000|Period 2|Withdrawal by Subject|2|||
164445538|NCT00801983|593999920|FG001|Period 2|Withdrawal by Subject|1|||
164445539|NCT03960463|594001310|FG000|Overall Study|Withdrawal by Subject|2|||
164706165|NCT01007942|594953390|FG000|Overall Study|New cancer therapy|5|||
164706166|NCT01007942|594953391|FG001|Overall Study|New cancer therapy|1|||
164706167|NCT01007942|594953390|FG000|Overall Study|Protocol Violation|1|||
164706168|NCT01007942|594953391|FG001|Overall Study|Protocol Violation|1|||
164403313|NCT03770494|593844382|FG008|Overall Study|Study terminated by sponsor|1|||
164403314|NCT03770494|593844383|FG009|Overall Study|Study terminated by sponsor|2|||
164403315|NCT03770494|593844384|FG010|Overall Study|Study terminated by sponsor|1|||
164403316|NCT03770494|593844385|FG011|Overall Study|Study terminated by sponsor|2|||
164403317|NCT03770494|593844386|FG012|Overall Study|Study terminated by sponsor|0|||
164403318|NCT03770494|593844387|FG013|Overall Study|Study terminated by sponsor|0|||
164403319|NCT03770494|593844374|FG000|Overall Study|Withdrawal by Subject|1|||
164403320|NCT03770494|593844375|FG001|Overall Study|Withdrawal by Subject|1|||
164403321|NCT03770494|593844376|FG002|Overall Study|Withdrawal by Subject|0|||
164403322|NCT03770494|593844377|FG003|Overall Study|Withdrawal by Subject|0|||
164403323|NCT03770494|593844378|FG004|Overall Study|Withdrawal by Subject|2|||
164403324|NCT03770494|593844379|FG005|Overall Study|Withdrawal by Subject|2|||
164403325|NCT03770494|593844380|FG006|Overall Study|Withdrawal by Subject|2|||
164403326|NCT03770494|593844381|FG007|Overall Study|Withdrawal by Subject|0|||
164403327|NCT03770494|593844382|FG008|Overall Study|Withdrawal by Subject|2|||
164403328|NCT03770494|593844383|FG009|Overall Study|Withdrawal by Subject|3|||
164403329|NCT03770494|593844384|FG010|Overall Study|Withdrawal by Subject|1|||
164403330|NCT03770494|593844385|FG011|Overall Study|Withdrawal by Subject|0|||
164403331|NCT03770494|593844386|FG012|Overall Study|Withdrawal by Subject|0|||
164403332|NCT03770494|593844387|FG013|Overall Study|Withdrawal by Subject|0|||
164403333|NCT01984697|593846223|FG000|Overall Study|Adverse Event|0|||
164403334|NCT01984697|593846224|FG001|Overall Study|Adverse Event|0|||
164403335|NCT01984697|593846225|FG002|Overall Study|Adverse Event|2|||
164403336|NCT01984697|593846226|FG003|Overall Study|Adverse Event|0|||
164403337|NCT01984697|593846227|FG004|Overall Study|Adverse Event|0|||
164403338|NCT01984697|593846223|FG000|Overall Study|Lost to Follow-up|14|||
164403339|NCT01984697|593846224|FG001|Overall Study|Lost to Follow-up|5|||
164403340|NCT01984697|593846225|FG002|Overall Study|Lost to Follow-up|10|||
164403341|NCT01984697|593846226|FG003|Overall Study|Lost to Follow-up|6|||
164403342|NCT01984697|593846227|FG004|Overall Study|Lost to Follow-up|21|||
164403343|NCT01984697|593846223|FG000|Overall Study|Physician Decision|3|||
164403344|NCT01984697|593846224|FG001|Overall Study|Physician Decision|0|||
164403345|NCT01984697|593846225|FG002|Overall Study|Physician Decision|0|||
164403346|NCT01984697|593846226|FG003|Overall Study|Physician Decision|1|||
164403347|NCT01984697|593846227|FG004|Overall Study|Physician Decision|0|||
164403348|NCT01984697|593846223|FG000|Overall Study|Protocol Violation|8|||
164403349|NCT01984697|593846224|FG001|Overall Study|Protocol Violation|5|||
164403350|NCT01984697|593846225|FG002|Overall Study|Protocol Violation|3|||
164403351|NCT01984697|593846226|FG003|Overall Study|Protocol Violation|2|||
164403352|NCT01984697|593846227|FG004|Overall Study|Protocol Violation|0|||
164403353|NCT01984697|593846223|FG000|Overall Study|Withdrawal by Subject|15|||
164403354|NCT01984697|593846224|FG001|Overall Study|Withdrawal by Subject|21|||
164403355|NCT01984697|593846225|FG002|Overall Study|Withdrawal by Subject|13|||
164403356|NCT01984697|593846226|FG003|Overall Study|Withdrawal by Subject|11|||
164403357|NCT01984697|593846227|FG004|Overall Study|Withdrawal by Subject|13|||
164403358|NCT01984697|593846223|FG000|Overall Study|Missed last follow-up visit|1|||
164403359|NCT01984697|593846224|FG001|Overall Study|Missed last follow-up visit|0|||
164403360|NCT01984697|593846225|FG002|Overall Study|Missed last follow-up visit|0|||
164403361|NCT01984697|593846226|FG003|Overall Study|Missed last follow-up visit|0|||
164403362|NCT01984697|593846227|FG004|Overall Study|Missed last follow-up visit|0|||
164403363|NCT01984697|593846223|FG000|Overall Study|Death|0|||
164403364|NCT01984697|593846224|FG001|Overall Study|Death|0|||
164403365|NCT01984697|593846225|FG002|Overall Study|Death|0|||
164403366|NCT01984697|593846226|FG003|Overall Study|Death|1|||
164403367|NCT01984697|593846227|FG004|Overall Study|Death|0|||
164403368|NCT01984697|593846223|FG000|Overall Study|Pregnancy|2|||
164403369|NCT01984697|593846224|FG001|Overall Study|Pregnancy|0|||
164403370|NCT01984697|593846225|FG002|Overall Study|Pregnancy|1|||
164403371|NCT01984697|593846226|FG003|Overall Study|Pregnancy|0|||
164403372|NCT01984697|593846227|FG004|Overall Study|Pregnancy|1|||
164403373|NCT01345630|593846228|FG000|Overall Study|Adverse Event|22|||
164403374|NCT01345630|593846229|FG001|Overall Study|Adverse Event|23|||
164403375|NCT01345630|593846228|FG000|Overall Study|Lost to Follow-up|17|||
164403376|NCT01345630|593846229|FG001|Overall Study|Lost to Follow-up|16|||
164403377|NCT01345630|593846228|FG000|Overall Study|Protocol Violation|4|||
164403378|NCT01345630|593846229|FG001|Overall Study|Protocol Violation|1|||
164403379|NCT01345630|593846228|FG000|Overall Study|Medication error without associated AE|0|||
164403380|NCT01345630|593846229|FG001|Overall Study|Medication error without associated AE|1|||
164403381|NCT01345630|593846228|FG000|Overall Study|Study terminated by sponsor|254|||
164403382|NCT01345630|593846229|FG001|Overall Study|Study terminated by sponsor|285|||
164403383|NCT01345630|593846228|FG000|Overall Study|Other reasons|6|||
164403384|NCT01345630|593846229|FG001|Overall Study|Other reasons|8|||
164403385|NCT01345630|593846228|FG000|Overall Study|Withdrawn due to pregnancy|1|||
164403386|NCT01345630|593846229|FG001|Overall Study|Withdrawn due to pregnancy|2|||
164403387|NCT01345630|593846228|FG000|Overall Study|No longer willing to participate|9|||
164706169|NCT01007942|594953390|FG000|Overall Study|Withdrawal by Subject|19|||
164706170|NCT01007942|594953391|FG001|Overall Study|Withdrawal by Subject|14|||
164706171|NCT01007942|594953390|FG000|Overall Study|Lost to Follow-up|1|||
164706172|NCT01007942|594953391|FG001|Overall Study|Lost to Follow-up|0|||
164706173|NCT01007942|594953390|FG000|Overall Study|Administrative problems|2|||
164403388|NCT01345630|593846229|FG001|Overall Study|No longer willing to participate|12|||
164403389|NCT01345630|593846228|FG000|Overall Study|Insufficient clinical response|48|||
164403390|NCT01345630|593846229|FG001|Overall Study|Insufficient clinical response|11|||
164403391|NCT01364922|593846237|FG000|Open-label (OL) Period|Adverse Event|7|||
164403392|NCT01364922|593846238|FG001|Open-label (OL) Period|Adverse Event|0|||
164403393|NCT01364922|593846239|FG002|Open-label (OL) Period|Adverse Event|0|||
164403394|NCT01364922|593846237|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
164403395|NCT01364922|593846238|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
164403396|NCT01364922|593846239|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
164403397|NCT01364922|593846237|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
164403398|NCT01364922|593846238|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
164403399|NCT01364922|593846239|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
164403400|NCT01364922|593846237|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
164403401|NCT01364922|593846238|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
164403402|NCT01364922|593846239|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
164403403|NCT01364922|593846237|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
164403404|NCT01364922|593846238|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
164403405|NCT01364922|593846239|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
164403406|NCT01364922|593846237|FG000|Open-label (OL) Period|Other, Unspecified|1|||
164403407|NCT01364922|593846238|FG001|Open-label (OL) Period|Other, Unspecified|0|||
164403408|NCT01364922|593846239|FG002|Open-label (OL) Period|Other, Unspecified|0|||
164403409|NCT01364922|593846237|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
164403410|NCT01364922|593846238|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
164403411|NCT01364922|593846239|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
164403412|NCT01364922|593846237|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
164403413|NCT01364922|593846238|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
164403414|NCT01364922|593846239|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
164403415|NCT01364922|593846237|FG000|Double-Blind (DB) Period|Adverse Event|0|||
164403416|NCT01364922|593846238|FG001|Double-Blind (DB) Period|Adverse Event|0|||
164403417|NCT01364922|593846239|FG002|Double-Blind (DB) Period|Adverse Event|1|||
164403418|NCT01364922|593846237|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
164403419|NCT01364922|593846238|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
164403420|NCT01364922|593846239|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
164403421|NCT01582789|593846240|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
164403422|NCT01582789|593846241|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
164403423|NCT05050578|593846242|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
164403424|NCT05050578|593846243|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
164403425|NCT05050578|593846242|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
164403426|NCT05050578|593846243|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
164403427|NCT05050578|593846242|FG000|Period 2, 30 Days|Protocol Violation|0|||
164403428|NCT05050578|593846243|FG001|Period 2, 30 Days|Protocol Violation|1|||
164403429|NCT02243280|593846244|FG000|Treated|Adverse Event|1|||
164403430|NCT02243280|593846245|FG001|Treated|Adverse Event|0|||
164403431|NCT02243280|593846246|FG002|Treated|Adverse Event|0|||
164403432|NCT02243280|593846247|FG003|Treated|Adverse Event|0|||
164403433|NCT02243280|593846248|FG004|Treated|Adverse Event|0|||
164403434|NCT02243280|593846249|FG005|Treated|Adverse Event|0|||
164403435|NCT02243280|593846250|FG006|Treated|Adverse Event|0|||
164403436|NCT02243280|593846251|FG007|Treated|Adverse Event|0|||
164403437|NCT02243280|593846252|FG008|Treated|Adverse Event|0|||
164403438|NCT02243280|593846253|FG009|Treated|Adverse Event|0|||
164403439|NCT02243280|593846254|FG010|Treated|Adverse Event|1|||
164403440|NCT02243280|593846244|FG000|Treated|Lost to Follow-up|0|||
164403441|NCT02243280|593846245|FG001|Treated|Lost to Follow-up|0|||
164403442|NCT02243280|593846246|FG002|Treated|Lost to Follow-up|0|||
164403443|NCT02243280|593846247|FG003|Treated|Lost to Follow-up|0|||
164403444|NCT02243280|593846248|FG004|Treated|Lost to Follow-up|0|||
164403445|NCT02243280|593846249|FG005|Treated|Lost to Follow-up|0|||
164445540|NCT03960463|594001311|FG001|Overall Study|Withdrawal by Subject|0|||
164706174|NCT01007942|594953391|FG001|Overall Study|Administrative problems|0|||
164706175|NCT01007942|594953390|FG000|Overall Study|Death|3|||
164706176|NCT01007942|594953391|FG001|Overall Study|Death|2|||
164403446|NCT02243280|593846250|FG006|Treated|Lost to Follow-up|0|||
164403447|NCT02243280|593846251|FG007|Treated|Lost to Follow-up|0|||
164403448|NCT02243280|593846252|FG008|Treated|Lost to Follow-up|1|||
164403449|NCT02243280|593846253|FG009|Treated|Lost to Follow-up|0|||
164403450|NCT02243280|593846254|FG010|Treated|Lost to Follow-up|2|||
164403451|NCT03386032|593846263|FG000|Overall Study|Lack of Efficacy|6|||
164706177|NCT01007942|594953390|FG000|Overall Study|Patients untreated|4|||
164706178|NCT01007942|594953391|FG001|Overall Study|Patients untreated|3|||
164144040|NCT00086281|592888579|FG008|Phase 2|Adverse Event|0|||
164445541|NCT03237481|594001314|FG000|Overall Study|Lost to Follow-up|1|||
164706179|NCT04492020|594953392|FG000|Overall Study|Adverse Event|1|||
164403452|NCT03386032|593846264|FG001|Overall Study|Lack of Efficacy|2|||
164403453|NCT03386032|593846265|FG002|Overall Study|Lack of Efficacy|0|||
164403454|NCT03386032|593846263|FG000|Overall Study|Adverse Event|2|||
164403455|NCT03386032|593846264|FG001|Overall Study|Adverse Event|2|||
164403456|NCT03386032|593846265|FG002|Overall Study|Adverse Event|0|||
164403457|NCT03386032|593846263|FG000|Overall Study|Withdrawal by Subject|1|||
164403458|NCT03386032|593846264|FG001|Overall Study|Withdrawal by Subject|0|||
164403459|NCT03386032|593846265|FG002|Overall Study|Withdrawal by Subject|0|||
164403460|NCT03386032|593846263|FG000|Overall Study|Lost to Follow-up|9|||
164403461|NCT03386032|593846264|FG001|Overall Study|Lost to Follow-up|3|||
164403462|NCT03386032|593846265|FG002|Overall Study|Lost to Follow-up|0|||
164403463|NCT04525547|593846274|FG000|Overall Study|Not treated with Ofev|2|||
164403464|NCT04525547|593846274|FG000|Overall Study|Off-label use|2|||
164403465|NCT04525547|593846274|FG000|Overall Study|Lost to Follow-up|1|||
164403466|NCT03122119|593846275|FG000|Overall Study|Did not meet eligibility critria|1|||
164403467|NCT01493687|593846285|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
164403468|NCT01493687|593846286|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
164403469|NCT01493687|593846285|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
164403470|NCT01493687|593846286|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
164403471|NCT01493687|593846285|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
164403472|NCT01493687|593846286|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
164403473|NCT01493687|593846285|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
164403474|NCT01493687|593846286|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
164403475|NCT01493687|593846285|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
164403476|NCT01493687|593846286|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
164403477|NCT01493687|593846285|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
164403478|NCT01493687|593846286|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
164403479|NCT01493687|593846285|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
164403480|NCT01493687|593846286|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
164403481|NCT01493687|593846285|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
164403482|NCT01493687|593846286|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
164403483|NCT01493687|593846285|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
164403484|NCT01493687|593846286|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
164403485|NCT01493687|593846285|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
164403486|NCT01493687|593846286|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
164403487|NCT01493687|593846285|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
164403488|NCT01493687|593846286|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
164403489|NCT01493687|593846285|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
164403490|NCT01493687|593846286|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
164403491|NCT01493687|593846285|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
164403492|NCT01493687|593846286|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
164403493|NCT01493687|593846285|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
164403494|NCT01493687|593846286|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
164403495|NCT01493687|593846285|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
164403496|NCT01493687|593846286|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
164403497|NCT00521144|593846287|FG000|Overall Study|Not Treated|0|||
164403498|NCT00521144|593846288|FG001|Overall Study|Not Treated|0|||
164403499|NCT00521144|593846289|FG002|Overall Study|Not Treated|0|||
164403500|NCT00521144|593846290|FG003|Overall Study|Not Treated|1|||
164403501|NCT00521144|593846291|FG004|Overall Study|Not Treated|0|||
164403502|NCT00521144|593846287|FG000|Overall Study|Adverse Event|0|||
164403503|NCT00521144|593846288|FG001|Overall Study|Adverse Event|1|||
164403504|NCT00521144|593846289|FG002|Overall Study|Adverse Event|0|||
164403505|NCT00521144|593846290|FG003|Overall Study|Adverse Event|0|||
164403506|NCT00521144|593846291|FG004|Overall Study|Adverse Event|1|||
164403507|NCT00521144|593846287|FG000|Overall Study|Progressive Disease|4|||
164403508|NCT00521144|593846288|FG001|Overall Study|Progressive Disease|2|||
164403509|NCT00521144|593846289|FG002|Overall Study|Progressive Disease|2|||
164403510|NCT00521144|593846290|FG003|Overall Study|Progressive Disease|0|||
164403511|NCT00521144|593846291|FG004|Overall Study|Progressive Disease|6|||
164403512|NCT00089141|593846293|FG000|Overall Study|Termination of trial|18|||
164403513|NCT00089141|593846294|FG001|Overall Study|Termination of trial|24|||
164403514|NCT00508261|593846297|FG000|Overall Study|Other|0|||
164403515|NCT00508261|593846298|FG001|Overall Study|Other|1|||
164403516|NCT00508261|593846299|FG002|Overall Study|Other|1|||
164403517|NCT00508261|593846300|FG003|Overall Study|Other|0|||
164403518|NCT00508261|593846297|FG000|Overall Study|Serious Adverse Event|0|||
164403519|NCT00508261|593846298|FG001|Overall Study|Serious Adverse Event|1|||
164403520|NCT00508261|593846299|FG002|Overall Study|Serious Adverse Event|0|||
164403521|NCT00508261|593846300|FG003|Overall Study|Serious Adverse Event|0|||
164403522|NCT00508261|593846297|FG000|Overall Study|Withdrawal by Subject|3|||
164403523|NCT00508261|593846298|FG001|Overall Study|Withdrawal by Subject|4|||
164445542|NCT03237481|594001315|FG001|Overall Study|Lost to Follow-up|0|||
164445543|NCT03237481|594001316|FG002|Overall Study|Lost to Follow-up|0|||
164445544|NCT03237481|594001314|FG000|Overall Study|Protocol Violation|1|||
164445545|NCT03237481|594001315|FG001|Overall Study|Protocol Violation|0|||
164445546|NCT03237481|594001316|FG002|Overall Study|Protocol Violation|0|||
164445547|NCT03237481|594001314|FG000|Overall Study|Withdrawal by Subject|3|||
164445548|NCT03237481|594001315|FG001|Overall Study|Withdrawal by Subject|2|||
164445549|NCT03237481|594001316|FG002|Overall Study|Withdrawal by Subject|1|||
164445550|NCT04201834|594001317|FG000|Overall Study|Screen fail|1|||
164445551|NCT04941287|594001318|FG000|Overall Study|Rapid decline before starting treatment|3|||
164445552|NCT04941287|594001319|FG001|Overall Study|Rapid decline before starting treatment|1|||
164445553|NCT01998984|594001320|FG000|Overall Study|Adverse Event|0|||
164445554|NCT01998984|594001321|FG001|Overall Study|Adverse Event|0|||
164445555|NCT01998984|594001322|FG002|Overall Study|Adverse Event|0|||
164445556|NCT01998984|594001323|FG003|Overall Study|Adverse Event|1|||
164445557|NCT01998984|594001320|FG000|Overall Study|Lost to Follow-up|0|||
164445558|NCT01998984|594001321|FG001|Overall Study|Lost to Follow-up|1|||
164445559|NCT01998984|594001322|FG002|Overall Study|Lost to Follow-up|0|||
164445560|NCT01998984|594001323|FG003|Overall Study|Lost to Follow-up|1|||
164445561|NCT01998984|594001320|FG000|Overall Study|Withdrawal by Subject|0|||
164445562|NCT01998984|594001321|FG001|Overall Study|Withdrawal by Subject|0|||
164445563|NCT01998984|594001322|FG002|Overall Study|Withdrawal by Subject|1|||
164445564|NCT01998984|594001323|FG003|Overall Study|Withdrawal by Subject|0|||
164445565|NCT01998984|594001320|FG000|Overall Study|Other|0|||
164445566|NCT01998984|594001321|FG001|Overall Study|Other|0|||
164445567|NCT01998984|594001322|FG002|Overall Study|Other|0|||
164445568|NCT01998984|594001323|FG003|Overall Study|Other|1|||
164445569|NCT05386238|594001324|FG000|Overall Study|Lost to Follow-up|3|||
164445570|NCT05386238|594001325|FG001|Overall Study|Lost to Follow-up|2|||
164445571|NCT05386238|594001324|FG000|Overall Study|Withdrawal by Subject|0|||
164445572|NCT05386238|594001325|FG001|Overall Study|Withdrawal by Subject|1|||
164445573|NCT04907474|594001326|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
164445574|NCT04907474|594001327|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
164445575|NCT01353313|594001334|FG000|Overall Study|Lost to Follow-up|22|||
164445576|NCT01353313|594001335|FG001|Overall Study|Lost to Follow-up|23|||
164445577|NCT01353313|594001334|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
164445578|NCT01353313|594001335|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
164445579|NCT01631214|594001339|FG000|Overall Study|Withdrawal by Subject|276|||
164445580|NCT01631214|594001340|FG001|Overall Study|Withdrawal by Subject|290|||
164445581|NCT01631214|594001339|FG000|Overall Study|Death|113|||
164445582|NCT01631214|594001340|FG001|Overall Study|Death|106|||
164445583|NCT01631214|594001339|FG000|Overall Study|Lost to Follow-up|54|||
164445584|NCT01631214|594001340|FG001|Overall Study|Lost to Follow-up|40|||
164445585|NCT01631214|594001339|FG000|Overall Study|Adverse Event|45|||
164445586|NCT01631214|594001340|FG001|Overall Study|Adverse Event|45|||
164445587|NCT01631214|594001339|FG000|Overall Study|Other|22|||
164445588|NCT01631214|594001340|FG001|Overall Study|Other|19|||
164445589|NCT01631214|594001339|FG000|Overall Study|Noncompliance|16|||
164445590|NCT01631214|594001340|FG001|Overall Study|Noncompliance|15|||
164445591|NCT01631214|594001339|FG000|Overall Study|Requirement for Alternative Therapy|8|||
164445592|NCT01631214|594001340|FG001|Overall Study|Requirement for Alternative Therapy|3|||
164445593|NCT01631214|594001339|FG000|Overall Study|Protocol Deviation|4|||
164445594|NCT01631214|594001340|FG001|Overall Study|Protocol Deviation|3|||
164445595|NCT01631214|594001339|FG000|Overall Study|Ineligibility determined|5|||
164445596|NCT01631214|594001340|FG001|Overall Study|Ineligibility determined|2|||
164445597|NCT01631214|594001339|FG000|Overall Study|Administrative Decision|1|||
164445598|NCT01631214|594001340|FG001|Overall Study|Administrative Decision|0|||
164445599|NCT03575052|594001341|FG000|Overall Study|Adverse Event|6|||
164445600|NCT03575052|594001342|FG001|Overall Study|Adverse Event|10|||
164445601|NCT03575052|594001341|FG000|Overall Study|Not further specified|5|||
164144041|NCT00086281|592888580|FG009|Phase 2|Adverse Event|0|||
164445602|NCT03575052|594001342|FG001|Overall Study|Not further specified|7|||
164445603|NCT03575052|594001341|FG000|Overall Study|Withdrawal by Subject|5|||
164445604|NCT03575052|594001342|FG001|Overall Study|Withdrawal by Subject|6|||
164445605|NCT03575052|594001341|FG000|Overall Study|Lost to Follow-up|3|||
164445606|NCT03575052|594001342|FG001|Overall Study|Lost to Follow-up|0|||
164445607|NCT03575052|594001341|FG000|Overall Study|Death|2|||
164445608|NCT03575052|594001342|FG001|Overall Study|Death|1|||
164445609|NCT03575052|594001341|FG000|Overall Study|Lack of Efficacy|2|||
164445610|NCT03575052|594001342|FG001|Overall Study|Lack of Efficacy|1|||
164445611|NCT03575052|594001341|FG000|Overall Study|Study drug noncompliance|1|||
164445612|NCT03575052|594001342|FG001|Overall Study|Study drug noncompliance|2|||
164445613|NCT03575052|594001341|FG000|Overall Study|Protocol Violation|0|||
164445614|NCT03575052|594001342|FG001|Overall Study|Protocol Violation|2|||
164445615|NCT03575052|594001341|FG000|Overall Study|Physician Decision|1|||
164445616|NCT03575052|594001342|FG001|Overall Study|Physician Decision|0|||
164445617|NCT04153565|594001353|FG000|Overall Study|Death|13|||
164445618|NCT02991807|594001356|FG000|Overall Study|Withdrawal by Subject|2|||
164445619|NCT02991807|594001357|FG001|Overall Study|Withdrawal by Subject|1|||
164445620|NCT02991807|594001356|FG000|Overall Study|Physician Decision|0|||
164445621|NCT02991807|594001357|FG001|Overall Study|Physician Decision|1|||
164445622|NCT02991807|594001356|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
164445623|NCT02991807|594001357|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
164445624|NCT02566902|594001358|FG000|Overall Study|Protocol Violation|2|||
164445625|NCT02566902|594001359|FG001|Overall Study|Protocol Violation|1|||
164445626|NCT01875848|594001360|FG000|Overall Study|Withdrawal by Subject|2|||
164445627|NCT01875848|594001361|FG001|Overall Study|Withdrawal by Subject|0|||
164445628|NCT02411084|594001362|FG000|Overall Study|Lack of Efficacy|6|||
164445629|NCT02411084|594001363|FG001|Overall Study|Lack of Efficacy|3|||
164445630|NCT02411084|594001362|FG000|Overall Study|Death|5|||
164445631|NCT02411084|594001363|FG001|Overall Study|Death|4|||
164445632|NCT02411084|594001362|FG000|Overall Study|Adverse Event|2|||
164445633|NCT02411084|594001363|FG001|Overall Study|Adverse Event|1|||
164445634|NCT02411084|594001362|FG000|Overall Study|Other reasons|0|||
164445635|NCT02411084|594001363|FG001|Overall Study|Other reasons|5|||
164445636|NCT04723394|594001374|FG000|Overall Study|Adverse Event|0|||
164445637|NCT04723394|594001375|FG001|Overall Study|Adverse Event|3|||
164445638|NCT04723394|594001374|FG000|Overall Study|Death|8|||
164445639|NCT04723394|594001375|FG001|Overall Study|Death|8|||
164445640|NCT04723394|594001374|FG000|Overall Study|Lost to Follow-up|20|||
164445641|NCT04723394|594001375|FG001|Overall Study|Lost to Follow-up|17|||
164445642|NCT04723394|594001374|FG000|Overall Study|Physician Decision|1|||
164445643|NCT04723394|594001375|FG001|Overall Study|Physician Decision|0|||
164445644|NCT04723394|594001374|FG000|Overall Study|Withdrawal by Subject|20|||
164445645|NCT04723394|594001375|FG001|Overall Study|Withdrawal by Subject|34|||
164445646|NCT04723394|594001374|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
164445647|NCT04723394|594001375|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
164445648|NCT00446459|594001376|FG000|8 Months|Protocol Violation|12|||
164445649|NCT00446459|594001376|FG000|12 Months|Protocol Violation|4|||
164445650|NCT00446459|594001376|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
164445651|NCT00858117|594001378|FG000|Treatment on Study|Adverse Event|2|||
164445652|NCT00858117|594001378|FG000|Follow up for 5 Years|Death|4|||
164445653|NCT00858117|594001378|FG000|Follow up for 5 Years|No further data collected for study|9|||
164445654|NCT00371787|594001381|FG000|Overall Study|Withdrawal by Subject|3|||
164445655|NCT00371787|594001382|FG001|Overall Study|Withdrawal by Subject|1|||
164445656|NCT02647905|594001383|FG000|Overall Study|Lost to Follow-up|1|||
164445657|NCT02647905|594001383|FG000|Overall Study|Withdrawal by Subject|2|||
164445658|NCT00077675|594001384|FG000|Overall Study|Adverse Event|1|||
164445659|NCT00077675|594001385|FG001|Overall Study|Adverse Event|2|||
164445660|NCT00077675|594001384|FG000|Overall Study|Lost to Follow-up|6|||
164445661|NCT00077675|594001385|FG001|Overall Study|Lost to Follow-up|3|||
164445662|NCT00077675|594001384|FG000|Overall Study|Withdrawal by Subject|1|||
164445663|NCT00077675|594001385|FG001|Overall Study|Withdrawal by Subject|0|||
164445664|NCT00077675|594001384|FG000|Overall Study|Other|0|||
164445665|NCT00077675|594001385|FG001|Overall Study|Other|1|||
164445666|NCT00077675|594001384|FG000|Overall Study|Never received study treatment|3|||
164445667|NCT00077675|594001385|FG001|Overall Study|Never received study treatment|3|||
164445668|NCT02601820|594001386|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
164445669|NCT02601820|594001386|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
164445670|NCT02601820|594001386|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
164445671|NCT02601820|594001386|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
164445672|NCT00642850|594001392|FG000|Overall Study|Death|7|||
164445673|NCT00642850|594001392|FG000|Overall Study|Adverse Event|2|||
164445674|NCT00642850|594001392|FG000|Overall Study|Lack of Efficacy|1|||
164445675|NCT00642850|594001392|FG000|Overall Study|Protocol Violation|2|||
164445676|NCT00642850|594001392|FG000|Overall Study|Kidney transplantation|8|||
164445677|NCT00642850|594001392|FG000|Overall Study|Blood transfusion|6|||
164445678|NCT00642850|594001392|FG000|Overall Study|Other reasons|7|||
164445679|NCT01236001|594001393|FG000|Overall Study|Adverse Event|5|||
164445680|NCT01236001|594001394|FG001|Overall Study|Adverse Event|14|||
164445681|NCT01236001|594001393|FG000|Overall Study|Lack of Efficacy|6|||
164445682|NCT01236001|594001394|FG001|Overall Study|Lack of Efficacy|6|||
164445683|NCT01236001|594001393|FG000|Overall Study|Lost to Follow-up|6|||
164445684|NCT01236001|594001394|FG001|Overall Study|Lost to Follow-up|1|||
164445685|NCT01236001|594001393|FG000|Overall Study|Incompliance|1|||
164445686|NCT01236001|594001394|FG001|Overall Study|Incompliance|0|||
164445687|NCT01236001|594001393|FG000|Overall Study|Planned Visit After End of Study|0|||
164445688|NCT01236001|594001394|FG001|Overall Study|Planned Visit After End of Study|1|||
164445689|NCT01414738|594001397|FG000|Overall Study|Death|26|||
164445690|NCT01414738|594001397|FG000|Overall Study|Refused testing|5|||
164445691|NCT01414738|594001397|FG000|Overall Study|Lost to Follow-up|2|||
164445692|NCT01414738|594001397|FG000|Overall Study|Refused, disease progression|8|||
164445693|NCT01414738|594001397|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
164445694|NCT01266122|594001398|FG000|Overall Study|Lost to Follow-up|6|||
164445695|NCT01266122|594001399|FG001|Overall Study|Lost to Follow-up|6|||
164445696|NCT02092116|594001401|FG000|Overall Study|Withdrawal by Subject|0|||
164445697|NCT02092116|594001402|FG001|Overall Study|Withdrawal by Subject|3|||
164445698|NCT02092116|594001401|FG000|Overall Study|Adverse Event|0|||
164445699|NCT02092116|594001402|FG001|Overall Study|Adverse Event|1|||
164445700|NCT03076515|594001403|FG000|Overall Study|DMC decision based on interim analysis|25|||
164445701|NCT03076515|594001404|FG001|Overall Study|DMC decision based on interim analysis|29|||
164445702|NCT01697969|594001405|FG000|Overall Study|Did not meet inc/exc criteria|3|||
164445703|NCT03485950|594001410|FG000|Overall Study|Adverse Event|1|||
164445704|NCT03485950|594001411|FG001|Overall Study|Adverse Event|0|||
164445705|NCT03485950|594001410|FG000|Overall Study|Death|3|||
164445706|NCT03485950|594001411|FG001|Overall Study|Death|2|||
164445707|NCT03485950|594001410|FG000|Overall Study|Withdrawal by Subject|3|||
164445708|NCT03485950|594001411|FG001|Overall Study|Withdrawal by Subject|0|||
164445709|NCT01198028|594001418|FG000|Overall Study|Adverse Event|5|||
164445710|NCT01198028|594001418|FG000|Overall Study|Death|3|||
164445711|NCT01198028|594001418|FG000|Overall Study|Physician Decision|2|||
164445712|NCT02918071|594001420|FG000|Overall Study|Withdrawal by Subject|2|||
164445713|NCT02918071|594001420|FG000|Overall Study|Lost to Follow-up|1|||
164445714|NCT01616459|594001421|FG000|Overall Study|Adverse Event|1|||
164445715|NCT01616459|594001422|FG001|Overall Study|Adverse Event|1|||
164445716|NCT01616459|594001423|FG002|Overall Study|Adverse Event|2|||
164445717|NCT01616459|594001424|FG003|Overall Study|Adverse Event|0|||
164445718|NCT01616459|594001421|FG000|Overall Study|Lost to Follow-up|1|||
164445719|NCT01616459|594001422|FG001|Overall Study|Lost to Follow-up|11|||
164445720|NCT01616459|594001423|FG002|Overall Study|Lost to Follow-up|3|||
164445721|NCT01616459|594001424|FG003|Overall Study|Lost to Follow-up|2|||
164445722|NCT01616459|594001421|FG000|Overall Study|Protocol Violation|0|||
164445723|NCT01616459|594001422|FG001|Overall Study|Protocol Violation|0|||
164445724|NCT01616459|594001423|FG002|Overall Study|Protocol Violation|0|||
164445725|NCT01616459|594001424|FG003|Overall Study|Protocol Violation|2|||
164445726|NCT01616459|594001421|FG000|Overall Study|Withdrawal by Subject|2|||
164445727|NCT01616459|594001422|FG001|Overall Study|Withdrawal by Subject|4|||
164445728|NCT01616459|594001423|FG002|Overall Study|Withdrawal by Subject|4|||
164445729|NCT01616459|594001424|FG003|Overall Study|Withdrawal by Subject|4|||
164445730|NCT01616459|594001421|FG000|Overall Study|Other reason|0|||
164445731|NCT01616459|594001422|FG001|Overall Study|Other reason|1|||
164445732|NCT01616459|594001423|FG002|Overall Study|Other reason|1|||
164445733|NCT01616459|594001424|FG003|Overall Study|Other reason|0|||
164445734|NCT04104321|594003204|FG000|Overall Study|didn't take the study drug|3|||
164445735|NCT02652260|594003209|FG000|Base Study|Pregnancy|0|||
164445736|NCT02652260|594003210|FG001|Base Study|Pregnancy|1|||
164445737|NCT02652260|594003209|FG000|Base Study|Withdrawal by Subject|0|||
164445738|NCT02652260|594003210|FG001|Base Study|Withdrawal by Subject|1|||
164445739|NCT02652260|594003209|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
164445740|NCT02652260|594003210|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
164445741|NCT02652260|594003209|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
164445742|NCT02652260|594003210|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
164445743|NCT02652260|594003209|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
164445744|NCT02652260|594003210|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
164445745|NCT02652260|594003209|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
164445746|NCT02652260|594003210|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
164445747|NCT02652260|594003209|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
164445748|NCT02652260|594003210|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
164445749|NCT02652260|594003209|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
164445750|NCT02652260|594003210|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
164445751|NCT02652260|594003209|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
164445752|NCT02652260|594003210|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
164445753|NCT02652260|594003209|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
164445754|NCT02652260|594003210|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
164445755|NCT02652260|594003209|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
164706180|NCT04492020|594953393|FG001|Overall Study|Adverse Event|3|||
164706181|NCT04492020|594953392|FG000|Overall Study|Withdrawal by Subject|4|||
164445756|NCT02652260|594003210|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
164445757|NCT02652260|594003209|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
164445758|NCT02652260|594003210|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
164445759|NCT02652260|594003209|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
164706182|NCT04492020|594953393|FG001|Overall Study|Withdrawal by Subject|3|||
164706183|NCT04492020|594953392|FG000|Overall Study|Lost to Follow-up|4|||
164445760|NCT02652260|594003210|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
164445761|NCT02652260|594003209|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
164445762|NCT02652260|594003210|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
164445763|NCT04300647|594003211|FG000|Pre-Crossover|Death|19|||
164445764|NCT04300647|594003212|FG001|Pre-Crossover|Death|58|||
164445765|NCT04300647|594003213|FG002|Pre-Crossover|Death|0|||
164445766|NCT04300647|594003211|FG000|Pre-Crossover|Lost to Follow-up|0|||
164706184|NCT04492020|594953393|FG001|Overall Study|Lost to Follow-up|3|||
164445767|NCT04300647|594003212|FG001|Pre-Crossover|Lost to Follow-up|3|||
164445768|NCT04300647|594003213|FG002|Pre-Crossover|Lost to Follow-up|0|||
164445769|NCT04300647|594003211|FG000|Pre-Crossover|Withdrawal by Subject|2|||
164706185|NCT04492020|594953392|FG000|Overall Study|Protocol Violation|5|||
164706186|NCT04492020|594953393|FG001|Overall Study|Protocol Violation|2|||
164445770|NCT04300647|594003212|FG001|Pre-Crossover|Withdrawal by Subject|4|||
164445771|NCT04300647|594003213|FG002|Pre-Crossover|Withdrawal by Subject|0|||
164445772|NCT04300647|594003211|FG000|Pre-Crossover|On-going in Study|24|||
164445773|NCT04300647|594003212|FG001|Pre-Crossover|On-going in Study|61|||
164445774|NCT04300647|594003213|FG002|Pre-Crossover|On-going in Study|0|||
164445775|NCT04300647|594003211|FG000|Post-Crossover|Death|0|||
164445776|NCT04300647|594003212|FG001|Post-Crossover|Death|0|||
164445777|NCT04300647|594003213|FG002|Post-Crossover|Death|3|||
164445778|NCT04300647|594003211|FG000|Post-Crossover|Lost to Follow-up|0|||
164445779|NCT04300647|594003212|FG001|Post-Crossover|Lost to Follow-up|0|||
164445780|NCT04300647|594003213|FG002|Post-Crossover|Lost to Follow-up|1|||
164445781|NCT04300647|594003211|FG000|Post-Crossover|Withdrawal by Subject|0|||
164445782|NCT04300647|594003212|FG001|Post-Crossover|Withdrawal by Subject|0|||
164445783|NCT04300647|594003213|FG002|Post-Crossover|Withdrawal by Subject|1|||
164445784|NCT04300647|594003211|FG000|Post-Crossover|On-going in Study|0|||
164445785|NCT04300647|594003212|FG001|Post-Crossover|On-going in Study|0|||
164445786|NCT04300647|594003213|FG002|Post-Crossover|On-going in Study|8|||
164445787|NCT05056246|594003214|FG000|Overall Study|Adverse Event|0|||
164445788|NCT05056246|594003215|FG001|Overall Study|Adverse Event|0|||
164445789|NCT05056246|594003216|FG002|Overall Study|Adverse Event|0|||
164445790|NCT05056246|594003217|FG003|Overall Study|Adverse Event|0|||
164445791|NCT05056246|594003218|FG004|Overall Study|Adverse Event|1|||
164445792|NCT05056246|594003214|FG000|Overall Study|Lost to Follow-up|0|||
164445793|NCT05056246|594003215|FG001|Overall Study|Lost to Follow-up|0|||
164445794|NCT05056246|594003216|FG002|Overall Study|Lost to Follow-up|0|||
164445795|NCT05056246|594003217|FG003|Overall Study|Lost to Follow-up|2|||
164445796|NCT05056246|594003218|FG004|Overall Study|Lost to Follow-up|0|||
164445797|NCT05056246|594003214|FG000|Overall Study|Withdrawal by Subject|0|||
164445798|NCT05056246|594003215|FG001|Overall Study|Withdrawal by Subject|1|||
164445799|NCT05056246|594003216|FG002|Overall Study|Withdrawal by Subject|0|||
164445800|NCT05056246|594003217|FG003|Overall Study|Withdrawal by Subject|0|||
164445801|NCT05056246|594003218|FG004|Overall Study|Withdrawal by Subject|0|||
164445802|NCT01622868|594003219|FG000|Overall Study|Protocol Violation|7|||
164445803|NCT01622868|594003220|FG001|Overall Study|Protocol Violation|0|||
164445804|NCT03285763|594003222|FG000|Overall Study|Death|470|||
164445805|NCT03285763|594003222|FG000|Overall Study|Lost to Follow-up|18|||
164445806|NCT03285763|594003222|FG000|Overall Study|Physician Decision|2|||
164445807|NCT03285763|594003222|FG000|Overall Study|Study Terminated By Sponsor|79|||
164445808|NCT03285763|594003222|FG000|Overall Study|Withdrawal by Subject|33|||
164445809|NCT03624972|594003223|FG000|Overall Study|Lost to Follow-up|2|||
164445810|NCT03624972|594003224|FG001|Overall Study|Lost to Follow-up|0|||
164445811|NCT03624972|594003225|FG002|Overall Study|Lost to Follow-up|0|||
164445812|NCT03624972|594003223|FG000|Overall Study|Withdrawal by Subject|0|||
164445813|NCT03624972|594003224|FG001|Overall Study|Withdrawal by Subject|2|||
164445814|NCT03624972|594003225|FG002|Overall Study|Withdrawal by Subject|0|||
164445815|NCT03112174|594003226|FG000|Overall Study|Withdrawal by Subject|3|||
164445816|NCT03112174|594003227|FG001|Overall Study|Withdrawal by Subject|0|||
164445817|NCT03112174|594003228|FG002|Overall Study|Withdrawal by Subject|11|||
164445818|NCT03112174|594003229|FG003|Overall Study|Withdrawal by Subject|9|||
164445819|NCT03112174|594003230|FG004|Overall Study|Withdrawal by Subject|7|||
164706187|NCT04492020|594953392|FG000|Overall Study|Lack of Qualifying Event|25|||
164706188|NCT04492020|594953393|FG001|Overall Study|Lack of Qualifying Event|27|||
164706189|NCT04492020|594953392|FG000|Overall Study|Non-compliance with Study Drug|2|||
164706190|NCT04492020|594953393|FG001|Overall Study|Non-compliance with Study Drug|1|||
164706191|NCT00325195|594953394|FG000|Randomized|Not dosed|5|||
164445820|NCT03112174|594003226|FG000|Overall Study|Lost to Follow-up|1|||
164445821|NCT03112174|594003227|FG001|Overall Study|Lost to Follow-up|1|||
164445822|NCT03112174|594003228|FG002|Overall Study|Lost to Follow-up|2|||
164445823|NCT03112174|594003229|FG003|Overall Study|Lost to Follow-up|3|||
164445824|NCT03112174|594003230|FG004|Overall Study|Lost to Follow-up|2|||
164445825|NCT03112174|594003226|FG000|Overall Study|Death|8|||
164445826|NCT03112174|594003227|FG001|Overall Study|Death|3|||
164445827|NCT03112174|594003228|FG002|Overall Study|Death|67|||
164445828|NCT03112174|594003229|FG003|Overall Study|Death|73|||
164445829|NCT03112174|594003230|FG004|Overall Study|Death|18|||
164445830|NCT03112174|594003226|FG000|Overall Study|Other, Not Specified|1|||
164445831|NCT03112174|594003227|FG001|Overall Study|Other, Not Specified|0|||
164445832|NCT03112174|594003228|FG002|Overall Study|Other, Not Specified|1|||
164445833|NCT03112174|594003229|FG003|Overall Study|Other, Not Specified|2|||
164445834|NCT03112174|594003230|FG004|Overall Study|Other, Not Specified|0|||
164445835|NCT04425629|594003231|FG000|Overall Study|Adverse Event|0|||
164445836|NCT04425629|594003232|FG001|Overall Study|Adverse Event|0|||
164445837|NCT04425629|594003233|FG002|Overall Study|Adverse Event|0|||
164706192|NCT00325195|594953395|FG001|Randomized|Not dosed|5|||
164706193|NCT00325195|594953396|FG002|Randomized|Not dosed|3|||
164445838|NCT04425629|594003234|FG003|Overall Study|Adverse Event|0|||
164445839|NCT04425629|594003235|FG004|Overall Study|Adverse Event|1|||
164445840|NCT04425629|594003236|FG005|Overall Study|Adverse Event|0|||
164445841|NCT04425629|594003237|FG006|Overall Study|Adverse Event|0|||
164445842|NCT04425629|594003238|FG007|Overall Study|Adverse Event|0|||
164445843|NCT04425629|594003239|FG008|Overall Study|Adverse Event|0|||
164445844|NCT04425629|594003240|FG009|Overall Study|Adverse Event|3|||
164445845|NCT04425629|594003241|FG010|Overall Study|Adverse Event|2|||
164445846|NCT04425629|594003242|FG011|Overall Study|Adverse Event|1|||
164445847|NCT04425629|594003243|FG012|Overall Study|Adverse Event|1|||
164445848|NCT04425629|594003244|FG013|Overall Study|Adverse Event|0|||
164445849|NCT04425629|594003245|FG014|Overall Study|Adverse Event|0|||
164445850|NCT04425629|594003246|FG015|Overall Study|Adverse Event|0|||
164445851|NCT04425629|594003247|FG016|Overall Study|Adverse Event|0|||
164445852|NCT04425629|594003248|FG017|Overall Study|Adverse Event|0|||
164445853|NCT04425629|594003249|FG018|Overall Study|Adverse Event|0|||
164445854|NCT04425629|594003231|FG000|Overall Study|Lost to Follow-up|1|||
164445855|NCT04425629|594003232|FG001|Overall Study|Lost to Follow-up|3|||
164445856|NCT04425629|594003233|FG002|Overall Study|Lost to Follow-up|1|||
164445857|NCT04425629|594003234|FG003|Overall Study|Lost to Follow-up|7|||
164445858|NCT04425629|594003235|FG004|Overall Study|Lost to Follow-up|1|||
164445859|NCT04425629|594003236|FG005|Overall Study|Lost to Follow-up|2|||
164445860|NCT04425629|594003237|FG006|Overall Study|Lost to Follow-up|1|||
164445861|NCT04425629|594003238|FG007|Overall Study|Lost to Follow-up|0|||
164445862|NCT04425629|594003239|FG008|Overall Study|Lost to Follow-up|1|||
164445863|NCT04425629|594003240|FG009|Overall Study|Lost to Follow-up|64|||
164445864|NCT04425629|594003241|FG010|Overall Study|Lost to Follow-up|70|||
164445865|NCT04425629|594003242|FG011|Overall Study|Lost to Follow-up|98|||
164445866|NCT04425629|594003243|FG012|Overall Study|Lost to Follow-up|30|||
164445867|NCT04425629|594003244|FG013|Overall Study|Lost to Follow-up|0|||
164706194|NCT00325195|594953394|FG000|Received Intervention: ITT Population|Adverse Event|15|||
164706195|NCT00325195|594953395|FG001|Received Intervention: ITT Population|Adverse Event|17|||
164706196|NCT00325195|594953396|FG002|Received Intervention: ITT Population|Adverse Event|1|||
164445868|NCT04425629|594003245|FG014|Overall Study|Lost to Follow-up|5|||
164445869|NCT04425629|594003246|FG015|Overall Study|Lost to Follow-up|4|||
164445870|NCT04425629|594003247|FG016|Overall Study|Lost to Follow-up|0|||
164445871|NCT04425629|594003248|FG017|Overall Study|Lost to Follow-up|3|||
164445872|NCT04425629|594003249|FG018|Overall Study|Lost to Follow-up|1|||
164445873|NCT04425629|594003231|FG000|Overall Study|Subject Decision|0|||
164445874|NCT04425629|594003232|FG001|Overall Study|Subject Decision|2|||
164445875|NCT04425629|594003233|FG002|Overall Study|Subject Decision|1|||
164445876|NCT04425629|594003234|FG003|Overall Study|Subject Decision|3|||
164596849|NCT02052778|594549001|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
164596850|NCT02052778|594549002|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
164596851|NCT02052778|594549003|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
164596852|NCT02052778|594549004|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
164596853|NCT02052778|594549005|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
164596854|NCT02052778|594549006|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
164706197|NCT00325195|594953394|FG000|Received Intervention: ITT Population|Death|3|||
164706198|NCT00325195|594953395|FG001|Received Intervention: ITT Population|Death|1|||
164596855|NCT02052778|594549007|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
164596856|NCT02052778|594549008|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
164706199|NCT00325195|594953396|FG002|Received Intervention: ITT Population|Death|0|||
164706200|NCT00325195|594953394|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
164706201|NCT00325195|594953395|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
164706202|NCT00325195|594953396|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
164706203|NCT00325195|594953394|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
164706204|NCT00325195|594953395|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
164706205|NCT00325195|594953396|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
164706206|NCT00325195|594953394|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
164706207|NCT00325195|594953395|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
164706208|NCT00325195|594953396|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
164706209|NCT04594707|594953397|FG000|Overall Study|Adverse Event|0|||
164445877|NCT04425629|594003235|FG004|Overall Study|Subject Decision|6|||
164445878|NCT04425629|594003236|FG005|Overall Study|Subject Decision|6|||
164445879|NCT04425629|594003237|FG006|Overall Study|Subject Decision|3|||
164445880|NCT04425629|594003238|FG007|Overall Study|Subject Decision|3|||
164445881|NCT04425629|594003239|FG008|Overall Study|Subject Decision|1|||
164445882|NCT04425629|594003240|FG009|Overall Study|Subject Decision|70|||
164596857|NCT02052778|594549009|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
164445883|NCT04425629|594003241|FG010|Overall Study|Subject Decision|95|||
164445884|NCT04425629|594003242|FG011|Overall Study|Subject Decision|124|||
164596858|NCT02052778|594549010|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
164445885|NCT04425629|594003243|FG012|Overall Study|Subject Decision|25|||
164706210|NCT04594707|594953398|FG001|Overall Study|Adverse Event|0|||
164706211|NCT04594707|594953399|FG002|Overall Study|Adverse Event|1|||
164706212|NCT04594707|594953397|FG000|Overall Study|Death|0|||
164706213|NCT04594707|594953398|FG001|Overall Study|Death|2|||
164706214|NCT04594707|594953399|FG002|Overall Study|Death|2|||
164706215|NCT04594707|594953397|FG000|Overall Study|Lung Transplant|0|||
164706216|NCT04594707|594953398|FG001|Overall Study|Lung Transplant|0|||
164403524|NCT00508261|593846299|FG002|Overall Study|Withdrawal by Subject|4|||
164403525|NCT00508261|593846300|FG003|Overall Study|Withdrawal by Subject|0|||
164403526|NCT00508261|593846297|FG000|Overall Study|Migrated/ moved from study area|0|||
164403527|NCT00508261|593846298|FG001|Overall Study|Migrated/ moved from study area|1|||
164403528|NCT00508261|593846299|FG002|Overall Study|Migrated/ moved from study area|0|||
164403529|NCT00508261|593846300|FG003|Overall Study|Migrated/ moved from study area|0|||
164403530|NCT00508261|593846297|FG000|Overall Study|Lost to Follow-up|0|||
164403531|NCT00508261|593846298|FG001|Overall Study|Lost to Follow-up|1|||
164403532|NCT00508261|593846299|FG002|Overall Study|Lost to Follow-up|1|||
164403533|NCT00508261|593846300|FG003|Overall Study|Lost to Follow-up|1|||
164403534|NCT00180479|593846301|FG000|Overall Study|Death|4|||
164403535|NCT00180479|593846302|FG001|Overall Study|Death|2|||
164403536|NCT00180479|593846301|FG000|Overall Study|Lost to Follow-up|9|||
164403537|NCT00180479|593846302|FG001|Overall Study|Lost to Follow-up|7|||
164403538|NCT00180479|593846301|FG000|Overall Study|Withdrawal by Subject|3|||
164403539|NCT00180479|593846302|FG001|Overall Study|Withdrawal by Subject|3|||
164403540|NCT00180479|593846301|FG000|Overall Study|Informed consent not signed|0|||
164403541|NCT00180479|593846302|FG001|Overall Study|Informed consent not signed|1|||
164403542|NCT04044456|593846310|FG000|Overall Study|Lost to Follow-up|4|||
164403543|NCT04044456|593846311|FG001|Overall Study|Lost to Follow-up|1|||
164403544|NCT04044456|593846310|FG000|Overall Study|Withdrawal by Subject|1|||
164403545|NCT04044456|593846311|FG001|Overall Study|Withdrawal by Subject|0|||
164403546|NCT02316769|593846313|FG000|Overall Study|Physician Decision|1|||
164403547|NCT02316769|593846314|FG001|Overall Study|Physician Decision|0|||
164403548|NCT02316769|593846313|FG000|Overall Study|Withdrawal by Subject|1|||
164403549|NCT02316769|593846314|FG001|Overall Study|Withdrawal by Subject|0|||
164403550|NCT04209725|593846324|FG000|Overall Study|Adverse Event|1|||
164403551|NCT01281644|593846327|FG000|Overall Study|Lost to Follow-up|3|||
164403552|NCT01281644|593846327|FG000|Overall Study|Withdrawal by Subject|2|||
164403553|NCT02954354|593846328|FG000|Overall Study|Adverse Event|2|||
164403554|NCT02954354|593846329|FG001|Overall Study|Adverse Event|2|||
164403555|NCT02954354|593846330|FG002|Overall Study|Adverse Event|4|||
164403556|NCT02954354|593846328|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
164403557|NCT02954354|593846329|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
164403558|NCT02954354|593846330|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
164403559|NCT02954354|593846328|FG000|Overall Study|Lack of Efficacy|0|||
164403560|NCT02954354|593846329|FG001|Overall Study|Lack of Efficacy|2|||
164403561|NCT02954354|593846330|FG002|Overall Study|Lack of Efficacy|0|||
164403562|NCT02954354|593846328|FG000|Overall Study|Withdrawal by Subject|17|||
164403563|NCT02954354|593846329|FG001|Overall Study|Withdrawal by Subject|9|||
164403564|NCT02954354|593846330|FG002|Overall Study|Withdrawal by Subject|11|||
164403565|NCT02954354|593846328|FG000|Overall Study|Lost to Follow-up|12|||
164403566|NCT02954354|593846329|FG001|Overall Study|Lost to Follow-up|5|||
164403567|NCT02954354|593846330|FG002|Overall Study|Lost to Follow-up|0|||
164403568|NCT02954354|593846328|FG000|Overall Study|Miscellaneous|2|||
164403569|NCT02954354|593846329|FG001|Overall Study|Miscellaneous|2|||
164403570|NCT02954354|593846330|FG002|Overall Study|Miscellaneous|1|||
164403571|NCT03039023|593846333|FG000|Overall Study|Withdrawal by Subject|1|||
164403572|NCT03039023|593846334|FG001|Overall Study|Withdrawal by Subject|0|||
164403573|NCT03039023|593846335|FG002|Overall Study|Withdrawal by Subject|1|||
164403574|NCT03039023|593846336|FG003|Overall Study|Withdrawal by Subject|1|||
164403575|NCT03039023|593846337|FG004|Overall Study|Withdrawal by Subject|0|||
164445886|NCT04425629|594003244|FG013|Overall Study|Subject Decision|0|||
164403576|NCT03039023|593846333|FG000|Overall Study|Physician Decision|0|||
164403577|NCT03039023|593846334|FG001|Overall Study|Physician Decision|0|||
164403578|NCT03039023|593846335|FG002|Overall Study|Physician Decision|0|||
164403579|NCT03039023|593846336|FG003|Overall Study|Physician Decision|1|||
164403580|NCT03039023|593846337|FG004|Overall Study|Physician Decision|0|||
164445887|NCT04425629|594003245|FG014|Overall Study|Subject Decision|1|||
164403581|NCT03338829|593846339|FG000|Overall Study|Lost to Follow-up|4|||
164403582|NCT03338829|593846340|FG001|Overall Study|Lost to Follow-up|2|||
164403583|NCT03338829|593846341|FG002|Overall Study|Lost to Follow-up|4|||
164403584|NCT03338829|593846339|FG000|Overall Study|Pregnancy loss|1|||
164445888|NCT04425629|594003246|FG015|Overall Study|Subject Decision|4|||
164706217|NCT04594707|594953399|FG002|Overall Study|Lung Transplant|1|||
164403585|NCT03338829|593846340|FG001|Overall Study|Pregnancy loss|1|||
164403586|NCT03338829|593846341|FG002|Overall Study|Pregnancy loss|0|||
164403587|NCT03338829|593846339|FG000|Overall Study|Protocol Violation|0|||
164403588|NCT03338829|593846340|FG001|Overall Study|Protocol Violation|1|||
164403589|NCT03338829|593846341|FG002|Overall Study|Protocol Violation|0|||
164706218|NCT04594707|594953397|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
164445889|NCT04425629|594003247|FG016|Overall Study|Subject Decision|1|||
164445890|NCT04425629|594003248|FG017|Overall Study|Subject Decision|0|||
164445891|NCT04425629|594003249|FG018|Overall Study|Subject Decision|2|||
164445892|NCT04425629|594003231|FG000|Overall Study|Death|0|||
164445893|NCT04425629|594003232|FG001|Overall Study|Death|0|||
164445894|NCT04425629|594003233|FG002|Overall Study|Death|0|||
164445895|NCT04425629|594003234|FG003|Overall Study|Death|0|||
164445896|NCT04425629|594003235|FG004|Overall Study|Death|0|||
164445897|NCT04425629|594003236|FG005|Overall Study|Death|0|||
164445898|NCT04425629|594003237|FG006|Overall Study|Death|0|||
164445899|NCT04425629|594003238|FG007|Overall Study|Death|0|||
164445900|NCT04425629|594003239|FG008|Overall Study|Death|0|||
164445901|NCT04425629|594003240|FG009|Overall Study|Death|11|||
164445902|NCT04425629|594003241|FG010|Overall Study|Death|2|||
164445903|NCT04425629|594003242|FG011|Overall Study|Death|4|||
164445904|NCT04425629|594003243|FG012|Overall Study|Death|0|||
164445905|NCT04425629|594003244|FG013|Overall Study|Death|0|||
164445906|NCT04425629|594003245|FG014|Overall Study|Death|0|||
164445907|NCT04425629|594003246|FG015|Overall Study|Death|0|||
164445908|NCT04425629|594003247|FG016|Overall Study|Death|0|||
164445909|NCT04425629|594003248|FG017|Overall Study|Death|0|||
164445910|NCT04425629|594003249|FG018|Overall Study|Death|0|||
164445911|NCT04425629|594003231|FG000|Overall Study|Sponsor Request|0|||
164445912|NCT04425629|594003232|FG001|Overall Study|Sponsor Request|0|||
164445913|NCT04425629|594003233|FG002|Overall Study|Sponsor Request|0|||
164445914|NCT04425629|594003234|FG003|Overall Study|Sponsor Request|2|||
164445915|NCT04425629|594003235|FG004|Overall Study|Sponsor Request|2|||
164445916|NCT04425629|594003236|FG005|Overall Study|Sponsor Request|2|||
164596859|NCT02052778|594549011|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
164596860|NCT02052778|594549012|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
164596861|NCT02052778|594549013|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
164596862|NCT02052778|594549014|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
164596863|NCT02052778|594549015|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
164596864|NCT02052778|594548993|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
164596865|NCT02052778|594548994|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
164596866|NCT02052778|594548995|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
164596867|NCT02052778|594548996|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
164596868|NCT02052778|594548997|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
164596869|NCT02052778|594548998|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
164596870|NCT02052778|594548999|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
164596871|NCT02052778|594549000|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
164596872|NCT02052778|594549001|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
164596873|NCT02052778|594549002|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
164596874|NCT02052778|594549003|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
164596875|NCT02052778|594549004|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
164596876|NCT02052778|594549005|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
164596877|NCT02052778|594549006|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
164596878|NCT02052778|594549007|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
164596879|NCT02052778|594549008|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
164596880|NCT02052778|594549009|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
164596881|NCT02052778|594549010|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
164596882|NCT02052778|594549011|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
164596883|NCT02052778|594549012|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
164596884|NCT02052778|594549013|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
164596885|NCT02052778|594549014|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
164596886|NCT02052778|594549015|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
164596887|NCT02052778|594548993|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164706219|NCT04594707|594953398|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
164706220|NCT04594707|594953399|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
164445917|NCT04425629|594003237|FG006|Overall Study|Sponsor Request|1|||
164445918|NCT04425629|594003238|FG007|Overall Study|Sponsor Request|0|||
164445919|NCT04425629|594003239|FG008|Overall Study|Sponsor Request|0|||
164445920|NCT04425629|594003240|FG009|Overall Study|Sponsor Request|9|||
164445921|NCT04425629|594003241|FG010|Overall Study|Sponsor Request|9|||
164445922|NCT04425629|594003242|FG011|Overall Study|Sponsor Request|10|||
164445923|NCT04425629|594003243|FG012|Overall Study|Sponsor Request|8|||
164445924|NCT04425629|594003244|FG013|Overall Study|Sponsor Request|0|||
164445925|NCT04425629|594003245|FG014|Overall Study|Sponsor Request|0|||
164445926|NCT04425629|594003246|FG015|Overall Study|Sponsor Request|1|||
164445927|NCT04425629|594003247|FG016|Overall Study|Sponsor Request|0|||
164445928|NCT04425629|594003248|FG017|Overall Study|Sponsor Request|0|||
164403590|NCT00448448|593846345|FG000|Overall Study|Withdrawal by Subject|13|||
164403591|NCT00448448|593846346|FG001|Overall Study|Withdrawal by Subject|2|||
164403592|NCT00448448|593846345|FG000|Overall Study|On protocol when study ended|83|||
164403593|NCT00448448|593846346|FG001|Overall Study|On protocol when study ended|36|||
164403594|NCT00448448|593846345|FG000|Overall Study|Lost to Follow-up|2|||
164403595|NCT00448448|593846346|FG001|Overall Study|Lost to Follow-up|1|||
164445929|NCT04425629|594003249|FG018|Overall Study|Sponsor Request|0|||
164445930|NCT04425629|594003231|FG000|Overall Study|Physician Decision|0|||
164445931|NCT04425629|594003232|FG001|Overall Study|Physician Decision|0|||
164445932|NCT04425629|594003233|FG002|Overall Study|Physician Decision|0|||
164445933|NCT04425629|594003234|FG003|Overall Study|Physician Decision|0|||
164445934|NCT04425629|594003235|FG004|Overall Study|Physician Decision|0|||
164445935|NCT04425629|594003236|FG005|Overall Study|Physician Decision|0|||
164445936|NCT04425629|594003237|FG006|Overall Study|Physician Decision|0|||
164445937|NCT04425629|594003238|FG007|Overall Study|Physician Decision|0|||
164445938|NCT04425629|594003239|FG008|Overall Study|Physician Decision|0|||
164445939|NCT04425629|594003240|FG009|Overall Study|Physician Decision|4|||
164445940|NCT04425629|594003241|FG010|Overall Study|Physician Decision|3|||
164445941|NCT04425629|594003242|FG011|Overall Study|Physician Decision|5|||
164445942|NCT04425629|594003243|FG012|Overall Study|Physician Decision|1|||
164445943|NCT04425629|594003244|FG013|Overall Study|Physician Decision|0|||
164445944|NCT04425629|594003245|FG014|Overall Study|Physician Decision|0|||
164445945|NCT04425629|594003246|FG015|Overall Study|Physician Decision|1|||
164445946|NCT04425629|594003247|FG016|Overall Study|Physician Decision|0|||
164445947|NCT04425629|594003248|FG017|Overall Study|Physician Decision|0|||
164445948|NCT04425629|594003249|FG018|Overall Study|Physician Decision|0|||
164445949|NCT04425629|594003231|FG000|Overall Study|Lack of Efficacy|0|||
164445950|NCT04425629|594003232|FG001|Overall Study|Lack of Efficacy|0|||
164445951|NCT04425629|594003233|FG002|Overall Study|Lack of Efficacy|0|||
164445952|NCT04425629|594003234|FG003|Overall Study|Lack of Efficacy|0|||
164445953|NCT04425629|594003235|FG004|Overall Study|Lack of Efficacy|0|||
164445954|NCT04425629|594003236|FG005|Overall Study|Lack of Efficacy|0|||
164445955|NCT04425629|594003237|FG006|Overall Study|Lack of Efficacy|0|||
164445956|NCT04425629|594003238|FG007|Overall Study|Lack of Efficacy|0|||
164445957|NCT04425629|594003239|FG008|Overall Study|Lack of Efficacy|0|||
164445958|NCT04425629|594003240|FG009|Overall Study|Lack of Efficacy|0|||
164445959|NCT04425629|594003241|FG010|Overall Study|Lack of Efficacy|1|||
164445960|NCT04425629|594003242|FG011|Overall Study|Lack of Efficacy|0|||
164445961|NCT04425629|594003243|FG012|Overall Study|Lack of Efficacy|0|||
164445962|NCT04425629|594003244|FG013|Overall Study|Lack of Efficacy|0|||
164445963|NCT04425629|594003245|FG014|Overall Study|Lack of Efficacy|0|||
164445964|NCT04425629|594003246|FG015|Overall Study|Lack of Efficacy|0|||
164445965|NCT04425629|594003247|FG016|Overall Study|Lack of Efficacy|0|||
164445966|NCT04425629|594003248|FG017|Overall Study|Lack of Efficacy|0|||
164445967|NCT04425629|594003249|FG018|Overall Study|Lack of Efficacy|0|||
164445968|NCT00610649|594003252|FG000|Overall Study|Adverse Event|1|||
164445969|NCT00610649|594003253|FG001|Overall Study|Adverse Event|0|||
164445970|NCT00610649|594003254|FG002|Overall Study|Adverse Event|0|||
164445971|NCT00610649|594003255|FG003|Overall Study|Adverse Event|0|||
164445972|NCT00610649|594003256|FG004|Overall Study|Adverse Event|0|||
164445973|NCT00610649|594003257|FG005|Overall Study|Adverse Event|0|||
164445974|NCT00610649|594003258|FG006|Overall Study|Adverse Event|0|||
164403596|NCT00448448|593846345|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
164403597|NCT00448448|593846346|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
164403598|NCT00448448|593846345|FG000|Overall Study|Signed consent lost|0|||
164403599|NCT00448448|593846346|FG001|Overall Study|Signed consent lost|1|||
164403600|NCT02340026|593846347|FG000|Treatment Phase|Withdrawal by Subject|2|||
164403601|NCT02340026|593846348|FG001|Treatment Phase|Withdrawal by Subject|2|||
164445975|NCT00610649|594003259|FG007|Overall Study|Adverse Event|0|||
164445976|NCT00610649|594003260|FG008|Overall Study|Adverse Event|0|||
164445977|NCT00610649|594003261|FG009|Overall Study|Adverse Event|0|||
164445978|NCT00610649|594003262|FG010|Overall Study|Adverse Event|1|||
164445979|NCT00610649|594003252|FG000|Overall Study|Family Emergency|0|||
164445980|NCT00610649|594003253|FG001|Overall Study|Family Emergency|1|||
164445981|NCT00610649|594003254|FG002|Overall Study|Family Emergency|0|||
164445982|NCT00610649|594003255|FG003|Overall Study|Family Emergency|0|||
164445983|NCT00610649|594003256|FG004|Overall Study|Family Emergency|0|||
164445984|NCT00610649|594003257|FG005|Overall Study|Family Emergency|0|||
164445985|NCT00610649|594003258|FG006|Overall Study|Family Emergency|0|||
164445986|NCT00610649|594003259|FG007|Overall Study|Family Emergency|0|||
164445987|NCT00610649|594003260|FG008|Overall Study|Family Emergency|0|||
164445988|NCT00610649|594003261|FG009|Overall Study|Family Emergency|0|||
164445989|NCT00610649|594003262|FG010|Overall Study|Family Emergency|0|||
164445990|NCT00610649|594003252|FG000|Overall Study|Withdrawal by Subject|0|||
164445991|NCT00610649|594003253|FG001|Overall Study|Withdrawal by Subject|0|||
164403602|NCT02340026|593846347|FG000|Follow-up Phase|Lost to Follow-up|1|||
164403603|NCT02340026|593846348|FG001|Follow-up Phase|Lost to Follow-up|0|||
164403604|NCT02684006|593846349|FG000|Overall Study|Other|18|||
164445992|NCT00610649|594003254|FG002|Overall Study|Withdrawal by Subject|0|||
164445993|NCT00610649|594003255|FG003|Overall Study|Withdrawal by Subject|0|||
164706221|NCT04594707|594953397|FG000|Overall Study|Study Terminated By Sponsor|19|||
164706222|NCT04594707|594953398|FG001|Overall Study|Study Terminated By Sponsor|47|||
164706223|NCT04594707|594953399|FG002|Overall Study|Study Terminated By Sponsor|41|||
164706224|NCT04594707|594953397|FG000|Overall Study|Withdrawal by Subject|1|||
164706225|NCT04594707|594953398|FG001|Overall Study|Withdrawal by Subject|0|||
164706226|NCT04594707|594953399|FG002|Overall Study|Withdrawal by Subject|2|||
164706227|NCT04585789|594953400|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
164706228|NCT04585789|594953401|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
164706229|NCT04585789|594953402|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
164706230|NCT04585789|594953400|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
164403605|NCT02684006|593846350|FG001|Overall Study|Other|6|||
164403606|NCT02684006|593846349|FG000|Overall Study|Protocol Violation|2|||
164403607|NCT02684006|593846350|FG001|Overall Study|Protocol Violation|1|||
164403608|NCT02684006|593846349|FG000|Overall Study|Non-compliance with study drug|1|||
164403609|NCT02684006|593846350|FG001|Overall Study|Non-compliance with study drug|1|||
164403610|NCT02684006|593846349|FG000|Overall Study|No longer met eligibility criteria|6|||
164403611|NCT02684006|593846350|FG001|Overall Study|No longer met eligibility criteria|2|||
164403612|NCT02684006|593846349|FG000|Overall Study|Lost to Follow-up|0|||
164403613|NCT02684006|593846350|FG001|Overall Study|Lost to Follow-up|1|||
164403614|NCT02684006|593846349|FG000|Overall Study|Death|25|||
164403615|NCT02684006|593846350|FG001|Overall Study|Death|22|||
164403616|NCT02684006|593846349|FG000|Overall Study|Global deterioration of health status|18|||
164403617|NCT02684006|593846350|FG001|Overall Study|Global deterioration of health status|20|||
164403618|NCT02684006|593846349|FG000|Overall Study|Physician Decision|15|||
164403619|NCT02684006|593846350|FG001|Overall Study|Physician Decision|8|||
164403620|NCT02684006|593846349|FG000|Overall Study|Adverse Event|86|||
164403621|NCT02684006|593846350|FG001|Overall Study|Adverse Event|65|||
164403622|NCT02684006|593846349|FG000|Overall Study|Withdrawal by Subject|29|||
164403623|NCT02684006|593846350|FG001|Overall Study|Withdrawal by Subject|43|||
164403624|NCT02684006|593846349|FG000|Overall Study|Progressive disease|236|||
164403625|NCT02684006|593846350|FG001|Overall Study|Progressive disease|266|||
164403626|NCT02684006|593846349|FG000|Overall Study|Participation terminated by sponsor|6|||
164403627|NCT02684006|593846350|FG001|Overall Study|Participation terminated by sponsor|9|||
164403628|NCT04642898|593846351|FG000|Overall Study|Withdrawal by Subject|2|||
164403629|NCT04642898|593846352|FG001|Overall Study|Withdrawal by Subject|4|||
164403630|NCT04642898|593846353|FG002|Overall Study|Withdrawal by Subject|4|||
164403631|NCT04642898|593846354|FG003|Overall Study|Withdrawal by Subject|6|||
164403632|NCT04642898|593846355|FG004|Overall Study|Withdrawal by Subject|2|||
164403633|NCT04642898|593846356|FG005|Overall Study|Withdrawal by Subject|6|||
164403634|NCT04642898|593846351|FG000|Overall Study|Lost to Follow-up|0|||
164403635|NCT04642898|593846352|FG001|Overall Study|Lost to Follow-up|0|||
164403636|NCT04642898|593846353|FG002|Overall Study|Lost to Follow-up|0|||
164403637|NCT04642898|593846354|FG003|Overall Study|Lost to Follow-up|2|||
164403638|NCT04642898|593846355|FG004|Overall Study|Lost to Follow-up|0|||
164403639|NCT04642898|593846356|FG005|Overall Study|Lost to Follow-up|1|||
164403640|NCT04642898|593846351|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
164403641|NCT04642898|593846352|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
164403642|NCT04642898|593846353|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
164403643|NCT04642898|593846354|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
164403644|NCT04642898|593846355|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
164403645|NCT04642898|593846356|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
164403646|NCT04642898|593846351|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
164403647|NCT04642898|593846352|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
164403648|NCT04642898|593846353|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
164403649|NCT04642898|593846354|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
164403650|NCT04642898|593846355|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
164403651|NCT04642898|593846356|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
164403652|NCT04495179|593846357|FG000|Overall Study|Lost to Follow-up|0|||
164403653|NCT04495179|593846358|FG001|Overall Study|Lost to Follow-up|1|||
164403654|NCT04495179|593846357|FG000|Overall Study|Withdrawal by Subject|2|||
164403655|NCT04495179|593846358|FG001|Overall Study|Withdrawal by Subject|4|||
164403656|NCT04495179|593846357|FG000|Overall Study|Study terminated by sponsor|0|||
164403657|NCT04495179|593846358|FG001|Overall Study|Study terminated by sponsor|18|||
164403658|NCT04495179|593846357|FG000|Overall Study|Death|0|||
164403659|NCT04495179|593846358|FG001|Overall Study|Death|4|||
164403660|NCT04495179|593846357|FG000|Overall Study|Adverse Event|0|||
164403661|NCT04495179|593846358|FG001|Overall Study|Adverse Event|1|||
164403662|NCT03434678|593846359|FG000|Overall Study|Withdrawal by Subject|13|||
164403663|NCT03434678|593846360|FG001|Overall Study|Withdrawal by Subject|13|||
164403664|NCT03434678|593846359|FG000|Overall Study|Found to be ineligible post randomization|2|||
164403665|NCT03434678|593846360|FG001|Overall Study|Found to be ineligible post randomization|1|||
164403666|NCT04085328|593846365|FG000|Overall Study|Witihdrew Consent|16|||
164445994|NCT00610649|594003256|FG004|Overall Study|Withdrawal by Subject|0|||
164445995|NCT00610649|594003257|FG005|Overall Study|Withdrawal by Subject|0|||
164445996|NCT00610649|594003258|FG006|Overall Study|Withdrawal by Subject|0|||
164445997|NCT00610649|594003259|FG007|Overall Study|Withdrawal by Subject|0|||
164445998|NCT00610649|594003260|FG008|Overall Study|Withdrawal by Subject|0|||
164445999|NCT00610649|594003261|FG009|Overall Study|Withdrawal by Subject|1|||
164446000|NCT00610649|594003262|FG010|Overall Study|Withdrawal by Subject|0|||
164446001|NCT04259450|594003266|FG000|Overall Study|Adverse event/ Toxicity|0|||
164446002|NCT04259450|594003267|FG001|Overall Study|Adverse event/ Toxicity|3|||
164446003|NCT04259450|594003268|FG002|Overall Study|Adverse event/ Toxicity|0|||
164446004|NCT04259450|594003269|FG003|Overall Study|Adverse event/ Toxicity|1|||
164446005|NCT04259450|594003270|FG004|Overall Study|Adverse event/ Toxicity|0|||
164446006|NCT04259450|594003271|FG005|Overall Study|Adverse event/ Toxicity|0|||
164446007|NCT04259450|594003272|FG006|Overall Study|Adverse event/ Toxicity|0|||
164446008|NCT04259450|594003273|FG007|Overall Study|Adverse event/ Toxicity|1|||
164446009|NCT04259450|594003274|FG008|Overall Study|Adverse event/ Toxicity|0|||
164446010|NCT04259450|594003275|FG009|Overall Study|Adverse event/ Toxicity|3|||
164446011|NCT04259450|594003266|FG000|Overall Study|Disease progression|2|||
164446012|NCT04259450|594003267|FG001|Overall Study|Disease progression|3|||
164446013|NCT04259450|594003268|FG002|Overall Study|Disease progression|4|||
164446014|NCT04259450|594003269|FG003|Overall Study|Disease progression|4|||
164446015|NCT04259450|594003270|FG004|Overall Study|Disease progression|6|||
164446016|NCT04259450|594003271|FG005|Overall Study|Disease progression|6|||
164446017|NCT04259450|594003272|FG006|Overall Study|Disease progression|6|||
164446018|NCT04259450|594003273|FG007|Overall Study|Disease progression|15|||
164446019|NCT04259450|594003274|FG008|Overall Study|Disease progression|6|||
164446020|NCT04259450|594003275|FG009|Overall Study|Disease progression|18|||
164446021|NCT04259450|594003266|FG000|Overall Study|Death|0|||
164446022|NCT04259450|594003267|FG001|Overall Study|Death|0|||
164446023|NCT04259450|594003268|FG002|Overall Study|Death|0|||
164446024|NCT04259450|594003269|FG003|Overall Study|Death|0|||
164446025|NCT04259450|594003270|FG004|Overall Study|Death|0|||
164446026|NCT04259450|594003271|FG005|Overall Study|Death|0|||
164446027|NCT04259450|594003272|FG006|Overall Study|Death|0|||
164446028|NCT04259450|594003273|FG007|Overall Study|Death|1|||
164446029|NCT04259450|594003274|FG008|Overall Study|Death|1|||
164446030|NCT04259450|594003275|FG009|Overall Study|Death|0|||
164446031|NCT04259450|594003266|FG000|Overall Study|Withdrawal by Subject|0|||
164446032|NCT04259450|594003267|FG001|Overall Study|Withdrawal by Subject|0|||
164446033|NCT04259450|594003268|FG002|Overall Study|Withdrawal by Subject|0|||
164446034|NCT04259450|594003269|FG003|Overall Study|Withdrawal by Subject|0|||
164446035|NCT04259450|594003270|FG004|Overall Study|Withdrawal by Subject|0|||
164446036|NCT04259450|594003271|FG005|Overall Study|Withdrawal by Subject|0|||
164446037|NCT04259450|594003272|FG006|Overall Study|Withdrawal by Subject|0|||
164446038|NCT04259450|594003273|FG007|Overall Study|Withdrawal by Subject|1|||
164446039|NCT04259450|594003274|FG008|Overall Study|Withdrawal by Subject|0|||
164446040|NCT04259450|594003275|FG009|Overall Study|Withdrawal by Subject|0|||
164446041|NCT04259450|594003266|FG000|Overall Study|Other than listed|0|||
164446042|NCT04259450|594003267|FG001|Overall Study|Other than listed|0|||
164446043|NCT04259450|594003268|FG002|Overall Study|Other than listed|0|||
164446044|NCT04259450|594003269|FG003|Overall Study|Other than listed|0|||
164446045|NCT04259450|594003270|FG004|Overall Study|Other than listed|0|||
164446046|NCT04259450|594003271|FG005|Overall Study|Other than listed|0|||
164446047|NCT04259450|594003272|FG006|Overall Study|Other than listed|0|||
164446048|NCT04259450|594003273|FG007|Overall Study|Other than listed|1|||
164446049|NCT04259450|594003274|FG008|Overall Study|Other than listed|1|||
164446050|NCT04259450|594003275|FG009|Overall Study|Other than listed|2|||
164446051|NCT00332241|594003282|FG000|Overall Study|Lack of Efficacy|6|||
164446052|NCT00332241|594003283|FG001|Overall Study|Lack of Efficacy|1|||
164446053|NCT00332241|594003282|FG000|Overall Study|Adverse Event|3|||
164446054|NCT00332241|594003283|FG001|Overall Study|Adverse Event|5|||
164446055|NCT00332241|594003282|FG000|Overall Study|Withdrawal by Subject|2|||
164446056|NCT00332241|594003283|FG001|Overall Study|Withdrawal by Subject|1|||
164446057|NCT00332241|594003282|FG000|Overall Study|Lost to Follow-up|4|||
164596888|NCT02052778|594548994|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164596889|NCT02052778|594548995|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164596890|NCT02052778|594548996|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164596891|NCT02052778|594548997|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164596892|NCT02052778|594548998|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164596893|NCT02052778|594548999|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164596894|NCT02052778|594549000|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164596895|NCT02052778|594549001|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164596896|NCT02052778|594549002|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164596897|NCT02052778|594549003|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164596898|NCT02052778|594549004|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164596899|NCT02052778|594549005|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164446058|NCT00332241|594003283|FG001|Overall Study|Lost to Follow-up|1|||
164446059|NCT00542789|594003285|FG000|Overall Study|Adverse Event|18|||
164446060|NCT00542789|594003286|FG001|Overall Study|Adverse Event|17|||
164446061|NCT00542789|594003285|FG000|Overall Study|Withdrawal by Subject|7|||
164446062|NCT00542789|594003286|FG001|Overall Study|Withdrawal by Subject|3|||
164446063|NCT00542789|594003285|FG000|Overall Study|Protocol Violation|8|||
164446064|NCT00542789|594003286|FG001|Overall Study|Protocol Violation|1|||
164446065|NCT00542789|594003285|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
164446066|NCT00542789|594003286|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
164446067|NCT02584829|594003288|FG000|Overall Study|Physician Decision|1|||
164446068|NCT02584829|594003289|FG001|Overall Study|Physician Decision|0|||
164446069|NCT02584829|594003288|FG000|Overall Study|Withdrawal by Subject|0|||
164446070|NCT02584829|594003289|FG001|Overall Study|Withdrawal by Subject|1|||
164446071|NCT02584829|594003288|FG000|Overall Study|Progressive Disease|0|||
164446072|NCT02584829|594003289|FG001|Overall Study|Progressive Disease|3|||
164446073|NCT02374463|594003290|FG000|Overall Study|Withdrawal by Subject|3|||
164446074|NCT02374463|594003291|FG001|Overall Study|Withdrawal by Subject|3|||
164446075|NCT00106080|594003299|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
164446076|NCT00106080|594003300|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
164446077|NCT01839331|594003301|FG000|Overall Study|Early Termination|3|||
164446078|NCT01839331|594003302|FG001|Overall Study|Early Termination|0|||
164446079|NCT01839331|594003303|FG002|Overall Study|Early Termination|1|||
164446080|NCT01839331|594003304|FG003|Overall Study|Early Termination|2|||
164446081|NCT01839331|594003301|FG000|Overall Study|Protocol Violation|1|||
164446082|NCT01839331|594003302|FG001|Overall Study|Protocol Violation|6|||
164446083|NCT01839331|594003303|FG002|Overall Study|Protocol Violation|4|||
164446084|NCT01839331|594003304|FG003|Overall Study|Protocol Violation|3|||
164446085|NCT00761605|594003308|FG000|Overall Study|Adverse Event|26|||
164446086|NCT00761605|594003308|FG000|Overall Study|Death|2|||
164446087|NCT00761605|594003308|FG000|Overall Study|Lack of Efficacy|26|||
164446088|NCT00761605|594003308|FG000|Overall Study|Lost to Follow-up|29|||
164446089|NCT00761605|594003308|FG000|Overall Study|Withdrawal by Subject|37|||
164446090|NCT00761605|594003308|FG000|Overall Study|Other|21|||
164446091|NCT03074331|594003309|FG000|Overall Study|Enrolled but Not Treated|1|||
164446092|NCT03074331|594003309|FG000|Overall Study|Lost to Follow-up|5|||
164446093|NCT03074331|594003309|FG000|Overall Study|Withdrew Consent|1|||
164446094|NCT00350792|594003311|FG000|Overall Study|Adverse Event|11|||
164446095|NCT00350792|594003311|FG000|Overall Study|Death from Study Disease|1|||
164446096|NCT00350792|594003311|FG000|Overall Study|Death from Study Drug Toxicity|1|||
164446097|NCT00350792|594003311|FG000|Overall Study|Death Not Study Drug Related|2|||
164446098|NCT00350792|594003311|FG000|Overall Study|Protocol Violation|1|||
164446099|NCT00350792|594003311|FG000|Overall Study|Withdrawal by Subject|4|||
164446100|NCT00350792|594003311|FG000|Overall Study|Physician Decision|2|||
164446101|NCT00350792|594003311|FG000|Overall Study|Lack of Efficacy|11|||
164446102|NCT03684044|594003319|FG000|Overall Study|Adverse Event|3|||
164446103|NCT03684044|594003320|FG001|Overall Study|Adverse Event|0|||
164446104|NCT03684044|594003319|FG000|Overall Study|Death|4|||
164446105|NCT03684044|594003320|FG001|Overall Study|Death|7|||
164446106|NCT03684044|594003319|FG000|Overall Study|Lost to Follow-up|3|||
164446107|NCT03684044|594003320|FG001|Overall Study|Lost to Follow-up|2|||
164446108|NCT03684044|594003319|FG000|Overall Study|Patient Not Available|0|||
164446109|NCT03684044|594003320|FG001|Overall Study|Patient Not Available|2|||
164446110|NCT03684044|594003319|FG000|Overall Study|Physician Decision|1|||
164446111|NCT03684044|594003320|FG001|Overall Study|Physician Decision|0|||
164446112|NCT03684044|594003319|FG000|Overall Study|Withdrawal by Subject|11|||
164446113|NCT03684044|594003320|FG001|Overall Study|Withdrawal by Subject|9|||
164446114|NCT03703336|594003321|FG000|Overall Study|Parent withdrew consent|29|||
164446115|NCT03703336|594003322|FG001|Overall Study|Parent withdrew consent|8|||
164446116|NCT03703336|594003321|FG000|Overall Study|Migration|3|||
164446117|NCT03703336|594003322|FG001|Overall Study|Migration|3|||
164446118|NCT03703336|594003321|FG000|Overall Study|Protocol Violation|3|||
164446119|NCT03703336|594003322|FG001|Overall Study|Protocol Violation|1|||
164596900|NCT02052778|594549006|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
164596901|NCT02052778|594549007|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164446120|NCT03703336|594003321|FG000|Overall Study|Physician Decision|2|||
164446121|NCT03703336|594003322|FG001|Overall Study|Physician Decision|0|||
164446122|NCT03703336|594003321|FG000|Overall Study|Adverse Event|0|||
164446123|NCT03703336|594003322|FG001|Overall Study|Adverse Event|2|||
164446124|NCT03703336|594003321|FG000|Overall Study|Lost to Follow-up|1|||
164446125|NCT03703336|594003322|FG001|Overall Study|Lost to Follow-up|0|||
164446126|NCT00595413|594003323|FG000|Overall Study|Adverse Event|0|||
164446127|NCT00595413|594003324|FG001|Overall Study|Adverse Event|2|||
164446128|NCT00595413|594003325|FG002|Overall Study|Adverse Event|1|||
164446129|NCT00595413|594003326|FG003|Overall Study|Adverse Event|1|||
164446130|NCT00595413|594003323|FG000|Overall Study|Lost to Follow-up|2|||
164446131|NCT00595413|594003324|FG001|Overall Study|Lost to Follow-up|2|||
164446132|NCT00595413|594003325|FG002|Overall Study|Lost to Follow-up|1|||
164446133|NCT00595413|594003326|FG003|Overall Study|Lost to Follow-up|3|||
164446134|NCT00595413|594003323|FG000|Overall Study|Death|0|||
164446135|NCT00595413|594003324|FG001|Overall Study|Death|0|||
164706231|NCT04585789|594953401|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
164706232|NCT04585789|594953402|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
164706233|NCT03412396|594953403|FG000|Overall Study|Withdrawal by Subject|2|||
164706234|NCT03412396|594953403|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
164706235|NCT03412396|594953403|FG000|Overall Study|Did not undergo RP|2|||
164403667|NCT04085328|593846366|FG001|Overall Study|Witihdrew Consent|16|||
164403668|NCT04085328|593846365|FG000|Overall Study|Adverse Event|8|||
164403669|NCT04085328|593846366|FG001|Overall Study|Adverse Event|7|||
164403670|NCT04085328|593846365|FG000|Overall Study|Lost to Follow-up|7|||
164403671|NCT04085328|593846366|FG001|Overall Study|Lost to Follow-up|2|||
164403672|NCT04085328|593846365|FG000|Overall Study|Physician Decision|0|||
164403673|NCT04085328|593846366|FG001|Overall Study|Physician Decision|1|||
164403674|NCT04085328|593846365|FG000|Overall Study|Pregnancy|0|||
164403675|NCT04085328|593846366|FG001|Overall Study|Pregnancy|1|||
164403676|NCT04085328|593846365|FG000|Overall Study|Reasons Related to COVID-19|5|||
164403677|NCT04085328|593846366|FG001|Overall Study|Reasons Related to COVID-19|8|||
164403678|NCT04085328|593846365|FG000|Overall Study|Did not meet inclusion criteria|1|||
164403679|NCT04085328|593846366|FG001|Overall Study|Did not meet inclusion criteria|1|||
164403680|NCT04085328|593846365|FG000|Overall Study|Early termination|1|||
164403681|NCT04085328|593846366|FG001|Overall Study|Early termination|0|||
164403682|NCT05608499|593846367|FG000|Overall Study|Lack of Efficacy|1|||
164403683|NCT05608499|593846368|FG001|Overall Study|Lack of Efficacy|0|||
164403684|NCT05608499|593846367|FG000|Overall Study|Lost to Follow-up|0|||
164403685|NCT05608499|593846368|FG001|Overall Study|Lost to Follow-up|1|||
164403686|NCT01422408|593846371|FG000|Overall Study|Adverse Event|1|||
164403687|NCT01422408|593846371|FG000|Overall Study|Withdrawal by Subject|3|||
164403688|NCT00724152|593846378|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
164403689|NCT00724152|593846379|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
164403690|NCT00724152|593846380|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
164403691|NCT00724152|593846378|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
164403692|NCT00724152|593846379|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
164403693|NCT00724152|593846380|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
164403694|NCT01328080|593846382|FG000|Overall Study|Lost to Follow-up|5|||
164403695|NCT00045305|593846383|FG000|Overall Study|Lack of Efficacy|6|||
164403696|NCT00045305|593846383|FG000|Overall Study|Adverse Event|3|||
164403697|NCT00045305|593846383|FG000|Overall Study|Death|3|||
164403698|NCT00045305|593846383|FG000|Overall Study|site error|2|||
164403699|NCT03266770|593846384|FG000|Overall Study|Physician Decision|3|||
164403700|NCT03266770|593846384|FG000|Overall Study|Insufficient study supplies|1|||
164403701|NCT03266770|593846384|FG000|Overall Study|Adverse Event|1|||
164403702|NCT04274894|593846385|FG000|Overall Study|Adverse Event|7|||
164403703|NCT04274894|593846385|FG000|Overall Study|Withdrew consent|5|||
164403704|NCT04274894|593846385|FG000|Overall Study|Lost to Follow-up|9|||
164403705|NCT04274894|593846385|FG000|Overall Study|COVID-19 infection|1|||
164403706|NCT04274894|593846385|FG000|Overall Study|Other, not specified|20|||
164403707|NCT01936857|593846386|FG000|Overall Study|Sent to prison or 06 center|11|||
164403708|NCT01936857|593846387|FG001|Overall Study|Sent to prison or 06 center|12|||
164403709|NCT01936857|593846386|FG000|Overall Study|Lost to Follow-up|10|||
164403710|NCT01936857|593846387|FG001|Overall Study|Lost to Follow-up|7|||
164403711|NCT01936857|593846386|FG000|Overall Study|Death|7|||
164403712|NCT01936857|593846387|FG001|Overall Study|Death|3|||
164403713|NCT01936857|593846386|FG000|Overall Study|Moved|2|||
164403714|NCT01936857|593846387|FG001|Overall Study|Moved|1|||
164403715|NCT01936857|593846386|FG000|Overall Study|Withdrawal by Subject|1|||
164403716|NCT01936857|593846387|FG001|Overall Study|Withdrawal by Subject|0|||
164403717|NCT01936857|593846386|FG000|Overall Study|Side effect of medication|1|||
164403718|NCT01936857|593846387|FG001|Overall Study|Side effect of medication|0|||
164403719|NCT01936857|593846386|FG000|Overall Study|Other|2|||
164403720|NCT01936857|593846387|FG001|Overall Study|Other|2|||
164403721|NCT03848403|593846388|FG000|Period 2 (Day 8)|Adverse Event|1|||
164403722|NCT03848403|593846389|FG001|Period 2 (Day 8)|Adverse Event|2|||
164403723|NCT03848403|593846390|FG002|Period 2 (Day 8)|Adverse Event|2|||
164403724|NCT03848403|593846388|FG000|Period 2 (Day 8)|Physician Decision|0|||
164403725|NCT03848403|593846389|FG001|Period 2 (Day 8)|Physician Decision|1|||
164403726|NCT03848403|593846390|FG002|Period 2 (Day 8)|Physician Decision|0|||
164403727|NCT03848403|593846388|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
164403728|NCT03848403|593846389|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
164403729|NCT03848403|593846390|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
164403730|NCT00168038|593846391|FG000|Overall Study|Adverse Event|1|||
164403731|NCT00168038|593846391|FG000|Overall Study|Therapy failure|1|||
164706236|NCT05083585|594953404|FG000|Overall Study|Death|1|||
164706237|NCT05083585|594953405|FG001|Overall Study|Death|1|||
164706238|NCT05083585|594953404|FG000|Overall Study|Lost to Follow-up|1|||
164706239|NCT05083585|594953405|FG001|Overall Study|Lost to Follow-up|1|||
164403732|NCT01971723|593846399|FG000|Overall Study|Withdrawal by Subject|1|||
164403733|NCT01971723|593846400|FG001|Overall Study|Withdrawal by Subject|1|||
164403734|NCT01971723|593846399|FG000|Overall Study|Protocol Violation|1|||
164403735|NCT01971723|593846400|FG001|Overall Study|Protocol Violation|2|||
164446136|NCT00595413|594003325|FG002|Overall Study|Death|1|||
164446137|NCT00595413|594003326|FG003|Overall Study|Death|0|||
164446138|NCT00595413|594003323|FG000|Overall Study|Other|5|||
164446139|NCT00595413|594003324|FG001|Overall Study|Other|1|||
164446140|NCT00595413|594003325|FG002|Overall Study|Other|5|||
164446141|NCT00595413|594003326|FG003|Overall Study|Other|0|||
164446142|NCT00807937|594003327|FG000|Overall Study|Adverse Event|12|||
164446143|NCT00807937|594003328|FG001|Overall Study|Adverse Event|12|||
164446144|NCT00807937|594003329|FG002|Overall Study|Adverse Event|5|||
164446145|NCT00807937|594003330|FG003|Overall Study|Adverse Event|4|||
164446146|NCT00807937|594003327|FG000|Overall Study|Protocol Violation|4|||
164446147|NCT00807937|594003328|FG001|Overall Study|Protocol Violation|5|||
164446148|NCT00807937|594003329|FG002|Overall Study|Protocol Violation|3|||
164446149|NCT00807937|594003330|FG003|Overall Study|Protocol Violation|3|||
164446150|NCT00807937|594003327|FG000|Overall Study|Withdrawal by Subject|5|||
164446151|NCT00807937|594003328|FG001|Overall Study|Withdrawal by Subject|4|||
164446152|NCT00807937|594003329|FG002|Overall Study|Withdrawal by Subject|1|||
164446153|NCT00807937|594003330|FG003|Overall Study|Withdrawal by Subject|4|||
164446154|NCT00807937|594003327|FG000|Overall Study|Lost to Follow-up|4|||
164446155|NCT00807937|594003328|FG001|Overall Study|Lost to Follow-up|0|||
164446156|NCT00807937|594003329|FG002|Overall Study|Lost to Follow-up|2|||
164446157|NCT00807937|594003330|FG003|Overall Study|Lost to Follow-up|1|||
164446158|NCT00807937|594003327|FG000|Overall Study|Lack of Efficacy|0|||
164446159|NCT00807937|594003328|FG001|Overall Study|Lack of Efficacy|0|||
164446160|NCT00807937|594003329|FG002|Overall Study|Lack of Efficacy|1|||
164446161|NCT00807937|594003330|FG003|Overall Study|Lack of Efficacy|2|||
164446162|NCT00807937|594003327|FG000|Overall Study|Intake of prohibited medicine|0|||
164446163|NCT00807937|594003328|FG001|Overall Study|Intake of prohibited medicine|0|||
164446164|NCT00807937|594003329|FG002|Overall Study|Intake of prohibited medicine|2|||
164446165|NCT00807937|594003330|FG003|Overall Study|Intake of prohibited medicine|0|||
164446166|NCT00807937|594003327|FG000|Overall Study|All other reasons (not provided)|2|||
164446167|NCT00807937|594003328|FG001|Overall Study|All other reasons (not provided)|4|||
164446168|NCT00807937|594003329|FG002|Overall Study|All other reasons (not provided)|0|||
164446169|NCT00807937|594003330|FG003|Overall Study|All other reasons (not provided)|1|||
164446170|NCT04629950|594003333|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
164446171|NCT04629950|594003334|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
164446172|NCT04629950|594003335|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
164446173|NCT04629950|594003336|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
164446174|NCT04629950|594003333|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
164446175|NCT04629950|594003334|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
164446176|NCT04629950|594003335|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
164446177|NCT04629950|594003336|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
164446178|NCT04629950|594003333|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
164446179|NCT04629950|594003334|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
164446180|NCT04629950|594003335|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
164446181|NCT04629950|594003336|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
164446182|NCT04629950|594003333|FG000|Extension Study|Withdrawal by Subject|0|||
164446183|NCT04629950|594003334|FG001|Extension Study|Withdrawal by Subject|0|||
164446184|NCT04629950|594003335|FG002|Extension Study|Withdrawal by Subject|1|||
164446185|NCT04629950|594003336|FG003|Extension Study|Withdrawal by Subject|0|||
164446186|NCT04629950|594003333|FG000|Extension Study|Adverse Event|0|||
164446187|NCT04629950|594003334|FG001|Extension Study|Adverse Event|0|||
164446188|NCT04629950|594003335|FG002|Extension Study|Adverse Event|0|||
164446189|NCT04629950|594003336|FG003|Extension Study|Adverse Event|1|||
164446190|NCT03233633|594003337|FG000|Overall Study|Adverse Event|2|||
164446191|NCT03233633|594003337|FG000|Overall Study|Less Than 3 Days of Data|6|||
164446192|NCT04594759|594003338|FG000|Overall Study|Lost to Follow-up|3|||
164446193|NCT03811574|594003339|FG000|Overall Study|Withdrawal by Subject|2|||
164446194|NCT03811574|594003340|FG001|Overall Study|Withdrawal by Subject|4|||
164446195|NCT03811574|594003341|FG002|Overall Study|Withdrawal by Subject|0|||
164446196|NCT02708108|594003342|FG000|Overall Study|Death|1|||
164446197|NCT02708108|594003343|FG001|Overall Study|Death|2|||
164446198|NCT02708108|594003342|FG000|Overall Study|Regimen change|1|||
164446199|NCT02708108|594003343|FG001|Overall Study|Regimen change|0|||
164446200|NCT02708108|594003342|FG000|Overall Study|No MRD and no imaging available|0|||
164446201|NCT02708108|594003343|FG001|Overall Study|No MRD and no imaging available|1|||
164446202|NCT02568683|594003345|FG000|Overall Study|Death|0|||
164446203|NCT02568683|594003346|FG001|Overall Study|Death|2|||
164446204|NCT02568683|594003345|FG000|Overall Study|Withdrew Consent|1|||
164446205|NCT02568683|594003346|FG001|Overall Study|Withdrew Consent|0|||
164446206|NCT02568683|594003345|FG000|Overall Study|Study Terminated By Sponsor|5|||
164446207|NCT02568683|594003346|FG001|Overall Study|Study Terminated By Sponsor|2|||
164446208|NCT01561989|594003349|FG000|Overall Study|accural target not met.|5|||
164446209|NCT01561989|594003350|FG001|Overall Study|accural target not met.|6|||
164446210|NCT04556981|594003352|FG000|Overall Study|Death|0|||
164446211|NCT04556981|594003353|FG001|Overall Study|Death|1|||
164446212|NCT04556981|594003352|FG000|Overall Study|Lost to Follow-up|2|||
164446213|NCT04556981|594003353|FG001|Overall Study|Lost to Follow-up|11|||
164446214|NCT04556981|594003352|FG000|Overall Study|Moved from the study area|1|||
164446215|NCT04556981|594003353|FG001|Overall Study|Moved from the study area|4|||
164446216|NCT04556981|594003352|FG000|Overall Study|Withdrawal by Subject|2|||
164446217|NCT04556981|594003353|FG001|Overall Study|Withdrawal by Subject|2|||
164446218|NCT04556981|594003352|FG000|Overall Study|Other|2|||
164446219|NCT04556981|594003353|FG001|Overall Study|Other|1|||
164446220|NCT00580866|594003354|FG000|Overall Study|Lost to Follow-up|2|||
164446221|NCT00580866|594003355|FG001|Overall Study|Lost to Follow-up|2|||
164446222|NCT02477605|594003356|FG000|Overall Study|Discontinued prior to treatment|1|||
164446223|NCT02477605|594003357|FG001|Overall Study|Discontinued prior to treatment|0|||
164446224|NCT02477605|594003356|FG000|Overall Study|Lost to Follow-up|0|||
164446225|NCT02477605|594003357|FG001|Overall Study|Lost to Follow-up|2|||
164446226|NCT02477605|594003356|FG000|Overall Study|Withdrawal by Subject|0|||
164446227|NCT02477605|594003357|FG001|Overall Study|Withdrawal by Subject|1|||
164446228|NCT02477605|594003356|FG000|Overall Study|Administered gas during surgery|0|||
164446229|NCT02477605|594003357|FG001|Overall Study|Administered gas during surgery|1|||
164446230|NCT03144674|594003360|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
164446231|NCT03144674|594003361|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
164446232|NCT03144674|594003362|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
164446233|NCT03144674|594003363|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
164446234|NCT03144674|594003360|FG000|Overall Study|Death|3|||
164446235|NCT03144674|594003361|FG001|Overall Study|Death|2|||
164446236|NCT03144674|594003362|FG002|Overall Study|Death|6|||
164446237|NCT03144674|594003363|FG003|Overall Study|Death|24|||
164446238|NCT03144674|594003360|FG000|Overall Study|Lost to Follow-up|0|||
164446239|NCT03144674|594003361|FG001|Overall Study|Lost to Follow-up|1|||
164446240|NCT03144674|594003362|FG002|Overall Study|Lost to Follow-up|0|||
164446241|NCT03144674|594003363|FG003|Overall Study|Lost to Follow-up|4|||
164446242|NCT03144674|594003360|FG000|Overall Study|Withdrawal by Participant|0|||
164446243|NCT03144674|594003361|FG001|Overall Study|Withdrawal by Participant|0|||
164446244|NCT03144674|594003362|FG002|Overall Study|Withdrawal by Participant|2|||
164446245|NCT03144674|594003363|FG003|Overall Study|Withdrawal by Participant|6|||
164446246|NCT03144674|594003360|FG000|Overall Study|Discharged from the Trust|0|||
164446247|NCT03144674|594003361|FG001|Overall Study|Discharged from the Trust|0|||
164446248|NCT03144674|594003362|FG002|Overall Study|Discharged from the Trust|1|||
164446249|NCT03144674|594003363|FG003|Overall Study|Discharged from the Trust|0|||
164446250|NCT03144674|594003360|FG000|Overall Study|Exclusion Criteria Met|0|||
164446251|NCT03144674|594003361|FG001|Overall Study|Exclusion Criteria Met|0|||
164446252|NCT03144674|594003362|FG002|Overall Study|Exclusion Criteria Met|1|||
164446253|NCT03144674|594003363|FG003|Overall Study|Exclusion Criteria Met|0|||
164446254|NCT03144674|594003360|FG000|Overall Study|Changed Physicians|0|||
164446255|NCT03144674|594003361|FG001|Overall Study|Changed Physicians|0|||
164446256|NCT03144674|594003362|FG002|Overall Study|Changed Physicians|0|||
164446257|NCT03144674|594003363|FG003|Overall Study|Changed Physicians|1|||
164446258|NCT03144674|594003360|FG000|Overall Study|Removed for Safety|0|||
164446259|NCT03144674|594003361|FG001|Overall Study|Removed for Safety|0|||
164446260|NCT03144674|594003362|FG002|Overall Study|Removed for Safety|0|||
164446261|NCT03144674|594003363|FG003|Overall Study|Removed for Safety|1|||
164446262|NCT03144674|594003360|FG000|Overall Study|Site Closed|0|||
164446263|NCT03144674|594003361|FG001|Overall Study|Site Closed|0|||
164446264|NCT03144674|594003362|FG002|Overall Study|Site Closed|0|||
164446265|NCT03144674|594003363|FG003|Overall Study|Site Closed|1|||
164446266|NCT03144674|594003360|FG000|Overall Study|Histological Criteria Not Met|0|||
164446267|NCT03144674|594003361|FG001|Overall Study|Histological Criteria Not Met|0|||
164446268|NCT03144674|594003362|FG002|Overall Study|Histological Criteria Not Met|0|||
164446269|NCT03144674|594003363|FG003|Overall Study|Histological Criteria Not Met|1|||
164446270|NCT03144674|594003360|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
164446271|NCT03144674|594003361|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
164446272|NCT03144674|594003362|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
164446273|NCT03144674|594003363|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
164446274|NCT03144674|594003360|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
164446275|NCT03144674|594003361|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
164446276|NCT03144674|594003362|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
164446277|NCT03144674|594003363|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
164446278|NCT01565148|594003364|FG000|Overall Study|Withdrawal by Subject|1|||
164446279|NCT01565148|594003365|FG001|Overall Study|Withdrawal by Subject|1|||
164446280|NCT01565148|594003366|FG002|Overall Study|Withdrawal by Subject|1|||
164446281|NCT01565148|594003367|FG003|Overall Study|Withdrawal by Subject|2|||
164706240|NCT05083585|594953404|FG000|Overall Study|Withdrawal by Subject|2|||
164706241|NCT05083585|594953405|FG001|Overall Study|Withdrawal by Subject|0|||
164446282|NCT01565148|594003364|FG000|Overall Study|Lost to Follow-up|4|||
164446283|NCT01565148|594003365|FG001|Overall Study|Lost to Follow-up|4|||
164446284|NCT01565148|594003366|FG002|Overall Study|Lost to Follow-up|0|||
164446285|NCT01565148|594003367|FG003|Overall Study|Lost to Follow-up|3|||
164706242|NCT05083585|594953404|FG000|Overall Study|Randomized but not vaccinated|2|||
164706243|NCT05083585|594953405|FG001|Overall Study|Randomized but not vaccinated|0|||
164706244|NCT01175811|594953406|FG000|Overall Study|Adverse Event|1|||
164706245|NCT01175811|594953407|FG001|Overall Study|Adverse Event|1|||
164706246|NCT01175811|594953406|FG000|Overall Study|Entry criteria not met|3|||
164706247|NCT01175811|594953407|FG001|Overall Study|Entry criteria not met|1|||
164706248|NCT01175811|594953406|FG000|Overall Study|Lack of Efficacy|1|||
164706249|NCT01175811|594953407|FG001|Overall Study|Lack of Efficacy|0|||
164446286|NCT01565148|594003364|FG000|Overall Study|Rescue Therapy|8|||
164446287|NCT01565148|594003365|FG001|Overall Study|Rescue Therapy|5|||
164446288|NCT01565148|594003366|FG002|Overall Study|Rescue Therapy|5|||
164446289|NCT01565148|594003367|FG003|Overall Study|Rescue Therapy|8|||
164446290|NCT01565148|594003364|FG000|Overall Study|Death|0|||
164446291|NCT01565148|594003365|FG001|Overall Study|Death|0|||
164446292|NCT01565148|594003366|FG002|Overall Study|Death|1|||
164446293|NCT01565148|594003367|FG003|Overall Study|Death|0|||
164446294|NCT01565148|594003364|FG000|Overall Study|Physician Decision|2|||
164446295|NCT01565148|594003365|FG001|Overall Study|Physician Decision|5|||
164446296|NCT01565148|594003366|FG002|Overall Study|Physician Decision|0|||
164446297|NCT01565148|594003367|FG003|Overall Study|Physician Decision|0|||
164446298|NCT01759771|594003368|FG000|Overall Study|Withdrawal by Subject|1|||
164446299|NCT01759771|594003369|FG001|Overall Study|Withdrawal by Subject|1|||
164446300|NCT00529659|594003372|FG000|Overall Study|Adverse Event|8|||
164446301|NCT00529659|594003373|FG001|Overall Study|Adverse Event|7|||
164446302|NCT00529659|594003372|FG000|Overall Study|Lost to Follow-up|0|||
164446303|NCT00529659|594003373|FG001|Overall Study|Lost to Follow-up|2|||
164446304|NCT00529659|594003372|FG000|Overall Study|Physician Decision|0|||
164446305|NCT00529659|594003373|FG001|Overall Study|Physician Decision|2|||
164446306|NCT00529659|594003372|FG000|Overall Study|Protocol Violation|2|||
164446307|NCT00529659|594003373|FG001|Overall Study|Protocol Violation|6|||
164446308|NCT00529659|594003372|FG000|Overall Study|Withdrawal by Subject|1|||
164446309|NCT00529659|594003373|FG001|Overall Study|Withdrawal by Subject|6|||
164446310|NCT01692730|594003374|FG000|Overall Study|Lost to Follow-up|225|||
164446311|NCT01692730|594003375|FG001|Overall Study|Lost to Follow-up|227|||
164446312|NCT01041417|594003376|FG000|Overall Study|Adverse Event|5|||
164446313|NCT01041417|594003377|FG001|Overall Study|Adverse Event|2|||
164446314|NCT01041417|594003376|FG000|Overall Study|Lost to Follow-up|1|||
164446315|NCT01041417|594003377|FG001|Overall Study|Lost to Follow-up|1|||
164446316|NCT01041417|594003376|FG000|Overall Study|Death|1|||
164446317|NCT01041417|594003377|FG001|Overall Study|Death|0|||
164446318|NCT03783026|594004699|FG000|Treatment Phase|Adverse Event|15|||
164446319|NCT03783026|594004699|FG000|Treatment Phase|Lack of Efficacy|11|||
164446320|NCT03783026|594004699|FG000|Treatment Phase|Withdrawal by Subject|6|||
164446321|NCT03783026|594004699|FG000|Treatment Phase|Lost to Follow-up|2|||
164446322|NCT03783026|594004699|FG000|Treatment Phase|Protocol Deviation|8|||
164446323|NCT03783026|594004699|FG000|Treatment Phase|Did Not Receive Treatment|1|||
164446324|NCT03783026|594004699|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
164446325|NCT04814186|594004700|FG000|Treatment Phase|Adverse Event|1|||
164446326|NCT04814186|594004700|FG000|Treatment Phase|Death|6|||
164446327|NCT04814186|594004700|FG000|Treatment Phase|Withdrawal by Subject|2|||
164446328|NCT04814186|594004700|FG000|Treatment Phase|Other|1|||
164446329|NCT04814186|594004700|FG000|Follow-Up Phase|Adverse Event|1|||
164446330|NCT04814186|594004700|FG000|Follow-Up Phase|Death|6|||
164446331|NCT04814186|594004700|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
164446332|NCT04814186|594004700|FG000|Follow-Up Phase|Other|1|||
164446333|NCT04043455|594004716|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
164446334|NCT04043455|594004717|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
164446335|NCT04043455|594004718|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
164706250|NCT01175811|594953406|FG000|Overall Study|Lost to Follow-up|3|||
164706251|NCT01175811|594953407|FG001|Overall Study|Lost to Follow-up|2|||
164706252|NCT01175811|594953406|FG000|Overall Study|Physician Decision|1|||
164706253|NCT01175811|594953407|FG001|Overall Study|Physician Decision|1|||
164706254|NCT01175811|594953406|FG000|Overall Study|Protocol Violation|1|||
164706255|NCT01175811|594953407|FG001|Overall Study|Protocol Violation|2|||
164446336|NCT04043455|594004719|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
164706256|NCT01175811|594953406|FG000|Overall Study|Withdrawal by Subject|6|||
164706257|NCT01175811|594953407|FG001|Overall Study|Withdrawal by Subject|7|||
164706258|NCT02628743|594953410|FG000|Overall Study|Other|3|||
164446337|NCT04043455|594004720|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
164446338|NCT04043455|594004721|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
164446339|NCT04043455|594004716|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
164446340|NCT04043455|594004717|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
164446341|NCT04043455|594004718|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
164446342|NCT04043455|594004719|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
164446343|NCT04043455|594004720|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
164446344|NCT04043455|594004721|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
164706259|NCT02628743|594953410|FG000|Overall Study|Withdrawal by Subject|50|||
164446345|NCT04043455|594004716|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
164446346|NCT04043455|594004717|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
164446347|NCT04043455|594004718|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
164446348|NCT04043455|594004719|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
164446349|NCT04043455|594004720|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
164446350|NCT04043455|594004721|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
164446351|NCT04043455|594004716|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
164446352|NCT04043455|594004717|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
164446353|NCT04043455|594004718|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
164446354|NCT04043455|594004719|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
164446355|NCT04043455|594004720|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
164446356|NCT04043455|594004721|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
164446357|NCT04043455|594004716|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
164446358|NCT04043455|594004717|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
164446359|NCT04043455|594004718|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
164446360|NCT04043455|594004719|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
164446361|NCT04043455|594004720|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
164446362|NCT04043455|594004721|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
164446363|NCT04043455|594004716|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
164446364|NCT04043455|594004717|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
164446365|NCT04043455|594004718|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
164446366|NCT04043455|594004719|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
164446367|NCT04043455|594004720|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
164446368|NCT04043455|594004721|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
164446369|NCT04043455|594004716|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
164446370|NCT04043455|594004717|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
164446371|NCT04043455|594004718|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
164446372|NCT04043455|594004719|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
164446373|NCT04043455|594004720|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
164446374|NCT04043455|594004721|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
164446375|NCT04043455|594004716|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
164446376|NCT04043455|594004717|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
164446377|NCT04043455|594004718|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
164446378|NCT04043455|594004719|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
164446379|NCT04043455|594004720|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
164446380|NCT04043455|594004721|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
164446381|NCT04043455|594004716|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
164446382|NCT04043455|594004717|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
164446383|NCT04043455|594004718|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
164446384|NCT04043455|594004719|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
164446385|NCT04043455|594004720|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
164446386|NCT04043455|594004721|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
164446387|NCT04043455|594004716|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
164446388|NCT04043455|594004717|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
164446389|NCT04043455|594004718|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
164446390|NCT04043455|594004719|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
164446391|NCT04043455|594004720|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
164446392|NCT04043455|594004721|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
164446393|NCT04043455|594004716|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
164446394|NCT04043455|594004717|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
164446395|NCT04043455|594004718|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
164446396|NCT04043455|594004719|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
164446397|NCT04043455|594004720|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
164446398|NCT04043455|594004721|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
164706260|NCT02628743|594953410|FG000|Overall Study|Study Terminated by Sponsor|76|||
164706261|NCT02628743|594953410|FG000|Overall Study|Physician Decision|2|||
164706262|NCT04715932|594953411|FG000|Overall Study|Lost to Follow-up|1|||
164706263|NCT04715932|594953412|FG001|Overall Study|Lost to Follow-up|0|||
164706264|NCT02740699|594953413|FG000|Overall Study|Lost to Follow-up|5|||
164706265|NCT02740699|594953413|FG000|Overall Study|Withdrawal by Subject|14|||
164706266|NCT02740699|594953413|FG000|Overall Study|Physician Decision|5|||
164706267|NCT02393248|594953414|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164706268|NCT02393248|594953415|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
164706269|NCT02393248|594953416|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164706270|NCT02393248|594953417|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164706271|NCT02393248|594953418|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164706272|NCT02393248|594953419|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
164706273|NCT02393248|594953420|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
164706274|NCT02393248|594953421|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164706275|NCT02393248|594953422|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164706276|NCT02393248|594953423|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164706277|NCT02393248|594953424|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164706278|NCT02393248|594953425|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164706279|NCT02393248|594953426|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164706280|NCT02393248|594953427|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164706281|NCT02393248|594953428|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164706282|NCT02393248|594953429|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164706283|NCT02393248|594953430|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164706284|NCT02393248|594953431|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164706285|NCT02393248|594953432|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164706286|NCT02393248|594953433|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164403736|NCT03017079|593846404|FG000|Overall Study|Physician Decision|1|||
164403737|NCT03017079|593846405|FG001|Overall Study|Physician Decision|1|||
164403738|NCT03017079|593846404|FG000|Overall Study|Death|3|||
164403739|NCT03017079|593846405|FG001|Overall Study|Death|2|||
164403740|NCT03017079|593846404|FG000|Overall Study|Lack of Efficacy|2|||
164403741|NCT03017079|593846405|FG001|Overall Study|Lack of Efficacy|2|||
164403742|NCT03017079|593846404|FG000|Overall Study|Protocol Violation|0|||
164403743|NCT03017079|593846405|FG001|Overall Study|Protocol Violation|1|||
164403744|NCT06223373|593846411|FG000|Overall Study|Lost to Follow-up|1|||
164403745|NCT06223373|593846412|FG001|Overall Study|Lost to Follow-up|2|||
164403746|NCT01255592|593848427|FG000|Overall Study|Adverse Event|5|||
164403747|NCT01255592|593848428|FG001|Overall Study|Adverse Event|0|||
164403748|NCT01255592|593848427|FG000|Overall Study|Withdrawal by Subject|1|||
164403749|NCT01255592|593848428|FG001|Overall Study|Withdrawal by Subject|0|||
164403750|NCT01255592|593848427|FG000|Overall Study|Other|0|||
164403751|NCT01255592|593848428|FG001|Overall Study|Other|1|||
164403752|NCT03315143|593848429|FG000|Overall Study|Death|240|||
164403753|NCT03315143|593848430|FG001|Overall Study|Death|246|||
164403754|NCT03315143|593848429|FG000|Overall Study|Withdrawal by Subject|57|||
164403755|NCT03315143|593848430|FG001|Overall Study|Withdrawal by Subject|68|||
164403756|NCT03315143|593848429|FG000|Overall Study|Site Terminated by Sponsor|256|||
164403757|NCT03315143|593848430|FG001|Overall Study|Site Terminated by Sponsor|282|||
164403758|NCT03315143|593848429|FG000|Overall Study|Study Terminated by Sponsor|4723|||
164403759|NCT03315143|593848430|FG001|Overall Study|Study Terminated by Sponsor|4664|||
164403760|NCT03315143|593848429|FG000|Overall Study|Reason not Specified|16|||
164403761|NCT03315143|593848430|FG001|Overall Study|Reason not Specified|32|||
164403762|NCT01242748|593848435|FG000|Overall Study|Adverse Event|10|||
164403763|NCT01242748|593848436|FG001|Overall Study|Adverse Event|5|||
164403764|NCT01242748|593848435|FG000|Overall Study|Lost to Follow-up|6|||
164403765|NCT01242748|593848436|FG001|Overall Study|Lost to Follow-up|2|||
164403766|NCT01242748|593848435|FG000|Overall Study|Physician Decision|3|||
164403767|NCT01242748|593848436|FG001|Overall Study|Physician Decision|2|||
164403768|NCT01242748|593848435|FG000|Overall Study|Protocol Violation|1|||
164403769|NCT01242748|593848436|FG001|Overall Study|Protocol Violation|0|||
164403770|NCT01242748|593848435|FG000|Overall Study|Withdrawal by Subject|10|||
164403771|NCT01242748|593848436|FG001|Overall Study|Withdrawal by Subject|2|||
164403772|NCT01242748|593848435|FG000|Overall Study|Miscellaneous reasons|8|||
164403773|NCT01242748|593848436|FG001|Overall Study|Miscellaneous reasons|3|||
164403774|NCT00840801|593848437|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
164403775|NCT00840801|593848438|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
164403776|NCT00840801|593848439|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
164403777|NCT00840801|593848437|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
164403778|NCT00840801|593848438|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
164403779|NCT00840801|593848439|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
164403780|NCT00840801|593848437|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
164403781|NCT00840801|593848438|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
164403782|NCT00840801|593848439|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
164403783|NCT00840801|593848437|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
164403784|NCT00840801|593848438|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
164403785|NCT00840801|593848439|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
164403786|NCT00335452|593848440|FG000|Overall Study|Death|156|||
164403787|NCT00335452|593848441|FG001|Overall Study|Death|144|||
164403788|NCT00335452|593848442|FG002|Overall Study|Death|158|||
164403789|NCT00335452|593848443|FG003|Overall Study|Death|129|||
164403790|NCT00335452|593848440|FG000|Overall Study|Lost to Follow-up|2|||
164596902|NCT02052778|594549008|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164403791|NCT00335452|593848441|FG001|Overall Study|Lost to Follow-up|3|||
164403792|NCT00335452|593848442|FG002|Overall Study|Lost to Follow-up|1|||
164403793|NCT00335452|593848443|FG003|Overall Study|Lost to Follow-up|2|||
164403794|NCT02736825|593848444|FG000|Overall Study|Lost to Follow-up|10|||
164403795|NCT02736825|593848445|FG001|Overall Study|Lost to Follow-up|11|||
164403796|NCT02736825|593848444|FG000|Overall Study|Early Termination|0|||
164403797|NCT02736825|593848445|FG001|Overall Study|Early Termination|1|||
164403798|NCT00790452|593848446|FG000|Overall Study|Drug supply issue|1|||
164403799|NCT00790452|593848447|FG001|Overall Study|Drug supply issue|0|||
164403800|NCT02901626|593848448|FG000|Overall Study|Lost to Follow-up|1|||
164403801|NCT02901626|593848449|FG001|Overall Study|Lost to Follow-up|1|||
164403802|NCT04082884|593848450|FG000|Overall Study|Withdrawal by Subject|1|||
164403803|NCT00659490|593848455|FG000|Overall Study|Lost to Follow-up|2|||
164403804|NCT00659490|593848456|FG001|Overall Study|Lost to Follow-up|0|||
164403805|NCT00659490|593848457|FG002|Overall Study|Lost to Follow-up|1|||
164403806|NCT01649232|593848458|FG000|Overall Study|Physician Decision|2|||
164403807|NCT01649232|593848459|FG001|Overall Study|Physician Decision|0|||
164403808|NCT02421666|593848460|FG000|6-month Follow-up|Lost to Follow-up|8|||
164403809|NCT02421666|593848461|FG001|6-month Follow-up|Lost to Follow-up|7|||
164403810|NCT02421666|593848460|FG000|6-month Follow-up|Withdrawal by Subject|5|||
164403811|NCT02421666|593848461|FG001|6-month Follow-up|Withdrawal by Subject|6|||
164403812|NCT02421666|593848460|FG000|12-month Follow-up|Lost to Follow-up|5|||
164403813|NCT02421666|593848461|FG001|12-month Follow-up|Lost to Follow-up|5|||
164403814|NCT02421666|593848460|FG000|12-month Follow-up|Withdrawal by Subject|6|||
164403815|NCT02421666|593848461|FG001|12-month Follow-up|Withdrawal by Subject|11|||
164403816|NCT01078155|593848463|FG000|Overall Study|Adverse Event|7|||
164403817|NCT01078155|593848463|FG000|Overall Study|Lack of Efficacy|16|||
164403818|NCT01078155|593848463|FG000|Overall Study|Participant's Decision|6|||
164403819|NCT01078155|593848463|FG000|Overall Study|Lost to Follow-up|15|||
164403820|NCT01621880|593848464|FG000|Overall Study|Adverse Event|5|||
164403821|NCT01621880|593848465|FG001|Overall Study|Adverse Event|1|||
164403822|NCT01621880|593848464|FG000|Overall Study|Withdrawal by Subject|5|||
164403823|NCT01621880|593848465|FG001|Overall Study|Withdrawal by Subject|4|||
164403824|NCT01814748|593848468|FG000|Overall Study|Lost to Follow-up|1|||
164403825|NCT01814748|593848469|FG001|Overall Study|Lost to Follow-up|2|||
164403826|NCT01814748|593848468|FG000|Overall Study|Study site terminated by sponsor|1|||
164403827|NCT01814748|593848469|FG001|Overall Study|Study site terminated by sponsor|1|||
164403828|NCT01814748|593848468|FG000|Overall Study|Withdrawal by Subject|6|||
164403829|NCT01814748|593848469|FG001|Overall Study|Withdrawal by Subject|4|||
164403830|NCT03701399|593848474|FG000|Overall Study|Adverse Event|3|||
164403831|NCT03701399|593848475|FG001|Overall Study|Adverse Event|5|||
164403832|NCT03701399|593848474|FG000|Overall Study|Withdrawal by Subject|6|||
164403833|NCT03701399|593848475|FG001|Overall Study|Withdrawal by Subject|3|||
164403834|NCT03701399|593848474|FG000|Overall Study|Investigators decision|1|||
164403835|NCT03701399|593848475|FG001|Overall Study|Investigators decision|2|||
164403836|NCT03701399|593848474|FG000|Overall Study|Lost to Follow-up|1|||
164403837|NCT03701399|593848475|FG001|Overall Study|Lost to Follow-up|2|||
164403838|NCT03701399|593848474|FG000|Overall Study|Death|1|||
164403839|NCT03701399|593848475|FG001|Overall Study|Death|1|||
164403840|NCT03701399|593848474|FG000|Overall Study|Randomized but not treated|1|||
164403841|NCT03701399|593848475|FG001|Overall Study|Randomized but not treated|0|||
164403842|NCT04179032|593848476|FG000|Part B (Up to Week 52)|Adverse Event|1|||
164403843|NCT04179032|593848476|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
164403844|NCT04179032|593848476|FG000|Access Extension Phase|Ongoing|11|||
164403845|NCT03945292|593848477|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
164403846|NCT03945292|593848478|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
164403847|NCT03945292|593848479|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
164403848|NCT03945292|593848480|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
164403849|NCT03945292|593848481|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
164403850|NCT03945292|593848482|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
164403851|NCT03945292|593848483|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
164403852|NCT03945292|593848484|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
164403853|NCT03945292|593848477|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
164403854|NCT03945292|593848478|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
164403855|NCT03945292|593848479|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
164403856|NCT03945292|593848480|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
164596903|NCT02052778|594549009|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164403857|NCT03945292|593848481|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
164403858|NCT03945292|593848482|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
164403859|NCT03945292|593848483|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
164403860|NCT03945292|593848484|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
164403861|NCT03945292|593848477|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
164596904|NCT02052778|594549010|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164403862|NCT03945292|593848478|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
164403863|NCT03945292|593848479|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
164403864|NCT03945292|593848480|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
164403865|NCT03945292|593848481|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
164403866|NCT03945292|593848482|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
164403867|NCT03945292|593848483|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
164403868|NCT03945292|593848484|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
164403869|NCT03033225|593848485|FG000|Overall Study|Withdrawal by Subject|5|||
164403870|NCT00946296|593848486|FG000|Overall Study|Physician Decision|3|||
164403871|NCT00946296|593848487|FG001|Overall Study|Physician Decision|0|||
164403872|NCT02618967|593848492|FG000|Overall Study|Lost to Follow-up|0|||
164403873|NCT02618967|593848493|FG001|Overall Study|Lost to Follow-up|0|||
164403874|NCT02618967|593848494|FG002|Overall Study|Lost to Follow-up|1|||
164403875|NCT02618967|593848495|FG003|Overall Study|Lost to Follow-up|0|||
164403876|NCT02618967|593848496|FG004|Overall Study|Lost to Follow-up|2|||
164403877|NCT02618967|593848497|FG005|Overall Study|Lost to Follow-up|0|||
164403878|NCT02618967|593848498|FG006|Overall Study|Lost to Follow-up|0|||
164403879|NCT02618967|593848499|FG007|Overall Study|Lost to Follow-up|0|||
164403880|NCT02618967|593848492|FG000|Overall Study|Withdrawal by Subject|1|||
164403881|NCT02618967|593848493|FG001|Overall Study|Withdrawal by Subject|0|||
164403882|NCT02618967|593848494|FG002|Overall Study|Withdrawal by Subject|0|||
164403883|NCT02618967|593848495|FG003|Overall Study|Withdrawal by Subject|0|||
164403884|NCT02618967|593848496|FG004|Overall Study|Withdrawal by Subject|0|||
164403885|NCT02618967|593848497|FG005|Overall Study|Withdrawal by Subject|0|||
164403886|NCT02618967|593848498|FG006|Overall Study|Withdrawal by Subject|0|||
164403887|NCT02618967|593848499|FG007|Overall Study|Withdrawal by Subject|0|||
164403888|NCT01368965|593848500|FG000|Overall Study|Lost to Follow-up|12|||
164403889|NCT06060457|593848501|FG000|Overall Study|Adverse Event|1|||
164403890|NCT06060457|593848502|FG001|Overall Study|Adverse Event|1|||
164403891|NCT06060457|593848501|FG000|Overall Study|Death|2|||
164403892|NCT06060457|593848502|FG001|Overall Study|Death|2|||
164403893|NCT06060457|593848501|FG000|Overall Study|Lost to Follow-up|17|||
164403894|NCT06060457|593848502|FG001|Overall Study|Lost to Follow-up|19|||
164403895|NCT06060457|593848501|FG000|Overall Study|Physician Decision|0|||
164403896|NCT06060457|593848502|FG001|Overall Study|Physician Decision|1|||
164403897|NCT06060457|593848501|FG000|Overall Study|Protocol Violation|1|||
164403898|NCT06060457|593848502|FG001|Overall Study|Protocol Violation|1|||
164403899|NCT06060457|593848501|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
164403900|NCT06060457|593848502|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
164403901|NCT06060457|593848501|FG000|Overall Study|Withdrawal by Subject|12|||
164403902|NCT06060457|593848502|FG001|Overall Study|Withdrawal by Subject|15|||
164403903|NCT06060457|593848501|FG000|Overall Study|Other Than Specified|2|||
164403904|NCT06060457|593848502|FG001|Overall Study|Other Than Specified|1|||
164403905|NCT00569582|593848513|FG000|Overall Study|Withdrawal by Subject|5|||
164403906|NCT00569582|593848513|FG000|Overall Study|Death|2|||
164403907|NCT00569582|593848513|FG000|Overall Study|Adverse Event|7|||
164403908|NCT00569582|593848513|FG000|Overall Study|Subject was too ill to travel.|1|||
164403909|NCT00569582|593848513|FG000|Overall Study|Subject was non-compliant.|1|||
164403910|NCT05103384|593848519|FG000|Overall Study|Too severely affected Off Meds/Off DBS to complete entire protocol|4|||
164403911|NCT02612311|593848520|FG000|Overall Study|Adverse Event|16|||
164403912|NCT02612311|593848521|FG001|Overall Study|Adverse Event|12|||
164403913|NCT02612311|593848522|FG002|Overall Study|Adverse Event|7|||
164403914|NCT02612311|593848523|FG003|Overall Study|Adverse Event|13|||
164403915|NCT02612311|593848520|FG000|Overall Study|Death|29|||
164403916|NCT02612311|593848521|FG001|Overall Study|Death|10|||
164403917|NCT02612311|593848522|FG002|Overall Study|Death|11|||
164403918|NCT02612311|593848523|FG003|Overall Study|Death|11|||
164403919|NCT02612311|593848520|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
164403920|NCT02612311|593848521|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
164403921|NCT02612311|593848522|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
164403922|NCT02612311|593848523|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
164403923|NCT02612311|593848520|FG000|Overall Study|Investigator's Decision|11|||
164403924|NCT02612311|593848521|FG001|Overall Study|Investigator's Decision|15|||
164403925|NCT02612311|593848522|FG002|Overall Study|Investigator's Decision|6|||
164403926|NCT02612311|593848523|FG003|Overall Study|Investigator's Decision|6|||
164403927|NCT02612311|593848520|FG000|Overall Study|Lack of Efficacy|0|||
164403928|NCT02612311|593848521|FG001|Overall Study|Lack of Efficacy|0|||
164403929|NCT02612311|593848522|FG002|Overall Study|Lack of Efficacy|1|||
164403930|NCT02612311|593848523|FG003|Overall Study|Lack of Efficacy|1|||
164403931|NCT02612311|593848520|FG000|Overall Study|Lost to Follow-up|2|||
164403932|NCT02612311|593848521|FG001|Overall Study|Lost to Follow-up|2|||
164403933|NCT02612311|593848522|FG002|Overall Study|Lost to Follow-up|1|||
164403934|NCT02612311|593848523|FG003|Overall Study|Lost to Follow-up|2|||
164403935|NCT02612311|593848520|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
164403936|NCT02612311|593848521|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
164446399|NCT03422276|594004722|FG000|Overall Study|Withdrawal by Subject|21|||
164446400|NCT03422276|594004723|FG001|Overall Study|Withdrawal by Subject|25|||
164446401|NCT03422276|594004724|FG002|Overall Study|Withdrawal by Subject|14|||
164446402|NCT03422276|594004725|FG003|Overall Study|Withdrawal by Subject|16|||
164446403|NCT03422276|594004722|FG000|Overall Study|Death|14|||
164446404|NCT03422276|594004723|FG001|Overall Study|Death|21|||
164446405|NCT03422276|594004724|FG002|Overall Study|Death|3|||
164446406|NCT03422276|594004725|FG003|Overall Study|Death|1|||
164446407|NCT03422276|594004722|FG000|Overall Study|Discontinued, ineligible|4|||
164446408|NCT03422276|594004723|FG001|Overall Study|Discontinued, ineligible|3|||
164446409|NCT03422276|594004724|FG002|Overall Study|Discontinued, ineligible|0|||
164446410|NCT03422276|594004725|FG003|Overall Study|Discontinued, ineligible|0|||
164446411|NCT03422276|594004722|FG000|Overall Study|Lost to Follow-up|15|||
164446412|NCT03422276|594004723|FG001|Overall Study|Lost to Follow-up|8|||
164403937|NCT02612311|593848522|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
164403938|NCT02612311|593848523|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
164403939|NCT02612311|593848520|FG000|Overall Study|Site Terminated by Sponsor|29|||
164403940|NCT02612311|593848521|FG001|Overall Study|Site Terminated by Sponsor|12|||
164403941|NCT02612311|593848522|FG002|Overall Study|Site Terminated by Sponsor|13|||
164403942|NCT02612311|593848523|FG003|Overall Study|Site Terminated by Sponsor|5|||
164403943|NCT02612311|593848520|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
164403944|NCT02612311|593848521|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
164403945|NCT02612311|593848522|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
164403946|NCT02612311|593848523|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
164403947|NCT02612311|593848520|FG000|Overall Study|Reason Not Specified|3|||
164403948|NCT02612311|593848521|FG001|Overall Study|Reason Not Specified|7|||
164403949|NCT02612311|593848522|FG002|Overall Study|Reason Not Specified|4|||
164403950|NCT02612311|593848523|FG003|Overall Study|Reason Not Specified|5|||
164403951|NCT02612311|593848520|FG000|Overall Study|Unknown/Missing|10|||
164403952|NCT02612311|593848521|FG001|Overall Study|Unknown/Missing|13|||
164403953|NCT02612311|593848522|FG002|Overall Study|Unknown/Missing|4|||
164403954|NCT02612311|593848523|FG003|Overall Study|Unknown/Missing|0|||
164403955|NCT02612311|593848520|FG000|Overall Study|Non-Compliance with Study|1|||
164403956|NCT02612311|593848521|FG001|Overall Study|Non-Compliance with Study|0|||
164403957|NCT02612311|593848522|FG002|Overall Study|Non-Compliance with Study|0|||
164403958|NCT02612311|593848523|FG003|Overall Study|Non-Compliance with Study|0|||
164403959|NCT00514735|593848527|FG000|Overall Study|Withdrawal by Subject|13|||
164403960|NCT00514735|593848528|FG001|Overall Study|Withdrawal by Subject|5|||
164403961|NCT00514735|593848527|FG000|Overall Study|Death|1|||
164403962|NCT00514735|593848528|FG001|Overall Study|Death|0|||
164403963|NCT00514735|593848527|FG000|Overall Study|Lost to Follow-up|0|||
164403964|NCT00514735|593848528|FG001|Overall Study|Lost to Follow-up|1|||
164403965|NCT04393441|593848534|FG000|Overall Study|Adverse Event|0|||
164403966|NCT04393441|593848535|FG001|Overall Study|Adverse Event|3|||
164403967|NCT04393441|593848534|FG000|Overall Study|Withdrawal by Subject|5|||
164403968|NCT04393441|593848535|FG001|Overall Study|Withdrawal by Subject|7|||
164403969|NCT04393441|593848534|FG000|Overall Study|Lost to Follow-up|0|||
164403970|NCT04393441|593848535|FG001|Overall Study|Lost to Follow-up|2|||
164403971|NCT04393441|593848534|FG000|Overall Study|Protocol Deviation|2|||
164403972|NCT04393441|593848535|FG001|Overall Study|Protocol Deviation|1|||
164403973|NCT04393441|593848534|FG000|Overall Study|Reason not Specified|1|||
164403974|NCT04393441|593848535|FG001|Overall Study|Reason not Specified|1|||
164403975|NCT02782169|593848536|FG000|Overall Study|Lost to Follow-up|1|||
164403976|NCT02782169|593848537|FG001|Overall Study|Lost to Follow-up|2|||
164403977|NCT04003610|593848538|FG000|Overall Study|Lost to Follow-up|0|||
164403978|NCT04003610|593848539|FG001|Overall Study|Lost to Follow-up|1|||
164403979|NCT04003610|593848540|FG002|Overall Study|Lost to Follow-up|0|||
164403980|NCT04003610|593848538|FG000|Overall Study|Death|0|||
164403981|NCT04003610|593848539|FG001|Overall Study|Death|0|||
164403982|NCT04003610|593848540|FG002|Overall Study|Death|3|||
164403983|NCT04003610|593848538|FG000|Overall Study|Study Terminated by Sponsor|0|||
164403984|NCT04003610|593848539|FG001|Overall Study|Study Terminated by Sponsor|0|||
164403985|NCT04003610|593848540|FG002|Overall Study|Study Terminated by Sponsor|3|||
164403986|NCT04751942|593848546|FG000|Overall Study|Lost to Follow-up|9|||
164403987|NCT04751942|593848547|FG001|Overall Study|Lost to Follow-up|6|||
164403988|NCT02953938|593848548|FG000|Overall Study|Adverse Event|0|||
164446413|NCT03422276|594004724|FG002|Overall Study|Lost to Follow-up|13|||
164446414|NCT03422276|594004725|FG003|Overall Study|Lost to Follow-up|4|||
164403989|NCT02953938|593848549|FG001|Overall Study|Adverse Event|1|||
164403990|NCT02953938|593848548|FG000|Overall Study|Withdrawal by Subject|1|||
164403991|NCT02953938|593848549|FG001|Overall Study|Withdrawal by Subject|1|||
164403992|NCT04510675|593848556|FG000|Overall Study|Withdrawal by Subject|5|||
164403993|NCT04198805|593848557|FG000|Overall Study|Death|0|||
164403994|NCT04198805|593848558|FG001|Overall Study|Death|0|||
164403995|NCT04198805|593848559|FG002|Overall Study|Death|0|||
164403996|NCT04198805|593848560|FG003|Overall Study|Death|1|||
164446415|NCT03422276|594004722|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
164446416|NCT03422276|594004723|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
164446417|NCT03422276|594004724|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
164446418|NCT03422276|594004725|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
164446419|NCT03422276|594004722|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
164446420|NCT03422276|594004723|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
164446421|NCT03422276|594004724|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
164446422|NCT03422276|594004725|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
164446423|NCT03422276|594004722|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
164446424|NCT03422276|594004723|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
164446425|NCT03422276|594004724|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
164446426|NCT03422276|594004725|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
164446427|NCT03422276|594004722|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
164446428|NCT03422276|594004723|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
164446429|NCT03422276|594004724|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
164446430|NCT03422276|594004725|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
164446431|NCT03422276|594004722|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
164446432|NCT03422276|594004723|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
164446433|NCT03422276|594004724|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
164446434|NCT03422276|594004725|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
164706287|NCT02393248|594953434|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164706288|NCT02393248|594953435|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164706289|NCT02393248|594953436|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164706290|NCT02393248|594953437|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164706291|NCT02393248|594953438|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164706292|NCT02393248|594953414|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164403997|NCT04198805|593848557|FG000|Overall Study|Early Termination|8|||
164403998|NCT04198805|593848558|FG001|Overall Study|Early Termination|4|||
164403999|NCT04198805|593848559|FG002|Overall Study|Early Termination|6|||
164404000|NCT04198805|593848560|FG003|Overall Study|Early Termination|9|||
164404001|NCT03078816|593848561|FG000|Overall Study|Withdrawal by Subject|1|||
164404002|NCT02114151|593848562|FG000|Overall Study|Death|1|||
164404003|NCT02114151|593848562|FG000|Overall Study|Lost to Follow-up|1|||
164404004|NCT02114151|593848562|FG000|Overall Study|Withdrawal by Subject|5|||
164404005|NCT01499082|593848563|FG000|Overall Study|Randomized but not Treated|0|||
164404006|NCT01499082|593848564|FG001|Overall Study|Randomized but not Treated|1|||
164404007|NCT01499082|593848563|FG000|Overall Study|Adverse Event|12|||
164404008|NCT01499082|593848564|FG001|Overall Study|Adverse Event|16|||
164404009|NCT01499082|593848563|FG000|Overall Study|Lack of Efficacy|1|||
164404010|NCT01499082|593848564|FG001|Overall Study|Lack of Efficacy|1|||
164404011|NCT01499082|593848563|FG000|Overall Study|Protocol Violation|6|||
164404012|NCT01499082|593848564|FG001|Overall Study|Protocol Violation|8|||
164404013|NCT01499082|593848563|FG000|Overall Study|Diverse Reasons|18|||
164404014|NCT01499082|593848564|FG001|Overall Study|Diverse Reasons|14|||
164404015|NCT01499082|593848563|FG000|Overall Study|Site Closure for Noncompliance|5|||
164404016|NCT01499082|593848564|FG001|Overall Study|Site Closure for Noncompliance|2|||
164404017|NCT01499082|593848563|FG000|Overall Study|Hypoglycemia|2|||
164404018|NCT01499082|593848564|FG001|Overall Study|Hypoglycemia|3|||
164404019|NCT01499082|593848563|FG000|Overall Study|Lost to Follow-up|1|||
164404020|NCT01499082|593848564|FG001|Overall Study|Lost to Follow-up|3|||
164404021|NCT00500903|593848570|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
164404022|NCT00500903|593848571|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
164404023|NCT00500903|593848572|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
164404024|NCT00500903|593848570|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
164404025|NCT00500903|593848571|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
164404026|NCT00500903|593848572|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
164404027|NCT00500903|593848570|FG000|Overall Study|Progressive Disease|41|||
164404028|NCT00500903|593848571|FG001|Overall Study|Progressive Disease|2|||
164404029|NCT00500903|593848572|FG002|Overall Study|Progressive Disease|15|||
164404030|NCT00500903|593848570|FG000|Overall Study|Patient Declined Further Treatment|0|||
164404031|NCT00500903|593848571|FG001|Overall Study|Patient Declined Further Treatment|0|||
164404032|NCT00500903|593848572|FG002|Overall Study|Patient Declined Further Treatment|3|||
164404033|NCT00500903|593848570|FG000|Overall Study|Symptomatic Deterioration|2|||
164404034|NCT00500903|593848571|FG001|Overall Study|Symptomatic Deterioration|0|||
164404035|NCT00500903|593848572|FG002|Overall Study|Symptomatic Deterioration|0|||
164404036|NCT00500903|593848570|FG000|Overall Study|Reason Not Specified|10|||
164404037|NCT00500903|593848571|FG001|Overall Study|Reason Not Specified|0|||
164404038|NCT00500903|593848572|FG002|Overall Study|Reason Not Specified|2|||
164404039|NCT00696410|593848573|FG000|Overall Study|Lost to Follow-up|2|||
164404040|NCT00696410|593848574|FG001|Overall Study|Lost to Follow-up|0|||
164446435|NCT05194917|594004726|FG000|Overall Study|Lost to Follow-up|7|||
164446436|NCT05194917|594004727|FG001|Overall Study|Lost to Follow-up|5|||
164446437|NCT05194917|594004728|FG002|Overall Study|Lost to Follow-up|6|||
164446438|NCT05194917|594004729|FG003|Overall Study|Lost to Follow-up|5|||
164446439|NCT04922021|594004730|FG000|Overall Study|Withdrawal by Subject|4|||
164446440|NCT04922021|594004731|FG001|Overall Study|Withdrawal by Subject|10|||
164446441|NCT04922021|594004730|FG000|Overall Study|Adverse Event|2|||
164446442|NCT04922021|594004731|FG001|Overall Study|Adverse Event|2|||
164446443|NCT04922021|594004730|FG000|Overall Study|Lack of Efficacy|0|||
164446444|NCT04922021|594004731|FG001|Overall Study|Lack of Efficacy|1|||
164446445|NCT04922021|594004730|FG000|Overall Study|Multiple reasons|1|||
164446446|NCT04922021|594004731|FG001|Overall Study|Multiple reasons|0|||
164446447|NCT04842500|594004741|FG000|Overall Study|Withdrawal by Subject|4|||
164446448|NCT04842500|594004742|FG001|Overall Study|Withdrawal by Subject|1|||
164446449|NCT04842500|594004743|FG002|Overall Study|Withdrawal by Subject|2|||
164446450|NCT04842500|594004744|FG003|Overall Study|Withdrawal by Subject|3|||
164446451|NCT04842500|594004741|FG000|Overall Study|Protocol Violation|1|||
164446452|NCT04842500|594004742|FG001|Overall Study|Protocol Violation|0|||
164446453|NCT04842500|594004743|FG002|Overall Study|Protocol Violation|0|||
164446454|NCT04842500|594004744|FG003|Overall Study|Protocol Violation|1|||
164446455|NCT02980276|594004745|FG000|Overall Study|Withdrawal by Subject|4|||
164446456|NCT02980276|594004746|FG001|Overall Study|Withdrawal by Subject|4|||
164446457|NCT02980276|594004745|FG000|Overall Study|Physician Decision|0|||
164446458|NCT02980276|594004746|FG001|Overall Study|Physician Decision|1|||
164446459|NCT02980276|594004745|FG000|Overall Study|Lost to Follow-up|18|||
164446460|NCT02980276|594004746|FG001|Overall Study|Lost to Follow-up|18|||
164446461|NCT02980276|594004745|FG000|Overall Study|Death|1|||
164446462|NCT02980276|594004746|FG001|Overall Study|Death|0|||
164446463|NCT02980276|594004745|FG000|Overall Study|Miscellaneous other|10|||
164446464|NCT02980276|594004746|FG001|Overall Study|Miscellaneous other|4|||
164446465|NCT04139668|594004748|FG000|Overall Study|Withdrawal by Subject|1|||
164446466|NCT02824029|594004751|FG000|Overall Study|Didn't receive treatment|2|||
164446467|NCT02824029|594004751|FG000|Overall Study|Patient decision to discontinue treatment|3|||
164446468|NCT02824029|594004751|FG000|Overall Study|Non-compliant|5|||
164446469|NCT02824029|594004751|FG000|Overall Study|Progression of disease|15|||
164446470|NCT02824029|594004751|FG000|Overall Study|Inadequate response to therapy|2|||
164446471|NCT02824029|594004751|FG000|Overall Study|Possible progression per treating physician|1|||
164446472|NCT04440176|594004752|FG000|Overall Study|Withdrawal by Subject|5|||
164446473|NCT04440176|594004753|FG001|Overall Study|Withdrawal by Subject|3|||
164446474|NCT04440176|594004752|FG000|Overall Study|Withdrawal by parent/guardian|4|||
164446475|NCT04440176|594004753|FG001|Overall Study|Withdrawal by parent/guardian|5|||
164446476|NCT04440176|594004752|FG000|Overall Study|Adverse Event|2|||
164446477|NCT04440176|594004753|FG001|Overall Study|Adverse Event|6|||
164446478|NCT04440176|594004752|FG000|Overall Study|Lost to Follow-up|22|||
164446479|NCT04440176|594004753|FG001|Overall Study|Lost to Follow-up|23|||
164446480|NCT04440176|594004752|FG000|Overall Study|Medication error without associated adverse event|0|||
164446481|NCT04440176|594004753|FG001|Overall Study|Medication error without associated adverse event|1|||
164446482|NCT04440176|594004752|FG000|Overall Study|No longer met eligibility criteria|7|||
164446483|NCT04440176|594004753|FG001|Overall Study|No longer met eligibility criteria|1|||
164446484|NCT04440176|594004752|FG000|Overall Study|Other|1|||
164446485|NCT04440176|594004753|FG001|Overall Study|Other|2|||
164446486|NCT04440176|594004752|FG000|Overall Study|Protocol deviation|6|||
164446487|NCT04440176|594004753|FG001|Overall Study|Protocol deviation|8|||
164446488|NCT04440176|594004752|FG000|Overall Study|Randomized but not vaccinated|6|||
164446489|NCT04440176|594004753|FG001|Overall Study|Randomized but not vaccinated|3|||
164446490|NCT04188379|594004754|FG000|Overall Study|Withdrawal by Subject|10|||
164446491|NCT04188379|594004755|FG001|Overall Study|Withdrawal by Subject|3|||
164446492|NCT04188379|594004754|FG000|Overall Study|Physician Decision|0|||
164446493|NCT04188379|594004755|FG001|Overall Study|Physician Decision|1|||
164446494|NCT04188379|594004754|FG000|Overall Study|Adverse Event|3|||
164446495|NCT04188379|594004755|FG001|Overall Study|Adverse Event|1|||
164446496|NCT04188379|594004754|FG000|Overall Study|Pregnancy|1|||
164446497|NCT04188379|594004755|FG001|Overall Study|Pregnancy|0|||
164446498|NCT04188379|594004754|FG000|Overall Study|Lack of Efficacy|8|||
164446499|NCT04188379|594004755|FG001|Overall Study|Lack of Efficacy|5|||
164446500|NCT04188379|594004754|FG000|Overall Study|Other|0|||
164446501|NCT04188379|594004755|FG001|Overall Study|Other|3|||
164446502|NCT05288283|594004756|FG000|Overall Study|Study Terminated Early|1|||
164446503|NCT05288283|594004757|FG001|Overall Study|Study Terminated Early|1|||
164446504|NCT00978042|594004760|FG000|Initial Treatment Period|Treated in Error|0|||
164446505|NCT00978042|594004761|FG001|Initial Treatment Period|Treated in Error|3|||
164446506|NCT00978042|594004760|FG000|Initial Treatment Period|Ineligibility|1|||
164446507|NCT00978042|594004761|FG001|Initial Treatment Period|Ineligibility|0|||
164446508|NCT00978042|594004760|FG000|Initial Treatment Period|Lost to Follow-up|21|||
164446509|NCT00978042|594004761|FG001|Initial Treatment Period|Lost to Follow-up|3|||
164446510|NCT00978042|594004760|FG000|Initial Treatment Period|Adverse Event|2|||
164446511|NCT00978042|594004761|FG001|Initial Treatment Period|Adverse Event|0|||
164446512|NCT00978042|594004760|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
164446513|NCT00978042|594004761|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
164446514|NCT00978042|594004760|FG000|Initial Treatment Period|Consent withdrawn|22|||
164446515|NCT00978042|594004761|FG001|Initial Treatment Period|Consent withdrawn|9|||
164446516|NCT00978042|594004760|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
164446517|NCT00978042|594004761|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
164446518|NCT03051165|594004762|FG000|Overall Study|Withdrawal by Subject|1|||
164446519|NCT03051165|594004762|FG000|Overall Study|Early termination of study|12|||
164446520|NCT03283371|594004763|FG000|Placebo-controlled|Adverse Event|1|||
164446521|NCT03283371|594004764|FG001|Placebo-controlled|Adverse Event|1|||
164446522|NCT03283371|594004765|FG002|Placebo-controlled|Adverse Event|0|||
164446523|NCT03283371|594004766|FG003|Placebo-controlled|Adverse Event|0|||
164446524|NCT03283371|594004763|FG000|Placebo-controlled|Lack of Efficacy|1|||
164446525|NCT03283371|594004764|FG001|Placebo-controlled|Lack of Efficacy|0|||
164446526|NCT03283371|594004765|FG002|Placebo-controlled|Lack of Efficacy|0|||
164446527|NCT03283371|594004766|FG003|Placebo-controlled|Lack of Efficacy|0|||
164446528|NCT03283371|594004763|FG000|Placebo-controlled|Withdrawal by Subject|1|||
164446529|NCT03283371|594004764|FG001|Placebo-controlled|Withdrawal by Subject|1|||
164446530|NCT03283371|594004765|FG002|Placebo-controlled|Withdrawal by Subject|0|||
164446531|NCT03283371|594004766|FG003|Placebo-controlled|Withdrawal by Subject|0|||
164446532|NCT03283371|594004763|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
164446533|NCT03283371|594004764|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
164446534|NCT03283371|594004765|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
164446535|NCT03283371|594004766|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
164446536|NCT03283371|594004763|FG000|Open-label Phase|Adverse Event|0|||
164446537|NCT03283371|594004764|FG001|Open-label Phase|Adverse Event|0|||
164446538|NCT03283371|594004765|FG002|Open-label Phase|Adverse Event|2|||
164446539|NCT03283371|594004766|FG003|Open-label Phase|Adverse Event|0|||
164446540|NCT03283371|594004763|FG000|Open-label Phase|Withdrawal by Subject|0|||
164446541|NCT03283371|594004764|FG001|Open-label Phase|Withdrawal by Subject|0|||
164446542|NCT03283371|594004765|FG002|Open-label Phase|Withdrawal by Subject|1|||
164446543|NCT03283371|594004766|FG003|Open-label Phase|Withdrawal by Subject|0|||
164446544|NCT03283371|594004763|FG000|Open-label Phase|Other|0|||
164446545|NCT03283371|594004764|FG001|Open-label Phase|Other|0|||
164446546|NCT03283371|594004765|FG002|Open-label Phase|Other|1|||
164446547|NCT03283371|594004766|FG003|Open-label Phase|Other|1|||
164446548|NCT01290341|594004767|FG000|Overall Study|Protocol Violation|7|||
164446549|NCT01290341|594004768|FG001|Overall Study|Protocol Violation|3|||
164446550|NCT01290341|594004767|FG000|Overall Study|Adverse Event|1|||
164446551|NCT01290341|594004768|FG001|Overall Study|Adverse Event|0|||
164446552|NCT01290341|594004767|FG000|Overall Study|Lost to Follow-up|21|||
164446553|NCT01290341|594004768|FG001|Overall Study|Lost to Follow-up|10|||
164446554|NCT01290341|594004767|FG000|Overall Study|Withdrawal by Subject|19|||
164446555|NCT01290341|594004768|FG001|Overall Study|Withdrawal by Subject|5|||
164446556|NCT01290341|594004767|FG000|Overall Study|Negative baseline culture and others|44|||
164446557|NCT01290341|594004768|FG001|Overall Study|Negative baseline culture and others|11|||
164446558|NCT02574455|594004780|FG000|Overall Study|Death|197|||
164446559|NCT02574455|594004781|FG001|Overall Study|Death|210|||
164446560|NCT02574455|594004780|FG000|Overall Study|Withdrawal of Consent|11|||
164706293|NCT02393248|594953415|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
164706294|NCT02393248|594953416|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164706295|NCT02393248|594953417|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164706296|NCT02393248|594953418|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164706297|NCT02393248|594953419|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164404041|NCT00696410|593848573|FG000|Overall Study|Withdrawal by Subject|8|||
164404042|NCT00696410|593848574|FG001|Overall Study|Withdrawal by Subject|0|||
164404043|NCT00696410|593848573|FG000|Overall Study|Physician Decision|3|||
164404044|NCT00696410|593848574|FG001|Overall Study|Physician Decision|0|||
164404045|NCT02134587|593848578|FG000|Overall Study|Did not completed all meetings|30|||
164404046|NCT00265889|593848579|FG000|Overall Study|Physician Decision|1|||
164404047|NCT00265889|593848579|FG000|Overall Study|Protocol Violation|1|||
164404048|NCT00265889|593848579|FG000|Overall Study|Insurance denied the request|3|||
164404049|NCT00803452|593848580|FG000|Overall Study|Adverse Event|0|||
164404050|NCT00803452|593848581|FG001|Overall Study|Adverse Event|2|||
164404051|NCT00803452|593848580|FG000|Overall Study|Lost to Follow-up|0|||
164446561|NCT02574455|594004781|FG001|Overall Study|Withdrawal of Consent|28|||
164446562|NCT02574455|594004780|FG000|Overall Study|Lost to Follow-up|4|||
164446563|NCT02574455|594004781|FG001|Overall Study|Lost to Follow-up|4|||
164446564|NCT02574455|594004780|FG000|Overall Study|Sponsor's Decision|55|||
164446565|NCT02574455|594004781|FG001|Overall Study|Sponsor's Decision|20|||
164446566|NCT00970359|594004787|FG000|Overall Study|Not Treated|4|||
164446567|NCT01388361|594004788|FG000|Overall Study|Adverse Event|0|||
164404052|NCT00803452|593848581|FG001|Overall Study|Lost to Follow-up|3|||
164446568|NCT01388361|594004789|FG001|Overall Study|Adverse Event|5|||
164446569|NCT01388361|594004790|FG002|Overall Study|Adverse Event|1|||
164446570|NCT01388361|594004788|FG000|Overall Study|Protocol Violation|0|||
164446571|NCT01388361|594004789|FG001|Overall Study|Protocol Violation|0|||
164446572|NCT01388361|594004790|FG002|Overall Study|Protocol Violation|2|||
164446573|NCT01388361|594004788|FG000|Overall Study|Withdrawal criteria|12|||
164446574|NCT01388361|594004789|FG001|Overall Study|Withdrawal criteria|7|||
164446575|NCT01388361|594004790|FG002|Overall Study|Withdrawal criteria|10|||
164446576|NCT01388361|594004788|FG000|Overall Study|Unclassified|0|||
164446577|NCT01388361|594004789|FG001|Overall Study|Unclassified|0|||
164446578|NCT01388361|594004790|FG002|Overall Study|Unclassified|1|||
164446579|NCT04200365|594004794|FG000|Overall Study|Adverse Event|2|||
164446580|NCT04200365|594004794|FG000|Overall Study|Progressive Disease|4|||
164446581|NCT04200365|594004794|FG000|Overall Study|Lack of Efficacy|1|||
164446582|NCT04200365|594004794|FG000|Overall Study|Study Closure|4|||
164446583|NCT01499199|594004797|FG000|Overall Study|Adverse Event|1|||
164446584|NCT01499199|594004797|FG000|Overall Study|Lack of Efficacy|1|||
164446585|NCT01199705|594004798|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
164446586|NCT01849055|594004804|FG000|Overall Study|Withdrawal by Subject|0|||
164446587|NCT01849055|594004805|FG001|Overall Study|Withdrawal by Subject|0|||
164446588|NCT01849055|594004806|FG002|Overall Study|Withdrawal by Subject|1|||
164446589|NCT01849055|594004807|FG003|Overall Study|Withdrawal by Subject|0|||
164446590|NCT01849055|594004808|FG004|Overall Study|Withdrawal by Subject|0|||
164446591|NCT01849055|594004809|FG005|Overall Study|Withdrawal by Subject|0|||
164446592|NCT01199575|594004810|FG000|Overall Study|Withdrawal by Subject|5|||
164446593|NCT00933400|594004811|FG000|Overall Study|Withdrawal by Subject|21|||
164446594|NCT00933400|594004812|FG001|Overall Study|Withdrawal by Subject|1|||
164446595|NCT00223795|594004817|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
164446596|NCT00223795|594004818|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
164446597|NCT00223795|594004817|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
164446598|NCT00223795|594004818|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
164446599|NCT01239316|594004819|FG000|Overall Study|Progression/Relapse|11|||
164446600|NCT01239316|594004819|FG000|Overall Study|Adverse Event|1|||
164446601|NCT02409667|594004824|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
164446602|NCT02409667|594004825|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
164446603|NCT02409667|594004826|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
164446604|NCT02409667|594004827|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
164446605|NCT02409667|594004828|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
164446606|NCT02409667|594004824|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
164446607|NCT02409667|594004825|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
164446608|NCT02409667|594004826|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
164446609|NCT02409667|594004827|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
164446610|NCT02409667|594004828|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
164446611|NCT02409667|594004824|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
164446612|NCT02409667|594004825|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
164446613|NCT02409667|594004826|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
164446614|NCT02409667|594004827|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
164446615|NCT02409667|594004828|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
164446616|NCT02409667|594004824|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
164446617|NCT02409667|594004825|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
164446618|NCT02409667|594004826|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
164446619|NCT02409667|594004827|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
164446620|NCT02409667|594004828|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
164446621|NCT02409667|594004824|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
164446622|NCT02409667|594004825|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
164446623|NCT02409667|594004826|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
164446624|NCT02409667|594004827|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
164446625|NCT02409667|594004828|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
164446626|NCT02409667|594004824|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
164446627|NCT02409667|594004825|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
164446628|NCT02409667|594004826|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
164446629|NCT02409667|594004827|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
164706298|NCT02393248|594953420|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164706299|NCT02393248|594953421|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164706300|NCT02393248|594953422|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164706301|NCT02393248|594953423|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164706302|NCT02393248|594953424|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164446630|NCT02409667|594004828|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
164446631|NCT02409667|594004824|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
164446632|NCT02409667|594004825|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
164446633|NCT02409667|594004826|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
164446634|NCT02409667|594004827|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
164446635|NCT02409667|594004828|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
164446636|NCT02409667|594004824|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
164446637|NCT02409667|594004825|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
164446638|NCT02409667|594004826|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
164446639|NCT02409667|594004827|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
164446640|NCT02409667|594004828|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
164446641|NCT02409667|594004824|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
164446642|NCT02409667|594004825|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
164404053|NCT03419364|593848584|FG000|Overall Study|Delivery due to maternal condition|2|||
164404054|NCT03419364|593848585|FG001|Overall Study|Delivery due to maternal condition|0|||
164404055|NCT03419364|593848586|FG002|Overall Study|Delivery due to maternal condition|0|||
164404056|NCT01352585|593849989|FG000|Overall Study|Adverse Event|2|||
164404057|NCT01352585|593849990|FG001|Overall Study|Adverse Event|1|||
164446643|NCT02409667|594004826|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
164446644|NCT02409667|594004827|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
164446645|NCT02409667|594004828|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
164446646|NCT02409667|594004824|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
164446647|NCT02409667|594004825|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
164404058|NCT01352585|593849989|FG000|Overall Study|Lost to Follow-up|1|||
164404059|NCT01352585|593849990|FG001|Overall Study|Lost to Follow-up|0|||
164404060|NCT01352585|593849989|FG000|Overall Study|Other|5|||
164404061|NCT01352585|593849990|FG001|Overall Study|Other|2|||
164404062|NCT00838682|593849993|FG000|Overall Study|Lost to Follow-up|21|||
164404063|NCT00838682|593849994|FG001|Overall Study|Lost to Follow-up|14|||
164404064|NCT00838682|593849993|FG000|Overall Study|detection of exclusion criteria|4|||
164404065|NCT00838682|593849994|FG001|Overall Study|detection of exclusion criteria|3|||
164404066|NCT00838682|593849993|FG000|Overall Study|Protocol Violation|0|||
164404067|NCT00838682|593849994|FG001|Overall Study|Protocol Violation|1|||
164404068|NCT00838682|593849993|FG000|Overall Study|Withdrawal by Subject|0|||
164404069|NCT00838682|593849994|FG001|Overall Study|Withdrawal by Subject|1|||
164404070|NCT02305381|593849995|FG000|Overall Study|Unclassified|5|||
164404071|NCT02305381|593849996|FG001|Overall Study|Unclassified|5|||
164404072|NCT02305381|593849997|FG002|Overall Study|Unclassified|7|||
164404073|NCT02276066|593849998|FG000|Overall Study|Lost to Follow-up|21|||
164404074|NCT02276066|593849999|FG001|Overall Study|Lost to Follow-up|11|||
164404075|NCT02882282|593850000|FG000|Overall Study|Adverse Event|1|||
164404076|NCT02882282|593850001|FG001|Overall Study|Adverse Event|0|||
164404077|NCT01807156|593850002|FG000|Overall Study|Physician Decision|1|||
164404078|NCT03928028|593850003|FG000|Overall Study|Physician Decision|9|||
164404079|NCT03928028|593850004|FG001|Overall Study|Physician Decision|6|||
164404080|NCT03928028|593850005|FG002|Overall Study|Physician Decision|3|||
164404081|NCT03928028|593850003|FG000|Overall Study|Withdrawal by Subject|12|||
164404082|NCT03928028|593850004|FG001|Overall Study|Withdrawal by Subject|3|||
164404083|NCT03928028|593850005|FG002|Overall Study|Withdrawal by Subject|3|||
164404084|NCT02710292|593850012|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
164404085|NCT02710292|593850013|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
164404086|NCT02710292|593850012|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
164404087|NCT02710292|593850013|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
164404088|NCT02323646|593850021|FG000|Treatment Course 1|Adverse Event|1|||
164404089|NCT02323646|593850022|FG001|Treatment Course 1|Adverse Event|0|||
164404090|NCT02323646|593850023|FG002|Treatment Course 1|Adverse Event|1|||
164404091|NCT02323646|593850021|FG000|Treatment Course 1|Heavy Bleeding|1|||
164404092|NCT02323646|593850022|FG001|Treatment Course 1|Heavy Bleeding|1|||
164404093|NCT02323646|593850023|FG002|Treatment Course 1|Heavy Bleeding|0|||
164404094|NCT02323646|593850021|FG000|Treatment Course 1|Lost to Follow-up|1|||
164404095|NCT02323646|593850022|FG001|Treatment Course 1|Lost to Follow-up|0|||
164404096|NCT02323646|593850023|FG002|Treatment Course 1|Lost to Follow-up|2|||
164404097|NCT02323646|593850021|FG000|Treatment Course 1|Withdrawal by Subject|0|||
164446648|NCT02409667|594004826|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
164706303|NCT02393248|594953425|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164404098|NCT02323646|593850022|FG001|Treatment Course 1|Withdrawal by Subject|2|||
164446649|NCT02409667|594004827|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
164446650|NCT02409667|594004828|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
164446651|NCT02409667|594004824|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
164706304|NCT02393248|594953426|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164404099|NCT02323646|593850023|FG002|Treatment Course 1|Withdrawal by Subject|0|||
164404100|NCT02323646|593850021|FG000|Treatment Course 2|Adverse Event|1|||
164404101|NCT02323646|593850022|FG001|Treatment Course 2|Adverse Event|0|||
164404102|NCT02323646|593850023|FG002|Treatment Course 2|Adverse Event|1|||
164144042|NCT00086281|592888581|FG010|Phase 2|Adverse Event|0|||
164446652|NCT02409667|594004825|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
164446653|NCT02409667|594004826|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
164446654|NCT02409667|594004827|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
164446655|NCT02409667|594004828|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
164446656|NCT02409667|594004824|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
164446657|NCT02409667|594004825|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
164446658|NCT02409667|594004826|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
164446659|NCT02409667|594004827|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
164446660|NCT02409667|594004828|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
164446661|NCT02409667|594004824|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
164446662|NCT02409667|594004825|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
164446663|NCT02409667|594004826|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
164446664|NCT02409667|594004827|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
164446665|NCT02409667|594004828|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
164446666|NCT02409667|594004824|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
164446667|NCT02409667|594004825|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
164446668|NCT02409667|594004826|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
164446669|NCT02409667|594004827|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
164446670|NCT02409667|594004828|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
164446671|NCT02409667|594004824|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
164446672|NCT02409667|594004825|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
164446673|NCT02409667|594004826|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
164446674|NCT02409667|594004827|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
164446675|NCT02409667|594004828|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
164446676|NCT02409667|594004824|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
164446677|NCT02409667|594004825|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
164446678|NCT02409667|594004826|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
164446679|NCT02409667|594004827|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
164446680|NCT02409667|594004828|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
164446681|NCT01925339|594004829|FG000|Overall Study|Adverse Event|2|||
164446682|NCT01925339|594004830|FG001|Overall Study|Adverse Event|0|||
164446683|NCT02769858|594004836|FG000|Overall Study|Withdrawal by Subject|2|||
164446684|NCT04939246|594004839|FG000|After Treatment|Death|4|||
164446685|NCT04939246|594004839|FG000|After Treatment|Lost to Follow-up|1|||
164446686|NCT04939246|594004839|FG000|After Treatment|Discharged to hospice|2|||
164532212|NCT00615836|594320503|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
164532213|NCT00615836|594320504|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
164532214|NCT00615836|594320505|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
164532215|NCT00615836|594320501|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
164532216|NCT00615836|594320502|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
164532217|NCT00615836|594320503|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
164532218|NCT00615836|594320504|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
164532219|NCT00615836|594320505|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
164532220|NCT00615836|594320501|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
164532221|NCT00615836|594320502|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
164532222|NCT00615836|594320503|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
164532223|NCT00615836|594320504|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
164532224|NCT00615836|594320505|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
164532225|NCT00615836|594320501|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
164532226|NCT00615836|594320502|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
164532227|NCT00615836|594320503|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
164532228|NCT00615836|594320504|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
164532229|NCT00615836|594320505|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
164532230|NCT00615836|594320501|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
164532231|NCT00615836|594320502|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
164532232|NCT00615836|594320503|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
164532233|NCT00615836|594320504|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
164532234|NCT00615836|594320505|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
164532235|NCT00615836|594320501|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
164532236|NCT00615836|594320502|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
164532237|NCT00615836|594320503|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
164532238|NCT00615836|594320504|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
164532239|NCT00615836|594320505|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
164532240|NCT00615836|594320501|FG000|Extension Study (FE992026 CS31)|Other|10|||
164144043|NCT00086281|592888582|FG011|Phase 2|Adverse Event|0|||
164446687|NCT05505045|594007374|FG000|Overall Study|Withdrawal by Subject|2|||
164446688|NCT05505045|594007375|FG001|Overall Study|Withdrawal by Subject|1|||
164446689|NCT01643070|594007376|FG000|Overall Study|Withdrawal by Subject|3|||
164446690|NCT01643070|594007377|FG001|Overall Study|Withdrawal by Subject|1|||
164446691|NCT01643070|594007376|FG000|Overall Study|Death|1|||
164446692|NCT01643070|594007377|FG001|Overall Study|Death|0|||
164446693|NCT01643070|594007376|FG000|Overall Study|Pregressive disease|0|||
164446694|NCT01643070|594007377|FG001|Overall Study|Pregressive disease|2|||
164446695|NCT03025789|594007378|FG000|Overall Study|Lack of Efficacy|6|||
164446696|NCT03025789|594007379|FG001|Overall Study|Lack of Efficacy|1|||
164446697|NCT03025789|594007378|FG000|Overall Study|Death|1|||
164446698|NCT03025789|594007379|FG001|Overall Study|Death|0|||
164446699|NCT03025789|594007378|FG000|Overall Study|Withdrawal by Subject|0|||
164446700|NCT03025789|594007379|FG001|Overall Study|Withdrawal by Subject|2|||
164446701|NCT03554265|594007380|FG000|Overall Study|Withdrawal by Subject|2|||
164446702|NCT03554265|594007381|FG001|Overall Study|Withdrawal by Subject|2|||
164446703|NCT03554265|594007382|FG002|Overall Study|Withdrawal by Subject|3|||
164446704|NCT03554265|594007380|FG000|Overall Study|Physician Decision|0|||
164446705|NCT03554265|594007381|FG001|Overall Study|Physician Decision|0|||
164446706|NCT03554265|594007382|FG002|Overall Study|Physician Decision|1|||
164446707|NCT02723955|594007383|FG000|Escalation Phase|Death|1|||
164446708|NCT02723955|594007384|FG001|Escalation Phase|Death|1|||
164446709|NCT02723955|594007385|FG002|Escalation Phase|Death|2|||
164446710|NCT02723955|594007386|FG003|Escalation Phase|Death|7|||
164446711|NCT02723955|594007387|FG004|Escalation Phase|Death|18|||
164446712|NCT02723955|594007388|FG005|Escalation Phase|Death|17|||
164446713|NCT02723955|594007389|FG006|Escalation Phase|Death|11|||
164446714|NCT02723955|594007390|FG007|Escalation Phase|Death|21|||
164446715|NCT02723955|594007391|FG008|Escalation Phase|Death|3|||
164446716|NCT02723955|594007392|FG009|Escalation Phase|Death|0|||
164446717|NCT02723955|594007393|FG010|Escalation Phase|Death|0|||
164446718|NCT02723955|594007394|FG011|Escalation Phase|Death|0|||
164446719|NCT02723955|594007395|FG012|Escalation Phase|Death|2|||
164446720|NCT02723955|594007396|FG013|Escalation Phase|Death|4|||
164446721|NCT02723955|594007397|FG014|Escalation Phase|Death|5|||
164446722|NCT02723955|594007398|FG015|Escalation Phase|Death|6|||
164446723|NCT02723955|594007399|FG016|Escalation Phase|Death|6|||
164446724|NCT02723955|594007400|FG017|Escalation Phase|Death|7|||
164446725|NCT02723955|594007401|FG018|Escalation Phase|Death|1|||
164446726|NCT02723955|594007402|FG019|Escalation Phase|Death|3|||
164446727|NCT02723955|594007403|FG020|Escalation Phase|Death|13|||
164446728|NCT02723955|594007404|FG021|Escalation Phase|Death|3|||
164446729|NCT02723955|594007405|FG022|Escalation Phase|Death|2|||
164446730|NCT02723955|594007406|FG023|Escalation Phase|Death|4|||
164446731|NCT02723955|594007407|FG024|Escalation Phase|Death|31|||
164446732|NCT02723955|594007408|FG025|Escalation Phase|Death|7|||
164446733|NCT02723955|594007409|FG026|Escalation Phase|Death|13|||
164446734|NCT02723955|594007410|FG027|Escalation Phase|Death|0|||
164446735|NCT02723955|594007411|FG028|Escalation Phase|Death|1|||
164446736|NCT02723955|594007412|FG029|Escalation Phase|Death|0|||
164446737|NCT02723955|594007413|FG030|Escalation Phase|Death|0|||
164446738|NCT02723955|594007414|FG031|Escalation Phase|Death|0|||
164446739|NCT02723955|594007415|FG032|Escalation Phase|Death|0|||
164446740|NCT02723955|594007416|FG033|Escalation Phase|Death|0|||
164446741|NCT02723955|594007417|FG034|Escalation Phase|Death|0|||
164446742|NCT02723955|594007418|FG035|Escalation Phase|Death|0|||
164596905|NCT02052778|594549011|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164596906|NCT02052778|594549012|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164596907|NCT02052778|594549013|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164596908|NCT02052778|594549014|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164596909|NCT02052778|594549015|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164596910|NCT02052778|594548993|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
164596911|NCT02052778|594548994|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
164596912|NCT02052778|594548995|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
164446743|NCT02723955|594007419|FG036|Escalation Phase|Death|0|||
164446744|NCT02723955|594007420|FG037|Escalation Phase|Death|0|||
164446745|NCT02723955|594007421|FG038|Escalation Phase|Death|0|||
164446746|NCT02723955|594007422|FG039|Escalation Phase|Death|0|||
164446747|NCT02723955|594007423|FG040|Escalation Phase|Death|0|||
164446748|NCT02723955|594007424|FG041|Escalation Phase|Death|0|||
164446749|NCT02723955|594007425|FG042|Escalation Phase|Death|0|||
164446750|NCT02723955|594007383|FG000|Escalation Phase|Lost to Follow-up|0|||
164446751|NCT02723955|594007384|FG001|Escalation Phase|Lost to Follow-up|0|||
164446752|NCT02723955|594007385|FG002|Escalation Phase|Lost to Follow-up|0|||
164446753|NCT02723955|594007386|FG003|Escalation Phase|Lost to Follow-up|0|||
164596913|NCT02052778|594548996|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
164446754|NCT02723955|594007387|FG004|Escalation Phase|Lost to Follow-up|0|||
164446755|NCT02723955|594007388|FG005|Escalation Phase|Lost to Follow-up|2|||
164446756|NCT02723955|594007389|FG006|Escalation Phase|Lost to Follow-up|1|||
164446757|NCT02723955|594007390|FG007|Escalation Phase|Lost to Follow-up|1|||
164446758|NCT02723955|594007391|FG008|Escalation Phase|Lost to Follow-up|1|||
164446759|NCT02723955|594007392|FG009|Escalation Phase|Lost to Follow-up|0|||
164446760|NCT02723955|594007393|FG010|Escalation Phase|Lost to Follow-up|0|||
164446761|NCT02723955|594007394|FG011|Escalation Phase|Lost to Follow-up|0|||
164446762|NCT02723955|594007395|FG012|Escalation Phase|Lost to Follow-up|1|||
164446763|NCT02723955|594007396|FG013|Escalation Phase|Lost to Follow-up|0|||
164446764|NCT02723955|594007397|FG014|Escalation Phase|Lost to Follow-up|0|||
164446765|NCT02723955|594007398|FG015|Escalation Phase|Lost to Follow-up|0|||
164446766|NCT02723955|594007399|FG016|Escalation Phase|Lost to Follow-up|1|||
164446767|NCT02723955|594007400|FG017|Escalation Phase|Lost to Follow-up|2|||
164446768|NCT02723955|594007401|FG018|Escalation Phase|Lost to Follow-up|0|||
164446769|NCT02723955|594007402|FG019|Escalation Phase|Lost to Follow-up|1|||
164446770|NCT02723955|594007403|FG020|Escalation Phase|Lost to Follow-up|2|||
164446771|NCT02723955|594007404|FG021|Escalation Phase|Lost to Follow-up|1|||
164446772|NCT02723955|594007405|FG022|Escalation Phase|Lost to Follow-up|0|||
164446773|NCT02723955|594007406|FG023|Escalation Phase|Lost to Follow-up|0|||
164446774|NCT02723955|594007407|FG024|Escalation Phase|Lost to Follow-up|1|||
164446775|NCT02723955|594007408|FG025|Escalation Phase|Lost to Follow-up|1|||
164446776|NCT02723955|594007409|FG026|Escalation Phase|Lost to Follow-up|3|||
164446777|NCT02723955|594007410|FG027|Escalation Phase|Lost to Follow-up|0|||
164446778|NCT02723955|594007411|FG028|Escalation Phase|Lost to Follow-up|1|||
164446779|NCT02723955|594007412|FG029|Escalation Phase|Lost to Follow-up|0|||
164446780|NCT02723955|594007413|FG030|Escalation Phase|Lost to Follow-up|0|||
164446781|NCT02723955|594007414|FG031|Escalation Phase|Lost to Follow-up|0|||
164446782|NCT02723955|594007415|FG032|Escalation Phase|Lost to Follow-up|0|||
164446783|NCT02723955|594007416|FG033|Escalation Phase|Lost to Follow-up|0|||
164446784|NCT02723955|594007417|FG034|Escalation Phase|Lost to Follow-up|0|||
164446785|NCT02723955|594007418|FG035|Escalation Phase|Lost to Follow-up|0|||
164446786|NCT02723955|594007419|FG036|Escalation Phase|Lost to Follow-up|0|||
164446787|NCT02723955|594007420|FG037|Escalation Phase|Lost to Follow-up|0|||
164446788|NCT02723955|594007421|FG038|Escalation Phase|Lost to Follow-up|0|||
164446789|NCT02723955|594007422|FG039|Escalation Phase|Lost to Follow-up|0|||
164446790|NCT02723955|594007423|FG040|Escalation Phase|Lost to Follow-up|0|||
164446791|NCT02723955|594007424|FG041|Escalation Phase|Lost to Follow-up|0|||
164446792|NCT02723955|594007425|FG042|Escalation Phase|Lost to Follow-up|0|||
164446793|NCT02723955|594007383|FG000|Escalation Phase|Physician Decision|0|||
164446794|NCT02723955|594007384|FG001|Escalation Phase|Physician Decision|0|||
164446795|NCT02723955|594007385|FG002|Escalation Phase|Physician Decision|0|||
164404103|NCT02323646|593850021|FG000|Treatment Course 2|Lost to Follow-up|0|||
164404104|NCT02323646|593850022|FG001|Treatment Course 2|Lost to Follow-up|0|||
164404105|NCT02323646|593850023|FG002|Treatment Course 2|Lost to Follow-up|1|||
164404106|NCT02323646|593850021|FG000|Treatment Course 2|Non-compliance|0|||
164404107|NCT02323646|593850022|FG001|Treatment Course 2|Non-compliance|1|||
164404108|NCT02323646|593850023|FG002|Treatment Course 2|Non-compliance|1|||
164404109|NCT01370525|593850024|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
164404110|NCT01370525|593850025|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
164404111|NCT01370525|593850024|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
164404112|NCT01370525|593850025|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164404113|NCT01370525|593850024|FG000|Overall Study|Adverse Event|0|||
164404114|NCT01370525|593850025|FG001|Overall Study|Adverse Event|1|||
164404115|NCT01370525|593850024|FG000|Overall Study|Protocol Violation|2|||
164404116|NCT01370525|593850025|FG001|Overall Study|Protocol Violation|1|||
164404117|NCT01370525|593850024|FG000|Overall Study|Lost to follow up|2|||
164404118|NCT01370525|593850025|FG001|Overall Study|Lost to follow up|6|||
164404119|NCT02459262|593850026|FG000|Overall Study|Withdrawal by Subject|0|||
164404120|NCT02459262|593850027|FG001|Overall Study|Withdrawal by Subject|0|||
164404121|NCT02459262|593850028|FG002|Overall Study|Withdrawal by Subject|0|||
164404122|NCT02459262|593850029|FG003|Overall Study|Withdrawal by Subject|0|||
164404123|NCT02459262|593850030|FG004|Overall Study|Withdrawal by Subject|0|||
164404124|NCT02459262|593850031|FG005|Overall Study|Withdrawal by Subject|0|||
164404125|NCT02459262|593850032|FG006|Overall Study|Withdrawal by Subject|0|||
164404126|NCT02459262|593850033|FG007|Overall Study|Withdrawal by Subject|0|||
164404127|NCT02459262|593850034|FG008|Overall Study|Withdrawal by Subject|0|||
164404128|NCT02459262|593850035|FG009|Overall Study|Withdrawal by Subject|1|||
164404129|NCT02459262|593850036|FG010|Overall Study|Withdrawal by Subject|0|||
164404130|NCT05168579|593850037|FG000|Overall Study|Lack of Consent|1|||
164404131|NCT05168579|593850038|FG001|Overall Study|Lack of Consent|0|||
164446796|NCT02723955|594007386|FG003|Escalation Phase|Physician Decision|0|||
164404132|NCT05168579|593850037|FG000|Overall Study|Conflicts with time|2|||
164404133|NCT05168579|593850038|FG001|Overall Study|Conflicts with time|0|||
164404134|NCT05168579|593850037|FG000|Overall Study|Time slots were full|3|||
164446797|NCT02723955|594007387|FG004|Escalation Phase|Physician Decision|0|||
164446798|NCT02723955|594007388|FG005|Escalation Phase|Physician Decision|2|||
164446799|NCT02723955|594007389|FG006|Escalation Phase|Physician Decision|0|||
164446800|NCT02723955|594007390|FG007|Escalation Phase|Physician Decision|0|||
164446801|NCT02723955|594007391|FG008|Escalation Phase|Physician Decision|0|||
164446802|NCT02723955|594007392|FG009|Escalation Phase|Physician Decision|0|||
164446803|NCT02723955|594007393|FG010|Escalation Phase|Physician Decision|0|||
164446804|NCT02723955|594007394|FG011|Escalation Phase|Physician Decision|0|||
164446805|NCT02723955|594007395|FG012|Escalation Phase|Physician Decision|0|||
164446806|NCT02723955|594007396|FG013|Escalation Phase|Physician Decision|0|||
164446807|NCT02723955|594007397|FG014|Escalation Phase|Physician Decision|0|||
164446808|NCT02723955|594007398|FG015|Escalation Phase|Physician Decision|0|||
164446809|NCT02723955|594007399|FG016|Escalation Phase|Physician Decision|0|||
164446810|NCT02723955|594007400|FG017|Escalation Phase|Physician Decision|0|||
164446811|NCT02723955|594007401|FG018|Escalation Phase|Physician Decision|0|||
164446812|NCT02723955|594007402|FG019|Escalation Phase|Physician Decision|0|||
164446813|NCT02723955|594007403|FG020|Escalation Phase|Physician Decision|0|||
164446814|NCT02723955|594007404|FG021|Escalation Phase|Physician Decision|0|||
164446815|NCT02723955|594007405|FG022|Escalation Phase|Physician Decision|0|||
164446816|NCT02723955|594007406|FG023|Escalation Phase|Physician Decision|0|||
164446817|NCT02723955|594007407|FG024|Escalation Phase|Physician Decision|0|||
164446818|NCT02723955|594007408|FG025|Escalation Phase|Physician Decision|0|||
164446819|NCT02723955|594007409|FG026|Escalation Phase|Physician Decision|2|||
164446820|NCT02723955|594007410|FG027|Escalation Phase|Physician Decision|0|||
164446821|NCT02723955|594007411|FG028|Escalation Phase|Physician Decision|0|||
164446822|NCT02723955|594007412|FG029|Escalation Phase|Physician Decision|0|||
164446823|NCT02723955|594007413|FG030|Escalation Phase|Physician Decision|0|||
164446824|NCT02723955|594007414|FG031|Escalation Phase|Physician Decision|0|||
164446825|NCT02723955|594007415|FG032|Escalation Phase|Physician Decision|0|||
164446826|NCT02723955|594007416|FG033|Escalation Phase|Physician Decision|0|||
164446827|NCT02723955|594007417|FG034|Escalation Phase|Physician Decision|0|||
164446828|NCT02723955|594007418|FG035|Escalation Phase|Physician Decision|0|||
164446829|NCT02723955|594007419|FG036|Escalation Phase|Physician Decision|0|||
164446830|NCT02723955|594007420|FG037|Escalation Phase|Physician Decision|0|||
164446831|NCT02723955|594007421|FG038|Escalation Phase|Physician Decision|0|||
164446832|NCT02723955|594007422|FG039|Escalation Phase|Physician Decision|0|||
164446833|NCT02723955|594007423|FG040|Escalation Phase|Physician Decision|0|||
164446834|NCT02723955|594007424|FG041|Escalation Phase|Physician Decision|0|||
164446835|NCT02723955|594007425|FG042|Escalation Phase|Physician Decision|0|||
164446836|NCT02723955|594007383|FG000|Escalation Phase|Withdrawal by Subject|0|||
164446837|NCT02723955|594007384|FG001|Escalation Phase|Withdrawal by Subject|0|||
164446838|NCT02723955|594007385|FG002|Escalation Phase|Withdrawal by Subject|0|||
164446839|NCT02723955|594007386|FG003|Escalation Phase|Withdrawal by Subject|0|||
164446840|NCT02723955|594007387|FG004|Escalation Phase|Withdrawal by Subject|1|||
164446841|NCT02723955|594007388|FG005|Escalation Phase|Withdrawal by Subject|1|||
164446842|NCT02723955|594007389|FG006|Escalation Phase|Withdrawal by Subject|1|||
164446843|NCT02723955|594007390|FG007|Escalation Phase|Withdrawal by Subject|1|||
164446844|NCT02723955|594007391|FG008|Escalation Phase|Withdrawal by Subject|0|||
164446845|NCT02723955|594007392|FG009|Escalation Phase|Withdrawal by Subject|0|||
164446846|NCT02723955|594007393|FG010|Escalation Phase|Withdrawal by Subject|0|||
164446847|NCT02723955|594007394|FG011|Escalation Phase|Withdrawal by Subject|0|||
164446848|NCT02723955|594007395|FG012|Escalation Phase|Withdrawal by Subject|1|||
164446849|NCT02723955|594007396|FG013|Escalation Phase|Withdrawal by Subject|0|||
164446850|NCT02723955|594007397|FG014|Escalation Phase|Withdrawal by Subject|0|||
164446851|NCT02723955|594007398|FG015|Escalation Phase|Withdrawal by Subject|0|||
164446852|NCT02723955|594007399|FG016|Escalation Phase|Withdrawal by Subject|1|||
164446853|NCT02723955|594007400|FG017|Escalation Phase|Withdrawal by Subject|0|||
164446854|NCT02723955|594007401|FG018|Escalation Phase|Withdrawal by Subject|0|||
164446855|NCT02723955|594007402|FG019|Escalation Phase|Withdrawal by Subject|0|||
164446856|NCT02723955|594007403|FG020|Escalation Phase|Withdrawal by Subject|0|||
164446857|NCT02723955|594007404|FG021|Escalation Phase|Withdrawal by Subject|0|||
164446858|NCT02723955|594007405|FG022|Escalation Phase|Withdrawal by Subject|0|||
164446859|NCT02723955|594007406|FG023|Escalation Phase|Withdrawal by Subject|2|||
164446860|NCT02723955|594007407|FG024|Escalation Phase|Withdrawal by Subject|0|||
164446861|NCT02723955|594007408|FG025|Escalation Phase|Withdrawal by Subject|1|||
164446862|NCT02723955|594007409|FG026|Escalation Phase|Withdrawal by Subject|0|||
164446863|NCT02723955|594007410|FG027|Escalation Phase|Withdrawal by Subject|0|||
164446864|NCT02723955|594007411|FG028|Escalation Phase|Withdrawal by Subject|1|||
164446865|NCT02723955|594007412|FG029|Escalation Phase|Withdrawal by Subject|0|||
164446866|NCT02723955|594007413|FG030|Escalation Phase|Withdrawal by Subject|0|||
164446867|NCT02723955|594007414|FG031|Escalation Phase|Withdrawal by Subject|0|||
164446868|NCT02723955|594007415|FG032|Escalation Phase|Withdrawal by Subject|0|||
164446869|NCT02723955|594007416|FG033|Escalation Phase|Withdrawal by Subject|0|||
164446870|NCT02723955|594007417|FG034|Escalation Phase|Withdrawal by Subject|0|||
164446871|NCT02723955|594007418|FG035|Escalation Phase|Withdrawal by Subject|0|||
164446872|NCT02723955|594007419|FG036|Escalation Phase|Withdrawal by Subject|0|||
164446873|NCT02723955|594007420|FG037|Escalation Phase|Withdrawal by Subject|0|||
164446874|NCT02723955|594007421|FG038|Escalation Phase|Withdrawal by Subject|0|||
164446875|NCT02723955|594007422|FG039|Escalation Phase|Withdrawal by Subject|0|||
164446876|NCT02723955|594007423|FG040|Escalation Phase|Withdrawal by Subject|0|||
164446877|NCT02723955|594007424|FG041|Escalation Phase|Withdrawal by Subject|0|||
164446878|NCT02723955|594007425|FG042|Escalation Phase|Withdrawal by Subject|0|||
164446879|NCT02723955|594007383|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446880|NCT02723955|594007384|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446881|NCT02723955|594007385|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446882|NCT02723955|594007386|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446883|NCT02723955|594007387|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
164446884|NCT02723955|594007388|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
164446885|NCT02723955|594007389|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
164446886|NCT02723955|594007390|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
164446887|NCT02723955|594007391|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
164446888|NCT02723955|594007392|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446889|NCT02723955|594007393|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446890|NCT02723955|594007394|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446891|NCT02723955|594007395|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446892|NCT02723955|594007396|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446893|NCT02723955|594007397|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446894|NCT02723955|594007398|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446895|NCT02723955|594007399|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446896|NCT02723955|594007400|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446897|NCT02723955|594007401|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446898|NCT02723955|594007402|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446899|NCT02723955|594007403|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446900|NCT02723955|594007404|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446901|NCT02723955|594007405|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446902|NCT02723955|594007406|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446903|NCT02723955|594007407|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446904|NCT02723955|594007408|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446905|NCT02723955|594007409|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446906|NCT02723955|594007410|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446907|NCT02723955|594007411|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446908|NCT02723955|594007412|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446909|NCT02723955|594007413|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446910|NCT02723955|594007414|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446911|NCT02723955|594007415|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446912|NCT02723955|594007416|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446913|NCT02723955|594007417|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446914|NCT02723955|594007418|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446915|NCT02723955|594007419|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446916|NCT02723955|594007420|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446917|NCT02723955|594007421|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446918|NCT02723955|594007422|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446919|NCT02723955|594007423|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446920|NCT02723955|594007424|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446921|NCT02723955|594007425|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164446922|NCT02723955|594007383|FG000|Escalation Phase|Site Closed|0|||
164446923|NCT02723955|594007384|FG001|Escalation Phase|Site Closed|0|||
164446924|NCT02723955|594007385|FG002|Escalation Phase|Site Closed|0|||
164446925|NCT02723955|594007386|FG003|Escalation Phase|Site Closed|0|||
164446926|NCT02723955|594007387|FG004|Escalation Phase|Site Closed|0|||
164596914|NCT02052778|594548997|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
164596915|NCT02052778|594548998|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
164596916|NCT02052778|594548999|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
164596917|NCT02052778|594549000|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
164596918|NCT02052778|594549001|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
164596919|NCT02052778|594549002|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
164596920|NCT02052778|594549003|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
164596921|NCT02052778|594549004|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
164446927|NCT02723955|594007388|FG005|Escalation Phase|Site Closed|0|||
164446928|NCT02723955|594007389|FG006|Escalation Phase|Site Closed|0|||
164446929|NCT02723955|594007390|FG007|Escalation Phase|Site Closed|0|||
164446930|NCT02723955|594007391|FG008|Escalation Phase|Site Closed|0|||
164446931|NCT02723955|594007392|FG009|Escalation Phase|Site Closed|0|||
164446932|NCT02723955|594007393|FG010|Escalation Phase|Site Closed|0|||
164446933|NCT02723955|594007394|FG011|Escalation Phase|Site Closed|0|||
164446934|NCT02723955|594007395|FG012|Escalation Phase|Site Closed|0|||
164446935|NCT02723955|594007396|FG013|Escalation Phase|Site Closed|0|||
164446936|NCT02723955|594007397|FG014|Escalation Phase|Site Closed|0|||
164446937|NCT02723955|594007398|FG015|Escalation Phase|Site Closed|1|||
164446938|NCT02723955|594007399|FG016|Escalation Phase|Site Closed|0|||
164446939|NCT02723955|594007400|FG017|Escalation Phase|Site Closed|2|||
164446940|NCT02723955|594007401|FG018|Escalation Phase|Site Closed|0|||
164446941|NCT02723955|594007402|FG019|Escalation Phase|Site Closed|0|||
164446942|NCT02723955|594007403|FG020|Escalation Phase|Site Closed|1|||
164446943|NCT02723955|594007404|FG021|Escalation Phase|Site Closed|0|||
164446944|NCT02723955|594007405|FG022|Escalation Phase|Site Closed|0|||
164446945|NCT02723955|594007406|FG023|Escalation Phase|Site Closed|0|||
164446946|NCT02723955|594007407|FG024|Escalation Phase|Site Closed|3|||
164446947|NCT02723955|594007408|FG025|Escalation Phase|Site Closed|1|||
164446948|NCT02723955|594007409|FG026|Escalation Phase|Site Closed|3|||
164446949|NCT02723955|594007410|FG027|Escalation Phase|Site Closed|1|||
164446950|NCT02723955|594007411|FG028|Escalation Phase|Site Closed|1|||
164446951|NCT02723955|594007412|FG029|Escalation Phase|Site Closed|0|||
164446952|NCT02723955|594007413|FG030|Escalation Phase|Site Closed|0|||
164446953|NCT02723955|594007414|FG031|Escalation Phase|Site Closed|0|||
164446954|NCT02723955|594007415|FG032|Escalation Phase|Site Closed|0|||
164446955|NCT02723955|594007416|FG033|Escalation Phase|Site Closed|0|||
164446956|NCT02723955|594007417|FG034|Escalation Phase|Site Closed|0|||
164446957|NCT02723955|594007418|FG035|Escalation Phase|Site Closed|0|||
164446958|NCT02723955|594007419|FG036|Escalation Phase|Site Closed|0|||
164446959|NCT02723955|594007420|FG037|Escalation Phase|Site Closed|0|||
164446960|NCT02723955|594007421|FG038|Escalation Phase|Site Closed|0|||
164446961|NCT02723955|594007422|FG039|Escalation Phase|Site Closed|0|||
164446962|NCT02723955|594007423|FG040|Escalation Phase|Site Closed|0|||
164446963|NCT02723955|594007424|FG041|Escalation Phase|Site Closed|0|||
164446964|NCT02723955|594007425|FG042|Escalation Phase|Site Closed|0|||
164446965|NCT02723955|594007383|FG000|Expansion Phase|Death|0|||
164446966|NCT02723955|594007384|FG001|Expansion Phase|Death|0|||
164446967|NCT02723955|594007385|FG002|Expansion Phase|Death|0|||
164446968|NCT02723955|594007386|FG003|Expansion Phase|Death|0|||
164446969|NCT02723955|594007387|FG004|Expansion Phase|Death|0|||
164446970|NCT02723955|594007388|FG005|Expansion Phase|Death|0|||
164446971|NCT02723955|594007389|FG006|Expansion Phase|Death|0|||
164446972|NCT02723955|594007390|FG007|Expansion Phase|Death|0|||
164446973|NCT02723955|594007391|FG008|Expansion Phase|Death|0|||
164446974|NCT02723955|594007392|FG009|Expansion Phase|Death|25|||
164446975|NCT02723955|594007393|FG010|Expansion Phase|Death|69|||
164446976|NCT02723955|594007394|FG011|Expansion Phase|Death|48|||
164446977|NCT02723955|594007395|FG012|Expansion Phase|Death|0|||
164446978|NCT02723955|594007396|FG013|Expansion Phase|Death|0|||
164446979|NCT02723955|594007397|FG014|Expansion Phase|Death|0|||
164446980|NCT02723955|594007398|FG015|Expansion Phase|Death|0|||
164446981|NCT02723955|594007399|FG016|Expansion Phase|Death|0|||
164446982|NCT02723955|594007400|FG017|Expansion Phase|Death|0|||
164446983|NCT02723955|594007401|FG018|Expansion Phase|Death|0|||
164446984|NCT02723955|594007402|FG019|Expansion Phase|Death|0|||
164596922|NCT02052778|594549005|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
164446985|NCT02723955|594007403|FG020|Expansion Phase|Death|0|||
164446986|NCT02723955|594007404|FG021|Expansion Phase|Death|0|||
164446987|NCT02723955|594007405|FG022|Expansion Phase|Death|0|||
164446988|NCT02723955|594007406|FG023|Expansion Phase|Death|0|||
164446989|NCT02723955|594007407|FG024|Expansion Phase|Death|0|||
164446990|NCT02723955|594007408|FG025|Expansion Phase|Death|0|||
164446991|NCT02723955|594007409|FG026|Expansion Phase|Death|0|||
164446992|NCT02723955|594007410|FG027|Expansion Phase|Death|0|||
164446993|NCT02723955|594007411|FG028|Expansion Phase|Death|0|||
164446994|NCT02723955|594007412|FG029|Expansion Phase|Death|12|||
164446995|NCT02723955|594007413|FG030|Expansion Phase|Death|202|||
164446996|NCT02723955|594007414|FG031|Expansion Phase|Death|31|||
164446997|NCT02723955|594007415|FG032|Expansion Phase|Death|17|||
164446998|NCT02723955|594007416|FG033|Expansion Phase|Death|2|||
164446999|NCT02723955|594007417|FG034|Expansion Phase|Death|3|||
164447000|NCT02723955|594007418|FG035|Expansion Phase|Death|3|||
164447001|NCT02723955|594007419|FG036|Expansion Phase|Death|1|||
164596923|NCT02052778|594549006|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
164596924|NCT02052778|594549007|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
164596925|NCT02052778|594549008|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
164596926|NCT02052778|594549009|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
164596927|NCT02052778|594549010|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
164447002|NCT02723955|594007420|FG037|Expansion Phase|Death|0|||
164447003|NCT02723955|594007421|FG038|Expansion Phase|Death|0|||
164447004|NCT02723955|594007422|FG039|Expansion Phase|Death|0|||
164447005|NCT02723955|594007423|FG040|Expansion Phase|Death|0|||
164447006|NCT02723955|594007424|FG041|Expansion Phase|Death|0|||
164447007|NCT02723955|594007425|FG042|Expansion Phase|Death|0|||
164447008|NCT02723955|594007383|FG000|Expansion Phase|Lost to Follow-up|0|||
164447009|NCT02723955|594007384|FG001|Expansion Phase|Lost to Follow-up|0|||
164447010|NCT02723955|594007385|FG002|Expansion Phase|Lost to Follow-up|0|||
164447011|NCT02723955|594007386|FG003|Expansion Phase|Lost to Follow-up|0|||
164447012|NCT02723955|594007387|FG004|Expansion Phase|Lost to Follow-up|0|||
164447013|NCT02723955|594007388|FG005|Expansion Phase|Lost to Follow-up|0|||
164447014|NCT02723955|594007389|FG006|Expansion Phase|Lost to Follow-up|0|||
164447015|NCT02723955|594007390|FG007|Expansion Phase|Lost to Follow-up|0|||
164447016|NCT02723955|594007391|FG008|Expansion Phase|Lost to Follow-up|0|||
164447017|NCT02723955|594007392|FG009|Expansion Phase|Lost to Follow-up|0|||
164447018|NCT02723955|594007393|FG010|Expansion Phase|Lost to Follow-up|4|||
164447019|NCT02723955|594007394|FG011|Expansion Phase|Lost to Follow-up|1|||
164447020|NCT02723955|594007395|FG012|Expansion Phase|Lost to Follow-up|0|||
164447021|NCT02723955|594007396|FG013|Expansion Phase|Lost to Follow-up|0|||
164447022|NCT02723955|594007397|FG014|Expansion Phase|Lost to Follow-up|0|||
164447023|NCT02723955|594007398|FG015|Expansion Phase|Lost to Follow-up|0|||
164447024|NCT02723955|594007399|FG016|Expansion Phase|Lost to Follow-up|0|||
164447025|NCT02723955|594007400|FG017|Expansion Phase|Lost to Follow-up|0|||
164447026|NCT02723955|594007401|FG018|Expansion Phase|Lost to Follow-up|0|||
164447027|NCT02723955|594007402|FG019|Expansion Phase|Lost to Follow-up|0|||
164447028|NCT02723955|594007403|FG020|Expansion Phase|Lost to Follow-up|0|||
164447029|NCT02723955|594007404|FG021|Expansion Phase|Lost to Follow-up|0|||
164447030|NCT02723955|594007405|FG022|Expansion Phase|Lost to Follow-up|0|||
164447031|NCT02723955|594007406|FG023|Expansion Phase|Lost to Follow-up|0|||
164447032|NCT02723955|594007407|FG024|Expansion Phase|Lost to Follow-up|0|||
164447033|NCT02723955|594007408|FG025|Expansion Phase|Lost to Follow-up|0|||
164447034|NCT02723955|594007409|FG026|Expansion Phase|Lost to Follow-up|0|||
164447035|NCT02723955|594007410|FG027|Expansion Phase|Lost to Follow-up|0|||
164447036|NCT02723955|594007411|FG028|Expansion Phase|Lost to Follow-up|0|||
164447037|NCT02723955|594007412|FG029|Expansion Phase|Lost to Follow-up|1|||
164447038|NCT02723955|594007413|FG030|Expansion Phase|Lost to Follow-up|19|||
164447039|NCT02723955|594007414|FG031|Expansion Phase|Lost to Follow-up|2|||
164447040|NCT02723955|594007415|FG032|Expansion Phase|Lost to Follow-up|1|||
164447041|NCT02723955|594007416|FG033|Expansion Phase|Lost to Follow-up|0|||
164447042|NCT02723955|594007417|FG034|Expansion Phase|Lost to Follow-up|0|||
164447043|NCT02723955|594007418|FG035|Expansion Phase|Lost to Follow-up|0|||
164447044|NCT02723955|594007419|FG036|Expansion Phase|Lost to Follow-up|0|||
164447045|NCT02723955|594007420|FG037|Expansion Phase|Lost to Follow-up|0|||
164447046|NCT02723955|594007421|FG038|Expansion Phase|Lost to Follow-up|0|||
164447047|NCT02723955|594007422|FG039|Expansion Phase|Lost to Follow-up|0|||
164447048|NCT02723955|594007423|FG040|Expansion Phase|Lost to Follow-up|0|||
164447049|NCT02723955|594007424|FG041|Expansion Phase|Lost to Follow-up|0|||
164447050|NCT02723955|594007425|FG042|Expansion Phase|Lost to Follow-up|0|||
164447051|NCT02723955|594007383|FG000|Expansion Phase|Physician Decision|0|||
164447052|NCT02723955|594007384|FG001|Expansion Phase|Physician Decision|0|||
164447053|NCT02723955|594007385|FG002|Expansion Phase|Physician Decision|0|||
164447054|NCT02723955|594007386|FG003|Expansion Phase|Physician Decision|0|||
164447055|NCT02723955|594007387|FG004|Expansion Phase|Physician Decision|0|||
164447056|NCT02723955|594007388|FG005|Expansion Phase|Physician Decision|0|||
164447057|NCT02723955|594007389|FG006|Expansion Phase|Physician Decision|0|||
164447058|NCT02723955|594007390|FG007|Expansion Phase|Physician Decision|0|||
164447059|NCT02723955|594007391|FG008|Expansion Phase|Physician Decision|0|||
164447060|NCT02723955|594007392|FG009|Expansion Phase|Physician Decision|0|||
164447061|NCT02723955|594007393|FG010|Expansion Phase|Physician Decision|0|||
164447062|NCT02723955|594007394|FG011|Expansion Phase|Physician Decision|0|||
164447063|NCT02723955|594007395|FG012|Expansion Phase|Physician Decision|0|||
164447064|NCT02723955|594007396|FG013|Expansion Phase|Physician Decision|0|||
164447065|NCT02723955|594007397|FG014|Expansion Phase|Physician Decision|0|||
164447066|NCT02723955|594007398|FG015|Expansion Phase|Physician Decision|0|||
164447067|NCT02723955|594007399|FG016|Expansion Phase|Physician Decision|0|||
164447068|NCT02723955|594007400|FG017|Expansion Phase|Physician Decision|0|||
164447069|NCT02723955|594007401|FG018|Expansion Phase|Physician Decision|0|||
164447070|NCT02723955|594007402|FG019|Expansion Phase|Physician Decision|0|||
164447071|NCT02723955|594007403|FG020|Expansion Phase|Physician Decision|0|||
164447072|NCT02723955|594007404|FG021|Expansion Phase|Physician Decision|0|||
164447073|NCT02723955|594007405|FG022|Expansion Phase|Physician Decision|0|||
164447074|NCT02723955|594007406|FG023|Expansion Phase|Physician Decision|0|||
164447075|NCT02723955|594007407|FG024|Expansion Phase|Physician Decision|0|||
164447076|NCT02723955|594007408|FG025|Expansion Phase|Physician Decision|0|||
164447077|NCT02723955|594007409|FG026|Expansion Phase|Physician Decision|0|||
164447078|NCT02723955|594007410|FG027|Expansion Phase|Physician Decision|0|||
164447079|NCT02723955|594007411|FG028|Expansion Phase|Physician Decision|0|||
164447080|NCT02723955|594007412|FG029|Expansion Phase|Physician Decision|0|||
164447081|NCT02723955|594007413|FG030|Expansion Phase|Physician Decision|1|||
164447082|NCT02723955|594007414|FG031|Expansion Phase|Physician Decision|1|||
164447083|NCT02723955|594007415|FG032|Expansion Phase|Physician Decision|0|||
164447084|NCT02723955|594007416|FG033|Expansion Phase|Physician Decision|0|||
164447085|NCT02723955|594007417|FG034|Expansion Phase|Physician Decision|0|||
164447086|NCT02723955|594007418|FG035|Expansion Phase|Physician Decision|0|||
164447087|NCT02723955|594007419|FG036|Expansion Phase|Physician Decision|0|||
164447088|NCT02723955|594007420|FG037|Expansion Phase|Physician Decision|0|||
164447089|NCT02723955|594007421|FG038|Expansion Phase|Physician Decision|0|||
164447090|NCT02723955|594007422|FG039|Expansion Phase|Physician Decision|0|||
164447091|NCT02723955|594007423|FG040|Expansion Phase|Physician Decision|0|||
164447092|NCT02723955|594007424|FG041|Expansion Phase|Physician Decision|0|||
164447093|NCT02723955|594007425|FG042|Expansion Phase|Physician Decision|0|||
164447094|NCT02723955|594007383|FG000|Expansion Phase|Withdrawal by Subject|0|||
164447095|NCT02723955|594007384|FG001|Expansion Phase|Withdrawal by Subject|0|||
164447096|NCT02723955|594007385|FG002|Expansion Phase|Withdrawal by Subject|0|||
164447097|NCT02723955|594007386|FG003|Expansion Phase|Withdrawal by Subject|0|||
164447098|NCT02723955|594007387|FG004|Expansion Phase|Withdrawal by Subject|0|||
164447099|NCT02723955|594007388|FG005|Expansion Phase|Withdrawal by Subject|0|||
164447100|NCT02723955|594007389|FG006|Expansion Phase|Withdrawal by Subject|0|||
164447101|NCT02723955|594007390|FG007|Expansion Phase|Withdrawal by Subject|0|||
164447102|NCT02723955|594007391|FG008|Expansion Phase|Withdrawal by Subject|0|||
164447103|NCT02723955|594007392|FG009|Expansion Phase|Withdrawal by Subject|2|||
164447104|NCT02723955|594007393|FG010|Expansion Phase|Withdrawal by Subject|1|||
164447105|NCT02723955|594007394|FG011|Expansion Phase|Withdrawal by Subject|0|||
164447106|NCT02723955|594007395|FG012|Expansion Phase|Withdrawal by Subject|0|||
164447107|NCT02723955|594007396|FG013|Expansion Phase|Withdrawal by Subject|0|||
164447108|NCT02723955|594007397|FG014|Expansion Phase|Withdrawal by Subject|0|||
164447109|NCT02723955|594007398|FG015|Expansion Phase|Withdrawal by Subject|0|||
164447110|NCT02723955|594007399|FG016|Expansion Phase|Withdrawal by Subject|0|||
164447111|NCT02723955|594007400|FG017|Expansion Phase|Withdrawal by Subject|0|||
164447112|NCT02723955|594007401|FG018|Expansion Phase|Withdrawal by Subject|0|||
164447113|NCT02723955|594007402|FG019|Expansion Phase|Withdrawal by Subject|0|||
164404135|NCT05168579|593850038|FG001|Overall Study|Time slots were full|0|||
164404136|NCT05168579|593850037|FG000|Overall Study|Lost to Follow-up|0|||
164404137|NCT05168579|593850038|FG001|Overall Study|Lost to Follow-up|15|||
164404138|NCT00387894|593850039|FG000|Overall Study|Withdrawal by Subject|1|||
164404139|NCT00827541|593850040|FG000|Overall Study|Exitus|1|||
164404140|NCT00827541|593850041|FG001|Overall Study|Exitus|8|||
164404141|NCT00827541|593850040|FG000|Overall Study|Other|1|||
164404142|NCT00827541|593850041|FG001|Overall Study|Other|3|||
164404143|NCT00827541|593850040|FG000|Overall Study|Pathogen not susceptible|1|||
164404144|NCT00827541|593850041|FG001|Overall Study|Pathogen not susceptible|0|||
164404145|NCT00827541|593850040|FG000|Overall Study|Lack of effectiveness|1|||
164404146|NCT00827541|593850041|FG001|Overall Study|Lack of effectiveness|0|||
164404147|NCT01750879|593850042|FG000|Overall Study|Adverse Event|8|||
164404148|NCT01750879|593850043|FG001|Overall Study|Adverse Event|0|||
164404149|NCT01750879|593850042|FG000|Overall Study|Lack of Efficacy|1|||
164404150|NCT01750879|593850043|FG001|Overall Study|Lack of Efficacy|0|||
164404151|NCT01750879|593850042|FG000|Overall Study|Withdrawal by Subject|1|||
164447114|NCT02723955|594007403|FG020|Expansion Phase|Withdrawal by Subject|0|||
164447115|NCT02723955|594007404|FG021|Expansion Phase|Withdrawal by Subject|0|||
164447116|NCT02723955|594007405|FG022|Expansion Phase|Withdrawal by Subject|0|||
164447117|NCT02723955|594007406|FG023|Expansion Phase|Withdrawal by Subject|0|||
164447118|NCT02723955|594007407|FG024|Expansion Phase|Withdrawal by Subject|0|||
164596928|NCT02052778|594549011|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
164596929|NCT02052778|594549012|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
164596930|NCT02052778|594549013|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
164596931|NCT02052778|594549014|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
164596932|NCT02052778|594549015|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
164596933|NCT02052778|594548993|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164596934|NCT02052778|594548994|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164596935|NCT02052778|594548995|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164596936|NCT02052778|594548996|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164596937|NCT02052778|594548997|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164596938|NCT02052778|594548998|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164596939|NCT02052778|594548999|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164596940|NCT02052778|594549000|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164596941|NCT02052778|594549001|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
164596942|NCT02052778|594549002|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164596943|NCT02052778|594549003|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164596944|NCT02052778|594549004|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164596945|NCT02052778|594549005|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164404152|NCT01750879|593850043|FG001|Overall Study|Withdrawal by Subject|0|||
164404153|NCT01750879|593850042|FG000|Overall Study|Did not complete per protocol|0|||
164404154|NCT01750879|593850043|FG001|Overall Study|Did not complete per protocol|3|||
164404155|NCT03642938|593850044|FG000|Overall Study|Withdrawal by Subject|0|||
164404156|NCT03642938|593850045|FG001|Overall Study|Withdrawal by Subject|0|||
164404157|NCT03642938|593850046|FG002|Overall Study|Withdrawal by Subject|0|||
164404158|NCT03642938|593850047|FG003|Overall Study|Withdrawal by Subject|1|||
164404159|NCT02347657|593850048|FG000|Overall Study|Physician Decision|0|||
164404160|NCT02347657|593850049|FG001|Overall Study|Physician Decision|1|||
164404161|NCT02347657|593850048|FG000|Overall Study|Adverse Event|8|||
164404162|NCT02347657|593850049|FG001|Overall Study|Adverse Event|4|||
164404163|NCT02347657|593850048|FG000|Overall Study|Withdrawal by Subject|6|||
164404164|NCT02347657|593850049|FG001|Overall Study|Withdrawal by Subject|7|||
164404165|NCT02347657|593850048|FG000|Overall Study|Randomized but not treated|1|||
164404166|NCT02347657|593850049|FG001|Overall Study|Randomized but not treated|0|||
164404167|NCT02347657|593850048|FG000|Overall Study|Other|3|||
164404168|NCT02347657|593850049|FG001|Overall Study|Other|3|||
164404169|NCT01424930|593850050|FG000|Overall Study|Adverse Event|0|||
164404170|NCT01424930|593850051|FG001|Overall Study|Adverse Event|1|||
164404171|NCT01424930|593850050|FG000|Overall Study|Death|1|||
164404172|NCT01424930|593850051|FG001|Overall Study|Death|0|||
164404173|NCT01424930|593850050|FG000|Overall Study|Progressive Disease|3|||
164404174|NCT01424930|593850051|FG001|Overall Study|Progressive Disease|6|||
164404175|NCT01424930|593850050|FG000|Overall Study|Screen Failure|0|||
164404176|NCT01424930|593850051|FG001|Overall Study|Screen Failure|1|||
164404177|NCT01424930|593850050|FG000|Overall Study|Reason not specified|0|||
164404178|NCT01424930|593850051|FG001|Overall Study|Reason not specified|6|||
164404179|NCT03286751|593850056|FG000|Washout Period 1|Withdrawal by Subject|0|||
164404180|NCT03286751|593850057|FG001|Washout Period 1|Withdrawal by Subject|0|||
164404181|NCT03286751|593850058|FG002|Washout Period 1|Withdrawal by Subject|0|||
164404182|NCT03286751|593850059|FG003|Washout Period 1|Withdrawal by Subject|0|||
164404183|NCT03286751|593850060|FG004|Washout Period 1|Withdrawal by Subject|1|||
164404184|NCT03286751|593850061|FG005|Washout Period 1|Withdrawal by Subject|0|||
164404185|NCT03286751|593850056|FG000|Washout Period 2|Personal Reasons|0|||
164404186|NCT03286751|593850057|FG001|Washout Period 2|Personal Reasons|1|||
164404187|NCT03286751|593850058|FG002|Washout Period 2|Personal Reasons|0|||
164404188|NCT03286751|593850059|FG003|Washout Period 2|Personal Reasons|0|||
164404189|NCT03286751|593850060|FG004|Washout Period 2|Personal Reasons|0|||
164404190|NCT03286751|593850061|FG005|Washout Period 2|Personal Reasons|0|||
164404191|NCT03286751|593850056|FG000|Washout Period 5|Adverse Event|0|||
164404192|NCT03286751|593850057|FG001|Washout Period 5|Adverse Event|0|||
164404193|NCT03286751|593850058|FG002|Washout Period 5|Adverse Event|0|||
164404194|NCT03286751|593850059|FG003|Washout Period 5|Adverse Event|0|||
164404195|NCT03286751|593850060|FG004|Washout Period 5|Adverse Event|1|||
164404196|NCT03286751|593850061|FG005|Washout Period 5|Adverse Event|0|||
164404197|NCT01119768|593850062|FG000|Treatment Period|Lack of Efficacy|18|||
164404198|NCT01119768|593850063|FG001|Treatment Period|Lack of Efficacy|25|||
164404199|NCT01301391|593850064|FG000|Overall Study|Death|13|||
164404200|NCT01301391|593850064|FG000|Overall Study|Lost to Follow-up|3|||
164404201|NCT01301391|593850064|FG000|Overall Study|Physician Decision|2|||
164404202|NCT01301391|593850064|FG000|Overall Study|Sponsor's decision|8|||
164404203|NCT01059643|593850065|FG000|Overall Study|Adverse Event|3|||
164404204|NCT01059643|593850065|FG000|Overall Study|Withdrawal by Subject|2|||
164404205|NCT01059643|593850065|FG000|Overall Study|Physician Decision|1|||
164404206|NCT00106184|593850068|FG000|Overall Study|Withdrawal by Subject|3|||
164404207|NCT00106184|593850069|FG001|Overall Study|Withdrawal by Subject|2|||
164404208|NCT00677352|593850075|FG000|Treatment Phase|Adverse Event|14|||
164404209|NCT00677352|593850076|FG001|Treatment Phase|Adverse Event|22|||
164404210|NCT00677352|593850075|FG000|Treatment Phase|Lack of Efficacy|2|||
164404211|NCT00677352|593850076|FG001|Treatment Phase|Lack of Efficacy|3|||
164404212|NCT00677352|593850075|FG000|Treatment Phase|Lost to Follow-up|0|||
164404213|NCT00677352|593850076|FG001|Treatment Phase|Lost to Follow-up|1|||
164404214|NCT00677352|593850075|FG000|Treatment Phase|Withdrawal by Subject|7|||
164404215|NCT00677352|593850076|FG001|Treatment Phase|Withdrawal by Subject|7|||
164404216|NCT00677352|593850075|FG000|Treatment Phase|Physician Decision|1|||
164404217|NCT00677352|593850076|FG001|Treatment Phase|Physician Decision|0|||
164404218|NCT00677352|593850075|FG000|Treatment Phase|Pregnancy|0|||
164404219|NCT00677352|593850076|FG001|Treatment Phase|Pregnancy|1|||
164404220|NCT00677352|593850075|FG000|Treatment Phase|Protocol Violation|1|||
164404221|NCT00677352|593850076|FG001|Treatment Phase|Protocol Violation|1|||
164404222|NCT00677352|593850075|FG000|Treatment Phase|Transference or work related matter|0|||
164404223|NCT00677352|593850076|FG001|Treatment Phase|Transference or work related matter|5|||
164404224|NCT00677352|593850075|FG000|Treatment Phase|Not treated|0|||
164404225|NCT00677352|593850076|FG001|Treatment Phase|Not treated|2|||
164404226|NCT00677352|593850075|FG000|Tapering Phase|Adverse Event|1|||
164404227|NCT00677352|593850076|FG001|Tapering Phase|Adverse Event|5|||
164404228|NCT00677352|593850075|FG000|Tapering Phase|Withdrawal by Subject|5|||
164404229|NCT00677352|593850076|FG001|Tapering Phase|Withdrawal by Subject|3|||
164404230|NCT00677352|593850075|FG000|Tapering Phase|Pregnancy|0|||
164447119|NCT02723955|594007408|FG025|Expansion Phase|Withdrawal by Subject|0|||
164447120|NCT02723955|594007409|FG026|Expansion Phase|Withdrawal by Subject|0|||
164447121|NCT02723955|594007410|FG027|Expansion Phase|Withdrawal by Subject|0|||
164447122|NCT02723955|594007411|FG028|Expansion Phase|Withdrawal by Subject|0|||
164447123|NCT02723955|594007412|FG029|Expansion Phase|Withdrawal by Subject|0|||
164447124|NCT02723955|594007413|FG030|Expansion Phase|Withdrawal by Subject|8|||
164447125|NCT02723955|594007414|FG031|Expansion Phase|Withdrawal by Subject|4|||
164447126|NCT02723955|594007415|FG032|Expansion Phase|Withdrawal by Subject|0|||
164447127|NCT02723955|594007416|FG033|Expansion Phase|Withdrawal by Subject|0|||
164447128|NCT02723955|594007417|FG034|Expansion Phase|Withdrawal by Subject|0|||
164447129|NCT02723955|594007418|FG035|Expansion Phase|Withdrawal by Subject|1|||
164447130|NCT02723955|594007419|FG036|Expansion Phase|Withdrawal by Subject|0|||
164447131|NCT02723955|594007420|FG037|Expansion Phase|Withdrawal by Subject|0|||
164447132|NCT02723955|594007421|FG038|Expansion Phase|Withdrawal by Subject|0|||
164447133|NCT02723955|594007422|FG039|Expansion Phase|Withdrawal by Subject|0|||
164447134|NCT02723955|594007423|FG040|Expansion Phase|Withdrawal by Subject|0|||
164447135|NCT02723955|594007424|FG041|Expansion Phase|Withdrawal by Subject|0|||
164447136|NCT02723955|594007425|FG042|Expansion Phase|Withdrawal by Subject|0|||
164447137|NCT02723955|594007383|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447138|NCT02723955|594007384|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447139|NCT02723955|594007385|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447140|NCT02723955|594007386|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447141|NCT02723955|594007387|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447142|NCT02723955|594007388|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447143|NCT02723955|594007389|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447144|NCT02723955|594007390|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447145|NCT02723955|594007391|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447146|NCT02723955|594007392|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
164447147|NCT02723955|594007393|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
164447148|NCT02723955|594007394|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
164447149|NCT02723955|594007395|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447150|NCT02723955|594007396|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447151|NCT02723955|594007397|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447152|NCT02723955|594007398|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447153|NCT02723955|594007399|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447154|NCT02723955|594007400|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447155|NCT02723955|594007401|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447156|NCT02723955|594007402|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447157|NCT02723955|594007403|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447158|NCT02723955|594007404|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447159|NCT02723955|594007405|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447160|NCT02723955|594007406|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447161|NCT02723955|594007407|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447162|NCT02723955|594007408|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447163|NCT02723955|594007409|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447164|NCT02723955|594007410|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447165|NCT02723955|594007411|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447166|NCT02723955|594007412|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447167|NCT02723955|594007413|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
164447168|NCT02723955|594007414|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164532241|NCT00615836|594320502|FG001|Extension Study (FE992026 CS31)|Other|7|||
164706305|NCT02393248|594953427|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164706306|NCT02393248|594953428|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164706307|NCT02393248|594953429|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164706308|NCT02393248|594953430|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164706309|NCT02393248|594953431|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164706310|NCT02393248|594953432|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164706311|NCT02393248|594953433|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164706312|NCT02393248|594953434|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164706313|NCT02393248|594953435|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164447169|NCT02723955|594007415|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447170|NCT02723955|594007416|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447171|NCT02723955|594007417|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447172|NCT02723955|594007418|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447173|NCT02723955|594007419|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447174|NCT02723955|594007420|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447175|NCT02723955|594007421|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447176|NCT02723955|594007422|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447177|NCT02723955|594007423|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447178|NCT02723955|594007424|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447179|NCT02723955|594007425|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
164447180|NCT02723955|594007383|FG000|Expansion Phase|Site Closed|0|||
164447181|NCT02723955|594007384|FG001|Expansion Phase|Site Closed|0|||
164447182|NCT02723955|594007385|FG002|Expansion Phase|Site Closed|0|||
164447183|NCT02723955|594007386|FG003|Expansion Phase|Site Closed|0|||
164447184|NCT02723955|594007387|FG004|Expansion Phase|Site Closed|0|||
164447185|NCT02723955|594007388|FG005|Expansion Phase|Site Closed|0|||
164447186|NCT02723955|594007389|FG006|Expansion Phase|Site Closed|0|||
164447187|NCT02723955|594007390|FG007|Expansion Phase|Site Closed|0|||
164596946|NCT02052778|594549006|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
164596947|NCT02052778|594549007|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164596948|NCT02052778|594549008|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164596949|NCT02052778|594549009|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164447188|NCT02723955|594007391|FG008|Expansion Phase|Site Closed|0|||
164447189|NCT02723955|594007392|FG009|Expansion Phase|Site Closed|1|||
164447190|NCT02723955|594007393|FG010|Expansion Phase|Site Closed|2|||
164447191|NCT02723955|594007394|FG011|Expansion Phase|Site Closed|6|||
164447192|NCT02723955|594007395|FG012|Expansion Phase|Site Closed|0|||
164596950|NCT02052778|594549010|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164596951|NCT02052778|594549011|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164596952|NCT02052778|594549012|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164596953|NCT02052778|594549013|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164596954|NCT02052778|594549014|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164596955|NCT02052778|594549015|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164596956|NCT02052778|594548993|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164596957|NCT02052778|594548994|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164596958|NCT02052778|594548995|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164596959|NCT02052778|594548996|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164596960|NCT02052778|594548997|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164596961|NCT02052778|594548998|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
164596962|NCT02052778|594548999|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164596963|NCT02052778|594549000|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164596964|NCT02052778|594549001|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164596965|NCT02052778|594549002|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164596966|NCT02052778|594549003|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164596967|NCT02052778|594549004|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164596968|NCT02052778|594549005|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
164596969|NCT02052778|594549006|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164596970|NCT02052778|594549007|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164596971|NCT02052778|594549008|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164596972|NCT02052778|594549009|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164596973|NCT02052778|594549010|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164596974|NCT02052778|594549011|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164596975|NCT02052778|594549012|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164596976|NCT02052778|594549013|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164596977|NCT02052778|594549014|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164596978|NCT02052778|594549015|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164596979|NCT02052778|594548993|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164596980|NCT02052778|594548994|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164596981|NCT02052778|594548995|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164596982|NCT02052778|594548996|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164447193|NCT02723955|594007396|FG013|Expansion Phase|Site Closed|0|||
164447194|NCT02723955|594007397|FG014|Expansion Phase|Site Closed|0|||
164447195|NCT02723955|594007398|FG015|Expansion Phase|Site Closed|0|||
164447196|NCT02723955|594007399|FG016|Expansion Phase|Site Closed|0|||
164447197|NCT02723955|594007400|FG017|Expansion Phase|Site Closed|0|||
164447198|NCT02723955|594007401|FG018|Expansion Phase|Site Closed|0|||
164447199|NCT02723955|594007402|FG019|Expansion Phase|Site Closed|0|||
164447200|NCT02723955|594007403|FG020|Expansion Phase|Site Closed|0|||
164447201|NCT02723955|594007404|FG021|Expansion Phase|Site Closed|0|||
164447202|NCT02723955|594007405|FG022|Expansion Phase|Site Closed|0|||
164447203|NCT02723955|594007406|FG023|Expansion Phase|Site Closed|0|||
164447204|NCT02723955|594007407|FG024|Expansion Phase|Site Closed|0|||
164447205|NCT02723955|594007408|FG025|Expansion Phase|Site Closed|0|||
164447206|NCT02723955|594007409|FG026|Expansion Phase|Site Closed|0|||
164447207|NCT02723955|594007410|FG027|Expansion Phase|Site Closed|0|||
164447208|NCT02723955|594007411|FG028|Expansion Phase|Site Closed|0|||
164447209|NCT02723955|594007412|FG029|Expansion Phase|Site Closed|0|||
164447210|NCT02723955|594007413|FG030|Expansion Phase|Site Closed|8|||
164447211|NCT02723955|594007414|FG031|Expansion Phase|Site Closed|4|||
164447212|NCT02723955|594007415|FG032|Expansion Phase|Site Closed|2|||
164447213|NCT02723955|594007416|FG033|Expansion Phase|Site Closed|2|||
164447214|NCT02723955|594007417|FG034|Expansion Phase|Site Closed|0|||
164447215|NCT02723955|594007418|FG035|Expansion Phase|Site Closed|0|||
164447216|NCT02723955|594007419|FG036|Expansion Phase|Site Closed|0|||
164447217|NCT02723955|594007420|FG037|Expansion Phase|Site Closed|0|||
164447218|NCT02723955|594007421|FG038|Expansion Phase|Site Closed|0|||
164447219|NCT02723955|594007422|FG039|Expansion Phase|Site Closed|0|||
164447220|NCT02723955|594007423|FG040|Expansion Phase|Site Closed|0|||
164447221|NCT02723955|594007424|FG041|Expansion Phase|Site Closed|0|||
164447222|NCT02723955|594007425|FG042|Expansion Phase|Site Closed|0|||
164447223|NCT02723955|594007383|FG000|Crossover/ Re-treatment Phase|Death|0|||
164447224|NCT02723955|594007384|FG001|Crossover/ Re-treatment Phase|Death|0|||
164447225|NCT02723955|594007385|FG002|Crossover/ Re-treatment Phase|Death|0|||
164447226|NCT02723955|594007386|FG003|Crossover/ Re-treatment Phase|Death|0|||
164447227|NCT02723955|594007387|FG004|Crossover/ Re-treatment Phase|Death|0|||
164447228|NCT02723955|594007388|FG005|Crossover/ Re-treatment Phase|Death|0|||
164447229|NCT02723955|594007389|FG006|Crossover/ Re-treatment Phase|Death|0|||
164447230|NCT02723955|594007390|FG007|Crossover/ Re-treatment Phase|Death|0|||
164447231|NCT02723955|594007391|FG008|Crossover/ Re-treatment Phase|Death|0|||
164447232|NCT02723955|594007392|FG009|Crossover/ Re-treatment Phase|Death|0|||
164447233|NCT02723955|594007393|FG010|Crossover/ Re-treatment Phase|Death|0|||
164447234|NCT02723955|594007394|FG011|Crossover/ Re-treatment Phase|Death|0|||
164447235|NCT02723955|594007395|FG012|Crossover/ Re-treatment Phase|Death|0|||
164447236|NCT02723955|594007396|FG013|Crossover/ Re-treatment Phase|Death|0|||
164447237|NCT02723955|594007397|FG014|Crossover/ Re-treatment Phase|Death|0|||
164447238|NCT02723955|594007398|FG015|Crossover/ Re-treatment Phase|Death|0|||
164447239|NCT02723955|594007399|FG016|Crossover/ Re-treatment Phase|Death|0|||
164447240|NCT02723955|594007400|FG017|Crossover/ Re-treatment Phase|Death|0|||
164447241|NCT02723955|594007401|FG018|Crossover/ Re-treatment Phase|Death|0|||
164447242|NCT02723955|594007402|FG019|Crossover/ Re-treatment Phase|Death|0|||
164447243|NCT02723955|594007403|FG020|Crossover/ Re-treatment Phase|Death|0|||
164447244|NCT02723955|594007404|FG021|Crossover/ Re-treatment Phase|Death|0|||
164447245|NCT02723955|594007405|FG022|Crossover/ Re-treatment Phase|Death|0|||
164447246|NCT02723955|594007406|FG023|Crossover/ Re-treatment Phase|Death|0|||
164447247|NCT02723955|594007407|FG024|Crossover/ Re-treatment Phase|Death|0|||
164447248|NCT02723955|594007408|FG025|Crossover/ Re-treatment Phase|Death|0|||
164447249|NCT02723955|594007409|FG026|Crossover/ Re-treatment Phase|Death|0|||
164447250|NCT02723955|594007410|FG027|Crossover/ Re-treatment Phase|Death|0|||
164447251|NCT02723955|594007411|FG028|Crossover/ Re-treatment Phase|Death|0|||
164447252|NCT02723955|594007412|FG029|Crossover/ Re-treatment Phase|Death|0|||
164447253|NCT02723955|594007413|FG030|Crossover/ Re-treatment Phase|Death|0|||
164447254|NCT02723955|594007414|FG031|Crossover/ Re-treatment Phase|Death|0|||
164447255|NCT02723955|594007415|FG032|Crossover/ Re-treatment Phase|Death|0|||
164447256|NCT02723955|594007416|FG033|Crossover/ Re-treatment Phase|Death|0|||
164447257|NCT02723955|594007417|FG034|Crossover/ Re-treatment Phase|Death|0|||
164447258|NCT02723955|594007418|FG035|Crossover/ Re-treatment Phase|Death|0|||
164447259|NCT02723955|594007419|FG036|Crossover/ Re-treatment Phase|Death|0|||
164447260|NCT02723955|594007420|FG037|Crossover/ Re-treatment Phase|Death|1|||
164447261|NCT02723955|594007421|FG038|Crossover/ Re-treatment Phase|Death|14|||
164447262|NCT02723955|594007422|FG039|Crossover/ Re-treatment Phase|Death|32|||
164447263|NCT02723955|594007423|FG040|Crossover/ Re-treatment Phase|Death|2|||
164447264|NCT02723955|594007424|FG041|Crossover/ Re-treatment Phase|Death|1|||
164447265|NCT02723955|594007425|FG042|Crossover/ Re-treatment Phase|Death|0|||
164447266|NCT02723955|594007383|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447267|NCT02723955|594007384|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447268|NCT02723955|594007385|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447269|NCT02723955|594007386|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447270|NCT02723955|594007387|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447271|NCT02723955|594007388|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447272|NCT02723955|594007389|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447273|NCT02723955|594007390|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447274|NCT02723955|594007391|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447275|NCT02723955|594007392|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447276|NCT02723955|594007393|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447277|NCT02723955|594007394|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447278|NCT02723955|594007395|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447279|NCT02723955|594007396|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447280|NCT02723955|594007397|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447281|NCT02723955|594007398|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447282|NCT02723955|594007399|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447283|NCT02723955|594007400|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447284|NCT02723955|594007401|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447285|NCT02723955|594007402|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447286|NCT02723955|594007403|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447287|NCT02723955|594007404|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447288|NCT02723955|594007405|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447289|NCT02723955|594007406|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447290|NCT02723955|594007407|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447291|NCT02723955|594007408|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447292|NCT02723955|594007409|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447293|NCT02723955|594007410|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447294|NCT02723955|594007411|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447295|NCT02723955|594007412|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447296|NCT02723955|594007413|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447297|NCT02723955|594007414|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447298|NCT02723955|594007415|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447299|NCT02723955|594007416|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447300|NCT02723955|594007417|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447301|NCT02723955|594007418|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447302|NCT02723955|594007419|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447303|NCT02723955|594007420|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447304|NCT02723955|594007421|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447305|NCT02723955|594007422|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
164447306|NCT02723955|594007423|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447307|NCT02723955|594007424|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447308|NCT02723955|594007425|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
164447309|NCT02723955|594007383|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447310|NCT02723955|594007384|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447311|NCT02723955|594007385|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447312|NCT02723955|594007386|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447313|NCT02723955|594007387|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447314|NCT02723955|594007388|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447315|NCT02723955|594007389|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447316|NCT02723955|594007390|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447317|NCT02723955|594007391|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447318|NCT02723955|594007392|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447319|NCT02723955|594007393|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447320|NCT02723955|594007394|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447321|NCT02723955|594007395|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447322|NCT02723955|594007396|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447323|NCT02723955|594007397|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447324|NCT02723955|594007398|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447325|NCT02723955|594007399|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447326|NCT02723955|594007400|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447327|NCT02723955|594007401|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447328|NCT02723955|594007402|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447329|NCT02723955|594007403|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447330|NCT02723955|594007404|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447331|NCT02723955|594007405|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447332|NCT02723955|594007406|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447333|NCT02723955|594007407|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447334|NCT02723955|594007408|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447335|NCT02723955|594007409|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447336|NCT02723955|594007410|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447337|NCT02723955|594007411|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447338|NCT02723955|594007412|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447339|NCT02723955|594007413|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447340|NCT02723955|594007414|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
164404231|NCT00677352|593850076|FG001|Tapering Phase|Pregnancy|1|||
164404232|NCT00677352|593850075|FG000|Tapering Phase|Job transfer|0|||
164404233|NCT00677352|593850076|FG001|Tapering Phase|Job transfer|1|||
164404234|NCT02182973|593850082|FG000|Overall Study|Withdrawal by Subject|3|||
164404235|NCT02182973|593850083|FG001|Overall Study|Withdrawal by Subject|0|||
164404236|NCT00238433|593850084|FG000|Overall Study|Screen failure|1|||
164404237|NCT00238433|593850084|FG000|Overall Study|Lost to Follow-up|1|||
164404238|NCT00238433|593850084|FG000|Overall Study|Death|1|||
164404239|NCT00409682|593850090|FG000|Open-label Induction Period|Adverse Event|1|||
164404240|NCT00409682|593850091|FG001|Open-label Induction Period|Adverse Event|0|||
164404241|NCT00409682|593850092|FG002|Open-label Induction Period|Adverse Event|0|||
164404242|NCT00409682|593850090|FG000|Open-label Induction Period|Lack of Efficacy|1|||
164404243|NCT00409682|593850091|FG001|Open-label Induction Period|Lack of Efficacy|0|||
164404244|NCT00409682|593850092|FG002|Open-label Induction Period|Lack of Efficacy|0|||
164404245|NCT00409682|593850090|FG000|Open-label Induction Period|Protocol Violation|1|||
164404246|NCT00409682|593850091|FG001|Open-label Induction Period|Protocol Violation|0|||
164404247|NCT00409682|593850092|FG002|Open-label Induction Period|Protocol Violation|0|||
164404248|NCT00409682|593850090|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
164404249|NCT00409682|593850091|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
164404250|NCT00409682|593850092|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
164404251|NCT00409682|593850090|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
164404252|NCT00409682|593850091|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
164404253|NCT00409682|593850092|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
164404254|NCT00409682|593850090|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
164404255|NCT00409682|593850091|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
164404256|NCT00409682|593850092|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
164404257|NCT00409682|593850090|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
164404258|NCT00409682|593850091|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
164404259|NCT00409682|593850092|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
164404260|NCT00409682|593850090|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
164404261|NCT00409682|593850091|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
164404262|NCT00409682|593850092|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
164404263|NCT00409682|593850090|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
164404264|NCT00409682|593850091|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
164404265|NCT00409682|593850092|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
164404266|NCT00409682|593850090|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
164404267|NCT00409682|593850091|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
164404268|NCT00409682|593850092|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
164404269|NCT03641313|593850093|FG000|Overall Study|Death|1|||
164404270|NCT03641313|593850093|FG000|Overall Study|Withdrawal by Subject|2|||
164404271|NCT03641313|593850093|FG000|Overall Study|Declining health|1|||
164404272|NCT03641313|593850093|FG000|Overall Study|Adverse Event|1|||
164404273|NCT05614089|593850097|FG000|Overall Study|Pregnancy|5|||
164404274|NCT05614089|593850098|FG001|Overall Study|Pregnancy|2|||
164404275|NCT05614089|593850097|FG000|Overall Study|Lost to Follow-up|5|||
164404276|NCT05614089|593850098|FG001|Overall Study|Lost to Follow-up|1|||
164404277|NCT05614089|593850097|FG000|Overall Study|Death|0|||
164404278|NCT05614089|593850098|FG001|Overall Study|Death|1|||
164404279|NCT05614089|593850097|FG000|Overall Study|Adverse Event|1|||
164404280|NCT05614089|593850098|FG001|Overall Study|Adverse Event|0|||
164404281|NCT05163522|593850099|FG000|Overall Study|Withdrawal by Subject|0|||
164404282|NCT05163522|593850100|FG001|Overall Study|Withdrawal by Subject|0|||
164404283|NCT05163522|593850101|FG002|Overall Study|Withdrawal by Subject|1|||
164404284|NCT05163522|593850102|FG003|Overall Study|Withdrawal by Subject|0|||
164404285|NCT05163522|593850103|FG004|Overall Study|Withdrawal by Subject|0|||
164404286|NCT05163522|593850104|FG005|Overall Study|Withdrawal by Subject|0|||
164404287|NCT05163522|593850105|FG006|Overall Study|Withdrawal by Subject|0|||
164404288|NCT05163522|593850106|FG007|Overall Study|Withdrawal by Subject|0|||
164404289|NCT05163522|593850107|FG008|Overall Study|Withdrawal by Subject|0|||
164404290|NCT05163522|593850108|FG009|Overall Study|Withdrawal by Subject|0|||
164404291|NCT05163522|593850109|FG010|Overall Study|Withdrawal by Subject|0|||
164404292|NCT03937219|593850111|FG000|Overall Study|Death|223|||
164404293|NCT03937219|593850112|FG001|Overall Study|Death|211|||
164404294|NCT03937219|593850111|FG000|Overall Study|Withdrawal by Subject|17|||
164404295|NCT03937219|593850112|FG001|Overall Study|Withdrawal by Subject|25|||
164404296|NCT03937219|593850111|FG000|Overall Study|Lost to Follow-up|3|||
164404297|NCT03937219|593850112|FG001|Overall Study|Lost to Follow-up|4|||
164404298|NCT00771810|593850113|FG000|Overall Study|Adverse Event|3|||
164404299|NCT00771810|593850114|FG001|Overall Study|Adverse Event|0|||
164404300|NCT00771810|593850115|FG002|Overall Study|Adverse Event|2|||
164404301|NCT00771810|593850113|FG000|Overall Study|Lost to Follow-up|0|||
164596983|NCT02052778|594548997|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164404302|NCT00771810|593850114|FG001|Overall Study|Lost to Follow-up|0|||
164404303|NCT00771810|593850115|FG002|Overall Study|Lost to Follow-up|1|||
164706314|NCT02393248|594953436|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164447341|NCT02723955|594007415|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447342|NCT02723955|594007416|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447343|NCT02723955|594007417|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447344|NCT02723955|594007418|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447345|NCT02723955|594007419|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447346|NCT02723955|594007420|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447347|NCT02723955|594007421|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
164447348|NCT02723955|594007422|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
164447349|NCT02723955|594007423|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447350|NCT02723955|594007424|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
164447351|NCT02723955|594007425|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
164447352|NCT02723955|594007383|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
164447353|NCT02723955|594007384|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
164447354|NCT02723955|594007385|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
164447355|NCT02723955|594007386|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
164447356|NCT02723955|594007387|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
164706315|NCT02393248|594953437|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164706316|NCT02393248|594953438|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164706317|NCT02393248|594953414|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
164706318|NCT02393248|594953415|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
164706319|NCT02393248|594953416|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
164706320|NCT02393248|594953417|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
164706321|NCT02393248|594953418|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
164706322|NCT02393248|594953419|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
164706323|NCT02393248|594953420|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
164706324|NCT02393248|594953421|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
164706325|NCT02393248|594953422|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
164706326|NCT02393248|594953423|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
164706327|NCT02393248|594953424|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
164706328|NCT02393248|594953425|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
164706329|NCT02393248|594953426|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
164706330|NCT02393248|594953427|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
164706331|NCT02393248|594953428|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
164706332|NCT02393248|594953429|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
164706333|NCT02393248|594953430|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
164404304|NCT00771810|593850113|FG000|Overall Study|Physician Decision|1|||
164404305|NCT00771810|593850114|FG001|Overall Study|Physician Decision|2|||
164404306|NCT00771810|593850115|FG002|Overall Study|Physician Decision|2|||
164404307|NCT00771810|593850113|FG000|Overall Study|Protocol Violation|0|||
164404308|NCT00771810|593850114|FG001|Overall Study|Protocol Violation|1|||
164404309|NCT00771810|593850115|FG002|Overall Study|Protocol Violation|1|||
164404310|NCT00771810|593850113|FG000|Overall Study|Withdrawal by Subject|1|||
164404311|NCT00771810|593850114|FG001|Overall Study|Withdrawal by Subject|2|||
164404312|NCT00771810|593850115|FG002|Overall Study|Withdrawal by Subject|0|||
164404313|NCT00771810|593850113|FG000|Overall Study|Other|0|||
164404314|NCT00771810|593850114|FG001|Overall Study|Other|0|||
164404315|NCT00771810|593850115|FG002|Overall Study|Other|1|||
164404316|NCT02660827|593850116|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
164404317|NCT02660827|593850116|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
164404318|NCT02660827|593850116|FG000|From Study to End of Continued Access|Adverse Event|3|||
164404319|NCT02660827|593850116|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
164404320|NCT02660827|593850116|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
164404321|NCT02660827|593850116|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
164404322|NCT02660827|593850116|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
164404323|NCT02660827|593850116|FG000|Period 2: Continued Access Period|Adverse Event|3|||
164404324|NCT02657031|593850117|FG000|Overall Study|Adverse Event|1|||
164404325|NCT02657031|593850118|FG001|Overall Study|Adverse Event|2|||
164404326|NCT03599349|593850119|FG000|Overall Study|Lost to Follow-up|1|||
164404327|NCT00810264|593850122|FG000|Overall Study|Lost to Follow-up|191|||
164404328|NCT00810264|593850122|FG000|Overall Study|Withdrawal by subject or physician|721|||
164404329|NCT00810264|593850122|FG000|Overall Study|Death|641|||
164404330|NCT01648348|593850125|FG000|Overall Study|Cancel|1|||
164404331|NCT01648348|593850126|FG001|Overall Study|Cancel|0|||
164404332|NCT01648348|593850127|FG002|Overall Study|Cancel|0|||
164404333|NCT01648348|593850128|FG003|Overall Study|Cancel|0|||
164404334|NCT01648348|593850129|FG004|Overall Study|Cancel|3|||
164447357|NCT02723955|594007388|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
164706334|NCT02393248|594953431|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
164404335|NCT01648348|593850130|FG005|Overall Study|Cancel|6|||
164404336|NCT01648348|593850125|FG000|Overall Study|Replaced for MTD analysis|1|||
164404337|NCT01648348|593850126|FG001|Overall Study|Replaced for MTD analysis|0|||
164404338|NCT01648348|593850127|FG002|Overall Study|Replaced for MTD analysis|1|||
164404339|NCT01648348|593850128|FG003|Overall Study|Replaced for MTD analysis|0|||
164447358|NCT02723955|594007389|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
164447359|NCT02723955|594007390|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
164447360|NCT02723955|594007391|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
164447361|NCT02723955|594007392|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
164447362|NCT02723955|594007393|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
164447363|NCT02723955|594007394|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
164447364|NCT02723955|594007395|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
164447365|NCT02723955|594007396|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
164447366|NCT02723955|594007397|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
164447367|NCT02723955|594007398|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
164447368|NCT02723955|594007399|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
164447369|NCT02723955|594007400|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
164447370|NCT02723955|594007401|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
164447371|NCT02723955|594007402|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
164447372|NCT02723955|594007403|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
164447373|NCT02723955|594007404|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
164447374|NCT02723955|594007405|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
164447375|NCT02723955|594007406|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
164447376|NCT02723955|594007407|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
164447377|NCT02723955|594007408|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
164447378|NCT02723955|594007409|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
164447379|NCT02723955|594007410|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
164447380|NCT02723955|594007411|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
164447381|NCT02723955|594007412|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
164447382|NCT02723955|594007413|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
164447383|NCT02723955|594007414|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
164447384|NCT02723955|594007415|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
164447385|NCT02723955|594007416|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
164447386|NCT02723955|594007417|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
164447387|NCT02723955|594007418|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
164447388|NCT02723955|594007419|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
164447389|NCT02723955|594007420|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
164447390|NCT02723955|594007421|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
164447391|NCT02723955|594007422|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
164447392|NCT02723955|594007423|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
164447393|NCT02723955|594007424|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
164447394|NCT02723955|594007425|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
164447395|NCT04999085|594007426|FG000|Overall Study|Death|1|||
164447396|NCT05057897|594007427|FG000|Overall Study|Site closure|2|||
164447397|NCT05057897|594007428|FG001|Overall Study|Site closure|2|||
164447398|NCT05057897|594007427|FG000|Overall Study|Death|1|||
164447399|NCT05057897|594007428|FG001|Overall Study|Death|0|||
164447400|NCT03088813|594007431|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
164447401|NCT03088813|594007432|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
164447402|NCT03088813|594007433|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
164447403|NCT03088813|594007434|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
164447404|NCT03088813|594007431|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
164447405|NCT03088813|594007432|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
164447406|NCT03088813|594007433|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
164447407|NCT03088813|594007434|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
164447408|NCT03088813|594007431|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
164447409|NCT03088813|594007432|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
164447410|NCT03088813|594007433|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
164447411|NCT03088813|594007434|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
164447412|NCT03088813|594007431|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
164447413|NCT03088813|594007432|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
164447414|NCT03088813|594007433|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
164447415|NCT03088813|594007434|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
164447416|NCT03088813|594007431|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
164447417|NCT03088813|594007432|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
164447418|NCT03088813|594007433|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
164447419|NCT03088813|594007434|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
164447420|NCT03088813|594007431|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
164447421|NCT03088813|594007432|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
164447422|NCT03088813|594007433|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
164447423|NCT03088813|594007434|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
164447424|NCT03088813|594007431|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
164447425|NCT03088813|594007432|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
164447426|NCT03088813|594007433|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
164447427|NCT03088813|594007434|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
164447428|NCT02152137|594007435|FG000|Overall Study|Withdrawal by Subject|1|||
164447429|NCT02152137|594007435|FG000|Overall Study|Originally assigned to Arm B|3|||
164447430|NCT04878354|594007436|FG000|Overall Study|Adverse Event|4|||
164447431|NCT04878354|594007437|FG001|Overall Study|Adverse Event|13|||
164447432|NCT04878354|594007436|FG000|Overall Study|Withdrawal by Subject|14|||
164447433|NCT04878354|594007437|FG001|Overall Study|Withdrawal by Subject|12|||
164447434|NCT04878354|594007436|FG000|Overall Study|Lost to Follow-up|4|||
164447435|NCT04878354|594007437|FG001|Overall Study|Lost to Follow-up|1|||
164447436|NCT04878354|594007436|FG000|Overall Study|Lack of Efficacy|1|||
164447437|NCT04878354|594007437|FG001|Overall Study|Lack of Efficacy|0|||
164447438|NCT04878354|594007436|FG000|Overall Study|Protocol Violation|0|||
164447439|NCT04878354|594007437|FG001|Overall Study|Protocol Violation|1|||
164447440|NCT04878354|594007436|FG000|Overall Study|"Reason stated as other in CRF"|2|||
164596984|NCT02052778|594548998|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164596985|NCT02052778|594548999|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164596986|NCT02052778|594549000|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164596987|NCT02052778|594549001|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164596988|NCT02052778|594549002|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164447441|NCT04878354|594007437|FG001|Overall Study|"Reason stated as other in CRF"|3|||
164447442|NCT01903811|594007442|FG000|Overall Study|No measurable disease|1|||
164447443|NCT01903811|594007443|FG001|Overall Study|No measurable disease|1|||
164447444|NCT01903811|594007442|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
164596989|NCT02052778|594549003|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164596990|NCT02052778|594549004|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164596991|NCT02052778|594549005|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164596992|NCT02052778|594549006|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164596993|NCT02052778|594549007|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
164596994|NCT02052778|594549008|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
164596995|NCT02052778|594549009|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
164596996|NCT02052778|594549010|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
164596997|NCT02052778|594549011|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
164596998|NCT02052778|594549012|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
164596999|NCT02052778|594549013|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
164597000|NCT02052778|594549014|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
164597001|NCT02052778|594549015|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164597002|NCT02052778|594548993|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164597003|NCT02052778|594548994|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164597004|NCT02052778|594548995|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164597005|NCT02052778|594548996|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164597006|NCT02052778|594548997|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164597007|NCT02052778|594548998|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164597008|NCT02052778|594548999|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164597009|NCT02052778|594549000|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164597010|NCT02052778|594549001|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164597011|NCT02052778|594549002|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164597012|NCT02052778|594549003|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164597013|NCT02052778|594549004|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164706335|NCT02393248|594953432|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
164447445|NCT01903811|594007443|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
164447446|NCT01903811|594007442|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
164447447|NCT01903811|594007443|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
164447448|NCT01903811|594007442|FG000|Overall Study|Withdrawal by Subject|0|||
164404340|NCT01648348|593850129|FG004|Overall Study|Replaced for MTD analysis|0|||
164404341|NCT01648348|593850130|FG005|Overall Study|Replaced for MTD analysis|0|||
164404342|NCT00453986|593850132|FG000|Overall Study|Lost to Follow-up|6|||
164404343|NCT00453986|593850133|FG001|Overall Study|Lost to Follow-up|5|||
164404344|NCT00453986|593850134|FG002|Overall Study|Lost to Follow-up|6|||
164404345|NCT00453986|593850135|FG003|Overall Study|Lost to Follow-up|2|||
164404346|NCT00453986|593850136|FG004|Overall Study|Lost to Follow-up|0|||
164404347|NCT03355326|593850141|FG000|Overall Study|Protocol Violation|3|||
164404348|NCT03355326|593850142|FG001|Overall Study|Protocol Violation|3|||
164404349|NCT00608582|593850151|FG000|Overall Study|Lost to Follow-up|2|||
164404350|NCT00608582|593850152|FG001|Overall Study|Lost to Follow-up|0|||
164447449|NCT01903811|594007443|FG001|Overall Study|Withdrawal by Subject|1|||
164447450|NCT03990649|594007446|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
164447451|NCT03990649|594007447|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
164404351|NCT00608582|593850151|FG000|Overall Study|No Best Response in Phase 1 located|1|||
164447452|NCT03990649|594007448|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
164447453|NCT03990649|594007446|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
164447454|NCT03990649|594007447|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
164447455|NCT03990649|594007448|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
164447456|NCT03990649|594007446|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
164447457|NCT03990649|594007447|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
164447458|NCT03990649|594007448|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
164447459|NCT03990649|594007446|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
164447460|NCT03990649|594007447|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
164447461|NCT03990649|594007448|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
164447462|NCT03990649|594007446|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
164447463|NCT03990649|594007447|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
164447464|NCT03990649|594007448|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
164447465|NCT03990649|594007446|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
164447466|NCT03990649|594007447|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
164447467|NCT03990649|594007448|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
164447468|NCT03990649|594007446|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
164447469|NCT03990649|594007447|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
164447470|NCT03990649|594007448|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
164447471|NCT03050814|594007449|FG000|Overall Study|Screen failures|0|||
164447472|NCT03050814|594007450|FG001|Overall Study|Screen failures|0|||
164447473|NCT03050814|594007451|FG002|Overall Study|Screen failures|4|||
164447474|NCT04512482|594007458|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
164447475|NCT04512482|594007459|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
164447476|NCT05119855|594007461|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
164447477|NCT05119855|594007462|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
164447478|NCT05119855|594007461|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
164447479|NCT05119855|594007462|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
164447480|NCT05119855|594007461|FG000|Overall Study|Lost to Follow-up|6|||
164447481|NCT05119855|594007462|FG001|Overall Study|Lost to Follow-up|8|||
164447482|NCT02932579|594007464|FG000|Overall Study|Withdrawal by Subject|4|||
164447483|NCT02932579|594007465|FG001|Overall Study|Withdrawal by Subject|1|||
164447484|NCT04759833|594007466|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
164447485|NCT04759833|594007467|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
164447486|NCT04759833|594007468|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
164447487|NCT04759833|594007469|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
164447488|NCT04759833|594007470|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
164447489|NCT04759833|594007466|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
164447490|NCT04759833|594007467|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
164447491|NCT04759833|594007468|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
164447492|NCT04759833|594007469|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
164447493|NCT04759833|594007470|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
164447494|NCT04759833|594007466|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
164447495|NCT04759833|594007467|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
164447496|NCT04759833|594007468|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
164447497|NCT04759833|594007469|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
164447498|NCT04759833|594007470|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
164447499|NCT04759833|594007466|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
164447500|NCT04759833|594007467|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
164447501|NCT04759833|594007468|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
164447502|NCT04759833|594007469|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
164447503|NCT04759833|594007470|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
164447504|NCT04759833|594007466|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
164447505|NCT04759833|594007467|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
164447506|NCT04759833|594007468|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
164447507|NCT04759833|594007469|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
164447508|NCT04759833|594007470|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
164447509|NCT04759833|594007466|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
164597014|NCT02052778|594549005|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164597015|NCT02052778|594549006|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164597016|NCT02052778|594549007|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
164597017|NCT02052778|594549008|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
164597018|NCT02052778|594549009|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164447510|NCT04759833|594007467|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
164447511|NCT04759833|594007468|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
164447512|NCT04759833|594007469|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
164447513|NCT04759833|594007470|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
164447514|NCT04759833|594007466|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
164447515|NCT04759833|594007467|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
164447516|NCT04759833|594007468|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
164447517|NCT04759833|594007469|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
164447518|NCT04759833|594007470|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
164447519|NCT04759833|594007466|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
164447520|NCT04759833|594007467|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
164447521|NCT04759833|594007468|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
164447522|NCT04759833|594007469|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
164447523|NCT04759833|594007470|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
164447524|NCT04759833|594007466|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
164447525|NCT04759833|594007467|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
164447526|NCT04759833|594007468|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
164447527|NCT04759833|594007469|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
164447528|NCT04759833|594007470|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
164447529|NCT04759833|594007466|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
164447530|NCT04759833|594007467|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
164447531|NCT04759833|594007468|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
164447532|NCT04759833|594007469|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
164447533|NCT04759833|594007470|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
164447534|NCT04759833|594007466|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
164447535|NCT04759833|594007467|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
164447536|NCT04759833|594007468|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
164447537|NCT04759833|594007469|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
164447538|NCT04759833|594007470|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
164447539|NCT04759833|594007466|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
164447540|NCT04759833|594007467|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
164447541|NCT04759833|594007468|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
164447542|NCT04759833|594007469|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
164447543|NCT04759833|594007470|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
164447544|NCT04759833|594007466|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
164447545|NCT04759833|594007467|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
164447546|NCT04759833|594007468|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
164447547|NCT04759833|594007469|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
164447548|NCT04759833|594007470|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
164447549|NCT00508924|594007471|FG000|Overall Study|Protocol Violation|0|||
164447550|NCT00508924|594007472|FG001|Overall Study|Protocol Violation|0|||
164447551|NCT00508924|594007473|FG002|Overall Study|Protocol Violation|1|||
164447552|NCT00508924|594007474|FG003|Overall Study|Protocol Violation|1|||
164447553|NCT00630058|594007476|FG000|Overall Study|Adverse Event|1|||
164447554|NCT00630058|594007477|FG001|Overall Study|Adverse Event|1|||
164447555|NCT00630058|594007476|FG000|Overall Study|Withdrawal by Subject|0|||
164447556|NCT00630058|594007477|FG001|Overall Study|Withdrawal by Subject|1|||
164597019|NCT02052778|594549010|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
164597020|NCT02052778|594549011|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
164597021|NCT02052778|594549012|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
164597022|NCT02052778|594549013|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
164597023|NCT02052778|594549014|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
164597024|NCT02052778|594549015|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164597025|NCT02052778|594548993|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164706336|NCT02393248|594953433|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
164706337|NCT02393248|594953434|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
164706338|NCT02393248|594953435|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
164597026|NCT02052778|594548994|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164597027|NCT02052778|594548995|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164597028|NCT02052778|594548996|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164597029|NCT02052778|594548997|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164706339|NCT02393248|594953436|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
164706340|NCT02393248|594953437|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
164706341|NCT02393248|594953438|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
164447557|NCT00630058|594007476|FG000|Overall Study|stopping criteria|3|||
164447558|NCT00630058|594007477|FG001|Overall Study|stopping criteria|2|||
164447559|NCT00391898|594007484|FG000|Overall Study|Adverse Event|3|||
164447560|NCT00391898|594007485|FG001|Overall Study|Adverse Event|0|||
164447561|NCT00391898|594007484|FG000|Overall Study|Other|8|||
164447562|NCT00391898|594007485|FG001|Overall Study|Other|10|||
164447563|NCT05489484|594007486|FG000|Overall Study|withdrawn|1|||
164447564|NCT02529995|594007487|FG000|Part A|Ongoing Study at Data Cut-off|14|||
164447565|NCT02529995|594007488|FG001|Part A|Ongoing Study at Data Cut-off|16|||
164447566|NCT02529995|594007487|FG000|Part A|Discontinued Study|1|||
164447567|NCT02529995|594007488|FG001|Part A|Discontinued Study|0|||
164447568|NCT02529995|594007487|FG000|Part B|Ongoing Study at Data Cut-off|0|||
164447569|NCT02529995|594007488|FG001|Part B|Ongoing Study at Data Cut-off|7|||
164447570|NCT02529995|594007487|FG000|Part B|Discontinued Study|6|||
164706342|NCT02393248|594953414|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
164706343|NCT02393248|594953415|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164706344|NCT02393248|594953416|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164706345|NCT02393248|594953417|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164706346|NCT02393248|594953418|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164706347|NCT02393248|594953419|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164706348|NCT02393248|594953420|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164706349|NCT02393248|594953421|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164706350|NCT02393248|594953422|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164706351|NCT02393248|594953423|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164706352|NCT02393248|594953424|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164706353|NCT02393248|594953425|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164706354|NCT02393248|594953426|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164706355|NCT02393248|594953427|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164706356|NCT02393248|594953428|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164706357|NCT02393248|594953429|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164447571|NCT02529995|594007488|FG001|Part B|Discontinued Study|5|||
164447572|NCT02706717|594007489|FG000|Overall Study|Withdrawal by Subject|1|||
164447573|NCT02706717|594007490|FG001|Overall Study|Withdrawal by Subject|8|||
164447574|NCT02706717|594007489|FG000|Overall Study|Lost to Follow-up|0|||
164447575|NCT02706717|594007490|FG001|Overall Study|Lost to Follow-up|1|||
164447576|NCT02706717|594007489|FG000|Overall Study|Physician Decision|0|||
164447577|NCT02706717|594007490|FG001|Overall Study|Physician Decision|1|||
164447578|NCT02706717|594007489|FG000|Overall Study|Death|0|||
164447579|NCT02706717|594007490|FG001|Overall Study|Death|1|||
164447580|NCT00444600|594007491|FG000|Overall Study|Death|7|||
164447581|NCT00444600|594007492|FG001|Overall Study|Death|5|||
164447582|NCT00444600|594007493|FG002|Overall Study|Death|3|||
164447583|NCT00444600|594007494|FG003|Overall Study|Death|2|||
164447584|NCT00444600|594007491|FG000|Overall Study|Dropped|11|||
164447585|NCT00444600|594007492|FG001|Overall Study|Dropped|11|||
164447586|NCT00444600|594007493|FG002|Overall Study|Dropped|7|||
164447587|NCT00444600|594007494|FG003|Overall Study|Dropped|7|||
164447588|NCT00444600|594007491|FG000|Overall Study|Missed visit|1|||
164447589|NCT00444600|594007492|FG001|Overall Study|Missed visit|0|||
164447590|NCT00444600|594007493|FG002|Overall Study|Missed visit|0|||
164447591|NCT00444600|594007494|FG003|Overall Study|Missed visit|1|||
164447592|NCT05132478|594007495|FG000|Overall Study|did not complete survey after consent|1|||
164447593|NCT05132478|594007496|FG001|Overall Study|did not complete survey after consent|1|||
164447594|NCT05132478|594007495|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
164706358|NCT02393248|594953430|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164706359|NCT02393248|594953431|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164706360|NCT02393248|594953432|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164706361|NCT02393248|594953433|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164706362|NCT02393248|594953434|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164706363|NCT02393248|594953435|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164706364|NCT02393248|594953436|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164447595|NCT05132478|594007496|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
164447596|NCT02549170|594007497|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
164447597|NCT02549170|594007498|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
164447598|NCT02549170|594007499|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
164447599|NCT02549170|594007500|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
164447600|NCT02549170|594007501|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
164447601|NCT02549170|594007497|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
164447602|NCT02549170|594007498|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
164447603|NCT02549170|594007499|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
164144044|NCT00086281|592888583|FG012|Phase 2|Adverse Event|1|||
164447604|NCT02549170|594007500|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
164447605|NCT02549170|594007501|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
164447606|NCT02549170|594007497|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
164447607|NCT02549170|594007498|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
164447608|NCT02549170|594007499|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
164447609|NCT02549170|594007500|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
164447610|NCT02549170|594007501|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
164447611|NCT02988817|594007502|FG000|Overall Study|Withdrawal by Subject|1|||
164447612|NCT02988817|594007503|FG001|Overall Study|Withdrawal by Subject|0|||
164447613|NCT02988817|594007504|FG002|Overall Study|Withdrawal by Subject|0|||
164447614|NCT02988817|594007505|FG003|Overall Study|Withdrawal by Subject|1|||
164447615|NCT02988817|594007506|FG004|Overall Study|Withdrawal by Subject|3|||
164447616|NCT02988817|594007507|FG005|Overall Study|Withdrawal by Subject|1|||
164447617|NCT02988817|594007508|FG006|Overall Study|Withdrawal by Subject|2|||
164447618|NCT02988817|594007509|FG007|Overall Study|Withdrawal by Subject|1|||
164447619|NCT02988817|594007510|FG008|Overall Study|Withdrawal by Subject|1|||
164447620|NCT02988817|594007511|FG009|Overall Study|Withdrawal by Subject|1|||
164447621|NCT02988817|594007512|FG010|Overall Study|Withdrawal by Subject|1|||
164447622|NCT02988817|594007513|FG011|Overall Study|Withdrawal by Subject|12|||
164447623|NCT02988817|594007514|FG012|Overall Study|Withdrawal by Subject|6|||
164447624|NCT02988817|594007515|FG013|Overall Study|Withdrawal by Subject|6|||
164447625|NCT02988817|594007516|FG014|Overall Study|Withdrawal by Subject|4|||
164447626|NCT02988817|594007517|FG015|Overall Study|Withdrawal by Subject|5|||
164447627|NCT02988817|594007518|FG016|Overall Study|Withdrawal by Subject|4|||
164447628|NCT02988817|594007519|FG017|Overall Study|Withdrawal by Subject|11|||
164447629|NCT02988817|594007520|FG018|Overall Study|Withdrawal by Subject|4|||
164447630|NCT02988817|594007521|FG019|Overall Study|Withdrawal by Subject|2|||
164447631|NCT02988817|594007502|FG000|Overall Study|Death|0|||
164447632|NCT02988817|594007503|FG001|Overall Study|Death|1|||
164447633|NCT02988817|594007504|FG002|Overall Study|Death|3|||
164447634|NCT02988817|594007505|FG003|Overall Study|Death|1|||
164447635|NCT02988817|594007506|FG004|Overall Study|Death|6|||
164447636|NCT02988817|594007507|FG005|Overall Study|Death|10|||
164447637|NCT02988817|594007508|FG006|Overall Study|Death|1|||
164447638|NCT02988817|594007509|FG007|Overall Study|Death|2|||
164447639|NCT02988817|594007510|FG008|Overall Study|Death|1|||
164447640|NCT02988817|594007511|FG009|Overall Study|Death|5|||
164447641|NCT02988817|594007512|FG010|Overall Study|Death|1|||
164447642|NCT02988817|594007513|FG011|Overall Study|Death|8|||
164447643|NCT02988817|594007514|FG012|Overall Study|Death|9|||
164447644|NCT02988817|594007515|FG013|Overall Study|Death|17|||
164447645|NCT02988817|594007516|FG014|Overall Study|Death|18|||
164447646|NCT02988817|594007517|FG015|Overall Study|Death|30|||
164447647|NCT02988817|594007518|FG016|Overall Study|Death|17|||
164447648|NCT02988817|594007519|FG017|Overall Study|Death|38|||
164447649|NCT02988817|594007520|FG018|Overall Study|Death|14|||
164447650|NCT02988817|594007521|FG019|Overall Study|Death|16|||
164447651|NCT02988817|594007502|FG000|Overall Study|Other|0|||
164447652|NCT02988817|594007503|FG001|Overall Study|Other|0|||
164447653|NCT02988817|594007504|FG002|Overall Study|Other|0|||
164447654|NCT02988817|594007505|FG003|Overall Study|Other|1|||
164447655|NCT02988817|594007506|FG004|Overall Study|Other|1|||
164447656|NCT02988817|594007507|FG005|Overall Study|Other|0|||
164447657|NCT02988817|594007508|FG006|Overall Study|Other|0|||
164447658|NCT02988817|594007509|FG007|Overall Study|Other|0|||
164447659|NCT02988817|594007510|FG008|Overall Study|Other|0|||
164447660|NCT02988817|594007511|FG009|Overall Study|Other|0|||
164447661|NCT02988817|594007512|FG010|Overall Study|Other|0|||
164447662|NCT02988817|594007513|FG011|Overall Study|Other|0|||
164447663|NCT02988817|594007514|FG012|Overall Study|Other|0|||
164447664|NCT02988817|594007515|FG013|Overall Study|Other|0|||
164447665|NCT02988817|594007516|FG014|Overall Study|Other|0|||
164447666|NCT02988817|594007517|FG015|Overall Study|Other|1|||
164447667|NCT02988817|594007518|FG016|Overall Study|Other|0|||
164447668|NCT02988817|594007519|FG017|Overall Study|Other|0|||
164447669|NCT02988817|594007520|FG018|Overall Study|Other|0|||
164447670|NCT02988817|594007521|FG019|Overall Study|Other|0|||
164447671|NCT02988817|594007502|FG000|Overall Study|Lost to Follow-up|0|||
164447672|NCT02988817|594007503|FG001|Overall Study|Lost to Follow-up|0|||
164447673|NCT02988817|594007504|FG002|Overall Study|Lost to Follow-up|0|||
164447674|NCT02988817|594007505|FG003|Overall Study|Lost to Follow-up|0|||
164447675|NCT02988817|594007506|FG004|Overall Study|Lost to Follow-up|0|||
164447676|NCT02988817|594007507|FG005|Overall Study|Lost to Follow-up|0|||
164447677|NCT02988817|594007508|FG006|Overall Study|Lost to Follow-up|0|||
164447678|NCT02988817|594007509|FG007|Overall Study|Lost to Follow-up|0|||
164447679|NCT02988817|594007510|FG008|Overall Study|Lost to Follow-up|1|||
164597030|NCT02052778|594548998|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164447680|NCT02988817|594007511|FG009|Overall Study|Lost to Follow-up|0|||
164447681|NCT02988817|594007512|FG010|Overall Study|Lost to Follow-up|1|||
164447682|NCT02988817|594007513|FG011|Overall Study|Lost to Follow-up|1|||
164447683|NCT02988817|594007514|FG012|Overall Study|Lost to Follow-up|0|||
164447684|NCT02988817|594007515|FG013|Overall Study|Lost to Follow-up|0|||
164447685|NCT02988817|594007516|FG014|Overall Study|Lost to Follow-up|1|||
164447686|NCT02988817|594007517|FG015|Overall Study|Lost to Follow-up|1|||
164706365|NCT02393248|594953437|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164706366|NCT02393248|594953438|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164706367|NCT02393248|594953414|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164706368|NCT02393248|594953415|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164706369|NCT02393248|594953416|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164706370|NCT02393248|594953417|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164706371|NCT02393248|594953418|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164447687|NCT02988817|594007518|FG016|Overall Study|Lost to Follow-up|2|||
164447688|NCT02988817|594007519|FG017|Overall Study|Lost to Follow-up|3|||
164447689|NCT02988817|594007520|FG018|Overall Study|Lost to Follow-up|0|||
164706372|NCT02393248|594953419|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
164447690|NCT02988817|594007521|FG019|Overall Study|Lost to Follow-up|0|||
164447691|NCT02988817|594007502|FG000|Overall Study|Sponsor decision|0|||
164447692|NCT02988817|594007503|FG001|Overall Study|Sponsor decision|0|||
164447693|NCT02988817|594007504|FG002|Overall Study|Sponsor decision|0|||
164447694|NCT02988817|594007505|FG003|Overall Study|Sponsor decision|0|||
164447695|NCT02988817|594007506|FG004|Overall Study|Sponsor decision|0|||
164447696|NCT02988817|594007507|FG005|Overall Study|Sponsor decision|0|||
164447697|NCT02988817|594007508|FG006|Overall Study|Sponsor decision|0|||
164447698|NCT02988817|594007509|FG007|Overall Study|Sponsor decision|0|||
164447699|NCT02988817|594007510|FG008|Overall Study|Sponsor decision|0|||
164447700|NCT02988817|594007511|FG009|Overall Study|Sponsor decision|0|||
164447701|NCT02988817|594007512|FG010|Overall Study|Sponsor decision|0|||
164447702|NCT02988817|594007513|FG011|Overall Study|Sponsor decision|1|||
164447703|NCT02988817|594007514|FG012|Overall Study|Sponsor decision|1|||
164447704|NCT02988817|594007515|FG013|Overall Study|Sponsor decision|2|||
164447705|NCT02988817|594007516|FG014|Overall Study|Sponsor decision|2|||
164706373|NCT02393248|594953420|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
164706374|NCT02393248|594953421|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164706375|NCT02393248|594953422|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164706376|NCT02393248|594953423|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
164706377|NCT02393248|594953424|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164404352|NCT00608582|593850152|FG001|Overall Study|No Best Response in Phase 1 located|1|||
164404353|NCT00608582|593850151|FG000|Overall Study|Illicit Drug Use|1|||
164404354|NCT00608582|593850152|FG001|Overall Study|Illicit Drug Use|0|||
164404355|NCT00608582|593850151|FG000|Overall Study|Early stage Design Change|0|||
164404356|NCT00608582|593850152|FG001|Overall Study|Early stage Design Change|3|||
164404357|NCT04922554|593850153|FG000|Overall Study|Adverse Event|4|||
164404358|NCT04922554|593850154|FG001|Overall Study|Adverse Event|0|||
164404359|NCT04922554|593850153|FG000|Overall Study|Withdrawal by Subject|1|||
164404360|NCT04922554|593850154|FG001|Overall Study|Withdrawal by Subject|0|||
164404361|NCT03308825|593851884|FG000|Overall Study|Lost to Follow-up|2|||
164404362|NCT03308825|593851885|FG001|Overall Study|Lost to Follow-up|2|||
164404363|NCT03308825|593851886|FG002|Overall Study|Lost to Follow-up|1|||
164404364|NCT03308825|593851887|FG003|Overall Study|Lost to Follow-up|0|||
164404365|NCT03308825|593851884|FG000|Overall Study|Protocol Violation|0|||
164404366|NCT03308825|593851885|FG001|Overall Study|Protocol Violation|2|||
164404367|NCT03308825|593851886|FG002|Overall Study|Protocol Violation|0|||
164404368|NCT03308825|593851887|FG003|Overall Study|Protocol Violation|0|||
164404369|NCT03559218|593851889|FG000|Overall Study|Withdrawal by Subject|1|||
164447706|NCT02988817|594007517|FG015|Overall Study|Sponsor decision|6|||
164447707|NCT02988817|594007518|FG016|Overall Study|Sponsor decision|2|||
164404370|NCT03559218|593851890|FG001|Overall Study|Withdrawal by Subject|0|||
164404371|NCT04277455|593851891|FG000|Overall Study|Lost to Follow-up|1|||
164404372|NCT04737109|593851901|FG000|Study Treatment|Disease Progression|5|||
164404373|NCT04737109|593851902|FG001|Study Treatment|Disease Progression|0|||
164404374|NCT04737109|593851903|FG002|Study Treatment|Disease Progression|0|||
164404375|NCT04737109|593851904|FG003|Study Treatment|Disease Progression|0|||
164447708|NCT02988817|594007519|FG017|Overall Study|Sponsor decision|3|||
164447709|NCT02988817|594007520|FG018|Overall Study|Sponsor decision|2|||
164447710|NCT02988817|594007521|FG019|Overall Study|Sponsor decision|7|||
164404376|NCT04737109|593851901|FG000|Study Treatment|Death on study|1|||
164404377|NCT04737109|593851902|FG001|Study Treatment|Death on study|0|||
164404378|NCT04737109|593851903|FG002|Study Treatment|Death on study|0|||
164447711|NCT02988817|594007502|FG000|Overall Study|Physician Decision|0|||
164447712|NCT02988817|594007503|FG001|Overall Study|Physician Decision|0|||
164447713|NCT02988817|594007504|FG002|Overall Study|Physician Decision|0|||
164447714|NCT02988817|594007505|FG003|Overall Study|Physician Decision|0|||
164447715|NCT02988817|594007506|FG004|Overall Study|Physician Decision|0|||
164447716|NCT02988817|594007507|FG005|Overall Study|Physician Decision|0|||
164447717|NCT02988817|594007508|FG006|Overall Study|Physician Decision|0|||
164447718|NCT02988817|594007509|FG007|Overall Study|Physician Decision|0|||
164447719|NCT02988817|594007510|FG008|Overall Study|Physician Decision|0|||
164447720|NCT02988817|594007511|FG009|Overall Study|Physician Decision|0|||
164447721|NCT02988817|594007512|FG010|Overall Study|Physician Decision|0|||
164447722|NCT02988817|594007513|FG011|Overall Study|Physician Decision|0|||
164447723|NCT02988817|594007514|FG012|Overall Study|Physician Decision|0|||
164447724|NCT02988817|594007515|FG013|Overall Study|Physician Decision|0|||
164447725|NCT02988817|594007516|FG014|Overall Study|Physician Decision|0|||
164447726|NCT02988817|594007517|FG015|Overall Study|Physician Decision|1|||
164447727|NCT02988817|594007518|FG016|Overall Study|Physician Decision|0|||
164447728|NCT02988817|594007519|FG017|Overall Study|Physician Decision|0|||
164447729|NCT02988817|594007520|FG018|Overall Study|Physician Decision|1|||
164447730|NCT02988817|594007521|FG019|Overall Study|Physician Decision|1|||
164447731|NCT00421889|594007523|FG000|Overall Study|Adverse Event|1|||
164447732|NCT00421889|594007524|FG001|Overall Study|Adverse Event|0|||
164447733|NCT00421889|594007525|FG002|Overall Study|Adverse Event|1|||
164447734|NCT00421889|594007526|FG003|Overall Study|Adverse Event|1|||
164447735|NCT00421889|594007527|FG004|Overall Study|Adverse Event|1|||
164447736|NCT00421889|594007528|FG005|Overall Study|Adverse Event|4|||
164447737|NCT00421889|594007529|FG006|Overall Study|Adverse Event|1|||
164447738|NCT00421889|594007530|FG007|Overall Study|Adverse Event|0|||
164447739|NCT00421889|594007531|FG008|Overall Study|Adverse Event|2|||
164447740|NCT00421889|594007523|FG000|Overall Study|Withdrawal by Subject|1|||
164447741|NCT00421889|594007524|FG001|Overall Study|Withdrawal by Subject|3|||
164447742|NCT00421889|594007525|FG002|Overall Study|Withdrawal by Subject|0|||
164447743|NCT00421889|594007526|FG003|Overall Study|Withdrawal by Subject|0|||
164447744|NCT00421889|594007527|FG004|Overall Study|Withdrawal by Subject|2|||
164447745|NCT00421889|594007528|FG005|Overall Study|Withdrawal by Subject|0|||
164447746|NCT00421889|594007529|FG006|Overall Study|Withdrawal by Subject|0|||
164447747|NCT00421889|594007530|FG007|Overall Study|Withdrawal by Subject|0|||
164447748|NCT00421889|594007531|FG008|Overall Study|Withdrawal by Subject|0|||
164447749|NCT00421889|594007523|FG000|Overall Study|Death|0|||
164447750|NCT00421889|594007524|FG001|Overall Study|Death|0|||
164447751|NCT00421889|594007525|FG002|Overall Study|Death|0|||
164447752|NCT00421889|594007526|FG003|Overall Study|Death|0|||
164447753|NCT00421889|594007527|FG004|Overall Study|Death|1|||
164447754|NCT00421889|594007528|FG005|Overall Study|Death|1|||
164447755|NCT00421889|594007529|FG006|Overall Study|Death|0|||
164447756|NCT00421889|594007530|FG007|Overall Study|Death|0|||
164447757|NCT00421889|594007531|FG008|Overall Study|Death|0|||
164447758|NCT00421889|594007523|FG000|Overall Study|Progressive disease|3|||
164447759|NCT00421889|594007524|FG001|Overall Study|Progressive disease|2|||
164447760|NCT00421889|594007525|FG002|Overall Study|Progressive disease|2|||
164447761|NCT00421889|594007526|FG003|Overall Study|Progressive disease|3|||
164447762|NCT00421889|594007527|FG004|Overall Study|Progressive disease|2|||
164447763|NCT00421889|594007528|FG005|Overall Study|Progressive disease|21|||
164447764|NCT00421889|594007529|FG006|Overall Study|Progressive disease|3|||
164447765|NCT00421889|594007530|FG007|Overall Study|Progressive disease|1|||
164447766|NCT00421889|594007531|FG008|Overall Study|Progressive disease|5|||
164447767|NCT00421889|594007523|FG000|Overall Study|Patient/Investigator request|0|||
164447768|NCT00421889|594007524|FG001|Overall Study|Patient/Investigator request|0|||
164447769|NCT00421889|594007525|FG002|Overall Study|Patient/Investigator request|0|||
164447770|NCT00421889|594007526|FG003|Overall Study|Patient/Investigator request|0|||
164706378|NCT02393248|594953425|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164706379|NCT02393248|594953426|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164706380|NCT02393248|594953427|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164706381|NCT02393248|594953428|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164706382|NCT02393248|594953429|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164706383|NCT02393248|594953430|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164447771|NCT00421889|594007527|FG004|Overall Study|Patient/Investigator request|0|||
164447772|NCT00421889|594007528|FG005|Overall Study|Patient/Investigator request|9|||
164447773|NCT00421889|594007529|FG006|Overall Study|Patient/Investigator request|0|||
164447774|NCT00421889|594007530|FG007|Overall Study|Patient/Investigator request|1|||
164447775|NCT00421889|594007531|FG008|Overall Study|Patient/Investigator request|3|||
164447776|NCT00421889|594007523|FG000|Overall Study|Lost to Follow-up|0|||
164447777|NCT00421889|594007524|FG001|Overall Study|Lost to Follow-up|0|||
164447778|NCT00421889|594007525|FG002|Overall Study|Lost to Follow-up|0|||
164447779|NCT00421889|594007526|FG003|Overall Study|Lost to Follow-up|0|||
164447780|NCT00421889|594007527|FG004|Overall Study|Lost to Follow-up|0|||
164447781|NCT00421889|594007528|FG005|Overall Study|Lost to Follow-up|0|||
164447782|NCT00421889|594007529|FG006|Overall Study|Lost to Follow-up|0|||
164447783|NCT00421889|594007530|FG007|Overall Study|Lost to Follow-up|0|||
164447784|NCT00421889|594007531|FG008|Overall Study|Lost to Follow-up|1|||
164447785|NCT00111813|594007532|FG000|Overall Study|Adverse Event|1|||
164447786|NCT00111813|594007533|FG001|Overall Study|Adverse Event|2|||
164447787|NCT00111813|594007534|FG002|Overall Study|Adverse Event|4|||
164447788|NCT00111813|594007535|FG003|Overall Study|Adverse Event|2|||
164447789|NCT00111813|594007536|FG004|Overall Study|Adverse Event|2|||
164447790|NCT00111813|594007537|FG005|Overall Study|Adverse Event|2|||
164447791|NCT00111813|594007532|FG000|Overall Study|Progressive disease|2|||
164447792|NCT00111813|594007533|FG001|Overall Study|Progressive disease|1|||
164447793|NCT00111813|594007534|FG002|Overall Study|Progressive disease|5|||
164447794|NCT00111813|594007535|FG003|Overall Study|Progressive disease|3|||
164447795|NCT00111813|594007536|FG004|Overall Study|Progressive disease|4|||
164447796|NCT00111813|594007537|FG005|Overall Study|Progressive disease|3|||
164447797|NCT00111813|594007532|FG000|Overall Study|Lack of Efficacy|0|||
164447798|NCT00111813|594007533|FG001|Overall Study|Lack of Efficacy|0|||
164447799|NCT00111813|594007534|FG002|Overall Study|Lack of Efficacy|0|||
164447800|NCT00111813|594007535|FG003|Overall Study|Lack of Efficacy|0|||
164447801|NCT00111813|594007536|FG004|Overall Study|Lack of Efficacy|0|||
164447802|NCT00111813|594007537|FG005|Overall Study|Lack of Efficacy|1|||
164447803|NCT00111813|594007532|FG000|Overall Study|Other|0|||
164447804|NCT00111813|594007533|FG001|Overall Study|Other|0|||
164447805|NCT00111813|594007534|FG002|Overall Study|Other|1|||
164447806|NCT00111813|594007535|FG003|Overall Study|Other|0|||
164447807|NCT00111813|594007536|FG004|Overall Study|Other|0|||
164447808|NCT00111813|594007537|FG005|Overall Study|Other|0|||
164447809|NCT01610297|594007538|FG000|Overall Study|Lost to Follow-up|1|||
164447810|NCT00818246|594007539|FG000|Overall Study|Impossible to match pictures|5|||
164447811|NCT02121002|594007540|FG000|Overall Study|Physician Decision|2|||
164447812|NCT02121002|594007541|FG001|Overall Study|Physician Decision|0|||
164447813|NCT02121002|594007542|FG002|Overall Study|Physician Decision|0|||
164447814|NCT02121002|594007540|FG000|Overall Study|Withdrawal by Subject|3|||
164447815|NCT02121002|594007541|FG001|Overall Study|Withdrawal by Subject|1|||
164447816|NCT02121002|594007542|FG002|Overall Study|Withdrawal by Subject|4|||
164447817|NCT02121002|594007540|FG000|Overall Study|Protocol Violation|1|||
164447818|NCT02121002|594007541|FG001|Overall Study|Protocol Violation|2|||
164447819|NCT02121002|594007542|FG002|Overall Study|Protocol Violation|4|||
164447820|NCT02121002|594007540|FG000|Overall Study|Concomitant therapy|0|||
164447821|NCT02121002|594007541|FG001|Overall Study|Concomitant therapy|1|||
164447822|NCT02121002|594007542|FG002|Overall Study|Concomitant therapy|1|||
164447823|NCT02121002|594007540|FG000|Overall Study|Others|1|||
164447824|NCT02121002|594007541|FG001|Overall Study|Others|0|||
164447825|NCT02121002|594007542|FG002|Overall Study|Others|1|||
164447826|NCT02590432|594007543|FG000|Open-label Treatment Period|Adverse Event|97|||
164447827|NCT02590432|594007544|FG001|Open-label Treatment Period|Adverse Event|79|||
164447828|NCT02590432|594007545|FG002|Open-label Treatment Period|Adverse Event|0|||
164447829|NCT02590432|594007546|FG003|Open-label Treatment Period|Adverse Event|0|||
164447830|NCT02590432|594007547|FG004|Open-label Treatment Period|Adverse Event|0|||
164447831|NCT02590432|594007548|FG005|Open-label Treatment Period|Adverse Event|0|||
164447832|NCT02590432|594007549|FG006|Open-label Treatment Period|Adverse Event|0|||
164447833|NCT02590432|594007550|FG007|Open-label Treatment Period|Adverse Event|0|||
164447834|NCT02590432|594007551|FG008|Open-label Treatment Period|Adverse Event|0|||
164447835|NCT02590432|594007543|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
164447836|NCT02590432|594007544|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
164597031|NCT02052778|594548999|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164597032|NCT02052778|594549000|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164597033|NCT02052778|594549001|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164597034|NCT02052778|594549002|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164597035|NCT02052778|594549003|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164597036|NCT02052778|594549004|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164597037|NCT02052778|594549005|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164597038|NCT02052778|594549006|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164597039|NCT02052778|594549007|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
164597040|NCT02052778|594549008|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
164144045|NCT00086281|592888584|FG013|Phase 2|Adverse Event|1|||
164447837|NCT02590432|594007545|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
164447838|NCT02590432|594007546|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
164447839|NCT02590432|594007547|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
164447840|NCT02590432|594007548|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
164447841|NCT02590432|594007549|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
164447842|NCT02590432|594007550|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
164447843|NCT02590432|594007551|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
164447844|NCT02590432|594007543|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
164447845|NCT02590432|594007544|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
164447846|NCT02590432|594007545|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
164447847|NCT02590432|594007546|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
164447848|NCT02590432|594007547|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
164447849|NCT02590432|594007548|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
164447850|NCT02590432|594007549|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
164447851|NCT02590432|594007550|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
164447852|NCT02590432|594007551|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
164447853|NCT02590432|594007543|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
164447854|NCT02590432|594007544|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
164447855|NCT02590432|594007545|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
164447856|NCT02590432|594007546|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
164447857|NCT02590432|594007547|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
164447858|NCT02590432|594007548|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
164447859|NCT02590432|594007549|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
164447860|NCT02590432|594007550|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
164447861|NCT02590432|594007551|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
164447862|NCT02590432|594007543|FG000|Open-label Treatment Period|Protocol Violation|10|||
164447863|NCT02590432|594007544|FG001|Open-label Treatment Period|Protocol Violation|4|||
164447864|NCT02590432|594007545|FG002|Open-label Treatment Period|Protocol Violation|0|||
164447865|NCT02590432|594007546|FG003|Open-label Treatment Period|Protocol Violation|0|||
164447866|NCT02590432|594007547|FG004|Open-label Treatment Period|Protocol Violation|0|||
164447867|NCT02590432|594007548|FG005|Open-label Treatment Period|Protocol Violation|0|||
164404379|NCT04737109|593851904|FG003|Study Treatment|Death on study|0|||
164404380|NCT03092375|593851905|FG000|Overall Study|Lack of Efficacy|0|||
164404381|NCT03092375|593851906|FG001|Overall Study|Lack of Efficacy|1|||
164404382|NCT03092375|593851907|FG002|Overall Study|Lack of Efficacy|1|||
164404383|NCT03092375|593851908|FG003|Overall Study|Lack of Efficacy|0|||
164404384|NCT01679301|593851909|FG000|Screening Period|screen failure|3|||
164404385|NCT01679301|593851910|FG001|Screening Period|screen failure|0|||
164404386|NCT01679301|593851911|FG002|Screening Period|screen failure|0|||
164404387|NCT02790073|593851914|FG000|Overall Study|Death|1|||
164404388|NCT02790073|593851914|FG000|Overall Study|Withdrawal from HD|1|||
164404389|NCT02790073|593851914|FG000|Overall Study|Withdrawal by Subject|1|||
164404390|NCT03328143|593851915|FG000|Overall Study|Declined|3|||
164404391|NCT03328143|593851915|FG000|Overall Study|Required increased sedation|4|||
164404392|NCT03328143|593851915|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
164404393|NCT03328143|593851915|FG000|Overall Study|Surgery cancelled|1|||
164404394|NCT00861614|593851916|FG000|Overall Study|Disease Progression|182|||
164404395|NCT00861614|593851917|FG001|Overall Study|Disease Progression|263|||
164404396|NCT00861614|593851916|FG000|Overall Study|Study Drug Toxicity|79|||
164404397|NCT00861614|593851917|FG001|Overall Study|Study Drug Toxicity|6|||
164404398|NCT00861614|593851916|FG000|Overall Study|Death|32|||
164404399|NCT00861614|593851917|FG001|Overall Study|Death|19|||
164404400|NCT00861614|593851916|FG000|Overall Study|Adverse Event|27|||
164404401|NCT00861614|593851917|FG001|Overall Study|Adverse Event|23|||
164404402|NCT00861614|593851916|FG000|Overall Study|Withdrawal by Subject|34|||
164404403|NCT00861614|593851917|FG001|Overall Study|Withdrawal by Subject|35|||
164404404|NCT00861614|593851916|FG000|Overall Study|Other|17|||
164404405|NCT00861614|593851917|FG001|Overall Study|Other|22|||
164404406|NCT00944658|593851918|FG000|Treatment 12 Weeks|Adverse Event|0|||
164404407|NCT00944658|593851919|FG001|Treatment 12 Weeks|Adverse Event|2|||
164404408|NCT02259517|593851920|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
164404409|NCT02259517|593851921|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
164404410|NCT02259517|593851922|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
164404411|NCT02259517|593851920|FG000|Overall Study|Withdrawal by Subject|0|||
164404412|NCT02259517|593851921|FG001|Overall Study|Withdrawal by Subject|0|||
164404413|NCT02259517|593851922|FG002|Overall Study|Withdrawal by Subject|3|||
164404414|NCT01289418|593851926|FG000|Day 8 Survey|email address invalid|283|||
164404415|NCT01289418|593851926|FG000|Day 8 Survey|participants did not complete the survey|1935|||
164404416|NCT01289418|593851926|FG000|Day 29 Survey|email address invalid|283|||
164404417|NCT01289418|593851926|FG000|Day 29 Survey|participants did not complete the survey|2185|||
164404418|NCT01564368|593851928|FG000|Overall Study|Ineligible|18|||
164404419|NCT01564368|593851928|FG000|Overall Study|Not Randomized in Parent study|116|||
164404420|NCT01564368|593851928|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
164404421|NCT01564368|593851928|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
164404422|NCT01802437|593851929|FG000|Overall Study|Lost to Follow-up|1|||
164404423|NCT01802437|593851930|FG001|Overall Study|Lost to Follow-up|0|||
164404424|NCT01802437|593851929|FG000|Overall Study|Withdrawal by Subject|3|||
164447868|NCT02590432|594007549|FG006|Open-label Treatment Period|Protocol Violation|0|||
164597041|NCT02052778|594549009|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
164597042|NCT02052778|594549010|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164597043|NCT02052778|594549011|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
164404425|NCT01802437|593851930|FG001|Overall Study|Withdrawal by Subject|4|||
164404426|NCT04810221|593851931|FG000|Overall Study|Physician Decision|3|||
164404427|NCT01181726|593851932|FG000|First Intervention|Adverse Event|1|||
164404428|NCT01181726|593851933|FG001|First Intervention|Adverse Event|0|||
164404429|NCT01264380|593851934|FG000|Period C|Disease Progression|0|||
164404430|NCT01264380|593851935|FG001|Period C|Disease Progression|0|||
164447869|NCT02590432|594007550|FG007|Open-label Treatment Period|Protocol Violation|0|||
164447870|NCT02590432|594007551|FG008|Open-label Treatment Period|Protocol Violation|0|||
164447871|NCT02590432|594007543|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
164447872|NCT02590432|594007544|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
164447873|NCT02590432|594007545|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
164447874|NCT02590432|594007546|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
164447875|NCT02590432|594007547|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
164447876|NCT02590432|594007548|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
164447877|NCT02590432|594007549|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
164447878|NCT02590432|594007550|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
164447879|NCT02590432|594007551|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
164447880|NCT02590432|594007543|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
164447881|NCT02590432|594007544|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
164447882|NCT02590432|594007545|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
164447883|NCT02590432|594007546|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
164447884|NCT02590432|594007547|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
164447885|NCT02590432|594007548|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
164447886|NCT02590432|594007549|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
164447887|NCT02590432|594007550|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
164447888|NCT02590432|594007551|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
164447889|NCT02590432|594007543|FG000|Double-blind Treatment Period|Adverse Event|0|||
164447890|NCT02590432|594007544|FG001|Double-blind Treatment Period|Adverse Event|0|||
164447891|NCT02590432|594007545|FG002|Double-blind Treatment Period|Adverse Event|14|||
164447892|NCT02590432|594007546|FG003|Double-blind Treatment Period|Adverse Event|12|||
164447893|NCT02590432|594007547|FG004|Double-blind Treatment Period|Adverse Event|6|||
164447894|NCT02590432|594007548|FG005|Double-blind Treatment Period|Adverse Event|22|||
164404431|NCT01264380|593851936|FG002|Period C|Disease Progression|4|||
164404432|NCT01264380|593851934|FG000|Period C|Death|0|||
164404433|NCT01264380|593851935|FG001|Period C|Death|0|||
164404434|NCT01264380|593851936|FG002|Period C|Death|2|||
164404435|NCT01264380|593851934|FG000|Period C|Follow-up for survival status|0|||
164404436|NCT01264380|593851935|FG001|Period C|Follow-up for survival status|0|||
164404437|NCT01264380|593851936|FG002|Period C|Follow-up for survival status|6|||
164404438|NCT01264380|593851934|FG000|Period C|Withdrawal by Subject|0|||
164404439|NCT01264380|593851935|FG001|Period C|Withdrawal by Subject|0|||
164404440|NCT01264380|593851936|FG002|Period C|Withdrawal by Subject|1|||
164404441|NCT01264380|593851934|FG000|Period C|Adverse Event|0|||
164404442|NCT01264380|593851935|FG001|Period C|Adverse Event|0|||
164404443|NCT01264380|593851936|FG002|Period C|Adverse Event|1|||
164404444|NCT04998604|593851938|FG000|Overall Study|Adverse Event|3|||
164404445|NCT04998604|593851939|FG001|Overall Study|Adverse Event|2|||
164404446|NCT04998604|593851938|FG000|Overall Study|Withdrawal by Subject|2|||
164404447|NCT04998604|593851939|FG001|Overall Study|Withdrawal by Subject|4|||
164404448|NCT04998604|593851938|FG000|Overall Study|Not related to coronavirus disease 2019 pandemic|2|||
164404449|NCT04998604|593851939|FG001|Overall Study|Not related to coronavirus disease 2019 pandemic|8|||
164404450|NCT05292534|593851944|FG000|Overall Study|Protocol Violation|3|||
164404451|NCT05292534|593851945|FG001|Overall Study|Protocol Violation|4|||
164404452|NCT05292534|593851944|FG000|Overall Study|Withdrawal by Subject|0|||
164404453|NCT05292534|593851945|FG001|Overall Study|Withdrawal by Subject|1|||
164404454|NCT01896869|593851950|FG000|Overall Study|Withdrawal by Subject|0|||
164404455|NCT01896869|593851951|FG001|Overall Study|Withdrawal by Subject|6|||
164404456|NCT01896869|593851950|FG000|Overall Study|Lost to Follow-up|1|||
164404457|NCT01896869|593851951|FG001|Overall Study|Lost to Follow-up|0|||
164404458|NCT04710927|593851957|FG000|Overall Study|Lost to Follow-up|7|||
164404459|NCT04710927|593851958|FG001|Overall Study|Lost to Follow-up|6|||
164404460|NCT04710927|593851959|FG002|Overall Study|Lost to Follow-up|5|||
164404461|NCT01376323|593851963|FG000|Overall Study|Adverse Event|1|||
164404462|NCT01376323|593851964|FG001|Overall Study|Adverse Event|0|||
164404463|NCT01376323|593851965|FG002|Overall Study|Adverse Event|0|||
164404464|NCT01376323|593851966|FG003|Overall Study|Adverse Event|2|||
164404465|NCT01376323|593851967|FG004|Overall Study|Adverse Event|0|||
164447895|NCT02590432|594007549|FG006|Double-blind Treatment Period|Adverse Event|20|||
164447896|NCT02590432|594007550|FG007|Double-blind Treatment Period|Adverse Event|0|||
164404466|NCT01376323|593851963|FG000|Overall Study|Lost to Follow-up|0|||
164404467|NCT01376323|593851964|FG001|Overall Study|Lost to Follow-up|0|||
164404468|NCT01376323|593851965|FG002|Overall Study|Lost to Follow-up|0|||
164404469|NCT01376323|593851966|FG003|Overall Study|Lost to Follow-up|2|||
164447897|NCT02590432|594007551|FG008|Double-blind Treatment Period|Adverse Event|0|||
164404470|NCT01376323|593851967|FG004|Overall Study|Lost to Follow-up|0|||
164404471|NCT01376323|593851963|FG000|Overall Study|Physician Decision|1|||
164404472|NCT01376323|593851964|FG001|Overall Study|Physician Decision|0|||
164404473|NCT01376323|593851965|FG002|Overall Study|Physician Decision|2|||
164404474|NCT01376323|593851966|FG003|Overall Study|Physician Decision|1|||
164404475|NCT01376323|593851967|FG004|Overall Study|Physician Decision|1|||
164447898|NCT02590432|594007543|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
164597044|NCT02052778|594549012|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
164597045|NCT02052778|594549013|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164597046|NCT02052778|594549014|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164597047|NCT02052778|594549015|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164597048|NCT02052778|594548993|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164447899|NCT02590432|594007544|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
164447900|NCT02590432|594007545|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
164447901|NCT02590432|594007546|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
164447902|NCT02590432|594007547|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
164447903|NCT02590432|594007548|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
164447904|NCT02590432|594007549|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
164447905|NCT02590432|594007550|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
164447906|NCT02590432|594007551|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
164447907|NCT02590432|594007543|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
164447908|NCT02590432|594007544|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
164447909|NCT02590432|594007545|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
164447910|NCT02590432|594007546|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
164447911|NCT02590432|594007547|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
164447912|NCT02590432|594007548|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
164447913|NCT02590432|594007549|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
164447914|NCT02590432|594007550|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
164447915|NCT02590432|594007551|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
164447916|NCT02590432|594007543|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
164447917|NCT02590432|594007544|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
164447918|NCT02590432|594007545|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
164447919|NCT02590432|594007546|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
164447920|NCT02590432|594007547|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
164447921|NCT02590432|594007548|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
164447922|NCT02590432|594007549|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
164447923|NCT02590432|594007550|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
164447924|NCT02590432|594007551|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
164447925|NCT02590432|594007543|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
164447926|NCT02590432|594007544|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
164447927|NCT02590432|594007545|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
164447928|NCT02590432|594007546|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
164447929|NCT02590432|594007547|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
164447930|NCT02590432|594007548|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
164447931|NCT02590432|594007549|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
164447932|NCT02590432|594007550|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
164447933|NCT02590432|594007551|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
164447934|NCT02590432|594007543|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
164447935|NCT02590432|594007544|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
164447936|NCT02590432|594007545|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
164447937|NCT02590432|594007546|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
164447938|NCT02590432|594007547|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
164447939|NCT02590432|594007548|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
164447940|NCT02590432|594007549|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
164447941|NCT02590432|594007550|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
164447942|NCT02590432|594007551|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
164447943|NCT02590432|594007543|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
164447944|NCT02590432|594007544|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
164447945|NCT02590432|594007545|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
164447946|NCT02590432|594007546|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
164447947|NCT02590432|594007547|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
164447948|NCT02590432|594007548|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
164447949|NCT02590432|594007549|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
164447950|NCT02590432|594007550|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
164447951|NCT02590432|594007551|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
164447952|NCT02590432|594007543|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
164447953|NCT02590432|594007544|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
164597049|NCT02052778|594548994|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164597050|NCT02052778|594548995|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164447954|NCT02590432|594007545|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
164447955|NCT02590432|594007546|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
164447956|NCT02590432|594007547|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
164447957|NCT02590432|594007548|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
164447958|NCT02590432|594007549|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
164447959|NCT02590432|594007550|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
164447960|NCT02590432|594007551|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
164447961|NCT02590432|594007543|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
164447962|NCT02590432|594007544|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
164447963|NCT02590432|594007545|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
164447964|NCT02590432|594007546|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
164447965|NCT02590432|594007547|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
164447966|NCT02590432|594007548|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
164447967|NCT02590432|594007549|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
164447968|NCT02590432|594007550|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
164447969|NCT02590432|594007551|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
164447970|NCT02590432|594007543|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
164447971|NCT02590432|594007544|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
164447972|NCT02590432|594007545|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
164447973|NCT02590432|594007546|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
164447974|NCT02590432|594007547|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
164447975|NCT02590432|594007548|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
164447976|NCT02590432|594007549|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
164447977|NCT02590432|594007550|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
164447978|NCT02590432|594007551|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
164447979|NCT02590432|594007543|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
164447980|NCT02590432|594007544|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
164447981|NCT02590432|594007545|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
164447982|NCT02590432|594007546|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
164447983|NCT02590432|594007547|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
164447984|NCT02590432|594007548|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
164447985|NCT02590432|594007549|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
164447986|NCT02590432|594007550|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
164447987|NCT02590432|594007551|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
164447988|NCT02590432|594007543|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
164447989|NCT02590432|594007544|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
164447990|NCT02590432|594007545|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
164447991|NCT02590432|594007546|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
164447992|NCT02590432|594007547|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
164447993|NCT02590432|594007548|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
164447994|NCT02590432|594007549|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
164447995|NCT02590432|594007550|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
164447996|NCT02590432|594007551|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
164447997|NCT00409838|594007552|FG000|Short-term Period|Adverse Event|0|||
164447998|NCT00409838|594007553|FG001|Short-term Period|Adverse Event|1|||
164447999|NCT00409838|594007552|FG000|Short-term Period|Lost to Follow-up|0|||
164448000|NCT00409838|594007553|FG001|Short-term Period|Lost to Follow-up|1|||
164448001|NCT00409838|594007552|FG000|Short-term Period|Withdrawal by Subject|2|||
164448002|NCT00409838|594007553|FG001|Short-term Period|Withdrawal by Subject|3|||
164448003|NCT00409838|594007552|FG000|Short-term Period|Never Treated|1|||
164448004|NCT00409838|594007553|FG001|Short-term Period|Never Treated|0|||
164448005|NCT00409838|594007552|FG000|Long-term Extension Period|Adverse Event|10|||
164448006|NCT00409838|594007553|FG001|Long-term Extension Period|Adverse Event|0|||
164448007|NCT00409838|594007552|FG000|Long-term Extension Period|Death|1|||
164448008|NCT00409838|594007553|FG001|Long-term Extension Period|Death|0|||
164448009|NCT00409838|594007552|FG000|Long-term Extension Period|Lack of Efficacy|2|||
164706384|NCT02393248|594953431|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164706385|NCT02393248|594953432|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164448010|NCT00409838|594007553|FG001|Long-term Extension Period|Lack of Efficacy|0|||
164448011|NCT00409838|594007552|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
164448012|NCT00409838|594007553|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
164448013|NCT00409838|594007552|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
164448014|NCT00409838|594007553|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
164448015|NCT00409838|594007552|FG000|Long-term Extension Period|Pregnancy|1|||
164706386|NCT02393248|594953433|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164706387|NCT02393248|594953434|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164448016|NCT00409838|594007553|FG001|Long-term Extension Period|Pregnancy|0|||
164448017|NCT01250769|594007555|FG000|Overall Study|Withdrawal by Subject|0|||
164448018|NCT01250769|594007556|FG001|Overall Study|Withdrawal by Subject|1|||
164448019|NCT01250769|594007557|FG002|Overall Study|Withdrawal by Subject|1|||
164448020|NCT01250769|594007558|FG003|Overall Study|Withdrawal by Subject|0|||
164448021|NCT01250769|594007555|FG000|Overall Study|Adverse Event|0|||
164448022|NCT01250769|594007556|FG001|Overall Study|Adverse Event|0|||
164448023|NCT01250769|594007557|FG002|Overall Study|Adverse Event|1|||
164448024|NCT01250769|594007558|FG003|Overall Study|Adverse Event|0|||
164448025|NCT04872738|594007559|FG000|Booster Survey|Did not respond or did not receive booster dose at the time of survey distribution|152|||
164448026|NCT04872738|594007560|FG001|Booster Survey|Did not respond or did not receive booster dose at the time of survey distribution|15|||
164448027|NCT05368831|594007565|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
164448028|NCT03565315|594007566|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
164448029|NCT03565315|594007567|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
164448030|NCT03565315|594007568|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
164448031|NCT03565315|594007569|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
164448032|NCT01170962|594007570|FG000|Treatment Period|Lack of Efficacy|96|||
164448033|NCT01170962|594007571|FG001|Treatment Period|Lack of Efficacy|91|||
164448034|NCT01170962|594007572|FG002|Treatment Period|Lack of Efficacy|7|||
164448035|NCT01170962|594007570|FG000|Treatment Period|Adverse Event|11|||
164448036|NCT01170962|594007571|FG001|Treatment Period|Adverse Event|12|||
164448037|NCT01170962|594007572|FG002|Treatment Period|Adverse Event|3|||
164448038|NCT01170962|594007570|FG000|Treatment Period|Withdrawal by Subject|2|||
164448039|NCT01170962|594007571|FG001|Treatment Period|Withdrawal by Subject|1|||
164448040|NCT01170962|594007572|FG002|Treatment Period|Withdrawal by Subject|0|||
164448041|NCT01170962|594007570|FG000|Treatment Period|Lost to Follow-up|1|||
164448042|NCT01170962|594007571|FG001|Treatment Period|Lost to Follow-up|1|||
164448043|NCT01170962|594007572|FG002|Treatment Period|Lost to Follow-up|1|||
164448044|NCT01170962|594007570|FG000|Treatment Period|Participant no longer meets criteria|0|||
164448045|NCT01170962|594007571|FG001|Treatment Period|Participant no longer meets criteria|1|||
164448046|NCT01170962|594007572|FG002|Treatment Period|Participant no longer meets criteria|0|||
164448047|NCT01170962|594007570|FG000|Treatment Period|Request to discontinue treatment|7|||
164448048|NCT01170962|594007571|FG001|Treatment Period|Request to discontinue treatment|3|||
164448049|NCT01170962|594007572|FG002|Treatment Period|Request to discontinue treatment|1|||
164448050|NCT01170962|594007570|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
164448051|NCT01170962|594007571|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
164448052|NCT01170962|594007572|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
164448053|NCT01170962|594007570|FG000|Follow up Period|Withdrawal by Subject|14|||
164448054|NCT01170962|594007571|FG001|Follow up Period|Withdrawal by Subject|10|||
164448055|NCT01170962|594007572|FG002|Follow up Period|Withdrawal by Subject|2|||
164448056|NCT01170962|594007570|FG000|Follow up Period|Lost to Follow-up|13|||
164448057|NCT01170962|594007571|FG001|Follow up Period|Lost to Follow-up|8|||
164448058|NCT01170962|594007572|FG002|Follow up Period|Lost to Follow-up|1|||
164448059|NCT01170962|594007570|FG000|Follow up Period|Death|2|||
164448060|NCT01170962|594007571|FG001|Follow up Period|Death|2|||
164448061|NCT01170962|594007572|FG002|Follow up Period|Death|0|||
164448062|NCT01170962|594007570|FG000|Follow up Period|Others|10|||
164448063|NCT01170962|594007571|FG001|Follow up Period|Others|7|||
164448064|NCT01170962|594007572|FG002|Follow up Period|Others|3|||
164448065|NCT03887650|594007573|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
164448066|NCT03887650|594007574|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
164448067|NCT03887650|594007573|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
164448068|NCT03887650|594007574|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
164448069|NCT03887650|594007573|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
164448070|NCT03887650|594007574|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
164448071|NCT01083316|594007575|FG000|Overall Study|Adverse Event|2|||
164448072|NCT01083316|594007575|FG000|Overall Study|Withdrawal by Subject|1|||
164448073|NCT03942042|594007576|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
164448074|NCT03942042|594007577|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
164448075|NCT03942042|594007576|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
164597051|NCT02052778|594548996|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164597052|NCT02052778|594548997|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164597053|NCT02052778|594548998|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164448076|NCT03942042|594007577|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
164448077|NCT04540913|594009657|FG000|Overall Study|Withdrawal by Subject|14|||
164448078|NCT04540913|594009658|FG001|Overall Study|Withdrawal by Subject|3|||
164448079|NCT05613205|594009659|FG000|Overall Study|Lost to Follow-up|0|||
164448080|NCT05613205|594009660|FG001|Overall Study|Lost to Follow-up|0|||
164448081|NCT05613205|594009661|FG002|Overall Study|Lost to Follow-up|1|||
164448082|NCT05613205|594009662|FG003|Overall Study|Lost to Follow-up|1|||
164448083|NCT05613205|594009663|FG004|Overall Study|Lost to Follow-up|0|||
164448084|NCT05613205|594009659|FG000|Overall Study|Withdrawal by Subject|0|||
164448085|NCT05613205|594009660|FG001|Overall Study|Withdrawal by Subject|0|||
164448086|NCT05613205|594009661|FG002|Overall Study|Withdrawal by Subject|1|||
164448087|NCT05613205|594009662|FG003|Overall Study|Withdrawal by Subject|1|||
164448088|NCT05613205|594009663|FG004|Overall Study|Withdrawal by Subject|0|||
164448089|NCT03602014|594009664|FG000|Overall Study|Lost to Follow-up|2|||
164448090|NCT03602014|594009665|FG001|Overall Study|Lost to Follow-up|0|||
164448091|NCT03602014|594009666|FG002|Overall Study|Lost to Follow-up|0|||
164448092|NCT01939899|594009667|FG000|Lead-in Dose Finding Phase|Death|0|||
164448093|NCT01939899|594009668|FG001|Lead-in Dose Finding Phase|Death|3|||
164448094|NCT01939899|594009669|FG002|Lead-in Dose Finding Phase|Death|1|||
164448095|NCT01939899|594009670|FG003|Lead-in Dose Finding Phase|Death|0|||
164448096|NCT01939899|594009671|FG004|Lead-in Dose Finding Phase|Death|0|||
164448097|NCT01939899|594009667|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
164448098|NCT01939899|594009668|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
164448099|NCT01939899|594009669|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
164448100|NCT01939899|594009670|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
164448101|NCT01939899|594009671|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
164448102|NCT01939899|594009667|FG000|Lead-in Dose Finding Phase|Other|0|||
164448103|NCT01939899|594009668|FG001|Lead-in Dose Finding Phase|Other|0|||
164448104|NCT01939899|594009669|FG002|Lead-in Dose Finding Phase|Other|1|||
164448105|NCT01939899|594009670|FG003|Lead-in Dose Finding Phase|Other|0|||
164448106|NCT01939899|594009671|FG004|Lead-in Dose Finding Phase|Other|0|||
164448107|NCT01939899|594009667|FG000|Phase 2|Withdrawal by Subject|0|||
164448108|NCT01939899|594009668|FG001|Phase 2|Withdrawal by Subject|0|||
164448109|NCT01939899|594009669|FG002|Phase 2|Withdrawal by Subject|0|||
164448110|NCT01939899|594009670|FG003|Phase 2|Withdrawal by Subject|2|||
164448111|NCT01939899|594009671|FG004|Phase 2|Withdrawal by Subject|0|||
164448112|NCT01939899|594009667|FG000|Phase 2|Disease Progression|0|||
164448113|NCT01939899|594009668|FG001|Phase 2|Disease Progression|0|||
164448114|NCT01939899|594009669|FG002|Phase 2|Disease Progression|0|||
164448115|NCT01939899|594009670|FG003|Phase 2|Disease Progression|9|||
164448116|NCT01939899|594009671|FG004|Phase 2|Disease Progression|1|||
164448117|NCT01854385|594009672|FG000|Pre-Treatment|Withdrawal by Subject|4|||
164448118|NCT01854385|594009672|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
164448119|NCT01854385|594009672|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
164448120|NCT01854385|594009672|FG000|Pre-Treatment|Unable to come for study visits|1|||
164448121|NCT01854385|594009672|FG000|Treatment|Lost to Follow-up|1|||
164448122|NCT04788641|594009674|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
164448123|NCT04788641|594009675|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
164448124|NCT04788641|594009676|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
164448125|NCT04788641|594009677|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
164448126|NCT04788641|594009674|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
164448127|NCT04788641|594009675|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
164448128|NCT04788641|594009676|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
164448129|NCT04788641|594009677|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
164448130|NCT04788641|594009674|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
164448131|NCT04788641|594009675|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
164448132|NCT04788641|594009676|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
164448133|NCT04788641|594009677|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
164448134|NCT01985334|594009678|FG000|Overall Study|Administrative problems|1|||
164448135|NCT01985334|594009679|FG001|Overall Study|Administrative problems|1|||
164448136|NCT01985334|594009680|FG002|Overall Study|Administrative problems|0|||
164448137|NCT01985334|594009681|FG003|Overall Study|Administrative problems|2|||
164448138|NCT01985334|594009682|FG004|Overall Study|Administrative problems|0|||
164448139|NCT01985334|594009683|FG005|Overall Study|Administrative problems|1|||
164448140|NCT01985334|594009684|FG006|Overall Study|Administrative problems|1|||
164448141|NCT01985334|594009685|FG007|Overall Study|Administrative problems|3|||
164448142|NCT01985334|594009678|FG000|Overall Study|Death|1|||
164448143|NCT01985334|594009679|FG001|Overall Study|Death|0|||
164448144|NCT01985334|594009680|FG002|Overall Study|Death|0|||
164448145|NCT01985334|594009681|FG003|Overall Study|Death|3|||
164448146|NCT01985334|594009682|FG004|Overall Study|Death|0|||
164448147|NCT01985334|594009683|FG005|Overall Study|Death|0|||
164448148|NCT01985334|594009684|FG006|Overall Study|Death|1|||
164448149|NCT01985334|594009685|FG007|Overall Study|Death|2|||
164448150|NCT01985334|594009678|FG000|Overall Study|Worsening of disease|0|||
164448151|NCT01985334|594009679|FG001|Overall Study|Worsening of disease|0|||
164448152|NCT01985334|594009680|FG002|Overall Study|Worsening of disease|0|||
164448153|NCT01985334|594009681|FG003|Overall Study|Worsening of disease|1|||
164448154|NCT01985334|594009682|FG004|Overall Study|Worsening of disease|0|||
164448155|NCT01985334|594009683|FG005|Overall Study|Worsening of disease|3|||
164448156|NCT01985334|594009684|FG006|Overall Study|Worsening of disease|0|||
164448157|NCT01985334|594009685|FG007|Overall Study|Worsening of disease|1|||
164448158|NCT01985334|594009678|FG000|Overall Study|Other|2|||
164448159|NCT01985334|594009679|FG001|Overall Study|Other|9|||
164448160|NCT01985334|594009680|FG002|Overall Study|Other|7|||
164448161|NCT01985334|594009681|FG003|Overall Study|Other|17|||
164448162|NCT01985334|594009682|FG004|Overall Study|Other|4|||
164448163|NCT01985334|594009683|FG005|Overall Study|Other|8|||
164448164|NCT01985334|594009684|FG006|Overall Study|Other|4|||
164448165|NCT01985334|594009685|FG007|Overall Study|Other|7|||
164448166|NCT01985334|594009678|FG000|Overall Study|Protocol deviation|6|||
164448167|NCT01985334|594009679|FG001|Overall Study|Protocol deviation|31|||
164448168|NCT01985334|594009680|FG002|Overall Study|Protocol deviation|25|||
164448169|NCT01985334|594009681|FG003|Overall Study|Protocol deviation|84|||
164448170|NCT01985334|594009682|FG004|Overall Study|Protocol deviation|17|||
164448171|NCT01985334|594009683|FG005|Overall Study|Protocol deviation|47|||
164448172|NCT01985334|594009684|FG006|Overall Study|Protocol deviation|15|||
164448173|NCT01985334|594009685|FG007|Overall Study|Protocol deviation|42|||
164448174|NCT01985334|594009678|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
164448175|NCT01985334|594009679|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
164448176|NCT01985334|594009680|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
164448177|NCT01985334|594009681|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
164448178|NCT01985334|594009682|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
164448179|NCT01985334|594009683|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
164448180|NCT01985334|594009684|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
164448181|NCT01985334|594009685|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
164448182|NCT01985334|594009678|FG000|Overall Study|Subject withdrawal of consent|3|||
164448183|NCT01985334|594009679|FG001|Overall Study|Subject withdrawal of consent|6|||
164448184|NCT01985334|594009680|FG002|Overall Study|Subject withdrawal of consent|2|||
164448185|NCT01985334|594009681|FG003|Overall Study|Subject withdrawal of consent|28|||
164448186|NCT01985334|594009682|FG004|Overall Study|Subject withdrawal of consent|4|||
164448187|NCT01985334|594009683|FG005|Overall Study|Subject withdrawal of consent|19|||
164448188|NCT01985334|594009684|FG006|Overall Study|Subject withdrawal of consent|0|||
164448189|NCT01985334|594009685|FG007|Overall Study|Subject withdrawal of consent|20|||
164448190|NCT01985334|594009678|FG000|Overall Study|Adverse Event|0|||
164448191|NCT01985334|594009679|FG001|Overall Study|Adverse Event|8|||
164448192|NCT01985334|594009680|FG002|Overall Study|Adverse Event|2|||
164448193|NCT01985334|594009681|FG003|Overall Study|Adverse Event|26|||
164448194|NCT01985334|594009682|FG004|Overall Study|Adverse Event|3|||
164448195|NCT01985334|594009683|FG005|Overall Study|Adverse Event|18|||
164448196|NCT01985334|594009684|FG006|Overall Study|Adverse Event|3|||
164448197|NCT01985334|594009685|FG007|Overall Study|Adverse Event|15|||
164448198|NCT01985334|594009678|FG000|Overall Study|Other|4|||
164448199|NCT01985334|594009679|FG001|Overall Study|Other|2|||
164448200|NCT01985334|594009680|FG002|Overall Study|Other|3|||
164448201|NCT01985334|594009681|FG003|Overall Study|Other|10|||
164448202|NCT01985334|594009682|FG004|Overall Study|Other|1|||
164448203|NCT01985334|594009683|FG005|Overall Study|Other|6|||
164448204|NCT01985334|594009684|FG006|Overall Study|Other|2|||
164448205|NCT01985334|594009685|FG007|Overall Study|Other|2|||
164448206|NCT01985334|594009678|FG000|Overall Study|Medication non-compliance|0|||
164448207|NCT01985334|594009679|FG001|Overall Study|Medication non-compliance|4|||
164448208|NCT01985334|594009680|FG002|Overall Study|Medication non-compliance|1|||
164448209|NCT01985334|594009681|FG003|Overall Study|Medication non-compliance|6|||
164448210|NCT01985334|594009682|FG004|Overall Study|Medication non-compliance|2|||
164448211|NCT01985334|594009683|FG005|Overall Study|Medication non-compliance|3|||
164448212|NCT01985334|594009684|FG006|Overall Study|Medication non-compliance|1|||
164448213|NCT01985334|594009685|FG007|Overall Study|Medication non-compliance|3|||
164448214|NCT01985334|594009678|FG000|Overall Study|Use of prohibited treatment|1|||
164448215|NCT01985334|594009679|FG001|Overall Study|Use of prohibited treatment|4|||
164448216|NCT01985334|594009680|FG002|Overall Study|Use of prohibited treatment|1|||
164448217|NCT01985334|594009681|FG003|Overall Study|Use of prohibited treatment|2|||
164448218|NCT01985334|594009682|FG004|Overall Study|Use of prohibited treatment|1|||
164448219|NCT01985334|594009683|FG005|Overall Study|Use of prohibited treatment|6|||
164448220|NCT01985334|594009684|FG006|Overall Study|Use of prohibited treatment|2|||
164597054|NCT02052778|594548999|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164448221|NCT01985334|594009685|FG007|Overall Study|Use of prohibited treatment|0|||
164448222|NCT01985334|594009678|FG000|Overall Study|Investigator decision|0|||
164448223|NCT01985334|594009679|FG001|Overall Study|Investigator decision|3|||
164597055|NCT02052778|594549000|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164597056|NCT02052778|594549001|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164448224|NCT01985334|594009680|FG002|Overall Study|Investigator decision|0|||
164448225|NCT01985334|594009681|FG003|Overall Study|Investigator decision|7|||
164448226|NCT01985334|594009682|FG004|Overall Study|Investigator decision|1|||
164448227|NCT01985334|594009683|FG005|Overall Study|Investigator decision|1|||
164448228|NCT01985334|594009684|FG006|Overall Study|Investigator decision|0|||
164448229|NCT01985334|594009685|FG007|Overall Study|Investigator decision|4|||
164448230|NCT01985334|594009678|FG000|Overall Study|Lost to Follow-up|0|||
164448231|NCT01985334|594009679|FG001|Overall Study|Lost to Follow-up|2|||
164448232|NCT01985334|594009680|FG002|Overall Study|Lost to Follow-up|0|||
164448233|NCT01985334|594009681|FG003|Overall Study|Lost to Follow-up|3|||
164448234|NCT01985334|594009682|FG004|Overall Study|Lost to Follow-up|1|||
164448235|NCT01985334|594009683|FG005|Overall Study|Lost to Follow-up|4|||
164448236|NCT01985334|594009684|FG006|Overall Study|Lost to Follow-up|0|||
164448237|NCT01985334|594009685|FG007|Overall Study|Lost to Follow-up|3|||
164448238|NCT05529979|594009686|FG000|Overall Study|Lost to Follow-up|6|||
164448239|NCT05529979|594009686|FG000|Overall Study|Physician Decision|1|||
164448240|NCT05529979|594009686|FG000|Overall Study|non-feasibility cases|4|||
164448241|NCT05529979|594009686|FG000|Overall Study|Lack of Efficacy|3|||
164448242|NCT05529979|594009686|FG000|Overall Study|ablation not performed|1|||
164448243|NCT00093015|594009687|FG000|Overall Study|Withdrawal by Subject|194|||
164448244|NCT00093015|594009688|FG001|Overall Study|Withdrawal by Subject|171|||
164448245|NCT00093015|594009687|FG000|Overall Study|Lost to Follow-up|96|||
164448246|NCT00093015|594009688|FG001|Overall Study|Lost to Follow-up|108|||
164448247|NCT00093015|594009687|FG000|Overall Study|Death|375|||
164448248|NCT00093015|594009688|FG001|Overall Study|Death|385|||
164448249|NCT04191499|594009689|FG000|Overall Study|Adverse Event|1|||
164448250|NCT04191499|594009690|FG001|Overall Study|Adverse Event|0|||
164448251|NCT04191499|594009689|FG000|Overall Study|Death|42|||
164448252|NCT04191499|594009690|FG001|Overall Study|Death|55|||
164448253|NCT04191499|594009689|FG000|Overall Study|Lost to Follow-up|4|||
164448254|NCT04191499|594009690|FG001|Overall Study|Lost to Follow-up|1|||
164448255|NCT04191499|594009689|FG000|Overall Study|Physician Decision|1|||
164448256|NCT04191499|594009690|FG001|Overall Study|Physician Decision|0|||
164448257|NCT04191499|594009689|FG000|Overall Study|Progressive Disease|1|||
164448258|NCT04191499|594009690|FG001|Overall Study|Progressive Disease|0|||
164448259|NCT04191499|594009689|FG000|Overall Study|Symptomatic Deterioration|1|||
164448260|NCT04191499|594009690|FG001|Overall Study|Symptomatic Deterioration|0|||
164448261|NCT04191499|594009689|FG000|Overall Study|Withdrawal by Subject|7|||
164448262|NCT04191499|594009690|FG001|Overall Study|Withdrawal by Subject|11|||
164448263|NCT04191499|594009689|FG000|Overall Study|Ongoing in the study|104|||
164448264|NCT04191499|594009690|FG001|Overall Study|Ongoing in the study|97|||
164448265|NCT03403413|594009693|FG000|Overall Study|Lack of Efficacy|2|||
164448266|NCT02924064|594009694|FG000|Overall Study|Adverse Event|2|||
164448267|NCT02924064|594009695|FG001|Overall Study|Adverse Event|2|||
164448268|NCT02924064|594009694|FG000|Overall Study|Lost to Follow-up|0|||
164448269|NCT02924064|594009695|FG001|Overall Study|Lost to Follow-up|2|||
164448270|NCT02924064|594009694|FG000|Overall Study|Physician Decision|0|||
164448271|NCT02924064|594009695|FG001|Overall Study|Physician Decision|2|||
164448272|NCT02924064|594009694|FG000|Overall Study|Protocol Violation|1|||
164448273|NCT02924064|594009695|FG001|Overall Study|Protocol Violation|3|||
164448274|NCT02924064|594009694|FG000|Overall Study|Withdrawal by Subject|4|||
164448275|NCT02924064|594009695|FG001|Overall Study|Withdrawal by Subject|5|||
164448276|NCT02924064|594009694|FG000|Overall Study|Other|17|||
164448277|NCT02924064|594009695|FG001|Overall Study|Other|29|||
164448278|NCT00529100|594009698|FG000|Overall Study|Adverse Event|0|||
164448279|NCT00529100|594009699|FG001|Overall Study|Adverse Event|5|||
164448280|NCT00529100|594009698|FG000|Overall Study|Protocol Violation|0|||
164448281|NCT00529100|594009699|FG001|Overall Study|Protocol Violation|1|||
164448282|NCT00529100|594009698|FG000|Overall Study|Progressive Disease|0|||
164448283|NCT00529100|594009699|FG001|Overall Study|Progressive Disease|1|||
164448284|NCT00529100|594009698|FG000|Overall Study|Withdrawal by Subject|0|||
164448285|NCT00529100|594009699|FG001|Overall Study|Withdrawal by Subject|1|||
164448286|NCT00529100|594009698|FG000|Overall Study|Participant Ineligibility|0|||
164448287|NCT00529100|594009699|FG001|Overall Study|Participant Ineligibility|1|||
164448288|NCT03951805|594009701|FG000|Overall Study|Adverse Event|1|||
164448289|NCT03951805|594009702|FG001|Overall Study|Adverse Event|0|||
164448290|NCT03951805|594009703|FG002|Overall Study|Adverse Event|0|||
164448291|NCT03951805|594009704|FG003|Overall Study|Adverse Event|0|||
164448292|NCT05524454|594009705|FG000|Overall Study|Withdrawal by Subject|1|||
164448293|NCT05999435|594009706|FG000|Overall Study|Adverse Event|1|||
164448294|NCT05999435|594009707|FG001|Overall Study|Adverse Event|0|||
164300200|NCT05966142|593475159|FG000|Overall Study|Study Logistical Reason|1|||
164300201|NCT05966142|593475160|FG001|Overall Study|Study Logistical Reason|0|||
164597057|NCT02052778|594549002|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164597058|NCT02052778|594549003|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164448295|NCT05999435|594009708|FG002|Overall Study|Adverse Event|0|||
164448296|NCT05999435|594009706|FG000|Overall Study|Withdrawal by Subject|2|||
164448297|NCT05999435|594009707|FG001|Overall Study|Withdrawal by Subject|1|||
164448298|NCT05999435|594009708|FG002|Overall Study|Withdrawal by Subject|0|||
164448299|NCT04982315|594009712|FG000|Overall Study|Death|1|||
164448300|NCT04982315|594009713|FG001|Overall Study|Death|0|||
164448301|NCT04982315|594009714|FG002|Overall Study|Death|1|||
164448302|NCT04982315|594009712|FG000|Overall Study|Lack of Efficacy|0|||
164448303|NCT04982315|594009713|FG001|Overall Study|Lack of Efficacy|0|||
164448304|NCT04982315|594009714|FG002|Overall Study|Lack of Efficacy|2|||
164448305|NCT04982315|594009712|FG000|Overall Study|Withdrawal by Subject|24|||
164448306|NCT04982315|594009713|FG001|Overall Study|Withdrawal by Subject|1|||
164448307|NCT04982315|594009714|FG002|Overall Study|Withdrawal by Subject|2|||
164448308|NCT04982315|594009712|FG000|Overall Study|Dealing with health/life issues|3|||
164448309|NCT04982315|594009713|FG001|Overall Study|Dealing with health/life issues|4|||
164448310|NCT04982315|594009714|FG002|Overall Study|Dealing with health/life issues|7|||
164448311|NCT04982315|594009712|FG000|Overall Study|Privacy concerns|1|||
164448312|NCT04982315|594009713|FG001|Overall Study|Privacy concerns|0|||
164448313|NCT04982315|594009714|FG002|Overall Study|Privacy concerns|0|||
164448314|NCT04982315|594009712|FG000|Overall Study|Withdrawal by research team|0|||
164448315|NCT04982315|594009713|FG001|Overall Study|Withdrawal by research team|0|||
164448316|NCT04982315|594009714|FG002|Overall Study|Withdrawal by research team|1|||
164448317|NCT01198145|594009721|FG000|Overall Study|Withdrawal by Subject|1|||
164448318|NCT01198145|594009722|FG001|Overall Study|Withdrawal by Subject|1|||
164448319|NCT00781274|594009724|FG000|Overall Study|Withdrawal by Subject|2|||
164448320|NCT00603954|594009726|FG000|Overall Study|Protocol Violation|1|||
164448321|NCT00603954|594009727|FG001|Overall Study|Protocol Violation|2|||
164448322|NCT04705480|594009735|FG000|Overall Study|Withdrawal by Subject|1|||
164448323|NCT04705480|594009736|FG001|Overall Study|Withdrawal by Subject|0|||
164448324|NCT04705480|594009737|FG002|Overall Study|Withdrawal by Subject|1|||
164448325|NCT04705480|594009735|FG000|Overall Study|Protocol Violation|2|||
164448326|NCT04705480|594009736|FG001|Overall Study|Protocol Violation|0|||
164448327|NCT04705480|594009737|FG002|Overall Study|Protocol Violation|2|||
164448328|NCT04705480|594009735|FG000|Overall Study|Decision to discharge before intervention|2|||
164448329|NCT04705480|594009736|FG001|Overall Study|Decision to discharge before intervention|0|||
164448330|NCT04705480|594009737|FG002|Overall Study|Decision to discharge before intervention|0|||
164448331|NCT00861692|594009738|FG000|Overall Study|Death|6|||
164448332|NCT06429163|594009739|FG000|Overall Study|uterine fibroid type 7|1|||
164448333|NCT06429163|594009740|FG001|Overall Study|uterine fibroid type 7|1|||
164448334|NCT06429163|594009741|FG002|Overall Study|uterine fibroid type 7|1|||
164448335|NCT06429163|594009739|FG000|Overall Study|severe adhesions|1|||
164448336|NCT06429163|594009740|FG001|Overall Study|severe adhesions|2|||
164448337|NCT06429163|594009741|FG002|Overall Study|severe adhesions|1|||
164448338|NCT06429163|594009739|FG000|Overall Study|conversion to laparotomy|0|||
164448339|NCT06429163|594009740|FG001|Overall Study|conversion to laparotomy|1|||
164448340|NCT06429163|594009741|FG002|Overall Study|conversion to laparotomy|0|||
164448341|NCT06429163|594009739|FG000|Overall Study|concomitant procedure|1|||
164448342|NCT06429163|594009740|FG001|Overall Study|concomitant procedure|0|||
164448343|NCT06429163|594009741|FG002|Overall Study|concomitant procedure|0|||
164448344|NCT04970654|594009742|FG000|Overall Study|Withdrawal by parents/guardian|1|||
164448345|NCT04970654|594009743|FG001|Overall Study|Withdrawal by parents/guardian|2|||
164448346|NCT04970654|594009742|FG000|Overall Study|Unclassified|2|||
164448347|NCT04970654|594009743|FG001|Overall Study|Unclassified|1|||
164448348|NCT04970654|594009742|FG000|Overall Study|Lost to Follow-up|1|||
164448349|NCT04970654|594009743|FG001|Overall Study|Lost to Follow-up|0|||
164448350|NCT01626885|594009744|FG000|Overall Study|Adverse Event|8|||
164448351|NCT01626885|594009744|FG000|Overall Study|Withdrawal by Subject|4|||
164448352|NCT01466192|594009747|FG000|Overall Study|Physician Decision|1|||
164448353|NCT01466192|594009747|FG000|Overall Study|Withdrawal by Subject|3|||
164448354|NCT02528188|594009748|FG000|Overall Study|Adverse Event|23|||
164448355|NCT02528188|594009749|FG001|Overall Study|Adverse Event|22|||
164448356|NCT02528188|594009750|FG002|Overall Study|Adverse Event|8|||
164448357|NCT02528188|594009748|FG000|Overall Study|Protocol Violation|4|||
164448358|NCT02528188|594009749|FG001|Overall Study|Protocol Violation|6|||
164448359|NCT02528188|594009750|FG002|Overall Study|Protocol Violation|4|||
164448360|NCT02528188|594009748|FG000|Overall Study|Lack of Efficacy|19|||
164448361|NCT02528188|594009749|FG001|Overall Study|Lack of Efficacy|21|||
164448362|NCT02528188|594009750|FG002|Overall Study|Lack of Efficacy|22|||
164448363|NCT02528188|594009748|FG000|Overall Study|Withdrawal by Subject|97|||
164448364|NCT02528188|594009749|FG001|Overall Study|Withdrawal by Subject|104|||
164448365|NCT02528188|594009750|FG002|Overall Study|Withdrawal by Subject|100|||
164448366|NCT02528188|594009748|FG000|Overall Study|Lost to Follow-up|25|||
164448367|NCT02528188|594009749|FG001|Overall Study|Lost to Follow-up|21|||
164448368|NCT02528188|594009750|FG002|Overall Study|Lost to Follow-up|31|||
164448369|NCT02528188|594009748|FG000|Overall Study|Death|4|||
164448370|NCT02528188|594009749|FG001|Overall Study|Death|4|||
164448371|NCT02528188|594009750|FG002|Overall Study|Death|0|||
164448372|NCT02528188|594009748|FG000|Overall Study|Other|89|||
164448373|NCT02528188|594009749|FG001|Overall Study|Other|91|||
164448374|NCT02528188|594009750|FG002|Overall Study|Other|74|||
164448375|NCT02528188|594009748|FG000|Overall Study|Randomized but not treated|6|||
164448376|NCT02528188|594009749|FG001|Overall Study|Randomized but not treated|7|||
164448377|NCT02528188|594009750|FG002|Overall Study|Randomized but not treated|12|||
164448378|NCT02321514|594009754|FG000|Overall Study|Death|15|||
164448379|NCT02321514|594009754|FG000|Overall Study|Missed Visit|7|||
164448380|NCT02321514|594009754|FG000|Overall Study|Study Exit|3|||
164448381|NCT00591214|594009755|FG000|Overall Study|Physician Decision|7|||
164448382|NCT00591214|594009755|FG000|Overall Study|Withdrawal by Subject|1|||
164448383|NCT02299375|594009757|FG000|Overall Study|Adverse Event, serious fatal|1|||
164448384|NCT02299375|594009758|FG001|Overall Study|Adverse Event, serious fatal|3|||
164448385|NCT02299375|594009757|FG000|Overall Study|Adverse Event, non-fatal|8|||
164448386|NCT02299375|594009758|FG001|Overall Study|Adverse Event, non-fatal|9|||
164448387|NCT02299375|594009757|FG000|Overall Study|Lack of Efficacy|1|||
164448388|NCT02299375|594009758|FG001|Overall Study|Lack of Efficacy|3|||
164448389|NCT02299375|594009757|FG000|Overall Study|Protocol Violation|1|||
164448390|NCT02299375|594009758|FG001|Overall Study|Protocol Violation|3|||
164448391|NCT02299375|594009757|FG000|Overall Study|Other: Met stopping criteria|1|||
164448392|NCT02299375|594009758|FG001|Overall Study|Other: Met stopping criteria|0|||
164448393|NCT02299375|594009757|FG000|Overall Study|Other: Study closed/terminated|66|||
164448394|NCT02299375|594009758|FG001|Overall Study|Other: Study closed/terminated|55|||
164448395|NCT02299375|594009757|FG000|Overall Study|Lost to Follow-up|0|||
164448396|NCT02299375|594009758|FG001|Overall Study|Lost to Follow-up|2|||
164448397|NCT02299375|594009757|FG000|Overall Study|Physician Decision|1|||
164448398|NCT02299375|594009758|FG001|Overall Study|Physician Decision|1|||
164448399|NCT02299375|594009757|FG000|Overall Study|Withdrawal by Subject|1|||
164448400|NCT02299375|594009758|FG001|Overall Study|Withdrawal by Subject|4|||
164448401|NCT00704184|594009763|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
164448402|NCT00704184|594009764|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
164448403|NCT00704184|594009765|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
164448404|NCT00704184|594009766|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
164448405|NCT00704184|594009767|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
164448406|NCT00704184|594009763|FG000|Open-Label Treatment|Adverse Event|0|||
164448407|NCT00704184|594009764|FG001|Open-Label Treatment|Adverse Event|0|||
164448408|NCT00704184|594009765|FG002|Open-Label Treatment|Adverse Event|2|||
164448409|NCT00704184|594009766|FG003|Open-Label Treatment|Adverse Event|0|||
164448410|NCT00704184|594009767|FG004|Open-Label Treatment|Adverse Event|1|||
164448411|NCT00704184|594009763|FG000|Open-Label Treatment|Lack of Efficacy|0|||
164448412|NCT00704184|594009764|FG001|Open-Label Treatment|Lack of Efficacy|2|||
164448413|NCT00704184|594009765|FG002|Open-Label Treatment|Lack of Efficacy|2|||
164448414|NCT00704184|594009766|FG003|Open-Label Treatment|Lack of Efficacy|2|||
164448415|NCT00704184|594009767|FG004|Open-Label Treatment|Lack of Efficacy|1|||
164448416|NCT00704184|594009763|FG000|Open-Label Treatment|Physician Decision|0|||
164448417|NCT00704184|594009764|FG001|Open-Label Treatment|Physician Decision|0|||
164448418|NCT00704184|594009765|FG002|Open-Label Treatment|Physician Decision|0|||
164448419|NCT00704184|594009766|FG003|Open-Label Treatment|Physician Decision|0|||
164448420|NCT00704184|594009767|FG004|Open-Label Treatment|Physician Decision|1|||
164448421|NCT00704184|594009763|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
164448422|NCT00704184|594009764|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
164448423|NCT00704184|594009765|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
164448424|NCT00704184|594009766|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
164448425|NCT00704184|594009767|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
164448426|NCT00716859|594009770|FG000|Overall Study|Adverse Event|4|||
164448427|NCT00716859|594009771|FG001|Overall Study|Adverse Event|1|||
164448428|NCT00716859|594009770|FG000|Overall Study|Lack of Efficacy|3|||
164448429|NCT00716859|594009771|FG001|Overall Study|Lack of Efficacy|0|||
164448430|NCT00716859|594009770|FG000|Overall Study|Withdrawal by Subject|1|||
164448431|NCT00716859|594009771|FG001|Overall Study|Withdrawal by Subject|3|||
164448432|NCT00716859|594009770|FG000|Overall Study|Not treated|1|||
164448433|NCT00716859|594009771|FG001|Overall Study|Not treated|1|||
164448434|NCT02178098|594009772|FG000|Overall Study|Withdrawal by Subject|0|||
164448435|NCT02178098|594009773|FG001|Overall Study|Withdrawal by Subject|6|||
164448436|NCT02178098|594009772|FG000|Overall Study|Adverse Event|1|||
164448437|NCT02178098|594009773|FG001|Overall Study|Adverse Event|2|||
164448438|NCT02178098|594009772|FG000|Overall Study|Protocol Violation|1|||
164448439|NCT02178098|594009773|FG001|Overall Study|Protocol Violation|1|||
164448440|NCT02178098|594009772|FG000|Overall Study|Lost to Follow-up|0|||
164448441|NCT02178098|594009773|FG001|Overall Study|Lost to Follow-up|1|||
164448442|NCT02178098|594009772|FG000|Overall Study|Sponsor Request|1|||
164448443|NCT02178098|594009773|FG001|Overall Study|Sponsor Request|0|||
164448444|NCT02178098|594009772|FG000|Overall Study|Other|2|||
164448445|NCT02178098|594009773|FG001|Overall Study|Other|2|||
164448446|NCT01109524|594009779|FG000|Overall Study|Disease Progression|29|||
164448447|NCT01109524|594009779|FG000|Overall Study|Study Drug toxicity|6|||
164448448|NCT01109524|594009779|FG000|Overall Study|Adverse Event|4|||
164144046|NCT00086281|592888585|FG014|Phase 2|Adverse Event|0|||
164448449|NCT01109524|594009779|FG000|Overall Study|Withdrawal by Subject|2|||
164448450|NCT01109524|594009779|FG000|Overall Study|Maximum clinical benefit|3|||
164448451|NCT01109524|594009779|FG000|Overall Study|Death|2|||
164448452|NCT01109524|594009779|FG000|Overall Study|No longer meets criteria|2|||
164448453|NCT01109524|594009779|FG000|Overall Study|Participant requested to end treatment|4|||
164448454|NCT01109524|594009779|FG000|Overall Study|Other|5|||
164448455|NCT00411216|594009780|FG000|Overall Study|Ten participants were entered into the c|0|||
164448456|NCT00411216|594009781|FG001|Overall Study|Ten participants were entered into the c|2|||
164448457|NCT01205048|594009782|FG000|Overall Study|Withdrawal by Subject|14|||
164448458|NCT01205048|594009782|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
164448459|NCT01205048|594009782|FG000|Overall Study|Lost to Follow-up|4|||
164448460|NCT01205048|594009782|FG000|Overall Study|Other|2|||
164448461|NCT00823472|594009783|FG000|Overall Study|Physician Decision|24|||
164448462|NCT00823472|594009784|FG001|Overall Study|Physician Decision|28|||
164448463|NCT01251354|594009797|FG000|Overall Study|Adverse Event|1|||
164448464|NCT01251354|594009797|FG000|Overall Study|Investigator's Decision|1|||
164448465|NCT01251354|594009797|FG000|Overall Study|Disease Progression|4|||
164448466|NCT03671811|594009804|FG000|Overall Study|Did not complete treatment (n=5), Disenrolled (n=1), Did not have hysterectomy (n=1)|4|||
164448467|NCT03671811|594009805|FG001|Overall Study|Did not complete treatment (n=5), Disenrolled (n=1), Did not have hysterectomy (n=1)|3|||
164448468|NCT01853748|594011501|FG000|Allocation|Withdrawal by Subject|1|||
164448469|NCT01853748|594011502|FG001|Allocation|Withdrawal by Subject|13|||
164448470|NCT01853748|594011501|FG000|Allocation|not sufficient to receive intervention|0|||
164448471|NCT01853748|594011502|FG001|Allocation|not sufficient to receive intervention|1|||
164448472|NCT01853748|594011501|FG000|Follow-Up|Withdrawal by Subject|7|||
164448473|NCT01853748|594011502|FG001|Follow-Up|Withdrawal by Subject|6|||
164448474|NCT01853748|594011501|FG000|Follow-Up|Adverse Event|67|||
164448475|NCT01853748|594011502|FG001|Follow-Up|Adverse Event|7|||
164448476|NCT01853748|594011501|FG000|Follow-Up|not available for data collection|16|||
164448477|NCT01853748|594011502|FG001|Follow-Up|not available for data collection|4|||
164448478|NCT00780416|594011507|FG000|Overall Study|Physician Decision|3|||
164448479|NCT00780416|594011508|FG001|Overall Study|Physician Decision|3|||
164448480|NCT00780416|594011507|FG000|Overall Study|Protocol Violation|1|||
164448481|NCT00780416|594011508|FG001|Overall Study|Protocol Violation|0|||
164448482|NCT00780416|594011507|FG000|Overall Study|Withdrawal by Subject|8|||
164448483|NCT00780416|594011508|FG001|Overall Study|Withdrawal by Subject|6|||
164448484|NCT02916706|594011509|FG000|Overall Study|Adverse Event|0|||
164448485|NCT02916706|594011510|FG001|Overall Study|Adverse Event|1|||
164448486|NCT02916706|594011509|FG000|Overall Study|Lost to Follow-up|0|||
164448487|NCT02916706|594011510|FG001|Overall Study|Lost to Follow-up|1|||
164448488|NCT02916706|594011509|FG000|Overall Study|Physician Decision|1|||
164448489|NCT02916706|594011510|FG001|Overall Study|Physician Decision|0|||
164448490|NCT02916706|594011509|FG000|Overall Study|Protocol Violation|3|||
164448491|NCT02916706|594011510|FG001|Overall Study|Protocol Violation|1|||
164448492|NCT02916706|594011509|FG000|Overall Study|Withdrawal by Subject|6|||
164448493|NCT02916706|594011510|FG001|Overall Study|Withdrawal by Subject|9|||
164448494|NCT02916706|594011509|FG000|Overall Study|Other|5|||
164448495|NCT02916706|594011510|FG001|Overall Study|Other|19|||
164448496|NCT05096819|594011511|FG000|Overall Study|Withdrawal by Subject|3|||
164448497|NCT05096819|594011512|FG001|Overall Study|Withdrawal by Subject|0|||
164448498|NCT03324984|594011513|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
164448499|NCT03324984|594011514|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
164448500|NCT03358875|594011518|FG000|Overall Study|Death|409|||
164448501|NCT03358875|594011519|FG001|Overall Study|Death|223|||
164448502|NCT03358875|594011518|FG000|Overall Study|Study Closed by Sponsor|66|||
164448503|NCT03358875|594011519|FG001|Overall Study|Study Closed by Sponsor|29|||
164448504|NCT03358875|594011518|FG000|Overall Study|Withdrawal by Subject|13|||
164448505|NCT03358875|594011519|FG001|Overall Study|Withdrawal by Subject|16|||
164448506|NCT03358875|594011518|FG000|Overall Study|Lost to Follow-up|13|||
164448507|NCT03358875|594011519|FG001|Overall Study|Lost to Follow-up|2|||
164448508|NCT03358875|594011518|FG000|Overall Study|Miscellaneous|33|||
164448509|NCT03358875|594011519|FG001|Overall Study|Miscellaneous|0|||
164448510|NCT03358875|594011518|FG000|Overall Study|Remained on Study|1|||
164448511|NCT03358875|594011519|FG001|Overall Study|Remained on Study|0|||
164448512|NCT04337372|594011521|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
164448513|NCT04337372|594011522|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
164448514|NCT04337372|594011523|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
164448515|NCT04337372|594011524|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
164448516|NCT04337372|594011521|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
164448517|NCT04337372|594011522|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
164448518|NCT04337372|594011523|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
164448519|NCT04337372|594011524|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
164448520|NCT04337372|594011521|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
164448521|NCT04337372|594011522|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
164448522|NCT04337372|594011523|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
164597059|NCT02052778|594549004|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164597060|NCT02052778|594549005|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164597061|NCT02052778|594549006|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164597062|NCT02052778|594549007|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
164597063|NCT02052778|594549008|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
164597064|NCT02052778|594549009|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164597065|NCT02052778|594549010|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164597066|NCT02052778|594549011|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164448523|NCT04337372|594011524|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
164448524|NCT04337372|594011521|FG000|Day 2: EEG Measures|Protocol Violation|6|||
164448525|NCT04337372|594011522|FG001|Day 2: EEG Measures|Protocol Violation|6|||
164448526|NCT04337372|594011523|FG002|Day 2: EEG Measures|Protocol Violation|5|||
164448527|NCT04337372|594011524|FG003|Day 2: EEG Measures|Protocol Violation|17|||
164448528|NCT02118961|594011539|FG000|Overall Study|Withdrawal by Subject|1|||
164448529|NCT02118961|594011540|FG001|Overall Study|Withdrawal by Subject|0|||
164448530|NCT03103321|594011541|FG000|Overall Study|Protocol Violation|1|||
164448531|NCT03103321|594011542|FG001|Overall Study|Protocol Violation|1|||
164448532|NCT03103321|594011543|FG002|Overall Study|Protocol Violation|1|||
164448533|NCT03103321|594011544|FG003|Overall Study|Protocol Violation|0|||
164448534|NCT06375421|594011547|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
164448535|NCT06375421|594011548|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
164448536|NCT06375421|594011549|FG002|First Intervention (1 Week)|Withdrawal by Subject|1|||
164448537|NCT06375421|594011550|FG003|First Intervention (1 Week)|Withdrawal by Subject|0|||
164448538|NCT03584516|594011556|FG000|Part 1|Death|2|||
164448539|NCT03584516|594011557|FG001|Part 1|Death|3|||
164448540|NCT03584516|594011558|FG002|Part 1|Death|0|||
164448541|NCT03584516|594011559|FG003|Part 1|Death|0|||
164448542|NCT03584516|594011560|FG004|Part 1|Death|0|||
164448543|NCT03584516|594011561|FG005|Part 1|Death|0|||
164448544|NCT03584516|594011556|FG000|Part 1|Withdrawal by Subject|2|||
164448545|NCT03584516|594011557|FG001|Part 1|Withdrawal by Subject|0|||
164448546|NCT03584516|594011558|FG002|Part 1|Withdrawal by Subject|0|||
164448547|NCT03584516|594011559|FG003|Part 1|Withdrawal by Subject|0|||
164448548|NCT03584516|594011560|FG004|Part 1|Withdrawal by Subject|0|||
164448549|NCT03584516|594011561|FG005|Part 1|Withdrawal by Subject|0|||
164448550|NCT03584516|594011556|FG000|Part 1|Lost to Follow-up|1|||
164448551|NCT03584516|594011557|FG001|Part 1|Lost to Follow-up|0|||
164448552|NCT03584516|594011558|FG002|Part 1|Lost to Follow-up|0|||
164448553|NCT03584516|594011559|FG003|Part 1|Lost to Follow-up|0|||
164448554|NCT03584516|594011560|FG004|Part 1|Lost to Follow-up|0|||
164448555|NCT03584516|594011561|FG005|Part 1|Lost to Follow-up|0|||
164448556|NCT03584516|594011556|FG000|Part 1|Study Terminated by Sponsor|0|||
164448557|NCT03584516|594011557|FG001|Part 1|Study Terminated by Sponsor|2|||
164448558|NCT03584516|594011558|FG002|Part 1|Study Terminated by Sponsor|0|||
164448559|NCT03584516|594011559|FG003|Part 1|Study Terminated by Sponsor|0|||
164448560|NCT03584516|594011560|FG004|Part 1|Study Terminated by Sponsor|0|||
164448561|NCT03584516|594011561|FG005|Part 1|Study Terminated by Sponsor|0|||
164448562|NCT03584516|594011556|FG000|Part 1 Expansion|Death|0|||
164448563|NCT03584516|594011557|FG001|Part 1 Expansion|Death|0|||
164448564|NCT03584516|594011558|FG002|Part 1 Expansion|Death|9|||
164448565|NCT03584516|594011559|FG003|Part 1 Expansion|Death|8|||
164448566|NCT03584516|594011560|FG004|Part 1 Expansion|Death|4|||
164448567|NCT03584516|594011561|FG005|Part 1 Expansion|Death|5|||
164448568|NCT03584516|594011556|FG000|Part 1 Expansion|Lost to Follow-up|0|||
164448569|NCT03584516|594011557|FG001|Part 1 Expansion|Lost to Follow-up|0|||
164448570|NCT03584516|594011558|FG002|Part 1 Expansion|Lost to Follow-up|0|||
164448571|NCT03584516|594011559|FG003|Part 1 Expansion|Lost to Follow-up|1|||
164448572|NCT03584516|594011560|FG004|Part 1 Expansion|Lost to Follow-up|0|||
164448573|NCT03584516|594011561|FG005|Part 1 Expansion|Lost to Follow-up|0|||
164448574|NCT03584516|594011556|FG000|Part 1 Expansion|Physician Decision|0|||
164448575|NCT03584516|594011557|FG001|Part 1 Expansion|Physician Decision|0|||
164448576|NCT03584516|594011558|FG002|Part 1 Expansion|Physician Decision|4|||
164448577|NCT03584516|594011559|FG003|Part 1 Expansion|Physician Decision|3|||
164448578|NCT03584516|594011560|FG004|Part 1 Expansion|Physician Decision|2|||
164448579|NCT03584516|594011561|FG005|Part 1 Expansion|Physician Decision|3|||
164448580|NCT03584516|594011556|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
164448581|NCT03584516|594011557|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
164448582|NCT03584516|594011558|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
164448583|NCT03584516|594011559|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
164448584|NCT03584516|594011560|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
164448585|NCT03584516|594011561|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
164448586|NCT03584516|594011556|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
164448587|NCT03584516|594011557|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
164448588|NCT03584516|594011558|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
164448589|NCT03584516|594011559|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
164448590|NCT03584516|594011560|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
164448591|NCT03584516|594011561|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
164448592|NCT03584516|594011556|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
164448593|NCT03584516|594011557|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
164448594|NCT03584516|594011558|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
164144047|NCT00908310|592888589|FG000|Overall Study|Death|37|||
164448595|NCT03584516|594011559|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
164448596|NCT03584516|594011560|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
164448597|NCT03584516|594011561|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
164448598|NCT03584516|594011556|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
164448599|NCT03584516|594011557|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
164448600|NCT03584516|594011558|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
164448601|NCT03584516|594011559|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
164448602|NCT03584516|594011560|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
164448603|NCT03584516|594011561|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
164448604|NCT05760313|594011570|FG000|Overall Study|Withdrawal by Subject|0|||
164448605|NCT05760313|594011571|FG001|Overall Study|Withdrawal by Subject|0|||
164448606|NCT05760313|594011572|FG002|Overall Study|Withdrawal by Subject|1|||
164448607|NCT05760313|594011570|FG000|Overall Study|Other|1|||
164448608|NCT05760313|594011571|FG001|Overall Study|Other|0|||
164448609|NCT05760313|594011572|FG002|Overall Study|Other|0|||
164448610|NCT00956007|594011573|FG000|Overall Study|Protocol Violation|27|||
164448611|NCT00956007|594011574|FG001|Overall Study|Protocol Violation|23|||
164448612|NCT05228470|594011575|FG000|Overall Study|Death|6|||
164448613|NCT05228470|594011576|FG001|Overall Study|Death|11|||
164448614|NCT05228470|594011575|FG000|Overall Study|Withdrawal by Subject|1|||
164448615|NCT05228470|594011576|FG001|Overall Study|Withdrawal by Subject|8|||
164448616|NCT05228470|594011575|FG000|Overall Study|Ongoing|1|||
164448617|NCT05228470|594011576|FG001|Overall Study|Ongoing|11|||
164448618|NCT03885037|594011577|FG000|Overall Study|Protocol Violation|16|||
164448619|NCT01492686|594011578|FG000|Double-blind Phase|Adverse Event|0|||
164448620|NCT01492686|594011579|FG001|Double-blind Phase|Adverse Event|2|||
164448621|NCT01492686|594011578|FG000|Double-blind Phase|Physician Decision|0|||
164448622|NCT01492686|594011579|FG001|Double-blind Phase|Physician Decision|1|||
164448623|NCT01492686|594011578|FG000|Double-blind Phase|Withdrawal by Subject|0|||
164448624|NCT01492686|594011579|FG001|Double-blind Phase|Withdrawal by Subject|2|||
164448625|NCT01492686|594011578|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
164448626|NCT01492686|594011579|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
164448627|NCT01492686|594011578|FG000|Open-label Phase|Adverse Event|1|||
164448628|NCT01492686|594011579|FG001|Open-label Phase|Adverse Event|2|||
164448629|NCT01492686|594011578|FG000|Open-label Phase|Physician Decision|1|||
164448630|NCT01492686|594011579|FG001|Open-label Phase|Physician Decision|0|||
164448631|NCT01492686|594011578|FG000|Open-label Phase|Withdrawal by Subject|6|||
164448632|NCT01492686|594011579|FG001|Open-label Phase|Withdrawal by Subject|7|||
164448633|NCT01492686|594011578|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
164448634|NCT01492686|594011579|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
164448635|NCT03314987|594011582|FG000|Overall Study|Lost to Follow-up|13|||
164448636|NCT03314987|594011583|FG001|Overall Study|Lost to Follow-up|13|||
164448637|NCT02992925|594011584|FG000|Cohort 2|Physician Decision|0|||
164448638|NCT02992925|594011585|FG001|Cohort 2|Physician Decision|0|||
164448639|NCT02992925|594011586|FG002|Cohort 2|Physician Decision|1|||
164448640|NCT02992925|594011587|FG003|Cohort 2|Physician Decision|0|||
164448641|NCT02992925|594011584|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
164448642|NCT02992925|594011585|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
164597067|NCT02052778|594549012|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164448643|NCT02992925|594011586|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
164448644|NCT02992925|594011587|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
164448645|NCT05678998|594011588|FG000|Overall Study|Withdrawal by Subject|1|||
164448646|NCT05678998|594011589|FG001|Overall Study|Withdrawal by Subject|1|||
164448647|NCT05678998|594011590|FG002|Overall Study|Withdrawal by Subject|3|||
164448648|NCT05678998|594011591|FG003|Overall Study|Withdrawal by Subject|0|||
164448649|NCT05678998|594011592|FG004|Overall Study|Withdrawal by Subject|1|||
164448650|NCT05678998|594011588|FG000|Overall Study|Lost to Follow-up|0|||
164448651|NCT05678998|594011589|FG001|Overall Study|Lost to Follow-up|0|||
164448652|NCT05678998|594011590|FG002|Overall Study|Lost to Follow-up|0|||
164448653|NCT05678998|594011591|FG003|Overall Study|Lost to Follow-up|0|||
164448654|NCT05678998|594011592|FG004|Overall Study|Lost to Follow-up|1|||
164448655|NCT05678998|594011588|FG000|Overall Study|Death|0|||
164448656|NCT05678998|594011589|FG001|Overall Study|Death|0|||
164448657|NCT05678998|594011590|FG002|Overall Study|Death|0|||
164597068|NCT02052778|594549013|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164597069|NCT02052778|594549014|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164597070|NCT02052778|594549015|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164597071|NCT02052778|594548993|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164597072|NCT02052778|594548994|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164597073|NCT02052778|594548995|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164597074|NCT02052778|594548996|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164597075|NCT02052778|594548997|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164597076|NCT02052778|594548998|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164597077|NCT02052778|594548999|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164597078|NCT02052778|594549000|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164597079|NCT02052778|594549001|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164448658|NCT05678998|594011591|FG003|Overall Study|Death|3|||
164448659|NCT05678998|594011592|FG004|Overall Study|Death|4|||
164448660|NCT05678998|594011588|FG000|Overall Study|Other|0|||
164448661|NCT05678998|594011589|FG001|Overall Study|Other|0|||
164448662|NCT05678998|594011590|FG002|Overall Study|Other|0|||
164448663|NCT05678998|594011591|FG003|Overall Study|Other|2|||
164448664|NCT05678998|594011592|FG004|Overall Study|Other|1|||
164448665|NCT05552963|594011593|FG000|Overall Study|Lost to Follow-up|1|||
164448666|NCT05552963|594011593|FG000|Overall Study|Study catheter was inserted, but PF energy was not delivered due to ECG interference|1|||
164448667|NCT05773313|594011596|FG000|Overall Study|Lost to Follow-up|3|||
164448668|NCT05137236|594011597|FG000|Part A|Other than Specified|1|||
164448669|NCT05137236|594011598|FG001|Part A|Other than Specified|0|||
164448670|NCT05137236|594011599|FG002|Part A|Other than Specified|0|||
164448671|NCT05137236|594011600|FG003|Part A|Other than Specified|0|||
164448672|NCT05137236|594011601|FG004|Part A|Other than Specified|0|||
164448673|NCT05137236|594011602|FG005|Part A|Other than Specified|0|||
164448674|NCT05137236|594011603|FG006|Part A|Other than Specified|0|||
164448675|NCT05137236|594011604|FG007|Part A|Other than Specified|0|||
164448676|NCT05137236|594011597|FG000|Part A|Withdrawal by Subject|0|||
164448677|NCT05137236|594011598|FG001|Part A|Withdrawal by Subject|4|||
164448678|NCT05137236|594011599|FG002|Part A|Withdrawal by Subject|1|||
164448679|NCT05137236|594011600|FG003|Part A|Withdrawal by Subject|1|||
164448680|NCT05137236|594011601|FG004|Part A|Withdrawal by Subject|3|||
164448681|NCT05137236|594011602|FG005|Part A|Withdrawal by Subject|2|||
164448682|NCT05137236|594011603|FG006|Part A|Withdrawal by Subject|0|||
164448683|NCT05137236|594011604|FG007|Part A|Withdrawal by Subject|0|||
164448684|NCT05137236|594011597|FG000|Part A|Lost to Follow-up|5|||
164448685|NCT05137236|594011598|FG001|Part A|Lost to Follow-up|7|||
164448686|NCT05137236|594011599|FG002|Part A|Lost to Follow-up|1|||
164448687|NCT05137236|594011600|FG003|Part A|Lost to Follow-up|3|||
164448688|NCT05137236|594011601|FG004|Part A|Lost to Follow-up|3|||
164448689|NCT05137236|594011602|FG005|Part A|Lost to Follow-up|8|||
164448690|NCT05137236|594011603|FG006|Part A|Lost to Follow-up|0|||
164448691|NCT05137236|594011604|FG007|Part A|Lost to Follow-up|0|||
164448692|NCT05137236|594011597|FG000|Part B|Withdrawal by Subject|0|||
164448693|NCT05137236|594011598|FG001|Part B|Withdrawal by Subject|0|||
164448694|NCT05137236|594011599|FG002|Part B|Withdrawal by Subject|0|||
164448695|NCT05137236|594011600|FG003|Part B|Withdrawal by Subject|0|||
164448696|NCT05137236|594011601|FG004|Part B|Withdrawal by Subject|0|||
164448697|NCT05137236|594011602|FG005|Part B|Withdrawal by Subject|0|||
164448698|NCT05137236|594011603|FG006|Part B|Withdrawal by Subject|0|||
164448699|NCT05137236|594011604|FG007|Part B|Withdrawal by Subject|2|||
164448700|NCT05137236|594011597|FG000|Part B|Lost to Follow-up|0|||
164448701|NCT05137236|594011598|FG001|Part B|Lost to Follow-up|0|||
164448702|NCT05137236|594011599|FG002|Part B|Lost to Follow-up|0|||
164448703|NCT05137236|594011600|FG003|Part B|Lost to Follow-up|0|||
164448704|NCT05137236|594011601|FG004|Part B|Lost to Follow-up|0|||
164448705|NCT05137236|594011602|FG005|Part B|Lost to Follow-up|0|||
164448706|NCT05137236|594011603|FG006|Part B|Lost to Follow-up|5|||
164448707|NCT05137236|594011604|FG007|Part B|Lost to Follow-up|5|||
164448708|NCT05137236|594011597|FG000|Part B|Death|0|||
164448709|NCT05137236|594011598|FG001|Part B|Death|0|||
164448710|NCT05137236|594011599|FG002|Part B|Death|0|||
164448711|NCT05137236|594011600|FG003|Part B|Death|0|||
164448712|NCT05137236|594011601|FG004|Part B|Death|0|||
164448713|NCT05137236|594011602|FG005|Part B|Death|0|||
164448714|NCT05137236|594011603|FG006|Part B|Death|0|||
164448715|NCT05137236|594011604|FG007|Part B|Death|2|||
164448716|NCT01534494|594011605|FG000|Overall Study|Withdrawal by Subject|1|||
164448717|NCT00802464|594011606|FG000|Month 0 - Month 8|Adverse Event|0|||
164144347|NCT02954991|592889833|FG001|Overall Study|Lost to Follow-up|2|||
164448718|NCT00802464|594011607|FG001|Month 0 - Month 8|Adverse Event|1|||
164448719|NCT00802464|594011608|FG002|Month 0 - Month 8|Adverse Event|1|||
164448720|NCT00802464|594011609|FG003|Month 0 - Month 8|Adverse Event|2|||
164448721|NCT00802464|594011606|FG000|Month 0 - Month 8|Protocol Violation|0|||
164448722|NCT00802464|594011607|FG001|Month 0 - Month 8|Protocol Violation|0|||
164448723|NCT00802464|594011608|FG002|Month 0 - Month 8|Protocol Violation|1|||
164448724|NCT00802464|594011609|FG003|Month 0 - Month 8|Protocol Violation|0|||
164448725|NCT00802464|594011606|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
164448726|NCT00802464|594011607|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
164448727|NCT00802464|594011608|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
164448728|NCT00802464|594011609|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
164448729|NCT00802464|594011606|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
164448730|NCT00802464|594011607|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
164448731|NCT00802464|594011608|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
164448732|NCT00802464|594011609|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
164448733|NCT00802464|594011606|FG000|Month 0 - Month 8|Other|0|||
164448734|NCT00802464|594011607|FG001|Month 0 - Month 8|Other|0|||
164448735|NCT00802464|594011608|FG002|Month 0 - Month 8|Other|1|||
164448736|NCT00802464|594011609|FG003|Month 0 - Month 8|Other|0|||
164448737|NCT00802464|594011606|FG000|Month 8 - Month 14|Adverse Event|0|||
164448738|NCT00802464|594011607|FG001|Month 8 - Month 14|Adverse Event|1|||
164448739|NCT00802464|594011608|FG002|Month 8 - Month 14|Adverse Event|0|||
164448740|NCT00802464|594011609|FG003|Month 8 - Month 14|Adverse Event|0|||
164448741|NCT00802464|594011606|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
164448742|NCT00802464|594011607|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
164448743|NCT00802464|594011608|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
164448744|NCT00802464|594011609|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
164448745|NCT00802464|594011606|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
164448746|NCT00802464|594011607|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
164448747|NCT00802464|594011608|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
164448748|NCT00802464|594011609|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
164448749|NCT00402246|594011610|FG000|Overall Study|Death|62|||
164448750|NCT00402246|594011611|FG001|Overall Study|Death|58|||
164448751|NCT00402246|594011610|FG000|Overall Study|Lost to Follow-up|20|||
164448752|NCT00402246|594011611|FG001|Overall Study|Lost to Follow-up|28|||
164448753|NCT00402246|594011610|FG000|Overall Study|Withdrawal by Subject|72|||
164448754|NCT00402246|594011611|FG001|Overall Study|Withdrawal by Subject|87|||
164448755|NCT00402246|594011610|FG000|Overall Study|Physician Decision|24|||
164448756|NCT00402246|594011611|FG001|Overall Study|Physician Decision|26|||
164448757|NCT00402246|594011610|FG000|Overall Study|Protocol Violation|25|||
164448758|NCT00402246|594011611|FG001|Overall Study|Protocol Violation|24|||
164448759|NCT00402246|594011610|FG000|Overall Study|Missed Final Visit|1|||
164448760|NCT00402246|594011611|FG001|Overall Study|Missed Final Visit|2|||
164448761|NCT00402246|594011610|FG000|Overall Study|Insurance Issues|2|||
164448762|NCT00402246|594011611|FG001|Overall Study|Insurance Issues|1|||
164448763|NCT00402246|594011610|FG000|Overall Study|Heart Transplant|0|||
164448764|NCT00402246|594011611|FG001|Overall Study|Heart Transplant|1|||
164448765|NCT00402246|594011610|FG000|Overall Study|Patient's device explanted|6|||
164448766|NCT00402246|594011611|FG001|Overall Study|Patient's device explanted|2|||
164448767|NCT00402246|594011610|FG000|Overall Study|Center Closure|5|||
164448768|NCT00402246|594011611|FG001|Overall Study|Center Closure|3|||
164448769|NCT00402246|594011610|FG000|Overall Study|Deterioriating Condition|3|||
164448770|NCT00402246|594011611|FG001|Overall Study|Deterioriating Condition|2|||
164448771|NCT00431834|594011613|FG000|Overall Study|Withdrawal by Subject|7|||
164448772|NCT00431834|594011613|FG000|Overall Study|Death|3|||
164448773|NCT00431834|594011613|FG000|Overall Study|Missed Endpoint Visit|2|||
164448774|NCT00431834|594011613|FG000|Overall Study|Lost to Follow-up|1|||
164448775|NCT01471691|594011614|FG000|Overall Study|Lack of Efficacy|0|||
164448776|NCT01471691|594011615|FG001|Overall Study|Lack of Efficacy|1|||
164448777|NCT01808339|594011618|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
164448778|NCT01808339|594011619|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
164448779|NCT01808339|594011620|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
164448780|NCT01808339|594011621|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
164448781|NCT01808339|594011622|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
164448782|NCT01808339|594011623|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
164448783|NCT01808339|594011618|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164448784|NCT01808339|594011619|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
164448785|NCT01808339|594011620|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164448786|NCT01808339|594011621|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
164448787|NCT01808339|594011622|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164448788|NCT01808339|594011623|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164448789|NCT01808339|594011618|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
164448790|NCT01808339|594011619|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
164448791|NCT01808339|594011620|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
164448792|NCT01808339|594011621|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
164448793|NCT01808339|594011622|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
164448794|NCT01808339|594011623|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
164448795|NCT02622568|594011626|FG000|Overall Study|Lost to Follow-up|5|||
164448796|NCT02622568|594011627|FG001|Overall Study|Lost to Follow-up|5|||
164448797|NCT02015520|594011632|FG000|Overall Study|Lack of Efficacy|1|||
164448798|NCT02015520|594011633|FG001|Overall Study|Lack of Efficacy|0|||
164448799|NCT02015520|594011634|FG002|Overall Study|Lack of Efficacy|3|||
164448800|NCT02015520|594011635|FG003|Overall Study|Lack of Efficacy|2|||
164448801|NCT02015520|594011632|FG000|Overall Study|Adverse Event|0|||
164448802|NCT02015520|594011633|FG001|Overall Study|Adverse Event|0|||
164448803|NCT02015520|594011634|FG002|Overall Study|Adverse Event|0|||
164448804|NCT02015520|594011635|FG003|Overall Study|Adverse Event|1|||
164448805|NCT02015520|594011632|FG000|Overall Study|Withdrawal by Subject|2|||
164448806|NCT02015520|594011633|FG001|Overall Study|Withdrawal by Subject|2|||
164448807|NCT02015520|594011634|FG002|Overall Study|Withdrawal by Subject|1|||
164448808|NCT02015520|594011635|FG003|Overall Study|Withdrawal by Subject|0|||
164448809|NCT02015520|594011632|FG000|Overall Study|Death|1|||
164448810|NCT02015520|594011633|FG001|Overall Study|Death|0|||
164448811|NCT02015520|594011634|FG002|Overall Study|Death|0|||
164448812|NCT02015520|594011635|FG003|Overall Study|Death|0|||
164448813|NCT02015520|594011632|FG000|Overall Study|Lost to Follow-up|0|||
164448814|NCT02015520|594011633|FG001|Overall Study|Lost to Follow-up|0|||
164448815|NCT02015520|594011634|FG002|Overall Study|Lost to Follow-up|1|||
164448816|NCT02015520|594011635|FG003|Overall Study|Lost to Follow-up|0|||
164448817|NCT02015520|594011632|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
164448818|NCT02015520|594011633|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
164448819|NCT02015520|594011634|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
164448820|NCT02015520|594011635|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
164448821|NCT02015520|594011632|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
164448822|NCT02015520|594011633|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
164448823|NCT02015520|594011634|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
164448824|NCT02015520|594011635|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
164448825|NCT00415519|594011642|FG000|Overall Study|Adverse Event|1|||
164448826|NCT00415519|594011643|FG001|Overall Study|Adverse Event|0|||
164448827|NCT00415519|594011642|FG000|Overall Study|Withdrawal by Subject|2|||
164448828|NCT00415519|594011643|FG001|Overall Study|Withdrawal by Subject|0|||
164448829|NCT00415519|594011642|FG000|Overall Study|Patient's convenience|1|||
164448830|NCT00415519|594011643|FG001|Overall Study|Patient's convenience|0|||
164448831|NCT04163718|594011644|FG000|Overall Study|Study terminated|12|||
164448832|NCT05054725|594011648|FG000|Overall Study|Withdrawal by Subject|3|||
164448833|NCT05054725|594011649|FG001|Overall Study|Withdrawal by Subject|4|||
164448834|NCT05054725|594011648|FG000|Overall Study|Sponsor's Decision to Terminate the Study|0|||
164448835|NCT05054725|594011649|FG001|Overall Study|Sponsor's Decision to Terminate the Study|3|||
164448836|NCT05054725|594011648|FG000|Overall Study|Death|1|||
164448837|NCT05054725|594011649|FG001|Overall Study|Death|21|||
164448838|NCT05054725|594011648|FG000|Overall Study|Sponsor amended protocol to terminate Long Term Follow Up (LTFU)|0|||
164448839|NCT05054725|594011649|FG001|Overall Study|Sponsor amended protocol to terminate Long Term Follow Up (LTFU)|3|||
164448840|NCT05054725|594011648|FG000|Overall Study|PI's decision that there is no benefit from LTFU|0|||
164448841|NCT05054725|594011649|FG001|Overall Study|PI's decision that there is no benefit from LTFU|6|||
164448842|NCT05054725|594011648|FG000|Overall Study|Due to AE#17 - Angiosarcoma of the breast with possible relation to study drug|0|||
164448843|NCT05054725|594011649|FG001|Overall Study|Due to AE#17 - Angiosarcoma of the breast with possible relation to study drug|1|||
164448844|NCT05054725|594011648|FG000|Overall Study|Agreed between patient and PI as safety follow up is not for benefit of the patient|0|||
164448845|NCT05054725|594011649|FG001|Overall Study|Agreed between patient and PI as safety follow up is not for benefit of the patient|1|||
164448846|NCT05054725|594011648|FG000|Overall Study|Physician discretion due to subject progression|0|||
164448847|NCT05054725|594011649|FG001|Overall Study|Physician discretion due to subject progression|1|||
164448848|NCT03674411|594011650|FG000|Overall Study|Non-treatment|4|||
164448849|NCT03674411|594011651|FG001|Overall Study|Non-treatment|0|||
164448850|NCT00780910|594011652|FG000|Overall Study|Adverse Event|2|||
164448851|NCT04929483|594011656|FG000|Main Study (24 Weeks)|Adverse Event|1|||
164448852|NCT04929483|594011657|FG001|Main Study (24 Weeks)|Adverse Event|6|||
164448853|NCT04929483|594011658|FG002|Main Study (24 Weeks)|Adverse Event|2|||
164448854|NCT04929483|594011659|FG003|Main Study (24 Weeks)|Adverse Event|1|||
164448855|NCT04929483|594011660|FG004|Main Study (24 Weeks)|Adverse Event|0|||
164448856|NCT04929483|594011661|FG005|Main Study (24 Weeks)|Adverse Event|0|||
164448857|NCT04929483|594011656|FG000|Main Study (24 Weeks)|Withdrawal by Subject|0|||
164448858|NCT04929483|594011657|FG001|Main Study (24 Weeks)|Withdrawal by Subject|3|||
164448859|NCT04929483|594011658|FG002|Main Study (24 Weeks)|Withdrawal by Subject|3|||
164448860|NCT04929483|594011659|FG003|Main Study (24 Weeks)|Withdrawal by Subject|3|||
164448861|NCT04929483|594011660|FG004|Main Study (24 Weeks)|Withdrawal by Subject|0|||
164448862|NCT04929483|594011661|FG005|Main Study (24 Weeks)|Withdrawal by Subject|0|||
164448863|NCT04929483|594011656|FG000|Main Study (24 Weeks)|Lost to Follow-up|0|||
164448864|NCT04929483|594011657|FG001|Main Study (24 Weeks)|Lost to Follow-up|2|||
164448865|NCT04929483|594011658|FG002|Main Study (24 Weeks)|Lost to Follow-up|0|||
164448866|NCT04929483|594011659|FG003|Main Study (24 Weeks)|Lost to Follow-up|2|||
164448867|NCT04929483|594011660|FG004|Main Study (24 Weeks)|Lost to Follow-up|0|||
164448868|NCT04929483|594011661|FG005|Main Study (24 Weeks)|Lost to Follow-up|0|||
164448869|NCT04929483|594011656|FG000|Main Study (24 Weeks)|Physician Decision|0|||
164448870|NCT04929483|594011657|FG001|Main Study (24 Weeks)|Physician Decision|2|||
164448871|NCT04929483|594011658|FG002|Main Study (24 Weeks)|Physician Decision|0|||
164448872|NCT04929483|594011659|FG003|Main Study (24 Weeks)|Physician Decision|0|||
164448873|NCT04929483|594011660|FG004|Main Study (24 Weeks)|Physician Decision|0|||
164448874|NCT04929483|594011661|FG005|Main Study (24 Weeks)|Physician Decision|0|||
164448875|NCT04929483|594011656|FG000|Main Study (24 Weeks)|Protocol Violation|0|||
164448876|NCT04929483|594011657|FG001|Main Study (24 Weeks)|Protocol Violation|0|||
164448877|NCT04929483|594011658|FG002|Main Study (24 Weeks)|Protocol Violation|1|||
164448878|NCT04929483|594011659|FG003|Main Study (24 Weeks)|Protocol Violation|0|||
164448879|NCT04929483|594011660|FG004|Main Study (24 Weeks)|Protocol Violation|0|||
164448880|NCT04929483|594011661|FG005|Main Study (24 Weeks)|Protocol Violation|0|||
164448881|NCT04929483|594011656|FG000|Main Study (24 Weeks)|Randomized in error|0|||
164448882|NCT04929483|594011657|FG001|Main Study (24 Weeks)|Randomized in error|1|||
164448883|NCT04929483|594011658|FG002|Main Study (24 Weeks)|Randomized in error|0|||
164448884|NCT04929483|594011659|FG003|Main Study (24 Weeks)|Randomized in error|2|||
164448885|NCT04929483|594011660|FG004|Main Study (24 Weeks)|Randomized in error|0|||
164448886|NCT04929483|594011661|FG005|Main Study (24 Weeks)|Randomized in error|0|||
164448887|NCT04929483|594011656|FG000|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
164448888|NCT04929483|594011657|FG001|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
164448889|NCT04929483|594011658|FG002|Extension Study (24 Weeks)|Withdrawal by Subject|3|||
164448890|NCT04929483|594011659|FG003|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
164448891|NCT04929483|594011660|FG004|Extension Study (24 Weeks)|Withdrawal by Subject|2|||
164448892|NCT04929483|594011661|FG005|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
164448893|NCT04929483|594011656|FG000|Extension Study (24 Weeks)|Lost to Follow-up|0|||
164448894|NCT04929483|594011657|FG001|Extension Study (24 Weeks)|Lost to Follow-up|1|||
164448895|NCT04929483|594011658|FG002|Extension Study (24 Weeks)|Lost to Follow-up|1|||
164448896|NCT04929483|594011659|FG003|Extension Study (24 Weeks)|Lost to Follow-up|0|||
164448897|NCT04929483|594011660|FG004|Extension Study (24 Weeks)|Lost to Follow-up|1|||
164448898|NCT04929483|594011661|FG005|Extension Study (24 Weeks)|Lost to Follow-up|0|||
164448899|NCT04929483|594011656|FG000|Extension Study (24 Weeks)|Other than specified|1|||
164448900|NCT04929483|594011657|FG001|Extension Study (24 Weeks)|Other than specified|0|||
164448901|NCT04929483|594011658|FG002|Extension Study (24 Weeks)|Other than specified|1|||
164448902|NCT04929483|594011659|FG003|Extension Study (24 Weeks)|Other than specified|0|||
164448903|NCT04929483|594011660|FG004|Extension Study (24 Weeks)|Other than specified|1|||
164448904|NCT04929483|594011661|FG005|Extension Study (24 Weeks)|Other than specified|0|||
164448905|NCT04929483|594011656|FG000|Extension Study (24 Weeks)|Adverse Event|0|||
164448906|NCT04929483|594011657|FG001|Extension Study (24 Weeks)|Adverse Event|2|||
164448907|NCT04929483|594011658|FG002|Extension Study (24 Weeks)|Adverse Event|3|||
164448908|NCT04929483|594011659|FG003|Extension Study (24 Weeks)|Adverse Event|0|||
164448909|NCT04929483|594011660|FG004|Extension Study (24 Weeks)|Adverse Event|0|||
164448910|NCT04929483|594011661|FG005|Extension Study (24 Weeks)|Adverse Event|0|||
164448911|NCT04083781|594011666|FG000|Main Part|Physician Decision|0|||
164448912|NCT04083781|594011667|FG001|Main Part|Physician Decision|1|||
164448913|NCT04083781|594011668|FG002|Main Part|Physician Decision|2|||
164448914|NCT04083781|594011669|FG003|Main Part|Physician Decision|0|||
164448915|NCT04083781|594011666|FG000|Main Part|Death|1|||
164448916|NCT04083781|594011667|FG001|Main Part|Death|3|||
164448917|NCT04083781|594011668|FG002|Main Part|Death|1|||
164448918|NCT04083781|594011669|FG003|Main Part|Death|0|||
164448919|NCT04083781|594011666|FG000|Main Part|Withdrawal by Subject|5|||
164448920|NCT04083781|594011667|FG001|Main Part|Withdrawal by Subject|2|||
164448921|NCT04083781|594011668|FG002|Main Part|Withdrawal by Subject|3|||
164448922|NCT04083781|594011669|FG003|Main Part|Withdrawal by Subject|7|||
164448923|NCT04083781|594011666|FG000|Extension Part|Physician Decision|0|||
164448924|NCT04083781|594011667|FG001|Extension Part|Physician Decision|0|||
164448925|NCT04083781|594011668|FG002|Extension Part|Physician Decision|0|||
164448926|NCT04083781|594011669|FG003|Extension Part|Physician Decision|1|||
164448927|NCT04083781|594011666|FG000|Extension Part|Death|0|||
164448928|NCT04083781|594011667|FG001|Extension Part|Death|1|||
164448929|NCT04083781|594011668|FG002|Extension Part|Death|0|||
164448930|NCT04083781|594011669|FG003|Extension Part|Death|1|||
164448931|NCT04083781|594011666|FG000|Extension Part|Withdrawal by Subject|0|||
164448932|NCT04083781|594011667|FG001|Extension Part|Withdrawal by Subject|1|||
164448933|NCT04083781|594011668|FG002|Extension Part|Withdrawal by Subject|0|||
164448934|NCT04083781|594011669|FG003|Extension Part|Withdrawal by Subject|0|||
164448935|NCT04083781|594011666|FG000|Extension Part|Ongoing|13|||
164448936|NCT04083781|594011667|FG001|Extension Part|Ongoing|25|||
164448937|NCT04083781|594011668|FG002|Extension Part|Ongoing|15|||
164448938|NCT04083781|594011669|FG003|Extension Part|Ongoing|51|||
164448939|NCT01143337|594011670|FG000|Overall Study|Adverse Event|3|||
164448940|NCT01143337|594011671|FG001|Overall Study|Adverse Event|9|||
164448941|NCT01143337|594011672|FG002|Overall Study|Adverse Event|5|||
164448942|NCT01143337|594011670|FG000|Overall Study|Lack of Efficacy|6|||
164448943|NCT01143337|594011671|FG001|Overall Study|Lack of Efficacy|2|||
164448944|NCT01143337|594011672|FG002|Overall Study|Lack of Efficacy|1|||
164448945|NCT01143337|594011670|FG000|Overall Study|Protocol Violation|1|||
164448946|NCT01143337|594011671|FG001|Overall Study|Protocol Violation|0|||
164448947|NCT01143337|594011672|FG002|Overall Study|Protocol Violation|0|||
164448948|NCT01143337|594011670|FG000|Overall Study|Withdrawal by Subject|0|||
164448949|NCT01143337|594011671|FG001|Overall Study|Withdrawal by Subject|0|||
164448950|NCT01143337|594011672|FG002|Overall Study|Withdrawal by Subject|1|||
164448951|NCT01143337|594011670|FG000|Overall Study|Other reason|0|||
164448952|NCT01143337|594011671|FG001|Overall Study|Other reason|0|||
164448953|NCT01143337|594011672|FG002|Overall Study|Other reason|5|||
164448954|NCT04992390|594011673|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
164448955|NCT04992390|594011674|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
164448956|NCT04992390|594011675|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
164448957|NCT04992390|594011673|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
164448958|NCT04992390|594011674|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
164448959|NCT04992390|594011675|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
164448960|NCT04992390|594011673|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
164448961|NCT04992390|594011674|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
164448962|NCT04992390|594011675|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
164448963|NCT04992390|594011673|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
164448964|NCT04992390|594011674|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
164448965|NCT04992390|594011675|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
164448966|NCT04992390|594011673|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
164448967|NCT04992390|594011674|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
164448968|NCT04992390|594011675|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
164448969|NCT04992390|594011673|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
164448970|NCT04992390|594011674|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
164448971|NCT04992390|594011675|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
164448972|NCT04992390|594011673|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
164448973|NCT04992390|594011674|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
164448974|NCT04992390|594011675|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
164448975|NCT04992390|594011673|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
164448976|NCT04992390|594011674|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
164448977|NCT04992390|594011675|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
164448978|NCT04992390|594011673|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
164448979|NCT04992390|594011674|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
164448980|NCT04992390|594011675|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
164448981|NCT04992390|594011673|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
164448982|NCT04992390|594011674|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
164448983|NCT04992390|594011675|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
164448984|NCT04992390|594011673|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
164448985|NCT04992390|594011674|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
164448986|NCT04992390|594011675|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
164448987|NCT04992390|594011673|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
164448988|NCT04992390|594011674|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
164448989|NCT04992390|594011675|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
164448990|NCT04992390|594011673|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
164448991|NCT04992390|594011674|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
164448992|NCT04992390|594011675|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
164448993|NCT04992390|594011673|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
164448994|NCT04992390|594011674|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
164448995|NCT04992390|594011675|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
164448996|NCT04992390|594011673|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
164448997|NCT04992390|594011674|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
164448998|NCT04992390|594011675|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
164448999|NCT04992390|594011673|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
164449000|NCT04992390|594011674|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
164449001|NCT04992390|594011675|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
164449002|NCT06938230|594011676|FG000|Overall Study|Lost to Follow-up|56|||
164449003|NCT06938230|594011677|FG001|Overall Study|Lost to Follow-up|18|||
164449004|NCT04310735|594012495|FG000|Overall Study|Withdrawal by Subject|1|||
164449005|NCT04310735|594012496|FG001|Overall Study|Withdrawal by Subject|3|||
164449006|NCT04310735|594012497|FG002|Overall Study|Withdrawal by Subject|8|||
164449007|NCT04310735|594012495|FG000|Overall Study|Equipment malfunction|0|||
164597080|NCT02052778|594549002|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164449008|NCT04310735|594012496|FG001|Overall Study|Equipment malfunction|1|||
164449009|NCT04310735|594012497|FG002|Overall Study|Equipment malfunction|0|||
164449010|NCT03012841|594012498|FG000|Overall Study|Protocol Violation|0|||
164449011|NCT03012841|594012499|FG001|Overall Study|Protocol Violation|10|||
164449012|NCT03012841|594012498|FG000|Overall Study|Lost to Follow-up|6|||
164449013|NCT03012841|594012499|FG001|Overall Study|Lost to Follow-up|1|||
164449014|NCT03012841|594012498|FG000|Overall Study|Withdrawal by Subject|6|||
164449015|NCT03012841|594012499|FG001|Overall Study|Withdrawal by Subject|0|||
164449016|NCT03012841|594012498|FG000|Overall Study|Unable to complete 12 month visit|6|||
164449017|NCT03012841|594012499|FG001|Overall Study|Unable to complete 12 month visit|0|||
164449018|NCT03012841|594012498|FG000|Overall Study|Subject relocation|1|||
164449019|NCT03012841|594012499|FG001|Overall Study|Subject relocation|0|||
164449020|NCT03012841|594012498|FG000|Overall Study|Seasonal winter travel|1|||
164449021|NCT03012841|594012499|FG001|Overall Study|Seasonal winter travel|0|||
164449022|NCT03012841|594012498|FG000|Overall Study|Physician Decision|0|||
164597081|NCT02052778|594549003|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164597082|NCT02052778|594549004|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164597083|NCT02052778|594549005|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164449023|NCT03012841|594012499|FG001|Overall Study|Physician Decision|2|||
164449024|NCT03012841|594012498|FG000|Overall Study|No ablation performed|0|||
164449025|NCT03012841|594012499|FG001|Overall Study|No ablation performed|2|||
164449026|NCT03012841|594012498|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
164449027|NCT03012841|594012499|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
164449028|NCT03012841|594012498|FG000|Overall Study|Insurance change|0|||
164449029|NCT03012841|594012499|FG001|Overall Study|Insurance change|1|||
164449030|NCT05696080|594012500|FG000|Overall Study|Lost to Follow-up|2|||
164449031|NCT05696080|594012501|FG001|Overall Study|Lost to Follow-up|1|||
164449032|NCT05696080|594012500|FG000|Overall Study|Physician Decision|1|||
164449033|NCT05696080|594012501|FG001|Overall Study|Physician Decision|0|||
164449034|NCT05696080|594012500|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164449035|NCT05696080|594012501|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
164449036|NCT05696080|594012500|FG000|Overall Study|Withdrawal by Subject|12|||
164449037|NCT05696080|594012501|FG001|Overall Study|Withdrawal by Subject|0|||
164449038|NCT03398200|594012502|FG000|Overall Study|Withdrawal by Subject|0|||
164449039|NCT03398200|594012503|FG001|Overall Study|Withdrawal by Subject|1|||
164449040|NCT04065048|594012504|FG000|Overall Study|Withdrawal by Subject|1|||
164449041|NCT04065048|594012505|FG001|Overall Study|Withdrawal by Subject|2|||
164449042|NCT04065048|594012506|FG002|Overall Study|Withdrawal by Subject|1|||
164449043|NCT04065048|594012507|FG003|Overall Study|Withdrawal by Subject|1|||
164449044|NCT04065048|594012504|FG000|Overall Study|Adverse Event|1|||
164449045|NCT04065048|594012505|FG001|Overall Study|Adverse Event|0|||
164449046|NCT04065048|594012506|FG002|Overall Study|Adverse Event|1|||
164449047|NCT04065048|594012507|FG003|Overall Study|Adverse Event|0|||
164449048|NCT05600283|594012510|FG000|Overall Study|Withdrawal by Subject|3|||
164449049|NCT05600283|594012511|FG001|Overall Study|Withdrawal by Subject|8|||
164449050|NCT05600283|594012510|FG000|Overall Study|Invalid Vaginal Swab|2|||
164449051|NCT05600283|594012511|FG001|Overall Study|Invalid Vaginal Swab|2|||
164449052|NCT05600283|594012510|FG000|Overall Study|Missing Clinician Collection|3|||
164449053|NCT05600283|594012511|FG001|Overall Study|Missing Clinician Collection|6|||
164449054|NCT05600283|594012510|FG000|Overall Study|Screen Failure|1|||
164449055|NCT05600283|594012511|FG001|Overall Study|Screen Failure|2|||
164449056|NCT05600283|594012510|FG000|Overall Study|Sample Lost in Transit|1|||
164449057|NCT05600283|594012511|FG001|Overall Study|Sample Lost in Transit|0|||
164449058|NCT00068601|594012512|FG000|Overall Study|Ineligible|11|||
164449059|NCT00068601|594012513|FG001|Overall Study|Ineligible|13|||
164449060|NCT00068601|594012512|FG000|Overall Study|Not evaluable: withdrew consent|5|||
164449061|NCT00068601|594012513|FG001|Overall Study|Not evaluable: withdrew consent|4|||
164449062|NCT00068601|594012512|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
164449063|NCT00068601|594012513|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
164449064|NCT00068601|594012512|FG000|Overall Study|Death|11|||
164449065|NCT00068601|594012513|FG001|Overall Study|Death|3|||
164449066|NCT00068601|594012512|FG000|Overall Study|Lost to Follow-up|3|||
164449067|NCT00068601|594012513|FG001|Overall Study|Lost to Follow-up|2|||
164449068|NCT00068601|594012512|FG000|Overall Study|Missing primary outcome data|30|||
164449069|NCT00068601|594012513|FG001|Overall Study|Missing primary outcome data|34|||
164449070|NCT01061671|594012514|FG000|Overall Study|Withdrawal by Subject|16|||
164449071|NCT01061671|594012515|FG001|Overall Study|Withdrawal by Subject|20|||
164449072|NCT01061671|594012514|FG000|Overall Study|Lost to Follow-up|3|||
164449073|NCT01061671|594012515|FG001|Overall Study|Lost to Follow-up|5|||
164449074|NCT01061671|594012514|FG000|Overall Study|Death|28|||
164449075|NCT01061671|594012515|FG001|Overall Study|Death|30|||
164449076|NCT02468128|594012516|FG000|Overall Study|Protocol Violation|6|||
164449077|NCT02468128|594012517|FG001|Overall Study|Protocol Violation|6|||
164449078|NCT00440011|594012521|FG000|Overall Study|Adverse Event|2|||
164449079|NCT00440011|594012522|FG001|Overall Study|Adverse Event|0|||
164449080|NCT00440011|594012521|FG000|Overall Study|Lost to Follow-up|0|||
164449081|NCT00440011|594012522|FG001|Overall Study|Lost to Follow-up|2|||
164449082|NCT00440011|594012521|FG000|Overall Study|Protocol Violation|1|||
164449083|NCT00440011|594012522|FG001|Overall Study|Protocol Violation|1|||
164449084|NCT00440011|594012521|FG000|Overall Study|Withdrawal by Subject|1|||
164449085|NCT00440011|594012522|FG001|Overall Study|Withdrawal by Subject|0|||
164449086|NCT00331136|594012525|FG000|Overall Study|Adverse Event|3|||
164449087|NCT00331136|594012526|FG001|Overall Study|Adverse Event|5|||
164449088|NCT00331136|594012527|FG002|Overall Study|Adverse Event|0|||
164449089|NCT00331136|594012528|FG003|Overall Study|Adverse Event|1|||
164449090|NCT00331136|594012525|FG000|Overall Study|Withdrawal by Subject|0|||
164449091|NCT00331136|594012526|FG001|Overall Study|Withdrawal by Subject|1|||
164449092|NCT00331136|594012527|FG002|Overall Study|Withdrawal by Subject|0|||
164449093|NCT00331136|594012528|FG003|Overall Study|Withdrawal by Subject|0|||
164449094|NCT00331136|594012525|FG000|Overall Study|Lost to Follow-up|0|||
164449095|NCT00331136|594012526|FG001|Overall Study|Lost to Follow-up|1|||
164449096|NCT00331136|594012527|FG002|Overall Study|Lost to Follow-up|0|||
164449097|NCT00331136|594012528|FG003|Overall Study|Lost to Follow-up|0|||
164449098|NCT00331136|594012525|FG000|Overall Study|Protocol Violation|1|||
164449099|NCT00331136|594012526|FG001|Overall Study|Protocol Violation|0|||
164449100|NCT00331136|594012527|FG002|Overall Study|Protocol Violation|0|||
164449101|NCT00331136|594012528|FG003|Overall Study|Protocol Violation|0|||
164449102|NCT00331136|594012525|FG000|Overall Study|Not treated|1|||
164449103|NCT00331136|594012526|FG001|Overall Study|Not treated|0|||
164449104|NCT00331136|594012527|FG002|Overall Study|Not treated|0|||
164449105|NCT00331136|594012528|FG003|Overall Study|Not treated|0|||
164449106|NCT00419341|594012529|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
164449107|NCT00419341|594012529|FG000|Wash in/Wash Out Period|Adverse Event|2|||
164449108|NCT00419341|594012529|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
164449109|NCT00419341|594012529|FG000|Efficacy Period|Withdrawal by Subject|6|||
164449110|NCT00419341|594012529|FG000|Efficacy Period|Protocol Violation|1|||
164449111|NCT00419341|594012529|FG000|Efficacy Period|Lost to Follow-up|1|||
164449112|NCT00419341|594012529|FG000|Efficacy Period|Non-compliance|1|||
164449113|NCT00419341|594012529|FG000|Efficacy Period|Termination of study site|1|||
164449114|NCT00621296|594012530|FG000|Overall Study|Adverse Event|2|||
164449115|NCT00621296|594012530|FG000|Overall Study|Lack of Efficacy|1|||
164449116|NCT00621296|594012530|FG000|Overall Study|Physician Decision|7|||
164449117|NCT00621296|594012530|FG000|Overall Study|Unmatch Criteria|1|||
164449118|NCT00621296|594012530|FG000|Overall Study|Stopping Criteria|3|||
164449119|NCT04166058|594012531|FG000|Overall Study|Adverse Event|1|||
164449120|NCT04166058|594012532|FG001|Overall Study|Adverse Event|1|||
164449121|NCT04166058|594012533|FG002|Overall Study|Adverse Event|0|||
164449122|NCT04166058|594012534|FG003|Overall Study|Adverse Event|0|||
164449123|NCT04166058|594012531|FG000|Overall Study|Withdrawal by Subject|4|||
164449124|NCT04166058|594012532|FG001|Overall Study|Withdrawal by Subject|4|||
164449125|NCT04166058|594012533|FG002|Overall Study|Withdrawal by Subject|1|||
164449126|NCT04166058|594012534|FG003|Overall Study|Withdrawal by Subject|10|||
164449127|NCT04166058|594012531|FG000|Overall Study|Lost to Follow-up|9|||
164449128|NCT04166058|594012532|FG001|Overall Study|Lost to Follow-up|2|||
164449129|NCT04166058|594012533|FG002|Overall Study|Lost to Follow-up|1|||
164449130|NCT04166058|594012534|FG003|Overall Study|Lost to Follow-up|1|||
164449131|NCT04166058|594012531|FG000|Overall Study|Pregnancy|1|||
164449132|NCT04166058|594012532|FG001|Overall Study|Pregnancy|0|||
164449133|NCT04166058|594012533|FG002|Overall Study|Pregnancy|0|||
164449134|NCT04166058|594012534|FG003|Overall Study|Pregnancy|0|||
164449135|NCT04166058|594012531|FG000|Overall Study|Physician Decision|2|||
164449136|NCT04166058|594012532|FG001|Overall Study|Physician Decision|0|||
164449137|NCT04166058|594012533|FG002|Overall Study|Physician Decision|0|||
164449138|NCT04166058|594012534|FG003|Overall Study|Physician Decision|2|||
164449139|NCT04166058|594012531|FG000|Overall Study|Protocol Violation|1|||
164449140|NCT04166058|594012532|FG001|Overall Study|Protocol Violation|0|||
164449141|NCT04166058|594012533|FG002|Overall Study|Protocol Violation|0|||
164449142|NCT04166058|594012534|FG003|Overall Study|Protocol Violation|0|||
164449143|NCT04166058|594012531|FG000|Overall Study|Lack of Efficacy|2|||
164449144|NCT04166058|594012532|FG001|Overall Study|Lack of Efficacy|0|||
164449145|NCT04166058|594012533|FG002|Overall Study|Lack of Efficacy|0|||
164706388|NCT02393248|594953435|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164449146|NCT04166058|594012534|FG003|Overall Study|Lack of Efficacy|0|||
164449147|NCT04166058|594012531|FG000|Overall Study|Other|1|||
164449148|NCT04166058|594012532|FG001|Overall Study|Other|0|||
164449149|NCT04166058|594012533|FG002|Overall Study|Other|0|||
164449150|NCT04166058|594012534|FG003|Overall Study|Other|1|||
164449151|NCT04166058|594012531|FG000|Overall Study|Non-compliance with study drug|0|||
164449152|NCT04166058|594012532|FG001|Overall Study|Non-compliance with study drug|0|||
164449153|NCT04166058|594012533|FG002|Overall Study|Non-compliance with study drug|0|||
164449154|NCT04166058|594012534|FG003|Overall Study|Non-compliance with study drug|2|||
164449155|NCT02998528|594012535|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
164449156|NCT02998528|594012536|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
164449157|NCT02998528|594012537|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
164449158|NCT02998528|594012535|FG000|Randomization Period|Participant withdrew consent|0|||
164449159|NCT02998528|594012536|FG001|Randomization Period|Participant withdrew consent|3|||
164449160|NCT02998528|594012537|FG002|Randomization Period|Participant withdrew consent|0|||
164449161|NCT02998528|594012535|FG000|Randomization Period|Participant no longer meets study criteria|1|||
164449162|NCT02998528|594012536|FG001|Randomization Period|Participant no longer meets study criteria|3|||
164449163|NCT02998528|594012537|FG002|Randomization Period|Participant no longer meets study criteria|2|||
164449164|NCT02998528|594012535|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
164449165|NCT02998528|594012536|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
164449166|NCT02998528|594012537|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
164449167|NCT02998528|594012535|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
164449168|NCT02998528|594012536|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
164449169|NCT02998528|594012537|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
164449170|NCT02998528|594012535|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
164449171|NCT02998528|594012536|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
164449172|NCT02998528|594012537|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
164706389|NCT02393248|594953436|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164706390|NCT02393248|594953437|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164706391|NCT02393248|594953438|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164706392|NCT02393248|594953414|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164706393|NCT02393248|594953415|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164706394|NCT02393248|594953416|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164706395|NCT02393248|594953417|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164706396|NCT02393248|594953418|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164706397|NCT02393248|594953419|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164706398|NCT02393248|594953420|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
164706399|NCT02393248|594953421|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164404476|NCT01376323|593851963|FG000|Overall Study|Withdrawal by Subject|0|||
164404477|NCT01376323|593851964|FG001|Overall Study|Withdrawal by Subject|1|||
164404478|NCT01376323|593851965|FG002|Overall Study|Withdrawal by Subject|1|||
164404479|NCT01376323|593851966|FG003|Overall Study|Withdrawal by Subject|0|||
164404480|NCT01376323|593851967|FG004|Overall Study|Withdrawal by Subject|0|||
164404481|NCT00454571|593851968|FG000|Overall Study|Adverse Event|2|||
164404482|NCT00454571|593851969|FG001|Overall Study|Adverse Event|0|||
164404483|NCT00454571|593851968|FG000|Overall Study|Physician Decision|0|||
164404484|NCT00454571|593851969|FG001|Overall Study|Physician Decision|1|||
164404485|NCT00454571|593851968|FG000|Overall Study|Protocol Violation|1|||
164404486|NCT00454571|593851969|FG001|Overall Study|Protocol Violation|0|||
164404487|NCT00454571|593851968|FG000|Overall Study|Withdrawal by Subject|10|||
164404488|NCT00454571|593851969|FG001|Overall Study|Withdrawal by Subject|5|||
164404489|NCT04681729|593851970|FG000|Overall Study|Lack of Efficacy|2|||
164404490|NCT04681729|593851971|FG001|Overall Study|Lack of Efficacy|2|||
164404491|NCT04681729|593851970|FG000|Overall Study|Withdrawal by Subject|8|||
164404492|NCT04681729|593851971|FG001|Overall Study|Withdrawal by Subject|9|||
164404493|NCT03595332|593851972|FG000|Overall Study|Lost to Follow-up|16|||
164404494|NCT03595332|593851973|FG001|Overall Study|Lost to Follow-up|22|||
164404495|NCT03595332|593851972|FG000|Overall Study|Unable to retrieve ID from school|0|||
164404496|NCT03595332|593851973|FG001|Overall Study|Unable to retrieve ID from school|2|||
164404497|NCT00792103|593851974|FG000|Overall Study|Enrolled, not treated|15|||
164404498|NCT00792103|593851974|FG000|Overall Study|Lost to Follow-up|17|||
164404499|NCT00792103|593851974|FG000|Overall Study|Adverse Event|25|||
164404500|NCT00792103|593851974|FG000|Overall Study|Withdrawal by Subject|52|||
164404501|NCT00792103|593851974|FG000|Overall Study|Protocol Violation|10|||
164404502|NCT00792103|593851974|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
164404503|NCT02227875|593851975|FG000|Overall Study|Protocol Violation|10|||
164404504|NCT02227875|593851976|FG001|Overall Study|Protocol Violation|7|||
164404505|NCT02227875|593851975|FG000|Overall Study|Other|1|||
164404506|NCT02227875|593851976|FG001|Overall Study|Other|3|||
164404507|NCT02227875|593851975|FG000|Overall Study|Physician Decision|1|||
164404508|NCT02227875|593851976|FG001|Overall Study|Physician Decision|0|||
164404509|NCT02227875|593851975|FG000|Overall Study|Adverse Event|3|||
164404510|NCT02227875|593851976|FG001|Overall Study|Adverse Event|0|||
164404511|NCT02227875|593851975|FG000|Overall Study|Withdrawal by Subject|12|||
164404512|NCT02227875|593851976|FG001|Overall Study|Withdrawal by Subject|13|||
164404513|NCT02227875|593851975|FG000|Overall Study|Lost to Follow-up|10|||
164404514|NCT02227875|593851976|FG001|Overall Study|Lost to Follow-up|10|||
164404515|NCT01201811|593851977|FG000|Overall Study|Adverse Event|6|||
164404516|NCT01201811|593851977|FG000|Overall Study|Disease progression|3|||
164404517|NCT01201811|593851977|FG000|Overall Study|Withdrawal by Subject|3|||
164404518|NCT01201811|593851977|FG000|Overall Study|Death|4|||
164404519|NCT01201811|593851977|FG000|Overall Study|Treatment Failure|2|||
164404520|NCT01201811|593851977|FG000|Overall Study|Physician Decision|1|||
164404521|NCT02857426|593851978|FG000|Overall Study|Disease progression|34|||
164404522|NCT02857426|593851979|FG001|Overall Study|Disease progression|13|||
164404523|NCT02857426|593851978|FG000|Overall Study|Study drug toxicity|4|||
164404524|NCT02857426|593851979|FG001|Overall Study|Study drug toxicity|1|||
164404525|NCT02857426|593851978|FG000|Overall Study|Death|1|||
164404526|NCT02857426|593851979|FG001|Overall Study|Death|0|||
164404527|NCT02857426|593851978|FG000|Overall Study|Adverse event unrelated to study drug|6|||
164404528|NCT02857426|593851979|FG001|Overall Study|Adverse event unrelated to study drug|2|||
164404529|NCT02857426|593851978|FG000|Overall Study|Participant withdrew consent|1|||
164404530|NCT02857426|593851979|FG001|Overall Study|Participant withdrew consent|1|||
164404531|NCT02857426|593851978|FG000|Overall Study|Maximum clinical benefit|1|||
164404532|NCT02857426|593851979|FG001|Overall Study|Maximum clinical benefit|0|||
164404533|NCT02857426|593851978|FG000|Overall Study|Completed treatment|0|||
164404534|NCT02857426|593851979|FG001|Overall Study|Completed treatment|2|||
164404535|NCT01960725|593851980|FG000|Overall Study|Lost to Follow-up|4|||
164404536|NCT01960725|593851981|FG001|Overall Study|Lost to Follow-up|3|||
164404537|NCT01960725|593851980|FG000|Overall Study|Withdrawal by Subject|1|||
164404538|NCT01960725|593851981|FG001|Overall Study|Withdrawal by Subject|0|||
164449173|NCT02998528|594012535|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
164449174|NCT02998528|594012536|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
164449175|NCT02998528|594012537|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
164449176|NCT02998528|594012535|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
164449177|NCT02998528|594012536|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
164449178|NCT02998528|594012537|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
164449179|NCT02998528|594012535|FG000|Neoadjuvant Treatment Period|Death|1|||
164449180|NCT02998528|594012536|FG001|Neoadjuvant Treatment Period|Death|0|||
164449181|NCT02998528|594012537|FG002|Neoadjuvant Treatment Period|Death|0|||
164449182|NCT02998528|594012535|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
164449183|NCT02998528|594012536|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
164449184|NCT02998528|594012537|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
164449185|NCT02998528|594012535|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
164449186|NCT02998528|594012536|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
164449187|NCT02998528|594012537|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
164449188|NCT02998528|594012535|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
164449189|NCT02998528|594012536|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
164449190|NCT02998528|594012537|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
164449191|NCT02998528|594012535|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
164449192|NCT02998528|594012536|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
164449193|NCT02998528|594012537|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
164449194|NCT02998528|594012535|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
164449195|NCT02998528|594012536|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
164449196|NCT02998528|594012537|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
164449197|NCT02998528|594012535|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
164449198|NCT02998528|594012536|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
164449199|NCT02998528|594012537|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
164449200|NCT02692417|594012538|FG000|Overall Study|Withdrawal by Subject|5|||
164449201|NCT02692417|594012539|FG001|Overall Study|Withdrawal by Subject|1|||
164449202|NCT02692417|594012538|FG000|Overall Study|Adverse Event|1|||
164449203|NCT02692417|594012539|FG001|Overall Study|Adverse Event|0|||
164449204|NCT02372253|594012548|FG000|Overall Study|Non Compliance|2|||
164449205|NCT02372253|594012549|FG001|Overall Study|Non Compliance|0|||
164449206|NCT03201562|594012550|FG000|Overall Study|Physician Decision|0|||
164449207|NCT03201562|594012551|FG001|Overall Study|Physician Decision|0|||
164449208|NCT03201562|594012552|FG002|Overall Study|Physician Decision|1|||
164449209|NCT03201562|594012550|FG000|Overall Study|Adverse Event|0|||
164449210|NCT03201562|594012551|FG001|Overall Study|Adverse Event|0|||
164449211|NCT03201562|594012552|FG002|Overall Study|Adverse Event|1|||
164449212|NCT03201562|594012550|FG000|Overall Study|Lost to Follow-up|0|||
164449213|NCT03201562|594012551|FG001|Overall Study|Lost to Follow-up|1|||
164449214|NCT03201562|594012552|FG002|Overall Study|Lost to Follow-up|2|||
164449215|NCT01803555|594012553|FG000|Overall Study|Adverse Event|3|||
164449216|NCT01803555|594012554|FG001|Overall Study|Adverse Event|2|||
164449217|NCT01803555|594012553|FG000|Overall Study|Withdrawal by Subject|3|||
164449218|NCT01803555|594012554|FG001|Overall Study|Withdrawal by Subject|3|||
164449219|NCT01803555|594012553|FG000|Overall Study|Non-compliance|1|||
164449220|NCT01803555|594012554|FG001|Overall Study|Non-compliance|1|||
164449221|NCT01803555|594012553|FG000|Overall Study|Protocol Violation|3|||
164449222|NCT01803555|594012554|FG001|Overall Study|Protocol Violation|5|||
164449223|NCT01803555|594012553|FG000|Overall Study|Lost to Follow-up|0|||
164449224|NCT01803555|594012554|FG001|Overall Study|Lost to Follow-up|2|||
164449225|NCT01803555|594012553|FG000|Overall Study|Other than specified|3|||
164449226|NCT01803555|594012554|FG001|Overall Study|Other than specified|5|||
164449227|NCT01753570|594012558|FG000|Overall Study|Adverse Event|1|||
164449228|NCT01753570|594012559|FG001|Overall Study|Adverse Event|0|||
164449229|NCT01753570|594012560|FG002|Overall Study|Adverse Event|1|||
164449230|NCT01753570|594012558|FG000|Overall Study|Physician Decision|0|||
164449231|NCT01753570|594012559|FG001|Overall Study|Physician Decision|1|||
164449232|NCT01753570|594012560|FG002|Overall Study|Physician Decision|0|||
164449233|NCT01753570|594012558|FG000|Overall Study|Withdrawal by Subject|1|||
164449234|NCT01753570|594012559|FG001|Overall Study|Withdrawal by Subject|4|||
164449235|NCT01753570|594012560|FG002|Overall Study|Withdrawal by Subject|0|||
164449236|NCT03892564|594012561|FG000|Overall Study|Withdrawal by Subject|2|||
164449237|NCT05308316|594012562|FG000|Overall Study|Withdrawal by Subject|2|||
164449238|NCT05308316|594012562|FG000|Overall Study|Physician Decision|1|||
164449239|NCT03997916|594012566|FG000|Overall Study|Protocol Violation|35|||
164449240|NCT04578106|594012569|FG000|Follow-up after 1 year|Lost to Follow-up|1|||
164449241|NCT03954184|594014243|FG000|Overall Study|Lost to Follow-up|500|||
164449242|NCT03954184|594014244|FG001|Overall Study|Lost to Follow-up|0|||
164449243|NCT03397108|594014245|FG000|Overall Study|Lost to Follow-up|15|||
164449244|NCT03397108|594014246|FG001|Overall Study|Lost to Follow-up|0|||
164449245|NCT03397108|594014245|FG000|Overall Study|Insufficient milk production|3|||
164449246|NCT03397108|594014246|FG001|Overall Study|Insufficient milk production|2|||
164449247|NCT03397108|594014245|FG000|Overall Study|Withdrawal by Subject|2|||
164449248|NCT03397108|594014246|FG001|Overall Study|Withdrawal by Subject|0|||
164449249|NCT04607044|594014249|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
164449250|NCT04607044|594014249|FG000|Overall Study|Adverse Event|1|||
164449251|NCT04607044|594014249|FG000|Overall Study|Did not receive study device|3|||
164449252|NCT04607044|594014249|FG000|Overall Study|Death|1|||
164449253|NCT05403801|594014250|FG000|Overall Study|Withdrawal by Subject|2|||
164449254|NCT05307783|594014253|FG000|Overall Study|Death|7|||
164449255|NCT05307783|594014253|FG000|Overall Study|Lost to Follow-up|4|||
164449256|NCT04883645|594014254|FG000|Overall Study|Death|1|||
164449257|NCT03460236|594014256|FG000|Overall Study|failed radiographic screening|16|||
164449258|NCT03460236|594014256|FG000|Overall Study|Withdrawal by Subject|11|||
164449259|NCT06194214|594014257|FG000|Overall Study|Adverse Event|1|||
164449260|NCT04869982|594014258|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
164449261|NCT04869982|594014259|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
164449262|NCT04869982|594014258|FG000|Overall Study|Migrated / moved from the study area|1|||
164449263|NCT04869982|594014259|FG001|Overall Study|Migrated / moved from the study area|1|||
164449264|NCT04869982|594014258|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
164449265|NCT04869982|594014259|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
164449266|NCT04869982|594014258|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
164449267|NCT04869982|594014259|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
164449268|NCT04869982|594014258|FG000|Overall Study|Solicited adverse event|2|||
164449269|NCT04869982|594014259|FG001|Overall Study|Solicited adverse event|1|||
164449270|NCT04608045|594014260|FG000|Overall Study|Physician Decision|1|||
164449271|NCT02473250|594014262|FG000|Overall Study|Lost to Follow-up|10|||
164449272|NCT02473250|594014262|FG000|Overall Study|Physician Decision|5|||
164449273|NCT02473250|594014262|FG000|Overall Study|Did not tolerate medication washout|3|||
164449274|NCT02473250|594014262|FG000|Overall Study|Antidepressant effect of divalproex|2|||
164449275|NCT05215847|594014263|FG000|Overall Study|Lost to Follow-up|1|||
164449276|NCT04847999|594014264|FG000|Overall Study|Lost to Follow-up|0|||
164449277|NCT04847999|594014265|FG001|Overall Study|Lost to Follow-up|1|||
164449278|NCT01704079|594014279|FG000|Overall Study|Withdrawal by Subject|5|||
164449279|NCT01704079|594014280|FG001|Overall Study|Withdrawal by Subject|7|||
164449280|NCT01704079|594014279|FG000|Overall Study|Lost to Follow-up|2|||
164449281|NCT01704079|594014280|FG001|Overall Study|Lost to Follow-up|5|||
164449282|NCT01704079|594014279|FG000|Overall Study|Adverse Event|4|||
164449283|NCT01704079|594014280|FG001|Overall Study|Adverse Event|7|||
164449284|NCT01704079|594014279|FG000|Overall Study|Protocol Violation|1|||
164449285|NCT01704079|594014280|FG001|Overall Study|Protocol Violation|0|||
164449286|NCT01704079|594014279|FG000|Overall Study|Subject noncompliance|2|||
164449287|NCT01704079|594014280|FG001|Overall Study|Subject noncompliance|3|||
164449288|NCT01704079|594014279|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
164449289|NCT01704079|594014280|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
164449290|NCT04300231|594014281|FG000|Overall Study|Protocol Violation|4|||
164449291|NCT04300231|594014282|FG001|Overall Study|Protocol Violation|3|||
164449292|NCT04300231|594014283|FG002|Overall Study|Protocol Violation|0|||
164449293|NCT04300231|594014284|FG003|Overall Study|Protocol Violation|2|||
164449294|NCT06023082|594014285|FG000|Overall Study|Withdrawal by Subject|2|||
164449295|NCT06023082|594014285|FG000|Overall Study|Lost to Follow-up|15|||
164449296|NCT06023082|594014285|FG000|Overall Study|Side effects|5|||
164449297|NCT05986565|594014286|FG000|Overall Study|Lost to Follow-up|8|||
164449298|NCT05986565|594014287|FG001|Overall Study|Lost to Follow-up|3|||
164449299|NCT05986565|594014286|FG000|Overall Study|Withdrawal by Subject|0|||
164449300|NCT05986565|594014287|FG001|Overall Study|Withdrawal by Subject|1|||
164449301|NCT05846646|594014290|FG000|Overall Study|Physician Decision|1|||
164449302|NCT05846646|594014291|FG001|Overall Study|Physician Decision|0|||
164449303|NCT05846646|594014292|FG002|Overall Study|Physician Decision|0|||
164449304|NCT05846646|594014290|FG000|Overall Study|Lack of Efficacy|1|||
164449305|NCT05846646|594014291|FG001|Overall Study|Lack of Efficacy|1|||
164449306|NCT05846646|594014292|FG002|Overall Study|Lack of Efficacy|0|||
164449307|NCT05846646|594014290|FG000|Overall Study|Early Study Termination|1|||
164449308|NCT05846646|594014291|FG001|Overall Study|Early Study Termination|2|||
164449309|NCT05846646|594014292|FG002|Overall Study|Early Study Termination|0|||
164597084|NCT02052778|594549006|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164597085|NCT02052778|594549007|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
164449310|NCT00670046|594014293|FG000|Overall Study|Lost to Follow-up|1|||
164449311|NCT00670046|594014294|FG001|Overall Study|Lost to Follow-up|1|||
164449312|NCT00670046|594014293|FG000|Overall Study|Withdrawal by Subject|0|||
164449313|NCT00670046|594014294|FG001|Overall Study|Withdrawal by Subject|1|||
164449314|NCT01443845|594014300|FG000|Overall Study|Protocol Violation|43|||
164449315|NCT01443845|594014301|FG001|Overall Study|Protocol Violation|45|||
164449316|NCT01443845|594014300|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
164449317|NCT01443845|594014301|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
164449318|NCT01443845|594014300|FG000|Overall Study|Deterioration in pulmonary function|1|||
164449319|NCT01443845|594014301|FG001|Overall Study|Deterioration in pulmonary function|4|||
164449320|NCT01443845|594014300|FG000|Overall Study|Lack of Efficacy|10|||
164449321|NCT01443845|594014301|FG001|Overall Study|Lack of Efficacy|5|||
164449322|NCT01443845|594014300|FG000|Overall Study|Adverse Event|64|||
164449323|NCT01443845|594014301|FG001|Overall Study|Adverse Event|138|||
164449324|NCT01443845|594014300|FG000|Overall Study|Withdrawal by Subject|63|||
164449325|NCT01443845|594014301|FG001|Overall Study|Withdrawal by Subject|67|||
164449326|NCT01443845|594014300|FG000|Overall Study|Military Conflict - Site Terminated|20|||
164449327|NCT01443845|594014301|FG001|Overall Study|Military Conflict - Site Terminated|21|||
164449328|NCT01443845|594014300|FG000|Overall Study|Lost to Follow-up|9|||
164449329|NCT01443845|594014301|FG001|Overall Study|Lost to Follow-up|13|||
164449330|NCT02461628|594014304|FG000|Overall Study|Refused to complete survey|4|||
164449331|NCT02461628|594014305|FG001|Overall Study|Refused to complete survey|7|||
164449332|NCT02006758|594014313|FG000|Overall Study|Protocol Violation|1|||
164449333|NCT02006758|594014313|FG000|Overall Study|Death|1|||
164449334|NCT02006758|594014313|FG000|Overall Study|Lost to Follow-up|4|||
164449335|NCT02006758|594014313|FG000|Overall Study|Withdrawal by Subject|4|||
164449336|NCT02006758|594014313|FG000|Overall Study|Procedurally excluded|1|||
164449337|NCT02006758|594014313|FG000|Overall Study|Other|2|||
164449338|NCT02462759|594014315|FG000|Part 1: Double Blind|Death|1|||
164449339|NCT02462759|594014316|FG001|Part 1: Double Blind|Death|0|||
164449340|NCT02462759|594014317|FG002|Part 1: Double Blind|Death|0|||
164449341|NCT00520546|594014321|FG000|Overall Study|Withdrawal by Subject|1|||
164449342|NCT00520546|594014321|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
164449343|NCT05052996|594014322|FG000|Overall Study|Still on study|0|||
164449344|NCT05052996|594014323|FG001|Overall Study|Still on study|0|||
164449345|NCT05052996|594014324|FG002|Overall Study|Still on study|47|||
164449346|NCT05052996|594014325|FG003|Overall Study|Still on study|44|||
164449347|NCT05052996|594014322|FG000|Overall Study|Cohort terminated by sponsor|21|||
164449348|NCT05052996|594014323|FG001|Overall Study|Cohort terminated by sponsor|12|||
164449349|NCT05052996|594014324|FG002|Overall Study|Cohort terminated by sponsor|0|||
164449350|NCT05052996|594014325|FG003|Overall Study|Cohort terminated by sponsor|0|||
164449351|NCT05052996|594014322|FG000|Overall Study|Withdrew consent|1|||
164449352|NCT05052996|594014323|FG001|Overall Study|Withdrew consent|0|||
164449353|NCT05052996|594014324|FG002|Overall Study|Withdrew consent|1|||
164449354|NCT05052996|594014325|FG003|Overall Study|Withdrew consent|2|||
164449355|NCT05052996|594014322|FG000|Overall Study|Lost to Follow-up|1|||
164449356|NCT05052996|594014323|FG001|Overall Study|Lost to Follow-up|0|||
164449357|NCT05052996|594014324|FG002|Overall Study|Lost to Follow-up|0|||
164449358|NCT05052996|594014325|FG003|Overall Study|Lost to Follow-up|2|||
164449359|NCT05052996|594014322|FG000|Overall Study|Adverse Event|0|||
164449360|NCT05052996|594014323|FG001|Overall Study|Adverse Event|0|||
164449361|NCT05052996|594014324|FG002|Overall Study|Adverse Event|2|||
164449362|NCT05052996|594014325|FG003|Overall Study|Adverse Event|0|||
164449363|NCT05052996|594014322|FG000|Overall Study|Randomized but never treated|0|||
164449364|NCT05052996|594014323|FG001|Overall Study|Randomized but never treated|0|||
164449365|NCT05052996|594014324|FG002|Overall Study|Randomized but never treated|1|||
164449366|NCT05052996|594014325|FG003|Overall Study|Randomized but never treated|1|||
164449367|NCT05052996|594014322|FG000|Overall Study|Protocol Violation|1|||
164449368|NCT05052996|594014323|FG001|Overall Study|Protocol Violation|0|||
164449369|NCT05052996|594014324|FG002|Overall Study|Protocol Violation|0|||
164449370|NCT05052996|594014325|FG003|Overall Study|Protocol Violation|0|||
164449371|NCT01695954|594014326|FG000|Overall Study|Withdrawal by Subject|4|||
164449372|NCT01695954|594014327|FG001|Overall Study|Withdrawal by Subject|0|||
164449373|NCT01695954|594014326|FG000|Overall Study|Adverse Event|0|||
164449374|NCT01695954|594014327|FG001|Overall Study|Adverse Event|2|||
164449375|NCT02088853|594014328|FG000|Overall Study|Pregnancy|1|||
164449376|NCT02088853|594014329|FG001|Overall Study|Pregnancy|0|||
164449377|NCT04704284|594014335|FG000|Overall Study|Withdrawal by Subject|1|||
164449378|NCT01248936|594014339|FG000|Overall Study|Sponsor Decision|259|||
164449379|NCT01248936|594014339|FG000|Overall Study|Progression of Disease|50|||
164449380|NCT01248936|594014339|FG000|Overall Study|Death|26|||
164449381|NCT01248936|594014339|FG000|Overall Study|Withdrawal of Consent|20|||
164449382|NCT01248936|594014339|FG000|Overall Study|Adverse Event|8|||
164597086|NCT02052778|594549008|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
164597087|NCT02052778|594549009|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164597088|NCT02052778|594549010|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164449383|NCT01248936|594014339|FG000|Overall Study|Lost to Follow-up|7|||
164449384|NCT01248936|594014339|FG000|Overall Study|Refused Treatment|1|||
164449385|NCT01248936|594014339|FG000|Overall Study|Other reason|3|||
164449386|NCT03930420|594014340|FG000|Overall Study|Withdrawal by Subject|7|||
164449387|NCT03930420|594014341|FG001|Overall Study|Withdrawal by Subject|9|||
164449388|NCT05609032|594014342|FG000|Overall Study|Lost to Follow-up|3|||
164449389|NCT05609032|594014343|FG001|Overall Study|Lost to Follow-up|1|||
164449390|NCT05609032|594014342|FG000|Overall Study|Withdrawal by Subject|1|||
164449391|NCT05609032|594014343|FG001|Overall Study|Withdrawal by Subject|0|||
164449392|NCT00609336|594014344|FG000|Overall Study|Protocol Violation|3|||
164449393|NCT00609336|594014344|FG000|Overall Study|Death|1|||
164449394|NCT00609336|594014344|FG000|Overall Study|LA or Met at Surgery|9|||
164449395|NCT00567489|594014345|FG000|Overall Study|Adverse Event|6|||
164449396|NCT00567489|594014346|FG001|Overall Study|Adverse Event|14|||
164597089|NCT02052778|594549011|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164597090|NCT02052778|594549012|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
164597091|NCT02052778|594549013|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164597092|NCT02052778|594549014|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164597093|NCT02052778|594549015|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164449397|NCT00567489|594014345|FG000|Overall Study|Physician Decision|0|||
164449398|NCT00567489|594014346|FG001|Overall Study|Physician Decision|4|||
164449399|NCT00567489|594014345|FG000|Overall Study|Withdrawal by Subject|0|||
164449400|NCT00567489|594014346|FG001|Overall Study|Withdrawal by Subject|2|||
164449401|NCT00567489|594014345|FG000|Overall Study|Renal Transplantation|0|||
164449402|NCT00567489|594014346|FG001|Overall Study|Renal Transplantation|3|||
164449403|NCT00567489|594014345|FG000|Overall Study|Other|1|||
164449404|NCT00567489|594014346|FG001|Overall Study|Other|0|||
164449405|NCT04019444|594014358|FG000|Overall Study|Withdrawal by Subject|0|||
164449406|NCT04019444|594014359|FG001|Overall Study|Withdrawal by Subject|1|||
164449407|NCT04019444|594014360|FG002|Overall Study|Withdrawal by Subject|0|||
164449408|NCT04019444|594014361|FG003|Overall Study|Withdrawal by Subject|1|||
164449409|NCT04019444|594014358|FG000|Overall Study|Solicited Event|0|||
164449410|NCT04019444|594014359|FG001|Overall Study|Solicited Event|0|||
164449411|NCT04019444|594014360|FG002|Overall Study|Solicited Event|2|||
164449412|NCT04019444|594014361|FG003|Overall Study|Solicited Event|0|||
164449413|NCT04690556|594014362|FG000|Overall Study|Adverse Event|6|||
164449414|NCT04690556|594014363|FG001|Overall Study|Adverse Event|4|||
164449415|NCT04690556|594014362|FG000|Overall Study|Death|3|||
164449416|NCT04690556|594014363|FG001|Overall Study|Death|4|||
164449417|NCT04690556|594014362|FG000|Overall Study|Lost to Follow-up|3|||
164449418|NCT04690556|594014363|FG001|Overall Study|Lost to Follow-up|2|||
164449419|NCT04690556|594014362|FG000|Overall Study|Protocol Violation|1|||
164449420|NCT04690556|594014363|FG001|Overall Study|Protocol Violation|4|||
164449421|NCT04690556|594014362|FG000|Overall Study|Physician Decision|2|||
164449422|NCT04690556|594014363|FG001|Overall Study|Physician Decision|0|||
164449423|NCT04690556|594014362|FG000|Overall Study|Withdrawal by Subject|25|||
164449424|NCT04690556|594014363|FG001|Overall Study|Withdrawal by Subject|17|||
164449425|NCT04690556|594014362|FG000|Overall Study|Prohibited medications and other reasons|3|||
164449426|NCT04690556|594014363|FG001|Overall Study|Prohibited medications and other reasons|1|||
164449427|NCT00497198|594014364|FG000|Overall Study|Adverse Event|4|||
164449428|NCT00497198|594014365|FG001|Overall Study|Adverse Event|2|||
164449429|NCT00497198|594014364|FG000|Overall Study|Physician Decision|1|||
164449430|NCT00497198|594014365|FG001|Overall Study|Physician Decision|2|||
164449431|NCT00497198|594014364|FG000|Overall Study|Withdrawal by Subject|0|||
164449432|NCT00497198|594014365|FG001|Overall Study|Withdrawal by Subject|1|||
164449433|NCT03891758|594014368|FG000|Overall Study|Adverse Event|2|||
164449434|NCT03891758|594014369|FG001|Overall Study|Adverse Event|0|||
164449435|NCT03891758|594014368|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164449436|NCT03891758|594014369|FG001|Overall Study|Withdrawal by parent/guardian|2|||
164449437|NCT04434729|594014372|FG000|Overall Study|Adverse Event|1|||
164449438|NCT04434729|594014372|FG000|Overall Study|Physician Decision|1|||
164449439|NCT00975819|594014373|FG000|Overall Study|Lack of Efficacy|8|||
164449440|NCT00975819|594014373|FG000|Overall Study|Adverse Event|2|||
164449441|NCT00975819|594014373|FG000|Overall Study|Physician Decision|2|||
164449442|NCT00975819|594014373|FG000|Overall Study|Withdrawal by Subject|2|||
164449443|NCT00975819|594014373|FG000|Overall Study|Protocol Violation|1|||
164449444|NCT01968109|594014374|FG000|Overall Study|DISEASE PROGRESSION|4|||
164449445|NCT01968109|594014375|FG001|Overall Study|DISEASE PROGRESSION|4|||
164449446|NCT01968109|594014376|FG002|Overall Study|DISEASE PROGRESSION|3|||
164449447|NCT01968109|594014377|FG003|Overall Study|DISEASE PROGRESSION|9|||
164449448|NCT01968109|594014378|FG004|Overall Study|DISEASE PROGRESSION|5|||
164597094|NCT02052778|594548993|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
164449449|NCT01968109|594014379|FG005|Overall Study|DISEASE PROGRESSION|6|||
164449450|NCT01968109|594014380|FG006|Overall Study|DISEASE PROGRESSION|6|||
164449451|NCT01968109|594014381|FG007|Overall Study|DISEASE PROGRESSION|6|||
164449452|NCT01968109|594014382|FG008|Overall Study|DISEASE PROGRESSION|4|||
164449453|NCT01968109|594014383|FG009|Overall Study|DISEASE PROGRESSION|5|||
164449454|NCT01968109|594014384|FG010|Overall Study|DISEASE PROGRESSION|8|||
164449455|NCT01968109|594014385|FG011|Overall Study|DISEASE PROGRESSION|4|||
164597095|NCT02052778|594548994|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
164449456|NCT01968109|594014386|FG012|Overall Study|DISEASE PROGRESSION|7|||
164449457|NCT01968109|594014387|FG013|Overall Study|DISEASE PROGRESSION|14|||
164449458|NCT01968109|594014388|FG014|Overall Study|DISEASE PROGRESSION|14|||
164449459|NCT01968109|594014389|FG015|Overall Study|DISEASE PROGRESSION|13|||
164449460|NCT01968109|594014390|FG016|Overall Study|DISEASE PROGRESSION|34|||
164449461|NCT01968109|594014391|FG017|Overall Study|DISEASE PROGRESSION|20|||
164449462|NCT01968109|594014392|FG018|Overall Study|DISEASE PROGRESSION|54|||
164449463|NCT01968109|594014393|FG019|Overall Study|DISEASE PROGRESSION|46|||
164449464|NCT01968109|594014394|FG020|Overall Study|DISEASE PROGRESSION|77|||
164449465|NCT01968109|594014395|FG021|Overall Study|DISEASE PROGRESSION|25|||
164449466|NCT01968109|594014396|FG022|Overall Study|DISEASE PROGRESSION|47|||
164449467|NCT01968109|594014397|FG023|Overall Study|DISEASE PROGRESSION|125|||
164449468|NCT01968109|594014398|FG024|Overall Study|DISEASE PROGRESSION|155|||
164449469|NCT01968109|594014399|FG025|Overall Study|DISEASE PROGRESSION|63|||
164449470|NCT01968109|594014400|FG026|Overall Study|DISEASE PROGRESSION|65|||
164449471|NCT01968109|594014401|FG027|Overall Study|DISEASE PROGRESSION|137|||
164449472|NCT01968109|594014402|FG028|Overall Study|DISEASE PROGRESSION|35|||
164449473|NCT01968109|594014403|FG029|Overall Study|DISEASE PROGRESSION|23|||
164449474|NCT01968109|594014404|FG030|Overall Study|DISEASE PROGRESSION|71|||
164449475|NCT01968109|594014374|FG000|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
164449476|NCT01968109|594014375|FG001|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
164449477|NCT01968109|594014376|FG002|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
164449478|NCT01968109|594014377|FG003|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
164449479|NCT01968109|594014378|FG004|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
164449480|NCT01968109|594014379|FG005|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
164449481|NCT01968109|594014380|FG006|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
164449482|NCT01968109|594014381|FG007|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
164449483|NCT01968109|594014382|FG008|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
164449484|NCT01968109|594014383|FG009|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
164449485|NCT01968109|594014384|FG010|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
164449486|NCT01968109|594014385|FG011|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
164449487|NCT01968109|594014386|FG012|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
164449488|NCT01968109|594014387|FG013|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
164449489|NCT01968109|594014388|FG014|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
164449490|NCT01968109|594014389|FG015|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
164449491|NCT01968109|594014390|FG016|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
164449492|NCT01968109|594014391|FG017|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
164449493|NCT01968109|594014392|FG018|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
164449494|NCT01968109|594014393|FG019|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
164449495|NCT01968109|594014394|FG020|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
164449496|NCT01968109|594014395|FG021|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
164449497|NCT01968109|594014396|FG022|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
164449498|NCT01968109|594014397|FG023|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|4|||
164449499|NCT01968109|594014398|FG024|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|7|||
164449500|NCT01968109|594014399|FG025|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
164449501|NCT01968109|594014400|FG026|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
164449502|NCT01968109|594014401|FG027|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
164449503|NCT01968109|594014402|FG028|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|8|||
164449504|NCT01968109|594014403|FG029|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|12|||
164449505|NCT01968109|594014404|FG030|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
164449506|NCT01968109|594014374|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
164449507|NCT01968109|594014375|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
164449508|NCT01968109|594014376|FG002|Overall Study|STUDY DRUG TOXICITY|1|||
164449509|NCT01968109|594014377|FG003|Overall Study|STUDY DRUG TOXICITY|2|||
164449510|NCT01968109|594014378|FG004|Overall Study|STUDY DRUG TOXICITY|1|||
164449511|NCT01968109|594014379|FG005|Overall Study|STUDY DRUG TOXICITY|1|||
164449512|NCT01968109|594014380|FG006|Overall Study|STUDY DRUG TOXICITY|1|||
164449513|NCT01968109|594014381|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
164449514|NCT01968109|594014382|FG008|Overall Study|STUDY DRUG TOXICITY|2|||
164449515|NCT01968109|594014383|FG009|Overall Study|STUDY DRUG TOXICITY|1|||
164449516|NCT01968109|594014384|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
164449517|NCT01968109|594014385|FG011|Overall Study|STUDY DRUG TOXICITY|2|||
164449518|NCT01968109|594014386|FG012|Overall Study|STUDY DRUG TOXICITY|0|||
164449519|NCT01968109|594014387|FG013|Overall Study|STUDY DRUG TOXICITY|2|||
164449520|NCT01968109|594014388|FG014|Overall Study|STUDY DRUG TOXICITY|2|||
164449521|NCT01968109|594014389|FG015|Overall Study|STUDY DRUG TOXICITY|4|||
164449522|NCT01968109|594014390|FG016|Overall Study|STUDY DRUG TOXICITY|11|||
164449523|NCT01968109|594014391|FG017|Overall Study|STUDY DRUG TOXICITY|3|||
164597096|NCT02052778|594548995|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
164597097|NCT02052778|594548996|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
164597098|NCT02052778|594548997|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
164597099|NCT02052778|594548998|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
164597100|NCT02052778|594548999|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
164449524|NCT01968109|594014392|FG018|Overall Study|STUDY DRUG TOXICITY|4|||
164449525|NCT01968109|594014393|FG019|Overall Study|STUDY DRUG TOXICITY|9|||
164449526|NCT01968109|594014394|FG020|Overall Study|STUDY DRUG TOXICITY|6|||
164449527|NCT01968109|594014395|FG021|Overall Study|STUDY DRUG TOXICITY|4|||
164449528|NCT01968109|594014396|FG022|Overall Study|STUDY DRUG TOXICITY|3|||
164449529|NCT01968109|594014397|FG023|Overall Study|STUDY DRUG TOXICITY|8|||
164449530|NCT01968109|594014398|FG024|Overall Study|STUDY DRUG TOXICITY|9|||
164449531|NCT01968109|594014399|FG025|Overall Study|STUDY DRUG TOXICITY|8|||
164449532|NCT01968109|594014400|FG026|Overall Study|STUDY DRUG TOXICITY|3|||
164449533|NCT01968109|594014401|FG027|Overall Study|STUDY DRUG TOXICITY|9|||
164449534|NCT01968109|594014402|FG028|Overall Study|STUDY DRUG TOXICITY|14|||
164449535|NCT01968109|594014403|FG029|Overall Study|STUDY DRUG TOXICITY|21|||
164449536|NCT01968109|594014404|FG030|Overall Study|STUDY DRUG TOXICITY|9|||
164449537|NCT01968109|594014374|FG000|Overall Study|SUBJECT WITHDREW CONSENT|0|||
164449538|NCT01968109|594014375|FG001|Overall Study|SUBJECT WITHDREW CONSENT|0|||
164449539|NCT01968109|594014376|FG002|Overall Study|SUBJECT WITHDREW CONSENT|0|||
164449540|NCT01968109|594014377|FG003|Overall Study|SUBJECT WITHDREW CONSENT|0|||
164449541|NCT01968109|594014378|FG004|Overall Study|SUBJECT WITHDREW CONSENT|0|||
164449542|NCT01968109|594014379|FG005|Overall Study|SUBJECT WITHDREW CONSENT|0|||
164449543|NCT01968109|594014380|FG006|Overall Study|SUBJECT WITHDREW CONSENT|0|||
164449544|NCT01968109|594014381|FG007|Overall Study|SUBJECT WITHDREW CONSENT|1|||
164449545|NCT01968109|594014382|FG008|Overall Study|SUBJECT WITHDREW CONSENT|0|||
164449546|NCT01968109|594014383|FG009|Overall Study|SUBJECT WITHDREW CONSENT|0|||
164449547|NCT01968109|594014384|FG010|Overall Study|SUBJECT WITHDREW CONSENT|0|||
164449548|NCT01968109|594014385|FG011|Overall Study|SUBJECT WITHDREW CONSENT|0|||
164449549|NCT01968109|594014386|FG012|Overall Study|SUBJECT WITHDREW CONSENT|0|||
164449550|NCT01968109|594014387|FG013|Overall Study|SUBJECT WITHDREW CONSENT|0|||
164449551|NCT01968109|594014388|FG014|Overall Study|SUBJECT WITHDREW CONSENT|0|||
164449552|NCT01968109|594014389|FG015|Overall Study|SUBJECT WITHDREW CONSENT|0|||
164449553|NCT01968109|594014390|FG016|Overall Study|SUBJECT WITHDREW CONSENT|0|||
164449554|NCT01968109|594014391|FG017|Overall Study|SUBJECT WITHDREW CONSENT|0|||
164449555|NCT01968109|594014392|FG018|Overall Study|SUBJECT WITHDREW CONSENT|1|||
164597101|NCT02052778|594549000|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
164597102|NCT02052778|594549001|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
164597103|NCT02052778|594549002|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
164597104|NCT02052778|594549003|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
164597105|NCT02052778|594549004|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
164404539|NCT01960725|593851980|FG000|Overall Study|unable to obtain blood sample|1|||
164404540|NCT01960725|593851981|FG001|Overall Study|unable to obtain blood sample|2|||
164404541|NCT02831257|593851985|FG000|Overall Study|Lack of Efficacy|3|||
164404542|NCT02831257|593851985|FG000|Overall Study|Adverse Event|2|||
164404543|NCT02831257|593851985|FG000|Overall Study|Physician Decision|1|||
164404544|NCT02831257|593851985|FG000|Overall Study|Withdrawal by Subject|6|||
164404545|NCT00611858|593851986|FG000|Overall Study|Adverse Event|2|||
164404546|NCT00611858|593851986|FG000|Overall Study|Withdrawal by Subject|2|||
164404547|NCT01844284|593851987|FG000|Overall Study|Lost to Follow-up|12|||
164404548|NCT01844284|593851988|FG001|Overall Study|Lost to Follow-up|7|||
164404549|NCT03138733|593851990|FG000|Overall Study|Death|17|||
164404550|NCT03138733|593851991|FG001|Overall Study|Death|18|||
164404551|NCT03138733|593851990|FG000|Overall Study|Withdrawal by Subject|11|||
164404552|NCT03138733|593851991|FG001|Overall Study|Withdrawal by Subject|6|||
164404553|NCT03138733|593851990|FG000|Overall Study|Lost to Follow-up|3|||
164404554|NCT03138733|593851991|FG001|Overall Study|Lost to Follow-up|2|||
164404555|NCT03138733|593851990|FG000|Overall Study|Adverse Event|1|||
164404556|NCT03138733|593851991|FG001|Overall Study|Adverse Event|0|||
164404557|NCT03138733|593851990|FG000|Overall Study|Protocol Violation|1|||
164404558|NCT03138733|593851991|FG001|Overall Study|Protocol Violation|3|||
164449556|NCT01968109|594014393|FG019|Overall Study|SUBJECT WITHDREW CONSENT|1|||
164449557|NCT01968109|594014394|FG020|Overall Study|SUBJECT WITHDREW CONSENT|1|||
164449558|NCT01968109|594014395|FG021|Overall Study|SUBJECT WITHDREW CONSENT|1|||
164449559|NCT01968109|594014396|FG022|Overall Study|SUBJECT WITHDREW CONSENT|0|||
164449560|NCT01968109|594014397|FG023|Overall Study|SUBJECT WITHDREW CONSENT|0|||
164449561|NCT01968109|594014398|FG024|Overall Study|SUBJECT WITHDREW CONSENT|3|||
164449562|NCT01968109|594014399|FG025|Overall Study|SUBJECT WITHDREW CONSENT|2|||
164449563|NCT01968109|594014400|FG026|Overall Study|SUBJECT WITHDREW CONSENT|1|||
164449564|NCT01968109|594014401|FG027|Overall Study|SUBJECT WITHDREW CONSENT|4|||
164449565|NCT01968109|594014402|FG028|Overall Study|SUBJECT WITHDREW CONSENT|0|||
164449566|NCT01968109|594014403|FG029|Overall Study|SUBJECT WITHDREW CONSENT|1|||
164449567|NCT01968109|594014404|FG030|Overall Study|SUBJECT WITHDREW CONSENT|1|||
164449568|NCT01968109|594014374|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
164449569|NCT01968109|594014375|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
164449570|NCT01968109|594014376|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
164449571|NCT01968109|594014377|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
164597106|NCT02052778|594549005|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
164597107|NCT02052778|594549006|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
164597108|NCT02052778|594549007|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
164404559|NCT03138733|593851990|FG000|Overall Study|Administrative or logistical reason|1|||
164404560|NCT03138733|593851991|FG001|Overall Study|Administrative or logistical reason|0|||
164404561|NCT03138733|593851990|FG000|Overall Study|The patient was transferred to another hospital|1|||
164404562|NCT03138733|593851991|FG001|Overall Study|The patient was transferred to another hospital|0|||
164449572|NCT01968109|594014378|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
164449573|NCT01968109|594014379|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
164449574|NCT01968109|594014380|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
164449575|NCT01968109|594014381|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
164449576|NCT01968109|594014382|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
164449577|NCT01968109|594014383|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
164449578|NCT01968109|594014384|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
164449579|NCT01968109|594014385|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
164449580|NCT01968109|594014386|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
164449581|NCT01968109|594014387|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
164449582|NCT01968109|594014388|FG014|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
164449583|NCT01968109|594014389|FG015|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
164449584|NCT01968109|594014390|FG016|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
164449585|NCT01968109|594014391|FG017|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
164449586|NCT01968109|594014392|FG018|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
164449587|NCT01968109|594014393|FG019|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
164449588|NCT01968109|594014394|FG020|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
164449589|NCT01968109|594014395|FG021|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
164449590|NCT01968109|594014396|FG022|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
164449591|NCT01968109|594014397|FG023|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
164449592|NCT01968109|594014398|FG024|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|5|||
164449593|NCT01968109|594014399|FG025|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|6|||
164449594|NCT01968109|594014400|FG026|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
164449595|NCT01968109|594014401|FG027|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
164449596|NCT01968109|594014402|FG028|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
164449597|NCT01968109|594014403|FG029|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
164449598|NCT01968109|594014404|FG030|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
164449599|NCT01968109|594014374|FG000|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
164449600|NCT01968109|594014375|FG001|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
164449601|NCT01968109|594014376|FG002|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
164449602|NCT01968109|594014377|FG003|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
164449603|NCT01968109|594014378|FG004|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
164449604|NCT01968109|594014379|FG005|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
164449605|NCT01968109|594014380|FG006|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
164449606|NCT01968109|594014381|FG007|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
164449607|NCT01968109|594014382|FG008|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
164449608|NCT01968109|594014383|FG009|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
164449609|NCT01968109|594014384|FG010|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
164449610|NCT01968109|594014385|FG011|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
164449611|NCT01968109|594014386|FG012|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
164449612|NCT01968109|594014387|FG013|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
164449613|NCT01968109|594014388|FG014|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
164449614|NCT01968109|594014389|FG015|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|3|||
164449615|NCT01968109|594014390|FG016|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|10|||
164449616|NCT01968109|594014391|FG017|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
164449617|NCT01968109|594014392|FG018|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
164449618|NCT01968109|594014393|FG019|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
164449619|NCT01968109|594014394|FG020|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|3|||
164449620|NCT01968109|594014395|FG021|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
164449621|NCT01968109|594014396|FG022|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
164449622|NCT01968109|594014397|FG023|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|10|||
164449623|NCT01968109|594014398|FG024|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|5|||
164449624|NCT01968109|594014399|FG025|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
164449625|NCT01968109|594014400|FG026|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
164449626|NCT01968109|594014401|FG027|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|2|||
164449627|NCT01968109|594014402|FG028|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
164449628|NCT01968109|594014403|FG029|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
164449629|NCT01968109|594014404|FG030|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
164449630|NCT01968109|594014374|FG000|Overall Study|OTHER REASONS|0|||
164449631|NCT01968109|594014375|FG001|Overall Study|OTHER REASONS|0|||
164449632|NCT01968109|594014376|FG002|Overall Study|OTHER REASONS|0|||
164449633|NCT01968109|594014377|FG003|Overall Study|OTHER REASONS|1|||
164449634|NCT01968109|594014378|FG004|Overall Study|OTHER REASONS|0|||
164449635|NCT01968109|594014379|FG005|Overall Study|OTHER REASONS|0|||
164449636|NCT01968109|594014380|FG006|Overall Study|OTHER REASONS|0|||
164449637|NCT01968109|594014381|FG007|Overall Study|OTHER REASONS|0|||
164449638|NCT01968109|594014382|FG008|Overall Study|OTHER REASONS|0|||
164449639|NCT01968109|594014383|FG009|Overall Study|OTHER REASONS|0|||
164449640|NCT01968109|594014384|FG010|Overall Study|OTHER REASONS|0|||
164449641|NCT01968109|594014385|FG011|Overall Study|OTHER REASONS|1|||
164449642|NCT01968109|594014386|FG012|Overall Study|OTHER REASONS|0|||
164449643|NCT01968109|594014387|FG013|Overall Study|OTHER REASONS|0|||
164449644|NCT01968109|594014388|FG014|Overall Study|OTHER REASONS|1|||
164449645|NCT01968109|594014389|FG015|Overall Study|OTHER REASONS|1|||
164449646|NCT01968109|594014390|FG016|Overall Study|OTHER REASONS|1|||
164449647|NCT01968109|594014391|FG017|Overall Study|OTHER REASONS|0|||
164449648|NCT01968109|594014392|FG018|Overall Study|OTHER REASONS|0|||
164449649|NCT01968109|594014393|FG019|Overall Study|OTHER REASONS|0|||
164449650|NCT01968109|594014394|FG020|Overall Study|OTHER REASONS|0|||
164449651|NCT01968109|594014395|FG021|Overall Study|OTHER REASONS|2|||
164449652|NCT01968109|594014396|FG022|Overall Study|OTHER REASONS|0|||
164449653|NCT01968109|594014397|FG023|Overall Study|OTHER REASONS|0|||
164449654|NCT01968109|594014398|FG024|Overall Study|OTHER REASONS|3|||
164449655|NCT01968109|594014399|FG025|Overall Study|OTHER REASONS|0|||
164449656|NCT01968109|594014400|FG026|Overall Study|OTHER REASONS|3|||
164449657|NCT01968109|594014401|FG027|Overall Study|OTHER REASONS|3|||
164449658|NCT01968109|594014402|FG028|Overall Study|OTHER REASONS|6|||
164449659|NCT01968109|594014403|FG029|Overall Study|OTHER REASONS|7|||
164449660|NCT01968109|594014404|FG030|Overall Study|OTHER REASONS|3|||
164449661|NCT01968109|594014374|FG000|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
164449662|NCT01968109|594014375|FG001|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
164449663|NCT01968109|594014376|FG002|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
164449664|NCT01968109|594014377|FG003|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
164449665|NCT01968109|594014378|FG004|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
164449666|NCT01968109|594014379|FG005|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
164449667|NCT01968109|594014380|FG006|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
164449668|NCT01968109|594014381|FG007|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
164449669|NCT01968109|594014382|FG008|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
164449670|NCT01968109|594014383|FG009|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
164449671|NCT01968109|594014384|FG010|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
164449672|NCT01968109|594014385|FG011|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
164449673|NCT01968109|594014386|FG012|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
164449674|NCT01968109|594014387|FG013|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
164449675|NCT01968109|594014388|FG014|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
164449676|NCT01968109|594014389|FG015|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
164449677|NCT01968109|594014390|FG016|Overall Study|MAXIMUM CLINICAL BENEFIT|5|||
164449678|NCT01968109|594014391|FG017|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
164449679|NCT01968109|594014392|FG018|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
164449680|NCT01968109|594014393|FG019|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
164449681|NCT01968109|594014394|FG020|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
164449682|NCT01968109|594014395|FG021|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
164449683|NCT01968109|594014396|FG022|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
164449684|NCT01968109|594014397|FG023|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
164449685|NCT01968109|594014398|FG024|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
164449686|NCT01968109|594014399|FG025|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
164449687|NCT01968109|594014400|FG026|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
164449688|NCT01968109|594014401|FG027|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
164449689|NCT01968109|594014402|FG028|Overall Study|MAXIMUM CLINICAL BENEFIT|3|||
164449690|NCT01968109|594014403|FG029|Overall Study|MAXIMUM CLINICAL BENEFIT|6|||
164449691|NCT01968109|594014404|FG030|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
164449692|NCT01968109|594014374|FG000|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449693|NCT01968109|594014375|FG001|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449694|NCT01968109|594014376|FG002|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449695|NCT01968109|594014377|FG003|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449696|NCT01968109|594014378|FG004|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449697|NCT01968109|594014379|FG005|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449698|NCT01968109|594014380|FG006|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449699|NCT01968109|594014381|FG007|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449700|NCT01968109|594014382|FG008|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449701|NCT01968109|594014383|FG009|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449702|NCT01968109|594014384|FG010|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164597109|NCT02052778|594549008|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
164449703|NCT01968109|594014385|FG011|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449704|NCT01968109|594014386|FG012|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164597110|NCT02052778|594549009|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
164449705|NCT01968109|594014387|FG013|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449706|NCT01968109|594014388|FG014|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449707|NCT01968109|594014389|FG015|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449708|NCT01968109|594014390|FG016|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449709|NCT01968109|594014391|FG017|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449710|NCT01968109|594014392|FG018|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449711|NCT01968109|594014393|FG019|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449712|NCT01968109|594014394|FG020|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|1|||
164449713|NCT01968109|594014395|FG021|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449714|NCT01968109|594014396|FG022|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449715|NCT01968109|594014397|FG023|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|3|||
164449716|NCT01968109|594014398|FG024|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449717|NCT01968109|594014399|FG025|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449718|NCT01968109|594014400|FG026|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449719|NCT01968109|594014401|FG027|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449720|NCT01968109|594014402|FG028|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449721|NCT01968109|594014403|FG029|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449722|NCT01968109|594014404|FG030|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
164449723|NCT01968109|594014374|FG000|Overall Study|Death|0|||
164449724|NCT01968109|594014375|FG001|Overall Study|Death|0|||
164449725|NCT01968109|594014376|FG002|Overall Study|Death|0|||
164449726|NCT01968109|594014377|FG003|Overall Study|Death|0|||
164449727|NCT01968109|594014378|FG004|Overall Study|Death|0|||
164449728|NCT01968109|594014379|FG005|Overall Study|Death|0|||
164449729|NCT01968109|594014380|FG006|Overall Study|Death|0|||
164449730|NCT01968109|594014381|FG007|Overall Study|Death|0|||
164449731|NCT01968109|594014382|FG008|Overall Study|Death|0|||
164449732|NCT01968109|594014383|FG009|Overall Study|Death|0|||
164449733|NCT01968109|594014384|FG010|Overall Study|Death|0|||
164449734|NCT01968109|594014385|FG011|Overall Study|Death|0|||
164449735|NCT01968109|594014386|FG012|Overall Study|Death|0|||
164449736|NCT01968109|594014387|FG013|Overall Study|Death|0|||
164449737|NCT01968109|594014388|FG014|Overall Study|Death|0|||
164449738|NCT01968109|594014389|FG015|Overall Study|Death|0|||
164449739|NCT01968109|594014390|FG016|Overall Study|Death|0|||
164449740|NCT01968109|594014391|FG017|Overall Study|Death|0|||
164449741|NCT01968109|594014392|FG018|Overall Study|Death|0|||
164449742|NCT01968109|594014393|FG019|Overall Study|Death|0|||
164449743|NCT01968109|594014394|FG020|Overall Study|Death|0|||
164449744|NCT01968109|594014395|FG021|Overall Study|Death|1|||
164449745|NCT01968109|594014396|FG022|Overall Study|Death|0|||
164449746|NCT01968109|594014397|FG023|Overall Study|Death|0|||
164449747|NCT01968109|594014398|FG024|Overall Study|Death|0|||
164449748|NCT01968109|594014399|FG025|Overall Study|Death|0|||
164449749|NCT01968109|594014400|FG026|Overall Study|Death|0|||
164449750|NCT01968109|594014401|FG027|Overall Study|Death|0|||
164449751|NCT01968109|594014402|FG028|Overall Study|Death|0|||
164449752|NCT01968109|594014403|FG029|Overall Study|Death|0|||
164449753|NCT01968109|594014404|FG030|Overall Study|Death|1|||
164449754|NCT03899792|594014411|FG000|Phase 2|Ongoing Treatment|0|||
164449755|NCT03899792|594014412|FG001|Phase 2|Ongoing Treatment|13|||
164449756|NCT03899792|594014413|FG002|Phase 2|Ongoing Treatment|14|||
164449757|NCT03899792|594014414|FG003|Phase 2|Ongoing Treatment|2|||
164449758|NCT03899792|594014411|FG000|Phase 2|Death|0|||
164449759|NCT03899792|594014412|FG001|Phase 2|Death|0|||
164449760|NCT03899792|594014413|FG002|Phase 2|Death|0|||
164449761|NCT03899792|594014414|FG003|Phase 2|Death|4|||
164449762|NCT03899792|594014411|FG000|Phase 2|Lost to Follow-up|0|||
164706400|NCT02393248|594953422|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164404563|NCT02597036|593851996|FG000|Overall Study|Progressive Disease|0|||
164404564|NCT02597036|593851997|FG001|Overall Study|Progressive Disease|0|||
164404565|NCT02597036|593851998|FG002|Overall Study|Progressive Disease|0|||
164404566|NCT02597036|593851999|FG003|Overall Study|Progressive Disease|0|||
164404567|NCT02597036|593852000|FG004|Overall Study|Progressive Disease|1|||
164404568|NCT02597036|593852001|FG005|Overall Study|Progressive Disease|1|||
164404569|NCT02597036|593852002|FG006|Overall Study|Progressive Disease|1|||
164404570|NCT02597036|593852003|FG007|Overall Study|Progressive Disease|0|||
164404571|NCT02597036|593852004|FG008|Overall Study|Progressive Disease|0|||
164404572|NCT02597036|593852005|FG009|Overall Study|Progressive Disease|0|||
164449763|NCT03899792|594014412|FG001|Phase 2|Lost to Follow-up|1|||
164449764|NCT03899792|594014413|FG002|Phase 2|Lost to Follow-up|1|||
164449765|NCT03899792|594014414|FG003|Phase 2|Lost to Follow-up|0|||
164449766|NCT03899792|594014411|FG000|Phase 2|Withdrawal by Subject|0|||
164449767|NCT03899792|594014412|FG001|Phase 2|Withdrawal by Subject|1|||
164404573|NCT02597036|593852006|FG010|Overall Study|Progressive Disease|0|||
164404574|NCT02597036|593852007|FG011|Overall Study|Progressive Disease|0|||
164449768|NCT03899792|594014413|FG002|Phase 2|Withdrawal by Subject|0|||
164449769|NCT03899792|594014414|FG003|Phase 2|Withdrawal by Subject|0|||
164449770|NCT00330681|594014415|FG000|Overall Study|Adverse Event|3|||
164449771|NCT00330681|594014416|FG001|Overall Study|Adverse Event|6|||
164449772|NCT00330681|594014415|FG000|Overall Study|Protocol Violation|0|||
164449773|NCT00330681|594014416|FG001|Overall Study|Protocol Violation|1|||
164449774|NCT00330681|594014415|FG000|Overall Study|Withdrawal by Subject|5|||
164449775|NCT00330681|594014416|FG001|Overall Study|Withdrawal by Subject|5|||
164404575|NCT02597036|593851996|FG000|Overall Study|Adverse Event|0|||
164449776|NCT00330681|594014415|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
164449777|NCT00330681|594014416|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
164449778|NCT03433339|594015714|FG000|Overall Study|Lost to Follow-up|2|||
164449779|NCT03433339|594015715|FG001|Overall Study|Lost to Follow-up|0|||
164706401|NCT02393248|594953423|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164706402|NCT02393248|594953424|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164706403|NCT02393248|594953425|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164706404|NCT02393248|594953426|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164706405|NCT02393248|594953427|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164706406|NCT02393248|594953428|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164706407|NCT02393248|594953429|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164706408|NCT02393248|594953430|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164706409|NCT02393248|594953431|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164706410|NCT02393248|594953432|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164706411|NCT02393248|594953433|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164706412|NCT02393248|594953434|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164706413|NCT02393248|594953435|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164706414|NCT02393248|594953436|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164706415|NCT02393248|594953437|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164706416|NCT02393248|594953438|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164449780|NCT03433339|594015714|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
164449781|NCT03433339|594015715|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
164449782|NCT03433339|594015714|FG000|Overall Study|Withdrawal by Subject|0|||
164449783|NCT03433339|594015715|FG001|Overall Study|Withdrawal by Subject|2|||
164449784|NCT01898494|594015719|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
164449785|NCT01898494|594015720|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
164449786|NCT01898494|594015721|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
164449787|NCT01898494|594015722|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
164449788|NCT01898494|594015723|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
164449789|NCT01898494|594015719|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
164449790|NCT01898494|594015720|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
164449791|NCT01898494|594015721|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
164449792|NCT01898494|594015722|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
164449793|NCT01898494|594015723|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
164449794|NCT01898494|594015719|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
164449795|NCT01898494|594015720|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
164449796|NCT01898494|594015721|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
164449797|NCT01898494|594015722|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
164449798|NCT01898494|594015723|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
164449799|NCT01898494|594015719|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
164449800|NCT01898494|594015720|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
164449801|NCT01898494|594015721|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
164449802|NCT01898494|594015722|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
164449803|NCT01898494|594015723|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
164449804|NCT01898494|594015719|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
164449805|NCT01898494|594015720|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
164449806|NCT01898494|594015721|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
164449807|NCT01898494|594015722|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
164449808|NCT01898494|594015723|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
164449809|NCT01898494|594015719|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
164449810|NCT01898494|594015720|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
164449811|NCT01898494|594015721|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
164449812|NCT01898494|594015722|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
164449813|NCT01898494|594015723|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
164449814|NCT01898494|594015719|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
164449815|NCT01898494|594015720|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
164449816|NCT01898494|594015721|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
164449817|NCT01898494|594015722|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
164449818|NCT01898494|594015723|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
164449819|NCT01898494|594015719|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
164449820|NCT01898494|594015720|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
164449821|NCT01898494|594015721|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
164449822|NCT01898494|594015722|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
164449823|NCT01898494|594015723|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
164706417|NCT02393248|594953414|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164449824|NCT01898494|594015719|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
164449825|NCT01898494|594015720|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
164449826|NCT01898494|594015721|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
164449827|NCT01898494|594015722|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
164449828|NCT01898494|594015723|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
164449829|NCT01898494|594015719|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
164449830|NCT01898494|594015720|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
164449831|NCT01898494|594015721|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
164449832|NCT01898494|594015722|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
164449833|NCT01898494|594015723|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
164449834|NCT01898494|594015719|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
164449835|NCT01898494|594015720|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
164449836|NCT01898494|594015721|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
164449837|NCT01898494|594015722|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
164449838|NCT01898494|594015723|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
164449839|NCT01898494|594015719|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
164449840|NCT01898494|594015720|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
164449841|NCT01898494|594015721|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
164449842|NCT01898494|594015722|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
164449843|NCT01898494|594015723|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
164449844|NCT01898494|594015719|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
164449845|NCT01898494|594015720|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
164449846|NCT01898494|594015721|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
164449847|NCT01898494|594015722|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
164449848|NCT01898494|594015723|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
164449849|NCT01898494|594015719|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
164449850|NCT01898494|594015720|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
164449851|NCT01898494|594015721|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
164449852|NCT01898494|594015722|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
164449853|NCT01898494|594015723|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
164449854|NCT02819843|594015726|FG000|Overall Study|Disease progression before RT|0|||
164449855|NCT02819843|594015727|FG001|Overall Study|Disease progression before RT|1|||
164449856|NCT04732494|594015728|FG000|Overall Study|Death|39|||
164449857|NCT04732494|594015729|FG001|Overall Study|Death|36|||
164449858|NCT04732494|594015728|FG000|Overall Study|Study Closed by Sponsor|20|||
164449859|NCT04732494|594015729|FG001|Overall Study|Study Closed by Sponsor|15|||
164449860|NCT04732494|594015728|FG000|Overall Study|Withdrawal by Subject|2|||
164449861|NCT04732494|594015729|FG001|Overall Study|Withdrawal by Subject|7|||
164449862|NCT04732494|594015728|FG000|Overall Study|Lost to Follow-up|1|||
164449863|NCT04732494|594015729|FG001|Overall Study|Lost to Follow-up|5|||
164449864|NCT03055858|594015730|FG000|Overall Study|Death|9|||
164449865|NCT03055858|594015730|FG000|Overall Study|Withdrawal by Subject|11|||
164449866|NCT03055858|594015730|FG000|Overall Study|Lost to Follow-up|6|||
164449867|NCT03055858|594015730|FG000|Overall Study|Missed Follow-Up Visits|18|||
164449868|NCT06629454|594015731|FG000|Overall Study|Withdraw by Clinician Decision|1|||
164449869|NCT05136404|594015732|FG000|Period 1|Adverse Event|0|||
164449870|NCT05136404|594015733|FG001|Period 1|Adverse Event|1|||
164449871|NCT05136404|594015734|FG002|Period 1|Adverse Event|1|||
164449872|NCT05136404|594015732|FG000|Period 2|Inappropriate Behavior|0|||
164449873|NCT05136404|594015733|FG001|Period 2|Inappropriate Behavior|0|||
164449874|NCT05136404|594015734|FG002|Period 2|Inappropriate Behavior|1|||
164449875|NCT05136404|594015732|FG000|Period 3|Adverse Event|0|||
164449876|NCT05136404|594015733|FG001|Period 3|Adverse Event|0|||
164449877|NCT05136404|594015734|FG002|Period 3|Adverse Event|1|||
164449878|NCT01820260|594015742|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
164449879|NCT01820260|594015743|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
164449880|NCT01820260|594015744|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
164449881|NCT01820260|594015745|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
164449882|NCT01820260|594015746|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
164449883|NCT01820260|594015747|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
164449884|NCT01820260|594015748|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
164449885|NCT01820260|594015749|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
164449886|NCT01820260|594015750|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
164449887|NCT01820260|594015751|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
164449888|NCT01820260|594015752|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
164706418|NCT02393248|594953415|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164449889|NCT01820260|594015753|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
164449890|NCT01820260|594015754|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
164449891|NCT01820260|594015755|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
164449892|NCT01820260|594015742|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
164449893|NCT01820260|594015743|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
164706419|NCT02393248|594953416|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164449894|NCT01820260|594015744|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
164449895|NCT01820260|594015745|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
164449896|NCT01820260|594015746|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
164449897|NCT01820260|594015747|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
164449898|NCT01820260|594015748|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
164449899|NCT01820260|594015749|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
164449900|NCT01820260|594015750|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
164449901|NCT01820260|594015751|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
164449902|NCT01820260|594015752|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
164449903|NCT01820260|594015753|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
164449904|NCT01820260|594015754|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
164449905|NCT01820260|594015755|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
164449906|NCT05444192|594015756|FG000|Overall Study|Lost to Follow-up|1|||
164449907|NCT05444192|594015757|FG001|Overall Study|Lost to Follow-up|0|||
164449908|NCT00505934|594015758|FG000|Overall Study|Adverse Event|1|||
164449909|NCT00505934|594015758|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
164449910|NCT00505934|594015758|FG000|Overall Study|Other: IV dose needed to be changed|1|||
164449911|NCT01046136|594015759|FG000|Overall Study|Withdrawal by Subject|0|||
164449912|NCT01046136|594015760|FG001|Overall Study|Withdrawal by Subject|4|||
164449913|NCT01046136|594015759|FG000|Overall Study|Physician Decision|1|||
164449914|NCT01046136|594015760|FG001|Overall Study|Physician Decision|1|||
164449915|NCT01046136|594015759|FG000|Overall Study|Lost to Follow-up|3|||
164449916|NCT01046136|594015760|FG001|Overall Study|Lost to Follow-up|3|||
164449917|NCT02058108|594015761|FG000|Overall Study|Abnormal Laboratory Values|0|||
164449918|NCT02058108|594015762|FG001|Overall Study|Abnormal Laboratory Values|1|||
164449919|NCT02058108|594015761|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
164449920|NCT02058108|594015762|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
164449921|NCT02058108|594015761|FG000|Overall Study|No longer requires study drug|0|||
164449922|NCT02058108|594015762|FG001|Overall Study|No longer requires study drug|1|||
164449923|NCT02058108|594015761|FG000|Overall Study|Withdrawal by Subject|1|||
164449924|NCT02058108|594015762|FG001|Overall Study|Withdrawal by Subject|0|||
164449925|NCT02058108|594015761|FG000|Overall Study|Administrative problems|3|||
164449926|NCT02058108|594015762|FG001|Overall Study|Administrative problems|3|||
164449927|NCT02058108|594015761|FG000|Overall Study|Protocol Violation|0|||
164449928|NCT02058108|594015762|FG001|Overall Study|Protocol Violation|1|||
164449929|NCT01376700|594015766|FG000|Overall Study|Sponsor terminated study early|8|||
164449930|NCT01376700|594015766|FG000|Overall Study|Low or high titer inhibitor|8|||
164449931|NCT00727909|594015767|FG000|Overall Study|Withdrawal by Subject|5|||
164449932|NCT00727909|594015768|FG001|Overall Study|Withdrawal by Subject|11|||
164449933|NCT00727909|594015769|FG002|Overall Study|Withdrawal by Subject|8|||
164449934|NCT00727909|594015770|FG003|Overall Study|Withdrawal by Subject|5|||
164449935|NCT00727909|594015767|FG000|Overall Study|Death|0|||
164449936|NCT00727909|594015768|FG001|Overall Study|Death|0|||
164449937|NCT00727909|594015769|FG002|Overall Study|Death|1|||
164449938|NCT00727909|594015770|FG003|Overall Study|Death|0|||
164449939|NCT01696773|594015771|FG000|Days 15-27, Washout|Adverse Event|1|||
164449940|NCT01696773|594015772|FG001|Days 15-27, Washout|Adverse Event|0|||
164449941|NCT05623345|594015773|FG000|Overall Study|Withdrawal by Subject|14|||
164449942|NCT05623345|594015774|FG001|Overall Study|Withdrawal by Subject|0|||
164449943|NCT05623345|594015775|FG002|Overall Study|Withdrawal by Subject|9|||
164449944|NCT05623345|594015776|FG003|Overall Study|Withdrawal by Subject|20|||
164449945|NCT05623345|594015773|FG000|Overall Study|Lost to Follow-up|3|||
164449946|NCT05623345|594015774|FG001|Overall Study|Lost to Follow-up|0|||
164449947|NCT05623345|594015775|FG002|Overall Study|Lost to Follow-up|7|||
164449948|NCT05623345|594015776|FG003|Overall Study|Lost to Follow-up|2|||
164449949|NCT05623345|594015773|FG000|Overall Study|Termination of Study By Sponsor|37|||
164449950|NCT05623345|594015774|FG001|Overall Study|Termination of Study By Sponsor|4|||
164449951|NCT05623345|594015775|FG002|Overall Study|Termination of Study By Sponsor|40|||
164449952|NCT05623345|594015776|FG003|Overall Study|Termination of Study By Sponsor|38|||
164449953|NCT01121991|594015779|FG000|Overall Study|Lack of Ovarian Response|2|||
164449954|NCT01121991|594015779|FG000|Overall Study|No Oocytes Retrieved|3|||
164449955|NCT01121991|594015779|FG000|Overall Study|No Fertilization|1|||
164449956|NCT02740231|594015780|FG000|Overall Study|Withdrawal by Subject|1|||
164449957|NCT02740231|594015781|FG001|Overall Study|Withdrawal by Subject|1|||
164449958|NCT02740231|594015782|FG002|Overall Study|Withdrawal by Subject|1|||
164449959|NCT02740231|594015783|FG003|Overall Study|Withdrawal by Subject|0|||
164449960|NCT02740231|594015780|FG000|Overall Study|Lack of Efficacy|0|||
164449961|NCT02740231|594015781|FG001|Overall Study|Lack of Efficacy|1|||
164449962|NCT02740231|594015782|FG002|Overall Study|Lack of Efficacy|0|||
164449963|NCT02740231|594015783|FG003|Overall Study|Lack of Efficacy|4|||
164449964|NCT02740231|594015780|FG000|Overall Study|Lost to Follow-up|1|||
164449965|NCT02740231|594015781|FG001|Overall Study|Lost to Follow-up|3|||
164449966|NCT02740231|594015782|FG002|Overall Study|Lost to Follow-up|0|||
164449967|NCT02740231|594015783|FG003|Overall Study|Lost to Follow-up|3|||
164449968|NCT02740231|594015780|FG000|Overall Study|Adverse Event|0|||
164449969|NCT02740231|594015781|FG001|Overall Study|Adverse Event|1|||
164706420|NCT02393248|594953417|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164449970|NCT02740231|594015782|FG002|Overall Study|Adverse Event|0|||
164449971|NCT02740231|594015783|FG003|Overall Study|Adverse Event|1|||
164449972|NCT00243503|594015784|FG000|Overall Study|Adverse Event|11|||
164449973|NCT00243503|594015784|FG000|Overall Study|Withdrawal by Subject|1|||
164449974|NCT00243503|594015784|FG000|Overall Study|Lack of Efficacy|44|||
164449975|NCT00243503|594015784|FG000|Overall Study|Death|1|||
164449976|NCT00243503|594015784|FG000|Overall Study|Other|1|||
164449977|NCT00914589|594015785|FG000|Overall Study|Adverse Event|1|||
164449978|NCT00914589|594015786|FG001|Overall Study|Adverse Event|0|||
164449979|NCT00914589|594015787|FG002|Overall Study|Adverse Event|1|||
164449980|NCT00914589|594015785|FG000|Overall Study|Protocol Violation|8|||
164449981|NCT00914589|594015786|FG001|Overall Study|Protocol Violation|6|||
164449982|NCT00914589|594015787|FG002|Overall Study|Protocol Violation|3|||
164449983|NCT00914589|594015785|FG000|Overall Study|unclassified|16|||
164449984|NCT00914589|594015786|FG001|Overall Study|unclassified|9|||
164449985|NCT00914589|594015787|FG002|Overall Study|unclassified|7|||
164449986|NCT00914589|594015785|FG000|Overall Study|Death|0|||
164449987|NCT00914589|594015786|FG001|Overall Study|Death|1|||
164449988|NCT00914589|594015787|FG002|Overall Study|Death|1|||
164449989|NCT04110054|594015788|FG000|Overall Study|COVID-19 reason other than AE|0|||
164449990|NCT04110054|594015789|FG001|Overall Study|COVID-19 reason other than AE|0|||
164449991|NCT04110054|594015790|FG002|Overall Study|COVID-19 reason other than AE|2|||
164449992|NCT04110054|594015791|FG003|Overall Study|COVID-19 reason other than AE|0|||
164449993|NCT04110054|594015788|FG000|Overall Study|Withdrawal by Subject|0|||
164449994|NCT04110054|594015789|FG001|Overall Study|Withdrawal by Subject|3|||
164449995|NCT04110054|594015790|FG002|Overall Study|Withdrawal by Subject|2|||
164449996|NCT04110054|594015791|FG003|Overall Study|Withdrawal by Subject|0|||
164449997|NCT04110054|594015788|FG000|Overall Study|Adverse Event|1|||
164449998|NCT04110054|594015789|FG001|Overall Study|Adverse Event|1|||
164449999|NCT04110054|594015790|FG002|Overall Study|Adverse Event|4|||
164450000|NCT04110054|594015791|FG003|Overall Study|Adverse Event|3|||
164450001|NCT01000480|594015793|FG000|Induction Phase|Adverse Event|2|||
164450002|NCT01000480|594015793|FG000|Induction Phase|Lost to Follow-up|1|||
164450003|NCT01000480|594015793|FG000|Induction Phase|Physician Decision|1|||
164450004|NCT01000480|594015793|FG000|Induction Phase|Entry Criteria Not Met|3|||
164450005|NCT01000480|594015793|FG000|Concurrent Therapy Phase|Adverse Event|4|||
164450006|NCT01000480|594015793|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
164450007|NCT01000480|594015793|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
164450008|NCT01000480|594015793|FG000|Concurrent Therapy Phase|Physician Decision|1|||
164450009|NCT02101281|594015795|FG000|Overall Study|Adverse Event|0|||
164450010|NCT02101281|594015796|FG001|Overall Study|Adverse Event|1|||
164450011|NCT05575076|594015797|FG000|Overall Study|Adverse Event|24|||
164450012|NCT05575076|594015797|FG000|Overall Study|Death|7|||
164450013|NCT05575076|594015797|FG000|Overall Study|Lost to Follow-up|16|||
164450014|NCT05575076|594015797|FG000|Overall Study|Non-Compliance|3|||
164450015|NCT05575076|594015797|FG000|Overall Study|Physician Decision|6|||
164450016|NCT05575076|594015797|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
164450017|NCT05575076|594015797|FG000|Overall Study|Withdrawal by Subject|71|||
164450018|NCT05575076|594015797|FG000|Overall Study|Study Terminated by Sponsor|630|||
164450019|NCT05575076|594015797|FG000|Overall Study|Other|17|||
164450020|NCT00510887|594015798|FG000|Overall Study|Lost to Follow-up|1|||
164450021|NCT01736215|594015808|FG000|Overall Study|Early termination of erythropoietin use|1|||
164450022|NCT01736215|594015808|FG000|Overall Study|Adverse Event|4|||
164450023|NCT01736215|594015808|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
164450024|NCT01736215|594015808|FG000|Overall Study|Insufficient data to perform analysis|8|||
164450025|NCT03447249|594015809|FG000|Overall Study|Adverse Event|1|||
164450026|NCT03447249|594015810|FG001|Overall Study|Adverse Event|0|||
164450027|NCT03447249|594015809|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
164450028|NCT03447249|594015810|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
164450029|NCT03447249|594015809|FG000|Overall Study|Other|3|||
164450030|NCT03447249|594015810|FG001|Overall Study|Other|0|||
164450031|NCT00988858|594015811|FG000|Overall Study|Adverse Event|7|||
164450032|NCT00988858|594015811|FG000|Overall Study|Death|1|||
164450033|NCT00988858|594015811|FG000|Overall Study|Physician Decision|1|||
164450034|NCT00988858|594015811|FG000|Overall Study|Sponsor Decision|1|||
164450035|NCT02376790|594015812|FG000|Overall Study|Withdrawal by Subject|43|||
164450036|NCT02376790|594015813|FG001|Overall Study|Withdrawal by Subject|36|||
164450037|NCT02376790|594015814|FG002|Overall Study|Withdrawal by Subject|37|||
164450038|NCT02376790|594015812|FG000|Overall Study|Decision by Sponsor|2|||
164450039|NCT02376790|594015813|FG001|Overall Study|Decision by Sponsor|1|||
164597111|NCT02052778|594549010|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
164450040|NCT02376790|594015814|FG002|Overall Study|Decision by Sponsor|4|||
164450041|NCT02376790|594015812|FG000|Overall Study|Lost to Follow-up|15|||
164450042|NCT02376790|594015813|FG001|Overall Study|Lost to Follow-up|10|||
164450043|NCT02376790|594015814|FG002|Overall Study|Lost to Follow-up|12|||
164450044|NCT02238483|594015815|FG000|Overall Study|Withdrawal by Subject|2|||
164597112|NCT02052778|594549011|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
164450045|NCT02238483|594015816|FG001|Overall Study|Withdrawal by Subject|7|||
164450046|NCT02238483|594015815|FG000|Overall Study|Lost to Follow-up|1|||
164450047|NCT02238483|594015816|FG001|Overall Study|Lost to Follow-up|1|||
164450048|NCT02238483|594015815|FG000|Overall Study|Protocol Violation|1|||
164450049|NCT02238483|594015816|FG001|Overall Study|Protocol Violation|2|||
164450050|NCT02238483|594015815|FG000|Overall Study|Death|1|||
164450051|NCT02238483|594015816|FG001|Overall Study|Death|0|||
164450052|NCT02238483|594015815|FG000|Overall Study|Adverse Event|7|||
164450053|NCT02238483|594015816|FG001|Overall Study|Adverse Event|3|||
164450054|NCT02238483|594015815|FG000|Overall Study|Withdrawn due to physician decision|1|||
164450055|NCT02238483|594015816|FG001|Overall Study|Withdrawn due to physician decision|0|||
164450056|NCT02238483|594015815|FG000|Overall Study|Completion status not recorded|1|||
164450057|NCT02238483|594015816|FG001|Overall Study|Completion status not recorded|1|||
164450058|NCT02238483|594015815|FG000|Overall Study|Illness in family member|1|||
164450059|NCT02238483|594015816|FG001|Overall Study|Illness in family member|0|||
164450060|NCT02538341|594015817|FG000|Overall Study|Lost to Follow-up|51|||
164450061|NCT02538341|594015818|FG001|Overall Study|Lost to Follow-up|46|||
164450062|NCT02538341|594015817|FG000|Overall Study|Withdrawal by Subject|3|||
164450063|NCT02538341|594015818|FG001|Overall Study|Withdrawal by Subject|1|||
164450064|NCT02538341|594015817|FG000|Overall Study|Death|2|||
164450065|NCT02538341|594015818|FG001|Overall Study|Death|0|||
164450066|NCT01551355|594015821|FG000|Overall Study|Lost to Follow-up|51|||
164450067|NCT01551355|594015822|FG001|Overall Study|Lost to Follow-up|49|||
164450068|NCT01551355|594015823|FG002|Overall Study|Lost to Follow-up|34|||
164450069|NCT01551355|594015824|FG003|Overall Study|Lost to Follow-up|24|||
164450070|NCT01551355|594015825|FG004|Overall Study|Lost to Follow-up|9|||
164450071|NCT01551355|594015826|FG005|Overall Study|Lost to Follow-up|6|||
164450072|NCT00031694|594015827|FG000|Overall Study|Adverse Event|12|||
164450073|NCT00031694|594015827|FG000|Overall Study|Death|2|||
164450074|NCT00031694|594015827|FG000|Overall Study|Withdrawal by Subject|5|||
164450075|NCT01538719|594015828|FG000|Overall Study|Lost to Follow-up|2|||
164450076|NCT01538719|594015829|FG001|Overall Study|Lost to Follow-up|0|||
164450077|NCT01255670|594015836|FG000|Overall Study|Adverse Event|10|||
164450078|NCT01255670|594015837|FG001|Overall Study|Adverse Event|10|||
164450079|NCT01255670|594015836|FG000|Overall Study|Lost to Follow-up|16|||
164450080|NCT01255670|594015837|FG001|Overall Study|Lost to Follow-up|10|||
164450081|NCT03664960|594015838|FG000|Overall Study|Adverse Event|0|||
164450082|NCT03664960|594015839|FG001|Overall Study|Adverse Event|3|||
164450083|NCT03664960|594015838|FG000|Overall Study|Lost to Follow-up|3|||
164450084|NCT03664960|594015839|FG001|Overall Study|Lost to Follow-up|2|||
164450085|NCT03664960|594015838|FG000|Overall Study|Physician Decision|1|||
164450086|NCT03664960|594015839|FG001|Overall Study|Physician Decision|0|||
164450087|NCT03664960|594015838|FG000|Overall Study|Withdrawal by Subject|3|||
164450088|NCT03664960|594015839|FG001|Overall Study|Withdrawal by Subject|14|||
164450089|NCT03664960|594015838|FG000|Overall Study|Sponsor Decision|1|||
164450090|NCT03664960|594015839|FG001|Overall Study|Sponsor Decision|1|||
164450091|NCT03664960|594015838|FG000|Overall Study|Other|1|||
164450092|NCT03664960|594015839|FG001|Overall Study|Other|2|||
164450093|NCT03807778|594015842|FG000|Overall Study|Adverse Event|0|||
164450094|NCT03807778|594015843|FG001|Overall Study|Adverse Event|0|||
164450095|NCT03807778|594015844|FG002|Overall Study|Adverse Event|3|||
164706421|NCT02393248|594953418|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164706422|NCT02393248|594953419|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164706423|NCT02393248|594953420|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164706424|NCT02393248|594953421|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164706425|NCT02393248|594953422|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164706426|NCT02393248|594953423|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164706427|NCT02393248|594953424|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164706428|NCT02393248|594953425|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
164450096|NCT03807778|594015845|FG003|Overall Study|Adverse Event|5|||
164450097|NCT03807778|594015842|FG000|Overall Study|Progressive Disease|4|||
164450098|NCT03807778|594015843|FG001|Overall Study|Progressive Disease|2|||
164450099|NCT03807778|594015844|FG002|Overall Study|Progressive Disease|8|||
164450100|NCT03807778|594015845|FG003|Overall Study|Progressive Disease|15|||
164450101|NCT03807778|594015842|FG000|Overall Study|Symptomatic Deterioration|0|||
164450102|NCT03807778|594015843|FG001|Overall Study|Symptomatic Deterioration|1|||
164450103|NCT03807778|594015844|FG002|Overall Study|Symptomatic Deterioration|0|||
164450104|NCT03807778|594015845|FG003|Overall Study|Symptomatic Deterioration|1|||
164450105|NCT03807778|594015842|FG000|Overall Study|Withdrawal by Subject|0|||
164450106|NCT03807778|594015843|FG001|Overall Study|Withdrawal by Subject|1|||
164450107|NCT03807778|594015844|FG002|Overall Study|Withdrawal by Subject|0|||
164450108|NCT03807778|594015845|FG003|Overall Study|Withdrawal by Subject|1|||
164450109|NCT03807778|594015842|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
164450110|NCT03807778|594015843|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
164450111|NCT03807778|594015844|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
164450112|NCT03807778|594015845|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
164450113|NCT01207492|594015846|FG000|Overall Study|Still on study|1|||
164450114|NCT01207492|594015846|FG000|Overall Study|Withdrawal by Subject|9|||
164450115|NCT01207492|594015846|FG000|Overall Study|Physician Decision|1|||
164450116|NCT01207492|594015846|FG000|Overall Study|Progressive disease|3|||
164450117|NCT01207492|594015846|FG000|Overall Study|Toxicity|1|||
164450118|NCT03582722|594015847|FG000|Overall Study|Lost to Follow-up|1|||
164450119|NCT03582722|594015848|FG001|Overall Study|Lost to Follow-up|4|||
164450120|NCT03582722|594015847|FG000|Overall Study|Withdrawal by Subject|3|||
164450121|NCT03582722|594015848|FG001|Overall Study|Withdrawal by Subject|3|||
164450122|NCT00424463|594015849|FG000|Overall Study|Adverse Event|2|||
164450123|NCT00424463|594015850|FG001|Overall Study|Adverse Event|3|||
164450124|NCT00424463|594015851|FG002|Overall Study|Adverse Event|2|||
164450125|NCT00424463|594015849|FG000|Overall Study|Physician Decision|0|||
164450126|NCT00424463|594015850|FG001|Overall Study|Physician Decision|2|||
164450127|NCT00424463|594015851|FG002|Overall Study|Physician Decision|2|||
164450128|NCT00424463|594015849|FG000|Overall Study|Withdrawal by Subject|4|||
164450129|NCT00424463|594015850|FG001|Overall Study|Withdrawal by Subject|2|||
164450130|NCT00424463|594015851|FG002|Overall Study|Withdrawal by Subject|5|||
164450131|NCT00424463|594015849|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
164450132|NCT00424463|594015850|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
164450133|NCT00424463|594015851|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
164450134|NCT00424463|594015849|FG000|Overall Study|Patient's convenience|0|||
164450135|NCT00424463|594015850|FG001|Overall Study|Patient's convenience|0|||
164450136|NCT00424463|594015851|FG002|Overall Study|Patient's convenience|1|||
164450137|NCT03570892|594015853|FG000|Overall Study|Death|51|||
164450138|NCT03570892|594015854|FG001|Overall Study|Death|45|||
164450139|NCT03570892|594015853|FG000|Overall Study|Subject decision|5|||
164450140|NCT03570892|594015854|FG001|Overall Study|Subject decision|3|||
164450141|NCT03570892|594015853|FG000|Overall Study|Protocol Violation|1|||
164450142|NCT03570892|594015854|FG001|Overall Study|Protocol Violation|4|||
164450143|NCT03570892|594015853|FG000|Overall Study|Physician Decision|0|||
164450144|NCT03570892|594015854|FG001|Overall Study|Physician Decision|2|||
164450145|NCT05028582|594015855|FG000|Overall Study|Lost to Follow-up|11|||
164450146|NCT05028582|594015856|FG001|Overall Study|Lost to Follow-up|9|||
164450147|NCT05028582|594015855|FG000|Overall Study|Withdrawal by Subject|9|||
164450148|NCT05028582|594015856|FG001|Overall Study|Withdrawal by Subject|10|||
164450149|NCT05028582|594015855|FG000|Overall Study|Adverse Event|5|||
164450150|NCT05028582|594015856|FG001|Overall Study|Adverse Event|2|||
164450151|NCT05028582|594015855|FG000|Overall Study|Miscellaneous|3|||
164450152|NCT05028582|594015856|FG001|Overall Study|Miscellaneous|2|||
164450153|NCT05028582|594015855|FG000|Overall Study|Lack of Efficacy|3|||
164450154|NCT05028582|594015856|FG001|Overall Study|Lack of Efficacy|1|||
164450155|NCT05028582|594015855|FG000|Overall Study|Physician Decision|0|||
164450156|NCT05028582|594015856|FG001|Overall Study|Physician Decision|1|||
164450157|NCT02576509|594017646|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
164450158|NCT02576509|594017647|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
164450159|NCT02576509|594017646|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
164450160|NCT02576509|594017647|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
164450161|NCT02576509|594017646|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
164450162|NCT02576509|594017647|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
164450163|NCT02576509|594017646|FG000|Treatment Period|Disease progression|263|||
164450164|NCT02576509|594017647|FG001|Treatment Period|Disease progression|244|||
164450165|NCT02576509|594017646|FG000|Treatment Period|Study drug toxicity|37|||
164597113|NCT02052778|594549012|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
164450166|NCT02576509|594017647|FG001|Treatment Period|Study drug toxicity|41|||
164450167|NCT02576509|594017646|FG000|Treatment Period|Death|1|||
164450168|NCT02576509|594017647|FG001|Treatment Period|Death|1|||
164450169|NCT02576509|594017646|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
164450170|NCT02576509|594017647|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
164450171|NCT02576509|594017646|FG000|Treatment Period|Participant request to stop treatment|8|||
164597114|NCT02052778|594549013|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
164597115|NCT02052778|594549014|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
164597116|NCT02052778|594549015|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
164597117|NCT02052778|594548993|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164597118|NCT02052778|594548994|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164597119|NCT02052778|594548995|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164597120|NCT02052778|594548996|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164597121|NCT02052778|594548997|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164597122|NCT02052778|594548998|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164597123|NCT02052778|594548999|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164597124|NCT02052778|594549000|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164597125|NCT02052778|594549001|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164597126|NCT02052778|594549002|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164597127|NCT02052778|594549003|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164450172|NCT02576509|594017647|FG001|Treatment Period|Participant request to stop treatment|18|||
164450173|NCT02576509|594017646|FG000|Treatment Period|Participant withdrew consent|3|||
164450174|NCT02576509|594017647|FG001|Treatment Period|Participant withdrew consent|7|||
164450175|NCT02576509|594017646|FG000|Treatment Period|Lost to Follow-up|0|||
164450176|NCT02576509|594017647|FG001|Treatment Period|Lost to Follow-up|1|||
164450177|NCT02576509|594017646|FG000|Treatment Period|Maximum clinical benefit|1|||
164450178|NCT02576509|594017647|FG001|Treatment Period|Maximum clinical benefit|0|||
164450179|NCT02576509|594017646|FG000|Treatment Period|Poor/non-compliance|1|||
164450180|NCT02576509|594017647|FG001|Treatment Period|Poor/non-compliance|1|||
164450181|NCT02576509|594017646|FG000|Treatment Period|Participant no longer meets criteria|1|||
164450182|NCT02576509|594017647|FG001|Treatment Period|Participant no longer meets criteria|0|||
164450183|NCT02576509|594017646|FG000|Treatment Period|Other reason|12|||
164450184|NCT02576509|594017647|FG001|Treatment Period|Other reason|8|||
164450185|NCT02576509|594017646|FG000|Treatment Period|NOT REPORTED|1|||
164450186|NCT02576509|594017647|FG001|Treatment Period|NOT REPORTED|0|||
164450187|NCT02576509|594017646|FG000|Treatment Period|Administrative reason by sponsor|0|||
164450188|NCT02576509|594017647|FG001|Treatment Period|Administrative reason by sponsor|1|||
164450189|NCT01216176|594017651|FG000|Overall Study|Adverse Event|0|||
164450190|NCT01216176|594017652|FG001|Overall Study|Adverse Event|8|||
164450191|NCT01216176|594017653|FG002|Overall Study|Adverse Event|0|||
164450192|NCT01216176|594017651|FG000|Overall Study|Physician Decision|0|||
164450193|NCT01216176|594017652|FG001|Overall Study|Physician Decision|0|||
164450194|NCT01216176|594017653|FG002|Overall Study|Physician Decision|1|||
164450195|NCT03725722|594017656|FG000|Overall Study|Lack of Efficacy|2|||
164450196|NCT03725722|594017657|FG001|Overall Study|Lack of Efficacy|1|||
164450197|NCT03725722|594017658|FG002|Overall Study|Lack of Efficacy|2|||
164450198|NCT03725722|594017659|FG003|Overall Study|Lack of Efficacy|0|||
164450199|NCT03725722|594017660|FG004|Overall Study|Lack of Efficacy|2|||
164450200|NCT03725722|594017656|FG000|Overall Study|Adverse Event|2|||
164450201|NCT03725722|594017657|FG001|Overall Study|Adverse Event|2|||
164450202|NCT03725722|594017658|FG002|Overall Study|Adverse Event|1|||
164450203|NCT03725722|594017659|FG003|Overall Study|Adverse Event|0|||
164450204|NCT03725722|594017660|FG004|Overall Study|Adverse Event|6|||
164450205|NCT03725722|594017656|FG000|Overall Study|Withdrawal by Subject|4|||
164450206|NCT03725722|594017657|FG001|Overall Study|Withdrawal by Subject|1|||
164450207|NCT03725722|594017658|FG002|Overall Study|Withdrawal by Subject|0|||
164450208|NCT03725722|594017659|FG003|Overall Study|Withdrawal by Subject|4|||
164450209|NCT03725722|594017660|FG004|Overall Study|Withdrawal by Subject|4|||
164450210|NCT03725722|594017656|FG000|Overall Study|Lost to Follow-up|3|||
164450211|NCT03725722|594017657|FG001|Overall Study|Lost to Follow-up|1|||
164450212|NCT03725722|594017658|FG002|Overall Study|Lost to Follow-up|2|||
164450213|NCT03725722|594017659|FG003|Overall Study|Lost to Follow-up|2|||
164450214|NCT03725722|594017660|FG004|Overall Study|Lost to Follow-up|1|||
164450215|NCT03725722|594017656|FG000|Overall Study|Personal reasons|0|||
164450216|NCT03725722|594017657|FG001|Overall Study|Personal reasons|0|||
164450217|NCT03725722|594017658|FG002|Overall Study|Personal reasons|1|||
164450218|NCT03725722|594017659|FG003|Overall Study|Personal reasons|0|||
164450219|NCT03725722|594017660|FG004|Overall Study|Personal reasons|1|||
164450220|NCT03725722|594017656|FG000|Overall Study|COVID-19 situation|0|||
164450221|NCT03725722|594017657|FG001|Overall Study|COVID-19 situation|1|||
164450222|NCT03725722|594017658|FG002|Overall Study|COVID-19 situation|0|||
164450223|NCT03725722|594017659|FG003|Overall Study|COVID-19 situation|0|||
164450224|NCT03725722|594017660|FG004|Overall Study|COVID-19 situation|0|||
164450225|NCT01600014|594017661|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
164450226|NCT01600014|594017662|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
164450227|NCT01600014|594017661|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
164450228|NCT01600014|594017662|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
164450229|NCT01600014|594017661|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
164450230|NCT01600014|594017662|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
164450231|NCT01600014|594017661|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
164450232|NCT01600014|594017662|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
164450233|NCT01600014|594017661|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
164450234|NCT01600014|594017662|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
164450235|NCT01600014|594017661|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
164450236|NCT01600014|594017662|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
164450237|NCT01600014|594017661|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
164450238|NCT01600014|594017662|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
164450239|NCT01600014|594017661|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
164450240|NCT01600014|594017662|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
164450241|NCT01600014|594017661|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
164450242|NCT01600014|594017662|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
164450243|NCT01600014|594017661|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
164450244|NCT01600014|594017662|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
164450245|NCT01600014|594017661|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
164450246|NCT01600014|594017662|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
164450247|NCT01600014|594017661|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
164450248|NCT01600014|594017662|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
164450249|NCT01600014|594017661|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
164450250|NCT01600014|594017662|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
164450251|NCT01600014|594017661|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
164450252|NCT01600014|594017662|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
164450253|NCT01600014|594017661|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
164450254|NCT01600014|594017662|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
164450255|NCT01600014|594017661|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
164450256|NCT01600014|594017662|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
164450257|NCT01600014|594017661|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
164450258|NCT01600014|594017662|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
164450259|NCT03481660|594017666|FG000|Overall Study|Adverse Event|5|||
164450260|NCT03481660|594017667|FG001|Overall Study|Adverse Event|4|||
164450261|NCT03481660|594017666|FG000|Overall Study|Death|13|||
164450262|NCT03481660|594017667|FG001|Overall Study|Death|9|||
164450263|NCT03481660|594017666|FG000|Overall Study|Lost to Follow-up|2|||
164450264|NCT03481660|594017667|FG001|Overall Study|Lost to Follow-up|2|||
164450265|NCT03481660|594017666|FG000|Overall Study|Physician Decision|2|||
164450266|NCT03481660|594017667|FG001|Overall Study|Physician Decision|3|||
164450267|NCT03481660|594017666|FG000|Overall Study|Withdrawal by Subject|14|||
164450268|NCT03481660|594017667|FG001|Overall Study|Withdrawal by Subject|7|||
164450269|NCT04278586|594017668|FG000|Overall Study|Withdrawal by Subject|13|||
164450270|NCT04278586|594017669|FG001|Overall Study|Withdrawal by Subject|6|||
164450271|NCT04278586|594017668|FG000|Overall Study|Lost to Follow-up|37|||
164450272|NCT04278586|594017669|FG001|Overall Study|Lost to Follow-up|24|||
164450273|NCT02791230|594017670|FG000|Overall Study|Adverse Event|10|||
164450274|NCT02791230|594017671|FG001|Overall Study|Adverse Event|9|||
164450275|NCT02791230|594017672|FG002|Overall Study|Adverse Event|66|||
164450276|NCT02791230|594017670|FG000|Overall Study|Death|38|||
164450277|NCT02791230|594017671|FG001|Overall Study|Death|25|||
164450278|NCT02791230|594017672|FG002|Overall Study|Death|184|||
164450279|NCT02791230|594017670|FG000|Overall Study|Lack of Efficacy|1|||
164450280|NCT02791230|594017671|FG001|Overall Study|Lack of Efficacy|0|||
164450281|NCT02791230|594017672|FG002|Overall Study|Lack of Efficacy|3|||
164450282|NCT02791230|594017670|FG000|Overall Study|Lost to Follow-up|0|||
164450283|NCT02791230|594017671|FG001|Overall Study|Lost to Follow-up|0|||
164450284|NCT02791230|594017672|FG002|Overall Study|Lost to Follow-up|10|||
164450285|NCT02791230|594017670|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
164450286|NCT02791230|594017671|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
164450287|NCT02791230|594017672|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
164450288|NCT02791230|594017670|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
164450289|NCT02791230|594017671|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
164450290|NCT02791230|594017672|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
164450291|NCT02791230|594017670|FG000|Overall Study|Study sites terminated by sponsor|1|||
164450292|NCT02791230|594017671|FG001|Overall Study|Study sites terminated by sponsor|0|||
164450293|NCT02791230|594017672|FG002|Overall Study|Study sites terminated by sponsor|5|||
164450294|NCT02791230|594017670|FG000|Overall Study|Other|9|||
164450295|NCT02791230|594017671|FG001|Overall Study|Other|1|||
164450296|NCT02791230|594017672|FG002|Overall Study|Other|28|||
164450297|NCT02791230|594017670|FG000|Overall Study|Protocol Violation|0|||
164450298|NCT02791230|594017671|FG001|Overall Study|Protocol Violation|0|||
164450299|NCT02791230|594017672|FG002|Overall Study|Protocol Violation|4|||
164450300|NCT02791230|594017670|FG000|Overall Study|Withdrawal by Subject|24|||
164450301|NCT02791230|594017671|FG001|Overall Study|Withdrawal by Subject|13|||
164450302|NCT02791230|594017672|FG002|Overall Study|Withdrawal by Subject|172|||
164450303|NCT02791230|594017670|FG000|Overall Study|Enrolled but not treated|0|||
164450304|NCT02791230|594017671|FG001|Overall Study|Enrolled but not treated|0|||
164450305|NCT02791230|594017672|FG002|Overall Study|Enrolled but not treated|5|||
164450306|NCT05307978|594017683|FG000|Overall Study|Lost to Follow-up|0|||
164450307|NCT05307978|594017684|FG001|Overall Study|Lost to Follow-up|1|||
164450308|NCT05307978|594017685|FG002|Overall Study|Lost to Follow-up|0|||
164450309|NCT05307978|594017686|FG003|Overall Study|Lost to Follow-up|4|||
164450310|NCT05307978|594017687|FG004|Overall Study|Lost to Follow-up|0|||
164706429|NCT02393248|594953426|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
164450311|NCT05307978|594017688|FG005|Overall Study|Lost to Follow-up|0|||
164450312|NCT05307978|594017689|FG006|Overall Study|Lost to Follow-up|1|||
164450313|NCT05075408|594017690|FG000|Overall Study|Withdrawal by Subject|5|||
164450314|NCT05075408|594017691|FG001|Overall Study|Withdrawal by Subject|3|||
164450315|NCT05075408|594017692|FG002|Overall Study|Withdrawal by Subject|4|||
164450316|NCT05075408|594017690|FG000|Overall Study|Adverse Event|5|||
164450317|NCT05075408|594017691|FG001|Overall Study|Adverse Event|7|||
164706430|NCT02393248|594953427|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
164450318|NCT05075408|594017692|FG002|Overall Study|Adverse Event|8|||
164450319|NCT05075408|594017690|FG000|Overall Study|Protocol Violation|0|||
164450320|NCT05075408|594017691|FG001|Overall Study|Protocol Violation|1|||
164450321|NCT05075408|594017692|FG002|Overall Study|Protocol Violation|0|||
164450322|NCT05075408|594017690|FG000|Overall Study|Lost to Follow-up|2|||
164450323|NCT05075408|594017691|FG001|Overall Study|Lost to Follow-up|1|||
164450324|NCT05075408|594017692|FG002|Overall Study|Lost to Follow-up|1|||
164450325|NCT05075408|594017690|FG000|Overall Study|Physician Decision|1|||
164450326|NCT05075408|594017691|FG001|Overall Study|Physician Decision|0|||
164450327|NCT05075408|594017692|FG002|Overall Study|Physician Decision|0|||
164404576|NCT02597036|593851997|FG001|Overall Study|Adverse Event|0|||
164404577|NCT02597036|593851998|FG002|Overall Study|Adverse Event|0|||
164404578|NCT02597036|593851999|FG003|Overall Study|Adverse Event|0|||
164404579|NCT02597036|593852000|FG004|Overall Study|Adverse Event|0|||
164404580|NCT02597036|593852001|FG005|Overall Study|Adverse Event|0|||
164404581|NCT02597036|593852002|FG006|Overall Study|Adverse Event|0|||
164404582|NCT02597036|593852003|FG007|Overall Study|Adverse Event|1|||
164404583|NCT02597036|593852004|FG008|Overall Study|Adverse Event|0|||
164404584|NCT02597036|593852005|FG009|Overall Study|Adverse Event|0|||
164404585|NCT02597036|593852006|FG010|Overall Study|Adverse Event|0|||
164404586|NCT02597036|593852007|FG011|Overall Study|Adverse Event|1|||
164404587|NCT02597036|593851996|FG000|Overall Study|Death|0|||
164404588|NCT02597036|593851997|FG001|Overall Study|Death|0|||
164404589|NCT02597036|593851998|FG002|Overall Study|Death|0|||
164404590|NCT02597036|593851999|FG003|Overall Study|Death|0|||
164404591|NCT02597036|593852000|FG004|Overall Study|Death|0|||
164404592|NCT02597036|593852001|FG005|Overall Study|Death|0|||
164404593|NCT02597036|593852002|FG006|Overall Study|Death|0|||
164404594|NCT02597036|593852003|FG007|Overall Study|Death|0|||
164404595|NCT02597036|593852004|FG008|Overall Study|Death|0|||
164404596|NCT02597036|593852005|FG009|Overall Study|Death|1|||
164404597|NCT02597036|593852006|FG010|Overall Study|Death|1|||
164404598|NCT02597036|593852007|FG011|Overall Study|Death|0|||
164404599|NCT02597036|593851996|FG000|Overall Study|Lost to Follow-up|0|||
164404600|NCT02597036|593851997|FG001|Overall Study|Lost to Follow-up|0|||
164404601|NCT02597036|593851998|FG002|Overall Study|Lost to Follow-up|0|||
164404602|NCT02597036|593851999|FG003|Overall Study|Lost to Follow-up|0|||
164404603|NCT02597036|593852000|FG004|Overall Study|Lost to Follow-up|0|||
164404604|NCT02597036|593852001|FG005|Overall Study|Lost to Follow-up|0|||
164404605|NCT02597036|593852002|FG006|Overall Study|Lost to Follow-up|0|||
164404606|NCT02597036|593852003|FG007|Overall Study|Lost to Follow-up|0|||
164404607|NCT02597036|593852004|FG008|Overall Study|Lost to Follow-up|0|||
164404608|NCT02597036|593852005|FG009|Overall Study|Lost to Follow-up|0|||
164404609|NCT02597036|593852006|FG010|Overall Study|Lost to Follow-up|1|||
164404610|NCT02597036|593852007|FG011|Overall Study|Lost to Follow-up|0|||
164404611|NCT02597036|593851996|FG000|Overall Study|Withdrawal by Subject|0|||
164404612|NCT02597036|593851997|FG001|Overall Study|Withdrawal by Subject|0|||
164404613|NCT02597036|593851998|FG002|Overall Study|Withdrawal by Subject|0|||
164404614|NCT02597036|593851999|FG003|Overall Study|Withdrawal by Subject|0|||
164404615|NCT02597036|593852000|FG004|Overall Study|Withdrawal by Subject|0|||
164404616|NCT02597036|593852001|FG005|Overall Study|Withdrawal by Subject|0|||
164404617|NCT02597036|593852002|FG006|Overall Study|Withdrawal by Subject|0|||
164404618|NCT02597036|593852003|FG007|Overall Study|Withdrawal by Subject|0|||
164404619|NCT02597036|593852004|FG008|Overall Study|Withdrawal by Subject|0|||
164404620|NCT02597036|593852005|FG009|Overall Study|Withdrawal by Subject|0|||
164404621|NCT02597036|593852006|FG010|Overall Study|Withdrawal by Subject|0|||
164404622|NCT02597036|593852007|FG011|Overall Study|Withdrawal by Subject|1|||
164404623|NCT02521285|593852008|FG000|Overall Study|Lost to Follow-up|1|||
164404624|NCT02521285|593852009|FG001|Overall Study|Lost to Follow-up|1|||
164404625|NCT02521285|593852008|FG000|Overall Study|Withdrawal by Subject|1|||
164404626|NCT02521285|593852009|FG001|Overall Study|Withdrawal by Subject|1|||
164404627|NCT02521285|593852008|FG000|Overall Study|Adverse Event|0|||
164404628|NCT02521285|593852009|FG001|Overall Study|Adverse Event|1|||
164404629|NCT05701995|593852011|FG000|Pre-Treatment|Randomization Error|1|||
164404630|NCT05701995|593852012|FG001|Pre-Treatment|Randomization Error|1|||
164404631|NCT05701995|593852011|FG000|Treatment|Withdrawal by Subject|8|||
164404632|NCT05701995|593852012|FG001|Treatment|Withdrawal by Subject|4|||
164450328|NCT05075408|594017690|FG000|Overall Study|Other-unspecified|3|||
164404633|NCT05701995|593852011|FG000|Treatment|Lost to Follow-up|2|||
164404634|NCT05701995|593852012|FG001|Treatment|Lost to Follow-up|3|||
164404635|NCT05701995|593852011|FG000|Treatment|Adverse Event|3|||
164404636|NCT05701995|593852012|FG001|Treatment|Adverse Event|1|||
164404637|NCT05701995|593852011|FG000|Treatment|Other Reason|1|||
164404638|NCT05701995|593852012|FG001|Treatment|Other Reason|1|||
164404639|NCT05701995|593852011|FG000|Treatment|Death|1|||
164404640|NCT05701995|593852012|FG001|Treatment|Death|0|||
164404641|NCT05701995|593852011|FG000|Treatment|Physician Decision|0|||
164404642|NCT05701995|593852012|FG001|Treatment|Physician Decision|1|||
164404643|NCT00715429|593852013|FG000|Overall Study|Did not complete the study diary|0|||
164404644|NCT00715429|593852014|FG001|Overall Study|Did not complete the study diary|1|||
164404645|NCT04899245|593852019|FG000|Overall Study|Withdrawal by Subject|3|||
164450329|NCT05075408|594017691|FG001|Overall Study|Other-unspecified|2|||
164450330|NCT05075408|594017692|FG002|Overall Study|Other-unspecified|0|||
164450331|NCT03651895|594017693|FG000|First Drug Assignment|Adverse Event|4|||
164450332|NCT03651895|594017694|FG001|First Drug Assignment|Adverse Event|5|||
164450333|NCT03651895|594017693|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
164450334|NCT03651895|594017694|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
164450335|NCT04527146|594017695|FG000|Overall Study|Withdrawal by Subject|12|||
164450336|NCT04527146|594017696|FG001|Overall Study|Withdrawal by Subject|15|||
164450337|NCT04527146|594017697|FG002|Overall Study|Withdrawal by Subject|7|||
164450338|NCT04527146|594017698|FG003|Overall Study|Withdrawal by Subject|16|||
164450339|NCT04527146|594017695|FG000|Overall Study|Lost to Follow-up|13|||
164450340|NCT04527146|594017696|FG001|Overall Study|Lost to Follow-up|9|||
164450341|NCT04527146|594017697|FG002|Overall Study|Lost to Follow-up|16|||
164450342|NCT04527146|594017698|FG003|Overall Study|Lost to Follow-up|13|||
164450343|NCT04527146|594017695|FG000|Overall Study|Death|0|||
164450344|NCT04527146|594017696|FG001|Overall Study|Death|1|||
164450345|NCT04527146|594017697|FG002|Overall Study|Death|1|||
164450346|NCT04527146|594017698|FG003|Overall Study|Death|0|||
164450347|NCT04527146|594017695|FG000|Overall Study|Adverse Event|0|||
164450348|NCT04527146|594017696|FG001|Overall Study|Adverse Event|0|||
164450349|NCT04527146|594017697|FG002|Overall Study|Adverse Event|1|||
164450350|NCT04527146|594017698|FG003|Overall Study|Adverse Event|0|||
164450351|NCT04527146|594017695|FG000|Overall Study|Ineligible after randomization|2|||
164450352|NCT04527146|594017696|FG001|Overall Study|Ineligible after randomization|0|||
164450353|NCT04527146|594017697|FG002|Overall Study|Ineligible after randomization|2|||
164450354|NCT04527146|594017698|FG003|Overall Study|Ineligible after randomization|2|||
164450355|NCT04527146|594017695|FG000|Overall Study|Moved to a different group|6|||
164450356|NCT04527146|594017696|FG001|Overall Study|Moved to a different group|3|||
164450357|NCT04527146|594017697|FG002|Overall Study|Moved to a different group|0|||
164450358|NCT04527146|594017698|FG003|Overall Study|Moved to a different group|2|||
164450359|NCT05510232|594017699|FG000|Overall Study|Withdrawal by Subject|2|||
164450360|NCT05510232|594017700|FG001|Overall Study|Withdrawal by Subject|7|||
164450361|NCT05510232|594017701|FG002|Overall Study|Withdrawal by Subject|6|||
164450362|NCT05687903|594017711|FG000|Overall Study|Protocol Deviation|1|||
164450363|NCT05687903|594017712|FG001|Overall Study|Protocol Deviation|1|||
164450364|NCT05687903|594017713|FG002|Overall Study|Protocol Deviation|0|||
164450365|NCT05687903|594017714|FG003|Overall Study|Protocol Deviation|1|||
164450366|NCT05687903|594017715|FG004|Overall Study|Protocol Deviation|0|||
164450367|NCT04468776|594017716|FG000|Overall Study|Lost to Follow-up|4|||
164450368|NCT04468776|594017717|FG001|Overall Study|Lost to Follow-up|3|||
164450369|NCT04468776|594017718|FG002|Overall Study|Lost to Follow-up|4|||
164450370|NCT04468776|594017716|FG000|Overall Study|Withdrawal by Subject|1|||
164450371|NCT04468776|594017717|FG001|Overall Study|Withdrawal by Subject|10|||
164450372|NCT04468776|594017718|FG002|Overall Study|Withdrawal by Subject|4|||
164450373|NCT04468776|594017716|FG000|Overall Study|Physician Decision|0|||
164450374|NCT04468776|594017717|FG001|Overall Study|Physician Decision|1|||
164450375|NCT04468776|594017718|FG002|Overall Study|Physician Decision|1|||
164450376|NCT04855760|594017719|FG000|Overall Study|Adverse Event|21|||
164597128|NCT02052778|594549004|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164597129|NCT02052778|594549005|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164597130|NCT02052778|594549006|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164597131|NCT02052778|594549007|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
164597132|NCT02052778|594549008|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
164597133|NCT02052778|594549009|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
164597134|NCT02052778|594549010|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164597135|NCT02052778|594549011|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
164597136|NCT02052778|594549012|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164597137|NCT02052778|594549013|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164597138|NCT02052778|594549014|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164450377|NCT04855760|594017719|FG000|Overall Study|Withdrawal by Subject|116|||
164450378|NCT04855760|594017719|FG000|Overall Study|Lack of Efficacy|21|||
164450379|NCT04855760|594017719|FG000|Overall Study|Lost to Follow-up|49|||
164450380|NCT04855760|594017719|FG000|Overall Study|Protocol Violation|2|||
164597139|NCT02052778|594549015|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164450381|NCT04855760|594017719|FG000|Overall Study|Physician Decision|5|||
164450382|NCT04855760|594017719|FG000|Overall Study|Pregnancy|1|||
164450383|NCT04855760|594017719|FG000|Overall Study|Non-Compliance with Study Drug|11|||
164450384|NCT04855760|594017719|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
164450385|NCT04855760|594017719|FG000|Overall Study|Study Completed by Sponsor|202|||
164450386|NCT04855760|594017719|FG000|Overall Study|Other|13|||
164450387|NCT04840199|594017722|FG000|Overall Study|Study Terminated by Sponsor|8|||
164450388|NCT04840199|594017723|FG001|Overall Study|Study Terminated by Sponsor|9|||
164450389|NCT04840199|594017722|FG000|Overall Study|Lost to Follow-up|0|||
164450390|NCT04840199|594017723|FG001|Overall Study|Lost to Follow-up|2|||
164450391|NCT04840199|594017722|FG000|Overall Study|Withdrawal by Subject|2|||
164450392|NCT04840199|594017723|FG001|Overall Study|Withdrawal by Subject|0|||
164450393|NCT04840199|594017722|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
164450394|NCT04840199|594017723|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
164450395|NCT02879448|594017724|FG000|Overall Study|Death|251|||
164450396|NCT02879448|594017725|FG001|Overall Study|Death|263|||
164450397|NCT02879448|594017724|FG000|Overall Study|Lost to Follow-up|23|||
164450398|NCT02879448|594017725|FG001|Overall Study|Lost to Follow-up|28|||
164450399|NCT02879448|594017724|FG000|Overall Study|Withdrawal by Subject|42|||
164450400|NCT02879448|594017725|FG001|Overall Study|Withdrawal by Subject|79|||
164450401|NCT02879448|594017724|FG000|Overall Study|Other Reasons|8|||
164450402|NCT02879448|594017725|FG001|Overall Study|Other Reasons|12|||
164450403|NCT02728557|594017726|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
164450404|NCT02728557|594017727|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
164450405|NCT02728557|594017726|FG000|Overall Study|Dissatisfaction with research tasks|0|||
164450406|NCT02728557|594017727|FG001|Overall Study|Dissatisfaction with research tasks|1|||
164450407|NCT02728557|594017726|FG000|Overall Study|Scheduling or change in availability|1|||
164450408|NCT02728557|594017727|FG001|Overall Study|Scheduling or change in availability|1|||
164450409|NCT01718743|594017728|FG000|Overall Study|Physician Decision|7|||
164450410|NCT01718743|594017728|FG000|Overall Study|Withdrawal by Subject|14|||
164450411|NCT01718743|594017728|FG000|Overall Study|Progressive Disease|22|||
164450412|NCT01718743|594017728|FG000|Overall Study|Toxicity|1|||
164450413|NCT01718743|594017728|FG000|Overall Study|Malignancy|1|||
164450414|NCT03416010|594017729|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
164450415|NCT03416010|594017730|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
164450416|NCT03416010|594017729|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
164450417|NCT03416010|594017730|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
164450418|NCT03416010|594017729|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
164450419|NCT03416010|594017730|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
164450420|NCT03416010|594017729|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
164450421|NCT03416010|594017730|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
164450422|NCT03416010|594017729|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
164450423|NCT03416010|594017730|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
164450424|NCT03416010|594017729|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
164450425|NCT03416010|594017730|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
164450426|NCT03416010|594017729|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
164450427|NCT03416010|594017730|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
164450428|NCT03948763|594017731|FG000|Overall Study|Sponsor's decision|0|||
164450429|NCT03948763|594017732|FG001|Overall Study|Sponsor's decision|2|||
164450430|NCT03948763|594017733|FG002|Overall Study|Sponsor's decision|6|||
164450431|NCT03948763|594017734|FG003|Overall Study|Sponsor's decision|4|||
164450432|NCT03948763|594017735|FG004|Overall Study|Sponsor's decision|0|||
164450433|NCT03948763|594017731|FG000|Overall Study|Physician Decision|0|||
164450434|NCT03948763|594017732|FG001|Overall Study|Physician Decision|0|||
164450435|NCT03948763|594017733|FG002|Overall Study|Physician Decision|1|||
164450436|NCT03948763|594017734|FG003|Overall Study|Physician Decision|0|||
164450437|NCT03948763|594017735|FG004|Overall Study|Physician Decision|0|||
164450438|NCT03948763|594017731|FG000|Overall Study|Lost to Follow-up|0|||
164450439|NCT03948763|594017732|FG001|Overall Study|Lost to Follow-up|0|||
164450440|NCT03948763|594017733|FG002|Overall Study|Lost to Follow-up|0|||
164450441|NCT03948763|594017734|FG003|Overall Study|Lost to Follow-up|0|||
164450442|NCT03948763|594017735|FG004|Overall Study|Lost to Follow-up|1|||
164450443|NCT03948763|594017731|FG000|Overall Study|Death|2|||
164450444|NCT03948763|594017732|FG001|Overall Study|Death|12|||
164450445|NCT03948763|594017733|FG002|Overall Study|Death|13|||
164450446|NCT03948763|594017734|FG003|Overall Study|Death|10|||
164450447|NCT03948763|594017735|FG004|Overall Study|Death|11|||
164450448|NCT03948763|594017731|FG000|Overall Study|Withdrawal by Subject|1|||
164450449|NCT03948763|594017732|FG001|Overall Study|Withdrawal by Subject|1|||
164450450|NCT03948763|594017733|FG002|Overall Study|Withdrawal by Subject|0|||
164450451|NCT03948763|594017734|FG003|Overall Study|Withdrawal by Subject|2|||
164450452|NCT03948763|594017735|FG004|Overall Study|Withdrawal by Subject|4|||
164450453|NCT03988023|594017740|FG000|Overall Study|Non-compliance|3|||
164450454|NCT03988023|594017741|FG001|Overall Study|Non-compliance|0|||
164450455|NCT03988023|594017740|FG000|Overall Study|Withdrawal by Subject|39|||
164450456|NCT03988023|594017741|FG001|Overall Study|Withdrawal by Subject|37|||
164450457|NCT03988023|594017740|FG000|Overall Study|Adverse Event|0|||
164706431|NCT02393248|594953428|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
164450458|NCT03988023|594017741|FG001|Overall Study|Adverse Event|2|||
164450459|NCT03988023|594017740|FG000|Overall Study|Physician Decision|0|||
164450460|NCT03988023|594017741|FG001|Overall Study|Physician Decision|1|||
164450461|NCT03988023|594017740|FG000|Overall Study|Lost to Follow-up|5|||
164450462|NCT03988023|594017741|FG001|Overall Study|Lost to Follow-up|8|||
164450463|NCT03988023|594017740|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
164450464|NCT03988023|594017741|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
164450465|NCT03988023|594017740|FG000|Overall Study|Lack of Efficacy|3|||
164450466|NCT03988023|594017741|FG001|Overall Study|Lack of Efficacy|1|||
164450467|NCT03988023|594017740|FG000|Overall Study|COVID-19 pandemic|225|||
164450468|NCT03988023|594017741|FG001|Overall Study|COVID-19 pandemic|227|||
164450469|NCT03655262|594017742|FG000|Overall Study|Withdrawal by Subject|0|||
164450470|NCT03655262|594017743|FG001|Overall Study|Withdrawal by Subject|0|||
164450471|NCT03655262|594017744|FG002|Overall Study|Withdrawal by Subject|1|||
164450472|NCT03733119|594017745|FG000|Overall Study|Physician Decision|2|||
164450473|NCT03733119|594017746|FG001|Overall Study|Physician Decision|1|||
164450474|NCT03733119|594017745|FG000|Overall Study|ineligible to treat per protocol|0|||
164450475|NCT03733119|594017746|FG001|Overall Study|ineligible to treat per protocol|1|||
164450476|NCT02554786|594017749|FG000|Overall Study|Subject/guardian decision|29|||
164450477|NCT02554786|594017750|FG001|Overall Study|Subject/guardian decision|17|||
164450478|NCT02554786|594017751|FG002|Overall Study|Subject/guardian decision|18|||
164450479|NCT02554786|594017752|FG003|Overall Study|Subject/guardian decision|30|||
164450480|NCT02554786|594017753|FG004|Overall Study|Subject/guardian decision|20|||
164450481|NCT02554786|594017749|FG000|Overall Study|Lost to Follow-up|4|||
164450482|NCT02554786|594017750|FG001|Overall Study|Lost to Follow-up|3|||
164450483|NCT02554786|594017751|FG002|Overall Study|Lost to Follow-up|4|||
164450484|NCT02554786|594017752|FG003|Overall Study|Lost to Follow-up|2|||
164450485|NCT02554786|594017753|FG004|Overall Study|Lost to Follow-up|2|||
164450486|NCT02554786|594017749|FG000|Overall Study|Protocol deviation|1|||
164450487|NCT02554786|594017750|FG001|Overall Study|Protocol deviation|3|||
164450488|NCT02554786|594017751|FG002|Overall Study|Protocol deviation|3|||
164450489|NCT02554786|594017752|FG003|Overall Study|Protocol deviation|4|||
164450490|NCT02554786|594017753|FG004|Overall Study|Protocol deviation|2|||
164450491|NCT02554786|594017749|FG000|Overall Study|Technical problems|1|||
164450492|NCT02554786|594017750|FG001|Overall Study|Technical problems|1|||
164450493|NCT02554786|594017751|FG002|Overall Study|Technical problems|0|||
164450494|NCT02554786|594017752|FG003|Overall Study|Technical problems|2|||
164450495|NCT02554786|594017753|FG004|Overall Study|Technical problems|1|||
164450496|NCT02554786|594017749|FG000|Overall Study|Adverse Event|0|||
164450497|NCT02554786|594017750|FG001|Overall Study|Adverse Event|0|||
164450498|NCT02554786|594017751|FG002|Overall Study|Adverse Event|0|||
164450499|NCT02554786|594017752|FG003|Overall Study|Adverse Event|0|||
164450500|NCT02554786|594017753|FG004|Overall Study|Adverse Event|2|||
164450501|NCT02554786|594017749|FG000|Overall Study|Death|0|||
164450502|NCT02554786|594017750|FG001|Overall Study|Death|0|||
164450503|NCT02554786|594017751|FG002|Overall Study|Death|0|||
164450504|NCT02554786|594017752|FG003|Overall Study|Death|1|||
164450505|NCT02554786|594017753|FG004|Overall Study|Death|0|||
164450506|NCT02554786|594017749|FG000|Overall Study|Non-compliance with study treatment|0|||
164450507|NCT02554786|594017750|FG001|Overall Study|Non-compliance with study treatment|1|||
164450508|NCT02554786|594017751|FG002|Overall Study|Non-compliance with study treatment|1|||
164450509|NCT02554786|594017752|FG003|Overall Study|Non-compliance with study treatment|0|||
164450510|NCT02554786|594017753|FG004|Overall Study|Non-compliance with study treatment|1|||
164450511|NCT02554786|594017749|FG000|Overall Study|Physician Decision|0|||
164450512|NCT02554786|594017750|FG001|Overall Study|Physician Decision|1|||
164450513|NCT02554786|594017751|FG002|Overall Study|Physician Decision|4|||
164450514|NCT02554786|594017752|FG003|Overall Study|Physician Decision|1|||
164450515|NCT02554786|594017753|FG004|Overall Study|Physician Decision|1|||
164450516|NCT02554786|594017749|FG000|Overall Study|Pregnancy|0|||
164450517|NCT02554786|594017750|FG001|Overall Study|Pregnancy|0|||
164450518|NCT02554786|594017751|FG002|Overall Study|Pregnancy|0|||
164450519|NCT02554786|594017752|FG003|Overall Study|Pregnancy|1|||
164450520|NCT02554786|594017753|FG004|Overall Study|Pregnancy|1|||
164450521|NCT04583423|594017764|FG000|Overall Study|Lost to Follow-up|0|||
164450522|NCT04583423|594017765|FG001|Overall Study|Lost to Follow-up|1|||
164450523|NCT04583423|594017766|FG002|Overall Study|Lost to Follow-up|0|||
164450524|NCT04583423|594017767|FG003|Overall Study|Lost to Follow-up|2|||
164450525|NCT04583423|594017764|FG000|Overall Study|Study Terminated by Sponsor|32|||
164450526|NCT04583423|594017765|FG001|Overall Study|Study Terminated by Sponsor|35|||
164450527|NCT04583423|594017766|FG002|Overall Study|Study Terminated by Sponsor|36|||
164450528|NCT04583423|594017767|FG003|Overall Study|Study Terminated by Sponsor|33|||
164450529|NCT04583423|594017764|FG000|Overall Study|Withdrawal by Subject|3|||
164450530|NCT04583423|594017765|FG001|Overall Study|Withdrawal by Subject|1|||
164597140|NCT02052778|594548993|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164450531|NCT04583423|594017766|FG002|Overall Study|Withdrawal by Subject|2|||
164450532|NCT04583423|594017767|FG003|Overall Study|Withdrawal by Subject|1|||
164450533|NCT03330795|594017768|FG000|Overall Study|Death|3|||
164450534|NCT03330795|594017768|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
164450535|NCT00393484|594017769|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
164450536|NCT00393484|594017770|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
164450537|NCT00393484|594017769|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
164450538|NCT00393484|594017770|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
164450539|NCT00393484|594017769|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
164450540|NCT00393484|594017770|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
164404646|NCT04899245|593852020|FG001|Overall Study|Withdrawal by Subject|5|||
164404647|NCT04899245|593852021|FG002|Overall Study|Withdrawal by Subject|2|||
164404648|NCT04899245|593852019|FG000|Overall Study|No longer eligible - Left staff position|0|||
164404649|NCT04899245|593852020|FG001|Overall Study|No longer eligible - Left staff position|0|||
164404650|NCT04899245|593852021|FG002|Overall Study|No longer eligible - Left staff position|1|||
164404651|NCT04899245|593852019|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
164404652|NCT04899245|593852020|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
164404653|NCT04899245|593852021|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
164404654|NCT04899245|593852019|FG000|Overall Study|No longer eligible - Moved away from area|2|||
164404655|NCT04899245|593852020|FG001|Overall Study|No longer eligible - Moved away from area|2|||
164404656|NCT04899245|593852021|FG002|Overall Study|No longer eligible - Moved away from area|0|||
164404657|NCT00386022|593852030|FG000|Plus Estrogen|Lost to Follow-up|2|||
164404658|NCT00386022|593852031|FG001|Plus Estrogen|Lost to Follow-up|0|||
164404659|NCT00386022|593852030|FG000|Plus Estrogen|Adverse Event|0|||
164404660|NCT00386022|593852031|FG001|Plus Estrogen|Adverse Event|1|||
164404661|NCT00504426|593852034|FG000|Overall Study|Adverse Event|0|||
164404662|NCT00504426|593852035|FG001|Overall Study|Adverse Event|0|||
164404663|NCT00504426|593852036|FG002|Overall Study|Adverse Event|2|||
164404664|NCT00504426|593852037|FG003|Overall Study|Adverse Event|0|||
164404665|NCT00504426|593852034|FG000|Overall Study|Protocol Violation|1|||
164404666|NCT00504426|593852035|FG001|Overall Study|Protocol Violation|1|||
164404667|NCT00504426|593852036|FG002|Overall Study|Protocol Violation|2|||
164404668|NCT00504426|593852037|FG003|Overall Study|Protocol Violation|0|||
164404669|NCT00504426|593852034|FG000|Overall Study|Withdrawal by Subject|2|||
164404670|NCT00504426|593852035|FG001|Overall Study|Withdrawal by Subject|0|||
164404671|NCT00504426|593852036|FG002|Overall Study|Withdrawal by Subject|0|||
164404672|NCT00504426|593852037|FG003|Overall Study|Withdrawal by Subject|0|||
164404673|NCT03988166|593852047|FG000|Overall Study|Lost to Follow-up|2|||
164404674|NCT03988166|593852047|FG000|Overall Study|Death|1|||
164404675|NCT03764072|593852048|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
164404676|NCT03764072|593852049|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
164404677|NCT03764072|593852050|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
164404678|NCT03764072|593852051|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
164404679|NCT03764072|593852052|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
164404680|NCT03764072|593852053|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
164404681|NCT03764072|593852048|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
164404682|NCT03764072|593852049|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
164404683|NCT03764072|593852050|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
164404684|NCT03764072|593852051|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
164404685|NCT03764072|593852052|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
164404686|NCT03764072|593852053|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
164404687|NCT03764072|593852048|FG000|Overall Study|Lost to Follow-up|0|||
164404688|NCT03764072|593852049|FG001|Overall Study|Lost to Follow-up|0|||
164404689|NCT03764072|593852050|FG002|Overall Study|Lost to Follow-up|0|||
164404690|NCT03764072|593852051|FG003|Overall Study|Lost to Follow-up|0|||
164404691|NCT03764072|593852052|FG004|Overall Study|Lost to Follow-up|1|||
164404692|NCT03764072|593852053|FG005|Overall Study|Lost to Follow-up|0|||
164404693|NCT02286089|593852054|FG000|Overall Study|Ongoing in Study|1|||
164404694|NCT02286089|593852055|FG001|Overall Study|Ongoing in Study|1|||
164404695|NCT02286089|593852056|FG002|Overall Study|Ongoing in Study|4|||
164404696|NCT02286089|593852057|FG003|Overall Study|Ongoing in Study|10|||
164404697|NCT02286089|593852054|FG000|Overall Study|Withdrawal by Subject|0|||
164404698|NCT02286089|593852055|FG001|Overall Study|Withdrawal by Subject|0|||
164404699|NCT02286089|593852056|FG002|Overall Study|Withdrawal by Subject|2|||
164404700|NCT02286089|593852057|FG003|Overall Study|Withdrawal by Subject|2|||
164404701|NCT00045708|593853776|FG000|Phase 1|early progressive disease|0|||
164404702|NCT00045708|593853777|FG001|Phase 1|early progressive disease|1|||
164404703|NCT00045708|593853778|FG002|Phase 1|early progressive disease|0|||
164404704|NCT00685945|593853779|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
164404705|NCT00847405|593853781|FG000|First Intervention|Adverse Event|0|||
164404706|NCT00847405|593853782|FG001|First Intervention|Adverse Event|1|||
164706432|NCT02393248|594953429|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164706433|NCT02393248|594953430|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164706434|NCT02393248|594953431|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164404707|NCT00847405|593853781|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
164404708|NCT00847405|593853782|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
164404709|NCT01728792|593853783|FG000|Overall Study|Withdrawal of Consent|1|||
164404710|NCT01728792|593853784|FG001|Overall Study|Withdrawal of Consent|1|||
164404711|NCT01728792|593853785|FG002|Overall Study|Withdrawal of Consent|0|||
164404712|NCT01728792|593853786|FG003|Overall Study|Withdrawal of Consent|1|||
164404713|NCT01728792|593853787|FG004|Overall Study|Withdrawal of Consent|0|||
164404714|NCT01728792|593853783|FG000|Overall Study|Lost to Follow-up|2|||
164706435|NCT02393248|594953432|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164450541|NCT00393484|594017769|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
164450542|NCT00393484|594017770|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
164450543|NCT00393484|594017769|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
164450544|NCT00393484|594017770|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
164450545|NCT00393484|594017769|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
164450546|NCT00393484|594017770|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
164450547|NCT00393484|594017769|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
164450548|NCT00393484|594017770|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
164450549|NCT00393484|594017769|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
164450550|NCT00393484|594017770|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
164450551|NCT00393484|594017769|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
164450552|NCT00393484|594017770|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
164450553|NCT00393484|594017769|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
164450554|NCT00393484|594017770|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
164450555|NCT01976312|594017781|FG000|Overall Study|Pregnancy|0|||
164450556|NCT01976312|594017782|FG001|Overall Study|Pregnancy|1|||
164450557|NCT01976312|594017781|FG000|Overall Study|Lost to Follow-up|2|||
164450558|NCT01976312|594017782|FG001|Overall Study|Lost to Follow-up|0|||
164450559|NCT01976312|594017781|FG000|Overall Study|Withdrawal by Subject|7|||
164450560|NCT01976312|594017782|FG001|Overall Study|Withdrawal by Subject|2|||
164450561|NCT01976312|594017781|FG000|Overall Study|Adverse Event|6|||
164450562|NCT01976312|594017782|FG001|Overall Study|Adverse Event|6|||
164450563|NCT01976312|594017781|FG000|Overall Study|Protocol Violation|2|||
164450564|NCT01976312|594017782|FG001|Overall Study|Protocol Violation|0|||
164450565|NCT02556138|594017783|FG000|Overall Study|Withdrawal by Subject|1|||
164450566|NCT03939312|594017784|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
164450567|NCT03939312|594017784|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
164450568|NCT03939312|594017784|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
164450569|NCT03939312|594017784|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
164450570|NCT03939312|594017784|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
164450571|NCT03939312|594017784|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
164450572|NCT03939312|594017784|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
164450573|NCT03939312|594017784|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
164450574|NCT03939312|594017784|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
164450575|NCT03939312|594017784|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
164450576|NCT03939312|594017784|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
164450577|NCT03939312|594017784|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
164450578|NCT01609218|594017786|FG000|Period 1|Adverse Event|3|||
164450579|NCT01609218|594017787|FG001|Period 1|Adverse Event|5|||
164450580|NCT01609218|594017786|FG000|Period 1|Sponsor Decision|0|||
164450581|NCT01609218|594017787|FG001|Period 1|Sponsor Decision|1|||
164450582|NCT01609218|594017786|FG000|Period 2|Adverse Event|1|||
164450583|NCT01609218|594017787|FG001|Period 2|Adverse Event|0|||
164450584|NCT02807779|594017788|FG000|Overall Study|Lost to Follow-up|1|||
164450585|NCT02807779|594017789|FG001|Overall Study|Lost to Follow-up|0|||
164450586|NCT02807779|594017790|FG002|Overall Study|Lost to Follow-up|0|||
164450587|NCT02807779|594017788|FG000|Overall Study|Physician Decision|2|||
164450588|NCT02807779|594017789|FG001|Overall Study|Physician Decision|0|||
164450589|NCT02807779|594017790|FG002|Overall Study|Physician Decision|1|||
164450590|NCT02807779|594017788|FG000|Overall Study|Death|1|||
164450591|NCT02807779|594017789|FG001|Overall Study|Death|1|||
164450592|NCT02807779|594017790|FG002|Overall Study|Death|0|||
164450593|NCT03398148|594019627|FG000|Substudy 1 Period 1|Adverse Event|5|||
164450594|NCT03398148|594019628|FG001|Substudy 1 Period 1|Adverse Event|2|||
164450595|NCT03398148|594019629|FG002|Substudy 1 Period 1|Adverse Event|2|||
164450596|NCT03398148|594019630|FG003|Substudy 1 Period 1|Adverse Event|0|||
164597141|NCT02052778|594548994|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164597142|NCT02052778|594548995|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164597143|NCT02052778|594548996|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164597144|NCT02052778|594548997|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164597145|NCT02052778|594548998|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164597146|NCT02052778|594548999|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164597147|NCT02052778|594549000|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164597148|NCT02052778|594549001|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164597149|NCT02052778|594549002|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164597150|NCT02052778|594549003|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164450597|NCT03398148|594019631|FG004|Substudy 1 Period 1|Adverse Event|8|||
164450598|NCT03398148|594019632|FG005|Substudy 1 Period 1|Adverse Event|0|||
164450599|NCT03398148|594019633|FG006|Substudy 1 Period 1|Adverse Event|0|||
164450600|NCT03398148|594019634|FG007|Substudy 1 Period 1|Adverse Event|0|||
164450601|NCT03398148|594019635|FG008|Substudy 1 Period 1|Adverse Event|0|||
164450602|NCT03398148|594019636|FG009|Substudy 1 Period 1|Adverse Event|0|||
164450603|NCT03398148|594019637|FG010|Substudy 1 Period 1|Adverse Event|0|||
164450604|NCT03398148|594019638|FG011|Substudy 1 Period 1|Adverse Event|0|||
164450605|NCT03398148|594019639|FG012|Substudy 1 Period 1|Adverse Event|0|||
164450606|NCT03398148|594019640|FG013|Substudy 1 Period 1|Adverse Event|0|||
164450607|NCT03398148|594019641|FG014|Substudy 1 Period 1|Adverse Event|0|||
164450608|NCT03398148|594019627|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
164450609|NCT03398148|594019628|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
164450610|NCT03398148|594019629|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
164450611|NCT03398148|594019630|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
164450612|NCT03398148|594019631|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
164450613|NCT03398148|594019632|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
164450614|NCT03398148|594019633|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
164450615|NCT03398148|594019634|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
164450616|NCT03398148|594019635|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
164450617|NCT03398148|594019636|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
164450618|NCT03398148|594019637|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
164450619|NCT03398148|594019638|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
164450620|NCT03398148|594019639|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
164450621|NCT03398148|594019640|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
164450622|NCT03398148|594019641|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
164450623|NCT03398148|594019627|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
164450624|NCT03398148|594019628|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
164450625|NCT03398148|594019629|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
164450626|NCT03398148|594019630|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
164450627|NCT03398148|594019631|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
164450628|NCT03398148|594019632|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
164450629|NCT03398148|594019633|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
164450630|NCT03398148|594019634|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
164450631|NCT03398148|594019635|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
164450632|NCT03398148|594019636|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
164450633|NCT03398148|594019637|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
164450634|NCT03398148|594019638|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
164450635|NCT03398148|594019639|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
164450636|NCT03398148|594019640|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
164450637|NCT03398148|594019641|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
164450638|NCT03398148|594019627|FG000|Substudy 1 Period 1|Other|0|||
164450639|NCT03398148|594019628|FG001|Substudy 1 Period 1|Other|1|||
164450640|NCT03398148|594019629|FG002|Substudy 1 Period 1|Other|0|||
164450641|NCT03398148|594019630|FG003|Substudy 1 Period 1|Other|0|||
164450642|NCT03398148|594019631|FG004|Substudy 1 Period 1|Other|3|||
164450643|NCT03398148|594019632|FG005|Substudy 1 Period 1|Other|0|||
164450644|NCT03398148|594019633|FG006|Substudy 1 Period 1|Other|0|||
164450645|NCT03398148|594019634|FG007|Substudy 1 Period 1|Other|0|||
164450646|NCT03398148|594019635|FG008|Substudy 1 Period 1|Other|0|||
164450647|NCT03398148|594019636|FG009|Substudy 1 Period 1|Other|0|||
164450648|NCT03398148|594019637|FG010|Substudy 1 Period 1|Other|0|||
164450649|NCT03398148|594019638|FG011|Substudy 1 Period 1|Other|0|||
164450650|NCT03398148|594019639|FG012|Substudy 1 Period 1|Other|0|||
164450651|NCT03398148|594019640|FG013|Substudy 1 Period 1|Other|0|||
164450652|NCT03398148|594019641|FG014|Substudy 1 Period 1|Other|0|||
164450653|NCT03398148|594019627|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
164450654|NCT03398148|594019628|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
164450655|NCT03398148|594019629|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
164450656|NCT03398148|594019630|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
164450657|NCT03398148|594019631|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
164450658|NCT03398148|594019632|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
164450659|NCT03398148|594019633|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
164450660|NCT03398148|594019634|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
164450661|NCT03398148|594019635|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
164450662|NCT03398148|594019636|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
164450663|NCT03398148|594019637|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
164450664|NCT03398148|594019638|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
164450665|NCT03398148|594019639|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
164706436|NCT02393248|594953433|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164706437|NCT02393248|594953434|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164706438|NCT02393248|594953435|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164706439|NCT02393248|594953436|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164450666|NCT03398148|594019640|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
164450667|NCT03398148|594019641|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
164450668|NCT03398148|594019627|FG000|Substudy 1 Period 2|Adverse Event|0|||
164450669|NCT03398148|594019628|FG001|Substudy 1 Period 2|Adverse Event|0|||
164450670|NCT03398148|594019629|FG002|Substudy 1 Period 2|Adverse Event|0|||
164450671|NCT03398148|594019630|FG003|Substudy 1 Period 2|Adverse Event|0|||
164450672|NCT03398148|594019631|FG004|Substudy 1 Period 2|Adverse Event|0|||
164450673|NCT03398148|594019632|FG005|Substudy 1 Period 2|Adverse Event|2|||
164450674|NCT03398148|594019633|FG006|Substudy 1 Period 2|Adverse Event|4|||
164450675|NCT03398148|594019634|FG007|Substudy 1 Period 2|Adverse Event|0|||
164450676|NCT03398148|594019635|FG008|Substudy 1 Period 2|Adverse Event|0|||
164706440|NCT02393248|594953437|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164706441|NCT02393248|594953438|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164706442|NCT02393248|594953414|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164706443|NCT02393248|594953415|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164706444|NCT02393248|594953416|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164706445|NCT02393248|594953417|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164706446|NCT02393248|594953418|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164706447|NCT02393248|594953419|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164450677|NCT03398148|594019636|FG009|Substudy 1 Period 2|Adverse Event|0|||
164450678|NCT03398148|594019637|FG010|Substudy 1 Period 2|Adverse Event|0|||
164450679|NCT03398148|594019638|FG011|Substudy 1 Period 2|Adverse Event|0|||
164450680|NCT03398148|594019639|FG012|Substudy 1 Period 2|Adverse Event|0|||
164450681|NCT03398148|594019640|FG013|Substudy 1 Period 2|Adverse Event|0|||
164450682|NCT03398148|594019641|FG014|Substudy 1 Period 2|Adverse Event|0|||
164450683|NCT03398148|594019627|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
164450684|NCT03398148|594019628|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
164450685|NCT03398148|594019629|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
164450686|NCT03398148|594019630|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
164450687|NCT03398148|594019631|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
164450688|NCT03398148|594019632|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
164450689|NCT03398148|594019633|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
164450690|NCT03398148|594019634|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
164450691|NCT03398148|594019635|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
164450692|NCT03398148|594019636|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
164450693|NCT03398148|594019637|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
164450694|NCT03398148|594019638|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
164450695|NCT03398148|594019639|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
164450696|NCT03398148|594019640|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
164450697|NCT03398148|594019641|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
164450698|NCT03398148|594019627|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
164450699|NCT03398148|594019628|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
164450700|NCT03398148|594019629|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
164450701|NCT03398148|594019630|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
164450702|NCT03398148|594019631|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
164450703|NCT03398148|594019632|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
164450704|NCT03398148|594019633|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
164450705|NCT03398148|594019634|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
164450706|NCT03398148|594019635|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
164450707|NCT03398148|594019636|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
164450708|NCT03398148|594019637|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
164450709|NCT03398148|594019638|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
164450710|NCT03398148|594019639|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
164450711|NCT03398148|594019640|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
164450712|NCT03398148|594019641|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
164450713|NCT03398148|594019627|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450714|NCT03398148|594019628|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450715|NCT03398148|594019629|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450716|NCT03398148|594019630|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450717|NCT03398148|594019631|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450718|NCT03398148|594019632|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450719|NCT03398148|594019633|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
164450720|NCT03398148|594019634|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450721|NCT03398148|594019635|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164706448|NCT02393248|594953420|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164450722|NCT03398148|594019636|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450723|NCT03398148|594019637|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450724|NCT03398148|594019638|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450725|NCT03398148|594019639|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450726|NCT03398148|594019640|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450727|NCT03398148|594019641|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450728|NCT03398148|594019627|FG000|Substudy 1 Period 2|Other|0|||
164450729|NCT03398148|594019628|FG001|Substudy 1 Period 2|Other|0|||
164450730|NCT03398148|594019629|FG002|Substudy 1 Period 2|Other|0|||
164450731|NCT03398148|594019630|FG003|Substudy 1 Period 2|Other|0|||
164450732|NCT03398148|594019631|FG004|Substudy 1 Period 2|Other|0|||
164450733|NCT03398148|594019632|FG005|Substudy 1 Period 2|Other|0|||
164450734|NCT03398148|594019633|FG006|Substudy 1 Period 2|Other|1|||
164450735|NCT03398148|594019634|FG007|Substudy 1 Period 2|Other|0|||
164450736|NCT03398148|594019635|FG008|Substudy 1 Period 2|Other|0|||
164450737|NCT03398148|594019636|FG009|Substudy 1 Period 2|Other|0|||
164450738|NCT03398148|594019637|FG010|Substudy 1 Period 2|Other|0|||
164450739|NCT03398148|594019638|FG011|Substudy 1 Period 2|Other|0|||
164450740|NCT03398148|594019639|FG012|Substudy 1 Period 2|Other|0|||
164450741|NCT03398148|594019640|FG013|Substudy 1 Period 2|Other|0|||
164450742|NCT03398148|594019641|FG014|Substudy 1 Period 2|Other|0|||
164450743|NCT03398148|594019627|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
164450744|NCT03398148|594019628|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
164450745|NCT03398148|594019629|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
164450746|NCT03398148|594019630|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
164450747|NCT03398148|594019631|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
164450748|NCT03398148|594019632|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
164450749|NCT03398148|594019633|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
164450750|NCT03398148|594019634|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
164450751|NCT03398148|594019635|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
164450752|NCT03398148|594019636|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
164450753|NCT03398148|594019637|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
164450754|NCT03398148|594019638|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
164450755|NCT03398148|594019639|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
164450756|NCT03398148|594019640|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
164450757|NCT03398148|594019641|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
164450758|NCT03398148|594019627|FG000|Substudy 2 Period 1|Adverse Event|0|||
164450759|NCT03398148|594019628|FG001|Substudy 2 Period 1|Adverse Event|0|||
164450760|NCT03398148|594019629|FG002|Substudy 2 Period 1|Adverse Event|0|||
164450761|NCT03398148|594019630|FG003|Substudy 2 Period 1|Adverse Event|0|||
164450762|NCT03398148|594019631|FG004|Substudy 2 Period 1|Adverse Event|0|||
164450763|NCT03398148|594019632|FG005|Substudy 2 Period 1|Adverse Event|0|||
164450764|NCT03398148|594019633|FG006|Substudy 2 Period 1|Adverse Event|0|||
164450765|NCT03398148|594019634|FG007|Substudy 2 Period 1|Adverse Event|0|||
164450766|NCT03398148|594019635|FG008|Substudy 2 Period 1|Adverse Event|0|||
164450767|NCT03398148|594019636|FG009|Substudy 2 Period 1|Adverse Event|12|||
164450768|NCT03398148|594019637|FG010|Substudy 2 Period 1|Adverse Event|2|||
164450769|NCT03398148|594019638|FG011|Substudy 2 Period 1|Adverse Event|0|||
164450770|NCT03398148|594019639|FG012|Substudy 2 Period 1|Adverse Event|0|||
164450771|NCT03398148|594019640|FG013|Substudy 2 Period 1|Adverse Event|0|||
164450772|NCT03398148|594019641|FG014|Substudy 2 Period 1|Adverse Event|0|||
164450773|NCT03398148|594019627|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
164450774|NCT03398148|594019628|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
164450775|NCT03398148|594019629|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
164450776|NCT03398148|594019630|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
164450777|NCT03398148|594019631|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
164450778|NCT03398148|594019632|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
164450779|NCT03398148|594019633|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
164450780|NCT03398148|594019634|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
164450781|NCT03398148|594019635|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
164450782|NCT03398148|594019636|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
164450783|NCT03398148|594019637|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
164450784|NCT03398148|594019638|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
164450785|NCT03398148|594019639|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
164450786|NCT03398148|594019640|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
164450787|NCT03398148|594019641|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
164450788|NCT03398148|594019627|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
164450789|NCT03398148|594019628|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
164450790|NCT03398148|594019629|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
164450791|NCT03398148|594019630|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
164450792|NCT03398148|594019631|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
164450793|NCT03398148|594019632|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
164450794|NCT03398148|594019633|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
164450795|NCT03398148|594019634|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
164597151|NCT02052778|594549004|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164597152|NCT02052778|594549005|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164597153|NCT02052778|594549006|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164597154|NCT02052778|594549007|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164597155|NCT02052778|594549008|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164597156|NCT02052778|594549009|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164597157|NCT02052778|594549010|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164450796|NCT03398148|594019635|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
164450797|NCT03398148|594019636|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
164450798|NCT03398148|594019637|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
164450799|NCT03398148|594019638|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
164450800|NCT03398148|594019639|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
164450801|NCT03398148|594019640|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
164450802|NCT03398148|594019641|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
164450803|NCT03398148|594019627|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
164450804|NCT03398148|594019628|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
164450805|NCT03398148|594019629|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
164450806|NCT03398148|594019630|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
164450807|NCT03398148|594019631|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
164597158|NCT02052778|594549011|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164597159|NCT02052778|594549012|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164706449|NCT02393248|594953421|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164706450|NCT02393248|594953422|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164706451|NCT02393248|594953423|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164706452|NCT02393248|594953424|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
164706453|NCT02393248|594953425|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
164706454|NCT02393248|594953426|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164706455|NCT02393248|594953427|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164706456|NCT02393248|594953428|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164404715|NCT01728792|593853784|FG001|Overall Study|Lost to Follow-up|1|||
164404716|NCT01728792|593853785|FG002|Overall Study|Lost to Follow-up|4|||
164404717|NCT01728792|593853786|FG003|Overall Study|Lost to Follow-up|2|||
164404718|NCT01728792|593853787|FG004|Overall Study|Lost to Follow-up|0|||
164404719|NCT00514683|593853789|FG000|Overall Study|Not treated|2|||
164404720|NCT00514683|593853790|FG001|Overall Study|Not treated|1|||
164404721|NCT00514683|593853791|FG002|Overall Study|Not treated|0|||
164404722|NCT00514683|593853792|FG003|Overall Study|Not treated|0|||
164404723|NCT00514683|593853793|FG004|Overall Study|Not treated|1|||
164404724|NCT00514683|593853789|FG000|Overall Study|Adverse Event|21|||
164404725|NCT00514683|593853790|FG001|Overall Study|Adverse Event|20|||
164404726|NCT00514683|593853791|FG002|Overall Study|Adverse Event|15|||
164404727|NCT00514683|593853792|FG003|Overall Study|Adverse Event|13|||
164404728|NCT00514683|593853793|FG004|Overall Study|Adverse Event|27|||
164404729|NCT00514683|593853789|FG000|Overall Study|Protocol Violation|1|||
164404730|NCT00514683|593853790|FG001|Overall Study|Protocol Violation|1|||
164404731|NCT00514683|593853791|FG002|Overall Study|Protocol Violation|0|||
164404732|NCT00514683|593853792|FG003|Overall Study|Protocol Violation|1|||
164404733|NCT00514683|593853793|FG004|Overall Study|Protocol Violation|0|||
164404734|NCT00514683|593853789|FG000|Overall Study|Withdrawal by Subject|2|||
164404735|NCT00514683|593853790|FG001|Overall Study|Withdrawal by Subject|2|||
164404736|NCT00514683|593853791|FG002|Overall Study|Withdrawal by Subject|1|||
164404737|NCT00514683|593853792|FG003|Overall Study|Withdrawal by Subject|0|||
164404738|NCT00514683|593853793|FG004|Overall Study|Withdrawal by Subject|4|||
164404739|NCT00514683|593853789|FG000|Overall Study|Reason other than listed above|0|||
164404740|NCT00514683|593853790|FG001|Overall Study|Reason other than listed above|1|||
164404741|NCT00514683|593853791|FG002|Overall Study|Reason other than listed above|2|||
164404742|NCT00514683|593853792|FG003|Overall Study|Reason other than listed above|0|||
164404743|NCT00514683|593853793|FG004|Overall Study|Reason other than listed above|1|||
164404744|NCT03953898|593853794|FG000|Overall Study|Lack of Efficacy|8|||
164404745|NCT03953898|593853794|FG000|Overall Study|Death|3|||
164404746|NCT03953898|593853794|FG000|Overall Study|Withdrawal by Subject|2|||
164404747|NCT03953898|593853794|FG000|Overall Study|Adverse Event|1|||
164404748|NCT00643123|593853795|FG000|Overall Study|Lost to Follow-up|4|||
164404749|NCT00643123|593853796|FG001|Overall Study|Lost to Follow-up|0|||
164404750|NCT00643123|593853795|FG000|Overall Study|Withdrawal by Subject|1|||
164404751|NCT00643123|593853796|FG001|Overall Study|Withdrawal by Subject|1|||
164404752|NCT02436811|593853797|FG000|Overall Study|Lost to Follow-up|2|||
164404753|NCT02436811|593853798|FG001|Overall Study|Lost to Follow-up|9|||
164404754|NCT02436811|593853799|FG002|Overall Study|Lost to Follow-up|7|||
164404755|NCT02856113|593853800|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
164404756|NCT02856113|593853801|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
164404757|NCT02856113|593853800|FG000|Overall Study|Significant Protocol Deviation|1|||
164404758|NCT02856113|593853801|FG001|Overall Study|Significant Protocol Deviation|0|||
164404759|NCT02856113|593853800|FG000|Overall Study|Lost to Follow-up|3|||
164404760|NCT02856113|593853801|FG001|Overall Study|Lost to Follow-up|5|||
164404761|NCT02856113|593853800|FG000|Overall Study|Voluntary Withdrawal|3|||
164404762|NCT02856113|593853801|FG001|Overall Study|Voluntary Withdrawal|5|||
164404763|NCT02856113|593853800|FG000|Overall Study|Pregnancy|0|||
164404764|NCT02856113|593853801|FG001|Overall Study|Pregnancy|1|||
164404765|NCT02856113|593853800|FG000|Overall Study|Principal Investigator Discretion|2|||
164404766|NCT02856113|593853801|FG001|Overall Study|Principal Investigator Discretion|1|||
164404767|NCT02856113|593853800|FG000|Overall Study|Randomized but not Treated|1|||
164404768|NCT02856113|593853801|FG001|Overall Study|Randomized but not Treated|0|||
164706457|NCT02393248|594953429|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164706458|NCT02393248|594953430|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164404769|NCT02856113|593853800|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
164404770|NCT02856113|593853801|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
164404771|NCT03494166|593853802|FG000|Overall Study|Death|0|||
164404772|NCT03494166|593853803|FG001|Overall Study|Death|0|||
164404773|NCT03494166|593853804|FG002|Overall Study|Death|0|||
164404774|NCT03494166|593853805|FG003|Overall Study|Death|1|||
164404775|NCT03494166|593853806|FG004|Overall Study|Death|3|||
164404776|NCT03494166|593853807|FG005|Overall Study|Death|0|||
164404777|NCT03494166|593853802|FG000|Overall Study|Lost to Follow-up|2|||
164404778|NCT03494166|593853803|FG001|Overall Study|Lost to Follow-up|2|||
164404779|NCT03494166|593853804|FG002|Overall Study|Lost to Follow-up|2|||
164404780|NCT03494166|593853805|FG003|Overall Study|Lost to Follow-up|2|||
164597160|NCT02052778|594549013|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164597161|NCT02052778|594549014|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164597162|NCT02052778|594549015|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
164597163|NCT02052778|594548993|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164404781|NCT03494166|593853806|FG004|Overall Study|Lost to Follow-up|14|||
164404782|NCT03494166|593853807|FG005|Overall Study|Lost to Follow-up|0|||
164404783|NCT03494166|593853802|FG000|Overall Study|Withdrawal by Subject|10|||
164404784|NCT03494166|593853803|FG001|Overall Study|Withdrawal by Subject|7|||
164404785|NCT03494166|593853804|FG002|Overall Study|Withdrawal by Subject|0|||
164404786|NCT03494166|593853805|FG003|Overall Study|Withdrawal by Subject|5|||
164404787|NCT03494166|593853806|FG004|Overall Study|Withdrawal by Subject|3|||
164404788|NCT03494166|593853807|FG005|Overall Study|Withdrawal by Subject|17|||
164404789|NCT03494166|593853802|FG000|Overall Study|Screen failure|1|||
164404790|NCT03494166|593853803|FG001|Overall Study|Screen failure|0|||
164404791|NCT03494166|593853804|FG002|Overall Study|Screen failure|0|||
164404792|NCT03494166|593853805|FG003|Overall Study|Screen failure|0|||
164404793|NCT03494166|593853806|FG004|Overall Study|Screen failure|1|||
164404794|NCT03494166|593853807|FG005|Overall Study|Screen failure|0|||
164404795|NCT02110901|593853809|FG000|Overall Study|Death|6|||
164404796|NCT02110901|593853810|FG001|Overall Study|Death|3|||
164404797|NCT02110901|593853809|FG000|Overall Study|Lost to Follow-up|12|||
164404798|NCT02110901|593853810|FG001|Overall Study|Lost to Follow-up|8|||
164404799|NCT02110901|593853809|FG000|Overall Study|Withdrawal by Subject|7|||
164404800|NCT02110901|593853810|FG001|Overall Study|Withdrawal by Subject|3|||
164404801|NCT02110901|593853809|FG000|Overall Study|received a kidney transplant|5|||
164404802|NCT02110901|593853810|FG001|Overall Study|received a kidney transplant|0|||
164404803|NCT00855595|593853812|FG000|Overall Study|Withdrawal by Subject|1|||
164404804|NCT00855595|593853813|FG001|Overall Study|Withdrawal by Subject|2|||
164404805|NCT00855595|593853812|FG000|Overall Study|Lost to Follow-up|3|||
164404806|NCT00855595|593853813|FG001|Overall Study|Lost to Follow-up|3|||
164404807|NCT00855595|593853812|FG000|Overall Study|Adverse Event|1|||
164404808|NCT00855595|593853813|FG001|Overall Study|Adverse Event|1|||
164404809|NCT00855595|593853812|FG000|Overall Study|patient moved out of state|1|||
164404810|NCT00855595|593853813|FG001|Overall Study|patient moved out of state|0|||
164404811|NCT00855595|593853812|FG000|Overall Study|patient left country|0|||
164404812|NCT00855595|593853813|FG001|Overall Study|patient left country|1|||
164404813|NCT01058304|593853815|FG000|Overall Study|Withdrawal by Subject|8|||
164404814|NCT01058304|593853816|FG001|Overall Study|Withdrawal by Subject|5|||
164404815|NCT01058304|593853815|FG000|Overall Study|Lost to Follow-up|13|||
164404816|NCT01058304|593853816|FG001|Overall Study|Lost to Follow-up|16|||
164404817|NCT01058304|593853815|FG000|Overall Study|Developed exclusion criterion|6|||
164404818|NCT01058304|593853816|FG001|Overall Study|Developed exclusion criterion|12|||
164404819|NCT01820559|593853817|FG000|Overall Study|Adverse Event|4|||
164404820|NCT01820559|593853818|FG001|Overall Study|Adverse Event|6|||
164404821|NCT01820559|593853819|FG002|Overall Study|Adverse Event|13|||
164404822|NCT01820559|593853817|FG000|Overall Study|Withdrawal by Subject|1|||
164404823|NCT01820559|593853818|FG001|Overall Study|Withdrawal by Subject|2|||
164404824|NCT01820559|593853819|FG002|Overall Study|Withdrawal by Subject|5|||
164404825|NCT01820559|593853817|FG000|Overall Study|Protocol Violation|2|||
164404826|NCT01820559|593853818|FG001|Overall Study|Protocol Violation|1|||
164404827|NCT01820559|593853819|FG002|Overall Study|Protocol Violation|3|||
164404828|NCT01820559|593853817|FG000|Overall Study|Subject's non-compliance|1|||
164404829|NCT01820559|593853818|FG001|Overall Study|Subject's non-compliance|0|||
164404830|NCT01820559|593853819|FG002|Overall Study|Subject's non-compliance|2|||
164404831|NCT01820559|593853817|FG000|Overall Study|Lost to Follow-up|3|||
164404832|NCT01820559|593853818|FG001|Overall Study|Lost to Follow-up|2|||
164404833|NCT01820559|593853819|FG002|Overall Study|Lost to Follow-up|2|||
164404834|NCT01820559|593853817|FG000|Overall Study|At sponsor request|0|||
164404835|NCT01820559|593853818|FG001|Overall Study|At sponsor request|0|||
164404836|NCT01820559|593853819|FG002|Overall Study|At sponsor request|1|||
164404837|NCT01820559|593853817|FG000|Overall Study|Lack of Efficacy|3|||
164404838|NCT01820559|593853818|FG001|Overall Study|Lack of Efficacy|2|||
164404839|NCT01820559|593853819|FG002|Overall Study|Lack of Efficacy|3|||
164404840|NCT02496767|593853820|FG000|Open-label Lead-in Phase|Adverse Event|176|||
164404841|NCT02496767|593853821|FG001|Open-label Lead-in Phase|Adverse Event|0|||
164404842|NCT02496767|593853822|FG002|Open-label Lead-in Phase|Adverse Event|0|||
164404843|NCT02496767|593853823|FG003|Open-label Lead-in Phase|Adverse Event|0|||
164404844|NCT02496767|593853824|FG004|Open-label Lead-in Phase|Adverse Event|0|||
164404845|NCT02496767|593853825|FG005|Open-label Lead-in Phase|Adverse Event|0|||
164404846|NCT02496767|593853826|FG006|Open-label Lead-in Phase|Adverse Event|0|||
164404847|NCT02496767|593853827|FG007|Open-label Lead-in Phase|Adverse Event|0|||
164404848|NCT02496767|593853820|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
164404849|NCT02496767|593853821|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
164404850|NCT02496767|593853822|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
164404851|NCT02496767|593853823|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
164404852|NCT02496767|593853824|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
164450808|NCT03398148|594019632|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
164450809|NCT03398148|594019633|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
164450810|NCT03398148|594019634|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
164450811|NCT03398148|594019635|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
164450812|NCT03398148|594019636|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
164450813|NCT03398148|594019637|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
164450814|NCT03398148|594019638|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
164450815|NCT03398148|594019639|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
164450816|NCT03398148|594019640|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
164450817|NCT03398148|594019641|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
164450818|NCT03398148|594019627|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450819|NCT03398148|594019628|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450820|NCT03398148|594019629|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450821|NCT03398148|594019630|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450822|NCT03398148|594019631|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450823|NCT03398148|594019632|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450824|NCT03398148|594019633|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450825|NCT03398148|594019634|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450826|NCT03398148|594019635|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450827|NCT03398148|594019636|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450828|NCT03398148|594019637|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
164450829|NCT03398148|594019638|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450830|NCT03398148|594019639|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450831|NCT03398148|594019640|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450832|NCT03398148|594019641|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164450833|NCT03398148|594019627|FG000|Substudy 2 Period 1|Other|0|||
164450834|NCT03398148|594019628|FG001|Substudy 2 Period 1|Other|0|||
164450835|NCT03398148|594019629|FG002|Substudy 2 Period 1|Other|0|||
164450836|NCT03398148|594019630|FG003|Substudy 2 Period 1|Other|0|||
164450837|NCT03398148|594019631|FG004|Substudy 2 Period 1|Other|0|||
164450838|NCT03398148|594019632|FG005|Substudy 2 Period 1|Other|0|||
164450839|NCT03398148|594019633|FG006|Substudy 2 Period 1|Other|0|||
164450840|NCT03398148|594019634|FG007|Substudy 2 Period 1|Other|0|||
164450841|NCT03398148|594019635|FG008|Substudy 2 Period 1|Other|0|||
164450842|NCT03398148|594019636|FG009|Substudy 2 Period 1|Other|4|||
164450843|NCT03398148|594019637|FG010|Substudy 2 Period 1|Other|4|||
164450844|NCT03398148|594019638|FG011|Substudy 2 Period 1|Other|0|||
164450845|NCT03398148|594019639|FG012|Substudy 2 Period 1|Other|0|||
164450846|NCT03398148|594019640|FG013|Substudy 2 Period 1|Other|0|||
164450847|NCT03398148|594019641|FG014|Substudy 2 Period 1|Other|0|||
164450848|NCT03398148|594019627|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
164450849|NCT03398148|594019628|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
164450850|NCT03398148|594019629|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
164450851|NCT03398148|594019630|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
164450852|NCT03398148|594019631|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
164450853|NCT03398148|594019632|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
164450854|NCT03398148|594019633|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
164450855|NCT03398148|594019634|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
164450856|NCT03398148|594019635|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
164450857|NCT03398148|594019636|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
164450858|NCT03398148|594019637|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
164450859|NCT03398148|594019638|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
164450860|NCT03398148|594019639|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
164450861|NCT03398148|594019640|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
164450862|NCT03398148|594019641|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
164450863|NCT03398148|594019627|FG000|Substudy 2 Period 2|Adverse Event|0|||
164450864|NCT03398148|594019628|FG001|Substudy 2 Period 2|Adverse Event|0|||
164450865|NCT03398148|594019629|FG002|Substudy 2 Period 2|Adverse Event|0|||
164450866|NCT03398148|594019630|FG003|Substudy 2 Period 2|Adverse Event|0|||
164450867|NCT03398148|594019631|FG004|Substudy 2 Period 2|Adverse Event|0|||
164450868|NCT03398148|594019632|FG005|Substudy 2 Period 2|Adverse Event|0|||
164450869|NCT03398148|594019633|FG006|Substudy 2 Period 2|Adverse Event|0|||
164450870|NCT03398148|594019634|FG007|Substudy 2 Period 2|Adverse Event|0|||
164450871|NCT03398148|594019635|FG008|Substudy 2 Period 2|Adverse Event|0|||
164450872|NCT03398148|594019636|FG009|Substudy 2 Period 2|Adverse Event|0|||
164450873|NCT03398148|594019637|FG010|Substudy 2 Period 2|Adverse Event|0|||
164450874|NCT03398148|594019638|FG011|Substudy 2 Period 2|Adverse Event|0|||
164450875|NCT03398148|594019639|FG012|Substudy 2 Period 2|Adverse Event|0|||
164450876|NCT03398148|594019640|FG013|Substudy 2 Period 2|Adverse Event|1|||
164450877|NCT03398148|594019641|FG014|Substudy 2 Period 2|Adverse Event|3|||
164450878|NCT03398148|594019627|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
164450879|NCT03398148|594019628|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
164450880|NCT03398148|594019629|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
164450881|NCT03398148|594019630|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
164450882|NCT03398148|594019631|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
164450883|NCT03398148|594019632|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
164450884|NCT03398148|594019633|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
164450885|NCT03398148|594019634|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
164450886|NCT03398148|594019635|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
164450887|NCT03398148|594019636|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
164450888|NCT03398148|594019637|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
164450889|NCT03398148|594019638|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
164450890|NCT03398148|594019639|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
164450891|NCT03398148|594019640|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
164450892|NCT03398148|594019641|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
164450893|NCT03398148|594019627|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
164450894|NCT03398148|594019628|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
164450895|NCT03398148|594019629|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
164450896|NCT03398148|594019630|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
164450897|NCT03398148|594019631|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
164450898|NCT03398148|594019632|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
164450899|NCT03398148|594019633|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
164450900|NCT03398148|594019634|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
164450901|NCT03398148|594019635|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
164450902|NCT03398148|594019636|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
164450903|NCT03398148|594019637|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
164450904|NCT03398148|594019638|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
164450905|NCT03398148|594019639|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
164450906|NCT03398148|594019640|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
164450907|NCT03398148|594019641|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
164450908|NCT03398148|594019627|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
164450909|NCT03398148|594019628|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
164450910|NCT03398148|594019629|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
164450911|NCT03398148|594019630|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
164450912|NCT03398148|594019631|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
164450913|NCT03398148|594019632|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
164450914|NCT03398148|594019633|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
164450915|NCT03398148|594019634|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
164450916|NCT03398148|594019635|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
164450917|NCT03398148|594019636|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
164450918|NCT03398148|594019637|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
164450919|NCT03398148|594019638|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
164450920|NCT03398148|594019639|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
164450921|NCT03398148|594019640|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
164450922|NCT03398148|594019641|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
164450923|NCT03398148|594019627|FG000|Substudy 2 Period 2|Other|0|||
164450924|NCT03398148|594019628|FG001|Substudy 2 Period 2|Other|0|||
164450925|NCT03398148|594019629|FG002|Substudy 2 Period 2|Other|0|||
164450926|NCT03398148|594019630|FG003|Substudy 2 Period 2|Other|0|||
164450927|NCT03398148|594019631|FG004|Substudy 2 Period 2|Other|0|||
164450928|NCT03398148|594019632|FG005|Substudy 2 Period 2|Other|0|||
164450929|NCT03398148|594019633|FG006|Substudy 2 Period 2|Other|0|||
164450930|NCT03398148|594019634|FG007|Substudy 2 Period 2|Other|0|||
164450931|NCT03398148|594019635|FG008|Substudy 2 Period 2|Other|0|||
164450932|NCT03398148|594019636|FG009|Substudy 2 Period 2|Other|0|||
164450933|NCT03398148|594019637|FG010|Substudy 2 Period 2|Other|0|||
164450934|NCT03398148|594019638|FG011|Substudy 2 Period 2|Other|0|||
164450935|NCT03398148|594019639|FG012|Substudy 2 Period 2|Other|0|||
164450936|NCT03398148|594019640|FG013|Substudy 2 Period 2|Other|1|||
164450937|NCT03398148|594019641|FG014|Substudy 2 Period 2|Other|1|||
164450938|NCT03398148|594019627|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
164450939|NCT03398148|594019628|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
164450940|NCT03398148|594019629|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
164450941|NCT03398148|594019630|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
164450942|NCT03398148|594019631|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
164450943|NCT03398148|594019632|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
164450944|NCT03398148|594019633|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
164450945|NCT03398148|594019634|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
164450946|NCT03398148|594019635|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
164450947|NCT03398148|594019636|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
164450948|NCT03398148|594019637|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
164450949|NCT03398148|594019638|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
164450950|NCT03398148|594019639|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
164450951|NCT03398148|594019640|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
164450952|NCT03398148|594019641|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
164450953|NCT01259401|594019642|FG000|4-month Follow-up|Death|0|||
164450954|NCT01259401|594019643|FG001|4-month Follow-up|Death|1|||
164450955|NCT01259401|594019642|FG000|4-month Follow-up|Lost to Follow-up|0|||
164450956|NCT01259401|594019643|FG001|4-month Follow-up|Lost to Follow-up|1|||
164450957|NCT00212355|594019644|FG000|Overall Study|Adverse Event|1|||
164450958|NCT00212355|594019644|FG000|Overall Study|Withdrawal by Subject|1|||
164450959|NCT00212355|594019644|FG000|Overall Study|A change of address|1|||
164706459|NCT02393248|594953431|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164404853|NCT02496767|593853825|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
164404854|NCT02496767|593853826|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
164404855|NCT02496767|593853827|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
164404856|NCT02496767|593853820|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
164404857|NCT02496767|593853821|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
164404858|NCT02496767|593853822|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
164404859|NCT02496767|593853823|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
164404860|NCT02496767|593853824|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
164404861|NCT02496767|593853825|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
164404862|NCT02496767|593853826|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
164404863|NCT02496767|593853827|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
164404864|NCT02496767|593853820|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
164404865|NCT02496767|593853821|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
164404866|NCT02496767|593853822|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
164404867|NCT02496767|593853823|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
164404868|NCT02496767|593853824|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
164404869|NCT02496767|593853825|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
164404870|NCT02496767|593853826|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
164404871|NCT02496767|593853827|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
164404872|NCT02496767|593853820|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
164404873|NCT02496767|593853821|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
164404874|NCT02496767|593853822|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
164404875|NCT02496767|593853823|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
164404876|NCT02496767|593853824|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
164404877|NCT02496767|593853825|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
164404878|NCT02496767|593853826|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
164404879|NCT02496767|593853827|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
164404880|NCT02496767|593853820|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
164404881|NCT02496767|593853821|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
164404882|NCT02496767|593853822|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
164404883|NCT02496767|593853823|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
164404884|NCT02496767|593853824|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
164404885|NCT02496767|593853825|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
164404886|NCT02496767|593853826|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
164404887|NCT02496767|593853827|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
164404888|NCT02496767|593853820|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
164404889|NCT02496767|593853821|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
164404890|NCT02496767|593853822|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
164404891|NCT02496767|593853823|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
164404892|NCT02496767|593853824|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
164404893|NCT02496767|593853825|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
164404894|NCT02496767|593853826|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
164404895|NCT02496767|593853827|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
164404896|NCT02496767|593853820|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
164404897|NCT02496767|593853821|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
164404898|NCT02496767|593853822|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
164404899|NCT02496767|593853823|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
164404900|NCT02496767|593853824|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
164404901|NCT02496767|593853825|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
164404902|NCT02496767|593853826|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
164404903|NCT02496767|593853827|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
164404904|NCT02496767|593853820|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
164404905|NCT02496767|593853821|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
164404906|NCT02496767|593853822|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
164404907|NCT02496767|593853823|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
164404908|NCT02496767|593853824|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
164404909|NCT02496767|593853825|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
164404910|NCT02496767|593853826|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
164404911|NCT02496767|593853827|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
164404912|NCT02496767|593853820|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
164450960|NCT00186992|594019647|FG000|Overall Study|Withdrawal by Subject|5|||
164706460|NCT02393248|594953432|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164706461|NCT02393248|594953433|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164706462|NCT02393248|594953434|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164404913|NCT02496767|593853821|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
164706463|NCT02393248|594953435|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164706464|NCT02393248|594953436|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164706465|NCT02393248|594953437|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164706466|NCT02393248|594953438|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164706467|NCT02393248|594953414|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
164706468|NCT02393248|594953415|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
164706469|NCT02393248|594953416|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
164706470|NCT02393248|594953417|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
164706471|NCT02393248|594953418|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
164706472|NCT02393248|594953419|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
164404914|NCT02496767|593853822|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
164404915|NCT02496767|593853823|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
164404916|NCT02496767|593853824|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
164404917|NCT02496767|593853825|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
164404918|NCT02496767|593853826|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
164404919|NCT02496767|593853827|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
164404920|NCT02496767|593853820|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
164404921|NCT02496767|593853821|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
164404922|NCT02496767|593853822|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
164404923|NCT02496767|593853823|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
164404924|NCT02496767|593853824|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
164404925|NCT02496767|593853825|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
164404926|NCT02496767|593853826|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
164404927|NCT02496767|593853827|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
164404928|NCT02496767|593853820|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
164404929|NCT02496767|593853821|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
164404930|NCT02496767|593853822|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
164404931|NCT02496767|593853823|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
164404932|NCT02496767|593853824|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
164404933|NCT02496767|593853825|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
164404934|NCT02496767|593853826|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
164404935|NCT02496767|593853827|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
164404936|NCT02496767|593853820|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
164404937|NCT02496767|593853821|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
164404938|NCT02496767|593853822|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
164404939|NCT02496767|593853823|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
164404940|NCT02496767|593853824|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
164404941|NCT02496767|593853825|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
164404942|NCT02496767|593853826|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
164404943|NCT02496767|593853827|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
164404944|NCT02496767|593853820|FG000|Double-blind, Withdrawal Phase|Death|0|||
164404945|NCT02496767|593853821|FG001|Double-blind, Withdrawal Phase|Death|0|||
164404946|NCT02496767|593853822|FG002|Double-blind, Withdrawal Phase|Death|0|||
164404947|NCT02496767|593853823|FG003|Double-blind, Withdrawal Phase|Death|0|||
164404948|NCT02496767|593853824|FG004|Double-blind, Withdrawal Phase|Death|0|||
164404949|NCT02496767|593853825|FG005|Double-blind, Withdrawal Phase|Death|0|||
164404950|NCT02496767|593853826|FG006|Double-blind, Withdrawal Phase|Death|1|||
164404951|NCT02496767|593853827|FG007|Double-blind, Withdrawal Phase|Death|2|||
164404952|NCT02496767|593853820|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
164404953|NCT02496767|593853821|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
164404954|NCT02496767|593853822|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
164404955|NCT02496767|593853823|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
164404956|NCT02496767|593853824|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
164404957|NCT02496767|593853825|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
164404958|NCT02496767|593853826|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
164404959|NCT02496767|593853827|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
164404960|NCT00166296|593853828|FG000|Overall Study|Withdrawal by Subject|1|||
164404961|NCT00166296|593853829|FG001|Overall Study|Withdrawal by Subject|3|||
164404962|NCT00166296|593853828|FG000|Overall Study|Adverse Event|2|||
164404963|NCT00166296|593853829|FG001|Overall Study|Adverse Event|4|||
164404964|NCT00166296|593853828|FG000|Overall Study|Lost to Follow-up|4|||
164706473|NCT02393248|594953420|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
164404965|NCT00166296|593853829|FG001|Overall Study|Lost to Follow-up|2|||
164404966|NCT04035200|593853835|FG000|Overall Study|Lost to Follow-up|0|||
164404967|NCT04035200|593853836|FG001|Overall Study|Lost to Follow-up|1|||
164404968|NCT04035200|593853837|FG002|Overall Study|Lost to Follow-up|0|||
164404969|NCT04035200|593853835|FG000|Overall Study|Withdrawal by Subject|1|||
164404970|NCT04035200|593853836|FG001|Overall Study|Withdrawal by Subject|4|||
164450961|NCT00186992|594019647|FG000|Overall Study|Physician's discretion|13|||
164706474|NCT02393248|594953421|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
164706475|NCT02393248|594953422|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
164706476|NCT02393248|594953423|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
164706477|NCT02393248|594953424|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
164706478|NCT02393248|594953425|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
164706479|NCT02393248|594953426|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
164706480|NCT02393248|594953427|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
164706481|NCT02393248|594953428|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
164706482|NCT02393248|594953429|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
164706483|NCT02393248|594953430|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
164706484|NCT02393248|594953431|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
164706485|NCT02393248|594953432|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
164706486|NCT02393248|594953433|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
164706487|NCT02393248|594953434|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
164706488|NCT02393248|594953435|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
164706489|NCT02393248|594953436|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
164706490|NCT02393248|594953437|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
164450962|NCT00186992|594019647|FG000|Overall Study|PI Discretion|4|||
164450963|NCT00186992|594019647|FG000|Overall Study|Ineligible|2|||
164450964|NCT00186992|594019647|FG000|Overall Study|Lost to Follow-up|2|||
164450965|NCT00186992|594019647|FG000|Overall Study|Still on Study|9|||
164450966|NCT05644002|594019650|FG000|Overall Study|Lost to Follow-up|1|||
164706491|NCT02393248|594953438|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
164706492|NCT02393248|594953414|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164404971|NCT04035200|593853837|FG002|Overall Study|Withdrawal by Subject|4|||
164404972|NCT04035200|593853835|FG000|Overall Study|COVID-19|1|||
164404973|NCT04035200|593853836|FG001|Overall Study|COVID-19|0|||
164404974|NCT04035200|593853837|FG002|Overall Study|COVID-19|0|||
164404975|NCT04035200|593853835|FG000|Overall Study|Early Termination|0|||
164404976|NCT04035200|593853836|FG001|Overall Study|Early Termination|1|||
164404977|NCT04035200|593853837|FG002|Overall Study|Early Termination|0|||
164404978|NCT04035200|593853835|FG000|Overall Study|Non-compliance|0|||
164404979|NCT04035200|593853836|FG001|Overall Study|Non-compliance|1|||
164404980|NCT04035200|593853837|FG002|Overall Study|Non-compliance|0|||
164404981|NCT02277990|593853838|FG000|Overall Study|Death|170|||
164404982|NCT02277990|593853839|FG001|Overall Study|Death|188|||
164404983|NCT02277990|593853838|FG000|Overall Study|Withdrawal by Subject|64|||
164404984|NCT02277990|593853839|FG001|Overall Study|Withdrawal by Subject|53|||
164404985|NCT02277990|593853838|FG000|Overall Study|Physician Decision|40|||
164404986|NCT02277990|593853839|FG001|Overall Study|Physician Decision|34|||
164404987|NCT02277990|593853838|FG000|Overall Study|Lost to Follow-up|66|||
164404988|NCT02277990|593853839|FG001|Overall Study|Lost to Follow-up|69|||
164404989|NCT02277990|593853838|FG000|Overall Study|Had other reason|26|||
164404990|NCT02277990|593853839|FG001|Overall Study|Had other reason|32|||
164404991|NCT04581200|593853840|FG000|Overall Study|Lost to Follow-up|6|||
164404992|NCT04581200|593853841|FG001|Overall Study|Lost to Follow-up|5|||
164404993|NCT04711603|593853842|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
164404994|NCT04711603|593853843|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
164404995|NCT04711603|593853844|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
164404996|NCT04711603|593853845|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
164404997|NCT04711603|593853842|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
164404998|NCT04711603|593853843|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
164404999|NCT04711603|593853844|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
164405000|NCT04711603|593853845|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
164405001|NCT04711603|593853842|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
164405002|NCT04711603|593853843|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
164405003|NCT04711603|593853844|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
164405004|NCT04711603|593853845|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
164405005|NCT04711603|593853842|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
164405006|NCT04711603|593853843|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
164405007|NCT04711603|593853844|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
164405008|NCT04711603|593853845|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
164405009|NCT04711603|593853842|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
164405010|NCT04711603|593853843|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
164405011|NCT04711603|593853844|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
164405012|NCT04711603|593853845|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
164405013|NCT04711603|593853842|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
164405014|NCT04711603|593853843|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
164450967|NCT05644002|594019651|FG001|Overall Study|Lost to Follow-up|2|||
164450968|NCT05644002|594019650|FG000|Overall Study|Withdrawal by Subject|0|||
164450969|NCT05644002|594019651|FG001|Overall Study|Withdrawal by Subject|1|||
164706493|NCT02393248|594953415|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164706494|NCT02393248|594953416|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164405015|NCT04711603|593853844|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
164450970|NCT03821844|594019654|FG000|Overall Study|Death|37|||
164450971|NCT03821844|594019655|FG001|Overall Study|Death|31|||
164450972|NCT03821844|594019654|FG000|Overall Study|Discharged|10|||
164450973|NCT03821844|594019655|FG001|Overall Study|Discharged|14|||
164450974|NCT03821844|594019654|FG000|Overall Study|Not present in facility at followup|2|||
164450975|NCT03821844|594019655|FG001|Overall Study|Not present in facility at followup|3|||
164450976|NCT02837510|594019656|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
164450977|NCT02837510|594019657|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
164450978|NCT02837510|594019656|FG000|Washout (2 Weeks)|Adverse Event|0|||
164450979|NCT02837510|594019657|FG001|Washout (2 Weeks)|Adverse Event|1|||
164450980|NCT02837510|594019656|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
164450981|NCT02837510|594019657|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
164450982|NCT02837510|594019656|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
164450983|NCT02837510|594019657|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
164450984|NCT02837510|594019656|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
164450985|NCT02837510|594019657|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
164450986|NCT02837510|594019656|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
164450987|NCT02837510|594019657|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
164450988|NCT04118452|594019660|FG000|Overall Study|Lost to Follow-up|5|||
164450989|NCT04118452|594019661|FG001|Overall Study|Lost to Follow-up|5|||
164450990|NCT04118452|594019660|FG000|Overall Study|Withdrawal by Subject|17|||
164450991|NCT04118452|594019661|FG001|Overall Study|Withdrawal by Subject|17|||
164450992|NCT04868110|594019669|FG000|Overall Study|Withdrawal by Subject|3|||
164597164|NCT02052778|594548994|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164597165|NCT02052778|594548995|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164597166|NCT02052778|594548996|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164597167|NCT02052778|594548997|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164597168|NCT02052778|594548998|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164405016|NCT04711603|593853845|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
164405017|NCT04711603|593853842|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
164405018|NCT04711603|593853843|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
164405019|NCT04711603|593853844|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
164405020|NCT04711603|593853845|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
164405021|NCT04711603|593853842|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
164405022|NCT04711603|593853843|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
164405023|NCT04711603|593853844|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
164405024|NCT04711603|593853845|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
164405025|NCT04711603|593853842|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
164405026|NCT04711603|593853843|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
164405027|NCT04711603|593853844|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
164405028|NCT04711603|593853845|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
164405029|NCT04711603|593853842|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
164405030|NCT04711603|593853843|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
164405031|NCT04711603|593853844|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
164405032|NCT04711603|593853845|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
164405033|NCT04711603|593853842|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
164405034|NCT04711603|593853843|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
164405035|NCT04711603|593853844|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
164405036|NCT04711603|593853845|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
164405037|NCT04711603|593853842|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
164405038|NCT04711603|593853843|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
164405039|NCT04711603|593853844|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
164405040|NCT04711603|593853845|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
164405041|NCT03351738|593853846|FG000|Overall Study|Withdrawal by Subject|0|||
164405042|NCT03351738|593853847|FG001|Overall Study|Withdrawal by Subject|1|||
164405043|NCT03351738|593853848|FG002|Overall Study|Withdrawal by Subject|0|||
164405044|NCT03351738|593853849|FG003|Overall Study|Withdrawal by Subject|1|||
164405045|NCT03351738|593853850|FG004|Overall Study|Withdrawal by Subject|0|||
164405046|NCT03351738|593853851|FG005|Overall Study|Withdrawal by Subject|0|||
164405047|NCT01089374|593853856|FG000|Overall Study|Lost to Follow-up|3|||
164450993|NCT04868110|594019670|FG001|Overall Study|Withdrawal by Subject|4|||
164450994|NCT02553642|594019673|FG000|Overall Study|Withdrawal by Subject|0|||
164450995|NCT02553642|594019674|FG001|Overall Study|Withdrawal by Subject|3|||
164450996|NCT02553642|594019673|FG000|Overall Study|Physician Decision|0|||
164450997|NCT02553642|594019674|FG001|Overall Study|Physician Decision|1|||
164450998|NCT02553642|594019673|FG000|Overall Study|Additional cancer dx|0|||
164450999|NCT02553642|594019674|FG001|Overall Study|Additional cancer dx|1|||
164451000|NCT02553642|594019673|FG000|Overall Study|Never started treatment|0|||
164451001|NCT02553642|594019674|FG001|Overall Study|Never started treatment|1|||
164451002|NCT04424927|594019680|FG000|Single-blind Period (4 Weeks)|Not treated|1|||
164706495|NCT02393248|594953417|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164706496|NCT02393248|594953418|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164706497|NCT02393248|594953419|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164706498|NCT02393248|594953420|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164451003|NCT04424927|594019681|FG001|Single-blind Period (4 Weeks)|Not treated|0|||
164451004|NCT04424927|594019682|FG002|Single-blind Period (4 Weeks)|Not treated|0|||
164451005|NCT04424927|594019683|FG003|Single-blind Period (4 Weeks)|Not treated|0|||
164451006|NCT04424927|594019684|FG004|Single-blind Period (4 Weeks)|Not treated|0|||
164451007|NCT04424927|594019680|FG000|Single-blind Period (4 Weeks)|Run-in failure|27|||
164451008|NCT04424927|594019681|FG001|Single-blind Period (4 Weeks)|Run-in failure|0|||
164451009|NCT04424927|594019682|FG002|Single-blind Period (4 Weeks)|Run-in failure|0|||
164451010|NCT04424927|594019683|FG003|Single-blind Period (4 Weeks)|Run-in failure|0|||
164451011|NCT04424927|594019684|FG004|Single-blind Period (4 Weeks)|Run-in failure|0|||
164451012|NCT04424927|594019680|FG000|Single-blind Period (4 Weeks)|Withdrawal by Subject|7|||
164451013|NCT04424927|594019681|FG001|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
164451014|NCT04424927|594019682|FG002|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
164451015|NCT04424927|594019683|FG003|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
164451016|NCT04424927|594019684|FG004|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
164451017|NCT04424927|594019680|FG000|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|1|||
164451018|NCT04424927|594019681|FG001|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
164451019|NCT04424927|594019682|FG002|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
164451020|NCT04424927|594019683|FG003|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
164451021|NCT04424927|594019684|FG004|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
164451022|NCT04424927|594019680|FG000|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
164451023|NCT04424927|594019681|FG001|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
164451024|NCT04424927|594019682|FG002|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
164451025|NCT04424927|594019683|FG003|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
164451026|NCT04424927|594019684|FG004|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
164451027|NCT04424927|594019680|FG000|Double-blind Period (24 Weeks)|Withdrawal by Subject|0|||
164451028|NCT04424927|594019681|FG001|Double-blind Period (24 Weeks)|Withdrawal by Subject|3|||
164451029|NCT04424927|594019682|FG002|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
164451030|NCT04424927|594019683|FG003|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
164451031|NCT04424927|594019684|FG004|Double-blind Period (24 Weeks)|Withdrawal by Subject|6|||
164451032|NCT04424927|594019680|FG000|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
164451033|NCT04424927|594019681|FG001|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
164451034|NCT04424927|594019682|FG002|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
164451035|NCT04424927|594019683|FG003|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
164451036|NCT04424927|594019684|FG004|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
164451037|NCT04424927|594019680|FG000|Double-blind Period (24 Weeks)|Other|0|||
164451038|NCT04424927|594019681|FG001|Double-blind Period (24 Weeks)|Other|1|||
164451039|NCT04424927|594019682|FG002|Double-blind Period (24 Weeks)|Other|3|||
164451040|NCT04424927|594019683|FG003|Double-blind Period (24 Weeks)|Other|1|||
164451041|NCT04424927|594019684|FG004|Double-blind Period (24 Weeks)|Other|0|||
164451042|NCT02386553|594019690|FG000|Overall Study|Reason Not Specified|1|||
164451043|NCT02386553|594019691|FG001|Overall Study|Reason Not Specified|1|||
164451044|NCT02386553|594019690|FG000|Overall Study|Withdrawal by parent/Guardian|1|||
164451045|NCT02386553|594019691|FG001|Overall Study|Withdrawal by parent/Guardian|0|||
164451046|NCT04149002|594019702|FG000|Overall Study|Lost to Follow-up|1|||
164706499|NCT02393248|594953421|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164706500|NCT02393248|594953422|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164451047|NCT04149002|594019703|FG001|Overall Study|Lost to Follow-up|0|||
164451048|NCT04149002|594019702|FG000|Overall Study|Withdrawal by Subject|1|||
164451049|NCT04149002|594019703|FG001|Overall Study|Withdrawal by Subject|0|||
164706501|NCT02393248|594953423|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164706502|NCT02393248|594953424|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164706503|NCT02393248|594953425|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
164451050|NCT06061081|594019705|FG000|Overall Study|Withdrawal by Subject|1|||
164451051|NCT06061081|594019706|FG001|Overall Study|Withdrawal by Subject|0|||
164451052|NCT06061081|594019707|FG002|Overall Study|Withdrawal by Subject|0|||
164451053|NCT06061081|594019708|FG003|Overall Study|Withdrawal by Subject|0|||
164451054|NCT06061081|594019709|FG004|Overall Study|Withdrawal by Subject|0|||
164451055|NCT05782231|594019710|FG000|Overall Study|Withdrawal by Subject|1|||
164706504|NCT02393248|594953426|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164706505|NCT02393248|594953427|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
164706506|NCT02393248|594953428|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164706507|NCT02393248|594953429|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164706508|NCT02393248|594953430|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164706509|NCT02393248|594953431|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164706510|NCT02393248|594953432|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164706511|NCT02393248|594953433|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164706512|NCT02393248|594953434|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164706513|NCT02393248|594953435|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164706514|NCT02393248|594953436|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164706515|NCT02393248|594953437|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164706516|NCT02393248|594953438|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164706517|NCT02393248|594953414|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164706518|NCT02393248|594953415|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164706519|NCT02393248|594953416|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164706520|NCT02393248|594953417|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164706521|NCT02393248|594953418|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164706522|NCT02393248|594953419|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164706523|NCT02393248|594953420|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164706524|NCT02393248|594953421|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164706525|NCT02393248|594953422|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164706526|NCT02393248|594953423|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164706527|NCT02393248|594953424|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164706528|NCT02393248|594953425|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164706529|NCT02393248|594953426|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164706530|NCT02393248|594953427|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164706531|NCT02393248|594953428|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164706532|NCT02393248|594953429|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164706533|NCT02393248|594953430|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164706534|NCT02393248|594953431|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164706535|NCT02393248|594953432|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
164405048|NCT01089374|593853857|FG001|Overall Study|Lost to Follow-up|0|||
164405049|NCT01089374|593853856|FG000|Overall Study|Withdrawal by Subject|1|||
164405050|NCT01089374|593853857|FG001|Overall Study|Withdrawal by Subject|0|||
164405051|NCT01089374|593853856|FG000|Overall Study|Study closed early - low accrual|6|||
164405052|NCT01089374|593853857|FG001|Overall Study|Study closed early - low accrual|0|||
164405053|NCT01533493|593853866|FG000|Overall Study|Adverse Event|2|||
164405054|NCT01533493|593853867|FG001|Overall Study|Adverse Event|1|||
164405055|NCT01533493|593853866|FG000|Overall Study|Withdrawal by Subject|1|||
164405056|NCT01533493|593853867|FG001|Overall Study|Withdrawal by Subject|2|||
164405057|NCT01533493|593853866|FG000|Overall Study|Lost to Follow-up|2|||
164405058|NCT01533493|593853867|FG001|Overall Study|Lost to Follow-up|0|||
164405059|NCT04672941|593853876|FG000|Overall Study|Investigator decision|1|||
164405060|NCT04672941|593853876|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
164405061|NCT04672941|593853876|FG000|Overall Study|COVID-19 related but no adverse event|1|||
164405062|NCT04672941|593853876|FG000|Overall Study|Adverse Event|2|||
164405063|NCT04672941|593853876|FG000|Overall Study|Lost to Follow-up|2|||
164405064|NCT00031486|593853877|FG000|Overall Study|Adverse Event|1|||
164405065|NCT00031486|593853878|FG001|Overall Study|Adverse Event|0|||
164405066|NCT00031486|593853877|FG000|Overall Study|Lost to Follow-up|0|||
164405067|NCT00031486|593853878|FG001|Overall Study|Lost to Follow-up|1|||
164405068|NCT00031486|593853877|FG000|Overall Study|Withdrawal by Subject|3|||
164405069|NCT00031486|593853878|FG001|Overall Study|Withdrawal by Subject|2|||
164405070|NCT00031486|593853877|FG000|Overall Study|Death|0|||
164405071|NCT00031486|593853878|FG001|Overall Study|Death|3|||
164405072|NCT00031486|593853877|FG000|Overall Study|Non-compliant|0|||
164405073|NCT00031486|593853878|FG001|Overall Study|Non-compliant|4|||
164405074|NCT00031486|593853877|FG000|Overall Study|Did not meet eligibility requirement|2|||
164405075|NCT00031486|593853878|FG001|Overall Study|Did not meet eligibility requirement|1|||
164405076|NCT00031486|593853877|FG000|Overall Study|Other|1|||
164405077|NCT00031486|593853878|FG001|Overall Study|Other|1|||
164405078|NCT03685591|593853879|FG000|Overall Study|Global Deterioration of Health Status|0|||
164405079|NCT03685591|593853880|FG001|Overall Study|Global Deterioration of Health Status|0|||
164405080|NCT03685591|593853881|FG002|Overall Study|Global Deterioration of Health Status|0|||
164405081|NCT03685591|593853882|FG003|Overall Study|Global Deterioration of Health Status|1|||
164405082|NCT03685591|593853883|FG004|Overall Study|Global Deterioration of Health Status|2|||
164405083|NCT03685591|593853884|FG005|Overall Study|Global Deterioration of Health Status|4|||
164706536|NCT02393248|594953433|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164706537|NCT02393248|594953434|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
164706538|NCT02393248|594953435|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
164451056|NCT02252172|594019711|FG000|Overall Study|Lost to Follow-up|9|||
164451057|NCT02252172|594019712|FG001|Overall Study|Lost to Follow-up|6|||
164451058|NCT02252172|594019711|FG000|Overall Study|Death|218|||
164451059|NCT02252172|594019712|FG001|Overall Study|Death|175|||
164451060|NCT02252172|594019711|FG000|Overall Study|Withdrawal by Subject|20|||
164451061|NCT02252172|594019712|FG001|Overall Study|Withdrawal by Subject|15|||
164451062|NCT02252172|594019711|FG000|Overall Study|Physician Decision|0|||
164451063|NCT02252172|594019712|FG001|Overall Study|Physician Decision|1|||
164451064|NCT02252172|594019711|FG000|Overall Study|End of data collection|122|||
164451065|NCT02252172|594019712|FG001|Overall Study|End of data collection|170|||
164451066|NCT02252172|594019711|FG000|Overall Study|Site closure|0|||
164451067|NCT02252172|594019712|FG001|Overall Study|Site closure|1|||
164451068|NCT03830866|594019713|FG000|Overall Study|Death|90|||
164451069|NCT03830866|594019714|FG001|Overall Study|Death|111|||
164451070|NCT03830866|594019713|FG000|Overall Study|Lost to Follow-up|7|||
164451071|NCT03830866|594019714|FG001|Overall Study|Lost to Follow-up|7|||
164451072|NCT03830866|594019713|FG000|Overall Study|Withdrawal by Subject|19|||
164451073|NCT03830866|594019714|FG001|Overall Study|Withdrawal by Subject|16|||
164451074|NCT03830866|594019713|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
164451075|NCT03830866|594019714|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
164451076|NCT03830866|594019713|FG000|Overall Study|Other|1|||
164451077|NCT03830866|594019714|FG001|Overall Study|Other|1|||
164451078|NCT01426412|594019715|FG000|Overall Study|Withdrawal by Subject|1|||
164451079|NCT01426412|594019716|FG001|Overall Study|Withdrawal by Subject|0|||
164451080|NCT01426412|594019717|FG002|Overall Study|Withdrawal by Subject|0|||
164451081|NCT01426412|594019718|FG003|Overall Study|Withdrawal by Subject|0|||
164451082|NCT01426412|594019719|FG004|Overall Study|Withdrawal by Subject|1|||
164451083|NCT01426412|594019720|FG005|Overall Study|Withdrawal by Subject|0|||
164451084|NCT01426412|594019721|FG006|Overall Study|Withdrawal by Subject|0|||
164451085|NCT01426412|594019722|FG007|Overall Study|Withdrawal by Subject|3|||
164451086|NCT01426412|594019723|FG008|Overall Study|Withdrawal by Subject|1|||
164451087|NCT03014453|594019724|FG000|Overall Study|Lost to Follow-up|12|||
164451088|NCT03014453|594019724|FG000|Overall Study|Discontinued GER|3|||
164451089|NCT03014453|594019724|FG000|Overall Study|Excluded|19|||
164451090|NCT03014453|594019724|FG000|Overall Study|Refused to take part in|37|||
164451091|NCT00262301|594019727|FG000|Double-blind Phase|Lost to Follow-up|1|||
164451092|NCT00262301|594019728|FG001|Double-blind Phase|Lost to Follow-up|0|||
164451093|NCT00262301|594019729|FG002|Double-blind Phase|Lost to Follow-up|0|||
164451094|NCT00262301|594019727|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
164451095|NCT00262301|594019728|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
164451096|NCT00262301|594019729|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
164451097|NCT01017146|594019730|FG000|Overall Study|Adverse Event|11|||
164451098|NCT01017146|594019731|FG001|Overall Study|Adverse Event|1|||
164451099|NCT01017146|594019730|FG000|Overall Study|Lost to Follow-up|14|||
164451100|NCT01017146|594019731|FG001|Overall Study|Lost to Follow-up|14|||
164451101|NCT01017146|594019730|FG000|Overall Study|Noncompliance with Study Product|1|||
164451102|NCT01017146|594019731|FG001|Overall Study|Noncompliance with Study Product|1|||
164451103|NCT01017146|594019730|FG000|Overall Study|Withdrawal by Subject|32|||
164451104|NCT01017146|594019731|FG001|Overall Study|Withdrawal by Subject|16|||
164451105|NCT01017146|594019730|FG000|Overall Study|Relocation|0|||
164451106|NCT01017146|594019731|FG001|Overall Study|Relocation|4|||
164451107|NCT01017146|594019730|FG000|Overall Study|Pregnancy|2|||
164451108|NCT01017146|594019731|FG001|Overall Study|Pregnancy|1|||
164451109|NCT01017146|594019730|FG000|Overall Study|Protocol Violation|2|||
164451110|NCT01017146|594019731|FG001|Overall Study|Protocol Violation|0|||
164451111|NCT01017146|594019730|FG000|Overall Study|Took Excluded Medication|2|||
164451112|NCT01017146|594019731|FG001|Overall Study|Took Excluded Medication|0|||
164451113|NCT01017146|594019730|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
164451114|NCT01017146|594019731|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
164451115|NCT01017146|594019730|FG000|Overall Study|Change in Work Situation|1|||
164597169|NCT02052778|594548999|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164597170|NCT02052778|594549000|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164597171|NCT02052778|594549001|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164451116|NCT01017146|594019731|FG001|Overall Study|Change in Work Situation|0|||
164597172|NCT02052778|594549002|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164451117|NCT00976495|594019742|FG000|Overall Study|Withdrawal by Subject|0|||
164597173|NCT02052778|594549003|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164597174|NCT02052778|594549004|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164597175|NCT02052778|594549005|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164597176|NCT02052778|594549006|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164597177|NCT02052778|594549007|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164597178|NCT02052778|594549008|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164597179|NCT02052778|594549009|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164597180|NCT02052778|594549010|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164597181|NCT02052778|594549011|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164451118|NCT00976495|594019743|FG001|Overall Study|Withdrawal by Subject|1|||
164451119|NCT00976495|594019744|FG002|Overall Study|Withdrawal by Subject|0|||
164451120|NCT00001277|594019746|FG000|Overall Study|Adverse Event|0|||
164451121|NCT00001277|594019747|FG001|Overall Study|Adverse Event|0|||
164451122|NCT00001277|594019748|FG002|Overall Study|Adverse Event|1|||
164451123|NCT00001277|594019746|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
164451124|NCT00001277|594019747|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
164451125|NCT00001277|594019748|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
164451126|NCT04484935|594019750|FG000|Overall Study|Other|0|||
164451127|NCT04484935|594019751|FG001|Overall Study|Other|1|||
164451128|NCT04484935|594019750|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164451129|NCT04484935|594019751|FG001|Overall Study|Withdrawal by parent/guardian|1|||
164451130|NCT04484935|594019750|FG000|Overall Study|Lost to Follow-up|1|||
164451131|NCT04484935|594019751|FG001|Overall Study|Lost to Follow-up|0|||
164451132|NCT04484935|594019750|FG000|Overall Study|Death|2|||
164451133|NCT04484935|594019751|FG001|Overall Study|Death|1|||
164451134|NCT03750968|594019752|FG000|Overall Study|Adverse Event|2|||
164451135|NCT03750968|594019753|FG001|Overall Study|Adverse Event|0|||
164451136|NCT03750968|594019752|FG000|Overall Study|Lost to Follow-up|1|||
164451137|NCT03750968|594019753|FG001|Overall Study|Lost to Follow-up|3|||
164451138|NCT02539225|594019756|FG000|Part A|Adverse Event|13|||
164451139|NCT02539225|594019757|FG001|Part A|Adverse Event|4|||
164451140|NCT02539225|594019756|FG000|Part A|Withdrawal by Subject|2|||
164451141|NCT02539225|594019757|FG001|Part A|Withdrawal by Subject|4|||
164451142|NCT02539225|594019756|FG000|Part A|Physician Decision|4|||
164451143|NCT02539225|594019757|FG001|Part A|Physician Decision|7|||
164451144|NCT02539225|594019756|FG000|Part A|Did Not Receive study Drug|1|||
164451145|NCT02539225|594019757|FG001|Part A|Did Not Receive study Drug|1|||
164451146|NCT02539225|594019756|FG000|Pre Treatment for Part B|Progressive disease|1|||
164451147|NCT02539225|594019757|FG001|Pre Treatment for Part B|Progressive disease|1|||
164451148|NCT02539225|594019756|FG000|Pre Treatment for Part B|Adverse Event|1|||
164451149|NCT02539225|594019757|FG001|Pre Treatment for Part B|Adverse Event|1|||
164451150|NCT02539225|594019756|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
164451151|NCT02539225|594019757|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
164451152|NCT02539225|594019756|FG000|Pre Treatment for Part B|Physician Decision|2|||
164451153|NCT02539225|594019757|FG001|Pre Treatment for Part B|Physician Decision|0|||
164451154|NCT02539225|594019756|FG000|Part B|Adverse Event|4|||
164451155|NCT02539225|594019757|FG001|Part B|Adverse Event|4|||
164451156|NCT02539225|594019756|FG000|Part B|Withdrawal by Subject|0|||
164451157|NCT02539225|594019757|FG001|Part B|Withdrawal by Subject|3|||
164451158|NCT02539225|594019756|FG000|Part B|Physician Decision|0|||
164451159|NCT02539225|594019757|FG001|Part B|Physician Decision|9|||
164451160|NCT03101371|594019760|FG000|Overall Study|Physician Decision|0|||
164451161|NCT03101371|594019761|FG001|Overall Study|Physician Decision|1|||
164451162|NCT03101371|594019760|FG000|Overall Study|Lost to Follow-up|1|||
164451163|NCT03101371|594019761|FG001|Overall Study|Lost to Follow-up|4|||
164451164|NCT03101371|594019760|FG000|Overall Study|Did not meet eligibility criteria|2|||
164451165|NCT03101371|594019761|FG001|Overall Study|Did not meet eligibility criteria|1|||
164451166|NCT01094184|594019765|FG000|Overall Study|Death|35|||
164451167|NCT01094184|594019766|FG001|Overall Study|Death|11|||
164451168|NCT02318134|594019767|FG000|Overall Study|Withdrawal by Subject|2|||
164451169|NCT02318134|594019768|FG001|Overall Study|Withdrawal by Subject|1|||
164451170|NCT03988842|594019769|FG000|Overall Study|Death|1|||
164451171|NCT04766034|594019770|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
164451172|NCT04766034|594019771|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
164451173|NCT04766034|594019772|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
164451174|NCT04766034|594019773|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
164451175|NCT04766034|594019774|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
164451176|NCT04766034|594019770|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
164451177|NCT04766034|594019771|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
164451178|NCT04766034|594019772|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
164451179|NCT04766034|594019773|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
164451180|NCT04766034|594019774|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
164451181|NCT04766034|594019770|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
164451182|NCT04766034|594019771|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
164451183|NCT04766034|594019772|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
164451184|NCT04766034|594019773|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
164451185|NCT04766034|594019774|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
164451186|NCT04766034|594019770|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
164451187|NCT04766034|594019771|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
164451188|NCT04766034|594019772|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
164451189|NCT04766034|594019773|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
164451190|NCT04766034|594019774|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
164451191|NCT02119650|594019776|FG000|Overall Study|Adverse Event|3|||
164451192|NCT02119650|594019777|FG001|Overall Study|Adverse Event|4|||
164451193|NCT02119650|594019776|FG000|Overall Study|Subject decision|2|||
164451194|NCT02119650|594019777|FG001|Overall Study|Subject decision|3|||
164451195|NCT02119650|594019776|FG000|Overall Study|Disease progression|11|||
164451196|NCT02119650|594019777|FG001|Overall Study|Disease progression|14|||
164451197|NCT02119650|594019776|FG000|Overall Study|Death|5|||
164451198|NCT02119650|594019777|FG001|Overall Study|Death|1|||
164451199|NCT02119650|594019776|FG000|Overall Study|Noncompliance with study treatment|1|||
164451200|NCT02119650|594019777|FG001|Overall Study|Noncompliance with study treatment|1|||
164451201|NCT02119650|594019776|FG000|Overall Study|Study terminated by the sponsor|1|||
164451202|NCT02119650|594019777|FG001|Overall Study|Study terminated by the sponsor|0|||
164451203|NCT02119650|594019776|FG000|Overall Study|Physician Decision|0|||
164451204|NCT02119650|594019777|FG001|Overall Study|Physician Decision|2|||
164451205|NCT02119650|594019776|FG000|Overall Study|Multiple reasons for termination|2|||
164451206|NCT02119650|594019777|FG001|Overall Study|Multiple reasons for termination|1|||
164451207|NCT03481816|594019778|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
164451208|NCT03481816|594019779|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
164451209|NCT03481816|594019778|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
164451210|NCT03481816|594019779|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
164451211|NCT03481816|594019778|FG000|Dose Expansion|Withdrawal by Subject|0|||
164451212|NCT03481816|594019779|FG001|Dose Expansion|Withdrawal by Subject|2|||
164451213|NCT03481816|594019778|FG000|Dose Expansion|Physician Decision|0|||
164451214|NCT03481816|594019779|FG001|Dose Expansion|Physician Decision|5|||
164451215|NCT02730871|594019780|FG000|Overall Study|Adverse Event|6|||
164451216|NCT02730871|594019781|FG001|Overall Study|Adverse Event|0|||
164451217|NCT05368558|594019782|FG000|Double Blind Period (DBP)|Withdrawal by Subject|1|||
164451218|NCT05368558|594019783|FG001|Double Blind Period (DBP)|Withdrawal by Subject|1|||
164451219|NCT05368558|594019784|FG002|Double Blind Period (DBP)|Withdrawal by Subject|2|||
164451220|NCT05368558|594019785|FG003|Double Blind Period (DBP)|Withdrawal by Subject|0|||
164451221|NCT05368558|594019786|FG004|Double Blind Period (DBP)|Withdrawal by Subject|0|||
164451222|NCT05368558|594019787|FG005|Double Blind Period (DBP)|Withdrawal by Subject|0|||
164451223|NCT05368558|594019788|FG006|Double Blind Period (DBP)|Withdrawal by Subject|0|||
164451224|NCT05368558|594019789|FG007|Double Blind Period (DBP)|Withdrawal by Subject|0|||
164451225|NCT05368558|594019790|FG008|Double Blind Period (DBP)|Withdrawal by Subject|0|||
164451226|NCT05368558|594019791|FG009|Double Blind Period (DBP)|Withdrawal by Subject|0|||
164451227|NCT05368558|594019792|FG010|Double Blind Period (DBP)|Withdrawal by Subject|0|||
164451228|NCT05368558|594019793|FG011|Double Blind Period (DBP)|Withdrawal by Subject|0|||
164451229|NCT05368558|594019782|FG000|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
164451230|NCT05368558|594019783|FG001|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
164451231|NCT05368558|594019784|FG002|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
164451232|NCT05368558|594019785|FG003|Blinded Extension Period (BEP)|Withdrawal by Subject|1|||
164451233|NCT05368558|594019786|FG004|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
164451234|NCT05368558|594019787|FG005|Blinded Extension Period (BEP)|Withdrawal by Subject|2|||
164451235|NCT05368558|594019788|FG006|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
164451236|NCT05368558|594019789|FG007|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
164451237|NCT05368558|594019790|FG008|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
164451238|NCT05368558|594019791|FG009|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
164451239|NCT05368558|594019792|FG010|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
164451240|NCT05368558|594019793|FG011|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
164451241|NCT05368558|594019782|FG000|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
164451242|NCT05368558|594019783|FG001|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
164451243|NCT05368558|594019784|FG002|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
164451244|NCT05368558|594019785|FG003|Blinded Extension Period (BEP)|Study terminated by sponsor|1|||
164451245|NCT05368558|594019786|FG004|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
164451246|NCT05368558|594019787|FG005|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
164597182|NCT02052778|594549012|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164451247|NCT05368558|594019788|FG006|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
164451248|NCT05368558|594019789|FG007|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
164597183|NCT02052778|594549013|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164597184|NCT02052778|594549014|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164597185|NCT02052778|594549015|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
164597186|NCT02052778|594548993|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164451249|NCT05368558|594019790|FG008|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
164451250|NCT05368558|594019791|FG009|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
164451251|NCT05368558|594019792|FG010|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
164451252|NCT05368558|594019793|FG011|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
164451253|NCT05368558|594019782|FG000|Blinded Extension Period (BEP)|other|0|||
164451254|NCT05368558|594019783|FG001|Blinded Extension Period (BEP)|other|0|||
164451255|NCT05368558|594019784|FG002|Blinded Extension Period (BEP)|other|0|||
164451256|NCT05368558|594019785|FG003|Blinded Extension Period (BEP)|other|0|||
164451257|NCT05368558|594019786|FG004|Blinded Extension Period (BEP)|other|0|||
164451258|NCT05368558|594019787|FG005|Blinded Extension Period (BEP)|other|1|||
164451259|NCT05368558|594019788|FG006|Blinded Extension Period (BEP)|other|0|||
164451260|NCT05368558|594019789|FG007|Blinded Extension Period (BEP)|other|0|||
164451261|NCT05368558|594019790|FG008|Blinded Extension Period (BEP)|other|0|||
164451262|NCT05368558|594019791|FG009|Blinded Extension Period (BEP)|other|0|||
164451263|NCT05368558|594019792|FG010|Blinded Extension Period (BEP)|other|0|||
164451264|NCT05368558|594019793|FG011|Blinded Extension Period (BEP)|other|0|||
164451265|NCT01303445|594019794|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
164451266|NCT01303445|594019795|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
164451267|NCT01303445|594019794|FG000|Second Intervention (7 Days)|Adverse Event|0|||
164451268|NCT01303445|594019795|FG001|Second Intervention (7 Days)|Adverse Event|2|||
164451269|NCT01303445|594019794|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
164451270|NCT01303445|594019795|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
164451271|NCT01303445|594019794|FG000|Washout (14 Days)|Protocol Violation|1|||
164451272|NCT01303445|594019795|FG001|Washout (14 Days)|Protocol Violation|0|||
164597187|NCT02052778|594548994|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164597188|NCT02052778|594548995|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164597189|NCT02052778|594548996|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164451273|NCT01303445|594019794|FG000|Washout (14 Days)|Lost to Follow-up|0|||
164451274|NCT01303445|594019795|FG001|Washout (14 Days)|Lost to Follow-up|2|||
164451275|NCT01303445|594019794|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
164451276|NCT01303445|594019795|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
164451277|NCT01303445|594019794|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
164451278|NCT01303445|594019795|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
164451279|NCT05094141|594019799|FG000|Overall Study|Death|0|||
164597190|NCT02052778|594548997|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164597191|NCT02052778|594548998|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164451280|NCT05094141|594019800|FG001|Overall Study|Death|0|||
164451281|NCT05094141|594019801|FG002|Overall Study|Death|1|||
164451282|NCT05094141|594019799|FG000|Overall Study|Withdrawal by Subject|0|||
164451283|NCT05094141|594019800|FG001|Overall Study|Withdrawal by Subject|0|||
164451284|NCT05094141|594019801|FG002|Overall Study|Withdrawal by Subject|1|||
164451285|NCT05094141|594019799|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
164451286|NCT05094141|594019800|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
164451287|NCT05094141|594019801|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
164451288|NCT05094141|594019799|FG000|Overall Study|Did not participate in randomization|0|||
164451289|NCT05094141|594019800|FG001|Overall Study|Did not participate in randomization|0|||
164451290|NCT05094141|594019801|FG002|Overall Study|Did not participate in randomization|33|||
164451291|NCT05756075|594021661|FG000|Overall Study|Withdrawal by Subject|16|||
164451292|NCT05756075|594021662|FG001|Overall Study|Withdrawal by Subject|9|||
164451293|NCT03913195|594021663|FG000|Overall Study|Adverse Event|0|||
164451294|NCT03913195|594021664|FG001|Overall Study|Adverse Event|0|||
164451295|NCT03913195|594021665|FG002|Overall Study|Adverse Event|1|||
164451296|NCT03913195|594021666|FG003|Overall Study|Adverse Event|1|||
164451297|NCT03913195|594021667|FG004|Overall Study|Adverse Event|0|||
164451298|NCT03913195|594021663|FG000|Overall Study|Withdrawal by Subject|0|||
164451299|NCT03913195|594021664|FG001|Overall Study|Withdrawal by Subject|0|||
164451300|NCT03913195|594021665|FG002|Overall Study|Withdrawal by Subject|1|||
164451301|NCT03913195|594021666|FG003|Overall Study|Withdrawal by Subject|0|||
164451302|NCT03913195|594021667|FG004|Overall Study|Withdrawal by Subject|1|||
164597192|NCT02052778|594548999|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164597193|NCT02052778|594549000|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164597194|NCT02052778|594549001|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164597195|NCT02052778|594549002|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164597196|NCT02052778|594549003|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164597197|NCT02052778|594549004|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164597198|NCT02052778|594549005|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164597199|NCT02052778|594549006|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164597200|NCT02052778|594549007|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164597201|NCT02052778|594549008|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164597202|NCT02052778|594549009|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164451303|NCT03913195|594021663|FG000|Overall Study|non adherence to study|0|||
164451304|NCT03913195|594021664|FG001|Overall Study|non adherence to study|0|||
164451305|NCT03913195|594021665|FG002|Overall Study|non adherence to study|1|||
164451306|NCT03913195|594021666|FG003|Overall Study|non adherence to study|0|||
164451307|NCT03913195|594021667|FG004|Overall Study|non adherence to study|0|||
164451308|NCT03899961|594021668|FG000|Overall Study|-delivery prior to|2|||
164451309|NCT03899961|594021669|FG001|Overall Study|-delivery prior to|7|||
164451310|NCT03899961|594021668|FG000|Overall Study|req general anesth|1|||
164451311|NCT03899961|594021669|FG001|Overall Study|req general anesth|2|||
164451312|NCT03899961|594021668|FG000|Overall Study|capacity|5|||
164451313|NCT03899961|594021669|FG001|Overall Study|capacity|6|||
164451314|NCT03899961|594021668|FG000|Overall Study|Withdrawal by Subject|1|||
164451315|NCT03899961|594021669|FG001|Overall Study|Withdrawal by Subject|1|||
164451316|NCT03416023|594021670|FG000|Overall Study|Exclusion criteria failure|1|||
164451317|NCT03416023|594021670|FG000|Overall Study|Withdrawal by Subject|6|||
164451318|NCT03416023|594021670|FG000|Overall Study|Explanted|7|||
164451319|NCT03416023|594021670|FG000|Overall Study|Physician Decision|1|||
164451320|NCT03416023|594021670|FG000|Overall Study|Lost to Follow-up|1|||
164451321|NCT03416023|594021670|FG000|Overall Study|Death|1|||
164451322|NCT05419505|594021671|FG000|Overall Study|Adverse Event|0|||
164451323|NCT05419505|594021672|FG001|Overall Study|Adverse Event|0|||
164597203|NCT02052778|594549010|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164597204|NCT02052778|594549011|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164597205|NCT02052778|594549012|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164597206|NCT02052778|594549013|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164597207|NCT02052778|594549014|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164597208|NCT02052778|594549015|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
164597209|NCT02052778|594548993|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164597210|NCT02052778|594548994|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164597211|NCT02052778|594548995|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164597212|NCT02052778|594548996|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164597213|NCT02052778|594548997|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164597214|NCT02052778|594548998|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164597215|NCT02052778|594548999|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164597216|NCT02052778|594549000|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164597217|NCT02052778|594549001|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164597218|NCT02052778|594549002|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164597219|NCT02052778|594549003|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164597220|NCT02052778|594549004|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164597221|NCT02052778|594549005|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164597222|NCT02052778|594549006|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164597223|NCT02052778|594549007|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164597224|NCT02052778|594549008|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164597225|NCT02052778|594549009|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164597226|NCT02052778|594549010|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164597227|NCT02052778|594549011|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164597228|NCT02052778|594549012|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164597229|NCT02052778|594549013|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164597230|NCT02052778|594549014|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164597231|NCT02052778|594549015|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
164597232|NCT02052778|594548993|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164597233|NCT02052778|594548994|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164597234|NCT02052778|594548995|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164597235|NCT02052778|594548996|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164597236|NCT02052778|594548997|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164597237|NCT02052778|594548998|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164597238|NCT02052778|594548999|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164597239|NCT02052778|594549000|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164597240|NCT02052778|594549001|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164451324|NCT05419505|594021673|FG002|Overall Study|Adverse Event|0|||
164451325|NCT05419505|594021674|FG003|Overall Study|Adverse Event|1|||
164451326|NCT05419505|594021675|FG004|Overall Study|Adverse Event|0|||
164451327|NCT05419505|594021676|FG005|Overall Study|Adverse Event|0|||
164451328|NCT05419505|594021677|FG006|Overall Study|Adverse Event|0|||
164451329|NCT05419505|594021678|FG007|Overall Study|Adverse Event|0|||
164597241|NCT02052778|594549002|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164451330|NCT05419505|594021671|FG000|Overall Study|Withdrawal by Subject|1|||
164451331|NCT05419505|594021672|FG001|Overall Study|Withdrawal by Subject|2|||
164451332|NCT05419505|594021673|FG002|Overall Study|Withdrawal by Subject|0|||
164451333|NCT05419505|594021674|FG003|Overall Study|Withdrawal by Subject|0|||
164451334|NCT05419505|594021675|FG004|Overall Study|Withdrawal by Subject|0|||
164451335|NCT05419505|594021676|FG005|Overall Study|Withdrawal by Subject|0|||
164451336|NCT05419505|594021677|FG006|Overall Study|Withdrawal by Subject|1|||
164451337|NCT05419505|594021678|FG007|Overall Study|Withdrawal by Subject|0|||
164451338|NCT05419505|594021671|FG000|Overall Study|Lost to Follow-up|2|||
164451339|NCT05419505|594021672|FG001|Overall Study|Lost to Follow-up|1|||
164451340|NCT05419505|594021673|FG002|Overall Study|Lost to Follow-up|0|||
164451341|NCT05419505|594021674|FG003|Overall Study|Lost to Follow-up|0|||
164451342|NCT05419505|594021675|FG004|Overall Study|Lost to Follow-up|1|||
164451343|NCT05419505|594021676|FG005|Overall Study|Lost to Follow-up|2|||
164451344|NCT05419505|594021677|FG006|Overall Study|Lost to Follow-up|0|||
164451345|NCT05419505|594021678|FG007|Overall Study|Lost to Follow-up|1|||
164451346|NCT02780388|594021681|FG000|Overall Study|Lost to Follow-up|0|||
164451347|NCT02780388|594021682|FG001|Overall Study|Lost to Follow-up|1|||
164451348|NCT02780388|594021683|FG002|Overall Study|Lost to Follow-up|0|||
164451349|NCT02780388|594021684|FG003|Overall Study|Lost to Follow-up|0|||
164451350|NCT02780388|594021685|FG004|Overall Study|Lost to Follow-up|0|||
164451351|NCT02780388|594021681|FG000|Overall Study|Withdrawal by Subject|1|||
164451352|NCT02780388|594021682|FG001|Overall Study|Withdrawal by Subject|1|||
164451353|NCT02780388|594021683|FG002|Overall Study|Withdrawal by Subject|0|||
164451354|NCT02780388|594021684|FG003|Overall Study|Withdrawal by Subject|0|||
164451355|NCT02780388|594021685|FG004|Overall Study|Withdrawal by Subject|0|||
164451356|NCT05107401|594021686|FG000|Overall Study|Lost to Follow-up|13|||
164451357|NCT05107401|594021687|FG001|Overall Study|Lost to Follow-up|12|||
164451358|NCT02349412|594021688|FG000|Overall Study|Withdrawal by Subject|7|||
164451359|NCT02349412|594021689|FG001|Overall Study|Withdrawal by Subject|7|||
164451360|NCT03857620|594021690|FG000|Overall Study|Death|4|||
164451361|NCT03857620|594021691|FG001|Overall Study|Death|5|||
164451362|NCT03857620|594021692|FG002|Overall Study|Death|7|||
164451363|NCT03857620|594021690|FG000|Overall Study|Lost to Follow-up|2|||
164451364|NCT03857620|594021691|FG001|Overall Study|Lost to Follow-up|5|||
164451365|NCT03857620|594021692|FG002|Overall Study|Lost to Follow-up|3|||
164451366|NCT03857620|594021690|FG000|Overall Study|Disease progression or relapse after study registration|1|||
164451367|NCT03857620|594021691|FG001|Overall Study|Disease progression or relapse after study registration|5|||
164451368|NCT03857620|594021692|FG002|Overall Study|Disease progression or relapse after study registration|1|||
164451369|NCT03857620|594021690|FG000|Overall Study|Ineligible|5|||
164451370|NCT03857620|594021691|FG001|Overall Study|Ineligible|0|||
164451371|NCT03857620|594021692|FG002|Overall Study|Ineligible|2|||
164451372|NCT03857620|594021690|FG000|Overall Study|No malignancy|1|||
164451373|NCT03857620|594021691|FG001|Overall Study|No malignancy|0|||
164451374|NCT03857620|594021692|FG002|Overall Study|No malignancy|1|||
164451375|NCT03857620|594021690|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
164451376|NCT03857620|594021691|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
164451377|NCT03857620|594021692|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
164451378|NCT03857620|594021690|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
164451379|NCT03857620|594021691|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
164451380|NCT03857620|594021692|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
164451381|NCT03857620|594021690|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
164451382|NCT03857620|594021691|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
164451383|NCT03857620|594021692|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
164451384|NCT03857620|594021690|FG000|Overall Study|Surgery not performed, patient decision|0|||
164451385|NCT03857620|594021691|FG001|Overall Study|Surgery not performed, patient decision|3|||
164451386|NCT03857620|594021692|FG002|Overall Study|Surgery not performed, patient decision|1|||
164451387|NCT03857620|594021690|FG000|Overall Study|Surgery not performed, other reason|3|||
164451388|NCT03857620|594021691|FG001|Overall Study|Surgery not performed, other reason|1|||
164451389|NCT03857620|594021692|FG002|Overall Study|Surgery not performed, other reason|4|||
164451390|NCT03857620|594021690|FG000|Overall Study|Worsening performance status after surgery performed|0|||
164451391|NCT03857620|594021691|FG001|Overall Study|Worsening performance status after surgery performed|1|||
164451392|NCT03857620|594021692|FG002|Overall Study|Worsening performance status after surgery performed|1|||
164451393|NCT04143061|594021697|FG000|Overall Study|Protocol Deviation|0|||
164451394|NCT04143061|594021698|FG001|Overall Study|Protocol Deviation|0|||
164451395|NCT04143061|594021699|FG002|Overall Study|Protocol Deviation|0|||
164451396|NCT04143061|594021700|FG003|Overall Study|Protocol Deviation|0|||
164451397|NCT04143061|594021701|FG004|Overall Study|Protocol Deviation|0|||
164451398|NCT04143061|594021702|FG005|Overall Study|Protocol Deviation|0|||
164451399|NCT04143061|594021703|FG006|Overall Study|Protocol Deviation|5|||
164451400|NCT04143061|594021704|FG007|Overall Study|Protocol Deviation|5|||
164451401|NCT04143061|594021697|FG000|Overall Study|Withdrawal by Subject|2|||
164706539|NCT02393248|594953436|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164451402|NCT04143061|594021698|FG001|Overall Study|Withdrawal by Subject|0|||
164451403|NCT04143061|594021699|FG002|Overall Study|Withdrawal by Subject|0|||
164597242|NCT02052778|594549003|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164597243|NCT02052778|594549004|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164706540|NCT02393248|594953437|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
164706541|NCT02393248|594953438|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164706542|NCT02393248|594953414|FG000|Part 3: Combination Therapy|Death|0|||
164706543|NCT02393248|594953415|FG001|Part 3: Combination Therapy|Death|0|||
164706544|NCT02393248|594953416|FG002|Part 3: Combination Therapy|Death|0|||
164706545|NCT02393248|594953417|FG003|Part 3: Combination Therapy|Death|0|||
164597244|NCT02052778|594549005|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164597245|NCT02052778|594549006|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164597246|NCT02052778|594549007|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164597247|NCT02052778|594549008|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164597248|NCT02052778|594549009|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164597249|NCT02052778|594549010|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164597250|NCT02052778|594549011|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164597251|NCT02052778|594549012|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164597252|NCT02052778|594549013|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164597253|NCT02052778|594549014|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164597254|NCT02052778|594549015|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
164597255|NCT02052778|594548993|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
164597256|NCT02052778|594548994|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
164597257|NCT02052778|594548995|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
164597258|NCT02052778|594548996|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
164597259|NCT02052778|594548997|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
164597260|NCT02052778|594548998|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
164597261|NCT02052778|594548999|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
164597262|NCT02052778|594549000|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
164597263|NCT02052778|594549001|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
164597264|NCT02052778|594549002|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
164597265|NCT02052778|594549003|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
164597266|NCT02052778|594549004|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
164597267|NCT02052778|594549005|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
164597268|NCT02052778|594549006|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
164597269|NCT02052778|594549007|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
164597270|NCT02052778|594549008|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
164597271|NCT02052778|594549009|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
164706546|NCT02393248|594953418|FG004|Part 3: Combination Therapy|Death|0|||
164706547|NCT02393248|594953419|FG005|Part 3: Combination Therapy|Death|0|||
164706548|NCT02393248|594953420|FG006|Part 3: Combination Therapy|Death|0|||
164706549|NCT02393248|594953421|FG007|Part 3: Combination Therapy|Death|0|||
164405084|NCT03685591|593853885|FG006|Overall Study|Global Deterioration of Health Status|1|||
164405085|NCT03685591|593853886|FG007|Overall Study|Global Deterioration of Health Status|1|||
164405086|NCT03685591|593853887|FG008|Overall Study|Global Deterioration of Health Status|0|||
164405087|NCT03685591|593853879|FG000|Overall Study|Progressive Disease|1|||
164405088|NCT03685591|593853880|FG001|Overall Study|Progressive Disease|1|||
164405089|NCT03685591|593853881|FG002|Overall Study|Progressive Disease|0|||
164405090|NCT03685591|593853882|FG003|Overall Study|Progressive Disease|3|||
164405091|NCT03685591|593853883|FG004|Overall Study|Progressive Disease|5|||
164405092|NCT03685591|593853884|FG005|Overall Study|Progressive Disease|4|||
164405093|NCT03685591|593853885|FG006|Overall Study|Progressive Disease|3|||
164405094|NCT03685591|593853886|FG007|Overall Study|Progressive Disease|2|||
164405095|NCT03685591|593853887|FG008|Overall Study|Progressive Disease|1|||
164405096|NCT03685591|593853879|FG000|Overall Study|Other|0|||
164405097|NCT03685591|593853880|FG001|Overall Study|Other|0|||
164405098|NCT03685591|593853881|FG002|Overall Study|Other|1|||
164405099|NCT03685591|593853882|FG003|Overall Study|Other|0|||
164405100|NCT03685591|593853883|FG004|Overall Study|Other|2|||
164405101|NCT03685591|593853884|FG005|Overall Study|Other|3|||
164405102|NCT03685591|593853885|FG006|Overall Study|Other|0|||
164405103|NCT03685591|593853886|FG007|Overall Study|Other|0|||
164405104|NCT03685591|593853887|FG008|Overall Study|Other|0|||
164405105|NCT03685591|593853879|FG000|Overall Study|Withdrawal by Subject|0|||
164405106|NCT03685591|593853880|FG001|Overall Study|Withdrawal by Subject|0|||
164405107|NCT03685591|593853881|FG002|Overall Study|Withdrawal by Subject|0|||
164405108|NCT03685591|593853882|FG003|Overall Study|Withdrawal by Subject|0|||
164405109|NCT03685591|593853883|FG004|Overall Study|Withdrawal by Subject|3|||
164405110|NCT03685591|593853884|FG005|Overall Study|Withdrawal by Subject|2|||
164405111|NCT03685591|593853885|FG006|Overall Study|Withdrawal by Subject|0|||
164405112|NCT03685591|593853886|FG007|Overall Study|Withdrawal by Subject|0|||
164405113|NCT03685591|593853887|FG008|Overall Study|Withdrawal by Subject|1|||
164405114|NCT03685591|593853879|FG000|Overall Study|Adverse Event|0|||
164405115|NCT03685591|593853880|FG001|Overall Study|Adverse Event|0|||
164405116|NCT03685591|593853881|FG002|Overall Study|Adverse Event|0|||
164405117|NCT03685591|593853882|FG003|Overall Study|Adverse Event|1|||
164405118|NCT03685591|593853883|FG004|Overall Study|Adverse Event|1|||
164405119|NCT03685591|593853884|FG005|Overall Study|Adverse Event|4|||
164451404|NCT04143061|594021700|FG003|Overall Study|Withdrawal by Subject|0|||
164451405|NCT04143061|594021701|FG004|Overall Study|Withdrawal by Subject|0|||
164451406|NCT04143061|594021702|FG005|Overall Study|Withdrawal by Subject|1|||
164451407|NCT04143061|594021703|FG006|Overall Study|Withdrawal by Subject|0|||
164451408|NCT04143061|594021704|FG007|Overall Study|Withdrawal by Subject|0|||
164451409|NCT04143061|594021697|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164451410|NCT04143061|594021698|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164451411|NCT04143061|594021699|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
164451412|NCT04143061|594021700|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
164451413|NCT04143061|594021701|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
164451414|NCT04143061|594021702|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
164451415|NCT04143061|594021703|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
164451416|NCT04143061|594021704|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
164451417|NCT04586920|594021705|FG000|Overall Study|Lost to Follow-up|0|||
164451418|NCT04586920|594021706|FG001|Overall Study|Lost to Follow-up|0|||
164451419|NCT04586920|594021707|FG002|Overall Study|Lost to Follow-up|0|||
164451420|NCT04586920|594021708|FG003|Overall Study|Lost to Follow-up|0|||
164451421|NCT04586920|594021709|FG004|Overall Study|Lost to Follow-up|0|||
164451422|NCT04586920|594021710|FG005|Overall Study|Lost to Follow-up|0|||
164451423|NCT04586920|594021711|FG006|Overall Study|Lost to Follow-up|1|||
164451424|NCT04586920|594021712|FG007|Overall Study|Lost to Follow-up|1|||
164451425|NCT04586920|594021713|FG008|Overall Study|Lost to Follow-up|0|||
164451426|NCT04586920|594021714|FG009|Overall Study|Lost to Follow-up|1|||
164451427|NCT04586920|594021715|FG010|Overall Study|Lost to Follow-up|0|||
164451428|NCT04586920|594021716|FG011|Overall Study|Lost to Follow-up|0|||
164451429|NCT04586920|594021717|FG012|Overall Study|Lost to Follow-up|0|||
164451430|NCT04586920|594021718|FG013|Overall Study|Lost to Follow-up|1|||
164451431|NCT04586920|594021719|FG014|Overall Study|Lost to Follow-up|0|||
164451432|NCT04586920|594021720|FG015|Overall Study|Lost to Follow-up|0|||
164451433|NCT04586920|594021721|FG016|Overall Study|Lost to Follow-up|0|||
164451434|NCT04586920|594021722|FG017|Overall Study|Lost to Follow-up|0|||
164451435|NCT04586920|594021705|FG000|Overall Study|Withdrawal by Subject|0|||
164451436|NCT04586920|594021706|FG001|Overall Study|Withdrawal by Subject|0|||
164451437|NCT04586920|594021707|FG002|Overall Study|Withdrawal by Subject|0|||
164451438|NCT04586920|594021708|FG003|Overall Study|Withdrawal by Subject|0|||
164451439|NCT04586920|594021709|FG004|Overall Study|Withdrawal by Subject|0|||
164451440|NCT04586920|594021710|FG005|Overall Study|Withdrawal by Subject|0|||
164451441|NCT04586920|594021711|FG006|Overall Study|Withdrawal by Subject|0|||
164451442|NCT04586920|594021712|FG007|Overall Study|Withdrawal by Subject|1|||
164451443|NCT04586920|594021713|FG008|Overall Study|Withdrawal by Subject|0|||
164451444|NCT04586920|594021714|FG009|Overall Study|Withdrawal by Subject|1|||
164451445|NCT04586920|594021715|FG010|Overall Study|Withdrawal by Subject|0|||
164451446|NCT04586920|594021716|FG011|Overall Study|Withdrawal by Subject|1|||
164451447|NCT04586920|594021717|FG012|Overall Study|Withdrawal by Subject|0|||
164451448|NCT04586920|594021718|FG013|Overall Study|Withdrawal by Subject|0|||
164451449|NCT04586920|594021719|FG014|Overall Study|Withdrawal by Subject|0|||
164451450|NCT04586920|594021720|FG015|Overall Study|Withdrawal by Subject|0|||
164451451|NCT04586920|594021721|FG016|Overall Study|Withdrawal by Subject|0|||
164451452|NCT04586920|594021722|FG017|Overall Study|Withdrawal by Subject|0|||
164451453|NCT04905407|594021728|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
164451454|NCT04905407|594021729|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
164451455|NCT04905407|594021730|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
164451456|NCT04905407|594021731|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
164451457|NCT04905407|594021728|FG000|Part 1 and Part 2|Death|7|||
164451458|NCT04905407|594021729|FG001|Part 1 and Part 2|Death|7|||
164451459|NCT04905407|594021730|FG002|Part 1 and Part 2|Death|7|||
164451460|NCT04905407|594021731|FG003|Part 1 and Part 2|Death|0|||
164451461|NCT04905407|594021728|FG000|Part 1 and Part 2|Other than specified|0|||
164451462|NCT04905407|594021729|FG001|Part 1 and Part 2|Other than specified|0|||
164451463|NCT04905407|594021730|FG002|Part 1 and Part 2|Other than specified|1|||
164451464|NCT04905407|594021731|FG003|Part 1 and Part 2|Other than specified|0|||
164451465|NCT04905407|594021728|FG000|Part 3|Death|0|||
164451466|NCT04905407|594021729|FG001|Part 3|Death|0|||
164451467|NCT04905407|594021730|FG002|Part 3|Death|0|||
164451468|NCT04905407|594021731|FG003|Part 3|Death|2|||
164451469|NCT00894543|594021735|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
164451470|NCT00894543|594021736|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
164451471|NCT00894543|594021735|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
164451472|NCT00894543|594021736|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
164451473|NCT03446157|594021737|FG000|Overall Study|Death|11|||
164451474|NCT03446157|594021738|FG001|Overall Study|Death|9|||
164451475|NCT03446157|594021737|FG000|Overall Study|Lost to Follow-up|0|||
164451476|NCT03446157|594021738|FG001|Overall Study|Lost to Follow-up|1|||
164451477|NCT03446157|594021737|FG000|Overall Study|Withdrawal by Subject|2|||
164451478|NCT03446157|594021738|FG001|Overall Study|Withdrawal by Subject|1|||
164451479|NCT05384730|594021747|FG000|Overall Study|Adverse Event|1|||
164451480|NCT05384730|594021748|FG001|Overall Study|Adverse Event|0|||
164451481|NCT05384730|594021747|FG000|Overall Study|Lack of social support|2|||
164451482|NCT05384730|594021748|FG001|Overall Study|Lack of social support|0|||
164451483|NCT05384730|594021747|FG000|Overall Study|Hospital readmission|2|||
164451484|NCT05384730|594021748|FG001|Overall Study|Hospital readmission|0|||
164451485|NCT05384730|594021747|FG000|Overall Study|Disease progression|5|||
164451486|NCT05384730|594021748|FG001|Overall Study|Disease progression|0|||
164451487|NCT05384730|594021747|FG000|Overall Study|Overwhelmed with College commitments|0|||
164451488|NCT05384730|594021748|FG001|Overall Study|Overwhelmed with College commitments|2|||
164451489|NCT00411151|594021749|FG000|Overall Study|Death|38|||
164451490|NCT00411151|594021749|FG000|Overall Study|Withdrawal by Subject|2|||
164451491|NCT00411151|594021749|FG000|Overall Study|Lost to Follow-up|2|||
164451492|NCT00411151|594021749|FG000|Overall Study|Protocol Violation|1|||
164451493|NCT00411151|594021749|FG000|Overall Study|Trial prematurely closed|4|||
164451494|NCT01619410|594021753|FG000|Overall Study|Lost to Follow-up|7|||
164451495|NCT01619410|594021754|FG001|Overall Study|Lost to Follow-up|4|||
164451496|NCT04452318|594021759|FG000|Overall Study|Physician Decision|1|||
164451497|NCT04452318|594021760|FG001|Overall Study|Physician Decision|2|||
164451498|NCT04452318|594021761|FG002|Overall Study|Physician Decision|0|||
164451499|NCT04452318|594021762|FG003|Overall Study|Physician Decision|2|||
164451500|NCT04452318|594021763|FG004|Overall Study|Physician Decision|0|||
164451501|NCT04452318|594021764|FG005|Overall Study|Physician Decision|2|||
164451502|NCT04452318|594021765|FG006|Overall Study|Physician Decision|5|||
164451503|NCT04452318|594021759|FG000|Overall Study|Death|2|||
164451504|NCT04452318|594021760|FG001|Overall Study|Death|3|||
164451505|NCT04452318|594021761|FG002|Overall Study|Death|0|||
164451506|NCT04452318|594021762|FG003|Overall Study|Death|0|||
164451507|NCT04452318|594021763|FG004|Overall Study|Death|0|||
164451508|NCT04452318|594021764|FG005|Overall Study|Death|0|||
164451509|NCT04452318|594021765|FG006|Overall Study|Death|0|||
164451510|NCT04452318|594021759|FG000|Overall Study|Lost to Follow-up|38|||
164451511|NCT04452318|594021760|FG001|Overall Study|Lost to Follow-up|28|||
164451512|NCT04452318|594021761|FG002|Overall Study|Lost to Follow-up|0|||
164451513|NCT04452318|594021762|FG003|Overall Study|Lost to Follow-up|3|||
164451514|NCT04452318|594021763|FG004|Overall Study|Lost to Follow-up|3|||
164451515|NCT04452318|594021764|FG005|Overall Study|Lost to Follow-up|2|||
164706550|NCT02393248|594953422|FG008|Part 3: Combination Therapy|Death|0|||
164451516|NCT04452318|594021765|FG006|Overall Study|Lost to Follow-up|1|||
164451517|NCT04452318|594021759|FG000|Overall Study|Withdrawal by Subject|46|||
164451518|NCT04452318|594021760|FG001|Overall Study|Withdrawal by Subject|40|||
164451519|NCT04452318|594021761|FG002|Overall Study|Withdrawal by Subject|0|||
164451520|NCT04452318|594021762|FG003|Overall Study|Withdrawal by Subject|18|||
164451521|NCT04452318|594021763|FG004|Overall Study|Withdrawal by Subject|6|||
164451522|NCT04452318|594021764|FG005|Overall Study|Withdrawal by Subject|8|||
164451523|NCT04452318|594021765|FG006|Overall Study|Withdrawal by Subject|6|||
164451524|NCT00448669|594021771|FG000|Overall Study|Lost to Follow-up|52|||
164451525|NCT00448669|594021772|FG001|Overall Study|Lost to Follow-up|63|||
164451526|NCT00448669|594021771|FG000|Overall Study|Withdrawal by Subject|90|||
164451527|NCT00448669|594021772|FG001|Overall Study|Withdrawal by Subject|74|||
164451528|NCT00448669|594021771|FG000|Overall Study|Relocated|49|||
164451529|NCT00448669|594021772|FG001|Overall Study|Relocated|36|||
164451530|NCT00448669|594021771|FG000|Overall Study|Were withdrawn by investigator|10|||
164451531|NCT00448669|594021772|FG001|Overall Study|Were withdrawn by investigator|6|||
164451532|NCT00448669|594021771|FG000|Overall Study|Death|2|||
164451533|NCT00448669|594021772|FG001|Overall Study|Death|4|||
164451534|NCT00448669|594021771|FG000|Overall Study|Had other reasons|5|||
164451535|NCT00448669|594021772|FG001|Overall Study|Had other reasons|6|||
164451536|NCT00448669|594021771|FG000|Overall Study|HIV-infected at enrollment|1|||
164451537|NCT00448669|594021772|FG001|Overall Study|HIV-infected at enrollment|2|||
164451538|NCT00448669|594021771|FG000|Overall Study|Never started drug|9|||
164451539|NCT00448669|594021772|FG001|Overall Study|Never started drug|7|||
164451540|NCT04287985|594021773|FG000|Overall Study|Adverse Event|1|||
164706551|NCT02393248|594953423|FG009|Part 3: Combination Therapy|Death|0|||
164451541|NCT04287985|594021774|FG001|Overall Study|Adverse Event|0|||
164451542|NCT04287985|594021775|FG002|Overall Study|Adverse Event|0|||
164451543|NCT04287985|594021776|FG003|Overall Study|Adverse Event|0|||
164451544|NCT04287985|594021773|FG000|Overall Study|Protocol Violation|0|||
164451545|NCT04287985|594021774|FG001|Overall Study|Protocol Violation|1|||
164451546|NCT04287985|594021775|FG002|Overall Study|Protocol Violation|0|||
164451547|NCT04287985|594021776|FG003|Overall Study|Protocol Violation|0|||
164451548|NCT04287985|594021773|FG000|Overall Study|Physician Decision|0|||
164451549|NCT04287985|594021774|FG001|Overall Study|Physician Decision|0|||
164451550|NCT04287985|594021775|FG002|Overall Study|Physician Decision|0|||
164451551|NCT04287985|594021776|FG003|Overall Study|Physician Decision|1|||
164451552|NCT04287985|594021773|FG000|Overall Study|Withdrawal by Subject|2|||
164451553|NCT04287985|594021774|FG001|Overall Study|Withdrawal by Subject|1|||
164451554|NCT04287985|594021775|FG002|Overall Study|Withdrawal by Subject|1|||
164451555|NCT04287985|594021776|FG003|Overall Study|Withdrawal by Subject|2|||
164451556|NCT02638337|594021777|FG000|Overall Study|Adverse Event|6|||
164451557|NCT02638337|594021778|FG001|Overall Study|Adverse Event|10|||
164451558|NCT02638337|594021777|FG000|Overall Study|Protocol Violation|3|||
164706552|NCT02393248|594953424|FG010|Part 3: Combination Therapy|Death|0|||
164451559|NCT02638337|594021778|FG001|Overall Study|Protocol Violation|0|||
164451560|NCT02638337|594021777|FG000|Overall Study|Withdrawal by Subject|13|||
164451561|NCT02638337|594021778|FG001|Overall Study|Withdrawal by Subject|16|||
164451562|NCT02638337|594021777|FG000|Overall Study|Lost to Follow-up|7|||
164451563|NCT02638337|594021778|FG001|Overall Study|Lost to Follow-up|7|||
164451564|NCT02638337|594021777|FG000|Overall Study|Other - Miscellaneous|4|||
164706553|NCT02393248|594953425|FG011|Part 3: Combination Therapy|Death|0|||
164706554|NCT02393248|594953426|FG012|Part 3: Combination Therapy|Death|0|||
164706555|NCT02393248|594953427|FG013|Part 3: Combination Therapy|Death|0|||
164706556|NCT02393248|594953428|FG014|Part 3: Combination Therapy|Death|0|||
164706557|NCT02393248|594953429|FG015|Part 3: Combination Therapy|Death|1|||
164706558|NCT02393248|594953430|FG016|Part 3: Combination Therapy|Death|7|||
164451565|NCT02638337|594021778|FG001|Overall Study|Other - Miscellaneous|3|||
164451566|NCT01340066|594021779|FG000|Placebo Run in Period|Screen Failures|27|||
164451567|NCT01340066|594021780|FG001|Placebo Run in Period|Screen Failures|0|||
164451568|NCT01340066|594021781|FG002|Placebo Run in Period|Screen Failures|0|||
164451569|NCT01340066|594021779|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
164451570|NCT01340066|594021780|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
164451571|NCT01340066|594021781|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
164451572|NCT01340066|594021779|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
164451573|NCT01340066|594021780|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
164451574|NCT01340066|594021781|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
164451575|NCT01340066|594021779|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
164451576|NCT01340066|594021780|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
164451577|NCT01340066|594021781|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
164451578|NCT02789020|594021782|FG000|Overall Study|Withdrawal by Subject|6|||
164451579|NCT02789020|594021783|FG001|Overall Study|Withdrawal by Subject|5|||
164451580|NCT03771352|594021786|FG000|Overall Study|Screen failure|2|||
164451581|NCT03771352|594021786|FG000|Overall Study|Withdrawal by Subject|2|||
164451582|NCT05512962|594021791|FG000|Overall Study|Withdrawal by Subject|1|||
164451583|NCT05512962|594021792|FG001|Overall Study|Withdrawal by Subject|0|||
164597272|NCT02052778|594549010|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
164597273|NCT02052778|594549011|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
164597274|NCT02052778|594549012|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
164597275|NCT02052778|594549013|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
164597276|NCT02052778|594549014|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
164597277|NCT02052778|594549015|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
164597278|NCT02052778|594548993|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
164597279|NCT02052778|594548994|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
164597280|NCT02052778|594548995|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
164597281|NCT02052778|594548996|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
164597282|NCT02052778|594548997|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
164597283|NCT02052778|594548998|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
164597284|NCT02052778|594548999|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
164597285|NCT02052778|594549000|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
164597286|NCT02052778|594549001|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
164597287|NCT02052778|594549002|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
164597288|NCT02052778|594549003|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
164597289|NCT02052778|594549004|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
164597290|NCT02052778|594549005|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
164706559|NCT02393248|594953431|FG017|Part 3: Combination Therapy|Death|5|||
164405120|NCT03685591|593853885|FG006|Overall Study|Adverse Event|0|||
164405121|NCT03685591|593853886|FG007|Overall Study|Adverse Event|1|||
164405122|NCT03685591|593853887|FG008|Overall Study|Adverse Event|1|||
164405123|NCT01685138|593853888|FG000|Overall Study|Lost to Follow-up|1|||
164405124|NCT01685138|593853888|FG000|Overall Study|Protocol Violation|1|||
164405125|NCT01685138|593853888|FG000|Overall Study|No longer requires treatment|1|||
164405126|NCT01685138|593853888|FG000|Overall Study|Subject/guardian decision|2|||
164405127|NCT01685138|593853888|FG000|Overall Study|Physician Decision|6|||
164405128|NCT01685138|593853888|FG000|Overall Study|Death|10|||
164405129|NCT01685138|593853888|FG000|Overall Study|Adverse Event|18|||
164405130|NCT01685138|593853888|FG000|Overall Study|Progressive disease|53|||
164405131|NCT00689026|593853891|FG000|Overall Study|Withdrawal by Subject|13|||
164405132|NCT00689026|593853892|FG001|Overall Study|Withdrawal by Subject|6|||
164405133|NCT03996291|593853898|FG000|Part A (Double-blind Period):39 Weeks|Other|1|||
164405134|NCT03996291|593853899|FG001|Part A (Double-blind Period):39 Weeks|Other|0|||
164405135|NCT03996291|593853900|FG002|Part A (Double-blind Period):39 Weeks|Other|0|||
164451584|NCT03380390|594021793|FG000|Overall Study|Adverse Event|3|||
164451585|NCT05494788|594021796|FG000|Initial Treatment Period|Adverse Event|2|||
164451586|NCT05494788|594021796|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
164597291|NCT02052778|594549006|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
164706560|NCT02393248|594953432|FG018|Part 3: Combination Therapy|Death|5|||
164706561|NCT02393248|594953433|FG019|Part 3: Combination Therapy|Death|3|||
164451587|NCT05494788|594021796|FG000|Extension Period|Adverse Event|1|||
164451588|NCT05494788|594021796|FG000|Extension Period|Withdrawal by Subject|1|||
164451589|NCT03101930|594021797|FG000|Overall Study|Withdrawal by Subject|2|||
164451590|NCT03101930|594021798|FG001|Overall Study|Withdrawal by Subject|1|||
164451591|NCT03101930|594021799|FG002|Overall Study|Withdrawal by Subject|2|||
164451592|NCT02814838|594021800|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
164451593|NCT02814838|594021801|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
164451594|NCT02814838|594021800|FG000|Overall Study|Consent withdrawal|1|||
164451595|NCT02814838|594021801|FG001|Overall Study|Consent withdrawal|1|||
164451596|NCT01747486|594021802|FG000|Stage 1|Physician Decision|3|||
164451597|NCT01747486|594021803|FG001|Stage 1|Physician Decision|0|||
164451598|NCT01747486|594021802|FG000|Stage 1|Withdrawal by Subject|4|||
164451599|NCT01747486|594021803|FG001|Stage 1|Withdrawal by Subject|3|||
164451600|NCT01747486|594021802|FG000|Stage 1|Disease progression|4|||
164451601|NCT01747486|594021803|FG001|Stage 1|Disease progression|9|||
164451602|NCT01747486|594021802|FG000|Stage 1|Death|1|||
164451603|NCT01747486|594021803|FG001|Stage 1|Death|1|||
164451604|NCT01747486|594021802|FG000|Stage 2|Physician Decision|2|||
164451605|NCT01747486|594021803|FG001|Stage 2|Physician Decision|0|||
164451606|NCT01747486|594021802|FG000|Stage 2|Withdrawal by Subject|1|||
164451607|NCT01747486|594021803|FG001|Stage 2|Withdrawal by Subject|0|||
164451608|NCT01747486|594021802|FG000|Stage 2|New Cancer Therapy|3|||
164451609|NCT01747486|594021803|FG001|Stage 2|New Cancer Therapy|0|||
164451610|NCT01747486|594021802|FG000|Stage 2|Disease Progression|3|||
164451611|NCT01747486|594021803|FG001|Stage 2|Disease Progression|0|||
164451612|NCT01771731|594021804|FG000|Overall Study|Physician Decision|1|||
164451613|NCT01771731|594021805|FG001|Overall Study|Physician Decision|0|||
164451614|NCT01771731|594021804|FG000|Overall Study|Protocol Violation|0|||
164451615|NCT01771731|594021805|FG001|Overall Study|Protocol Violation|1|||
164451616|NCT01771731|594021804|FG000|Overall Study|Adverse event: Pain Crisis|1|||
164451617|NCT01771731|594021805|FG001|Overall Study|Adverse event: Pain Crisis|1|||
164451618|NCT00087139|594021806|FG000|Overall Study|Adverse Event|18|||
164451619|NCT00087139|594021807|FG001|Overall Study|Adverse Event|17|||
164451620|NCT00087139|594021808|FG002|Overall Study|Adverse Event|13|||
164451621|NCT00087139|594021806|FG000|Overall Study|Death|2|||
164451622|NCT00087139|594021807|FG001|Overall Study|Death|1|||
164451623|NCT00087139|594021808|FG002|Overall Study|Death|0|||
164451624|NCT00087139|594021806|FG000|Overall Study|Withdrawal by Subject|3|||
164451625|NCT00087139|594021807|FG001|Overall Study|Withdrawal by Subject|2|||
164451626|NCT00087139|594021808|FG002|Overall Study|Withdrawal by Subject|2|||
164451627|NCT00087139|594021806|FG000|Overall Study|Physician Decision|1|||
164451628|NCT00087139|594021807|FG001|Overall Study|Physician Decision|1|||
164451629|NCT00087139|594021808|FG002|Overall Study|Physician Decision|1|||
164451630|NCT00087139|594021806|FG000|Overall Study|Disease progression|9|||
164451631|NCT00087139|594021807|FG001|Overall Study|Disease progression|19|||
164451632|NCT00087139|594021808|FG002|Overall Study|Disease progression|12|||
164451633|NCT00087139|594021806|FG000|Overall Study|Ineligible|4|||
164451634|NCT00087139|594021807|FG001|Overall Study|Ineligible|7|||
164451635|NCT00087139|594021808|FG002|Overall Study|Ineligible|4|||
164451636|NCT00087139|594021806|FG000|Overall Study|Symptomatic deterioration|1|||
164451637|NCT00087139|594021807|FG001|Overall Study|Symptomatic deterioration|1|||
164451638|NCT00087139|594021808|FG002|Overall Study|Symptomatic deterioration|3|||
164451639|NCT00087139|594021806|FG000|Overall Study|Use of coumadin|1|||
164451640|NCT00087139|594021807|FG001|Overall Study|Use of coumadin|0|||
164451641|NCT00087139|594021808|FG002|Overall Study|Use of coumadin|0|||
164451642|NCT00087139|594021806|FG000|Overall Study|Response achieved|0|||
164451643|NCT00087139|594021807|FG001|Overall Study|Response achieved|1|||
164451644|NCT00087139|594021808|FG002|Overall Study|Response achieved|0|||
164451645|NCT00087139|594021806|FG000|Overall Study|Extradural disease|0|||
164451646|NCT00087139|594021807|FG001|Overall Study|Extradural disease|0|||
164451647|NCT00087139|594021808|FG002|Overall Study|Extradural disease|1|||
164451648|NCT00073749|594021809|FG000|Overall Study|Disease Progression|2|||
164451649|NCT00073749|594021810|FG001|Overall Study|Disease Progression|0|||
164451650|NCT00073749|594021811|FG002|Overall Study|Disease Progression|3|||
164451651|NCT00073749|594021812|FG003|Overall Study|Disease Progression|2|||
164451652|NCT00073749|594021813|FG004|Overall Study|Disease Progression|3|||
164451653|NCT00073749|594021814|FG005|Overall Study|Disease Progression|1|||
164451654|NCT00073749|594021815|FG006|Overall Study|Disease Progression|3|||
164451655|NCT00073749|594021809|FG000|Overall Study|Death|0|||
164451656|NCT00073749|594021810|FG001|Overall Study|Death|1|||
164451657|NCT00073749|594021811|FG002|Overall Study|Death|1|||
164451658|NCT00073749|594021812|FG003|Overall Study|Death|0|||
164451659|NCT00073749|594021813|FG004|Overall Study|Death|0|||
164451660|NCT00073749|594021814|FG005|Overall Study|Death|0|||
164451661|NCT00073749|594021815|FG006|Overall Study|Death|29|||
164451662|NCT00073749|594021809|FG000|Overall Study|Adverse Event|0|||
164451663|NCT00073749|594021810|FG001|Overall Study|Adverse Event|3|||
164451664|NCT00073749|594021811|FG002|Overall Study|Adverse Event|6|||
164451665|NCT00073749|594021812|FG003|Overall Study|Adverse Event|4|||
164451666|NCT00073749|594021813|FG004|Overall Study|Adverse Event|2|||
164451667|NCT00073749|594021814|FG005|Overall Study|Adverse Event|1|||
164451668|NCT00073749|594021815|FG006|Overall Study|Adverse Event|0|||
164451669|NCT00073749|594021809|FG000|Overall Study|Physician Decision|0|||
164451670|NCT00073749|594021810|FG001|Overall Study|Physician Decision|0|||
164597292|NCT02052778|594549007|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
164597293|NCT02052778|594549008|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
164597294|NCT02052778|594549009|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
164597295|NCT02052778|594549010|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
164597296|NCT02052778|594549011|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
164597297|NCT02052778|594549012|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
164597298|NCT02052778|594549013|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
164597299|NCT02052778|594549014|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
164597300|NCT02052778|594549015|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
164597301|NCT01774344|594549016|FG000|Overall Study|Withdrawal by Subject|3|||
164597302|NCT01774344|594549017|FG001|Overall Study|Withdrawal by Subject|10|||
164597303|NCT01774344|594549016|FG000|Overall Study|Protocol Violation|0|||
164597304|NCT01774344|594549017|FG001|Overall Study|Protocol Violation|1|||
164597305|NCT01774344|594549016|FG000|Overall Study|Lost to Follow-up|4|||
164597306|NCT01774344|594549017|FG001|Overall Study|Lost to Follow-up|10|||
164597307|NCT01774344|594549016|FG000|Overall Study|End of survival follow-up not available|2|||
164597308|NCT01774344|594549017|FG001|Overall Study|End of survival follow-up not available|2|||
164597309|NCT01774344|594549016|FG000|Overall Study|Data collection finished|4|||
164597310|NCT01774344|594549017|FG001|Overall Study|Data collection finished|14|||
164597311|NCT01774344|594549016|FG000|Overall Study|Other|0|||
164597312|NCT01774344|594549017|FG001|Overall Study|Other|1|||
164597313|NCT01774344|594549016|FG000|Overall Study|Did not enter Survival Follow up|49|||
164597314|NCT01774344|594549017|FG001|Overall Study|Did not enter Survival Follow up|83|||
164597315|NCT00502320|594549023|FG000|Overall Study|Lost to Follow-up|1|||
164597316|NCT00502320|594549024|FG001|Overall Study|Lost to Follow-up|1|||
164597317|NCT00502320|594549023|FG000|Overall Study|Withdrew Consent|1|||
164597318|NCT00502320|594549024|FG001|Overall Study|Withdrew Consent|0|||
164597319|NCT00502320|594549023|FG000|Overall Study|No longer met criteria|1|||
164597320|NCT00502320|594549024|FG001|Overall Study|No longer met criteria|0|||
164597321|NCT00502320|594549023|FG000|Overall Study|Screen Failure|0|||
164597322|NCT00502320|594549024|FG001|Overall Study|Screen Failure|1|||
164405136|NCT03996291|593853901|FG003|Part A (Double-blind Period):39 Weeks|Other|0|||
164405137|NCT03996291|593853902|FG004|Part A (Double-blind Period):39 Weeks|Other|0|||
164405138|NCT03996291|593853903|FG005|Part A (Double-blind Period):39 Weeks|Other|0|||
164405139|NCT03996291|593853904|FG006|Part A (Double-blind Period):39 Weeks|Other|0|||
164405140|NCT03996291|593853905|FG007|Part A (Double-blind Period):39 Weeks|Other|0|||
164405141|NCT03996291|593853898|FG000|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
164405142|NCT03996291|593853899|FG001|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
164405143|NCT03996291|593853900|FG002|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
164405144|NCT03996291|593853901|FG003|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
164405145|NCT03996291|593853902|FG004|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
164405146|NCT03996291|593853903|FG005|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
164405147|NCT03996291|593853904|FG006|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
164405148|NCT03996291|593853905|FG007|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
164405149|NCT03996291|593853898|FG000|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
164405150|NCT03996291|593853899|FG001|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
164405151|NCT03996291|593853900|FG002|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
164405152|NCT03996291|593853901|FG003|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
164405153|NCT03996291|593853902|FG004|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
164405154|NCT03996291|593853903|FG005|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
164405155|NCT03996291|593853904|FG006|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
164405156|NCT03996291|593853905|FG007|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
164405157|NCT03996291|593853898|FG000|Part B (Open-label Period):222 Weeks|Other|0|||
164405158|NCT03996291|593853899|FG001|Part B (Open-label Period):222 Weeks|Other|0|||
164405159|NCT03996291|593853900|FG002|Part B (Open-label Period):222 Weeks|Other|0|||
164405160|NCT03996291|593853901|FG003|Part B (Open-label Period):222 Weeks|Other|0|||
164405161|NCT03996291|593853902|FG004|Part B (Open-label Period):222 Weeks|Other|8|||
164405162|NCT03996291|593853903|FG005|Part B (Open-label Period):222 Weeks|Other|7|||
164405163|NCT03996291|593853904|FG006|Part B (Open-label Period):222 Weeks|Other|10|||
164405164|NCT03996291|593853905|FG007|Part B (Open-label Period):222 Weeks|Other|5|||
164405165|NCT03996291|593853898|FG000|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
164405166|NCT03996291|593853899|FG001|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
164597323|NCT00502320|594549023|FG000|Overall Study|Adverse Event|3|||
164405167|NCT03996291|593853900|FG002|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
164451671|NCT00073749|594021811|FG002|Overall Study|Physician Decision|1|||
164597324|NCT00502320|594549024|FG001|Overall Study|Adverse Event|5|||
164597325|NCT00543569|594549025|FG000|Overall Study|Death|2|||
164597326|NCT00543569|594549026|FG001|Overall Study|Death|2|||
164451672|NCT00073749|594021812|FG003|Overall Study|Physician Decision|0|||
164451673|NCT00073749|594021813|FG004|Overall Study|Physician Decision|0|||
164451674|NCT00073749|594021814|FG005|Overall Study|Physician Decision|2|||
164451675|NCT00073749|594021815|FG006|Overall Study|Physician Decision|0|||
164451676|NCT00073749|594021809|FG000|Overall Study|Withdrawal by Subject|0|||
164451677|NCT00073749|594021810|FG001|Overall Study|Withdrawal by Subject|1|||
164451678|NCT00073749|594021811|FG002|Overall Study|Withdrawal by Subject|0|||
164451679|NCT00073749|594021812|FG003|Overall Study|Withdrawal by Subject|0|||
164451680|NCT00073749|594021813|FG004|Overall Study|Withdrawal by Subject|1|||
164451681|NCT00073749|594021814|FG005|Overall Study|Withdrawal by Subject|0|||
164451682|NCT00073749|594021815|FG006|Overall Study|Withdrawal by Subject|2|||
164451683|NCT00073749|594021809|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
164451684|NCT00073749|594021810|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
164451685|NCT00073749|594021811|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
164451686|NCT00073749|594021812|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
164451687|NCT00073749|594021813|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
164451688|NCT00073749|594021814|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
164451689|NCT00073749|594021815|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
164451690|NCT00073749|594021809|FG000|Overall Study|Lost to Follow-up|0|||
164451691|NCT00073749|594021810|FG001|Overall Study|Lost to Follow-up|0|||
164451692|NCT00073749|594021811|FG002|Overall Study|Lost to Follow-up|0|||
164451693|NCT00073749|594021812|FG003|Overall Study|Lost to Follow-up|0|||
164451694|NCT00073749|594021813|FG004|Overall Study|Lost to Follow-up|0|||
164451695|NCT00073749|594021814|FG005|Overall Study|Lost to Follow-up|0|||
164451696|NCT00073749|594021815|FG006|Overall Study|Lost to Follow-up|2|||
164451697|NCT00073749|594021809|FG000|Overall Study|Other|0|||
164451698|NCT00073749|594021810|FG001|Overall Study|Other|0|||
164451699|NCT00073749|594021811|FG002|Overall Study|Other|0|||
164451700|NCT00073749|594021812|FG003|Overall Study|Other|0|||
164451701|NCT00073749|594021813|FG004|Overall Study|Other|0|||
164451702|NCT00073749|594021814|FG005|Overall Study|Other|2|||
164451703|NCT00073749|594021815|FG006|Overall Study|Other|0|||
164451704|NCT02272816|594021816|FG000|Overall Study|Adverse Event|1|||
164451705|NCT04154384|594021823|FG000|Overall Study|Lost to Follow-up|24|||
164451706|NCT04154384|594021824|FG001|Overall Study|Lost to Follow-up|33|||
164451707|NCT04154384|594021825|FG002|Overall Study|Lost to Follow-up|0|||
164451708|NCT04154384|594021823|FG000|Overall Study|Withdrawal by Subject|7|||
164451709|NCT04154384|594021824|FG001|Overall Study|Withdrawal by Subject|18|||
164451710|NCT04154384|594021825|FG002|Overall Study|Withdrawal by Subject|0|||
164451711|NCT04154384|594021823|FG000|Overall Study|Missing outcome data|1|||
164451712|NCT04154384|594021824|FG001|Overall Study|Missing outcome data|0|||
164451713|NCT04154384|594021825|FG002|Overall Study|Missing outcome data|0|||
164451714|NCT04095104|594021826|FG000|Overall Study|Withdrawal by Subject|0|||
164451715|NCT04095104|594021827|FG001|Overall Study|Withdrawal by Subject|1|||
164451716|NCT01136876|594021828|FG000|Overall Study|Lost to Follow-up|0|||
164451717|NCT01136876|594021829|FG001|Overall Study|Lost to Follow-up|1|||
164451718|NCT01136876|594021828|FG000|Overall Study|Physician Decision|3|||
164451719|NCT01136876|594021829|FG001|Overall Study|Physician Decision|5|||
164451720|NCT01136876|594021828|FG000|Overall Study|Missing NGAL measurement|2|||
164451721|NCT01136876|594021829|FG001|Overall Study|Missing NGAL measurement|5|||
164451722|NCT04732338|594021832|FG000|Overall Study|Lost to Follow-up|3|||
164451723|NCT04732338|594021833|FG001|Overall Study|Lost to Follow-up|3|||
164451724|NCT00065260|594021834|FG000|Overall Study|Death|0|||
164451725|NCT00065260|594021835|FG001|Overall Study|Death|1|||
164451726|NCT00088413|594021838|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
164451727|NCT00088413|594021839|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
164451728|NCT00088413|594021840|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
164451729|NCT00088413|594021841|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
164451730|NCT00088413|594021838|FG000|Overall Study|Adverse Events/Side Effects|0|||
164451731|NCT00088413|594021839|FG001|Overall Study|Adverse Events/Side Effects|1|||
164451732|NCT00088413|594021840|FG002|Overall Study|Adverse Events/Side Effects|1|||
164451733|NCT00088413|594021841|FG003|Overall Study|Adverse Events/Side Effects|0|||
164451734|NCT00088413|594021838|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
164451735|NCT00088413|594021839|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
164451736|NCT00088413|594021840|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
164451737|NCT00088413|594021841|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
164451738|NCT00088413|594021838|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
164451739|NCT00088413|594021839|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
164451740|NCT00088413|594021840|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
164451741|NCT00088413|594021841|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
164451742|NCT00088413|594021838|FG000|Overall Study|Death|0|||
164451743|NCT00088413|594021839|FG001|Overall Study|Death|1|||
164451744|NCT00088413|594021840|FG002|Overall Study|Death|0|||
164451745|NCT00088413|594021841|FG003|Overall Study|Death|0|||
164706562|NCT02393248|594953434|FG020|Part 3: Combination Therapy|Death|7|||
164706563|NCT02393248|594953435|FG021|Part 3: Combination Therapy|Death|5|||
164706564|NCT02393248|594953436|FG022|Part 3: Combination Therapy|Death|6|||
164706565|NCT02393248|594953437|FG023|Part 3: Combination Therapy|Death|3|||
164706566|NCT02393248|594953438|FG024|Part 3: Combination Therapy|Death|0|||
164451746|NCT00088413|594021838|FG000|Overall Study|Progressive disease|9|||
164451747|NCT00088413|594021839|FG001|Overall Study|Progressive disease|11|||
164451748|NCT00088413|594021840|FG002|Overall Study|Progressive disease|8|||
164451749|NCT00088413|594021841|FG003|Overall Study|Progressive disease|14|||
164451750|NCT00088413|594021838|FG000|Overall Study|Other|0|||
164451751|NCT00088413|594021839|FG001|Overall Study|Other|1|||
164451752|NCT00088413|594021840|FG002|Overall Study|Other|0|||
164451753|NCT00088413|594021841|FG003|Overall Study|Other|0|||
164451754|NCT00088413|594021838|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
164451755|NCT00088413|594021839|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
164451756|NCT00088413|594021840|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
164451757|NCT00088413|594021841|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
164451758|NCT02759016|594021842|FG000|Overall Study|Not treated with BI 836826|1|||
164451759|NCT02759016|594021843|FG001|Overall Study|Not treated with BI 836826|0|||
164451760|NCT02759016|594021842|FG000|Overall Study|Progressive disease|1|||
164451761|NCT02759016|594021843|FG001|Overall Study|Progressive disease|0|||
164451762|NCT02759016|594021842|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
164451763|NCT02759016|594021843|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
164451764|NCT02759016|594021842|FG000|Overall Study|Other not defined above|2|||
164451765|NCT02759016|594021843|FG001|Overall Study|Other not defined above|1|||
164451766|NCT02891915|594021852|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
164451767|NCT02891915|594021853|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
164451768|NCT02891915|594021852|FG000|Overall Study|Withdrawal by Subject|3|||
164451769|NCT02891915|594021853|FG001|Overall Study|Withdrawal by Subject|3|||
164451770|NCT02891915|594021852|FG000|Overall Study|Became Ineligible After Enrollment|2|||
164451771|NCT02891915|594021853|FG001|Overall Study|Became Ineligible After Enrollment|1|||
164451772|NCT02891915|594021852|FG000|Overall Study|Lost to Follow-up|1|||
164451773|NCT02891915|594021853|FG001|Overall Study|Lost to Follow-up|4|||
164451774|NCT02891915|594021852|FG000|Overall Study|Physician Decision|1|||
164451775|NCT02891915|594021853|FG001|Overall Study|Physician Decision|0|||
164451776|NCT04048382|594021854|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
164451777|NCT04048382|594021855|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
164451778|NCT04048382|594021854|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
164451779|NCT04048382|594021855|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
164451780|NCT04048382|594021854|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
164451781|NCT04048382|594021855|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
164451782|NCT02269475|594021859|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
164451783|NCT02269475|594021860|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
164451784|NCT02269475|594021859|FG000|Overall Study|Withdrawal by Subject|0|||
164451785|NCT02269475|594021860|FG001|Overall Study|Withdrawal by Subject|1|||
164451786|NCT05134337|594023891|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
164451787|NCT05134337|594023892|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
164451788|NCT04923347|594023893|FG000|Overall Study|Withdrawal by Subject|14|||
164451789|NCT03683069|594023897|FG000|Overall Study|see limitations|12|||
164451790|NCT03683069|594023898|FG001|Overall Study|see limitations|13|||
164451791|NCT04924062|594023899|FG000|Overall Study|Death|49|||
164451792|NCT04924062|594023900|FG001|Overall Study|Death|63|||
164451793|NCT04924062|594023899|FG000|Overall Study|Participant On-going|26|||
164451794|NCT04924062|594023900|FG001|Overall Study|Participant On-going|20|||
164451795|NCT05478525|594023903|FG000|Overall Study|Withdrawal by Subject|0|||
164451796|NCT05478525|594023904|FG001|Overall Study|Withdrawal by Subject|1|||
164451797|NCT05478525|594023905|FG002|Overall Study|Withdrawal by Subject|2|||
164451798|NCT05478525|594023906|FG003|Overall Study|Withdrawal by Subject|0|||
164451799|NCT05478525|594023903|FG000|Overall Study|COVID-19 Infection|2|||
164451800|NCT05478525|594023904|FG001|Overall Study|COVID-19 Infection|0|||
164451801|NCT05478525|594023905|FG002|Overall Study|COVID-19 Infection|1|||
164451802|NCT05478525|594023906|FG003|Overall Study|COVID-19 Infection|1|||
164451803|NCT01649271|594023907|FG000|Overall Study|Progressive disease|4|||
164451804|NCT01649271|594023908|FG001|Overall Study|Progressive disease|5|||
164451805|NCT01649271|594023907|FG000|Overall Study|Other Adverse Event|0|||
164706567|NCT02393248|594953414|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164706568|NCT02393248|594953415|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164451806|NCT01649271|594023908|FG001|Overall Study|Other Adverse Event|2|||
164451807|NCT01649271|594023907|FG000|Overall Study|Withdrawal by Subject|1|||
164451808|NCT01649271|594023908|FG001|Overall Study|Withdrawal by Subject|0|||
164706569|NCT02393248|594953416|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164451809|NCT01649271|594023907|FG000|Overall Study|Other than stated above|1|||
164451810|NCT01649271|594023908|FG001|Overall Study|Other than stated above|0|||
164451811|NCT01991977|594023909|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
164451812|NCT01991977|594023909|FG000|Overall Study|Withdrew after start of treatment|5|||
164451813|NCT04038957|594023911|FG000|Overall Study|Withdrawal by Subject|1|||
164451814|NCT04038957|594023911|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
164451815|NCT02605837|594023913|FG000|Overall Study|Adverse Event|3|||
164451816|NCT02605837|594023914|FG001|Overall Study|Adverse Event|1|||
164451817|NCT02605837|594023913|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164451818|NCT02605837|594023914|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164451819|NCT02605837|594023913|FG000|Overall Study|Withdrawal by Subject|8|||
164451820|NCT02605837|594023914|FG001|Overall Study|Withdrawal by Subject|8|||
164451821|NCT02605837|594023913|FG000|Overall Study|Physician Decision|0|||
164451822|NCT02605837|594023914|FG001|Overall Study|Physician Decision|1|||
164451823|NCT05104697|594023915|FG000|Overall Study|Withdrawal by Subject|0|||
164451824|NCT05104697|594023916|FG001|Overall Study|Withdrawal by Subject|1|||
164451825|NCT03845465|594023917|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
164451826|NCT03845465|594023918|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
164451827|NCT03845465|594023917|FG000|6-month Data Collection|Withdrawal by Subject|0|||
164451828|NCT03845465|594023918|FG001|6-month Data Collection|Withdrawal by Subject|2|||
164451829|NCT03845465|594023917|FG000|12-month Data Collection|Withdrawal by Subject|0|||
164451830|NCT03845465|594023918|FG001|12-month Data Collection|Withdrawal by Subject|2|||
164451831|NCT05656911|594023923|FG000|Treatment Phase|Physician Decision|2|||
164451832|NCT05656911|594023924|FG001|Treatment Phase|Physician Decision|0|||
164451833|NCT05656911|594023923|FG000|Treatment Phase|Lack of Efficacy|6|||
164451834|NCT05656911|594023924|FG001|Treatment Phase|Lack of Efficacy|3|||
164451835|NCT05656911|594023923|FG000|Treatment Phase|Subject Decision|4|||
164451836|NCT05656911|594023924|FG001|Treatment Phase|Subject Decision|2|||
164451837|NCT05656911|594023923|FG000|Treatment Phase|Other Reasons|1|||
164451838|NCT05656911|594023924|FG001|Treatment Phase|Other Reasons|0|||
164451839|NCT05656911|594023923|FG000|Treatment Phase|Adverse Event|3|||
164451840|NCT05656911|594023924|FG001|Treatment Phase|Adverse Event|1|||
164451841|NCT05656911|594023923|FG000|Follow-up Phase|Subject Decision|0|||
164451842|NCT05656911|594023924|FG001|Follow-up Phase|Subject Decision|1|||
164451843|NCT05656911|594023923|FG000|Follow-up Phase|Missing|1|||
164451844|NCT05656911|594023924|FG001|Follow-up Phase|Missing|0|||
164451845|NCT03547908|594023925|FG000|Blinded Phase|Lost to Follow-up|3|||
164451846|NCT03547908|594023926|FG001|Blinded Phase|Lost to Follow-up|3|||
164451847|NCT03547908|594023927|FG002|Blinded Phase|Lost to Follow-up|0|||
164451848|NCT03547908|594023928|FG003|Blinded Phase|Lost to Follow-up|0|||
164451849|NCT03547908|594023925|FG000|Blinded Phase|Withdrew Consent|2|||
164451850|NCT03547908|594023926|FG001|Blinded Phase|Withdrew Consent|3|||
164451851|NCT03547908|594023927|FG002|Blinded Phase|Withdrew Consent|0|||
164451852|NCT03547908|594023928|FG003|Blinded Phase|Withdrew Consent|0|||
164451853|NCT03547908|594023925|FG000|Blinded Phase|Investigator's Discretion|2|||
164451854|NCT03547908|594023926|FG001|Blinded Phase|Investigator's Discretion|1|||
164451855|NCT03547908|594023927|FG002|Blinded Phase|Investigator's Discretion|0|||
164451856|NCT03547908|594023928|FG003|Blinded Phase|Investigator's Discretion|0|||
164451857|NCT03547908|594023925|FG000|Blinded Phase|Death|2|||
164451858|NCT03547908|594023926|FG001|Blinded Phase|Death|0|||
164451859|NCT03547908|594023927|FG002|Blinded Phase|Death|0|||
164451860|NCT03547908|594023928|FG003|Blinded Phase|Death|0|||
164451861|NCT03547908|594023925|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
164451862|NCT03547908|594023926|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
164451863|NCT03547908|594023927|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
164451864|NCT03547908|594023928|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
164451865|NCT03547908|594023925|FG000|Blinded Phase|Adverse Event|1|||
164451866|NCT03547908|594023926|FG001|Blinded Phase|Adverse Event|0|||
164451867|NCT03547908|594023927|FG002|Blinded Phase|Adverse Event|0|||
164451868|NCT03547908|594023928|FG003|Blinded Phase|Adverse Event|0|||
164451869|NCT03547908|594023925|FG000|Blinded Phase|Randomized But Never Treated|1|||
164451870|NCT03547908|594023926|FG001|Blinded Phase|Randomized But Never Treated|0|||
164451871|NCT03547908|594023927|FG002|Blinded Phase|Randomized But Never Treated|0|||
164451872|NCT03547908|594023928|FG003|Blinded Phase|Randomized But Never Treated|0|||
164451873|NCT03547908|594023925|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
164451874|NCT03547908|594023926|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
164451875|NCT03547908|594023927|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
164451876|NCT03547908|594023928|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
164451877|NCT03547908|594023925|FG000|Open-label Extension Phase|Death|0|||
164451878|NCT03547908|594023926|FG001|Open-label Extension Phase|Death|0|||
164451879|NCT03547908|594023927|FG002|Open-label Extension Phase|Death|1|||
164451880|NCT03547908|594023928|FG003|Open-label Extension Phase|Death|0|||
164451881|NCT04059354|594023935|FG000|Overall Study|COVID-19 pandemic|3|||
164451882|NCT00567398|594023938|FG000|Overall Study|Adverse Event|6|||
164451883|NCT00567398|594023939|FG001|Overall Study|Adverse Event|14|||
164451884|NCT00567398|594023938|FG000|Overall Study|Physician Decision|0|||
164451885|NCT00567398|594023939|FG001|Overall Study|Physician Decision|4|||
164451886|NCT00567398|594023938|FG000|Overall Study|Withdrawal by Subject|0|||
164451887|NCT00567398|594023939|FG001|Overall Study|Withdrawal by Subject|2|||
164451888|NCT00567398|594023938|FG000|Overall Study|Renal Transplantation|0|||
164451889|NCT00567398|594023939|FG001|Overall Study|Renal Transplantation|3|||
164451890|NCT00567398|594023938|FG000|Overall Study|Other|1|||
164451891|NCT00567398|594023939|FG001|Overall Study|Other|0|||
164451892|NCT03517553|594023940|FG000|Overall Study|Withdrawal by Subject|2|||
164451893|NCT03271151|594023941|FG000|Overall Study|Lost to Follow-up|1|||
164451894|NCT03271151|594023942|FG001|Overall Study|Lost to Follow-up|3|||
164451895|NCT03271151|594023941|FG000|Overall Study|Withdrawal by Subject|1|||
164451896|NCT03271151|594023942|FG001|Overall Study|Withdrawal by Subject|0|||
164451897|NCT04093362|594023943|FG000|Overall Study|Study Termination|1|||
164451898|NCT04093362|594023944|FG001|Overall Study|Study Termination|1|||
164451899|NCT04093362|594023943|FG000|Overall Study|Withdrawal of Consent|1|||
164451900|NCT04093362|594023944|FG001|Overall Study|Withdrawal of Consent|0|||
164451901|NCT04093362|594023943|FG000|Overall Study|Death|1|||
164451902|NCT04093362|594023944|FG001|Overall Study|Death|3|||
164451903|NCT04093362|594023943|FG000|Overall Study|Reason not Specified|1|||
164451904|NCT04093362|594023944|FG001|Overall Study|Reason not Specified|2|||
164451905|NCT02201108|594023945|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
164451906|NCT02201108|594023946|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
164451907|NCT02201108|594023947|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
164451908|NCT02201108|594023945|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
164451909|NCT02201108|594023946|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
164451910|NCT02201108|594023947|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
164451911|NCT02201108|594023945|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
164451912|NCT02201108|594023946|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
164451913|NCT02201108|594023947|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
164451914|NCT02201108|594023945|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
164451915|NCT02201108|594023946|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
164451916|NCT02201108|594023947|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
164451917|NCT02201108|594023945|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
164451918|NCT02201108|594023946|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
164451919|NCT02201108|594023947|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
164451920|NCT02201108|594023945|FG000|Open Label Period (up to Week 192)|Other reason|4|||
164451921|NCT02201108|594023946|FG001|Open Label Period (up to Week 192)|Other reason|7|||
164451922|NCT02201108|594023947|FG002|Open Label Period (up to Week 192)|Other reason|0|||
164451923|NCT02201108|594023945|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
164451924|NCT02201108|594023946|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
164451925|NCT02201108|594023947|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
164451926|NCT02201108|594023945|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
164451927|NCT02201108|594023946|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
164451928|NCT02201108|594023947|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
164451929|NCT02201108|594023945|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
164706570|NCT02393248|594953417|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164706571|NCT02393248|594953418|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164706572|NCT02393248|594953419|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164706573|NCT02393248|594953420|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164706574|NCT02393248|594953421|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164706575|NCT02393248|594953422|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164706576|NCT02393248|594953423|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164451930|NCT02201108|594023946|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
164451931|NCT02201108|594023947|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
164451932|NCT03055377|594023957|FG000|Treatment Phase|Lost to Follow-up|28|||
164451933|NCT03055377|594023958|FG001|Treatment Phase|Lost to Follow-up|24|||
164451934|NCT03055377|594023957|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
164451935|NCT03055377|594023958|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
164451936|NCT05952076|594023959|FG000|Overall Study|Death|1|||
164451937|NCT05952076|594023960|FG001|Overall Study|Death|1|||
164451938|NCT05952076|594023959|FG000|Overall Study|Lost to Follow-up|0|||
164451939|NCT05952076|594023960|FG001|Overall Study|Lost to Follow-up|1|||
164451940|NCT05387447|594023961|FG000|Overall Study|Participants changed their minds about study participation.|3|||
164451941|NCT05387447|594023962|FG001|Overall Study|Participants changed their minds about study participation.|5|||
164451942|NCT01673984|594023963|FG000|Overall Study|Adverse Event|1|||
164451943|NCT01673984|594023964|FG001|Overall Study|Adverse Event|0|||
164451944|NCT01673984|594023963|FG000|Overall Study|Study termination|9|||
164451945|NCT01673984|594023964|FG001|Overall Study|Study termination|6|||
164451946|NCT05919082|594023967|FG000|Overall Study|Adverse Event|3|||
164451947|NCT05919082|594023968|FG001|Overall Study|Adverse Event|0|||
164451948|NCT05919082|594023967|FG000|Overall Study|Lost to Follow-up|0|||
164451949|NCT05919082|594023968|FG001|Overall Study|Lost to Follow-up|1|||
164451950|NCT05919082|594023967|FG000|Overall Study|Withdrawal by Subject|8|||
164451951|NCT05919082|594023968|FG001|Overall Study|Withdrawal by Subject|9|||
164706577|NCT02393248|594953424|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164451952|NCT05919082|594023967|FG000|Overall Study|Lack of Efficacy|0|||
164451953|NCT05919082|594023968|FG001|Overall Study|Lack of Efficacy|1|||
164451954|NCT05919082|594023967|FG000|Overall Study|Investigator Decision|1|||
164451955|NCT05919082|594023968|FG001|Overall Study|Investigator Decision|0|||
164451956|NCT02287311|594023972|FG000|Cohort 1: Dose Level 1|Death|2|||
164451957|NCT02287311|594023973|FG001|Cohort 1: Dose Level 1|Death|0|||
164451958|NCT02287311|594023974|FG002|Cohort 1: Dose Level 1|Death|0|||
164451959|NCT02287311|594023975|FG003|Cohort 1: Dose Level 1|Death|3|||
164451960|NCT02287311|594023976|FG004|Cohort 1: Dose Level 1|Death|0|||
164451961|NCT02287311|594023977|FG005|Cohort 1: Dose Level 1|Death|0|||
164451962|NCT02287311|594023978|FG006|Cohort 1: Dose Level 1|Death|1|||
164451963|NCT02287311|594023979|FG007|Cohort 1: Dose Level 1|Death|0|||
164451964|NCT02287311|594023980|FG008|Cohort 1: Dose Level 1|Death|0|||
164451965|NCT02287311|594023972|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
164451966|NCT02287311|594023973|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
164451967|NCT02287311|594023974|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
164451968|NCT02287311|594023975|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
164451969|NCT02287311|594023976|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
164451970|NCT02287311|594023977|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
164451971|NCT02287311|594023978|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
164451972|NCT02287311|594023979|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
164451973|NCT02287311|594023980|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
164451974|NCT02287311|594023972|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
164451975|NCT02287311|594023973|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
164451976|NCT02287311|594023974|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
164451977|NCT02287311|594023975|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
164451978|NCT02287311|594023976|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
164451979|NCT02287311|594023977|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
164451980|NCT02287311|594023978|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
164451981|NCT02287311|594023979|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
164451982|NCT02287311|594023980|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
164451983|NCT02287311|594023972|FG000|Cohort 2: Dose Level 2|Death|0|||
164451984|NCT02287311|594023973|FG001|Cohort 2: Dose Level 2|Death|2|||
164451985|NCT02287311|594023974|FG002|Cohort 2: Dose Level 2|Death|0|||
164597327|NCT00543569|594549027|FG002|Overall Study|Death|3|||
164597328|NCT00543569|594549028|FG003|Overall Study|Death|1|||
164597329|NCT00543569|594549025|FG000|Overall Study|Lost to Follow-up|0|||
164451986|NCT02287311|594023975|FG003|Cohort 2: Dose Level 2|Death|0|||
164451987|NCT02287311|594023976|FG004|Cohort 2: Dose Level 2|Death|2|||
164451988|NCT02287311|594023977|FG005|Cohort 2: Dose Level 2|Death|0|||
164451989|NCT02287311|594023978|FG006|Cohort 2: Dose Level 2|Death|0|||
164597330|NCT00543569|594549026|FG001|Overall Study|Lost to Follow-up|0|||
164597331|NCT00543569|594549027|FG002|Overall Study|Lost to Follow-up|1|||
164597332|NCT00543569|594549028|FG003|Overall Study|Lost to Follow-up|1|||
164597333|NCT00543569|594549025|FG000|Overall Study|Miscellaneous Reasons|7|||
164597334|NCT00543569|594549026|FG001|Overall Study|Miscellaneous Reasons|3|||
164597335|NCT00543569|594549027|FG002|Overall Study|Miscellaneous Reasons|11|||
164597336|NCT00543569|594549028|FG003|Overall Study|Miscellaneous Reasons|4|||
164597337|NCT00543569|594549025|FG000|Overall Study|Randomized but never received study drug|3|||
164597338|NCT00543569|594549026|FG001|Overall Study|Randomized but never received study drug|3|||
164597339|NCT00543569|594549027|FG002|Overall Study|Randomized but never received study drug|5|||
164597340|NCT00543569|594549028|FG003|Overall Study|Randomized but never received study drug|3|||
164597341|NCT00862849|594549030|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
164597342|NCT00862849|594549031|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
164597343|NCT00862849|594549032|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
164597344|NCT00862849|594549033|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
164597345|NCT00862849|594549034|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
164597346|NCT00862849|594549035|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
164597347|NCT00862849|594549030|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
164597348|NCT00862849|594549031|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
164597349|NCT00862849|594549032|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
164597350|NCT00862849|594549033|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
164597351|NCT00862849|594549034|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
164597352|NCT00862849|594549035|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
164597353|NCT00617409|594549036|FG000|Overall Study|Withdrawal by Subject|4|||
164597354|NCT00617409|594549037|FG001|Overall Study|Withdrawal by Subject|1|||
164597355|NCT00617409|594549038|FG002|Overall Study|Withdrawal by Subject|2|||
164597356|NCT00617409|594549036|FG000|Overall Study|Adverse Event|0|||
164597357|NCT00617409|594549037|FG001|Overall Study|Adverse Event|2|||
164597358|NCT00617409|594549038|FG002|Overall Study|Adverse Event|3|||
164597359|NCT00617409|594549036|FG000|Overall Study|Disease Progression|8|||
164597360|NCT00617409|594549037|FG001|Overall Study|Disease Progression|8|||
164597361|NCT00617409|594549038|FG002|Overall Study|Disease Progression|18|||
164597362|NCT00617409|594549036|FG000|Overall Study|Death|3|||
164597363|NCT00617409|594549037|FG001|Overall Study|Death|5|||
164597364|NCT00617409|594549038|FG002|Overall Study|Death|4|||
164597365|NCT00617409|594549036|FG000|Overall Study|Alternative Therapy|1|||
164451990|NCT02287311|594023979|FG007|Cohort 2: Dose Level 2|Death|2|||
164451991|NCT02287311|594023980|FG008|Cohort 2: Dose Level 2|Death|0|||
164451992|NCT02287311|594023972|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
164451993|NCT02287311|594023973|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
164451994|NCT02287311|594023974|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
164451995|NCT02287311|594023975|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
164451996|NCT02287311|594023976|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
164451997|NCT02287311|594023977|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
164451998|NCT02287311|594023978|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
164451999|NCT02287311|594023979|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
164452000|NCT02287311|594023980|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
164452001|NCT02287311|594023972|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
164452002|NCT02287311|594023973|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
164452003|NCT02287311|594023974|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
164452004|NCT02287311|594023975|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
164452005|NCT02287311|594023976|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
164452006|NCT02287311|594023977|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
164452007|NCT02287311|594023978|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
164452008|NCT02287311|594023979|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
164452009|NCT02287311|594023980|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
164452010|NCT02287311|594023972|FG000|Cohort 3: Dose Level 3|Death|0|||
164452011|NCT02287311|594023973|FG001|Cohort 3: Dose Level 3|Death|0|||
164452012|NCT02287311|594023974|FG002|Cohort 3: Dose Level 3|Death|4|||
164452013|NCT02287311|594023975|FG003|Cohort 3: Dose Level 3|Death|0|||
164452014|NCT02287311|594023976|FG004|Cohort 3: Dose Level 3|Death|0|||
164452015|NCT02287311|594023977|FG005|Cohort 3: Dose Level 3|Death|4|||
164144348|NCT02954991|592889834|FG002|Overall Study|Lost to Follow-up|0|||
164452016|NCT02287311|594023978|FG006|Cohort 3: Dose Level 3|Death|0|||
164452017|NCT02287311|594023979|FG007|Cohort 3: Dose Level 3|Death|0|||
164452018|NCT02287311|594023980|FG008|Cohort 3: Dose Level 3|Death|2|||
164452019|NCT02287311|594023972|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
164452020|NCT02287311|594023973|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
164452021|NCT02287311|594023974|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
164452022|NCT02287311|594023975|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
164452023|NCT02287311|594023976|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
164452024|NCT02287311|594023977|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
164452025|NCT02287311|594023978|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
164452026|NCT02287311|594023979|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
164452027|NCT02287311|594023980|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
164452028|NCT02287311|594023972|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
164452029|NCT02287311|594023973|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
164452030|NCT02287311|594023974|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
164452031|NCT02287311|594023975|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
164452032|NCT02287311|594023976|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
164452033|NCT02287311|594023977|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
164452034|NCT02287311|594023978|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
164452035|NCT02287311|594023979|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
164452036|NCT02287311|594023980|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
164452037|NCT05461131|594023981|FG000|Overall Study|Lost to Follow-up|0|||
164452038|NCT05461131|594023982|FG001|Overall Study|Lost to Follow-up|2|||
164452039|NCT03896516|594023983|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
164452040|NCT03896516|594023984|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
164452041|NCT03896516|594023983|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
164452042|NCT03896516|594023984|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
164452043|NCT03896516|594023983|FG000|Washout Period|Physician Decision|3|||
164452044|NCT03896516|594023984|FG001|Washout Period|Physician Decision|1|||
164452045|NCT03896516|594023983|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
164452046|NCT03896516|594023984|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
164452047|NCT00150813|594023987|FG000|Overall Study|Adverse Event|1|||
164452048|NCT00150813|594023987|FG000|Overall Study|Lack of Efficacy|1|||
164452049|NCT00150813|594023987|FG000|Overall Study|Lost to Follow-up|5|||
164452050|NCT00150813|594023987|FG000|Overall Study|Withdrawal by Subject|5|||
164597366|NCT00617409|594549037|FG001|Overall Study|Alternative Therapy|2|||
164597367|NCT00617409|594549038|FG002|Overall Study|Alternative Therapy|0|||
164597368|NCT02124707|594549047|FG000|Overall Study|Adverse Event|5|||
164452051|NCT00150813|594023987|FG000|Overall Study|Remission|3|||
164597369|NCT02124707|594549047|FG000|Overall Study|Physician Decision|1|||
164597370|NCT02124707|594549047|FG000|Overall Study|Death|1|||
164597371|NCT01363713|594549050|FG000|Overall Study|Adverse Event|1|||
164597372|NCT01363713|594549050|FG000|Overall Study|Protocol Violation|3|||
164597373|NCT01363713|594549050|FG000|Overall Study|Withdrawal by Subject|2|||
164597374|NCT02432040|594549051|FG000|Overall Study|Lack of Efficacy|3|||
164597375|NCT02432040|594549052|FG001|Overall Study|Lack of Efficacy|0|||
164597376|NCT02432040|594549051|FG000|Overall Study|Lost to Follow-up|4|||
164597377|NCT02432040|594549052|FG001|Overall Study|Lost to Follow-up|5|||
164597378|NCT02432040|594549051|FG000|Overall Study|Physician Decision|1|||
164452052|NCT00150813|594023987|FG000|Overall Study|Planned pregancy|1|||
164597379|NCT02432040|594549052|FG001|Overall Study|Physician Decision|1|||
164452053|NCT00150813|594023987|FG000|Overall Study|Switch to commercially available LEV|2|||
164452054|NCT04048681|594023994|FG000|Overall Study|family emergency|0|||
164452055|NCT04048681|594023995|FG001|Overall Study|family emergency|0|||
164452056|NCT04048681|594023996|FG002|Overall Study|family emergency|0|||
164452057|NCT04048681|594023997|FG003|Overall Study|family emergency|1|||
164452058|NCT04048681|594023998|FG004|Overall Study|family emergency|0|||
164452059|NCT00136435|594023999|FG000|Overall Study|Ineligible|8|||
164452060|NCT00136435|594023999|FG000|Overall Study|Induction Death|1|||
164452061|NCT00136435|594023999|FG000|Overall Study|Induction Failure|10|||
164452062|NCT00136435|594023999|FG000|Overall Study|Withdrew prior to initiating imatinib/Ph+|3|||
164706578|NCT02393248|594953425|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164452063|NCT00136435|594023999|FG000|Overall Study|Withdrawal by Subject|3|||
164452064|NCT00136435|594023999|FG000|Overall Study|Adverse Event|19|||
164452065|NCT00136435|594023999|FG000|Overall Study|Relapse|4|||
164452066|NCT00136435|594023999|FG000|Overall Study|Transplant in first Complete Remission (CR)|16|||
164452067|NCT00390299|594024004|FG000|Overall Study|Cancellation|1|||
164452068|NCT00390299|594024005|FG001|Overall Study|Cancellation|0|||
164452069|NCT00390299|594024006|FG002|Overall Study|Cancellation|0|||
164452070|NCT00390299|594024007|FG003|Overall Study|Cancellation|0|||
164452071|NCT00390299|594024008|FG004|Overall Study|Cancellation|0|||
164452072|NCT02965846|594024010|FG000|Overall Study|Lost to Follow-up|1|||
164452073|NCT02965846|594024011|FG001|Overall Study|Lost to Follow-up|0|||
164452074|NCT02965846|594024012|FG002|Overall Study|Lost to Follow-up|0|||
164452075|NCT02965846|594024010|FG000|Overall Study|Withdrawal by Subject|0|||
164452076|NCT02965846|594024011|FG001|Overall Study|Withdrawal by Subject|1|||
164452077|NCT02965846|594024012|FG002|Overall Study|Withdrawal by Subject|0|||
164452078|NCT02965846|594024010|FG000|Overall Study|Study Terminated By Sponsor|4|||
164452079|NCT02965846|594024011|FG001|Overall Study|Study Terminated By Sponsor|4|||
164452080|NCT02965846|594024012|FG002|Overall Study|Study Terminated By Sponsor|0|||
164452081|NCT02965846|594024010|FG000|Overall Study|Participants not randomized|0|||
164452082|NCT02965846|594024011|FG001|Overall Study|Participants not randomized|0|||
164452083|NCT02965846|594024012|FG002|Overall Study|Participants not randomized|33|||
164452084|NCT00539734|594024013|FG000|Overall Study|Protocol Violation|1|||
164452085|NCT02794480|594024014|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
164452086|NCT02794480|594024015|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
164452087|NCT02794480|594024016|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
164452088|NCT02794480|594024017|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
164452089|NCT02794480|594024014|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
164452090|NCT02794480|594024015|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
164452091|NCT02794480|594024016|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
164452092|NCT02794480|594024017|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
164452093|NCT02794480|594024014|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164452094|NCT02794480|594024015|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164452095|NCT02794480|594024016|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164452096|NCT02794480|594024017|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
164452097|NCT02794480|594024014|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164452098|NCT02794480|594024015|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
164452099|NCT02794480|594024016|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164452100|NCT02794480|594024017|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
164452101|NCT02794480|594024014|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
164452102|NCT02794480|594024015|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
164452103|NCT02794480|594024016|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
164706579|NCT02393248|594953426|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164706580|NCT02393248|594953427|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164706581|NCT02393248|594953428|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164706582|NCT02393248|594953429|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164706583|NCT02393248|594953430|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164706584|NCT02393248|594953431|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
164706585|NCT02393248|594953432|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
164452104|NCT02794480|594024017|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
164452105|NCT01070069|594024018|FG000|Overall Study|Death|1|||
164452106|NCT01070069|594024019|FG001|Overall Study|Death|0|||
164452107|NCT01070069|594024020|FG002|Overall Study|Death|2|||
164452108|NCT01070069|594024021|FG003|Overall Study|Death|0|||
164452109|NCT01070069|594024022|FG004|Overall Study|Death|1|||
164452110|NCT01070069|594024018|FG000|Overall Study|Withdrawal by Subject|1|||
164452111|NCT01070069|594024019|FG001|Overall Study|Withdrawal by Subject|1|||
164452112|NCT01070069|594024020|FG002|Overall Study|Withdrawal by Subject|4|||
164452113|NCT01070069|594024021|FG003|Overall Study|Withdrawal by Subject|0|||
164452114|NCT01070069|594024022|FG004|Overall Study|Withdrawal by Subject|0|||
164452115|NCT01070069|594024018|FG000|Overall Study|Lost to Follow-up|4|||
164706586|NCT02393248|594953433|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164706587|NCT02393248|594953434|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
164706588|NCT02393248|594953435|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
164706589|NCT02393248|594953436|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
164706590|NCT02393248|594953437|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
164706591|NCT02393248|594953438|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
164706592|NCT02393248|594953414|FG000|Part 3: Combination Therapy|Disease Progression|0|||
164706593|NCT02393248|594953415|FG001|Part 3: Combination Therapy|Disease Progression|0|||
164706594|NCT02393248|594953416|FG002|Part 3: Combination Therapy|Disease Progression|0|||
164706595|NCT02393248|594953417|FG003|Part 3: Combination Therapy|Disease Progression|0|||
164706596|NCT02393248|594953418|FG004|Part 3: Combination Therapy|Disease Progression|0|||
164706597|NCT02393248|594953419|FG005|Part 3: Combination Therapy|Disease Progression|0|||
164706598|NCT02393248|594953420|FG006|Part 3: Combination Therapy|Disease Progression|0|||
164706599|NCT02393248|594953421|FG007|Part 3: Combination Therapy|Disease Progression|0|||
164706600|NCT02393248|594953422|FG008|Part 3: Combination Therapy|Disease Progression|0|||
164706601|NCT02393248|594953423|FG009|Part 3: Combination Therapy|Disease Progression|0|||
164706602|NCT02393248|594953424|FG010|Part 3: Combination Therapy|Disease Progression|0|||
164706603|NCT02393248|594953425|FG011|Part 3: Combination Therapy|Disease Progression|0|||
164452116|NCT01070069|594024019|FG001|Overall Study|Lost to Follow-up|1|||
164452117|NCT01070069|594024020|FG002|Overall Study|Lost to Follow-up|0|||
164452118|NCT01070069|594024021|FG003|Overall Study|Lost to Follow-up|0|||
164452119|NCT01070069|594024022|FG004|Overall Study|Lost to Follow-up|3|||
164452120|NCT00632749|594024023|FG000|Overall Study|Progressive disease|3|||
164452121|NCT00632749|594024024|FG001|Overall Study|Progressive disease|2|||
164452122|NCT00632749|594024025|FG002|Overall Study|Progressive disease|2|||
164452123|NCT00632749|594024026|FG003|Overall Study|Progressive disease|2|||
164452124|NCT00632749|594024027|FG004|Overall Study|Progressive disease|4|||
164452125|NCT00632749|594024028|FG005|Overall Study|Progressive disease|4|||
164452126|NCT00632749|594024029|FG006|Overall Study|Progressive disease|3|||
164452127|NCT00632749|594024030|FG007|Overall Study|Progressive disease|2|||
164452128|NCT00632749|594024031|FG008|Overall Study|Progressive disease|3|||
164452129|NCT00632749|594024032|FG009|Overall Study|Progressive disease|2|||
164452130|NCT00632749|594024033|FG010|Overall Study|Progressive disease|4|||
164452131|NCT00632749|594024034|FG011|Overall Study|Progressive disease|3|||
164452132|NCT00632749|594024035|FG012|Overall Study|Progressive disease|2|||
164452133|NCT00632749|594024036|FG013|Overall Study|Progressive disease|4|||
164452134|NCT00632749|594024023|FG000|Overall Study|Other Adverse event|1|||
164452135|NCT00632749|594024024|FG001|Overall Study|Other Adverse event|1|||
164452136|NCT00632749|594024025|FG002|Overall Study|Other Adverse event|1|||
164452137|NCT00632749|594024026|FG003|Overall Study|Other Adverse event|1|||
164452138|NCT00632749|594024027|FG004|Overall Study|Other Adverse event|2|||
164452139|NCT00632749|594024028|FG005|Overall Study|Other Adverse event|4|||
164452140|NCT00632749|594024029|FG006|Overall Study|Other Adverse event|1|||
164452141|NCT00632749|594024030|FG007|Overall Study|Other Adverse event|2|||
164452142|NCT00632749|594024031|FG008|Overall Study|Other Adverse event|2|||
164452143|NCT00632749|594024032|FG009|Overall Study|Other Adverse event|0|||
164452144|NCT00632749|594024033|FG010|Overall Study|Other Adverse event|1|||
164452145|NCT00632749|594024034|FG011|Overall Study|Other Adverse event|0|||
164706604|NCT02393248|594953426|FG012|Part 3: Combination Therapy|Disease Progression|0|||
164706605|NCT02393248|594953427|FG013|Part 3: Combination Therapy|Disease Progression|0|||
164706606|NCT02393248|594953428|FG014|Part 3: Combination Therapy|Disease Progression|0|||
164706607|NCT02393248|594953429|FG015|Part 3: Combination Therapy|Disease Progression|0|||
164706608|NCT02393248|594953430|FG016|Part 3: Combination Therapy|Disease Progression|0|||
164706609|NCT02393248|594953431|FG017|Part 3: Combination Therapy|Disease Progression|0|||
164706610|NCT02393248|594953432|FG018|Part 3: Combination Therapy|Disease Progression|0|||
164706611|NCT02393248|594953433|FG019|Part 3: Combination Therapy|Disease Progression|0|||
164452146|NCT00632749|594024035|FG012|Overall Study|Other Adverse event|1|||
164452147|NCT00632749|594024036|FG013|Overall Study|Other Adverse event|0|||
164452148|NCT00632749|594024023|FG000|Overall Study|Refuse to continue medication|0|||
164452149|NCT00632749|594024024|FG001|Overall Study|Refuse to continue medication|0|||
164452150|NCT00632749|594024025|FG002|Overall Study|Refuse to continue medication|0|||
164452151|NCT00632749|594024026|FG003|Overall Study|Refuse to continue medication|1|||
164452152|NCT00632749|594024027|FG004|Overall Study|Refuse to continue medication|0|||
164452153|NCT00632749|594024028|FG005|Overall Study|Refuse to continue medication|0|||
164706612|NCT02393248|594953434|FG020|Part 3: Combination Therapy|Disease Progression|2|||
164706613|NCT02393248|594953435|FG021|Part 3: Combination Therapy|Disease Progression|1|||
164706614|NCT02393248|594953436|FG022|Part 3: Combination Therapy|Disease Progression|0|||
164452154|NCT00632749|594024029|FG006|Overall Study|Refuse to continue medication|0|||
164452155|NCT00632749|594024030|FG007|Overall Study|Refuse to continue medication|0|||
164452156|NCT00632749|594024031|FG008|Overall Study|Refuse to continue medication|0|||
164452157|NCT00632749|594024032|FG009|Overall Study|Refuse to continue medication|1|||
164452158|NCT00632749|594024033|FG010|Overall Study|Refuse to continue medication|0|||
164452159|NCT00632749|594024034|FG011|Overall Study|Refuse to continue medication|0|||
164452160|NCT00632749|594024035|FG012|Overall Study|Refuse to continue medication|0|||
164452161|NCT00632749|594024036|FG013|Overall Study|Refuse to continue medication|0|||
164452162|NCT00632749|594024023|FG000|Overall Study|Reason other than those specified above|0|||
164452163|NCT00632749|594024024|FG001|Overall Study|Reason other than those specified above|2|||
164452164|NCT00632749|594024025|FG002|Overall Study|Reason other than those specified above|0|||
164452165|NCT00632749|594024026|FG003|Overall Study|Reason other than those specified above|0|||
164452166|NCT00632749|594024027|FG004|Overall Study|Reason other than those specified above|1|||
164452167|NCT00632749|594024028|FG005|Overall Study|Reason other than those specified above|0|||
164452168|NCT00632749|594024029|FG006|Overall Study|Reason other than those specified above|1|||
164452169|NCT00632749|594024030|FG007|Overall Study|Reason other than those specified above|0|||
164452170|NCT00632749|594024031|FG008|Overall Study|Reason other than those specified above|0|||
164452171|NCT00632749|594024032|FG009|Overall Study|Reason other than those specified above|0|||
164452172|NCT00632749|594024033|FG010|Overall Study|Reason other than those specified above|2|||
164452173|NCT00632749|594024034|FG011|Overall Study|Reason other than those specified above|1|||
164452174|NCT00632749|594024035|FG012|Overall Study|Reason other than those specified above|0|||
164452175|NCT00632749|594024036|FG013|Overall Study|Reason other than those specified above|2|||
164452176|NCT00611559|594024037|FG000|Overall Study|Lost to Follow-up|0|||
164452177|NCT00611559|594024038|FG001|Overall Study|Lost to Follow-up|1|||
164452178|NCT00611559|594024039|FG002|Overall Study|Lost to Follow-up|0|||
164452179|NCT00611559|594024037|FG000|Overall Study|Protocol Violation|1|||
164452180|NCT00611559|594024038|FG001|Overall Study|Protocol Violation|0|||
164452181|NCT00611559|594024039|FG002|Overall Study|Protocol Violation|1|||
164452182|NCT00879333|594024040|FG000|Overall Study|Adverse Event|94|||
164452183|NCT00879333|594024041|FG001|Overall Study|Adverse Event|34|||
164452184|NCT00879333|594024040|FG000|Overall Study|Abnormal Laboratory Value|1|||
164452185|NCT00879333|594024041|FG001|Overall Study|Abnormal Laboratory Value|0|||
164452186|NCT00879333|594024040|FG000|Overall Study|Withdrawal by Subject|20|||
164452187|NCT00879333|594024041|FG001|Overall Study|Withdrawal by Subject|7|||
164452188|NCT00879333|594024040|FG000|Overall Study|Lost to Follow-up|2|||
164452189|NCT00879333|594024041|FG001|Overall Study|Lost to Follow-up|1|||
164452190|NCT00879333|594024040|FG000|Overall Study|Administrative Problems|2|||
164452191|NCT00879333|594024041|FG001|Overall Study|Administrative Problems|0|||
164452192|NCT00879333|594024040|FG000|Overall Study|Death|16|||
164452193|NCT00879333|594024041|FG001|Overall Study|Death|5|||
164452194|NCT00879333|594024040|FG000|Overall Study|Disease Progression|292|||
164452195|NCT00879333|594024041|FG001|Overall Study|Disease Progression|169|||
164452196|NCT00879333|594024040|FG000|Overall Study|Protocol Violation|1|||
164452197|NCT00879333|594024041|FG001|Overall Study|Protocol Violation|1|||
164452198|NCT05321069|594024044|FG000|Overall Study|Adverse Event|52|||
164452199|NCT05321069|594024045|FG001|Overall Study|Adverse Event|52|||
164452200|NCT05321069|594024046|FG002|Overall Study|Adverse Event|64|||
164452201|NCT05321069|594024044|FG000|Overall Study|Protocol Violation|1|||
164452202|NCT05321069|594024045|FG001|Overall Study|Protocol Violation|1|||
164452203|NCT05321069|594024046|FG002|Overall Study|Protocol Violation|0|||
164452204|NCT05321069|594024044|FG000|Overall Study|Withdrawal by Subject|23|||
164452205|NCT05321069|594024045|FG001|Overall Study|Withdrawal by Subject|18|||
164452206|NCT05321069|594024046|FG002|Overall Study|Withdrawal by Subject|12|||
164452207|NCT05321069|594024044|FG000|Overall Study|Lost to Follow-up|1|||
164452208|NCT05321069|594024045|FG001|Overall Study|Lost to Follow-up|0|||
164452209|NCT05321069|594024046|FG002|Overall Study|Lost to Follow-up|1|||
164452210|NCT05321069|594024044|FG000|Overall Study|No reason stated by the participants|23|||
164452211|NCT05321069|594024045|FG001|Overall Study|No reason stated by the participants|22|||
164597380|NCT00718666|594549053|FG000|Booster Phase Year 5|No active participation request|0|||
164597381|NCT00718666|594549054|FG001|Booster Phase Year 5|No active participation request|0|||
164597382|NCT00718666|594549055|FG002|Booster Phase Year 5|No active participation request|1|||
164597383|NCT00718666|594549053|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
164597384|NCT00718666|594549054|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
164597385|NCT00718666|594549055|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
164597386|NCT00718666|594549053|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
164597387|NCT00718666|594549054|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
164597388|NCT00718666|594549055|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
164597389|NCT00718666|594549053|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
164597390|NCT00718666|594549054|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
164597391|NCT00718666|594549055|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
164597392|NCT02196038|594549056|FG000|Overall Study|Death|16|||
164597393|NCT02196038|594549057|FG001|Overall Study|Death|21|||
164597394|NCT02196038|594549056|FG000|Overall Study|Withdrawal by Subject|0|||
164597395|NCT02196038|594549057|FG001|Overall Study|Withdrawal by Subject|1|||
164597396|NCT02196038|594549056|FG000|Overall Study|Lost to Follow-up|1|||
164597397|NCT02196038|594549057|FG001|Overall Study|Lost to Follow-up|0|||
164597398|NCT04544709|594549063|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
164597399|NCT03135028|594549064|FG000|Overall Study|Death|6|||
164597400|NCT03135028|594549064|FG000|Overall Study|Study Terminated by Sponsor|2|||
164597401|NCT03135028|594549064|FG000|Overall Study|Withdrew Consent|1|||
164597402|NCT00496873|594549065|FG000|Overall Study|Ineligible|2|||
164597403|NCT00496873|594549065|FG000|Overall Study|Death|2|||
164452212|NCT05321069|594024046|FG002|Overall Study|No reason stated by the participants|16|||
164452213|NCT05321069|594024044|FG000|Overall Study|Lack of Efficacy|1|||
164452214|NCT05321069|594024045|FG001|Overall Study|Lack of Efficacy|1|||
164452215|NCT05321069|594024046|FG002|Overall Study|Lack of Efficacy|0|||
164452216|NCT05048186|594024049|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
164452217|NCT05048186|594024050|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
164452218|NCT05048186|594024049|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
164452219|NCT05048186|594024050|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
164452220|NCT02412748|594024051|FG000|Overall Study|Lost to Follow-up|38|||
164452221|NCT02412748|594024052|FG001|Overall Study|Lost to Follow-up|39|||
164452222|NCT04218266|594024055|FG000|Overall Study|Death|1|||
164452223|NCT04218266|594024056|FG001|Overall Study|Death|2|||
164452224|NCT04218266|594024057|FG002|Overall Study|Death|3|||
164452225|NCT04218266|594024055|FG000|Overall Study|Adverse Event|13|||
164452226|NCT04218266|594024056|FG001|Overall Study|Adverse Event|14|||
164452227|NCT04218266|594024057|FG002|Overall Study|Adverse Event|11|||
164452228|NCT04218266|594024055|FG000|Overall Study|Other|7|||
164452229|NCT04218266|594024056|FG001|Overall Study|Other|5|||
164452230|NCT04218266|594024057|FG002|Overall Study|Other|14|||
164452231|NCT04218266|594024055|FG000|Overall Study|Physician Decision|1|||
164452232|NCT04218266|594024056|FG001|Overall Study|Physician Decision|3|||
164452233|NCT04218266|594024057|FG002|Overall Study|Physician Decision|2|||
164452234|NCT04218266|594024055|FG000|Overall Study|Non-compliance with study drug|0|||
164452235|NCT04218266|594024056|FG001|Overall Study|Non-compliance with study drug|0|||
164452236|NCT04218266|594024057|FG002|Overall Study|Non-compliance with study drug|1|||
164452237|NCT04218266|594024055|FG000|Overall Study|Withdrawal by Subject|1|||
164452238|NCT04218266|594024056|FG001|Overall Study|Withdrawal by Subject|3|||
164452239|NCT04218266|594024057|FG002|Overall Study|Withdrawal by Subject|1|||
164452240|NCT04218266|594024055|FG000|Overall Study|Study drug never administered|2|||
164452241|NCT04218266|594024056|FG001|Overall Study|Study drug never administered|0|||
164452242|NCT04218266|594024057|FG002|Overall Study|Study drug never administered|0|||
164452243|NCT04820686|594024062|FG000|Overall Study|Withdrawal by Subject|5|||
164452244|NCT04820686|594024063|FG001|Overall Study|Withdrawal by Subject|2|||
164452245|NCT04820686|594024064|FG002|Overall Study|Withdrawal by Subject|3|||
164452246|NCT04820686|594024062|FG000|Overall Study|Study Termination|25|||
164452247|NCT04820686|594024063|FG001|Overall Study|Study Termination|13|||
164452248|NCT04820686|594024064|FG002|Overall Study|Study Termination|14|||
164452249|NCT04820686|594024062|FG000|Overall Study|Adverse Event|0|||
164452250|NCT04820686|594024063|FG001|Overall Study|Adverse Event|1|||
164452251|NCT04820686|594024064|FG002|Overall Study|Adverse Event|0|||
164452252|NCT01424670|594024065|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
164452253|NCT01424670|594024066|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
164452254|NCT01424670|594024065|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
164452255|NCT01424670|594024066|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
164452256|NCT01424670|594024065|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
164452257|NCT01424670|594024066|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
164452258|NCT01424670|594024065|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
164452259|NCT01424670|594024066|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
164452260|NCT01424670|594024065|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
164452261|NCT01424670|594024066|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
164452262|NCT01424670|594024065|FG000|Continuation Period|Adverse Event|13|||
164452263|NCT01424670|594024066|FG001|Continuation Period|Adverse Event|5|||
164452264|NCT01424670|594024065|FG000|Continuation Period|Lost to Follow-up|2|||
164597404|NCT00496873|594549065|FG000|Overall Study|Withdrawal by Subject|3|||
164597405|NCT02402218|594549066|FG000|Overall Study|Did not pickup study medication|12|||
164597406|NCT02402218|594549067|FG001|Overall Study|Did not pickup study medication|9|||
164597407|NCT02402218|594549068|FG002|Overall Study|Did not pickup study medication|13|||
164597408|NCT02402218|594549066|FG000|Overall Study|Lack of Efficacy|0|||
164452265|NCT01424670|594024066|FG001|Continuation Period|Lost to Follow-up|0|||
164597409|NCT02402218|594549067|FG001|Overall Study|Lack of Efficacy|1|||
164452266|NCT01424670|594024065|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
164597410|NCT02402218|594549068|FG002|Overall Study|Lack of Efficacy|1|||
164597411|NCT02402218|594549066|FG000|Overall Study|Death|1|||
164452267|NCT01424670|594024066|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
164452268|NCT01424670|594024065|FG000|Continuation Period|Physician Decision|5|||
164452269|NCT01424670|594024066|FG001|Continuation Period|Physician Decision|4|||
164452270|NCT01424670|594024065|FG000|Continuation Period|Withdrawal by Subject|13|||
164452271|NCT01424670|594024066|FG001|Continuation Period|Withdrawal by Subject|4|||
164452272|NCT00761189|594024067|FG000|Overall Study|Adverse Event|42|||
164452273|NCT00761189|594024067|FG000|Overall Study|Lack of Efficacy|45|||
164452274|NCT00761189|594024067|FG000|Overall Study|Lost to Follow-up|36|||
164597412|NCT02402218|594549067|FG001|Overall Study|Death|0|||
164597413|NCT02402218|594549068|FG002|Overall Study|Death|0|||
164597414|NCT02402218|594549066|FG000|Overall Study|Reinfection|0|||
164452275|NCT00761189|594024067|FG000|Overall Study|Withdrawal by Subject|49|||
164452276|NCT00761189|594024067|FG000|Overall Study|Other|13|||
164452277|NCT04377308|594024068|FG000|Overall Study|Withdrawal by Subject|0|||
164452278|NCT04377308|594024069|FG001|Overall Study|Withdrawal by Subject|1|||
164452279|NCT01494922|594024070|FG000|Overall Study|Adverse Event|1|||
164452280|NCT00709098|594024074|FG000|Double-blind Period|Withdrawal of consent|3|||
164452281|NCT00709098|594024075|FG001|Double-blind Period|Withdrawal of consent|3|||
164452282|NCT00709098|594024076|FG002|Double-blind Period|Withdrawal of consent|0|||
164452283|NCT00709098|594024074|FG000|Double-blind Period|Administrative reason|1|||
164452284|NCT00709098|594024075|FG001|Double-blind Period|Administrative reason|3|||
164452285|NCT00709098|594024076|FG002|Double-blind Period|Administrative reason|0|||
164452286|NCT00709098|594024074|FG000|Double-blind Period|Death|1|||
164452287|NCT00709098|594024075|FG001|Double-blind Period|Death|1|||
164452288|NCT00709098|594024076|FG002|Double-blind Period|Death|0|||
164452289|NCT00709098|594024074|FG000|Double-blind Period|Lost to Follow-up|1|||
164452290|NCT00709098|594024075|FG001|Double-blind Period|Lost to Follow-up|1|||
164452291|NCT00709098|594024076|FG002|Double-blind Period|Lost to Follow-up|0|||
164597415|NCT02402218|594549067|FG001|Overall Study|Reinfection|0|||
164597416|NCT02402218|594549068|FG002|Overall Study|Reinfection|1|||
164452292|NCT00709098|594024074|FG000|Open-label Period|Withdrawal of consent|0|||
164452293|NCT00709098|594024075|FG001|Open-label Period|Withdrawal of consent|0|||
164452294|NCT00709098|594024076|FG002|Open-label Period|Withdrawal of consent|7|||
164452295|NCT00709098|594024074|FG000|Open-label Period|Administrative reason|0|||
164452296|NCT00709098|594024075|FG001|Open-label Period|Administrative reason|0|||
164452297|NCT00709098|594024076|FG002|Open-label Period|Administrative reason|5|||
164452298|NCT00709098|594024074|FG000|Open-label Period|Death|0|||
164452299|NCT00709098|594024075|FG001|Open-label Period|Death|0|||
164452300|NCT00709098|594024076|FG002|Open-label Period|Death|1|||
164452301|NCT00709098|594024074|FG000|Open-label Period|Lost to Follow-up|0|||
164452302|NCT00709098|594024075|FG001|Open-label Period|Lost to Follow-up|0|||
164452303|NCT00709098|594024076|FG002|Open-label Period|Lost to Follow-up|1|||
164452304|NCT01037985|594024077|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
164452305|NCT01037985|594024078|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
164452306|NCT01037985|594024077|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
164452307|NCT01037985|594024078|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
164452308|NCT01037985|594024077|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
164452309|NCT01037985|594024078|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
164452310|NCT01037985|594024077|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
164452311|NCT01037985|594024078|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
164452312|NCT00774852|594024082|FG000|Overall Study|Adverse Event|9|||
164452313|NCT00774852|594024083|FG001|Overall Study|Adverse Event|6|||
164452314|NCT00774852|594024082|FG000|Overall Study|Death|2|||
164452315|NCT00774852|594024083|FG001|Overall Study|Death|1|||
164452316|NCT00774852|594024082|FG000|Overall Study|Lack of Efficacy|3|||
164452317|NCT00774852|594024083|FG001|Overall Study|Lack of Efficacy|7|||
164452318|NCT00774852|594024082|FG000|Overall Study|Lost to Follow-up|9|||
164452319|NCT00774852|594024083|FG001|Overall Study|Lost to Follow-up|5|||
164452320|NCT00774852|594024082|FG000|Overall Study|Physician Decision|2|||
164597417|NCT02402218|594549066|FG000|Overall Study|Adverse Event|0|||
164597418|NCT02402218|594549067|FG001|Overall Study|Adverse Event|2|||
164597419|NCT02402218|594549068|FG002|Overall Study|Adverse Event|1|||
164597420|NCT02402218|594549066|FG000|Overall Study|Withdrawal by Subject|1|||
164597421|NCT02402218|594549067|FG001|Overall Study|Withdrawal by Subject|1|||
164597422|NCT02402218|594549068|FG002|Overall Study|Withdrawal by Subject|1|||
164597423|NCT03827473|594549069|FG000|Overall Study|Withdrawal by Subject|1|||
164597424|NCT03827473|594549070|FG001|Overall Study|Withdrawal by Subject|0|||
164597425|NCT04436822|594549071|FG000|Overall Study|Physician Decision|2|||
164597426|NCT04436822|594549072|FG001|Overall Study|Physician Decision|0|||
164597427|NCT04436822|594549071|FG000|Overall Study|Sponsor request|1|||
164597428|NCT04436822|594549072|FG001|Overall Study|Sponsor request|0|||
164597429|NCT04436822|594549071|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164597430|NCT04436822|594549072|FG001|Overall Study|Withdrawal by parent/guardian|3|||
164597431|NCT04436822|594549071|FG000|Overall Study|Unsuccessful procedure|0|||
164597432|NCT04436822|594549072|FG001|Overall Study|Unsuccessful procedure|1|||
164597433|NCT04436822|594549071|FG000|Overall Study|Withdrawal due to Covid-19|8|||
164597434|NCT04436822|594549072|FG001|Overall Study|Withdrawal due to Covid-19|1|||
164597435|NCT04436822|594549071|FG000|Overall Study|Withdrawal by Subject|1|||
164597436|NCT04436822|594549072|FG001|Overall Study|Withdrawal by Subject|0|||
164597437|NCT04436822|594549071|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
164597438|NCT04436822|594549072|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
164597439|NCT03807739|594549073|FG000|Overall Study|Adverse Event|1|||
164597440|NCT03807739|594549074|FG001|Overall Study|Adverse Event|0|||
164597441|NCT03807739|594549075|FG002|Overall Study|Adverse Event|0|||
164597442|NCT03807739|594549076|FG003|Overall Study|Adverse Event|0|||
164597443|NCT03807739|594549073|FG000|Overall Study|Withdrawal by Subject|1|||
164706615|NCT02393248|594953437|FG023|Part 3: Combination Therapy|Disease Progression|0|||
164706616|NCT02393248|594953438|FG024|Part 3: Combination Therapy|Disease Progression|0|||
164706617|NCT02393248|594953414|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
164706618|NCT02393248|594953415|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
164706619|NCT02393248|594953416|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
164706620|NCT02393248|594953417|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
164706621|NCT02393248|594953418|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
164706622|NCT02393248|594953419|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
164706623|NCT02393248|594953420|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
164706624|NCT02393248|594953421|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
164706625|NCT02393248|594953422|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
164706626|NCT02393248|594953423|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
164706627|NCT02393248|594953424|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
164706628|NCT02393248|594953425|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
164706629|NCT02393248|594953426|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
164706630|NCT02393248|594953427|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
164706631|NCT02393248|594953428|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
164706632|NCT02393248|594953429|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
164706633|NCT02393248|594953430|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
164706634|NCT02393248|594953431|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
164706635|NCT02393248|594953432|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
164706636|NCT02393248|594953433|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
164706637|NCT02393248|594953434|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
164706638|NCT02393248|594953435|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
164706639|NCT02393248|594953436|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
164706640|NCT02393248|594953437|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
164706641|NCT02393248|594953438|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
164706642|NCT02393248|594953414|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164706643|NCT02393248|594953415|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164405168|NCT03996291|593853901|FG003|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
164405169|NCT03996291|593853902|FG004|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|1|||
164405170|NCT03996291|593853903|FG005|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
164405171|NCT03996291|593853904|FG006|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
164405172|NCT03996291|593853905|FG007|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
164405173|NCT03933826|593853906|FG000|Overall Study|Withdrawal by Subject|8|||
164405174|NCT03933826|593853907|FG001|Overall Study|Withdrawal by Subject|1|||
164405175|NCT03933826|593853906|FG000|Overall Study|Death|19|||
164405176|NCT03933826|593853907|FG001|Overall Study|Death|11|||
164405177|NCT03933826|593853906|FG000|Overall Study|Lost to Follow-up|41|||
164405178|NCT03933826|593853907|FG001|Overall Study|Lost to Follow-up|13|||
164405179|NCT02638948|593853908|FG000|Overall Study|Withdrawal by Subject|4|||
164405180|NCT02638948|593853909|FG001|Overall Study|Withdrawal by Subject|5|||
164405181|NCT02638948|593853910|FG002|Overall Study|Withdrawal by Subject|3|||
164405182|NCT02638948|593853911|FG003|Overall Study|Withdrawal by Subject|1|||
164405183|NCT02638948|593853908|FG000|Overall Study|Administrative Reason by Sponsor|0|||
164405184|NCT02638948|593853909|FG001|Overall Study|Administrative Reason by Sponsor|1|||
164405185|NCT02638948|593853910|FG002|Overall Study|Administrative Reason by Sponsor|0|||
164405186|NCT02638948|593853911|FG003|Overall Study|Administrative Reason by Sponsor|4|||
164405187|NCT02638948|593853908|FG000|Overall Study|Adverse Event|0|||
164405188|NCT02638948|593853909|FG001|Overall Study|Adverse Event|0|||
164405189|NCT02638948|593853910|FG002|Overall Study|Adverse Event|1|||
164405190|NCT02638948|593853911|FG003|Overall Study|Adverse Event|1|||
164405191|NCT02638948|593853908|FG000|Overall Study|Lack of Efficacy|1|||
164405192|NCT02638948|593853909|FG001|Overall Study|Lack of Efficacy|1|||
164405193|NCT02638948|593853910|FG002|Overall Study|Lack of Efficacy|0|||
164405194|NCT02638948|593853911|FG003|Overall Study|Lack of Efficacy|0|||
164405195|NCT02638948|593853908|FG000|Overall Study|Lost to Follow-up|0|||
164405196|NCT02638948|593853909|FG001|Overall Study|Lost to Follow-up|0|||
164405197|NCT02638948|593853910|FG002|Overall Study|Lost to Follow-up|1|||
164405198|NCT02638948|593853911|FG003|Overall Study|Lost to Follow-up|1|||
164405199|NCT02638948|593853908|FG000|Overall Study|Poor/Non-Compliance|0|||
164405200|NCT02638948|593853909|FG001|Overall Study|Poor/Non-Compliance|2|||
164405201|NCT02638948|593853910|FG002|Overall Study|Poor/Non-Compliance|1|||
164405202|NCT02638948|593853911|FG003|Overall Study|Poor/Non-Compliance|0|||
164405203|NCT02638948|593853908|FG000|Overall Study|Participant no longer met study criteria|0|||
164405204|NCT02638948|593853909|FG001|Overall Study|Participant no longer met study criteria|1|||
164405205|NCT02638948|593853910|FG002|Overall Study|Participant no longer met study criteria|0|||
164405206|NCT02638948|593853911|FG003|Overall Study|Participant no longer met study criteria|0|||
164405207|NCT02638948|593853908|FG000|Overall Study|Other than specified above|4|||
164405208|NCT02638948|593853909|FG001|Overall Study|Other than specified above|1|||
164405209|NCT02638948|593853910|FG002|Overall Study|Other than specified above|1|||
164144429|NCT00134901|592889869|FG001|Overall Study|Lost to Follow-up|5|||
164706644|NCT02393248|594953416|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164706645|NCT02393248|594953417|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164706646|NCT02393248|594953418|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164706647|NCT02393248|594953419|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164706648|NCT02393248|594953420|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164706649|NCT02393248|594953421|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164706650|NCT02393248|594953422|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164706651|NCT02393248|594953423|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164706652|NCT02393248|594953424|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164706653|NCT02393248|594953425|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164706654|NCT02393248|594953426|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164706655|NCT02393248|594953427|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164405210|NCT02638948|593853911|FG003|Overall Study|Other than specified above|1|||
164405211|NCT04992546|593853912|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
164405212|NCT04992546|593853912|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
164405213|NCT04992546|593853912|FG000|Open-Label Treatment Period|Adverse Event|3|||
164405214|NCT04992546|593853912|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
164405215|NCT05007392|593853914|FG000|Overall Study|Randomized but not treated|1|||
164405216|NCT05007392|593853915|FG001|Overall Study|Randomized but not treated|2|||
164405217|NCT05007392|593853914|FG000|Overall Study|Other|5|||
164405218|NCT05007392|593853915|FG001|Overall Study|Other|4|||
164405219|NCT05007392|593853914|FG000|Overall Study|Lost to Follow-up|1|||
164405220|NCT05007392|593853915|FG001|Overall Study|Lost to Follow-up|2|||
164405221|NCT05007392|593853914|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
164405222|NCT05007392|593853915|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
164405223|NCT05007392|593853914|FG000|Overall Study|Use of prohibited concomitant drug|1|||
164405224|NCT05007392|593853915|FG001|Overall Study|Use of prohibited concomitant drug|1|||
164405225|NCT05007392|593853914|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
164405226|NCT05007392|593853915|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
164405227|NCT05007392|593853914|FG000|Overall Study|Adverse Event|10|||
164405228|NCT05007392|593853915|FG001|Overall Study|Adverse Event|6|||
164405229|NCT05007392|593853914|FG000|Overall Study|Participant choice|5|||
164405230|NCT05007392|593853915|FG001|Overall Study|Participant choice|10|||
164405231|NCT05007392|593853914|FG000|Overall Study|Withdrawal of consent|5|||
164405232|NCT05007392|593853915|FG001|Overall Study|Withdrawal of consent|4|||
164405233|NCT02703922|593853916|FG000|Overall Study|Death|5|||
164405234|NCT02703922|593853917|FG001|Overall Study|Death|8|||
164405235|NCT02703922|593853916|FG000|Overall Study|Lost to Follow-up|10|||
164405236|NCT02703922|593853917|FG001|Overall Study|Lost to Follow-up|10|||
164405237|NCT05805657|593853922|FG000|Overall Study|Patients lost to post or 6-month follow-up|12|||
164405238|NCT05805657|593853923|FG001|Overall Study|Patients lost to post or 6-month follow-up|64|||
164405239|NCT04058353|593853924|FG000|Overall Study|Adverse Event|2|||
164405240|NCT04058353|593853925|FG001|Overall Study|Adverse Event|1|||
164405241|NCT04058353|593853924|FG000|Overall Study|Physician Decision|1|||
164405242|NCT04058353|593853925|FG001|Overall Study|Physician Decision|0|||
164405243|NCT04058353|593853924|FG000|Overall Study|Other|1|||
164405244|NCT04058353|593853925|FG001|Overall Study|Other|0|||
164405245|NCT00316173|593853929|FG000|Run-in Phase|Adverse Event|1|||
164405246|NCT00316173|593853930|FG001|Run-in Phase|Adverse Event|0|||
164405247|NCT00316173|593853929|FG000|Run-in Phase|Protocol Violation|1|||
164405248|NCT00316173|593853930|FG001|Run-in Phase|Protocol Violation|0|||
164405249|NCT00316173|593853929|FG000|Run-in Phase|Study Follow-up Stopped|5|||
164405250|NCT00316173|593853930|FG001|Run-in Phase|Study Follow-up Stopped|0|||
164405251|NCT00316173|593853929|FG000|Treatment Phase|Adverse Event|0|||
164405252|NCT00316173|593853930|FG001|Treatment Phase|Adverse Event|1|||
164405253|NCT00316173|593853929|FG000|Treatment Phase|Lack of Efficacy|0|||
164405254|NCT00316173|593853930|FG001|Treatment Phase|Lack of Efficacy|3|||
164405255|NCT00316173|593853929|FG000|Treatment Phase|Lost to Follow-up|0|||
164405256|NCT00316173|593853930|FG001|Treatment Phase|Lost to Follow-up|3|||
164405257|NCT00316173|593853929|FG000|Treatment Phase|Withdrawal by Subject|0|||
164405258|NCT00316173|593853930|FG001|Treatment Phase|Withdrawal by Subject|1|||
164405259|NCT00316173|593853929|FG000|Treatment Phase|Study Follow-up Stopped|0|||
164405260|NCT00316173|593853930|FG001|Treatment Phase|Study Follow-up Stopped|34|||
164405261|NCT02390531|593853931|FG000|Overall Study|Death|0|||
164405262|NCT02390531|593853932|FG001|Overall Study|Death|2|||
164405263|NCT02390531|593853933|FG002|Overall Study|Death|0|||
164405264|NCT02390531|593853934|FG003|Overall Study|Death|1|||
164405265|NCT02390531|593853935|FG004|Overall Study|Death|0|||
164405266|NCT02390531|593853936|FG005|Overall Study|Death|0|||
164452321|NCT00774852|594024083|FG001|Overall Study|Physician Decision|6|||
164452322|NCT00774852|594024082|FG000|Overall Study|Pregnancy|1|||
164452323|NCT00774852|594024083|FG001|Overall Study|Pregnancy|2|||
164452324|NCT00774852|594024082|FG000|Overall Study|Withdrawal by Subject|2|||
164452325|NCT00774852|594024083|FG001|Overall Study|Withdrawal by Subject|2|||
164452326|NCT00774852|594024082|FG000|Overall Study|Non-responder|15|||
164452327|NCT00774852|594024083|FG001|Overall Study|Non-responder|11|||
164452328|NCT00774852|594024082|FG000|Overall Study|Subject non-compliance|0|||
164452329|NCT00774852|594024083|FG001|Overall Study|Subject non-compliance|1|||
164452330|NCT00774852|594024082|FG000|Overall Study|Protocol Violation|1|||
164452331|NCT00774852|594024083|FG001|Overall Study|Protocol Violation|0|||
164452332|NCT00774852|594024082|FG000|Overall Study|Subject received prohibited medication|1|||
164452333|NCT00774852|594024083|FG001|Overall Study|Subject received prohibited medication|0|||
164452334|NCT04428112|594024084|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
164452335|NCT04428112|594024085|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
164452336|NCT04428112|594024084|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
164452337|NCT04428112|594024085|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
164452338|NCT04428112|594024084|FG000|Overall Study|Withdrawal by Subject|9|||
164452339|NCT04428112|594024085|FG001|Overall Study|Withdrawal by Subject|4|||
164452340|NCT04428112|594024084|FG000|Overall Study|Lost to Follow-up|27|||
164452341|NCT04428112|594024085|FG001|Overall Study|Lost to Follow-up|7|||
164452342|NCT04402294|594024088|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
164452343|NCT04402294|594024089|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
164452344|NCT04402294|594024088|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
164452345|NCT04402294|594024089|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
164452346|NCT04459416|594025374|FG000|Overall Study|Lost to Follow-up|2|||
164452347|NCT04459416|594025375|FG001|Overall Study|Lost to Follow-up|0|||
164452348|NCT04459416|594025374|FG000|Overall Study|Withdrawal by Subject|8|||
164452349|NCT04459416|594025375|FG001|Overall Study|Withdrawal by Subject|10|||
164452350|NCT04459416|594025374|FG000|Overall Study|Disease progression|0|||
164452351|NCT04459416|594025375|FG001|Overall Study|Disease progression|3|||
164597444|NCT03807739|594549074|FG001|Overall Study|Withdrawal by Subject|0|||
164144507|NCT04123561|592889897|FG001|Overall Study|Protocol Violation|1|||
164405267|NCT02390531|593853937|FG006|Overall Study|Death|0|||
164405268|NCT02390531|593853938|FG007|Overall Study|Death|1|||
164405269|NCT02390531|593853931|FG000|Overall Study|Protocol Violation|0|||
164405270|NCT02390531|593853932|FG001|Overall Study|Protocol Violation|0|||
164405271|NCT02390531|593853933|FG002|Overall Study|Protocol Violation|0|||
164405272|NCT02390531|593853934|FG003|Overall Study|Protocol Violation|0|||
164405273|NCT02390531|593853935|FG004|Overall Study|Protocol Violation|1|||
164405274|NCT02390531|593853936|FG005|Overall Study|Protocol Violation|0|||
164405275|NCT02390531|593853937|FG006|Overall Study|Protocol Violation|2|||
164405276|NCT02390531|593853938|FG007|Overall Study|Protocol Violation|0|||
164405277|NCT00552084|593853942|FG000|Overall Study|Adverse Event|2|||
164405278|NCT00552084|593853943|FG001|Overall Study|Adverse Event|3|||
164405279|NCT00552084|593853942|FG000|Overall Study|Withdrawal by Subject|4|||
164405280|NCT00552084|593853943|FG001|Overall Study|Withdrawal by Subject|5|||
164405281|NCT00552084|593853942|FG000|Overall Study|Protocol Violation|1|||
164405282|NCT00552084|593853943|FG001|Overall Study|Protocol Violation|0|||
164405283|NCT00552084|593853942|FG000|Overall Study|change in anti-arrythmic drug|1|||
164405284|NCT00552084|593853943|FG001|Overall Study|change in anti-arrythmic drug|1|||
164405285|NCT01338025|593853944|FG000|Overall Study|Unexpected closure of study|10|||
164405286|NCT01338025|593853945|FG001|Overall Study|Unexpected closure of study|9|||
164405287|NCT01338025|593853944|FG000|Overall Study|Withdrawal by Subject|0|||
164405288|NCT01338025|593853945|FG001|Overall Study|Withdrawal by Subject|2|||
164405289|NCT01338025|593853944|FG000|Overall Study|Found ineligible after starting|1|||
164405290|NCT01338025|593853945|FG001|Overall Study|Found ineligible after starting|0|||
164405291|NCT03188055|593853946|FG000|Overall Study|Unavailable for training|0|||
164405292|NCT03188055|593853947|FG001|Overall Study|Unavailable for training|0|||
164405293|NCT03188055|593853948|FG002|Overall Study|Unavailable for training|19|||
164405294|NCT03188055|593853949|FG003|Overall Study|Unavailable for training|0|||
164405295|NCT03188055|593853950|FG004|Overall Study|Unavailable for training|0|||
164405296|NCT03188055|593853951|FG005|Overall Study|Unavailable for training|0|||
164405297|NCT03188055|593853946|FG000|Overall Study|Lost to Follow-up|0|||
164405298|NCT03188055|593853947|FG001|Overall Study|Lost to Follow-up|18|||
164405299|NCT03188055|593853948|FG002|Overall Study|Lost to Follow-up|0|||
164405300|NCT03188055|593853949|FG003|Overall Study|Lost to Follow-up|11|||
164405301|NCT03188055|593853950|FG004|Overall Study|Lost to Follow-up|0|||
164405302|NCT03188055|593853951|FG005|Overall Study|Lost to Follow-up|0|||
164405303|NCT03188055|593853946|FG000|Overall Study|Withdrawal by Subject|0|||
164452352|NCT03744312|594025376|FG000|Overall Study|Withdrawal by Subject|0|||
164405304|NCT03188055|593853947|FG001|Overall Study|Withdrawal by Subject|1|||
164405305|NCT03188055|593853948|FG002|Overall Study|Withdrawal by Subject|0|||
164452353|NCT03744312|594025377|FG001|Overall Study|Withdrawal by Subject|1|||
164452354|NCT03744312|594025376|FG000|Overall Study|Screen fail|0|||
164452355|NCT03744312|594025377|FG001|Overall Study|Screen fail|1|||
164452356|NCT03152786|594025378|FG000|Overall Study|Withdrawal by Subject|2|||
164452357|NCT03152786|594025379|FG001|Overall Study|Withdrawal by Subject|1|||
164452358|NCT02597946|594025383|FG000|Overall Study|Withdrawal by Subject|1|||
164452359|NCT02597946|594025383|FG000|Overall Study|Progressive disease|16|||
164452360|NCT02597946|594025383|FG000|Overall Study|Other than above|1|||
164452361|NCT04823611|594025390|FG000|Overall Study|Adverse Event|2|||
164452362|NCT04823611|594025391|FG001|Overall Study|Adverse Event|0|||
164452363|NCT04823611|594025392|FG002|Overall Study|Adverse Event|1|||
164452364|NCT04823611|594025393|FG003|Overall Study|Adverse Event|0|||
164452365|NCT04823611|594025394|FG004|Overall Study|Adverse Event|0|||
164452366|NCT04823611|594025395|FG005|Overall Study|Adverse Event|0|||
164452367|NCT04823611|594025396|FG006|Overall Study|Adverse Event|0|||
164452368|NCT05038566|594025397|FG000|Overall Study|Technical Difficulties with the Device|0|||
164452369|NCT05038566|594025398|FG001|Overall Study|Technical Difficulties with the Device|1|||
164452370|NCT04850807|594025407|FG000|Overall Study|Death|50|||
164452371|NCT04850807|594025408|FG001|Overall Study|Death|55|||
164452372|NCT04850807|594025407|FG000|Overall Study|Discharged|17|||
164452373|NCT04850807|594025408|FG001|Overall Study|Discharged|13|||
164452374|NCT04850807|594025407|FG000|Overall Study|Incomplete baseline data|3|||
164452375|NCT04850807|594025408|FG001|Overall Study|Incomplete baseline data|2|||
164452376|NCT03739996|594025409|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
164452377|NCT03739996|594025409|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
164452378|NCT03739996|594025409|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
164452379|NCT03739996|594025409|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
164452380|NCT03739996|594025409|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
164452381|NCT03739996|594025409|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
164452382|NCT03739996|594025409|FG000|Step 3 (SOC ART)|Death|1|||
164452383|NCT03739996|594025409|FG000|Step 3 (SOC ART)|Participant moved|1|||
164452384|NCT05141903|594025410|FG000|Overall Study|Withdrawal by Subject|0|||
164452385|NCT05141903|594025411|FG001|Overall Study|Withdrawal by Subject|1|||
164452386|NCT05141903|594025412|FG002|Overall Study|Withdrawal by Subject|1|||
164452387|NCT05141903|594025413|FG003|Overall Study|Withdrawal by Subject|0|||
164452388|NCT05141903|594025414|FG004|Overall Study|Withdrawal by Subject|0|||
164452389|NCT05141903|594025410|FG000|Overall Study|Other|1|||
164452390|NCT05141903|594025411|FG001|Overall Study|Other|1|||
164452391|NCT05141903|594025412|FG002|Overall Study|Other|0|||
164452392|NCT05141903|594025413|FG003|Overall Study|Other|0|||
164452393|NCT05141903|594025414|FG004|Overall Study|Other|0|||
164452394|NCT04437433|594025420|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
164452395|NCT04437433|594025421|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
164452396|NCT04437433|594025420|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
164452397|NCT04437433|594025421|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
164452398|NCT04437433|594025420|FG000|Overall Study|Adverse Event|9|||
164452399|NCT04437433|594025421|FG001|Overall Study|Adverse Event|0|||
164452400|NCT04437433|594025420|FG000|Overall Study|Lack of Efficacy|4|||
164452401|NCT04437433|594025421|FG001|Overall Study|Lack of Efficacy|0|||
164452402|NCT04437433|594025420|FG000|Overall Study|Withdrawal by Subject|4|||
164452403|NCT04437433|594025421|FG001|Overall Study|Withdrawal by Subject|1|||
164452404|NCT04437433|594025420|FG000|Overall Study|Protocol Deviation|0|||
164452405|NCT04437433|594025421|FG001|Overall Study|Protocol Deviation|1|||
164452406|NCT04437433|594025420|FG000|Overall Study|Other, not specified|0|||
164452407|NCT04437433|594025421|FG001|Overall Study|Other, not specified|1|||
164452408|NCT04579250|594025423|FG000|Overall Study|Withdrawal by Subject|1|||
164452409|NCT04579250|594025424|FG001|Overall Study|Withdrawal by Subject|1|||
164597445|NCT03807739|594549075|FG002|Overall Study|Withdrawal by Subject|0|||
164597446|NCT03807739|594549076|FG003|Overall Study|Withdrawal by Subject|0|||
164452410|NCT04579250|594025425|FG002|Overall Study|Withdrawal by Subject|0|||
164452411|NCT04579250|594025423|FG000|Overall Study|Lost to Follow-up|1|||
164452412|NCT04579250|594025424|FG001|Overall Study|Lost to Follow-up|1|||
164452413|NCT04579250|594025425|FG002|Overall Study|Lost to Follow-up|0|||
164452414|NCT04579250|594025423|FG000|Overall Study|Moved from area|0|||
164452415|NCT04579250|594025424|FG001|Overall Study|Moved from area|1|||
164452416|NCT04579250|594025425|FG002|Overall Study|Moved from area|2|||
164452417|NCT02919449|594025426|FG000|Overall Study|Withdrawal by Subject|1|||
164452418|NCT02919449|594025426|FG000|Overall Study|Investigator decision|1|||
164597447|NCT02371759|594549077|FG000|Overall Study|Protocol Violation|3|||
164597448|NCT02371759|594549078|FG001|Overall Study|Protocol Violation|1|||
164597449|NCT02371759|594549079|FG002|Overall Study|Protocol Violation|1|||
164597450|NCT02371759|594549080|FG003|Overall Study|Protocol Violation|0|||
164597451|NCT02371759|594549081|FG004|Overall Study|Protocol Violation|3|||
164597452|NCT02371759|594549082|FG005|Overall Study|Protocol Violation|1|||
164597453|NCT02371759|594549083|FG006|Overall Study|Protocol Violation|0|||
164597454|NCT02371759|594549084|FG007|Overall Study|Protocol Violation|3|||
164597455|NCT02371759|594549077|FG000|Overall Study|Withdrawal by Subject|0|||
164452419|NCT04711135|594025430|FG000|Overall Study|Physician Decision|0|||
164452420|NCT04711135|594025431|FG001|Overall Study|Physician Decision|1|||
164452421|NCT04711135|594025430|FG000|Overall Study|Ongoing treatment|0|||
164452422|NCT04711135|594025431|FG001|Overall Study|Ongoing treatment|1|||
164452423|NCT03578536|594025434|FG000|Overall Study|Lost to Follow-up|1|||
164452424|NCT02538900|594025437|FG000|Overall Study|Death|2|||
164452425|NCT02538900|594025438|FG001|Overall Study|Death|2|||
164452426|NCT02538900|594025439|FG002|Overall Study|Death|2|||
164452427|NCT02538900|594025437|FG000|Overall Study|Withdrawal by Subject|18|||
164452428|NCT02538900|594025438|FG001|Overall Study|Withdrawal by Subject|16|||
164452429|NCT02538900|594025439|FG002|Overall Study|Withdrawal by Subject|15|||
164452430|NCT03732820|594025440|FG000|Overall Study|Death|168|||
164452431|NCT03732820|594025441|FG001|Overall Study|Death|203|||
164452432|NCT03732820|594025440|FG000|Overall Study|Other|2|||
164452433|NCT03732820|594025441|FG001|Overall Study|Other|2|||
164452434|NCT03732820|594025440|FG000|Overall Study|Failure to meet randomisation criteria|1|||
164452435|NCT03732820|594025441|FG001|Overall Study|Failure to meet randomisation criteria|1|||
164452436|NCT03732820|594025440|FG000|Overall Study|Patient decision|14|||
164452437|NCT03732820|594025441|FG001|Overall Study|Patient decision|10|||
164452438|NCT03732820|594025440|FG000|Overall Study|Screen failure|0|||
164452439|NCT03732820|594025441|FG001|Overall Study|Screen failure|1|||
164452440|NCT03732820|594025440|FG000|Overall Study|Patients ongoing study at data cut off|210|||
164452441|NCT03732820|594025441|FG001|Overall Study|Patients ongoing study at data cut off|178|||
164452442|NCT03732820|594025440|FG000|Overall Study|Lost to Follow-up|4|||
164452443|NCT03732820|594025441|FG001|Overall Study|Lost to Follow-up|2|||
164452444|NCT02374307|594025444|FG000|3-months Follow-up|Lost to Follow-up|1|||
164452445|NCT02374307|594025445|FG001|3-months Follow-up|Lost to Follow-up|2|||
164452446|NCT02374307|594025444|FG000|3-months Follow-up|Withdrawal by Subject|1|||
164452447|NCT02374307|594025445|FG001|3-months Follow-up|Withdrawal by Subject|4|||
164452448|NCT02374307|594025444|FG000|3-months Follow-up|Death|1|||
164452449|NCT02374307|594025445|FG001|3-months Follow-up|Death|2|||
164452450|NCT02374307|594025444|FG000|3-months Follow-up|Missed first follow-up|5|||
164452451|NCT02374307|594025445|FG001|3-months Follow-up|Missed first follow-up|1|||
164452452|NCT02374307|594025444|FG000|6-months Follow-up|Lost to Follow-up|1|||
164452453|NCT02374307|594025445|FG001|6-months Follow-up|Lost to Follow-up|2|||
164452454|NCT02374307|594025444|FG000|6-months Follow-up|Death|2|||
164452455|NCT02374307|594025445|FG001|6-months Follow-up|Death|1|||
164452456|NCT02374307|594025444|FG000|6-months Follow-up|Withdrawal by Subject|0|||
164452457|NCT02374307|594025445|FG001|6-months Follow-up|Withdrawal by Subject|3|||
164452458|NCT01989455|594025446|FG000|Overall Study|Adverse Event|0|||
164452459|NCT01989455|594025447|FG001|Overall Study|Adverse Event|1|||
164452460|NCT01989455|594025448|FG002|Overall Study|Adverse Event|0|||
164452461|NCT01989455|594025449|FG003|Overall Study|Adverse Event|0|||
164452462|NCT01989455|594025450|FG004|Overall Study|Adverse Event|0|||
164452463|NCT01989455|594025446|FG000|Overall Study|Withdrawal by Subject|0|||
164452464|NCT01989455|594025447|FG001|Overall Study|Withdrawal by Subject|1|||
164452465|NCT01989455|594025448|FG002|Overall Study|Withdrawal by Subject|0|||
164452466|NCT01989455|594025449|FG003|Overall Study|Withdrawal by Subject|0|||
164452467|NCT01989455|594025450|FG004|Overall Study|Withdrawal by Subject|0|||
164452468|NCT01989455|594025446|FG000|Overall Study|Technical problems with infusion|0|||
164452469|NCT01989455|594025447|FG001|Overall Study|Technical problems with infusion|0|||
164452470|NCT01989455|594025448|FG002|Overall Study|Technical problems with infusion|1|||
164452471|NCT01989455|594025449|FG003|Overall Study|Technical problems with infusion|0|||
164452472|NCT01989455|594025450|FG004|Overall Study|Technical problems with infusion|1|||
164452473|NCT00632203|594025451|FG000|Overall Study|Did not start study treatment|1|||
164452474|NCT00632203|594025452|FG001|Overall Study|Did not start study treatment|0|||
164452475|NCT00999167|594025453|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
164452476|NCT00999167|594025454|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
164452477|NCT00999167|594025455|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
164452478|NCT00999167|594025453|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
164452479|NCT00999167|594025454|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
164452480|NCT00999167|594025455|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
164452481|NCT00999167|594025453|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
164452482|NCT00999167|594025454|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
164452483|NCT00999167|594025455|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
164452484|NCT00999167|594025453|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
164452485|NCT00999167|594025454|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
164452486|NCT00999167|594025455|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
164452487|NCT00999167|594025453|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
164452488|NCT00999167|594025454|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
164452489|NCT00999167|594025455|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
164452490|NCT00999167|594025453|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
164452491|NCT00999167|594025454|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
164452492|NCT00999167|594025455|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
164452493|NCT00999167|594025453|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
164452494|NCT00999167|594025454|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
164452495|NCT00999167|594025455|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
164452496|NCT00999167|594025453|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
164452497|NCT00999167|594025454|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
164452498|NCT00999167|594025455|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
164452499|NCT00604669|594025456|FG000|Overall Study|lack of information in chart|7|||
164452500|NCT04238247|594025457|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
164706656|NCT02393248|594953428|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164706657|NCT02393248|594953429|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164706658|NCT02393248|594953430|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164405306|NCT03188055|593853949|FG003|Overall Study|Withdrawal by Subject|1|||
164452501|NCT04238247|594025458|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
164452502|NCT04238247|594025459|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
164405307|NCT03188055|593853950|FG004|Overall Study|Withdrawal by Subject|0|||
164405308|NCT03188055|593853951|FG005|Overall Study|Withdrawal by Subject|0|||
164405309|NCT03657277|593853952|FG000|Overall Study|Physician Decision|2|||
164405310|NCT03657277|593853952|FG000|Overall Study|Lost to Follow-up|1|||
164405311|NCT03657277|593853952|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
164405312|NCT01024608|593853955|FG000|Overall Study|Adverse Event|1|||
164405313|NCT01024608|593853956|FG001|Overall Study|Adverse Event|0|||
164405314|NCT01024608|593853955|FG000|Overall Study|Withdrawal by Subject|1|||
164405315|NCT01024608|593853956|FG001|Overall Study|Withdrawal by Subject|0|||
164405316|NCT01024608|593853955|FG000|Overall Study|Lost to Follow-up|0|||
164405317|NCT01024608|593853956|FG001|Overall Study|Lost to Follow-up|1|||
164405318|NCT01024608|593853955|FG000|Overall Study|Protocol Violation|0|||
164405319|NCT01024608|593853956|FG001|Overall Study|Protocol Violation|3|||
164405320|NCT01024608|593853955|FG000|Overall Study|Never received study treatment|2|||
164405321|NCT01024608|593853956|FG001|Overall Study|Never received study treatment|0|||
164405322|NCT04349280|593853957|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
164405323|NCT04349280|593853958|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
164405324|NCT04349280|593853957|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
164405325|NCT04349280|593853958|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
164405326|NCT04349280|593853957|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
164405327|NCT04349280|593853958|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
164405328|NCT00657618|593853963|FG000|Overall Study|Adverse Event|32|||
164405329|NCT00657618|593853963|FG000|Overall Study|Withdrawal by Subject|8|||
164405330|NCT00657618|593853963|FG000|Overall Study|negative for leishmaniasis|2|||
164405331|NCT00657618|593853963|FG000|Overall Study|didn't start due to schedule conflicts|1|||
164405332|NCT01659151|593853964|FG000|Overall Study|Inadequate TIL growth|1|||
164405333|NCT05774197|593853965|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
164405334|NCT05073133|593853966|FG000|Overall Study|Death|2|||
164405335|NCT04981678|593853967|FG000|Overall Study|Lost to Follow-up|0|||
164405336|NCT04981678|593853968|FG001|Overall Study|Lost to Follow-up|1|||
164405337|NCT02044848|593855427|FG000|Overall Study|Administrative Problems|2|||
164405338|NCT02044848|593855428|FG001|Overall Study|Administrative Problems|3|||
164405339|NCT04791761|593855429|FG000|Overall Study|Lost to Follow-up|8|||
164405340|NCT04791761|593855430|FG001|Overall Study|Lost to Follow-up|6|||
164405341|NCT04791761|593855431|FG002|Overall Study|Lost to Follow-up|10|||
164405342|NCT04791761|593855429|FG000|Overall Study|Withdrawal by Subject|0|||
164405343|NCT04791761|593855430|FG001|Overall Study|Withdrawal by Subject|1|||
164405344|NCT04791761|593855431|FG002|Overall Study|Withdrawal by Subject|1|||
164405345|NCT04791761|593855429|FG000|Overall Study|Protocol Violation|0|||
164405346|NCT04791761|593855430|FG001|Overall Study|Protocol Violation|1|||
164405347|NCT04791761|593855431|FG002|Overall Study|Protocol Violation|1|||
164405348|NCT04669600|593855432|FG000|Overall Study|Withdrawal by Subject|1|||
164405349|NCT04669600|593855432|FG000|Overall Study|Other|6|||
164405350|NCT00676130|593855439|FG000|Overall Study|Lost to Follow-up|0|||
164405351|NCT00676130|593855440|FG001|Overall Study|Lost to Follow-up|1|||
164405352|NCT00676130|593855439|FG000|Overall Study|Found ineligible|3|||
164405353|NCT00676130|593855440|FG001|Overall Study|Found ineligible|2|||
164405354|NCT00676130|593855439|FG000|Overall Study|Withdrawal by Subject|0|||
164405355|NCT00676130|593855440|FG001|Overall Study|Withdrawal by Subject|1|||
164405356|NCT04857034|593855445|FG000|Placebo-Controlled Period|Request to discontinue|2|||
164405357|NCT04857034|593855446|FG001|Placebo-Controlled Period|Request to discontinue|2|||
164405358|NCT04857034|593855447|FG002|Placebo-Controlled Period|Request to discontinue|0|||
164405359|NCT04857034|593855448|FG003|Placebo-Controlled Period|Request to discontinue|0|||
164452503|NCT04238247|594025460|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
164405360|NCT04857034|593855449|FG004|Placebo-Controlled Period|Request to discontinue|0|||
164405361|NCT04857034|593855445|FG000|Placebo-Controlled Period|withdrew consent|1|||
164452504|NCT04238247|594025457|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
164452505|NCT04238247|594025458|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
164452506|NCT04238247|594025459|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
164452507|NCT04238247|594025460|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
164452508|NCT04238247|594025457|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
164452509|NCT04238247|594025458|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
164452510|NCT04238247|594025459|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
164452511|NCT04238247|594025460|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
164452512|NCT04238247|594025457|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
164452513|NCT04238247|594025458|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
164452514|NCT04238247|594025459|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
164452515|NCT04238247|594025460|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
164452516|NCT04950127|594025461|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
164452517|NCT04950127|594025462|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
164452518|NCT04950127|594025463|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
164452519|NCT04950127|594025464|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
164452520|NCT04950127|594025465|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
164452521|NCT04950127|594025466|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
164452522|NCT04950127|594025461|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
164452523|NCT04950127|594025462|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
164452524|NCT04950127|594025463|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
164452525|NCT04950127|594025464|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
164452526|NCT04950127|594025465|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
164452527|NCT04950127|594025466|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
164452528|NCT04950127|594025461|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
164452529|NCT04950127|594025462|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
164452530|NCT04950127|594025463|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
164452531|NCT04950127|594025464|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
164452532|NCT04950127|594025465|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
164452533|NCT04950127|594025466|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
164452534|NCT04950127|594025461|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
164452535|NCT04950127|594025462|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
164452536|NCT04950127|594025463|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
164452537|NCT04950127|594025464|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
164452538|NCT04950127|594025465|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
164452539|NCT04950127|594025466|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
164452540|NCT04950127|594025461|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
164452541|NCT04950127|594025462|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
164452542|NCT04950127|594025463|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
164452543|NCT04950127|594025464|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
164452544|NCT04950127|594025465|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
164452545|NCT04950127|594025466|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
164452546|NCT01711632|594025467|FG000|Overall Study|Adverse Event|4|||
164452547|NCT01711632|594025467|FG000|Overall Study|Death|3|||
164452548|NCT01711632|594025467|FG000|Overall Study|Lost to Follow-up|3|||
164452549|NCT01711632|594025467|FG000|Overall Study|Withdrawal by Subject|4|||
164452550|NCT01711632|594025467|FG000|Overall Study|Progressive disease|2|||
164452551|NCT01711632|594025467|FG000|Overall Study|No follow up required in re-treatment|3|||
164452552|NCT01711632|594025467|FG000|Overall Study|No follow up required in re-treatment|3|||
164452553|NCT04315181|594025468|FG000|Overall Study|Non-responsive to drug conditions.|1|||
164452554|NCT01948661|594025469|FG000|Overall Study|Withdrawal by Subject|2|||
164452555|NCT01948661|594025470|FG001|Overall Study|Withdrawal by Subject|4|||
164452556|NCT03517969|594025471|FG000|Overall Study|Never started protocol treatment|3|||
164452557|NCT03517969|594025472|FG001|Overall Study|Never started protocol treatment|5|||
164452558|NCT03517969|594025471|FG000|Overall Study|Disease progression|11|||
164452559|NCT03517969|594025472|FG001|Overall Study|Disease progression|16|||
164452560|NCT03517969|594025471|FG000|Overall Study|PSA progression|8|||
164452561|NCT03517969|594025472|FG001|Overall Study|PSA progression|1|||
164452562|NCT03517969|594025471|FG000|Overall Study|Clinical progression|4|||
164452563|NCT03517969|594025472|FG001|Overall Study|Clinical progression|2|||
164452564|NCT03517969|594025471|FG000|Overall Study|Adverse Event|5|||
164452565|NCT03517969|594025472|FG001|Overall Study|Adverse Event|4|||
164452566|NCT03517969|594025471|FG000|Overall Study|Intercurrent illness|1|||
164452567|NCT03517969|594025472|FG001|Overall Study|Intercurrent illness|2|||
164452568|NCT03517969|594025471|FG000|Overall Study|Death|1|||
164452569|NCT03517969|594025472|FG001|Overall Study|Death|1|||
164452570|NCT03517969|594025471|FG000|Overall Study|Withdrawal by Subject|1|||
164452571|NCT03517969|594025472|FG001|Overall Study|Withdrawal by Subject|2|||
164452572|NCT03517969|594025471|FG000|Overall Study|Physician Decision|1|||
164452573|NCT03517969|594025472|FG001|Overall Study|Physician Decision|1|||
164597456|NCT02371759|594549078|FG001|Overall Study|Withdrawal by Subject|0|||
164597457|NCT02371759|594549079|FG002|Overall Study|Withdrawal by Subject|0|||
164405362|NCT04857034|593855446|FG001|Placebo-Controlled Period|withdrew consent|1|||
164405363|NCT04857034|593855447|FG002|Placebo-Controlled Period|withdrew consent|2|||
164405364|NCT04857034|593855448|FG003|Placebo-Controlled Period|withdrew consent|0|||
164405365|NCT04857034|593855449|FG004|Placebo-Controlled Period|withdrew consent|0|||
164405366|NCT04857034|593855445|FG000|Placebo-Controlled Period|Pregnancy|1|||
164405367|NCT04857034|593855446|FG001|Placebo-Controlled Period|Pregnancy|1|||
164405368|NCT04857034|593855447|FG002|Placebo-Controlled Period|Pregnancy|0|||
164405369|NCT04857034|593855448|FG003|Placebo-Controlled Period|Pregnancy|0|||
164405370|NCT04857034|593855449|FG004|Placebo-Controlled Period|Pregnancy|0|||
164405371|NCT04857034|593855445|FG000|Placebo-Controlled Period|Ongoing study period|0|||
164405372|NCT04857034|593855446|FG001|Placebo-Controlled Period|Ongoing study period|1|||
164405373|NCT04857034|593855447|FG002|Placebo-Controlled Period|Ongoing study period|0|||
164405374|NCT04857034|593855448|FG003|Placebo-Controlled Period|Ongoing study period|0|||
164405375|NCT04857034|593855449|FG004|Placebo-Controlled Period|Ongoing study period|0|||
164405376|NCT04857034|593855445|FG000|Active Treatment Period|Lack of Efficacy|1|||
164405377|NCT04857034|593855446|FG001|Active Treatment Period|Lack of Efficacy|0|||
164405378|NCT04857034|593855447|FG002|Active Treatment Period|Lack of Efficacy|0|||
164405379|NCT04857034|593855448|FG003|Active Treatment Period|Lack of Efficacy|0|||
164405380|NCT04857034|593855449|FG004|Active Treatment Period|Lack of Efficacy|0|||
164405381|NCT04857034|593855445|FG000|Active Treatment Period|request to discontinue|0|||
164405382|NCT04857034|593855446|FG001|Active Treatment Period|request to discontinue|1|||
164405383|NCT04857034|593855447|FG002|Active Treatment Period|request to discontinue|0|||
164405384|NCT04857034|593855448|FG003|Active Treatment Period|request to discontinue|1|||
164405385|NCT04857034|593855449|FG004|Active Treatment Period|request to discontinue|0|||
164405386|NCT04857034|593855445|FG000|Active Treatment Period|administrative reason by sponsor|1|||
164405387|NCT04857034|593855446|FG001|Active Treatment Period|administrative reason by sponsor|5|||
164405388|NCT04857034|593855447|FG002|Active Treatment Period|administrative reason by sponsor|0|||
164405389|NCT04857034|593855448|FG003|Active Treatment Period|administrative reason by sponsor|2|||
164405390|NCT04857034|593855449|FG004|Active Treatment Period|administrative reason by sponsor|2|||
164405391|NCT04857034|593855445|FG000|Active Treatment Period|other reasons|1|||
164405392|NCT04857034|593855446|FG001|Active Treatment Period|other reasons|1|||
164405393|NCT04857034|593855447|FG002|Active Treatment Period|other reasons|0|||
164405394|NCT04857034|593855448|FG003|Active Treatment Period|other reasons|0|||
164405395|NCT04857034|593855449|FG004|Active Treatment Period|other reasons|1|||
164405396|NCT04857034|593855445|FG000|Active Treatment Period|Ongoing Study Period|2|||
164405397|NCT04857034|593855446|FG001|Active Treatment Period|Ongoing Study Period|4|||
164405398|NCT04857034|593855447|FG002|Active Treatment Period|Ongoing Study Period|0|||
164405399|NCT04857034|593855448|FG003|Active Treatment Period|Ongoing Study Period|1|||
164405400|NCT04857034|593855449|FG004|Active Treatment Period|Ongoing Study Period|0|||
164405401|NCT00261495|593855454|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
164405402|NCT00261495|593855455|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
164405403|NCT00261495|593855454|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
164405404|NCT00261495|593855455|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
164405405|NCT00261495|593855454|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
164405406|NCT00261495|593855455|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
164405407|NCT00261495|593855454|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
164405408|NCT00261495|593855455|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
164405409|NCT00261495|593855454|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
164405410|NCT00261495|593855455|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
164405411|NCT00261495|593855454|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
164405412|NCT00261495|593855455|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
164405413|NCT00261495|593855454|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
164405414|NCT00261495|593855455|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
164405415|NCT00261495|593855454|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
164405416|NCT00261495|593855455|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
164405417|NCT00261495|593855454|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
164405418|NCT00261495|593855455|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
164405419|NCT00261495|593855454|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
164405420|NCT00261495|593855455|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
164405421|NCT00261495|593855454|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
164405422|NCT00261495|593855455|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
164405423|NCT00261495|593855454|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
164405424|NCT00261495|593855455|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
164405425|NCT00261495|593855454|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
164405426|NCT00261495|593855455|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
164405427|NCT00261495|593855454|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
164405428|NCT00261495|593855455|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
164405429|NCT00261495|593855454|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
164452574|NCT03517969|594025471|FG000|Overall Study|No clinical benefit|1|||
164452575|NCT03517969|594025472|FG001|Overall Study|No clinical benefit|0|||
164452576|NCT03517969|594025471|FG000|Overall Study|Delayed treatment for dental treatment|1|||
164452577|NCT03517969|594025472|FG001|Overall Study|Delayed treatment for dental treatment|0|||
164452578|NCT03517969|594025471|FG000|Overall Study|Difficult to maintain appointment|0|||
164452579|NCT03517969|594025472|FG001|Overall Study|Difficult to maintain appointment|1|||
164452580|NCT03517969|594025471|FG000|Overall Study|Protocol Violation|0|||
164452581|NCT03517969|594025472|FG001|Overall Study|Protocol Violation|1|||
164452582|NCT03271489|594025473|FG000|Double-Blind (DB) Period|Adverse Event|4|||
164452583|NCT03271489|594025474|FG001|Double-Blind (DB) Period|Adverse Event|1|||
164452584|NCT03271489|594025473|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
164452585|NCT03271489|594025474|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
164452586|NCT03271489|594025473|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
164452587|NCT03271489|594025474|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
164452588|NCT03271489|594025473|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
164452589|NCT03271489|594025474|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
164452590|NCT03271489|594025473|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
164452591|NCT03271489|594025474|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
164452592|NCT03271489|594025473|FG000|Double-Blind (DB) Period|Other|6|||
164452593|NCT03271489|594025474|FG001|Double-Blind (DB) Period|Other|1|||
164452594|NCT03271489|594025473|FG000|Double-Blind (DB) Period|Missing|1|||
164452595|NCT03271489|594025474|FG001|Double-Blind (DB) Period|Missing|0|||
164452596|NCT03271489|594025473|FG000|Open-Label (OL) Period|Adverse Event|2|||
164452597|NCT03271489|594025474|FG001|Open-Label (OL) Period|Adverse Event|0|||
164452598|NCT03271489|594025473|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
164452599|NCT03271489|594025474|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
164452600|NCT03271489|594025473|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
164452601|NCT03271489|594025474|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
164452602|NCT03271489|594025473|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
164452603|NCT03271489|594025474|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
164452604|NCT03271489|594025473|FG000|Open-Label (OL) Period|No Specified|2|||
164452605|NCT03271489|594025474|FG001|Open-Label (OL) Period|No Specified|2|||
164452606|NCT03271489|594025473|FG000|Open-Label (OL) Period|Missing|2|||
164452607|NCT03271489|594025474|FG001|Open-Label (OL) Period|Missing|0|||
164452608|NCT03271489|594025473|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
164452609|NCT03271489|594025474|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
164452610|NCT03271489|594025473|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
164452611|NCT03271489|594025474|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
164452612|NCT03271489|594025473|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
164452613|NCT03271489|594025474|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
164452614|NCT03271489|594025473|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
164452615|NCT03271489|594025474|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
164452616|NCT03271489|594025473|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
164452617|NCT03271489|594025474|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
164452618|NCT03271489|594025473|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
164452619|NCT03271489|594025474|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
164452620|NCT03271489|594025473|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
164452621|NCT03271489|594025474|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
164452622|NCT03271489|594025473|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
164452623|NCT03271489|594025474|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
164452624|NCT02860130|594025475|FG000|Overall Study|Adverse Event|2|||
164452625|NCT02860130|594025476|FG001|Overall Study|Adverse Event|3|||
164452626|NCT02860130|594025475|FG000|Overall Study|Protocol Violation|1|||
164452627|NCT02860130|594025476|FG001|Overall Study|Protocol Violation|1|||
164452628|NCT02860130|594025475|FG000|Overall Study|Withdrawal by Subject|0|||
164452629|NCT02860130|594025476|FG001|Overall Study|Withdrawal by Subject|2|||
164452630|NCT02860130|594025475|FG000|Overall Study|Physician Decision|2|||
164452631|NCT02860130|594025476|FG001|Overall Study|Physician Decision|2|||
164452632|NCT02860130|594025475|FG000|Overall Study|Other|2|||
164452633|NCT02860130|594025476|FG001|Overall Study|Other|1|||
164452634|NCT02886286|594025477|FG000|Overall Study|pump motor stall|0|||
164452635|NCT02886286|594025478|FG001|Overall Study|pump motor stall|1|||
164452636|NCT01127373|594025479|FG000|Overall Study|Not Treated|3|||
164597458|NCT02371759|594549080|FG003|Overall Study|Withdrawal by Subject|0|||
164597459|NCT02371759|594549081|FG004|Overall Study|Withdrawal by Subject|0|||
164597460|NCT02371759|594549082|FG005|Overall Study|Withdrawal by Subject|0|||
164597461|NCT02371759|594549083|FG006|Overall Study|Withdrawal by Subject|0|||
164597462|NCT02371759|594549084|FG007|Overall Study|Withdrawal by Subject|1|||
164597463|NCT03136185|594549089|FG000|Overall Study|Adverse Event|0|||
164597464|NCT03136185|594549090|FG001|Overall Study|Adverse Event|1|||
164452637|NCT01127373|594025479|FG000|Overall Study|Lost to Follow-up|7|||
164452638|NCT01127373|594025479|FG000|Overall Study|Withdrawal by Subject|1|||
164452639|NCT01127373|594025479|FG000|Overall Study|Disease progression|1|||
164452640|NCT00522951|594025482|FG000|Period 1|body motion|0|||
164452641|NCT00522951|594025483|FG001|Period 1|body motion|1|||
164452642|NCT00522951|594025482|FG000|Washout Period|Adverse Event|0|||
164452643|NCT00522951|594025483|FG001|Washout Period|Adverse Event|1|||
164452644|NCT00522951|594025482|FG000|Washout Period|Death|0|||
164452645|NCT00522951|594025483|FG001|Washout Period|Death|1|||
164452646|NCT00522951|594025482|FG000|Period 2|Withdrawal by Subject|1|||
164452647|NCT00522951|594025483|FG001|Period 2|Withdrawal by Subject|0|||
164452648|NCT00522951|594025482|FG000|Period 2|residual contrast medium|1|||
164452649|NCT00522951|594025483|FG001|Period 2|residual contrast medium|1|||
164452650|NCT02140645|594025487|FG000|Overall Study|Not linked|5489|||
164452651|NCT02140645|594025488|FG001|Overall Study|Not linked|61654|||
164452652|NCT02140645|594025489|FG002|Overall Study|Not linked|4236|||
164452653|NCT02140645|594025490|FG003|Overall Study|Not linked|13833|||
164452654|NCT02140645|594025491|FG004|Overall Study|Not linked|3286|||
164452655|NCT02140645|594025492|FG005|Overall Study|Not linked|70896|||
164452656|NCT05450458|594025493|FG000|Overall Study|Lost to Follow-up|4|||
164452657|NCT01101451|594025495|FG000|Overall Study|Eligible and never treated|0|||
164452658|NCT01101451|594025496|FG001|Overall Study|Eligible and never treated|5|||
164452659|NCT01101451|594025495|FG000|Overall Study|Ineligible and treated|12|||
164452660|NCT01101451|594025496|FG001|Overall Study|Ineligible and treated|8|||
164452661|NCT01101451|594025495|FG000|Overall Study|Ineligible and never treated|2|||
164452662|NCT01101451|594025496|FG001|Overall Study|Ineligible and never treated|2|||
164452663|NCT01044303|594025498|FG000|Overall Study|Lost to Follow-up|2|||
164452664|NCT01227265|594025499|FG000|Overall Study|Did Not Receive Treatment|1|||
164452665|NCT01227265|594025500|FG001|Overall Study|Did Not Receive Treatment|2|||
164452666|NCT01227265|594025501|FG002|Overall Study|Did Not Receive Treatment|0|||
164452667|NCT01227265|594025499|FG000|Overall Study|Administrative|1|||
164452668|NCT01227265|594025500|FG001|Overall Study|Administrative|0|||
164452669|NCT01227265|594025501|FG002|Overall Study|Administrative|2|||
164452670|NCT01227265|594025499|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
164452671|NCT01227265|594025500|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
164452672|NCT01227265|594025501|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
164452673|NCT01227265|594025499|FG000|Overall Study|Protocol Violation|2|||
164452674|NCT01227265|594025500|FG001|Overall Study|Protocol Violation|1|||
164452675|NCT01227265|594025501|FG002|Overall Study|Protocol Violation|0|||
164452676|NCT01227265|594025499|FG000|Overall Study|Withdrawal by Subject|7|||
164452677|NCT01227265|594025500|FG001|Overall Study|Withdrawal by Subject|7|||
164452678|NCT01227265|594025501|FG002|Overall Study|Withdrawal by Subject|3|||
164452679|NCT01227265|594025499|FG000|Overall Study|Lost to Follow-up|2|||
164452680|NCT01227265|594025500|FG001|Overall Study|Lost to Follow-up|0|||
164452681|NCT01227265|594025501|FG002|Overall Study|Lost to Follow-up|3|||
164452682|NCT01227265|594025499|FG000|Overall Study|Adverse Event|6|||
164452683|NCT01227265|594025500|FG001|Overall Study|Adverse Event|10|||
164452684|NCT01227265|594025501|FG002|Overall Study|Adverse Event|5|||
164452685|NCT02910713|594025502|FG000|Overall Study|Protocol Violation|2|||
164452686|NCT02910713|594025502|FG000|Overall Study|Subject Choice|4|||
164452687|NCT02910713|594025502|FG000|Overall Study|Received One Application|10|||
164452688|NCT02910713|594025502|FG000|Overall Study|Received Neither Application|18|||
164452689|NCT02910713|594025502|FG000|Overall Study|Enrollment cap|7|||
164452690|NCT02910713|594025502|FG000|Overall Study|Investigator Discretion|1|||
164452691|NCT06450405|594025511|FG000|Overall Study|Study funding terminated.|0|||
164452692|NCT06450405|594025512|FG001|Overall Study|Study funding terminated.|2|||
164452693|NCT02396199|594028055|FG000|Overall Study|Lost to Follow-up|1|||
164452694|NCT02396199|594028055|FG000|Overall Study|Death|4|||
164452695|NCT00979576|594028058|FG000|Combination Treatment Phase|Progressive disease|3|||
164452696|NCT00979576|594028059|FG001|Combination Treatment Phase|Progressive disease|1|||
164452697|NCT00979576|594028060|FG002|Combination Treatment Phase|Progressive disease|5|||
164452698|NCT00979576|594028058|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
164452699|NCT00979576|594028059|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
164452700|NCT00979576|594028060|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
164452701|NCT00979576|594028058|FG000|Combination Treatment Phase|Adverse Event|0|||
164597465|NCT03136185|594549091|FG002|Overall Study|Adverse Event|3|||
164597466|NCT03136185|594549092|FG003|Overall Study|Adverse Event|1|||
164597467|NCT03136185|594549093|FG004|Overall Study|Adverse Event|2|||
164597468|NCT03136185|594549094|FG005|Overall Study|Adverse Event|2|||
164452702|NCT00979576|594028059|FG001|Combination Treatment Phase|Adverse Event|2|||
164597469|NCT03136185|594549095|FG006|Overall Study|Adverse Event|5|||
164452703|NCT00979576|594028060|FG002|Combination Treatment Phase|Adverse Event|2|||
164452704|NCT00979576|594028058|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
164452705|NCT00979576|594028059|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
164452706|NCT00979576|594028060|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
164452707|NCT05338086|594028061|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
164452708|NCT05338086|594028062|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
164452709|NCT05338086|594028063|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
164452710|NCT05338086|594028064|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
164452711|NCT05338086|594028065|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
164452712|NCT05338086|594028061|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
164452713|NCT05338086|594028062|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
164452714|NCT05338086|594028063|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
164452715|NCT05338086|594028064|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
164452716|NCT05338086|594028065|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
164452717|NCT05338086|594028061|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
164452718|NCT05338086|594028062|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
164452719|NCT05338086|594028063|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
164452720|NCT05338086|594028064|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
164452721|NCT05338086|594028065|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
164452722|NCT05338086|594028061|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
164452723|NCT05338086|594028062|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
164452724|NCT05338086|594028063|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
164452725|NCT05338086|594028064|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
164452726|NCT05338086|594028065|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
164452727|NCT05338086|594028061|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
164452728|NCT05338086|594028062|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
164452729|NCT05338086|594028063|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
164452730|NCT05338086|594028064|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
164452731|NCT05338086|594028065|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
164452732|NCT05338086|594028061|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
164452733|NCT05338086|594028062|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
164452734|NCT05338086|594028063|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
164452735|NCT05338086|594028064|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
164452736|NCT05338086|594028065|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
164452737|NCT05338086|594028061|FG000|Transition Period (M12 to M18)|Death|0|||
164452738|NCT05338086|594028062|FG001|Transition Period (M12 to M18)|Death|0|||
164452739|NCT05338086|594028063|FG002|Transition Period (M12 to M18)|Death|1|||
164452740|NCT05338086|594028064|FG003|Transition Period (M12 to M18)|Death|0|||
164452741|NCT05338086|594028065|FG004|Transition Period (M12 to M18)|Death|0|||
164452742|NCT05338086|594028061|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
164452743|NCT05338086|594028062|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
164452744|NCT05338086|594028063|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
164452745|NCT05338086|594028064|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
164452746|NCT05338086|594028065|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
164452747|NCT05338086|594028061|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
164597470|NCT03136185|594549096|FG007|Overall Study|Adverse Event|1|||
164597471|NCT03136185|594549097|FG008|Overall Study|Adverse Event|1|||
164597472|NCT03136185|594549089|FG000|Overall Study|Death|0|||
164597473|NCT03136185|594549090|FG001|Overall Study|Death|0|||
164597474|NCT03136185|594549091|FG002|Overall Study|Death|0|||
164597475|NCT03136185|594549092|FG003|Overall Study|Death|1|||
164597476|NCT03136185|594549093|FG004|Overall Study|Death|1|||
164597477|NCT03136185|594549094|FG005|Overall Study|Death|0|||
164597478|NCT03136185|594549095|FG006|Overall Study|Death|1|||
164597479|NCT03136185|594549096|FG007|Overall Study|Death|0|||
164405430|NCT00261495|593855455|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
164405431|NCT00261495|593855454|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
164405432|NCT00261495|593855455|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
164405433|NCT00261495|593855454|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
164405434|NCT00261495|593855455|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
164405435|NCT00261495|593855454|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
164405436|NCT00261495|593855455|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
164405437|NCT00261495|593855454|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
164405438|NCT00261495|593855455|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
164405439|NCT00261495|593855454|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
164405440|NCT00261495|593855455|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
164405441|NCT00261495|593855454|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
164405442|NCT00261495|593855455|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
164405443|NCT01520402|593855460|FG000|Overall Study|Withdrawal by Subject|2|||
164405444|NCT01520402|593855460|FG000|Overall Study|Physician Decision|3|||
164405445|NCT02287584|593855461|FG000|the Double-blind Phase|Adverse Event|17|||
164405446|NCT02287584|593855462|FG001|the Double-blind Phase|Adverse Event|17|||
164405447|NCT02287584|593855463|FG002|the Double-blind Phase|Adverse Event|12|||
164706659|NCT02393248|594953431|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164706660|NCT02393248|594953432|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164706661|NCT02393248|594953433|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164706662|NCT02393248|594953434|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
164706663|NCT02393248|594953435|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164706664|NCT02393248|594953436|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164706665|NCT02393248|594953437|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164706666|NCT02393248|594953438|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164706667|NCT02393248|594953414|FG000|Part 3: Combination Therapy|Adverse Event|0|||
164706668|NCT02393248|594953415|FG001|Part 3: Combination Therapy|Adverse Event|0|||
164706669|NCT02393248|594953416|FG002|Part 3: Combination Therapy|Adverse Event|0|||
164706670|NCT02393248|594953417|FG003|Part 3: Combination Therapy|Adverse Event|0|||
164706671|NCT02393248|594953418|FG004|Part 3: Combination Therapy|Adverse Event|0|||
164706672|NCT02393248|594953419|FG005|Part 3: Combination Therapy|Adverse Event|0|||
164706673|NCT02393248|594953420|FG006|Part 3: Combination Therapy|Adverse Event|0|||
164706674|NCT02393248|594953421|FG007|Part 3: Combination Therapy|Adverse Event|0|||
164706675|NCT02393248|594953422|FG008|Part 3: Combination Therapy|Adverse Event|0|||
164706676|NCT02393248|594953423|FG009|Part 3: Combination Therapy|Adverse Event|0|||
164706677|NCT02393248|594953424|FG010|Part 3: Combination Therapy|Adverse Event|0|||
164706678|NCT02393248|594953425|FG011|Part 3: Combination Therapy|Adverse Event|0|||
164706679|NCT02393248|594953426|FG012|Part 3: Combination Therapy|Adverse Event|0|||
164706680|NCT02393248|594953427|FG013|Part 3: Combination Therapy|Adverse Event|0|||
164706681|NCT02393248|594953428|FG014|Part 3: Combination Therapy|Adverse Event|0|||
164706682|NCT02393248|594953429|FG015|Part 3: Combination Therapy|Adverse Event|0|||
164706683|NCT02393248|594953430|FG016|Part 3: Combination Therapy|Adverse Event|0|||
164706684|NCT02393248|594953431|FG017|Part 3: Combination Therapy|Adverse Event|0|||
164706685|NCT02393248|594953432|FG018|Part 3: Combination Therapy|Adverse Event|0|||
164706686|NCT02393248|594953433|FG019|Part 3: Combination Therapy|Adverse Event|0|||
164706687|NCT02393248|594953434|FG020|Part 3: Combination Therapy|Adverse Event|0|||
164706688|NCT02393248|594953435|FG021|Part 3: Combination Therapy|Adverse Event|0|||
164706689|NCT02393248|594953436|FG022|Part 3: Combination Therapy|Adverse Event|0|||
164706690|NCT02393248|594953437|FG023|Part 3: Combination Therapy|Adverse Event|1|||
164706691|NCT02393248|594953438|FG024|Part 3: Combination Therapy|Adverse Event|0|||
164706692|NCT02393248|594953414|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164706693|NCT02393248|594953415|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164706694|NCT02393248|594953416|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164706695|NCT02393248|594953417|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164405448|NCT02287584|593855464|FG003|the Double-blind Phase|Adverse Event|0|||
164405449|NCT02287584|593855465|FG004|the Double-blind Phase|Adverse Event|0|||
164405450|NCT02287584|593855466|FG005|the Double-blind Phase|Adverse Event|0|||
164405451|NCT02287584|593855461|FG000|the Double-blind Phase|Lack of Efficacy|18|||
164405452|NCT02287584|593855462|FG001|the Double-blind Phase|Lack of Efficacy|8|||
164405453|NCT02287584|593855463|FG002|the Double-blind Phase|Lack of Efficacy|8|||
164405454|NCT02287584|593855464|FG003|the Double-blind Phase|Lack of Efficacy|0|||
164405455|NCT02287584|593855465|FG004|the Double-blind Phase|Lack of Efficacy|0|||
164405456|NCT02287584|593855466|FG005|the Double-blind Phase|Lack of Efficacy|0|||
164405457|NCT02287584|593855461|FG000|the Double-blind Phase|Lost to Follow-up|0|||
164405458|NCT02287584|593855462|FG001|the Double-blind Phase|Lost to Follow-up|1|||
164405459|NCT02287584|593855463|FG002|the Double-blind Phase|Lost to Follow-up|1|||
164405460|NCT02287584|593855464|FG003|the Double-blind Phase|Lost to Follow-up|0|||
164405461|NCT02287584|593855465|FG004|the Double-blind Phase|Lost to Follow-up|0|||
164405462|NCT02287584|593855466|FG005|the Double-blind Phase|Lost to Follow-up|0|||
164405463|NCT02287584|593855461|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
164405464|NCT02287584|593855462|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
164405465|NCT02287584|593855463|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
164405466|NCT02287584|593855464|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
164405467|NCT02287584|593855465|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
164405468|NCT02287584|593855466|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
164405469|NCT02287584|593855461|FG000|the Double-blind Phase|Pregnancy|0|||
164405470|NCT02287584|593855462|FG001|the Double-blind Phase|Pregnancy|1|||
164405471|NCT02287584|593855463|FG002|the Double-blind Phase|Pregnancy|0|||
164405472|NCT02287584|593855464|FG003|the Double-blind Phase|Pregnancy|0|||
164405473|NCT02287584|593855465|FG004|the Double-blind Phase|Pregnancy|0|||
164405474|NCT02287584|593855466|FG005|the Double-blind Phase|Pregnancy|0|||
164405475|NCT02287584|593855461|FG000|the Double-blind Phase|Protocol Violation|0|||
164405476|NCT02287584|593855462|FG001|the Double-blind Phase|Protocol Violation|3|||
164405477|NCT02287584|593855463|FG002|the Double-blind Phase|Protocol Violation|0|||
164405478|NCT02287584|593855464|FG003|the Double-blind Phase|Protocol Violation|0|||
164405479|NCT02287584|593855465|FG004|the Double-blind Phase|Protocol Violation|0|||
164405480|NCT02287584|593855466|FG005|the Double-blind Phase|Protocol Violation|0|||
164597480|NCT03136185|594549097|FG008|Overall Study|Death|0|||
164597481|NCT03136185|594549089|FG000|Overall Study|Physician Decision|3|||
164405481|NCT02287584|593855461|FG000|the Double-blind Phase|other reasons|0|||
164405482|NCT02287584|593855462|FG001|the Double-blind Phase|other reasons|0|||
164405483|NCT02287584|593855463|FG002|the Double-blind Phase|other reasons|1|||
164405484|NCT02287584|593855464|FG003|the Double-blind Phase|other reasons|0|||
164405485|NCT02287584|593855465|FG004|the Double-blind Phase|other reasons|0|||
164405486|NCT02287584|593855466|FG005|the Double-blind Phase|other reasons|0|||
164405487|NCT02287584|593855461|FG000|the Open-label Phase|Did not receive drug|0|||
164405488|NCT02287584|593855462|FG001|the Open-label Phase|Did not receive drug|0|||
164405489|NCT02287584|593855463|FG002|the Open-label Phase|Did not receive drug|0|||
164405490|NCT02287584|593855464|FG003|the Open-label Phase|Did not receive drug|7|||
164405491|NCT02287584|593855465|FG004|the Open-label Phase|Did not receive drug|6|||
164405492|NCT02287584|593855466|FG005|the Open-label Phase|Did not receive drug|4|||
164405493|NCT02287584|593855461|FG000|the Open-label Phase|Adverse Event|0|||
164405494|NCT02287584|593855462|FG001|the Open-label Phase|Adverse Event|0|||
164405495|NCT02287584|593855463|FG002|the Open-label Phase|Adverse Event|0|||
164405496|NCT02287584|593855464|FG003|the Open-label Phase|Adverse Event|15|||
164405497|NCT02287584|593855465|FG004|the Open-label Phase|Adverse Event|12|||
164405498|NCT02287584|593855466|FG005|the Open-label Phase|Adverse Event|16|||
164405499|NCT02287584|593855461|FG000|the Open-label Phase|Lack of Efficacy|0|||
164405500|NCT02287584|593855462|FG001|the Open-label Phase|Lack of Efficacy|0|||
164405501|NCT02287584|593855463|FG002|the Open-label Phase|Lack of Efficacy|0|||
164405502|NCT02287584|593855464|FG003|the Open-label Phase|Lack of Efficacy|8|||
164405503|NCT02287584|593855465|FG004|the Open-label Phase|Lack of Efficacy|3|||
164405504|NCT02287584|593855466|FG005|the Open-label Phase|Lack of Efficacy|7|||
164405505|NCT02287584|593855461|FG000|the Open-label Phase|Lost to Follow-up|0|||
164405506|NCT02287584|593855462|FG001|the Open-label Phase|Lost to Follow-up|0|||
164405507|NCT02287584|593855463|FG002|the Open-label Phase|Lost to Follow-up|0|||
164405508|NCT02287584|593855464|FG003|the Open-label Phase|Lost to Follow-up|4|||
164405509|NCT02287584|593855465|FG004|the Open-label Phase|Lost to Follow-up|1|||
164405510|NCT02287584|593855466|FG005|the Open-label Phase|Lost to Follow-up|2|||
164405511|NCT02287584|593855461|FG000|the Open-label Phase|Withdrawal by Subject|0|||
164405512|NCT02287584|593855462|FG001|the Open-label Phase|Withdrawal by Subject|0|||
164405513|NCT02287584|593855463|FG002|the Open-label Phase|Withdrawal by Subject|0|||
164405514|NCT02287584|593855464|FG003|the Open-label Phase|Withdrawal by Subject|18|||
164405515|NCT02287584|593855465|FG004|the Open-label Phase|Withdrawal by Subject|29|||
164405516|NCT02287584|593855466|FG005|the Open-label Phase|Withdrawal by Subject|21|||
164405517|NCT02287584|593855461|FG000|the Open-label Phase|non-compliance|0|||
164405518|NCT02287584|593855462|FG001|the Open-label Phase|non-compliance|0|||
164405519|NCT02287584|593855463|FG002|the Open-label Phase|non-compliance|0|||
164405520|NCT02287584|593855464|FG003|the Open-label Phase|non-compliance|2|||
164405521|NCT02287584|593855465|FG004|the Open-label Phase|non-compliance|5|||
164405522|NCT02287584|593855466|FG005|the Open-label Phase|non-compliance|1|||
164405523|NCT02287584|593855461|FG000|the Open-label Phase|other reasons|0|||
164405524|NCT02287584|593855462|FG001|the Open-label Phase|other reasons|0|||
164405525|NCT02287584|593855463|FG002|the Open-label Phase|other reasons|0|||
164405526|NCT02287584|593855464|FG003|the Open-label Phase|other reasons|3|||
164405527|NCT02287584|593855465|FG004|the Open-label Phase|other reasons|6|||
164405528|NCT02287584|593855466|FG005|the Open-label Phase|other reasons|6|||
164405529|NCT01722162|593855472|FG000|Overall Study|Withdrawal by Subject|1|||
164405530|NCT01722162|593855473|FG001|Overall Study|Withdrawal by Subject|1|||
164405531|NCT01722162|593855472|FG000|Overall Study|Found ineligible|1|||
164405532|NCT01722162|593855473|FG001|Overall Study|Found ineligible|0|||
164405533|NCT01722162|593855472|FG000|Overall Study|Unrelated to study adverse event|2|||
164405534|NCT01722162|593855473|FG001|Overall Study|Unrelated to study adverse event|2|||
164405535|NCT01722162|593855472|FG000|Overall Study|Adverse Event|1|||
164405536|NCT01722162|593855473|FG001|Overall Study|Adverse Event|1|||
164405537|NCT01722162|593855472|FG000|Overall Study|Insurance denial post enrollment|0|||
164405538|NCT01722162|593855473|FG001|Overall Study|Insurance denial post enrollment|1|||
164405539|NCT01722162|593855472|FG000|Overall Study|Noncompliance|0|||
164405540|NCT01722162|593855473|FG001|Overall Study|Noncompliance|1|||
164405541|NCT03086018|593855474|FG000|Final Testing for End of Trial|Adverse Event|1|||
164405542|NCT03086018|593855474|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
164405543|NCT01538472|593855475|FG000|Overall Study|Disease Progression|3|||
164405544|NCT01538472|593855475|FG000|Overall Study|Death|1|||
164405545|NCT01892345|593855476|FG000|Overall Study|Adverse Event|0|||
164405546|NCT01892345|593855477|FG001|Overall Study|Adverse Event|2|||
164405547|NCT01892345|593855476|FG000|Overall Study|Death|1|||
164405548|NCT01892345|593855477|FG001|Overall Study|Death|0|||
164405549|NCT01892345|593855476|FG000|Overall Study|Lost to Follow-up|3|||
164405550|NCT01892345|593855477|FG001|Overall Study|Lost to Follow-up|0|||
164405551|NCT01892345|593855476|FG000|Overall Study|Withdrawal by Subject|12|||
164405552|NCT01892345|593855477|FG001|Overall Study|Withdrawal by Subject|1|||
164405553|NCT00659984|593855478|FG000|Overall Study|Adverse Event|1|||
164597482|NCT03136185|594549090|FG001|Overall Study|Physician Decision|1|||
164452748|NCT05338086|594028062|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
164452749|NCT05338086|594028063|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
164452750|NCT05338086|594028064|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
164452751|NCT05338086|594028065|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
164452752|NCT05338086|594028061|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
164452753|NCT05338086|594028062|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
164452754|NCT05338086|594028063|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
164452755|NCT05338086|594028064|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
164452756|NCT05338086|594028065|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
164452757|NCT03424811|594028072|FG000|Overall Study|Lost to Follow-up|9|||
164452758|NCT03424811|594028073|FG001|Overall Study|Lost to Follow-up|0|||
164452759|NCT06066541|594028083|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
164452760|NCT06066541|594028084|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
164452761|NCT06066541|594028085|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
164452762|NCT06066541|594028086|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
164452763|NCT06066541|594028087|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
164452764|NCT06066541|594028088|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
164452765|NCT06066541|594028089|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
164452766|NCT06066541|594028083|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
164452767|NCT06066541|594028084|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
164452768|NCT06066541|594028085|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
164452769|NCT06066541|594028086|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
164452770|NCT06066541|594028087|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
164452771|NCT06066541|594028088|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
164452772|NCT06066541|594028089|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
164452773|NCT04533022|594028090|FG000|Overall Study|Withdrawal by Subject|15|||
164452774|NCT04533022|594028090|FG000|Overall Study|Adverse Event|6|||
164452775|NCT04533022|594028090|FG000|Overall Study|Death|1|||
164452776|NCT04533022|594028090|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
164452777|NCT04533022|594028090|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
164452778|NCT02163447|594028091|FG000|Overall Study|Withdrawal by Subject|2|||
164452779|NCT02163447|594028092|FG001|Overall Study|Withdrawal by Subject|0|||
164452780|NCT02163447|594028093|FG002|Overall Study|Withdrawal by Subject|1|||
164452781|NCT02163447|594028091|FG000|Overall Study|Lost to Follow-up|1|||
164452782|NCT02163447|594028092|FG001|Overall Study|Lost to Follow-up|3|||
164452783|NCT02163447|594028093|FG002|Overall Study|Lost to Follow-up|0|||
164452784|NCT02163447|594028091|FG000|Overall Study|Moved out of study area|2|||
164452785|NCT02163447|594028092|FG001|Overall Study|Moved out of study area|3|||
164452786|NCT02163447|594028093|FG002|Overall Study|Moved out of study area|2|||
164452787|NCT02163447|594028091|FG000|Overall Study|Became HIV infected at time of delivery|1|||
164452788|NCT02163447|594028092|FG001|Overall Study|Became HIV infected at time of delivery|0|||
164452789|NCT02163447|594028093|FG002|Overall Study|Became HIV infected at time of delivery|0|||
164452790|NCT03897686|594028094|FG000|Overall Study|Protocol Violation|1|||
164452791|NCT03897686|594028095|FG001|Overall Study|Protocol Violation|1|||
164452792|NCT03897686|594028094|FG000|Overall Study|Withdrawal by Subject|1|||
164452793|NCT03897686|594028095|FG001|Overall Study|Withdrawal by Subject|1|||
164452794|NCT05415436|594028096|FG000|Overall Study|Surgeon cancelled procedure|1|||
164452795|NCT05415436|594028097|FG001|Overall Study|Surgeon cancelled procedure|0|||
164452796|NCT05415436|594028096|FG000|Overall Study|Death|1|||
164452797|NCT05415436|594028097|FG001|Overall Study|Death|0|||
164452798|NCT05386355|594028108|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
164452799|NCT05386355|594028109|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
164452800|NCT05386355|594028110|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
164452801|NCT05386355|594028111|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
164452802|NCT03157167|594028114|FG000|Overall Study|Withdrawal by Subject|1|||
164452803|NCT03157167|594028115|FG001|Overall Study|Withdrawal by Subject|0|||
164452804|NCT03157167|594028116|FG002|Overall Study|Withdrawal by Subject|0|||
164452805|NCT03263026|594028119|FG000|Overall Study|Withdrawal by Subject|1|||
164452806|NCT03263026|594028120|FG001|Overall Study|Withdrawal by Subject|0|||
164452807|NCT03263026|594028119|FG000|Overall Study|Death|1|||
164452808|NCT03263026|594028120|FG001|Overall Study|Death|0|||
164452809|NCT03263026|594028119|FG000|Overall Study|Other/ Various|41|||
164452810|NCT03263026|594028120|FG001|Overall Study|Other/ Various|29|||
164452811|NCT03775109|594028122|FG000|Overall Study|Adverse Event|1|||
164452812|NCT03775109|594028123|FG001|Overall Study|Adverse Event|0|||
164452813|NCT03775109|594028122|FG000|Overall Study|COVID-19 outbreak|2|||
164452814|NCT03775109|594028123|FG001|Overall Study|COVID-19 outbreak|0|||
164452815|NCT03775109|594028122|FG000|Overall Study|Lost to Follow-up|0|||
164706696|NCT02393248|594953418|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164706697|NCT02393248|594953419|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164706698|NCT02393248|594953420|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164706699|NCT02393248|594953421|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164706700|NCT02393248|594953422|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164706701|NCT02393248|594953423|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164706702|NCT02393248|594953424|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164706703|NCT02393248|594953425|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164706704|NCT02393248|594953426|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164706705|NCT02393248|594953427|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164706706|NCT02393248|594953428|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164452816|NCT03775109|594028123|FG001|Overall Study|Lost to Follow-up|2|||
164452817|NCT03775109|594028122|FG000|Overall Study|Withdrawal by Subject|1|||
164452818|NCT03775109|594028123|FG001|Overall Study|Withdrawal by Subject|1|||
164452819|NCT03775109|594028122|FG000|Overall Study|Death|0|||
164452820|NCT03775109|594028123|FG001|Overall Study|Death|1|||
164452821|NCT03775109|594028122|FG000|Overall Study|Lack of Efficacy|1|||
164452822|NCT03775109|594028123|FG001|Overall Study|Lack of Efficacy|0|||
164452823|NCT04178733|594028124|FG000|Overall Study|Investigator Decision|0|||
164452824|NCT04178733|594028125|FG001|Overall Study|Investigator Decision|0|||
164452825|NCT04178733|594028126|FG002|Overall Study|Investigator Decision|0|||
164452826|NCT04178733|594028127|FG003|Overall Study|Investigator Decision|1|||
164452827|NCT04178733|594028128|FG004|Overall Study|Investigator Decision|2|||
164452828|NCT03655132|594028133|FG000|Overall Study|Lost to Follow-up|2|||
164452829|NCT03655132|594028134|FG001|Overall Study|Lost to Follow-up|1|||
164452830|NCT03655132|594028133|FG000|Overall Study|Withdrawal by Subject|0|||
164452831|NCT03655132|594028134|FG001|Overall Study|Withdrawal by Subject|1|||
164452832|NCT03655132|594028133|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
164452833|NCT03655132|594028134|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
164452834|NCT02651324|594028136|FG000|Overall Study|drug not administered, due dispensing issue|1|||
164452835|NCT02651324|594028137|FG001|Overall Study|drug not administered, due dispensing issue|0|||
164452836|NCT05439603|594028138|FG000|Overall Study|met withdrawal criteria|2|||
164452837|NCT04549168|594028144|FG000|Randomization Phase|Adverse Event|0|||
164452838|NCT04549168|594028145|FG001|Randomization Phase|Adverse Event|0|||
164452839|NCT04549168|594028146|FG002|Randomization Phase|Adverse Event|1|||
164452840|NCT04549168|594028144|FG000|Randomization Phase|Other|0|||
164452841|NCT04549168|594028145|FG001|Randomization Phase|Other|2|||
164452842|NCT04549168|594028146|FG002|Randomization Phase|Other|0|||
164452843|NCT04549168|594028144|FG000|Randomization Phase|Withdrawal by Subject|0|||
164452844|NCT04549168|594028145|FG001|Randomization Phase|Withdrawal by Subject|2|||
164452845|NCT04549168|594028146|FG002|Randomization Phase|Withdrawal by Subject|1|||
164452846|NCT04737772|594028150|FG000|Phase 2 Study|Lost to Follow-up|15|||
164452847|NCT04737772|594028151|FG001|Phase 2 Study|Lost to Follow-up|15|||
164452848|NCT04737772|594028150|FG000|Phase 2 Study|Withdrawal by Subject|0|||
164452849|NCT04737772|594028151|FG001|Phase 2 Study|Withdrawal by Subject|1|||
164452850|NCT04737772|594028150|FG000|Phase 2 Study|Did not take any coaching calls|4|||
164452851|NCT04737772|594028151|FG001|Phase 2 Study|Did not take any coaching calls|0|||
164452852|NCT04737772|594028150|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
164452853|NCT04737772|594028151|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
164452854|NCT04737772|594028150|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
164452855|NCT04737772|594028151|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
164452856|NCT02549339|594028152|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
164452857|NCT02549339|594028153|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
164452858|NCT02549339|594028152|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
164452859|NCT02549339|594028153|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
164452860|NCT02549339|594028152|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
164452861|NCT02549339|594028153|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
164452862|NCT02549339|594028152|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
164452863|NCT02549339|594028153|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
164452864|NCT02549339|594028152|FG000|12-month Follow-up|Lack of Efficacy|0|||
164452865|NCT02549339|594028153|FG001|12-month Follow-up|Lack of Efficacy|2|||
164452866|NCT02549339|594028152|FG000|12-month Follow-up|Withdrawal by Subject|8|||
164452867|NCT02549339|594028153|FG001|12-month Follow-up|Withdrawal by Subject|3|||
164452868|NCT02549339|594028152|FG000|12-month Follow-up|Lost to Follow-up|1|||
164452869|NCT02549339|594028153|FG001|12-month Follow-up|Lost to Follow-up|3|||
164452870|NCT02549339|594028152|FG000|12-month Follow-up|Other|0|||
164452871|NCT02549339|594028153|FG001|12-month Follow-up|Other|3|||
164144508|NCT04123561|592889898|FG002|Overall Study|Protocol Violation|0|||
164405554|NCT02133872|593855479|FG000|Overall Study|Withdrawal by Subject|5|||
164405555|NCT02133872|593855480|FG001|Overall Study|Withdrawal by Subject|3|||
164405556|NCT02133872|593855481|FG002|Overall Study|Withdrawal by Subject|0|||
164405557|NCT02923739|593855482|FG000|Overall Study|Withdrawal by Subject|2|||
164452872|NCT05415410|594028154|FG000|Overall Study|Death|3|||
164452873|NCT05415410|594028155|FG001|Overall Study|Death|6|||
164452874|NCT05415410|594028156|FG002|Overall Study|Death|1|||
164452875|NCT05415410|594028154|FG000|Overall Study|Trial Terminated by Sponsor|1|||
164452876|NCT05415410|594028155|FG001|Overall Study|Trial Terminated by Sponsor|5|||
164452877|NCT05415410|594028156|FG002|Overall Study|Trial Terminated by Sponsor|0|||
164452878|NCT05415410|594028154|FG000|Overall Study|Adverse Event|2|||
164452879|NCT05415410|594028155|FG001|Overall Study|Adverse Event|1|||
164452880|NCT05415410|594028156|FG002|Overall Study|Adverse Event|0|||
164452881|NCT05415410|594028154|FG000|Overall Study|Physician Decision due to Non-Compliance|1|||
164452882|NCT05415410|594028155|FG001|Overall Study|Physician Decision due to Non-Compliance|0|||
164452883|NCT05415410|594028156|FG002|Overall Study|Physician Decision due to Non-Compliance|0|||
164452884|NCT05415410|594028154|FG000|Overall Study|Withdrawal by Subject|1|||
164452885|NCT05415410|594028155|FG001|Overall Study|Withdrawal by Subject|0|||
164452886|NCT05415410|594028156|FG002|Overall Study|Withdrawal by Subject|0|||
164452887|NCT05415410|594028154|FG000|Overall Study|Pregnancy|5|||
164452888|NCT05415410|594028155|FG001|Overall Study|Pregnancy|2|||
164452889|NCT05415410|594028156|FG002|Overall Study|Pregnancy|0|||
164452890|NCT02365766|594028157|FG000|Overall Study|Withdrawal by Subject|0|||
164452891|NCT02365766|594028158|FG001|Overall Study|Withdrawal by Subject|0|||
164452892|NCT02365766|594028159|FG002|Overall Study|Withdrawal by Subject|1|||
164452893|NCT02365766|594028157|FG000|Overall Study|Eligibility Criteria Not Met|0|||
164452894|NCT02365766|594028158|FG001|Overall Study|Eligibility Criteria Not Met|0|||
164452895|NCT02365766|594028159|FG002|Overall Study|Eligibility Criteria Not Met|1|||
164452896|NCT02724956|594028164|FG000|Overall Study|Physician Decision|1|||
164452897|NCT02724956|594028165|FG001|Overall Study|Physician Decision|0|||
164452898|NCT02724956|594028164|FG000|Overall Study|Lack of Efficacy|0|||
164452899|NCT02724956|594028165|FG001|Overall Study|Lack of Efficacy|1|||
164452900|NCT02724956|594028164|FG000|Overall Study|Withdrawal by Subject|0|||
164452901|NCT02724956|594028165|FG001|Overall Study|Withdrawal by Subject|1|||
164452902|NCT04600752|594028171|FG000|Overall Study|Physician Decision|0|||
164452903|NCT04600752|594028172|FG001|Overall Study|Physician Decision|0|||
164452904|NCT04600752|594028173|FG002|Overall Study|Physician Decision|1|||
164452905|NCT04600752|594028171|FG000|Overall Study|Adverse Event|0|||
164452906|NCT04600752|594028172|FG001|Overall Study|Adverse Event|1|||
164452907|NCT04600752|594028173|FG002|Overall Study|Adverse Event|0|||
164452908|NCT04600752|594028171|FG000|Overall Study|Withdrawal by Subject|2|||
164452909|NCT04600752|594028172|FG001|Overall Study|Withdrawal by Subject|1|||
164452910|NCT04600752|594028173|FG002|Overall Study|Withdrawal by Subject|0|||
164452911|NCT04600752|594028171|FG000|Overall Study|Lack of Efficacy|1|||
164452912|NCT04600752|594028172|FG001|Overall Study|Lack of Efficacy|0|||
164452913|NCT04600752|594028173|FG002|Overall Study|Lack of Efficacy|0|||
164597483|NCT03136185|594549091|FG002|Overall Study|Physician Decision|1|||
164597484|NCT03136185|594549092|FG003|Overall Study|Physician Decision|2|||
164597485|NCT03136185|594549093|FG004|Overall Study|Physician Decision|1|||
164597486|NCT03136185|594549094|FG005|Overall Study|Physician Decision|2|||
164597487|NCT03136185|594549095|FG006|Overall Study|Physician Decision|1|||
164597488|NCT03136185|594549096|FG007|Overall Study|Physician Decision|0|||
164597489|NCT03136185|594549097|FG008|Overall Study|Physician Decision|1|||
164597490|NCT03136185|594549089|FG000|Overall Study|Protocol Defined Disease Progression|0|||
164597491|NCT03136185|594549090|FG001|Overall Study|Protocol Defined Disease Progression|0|||
164597492|NCT03136185|594549091|FG002|Overall Study|Protocol Defined Disease Progression|1|||
164597493|NCT03136185|594549092|FG003|Overall Study|Protocol Defined Disease Progression|0|||
164597494|NCT03136185|594549093|FG004|Overall Study|Protocol Defined Disease Progression|0|||
164597495|NCT03136185|594549094|FG005|Overall Study|Protocol Defined Disease Progression|1|||
164597496|NCT03136185|594549095|FG006|Overall Study|Protocol Defined Disease Progression|0|||
164597497|NCT03136185|594549096|FG007|Overall Study|Protocol Defined Disease Progression|1|||
164405558|NCT02923739|593855483|FG001|Overall Study|Withdrawal by Subject|0|||
164405559|NCT02923739|593855484|FG002|Overall Study|Withdrawal by Subject|0|||
164405560|NCT02923739|593855485|FG003|Overall Study|Withdrawal by Subject|0|||
164405561|NCT02923739|593855482|FG000|Overall Study|Failed Screening|3|||
164405562|NCT02923739|593855483|FG001|Overall Study|Failed Screening|0|||
164405563|NCT02923739|593855484|FG002|Overall Study|Failed Screening|0|||
164405564|NCT02923739|593855485|FG003|Overall Study|Failed Screening|0|||
164405565|NCT00948974|593855490|FG000|Overall Study|Lost to Follow-up|23|||
164405566|NCT00948974|593855491|FG001|Overall Study|Lost to Follow-up|20|||
164405567|NCT02487810|593855492|FG000|Overall Study|Withdrawal by Subject|1|||
164405568|NCT02487810|593855493|FG001|Overall Study|Withdrawal by Subject|0|||
164405569|NCT01972529|593855494|FG000|Overall Study|Adverse Event|0|||
164405570|NCT01972529|593855495|FG001|Overall Study|Adverse Event|1|||
164452914|NCT04436107|594028174|FG000|Overall Study|Sponsor Ended Study|2|||
164452915|NCT04436107|594028175|FG001|Overall Study|Sponsor Ended Study|4|||
164452916|NCT04436107|594028176|FG002|Overall Study|Sponsor Ended Study|8|||
164452917|NCT04436107|594028177|FG003|Overall Study|Sponsor Ended Study|20|||
164452918|NCT04436107|594028174|FG000|Overall Study|Death|3|||
164452919|NCT04436107|594028175|FG001|Overall Study|Death|5|||
164452920|NCT04436107|594028176|FG002|Overall Study|Death|3|||
164452921|NCT04436107|594028177|FG003|Overall Study|Death|18|||
164452922|NCT04436107|594028174|FG000|Overall Study|Withdrawal by Subject|1|||
164452923|NCT04436107|594028175|FG001|Overall Study|Withdrawal by Subject|1|||
164452924|NCT04436107|594028176|FG002|Overall Study|Withdrawal by Subject|0|||
164452925|NCT04436107|594028177|FG003|Overall Study|Withdrawal by Subject|1|||
164452926|NCT00274469|594028191|FG000|Overall Study|Death|63|||
164452927|NCT00274469|594028192|FG001|Overall Study|Death|74|||
164452928|NCT00274469|594028191|FG000|Overall Study|Did not consent to OS follow-up|16|||
164452929|NCT00274469|594028192|FG001|Overall Study|Did not consent to OS follow-up|19|||
164452930|NCT03338816|594028198|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
164452931|NCT03338816|594028199|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
164452932|NCT03338816|594028200|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
164452933|NCT03338816|594028201|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
164452934|NCT03338816|594028198|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
164452935|NCT03338816|594028199|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
164452936|NCT03338816|594028200|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
164452937|NCT03338816|594028201|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
164452938|NCT03338816|594028198|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
164452939|NCT03338816|594028199|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
164452940|NCT03338816|594028200|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
164452941|NCT03338816|594028201|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
164452942|NCT03338816|594028198|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
164452943|NCT03338816|594028199|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
164452944|NCT03338816|594028200|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
164452945|NCT03338816|594028201|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
164452946|NCT03338816|594028198|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
164452947|NCT03338816|594028199|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
164452948|NCT03338816|594028200|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
164452949|NCT03338816|594028201|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
164452950|NCT03338816|594028198|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
164452951|NCT03338816|594028199|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
164452952|NCT03338816|594028200|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
164452953|NCT03338816|594028201|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
164452954|NCT03338816|594028198|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
164452955|NCT03338816|594028199|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
164452956|NCT03338816|594028200|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
164452957|NCT03338816|594028201|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
164452958|NCT04999592|594028202|FG000|Overall Study|Withdrawal by Subject|1|||
164452959|NCT04999592|594028203|FG001|Overall Study|Withdrawal by Subject|0|||
164452960|NCT02671435|594028204|FG000|Overall Study|Death|1|||
164452961|NCT02671435|594028205|FG001|Overall Study|Death|3|||
164452962|NCT02671435|594028206|FG002|Overall Study|Death|0|||
164452963|NCT02671435|594028207|FG003|Overall Study|Death|16|||
164452964|NCT02671435|594028208|FG004|Overall Study|Death|14|||
164452965|NCT02671435|594028209|FG005|Overall Study|Death|29|||
164452966|NCT02671435|594028210|FG006|Overall Study|Death|34|||
164452967|NCT02671435|594028211|FG007|Overall Study|Death|28|||
164452968|NCT02671435|594028212|FG008|Overall Study|Death|19|||
164452969|NCT02671435|594028213|FG009|Overall Study|Death|10|||
164452970|NCT02671435|594028214|FG010|Overall Study|Death|8|||
164452971|NCT02671435|594028215|FG011|Overall Study|Death|29|||
164452972|NCT02671435|594028216|FG012|Overall Study|Death|29|||
164452973|NCT02671435|594028217|FG013|Overall Study|Death|29|||
164452974|NCT02671435|594028218|FG014|Overall Study|Death|27|||
164452975|NCT02671435|594028204|FG000|Overall Study|Lost to Follow-up|0|||
164452976|NCT02671435|594028205|FG001|Overall Study|Lost to Follow-up|0|||
164452977|NCT02671435|594028206|FG002|Overall Study|Lost to Follow-up|1|||
164452978|NCT02671435|594028207|FG003|Overall Study|Lost to Follow-up|0|||
164452979|NCT02671435|594028208|FG004|Overall Study|Lost to Follow-up|1|||
164452980|NCT02671435|594028209|FG005|Overall Study|Lost to Follow-up|1|||
164452981|NCT02671435|594028210|FG006|Overall Study|Lost to Follow-up|2|||
164452982|NCT02671435|594028211|FG007|Overall Study|Lost to Follow-up|2|||
164452983|NCT02671435|594028212|FG008|Overall Study|Lost to Follow-up|0|||
164452984|NCT02671435|594028213|FG009|Overall Study|Lost to Follow-up|2|||
164452985|NCT02671435|594028214|FG010|Overall Study|Lost to Follow-up|0|||
164452986|NCT02671435|594028215|FG011|Overall Study|Lost to Follow-up|3|||
164452987|NCT02671435|594028216|FG012|Overall Study|Lost to Follow-up|3|||
164452988|NCT02671435|594028217|FG013|Overall Study|Lost to Follow-up|2|||
164452989|NCT02671435|594028218|FG014|Overall Study|Lost to Follow-up|0|||
164597498|NCT03136185|594549097|FG008|Overall Study|Protocol Defined Disease Progression|1|||
164452990|NCT02671435|594028204|FG000|Overall Study|Withdrawal by Subject|2|||
164452991|NCT02671435|594028205|FG001|Overall Study|Withdrawal by Subject|0|||
164452992|NCT02671435|594028206|FG002|Overall Study|Withdrawal by Subject|2|||
164452993|NCT02671435|594028207|FG003|Overall Study|Withdrawal by Subject|2|||
164452994|NCT02671435|594028208|FG004|Overall Study|Withdrawal by Subject|2|||
164452995|NCT02671435|594028209|FG005|Overall Study|Withdrawal by Subject|7|||
164452996|NCT02671435|594028210|FG006|Overall Study|Withdrawal by Subject|2|||
164452997|NCT02671435|594028211|FG007|Overall Study|Withdrawal by Subject|7|||
164452998|NCT02671435|594028212|FG008|Overall Study|Withdrawal by Subject|1|||
164452999|NCT02671435|594028213|FG009|Overall Study|Withdrawal by Subject|1|||
164453000|NCT02671435|594028214|FG010|Overall Study|Withdrawal by Subject|2|||
164453001|NCT02671435|594028215|FG011|Overall Study|Withdrawal by Subject|4|||
164453002|NCT02671435|594028216|FG012|Overall Study|Withdrawal by Subject|4|||
164453003|NCT02671435|594028217|FG013|Overall Study|Withdrawal by Subject|4|||
164453004|NCT02671435|594028218|FG014|Overall Study|Withdrawal by Subject|2|||
164453005|NCT02671435|594028204|FG000|Overall Study|Un-specified|0|||
164453006|NCT02671435|594028205|FG001|Overall Study|Un-specified|0|||
164453007|NCT02671435|594028206|FG002|Overall Study|Un-specified|0|||
164453008|NCT02671435|594028207|FG003|Overall Study|Un-specified|0|||
164453009|NCT02671435|594028208|FG004|Overall Study|Un-specified|1|||
164453010|NCT02671435|594028209|FG005|Overall Study|Un-specified|3|||
164453011|NCT02671435|594028210|FG006|Overall Study|Un-specified|2|||
164453012|NCT02671435|594028211|FG007|Overall Study|Un-specified|3|||
164453013|NCT02671435|594028212|FG008|Overall Study|Un-specified|0|||
164453014|NCT02671435|594028213|FG009|Overall Study|Un-specified|5|||
164453015|NCT02671435|594028214|FG010|Overall Study|Un-specified|8|||
164453016|NCT02671435|594028215|FG011|Overall Study|Un-specified|4|||
164453017|NCT02671435|594028216|FG012|Overall Study|Un-specified|5|||
164453018|NCT02671435|594028217|FG013|Overall Study|Un-specified|9|||
164453019|NCT02671435|594028218|FG014|Overall Study|Un-specified|8|||
164453020|NCT04128319|594028221|FG000|Overall Study|Death|3|||
164453021|NCT00976937|594028222|FG000|Overall Study|Adverse Event|4|||
164453022|NCT00976937|594028223|FG001|Overall Study|Adverse Event|5|||
164453023|NCT00976937|594028222|FG000|Overall Study|Lost to Follow-up|2|||
164453024|NCT00976937|594028223|FG001|Overall Study|Lost to Follow-up|1|||
164453025|NCT00976937|594028222|FG000|Overall Study|Withdrawal by Subject|5|||
164453026|NCT00976937|594028223|FG001|Overall Study|Withdrawal by Subject|3|||
164453027|NCT00976937|594028222|FG000|Overall Study|Poor compliance to protocol|3|||
164453028|NCT00976937|594028223|FG001|Overall Study|Poor compliance to protocol|0|||
164453029|NCT00976937|594028222|FG000|Overall Study|Personal and Familial Reason|2|||
164453030|NCT00976937|594028223|FG001|Overall Study|Personal and Familial Reason|2|||
164453031|NCT04442126|594028228|FG000|Overall Study|Withdrawal by Subject|0|||
164453032|NCT04442126|594028229|FG001|Overall Study|Withdrawal by Subject|0|||
164453033|NCT04442126|594028230|FG002|Overall Study|Withdrawal by Subject|0|||
164453034|NCT04442126|594028231|FG003|Overall Study|Withdrawal by Subject|2|||
164453035|NCT04442126|594028232|FG004|Overall Study|Withdrawal by Subject|1|||
164453036|NCT04442126|594028233|FG005|Overall Study|Withdrawal by Subject|0|||
164453037|NCT04442126|594028234|FG006|Overall Study|Withdrawal by Subject|1|||
164453038|NCT04442126|594028235|FG007|Overall Study|Withdrawal by Subject|1|||
164453039|NCT04442126|594028236|FG008|Overall Study|Withdrawal by Subject|3|||
164453040|NCT04442126|594028228|FG000|Overall Study|Death|1|||
164453041|NCT04442126|594028229|FG001|Overall Study|Death|0|||
164453042|NCT04442126|594028230|FG002|Overall Study|Death|0|||
164453043|NCT04442126|594028231|FG003|Overall Study|Death|1|||
164453044|NCT04442126|594028232|FG004|Overall Study|Death|2|||
164453045|NCT04442126|594028233|FG005|Overall Study|Death|2|||
164453046|NCT04442126|594028234|FG006|Overall Study|Death|4|||
164453047|NCT04442126|594028235|FG007|Overall Study|Death|1|||
164453048|NCT04442126|594028236|FG008|Overall Study|Death|5|||
164453049|NCT04442126|594028228|FG000|Overall Study|Study Terminated by Sponsor|0|||
164453050|NCT04442126|594028229|FG001|Overall Study|Study Terminated by Sponsor|0|||
164597499|NCT03136185|594549089|FG000|Overall Study|Withdrawal by Subject|1|||
164597500|NCT03136185|594549090|FG001|Overall Study|Withdrawal by Subject|0|||
164453051|NCT04442126|594028230|FG002|Overall Study|Study Terminated by Sponsor|0|||
164453052|NCT04442126|594028231|FG003|Overall Study|Study Terminated by Sponsor|0|||
164453053|NCT04442126|594028232|FG004|Overall Study|Study Terminated by Sponsor|0|||
164453054|NCT04442126|594028233|FG005|Overall Study|Study Terminated by Sponsor|1|||
164453055|NCT04442126|594028234|FG006|Overall Study|Study Terminated by Sponsor|4|||
164453056|NCT04442126|594028235|FG007|Overall Study|Study Terminated by Sponsor|2|||
164453057|NCT04442126|594028236|FG008|Overall Study|Study Terminated by Sponsor|10|||
164453058|NCT04442126|594028228|FG000|Overall Study|Lost to Follow-up|0|||
164453059|NCT04442126|594028229|FG001|Overall Study|Lost to Follow-up|0|||
164453060|NCT04442126|594028230|FG002|Overall Study|Lost to Follow-up|0|||
164453061|NCT04442126|594028231|FG003|Overall Study|Lost to Follow-up|0|||
164453062|NCT04442126|594028232|FG004|Overall Study|Lost to Follow-up|0|||
164453063|NCT04442126|594028233|FG005|Overall Study|Lost to Follow-up|0|||
164453064|NCT04442126|594028234|FG006|Overall Study|Lost to Follow-up|0|||
164453065|NCT04442126|594028235|FG007|Overall Study|Lost to Follow-up|1|||
164453066|NCT04442126|594028236|FG008|Overall Study|Lost to Follow-up|2|||
164453067|NCT04442126|594028228|FG000|Overall Study|Progressive Disease|0|||
164453068|NCT04442126|594028229|FG001|Overall Study|Progressive Disease|1|||
164453069|NCT04442126|594028230|FG002|Overall Study|Progressive Disease|3|||
164453070|NCT04442126|594028231|FG003|Overall Study|Progressive Disease|0|||
164453071|NCT04442126|594028232|FG004|Overall Study|Progressive Disease|3|||
164453072|NCT04442126|594028233|FG005|Overall Study|Progressive Disease|0|||
164453073|NCT04442126|594028234|FG006|Overall Study|Progressive Disease|0|||
164453074|NCT04442126|594028235|FG007|Overall Study|Progressive Disease|0|||
164453075|NCT04442126|594028236|FG008|Overall Study|Progressive Disease|0|||
164453076|NCT04442126|594028228|FG000|Overall Study|Other|0|||
164453077|NCT04442126|594028229|FG001|Overall Study|Other|0|||
164453078|NCT04442126|594028230|FG002|Overall Study|Other|0|||
164453079|NCT04442126|594028231|FG003|Overall Study|Other|0|||
164453080|NCT04442126|594028232|FG004|Overall Study|Other|0|||
164453081|NCT04442126|594028233|FG005|Overall Study|Other|0|||
164453082|NCT04442126|594028234|FG006|Overall Study|Other|0|||
164453083|NCT04442126|594028235|FG007|Overall Study|Other|0|||
164453084|NCT04442126|594028236|FG008|Overall Study|Other|1|||
164453085|NCT03767517|594028237|FG000|Overall Study|Lost to Follow-up|16|||
164453086|NCT03767517|594028238|FG001|Overall Study|Lost to Follow-up|10|||
164453087|NCT03767517|594028237|FG000|Overall Study|Death|2|||
164453088|NCT03767517|594028238|FG001|Overall Study|Death|3|||
164453089|NCT04994509|594028240|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
164453090|NCT04994509|594028241|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
164453091|NCT04994509|594028242|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
164453092|NCT04994509|594028240|FG000|Overall Study|Withdrew Consent|73|||
164453093|NCT04994509|594028241|FG001|Overall Study|Withdrew Consent|72|||
164453094|NCT04994509|594028242|FG002|Overall Study|Withdrew Consent|46|||
164453095|NCT04994509|594028240|FG000|Overall Study|Lost to Follow-up|39|||
164453096|NCT04994509|594028241|FG001|Overall Study|Lost to Follow-up|36|||
164453097|NCT04994509|594028242|FG002|Overall Study|Lost to Follow-up|26|||
164453098|NCT04994509|594028240|FG000|Overall Study|HIV-1 Infection|4|||
164453099|NCT04994509|594028241|FG001|Overall Study|HIV-1 Infection|20|||
164453100|NCT04994509|594028242|FG002|Overall Study|HIV-1 Infection|12|||
164453101|NCT04994509|594028240|FG000|Overall Study|Investigator's Discretion|9|||
164453102|NCT04994509|594028241|FG001|Overall Study|Investigator's Discretion|8|||
164453103|NCT04994509|594028242|FG002|Overall Study|Investigator's Discretion|11|||
164453104|NCT04994509|594028240|FG000|Overall Study|Randomized but Never Treated|10|||
164453105|NCT04994509|594028241|FG001|Overall Study|Randomized but Never Treated|10|||
164453106|NCT04994509|594028242|FG002|Overall Study|Randomized but Never Treated|3|||
164453107|NCT04994509|594028240|FG000|Overall Study|Pregnancy|5|||
164453108|NCT04994509|594028241|FG001|Overall Study|Pregnancy|5|||
164453109|NCT04994509|594028242|FG002|Overall Study|Pregnancy|0|||
164453110|NCT04994509|594028240|FG000|Overall Study|Death|0|||
164453111|NCT04994509|594028241|FG001|Overall Study|Death|5|||
164453112|NCT04994509|594028242|FG002|Overall Study|Death|0|||
164453113|NCT04994509|594028240|FG000|Overall Study|Adverse Event|2|||
164453114|NCT04994509|594028241|FG001|Overall Study|Adverse Event|1|||
164453115|NCT04994509|594028242|FG002|Overall Study|Adverse Event|0|||
164453116|NCT04994509|594028240|FG000|Overall Study|Non-compliance With Study Drug|1|||
164453117|NCT04994509|594028241|FG001|Overall Study|Non-compliance With Study Drug|1|||
164453118|NCT04994509|594028242|FG002|Overall Study|Non-compliance With Study Drug|1|||
164597501|NCT03136185|594549091|FG002|Overall Study|Withdrawal by Subject|1|||
164597502|NCT03136185|594549092|FG003|Overall Study|Withdrawal by Subject|1|||
164597503|NCT03136185|594549093|FG004|Overall Study|Withdrawal by Subject|1|||
164597504|NCT03136185|594549094|FG005|Overall Study|Withdrawal by Subject|1|||
164597505|NCT03136185|594549095|FG006|Overall Study|Withdrawal by Subject|2|||
164597506|NCT03136185|594549096|FG007|Overall Study|Withdrawal by Subject|3|||
164597507|NCT03136185|594549097|FG008|Overall Study|Withdrawal by Subject|3|||
164597508|NCT03136185|594549089|FG000|Overall Study|Not Reported|4|||
164597509|NCT03136185|594549090|FG001|Overall Study|Not Reported|1|||
164597510|NCT03136185|594549091|FG002|Overall Study|Not Reported|0|||
164597511|NCT03136185|594549092|FG003|Overall Study|Not Reported|1|||
164597512|NCT03136185|594549093|FG004|Overall Study|Not Reported|0|||
164597513|NCT03136185|594549094|FG005|Overall Study|Not Reported|2|||
164453119|NCT04994509|594028240|FG000|Overall Study|Withdrew Assent|3|||
164453120|NCT04994509|594028241|FG001|Overall Study|Withdrew Assent|0|||
164453121|NCT04994509|594028242|FG002|Overall Study|Withdrew Assent|0|||
164597514|NCT03136185|594549095|FG006|Overall Study|Not Reported|1|||
164453122|NCT04994509|594028240|FG000|Overall Study|Protocol Violation|1|||
164453123|NCT04994509|594028241|FG001|Overall Study|Protocol Violation|0|||
164453124|NCT04994509|594028242|FG002|Overall Study|Protocol Violation|0|||
164453125|NCT02525692|594029383|FG000|Overall Study|Withdrawal by Subject|1|||
164453126|NCT02525692|594029384|FG001|Overall Study|Withdrawal by Subject|1|||
164453127|NCT02525692|594029385|FG002|Overall Study|Withdrawal by Subject|0|||
164453128|NCT02525692|594029386|FG003|Overall Study|Withdrawal by Subject|5|||
164453129|NCT02525692|594029387|FG004|Overall Study|Withdrawal by Subject|0|||
164453130|NCT02525692|594029388|FG005|Overall Study|Withdrawal by Subject|1|||
164453131|NCT02525692|594029383|FG000|Overall Study|Death|16|||
164453132|NCT02525692|594029384|FG001|Overall Study|Death|18|||
164453133|NCT02525692|594029385|FG002|Overall Study|Death|7|||
164453134|NCT02525692|594029386|FG003|Overall Study|Death|20|||
164453135|NCT02525692|594029387|FG004|Overall Study|Death|3|||
164453136|NCT02525692|594029388|FG005|Overall Study|Death|6|||
164453137|NCT02525692|594029383|FG000|Overall Study|Lost to Follow-up|0|||
164453138|NCT02525692|594029384|FG001|Overall Study|Lost to Follow-up|0|||
164453139|NCT02525692|594029385|FG002|Overall Study|Lost to Follow-up|1|||
164453140|NCT02525692|594029386|FG003|Overall Study|Lost to Follow-up|5|||
164453141|NCT02525692|594029387|FG004|Overall Study|Lost to Follow-up|0|||
164453142|NCT02525692|594029388|FG005|Overall Study|Lost to Follow-up|0|||
164453143|NCT04112316|594029389|FG000|First Period (8 Weeks)|Protocol Violation|1|||
164453144|NCT04112316|594029390|FG001|First Period (8 Weeks)|Protocol Violation|0|||
164453145|NCT04112316|594029389|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
164453146|NCT04112316|594029390|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
164453147|NCT04247542|594029393|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
164453148|NCT04247542|594029394|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
164453149|NCT04247542|594029395|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
164453150|NCT04247542|594029393|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
164453151|NCT04247542|594029394|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
164453152|NCT04247542|594029395|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
164453153|NCT03438188|594029396|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
164453154|NCT03438188|594029397|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
164453155|NCT03438188|594029398|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
164453156|NCT03438188|594029396|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
164453157|NCT03438188|594029397|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
164453158|NCT03438188|594029398|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
164453159|NCT03438188|594029396|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
164453160|NCT03438188|594029397|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
164453161|NCT03438188|594029398|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
164453162|NCT03438188|594029396|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
164453163|NCT03438188|594029397|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
164453164|NCT03438188|594029398|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
164453165|NCT03438188|594029396|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
164453166|NCT03438188|594029397|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
164453167|NCT03438188|594029398|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
164453168|NCT05058391|594029399|FG000|Overall Study|Adverse Event|1|||
164453169|NCT03833245|594029404|FG000|Overall Study|Death|0|||
164453170|NCT03833245|594029405|FG001|Overall Study|Death|1|||
164453171|NCT03347383|594029406|FG000|Overall Study|Death|39|||
164453172|NCT03347383|594029406|FG000|Overall Study|Withdrawal by Subject|3|||
164453173|NCT03347383|594029406|FG000|Overall Study|Lost to Follow-up|9|||
164453174|NCT05691452|594029411|FG000|Overall Study|Withdrawal by Subject|1|||
164453175|NCT05691452|594029412|FG001|Overall Study|Withdrawal by Subject|1|||
164453176|NCT05691452|594029413|FG002|Overall Study|Withdrawal by Subject|0|||
164453177|NCT05691452|594029411|FG000|Overall Study|Physician Decision|1|||
164453178|NCT05691452|594029412|FG001|Overall Study|Physician Decision|0|||
164453179|NCT05691452|594029413|FG002|Overall Study|Physician Decision|0|||
164597515|NCT03136185|594549096|FG007|Overall Study|Not Reported|1|||
164597516|NCT03136185|594549097|FG008|Overall Study|Not Reported|0|||
164597517|NCT05118386|594549105|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
164597518|NCT05118386|594549106|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
164597519|NCT05118386|594549107|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
164597520|NCT05118386|594549108|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
164597521|NCT05118386|594549109|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
164453180|NCT05691452|594029411|FG000|Overall Study|Lost to Follow-up|0|||
164453181|NCT05691452|594029412|FG001|Overall Study|Lost to Follow-up|0|||
164453182|NCT05691452|594029413|FG002|Overall Study|Lost to Follow-up|1|||
164453183|NCT05691452|594029411|FG000|Overall Study|Adverse Event|0|||
164453184|NCT05691452|594029412|FG001|Overall Study|Adverse Event|0|||
164453185|NCT05691452|594029413|FG002|Overall Study|Adverse Event|1|||
164453186|NCT01938547|594029416|FG000|Overall Study|Physician Decision|1|||
164453187|NCT05320432|594029421|FG000|Overall Study|Withdrawal by Subject|0|||
164453188|NCT05320432|594029422|FG001|Overall Study|Withdrawal by Subject|2|||
164453189|NCT04842643|594029423|FG000|Overall Study|Physician Decision|1|||
164453190|NCT04842643|594029423|FG000|Overall Study|Other|1|||
164453191|NCT03484702|594029424|FG000|Treatment Period|Death|3|||
164453192|NCT03484702|594029425|FG001|Treatment Period|Death|1|||
164453193|NCT03484702|594029426|FG002|Treatment Period|Death|0|||
164453194|NCT03484702|594029427|FG003|Treatment Period|Death|0|||
164453195|NCT03484702|594029428|FG004|Treatment Period|Death|0|||
164453196|NCT03484702|594029429|FG005|Treatment Period|Death|0|||
164453197|NCT03484702|594029424|FG000|Treatment Period|Adverse Event|1|||
164453198|NCT03484702|594029425|FG001|Treatment Period|Adverse Event|0|||
164453199|NCT03484702|594029426|FG002|Treatment Period|Adverse Event|0|||
164453200|NCT03484702|594029427|FG003|Treatment Period|Adverse Event|0|||
164453201|NCT03484702|594029428|FG004|Treatment Period|Adverse Event|0|||
164453202|NCT03484702|594029429|FG005|Treatment Period|Adverse Event|0|||
164453203|NCT03484702|594029424|FG000|Treatment Period|Participant Withdrew from Study|0|||
164453204|NCT03484702|594029425|FG001|Treatment Period|Participant Withdrew from Study|1|||
164453205|NCT03484702|594029426|FG002|Treatment Period|Participant Withdrew from Study|0|||
164453206|NCT03484702|594029427|FG003|Treatment Period|Participant Withdrew from Study|0|||
164453207|NCT03484702|594029428|FG004|Treatment Period|Participant Withdrew from Study|0|||
164453208|NCT03484702|594029429|FG005|Treatment Period|Participant Withdrew from Study|0|||
164453209|NCT03484702|594029424|FG000|Treatment Period|Physician Decision|0|||
164453210|NCT03484702|594029425|FG001|Treatment Period|Physician Decision|1|||
164453211|NCT03484702|594029426|FG002|Treatment Period|Physician Decision|0|||
164453212|NCT03484702|594029427|FG003|Treatment Period|Physician Decision|0|||
164453213|NCT03484702|594029428|FG004|Treatment Period|Physician Decision|0|||
164453214|NCT03484702|594029429|FG005|Treatment Period|Physician Decision|1|||
164453215|NCT01894061|594029433|FG000|Overall Study|Screen failure|1|||
164453216|NCT01894061|594029433|FG000|Overall Study|Withdrawal by Subject|1|||
164453217|NCT02840474|594029434|FG000|Overall Study|Lost to Follow-up|1|||
164453218|NCT02840474|594029435|FG001|Overall Study|Lost to Follow-up|0|||
164453219|NCT04638998|594029440|FG000|Overall Study|Withdrawal by Subject|1|||
164453220|NCT04638998|594029441|FG001|Overall Study|Withdrawal by Subject|3|||
164453221|NCT03713086|594029444|FG000|Overall Study|Withdrawal by Subject|0|||
164453222|NCT03713086|594029445|FG001|Overall Study|Withdrawal by Subject|2|||
164453223|NCT03713086|594029446|FG002|Overall Study|Withdrawal by Subject|1|||
164453224|NCT03713086|594029447|FG003|Overall Study|Withdrawal by Subject|0|||
164453225|NCT03713086|594029444|FG000|Overall Study|Lost to Follow-up|0|||
164453226|NCT03713086|594029445|FG001|Overall Study|Lost to Follow-up|1|||
164453227|NCT03713086|594029446|FG002|Overall Study|Lost to Follow-up|0|||
164453228|NCT03713086|594029447|FG003|Overall Study|Lost to Follow-up|1|||
164453229|NCT02728076|594029448|FG000|Overall Study|Physician Decision|4|||
164453230|NCT05054374|594029449|FG000|Overall Study|Withdrawal by Subject|1|||
164453231|NCT05054374|594029450|FG001|Overall Study|Withdrawal by Subject|0|||
164453232|NCT05054374|594029451|FG002|Overall Study|Withdrawal by Subject|0|||
164453233|NCT05054374|594029452|FG003|Overall Study|Withdrawal by Subject|0|||
164453234|NCT05054374|594029449|FG000|Overall Study|Progressive Disease|5|||
164453235|NCT05054374|594029450|FG001|Overall Study|Progressive Disease|0|||
164453236|NCT05054374|594029451|FG002|Overall Study|Progressive Disease|0|||
164453237|NCT05054374|594029452|FG003|Overall Study|Progressive Disease|0|||
164453238|NCT04791709|594029453|FG000|Overall Study|Withdrawal by Subject|3|||
164453239|NCT03385629|594029454|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
164453240|NCT03385629|594029455|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
164453241|NCT03385629|594029454|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
164453242|NCT03385629|594029455|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
164453243|NCT03385629|594029454|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
164453244|NCT03385629|594029455|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
164453245|NCT01532388|594029456|FG000|3-month Follow-up|Lost to Follow-up|68|||
164453246|NCT01532388|594029457|FG001|3-month Follow-up|Lost to Follow-up|68|||
164453247|NCT01532388|594029456|FG000|6-month Follow-up|Lost to Follow-up|74|||
164453248|NCT01532388|594029457|FG001|6-month Follow-up|Lost to Follow-up|66|||
164453249|NCT01532388|594029456|FG000|12-month Follow-up|Lost to Follow-up|69|||
164453250|NCT01532388|594029457|FG001|12-month Follow-up|Lost to Follow-up|67|||
164453251|NCT04431726|594029463|FG000|Overall Study|Ongoing in the Study|55|||
164453252|NCT01095796|594029464|FG000|Overall Study|Randomized but Not Treated|5|||
164453253|NCT01095796|594029465|FG001|Overall Study|Randomized but Not Treated|2|||
164453254|NCT01095796|594029464|FG000|Overall Study|Adverse Event|9|||
164453255|NCT01095796|594029465|FG001|Overall Study|Adverse Event|19|||
164453256|NCT01095796|594029464|FG000|Overall Study|Death|3|||
164453257|NCT01095796|594029465|FG001|Overall Study|Death|2|||
164453258|NCT01095796|594029464|FG000|Overall Study|Pregnancy|2|||
164453259|NCT01095796|594029465|FG001|Overall Study|Pregnancy|0|||
164453260|NCT01095796|594029464|FG000|Overall Study|Lack of Efficacy|5|||
164453261|NCT01095796|594029465|FG001|Overall Study|Lack of Efficacy|3|||
164453262|NCT01095796|594029464|FG000|Overall Study|Investigator's Discretion|7|||
164453263|NCT01095796|594029465|FG001|Overall Study|Investigator's Discretion|2|||
164453264|NCT01095796|594029464|FG000|Overall Study|Withdrew Consent|16|||
164453265|NCT01095796|594029465|FG001|Overall Study|Withdrew Consent|22|||
164453266|NCT01095796|594029464|FG000|Overall Study|Lost to Follow-up|27|||
164453267|NCT01095796|594029465|FG001|Overall Study|Lost to Follow-up|29|||
164453268|NCT01095796|594029464|FG000|Overall Study|Participant Noncompliance|5|||
164453269|NCT01095796|594029465|FG001|Overall Study|Participant Noncompliance|10|||
164453270|NCT01095796|594029464|FG000|Overall Study|Protocol Violation|1|||
164453271|NCT01095796|594029465|FG001|Overall Study|Protocol Violation|0|||
164453272|NCT01095796|594029464|FG000|Overall Study|Participant Transferred to Another Study|215|||
164453273|NCT01095796|594029465|FG001|Overall Study|Participant Transferred to Another Study|200|||
164453274|NCT05480943|594029470|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
164453275|NCT05480943|594029470|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
164453276|NCT05480943|594029470|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
164453277|NCT05480943|594029470|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
164597522|NCT05118386|594549110|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
164597523|NCT05118386|594549105|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
164597524|NCT05118386|594549106|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
164597525|NCT05118386|594549107|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
164597526|NCT05118386|594549108|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
164597527|NCT05118386|594549109|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
164597528|NCT05118386|594549110|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
164597529|NCT00488033|594549111|FG000|Overall Study|Withdrawal by Subject|1|||
164597530|NCT00488033|594549112|FG001|Overall Study|Withdrawal by Subject|0|||
164597531|NCT03855137|594549119|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
164597532|NCT03855137|594549120|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
164597533|NCT03855137|594549121|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
164597534|NCT03855137|594549119|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
164597535|NCT03855137|594549120|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
164597536|NCT03855137|594549121|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
164597537|NCT03855137|594549119|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
164597538|NCT03855137|594549120|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
164597539|NCT03855137|594549121|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
164597540|NCT03855137|594549119|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
164597541|NCT03855137|594549120|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
164597542|NCT03855137|594549121|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
164597543|NCT03855137|594549119|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
164706707|NCT02393248|594953429|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164706708|NCT02393248|594953430|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164706709|NCT02393248|594953431|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164706710|NCT02393248|594953432|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164706711|NCT02393248|594953433|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164706712|NCT02393248|594953434|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164706713|NCT02393248|594953435|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164706714|NCT02393248|594953436|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164706715|NCT02393248|594953437|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
164706716|NCT02393248|594953438|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164706717|NCT03560986|594953439|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
164706718|NCT03560986|594953440|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
164706719|NCT03560986|594953439|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
164706720|NCT03560986|594953440|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
164706721|NCT03560986|594953439|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
164706722|NCT03560986|594953440|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
164706723|NCT03560986|594953439|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
164706724|NCT03560986|594953440|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
164706725|NCT03560986|594953439|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
164706726|NCT03560986|594953440|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
164706727|NCT03560986|594953439|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
164706728|NCT03560986|594953440|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
164706729|NCT03560986|594953439|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
164706730|NCT03560986|594953440|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
164706731|NCT02585934|594953441|FG000|Overall Study|Lost to Follow-up|2|||
164706732|NCT02585934|594953442|FG001|Overall Study|Lost to Follow-up|2|||
164706733|NCT02585934|594953441|FG000|Overall Study|Protocol Violation|14|||
164453278|NCT03069313|594029471|FG000|Overall Study|Adverse Event|5|||
164453279|NCT03912831|594029472|FG000|Overall Study|Death|1|||
164453280|NCT03912831|594029473|FG001|Overall Study|Death|1|||
164453281|NCT03912831|594029474|FG002|Overall Study|Death|1|||
164453282|NCT03912831|594029475|FG003|Overall Study|Death|1|||
164453283|NCT03912831|594029476|FG004|Overall Study|Death|1|||
164453284|NCT03912831|594029477|FG005|Overall Study|Death|1|||
164453285|NCT03912831|594029472|FG000|Overall Study|Reason not Specified|0|||
164453286|NCT03912831|594029473|FG001|Overall Study|Reason not Specified|0|||
164453287|NCT03912831|594029474|FG002|Overall Study|Reason not Specified|0|||
164453288|NCT03912831|594029475|FG003|Overall Study|Reason not Specified|0|||
164453289|NCT03912831|594029476|FG004|Overall Study|Reason not Specified|1|||
164453290|NCT03912831|594029477|FG005|Overall Study|Reason not Specified|0|||
164453291|NCT03912831|594029472|FG000|Overall Study|Withdrawal by Participant|0|||
164453292|NCT03912831|594029473|FG001|Overall Study|Withdrawal by Participant|0|||
164453293|NCT03912831|594029474|FG002|Overall Study|Withdrawal by Participant|0|||
164453294|NCT03912831|594029475|FG003|Overall Study|Withdrawal by Participant|0|||
164453295|NCT03912831|594029476|FG004|Overall Study|Withdrawal by Participant|1|||
164453296|NCT03912831|594029477|FG005|Overall Study|Withdrawal by Participant|0|||
164453297|NCT04623775|594029479|FG000|Randomization|No Longer Meets Study Criteria|2|||
164453298|NCT04623775|594029480|FG001|Randomization|No Longer Meets Study Criteria|1|||
164453299|NCT04623775|594029481|FG002|Randomization|No Longer Meets Study Criteria|0|||
164453300|NCT04623775|594029482|FG003|Randomization|No Longer Meets Study Criteria|0|||
164453301|NCT04623775|594029479|FG000|Randomization|Withdrew Consent|0|||
164453302|NCT04623775|594029480|FG001|Randomization|Withdrew Consent|0|||
164453303|NCT04623775|594029481|FG002|Randomization|Withdrew Consent|0|||
164453304|NCT04623775|594029482|FG003|Randomization|Withdrew Consent|1|||
164453305|NCT04623775|594029479|FG000|Randomization|Other Reasons|0|||
164453306|NCT04623775|594029480|FG001|Randomization|Other Reasons|0|||
164453307|NCT04623775|594029481|FG002|Randomization|Other Reasons|0|||
164453308|NCT04623775|594029482|FG003|Randomization|Other Reasons|1|||
164453309|NCT04623775|594029479|FG000|Treatment Period|participant withdrew consent|4|||
164453310|NCT04623775|594029480|FG001|Treatment Period|participant withdrew consent|0|||
164453311|NCT04623775|594029481|FG002|Treatment Period|participant withdrew consent|1|||
164453312|NCT04623775|594029482|FG003|Treatment Period|participant withdrew consent|2|||
164453313|NCT04623775|594029479|FG000|Treatment Period|Death|3|||
164453314|NCT04623775|594029480|FG001|Treatment Period|Death|1|||
164453315|NCT04623775|594029481|FG002|Treatment Period|Death|4|||
164453316|NCT04623775|594029482|FG003|Treatment Period|Death|2|||
164453317|NCT04623775|594029479|FG000|Treatment Period|Lost to Follow-up|0|||
164453318|NCT04623775|594029480|FG001|Treatment Period|Lost to Follow-up|2|||
164453319|NCT04623775|594029481|FG002|Treatment Period|Lost to Follow-up|0|||
164453320|NCT04623775|594029482|FG003|Treatment Period|Lost to Follow-up|0|||
164453321|NCT04623775|594029479|FG000|Treatment Period|poor/non compliance|0|||
164453322|NCT04623775|594029480|FG001|Treatment Period|poor/non compliance|0|||
164453323|NCT04623775|594029481|FG002|Treatment Period|poor/non compliance|1|||
164453324|NCT04623775|594029482|FG003|Treatment Period|poor/non compliance|0|||
164453325|NCT04623775|594029479|FG000|Treatment Period|participant no longer meets study criteria|0|||
164453326|NCT04623775|594029480|FG001|Treatment Period|participant no longer meets study criteria|1|||
164453327|NCT04623775|594029481|FG002|Treatment Period|participant no longer meets study criteria|0|||
164453328|NCT04623775|594029482|FG003|Treatment Period|participant no longer meets study criteria|0|||
164597544|NCT03855137|594549120|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
164597545|NCT03855137|594549121|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
164597546|NCT03855137|594549119|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
164597547|NCT03855137|594549120|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
164597548|NCT03855137|594549121|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
164597549|NCT03855137|594549119|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
164453329|NCT04623775|594029479|FG000|Treatment Period|administrative reasons by sponsor|3|||
164453330|NCT04623775|594029480|FG001|Treatment Period|administrative reasons by sponsor|2|||
164453331|NCT04623775|594029481|FG002|Treatment Period|administrative reasons by sponsor|0|||
164453332|NCT04623775|594029482|FG003|Treatment Period|administrative reasons by sponsor|0|||
164453333|NCT04623775|594029479|FG000|Treatment Period|other reasons|2|||
164453334|NCT04623775|594029480|FG001|Treatment Period|other reasons|0|||
164453335|NCT04623775|594029481|FG002|Treatment Period|other reasons|1|||
164453336|NCT04623775|594029482|FG003|Treatment Period|other reasons|1|||
164453337|NCT04623775|594029479|FG000|Treatment Period|disease progression|40|||
164453338|NCT04623775|594029480|FG001|Treatment Period|disease progression|35|||
164453339|NCT04623775|594029481|FG002|Treatment Period|disease progression|63|||
164453340|NCT04623775|594029482|FG003|Treatment Period|disease progression|63|||
164453341|NCT04623775|594029479|FG000|Treatment Period|study drug toxicity|12|||
164144656|NCT01495702|592891745|FG000|Randomized Phase|Adverse Event|2|||
164453342|NCT04623775|594029480|FG001|Treatment Period|study drug toxicity|15|||
164453343|NCT04623775|594029481|FG002|Treatment Period|study drug toxicity|13|||
164453344|NCT04623775|594029482|FG003|Treatment Period|study drug toxicity|12|||
164453345|NCT04623775|594029479|FG000|Treatment Period|AE unrelated to study drug|4|||
164453346|NCT04623775|594029480|FG001|Treatment Period|AE unrelated to study drug|9|||
164453347|NCT04623775|594029481|FG002|Treatment Period|AE unrelated to study drug|12|||
164453348|NCT04623775|594029482|FG003|Treatment Period|AE unrelated to study drug|9|||
164706734|NCT02585934|594953442|FG001|Overall Study|Protocol Violation|11|||
164706735|NCT02585934|594953441|FG000|Overall Study|Adverse Event|21|||
164453349|NCT04623775|594029479|FG000|Treatment Period|participant request to discontinue treatment|0|||
164453350|NCT04623775|594029480|FG001|Treatment Period|participant request to discontinue treatment|2|||
164453351|NCT04623775|594029481|FG002|Treatment Period|participant request to discontinue treatment|2|||
164453352|NCT04623775|594029482|FG003|Treatment Period|participant request to discontinue treatment|0|||
164453353|NCT06024174|594029483|FG000|Overall Study|Other Reasons|1|||
164453354|NCT06024174|594029483|FG000|Overall Study|Study terminated by Sponsor|4|||
164453355|NCT03819686|594031029|FG000|Overall Study|Lost to Follow-up|2|||
164453356|NCT03819686|594031030|FG001|Overall Study|Lost to Follow-up|3|||
164453357|NCT06143670|594031031|FG000|Overall Study|Lost to Follow-up|0|||
164453358|NCT06143670|594031032|FG001|Overall Study|Lost to Follow-up|1|||
164453359|NCT06143670|594031031|FG000|Overall Study|Withdrawal by Subject|3|||
164453360|NCT06143670|594031032|FG001|Overall Study|Withdrawal by Subject|0|||
164453361|NCT00739648|594031035|FG000|Overall Study|Adverse Event|3|||
164453362|NCT00739648|594031036|FG001|Overall Study|Adverse Event|15|||
164453363|NCT00739648|594031035|FG000|Overall Study|Withdrawal by Subject|13|||
164453364|NCT00739648|594031036|FG001|Overall Study|Withdrawal by Subject|25|||
164453365|NCT00739648|594031035|FG000|Overall Study|Lost to Follow-up|4|||
164453366|NCT00739648|594031036|FG001|Overall Study|Lost to Follow-up|7|||
164453367|NCT00739648|594031035|FG000|Overall Study|Death|2|||
164453368|NCT00739648|594031036|FG001|Overall Study|Death|0|||
164453369|NCT00739648|594031035|FG000|Overall Study|Do not know|4|||
164453370|NCT00739648|594031036|FG001|Overall Study|Do not know|6|||
164453371|NCT05110495|594031037|FG000|Overall Study|Lost to Follow-up|1|||
164453372|NCT05110495|594031037|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
164453373|NCT04173663|594031038|FG000|Overall Study|Withdrawal by Subject|1|||
164453374|NCT04173663|594031039|FG001|Overall Study|Withdrawal by Subject|6|||
164453375|NCT04173663|594031038|FG000|Overall Study|Lost to Follow-up|17|||
164453376|NCT04173663|594031039|FG001|Overall Study|Lost to Follow-up|24|||
164453377|NCT04716634|594031041|FG000|Overall Study|Death|24|||
164453378|NCT04716634|594031042|FG001|Overall Study|Death|24|||
164453379|NCT04716634|594031043|FG002|Overall Study|Death|8|||
164453380|NCT04716634|594031041|FG000|Overall Study|Closed by Sponsor|4|||
164453381|NCT04716634|594031042|FG001|Overall Study|Closed by Sponsor|4|||
164453382|NCT04716634|594031043|FG002|Overall Study|Closed by Sponsor|5|||
164453383|NCT04716634|594031041|FG000|Overall Study|Lost to Follow-up|1|||
164453384|NCT04716634|594031042|FG001|Overall Study|Lost to Follow-up|0|||
164453385|NCT04716634|594031043|FG002|Overall Study|Lost to Follow-up|1|||
164453386|NCT04716634|594031041|FG000|Overall Study|Withdrawal by Subject|0|||
164453387|NCT04716634|594031042|FG001|Overall Study|Withdrawal by Subject|0|||
164453388|NCT04716634|594031043|FG002|Overall Study|Withdrawal by Subject|1|||
164453389|NCT04833777|594031044|FG000|Overall Study|Lost to Follow-up|1|||
164453390|NCT04833777|594031045|FG001|Overall Study|Lost to Follow-up|0|||
164453391|NCT03089398|594031053|FG000|Overall Study|Death|4|||
164453392|NCT03089398|594031054|FG001|Overall Study|Death|9|||
164453393|NCT03089398|594031053|FG000|Overall Study|Lost to Follow-up|21|||
164453394|NCT03089398|594031054|FG001|Overall Study|Lost to Follow-up|30|||
164453395|NCT03089398|594031053|FG000|Overall Study|Withdrawal by Subject|2|||
164453396|NCT03089398|594031054|FG001|Overall Study|Withdrawal by Subject|2|||
164453397|NCT05374837|594031060|FG000|Overall Study|Lost to Follow-up|17|||
164453398|NCT05374837|594031061|FG001|Overall Study|Lost to Follow-up|18|||
164453399|NCT05406921|594031064|FG000|Overall Study|Withdrawal by Subject|25|||
164453400|NCT05406921|594031065|FG001|Overall Study|Withdrawal by Subject|0|||
164453401|NCT05406921|594031066|FG002|Overall Study|Withdrawal by Subject|25|||
164453402|NCT05406921|594031064|FG000|Overall Study|Protocol Violation|0|||
164453403|NCT05406921|594031065|FG001|Overall Study|Protocol Violation|12|||
164453404|NCT05406921|594031066|FG002|Overall Study|Protocol Violation|0|||
164453405|NCT04831281|594031069|FG000|Overall Study|Adverse Event|1|||
164453406|NCT04831281|594031070|FG001|Overall Study|Adverse Event|0|||
164453407|NCT04831281|594031071|FG002|Overall Study|Adverse Event|3|||
164453408|NCT04831281|594031069|FG000|Overall Study|Withdrawal by Subject|0|||
164453409|NCT04831281|594031070|FG001|Overall Study|Withdrawal by Subject|1|||
164706736|NCT02585934|594953442|FG001|Overall Study|Adverse Event|22|||
164453410|NCT04831281|594031071|FG002|Overall Study|Withdrawal by Subject|2|||
164453411|NCT04831281|594031069|FG000|Overall Study|Undetermined|1|||
164453412|NCT04831281|594031070|FG001|Overall Study|Undetermined|1|||
164453413|NCT04831281|594031071|FG002|Overall Study|Undetermined|0|||
164453414|NCT02249949|594031072|FG000|Overall Study|Cancelled prior to treatment|2|||
164453415|NCT02097420|594031075|FG000|Overall Study|Death|6|||
164453416|NCT02097420|594031075|FG000|Overall Study|Valve explanted|13|||
164453417|NCT02097420|594031075|FG000|Overall Study|Other Reason|1|||
164453418|NCT05059262|594031076|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
164453419|NCT05059262|594031077|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
164706737|NCT02585934|594953441|FG000|Overall Study|Physician Decision|3|||
164453420|NCT05059262|594031076|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
164453421|NCT05059262|594031077|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
164597550|NCT03855137|594549120|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
164597551|NCT03855137|594549121|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
164597552|NCT03855137|594549119|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
164597553|NCT03855137|594549120|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
164453422|NCT05059262|594031076|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
164453423|NCT05059262|594031077|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
164453424|NCT05059262|594031076|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
164453425|NCT05059262|594031077|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
164453426|NCT05059262|594031076|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
164453427|NCT05059262|594031077|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
164453428|NCT05059262|594031076|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
164453429|NCT05059262|594031077|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
164453430|NCT05059262|594031076|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
164453431|NCT05059262|594031077|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
164453432|NCT05059262|594031076|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
164453433|NCT05059262|594031077|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
164453434|NCT05059262|594031076|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
164453435|NCT05059262|594031077|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
164453436|NCT02312960|594031078|FG000|Overall Study|Death|24|||
164453437|NCT02312960|594031079|FG001|Overall Study|Death|32|||
164453438|NCT02312960|594031080|FG002|Overall Study|Death|25|||
164453439|NCT02312960|594031081|FG003|Overall Study|Death|11|||
164453440|NCT02312960|594031082|FG004|Overall Study|Death|5|||
164453441|NCT02312960|594031083|FG005|Overall Study|Death|5|||
164453442|NCT02312960|594031084|FG006|Overall Study|Death|8|||
164453443|NCT02312960|594031085|FG007|Overall Study|Death|5|||
164453444|NCT02312960|594031086|FG008|Overall Study|Death|7|||
164453445|NCT02312960|594031087|FG009|Overall Study|Death|3|||
164453446|NCT02312960|594031088|FG010|Overall Study|Death|3|||
164453447|NCT02312960|594031089|FG011|Overall Study|Death|1|||
164453448|NCT02312960|594031090|FG012|Overall Study|Death|25|||
164453449|NCT02312960|594031091|FG013|Overall Study|Death|19|||
164453450|NCT02312960|594031078|FG000|Overall Study|Missing|0|||
164453451|NCT02312960|594031079|FG001|Overall Study|Missing|0|||
164453452|NCT02312960|594031080|FG002|Overall Study|Missing|2|||
164453453|NCT02312960|594031081|FG003|Overall Study|Missing|0|||
164453454|NCT02312960|594031082|FG004|Overall Study|Missing|0|||
164453455|NCT02312960|594031083|FG005|Overall Study|Missing|0|||
164453456|NCT02312960|594031084|FG006|Overall Study|Missing|0|||
164453457|NCT02312960|594031085|FG007|Overall Study|Missing|0|||
164453458|NCT02312960|594031086|FG008|Overall Study|Missing|0|||
164453459|NCT02312960|594031087|FG009|Overall Study|Missing|0|||
164453460|NCT02312960|594031088|FG010|Overall Study|Missing|0|||
164453461|NCT02312960|594031089|FG011|Overall Study|Missing|0|||
164453462|NCT02312960|594031090|FG012|Overall Study|Missing|0|||
164453463|NCT02312960|594031091|FG013|Overall Study|Missing|0|||
164453464|NCT02312960|594031078|FG000|Overall Study|Lost to Follow-up|0|||
164453465|NCT02312960|594031079|FG001|Overall Study|Lost to Follow-up|0|||
164453466|NCT02312960|594031080|FG002|Overall Study|Lost to Follow-up|1|||
164453467|NCT02312960|594031081|FG003|Overall Study|Lost to Follow-up|0|||
164453468|NCT02312960|594031082|FG004|Overall Study|Lost to Follow-up|0|||
164453469|NCT02312960|594031083|FG005|Overall Study|Lost to Follow-up|0|||
164453470|NCT02312960|594031084|FG006|Overall Study|Lost to Follow-up|1|||
164453471|NCT02312960|594031085|FG007|Overall Study|Lost to Follow-up|1|||
164453472|NCT02312960|594031086|FG008|Overall Study|Lost to Follow-up|0|||
164453473|NCT02312960|594031087|FG009|Overall Study|Lost to Follow-up|1|||
164453474|NCT02312960|594031088|FG010|Overall Study|Lost to Follow-up|0|||
164453475|NCT02312960|594031089|FG011|Overall Study|Lost to Follow-up|0|||
164453476|NCT02312960|594031090|FG012|Overall Study|Lost to Follow-up|1|||
164453477|NCT02312960|594031091|FG013|Overall Study|Lost to Follow-up|0|||
164453478|NCT02312960|594031078|FG000|Overall Study|Withdrawal by Subject|1|||
164453479|NCT02312960|594031079|FG001|Overall Study|Withdrawal by Subject|2|||
164453480|NCT02312960|594031080|FG002|Overall Study|Withdrawal by Subject|0|||
164453481|NCT02312960|594031081|FG003|Overall Study|Withdrawal by Subject|0|||
164453482|NCT02312960|594031082|FG004|Overall Study|Withdrawal by Subject|1|||
164453483|NCT02312960|594031083|FG005|Overall Study|Withdrawal by Subject|0|||
164453484|NCT02312960|594031084|FG006|Overall Study|Withdrawal by Subject|1|||
164453485|NCT02312960|594031085|FG007|Overall Study|Withdrawal by Subject|2|||
164453486|NCT02312960|594031086|FG008|Overall Study|Withdrawal by Subject|2|||
164453487|NCT02312960|594031087|FG009|Overall Study|Withdrawal by Subject|3|||
164597554|NCT03855137|594549121|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
164597555|NCT03855137|594549119|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
164597556|NCT03855137|594549120|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
164597557|NCT03855137|594549121|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
164453488|NCT02312960|594031088|FG010|Overall Study|Withdrawal by Subject|0|||
164453489|NCT02312960|594031089|FG011|Overall Study|Withdrawal by Subject|0|||
164453490|NCT02312960|594031090|FG012|Overall Study|Withdrawal by Subject|2|||
164453491|NCT02312960|594031091|FG013|Overall Study|Withdrawal by Subject|0|||
164453492|NCT05691309|594031108|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
164453493|NCT05691309|594031108|FG000|Overall Study|vancomycin levels not evaluable|2|||
164453494|NCT03131648|594031109|FG000|Initial Treatment Period|Not dosed|2|||
164453495|NCT03131648|594031110|FG001|Initial Treatment Period|Not dosed|2|||
164453496|NCT03131648|594031111|FG002|Initial Treatment Period|Not dosed|0|||
164453497|NCT03131648|594031112|FG003|Initial Treatment Period|Not dosed|0|||
164453498|NCT03131648|594031113|FG004|Initial Treatment Period|Not dosed|0|||
164453499|NCT03131648|594031114|FG005|Initial Treatment Period|Not dosed|0|||
164453500|NCT03131648|594031115|FG006|Initial Treatment Period|Not dosed|0|||
164453501|NCT03131648|594031116|FG007|Initial Treatment Period|Not dosed|0|||
164453502|NCT03131648|594031109|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
164453503|NCT03131648|594031110|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
164453504|NCT03131648|594031111|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
164453505|NCT03131648|594031112|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
164453506|NCT03131648|594031113|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
164453507|NCT03131648|594031114|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
164453508|NCT03131648|594031115|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
164453509|NCT03131648|594031116|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
164453510|NCT03131648|594031109|FG000|Open-label Treatment|Discontinued IMP|0|||
164453511|NCT03131648|594031110|FG001|Open-label Treatment|Discontinued IMP|0|||
164453512|NCT03131648|594031111|FG002|Open-label Treatment|Discontinued IMP|0|||
164453513|NCT03131648|594031112|FG003|Open-label Treatment|Discontinued IMP|0|||
164453514|NCT03131648|594031113|FG004|Open-label Treatment|Discontinued IMP|0|||
164453515|NCT03131648|594031114|FG005|Open-label Treatment|Discontinued IMP|0|||
164453516|NCT03131648|594031115|FG006|Open-label Treatment|Discontinued IMP|112|||
164453517|NCT03131648|594031116|FG007|Open-label Treatment|Discontinued IMP|0|||
164453518|NCT03131648|594031109|FG000|Open-label Treatment|Completed Week 50|0|||
164453519|NCT03131648|594031110|FG001|Open-label Treatment|Completed Week 50|0|||
164453520|NCT03131648|594031111|FG002|Open-label Treatment|Completed Week 50|0|||
164453521|NCT03131648|594031112|FG003|Open-label Treatment|Completed Week 50|0|||
164453522|NCT03131648|594031113|FG004|Open-label Treatment|Completed Week 50|0|||
164453523|NCT03131648|594031114|FG005|Open-label Treatment|Completed Week 50|0|||
164453524|NCT03131648|594031115|FG006|Open-label Treatment|Completed Week 50|6|||
164453525|NCT03131648|594031116|FG007|Open-label Treatment|Completed Week 50|0|||
164453526|NCT03131648|594031109|FG000|Maintenance Treatment Period|Not dosed|0|||
164453527|NCT03131648|594031110|FG001|Maintenance Treatment Period|Not dosed|0|||
164453528|NCT03131648|594031111|FG002|Maintenance Treatment Period|Not dosed|3|||
164453529|NCT03131648|594031112|FG003|Maintenance Treatment Period|Not dosed|2|||
164453530|NCT03131648|594031113|FG004|Maintenance Treatment Period|Not dosed|1|||
164453531|NCT03131648|594031114|FG005|Maintenance Treatment Period|Not dosed|0|||
164453532|NCT03131648|594031115|FG006|Maintenance Treatment Period|Not dosed|0|||
164453533|NCT03131648|594031116|FG007|Maintenance Treatment Period|Not dosed|0|||
164453534|NCT03131648|594031109|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
164453535|NCT03131648|594031110|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
164453536|NCT03131648|594031111|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
164453537|NCT03131648|594031112|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
164453538|NCT03131648|594031113|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
164453539|NCT03131648|594031114|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
164453540|NCT03131648|594031115|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
164453541|NCT03131648|594031116|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
164453542|NCT03131648|594031109|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
164453543|NCT03131648|594031110|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
164453544|NCT03131648|594031111|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
164453545|NCT03131648|594031112|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
164453546|NCT03131648|594031113|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
164453547|NCT03131648|594031114|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
164453548|NCT03131648|594031115|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
164453549|NCT03131648|594031116|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
164453550|NCT03131648|594031109|FG000|Maintenance Treatment Period|Completed Week 50|0|||
164453551|NCT03131648|594031110|FG001|Maintenance Treatment Period|Completed Week 50|0|||
164453552|NCT03131648|594031111|FG002|Maintenance Treatment Period|Completed Week 50|0|||
164453553|NCT03131648|594031112|FG003|Maintenance Treatment Period|Completed Week 50|0|||
164453554|NCT03131648|594031113|FG004|Maintenance Treatment Period|Completed Week 50|1|||
164453555|NCT03131648|594031114|FG005|Maintenance Treatment Period|Completed Week 50|0|||
164453556|NCT03131648|594031115|FG006|Maintenance Treatment Period|Completed Week 50|0|||
164453557|NCT03131648|594031116|FG007|Maintenance Treatment Period|Completed Week 50|0|||
164453558|NCT03131648|594031109|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
164453559|NCT03131648|594031110|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
164453560|NCT03131648|594031111|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
164453561|NCT03131648|594031112|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
164597558|NCT03855137|594549119|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
164597559|NCT03855137|594549120|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
164597560|NCT03855137|594549121|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
164405571|NCT01972529|593855496|FG002|Overall Study|Adverse Event|0|||
164405572|NCT01972529|593855497|FG003|Overall Study|Adverse Event|0|||
164405573|NCT01972529|593855494|FG000|Overall Study|Lost to Follow-up|1|||
164405574|NCT01972529|593855495|FG001|Overall Study|Lost to Follow-up|0|||
164405575|NCT01972529|593855496|FG002|Overall Study|Lost to Follow-up|0|||
164405576|NCT01972529|593855497|FG003|Overall Study|Lost to Follow-up|0|||
164405577|NCT01972529|593855494|FG000|Overall Study|Participant Choice|0|||
164405578|NCT01972529|593855495|FG001|Overall Study|Participant Choice|1|||
164405579|NCT01972529|593855496|FG002|Overall Study|Participant Choice|0|||
164405580|NCT01972529|593855497|FG003|Overall Study|Participant Choice|0|||
164405581|NCT01972529|593855494|FG000|Overall Study|Withdrawl of Consent|1|||
164405582|NCT01972529|593855495|FG001|Overall Study|Withdrawl of Consent|2|||
164405583|NCT01972529|593855496|FG002|Overall Study|Withdrawl of Consent|0|||
164405584|NCT01972529|593855497|FG003|Overall Study|Withdrawl of Consent|1|||
164405585|NCT01972529|593855494|FG000|Overall Study|Other|0|||
164405586|NCT01972529|593855495|FG001|Overall Study|Other|0|||
164405587|NCT01972529|593855496|FG002|Overall Study|Other|0|||
164405588|NCT01972529|593855497|FG003|Overall Study|Other|2|||
164405589|NCT01972529|593855494|FG000|Overall Study|Not treated|0|||
164405590|NCT01972529|593855495|FG001|Overall Study|Not treated|1|||
164405591|NCT01972529|593855496|FG002|Overall Study|Not treated|2|||
164405592|NCT01972529|593855497|FG003|Overall Study|Not treated|1|||
164405593|NCT01889186|593855498|FG000|Overall Study|Adverse event- not related to progression|18|||
164405594|NCT01889186|593855499|FG001|Overall Study|Adverse event- not related to progression|5|||
164405595|NCT01889186|593855498|FG000|Overall Study|Adverse event- related to progression|7|||
164405596|NCT01889186|593855499|FG001|Overall Study|Adverse event- related to progression|2|||
164405597|NCT01889186|593855498|FG000|Overall Study|COVID-19 logistical restrictions|1|||
164405598|NCT01889186|593855499|FG001|Overall Study|COVID-19 logistical restrictions|0|||
164405599|NCT01889186|593855498|FG000|Overall Study|Investigator request|1|||
164405600|NCT01889186|593855499|FG001|Overall Study|Investigator request|1|||
164405601|NCT01889186|593855498|FG000|Overall Study|Progressive disease- Richter's|12|||
164405602|NCT01889186|593855499|FG001|Overall Study|Progressive disease- Richter's|7|||
164405603|NCT01889186|593855498|FG000|Overall Study|Progressive disease per protocol|46|||
164405604|NCT01889186|593855499|FG001|Overall Study|Progressive disease per protocol|17|||
164405605|NCT01889186|593855498|FG000|Overall Study|Stem cell transplant|2|||
164405606|NCT01889186|593855499|FG001|Overall Study|Stem cell transplant|1|||
164405607|NCT01889186|593855498|FG000|Overall Study|Withdrew consent|2|||
164405608|NCT01889186|593855499|FG001|Overall Study|Withdrew consent|3|||
164405609|NCT01889186|593855498|FG000|Overall Study|Other, not specified|18|||
164405610|NCT01889186|593855499|FG001|Overall Study|Other, not specified|15|||
164405611|NCT00118716|593855503|FG000|Overall Study|Adverse Event|2|||
164405612|NCT00118716|593855504|FG001|Overall Study|Adverse Event|7|||
164405613|NCT00118716|593855503|FG000|Overall Study|Protocol Violation|5|||
164405614|NCT00118716|593855504|FG001|Overall Study|Protocol Violation|4|||
164405615|NCT00118716|593855503|FG000|Overall Study|Withdrawal by Subject|0|||
164405616|NCT00118716|593855504|FG001|Overall Study|Withdrawal by Subject|1|||
164405617|NCT00118716|593855503|FG000|Overall Study|Exacerbation|2|||
164405618|NCT00118716|593855504|FG001|Overall Study|Exacerbation|2|||
164405619|NCT00118716|593855503|FG000|Overall Study|Discontinued by sponsor|1|||
164405620|NCT00118716|593855504|FG001|Overall Study|Discontinued by sponsor|1|||
164405621|NCT00118716|593855503|FG000|Overall Study|Non-compliance|1|||
164405622|NCT00118716|593855504|FG001|Overall Study|Non-compliance|3|||
164405623|NCT00118716|593855503|FG000|Overall Study|misrandomized|1|||
164405624|NCT00118716|593855504|FG001|Overall Study|misrandomized|1|||
164405625|NCT00118716|593855503|FG000|Overall Study|Expired drug use|1|||
164405626|NCT00118716|593855504|FG001|Overall Study|Expired drug use|2|||
164405627|NCT00118716|593855503|FG000|Overall Study|Investigator discretion|0|||
164405628|NCT00118716|593855504|FG001|Overall Study|Investigator discretion|1|||
164405629|NCT00621543|593855505|FG000|Overall Study|Lost to Follow-up|23|||
164405630|NCT00855062|593855506|FG000|Step1|Early Study Closure|5|||
164405631|NCT00855062|593855507|FG001|Step1|Early Study Closure|7|||
164405632|NCT00855062|593855506|FG000|Step1|Adverse Event|1|||
164405633|NCT00855062|593855507|FG001|Step1|Adverse Event|1|||
164405634|NCT00855062|593855506|FG000|Step1|Protocol Violation|1|||
164405635|NCT00855062|593855507|FG001|Step1|Protocol Violation|0|||
164405636|NCT00855062|593855506|FG000|Step1|Pregnancy|1|||
164405637|NCT00855062|593855507|FG001|Step1|Pregnancy|0|||
164405638|NCT00855062|593855506|FG000|Step1|Withdrawal by Subject|2|||
164405639|NCT00855062|593855507|FG001|Step1|Withdrawal by Subject|3|||
164405640|NCT00855062|593855506|FG000|Step2|Early Study Closure|6|||
164405641|NCT00855062|593855507|FG001|Step2|Early Study Closure|2|||
164405642|NCT00855062|593855506|FG000|Step2|Adverse Event|0|||
164405643|NCT00855062|593855507|FG001|Step2|Adverse Event|3|||
164405644|NCT00855062|593855506|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
164405645|NCT00855062|593855507|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
164405646|NCT03745222|593855508|FG000|Overall Study|Withdrawal by Subject|0|||
164706738|NCT02585934|594953442|FG001|Overall Study|Physician Decision|2|||
164706739|NCT02585934|594953441|FG000|Overall Study|Withdrawal by Subject|7|||
164706740|NCT02585934|594953442|FG001|Overall Study|Withdrawal by Subject|21|||
164706741|NCT02585934|594953441|FG000|Overall Study|Lack of Efficacy|2|||
164706742|NCT02585934|594953442|FG001|Overall Study|Lack of Efficacy|1|||
164706743|NCT02585934|594953441|FG000|Overall Study|Death|2|||
164706744|NCT02585934|594953442|FG001|Overall Study|Death|0|||
164706745|NCT02585934|594953441|FG000|Overall Study|Caregiver Withdrew Consent|7|||
164706746|NCT02585934|594953442|FG001|Overall Study|Caregiver Withdrew Consent|7|||
164706747|NCT02585934|594953441|FG000|Overall Study|Sponsor Termination|1|||
164706748|NCT02585934|594953442|FG001|Overall Study|Sponsor Termination|2|||
164706749|NCT02585934|594953441|FG000|Overall Study|Another Reason|10|||
164706750|NCT02585934|594953442|FG001|Overall Study|Another Reason|5|||
164706751|NCT00655876|594953454|FG000|Overall Study|Protocol Violation|9|||
164706752|NCT00655876|594953455|FG001|Overall Study|Protocol Violation|7|||
164706753|NCT00326963|594953456|FG000|Overall Study|Adverse Event|2|||
164706754|NCT00326963|594953456|FG000|Overall Study|Injection site reaction|1|||
164706755|NCT00326963|594953456|FG000|Overall Study|Death|1|||
164706756|NCT00326963|594953456|FG000|Overall Study|Failure to return|10|||
164706757|NCT00326963|594953456|FG000|Overall Study|Withdrawal by Subject|10|||
164706758|NCT00326963|594953456|FG000|Overall Study|Refused treatment / did not cooperate|5|||
164706759|NCT00326963|594953456|FG000|Overall Study|Violation of selection criteria at entry|2|||
164706760|NCT00326963|594953456|FG000|Overall Study|Other protocol violation|1|||
164706761|NCT00326963|594953456|FG000|Overall Study|Administrative / other|1|||
164706762|NCT04729309|594953460|FG000|Period 1|Subject unable to return for Period 2|3|||
164706763|NCT04729309|594953461|FG001|Period 1|Subject unable to return for Period 2|0|||
164706764|NCT04729309|594953460|FG000|Period 1|Lost to Follow-up|1|||
164706765|NCT04729309|594953461|FG001|Period 1|Lost to Follow-up|0|||
164706766|NCT00895947|594953462|FG000|Overall Study|Adverse Event|3|||
164706767|NCT00895947|594953463|FG001|Overall Study|Adverse Event|4|||
164706768|NCT00895947|594953462|FG000|Overall Study|Lost to Follow-up|3|||
164706769|NCT00895947|594953463|FG001|Overall Study|Lost to Follow-up|4|||
164706770|NCT00895947|594953462|FG000|Overall Study|Protocol Violation|4|||
164405647|NCT03745222|593855509|FG001|Overall Study|Withdrawal by Subject|1|||
164405648|NCT03745222|593855510|FG002|Overall Study|Withdrawal by Subject|0|||
164405649|NCT02657317|593855511|FG000|Overall Study|Withdrawal by Subject|2|||
164405650|NCT02657317|593855512|FG001|Overall Study|Withdrawal by Subject|0|||
164405651|NCT02657317|593855511|FG000|Overall Study|Lost to Follow-up|3|||
164405652|NCT02657317|593855512|FG001|Overall Study|Lost to Follow-up|3|||
164405653|NCT02755597|593855513|FG000|Overall Study|Withdrew consent|27|||
164405654|NCT02755597|593855514|FG001|Overall Study|Withdrew consent|11|||
164405655|NCT02755597|593855513|FG000|Overall Study|Lost to Follow-up|1|||
164405656|NCT02755597|593855514|FG001|Overall Study|Lost to Follow-up|0|||
164405657|NCT02755597|593855513|FG000|Overall Study|Death|78|||
164405658|NCT02755597|593855514|FG001|Overall Study|Death|36|||
164405659|NCT02755597|593855513|FG000|Overall Study|Study terminated by Sponsor|67|||
164405660|NCT02755597|593855514|FG001|Overall Study|Study terminated by Sponsor|47|||
164405661|NCT02755597|593855513|FG000|Overall Study|Other, not specified|20|||
164405662|NCT02755597|593855514|FG001|Overall Study|Other, not specified|3|||
164405663|NCT02755597|593855513|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
164405664|NCT02755597|593855514|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
164405665|NCT04252742|593855516|FG000|Overall Study|Decision by sponsor|0|||
164405666|NCT04252742|593855517|FG001|Overall Study|Decision by sponsor|2|||
164405667|NCT04252742|593855516|FG000|Overall Study|Withdrawal by Subject|15|||
164405668|NCT04252742|593855517|FG001|Overall Study|Withdrawal by Subject|9|||
164405669|NCT04252742|593855516|FG000|Overall Study|Lost to Follow-up|0|||
164405670|NCT04252742|593855517|FG001|Overall Study|Lost to Follow-up|1|||
164405671|NCT03759834|593855520|FG000|Overall Study|Withdrawal by Subject|1|||
164405672|NCT01666808|593855523|FG000|Overall Study|Lost to Follow-up|9|||
164405673|NCT01666808|593855524|FG001|Overall Study|Lost to Follow-up|15|||
164405674|NCT01666808|593855523|FG000|Overall Study|Withdrawal by Subject|3|||
164405675|NCT01666808|593855524|FG001|Overall Study|Withdrawal by Subject|1|||
164405676|NCT01666808|593855523|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
164405677|NCT01666808|593855524|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
164405678|NCT02220894|593855525|FG000|Overall Study|Adverse Event|127|||
164405679|NCT02220894|593855526|FG001|Overall Study|Adverse Event|74|||
164405680|NCT02220894|593855525|FG000|Overall Study|Death|418|||
164405681|NCT02220894|593855526|FG001|Overall Study|Death|508|||
164405682|NCT02220894|593855525|FG000|Overall Study|Lost to Follow-up|0|||
164405683|NCT02220894|593855526|FG001|Overall Study|Lost to Follow-up|4|||
164405684|NCT02220894|593855525|FG000|Overall Study|Site Terminated by Sponsor|2|||
164706771|NCT00895947|594953463|FG001|Overall Study|Protocol Violation|2|||
164706772|NCT00895947|594953462|FG000|Overall Study|Withdrawal by Subject|2|||
164706773|NCT00895947|594953463|FG001|Overall Study|Withdrawal by Subject|0|||
164706774|NCT00616629|594953466|FG000|Overall Study|Protocol Violation|1|||
164706775|NCT00616629|594953467|FG001|Overall Study|Protocol Violation|2|||
164706776|NCT00616629|594953468|FG002|Overall Study|Protocol Violation|1|||
164453562|NCT03131648|594031113|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
164453563|NCT03131648|594031114|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
164453564|NCT03131648|594031115|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
164453565|NCT03131648|594031116|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
164453566|NCT01707030|594031117|FG000|Overall Study|Death|1|||
164453567|NCT01707030|594031118|FG001|Overall Study|Death|1|||
164453568|NCT01707030|594031117|FG000|Overall Study|Withdrawal by Subject|2|||
164453569|NCT01707030|594031118|FG001|Overall Study|Withdrawal by Subject|3|||
164453570|NCT01707030|594031117|FG000|Overall Study|Lost to Follow-up|8|||
164453571|NCT01707030|594031118|FG001|Overall Study|Lost to Follow-up|13|||
164453572|NCT02724878|594031119|FG000|Overall Study|Still on Active Therapy|15|||
164453573|NCT02724878|594031119|FG000|Overall Study|Disease Progression|31|||
164453574|NCT02724878|594031119|FG000|Overall Study|Toxicity|5|||
164453575|NCT02724878|594031119|FG000|Overall Study|Death|1|||
164453576|NCT02724878|594031119|FG000|Overall Study|Withdrawal by Subject|4|||
164453577|NCT02724878|594031119|FG000|Overall Study|Lost to Follow-up|2|||
164453578|NCT02724878|594031119|FG000|Overall Study|Protocol Violation|1|||
164453579|NCT02724878|594031119|FG000|Overall Study|Ineligible for Study Drug|5|||
164453580|NCT02724878|594031119|FG000|Overall Study|not started|1|||
164453581|NCT04263311|594031121|FG000|Overall Study|Lost to Follow-up|1|||
164453582|NCT04263311|594031122|FG001|Overall Study|Lost to Follow-up|2|||
164453583|NCT04263311|594031123|FG002|Overall Study|Lost to Follow-up|0|||
164453584|NCT04263311|594031121|FG000|Overall Study|Health Issues|1|||
164453585|NCT04263311|594031122|FG001|Overall Study|Health Issues|0|||
164453586|NCT04263311|594031123|FG002|Overall Study|Health Issues|0|||
164453587|NCT04263311|594031121|FG000|Overall Study|Left the country|1|||
164453588|NCT04263311|594031122|FG001|Overall Study|Left the country|0|||
164453589|NCT04263311|594031123|FG002|Overall Study|Left the country|0|||
164453590|NCT04263311|594031121|FG000|Overall Study|Unable to maintain time commitment|1|||
164453591|NCT04263311|594031122|FG001|Overall Study|Unable to maintain time commitment|0|||
164453592|NCT04263311|594031123|FG002|Overall Study|Unable to maintain time commitment|0|||
164453593|NCT04263311|594031121|FG000|Overall Study|No longer interested|1|||
164453594|NCT04263311|594031122|FG001|Overall Study|No longer interested|0|||
164453595|NCT04263311|594031123|FG002|Overall Study|No longer interested|0|||
164453596|NCT04263311|594031121|FG000|Overall Study|Ineligible post consent|0|||
164453597|NCT04263311|594031122|FG001|Overall Study|Ineligible post consent|0|||
164453598|NCT04263311|594031123|FG002|Overall Study|Ineligible post consent|5|||
164453599|NCT04820855|594031124|FG000|Overall Study|Lost to Follow-up|6|||
164453600|NCT04820855|594031125|FG001|Overall Study|Lost to Follow-up|9|||
164453601|NCT04838262|594031126|FG000|Overall Study|Withdrawal by Subject|9|||
164453602|NCT04838262|594031127|FG001|Overall Study|Withdrawal by Subject|4|||
164453603|NCT02927769|594031128|FG000|Induction Phase|Study drug toxicity|1|||
164453604|NCT02927769|594031129|FG001|Induction Phase|Study drug toxicity|1|||
164453605|NCT02927769|594031128|FG000|Induction Phase|Disease progression|0|||
164453606|NCT02927769|594031129|FG001|Induction Phase|Disease progression|1|||
164453607|NCT02927769|594031128|FG000|Intensification Phase|Study drug toxicity|1|||
164453608|NCT02927769|594031129|FG001|Intensification Phase|Study drug toxicity|0|||
164453609|NCT05524233|594031132|FG000|Overall Study|Lost to Follow-up|2|||
164453610|NCT05524233|594031132|FG000|Overall Study|Adverse Event|2|||
164453611|NCT05524233|594031132|FG000|Overall Study|Withdrawal by Subject|1|||
164453612|NCT00650104|594031134|FG000|Overall Study|Adverse Event|17|||
164453613|NCT00650104|594031134|FG000|Overall Study|Death|2|||
164453614|NCT00650104|594031134|FG000|Overall Study|Withdrawal by Subject|11|||
164453615|NCT00650104|594031134|FG000|Overall Study|Physician Decision|7|||
164453616|NCT00650104|594031134|FG000|Overall Study|Lost to Follow-up|1|||
164453617|NCT00650104|594031134|FG000|Overall Study|Non-compliance|2|||
164453618|NCT00650104|594031134|FG000|Overall Study|Sponsor Terminated Dosing|1|||
164453619|NCT03436745|594031135|FG000|Overall Study|Ineligible|0|||
164453620|NCT03436745|594031136|FG001|Overall Study|Ineligible|0|||
164453621|NCT03436745|594031137|FG002|Overall Study|Ineligible|1|||
164453622|NCT00792636|594031138|FG000|Overall Study|Protocol Violation|17|||
164597561|NCT02635737|594549122|FG000|Overall Study|Protocol Violation|1|||
164453623|NCT00792636|594031139|FG001|Overall Study|Protocol Violation|23|||
164453624|NCT00792636|594031140|FG002|Overall Study|Protocol Violation|20|||
164453625|NCT00792636|594031138|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
164597562|NCT00789191|594551190|FG000|Overall Study|Adverse Event|2|||
164453626|NCT00792636|594031139|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
164597563|NCT00789191|594551191|FG001|Overall Study|Adverse Event|4|||
164453627|NCT00792636|594031140|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
164453628|NCT00792636|594031138|FG000|Overall Study|Lost to Follow-up|13|||
164453629|NCT00792636|594031139|FG001|Overall Study|Lost to Follow-up|19|||
164597564|NCT00789191|594551190|FG000|Overall Study|Lack of Efficacy|0|||
164453630|NCT00792636|594031140|FG002|Overall Study|Lost to Follow-up|14|||
164453631|NCT00792636|594031138|FG000|Overall Study|Withdrew Consent|10|||
164453632|NCT00792636|594031139|FG001|Overall Study|Withdrew Consent|13|||
164453633|NCT00792636|594031140|FG002|Overall Study|Withdrew Consent|9|||
164453634|NCT00792636|594031138|FG000|Overall Study|Lack of Efficacy|3|||
164453635|NCT00792636|594031139|FG001|Overall Study|Lack of Efficacy|4|||
164453636|NCT00792636|594031140|FG002|Overall Study|Lack of Efficacy|13|||
164453637|NCT00792636|594031138|FG000|Overall Study|Adverse Event|4|||
164453638|NCT00792636|594031139|FG001|Overall Study|Adverse Event|2|||
164453639|NCT00792636|594031140|FG002|Overall Study|Adverse Event|3|||
164453640|NCT00792636|594031138|FG000|Overall Study|Investigator Discretion|2|||
164453641|NCT00792636|594031139|FG001|Overall Study|Investigator Discretion|0|||
164453642|NCT00792636|594031140|FG002|Overall Study|Investigator Discretion|2|||
164453643|NCT01772472|594031147|FG000|Overall Study|Death|126|||
164453644|NCT01772472|594031148|FG001|Overall Study|Death|94|||
164453645|NCT01772472|594031147|FG000|Overall Study|Lost to Follow-up|51|||
164453646|NCT01772472|594031148|FG001|Overall Study|Lost to Follow-up|50|||
164453647|NCT01772472|594031147|FG000|Overall Study|Other|9|||
164453648|NCT01772472|594031148|FG001|Overall Study|Other|7|||
164453649|NCT01772472|594031147|FG000|Overall Study|Physician Decision|1|||
164453650|NCT01772472|594031148|FG001|Overall Study|Physician Decision|7|||
164453651|NCT01772472|594031147|FG000|Overall Study|Withdrawal by Subject|115|||
164453652|NCT01772472|594031148|FG001|Overall Study|Withdrawal by Subject|90|||
164453653|NCT01772472|594031147|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
164453654|NCT01772472|594031148|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
164597565|NCT00789191|594551191|FG001|Overall Study|Lack of Efficacy|5|||
164597566|NCT00789191|594551190|FG000|Overall Study|Protocol Violation|5|||
164597567|NCT00789191|594551191|FG001|Overall Study|Protocol Violation|3|||
164405685|NCT02220894|593855526|FG001|Overall Study|Site Terminated by Sponsor|0|||
164405686|NCT02220894|593855525|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
164405687|NCT02220894|593855526|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
164405688|NCT02220894|593855525|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164405689|NCT02220894|593855526|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
164405690|NCT02220894|593855525|FG000|Overall Study|Withdrawal by Subject|10|||
164405691|NCT02220894|593855526|FG001|Overall Study|Withdrawal by Subject|9|||
164405692|NCT03217747|593855527|FG000|Overall Study|Adverse Event|0|||
164405693|NCT03217747|593855528|FG001|Overall Study|Adverse Event|1|||
164405694|NCT03217747|593855529|FG002|Overall Study|Adverse Event|0|||
164405695|NCT03217747|593855530|FG003|Overall Study|Adverse Event|0|||
164405696|NCT03217747|593855531|FG004|Overall Study|Adverse Event|0|||
164405697|NCT03217747|593855532|FG005|Overall Study|Adverse Event|0|||
164405698|NCT03217747|593855533|FG006|Overall Study|Adverse Event|0|||
164405699|NCT03217747|593855534|FG007|Overall Study|Adverse Event|0|||
164405700|NCT03217747|593855535|FG008|Overall Study|Adverse Event|0|||
164405701|NCT03217747|593855536|FG009|Overall Study|Adverse Event|0|||
164405702|NCT03217747|593855537|FG010|Overall Study|Adverse Event|0|||
164405703|NCT03217747|593855538|FG011|Overall Study|Adverse Event|0|||
164405704|NCT03217747|593855539|FG012|Overall Study|Adverse Event|1|||
164405705|NCT03217747|593855540|FG013|Overall Study|Adverse Event|1|||
164405706|NCT03217747|593855527|FG000|Overall Study|Death|0|||
164405707|NCT03217747|593855528|FG001|Overall Study|Death|0|||
164405708|NCT03217747|593855529|FG002|Overall Study|Death|0|||
164405709|NCT03217747|593855530|FG003|Overall Study|Death|0|||
164405710|NCT03217747|593855531|FG004|Overall Study|Death|0|||
164405711|NCT03217747|593855532|FG005|Overall Study|Death|0|||
164405712|NCT03217747|593855533|FG006|Overall Study|Death|0|||
164405713|NCT03217747|593855534|FG007|Overall Study|Death|0|||
164405714|NCT03217747|593855535|FG008|Overall Study|Death|1|||
164405715|NCT03217747|593855536|FG009|Overall Study|Death|0|||
164405716|NCT03217747|593855537|FG010|Overall Study|Death|0|||
164405717|NCT03217747|593855538|FG011|Overall Study|Death|0|||
164405718|NCT03217747|593855539|FG012|Overall Study|Death|0|||
164405719|NCT03217747|593855540|FG013|Overall Study|Death|0|||
164405720|NCT03217747|593855527|FG000|Overall Study|Lack of Efficacy|12|||
164405721|NCT03217747|593855528|FG001|Overall Study|Lack of Efficacy|6|||
164405722|NCT03217747|593855529|FG002|Overall Study|Lack of Efficacy|15|||
164405723|NCT03217747|593855530|FG003|Overall Study|Lack of Efficacy|11|||
164405724|NCT03217747|593855531|FG004|Overall Study|Lack of Efficacy|3|||
164405725|NCT03217747|593855532|FG005|Overall Study|Lack of Efficacy|14|||
164405726|NCT03217747|593855533|FG006|Overall Study|Lack of Efficacy|10|||
164405727|NCT03217747|593855534|FG007|Overall Study|Lack of Efficacy|4|||
164405728|NCT03217747|593855535|FG008|Overall Study|Lack of Efficacy|2|||
164405729|NCT03217747|593855536|FG009|Overall Study|Lack of Efficacy|7|||
164405730|NCT03217747|593855537|FG010|Overall Study|Lack of Efficacy|3|||
164453655|NCT04838613|594031149|FG000|Overall Study|Withdrawal by Subject|3|||
164597568|NCT00789191|594551190|FG000|Overall Study|Withdrawal Criteria|2|||
164597569|NCT00789191|594551191|FG001|Overall Study|Withdrawal Criteria|4|||
164405731|NCT03217747|593855538|FG011|Overall Study|Lack of Efficacy|1|||
164453656|NCT04838613|594031150|FG001|Overall Study|Withdrawal by Subject|6|||
164453657|NCT04838613|594031149|FG000|Overall Study|Protocol Deviation|3|||
164453658|NCT04838613|594031150|FG001|Overall Study|Protocol Deviation|2|||
164405732|NCT03217747|593855539|FG012|Overall Study|Lack of Efficacy|3|||
164405733|NCT03217747|593855540|FG013|Overall Study|Lack of Efficacy|1|||
164453659|NCT04838613|594031149|FG000|Overall Study|Technical Problems|0|||
164706777|NCT00616629|594953469|FG003|Overall Study|Protocol Violation|0|||
164706778|NCT00616629|594953470|FG004|Overall Study|Protocol Violation|0|||
164405734|NCT03217747|593855527|FG000|Overall Study|Withdrawal by Subject|2|||
164405735|NCT03217747|593855528|FG001|Overall Study|Withdrawal by Subject|1|||
164405736|NCT03217747|593855529|FG002|Overall Study|Withdrawal by Subject|1|||
164405737|NCT03217747|593855530|FG003|Overall Study|Withdrawal by Subject|1|||
164405738|NCT03217747|593855531|FG004|Overall Study|Withdrawal by Subject|1|||
164405739|NCT03217747|593855532|FG005|Overall Study|Withdrawal by Subject|2|||
164405740|NCT03217747|593855533|FG006|Overall Study|Withdrawal by Subject|1|||
164405741|NCT03217747|593855534|FG007|Overall Study|Withdrawal by Subject|0|||
164405742|NCT03217747|593855535|FG008|Overall Study|Withdrawal by Subject|0|||
164405743|NCT03217747|593855536|FG009|Overall Study|Withdrawal by Subject|0|||
164405744|NCT03217747|593855537|FG010|Overall Study|Withdrawal by Subject|0|||
164405745|NCT03217747|593855538|FG011|Overall Study|Withdrawal by Subject|1|||
164405746|NCT03217747|593855539|FG012|Overall Study|Withdrawal by Subject|0|||
164405747|NCT03217747|593855540|FG013|Overall Study|Withdrawal by Subject|1|||
164405748|NCT03217747|593855527|FG000|Overall Study|Toxicity and progression|1|||
164405749|NCT03217747|593855528|FG001|Overall Study|Toxicity and progression|0|||
164405750|NCT03217747|593855529|FG002|Overall Study|Toxicity and progression|0|||
164405751|NCT03217747|593855530|FG003|Overall Study|Toxicity and progression|0|||
164405752|NCT03217747|593855531|FG004|Overall Study|Toxicity and progression|0|||
164405753|NCT03217747|593855532|FG005|Overall Study|Toxicity and progression|0|||
164405754|NCT03217747|593855533|FG006|Overall Study|Toxicity and progression|0|||
164405755|NCT03217747|593855534|FG007|Overall Study|Toxicity and progression|0|||
164405756|NCT03217747|593855535|FG008|Overall Study|Toxicity and progression|0|||
164405757|NCT03217747|593855536|FG009|Overall Study|Toxicity and progression|0|||
164405758|NCT03217747|593855537|FG010|Overall Study|Toxicity and progression|0|||
164405759|NCT03217747|593855538|FG011|Overall Study|Toxicity and progression|0|||
164405760|NCT03217747|593855539|FG012|Overall Study|Toxicity and progression|0|||
164405761|NCT03217747|593855540|FG013|Overall Study|Toxicity and progression|0|||
164405762|NCT03217747|593855527|FG000|Overall Study|Removal of sole target lesion|1|||
164405763|NCT03217747|593855528|FG001|Overall Study|Removal of sole target lesion|0|||
164405764|NCT03217747|593855529|FG002|Overall Study|Removal of sole target lesion|0|||
164405765|NCT03217747|593855530|FG003|Overall Study|Removal of sole target lesion|0|||
164405766|NCT03217747|593855531|FG004|Overall Study|Removal of sole target lesion|0|||
164405767|NCT03217747|593855532|FG005|Overall Study|Removal of sole target lesion|0|||
164405768|NCT03217747|593855533|FG006|Overall Study|Removal of sole target lesion|0|||
164405769|NCT03217747|593855534|FG007|Overall Study|Removal of sole target lesion|0|||
164405770|NCT03217747|593855535|FG008|Overall Study|Removal of sole target lesion|0|||
164405771|NCT03217747|593855536|FG009|Overall Study|Removal of sole target lesion|0|||
164405772|NCT03217747|593855537|FG010|Overall Study|Removal of sole target lesion|0|||
164405773|NCT03217747|593855538|FG011|Overall Study|Removal of sole target lesion|0|||
164405774|NCT03217747|593855539|FG012|Overall Study|Removal of sole target lesion|0|||
164405775|NCT03217747|593855540|FG013|Overall Study|Removal of sole target lesion|0|||
164405776|NCT03217747|593855527|FG000|Overall Study|Stroke|0|||
164405777|NCT03217747|593855528|FG001|Overall Study|Stroke|0|||
164405778|NCT03217747|593855529|FG002|Overall Study|Stroke|0|||
164405779|NCT03217747|593855530|FG003|Overall Study|Stroke|0|||
164405780|NCT03217747|593855531|FG004|Overall Study|Stroke|0|||
164405781|NCT03217747|593855532|FG005|Overall Study|Stroke|1|||
164405782|NCT03217747|593855533|FG006|Overall Study|Stroke|0|||
164405783|NCT03217747|593855534|FG007|Overall Study|Stroke|0|||
164405784|NCT03217747|593855535|FG008|Overall Study|Stroke|0|||
164405785|NCT03217747|593855536|FG009|Overall Study|Stroke|0|||
164405786|NCT03217747|593855537|FG010|Overall Study|Stroke|0|||
164405787|NCT03217747|593855538|FG011|Overall Study|Stroke|1|||
164405788|NCT03217747|593855539|FG012|Overall Study|Stroke|0|||
164405789|NCT03217747|593855540|FG013|Overall Study|Stroke|0|||
164405790|NCT03248375|593855541|FG000|Overall Study|Lost to Follow-up|5|||
164405791|NCT00394355|593855542|FG000|Overall Study|Adverse Event|10|||
164405792|NCT00394355|593855543|FG001|Overall Study|Adverse Event|6|||
164405793|NCT00394355|593855544|FG002|Overall Study|Adverse Event|7|||
164405794|NCT00394355|593855545|FG003|Overall Study|Adverse Event|8|||
164405795|NCT00394355|593855542|FG000|Overall Study|Did not meet protocol eligibility|1|||
164405796|NCT00394355|593855543|FG001|Overall Study|Did not meet protocol eligibility|5|||
164405797|NCT00394355|593855544|FG002|Overall Study|Did not meet protocol eligibility|4|||
164405798|NCT00394355|593855545|FG003|Overall Study|Did not meet protocol eligibility|2|||
164405799|NCT00394355|593855542|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
164405800|NCT00394355|593855543|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
164405801|NCT00394355|593855544|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
164405802|NCT00394355|593855545|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
164405803|NCT00394355|593855542|FG000|Overall Study|Subject withdrawal - related to drug|1|||
164405804|NCT00394355|593855543|FG001|Overall Study|Subject withdrawal - related to drug|0|||
164405805|NCT00394355|593855544|FG002|Overall Study|Subject withdrawal - related to drug|0|||
164405806|NCT00394355|593855545|FG003|Overall Study|Subject withdrawal - related to drug|0|||
164453660|NCT04838613|594031150|FG001|Overall Study|Technical Problems|5|||
164453661|NCT04838613|594031149|FG000|Overall Study|Physician Decision|2|||
164453662|NCT04838613|594031150|FG001|Overall Study|Physician Decision|0|||
164453663|NCT04757610|594031151|FG000|Overall Study|Adverse Event|13|||
164453664|NCT04757610|594031152|FG001|Overall Study|Adverse Event|10|||
164453665|NCT04757610|594031153|FG002|Overall Study|Adverse Event|5|||
164453666|NCT04757610|594031151|FG000|Overall Study|Death|5|||
164453667|NCT04757610|594031152|FG001|Overall Study|Death|13|||
164453668|NCT04757610|594031153|FG002|Overall Study|Death|8|||
164453669|NCT04757610|594031151|FG000|Overall Study|Lack of Efficacy|1|||
164453670|NCT04757610|594031152|FG001|Overall Study|Lack of Efficacy|2|||
164453671|NCT04757610|594031153|FG002|Overall Study|Lack of Efficacy|3|||
164453672|NCT04757610|594031151|FG000|Overall Study|Lost to Follow-up|7|||
164453673|NCT04757610|594031152|FG001|Overall Study|Lost to Follow-up|2|||
164453674|NCT04757610|594031153|FG002|Overall Study|Lost to Follow-up|7|||
164453675|NCT04757610|594031151|FG000|Overall Study|Physician Decision|4|||
164453676|NCT04757610|594031152|FG001|Overall Study|Physician Decision|1|||
164453677|NCT04757610|594031153|FG002|Overall Study|Physician Decision|2|||
164597570|NCT00789191|594551190|FG000|Overall Study|Unclassified|5|||
164597571|NCT00789191|594551191|FG001|Overall Study|Unclassified|3|||
164597572|NCT01911845|594551205|FG000|Overall Study|Adverse Event|2|||
164597573|NCT01911845|594551205|FG000|Overall Study|Lost to Follow-up|1|||
164597574|NCT01911845|594551205|FG000|Overall Study|Other (not specified)|3|||
164597575|NCT04507867|594551216|FG000|Overall Study|Death|7|||
164597576|NCT04507867|594551217|FG001|Overall Study|Death|1|||
164597577|NCT02175771|594551218|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
164597578|NCT02175771|594551219|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164597579|NCT02175771|594551220|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164597580|NCT02175771|594551221|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164597581|NCT02175771|594551222|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164597582|NCT02175771|594551223|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164597583|NCT02175771|594551224|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164597584|NCT02175771|594551225|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164597585|NCT02175771|594551226|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164597586|NCT02175771|594551218|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
164597587|NCT02175771|594551219|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164597588|NCT02175771|594551220|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164597589|NCT02175771|594551221|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164597590|NCT02175771|594551222|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164597591|NCT02175771|594551223|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164597592|NCT02175771|594551224|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164597593|NCT02175771|594551225|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164597594|NCT02175771|594551226|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164597595|NCT02175771|594551218|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
164597596|NCT02175771|594551219|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164597597|NCT02175771|594551220|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164597598|NCT02175771|594551221|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164597599|NCT02175771|594551222|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164597600|NCT02175771|594551223|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164597601|NCT02175771|594551224|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164597602|NCT02175771|594551225|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164597603|NCT02175771|594551226|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164597604|NCT02175771|594551218|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
164597605|NCT02175771|594551219|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
164597606|NCT02175771|594551220|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
164597607|NCT02175771|594551221|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
164597608|NCT02175771|594551222|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
164597609|NCT02175771|594551223|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
164597610|NCT02175771|594551224|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
164597611|NCT02175771|594551225|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
164597612|NCT02175771|594551226|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
164597613|NCT02175771|594551218|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
164597614|NCT02175771|594551219|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164597615|NCT02175771|594551220|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164597616|NCT02175771|594551221|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164597617|NCT02175771|594551222|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164597618|NCT02175771|594551223|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164597619|NCT02175771|594551224|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164597620|NCT02175771|594551225|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164597621|NCT02175771|594551226|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164597622|NCT02175771|594551218|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
164453678|NCT04757610|594031151|FG000|Overall Study|Withdrawal by Subject|26|||
164453679|NCT04757610|594031152|FG001|Overall Study|Withdrawal by Subject|25|||
164453680|NCT04757610|594031153|FG002|Overall Study|Withdrawal by Subject|25|||
164453681|NCT04757610|594031151|FG000|Overall Study|Study Terminated by Sponsor|105|||
164453682|NCT04757610|594031152|FG001|Overall Study|Study Terminated by Sponsor|105|||
164453683|NCT04757610|594031153|FG002|Overall Study|Study Terminated by Sponsor|110|||
164453684|NCT04757610|594031151|FG000|Overall Study|Randomized in Error|1|||
164453685|NCT04757610|594031152|FG001|Overall Study|Randomized in Error|0|||
164453686|NCT04757610|594031153|FG002|Overall Study|Randomized in Error|0|||
164453687|NCT00951379|594031157|FG000|Overall Study|Adverse Event|4|||
164453688|NCT00951379|594031158|FG001|Overall Study|Adverse Event|1|||
164453689|NCT00951379|594031157|FG000|Overall Study|Withdrawal by Subject|1|||
164453690|NCT00951379|594031158|FG001|Overall Study|Withdrawal by Subject|0|||
164453691|NCT00951379|594031157|FG000|Overall Study|Noncompliance|1|||
164453692|NCT00951379|594031158|FG001|Overall Study|Noncompliance|0|||
164453693|NCT00951379|594031157|FG000|Overall Study|Disease Progression|0|||
164453694|NCT00951379|594031158|FG001|Overall Study|Disease Progression|1|||
164453695|NCT03432858|594031159|FG000|Overall Study|Protocol Violation|2|||
164453696|NCT03432858|594031160|FG001|Overall Study|Protocol Violation|1|||
164453697|NCT03432858|594031161|FG002|Overall Study|Protocol Violation|9|||
164453698|NCT03432858|594031159|FG000|Overall Study|Withdrawal by Subject|0|||
164453699|NCT03432858|594031160|FG001|Overall Study|Withdrawal by Subject|1|||
164453700|NCT03432858|594031161|FG002|Overall Study|Withdrawal by Subject|1|||
164453701|NCT03432858|594031159|FG000|Overall Study|Procedure canceled/rescheduled|0|||
164453702|NCT03432858|594031160|FG001|Overall Study|Procedure canceled/rescheduled|9|||
164453703|NCT03432858|594031161|FG002|Overall Study|Procedure canceled/rescheduled|6|||
164453704|NCT03432858|594031159|FG000|Overall Study|Required postop mobilization with splinting|0|||
164453705|NCT03432858|594031160|FG001|Overall Study|Required postop mobilization with splinting|0|||
164453706|NCT03432858|594031161|FG002|Overall Study|Required postop mobilization with splinting|1|||
164453707|NCT03580369|594031165|FG000|Overall Study|No treatment due to mis-randomization|1|||
164453708|NCT03580369|594031166|FG001|Overall Study|No treatment due to mis-randomization|0|||
164453709|NCT03580369|594031167|FG002|Overall Study|No treatment due to mis-randomization|0|||
164453710|NCT03580369|594031168|FG003|Overall Study|No treatment due to mis-randomization|0|||
164453711|NCT03580369|594031169|FG004|Overall Study|No treatment due to mis-randomization|3|||
164453712|NCT03580369|594031170|FG005|Overall Study|No treatment due to mis-randomization|0|||
164453713|NCT03580369|594031171|FG006|Overall Study|No treatment due to mis-randomization|0|||
164453714|NCT03580369|594031172|FG007|Overall Study|No treatment due to mis-randomization|0|||
164453715|NCT03580369|594031165|FG000|Overall Study|Reason unknown|0|||
164453716|NCT03580369|594031166|FG001|Overall Study|Reason unknown|0|||
164453717|NCT03580369|594031167|FG002|Overall Study|Reason unknown|1|||
164453718|NCT03580369|594031168|FG003|Overall Study|Reason unknown|0|||
164453719|NCT03580369|594031169|FG004|Overall Study|Reason unknown|0|||
164453720|NCT03580369|594031170|FG005|Overall Study|Reason unknown|0|||
164453721|NCT03580369|594031171|FG006|Overall Study|Reason unknown|0|||
164453722|NCT03580369|594031172|FG007|Overall Study|Reason unknown|0|||
164453723|NCT03580369|594031165|FG000|Overall Study|Technical problems|0|||
164453724|NCT03580369|594031166|FG001|Overall Study|Technical problems|0|||
164453725|NCT03580369|594031167|FG002|Overall Study|Technical problems|0|||
164453726|NCT03580369|594031168|FG003|Overall Study|Technical problems|0|||
164453727|NCT03580369|594031169|FG004|Overall Study|Technical problems|1|||
164453728|NCT03580369|594031170|FG005|Overall Study|Technical problems|0|||
164453729|NCT03580369|594031171|FG006|Overall Study|Technical problems|2|||
164453730|NCT03580369|594031172|FG007|Overall Study|Technical problems|0|||
164453731|NCT03580369|594031165|FG000|Overall Study|Pregnancy|2|||
164453732|NCT03580369|594031166|FG001|Overall Study|Pregnancy|0|||
164453733|NCT03580369|594031167|FG002|Overall Study|Pregnancy|3|||
164453734|NCT03580369|594031168|FG003|Overall Study|Pregnancy|0|||
164453735|NCT03580369|594031169|FG004|Overall Study|Pregnancy|2|||
164453736|NCT03580369|594031170|FG005|Overall Study|Pregnancy|0|||
164453737|NCT03580369|594031171|FG006|Overall Study|Pregnancy|0|||
164453738|NCT03580369|594031172|FG007|Overall Study|Pregnancy|0|||
164453739|NCT03580369|594031165|FG000|Overall Study|Lost to Follow-up|2|||
164453740|NCT03580369|594031166|FG001|Overall Study|Lost to Follow-up|0|||
164453741|NCT03580369|594031167|FG002|Overall Study|Lost to Follow-up|2|||
164597623|NCT02175771|594551219|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164597624|NCT02175771|594551220|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164597625|NCT02175771|594551221|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164453742|NCT03580369|594031168|FG003|Overall Study|Lost to Follow-up|0|||
164453743|NCT03580369|594031169|FG004|Overall Study|Lost to Follow-up|3|||
164597626|NCT02175771|594551222|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164453744|NCT03580369|594031170|FG005|Overall Study|Lost to Follow-up|0|||
164453745|NCT03580369|594031171|FG006|Overall Study|Lost to Follow-up|1|||
164453746|NCT03580369|594031172|FG007|Overall Study|Lost to Follow-up|0|||
164453747|NCT03580369|594031165|FG000|Overall Study|Physician Decision|4|||
164453748|NCT03580369|594031166|FG001|Overall Study|Physician Decision|0|||
164453749|NCT03580369|594031167|FG002|Overall Study|Physician Decision|4|||
164453750|NCT03580369|594031168|FG003|Overall Study|Physician Decision|1|||
164453751|NCT03580369|594031169|FG004|Overall Study|Physician Decision|1|||
164453752|NCT03580369|594031170|FG005|Overall Study|Physician Decision|0|||
164453753|NCT03580369|594031171|FG006|Overall Study|Physician Decision|0|||
164453754|NCT03580369|594031172|FG007|Overall Study|Physician Decision|0|||
164453755|NCT03580369|594031165|FG000|Overall Study|Lack of Efficacy|3|||
164453756|NCT03580369|594031166|FG001|Overall Study|Lack of Efficacy|0|||
164453757|NCT03580369|594031167|FG002|Overall Study|Lack of Efficacy|7|||
164453758|NCT03580369|594031168|FG003|Overall Study|Lack of Efficacy|0|||
164453759|NCT03580369|594031169|FG004|Overall Study|Lack of Efficacy|2|||
164453760|NCT03580369|594031170|FG005|Overall Study|Lack of Efficacy|0|||
164453761|NCT03580369|594031171|FG006|Overall Study|Lack of Efficacy|3|||
164453762|NCT03580369|594031172|FG007|Overall Study|Lack of Efficacy|0|||
164453763|NCT03580369|594031165|FG000|Overall Study|Protocol Violation|6|||
164453764|NCT03580369|594031166|FG001|Overall Study|Protocol Violation|0|||
164453765|NCT03580369|594031167|FG002|Overall Study|Protocol Violation|6|||
164453766|NCT03580369|594031168|FG003|Overall Study|Protocol Violation|1|||
164453767|NCT03580369|594031169|FG004|Overall Study|Protocol Violation|8|||
164453768|NCT03580369|594031170|FG005|Overall Study|Protocol Violation|2|||
164453769|NCT03580369|594031171|FG006|Overall Study|Protocol Violation|1|||
164453770|NCT03580369|594031172|FG007|Overall Study|Protocol Violation|0|||
164453771|NCT03580369|594031165|FG000|Overall Study|Adverse Event|7|||
164453772|NCT03580369|594031166|FG001|Overall Study|Adverse Event|0|||
164453773|NCT03580369|594031167|FG002|Overall Study|Adverse Event|14|||
164453774|NCT03580369|594031168|FG003|Overall Study|Adverse Event|1|||
164453775|NCT03580369|594031169|FG004|Overall Study|Adverse Event|6|||
164453776|NCT03580369|594031170|FG005|Overall Study|Adverse Event|0|||
164453777|NCT03580369|594031171|FG006|Overall Study|Adverse Event|1|||
164453778|NCT03580369|594031172|FG007|Overall Study|Adverse Event|0|||
164453779|NCT03580369|594031165|FG000|Overall Study|Withdrawal by Subject|19|||
164453780|NCT03580369|594031166|FG001|Overall Study|Withdrawal by Subject|0|||
164453781|NCT03580369|594031167|FG002|Overall Study|Withdrawal by Subject|17|||
164453782|NCT03580369|594031168|FG003|Overall Study|Withdrawal by Subject|0|||
164453783|NCT03580369|594031169|FG004|Overall Study|Withdrawal by Subject|16|||
164453784|NCT03580369|594031170|FG005|Overall Study|Withdrawal by Subject|1|||
164453785|NCT03580369|594031171|FG006|Overall Study|Withdrawal by Subject|7|||
164453786|NCT03580369|594031172|FG007|Overall Study|Withdrawal by Subject|0|||
164453787|NCT05239039|594031176|FG000|Overall Study|Withdrawal by Subject|0|||
164453788|NCT05239039|594031177|FG001|Overall Study|Withdrawal by Subject|1|||
164453789|NCT03690206|594031178|FG000|Overall Study|Withdrawal by Subject|2|||
164453790|NCT03690206|594031179|FG001|Overall Study|Withdrawal by Subject|0|||
164453791|NCT03690206|594031180|FG002|Overall Study|Withdrawal by Subject|0|||
164453792|NCT03690206|594031178|FG000|Overall Study|ICF withdrawal|2|||
164453793|NCT03690206|594031179|FG001|Overall Study|ICF withdrawal|0|||
164453794|NCT03690206|594031180|FG002|Overall Study|ICF withdrawal|0|||
164453795|NCT03747484|594032430|FG000|Overall Study|Lack of Efficacy|0|||
164453796|NCT03747484|594032431|FG001|Overall Study|Lack of Efficacy|1|||
164453797|NCT03747484|594032432|FG002|Overall Study|Lack of Efficacy|1|||
164453798|NCT03747484|594032433|FG003|Overall Study|Lack of Efficacy|2|||
164453799|NCT03747484|594032434|FG004|Overall Study|Lack of Efficacy|2|||
164453800|NCT03625882|594032436|FG000|Overall Study|Protocol Violation|3|||
164453801|NCT05418296|594032447|FG000|Overall Study|Withdrawal by Subject|4|||
164453802|NCT05418296|594032448|FG001|Overall Study|Withdrawal by Subject|1|||
164453803|NCT03101904|594032449|FG000|Wash Out (10 Days)|Adverse Event|1|||
164597627|NCT02175771|594551223|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164597628|NCT02175771|594551224|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164597629|NCT02175771|594551225|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164597630|NCT02175771|594551226|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164597631|NCT02175771|594551218|FG000|Run-In Period (Pre-assignment)|Other|8|||
164597632|NCT02175771|594551219|FG001|Run-In Period (Pre-assignment)|Other|0|||
164597633|NCT02175771|594551220|FG002|Run-In Period (Pre-assignment)|Other|0|||
164597634|NCT02175771|594551221|FG003|Run-In Period (Pre-assignment)|Other|0|||
164597635|NCT02175771|594551222|FG004|Run-In Period (Pre-assignment)|Other|0|||
164597636|NCT02175771|594551223|FG005|Run-In Period (Pre-assignment)|Other|0|||
164597637|NCT02175771|594551224|FG006|Run-In Period (Pre-assignment)|Other|0|||
164597638|NCT02175771|594551225|FG007|Run-In Period (Pre-assignment)|Other|0|||
164597639|NCT02175771|594551226|FG008|Run-In Period (Pre-assignment)|Other|0|||
164597640|NCT02175771|594551218|FG000|Treatment Period|Adverse Event|0|||
164597641|NCT02175771|594551219|FG001|Treatment Period|Adverse Event|2|||
164597642|NCT02175771|594551220|FG002|Treatment Period|Adverse Event|1|||
164597643|NCT02175771|594551221|FG003|Treatment Period|Adverse Event|1|||
164597644|NCT02175771|594551222|FG004|Treatment Period|Adverse Event|1|||
164597645|NCT02175771|594551223|FG005|Treatment Period|Adverse Event|3|||
164597646|NCT02175771|594551224|FG006|Treatment Period|Adverse Event|2|||
164597647|NCT02175771|594551225|FG007|Treatment Period|Adverse Event|0|||
164453804|NCT03101904|594032450|FG001|Wash Out (10 Days)|Adverse Event|0|||
164453805|NCT03101904|594032449|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
164453806|NCT03101904|594032450|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
164453807|NCT04538417|594032451|FG000|Overall Study|Withdrawal by Subject|2|||
164453808|NCT04703322|594032453|FG000|Overall Study|Ongoing|8|||
164453809|NCT04703322|594032453|FG000|Overall Study|Withdrawal by Subject|1|||
164453810|NCT01180634|594032454|FG000|Overall Study|Adverse Event|4|||
164453811|NCT01180634|594032455|FG001|Overall Study|Adverse Event|1|||
164453812|NCT01180634|594032454|FG000|Overall Study|Miscellaneous|2|||
164453813|NCT01180634|594032455|FG001|Overall Study|Miscellaneous|0|||
164453814|NCT01180634|594032454|FG000|Overall Study|Withdrawal by Subject|4|||
164453815|NCT01180634|594032455|FG001|Overall Study|Withdrawal by Subject|0|||
164453816|NCT04419168|594032456|FG000|Overall Study|Protocol Violation|1|||
164453817|NCT04419168|594032457|FG001|Overall Study|Protocol Violation|1|||
164453818|NCT04419168|594032456|FG000|Overall Study|Lost to Follow-up|7|||
164453819|NCT04419168|594032457|FG001|Overall Study|Lost to Follow-up|7|||
164453820|NCT04419168|594032456|FG000|Overall Study|Missed 6-month Visit|48|||
164453821|NCT04419168|594032457|FG001|Overall Study|Missed 6-month Visit|45|||
164453822|NCT05009251|594032461|FG000|Overall Study|Protocol Violation|100|||
164453823|NCT05009251|594032462|FG001|Overall Study|Protocol Violation|105|||
164453824|NCT05009251|594032463|FG002|Overall Study|Protocol Violation|119|||
164453825|NCT05009251|594032464|FG003|Overall Study|Protocol Violation|120|||
164453826|NCT05009251|594032465|FG004|Overall Study|Protocol Violation|119|||
164453827|NCT05009251|594032461|FG000|Overall Study|Death|25|||
164453828|NCT05009251|594032462|FG001|Overall Study|Death|22|||
164453829|NCT05009251|594032463|FG002|Overall Study|Death|24|||
164453830|NCT05009251|594032464|FG003|Overall Study|Death|19|||
164453831|NCT05009251|594032465|FG004|Overall Study|Death|15|||
164453832|NCT02662062|594032470|FG000|Overall Study|Withdrawal by Subject|1|||
164453833|NCT05249439|594032471|FG000|Overall Study|Withdrawal by Subject|2|||
164453834|NCT05249439|594032472|FG001|Overall Study|Withdrawal by Subject|5|||
164453835|NCT05249439|594032471|FG000|Overall Study|Physician Decision|3|||
164453836|NCT05249439|594032472|FG001|Overall Study|Physician Decision|1|||
164453837|NCT00616967|594032473|FG000|Overall Study|Withdrawal by Subject|0|||
164453838|NCT00616967|594032474|FG001|Overall Study|Withdrawal by Subject|0|||
164453839|NCT00616967|594032475|FG002|Overall Study|Withdrawal by Subject|1|||
164453840|NCT02910583|594032476|FG000|Overall Study|Death|7|||
164453841|NCT02910583|594032477|FG001|Overall Study|Death|3|||
164453842|NCT02910583|594032476|FG000|Overall Study|Lost to Follow-up|1|||
164453843|NCT02910583|594032477|FG001|Overall Study|Lost to Follow-up|0|||
164453844|NCT02910583|594032476|FG000|Overall Study|Withdrawal by Subject|12|||
164453845|NCT02910583|594032477|FG001|Overall Study|Withdrawal by Subject|8|||
164453846|NCT02910583|594032476|FG000|Overall Study|Other, Not Specified|6|||
164453847|NCT02910583|594032477|FG001|Overall Study|Other, Not Specified|3|||
164453848|NCT01331005|594032479|FG000|Overall Study|Lost to Follow-up|2|||
164453849|NCT01331005|594032480|FG001|Overall Study|Lost to Follow-up|1|||
164453850|NCT01331005|594032479|FG000|Overall Study|Withdrawal by Subject|2|||
164453851|NCT01331005|594032480|FG001|Overall Study|Withdrawal by Subject|3|||
164453852|NCT03161379|594032492|FG000|Overall Study|Withdrawal by Subject|4|||
164453853|NCT03161379|594032492|FG000|Overall Study|disease progression during chemotherapy|5|||
164453854|NCT03161379|594032492|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
164453855|NCT03161379|594032492|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
164453856|NCT05021640|594032493|FG000|Overall Study|Lost to Follow-up|0|||
164453857|NCT05021640|594032494|FG001|Overall Study|Lost to Follow-up|0|||
164453858|NCT05021640|594032495|FG002|Overall Study|Lost to Follow-up|0|||
164453859|NCT05021640|594032496|FG003|Overall Study|Lost to Follow-up|0|||
164453860|NCT05021640|594032497|FG004|Overall Study|Lost to Follow-up|1|||
164453861|NCT02307565|594032501|FG000|Overall Study|Adverse Event|3|||
164453862|NCT02307565|594032502|FG001|Overall Study|Adverse Event|2|||
164453863|NCT02307565|594032501|FG000|Overall Study|Withdrawal by Subject|2|||
164453864|NCT02307565|594032502|FG001|Overall Study|Withdrawal by Subject|2|||
164453865|NCT02697136|594032505|FG000|Overall Study|Adverse Event|3|||
164453866|NCT02697136|594032506|FG001|Overall Study|Adverse Event|0|||
164453867|NCT04391894|594032510|FG000|Overall Study|Adverse Event|1|||
164453868|NCT04391894|594032511|FG001|Overall Study|Adverse Event|1|||
164453869|NCT04391894|594032512|FG002|Overall Study|Adverse Event|1|||
164453870|NCT04391894|594032513|FG003|Overall Study|Adverse Event|1|||
164453871|NCT04391894|594032514|FG004|Overall Study|Adverse Event|1|||
164453872|NCT04391894|594032510|FG000|Overall Study|Lost to Follow-up|1|||
164453873|NCT04391894|594032511|FG001|Overall Study|Lost to Follow-up|0|||
164453874|NCT04391894|594032512|FG002|Overall Study|Lost to Follow-up|0|||
164453875|NCT04391894|594032513|FG003|Overall Study|Lost to Follow-up|0|||
164453876|NCT04391894|594032514|FG004|Overall Study|Lost to Follow-up|0|||
164453877|NCT04391894|594032510|FG000|Overall Study|Protocol Violation|0|||
164453878|NCT04391894|594032511|FG001|Overall Study|Protocol Violation|0|||
164453879|NCT04391894|594032512|FG002|Overall Study|Protocol Violation|0|||
164453880|NCT04391894|594032513|FG003|Overall Study|Protocol Violation|1|||
164453881|NCT04391894|594032514|FG004|Overall Study|Protocol Violation|0|||
164453882|NCT04391894|594032510|FG000|Overall Study|Withdrawal by Subject|2|||
164453883|NCT04391894|594032511|FG001|Overall Study|Withdrawal by Subject|0|||
164453884|NCT04391894|594032512|FG002|Overall Study|Withdrawal by Subject|3|||
164453885|NCT04391894|594032513|FG003|Overall Study|Withdrawal by Subject|0|||
164453886|NCT04391894|594032514|FG004|Overall Study|Withdrawal by Subject|1|||
164453887|NCT04391894|594032510|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
164453888|NCT04391894|594032511|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
164453889|NCT04391894|594032512|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
164453890|NCT04391894|594032513|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
164453891|NCT04391894|594032514|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
164453892|NCT02323321|594032518|FG000|Overall Study|Re-Transplant|1|||
164453893|NCT02323321|594032518|FG000|Overall Study|Death|12|||
164453894|NCT00446225|594032519|FG000|Overall Study|Protocol Violation|1|||
164453895|NCT00446225|594032520|FG001|Overall Study|Protocol Violation|0|||
164453896|NCT05633407|594032521|FG000|Overall Study|Physician Decision|2|||
164453897|NCT05633407|594032522|FG001|Overall Study|Physician Decision|0|||
164453898|NCT05633407|594032521|FG000|Overall Study|Adverse Event|1|||
164453899|NCT05633407|594032522|FG001|Overall Study|Adverse Event|0|||
164453900|NCT05633407|594032521|FG000|Overall Study|Withdrawal by Subject|1|||
164453901|NCT05633407|594032522|FG001|Overall Study|Withdrawal by Subject|0|||
164453902|NCT05633407|594032521|FG000|Overall Study|Other|1|||
164453903|NCT05633407|594032522|FG001|Overall Study|Other|1|||
164453904|NCT02500758|594032525|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
164453905|NCT02500758|594032526|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
164453906|NCT02500758|594032525|FG000|Washout (1 Week)|Lost to Follow-up|2|||
164453907|NCT02500758|594032526|FG001|Washout (1 Week)|Lost to Follow-up|2|||
164453908|NCT02500758|594032525|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
164597648|NCT02175771|594551226|FG008|Treatment Period|Adverse Event|1|||
164597649|NCT02175771|594551218|FG000|Treatment Period|Withdrawal by Subject|0|||
164597650|NCT02175771|594551219|FG001|Treatment Period|Withdrawal by Subject|9|||
164597651|NCT02175771|594551220|FG002|Treatment Period|Withdrawal by Subject|3|||
164597652|NCT02175771|594551221|FG003|Treatment Period|Withdrawal by Subject|6|||
164405807|NCT00394355|593855542|FG000|Overall Study|Lost to Follow-up|7|||
164405808|NCT00394355|593855543|FG001|Overall Study|Lost to Follow-up|5|||
164405809|NCT00394355|593855544|FG002|Overall Study|Lost to Follow-up|4|||
164405810|NCT00394355|593855545|FG003|Overall Study|Lost to Follow-up|3|||
164405811|NCT00394355|593855542|FG000|Overall Study|Noncompliance with protocol|4|||
164405812|NCT00394355|593855543|FG001|Overall Study|Noncompliance with protocol|3|||
164405813|NCT00394355|593855544|FG002|Overall Study|Noncompliance with protocol|10|||
164405814|NCT00394355|593855545|FG003|Overall Study|Noncompliance with protocol|8|||
164405815|NCT00394355|593855542|FG000|Overall Study|Administrative|0|||
164405816|NCT00394355|593855543|FG001|Overall Study|Administrative|1|||
164405817|NCT00394355|593855544|FG002|Overall Study|Administrative|1|||
164405818|NCT00394355|593855545|FG003|Overall Study|Administrative|1|||
164405819|NCT00394355|593855542|FG000|Overall Study|Lack of Efficacy|0|||
164405820|NCT00394355|593855543|FG001|Overall Study|Lack of Efficacy|0|||
164405821|NCT00394355|593855544|FG002|Overall Study|Lack of Efficacy|2|||
164405822|NCT00394355|593855545|FG003|Overall Study|Lack of Efficacy|3|||
164405823|NCT02618616|593855548|FG000|Overall Study|Lack of Efficacy|4|||
164405824|NCT02618616|593855549|FG001|Overall Study|Lack of Efficacy|0|||
164405825|NCT02618616|593855548|FG000|Overall Study|Pregnancy|0|||
164405826|NCT02618616|593855549|FG001|Overall Study|Pregnancy|1|||
164405827|NCT02618616|593855548|FG000|Overall Study|Adverse Event|8|||
164405828|NCT02618616|593855549|FG001|Overall Study|Adverse Event|0|||
164405829|NCT02618616|593855548|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
164405830|NCT02618616|593855549|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
164405831|NCT02618616|593855548|FG000|Overall Study|Consent withdrawn by subject|8|||
164405832|NCT02618616|593855549|FG001|Overall Study|Consent withdrawn by subject|5|||
164405833|NCT02618616|593855548|FG000|Overall Study|Lost to Follow-up|0|||
164405834|NCT02618616|593855549|FG001|Overall Study|Lost to Follow-up|1|||
164405835|NCT01951638|593855550|FG000|Treatment Period|Protocol Violation|0|||
164405836|NCT01951638|593855551|FG001|Treatment Period|Protocol Violation|0|||
164405837|NCT01951638|593855552|FG002|Treatment Period|Protocol Violation|0|||
164405838|NCT01951638|593855553|FG003|Treatment Period|Protocol Violation|2|||
164405839|NCT01951638|593855554|FG004|Treatment Period|Protocol Violation|0|||
164405840|NCT01951638|593855550|FG000|Treatment Period|Protocol-driven decision point|1|||
164405841|NCT01951638|593855551|FG001|Treatment Period|Protocol-driven decision point|3|||
164405842|NCT01951638|593855552|FG002|Treatment Period|Protocol-driven decision point|0|||
164405843|NCT01951638|593855553|FG003|Treatment Period|Protocol-driven decision point|0|||
164405844|NCT01951638|593855554|FG004|Treatment Period|Protocol-driven decision point|0|||
164405845|NCT01951638|593855550|FG000|Treatment Period|Logistical difficulties|0|||
164405846|NCT01951638|593855551|FG001|Treatment Period|Logistical difficulties|1|||
164405847|NCT01951638|593855552|FG002|Treatment Period|Logistical difficulties|1|||
164405848|NCT01951638|593855553|FG003|Treatment Period|Logistical difficulties|0|||
164405849|NCT01951638|593855554|FG004|Treatment Period|Logistical difficulties|0|||
164405850|NCT01951638|593855550|FG000|Treatment Period|Withdrawal by Subject|9|||
164405851|NCT01951638|593855551|FG001|Treatment Period|Withdrawal by Subject|6|||
164405852|NCT01951638|593855552|FG002|Treatment Period|Withdrawal by Subject|4|||
164405853|NCT01951638|593855553|FG003|Treatment Period|Withdrawal by Subject|5|||
164405854|NCT01951638|593855554|FG004|Treatment Period|Withdrawal by Subject|4|||
164405855|NCT01951638|593855550|FG000|Treatment Period|Death|0|||
164453909|NCT02500758|594032526|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
164453910|NCT02500758|594032525|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
164453911|NCT02500758|594032526|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
164453912|NCT02500758|594032525|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
164453913|NCT02500758|594032526|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
164453914|NCT00220740|594032527|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
164453915|NCT00220740|594032528|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
164453916|NCT00220740|594032527|FG000|Efficacy Period|Adverse Event|1|||
164453917|NCT00220740|594032528|FG001|Efficacy Period|Adverse Event|1|||
164453918|NCT00220740|594032527|FG000|Efficacy Period|Withdrawal by Subject|1|||
164453919|NCT00220740|594032528|FG001|Efficacy Period|Withdrawal by Subject|0|||
164453920|NCT00220740|594032527|FG000|Efficacy Period|Protocol Violation|1|||
164453921|NCT00220740|594032528|FG001|Efficacy Period|Protocol Violation|0|||
164453922|NCT00220740|594032527|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
164453923|NCT00220740|594032528|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
164453924|NCT01057433|594032529|FG000|Overall Study|Adverse Event|1|||
164453925|NCT04854096|594032532|FG000|Overall Study|Adverse Event|1|||
164453926|NCT04854096|594032533|FG001|Overall Study|Adverse Event|0|||
164453927|NCT04854096|594032532|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
164453928|NCT04854096|594032533|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
164453929|NCT04854096|594032532|FG000|Overall Study|Withdrawal by Subject|1|||
164453930|NCT04854096|594032533|FG001|Overall Study|Withdrawal by Subject|0|||
164453931|NCT04854096|594032532|FG000|Overall Study|Other reasons|1|||
164453932|NCT04854096|594032533|FG001|Overall Study|Other reasons|0|||
164453933|NCT00593489|594032535|FG000|Allocation|did not attend workshop; allocation not|2|||
164453934|NCT00593489|594032536|FG001|Allocation|did not attend workshop; allocation not|1|||
164453935|NCT03930342|594032539|FG000|Overall Study|Lost to Follow-up|70|||
164453936|NCT03930342|594032540|FG001|Overall Study|Lost to Follow-up|77|||
164453937|NCT02742519|594032541|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
164453938|NCT02742519|594032542|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
164453939|NCT02742519|594032543|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
164453940|NCT02742519|594032541|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
164453941|NCT02742519|594032542|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
164453942|NCT02742519|594032543|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
164453943|NCT02742519|594032541|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
164453944|NCT02742519|594032542|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
164453945|NCT02742519|594032543|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
164453946|NCT01011946|594032545|FG000|Overall Study|Transferred to another hospital|2|||
164453947|NCT01011946|594032545|FG000|Overall Study|No pathological lab value|1|||
164453948|NCT03527160|594032547|FG000|Overall Study|No urine collected|13|||
164453949|NCT03527160|594032547|FG000|Overall Study|No clinical serum creatinine collected|6|||
164453950|NCT03527160|594032547|FG000|Overall Study|Did not meet inclusion|2|||
164453951|NCT01721291|594032549|FG000|Overall Study|Withdrawal by Subject|1|||
164453952|NCT01721291|594032550|FG001|Overall Study|Withdrawal by Subject|0|||
164453953|NCT01721291|594032549|FG000|Overall Study|did not like the treatment|1|||
164453954|NCT01721291|594032550|FG001|Overall Study|did not like the treatment|0|||
164453955|NCT01091168|594032551|FG000|Overall Study|Progressive disease|250|||
164453956|NCT01091168|594032552|FG001|Overall Study|Progressive disease|234|||
164453957|NCT01091168|594032551|FG000|Overall Study|Adverse Event|21|||
164453958|NCT01091168|594032552|FG001|Overall Study|Adverse Event|24|||
164453959|NCT01091168|594032551|FG000|Overall Study|Lost to Follow-up|0|||
164453960|NCT01091168|594032552|FG001|Overall Study|Lost to Follow-up|1|||
164453961|NCT01091168|594032551|FG000|Overall Study|Physician, patient's decision, other|27|||
164453962|NCT01091168|594032552|FG001|Overall Study|Physician, patient's decision, other|37|||
164453963|NCT03978637|594032553|FG000|Overall Study|Death|0|||
164453964|NCT03978637|594032554|FG001|Overall Study|Death|2|||
164453965|NCT03978637|594032555|FG002|Overall Study|Death|2|||
164453966|NCT03978637|594032556|FG003|Overall Study|Death|0|||
164453967|NCT03978637|594032553|FG000|Overall Study|Withdrawal by Subject|0|||
164453968|NCT03978637|594032554|FG001|Overall Study|Withdrawal by Subject|0|||
164453969|NCT03978637|594032555|FG002|Overall Study|Withdrawal by Subject|1|||
164453970|NCT03978637|594032556|FG003|Overall Study|Withdrawal by Subject|0|||
164453971|NCT03978637|594032553|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
164453972|NCT03978637|594032554|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
164453973|NCT03978637|594032555|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
164453974|NCT03978637|594032556|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
164453975|NCT01959698|594032557|FG000|Overall Study|Adverse Event|0|||
164597653|NCT02175771|594551222|FG004|Treatment Period|Withdrawal by Subject|2|||
164597654|NCT02175771|594551223|FG005|Treatment Period|Withdrawal by Subject|4|||
164597655|NCT02175771|594551224|FG006|Treatment Period|Withdrawal by Subject|2|||
164453976|NCT01959698|594032558|FG001|Overall Study|Adverse Event|0|||
164453977|NCT01959698|594032559|FG002|Overall Study|Adverse Event|0|||
164453978|NCT01959698|594032560|FG003|Overall Study|Adverse Event|0|||
164453979|NCT01959698|594032561|FG004|Overall Study|Adverse Event|0|||
164453980|NCT01959698|594032562|FG005|Overall Study|Adverse Event|0|||
164453981|NCT01959698|594032563|FG006|Overall Study|Adverse Event|1|||
164453982|NCT01959698|594032557|FG000|Overall Study|Physician Decision|1|||
164453983|NCT01959698|594032558|FG001|Overall Study|Physician Decision|0|||
164453984|NCT01959698|594032559|FG002|Overall Study|Physician Decision|1|||
164453985|NCT01959698|594032560|FG003|Overall Study|Physician Decision|2|||
164453986|NCT01959698|594032561|FG004|Overall Study|Physician Decision|0|||
164453987|NCT01959698|594032562|FG005|Overall Study|Physician Decision|3|||
164453988|NCT01959698|594032563|FG006|Overall Study|Physician Decision|3|||
164453989|NCT05792423|594032564|FG000|Overall Study|Withdrawal by Subject|2|||
164453990|NCT05062265|594034244|FG000|Overall Study|Withdrawal by Subject|1|||
164453991|NCT05062265|594034245|FG001|Overall Study|Withdrawal by Subject|0|||
164453992|NCT06311084|594034249|FG000|Overall Study|Lost to Follow-up|14|||
164453993|NCT04725240|594034250|FG000|Overall Study|Adverse Event|2|||
164453994|NCT00676715|594034253|FG000|Treatment Period (TP)|Adverse Event|0|||
164453995|NCT00676715|594034254|FG001|Treatment Period (TP)|Adverse Event|3|||
164453996|NCT00676715|594034255|FG002|Treatment Period (TP)|Adverse Event|2|||
164453997|NCT00676715|594034256|FG003|Treatment Period (TP)|Adverse Event|2|||
164453998|NCT00676715|594034253|FG000|Treatment Period (TP)|Death|0|||
164453999|NCT00676715|594034254|FG001|Treatment Period (TP)|Death|0|||
164454000|NCT00676715|594034255|FG002|Treatment Period (TP)|Death|1|||
164454001|NCT00676715|594034256|FG003|Treatment Period (TP)|Death|0|||
164454002|NCT00676715|594034253|FG000|Treatment Period (TP)|Failure to return|1|||
164454003|NCT00676715|594034254|FG001|Treatment Period (TP)|Failure to return|0|||
164454004|NCT00676715|594034255|FG002|Treatment Period (TP)|Failure to return|0|||
164597656|NCT02175771|594551225|FG007|Treatment Period|Withdrawal by Subject|9|||
164597657|NCT02175771|594551226|FG008|Treatment Period|Withdrawal by Subject|2|||
164454005|NCT00676715|594034256|FG003|Treatment Period (TP)|Failure to return|0|||
164454006|NCT00676715|594034253|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
164597658|NCT02175771|594551218|FG000|Treatment Period|Noncompliance|0|||
164597659|NCT02175771|594551219|FG001|Treatment Period|Noncompliance|1|||
164597660|NCT02175771|594551220|FG002|Treatment Period|Noncompliance|2|||
164597661|NCT02175771|594551221|FG003|Treatment Period|Noncompliance|0|||
164597662|NCT02175771|594551222|FG004|Treatment Period|Noncompliance|0|||
164597663|NCT02175771|594551223|FG005|Treatment Period|Noncompliance|0|||
164597664|NCT02175771|594551224|FG006|Treatment Period|Noncompliance|0|||
164597665|NCT02175771|594551225|FG007|Treatment Period|Noncompliance|0|||
164597666|NCT02175771|594551226|FG008|Treatment Period|Noncompliance|1|||
164597667|NCT02175771|594551218|FG000|Treatment Period|Protocol Violation|0|||
164597668|NCT02175771|594551219|FG001|Treatment Period|Protocol Violation|0|||
164597669|NCT02175771|594551220|FG002|Treatment Period|Protocol Violation|0|||
164597670|NCT02175771|594551221|FG003|Treatment Period|Protocol Violation|0|||
164597671|NCT02175771|594551222|FG004|Treatment Period|Protocol Violation|0|||
164597672|NCT02175771|594551223|FG005|Treatment Period|Protocol Violation|0|||
164597673|NCT02175771|594551224|FG006|Treatment Period|Protocol Violation|0|||
164597674|NCT02175771|594551225|FG007|Treatment Period|Protocol Violation|1|||
164597675|NCT02175771|594551226|FG008|Treatment Period|Protocol Violation|0|||
164597676|NCT02175771|594551218|FG000|Treatment Period|Disease progression|0|||
164597677|NCT02175771|594551219|FG001|Treatment Period|Disease progression|0|||
164597678|NCT02175771|594551220|FG002|Treatment Period|Disease progression|0|||
164597679|NCT02175771|594551221|FG003|Treatment Period|Disease progression|0|||
164597680|NCT02175771|594551222|FG004|Treatment Period|Disease progression|0|||
164597681|NCT02175771|594551223|FG005|Treatment Period|Disease progression|0|||
164597682|NCT02175771|594551224|FG006|Treatment Period|Disease progression|0|||
164597683|NCT02175771|594551225|FG007|Treatment Period|Disease progression|2|||
164597684|NCT02175771|594551226|FG008|Treatment Period|Disease progression|0|||
164597685|NCT02175771|594551218|FG000|Treatment Period|Lost to Follow-up|0|||
164597686|NCT02175771|594551219|FG001|Treatment Period|Lost to Follow-up|3|||
164597687|NCT02175771|594551220|FG002|Treatment Period|Lost to Follow-up|1|||
164597688|NCT02175771|594551221|FG003|Treatment Period|Lost to Follow-up|3|||
164597689|NCT02175771|594551222|FG004|Treatment Period|Lost to Follow-up|1|||
164597690|NCT02175771|594551223|FG005|Treatment Period|Lost to Follow-up|2|||
164597691|NCT02175771|594551224|FG006|Treatment Period|Lost to Follow-up|1|||
164597692|NCT02175771|594551225|FG007|Treatment Period|Lost to Follow-up|2|||
164597693|NCT02175771|594551226|FG008|Treatment Period|Lost to Follow-up|2|||
164597694|NCT02175771|594551218|FG000|Treatment Period|Lack of Efficacy|0|||
164597695|NCT02175771|594551219|FG001|Treatment Period|Lack of Efficacy|0|||
164597696|NCT02175771|594551220|FG002|Treatment Period|Lack of Efficacy|0|||
164597697|NCT02175771|594551221|FG003|Treatment Period|Lack of Efficacy|0|||
164597698|NCT02175771|594551222|FG004|Treatment Period|Lack of Efficacy|0|||
164597699|NCT02175771|594551223|FG005|Treatment Period|Lack of Efficacy|1|||
164597700|NCT02175771|594551224|FG006|Treatment Period|Lack of Efficacy|0|||
164597701|NCT02175771|594551225|FG007|Treatment Period|Lack of Efficacy|1|||
164597702|NCT02175771|594551226|FG008|Treatment Period|Lack of Efficacy|0|||
164597703|NCT02175771|594551218|FG000|Treatment Period|Other|0|||
164597704|NCT02175771|594551219|FG001|Treatment Period|Other|1|||
164454007|NCT00676715|594034254|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
164454008|NCT00676715|594034255|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
164454009|NCT00676715|594034256|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
164454010|NCT00676715|594034253|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
164454011|NCT00676715|594034254|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
164454012|NCT00676715|594034255|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
164454013|NCT00676715|594034256|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
164454014|NCT00676715|594034253|FG000|Treatment Period (TP)|Withdrew consent|3|||
164454015|NCT00676715|594034254|FG001|Treatment Period (TP)|Withdrew consent|3|||
164454016|NCT00676715|594034255|FG002|Treatment Period (TP)|Withdrew consent|3|||
164454017|NCT00676715|594034256|FG003|Treatment Period (TP)|Withdrew consent|3|||
164454018|NCT00676715|594034253|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
164454019|NCT00676715|594034254|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
164454020|NCT00676715|594034255|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
164454021|NCT00676715|594034256|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
164454022|NCT00676715|594034253|FG000|Treatment Period (TP)|Administrative|0|||
164454023|NCT00676715|594034254|FG001|Treatment Period (TP)|Administrative|0|||
164454024|NCT00676715|594034255|FG002|Treatment Period (TP)|Administrative|0|||
164454025|NCT00676715|594034256|FG003|Treatment Period (TP)|Administrative|1|||
164454026|NCT00676715|594034253|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
164454027|NCT00676715|594034254|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
164454028|NCT00676715|594034255|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
164597705|NCT02175771|594551220|FG002|Treatment Period|Other|0|||
164597706|NCT02175771|594551221|FG003|Treatment Period|Other|3|||
164597707|NCT02175771|594551222|FG004|Treatment Period|Other|1|||
164454029|NCT00676715|594034256|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
164454030|NCT00676715|594034253|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
164454031|NCT00676715|594034254|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
164597708|NCT02175771|594551223|FG005|Treatment Period|Other|0|||
164597709|NCT02175771|594551224|FG006|Treatment Period|Other|0|||
164597710|NCT02175771|594551225|FG007|Treatment Period|Other|2|||
164597711|NCT02175771|594551226|FG008|Treatment Period|Other|0|||
164597712|NCT02504268|594551227|FG000|Overall Study|Adverse Event|18|||
164597713|NCT02504268|594551228|FG001|Overall Study|Adverse Event|8|||
164597714|NCT02504268|594551229|FG002|Overall Study|Adverse Event|14|||
164597715|NCT02504268|594551230|FG003|Overall Study|Adverse Event|0|||
164597716|NCT02504268|594551231|FG004|Overall Study|Adverse Event|0|||
164597717|NCT02504268|594551232|FG005|Overall Study|Adverse Event|0|||
164597718|NCT02504268|594551233|FG006|Overall Study|Adverse Event|0|||
164597719|NCT02504268|594551234|FG007|Overall Study|Adverse Event|0|||
164597720|NCT02504268|594551235|FG008|Overall Study|Adverse Event|0|||
164597721|NCT02504268|594551227|FG000|Overall Study|Withdrawal of Consent|11|||
164597722|NCT02504268|594551228|FG001|Overall Study|Withdrawal of Consent|10|||
164597723|NCT02504268|594551229|FG002|Overall Study|Withdrawal of Consent|3|||
164597724|NCT02504268|594551230|FG003|Overall Study|Withdrawal of Consent|0|||
164597725|NCT02504268|594551231|FG004|Overall Study|Withdrawal of Consent|0|||
164597726|NCT02504268|594551232|FG005|Overall Study|Withdrawal of Consent|0|||
164597727|NCT02504268|594551233|FG006|Overall Study|Withdrawal of Consent|0|||
164597728|NCT02504268|594551234|FG007|Overall Study|Withdrawal of Consent|0|||
164597729|NCT02504268|594551235|FG008|Overall Study|Withdrawal of Consent|0|||
164597730|NCT02504268|594551227|FG000|Overall Study|Pregnancy|2|||
164597731|NCT02504268|594551228|FG001|Overall Study|Pregnancy|0|||
164597732|NCT02504268|594551229|FG002|Overall Study|Pregnancy|0|||
164597733|NCT02504268|594551230|FG003|Overall Study|Pregnancy|0|||
164597734|NCT02504268|594551231|FG004|Overall Study|Pregnancy|0|||
164597735|NCT02504268|594551232|FG005|Overall Study|Pregnancy|0|||
164597736|NCT02504268|594551233|FG006|Overall Study|Pregnancy|0|||
164597737|NCT02504268|594551234|FG007|Overall Study|Pregnancy|0|||
164597738|NCT02504268|594551235|FG008|Overall Study|Pregnancy|0|||
164597739|NCT02504268|594551227|FG000|Overall Study|Lost to Follow-up|3|||
164597740|NCT02504268|594551228|FG001|Overall Study|Lost to Follow-up|6|||
164597741|NCT02504268|594551229|FG002|Overall Study|Lost to Follow-up|4|||
164597742|NCT02504268|594551230|FG003|Overall Study|Lost to Follow-up|0|||
164597743|NCT02504268|594551231|FG004|Overall Study|Lost to Follow-up|0|||
164597744|NCT02504268|594551232|FG005|Overall Study|Lost to Follow-up|0|||
164597745|NCT02504268|594551233|FG006|Overall Study|Lost to Follow-up|0|||
164454032|NCT00676715|594034255|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
164454033|NCT00676715|594034256|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
164597746|NCT02504268|594551234|FG007|Overall Study|Lost to Follow-up|0|||
164597747|NCT02504268|594551235|FG008|Overall Study|Lost to Follow-up|0|||
164597748|NCT02504268|594551227|FG000|Overall Study|Death|1|||
164597749|NCT02504268|594551228|FG001|Overall Study|Death|1|||
164597750|NCT02504268|594551229|FG002|Overall Study|Death|0|||
164597751|NCT02504268|594551230|FG003|Overall Study|Death|0|||
164597752|NCT02504268|594551231|FG004|Overall Study|Death|0|||
164597753|NCT02504268|594551232|FG005|Overall Study|Death|0|||
164597754|NCT02504268|594551233|FG006|Overall Study|Death|0|||
164597755|NCT02504268|594551234|FG007|Overall Study|Death|0|||
164706779|NCT00616629|594953466|FG000|Overall Study|AV-block|1|||
164706780|NCT00616629|594953467|FG001|Overall Study|AV-block|0|||
164706781|NCT00616629|594953468|FG002|Overall Study|AV-block|0|||
164706782|NCT00616629|594953469|FG003|Overall Study|AV-block|0|||
164706783|NCT00616629|594953470|FG004|Overall Study|AV-block|0|||
164706784|NCT01739348|594953471|FG000|Part I (Base Study)|Adverse Event|41|||
164706785|NCT01739348|594953472|FG001|Part I (Base Study)|Adverse Event|52|||
164706786|NCT01739348|594953473|FG002|Part I (Base Study)|Adverse Event|8|||
164706787|NCT01739348|594953474|FG003|Part I (Base Study)|Adverse Event|33|||
164706788|NCT01739348|594953471|FG000|Part I (Base Study)|Death|10|||
164706789|NCT01739348|594953472|FG001|Part I (Base Study)|Death|7|||
164706790|NCT01739348|594953473|FG002|Part I (Base Study)|Death|2|||
164706791|NCT01739348|594953474|FG003|Part I (Base Study)|Death|8|||
164706792|NCT01739348|594953471|FG000|Part I (Base Study)|Lack of Efficacy|3|||
164706793|NCT01739348|594953472|FG001|Part I (Base Study)|Lack of Efficacy|8|||
164706794|NCT01739348|594953473|FG002|Part I (Base Study)|Lack of Efficacy|0|||
164706795|NCT01739348|594953474|FG003|Part I (Base Study)|Lack of Efficacy|7|||
164706796|NCT01739348|594953471|FG000|Part I (Base Study)|Lost to Follow-up|4|||
164597756|NCT02504268|594551235|FG008|Overall Study|Death|0|||
164597757|NCT02504268|594551227|FG000|Overall Study|Subject Request to Discontinue|11|||
164597758|NCT02504268|594551228|FG001|Overall Study|Subject Request to Discontinue|3|||
164597759|NCT02504268|594551229|FG002|Overall Study|Subject Request to Discontinue|6|||
164597760|NCT02504268|594551230|FG003|Overall Study|Subject Request to Discontinue|0|||
164597761|NCT02504268|594551231|FG004|Overall Study|Subject Request to Discontinue|0|||
164597762|NCT02504268|594551232|FG005|Overall Study|Subject Request to Discontinue|0|||
164597763|NCT02504268|594551233|FG006|Overall Study|Subject Request to Discontinue|0|||
164597764|NCT02504268|594551234|FG007|Overall Study|Subject Request to Discontinue|0|||
164597765|NCT02504268|594551235|FG008|Overall Study|Subject Request to Discontinue|0|||
164597766|NCT02504268|594551227|FG000|Overall Study|No Longer Meets Study Criteria|2|||
164597767|NCT02504268|594551228|FG001|Overall Study|No Longer Meets Study Criteria|3|||
164597768|NCT02504268|594551229|FG002|Overall Study|No Longer Meets Study Criteria|0|||
164597769|NCT02504268|594551230|FG003|Overall Study|No Longer Meets Study Criteria|0|||
164597770|NCT02504268|594551231|FG004|Overall Study|No Longer Meets Study Criteria|0|||
164597771|NCT02504268|594551232|FG005|Overall Study|No Longer Meets Study Criteria|0|||
164597772|NCT02504268|594551233|FG006|Overall Study|No Longer Meets Study Criteria|0|||
164597773|NCT02504268|594551234|FG007|Overall Study|No Longer Meets Study Criteria|0|||
164597774|NCT02504268|594551235|FG008|Overall Study|No Longer Meets Study Criteria|0|||
164597775|NCT02504268|594551227|FG000|Overall Study|Lack of Efficacy|11|||
164597776|NCT02504268|594551228|FG001|Overall Study|Lack of Efficacy|35|||
164597777|NCT02504268|594551229|FG002|Overall Study|Lack of Efficacy|9|||
164597778|NCT02504268|594551230|FG003|Overall Study|Lack of Efficacy|0|||
164597779|NCT02504268|594551231|FG004|Overall Study|Lack of Efficacy|0|||
164597780|NCT02504268|594551232|FG005|Overall Study|Lack of Efficacy|0|||
164597781|NCT02504268|594551233|FG006|Overall Study|Lack of Efficacy|0|||
164597782|NCT02504268|594551234|FG007|Overall Study|Lack of Efficacy|0|||
164597783|NCT02504268|594551235|FG008|Overall Study|Lack of Efficacy|0|||
164597784|NCT02504268|594551227|FG000|Overall Study|Poor/Non-Compliance|3|||
164597785|NCT02504268|594551228|FG001|Overall Study|Poor/Non-Compliance|2|||
164597786|NCT02504268|594551229|FG002|Overall Study|Poor/Non-Compliance|3|||
164597787|NCT02504268|594551230|FG003|Overall Study|Poor/Non-Compliance|0|||
164597788|NCT02504268|594551231|FG004|Overall Study|Poor/Non-Compliance|0|||
164597789|NCT02504268|594551232|FG005|Overall Study|Poor/Non-Compliance|0|||
164597790|NCT02504268|594551233|FG006|Overall Study|Poor/Non-Compliance|0|||
164597791|NCT02504268|594551234|FG007|Overall Study|Poor/Non-Compliance|0|||
164597792|NCT02504268|594551235|FG008|Overall Study|Poor/Non-Compliance|0|||
164597793|NCT02504268|594551227|FG000|Overall Study|Not Disclosed|1|||
164597794|NCT02504268|594551228|FG001|Overall Study|Not Disclosed|0|||
164597795|NCT02504268|594551229|FG002|Overall Study|Not Disclosed|2|||
164597796|NCT02504268|594551230|FG003|Overall Study|Not Disclosed|0|||
164597797|NCT02504268|594551231|FG004|Overall Study|Not Disclosed|0|||
164597798|NCT02504268|594551232|FG005|Overall Study|Not Disclosed|0|||
164597799|NCT02504268|594551233|FG006|Overall Study|Not Disclosed|0|||
164597800|NCT02504268|594551234|FG007|Overall Study|Not Disclosed|0|||
164597801|NCT02504268|594551235|FG008|Overall Study|Not Disclosed|0|||
164597802|NCT03198754|594551248|FG000|Overall Study|Withdrawal by Subject|5|||
164597803|NCT03198754|594551249|FG001|Overall Study|Withdrawal by Subject|4|||
164706797|NCT01739348|594953472|FG001|Part I (Base Study)|Lost to Follow-up|2|||
164597804|NCT03198754|594551248|FG000|Overall Study|Lost to Follow-up|4|||
164706798|NCT01739348|594953473|FG002|Part I (Base Study)|Lost to Follow-up|4|||
164706799|NCT01739348|594953474|FG003|Part I (Base Study)|Lost to Follow-up|4|||
164706800|NCT01739348|594953471|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
164597805|NCT03198754|594551249|FG001|Overall Study|Lost to Follow-up|3|||
164597806|NCT03198754|594551248|FG000|Overall Study|Ineligible|2|||
164597807|NCT03198754|594551249|FG001|Overall Study|Ineligible|1|||
164597808|NCT03247413|594551250|FG000|Overall Study|Lost to Follow-up|28|||
164597809|NCT00668200|594551251|FG000|Overall Study|Withdrawal by Subject|2|||
164706801|NCT01739348|594953472|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
164706802|NCT01739348|594953473|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
164454034|NCT00676715|594034253|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
164454035|NCT00676715|594034254|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
164454036|NCT00676715|594034255|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
164454037|NCT00676715|594034256|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
164454038|NCT00676715|594034253|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
164454039|NCT00676715|594034254|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
164454040|NCT00676715|594034255|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
164454041|NCT00676715|594034256|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
164454042|NCT00676715|594034253|FG000|Treatment-free Period (TFP)|Death|1|||
164454043|NCT00676715|594034254|FG001|Treatment-free Period (TFP)|Death|1|||
164454044|NCT00676715|594034255|FG002|Treatment-free Period (TFP)|Death|1|||
164454045|NCT00676715|594034256|FG003|Treatment-free Period (TFP)|Death|0|||
164454046|NCT00676715|594034253|FG000|Open Label Extension (OLE)|Reason not provided|3|||
164454047|NCT00676715|594034254|FG001|Open Label Extension (OLE)|Reason not provided|4|||
164454048|NCT00676715|594034255|FG002|Open Label Extension (OLE)|Reason not provided|1|||
164454049|NCT00676715|594034256|FG003|Open Label Extension (OLE)|Reason not provided|4|||
164454050|NCT00676715|594034253|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
164454051|NCT00676715|594034254|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
164454052|NCT00676715|594034255|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
164454053|NCT00676715|594034256|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
164454054|NCT00676715|594034253|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
164454055|NCT00676715|594034254|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
164454056|NCT00676715|594034255|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
164454057|NCT00676715|594034256|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
164454058|NCT00676715|594034253|FG000|Open Label Extension (OLE)|Adverse Event|0|||
164454059|NCT00676715|594034254|FG001|Open Label Extension (OLE)|Adverse Event|3|||
164454060|NCT00676715|594034255|FG002|Open Label Extension (OLE)|Adverse Event|1|||
164454061|NCT00676715|594034256|FG003|Open Label Extension (OLE)|Adverse Event|0|||
164454062|NCT00676715|594034253|FG000|Open Label Extension (OLE)|Death|2|||
164454063|NCT00676715|594034254|FG001|Open Label Extension (OLE)|Death|0|||
164454064|NCT00676715|594034255|FG002|Open Label Extension (OLE)|Death|2|||
164454065|NCT00676715|594034256|FG003|Open Label Extension (OLE)|Death|2|||
164454066|NCT03393975|594034258|FG000|Urgent Treatment Period|Physician Decision|0|||
164454067|NCT03393975|594034259|FG001|Urgent Treatment Period|Physician Decision|0|||
164454068|NCT03393975|594034260|FG002|Urgent Treatment Period|Physician Decision|0|||
164454069|NCT03393975|594034261|FG003|Urgent Treatment Period|Physician Decision|1|||
164454070|NCT03393975|594034258|FG000|Prophylaxis Period 1|Reason not Specified|0|||
164454071|NCT03393975|594034259|FG001|Prophylaxis Period 1|Reason not Specified|1|||
164454072|NCT03393975|594034260|FG002|Prophylaxis Period 1|Reason not Specified|0|||
164454073|NCT03393975|594034261|FG003|Prophylaxis Period 1|Reason not Specified|0|||
164454074|NCT03393975|594034258|FG000|Prophylaxis Period 2|Reason not Specified|0|||
164454075|NCT03393975|594034259|FG001|Prophylaxis Period 2|Reason not Specified|1|||
164454076|NCT03393975|594034260|FG002|Prophylaxis Period 2|Reason not Specified|0|||
164454077|NCT03393975|594034261|FG003|Prophylaxis Period 2|Reason not Specified|0|||
164454078|NCT03779204|594034262|FG000|Overall Study|Lost to Follow-up|2|||
164454079|NCT03779204|594034263|FG001|Overall Study|Lost to Follow-up|0|||
164454080|NCT03090152|594034264|FG000|Overall Study|Withdrawal by Subject|0|||
164454081|NCT03090152|594034265|FG001|Overall Study|Withdrawal by Subject|2|||
164454082|NCT03090152|594034266|FG002|Overall Study|Withdrawal by Subject|1|||
164454083|NCT03090152|594034264|FG000|Overall Study|Surgery Canceled|1|||
164454084|NCT03090152|594034265|FG001|Overall Study|Surgery Canceled|0|||
164454085|NCT03090152|594034266|FG002|Overall Study|Surgery Canceled|0|||
164454086|NCT03090152|594034264|FG000|Overall Study|Epidural catheter could not be placed|0|||
164454087|NCT03090152|594034265|FG001|Overall Study|Epidural catheter could not be placed|2|||
164454088|NCT03090152|594034266|FG002|Overall Study|Epidural catheter could not be placed|0|||
164454089|NCT03958955|594034267|FG000|Overall Study|Adverse Event|1|||
164454090|NCT04088630|594034268|FG000|Overall Study|Lost to Follow-up|3|||
164454091|NCT04088630|594034269|FG001|Overall Study|Lost to Follow-up|2|||
164454092|NCT04088630|594034270|FG002|Overall Study|Lost to Follow-up|6|||
164454093|NCT04088630|594034268|FG000|Overall Study|Death|3|||
164454094|NCT04088630|594034269|FG001|Overall Study|Death|1|||
164454095|NCT04088630|594034270|FG002|Overall Study|Death|1|||
164454096|NCT04088630|594034268|FG000|Overall Study|Physician Decision|0|||
164454097|NCT04088630|594034269|FG001|Overall Study|Physician Decision|1|||
164454098|NCT04088630|594034270|FG002|Overall Study|Physician Decision|1|||
164454099|NCT03315754|594034271|FG000|Overall Study|COVID-19 complications leading to death|1|||
164454100|NCT03315754|594034271|FG000|Overall Study|insurance coverage issue|1|||
164454101|NCT02954341|594034272|FG000|Overall Study|Attempted Implant unsuccessful|5|||
164454102|NCT02954341|594034272|FG000|Overall Study|Death|90|||
164454103|NCT02954341|594034272|FG000|Overall Study|Withdrawal by Subject|4|||
164454104|NCT02954341|594034272|FG000|Overall Study|Physician Decision|13|||
164454105|NCT02954341|594034272|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
164454106|NCT02954341|594034272|FG000|Overall Study|Not implanted due to physician's decision|1|||
164454107|NCT02954341|594034272|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
164454108|NCT05227209|594034273|FG000|Overall Study|Adverse Event|11|||
164454109|NCT05227209|594034273|FG000|Overall Study|Lost to Follow-up|1|||
164454110|NCT05227209|594034273|FG000|Overall Study|Withdrawal by Subject|7|||
164454111|NCT05227209|594034273|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
164454112|NCT05633953|594034274|FG000|Overall Study|Adverse Event|7|||
164454113|NCT05633953|594034274|FG000|Overall Study|Death|30|||
164454114|NCT05633953|594034274|FG000|Overall Study|Lost to Follow-up|1|||
164454115|NCT05633953|594034274|FG000|Overall Study|Osilodrostat discontinued|4|||
164454116|NCT05633953|594034274|FG000|Overall Study|Physician Decision|1|||
164454117|NCT05633953|594034274|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
164454118|NCT05633953|594034274|FG000|Overall Study|Progressive disease|2|||
164454119|NCT04245501|594034278|FG000|Overall Study|Adverse Event|2|||
164454120|NCT04245501|594034279|FG001|Overall Study|Adverse Event|0|||
164454121|NCT04245501|594034278|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
164454122|NCT04245501|594034279|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
164454123|NCT05337748|594034285|FG000|Overall Study|Withdrawal by Subject|1|||
164454124|NCT05337748|594034286|FG001|Overall Study|Withdrawal by Subject|0|||
164454125|NCT05337748|594034285|FG000|Overall Study|Death|1|||
164454126|NCT05337748|594034286|FG001|Overall Study|Death|0|||
164454127|NCT02506959|594034287|FG000|Overall Study|Physician Decision|2|||
164454128|NCT02506959|594034288|FG001|Overall Study|Physician Decision|1|||
164454129|NCT03453619|594034290|FG000|Core Study (Part A)|Physician Decision|0|||
164454130|NCT03453619|594034291|FG001|Core Study (Part A)|Physician Decision|0|||
164454131|NCT03453619|594034292|FG002|Core Study (Part A)|Physician Decision|2|||
164454132|NCT03453619|594034293|FG003|Core Study (Part A)|Physician Decision|0|||
164454133|NCT03453619|594034290|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
164454134|NCT03453619|594034291|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
164454135|NCT03453619|594034292|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
164454136|NCT03453619|594034293|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
164454137|NCT03453619|594034290|FG000|Core Study (Part A)|Other|0|||
164454138|NCT03453619|594034291|FG001|Core Study (Part A)|Other|1|||
164454139|NCT03453619|594034292|FG002|Core Study (Part A)|Other|0|||
164454140|NCT03453619|594034293|FG003|Core Study (Part A)|Other|0|||
164454141|NCT03453619|594034290|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
164454142|NCT03453619|594034291|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
164454143|NCT03453619|594034292|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
164454144|NCT03453619|594034293|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
164454145|NCT03453619|594034290|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
164454146|NCT03453619|594034291|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
164454147|NCT03453619|594034292|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
164454148|NCT03453619|594034293|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
164454149|NCT03453619|594034290|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
164454150|NCT03453619|594034291|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
164454151|NCT03453619|594034292|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
164454152|NCT03453619|594034293|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
164454153|NCT03453619|594034290|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
164454154|NCT03453619|594034291|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
164454155|NCT03453619|594034292|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
164454156|NCT03453619|594034293|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
164454157|NCT04089371|594034296|FG000|Overall Study|Withdrawal by Subject|0|||
164454158|NCT04089371|594034297|FG001|Overall Study|Withdrawal by Subject|1|||
164454159|NCT04089371|594034296|FG000|Overall Study|Study terminated early|0|||
164454160|NCT04089371|594034297|FG001|Overall Study|Study terminated early|9|||
164454161|NCT04541706|594034298|FG000|Overall Study|Withdrawal by Subject|3|||
164454162|NCT04541706|594034298|FG000|Overall Study|Progressive disease|33|||
164454163|NCT04541706|594034298|FG000|Overall Study|Physician Decision|1|||
164454164|NCT04541706|594034298|FG000|Overall Study|Lost to Follow-up|2|||
164454165|NCT04541706|594034298|FG000|Overall Study|Death|5|||
164454166|NCT04541706|594034298|FG000|Overall Study|Adverse Event|1|||
164454167|NCT05536440|594034299|FG000|Overall Study|Adverse Event|0|||
164454168|NCT05536440|594034300|FG001|Overall Study|Adverse Event|0|||
164454169|NCT05536440|594034301|FG002|Overall Study|Adverse Event|0|||
164454170|NCT05536440|594034302|FG003|Overall Study|Adverse Event|0|||
164454171|NCT05536440|594034303|FG004|Overall Study|Adverse Event|0|||
164454172|NCT05536440|594034304|FG005|Overall Study|Adverse Event|0|||
164454173|NCT05536440|594034305|FG006|Overall Study|Adverse Event|0|||
164454174|NCT05536440|594034306|FG007|Overall Study|Adverse Event|0|||
164454175|NCT05536440|594034307|FG008|Overall Study|Adverse Event|1|||
164454176|NCT01566695|594034308|FG000|Overall Study|Lack of Efficacy|1|||
164454177|NCT01566695|594034309|FG001|Overall Study|Lack of Efficacy|0|||
164454178|NCT01566695|594034308|FG000|Overall Study|Adverse Event|3|||
164454179|NCT01566695|594034309|FG001|Overall Study|Adverse Event|0|||
164454180|NCT01566695|594034308|FG000|Overall Study|Death|79|||
164454181|NCT01566695|594034309|FG001|Overall Study|Death|86|||
164454182|NCT01566695|594034308|FG000|Overall Study|Withdrawal by Subject|13|||
164454183|NCT01566695|594034309|FG001|Overall Study|Withdrawal by Subject|12|||
164454184|NCT01566695|594034308|FG000|Overall Study|Lost to Follow-up|0|||
164706803|NCT01739348|594953474|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
164706804|NCT01739348|594953471|FG000|Part I (Base Study)|Physician Decision|10|||
164706805|NCT01739348|594953472|FG001|Part I (Base Study)|Physician Decision|7|||
164706806|NCT01739348|594953473|FG002|Part I (Base Study)|Physician Decision|1|||
164405856|NCT01951638|593855551|FG001|Treatment Period|Death|0|||
164405857|NCT01951638|593855552|FG002|Treatment Period|Death|0|||
164405858|NCT01951638|593855553|FG003|Treatment Period|Death|3|||
164405859|NCT01951638|593855554|FG004|Treatment Period|Death|1|||
164405860|NCT01951638|593855550|FG000|Treatment Period|Adverse Event|3|||
164405861|NCT01951638|593855551|FG001|Treatment Period|Adverse Event|4|||
164405862|NCT01951638|593855552|FG002|Treatment Period|Adverse Event|8|||
164405863|NCT01951638|593855553|FG003|Treatment Period|Adverse Event|6|||
164405864|NCT01951638|593855554|FG004|Treatment Period|Adverse Event|5|||
164405865|NCT01951638|593855550|FG000|Follow-up Period|Protocol Violation|0|||
164405866|NCT01951638|593855551|FG001|Follow-up Period|Protocol Violation|0|||
164405867|NCT01951638|593855552|FG002|Follow-up Period|Protocol Violation|0|||
164405868|NCT01951638|593855553|FG003|Follow-up Period|Protocol Violation|1|||
164405869|NCT01951638|593855554|FG004|Follow-up Period|Protocol Violation|0|||
164405870|NCT01951638|593855550|FG000|Follow-up Period|Logistical difficulties|0|||
164405871|NCT01951638|593855551|FG001|Follow-up Period|Logistical difficulties|2|||
164405872|NCT01951638|593855552|FG002|Follow-up Period|Logistical difficulties|0|||
164405873|NCT01951638|593855553|FG003|Follow-up Period|Logistical difficulties|0|||
164405874|NCT01951638|593855554|FG004|Follow-up Period|Logistical difficulties|1|||
164405875|NCT01951638|593855550|FG000|Follow-up Period|Withdrawal by Subject|1|||
164405876|NCT01951638|593855551|FG001|Follow-up Period|Withdrawal by Subject|5|||
164405877|NCT01951638|593855552|FG002|Follow-up Period|Withdrawal by Subject|2|||
164405878|NCT01951638|593855553|FG003|Follow-up Period|Withdrawal by Subject|1|||
164405879|NCT01951638|593855554|FG004|Follow-up Period|Withdrawal by Subject|2|||
164405880|NCT01951638|593855550|FG000|Follow-up Period|Lost to Follow-up|0|||
164405881|NCT01951638|593855551|FG001|Follow-up Period|Lost to Follow-up|1|||
164405882|NCT01951638|593855552|FG002|Follow-up Period|Lost to Follow-up|0|||
164405883|NCT01951638|593855553|FG003|Follow-up Period|Lost to Follow-up|1|||
164405884|NCT01951638|593855554|FG004|Follow-up Period|Lost to Follow-up|0|||
164405885|NCT01951638|593855550|FG000|Follow-up Period|Death|1|||
164405886|NCT01951638|593855551|FG001|Follow-up Period|Death|0|||
164405887|NCT01951638|593855552|FG002|Follow-up Period|Death|1|||
164405888|NCT01951638|593855553|FG003|Follow-up Period|Death|4|||
164405889|NCT01951638|593855554|FG004|Follow-up Period|Death|1|||
164405890|NCT01951638|593855550|FG000|Follow-up Period|Adverse Event|0|||
164405891|NCT01951638|593855551|FG001|Follow-up Period|Adverse Event|1|||
164405892|NCT01951638|593855552|FG002|Follow-up Period|Adverse Event|2|||
164405893|NCT01951638|593855553|FG003|Follow-up Period|Adverse Event|1|||
164405894|NCT01951638|593855554|FG004|Follow-up Period|Adverse Event|1|||
164405895|NCT00459342|593855555|FG000|Overall Study|Not eligible|1|||
164405896|NCT00558064|593855556|FG000|Overall Study|Adverse Event|3|||
164405897|NCT00558064|593855557|FG001|Overall Study|Adverse Event|2|||
164405898|NCT00558064|593855556|FG000|Overall Study|Lack of Efficacy|0|||
164405899|NCT00558064|593855557|FG001|Overall Study|Lack of Efficacy|1|||
164405900|NCT00558064|593855556|FG000|Overall Study|Protocol Violation|1|||
164405901|NCT00558064|593855557|FG001|Overall Study|Protocol Violation|0|||
164405902|NCT00558064|593855556|FG000|Overall Study|Lost to Follow-up|0|||
164405903|NCT00558064|593855557|FG001|Overall Study|Lost to Follow-up|1|||
164405904|NCT00558064|593855556|FG000|Overall Study|Withdrawal by Subject|0|||
164405905|NCT00558064|593855557|FG001|Overall Study|Withdrawal by Subject|1|||
164405906|NCT00558064|593855556|FG000|Overall Study|No visit within allowance period|1|||
164405907|NCT00558064|593855557|FG001|Overall Study|No visit within allowance period|0|||
164405908|NCT02027402|593855558|FG000|Overall Study|Withdrawal by Subject|4|||
164405909|NCT02027402|593855559|FG001|Overall Study|Withdrawal by Subject|1|||
164405910|NCT04108000|593855562|FG000|Overall Study|Death of patient|1|||
164405911|NCT04108000|593855563|FG001|Overall Study|Death of patient|0|||
164405912|NCT04108000|593855564|FG002|Overall Study|Death of patient|1|||
164706807|NCT01739348|594953474|FG003|Part I (Base Study)|Physician Decision|4|||
164405913|NCT04108000|593855565|FG003|Overall Study|Death of patient|0|||
164405914|NCT04108000|593855562|FG000|Overall Study|Withdrawal by Subject|2|||
164405915|NCT04108000|593855563|FG001|Overall Study|Withdrawal by Subject|2|||
164405916|NCT04108000|593855564|FG002|Overall Study|Withdrawal by Subject|0|||
164405917|NCT04108000|593855565|FG003|Overall Study|Withdrawal by Subject|0|||
164405918|NCT04108000|593855562|FG000|Overall Study|Death of surrogate partner|0|||
164405919|NCT04108000|593855563|FG001|Overall Study|Death of surrogate partner|1|||
164405920|NCT04108000|593855564|FG002|Overall Study|Death of surrogate partner|0|||
164405921|NCT04108000|593855565|FG003|Overall Study|Death of surrogate partner|1|||
164405922|NCT03904043|593855566|FG000|Overall Study|Adverse Event|1|||
164405923|NCT03904043|593855567|FG001|Overall Study|Adverse Event|1|||
164405924|NCT03904043|593855566|FG000|Overall Study|Withdrawal by Subject|1|||
164405925|NCT03904043|593855567|FG001|Overall Study|Withdrawal by Subject|0|||
164405926|NCT03904043|593855566|FG000|Overall Study|Non-compliance|1|||
164405927|NCT03904043|593855567|FG001|Overall Study|Non-compliance|0|||
164405928|NCT03904043|593855566|FG000|Overall Study|Did not start treatment|1|||
164454185|NCT01566695|594034309|FG001|Overall Study|Lost to Follow-up|3|||
164405929|NCT03904043|593855567|FG001|Overall Study|Did not start treatment|0|||
164405930|NCT05002218|593855575|FG000|Overall Study|Lost to Follow-up|5|||
164405931|NCT05002218|593855576|FG001|Overall Study|Lost to Follow-up|6|||
164405932|NCT03779906|593855577|FG000|Overall Study|Lost to Follow-up|7|||
164405933|NCT03779906|593855577|FG000|Overall Study|COVID pandemic|1|||
164405934|NCT03421808|593855578|FG000|Overall Study|COVID related problems|2|||
164405935|NCT03421808|593855579|FG001|Overall Study|COVID related problems|0|||
164405936|NCT03421808|593855578|FG000|Overall Study|Withdrawal by Subject|1|||
164405937|NCT03421808|593855579|FG001|Overall Study|Withdrawal by Subject|0|||
164405938|NCT03421808|593855578|FG000|Overall Study|Protocol Violation|0|||
164405939|NCT03421808|593855579|FG001|Overall Study|Protocol Violation|1|||
164405940|NCT03764774|593855580|FG000|Overall Study|Withdrawal by Subject|0|||
164405941|NCT03764774|593855581|FG001|Overall Study|Withdrawal by Subject|0|||
164405942|NCT03764774|593855582|FG002|Overall Study|Withdrawal by Subject|0|||
164405943|NCT03764774|593855583|FG003|Overall Study|Withdrawal by Subject|0|||
164405944|NCT03764774|593855584|FG004|Overall Study|Withdrawal by Subject|0|||
164405945|NCT03764774|593855585|FG005|Overall Study|Withdrawal by Subject|0|||
164405946|NCT03764774|593855586|FG006|Overall Study|Withdrawal by Subject|0|||
164405947|NCT03764774|593855587|FG007|Overall Study|Withdrawal by Subject|0|||
164405948|NCT03764774|593855588|FG008|Overall Study|Withdrawal by Subject|0|||
164405949|NCT03764774|593855589|FG009|Overall Study|Withdrawal by Subject|0|||
164405950|NCT03764774|593855590|FG010|Overall Study|Withdrawal by Subject|1|||
164405951|NCT03764774|593855591|FG011|Overall Study|Withdrawal by Subject|0|||
164405952|NCT03764774|593855592|FG012|Overall Study|Withdrawal by Subject|0|||
164405953|NCT03764774|593855593|FG013|Overall Study|Withdrawal by Subject|0|||
164405954|NCT03764774|593855580|FG000|Overall Study|Adverse Event|0|||
164405955|NCT03764774|593855581|FG001|Overall Study|Adverse Event|0|||
164405956|NCT03764774|593855582|FG002|Overall Study|Adverse Event|0|||
164405957|NCT03764774|593855583|FG003|Overall Study|Adverse Event|0|||
164405958|NCT03764774|593855584|FG004|Overall Study|Adverse Event|0|||
164405959|NCT03764774|593855585|FG005|Overall Study|Adverse Event|0|||
164405960|NCT03764774|593855586|FG006|Overall Study|Adverse Event|0|||
164405961|NCT03764774|593855587|FG007|Overall Study|Adverse Event|0|||
164405962|NCT03764774|593855588|FG008|Overall Study|Adverse Event|0|||
164405963|NCT03764774|593855589|FG009|Overall Study|Adverse Event|0|||
164405964|NCT03764774|593855590|FG010|Overall Study|Adverse Event|0|||
164405965|NCT03764774|593855591|FG011|Overall Study|Adverse Event|0|||
164405966|NCT03764774|593855592|FG012|Overall Study|Adverse Event|2|||
164405967|NCT03764774|593855593|FG013|Overall Study|Adverse Event|0|||
164405968|NCT03764774|593855580|FG000|Overall Study|Lost to Follow-up|0|||
164405969|NCT03764774|593855581|FG001|Overall Study|Lost to Follow-up|0|||
164405970|NCT03764774|593855582|FG002|Overall Study|Lost to Follow-up|0|||
164405971|NCT03764774|593855583|FG003|Overall Study|Lost to Follow-up|0|||
164405972|NCT03764774|593855584|FG004|Overall Study|Lost to Follow-up|0|||
164405973|NCT03764774|593855585|FG005|Overall Study|Lost to Follow-up|0|||
164405974|NCT03764774|593855586|FG006|Overall Study|Lost to Follow-up|0|||
164405975|NCT03764774|593855587|FG007|Overall Study|Lost to Follow-up|0|||
164405976|NCT03764774|593855588|FG008|Overall Study|Lost to Follow-up|0|||
164405977|NCT03764774|593855589|FG009|Overall Study|Lost to Follow-up|0|||
164405978|NCT03764774|593855590|FG010|Overall Study|Lost to Follow-up|0|||
164405979|NCT03764774|593855591|FG011|Overall Study|Lost to Follow-up|0|||
164405980|NCT03764774|593855592|FG012|Overall Study|Lost to Follow-up|0|||
164405981|NCT03764774|593855593|FG013|Overall Study|Lost to Follow-up|1|||
164405982|NCT03764774|593855580|FG000|Overall Study|Physician Decision|0|||
164405983|NCT03764774|593855581|FG001|Overall Study|Physician Decision|0|||
164405984|NCT03764774|593855582|FG002|Overall Study|Physician Decision|0|||
164405985|NCT03764774|593855583|FG003|Overall Study|Physician Decision|0|||
164405986|NCT03764774|593855584|FG004|Overall Study|Physician Decision|0|||
164405987|NCT03764774|593855585|FG005|Overall Study|Physician Decision|0|||
164405988|NCT03764774|593855586|FG006|Overall Study|Physician Decision|0|||
164405989|NCT03764774|593855587|FG007|Overall Study|Physician Decision|0|||
164405990|NCT03764774|593855588|FG008|Overall Study|Physician Decision|0|||
164405991|NCT03764774|593855589|FG009|Overall Study|Physician Decision|4|||
164454186|NCT01566695|594034308|FG000|Overall Study|Other reasons|11|||
164454187|NCT01566695|594034309|FG001|Overall Study|Other reasons|8|||
164454188|NCT04812535|594034321|FG000|Overall Study|Withdrawal by Subject|0|||
164405992|NCT03764774|593855590|FG010|Overall Study|Physician Decision|1|||
164405993|NCT03764774|593855591|FG011|Overall Study|Physician Decision|4|||
164405994|NCT03764774|593855592|FG012|Overall Study|Physician Decision|9|||
164405995|NCT03764774|593855593|FG013|Overall Study|Physician Decision|0|||
164405996|NCT03764774|593855580|FG000|Overall Study|Study Termination|0|||
164405997|NCT03764774|593855581|FG001|Overall Study|Study Termination|0|||
164405998|NCT03764774|593855582|FG002|Overall Study|Study Termination|0|||
164405999|NCT03764774|593855583|FG003|Overall Study|Study Termination|0|||
164406000|NCT03764774|593855584|FG004|Overall Study|Study Termination|0|||
164406001|NCT03764774|593855585|FG005|Overall Study|Study Termination|0|||
164406002|NCT03764774|593855586|FG006|Overall Study|Study Termination|0|||
164406003|NCT03764774|593855587|FG007|Overall Study|Study Termination|0|||
164406004|NCT03764774|593855588|FG008|Overall Study|Study Termination|0|||
164454189|NCT04812535|594034322|FG001|Overall Study|Withdrawal by Subject|0|||
164454190|NCT04812535|594034323|FG002|Overall Study|Withdrawal by Subject|0|||
164706808|NCT01739348|594953471|FG000|Part I (Base Study)|Protocol Violation|2|||
164706809|NCT01739348|594953472|FG001|Part I (Base Study)|Protocol Violation|0|||
164706810|NCT01739348|594953473|FG002|Part I (Base Study)|Protocol Violation|1|||
164706811|NCT01739348|594953474|FG003|Part I (Base Study)|Protocol Violation|2|||
164706812|NCT01739348|594953471|FG000|Part I (Base Study)|Screen Failure|2|||
164706813|NCT01739348|594953472|FG001|Part I (Base Study)|Screen Failure|0|||
164706814|NCT01739348|594953473|FG002|Part I (Base Study)|Screen Failure|0|||
164706815|NCT01739348|594953474|FG003|Part I (Base Study)|Screen Failure|0|||
164706816|NCT01739348|594953471|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
164706817|NCT01739348|594953472|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
164706818|NCT01739348|594953473|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
164706819|NCT01739348|594953474|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
164706820|NCT01739348|594953471|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
164706821|NCT01739348|594953472|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
164706822|NCT01739348|594953473|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
164706823|NCT01739348|594953474|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
164706824|NCT01739348|594953471|FG000|Part I (Base Study)|Participant Moved|4|||
164706825|NCT01739348|594953472|FG001|Part I (Base Study)|Participant Moved|3|||
164706826|NCT01739348|594953473|FG002|Part I (Base Study)|Participant Moved|1|||
164706827|NCT01739348|594953474|FG003|Part I (Base Study)|Participant Moved|7|||
164706828|NCT01739348|594953471|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
164706829|NCT01739348|594953472|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
164706830|NCT01739348|594953473|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
164706831|NCT01739348|594953474|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
164706832|NCT01739348|594953471|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
164706833|NCT01739348|594953472|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
164706834|NCT01739348|594953473|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
164706835|NCT01739348|594953474|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
164706836|NCT01739348|594953471|FG000|Part II (Extension Study)|Adverse Event|10|||
164706837|NCT01739348|594953472|FG001|Part II (Extension Study)|Adverse Event|11|||
164706838|NCT01739348|594953473|FG002|Part II (Extension Study)|Adverse Event|7|||
164706839|NCT01739348|594953474|FG003|Part II (Extension Study)|Adverse Event|26|||
164706840|NCT01739348|594953471|FG000|Part II (Extension Study)|Death|3|||
164706841|NCT01739348|594953472|FG001|Part II (Extension Study)|Death|3|||
164706842|NCT01739348|594953473|FG002|Part II (Extension Study)|Death|2|||
164706843|NCT01739348|594953474|FG003|Part II (Extension Study)|Death|6|||
164706844|NCT01739348|594953471|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
164706845|NCT01739348|594953472|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
164706846|NCT01739348|594953473|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
164706847|NCT01739348|594953474|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
164706848|NCT01739348|594953471|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
164706849|NCT01739348|594953472|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
164706850|NCT01739348|594953473|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
164706851|NCT01739348|594953474|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
164706852|NCT01739348|594953471|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
164706853|NCT01739348|594953472|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
164706854|NCT01739348|594953473|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
164706855|NCT01739348|594953474|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
164706856|NCT01739348|594953471|FG000|Part II (Extension Study)|Physician Decision|7|||
164706857|NCT01739348|594953472|FG001|Part II (Extension Study)|Physician Decision|11|||
164706858|NCT01739348|594953473|FG002|Part II (Extension Study)|Physician Decision|6|||
164706859|NCT01739348|594953474|FG003|Part II (Extension Study)|Physician Decision|12|||
164706860|NCT01739348|594953471|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
164706861|NCT01739348|594953472|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
164706862|NCT01739348|594953473|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
164706863|NCT01739348|594953474|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
164706864|NCT01739348|594953471|FG000|Part II (Extension Study)|Participant Moved|3|||
164706865|NCT01739348|594953472|FG001|Part II (Extension Study)|Participant Moved|3|||
164454191|NCT04812535|594034324|FG003|Overall Study|Withdrawal by Subject|1|||
164454192|NCT04812535|594034321|FG000|Overall Study|Death|7|||
164454193|NCT04812535|594034322|FG001|Overall Study|Death|2|||
164454194|NCT04812535|594034323|FG002|Overall Study|Death|4|||
164706866|NCT01739348|594953473|FG002|Part II (Extension Study)|Participant Moved|0|||
164706867|NCT01739348|594953474|FG003|Part II (Extension Study)|Participant Moved|3|||
164706868|NCT01739348|594953471|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
164706869|NCT01739348|594953472|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
164706870|NCT01739348|594953473|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
164706871|NCT01739348|594953474|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
164454195|NCT04812535|594034324|FG003|Overall Study|Death|1|||
164454196|NCT04812535|594034321|FG000|Overall Study|Due to premature study termination by sponsor|2|||
164454197|NCT04812535|594034322|FG001|Overall Study|Due to premature study termination by sponsor|0|||
164454198|NCT04812535|594034323|FG002|Overall Study|Due to premature study termination by sponsor|1|||
164454199|NCT04812535|594034324|FG003|Overall Study|Due to premature study termination by sponsor|3|||
164454200|NCT03336333|594034325|FG000|Overall Study|Remained on study at time of data cut-off|202|||
164454201|NCT03336333|594034326|FG001|Overall Study|Remained on study at time of data cut-off|219|||
164454202|NCT03336333|594034327|FG002|Overall Study|Remained on study at time of data cut-off|102|||
164454203|NCT03336333|594034325|FG000|Overall Study|Death|14|||
164454204|NCT03336333|594034326|FG001|Overall Study|Death|16|||
164454205|NCT03336333|594034327|FG002|Overall Study|Death|8|||
164454206|NCT03336333|594034325|FG000|Overall Study|Withdrawal by Subject|16|||
164454207|NCT03336333|594034326|FG001|Overall Study|Withdrawal by Subject|5|||
164454208|NCT03336333|594034327|FG002|Overall Study|Withdrawal by Subject|1|||
164454209|NCT03336333|594034325|FG000|Overall Study|Physician Decision|5|||
164454210|NCT03336333|594034326|FG001|Overall Study|Physician Decision|1|||
164454211|NCT03336333|594034327|FG002|Overall Study|Physician Decision|0|||
164454212|NCT03336333|594034325|FG000|Overall Study|Lost to Follow-up|1|||
164454213|NCT03336333|594034326|FG001|Overall Study|Lost to Follow-up|0|||
164454214|NCT03336333|594034327|FG002|Overall Study|Lost to Follow-up|0|||
164454215|NCT04401800|594034330|FG000|Overall Study|Death|17|||
164454216|NCT04401800|594034330|FG000|Overall Study|Lost to Follow-up|5|||
164454217|NCT04401800|594034330|FG000|Overall Study|Withdrawal by Subject|4|||
164454218|NCT04927065|594034331|FG000|First Booster|Adverse Event|1|||
164454219|NCT04927065|594034332|FG001|First Booster|Adverse Event|0|||
164454220|NCT04927065|594034333|FG002|First Booster|Adverse Event|0|||
164454221|NCT04927065|594034334|FG003|First Booster|Adverse Event|0|||
164454222|NCT04927065|594034335|FG004|First Booster|Adverse Event|0|||
164454223|NCT04927065|594034336|FG005|First Booster|Adverse Event|0|||
164454224|NCT04927065|594034337|FG006|First Booster|Adverse Event|0|||
164454225|NCT04927065|594034338|FG007|First Booster|Adverse Event|1|||
164454226|NCT04927065|594034339|FG008|First Booster|Adverse Event|0|||
164454227|NCT04927065|594034340|FG009|First Booster|Adverse Event|0|||
164454228|NCT04927065|594034341|FG010|First Booster|Adverse Event|0|||
164454229|NCT04927065|594034342|FG011|First Booster|Adverse Event|0|||
164454230|NCT04927065|594034343|FG012|First Booster|Adverse Event|0|||
164454231|NCT04927065|594034344|FG013|First Booster|Adverse Event|0|||
164454232|NCT04927065|594034345|FG014|First Booster|Adverse Event|0|||
164454233|NCT04927065|594034346|FG015|First Booster|Adverse Event|0|||
164454234|NCT04927065|594034331|FG000|First Booster|Death|1|||
164454235|NCT04927065|594034332|FG001|First Booster|Death|0|||
164454236|NCT04927065|594034333|FG002|First Booster|Death|0|||
164454237|NCT04927065|594034334|FG003|First Booster|Death|1|||
164454238|NCT04927065|594034335|FG004|First Booster|Death|0|||
164454239|NCT04927065|594034336|FG005|First Booster|Death|1|||
164454240|NCT04927065|594034337|FG006|First Booster|Death|0|||
164454241|NCT04927065|594034338|FG007|First Booster|Death|0|||
164454242|NCT04927065|594034339|FG008|First Booster|Death|0|||
164454243|NCT04927065|594034340|FG009|First Booster|Death|0|||
164454244|NCT04927065|594034341|FG010|First Booster|Death|0|||
164454245|NCT04927065|594034342|FG011|First Booster|Death|0|||
164454246|NCT04927065|594034343|FG012|First Booster|Death|0|||
164454247|NCT04927065|594034344|FG013|First Booster|Death|0|||
164454248|NCT04927065|594034345|FG014|First Booster|Death|0|||
164454249|NCT04927065|594034346|FG015|First Booster|Death|0|||
164454250|NCT04927065|594034331|FG000|First Booster|Lost to Follow-up|8|||
164454251|NCT04927065|594034332|FG001|First Booster|Lost to Follow-up|20|||
164454252|NCT04927065|594034333|FG002|First Booster|Lost to Follow-up|0|||
164597810|NCT00668200|594551251|FG000|Overall Study|Lost to Follow-up|1|||
164597811|NCT00642746|594551252|FG000|Overall Study|Patient unevaluable|1|||
164597812|NCT00642746|594551253|FG001|Overall Study|Patient unevaluable|0|||
164597813|NCT00424294|594551257|FG000|Overall Study|Adverse Event|4|||
164454253|NCT04927065|594034334|FG003|First Booster|Lost to Follow-up|11|||
164454254|NCT04927065|594034335|FG004|First Booster|Lost to Follow-up|43|||
164454255|NCT04927065|594034336|FG005|First Booster|Lost to Follow-up|30|||
164454256|NCT04927065|594034337|FG006|First Booster|Lost to Follow-up|28|||
164454257|NCT04927065|594034338|FG007|First Booster|Lost to Follow-up|23|||
164454258|NCT04927065|594034339|FG008|First Booster|Lost to Follow-up|4|||
164454259|NCT04927065|594034340|FG009|First Booster|Lost to Follow-up|15|||
164454260|NCT04927065|594034341|FG010|First Booster|Lost to Follow-up|0|||
164454261|NCT04927065|594034342|FG011|First Booster|Lost to Follow-up|0|||
164454262|NCT04927065|594034343|FG012|First Booster|Lost to Follow-up|0|||
164454263|NCT04927065|594034344|FG013|First Booster|Lost to Follow-up|0|||
164454264|NCT04927065|594034345|FG014|First Booster|Lost to Follow-up|0|||
164454265|NCT04927065|594034346|FG015|First Booster|Lost to Follow-up|0|||
164454266|NCT04927065|594034331|FG000|First Booster|Physician Decision|1|||
164454267|NCT04927065|594034332|FG001|First Booster|Physician Decision|0|||
164454268|NCT04927065|594034333|FG002|First Booster|Physician Decision|0|||
164454269|NCT04927065|594034334|FG003|First Booster|Physician Decision|3|||
164597814|NCT00424294|594551258|FG001|Overall Study|Adverse Event|10|||
164454270|NCT04927065|594034335|FG004|First Booster|Physician Decision|1|||
164454271|NCT04927065|594034336|FG005|First Booster|Physician Decision|1|||
164454272|NCT04927065|594034337|FG006|First Booster|Physician Decision|0|||
164454273|NCT04927065|594034338|FG007|First Booster|Physician Decision|3|||
164454274|NCT04927065|594034339|FG008|First Booster|Physician Decision|0|||
164454275|NCT04927065|594034340|FG009|First Booster|Physician Decision|0|||
164454276|NCT04927065|594034341|FG010|First Booster|Physician Decision|0|||
164454277|NCT04927065|594034342|FG011|First Booster|Physician Decision|0|||
164454278|NCT04927065|594034343|FG012|First Booster|Physician Decision|0|||
164454279|NCT04927065|594034344|FG013|First Booster|Physician Decision|0|||
164454280|NCT04927065|594034345|FG014|First Booster|Physician Decision|0|||
164454281|NCT04927065|594034346|FG015|First Booster|Physician Decision|0|||
164454282|NCT04927065|594034331|FG000|First Booster|Protocol Violation|4|||
164454283|NCT04927065|594034332|FG001|First Booster|Protocol Violation|4|||
164454284|NCT04927065|594034333|FG002|First Booster|Protocol Violation|0|||
164454285|NCT04927065|594034334|FG003|First Booster|Protocol Violation|3|||
164454286|NCT04927065|594034335|FG004|First Booster|Protocol Violation|0|||
164454287|NCT04927065|594034336|FG005|First Booster|Protocol Violation|0|||
164454288|NCT04927065|594034337|FG006|First Booster|Protocol Violation|0|||
164454289|NCT04927065|594034338|FG007|First Booster|Protocol Violation|2|||
164454290|NCT04927065|594034339|FG008|First Booster|Protocol Violation|0|||
164454291|NCT04927065|594034340|FG009|First Booster|Protocol Violation|0|||
164454292|NCT04927065|594034341|FG010|First Booster|Protocol Violation|0|||
164454293|NCT04927065|594034342|FG011|First Booster|Protocol Violation|0|||
164454294|NCT04927065|594034343|FG012|First Booster|Protocol Violation|0|||
164454295|NCT04927065|594034344|FG013|First Booster|Protocol Violation|0|||
164454296|NCT04927065|594034345|FG014|First Booster|Protocol Violation|0|||
164454297|NCT04927065|594034346|FG015|First Booster|Protocol Violation|0|||
164454298|NCT04927065|594034331|FG000|First Booster|Withdrawal by Subject|8|||
164454299|NCT04927065|594034332|FG001|First Booster|Withdrawal by Subject|23|||
164454300|NCT04927065|594034333|FG002|First Booster|Withdrawal by Subject|0|||
164454301|NCT04927065|594034334|FG003|First Booster|Withdrawal by Subject|19|||
164454302|NCT04927065|594034335|FG004|First Booster|Withdrawal by Subject|20|||
164454303|NCT04927065|594034336|FG005|First Booster|Withdrawal by Subject|15|||
164454304|NCT04927065|594034337|FG006|First Booster|Withdrawal by Subject|6|||
164454305|NCT04927065|594034338|FG007|First Booster|Withdrawal by Subject|24|||
164454306|NCT04927065|594034339|FG008|First Booster|Withdrawal by Subject|0|||
164454307|NCT04927065|594034340|FG009|First Booster|Withdrawal by Subject|4|||
164454308|NCT04927065|594034341|FG010|First Booster|Withdrawal by Subject|0|||
164454309|NCT04927065|594034342|FG011|First Booster|Withdrawal by Subject|0|||
164454310|NCT04927065|594034343|FG012|First Booster|Withdrawal by Subject|0|||
164454311|NCT04927065|594034344|FG013|First Booster|Withdrawal by Subject|0|||
164454312|NCT04927065|594034345|FG014|First Booster|Withdrawal by Subject|0|||
164454313|NCT04927065|594034346|FG015|First Booster|Withdrawal by Subject|0|||
164454314|NCT04927065|594034331|FG000|First Booster|Other Than Specified|1|||
164454315|NCT04927065|594034332|FG001|First Booster|Other Than Specified|1|||
164454316|NCT04927065|594034333|FG002|First Booster|Other Than Specified|0|||
164454317|NCT04927065|594034334|FG003|First Booster|Other Than Specified|1|||
164454318|NCT04927065|594034335|FG004|First Booster|Other Than Specified|2|||
164454319|NCT04927065|594034336|FG005|First Booster|Other Than Specified|3|||
164454320|NCT04927065|594034337|FG006|First Booster|Other Than Specified|2|||
164454321|NCT04927065|594034338|FG007|First Booster|Other Than Specified|6|||
164454322|NCT04927065|594034339|FG008|First Booster|Other Than Specified|0|||
164454323|NCT04927065|594034340|FG009|First Booster|Other Than Specified|4|||
164454324|NCT04927065|594034341|FG010|First Booster|Other Than Specified|0|||
164454325|NCT04927065|594034342|FG011|First Booster|Other Than Specified|0|||
164454326|NCT04927065|594034343|FG012|First Booster|Other Than Specified|0|||
164454327|NCT04927065|594034344|FG013|First Booster|Other Than Specified|0|||
164597815|NCT00424294|594551257|FG000|Overall Study|Lack of Efficacy|2|||
164597816|NCT00424294|594551258|FG001|Overall Study|Lack of Efficacy|1|||
164597817|NCT00424294|594551257|FG000|Overall Study|Withdrawal by Subject|1|||
164597818|NCT00424294|594551258|FG001|Overall Study|Withdrawal by Subject|2|||
164597819|NCT00424294|594551257|FG000|Overall Study|Other|0|||
164454328|NCT04927065|594034345|FG014|First Booster|Other Than Specified|0|||
164454329|NCT04927065|594034346|FG015|First Booster|Other Than Specified|0|||
164454330|NCT04927065|594034331|FG000|Second Booster|Death|0|||
164597820|NCT00424294|594551258|FG001|Overall Study|Other|2|||
164454331|NCT04927065|594034332|FG001|Second Booster|Death|0|||
164454332|NCT04927065|594034333|FG002|Second Booster|Death|0|||
164454333|NCT04927065|594034334|FG003|Second Booster|Death|0|||
164454334|NCT04927065|594034335|FG004|Second Booster|Death|0|||
164454335|NCT04927065|594034336|FG005|Second Booster|Death|0|||
164454336|NCT04927065|594034337|FG006|Second Booster|Death|0|||
164454337|NCT04927065|594034338|FG007|Second Booster|Death|0|||
164454338|NCT04927065|594034339|FG008|Second Booster|Death|0|||
164454339|NCT04927065|594034340|FG009|Second Booster|Death|0|||
164454340|NCT04927065|594034341|FG010|Second Booster|Death|2|||
164597821|NCT00424294|594551257|FG000|Overall Study|Randomized but not Treated|1|||
164597822|NCT00424294|594551258|FG001|Overall Study|Randomized but not Treated|0|||
164454341|NCT04927065|594034342|FG011|Second Booster|Death|0|||
164454342|NCT04927065|594034343|FG012|Second Booster|Death|2|||
164454343|NCT04927065|594034344|FG013|Second Booster|Death|2|||
164454344|NCT04927065|594034345|FG014|Second Booster|Death|0|||
164454345|NCT04927065|594034346|FG015|Second Booster|Death|0|||
164454346|NCT04927065|594034331|FG000|Second Booster|Lost to Follow-up|0|||
164454347|NCT04927065|594034332|FG001|Second Booster|Lost to Follow-up|0|||
164454348|NCT04927065|594034333|FG002|Second Booster|Lost to Follow-up|3|||
164454349|NCT04927065|594034334|FG003|Second Booster|Lost to Follow-up|0|||
164454350|NCT04927065|594034335|FG004|Second Booster|Lost to Follow-up|0|||
164454351|NCT04927065|594034336|FG005|Second Booster|Lost to Follow-up|0|||
164454352|NCT04927065|594034337|FG006|Second Booster|Lost to Follow-up|0|||
164454353|NCT04927065|594034338|FG007|Second Booster|Lost to Follow-up|0|||
164454354|NCT04927065|594034339|FG008|Second Booster|Lost to Follow-up|0|||
164454355|NCT04927065|594034340|FG009|Second Booster|Lost to Follow-up|0|||
164454356|NCT04927065|594034341|FG010|Second Booster|Lost to Follow-up|14|||
164454357|NCT04927065|594034342|FG011|Second Booster|Lost to Follow-up|10|||
164597823|NCT01496430|594551259|FG000|Overall Study|Adverse Event|0|||
164406005|NCT03764774|593855589|FG009|Overall Study|Study Termination|1|||
164406006|NCT03764774|593855590|FG010|Overall Study|Study Termination|0|||
164406007|NCT03764774|593855591|FG011|Overall Study|Study Termination|0|||
164406008|NCT03764774|593855592|FG012|Overall Study|Study Termination|0|||
164406009|NCT03764774|593855593|FG013|Overall Study|Study Termination|2|||
164406010|NCT06027619|593855594|FG000|Overall Study|Adverse Event|0|||
164406011|NCT06027619|593855595|FG001|Overall Study|Adverse Event|0|||
164406012|NCT06027619|593855596|FG002|Overall Study|Adverse Event|1|||
164406013|NCT01493960|593857380|FG000|Overall Study|Adverse Event|0|||
164406014|NCT01493960|593857381|FG001|Overall Study|Adverse Event|1|||
164406015|NCT01493960|593857380|FG000|Overall Study|Lack of Efficacy|15|||
164406016|NCT01493960|593857381|FG001|Overall Study|Lack of Efficacy|9|||
164406017|NCT01493960|593857380|FG000|Overall Study|Protocol Violation|3|||
164406018|NCT01493960|593857381|FG001|Overall Study|Protocol Violation|0|||
164406019|NCT01493960|593857380|FG000|Overall Study|Withdrawal by Subject|10|||
164406020|NCT01493960|593857381|FG001|Overall Study|Withdrawal by Subject|4|||
164406021|NCT01493960|593857380|FG000|Overall Study|Non-specified|4|||
164406022|NCT01493960|593857381|FG001|Overall Study|Non-specified|4|||
164406023|NCT01679236|593857386|FG000|Overall Study|Lost to Follow-up|15|||
164406024|NCT01679236|593857387|FG001|Overall Study|Lost to Follow-up|15|||
164406025|NCT00284141|593857388|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
164406026|NCT00284141|593857388|FG000|Overall Study|Adverse Event|19|||
164406027|NCT00284141|593857388|FG000|Overall Study|Participant's request|9|||
164406028|NCT00284141|593857388|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
164406029|NCT00284141|593857388|FG000|Overall Study|Clinical deterioration / death|2|||
164406030|NCT00284141|593857388|FG000|Overall Study|General decline|1|||
164406031|NCT00284141|593857388|FG000|Overall Study|Pneumonia|1|||
164406032|NCT00284141|593857388|FG000|Overall Study|Did not take study medication|2|||
164406033|NCT00284141|593857388|FG000|Overall Study|Ongoing treatment|2|||
164406034|NCT03935217|593857391|FG000|Overall Study|Adverse Event|1|||
164406035|NCT03935217|593857392|FG001|Overall Study|Adverse Event|0|||
164406036|NCT03935217|593857391|FG000|Overall Study|Lost to Follow-up|0|||
164406037|NCT03935217|593857392|FG001|Overall Study|Lost to Follow-up|1|||
164406038|NCT03935217|593857391|FG000|Overall Study|Withdrawal by Subject|0|||
164406039|NCT03935217|593857392|FG001|Overall Study|Withdrawal by Subject|2|||
164406040|NCT00803101|593857399|FG000|Overall Study|Death / Serious Adverse Event|4|||
164406041|NCT00803101|593857400|FG001|Overall Study|Death / Serious Adverse Event|6|||
164406042|NCT00803101|593857399|FG000|Overall Study|Withdrawal by Subject|6|||
164406043|NCT00803101|593857400|FG001|Overall Study|Withdrawal by Subject|4|||
164406044|NCT00803101|593857399|FG000|Overall Study|Lost to Follow-up|2|||
164406045|NCT00803101|593857400|FG001|Overall Study|Lost to Follow-up|2|||
164406046|NCT00803101|593857399|FG000|Overall Study|Protocol Violation|1|||
164406047|NCT00803101|593857400|FG001|Overall Study|Protocol Violation|7|||
164406048|NCT00803101|593857399|FG000|Overall Study|Surgery finished outside protocol window|1|||
164406049|NCT00803101|593857400|FG001|Overall Study|Surgery finished outside protocol window|1|||
164406050|NCT00803101|593857399|FG000|Overall Study|Patient died outside SAE report period|1|||
164406051|NCT00803101|593857400|FG001|Overall Study|Patient died outside SAE report period|0|||
164406052|NCT00803101|593857399|FG000|Overall Study|Patient did not attend scheduled visit|2|||
164406053|NCT00803101|593857400|FG001|Overall Study|Patient did not attend scheduled visit|1|||
164454358|NCT04927065|594034343|FG012|Second Booster|Lost to Follow-up|13|||
164454359|NCT04927065|594034344|FG013|Second Booster|Lost to Follow-up|16|||
164454360|NCT04927065|594034345|FG014|Second Booster|Lost to Follow-up|0|||
164454361|NCT04927065|594034346|FG015|Second Booster|Lost to Follow-up|0|||
164454362|NCT04927065|594034331|FG000|Second Booster|Physician Decision|0|||
164454363|NCT04927065|594034332|FG001|Second Booster|Physician Decision|0|||
164454364|NCT04927065|594034333|FG002|Second Booster|Physician Decision|0|||
164454365|NCT04927065|594034334|FG003|Second Booster|Physician Decision|0|||
164597824|NCT01496430|594551260|FG001|Overall Study|Adverse Event|0|||
164597825|NCT01496430|594551261|FG002|Overall Study|Adverse Event|1|||
164597826|NCT01496430|594551259|FG000|Overall Study|Major Protocol Deviation|0|||
164454366|NCT04927065|594034335|FG004|Second Booster|Physician Decision|0|||
164454367|NCT04927065|594034336|FG005|Second Booster|Physician Decision|0|||
164454368|NCT04927065|594034337|FG006|Second Booster|Physician Decision|0|||
164454369|NCT04927065|594034338|FG007|Second Booster|Physician Decision|0|||
164454370|NCT04927065|594034339|FG008|Second Booster|Physician Decision|0|||
164454371|NCT04927065|594034340|FG009|Second Booster|Physician Decision|0|||
164454372|NCT04927065|594034341|FG010|Second Booster|Physician Decision|0|||
164454373|NCT04927065|594034342|FG011|Second Booster|Physician Decision|3|||
164454374|NCT04927065|594034343|FG012|Second Booster|Physician Decision|0|||
164454375|NCT04927065|594034344|FG013|Second Booster|Physician Decision|1|||
164454376|NCT04927065|594034345|FG014|Second Booster|Physician Decision|0|||
164454377|NCT04927065|594034346|FG015|Second Booster|Physician Decision|0|||
164454378|NCT04927065|594034331|FG000|Second Booster|Withdrawal by Subject|0|||
164454379|NCT04927065|594034332|FG001|Second Booster|Withdrawal by Subject|0|||
164454380|NCT04927065|594034333|FG002|Second Booster|Withdrawal by Subject|4|||
164454381|NCT04927065|594034334|FG003|Second Booster|Withdrawal by Subject|0|||
164454382|NCT04927065|594034335|FG004|Second Booster|Withdrawal by Subject|0|||
164454383|NCT04927065|594034336|FG005|Second Booster|Withdrawal by Subject|0|||
164454384|NCT04927065|594034337|FG006|Second Booster|Withdrawal by Subject|0|||
164454385|NCT04927065|594034338|FG007|Second Booster|Withdrawal by Subject|0|||
164454386|NCT04927065|594034339|FG008|Second Booster|Withdrawal by Subject|0|||
164454387|NCT04927065|594034340|FG009|Second Booster|Withdrawal by Subject|0|||
164454388|NCT04927065|594034341|FG010|Second Booster|Withdrawal by Subject|3|||
164454389|NCT04927065|594034342|FG011|Second Booster|Withdrawal by Subject|16|||
164454390|NCT04927065|594034343|FG012|Second Booster|Withdrawal by Subject|13|||
164454391|NCT04927065|594034344|FG013|Second Booster|Withdrawal by Subject|9|||
164454392|NCT04927065|594034345|FG014|Second Booster|Withdrawal by Subject|0|||
164597827|NCT01496430|594551260|FG001|Overall Study|Major Protocol Deviation|0|||
164706872|NCT01739348|594953471|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
164706873|NCT01739348|594953472|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
164706874|NCT01739348|594953473|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
164706875|NCT01739348|594953474|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
164706876|NCT01447420|594953477|FG000|Overall Study|Adverse Event|2|||
164706877|NCT01447420|594953478|FG001|Overall Study|Adverse Event|4|||
164706878|NCT01447420|594953479|FG002|Overall Study|Adverse Event|2|||
164706879|NCT01447420|594953477|FG000|Overall Study|Protocol Violation|3|||
164706880|NCT01447420|594953478|FG001|Overall Study|Protocol Violation|3|||
164706881|NCT01447420|594953479|FG002|Overall Study|Protocol Violation|0|||
164706882|NCT01447420|594953477|FG000|Overall Study|Withdrawal by Subject|4|||
164706883|NCT01447420|594953478|FG001|Overall Study|Withdrawal by Subject|1|||
164706884|NCT01447420|594953479|FG002|Overall Study|Withdrawal by Subject|0|||
164706885|NCT01447420|594953477|FG000|Overall Study|Lack of Efficacy|1|||
164706886|NCT01447420|594953478|FG001|Overall Study|Lack of Efficacy|19|||
164706887|NCT01447420|594953479|FG002|Overall Study|Lack of Efficacy|8|||
164706888|NCT00528411|594953485|FG000|Overall Study|Adverse Event|4|||
164706889|NCT00528411|594953486|FG001|Overall Study|Adverse Event|0|||
164706890|NCT00528411|594953487|FG002|Overall Study|Adverse Event|1|||
164706891|NCT00528411|594953485|FG000|Overall Study|Incorrect Enrolment|1|||
164706892|NCT00528411|594953486|FG001|Overall Study|Incorrect Enrolment|1|||
164706893|NCT00528411|594953487|FG002|Overall Study|Incorrect Enrolment|0|||
164706894|NCT00528411|594953485|FG000|Overall Study|Severe non-compliance to protocol|0|||
164706895|NCT00528411|594953486|FG001|Overall Study|Severe non-compliance to protocol|1|||
164706896|NCT00528411|594953487|FG002|Overall Study|Severe non-compliance to protocol|0|||
164706897|NCT00528411|594953485|FG000|Overall Study|Prior commitment medication|0|||
164706898|NCT00528411|594953486|FG001|Overall Study|Prior commitment medication|1|||
164706899|NCT00528411|594953487|FG002|Overall Study|Prior commitment medication|0|||
164706900|NCT02695537|594953497|FG000|Overall Study|Adverse Event|3|||
164454393|NCT04927065|594034346|FG015|Second Booster|Withdrawal by Subject|0|||
164454394|NCT04927065|594034331|FG000|Second Booster|Other Than Specified|0|||
164454395|NCT04927065|594034332|FG001|Second Booster|Other Than Specified|0|||
164454396|NCT04927065|594034333|FG002|Second Booster|Other Than Specified|0|||
164454397|NCT04927065|594034334|FG003|Second Booster|Other Than Specified|0|||
164454398|NCT04927065|594034335|FG004|Second Booster|Other Than Specified|0|||
164597828|NCT01496430|594551261|FG002|Overall Study|Major Protocol Deviation|1|||
164597829|NCT01496430|594551259|FG000|Overall Study|Lost to Follow-up|2|||
164597830|NCT01496430|594551260|FG001|Overall Study|Lost to Follow-up|3|||
164597831|NCT01496430|594551261|FG002|Overall Study|Lost to Follow-up|1|||
164597832|NCT01496430|594551259|FG000|Overall Study|Voluntary Withdrawal|2|||
164597833|NCT01496430|594551260|FG001|Overall Study|Voluntary Withdrawal|1|||
164597834|NCT01496430|594551261|FG002|Overall Study|Voluntary Withdrawal|6|||
164597835|NCT01496430|594551259|FG000|Overall Study|Principal Investigator Discretion|0|||
164597836|NCT01496430|594551260|FG001|Overall Study|Principal Investigator Discretion|1|||
164706901|NCT02695537|594953497|FG000|Overall Study|Lack of Efficacy|28|||
164706902|NCT02695537|594953497|FG000|Overall Study|Withdrawal by Subject|4|||
164454399|NCT04927065|594034336|FG005|Second Booster|Other Than Specified|0|||
164597837|NCT01496430|594551261|FG002|Overall Study|Principal Investigator Discretion|1|||
164454400|NCT04927065|594034337|FG006|Second Booster|Other Than Specified|0|||
164454401|NCT04927065|594034338|FG007|Second Booster|Other Than Specified|0|||
164454402|NCT04927065|594034339|FG008|Second Booster|Other Than Specified|0|||
164454403|NCT04927065|594034340|FG009|Second Booster|Other Than Specified|0|||
164454404|NCT04927065|594034341|FG010|Second Booster|Other Than Specified|1|||
164454405|NCT04927065|594034342|FG011|Second Booster|Other Than Specified|1|||
164454406|NCT04927065|594034343|FG012|Second Booster|Other Than Specified|4|||
164454407|NCT04927065|594034344|FG013|Second Booster|Other Than Specified|0|||
164454408|NCT04927065|594034345|FG014|Second Booster|Other Than Specified|0|||
164454409|NCT04927065|594034346|FG015|Second Booster|Other Than Specified|0|||
164454410|NCT04927065|594034331|FG000|Third Booster|Lost to Follow-up|0|||
164454411|NCT04927065|594034332|FG001|Third Booster|Lost to Follow-up|0|||
164454412|NCT04927065|594034333|FG002|Third Booster|Lost to Follow-up|0|||
164454413|NCT04927065|594034334|FG003|Third Booster|Lost to Follow-up|0|||
164454414|NCT04927065|594034335|FG004|Third Booster|Lost to Follow-up|0|||
164454415|NCT04927065|594034336|FG005|Third Booster|Lost to Follow-up|0|||
164454416|NCT04927065|594034337|FG006|Third Booster|Lost to Follow-up|0|||
164454417|NCT04927065|594034338|FG007|Third Booster|Lost to Follow-up|0|||
164454418|NCT04927065|594034339|FG008|Third Booster|Lost to Follow-up|0|||
164454419|NCT04927065|594034340|FG009|Third Booster|Lost to Follow-up|0|||
164454420|NCT04927065|594034341|FG010|Third Booster|Lost to Follow-up|0|||
164454421|NCT04927065|594034342|FG011|Third Booster|Lost to Follow-up|0|||
164454422|NCT04927065|594034343|FG012|Third Booster|Lost to Follow-up|0|||
164454423|NCT04927065|594034344|FG013|Third Booster|Lost to Follow-up|0|||
164454424|NCT04927065|594034345|FG014|Third Booster|Lost to Follow-up|0|||
164454425|NCT04927065|594034346|FG015|Third Booster|Lost to Follow-up|1|||
164454426|NCT04927065|594034331|FG000|Third Booster|Withdrawal by Subject|0|||
164454427|NCT04927065|594034332|FG001|Third Booster|Withdrawal by Subject|0|||
164454428|NCT04927065|594034333|FG002|Third Booster|Withdrawal by Subject|0|||
164454429|NCT04927065|594034334|FG003|Third Booster|Withdrawal by Subject|0|||
164454430|NCT04927065|594034335|FG004|Third Booster|Withdrawal by Subject|0|||
164454431|NCT04927065|594034336|FG005|Third Booster|Withdrawal by Subject|0|||
164454432|NCT04927065|594034337|FG006|Third Booster|Withdrawal by Subject|0|||
164454433|NCT04927065|594034338|FG007|Third Booster|Withdrawal by Subject|0|||
164454434|NCT04927065|594034339|FG008|Third Booster|Withdrawal by Subject|0|||
164454435|NCT04927065|594034340|FG009|Third Booster|Withdrawal by Subject|0|||
164454436|NCT04927065|594034341|FG010|Third Booster|Withdrawal by Subject|0|||
164454437|NCT04927065|594034342|FG011|Third Booster|Withdrawal by Subject|0|||
164454438|NCT04927065|594034343|FG012|Third Booster|Withdrawal by Subject|0|||
164454439|NCT04927065|594034344|FG013|Third Booster|Withdrawal by Subject|0|||
164454440|NCT04927065|594034345|FG014|Third Booster|Withdrawal by Subject|0|||
164454441|NCT04927065|594034346|FG015|Third Booster|Withdrawal by Subject|1|||
164454442|NCT03846505|594034352|FG000|Treatment Phase|Withdrawal by Subject|9|||
164454443|NCT03846505|594034353|FG001|Treatment Phase|Withdrawal by Subject|11|||
164454444|NCT03846505|594034352|FG000|Treatment Phase|Lost to Follow-up|6|||
164454445|NCT03846505|594034353|FG001|Treatment Phase|Lost to Follow-up|2|||
164454446|NCT03846505|594034352|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
164454447|NCT03846505|594034353|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
164454448|NCT03846505|594034352|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
164454449|NCT03846505|594034353|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
164454450|NCT04021602|594034360|FG000|Overall Study|Lost to Follow-up|3|||
164454451|NCT04021602|594034361|FG001|Overall Study|Lost to Follow-up|3|||
164454452|NCT04021602|594034362|FG002|Overall Study|Lost to Follow-up|1|||
164454453|NCT04021602|594034360|FG000|Overall Study|Adverse Event|1|||
164454454|NCT04021602|594034361|FG001|Overall Study|Adverse Event|0|||
164454455|NCT04021602|594034362|FG002|Overall Study|Adverse Event|1|||
164454456|NCT02689284|594034363|FG000|Overall Study|Adverse Event|1|||
164454457|NCT02689284|594034364|FG001|Overall Study|Adverse Event|8|||
164454458|NCT02689284|594034363|FG000|Overall Study|Death|0|||
164454459|NCT02689284|594034364|FG001|Overall Study|Death|1|||
164454460|NCT02689284|594034363|FG000|Overall Study|Physician Decision|1|||
164706903|NCT02695537|594953497|FG000|Overall Study|Protocol Violation|3|||
164706904|NCT02792699|594953498|FG000|Overall Study|Adverse Event|1|||
164706905|NCT02792699|594953499|FG001|Overall Study|Adverse Event|2|||
164454461|NCT02689284|594034364|FG001|Overall Study|Physician Decision|2|||
164454462|NCT02689284|594034363|FG000|Overall Study|Withdrawal by Subject|0|||
164454463|NCT02689284|594034364|FG001|Overall Study|Withdrawal by Subject|1|||
164454464|NCT02689284|594034363|FG000|Overall Study|progression of cancer|1|||
164706906|NCT02792699|594953500|FG002|Overall Study|Adverse Event|4|||
164454465|NCT02689284|594034364|FG001|Overall Study|progression of cancer|72|||
164454466|NCT02689284|594034363|FG000|Overall Study|decreased heart function|0|||
164706907|NCT02792699|594953498|FG000|Overall Study|Withdrawal by Subject|4|||
164454467|NCT02689284|594034364|FG001|Overall Study|decreased heart function|1|||
164454468|NCT02689284|594034363|FG000|Overall Study|concern for anemia|0|||
164454469|NCT02689284|594034364|FG001|Overall Study|concern for anemia|1|||
164454470|NCT02689284|594034363|FG000|Overall Study|no measurable cancer for evaluation|0|||
164454471|NCT02689284|594034364|FG001|Overall Study|no measurable cancer for evaluation|1|||
164454472|NCT05592418|594034365|FG000|Overall Study|Adverse Event|1|||
164454473|NCT05592418|594034366|FG001|Overall Study|Adverse Event|0|||
164454474|NCT05592418|594034365|FG000|Overall Study|Lost to Follow-up|1|||
164454475|NCT05592418|594034366|FG001|Overall Study|Lost to Follow-up|3|||
164454476|NCT05592418|594034365|FG000|Overall Study|Withdrawal by Subject|2|||
164454477|NCT05592418|594034366|FG001|Overall Study|Withdrawal by Subject|7|||
164454478|NCT05481320|594034368|FG000|Overall Study|Withdrawal by Subject|1|||
164454479|NCT05481320|594034369|FG001|Overall Study|Withdrawal by Subject|1|||
164454480|NCT05481320|594034368|FG000|Overall Study|Care recipent passed away|0|||
164706908|NCT02792699|594953499|FG001|Overall Study|Withdrawal by Subject|4|||
164706909|NCT02792699|594953500|FG002|Overall Study|Withdrawal by Subject|3|||
164706910|NCT02792699|594953498|FG000|Overall Study|Lost to Follow-up|0|||
164706911|NCT02792699|594953499|FG001|Overall Study|Lost to Follow-up|1|||
164706912|NCT02792699|594953500|FG002|Overall Study|Lost to Follow-up|2|||
164706913|NCT02792699|594953498|FG000|Overall Study|Physician Decision|2|||
164706914|NCT02792699|594953499|FG001|Overall Study|Physician Decision|0|||
164706915|NCT02792699|594953500|FG002|Overall Study|Physician Decision|0|||
164706916|NCT02792699|594953498|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
164706917|NCT02792699|594953499|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
164706918|NCT02792699|594953500|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
164706919|NCT02792699|594953498|FG000|Overall Study|Other|1|||
164406054|NCT00803101|593857399|FG000|Overall Study|Patient did not have surgery|1|||
164406055|NCT00803101|593857400|FG001|Overall Study|Patient did not have surgery|1|||
164406056|NCT01782742|593857401|FG000|Double-blind Treatment Phase|Adverse Event|1|||
164406057|NCT01782742|593857402|FG001|Double-blind Treatment Phase|Adverse Event|0|||
164406058|NCT02026232|593857405|FG000|Overall Study|incomplete visit/missing data|3|||
164406059|NCT02026232|593857406|FG001|Overall Study|incomplete visit/missing data|2|||
164406060|NCT01529008|593857407|FG000|Bone Marrow Harvesting|Physician Decision|1|||
164406061|NCT01529008|593857408|FG001|Bone Marrow Harvesting|Physician Decision|1|||
164406062|NCT01529008|593857407|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
164406063|NCT01529008|593857408|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
164406064|NCT01529008|593857407|FG000|Treatment|Adverse Event|6|||
164406065|NCT01529008|593857408|FG001|Treatment|Adverse Event|0|||
164406066|NCT01529008|593857407|FG000|Treatment|Other|3|||
164406067|NCT01529008|593857408|FG001|Treatment|Other|1|||
164406068|NCT01529008|593857407|FG000|Efficacy Analysis|Protocol Violation|2|||
164406069|NCT01529008|593857408|FG001|Efficacy Analysis|Protocol Violation|0|||
164406070|NCT01529008|593857407|FG000|Efficacy Analysis|Physician Decision|0|||
164406071|NCT01529008|593857408|FG001|Efficacy Analysis|Physician Decision|1|||
164406072|NCT01529008|593857407|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
164406073|NCT01529008|593857408|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
164406074|NCT01382602|593857409|FG000|Overall Study|Protocol Violation|0|||
164406075|NCT01382602|593857410|FG001|Overall Study|Protocol Violation|3|||
164406076|NCT01382602|593857409|FG000|Overall Study|Withdrawal by Subject|0|||
164406077|NCT01382602|593857410|FG001|Overall Study|Withdrawal by Subject|1|||
164406078|NCT04170686|593857415|FG000|Screening|Physician Decision|12|||
164406079|NCT04170686|593857416|FG001|Screening|Physician Decision|13|||
164406080|NCT04170686|593857415|FG000|Randomization and Treatment|Lost to Follow-up|26|||
164406081|NCT04170686|593857416|FG001|Randomization and Treatment|Lost to Follow-up|15|||
164406082|NCT04425902|593857422|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
164406083|NCT01191840|593857423|FG000|Overall Study|withdrew consent|2|||
164406084|NCT01191840|593857424|FG001|Overall Study|withdrew consent|1|||
164406085|NCT01191840|593857423|FG000|Overall Study|Subject discontinued treatment|1|||
164406086|NCT01191840|593857424|FG001|Overall Study|Subject discontinued treatment|2|||
164406087|NCT01191840|593857423|FG000|Overall Study|Lost to Follow-up|4|||
164406088|NCT01191840|593857424|FG001|Overall Study|Lost to Follow-up|6|||
164406089|NCT01191840|593857423|FG000|Overall Study|Non Staph Infection|4|||
164406090|NCT01191840|593857424|FG001|Overall Study|Non Staph Infection|3|||
164406091|NCT01191840|593857423|FG000|Overall Study|ineligible at enrollment|1|||
164406092|NCT01191840|593857424|FG001|Overall Study|ineligible at enrollment|0|||
164406093|NCT01191840|593857423|FG000|Overall Study|IRB approval lapse|0|||
164406094|NCT01191840|593857424|FG001|Overall Study|IRB approval lapse|2|||
164406095|NCT01191840|593857423|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
164406096|NCT01191840|593857424|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
164406097|NCT01191840|593857423|FG000|Overall Study|Withdrawal by Subject|2|||
164406098|NCT01191840|593857424|FG001|Overall Study|Withdrawal by Subject|0|||
164406099|NCT01392300|593857425|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
164406100|NCT01392300|593857426|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
164406101|NCT01392300|593857427|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
164406102|NCT01392300|593857425|FG000|Main Period (MP)|Withdrawal by Subject|5|||
164406103|NCT01392300|593857426|FG001|Main Period (MP)|Withdrawal by Subject|1|||
164406104|NCT01392300|593857427|FG002|Main Period (MP)|Withdrawal by Subject|0|||
164406105|NCT01392300|593857425|FG000|Main Period (MP)|Lost to Follow-up|3|||
164454481|NCT05481320|594034369|FG001|Overall Study|Care recipent passed away|1|||
164706920|NCT02792699|594953499|FG001|Overall Study|Other|0|||
164706921|NCT02792699|594953500|FG002|Overall Study|Other|0|||
164454482|NCT05481320|594034368|FG000|Overall Study|Out-of-window assessment|0|||
164454483|NCT05481320|594034369|FG001|Overall Study|Out-of-window assessment|1|||
164454484|NCT05481320|594034368|FG000|Overall Study|No longer a primary caregiver|3|||
164454485|NCT05481320|594034369|FG001|Overall Study|No longer a primary caregiver|0|||
164454486|NCT05481320|594034368|FG000|Overall Study|Unable to contact|1|||
164454487|NCT05481320|594034369|FG001|Overall Study|Unable to contact|0|||
164454488|NCT02923180|594034370|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
164454489|NCT02923180|594034370|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
164454490|NCT05198310|594034371|FG000|Overall Study|Lost to Follow-up|0|||
164454491|NCT05198310|594034372|FG001|Overall Study|Lost to Follow-up|1|||
164454492|NCT05198310|594034373|FG002|Overall Study|Lost to Follow-up|0|||
164406106|NCT01392300|593857426|FG001|Main Period (MP)|Lost to Follow-up|3|||
164406107|NCT01392300|593857427|FG002|Main Period (MP)|Lost to Follow-up|0|||
164406108|NCT01392300|593857425|FG000|Main Period (MP)|Non-compliance|1|||
164406109|NCT01392300|593857426|FG001|Main Period (MP)|Non-compliance|0|||
164406110|NCT01392300|593857427|FG002|Main Period (MP)|Non-compliance|0|||
164406111|NCT01392300|593857425|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
164406112|NCT01392300|593857426|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
164406113|NCT01392300|593857427|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
164406114|NCT01392300|593857425|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
164406115|NCT01392300|593857426|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
164406116|NCT01392300|593857427|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
164406117|NCT01392300|593857425|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
164406118|NCT01392300|593857426|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
164406119|NCT01392300|593857427|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
164406120|NCT01392300|593857425|FG000|Open Label Extension (OLEX) Period|Death|0|||
164406121|NCT01392300|593857426|FG001|Open Label Extension (OLEX) Period|Death|0|||
164406122|NCT01392300|593857427|FG002|Open Label Extension (OLEX) Period|Death|4|||
164406123|NCT01392300|593857425|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
164406124|NCT01392300|593857426|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
164406125|NCT01392300|593857427|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
164406126|NCT01392300|593857425|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
164406127|NCT01392300|593857426|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
164406128|NCT01392300|593857427|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
164406129|NCT01392300|593857425|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
164406130|NCT01392300|593857426|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
164406131|NCT01392300|593857427|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
164406132|NCT02487498|593857430|FG000|Period: Period 1|Adverse Event|2|||
164406133|NCT02487498|593857431|FG001|Period: Period 1|Adverse Event|4|||
164406134|NCT02487498|593857430|FG000|Period: Period 1|Subject/guardian decision|2|||
164406135|NCT02487498|593857431|FG001|Period: Period 1|Subject/guardian decision|4|||
164406136|NCT02487498|593857430|FG000|Period: Period 1|Lost to Follow-up|0|||
164406137|NCT02487498|593857431|FG001|Period: Period 1|Lost to Follow-up|2|||
164406138|NCT02487498|593857430|FG000|Period: Period 1|Lack of Efficacy|1|||
164406139|NCT02487498|593857431|FG001|Period: Period 1|Lack of Efficacy|0|||
164406140|NCT02487498|593857430|FG000|Period: Period 1|Physician Decision|0|||
164406141|NCT02487498|593857431|FG001|Period: Period 1|Physician Decision|1|||
164406142|NCT02487498|593857430|FG000|Period: Period 1|Protocol deviation|1|||
164406143|NCT02487498|593857431|FG001|Period: Period 1|Protocol deviation|0|||
164406144|NCT02487498|593857430|FG000|Period: Washout|Subject/guardian decision|0|||
164406145|NCT02487498|593857431|FG001|Period: Washout|Subject/guardian decision|5|||
164406146|NCT02487498|593857430|FG000|Period: Washout|Lack of Efficacy|1|||
164406147|NCT02487498|593857431|FG001|Period: Washout|Lack of Efficacy|1|||
164406148|NCT02487498|593857430|FG000|Period: Washout|Physician Decision|1|||
164406149|NCT02487498|593857431|FG001|Period: Washout|Physician Decision|0|||
164406150|NCT02487498|593857430|FG000|Period: Washout|Non-compliance with study treatment|0|||
164406151|NCT02487498|593857431|FG001|Period: Washout|Non-compliance with study treatment|1|||
164406152|NCT02487498|593857430|FG000|Period: Period 2|Adverse Event|2|||
164406153|NCT02487498|593857431|FG001|Period: Period 2|Adverse Event|2|||
164406154|NCT02487498|593857430|FG000|Period: Period 2|Subject/guardian decision|2|||
164406155|NCT02487498|593857431|FG001|Period: Period 2|Subject/guardian decision|1|||
164406156|NCT02487498|593857430|FG000|Period: Period 2|Lost to Follow-up|1|||
164406157|NCT02487498|593857431|FG001|Period: Period 2|Lost to Follow-up|1|||
164406158|NCT02487498|593857430|FG000|Period: Period 2|Death|0|||
164406159|NCT02487498|593857431|FG001|Period: Period 2|Death|1|||
164406160|NCT02487498|593857430|FG000|Period: Period 2|Physician Decision|1|||
164406161|NCT02487498|593857431|FG001|Period: Period 2|Physician Decision|0|||
164406162|NCT00755222|593857435|FG000|Overall Study|Withdrawal by Subject|4|||
164406163|NCT00755222|593857436|FG001|Overall Study|Withdrawal by Subject|2|||
164406164|NCT00755222|593857435|FG000|Overall Study|Adverse Event|2|||
164406165|NCT00755222|593857436|FG001|Overall Study|Adverse Event|0|||
164406166|NCT00755222|593857435|FG000|Overall Study|Protocol Violation|2|||
164454493|NCT05198310|594034374|FG003|Overall Study|Lost to Follow-up|0|||
164454494|NCT05198310|594034375|FG004|Overall Study|Lost to Follow-up|0|||
164706922|NCT00077857|594953503|FG000|Overall Study|Adverse Event|30|||
164706923|NCT00077857|594953504|FG001|Overall Study|Adverse Event|32|||
164706924|NCT00077857|594953503|FG000|Overall Study|Death|7|||
164706925|NCT00077857|594953504|FG001|Overall Study|Death|3|||
164706926|NCT00077857|594953503|FG000|Overall Study|Insufficient therapeutic response|112|||
164706927|NCT00077857|594953504|FG001|Overall Study|Insufficient therapeutic response|128|||
164706928|NCT00077857|594953503|FG000|Overall Study|Violation of selection criteria at entry|3|||
164706929|NCT00077857|594953504|FG001|Overall Study|Violation of selection criteria at entry|1|||
164706930|NCT00077857|594953503|FG000|Overall Study|Other protocol violation|0|||
164706931|NCT00077857|594953504|FG001|Overall Study|Other protocol violation|1|||
164706932|NCT00077857|594953503|FG000|Overall Study|Refused treatment|29|||
164706933|NCT00077857|594953504|FG001|Overall Study|Refused treatment|21|||
164406167|NCT00755222|593857436|FG001|Overall Study|Protocol Violation|0|||
164406168|NCT00331344|593857437|FG000|Phase I|Adverse Event|0|||
164406169|NCT00331344|593857438|FG001|Phase I|Adverse Event|0|||
164406170|NCT00331344|593857439|FG002|Phase I|Adverse Event|0|||
164406171|NCT00331344|593857440|FG003|Phase I|Adverse Event|1|||
164406172|NCT00331344|593857441|FG004|Phase I|Adverse Event|2|||
164406173|NCT00331344|593857442|FG005|Phase I|Adverse Event|2|||
164406174|NCT00331344|593857443|FG006|Phase I|Adverse Event|0|||
164406175|NCT00331344|593857444|FG007|Phase I|Adverse Event|1|||
164406176|NCT00331344|593857445|FG008|Phase I|Adverse Event|0|||
164406177|NCT00331344|593857437|FG000|Phase II|Death|0|||
164406178|NCT00331344|593857438|FG001|Phase II|Death|0|||
164406179|NCT00331344|593857439|FG002|Phase II|Death|0|||
164406180|NCT00331344|593857440|FG003|Phase II|Death|0|||
164406181|NCT00331344|593857441|FG004|Phase II|Death|0|||
164406182|NCT00331344|593857442|FG005|Phase II|Death|0|||
164406183|NCT00331344|593857443|FG006|Phase II|Death|0|||
164406184|NCT00331344|593857444|FG007|Phase II|Death|0|||
164406185|NCT00331344|593857445|FG008|Phase II|Death|4|||
164406186|NCT02940574|593857452|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
164406187|NCT02940574|593857453|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
164406188|NCT02940574|593857452|FG000|1-year Follow-up|Lost to Follow-up|3|||
164406189|NCT02940574|593857453|FG001|1-year Follow-up|Lost to Follow-up|4|||
164406190|NCT04538144|593857454|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
164406191|NCT04538144|593857455|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
164406192|NCT04538144|593857456|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
164406193|NCT04538144|593857457|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
164406194|NCT00520975|593857462|FG000|Overall Study|Disease progression|31|||
164406195|NCT00520975|593857463|FG001|Overall Study|Disease progression|23|||
164406196|NCT00520975|593857462|FG000|Overall Study|Adverse Event|7|||
164406197|NCT00520975|593857463|FG001|Overall Study|Adverse Event|10|||
164406198|NCT00520975|593857462|FG000|Overall Study|Death|0|||
164406199|NCT00520975|593857463|FG001|Overall Study|Death|2|||
164406200|NCT00520975|593857462|FG000|Overall Study|Withdrawal by Subject|3|||
164406201|NCT00520975|593857463|FG001|Overall Study|Withdrawal by Subject|5|||
164406202|NCT00520975|593857462|FG000|Overall Study|Other therapy|2|||
164406203|NCT00520975|593857463|FG001|Overall Study|Other therapy|4|||
164406204|NCT00520975|593857462|FG000|Overall Study|Other reasons|4|||
164406205|NCT00520975|593857463|FG001|Overall Study|Other reasons|2|||
164406206|NCT00520975|593857462|FG000|Overall Study|Not start protocol therapy|1|||
164406207|NCT00520975|593857463|FG001|Overall Study|Not start protocol therapy|2|||
164406208|NCT01682213|593857464|FG000|Overall Study|Withdrawal by Subject|2|||
164406209|NCT04382924|593857465|FG000|Overall Study|Death|2|||
164406210|NCT04382924|593857466|FG001|Overall Study|Death|5|||
164406211|NCT04382924|593857467|FG002|Overall Study|Death|4|||
164406212|NCT04382924|593857465|FG000|Overall Study|Protocol Violation|0|||
164406213|NCT04382924|593857466|FG001|Overall Study|Protocol Violation|1|||
164406214|NCT04382924|593857467|FG002|Overall Study|Protocol Violation|1|||
164406215|NCT04382924|593857465|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
164406216|NCT04382924|593857466|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
164406217|NCT04382924|593857467|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
164406218|NCT04382924|593857465|FG000|Overall Study|Withdrawal by Subject|6|||
164406219|NCT04382924|593857466|FG001|Overall Study|Withdrawal by Subject|3|||
164406220|NCT04382924|593857467|FG002|Overall Study|Withdrawal by Subject|6|||
164406221|NCT00642902|593857468|FG000|Overall Study|Adverse Event|0|||
164454495|NCT05198310|594034376|FG005|Overall Study|Lost to Follow-up|0|||
164406222|NCT00642902|593857469|FG001|Overall Study|Adverse Event|1|||
164406223|NCT00642902|593857470|FG002|Overall Study|Adverse Event|3|||
164406224|NCT00642902|593857471|FG003|Overall Study|Adverse Event|1|||
164406225|NCT00642902|593857468|FG000|Overall Study|Lost to Follow-up|1|||
164454496|NCT05198310|594034377|FG006|Overall Study|Lost to Follow-up|0|||
164706934|NCT00077857|594953503|FG000|Overall Study|Failure to return|5|||
164406226|NCT00642902|593857469|FG001|Overall Study|Lost to Follow-up|1|||
164406227|NCT00642902|593857470|FG002|Overall Study|Lost to Follow-up|0|||
164406228|NCT00642902|593857471|FG003|Overall Study|Lost to Follow-up|0|||
164406229|NCT00642902|593857468|FG000|Overall Study|Lack of Efficacy|0|||
164706935|NCT00077857|594953504|FG001|Overall Study|Failure to return|5|||
164706936|NCT00077857|594953503|FG000|Overall Study|Other|15|||
164454497|NCT05198310|594034378|FG007|Overall Study|Lost to Follow-up|0|||
164454498|NCT05198310|594034371|FG000|Overall Study|Withdrawal by Subject|0|||
164454499|NCT05198310|594034372|FG001|Overall Study|Withdrawal by Subject|0|||
164454500|NCT05198310|594034373|FG002|Overall Study|Withdrawal by Subject|0|||
164454501|NCT05198310|594034374|FG003|Overall Study|Withdrawal by Subject|2|||
164454502|NCT05198310|594034375|FG004|Overall Study|Withdrawal by Subject|0|||
164454503|NCT05198310|594034376|FG005|Overall Study|Withdrawal by Subject|2|||
164454504|NCT05198310|594034377|FG006|Overall Study|Withdrawal by Subject|1|||
164454505|NCT05198310|594034378|FG007|Overall Study|Withdrawal by Subject|3|||
164454506|NCT04116736|594034379|FG000|Overall Study|Withdrew consent during study|3|||
164454507|NCT04116736|594034380|FG001|Overall Study|Withdrew consent during study|1|||
164597838|NCT01496430|594551259|FG000|Overall Study|Other|2|||
164597839|NCT01496430|594551260|FG001|Overall Study|Other|0|||
164597840|NCT01496430|594551261|FG002|Overall Study|Other|0|||
164597841|NCT01100307|594551262|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
164597842|NCT01100307|594551263|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
164597843|NCT01100307|594551262|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
164597844|NCT01100307|594551263|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
164706937|NCT00077857|594953504|FG001|Overall Study|Other|13|||
164706938|NCT05084963|594953507|FG000|Overall Study|Withdrawal by Subject|0|||
164706939|NCT05084963|594953508|FG001|Overall Study|Withdrawal by Subject|0|||
164406230|NCT00642902|593857469|FG001|Overall Study|Lack of Efficacy|3|||
164406231|NCT00642902|593857470|FG002|Overall Study|Lack of Efficacy|3|||
164406232|NCT00642902|593857471|FG003|Overall Study|Lack of Efficacy|0|||
164406233|NCT00642902|593857468|FG000|Overall Study|Death|1|||
164406234|NCT00642902|593857469|FG001|Overall Study|Death|0|||
164406235|NCT00642902|593857470|FG002|Overall Study|Death|0|||
164406236|NCT00642902|593857471|FG003|Overall Study|Death|0|||
164406237|NCT00642902|593857468|FG000|Overall Study|Premature termination of clinical trial|37|||
164406238|NCT00642902|593857469|FG001|Overall Study|Premature termination of clinical trial|32|||
164406239|NCT00642902|593857470|FG002|Overall Study|Premature termination of clinical trial|35|||
164406240|NCT00642902|593857471|FG003|Overall Study|Premature termination of clinical trial|35|||
164406241|NCT00642902|593857468|FG000|Overall Study|Randomized, but not treated|0|||
164406242|NCT00642902|593857469|FG001|Overall Study|Randomized, but not treated|0|||
164406243|NCT00642902|593857470|FG002|Overall Study|Randomized, but not treated|1|||
164406244|NCT00642902|593857471|FG003|Overall Study|Randomized, but not treated|0|||
164406245|NCT00642902|593857468|FG000|Overall Study|Other|1|||
164406246|NCT00642902|593857469|FG001|Overall Study|Other|5|||
164406247|NCT00642902|593857470|FG002|Overall Study|Other|1|||
164406248|NCT00642902|593857471|FG003|Overall Study|Other|4|||
164406249|NCT00429663|593857472|FG000|Overall Study|Lost to Follow-up|24|||
164406250|NCT00429663|593857473|FG001|Overall Study|Lost to Follow-up|31|||
164406251|NCT00429663|593857472|FG000|Overall Study|Physician Decision|6|||
164406252|NCT00429663|593857473|FG001|Overall Study|Physician Decision|3|||
164406253|NCT00429663|593857472|FG000|Overall Study|Withdrawal by Subject|2|||
164406254|NCT00429663|593857473|FG001|Overall Study|Withdrawal by Subject|5|||
164406255|NCT00429663|593857472|FG000|Overall Study|Death|4|||
164406256|NCT00429663|593857473|FG001|Overall Study|Death|0|||
164406257|NCT04207840|593857474|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
164406258|NCT04207840|593857475|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
164406259|NCT04207840|593857476|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
164406260|NCT04207840|593857474|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
164406261|NCT04207840|593857475|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
164406262|NCT04207840|593857476|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
164406263|NCT03243422|593857479|FG000|Overall Study|Death|20|||
164406264|NCT03243422|593857480|FG001|Overall Study|Death|21|||
164406265|NCT03243422|593857479|FG000|Overall Study|Lost to Follow-up|9|||
164406266|NCT03243422|593857480|FG001|Overall Study|Lost to Follow-up|21|||
164406267|NCT03243422|593857479|FG000|Overall Study|Withdrawal by Subject|22|||
164406268|NCT03243422|593857480|FG001|Overall Study|Withdrawal by Subject|8|||
164406269|NCT03420781|593857483|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
164406270|NCT03420781|593857484|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
164406271|NCT03420781|593857485|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
164406272|NCT03420781|593857486|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
164406273|NCT03420781|593857487|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
164406274|NCT03420781|593857483|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
164406275|NCT03420781|593857484|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
164406276|NCT03420781|593857485|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
164406277|NCT03420781|593857486|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
164597845|NCT01100307|594551262|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
164597846|NCT01100307|594551263|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
164706940|NCT05084963|594953509|FG002|Overall Study|Withdrawal by Subject|1|||
164406278|NCT03420781|593857487|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
164406279|NCT03420781|593857483|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
164597847|NCT01100307|594551262|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
164406280|NCT03420781|593857484|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
164454508|NCT04116736|594034379|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
164454509|NCT04116736|594034380|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
164454510|NCT04116736|594034379|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
164454511|NCT04116736|594034380|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
164454512|NCT04116736|594034379|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
164454513|NCT04116736|594034380|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
164454514|NCT04116736|594034379|FG000|Overall Study|Subject was enrolled in error|2|||
164454515|NCT04116736|594034380|FG001|Overall Study|Subject was enrolled in error|0|||
164454516|NCT04116736|594034379|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
164454517|NCT04116736|594034380|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
164454518|NCT04116736|594034379|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
164454519|NCT04116736|594034380|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
164454520|NCT04116736|594034379|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
164454521|NCT04116736|594034380|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
164454522|NCT01872078|594034388|FG000|Overall Study|Adverse Event|0|||
164454523|NCT01872078|594034389|FG001|Overall Study|Adverse Event|0|||
164454524|NCT01872078|594034390|FG002|Overall Study|Adverse Event|1|||
164454525|NCT01872078|594034391|FG003|Overall Study|Adverse Event|0|||
164454526|NCT01872078|594034388|FG000|Overall Study|Dose administration non-compliance|0|||
164454527|NCT01872078|594034389|FG001|Overall Study|Dose administration non-compliance|0|||
164454528|NCT01872078|594034390|FG002|Overall Study|Dose administration non-compliance|0|||
164454529|NCT01872078|594034391|FG003|Overall Study|Dose administration non-compliance|1|||
164454530|NCT01872078|594034388|FG000|Overall Study|Protocol Violation|0|||
164454531|NCT01872078|594034389|FG001|Overall Study|Protocol Violation|0|||
164454532|NCT01872078|594034390|FG002|Overall Study|Protocol Violation|1|||
164454533|NCT01872078|594034391|FG003|Overall Study|Protocol Violation|0|||
164454534|NCT01872078|594034388|FG000|Overall Study|Withdrawal by Subject|0|||
164454535|NCT01872078|594034389|FG001|Overall Study|Withdrawal by Subject|0|||
164454536|NCT01872078|594034390|FG002|Overall Study|Withdrawal by Subject|1|||
164454537|NCT01872078|594034391|FG003|Overall Study|Withdrawal by Subject|0|||
164454538|NCT01872078|594034388|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
164454539|NCT01872078|594034389|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
164454540|NCT01872078|594034390|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
164454541|NCT01872078|594034391|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
164454542|NCT00753090|594036242|FG000|Overall Study|Withdrawal by Subject|10|||
164454543|NCT00753090|594036243|FG001|Overall Study|Withdrawal by Subject|10|||
164454544|NCT00753090|594036242|FG000|Overall Study|Death|17|||
164454545|NCT00753090|594036243|FG001|Overall Study|Death|6|||
164454546|NCT00753090|594036242|FG000|Overall Study|Study Prosthesis Removed|12|||
164454547|NCT00753090|594036243|FG001|Overall Study|Study Prosthesis Removed|3|||
164454548|NCT00753090|594036242|FG000|Overall Study|Lost to Follow-up|2|||
164454549|NCT00753090|594036243|FG001|Overall Study|Lost to Follow-up|2|||
164454550|NCT00753090|594036242|FG000|Overall Study|Other|127|||
164454551|NCT00753090|594036243|FG001|Overall Study|Other|75|||
164454552|NCT04052516|594036245|FG000|Overall Study|Withdrawal by Subject|4|||
164454553|NCT04052516|594036246|FG001|Overall Study|Withdrawal by Subject|5|||
164454554|NCT04052516|594036247|FG002|Overall Study|Withdrawal by Subject|6|||
164454555|NCT04052516|594036245|FG000|Overall Study|Adverse Event|3|||
164454556|NCT04052516|594036246|FG001|Overall Study|Adverse Event|2|||
164454557|NCT04052516|594036247|FG002|Overall Study|Adverse Event|8|||
164454558|NCT04052516|594036245|FG000|Overall Study|Lost to Follow-up|2|||
164454559|NCT04052516|594036246|FG001|Overall Study|Lost to Follow-up|5|||
164454560|NCT04052516|594036247|FG002|Overall Study|Lost to Follow-up|3|||
164454561|NCT04052516|594036245|FG000|Overall Study|Protocol Violation|1|||
164454562|NCT04052516|594036246|FG001|Overall Study|Protocol Violation|1|||
164454563|NCT04052516|594036247|FG002|Overall Study|Protocol Violation|0|||
164454564|NCT04052516|594036245|FG000|Overall Study|Death|1|||
164454565|NCT04052516|594036246|FG001|Overall Study|Death|0|||
164454566|NCT04052516|594036247|FG002|Overall Study|Death|0|||
164454567|NCT04052516|594036245|FG000|Overall Study|Physician Decision|0|||
164454568|NCT04052516|594036246|FG001|Overall Study|Physician Decision|1|||
164454569|NCT04052516|594036247|FG002|Overall Study|Physician Decision|0|||
164454570|NCT04052516|594036245|FG000|Overall Study|Pregnancy|1|||
164454571|NCT04052516|594036246|FG001|Overall Study|Pregnancy|0|||
164454572|NCT04052516|594036247|FG002|Overall Study|Pregnancy|0|||
164454573|NCT04052516|594036245|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
164454574|NCT04052516|594036246|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
164454575|NCT04052516|594036247|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
164454576|NCT04052516|594036245|FG000|Overall Study|Reason not recorded|0|||
164454577|NCT04052516|594036246|FG001|Overall Study|Reason not recorded|1|||
164454578|NCT04052516|594036247|FG002|Overall Study|Reason not recorded|0|||
164454579|NCT04521478|594036251|FG000|Overall Study|Protocol Violation|2|||
164454580|NCT04521478|594036252|FG001|Overall Study|Protocol Violation|0|||
164706941|NCT06354998|594953510|FG000|Overall Study|Withdrawal by Subject|3|||
164706942|NCT06354998|594953511|FG001|Overall Study|Withdrawal by Subject|0|||
164706943|NCT03819049|594953512|FG000|Overall Study|Lost to Follow-up|1|||
164706944|NCT03819049|594953513|FG001|Overall Study|Lost to Follow-up|2|||
164706945|NCT03819049|594953514|FG002|Overall Study|Lost to Follow-up|9|||
164706946|NCT03819049|594953515|FG003|Overall Study|Lost to Follow-up|0|||
164706947|NCT03819049|594953516|FG004|Overall Study|Lost to Follow-up|3|||
164706948|NCT03819049|594953517|FG005|Overall Study|Lost to Follow-up|1|||
164706949|NCT03819049|594953518|FG006|Overall Study|Lost to Follow-up|0|||
164706950|NCT03819049|594953512|FG000|Overall Study|Withdrawal by Subject|0|||
164706951|NCT03819049|594953513|FG001|Overall Study|Withdrawal by Subject|0|||
164706952|NCT03819049|594953514|FG002|Overall Study|Withdrawal by Subject|18|||
164706953|NCT03819049|594953515|FG003|Overall Study|Withdrawal by Subject|0|||
164706954|NCT03819049|594953516|FG004|Overall Study|Withdrawal by Subject|10|||
164706955|NCT03819049|594953517|FG005|Overall Study|Withdrawal by Subject|9|||
164706956|NCT03819049|594953518|FG006|Overall Study|Withdrawal by Subject|1|||
164706957|NCT03819049|594953512|FG000|Overall Study|Ongoing|0|||
164706958|NCT03819049|594953513|FG001|Overall Study|Ongoing|0|||
164706959|NCT03819049|594953514|FG002|Overall Study|Ongoing|75|||
164706960|NCT03819049|594953515|FG003|Overall Study|Ongoing|0|||
164706961|NCT03819049|594953516|FG004|Overall Study|Ongoing|41|||
164706962|NCT03819049|594953517|FG005|Overall Study|Ongoing|0|||
164706963|NCT03819049|594953518|FG006|Overall Study|Ongoing|0|||
164706964|NCT03819049|594953512|FG000|Overall Study|Other|0|||
164706965|NCT03819049|594953513|FG001|Overall Study|Other|0|||
164706966|NCT03819049|594953514|FG002|Overall Study|Other|2|||
164406281|NCT03420781|593857485|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
164406282|NCT03420781|593857486|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
164406283|NCT03420781|593857487|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
164406284|NCT03420781|593857483|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
164406285|NCT03420781|593857484|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
164406286|NCT03420781|593857485|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
164406287|NCT03420781|593857486|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
164406288|NCT03420781|593857487|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
164406289|NCT03420781|593857483|FG000|Treatment Period (40 Weeks)|Death|2|||
164406290|NCT03420781|593857484|FG001|Treatment Period (40 Weeks)|Death|2|||
164406291|NCT03420781|593857485|FG002|Treatment Period (40 Weeks)|Death|0|||
164406292|NCT03420781|593857486|FG003|Treatment Period (40 Weeks)|Death|0|||
164406293|NCT03420781|593857487|FG004|Treatment Period (40 Weeks)|Death|0|||
164406294|NCT03420781|593857483|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
164406295|NCT03420781|593857484|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
164406296|NCT03420781|593857485|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
164406297|NCT03420781|593857486|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
164406298|NCT03420781|593857487|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
164406299|NCT03420781|593857483|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
164406300|NCT03420781|593857484|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
164406301|NCT03420781|593857485|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
164406302|NCT03420781|593857486|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
164406303|NCT03420781|593857487|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
164406304|NCT03420781|593857483|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
164406305|NCT03420781|593857484|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
164406306|NCT03420781|593857485|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
164406307|NCT03420781|593857486|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
164406308|NCT03420781|593857487|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
164406309|NCT03420781|593857483|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
164406310|NCT03420781|593857484|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
164406311|NCT03420781|593857485|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
164406312|NCT03420781|593857486|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
164406313|NCT03420781|593857487|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
164406314|NCT03420781|593857483|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
164406315|NCT03420781|593857484|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
164406316|NCT03420781|593857485|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
164406317|NCT03420781|593857486|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
164406318|NCT03420781|593857487|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
164406319|NCT03420781|593857483|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
164406320|NCT03420781|593857484|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
164406321|NCT03420781|593857485|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
164454581|NCT04521478|594036253|FG002|Overall Study|Protocol Violation|1|||
164706967|NCT03819049|594953515|FG003|Overall Study|Other|0|||
164706968|NCT03819049|594953516|FG004|Overall Study|Other|0|||
164706969|NCT03819049|594953517|FG005|Overall Study|Other|0|||
164706970|NCT03819049|594953518|FG006|Overall Study|Other|0|||
164706971|NCT03819049|594953512|FG000|Overall Study|Randomized but not vaccinated|0|||
164706972|NCT03819049|594953513|FG001|Overall Study|Randomized but not vaccinated|0|||
164454582|NCT04521478|594036254|FG003|Overall Study|Protocol Violation|0|||
164454583|NCT04521478|594036255|FG004|Overall Study|Protocol Violation|0|||
164454584|NCT04521478|594036256|FG005|Overall Study|Protocol Violation|0|||
164454585|NCT04521478|594036251|FG000|Overall Study|Technical Problems|0|||
164454586|NCT04521478|594036252|FG001|Overall Study|Technical Problems|0|||
164454587|NCT04521478|594036253|FG002|Overall Study|Technical Problems|0|||
164454588|NCT04521478|594036254|FG003|Overall Study|Technical Problems|1|||
164454589|NCT04521478|594036255|FG004|Overall Study|Technical Problems|0|||
164454590|NCT04521478|594036256|FG005|Overall Study|Technical Problems|0|||
164454591|NCT04521478|594036251|FG000|Overall Study|Burden of Study Procedures|1|||
164454592|NCT04521478|594036252|FG001|Overall Study|Burden of Study Procedures|0|||
164454593|NCT04521478|594036253|FG002|Overall Study|Burden of Study Procedures|0|||
164454594|NCT04521478|594036254|FG003|Overall Study|Burden of Study Procedures|1|||
164454595|NCT04521478|594036255|FG004|Overall Study|Burden of Study Procedures|0|||
164454596|NCT04521478|594036256|FG005|Overall Study|Burden of Study Procedures|1|||
164454597|NCT04521478|594036251|FG000|Overall Study|Lack of Efficacy|0|||
164454598|NCT04521478|594036252|FG001|Overall Study|Lack of Efficacy|0|||
164454599|NCT04521478|594036253|FG002|Overall Study|Lack of Efficacy|0|||
164454600|NCT04521478|594036254|FG003|Overall Study|Lack of Efficacy|0|||
164454601|NCT04521478|594036255|FG004|Overall Study|Lack of Efficacy|1|||
164454602|NCT04521478|594036256|FG005|Overall Study|Lack of Efficacy|1|||
164454603|NCT04521478|594036251|FG000|Overall Study|Adverse Event|7|||
164454604|NCT04521478|594036252|FG001|Overall Study|Adverse Event|0|||
164454605|NCT04521478|594036253|FG002|Overall Study|Adverse Event|2|||
164454606|NCT04521478|594036254|FG003|Overall Study|Adverse Event|1|||
164454607|NCT04521478|594036255|FG004|Overall Study|Adverse Event|2|||
164597848|NCT01100307|594551263|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
164597849|NCT01100307|594551262|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
164406322|NCT03420781|593857486|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
164406323|NCT03420781|593857487|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
164406324|NCT03420781|593857483|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
164406325|NCT03420781|593857484|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
164406326|NCT03420781|593857485|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
164406327|NCT03420781|593857486|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
164406328|NCT03420781|593857487|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
164406329|NCT03420781|593857483|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
164406330|NCT03420781|593857484|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
164406331|NCT03420781|593857485|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
164406332|NCT03420781|593857486|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
164406333|NCT03420781|593857487|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
164406334|NCT01226511|593857492|FG000|Acute Treatment Period|Adverse Event|7|||
164406335|NCT01226511|593857493|FG001|Acute Treatment Period|Adverse Event|6|||
164406336|NCT01226511|593857492|FG000|Acute Treatment Period|Lack of Efficacy|2|||
164406337|NCT01226511|593857493|FG001|Acute Treatment Period|Lack of Efficacy|1|||
164406338|NCT01226511|593857492|FG000|Acute Treatment Period|Lost to Follow-up|3|||
164406339|NCT01226511|593857493|FG001|Acute Treatment Period|Lost to Follow-up|6|||
164406340|NCT01226511|593857492|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
164406341|NCT01226511|593857493|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
164406342|NCT01226511|593857492|FG000|Acute Treatment Period|Protocol Violation|5|||
164406343|NCT01226511|593857493|FG001|Acute Treatment Period|Protocol Violation|5|||
164406344|NCT01226511|593857492|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
164406345|NCT01226511|593857493|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
164406346|NCT01226511|593857492|FG000|Extension Treatment Period|Adverse Event|8|||
164406347|NCT01226511|593857493|FG001|Extension Treatment Period|Adverse Event|8|||
164406348|NCT01226511|593857492|FG000|Extension Treatment Period|Lack of Efficacy|3|||
164406349|NCT01226511|593857493|FG001|Extension Treatment Period|Lack of Efficacy|2|||
164406350|NCT01226511|593857492|FG000|Extension Treatment Period|Lost to Follow-up|4|||
164406351|NCT01226511|593857493|FG001|Extension Treatment Period|Lost to Follow-up|3|||
164406352|NCT01226511|593857492|FG000|Extension Treatment Period|Protocol Violation|2|||
164406353|NCT01226511|593857493|FG001|Extension Treatment Period|Protocol Violation|2|||
164406354|NCT01226511|593857492|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
164406355|NCT01226511|593857493|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
164406356|NCT01226511|593857492|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
164406357|NCT01226511|593857493|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
164406358|NCT01226511|593857492|FG000|Extension Treatment Period|Sponsor Decision|1|||
164406359|NCT01226511|593857493|FG001|Extension Treatment Period|Sponsor Decision|1|||
164454608|NCT04521478|594036256|FG005|Overall Study|Adverse Event|7|||
164454609|NCT04521478|594036251|FG000|Overall Study|No Reason Available|0|||
164454610|NCT04521478|594036252|FG001|Overall Study|No Reason Available|2|||
164454611|NCT04521478|594036253|FG002|Overall Study|No Reason Available|0|||
164454612|NCT04521478|594036254|FG003|Overall Study|No Reason Available|0|||
164454613|NCT04521478|594036255|FG004|Overall Study|No Reason Available|1|||
164454614|NCT04521478|594036256|FG005|Overall Study|No Reason Available|0|||
164706973|NCT03819049|594953514|FG002|Overall Study|Randomized but not vaccinated|0|||
164706974|NCT03819049|594953515|FG003|Overall Study|Randomized but not vaccinated|1|||
164706975|NCT03819049|594953516|FG004|Overall Study|Randomized but not vaccinated|0|||
164706976|NCT03819049|594953517|FG005|Overall Study|Randomized but not vaccinated|2|||
164706977|NCT03819049|594953518|FG006|Overall Study|Randomized but not vaccinated|1|||
164706978|NCT03819049|594953512|FG000|Overall Study|Physician Decision|0|||
164706979|NCT03819049|594953513|FG001|Overall Study|Physician Decision|0|||
164706980|NCT03819049|594953514|FG002|Overall Study|Physician Decision|0|||
164706981|NCT03819049|594953515|FG003|Overall Study|Physician Decision|0|||
164706982|NCT03819049|594953516|FG004|Overall Study|Physician Decision|0|||
164706983|NCT03819049|594953517|FG005|Overall Study|Physician Decision|0|||
164706984|NCT03819049|594953518|FG006|Overall Study|Physician Decision|1|||
164706985|NCT00816361|594953519|FG000|Overall Study|Withdrawal by Subject|0|||
164706986|NCT00816361|594953520|FG001|Overall Study|Withdrawal by Subject|0|||
164706987|NCT00816361|594953521|FG002|Overall Study|Withdrawal by Subject|0|||
164706988|NCT00816361|594953522|FG003|Overall Study|Withdrawal by Subject|0|||
164706989|NCT00816361|594953523|FG004|Overall Study|Withdrawal by Subject|1|||
164706990|NCT00816361|594953524|FG005|Overall Study|Withdrawal by Subject|2|||
164706991|NCT00816361|594953525|FG006|Overall Study|Withdrawal by Subject|0|||
164706992|NCT00816361|594953526|FG007|Overall Study|Withdrawal by Subject|2|||
164706993|NCT00816361|594953527|FG008|Overall Study|Withdrawal by Subject|1|||
164706994|NCT00816361|594953519|FG000|Overall Study|Death|4|||
164706995|NCT00816361|594953520|FG001|Overall Study|Death|3|||
164706996|NCT00816361|594953521|FG002|Overall Study|Death|3|||
164454615|NCT04521478|594036251|FG000|Overall Study|Other than listed|3|||
164454616|NCT04521478|594036252|FG001|Overall Study|Other than listed|3|||
164454617|NCT04521478|594036253|FG002|Overall Study|Other than listed|3|||
164454618|NCT04521478|594036254|FG003|Overall Study|Other than listed|2|||
164454619|NCT04521478|594036255|FG004|Overall Study|Other than listed|3|||
164454620|NCT04521478|594036256|FG005|Overall Study|Other than listed|3|||
164454621|NCT04521478|594036251|FG000|Overall Study|Not treated|0|||
164454622|NCT04521478|594036252|FG001|Overall Study|Not treated|0|||
164454623|NCT04521478|594036253|FG002|Overall Study|Not treated|0|||
164454624|NCT04521478|594036254|FG003|Overall Study|Not treated|0|||
164454625|NCT04521478|594036255|FG004|Overall Study|Not treated|0|||
164454626|NCT04521478|594036256|FG005|Overall Study|Not treated|1|||
164454627|NCT02630823|594036268|FG000|Overall Study|Withdrawal by Subject|1|||
164454628|NCT02630823|594036268|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
164454629|NCT02682316|594036281|FG000|Overall Study|Benign Final Pathology|27|||
164454630|NCT02682316|594036282|FG001|Overall Study|Benign Final Pathology|26|||
164454631|NCT02682316|594036281|FG000|Overall Study|Reoperation before 30 days|7|||
164454632|NCT02682316|594036282|FG001|Overall Study|Reoperation before 30 days|6|||
164454633|NCT02682316|594036281|FG000|Overall Study|Ineligible|1|||
164454634|NCT02682316|594036282|FG001|Overall Study|Ineligible|0|||
164454635|NCT02682316|594036281|FG000|Overall Study|Death|1|||
164454636|NCT02682316|594036282|FG001|Overall Study|Death|0|||
164706997|NCT00816361|594953522|FG003|Overall Study|Death|3|||
164706998|NCT00816361|594953523|FG004|Overall Study|Death|1|||
164706999|NCT00816361|594953524|FG005|Overall Study|Death|1|||
164707000|NCT00816361|594953525|FG006|Overall Study|Death|3|||
164707001|NCT00816361|594953526|FG007|Overall Study|Death|7|||
164454637|NCT02682316|594036281|FG000|Overall Study|Lost to Follow-up|7|||
164454638|NCT02682316|594036282|FG001|Overall Study|Lost to Follow-up|3|||
164454639|NCT04083235|594036309|FG000|Overall Study|Death|252|||
164707002|NCT00816361|594953527|FG008|Overall Study|Death|8|||
164454640|NCT04083235|594036310|FG001|Overall Study|Death|277|||
164454641|NCT04083235|594036309|FG000|Overall Study|Withdrawal by Subject|13|||
164454642|NCT04083235|594036310|FG001|Overall Study|Withdrawal by Subject|17|||
164454643|NCT04083235|594036309|FG000|Overall Study|Lost to Follow-up|1|||
164454644|NCT04083235|594036310|FG001|Overall Study|Lost to Follow-up|1|||
164454645|NCT04083235|594036309|FG000|Overall Study|Does not meet entry criteria|1|||
164454646|NCT04083235|594036310|FG001|Overall Study|Does not meet entry criteria|0|||
164707003|NCT00816361|594953519|FG000|Overall Study|Other|0|||
164707004|NCT00816361|594953520|FG001|Overall Study|Other|0|||
164707005|NCT00816361|594953521|FG002|Overall Study|Other|0|||
164707006|NCT00816361|594953522|FG003|Overall Study|Other|0|||
164707007|NCT00816361|594953523|FG004|Overall Study|Other|0|||
164707008|NCT00816361|594953524|FG005|Overall Study|Other|0|||
164454647|NCT04083235|594036309|FG000|Overall Study|Did not receive treatment|13|||
164454648|NCT04083235|594036310|FG001|Overall Study|Did not receive treatment|8|||
164454649|NCT04083235|594036309|FG000|Overall Study|Ongoing at the time of DCO|44|||
164454650|NCT04083235|594036310|FG001|Overall Study|Ongoing at the time of DCO|7|||
164454651|NCT03016169|594036311|FG000|Overall Study|Lost to Follow-up|4|||
164454652|NCT03016169|594036311|FG000|Overall Study|Death|54|||
164707009|NCT00816361|594953525|FG006|Overall Study|Other|0|||
164707010|NCT00816361|594953526|FG007|Overall Study|Other|0|||
164707011|NCT00816361|594953527|FG008|Overall Study|Other|1|||
164707012|NCT02500641|594953528|FG000|Overall Study|Adverse Event|0|||
164707013|NCT02500641|594953529|FG001|Overall Study|Adverse Event|2|||
164707014|NCT02500641|594953528|FG000|Overall Study|Withdrawal by Subject|4|||
164454653|NCT03016169|594036311|FG000|Overall Study|Device Explant|11|||
164454654|NCT03016169|594036311|FG000|Overall Study|Withdrawal by Subject|19|||
164454655|NCT03016169|594036311|FG000|Overall Study|Other Reasons|1|||
164454656|NCT04060355|594036312|FG000|Overall Study|Lost to Follow-up|41|||
164454657|NCT01140880|594036313|FG000|Overall Study|Death|0|||
164454658|NCT01140880|594036314|FG001|Overall Study|Death|1|||
164454659|NCT01140880|594036313|FG000|Overall Study|Withdrawal by Subject|6|||
164454660|NCT01140880|594036314|FG001|Overall Study|Withdrawal by Subject|3|||
164454661|NCT01140880|594036313|FG000|Overall Study|Lost to Follow-up|8|||
164454662|NCT01140880|594036314|FG001|Overall Study|Lost to Follow-up|10|||
164454663|NCT01140880|594036313|FG000|Overall Study|Protocol Violation|0|||
164454664|NCT01140880|594036314|FG001|Overall Study|Protocol Violation|30|||
164454665|NCT02592330|594036315|FG000|Overall Study|Withdrawal by Subject|1|||
164454666|NCT02592330|594036316|FG001|Overall Study|Withdrawal by Subject|0|||
164454667|NCT02592330|594036315|FG000|Overall Study|Failed Biopsy|1|||
164454668|NCT02592330|594036316|FG001|Overall Study|Failed Biopsy|0|||
164454669|NCT04673929|594036317|FG000|Overall Study|Death|73|||
164454670|NCT04673929|594036317|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
164454671|NCT02807636|594036321|FG000|Overall Study|Lost to Follow-up|10|||
164454672|NCT02807636|594036322|FG001|Overall Study|Lost to Follow-up|13|||
164454673|NCT02807636|594036323|FG002|Overall Study|Lost to Follow-up|6|||
164454674|NCT02807636|594036321|FG000|Overall Study|Protocol Deviation|1|||
164454675|NCT02807636|594036322|FG001|Overall Study|Protocol Deviation|0|||
164454676|NCT02807636|594036323|FG002|Overall Study|Protocol Deviation|0|||
164454677|NCT02807636|594036321|FG000|Overall Study|Symptomatic Deterioration|0|||
164454678|NCT02807636|594036322|FG001|Overall Study|Symptomatic Deterioration|1|||
164454679|NCT02807636|594036323|FG002|Overall Study|Symptomatic Deterioration|0|||
164454680|NCT02807636|594036321|FG000|Overall Study|Withdrawal by Subject|39|||
164454681|NCT02807636|594036322|FG001|Overall Study|Withdrawal by Subject|28|||
164454682|NCT02807636|594036323|FG002|Overall Study|Withdrawal by Subject|24|||
164454683|NCT02807636|594036321|FG000|Overall Study|Death|303|||
164454684|NCT02807636|594036322|FG001|Overall Study|Death|332|||
164454685|NCT02807636|594036323|FG002|Overall Study|Death|272|||
164454686|NCT02807636|594036321|FG000|Overall Study|Study Terminated By Sponsor|47|||
164454687|NCT02807636|594036322|FG001|Overall Study|Study Terminated By Sponsor|76|||
164454688|NCT02807636|594036323|FG002|Overall Study|Study Terminated By Sponsor|60|||
164454689|NCT02807636|594036321|FG000|Overall Study|Physician Decision|0|||
164454690|NCT02807636|594036322|FG001|Overall Study|Physician Decision|1|||
164454691|NCT02807636|594036323|FG002|Overall Study|Physician Decision|0|||
164454692|NCT05082909|594036324|FG000|Overall Study|Protocol Violation|0|||
164454693|NCT05082909|594036325|FG001|Overall Study|Protocol Violation|0|||
164454694|NCT05082909|594036326|FG002|Overall Study|Protocol Violation|1|||
164454695|NCT05082909|594036327|FG003|Overall Study|Protocol Violation|0|||
164454696|NCT05082909|594036328|FG004|Overall Study|Protocol Violation|0|||
164454697|NCT05082909|594036329|FG005|Overall Study|Protocol Violation|0|||
164454698|NCT03526861|594036344|FG000|Initial Treatment Period|Not dosed|1|||
164454699|NCT03526861|594036345|FG001|Initial Treatment Period|Not dosed|1|||
164454700|NCT03526861|594036346|FG002|Initial Treatment Period|Not dosed|1|||
164454701|NCT03526861|594036347|FG003|Initial Treatment Period|Not dosed|0|||
164454702|NCT03526861|594036348|FG004|Initial Treatment Period|Not dosed|0|||
164454703|NCT03526861|594036349|FG005|Initial Treatment Period|Not dosed|0|||
164454704|NCT03526861|594036350|FG006|Initial Treatment Period|Not dosed|0|||
164454705|NCT03526861|594036351|FG007|Initial Treatment Period|Not dosed|0|||
164454706|NCT03526861|594036352|FG008|Initial Treatment Period|Not dosed|0|||
164454707|NCT03526861|594036344|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
164454708|NCT03526861|594036345|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
164454709|NCT03526861|594036346|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
164454710|NCT03526861|594036347|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
164454711|NCT03526861|594036348|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
164454712|NCT03526861|594036349|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
164454713|NCT03526861|594036350|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
164532242|NCT00615836|594320503|FG002|Extension Study (FE992026 CS31)|Other|8|||
164532243|NCT00615836|594320504|FG003|Extension Study (FE992026 CS31)|Other|8|||
164532244|NCT00615836|594320505|FG004|Extension Study (FE992026 CS31)|Other|0|||
164532245|NCT00615836|594320501|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
164532246|NCT00615836|594320502|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
164532247|NCT00615836|594320503|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
164532248|NCT00615836|594320504|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
164532249|NCT00615836|594320505|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
164532250|NCT00615836|594320501|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
164532251|NCT00615836|594320502|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
164707015|NCT02500641|594953529|FG001|Overall Study|Withdrawal by Subject|5|||
164707016|NCT02500641|594953528|FG000|Overall Study|Unable to follow study procedures|3|||
164707017|NCT02500641|594953529|FG001|Overall Study|Unable to follow study procedures|2|||
164707018|NCT02500641|594953528|FG000|Overall Study|Protocol Violation|1|||
164707019|NCT02500641|594953529|FG001|Overall Study|Protocol Violation|2|||
164707020|NCT02500641|594953528|FG000|Overall Study|Lost to Follow-up|1|||
164707021|NCT02500641|594953529|FG001|Overall Study|Lost to Follow-up|0|||
164707022|NCT02500641|594953528|FG000|Overall Study|Sponsor decision|1|||
164707023|NCT02500641|594953529|FG001|Overall Study|Sponsor decision|0|||
164707024|NCT02500641|594953528|FG000|Overall Study|Non compliance to study drug|0|||
164707025|NCT02500641|594953529|FG001|Overall Study|Non compliance to study drug|1|||
164707026|NCT02440568|594953530|FG000|Overall Study|Death|1|||
164707027|NCT02440568|594953531|FG001|Overall Study|Death|3|||
164707028|NCT02440568|594953532|FG002|Overall Study|Death|4|||
164707029|NCT02440568|594953533|FG003|Overall Study|Death|2|||
164707030|NCT02440568|594953530|FG000|Overall Study|Lack of Efficacy|2|||
164707031|NCT02440568|594953531|FG001|Overall Study|Lack of Efficacy|0|||
164707032|NCT02440568|594953532|FG002|Overall Study|Lack of Efficacy|1|||
164707033|NCT02440568|594953533|FG003|Overall Study|Lack of Efficacy|0|||
164707034|NCT02440568|594953530|FG000|Overall Study|Lost to Follow-up|1|||
164707035|NCT02440568|594953531|FG001|Overall Study|Lost to Follow-up|0|||
164707036|NCT02440568|594953532|FG002|Overall Study|Lost to Follow-up|0|||
164707037|NCT02440568|594953533|FG003|Overall Study|Lost to Follow-up|0|||
164707038|NCT01763684|594953534|FG000|Overall Study|Study terminated early due to low enrollment|126|||
164454714|NCT03526861|594036351|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
164454715|NCT03526861|594036352|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
164454716|NCT03526861|594036344|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
164454717|NCT03526861|594036345|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
164454718|NCT03526861|594036346|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
164454719|NCT03526861|594036347|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
164454720|NCT03526861|594036348|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
164454721|NCT03526861|594036349|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
164454722|NCT03526861|594036350|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
164454723|NCT03526861|594036351|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
164454724|NCT03526861|594036352|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
164454725|NCT03526861|594036344|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
164454726|NCT03526861|594036345|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
164454727|NCT03526861|594036346|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
164454728|NCT03526861|594036347|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
164454729|NCT03526861|594036348|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
164454730|NCT03526861|594036349|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
164454731|NCT03526861|594036350|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
164454732|NCT03526861|594036351|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
164454733|NCT03526861|594036352|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
164454734|NCT03526861|594036344|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
164454735|NCT03526861|594036345|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
164454736|NCT03526861|594036346|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
164454737|NCT03526861|594036347|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
164454738|NCT03526861|594036348|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
164454739|NCT03526861|594036349|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
164454740|NCT03526861|594036350|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
164454741|NCT03526861|594036351|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
164454742|NCT03526861|594036352|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
164454743|NCT03526861|594036344|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
164454744|NCT03526861|594036345|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
164532252|NCT00615836|594320503|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
164707039|NCT01763684|594953535|FG001|Overall Study|Study terminated early due to low enrollment|127|||
164707040|NCT01763684|594953534|FG000|Overall Study|Study surgery not performed|7|||
164707041|NCT01763684|594953535|FG001|Overall Study|Study surgery not performed|6|||
164707042|NCT03283761|594953536|FG000|Study Treatment|Patient Non-Compliance|1|||
164707043|NCT03283761|594953536|FG000|Study Treatment|Alternative Cancer Therapy|7|||
164597850|NCT01100307|594551263|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
164597851|NCT01100307|594551262|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
164454745|NCT03526861|594036346|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
164454746|NCT03526861|594036347|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
164454747|NCT03526861|594036348|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
164454748|NCT03526861|594036349|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
164454749|NCT03526861|594036350|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
164454750|NCT03526861|594036351|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
164454751|NCT03526861|594036352|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
164454752|NCT03526861|594036344|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
164454753|NCT03526861|594036345|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
164454754|NCT03526861|594036346|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
164454755|NCT03526861|594036347|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
164454756|NCT03526861|594036348|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
164454757|NCT03526861|594036349|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
164454758|NCT03526861|594036350|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
164454759|NCT03526861|594036351|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
164454760|NCT03526861|594036352|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
164454761|NCT03526861|594036344|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
164454762|NCT03526861|594036345|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
164454763|NCT03526861|594036346|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
164454764|NCT03526861|594036347|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
164454765|NCT03526861|594036348|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
164454766|NCT03526861|594036349|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
164454767|NCT03526861|594036350|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
164454768|NCT03526861|594036351|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
164454769|NCT03526861|594036352|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
164454770|NCT03526861|594036344|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
164454771|NCT03526861|594036345|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
164454772|NCT03526861|594036346|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
164454773|NCT03526861|594036347|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
164454774|NCT03526861|594036348|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
164454775|NCT03526861|594036349|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
164454776|NCT03526861|594036350|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
164454777|NCT03526861|594036351|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
164454778|NCT03526861|594036352|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
164454779|NCT04237298|594036353|FG000|Overall Study|Lost to Follow-up|4|||
164454780|NCT04237298|594036354|FG001|Overall Study|Lost to Follow-up|5|||
164454781|NCT04556656|594036358|FG000|Overall Study|Withdrawal by Subject|14|||
164454782|NCT04556656|594036359|FG001|Overall Study|Withdrawal by Subject|12|||
164454783|NCT04556656|594036358|FG000|Overall Study|Physician Decision|1|||
164454784|NCT04556656|594036359|FG001|Overall Study|Physician Decision|0|||
164597852|NCT01100307|594551263|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
164597853|NCT02108951|594551264|FG000|Overall Study|Lost to Follow-up|1|||
164597854|NCT02108951|594551264|FG000|Overall Study|Patient's/guardian's decision|1|||
164597855|NCT02108951|594551264|FG000|Overall Study|Study Terminated by Sponsor|14|||
164597856|NCT00997321|594551265|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
164597857|NCT00997321|594551266|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
164597858|NCT01151579|594551282|FG000|Overall Study|Physician Decision|3|||
164454785|NCT04556656|594036358|FG000|Overall Study|Adverse Event|4|||
164454786|NCT04556656|594036359|FG001|Overall Study|Adverse Event|7|||
164454787|NCT04556656|594036358|FG000|Overall Study|Death|4|||
164454788|NCT04556656|594036359|FG001|Overall Study|Death|0|||
164454789|NCT04556656|594036358|FG000|Overall Study|Lost to Follow-up|3|||
164454790|NCT04556656|594036359|FG001|Overall Study|Lost to Follow-up|2|||
164454791|NCT04556656|594036358|FG000|Overall Study|Not further specified|2|||
164454792|NCT04556656|594036359|FG001|Overall Study|Not further specified|1|||
164454793|NCT01416831|594036360|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
164454794|NCT01416831|594036361|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
164454795|NCT05470400|594036362|FG000|Overall Study|Lost to Follow-up|0|||
164454796|NCT05470400|594036363|FG001|Overall Study|Lost to Follow-up|0|||
164454797|NCT05470400|594036364|FG002|Overall Study|Lost to Follow-up|0|||
164454798|NCT05470400|594036365|FG003|Overall Study|Lost to Follow-up|0|||
164454799|NCT05470400|594036366|FG004|Overall Study|Lost to Follow-up|0|||
164454800|NCT05470400|594036367|FG005|Overall Study|Lost to Follow-up|0|||
164454801|NCT05470400|594036368|FG006|Overall Study|Lost to Follow-up|0|||
164454802|NCT05470400|594036369|FG007|Overall Study|Lost to Follow-up|1|||
164454803|NCT05470400|594036362|FG000|Overall Study|Withdrawal by Subject|1|||
164454804|NCT05470400|594036363|FG001|Overall Study|Withdrawal by Subject|0|||
164454805|NCT05470400|594036364|FG002|Overall Study|Withdrawal by Subject|0|||
164454806|NCT05470400|594036365|FG003|Overall Study|Withdrawal by Subject|0|||
164454807|NCT05470400|594036366|FG004|Overall Study|Withdrawal by Subject|0|||
164454808|NCT05470400|594036367|FG005|Overall Study|Withdrawal by Subject|1|||
164454809|NCT05470400|594036368|FG006|Overall Study|Withdrawal by Subject|0|||
164454810|NCT05470400|594036369|FG007|Overall Study|Withdrawal by Subject|2|||
164454811|NCT05956002|594036370|FG000|Treatment Period 3|Adverse Event|0|||
164454812|NCT05956002|594036371|FG001|Treatment Period 3|Adverse Event|0|||
164454813|NCT05956002|594036372|FG002|Treatment Period 3|Adverse Event|1|||
164454814|NCT05956002|594036373|FG003|Treatment Period 3|Adverse Event|0|||
164454815|NCT04784559|594036374|FG000|Overall Study|Withdrawal by Subject|3|||
164454816|NCT04784559|594036375|FG001|Overall Study|Withdrawal by Subject|2|||
164454817|NCT04784559|594036376|FG002|Overall Study|Withdrawal by Subject|1|||
164454818|NCT04784559|594036374|FG000|Overall Study|Death|2|||
164454819|NCT04784559|594036375|FG001|Overall Study|Death|1|||
164454820|NCT04784559|594036376|FG002|Overall Study|Death|2|||
164454821|NCT04784559|594036374|FG000|Overall Study|Lost to Follow-up|0|||
164454822|NCT04784559|594036375|FG001|Overall Study|Lost to Follow-up|0|||
164454823|NCT04784559|594036376|FG002|Overall Study|Lost to Follow-up|2|||
164454824|NCT04784559|594036374|FG000|Overall Study|Participant worsened, PI decision|1|||
164454825|NCT04784559|594036375|FG001|Overall Study|Participant worsened, PI decision|0|||
164454826|NCT04784559|594036376|FG002|Overall Study|Participant worsened, PI decision|0|||
164454827|NCT04784559|594036374|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
164454828|NCT04784559|594036375|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
164454829|NCT04784559|594036376|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
164454830|NCT04784559|594036374|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
164454831|NCT04784559|594036375|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
164454832|NCT04784559|594036376|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
164454833|NCT04784559|594036374|FG000|Overall Study|Did not meet all inclusion criteria|0|||
164454834|NCT04784559|594036375|FG001|Overall Study|Did not meet all inclusion criteria|1|||
164454835|NCT04784559|594036376|FG002|Overall Study|Did not meet all inclusion criteria|0|||
164454836|NCT04784559|594036374|FG000|Overall Study|The participant was transferred to IRCU|0|||
164454837|NCT04784559|594036375|FG001|Overall Study|The participant was transferred to IRCU|1|||
164454838|NCT04784559|594036376|FG002|Overall Study|The participant was transferred to IRCU|0|||
164454839|NCT04784559|594036374|FG000|Overall Study|SAE|0|||
164454840|NCT04784559|594036375|FG001|Overall Study|SAE|1|||
164454841|NCT04784559|594036376|FG002|Overall Study|SAE|0|||
164454842|NCT04784559|594036374|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
164454843|NCT04784559|594036375|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
164454844|NCT04784559|594036376|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
164454845|NCT05323084|594036377|FG000|Period 2 - Washout|Lost to Follow-up|0|||
164454846|NCT05323084|594036378|FG001|Period 2 - Washout|Lost to Follow-up|1|||
164597859|NCT01151579|594551283|FG001|Overall Study|Physician Decision|1|||
164597860|NCT01151579|594551282|FG000|Overall Study|Withdrawal by Subject|3|||
164454847|NCT01261312|594036379|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
164597861|NCT01151579|594551283|FG001|Overall Study|Withdrawal by Subject|2|||
164597862|NCT01151579|594551282|FG000|Overall Study|Not meet inclusion criteria|6|||
164454848|NCT01261312|594036380|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
164454849|NCT01261312|594036381|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
164454850|NCT01261312|594036382|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
164454851|NCT01261312|594036383|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
164454852|NCT01261312|594036384|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
164597863|NCT01151579|594551283|FG001|Overall Study|Not meet inclusion criteria|4|||
164406360|NCT01226511|593857492|FG000|Taper Period|Adverse Event|1|||
164454853|NCT01261312|594036385|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
164454854|NCT01261312|594036386|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
164454855|NCT01261312|594036387|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
164454856|NCT01261312|594036388|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
164454857|NCT01261312|594036389|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
164454858|NCT01261312|594036390|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
164454859|NCT01261312|594036391|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
164454860|NCT01261312|594036379|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
164406361|NCT01226511|593857493|FG001|Taper Period|Adverse Event|0|||
164406362|NCT01226511|593857492|FG000|Taper Period|Lost to Follow-up|2|||
164406363|NCT01226511|593857493|FG001|Taper Period|Lost to Follow-up|2|||
164406364|NCT01226511|593857492|FG000|Taper Period|Protocol Violation|1|||
164406365|NCT01226511|593857493|FG001|Taper Period|Protocol Violation|0|||
164406366|NCT01226511|593857492|FG000|Taper Period|Parent/Caregiver Decision|1|||
164406367|NCT01226511|593857493|FG001|Taper Period|Parent/Caregiver Decision|1|||
164406368|NCT02696564|593857494|FG000|Overall Study|Death|1|||
164406369|NCT02696564|593857495|FG001|Overall Study|Death|2|||
164406370|NCT02696564|593857494|FG000|Overall Study|Withdrawal by Subject|3|||
164406371|NCT02696564|593857495|FG001|Overall Study|Withdrawal by Subject|2|||
164406372|NCT02696564|593857494|FG000|Overall Study|Lost to Follow-up|3|||
164406373|NCT02696564|593857495|FG001|Overall Study|Lost to Follow-up|3|||
164406374|NCT02696564|593857494|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
164406375|NCT02696564|593857495|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
164406376|NCT02696564|593857494|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
164406377|NCT02696564|593857495|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
164406378|NCT02696564|593857494|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
164406379|NCT02696564|593857495|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
164406380|NCT02696564|593857494|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
164406381|NCT02696564|593857495|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
164406382|NCT02696564|593857494|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
164406383|NCT02696564|593857495|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
164406384|NCT05267600|593857496|FG000|Overall Study|Adverse Event|1|||
164406385|NCT05267600|593857497|FG001|Overall Study|Adverse Event|4|||
164406386|NCT05267600|593857496|FG000|Overall Study|Death|1|||
164406387|NCT05267600|593857497|FG001|Overall Study|Death|2|||
164406388|NCT05267600|593857496|FG000|Overall Study|Lack of Efficacy|1|||
164406389|NCT05267600|593857497|FG001|Overall Study|Lack of Efficacy|2|||
164406390|NCT05267600|593857496|FG000|Overall Study|Lost to Follow-up|3|||
164406391|NCT05267600|593857497|FG001|Overall Study|Lost to Follow-up|0|||
164406392|NCT05267600|593857496|FG000|Overall Study|Physician Decision|4|||
164406393|NCT05267600|593857497|FG001|Overall Study|Physician Decision|0|||
164406394|NCT05267600|593857496|FG000|Overall Study|Treatment Unblinded|0|||
164406395|NCT05267600|593857497|FG001|Overall Study|Treatment Unblinded|1|||
164406396|NCT05267600|593857496|FG000|Overall Study|Withdrawal by Subject|5|||
164406397|NCT05267600|593857497|FG001|Overall Study|Withdrawal by Subject|4|||
164406398|NCT04067401|593857498|FG000|Overall Study|Withdrawal by Subject|7|||
164406399|NCT04067401|593857499|FG001|Overall Study|Withdrawal by Subject|0|||
164406400|NCT04067401|593857498|FG000|Overall Study|no data provided|1|||
164406401|NCT04067401|593857499|FG001|Overall Study|no data provided|0|||
164406402|NCT03633929|593857502|FG000|Overall Study|Lost to Follow-up|1|||
164406403|NCT03633929|593857502|FG000|Overall Study|Did not login to software. Did not participate|3|||
164406404|NCT03430063|593857504|FG000|Overall Study|Adverse Event|0|||
164406405|NCT03430063|593857505|FG001|Overall Study|Adverse Event|1|||
164406406|NCT03430063|593857506|FG002|Overall Study|Adverse Event|0|||
164406407|NCT03430063|593857504|FG000|Overall Study|Death|3|||
164406408|NCT03430063|593857505|FG001|Overall Study|Death|2|||
164406409|NCT03430063|593857506|FG002|Overall Study|Death|3|||
164406410|NCT03430063|593857504|FG000|Overall Study|Lost to Follow-up|0|||
164406411|NCT03430063|593857505|FG001|Overall Study|Lost to Follow-up|1|||
164406412|NCT03430063|593857506|FG002|Overall Study|Lost to Follow-up|0|||
164406413|NCT03430063|593857504|FG000|Overall Study|Withdrawal by Subject|0|||
164406414|NCT03430063|593857505|FG001|Overall Study|Withdrawal by Subject|0|||
164406415|NCT03430063|593857506|FG002|Overall Study|Withdrawal by Subject|1|||
164406416|NCT03430063|593857504|FG000|Overall Study|Withdrawal of consent|3|||
164406417|NCT03430063|593857505|FG001|Overall Study|Withdrawal of consent|1|||
164406418|NCT03430063|593857506|FG002|Overall Study|Withdrawal of consent|2|||
164454861|NCT01261312|594036380|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
164406419|NCT03430063|593857504|FG000|Overall Study|Progressive disease|1|||
164406420|NCT03430063|593857505|FG001|Overall Study|Progressive disease|2|||
164406421|NCT03430063|593857506|FG002|Overall Study|Progressive disease|1|||
164406422|NCT03430063|593857504|FG000|Overall Study|Other un-specified|1|||
164406423|NCT03430063|593857505|FG001|Overall Study|Other un-specified|1|||
164406424|NCT03430063|593857506|FG002|Overall Study|Other un-specified|0|||
164406425|NCT03430063|593857504|FG000|Overall Study|Randomized, but never treated|0|||
164406426|NCT03430063|593857505|FG001|Overall Study|Randomized, but never treated|0|||
164406427|NCT03430063|593857506|FG002|Overall Study|Randomized, but never treated|1|||
164597864|NCT00608530|594551284|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
164597865|NCT00608530|594551285|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
164597866|NCT00608530|594551286|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
164597867|NCT00608530|594551287|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
164406428|NCT03124199|593857507|FG000|Overall Study|Lost to Follow-up|4|||
164406429|NCT02798211|593857508|FG000|Period 1|Adverse Event|1|||
164406430|NCT02798211|593857509|FG001|Period 1|Adverse Event|1|||
164406431|NCT02798211|593857510|FG002|Period 1|Adverse Event|0|||
164406432|NCT02798211|593857511|FG003|Period 1|Adverse Event|0|||
164406433|NCT02798211|593857512|FG004|Period 1|Adverse Event|0|||
164406434|NCT02798211|593857513|FG005|Period 1|Adverse Event|0|||
164406435|NCT02798211|593857508|FG000|Period 1|Lost to Follow-up|2|||
164406436|NCT02798211|593857509|FG001|Period 1|Lost to Follow-up|1|||
164406437|NCT02798211|593857510|FG002|Period 1|Lost to Follow-up|0|||
164406438|NCT02798211|593857511|FG003|Period 1|Lost to Follow-up|0|||
164406439|NCT02798211|593857512|FG004|Period 1|Lost to Follow-up|0|||
164406440|NCT02798211|593857513|FG005|Period 1|Lost to Follow-up|0|||
164406441|NCT02798211|593857508|FG000|Period 1|Protocol Violation|0|||
164406442|NCT02798211|593857509|FG001|Period 1|Protocol Violation|0|||
164406443|NCT02798211|593857510|FG002|Period 1|Protocol Violation|2|||
164406444|NCT02798211|593857511|FG003|Period 1|Protocol Violation|0|||
164406445|NCT02798211|593857512|FG004|Period 1|Protocol Violation|0|||
164406446|NCT02798211|593857513|FG005|Period 1|Protocol Violation|0|||
164406447|NCT02798211|593857508|FG000|Period 1|Withdrawal by Subject|1|||
164406448|NCT02798211|593857509|FG001|Period 1|Withdrawal by Subject|1|||
164406449|NCT02798211|593857510|FG002|Period 1|Withdrawal by Subject|0|||
164406450|NCT02798211|593857511|FG003|Period 1|Withdrawal by Subject|0|||
164406451|NCT02798211|593857512|FG004|Period 1|Withdrawal by Subject|0|||
164406452|NCT02798211|593857513|FG005|Period 1|Withdrawal by Subject|0|||
164406453|NCT02798211|593857508|FG000|Period 1|Death|0|||
164406454|NCT02798211|593857509|FG001|Period 1|Death|0|||
164406455|NCT02798211|593857510|FG002|Period 1|Death|1|||
164406456|NCT02798211|593857511|FG003|Period 1|Death|0|||
164406457|NCT02798211|593857512|FG004|Period 1|Death|0|||
164406458|NCT02798211|593857513|FG005|Period 1|Death|0|||
164406459|NCT02798211|593857508|FG000|Period 1|Withdrawal of Informed Consent|2|||
164406460|NCT02798211|593857509|FG001|Period 1|Withdrawal of Informed Consent|7|||
164406461|NCT02798211|593857510|FG002|Period 1|Withdrawal of Informed Consent|3|||
164406462|NCT02798211|593857511|FG003|Period 1|Withdrawal of Informed Consent|0|||
164406463|NCT02798211|593857512|FG004|Period 1|Withdrawal of Informed Consent|0|||
164406464|NCT02798211|593857513|FG005|Period 1|Withdrawal of Informed Consent|0|||
164406465|NCT02798211|593857508|FG000|Period 2|Withdrawal by Subject|2|||
164406466|NCT02798211|593857509|FG001|Period 2|Withdrawal by Subject|0|||
164406467|NCT02798211|593857510|FG002|Period 2|Withdrawal by Subject|0|||
164406468|NCT02798211|593857511|FG003|Period 2|Withdrawal by Subject|0|||
164406469|NCT02798211|593857512|FG004|Period 2|Withdrawal by Subject|2|||
164406470|NCT02798211|593857513|FG005|Period 2|Withdrawal by Subject|2|||
164406471|NCT02798211|593857508|FG000|Period 2|Adverse Event|5|||
164406472|NCT02798211|593857509|FG001|Period 2|Adverse Event|0|||
164406473|NCT02798211|593857510|FG002|Period 2|Adverse Event|0|||
164406474|NCT02798211|593857511|FG003|Period 2|Adverse Event|0|||
164406475|NCT02798211|593857512|FG004|Period 2|Adverse Event|1|||
164406476|NCT02798211|593857513|FG005|Period 2|Adverse Event|0|||
164406477|NCT02798211|593857508|FG000|Period 2|Lack of Efficacy|1|||
164406478|NCT02798211|593857509|FG001|Period 2|Lack of Efficacy|0|||
164406479|NCT02798211|593857510|FG002|Period 2|Lack of Efficacy|0|||
164406480|NCT02798211|593857511|FG003|Period 2|Lack of Efficacy|1|||
164406481|NCT02798211|593857512|FG004|Period 2|Lack of Efficacy|0|||
164406482|NCT02798211|593857513|FG005|Period 2|Lack of Efficacy|1|||
164406483|NCT02798211|593857508|FG000|Period 2|Lost to Follow-up|3|||
164597868|NCT00608530|594551284|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
164597869|NCT00608530|594551285|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
164597870|NCT00608530|594551286|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
164597871|NCT00608530|594551287|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
164597872|NCT00608530|594551284|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
164597873|NCT00608530|594551285|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
164406484|NCT02798211|593857509|FG001|Period 2|Lost to Follow-up|0|||
164406485|NCT02798211|593857510|FG002|Period 2|Lost to Follow-up|0|||
164406486|NCT02798211|593857511|FG003|Period 2|Lost to Follow-up|0|||
164406487|NCT02798211|593857512|FG004|Period 2|Lost to Follow-up|2|||
164406488|NCT02798211|593857513|FG005|Period 2|Lost to Follow-up|0|||
164406489|NCT02798211|593857508|FG000|Period 2|Physician Decision|1|||
164406490|NCT02798211|593857509|FG001|Period 2|Physician Decision|0|||
164406491|NCT02798211|593857510|FG002|Period 2|Physician Decision|0|||
164406492|NCT02798211|593857511|FG003|Period 2|Physician Decision|1|||
164707044|NCT03283761|594953536|FG000|Study Treatment|Disease progression|21|||
164707045|NCT03283761|594953536|FG000|Study Treatment|Adverse Event|3|||
164707046|NCT03283761|594953536|FG000|Study Treatment|Withdrawal by Subject|4|||
164707047|NCT03283761|594953536|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
164707048|NCT03283761|594953536|FG000|Study Treatment|Symptomatic Deterioration|1|||
164707049|NCT03283761|594953536|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
164707050|NCT03283761|594953536|FG000|Follow up|Lost to Follow-up|1|||
164406493|NCT02798211|593857512|FG004|Period 2|Physician Decision|1|||
164406494|NCT02798211|593857513|FG005|Period 2|Physician Decision|0|||
164406495|NCT02798211|593857508|FG000|Period 2|Pregnancy|0|||
164406496|NCT02798211|593857509|FG001|Period 2|Pregnancy|0|||
164406497|NCT02798211|593857510|FG002|Period 2|Pregnancy|0|||
164406498|NCT02798211|593857511|FG003|Period 2|Pregnancy|2|||
164406499|NCT02798211|593857512|FG004|Period 2|Pregnancy|0|||
164406500|NCT02798211|593857513|FG005|Period 2|Pregnancy|0|||
164406501|NCT02798211|593857508|FG000|Period 2|Technical problems|1|||
164406502|NCT02798211|593857509|FG001|Period 2|Technical problems|0|||
164406503|NCT02798211|593857510|FG002|Period 2|Technical problems|0|||
164406504|NCT02798211|593857511|FG003|Period 2|Technical problems|1|||
164406505|NCT02798211|593857512|FG004|Period 2|Technical problems|0|||
164406506|NCT02798211|593857513|FG005|Period 2|Technical problems|0|||
164406507|NCT02798211|593857508|FG000|Period 2|Withdrawal of Informed Consent|1|||
164406508|NCT02798211|593857509|FG001|Period 2|Withdrawal of Informed Consent|0|||
164406509|NCT02798211|593857510|FG002|Period 2|Withdrawal of Informed Consent|0|||
164406510|NCT02798211|593857511|FG003|Period 2|Withdrawal of Informed Consent|2|||
164406511|NCT02798211|593857512|FG004|Period 2|Withdrawal of Informed Consent|2|||
164406512|NCT02798211|593857513|FG005|Period 2|Withdrawal of Informed Consent|3|||
164406513|NCT01784068|593857514|FG000|NTCS Phase|Adverse Event|5|||
164406514|NCT01784068|593857515|FG001|NTCS Phase|Adverse Event|0|||
164406515|NCT01784068|593857514|FG000|NTCS Phase|Physician Decision|2|||
164406516|NCT01784068|593857515|FG001|NTCS Phase|Physician Decision|0|||
164406517|NCT01784068|593857514|FG000|NTCS Phase|Patient/guardian decision|3|||
164406518|NCT01784068|593857515|FG001|NTCS Phase|Patient/guardian decision|0|||
164406519|NCT01784068|593857514|FG000|NTCS Phase|Death|2|||
164406520|NCT01784068|593857515|FG001|NTCS Phase|Death|0|||
164406521|NCT01784068|593857514|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
164406522|NCT01784068|593857515|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
164406523|NCT01784068|593857514|FG000|TFR Phase|Physician Decision|0|||
164406524|NCT01784068|593857515|FG001|TFR Phase|Physician Decision|1|||
164406525|NCT01784068|593857514|FG000|TFR Phase|Patient/guardian decision|0|||
164406526|NCT01784068|593857515|FG001|TFR Phase|Patient/guardian decision|3|||
164406527|NCT01784068|593857514|FG000|TFR Phase|Death|0|||
164406528|NCT01784068|593857515|FG001|TFR Phase|Death|1|||
164406529|NCT01784068|593857514|FG000|TFR Phase|Lack of Efficacy|0|||
164406530|NCT01784068|593857515|FG001|TFR Phase|Lack of Efficacy|88|||
164406531|NCT06351371|593857516|FG000|Overall Study|Mutation Status Not Confirmed|9|||
164406532|NCT06351371|593857516|FG000|Overall Study|Ineligible|1|||
164406533|NCT06351371|593857516|FG000|Overall Study|Adverse Event|4|||
164406534|NCT06351371|593857516|FG000|Overall Study|Death|1|||
164406535|NCT06351371|593857516|FG000|Overall Study|Disease progression|14|||
164406536|NCT06351371|593857516|FG000|Overall Study|Withdrawal by Subject|3|||
164406537|NCT06351371|593857516|FG000|Overall Study|Physician Decision|3|||
164406538|NCT04359784|593857517|FG000|Overall Study|Death|2|||
164406539|NCT02063828|593857518|FG000|Overall Study|Withdrawal by Subject|4|||
164406540|NCT02063828|593857519|FG001|Overall Study|Withdrawal by Subject|6|||
164406541|NCT02063828|593857520|FG002|Overall Study|Withdrawal by Subject|3|||
164406542|NCT02063828|593857518|FG000|Overall Study|Death|0|||
164406543|NCT02063828|593857519|FG001|Overall Study|Death|0|||
164406544|NCT02063828|593857520|FG002|Overall Study|Death|1|||
164406545|NCT02753595|593857521|FG000|Overall Study|Sponsor termination|2|||
164406546|NCT02753595|593857522|FG001|Overall Study|Sponsor termination|2|||
164406547|NCT02515279|593857526|FG000|Overall Study|Adverse Event|7|||
164406548|NCT02515279|593857526|FG000|Overall Study|Lack of Efficacy|31|||
164406549|NCT02515279|593857526|FG000|Overall Study|Lost to Follow-up|9|||
164406550|NCT02515279|593857526|FG000|Overall Study|Withdrawal by Subject|18|||
164406551|NCT02515279|593857526|FG000|Overall Study|End-of-treatment visit not attended|17|||
164406552|NCT02515279|593857526|FG000|Overall Study|Other|22|||
164406553|NCT01800968|593857527|FG000|Overall Study|Death|23|||
164406554|NCT01800968|593857528|FG001|Overall Study|Death|16|||
164406555|NCT01800968|593857527|FG000|Overall Study|Lost to Follow-up|5|||
164406556|NCT01800968|593857528|FG001|Overall Study|Lost to Follow-up|7|||
164406557|NCT01800968|593857527|FG000|Overall Study|Withdrawal by Subject|7|||
164406558|NCT01800968|593857528|FG001|Overall Study|Withdrawal by Subject|9|||
164406559|NCT01800968|593857527|FG000|Overall Study|Physician Decision|1|||
164406560|NCT01800968|593857528|FG001|Overall Study|Physician Decision|0|||
164406561|NCT04987762|593857530|FG000|Overall Study|Study was Terminated by Sponsor|103|||
164406562|NCT00701038|593857531|FG000|Overall Study|study amended pilot group of patients|4|||
164406563|NCT00701038|593857532|FG001|Overall Study|study amended pilot group of patients|4|||
164454862|NCT01261312|594036381|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
164454863|NCT01261312|594036382|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
164454864|NCT01261312|594036383|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
164454865|NCT01261312|594036384|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
164454866|NCT01261312|594036385|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
164454867|NCT01261312|594036386|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
164454868|NCT01261312|594036387|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
164454869|NCT01261312|594036388|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
164454870|NCT01261312|594036389|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
164454871|NCT01261312|594036390|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
164454872|NCT01261312|594036391|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
164454873|NCT01261312|594036379|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
164454874|NCT01261312|594036380|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
164454875|NCT01261312|594036381|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
164454876|NCT01261312|594036382|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
164454877|NCT01261312|594036383|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
164454878|NCT01261312|594036384|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
164454879|NCT01261312|594036385|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
164454880|NCT01261312|594036386|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
164454881|NCT01261312|594036387|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
164454882|NCT01261312|594036388|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
164454883|NCT01261312|594036389|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
164454884|NCT01261312|594036390|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
164454885|NCT01261312|594036391|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
164454886|NCT01261312|594036379|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
164454887|NCT01261312|594036380|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
164454888|NCT01261312|594036381|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
164454889|NCT01261312|594036382|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
164454890|NCT01261312|594036383|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
164454891|NCT01261312|594036384|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
164454892|NCT01261312|594036385|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
164454893|NCT01261312|594036386|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
164454894|NCT01261312|594036387|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
164454895|NCT01261312|594036388|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
164454896|NCT01261312|594036389|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
164454897|NCT01261312|594036390|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
164454898|NCT01261312|594036391|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
164454899|NCT01261312|594036379|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
164454900|NCT01261312|594036380|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
164454901|NCT01261312|594036381|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
164454902|NCT01261312|594036382|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
164454903|NCT01261312|594036383|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
164454904|NCT01261312|594036384|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
164454905|NCT01261312|594036385|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
164454906|NCT01261312|594036386|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
164454907|NCT01261312|594036387|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
164454908|NCT01261312|594036388|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
164454909|NCT01261312|594036389|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
164454910|NCT01261312|594036390|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
164454911|NCT01261312|594036391|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
164454912|NCT01261312|594036379|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
164454913|NCT01261312|594036380|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
164454914|NCT01261312|594036381|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
164454915|NCT01261312|594036382|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
164454916|NCT01261312|594036383|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
164454917|NCT01261312|594036384|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
164454918|NCT01261312|594036385|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
164454919|NCT01261312|594036386|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
164454920|NCT01261312|594036387|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
164707051|NCT03283761|594953536|FG000|Follow up|Symptomatic Deterioration|1|||
164454921|NCT01261312|594036388|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
164454922|NCT01261312|594036389|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
164707052|NCT03283761|594953536|FG000|Follow up|Death|29|||
164707053|NCT03283761|594953536|FG000|Follow up|study terminated|4|||
164707054|NCT03283761|594953536|FG000|Follow up|Primary Investigator Withdrawal|1|||
164707055|NCT03283761|594953536|FG000|Follow up|Switched to alternative therapy|1|||
164707056|NCT03283761|594953536|FG000|Follow up|Subject is now in Hospice|1|||
164707057|NCT03275064|594953537|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
164707058|NCT03275064|594953538|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
164707059|NCT03275064|594953539|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
164707060|NCT03275064|594953540|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
164707061|NCT03275064|594953541|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
164707062|NCT03275064|594953537|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
164707063|NCT03275064|594953538|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
164707064|NCT03275064|594953539|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
164707065|NCT03275064|594953540|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
164707066|NCT03275064|594953541|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
164454923|NCT01261312|594036390|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
164454924|NCT01261312|594036391|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
164454925|NCT01261312|594036379|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
164454926|NCT01261312|594036380|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
164454927|NCT01261312|594036381|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
164454928|NCT01261312|594036382|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
164454929|NCT01261312|594036383|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
164454930|NCT01261312|594036384|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
164454931|NCT01261312|594036385|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
164454932|NCT01261312|594036386|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
164454933|NCT01261312|594036387|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
164454934|NCT01261312|594036388|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
164454935|NCT01261312|594036389|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
164454936|NCT01261312|594036390|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
164454937|NCT01261312|594036391|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
164454938|NCT01261312|594036379|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
164454939|NCT01261312|594036380|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
164454940|NCT01261312|594036381|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
164454941|NCT01261312|594036382|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
164454942|NCT01261312|594036383|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
164454943|NCT01261312|594036384|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
164454944|NCT01261312|594036385|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
164454945|NCT01261312|594036386|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
164454946|NCT01261312|594036387|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
164454947|NCT01261312|594036388|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
164454948|NCT01261312|594036389|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
164454949|NCT01261312|594036390|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
164454950|NCT01261312|594036391|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
164454951|NCT01261312|594036379|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
164454952|NCT01261312|594036380|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
164454953|NCT01261312|594036381|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
164454954|NCT01261312|594036382|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
164454955|NCT01261312|594036383|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
164454956|NCT01261312|594036384|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
164454957|NCT01261312|594036385|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
164454958|NCT01261312|594036386|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
164454959|NCT01261312|594036387|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
164454960|NCT01261312|594036388|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
164454961|NCT01261312|594036389|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
164454962|NCT01261312|594036390|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
164454963|NCT01261312|594036391|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
164454964|NCT01261312|594036379|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
164454965|NCT01261312|594036380|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
164454966|NCT01261312|594036381|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
164454967|NCT01261312|594036382|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
164454968|NCT01261312|594036383|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
164454969|NCT01261312|594036384|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
164454970|NCT01261312|594036385|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
164454971|NCT01261312|594036386|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
164707067|NCT03275064|594953537|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
164707068|NCT03275064|594953538|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
164406564|NCT05099926|593857535|FG000|Overall Study|Lost to Follow-up|1|||
164406565|NCT02068495|593857538|FG000|Overall Study|Case Report Forms Uncollected|60|||
164406566|NCT02068495|593857538|FG000|Overall Study|Protocol Deviation|49|||
164406567|NCT00766675|593859037|FG000|Overall Study|Adverse Event|16|||
164406568|NCT00766675|593859037|FG000|Overall Study|Lost to Follow-up|2|||
164406569|NCT00766675|593859037|FG000|Overall Study|Withdrawal by Subject|11|||
164406570|NCT00766675|593859037|FG000|Overall Study|Protocol Violation|8|||
164406571|NCT00766675|593859037|FG000|Overall Study|Participant took prohibited medication|1|||
164406572|NCT00766675|593859037|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
164406573|NCT00766675|593859037|FG000|Overall Study|Insufficient therapy|1|||
164406574|NCT03183388|593859038|FG000|Overall Study|Lost to Follow-up|3|||
164406575|NCT03183388|593859039|FG001|Overall Study|Lost to Follow-up|5|||
164406576|NCT03183388|593859038|FG000|Overall Study|Physician Decision|1|||
164406577|NCT03183388|593859039|FG001|Overall Study|Physician Decision|4|||
164406578|NCT03183388|593859038|FG000|Overall Study|Withdrawal by Subject|4|||
164406579|NCT03183388|593859039|FG001|Overall Study|Withdrawal by Subject|1|||
164406580|NCT03183388|593859038|FG000|Overall Study|Moved|1|||
164406581|NCT03183388|593859039|FG001|Overall Study|Moved|0|||
164406582|NCT03183388|593859038|FG000|Overall Study|Met Exclusion Criteria|2|||
164406583|NCT03183388|593859039|FG001|Overall Study|Met Exclusion Criteria|2|||
164406584|NCT03183388|593859038|FG000|Overall Study|COVID Pandemic Related|2|||
164406585|NCT03183388|593859039|FG001|Overall Study|COVID Pandemic Related|4|||
164406586|NCT01160484|593859043|FG000|Overall Study|Lack of Efficacy|9|||
164406587|NCT01160484|593859043|FG000|Overall Study|Adverse Event|6|||
164406588|NCT01160484|593859043|FG000|Overall Study|Withdrawal by Subject|2|||
164406589|NCT01160484|593859043|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
164406590|NCT02228967|593859044|FG000|Overall Study|Lost to Follow-up|146|||
164406591|NCT02228967|593859045|FG001|Overall Study|Lost to Follow-up|142|||
164406592|NCT02228967|593859044|FG000|Overall Study|Withdrawal by Subject|13|||
164406593|NCT02228967|593859045|FG001|Overall Study|Withdrawal by Subject|18|||
164406594|NCT01995539|593859048|FG000|Overall Study|Screening Failure|1|||
164406595|NCT01995539|593859048|FG000|Overall Study|Withdrawal by Investigator|15|||
164406596|NCT01995539|593859048|FG000|Overall Study|Withdrawal by Subject|11|||
164406597|NCT01995539|593859048|FG000|Overall Study|Lost to Follow-up|5|||
164406598|NCT01995539|593859048|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
164406599|NCT03261271|593859052|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
164406600|NCT03261271|593859053|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
164406601|NCT02173054|593859054|FG000|Overall Study|lack of compliance|1|||
164406602|NCT02173054|593859055|FG001|Overall Study|lack of compliance|0|||
164406603|NCT02173054|593859056|FG002|Overall Study|lack of compliance|0|||
164406604|NCT02173054|593859054|FG000|Overall Study|Withdrawal by Subject|0|||
164406605|NCT02173054|593859055|FG001|Overall Study|Withdrawal by Subject|0|||
164406606|NCT02173054|593859056|FG002|Overall Study|Withdrawal by Subject|1|||
164406607|NCT01932697|593859057|FG000|Overall Study|Received a different amount of tx|1|||
164406608|NCT01932697|593859058|FG001|Overall Study|Received a different amount of tx|0|||
164406609|NCT01932697|593859057|FG000|Overall Study|Ineligible|1|||
164406610|NCT01932697|593859058|FG001|Overall Study|Ineligible|0|||
164406611|NCT01330316|593859063|FG000|Overall Study|Adverse Event|2|||
164406612|NCT01330316|593859064|FG001|Overall Study|Adverse Event|2|||
164406613|NCT01330316|593859063|FG000|Overall Study|Lack of Efficacy|0|||
164406614|NCT01330316|593859064|FG001|Overall Study|Lack of Efficacy|10|||
164406615|NCT01330316|593859063|FG000|Overall Study|Lost to Follow-up|0|||
164406616|NCT01330316|593859064|FG001|Overall Study|Lost to Follow-up|1|||
164406617|NCT01330316|593859063|FG000|Overall Study|Withdrawal by Subject|0|||
164406618|NCT01330316|593859064|FG001|Overall Study|Withdrawal by Subject|1|||
164406619|NCT01330316|593859063|FG000|Overall Study|other than above|0|||
164406620|NCT01330316|593859064|FG001|Overall Study|other than above|1|||
164406621|NCT00215540|593859065|FG000|Overall Study|Withdrew from study medication|1|||
164406622|NCT00215540|593859066|FG001|Overall Study|Withdrew from study medication|0|||
164406623|NCT00215540|593859067|FG002|Overall Study|Withdrew from study medication|0|||
164406624|NCT00246337|593859070|FG000|Overall Study|Lost to Follow-up|3|||
164406625|NCT00246337|593859071|FG001|Overall Study|Lost to Follow-up|0|||
164406626|NCT00246337|593859072|FG002|Overall Study|Lost to Follow-up|0|||
164406627|NCT00246337|593859073|FG003|Overall Study|Lost to Follow-up|0|||
164406628|NCT00246337|593859074|FG004|Overall Study|Lost to Follow-up|2|||
164406629|NCT00246337|593859075|FG005|Overall Study|Lost to Follow-up|2|||
164406630|NCT00246337|593859076|FG006|Overall Study|Lost to Follow-up|1|||
164406631|NCT00246337|593859077|FG007|Overall Study|Lost to Follow-up|2|||
164406632|NCT00246337|593859078|FG008|Overall Study|Lost to Follow-up|0|||
164406633|NCT00246337|593859070|FG000|Overall Study|Protocol Violation|1|||
164406634|NCT00246337|593859071|FG001|Overall Study|Protocol Violation|0|||
164406635|NCT00246337|593859072|FG002|Overall Study|Protocol Violation|0|||
164406636|NCT00246337|593859073|FG003|Overall Study|Protocol Violation|0|||
164406637|NCT00246337|593859074|FG004|Overall Study|Protocol Violation|1|||
164406638|NCT00246337|593859075|FG005|Overall Study|Protocol Violation|0|||
164597874|NCT00608530|594551286|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
164597875|NCT00608530|594551287|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
164597876|NCT00608530|594551284|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
164597877|NCT00608530|594551285|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
164597878|NCT00608530|594551286|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
164597879|NCT00608530|594551287|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
164597880|NCT00608530|594551284|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
164597881|NCT00608530|594551285|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
164597882|NCT00608530|594551286|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
164597883|NCT00608530|594551287|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
164597884|NCT00608530|594551284|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
164406639|NCT00246337|593859076|FG006|Overall Study|Protocol Violation|1|||
164406640|NCT00246337|593859077|FG007|Overall Study|Protocol Violation|1|||
164406641|NCT00246337|593859078|FG008|Overall Study|Protocol Violation|0|||
164406642|NCT00246337|593859070|FG000|Overall Study|Withdrawal by Subject|2|||
164406643|NCT00246337|593859071|FG001|Overall Study|Withdrawal by Subject|0|||
164406644|NCT00246337|593859072|FG002|Overall Study|Withdrawal by Subject|0|||
164406645|NCT00246337|593859073|FG003|Overall Study|Withdrawal by Subject|0|||
164406646|NCT00246337|593859074|FG004|Overall Study|Withdrawal by Subject|0|||
164406647|NCT00246337|593859075|FG005|Overall Study|Withdrawal by Subject|0|||
164406648|NCT00246337|593859076|FG006|Overall Study|Withdrawal by Subject|1|||
164406649|NCT00246337|593859077|FG007|Overall Study|Withdrawal by Subject|1|||
164406650|NCT00246337|593859078|FG008|Overall Study|Withdrawal by Subject|0|||
164406651|NCT00246337|593859070|FG000|Overall Study|Lack of Qualifying Event|8|||
164406652|NCT00246337|593859071|FG001|Overall Study|Lack of Qualifying Event|2|||
164406653|NCT00246337|593859072|FG002|Overall Study|Lack of Qualifying Event|1|||
164406654|NCT00246337|593859073|FG003|Overall Study|Lack of Qualifying Event|1|||
164406655|NCT00246337|593859074|FG004|Overall Study|Lack of Qualifying Event|1|||
164406656|NCT00246337|593859075|FG005|Overall Study|Lack of Qualifying Event|3|||
164406657|NCT00246337|593859076|FG006|Overall Study|Lack of Qualifying Event|3|||
164406658|NCT00246337|593859077|FG007|Overall Study|Lack of Qualifying Event|2|||
164406659|NCT00246337|593859078|FG008|Overall Study|Lack of Qualifying Event|5|||
164406660|NCT00246337|593859070|FG000|Overall Study|Site Terminated|10|||
164406661|NCT00246337|593859071|FG001|Overall Study|Site Terminated|0|||
164406662|NCT00246337|593859072|FG002|Overall Study|Site Terminated|0|||
164406663|NCT00246337|593859073|FG003|Overall Study|Site Terminated|0|||
164406664|NCT00246337|593859074|FG004|Overall Study|Site Terminated|0|||
164406665|NCT00246337|593859075|FG005|Overall Study|Site Terminated|7|||
164406666|NCT00246337|593859076|FG006|Overall Study|Site Terminated|1|||
164406667|NCT00246337|593859077|FG007|Overall Study|Site Terminated|6|||
164406668|NCT00246337|593859078|FG008|Overall Study|Site Terminated|2|||
164406669|NCT00246337|593859070|FG000|Overall Study|Abnormal baseline lab values|7|||
164406670|NCT00246337|593859071|FG001|Overall Study|Abnormal baseline lab values|0|||
164406671|NCT00246337|593859072|FG002|Overall Study|Abnormal baseline lab values|2|||
164406672|NCT00246337|593859073|FG003|Overall Study|Abnormal baseline lab values|0|||
164406673|NCT00246337|593859074|FG004|Overall Study|Abnormal baseline lab values|0|||
164406674|NCT00246337|593859075|FG005|Overall Study|Abnormal baseline lab values|2|||
164406675|NCT00246337|593859076|FG006|Overall Study|Abnormal baseline lab values|2|||
164406676|NCT00246337|593859077|FG007|Overall Study|Abnormal baseline lab values|0|||
164406677|NCT00246337|593859078|FG008|Overall Study|Abnormal baseline lab values|4|||
164406678|NCT00246337|593859070|FG000|Overall Study|Overwhelmed|0|||
164406679|NCT00246337|593859071|FG001|Overall Study|Overwhelmed|0|||
164406680|NCT00246337|593859072|FG002|Overall Study|Overwhelmed|0|||
164406681|NCT00246337|593859073|FG003|Overall Study|Overwhelmed|0|||
164406682|NCT00246337|593859074|FG004|Overall Study|Overwhelmed|0|||
164406683|NCT00246337|593859075|FG005|Overall Study|Overwhelmed|1|||
164406684|NCT00246337|593859076|FG006|Overall Study|Overwhelmed|0|||
164406685|NCT00246337|593859077|FG007|Overall Study|Overwhelmed|0|||
164406686|NCT00246337|593859078|FG008|Overall Study|Overwhelmed|0|||
164406687|NCT00246337|593859070|FG000|Overall Study|Protocol Violator|1|||
164406688|NCT00246337|593859071|FG001|Overall Study|Protocol Violator|0|||
164406689|NCT00246337|593859072|FG002|Overall Study|Protocol Violator|0|||
164406690|NCT00246337|593859073|FG003|Overall Study|Protocol Violator|0|||
164406691|NCT00246337|593859074|FG004|Overall Study|Protocol Violator|0|||
164406692|NCT00246337|593859075|FG005|Overall Study|Protocol Violator|0|||
164406693|NCT00246337|593859076|FG006|Overall Study|Protocol Violator|0|||
164406694|NCT00246337|593859077|FG007|Overall Study|Protocol Violator|0|||
164406695|NCT00246337|593859078|FG008|Overall Study|Protocol Violator|0|||
164406696|NCT00246337|593859070|FG000|Overall Study|Reported as completing trial in error|0|||
164406697|NCT00246337|593859071|FG001|Overall Study|Reported as completing trial in error|0|||
164406698|NCT00246337|593859072|FG002|Overall Study|Reported as completing trial in error|0|||
164406699|NCT00246337|593859073|FG003|Overall Study|Reported as completing trial in error|0|||
164406700|NCT00246337|593859074|FG004|Overall Study|Reported as completing trial in error|0|||
164406701|NCT00246337|593859075|FG005|Overall Study|Reported as completing trial in error|0|||
164406702|NCT00246337|593859076|FG006|Overall Study|Reported as completing trial in error|0|||
164454972|NCT01261312|594036387|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
164454973|NCT01261312|594036388|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
164454974|NCT01261312|594036389|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
164454975|NCT01261312|594036390|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
164454976|NCT01261312|594036391|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
164454977|NCT01261312|594036379|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
164454978|NCT01261312|594036380|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
164454979|NCT01261312|594036381|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
164454980|NCT01261312|594036382|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
164454981|NCT01261312|594036383|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
164454982|NCT01261312|594036384|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
164454983|NCT01261312|594036385|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
164454984|NCT01261312|594036386|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
164454985|NCT01261312|594036387|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
164454986|NCT01261312|594036388|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
164454987|NCT01261312|594036389|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
164454988|NCT01261312|594036390|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
164454989|NCT01261312|594036391|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
164454990|NCT01261312|594036379|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
164454991|NCT01261312|594036380|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
164454992|NCT01261312|594036381|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
164454993|NCT01261312|594036382|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
164454994|NCT01261312|594036383|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
164454995|NCT01261312|594036384|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
164454996|NCT01261312|594036385|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
164454997|NCT01261312|594036386|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
164454998|NCT01261312|594036387|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
164454999|NCT01261312|594036388|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
164455000|NCT01261312|594036389|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
164455001|NCT01261312|594036390|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
164455002|NCT01261312|594036391|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
164455003|NCT01261312|594036379|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
164455004|NCT01261312|594036380|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
164455005|NCT01261312|594036381|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
164455006|NCT01261312|594036382|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
164455007|NCT01261312|594036383|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
164455008|NCT01261312|594036384|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
164455009|NCT01261312|594036385|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
164455010|NCT01261312|594036386|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
164455011|NCT01261312|594036387|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
164455012|NCT01261312|594036388|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
164455013|NCT01261312|594036389|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
164455014|NCT01261312|594036390|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
164455015|NCT01261312|594036391|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
164455016|NCT01261312|594036379|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
164455017|NCT01261312|594036380|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
164455018|NCT01261312|594036381|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
164455019|NCT01261312|594036382|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
164455020|NCT01261312|594036383|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
164455021|NCT01261312|594036384|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
164455022|NCT01261312|594036385|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
164455023|NCT01261312|594036386|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
164455024|NCT01261312|594036387|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
164406703|NCT00246337|593859077|FG007|Overall Study|Reported as completing trial in error|1|||
164406704|NCT00246337|593859078|FG008|Overall Study|Reported as completing trial in error|0|||
164406705|NCT00674570|593859080|FG000|Overall Study|Withdrawal by Subject|0|||
164406706|NCT00674570|593859081|FG001|Overall Study|Withdrawal by Subject|2|||
164406707|NCT00674570|593859082|FG002|Overall Study|Withdrawal by Subject|0|||
164406708|NCT01337986|593859083|FG000|Overall Study|Adverse Event|2|||
164406709|NCT01337986|593859084|FG001|Overall Study|Adverse Event|2|||
164406710|NCT01337986|593859083|FG000|Overall Study|Lost to Follow-up|1|||
164406711|NCT01337986|593859084|FG001|Overall Study|Lost to Follow-up|0|||
164406712|NCT01337986|593859083|FG000|Overall Study|Protocol Violation|0|||
164406713|NCT01337986|593859084|FG001|Overall Study|Protocol Violation|3|||
164406714|NCT02313909|593859085|FG000|Overall Study|Consent withdrawn by participant|33|||
164406715|NCT02313909|593859086|FG001|Overall Study|Consent withdrawn by participant|33|||
164406716|NCT02313909|593859085|FG000|Overall Study|Lost to Follow-up|24|||
164406717|NCT02313909|593859086|FG001|Overall Study|Lost to Follow-up|17|||
164455025|NCT01261312|594036388|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
164406718|NCT01782872|593859088|FG000|Overall Study|Protocol Violation|0|||
164406719|NCT01782872|593859089|FG001|Overall Study|Protocol Violation|0|||
164455026|NCT01261312|594036389|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
164455027|NCT01261312|594036390|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
164455028|NCT01261312|594036391|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
164455029|NCT01261312|594036379|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
164455030|NCT01261312|594036380|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
164455031|NCT01261312|594036381|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
164455032|NCT01261312|594036382|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
164455033|NCT01261312|594036383|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
164455034|NCT01261312|594036384|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
164455035|NCT01261312|594036385|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
164455036|NCT01261312|594036386|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
164455037|NCT01261312|594036387|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
164455038|NCT01261312|594036388|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
164455039|NCT01261312|594036389|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
164455040|NCT01261312|594036390|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
164455041|NCT01261312|594036391|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
164455042|NCT01261312|594036379|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
164455043|NCT01261312|594036380|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
164455044|NCT01261312|594036381|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
164455045|NCT01261312|594036382|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
164455046|NCT01261312|594036383|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
164455047|NCT01261312|594036384|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
164455048|NCT01261312|594036385|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
164455049|NCT01261312|594036386|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
164455050|NCT01261312|594036387|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
164455051|NCT01261312|594036388|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
164455052|NCT01261312|594036389|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
164455053|NCT01261312|594036390|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
164455054|NCT01261312|594036391|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
164455055|NCT01261312|594036379|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
164455056|NCT01261312|594036380|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
164455057|NCT01261312|594036381|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
164455058|NCT01261312|594036382|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
164455059|NCT01261312|594036383|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
164455060|NCT01261312|594036384|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
164455061|NCT01261312|594036385|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
164455062|NCT01261312|594036386|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
164455063|NCT01261312|594036387|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
164455064|NCT01261312|594036388|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
164455065|NCT01261312|594036389|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
164455066|NCT01261312|594036390|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
164455067|NCT01261312|594036391|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
164455068|NCT01261312|594036379|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
164455069|NCT01261312|594036380|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
164455070|NCT01261312|594036381|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
164455071|NCT01261312|594036382|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
164455072|NCT01261312|594036383|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
164455073|NCT01261312|594036384|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
164455074|NCT01261312|594036385|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
164455075|NCT01261312|594036386|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
164455076|NCT01261312|594036387|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
164455077|NCT01261312|594036388|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
164455078|NCT01261312|594036389|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
164455079|NCT01261312|594036390|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
164455080|NCT01261312|594036391|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
164455081|NCT01261312|594036379|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
164455082|NCT01261312|594036380|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
164455083|NCT01261312|594036381|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
164455084|NCT01261312|594036382|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
164455085|NCT01261312|594036383|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
164597885|NCT00608530|594551285|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
164597886|NCT00608530|594551286|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
164597887|NCT00608530|594551287|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
164597888|NCT00077610|594551288|FG000|Overall Study|Adverse Event|9|||
164597889|NCT00077610|594551289|FG001|Overall Study|Adverse Event|7|||
164597890|NCT00077610|594551290|FG002|Overall Study|Adverse Event|1|||
164597891|NCT00077610|594551288|FG000|Overall Study|Lost to Follow-up|0|||
164597892|NCT00077610|594551289|FG001|Overall Study|Lost to Follow-up|1|||
164597893|NCT00077610|594551290|FG002|Overall Study|Lost to Follow-up|2|||
164597894|NCT00077610|594551288|FG000|Overall Study|Withdrawal by Subject|4|||
164597895|NCT00077610|594551289|FG001|Overall Study|Withdrawal by Subject|10|||
164597896|NCT00077610|594551290|FG002|Overall Study|Withdrawal by Subject|6|||
164597897|NCT00077610|594551288|FG000|Overall Study|Death|17|||
164597898|NCT00077610|594551289|FG001|Overall Study|Death|13|||
164597899|NCT00077610|594551290|FG002|Overall Study|Death|13|||
164597900|NCT00077610|594551288|FG000|Overall Study|Renal transplant|12|||
164597901|NCT00077610|594551289|FG001|Overall Study|Renal transplant|15|||
164597902|NCT00077610|594551290|FG002|Overall Study|Renal transplant|11|||
164597903|NCT00077610|594551288|FG000|Overall Study|Withdrew from dialysis care|5|||
164597904|NCT00077610|594551289|FG001|Overall Study|Withdrew from dialysis care|0|||
164455086|NCT01261312|594036384|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
164455087|NCT01261312|594036385|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
164455088|NCT01261312|594036386|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
164455089|NCT01261312|594036387|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
164455090|NCT01261312|594036388|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
164455091|NCT01261312|594036389|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
164455092|NCT01261312|594036390|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
164455093|NCT01261312|594036391|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
164455094|NCT01261312|594036379|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
164455095|NCT01261312|594036380|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
164455096|NCT01261312|594036381|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
164455097|NCT01261312|594036382|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
164455098|NCT01261312|594036383|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
164455099|NCT01261312|594036384|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
164455100|NCT01261312|594036385|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
164455101|NCT01261312|594036386|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
164455102|NCT01261312|594036387|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
164707069|NCT03275064|594953539|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
164707070|NCT03275064|594953540|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
164707071|NCT03275064|594953541|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
164707072|NCT03275064|594953537|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
164707073|NCT03275064|594953538|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
164707074|NCT03275064|594953539|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
164707075|NCT03275064|594953540|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
164707076|NCT03275064|594953541|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
164707077|NCT03275064|594953537|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
164707078|NCT03275064|594953538|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
164707079|NCT03275064|594953539|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
164455103|NCT01261312|594036388|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
164455104|NCT01261312|594036389|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
164455105|NCT01261312|594036390|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
164455106|NCT01261312|594036391|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
164455107|NCT01261312|594036379|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
164455108|NCT01261312|594036380|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
164455109|NCT01261312|594036381|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
164455110|NCT01261312|594036382|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
164455111|NCT01261312|594036383|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
164455112|NCT01261312|594036384|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
164455113|NCT01261312|594036385|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
164455114|NCT01261312|594036386|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
164597905|NCT00077610|594551290|FG002|Overall Study|Withdrew from dialysis care|3|||
164597906|NCT00077610|594551288|FG000|Overall Study|Insufficient Therapeutic Response|1|||
164597907|NCT00077610|594551289|FG001|Overall Study|Insufficient Therapeutic Response|0|||
164597908|NCT00077610|594551290|FG002|Overall Study|Insufficient Therapeutic Response|0|||
164597909|NCT00077610|594551288|FG000|Overall Study|Multiple blood transfusions|0|||
164597910|NCT00077610|594551289|FG001|Overall Study|Multiple blood transfusions|0|||
164597911|NCT00077610|594551290|FG002|Overall Study|Multiple blood transfusions|1|||
164597912|NCT00077610|594551288|FG000|Overall Study|Principal Investigator's decision|1|||
164597913|NCT00077610|594551289|FG001|Overall Study|Principal Investigator's decision|0|||
164597914|NCT00077610|594551290|FG002|Overall Study|Principal Investigator's decision|1|||
164597915|NCT00077610|594551288|FG000|Overall Study|Worsening of health condition|1|||
164597916|NCT00077610|594551289|FG001|Overall Study|Worsening of health condition|1|||
164597917|NCT00077610|594551290|FG002|Overall Study|Worsening of health condition|0|||
164597918|NCT00077610|594551288|FG000|Overall Study|Given Epogen in hospital|1|||
164597919|NCT00077610|594551289|FG001|Overall Study|Given Epogen in hospital|0|||
164597920|NCT00077610|594551290|FG002|Overall Study|Given Epogen in hospital|0|||
164455115|NCT01261312|594036387|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
164455116|NCT01261312|594036388|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
164455117|NCT01261312|594036389|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
164455118|NCT01261312|594036390|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
164455119|NCT01261312|594036391|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
164455120|NCT01261312|594036379|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
164455121|NCT01261312|594036380|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
164455122|NCT01261312|594036381|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
164455123|NCT01261312|594036382|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
164455124|NCT01261312|594036383|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
164455125|NCT01261312|594036384|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
164455126|NCT01261312|594036385|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
164455127|NCT01261312|594036386|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
164455128|NCT01261312|594036387|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
164455129|NCT01261312|594036388|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
164455130|NCT01261312|594036389|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
164455131|NCT01261312|594036390|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
164455132|NCT01261312|594036391|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
164455133|NCT01261312|594036379|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
164455134|NCT01261312|594036380|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
164455135|NCT01261312|594036381|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
164455136|NCT01261312|594036382|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
164455137|NCT01261312|594036383|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
164455138|NCT01261312|594036384|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
164455139|NCT01261312|594036385|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
164455140|NCT01261312|594036386|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
164455141|NCT01261312|594036387|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
164455142|NCT01261312|594036388|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
164455143|NCT01261312|594036389|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
164455144|NCT01261312|594036390|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
164455145|NCT01261312|594036391|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
164455146|NCT01261312|594036379|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
164455147|NCT01261312|594036380|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
164455148|NCT01261312|594036381|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
164455149|NCT01261312|594036382|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
164455150|NCT01261312|594036383|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
164455151|NCT01261312|594036384|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
164455152|NCT01261312|594036385|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
164455153|NCT01261312|594036386|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
164455154|NCT01261312|594036387|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
164455155|NCT01261312|594036388|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
164455156|NCT01261312|594036389|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
164455157|NCT01261312|594036390|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
164455158|NCT01261312|594036391|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
164455159|NCT01261312|594036379|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
164455160|NCT01261312|594036380|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
164455161|NCT01261312|594036381|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
164455162|NCT01261312|594036382|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
164455163|NCT01261312|594036383|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
164455164|NCT01261312|594036384|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
164455165|NCT01261312|594036385|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
164455166|NCT01261312|594036386|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
164455167|NCT01261312|594036387|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
164455168|NCT01261312|594036388|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
164455169|NCT01261312|594036389|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
164455170|NCT01261312|594036390|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
164455171|NCT01261312|594036391|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
164455172|NCT01261312|594036379|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
164455173|NCT01261312|594036380|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
164455174|NCT01261312|594036381|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
164455175|NCT01261312|594036382|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
164455176|NCT01261312|594036383|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
164455177|NCT01261312|594036384|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
164455178|NCT01261312|594036385|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
164455179|NCT01261312|594036386|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
164455180|NCT01261312|594036387|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
164455181|NCT01261312|594036388|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
164455182|NCT01261312|594036389|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
164455183|NCT01261312|594036390|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
164455184|NCT01261312|594036391|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
164455185|NCT01261312|594036379|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
164455186|NCT01261312|594036380|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
164455187|NCT01261312|594036381|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
164455188|NCT01261312|594036382|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
164455189|NCT01261312|594036383|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
164455190|NCT01261312|594036384|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
164455191|NCT01261312|594036385|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
164455192|NCT01261312|594036386|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
164455193|NCT01261312|594036387|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
164455194|NCT01261312|594036388|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
164455195|NCT01261312|594036389|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
164455196|NCT01261312|594036390|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
164455197|NCT01261312|594036391|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
164455198|NCT01261312|594036379|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
164455199|NCT01261312|594036380|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
164455200|NCT01261312|594036381|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
164455201|NCT01261312|594036382|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
164455202|NCT01261312|594036383|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
164455203|NCT01261312|594036384|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
164455204|NCT01261312|594036385|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
164455205|NCT01261312|594036386|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
164455206|NCT01261312|594036387|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
164455207|NCT01261312|594036388|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
164455208|NCT01261312|594036389|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
164455209|NCT01261312|594036390|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
164455210|NCT01261312|594036391|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
164455211|NCT04294225|594036392|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
164455212|NCT04294225|594036392|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
164455213|NCT04294225|594036392|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
164455214|NCT04294225|594036392|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
164455215|NCT04294225|594036392|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
164455216|NCT03665597|594036393|FG000|Period 1|Adverse Event|1|||
164455217|NCT03665597|594036394|FG001|Period 1|Adverse Event|0|||
164455218|NCT03665597|594036395|FG002|Period 1|Adverse Event|0|||
164455219|NCT03665597|594036396|FG003|Period 1|Adverse Event|1|||
164455220|NCT03665597|594036397|FG004|Period 1|Adverse Event|0|||
164455221|NCT03665597|594036398|FG005|Period 1|Adverse Event|0|||
164455222|NCT03665597|594036399|FG006|Period 1|Adverse Event|0|||
164455223|NCT03665597|594036393|FG000|Period 1|Screen Failure|0|||
164455224|NCT03665597|594036394|FG001|Period 1|Screen Failure|0|||
164455225|NCT03665597|594036395|FG002|Period 1|Screen Failure|0|||
164455226|NCT03665597|594036396|FG003|Period 1|Screen Failure|1|||
164455227|NCT03665597|594036397|FG004|Period 1|Screen Failure|0|||
164455228|NCT03665597|594036398|FG005|Period 1|Screen Failure|0|||
164455229|NCT03665597|594036399|FG006|Period 1|Screen Failure|0|||
164455230|NCT03665597|594036393|FG000|Period 1|Death|0|||
164455231|NCT03665597|594036394|FG001|Period 1|Death|0|||
164455232|NCT03665597|594036395|FG002|Period 1|Death|0|||
164455233|NCT03665597|594036396|FG003|Period 1|Death|0|||
164455234|NCT03665597|594036397|FG004|Period 1|Death|0|||
164455235|NCT03665597|594036398|FG005|Period 1|Death|0|||
164455236|NCT03665597|594036399|FG006|Period 1|Death|45|||
164455237|NCT03665597|594036393|FG000|Period 1|Withdrawal by Subject|0|||
164455238|NCT03665597|594036394|FG001|Period 1|Withdrawal by Subject|0|||
164455239|NCT03665597|594036395|FG002|Period 1|Withdrawal by Subject|0|||
164455240|NCT03665597|594036396|FG003|Period 1|Withdrawal by Subject|0|||
164455241|NCT03665597|594036397|FG004|Period 1|Withdrawal by Subject|0|||
164455242|NCT03665597|594036398|FG005|Period 1|Withdrawal by Subject|0|||
164455243|NCT03665597|594036399|FG006|Period 1|Withdrawal by Subject|5|||
164455244|NCT03665597|594036393|FG000|Period 2|Adverse Event|0|||
164455245|NCT03665597|594036394|FG001|Period 2|Adverse Event|0|||
164455246|NCT03665597|594036395|FG002|Period 2|Adverse Event|0|||
164707080|NCT03275064|594953540|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
164455247|NCT03665597|594036396|FG003|Period 2|Adverse Event|0|||
164144657|NCT01495702|592891746|FG001|Randomized Phase|Adverse Event|2|||
164455248|NCT03665597|594036397|FG004|Period 2|Adverse Event|0|||
164455249|NCT03665597|594036398|FG005|Period 2|Adverse Event|1|||
164455250|NCT03665597|594036399|FG006|Period 2|Adverse Event|0|||
164455251|NCT03665597|594036393|FG000|Period 3|Adverse Event|0|||
164455252|NCT03665597|594036394|FG001|Period 3|Adverse Event|1|||
164455253|NCT03665597|594036395|FG002|Period 3|Adverse Event|0|||
164455254|NCT03665597|594036396|FG003|Period 3|Adverse Event|0|||
164455255|NCT03665597|594036397|FG004|Period 3|Adverse Event|0|||
164455256|NCT03665597|594036398|FG005|Period 3|Adverse Event|0|||
164455257|NCT03665597|594036399|FG006|Period 3|Adverse Event|0|||
164455258|NCT03665597|594036393|FG000|Period 3|Death|0|||
164455259|NCT03665597|594036394|FG001|Period 3|Death|0|||
164455260|NCT03665597|594036395|FG002|Period 3|Death|0|||
164455261|NCT03665597|594036396|FG003|Period 3|Death|0|||
164455262|NCT03665597|594036397|FG004|Period 3|Death|1|||
164455263|NCT03665597|594036398|FG005|Period 3|Death|0|||
164455264|NCT03665597|594036399|FG006|Period 3|Death|0|||
164455265|NCT03665597|594036393|FG000|Period 4|Adverse Event|2|||
164455266|NCT03665597|594036394|FG001|Period 4|Adverse Event|2|||
164455267|NCT03665597|594036395|FG002|Period 4|Adverse Event|2|||
164455268|NCT03665597|594036396|FG003|Period 4|Adverse Event|2|||
164455269|NCT03665597|594036397|FG004|Period 4|Adverse Event|1|||
164455270|NCT03665597|594036398|FG005|Period 4|Adverse Event|0|||
164455271|NCT03665597|594036399|FG006|Period 4|Adverse Event|0|||
164455272|NCT03665597|594036393|FG000|Period 4|Death|0|||
164455273|NCT03665597|594036394|FG001|Period 4|Death|0|||
164455274|NCT03665597|594036395|FG002|Period 4|Death|2|||
164455275|NCT03665597|594036396|FG003|Period 4|Death|0|||
164455276|NCT03665597|594036397|FG004|Period 4|Death|0|||
164455277|NCT03665597|594036398|FG005|Period 4|Death|0|||
164455278|NCT03665597|594036399|FG006|Period 4|Death|0|||
164455279|NCT03665597|594036393|FG000|Period 4|Physician Decision|1|||
164455280|NCT03665597|594036394|FG001|Period 4|Physician Decision|2|||
164455281|NCT03665597|594036395|FG002|Period 4|Physician Decision|0|||
164455282|NCT03665597|594036396|FG003|Period 4|Physician Decision|0|||
164455283|NCT03665597|594036397|FG004|Period 4|Physician Decision|0|||
164455284|NCT03665597|594036398|FG005|Period 4|Physician Decision|0|||
164455285|NCT03665597|594036399|FG006|Period 4|Physician Decision|0|||
164455286|NCT05516147|594036400|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
164455287|NCT04450342|594036402|FG000|Overall Study|Adverse Event|1|||
164455288|NCT04450342|594036403|FG001|Overall Study|Adverse Event|1|||
164455289|NCT04450342|594036404|FG002|Overall Study|Adverse Event|0|||
164455290|NCT04450342|594036402|FG000|Overall Study|Device not used|1|||
164455291|NCT04450342|594036403|FG001|Overall Study|Device not used|0|||
164455292|NCT04450342|594036404|FG002|Overall Study|Device not used|0|||
164455293|NCT04450342|594036402|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
164455294|NCT04450342|594036403|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
164455295|NCT04450342|594036404|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
164455296|NCT04450342|594036402|FG000|Overall Study|Physician Decision|1|||
164455297|NCT04450342|594036403|FG001|Overall Study|Physician Decision|0|||
164455298|NCT04450342|594036404|FG002|Overall Study|Physician Decision|1|||
164455299|NCT04450342|594036402|FG000|Overall Study|Protocol Deviation|0|||
164455300|NCT04450342|594036403|FG001|Overall Study|Protocol Deviation|1|||
164455301|NCT04450342|594036404|FG002|Overall Study|Protocol Deviation|0|||
164455302|NCT04450342|594036402|FG000|Overall Study|Reoperation|1|||
164455303|NCT04450342|594036403|FG001|Overall Study|Reoperation|1|||
164455304|NCT04450342|594036404|FG002|Overall Study|Reoperation|0|||
164455305|NCT04450342|594036402|FG000|Overall Study|Screen Failures|0|||
164455306|NCT04450342|594036403|FG001|Overall Study|Screen Failures|0|||
164455307|NCT04450342|594036404|FG002|Overall Study|Screen Failures|2|||
164455308|NCT04450342|594036402|FG000|Overall Study|Site Terminated by Sponsor|1|||
164455309|NCT04450342|594036403|FG001|Overall Study|Site Terminated by Sponsor|1|||
164455310|NCT04450342|594036404|FG002|Overall Study|Site Terminated by Sponsor|1|||
164455311|NCT04450342|594036402|FG000|Overall Study|Study Terminated by Sponsor|31|||
164455312|NCT04450342|594036403|FG001|Overall Study|Study Terminated by Sponsor|29|||
164455313|NCT04450342|594036404|FG002|Overall Study|Study Terminated by Sponsor|6|||
164455314|NCT04450342|594036402|FG000|Overall Study|Withdrawal by Subject|0|||
164455315|NCT04450342|594036403|FG001|Overall Study|Withdrawal by Subject|1|||
164455316|NCT04450342|594036404|FG002|Overall Study|Withdrawal by Subject|2|||
164455317|NCT02874534|594036405|FG000|Overall Study|Withdrawal by Subject|5|||
164455318|NCT02874534|594036406|FG001|Overall Study|Withdrawal by Subject|8|||
164455319|NCT02874534|594036405|FG000|Overall Study|Lost to Follow-up|2|||
164455320|NCT02874534|594036406|FG001|Overall Study|Lost to Follow-up|2|||
164455321|NCT02874534|594036405|FG000|Overall Study|Ongoing in study|1|||
164455322|NCT02874534|594036406|FG001|Overall Study|Ongoing in study|1|||
164455323|NCT03941860|594036410|FG000|Overall Study|Withdrawal by Subject|0|||
164455324|NCT03941860|594036411|FG001|Overall Study|Withdrawal by Subject|1|||
164455325|NCT04093752|594036412|FG000|Overall Study|Adverse Event|7|||
164455326|NCT04093752|594036413|FG001|Overall Study|Adverse Event|19|||
164455327|NCT04093752|594036414|FG002|Overall Study|Adverse Event|18|||
164455328|NCT04093752|594036415|FG003|Overall Study|Adverse Event|4|||
164455329|NCT04093752|594036412|FG000|Overall Study|Withdrawal by Subject|6|||
164455330|NCT04093752|594036413|FG001|Overall Study|Withdrawal by Subject|6|||
164455331|NCT04093752|594036414|FG002|Overall Study|Withdrawal by Subject|8|||
164455332|NCT04093752|594036415|FG003|Overall Study|Withdrawal by Subject|20|||
164455333|NCT04093752|594036412|FG000|Overall Study|Lost to Follow-up|2|||
164455334|NCT04093752|594036413|FG001|Overall Study|Lost to Follow-up|1|||
164455335|NCT04093752|594036414|FG002|Overall Study|Lost to Follow-up|1|||
164455336|NCT04093752|594036415|FG003|Overall Study|Lost to Follow-up|1|||
164455337|NCT04093752|594036412|FG000|Overall Study|Death|0|||
164455338|NCT04093752|594036413|FG001|Overall Study|Death|0|||
164455339|NCT04093752|594036414|FG002|Overall Study|Death|1|||
164455340|NCT04093752|594036415|FG003|Overall Study|Death|2|||
164455341|NCT04093752|594036412|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
164455342|NCT04093752|594036413|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
164455343|NCT04093752|594036414|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
164455344|NCT04093752|594036415|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
164455345|NCT04093752|594036412|FG000|Overall Study|Covid 19|0|||
164455346|NCT04093752|594036413|FG001|Overall Study|Covid 19|0|||
164455347|NCT04093752|594036414|FG002|Overall Study|Covid 19|0|||
164455348|NCT04093752|594036415|FG003|Overall Study|Covid 19|1|||
164455349|NCT04093752|594036412|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
164455350|NCT04093752|594036413|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
164455351|NCT04093752|594036414|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
164455352|NCT04093752|594036415|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
164455353|NCT04093752|594036412|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
164455354|NCT04093752|594036413|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
164455355|NCT04093752|594036414|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
164455356|NCT04093752|594036415|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
164455357|NCT04093752|594036412|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
164455358|NCT04093752|594036413|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
164455359|NCT04093752|594036414|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
164455360|NCT04093752|594036415|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
164455361|NCT04774237|594036422|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
164455362|NCT04774237|594036423|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
164455363|NCT04774237|594036424|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
164455364|NCT04774237|594036425|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
164455365|NCT04774237|594036426|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
164455366|NCT04774237|594036427|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
164455367|NCT02187003|594038194|FG000|Overall Study|Adverse Event|2|||
164455368|NCT02187003|594038195|FG001|Overall Study|Adverse Event|0|||
164455369|NCT02187003|594038194|FG000|Overall Study|Lost to Follow-up|14|||
164455370|NCT02187003|594038195|FG001|Overall Study|Lost to Follow-up|10|||
164455371|NCT02187003|594038194|FG000|Overall Study|Withdrawal by Subject|3|||
164455372|NCT02187003|594038195|FG001|Overall Study|Withdrawal by Subject|7|||
164455373|NCT02187003|594038194|FG000|Overall Study|Protocol Violation|2|||
164455374|NCT02187003|594038195|FG001|Overall Study|Protocol Violation|4|||
164455375|NCT02187003|594038194|FG000|Overall Study|Other|5|||
164455376|NCT02187003|594038195|FG001|Overall Study|Other|5|||
164455377|NCT02187003|594038194|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
164455378|NCT02187003|594038195|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
164455379|NCT03648840|594038198|FG000|First IV Infusion Session|Adverse Event|0|||
164455380|NCT03648840|594038199|FG001|First IV Infusion Session|Adverse Event|2|||
164455381|NCT03648840|594038198|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
164455382|NCT03648840|594038199|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
164455383|NCT03648840|594038198|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
164455384|NCT03648840|594038199|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
164455385|NCT03648840|594038198|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
164455386|NCT03648840|594038199|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
164455387|NCT05382936|594038200|FG000|Overall Study|Progressive Disease|3|||
164455388|NCT05382936|594038201|FG001|Overall Study|Progressive Disease|5|||
164455389|NCT05382936|594038202|FG002|Overall Study|Progressive Disease|2|||
164455390|NCT05382936|594038203|FG003|Overall Study|Progressive Disease|5|||
164455391|NCT05382936|594038200|FG000|Overall Study|Adverse Event|0|||
164455392|NCT05382936|594038201|FG001|Overall Study|Adverse Event|1|||
164455393|NCT05382936|594038202|FG002|Overall Study|Adverse Event|1|||
164455394|NCT05382936|594038203|FG003|Overall Study|Adverse Event|0|||
164455395|NCT05382936|594038200|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
164455396|NCT05382936|594038201|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
164455397|NCT05382936|594038202|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
164455398|NCT05382936|594038203|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
164455399|NCT05382936|594038200|FG000|Overall Study|Withdrawal by Subject|0|||
164455400|NCT05382936|594038201|FG001|Overall Study|Withdrawal by Subject|0|||
164455401|NCT05382936|594038202|FG002|Overall Study|Withdrawal by Subject|1|||
164455402|NCT05382936|594038203|FG003|Overall Study|Withdrawal by Subject|1|||
164455403|NCT05063994|594038204|FG000|Cortef Run-In|Withdrawal of Consent|1|||
164455404|NCT05063994|594038205|FG001|Cortef Run-In|Withdrawal of Consent|0|||
164455405|NCT05063994|594038206|FG002|Cortef Run-In|Withdrawal of Consent|0|||
164455406|NCT05063994|594038204|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
164455407|NCT05063994|594038205|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
164455408|NCT05063994|594038206|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
164455409|NCT05063994|594038204|FG000|Treatment|Physician Decision|0|||
164455410|NCT05063994|594038205|FG001|Treatment|Physician Decision|0|||
164455411|NCT05063994|594038206|FG002|Treatment|Physician Decision|1|||
164455412|NCT05063994|594038204|FG000|Treatment|Withdrawal by Subject|0|||
164455413|NCT05063994|594038205|FG001|Treatment|Withdrawal by Subject|0|||
164455414|NCT05063994|594038206|FG002|Treatment|Withdrawal by Subject|1|||
164455415|NCT05063994|594038204|FG000|Treatment|Withdrawal of Consent|0|||
164455416|NCT05063994|594038205|FG001|Treatment|Withdrawal of Consent|0|||
164455417|NCT05063994|594038206|FG002|Treatment|Withdrawal of Consent|1|||
164455418|NCT04630262|594038207|FG000|Overall Study|Intraoperative Screen Failure|5|||
164455419|NCT04630262|594038207|FG000|Overall Study|Study terminated prematurely|71|||
164455420|NCT04630262|594038207|FG000|Overall Study|Withdrawal by Subject|2|||
164455421|NCT04630262|594038207|FG000|Overall Study|Physician Decision|2|||
164455422|NCT01195831|594038208|FG000|Overall Study|Lost to Follow-up|2|||
164455423|NCT01195831|594038209|FG001|Overall Study|Lost to Follow-up|4|||
164455424|NCT01195831|594038208|FG000|Overall Study|Withdrawal by Subject|2|||
164455425|NCT01195831|594038209|FG001|Overall Study|Withdrawal by Subject|2|||
164455426|NCT01195831|594038208|FG000|Overall Study|Adverse Event|4|||
164455427|NCT01195831|594038209|FG001|Overall Study|Adverse Event|2|||
164455428|NCT01195831|594038208|FG000|Overall Study|Protocol Violation|0|||
164455429|NCT01195831|594038209|FG001|Overall Study|Protocol Violation|2|||
164455430|NCT03692676|594038210|FG000|Overall Study|exclude patients with prior use|4424|||
164455431|NCT03692676|594038211|FG001|Overall Study|exclude patients with prior use|24726|||
164455432|NCT03692676|594038212|FG002|Overall Study|exclude patients with prior use|0|||
164455433|NCT03692676|594038213|FG003|Overall Study|exclude patients with prior use|0|||
164455434|NCT03692676|594038210|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
164455435|NCT03692676|594038211|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
164455436|NCT03692676|594038212|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
164455437|NCT03692676|594038213|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
164455438|NCT03692676|594038210|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
164455439|NCT03692676|594038211|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
164455440|NCT03692676|594038212|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
164455441|NCT03692676|594038213|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
164455442|NCT03692676|594038210|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
164455443|NCT03692676|594038211|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
164455444|NCT03692676|594038212|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
164455445|NCT03692676|594038213|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
164455446|NCT03692676|594038210|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
164455447|NCT03692676|594038211|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
164455448|NCT03692676|594038212|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
164455449|NCT03692676|594038213|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
164455450|NCT03692676|594038210|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
164455451|NCT03692676|594038211|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
164455452|NCT03692676|594038212|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
164455453|NCT03692676|594038213|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
164455454|NCT03692676|594038210|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
164455455|NCT03692676|594038211|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
164455456|NCT03692676|594038212|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
164455457|NCT03692676|594038213|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
164455458|NCT03692676|594038210|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
164455459|NCT03692676|594038211|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
164455460|NCT03692676|594038212|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
164455461|NCT03692676|594038213|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
164455462|NCT03692676|594038210|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
164455463|NCT03692676|594038211|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
164455464|NCT03692676|594038212|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
164455465|NCT03692676|594038213|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
164455466|NCT03692676|594038210|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
164455467|NCT03692676|594038211|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
164455468|NCT03692676|594038212|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
164455469|NCT03692676|594038213|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
164455470|NCT03692676|594038210|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
164455471|NCT03692676|594038211|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
164455472|NCT03692676|594038212|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
164455473|NCT03692676|594038213|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
164455474|NCT03692676|594038210|FG000|Overall Study|Other|0|||
164455475|NCT03692676|594038211|FG001|Overall Study|Other|805|||
164455476|NCT03692676|594038212|FG002|Overall Study|Other|758|||
164455477|NCT03692676|594038213|FG003|Overall Study|Other|277|||
164455478|NCT03692676|594038210|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
164455479|NCT03692676|594038211|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
164455480|NCT03692676|594038212|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
164455481|NCT03692676|594038213|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
164455482|NCT03692611|594038214|FG000|Overall Study|Found to be ineligible postrandomization|3|||
164455483|NCT03692611|594038215|FG001|Overall Study|Found to be ineligible postrandomization|0|||
164455484|NCT03988634|594038217|FG000|Double-Blind|Adverse Event|4|||
164455485|NCT03988634|594038218|FG001|Double-Blind|Adverse Event|0|||
164455486|NCT03988634|594038219|FG002|Double-Blind|Adverse Event|0|||
164455487|NCT03988634|594038217|FG000|Double-Blind|Death|18|||
164455488|NCT03988634|594038218|FG001|Double-Blind|Death|26|||
164455489|NCT03988634|594038219|FG002|Double-Blind|Death|0|||
164455490|NCT03988634|594038217|FG000|Double-Blind|Lost to Follow-up|6|||
164455491|NCT03988634|594038218|FG001|Double-Blind|Lost to Follow-up|7|||
164455492|NCT03988634|594038219|FG002|Double-Blind|Lost to Follow-up|0|||
164455493|NCT03988634|594038217|FG000|Double-Blind|Physician Decision|9|||
164455494|NCT03988634|594038218|FG001|Double-Blind|Physician Decision|5|||
164455495|NCT03988634|594038219|FG002|Double-Blind|Physician Decision|0|||
164455496|NCT03988634|594038217|FG000|Double-Blind|Subject decision|24|||
164455497|NCT03988634|594038218|FG001|Double-Blind|Subject decision|13|||
164455498|NCT03988634|594038219|FG002|Double-Blind|Subject decision|0|||
164455499|NCT03988634|594038217|FG000|Open-Label|Adverse Event|0|||
164455500|NCT03988634|594038218|FG001|Open-Label|Adverse Event|0|||
164455501|NCT03988634|594038219|FG002|Open-Label|Adverse Event|7|||
164455502|NCT03988634|594038217|FG000|Open-Label|Physician Decision|0|||
164455503|NCT03988634|594038218|FG001|Open-Label|Physician Decision|0|||
164455504|NCT03988634|594038219|FG002|Open-Label|Physician Decision|1|||
164455505|NCT03988634|594038217|FG000|Open-Label|Technical problems|0|||
164455506|NCT03988634|594038218|FG001|Open-Label|Technical problems|0|||
164455507|NCT03988634|594038219|FG002|Open-Label|Technical problems|1|||
164455508|NCT02995434|594038224|FG000|Overall Study|Adverse Event|1|||
164455509|NCT02995434|594038225|FG001|Overall Study|Adverse Event|0|||
164455510|NCT02995434|594038224|FG000|Overall Study|Withdrawal by Subject|6|||
164455511|NCT02995434|594038225|FG001|Overall Study|Withdrawal by Subject|3|||
164455512|NCT04421378|594038231|FG000|Overall Study|Adverse Event|2|||
164455513|NCT04421378|594038232|FG001|Overall Study|Adverse Event|7|||
164455514|NCT04421378|594038233|FG002|Overall Study|Adverse Event|0|||
164455515|NCT04421378|594038234|FG003|Overall Study|Adverse Event|1|||
164455516|NCT04421378|594038235|FG004|Overall Study|Adverse Event|0|||
164455517|NCT04421378|594038231|FG000|Overall Study|Physician Decision|1|||
164455518|NCT04421378|594038232|FG001|Overall Study|Physician Decision|2|||
164455519|NCT04421378|594038233|FG002|Overall Study|Physician Decision|0|||
164455520|NCT04421378|594038234|FG003|Overall Study|Physician Decision|0|||
164455521|NCT04421378|594038235|FG004|Overall Study|Physician Decision|0|||
164455522|NCT04421378|594038231|FG000|Overall Study|Progressive Disease|16|||
164455523|NCT04421378|594038232|FG001|Overall Study|Progressive Disease|4|||
164455524|NCT04421378|594038233|FG002|Overall Study|Progressive Disease|18|||
164455525|NCT04421378|594038234|FG003|Overall Study|Progressive Disease|11|||
164455526|NCT04421378|594038235|FG004|Overall Study|Progressive Disease|3|||
164455527|NCT04421378|594038231|FG000|Overall Study|Study Terminated by Sponsor|0|||
164455528|NCT04421378|594038232|FG001|Overall Study|Study Terminated by Sponsor|1|||
164455529|NCT04421378|594038233|FG002|Overall Study|Study Terminated by Sponsor|1|||
164455530|NCT04421378|594038234|FG003|Overall Study|Study Terminated by Sponsor|0|||
164455531|NCT04421378|594038235|FG004|Overall Study|Study Terminated by Sponsor|0|||
164455532|NCT04421378|594038231|FG000|Overall Study|Withdrawal by Subject|3|||
164455533|NCT04421378|594038232|FG001|Overall Study|Withdrawal by Subject|1|||
164455534|NCT04421378|594038233|FG002|Overall Study|Withdrawal by Subject|0|||
164455535|NCT04421378|594038234|FG003|Overall Study|Withdrawal by Subject|2|||
164455536|NCT04421378|594038235|FG004|Overall Study|Withdrawal by Subject|0|||
164455537|NCT04421378|594038231|FG000|Overall Study|Other|1|||
164455538|NCT04421378|594038232|FG001|Overall Study|Other|0|||
164455539|NCT04421378|594038233|FG002|Overall Study|Other|0|||
164455540|NCT04421378|594038234|FG003|Overall Study|Other|0|||
164455541|NCT04421378|594038235|FG004|Overall Study|Other|0|||
164455542|NCT04150718|594038236|FG000|Overall Study|Withdrawal by Subject|2|||
164455543|NCT04150718|594038237|FG001|Overall Study|Withdrawal by Subject|7|||
164455544|NCT04150718|594038238|FG002|Overall Study|Withdrawal by Subject|1|||
164455545|NCT04150718|594038236|FG000|Overall Study|Lost to Follow-up|1|||
164455546|NCT04150718|594038237|FG001|Overall Study|Lost to Follow-up|2|||
164455547|NCT04150718|594038238|FG002|Overall Study|Lost to Follow-up|0|||
164455548|NCT04150718|594038236|FG000|Overall Study|Ineligible|1|||
164455549|NCT04150718|594038237|FG001|Overall Study|Ineligible|0|||
164455550|NCT04150718|594038238|FG002|Overall Study|Ineligible|10|||
164455551|NCT04258709|594038239|FG000|Overall Study|Lost to Follow-up|10|||
164455552|NCT04258709|594038240|FG001|Overall Study|Lost to Follow-up|4|||
164455553|NCT04258709|594038239|FG000|Overall Study|Withdrawal by Subject|1|||
164455554|NCT04258709|594038240|FG001|Overall Study|Withdrawal by Subject|0|||
164455555|NCT04258709|594038239|FG000|Overall Study|Fetal demise|0|||
164455556|NCT04258709|594038240|FG001|Overall Study|Fetal demise|1|||
164455557|NCT04258709|594038239|FG000|Overall Study|Protocol Violation|1|||
164455558|NCT04258709|594038240|FG001|Overall Study|Protocol Violation|1|||
164455559|NCT03175029|594038241|FG000|Overall Study|Withdrawal by Subject|2|||
164455560|NCT03175029|594038242|FG001|Overall Study|Withdrawal by Subject|1|||
164455561|NCT03175029|594038241|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
164455562|NCT03175029|594038242|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
164455563|NCT03047928|594038248|FG000|Overall Study|Adverse Event|0|||
164455564|NCT03047928|594038249|FG001|Overall Study|Adverse Event|2|||
164455565|NCT03047928|594038250|FG002|Overall Study|Adverse Event|0|||
164455566|NCT03047928|594038248|FG000|Overall Study|Protocol Violation|0|||
164455567|NCT03047928|594038249|FG001|Overall Study|Protocol Violation|1|||
164455568|NCT03047928|594038250|FG002|Overall Study|Protocol Violation|0|||
164455569|NCT03047928|594038248|FG000|Overall Study|included in another protocol|0|||
164455570|NCT03047928|594038249|FG001|Overall Study|included in another protocol|1|||
164455571|NCT03047928|594038250|FG002|Overall Study|included in another protocol|0|||
164455572|NCT02729311|594038251|FG000|Overall Study|Withdrawal by Subject|8|||
164455573|NCT02729311|594038252|FG001|Overall Study|Withdrawal by Subject|2|||
164455574|NCT05324124|594038253|FG000|Period 1|Withdrawal by Subject|1|||
164455575|NCT05324124|594038254|FG001|Period 1|Withdrawal by Subject|0|||
164455576|NCT05324124|594038253|FG000|Period 1|Physician Decision|0|||
164455577|NCT05324124|594038254|FG001|Period 1|Physician Decision|1|||
164455578|NCT05034952|594038255|FG000|Overall Study|Adverse Event|1|||
164455579|NCT05034952|594038256|FG001|Overall Study|Adverse Event|0|||
164455580|NCT05034952|594038257|FG002|Overall Study|Adverse Event|0|||
164455581|NCT05034952|594038258|FG003|Overall Study|Adverse Event|0|||
164455582|NCT05034952|594038255|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
164455583|NCT05034952|594038256|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
164455584|NCT05034952|594038257|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
164455585|NCT05034952|594038258|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
164455586|NCT05034952|594038255|FG000|Overall Study|Lost to Follow-up|1|||
164455587|NCT05034952|594038256|FG001|Overall Study|Lost to Follow-up|4|||
164455588|NCT05034952|594038257|FG002|Overall Study|Lost to Follow-up|3|||
164455589|NCT05034952|594038258|FG003|Overall Study|Lost to Follow-up|3|||
164455590|NCT05034952|594038255|FG000|Overall Study|Other|0|||
164455591|NCT05034952|594038256|FG001|Overall Study|Other|0|||
164455592|NCT05034952|594038257|FG002|Overall Study|Other|0|||
164455593|NCT05034952|594038258|FG003|Overall Study|Other|1|||
164455594|NCT02287610|594038259|FG000|Overall Study|Lost to Follow-up|3|||
164455595|NCT02287610|594038259|FG000|Overall Study|Withdrawal by Subject|8|||
164455596|NCT02287610|594038259|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
164455597|NCT04950660|594038260|FG000|Overall Study|Protocol Violation|4|||
164455598|NCT04950660|594038261|FG001|Overall Study|Protocol Violation|2|||
164455599|NCT04950660|594038260|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
164455600|NCT04950660|594038261|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
164455601|NCT04950660|594038260|FG000|Overall Study|Withdrawal by Subject|0|||
164455602|NCT04950660|594038261|FG001|Overall Study|Withdrawal by Subject|1|||
164455603|NCT04950660|594038260|FG000|Overall Study|Hypotension|1|||
164455604|NCT04950660|594038261|FG001|Overall Study|Hypotension|0|||
164455605|NCT04783935|594038264|FG000|Overall Study|Withdrawal by Subject|6|||
164455606|NCT04783935|594038264|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
164455607|NCT04783935|594038264|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
164455608|NCT04783935|594038264|FG000|Overall Study|Lost to Follow-up|3|||
164455609|NCT04783935|594038264|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
164455610|NCT02437318|594038265|FG000|Overall Study|Progressive disease|207|||
164455611|NCT02437318|594038266|FG001|Overall Study|Progressive disease|240|||
164455612|NCT02437318|594038265|FG000|Overall Study|Subject/guardian decision|24|||
164455613|NCT02437318|594038266|FG001|Overall Study|Subject/guardian decision|11|||
164455614|NCT02437318|594038265|FG000|Overall Study|Physician Decision|29|||
164455615|NCT02437318|594038266|FG001|Overall Study|Physician Decision|22|||
164455616|NCT02437318|594038265|FG000|Overall Study|Adverse Event|14|||
164455617|NCT02437318|594038266|FG001|Overall Study|Adverse Event|4|||
164455618|NCT02437318|594038265|FG000|Overall Study|Death|4|||
164455619|NCT02437318|594038266|FG001|Overall Study|Death|4|||
164455620|NCT02437318|594038265|FG000|Overall Study|Protocol deviation|5|||
164455621|NCT02437318|594038266|FG001|Overall Study|Protocol deviation|7|||
164455622|NCT02437318|594038265|FG000|Overall Study|Sponsor decision|1|||
164455623|NCT02437318|594038266|FG001|Overall Study|Sponsor decision|0|||
164455624|NCT06074523|594038270|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
164455625|NCT06074523|594038270|FG000|Overall Study|Withdrawal by Subject|1|||
164455626|NCT05273749|594038271|FG000|Overall Study|Adverse Event|14|||
164455627|NCT05273749|594038272|FG001|Overall Study|Adverse Event|8|||
164455628|NCT05273749|594038271|FG000|Overall Study|Lack of Efficacy|2|||
164455629|NCT05273749|594038272|FG001|Overall Study|Lack of Efficacy|8|||
164455630|NCT05273749|594038271|FG000|Overall Study|Physician Decision|0|||
164455631|NCT05273749|594038272|FG001|Overall Study|Physician Decision|2|||
164455632|NCT05273749|594038271|FG000|Overall Study|Withdrawal by Subject|14|||
164455633|NCT05273749|594038272|FG001|Overall Study|Withdrawal by Subject|16|||
164455634|NCT05273749|594038271|FG000|Overall Study|Lost to Follow-up|10|||
164455635|NCT05273749|594038272|FG001|Overall Study|Lost to Follow-up|10|||
164455636|NCT05273749|594038271|FG000|Overall Study|Pregnancy|1|||
164455637|NCT05273749|594038272|FG001|Overall Study|Pregnancy|0|||
164455638|NCT05273749|594038271|FG000|Overall Study|Non-Compliance|3|||
164455639|NCT05273749|594038272|FG001|Overall Study|Non-Compliance|2|||
164455640|NCT05273749|594038271|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
164455641|NCT05273749|594038272|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
164455642|NCT04382898|594038273|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
164455643|NCT04382898|594038274|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
164455644|NCT04382898|594038275|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
164455645|NCT04382898|594038276|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
164455646|NCT04382898|594038277|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
164455647|NCT04382898|594038273|FG000|Part 1: Dose Titration|Death|6|||
164455648|NCT04382898|594038274|FG001|Part 1: Dose Titration|Death|0|||
164455649|NCT04382898|594038275|FG002|Part 1: Dose Titration|Death|0|||
164455650|NCT04382898|594038276|FG003|Part 1: Dose Titration|Death|0|||
164455651|NCT04382898|594038277|FG004|Part 1: Dose Titration|Death|0|||
164455652|NCT04382898|594038273|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164455653|NCT04382898|594038274|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164455654|NCT04382898|594038275|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
164455655|NCT04382898|594038276|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164455656|NCT04382898|594038277|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164455657|NCT04382898|594038273|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
164455658|NCT04382898|594038274|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
164455659|NCT04382898|594038275|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
164455660|NCT04382898|594038276|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
164455661|NCT04382898|594038277|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
164455662|NCT04382898|594038273|FG000|Part 2: Dose Expansion|Death|0|||
164455663|NCT04382898|594038274|FG001|Part 2: Dose Expansion|Death|17|||
164455664|NCT04382898|594038275|FG002|Part 2: Dose Expansion|Death|13|||
164455665|NCT04382898|594038276|FG003|Part 2: Dose Expansion|Death|1|||
164455666|NCT04382898|594038277|FG004|Part 2: Dose Expansion|Death|0|||
164455667|NCT04382898|594038273|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
164455668|NCT04382898|594038274|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
164455669|NCT04382898|594038275|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
164597921|NCT00077610|594551288|FG000|Overall Study|Transferred to other unit|0|||
164597922|NCT00077610|594551289|FG001|Overall Study|Transferred to other unit|0|||
164455670|NCT04382898|594038276|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
164455671|NCT04382898|594038277|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
164455672|NCT04382898|594038273|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
164455673|NCT04382898|594038274|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
164455674|NCT04382898|594038275|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
164455675|NCT04382898|594038276|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
164455676|NCT04382898|594038277|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
164455677|NCT04382898|594038273|FG000|Part 2: Dose Expansion|Other|0|||
164455678|NCT04382898|594038274|FG001|Part 2: Dose Expansion|Other|0|||
164597923|NCT00077610|594551290|FG002|Overall Study|Transferred to other unit|1|||
164597924|NCT00077610|594551288|FG000|Overall Study|Transferred to nursing home|0|||
164597925|NCT00077610|594551289|FG001|Overall Study|Transferred to nursing home|0|||
164597926|NCT00077610|594551290|FG002|Overall Study|Transferred to nursing home|1|||
164597927|NCT00077610|594551288|FG000|Overall Study|Transfer to satellite unit|1|||
164597928|NCT00077610|594551289|FG001|Overall Study|Transfer to satellite unit|0|||
164597929|NCT00077610|594551290|FG002|Overall Study|Transfer to satellite unit|0|||
164455679|NCT04382898|594038275|FG002|Part 2: Dose Expansion|Other|1|||
164455680|NCT04382898|594038276|FG003|Part 2: Dose Expansion|Other|0|||
164455681|NCT04382898|594038277|FG004|Part 2: Dose Expansion|Other|0|||
164455682|NCT05229120|594038278|FG000|Overall Study|Withdrawal by Subject|8|||
164455683|NCT03932682|594038281|FG000|Overall Study|Death|1|||
164455684|NCT03932682|594038282|FG001|Overall Study|Death|2|||
164455685|NCT03932682|594038281|FG000|Overall Study|Withdrawal by Subject|37|||
164455686|NCT03932682|594038282|FG001|Overall Study|Withdrawal by Subject|45|||
164455687|NCT03932682|594038281|FG000|Overall Study|Lost to Follow-up|19|||
164455688|NCT03932682|594038282|FG001|Overall Study|Lost to Follow-up|25|||
164455689|NCT03932682|594038281|FG000|Overall Study|Protocol Violation|0|||
164455690|NCT03932682|594038282|FG001|Overall Study|Protocol Violation|2|||
164455691|NCT03932682|594038281|FG000|Overall Study|Other|9|||
164455692|NCT03932682|594038282|FG001|Overall Study|Other|23|||
164455693|NCT04321031|594038283|FG000|Overall Study|Adverse Event|0|||
164455694|NCT04321031|594038284|FG001|Overall Study|Adverse Event|2|||
164455695|NCT04321031|594038285|FG002|Overall Study|Adverse Event|2|||
164455696|NCT04321031|594038286|FG003|Overall Study|Adverse Event|2|||
164455697|NCT04321031|594038287|FG004|Overall Study|Adverse Event|2|||
164455698|NCT04321031|594038288|FG005|Overall Study|Adverse Event|2|||
164455699|NCT04321031|594038289|FG006|Overall Study|Adverse Event|0|||
164455700|NCT04321031|594038283|FG000|Overall Study|Lost to Follow-up|0|||
164455701|NCT04321031|594038284|FG001|Overall Study|Lost to Follow-up|0|||
164455702|NCT04321031|594038285|FG002|Overall Study|Lost to Follow-up|0|||
164455703|NCT04321031|594038286|FG003|Overall Study|Lost to Follow-up|1|||
164455704|NCT04321031|594038287|FG004|Overall Study|Lost to Follow-up|0|||
164455705|NCT04321031|594038288|FG005|Overall Study|Lost to Follow-up|2|||
164455706|NCT04321031|594038289|FG006|Overall Study|Lost to Follow-up|1|||
164455707|NCT04321031|594038283|FG000|Overall Study|Withdrawal by Subject|2|||
164455708|NCT04321031|594038284|FG001|Overall Study|Withdrawal by Subject|2|||
164455709|NCT04321031|594038285|FG002|Overall Study|Withdrawal by Subject|1|||
164455710|NCT04321031|594038286|FG003|Overall Study|Withdrawal by Subject|3|||
164455711|NCT04321031|594038287|FG004|Overall Study|Withdrawal by Subject|1|||
164455712|NCT04321031|594038288|FG005|Overall Study|Withdrawal by Subject|0|||
164455713|NCT04321031|594038289|FG006|Overall Study|Withdrawal by Subject|1|||
164455714|NCT04321031|594038283|FG000|Overall Study|Non-compliance with study drug|0|||
164455715|NCT04321031|594038284|FG001|Overall Study|Non-compliance with study drug|0|||
164455716|NCT04321031|594038285|FG002|Overall Study|Non-compliance with study drug|0|||
164455717|NCT04321031|594038286|FG003|Overall Study|Non-compliance with study drug|0|||
164455718|NCT04321031|594038287|FG004|Overall Study|Non-compliance with study drug|0|||
164455719|NCT04321031|594038288|FG005|Overall Study|Non-compliance with study drug|1|||
164455720|NCT04321031|594038289|FG006|Overall Study|Non-compliance with study drug|0|||
164455721|NCT04321031|594038283|FG000|Overall Study|Other|0|||
164455722|NCT04321031|594038284|FG001|Overall Study|Other|0|||
164455723|NCT04321031|594038285|FG002|Overall Study|Other|0|||
164455724|NCT04321031|594038286|FG003|Overall Study|Other|1|||
164455725|NCT04321031|594038287|FG004|Overall Study|Other|0|||
164455726|NCT04321031|594038288|FG005|Overall Study|Other|0|||
164455727|NCT04321031|594038289|FG006|Overall Study|Other|0|||
164455728|NCT05687916|594038298|FG000|Overall Study|Adverse Event|1|||
164455729|NCT05687916|594038299|FG001|Overall Study|Adverse Event|2|||
164455730|NCT05687916|594038300|FG002|Overall Study|Adverse Event|0|||
164455731|NCT05687916|594038298|FG000|Overall Study|Withdrawal by Subject|1|||
164455732|NCT05687916|594038299|FG001|Overall Study|Withdrawal by Subject|0|||
164455733|NCT05687916|594038300|FG002|Overall Study|Withdrawal by Subject|1|||
164455734|NCT05687916|594038298|FG000|Overall Study|Protocol Violation|0|||
164455735|NCT05687916|594038299|FG001|Overall Study|Protocol Violation|2|||
164455736|NCT05687916|594038300|FG002|Overall Study|Protocol Violation|1|||
164406720|NCT01782872|593859090|FG002|Overall Study|Protocol Violation|0|||
164406721|NCT01782872|593859091|FG003|Overall Study|Protocol Violation|1|||
164406722|NCT01782872|593859088|FG000|Overall Study|Withdrawal by Subject|0|||
164406723|NCT01782872|593859089|FG001|Overall Study|Withdrawal by Subject|1|||
164406724|NCT01782872|593859090|FG002|Overall Study|Withdrawal by Subject|0|||
164406725|NCT01782872|593859091|FG003|Overall Study|Withdrawal by Subject|0|||
164406726|NCT02309112|593859092|FG000|Overall Study|Withdrawal by Subject|1|||
164406727|NCT02309112|593859093|FG001|Overall Study|Withdrawal by Subject|0|||
164406728|NCT02309112|593859094|FG002|Overall Study|Withdrawal by Subject|1|||
164406729|NCT02309112|593859092|FG000|Overall Study|Lost to Follow-up|0|||
164406730|NCT02309112|593859093|FG001|Overall Study|Lost to Follow-up|1|||
164406731|NCT02309112|593859094|FG002|Overall Study|Lost to Follow-up|0|||
164406732|NCT03505476|593859096|FG000|Overall Study|Physician Decision|18|||
164406733|NCT03505476|593859096|FG000|Overall Study|Device Malfunctioned|101|||
164455737|NCT05687916|594038298|FG000|Overall Study|Reason not Specified|1|||
164455738|NCT05687916|594038299|FG001|Overall Study|Reason not Specified|0|||
164455739|NCT05687916|594038300|FG002|Overall Study|Reason not Specified|0|||
164455740|NCT00931710|594038303|FG000|Overall Study|Adverse Event|16|||
164455741|NCT00931710|594038304|FG001|Overall Study|Adverse Event|10|||
164455742|NCT00931710|594038303|FG000|Overall Study|Abnormal test procedure results|2|||
164455743|NCT00931710|594038304|FG001|Overall Study|Abnormal test procedure results|0|||
164455744|NCT00931710|594038303|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
164455745|NCT00931710|594038304|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
164455746|NCT00931710|594038303|FG000|Overall Study|Patient withdrew consent|4|||
164455747|NCT00931710|594038304|FG001|Overall Study|Patient withdrew consent|9|||
164455748|NCT00931710|594038303|FG000|Overall Study|Lost to Follow-up|6|||
164455749|NCT00931710|594038304|FG001|Overall Study|Lost to Follow-up|5|||
164455750|NCT00931710|594038303|FG000|Overall Study|Protocol deviation|1|||
164455751|NCT00931710|594038304|FG001|Overall Study|Protocol deviation|2|||
164455752|NCT03338790|594038305|FG000|Overall Study|Disease Progression|65|||
164455753|NCT03338790|594038306|FG001|Overall Study|Disease Progression|43|||
164455754|NCT03338790|594038307|FG002|Overall Study|Disease Progression|50|||
164455755|NCT03338790|594038308|FG003|Overall Study|Disease Progression|37|||
164455756|NCT03338790|594038305|FG000|Overall Study|Study Drug Toxicity|9|||
164455757|NCT03338790|594038306|FG001|Overall Study|Study Drug Toxicity|8|||
164455758|NCT03338790|594038307|FG002|Overall Study|Study Drug Toxicity|15|||
164455759|NCT03338790|594038308|FG003|Overall Study|Study Drug Toxicity|0|||
164455760|NCT03338790|594038305|FG000|Overall Study|Death|1|||
164455761|NCT03338790|594038306|FG001|Overall Study|Death|1|||
164455762|NCT03338790|594038307|FG002|Overall Study|Death|1|||
164455763|NCT03338790|594038308|FG003|Overall Study|Death|0|||
164455764|NCT03338790|594038305|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
164455765|NCT03338790|594038306|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
164455766|NCT03338790|594038307|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
164455767|NCT03338790|594038308|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
164455768|NCT03338790|594038305|FG000|Overall Study|Participant request to discontinue study treatment|3|||
164455769|NCT03338790|594038306|FG001|Overall Study|Participant request to discontinue study treatment|3|||
164455770|NCT03338790|594038307|FG002|Overall Study|Participant request to discontinue study treatment|2|||
164455771|NCT03338790|594038308|FG003|Overall Study|Participant request to discontinue study treatment|1|||
164455772|NCT03338790|594038305|FG000|Overall Study|Poor/non-compliance|0|||
164597930|NCT00077610|594551288|FG000|Overall Study|Transfer to other center for surgery|1|||
164597931|NCT00077610|594551289|FG001|Overall Study|Transfer to other center for surgery|0|||
164597932|NCT00077610|594551290|FG002|Overall Study|Transfer to other center for surgery|0|||
164597933|NCT00077610|594551288|FG000|Overall Study|Change in dialysis modality|1|||
164597934|NCT00077610|594551289|FG001|Overall Study|Change in dialysis modality|0|||
164597935|NCT00077610|594551290|FG002|Overall Study|Change in dialysis modality|0|||
164597936|NCT00077610|594551288|FG000|Overall Study|Relocation|0|||
164597937|NCT00077610|594551289|FG001|Overall Study|Relocation|8|||
164597938|NCT00077610|594551290|FG002|Overall Study|Relocation|5|||
164597939|NCT00077610|594551288|FG000|Overall Study|Financial issues|0|||
164597940|NCT00077610|594551289|FG001|Overall Study|Financial issues|1|||
164597941|NCT00077610|594551290|FG002|Overall Study|Financial issues|0|||
164597942|NCT00077610|594551288|FG000|Overall Study|Sponsors decision to withdraw|0|||
164597943|NCT00077610|594551289|FG001|Overall Study|Sponsors decision to withdraw|0|||
164597944|NCT00077610|594551290|FG002|Overall Study|Sponsors decision to withdraw|1|||
164597945|NCT00305253|594551296|FG000|Overall Study|Withdrawal by Subject|0|||
164597946|NCT00305253|594551297|FG001|Overall Study|Withdrawal by Subject|1|||
164597947|NCT01357915|594551298|FG000|Overall Study|Lost to Follow-up|3|||
164455773|NCT03338790|594038306|FG001|Overall Study|Poor/non-compliance|1|||
164455774|NCT03338790|594038307|FG002|Overall Study|Poor/non-compliance|0|||
164455775|NCT03338790|594038308|FG003|Overall Study|Poor/non-compliance|0|||
164455776|NCT03338790|594038305|FG000|Overall Study|Participant withdrew consent|1|||
164455777|NCT03338790|594038306|FG001|Overall Study|Participant withdrew consent|0|||
164455778|NCT03338790|594038307|FG002|Overall Study|Participant withdrew consent|1|||
164455779|NCT03338790|594038308|FG003|Overall Study|Participant withdrew consent|1|||
164455780|NCT03338790|594038305|FG000|Overall Study|Other reasons|0|||
164455781|NCT03338790|594038306|FG001|Overall Study|Other reasons|5|||
164455782|NCT03338790|594038307|FG002|Overall Study|Other reasons|0|||
164455783|NCT03338790|594038308|FG003|Overall Study|Other reasons|2|||
164455784|NCT03338790|594038305|FG000|Overall Study|Not reported|0|||
164455785|NCT03338790|594038306|FG001|Overall Study|Not reported|0|||
164455786|NCT03338790|594038307|FG002|Overall Study|Not reported|1|||
164455787|NCT03338790|594038308|FG003|Overall Study|Not reported|0|||
164455788|NCT03338790|594038305|FG000|Overall Study|Completed treatment period|1|||
164455789|NCT03338790|594038306|FG001|Overall Study|Completed treatment period|2|||
164455790|NCT03338790|594038307|FG002|Overall Study|Completed treatment period|0|||
164597948|NCT01357915|594551299|FG001|Overall Study|Lost to Follow-up|0|||
164597949|NCT01098461|594551300|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
164597950|NCT01098461|594551301|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
164455791|NCT03338790|594038308|FG003|Overall Study|Completed treatment period|0|||
164455792|NCT04588298|594038312|FG000|Overall Study|Adverse Event|0|||
164455793|NCT04588298|594038313|FG001|Overall Study|Adverse Event|0|||
164455794|NCT04588298|594038314|FG002|Overall Study|Adverse Event|1|||
164455795|NCT04588298|594038315|FG003|Overall Study|Adverse Event|0|||
164455796|NCT04588298|594038316|FG004|Overall Study|Adverse Event|2|||
164455797|NCT04588298|594038312|FG000|Overall Study|Withdrawal by Subject|1|||
164597951|NCT01098461|594551302|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
164455798|NCT04588298|594038313|FG001|Overall Study|Withdrawal by Subject|0|||
164455799|NCT04588298|594038314|FG002|Overall Study|Withdrawal by Subject|0|||
164455800|NCT04588298|594038315|FG003|Overall Study|Withdrawal by Subject|1|||
164455801|NCT04588298|594038316|FG004|Overall Study|Withdrawal by Subject|0|||
164455802|NCT03892616|594038317|FG000|Washout Period 2|Met discontinuation criterion|0|||
164455803|NCT03892616|594038318|FG001|Washout Period 2|Met discontinuation criterion|0|||
164455804|NCT03892616|594038319|FG002|Washout Period 2|Met discontinuation criterion|0|||
164455805|NCT03892616|594038320|FG003|Washout Period 2|Met discontinuation criterion|0|||
164455806|NCT03892616|594038321|FG004|Washout Period 2|Met discontinuation criterion|0|||
164455807|NCT03892616|594038322|FG005|Washout Period 2|Met discontinuation criterion|0|||
164455808|NCT03892616|594038323|FG006|Washout Period 2|Met discontinuation criterion|0|||
164455809|NCT03892616|594038324|FG007|Washout Period 2|Met discontinuation criterion|0|||
164455810|NCT03892616|594038325|FG008|Washout Period 2|Met discontinuation criterion|1|||
164455811|NCT03892616|594038326|FG009|Washout Period 2|Met discontinuation criterion|0|||
164455812|NCT03892616|594038327|FG010|Washout Period 2|Met discontinuation criterion|0|||
164455813|NCT03892616|594038328|FG011|Washout Period 2|Met discontinuation criterion|0|||
164455814|NCT03924986|594038329|FG000|Overall Study|Death|57|||
164455815|NCT03924986|594038330|FG001|Overall Study|Death|66|||
164455816|NCT03924986|594038329|FG000|Overall Study|Study Concluded by Sponsor|51|||
164455817|NCT03924986|594038330|FG001|Overall Study|Study Concluded by Sponsor|41|||
164455818|NCT03924986|594038329|FG000|Overall Study|Withdrawal by Subject|15|||
164455819|NCT03924986|594038330|FG001|Overall Study|Withdrawal by Subject|20|||
164455820|NCT03924986|594038329|FG000|Overall Study|Lost to Follow-up|7|||
164455821|NCT03924986|594038330|FG001|Overall Study|Lost to Follow-up|5|||
164455822|NCT03924986|594038329|FG000|Overall Study|Miscellaneous|1|||
164455823|NCT03924986|594038330|FG001|Overall Study|Miscellaneous|0|||
164455824|NCT02907099|594038336|FG000|Overall Study|Adverse Event|1|||
164455825|NCT02907099|594038336|FG000|Overall Study|Withdrawal by Subject|2|||
164455826|NCT02907099|594038336|FG000|Overall Study|Screen Fail|2|||
164455827|NCT05569252|594038337|FG000|Overall Study|Adverse event (central vision loss)|1|||
164455828|NCT05569252|594038338|FG001|Overall Study|Adverse event (central vision loss)|0|||
164455829|NCT05569252|594038339|FG002|Overall Study|Adverse event (central vision loss)|0|||
164455830|NCT05569252|594038340|FG003|Overall Study|Adverse event (central vision loss)|0|||
164455831|NCT02949362|594038341|FG000|Retrospective Period|Inform consent not signed by participant|4|||
164455832|NCT02949362|594038342|FG001|Retrospective Period|Inform consent not signed by participant|1|||
164455833|NCT02949362|594038343|FG002|Retrospective Period|Inform consent not signed by participant|0|||
164455834|NCT02949362|594038344|FG003|Retrospective Period|Inform consent not signed by participant|0|||
164455835|NCT02949362|594038341|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
164455836|NCT02949362|594038342|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
164455837|NCT02949362|594038343|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
164455838|NCT02949362|594038344|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
164455839|NCT02949362|594038341|FG000|Prospective Period|Other|0|||
164455840|NCT02949362|594038342|FG001|Prospective Period|Other|0|||
164455841|NCT02949362|594038343|FG002|Prospective Period|Other|0|||
164455842|NCT02949362|594038344|FG003|Prospective Period|Other|4|||
164597952|NCT01098461|594551303|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
164597953|NCT01098461|594551300|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
164597954|NCT01098461|594551301|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
164597955|NCT01098461|594551302|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
164597956|NCT01098461|594551303|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
164597957|NCT01098461|594551300|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
164597958|NCT01098461|594551301|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
164597959|NCT01098461|594551302|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
164597960|NCT01098461|594551303|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
164597961|NCT01098461|594551300|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
164597962|NCT01098461|594551301|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
164597963|NCT01098461|594551302|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
164597964|NCT01098461|594551303|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
164597965|NCT01098461|594551300|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
164597966|NCT01098461|594551301|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
164597967|NCT01098461|594551302|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
164597968|NCT01098461|594551303|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
164597969|NCT01098461|594551300|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
164597970|NCT01098461|594551301|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
164455843|NCT05268302|594038345|FG000|Overall Study|Death|0|||
164455844|NCT05268302|594038346|FG001|Overall Study|Death|1|||
164455845|NCT02811679|594038347|FG000|Overall Study|Adverse Event|1|||
164455846|NCT02811679|594038347|FG000|Overall Study|Lack of Efficacy|6|||
164455847|NCT02811679|594038347|FG000|Overall Study|Early study closure due to slow accrual|3|||
164455848|NCT05319860|594038351|FG000|Overall Study|Death|1|||
164455849|NCT05319860|594038352|FG001|Overall Study|Death|1|||
164455850|NCT05319860|594038351|FG000|Overall Study|Lost to Follow-up|3|||
164455851|NCT05319860|594038352|FG001|Overall Study|Lost to Follow-up|1|||
164455852|NCT05319860|594038351|FG000|Overall Study|Withdrawal by Subject|1|||
164455853|NCT05319860|594038352|FG001|Overall Study|Withdrawal by Subject|7|||
164455854|NCT04314895|594038353|FG000|Overall Study|Lost to Follow-up|1|||
164455855|NCT04314895|594038353|FG000|Overall Study|Death|10|||
164455856|NCT04314895|594038353|FG000|Overall Study|Physician Decision|2|||
164455857|NCT03361748|594038354|FG000|Overall Study|Death|77|||
164455858|NCT03361748|594038354|FG000|Overall Study|Lost to Follow-up|4|||
164455859|NCT03361748|594038354|FG000|Overall Study|Withdrawal by Subject|20|||
164455860|NCT01084707|594038355|FG000|Overall Study|Withdrawal by Subject|6|||
164455861|NCT00901901|594038356|FG000|Treatment Period|Adverse Event|120|||
164455862|NCT00901901|594038357|FG001|Treatment Period|Adverse Event|128|||
164455863|NCT00901901|594038356|FG000|Treatment Period|Withdrawal by Subject|26|||
164455864|NCT00901901|594038357|FG001|Treatment Period|Withdrawal by Subject|24|||
164455865|NCT00901901|594038356|FG000|Treatment Period|Physician Decision|2|||
164455866|NCT00901901|594038357|FG001|Treatment Period|Physician Decision|2|||
164455867|NCT00901901|594038356|FG000|Treatment Period|Lost to Follow-up|3|||
164455868|NCT00901901|594038357|FG001|Treatment Period|Lost to Follow-up|5|||
164455869|NCT00901901|594038356|FG000|Treatment Period|Noncompliance with study medication|4|||
164455870|NCT00901901|594038357|FG001|Treatment Period|Noncompliance with study medication|1|||
164455871|NCT00901901|594038356|FG000|Treatment Period|Missing|1|||
164455872|NCT00901901|594038357|FG001|Treatment Period|Missing|0|||
164455873|NCT00901901|594038356|FG000|Treatment Period|Never treated|0|||
164455874|NCT00901901|594038357|FG001|Treatment Period|Never treated|3|||
164455875|NCT00901901|594038356|FG000|Treatment Period|Protocol driven decision point|0|||
164455876|NCT00901901|594038357|FG001|Treatment Period|Protocol driven decision point|2|||
164455877|NCT00901901|594038356|FG000|Treatment Period|Study terminated by sponsor|2|||
164455878|NCT00901901|594038357|FG001|Treatment Period|Study terminated by sponsor|0|||
164455879|NCT00901901|594038356|FG000|Treatment Period|Protocol Violation|5|||
164455880|NCT00901901|594038357|FG001|Treatment Period|Protocol Violation|9|||
164455881|NCT00901901|594038356|FG000|Treatment Period|Switch to commercial drug|1|||
164455882|NCT00901901|594038357|FG001|Treatment Period|Switch to commercial drug|1|||
164455883|NCT00901901|594038356|FG000|Treatment Period|Transfer to treatment continuation study|5|||
164455884|NCT00901901|594038357|FG001|Treatment Period|Transfer to treatment continuation study|2|||
164455885|NCT00901901|594038356|FG000|Follow-up Period|Death|181|||
164455886|NCT00901901|594038357|FG001|Follow-up Period|Death|208|||
164455887|NCT00901901|594038356|FG000|Follow-up Period|Protocol driven decision point|47|||
164455888|NCT00901901|594038357|FG001|Follow-up Period|Protocol driven decision point|36|||
164455889|NCT00901901|594038356|FG000|Follow-up Period|Withdrawal by Subject|6|||
164455890|NCT00901901|594038357|FG001|Follow-up Period|Withdrawal by Subject|9|||
164455891|NCT00901901|594038356|FG000|Follow-up Period|Lost to Follow-up|12|||
164455892|NCT00901901|594038357|FG001|Follow-up Period|Lost to Follow-up|8|||
164455893|NCT00901901|594038356|FG000|Follow-up Period|Missing|94|||
164455894|NCT00901901|594038357|FG001|Follow-up Period|Missing|80|||
164455895|NCT05113966|594040233|FG000|Overall Study|Death|21|||
164455896|NCT05113966|594040233|FG000|Overall Study|Study Terminated by Sponsor|9|||
164455897|NCT04490915|594040234|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
164455898|NCT04490915|594040235|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
164455899|NCT04490915|594040234|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
164455900|NCT04490915|594040235|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
164455901|NCT04490915|594040234|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
164455902|NCT04490915|594040235|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
164455903|NCT04490915|594040234|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
164455904|NCT04490915|594040235|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
164455905|NCT04490915|594040234|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
164455906|NCT04490915|594040235|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
164455907|NCT04490915|594040234|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
164455908|NCT04490915|594040235|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
164455909|NCT04490915|594040234|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
164455910|NCT04490915|594040235|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
164455911|NCT00667251|594040237|FG000|Overall Study|Disease progression|232|||
164455912|NCT00667251|594040238|FG001|Overall Study|Disease progression|203|||
164455913|NCT00667251|594040237|FG000|Overall Study|Toxicity|44|||
164455914|NCT00667251|594040238|FG001|Overall Study|Toxicity|23|||
164455915|NCT00667251|594040237|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
164455916|NCT00667251|594040238|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
164455917|NCT00667251|594040237|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
164455918|NCT00667251|594040238|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
164455919|NCT00667251|594040237|FG000|Overall Study|Symptomatic progression|8|||
164455920|NCT00667251|594040238|FG001|Overall Study|Symptomatic progression|4|||
164455921|NCT00667251|594040237|FG000|Overall Study|Death|6|||
164455922|NCT00667251|594040238|FG001|Overall Study|Death|11|||
164455923|NCT00667251|594040237|FG000|Overall Study|Intercurrent illness|5|||
164455924|NCT00667251|594040238|FG001|Overall Study|Intercurrent illness|6|||
164455925|NCT00667251|594040237|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
164455926|NCT00667251|594040238|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
164455927|NCT00667251|594040237|FG000|Overall Study|Randomized not Treated|4|||
164455928|NCT00667251|594040238|FG001|Overall Study|Randomized not Treated|1|||
164455929|NCT03376321|594040239|FG000|Overall Study|Other|5|||
164455930|NCT03376321|594040240|FG001|Overall Study|Other|1|||
164455931|NCT03376321|594040239|FG000|Overall Study|Withdrawal by Subject|8|||
164455932|NCT03376321|594040240|FG001|Overall Study|Withdrawal by Subject|14|||
164455933|NCT03376321|594040239|FG000|Overall Study|Lost to Follow-up|1|||
164455934|NCT03376321|594040240|FG001|Overall Study|Lost to Follow-up|7|||
164455935|NCT03376321|594040239|FG000|Overall Study|Death|4|||
164455936|NCT03376321|594040240|FG001|Overall Study|Death|0|||
164455937|NCT03376321|594040239|FG000|Overall Study|Randomized, not treated|5|||
164455938|NCT03376321|594040240|FG001|Overall Study|Randomized, not treated|3|||
164455939|NCT01426425|594040241|FG000|Overall Study|Exited prior to EP study|22|||
164455940|NCT01426425|594040241|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
164455941|NCT01426425|594040241|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
164455942|NCT03281291|594040247|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
164455943|NCT03281291|594040248|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
164455944|NCT03281291|594040249|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
164455945|NCT03281291|594040250|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
164455946|NCT03281291|594040251|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
164455947|NCT03281291|594040247|FG000|Overall Study|Protocol Deviation|2|||
164455948|NCT03281291|594040248|FG001|Overall Study|Protocol Deviation|0|||
164455949|NCT03281291|594040249|FG002|Overall Study|Protocol Deviation|1|||
164455950|NCT03281291|594040250|FG003|Overall Study|Protocol Deviation|2|||
164455951|NCT03281291|594040251|FG004|Overall Study|Protocol Deviation|1|||
164455952|NCT03281291|594040247|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
164455953|NCT03281291|594040248|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
164455954|NCT03281291|594040249|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
164455955|NCT03281291|594040250|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
164455956|NCT03281291|594040251|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
164455957|NCT03281291|594040247|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
164455958|NCT03281291|594040248|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
164455959|NCT03281291|594040249|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
164455960|NCT03281291|594040250|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
164455961|NCT03281291|594040251|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
164455962|NCT03281291|594040247|FG000|Overall Study|Lost to Follow-up|10|||
164455963|NCT03281291|594040248|FG001|Overall Study|Lost to Follow-up|10|||
164455964|NCT03281291|594040249|FG002|Overall Study|Lost to Follow-up|4|||
164455965|NCT03281291|594040250|FG003|Overall Study|Lost to Follow-up|6|||
164455966|NCT03281291|594040251|FG004|Overall Study|Lost to Follow-up|10|||
164455967|NCT03281291|594040247|FG000|Overall Study|Other|0|||
164455968|NCT03281291|594040248|FG001|Overall Study|Other|2|||
164455969|NCT03281291|594040249|FG002|Overall Study|Other|0|||
164455970|NCT03281291|594040250|FG003|Overall Study|Other|2|||
164455971|NCT03281291|594040251|FG004|Overall Study|Other|1|||
164455972|NCT00512070|594040252|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
164455973|NCT00512070|594040253|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
164455974|NCT00512070|594040254|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
164455975|NCT00512070|594040252|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
164597971|NCT01098461|594551302|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
164597972|NCT01098461|594551303|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
164597973|NCT01098461|594551300|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
164455976|NCT00512070|594040253|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
164455977|NCT00512070|594040254|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
164455978|NCT04956861|594040255|FG000|Overall Study|Withdrawal by Subject|4|||
164455979|NCT04956861|594040256|FG001|Overall Study|Withdrawal by Subject|4|||
164455980|NCT04956861|594040257|FG002|Overall Study|Withdrawal by Subject|2|||
164455981|NCT04956861|594040255|FG000|Overall Study|Physician Decision|4|||
164455982|NCT04956861|594040256|FG001|Overall Study|Physician Decision|5|||
164455983|NCT04956861|594040257|FG002|Overall Study|Physician Decision|1|||
164455984|NCT00961571|594040258|FG000|Overall Study|Physician Decision|39|||
164455985|NCT02900924|594040262|FG000|Overall Study|Death|52|||
164455986|NCT02900924|594040262|FG000|Overall Study|Lost to Follow-up|4|||
164455987|NCT02900924|594040262|FG000|Overall Study|Withdrawal by Subject|20|||
164455988|NCT02900924|594040262|FG000|Overall Study|Missed Visit|33|||
164455989|NCT03143153|594040263|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
164455990|NCT03143153|594040264|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
164455991|NCT03143153|594040265|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
164455992|NCT03143153|594040263|FG000|Pre-Treatment|Participant withdrew consent|0|||
164455993|NCT03143153|594040264|FG001|Pre-Treatment|Participant withdrew consent|1|||
164455994|NCT03143153|594040265|FG002|Pre-Treatment|Participant withdrew consent|12|||
164455995|NCT03143153|594040263|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
164455996|NCT03143153|594040264|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
164455997|NCT03143153|594040265|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
164455998|NCT03143153|594040263|FG000|Pre-Treatment|Other Reasons|1|||
164455999|NCT03143153|594040264|FG001|Pre-Treatment|Other Reasons|2|||
164456000|NCT03143153|594040265|FG002|Pre-Treatment|Other Reasons|1|||
164456001|NCT03143153|594040263|FG000|Pre-Treatment|Disease Progression|1|||
164456002|NCT03143153|594040264|FG001|Pre-Treatment|Disease Progression|1|||
164456003|NCT03143153|594040265|FG002|Pre-Treatment|Disease Progression|2|||
164456004|NCT03143153|594040263|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
164456005|NCT03143153|594040264|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
164456006|NCT03143153|594040265|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
164456007|NCT03143153|594040263|FG000|Treatment|Disease progression|174|||
164456008|NCT03143153|594040264|FG001|Treatment|Disease progression|184|||
164456009|NCT03143153|594040265|FG002|Treatment|Disease progression|193|||
164456010|NCT03143153|594040263|FG000|Treatment|Study drug toxicity|59|||
164456011|NCT03143153|594040264|FG001|Treatment|Study drug toxicity|33|||
164456012|NCT03143153|594040265|FG002|Treatment|Study drug toxicity|40|||
164456013|NCT03143153|594040263|FG000|Treatment|Death|5|||
164456014|NCT03143153|594040264|FG001|Treatment|Death|3|||
164456015|NCT03143153|594040265|FG002|Treatment|Death|4|||
164456016|NCT03143153|594040263|FG000|Treatment|Adverse event unrelated to study drug|19|||
164456017|NCT03143153|594040264|FG001|Treatment|Adverse event unrelated to study drug|28|||
164456018|NCT03143153|594040265|FG002|Treatment|Adverse event unrelated to study drug|12|||
164456019|NCT03143153|594040263|FG000|Treatment|Participant request to discontinue study treatment|13|||
164456020|NCT03143153|594040264|FG001|Treatment|Participant request to discontinue study treatment|15|||
164456021|NCT03143153|594040265|FG002|Treatment|Participant request to discontinue study treatment|20|||
164456022|NCT03143153|594040263|FG000|Treatment|Participant withdrew consent|3|||
164456023|NCT03143153|594040264|FG001|Treatment|Participant withdrew consent|4|||
164456024|NCT03143153|594040265|FG002|Treatment|Participant withdrew consent|12|||
164456025|NCT03143153|594040263|FG000|Treatment|Pregnancy|1|||
164456026|NCT03143153|594040264|FG001|Treatment|Pregnancy|0|||
164456027|NCT03143153|594040265|FG002|Treatment|Pregnancy|0|||
164456028|NCT03143153|594040263|FG000|Treatment|Maximum clinical benefit|1|||
164456029|NCT03143153|594040264|FG001|Treatment|Maximum clinical benefit|3|||
164456030|NCT03143153|594040265|FG002|Treatment|Maximum clinical benefit|4|||
164456031|NCT03143153|594040263|FG000|Treatment|Completed treatment as per Protocol|13|||
164456032|NCT03143153|594040264|FG001|Treatment|Completed treatment as per Protocol|8|||
164456033|NCT03143153|594040265|FG002|Treatment|Completed treatment as per Protocol|0|||
164456034|NCT03143153|594040263|FG000|Treatment|Other reasons|12|||
164456035|NCT03143153|594040264|FG001|Treatment|Other reasons|7|||
164456036|NCT03143153|594040265|FG002|Treatment|Other reasons|15|||
164456037|NCT03143153|594040263|FG000|Treatment|Not reported|1|||
164456038|NCT03143153|594040264|FG001|Treatment|Not reported|0|||
164456039|NCT03143153|594040265|FG002|Treatment|Not reported|0|||
164456040|NCT02736409|594040271|FG000|Overall Study|Withdrawal by Subject|4|||
164456041|NCT02736409|594040272|FG001|Overall Study|Withdrawal by Subject|2|||
164456042|NCT02736409|594040273|FG002|Overall Study|Withdrawal by Subject|17|||
164456043|NCT02736409|594040274|FG003|Overall Study|Withdrawal by Subject|3|||
164456044|NCT02736409|594040271|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164456045|NCT02736409|594040272|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164456046|NCT02736409|594040273|FG002|Overall Study|Non-Compliance with Study Drug|0|||
164456047|NCT02736409|594040274|FG003|Overall Study|Non-Compliance with Study Drug|1|||
164456048|NCT02736409|594040271|FG000|Overall Study|Adverse Event|0|||
164456049|NCT02736409|594040272|FG001|Overall Study|Adverse Event|1|||
164597974|NCT01098461|594551301|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
164597975|NCT01098461|594551302|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
164456050|NCT02736409|594040273|FG002|Overall Study|Adverse Event|5|||
164456051|NCT02736409|594040274|FG003|Overall Study|Adverse Event|4|||
164456052|NCT02736409|594040271|FG000|Overall Study|Other|0|||
164456053|NCT02736409|594040272|FG001|Overall Study|Other|0|||
164597976|NCT01098461|594551303|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
164456054|NCT02736409|594040273|FG002|Overall Study|Other|1|||
164456055|NCT02736409|594040274|FG003|Overall Study|Other|1|||
164456056|NCT02736409|594040271|FG000|Overall Study|Pregnancy|0|||
164456057|NCT02736409|594040272|FG001|Overall Study|Pregnancy|0|||
164456058|NCT02736409|594040273|FG002|Overall Study|Pregnancy|1|||
164456059|NCT02736409|594040274|FG003|Overall Study|Pregnancy|0|||
164456060|NCT02736409|594040271|FG000|Overall Study|Lost to Follow-up|0|||
164456061|NCT02736409|594040272|FG001|Overall Study|Lost to Follow-up|0|||
164597977|NCT02662985|594551304|FG000|Treatment Period 1|Adverse Event|0|||
164456062|NCT02736409|594040273|FG002|Overall Study|Lost to Follow-up|2|||
164456063|NCT02736409|594040274|FG003|Overall Study|Lost to Follow-up|1|||
164456064|NCT02736409|594040271|FG000|Overall Study|Physician Decision|0|||
164456065|NCT02736409|594040272|FG001|Overall Study|Physician Decision|0|||
164456066|NCT02736409|594040273|FG002|Overall Study|Physician Decision|0|||
164456067|NCT02736409|594040274|FG003|Overall Study|Physician Decision|2|||
164456068|NCT01415154|594040275|FG000|Overall Study|Lack of Efficacy|4|||
164456069|NCT01415154|594040276|FG001|Overall Study|Lack of Efficacy|5|||
164456070|NCT01415154|594040275|FG000|Overall Study|Withdrawal by Subject|7|||
164456071|NCT01415154|594040276|FG001|Overall Study|Withdrawal by Subject|8|||
164456072|NCT01415154|594040275|FG000|Overall Study|Lost to Follow-up|1|||
164456073|NCT01415154|594040276|FG001|Overall Study|Lost to Follow-up|4|||
164456074|NCT01415154|594040275|FG000|Overall Study|Protocol Violation|0|||
164456075|NCT01415154|594040276|FG001|Overall Study|Protocol Violation|1|||
164456076|NCT01415154|594040275|FG000|Overall Study|Satisfactory Response|0|||
164456077|NCT01415154|594040276|FG001|Overall Study|Satisfactory Response|1|||
164456078|NCT01415154|594040275|FG000|Overall Study|Adverse Event|1|||
164456079|NCT01415154|594040276|FG001|Overall Study|Adverse Event|1|||
164456080|NCT04382404|594040297|FG000|Overall Study|Adverse Event|1|||
164456081|NCT04382404|594040297|FG000|Overall Study|Lost to Follow-up|2|||
164456082|NCT01580488|594040301|FG000|Overall Study|Withdrawal by Subject|1|||
164456083|NCT03406871|594040304|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
164456084|NCT03406871|594040305|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
164456085|NCT03406871|594040306|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
164456086|NCT03406871|594040304|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
164456087|NCT03406871|594040305|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
164456088|NCT03406871|594040306|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
164456089|NCT03406871|594040304|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
164456090|NCT03406871|594040305|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
164456091|NCT03406871|594040306|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
164456092|NCT03406871|594040304|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
164456093|NCT03406871|594040305|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
164456094|NCT03406871|594040306|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
164456095|NCT03406871|594040304|FG000|Expansion Cohort(Final Analysis)|Death|0|||
164456096|NCT03406871|594040305|FG001|Expansion Cohort(Final Analysis)|Death|1|||
164456097|NCT03406871|594040306|FG002|Expansion Cohort(Final Analysis)|Death|0|||
164456098|NCT03406871|594040304|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
164456099|NCT03406871|594040305|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
164456100|NCT03406871|594040306|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
164456101|NCT02281955|594040311|FG000|Overall Study|Death|1|||
164456102|NCT04177823|594040312|FG000|Overall Study|Physician Decision|1|||
164456103|NCT04177823|594040312|FG000|Overall Study|Withdrawal by Subject|1|||
164456104|NCT03683719|594040313|FG000|Overall Study|Lack of Efficacy|1|||
164456105|NCT03683719|594040314|FG001|Overall Study|Lack of Efficacy|3|||
164456106|NCT03683719|594040315|FG002|Overall Study|Lack of Efficacy|4|||
164456107|NCT03683719|594040316|FG003|Overall Study|Lack of Efficacy|0|||
164456108|NCT03683719|594040317|FG004|Overall Study|Lack of Efficacy|4|||
164456109|NCT03683719|594040313|FG000|Overall Study|Adverse Event|6|||
164456110|NCT03683719|594040314|FG001|Overall Study|Adverse Event|6|||
164456111|NCT03683719|594040315|FG002|Overall Study|Adverse Event|0|||
164456112|NCT03683719|594040316|FG003|Overall Study|Adverse Event|1|||
164456113|NCT03683719|594040317|FG004|Overall Study|Adverse Event|3|||
164456114|NCT03683719|594040313|FG000|Overall Study|Withdrawal by Subject|4|||
164456115|NCT03683719|594040314|FG001|Overall Study|Withdrawal by Subject|4|||
164456116|NCT03683719|594040315|FG002|Overall Study|Withdrawal by Subject|3|||
164456117|NCT03683719|594040316|FG003|Overall Study|Withdrawal by Subject|5|||
164456118|NCT03683719|594040317|FG004|Overall Study|Withdrawal by Subject|5|||
164456119|NCT03683719|594040313|FG000|Overall Study|Lost to Follow-up|1|||
164456120|NCT03683719|594040314|FG001|Overall Study|Lost to Follow-up|0|||
164456121|NCT03683719|594040315|FG002|Overall Study|Lost to Follow-up|0|||
164456122|NCT03683719|594040316|FG003|Overall Study|Lost to Follow-up|1|||
164456123|NCT03683719|594040317|FG004|Overall Study|Lost to Follow-up|1|||
164456124|NCT03683719|594040313|FG000|Overall Study|Other personal reasons|0|||
164456125|NCT03683719|594040314|FG001|Overall Study|Other personal reasons|0|||
164456126|NCT03683719|594040315|FG002|Overall Study|Other personal reasons|1|||
164456127|NCT03683719|594040316|FG003|Overall Study|Other personal reasons|0|||
164456128|NCT03683719|594040317|FG004|Overall Study|Other personal reasons|1|||
164456129|NCT03792256|594040319|FG000|Overall Study|Death|0|||
164456130|NCT03792256|594040320|FG001|Overall Study|Death|1|||
164456131|NCT03792256|594040319|FG000|Overall Study|Lack of Efficacy|0|||
164456132|NCT03792256|594040320|FG001|Overall Study|Lack of Efficacy|1|||
164456133|NCT03792256|594040319|FG000|Overall Study|Withdrawal by Subject|0|||
164456134|NCT03792256|594040320|FG001|Overall Study|Withdrawal by Subject|1|||
164456135|NCT00601900|594040321|FG000|Overall Study|Withdrawal by Subject|0|||
164456136|NCT00601900|594040322|FG001|Overall Study|Withdrawal by Subject|3|||
164707081|NCT03275064|594953541|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
164707082|NCT00620555|594953542|FG000|Overall Study|Adverse Event|4|||
164707083|NCT00620555|594953542|FG000|Overall Study|Protocol Violation|2|||
164707084|NCT00620555|594953542|FG000|Overall Study|Lack of Efficacy|12|||
164707085|NCT00620555|594953542|FG000|Overall Study|Withdrawal by Subject|1|||
164707086|NCT00620555|594953542|FG000|Overall Study|Choice of other treatment|1|||
164707087|NCT00620555|594953542|FG000|Overall Study|Visit failure against planned|1|||
164707088|NCT01181271|594953545|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
164707089|NCT01181271|594953545|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
164707090|NCT01181271|594953545|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
164707091|NCT01181271|594953545|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
164707092|NCT00444457|594953546|FG000|Infant Series|Other|0|||
164707093|NCT00444457|594953547|FG001|Infant Series|Other|1|||
164707094|NCT00444457|594953548|FG002|Infant Series|Other|0|||
164707095|NCT00444457|594953549|FG003|Infant Series|Other|0|||
164707096|NCT00444457|594953546|FG000|Infant Series|Parent or legal guardian request|18|||
164707097|NCT00444457|594953547|FG001|Infant Series|Parent or legal guardian request|29|||
164707098|NCT00444457|594953548|FG002|Infant Series|Parent or legal guardian request|34|||
164707099|NCT00444457|594953549|FG003|Infant Series|Parent or legal guardian request|14|||
164707100|NCT00444457|594953546|FG000|Infant Series|Lost to Follow-up|10|||
164707101|NCT00444457|594953547|FG001|Infant Series|Lost to Follow-up|11|||
164707102|NCT00444457|594953548|FG002|Infant Series|Lost to Follow-up|7|||
164707103|NCT00444457|594953549|FG003|Infant Series|Lost to Follow-up|6|||
164707104|NCT00444457|594953546|FG000|Infant Series|Protocol Violation|16|||
164707105|NCT00444457|594953547|FG001|Infant Series|Protocol Violation|8|||
164406734|NCT03505476|593859096|FG000|Overall Study|Data Corrupt|6|||
164406735|NCT03505476|593859096|FG000|Overall Study|Device application insufficiant|3|||
164406736|NCT04026165|593859097|FG000|Run-in Placebo Period|Enrollment Error|13|||
164406737|NCT04026165|593859098|FG001|Run-in Placebo Period|Enrollment Error|0|||
164406738|NCT04026165|593859099|FG002|Run-in Placebo Period|Enrollment Error|0|||
164406739|NCT04026165|593859100|FG003|Run-in Placebo Period|Enrollment Error|0|||
164406740|NCT04026165|593859097|FG000|Run-in Placebo Period|Run-in Failure|4|||
164406741|NCT04026165|593859098|FG001|Run-in Placebo Period|Run-in Failure|0|||
164406742|NCT04026165|593859099|FG002|Run-in Placebo Period|Run-in Failure|0|||
164406743|NCT04026165|593859100|FG003|Run-in Placebo Period|Run-in Failure|0|||
164406744|NCT04026165|593859097|FG000|Run-in Placebo Period|Protocol Violation|2|||
164406745|NCT04026165|593859098|FG001|Run-in Placebo Period|Protocol Violation|0|||
164406746|NCT04026165|593859099|FG002|Run-in Placebo Period|Protocol Violation|0|||
164406747|NCT04026165|593859100|FG003|Run-in Placebo Period|Protocol Violation|0|||
164406748|NCT04026165|593859097|FG000|Run-in Placebo Period|Withdrew Consent|2|||
164406749|NCT04026165|593859098|FG001|Run-in Placebo Period|Withdrew Consent|0|||
164406750|NCT04026165|593859099|FG002|Run-in Placebo Period|Withdrew Consent|0|||
164406751|NCT04026165|593859100|FG003|Run-in Placebo Period|Withdrew Consent|0|||
164406752|NCT04026165|593859097|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
164406753|NCT04026165|593859098|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
164406754|NCT04026165|593859099|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
164406755|NCT04026165|593859100|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
164406756|NCT04026165|593859097|FG000|Run-in SEL Period|Run-in Failure|0|||
164406757|NCT04026165|593859098|FG001|Run-in SEL Period|Run-in Failure|26|||
164406758|NCT04026165|593859099|FG002|Run-in SEL Period|Run-in Failure|0|||
164406759|NCT04026165|593859100|FG003|Run-in SEL Period|Run-in Failure|0|||
164406760|NCT04026165|593859097|FG000|Run-in SEL Period|Withdrew Consent|0|||
164406761|NCT04026165|593859098|FG001|Run-in SEL Period|Withdrew Consent|10|||
164406762|NCT04026165|593859099|FG002|Run-in SEL Period|Withdrew Consent|0|||
164406763|NCT04026165|593859100|FG003|Run-in SEL Period|Withdrew Consent|0|||
164406764|NCT04026165|593859097|FG000|Run-in SEL Period|Enrollment Error|0|||
164406765|NCT04026165|593859098|FG001|Run-in SEL Period|Enrollment Error|4|||
164406766|NCT04026165|593859099|FG002|Run-in SEL Period|Enrollment Error|0|||
164406767|NCT04026165|593859100|FG003|Run-in SEL Period|Enrollment Error|0|||
164406768|NCT04026165|593859097|FG000|Run-in SEL Period|Protocol Violation|0|||
164406769|NCT04026165|593859098|FG001|Run-in SEL Period|Protocol Violation|3|||
164406770|NCT04026165|593859099|FG002|Run-in SEL Period|Protocol Violation|0|||
164406771|NCT04026165|593859100|FG003|Run-in SEL Period|Protocol Violation|0|||
164406772|NCT04026165|593859097|FG000|Run-in SEL Period|Investigator's Discretion|0|||
164406773|NCT04026165|593859098|FG001|Run-in SEL Period|Investigator's Discretion|2|||
164406774|NCT04026165|593859099|FG002|Run-in SEL Period|Investigator's Discretion|0|||
164406775|NCT04026165|593859100|FG003|Run-in SEL Period|Investigator's Discretion|0|||
164406776|NCT04026165|593859097|FG000|Run-in SEL Period|Death|0|||
164406777|NCT04026165|593859098|FG001|Run-in SEL Period|Death|1|||
164707106|NCT00444457|594953548|FG002|Infant Series|Protocol Violation|6|||
164406778|NCT04026165|593859099|FG002|Run-in SEL Period|Death|0|||
164406779|NCT04026165|593859100|FG003|Run-in SEL Period|Death|0|||
164707107|NCT00444457|594953549|FG003|Infant Series|Protocol Violation|3|||
164707108|NCT00444457|594953546|FG000|Infant Series|Failed to return|5|||
164707109|NCT00444457|594953547|FG001|Infant Series|Failed to return|4|||
164456137|NCT03699709|594040327|FG000|Overall Study|Death|1|||
164456138|NCT03699709|594040328|FG001|Overall Study|Death|2|||
164456139|NCT03699709|594040327|FG000|Overall Study|Lost to Follow-up|10|||
164456140|NCT03699709|594040328|FG001|Overall Study|Lost to Follow-up|3|||
164456141|NCT03699709|594040327|FG000|Overall Study|Withdrawal by Subject|5|||
164456142|NCT03699709|594040328|FG001|Overall Study|Withdrawal by Subject|0|||
164456143|NCT03699709|594040327|FG000|Overall Study|incarcerated|1|||
164456144|NCT03699709|594040328|FG001|Overall Study|incarcerated|0|||
164456145|NCT03699709|594040327|FG000|Overall Study|scheduled, but no show|0|||
164456146|NCT03699709|594040328|FG001|Overall Study|scheduled, but no show|1|||
164456147|NCT04562649|594040329|FG000|Overall Study|Withdrawal by Subject|11|||
164456148|NCT04562649|594040330|FG001|Overall Study|Withdrawal by Subject|8|||
164456149|NCT04562649|594040329|FG000|Overall Study|Lost to Follow-up|26|||
164456150|NCT04562649|594040330|FG001|Overall Study|Lost to Follow-up|20|||
164456151|NCT05368103|594040331|FG000|Overall Study|Withdrawal by Subject|4|||
164456152|NCT05368103|594040331|FG000|Overall Study|Lost to Follow-up|1|||
164456153|NCT05368103|594040331|FG000|Overall Study|Lack of Efficacy|3|||
164456154|NCT03519581|594040335|FG000|Overall Study|Lost to Follow-up|3|||
164456155|NCT03519581|594040336|FG001|Overall Study|Lost to Follow-up|2|||
164456156|NCT03519581|594040335|FG000|Overall Study|Adverse Event|5|||
164456157|NCT03519581|594040336|FG001|Overall Study|Adverse Event|2|||
164456158|NCT03519581|594040335|FG000|Overall Study|Withdrawal by Subject|2|||
164456159|NCT03519581|594040336|FG001|Overall Study|Withdrawal by Subject|0|||
164456160|NCT03519581|594040335|FG000|Overall Study|Change to insurance|2|||
164456161|NCT03519581|594040336|FG001|Overall Study|Change to insurance|1|||
164456162|NCT03519581|594040335|FG000|Overall Study|Other|2|||
164456163|NCT03519581|594040336|FG001|Overall Study|Other|4|||
164456164|NCT05371652|594040338|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
164456165|NCT05371652|594040338|FG000|Overall Study|Withdrawal by Subject|12|||
164456166|NCT05371652|594040338|FG000|Overall Study|Adverse Event|1|||
164456167|NCT05371652|594040338|FG000|Overall Study|Other|11|||
164456168|NCT04410042|594040339|FG000|Overall Study|Not Eligible|1|||
164456169|NCT04410042|594040340|FG001|Overall Study|Not Eligible|1|||
164456170|NCT04322643|594040343|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
164456171|NCT05486078|594040346|FG000|Overall Study|4 drop out and one withdrawn|5|||
164456172|NCT03302494|594040347|FG000|Overall Study|Other|7|||
164456173|NCT03302494|594040348|FG001|Overall Study|Other|4|||
164456174|NCT03302494|594040349|FG002|Overall Study|Other|6|||
164456175|NCT03302494|594040347|FG000|Overall Study|Withdrawal by Subject|10|||
164456176|NCT03302494|594040348|FG001|Overall Study|Withdrawal by Subject|2|||
164456177|NCT03302494|594040349|FG002|Overall Study|Withdrawal by Subject|9|||
164456178|NCT03302494|594040347|FG000|Overall Study|Study Terminated by Sponsor|32|||
164456179|NCT03302494|594040348|FG001|Overall Study|Study Terminated by Sponsor|29|||
164456180|NCT03302494|594040349|FG002|Overall Study|Study Terminated by Sponsor|30|||
164456181|NCT03302494|594040347|FG000|Overall Study|Physician Decision|1|||
164456182|NCT03302494|594040348|FG001|Overall Study|Physician Decision|0|||
164456183|NCT03302494|594040349|FG002|Overall Study|Physician Decision|1|||
164456184|NCT03302494|594040347|FG000|Overall Study|Lost to Follow-up|1|||
164456185|NCT03302494|594040348|FG001|Overall Study|Lost to Follow-up|3|||
164456186|NCT03302494|594040349|FG002|Overall Study|Lost to Follow-up|3|||
164456187|NCT03302494|594040347|FG000|Overall Study|Death|13|||
164456188|NCT03302494|594040348|FG001|Overall Study|Death|11|||
164456189|NCT03302494|594040349|FG002|Overall Study|Death|4|||
164456190|NCT03302494|594040347|FG000|Overall Study|Adverse Event|1|||
164456191|NCT03302494|594040348|FG001|Overall Study|Adverse Event|2|||
164456192|NCT03302494|594040349|FG002|Overall Study|Adverse Event|0|||
164456193|NCT03302494|594040347|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
164456194|NCT03302494|594040348|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
164707110|NCT00444457|594953548|FG002|Infant Series|Failed to return|4|||
164707111|NCT00444457|594953549|FG003|Infant Series|Failed to return|2|||
164707112|NCT00444457|594953546|FG000|Infant Series|Investigator request|4|||
164707113|NCT00444457|594953547|FG001|Infant Series|Investigator request|3|||
164707114|NCT00444457|594953548|FG002|Infant Series|Investigator request|3|||
164456195|NCT03302494|594040349|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
164456196|NCT05134233|594040350|FG000|Overall Study|Pregnancy|1|||
164456197|NCT05134233|594040350|FG000|Overall Study|MEP value too low|2|||
164456198|NCT05134233|594040350|FG000|Overall Study|Lost to Follow-up|1|||
164456199|NCT03978871|594040351|FG000|Overall Study|Lost to Follow-up|11|||
164456200|NCT03978871|594040352|FG001|Overall Study|Lost to Follow-up|12|||
164456201|NCT05710107|594040353|FG000|Overall Study|Withdrawal by Subject|1|||
164456202|NCT05710107|594040354|FG001|Overall Study|Withdrawal by Subject|1|||
164456203|NCT05710107|594040353|FG000|Overall Study|Lost to Follow-up|8|||
164707115|NCT00444457|594953549|FG003|Infant Series|Investigator request|2|||
164707116|NCT00444457|594953546|FG000|Infant Series|Other|0|||
164456204|NCT05710107|594040354|FG001|Overall Study|Lost to Follow-up|9|||
164707117|NCT00444457|594953547|FG001|Infant Series|Other|2|||
164456205|NCT05710107|594040353|FG000|Overall Study|Unable to place assigned block|2|||
164456206|NCT05710107|594040354|FG001|Overall Study|Unable to place assigned block|0|||
164707118|NCT00444457|594953548|FG002|Infant Series|Other|4|||
164707119|NCT00444457|594953549|FG003|Infant Series|Other|0|||
164707120|NCT00444457|594953546|FG000|Infant Series|Adverse Event|1|||
164456207|NCT05710107|594040353|FG000|Overall Study|Withdrawn by study team|0|||
164456208|NCT05710107|594040354|FG001|Overall Study|Withdrawn by study team|1|||
164456209|NCT04166773|594040355|FG000|Overall Study|Adverse Event|2|||
164456210|NCT04166773|594040356|FG001|Overall Study|Adverse Event|0|||
164456211|NCT04166773|594040357|FG002|Overall Study|Adverse Event|2|||
164456212|NCT04166773|594040358|FG003|Overall Study|Adverse Event|1|||
164456213|NCT04166773|594040355|FG000|Overall Study|Lost to Follow-up|4|||
164456214|NCT04166773|594040356|FG001|Overall Study|Lost to Follow-up|2|||
164456215|NCT04166773|594040357|FG002|Overall Study|Lost to Follow-up|1|||
164456216|NCT04166773|594040358|FG003|Overall Study|Lost to Follow-up|3|||
164456217|NCT04166773|594040355|FG000|Overall Study|Physician Decision|0|||
164456218|NCT04166773|594040356|FG001|Overall Study|Physician Decision|0|||
164456219|NCT04166773|594040357|FG002|Overall Study|Physician Decision|0|||
164456220|NCT04166773|594040358|FG003|Overall Study|Physician Decision|1|||
164456221|NCT04166773|594040355|FG000|Overall Study|Withdrawal by Subject|1|||
164456222|NCT04166773|594040356|FG001|Overall Study|Withdrawal by Subject|1|||
164456223|NCT04166773|594040357|FG002|Overall Study|Withdrawal by Subject|2|||
164456224|NCT04166773|594040358|FG003|Overall Study|Withdrawal by Subject|5|||
164456225|NCT04072822|594040359|FG000|Treatment|Adverse Event|9|||
164456226|NCT04072822|594040360|FG001|Treatment|Adverse Event|5|||
164456227|NCT04072822|594040359|FG000|Treatment|Met Stopping Criteria|13|||
164456228|NCT04072822|594040360|FG001|Treatment|Met Stopping Criteria|24|||
164456229|NCT04072822|594040359|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
164456230|NCT04072822|594040360|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
164456231|NCT04072822|594040359|FG000|Treatment|Withdrawal by Subject|0|||
164456232|NCT04072822|594040360|FG001|Treatment|Withdrawal by Subject|2|||
164456233|NCT04072822|594040359|FG000|Treatment|Death|0|||
164456234|NCT04072822|594040360|FG001|Treatment|Death|2|||
164456235|NCT04072822|594040359|FG000|Treatment|Lost to Follow-up|11|||
164456236|NCT04072822|594040360|FG001|Treatment|Lost to Follow-up|3|||
164456237|NCT04072822|594040359|FG000|Treatment|Physician Decision|1|||
164456238|NCT04072822|594040360|FG001|Treatment|Physician Decision|0|||
164456239|NCT04072822|594040359|FG000|Treatment|Other|7|||
164456240|NCT04072822|594040360|FG001|Treatment|Other|9|||
164456241|NCT04072822|594040359|FG000|Follow-up|Withdrawal by Subject|1|||
164456242|NCT04072822|594040360|FG001|Follow-up|Withdrawal by Subject|0|||
164456243|NCT04072822|594040359|FG000|Follow-up|Lost to Follow-up|5|||
164456244|NCT04072822|594040360|FG001|Follow-up|Lost to Follow-up|4|||
164456245|NCT03033576|594040361|FG000|Overall Study|Ineligible|1|||
164456246|NCT03033576|594040362|FG001|Overall Study|Ineligible|1|||
164456247|NCT03033576|594040361|FG000|Overall Study|Adverse Event|4|||
164456248|NCT03033576|594040362|FG001|Overall Study|Adverse Event|20|||
164456249|NCT03033576|594040361|FG000|Overall Study|Progression/relapse|9|||
164456250|NCT03033576|594040362|FG001|Overall Study|Progression/relapse|36|||
164456251|NCT03033576|594040361|FG000|Overall Study|Death|1|||
164456252|NCT03033576|594040362|FG001|Overall Study|Death|1|||
164456253|NCT03033576|594040361|FG000|Overall Study|Patient refusal|1|||
164456254|NCT03033576|594040362|FG001|Overall Study|Patient refusal|6|||
164456255|NCT03033576|594040361|FG000|Overall Study|Other, unspecified reasons|0|||
164456256|NCT03033576|594040362|FG001|Overall Study|Other, unspecified reasons|4|||
164456257|NCT03033576|594040361|FG000|Overall Study|Currently on protocol therapy|0|||
164456258|NCT03033576|594040362|FG001|Overall Study|Currently on protocol therapy|2|||
164456259|NCT03719443|594040363|FG000|Overall Study|Lost to Follow-up|0|||
164456260|NCT03719443|594040364|FG001|Overall Study|Lost to Follow-up|0|||
164456261|NCT03719443|594040365|FG002|Overall Study|Lost to Follow-up|1|||
164456262|NCT03719443|594040366|FG003|Overall Study|Lost to Follow-up|0|||
164456263|NCT03719443|594040367|FG004|Overall Study|Lost to Follow-up|1|||
164456264|NCT03719443|594040368|FG005|Overall Study|Lost to Follow-up|0|||
164456265|NCT03719443|594040369|FG006|Overall Study|Lost to Follow-up|1|||
164707121|NCT00444457|594953547|FG001|Infant Series|Adverse Event|2|||
164707122|NCT00444457|594953548|FG002|Infant Series|Adverse Event|2|||
164456266|NCT03719443|594040363|FG000|Overall Study|Withdrawal by Subject|0|||
164456267|NCT03719443|594040364|FG001|Overall Study|Withdrawal by Subject|0|||
164456268|NCT03719443|594040365|FG002|Overall Study|Withdrawal by Subject|1|||
164456269|NCT03719443|594040366|FG003|Overall Study|Withdrawal by Subject|0|||
164456270|NCT03719443|594040367|FG004|Overall Study|Withdrawal by Subject|0|||
164456271|NCT03719443|594040368|FG005|Overall Study|Withdrawal by Subject|0|||
164456272|NCT03719443|594040369|FG006|Overall Study|Withdrawal by Subject|0|||
164456273|NCT01214616|594040374|FG000|Overall Study|Progressive disease|2|||
164456274|NCT01214616|594040375|FG001|Overall Study|Progressive disease|2|||
164456275|NCT01214616|594040376|FG002|Overall Study|Progressive disease|2|||
164456276|NCT01214616|594040377|FG003|Overall Study|Progressive disease|4|||
164456277|NCT01214616|594040374|FG000|Overall Study|Dose limiting toxicity|0|||
164456278|NCT01214616|594040375|FG001|Overall Study|Dose limiting toxicity|2|||
164456279|NCT01214616|594040376|FG002|Overall Study|Dose limiting toxicity|0|||
164456280|NCT01214616|594040377|FG003|Overall Study|Dose limiting toxicity|0|||
164456281|NCT01214616|594040374|FG000|Overall Study|Other adverse events|0|||
164456282|NCT01214616|594040375|FG001|Overall Study|Other adverse events|1|||
164456283|NCT01214616|594040376|FG002|Overall Study|Other adverse events|1|||
164456284|NCT01214616|594040377|FG003|Overall Study|Other adverse events|1|||
164456285|NCT01214616|594040374|FG000|Overall Study|Withdrawal by Subject|1|||
164456286|NCT01214616|594040375|FG001|Overall Study|Withdrawal by Subject|0|||
164456287|NCT01214616|594040376|FG002|Overall Study|Withdrawal by Subject|0|||
164456288|NCT01214616|594040377|FG003|Overall Study|Withdrawal by Subject|1|||
164456289|NCT03447470|594040378|FG000|Overall Study|Death|0|||
164456290|NCT03447470|594040379|FG001|Overall Study|Death|1|||
164456291|NCT03447470|594040380|FG002|Overall Study|Death|3|||
164456292|NCT03447470|594040381|FG003|Overall Study|Death|0|||
164456293|NCT03447470|594040382|FG004|Overall Study|Death|1|||
164456294|NCT03447470|594040383|FG005|Overall Study|Death|0|||
164456295|NCT03447470|594040384|FG006|Overall Study|Death|3|||
164456296|NCT03447470|594040385|FG007|Overall Study|Death|3|||
164456297|NCT03447470|594040386|FG008|Overall Study|Death|1|||
164456298|NCT03447470|594040378|FG000|Overall Study|Withdrawal by Subject|1|||
164456299|NCT03447470|594040379|FG001|Overall Study|Withdrawal by Subject|0|||
164456300|NCT03447470|594040380|FG002|Overall Study|Withdrawal by Subject|0|||
164456301|NCT03447470|594040381|FG003|Overall Study|Withdrawal by Subject|0|||
164456302|NCT03447470|594040382|FG004|Overall Study|Withdrawal by Subject|1|||
164456303|NCT03447470|594040383|FG005|Overall Study|Withdrawal by Subject|0|||
164456304|NCT03447470|594040384|FG006|Overall Study|Withdrawal by Subject|1|||
164456305|NCT03447470|594040385|FG007|Overall Study|Withdrawal by Subject|1|||
164456306|NCT03447470|594040386|FG008|Overall Study|Withdrawal by Subject|3|||
164456307|NCT03447470|594040378|FG000|Overall Study|Treatment discontinued|3|||
164456308|NCT03447470|594040379|FG001|Overall Study|Treatment discontinued|2|||
164456309|NCT03447470|594040380|FG002|Overall Study|Treatment discontinued|4|||
164456310|NCT03447470|594040381|FG003|Overall Study|Treatment discontinued|6|||
164456311|NCT03447470|594040382|FG004|Overall Study|Treatment discontinued|2|||
164456312|NCT03447470|594040383|FG005|Overall Study|Treatment discontinued|1|||
164456313|NCT03447470|594040384|FG006|Overall Study|Treatment discontinued|2|||
164456314|NCT03447470|594040385|FG007|Overall Study|Treatment discontinued|4|||
164456315|NCT03447470|594040386|FG008|Overall Study|Treatment discontinued|3|||
164456316|NCT01361711|594040390|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
164456317|NCT01361711|594040390|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
164456318|NCT01361711|594040390|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
164456319|NCT01361711|594040390|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
164456320|NCT01361711|594040390|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
164456321|NCT01361711|594040390|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
164456322|NCT01361711|594040390|FG000|Completed Week 18 of Treatment|Other|9|||
164456323|NCT01361711|594040390|FG000|10 Year Follow-up|Still in follow-up|22|||
164456324|NCT01361711|594040390|FG000|10 Year Follow-up|Death|7|||
164456325|NCT01361711|594040390|FG000|10 Year Follow-up|Developed new cancer|1|||
164456326|NCT01361711|594040390|FG000|10 Year Follow-up|Lost to Follow-up|2|||
164456327|NCT01361711|594040390|FG000|10 Year Follow-up|New treatment started|6|||
164597978|NCT02662985|594551305|FG001|Treatment Period 1|Adverse Event|2|||
164597979|NCT02662985|594551304|FG000|Treatment Period 1|Protocol Violation|0|||
164456328|NCT01361711|594040390|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
164456329|NCT01361711|594040390|FG000|10 Year Follow-up|Progressive Disease|1|||
164456330|NCT02596126|594040391|FG000|Overall Study|Lost to Follow-up|12|||
164456331|NCT02596126|594040392|FG001|Overall Study|Lost to Follow-up|21|||
164456332|NCT02596126|594040391|FG000|Overall Study|Protocol Violation|7|||
164456333|NCT02596126|594040392|FG001|Overall Study|Protocol Violation|9|||
164456334|NCT02471638|594040395|FG000|Overall Study|Early Term Withdrawal|10|||
164456335|NCT04024813|594042950|FG000|Overall Study|Study terminated by Sponsor|1|||
164456336|NCT04034251|594042951|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
164456337|NCT04034251|594042952|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
164456338|NCT04034251|594042953|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
164597980|NCT02662985|594551305|FG001|Treatment Period 1|Protocol Violation|1|||
164456339|NCT05862870|594042957|FG000|Overall Study|Lost to Follow-up|3|||
164456340|NCT00170573|594042958|FG000|Overall Study|Violation of inclusion criteria|13|||
164456341|NCT05563246|594042986|FG000|Overall Study|Withdrawal by Subject|1|||
164456342|NCT05563246|594042987|FG001|Overall Study|Withdrawal by Subject|2|||
164456343|NCT05563246|594042988|FG002|Overall Study|Withdrawal by Subject|0|||
164456344|NCT05563246|594042989|FG003|Overall Study|Withdrawal by Subject|0|||
164456345|NCT05563246|594042986|FG000|Overall Study|Protocol Deviation|0|||
164456346|NCT05563246|594042987|FG001|Overall Study|Protocol Deviation|1|||
164456347|NCT05563246|594042988|FG002|Overall Study|Protocol Deviation|0|||
164456348|NCT05563246|594042989|FG003|Overall Study|Protocol Deviation|0|||
164456349|NCT05563246|594042986|FG000|Overall Study|Physician Decision|0|||
164456350|NCT05563246|594042987|FG001|Overall Study|Physician Decision|1|||
164456351|NCT05563246|594042988|FG002|Overall Study|Physician Decision|0|||
164456352|NCT05563246|594042989|FG003|Overall Study|Physician Decision|0|||
164456353|NCT05563246|594042986|FG000|Overall Study|Adverse Event|0|||
164456354|NCT05563246|594042987|FG001|Overall Study|Adverse Event|0|||
164456355|NCT05563246|594042988|FG002|Overall Study|Adverse Event|2|||
164456356|NCT05563246|594042989|FG003|Overall Study|Adverse Event|0|||
164456357|NCT05563246|594042986|FG000|Overall Study|Lost to Follow-up|0|||
164456358|NCT05563246|594042987|FG001|Overall Study|Lost to Follow-up|0|||
164456359|NCT05563246|594042988|FG002|Overall Study|Lost to Follow-up|1|||
164456360|NCT05563246|594042989|FG003|Overall Study|Lost to Follow-up|0|||
164456361|NCT03332017|594042990|FG000|Overall Study|Lost to Follow-up|1|||
164456362|NCT03332017|594042991|FG001|Overall Study|Lost to Follow-up|2|||
164456363|NCT03332017|594042990|FG000|Overall Study|Death|17|||
164456364|NCT03332017|594042991|FG001|Overall Study|Death|16|||
164456365|NCT03332017|594042990|FG000|Overall Study|Withdrawal by Subject|6|||
164456366|NCT03332017|594042991|FG001|Overall Study|Withdrawal by Subject|14|||
164456367|NCT03332017|594042990|FG000|Overall Study|Other|1|||
164456368|NCT03332017|594042991|FG001|Overall Study|Other|3|||
164456369|NCT03332017|594042990|FG000|Overall Study|Remained in Study (Ongoing)|47|||
164456370|NCT03332017|594042991|FG001|Overall Study|Remained in Study (Ongoing)|110|||
164456371|NCT02783300|594042993|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456372|NCT02783300|594042994|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456373|NCT02783300|594042995|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456374|NCT02783300|594042996|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456375|NCT02783300|594042997|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456376|NCT02783300|594042998|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456377|NCT02783300|594042999|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
164456378|NCT02783300|594043000|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456379|NCT02783300|594043001|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456380|NCT02783300|594043002|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456381|NCT02783300|594043003|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456382|NCT02783300|594043004|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456383|NCT02783300|594043005|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456384|NCT02783300|594043006|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456385|NCT02783300|594043007|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456386|NCT02783300|594043008|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456387|NCT02783300|594043009|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456388|NCT02783300|594043010|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456389|NCT02783300|594043011|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456390|NCT02783300|594043012|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456391|NCT02783300|594043013|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456392|NCT02783300|594043014|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456393|NCT02783300|594043015|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456394|NCT02783300|594043016|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456395|NCT02783300|594043017|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456396|NCT02783300|594043018|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456397|NCT02783300|594043019|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164456398|NCT02783300|594042993|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456399|NCT02783300|594042994|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456400|NCT02783300|594042995|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456401|NCT02783300|594042996|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
164456402|NCT02783300|594042997|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456403|NCT02783300|594042998|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456404|NCT02783300|594042999|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456405|NCT02783300|594043000|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456406|NCT02783300|594043001|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456407|NCT02783300|594043002|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456408|NCT02783300|594043003|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456409|NCT02783300|594043004|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456410|NCT02783300|594043005|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456411|NCT02783300|594043006|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456412|NCT02783300|594043007|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456413|NCT02783300|594043008|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456414|NCT02783300|594043009|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456415|NCT02783300|594043010|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456416|NCT02783300|594043011|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456417|NCT02783300|594043012|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456418|NCT02783300|594043013|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456419|NCT02783300|594043014|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456420|NCT02783300|594043015|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456421|NCT02783300|594043016|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456422|NCT02783300|594043017|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456423|NCT02783300|594043018|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456424|NCT02783300|594043019|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
164456425|NCT02783300|594042993|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
164456426|NCT02783300|594042994|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
164456427|NCT02783300|594042995|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
164456428|NCT02783300|594042996|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
164456429|NCT02783300|594042997|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
164456430|NCT02783300|594042998|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
164456431|NCT02783300|594042999|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
164456432|NCT02783300|594043000|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
164456433|NCT02783300|594043001|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
164456434|NCT02783300|594043002|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
164456435|NCT02783300|594043003|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
164456436|NCT02783300|594043004|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
164456437|NCT02783300|594043005|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
164456438|NCT02783300|594043006|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
164456439|NCT02783300|594043007|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
164456440|NCT02783300|594043008|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
164456441|NCT02783300|594043009|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
164456442|NCT02783300|594043010|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
164456443|NCT02783300|594043011|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
164456444|NCT02783300|594043012|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
164456445|NCT02783300|594043013|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
164456446|NCT02783300|594043014|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
164456447|NCT02783300|594043015|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
164456448|NCT02783300|594043016|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
164456449|NCT02783300|594043017|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
164456450|NCT02783300|594043018|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
164456451|NCT02783300|594043019|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
164456452|NCT02783300|594042993|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164456453|NCT02783300|594042994|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164456454|NCT02783300|594042995|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164456455|NCT02783300|594042996|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164456456|NCT02783300|594042997|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164456457|NCT02783300|594042998|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164456458|NCT02783300|594042999|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
164456459|NCT02783300|594043000|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164456460|NCT02783300|594043001|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164456461|NCT02783300|594043002|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164456462|NCT02783300|594043003|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164456463|NCT02783300|594043004|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164456464|NCT02783300|594043005|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
164456465|NCT02783300|594043006|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164456466|NCT02783300|594043007|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164456467|NCT02783300|594043008|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164456468|NCT02783300|594043009|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164456469|NCT02783300|594043010|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164456470|NCT02783300|594043011|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164456471|NCT02783300|594043012|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164456472|NCT02783300|594043013|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164456473|NCT02783300|594043014|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164456474|NCT02783300|594043015|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164597981|NCT02662985|594551304|FG000|Treatment Period 1|Physician Decision|1|||
164597982|NCT02662985|594551305|FG001|Treatment Period 1|Physician Decision|0|||
164597983|NCT02662985|594551304|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164456475|NCT02783300|594043016|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164597984|NCT02662985|594551305|FG001|Treatment Period 1|Withdrawal by Subject|1|||
164597985|NCT02662985|594551304|FG000|Treatment Period 2|Lack of Efficacy|0|||
164707123|NCT00444457|594953549|FG003|Infant Series|Adverse Event|0|||
164707124|NCT00444457|594953546|FG000|Infant Series|Death|0|||
164707125|NCT00444457|594953547|FG001|Infant Series|Death|1|||
164707126|NCT00444457|594953548|FG002|Infant Series|Death|1|||
164456476|NCT02783300|594043017|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164456477|NCT02783300|594043018|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164456478|NCT02783300|594043019|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
164456479|NCT02783300|594042993|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
164456480|NCT02783300|594042994|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
164456481|NCT02783300|594042995|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
164456482|NCT02783300|594042996|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
164456483|NCT02783300|594042997|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
164456484|NCT02783300|594042998|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
164456485|NCT02783300|594042999|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
164456486|NCT02783300|594043000|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
164456487|NCT02783300|594043001|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
164456488|NCT02783300|594043002|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
164456489|NCT02783300|594043003|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
164456490|NCT02783300|594043004|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
164456491|NCT02783300|594043005|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
164456492|NCT02783300|594043006|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
164456493|NCT02783300|594043007|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
164456494|NCT02783300|594043008|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
164456495|NCT02783300|594043009|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
164456496|NCT02783300|594043010|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
164456497|NCT02783300|594043011|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
164456498|NCT02783300|594043012|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
164456499|NCT02783300|594043013|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
164456500|NCT02783300|594043014|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
164456501|NCT02783300|594043015|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
164456502|NCT02783300|594043016|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
164456503|NCT02783300|594043017|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
164456504|NCT02783300|594043018|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
164456505|NCT02783300|594043019|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
164456506|NCT02783300|594042993|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
164456507|NCT02783300|594042994|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
164456508|NCT02783300|594042995|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
164456509|NCT02783300|594042996|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
164456510|NCT02783300|594042997|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
164456511|NCT02783300|594042998|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
164456512|NCT02783300|594042999|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
164456513|NCT02783300|594043000|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
164456514|NCT02783300|594043001|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
164456515|NCT02783300|594043002|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
164456516|NCT02783300|594043003|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
164456517|NCT02783300|594043004|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
164456518|NCT02783300|594043005|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
164456519|NCT02783300|594043006|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
164456520|NCT02783300|594043007|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
164456521|NCT02783300|594043008|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
164456522|NCT02783300|594043009|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
164456523|NCT02783300|594043010|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
164456524|NCT02783300|594043011|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
164456525|NCT02783300|594043012|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
164456526|NCT02783300|594043013|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
164456527|NCT02783300|594043014|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
164456528|NCT02783300|594043015|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
164456529|NCT02783300|594043016|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
164456530|NCT02783300|594043017|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
164456531|NCT02783300|594043018|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
164456532|NCT02783300|594043019|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
164456533|NCT02783300|594042993|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164707127|NCT00444457|594953549|FG003|Infant Series|Death|1|||
164707128|NCT00444457|594953546|FG000|After Infant Series|Other|0|||
164707129|NCT00444457|594953547|FG001|After Infant Series|Other|1|||
164456534|NCT02783300|594042994|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164456535|NCT02783300|594042995|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164456536|NCT02783300|594042996|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164456537|NCT02783300|594042997|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164456538|NCT02783300|594042998|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164456539|NCT02783300|594042999|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164456540|NCT02783300|594043000|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164456541|NCT02783300|594043001|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164456542|NCT02783300|594043002|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164456543|NCT02783300|594043003|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164456544|NCT02783300|594043004|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164456545|NCT02783300|594043005|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164456546|NCT02783300|594043006|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164707130|NCT00444457|594953548|FG002|After Infant Series|Other|1|||
164707131|NCT00444457|594953549|FG003|After Infant Series|Other|1|||
164707132|NCT00444457|594953546|FG000|After Infant Series|Parent or legal guardian request|4|||
164707133|NCT00444457|594953547|FG001|After Infant Series|Parent or legal guardian request|11|||
164456547|NCT02783300|594043007|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164456548|NCT02783300|594043008|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164456549|NCT02783300|594043009|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
164456550|NCT02783300|594043010|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164456551|NCT02783300|594043011|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
164456552|NCT02783300|594043012|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
164456553|NCT02783300|594043013|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164456554|NCT02783300|594043014|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164456555|NCT02783300|594043015|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164456556|NCT02783300|594043016|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164456557|NCT02783300|594043017|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164456558|NCT02783300|594043018|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164456559|NCT02783300|594043019|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164456560|NCT02783300|594042993|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
164456561|NCT02783300|594042994|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
164456562|NCT02783300|594042995|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
164456563|NCT02783300|594042996|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
164456564|NCT02783300|594042997|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
164456565|NCT02783300|594042998|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
164456566|NCT02783300|594042999|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
164456567|NCT02783300|594043000|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
164456568|NCT02783300|594043001|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
164456569|NCT02783300|594043002|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
164456570|NCT02783300|594043003|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
164456571|NCT02783300|594043004|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
164456572|NCT02783300|594043005|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
164456573|NCT02783300|594043006|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
164456574|NCT02783300|594043007|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
164456575|NCT02783300|594043008|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
164456576|NCT02783300|594043009|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
164456577|NCT02783300|594043010|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
164456578|NCT02783300|594043011|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
164456579|NCT02783300|594043012|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
164456580|NCT02783300|594043013|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
164456581|NCT02783300|594043014|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
164456582|NCT02783300|594043015|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
164456583|NCT02783300|594043016|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
164456584|NCT02783300|594043017|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
164456585|NCT02783300|594043018|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
164456586|NCT02783300|594043019|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
164456587|NCT02783300|594042993|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164456588|NCT02783300|594042994|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164456589|NCT02783300|594042995|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164707134|NCT00444457|594953548|FG002|After Infant Series|Parent or legal guardian request|6|||
164707135|NCT00444457|594953549|FG003|After Infant Series|Parent or legal guardian request|3|||
164456590|NCT02783300|594042996|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164456591|NCT02783300|594042997|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164456592|NCT02783300|594042998|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164456593|NCT02783300|594042999|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164456594|NCT02783300|594043000|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164456595|NCT02783300|594043001|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164456596|NCT02783300|594043002|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164456597|NCT02783300|594043003|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164456598|NCT02783300|594043004|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164456599|NCT02783300|594043005|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164456600|NCT02783300|594043006|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164456601|NCT02783300|594043007|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164456602|NCT02783300|594043008|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
164456603|NCT02783300|594043009|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164456604|NCT02783300|594043010|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164456605|NCT02783300|594043011|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164456606|NCT02783300|594043012|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164456607|NCT02783300|594043013|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164456608|NCT02783300|594043014|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164456609|NCT02783300|594043015|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
164456610|NCT02783300|594043016|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164456611|NCT02783300|594043017|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164456612|NCT02783300|594043018|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164456613|NCT02783300|594043019|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164456614|NCT02783300|594042993|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
164456615|NCT02783300|594042994|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
164456616|NCT02783300|594042995|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
164456617|NCT02783300|594042996|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
164456618|NCT02783300|594042997|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
164456619|NCT02783300|594042998|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
164456620|NCT02783300|594042999|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
164456621|NCT02783300|594043000|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
164456622|NCT02783300|594043001|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
164456623|NCT02783300|594043002|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
164456624|NCT02783300|594043003|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
164456625|NCT02783300|594043004|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
164456626|NCT02783300|594043005|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
164456627|NCT02783300|594043006|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
164456628|NCT02783300|594043007|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
164456629|NCT02783300|594043008|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
164456630|NCT02783300|594043009|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
164456631|NCT02783300|594043010|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
164456632|NCT02783300|594043011|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
164456633|NCT02783300|594043012|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
164456634|NCT02783300|594043013|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
164456635|NCT02783300|594043014|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
164456636|NCT02783300|594043015|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
164456637|NCT02783300|594043016|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
164456638|NCT02783300|594043017|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
164456639|NCT02783300|594043018|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
164456640|NCT02783300|594043019|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
164456641|NCT02783300|594042993|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
164456642|NCT02783300|594042994|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
164456643|NCT02783300|594042995|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
164456644|NCT02783300|594042996|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
164456645|NCT02783300|594042997|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
164456646|NCT02783300|594042998|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
164456647|NCT02783300|594042999|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
164456648|NCT02783300|594043000|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
164456649|NCT02783300|594043001|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
164456650|NCT02783300|594043002|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
164456651|NCT02783300|594043003|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
164456652|NCT02783300|594043004|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
164456653|NCT02783300|594043005|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
164456654|NCT02783300|594043006|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
164456655|NCT02783300|594043007|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
164456656|NCT02783300|594043008|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
164456657|NCT02783300|594043009|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
164456658|NCT02783300|594043010|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
164456659|NCT02783300|594043011|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
164456660|NCT02783300|594043012|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
164456661|NCT02783300|594043013|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
164456662|NCT02783300|594043014|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
164456663|NCT02783300|594043015|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
164456664|NCT02783300|594043016|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
164456665|NCT02783300|594043017|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
164456666|NCT02783300|594043018|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
164456667|NCT02783300|594043019|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
164456668|NCT02783300|594042993|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456669|NCT02783300|594042994|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456670|NCT02783300|594042995|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456671|NCT02783300|594042996|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456672|NCT02783300|594042997|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456673|NCT02783300|594042998|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456674|NCT02783300|594042999|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456675|NCT02783300|594043000|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456676|NCT02783300|594043001|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456677|NCT02783300|594043002|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456678|NCT02783300|594043003|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456679|NCT02783300|594043004|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456680|NCT02783300|594043005|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456681|NCT02783300|594043006|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456682|NCT02783300|594043007|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456683|NCT02783300|594043008|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456684|NCT02783300|594043009|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456685|NCT02783300|594043010|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456686|NCT02783300|594043011|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456687|NCT02783300|594043012|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456688|NCT02783300|594043013|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456689|NCT02783300|594043014|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456690|NCT02783300|594043015|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456691|NCT02783300|594043016|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456692|NCT02783300|594043017|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456693|NCT02783300|594043018|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164456694|NCT02783300|594043019|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
164456695|NCT02783300|594042993|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
164456696|NCT02783300|594042994|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
164456697|NCT02783300|594042995|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
164456698|NCT02783300|594042996|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
164456699|NCT02783300|594042997|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
164456700|NCT02783300|594042998|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
164456701|NCT02783300|594042999|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
164456702|NCT02783300|594043000|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
164456703|NCT02783300|594043001|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
164597986|NCT02662985|594551305|FG001|Treatment Period 2|Lack of Efficacy|1|||
164597987|NCT02662985|594551304|FG000|Treatment Period 2|Lost to Follow-up|1|||
164597988|NCT02662985|594551305|FG001|Treatment Period 2|Lost to Follow-up|0|||
164597989|NCT02662985|594551304|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
164597990|NCT02662985|594551305|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
164597991|NCT02662985|594551304|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
164597992|NCT02662985|594551305|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
164597993|NCT02662985|594551304|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
164597994|NCT02662985|594551305|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
164456704|NCT02783300|594043002|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
164456705|NCT02783300|594043003|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
164456706|NCT02783300|594043004|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
164456707|NCT02783300|594043005|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
164456708|NCT02783300|594043006|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
164456709|NCT02783300|594043007|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
164456710|NCT02783300|594043008|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
164456711|NCT02783300|594043009|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
164456712|NCT02783300|594043010|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
164456713|NCT02783300|594043011|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
164456714|NCT02783300|594043012|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
164456715|NCT02783300|594043013|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
164456716|NCT02783300|594043014|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
164456717|NCT02783300|594043015|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
164456718|NCT02783300|594043016|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
164456719|NCT02783300|594043017|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
164597995|NCT02662985|594551304|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
164597996|NCT02662985|594551305|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
164597997|NCT02662985|594551304|FG000|Treatment Period 3 (Extension Period)|Death|0|||
164597998|NCT02662985|594551305|FG001|Treatment Period 3 (Extension Period)|Death|1|||
164597999|NCT03633227|594551306|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
164598000|NCT03633227|594551307|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
164598001|NCT03633227|594551306|FG000|Double Blind (DB), up to Week 48|Death|2|||
164598002|NCT03633227|594551307|FG001|Double Blind (DB), up to Week 48|Death|1|||
164598003|NCT03633227|594551306|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
164598004|NCT03633227|594551307|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
164598005|NCT03633227|594551306|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
164598006|NCT03633227|594551307|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
164598007|NCT03633227|594551306|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
164598008|NCT03633227|594551307|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
164598009|NCT03633227|594551306|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
164598010|NCT03633227|594551307|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
164598011|NCT03633227|594551306|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
164598012|NCT03633227|594551307|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
164598013|NCT03633227|594551306|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
164598014|NCT03633227|594551307|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
164598015|NCT03633227|594551306|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
164598016|NCT03633227|594551307|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
164598017|NCT03633227|594551306|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
164598018|NCT03633227|594551307|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
164598019|NCT03633227|594551306|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
164598020|NCT03633227|594551307|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
164598021|NCT03633227|594551306|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
164406780|NCT04026165|593859097|FG000|Randomized Period|Withdrew Consent|0|||
164406781|NCT04026165|593859098|FG001|Randomized Period|Withdrew Consent|0|||
164406782|NCT04026165|593859099|FG002|Randomized Period|Withdrew Consent|5|||
164406783|NCT04026165|593859100|FG003|Randomized Period|Withdrew Consent|8|||
164406784|NCT04026165|593859097|FG000|Randomized Period|Death|0|||
164406785|NCT04026165|593859098|FG001|Randomized Period|Death|0|||
164406786|NCT04026165|593859099|FG002|Randomized Period|Death|5|||
164406787|NCT04026165|593859100|FG003|Randomized Period|Death|7|||
164406788|NCT04026165|593859097|FG000|Randomized Period|Investigator's Discretion|0|||
164406789|NCT04026165|593859098|FG001|Randomized Period|Investigator's Discretion|0|||
164406790|NCT04026165|593859099|FG002|Randomized Period|Investigator's Discretion|2|||
164406791|NCT04026165|593859100|FG003|Randomized Period|Investigator's Discretion|2|||
164406792|NCT04026165|593859097|FG000|Randomized Period|Lost to Follow-up|0|||
164406793|NCT04026165|593859098|FG001|Randomized Period|Lost to Follow-up|0|||
164406794|NCT04026165|593859099|FG002|Randomized Period|Lost to Follow-up|2|||
164406795|NCT04026165|593859100|FG003|Randomized Period|Lost to Follow-up|2|||
164406796|NCT01059630|593859103|FG000|Overall Study|Death|100|||
164406797|NCT01059630|593859104|FG001|Overall Study|Death|84|||
164406798|NCT01059630|593859103|FG000|Overall Study|Lost to Follow-up|4|||
164406799|NCT01059630|593859104|FG001|Overall Study|Lost to Follow-up|1|||
164406800|NCT01059630|593859103|FG000|Overall Study|Physician Decision|2|||
164406801|NCT01059630|593859104|FG001|Overall Study|Physician Decision|4|||
164406802|NCT01059630|593859103|FG000|Overall Study|Withdrawal by Subject|21|||
164406803|NCT01059630|593859104|FG001|Overall Study|Withdrawal by Subject|14|||
164406804|NCT00441701|593859105|FG000|Overall Study|Adverse Event|3|||
164406805|NCT00441701|593859106|FG001|Overall Study|Adverse Event|2|||
164707136|NCT00444457|594953546|FG000|After Infant Series|Failed to return|7|||
164707137|NCT00444457|594953547|FG001|After Infant Series|Failed to return|6|||
164707138|NCT00444457|594953548|FG002|After Infant Series|Failed to return|5|||
164707139|NCT00444457|594953549|FG003|After Infant Series|Failed to return|1|||
164707140|NCT00444457|594953546|FG000|After Infant Series|Lost to Follow-up|5|||
164707141|NCT00444457|594953547|FG001|After Infant Series|Lost to Follow-up|5|||
164707142|NCT00444457|594953548|FG002|After Infant Series|Lost to Follow-up|5|||
164707143|NCT00444457|594953549|FG003|After Infant Series|Lost to Follow-up|2|||
164707144|NCT00444457|594953546|FG000|After Infant Series|Protocol Violation|2|||
164707145|NCT00444457|594953547|FG001|After Infant Series|Protocol Violation|4|||
164707146|NCT00444457|594953548|FG002|After Infant Series|Protocol Violation|2|||
164707147|NCT00444457|594953549|FG003|After Infant Series|Protocol Violation|2|||
164707148|NCT00444457|594953546|FG000|After Infant Series|Adverse Event|2|||
164707149|NCT00444457|594953547|FG001|After Infant Series|Adverse Event|2|||
164707150|NCT00444457|594953548|FG002|After Infant Series|Adverse Event|0|||
164707151|NCT00444457|594953549|FG003|After Infant Series|Adverse Event|0|||
164707152|NCT00444457|594953546|FG000|After Infant Series|Investigator request|0|||
164707153|NCT00444457|594953547|FG001|After Infant Series|Investigator request|0|||
164707154|NCT00444457|594953548|FG002|After Infant Series|Investigator request|0|||
164707155|NCT00444457|594953549|FG003|After Infant Series|Investigator request|1|||
164707156|NCT00444457|594953546|FG000|After Infant Series|Other|0|||
164707157|NCT00444457|594953547|FG001|After Infant Series|Other|1|||
164707158|NCT00444457|594953548|FG002|After Infant Series|Other|0|||
164406806|NCT00441701|593859107|FG002|Overall Study|Adverse Event|1|||
164406807|NCT00441701|593859108|FG003|Overall Study|Adverse Event|0|||
164406808|NCT00441701|593859109|FG004|Overall Study|Adverse Event|2|||
164406809|NCT00441701|593859110|FG005|Overall Study|Adverse Event|2|||
164406810|NCT00441701|593859111|FG006|Overall Study|Adverse Event|0|||
164406811|NCT00441701|593859112|FG007|Overall Study|Adverse Event|0|||
164406812|NCT00441701|593859113|FG008|Overall Study|Adverse Event|0|||
164406813|NCT00441701|593859114|FG009|Overall Study|Adverse Event|0|||
164406814|NCT00441701|593859105|FG000|Overall Study|Lack of Efficacy|2|||
164406815|NCT00441701|593859106|FG001|Overall Study|Lack of Efficacy|0|||
164406816|NCT00441701|593859107|FG002|Overall Study|Lack of Efficacy|2|||
164406817|NCT00441701|593859108|FG003|Overall Study|Lack of Efficacy|2|||
164406818|NCT00441701|593859109|FG004|Overall Study|Lack of Efficacy|0|||
164406819|NCT00441701|593859110|FG005|Overall Study|Lack of Efficacy|1|||
164406820|NCT00441701|593859111|FG006|Overall Study|Lack of Efficacy|0|||
164406821|NCT00441701|593859112|FG007|Overall Study|Lack of Efficacy|0|||
164406822|NCT00441701|593859113|FG008|Overall Study|Lack of Efficacy|0|||
164406823|NCT00441701|593859114|FG009|Overall Study|Lack of Efficacy|0|||
164406824|NCT00441701|593859105|FG000|Overall Study|Withdrawal by Subject|0|||
164406825|NCT00441701|593859106|FG001|Overall Study|Withdrawal by Subject|2|||
164406826|NCT00441701|593859107|FG002|Overall Study|Withdrawal by Subject|1|||
164406827|NCT00441701|593859108|FG003|Overall Study|Withdrawal by Subject|1|||
164406828|NCT00441701|593859109|FG004|Overall Study|Withdrawal by Subject|0|||
164406829|NCT00441701|593859110|FG005|Overall Study|Withdrawal by Subject|0|||
164406830|NCT00441701|593859111|FG006|Overall Study|Withdrawal by Subject|0|||
164406831|NCT00441701|593859112|FG007|Overall Study|Withdrawal by Subject|0|||
164406832|NCT00441701|593859113|FG008|Overall Study|Withdrawal by Subject|0|||
164406833|NCT00441701|593859114|FG009|Overall Study|Withdrawal by Subject|0|||
164406834|NCT01287611|593859120|FG000|Overall Study|Lost to Follow-up|29|||
164406835|NCT01287611|593859121|FG001|Overall Study|Lost to Follow-up|16|||
164406836|NCT01287611|593859120|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
164406837|NCT01287611|593859121|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
164406838|NCT02255357|593859124|FG000|Overall Study|Physician Decision|10|||
164406839|NCT02255357|593859125|FG001|Overall Study|Physician Decision|24|||
164406840|NCT02192970|593859130|FG000|Overall Study|Lost to Follow-up|6|||
164406841|NCT02192970|593859131|FG001|Overall Study|Lost to Follow-up|0|||
164406842|NCT04074590|593859132|FG000|Overall Study|Adverse Event|1|||
164406843|NCT04074590|593859133|FG001|Overall Study|Adverse Event|0|||
164406844|NCT04074590|593859132|FG000|Overall Study|Physician Decision|1|||
164406845|NCT04074590|593859133|FG001|Overall Study|Physician Decision|0|||
164406846|NCT04074590|593859132|FG000|Overall Study|Withdrawal by Subject|2|||
164406847|NCT04074590|593859133|FG001|Overall Study|Withdrawal by Subject|0|||
164707159|NCT00444457|594953549|FG003|After Infant Series|Other|0|||
164707160|NCT00444457|594953546|FG000|Toddler Dose|Lost to Follow-up|4|||
164707161|NCT00444457|594953547|FG001|Toddler Dose|Lost to Follow-up|1|||
164707162|NCT00444457|594953548|FG002|Toddler Dose|Lost to Follow-up|1|||
164707163|NCT00444457|594953549|FG003|Toddler Dose|Lost to Follow-up|3|||
164406848|NCT00509236|593859136|FG000|Overall Study|Adverse Event|7|||
164406849|NCT00509236|593859137|FG001|Overall Study|Adverse Event|9|||
164406850|NCT00509236|593859136|FG000|Overall Study|Withdrawal by Subject|5|||
164406851|NCT00509236|593859137|FG001|Overall Study|Withdrawal by Subject|10|||
164406852|NCT00509236|593859136|FG000|Overall Study|Protocol Violation|3|||
164406853|NCT00509236|593859137|FG001|Overall Study|Protocol Violation|0|||
164406854|NCT00509236|593859136|FG000|Overall Study|Excluded Medication|1|||
164406855|NCT00509236|593859137|FG001|Overall Study|Excluded Medication|1|||
164707164|NCT00444457|594953546|FG000|Toddler Dose|Failed to return|2|||
164707165|NCT00444457|594953547|FG001|Toddler Dose|Failed to return|2|||
164707166|NCT00444457|594953548|FG002|Toddler Dose|Failed to return|1|||
164707167|NCT00444457|594953549|FG003|Toddler Dose|Failed to return|3|||
164707168|NCT00444457|594953546|FG000|Toddler Dose|Parent or legal guardian request|0|||
164707169|NCT00444457|594953547|FG001|Toddler Dose|Parent or legal guardian request|3|||
164707170|NCT00444457|594953548|FG002|Toddler Dose|Parent or legal guardian request|2|||
164707171|NCT00444457|594953549|FG003|Toddler Dose|Parent or legal guardian request|1|||
164707172|NCT00444457|594953546|FG000|Toddler Dose|Protocol Violation|1|||
164707173|NCT00444457|594953547|FG001|Toddler Dose|Protocol Violation|0|||
164707174|NCT00444457|594953548|FG002|Toddler Dose|Protocol Violation|0|||
164707175|NCT00444457|594953549|FG003|Toddler Dose|Protocol Violation|1|||
164707176|NCT01121666|594953550|FG000|Overall Study|Protocol Violation|29|||
164707177|NCT01121666|594953551|FG001|Overall Study|Protocol Violation|10|||
164707178|NCT02041091|594953554|FG000|Treatment|Adverse Event|3|||
164707179|NCT02041091|594953555|FG001|Treatment|Adverse Event|3|||
164707180|NCT02041091|594953554|FG000|Treatment|Withdrawal by Subject|2|||
164707181|NCT02041091|594953555|FG001|Treatment|Withdrawal by Subject|4|||
164707182|NCT02041091|594953554|FG000|Treatment|Physician Decision|1|||
164707183|NCT02041091|594953555|FG001|Treatment|Physician Decision|0|||
164707184|NCT02041091|594953554|FG000|Treatment|Sponsor Decision|15|||
164707185|NCT02041091|594953555|FG001|Treatment|Sponsor Decision|16|||
164707186|NCT02041091|594953554|FG000|Treatment|Lost to Follow-up|1|||
164707187|NCT02041091|594953555|FG001|Treatment|Lost to Follow-up|0|||
164707188|NCT02041091|594953554|FG000|Optional Safety Extension Period|Adverse Event|4|||
164707189|NCT02041091|594953555|FG001|Optional Safety Extension Period|Adverse Event|2|||
164707190|NCT02041091|594953554|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
164707191|NCT02041091|594953555|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
164707192|NCT02041091|594953554|FG000|Optional Safety Extension Period|Protocol Violation|2|||
164707193|NCT02041091|594953555|FG001|Optional Safety Extension Period|Protocol Violation|0|||
164707194|NCT02041091|594953554|FG000|Optional Safety Extension Period|Physician Decision|2|||
164707195|NCT02041091|594953555|FG001|Optional Safety Extension Period|Physician Decision|1|||
164707196|NCT02041091|594953554|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
164707197|NCT02041091|594953555|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
164707198|NCT02041091|594953554|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
164707199|NCT02041091|594953555|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
164707200|NCT01855074|594953556|FG000|Overall Study|Adverse Event|1|||
164707201|NCT01855074|594953556|FG000|Overall Study|Lost to Follow-up|4|||
164707202|NCT01855074|594953556|FG000|Overall Study|Withdrawal by Subject|8|||
164707203|NCT01855074|594953556|FG000|Overall Study|Started but not treated|1|||
164707204|NCT02991430|594953557|FG000|Treatment Period 1|Adverse Event|1|||
164707205|NCT02991430|594953558|FG001|Treatment Period 1|Adverse Event|0|||
164707206|NCT02991430|594953559|FG002|Treatment Period 1|Adverse Event|2|||
164707207|NCT02991430|594953557|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164707208|NCT02991430|594953558|FG001|Treatment Period 1|Withdrawal by Subject|4|||
164707209|NCT02991430|594953559|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164707210|NCT02991430|594953557|FG000|Treatment Period 2|Study Termination|6|||
164707211|NCT02991430|594953558|FG001|Treatment Period 2|Study Termination|3|||
164707212|NCT02991430|594953559|FG002|Treatment Period 2|Study Termination|3|||
164707213|NCT02991430|594953557|FG000|Treatment Period 2|Lost to Follow-up|0|||
164406856|NCT00509236|593859136|FG000|Overall Study|Scheduled Kidney Transplant|1|||
164406857|NCT00509236|593859137|FG001|Overall Study|Scheduled Kidney Transplant|0|||
164406858|NCT02709005|593859149|FG000|Overall Study|Lost to Follow-up|1|||
164406859|NCT02709005|593859150|FG001|Overall Study|Lost to Follow-up|1|||
164406860|NCT02709005|593859149|FG000|Overall Study|Withdrawal by Subject|3|||
164406861|NCT02709005|593859150|FG001|Overall Study|Withdrawal by Subject|0|||
164406862|NCT01572389|593859151|FG000|Overall Study|Death|1|||
164406863|NCT01572389|593859152|FG001|Overall Study|Death|3|||
164406864|NCT01572389|593859151|FG000|Overall Study|Withdrawal by Subject|14|||
164406865|NCT01572389|593859152|FG001|Overall Study|Withdrawal by Subject|2|||
164406866|NCT01572389|593859151|FG000|Overall Study|Lost to Follow-up|25|||
164406867|NCT01572389|593859152|FG001|Overall Study|Lost to Follow-up|14|||
164406868|NCT01572389|593859151|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
164406869|NCT01572389|593859152|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
164406870|NCT02634788|593859157|FG000|Overall Study|Adverse Event|0|||
164406871|NCT02634788|593859158|FG001|Overall Study|Adverse Event|8|||
164406872|NCT02634788|593859159|FG002|Overall Study|Adverse Event|3|||
164406873|NCT02634788|593859160|FG003|Overall Study|Adverse Event|1|||
164406874|NCT02634788|593859157|FG000|Overall Study|Lack of Efficacy|4|||
164406875|NCT02634788|593859158|FG001|Overall Study|Lack of Efficacy|0|||
164707214|NCT02991430|594953558|FG001|Treatment Period 2|Lost to Follow-up|0|||
164707215|NCT02991430|594953559|FG002|Treatment Period 2|Lost to Follow-up|1|||
164707216|NCT02991430|594953557|FG000|Post-treatment Observation Period|Study Termination|3|||
164707217|NCT02991430|594953558|FG001|Post-treatment Observation Period|Study Termination|6|||
164707218|NCT02991430|594953559|FG002|Post-treatment Observation Period|Study Termination|5|||
164707219|NCT03970837|594953560|FG000|Overall Study|Adverse Event|23|||
164707220|NCT03970837|594953561|FG001|Overall Study|Adverse Event|20|||
164707221|NCT03970837|594953562|FG002|Overall Study|Adverse Event|16|||
164456720|NCT02783300|594043018|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
164456721|NCT02783300|594043019|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
164456722|NCT00378105|594043022|FG000|Overall Study|Adverse Event|3|||
164456723|NCT00378105|594043023|FG001|Overall Study|Adverse Event|1|||
164456724|NCT00378105|594043022|FG000|Overall Study|Withdrawal by Subject|3|||
164456725|NCT00378105|594043023|FG001|Overall Study|Withdrawal by Subject|3|||
164456726|NCT00378105|594043022|FG000|Overall Study|Death|1|||
164456727|NCT00378105|594043023|FG001|Overall Study|Death|0|||
164456728|NCT00378105|594043022|FG000|Overall Study|Going to transplant|7|||
164456729|NCT00378105|594043023|FG001|Overall Study|Going to transplant|8|||
164456730|NCT00378105|594043022|FG000|Overall Study|Progressive disease|3|||
164456731|NCT00378105|594043023|FG001|Overall Study|Progressive disease|3|||
164456732|NCT00378105|594043022|FG000|Overall Study|remain on study|3|||
164456733|NCT00378105|594043023|FG001|Overall Study|remain on study|11|||
164456734|NCT00378105|594043022|FG000|Overall Study|Physician Decision|0|||
164456735|NCT00378105|594043023|FG001|Overall Study|Physician Decision|2|||
164456736|NCT00378105|594043022|FG000|Overall Study|Going non-protocol therapy|0|||
164456737|NCT00378105|594043023|FG001|Overall Study|Going non-protocol therapy|1|||
164456738|NCT00378105|594043022|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
164456739|NCT00378105|594043023|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
164456740|NCT02243709|594043025|FG000|Phase 1|Lost to Follow-up|0|||
164456741|NCT02243709|594043026|FG001|Phase 1|Lost to Follow-up|1|||
164456742|NCT02243709|594043025|FG000|Phase 1|Withdrawal by Subject|1|||
164456743|NCT02243709|594043026|FG001|Phase 1|Withdrawal by Subject|0|||
164456744|NCT02243709|594043025|FG000|Phase 1|Protocol Violation|0|||
164456745|NCT02243709|594043026|FG001|Phase 1|Protocol Violation|1|||
164456746|NCT02243709|594043025|FG000|Phase 1|Adverse Event|0|||
164456747|NCT02243709|594043026|FG001|Phase 1|Adverse Event|1|||
164456748|NCT03443323|594043032|FG000|Overall Study|Lost to Follow-up|2|||
164456749|NCT03443323|594043033|FG001|Overall Study|Lost to Follow-up|2|||
164456750|NCT03443323|594043032|FG000|Overall Study|PI withdrawal|1|||
164456751|NCT03443323|594043033|FG001|Overall Study|PI withdrawal|0|||
164456752|NCT05178316|594043039|FG000|Overall Study|Adverse Event|5|||
164456753|NCT05178316|594043040|FG001|Overall Study|Adverse Event|4|||
164456754|NCT05178316|594043041|FG002|Overall Study|Adverse Event|9|||
164456755|NCT05178316|594043039|FG000|Overall Study|Enrolled in Error|1|||
164456756|NCT05178316|594043040|FG001|Overall Study|Enrolled in Error|2|||
164456757|NCT05178316|594043041|FG002|Overall Study|Enrolled in Error|1|||
164456758|NCT05178316|594043039|FG000|Overall Study|Lost to Follow-up|3|||
164456759|NCT05178316|594043040|FG001|Overall Study|Lost to Follow-up|15|||
164456760|NCT05178316|594043041|FG002|Overall Study|Lost to Follow-up|11|||
164456761|NCT05178316|594043039|FG000|Overall Study|Noncompliance|1|||
164456762|NCT05178316|594043040|FG001|Overall Study|Noncompliance|3|||
164456763|NCT05178316|594043041|FG002|Overall Study|Noncompliance|1|||
164456764|NCT05178316|594043039|FG000|Overall Study|Other|0|||
164456765|NCT05178316|594043040|FG001|Overall Study|Other|1|||
164456766|NCT05178316|594043041|FG002|Overall Study|Other|0|||
164456767|NCT05178316|594043039|FG000|Overall Study|Physician Decision|0|||
164456768|NCT05178316|594043040|FG001|Overall Study|Physician Decision|3|||
164456769|NCT05178316|594043041|FG002|Overall Study|Physician Decision|2|||
164456770|NCT05178316|594043039|FG000|Overall Study|Protocol deviation|1|||
164707222|NCT03970837|594953563|FG003|Overall Study|Adverse Event|6|||
164707223|NCT03970837|594953564|FG004|Overall Study|Adverse Event|4|||
164707224|NCT03970837|594953565|FG005|Overall Study|Adverse Event|5|||
164707225|NCT03970837|594953566|FG006|Overall Study|Adverse Event|1|||
164707226|NCT03970837|594953567|FG007|Overall Study|Adverse Event|5|||
164707227|NCT03970837|594953568|FG008|Overall Study|Adverse Event|0|||
164456771|NCT05178316|594043040|FG001|Overall Study|Protocol deviation|0|||
164456772|NCT05178316|594043041|FG002|Overall Study|Protocol deviation|1|||
164456773|NCT05178316|594043039|FG000|Overall Study|Sponsor decision|1|||
164456774|NCT05178316|594043040|FG001|Overall Study|Sponsor decision|0|||
164456775|NCT05178316|594043041|FG002|Overall Study|Sponsor decision|1|||
164456776|NCT05178316|594043039|FG000|Overall Study|Withdrawal by Subject|5|||
164456777|NCT05178316|594043040|FG001|Overall Study|Withdrawal by Subject|11|||
164456778|NCT05178316|594043041|FG002|Overall Study|Withdrawal by Subject|5|||
164456779|NCT04169373|594043042|FG000|Week 1 to Week 14|Adverse Event|1|||
164456780|NCT04169373|594043043|FG001|Week 1 to Week 14|Adverse Event|0|||
164456781|NCT04169373|594043044|FG002|Week 1 to Week 14|Adverse Event|1|||
164456782|NCT04169373|594043045|FG003|Week 1 to Week 14|Adverse Event|2|||
164707228|NCT03970837|594953569|FG009|Overall Study|Adverse Event|0|||
164456783|NCT04169373|594043042|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
164456784|NCT04169373|594043043|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
164456785|NCT04169373|594043044|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
164456786|NCT04169373|594043045|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
164456787|NCT04169373|594043042|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
164456788|NCT04169373|594043043|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
164456789|NCT04169373|594043044|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
164456790|NCT04169373|594043045|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
164707229|NCT03970837|594953570|FG010|Overall Study|Adverse Event|1|||
164456791|NCT04169373|594043042|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
164456792|NCT04169373|594043043|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
164456793|NCT04169373|594043044|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
164456794|NCT04169373|594043045|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
164456795|NCT04169373|594043042|FG000|Week 1 to Week 14|Other|1|||
164456796|NCT04169373|594043043|FG001|Week 1 to Week 14|Other|3|||
164456797|NCT04169373|594043044|FG002|Week 1 to Week 14|Other|3|||
164456798|NCT04169373|594043045|FG003|Week 1 to Week 14|Other|5|||
164456799|NCT04169373|594043042|FG000|Week 14 to Week 52|Adverse Event|1|||
164456800|NCT04169373|594043043|FG001|Week 14 to Week 52|Adverse Event|0|||
164456801|NCT04169373|594043044|FG002|Week 14 to Week 52|Adverse Event|0|||
164456802|NCT04169373|594043045|FG003|Week 14 to Week 52|Adverse Event|1|||
164456803|NCT04169373|594043042|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
164456804|NCT04169373|594043043|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
164456805|NCT04169373|594043044|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
164456806|NCT04169373|594043045|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
164456807|NCT04169373|594043042|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
164456808|NCT04169373|594043043|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
164456809|NCT04169373|594043044|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
164456810|NCT04169373|594043045|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
164456811|NCT04169373|594043042|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
164456812|NCT04169373|594043043|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
164456813|NCT04169373|594043044|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
164456814|NCT04169373|594043045|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
164456815|NCT04169373|594043042|FG000|Week 14 to Week 52|Other|4|||
164456816|NCT04169373|594043043|FG001|Week 14 to Week 52|Other|5|||
164456817|NCT04169373|594043044|FG002|Week 14 to Week 52|Other|4|||
164456818|NCT04169373|594043045|FG003|Week 14 to Week 52|Other|5|||
164456819|NCT04169373|594043042|FG000|Week 14 to Week 52|Ongoing|0|||
164456820|NCT04169373|594043043|FG001|Week 14 to Week 52|Ongoing|1|||
164456821|NCT04169373|594043044|FG002|Week 14 to Week 52|Ongoing|0|||
164456822|NCT04169373|594043045|FG003|Week 14 to Week 52|Ongoing|0|||
164456823|NCT04610892|594043046|FG000|Overall Study|Adverse Event|1|||
164456824|NCT04610892|594043047|FG001|Overall Study|Adverse Event|0|||
164456825|NCT04610892|594043048|FG002|Overall Study|Adverse Event|0|||
164456826|NCT04610892|594043049|FG003|Overall Study|Adverse Event|1|||
164456827|NCT04610892|594043050|FG004|Overall Study|Adverse Event|3|||
164456828|NCT04610892|594043046|FG000|Overall Study|Death|0|||
164456829|NCT04610892|594043047|FG001|Overall Study|Death|1|||
164456830|NCT04610892|594043048|FG002|Overall Study|Death|0|||
164456831|NCT04610892|594043049|FG003|Overall Study|Death|1|||
164456832|NCT04610892|594043050|FG004|Overall Study|Death|0|||
164456833|NCT04610892|594043046|FG000|Overall Study|Withdrawal by Subject|3|||
164456834|NCT04610892|594043047|FG001|Overall Study|Withdrawal by Subject|2|||
164456835|NCT04610892|594043048|FG002|Overall Study|Withdrawal by Subject|0|||
164456836|NCT04610892|594043049|FG003|Overall Study|Withdrawal by Subject|6|||
164456837|NCT04610892|594043050|FG004|Overall Study|Withdrawal by Subject|6|||
164456838|NCT04610892|594043046|FG000|Overall Study|Subjects who did not receive treatment|1|||
164456839|NCT04610892|594043047|FG001|Overall Study|Subjects who did not receive treatment|0|||
164456840|NCT04610892|594043048|FG002|Overall Study|Subjects who did not receive treatment|0|||
164456841|NCT04610892|594043049|FG003|Overall Study|Subjects who did not receive treatment|0|||
164456842|NCT04610892|594043050|FG004|Overall Study|Subjects who did not receive treatment|2|||
164456843|NCT01413100|594043051|FG000|Overall Study|Withdrawal by Subject|1|||
164456844|NCT05369403|594043052|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
164456845|NCT05369403|594043053|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
164456846|NCT05369403|594043054|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
164456847|NCT05369403|594043052|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
164456848|NCT05369403|594043053|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
164456849|NCT05369403|594043054|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
164456850|NCT05369403|594043052|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
164456851|NCT05369403|594043053|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
164456852|NCT05369403|594043054|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
164456853|NCT05369403|594043052|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
164456854|NCT05369403|594043053|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
164456855|NCT05369403|594043054|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
164456856|NCT05369403|594043052|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
164456857|NCT05369403|594043053|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
164456858|NCT05369403|594043054|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
164456859|NCT05369403|594043052|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
164456860|NCT05369403|594043053|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
164456861|NCT05369403|594043054|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
164456862|NCT05369403|594043052|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
164456863|NCT05369403|594043053|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
164456864|NCT05369403|594043054|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
164456865|NCT05369403|594043052|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
164456866|NCT05369403|594043053|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
164456867|NCT05369403|594043054|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
164456868|NCT05369403|594043052|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
164456869|NCT05369403|594043053|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
164456870|NCT05369403|594043054|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
164456871|NCT05369403|594043052|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
164456872|NCT05369403|594043053|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
164456873|NCT05369403|594043054|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
164456874|NCT05369403|594043052|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
164456875|NCT05369403|594043053|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
164456876|NCT05369403|594043054|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
164456877|NCT04760678|594043055|FG000|Overall Study|Death|13|||
164456878|NCT04760678|594043055|FG000|Overall Study|Lost to Follow-up|48|||
164456879|NCT04760678|594043055|FG000|Overall Study|Withdrawal by Subject|1|||
164456880|NCT01748448|594043058|FG000|Treatment Period|Consent withdrawn by subject|1|||
164456881|NCT01748448|594043059|FG001|Treatment Period|Consent withdrawn by subject|0|||
164456882|NCT01748448|594043058|FG000|Treatment Period|Adverse Event|1|||
164456883|NCT01748448|594043059|FG001|Treatment Period|Adverse Event|0|||
164456884|NCT01748448|594043058|FG000|Treatment Period|Personal|0|||
164456885|NCT01748448|594043059|FG001|Treatment Period|Personal|1|||
164456886|NCT05784662|594043062|FG000|Overall Study|Lost to Follow-up|21|||
164456887|NCT05784662|594043063|FG001|Overall Study|Lost to Follow-up|17|||
164456888|NCT02913872|594043071|FG000|Overall Study|Withdrawal by Subject|1|||
164456889|NCT04739956|594043074|FG000|Overall Study|Withdrawal by Subject|1|||
164456890|NCT04739956|594043075|FG001|Overall Study|Withdrawal by Subject|1|||
164456891|NCT03920111|594043076|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
164456892|NCT03920111|594043077|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
164456893|NCT03920111|594043078|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
164456894|NCT05177848|594043081|FG000|Overall Study|Lost to Follow-up|1|||
164456895|NCT05177848|594043082|FG001|Overall Study|Lost to Follow-up|4|||
164456896|NCT05177848|594043081|FG000|Overall Study|Discontinued|2|||
164456897|NCT05177848|594043082|FG001|Overall Study|Discontinued|1|||
164456898|NCT06414213|594043083|FG000|Overall Study|Lost to Follow-up|1|||
164456899|NCT06414213|594043084|FG001|Overall Study|Lost to Follow-up|1|||
164456900|NCT06414213|594043085|FG002|Overall Study|Lost to Follow-up|3|||
164456901|NCT03110315|594043086|FG000|Overall Study|Withdrawal by Subject|1|||
164456902|NCT03110315|594043087|FG001|Overall Study|Withdrawal by Subject|0|||
164456903|NCT05256706|594043092|FG000|Overall Study|Lost to Follow-up|9|||
164456904|NCT05256706|594043093|FG001|Overall Study|Lost to Follow-up|3|||
164456905|NCT05256706|594043092|FG000|Overall Study|Withdrawal by Subject|7|||
164456906|NCT05256706|594043093|FG001|Overall Study|Withdrawal by Subject|11|||
164456907|NCT05256706|594043092|FG000|Overall Study|Screen Failures|3|||
164456908|NCT05256706|594043093|FG001|Overall Study|Screen Failures|0|||
164456909|NCT03720795|594043096|FG000|Phase 1|Lost to Follow-up|4|||
164456910|NCT03720795|594043096|FG000|Phase 1|Withdrawal by Subject|6|||
164456911|NCT03720795|594043096|FG000|Phase 1|Protocol Violation|1|||
164456912|NCT03720795|594043096|FG000|Phase 1|Other|1|||
164456913|NCT03720795|594043096|FG000|Phase 2|Lost to Follow-up|5|||
164456914|NCT03720795|594043096|FG000|Phase 2|Withdrawal by Subject|10|||
164456915|NCT03720795|594043096|FG000|Phase 2|Protocol Violation|2|||
164456916|NCT03720795|594043096|FG000|3 Month Follow Up|Lost to Follow-up|2|||
164456917|NCT01573442|594043099|FG000|Overall Study|Cancels|9|||
164456918|NCT01573442|594043100|FG001|Overall Study|Cancels|10|||
164456919|NCT04763265|594043106|FG000|Overall Study|Adverse Event|1|||
164456920|NCT04763265|594043107|FG001|Overall Study|Adverse Event|0|||
164456921|NCT04763265|594043106|FG000|Overall Study|Lost to Follow-up|2|||
164456922|NCT04763265|594043107|FG001|Overall Study|Lost to Follow-up|4|||
164456923|NCT04763265|594043106|FG000|Overall Study|Withdrawal by Subject|0|||
164456924|NCT04763265|594043107|FG001|Overall Study|Withdrawal by Subject|1|||
164456925|NCT03269136|594043114|FG000|Part 1: Dose Escalation|Other|0|||
164456926|NCT03269136|594043115|FG001|Part 1: Dose Escalation|Other|0|||
164456927|NCT03269136|594043116|FG002|Part 1: Dose Escalation|Other|0|||
164456928|NCT03269136|594043117|FG003|Part 1: Dose Escalation|Other|0|||
164456929|NCT03269136|594043118|FG004|Part 1: Dose Escalation|Other|0|||
164456930|NCT03269136|594043119|FG005|Part 1: Dose Escalation|Other|0|||
164456931|NCT03269136|594043120|FG006|Part 1: Dose Escalation|Other|0|||
164456932|NCT03269136|594043121|FG007|Part 1: Dose Escalation|Other|0|||
164456933|NCT03269136|594043122|FG008|Part 1: Dose Escalation|Other|0|||
164456934|NCT03269136|594043123|FG009|Part 1: Dose Escalation|Other|0|||
164456935|NCT03269136|594043124|FG010|Part 1: Dose Escalation|Other|1|||
164456936|NCT03269136|594043125|FG011|Part 1: Dose Escalation|Other|1|||
164707230|NCT03970837|594953571|FG011|Overall Study|Adverse Event|1|||
164707231|NCT03970837|594953560|FG000|Overall Study|Lack of Efficacy|14|||
164707232|NCT03970837|594953561|FG001|Overall Study|Lack of Efficacy|12|||
164707233|NCT03970837|594953562|FG002|Overall Study|Lack of Efficacy|1|||
164707234|NCT03970837|594953563|FG003|Overall Study|Lack of Efficacy|2|||
164707235|NCT03970837|594953564|FG004|Overall Study|Lack of Efficacy|3|||
164707236|NCT03970837|594953565|FG005|Overall Study|Lack of Efficacy|4|||
164707237|NCT03970837|594953566|FG006|Overall Study|Lack of Efficacy|6|||
164707238|NCT03970837|594953567|FG007|Overall Study|Lack of Efficacy|1|||
164707239|NCT03970837|594953568|FG008|Overall Study|Lack of Efficacy|1|||
164707240|NCT03970837|594953569|FG009|Overall Study|Lack of Efficacy|0|||
164707241|NCT03970837|594953570|FG010|Overall Study|Lack of Efficacy|0|||
164707242|NCT03970837|594953571|FG011|Overall Study|Lack of Efficacy|0|||
164707243|NCT03970837|594953560|FG000|Overall Study|Lost to Follow-up|6|||
164707244|NCT03970837|594953561|FG001|Overall Study|Lost to Follow-up|5|||
164707245|NCT03970837|594953562|FG002|Overall Study|Lost to Follow-up|5|||
164707246|NCT03970837|594953563|FG003|Overall Study|Lost to Follow-up|1|||
164707247|NCT03970837|594953564|FG004|Overall Study|Lost to Follow-up|0|||
164707248|NCT03970837|594953565|FG005|Overall Study|Lost to Follow-up|2|||
164707249|NCT03970837|594953566|FG006|Overall Study|Lost to Follow-up|0|||
164707250|NCT03970837|594953567|FG007|Overall Study|Lost to Follow-up|0|||
164707251|NCT03970837|594953568|FG008|Overall Study|Lost to Follow-up|0|||
164707252|NCT03970837|594953569|FG009|Overall Study|Lost to Follow-up|0|||
164707253|NCT03970837|594953570|FG010|Overall Study|Lost to Follow-up|0|||
164707254|NCT03970837|594953571|FG011|Overall Study|Lost to Follow-up|0|||
164707255|NCT03970837|594953560|FG000|Overall Study|Protocol Violation|1|||
164707256|NCT03970837|594953561|FG001|Overall Study|Protocol Violation|0|||
164406876|NCT02634788|593859159|FG002|Overall Study|Lack of Efficacy|1|||
164406877|NCT02634788|593859160|FG003|Overall Study|Lack of Efficacy|4|||
164406878|NCT02634788|593859157|FG000|Overall Study|Lost to Follow-up|0|||
164406879|NCT02634788|593859158|FG001|Overall Study|Lost to Follow-up|1|||
164406880|NCT02634788|593859159|FG002|Overall Study|Lost to Follow-up|0|||
164406881|NCT02634788|593859160|FG003|Overall Study|Lost to Follow-up|0|||
164406882|NCT02634788|593859157|FG000|Overall Study|Withdrawal by Subject|0|||
164406883|NCT02634788|593859158|FG001|Overall Study|Withdrawal by Subject|1|||
164406884|NCT02634788|593859159|FG002|Overall Study|Withdrawal by Subject|1|||
164406885|NCT02634788|593859160|FG003|Overall Study|Withdrawal by Subject|0|||
164406886|NCT00758459|593859161|FG000|Overall Study|Adverse Event|3|||
164406887|NCT00758459|593859162|FG001|Overall Study|Adverse Event|2|||
164406888|NCT00758459|593859161|FG000|Overall Study|Protocol Violation|0|||
164406889|NCT00758459|593859162|FG001|Overall Study|Protocol Violation|1|||
164406890|NCT00758459|593859161|FG000|Overall Study|Withdrawal by Subject|0|||
164406891|NCT00758459|593859162|FG001|Overall Study|Withdrawal by Subject|1|||
164406892|NCT01780935|593859166|FG000|Overall Study|Admin problems due to early termination|321|||
164406893|NCT01780935|593859167|FG001|Overall Study|Admin problems due to early termination|309|||
164406894|NCT01780935|593859166|FG000|Overall Study|Adverse Event|2|||
164406895|NCT01780935|593859167|FG001|Overall Study|Adverse Event|4|||
164406896|NCT01780935|593859166|FG000|Overall Study|Death|1|||
164406897|NCT01780935|593859167|FG001|Overall Study|Death|6|||
164406898|NCT01780935|593859166|FG000|Overall Study|Lost to Follow-up|2|||
164406899|NCT01780935|593859167|FG001|Overall Study|Lost to Follow-up|6|||
164406900|NCT01780935|593859166|FG000|Overall Study|Physician Decision|1|||
164406901|NCT01780935|593859167|FG001|Overall Study|Physician Decision|1|||
164406902|NCT01780935|593859166|FG000|Overall Study|Protocol deviation|0|||
164406903|NCT01780935|593859167|FG001|Overall Study|Protocol deviation|1|||
164406904|NCT01780935|593859166|FG000|Overall Study|Patient withdrew consent|8|||
164406905|NCT01780935|593859167|FG001|Overall Study|Patient withdrew consent|9|||
164406906|NCT01281202|593859168|FG000|Overall Study|Adverse Event|2|||
164406907|NCT01281202|593859169|FG001|Overall Study|Adverse Event|0|||
164406908|NCT01281202|593859168|FG000|Overall Study|Withdrawal by Subject|2|||
164406909|NCT01281202|593859169|FG001|Overall Study|Withdrawal by Subject|2|||
164406910|NCT01281202|593859168|FG000|Overall Study|Protocol Violation|11|||
164406911|NCT01281202|593859169|FG001|Overall Study|Protocol Violation|10|||
164406912|NCT01281202|593859168|FG000|Overall Study|Administrative|2|||
164406913|NCT01281202|593859169|FG001|Overall Study|Administrative|8|||
164707257|NCT03970837|594953562|FG002|Overall Study|Protocol Violation|0|||
164707258|NCT03970837|594953563|FG003|Overall Study|Protocol Violation|0|||
164406914|NCT01281202|593859168|FG000|Overall Study|Lost to Follow-up|11|||
164406915|NCT01281202|593859169|FG001|Overall Study|Lost to Follow-up|13|||
164406916|NCT01281202|593859168|FG000|Overall Study|Incarceration|0|||
164406917|NCT01281202|593859169|FG001|Overall Study|Incarceration|3|||
164406918|NCT01215357|593859170|FG000|Overall Study|Withdrawal by Subject|3|||
164406919|NCT01215357|593859170|FG000|Overall Study|Protocol Violation|9|||
164707259|NCT03970837|594953564|FG004|Overall Study|Protocol Violation|0|||
164707260|NCT03970837|594953565|FG005|Overall Study|Protocol Violation|0|||
164707261|NCT03970837|594953566|FG006|Overall Study|Protocol Violation|0|||
164707262|NCT03970837|594953567|FG007|Overall Study|Protocol Violation|0|||
164707263|NCT03970837|594953568|FG008|Overall Study|Protocol Violation|0|||
164707264|NCT03970837|594953569|FG009|Overall Study|Protocol Violation|0|||
164707265|NCT03970837|594953570|FG010|Overall Study|Protocol Violation|0|||
164707266|NCT03970837|594953571|FG011|Overall Study|Protocol Violation|0|||
164707267|NCT03970837|594953560|FG000|Overall Study|Physician Decision|5|||
164707268|NCT03970837|594953561|FG001|Overall Study|Physician Decision|8|||
164456937|NCT03269136|594043126|FG012|Part 1: Dose Escalation|Other|1|||
164456938|NCT03269136|594043127|FG013|Part 1: Dose Escalation|Other|0|||
164456939|NCT03269136|594043128|FG014|Part 1: Dose Escalation|Other|3|||
164456940|NCT03269136|594043129|FG015|Part 1: Dose Escalation|Other|1|||
164456941|NCT03269136|594043130|FG016|Part 1: Dose Escalation|Other|1|||
164456942|NCT03269136|594043131|FG017|Part 1: Dose Escalation|Other|0|||
164456943|NCT03269136|594043114|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
164456944|NCT03269136|594043115|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
164456945|NCT03269136|594043116|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
164456946|NCT03269136|594043117|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
164456947|NCT03269136|594043118|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
164456948|NCT03269136|594043119|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
164456949|NCT03269136|594043120|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
164456950|NCT03269136|594043121|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
164456951|NCT03269136|594043122|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
164456952|NCT03269136|594043123|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
164456953|NCT03269136|594043124|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
164456954|NCT03269136|594043125|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
164456955|NCT03269136|594043126|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
164456956|NCT03269136|594043127|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
164456957|NCT03269136|594043128|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
164456958|NCT03269136|594043129|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
164456959|NCT03269136|594043130|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
164456960|NCT03269136|594043131|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
164456961|NCT03269136|594043114|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
164456962|NCT03269136|594043115|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
164456963|NCT03269136|594043116|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
164456964|NCT03269136|594043117|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
164456965|NCT03269136|594043118|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
164456966|NCT03269136|594043119|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
164456967|NCT03269136|594043120|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
164456968|NCT03269136|594043121|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
164456969|NCT03269136|594043122|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
164456970|NCT03269136|594043123|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
164456971|NCT03269136|594043124|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
164456972|NCT03269136|594043125|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
164456973|NCT03269136|594043126|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
164456974|NCT03269136|594043127|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
164456975|NCT03269136|594043128|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
164456976|NCT03269136|594043129|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
164456977|NCT03269136|594043130|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
164456978|NCT03269136|594043131|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
164456979|NCT03269136|594043114|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
164456980|NCT03269136|594043115|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
164456981|NCT03269136|594043116|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
164456982|NCT03269136|594043117|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
164456983|NCT03269136|594043118|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
164456984|NCT03269136|594043119|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
164456985|NCT03269136|594043120|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
164456986|NCT03269136|594043121|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
164456987|NCT03269136|594043122|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
164456988|NCT03269136|594043123|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
164456989|NCT03269136|594043124|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
164456990|NCT03269136|594043125|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
164707269|NCT03970837|594953562|FG002|Overall Study|Physician Decision|4|||
164707270|NCT03970837|594953563|FG003|Overall Study|Physician Decision|1|||
164707271|NCT03970837|594953564|FG004|Overall Study|Physician Decision|5|||
164456991|NCT03269136|594043126|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
164456992|NCT03269136|594043127|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
164456993|NCT03269136|594043128|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
164456994|NCT03269136|594043129|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
164456995|NCT03269136|594043130|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
164456996|NCT03269136|594043131|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
164456997|NCT03269136|594043114|FG000|Part 1: Dose Escalation|Death|0|||
164456998|NCT03269136|594043115|FG001|Part 1: Dose Escalation|Death|0|||
164707272|NCT03970837|594953565|FG005|Overall Study|Physician Decision|2|||
164707273|NCT03970837|594953566|FG006|Overall Study|Physician Decision|4|||
164707274|NCT03970837|594953567|FG007|Overall Study|Physician Decision|5|||
164707275|NCT03970837|594953568|FG008|Overall Study|Physician Decision|0|||
164707276|NCT03970837|594953569|FG009|Overall Study|Physician Decision|1|||
164707277|NCT03970837|594953570|FG010|Overall Study|Physician Decision|0|||
164707278|NCT03970837|594953571|FG011|Overall Study|Physician Decision|0|||
164707279|NCT03970837|594953560|FG000|Overall Study|Withdrawal by Subject|32|||
164707280|NCT03970837|594953561|FG001|Overall Study|Withdrawal by Subject|35|||
164707281|NCT03970837|594953562|FG002|Overall Study|Withdrawal by Subject|12|||
164406920|NCT05479604|593859171|FG000|Overall Study|Lost to Follow-up|1|||
164406921|NCT05479604|593859172|FG001|Overall Study|Lost to Follow-up|5|||
164406922|NCT01591382|593859173|FG000|Overall Study|Discharged Prior to Study Completion|2|||
164406923|NCT01591382|593859174|FG001|Overall Study|Discharged Prior to Study Completion|1|||
164406924|NCT01591382|593859173|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
164406925|NCT01591382|593859174|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
164406926|NCT02686034|593859183|FG000|Run-In Period 1|Eligibility|12|||
164406927|NCT02686034|593859184|FG001|Run-In Period 1|Eligibility|10|||
164406928|NCT02686034|593859183|FG000|Run-In Period 1|Withdrawal by Subject|4|||
164406929|NCT02686034|593859184|FG001|Run-In Period 1|Withdrawal by Subject|3|||
164406930|NCT02686034|593859183|FG000|Run-In Period 1|Lost to Follow-up|4|||
164406931|NCT02686034|593859184|FG001|Run-In Period 1|Lost to Follow-up|4|||
164406932|NCT02686034|593859183|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
164406933|NCT02686034|593859184|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
164406934|NCT02686034|593859183|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
164406935|NCT02686034|593859184|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
164406936|NCT02686034|593859183|FG000|Randomized Controlled Period 2|Adverse Event|0|||
164406937|NCT02686034|593859184|FG001|Randomized Controlled Period 2|Adverse Event|2|||
164406938|NCT02686034|593859183|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
164406939|NCT02686034|593859184|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
164406940|NCT02686034|593859183|FG000|Open Label Period 3|Lost to Follow-up|0|||
164406941|NCT02686034|593859184|FG001|Open Label Period 3|Lost to Follow-up|1|||
164406942|NCT01678131|593859185|FG000|Overall Study|Adverse Event|0|||
164406943|NCT01678131|593859186|FG001|Overall Study|Adverse Event|1|||
164406944|NCT01678131|593859187|FG002|Overall Study|Adverse Event|0|||
164406945|NCT01678131|593859185|FG000|Overall Study|Withdrawal by Subject|0|||
164406946|NCT01678131|593859186|FG001|Overall Study|Withdrawal by Subject|0|||
164406947|NCT01678131|593859187|FG002|Overall Study|Withdrawal by Subject|2|||
164406948|NCT00982930|593859191|FG000|Overall Study|Adverse Event|1|||
164406949|NCT00982930|593859191|FG000|Overall Study|Withdrawal by Subject|1|||
164406950|NCT00982930|593859191|FG000|Overall Study|Administrative Problems|2|||
164406951|NCT00941798|593859192|FG000|Overall Study|Withdrawal by Subject|72|||
164406952|NCT00941798|593859193|FG001|Overall Study|Withdrawal by Subject|74|||
164406953|NCT00941798|593859192|FG000|Overall Study|Adverse Event|43|||
164406954|NCT00941798|593859193|FG001|Overall Study|Adverse Event|23|||
164406955|NCT00941798|593859192|FG000|Overall Study|Lost to Follow-up|29|||
164406956|NCT00941798|593859193|FG001|Overall Study|Lost to Follow-up|23|||
164406957|NCT00941798|593859192|FG000|Overall Study|Protocol Violation|17|||
164406958|NCT00941798|593859193|FG001|Overall Study|Protocol Violation|20|||
164406959|NCT00941798|593859192|FG000|Overall Study|Administrative problems|13|||
164406960|NCT00941798|593859193|FG001|Overall Study|Administrative problems|23|||
164406961|NCT00941798|593859192|FG000|Overall Study|Lack of Efficacy|10|||
164406962|NCT00941798|593859193|FG001|Overall Study|Lack of Efficacy|17|||
164406963|NCT00941798|593859192|FG000|Overall Study|Patient's inability to use device|6|||
164406964|NCT00941798|593859193|FG001|Overall Study|Patient's inability to use device|1|||
164406965|NCT00941798|593859192|FG000|Overall Study|Abnormal test procedure results|3|||
164406966|NCT00941798|593859193|FG001|Overall Study|Abnormal test procedure results|1|||
164406967|NCT00941798|593859192|FG000|Overall Study|Abnormal laboratory values|1|||
164406968|NCT00941798|593859193|FG001|Overall Study|Abnormal laboratory values|2|||
164406969|NCT00941798|593859192|FG000|Overall Study|Death|0|||
164406970|NCT00941798|593859193|FG001|Overall Study|Death|1|||
164406971|NCT05597722|593859194|FG000|Overall Study|Study was terminated|6|||
164406972|NCT05597722|593859195|FG001|Overall Study|Study was terminated|1|||
164406973|NCT00404495|593859196|FG000|Overall Study|Death|37|||
164406974|NCT00404495|593859197|FG001|Overall Study|Death|11|||
164406975|NCT00404495|593859196|FG000|Overall Study|Lost to Follow-up|5|||
164406976|NCT00404495|593859197|FG001|Overall Study|Lost to Follow-up|0|||
164406977|NCT00404495|593859196|FG000|Overall Study|Other|1|||
164406978|NCT00404495|593859197|FG001|Overall Study|Other|0|||
164406979|NCT00404495|593859196|FG000|Overall Study|Withdrawal by Subject|1|||
164406980|NCT00404495|593859197|FG001|Overall Study|Withdrawal by Subject|0|||
164406981|NCT03750006|593859200|FG000|Overall Study|Withdrawal by Subject|8|||
164406982|NCT03750006|593859200|FG000|Overall Study|COVID PANDEMIC|11|||
164406983|NCT03538951|593859201|FG000|Overall Study|Withdrawal by Subject|1|||
164406984|NCT03538951|593859202|FG001|Overall Study|Withdrawal by Subject|2|||
164406985|NCT02569437|593860588|FG000|Overall Study|Lost to Follow-up|12|||
164406986|NCT02569437|593860589|FG001|Overall Study|Lost to Follow-up|14|||
164406987|NCT00077064|593860590|FG000|Overall Study|Adverse Event|0|||
164406988|NCT00077064|593860591|FG001|Overall Study|Adverse Event|4|||
164707282|NCT03970837|594953563|FG003|Overall Study|Withdrawal by Subject|8|||
164707283|NCT03970837|594953564|FG004|Overall Study|Withdrawal by Subject|6|||
164707284|NCT03970837|594953565|FG005|Overall Study|Withdrawal by Subject|8|||
164707285|NCT03970837|594953566|FG006|Overall Study|Withdrawal by Subject|2|||
164707286|NCT03970837|594953567|FG007|Overall Study|Withdrawal by Subject|3|||
164707287|NCT03970837|594953568|FG008|Overall Study|Withdrawal by Subject|0|||
164707288|NCT03970837|594953569|FG009|Overall Study|Withdrawal by Subject|0|||
164707289|NCT03970837|594953570|FG010|Overall Study|Withdrawal by Subject|0|||
164707290|NCT03970837|594953571|FG011|Overall Study|Withdrawal by Subject|1|||
164707291|NCT03970837|594953560|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
164406989|NCT00077064|593860590|FG000|Overall Study|Patient refusal|0|||
164406990|NCT00077064|593860591|FG001|Overall Study|Patient refusal|2|||
164406991|NCT00985985|593860592|FG000|Overall Study|Adverse Event|4|||
164406992|NCT00985985|593860593|FG001|Overall Study|Adverse Event|2|||
164406993|NCT00985985|593860594|FG002|Overall Study|Adverse Event|2|||
164406994|NCT00985985|593860595|FG003|Overall Study|Adverse Event|2|||
164406995|NCT00985985|593860592|FG000|Overall Study|Lost to Follow-up|4|||
164406996|NCT00985985|593860593|FG001|Overall Study|Lost to Follow-up|11|||
164406997|NCT00985985|593860594|FG002|Overall Study|Lost to Follow-up|2|||
164406998|NCT00985985|593860595|FG003|Overall Study|Lost to Follow-up|3|||
164406999|NCT00985985|593860592|FG000|Overall Study|Protocol Violation|1|||
164407000|NCT00985985|593860593|FG001|Overall Study|Protocol Violation|2|||
164407001|NCT00985985|593860594|FG002|Overall Study|Protocol Violation|0|||
164407002|NCT00985985|593860595|FG003|Overall Study|Protocol Violation|1|||
164407003|NCT00985985|593860592|FG000|Overall Study|Lack of Efficacy|5|||
164407004|NCT00985985|593860593|FG001|Overall Study|Lack of Efficacy|6|||
164407005|NCT00985985|593860594|FG002|Overall Study|Lack of Efficacy|1|||
164407006|NCT00985985|593860595|FG003|Overall Study|Lack of Efficacy|3|||
164407007|NCT00985985|593860592|FG000|Overall Study|Withdrawal by Subject|4|||
164407008|NCT00985985|593860593|FG001|Overall Study|Withdrawal by Subject|2|||
164407009|NCT00985985|593860594|FG002|Overall Study|Withdrawal by Subject|2|||
164407010|NCT00985985|593860595|FG003|Overall Study|Withdrawal by Subject|2|||
164407011|NCT00985985|593860592|FG000|Overall Study|Other Reason|6|||
164407012|NCT00985985|593860593|FG001|Overall Study|Other Reason|1|||
164407013|NCT00985985|593860594|FG002|Overall Study|Other Reason|4|||
164407014|NCT00985985|593860595|FG003|Overall Study|Other Reason|2|||
164407015|NCT02007434|593860598|FG000|Overall Study|Lost to Follow-up|0|||
164407016|NCT02007434|593860599|FG001|Overall Study|Lost to Follow-up|1|||
164407017|NCT02007434|593860600|FG002|Overall Study|Lost to Follow-up|0|||
164407018|NCT02007434|593860601|FG003|Overall Study|Lost to Follow-up|0|||
164407019|NCT02007434|593860602|FG004|Overall Study|Lost to Follow-up|0|||
164407020|NCT02007434|593860603|FG005|Overall Study|Lost to Follow-up|0|||
164407021|NCT02007434|593860604|FG006|Overall Study|Lost to Follow-up|0|||
164407022|NCT02007434|593860605|FG007|Overall Study|Lost to Follow-up|0|||
164407023|NCT02007434|593860598|FG000|Overall Study|Non-compliance|1|||
164407024|NCT02007434|593860599|FG001|Overall Study|Non-compliance|0|||
164407025|NCT02007434|593860600|FG002|Overall Study|Non-compliance|1|||
164407026|NCT02007434|593860601|FG003|Overall Study|Non-compliance|0|||
164407027|NCT02007434|593860602|FG004|Overall Study|Non-compliance|0|||
164407028|NCT02007434|593860603|FG005|Overall Study|Non-compliance|0|||
164407029|NCT02007434|593860604|FG006|Overall Study|Non-compliance|0|||
164407030|NCT02007434|593860605|FG007|Overall Study|Non-compliance|0|||
164407031|NCT00763958|593860606|FG000|Overall Study|did not meet final criteria|4|||
164407032|NCT00763958|593860607|FG001|Overall Study|did not meet final criteria|4|||
164407033|NCT00763958|593860606|FG000|Overall Study|Lost to Follow-up|10|||
164407034|NCT00763958|593860607|FG001|Overall Study|Lost to Follow-up|2|||
164407035|NCT00763958|593860606|FG000|Overall Study|Believed they were receiving placebo|0|||
164407036|NCT00763958|593860607|FG001|Overall Study|Believed they were receiving placebo|5|||
164407037|NCT00927355|593860608|FG000|Overall Study|Adverse Event|1|||
164407038|NCT00927355|593860609|FG001|Overall Study|Adverse Event|1|||
164407039|NCT03299686|593860610|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
164407040|NCT03299686|593860611|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
164407041|NCT03299686|593860610|FG000|Treatment Epoch|Physician Decision|1|||
164407042|NCT03299686|593860611|FG001|Treatment Epoch|Physician Decision|0|||
164407043|NCT03299686|593860610|FG000|Treatment Epoch|Adverse Event|8|||
164407044|NCT03299686|593860611|FG001|Treatment Epoch|Adverse Event|4|||
164407045|NCT03299686|593860610|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
164407046|NCT03299686|593860611|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
164407047|NCT00499863|593860613|FG000|Overall Study|Lack of Efficacy|21|||
164407048|NCT00499863|593860614|FG001|Overall Study|Lack of Efficacy|27|||
164407049|NCT00499863|593860613|FG000|Overall Study|Protocol Violation|12|||
164407050|NCT00499863|593860614|FG001|Overall Study|Protocol Violation|7|||
164407051|NCT00499863|593860613|FG000|Overall Study|Withdrawal by Subject|6|||
164407052|NCT00499863|593860614|FG001|Overall Study|Withdrawal by Subject|4|||
164407053|NCT00499863|593860613|FG000|Overall Study|Adverse Event|8|||
164407054|NCT00499863|593860614|FG001|Overall Study|Adverse Event|2|||
164707292|NCT03970837|594953561|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
164707293|NCT03970837|594953562|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
164707294|NCT03970837|594953563|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
164707295|NCT03970837|594953564|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
164707296|NCT03970837|594953565|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
164456999|NCT03269136|594043116|FG002|Part 1: Dose Escalation|Death|0|||
164457000|NCT03269136|594043117|FG003|Part 1: Dose Escalation|Death|0|||
164457001|NCT03269136|594043118|FG004|Part 1: Dose Escalation|Death|0|||
164457002|NCT03269136|594043119|FG005|Part 1: Dose Escalation|Death|0|||
164457003|NCT03269136|594043120|FG006|Part 1: Dose Escalation|Death|0|||
164457004|NCT03269136|594043121|FG007|Part 1: Dose Escalation|Death|0|||
164457005|NCT03269136|594043122|FG008|Part 1: Dose Escalation|Death|0|||
164457006|NCT03269136|594043123|FG009|Part 1: Dose Escalation|Death|1|||
164457007|NCT03269136|594043124|FG010|Part 1: Dose Escalation|Death|0|||
164457008|NCT03269136|594043125|FG011|Part 1: Dose Escalation|Death|1|||
164457009|NCT03269136|594043126|FG012|Part 1: Dose Escalation|Death|0|||
164457010|NCT03269136|594043127|FG013|Part 1: Dose Escalation|Death|1|||
164457011|NCT03269136|594043128|FG014|Part 1: Dose Escalation|Death|0|||
164457012|NCT03269136|594043129|FG015|Part 1: Dose Escalation|Death|0|||
164457013|NCT03269136|594043130|FG016|Part 1: Dose Escalation|Death|2|||
164457014|NCT03269136|594043131|FG017|Part 1: Dose Escalation|Death|0|||
164457015|NCT03269136|594043114|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
164457016|NCT03269136|594043115|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
164457017|NCT03269136|594043116|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
164457018|NCT03269136|594043117|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
164457019|NCT03269136|594043118|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
164457020|NCT03269136|594043119|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
164457021|NCT03269136|594043120|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
164457022|NCT03269136|594043121|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
164457023|NCT03269136|594043122|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
164457024|NCT03269136|594043123|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
164457025|NCT03269136|594043124|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
164457026|NCT03269136|594043125|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
164457027|NCT03269136|594043126|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
164457028|NCT03269136|594043127|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
164457029|NCT03269136|594043128|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
164598022|NCT03633227|594551307|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
164598023|NCT01766336|594551313|FG000|Overall Study|Adverse Event|11|||
164598024|NCT01766336|594551314|FG001|Overall Study|Adverse Event|8|||
164598025|NCT01766336|594551313|FG000|Overall Study|Death|4|||
164598026|NCT01766336|594551314|FG001|Overall Study|Death|3|||
164598027|NCT01766336|594551313|FG000|Overall Study|Lost to Follow-up|1|||
164598028|NCT01766336|594551314|FG001|Overall Study|Lost to Follow-up|3|||
164598029|NCT01766336|594551313|FG000|Overall Study|Physician Decision|4|||
164598030|NCT01766336|594551314|FG001|Overall Study|Physician Decision|2|||
164598031|NCT01766336|594551313|FG000|Overall Study|Protocol Violation|0|||
164598032|NCT01766336|594551314|FG001|Overall Study|Protocol Violation|1|||
164598033|NCT01766336|594551313|FG000|Overall Study|Sponsor Decision|52|||
164598034|NCT01766336|594551314|FG001|Overall Study|Sponsor Decision|43|||
164598035|NCT01766336|594551313|FG000|Overall Study|Withdrawal by Subject|18|||
164598036|NCT01766336|594551314|FG001|Overall Study|Withdrawal by Subject|15|||
164598037|NCT03029650|594551315|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
164707297|NCT03970837|594953566|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
164707298|NCT03970837|594953567|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
164707299|NCT03970837|594953568|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
164707300|NCT03970837|594953569|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
164407055|NCT00499863|593860613|FG000|Overall Study|Sponsor decision|2|||
164407056|NCT00499863|593860614|FG001|Overall Study|Sponsor decision|2|||
164407057|NCT00499863|593860613|FG000|Overall Study|Lost to Follow-up|1|||
164407058|NCT00499863|593860614|FG001|Overall Study|Lost to Follow-up|1|||
164407059|NCT02535364|593860615|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
164407060|NCT02535364|593860615|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
164407061|NCT02535364|593860615|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
164457030|NCT03269136|594043129|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
164457031|NCT03269136|594043130|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
164457032|NCT03269136|594043131|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
164457033|NCT03269136|594043114|FG000|Part 1: Dose Escalation|Adverse Event|0|||
164457034|NCT03269136|594043115|FG001|Part 1: Dose Escalation|Adverse Event|0|||
164598038|NCT03029650|594551316|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
164598039|NCT03029650|594551315|FG000|Washout (1 Week)|Physician Decision|0|||
164407062|NCT02535364|593860615|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
164457035|NCT03269136|594043116|FG002|Part 1: Dose Escalation|Adverse Event|0|||
164457036|NCT03269136|594043117|FG003|Part 1: Dose Escalation|Adverse Event|0|||
164457037|NCT03269136|594043118|FG004|Part 1: Dose Escalation|Adverse Event|0|||
164457038|NCT03269136|594043119|FG005|Part 1: Dose Escalation|Adverse Event|0|||
164457039|NCT03269136|594043120|FG006|Part 1: Dose Escalation|Adverse Event|2|||
164457040|NCT03269136|594043121|FG007|Part 1: Dose Escalation|Adverse Event|0|||
164457041|NCT03269136|594043122|FG008|Part 1: Dose Escalation|Adverse Event|0|||
164457042|NCT03269136|594043123|FG009|Part 1: Dose Escalation|Adverse Event|0|||
164457043|NCT03269136|594043124|FG010|Part 1: Dose Escalation|Adverse Event|1|||
164457044|NCT03269136|594043125|FG011|Part 1: Dose Escalation|Adverse Event|2|||
164457045|NCT03269136|594043126|FG012|Part 1: Dose Escalation|Adverse Event|0|||
164457046|NCT03269136|594043127|FG013|Part 1: Dose Escalation|Adverse Event|1|||
164457047|NCT03269136|594043128|FG014|Part 1: Dose Escalation|Adverse Event|0|||
164457048|NCT03269136|594043129|FG015|Part 1: Dose Escalation|Adverse Event|0|||
164707301|NCT03970837|594953570|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
164457049|NCT03269136|594043130|FG016|Part 1: Dose Escalation|Adverse Event|1|||
164457050|NCT03269136|594043131|FG017|Part 1: Dose Escalation|Adverse Event|0|||
164457051|NCT03269136|594043114|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
164457052|NCT03269136|594043115|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
164457053|NCT03269136|594043116|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
164457054|NCT03269136|594043117|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
164457055|NCT03269136|594043118|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
164457056|NCT03269136|594043119|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
164457057|NCT03269136|594043120|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
164457058|NCT03269136|594043121|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
164457059|NCT03269136|594043122|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
164457060|NCT03269136|594043123|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
164457061|NCT03269136|594043124|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
164457062|NCT03269136|594043125|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
164457063|NCT03269136|594043126|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
164457064|NCT03269136|594043127|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
164457065|NCT03269136|594043128|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
164457066|NCT03269136|594043129|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
164457067|NCT03269136|594043130|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
164457068|NCT03269136|594043131|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
164457069|NCT03269136|594043114|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164457070|NCT03269136|594043115|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164457071|NCT03269136|594043116|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164457072|NCT03269136|594043117|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164457073|NCT03269136|594043118|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164457074|NCT03269136|594043119|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164457075|NCT03269136|594043120|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164457076|NCT03269136|594043121|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164457077|NCT03269136|594043122|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164457078|NCT03269136|594043123|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164457079|NCT03269136|594043124|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164457080|NCT03269136|594043125|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164457081|NCT03269136|594043126|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
164457082|NCT03269136|594043127|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
164457083|NCT03269136|594043128|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
164457084|NCT03269136|594043129|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164457085|NCT03269136|594043130|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
164457086|NCT03269136|594043131|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164457087|NCT03269136|594043114|FG000|Part 2A: Dose Expansion|Other|0|||
164457088|NCT03269136|594043115|FG001|Part 2A: Dose Expansion|Other|0|||
164457089|NCT03269136|594043116|FG002|Part 2A: Dose Expansion|Other|0|||
164457090|NCT03269136|594043117|FG003|Part 2A: Dose Expansion|Other|0|||
164707302|NCT03970837|594953571|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
164707303|NCT03970837|594953560|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
164457091|NCT03269136|594043118|FG004|Part 2A: Dose Expansion|Other|0|||
164457092|NCT03269136|594043119|FG005|Part 2A: Dose Expansion|Other|0|||
164457093|NCT03269136|594043120|FG006|Part 2A: Dose Expansion|Other|0|||
164707304|NCT03970837|594953561|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
164707305|NCT03970837|594953562|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
164707306|NCT03970837|594953563|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
164707307|NCT03970837|594953564|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
164707308|NCT03970837|594953565|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
164707309|NCT03970837|594953566|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
164707310|NCT03970837|594953567|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
164457094|NCT03269136|594043121|FG007|Part 2A: Dose Expansion|Other|0|||
164457095|NCT03269136|594043122|FG008|Part 2A: Dose Expansion|Other|0|||
164457096|NCT03269136|594043123|FG009|Part 2A: Dose Expansion|Other|0|||
164457097|NCT03269136|594043124|FG010|Part 2A: Dose Expansion|Other|0|||
164707311|NCT03970837|594953568|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
164707312|NCT03970837|594953569|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
164457098|NCT03269136|594043125|FG011|Part 2A: Dose Expansion|Other|0|||
164457099|NCT03269136|594043126|FG012|Part 2A: Dose Expansion|Other|0|||
164707313|NCT03970837|594953570|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
164707314|NCT03970837|594953571|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
164707315|NCT02132754|594953572|FG000|Overall Study|Adverse Event|0|||
164707316|NCT02132754|594953573|FG001|Overall Study|Adverse Event|0|||
164707317|NCT02132754|594953574|FG002|Overall Study|Adverse Event|0|||
164707318|NCT02132754|594953575|FG003|Overall Study|Adverse Event|0|||
164707319|NCT02132754|594953576|FG004|Overall Study|Adverse Event|0|||
164707320|NCT02132754|594953577|FG005|Overall Study|Adverse Event|0|||
164707321|NCT02132754|594953578|FG006|Overall Study|Adverse Event|0|||
164707322|NCT02132754|594953579|FG007|Overall Study|Adverse Event|0|||
164707323|NCT02132754|594953580|FG008|Overall Study|Adverse Event|0|||
164707324|NCT02132754|594953581|FG009|Overall Study|Adverse Event|0|||
164707325|NCT02132754|594953582|FG010|Overall Study|Adverse Event|0|||
164707326|NCT02132754|594953583|FG011|Overall Study|Adverse Event|0|||
164707327|NCT02132754|594953584|FG012|Overall Study|Adverse Event|0|||
164707328|NCT02132754|594953585|FG013|Overall Study|Adverse Event|0|||
164707329|NCT02132754|594953586|FG014|Overall Study|Adverse Event|0|||
164707330|NCT02132754|594953587|FG015|Overall Study|Adverse Event|0|||
164707331|NCT02132754|594953588|FG016|Overall Study|Adverse Event|0|||
164707332|NCT02132754|594953589|FG017|Overall Study|Adverse Event|1|||
164707333|NCT02132754|594953590|FG018|Overall Study|Adverse Event|0|||
164707334|NCT02132754|594953591|FG019|Overall Study|Adverse Event|0|||
164457100|NCT03269136|594043127|FG013|Part 2A: Dose Expansion|Other|0|||
164457101|NCT03269136|594043128|FG014|Part 2A: Dose Expansion|Other|0|||
164457102|NCT03269136|594043129|FG015|Part 2A: Dose Expansion|Other|0|||
164457103|NCT03269136|594043130|FG016|Part 2A: Dose Expansion|Other|0|||
164457104|NCT03269136|594043131|FG017|Part 2A: Dose Expansion|Other|1|||
164457105|NCT03269136|594043114|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
164457106|NCT03269136|594043115|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
164457107|NCT03269136|594043116|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
164457108|NCT03269136|594043117|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
164457109|NCT03269136|594043118|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
164457110|NCT03269136|594043119|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
164457111|NCT03269136|594043120|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
164457112|NCT03269136|594043121|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
164457113|NCT03269136|594043122|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
164457114|NCT03269136|594043123|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
164457115|NCT03269136|594043124|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
164457116|NCT03269136|594043125|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
164457117|NCT03269136|594043126|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
164457118|NCT03269136|594043127|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
164457119|NCT03269136|594043128|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
164457120|NCT03269136|594043129|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
164457121|NCT03269136|594043130|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
164457122|NCT03269136|594043131|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
164457123|NCT03269136|594043114|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
164457124|NCT03269136|594043115|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
164457125|NCT03269136|594043116|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
164457126|NCT03269136|594043117|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
164457127|NCT03269136|594043118|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
164457128|NCT03269136|594043119|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
164457129|NCT03269136|594043120|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
164457130|NCT03269136|594043121|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
164457131|NCT03269136|594043122|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
164457132|NCT03269136|594043123|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
164457133|NCT03269136|594043124|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
164457134|NCT03269136|594043125|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
164457135|NCT03269136|594043126|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
164457136|NCT03269136|594043127|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
164598040|NCT03029650|594551316|FG001|Washout (1 Week)|Physician Decision|1|||
164598041|NCT02065869|594551318|FG000|Overall Study|Death|7|||
164598042|NCT02065869|594551318|FG000|Overall Study|Disease relapse|16|||
164598043|NCT02065869|594551318|FG000|Overall Study|Lost to Follow-up|4|||
164598044|NCT02065869|594551318|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
164598045|NCT02065869|594551318|FG000|Overall Study|Withdrawal by Subject|1|||
164598046|NCT01842620|594551319|FG000|Period 1|Withdrawal by Subject|1|||
164598047|NCT01842620|594551320|FG001|Period 1|Withdrawal by Subject|0|||
164598048|NCT01814800|594551323|FG000|Overall Study|Adverse Event|2|||
164598049|NCT01814800|594551323|FG000|Overall Study|Pregnancy|1|||
164598050|NCT01814800|594551323|FG000|Overall Study|Sponsor decision|1|||
164598051|NCT01814800|594551323|FG000|Overall Study|Subject relocation|1|||
164707335|NCT02132754|594953592|FG020|Overall Study|Adverse Event|0|||
164707336|NCT02132754|594953593|FG021|Overall Study|Adverse Event|0|||
164707337|NCT02132754|594953594|FG022|Overall Study|Adverse Event|0|||
164707338|NCT02132754|594953595|FG023|Overall Study|Adverse Event|0|||
164707339|NCT02132754|594953596|FG024|Overall Study|Adverse Event|0|||
164707340|NCT02132754|594953597|FG025|Overall Study|Adverse Event|1|||
164707341|NCT02132754|594953598|FG026|Overall Study|Adverse Event|1|||
164707342|NCT02132754|594953599|FG027|Overall Study|Adverse Event|0|||
164707343|NCT02132754|594953600|FG028|Overall Study|Adverse Event|0|||
164707344|NCT02132754|594953601|FG029|Overall Study|Adverse Event|0|||
164707345|NCT02132754|594953602|FG030|Overall Study|Adverse Event|1|||
164707346|NCT02132754|594953603|FG031|Overall Study|Adverse Event|0|||
164707347|NCT02132754|594953604|FG032|Overall Study|Adverse Event|1|||
164707348|NCT02132754|594953605|FG033|Overall Study|Adverse Event|1|||
164407063|NCT02535364|593860615|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
164407064|NCT02535364|593860615|FG000|Part B Screening|Death|2|||
164407065|NCT02535364|593860615|FG000|Part B Screening|Physician Decision|1|||
164407066|NCT02535364|593860615|FG000|Part B Screening|Withdrawal by Subject|1|||
164407067|NCT02535364|593860615|FG000|Part B Screening|Adverse Event|1|||
164407068|NCT02535364|593860615|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
164407069|NCT02535364|593860615|FG000|Study Treatment|Death|1|||
164407070|NCT02535364|593860615|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
164407071|NCT02535364|593860615|FG000|12-Month Follow-up Period|Disease progression|22|||
164407072|NCT02535364|593860615|FG000|12-Month Follow-up Period|Death|5|||
164407073|NCT02535364|593860615|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
164407074|NCT02535364|593860615|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
164407075|NCT02535364|593860615|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
164407076|NCT00571701|593860616|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
164407077|NCT00571701|593860617|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
164407078|NCT00571701|593860616|FG000|First Intervention 12 Months|Death|1|||
164407079|NCT00571701|593860617|FG001|First Intervention 12 Months|Death|0|||
164407080|NCT00571701|593860616|FG000|Second Intervention 12 Months|Adverse Event|0|||
164407081|NCT00571701|593860617|FG001|Second Intervention 12 Months|Adverse Event|1|||
164407082|NCT00571701|593860616|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
164407083|NCT00571701|593860617|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
164407084|NCT00691132|593860618|FG000|Overall Study|Adverse Event|2|||
164407085|NCT00691132|593860619|FG001|Overall Study|Adverse Event|3|||
164407086|NCT00691132|593860618|FG000|Overall Study|Withdrawal by Subject|10|||
164407087|NCT00691132|593860619|FG001|Overall Study|Withdrawal by Subject|10|||
164407088|NCT01959347|593860630|FG000|Overall Study|Protocol Violation|9|||
164407089|NCT01959347|593860631|FG001|Overall Study|Protocol Violation|7|||
164407090|NCT01282801|593860632|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
164407091|NCT01282801|593860633|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
164407092|NCT02889133|593860637|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
164407093|NCT02889133|593860638|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
164407094|NCT02889133|593860637|FG000|Completed Primary Outcome|Manufacturing error|3|||
164407095|NCT02889133|593860638|FG001|Completed Primary Outcome|Manufacturing error|8|||
164407096|NCT02889133|593860637|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
164407097|NCT02889133|593860638|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
164407098|NCT02889133|593860637|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
164407099|NCT02889133|593860638|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
164407100|NCT02889133|593860637|FG000|Completed Primary Outcome|Protocol Violation|1|||
164407101|NCT02889133|593860638|FG001|Completed Primary Outcome|Protocol Violation|0|||
164407102|NCT02889133|593860637|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
164407103|NCT02889133|593860638|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
164407104|NCT02889133|593860637|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
164407105|NCT02889133|593860638|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
164407106|NCT02889133|593860637|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
164407107|NCT02889133|593860638|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
164407108|NCT02889133|593860637|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
164407109|NCT02889133|593860638|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
164407110|NCT02889133|593860637|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
164407111|NCT02889133|593860638|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
164407112|NCT01060553|593860639|FG000|Overall Study|Lost to Follow-up|3|||
164407113|NCT01060553|593860640|FG001|Overall Study|Lost to Follow-up|5|||
164407114|NCT01060553|593860639|FG000|Overall Study|Withdrawal by Subject|5|||
164407115|NCT01060553|593860640|FG001|Overall Study|Withdrawal by Subject|5|||
164407116|NCT01060553|593860639|FG000|Overall Study|Lack of Efficacy|1|||
164407117|NCT01060553|593860640|FG001|Overall Study|Lack of Efficacy|0|||
164407118|NCT01446796|593860641|FG000|Overall Study|Withdrawal by Subject|1|||
164407119|NCT01446796|593860642|FG001|Overall Study|Withdrawal by Subject|0|||
164407120|NCT00954733|593860647|FG000|Overall Study|blood gas machine did not work|1|||
164407121|NCT03131960|593860648|FG000|Overall Study|Adverse Event|0|||
164707349|NCT02132754|594953572|FG000|Overall Study|Clinical Progression|0|||
164707350|NCT02132754|594953573|FG001|Overall Study|Clinical Progression|0|||
164707351|NCT02132754|594953574|FG002|Overall Study|Clinical Progression|0|||
164457137|NCT03269136|594043128|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
164457138|NCT03269136|594043129|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
164457139|NCT03269136|594043130|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
164457140|NCT03269136|594043131|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
164457141|NCT03269136|594043114|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
164457142|NCT03269136|594043115|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
164457143|NCT03269136|594043116|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
164457144|NCT03269136|594043117|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
164457145|NCT03269136|594043118|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
164457146|NCT03269136|594043119|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
164457147|NCT03269136|594043120|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
164457148|NCT03269136|594043121|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
164457149|NCT03269136|594043122|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
164457150|NCT03269136|594043123|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
164457151|NCT03269136|594043124|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
164457152|NCT03269136|594043125|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
164457153|NCT03269136|594043126|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
164457154|NCT03269136|594043127|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
164457155|NCT03269136|594043128|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
164457156|NCT03269136|594043129|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
164457157|NCT03269136|594043130|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
164457158|NCT03269136|594043131|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
164457159|NCT03269136|594043114|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
164457160|NCT03269136|594043115|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
164457161|NCT03269136|594043116|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
164457162|NCT03269136|594043117|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
164457163|NCT03269136|594043118|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
164457164|NCT03269136|594043119|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
164457165|NCT03269136|594043120|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
164457166|NCT03269136|594043121|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
164457167|NCT03269136|594043122|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
164457168|NCT03269136|594043123|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
164457169|NCT03269136|594043124|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
164457170|NCT03269136|594043125|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
164457171|NCT03269136|594043126|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
164457172|NCT03269136|594043127|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
164457173|NCT03269136|594043128|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
164457174|NCT03269136|594043129|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
164457175|NCT03269136|594043130|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
164457176|NCT03269136|594043131|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
164457177|NCT04952909|594043134|FG000|Overall Study|Death|3|||
164457178|NCT05308004|594043135|FG000|Overall Study|Not seen by Palliative Care NP|0|||
164457179|NCT05308004|594043136|FG001|Overall Study|Not seen by Palliative Care NP|1|||
164457180|NCT04552223|594043143|FG000|Overall Study|Withdrawal by Subject|1|||
164457181|NCT04856163|594043144|FG000|Overall Study|Lost to Follow-up|97|||
164457182|NCT04856163|594043145|FG001|Overall Study|Lost to Follow-up|100|||
164457183|NCT00881621|594043147|FG000|Overall Study|Physician Decision|34|||
164457184|NCT02515773|594043149|FG000|Overall Study|Withdrawal by Subject|12|||
164457185|NCT02515773|594043150|FG001|Overall Study|Withdrawal by Subject|2|||
164457186|NCT02515773|594043149|FG000|Overall Study|Lost to Follow-up|119|||
164457187|NCT02515773|594043150|FG001|Overall Study|Lost to Follow-up|126|||
164457188|NCT02515773|594043149|FG000|Overall Study|Discharged from Clinic Services|53|||
164457189|NCT02515773|594043150|FG001|Overall Study|Discharged from Clinic Services|84|||
164457190|NCT02515773|594043149|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
164457191|NCT02515773|594043150|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
164457192|NCT02515773|594043149|FG000|Overall Study|Follow-up at non-study site|8|||
164457193|NCT02515773|594043150|FG001|Overall Study|Follow-up at non-study site|16|||
164457194|NCT02515773|594043149|FG000|Overall Study|Moved from area|9|||
164457195|NCT02515773|594043150|FG001|Overall Study|Moved from area|14|||
164457196|NCT04176965|594043151|FG000|Overall Study|Death|1|||
164598052|NCT00894413|594551328|FG000|Overall Study|Physician Decision|0|||
164598053|NCT00894413|594551329|FG001|Overall Study|Physician Decision|2|||
164457197|NCT04176965|594043152|FG001|Overall Study|Death|2|||
164457198|NCT04176965|594043151|FG000|Overall Study|Lost to Follow-up|10|||
164457199|NCT04176965|594043152|FG001|Overall Study|Lost to Follow-up|2|||
164457200|NCT04176965|594043151|FG000|Overall Study|Withdrawal by Subject|6|||
164457201|NCT04176965|594043152|FG001|Overall Study|Withdrawal by Subject|1|||
164457202|NCT03903146|594043153|FG000|Overall Study|Lost to Follow-up|6|||
164457203|NCT03903146|594043154|FG001|Overall Study|Lost to Follow-up|4|||
164457204|NCT03903146|594043153|FG000|Overall Study|Withdrawal by Subject|0|||
164457205|NCT03903146|594043154|FG001|Overall Study|Withdrawal by Subject|1|||
164598054|NCT00894413|594551328|FG000|Overall Study|Adverse Event|0|||
164598055|NCT00894413|594551329|FG001|Overall Study|Adverse Event|2|||
164598056|NCT00894413|594551328|FG000|Overall Study|Withdrawal by Subject|0|||
164457206|NCT04072380|594043156|FG000|Overall Study|Adverse Event|4|||
164457207|NCT04072380|594043157|FG001|Overall Study|Adverse Event|6|||
164457208|NCT04072380|594043158|FG002|Overall Study|Adverse Event|0|||
164457209|NCT04072380|594043156|FG000|Overall Study|Withdrawal by Subject|3|||
164457210|NCT04072380|594043157|FG001|Overall Study|Withdrawal by Subject|1|||
164457211|NCT04072380|594043158|FG002|Overall Study|Withdrawal by Subject|1|||
164457212|NCT04072380|594043156|FG000|Overall Study|Physician Decision|2|||
164457213|NCT04072380|594043157|FG001|Overall Study|Physician Decision|0|||
164457214|NCT04072380|594043158|FG002|Overall Study|Physician Decision|0|||
164457215|NCT04072380|594043156|FG000|Overall Study|Protocol Violation|0|||
164457216|NCT04072380|594043157|FG001|Overall Study|Protocol Violation|2|||
164457217|NCT04072380|594043158|FG002|Overall Study|Protocol Violation|3|||
164457218|NCT04072380|594043156|FG000|Overall Study|Intercurrent Illness and Others|3|||
164457219|NCT04072380|594043157|FG001|Overall Study|Intercurrent Illness and Others|5|||
164457220|NCT04072380|594043158|FG002|Overall Study|Intercurrent Illness and Others|6|||
164457221|NCT05816551|594045129|FG000|Overall Study|Withdrawal by Subject|0|||
164457222|NCT05816551|594045130|FG001|Overall Study|Withdrawal by Subject|1|||
164457223|NCT05816551|594045129|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
164457224|NCT05816551|594045130|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
164457225|NCT04353661|594045131|FG000|Overall Study|Protocol Violation|0|||
164457226|NCT04353661|594045132|FG001|Overall Study|Protocol Violation|0|||
164457227|NCT04353661|594045133|FG002|Overall Study|Protocol Violation|1|||
164457228|NCT04353661|594045131|FG000|Overall Study|Study termination by the Sponsor|1|||
164457229|NCT04353661|594045132|FG001|Overall Study|Study termination by the Sponsor|1|||
164457230|NCT04353661|594045133|FG002|Overall Study|Study termination by the Sponsor|1|||
164457231|NCT00920621|594045136|FG000|Overall Study|Lost to Follow-up|16|||
164457232|NCT00920621|594045137|FG001|Overall Study|Lost to Follow-up|17|||
164457233|NCT00920621|594045138|FG002|Overall Study|Lost to Follow-up|19|||
164457234|NCT00920621|594045139|FG003|Overall Study|Lost to Follow-up|21|||
164457235|NCT00920621|594045136|FG000|Overall Study|Fetal/neonatal deaths|16|||
164457236|NCT00920621|594045137|FG001|Overall Study|Fetal/neonatal deaths|14|||
164457237|NCT00920621|594045138|FG002|Overall Study|Fetal/neonatal deaths|16|||
164457238|NCT00920621|594045139|FG003|Overall Study|Fetal/neonatal deaths|14|||
164457239|NCT00920621|594045136|FG000|Overall Study|Blood sample not collected|22|||
164457240|NCT00920621|594045137|FG001|Overall Study|Blood sample not collected|14|||
164457241|NCT00920621|594045138|FG002|Overall Study|Blood sample not collected|0|||
164457242|NCT00920621|594045139|FG003|Overall Study|Blood sample not collected|0|||
164457243|NCT02543281|594045146|FG000|Overall Study|Lost to Follow-up|0|||
164457244|NCT02543281|594045147|FG001|Overall Study|Lost to Follow-up|0|||
164457245|NCT02543281|594045148|FG002|Overall Study|Lost to Follow-up|1|||
164457246|NCT02530671|594045149|FG000|Overall Study|Lost to Follow-up|2|||
164457247|NCT02530671|594045150|FG001|Overall Study|Lost to Follow-up|0|||
164457248|NCT02530671|594045149|FG000|Overall Study|Withdrawal by Subject|1|||
164457249|NCT02530671|594045150|FG001|Overall Study|Withdrawal by Subject|0|||
164457250|NCT05247489|594045151|FG000|Overall Study|Lost to Follow-up|5|||
164457251|NCT05247489|594045152|FG001|Overall Study|Lost to Follow-up|1|||
164457252|NCT05247489|594045151|FG000|Overall Study|Withdrawal by Subject|6|||
164457253|NCT05247489|594045152|FG001|Overall Study|Withdrawal by Subject|7|||
164457254|NCT05247489|594045151|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
164457255|NCT05247489|594045152|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
164457256|NCT05247489|594045151|FG000|Overall Study|Left Country|1|||
164457257|NCT05247489|594045152|FG001|Overall Study|Left Country|0|||
164457258|NCT05247489|594045151|FG000|Overall Study|Noncompliance with Investigational Product|1|||
164457259|NCT05247489|594045152|FG001|Overall Study|Noncompliance with Investigational Product|0|||
164707352|NCT02132754|594953575|FG003|Overall Study|Clinical Progression|0|||
164707353|NCT02132754|594953576|FG004|Overall Study|Clinical Progression|0|||
164707354|NCT02132754|594953577|FG005|Overall Study|Clinical Progression|0|||
164707355|NCT02132754|594953578|FG006|Overall Study|Clinical Progression|0|||
164707356|NCT02132754|594953579|FG007|Overall Study|Clinical Progression|0|||
164707357|NCT02132754|594953580|FG008|Overall Study|Clinical Progression|0|||
164457260|NCT05247489|594045151|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
164707358|NCT02132754|594953581|FG009|Overall Study|Clinical Progression|1|||
164457261|NCT05247489|594045152|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
164457262|NCT03126019|594045153|FG000|Overall Study|Death|5|||
164457263|NCT03126019|594045154|FG001|Overall Study|Death|27|||
164457264|NCT03126019|594045153|FG000|Overall Study|Lost to Follow-up|2|||
164457265|NCT03126019|594045154|FG001|Overall Study|Lost to Follow-up|4|||
164457266|NCT03126019|594045153|FG000|Overall Study|Withdrawal by Subject|1|||
164457267|NCT03126019|594045154|FG001|Overall Study|Withdrawal by Subject|9|||
164457268|NCT03126019|594045153|FG000|Overall Study|Physician Decision|1|||
164457269|NCT03126019|594045154|FG001|Overall Study|Physician Decision|0|||
164457270|NCT03126019|594045153|FG000|Overall Study|Transitioned to Rollover Study|0|||
164457271|NCT03126019|594045154|FG001|Overall Study|Transitioned to Rollover Study|11|||
164707359|NCT02132754|594953582|FG010|Overall Study|Clinical Progression|0|||
164457272|NCT03126019|594045153|FG000|Overall Study|Did Not Return to Site for Care|0|||
164457273|NCT03126019|594045154|FG001|Overall Study|Did Not Return to Site for Care|1|||
164457274|NCT03126019|594045153|FG000|Overall Study|Site Closed|0|||
164457275|NCT03126019|594045154|FG001|Overall Study|Site Closed|1|||
164457276|NCT03763708|594045157|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
164457277|NCT03763708|594045158|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
164457278|NCT03763708|594045159|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
164457279|NCT03763708|594045160|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
164457280|NCT03763708|594045161|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
164457281|NCT03763708|594045162|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
164457282|NCT03763708|594045163|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
164457283|NCT03763708|594045164|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
164457284|NCT03763708|594045165|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
164457285|NCT03763708|594045157|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
164457286|NCT03763708|594045158|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
164457287|NCT03763708|594045159|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
164457288|NCT03763708|594045160|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
164457289|NCT03763708|594045161|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
164457290|NCT03763708|594045162|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
164457291|NCT03763708|594045163|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
164457292|NCT03763708|594045164|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
164457293|NCT03763708|594045165|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
164457294|NCT03763708|594045157|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
164457295|NCT03763708|594045158|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
164457296|NCT03763708|594045159|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
164457297|NCT03763708|594045160|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
164457298|NCT03763708|594045161|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
164457299|NCT03763708|594045162|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
164457300|NCT03763708|594045163|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
164457301|NCT03763708|594045164|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
164457302|NCT03763708|594045165|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
164457303|NCT03763708|594045157|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
164457304|NCT03763708|594045158|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
164457305|NCT03763708|594045159|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
164457306|NCT03763708|594045160|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
164457307|NCT03763708|594045161|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
164457308|NCT03763708|594045162|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
164457309|NCT03763708|594045163|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
164457310|NCT03763708|594045164|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
164457311|NCT03763708|594045165|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
164457312|NCT03763708|594045157|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
164457313|NCT03763708|594045158|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
164457314|NCT03763708|594045159|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
164457315|NCT03763708|594045160|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
164457316|NCT03763708|594045161|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
164457317|NCT03763708|594045162|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
164457318|NCT03763708|594045163|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
164457319|NCT03763708|594045164|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
164457320|NCT03763708|594045165|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
164457321|NCT03763708|594045157|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
164457322|NCT03763708|594045158|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
164457323|NCT03763708|594045159|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
164457324|NCT03763708|594045160|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
164457325|NCT03763708|594045161|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
164457326|NCT03763708|594045162|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
164457327|NCT03763708|594045163|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
164457328|NCT03763708|594045164|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
164457329|NCT03763708|594045165|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
164457330|NCT03763708|594045157|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
164457331|NCT03763708|594045158|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
164457332|NCT03763708|594045159|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
164457333|NCT03763708|594045160|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
164457334|NCT03763708|594045161|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
164457335|NCT03763708|594045162|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
164457336|NCT03763708|594045163|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
164457337|NCT03763708|594045164|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
164457338|NCT03763708|594045165|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
164457339|NCT03763708|594045157|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
164457340|NCT03763708|594045158|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
164457341|NCT03763708|594045159|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
164457342|NCT03763708|594045160|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
164457343|NCT03763708|594045161|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
164457344|NCT03763708|594045162|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
164457345|NCT03763708|594045163|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
164457346|NCT03763708|594045164|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
164457347|NCT03763708|594045165|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
164457348|NCT03763708|594045157|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
164457349|NCT03763708|594045158|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
164457350|NCT03763708|594045159|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
164457351|NCT03763708|594045160|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
164457352|NCT03763708|594045161|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
164457353|NCT03763708|594045162|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
164457354|NCT03763708|594045163|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
164457355|NCT03763708|594045164|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
164457356|NCT03763708|594045165|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
164457357|NCT05215314|594045166|FG000|Overall Study|Lost to Follow-up|2|||
164457358|NCT05215314|594045167|FG001|Overall Study|Lost to Follow-up|2|||
164457359|NCT05215314|594045166|FG000|Overall Study|Withdrawal by Subject|2|||
164457360|NCT05215314|594045167|FG001|Overall Study|Withdrawal by Subject|0|||
164457361|NCT05215314|594045166|FG000|Overall Study|Physician Decision|1|||
164457362|NCT05215314|594045167|FG001|Overall Study|Physician Decision|0|||
164457363|NCT04179500|594045168|FG000|Treatment|Withdrawal by Subject|1|||
164457364|NCT04179500|594045168|FG000|Treatment|Adverse Event|2|||
164457365|NCT04179500|594045168|FG000|Treatment|pyrazinamide resistance|1|||
164457366|NCT03792555|594045181|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
164457367|NCT03792555|594045182|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
164457368|NCT03792555|594045183|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
164457369|NCT03792555|594045181|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
164457370|NCT03792555|594045182|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
164457371|NCT03792555|594045183|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
164457372|NCT03792555|594045181|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
164457373|NCT03792555|594045182|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
164457374|NCT03792555|594045183|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
164457375|NCT04485039|594045187|FG000|TPOXX Only|Adverse Event|2|||
164457376|NCT04485039|594045187|FG000|TPOXX Only|Physician Decision|1|||
164457377|NCT04485039|594045187|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
164457378|NCT04485039|594045187|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
164457379|NCT04005716|594045191|FG000|Overall Study|Death|175|||
164457380|NCT04005716|594045192|FG001|Overall Study|Death|196|||
164457381|NCT04005716|594045191|FG000|Overall Study|Withdrawal by Subject|1|||
164457382|NCT04005716|594045192|FG001|Overall Study|Withdrawal by Subject|6|||
164457383|NCT04005716|594045191|FG000|Overall Study|Lost to Follow-up|2|||
164457384|NCT04005716|594045192|FG001|Overall Study|Lost to Follow-up|2|||
164457385|NCT03535272|594045193|FG000|Overall Study|Lost to Follow-up|71|||
164457386|NCT03535272|594045194|FG001|Overall Study|Lost to Follow-up|73|||
164457387|NCT01744782|594045195|FG000|Overall Study|Death|1|||
164457388|NCT04347161|594045198|FG000|Overall Study|Death|0|||
164457389|NCT04347161|594045199|FG001|Overall Study|Death|2|||
164457390|NCT04347161|594045198|FG000|Overall Study|Withdrawal by Subject|1|||
164457391|NCT04347161|594045199|FG001|Overall Study|Withdrawal by Subject|0|||
164457392|NCT04347161|594045198|FG000|Overall Study|Lost to Follow-up|0|||
164457393|NCT04347161|594045199|FG001|Overall Study|Lost to Follow-up|1|||
164457394|NCT04347161|594045198|FG000|Overall Study|No longer on study medication|1|||
164457395|NCT04347161|594045199|FG001|Overall Study|No longer on study medication|1|||
164457396|NCT03675282|594045205|FG000|Overall Study|Lost to Follow-up|4|||
164457397|NCT03675282|594045206|FG001|Overall Study|Lost to Follow-up|8|||
164457398|NCT03675282|594045207|FG002|Overall Study|Lost to Follow-up|1|||
164457399|NCT03675282|594045208|FG003|Overall Study|Lost to Follow-up|0|||
164707360|NCT02132754|594953583|FG011|Overall Study|Clinical Progression|0|||
164707361|NCT02132754|594953584|FG012|Overall Study|Clinical Progression|0|||
164707362|NCT02132754|594953585|FG013|Overall Study|Clinical Progression|0|||
164707363|NCT02132754|594953586|FG014|Overall Study|Clinical Progression|0|||
164707364|NCT02132754|594953587|FG015|Overall Study|Clinical Progression|0|||
164457400|NCT03675282|594045209|FG004|Overall Study|Lost to Follow-up|2|||
164457401|NCT03675282|594045210|FG005|Overall Study|Lost to Follow-up|7|||
164457402|NCT03675282|594045205|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
164457403|NCT03675282|594045206|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
164457404|NCT03675282|594045207|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
164457405|NCT03675282|594045208|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
164457406|NCT03675282|594045209|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
164457407|NCT03675282|594045210|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
164457408|NCT03675282|594045205|FG000|Overall Study|Physician Decision|1|||
164457409|NCT03675282|594045206|FG001|Overall Study|Physician Decision|0|||
164457410|NCT03675282|594045207|FG002|Overall Study|Physician Decision|0|||
164707365|NCT02132754|594953588|FG016|Overall Study|Clinical Progression|1|||
164457411|NCT03675282|594045208|FG003|Overall Study|Physician Decision|0|||
164457412|NCT03675282|594045209|FG004|Overall Study|Physician Decision|0|||
164457413|NCT03675282|594045210|FG005|Overall Study|Physician Decision|0|||
164457414|NCT03232138|594045212|FG000|Overall Study|Physician Decision|1|||
164457415|NCT03232138|594045213|FG001|Overall Study|Physician Decision|0|||
164457416|NCT03232138|594045212|FG000|Overall Study|Adverse Event|2|||
164457417|NCT03232138|594045213|FG001|Overall Study|Adverse Event|0|||
164457418|NCT03232138|594045212|FG000|Overall Study|Withdrawal by Subject|1|||
164457419|NCT03232138|594045213|FG001|Overall Study|Withdrawal by Subject|2|||
164457420|NCT04142788|594045214|FG000|Overall Study|Trial terminated prematurely|2|||
164457421|NCT04142788|594045215|FG001|Overall Study|Trial terminated prematurely|2|||
164457422|NCT02035787|594045217|FG000|Overall Study- 12 Months|Adverse Event|3|||
164457423|NCT02035787|594045218|FG001|Overall Study- 12 Months|Adverse Event|0|||
164457424|NCT02035787|594045217|FG000|Overall Study- 12 Months|Complete response|4|||
164457425|NCT02035787|594045218|FG001|Overall Study- 12 Months|Complete response|1|||
164457426|NCT02035787|594045217|FG000|Overall Study- 12 Months|Protocol Violation|1|||
164457427|NCT02035787|594045218|FG001|Overall Study- 12 Months|Protocol Violation|1|||
164457428|NCT03853746|594045219|FG000|Overall Study|Withdrawal by Subject|1|||
164457429|NCT05028634|594045222|FG000|Overall Study|Withdrawal by Subject|0|||
164457430|NCT05028634|594045223|FG001|Overall Study|Withdrawal by Subject|1|||
164457431|NCT05076708|594045234|FG000|Overall Study|Withdrawal by Subject|4|||
164457432|NCT05076708|594045234|FG000|Overall Study|Lost to study during switch phase|8|||
164457433|NCT05590403|594045237|FG000|Overall Study|Lost to Follow-up|13|||
164457434|NCT05590403|594045238|FG001|Overall Study|Lost to Follow-up|1|||
164457435|NCT05590403|594045239|FG002|Overall Study|Lost to Follow-up|7|||
164457436|NCT05590403|594045240|FG003|Overall Study|Lost to Follow-up|3|||
164457437|NCT05590403|594045241|FG004|Overall Study|Lost to Follow-up|4|||
164457438|NCT05590403|594045237|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
164457439|NCT05590403|594045238|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
164457440|NCT05590403|594045239|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
164457441|NCT05590403|594045240|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
164457442|NCT05590403|594045241|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
164457443|NCT05590403|594045237|FG000|Overall Study|Other|2|||
164457444|NCT05590403|594045238|FG001|Overall Study|Other|0|||
164457445|NCT05590403|594045239|FG002|Overall Study|Other|2|||
164457446|NCT05590403|594045240|FG003|Overall Study|Other|2|||
164457447|NCT05590403|594045241|FG004|Overall Study|Other|0|||
164457448|NCT05590403|594045237|FG000|Overall Study|Migrated / moved from the study area|1|||
164457449|NCT05590403|594045238|FG001|Overall Study|Migrated / moved from the study area|1|||
164457450|NCT05590403|594045239|FG002|Overall Study|Migrated / moved from the study area|0|||
164457451|NCT05590403|594045240|FG003|Overall Study|Migrated / moved from the study area|3|||
164457452|NCT05590403|594045241|FG004|Overall Study|Migrated / moved from the study area|1|||
164457453|NCT05590403|594045237|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
164457454|NCT05590403|594045238|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
164457455|NCT05590403|594045239|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
164457456|NCT05590403|594045240|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
164457457|NCT05590403|594045241|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
164457458|NCT04717492|594045244|FG000|Overall Study|Withdrawal by Subject|2|||
164457459|NCT04717492|594045245|FG001|Overall Study|Withdrawal by Subject|13|||
164457460|NCT04717492|594045244|FG000|Overall Study|Lost to Follow-up|2|||
164457461|NCT04717492|594045245|FG001|Overall Study|Lost to Follow-up|9|||
164457462|NCT03766009|594045246|FG000|Usual Care|Death|0|||
164457463|NCT03766009|594045247|FG001|Usual Care|Death|0|||
164457464|NCT03766009|594045248|FG002|Usual Care|Death|0|||
164457465|NCT03766009|594045249|FG003|Usual Care|Death|1|||
164457466|NCT03766009|594045250|FG004|Usual Care|Death|0|||
164457467|NCT03766009|594045251|FG005|Usual Care|Death|0|||
164457468|NCT03766009|594045246|FG000|Usual Care|Lost to Follow-up|0|||
164457469|NCT03766009|594045247|FG001|Usual Care|Lost to Follow-up|0|||
164457470|NCT03766009|594045248|FG002|Usual Care|Lost to Follow-up|0|||
164457471|NCT03766009|594045249|FG003|Usual Care|Lost to Follow-up|1|||
164457472|NCT03766009|594045250|FG004|Usual Care|Lost to Follow-up|0|||
164457473|NCT03766009|594045251|FG005|Usual Care|Lost to Follow-up|0|||
164457474|NCT03766009|594045246|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
164457475|NCT03766009|594045247|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
164457476|NCT03766009|594045248|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
164457477|NCT03766009|594045249|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
164457478|NCT03766009|594045250|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
164457479|NCT03766009|594045251|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
164457480|NCT03766009|594045246|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
164457481|NCT03766009|594045247|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
164457482|NCT03766009|594045248|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
164457483|NCT03766009|594045249|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
164707366|NCT02132754|594953589|FG017|Overall Study|Clinical Progression|1|||
164707367|NCT02132754|594953590|FG018|Overall Study|Clinical Progression|0|||
164707368|NCT02132754|594953591|FG019|Overall Study|Clinical Progression|1|||
164707369|NCT02132754|594953592|FG020|Overall Study|Clinical Progression|0|||
164457484|NCT03766009|594045250|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
164457485|NCT03766009|594045251|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
164457486|NCT03766009|594045246|FG000|Usual Care|No treatment or declined surgery|0|||
164707370|NCT02132754|594953593|FG021|Overall Study|Clinical Progression|0|||
164707371|NCT02132754|594953594|FG022|Overall Study|Clinical Progression|1|||
164707372|NCT02132754|594953595|FG023|Overall Study|Clinical Progression|0|||
164707373|NCT02132754|594953596|FG024|Overall Study|Clinical Progression|1|||
164707374|NCT02132754|594953597|FG025|Overall Study|Clinical Progression|1|||
164707375|NCT02132754|594953598|FG026|Overall Study|Clinical Progression|0|||
164707376|NCT02132754|594953599|FG027|Overall Study|Clinical Progression|1|||
164707377|NCT02132754|594953600|FG028|Overall Study|Clinical Progression|1|||
164707378|NCT02132754|594953601|FG029|Overall Study|Clinical Progression|0|||
164707379|NCT02132754|594953602|FG030|Overall Study|Clinical Progression|1|||
164707380|NCT02132754|594953603|FG031|Overall Study|Clinical Progression|0|||
164707381|NCT02132754|594953604|FG032|Overall Study|Clinical Progression|0|||
164707382|NCT02132754|594953605|FG033|Overall Study|Clinical Progression|2|||
164707383|NCT02132754|594953572|FG000|Overall Study|Death|0|||
164707384|NCT02132754|594953573|FG001|Overall Study|Death|0|||
164707385|NCT02132754|594953574|FG002|Overall Study|Death|0|||
164707386|NCT02132754|594953575|FG003|Overall Study|Death|0|||
164707387|NCT02132754|594953576|FG004|Overall Study|Death|0|||
164707388|NCT02132754|594953577|FG005|Overall Study|Death|0|||
164707389|NCT02132754|594953578|FG006|Overall Study|Death|0|||
164707390|NCT02132754|594953579|FG007|Overall Study|Death|0|||
164707391|NCT02132754|594953580|FG008|Overall Study|Death|0|||
164707392|NCT02132754|594953581|FG009|Overall Study|Death|0|||
164707393|NCT02132754|594953582|FG010|Overall Study|Death|0|||
164707394|NCT02132754|594953583|FG011|Overall Study|Death|0|||
164707395|NCT02132754|594953584|FG012|Overall Study|Death|0|||
164707396|NCT02132754|594953585|FG013|Overall Study|Death|0|||
164707397|NCT02132754|594953586|FG014|Overall Study|Death|0|||
164707398|NCT02132754|594953587|FG015|Overall Study|Death|1|||
164707399|NCT02132754|594953588|FG016|Overall Study|Death|0|||
164707400|NCT02132754|594953589|FG017|Overall Study|Death|0|||
164707401|NCT02132754|594953590|FG018|Overall Study|Death|0|||
164707402|NCT02132754|594953591|FG019|Overall Study|Death|1|||
164707403|NCT02132754|594953592|FG020|Overall Study|Death|0|||
164707404|NCT02132754|594953593|FG021|Overall Study|Death|1|||
164707405|NCT02132754|594953594|FG022|Overall Study|Death|0|||
164707406|NCT02132754|594953595|FG023|Overall Study|Death|0|||
164407122|NCT03131960|593860649|FG001|Overall Study|Adverse Event|1|||
164407123|NCT01781390|593860650|FG000|Overall Study|Withdrawal of Consent|0|||
164407124|NCT01781390|593860651|FG001|Overall Study|Withdrawal of Consent|3|||
164407125|NCT01781390|593860652|FG002|Overall Study|Withdrawal of Consent|1|||
164407126|NCT01781390|593860650|FG000|Overall Study|Lost to Follow-up|1|||
164407127|NCT01781390|593860651|FG001|Overall Study|Lost to Follow-up|1|||
164407128|NCT01781390|593860652|FG002|Overall Study|Lost to Follow-up|1|||
164407129|NCT01781390|593860650|FG000|Overall Study|Adverse Event|1|||
164407130|NCT01781390|593860651|FG001|Overall Study|Adverse Event|2|||
164407131|NCT01781390|593860652|FG002|Overall Study|Adverse Event|1|||
164407132|NCT01781390|593860650|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
164407133|NCT01781390|593860651|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
164407134|NCT01781390|593860652|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
164407135|NCT04707196|593860653|FG000|Overall Study|Withdrawal by Subject|9|||
164407136|NCT04707196|593860654|FG001|Overall Study|Withdrawal by Subject|6|||
164407137|NCT04707196|593860653|FG000|Overall Study|Lost to Follow-up|1|||
164407138|NCT04707196|593860654|FG001|Overall Study|Lost to Follow-up|0|||
164407139|NCT04707196|593860653|FG000|Overall Study|Protocol Violation|4|||
164407140|NCT04707196|593860654|FG001|Overall Study|Protocol Violation|1|||
164407141|NCT04707196|593860653|FG000|Overall Study|Adverse Event|2|||
164457487|NCT03766009|594045247|FG001|Usual Care|No treatment or declined surgery|0|||
164457488|NCT03766009|594045248|FG002|Usual Care|No treatment or declined surgery|0|||
164707407|NCT02132754|594953596|FG024|Overall Study|Death|0|||
164707408|NCT02132754|594953597|FG025|Overall Study|Death|0|||
164707409|NCT02132754|594953598|FG026|Overall Study|Death|1|||
164707410|NCT02132754|594953599|FG027|Overall Study|Death|0|||
164707411|NCT02132754|594953600|FG028|Overall Study|Death|0|||
164707412|NCT02132754|594953601|FG029|Overall Study|Death|0|||
164707413|NCT02132754|594953602|FG030|Overall Study|Death|0|||
164707414|NCT02132754|594953603|FG031|Overall Study|Death|0|||
164707415|NCT02132754|594953604|FG032|Overall Study|Death|0|||
164707416|NCT02132754|594953605|FG033|Overall Study|Death|2|||
164407142|NCT04707196|593860654|FG001|Overall Study|Adverse Event|2|||
164407143|NCT04707196|593860653|FG000|Overall Study|Death|3|||
164407144|NCT04707196|593860654|FG001|Overall Study|Death|1|||
164707417|NCT02132754|594953572|FG000|Overall Study|Excluded Medication|0|||
164707418|NCT02132754|594953573|FG001|Overall Study|Excluded Medication|0|||
164707419|NCT02132754|594953574|FG002|Overall Study|Excluded Medication|0|||
164707420|NCT02132754|594953575|FG003|Overall Study|Excluded Medication|0|||
164457489|NCT03766009|594045249|FG003|Usual Care|No treatment or declined surgery|2|||
164457490|NCT03766009|594045250|FG004|Usual Care|No treatment or declined surgery|0|||
164457491|NCT03766009|594045251|FG005|Usual Care|No treatment or declined surgery|0|||
164457492|NCT03766009|594045246|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
164457493|NCT03766009|594045247|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
164457494|NCT03766009|594045248|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
164457495|NCT03766009|594045249|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
164457496|NCT03766009|594045250|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
164457497|NCT03766009|594045251|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
164457498|NCT03766009|594045246|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
164457499|NCT03766009|594045247|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
164457500|NCT03766009|594045248|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
164457501|NCT03766009|594045249|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
164457502|NCT03766009|594045250|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
164457503|NCT03766009|594045251|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
164457504|NCT03766009|594045246|FG000|Usual Care|Ineligible|0|||
164457505|NCT03766009|594045247|FG001|Usual Care|Ineligible|1|||
164457506|NCT03766009|594045248|FG002|Usual Care|Ineligible|0|||
164457507|NCT03766009|594045249|FG003|Usual Care|Ineligible|0|||
164457508|NCT03766009|594045250|FG004|Usual Care|Ineligible|0|||
164457509|NCT03766009|594045251|FG005|Usual Care|Ineligible|0|||
164457510|NCT03766009|594045246|FG000|Usual Care|Other: Staff turnover|0|||
164457511|NCT03766009|594045247|FG001|Usual Care|Other: Staff turnover|0|||
164457512|NCT03766009|594045248|FG002|Usual Care|Other: Staff turnover|0|||
164457513|NCT03766009|594045249|FG003|Usual Care|Other: Staff turnover|0|||
164457514|NCT03766009|594045250|FG004|Usual Care|Other: Staff turnover|0|||
164457515|NCT03766009|594045251|FG005|Usual Care|Other: Staff turnover|2|||
164457516|NCT05071807|594045252|FG000|Overall Study|Withdrawal by Subject|4|||
164457517|NCT05071807|594045253|FG001|Overall Study|Withdrawal by Subject|0|||
164457518|NCT05071807|594045252|FG000|Overall Study|Unrelated medical issues|3|||
164457519|NCT05071807|594045253|FG001|Overall Study|Unrelated medical issues|0|||
164457520|NCT05071807|594045252|FG000|Overall Study|Relocated|0|||
164457521|NCT05071807|594045253|FG001|Overall Study|Relocated|1|||
164457522|NCT04359108|594045255|FG000|Overall Study|Withdrawal by Subject|1|||
164457523|NCT04359108|594045256|FG001|Overall Study|Withdrawal by Subject|0|||
164457524|NCT04359108|594045255|FG000|Overall Study|Unable or too feeble to walk independently|0|||
164457525|NCT04359108|594045256|FG001|Overall Study|Unable or too feeble to walk independently|2|||
164457526|NCT04359108|594045255|FG000|Overall Study|Argus II system stopped functioning|0|||
164457527|NCT04359108|594045256|FG001|Overall Study|Argus II system stopped functioning|1|||
164457528|NCT04359108|594045255|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
164457529|NCT04359108|594045256|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
164457530|NCT06393088|594045257|FG000|Overall Study|Withdrawal by Subject|0|||
164457531|NCT06393088|594045258|FG001|Overall Study|Withdrawal by Subject|2|||
164457532|NCT03197662|594045263|FG000|Overall Study|Withdrawn by family|0|||
164457533|NCT03197662|594045264|FG001|Overall Study|Withdrawn by family|2|||
164457534|NCT03721952|594045265|FG000|Overall Study|Lost to Follow-up|0|||
164457535|NCT03721952|594045266|FG001|Overall Study|Lost to Follow-up|0|||
164457536|NCT03721952|594045267|FG002|Overall Study|Lost to Follow-up|2|||
164457537|NCT03721952|594045268|FG003|Overall Study|Lost to Follow-up|0|||
164457538|NCT03721952|594045269|FG004|Overall Study|Lost to Follow-up|0|||
164707421|NCT02132754|594953576|FG004|Overall Study|Excluded Medication|0|||
164707422|NCT02132754|594953577|FG005|Overall Study|Excluded Medication|0|||
164457539|NCT03721952|594045265|FG000|Overall Study|Protocol Violation|0|||
164457540|NCT03721952|594045266|FG001|Overall Study|Protocol Violation|1|||
164457541|NCT03721952|594045267|FG002|Overall Study|Protocol Violation|0|||
164707423|NCT02132754|594953578|FG006|Overall Study|Excluded Medication|0|||
164707424|NCT02132754|594953579|FG007|Overall Study|Excluded Medication|0|||
164707425|NCT02132754|594953580|FG008|Overall Study|Excluded Medication|0|||
164457542|NCT03721952|594045268|FG003|Overall Study|Protocol Violation|0|||
164457543|NCT03721952|594045269|FG004|Overall Study|Protocol Violation|0|||
164457544|NCT03721952|594045265|FG000|Overall Study|Withdrawal by Subject|1|||
164457545|NCT03721952|594045266|FG001|Overall Study|Withdrawal by Subject|0|||
164457546|NCT03721952|594045267|FG002|Overall Study|Withdrawal by Subject|40|||
164457547|NCT03721952|594045268|FG003|Overall Study|Withdrawal by Subject|28|||
164457548|NCT03721952|594045269|FG004|Overall Study|Withdrawal by Subject|0|||
164457549|NCT04624633|594045276|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
164457550|NCT04624633|594045277|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
164707426|NCT02132754|594953581|FG009|Overall Study|Excluded Medication|0|||
164707427|NCT02132754|594953582|FG010|Overall Study|Excluded Medication|0|||
164707428|NCT02132754|594953583|FG011|Overall Study|Excluded Medication|0|||
164457551|NCT04624633|594045276|FG000|Overall Study|Death|1|||
164457552|NCT04624633|594045277|FG001|Overall Study|Death|0|||
164457553|NCT01902173|594045281|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
164457554|NCT01902173|594045282|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
164457555|NCT01902173|594045283|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
164457556|NCT01902173|594045284|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
164457557|NCT01902173|594045285|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
164457558|NCT01902173|594045286|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
164457559|NCT01902173|594045281|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
164457560|NCT01902173|594045282|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
164457561|NCT01902173|594045283|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
164457562|NCT01902173|594045284|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
164457563|NCT01902173|594045285|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
164457564|NCT01902173|594045286|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
164457565|NCT01902173|594045281|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
164457566|NCT01902173|594045282|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
164457567|NCT01902173|594045283|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
164457568|NCT01902173|594045284|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
164457569|NCT01902173|594045285|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
164457570|NCT01902173|594045286|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
164457571|NCT01902173|594045281|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
164457572|NCT01902173|594045282|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
164457573|NCT01902173|594045283|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
164457574|NCT01902173|594045284|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
164457575|NCT01902173|594045285|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
164457576|NCT01902173|594045286|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
164457577|NCT01902173|594045281|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
164457578|NCT01902173|594045282|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
164457579|NCT01902173|594045283|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
164457580|NCT01902173|594045284|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
164457581|NCT01902173|594045285|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
164457582|NCT01902173|594045286|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
164457583|NCT01902173|594045281|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
164457584|NCT01902173|594045282|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
164457585|NCT01902173|594045283|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
164457586|NCT01902173|594045284|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
164457587|NCT01902173|594045285|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
164457588|NCT01902173|594045286|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
164457589|NCT01902173|594045281|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
164457590|NCT01902173|594045282|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
164457591|NCT01902173|594045283|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
164457592|NCT01902173|594045284|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
164457593|NCT01902173|594045285|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
164457594|NCT01902173|594045286|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
164457595|NCT01902173|594045281|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
164457596|NCT01902173|594045282|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
164457597|NCT01902173|594045283|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
164457598|NCT01902173|594045284|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
164457599|NCT01902173|594045285|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
164457600|NCT01902173|594045286|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
164457601|NCT01902173|594045281|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
164457602|NCT01902173|594045282|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
164457603|NCT01902173|594045283|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
164457604|NCT01902173|594045284|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
164457605|NCT01902173|594045285|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
164457606|NCT01902173|594045286|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
164457607|NCT01902173|594045281|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
164457608|NCT01902173|594045282|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
164457609|NCT01902173|594045283|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
164457610|NCT01902173|594045284|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
164457611|NCT01902173|594045285|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
164457612|NCT01902173|594045286|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
164598057|NCT00894413|594551329|FG001|Overall Study|Withdrawal by Subject|4|||
164598058|NCT01067508|594551332|FG000|Overall Study|Physician Decision|0|||
164598059|NCT01067508|594551333|FG001|Overall Study|Physician Decision|1|||
164598060|NCT01067508|594551332|FG000|Overall Study|Withdrawal by Subject|0|||
164598061|NCT01067508|594551333|FG001|Overall Study|Withdrawal by Subject|1|||
164598062|NCT01552928|594551337|FG000|Period 3|Adverse Event|0|||
164598063|NCT01552928|594551338|FG001|Period 3|Adverse Event|0|||
164598064|NCT01552928|594551339|FG002|Period 3|Adverse Event|1|||
164407145|NCT04707196|593860653|FG000|Overall Study|Non-compliance with study drug|1|||
164407146|NCT04707196|593860654|FG001|Overall Study|Non-compliance with study drug|0|||
164407147|NCT04707196|593860653|FG000|Overall Study|Progressive disease|9|||
164407148|NCT04707196|593860654|FG001|Overall Study|Progressive disease|10|||
164407149|NCT01862796|593860658|FG000|Overall Study|Prohibited medications|0|||
164407150|NCT01862796|593860659|FG001|Overall Study|Prohibited medications|0|||
164407151|NCT01862796|593860660|FG002|Overall Study|Prohibited medications|1|||
164407152|NCT01462162|593860661|FG000|Overall Study|Adverse Event|5|||
164407153|NCT01462162|593860661|FG000|Overall Study|Lack of Efficacy|4|||
164407154|NCT01462162|593860661|FG000|Overall Study|Abnormal laboratory parameters|1|||
164407155|NCT01462162|593860661|FG000|Overall Study|Other|2|||
164407156|NCT03485911|593860662|FG000|Part 1|Perceived lack of efficacy|1|||
164407157|NCT03485911|593860663|FG001|Part 1|Perceived lack of efficacy|1|||
164407158|NCT03485911|593860664|FG002|Part 1|Perceived lack of efficacy|2|||
164407159|NCT03485911|593860665|FG003|Part 1|Perceived lack of efficacy|0|||
164407160|NCT03485911|593860662|FG000|Part 1|Subject withdrew consent|0|||
164407161|NCT03485911|593860663|FG001|Part 1|Subject withdrew consent|1|||
164407162|NCT03485911|593860664|FG002|Part 1|Subject withdrew consent|0|||
164407163|NCT03485911|593860665|FG003|Part 1|Subject withdrew consent|1|||
164407164|NCT03485911|593860662|FG000|Part 1|Lab abnormalities/AEs|3|||
164407165|NCT03485911|593860663|FG001|Part 1|Lab abnormalities/AEs|1|||
164407166|NCT03485911|593860664|FG002|Part 1|Lab abnormalities/AEs|1|||
164407167|NCT03485911|593860665|FG003|Part 1|Lab abnormalities/AEs|0|||
164407168|NCT03485911|593860662|FG000|Part 1|Withdrew Consent prior to dosing|0|||
164407169|NCT03485911|593860663|FG001|Part 1|Withdrew Consent prior to dosing|0|||
164407170|NCT03485911|593860664|FG002|Part 1|Withdrew Consent prior to dosing|0|||
164407171|NCT03485911|593860665|FG003|Part 1|Withdrew Consent prior to dosing|1|||
164407172|NCT03485911|593860662|FG000|Part 1|Other NOS|0|||
164407173|NCT03485911|593860663|FG001|Part 1|Other NOS|0|||
164407174|NCT03485911|593860664|FG002|Part 1|Other NOS|0|||
164407175|NCT03485911|593860665|FG003|Part 1|Other NOS|1|||
164407176|NCT03485911|593860662|FG000|Part 2|Perceived lack of efficacy|5|||
164407177|NCT03485911|593860663|FG001|Part 2|Perceived lack of efficacy|3|||
164407178|NCT03485911|593860664|FG002|Part 2|Perceived lack of efficacy|0|||
164407179|NCT03485911|593860665|FG003|Part 2|Perceived lack of efficacy|2|||
164407180|NCT03485911|593860662|FG000|Part 2|Subject withdrew consent|1|||
164407181|NCT03485911|593860663|FG001|Part 2|Subject withdrew consent|0|||
164407182|NCT03485911|593860664|FG002|Part 2|Subject withdrew consent|2|||
164407183|NCT03485911|593860665|FG003|Part 2|Subject withdrew consent|1|||
164407184|NCT03485911|593860662|FG000|Part 2|Lab abnormalities/AEs|1|||
164407185|NCT03485911|593860663|FG001|Part 2|Lab abnormalities/AEs|2|||
164407186|NCT03485911|593860664|FG002|Part 2|Lab abnormalities/AEs|0|||
164407187|NCT03485911|593860665|FG003|Part 2|Lab abnormalities/AEs|0|||
164407188|NCT03485911|593860662|FG000|Part 2|Other NOS|0|||
164407189|NCT03485911|593860663|FG001|Part 2|Other NOS|1|||
164407190|NCT03485911|593860664|FG002|Part 2|Other NOS|0|||
164407191|NCT03485911|593860665|FG003|Part 2|Other NOS|0|||
164407192|NCT03485911|593860662|FG000|Part 2|Intercurrent illness/new medical condition|1|||
164407193|NCT03485911|593860663|FG001|Part 2|Intercurrent illness/new medical condition|0|||
164407194|NCT03485911|593860664|FG002|Part 2|Intercurrent illness/new medical condition|0|||
164407195|NCT03485911|593860665|FG003|Part 2|Intercurrent illness/new medical condition|0|||
164407196|NCT03485911|593860662|FG000|Part 2|Investigator judgement|1|||
164407197|NCT03485911|593860663|FG001|Part 2|Investigator judgement|0|||
164407198|NCT03485911|593860664|FG002|Part 2|Investigator judgement|0|||
164407199|NCT03485911|593860665|FG003|Part 2|Investigator judgement|0|||
164407200|NCT03485911|593860662|FG000|Part 3|Perceived lack of efficacy|2|||
164407201|NCT03485911|593860663|FG001|Part 3|Perceived lack of efficacy|2|||
164407202|NCT03485911|593860664|FG002|Part 3|Perceived lack of efficacy|2|||
164407203|NCT03485911|593860665|FG003|Part 3|Perceived lack of efficacy|0|||
164407204|NCT03485911|593860662|FG000|Part 3|Subject withdrew consent|1|||
164598065|NCT01552928|594551340|FG003|Period 3|Adverse Event|0|||
164598066|NCT00632463|594551342|FG000|Overall Study|Adverse Event|0|||
164598067|NCT00632463|594551343|FG001|Overall Study|Adverse Event|1|||
164598068|NCT00632463|594551344|FG002|Overall Study|Adverse Event|0|||
164598069|NCT02065622|594551345|FG000|Induction Study|Adverse Event|13|||
164598070|NCT02065622|594551346|FG001|Induction Study|Adverse Event|19|||
164598071|NCT02065622|594551347|FG002|Induction Study|Adverse Event|0|||
164598072|NCT02065622|594551348|FG003|Induction Study|Adverse Event|0|||
164598073|NCT02065622|594551349|FG004|Induction Study|Adverse Event|0|||
164598074|NCT02065622|594551345|FG000|Induction Study|Withdrawal by Subject|3|||
164598075|NCT02065622|594551346|FG001|Induction Study|Withdrawal by Subject|5|||
164598076|NCT02065622|594551347|FG002|Induction Study|Withdrawal by Subject|0|||
164598077|NCT02065622|594551348|FG003|Induction Study|Withdrawal by Subject|0|||
164598078|NCT02065622|594551349|FG004|Induction Study|Withdrawal by Subject|0|||
164598079|NCT02065622|594551345|FG000|Induction Study|Lost to Follow-up|1|||
164598080|NCT02065622|594551346|FG001|Induction Study|Lost to Follow-up|0|||
164598081|NCT02065622|594551347|FG002|Induction Study|Lost to Follow-up|0|||
164598082|NCT02065622|594551348|FG003|Induction Study|Lost to Follow-up|0|||
164598083|NCT02065622|594551349|FG004|Induction Study|Lost to Follow-up|0|||
164598084|NCT02065622|594551345|FG000|Induction Study|Lack of Efficacy|22|||
164598085|NCT02065622|594551346|FG001|Induction Study|Lack of Efficacy|27|||
164407205|NCT03485911|593860663|FG001|Part 3|Subject withdrew consent|4|||
164407206|NCT03485911|593860664|FG002|Part 3|Subject withdrew consent|0|||
164407207|NCT03485911|593860665|FG003|Part 3|Subject withdrew consent|1|||
164407208|NCT03485911|593860662|FG000|Part 3|Lab abnormalities/AEs|1|||
164407209|NCT03485911|593860663|FG001|Part 3|Lab abnormalities/AEs|1|||
164407210|NCT03485911|593860664|FG002|Part 3|Lab abnormalities/AEs|0|||
164407211|NCT03485911|593860665|FG003|Part 3|Lab abnormalities/AEs|2|||
164407212|NCT03485911|593860662|FG000|Part 3|Other NOS|1|||
164407213|NCT03485911|593860663|FG001|Part 3|Other NOS|1|||
164407214|NCT03485911|593860664|FG002|Part 3|Other NOS|0|||
164407215|NCT03485911|593860665|FG003|Part 3|Other NOS|0|||
164407216|NCT03485911|593860662|FG000|Part 3|Intercurrent illness/new medical condition|0|||
164407217|NCT03485911|593860663|FG001|Part 3|Intercurrent illness/new medical condition|1|||
164407218|NCT03485911|593860664|FG002|Part 3|Intercurrent illness/new medical condition|1|||
164407219|NCT03485911|593860665|FG003|Part 3|Intercurrent illness/new medical condition|0|||
164407220|NCT03485911|593860662|FG000|Part 3|Sponsor discontinuation|1|||
164407221|NCT03485911|593860663|FG001|Part 3|Sponsor discontinuation|0|||
164407222|NCT03485911|593860664|FG002|Part 3|Sponsor discontinuation|0|||
164407223|NCT03485911|593860665|FG003|Part 3|Sponsor discontinuation|0|||
164407224|NCT03485911|593860662|FG000|Part 3|Berotralstat provided by alternative means|13|||
164407225|NCT03485911|593860663|FG001|Part 3|Berotralstat provided by alternative means|13|||
164407226|NCT03485911|593860664|FG002|Part 3|Berotralstat provided by alternative means|7|||
164407227|NCT03485911|593860665|FG003|Part 3|Berotralstat provided by alternative means|7|||
164407228|NCT03333928|593860666|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
164407229|NCT03333928|593860667|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
164407230|NCT03333928|593860668|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
164407231|NCT03333928|593860666|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
164407232|NCT03333928|593860667|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
164407233|NCT03333928|593860668|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
164407234|NCT03333928|593860666|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
164407235|NCT03333928|593860667|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
164407236|NCT03333928|593860668|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
164407237|NCT03333928|593860666|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
164407238|NCT03333928|593860667|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
164407239|NCT03333928|593860668|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
164407240|NCT03333928|593860666|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
164407241|NCT03333928|593860667|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
164407242|NCT03333928|593860668|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
164407243|NCT03333928|593860666|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
164407244|NCT03333928|593860667|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
164407245|NCT03333928|593860668|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
164407246|NCT03333928|593860666|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
164407247|NCT03333928|593860667|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
164407248|NCT03333928|593860668|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
164407249|NCT03333928|593860666|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
164407250|NCT03333928|593860667|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
164407251|NCT03333928|593860668|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
164407252|NCT01375205|593860673|FG000|Overall Study|Lost to Follow-up|15|||
164407253|NCT01375205|593860674|FG001|Overall Study|Lost to Follow-up|12|||
164407254|NCT01375205|593860673|FG000|Overall Study|Withdrawal by Subject|6|||
164407255|NCT01375205|593860674|FG001|Overall Study|Withdrawal by Subject|1|||
164407256|NCT01859793|593860675|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
164407257|NCT01859793|593860676|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
164407258|NCT01859793|593860675|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
164407259|NCT01859793|593860676|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
164598086|NCT02065622|594551347|FG002|Induction Study|Lack of Efficacy|0|||
164598087|NCT02065622|594551348|FG003|Induction Study|Lack of Efficacy|0|||
164144658|NCT01495702|592891745|FG000|Randomized Phase|Death|1|||
164598088|NCT02065622|594551349|FG004|Induction Study|Lack of Efficacy|0|||
164598089|NCT02065622|594551345|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
164598090|NCT02065622|594551346|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
164598091|NCT02065622|594551347|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
164598092|NCT02065622|594551348|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
164598093|NCT02065622|594551349|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
164598094|NCT02065622|594551345|FG000|Induction Study|Subject Noncompliance|1|||
164598095|NCT02065622|594551346|FG001|Induction Study|Subject Noncompliance|1|||
164598096|NCT02065622|594551347|FG002|Induction Study|Subject Noncompliance|0|||
164598097|NCT02065622|594551348|FG003|Induction Study|Subject Noncompliance|0|||
164598098|NCT02065622|594551349|FG004|Induction Study|Subject Noncompliance|0|||
164598099|NCT02065622|594551345|FG000|Induction Study|Other, Not Specified|3|||
164598100|NCT02065622|594551346|FG001|Induction Study|Other, Not Specified|2|||
164457613|NCT01902173|594045281|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
164457614|NCT01902173|594045282|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
164457615|NCT01902173|594045283|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
164457616|NCT01902173|594045284|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
164457617|NCT01902173|594045285|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
164457618|NCT01902173|594045286|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
164457619|NCT01902173|594045281|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
164457620|NCT01902173|594045282|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
164457621|NCT01902173|594045283|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
164457622|NCT01902173|594045284|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
164457623|NCT01902173|594045285|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
164457624|NCT01902173|594045286|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
164457625|NCT01902173|594045281|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
164457626|NCT01902173|594045282|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
164457627|NCT01902173|594045283|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
164457628|NCT01902173|594045284|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
164457629|NCT01902173|594045285|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
164457630|NCT01902173|594045286|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
164457631|NCT01902173|594045281|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
164457632|NCT01902173|594045282|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
164457633|NCT01902173|594045283|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
164457634|NCT01902173|594045284|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
164457635|NCT01902173|594045285|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
164598101|NCT02065622|594551347|FG002|Induction Study|Other, Not Specified|0|||
164598102|NCT02065622|594551348|FG003|Induction Study|Other, Not Specified|0|||
164598103|NCT02065622|594551349|FG004|Induction Study|Other, Not Specified|0|||
164598104|NCT02065622|594551345|FG000|Maintenance Study|Adverse Event|0|||
164598105|NCT02065622|594551346|FG001|Maintenance Study|Adverse Event|0|||
164598106|NCT02065622|594551347|FG002|Maintenance Study|Adverse Event|25|||
164598107|NCT02065622|594551348|FG003|Maintenance Study|Adverse Event|22|||
164598108|NCT02065622|594551349|FG004|Maintenance Study|Adverse Event|11|||
164598109|NCT02065622|594551345|FG000|Maintenance Study|Withdrawal by Subject|0|||
164598110|NCT02065622|594551346|FG001|Maintenance Study|Withdrawal by Subject|0|||
164598111|NCT02065622|594551347|FG002|Maintenance Study|Withdrawal by Subject|11|||
164598112|NCT02065622|594551348|FG003|Maintenance Study|Withdrawal by Subject|5|||
164598113|NCT02065622|594551349|FG004|Maintenance Study|Withdrawal by Subject|7|||
164598114|NCT02065622|594551345|FG000|Maintenance Study|Lost to Follow-up|0|||
164598115|NCT02065622|594551346|FG001|Maintenance Study|Lost to Follow-up|0|||
164598116|NCT02065622|594551347|FG002|Maintenance Study|Lost to Follow-up|4|||
164598117|NCT02065622|594551348|FG003|Maintenance Study|Lost to Follow-up|1|||
164598118|NCT02065622|594551349|FG004|Maintenance Study|Lost to Follow-up|1|||
164598119|NCT02065622|594551345|FG000|Maintenance Study|Lack of Efficacy|0|||
164598120|NCT02065622|594551346|FG001|Maintenance Study|Lack of Efficacy|0|||
164598121|NCT02065622|594551347|FG002|Maintenance Study|Lack of Efficacy|70|||
164598122|NCT02065622|594551348|FG003|Maintenance Study|Lack of Efficacy|55|||
164598123|NCT02065622|594551349|FG004|Maintenance Study|Lack of Efficacy|19|||
164598124|NCT02065622|594551345|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
164598125|NCT02065622|594551346|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
164598126|NCT02065622|594551347|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
164598127|NCT02065622|594551348|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
164598128|NCT02065622|594551349|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
164598129|NCT02065622|594551345|FG000|Maintenance Study|Subject Non-Compliance|0|||
164598130|NCT02065622|594551346|FG001|Maintenance Study|Subject Non-Compliance|0|||
164598131|NCT02065622|594551347|FG002|Maintenance Study|Subject Non-Compliance|1|||
164598132|NCT02065622|594551348|FG003|Maintenance Study|Subject Non-Compliance|3|||
164598133|NCT02065622|594551349|FG004|Maintenance Study|Subject Non-Compliance|2|||
164598134|NCT02065622|594551345|FG000|Maintenance Study|Other, Not Specified|0|||
164598135|NCT02065622|594551346|FG001|Maintenance Study|Other, Not Specified|0|||
164598136|NCT02065622|594551347|FG002|Maintenance Study|Other, Not Specified|6|||
164598137|NCT02065622|594551348|FG003|Maintenance Study|Other, Not Specified|14|||
164598138|NCT02065622|594551349|FG004|Maintenance Study|Other, Not Specified|2|||
164598139|NCT02065622|594551345|FG000|Maintenance Study|Unknown Reason|0|||
164598140|NCT02065622|594551346|FG001|Maintenance Study|Unknown Reason|0|||
164598141|NCT02065622|594551347|FG002|Maintenance Study|Unknown Reason|0|||
164707429|NCT02132754|594953584|FG012|Overall Study|Excluded Medication|0|||
164707430|NCT02132754|594953585|FG013|Overall Study|Excluded Medication|0|||
164457636|NCT01902173|594045286|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
164457637|NCT03640312|594045291|FG000|Overall Study|Lost to Follow-up|3|||
164598142|NCT02065622|594551348|FG003|Maintenance Study|Unknown Reason|1|||
164598143|NCT02065622|594551349|FG004|Maintenance Study|Unknown Reason|0|||
164598144|NCT00406640|594551356|FG000|Acute Phase|Adverse Event|18|||
164598145|NCT00406640|594551357|FG001|Acute Phase|Adverse Event|13|||
164598146|NCT00406640|594551356|FG000|Acute Phase|Failed to Return|5|||
164707431|NCT02132754|594953586|FG014|Overall Study|Excluded Medication|0|||
164457638|NCT03640312|594045292|FG001|Overall Study|Lost to Follow-up|6|||
164457639|NCT03536754|594045293|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
164457640|NCT03536754|594045294|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
164457641|NCT03536754|594045295|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
164457642|NCT03536754|594045296|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
164457643|NCT03536754|594045297|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
164457644|NCT03536754|594045293|FG000|Open Label Extension|Other|0|||
164457645|NCT03536754|594045294|FG001|Open Label Extension|Other|0|||
164457646|NCT03536754|594045295|FG002|Open Label Extension|Other|0|||
164457647|NCT03536754|594045296|FG003|Open Label Extension|Other|0|||
164457648|NCT03536754|594045297|FG004|Open Label Extension|Other|1|||
164457649|NCT03382652|594045300|FG000|Overall Study|Lost to Follow-up|6|||
164457650|NCT03382652|594045300|FG000|Overall Study|Death|4|||
164457651|NCT03382652|594045300|FG000|Overall Study|Revision|5|||
164457652|NCT03382652|594045300|FG000|Overall Study|Patient withdrew|3|||
164457653|NCT03382652|594045300|FG000|Overall Study|Other reasons|21|||
164457654|NCT04810650|594045301|FG000|Overall Study|Disenrolled in error|0|||
164457655|NCT04810650|594045302|FG001|Overall Study|Disenrolled in error|0|||
164457656|NCT04810650|594045303|FG002|Overall Study|Disenrolled in error|0|||
164457657|NCT04810650|594045304|FG003|Overall Study|Disenrolled in error|0|||
164457658|NCT04810650|594045305|FG004|Overall Study|Disenrolled in error|0|||
164457659|NCT04810650|594045306|FG005|Overall Study|Disenrolled in error|0|||
164457660|NCT04810650|594045307|FG006|Overall Study|Disenrolled in error|0|||
164457661|NCT04810650|594045308|FG007|Overall Study|Disenrolled in error|0|||
164457662|NCT04810650|594045309|FG008|Overall Study|Disenrolled in error|1|||
164457663|NCT04810650|594045310|FG009|Overall Study|Disenrolled in error|0|||
164457664|NCT04810650|594045311|FG010|Overall Study|Disenrolled in error|0|||
164457665|NCT04810650|594045312|FG011|Overall Study|Disenrolled in error|0|||
164457666|NCT04810650|594045313|FG012|Overall Study|Disenrolled in error|0|||
164457667|NCT04810650|594045314|FG013|Overall Study|Disenrolled in error|0|||
164457668|NCT04810650|594045301|FG000|Overall Study|Death|0|||
164457669|NCT04810650|594045302|FG001|Overall Study|Death|0|||
164598147|NCT00406640|594551357|FG001|Acute Phase|Failed to Return|1|||
164598148|NCT00406640|594551356|FG000|Acute Phase|Physician Decision|0|||
164598149|NCT00406640|594551357|FG001|Acute Phase|Physician Decision|1|||
164598150|NCT00406640|594551356|FG000|Acute Phase|Lost to Follow-up|7|||
164598151|NCT00406640|594551357|FG001|Acute Phase|Lost to Follow-up|4|||
164598152|NCT00406640|594551356|FG000|Acute Phase|Protocol deviation|4|||
164598153|NCT00406640|594551357|FG001|Acute Phase|Protocol deviation|10|||
164598154|NCT00406640|594551356|FG000|Acute Phase|Protocol Violation|3|||
164598155|NCT00406640|594551357|FG001|Acute Phase|Protocol Violation|2|||
164598156|NCT00406640|594551356|FG000|Acute Phase|Withdrawal by Subject|11|||
164707432|NCT02132754|594953587|FG015|Overall Study|Excluded Medication|0|||
164407260|NCT01859793|593860675|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
164407261|NCT01859793|593860676|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
164407262|NCT01859793|593860675|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
164407263|NCT01859793|593860676|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
164407264|NCT00728962|593860681|FG000|Implant Placement Surgery|Adverse Event|8|||
164407265|NCT00728962|593860681|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
164407266|NCT00728962|593860681|FG000|Implant Placement Surgery|Protocol Violation|1|||
164407267|NCT00728962|593860681|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
164407268|NCT00728962|593860681|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
164407269|NCT04954586|593860684|FG000|Overall Study|Withdrawal by Subject|5|||
164407270|NCT03185481|593860691|FG000|Overall Study|Adverse Event|1|||
164407271|NCT03185481|593860691|FG000|Overall Study|Study Terminated by Sponsor|4|||
164407272|NCT03371940|593860694|FG000|Overall Study|Withdrawal by Subject|8|||
164407273|NCT03371940|593860695|FG001|Overall Study|Withdrawal by Subject|1|||
164407274|NCT03371940|593860696|FG002|Overall Study|Withdrawal by Subject|3|||
164407275|NCT03371940|593860697|FG003|Overall Study|Withdrawal by Subject|4|||
164407276|NCT01064297|593860698|FG000|Overall Study|Lost to Follow-up|791|||
164407277|NCT01064297|593860699|FG001|Overall Study|Lost to Follow-up|48|||
164407278|NCT01064297|593860700|FG002|Overall Study|Lost to Follow-up|133|||
164407279|NCT01987817|593860716|FG000|Overall Study|Adverse Event|4|||
164407280|NCT01987817|593860717|FG001|Overall Study|Adverse Event|0|||
164407281|NCT01987817|593860716|FG000|Overall Study|Withdrawal by Subject|1|||
164407282|NCT01987817|593860717|FG001|Overall Study|Withdrawal by Subject|1|||
164407283|NCT01987817|593860716|FG000|Overall Study|Physician Decision|1|||
164407284|NCT01987817|593860717|FG001|Overall Study|Physician Decision|0|||
164407285|NCT00511875|593860725|FG000|Overall Study|Lost to Follow-up|4|||
164407286|NCT00511875|593860726|FG001|Overall Study|Lost to Follow-up|0|||
164407287|NCT00511875|593860725|FG000|Overall Study|Missing variables|1|||
164407288|NCT00511875|593860726|FG001|Overall Study|Missing variables|0|||
164407289|NCT00542880|593860728|FG000|Period 1|Eligibility criteria not fulfilled|2|||
164407290|NCT00542880|593860729|FG001|Period 1|Eligibility criteria not fulfilled|6|||
164407291|NCT00542880|593860728|FG000|Period 1|Adverse Event|2|||
164407292|NCT00542880|593860729|FG001|Period 1|Adverse Event|2|||
164598157|NCT00406640|594551357|FG001|Acute Phase|Withdrawal by Subject|9|||
164457670|NCT04810650|594045303|FG002|Overall Study|Death|0|||
164457671|NCT04810650|594045304|FG003|Overall Study|Death|0|||
164457672|NCT04810650|594045305|FG004|Overall Study|Death|0|||
164457673|NCT04810650|594045306|FG005|Overall Study|Death|0|||
164457674|NCT04810650|594045307|FG006|Overall Study|Death|2|||
164457675|NCT04810650|594045308|FG007|Overall Study|Death|2|||
164457676|NCT04810650|594045309|FG008|Overall Study|Death|0|||
164457677|NCT04810650|594045310|FG009|Overall Study|Death|1|||
164457678|NCT04810650|594045311|FG010|Overall Study|Death|0|||
164457679|NCT04810650|594045312|FG011|Overall Study|Death|0|||
164457680|NCT04810650|594045313|FG012|Overall Study|Death|2|||
164457681|NCT04810650|594045314|FG013|Overall Study|Death|1|||
164457682|NCT04810650|594045301|FG000|Overall Study|Moved/transferred care|0|||
164457683|NCT04810650|594045302|FG001|Overall Study|Moved/transferred care|0|||
164457684|NCT04810650|594045303|FG002|Overall Study|Moved/transferred care|0|||
164457685|NCT04810650|594045304|FG003|Overall Study|Moved/transferred care|0|||
164457686|NCT04810650|594045305|FG004|Overall Study|Moved/transferred care|0|||
164457687|NCT04810650|594045306|FG005|Overall Study|Moved/transferred care|0|||
164457688|NCT04810650|594045307|FG006|Overall Study|Moved/transferred care|0|||
164457689|NCT04810650|594045308|FG007|Overall Study|Moved/transferred care|1|||
164457690|NCT04810650|594045309|FG008|Overall Study|Moved/transferred care|12|||
164598158|NCT00406640|594551356|FG000|Acute Phase|Lack of Efficacy|3|||
164598159|NCT00406640|594551357|FG001|Acute Phase|Lack of Efficacy|3|||
164598160|NCT00406640|594551356|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
164598161|NCT00406640|594551357|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
164598162|NCT00406640|594551356|FG000|DB Continuation Phase for Responders|Death|1|||
164598163|NCT00406640|594551357|FG001|DB Continuation Phase for Responders|Death|0|||
164598164|NCT00406640|594551356|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
164598165|NCT00406640|594551357|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
164598166|NCT00406640|594551356|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
164598167|NCT00406640|594551357|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
164598168|NCT00406640|594551356|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
164598169|NCT00406640|594551357|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
164598170|NCT00406640|594551356|FG000|DB Continuation Phase for Responders|non-compliance|7|||
164598171|NCT00406640|594551357|FG001|DB Continuation Phase for Responders|non-compliance|5|||
164598172|NCT00406640|594551356|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
164598173|NCT00406640|594551357|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
164598174|NCT00406640|594551356|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
164598175|NCT00406640|594551357|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
164598176|NCT00406640|594551356|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
164598177|NCT00406640|594551357|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
164598178|NCT00406640|594551356|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
164598179|NCT00406640|594551357|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
164598180|NCT00406640|594551356|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
164598181|NCT00406640|594551357|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
164598182|NCT00406640|594551356|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
164598183|NCT00406640|594551357|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
164598184|NCT00406640|594551356|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
164598185|NCT00406640|594551357|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
164598186|NCT00406640|594551356|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
164598187|NCT00406640|594551357|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
164598188|NCT00406640|594551356|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
164598189|NCT00406640|594551357|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
164598190|NCT00406640|594551356|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
164598191|NCT00406640|594551357|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
164598192|NCT00488618|594551358|FG000|Overall Study|Adverse Event|13|||
164598193|NCT00488618|594551359|FG001|Overall Study|Adverse Event|17|||
164598194|NCT00488618|594551358|FG000|Overall Study|Insufficient Therapeutic Response|18|||
164598195|NCT00488618|594551359|FG001|Overall Study|Insufficient Therapeutic Response|11|||
164598196|NCT00488618|594551358|FG000|Overall Study|Protocol Violation|0|||
164598197|NCT00488618|594551359|FG001|Overall Study|Protocol Violation|2|||
164598198|NCT00488618|594551358|FG000|Overall Study|Withdrawal of Consent|15|||
164457691|NCT04810650|594045310|FG009|Overall Study|Moved/transferred care|10|||
164457692|NCT04810650|594045311|FG010|Overall Study|Moved/transferred care|0|||
164457693|NCT04810650|594045312|FG011|Overall Study|Moved/transferred care|0|||
164457694|NCT04810650|594045313|FG012|Overall Study|Moved/transferred care|0|||
164457695|NCT04810650|594045314|FG013|Overall Study|Moved/transferred care|0|||
164457696|NCT04810650|594045301|FG000|Overall Study|Lost to Follow-up|15|||
164457697|NCT04810650|594045302|FG001|Overall Study|Lost to Follow-up|12|||
164457698|NCT04810650|594045303|FG002|Overall Study|Lost to Follow-up|7|||
164457699|NCT04810650|594045304|FG003|Overall Study|Lost to Follow-up|9|||
164598199|NCT00488618|594551359|FG001|Overall Study|Withdrawal of Consent|13|||
164598200|NCT00488618|594551358|FG000|Overall Study|Lost to Follow-up|1|||
164457700|NCT04810650|594045305|FG004|Overall Study|Lost to Follow-up|10|||
164457701|NCT04810650|594045306|FG005|Overall Study|Lost to Follow-up|6|||
164457702|NCT04810650|594045307|FG006|Overall Study|Lost to Follow-up|0|||
164457703|NCT04810650|594045308|FG007|Overall Study|Lost to Follow-up|0|||
164457704|NCT04810650|594045309|FG008|Overall Study|Lost to Follow-up|0|||
164457705|NCT04810650|594045310|FG009|Overall Study|Lost to Follow-up|0|||
164457706|NCT04810650|594045311|FG010|Overall Study|Lost to Follow-up|1|||
164457707|NCT04810650|594045312|FG011|Overall Study|Lost to Follow-up|0|||
164457708|NCT04810650|594045313|FG012|Overall Study|Lost to Follow-up|3|||
164457709|NCT04810650|594045314|FG013|Overall Study|Lost to Follow-up|9|||
164457710|NCT04810650|594045301|FG000|Overall Study|Participant declined|0|||
164457711|NCT04810650|594045302|FG001|Overall Study|Participant declined|0|||
164457712|NCT04810650|594045303|FG002|Overall Study|Participant declined|0|||
164457713|NCT04810650|594045304|FG003|Overall Study|Participant declined|0|||
164457714|NCT04810650|594045305|FG004|Overall Study|Participant declined|0|||
164457715|NCT04810650|594045306|FG005|Overall Study|Participant declined|0|||
164457716|NCT04810650|594045307|FG006|Overall Study|Participant declined|0|||
164457717|NCT04810650|594045308|FG007|Overall Study|Participant declined|0|||
164457718|NCT04810650|594045309|FG008|Overall Study|Participant declined|0|||
164457719|NCT04810650|594045310|FG009|Overall Study|Participant declined|0|||
164457720|NCT04810650|594045311|FG010|Overall Study|Participant declined|2|||
164457721|NCT04810650|594045312|FG011|Overall Study|Participant declined|0|||
164457722|NCT04810650|594045313|FG012|Overall Study|Participant declined|0|||
164457723|NCT04810650|594045314|FG013|Overall Study|Participant declined|0|||
164457724|NCT05008835|594045318|FG000|Overall Study|Adverse Event|5|||
164457725|NCT05008835|594045319|FG001|Overall Study|Adverse Event|2|||
164457726|NCT05008835|594045320|FG002|Overall Study|Adverse Event|1|||
164457727|NCT05008835|594045318|FG000|Overall Study|Lack of Efficacy|0|||
164457728|NCT05008835|594045319|FG001|Overall Study|Lack of Efficacy|0|||
164457729|NCT05008835|594045320|FG002|Overall Study|Lack of Efficacy|1|||
164457730|NCT05008835|594045318|FG000|Overall Study|Study terminated by sponsor|0|||
164457731|NCT05008835|594045319|FG001|Overall Study|Study terminated by sponsor|0|||
164457732|NCT05008835|594045320|FG002|Overall Study|Study terminated by sponsor|1|||
164457733|NCT05008835|594045318|FG000|Overall Study|Not further specified|3|||
164457734|NCT05008835|594045319|FG001|Overall Study|Not further specified|2|||
164457735|NCT05008835|594045320|FG002|Overall Study|Not further specified|1|||
164457736|NCT04876118|594045321|FG000|Overall Study|Pregnancy|1|||
164457737|NCT04876118|594045321|FG000|Overall Study|Withdrawal by Subject|14|||
164457738|NCT04593472|594047156|FG000|Overall Study|Death|31|||
164457739|NCT04593472|594047157|FG001|Overall Study|Death|27|||
164457740|NCT04593472|594047156|FG000|Overall Study|Withdrawal by Subject|12|||
164457741|NCT04593472|594047157|FG001|Overall Study|Withdrawal by Subject|12|||
164457742|NCT04593472|594047156|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
164457743|NCT04593472|594047157|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
164457744|NCT04593472|594047156|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
164457745|NCT04593472|594047157|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
164598201|NCT00488618|594551359|FG001|Overall Study|Lost to Follow-up|0|||
164598202|NCT03073213|594552951|FG000|Multiple Dose Period|Protocol Violation|0|||
164598203|NCT03073213|594552952|FG001|Multiple Dose Period|Protocol Violation|0|||
164598204|NCT03073213|594552953|FG002|Multiple Dose Period|Protocol Violation|1|||
164598205|NCT00296725|594552963|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
164598206|NCT00296725|594552963|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
164598207|NCT00296725|594552963|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
164598208|NCT00356863|594552964|FG000|Overall Study|Death|16|||
164598209|NCT00356863|594552965|FG001|Overall Study|Death|32|||
164598210|NCT00356863|594552964|FG000|Overall Study|Lost to Follow-up|76|||
164598211|NCT00356863|594552965|FG001|Overall Study|Lost to Follow-up|43|||
164598212|NCT00836277|594552976|FG000|Overall Study|Not evaluable for response|6|||
164598213|NCT00333619|594552977|FG000|Overall Study|Death|12|||
164598214|NCT00333619|594552978|FG001|Overall Study|Death|6|||
164598215|NCT00333619|594552977|FG000|Overall Study|Withdrawal by Subject|6|||
164598216|NCT00333619|594552978|FG001|Overall Study|Withdrawal by Subject|1|||
164598217|NCT00333619|594552977|FG000|Overall Study|Lost to Follow-up|3|||
164598218|NCT00333619|594552978|FG001|Overall Study|Lost to Follow-up|3|||
164457746|NCT04593472|594047156|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
164457747|NCT04593472|594047157|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
164457748|NCT04593472|594047156|FG000|Overall Study|Lost to Follow-up|0|||
164457749|NCT04593472|594047157|FG001|Overall Study|Lost to Follow-up|2|||
164457750|NCT04593472|594047156|FG000|Overall Study|Still collecting 24-month assessment|17|||
164457751|NCT04593472|594047157|FG001|Overall Study|Still collecting 24-month assessment|10|||
164598219|NCT00280150|594552979|FG000|Overall Study|Adverse Event|0|||
164598220|NCT00280150|594552980|FG001|Overall Study|Adverse Event|1|||
164598221|NCT00280150|594552981|FG002|Overall Study|Adverse Event|2|||
164598222|NCT00280150|594552982|FG003|Overall Study|Adverse Event|3|||
164598223|NCT00280150|594552979|FG000|Overall Study|Lack of Efficacy|0|||
164457752|NCT02671903|594047164|FG000|Period 0 (Run-In)|Death|0|||
164457753|NCT02671903|594047165|FG001|Period 0 (Run-In)|Death|0|||
164457754|NCT02671903|594047166|FG002|Period 0 (Run-In)|Death|3|||
164457755|NCT02671903|594047164|FG000|Period 0 (Run-In)|Physician Decision|0|||
164457756|NCT02671903|594047165|FG001|Period 0 (Run-In)|Physician Decision|0|||
164457757|NCT02671903|594047166|FG002|Period 0 (Run-In)|Physician Decision|4|||
164457758|NCT02671903|594047164|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
164457759|NCT02671903|594047165|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
164457760|NCT02671903|594047166|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
164457761|NCT02671903|594047164|FG000|Period 0 (Run-In)|Protocol Violation|0|||
164457762|NCT02671903|594047165|FG001|Period 0 (Run-In)|Protocol Violation|0|||
164457763|NCT02671903|594047166|FG002|Period 0 (Run-In)|Protocol Violation|1|||
164457764|NCT02671903|594047164|FG000|Period 0 (Run-In)|Adverse Event|0|||
164457765|NCT02671903|594047165|FG001|Period 0 (Run-In)|Adverse Event|0|||
164457766|NCT02671903|594047166|FG002|Period 0 (Run-In)|Adverse Event|1|||
164457767|NCT02671903|594047164|FG000|Period 0 (Run-In)|Implantation Failure|0|||
164457768|NCT02671903|594047165|FG001|Period 0 (Run-In)|Implantation Failure|0|||
164457769|NCT02671903|594047166|FG002|Period 0 (Run-In)|Implantation Failure|2|||
164457770|NCT02671903|594047164|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
164457771|NCT02671903|594047165|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
164457772|NCT02671903|594047166|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
164457773|NCT04806594|594047171|FG000|Overall Study|Withdrawal by Subject|2|||
164457774|NCT04806594|594047171|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
164457775|NCT04390048|594047172|FG000|Overall Study|Withdrawal by Subject|1|||
164457776|NCT04390048|594047173|FG001|Overall Study|Withdrawal by Subject|3|||
164457777|NCT03138512|594047174|FG000|Randomization|Participants withdrew consent|0|||
164457778|NCT03138512|594047175|FG001|Randomization|Participants withdrew consent|1|||
164457779|NCT03138512|594047176|FG002|Randomization|Participants withdrew consent|1|||
164457780|NCT03138512|594047177|FG003|Randomization|Participants withdrew consent|0|||
164457781|NCT03138512|594047178|FG004|Randomization|Participants withdrew consent|0|||
164457782|NCT03138512|594047174|FG000|Randomization|Participant no longer meets study criteria|0|||
164457783|NCT03138512|594047175|FG001|Randomization|Participant no longer meets study criteria|3|||
164457784|NCT03138512|594047176|FG002|Randomization|Participant no longer meets study criteria|1|||
164457785|NCT03138512|594047177|FG003|Randomization|Participant no longer meets study criteria|1|||
164457786|NCT03138512|594047178|FG004|Randomization|Participant no longer meets study criteria|3|||
164457787|NCT03138512|594047174|FG000|Randomization|Other reasons|1|||
164457788|NCT03138512|594047175|FG001|Randomization|Other reasons|0|||
164457789|NCT03138512|594047176|FG002|Randomization|Other reasons|0|||
164457790|NCT03138512|594047177|FG003|Randomization|Other reasons|0|||
164457791|NCT03138512|594047178|FG004|Randomization|Other reasons|0|||
164457792|NCT03138512|594047174|FG000|Treatment Part A|Disease recurrence|10|||
164457793|NCT03138512|594047175|FG001|Treatment Part A|Disease recurrence|20|||
164457794|NCT03138512|594047176|FG002|Treatment Part A|Disease recurrence|0|||
164457795|NCT03138512|594047177|FG003|Treatment Part A|Disease recurrence|0|||
164457796|NCT03138512|594047178|FG004|Treatment Part A|Disease recurrence|0|||
164457797|NCT03138512|594047174|FG000|Treatment Part A|Study Drug Toxicity|132|||
164457798|NCT03138512|594047175|FG001|Treatment Part A|Study Drug Toxicity|5|||
164457799|NCT03138512|594047176|FG002|Treatment Part A|Study Drug Toxicity|0|||
164457800|NCT03138512|594047177|FG003|Treatment Part A|Study Drug Toxicity|0|||
164457801|NCT03138512|594047178|FG004|Treatment Part A|Study Drug Toxicity|0|||
164457802|NCT03138512|594047174|FG000|Treatment Part A|Death|1|||
164457803|NCT03138512|594047175|FG001|Treatment Part A|Death|0|||
164457804|NCT03138512|594047176|FG002|Treatment Part A|Death|0|||
164457805|NCT03138512|594047177|FG003|Treatment Part A|Death|0|||
164457806|NCT03138512|594047178|FG004|Treatment Part A|Death|0|||
164457807|NCT03138512|594047174|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
164457808|NCT03138512|594047175|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
164457809|NCT03138512|594047176|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
164457810|NCT03138512|594047177|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
164457811|NCT03138512|594047178|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
164457812|NCT03138512|594047174|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
164457813|NCT03138512|594047175|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
164457814|NCT03138512|594047176|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
164457815|NCT03138512|594047177|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
164457816|NCT03138512|594047178|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
164457817|NCT03138512|594047174|FG000|Treatment Part A|Participant withdrew consent|2|||
164457818|NCT03138512|594047175|FG001|Treatment Part A|Participant withdrew consent|4|||
164457819|NCT03138512|594047176|FG002|Treatment Part A|Participant withdrew consent|0|||
164457820|NCT03138512|594047177|FG003|Treatment Part A|Participant withdrew consent|0|||
164457821|NCT03138512|594047178|FG004|Treatment Part A|Participant withdrew consent|0|||
164457822|NCT03138512|594047174|FG000|Treatment Part A|Lost to Follow-up|0|||
164457823|NCT03138512|594047175|FG001|Treatment Part A|Lost to Follow-up|1|||
164457824|NCT03138512|594047176|FG002|Treatment Part A|Lost to Follow-up|0|||
164457825|NCT03138512|594047177|FG003|Treatment Part A|Lost to Follow-up|0|||
164457826|NCT03138512|594047178|FG004|Treatment Part A|Lost to Follow-up|0|||
164457827|NCT03138512|594047174|FG000|Treatment Part A|Poor/non-compliance|1|||
164457828|NCT03138512|594047175|FG001|Treatment Part A|Poor/non-compliance|0|||
164457829|NCT03138512|594047176|FG002|Treatment Part A|Poor/non-compliance|0|||
164457830|NCT03138512|594047177|FG003|Treatment Part A|Poor/non-compliance|0|||
164457831|NCT03138512|594047178|FG004|Treatment Part A|Poor/non-compliance|0|||
164457832|NCT03138512|594047174|FG000|Treatment Part A|Pregnancy|0|||
164457833|NCT03138512|594047175|FG001|Treatment Part A|Pregnancy|1|||
164457834|NCT03138512|594047176|FG002|Treatment Part A|Pregnancy|0|||
164457835|NCT03138512|594047177|FG003|Treatment Part A|Pregnancy|0|||
164457836|NCT03138512|594047178|FG004|Treatment Part A|Pregnancy|0|||
164457837|NCT03138512|594047174|FG000|Treatment Part A|Other reasons|11|||
164457838|NCT03138512|594047175|FG001|Treatment Part A|Other reasons|8|||
164457839|NCT03138512|594047176|FG002|Treatment Part A|Other reasons|0|||
164457840|NCT03138512|594047177|FG003|Treatment Part A|Other reasons|0|||
164457841|NCT03138512|594047178|FG004|Treatment Part A|Other reasons|0|||
164457842|NCT03138512|594047174|FG000|Treatment Part B|Disease recurrence|0|||
164457843|NCT03138512|594047175|FG001|Treatment Part B|Disease recurrence|0|||
164457844|NCT03138512|594047176|FG002|Treatment Part B|Disease recurrence|6|||
164457845|NCT03138512|594047177|FG003|Treatment Part B|Disease recurrence|12|||
164457846|NCT03138512|594047178|FG004|Treatment Part B|Disease recurrence|10|||
164457847|NCT03138512|594047174|FG000|Treatment Part B|Study drug toxicity|0|||
164457848|NCT03138512|594047175|FG001|Treatment Part B|Study drug toxicity|0|||
164457849|NCT03138512|594047176|FG002|Treatment Part B|Study drug toxicity|63|||
164457850|NCT03138512|594047177|FG003|Treatment Part B|Study drug toxicity|3|||
164457851|NCT03138512|594047178|FG004|Treatment Part B|Study drug toxicity|45|||
164457852|NCT03138512|594047174|FG000|Treatment Part B|Death|0|||
164457853|NCT03138512|594047175|FG001|Treatment Part B|Death|0|||
164457854|NCT03138512|594047176|FG002|Treatment Part B|Death|1|||
164457855|NCT03138512|594047177|FG003|Treatment Part B|Death|0|||
164457856|NCT03138512|594047178|FG004|Treatment Part B|Death|0|||
164457857|NCT03138512|594047174|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
164457858|NCT03138512|594047175|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
164457859|NCT03138512|594047176|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
164457860|NCT03138512|594047177|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
164457861|NCT03138512|594047178|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
164457862|NCT03138512|594047174|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
164457863|NCT03138512|594047175|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
164457864|NCT03138512|594047176|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
164457865|NCT03138512|594047177|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
164457866|NCT03138512|594047178|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
164457867|NCT03138512|594047174|FG000|Treatment Part B|Participant withdrew consent|0|||
164457868|NCT03138512|594047175|FG001|Treatment Part B|Participant withdrew consent|0|||
164457869|NCT03138512|594047176|FG002|Treatment Part B|Participant withdrew consent|1|||
164457870|NCT03138512|594047177|FG003|Treatment Part B|Participant withdrew consent|1|||
164457871|NCT03138512|594047178|FG004|Treatment Part B|Participant withdrew consent|2|||
164457872|NCT03138512|594047174|FG000|Treatment Part B|Lost to Follow-up|0|||
164457873|NCT03138512|594047175|FG001|Treatment Part B|Lost to Follow-up|0|||
164457874|NCT03138512|594047176|FG002|Treatment Part B|Lost to Follow-up|0|||
164457875|NCT03138512|594047177|FG003|Treatment Part B|Lost to Follow-up|1|||
164457876|NCT03138512|594047178|FG004|Treatment Part B|Lost to Follow-up|0|||
164457877|NCT03138512|594047174|FG000|Treatment Part B|Poor/non-compliance|0|||
164457878|NCT03138512|594047175|FG001|Treatment Part B|Poor/non-compliance|0|||
164457879|NCT03138512|594047176|FG002|Treatment Part B|Poor/non-compliance|1|||
164457880|NCT03138512|594047177|FG003|Treatment Part B|Poor/non-compliance|1|||
164457881|NCT03138512|594047178|FG004|Treatment Part B|Poor/non-compliance|1|||
164707433|NCT02132754|594953588|FG016|Overall Study|Excluded Medication|0|||
164707434|NCT02132754|594953589|FG017|Overall Study|Excluded Medication|0|||
164457882|NCT03138512|594047174|FG000|Treatment Part B|Other reasons|0|||
164457883|NCT03138512|594047175|FG001|Treatment Part B|Other reasons|0|||
164457884|NCT03138512|594047176|FG002|Treatment Part B|Other reasons|3|||
164457885|NCT03138512|594047177|FG003|Treatment Part B|Other reasons|1|||
164457886|NCT03138512|594047178|FG004|Treatment Part B|Other reasons|5|||
164457887|NCT03673111|594047183|FG000|Overall Study|Protocol Violation|0|||
164457888|NCT03673111|594047184|FG001|Overall Study|Protocol Violation|0|||
164707435|NCT02132754|594953590|FG018|Overall Study|Excluded Medication|0|||
164457889|NCT03673111|594047185|FG002|Overall Study|Protocol Violation|0|||
164457890|NCT03673111|594047186|FG003|Overall Study|Protocol Violation|0|||
164457891|NCT03673111|594047187|FG004|Overall Study|Protocol Violation|0|||
164457892|NCT03673111|594047188|FG005|Overall Study|Protocol Violation|0|||
164457893|NCT03673111|594047189|FG006|Overall Study|Protocol Violation|0|||
164457894|NCT03673111|594047190|FG007|Overall Study|Protocol Violation|0|||
164457895|NCT03673111|594047191|FG008|Overall Study|Protocol Violation|0|||
164707436|NCT02132754|594953591|FG019|Overall Study|Excluded Medication|0|||
164457896|NCT03673111|594047192|FG009|Overall Study|Protocol Violation|0|||
164457897|NCT03673111|594047193|FG010|Overall Study|Protocol Violation|1|||
164457898|NCT03673111|594047194|FG011|Overall Study|Protocol Violation|0|||
164457899|NCT03673111|594047195|FG012|Overall Study|Protocol Violation|0|||
164457900|NCT03673111|594047196|FG013|Overall Study|Protocol Violation|0|||
164457901|NCT03673111|594047183|FG000|Overall Study|Adverse Event|1|||
164457902|NCT03673111|594047184|FG001|Overall Study|Adverse Event|0|||
164457903|NCT03673111|594047185|FG002|Overall Study|Adverse Event|0|||
164457904|NCT03673111|594047186|FG003|Overall Study|Adverse Event|0|||
164457905|NCT03673111|594047187|FG004|Overall Study|Adverse Event|0|||
164457906|NCT03673111|594047188|FG005|Overall Study|Adverse Event|0|||
164457907|NCT03673111|594047189|FG006|Overall Study|Adverse Event|0|||
164457908|NCT03673111|594047190|FG007|Overall Study|Adverse Event|0|||
164457909|NCT03673111|594047191|FG008|Overall Study|Adverse Event|0|||
164457910|NCT03673111|594047192|FG009|Overall Study|Adverse Event|0|||
164457911|NCT03673111|594047193|FG010|Overall Study|Adverse Event|0|||
164457912|NCT03673111|594047194|FG011|Overall Study|Adverse Event|0|||
164457913|NCT03673111|594047195|FG012|Overall Study|Adverse Event|0|||
164457914|NCT03673111|594047196|FG013|Overall Study|Adverse Event|0|||
164457915|NCT02120456|594047202|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
164457916|NCT02120456|594047203|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
164457917|NCT02120456|594047204|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
164457918|NCT02120456|594047205|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
164457919|NCT02120456|594047206|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
164457920|NCT02120456|594047207|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
164598224|NCT00280150|594552980|FG001|Overall Study|Lack of Efficacy|0|||
164598225|NCT00280150|594552981|FG002|Overall Study|Lack of Efficacy|0|||
164598226|NCT00280150|594552982|FG003|Overall Study|Lack of Efficacy|3|||
164598227|NCT00280150|594552979|FG000|Overall Study|Physician Decision|0|||
164598228|NCT00280150|594552980|FG001|Overall Study|Physician Decision|0|||
164598229|NCT00280150|594552981|FG002|Overall Study|Physician Decision|0|||
164598230|NCT00280150|594552982|FG003|Overall Study|Physician Decision|1|||
164598231|NCT00280150|594552979|FG000|Overall Study|Protocol Violation|0|||
164598232|NCT00280150|594552980|FG001|Overall Study|Protocol Violation|0|||
164598233|NCT00280150|594552981|FG002|Overall Study|Protocol Violation|0|||
164598234|NCT00280150|594552982|FG003|Overall Study|Protocol Violation|1|||
164598235|NCT00280150|594552979|FG000|Overall Study|Withdrawal by Subject|0|||
164598236|NCT00280150|594552980|FG001|Overall Study|Withdrawal by Subject|0|||
164598237|NCT00280150|594552981|FG002|Overall Study|Withdrawal by Subject|0|||
164598238|NCT00280150|594552982|FG003|Overall Study|Withdrawal by Subject|1|||
164598239|NCT00280150|594552979|FG000|Overall Study|Did not get consolidation therapy|3|||
164598240|NCT00280150|594552980|FG001|Overall Study|Did not get consolidation therapy|0|||
164598241|NCT00280150|594552981|FG002|Overall Study|Did not get consolidation therapy|3|||
164457921|NCT02120456|594047208|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
164457922|NCT02120456|594047209|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
164457923|NCT02120456|594047210|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
164457924|NCT02120456|594047202|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
164457925|NCT02120456|594047203|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
164457926|NCT02120456|594047204|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
164457927|NCT02120456|594047205|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
164457928|NCT02120456|594047206|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
164457929|NCT02120456|594047207|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
164457930|NCT02120456|594047208|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
164457931|NCT02120456|594047209|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
164457932|NCT02120456|594047210|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
164457933|NCT02120456|594047202|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
164457934|NCT02120456|594047203|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
164457935|NCT02120456|594047204|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
164457936|NCT02120456|594047205|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
164457937|NCT02120456|594047206|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
164598242|NCT00280150|594552982|FG003|Overall Study|Did not get consolidation therapy|0|||
164598243|NCT00280150|594552979|FG000|Overall Study|Declining Performance Status|0|||
164598244|NCT00280150|594552980|FG001|Overall Study|Declining Performance Status|0|||
164598245|NCT00280150|594552981|FG002|Overall Study|Declining Performance Status|0|||
164598246|NCT00280150|594552982|FG003|Overall Study|Declining Performance Status|1|||
164598247|NCT01120379|594552998|FG000|One Year Timepoint|Withdrawal by Subject|41|||
164457938|NCT02120456|594047207|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
164457939|NCT02120456|594047208|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
164598248|NCT01120379|594552998|FG000|One Year Timepoint|Lost to Follow-up|115|||
164598249|NCT01120379|594552998|FG000|One Year Timepoint|Death|108|||
164598250|NCT01120379|594552998|FG000|One Year Timepoint|Physician Decision|9|||
164707437|NCT02132754|594953592|FG020|Overall Study|Excluded Medication|1|||
164457940|NCT02120456|594047209|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
164598251|NCT01120379|594552998|FG000|One Year Timepoint|Any other reason for early termination|5|||
164457941|NCT02120456|594047210|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
164457942|NCT05192200|594047211|FG000|Treatment Period|Other|1|||
164457943|NCT05192200|594047211|FG000|Treatment Period|Lack of Efficacy|1|||
164457944|NCT05192200|594047211|FG000|Treatment Period|Withdrawal by Subject|1|||
164457945|NCT05192200|594047211|FG000|Follow-up|Withdrawal by Subject|1|||
164457946|NCT03623321|594047212|FG000|Overall Study|Adverse Event|32|||
164457947|NCT03623321|594047212|FG000|Overall Study|Death|9|||
164457948|NCT03623321|594047212|FG000|Overall Study|Lack of Efficacy|9|||
164457949|NCT03623321|594047212|FG000|Overall Study|Lost to Follow-up|6|||
164457950|NCT03623321|594047212|FG000|Overall Study|Noncompliance with study drug|6|||
164457951|NCT03623321|594047212|FG000|Overall Study|Use of prohibited medication|3|||
164457952|NCT03623321|594047212|FG000|Overall Study|Physician Decision|5|||
164457953|NCT03623321|594047212|FG000|Overall Study|Protocol Violation|1|||
164457954|NCT03623321|594047212|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
164457955|NCT03623321|594047212|FG000|Overall Study|Not further specified|43|||
164457956|NCT04241068|594047213|FG000|Core Treatment Period|Adverse Event|91|||
164457957|NCT04241068|594047213|FG000|Core Treatment Period|Change of Treatment|4|||
164598252|NCT01120379|594552998|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
164598253|NCT01120379|594552998|FG000|Two Year Timepoint|Lost to Follow-up|87|||
164598254|NCT01120379|594552998|FG000|Two Year Timepoint|Death|123|||
164598255|NCT01120379|594552998|FG000|Two Year Timepoint|Physician Decision|12|||
164598256|NCT01120379|594552998|FG000|Two Year Timepoint|Any other reason for early termination|4|||
164598257|NCT01120379|594552998|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
164598258|NCT01120379|594552998|FG000|Three Year Timepoint|Lost to Follow-up|43|||
164598259|NCT01120379|594552998|FG000|Three Year Timepoint|Death|120|||
164598260|NCT01120379|594552998|FG000|Three Year Timepoint|Physician Decision|9|||
164598261|NCT01120379|594552998|FG000|Three Year Timepoint|Any other reason for early termination|17|||
164598262|NCT01120379|594552998|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
164598263|NCT01120379|594552998|FG000|Four Year Timepoint|Lost to Follow-up|10|||
164598264|NCT01120379|594552998|FG000|Four Year Timepoint|Death|131|||
164598265|NCT01120379|594552998|FG000|Four Year Timepoint|Physician Decision|5|||
164598266|NCT01120379|594552998|FG000|Four Year Timepoint|Any other reason for early termination|217|||
164598267|NCT03162055|594552999|FG000|Overall Study|Adverse Event|6|||
164598268|NCT03162055|594553000|FG001|Overall Study|Adverse Event|5|||
164598269|NCT03162055|594552999|FG000|Overall Study|Death|3|||
164598270|NCT03162055|594553000|FG001|Overall Study|Death|3|||
164598271|NCT03162055|594552999|FG000|Overall Study|Lost to Follow-up|0|||
164598272|NCT03162055|594553000|FG001|Overall Study|Lost to Follow-up|1|||
164598273|NCT03162055|594552999|FG000|Overall Study|Study-specific withdrawal criteria|22|||
164598274|NCT03162055|594553000|FG001|Overall Study|Study-specific withdrawal criteria|14|||
164598275|NCT03162055|594552999|FG000|Overall Study|Withdrawal by Subject|17|||
164598276|NCT03162055|594553000|FG001|Overall Study|Withdrawal by Subject|2|||
164598277|NCT03162055|594552999|FG000|Overall Study|Did not receive treatment|2|||
164598278|NCT03162055|594553000|FG001|Overall Study|Did not receive treatment|0|||
164598279|NCT03162055|594552999|FG000|Overall Study|Incorrect randomization|4|||
164598280|NCT03162055|594553000|FG001|Overall Study|Incorrect randomization|3|||
164598281|NCT03162055|594552999|FG000|Overall Study|Other|8|||
164598282|NCT03162055|594553000|FG001|Overall Study|Other|15|||
164598283|NCT04031404|594553001|FG000|Baseline|Lost to Follow-up|0|||
164598284|NCT04031404|594553002|FG001|Baseline|Lost to Follow-up|1|||
164598285|NCT04031404|594553001|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
164598286|NCT04031404|594553002|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
164598287|NCT04031404|594553001|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
164598288|NCT04031404|594553002|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
164598289|NCT04031404|594553001|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
164598290|NCT04031404|594553002|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
164598291|NCT04031404|594553001|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
164598292|NCT04031404|594553002|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
164598293|NCT01993615|594553006|FG000|Overall Study|Death|1|||
164598294|NCT01993615|594553007|FG001|Overall Study|Death|0|||
164457958|NCT04241068|594047213|FG000|Core Treatment Period|Consent Withdrawn|143|||
164457959|NCT04241068|594047213|FG000|Core Treatment Period|Death|26|||
164598295|NCT02064205|594553010|FG000|Overall Study|Withdrawal by Subject|1|||
164598296|NCT01354353|594553014|FG000|Overall Study|Adverse Event|1|||
164598297|NCT01354353|594553015|FG001|Overall Study|Adverse Event|0|||
164598298|NCT01354353|594553016|FG002|Overall Study|Adverse Event|0|||
164457960|NCT04241068|594047213|FG000|Core Treatment Period|Disease Progression|67|||
164457961|NCT04241068|594047213|FG000|Core Treatment Period|Investigator Decision|40|||
164457962|NCT04241068|594047213|FG000|Core Treatment Period|Loss of Capacity|9|||
164457963|NCT04241068|594047213|FG000|Core Treatment Period|Lost to Follow-up|11|||
164457964|NCT04241068|594047213|FG000|Core Treatment Period|Relocation|4|||
164598299|NCT01354353|594553017|FG003|Overall Study|Adverse Event|4|||
164598300|NCT01354353|594553018|FG004|Overall Study|Adverse Event|0|||
164598301|NCT01354353|594553019|FG005|Overall Study|Adverse Event|5|||
164598302|NCT01354353|594553014|FG000|Overall Study|Entry Criteria Not Met|0|||
164598303|NCT01354353|594553015|FG001|Overall Study|Entry Criteria Not Met|0|||
164598304|NCT01354353|594553016|FG002|Overall Study|Entry Criteria Not Met|0|||
164598305|NCT01354353|594553017|FG003|Overall Study|Entry Criteria Not Met|1|||
164598306|NCT01354353|594553018|FG004|Overall Study|Entry Criteria Not Met|1|||
164598307|NCT01354353|594553019|FG005|Overall Study|Entry Criteria Not Met|0|||
164598308|NCT01354353|594553014|FG000|Overall Study|Physician Decision|0|||
164598309|NCT01354353|594553015|FG001|Overall Study|Physician Decision|1|||
164598310|NCT01354353|594553016|FG002|Overall Study|Physician Decision|1|||
164598311|NCT01354353|594553017|FG003|Overall Study|Physician Decision|0|||
164598312|NCT01354353|594553018|FG004|Overall Study|Physician Decision|0|||
164598313|NCT01354353|594553019|FG005|Overall Study|Physician Decision|0|||
164598314|NCT01354353|594553014|FG000|Overall Study|Withdrawal by Subject|2|||
164598315|NCT01354353|594553015|FG001|Overall Study|Withdrawal by Subject|0|||
164598316|NCT01354353|594553016|FG002|Overall Study|Withdrawal by Subject|1|||
164598317|NCT01354353|594553017|FG003|Overall Study|Withdrawal by Subject|0|||
164598318|NCT01354353|594553018|FG004|Overall Study|Withdrawal by Subject|0|||
164598319|NCT01354353|594553019|FG005|Overall Study|Withdrawal by Subject|1|||
164598320|NCT05674344|594553020|FG000|Overall Study|Screen Fail|21|||
164598321|NCT05674344|594553020|FG000|Overall Study|Incomplete study procedures|3|||
164598322|NCT00111917|594553021|FG000|Overall Study|Withdrawal by Subject|1|||
164598323|NCT00111917|594553022|FG001|Overall Study|Withdrawal by Subject|1|||
164598324|NCT01640925|594553023|FG000|Overall Study|Withdrawal by Subject|1|||
164598325|NCT01640925|594553024|FG001|Overall Study|Withdrawal by Subject|0|||
164598326|NCT01640925|594553023|FG000|Overall Study|Previously enrolled in this trial|13|||
164598327|NCT01640925|594553024|FG001|Overall Study|Previously enrolled in this trial|11|||
164598328|NCT02156492|594553025|FG000|Period 1|No Reason Given|0|||
164598329|NCT02156492|594553026|FG001|Period 1|No Reason Given|1|||
164598330|NCT02156492|594553027|FG002|Period 1|No Reason Given|0|||
164598331|NCT02156492|594553025|FG000|Period 3|Adverse Event|0|||
164598332|NCT02156492|594553026|FG001|Period 3|Adverse Event|1|||
164598333|NCT02156492|594553027|FG002|Period 3|Adverse Event|0|||
164598334|NCT05254613|594553032|FG000|Overall Study|Lost to Follow-up|0|||
164598335|NCT05254613|594553033|FG001|Overall Study|Lost to Follow-up|0|||
164598336|NCT05254613|594553034|FG002|Overall Study|Lost to Follow-up|1|||
164598337|NCT01944969|594553037|FG000|Overall Study|Adverse Event|1|||
164598338|NCT01944969|594553037|FG000|Overall Study|Lack of Efficacy|1|||
164598339|NCT01944969|594553037|FG000|Overall Study|Non-compliance with IMP|1|||
164598340|NCT01944969|594553037|FG000|Overall Study|Administrative or other reasons|23|||
164598341|NCT01104584|594553039|FG000|Overall Study|Study drug never administered|21|||
164598342|NCT01104584|594553039|FG000|Overall Study|Study prematurely discontinued|2|||
164598343|NCT02370498|594553040|FG000|Overall Study|Adverse Event|10|||
164457965|NCT04241068|594047213|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
164457966|NCT04241068|594047213|FG000|Core Treatment Period|Study Visit Burden|40|||
164457967|NCT04241068|594047213|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
164457968|NCT04241068|594047213|FG000|Core Treatment Period|Missing|2|||
164457969|NCT04241068|594047213|FG000|Core Treatment Period|Reason Not Specified|41|||
164457970|NCT04241068|594047213|FG000|LTE Period|Adverse Event|19|||
164457971|NCT04241068|594047213|FG000|LTE Period|Change of Treatment|1|||
164457972|NCT04241068|594047213|FG000|LTE Period|Consent Withdrawn|71|||
164457973|NCT04241068|594047213|FG000|LTE Period|Death|8|||
164457974|NCT04241068|594047213|FG000|LTE Period|Disease Progression|11|||
164457975|NCT04241068|594047213|FG000|LTE Period|Investigator Decision|12|||
164457976|NCT04241068|594047213|FG000|LTE Period|Loss of Capacity|2|||
164457977|NCT04241068|594047213|FG000|LTE Period|Lost to Follow-up|7|||
164457978|NCT04241068|594047213|FG000|LTE Period|Relocation|6|||
164457979|NCT04241068|594047213|FG000|LTE Period|Site Terminated by Sponsor|26|||
164457980|NCT04241068|594047213|FG000|LTE Period|Study Terminated by Sponsor|276|||
164457981|NCT04241068|594047213|FG000|LTE Period|Study Visit Burden|10|||
164457982|NCT04241068|594047213|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
164457983|NCT04241068|594047213|FG000|LTE Period|Reason Not Specified|65|||
164457984|NCT04492007|594047214|FG000|Overall Study|Lost to Follow-up|1|||
164598344|NCT02370498|594553041|FG001|Overall Study|Adverse Event|8|||
164598345|NCT02370498|594553040|FG000|Overall Study|Death|263|||
164598346|NCT02370498|594553041|FG001|Overall Study|Death|265|||
164707438|NCT02132754|594953593|FG021|Overall Study|Excluded Medication|0|||
164457985|NCT04492007|594047215|FG001|Overall Study|Lost to Follow-up|1|||
164457986|NCT04492007|594047216|FG002|Overall Study|Lost to Follow-up|2|||
164457987|NCT04492007|594047217|FG003|Overall Study|Lost to Follow-up|2|||
164457988|NCT04492007|594047214|FG000|Overall Study|Protocol Violation|1|||
164707439|NCT02132754|594953594|FG022|Overall Study|Excluded Medication|0|||
164457989|NCT04492007|594047215|FG001|Overall Study|Protocol Violation|1|||
164457990|NCT04492007|594047216|FG002|Overall Study|Protocol Violation|1|||
164457991|NCT04492007|594047217|FG003|Overall Study|Protocol Violation|1|||
164598347|NCT02370498|594553040|FG000|Overall Study|Protocol Violation|1|||
164598348|NCT02370498|594553041|FG001|Overall Study|Protocol Violation|2|||
164598349|NCT02370498|594553040|FG000|Overall Study|Withdrawal by Subject|7|||
164598350|NCT02370498|594553041|FG001|Overall Study|Withdrawal by Subject|12|||
164598351|NCT02370498|594553040|FG000|Overall Study|Sponsor's decision|15|||
164707440|NCT02132754|594953595|FG023|Overall Study|Excluded Medication|0|||
164598352|NCT02370498|594553041|FG001|Overall Study|Sponsor's decision|9|||
164457992|NCT04492007|594047214|FG000|Overall Study|Withdrawal by Subject|0|||
164457993|NCT04492007|594047215|FG001|Overall Study|Withdrawal by Subject|0|||
164457994|NCT04492007|594047216|FG002|Overall Study|Withdrawal by Subject|1|||
164457995|NCT04492007|594047217|FG003|Overall Study|Withdrawal by Subject|1|||
164457996|NCT04229992|594047220|FG000|Overall Study|Withdrawal by Subject|0|||
164457997|NCT04229992|594047221|FG001|Overall Study|Withdrawal by Subject|2|||
164457998|NCT04229992|594047222|FG002|Overall Study|Withdrawal by Subject|1|||
164457999|NCT04229992|594047223|FG003|Overall Study|Withdrawal by Subject|1|||
164458000|NCT04229992|594047220|FG000|Overall Study|Adverse Event|1|||
164458001|NCT04229992|594047221|FG001|Overall Study|Adverse Event|1|||
164458002|NCT04229992|594047222|FG002|Overall Study|Adverse Event|3|||
164458003|NCT04229992|594047223|FG003|Overall Study|Adverse Event|1|||
164598353|NCT02387372|594553045|FG000|Overall Study|Not Treated|1|||
164598354|NCT02387372|594553046|FG001|Overall Study|Not Treated|0|||
164598355|NCT03225716|594553047|FG000|Overall Study|Withdrawal by Subject|2|||
164598356|NCT03225716|594553048|FG001|Overall Study|Withdrawal by Subject|2|||
164598357|NCT03225716|594553049|FG002|Overall Study|Withdrawal by Subject|0|||
164598358|NCT03225716|594553047|FG000|Overall Study|Lack of Efficacy|1|||
164598359|NCT03225716|594553048|FG001|Overall Study|Lack of Efficacy|0|||
164598360|NCT03225716|594553049|FG002|Overall Study|Lack of Efficacy|0|||
164598361|NCT03225716|594553047|FG000|Overall Study|Adverse Event|2|||
164598362|NCT03225716|594553048|FG001|Overall Study|Adverse Event|0|||
164598363|NCT03225716|594553049|FG002|Overall Study|Adverse Event|1|||
164598364|NCT03225716|594553047|FG000|Overall Study|Study early termination by Sponsor|0|||
164598365|NCT03225716|594553048|FG001|Overall Study|Study early termination by Sponsor|0|||
164598366|NCT03225716|594553049|FG002|Overall Study|Study early termination by Sponsor|2|||
164598367|NCT03421964|594553050|FG000|Overall Study|Lost to Follow-up|11|||
164598368|NCT03421964|594553051|FG001|Overall Study|Lost to Follow-up|21|||
164598369|NCT03421964|594553050|FG000|Overall Study|Withdrawal by Subject|9|||
164598370|NCT03421964|594553051|FG001|Overall Study|Withdrawal by Subject|3|||
164598371|NCT03421964|594553050|FG000|Overall Study|Incarcerated|1|||
164707441|NCT02132754|594953596|FG024|Overall Study|Excluded Medication|0|||
164707442|NCT02132754|594953597|FG025|Overall Study|Excluded Medication|0|||
164707443|NCT02132754|594953598|FG026|Overall Study|Excluded Medication|0|||
164707444|NCT02132754|594953599|FG027|Overall Study|Excluded Medication|0|||
164707445|NCT02132754|594953600|FG028|Overall Study|Excluded Medication|0|||
164707446|NCT02132754|594953601|FG029|Overall Study|Excluded Medication|0|||
164707447|NCT02132754|594953602|FG030|Overall Study|Excluded Medication|0|||
164407293|NCT00542880|593860728|FG000|Period 1|Development of study-specific criteria|1|||
164407294|NCT00542880|593860729|FG001|Period 1|Development of study-specific criteria|2|||
164407295|NCT00542880|593860728|FG000|Period 1|Withdrawal by Subject|1|||
164407296|NCT00542880|593860729|FG001|Period 1|Withdrawal by Subject|1|||
164407297|NCT00542880|593860728|FG000|Period 1|Protocol Violation|0|||
164407298|NCT00542880|593860729|FG001|Period 1|Protocol Violation|1|||
164407299|NCT00542880|593860728|FG000|Period 2|Adverse Event|5|||
164407300|NCT00542880|593860729|FG001|Period 2|Adverse Event|7|||
164407301|NCT00542880|593860728|FG000|Period 2|Eligibility not fulfilled|0|||
164407302|NCT00542880|593860729|FG001|Period 2|Eligibility not fulfilled|1|||
164407303|NCT00542880|593860728|FG000|Period 2|Discontinuation criteria|2|||
164407304|NCT00542880|593860729|FG001|Period 2|Discontinuation criteria|0|||
164407305|NCT00542880|593860728|FG000|Period 2|Severe non-compliance|0|||
164407306|NCT00542880|593860729|FG001|Period 2|Severe non-compliance|1|||
164407307|NCT00542880|593860728|FG000|Period 2|Other|0|||
164407308|NCT00542880|593860729|FG001|Period 2|Other|1|||
164407309|NCT00542880|593860728|FG000|Period 3|Adverse Event|0|||
164407310|NCT00542880|593860729|FG001|Period 3|Adverse Event|2|||
164407311|NCT01816763|593862024|FG000|Overall Study|The main reason for an incomplete survey|4|||
164407312|NCT01816763|593862025|FG001|Overall Study|The main reason for an incomplete survey|15|||
164407313|NCT01816763|593862026|FG002|Overall Study|The main reason for an incomplete survey|11|||
164407314|NCT02243202|593862031|FG000|Overall Study|Adverse Event|5|||
164407315|NCT02243202|593862032|FG001|Overall Study|Adverse Event|6|||
164458004|NCT04229992|594047220|FG000|Overall Study|Lost to Follow-up|0|||
164458005|NCT04229992|594047221|FG001|Overall Study|Lost to Follow-up|0|||
164598372|NCT03421964|594553051|FG001|Overall Study|Incarcerated|0|||
164598373|NCT03421964|594553050|FG000|Overall Study|Inpt Treatment Facility|1|||
164598374|NCT03421964|594553051|FG001|Overall Study|Inpt Treatment Facility|1|||
164598375|NCT03421964|594553050|FG000|Overall Study|Virtual Platform Issues|1|||
164598376|NCT03421964|594553051|FG001|Overall Study|Virtual Platform Issues|1|||
164407316|NCT02243202|593862033|FG002|Overall Study|Adverse Event|10|||
164407317|NCT02243202|593862034|FG003|Overall Study|Adverse Event|4|||
164407318|NCT02243202|593862031|FG000|Overall Study|Lost to Follow-up|9|||
164458006|NCT04229992|594047222|FG002|Overall Study|Lost to Follow-up|0|||
164458007|NCT04229992|594047223|FG003|Overall Study|Lost to Follow-up|1|||
164598377|NCT01153763|594553052|FG000|Overall Study|Study Closed|16|||
164707448|NCT02132754|594953603|FG031|Overall Study|Excluded Medication|0|||
164407319|NCT02243202|593862032|FG001|Overall Study|Lost to Follow-up|9|||
164407320|NCT02243202|593862033|FG002|Overall Study|Lost to Follow-up|14|||
164407321|NCT02243202|593862034|FG003|Overall Study|Lost to Follow-up|11|||
164407322|NCT02243202|593862031|FG000|Overall Study|Protocol Violation|3|||
164598378|NCT01153763|594553052|FG000|Overall Study|Lost to Follow-up|1|||
164598379|NCT01153763|594553052|FG000|Overall Study|Physician Decision|2|||
164598380|NCT01153763|594553052|FG000|Overall Study|Withdrawal by Subject|2|||
164598381|NCT05373706|594553057|FG000|Overall Study|Lost to Follow-up|2|||
164598382|NCT05373706|594553058|FG001|Overall Study|Lost to Follow-up|2|||
164598383|NCT03491553|594553059|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
164598384|NCT03491553|594553060|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
164598385|NCT03491553|594553061|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
164598386|NCT03491553|594553062|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
164598387|NCT03491553|594553063|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
164598388|NCT03491553|594553064|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
164598389|NCT03491553|594553059|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
164598390|NCT03491553|594553060|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
164598391|NCT03491553|594553061|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
164598392|NCT03491553|594553062|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
164598393|NCT03491553|594553063|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
164598394|NCT03491553|594553064|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
164598395|NCT01479374|594553065|FG000|Overall Study|Adverse Event|2|||
164598396|NCT01479374|594553066|FG001|Overall Study|Adverse Event|1|||
164598397|NCT01479374|594553067|FG002|Overall Study|Adverse Event|0|||
164598398|NCT01479374|594553065|FG000|Overall Study|Lost to Follow-up|1|||
164598399|NCT01479374|594553066|FG001|Overall Study|Lost to Follow-up|2|||
164598400|NCT01479374|594553067|FG002|Overall Study|Lost to Follow-up|0|||
164598401|NCT01479374|594553065|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
164598402|NCT01479374|594553066|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
164598403|NCT01479374|594553067|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
164598404|NCT01479374|594553065|FG000|Overall Study|Other|0|||
164598405|NCT01479374|594553066|FG001|Overall Study|Other|4|||
164598406|NCT01479374|594553067|FG002|Overall Study|Other|5|||
164598407|NCT01606761|594553069|FG000|Prior to Week 24|Lost to Follow-up|0|||
164598408|NCT01606761|594553070|FG001|Prior to Week 24|Lost to Follow-up|3|||
164598409|NCT01606761|594553071|FG002|Prior to Week 24|Lost to Follow-up|2|||
164598410|NCT01606761|594553072|FG003|Prior to Week 24|Lost to Follow-up|0|||
164598411|NCT01606761|594553073|FG004|Prior to Week 24|Lost to Follow-up|0|||
164598412|NCT01606761|594553069|FG000|Prior to Week 24|Withdrawal by Subject|12|||
164598413|NCT01606761|594553070|FG001|Prior to Week 24|Withdrawal by Subject|10|||
164598414|NCT01606761|594553071|FG002|Prior to Week 24|Withdrawal by Subject|9|||
164598415|NCT01606761|594553072|FG003|Prior to Week 24|Withdrawal by Subject|0|||
164458008|NCT03457142|594047224|FG000|Overall Study|Death|1|||
164458009|NCT03770273|594047225|FG000|Overall Study|Adverse Event|2|||
164458010|NCT03770273|594047226|FG001|Overall Study|Adverse Event|0|||
164458011|NCT03770273|594047225|FG000|Overall Study|Lost to Follow-up|1|||
164458012|NCT03770273|594047226|FG001|Overall Study|Lost to Follow-up|1|||
164458013|NCT00418886|594047227|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
164458014|NCT00418886|594047228|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
164458015|NCT00418886|594047227|FG000|Randomized Period|Death|122|||
164458016|NCT00418886|594047228|FG001|Randomized Period|Death|147|||
164458017|NCT00418886|594047227|FG000|Randomized Period|Withdrawal by Subject|9|||
164458018|NCT00418886|594047228|FG001|Randomized Period|Withdrawal by Subject|10|||
164458019|NCT00418886|594047227|FG000|Randomized Period|Lost to Follow-up|4|||
164458020|NCT00418886|594047228|FG001|Randomized Period|Lost to Follow-up|6|||
164458021|NCT00418886|594047227|FG000|Randomized Period|withdrawn due to other reason|1|||
164458022|NCT00418886|594047228|FG001|Randomized Period|withdrawn due to other reason|0|||
164458023|NCT00418886|594047227|FG000|Randomized Period|randomised but no treatment received|0|||
164458024|NCT00418886|594047228|FG001|Randomized Period|randomised but no treatment received|1|||
164458025|NCT04060654|594047229|FG000|Overall Study|Withdrawal by Subject|1|||
164458026|NCT04060654|594047229|FG000|Overall Study|Lost to Follow-up|5|||
164458027|NCT03907397|594047232|FG000|Overall Study|Lost to Follow-up|0|||
164458028|NCT03907397|594047233|FG001|Overall Study|Lost to Follow-up|1|||
164458029|NCT03907397|594047232|FG000|Overall Study|Physician Decision|2|||
164458030|NCT03907397|594047233|FG001|Overall Study|Physician Decision|1|||
164598416|NCT01606761|594553073|FG004|Prior to Week 24|Withdrawal by Subject|0|||
164458031|NCT03907397|594047232|FG000|Overall Study|Withdrawal by Subject|5|||
164458032|NCT03907397|594047233|FG001|Overall Study|Withdrawal by Subject|4|||
164598417|NCT01606761|594553069|FG000|Prior to Week 24|Adverse Event|11|||
164458033|NCT03907397|594047232|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
164598418|NCT01606761|594553070|FG001|Prior to Week 24|Adverse Event|18|||
164598419|NCT01606761|594553071|FG002|Prior to Week 24|Adverse Event|22|||
164598420|NCT01606761|594553072|FG003|Prior to Week 24|Adverse Event|0|||
164458034|NCT03907397|594047233|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
164458035|NCT05948670|594047239|FG000|Overall Study|Protocol Violation|6|||
164458036|NCT05948670|594047240|FG001|Overall Study|Protocol Violation|8|||
164598421|NCT01606761|594553073|FG004|Prior to Week 24|Adverse Event|0|||
164598422|NCT01606761|594553069|FG000|Prior to Week 24|Lack of Efficacy|15|||
164598423|NCT01606761|594553070|FG001|Prior to Week 24|Lack of Efficacy|14|||
164598424|NCT01606761|594553071|FG002|Prior to Week 24|Lack of Efficacy|8|||
164707449|NCT02132754|594953604|FG032|Overall Study|Excluded Medication|0|||
164707450|NCT02132754|594953605|FG033|Overall Study|Excluded Medication|1|||
164707451|NCT02132754|594953572|FG000|Overall Study|Physician Decision|0|||
164707452|NCT02132754|594953573|FG001|Overall Study|Physician Decision|0|||
164707453|NCT02132754|594953574|FG002|Overall Study|Physician Decision|0|||
164707454|NCT02132754|594953575|FG003|Overall Study|Physician Decision|0|||
164707455|NCT02132754|594953576|FG004|Overall Study|Physician Decision|0|||
164707456|NCT02132754|594953577|FG005|Overall Study|Physician Decision|0|||
164707457|NCT02132754|594953578|FG006|Overall Study|Physician Decision|0|||
164707458|NCT02132754|594953579|FG007|Overall Study|Physician Decision|0|||
164707459|NCT02132754|594953580|FG008|Overall Study|Physician Decision|0|||
164707460|NCT02132754|594953581|FG009|Overall Study|Physician Decision|1|||
164707461|NCT02132754|594953582|FG010|Overall Study|Physician Decision|0|||
164707462|NCT02132754|594953583|FG011|Overall Study|Physician Decision|1|||
164707463|NCT02132754|594953584|FG012|Overall Study|Physician Decision|1|||
164707464|NCT02132754|594953585|FG013|Overall Study|Physician Decision|0|||
164707465|NCT02132754|594953586|FG014|Overall Study|Physician Decision|0|||
164707466|NCT02132754|594953587|FG015|Overall Study|Physician Decision|1|||
164707467|NCT02132754|594953588|FG016|Overall Study|Physician Decision|0|||
164707468|NCT02132754|594953589|FG017|Overall Study|Physician Decision|0|||
164707469|NCT02132754|594953590|FG018|Overall Study|Physician Decision|0|||
164707470|NCT02132754|594953591|FG019|Overall Study|Physician Decision|0|||
164707471|NCT02132754|594953592|FG020|Overall Study|Physician Decision|0|||
164707472|NCT02132754|594953593|FG021|Overall Study|Physician Decision|0|||
164707473|NCT02132754|594953594|FG022|Overall Study|Physician Decision|0|||
164707474|NCT02132754|594953595|FG023|Overall Study|Physician Decision|0|||
164707475|NCT02132754|594953596|FG024|Overall Study|Physician Decision|1|||
164707476|NCT02132754|594953597|FG025|Overall Study|Physician Decision|0|||
164707477|NCT02132754|594953598|FG026|Overall Study|Physician Decision|0|||
164707478|NCT02132754|594953599|FG027|Overall Study|Physician Decision|0|||
164707479|NCT02132754|594953600|FG028|Overall Study|Physician Decision|0|||
164707480|NCT02132754|594953601|FG029|Overall Study|Physician Decision|0|||
164707481|NCT02132754|594953602|FG030|Overall Study|Physician Decision|0|||
164707482|NCT02132754|594953603|FG031|Overall Study|Physician Decision|1|||
164707483|NCT02132754|594953604|FG032|Overall Study|Physician Decision|0|||
164707484|NCT02132754|594953605|FG033|Overall Study|Physician Decision|3|||
164707485|NCT02132754|594953572|FG000|Overall Study|Progressive Disease|1|||
164707486|NCT02132754|594953573|FG001|Overall Study|Progressive Disease|1|||
164707487|NCT02132754|594953574|FG002|Overall Study|Progressive Disease|1|||
164707488|NCT02132754|594953575|FG003|Overall Study|Progressive Disease|1|||
164707489|NCT02132754|594953576|FG004|Overall Study|Progressive Disease|1|||
164707490|NCT02132754|594953577|FG005|Overall Study|Progressive Disease|1|||
164707491|NCT02132754|594953578|FG006|Overall Study|Progressive Disease|1|||
164707492|NCT02132754|594953579|FG007|Overall Study|Progressive Disease|1|||
164707493|NCT02132754|594953580|FG008|Overall Study|Progressive Disease|1|||
164707494|NCT02132754|594953581|FG009|Overall Study|Progressive Disease|3|||
164707495|NCT02132754|594953582|FG010|Overall Study|Progressive Disease|3|||
164707496|NCT02132754|594953583|FG011|Overall Study|Progressive Disease|2|||
164707497|NCT02132754|594953584|FG012|Overall Study|Progressive Disease|2|||
164707498|NCT02132754|594953585|FG013|Overall Study|Progressive Disease|3|||
164707499|NCT02132754|594953586|FG014|Overall Study|Progressive Disease|2|||
164707500|NCT02132754|594953587|FG015|Overall Study|Progressive Disease|1|||
164707501|NCT02132754|594953588|FG016|Overall Study|Progressive Disease|2|||
164707502|NCT02132754|594953589|FG017|Overall Study|Progressive Disease|1|||
164707503|NCT02132754|594953590|FG018|Overall Study|Progressive Disease|3|||
164707504|NCT02132754|594953591|FG019|Overall Study|Progressive Disease|1|||
164707505|NCT02132754|594953592|FG020|Overall Study|Progressive Disease|1|||
164707506|NCT02132754|594953593|FG021|Overall Study|Progressive Disease|3|||
164707507|NCT02132754|594953594|FG022|Overall Study|Progressive Disease|2|||
164707508|NCT02132754|594953595|FG023|Overall Study|Progressive Disease|3|||
164707509|NCT02132754|594953596|FG024|Overall Study|Progressive Disease|0|||
164707510|NCT02132754|594953597|FG025|Overall Study|Progressive Disease|1|||
164707511|NCT02132754|594953598|FG026|Overall Study|Progressive Disease|2|||
164407323|NCT02243202|593862032|FG001|Overall Study|Protocol Violation|1|||
164407324|NCT02243202|593862033|FG002|Overall Study|Protocol Violation|2|||
164407325|NCT02243202|593862034|FG003|Overall Study|Protocol Violation|1|||
164407326|NCT02243202|593862031|FG000|Overall Study|Withdrawal by Subject|7|||
164407327|NCT02243202|593862032|FG001|Overall Study|Withdrawal by Subject|6|||
164407328|NCT02243202|593862033|FG002|Overall Study|Withdrawal by Subject|4|||
164407329|NCT02243202|593862034|FG003|Overall Study|Withdrawal by Subject|4|||
164407330|NCT02243202|593862031|FG000|Overall Study|Other|1|||
164407331|NCT02243202|593862032|FG001|Overall Study|Other|3|||
164407332|NCT02243202|593862033|FG002|Overall Study|Other|1|||
164707512|NCT02132754|594953599|FG027|Overall Study|Progressive Disease|1|||
164707513|NCT02132754|594953600|FG028|Overall Study|Progressive Disease|2|||
164707514|NCT02132754|594953601|FG029|Overall Study|Progressive Disease|3|||
164707515|NCT02132754|594953602|FG030|Overall Study|Progressive Disease|1|||
164707516|NCT02132754|594953603|FG031|Overall Study|Progressive Disease|1|||
164707517|NCT02132754|594953604|FG032|Overall Study|Progressive Disease|3|||
164707518|NCT02132754|594953605|FG033|Overall Study|Progressive Disease|6|||
164707519|NCT02132754|594953572|FG000|Overall Study|Screen Failure|0|||
164458037|NCT05948670|594047239|FG000|Overall Study|Withdrawal by Subject|0|||
164458038|NCT05948670|594047240|FG001|Overall Study|Withdrawal by Subject|1|||
164458039|NCT03056040|594047242|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
164458040|NCT03056040|594047243|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
164458041|NCT03056040|594047242|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
164458042|NCT03056040|594047243|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
164458043|NCT03056040|594047242|FG000|Primary Evaluation Period|Pregnancy|0|||
164458044|NCT03056040|594047243|FG001|Primary Evaluation Period|Pregnancy|1|||
164458045|NCT03056040|594047242|FG000|Primary Evaluation Period|Randomized, not treated|1|||
164458046|NCT03056040|594047243|FG001|Primary Evaluation Period|Randomized, not treated|1|||
164458047|NCT03056040|594047242|FG000|Extension Period|Physician Decision|3|||
164458048|NCT03056040|594047243|FG001|Extension Period|Physician Decision|3|||
164458049|NCT03056040|594047242|FG000|Extension Period|Lost to Follow-up|0|||
164458050|NCT03056040|594047243|FG001|Extension Period|Lost to Follow-up|1|||
164458051|NCT03056040|594047242|FG000|Extension Period|Death|0|||
164458052|NCT03056040|594047243|FG001|Extension Period|Death|3|||
164458053|NCT03056040|594047242|FG000|Extension Period|Withdrawal by Subject|1|||
164458054|NCT03056040|594047243|FG001|Extension Period|Withdrawal by Subject|0|||
164458055|NCT05268393|594047249|FG000|Overall Study|Withdrawal by Subject|2|||
164458056|NCT05268393|594047250|FG001|Overall Study|Withdrawal by Subject|1|||
164458057|NCT00999804|594047252|FG000|Overall Study|Lack of Efficacy|9|||
164458058|NCT00999804|594047253|FG001|Overall Study|Lack of Efficacy|2|||
164458059|NCT00999804|594047252|FG000|Overall Study|Adverse Event|4|||
164458060|NCT00999804|594047253|FG001|Overall Study|Adverse Event|3|||
164458061|NCT00999804|594047252|FG000|Overall Study|Withdrawal by Subject|4|||
164458062|NCT00999804|594047253|FG001|Overall Study|Withdrawal by Subject|0|||
164458063|NCT00999804|594047252|FG000|Overall Study|Death|1|||
164458064|NCT00999804|594047253|FG001|Overall Study|Death|0|||
164458065|NCT00999804|594047252|FG000|Overall Study|Ineligible|3|||
164458066|NCT00999804|594047253|FG001|Overall Study|Ineligible|0|||
164458067|NCT03850678|594047255|FG000|Overall Study|Withdrawal by Subject|3|||
164458068|NCT03850678|594047256|FG001|Overall Study|Withdrawal by Subject|0|||
164458069|NCT03850678|594047255|FG000|Overall Study|Experimenter Error|1|||
164458070|NCT03850678|594047256|FG001|Overall Study|Experimenter Error|1|||
164458071|NCT03850678|594047255|FG000|Overall Study|Did Not Condition To Experiment|7|||
164458072|NCT03850678|594047256|FG001|Overall Study|Did Not Condition To Experiment|2|||
164458073|NCT02724631|594047260|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
164458074|NCT02908477|594047261|FG000|Overall Study|Withdrawal by Subject|8|||
164458075|NCT02908477|594047262|FG001|Overall Study|Withdrawal by Subject|28|||
164458076|NCT02100813|594047269|FG000|Overall Study|Adverse Event|0|||
164458077|NCT02100813|594047270|FG001|Overall Study|Adverse Event|0|||
164458078|NCT02100813|594047271|FG002|Overall Study|Adverse Event|0|||
164458079|NCT02100813|594047272|FG003|Overall Study|Adverse Event|0|||
164458080|NCT02100813|594047273|FG004|Overall Study|Adverse Event|0|||
164458081|NCT02100813|594047274|FG005|Overall Study|Adverse Event|0|||
164458082|NCT02100813|594047275|FG006|Overall Study|Adverse Event|0|||
164458083|NCT02100813|594047276|FG007|Overall Study|Adverse Event|1|||
164458084|NCT03575897|594047278|FG000|Overall Study|Lost to Follow-up|12|||
164458085|NCT03575897|594047279|FG001|Overall Study|Lost to Follow-up|13|||
164458086|NCT03150810|594047285|FG000|Overall Study|Death|4|||
164458087|NCT03150810|594047286|FG001|Overall Study|Death|8|||
164458088|NCT03150810|594047287|FG002|Overall Study|Death|7|||
164458089|NCT03150810|594047288|FG003|Overall Study|Death|2|||
164458090|NCT03150810|594047289|FG004|Overall Study|Death|2|||
164458091|NCT03150810|594047290|FG005|Overall Study|Death|10|||
164458092|NCT03150810|594047291|FG006|Overall Study|Death|8|||
164458093|NCT03150810|594047292|FG007|Overall Study|Death|6|||
164458094|NCT03150810|594047293|FG008|Overall Study|Death|18|||
164458095|NCT03150810|594047294|FG009|Overall Study|Death|3|||
164458096|NCT03150810|594047295|FG010|Overall Study|Death|19|||
164458097|NCT03150810|594047296|FG011|Overall Study|Death|1|||
164458098|NCT03150810|594047297|FG012|Overall Study|Death|19|||
164458099|NCT03150810|594047285|FG000|Overall Study|Withdrawal by Subject|0|||
164598425|NCT01606761|594553072|FG003|Prior to Week 24|Lack of Efficacy|0|||
164598426|NCT01606761|594553073|FG004|Prior to Week 24|Lack of Efficacy|0|||
164458100|NCT03150810|594047286|FG001|Overall Study|Withdrawal by Subject|1|||
164458101|NCT03150810|594047287|FG002|Overall Study|Withdrawal by Subject|1|||
164458102|NCT03150810|594047288|FG003|Overall Study|Withdrawal by Subject|1|||
164458103|NCT03150810|594047289|FG004|Overall Study|Withdrawal by Subject|0|||
164458104|NCT03150810|594047290|FG005|Overall Study|Withdrawal by Subject|0|||
164458105|NCT03150810|594047291|FG006|Overall Study|Withdrawal by Subject|2|||
164458106|NCT03150810|594047292|FG007|Overall Study|Withdrawal by Subject|0|||
164458107|NCT03150810|594047293|FG008|Overall Study|Withdrawal by Subject|2|||
164458108|NCT03150810|594047294|FG009|Overall Study|Withdrawal by Subject|0|||
164458109|NCT03150810|594047295|FG010|Overall Study|Withdrawal by Subject|1|||
164458110|NCT03150810|594047296|FG011|Overall Study|Withdrawal by Subject|0|||
164458111|NCT03150810|594047297|FG012|Overall Study|Withdrawal by Subject|1|||
164458112|NCT03150810|594047285|FG000|Overall Study|Sponsor Decision|0|||
164458113|NCT03150810|594047286|FG001|Overall Study|Sponsor Decision|2|||
164407333|NCT02243202|593862034|FG003|Overall Study|Other|2|||
164407334|NCT02243202|593862031|FG000|Overall Study|Randomized but not received treatment|0|||
164407335|NCT02243202|593862032|FG001|Overall Study|Randomized but not received treatment|0|||
164407336|NCT02243202|593862033|FG002|Overall Study|Randomized but not received treatment|0|||
164407337|NCT02243202|593862034|FG003|Overall Study|Randomized but not received treatment|1|||
164407338|NCT01147822|593862035|FG000|Overall Study|Lost to Follow-up|14|||
164407339|NCT01147822|593862036|FG001|Overall Study|Lost to Follow-up|6|||
164407340|NCT01147822|593862035|FG000|Overall Study|Withdrawal by Subject|10|||
164407341|NCT01147822|593862036|FG001|Overall Study|Withdrawal by Subject|16|||
164407342|NCT01147822|593862035|FG000|Overall Study|Physician Decision|9|||
164407343|NCT01147822|593862036|FG001|Overall Study|Physician Decision|8|||
164407344|NCT01147822|593862035|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
164407345|NCT01147822|593862036|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
164407346|NCT01147822|593862035|FG000|Overall Study|Protocol Violation|1|||
164407347|NCT01147822|593862036|FG001|Overall Study|Protocol Violation|1|||
164407348|NCT03010462|593862040|FG000|Overall Study|Withdrawal by Subject|3|||
164407349|NCT03010462|593862041|FG001|Overall Study|Withdrawal by Subject|1|||
164407350|NCT01966003|593862042|FG000|Overall Study|Death|43|||
164407351|NCT01966003|593862043|FG001|Overall Study|Death|36|||
164407352|NCT01966003|593862042|FG000|Overall Study|Protocol Violation|6|||
164407353|NCT01966003|593862043|FG001|Overall Study|Protocol Violation|4|||
164407354|NCT01966003|593862042|FG000|Overall Study|Lost to Follow-up|4|||
164407355|NCT01966003|593862043|FG001|Overall Study|Lost to Follow-up|3|||
164407356|NCT01966003|593862042|FG000|Overall Study|Physician Decision|12|||
164407357|NCT01966003|593862043|FG001|Overall Study|Physician Decision|13|||
164407358|NCT01966003|593862042|FG000|Overall Study|Withdrawal by Subject|29|||
164407359|NCT01966003|593862043|FG001|Overall Study|Withdrawal by Subject|19|||
164407360|NCT01966003|593862042|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
164407361|NCT01966003|593862043|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
164407362|NCT01966003|593862042|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
164407363|NCT01966003|593862043|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
164407364|NCT01966003|593862042|FG000|Overall Study|Other|1|||
164407365|NCT01966003|593862043|FG001|Overall Study|Other|1|||
164407366|NCT00185640|593862046|FG000|Overall Study|Not Eligible|4|||
164407367|NCT00185640|593862046|FG000|Overall Study|Withdrawal by Subject|3|||
164407368|NCT00185640|593862046|FG000|Overall Study|Death|138|||
164407369|NCT00058422|593862047|FG000|Overall Study|Not treated|2|||
164407370|NCT00871403|593862053|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
164407371|NCT00871403|593862054|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
164407372|NCT00871403|593862055|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
164407373|NCT00871403|593862053|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
164407374|NCT00871403|593862054|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
164407375|NCT00871403|593862055|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
164407376|NCT00871403|593862053|FG000|Combination Treatment Phase|Adverse Event|0|||
164407377|NCT00871403|593862054|FG001|Combination Treatment Phase|Adverse Event|17|||
164407378|NCT00871403|593862055|FG002|Combination Treatment Phase|Adverse Event|2|||
164407379|NCT00871403|593862053|FG000|Combination Treatment Phase|Disease Progression|0|||
164407380|NCT00871403|593862054|FG001|Combination Treatment Phase|Disease Progression|8|||
164407381|NCT00871403|593862055|FG002|Combination Treatment Phase|Disease Progression|5|||
164407382|NCT00871403|593862053|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
164407383|NCT00871403|593862054|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
164407384|NCT00871403|593862055|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
164407385|NCT00871403|593862053|FG000|Combination Treatment Phase|Physician Decision|0|||
164407386|NCT00871403|593862054|FG001|Combination Treatment Phase|Physician Decision|1|||
164407387|NCT00871403|593862055|FG002|Combination Treatment Phase|Physician Decision|3|||
164407388|NCT00871403|593862053|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
164407389|NCT00871403|593862054|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
164407390|NCT00871403|593862055|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
164407391|NCT00871403|593862053|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
164407392|NCT00871403|593862054|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
164707520|NCT02132754|594953573|FG001|Overall Study|Screen Failure|0|||
164407393|NCT00871403|593862055|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
164407394|NCT02748694|593862056|FG000|Overall Study|Voluntary Withdrawal|0|||
164407395|NCT02748694|593862057|FG001|Overall Study|Voluntary Withdrawal|0|||
164407396|NCT02748694|593862058|FG002|Overall Study|Voluntary Withdrawal|0|||
164407397|NCT02748694|593862059|FG003|Overall Study|Voluntary Withdrawal|0|||
164407398|NCT02748694|593862060|FG004|Overall Study|Voluntary Withdrawal|0|||
164407399|NCT02748694|593862061|FG005|Overall Study|Voluntary Withdrawal|0|||
164407400|NCT02748694|593862062|FG006|Overall Study|Voluntary Withdrawal|0|||
164407401|NCT02748694|593862063|FG007|Overall Study|Voluntary Withdrawal|0|||
164407402|NCT02748694|593862064|FG008|Overall Study|Voluntary Withdrawal|0|||
164407403|NCT02748694|593862065|FG009|Overall Study|Voluntary Withdrawal|0|||
164458114|NCT03150810|594047287|FG002|Overall Study|Sponsor Decision|0|||
164707521|NCT02132754|594953574|FG002|Overall Study|Screen Failure|0|||
164458115|NCT03150810|594047288|FG003|Overall Study|Sponsor Decision|0|||
164458116|NCT03150810|594047289|FG004|Overall Study|Sponsor Decision|1|||
164458117|NCT03150810|594047290|FG005|Overall Study|Sponsor Decision|1|||
164458118|NCT03150810|594047291|FG006|Overall Study|Sponsor Decision|0|||
164458119|NCT03150810|594047292|FG007|Overall Study|Sponsor Decision|0|||
164458120|NCT03150810|594047293|FG008|Overall Study|Sponsor Decision|1|||
164458121|NCT03150810|594047294|FG009|Overall Study|Sponsor Decision|0|||
164458122|NCT03150810|594047295|FG010|Overall Study|Sponsor Decision|0|||
164458123|NCT03150810|594047296|FG011|Overall Study|Sponsor Decision|0|||
164458124|NCT03150810|594047297|FG012|Overall Study|Sponsor Decision|5|||
164458125|NCT03150810|594047285|FG000|Overall Study|Lost to Follow-up|0|||
164458126|NCT03150810|594047286|FG001|Overall Study|Lost to Follow-up|1|||
164458127|NCT03150810|594047287|FG002|Overall Study|Lost to Follow-up|1|||
164458128|NCT03150810|594047288|FG003|Overall Study|Lost to Follow-up|0|||
164458129|NCT03150810|594047289|FG004|Overall Study|Lost to Follow-up|0|||
164458130|NCT03150810|594047290|FG005|Overall Study|Lost to Follow-up|0|||
164458131|NCT03150810|594047291|FG006|Overall Study|Lost to Follow-up|1|||
164458132|NCT03150810|594047292|FG007|Overall Study|Lost to Follow-up|0|||
164458133|NCT03150810|594047293|FG008|Overall Study|Lost to Follow-up|0|||
164458134|NCT03150810|594047294|FG009|Overall Study|Lost to Follow-up|0|||
164458135|NCT03150810|594047295|FG010|Overall Study|Lost to Follow-up|1|||
164458136|NCT03150810|594047296|FG011|Overall Study|Lost to Follow-up|0|||
164458137|NCT03150810|594047297|FG012|Overall Study|Lost to Follow-up|0|||
164458138|NCT03150810|594047285|FG000|Overall Study|Physician Decision|0|||
164458139|NCT03150810|594047286|FG001|Overall Study|Physician Decision|0|||
164458140|NCT03150810|594047287|FG002|Overall Study|Physician Decision|0|||
164458141|NCT03150810|594047288|FG003|Overall Study|Physician Decision|0|||
164458142|NCT03150810|594047289|FG004|Overall Study|Physician Decision|0|||
164458143|NCT03150810|594047290|FG005|Overall Study|Physician Decision|1|||
164458144|NCT03150810|594047291|FG006|Overall Study|Physician Decision|1|||
164458145|NCT03150810|594047292|FG007|Overall Study|Physician Decision|0|||
164458146|NCT03150810|594047293|FG008|Overall Study|Physician Decision|0|||
164458147|NCT03150810|594047294|FG009|Overall Study|Physician Decision|0|||
164458148|NCT03150810|594047295|FG010|Overall Study|Physician Decision|0|||
164458149|NCT03150810|594047296|FG011|Overall Study|Physician Decision|0|||
164458150|NCT03150810|594047297|FG012|Overall Study|Physician Decision|0|||
164458151|NCT03150810|594047285|FG000|Overall Study|Site withdrawal from study|0|||
164458152|NCT03150810|594047286|FG001|Overall Study|Site withdrawal from study|1|||
164458153|NCT03150810|594047287|FG002|Overall Study|Site withdrawal from study|0|||
164458154|NCT03150810|594047288|FG003|Overall Study|Site withdrawal from study|0|||
164458155|NCT03150810|594047289|FG004|Overall Study|Site withdrawal from study|0|||
164458156|NCT03150810|594047290|FG005|Overall Study|Site withdrawal from study|0|||
164458157|NCT03150810|594047291|FG006|Overall Study|Site withdrawal from study|0|||
164458158|NCT03150810|594047292|FG007|Overall Study|Site withdrawal from study|0|||
164458159|NCT03150810|594047293|FG008|Overall Study|Site withdrawal from study|0|||
164458160|NCT03150810|594047294|FG009|Overall Study|Site withdrawal from study|1|||
164458161|NCT03150810|594047295|FG010|Overall Study|Site withdrawal from study|1|||
164458162|NCT03150810|594047296|FG011|Overall Study|Site withdrawal from study|0|||
164458163|NCT03150810|594047297|FG012|Overall Study|Site withdrawal from study|0|||
164458164|NCT03150810|594047285|FG000|Overall Study|Hospice|0|||
164458165|NCT03150810|594047286|FG001|Overall Study|Hospice|0|||
164458166|NCT03150810|594047287|FG002|Overall Study|Hospice|0|||
164458167|NCT03150810|594047288|FG003|Overall Study|Hospice|0|||
164458168|NCT03150810|594047289|FG004|Overall Study|Hospice|0|||
164458169|NCT03150810|594047290|FG005|Overall Study|Hospice|1|||
164707522|NCT02132754|594953575|FG003|Overall Study|Screen Failure|0|||
164707523|NCT02132754|594953576|FG004|Overall Study|Screen Failure|0|||
164707524|NCT02132754|594953577|FG005|Overall Study|Screen Failure|0|||
164707525|NCT02132754|594953578|FG006|Overall Study|Screen Failure|0|||
164707526|NCT02132754|594953579|FG007|Overall Study|Screen Failure|0|||
164707527|NCT02132754|594953580|FG008|Overall Study|Screen Failure|0|||
164707528|NCT02132754|594953581|FG009|Overall Study|Screen Failure|0|||
164707529|NCT02132754|594953582|FG010|Overall Study|Screen Failure|0|||
164458170|NCT03150810|594047291|FG006|Overall Study|Hospice|0|||
164458171|NCT03150810|594047292|FG007|Overall Study|Hospice|0|||
164458172|NCT03150810|594047293|FG008|Overall Study|Hospice|0|||
164458173|NCT03150810|594047294|FG009|Overall Study|Hospice|0|||
164458174|NCT03150810|594047295|FG010|Overall Study|Hospice|0|||
164458175|NCT03150810|594047296|FG011|Overall Study|Hospice|0|||
164458176|NCT03150810|594047297|FG012|Overall Study|Hospice|0|||
164458177|NCT03150810|594047285|FG000|Overall Study|Participant relocated abroad.|0|||
164707530|NCT02132754|594953583|FG011|Overall Study|Screen Failure|0|||
164458178|NCT03150810|594047286|FG001|Overall Study|Participant relocated abroad.|0|||
164458179|NCT03150810|594047287|FG002|Overall Study|Participant relocated abroad.|0|||
164458180|NCT03150810|594047288|FG003|Overall Study|Participant relocated abroad.|0|||
164458181|NCT03150810|594047289|FG004|Overall Study|Participant relocated abroad.|0|||
164458182|NCT03150810|594047290|FG005|Overall Study|Participant relocated abroad.|1|||
164458183|NCT03150810|594047291|FG006|Overall Study|Participant relocated abroad.|0|||
164458184|NCT03150810|594047292|FG007|Overall Study|Participant relocated abroad.|0|||
164458185|NCT03150810|594047293|FG008|Overall Study|Participant relocated abroad.|0|||
164458186|NCT03150810|594047294|FG009|Overall Study|Participant relocated abroad.|0|||
164458187|NCT03150810|594047295|FG010|Overall Study|Participant relocated abroad.|0|||
164458188|NCT03150810|594047296|FG011|Overall Study|Participant relocated abroad.|0|||
164458189|NCT03150810|594047297|FG012|Overall Study|Participant relocated abroad.|0|||
164458190|NCT03150810|594047285|FG000|Overall Study|Transferred care to oncologist|0|||
164458191|NCT03150810|594047286|FG001|Overall Study|Transferred care to oncologist|0|||
164458192|NCT03150810|594047287|FG002|Overall Study|Transferred care to oncologist|0|||
164458193|NCT03150810|594047288|FG003|Overall Study|Transferred care to oncologist|0|||
164458194|NCT03150810|594047289|FG004|Overall Study|Transferred care to oncologist|0|||
164458195|NCT03150810|594047290|FG005|Overall Study|Transferred care to oncologist|0|||
164458196|NCT03150810|594047291|FG006|Overall Study|Transferred care to oncologist|2|||
164458197|NCT03150810|594047292|FG007|Overall Study|Transferred care to oncologist|0|||
164458198|NCT03150810|594047293|FG008|Overall Study|Transferred care to oncologist|0|||
164458199|NCT03150810|594047294|FG009|Overall Study|Transferred care to oncologist|0|||
164458200|NCT03150810|594047295|FG010|Overall Study|Transferred care to oncologist|0|||
164458201|NCT03150810|594047296|FG011|Overall Study|Transferred care to oncologist|0|||
164458202|NCT03150810|594047297|FG012|Overall Study|Transferred care to oncologist|0|||
164458203|NCT04526704|594047298|FG000|Overall Study|Adverse Event|1|||
164458204|NCT04526704|594047299|FG001|Overall Study|Adverse Event|0|||
164458205|NCT04526704|594047298|FG000|Overall Study|Physician Decision|1|||
164458206|NCT04526704|594047299|FG001|Overall Study|Physician Decision|0|||
164458207|NCT04526704|594047298|FG000|Overall Study|Withdrawal by Subject|2|||
164458208|NCT04526704|594047299|FG001|Overall Study|Withdrawal by Subject|0|||
164458209|NCT05434078|594047303|FG000|Overall Study|Lost to Follow-up|2|||
164458210|NCT05434078|594047304|FG001|Overall Study|Lost to Follow-up|1|||
164458211|NCT05434078|594047303|FG000|Overall Study|Withdrawal by Subject|1|||
164458212|NCT05434078|594047304|FG001|Overall Study|Withdrawal by Subject|0|||
164458213|NCT03652688|594047305|FG000|Baseline|Withdrawal by Subject|0|||
164458214|NCT03652688|594047306|FG001|Baseline|Withdrawal by Subject|3|||
164458215|NCT03652688|594047305|FG000|Follow-up|Lost to Follow-up|56|||
164598427|NCT01606761|594553069|FG000|Prior to Week 24|Physician Decision|0|||
164598428|NCT01606761|594553070|FG001|Prior to Week 24|Physician Decision|3|||
164598429|NCT01606761|594553071|FG002|Prior to Week 24|Physician Decision|1|||
164598430|NCT01606761|594553072|FG003|Prior to Week 24|Physician Decision|0|||
164598431|NCT01606761|594553073|FG004|Prior to Week 24|Physician Decision|0|||
164598432|NCT01606761|594553069|FG000|Prior to Week 24|Other|4|||
164598433|NCT01606761|594553070|FG001|Prior to Week 24|Other|7|||
164598434|NCT01606761|594553071|FG002|Prior to Week 24|Other|5|||
164598435|NCT01606761|594553072|FG003|Prior to Week 24|Other|0|||
164598436|NCT01606761|594553073|FG004|Prior to Week 24|Other|0|||
164458216|NCT03652688|594047306|FG001|Follow-up|Lost to Follow-up|54|||
164458217|NCT03829410|594047308|FG000|Overall Study|Adverse Event|1|||
164458218|NCT03829410|594047309|FG001|Overall Study|Adverse Event|0|||
164458219|NCT03829410|594047310|FG002|Overall Study|Adverse Event|1|||
164458220|NCT03829410|594047311|FG003|Overall Study|Adverse Event|4|||
164458221|NCT03829410|594047308|FG000|Overall Study|Physician Decision|0|||
164458222|NCT03829410|594047309|FG001|Overall Study|Physician Decision|0|||
164458223|NCT03829410|594047310|FG002|Overall Study|Physician Decision|0|||
164458224|NCT03829410|594047311|FG003|Overall Study|Physician Decision|2|||
164458225|NCT03829410|594047308|FG000|Overall Study|Disease Progressing|3|||
164458226|NCT03829410|594047309|FG001|Overall Study|Disease Progressing|4|||
164458227|NCT03829410|594047310|FG002|Overall Study|Disease Progressing|2|||
164458228|NCT03829410|594047311|FG003|Overall Study|Disease Progressing|31|||
164458229|NCT03829410|594047308|FG000|Overall Study|Miscellaneous|2|||
164458230|NCT03829410|594047309|FG001|Overall Study|Miscellaneous|4|||
164458231|NCT03829410|594047310|FG002|Overall Study|Miscellaneous|3|||
164458232|NCT03829410|594047311|FG003|Overall Study|Miscellaneous|10|||
164458233|NCT05179837|594047312|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
164458234|NCT05179837|594047312|FG000|Overall Study|Device malfunctioned|1|||
164458235|NCT05179837|594047312|FG000|Overall Study|Image quality too low|2|||
164458236|NCT04924660|594047313|FG000|United States|Death|29|||
164598437|NCT01606761|594553069|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
164598438|NCT01606761|594553070|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
164598439|NCT01606761|594553071|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
164598440|NCT01606761|594553072|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
164598441|NCT01606761|594553073|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
164458237|NCT04924660|594047314|FG001|United States|Death|32|||
164458238|NCT04924660|594047315|FG002|United States|Death|34|||
164458239|NCT04924660|594047316|FG003|United States|Death|25|||
164707531|NCT02132754|594953584|FG012|Overall Study|Screen Failure|0|||
164458240|NCT04924660|594047317|FG004|United States|Death|26|||
164458241|NCT04924660|594047318|FG005|United States|Death|23|||
164458242|NCT04924660|594047313|FG000|United States|Lost to Follow-up|15|||
164458243|NCT04924660|594047314|FG001|United States|Lost to Follow-up|10|||
164458244|NCT04924660|594047315|FG002|United States|Lost to Follow-up|13|||
164458245|NCT04924660|594047316|FG003|United States|Lost to Follow-up|5|||
164458246|NCT04924660|594047317|FG004|United States|Lost to Follow-up|19|||
164458247|NCT04924660|594047318|FG005|United States|Lost to Follow-up|20|||
164458248|NCT04924660|594047313|FG000|United States|Withdrawal by Subject|8|||
164458249|NCT04924660|594047314|FG001|United States|Withdrawal by Subject|3|||
164458250|NCT04924660|594047315|FG002|United States|Withdrawal by Subject|3|||
164458251|NCT04924660|594047316|FG003|United States|Withdrawal by Subject|3|||
164458252|NCT04924660|594047317|FG004|United States|Withdrawal by Subject|8|||
164458253|NCT04924660|594047318|FG005|United States|Withdrawal by Subject|4|||
164458254|NCT04924660|594047313|FG000|Spain|Death|0|||
164458255|NCT04924660|594047314|FG001|Spain|Death|0|||
164458256|NCT04924660|594047315|FG002|Spain|Death|0|||
164458257|NCT04924660|594047316|FG003|Spain|Death|0|||
164458258|NCT04924660|594047317|FG004|Spain|Death|0|||
164458259|NCT04924660|594047318|FG005|Spain|Death|2|||
164458260|NCT04924660|594047313|FG000|Spain|Lost to Follow-up|0|||
164458261|NCT04924660|594047314|FG001|Spain|Lost to Follow-up|0|||
164458262|NCT04924660|594047315|FG002|Spain|Lost to Follow-up|0|||
164458263|NCT04924660|594047316|FG003|Spain|Lost to Follow-up|0|||
164458264|NCT04924660|594047317|FG004|Spain|Lost to Follow-up|1|||
164458265|NCT04924660|594047318|FG005|Spain|Lost to Follow-up|0|||
164458266|NCT04924660|594047313|FG000|Brazil|Death|0|||
164458267|NCT04924660|594047314|FG001|Brazil|Death|0|||
164458268|NCT04924660|594047315|FG002|Brazil|Death|0|||
164458269|NCT04924660|594047316|FG003|Brazil|Death|0|||
164458270|NCT04924660|594047317|FG004|Brazil|Death|1|||
164458271|NCT04924660|594047318|FG005|Brazil|Death|0|||
164458272|NCT04924660|594047313|FG000|Italy|Lost to Follow-up|0|||
164458273|NCT04924660|594047314|FG001|Italy|Lost to Follow-up|0|||
164458274|NCT04924660|594047315|FG002|Italy|Lost to Follow-up|0|||
164458275|NCT04924660|594047316|FG003|Italy|Lost to Follow-up|0|||
164458276|NCT04924660|594047317|FG004|Italy|Lost to Follow-up|0|||
164458277|NCT04924660|594047318|FG005|Italy|Lost to Follow-up|1|||
164458278|NCT04924660|594047313|FG000|South Africa|Death|0|||
164458279|NCT04924660|594047314|FG001|South Africa|Death|0|||
164458280|NCT04924660|594047315|FG002|South Africa|Death|0|||
164458281|NCT04924660|594047316|FG003|South Africa|Death|0|||
164458282|NCT04924660|594047317|FG004|South Africa|Death|0|||
164458283|NCT04924660|594047318|FG005|South Africa|Death|1|||
164458284|NCT04924660|594047313|FG000|South Africa|Lost to Follow-up|0|||
164458285|NCT04924660|594047314|FG001|South Africa|Lost to Follow-up|0|||
164458286|NCT04924660|594047315|FG002|South Africa|Lost to Follow-up|0|||
164458287|NCT04924660|594047316|FG003|South Africa|Lost to Follow-up|0|||
164458288|NCT04924660|594047317|FG004|South Africa|Lost to Follow-up|0|||
164458289|NCT04924660|594047318|FG005|South Africa|Lost to Follow-up|1|||
164458290|NCT02105766|594047319|FG000|Overall Study|Physician Decision|1|||
164458291|NCT02105766|594047320|FG001|Overall Study|Physician Decision|1|||
164458292|NCT02105766|594047321|FG002|Overall Study|Physician Decision|0|||
164458293|NCT02105766|594047319|FG000|Overall Study|Lost to Follow-up|2|||
164458294|NCT02105766|594047320|FG001|Overall Study|Lost to Follow-up|0|||
164458295|NCT02105766|594047321|FG002|Overall Study|Lost to Follow-up|0|||
164458296|NCT02105766|594047319|FG000|Overall Study|Death|1|||
164458297|NCT02105766|594047320|FG001|Overall Study|Death|1|||
164458298|NCT02105766|594047321|FG002|Overall Study|Death|0|||
164458299|NCT00554788|594047322|FG000|Overall Study|Adverse Event|0|||
164458300|NCT00554788|594047323|FG001|Overall Study|Adverse Event|1|||
164458301|NCT00554788|594047324|FG002|Overall Study|Adverse Event|2|||
164458302|NCT00554788|594047322|FG000|Overall Study|Lost to Follow-up|4|||
164458303|NCT00554788|594047323|FG001|Overall Study|Lost to Follow-up|3|||
164458304|NCT00554788|594047324|FG002|Overall Study|Lost to Follow-up|3|||
164458305|NCT00554788|594047322|FG000|Overall Study|Physician Decision|1|||
164598442|NCT01606761|594553069|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
164458306|NCT00554788|594047323|FG001|Overall Study|Physician Decision|1|||
164458307|NCT00554788|594047324|FG002|Overall Study|Physician Decision|3|||
164458308|NCT00554788|594047322|FG000|Overall Study|Withdrawal by Subject|0|||
164458309|NCT00554788|594047323|FG001|Overall Study|Withdrawal by Subject|0|||
164458310|NCT00554788|594047324|FG002|Overall Study|Withdrawal by Subject|1|||
164458311|NCT00554788|594047322|FG000|Overall Study|Refusal of further protocol therapy|0|||
164458312|NCT00554788|594047323|FG001|Overall Study|Refusal of further protocol therapy|1|||
164458313|NCT00554788|594047324|FG002|Overall Study|Refusal of further protocol therapy|1|||
164458314|NCT00554788|594047322|FG000|Overall Study|Progressive disease|0|||
164458315|NCT00554788|594047323|FG001|Overall Study|Progressive disease|0|||
164458316|NCT00554788|594047324|FG002|Overall Study|Progressive disease|3|||
164458317|NCT00554788|594047322|FG000|Overall Study|Ineligible|2|||
164598443|NCT01606761|594553070|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
164598444|NCT01606761|594553071|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
164598445|NCT01606761|594553072|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
164458318|NCT00554788|594047323|FG001|Overall Study|Ineligible|0|||
164458319|NCT00554788|594047324|FG002|Overall Study|Ineligible|1|||
164458320|NCT03557697|594047325|FG000|Overall Study|Withdrawal by Subject|2|||
164458321|NCT03557697|594047326|FG001|Overall Study|Withdrawal by Subject|4|||
164458322|NCT05409183|594047340|FG000|Complete Study|Adverse Event|1|||
164458323|NCT05409183|594047341|FG001|Complete Study|Adverse Event|2|||
164458324|NCT05409183|594047340|FG000|Complete Study|Withdrawal by Subject|3|||
164598446|NCT01606761|594553073|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
164458325|NCT05409183|594047341|FG001|Complete Study|Withdrawal by Subject|0|||
164458326|NCT02274662|594047342|FG000|Overall Study|Death|1|||
164458327|NCT02274662|594047342|FG000|Overall Study|Lost to Follow-up|3|||
164458328|NCT04495894|594047347|FG000|Overall Study|Withdrawal by Subject|2|||
164458329|NCT04495894|594047348|FG001|Overall Study|Withdrawal by Subject|0|||
164458330|NCT04495894|594047349|FG002|Overall Study|Withdrawal by Subject|2|||
164458331|NCT04495894|594047350|FG003|Overall Study|Withdrawal by Subject|3|||
164458332|NCT04495894|594047347|FG000|Overall Study|Early termination|0|||
164458333|NCT04495894|594047348|FG001|Overall Study|Early termination|0|||
164458334|NCT04495894|594047349|FG002|Overall Study|Early termination|3|||
164458335|NCT04495894|594047350|FG003|Overall Study|Early termination|0|||
164458336|NCT03364647|594047351|FG000|Overall Study|Withdrawal by Subject|3|||
164458337|NCT03364647|594047352|FG001|Overall Study|Withdrawal by Subject|1|||
164458338|NCT04064164|594047353|FG000|Overall Study|Withdrawal by Subject|8|||
164458339|NCT04064164|594047354|FG001|Overall Study|Withdrawal by Subject|8|||
164458340|NCT01000961|594047355|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
164458341|NCT01000961|594047356|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
164458342|NCT01000961|594047355|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
164458343|NCT01000961|594047356|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
164458344|NCT03476460|594047360|FG000|Overall Study|Withdrawal by Subject|3|||
164458345|NCT03476460|594047361|FG001|Overall Study|Withdrawal by Subject|2|||
164458346|NCT03476460|594047360|FG000|Overall Study|Non-compliance with treatment|3|||
164458347|NCT03476460|594047361|FG001|Overall Study|Non-compliance with treatment|0|||
164458348|NCT03476460|594047360|FG000|Overall Study|Missing laboratory tests|5|||
164458349|NCT03476460|594047361|FG001|Overall Study|Missing laboratory tests|5|||
164458350|NCT03476460|594047360|FG000|Overall Study|Adverse Event|0|||
164458351|NCT03476460|594047361|FG001|Overall Study|Adverse Event|1|||
164458352|NCT05746455|594047362|FG000|Overall Study|Discharged from Clinical Service|1|||
164458353|NCT05746455|594047362|FG000|Overall Study|Lost to Follow-up|1|||
164458354|NCT02023866|594047363|FG000|Overall Study|Non-compliance|2|||
164458355|NCT02023866|594047363|FG000|Overall Study|Adverse Event|3|||
164458356|NCT02023866|594047363|FG000|Overall Study|Withdrawal by Subject|1|||
164458357|NCT03307343|594047364|FG000|Overall Study|Withdrawal by Subject|1|||
164458358|NCT03307343|594047365|FG001|Overall Study|Withdrawal by Subject|2|||
164458359|NCT03307343|594047364|FG000|Overall Study|Pregnancy|0|||
164458360|NCT03307343|594047365|FG001|Overall Study|Pregnancy|2|||
164458361|NCT03307343|594047364|FG000|Overall Study|Physician Decision|1|||
164458362|NCT03307343|594047365|FG001|Overall Study|Physician Decision|0|||
164458363|NCT03307343|594047364|FG000|Overall Study|Lost to Follow-up|0|||
164458364|NCT03307343|594047365|FG001|Overall Study|Lost to Follow-up|2|||
164458365|NCT03707951|594048879|FG000|Overall Study|Lost to Follow-up|8|||
164458366|NCT03707951|594048880|FG001|Overall Study|Lost to Follow-up|17|||
164458367|NCT03707951|594048879|FG000|Overall Study|Withdrawal by Subject|6|||
164458368|NCT03707951|594048880|FG001|Overall Study|Withdrawal by Subject|6|||
164458369|NCT04887129|594048881|FG000|Overall Study|Lost to Follow-up|0|||
164458370|NCT04887129|594048882|FG001|Overall Study|Lost to Follow-up|24|||
164458371|NCT04887129|594048881|FG000|Overall Study|Withdrawal by Subject|9|||
164458372|NCT04887129|594048882|FG001|Overall Study|Withdrawal by Subject|57|||
164458373|NCT04887129|594048881|FG000|Overall Study|Other|2|||
164458374|NCT04887129|594048882|FG001|Overall Study|Other|9|||
164458375|NCT04533347|594048884|FG000|Overall Study|Adverse Event|1|||
164458376|NCT04533347|594048885|FG001|Overall Study|Adverse Event|2|||
164458377|NCT04533347|594048884|FG000|Overall Study|Lost to Follow-up|2|||
164458378|NCT04533347|594048885|FG001|Overall Study|Lost to Follow-up|0|||
164458379|NCT04533347|594048884|FG000|Overall Study|Withdrawal by Subject|1|||
164458380|NCT04533347|594048885|FG001|Overall Study|Withdrawal by Subject|0|||
164458381|NCT05520190|594048886|FG000|Overall Study|Lost to Follow-up|7|||
164458382|NCT05520190|594048886|FG000|Overall Study|Withdrawal by Subject|2|||
164458383|NCT01999075|594048887|FG000|Overall Study|Lost to Follow-up|0|||
164458384|NCT01999075|594048888|FG001|Overall Study|Lost to Follow-up|2|||
164458385|NCT01999075|594048887|FG000|Overall Study|Withdrawal by Subject|2|||
164458386|NCT01999075|594048888|FG001|Overall Study|Withdrawal by Subject|7|||
164458387|NCT01999075|594048887|FG000|Overall Study|Enrolled in drug trial|3|||
164458388|NCT01999075|594048888|FG001|Overall Study|Enrolled in drug trial|1|||
164458389|NCT01999075|594048887|FG000|Overall Study|Became ineligible|0|||
164458390|NCT01999075|594048888|FG001|Overall Study|Became ineligible|2|||
164458391|NCT04896476|594048896|FG000|Overall Study|Withdrawal by Subject|1|||
164458392|NCT04896476|594048896|FG000|Overall Study|Lost to Follow-up|2|||
164458393|NCT03476187|594048897|FG000|Overall Study|Protocol Violation|7|||
164458394|NCT03476187|594048897|FG000|Overall Study|Physician Decision|5|||
164458395|NCT03445988|594048898|FG000|Overall Study|Lost to Follow-up|14|||
164458396|NCT03445988|594048899|FG001|Overall Study|Lost to Follow-up|26|||
164598447|NCT01606761|594553069|FG000|Week 24 to Week 52|Adverse Event|0|||
164458397|NCT03445988|594048900|FG002|Overall Study|Lost to Follow-up|27|||
164458398|NCT03445988|594048901|FG003|Overall Study|Lost to Follow-up|66|||
164458399|NCT03445988|594048898|FG000|Overall Study|Withdrawal by Subject|7|||
164458400|NCT03445988|594048899|FG001|Overall Study|Withdrawal by Subject|4|||
164598448|NCT01606761|594553070|FG001|Week 24 to Week 52|Adverse Event|11|||
164458401|NCT03445988|594048900|FG002|Overall Study|Withdrawal by Subject|3|||
164458402|NCT03445988|594048901|FG003|Overall Study|Withdrawal by Subject|5|||
164458403|NCT03445988|594048898|FG000|Overall Study|Death (unrelated to study)|5|||
164458404|NCT03445988|594048899|FG001|Overall Study|Death (unrelated to study)|1|||
164458405|NCT03445988|594048900|FG002|Overall Study|Death (unrelated to study)|2|||
164458406|NCT03445988|594048901|FG003|Overall Study|Death (unrelated to study)|4|||
164458407|NCT04977947|594048902|FG000|Overall Study|Lost to Follow-up|1|||
164458408|NCT04977947|594048903|FG001|Overall Study|Lost to Follow-up|1|||
164458409|NCT02921230|594048904|FG000|Overall Study|Withdrawal by Subject|20|||
164458410|NCT02921230|594048905|FG001|Overall Study|Withdrawal by Subject|8|||
164458411|NCT02921230|594048904|FG000|Overall Study|Death|12|||
164458412|NCT02921230|594048905|FG001|Overall Study|Death|3|||
164458413|NCT02921230|594048904|FG000|Overall Study|Protocol Violation|17|||
164458414|NCT02921230|594048905|FG001|Overall Study|Protocol Violation|6|||
164458415|NCT02921230|594048904|FG000|Overall Study|Early completion|5|||
164458416|NCT02921230|594048905|FG001|Overall Study|Early completion|1|||
164458417|NCT02921230|594048904|FG000|Overall Study|Pending data entry|1|||
164458418|NCT02921230|594048905|FG001|Overall Study|Pending data entry|0|||
164458419|NCT05875142|594048906|FG000|Overall Study|Lost to Follow-up|0|||
164458420|NCT05875142|594048907|FG001|Overall Study|Lost to Follow-up|1|||
164458421|NCT05875142|594048908|FG002|Overall Study|Lost to Follow-up|1|||
164458422|NCT03436290|594048909|FG000|Overall Study|Post-randomization Exclusion|1|||
164458423|NCT03436290|594048910|FG001|Overall Study|Post-randomization Exclusion|0|||
164458424|NCT03436290|594048909|FG000|Overall Study|Death|6|||
164458425|NCT03436290|594048910|FG001|Overall Study|Death|0|||
164458426|NCT03436290|594048909|FG000|Overall Study|Withdrawal by Subject|4|||
164458427|NCT03436290|594048910|FG001|Overall Study|Withdrawal by Subject|0|||
164458428|NCT03436290|594048909|FG000|Overall Study|Protocol Violation|30|||
164458429|NCT03436290|594048910|FG001|Overall Study|Protocol Violation|0|||
164458430|NCT04274764|594048918|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
164458431|NCT04274764|594048919|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
164458432|NCT03396926|594048924|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
164458433|NCT03396926|594048925|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
164458434|NCT01396278|594048926|FG000|Overall Study|Adverse Event|0|||
164458435|NCT01396278|594048927|FG001|Overall Study|Adverse Event|0|||
164458436|NCT01396278|594048928|FG002|Overall Study|Adverse Event|0|||
164458437|NCT01396278|594048929|FG003|Overall Study|Adverse Event|2|||
164458438|NCT01396278|594048930|FG004|Overall Study|Adverse Event|0|||
164458439|NCT01396278|594048926|FG000|Overall Study|Withdraw due to trial termination|2|||
164458440|NCT01396278|594048927|FG001|Overall Study|Withdraw due to trial termination|1|||
164458441|NCT01396278|594048928|FG002|Overall Study|Withdraw due to trial termination|1|||
164458442|NCT01396278|594048929|FG003|Overall Study|Withdraw due to trial termination|0|||
164458443|NCT01396278|594048930|FG004|Overall Study|Withdraw due to trial termination|2|||
164458444|NCT01997840|594048931|FG000|Overall Study|Lost to Follow-up|0|||
164458445|NCT01997840|594048932|FG001|Overall Study|Lost to Follow-up|0|||
164458446|NCT01997840|594048933|FG002|Overall Study|Lost to Follow-up|1|||
164458447|NCT01997840|594048934|FG003|Overall Study|Lost to Follow-up|0|||
164598449|NCT01606761|594553071|FG002|Week 24 to Week 52|Adverse Event|14|||
164598450|NCT01606761|594553072|FG003|Week 24 to Week 52|Adverse Event|3|||
164598451|NCT01606761|594553073|FG004|Week 24 to Week 52|Adverse Event|15|||
164598452|NCT01606761|594553069|FG000|Week 24 to Week 52|Death|0|||
164598453|NCT01606761|594553070|FG001|Week 24 to Week 52|Death|0|||
164598454|NCT01606761|594553071|FG002|Week 24 to Week 52|Death|2|||
164598455|NCT01606761|594553072|FG003|Week 24 to Week 52|Death|1|||
164598456|NCT01606761|594553073|FG004|Week 24 to Week 52|Death|0|||
164598457|NCT01606761|594553069|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
164598458|NCT01606761|594553070|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
164598459|NCT01606761|594553071|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
164598460|NCT01606761|594553072|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
164598461|NCT01606761|594553073|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
164598462|NCT01606761|594553069|FG000|Week 24 to Week 52|Physician Decision|0|||
164598463|NCT01606761|594553070|FG001|Week 24 to Week 52|Physician Decision|1|||
164598464|NCT01606761|594553071|FG002|Week 24 to Week 52|Physician Decision|1|||
164598465|NCT01606761|594553072|FG003|Week 24 to Week 52|Physician Decision|0|||
164598466|NCT01606761|594553073|FG004|Week 24 to Week 52|Physician Decision|0|||
164598467|NCT01606761|594553069|FG000|Week 24 to Week 52|Other|0|||
164598468|NCT01606761|594553070|FG001|Week 24 to Week 52|Other|1|||
164598469|NCT01606761|594553071|FG002|Week 24 to Week 52|Other|5|||
164598470|NCT01606761|594553072|FG003|Week 24 to Week 52|Other|2|||
164598471|NCT01606761|594553073|FG004|Week 24 to Week 52|Other|2|||
164598472|NCT01606761|594553069|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
164598473|NCT01606761|594553070|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
164598474|NCT01606761|594553071|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
164598475|NCT01606761|594553072|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
164598476|NCT01606761|594553073|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
164598477|NCT01606761|594553069|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
164458448|NCT01997840|594048931|FG000|Overall Study|Withdrawal by participant|0|||
164458449|NCT01997840|594048932|FG001|Overall Study|Withdrawal by participant|0|||
164458450|NCT01997840|594048933|FG002|Overall Study|Withdrawal by participant|8|||
164458451|NCT01997840|594048934|FG003|Overall Study|Withdrawal by participant|1|||
164458452|NCT01997840|594048931|FG000|Overall Study|Physician Decision|0|||
164458453|NCT01997840|594048932|FG001|Overall Study|Physician Decision|0|||
164458454|NCT01997840|594048933|FG002|Overall Study|Physician Decision|3|||
164458455|NCT01997840|594048934|FG003|Overall Study|Physician Decision|0|||
164458456|NCT01997840|594048931|FG000|Overall Study|Progressive disease|3|||
164458457|NCT01997840|594048932|FG001|Overall Study|Progressive disease|4|||
164458458|NCT01997840|594048933|FG002|Overall Study|Progressive disease|57|||
164458459|NCT01997840|594048934|FG003|Overall Study|Progressive disease|8|||
164458460|NCT01997840|594048931|FG000|Overall Study|Other reasons|0|||
164458461|NCT01997840|594048932|FG001|Overall Study|Other reasons|0|||
164458462|NCT01997840|594048933|FG002|Overall Study|Other reasons|1|||
164458463|NCT01997840|594048934|FG003|Overall Study|Other reasons|0|||
164458464|NCT01997840|594048931|FG000|Overall Study|Adverse Event|0|||
164458465|NCT01997840|594048932|FG001|Overall Study|Adverse Event|0|||
164458466|NCT01997840|594048933|FG002|Overall Study|Adverse Event|15|||
164458467|NCT01997840|594048934|FG003|Overall Study|Adverse Event|2|||
164458468|NCT05311384|594048938|FG000|Overall Study|Uncontrolled health conditions|2|||
164458469|NCT05311384|594048938|FG000|Overall Study|Withdrawal by Subject|1|||
164458470|NCT03891667|594048941|FG000|Overall Study|Physician Decision|1|||
164458471|NCT03891667|594048942|FG001|Overall Study|Physician Decision|1|||
164458472|NCT03891667|594048941|FG000|Overall Study|COVID related pause|1|||
164458473|NCT03891667|594048942|FG001|Overall Study|COVID related pause|0|||
164458474|NCT03891667|594048941|FG000|Overall Study|Withdrawal by Subject|0|||
164458475|NCT03891667|594048942|FG001|Overall Study|Withdrawal by Subject|1|||
164458476|NCT03891667|594048941|FG000|Overall Study|Adverse Event|0|||
164458477|NCT03891667|594048942|FG001|Overall Study|Adverse Event|1|||
164458478|NCT00506519|594048948|FG000|Overall Study|Death|4|||
164458479|NCT00506519|594048949|FG001|Overall Study|Death|6|||
164458480|NCT00506519|594048950|FG002|Overall Study|Death|0|||
164458481|NCT00506519|594048948|FG000|Overall Study|Adverse Event|1|||
164458482|NCT00506519|594048949|FG001|Overall Study|Adverse Event|0|||
164458483|NCT00506519|594048950|FG002|Overall Study|Adverse Event|0|||
164458484|NCT02975882|594048951|FG000|Overall Study|Adverse Event|1|||
164458485|NCT02975882|594048952|FG001|Overall Study|Adverse Event|2|||
164458486|NCT02975882|594048953|FG002|Overall Study|Adverse Event|1|||
164458487|NCT02975882|594048954|FG003|Overall Study|Adverse Event|1|||
164458488|NCT02975882|594048951|FG000|Overall Study|Death|0|||
164458489|NCT02975882|594048952|FG001|Overall Study|Death|1|||
164458490|NCT02975882|594048953|FG002|Overall Study|Death|0|||
164458491|NCT02975882|594048954|FG003|Overall Study|Death|0|||
164458492|NCT02975882|594048951|FG000|Overall Study|Lack of Efficacy|3|||
164458493|NCT02975882|594048952|FG001|Overall Study|Lack of Efficacy|7|||
164458494|NCT02975882|594048953|FG002|Overall Study|Lack of Efficacy|4|||
164458495|NCT02975882|594048954|FG003|Overall Study|Lack of Efficacy|3|||
164458496|NCT02975882|594048951|FG000|Overall Study|Physician Decision|0|||
164458497|NCT02975882|594048952|FG001|Overall Study|Physician Decision|2|||
164458498|NCT02975882|594048953|FG002|Overall Study|Physician Decision|4|||
164458499|NCT02975882|594048954|FG003|Overall Study|Physician Decision|2|||
164458500|NCT02975882|594048951|FG000|Overall Study|Ineligible|0|||
164458501|NCT02975882|594048952|FG001|Overall Study|Ineligible|1|||
164458502|NCT02975882|594048953|FG002|Overall Study|Ineligible|0|||
164458503|NCT02975882|594048954|FG003|Overall Study|Ineligible|0|||
164458504|NCT05116787|594048955|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
164458505|NCT05116787|594048956|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
164458506|NCT05116787|594048955|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
164598478|NCT01606761|594553070|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
164598479|NCT01606761|594553071|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
164598480|NCT01606761|594553072|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
164598481|NCT01606761|594553073|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
164598482|NCT01606761|594553069|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
164598483|NCT01606761|594553070|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
164598484|NCT01606761|594553071|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
164598485|NCT01606761|594553072|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
164458507|NCT05116787|594048956|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
164598486|NCT01606761|594553073|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
164598487|NCT01606761|594553069|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
164598488|NCT01606761|594553070|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
164458508|NCT05116787|594048955|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
164458509|NCT05116787|594048956|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
164458510|NCT05116787|594048955|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
164458511|NCT05116787|594048956|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
164458512|NCT02737436|594048957|FG000|Washout Period|Lost to Follow-up|5|||
164458513|NCT02737436|594048958|FG001|Washout Period|Lost to Follow-up|11|||
164458514|NCT02737436|594048957|FG000|Data Analysis|Scanning data problems|5|||
164458515|NCT02737436|594048958|FG001|Data Analysis|Scanning data problems|8|||
164458516|NCT03936322|594048959|FG000|Overall Study|Lost to Follow-up|1|||
164458517|NCT03936322|594048959|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
164458518|NCT01160211|594048961|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
164458519|NCT01160211|594048962|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
164458520|NCT01160211|594048963|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
164458521|NCT01160211|594048961|FG000|Overall Study|Lost to Follow-up|4|||
164458522|NCT01160211|594048962|FG001|Overall Study|Lost to Follow-up|8|||
164458523|NCT01160211|594048963|FG002|Overall Study|Lost to Follow-up|4|||
164458524|NCT01160211|594048961|FG000|Overall Study|Physician Decision|1|||
164458525|NCT01160211|594048962|FG001|Overall Study|Physician Decision|0|||
164458526|NCT01160211|594048963|FG002|Overall Study|Physician Decision|0|||
164458527|NCT01160211|594048961|FG000|Overall Study|Withdrawal by Subject|4|||
164458528|NCT01160211|594048962|FG001|Overall Study|Withdrawal by Subject|2|||
164458529|NCT01160211|594048963|FG002|Overall Study|Withdrawal by Subject|2|||
164458530|NCT01160211|594048961|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
164458531|NCT01160211|594048962|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
164458532|NCT01160211|594048963|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
164458533|NCT05551637|594048964|FG000|Overall Study|Lack of Efficacy|0|||
164458534|NCT05551637|594048965|FG001|Overall Study|Lack of Efficacy|6|||
164458535|NCT05551637|594048964|FG000|Overall Study|Lost to Follow-up|1|||
164458536|NCT05551637|594048965|FG001|Overall Study|Lost to Follow-up|1|||
164458537|NCT02734290|594048968|FG000|Overall Study|Adverse Event|1|||
164458538|NCT02734290|594048969|FG001|Overall Study|Adverse Event|0|||
164458539|NCT02734290|594048968|FG000|Overall Study|Death|1|||
164458540|NCT02734290|594048969|FG001|Overall Study|Death|0|||
164458541|NCT03158129|594048970|FG000|Overall Study|Adverse Event|0|||
164458542|NCT03158129|594048971|FG001|Overall Study|Adverse Event|1|||
164458543|NCT03158129|594048972|FG002|Overall Study|Adverse Event|0|||
164458544|NCT03158129|594048973|FG003|Overall Study|Adverse Event|0|||
164458545|NCT03158129|594048970|FG000|Overall Study|Death|0|||
164458546|NCT03158129|594048971|FG001|Overall Study|Death|0|||
164458547|NCT03158129|594048972|FG002|Overall Study|Death|0|||
164458548|NCT03158129|594048973|FG003|Overall Study|Death|1|||
164458549|NCT03158129|594048970|FG000|Overall Study|High surgical risk|1|||
164458550|NCT03158129|594048971|FG001|Overall Study|High surgical risk|1|||
164458551|NCT03158129|594048972|FG002|Overall Study|High surgical risk|0|||
164458552|NCT03158129|594048973|FG003|Overall Study|High surgical risk|0|||
164458553|NCT03158129|594048970|FG000|Overall Study|Progression|1|||
164458554|NCT03158129|594048971|FG001|Overall Study|Progression|1|||
164458555|NCT03158129|594048972|FG002|Overall Study|Progression|0|||
164458556|NCT03158129|594048973|FG003|Overall Study|Progression|0|||
164458557|NCT03158129|594048970|FG000|Overall Study|Lack of resectability|0|||
164458558|NCT03158129|594048971|FG001|Overall Study|Lack of resectability|1|||
164458559|NCT03158129|594048972|FG002|Overall Study|Lack of resectability|0|||
164458560|NCT03158129|594048973|FG003|Overall Study|Lack of resectability|0|||
164458561|NCT03158129|594048970|FG000|Overall Study|Declined surgery|0|||
164458562|NCT03158129|594048971|FG001|Overall Study|Declined surgery|1|||
164458563|NCT03158129|594048972|FG002|Overall Study|Declined surgery|0|||
164458564|NCT03158129|594048973|FG003|Overall Study|Declined surgery|0|||
164458565|NCT03158129|594048970|FG000|Overall Study|No longer surgical candidate|0|||
164458566|NCT03158129|594048971|FG001|Overall Study|No longer surgical candidate|0|||
164458567|NCT03158129|594048972|FG002|Overall Study|No longer surgical candidate|0|||
164458568|NCT03158129|594048973|FG003|Overall Study|No longer surgical candidate|1|||
164458569|NCT03867500|594048974|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
164458570|NCT04806451|594048978|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
164458571|NCT04806451|594048979|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
164458572|NCT04806451|594048978|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
164458573|NCT04806451|594048979|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
164458574|NCT04806451|594048978|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
164458575|NCT04806451|594048979|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
164458576|NCT02936752|594048980|FG000|Overall Study|Death|2|||
164458577|NCT02936752|594048981|FG001|Overall Study|Death|1|||
164458578|NCT02936752|594048980|FG000|Overall Study|Physician Decision|4|||
164707532|NCT02132754|594953585|FG013|Overall Study|Screen Failure|0|||
164458579|NCT02936752|594048981|FG001|Overall Study|Physician Decision|0|||
164458580|NCT02936752|594048980|FG000|Overall Study|Withdrawal by Subject|0|||
164458581|NCT02936752|594048981|FG001|Overall Study|Withdrawal by Subject|2|||
164458582|NCT05894577|594048982|FG000|Overall Study|No receipt of study drug|14|||
164458583|NCT05894577|594048983|FG001|Overall Study|No receipt of study drug|13|||
164707533|NCT02132754|594953586|FG014|Overall Study|Screen Failure|0|||
164707534|NCT02132754|594953587|FG015|Overall Study|Screen Failure|0|||
164707535|NCT02132754|594953588|FG016|Overall Study|Screen Failure|0|||
164458584|NCT05894577|594048982|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
164458585|NCT05894577|594048983|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
164458586|NCT05894577|594048982|FG000|Overall Study|Screen Fail|2|||
164458587|NCT05894577|594048983|FG001|Overall Study|Screen Fail|0|||
164458588|NCT05894577|594048982|FG000|Overall Study|Study drug recall|86|||
164458589|NCT05894577|594048983|FG001|Overall Study|Study drug recall|63|||
164458590|NCT01798498|594049002|FG000|Overall Study|Lost to Follow-up|1|||
164458591|NCT05184192|594049004|FG000|Overall Study|Lost to Follow-up|4|||
164458592|NCT05184192|594049005|FG001|Overall Study|Lost to Follow-up|7|||
164458593|NCT05184192|594049004|FG000|Overall Study|Adverse Event|1|||
164458594|NCT05184192|594049005|FG001|Overall Study|Adverse Event|4|||
164458595|NCT05184192|594049004|FG000|Overall Study|PI withdrawal|1|||
164458596|NCT05184192|594049005|FG001|Overall Study|PI withdrawal|2|||
164458597|NCT05184192|594049004|FG000|Overall Study|Withdrew due to adverse effect|1|||
164458598|NCT05184192|594049005|FG001|Overall Study|Withdrew due to adverse effect|0|||
164458599|NCT05184192|594049004|FG000|Overall Study|Medication schedule|1|||
164458600|NCT05184192|594049005|FG001|Overall Study|Medication schedule|0|||
164458601|NCT05184192|594049004|FG000|Overall Study|Concern for adverse effects|0|||
164458602|NCT05184192|594049005|FG001|Overall Study|Concern for adverse effects|4|||
164458603|NCT05794243|594049016|FG000|Overall Study|Withdrawal by Subject|1|||
164458604|NCT05794243|594049017|FG001|Overall Study|Withdrawal by Subject|0|||
164458605|NCT05794243|594049018|FG002|Overall Study|Withdrawal by Subject|1|||
164458606|NCT05794243|594049016|FG000|Overall Study|Physician Decision|0|||
164458607|NCT05794243|594049017|FG001|Overall Study|Physician Decision|3|||
164458608|NCT05794243|594049018|FG002|Overall Study|Physician Decision|1|||
164458609|NCT05609760|594049024|FG000|Overall Study|Lost to Follow-up|0|||
164458610|NCT05609760|594049025|FG001|Overall Study|Lost to Follow-up|1|||
164458611|NCT05609760|594049024|FG000|Overall Study|Withdrawal by Subject|1|||
164458612|NCT05609760|594049025|FG001|Overall Study|Withdrawal by Subject|0|||
164458613|NCT05089734|594049026|FG000|Overall Study|Still on study|122|||
164458614|NCT05089734|594049027|FG001|Overall Study|Still on study|101|||
164458615|NCT05089734|594049026|FG000|Overall Study|Death|161|||
164458616|NCT05089734|594049027|FG001|Overall Study|Death|179|||
164458617|NCT05089734|594049026|FG000|Overall Study|Withdrew consent|11|||
164458618|NCT05089734|594049027|FG001|Overall Study|Withdrew consent|24|||
164458619|NCT05089734|594049026|FG000|Overall Study|Lost to Follow-up|5|||
164458620|NCT05089734|594049027|FG001|Overall Study|Lost to Follow-up|0|||
164458621|NCT05179395|594049028|FG000|Overall Study|Lack of Efficacy|1|||
164458622|NCT05093829|594049029|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
164458623|NCT05093829|594049030|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
164458624|NCT05093829|594049031|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
164458625|NCT05093829|594049032|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
164458626|NCT05093829|594049033|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
164458627|NCT04318548|594050704|FG000|Overall Study|Adverse Event|0|||
164458628|NCT04318548|594050705|FG001|Overall Study|Adverse Event|0|||
164458629|NCT04318548|594050706|FG002|Overall Study|Adverse Event|1|||
164458630|NCT04318548|594050704|FG000|Overall Study|Lost to Follow-up|6|||
164458631|NCT04318548|594050705|FG001|Overall Study|Lost to Follow-up|13|||
164598489|NCT01606761|594553071|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
164598490|NCT01606761|594553072|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
164598491|NCT01606761|594553073|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
164598492|NCT05086289|594553074|FG000|Overall Study|Adverse Event|4|||
164598493|NCT05086289|594553075|FG001|Overall Study|Adverse Event|2|||
164598494|NCT05086289|594553074|FG000|Overall Study|Lost to Follow-up|2|||
164598495|NCT05086289|594553075|FG001|Overall Study|Lost to Follow-up|0|||
164598496|NCT05086289|594553074|FG000|Overall Study|Non-compliance with study drug|2|||
164598497|NCT05086289|594553075|FG001|Overall Study|Non-compliance with study drug|1|||
164598498|NCT05086289|594553074|FG000|Overall Study|Physician Decision|2|||
164598499|NCT05086289|594553075|FG001|Overall Study|Physician Decision|0|||
164598500|NCT05086289|594553074|FG000|Overall Study|Withdrawal by Subject|5|||
164598501|NCT05086289|594553075|FG001|Overall Study|Withdrawal by Subject|2|||
164598502|NCT03628508|594553081|FG000|Overall Study|Lost to Follow-up|1|||
164598503|NCT01996748|594553082|FG000|Overall Study|Personal reason|1|||
164598504|NCT01996748|594553083|FG001|Overall Study|Personal reason|0|||
164598505|NCT01996748|594553082|FG000|Overall Study|Physician Decision|2|||
164598506|NCT01996748|594553083|FG001|Overall Study|Physician Decision|0|||
164707536|NCT02132754|594953589|FG017|Overall Study|Screen Failure|0|||
164707537|NCT02132754|594953590|FG018|Overall Study|Screen Failure|0|||
164458632|NCT04318548|594050706|FG002|Overall Study|Lost to Follow-up|9|||
164458633|NCT04318548|594050704|FG000|Overall Study|Protocol Violation|1|||
164458634|NCT04318548|594050705|FG001|Overall Study|Protocol Violation|0|||
164458635|NCT04318548|594050706|FG002|Overall Study|Protocol Violation|2|||
164458636|NCT04318548|594050704|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
164458637|NCT04318548|594050705|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
164458638|NCT04318548|594050706|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
164458639|NCT04318548|594050704|FG000|Overall Study|Migrated / moved from the study area|0|||
164458640|NCT04318548|594050705|FG001|Overall Study|Migrated / moved from the study area|0|||
164458641|NCT04318548|594050706|FG002|Overall Study|Migrated / moved from the study area|1|||
164707538|NCT02132754|594953591|FG019|Overall Study|Screen Failure|1|||
164458642|NCT04318548|594050704|FG000|Overall Study|Other|1|||
164458643|NCT04318548|594050705|FG001|Overall Study|Other|2|||
164458644|NCT04318548|594050706|FG002|Overall Study|Other|3|||
164458645|NCT06283173|594050707|FG000|Overall Study|Did not show for first visit|10|||
164458646|NCT06283173|594050707|FG000|Overall Study|Lost to Follow-up|12|||
164458647|NCT06283173|594050707|FG000|Overall Study|Physician Decision|7|||
164458648|NCT03366649|594050708|FG000|Overall Study|Failed preoperative screening|4|||
164458649|NCT03366649|594050709|FG001|Overall Study|Failed preoperative screening|0|||
164458650|NCT03366649|594050710|FG002|Overall Study|Failed preoperative screening|0|||
164458651|NCT03366649|594050708|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
164458652|NCT03366649|594050709|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
164458653|NCT03366649|594050710|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
164458654|NCT00450658|594050725|FG000|Overall Study|Adverse Event|24|||
164458655|NCT00450658|594050726|FG001|Overall Study|Adverse Event|15|||
164458656|NCT00450658|594050725|FG000|Overall Study|Withdrawal by Subject|43|||
164458657|NCT00450658|594050726|FG001|Overall Study|Withdrawal by Subject|26|||
164458658|NCT00450658|594050725|FG000|Overall Study|Lost to Follow-up|22|||
164458659|NCT00450658|594050726|FG001|Overall Study|Lost to Follow-up|5|||
164458660|NCT00450658|594050725|FG000|Overall Study|UGI ulcer|33|||
164458661|NCT00450658|594050726|FG001|Overall Study|UGI ulcer|34|||
164458662|NCT00450658|594050725|FG000|Overall Study|misc|21|||
164458663|NCT00450658|594050726|FG001|Overall Study|misc|10|||
164458664|NCT04727554|594050728|FG000|Overall Study|Lost to Follow-up|0|||
164458665|NCT04727554|594050729|FG001|Overall Study|Lost to Follow-up|1|||
164458666|NCT04727554|594050728|FG000|Overall Study|Death|2|||
164458667|NCT04727554|594050729|FG001|Overall Study|Death|6|||
164458668|NCT04727554|594050728|FG000|Overall Study|Withdrawal by Subject|1|||
164707539|NCT02132754|594953592|FG020|Overall Study|Screen Failure|0|||
164707540|NCT02132754|594953593|FG021|Overall Study|Screen Failure|1|||
164707541|NCT02132754|594953594|FG022|Overall Study|Screen Failure|0|||
164707542|NCT02132754|594953595|FG023|Overall Study|Screen Failure|0|||
164707543|NCT02132754|594953596|FG024|Overall Study|Screen Failure|0|||
164707544|NCT02132754|594953597|FG025|Overall Study|Screen Failure|0|||
164707545|NCT02132754|594953598|FG026|Overall Study|Screen Failure|0|||
164707546|NCT02132754|594953599|FG027|Overall Study|Screen Failure|0|||
164707547|NCT02132754|594953600|FG028|Overall Study|Screen Failure|0|||
164707548|NCT02132754|594953601|FG029|Overall Study|Screen Failure|0|||
164707549|NCT02132754|594953602|FG030|Overall Study|Screen Failure|0|||
164707550|NCT02132754|594953603|FG031|Overall Study|Screen Failure|0|||
164707551|NCT02132754|594953604|FG032|Overall Study|Screen Failure|0|||
164707552|NCT02132754|594953605|FG033|Overall Study|Screen Failure|0|||
164707553|NCT02132754|594953572|FG000|Overall Study|Transferred to Extension Study|0|||
164707554|NCT02132754|594953573|FG001|Overall Study|Transferred to Extension Study|0|||
164707555|NCT02132754|594953574|FG002|Overall Study|Transferred to Extension Study|0|||
164707556|NCT02132754|594953575|FG003|Overall Study|Transferred to Extension Study|0|||
164707557|NCT02132754|594953576|FG004|Overall Study|Transferred to Extension Study|0|||
164707558|NCT02132754|594953577|FG005|Overall Study|Transferred to Extension Study|0|||
164707559|NCT02132754|594953578|FG006|Overall Study|Transferred to Extension Study|0|||
164707560|NCT02132754|594953579|FG007|Overall Study|Transferred to Extension Study|0|||
164707561|NCT02132754|594953580|FG008|Overall Study|Transferred to Extension Study|0|||
164707562|NCT02132754|594953581|FG009|Overall Study|Transferred to Extension Study|0|||
164707563|NCT02132754|594953582|FG010|Overall Study|Transferred to Extension Study|0|||
164707564|NCT02132754|594953583|FG011|Overall Study|Transferred to Extension Study|0|||
164458669|NCT04727554|594050729|FG001|Overall Study|Withdrawal by Subject|0|||
164458670|NCT05763823|594050730|FG000|Overall Study|Death|6|||
164458671|NCT05763823|594050730|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
164458672|NCT05763823|594050730|FG000|Overall Study|Withdrawal by Subject|6|||
164458673|NCT05659537|594050736|FG000|Overall Study|Adverse Event|5|||
164458674|NCT05659537|594050736|FG000|Overall Study|Lost to Follow-up|4|||
164458675|NCT05659537|594050736|FG000|Overall Study|Withdrawal by Subject|13|||
164458676|NCT05659537|594050736|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
164707565|NCT02132754|594953584|FG012|Overall Study|Transferred to Extension Study|0|||
164707566|NCT02132754|594953585|FG013|Overall Study|Transferred to Extension Study|0|||
164707567|NCT02132754|594953586|FG014|Overall Study|Transferred to Extension Study|0|||
164707568|NCT02132754|594953587|FG015|Overall Study|Transferred to Extension Study|0|||
164458677|NCT05659537|594050736|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
164707569|NCT02132754|594953588|FG016|Overall Study|Transferred to Extension Study|0|||
164458678|NCT05659537|594050736|FG000|Overall Study|Participant was suffering from anaemia|1|||
164458679|NCT04971395|594050737|FG000|Overall Study|Withdrawal by Subject|0|||
164458680|NCT04971395|594050738|FG001|Overall Study|Withdrawal by Subject|1|||
164458681|NCT04971395|594050739|FG002|Overall Study|Withdrawal by Subject|0|||
164458682|NCT04456517|594050740|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
164458683|NCT04456517|594050741|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
164458684|NCT02924272|594050742|FG000|Overall Study|Site Terminated by Sponsor|4|||
164458685|NCT02924272|594050743|FG001|Overall Study|Site Terminated by Sponsor|1|||
164458686|NCT02924272|594050742|FG000|Overall Study|Withdrawal by Subject|2|||
164458687|NCT02924272|594050743|FG001|Overall Study|Withdrawal by Subject|0|||
164458688|NCT02924272|594050742|FG000|Overall Study|Adverse Event|3|||
164458689|NCT02924272|594050743|FG001|Overall Study|Adverse Event|0|||
164458690|NCT02924272|594050742|FG000|Overall Study|Progressive Disease|11|||
164458691|NCT02924272|594050743|FG001|Overall Study|Progressive Disease|8|||
164458692|NCT02924272|594050742|FG000|Overall Study|Clinical Deterioration|1|||
164458693|NCT02924272|594050743|FG001|Overall Study|Clinical Deterioration|0|||
164458694|NCT02924272|594050742|FG000|Overall Study|Death|1|||
164458695|NCT02924272|594050743|FG001|Overall Study|Death|0|||
164458696|NCT02924272|594050742|FG000|Overall Study|Reason Not Specified|1|||
164458697|NCT02924272|594050743|FG001|Overall Study|Reason Not Specified|0|||
164458698|NCT01186367|594050745|FG000|Overall Study|Lost to Follow-up|7|||
164458699|NCT01186367|594050746|FG001|Overall Study|Lost to Follow-up|4|||
164458700|NCT01186367|594050747|FG002|Overall Study|Lost to Follow-up|7|||
164458701|NCT01186367|594050745|FG000|Overall Study|Did not receive study treatment|0|||
164458702|NCT01186367|594050746|FG001|Overall Study|Did not receive study treatment|1|||
164458703|NCT01186367|594050747|FG002|Overall Study|Did not receive study treatment|0|||
164458704|NCT02919683|594050748|FG000|Post-Surgery Follow-Up|Death|2|||
164458705|NCT02919683|594050749|FG001|Post-Surgery Follow-Up|Death|2|||
164458706|NCT02919683|594050748|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
164458707|NCT02919683|594050749|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
164458708|NCT05051124|594050750|FG000|Overall Study|Lost to Follow-up|2|||
164458709|NCT05051124|594050750|FG000|Overall Study|Withdrawal by Subject|1|||
164458710|NCT05051124|594050750|FG000|Overall Study|Residential relocation|2|||
164458711|NCT05051124|594050750|FG000|Overall Study|Death|1|||
164458712|NCT04782973|594050751|FG000|Overall Study|Withdrawal by Subject|5|||
164458713|NCT04782973|594050751|FG000|Overall Study|Protocol Violation|6|||
164458714|NCT04782973|594050751|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
164458715|NCT06205407|594050756|FG000|Period 2|Withdrawal by Subject|0|||
164458716|NCT06205407|594050757|FG001|Period 2|Withdrawal by Subject|1|||
164458717|NCT06205407|594050756|FG000|Period 2|Adverse Event|2|||
164458718|NCT06205407|594050757|FG001|Period 2|Adverse Event|1|||
164458719|NCT03611491|594050758|FG000|Overall Study|Lost to Follow-up|1|||
164458720|NCT04676022|594050759|FG000|Overall Study|Screen Failure/|1|||
164458721|NCT04676022|594050760|FG001|Overall Study|Screen Failure/|1|||
164458722|NCT04676022|594050761|FG002|Overall Study|Screen Failure/|85|||
164458723|NCT04676022|594050759|FG000|Overall Study|Lost to Follow-up|1|||
164458724|NCT04676022|594050760|FG001|Overall Study|Lost to Follow-up|1|||
164458725|NCT04676022|594050761|FG002|Overall Study|Lost to Follow-up|0|||
164458726|NCT04676022|594050759|FG000|Overall Study|Adverse Event|2|||
164458727|NCT04676022|594050760|FG001|Overall Study|Adverse Event|0|||
164458728|NCT04676022|594050761|FG002|Overall Study|Adverse Event|1|||
164458729|NCT04676022|594050759|FG000|Overall Study|Physician Decision|2|||
164458730|NCT04676022|594050760|FG001|Overall Study|Physician Decision|0|||
164458731|NCT04676022|594050761|FG002|Overall Study|Physician Decision|1|||
164458732|NCT04676022|594050759|FG000|Overall Study|Withdrawal by Subject|3|||
164458733|NCT04676022|594050760|FG001|Overall Study|Withdrawal by Subject|1|||
164458734|NCT04676022|594050761|FG002|Overall Study|Withdrawal by Subject|6|||
164458735|NCT04676022|594050759|FG000|Overall Study|Will not move forward with permanent implant|6|||
164458736|NCT04676022|594050760|FG001|Overall Study|Will not move forward with permanent implant|0|||
164598507|NCT01996748|594553082|FG000|Overall Study|Adverse Event|1|||
164598508|NCT01996748|594553083|FG001|Overall Study|Adverse Event|4|||
164598509|NCT01996748|594553082|FG000|Overall Study|Withdrawal by Subject|0|||
164598510|NCT01996748|594553083|FG001|Overall Study|Withdrawal by Subject|1|||
164598511|NCT01996748|594553082|FG000|Overall Study|Lost to Follow-up|4|||
164598512|NCT01996748|594553083|FG001|Overall Study|Lost to Follow-up|1|||
164598513|NCT03238235|594553084|FG000|Overall Study|Adverse Event|2|||
164598514|NCT03238235|594553085|FG001|Overall Study|Adverse Event|0|||
164598515|NCT03238235|594553084|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
164598516|NCT03238235|594553085|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
164598517|NCT03011840|594553090|FG000|Overall Study|Not received PIL in post PIL phase|0|||
164598518|NCT03011840|594553091|FG001|Overall Study|Not received PIL in post PIL phase|21|||
164598519|NCT03201198|594553095|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
164598520|NCT03201198|594553096|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
164598521|NCT03201198|594553095|FG000|Overall Study|Withdrawal by Subject|2|||
164598522|NCT03201198|594553096|FG001|Overall Study|Withdrawal by Subject|3|||
164598523|NCT00471445|594553097|FG000|Overall Study|Withdrawal by Subject|1|||
164598524|NCT00471445|594553098|FG001|Overall Study|Withdrawal by Subject|1|||
164598525|NCT00471445|594553097|FG000|Overall Study|Ineligible|1|||
164598526|NCT00471445|594553098|FG001|Overall Study|Ineligible|0|||
164598527|NCT00471445|594553097|FG000|Overall Study|Protocol Violation|0|||
164407404|NCT02748694|593862066|FG010|Overall Study|Voluntary Withdrawal|0|||
164407405|NCT02748694|593862067|FG011|Overall Study|Voluntary Withdrawal|0|||
164407406|NCT02748694|593862068|FG012|Overall Study|Voluntary Withdrawal|0|||
164598528|NCT00471445|594553098|FG001|Overall Study|Protocol Violation|1|||
164598529|NCT04715230|594553099|FG000|Overall Study|Withdrawal by Subject|1|||
164407407|NCT02748694|593862069|FG013|Overall Study|Voluntary Withdrawal|0|||
164407408|NCT02748694|593862070|FG014|Overall Study|Voluntary Withdrawal|2|||
164407409|NCT03170375|593862073|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
164407410|NCT03170375|593862074|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
164407411|NCT03170375|593862075|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
164407412|NCT03170375|593862073|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
164407413|NCT03170375|593862074|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
164407414|NCT03170375|593862075|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
164407415|NCT01691521|593862076|FG000|Overall Study|Adverse Event|4|||
164407416|NCT01691521|593862077|FG001|Overall Study|Adverse Event|0|||
164407417|NCT01691521|593862078|FG002|Overall Study|Adverse Event|1|||
164407418|NCT01691521|593862076|FG000|Overall Study|Lack of Efficacy|1|||
164407419|NCT01691521|593862077|FG001|Overall Study|Lack of Efficacy|1|||
164407420|NCT01691521|593862078|FG002|Overall Study|Lack of Efficacy|2|||
164407421|NCT01691521|593862076|FG000|Overall Study|Protocol Violation|0|||
164407422|NCT01691521|593862077|FG001|Overall Study|Protocol Violation|3|||
164407423|NCT01691521|593862078|FG002|Overall Study|Protocol Violation|0|||
164407424|NCT01691521|593862076|FG000|Overall Study|Lost to Follow-up|0|||
164407425|NCT01691521|593862077|FG001|Overall Study|Lost to Follow-up|2|||
164407426|NCT01691521|593862078|FG002|Overall Study|Lost to Follow-up|2|||
164407427|NCT01691521|593862076|FG000|Overall Study|Physician Decision|2|||
164407428|NCT01691521|593862077|FG001|Overall Study|Physician Decision|1|||
164407429|NCT01691521|593862078|FG002|Overall Study|Physician Decision|0|||
164407430|NCT01691521|593862076|FG000|Overall Study|Withdrawal by Subject|5|||
164598530|NCT04715230|594553100|FG001|Overall Study|Withdrawal by Subject|0|||
164598531|NCT04715230|594553101|FG002|Overall Study|Withdrawal by Subject|0|||
164598532|NCT04715230|594553099|FG000|Overall Study|Lost to Follow-up|0|||
164598533|NCT04715230|594553100|FG001|Overall Study|Lost to Follow-up|5|||
164598534|NCT04715230|594553101|FG002|Overall Study|Lost to Follow-up|1|||
164598535|NCT04973228|594553106|FG000|Overall Study|Adverse Event|2|||
164598536|NCT04973228|594553107|FG001|Overall Study|Adverse Event|3|||
164598537|NCT04973228|594553106|FG000|Overall Study|Lack of Efficacy|1|||
164598538|NCT04973228|594553107|FG001|Overall Study|Lack of Efficacy|3|||
164598539|NCT04973228|594553106|FG000|Overall Study|Lost to Follow-up|12|||
164598540|NCT04973228|594553107|FG001|Overall Study|Lost to Follow-up|4|||
164598541|NCT04973228|594553106|FG000|Overall Study|Withdrawal by Subject|11|||
164598542|NCT04973228|594553107|FG001|Overall Study|Withdrawal by Subject|4|||
164598543|NCT04973228|594553106|FG000|Overall Study|Did not tolerate application|1|||
164598544|NCT04973228|594553107|FG001|Overall Study|Did not tolerate application|0|||
164598545|NCT04973228|594553106|FG000|Overall Study|Wanted to early terminate and use own product|0|||
164598546|NCT04973228|594553107|FG001|Overall Study|Wanted to early terminate and use own product|1|||
164598547|NCT04973228|594553106|FG000|Overall Study|Missed visits due to new work schedule|1|||
164598548|NCT04973228|594553107|FG001|Overall Study|Missed visits due to new work schedule|0|||
164598549|NCT01927744|594554723|FG000|Overall Study|Death|2|||
164598550|NCT01927744|594554724|FG001|Overall Study|Death|9|||
164598551|NCT00369967|594554725|FG000|Overall Study|Lost to Follow-up|23|||
164598552|NCT00369967|594554726|FG001|Overall Study|Lost to Follow-up|12|||
164598553|NCT00605722|594554727|FG000|Overall Study|Adverse Event|6|||
164598554|NCT00605722|594554727|FG000|Overall Study|Insufficient therapeutic response|44|||
164598555|NCT00605722|594554727|FG000|Overall Study|Failure to return|1|||
164598556|NCT04017442|594554735|FG000|Overall Study|Withdrawal by Subject|0|||
164598557|NCT04017442|594554736|FG001|Overall Study|Withdrawal by Subject|3|||
164598558|NCT04017442|594554735|FG000|Overall Study|Lost to Follow-up|21|||
164598559|NCT04017442|594554736|FG001|Overall Study|Lost to Follow-up|19|||
164598560|NCT00848250|594554737|FG000|Overall Study|surgery was completed without cardiopulm|0|||
164598561|NCT00848250|594554738|FG001|Overall Study|surgery was completed without cardiopulm|1|||
164598562|NCT01205451|594554746|FG000|Overall Study|Lost to Follow-up|1|||
164598563|NCT01205451|594554747|FG001|Overall Study|Lost to Follow-up|1|||
164598564|NCT01205451|594554746|FG000|Overall Study|Withdrawal by Subject|5|||
164598565|NCT01205451|594554747|FG001|Overall Study|Withdrawal by Subject|9|||
164598566|NCT02226146|594554751|FG000|Overall Study|Received rescue therapy|1|||
164598567|NCT02226146|594554751|FG000|Overall Study|Withdrawal by Subject|2|||
164598568|NCT05464836|594554752|FG000|Overall Study|Progression of Disease|1|||
164598569|NCT05464836|594554752|FG000|Overall Study|Physician Decision|1|||
164598570|NCT01522976|594554753|FG000|Overall Study|Ineligible|4|||
164598571|NCT01522976|594554754|FG001|Overall Study|Ineligible|0|||
164598572|NCT01522976|594554755|FG002|Overall Study|Ineligible|1|||
164598573|NCT01522976|594554753|FG000|Overall Study|Death|7|||
164598574|NCT01522976|594554754|FG001|Overall Study|Death|6|||
164598575|NCT01522976|594554755|FG002|Overall Study|Death|2|||
164598576|NCT01522976|594554753|FG000|Overall Study|Still on treatment|9|||
164598577|NCT01522976|594554754|FG001|Overall Study|Still on treatment|9|||
164598578|NCT01522976|594554755|FG002|Overall Study|Still on treatment|6|||
164458737|NCT04676022|594050761|FG002|Overall Study|Will not move forward with permanent implant|0|||
164458738|NCT04676022|594050759|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
164458739|NCT04676022|594050760|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
164458740|NCT04676022|594050761|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
164458741|NCT03134196|594050764|FG000|Overall Study|Death|2|||
164458742|NCT03134196|594050765|FG001|Overall Study|Death|1|||
164458743|NCT03134196|594050764|FG000|Overall Study|Lost to Follow-up|13|||
164458744|NCT03134196|594050765|FG001|Overall Study|Lost to Follow-up|15|||
164458745|NCT03134196|594050764|FG000|Overall Study|Physician Decision|0|||
164458746|NCT03134196|594050765|FG001|Overall Study|Physician Decision|1|||
164458747|NCT03134196|594050764|FG000|Overall Study|Withdrawal by Subject|19|||
164458748|NCT03134196|594050765|FG001|Overall Study|Withdrawal by Subject|12|||
164458749|NCT03134196|594050764|FG000|Overall Study|Site Unable to Contact Participant|2|||
164458750|NCT03134196|594050765|FG001|Overall Study|Site Unable to Contact Participant|0|||
164458751|NCT03134196|594050764|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
164458752|NCT03134196|594050765|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
164458753|NCT03134196|594050764|FG000|Overall Study|Scheduling Conflict|1|||
164458754|NCT03134196|594050765|FG001|Overall Study|Scheduling Conflict|0|||
164458755|NCT04683744|594050773|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
164458756|NCT04683744|594050774|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
164458757|NCT04683744|594050775|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
164458758|NCT04592549|594050780|FG000|Overall Study|Withdrawal by Subject|0|||
164458759|NCT04592549|594050781|FG001|Overall Study|Withdrawal by Subject|1|||
164458760|NCT04592549|594050782|FG002|Overall Study|Withdrawal by Subject|0|||
164458761|NCT04592549|594050783|FG003|Overall Study|Withdrawal by Subject|1|||
164458762|NCT04592549|594050784|FG004|Overall Study|Withdrawal by Subject|1|||
164458763|NCT04592549|594050785|FG005|Overall Study|Withdrawal by Subject|0|||
164458764|NCT04592549|594050780|FG000|Overall Study|Lost to Follow-up|2|||
164458765|NCT04592549|594050781|FG001|Overall Study|Lost to Follow-up|0|||
164458766|NCT04592549|594050782|FG002|Overall Study|Lost to Follow-up|0|||
164458767|NCT04592549|594050783|FG003|Overall Study|Lost to Follow-up|1|||
164458768|NCT04592549|594050784|FG004|Overall Study|Lost to Follow-up|1|||
164458769|NCT04592549|594050785|FG005|Overall Study|Lost to Follow-up|1|||
164458770|NCT02919306|594050789|FG000|Overall Study|Withdrawal by Subject|1|||
164458771|NCT02919306|594050790|FG001|Overall Study|Withdrawal by Subject|0|||
164458772|NCT02919306|594050789|FG000|Overall Study|Protocol Violation|1|||
164458773|NCT02919306|594050790|FG001|Overall Study|Protocol Violation|0|||
164458774|NCT04293055|594050791|FG000|Overall Study|Lost to Follow-up|1|||
164458775|NCT04293055|594050792|FG001|Overall Study|Lost to Follow-up|1|||
164458776|NCT04293055|594050791|FG000|Overall Study|Did not trigger randomization|6|||
164458777|NCT04293055|594050792|FG001|Overall Study|Did not trigger randomization|5|||
164458778|NCT04625283|594050793|FG000|Overall Study|post randomization exclusion|28|||
164458779|NCT04625283|594050794|FG001|Overall Study|post randomization exclusion|20|||
164458780|NCT01824394|594050795|FG000|Overall Study|Early Termination|1|||
164458781|NCT01824394|594050796|FG001|Overall Study|Early Termination|1|||
164458782|NCT01824394|594050797|FG002|Overall Study|Early Termination|3|||
164458783|NCT01824394|594050795|FG000|Overall Study|Withdrawn due to Study Termination|91|||
164458784|NCT01824394|594050796|FG001|Overall Study|Withdrawn due to Study Termination|83|||
164458785|NCT01824394|594050797|FG002|Overall Study|Withdrawn due to Study Termination|41|||
164458786|NCT01824394|594050795|FG000|Overall Study|Lost to Follow-up|0|||
164458787|NCT01824394|594050796|FG001|Overall Study|Lost to Follow-up|9|||
164458788|NCT01824394|594050797|FG002|Overall Study|Lost to Follow-up|3|||
164458789|NCT01824394|594050795|FG000|Overall Study|Death|3|||
164458790|NCT01824394|594050796|FG001|Overall Study|Death|2|||
164458791|NCT01824394|594050797|FG002|Overall Study|Death|4|||
164458792|NCT01824394|594050795|FG000|Overall Study|Discontinued Subjects|1|||
164458793|NCT01824394|594050796|FG001|Overall Study|Discontinued Subjects|1|||
164458794|NCT01824394|594050797|FG002|Overall Study|Discontinued Subjects|2|||
164458795|NCT01824394|594050795|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
164458796|NCT01824394|594050796|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
164458797|NCT01824394|594050797|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
164458798|NCT05364671|594050798|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
164458799|NCT05364671|594050799|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
164458800|NCT05364671|594050798|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
164458801|NCT05364671|594050799|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
164458802|NCT05364671|594050798|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
164458803|NCT05364671|594050799|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
164458804|NCT05364671|594050798|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
164458805|NCT05364671|594050799|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
164458806|NCT05364671|594050798|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
164532253|NCT00615836|594320504|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
164458807|NCT05364671|594050799|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
164458808|NCT04376502|594050800|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
164458809|NCT04111536|594050801|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
164458810|NCT04111536|594050802|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
164458811|NCT04111536|594050801|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
164458812|NCT04111536|594050802|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
164458813|NCT04111536|594050801|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
164458814|NCT04111536|594050802|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
164458815|NCT04111536|594050801|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
164458816|NCT04111536|594050802|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
164458817|NCT06037369|594050804|FG000|Overall Study|Lost to Follow-up|0|||
164458818|NCT06037369|594050805|FG001|Overall Study|Lost to Follow-up|1|||
164458819|NCT05603143|594050806|FG000|Overall Study|Withdrew consent|6|||
164458820|NCT05603143|594050807|FG001|Overall Study|Withdrew consent|2|||
164458821|NCT05603143|594050806|FG000|Overall Study|Randomized but never treated|0|||
164458822|NCT05603143|594050807|FG001|Overall Study|Randomized but never treated|3|||
164458823|NCT05603143|594050806|FG000|Overall Study|Adverse Event|2|||
164458824|NCT05603143|594050807|FG001|Overall Study|Adverse Event|0|||
164458825|NCT05603143|594050806|FG000|Overall Study|Death|0|||
164458826|NCT05603143|594050807|FG001|Overall Study|Death|1|||
164458827|NCT05603143|594050806|FG000|Overall Study|Investigator's discretion|1|||
164458828|NCT05603143|594050807|FG001|Overall Study|Investigator's discretion|0|||
164458829|NCT05603143|594050806|FG000|Overall Study|Lost to Follow-up|0|||
164458830|NCT05603143|594050807|FG001|Overall Study|Lost to Follow-up|1|||
164458831|NCT05603143|594050806|FG000|Overall Study|Protocol Violation|0|||
164458832|NCT05603143|594050807|FG001|Overall Study|Protocol Violation|1|||
164458833|NCT04209465|594050808|FG000|Overall Study|Adverse Event|0|||
164458834|NCT04209465|594050809|FG001|Overall Study|Adverse Event|0|||
164458835|NCT04209465|594050810|FG002|Overall Study|Adverse Event|0|||
164458836|NCT04209465|594050811|FG003|Overall Study|Adverse Event|0|||
164458837|NCT04209465|594050812|FG004|Overall Study|Adverse Event|0|||
164458838|NCT04209465|594050813|FG005|Overall Study|Adverse Event|1|||
164458839|NCT04209465|594050814|FG006|Overall Study|Adverse Event|0|||
164458840|NCT04209465|594050815|FG007|Overall Study|Adverse Event|0|||
164458841|NCT04209465|594050816|FG008|Overall Study|Adverse Event|1|||
164458842|NCT04209465|594050817|FG009|Overall Study|Adverse Event|0|||
164458843|NCT04209465|594050818|FG010|Overall Study|Adverse Event|2|||
164458844|NCT04209465|594050819|FG011|Overall Study|Adverse Event|1|||
164458845|NCT04209465|594050820|FG012|Overall Study|Adverse Event|1|||
164458846|NCT04209465|594050808|FG000|Overall Study|Death|1|||
164458847|NCT04209465|594050809|FG001|Overall Study|Death|0|||
164458848|NCT04209465|594050810|FG002|Overall Study|Death|0|||
164458849|NCT04209465|594050811|FG003|Overall Study|Death|0|||
164458850|NCT04209465|594050812|FG004|Overall Study|Death|2|||
164458851|NCT04209465|594050813|FG005|Overall Study|Death|7|||
164458852|NCT04209465|594050814|FG006|Overall Study|Death|2|||
164458853|NCT04209465|594050815|FG007|Overall Study|Death|2|||
164458854|NCT04209465|594050816|FG008|Overall Study|Death|1|||
164458855|NCT04209465|594050817|FG009|Overall Study|Death|1|||
164458856|NCT04209465|594050818|FG010|Overall Study|Death|1|||
164458857|NCT04209465|594050819|FG011|Overall Study|Death|0|||
164458858|NCT04209465|594050820|FG012|Overall Study|Death|10|||
164458859|NCT04209465|594050808|FG000|Overall Study|Physician Decision|0|||
164458860|NCT04209465|594050809|FG001|Overall Study|Physician Decision|1|||
164458861|NCT04209465|594050810|FG002|Overall Study|Physician Decision|0|||
164458862|NCT04209465|594050811|FG003|Overall Study|Physician Decision|0|||
164458863|NCT04209465|594050812|FG004|Overall Study|Physician Decision|0|||
164458864|NCT04209465|594050813|FG005|Overall Study|Physician Decision|0|||
164458865|NCT04209465|594050814|FG006|Overall Study|Physician Decision|0|||
164458866|NCT04209465|594050815|FG007|Overall Study|Physician Decision|0|||
164458867|NCT04209465|594050816|FG008|Overall Study|Physician Decision|0|||
164458868|NCT04209465|594050817|FG009|Overall Study|Physician Decision|0|||
164458869|NCT04209465|594050818|FG010|Overall Study|Physician Decision|0|||
164458870|NCT04209465|594050819|FG011|Overall Study|Physician Decision|0|||
164458871|NCT04209465|594050820|FG012|Overall Study|Physician Decision|0|||
164458872|NCT04209465|594050808|FG000|Overall Study|Progressive Disease|0|||
164458873|NCT04209465|594050809|FG001|Overall Study|Progressive Disease|0|||
164458874|NCT04209465|594050810|FG002|Overall Study|Progressive Disease|1|||
164458875|NCT04209465|594050811|FG003|Overall Study|Progressive Disease|2|||
164458876|NCT04209465|594050812|FG004|Overall Study|Progressive Disease|8|||
164458877|NCT04209465|594050813|FG005|Overall Study|Progressive Disease|5|||
164458878|NCT04209465|594050814|FG006|Overall Study|Progressive Disease|3|||
164458879|NCT04209465|594050815|FG007|Overall Study|Progressive Disease|4|||
164458880|NCT04209465|594050816|FG008|Overall Study|Progressive Disease|1|||
164458881|NCT04209465|594050817|FG009|Overall Study|Progressive Disease|3|||
164458882|NCT04209465|594050818|FG010|Overall Study|Progressive Disease|2|||
164458883|NCT04209465|594050819|FG011|Overall Study|Progressive Disease|1|||
164458884|NCT04209465|594050820|FG012|Overall Study|Progressive Disease|0|||
164458885|NCT04209465|594050808|FG000|Overall Study|Withdrawal by Subject|0|||
164458886|NCT04209465|594050809|FG001|Overall Study|Withdrawal by Subject|0|||
164458887|NCT04209465|594050810|FG002|Overall Study|Withdrawal by Subject|0|||
164458888|NCT04209465|594050811|FG003|Overall Study|Withdrawal by Subject|0|||
164458889|NCT04209465|594050812|FG004|Overall Study|Withdrawal by Subject|0|||
164458890|NCT04209465|594050813|FG005|Overall Study|Withdrawal by Subject|1|||
164458891|NCT04209465|594050814|FG006|Overall Study|Withdrawal by Subject|2|||
164458892|NCT04209465|594050815|FG007|Overall Study|Withdrawal by Subject|0|||
164458893|NCT04209465|594050816|FG008|Overall Study|Withdrawal by Subject|1|||
164458894|NCT04209465|594050817|FG009|Overall Study|Withdrawal by Subject|0|||
164458895|NCT04209465|594050818|FG010|Overall Study|Withdrawal by Subject|0|||
164458896|NCT04209465|594050819|FG011|Overall Study|Withdrawal by Subject|2|||
164458897|NCT04209465|594050820|FG012|Overall Study|Withdrawal by Subject|2|||
164458898|NCT04209465|594050808|FG000|Overall Study|Lost to Follow-up|0|||
164458899|NCT04209465|594050809|FG001|Overall Study|Lost to Follow-up|0|||
164458900|NCT04209465|594050810|FG002|Overall Study|Lost to Follow-up|0|||
164458901|NCT04209465|594050811|FG003|Overall Study|Lost to Follow-up|0|||
164458902|NCT04209465|594050812|FG004|Overall Study|Lost to Follow-up|0|||
164458903|NCT04209465|594050813|FG005|Overall Study|Lost to Follow-up|1|||
164458904|NCT04209465|594050814|FG006|Overall Study|Lost to Follow-up|0|||
164458905|NCT04209465|594050815|FG007|Overall Study|Lost to Follow-up|0|||
164458906|NCT04209465|594050816|FG008|Overall Study|Lost to Follow-up|1|||
164458907|NCT04209465|594050817|FG009|Overall Study|Lost to Follow-up|0|||
164458908|NCT04209465|594050818|FG010|Overall Study|Lost to Follow-up|0|||
164458909|NCT04209465|594050819|FG011|Overall Study|Lost to Follow-up|1|||
164458910|NCT04209465|594050820|FG012|Overall Study|Lost to Follow-up|0|||
164458911|NCT04209465|594050808|FG000|Overall Study|Started new therapy|0|||
164458912|NCT04209465|594050809|FG001|Overall Study|Started new therapy|0|||
164458913|NCT04209465|594050810|FG002|Overall Study|Started new therapy|0|||
164458914|NCT04209465|594050811|FG003|Overall Study|Started new therapy|0|||
164458915|NCT04209465|594050812|FG004|Overall Study|Started new therapy|0|||
164458916|NCT04209465|594050813|FG005|Overall Study|Started new therapy|1|||
164458917|NCT04209465|594050814|FG006|Overall Study|Started new therapy|0|||
164458918|NCT04209465|594050815|FG007|Overall Study|Started new therapy|0|||
164458919|NCT04209465|594050816|FG008|Overall Study|Started new therapy|0|||
164458920|NCT04209465|594050817|FG009|Overall Study|Started new therapy|0|||
164458921|NCT04209465|594050818|FG010|Overall Study|Started new therapy|0|||
164458922|NCT04209465|594050819|FG011|Overall Study|Started new therapy|0|||
164458923|NCT04209465|594050820|FG012|Overall Study|Started new therapy|0|||
164458924|NCT04209465|594050808|FG000|Overall Study|Study terminated early by sponsor|0|||
164458925|NCT04209465|594050809|FG001|Overall Study|Study terminated early by sponsor|0|||
164458926|NCT04209465|594050810|FG002|Overall Study|Study terminated early by sponsor|0|||
164458927|NCT04209465|594050811|FG003|Overall Study|Study terminated early by sponsor|0|||
164458928|NCT04209465|594050812|FG004|Overall Study|Study terminated early by sponsor|0|||
164458929|NCT04209465|594050813|FG005|Overall Study|Study terminated early by sponsor|0|||
164458930|NCT04209465|594050814|FG006|Overall Study|Study terminated early by sponsor|3|||
164458931|NCT04209465|594050815|FG007|Overall Study|Study terminated early by sponsor|0|||
164458932|NCT04209465|594050816|FG008|Overall Study|Study terminated early by sponsor|0|||
164458933|NCT04209465|594050817|FG009|Overall Study|Study terminated early by sponsor|0|||
164458934|NCT04209465|594050818|FG010|Overall Study|Study terminated early by sponsor|0|||
164458935|NCT04209465|594050819|FG011|Overall Study|Study terminated early by sponsor|0|||
164458936|NCT04209465|594050820|FG012|Overall Study|Study terminated early by sponsor|3|||
164458937|NCT04209465|594050808|FG000|Overall Study|Other|0|||
164458938|NCT04209465|594050809|FG001|Overall Study|Other|0|||
164458939|NCT04209465|594050810|FG002|Overall Study|Other|0|||
164458940|NCT04209465|594050811|FG003|Overall Study|Other|0|||
164458941|NCT04209465|594050812|FG004|Overall Study|Other|0|||
164458942|NCT04209465|594050813|FG005|Overall Study|Other|0|||
164458943|NCT04209465|594050814|FG006|Overall Study|Other|0|||
164458944|NCT04209465|594050815|FG007|Overall Study|Other|0|||
164458945|NCT04209465|594050816|FG008|Overall Study|Other|1|||
164458946|NCT04209465|594050817|FG009|Overall Study|Other|0|||
164458947|NCT04209465|594050818|FG010|Overall Study|Other|0|||
164458948|NCT04209465|594050819|FG011|Overall Study|Other|0|||
164458949|NCT04209465|594050820|FG012|Overall Study|Other|0|||
164458950|NCT05647304|594050821|FG000|Overall Study|Withdrawal by Subject|1|||
164458951|NCT05647304|594050822|FG001|Overall Study|Withdrawal by Subject|0|||
164458952|NCT04171999|594050823|FG000|Overall Study|deemed ineligible after randomization|2|||
164458953|NCT04171999|594050824|FG001|Overall Study|deemed ineligible after randomization|1|||
164458954|NCT04505904|594050829|FG000|Overall Study|Withdrawal by Subject|1|||
164458955|NCT04505904|594050830|FG001|Overall Study|Withdrawal by Subject|2|||
164458956|NCT04505904|594050831|FG002|Overall Study|Withdrawal by Subject|0|||
164458957|NCT04505904|594050832|FG003|Overall Study|Withdrawal by Subject|0|||
164458958|NCT04505904|594050829|FG000|Overall Study|Physician Decision|1|||
164458959|NCT04505904|594050830|FG001|Overall Study|Physician Decision|0|||
164458960|NCT04505904|594050831|FG002|Overall Study|Physician Decision|0|||
164458961|NCT04505904|594050832|FG003|Overall Study|Physician Decision|0|||
164458962|NCT04505904|594050829|FG000|Overall Study|Adverse Event|0|||
164458963|NCT04505904|594050830|FG001|Overall Study|Adverse Event|1|||
164458964|NCT04505904|594050831|FG002|Overall Study|Adverse Event|0|||
164458965|NCT04505904|594050832|FG003|Overall Study|Adverse Event|0|||
164458966|NCT04277442|594050835|FG000|Overall Study|Death|1|||
164458967|NCT03092518|594050836|FG000|Overall Study|Ineligible|2|||
164458968|NCT02547987|594050839|FG000|Overall Study|Withdrawal by Subject|1|||
164458969|NCT02547987|594050839|FG000|Overall Study|Adverse Event|2|||
164458970|NCT04282148|594050840|FG000|Overall Study|Death|7|||
164458971|NCT04282148|594050840|FG000|Overall Study|Withdrawal by Subject|1|||
164458972|NCT04282148|594050840|FG000|Overall Study|Physician Decision|1|||
164458973|NCT03808818|594050841|FG000|Overall Study|Death|6|||
164458974|NCT03808818|594050842|FG001|Overall Study|Death|6|||
164458975|NCT03808818|594050841|FG000|Overall Study|Withdrawal by Subject|7|||
164458976|NCT03808818|594050842|FG001|Overall Study|Withdrawal by Subject|18|||
164458977|NCT03808818|594050841|FG000|Overall Study|Lost to Follow-up|31|||
164458978|NCT03808818|594050842|FG001|Overall Study|Lost to Follow-up|33|||
164458979|NCT03865498|594050844|FG000|Overall Study|Lack of Efficacy|12|||
164458980|NCT03865498|594050845|FG001|Overall Study|Lack of Efficacy|11|||
164458981|NCT03865498|594050844|FG000|Overall Study|Lost to Follow-up|125|||
164458982|NCT03865498|594050845|FG001|Overall Study|Lost to Follow-up|133|||
164458983|NCT03865498|594050844|FG000|Overall Study|Withdrawal by Subject|2|||
164458984|NCT03865498|594050845|FG001|Overall Study|Withdrawal by Subject|4|||
164458985|NCT05084508|594050846|FG000|Overall Study|Lost to Follow-up|6|||
164458986|NCT05084508|594050847|FG001|Overall Study|Lost to Follow-up|3|||
164458987|NCT05084508|594050848|FG002|Overall Study|Lost to Follow-up|7|||
164458988|NCT05084508|594050849|FG003|Overall Study|Lost to Follow-up|3|||
164458989|NCT05084508|594050846|FG000|Overall Study|Withdrawal by Subject|0|||
164458990|NCT05084508|594050847|FG001|Overall Study|Withdrawal by Subject|2|||
164458991|NCT05084508|594050848|FG002|Overall Study|Withdrawal by Subject|3|||
164458992|NCT05084508|594050849|FG003|Overall Study|Withdrawal by Subject|1|||
164458993|NCT05084508|594050846|FG000|Overall Study|Other|0|||
164458994|NCT05084508|594050847|FG001|Overall Study|Other|0|||
164458995|NCT05084508|594050848|FG002|Overall Study|Other|0|||
164458996|NCT05084508|594050849|FG003|Overall Study|Other|1|||
164458997|NCT04137289|594050850|FG000|Overall Study|Death|0|||
164458998|NCT04137289|594050851|FG001|Overall Study|Death|0|||
164458999|NCT04137289|594050852|FG002|Overall Study|Death|0|||
164459000|NCT04137289|594050853|FG003|Overall Study|Death|0|||
164459001|NCT04137289|594050854|FG004|Overall Study|Death|0|||
164459002|NCT04137289|594050855|FG005|Overall Study|Death|0|||
164459003|NCT04137289|594050856|FG006|Overall Study|Death|1|||
164459004|NCT04137289|594050857|FG007|Overall Study|Death|0|||
164459005|NCT04137289|594050858|FG008|Overall Study|Death|0|||
164459006|NCT04137289|594050850|FG000|Overall Study|Clinical disease progression|0|||
164459007|NCT04137289|594050851|FG001|Overall Study|Clinical disease progression|0|||
164459008|NCT04137289|594050852|FG002|Overall Study|Clinical disease progression|0|||
164459009|NCT04137289|594050853|FG003|Overall Study|Clinical disease progression|4|||
164459010|NCT04137289|594050854|FG004|Overall Study|Clinical disease progression|4|||
164459011|NCT04137289|594050855|FG005|Overall Study|Clinical disease progression|2|||
164459012|NCT04137289|594050856|FG006|Overall Study|Clinical disease progression|5|||
164459013|NCT04137289|594050857|FG007|Overall Study|Clinical disease progression|1|||
164459014|NCT04137289|594050858|FG008|Overall Study|Clinical disease progression|0|||
164459015|NCT04137289|594050850|FG000|Overall Study|Lost to Follow-up|0|||
164459016|NCT04137289|594050851|FG001|Overall Study|Lost to Follow-up|0|||
164459017|NCT04137289|594050852|FG002|Overall Study|Lost to Follow-up|0|||
164459018|NCT04137289|594050853|FG003|Overall Study|Lost to Follow-up|1|||
164459019|NCT04137289|594050854|FG004|Overall Study|Lost to Follow-up|0|||
164459020|NCT04137289|594050855|FG005|Overall Study|Lost to Follow-up|0|||
164459021|NCT04137289|594050856|FG006|Overall Study|Lost to Follow-up|0|||
164459022|NCT04137289|594050857|FG007|Overall Study|Lost to Follow-up|0|||
164459023|NCT04137289|594050858|FG008|Overall Study|Lost to Follow-up|0|||
164459024|NCT04137289|594050850|FG000|Overall Study|Adverse Event|0|||
164459025|NCT04137289|594050851|FG001|Overall Study|Adverse Event|0|||
164459026|NCT04137289|594050852|FG002|Overall Study|Adverse Event|1|||
164459027|NCT04137289|594050853|FG003|Overall Study|Adverse Event|0|||
164459028|NCT04137289|594050854|FG004|Overall Study|Adverse Event|0|||
164459029|NCT04137289|594050855|FG005|Overall Study|Adverse Event|1|||
164459030|NCT04137289|594050856|FG006|Overall Study|Adverse Event|0|||
164459031|NCT04137289|594050857|FG007|Overall Study|Adverse Event|0|||
164459032|NCT04137289|594050858|FG008|Overall Study|Adverse Event|0|||
164459033|NCT04137289|594050850|FG000|Overall Study|Lack of clinical benefit|0|||
164459034|NCT04137289|594050851|FG001|Overall Study|Lack of clinical benefit|0|||
164459035|NCT04137289|594050852|FG002|Overall Study|Lack of clinical benefit|0|||
164459036|NCT04137289|594050853|FG003|Overall Study|Lack of clinical benefit|0|||
164459037|NCT04137289|594050854|FG004|Overall Study|Lack of clinical benefit|0|||
164459038|NCT04137289|594050855|FG005|Overall Study|Lack of clinical benefit|0|||
164459039|NCT04137289|594050856|FG006|Overall Study|Lack of clinical benefit|0|||
164459040|NCT04137289|594050857|FG007|Overall Study|Lack of clinical benefit|0|||
164459041|NCT04137289|594050858|FG008|Overall Study|Lack of clinical benefit|1|||
164459042|NCT04137289|594050850|FG000|Overall Study|Objective disease progression|1|||
164459043|NCT04137289|594050851|FG001|Overall Study|Objective disease progression|1|||
164459044|NCT04137289|594050852|FG002|Overall Study|Objective disease progression|6|||
164459045|NCT04137289|594050853|FG003|Overall Study|Objective disease progression|18|||
164459046|NCT04137289|594050854|FG004|Overall Study|Objective disease progression|12|||
164459047|NCT04137289|594050855|FG005|Overall Study|Objective disease progression|20|||
164459048|NCT04137289|594050856|FG006|Overall Study|Objective disease progression|18|||
164459049|NCT04137289|594050857|FG007|Overall Study|Objective disease progression|7|||
164459050|NCT04137289|594050858|FG008|Overall Study|Objective disease progression|6|||
164459051|NCT03931174|594050863|FG000|Providers|Staff left organization|26|||
164459052|NCT03931174|594050864|FG001|Providers|Staff left organization|25|||
164459053|NCT03931174|594050863|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
164459054|NCT03931174|594050864|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
164459055|NCT03931174|594050863|FG000|Providers|Lost to Follow-up|4|||
164459056|NCT03931174|594050864|FG001|Providers|Lost to Follow-up|4|||
164459057|NCT03931174|594050863|FG000|Patients|Post-consent screening failure|1|||
164459058|NCT03931174|594050864|FG001|Patients|Post-consent screening failure|1|||
164459059|NCT03931174|594050863|FG000|Patients|Death|1|||
164459060|NCT03931174|594050864|FG001|Patients|Death|1|||
164459061|NCT03931174|594050863|FG000|Patients|Lost to Follow-up|60|||
164459062|NCT03931174|594050864|FG001|Patients|Lost to Follow-up|89|||
164459063|NCT05386030|594050865|FG000|Overall Study|Death|1|||
164459064|NCT05386030|594050866|FG001|Overall Study|Death|0|||
164459065|NCT05386030|594050865|FG000|Overall Study|Physician Decision|2|||
164459066|NCT05386030|594050866|FG001|Overall Study|Physician Decision|1|||
164459067|NCT05386030|594050865|FG000|Overall Study|Lost to Follow-up|19|||
164459068|NCT05386030|594050866|FG001|Overall Study|Lost to Follow-up|7|||
164459069|NCT05386030|594050865|FG000|Overall Study|Withdrawal by Subject|20|||
164459070|NCT05386030|594050866|FG001|Overall Study|Withdrawal by Subject|10|||
164459071|NCT05386030|594050865|FG000|Overall Study|Eligibility criteria violation|1|||
164459072|NCT05386030|594050866|FG001|Overall Study|Eligibility criteria violation|1|||
164459073|NCT05386030|594050865|FG000|Overall Study|Personal Reasons|1|||
164459074|NCT05386030|594050866|FG001|Overall Study|Personal Reasons|0|||
164459075|NCT05228457|594050867|FG000|Overall Study|Withdrawal by Subject|1|||
164459076|NCT05228457|594050868|FG001|Overall Study|Withdrawal by Subject|1|||
164459077|NCT01785719|594053025|FG000|4-week Baseline Evaluation|Physician Decision|1|||
164459078|NCT01785719|594053026|FG001|4-week Baseline Evaluation|Physician Decision|0|||
164459079|NCT01785719|594053025|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
164459080|NCT01785719|594053026|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
164459081|NCT01785719|594053025|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
164459082|NCT01785719|594053026|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
164459083|NCT01785719|594053025|FG000|4-week Baseline Evaluation|Pregnancy|0|||
164459084|NCT01785719|594053026|FG001|4-week Baseline Evaluation|Pregnancy|2|||
164459085|NCT01785719|594053025|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
164459086|NCT01785719|594053026|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
164459087|NCT01785719|594053025|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
164459088|NCT01785719|594053026|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
164459089|NCT01785719|594053025|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
164459090|NCT01785719|594053026|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
164459091|NCT01785719|594053025|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
164459092|NCT01785719|594053026|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
164459093|NCT01785719|594053025|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
164459094|NCT01785719|594053026|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
164459095|NCT01785719|594053025|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
164459096|NCT01785719|594053026|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
164459097|NCT01785719|594053025|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
164459098|NCT01785719|594053026|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
164459099|NCT01785719|594053025|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
164459100|NCT01785719|594053026|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
164459101|NCT01785719|594053025|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
164459102|NCT01785719|594053026|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
164707570|NCT02132754|594953589|FG017|Overall Study|Transferred to Extension Study|0|||
164707571|NCT02132754|594953590|FG018|Overall Study|Transferred to Extension Study|0|||
164707572|NCT02132754|594953591|FG019|Overall Study|Transferred to Extension Study|0|||
164707573|NCT02132754|594953592|FG020|Overall Study|Transferred to Extension Study|0|||
164707574|NCT02132754|594953593|FG021|Overall Study|Transferred to Extension Study|0|||
164459103|NCT01785719|594053025|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
164459104|NCT01785719|594053026|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
164459105|NCT01785719|594053025|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
164459106|NCT01785719|594053026|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
164459107|NCT04029688|594053027|FG000|Overall Study|Death|8|||
164459108|NCT04029688|594053028|FG001|Overall Study|Death|3|||
164459109|NCT04029688|594053029|FG002|Overall Study|Death|6|||
164459110|NCT04029688|594053030|FG003|Overall Study|Death|2|||
164459111|NCT04029688|594053031|FG004|Overall Study|Death|5|||
164459112|NCT04029688|594053032|FG005|Overall Study|Death|0|||
164459113|NCT04029688|594053033|FG006|Overall Study|Death|2|||
164459114|NCT04029688|594053034|FG007|Overall Study|Death|3|||
164459115|NCT04029688|594053027|FG000|Overall Study|Study Terminated by Sponsor|0|||
164459116|NCT04029688|594053028|FG001|Overall Study|Study Terminated by Sponsor|0|||
164459117|NCT04029688|594053029|FG002|Overall Study|Study Terminated by Sponsor|0|||
164459118|NCT04029688|594053030|FG003|Overall Study|Study Terminated by Sponsor|0|||
164459119|NCT04029688|594053031|FG004|Overall Study|Study Terminated by Sponsor|1|||
164459120|NCT04029688|594053032|FG005|Overall Study|Study Terminated by Sponsor|3|||
164459121|NCT04029688|594053033|FG006|Overall Study|Study Terminated by Sponsor|1|||
164459122|NCT04029688|594053034|FG007|Overall Study|Study Terminated by Sponsor|3|||
164459123|NCT04029688|594053027|FG000|Overall Study|Withdrawal by Subject|0|||
164459124|NCT04029688|594053028|FG001|Overall Study|Withdrawal by Subject|0|||
164459125|NCT04029688|594053029|FG002|Overall Study|Withdrawal by Subject|0|||
164459126|NCT04029688|594053030|FG003|Overall Study|Withdrawal by Subject|1|||
164459127|NCT04029688|594053031|FG004|Overall Study|Withdrawal by Subject|0|||
164459128|NCT04029688|594053032|FG005|Overall Study|Withdrawal by Subject|0|||
164459129|NCT04029688|594053033|FG006|Overall Study|Withdrawal by Subject|0|||
164459130|NCT04029688|594053034|FG007|Overall Study|Withdrawal by Subject|0|||
164459131|NCT06491433|594053047|FG000|Overall Study|Protocol Violation|51|||
164459132|NCT06491433|594053047|FG000|Overall Study|consent withdrawal|2|||
164459133|NCT06491433|594053047|FG000|Overall Study|screen failure|1|||
164459134|NCT04749615|594053049|FG000|Overall Study|Lost to Follow-up|6|||
164459135|NCT04749615|594053050|FG001|Overall Study|Lost to Follow-up|10|||
164459136|NCT05292365|594053053|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
164459137|NCT05292365|594053054|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
164459138|NCT05292365|594053055|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
164459139|NCT05292365|594053056|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
164459140|NCT05282173|594053057|FG000|Overall Study|Missed|3|||
164459141|NCT05282173|594053058|FG001|Overall Study|Missed|2|||
164459142|NCT05282173|594053059|FG002|Overall Study|Missed|4|||
164459143|NCT04185298|594053066|FG000|Overall Study|Lost to Follow-up|1|||
164459144|NCT04185298|594053067|FG001|Overall Study|Lost to Follow-up|3|||
164459145|NCT04185298|594053066|FG000|Overall Study|Withdrawal by Subject|0|||
164459146|NCT04185298|594053067|FG001|Overall Study|Withdrawal by Subject|3|||
164459147|NCT04295798|594053068|FG000|Overall Study|Lost to Follow-up|1|||
164459148|NCT03524118|594053069|FG000|Overall Study|Lost to Follow-up|0|||
164459149|NCT03524118|594053070|FG001|Overall Study|Lost to Follow-up|0|||
164459150|NCT03524118|594053071|FG002|Overall Study|Lost to Follow-up|0|||
164459151|NCT03524118|594053072|FG003|Overall Study|Lost to Follow-up|0|||
164459152|NCT03524118|594053073|FG004|Overall Study|Lost to Follow-up|1|||
164459153|NCT03524118|594053074|FG005|Overall Study|Lost to Follow-up|0|||
164459154|NCT03524118|594053069|FG000|Overall Study|Other|0|||
164459155|NCT03524118|594053070|FG001|Overall Study|Other|1|||
164459156|NCT03524118|594053071|FG002|Overall Study|Other|0|||
164459157|NCT03524118|594053072|FG003|Overall Study|Other|0|||
164459158|NCT03524118|594053073|FG004|Overall Study|Other|1|||
164459159|NCT03524118|594053074|FG005|Overall Study|Other|1|||
164459160|NCT03524118|594053069|FG000|Overall Study|Physician Decision|0|||
164459161|NCT03524118|594053070|FG001|Overall Study|Physician Decision|0|||
164459162|NCT03524118|594053071|FG002|Overall Study|Physician Decision|0|||
164459163|NCT03524118|594053072|FG003|Overall Study|Physician Decision|0|||
164459164|NCT03524118|594053073|FG004|Overall Study|Physician Decision|1|||
164459165|NCT03524118|594053074|FG005|Overall Study|Physician Decision|0|||
164459166|NCT03524118|594053069|FG000|Overall Study|Protocol Violation|0|||
164459167|NCT03524118|594053070|FG001|Overall Study|Protocol Violation|0|||
164459168|NCT03524118|594053071|FG002|Overall Study|Protocol Violation|1|||
164459169|NCT03524118|594053072|FG003|Overall Study|Protocol Violation|0|||
164459170|NCT03524118|594053073|FG004|Overall Study|Protocol Violation|1|||
164459171|NCT03524118|594053074|FG005|Overall Study|Protocol Violation|0|||
164459172|NCT03524118|594053069|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164459173|NCT03524118|594053070|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
164459174|NCT03524118|594053071|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
164459175|NCT03524118|594053072|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
164459176|NCT03524118|594053073|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
164459177|NCT03524118|594053074|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
164459178|NCT04316871|594053077|FG000|Overall Study|Protocol Violation|2|||
164459179|NCT04316871|594053078|FG001|Overall Study|Protocol Violation|2|||
164459180|NCT04316871|594053079|FG002|Overall Study|Protocol Violation|2|||
164459181|NCT04316871|594053080|FG003|Overall Study|Protocol Violation|2|||
164459182|NCT04650269|594053081|FG000|Overall Study|Death|3|||
164459183|NCT04650269|594053081|FG000|Overall Study|Lost to Follow-up|6|||
164459184|NCT01437709|594053082|FG000|Overall Study|Adverse Event|0|||
164459185|NCT01437709|594053083|FG001|Overall Study|Adverse Event|1|||
164459186|NCT01437709|594053084|FG002|Overall Study|Adverse Event|0|||
164407431|NCT01691521|593862077|FG001|Overall Study|Withdrawal by Subject|9|||
164407432|NCT01691521|593862078|FG002|Overall Study|Withdrawal by Subject|4|||
164407433|NCT02343003|593862079|FG000|Overall Study|Withdrawal by Subject|9|||
164407434|NCT02343003|593862080|FG001|Overall Study|Withdrawal by Subject|4|||
164407435|NCT02343003|593862079|FG000|Overall Study|Lost to Follow-up|5|||
164407436|NCT02343003|593862080|FG001|Overall Study|Lost to Follow-up|1|||
164407437|NCT02343003|593862079|FG000|Overall Study|Protocol Violation|1|||
164407438|NCT02343003|593862080|FG001|Overall Study|Protocol Violation|0|||
164407439|NCT02343003|593862079|FG000|Overall Study|Death|0|||
164407440|NCT02343003|593862080|FG001|Overall Study|Death|1|||
164407441|NCT02343003|593862079|FG000|Overall Study|exclusion criteria met|1|||
164407442|NCT02343003|593862080|FG001|Overall Study|exclusion criteria met|1|||
164407443|NCT02343003|593862079|FG000|Overall Study|terminated by sponsor|2|||
164407444|NCT02343003|593862080|FG001|Overall Study|terminated by sponsor|0|||
164407445|NCT00622713|593862085|FG000|Overall Study|Adverse Event|35|||
164407446|NCT00622713|593862085|FG000|Overall Study|Administrative problems|4|||
164407447|NCT00622713|593862085|FG000|Overall Study|Withdrawal by Subject|11|||
164407448|NCT00622713|593862085|FG000|Overall Study|Lost to Follow-up|5|||
164407449|NCT00622713|593862085|FG000|Overall Study|Death|2|||
164407450|NCT00622713|593862085|FG000|Overall Study|Subject no longer required study drug|1|||
164407451|NCT00622713|593862085|FG000|Overall Study|Did not meet eligibility criteria|1|||
164407452|NCT00879996|593862088|FG000|Overall Study|Lost to Follow-up|7|||
164407453|NCT00879996|593862089|FG001|Overall Study|Lost to Follow-up|6|||
164407454|NCT00879996|593862088|FG000|Overall Study|non-compliance|6|||
164407455|NCT00879996|593862089|FG001|Overall Study|non-compliance|4|||
164407456|NCT00879996|593862088|FG000|Overall Study|Physician Decision|1|||
164407457|NCT00879996|593862089|FG001|Overall Study|Physician Decision|2|||
164407458|NCT00879996|593862088|FG000|Overall Study|psychiatric problem|0|||
164407459|NCT00879996|593862089|FG001|Overall Study|psychiatric problem|1|||
164407460|NCT00879996|593862088|FG000|Overall Study|put on parole|1|||
164407461|NCT00879996|593862089|FG001|Overall Study|put on parole|0|||
164407462|NCT03056534|593862092|FG000|Overall Study|Participant withdrew consent|8|||
164407463|NCT03056534|593862092|FG000|Overall Study|Participant not able to return|6|||
164407464|NCT03056534|593862092|FG000|Overall Study|Lost to Follow-up|37|||
164407465|NCT03056534|593862092|FG000|Overall Study|Investigator judgment|1|||
164407466|NCT03056534|593862092|FG000|Overall Study|Death|4|||
164407467|NCT03056534|593862092|FG000|Overall Study|Adverse Event|1|||
164407468|NCT03056534|593862092|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
164407469|NCT04270747|593862094|FG000|Through Week 16|Adverse Event|1|||
164407470|NCT04270747|593862095|FG001|Through Week 16|Adverse Event|2|||
164407471|NCT04270747|593862096|FG002|Through Week 16|Adverse Event|0|||
164407472|NCT04270747|593862094|FG000|Through Week 16|Death|0|||
164407473|NCT04270747|593862095|FG001|Through Week 16|Death|2|||
164407474|NCT04270747|593862096|FG002|Through Week 16|Death|0|||
164407475|NCT04270747|593862094|FG000|Through Week 16|Consent Withdrawn|3|||
164407476|NCT04270747|593862095|FG001|Through Week 16|Consent Withdrawn|3|||
164407477|NCT04270747|593862096|FG002|Through Week 16|Consent Withdrawn|0|||
164407478|NCT04270747|593862094|FG000|Through Week 16|Physician Decision|1|||
164407479|NCT04270747|593862095|FG001|Through Week 16|Physician Decision|1|||
164407480|NCT04270747|593862096|FG002|Through Week 16|Physician Decision|0|||
164407481|NCT04270747|593862094|FG000|Through Week 16|Lost to Follow-up|2|||
164407482|NCT04270747|593862095|FG001|Through Week 16|Lost to Follow-up|0|||
164407483|NCT04270747|593862096|FG002|Through Week 16|Lost to Follow-up|0|||
164407484|NCT04270747|593862094|FG000|Through Week 16|Protocol Violation|1|||
164407485|NCT04270747|593862095|FG001|Through Week 16|Protocol Violation|2|||
164407486|NCT04270747|593862096|FG002|Through Week 16|Protocol Violation|0|||
164407487|NCT04270747|593862094|FG000|Through Week 16|Protocol Specified Criteria|6|||
164407488|NCT04270747|593862095|FG001|Through Week 16|Protocol Specified Criteria|7|||
164407489|NCT04270747|593862096|FG002|Through Week 16|Protocol Specified Criteria|0|||
164407490|NCT04270747|593862094|FG000|Through Week 16|Miscellaneous|1|||
164407491|NCT04270747|593862095|FG001|Through Week 16|Miscellaneous|1|||
164407492|NCT04270747|593862096|FG002|Through Week 16|Miscellaneous|0|||
164407493|NCT04270747|593862094|FG000|Post Week 16|Adverse Event|7|||
164407494|NCT04270747|593862095|FG001|Post Week 16|Adverse Event|5|||
164407495|NCT04270747|593862096|FG002|Post Week 16|Adverse Event|1|||
164407496|NCT04270747|593862094|FG000|Post Week 16|Death|2|||
164407497|NCT04270747|593862095|FG001|Post Week 16|Death|0|||
164407498|NCT04270747|593862096|FG002|Post Week 16|Death|2|||
164407499|NCT04270747|593862094|FG000|Post Week 16|Consent Withdrawn|4|||
164407500|NCT04270747|593862095|FG001|Post Week 16|Consent Withdrawn|3|||
164407501|NCT04270747|593862096|FG002|Post Week 16|Consent Withdrawn|6|||
164407502|NCT04270747|593862094|FG000|Post Week 16|Physician Decision|3|||
164407503|NCT04270747|593862095|FG001|Post Week 16|Physician Decision|1|||
164407504|NCT04270747|593862096|FG002|Post Week 16|Physician Decision|1|||
164407505|NCT04270747|593862094|FG000|Post Week 16|Lost to Follow-up|2|||
164407506|NCT04270747|593862095|FG001|Post Week 16|Lost to Follow-up|1|||
164598579|NCT01522976|594554753|FG000|Overall Study|Disease progression|28|||
164407507|NCT04270747|593862096|FG002|Post Week 16|Lost to Follow-up|0|||
164407508|NCT04270747|593862094|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
164459187|NCT01437709|594053082|FG000|Overall Study|Pt trasnferred care|0|||
164459188|NCT01437709|594053083|FG001|Overall Study|Pt trasnferred care|1|||
164459189|NCT01437709|594053084|FG002|Overall Study|Pt trasnferred care|0|||
164459190|NCT04091750|594053085|FG000|Overall Study|Adverse Event|4|||
164459191|NCT04091750|594053085|FG000|Overall Study|Withdrawal by Subject|1|||
164459192|NCT02262728|594053086|FG000|Follow-up Phase (3 Years)|Death|0|||
164459193|NCT02262728|594053087|FG001|Follow-up Phase (3 Years)|Death|1|||
164459194|NCT02262728|594053086|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
164459195|NCT02262728|594053087|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
164459196|NCT02262728|594053086|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
164459197|NCT02262728|594053087|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
164459198|NCT02619838|594053088|FG000|Overall Study|Lost to Follow-up|9|||
164459199|NCT02619838|594053088|FG000|Overall Study|Withdrawal by Subject|15|||
164459200|NCT01715285|594053089|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
164459201|NCT01715285|594053090|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
164459202|NCT01715285|594053091|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
164459203|NCT01715285|594053089|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
164459204|NCT01715285|594053090|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
164459205|NCT01715285|594053091|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
164459206|NCT01715285|594053089|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
164459207|NCT01715285|594053090|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
164459208|NCT01715285|594053091|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
164459209|NCT01715285|594053089|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
164459210|NCT01715285|594053090|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
164459211|NCT01715285|594053091|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
164459212|NCT01715285|594053089|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
164459213|NCT01715285|594053090|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
164459214|NCT01715285|594053091|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
164459215|NCT01715285|594053089|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
164459216|NCT01715285|594053090|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
164459217|NCT01715285|594053091|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
164459218|NCT01715285|594053089|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
164459219|NCT01715285|594053090|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
164459220|NCT01715285|594053091|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
164459221|NCT01715285|594053089|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
164459222|NCT01715285|594053090|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
164598580|NCT01522976|594554754|FG001|Overall Study|Disease progression|30|||
164598581|NCT01522976|594554755|FG002|Overall Study|Disease progression|25|||
164598582|NCT01522976|594554753|FG000|Overall Study|Adverse Event|17|||
164598583|NCT01522976|594554754|FG001|Overall Study|Adverse Event|7|||
164598584|NCT01522976|594554755|FG002|Overall Study|Adverse Event|18|||
164598585|NCT01522976|594554753|FG000|Overall Study|Refusal unrelated to adverse event|10|||
164598586|NCT01522976|594554754|FG001|Overall Study|Refusal unrelated to adverse event|13|||
164598587|NCT01522976|594554755|FG002|Overall Study|Refusal unrelated to adverse event|14|||
164707575|NCT02132754|594953594|FG022|Overall Study|Transferred to Extension Study|0|||
164707576|NCT02132754|594953595|FG023|Overall Study|Transferred to Extension Study|0|||
164707577|NCT02132754|594953596|FG024|Overall Study|Transferred to Extension Study|0|||
164707578|NCT02132754|594953597|FG025|Overall Study|Transferred to Extension Study|0|||
164707579|NCT02132754|594953598|FG026|Overall Study|Transferred to Extension Study|0|||
164707580|NCT02132754|594953599|FG027|Overall Study|Transferred to Extension Study|0|||
164707581|NCT02132754|594953600|FG028|Overall Study|Transferred to Extension Study|0|||
164707582|NCT02132754|594953601|FG029|Overall Study|Transferred to Extension Study|0|||
164707583|NCT02132754|594953602|FG030|Overall Study|Transferred to Extension Study|0|||
164707584|NCT02132754|594953603|FG031|Overall Study|Transferred to Extension Study|0|||
164707585|NCT02132754|594953604|FG032|Overall Study|Transferred to Extension Study|0|||
164707586|NCT02132754|594953605|FG033|Overall Study|Transferred to Extension Study|6|||
164459223|NCT01715285|594053091|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
164459224|NCT01715285|594053089|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
164459225|NCT01715285|594053090|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
164459226|NCT01715285|594053091|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
164459227|NCT01715285|594053089|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
164459228|NCT01715285|594053090|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
164459229|NCT01715285|594053091|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
164459230|NCT01715285|594053089|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
164598588|NCT01522976|594554753|FG000|Overall Study|Not protocol specified|22|||
164707587|NCT02132754|594953572|FG000|Overall Study|Withdrawal by Subject|0|||
164707588|NCT02132754|594953573|FG001|Overall Study|Withdrawal by Subject|0|||
164459231|NCT01715285|594053090|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
164598589|NCT01522976|594554754|FG001|Overall Study|Not protocol specified|27|||
164598590|NCT01522976|594554755|FG002|Overall Study|Not protocol specified|27|||
164459232|NCT01715285|594053091|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
164459233|NCT01715285|594053089|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
164459234|NCT01715285|594053090|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
164459235|NCT01715285|594053091|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
164459236|NCT01715285|594053089|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
164459237|NCT01715285|594053090|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
164459238|NCT01715285|594053091|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
164459239|NCT01715285|594053089|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
164459240|NCT01715285|594053090|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
164459241|NCT01715285|594053091|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
164459242|NCT05020249|594053092|FG000|Overall Study|Protocol Violation|1|||
164459243|NCT05020249|594053093|FG001|Overall Study|Protocol Violation|0|||
164459244|NCT04015167|594053099|FG000|Overall Study|Lost to Follow-up|40|||
164459245|NCT04015167|594053099|FG000|Overall Study|Adverse Event|5|||
164459246|NCT04015167|594053099|FG000|Overall Study|Withdrawal by Subject|2|||
164459247|NCT04015167|594053099|FG000|Overall Study|Subject went to jail|1|||
164459248|NCT03474679|594053108|FG000|Overall Study|Death|7|||
164459249|NCT03474679|594053108|FG000|Overall Study|Withdrawal by Subject|1|||
164459250|NCT03452579|594053109|FG000|Overall Study|Death|0|||
164459251|NCT03452579|594053110|FG001|Overall Study|Death|1|||
164459252|NCT03452579|594053109|FG000|Overall Study|Withdrawal by Subject|2|||
164459253|NCT03452579|594053110|FG001|Overall Study|Withdrawal by Subject|0|||
164459254|NCT03452579|594053109|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
164459255|NCT03452579|594053110|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
164459256|NCT03452579|594053109|FG000|Overall Study|Physician Decision|1|||
164459257|NCT03452579|594053110|FG001|Overall Study|Physician Decision|1|||
164459258|NCT03452579|594053109|FG000|Overall Study|Adverse Event|1|||
164459259|NCT03452579|594053110|FG001|Overall Study|Adverse Event|4|||
164459260|NCT01539083|594053117|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
164459261|NCT01539083|594053118|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
164459262|NCT01539083|594053119|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
164459263|NCT01539083|594053117|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
164459264|NCT01539083|594053118|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
164459265|NCT01539083|594053119|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
164459266|NCT01539083|594053117|FG000|Before Randomization (VCD Induction)|Death|6|||
164459267|NCT01539083|594053118|FG001|Before Randomization (VCD Induction)|Death|0|||
164459268|NCT01539083|594053119|FG002|Before Randomization (VCD Induction)|Death|0|||
164459269|NCT01539083|594053117|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
164598591|NCT02883049|594554756|FG000|Induction|Adverse Event|52|||
164407509|NCT04270747|593862095|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
164407510|NCT04270747|593862096|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
164407511|NCT04270747|593862094|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
164407512|NCT04270747|593862095|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
164407513|NCT04270747|593862096|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
164407514|NCT04270747|593862094|FG000|Post Week 16|Miscellaneous|1|||
164407515|NCT04270747|593862095|FG001|Post Week 16|Miscellaneous|0|||
164407516|NCT04270747|593862096|FG002|Post Week 16|Miscellaneous|1|||
164407517|NCT05004688|593862097|FG000|Overall Study|Protocol Violation|7|||
164407518|NCT05004688|593862097|FG000|Overall Study|Physician Decision|2|||
164407519|NCT05004688|593862097|FG000|Overall Study|Withdrawal by Subject|2|||
164407520|NCT05918978|593862100|FG000|Overall Study|Study Terminated by Sponsor|17|||
164407521|NCT05918978|593862101|FG001|Overall Study|Study Terminated by Sponsor|11|||
164407522|NCT05918978|593862100|FG000|Overall Study|Withdrawal by Subject|1|||
164407523|NCT05918978|593862101|FG001|Overall Study|Withdrawal by Subject|1|||
164407524|NCT05918978|593862100|FG000|Overall Study|Adverse Event|1|||
164407525|NCT05918978|593862101|FG001|Overall Study|Adverse Event|0|||
164407526|NCT05918978|593862100|FG000|Overall Study|Other|0|||
164407527|NCT05918978|593862101|FG001|Overall Study|Other|1|||
164407528|NCT00622180|593862102|FG000|Overall Study|Lost to Follow-up|1|||
164407529|NCT00622180|593862103|FG001|Overall Study|Lost to Follow-up|2|||
164407530|NCT00698646|593862106|FG000|Overall Study|Adverse Event|8|||
164407531|NCT00698646|593862107|FG001|Overall Study|Adverse Event|7|||
164407532|NCT00698646|593862108|FG002|Overall Study|Adverse Event|8|||
164407533|NCT00698646|593862106|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
164407534|NCT00698646|593862107|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
164407535|NCT00698646|593862108|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
164407536|NCT00698646|593862106|FG000|Overall Study|Protocol Deviation|6|||
164407537|NCT00698646|593862107|FG001|Overall Study|Protocol Deviation|2|||
164407538|NCT00698646|593862108|FG002|Overall Study|Protocol Deviation|3|||
164407539|NCT00698646|593862106|FG000|Overall Study|Withdrawal by Subject|10|||
164407540|NCT00698646|593862107|FG001|Overall Study|Withdrawal by Subject|11|||
164407541|NCT00698646|593862108|FG002|Overall Study|Withdrawal by Subject|8|||
164407542|NCT00698646|593862106|FG000|Overall Study|Lost to Follow-up|0|||
164407543|NCT00698646|593862107|FG001|Overall Study|Lost to Follow-up|0|||
164598592|NCT02883049|594554757|FG001|Induction|Adverse Event|2|||
164598593|NCT02883049|594554758|FG002|Induction|Adverse Event|0|||
164598594|NCT02883049|594554759|FG003|Induction|Adverse Event|0|||
164598595|NCT02883049|594554760|FG004|Induction|Adverse Event|0|||
164598596|NCT02883049|594554761|FG005|Induction|Adverse Event|0|||
164598597|NCT02883049|594554762|FG006|Induction|Adverse Event|0|||
164598598|NCT02883049|594554763|FG007|Induction|Adverse Event|0|||
164598599|NCT02883049|594554764|FG008|Induction|Adverse Event|0|||
164598600|NCT02883049|594554765|FG009|Induction|Adverse Event|0|||
164707589|NCT02132754|594953574|FG002|Overall Study|Withdrawal by Subject|0|||
164407544|NCT00698646|593862108|FG002|Overall Study|Lost to Follow-up|2|||
164407545|NCT00698646|593862106|FG000|Overall Study|Administrative problems|1|||
164407546|NCT00698646|593862107|FG001|Overall Study|Administrative problems|0|||
164407547|NCT00698646|593862108|FG002|Overall Study|Administrative problems|1|||
164407548|NCT00279201|593862111|FG000|Initiation|Death|1|||
164407549|NCT00279201|593862112|FG001|Initiation|Death|5|||
164407550|NCT00279201|593862113|FG002|Initiation|Death|0|||
164407551|NCT00279201|593862114|FG003|Initiation|Death|0|||
164407552|NCT00279201|593862115|FG004|Initiation|Death|0|||
164407553|NCT00279201|593862116|FG005|Initiation|Death|0|||
164407554|NCT00279201|593862111|FG000|Initiation|Adverse Event|6|||
164407555|NCT00279201|593862112|FG001|Initiation|Adverse Event|15|||
164407556|NCT00279201|593862113|FG002|Initiation|Adverse Event|0|||
164407557|NCT00279201|593862114|FG003|Initiation|Adverse Event|0|||
164407558|NCT00279201|593862115|FG004|Initiation|Adverse Event|0|||
164407559|NCT00279201|593862116|FG005|Initiation|Adverse Event|0|||
164407560|NCT00279201|593862111|FG000|Initiation|Lost to Follow-up|42|||
164407561|NCT00279201|593862112|FG001|Initiation|Lost to Follow-up|41|||
164407562|NCT00279201|593862113|FG002|Initiation|Lost to Follow-up|0|||
164407563|NCT00279201|593862114|FG003|Initiation|Lost to Follow-up|0|||
164407564|NCT00279201|593862115|FG004|Initiation|Lost to Follow-up|0|||
164407565|NCT00279201|593862116|FG005|Initiation|Lost to Follow-up|0|||
164407566|NCT00279201|593862111|FG000|Initiation|Entry Criteria Exclusion|7|||
164407567|NCT00279201|593862112|FG001|Initiation|Entry Criteria Exclusion|9|||
164407568|NCT00279201|593862113|FG002|Initiation|Entry Criteria Exclusion|0|||
164407569|NCT00279201|593862114|FG003|Initiation|Entry Criteria Exclusion|0|||
164407570|NCT00279201|593862115|FG004|Initiation|Entry Criteria Exclusion|0|||
164407571|NCT00279201|593862116|FG005|Initiation|Entry Criteria Exclusion|0|||
164407572|NCT00279201|593862111|FG000|Initiation|Protocol Violation|9|||
164407573|NCT00279201|593862112|FG001|Initiation|Protocol Violation|10|||
164407574|NCT00279201|593862113|FG002|Initiation|Protocol Violation|0|||
164407575|NCT00279201|593862114|FG003|Initiation|Protocol Violation|0|||
164407576|NCT00279201|593862115|FG004|Initiation|Protocol Violation|0|||
164407577|NCT00279201|593862116|FG005|Initiation|Protocol Violation|0|||
164407578|NCT00279201|593862111|FG000|Initiation|Withdrawal by Subject|35|||
164407579|NCT00279201|593862112|FG001|Initiation|Withdrawal by Subject|41|||
164407580|NCT00279201|593862113|FG002|Initiation|Withdrawal by Subject|0|||
164407581|NCT00279201|593862114|FG003|Initiation|Withdrawal by Subject|0|||
164407582|NCT00279201|593862115|FG004|Initiation|Withdrawal by Subject|0|||
164407583|NCT00279201|593862116|FG005|Initiation|Withdrawal by Subject|0|||
164407584|NCT00279201|593862111|FG000|Initiation|Physician Decision|15|||
164407585|NCT00279201|593862112|FG001|Initiation|Physician Decision|18|||
164407586|NCT00279201|593862113|FG002|Initiation|Physician Decision|0|||
164407587|NCT00279201|593862114|FG003|Initiation|Physician Decision|0|||
164407588|NCT00279201|593862115|FG004|Initiation|Physician Decision|0|||
164407589|NCT00279201|593862116|FG005|Initiation|Physician Decision|0|||
164407590|NCT00279201|593862111|FG000|Initiation|Sponsor Decision|13|||
164407591|NCT00279201|593862112|FG001|Initiation|Sponsor Decision|5|||
164407592|NCT00279201|593862113|FG002|Initiation|Sponsor Decision|0|||
164407593|NCT00279201|593862114|FG003|Initiation|Sponsor Decision|0|||
164407594|NCT00279201|593862115|FG004|Initiation|Sponsor Decision|0|||
164407595|NCT00279201|593862116|FG005|Initiation|Sponsor Decision|0|||
164407596|NCT00279201|593862111|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
164407597|NCT00279201|593862112|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
164407598|NCT00279201|593862113|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
164407599|NCT00279201|593862114|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
164407600|NCT00279201|593862115|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
164407601|NCT00279201|593862116|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
164407602|NCT00279201|593862111|FG000|Maintenance|Lack of Efficacy|32|||
164598601|NCT02883049|594554766|FG010|Induction|Adverse Event|0|||
164707590|NCT02132754|594953575|FG003|Overall Study|Withdrawal by Subject|0|||
164407603|NCT00279201|593862112|FG001|Maintenance|Lack of Efficacy|30|||
164407604|NCT00279201|593862113|FG002|Maintenance|Lack of Efficacy|0|||
164407605|NCT00279201|593862114|FG003|Maintenance|Lack of Efficacy|0|||
164407606|NCT00279201|593862115|FG004|Maintenance|Lack of Efficacy|0|||
164407607|NCT00279201|593862116|FG005|Maintenance|Lack of Efficacy|0|||
164407608|NCT00279201|593862111|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
164407609|NCT00279201|593862112|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
164407610|NCT00279201|593862113|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
164598602|NCT02883049|594554767|FG011|Induction|Adverse Event|0|||
164598603|NCT02883049|594554768|FG012|Induction|Adverse Event|0|||
164598604|NCT02883049|594554769|FG013|Induction|Adverse Event|0|||
164598605|NCT02883049|594554770|FG014|Induction|Adverse Event|0|||
164407611|NCT00279201|593862114|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
164407612|NCT00279201|593862115|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
164407613|NCT00279201|593862116|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
164407614|NCT00279201|593862111|FG000|Maintenance|Adverse Event|4|||
164407615|NCT00279201|593862112|FG001|Maintenance|Adverse Event|4|||
164407616|NCT00279201|593862113|FG002|Maintenance|Adverse Event|0|||
164407617|NCT00279201|593862114|FG003|Maintenance|Adverse Event|0|||
164407618|NCT00279201|593862115|FG004|Maintenance|Adverse Event|0|||
164407619|NCT00279201|593862116|FG005|Maintenance|Adverse Event|0|||
164407620|NCT00279201|593862111|FG000|Maintenance|Death|4|||
164407621|NCT00279201|593862112|FG001|Maintenance|Death|4|||
164407622|NCT00279201|593862113|FG002|Maintenance|Death|0|||
164407623|NCT00279201|593862114|FG003|Maintenance|Death|0|||
164407624|NCT00279201|593862115|FG004|Maintenance|Death|0|||
164407625|NCT00279201|593862116|FG005|Maintenance|Death|0|||
164407626|NCT00279201|593862111|FG000|Maintenance|Lost to Follow-up|17|||
164407627|NCT00279201|593862112|FG001|Maintenance|Lost to Follow-up|13|||
164407628|NCT00279201|593862113|FG002|Maintenance|Lost to Follow-up|0|||
164407629|NCT00279201|593862114|FG003|Maintenance|Lost to Follow-up|0|||
164407630|NCT00279201|593862115|FG004|Maintenance|Lost to Follow-up|0|||
164407631|NCT00279201|593862116|FG005|Maintenance|Lost to Follow-up|0|||
164407632|NCT00279201|593862111|FG000|Maintenance|Entry Criteria Exclusion|1|||
164407633|NCT00279201|593862112|FG001|Maintenance|Entry Criteria Exclusion|4|||
164407634|NCT00279201|593862113|FG002|Maintenance|Entry Criteria Exclusion|0|||
164407635|NCT00279201|593862114|FG003|Maintenance|Entry Criteria Exclusion|0|||
164407636|NCT00279201|593862115|FG004|Maintenance|Entry Criteria Exclusion|0|||
164407637|NCT00279201|593862116|FG005|Maintenance|Entry Criteria Exclusion|0|||
164407638|NCT00279201|593862111|FG000|Maintenance|Protocol Violation|16|||
164407639|NCT00279201|593862112|FG001|Maintenance|Protocol Violation|24|||
164407640|NCT00279201|593862113|FG002|Maintenance|Protocol Violation|0|||
164407641|NCT00279201|593862114|FG003|Maintenance|Protocol Violation|0|||
164407642|NCT00279201|593862115|FG004|Maintenance|Protocol Violation|0|||
164407643|NCT00279201|593862116|FG005|Maintenance|Protocol Violation|0|||
164407644|NCT00279201|593862111|FG000|Maintenance|Withdrawal by Subject|18|||
164407645|NCT00279201|593862112|FG001|Maintenance|Withdrawal by Subject|18|||
164407646|NCT00279201|593862113|FG002|Maintenance|Withdrawal by Subject|0|||
164407647|NCT00279201|593862114|FG003|Maintenance|Withdrawal by Subject|0|||
164407648|NCT00279201|593862115|FG004|Maintenance|Withdrawal by Subject|0|||
164407649|NCT00279201|593862116|FG005|Maintenance|Withdrawal by Subject|0|||
164407650|NCT00279201|593862111|FG000|Maintenance|Physician Decision|9|||
164407651|NCT00279201|593862112|FG001|Maintenance|Physician Decision|9|||
164407652|NCT00279201|593862113|FG002|Maintenance|Physician Decision|0|||
164407653|NCT00279201|593862114|FG003|Maintenance|Physician Decision|0|||
164407654|NCT00279201|593862115|FG004|Maintenance|Physician Decision|0|||
164407655|NCT00279201|593862116|FG005|Maintenance|Physician Decision|0|||
164407656|NCT00279201|593862111|FG000|Maintenance|Sponsor Decision|4|||
164407657|NCT00279201|593862112|FG001|Maintenance|Sponsor Decision|0|||
164407658|NCT00279201|593862113|FG002|Maintenance|Sponsor Decision|0|||
164407659|NCT00279201|593862114|FG003|Maintenance|Sponsor Decision|0|||
164407660|NCT00279201|593862115|FG004|Maintenance|Sponsor Decision|0|||
164407661|NCT00279201|593862116|FG005|Maintenance|Sponsor Decision|0|||
164407662|NCT00279201|593862111|FG000|Maintenance|HbA1c>7.5%|123|||
164407663|NCT00279201|593862112|FG001|Maintenance|HbA1c>7.5%|126|||
164407664|NCT00279201|593862113|FG002|Maintenance|HbA1c>7.5%|0|||
164407665|NCT00279201|593862114|FG003|Maintenance|HbA1c>7.5%|0|||
164407666|NCT00279201|593862115|FG004|Maintenance|HbA1c>7.5%|0|||
164407667|NCT00279201|593862116|FG005|Maintenance|HbA1c>7.5%|0|||
164407668|NCT00279201|593862111|FG000|Intensification Addendum|Withdrawal by Subject|0|||
164407669|NCT00279201|593862112|FG001|Intensification Addendum|Withdrawal by Subject|0|||
164407670|NCT00279201|593862113|FG002|Intensification Addendum|Withdrawal by Subject|12|||
164407671|NCT00279201|593862114|FG003|Intensification Addendum|Withdrawal by Subject|14|||
164407672|NCT00279201|593862115|FG004|Intensification Addendum|Withdrawal by Subject|9|||
164407673|NCT00279201|593862116|FG005|Intensification Addendum|Withdrawal by Subject|18|||
164407674|NCT00279201|593862111|FG000|Intensification Addendum|Lost to Follow-up|0|||
164407675|NCT00279201|593862112|FG001|Intensification Addendum|Lost to Follow-up|0|||
164407676|NCT00279201|593862113|FG002|Intensification Addendum|Lost to Follow-up|4|||
164407677|NCT00279201|593862114|FG003|Intensification Addendum|Lost to Follow-up|6|||
164407678|NCT00279201|593862115|FG004|Intensification Addendum|Lost to Follow-up|7|||
164407679|NCT00279201|593862116|FG005|Intensification Addendum|Lost to Follow-up|7|||
164407680|NCT00279201|593862111|FG000|Intensification Addendum|Protocol Violation|0|||
164407681|NCT00279201|593862112|FG001|Intensification Addendum|Protocol Violation|0|||
164407682|NCT00279201|593862113|FG002|Intensification Addendum|Protocol Violation|2|||
164407683|NCT00279201|593862114|FG003|Intensification Addendum|Protocol Violation|2|||
164407684|NCT00279201|593862115|FG004|Intensification Addendum|Protocol Violation|6|||
164407685|NCT00279201|593862116|FG005|Intensification Addendum|Protocol Violation|6|||
164407686|NCT00279201|593862111|FG000|Intensification Addendum|Adverse Event|0|||
164459270|NCT01539083|594053118|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
164459271|NCT01539083|594053119|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
164459272|NCT01539083|594053117|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
164459273|NCT01539083|594053118|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
164459274|NCT01539083|594053119|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
164459275|NCT01539083|594053117|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
164459276|NCT01539083|594053118|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
164459277|NCT01539083|594053119|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
164459278|NCT01539083|594053117|FG000|Before Randomization (VCD Induction)|Other|5|||
164459279|NCT01539083|594053118|FG001|Before Randomization (VCD Induction)|Other|0|||
164459280|NCT01539083|594053119|FG002|Before Randomization (VCD Induction)|Other|0|||
164459281|NCT01539083|594053117|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
164459282|NCT01539083|594053118|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
164459283|NCT01539083|594053119|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
164459284|NCT01539083|594053117|FG000|After Randomization (TP and VTP)|Other|0|||
164459285|NCT01539083|594053118|FG001|After Randomization (TP and VTP)|Other|1|||
164459286|NCT01539083|594053119|FG002|After Randomization (TP and VTP)|Other|1|||
164459287|NCT01539083|594053117|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
164459288|NCT01539083|594053118|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
164459289|NCT01539083|594053119|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
164459290|NCT01539083|594053117|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
164459291|NCT01539083|594053118|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
164459292|NCT01539083|594053119|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
164459293|NCT01539083|594053117|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
164459294|NCT01539083|594053118|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
164459295|NCT01539083|594053119|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
164459296|NCT01539083|594053117|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
164459297|NCT01539083|594053118|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
164459298|NCT01539083|594053119|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
164459299|NCT01539083|594053117|FG000|After Randomization (TP and VTP)|Death|0|||
164459300|NCT01539083|594053118|FG001|After Randomization (TP and VTP)|Death|6|||
164459301|NCT01539083|594053119|FG002|After Randomization (TP and VTP)|Death|11|||
164459302|NCT04350463|594053135|FG000|Overall Study|Other reason|0|||
164459303|NCT04350463|594053136|FG001|Overall Study|Other reason|0|||
164459304|NCT04350463|594053137|FG002|Overall Study|Other reason|0|||
164459305|NCT04350463|594053138|FG003|Overall Study|Other reason|1|||
164459306|NCT04350463|594053135|FG000|Overall Study|Lost to Follow-up|0|||
164459307|NCT04350463|594053136|FG001|Overall Study|Lost to Follow-up|0|||
164459308|NCT04350463|594053137|FG002|Overall Study|Lost to Follow-up|0|||
164459309|NCT04350463|594053138|FG003|Overall Study|Lost to Follow-up|2|||
164459310|NCT04350463|594053135|FG000|Overall Study|Withdrawal by Subject|4|||
164459311|NCT04350463|594053136|FG001|Overall Study|Withdrawal by Subject|0|||
164459312|NCT04350463|594053137|FG002|Overall Study|Withdrawal by Subject|1|||
164459313|NCT04350463|594053138|FG003|Overall Study|Withdrawal by Subject|4|||
164459314|NCT04350463|594053135|FG000|Overall Study|Adverse Event|0|||
164459315|NCT04350463|594053136|FG001|Overall Study|Adverse Event|0|||
164459316|NCT04350463|594053137|FG002|Overall Study|Adverse Event|0|||
164459317|NCT04350463|594053138|FG003|Overall Study|Adverse Event|2|||
164598606|NCT02883049|594554771|FG015|Induction|Adverse Event|0|||
164598607|NCT02883049|594554756|FG000|Induction|Death|76|||
164598608|NCT02883049|594554757|FG001|Induction|Death|8|||
164598609|NCT02883049|594554758|FG002|Induction|Death|0|||
164598610|NCT02883049|594554759|FG003|Induction|Death|0|||
164598611|NCT02883049|594554760|FG004|Induction|Death|0|||
164598612|NCT02883049|594554761|FG005|Induction|Death|0|||
164598613|NCT02883049|594554762|FG006|Induction|Death|0|||
164598614|NCT02883049|594554763|FG007|Induction|Death|0|||
164598615|NCT02883049|594554764|FG008|Induction|Death|0|||
164598616|NCT02883049|594554765|FG009|Induction|Death|0|||
164598617|NCT02883049|594554766|FG010|Induction|Death|0|||
164598618|NCT02883049|594554767|FG011|Induction|Death|0|||
164459318|NCT04350463|594053135|FG000|Overall Study|Death|27|||
164459319|NCT04350463|594053136|FG001|Overall Study|Death|2|||
164459320|NCT04350463|594053137|FG002|Overall Study|Death|13|||
164459321|NCT04350463|594053138|FG003|Overall Study|Death|26|||
164459322|NCT04652700|594053139|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
164459323|NCT04652700|594053140|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
164459324|NCT04652700|594053139|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
164459325|NCT04652700|594053140|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
164459326|NCT04652700|594053139|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
164459327|NCT04652700|594053140|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
164598619|NCT02883049|594554768|FG012|Induction|Death|0|||
164598620|NCT02883049|594554769|FG013|Induction|Death|0|||
164598621|NCT02883049|594554770|FG014|Induction|Death|0|||
164598622|NCT02883049|594554771|FG015|Induction|Death|0|||
164459328|NCT04652700|594053139|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
164459329|NCT04652700|594053140|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
164459330|NCT04652700|594053139|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
164459331|NCT04652700|594053140|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
164459332|NCT04652700|594053139|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
164459333|NCT04652700|594053140|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
164459334|NCT04652700|594053139|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
164459335|NCT04652700|594053140|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
164459336|NCT04652700|594053139|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
164459337|NCT04652700|594053140|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
164459338|NCT04652700|594053139|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
164459339|NCT04652700|594053140|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
164459340|NCT04187833|594053141|FG000|Overall Study|Withdrawal by Subject|1|||
164459341|NCT03097549|594053144|FG000|Overall Study|Withdrawal by Subject|1|||
164459342|NCT03097549|594053145|FG001|Overall Study|Withdrawal by Subject|0|||
164459343|NCT03097549|594053144|FG000|Overall Study|Lost to Follow-up|1|||
164459344|NCT03097549|594053145|FG001|Overall Study|Lost to Follow-up|0|||
164459345|NCT01824537|594053146|FG000|Overall Study|Lost to Follow-up|78|||
164459346|NCT01824537|594053147|FG001|Overall Study|Lost to Follow-up|87|||
164459347|NCT02146378|594053148|FG000|Overall Study|No information of administration|2|||
164459348|NCT04044768|594053157|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
164459349|NCT04044768|594053158|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
164459350|NCT05089019|594053162|FG000|Period 1|Withdrawal by Subject|0|||
164459351|NCT05089019|594053163|FG001|Period 1|Withdrawal by Subject|1|||
164459352|NCT05089019|594053162|FG000|Washout Period|Adverse Event|3|||
164459353|NCT05089019|594053163|FG001|Washout Period|Adverse Event|4|||
164459354|NCT05089019|594053162|FG000|Washout Period|Lost to Follow-up|1|||
164459355|NCT05089019|594053163|FG001|Washout Period|Lost to Follow-up|0|||
164459356|NCT05089019|594053162|FG000|Washout Period|Physician Decision|2|||
164459357|NCT05089019|594053163|FG001|Washout Period|Physician Decision|0|||
164459358|NCT05089019|594053162|FG000|Washout Period|Withdrawal by Subject|6|||
164459359|NCT05089019|594053163|FG001|Washout Period|Withdrawal by Subject|3|||
164459360|NCT05089019|594053162|FG000|Period 2|Adverse Event|4|||
164459361|NCT05089019|594053163|FG001|Period 2|Adverse Event|2|||
164459362|NCT05089019|594053162|FG000|Period 2|Lost to Follow-up|1|||
164459363|NCT05089019|594053163|FG001|Period 2|Lost to Follow-up|0|||
164459364|NCT05089019|594053162|FG000|Period 2|Withdrawal by Subject|0|||
164459365|NCT05089019|594053163|FG001|Period 2|Withdrawal by Subject|1|||
164459366|NCT04925986|594053164|FG000|Overall Study|Death|0|||
164459367|NCT04925986|594053165|FG001|Overall Study|Death|0|||
164459368|NCT04925986|594053166|FG002|Overall Study|Death|2|||
164459369|NCT04925986|594053167|FG003|Overall Study|Death|0|||
164459370|NCT04925986|594053164|FG000|Overall Study|Lack of Efficacy|1|||
164459371|NCT04925986|594053165|FG001|Overall Study|Lack of Efficacy|2|||
164459372|NCT04925986|594053166|FG002|Overall Study|Lack of Efficacy|0|||
164459373|NCT04925986|594053167|FG003|Overall Study|Lack of Efficacy|1|||
164459374|NCT04925986|594053164|FG000|Overall Study|Withdrawal by Subject|0|||
164459375|NCT04925986|594053165|FG001|Overall Study|Withdrawal by Subject|0|||
164459376|NCT04925986|594053166|FG002|Overall Study|Withdrawal by Subject|1|||
164459377|NCT04925986|594053167|FG003|Overall Study|Withdrawal by Subject|2|||
164459378|NCT03858634|594053168|FG000|Overall Study|Withdrawal by Subject|1|||
164459379|NCT03858634|594053169|FG001|Overall Study|Withdrawal by Subject|0|||
164459380|NCT03858634|594053168|FG000|Overall Study|Adverse Event|1|||
164459381|NCT03858634|594053169|FG001|Overall Study|Adverse Event|0|||
164459382|NCT03858634|594053168|FG000|Overall Study|Lost to Follow-up|0|||
164459383|NCT03858634|594053169|FG001|Overall Study|Lost to Follow-up|1|||
164459384|NCT03858634|594053168|FG000|Overall Study|Other, Not Specified|1|||
164459385|NCT03858634|594053169|FG001|Overall Study|Other, Not Specified|1|||
164459386|NCT06181760|594053170|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
164459387|NCT06181760|594053171|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
164459388|NCT06181760|594053172|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
164459389|NCT06181760|594053173|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
164598623|NCT02883049|594554756|FG000|Induction|Lost to Follow-up|2|||
164459390|NCT05415722|594053175|FG000|Overall Study|Lost to Follow-up|0|||
164459391|NCT05415722|594053176|FG001|Overall Study|Lost to Follow-up|2|||
164459392|NCT05415722|594053177|FG002|Overall Study|Lost to Follow-up|0|||
164459393|NCT05415722|594053178|FG003|Overall Study|Lost to Follow-up|1|||
164459394|NCT05415722|594053179|FG004|Overall Study|Lost to Follow-up|0|||
164459395|NCT05415722|594053180|FG005|Overall Study|Lost to Follow-up|0|||
164459396|NCT05415722|594053181|FG006|Overall Study|Lost to Follow-up|1|||
164459397|NCT05415722|594053175|FG000|Overall Study|Physician Decision|0|||
164459398|NCT05415722|594053176|FG001|Overall Study|Physician Decision|0|||
164459399|NCT05415722|594053177|FG002|Overall Study|Physician Decision|0|||
164459400|NCT05415722|594053178|FG003|Overall Study|Physician Decision|1|||
164144659|NCT01495702|592891746|FG001|Randomized Phase|Death|0|||
164459401|NCT05415722|594053179|FG004|Overall Study|Physician Decision|0|||
164407687|NCT00279201|593862112|FG001|Intensification Addendum|Adverse Event|0|||
164407688|NCT00279201|593862113|FG002|Intensification Addendum|Adverse Event|0|||
164407689|NCT00279201|593862114|FG003|Intensification Addendum|Adverse Event|4|||
164407690|NCT00279201|593862115|FG004|Intensification Addendum|Adverse Event|1|||
164407691|NCT00279201|593862116|FG005|Intensification Addendum|Adverse Event|3|||
164407692|NCT00279201|593862111|FG000|Intensification Addendum|Physician Decision|0|||
164407693|NCT00279201|593862112|FG001|Intensification Addendum|Physician Decision|0|||
164407694|NCT00279201|593862113|FG002|Intensification Addendum|Physician Decision|4|||
164598624|NCT02883049|594554757|FG001|Induction|Lost to Follow-up|0|||
164598625|NCT02883049|594554758|FG002|Induction|Lost to Follow-up|0|||
164598626|NCT02883049|594554759|FG003|Induction|Lost to Follow-up|0|||
164598627|NCT02883049|594554760|FG004|Induction|Lost to Follow-up|0|||
164598628|NCT02883049|594554761|FG005|Induction|Lost to Follow-up|0|||
164598629|NCT02883049|594554762|FG006|Induction|Lost to Follow-up|0|||
164598630|NCT02883049|594554763|FG007|Induction|Lost to Follow-up|0|||
164407695|NCT00279201|593862114|FG003|Intensification Addendum|Physician Decision|1|||
164407696|NCT00279201|593862115|FG004|Intensification Addendum|Physician Decision|3|||
164407697|NCT00279201|593862116|FG005|Intensification Addendum|Physician Decision|2|||
164407698|NCT00279201|593862111|FG000|Intensification Addendum|Sponsor Decision|0|||
164407699|NCT00279201|593862112|FG001|Intensification Addendum|Sponsor Decision|0|||
164407700|NCT00279201|593862113|FG002|Intensification Addendum|Sponsor Decision|0|||
164407701|NCT00279201|593862114|FG003|Intensification Addendum|Sponsor Decision|0|||
164407702|NCT00279201|593862115|FG004|Intensification Addendum|Sponsor Decision|1|||
164407703|NCT00279201|593862116|FG005|Intensification Addendum|Sponsor Decision|1|||
164407704|NCT00279201|593862111|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
164407705|NCT00279201|593862112|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
164407706|NCT00279201|593862113|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
164407707|NCT00279201|593862114|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
164407708|NCT00279201|593862115|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
164407709|NCT00279201|593862116|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
164407710|NCT00279201|593862111|FG000|Intensification Addendum|Lack of Efficacy|0|||
164407711|NCT00279201|593862112|FG001|Intensification Addendum|Lack of Efficacy|0|||
164407712|NCT00279201|593862113|FG002|Intensification Addendum|Lack of Efficacy|0|||
164407713|NCT00279201|593862114|FG003|Intensification Addendum|Lack of Efficacy|1|||
164407714|NCT00279201|593862115|FG004|Intensification Addendum|Lack of Efficacy|1|||
164407715|NCT00279201|593862116|FG005|Intensification Addendum|Lack of Efficacy|0|||
164407716|NCT00279201|593862111|FG000|Intensification Addendum|Death|0|||
164407717|NCT00279201|593862112|FG001|Intensification Addendum|Death|0|||
164407718|NCT00279201|593862113|FG002|Intensification Addendum|Death|0|||
164407719|NCT00279201|593862114|FG003|Intensification Addendum|Death|0|||
164407720|NCT00279201|593862115|FG004|Intensification Addendum|Death|1|||
164407721|NCT00279201|593862116|FG005|Intensification Addendum|Death|0|||
164407722|NCT04179721|593862132|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
164407723|NCT04179721|593862133|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
164407724|NCT04179721|593862132|FG000|Overall Study|Lost to Follow-up|0|||
164407725|NCT04179721|593862133|FG001|Overall Study|Lost to Follow-up|1|||
164407726|NCT01489189|593862134|FG000|Overall Study|Withdrawal by Subject|20|||
164407727|NCT01489189|593862135|FG001|Overall Study|Withdrawal by Subject|23|||
164407728|NCT01489189|593862134|FG000|Overall Study|Death|10|||
164407729|NCT01489189|593862135|FG001|Overall Study|Death|8|||
164407730|NCT01489189|593862134|FG000|Overall Study|Missed Visit|1|||
164407731|NCT01489189|593862135|FG001|Overall Study|Missed Visit|4|||
164407732|NCT00112580|593862136|FG000|Overall Study|Adverse Event|1|||
164407733|NCT00112580|593862137|FG001|Overall Study|Adverse Event|2|||
164407734|NCT00112580|593862136|FG000|Overall Study|Disease progression|5|||
164407735|NCT00112580|593862137|FG001|Overall Study|Disease progression|16|||
164407736|NCT00112580|593862136|FG000|Overall Study|Participant withdrew consent|2|||
164407737|NCT00112580|593862137|FG001|Overall Study|Participant withdrew consent|1|||
164407738|NCT05559866|593862138|FG000|Overall Study|Withdrawal by Subject|1|||
164407739|NCT05559866|593862139|FG001|Overall Study|Withdrawal by Subject|0|||
164407740|NCT03444376|593862142|FG000|Part A|Disease relapse or Progression|1|||
164407741|NCT03444376|593862142|FG000|Part A|Withdrawal by Subject|2|||
164407742|NCT03444376|593862142|FG000|Part A|Adverse Event|1|||
164407743|NCT03444376|593862142|FG000|Part B|Disease relapse or Progression|18|||
164407744|NCT03444376|593862142|FG000|Part B|Withdrawal by Subject|2|||
164407745|NCT03444376|593862142|FG000|Part B|Adverse Event|2|||
164407746|NCT03444376|593862142|FG000|Part B|Physician Decision|1|||
164598631|NCT02883049|594554764|FG008|Induction|Lost to Follow-up|0|||
164598632|NCT02883049|594554765|FG009|Induction|Lost to Follow-up|0|||
164598633|NCT02883049|594554766|FG010|Induction|Lost to Follow-up|0|||
164598634|NCT02883049|594554767|FG011|Induction|Lost to Follow-up|0|||
164598635|NCT02883049|594554768|FG012|Induction|Lost to Follow-up|0|||
164598636|NCT02883049|594554769|FG013|Induction|Lost to Follow-up|0|||
164598637|NCT02883049|594554770|FG014|Induction|Lost to Follow-up|0|||
164598638|NCT02883049|594554771|FG015|Induction|Lost to Follow-up|0|||
164598639|NCT02883049|594554756|FG000|Induction|Physician Decision|1407|||
164598640|NCT02883049|594554757|FG001|Induction|Physician Decision|8|||
164459402|NCT05415722|594053180|FG005|Overall Study|Physician Decision|0|||
164459403|NCT05415722|594053181|FG006|Overall Study|Physician Decision|1|||
164459404|NCT05415722|594053175|FG000|Overall Study|Protocol Violation|0|||
164459405|NCT05415722|594053176|FG001|Overall Study|Protocol Violation|0|||
164459406|NCT05415722|594053177|FG002|Overall Study|Protocol Violation|0|||
164459407|NCT05415722|594053178|FG003|Overall Study|Protocol Violation|1|||
164459408|NCT05415722|594053179|FG004|Overall Study|Protocol Violation|0|||
164459409|NCT05415722|594053180|FG005|Overall Study|Protocol Violation|0|||
164459410|NCT05415722|594053181|FG006|Overall Study|Protocol Violation|0|||
164459411|NCT05415722|594053175|FG000|Overall Study|Sponsor Discretion|0|||
164459412|NCT05415722|594053176|FG001|Overall Study|Sponsor Discretion|0|||
164459413|NCT05415722|594053177|FG002|Overall Study|Sponsor Discretion|0|||
164459414|NCT05415722|594053178|FG003|Overall Study|Sponsor Discretion|0|||
164459415|NCT05415722|594053179|FG004|Overall Study|Sponsor Discretion|1|||
164407747|NCT03444376|593862142|FG000|Part C|Disease relapse or Progression|43|||
164407748|NCT03444376|593862142|FG000|Part C|Withdrawal by Subject|5|||
164407749|NCT03444376|593862142|FG000|Part C|Adverse Event|2|||
164407750|NCT03444376|593862142|FG000|Part C|Physician Decision|2|||
164407751|NCT03444376|593862142|FG000|Part C|Death|1|||
164407752|NCT03881696|593862146|FG000|Overall Study|Adverse Event|2|||
164407753|NCT03881696|593862147|FG001|Overall Study|Adverse Event|0|||
164407754|NCT03881696|593862146|FG000|Overall Study|Withdrawal by Subject|2|||
164407755|NCT03881696|593862147|FG001|Overall Study|Withdrawal by Subject|0|||
164407756|NCT03881696|593862146|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
164407757|NCT03881696|593862147|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
164407758|NCT03881696|593862146|FG000|Overall Study|Failure to meet continuation criteria|1|||
164407759|NCT03881696|593862147|FG001|Overall Study|Failure to meet continuation criteria|0|||
164407760|NCT00856167|593862150|FG000|Period 1|Withdrawal by Subject|1|||
164407761|NCT00856167|593862151|FG001|Period 1|Withdrawal by Subject|4|||
164407762|NCT00856167|593862152|FG002|Period 1|Withdrawal by Subject|0|||
164407763|NCT00856167|593862153|FG003|Period 1|Withdrawal by Subject|0|||
164407764|NCT00856167|593862150|FG000|Period 1|Lost to Follow-up|2|||
164407765|NCT00856167|593862151|FG001|Period 1|Lost to Follow-up|1|||
164407766|NCT00856167|593862152|FG002|Period 1|Lost to Follow-up|0|||
164407767|NCT00856167|593862153|FG003|Period 1|Lost to Follow-up|0|||
164407768|NCT00856167|593862150|FG000|Period 2|Lost to Follow-up|0|||
164407769|NCT00856167|593862151|FG001|Period 2|Lost to Follow-up|0|||
164407770|NCT00856167|593862152|FG002|Period 2|Lost to Follow-up|3|||
164407771|NCT00856167|593862153|FG003|Period 2|Lost to Follow-up|1|||
164407772|NCT00856167|593862150|FG000|Period 2|Withdrawal by Subject|0|||
164407773|NCT00856167|593862151|FG001|Period 2|Withdrawal by Subject|0|||
164407774|NCT00856167|593862152|FG002|Period 2|Withdrawal by Subject|2|||
164407775|NCT00856167|593862153|FG003|Period 2|Withdrawal by Subject|4|||
164407776|NCT01061333|593862156|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
164407777|NCT01061333|593862157|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
164407778|NCT02764775|593864435|FG000|Overall Study|Death|1|||
164407779|NCT02764775|593864435|FG000|Overall Study|Lost to Follow-up|2|||
164407780|NCT02764775|593864435|FG000|Overall Study|Withdrawal by Subject|3|||
164407781|NCT00975221|593864436|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
164407782|NCT00975221|593864437|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
164407783|NCT00975221|593864436|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
164407784|NCT00975221|593864437|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
164407785|NCT00975221|593864436|FG000|Titration Phase (Weeks 1-12)|Other|0|||
164407786|NCT00975221|593864437|FG001|Titration Phase (Weeks 1-12)|Other|1|||
164407787|NCT00975221|593864436|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
164407788|NCT00975221|593864437|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
164407789|NCT00975221|593864436|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
164407790|NCT00975221|593864437|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
164407791|NCT00975221|593864436|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
164407792|NCT00975221|593864437|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
164407793|NCT04022889|593864438|FG000|Stage 1: Period 1|Adverse Event|1|||
164407794|NCT04022889|593864439|FG001|Stage 1: Period 1|Adverse Event|0|||
164407795|NCT04022889|593864440|FG002|Stage 1: Period 1|Adverse Event|0|||
164407796|NCT04022889|593864438|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
164407797|NCT04022889|593864439|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
164407798|NCT04022889|593864440|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
164407799|NCT04022889|593864438|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
164407800|NCT04022889|593864439|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
164407801|NCT04022889|593864440|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
164407802|NCT04022889|593864438|FG000|Stage 2|Screen Failure|0|||
164407803|NCT04022889|593864439|FG001|Stage 2|Screen Failure|0|||
164407804|NCT04022889|593864440|FG002|Stage 2|Screen Failure|3|||
164407805|NCT04022889|593864438|FG000|Stage 2|Ineligible for apheresis donation|0|||
164407806|NCT04022889|593864439|FG001|Stage 2|Ineligible for apheresis donation|0|||
164459416|NCT05415722|594053180|FG005|Overall Study|Sponsor Discretion|1|||
164707591|NCT02132754|594953576|FG004|Overall Study|Withdrawal by Subject|0|||
164707592|NCT02132754|594953577|FG005|Overall Study|Withdrawal by Subject|0|||
164707593|NCT02132754|594953578|FG006|Overall Study|Withdrawal by Subject|0|||
164707594|NCT02132754|594953579|FG007|Overall Study|Withdrawal by Subject|0|||
164459417|NCT05415722|594053181|FG006|Overall Study|Sponsor Discretion|0|||
164459418|NCT05415722|594053175|FG000|Overall Study|Withdrawal by Subject|0|||
164459419|NCT05415722|594053176|FG001|Overall Study|Withdrawal by Subject|1|||
164459420|NCT05415722|594053177|FG002|Overall Study|Withdrawal by Subject|0|||
164459421|NCT05415722|594053178|FG003|Overall Study|Withdrawal by Subject|1|||
164459422|NCT05415722|594053179|FG004|Overall Study|Withdrawal by Subject|1|||
164459423|NCT05415722|594053180|FG005|Overall Study|Withdrawal by Subject|0|||
164459424|NCT05415722|594053181|FG006|Overall Study|Withdrawal by Subject|1|||
164459425|NCT03524612|594053182|FG000|Overall Study|Lack of Efficacy|10|||
164459426|NCT03524612|594053182|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
164459427|NCT03524612|594053182|FG000|Overall Study|Adverse Event|10|||
164459428|NCT03524612|594053182|FG000|Overall Study|Withdrawal by Subject|7|||
164459429|NCT03524612|594053182|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
164459430|NCT03524612|594053182|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
164459431|NCT03524612|594053182|FG000|Overall Study|New therapy for study indication|6|||
164459432|NCT03524612|594053182|FG000|Overall Study|Death|3|||
164459433|NCT03524612|594053182|FG000|Overall Study|Lost to Follow-up|2|||
164459434|NCT03524612|594053182|FG000|Overall Study|Protocol Violation|1|||
164459435|NCT04537715|594053183|FG000|Overall Study|Death|3|||
164459436|NCT04537715|594053184|FG001|Overall Study|Death|1|||
164459437|NCT04537715|594053183|FG000|Overall Study|Withdrawal by Subject|3|||
164459438|NCT04537715|594053184|FG001|Overall Study|Withdrawal by Subject|1|||
164459439|NCT04537715|594053183|FG000|Overall Study|Other|4|||
164459440|NCT04537715|594053184|FG001|Overall Study|Other|3|||
164459441|NCT04537715|594053183|FG000|Overall Study|Progressive disease|1|||
164459442|NCT04537715|594053184|FG001|Overall Study|Progressive disease|0|||
164459443|NCT05457647|594053186|FG000|Overall Study|Lost to Follow-up|3|||
164459444|NCT04623671|594053187|FG000|Overall Study|Adverse Event|0|||
164459445|NCT04623671|594053188|FG001|Overall Study|Adverse Event|1|||
164459446|NCT04623671|594053187|FG000|Overall Study|Lost to Follow-up|2|||
164459447|NCT04623671|594053188|FG001|Overall Study|Lost to Follow-up|1|||
164459448|NCT04623671|594053187|FG000|Overall Study|Death|5|||
164459449|NCT04623671|594053188|FG001|Overall Study|Death|5|||
164459450|NCT03448107|594053189|FG000|Overall Study|Lost to Follow-up|229|||
164459451|NCT03448107|594053190|FG001|Overall Study|Lost to Follow-up|258|||
164459452|NCT01648023|594053191|FG000|Overall Study|Screen Fail Post Randomization|1|||
164459453|NCT01648023|594053192|FG001|Overall Study|Screen Fail Post Randomization|2|||
164459454|NCT03213691|594053201|FG000|Overall Study|Adverse Event|2|||
164459455|NCT03213691|594053201|FG000|Overall Study|Death|3|||
164459456|NCT03213691|594053201|FG000|Overall Study|Physician Decision|1|||
164459457|NCT03213691|594053201|FG000|Overall Study|Progressive Disease|14|||
164459458|NCT03213691|594053201|FG000|Overall Study|Ineligible|1|||
164459459|NCT03161028|594053202|FG000|Overall Study|Withdrawal by Subject|6|||
164459460|NCT03161028|594053203|FG001|Overall Study|Withdrawal by Subject|4|||
164459461|NCT03161028|594053202|FG000|Overall Study|Adverse Event|5|||
164459462|NCT03161028|594053203|FG001|Overall Study|Adverse Event|1|||
164459463|NCT03161028|594053202|FG000|Overall Study|Study drug side effects|2|||
164459464|NCT03161028|594053203|FG001|Overall Study|Study drug side effects|2|||
164459465|NCT03161028|594053202|FG000|Overall Study|Administrative PD/UP|4|||
164459466|NCT03161028|594053203|FG001|Overall Study|Administrative PD/UP|2|||
164459467|NCT03161028|594053202|FG000|Overall Study|Lost to Follow-up|2|||
164459468|NCT03161028|594053203|FG001|Overall Study|Lost to Follow-up|0|||
164707595|NCT02132754|594953580|FG008|Overall Study|Withdrawal by Subject|0|||
164707596|NCT02132754|594953581|FG009|Overall Study|Withdrawal by Subject|1|||
164707597|NCT02132754|594953582|FG010|Overall Study|Withdrawal by Subject|0|||
164707598|NCT02132754|594953583|FG011|Overall Study|Withdrawal by Subject|0|||
164459469|NCT03161028|594053202|FG000|Overall Study|Unable to comply with procedures|1|||
164459470|NCT03161028|594053203|FG001|Overall Study|Unable to comply with procedures|1|||
164459471|NCT03492216|594053206|FG000|Overall Study|Death|1|||
164459472|NCT03492216|594053207|FG001|Overall Study|Death|0|||
164707599|NCT02132754|594953584|FG012|Overall Study|Withdrawal by Subject|1|||
164459473|NCT03492216|594053208|FG002|Overall Study|Death|4|||
164459474|NCT03492216|594053209|FG003|Overall Study|Death|0|||
164459475|NCT03492216|594053206|FG000|Overall Study|Withdrawal by Subject|5|||
164459476|NCT03492216|594053207|FG001|Overall Study|Withdrawal by Subject|3|||
164459477|NCT03492216|594053208|FG002|Overall Study|Withdrawal by Subject|1|||
164459478|NCT03492216|594053209|FG003|Overall Study|Withdrawal by Subject|1|||
164459479|NCT03492216|594053206|FG000|Overall Study|Lost to Follow-up|9|||
164459480|NCT03492216|594053207|FG001|Overall Study|Lost to Follow-up|2|||
164459481|NCT03492216|594053208|FG002|Overall Study|Lost to Follow-up|7|||
164459482|NCT03492216|594053209|FG003|Overall Study|Lost to Follow-up|8|||
164459483|NCT03492216|594053206|FG000|Overall Study|Moved|5|||
164459484|NCT03492216|594053207|FG001|Overall Study|Moved|3|||
164459485|NCT03492216|594053208|FG002|Overall Study|Moved|3|||
164459486|NCT03492216|594053209|FG003|Overall Study|Moved|5|||
164459487|NCT03492216|594053206|FG000|Overall Study|Too ill|0|||
164459488|NCT03492216|594053207|FG001|Overall Study|Too ill|1|||
164459489|NCT03492216|594053208|FG002|Overall Study|Too ill|0|||
164459490|NCT03492216|594053209|FG003|Overall Study|Too ill|0|||
164459491|NCT03492216|594053206|FG000|Overall Study|Incarcerated|0|||
164459492|NCT03492216|594053207|FG001|Overall Study|Incarcerated|0|||
164459493|NCT03492216|594053208|FG002|Overall Study|Incarcerated|2|||
164459494|NCT03492216|594053209|FG003|Overall Study|Incarcerated|0|||
164459495|NCT00736723|594053210|FG000|Overall Study|Withdrawal by Subject|4|||
164459496|NCT00736723|594053211|FG001|Overall Study|Withdrawal by Subject|3|||
164459497|NCT01799265|594053214|FG000|Overall Study|Lost to Follow-up|1|||
164459498|NCT01799265|594053215|FG001|Overall Study|Lost to Follow-up|0|||
164459499|NCT01799265|594053214|FG000|Overall Study|Protocol Violation|2|||
164459500|NCT01799265|594053215|FG001|Overall Study|Protocol Violation|1|||
164459501|NCT01799265|594053214|FG000|Overall Study|inadequate sleep study|0|||
164459502|NCT01799265|594053215|FG001|Overall Study|inadequate sleep study|2|||
164459503|NCT05704543|594053219|FG000|Overall Study|Withdrawal by Subject|1|||
164459504|NCT05704543|594053220|FG001|Overall Study|Withdrawal by Subject|1|||
164459505|NCT05704543|594053221|FG002|Overall Study|Withdrawal by Subject|0|||
164459506|NCT05704543|594053222|FG003|Overall Study|Withdrawal by Subject|2|||
164459507|NCT05704543|594053219|FG000|Overall Study|Lost to Follow-up|1|||
164459508|NCT05704543|594053220|FG001|Overall Study|Lost to Follow-up|2|||
164459509|NCT05704543|594053221|FG002|Overall Study|Lost to Follow-up|0|||
164459510|NCT05704543|594053222|FG003|Overall Study|Lost to Follow-up|0|||
164459511|NCT05351554|594053227|FG000|Overall Study|Study terminated by sponsor|1|||
164459512|NCT05030233|594053228|FG000|Overall Study|withdrawn for transfer|1|||
164459513|NCT05030233|594053229|FG001|Overall Study|withdrawn for transfer|0|||
164459514|NCT02727699|594055351|FG000|Overall Study|Adverse Event|2|||
164459515|NCT02727699|594055352|FG001|Overall Study|Adverse Event|0|||
164459516|NCT02727699|594055351|FG000|Overall Study|Withdrawal by Subject|5|||
164459517|NCT02727699|594055352|FG001|Overall Study|Withdrawal by Subject|3|||
164459518|NCT02727699|594055351|FG000|Overall Study|Protocol Violation|0|||
164459519|NCT02727699|594055352|FG001|Overall Study|Protocol Violation|1|||
164459520|NCT02727699|594055351|FG000|Overall Study|Physician Decision|0|||
164459521|NCT02727699|594055352|FG001|Overall Study|Physician Decision|1|||
164459522|NCT02727699|594055351|FG000|Overall Study|Lost to Follow-up|1|||
164459523|NCT02727699|594055352|FG001|Overall Study|Lost to Follow-up|0|||
164459524|NCT02727699|594055351|FG000|Overall Study|Sponsor Decision|1|||
164459525|NCT02727699|594055352|FG001|Overall Study|Sponsor Decision|0|||
164459526|NCT03287817|594055353|FG000|Overall Study|Progressive disease|4|||
164459527|NCT03287817|594055354|FG001|Overall Study|Progressive disease|2|||
164459528|NCT03287817|594055355|FG002|Overall Study|Progressive disease|3|||
164707600|NCT02132754|594953585|FG013|Overall Study|Withdrawal by Subject|0|||
164459529|NCT03287817|594055356|FG003|Overall Study|Progressive disease|10|||
164459530|NCT03287817|594055357|FG004|Overall Study|Progressive disease|8|||
164459531|NCT03287817|594055353|FG000|Overall Study|Death|0|||
164459532|NCT03287817|594055354|FG001|Overall Study|Death|0|||
164459533|NCT03287817|594055355|FG002|Overall Study|Death|2|||
164459534|NCT03287817|594055356|FG003|Overall Study|Death|3|||
164459535|NCT03287817|594055357|FG004|Overall Study|Death|4|||
164459536|NCT03287817|594055353|FG000|Overall Study|Physician Decision|0|||
164459537|NCT03287817|594055354|FG001|Overall Study|Physician Decision|0|||
164459538|NCT03287817|594055355|FG002|Overall Study|Physician Decision|0|||
164459539|NCT03287817|594055356|FG003|Overall Study|Physician Decision|1|||
164459540|NCT03287817|594055357|FG004|Overall Study|Physician Decision|0|||
164459541|NCT03287817|594055353|FG000|Overall Study|Withdrawal by Subject|0|||
164459542|NCT03287817|594055354|FG001|Overall Study|Withdrawal by Subject|0|||
164459543|NCT03287817|594055355|FG002|Overall Study|Withdrawal by Subject|0|||
164707601|NCT02132754|594953586|FG014|Overall Study|Withdrawal by Subject|1|||
164459544|NCT03287817|594055356|FG003|Overall Study|Withdrawal by Subject|0|||
164459545|NCT03287817|594055357|FG004|Overall Study|Withdrawal by Subject|4|||
164459546|NCT05251909|594055362|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
164459547|NCT05251909|594055363|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
164707602|NCT02132754|594953587|FG015|Overall Study|Withdrawal by Subject|2|||
164459548|NCT02677298|594055364|FG000|Double Blind Phase|Adverse Event|2|||
164459549|NCT02677298|594055365|FG001|Double Blind Phase|Adverse Event|1|||
164459550|NCT02677298|594055366|FG002|Double Blind Phase|Adverse Event|0|||
164459551|NCT02677298|594055364|FG000|Double Blind Phase|Physician Decision|5|||
164459552|NCT02677298|594055365|FG001|Double Blind Phase|Physician Decision|0|||
164459553|NCT02677298|594055366|FG002|Double Blind Phase|Physician Decision|0|||
164707603|NCT02132754|594953588|FG016|Overall Study|Withdrawal by Subject|1|||
164459554|NCT02677298|594055364|FG000|Double Blind Phase|Lost to Follow-up|11|||
164459555|NCT02677298|594055365|FG001|Double Blind Phase|Lost to Follow-up|7|||
164459556|NCT02677298|594055366|FG002|Double Blind Phase|Lost to Follow-up|0|||
164459557|NCT02677298|594055364|FG000|Double Blind Phase|Withdrawal by Subject|11|||
164459558|NCT02677298|594055365|FG001|Double Blind Phase|Withdrawal by Subject|8|||
164459559|NCT02677298|594055366|FG002|Double Blind Phase|Withdrawal by Subject|0|||
164459560|NCT02677298|594055364|FG000|Double Blind Phase|No study drug available at site|0|||
164459561|NCT02677298|594055365|FG001|Double Blind Phase|No study drug available at site|1|||
164459562|NCT02677298|594055366|FG002|Double Blind Phase|No study drug available at site|0|||
164459563|NCT02677298|594055364|FG000|Open Label Phase|Adverse Event|0|||
164459564|NCT02677298|594055365|FG001|Open Label Phase|Adverse Event|0|||
164459565|NCT02677298|594055366|FG002|Open Label Phase|Adverse Event|4|||
164459566|NCT02677298|594055364|FG000|Open Label Phase|Physician Decision|0|||
164459567|NCT02677298|594055365|FG001|Open Label Phase|Physician Decision|0|||
164459568|NCT02677298|594055366|FG002|Open Label Phase|Physician Decision|1|||
164459569|NCT02677298|594055364|FG000|Open Label Phase|Lost to Follow-up|0|||
164459570|NCT02677298|594055365|FG001|Open Label Phase|Lost to Follow-up|0|||
164459571|NCT02677298|594055366|FG002|Open Label Phase|Lost to Follow-up|17|||
164459572|NCT02677298|594055364|FG000|Open Label Phase|Withdrawal by Subject|0|||
164459573|NCT02677298|594055365|FG001|Open Label Phase|Withdrawal by Subject|0|||
164459574|NCT02677298|594055366|FG002|Open Label Phase|Withdrawal by Subject|38|||
164459575|NCT03611621|594055380|FG000|Overall Study|Graft loss|3|||
164459576|NCT03611621|594055380|FG000|Overall Study|Death|3|||
164459577|NCT03611621|594055380|FG000|Overall Study|Lost to Follow-up|1|||
164459578|NCT04130438|594055381|FG000|Overall Study|Lost to Follow-up|0|||
164459579|NCT04130438|594055382|FG001|Overall Study|Lost to Follow-up|0|||
164459580|NCT04130438|594055383|FG002|Overall Study|Lost to Follow-up|1|||
164459581|NCT03338933|594055385|FG000|Screening Visit|Lost to Follow-up|1|||
164459582|NCT03338933|594055386|FG001|Screening Visit|Lost to Follow-up|3|||
164459583|NCT03338933|594055387|FG002|Screening Visit|Lost to Follow-up|1|||
164459584|NCT03338933|594055388|FG003|Screening Visit|Lost to Follow-up|4|||
164459585|NCT03338933|594055385|FG000|Screening Visit|Screen fail after consent|2|||
164459586|NCT03338933|594055386|FG001|Screening Visit|Screen fail after consent|7|||
164459587|NCT03338933|594055387|FG002|Screening Visit|Screen fail after consent|1|||
164459588|NCT03338933|594055388|FG003|Screening Visit|Screen fail after consent|4|||
164459589|NCT03338933|594055385|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
164459590|NCT03338933|594055386|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
164459591|NCT03338933|594055387|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
164459592|NCT03338933|594055388|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
164459593|NCT03338933|594055385|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
164459594|NCT03338933|594055386|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
164459595|NCT03338933|594055387|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
164459596|NCT03338933|594055388|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
164459597|NCT03338933|594055385|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
164459598|NCT03338933|594055386|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
164459599|NCT03338933|594055387|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
164459600|NCT03338933|594055388|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
164459601|NCT01084876|594055389|FG000|Main Study Treatment Period|Adverse Event|12|||
164459602|NCT01084876|594055390|FG001|Main Study Treatment Period|Adverse Event|7|||
164459603|NCT01084876|594055389|FG000|Main Study Treatment Period|Disease Progression|41|||
164459604|NCT01084876|594055390|FG001|Main Study Treatment Period|Disease Progression|24|||
164459605|NCT01084876|594055389|FG000|Main Study Treatment Period|Physician Decision|2|||
164459606|NCT01084876|594055390|FG001|Main Study Treatment Period|Physician Decision|0|||
164459607|NCT01084876|594055389|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
164459608|NCT01084876|594055390|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
164459609|NCT01084876|594055389|FG000|Main Study Treatment Period|Other Reason|0|||
164459610|NCT01084876|594055390|FG001|Main Study Treatment Period|Other Reason|1|||
164459611|NCT01084876|594055389|FG000|Main Study Treatment Period|Other|0|||
164459612|NCT01084876|594055390|FG001|Main Study Treatment Period|Other|1|||
164459613|NCT01084876|594055389|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
164459614|NCT01084876|594055390|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
164459615|NCT01084876|594055389|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
164459616|NCT01084876|594055390|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
164459617|NCT01084876|594055389|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
164459618|NCT01084876|594055390|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
164459619|NCT01084876|594055389|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
164459620|NCT01084876|594055390|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
164459621|NCT01084876|594055389|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
164459622|NCT01084876|594055390|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
164598641|NCT02883049|594554758|FG002|Induction|Physician Decision|0|||
164598642|NCT02883049|594554759|FG003|Induction|Physician Decision|0|||
164598643|NCT02883049|594554760|FG004|Induction|Physician Decision|0|||
164598644|NCT02883049|594554761|FG005|Induction|Physician Decision|0|||
164459623|NCT01084876|594055389|FG000|Treatment Period Beyond Cycle 8|Other|6|||
164459624|NCT01084876|594055390|FG001|Treatment Period Beyond Cycle 8|Other|9|||
164459625|NCT04515576|594055391|FG000|Overall Study|Withdrawal by Subject|0|||
164459626|NCT04515576|594055392|FG001|Overall Study|Withdrawal by Subject|0|||
164459627|NCT04515576|594055393|FG002|Overall Study|Withdrawal by Subject|0|||
164459628|NCT04515576|594055394|FG003|Overall Study|Withdrawal by Subject|0|||
164459629|NCT04515576|594055395|FG004|Overall Study|Withdrawal by Subject|0|||
164459630|NCT04515576|594055396|FG005|Overall Study|Withdrawal by Subject|1|||
164459631|NCT03812679|594055398|FG000|Overall Study|Adverse Event|2|||
164459632|NCT03812679|594055398|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
164459633|NCT03812679|594055398|FG000|Overall Study|Renal transplant|1|||
164459634|NCT03812679|594055398|FG000|Overall Study|Withdrawal by Subject|1|||
164459635|NCT03812679|594055398|FG000|Overall Study|Termination of study|2|||
164459636|NCT03812679|594055398|FG000|Overall Study|Water device replacement|1|||
164459637|NCT05653427|594055399|FG000|Overall Study|Study Terminated by Sponsor|13|||
164459638|NCT04256941|594055400|FG000|Overall Study|Withdrawal by Subject|0|||
164459639|NCT04256941|594055401|FG001|Overall Study|Withdrawal by Subject|1|||
164459640|NCT04256941|594055400|FG000|Overall Study|Death|1|||
164459641|NCT04256941|594055401|FG001|Overall Study|Death|0|||
164459642|NCT04256941|594055400|FG000|Overall Study|Disease Progession|0|||
164459643|NCT04256941|594055401|FG001|Overall Study|Disease Progession|2|||
164459644|NCT02140554|594055410|FG000|Overall Study|Withdrawal of consent|1|||
164459645|NCT02140554|594055411|FG001|Overall Study|Withdrawal of consent|0|||
164459646|NCT02140554|594055412|FG002|Overall Study|Withdrawal of consent|4|||
164459647|NCT02140554|594055410|FG000|Overall Study|Physician Decision|1|||
164459648|NCT02140554|594055411|FG001|Overall Study|Physician Decision|0|||
164459649|NCT02140554|594055412|FG002|Overall Study|Physician Decision|2|||
164459650|NCT02140554|594055410|FG000|Overall Study|Death|0|||
164459651|NCT02140554|594055411|FG001|Overall Study|Death|0|||
164459652|NCT02140554|594055412|FG002|Overall Study|Death|1|||
164459653|NCT02140554|594055410|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
164459654|NCT02140554|594055411|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
164459655|NCT02140554|594055412|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
164459656|NCT03953508|594055414|FG000|Baseline|Lost to Follow-up|3|||
164459657|NCT03953508|594055415|FG001|Baseline|Lost to Follow-up|2|||
164459658|NCT03953508|594055414|FG000|6-month Follow-up|Lost to Follow-up|62|||
164459659|NCT03953508|594055415|FG001|6-month Follow-up|Lost to Follow-up|70|||
164459660|NCT03771417|594055416|FG000|Overall Study|Withdrawal by Subject|1|||
164459661|NCT03771417|594055417|FG001|Overall Study|Withdrawal by Subject|0|||
164459662|NCT03771417|594055418|FG002|Overall Study|Withdrawal by Subject|0|||
164459663|NCT03771417|594055416|FG000|Overall Study|Covid-19 Shutdown|0|||
164459664|NCT03771417|594055417|FG001|Overall Study|Covid-19 Shutdown|1|||
164459665|NCT03771417|594055418|FG002|Overall Study|Covid-19 Shutdown|0|||
164459666|NCT03869866|594055421|FG000|Overall Study|Protocol Violation|1|||
164459667|NCT03869866|594055421|FG000|Overall Study|Withdrawal by Subject|3|||
164459668|NCT06181227|594055422|FG000|Overall Study|Study terminated by sponsor|7|||
164459669|NCT06181227|594055423|FG001|Overall Study|Study terminated by sponsor|9|||
164459670|NCT05543915|594055425|FG000|Overall Study|Lost to Follow-up|0|||
164459671|NCT05543915|594055426|FG001|Overall Study|Lost to Follow-up|1|||
164459672|NCT02577835|594055427|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
164459673|NCT04342494|594055428|FG000|Overall Study|Questionnaire partially completed|1|||
164459674|NCT04342494|594055429|FG001|Overall Study|Questionnaire partially completed|0|||
164459675|NCT04342494|594055430|FG002|Overall Study|Questionnaire partially completed|2|||
164459676|NCT04342494|594055431|FG003|Overall Study|Questionnaire partially completed|0|||
164459677|NCT04342494|594055432|FG004|Overall Study|Questionnaire partially completed|1|||
164459678|NCT04342494|594055428|FG000|Overall Study|Lost to Follow-up|49|||
164459679|NCT04342494|594055429|FG001|Overall Study|Lost to Follow-up|38|||
164459680|NCT04342494|594055430|FG002|Overall Study|Lost to Follow-up|34|||
164459681|NCT04342494|594055431|FG003|Overall Study|Lost to Follow-up|34|||
164459682|NCT04342494|594055432|FG004|Overall Study|Lost to Follow-up|35|||
164459683|NCT05119023|594055434|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
164459684|NCT05119023|594055434|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
164459685|NCT05119023|594055434|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
164459686|NCT03194217|594055435|FG000|Overall Study|Adverse Event|0|||
164459687|NCT03194217|594055436|FG001|Overall Study|Adverse Event|2|||
164459688|NCT03194217|594055437|FG002|Overall Study|Adverse Event|3|||
164707604|NCT02132754|594953589|FG017|Overall Study|Withdrawal by Subject|0|||
164707605|NCT02132754|594953590|FG018|Overall Study|Withdrawal by Subject|0|||
164707606|NCT02132754|594953591|FG019|Overall Study|Withdrawal by Subject|0|||
164707607|NCT02132754|594953592|FG020|Overall Study|Withdrawal by Subject|1|||
164707608|NCT02132754|594953593|FG021|Overall Study|Withdrawal by Subject|0|||
164459689|NCT03194217|594055438|FG003|Overall Study|Adverse Event|3|||
164459690|NCT03194217|594055435|FG000|Overall Study|Failure to meet randomisation criteria|0|||
164459691|NCT03194217|594055436|FG001|Overall Study|Failure to meet randomisation criteria|0|||
164459692|NCT03194217|594055437|FG002|Overall Study|Failure to meet randomisation criteria|0|||
164459693|NCT03194217|594055438|FG003|Overall Study|Failure to meet randomisation criteria|1|||
164459694|NCT03194217|594055435|FG000|Overall Study|Other|0|||
164459695|NCT03194217|594055436|FG001|Overall Study|Other|1|||
164459696|NCT03194217|594055437|FG002|Overall Study|Other|1|||
164459697|NCT03194217|594055438|FG003|Overall Study|Other|0|||
164459698|NCT02962895|594055439|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
164459699|NCT02962895|594055440|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
164459700|NCT02962895|594055441|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
164459701|NCT02962895|594055442|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
164459702|NCT02962895|594055443|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
164459703|NCT02962895|594055444|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
164459704|NCT02962895|594055445|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
164459705|NCT02962895|594055439|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
164459706|NCT02962895|594055440|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
164459707|NCT02962895|594055441|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
164459708|NCT02962895|594055442|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
164459709|NCT02962895|594055443|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
164459710|NCT02962895|594055444|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
164459711|NCT02962895|594055445|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
164459712|NCT02962895|594055439|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
164459713|NCT02962895|594055440|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
164459714|NCT02962895|594055441|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
164459715|NCT02962895|594055442|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
164459716|NCT02962895|594055443|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
164459717|NCT02962895|594055444|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
164459718|NCT02962895|594055445|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
164459719|NCT02962895|594055439|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
164459720|NCT02962895|594055440|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
164459721|NCT02962895|594055441|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
164459722|NCT02962895|594055442|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
164459723|NCT02962895|594055443|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
164459724|NCT02962895|594055444|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
164459725|NCT02962895|594055445|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
164459726|NCT02962895|594055439|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
164459727|NCT02962895|594055440|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
164459728|NCT02962895|594055441|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
164459729|NCT02962895|594055442|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
164459730|NCT02962895|594055443|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
164459731|NCT02962895|594055444|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
164459732|NCT02962895|594055445|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
164459733|NCT02962895|594055439|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
164459734|NCT02962895|594055440|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
164459735|NCT02962895|594055441|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
164459736|NCT02962895|594055442|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
164459737|NCT02962895|594055443|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
164459738|NCT02962895|594055444|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
164459739|NCT02962895|594055445|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
164459740|NCT02962895|594055439|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
164459741|NCT02962895|594055440|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
164459742|NCT02962895|594055441|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
164459743|NCT02962895|594055442|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
164459744|NCT02962895|594055443|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
164459745|NCT02962895|594055444|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
164459746|NCT02962895|594055445|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
164459747|NCT02962895|594055439|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
164459748|NCT02962895|594055440|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
164459749|NCT02962895|594055441|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
164459750|NCT02962895|594055442|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
164459751|NCT02962895|594055443|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
164459752|NCT02962895|594055444|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
164459753|NCT02962895|594055445|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
164459754|NCT02962895|594055439|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
164459755|NCT02962895|594055440|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
164459756|NCT02962895|594055441|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
164459757|NCT02962895|594055442|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
164459758|NCT02962895|594055443|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
164459759|NCT02962895|594055444|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
164459760|NCT02962895|594055445|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
164459761|NCT02962895|594055439|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
164459762|NCT02962895|594055440|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
164459763|NCT02962895|594055441|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
164459764|NCT02962895|594055442|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
164459765|NCT02962895|594055443|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
164459766|NCT02962895|594055444|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
164459767|NCT02962895|594055445|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
164459768|NCT02962895|594055439|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
164459769|NCT02962895|594055440|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
164459770|NCT02962895|594055441|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
164459771|NCT02962895|594055442|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
164459772|NCT02962895|594055443|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
164459773|NCT02962895|594055444|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
164459774|NCT02962895|594055445|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
164459775|NCT02962895|594055439|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
164459776|NCT02962895|594055440|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
164459777|NCT02962895|594055441|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
164459778|NCT02962895|594055442|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
164459779|NCT02962895|594055443|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
164459780|NCT02962895|594055444|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
164459781|NCT02962895|594055445|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
164598645|NCT02883049|594554762|FG006|Induction|Physician Decision|0|||
164598646|NCT02883049|594554763|FG007|Induction|Physician Decision|0|||
164598647|NCT02883049|594554764|FG008|Induction|Physician Decision|0|||
164598648|NCT02883049|594554765|FG009|Induction|Physician Decision|0|||
164598649|NCT02883049|594554766|FG010|Induction|Physician Decision|0|||
164598650|NCT02883049|594554767|FG011|Induction|Physician Decision|0|||
164598651|NCT02883049|594554768|FG012|Induction|Physician Decision|0|||
164598652|NCT02883049|594554769|FG013|Induction|Physician Decision|0|||
164598653|NCT02883049|594554770|FG014|Induction|Physician Decision|0|||
164598654|NCT02883049|594554771|FG015|Induction|Physician Decision|0|||
164598655|NCT02883049|594554756|FG000|Induction|Protocol Violation|6|||
164598656|NCT02883049|594554757|FG001|Induction|Protocol Violation|0|||
164598657|NCT02883049|594554758|FG002|Induction|Protocol Violation|0|||
164598658|NCT02883049|594554759|FG003|Induction|Protocol Violation|0|||
164598659|NCT02883049|594554760|FG004|Induction|Protocol Violation|0|||
164598660|NCT02883049|594554761|FG005|Induction|Protocol Violation|0|||
164598661|NCT02883049|594554762|FG006|Induction|Protocol Violation|0|||
164598662|NCT02883049|594554763|FG007|Induction|Protocol Violation|0|||
164598663|NCT02883049|594554764|FG008|Induction|Protocol Violation|0|||
164598664|NCT02883049|594554765|FG009|Induction|Protocol Violation|0|||
164598665|NCT02883049|594554766|FG010|Induction|Protocol Violation|0|||
164598666|NCT02883049|594554767|FG011|Induction|Protocol Violation|0|||
164598667|NCT02883049|594554768|FG012|Induction|Protocol Violation|0|||
164598668|NCT02883049|594554769|FG013|Induction|Protocol Violation|0|||
164598669|NCT02883049|594554770|FG014|Induction|Protocol Violation|0|||
164598670|NCT02883049|594554771|FG015|Induction|Protocol Violation|0|||
164598671|NCT02883049|594554756|FG000|Induction|Withdrawal by Subject|6|||
164598672|NCT02883049|594554757|FG001|Induction|Withdrawal by Subject|0|||
164598673|NCT02883049|594554758|FG002|Induction|Withdrawal by Subject|0|||
164598674|NCT02883049|594554759|FG003|Induction|Withdrawal by Subject|0|||
164598675|NCT02883049|594554760|FG004|Induction|Withdrawal by Subject|0|||
164598676|NCT02883049|594554761|FG005|Induction|Withdrawal by Subject|0|||
164598677|NCT02883049|594554762|FG006|Induction|Withdrawal by Subject|0|||
164598678|NCT02883049|594554763|FG007|Induction|Withdrawal by Subject|0|||
164598679|NCT02883049|594554764|FG008|Induction|Withdrawal by Subject|0|||
164598680|NCT02883049|594554765|FG009|Induction|Withdrawal by Subject|0|||
164598681|NCT02883049|594554766|FG010|Induction|Withdrawal by Subject|0|||
164598682|NCT02883049|594554767|FG011|Induction|Withdrawal by Subject|0|||
164598683|NCT02883049|594554768|FG012|Induction|Withdrawal by Subject|0|||
164598684|NCT02883049|594554769|FG013|Induction|Withdrawal by Subject|0|||
164598685|NCT02883049|594554770|FG014|Induction|Withdrawal by Subject|0|||
164598686|NCT02883049|594554771|FG015|Induction|Withdrawal by Subject|0|||
164598687|NCT02883049|594554756|FG000|Induction|Ineligible|35|||
164598688|NCT02883049|594554757|FG001|Induction|Ineligible|1|||
164598689|NCT02883049|594554758|FG002|Induction|Ineligible|0|||
164598690|NCT02883049|594554759|FG003|Induction|Ineligible|0|||
164598691|NCT02883049|594554760|FG004|Induction|Ineligible|0|||
164598692|NCT02883049|594554761|FG005|Induction|Ineligible|0|||
164598693|NCT02883049|594554762|FG006|Induction|Ineligible|0|||
164598694|NCT02883049|594554763|FG007|Induction|Ineligible|0|||
164598695|NCT02883049|594554764|FG008|Induction|Ineligible|0|||
164598696|NCT02883049|594554765|FG009|Induction|Ineligible|0|||
164598697|NCT02883049|594554766|FG010|Induction|Ineligible|0|||
164598698|NCT02883049|594554767|FG011|Induction|Ineligible|0|||
164598699|NCT02883049|594554768|FG012|Induction|Ineligible|0|||
164707609|NCT02132754|594953594|FG022|Overall Study|Withdrawal by Subject|0|||
164707610|NCT02132754|594953595|FG023|Overall Study|Withdrawal by Subject|0|||
164707611|NCT02132754|594953596|FG024|Overall Study|Withdrawal by Subject|1|||
164707612|NCT02132754|594953597|FG025|Overall Study|Withdrawal by Subject|0|||
164707613|NCT02132754|594953598|FG026|Overall Study|Withdrawal by Subject|0|||
164707614|NCT02132754|594953599|FG027|Overall Study|Withdrawal by Subject|1|||
164707615|NCT02132754|594953600|FG028|Overall Study|Withdrawal by Subject|0|||
164707616|NCT02132754|594953601|FG029|Overall Study|Withdrawal by Subject|0|||
164707617|NCT02132754|594953602|FG030|Overall Study|Withdrawal by Subject|0|||
164707618|NCT02132754|594953603|FG031|Overall Study|Withdrawal by Subject|1|||
164707619|NCT02132754|594953604|FG032|Overall Study|Withdrawal by Subject|0|||
164707620|NCT02132754|594953605|FG033|Overall Study|Withdrawal by Subject|2|||
164707621|NCT01193127|594953614|FG000|Randomized|Surgery Cancelled|0|||
164707622|NCT01193127|594953615|FG001|Randomized|Surgery Cancelled|0|||
164707623|NCT01193127|594953616|FG002|Randomized|Surgery Cancelled|0|||
164707624|NCT01193127|594953617|FG003|Randomized|Surgery Cancelled|1|||
164707625|NCT01193127|594953614|FG000|Treated|Withdrawal by Subject|0|||
164707626|NCT01193127|594953615|FG001|Treated|Withdrawal by Subject|0|||
164707627|NCT01193127|594953616|FG002|Treated|Withdrawal by Subject|0|||
164707628|NCT01193127|594953617|FG003|Treated|Withdrawal by Subject|1|||
164707629|NCT00761865|594953621|FG000|Overall Study|Lost to Follow-up|8|||
164707630|NCT00761865|594953622|FG001|Overall Study|Lost to Follow-up|7|||
164707631|NCT03190330|594955278|FG000|Overall Study|Adverse Event|2|||
164707632|NCT03190330|594955278|FG000|Overall Study|Death|10|||
164707633|NCT03190330|594955278|FG000|Overall Study|Lost to Follow-up|1|||
164707634|NCT03190330|594955278|FG000|Overall Study|Withdrawal by Subject|6|||
164707635|NCT03190330|594955278|FG000|Overall Study|Progressive Disease|1|||
164707636|NCT02081209|594955279|FG000|Overall Study|Withdrawal by Subject|1|||
164707637|NCT02370329|594955280|FG000|Overall Study|Alternate treatment|1|||
164707638|NCT02370329|594955280|FG000|Overall Study|Adverse Event|1|||
164707639|NCT02370329|594955280|FG000|Overall Study|Disease progression|3|||
164707640|NCT02370329|594955280|FG000|Overall Study|Physician Decision|2|||
164707641|NCT02370329|594955280|FG000|Overall Study|Study closure|4|||
164707642|NCT02022748|594955284|FG000|Overall Study|Adverse Event|1|||
164707643|NCT02022748|594955285|FG001|Overall Study|Adverse Event|1|||
164459782|NCT02962895|594055439|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
164459783|NCT02962895|594055440|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
164459784|NCT02962895|594055441|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
164459785|NCT02962895|594055442|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
164459786|NCT02962895|594055443|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
164459787|NCT02962895|594055444|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
164459788|NCT02962895|594055445|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
164459789|NCT02962895|594055439|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
164459790|NCT02962895|594055440|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
164459791|NCT02962895|594055441|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
164459792|NCT02962895|594055442|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
164459793|NCT02962895|594055443|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
164459794|NCT02962895|594055444|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
164459795|NCT02962895|594055445|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
164459796|NCT04719390|594055449|FG000|Overall Study|Withdrawal by Subject|1|||
164459797|NCT03016754|594055451|FG000|Overall Study|Death|5|||
164459798|NCT03016754|594055452|FG001|Overall Study|Death|4|||
164459799|NCT03016754|594055453|FG002|Overall Study|Death|5|||
164459800|NCT03016754|594055454|FG003|Overall Study|Death|1|||
164459801|NCT03016754|594055451|FG000|Overall Study|Lost to Follow-up|23|||
164459802|NCT03016754|594055452|FG001|Overall Study|Lost to Follow-up|17|||
164459803|NCT03016754|594055453|FG002|Overall Study|Lost to Follow-up|4|||
164459804|NCT03016754|594055454|FG003|Overall Study|Lost to Follow-up|2|||
164459805|NCT03016754|594055451|FG000|Overall Study|Withdrawal by Subject|6|||
164459806|NCT03016754|594055452|FG001|Overall Study|Withdrawal by Subject|6|||
164459807|NCT03016754|594055453|FG002|Overall Study|Withdrawal by Subject|2|||
164707644|NCT02022748|594955286|FG002|Overall Study|Adverse Event|0|||
164459808|NCT03016754|594055454|FG003|Overall Study|Withdrawal by Subject|2|||
164459809|NCT03016754|594055451|FG000|Overall Study|Other/Unknown|2|||
164459810|NCT03016754|594055452|FG001|Overall Study|Other/Unknown|4|||
164459811|NCT03016754|594055453|FG002|Overall Study|Other/Unknown|2|||
164707645|NCT02022748|594955284|FG000|Overall Study|Withdrawal by Subject|0|||
164707646|NCT02022748|594955285|FG001|Overall Study|Withdrawal by Subject|1|||
164707647|NCT02022748|594955286|FG002|Overall Study|Withdrawal by Subject|0|||
164459812|NCT03016754|594055454|FG003|Overall Study|Other/Unknown|1|||
164459813|NCT03016754|594055451|FG000|Overall Study|Protocol Violation|0|||
164707648|NCT04347122|594955289|FG000|Overall Study|Physician Decision|0|||
164707649|NCT04347122|594955290|FG001|Overall Study|Physician Decision|3|||
164707650|NCT04347122|594955291|FG002|Overall Study|Physician Decision|3|||
164707651|NCT04347122|594955292|FG003|Overall Study|Physician Decision|6|||
164707652|NCT03510598|594955293|FG000|Overall Study|Withdrawal by Subject|1|||
164459814|NCT03016754|594055452|FG001|Overall Study|Protocol Violation|0|||
164459815|NCT03016754|594055453|FG002|Overall Study|Protocol Violation|0|||
164459816|NCT03016754|594055454|FG003|Overall Study|Protocol Violation|4|||
164459817|NCT04019873|594055455|FG000|Overall Study|Discontinued from the treatment|1|||
164459818|NCT04019873|594055456|FG001|Overall Study|Discontinued from the treatment|39|||
164459819|NCT04019873|594055457|FG002|Overall Study|Discontinued from the treatment|2|||
164459820|NCT01606215|594055459|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
164459821|NCT01606215|594055460|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
164459822|NCT05087992|594055462|FG000|Overall Study|Adverse Event|0|||
164459823|NCT05087992|594055463|FG001|Overall Study|Adverse Event|1|||
164459824|NCT05087992|594055464|FG002|Overall Study|Adverse Event|0|||
164459825|NCT05087992|594055462|FG000|Overall Study|Withdrawal by Subject|2|||
164459826|NCT05087992|594055463|FG001|Overall Study|Withdrawal by Subject|0|||
164459827|NCT05087992|594055464|FG002|Overall Study|Withdrawal by Subject|0|||
164459828|NCT05087992|594055462|FG000|Overall Study|clinical disease progression|3|||
164459829|NCT05087992|594055463|FG001|Overall Study|clinical disease progression|1|||
164459830|NCT05087992|594055464|FG002|Overall Study|clinical disease progression|0|||
164459831|NCT05087992|594055462|FG000|Overall Study|objective disease progression|4|||
164459832|NCT05087992|594055463|FG001|Overall Study|objective disease progression|1|||
164459833|NCT05087992|594055464|FG002|Overall Study|objective disease progression|0|||
164459834|NCT01842542|594055465|FG000|Overall Study|Withdrawal by Subject|2|||
164459835|NCT01842542|594055465|FG000|Overall Study|Lack of Efficacy|1|||
164459836|NCT01842542|594055465|FG000|Overall Study|Protocol Non-compliance|2|||
164459837|NCT01842542|594055465|FG000|Overall Study|Lost to Follow-up|1|||
164459838|NCT04858321|594055474|FG000|Overall Study|Withdrawal by Subject|3|||
164459839|NCT02573493|594055476|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
164459840|NCT02573493|594055477|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
164459841|NCT02573493|594055478|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
164459842|NCT02573493|594055479|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
164459843|NCT02761057|594055480|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
164459844|NCT02761057|594055481|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
164459845|NCT02761057|594055482|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
164459846|NCT02761057|594055483|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
164459847|NCT02761057|594055480|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
164459848|NCT02761057|594055481|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
164459849|NCT02761057|594055482|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
164459850|NCT02761057|594055483|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
164459851|NCT02761057|594055480|FG000|Overall Study|Currently On Study Treatment|0|||
164459852|NCT02761057|594055481|FG001|Overall Study|Currently On Study Treatment|3|||
164459853|NCT02761057|594055482|FG002|Overall Study|Currently On Study Treatment|0|||
164459854|NCT02761057|594055483|FG003|Overall Study|Currently On Study Treatment|0|||
164459855|NCT02761057|594055480|FG000|Overall Study|Adverse Event|11|||
164459856|NCT02761057|594055481|FG001|Overall Study|Adverse Event|9|||
164459857|NCT02761057|594055482|FG002|Overall Study|Adverse Event|5|||
164459858|NCT02761057|594055483|FG003|Overall Study|Adverse Event|3|||
164459859|NCT02761057|594055480|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
164459860|NCT02761057|594055481|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
164459861|NCT02761057|594055482|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
164459862|NCT02761057|594055483|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
164459863|NCT02761057|594055480|FG000|Overall Study|Progression/Relapse|29|||
164459864|NCT02761057|594055481|FG001|Overall Study|Progression/Relapse|27|||
164459865|NCT02761057|594055482|FG002|Overall Study|Progression/Relapse|20|||
164459866|NCT02761057|594055483|FG003|Overall Study|Progression/Relapse|23|||
164459867|NCT02761057|594055480|FG000|Overall Study|Death|2|||
164459868|NCT02761057|594055481|FG001|Overall Study|Death|2|||
164459869|NCT02761057|594055482|FG002|Overall Study|Death|1|||
164459870|NCT02761057|594055483|FG003|Overall Study|Death|1|||
164459871|NCT02761057|594055480|FG000|Overall Study|Other - Not Protocol Specified|2|||
164459872|NCT02761057|594055481|FG001|Overall Study|Other - Not Protocol Specified|1|||
164459873|NCT02761057|594055482|FG002|Overall Study|Other - Not Protocol Specified|2|||
164459874|NCT02761057|594055483|FG003|Overall Study|Other - Not Protocol Specified|0|||
164459875|NCT04971681|594055484|FG000|Followup|Lost to Follow-up|1|||
164459876|NCT04971681|594055485|FG001|Followup|Lost to Follow-up|0|||
164459877|NCT00686335|594055486|FG000|Run-in Period|Adverse Event|1|||
164459878|NCT00686335|594055486|FG000|Run-in Period|asthma exacerbation|1|||
164459879|NCT00686335|594055486|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
164598700|NCT02883049|594554769|FG013|Induction|Ineligible|0|||
164598701|NCT02883049|594554770|FG014|Induction|Ineligible|0|||
164598702|NCT02883049|594554771|FG015|Induction|Ineligible|0|||
164598703|NCT02883049|594554756|FG000|Induction|Refusal of further protocol therapy|466|||
164598704|NCT02883049|594554757|FG001|Induction|Refusal of further protocol therapy|2|||
164598705|NCT02883049|594554758|FG002|Induction|Refusal of further protocol therapy|0|||
164707653|NCT00112866|594955296|FG000|Overall Study|Protocol Violation|1|||
164707654|NCT00112866|594955297|FG001|Overall Study|Protocol Violation|0|||
164707655|NCT00112866|594955296|FG000|Overall Study|did not start treatment post-op|1|||
164707656|NCT00112866|594955297|FG001|Overall Study|did not start treatment post-op|2|||
164707657|NCT00658658|594955301|FG000|Overall Study|Withdrawal by Subject|0|||
164707658|NCT00658658|594955302|FG001|Overall Study|Withdrawal by Subject|1|||
164707659|NCT00658658|594955303|FG002|Overall Study|Withdrawal by Subject|0|||
164707660|NCT00658658|594955304|FG003|Overall Study|Withdrawal by Subject|0|||
164707661|NCT00658658|594955305|FG004|Overall Study|Withdrawal by Subject|0|||
164707662|NCT00658658|594955301|FG000|Overall Study|Death|4|||
164707663|NCT00658658|594955302|FG001|Overall Study|Death|0|||
164707664|NCT00658658|594955303|FG002|Overall Study|Death|0|||
164707665|NCT00658658|594955304|FG003|Overall Study|Death|1|||
164707666|NCT00658658|594955305|FG004|Overall Study|Death|1|||
164707667|NCT00658658|594955301|FG000|Overall Study|Disease Progression|0|||
164707668|NCT00658658|594955302|FG001|Overall Study|Disease Progression|1|||
164707669|NCT00658658|594955303|FG002|Overall Study|Disease Progression|0|||
164707670|NCT00658658|594955304|FG003|Overall Study|Disease Progression|1|||
164407807|NCT04022889|593864440|FG002|Stage 2|Ineligible for apheresis donation|2|||
164407808|NCT04022889|593864438|FG000|Stage 2|Adverse Event|0|||
164407809|NCT04022889|593864439|FG001|Stage 2|Adverse Event|0|||
164407810|NCT04022889|593864440|FG002|Stage 2|Adverse Event|2|||
164407811|NCT04022889|593864438|FG000|Stage 2|Protocol Violation|0|||
164407812|NCT04022889|593864439|FG001|Stage 2|Protocol Violation|0|||
164407813|NCT04022889|593864440|FG002|Stage 2|Protocol Violation|1|||
164407814|NCT04022889|593864438|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
164407815|NCT04022889|593864439|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
164407816|NCT04022889|593864440|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
164407817|NCT01186328|593864445|FG000|Overall Study|Death|1|||
164407818|NCT01186328|593864446|FG001|Overall Study|Death|0|||
164407819|NCT01186328|593864447|FG002|Overall Study|Death|0|||
164407820|NCT02202434|593864448|FG000|Overall Study|Death|70|||
164407821|NCT02202434|593864449|FG001|Overall Study|Death|39|||
164407822|NCT02202434|593864450|FG002|Overall Study|Death|13|||
164407823|NCT02202434|593864451|FG003|Overall Study|Death|27|||
164407824|NCT02202434|593864448|FG000|Overall Study|Lost to Follow-up|1|||
164407825|NCT02202434|593864449|FG001|Overall Study|Lost to Follow-up|1|||
164407826|NCT02202434|593864450|FG002|Overall Study|Lost to Follow-up|1|||
164407827|NCT02202434|593864451|FG003|Overall Study|Lost to Follow-up|0|||
164407828|NCT02202434|593864448|FG000|Overall Study|Physician Decision|2|||
164407829|NCT02202434|593864449|FG001|Overall Study|Physician Decision|3|||
164407830|NCT02202434|593864450|FG002|Overall Study|Physician Decision|0|||
164407831|NCT02202434|593864451|FG003|Overall Study|Physician Decision|0|||
164407832|NCT02202434|593864448|FG000|Overall Study|Withdrawal by Subject|13|||
164407833|NCT02202434|593864449|FG001|Overall Study|Withdrawal by Subject|14|||
164407834|NCT02202434|593864450|FG002|Overall Study|Withdrawal by Subject|1|||
164407835|NCT02202434|593864451|FG003|Overall Study|Withdrawal by Subject|4|||
164407836|NCT02202434|593864448|FG000|Overall Study|Completed Study|1|||
164407837|NCT02202434|593864449|FG001|Overall Study|Completed Study|0|||
164407838|NCT02202434|593864450|FG002|Overall Study|Completed Study|0|||
164407839|NCT02202434|593864451|FG003|Overall Study|Completed Study|0|||
164407840|NCT02202434|593864448|FG000|Overall Study|Visit Missed|21|||
164407841|NCT02202434|593864449|FG001|Overall Study|Visit Missed|12|||
164407842|NCT02202434|593864450|FG002|Overall Study|Visit Missed|0|||
164407843|NCT02202434|593864451|FG003|Overall Study|Visit Missed|5|||
164407844|NCT02202434|593864448|FG000|Overall Study|Other|1|||
164407845|NCT02202434|593864449|FG001|Overall Study|Other|0|||
164407846|NCT02202434|593864450|FG002|Overall Study|Other|0|||
164407847|NCT02202434|593864451|FG003|Overall Study|Other|1|||
164407848|NCT03237858|593864452|FG000|Overall Study|Death|19|||
164407849|NCT03237858|593864452|FG000|Overall Study|Withdrawal by Subject|37|||
164407850|NCT02207725|593864456|FG000|Overall Study|Did Not Receive Treatment|0|||
164407851|NCT02207725|593864457|FG001|Overall Study|Did Not Receive Treatment|1|||
164407852|NCT02207725|593864458|FG002|Overall Study|Did Not Receive Treatment|1|||
164407853|NCT02207725|593864459|FG003|Overall Study|Did Not Receive Treatment|1|||
164407854|NCT03579290|593864462|FG000|Overall Study|Lost to Follow-up|9|||
164407855|NCT04404478|593864463|FG000|Overall Study|Withdrawal by Subject|1|||
164407856|NCT04404478|593864464|FG001|Overall Study|Withdrawal by Subject|3|||
164407857|NCT01674621|593864475|FG000|Overall Study|Adverse Event|3|||
164407858|NCT01674621|593864476|FG001|Overall Study|Adverse Event|2|||
164407859|NCT01674621|593864477|FG002|Overall Study|Adverse Event|5|||
164407860|NCT01674621|593864478|FG003|Overall Study|Adverse Event|5|||
164407861|NCT01674621|593864479|FG004|Overall Study|Adverse Event|1|||
164407862|NCT01674621|593864475|FG000|Overall Study|Inability to Complete Study Procedures|0|||
164407863|NCT01674621|593864476|FG001|Overall Study|Inability to Complete Study Procedures|0|||
164407864|NCT01674621|593864477|FG002|Overall Study|Inability to Complete Study Procedures|0|||
164407865|NCT01674621|593864478|FG003|Overall Study|Inability to Complete Study Procedures|0|||
164407866|NCT01674621|593864479|FG004|Overall Study|Inability to Complete Study Procedures|2|||
164407867|NCT01674621|593864475|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
164407868|NCT01674621|593864476|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
164407869|NCT01674621|593864477|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
164407870|NCT01674621|593864478|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
164407871|NCT01674621|593864479|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
164407872|NCT01674621|593864475|FG000|Overall Study|Withdrawal by Subject|2|||
164407873|NCT01674621|593864476|FG001|Overall Study|Withdrawal by Subject|5|||
164407874|NCT01674621|593864477|FG002|Overall Study|Withdrawal by Subject|2|||
164407875|NCT01674621|593864478|FG003|Overall Study|Withdrawal by Subject|0|||
164407876|NCT01674621|593864479|FG004|Overall Study|Withdrawal by Subject|1|||
164459880|NCT04149704|594055490|FG000|Three Month Follow-up|Death|2|||
164459881|NCT04149704|594055491|FG001|Three Month Follow-up|Death|0|||
164459882|NCT04149704|594055492|FG002|Three Month Follow-up|Death|0|||
164459883|NCT04149704|594055493|FG003|Three Month Follow-up|Death|0|||
164459884|NCT04149704|594055490|FG000|Three Month Follow-up|Lost to Follow-up|1|||
164459885|NCT04149704|594055491|FG001|Three Month Follow-up|Lost to Follow-up|4|||
164459886|NCT04149704|594055492|FG002|Three Month Follow-up|Lost to Follow-up|5|||
164459887|NCT04149704|594055493|FG003|Three Month Follow-up|Lost to Follow-up|5|||
164459888|NCT04149704|594055490|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
164459889|NCT04149704|594055491|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
164459890|NCT04149704|594055492|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
164459891|NCT04149704|594055493|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
164459892|NCT04149704|594055490|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
164459893|NCT04149704|594055491|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
164459894|NCT04149704|594055492|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
164459895|NCT04149704|594055493|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
164459896|NCT04632992|594055503|FG000|Overall Study|Adverse Event|0|||
164459897|NCT04632992|594055504|FG001|Overall Study|Adverse Event|0|||
164459898|NCT04632992|594055505|FG002|Overall Study|Adverse Event|0|||
164459899|NCT04632992|594055506|FG003|Overall Study|Adverse Event|0|||
164459900|NCT04632992|594055507|FG004|Overall Study|Adverse Event|0|||
164459901|NCT04632992|594055508|FG005|Overall Study|Adverse Event|0|||
164459902|NCT04632992|594055509|FG006|Overall Study|Adverse Event|0|||
164459903|NCT04632992|594055510|FG007|Overall Study|Adverse Event|0|||
164459904|NCT04632992|594055511|FG008|Overall Study|Adverse Event|0|||
164459905|NCT04632992|594055512|FG009|Overall Study|Adverse Event|0|||
164459906|NCT04632992|594055513|FG010|Overall Study|Adverse Event|0|||
164459907|NCT04632992|594055514|FG011|Overall Study|Adverse Event|0|||
164459908|NCT04632992|594055515|FG012|Overall Study|Adverse Event|1|||
164459909|NCT04632992|594055516|FG013|Overall Study|Adverse Event|0|||
164459910|NCT04632992|594055503|FG000|Overall Study|Death|17|||
164459911|NCT04632992|594055504|FG001|Overall Study|Death|1|||
164459912|NCT04632992|594055505|FG002|Overall Study|Death|14|||
164459913|NCT04632992|594055506|FG003|Overall Study|Death|14|||
164459914|NCT04632992|594055507|FG004|Overall Study|Death|13|||
164459915|NCT04632992|594055508|FG005|Overall Study|Death|6|||
164459916|NCT04632992|594055509|FG006|Overall Study|Death|7|||
164459917|NCT04632992|594055510|FG007|Overall Study|Death|12|||
164459918|NCT04632992|594055511|FG008|Overall Study|Death|15|||
164407877|NCT01674621|593864475|FG000|Overall Study|Other than specified|0|||
164459919|NCT04632992|594055512|FG009|Overall Study|Death|20|||
164459920|NCT04632992|594055513|FG010|Overall Study|Death|8|||
164459921|NCT04632992|594055514|FG011|Overall Study|Death|2|||
164459922|NCT04632992|594055515|FG012|Overall Study|Death|10|||
164459923|NCT04632992|594055516|FG013|Overall Study|Death|1|||
164459924|NCT04632992|594055503|FG000|Overall Study|Lost to Follow-up|1|||
164459925|NCT04632992|594055504|FG001|Overall Study|Lost to Follow-up|0|||
164459926|NCT04632992|594055505|FG002|Overall Study|Lost to Follow-up|1|||
164459927|NCT04632992|594055506|FG003|Overall Study|Lost to Follow-up|0|||
164459928|NCT04632992|594055507|FG004|Overall Study|Lost to Follow-up|2|||
164459929|NCT04632992|594055508|FG005|Overall Study|Lost to Follow-up|0|||
164459930|NCT04632992|594055509|FG006|Overall Study|Lost to Follow-up|1|||
164459931|NCT04632992|594055510|FG007|Overall Study|Lost to Follow-up|1|||
164459932|NCT04632992|594055511|FG008|Overall Study|Lost to Follow-up|1|||
164459933|NCT04632992|594055512|FG009|Overall Study|Lost to Follow-up|1|||
164598706|NCT02883049|594554759|FG003|Induction|Refusal of further protocol therapy|0|||
164598707|NCT02883049|594554760|FG004|Induction|Refusal of further protocol therapy|0|||
164598708|NCT02883049|594554761|FG005|Induction|Refusal of further protocol therapy|0|||
164598709|NCT02883049|594554762|FG006|Induction|Refusal of further protocol therapy|0|||
164598710|NCT02883049|594554763|FG007|Induction|Refusal of further protocol therapy|0|||
164598711|NCT02883049|594554764|FG008|Induction|Refusal of further protocol therapy|0|||
164598712|NCT02883049|594554765|FG009|Induction|Refusal of further protocol therapy|0|||
164598713|NCT02883049|594554766|FG010|Induction|Refusal of further protocol therapy|0|||
164598714|NCT02883049|594554767|FG011|Induction|Refusal of further protocol therapy|0|||
164707671|NCT00658658|594955305|FG004|Overall Study|Disease Progression|3|||
164459934|NCT04632992|594055513|FG010|Overall Study|Lost to Follow-up|2|||
164459935|NCT04632992|594055514|FG011|Overall Study|Lost to Follow-up|0|||
164459936|NCT04632992|594055515|FG012|Overall Study|Lost to Follow-up|0|||
164459937|NCT04632992|594055516|FG013|Overall Study|Lost to Follow-up|0|||
164459938|NCT04632992|594055503|FG000|Overall Study|Reason not Specified|2|||
164459939|NCT04632992|594055504|FG001|Overall Study|Reason not Specified|0|||
164459940|NCT04632992|594055505|FG002|Overall Study|Reason not Specified|1|||
164459941|NCT04632992|594055506|FG003|Overall Study|Reason not Specified|1|||
164459942|NCT04632992|594055507|FG004|Overall Study|Reason not Specified|0|||
164459943|NCT04632992|594055508|FG005|Overall Study|Reason not Specified|0|||
164459944|NCT04632992|594055509|FG006|Overall Study|Reason not Specified|0|||
164459945|NCT04632992|594055510|FG007|Overall Study|Reason not Specified|0|||
164459946|NCT04632992|594055511|FG008|Overall Study|Reason not Specified|0|||
164459947|NCT04632992|594055512|FG009|Overall Study|Reason not Specified|0|||
164459948|NCT04632992|594055513|FG010|Overall Study|Reason not Specified|1|||
164459949|NCT04632992|594055514|FG011|Overall Study|Reason not Specified|0|||
164459950|NCT04632992|594055515|FG012|Overall Study|Reason not Specified|0|||
164459951|NCT04632992|594055516|FG013|Overall Study|Reason not Specified|0|||
164459952|NCT04632992|594055503|FG000|Overall Study|Physician Decision|0|||
164459953|NCT04632992|594055504|FG001|Overall Study|Physician Decision|0|||
164459954|NCT04632992|594055505|FG002|Overall Study|Physician Decision|0|||
164459955|NCT04632992|594055506|FG003|Overall Study|Physician Decision|2|||
164459956|NCT04632992|594055507|FG004|Overall Study|Physician Decision|1|||
164459957|NCT04632992|594055508|FG005|Overall Study|Physician Decision|0|||
164459958|NCT04632992|594055509|FG006|Overall Study|Physician Decision|0|||
164459959|NCT04632992|594055510|FG007|Overall Study|Physician Decision|0|||
164459960|NCT04632992|594055511|FG008|Overall Study|Physician Decision|0|||
164459961|NCT04632992|594055512|FG009|Overall Study|Physician Decision|0|||
164459962|NCT04632992|594055513|FG010|Overall Study|Physician Decision|0|||
164459963|NCT04632992|594055514|FG011|Overall Study|Physician Decision|0|||
164459964|NCT04632992|594055515|FG012|Overall Study|Physician Decision|3|||
164459965|NCT04632992|594055516|FG013|Overall Study|Physician Decision|0|||
164459966|NCT04632992|594055503|FG000|Overall Study|Progressive Disease|0|||
164459967|NCT04632992|594055504|FG001|Overall Study|Progressive Disease|0|||
164459968|NCT04632992|594055505|FG002|Overall Study|Progressive Disease|0|||
164459969|NCT04632992|594055506|FG003|Overall Study|Progressive Disease|0|||
164459970|NCT04632992|594055507|FG004|Overall Study|Progressive Disease|1|||
164459971|NCT04632992|594055508|FG005|Overall Study|Progressive Disease|0|||
164459972|NCT04632992|594055509|FG006|Overall Study|Progressive Disease|0|||
164459973|NCT04632992|594055510|FG007|Overall Study|Progressive Disease|0|||
164459974|NCT04632992|594055511|FG008|Overall Study|Progressive Disease|0|||
164459975|NCT04632992|594055512|FG009|Overall Study|Progressive Disease|1|||
164459976|NCT04632992|594055513|FG010|Overall Study|Progressive Disease|1|||
164459977|NCT04632992|594055514|FG011|Overall Study|Progressive Disease|0|||
164459978|NCT04632992|594055515|FG012|Overall Study|Progressive Disease|2|||
164459979|NCT04632992|594055516|FG013|Overall Study|Progressive Disease|0|||
164459980|NCT04632992|594055503|FG000|Overall Study|Withdrawal by Subject|4|||
164459981|NCT04632992|594055504|FG001|Overall Study|Withdrawal by Subject|1|||
164459982|NCT04632992|594055505|FG002|Overall Study|Withdrawal by Subject|5|||
164459983|NCT04632992|594055506|FG003|Overall Study|Withdrawal by Subject|4|||
164459984|NCT04632992|594055507|FG004|Overall Study|Withdrawal by Subject|3|||
164459985|NCT04632992|594055508|FG005|Overall Study|Withdrawal by Subject|3|||
164459986|NCT04632992|594055509|FG006|Overall Study|Withdrawal by Subject|0|||
164459987|NCT04632992|594055510|FG007|Overall Study|Withdrawal by Subject|5|||
164459988|NCT04632992|594055511|FG008|Overall Study|Withdrawal by Subject|0|||
164459989|NCT04632992|594055512|FG009|Overall Study|Withdrawal by Subject|2|||
164459990|NCT04632992|594055513|FG010|Overall Study|Withdrawal by Subject|8|||
164459991|NCT04632992|594055514|FG011|Overall Study|Withdrawal by Subject|0|||
164459992|NCT04632992|594055515|FG012|Overall Study|Withdrawal by Subject|1|||
164459993|NCT04632992|594055516|FG013|Overall Study|Withdrawal by Subject|1|||
164459994|NCT02677805|594055517|FG000|Double Blind Phase|Lost to Follow-up|8|||
164459995|NCT02677805|594055518|FG001|Double Blind Phase|Lost to Follow-up|3|||
164459996|NCT02677805|594055519|FG002|Double Blind Phase|Lost to Follow-up|0|||
164459997|NCT02677805|594055517|FG000|Double Blind Phase|Withdrawal by Subject|5|||
164459998|NCT02677805|594055518|FG001|Double Blind Phase|Withdrawal by Subject|2|||
164459999|NCT02677805|594055519|FG002|Double Blind Phase|Withdrawal by Subject|0|||
164460000|NCT02677805|594055517|FG000|Open Label Phase|Lost to Follow-up|0|||
164460001|NCT02677805|594055518|FG001|Open Label Phase|Lost to Follow-up|0|||
164460002|NCT02677805|594055519|FG002|Open Label Phase|Lost to Follow-up|10|||
164460003|NCT02677805|594055517|FG000|Open Label Phase|Withdrawal by Subject|0|||
164460004|NCT02677805|594055518|FG001|Open Label Phase|Withdrawal by Subject|0|||
164460005|NCT02677805|594055519|FG002|Open Label Phase|Withdrawal by Subject|6|||
164460006|NCT05362487|594055524|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
164707672|NCT00658658|594955301|FG000|Overall Study|Protocol-specified Criteria|1|||
164707673|NCT00658658|594955302|FG001|Overall Study|Protocol-specified Criteria|0|||
164460007|NCT06215521|594055525|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
164460008|NCT06215521|594055526|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
164460009|NCT06215521|594055527|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
164460010|NCT06215521|594055528|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
164460011|NCT06215521|594055529|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
164460012|NCT06215521|594055530|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
164460013|NCT04096040|594055531|FG000|Overall Study|Protocol Violation|12|||
164460014|NCT04096040|594055531|FG000|Overall Study|Non-compliant site|4|||
164460015|NCT04973254|594055532|FG000|Overall Study|Not adherent|0|||
164460016|NCT04973254|594055533|FG001|Overall Study|Not adherent|1|||
164460017|NCT04973254|594055534|FG002|Overall Study|Not adherent|0|||
164460018|NCT04938492|594055535|FG000|Overall Study|Lost to Follow-up|17|||
164460019|NCT04938492|594055536|FG001|Overall Study|Lost to Follow-up|18|||
164460020|NCT04025554|594055537|FG000|Overall Study|Adverse Event|3|||
164460021|NCT01802788|594055538|FG000|Overall Study|Withdrawal by Subject|102|||
164460022|NCT01802788|594055539|FG001|Overall Study|Withdrawal by Subject|5|||
164460023|NCT01802788|594055538|FG000|Overall Study|Death|382|||
164460024|NCT01802788|594055539|FG001|Overall Study|Death|18|||
164460025|NCT01802788|594055538|FG000|Overall Study|Lost to Follow-up|31|||
164460026|NCT01802788|594055539|FG001|Overall Study|Lost to Follow-up|2|||
164460027|NCT01802788|594055538|FG000|Overall Study|Physician Decision|3|||
164460028|NCT01802788|594055539|FG001|Overall Study|Physician Decision|0|||
164460029|NCT01802788|594055538|FG000|Overall Study|Patient Non-Compliance|1|||
164460030|NCT01802788|594055539|FG001|Overall Study|Patient Non-Compliance|0|||
164460031|NCT01802788|594055538|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
164460032|NCT01802788|594055539|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
164460033|NCT01802788|594055538|FG000|Overall Study|Other Reasons|19|||
164460034|NCT01802788|594055539|FG001|Overall Study|Other Reasons|0|||
164460035|NCT00764751|594055542|FG000|Overall Study|Adverse Event|1|||
164460036|NCT00764751|594055543|FG001|Overall Study|Adverse Event|1|||
164460037|NCT00764751|594055542|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
164460038|NCT00764751|594055543|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
164460039|NCT05296525|594055547|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
164460040|NCT05296525|594055548|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
164460041|NCT05296525|594055549|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
164460042|NCT05296525|594055550|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
164460043|NCT04830800|594055551|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
164460044|NCT04830800|594055552|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
164460045|NCT04830800|594055553|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
164460046|NCT04830800|594055554|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
164460047|NCT04830800|594055555|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
164460048|NCT03396588|594055558|FG000|Overall Study|Physician Decision|2|||
164460049|NCT03396588|594055559|FG001|Overall Study|Physician Decision|3|||
164460050|NCT00812461|594055561|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
164460051|NCT00812461|594055562|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
164460052|NCT00812461|594055561|FG000|All Treated Patients|Adverse Event|8|||
164460053|NCT00812461|594055562|FG001|All Treated Patients|Adverse Event|15|||
164460054|NCT00812461|594055561|FG000|All Treated Patients|Lack of Efficacy|13|||
164460055|NCT00812461|594055562|FG001|All Treated Patients|Lack of Efficacy|7|||
164460056|NCT00812461|594055561|FG000|All Treated Patients|Non-compliance|6|||
164460057|NCT00812461|594055562|FG001|All Treated Patients|Non-compliance|9|||
164460058|NCT00812461|594055561|FG000|All Treated Patients|Protocol Violation|36|||
164460059|NCT00812461|594055562|FG001|All Treated Patients|Protocol Violation|27|||
164460060|NCT00812461|594055561|FG000|All Treated Patients|Withdrawal by Subject|45|||
164460061|NCT00812461|594055562|FG001|All Treated Patients|Withdrawal by Subject|54|||
164460062|NCT00812461|594055561|FG000|All Treated Patients|Lost to Follow-up|11|||
164460063|NCT00812461|594055562|FG001|All Treated Patients|Lost to Follow-up|14|||
164460064|NCT00812461|594055561|FG000|All Treated Patients|Other Reason|13|||
164460065|NCT00812461|594055562|FG001|All Treated Patients|Other Reason|21|||
164460066|NCT05835336|594057326|FG000|Overall Study|Withdrawal by Subject|5|||
164460067|NCT05835336|594057326|FG000|Overall Study|Did not complete the personalization process|3|||
164460068|NCT03896789|594057340|FG000|Baseline|Lost to Follow-up|1|||
164460069|NCT03896789|594057341|FG001|Baseline|Lost to Follow-up|2|||
164460070|NCT03896789|594057340|FG000|Baseline|Death|3|||
164460071|NCT03896789|594057341|FG001|Baseline|Death|6|||
164598715|NCT02883049|594554768|FG012|Induction|Refusal of further protocol therapy|0|||
164598716|NCT02883049|594554769|FG013|Induction|Refusal of further protocol therapy|0|||
164460072|NCT03896789|594057340|FG000|Post-Randomization|Lost to Follow-up|12|||
164460073|NCT03896789|594057341|FG001|Post-Randomization|Lost to Follow-up|11|||
164460074|NCT03896789|594057340|FG000|Post-Randomization|Death|12|||
164460075|NCT03896789|594057341|FG001|Post-Randomization|Death|13|||
164460076|NCT04908722|594057342|FG000|Overall Study|Protocol deviation|1|||
164460077|NCT04908722|594057343|FG001|Overall Study|Protocol deviation|0|||
164460078|NCT04908722|594057344|FG002|Overall Study|Protocol deviation|0|||
164460079|NCT04908722|594057345|FG003|Overall Study|Protocol deviation|0|||
164598717|NCT02883049|594554770|FG014|Induction|Refusal of further protocol therapy|0|||
164460080|NCT04908722|594057346|FG004|Overall Study|Protocol deviation|0|||
164460081|NCT04908722|594057347|FG005|Overall Study|Protocol deviation|1|||
164460082|NCT04908722|594057342|FG000|Overall Study|Lost to Follow-up|33|||
164460083|NCT04908722|594057343|FG001|Overall Study|Lost to Follow-up|33|||
164460084|NCT04908722|594057344|FG002|Overall Study|Lost to Follow-up|36|||
164460085|NCT04908722|594057345|FG003|Overall Study|Lost to Follow-up|30|||
164460086|NCT04908722|594057346|FG004|Overall Study|Lost to Follow-up|32|||
164460087|NCT04908722|594057347|FG005|Overall Study|Lost to Follow-up|34|||
164460088|NCT04908722|594057342|FG000|Overall Study|Physician Decision|1|||
164460089|NCT04908722|594057343|FG001|Overall Study|Physician Decision|1|||
164460090|NCT04908722|594057344|FG002|Overall Study|Physician Decision|1|||
164460091|NCT04908722|594057345|FG003|Overall Study|Physician Decision|2|||
164460092|NCT04908722|594057346|FG004|Overall Study|Physician Decision|0|||
164460093|NCT04908722|594057347|FG005|Overall Study|Physician Decision|0|||
164460094|NCT04908722|594057342|FG000|Overall Study|Death|1|||
164460095|NCT04908722|594057343|FG001|Overall Study|Death|0|||
164460096|NCT04908722|594057344|FG002|Overall Study|Death|0|||
164460097|NCT04908722|594057345|FG003|Overall Study|Death|0|||
164460098|NCT04908722|594057346|FG004|Overall Study|Death|0|||
164460099|NCT04908722|594057347|FG005|Overall Study|Death|1|||
164460100|NCT04908722|594057342|FG000|Overall Study|Withdrawal by Subject|12|||
164460101|NCT04908722|594057343|FG001|Overall Study|Withdrawal by Subject|8|||
164460102|NCT04908722|594057344|FG002|Overall Study|Withdrawal by Subject|7|||
164460103|NCT04908722|594057345|FG003|Overall Study|Withdrawal by Subject|6|||
164460104|NCT04908722|594057346|FG004|Overall Study|Withdrawal by Subject|12|||
164460105|NCT04908722|594057347|FG005|Overall Study|Withdrawal by Subject|14|||
164460106|NCT04908722|594057342|FG000|Overall Study|Other|3|||
164460107|NCT04908722|594057343|FG001|Overall Study|Other|1|||
164460108|NCT04908722|594057344|FG002|Overall Study|Other|3|||
164598718|NCT02883049|594554771|FG015|Induction|Refusal of further protocol therapy|0|||
164598719|NCT02883049|594554756|FG000|Induction|Identified as Ph+ patients|279|||
164460109|NCT04908722|594057345|FG003|Overall Study|Other|2|||
164460110|NCT04908722|594057346|FG004|Overall Study|Other|4|||
164460111|NCT04908722|594057347|FG005|Overall Study|Other|1|||
164460112|NCT04908722|594057342|FG000|Overall Study|Initiated prohibited medication|0|||
164460113|NCT04908722|594057343|FG001|Overall Study|Initiated prohibited medication|0|||
164460114|NCT04908722|594057344|FG002|Overall Study|Initiated prohibited medication|0|||
164460115|NCT04908722|594057345|FG003|Overall Study|Initiated prohibited medication|1|||
164460116|NCT04908722|594057346|FG004|Overall Study|Initiated prohibited medication|0|||
164598720|NCT02883049|594554757|FG001|Induction|Identified as Ph+ patients|1|||
164598721|NCT02883049|594554758|FG002|Induction|Identified as Ph+ patients|0|||
164598722|NCT02883049|594554759|FG003|Induction|Identified as Ph+ patients|0|||
164598723|NCT02883049|594554760|FG004|Induction|Identified as Ph+ patients|0|||
164598724|NCT02883049|594554761|FG005|Induction|Identified as Ph+ patients|0|||
164598725|NCT02883049|594554762|FG006|Induction|Identified as Ph+ patients|0|||
164598726|NCT02883049|594554763|FG007|Induction|Identified as Ph+ patients|0|||
164598727|NCT02883049|594554764|FG008|Induction|Identified as Ph+ patients|0|||
164598728|NCT02883049|594554765|FG009|Induction|Identified as Ph+ patients|0|||
164598729|NCT02883049|594554766|FG010|Induction|Identified as Ph+ patients|0|||
164598730|NCT02883049|594554767|FG011|Induction|Identified as Ph+ patients|0|||
164598731|NCT02883049|594554768|FG012|Induction|Identified as Ph+ patients|0|||
164598732|NCT02883049|594554769|FG013|Induction|Identified as Ph+ patients|0|||
164598733|NCT02883049|594554770|FG014|Induction|Identified as Ph+ patients|0|||
164598734|NCT02883049|594554771|FG015|Induction|Identified as Ph+ patients|0|||
164598735|NCT02883049|594554756|FG000|Induction|M3 Marrow at Day29|8|||
164598736|NCT02883049|594554757|FG001|Induction|M3 Marrow at Day29|1|||
164598737|NCT02883049|594554758|FG002|Induction|M3 Marrow at Day29|0|||
164598738|NCT02883049|594554759|FG003|Induction|M3 Marrow at Day29|0|||
164598739|NCT02883049|594554760|FG004|Induction|M3 Marrow at Day29|0|||
164598740|NCT02883049|594554761|FG005|Induction|M3 Marrow at Day29|0|||
164598741|NCT02883049|594554762|FG006|Induction|M3 Marrow at Day29|0|||
164598742|NCT02883049|594554763|FG007|Induction|M3 Marrow at Day29|0|||
164598743|NCT02883049|594554764|FG008|Induction|M3 Marrow at Day29|0|||
164598744|NCT02883049|594554765|FG009|Induction|M3 Marrow at Day29|0|||
164598745|NCT02883049|594554766|FG010|Induction|M3 Marrow at Day29|0|||
164598746|NCT02883049|594554767|FG011|Induction|M3 Marrow at Day29|0|||
164598747|NCT02883049|594554768|FG012|Induction|M3 Marrow at Day29|0|||
164598748|NCT02883049|594554769|FG013|Induction|M3 Marrow at Day29|0|||
164598749|NCT02883049|594554770|FG014|Induction|M3 Marrow at Day29|0|||
164598750|NCT02883049|594554771|FG015|Induction|M3 Marrow at Day29|0|||
164598751|NCT02883049|594554756|FG000|Induction|Inevaluable|33|||
164598752|NCT02883049|594554757|FG001|Induction|Inevaluable|1|||
164598753|NCT02883049|594554758|FG002|Induction|Inevaluable|0|||
164598754|NCT02883049|594554759|FG003|Induction|Inevaluable|0|||
164598755|NCT02883049|594554760|FG004|Induction|Inevaluable|0|||
164598756|NCT02883049|594554761|FG005|Induction|Inevaluable|0|||
164598757|NCT02883049|594554762|FG006|Induction|Inevaluable|0|||
164598758|NCT02883049|594554763|FG007|Induction|Inevaluable|0|||
164460117|NCT04908722|594057347|FG005|Overall Study|Initiated prohibited medication|1|||
164460118|NCT04908722|594057342|FG000|Overall Study|Randomized but not vaccinated|3|||
164460119|NCT04908722|594057343|FG001|Overall Study|Randomized but not vaccinated|1|||
164460120|NCT04908722|594057344|FG002|Overall Study|Randomized but not vaccinated|2|||
164460121|NCT04908722|594057345|FG003|Overall Study|Randomized but not vaccinated|2|||
164460122|NCT04908722|594057346|FG004|Overall Study|Randomized but not vaccinated|3|||
164460123|NCT04908722|594057347|FG005|Overall Study|Randomized but not vaccinated|4|||
164460124|NCT01369355|594057348|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
164460125|NCT01369355|594057349|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
164460126|NCT01369355|594057350|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
164460127|NCT01369355|594057351|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
164460128|NCT01369355|594057352|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
164460129|NCT01369355|594057353|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
164460130|NCT01369355|594057354|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
164460131|NCT01369355|594057355|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
164460132|NCT01369355|594057356|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
164460133|NCT01369355|594057348|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
164460134|NCT01369355|594057349|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
164460135|NCT01369355|594057350|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
164460136|NCT01369355|594057351|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
164460137|NCT01369355|594057352|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
164460138|NCT01369355|594057353|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
164460139|NCT01369355|594057354|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
164460140|NCT01369355|594057355|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
164460141|NCT01369355|594057356|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
164460142|NCT01369355|594057348|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
164460143|NCT01369355|594057349|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
164460144|NCT01369355|594057350|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
164460145|NCT01369355|594057351|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
164460146|NCT01369355|594057352|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
164460147|NCT01369355|594057353|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
164460148|NCT01369355|594057354|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
164460149|NCT01369355|594057355|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
164460150|NCT01369355|594057356|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
164460151|NCT01369355|594057348|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
164460152|NCT01369355|594057349|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
164460153|NCT01369355|594057350|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
164460154|NCT01369355|594057351|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
164460155|NCT01369355|594057352|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
164460156|NCT01369355|594057353|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
164460157|NCT01369355|594057354|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
164460158|NCT01369355|594057355|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
164460159|NCT01369355|594057356|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
164460160|NCT01369355|594057348|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
164460161|NCT01369355|594057349|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
164460162|NCT01369355|594057350|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
164460163|NCT01369355|594057351|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
164460164|NCT01369355|594057352|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
164460165|NCT01369355|594057353|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
164460166|NCT01369355|594057354|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
164460167|NCT01369355|594057355|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
164460168|NCT01369355|594057356|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
164460169|NCT01369355|594057348|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
164460170|NCT01369355|594057349|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
164460171|NCT01369355|594057350|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
164460172|NCT01369355|594057351|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
164460173|NCT01369355|594057352|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
164460174|NCT01369355|594057353|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
164460175|NCT01369355|594057354|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
164460176|NCT01369355|594057355|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
164460177|NCT01369355|594057356|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
164707674|NCT00658658|594955303|FG002|Overall Study|Protocol-specified Criteria|0|||
164707675|NCT00658658|594955304|FG003|Overall Study|Protocol-specified Criteria|0|||
164707676|NCT00658658|594955305|FG004|Overall Study|Protocol-specified Criteria|0|||
164707677|NCT00658658|594955301|FG000|Overall Study|Other|0|||
164707678|NCT00658658|594955302|FG001|Overall Study|Other|0|||
164707679|NCT00658658|594955303|FG002|Overall Study|Other|0|||
164460178|NCT01369355|594057348|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
164460179|NCT01369355|594057349|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
164707680|NCT00658658|594955304|FG003|Overall Study|Other|0|||
164707681|NCT00658658|594955305|FG004|Overall Study|Other|1|||
164460180|NCT01369355|594057350|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
164460181|NCT01369355|594057351|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
164460182|NCT01369355|594057352|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
164460183|NCT01369355|594057353|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
164460184|NCT01369355|594057354|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
164460185|NCT01369355|594057355|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
164460186|NCT01369355|594057356|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
164460187|NCT01369355|594057348|FG000|Long-term Extension (Week 44-272)|Death|0|||
164460188|NCT01369355|594057349|FG001|Long-term Extension (Week 44-272)|Death|0|||
164460189|NCT01369355|594057350|FG002|Long-term Extension (Week 44-272)|Death|0|||
164460190|NCT01369355|594057351|FG003|Long-term Extension (Week 44-272)|Death|0|||
164460191|NCT01369355|594057352|FG004|Long-term Extension (Week 44-272)|Death|0|||
164460192|NCT01369355|594057353|FG005|Long-term Extension (Week 44-272)|Death|0|||
164460193|NCT01369355|594057354|FG006|Long-term Extension (Week 44-272)|Death|0|||
164460194|NCT01369355|594057355|FG007|Long-term Extension (Week 44-272)|Death|1|||
164460195|NCT01369355|594057356|FG008|Long-term Extension (Week 44-272)|Death|3|||
164460196|NCT01369355|594057348|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
164460197|NCT01369355|594057349|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
164460198|NCT01369355|594057350|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
164460199|NCT01369355|594057351|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
164460200|NCT01369355|594057352|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
164460201|NCT01369355|594057353|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
164460202|NCT01369355|594057354|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
164460203|NCT01369355|594057355|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
164460204|NCT01369355|594057356|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
164460205|NCT01369355|594057348|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
164460206|NCT01369355|594057349|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
164460207|NCT01369355|594057350|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
164460208|NCT01369355|594057351|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
164460209|NCT01369355|594057352|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
164460210|NCT01369355|594057353|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
164460211|NCT01369355|594057354|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
164460212|NCT01369355|594057355|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
164460213|NCT01369355|594057356|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
164460214|NCT01369355|594057348|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
164460215|NCT01369355|594057349|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
164460216|NCT01369355|594057350|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
164460217|NCT01369355|594057351|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
164460218|NCT01369355|594057352|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
164460219|NCT01369355|594057353|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
164460220|NCT01369355|594057354|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
164460221|NCT01369355|594057355|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
164460222|NCT01369355|594057356|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
164460223|NCT01369355|594057348|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
164460224|NCT01369355|594057349|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
164460225|NCT01369355|594057350|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
164460226|NCT01369355|594057351|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
164460227|NCT01369355|594057352|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
164460228|NCT01369355|594057353|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
164460229|NCT01369355|594057354|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
164460230|NCT01369355|594057355|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
164460231|NCT01369355|594057356|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
164460232|NCT01369355|594057348|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
164460233|NCT01369355|594057349|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
164460234|NCT01369355|594057350|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
164460235|NCT01369355|594057351|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
164460236|NCT01369355|594057352|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
164460237|NCT01369355|594057353|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
164460238|NCT01369355|594057354|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
164460239|NCT01369355|594057355|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
164460240|NCT01369355|594057356|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
164460241|NCT01369355|594057348|FG000|Long-term Extension (Week 44-272)|Other|0|||
164598759|NCT02883049|594554764|FG008|Induction|Inevaluable|0|||
164598760|NCT02883049|594554765|FG009|Induction|Inevaluable|0|||
164598761|NCT02883049|594554766|FG010|Induction|Inevaluable|0|||
164598762|NCT02883049|594554767|FG011|Induction|Inevaluable|0|||
164598763|NCT02883049|594554768|FG012|Induction|Inevaluable|0|||
164598764|NCT02883049|594554769|FG013|Induction|Inevaluable|0|||
164598765|NCT02883049|594554770|FG014|Induction|Inevaluable|0|||
164460242|NCT01369355|594057349|FG001|Long-term Extension (Week 44-272)|Other|0|||
164460243|NCT01369355|594057350|FG002|Long-term Extension (Week 44-272)|Other|0|||
164460244|NCT01369355|594057351|FG003|Long-term Extension (Week 44-272)|Other|0|||
164460245|NCT01369355|594057352|FG004|Long-term Extension (Week 44-272)|Other|0|||
164460246|NCT01369355|594057353|FG005|Long-term Extension (Week 44-272)|Other|0|||
164460247|NCT01369355|594057354|FG006|Long-term Extension (Week 44-272)|Other|110|||
164460248|NCT01369355|594057355|FG007|Long-term Extension (Week 44-272)|Other|9|||
164460249|NCT01369355|594057356|FG008|Long-term Extension (Week 44-272)|Other|17|||
164460250|NCT02319759|594057357|FG000|Week 0 - 16|Lack of Efficacy|1|||
164460251|NCT02319759|594057358|FG001|Week 0 - 16|Lack of Efficacy|0|||
164460252|NCT02319759|594057359|FG002|Week 0 - 16|Lack of Efficacy|0|||
164460253|NCT02319759|594057360|FG003|Week 0 - 16|Lack of Efficacy|0|||
164460254|NCT02319759|594057361|FG004|Week 0 - 16|Lack of Efficacy|0|||
164460255|NCT02319759|594057357|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
164460256|NCT02319759|594057358|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
164460257|NCT02319759|594057359|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
164460258|NCT02319759|594057360|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
164460259|NCT02319759|594057361|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
164460260|NCT02319759|594057357|FG000|Week 16 - 24|Lack of Efficacy|1|||
164460261|NCT02319759|594057358|FG001|Week 16 - 24|Lack of Efficacy|0|||
164460262|NCT02319759|594057359|FG002|Week 16 - 24|Lack of Efficacy|1|||
164460263|NCT02319759|594057360|FG003|Week 16 - 24|Lack of Efficacy|0|||
164460264|NCT02319759|594057361|FG004|Week 16 - 24|Lack of Efficacy|0|||
164460265|NCT02319759|594057357|FG000|Week 16 - 24|Lost to Follow-up|1|||
164460266|NCT02319759|594057358|FG001|Week 16 - 24|Lost to Follow-up|0|||
164460267|NCT02319759|594057359|FG002|Week 16 - 24|Lost to Follow-up|0|||
164460268|NCT02319759|594057360|FG003|Week 16 - 24|Lost to Follow-up|0|||
164460269|NCT02319759|594057361|FG004|Week 16 - 24|Lost to Follow-up|0|||
164460270|NCT02319759|594057357|FG000|Week 16 - 24|Withdrawal by Subject|0|||
164460271|NCT02319759|594057358|FG001|Week 16 - 24|Withdrawal by Subject|0|||
164460272|NCT02319759|594057359|FG002|Week 16 - 24|Withdrawal by Subject|2|||
164460273|NCT02319759|594057360|FG003|Week 16 - 24|Withdrawal by Subject|0|||
164460274|NCT02319759|594057361|FG004|Week 16 - 24|Withdrawal by Subject|0|||
164460275|NCT02319759|594057357|FG000|Week 24 - 56|Adverse Event|0|||
164460276|NCT02319759|594057358|FG001|Week 24 - 56|Adverse Event|0|||
164460277|NCT02319759|594057359|FG002|Week 24 - 56|Adverse Event|2|||
164460278|NCT02319759|594057360|FG003|Week 24 - 56|Adverse Event|0|||
164460279|NCT02319759|594057361|FG004|Week 24 - 56|Adverse Event|0|||
164460280|NCT02319759|594057357|FG000|Week 24 - 56|Lack of Efficacy|0|||
164460281|NCT02319759|594057358|FG001|Week 24 - 56|Lack of Efficacy|0|||
164460282|NCT02319759|594057359|FG002|Week 24 - 56|Lack of Efficacy|0|||
164460283|NCT02319759|594057360|FG003|Week 24 - 56|Lack of Efficacy|2|||
164460284|NCT02319759|594057361|FG004|Week 24 - 56|Lack of Efficacy|1|||
164460285|NCT02319759|594057357|FG000|Week 24 - 56|Withdrawal by Subject|0|||
164460286|NCT02319759|594057358|FG001|Week 24 - 56|Withdrawal by Subject|1|||
164460287|NCT02319759|594057359|FG002|Week 24 - 56|Withdrawal by Subject|0|||
164460288|NCT02319759|594057360|FG003|Week 24 - 56|Withdrawal by Subject|0|||
164460289|NCT02319759|594057361|FG004|Week 24 - 56|Withdrawal by Subject|0|||
164460290|NCT02319759|594057357|FG000|Week 24 - 56|Lost to Follow-up|0|||
164460291|NCT02319759|594057358|FG001|Week 24 - 56|Lost to Follow-up|0|||
164460292|NCT02319759|594057359|FG002|Week 24 - 56|Lost to Follow-up|0|||
164460293|NCT02319759|594057360|FG003|Week 24 - 56|Lost to Follow-up|0|||
164460294|NCT02319759|594057361|FG004|Week 24 - 56|Lost to Follow-up|1|||
164460295|NCT01987895|594057366|FG000|Overall Study|Withdrawal by Subject|12|||
164460296|NCT01987895|594057367|FG001|Overall Study|Withdrawal by Subject|7|||
164460297|NCT01987895|594057366|FG000|Overall Study|Physician Decision|8|||
164460298|NCT01987895|594057367|FG001|Overall Study|Physician Decision|10|||
164460299|NCT01987895|594057366|FG000|Overall Study|Death|7|||
164460300|NCT01987895|594057367|FG001|Overall Study|Death|7|||
164460301|NCT01987895|594057366|FG000|Overall Study|Lost to Follow-up|3|||
164460302|NCT01987895|594057367|FG001|Overall Study|Lost to Follow-up|5|||
164707682|NCT01167257|594955306|FG000|Overall Study|Lost to Follow-up|2|||
164707683|NCT01167257|594955307|FG001|Overall Study|Lost to Follow-up|2|||
164707684|NCT01167257|594955306|FG000|Overall Study|Withdrew consent|1|||
164707685|NCT01167257|594955307|FG001|Overall Study|Withdrew consent|1|||
164460303|NCT01987895|594057366|FG000|Overall Study|randomized before giving IC|0|||
164460304|NCT01987895|594057367|FG001|Overall Study|randomized before giving IC|1|||
164460305|NCT02979327|594057368|FG000|First Intervention|Protocol Violation|1|||
164460306|NCT02979327|594057369|FG001|First Intervention|Protocol Violation|0|||
164460307|NCT05006872|594057371|FG000|Overall Study|Lost to Follow-up|37|||
164460308|NCT05006872|594057372|FG001|Overall Study|Lost to Follow-up|31|||
164460309|NCT05499377|594057377|FG000|Overall Study|Withdrawal by Subject|2|||
164460310|NCT05499377|594057378|FG001|Overall Study|Withdrawal by Subject|0|||
164460311|NCT05499377|594057377|FG000|Overall Study|Physician Decision|1|||
164460312|NCT05499377|594057378|FG001|Overall Study|Physician Decision|0|||
164460313|NCT04332926|594057379|FG000|Overall Study|Withdrawal by Subject|6|||
164460314|NCT04332926|594057379|FG000|Overall Study|Physician Decision|6|||
164460315|NCT03115476|594057381|FG000|LP0084-1369|Death|1|||
164144660|NCT01495702|592891745|FG000|Randomized Phase|Lack of Efficacy|2|||
164460316|NCT03115476|594057382|FG001|LP0084-1369|Death|0|||
164460317|NCT03115476|594057383|FG002|LP0084-1369|Death|2|||
164460318|NCT03115476|594057381|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
164460319|NCT03115476|594057382|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
164460320|NCT03115476|594057383|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
164460321|NCT05257486|594057387|FG000|Overall Study|Protocol Violation|3|||
164460322|NCT04542317|594057388|FG000|Overall Study|Care recipients passed away|18|||
164460323|NCT04542317|594057389|FG001|Overall Study|Care recipients passed away|13|||
164460324|NCT04542317|594057388|FG000|Overall Study|No longer a primary caregiver|5|||
164460325|NCT04542317|594057389|FG001|Overall Study|No longer a primary caregiver|1|||
164460326|NCT04542317|594057388|FG000|Overall Study|Withdrawal by Subject|4|||
164460327|NCT04542317|594057389|FG001|Overall Study|Withdrawal by Subject|2|||
164460328|NCT04542317|594057388|FG000|Overall Study|Caregivers passed away|0|||
164460329|NCT04542317|594057389|FG001|Overall Study|Caregivers passed away|2|||
164460330|NCT04700163|594057390|FG000|Overall Study|Lost to Follow-up|0|||
164460331|NCT04700163|594057391|FG001|Overall Study|Lost to Follow-up|0|||
164460332|NCT04700163|594057392|FG002|Overall Study|Lost to Follow-up|0|||
164460333|NCT04700163|594057393|FG003|Overall Study|Lost to Follow-up|0|||
164460334|NCT04700163|594057394|FG004|Overall Study|Lost to Follow-up|0|||
164460335|NCT04700163|594057395|FG005|Overall Study|Lost to Follow-up|1|||
164460336|NCT03848065|594057398|FG000|Overall Study|Death|0|||
164460337|NCT03848065|594057399|FG001|Overall Study|Death|1|||
164460338|NCT03848065|594057400|FG002|Overall Study|Death|0|||
164460339|NCT03848065|594057398|FG000|Overall Study|Lost to Follow-up|0|||
164460340|NCT03848065|594057399|FG001|Overall Study|Lost to Follow-up|0|||
164460341|NCT03848065|594057400|FG002|Overall Study|Lost to Follow-up|1|||
164460342|NCT03848065|594057398|FG000|Overall Study|Physician Decision|0|||
164460343|NCT03848065|594057399|FG001|Overall Study|Physician Decision|0|||
164460344|NCT03848065|594057400|FG002|Overall Study|Physician Decision|1|||
164460345|NCT05543629|594057405|FG000|Overall Study|Death|1|||
164460346|NCT05543629|594057406|FG001|Overall Study|Death|0|||
164460347|NCT05543629|594057407|FG002|Overall Study|Death|1|||
164460348|NCT05543629|594057408|FG003|Overall Study|Death|0|||
164460349|NCT05543629|594057409|FG004|Overall Study|Death|0|||
164460350|NCT05543629|594057410|FG005|Overall Study|Death|1|||
164460351|NCT05543629|594057411|FG006|Overall Study|Death|2|||
164460352|NCT05543629|594057412|FG007|Overall Study|Death|2|||
164460353|NCT05543629|594057405|FG000|Overall Study|Other Reasons|0|||
164460354|NCT05543629|594057406|FG001|Overall Study|Other Reasons|0|||
164460355|NCT05543629|594057407|FG002|Overall Study|Other Reasons|0|||
164460356|NCT05543629|594057408|FG003|Overall Study|Other Reasons|0|||
164460357|NCT05543629|594057409|FG004|Overall Study|Other Reasons|1|||
164460358|NCT05543629|594057410|FG005|Overall Study|Other Reasons|0|||
164460359|NCT05543629|594057411|FG006|Overall Study|Other Reasons|0|||
164460360|NCT05543629|594057412|FG007|Overall Study|Other Reasons|0|||
164460361|NCT05543629|594057405|FG000|Overall Study|Physician Decision|0|||
164460362|NCT05543629|594057406|FG001|Overall Study|Physician Decision|0|||
164460363|NCT05543629|594057407|FG002|Overall Study|Physician Decision|3|||
164460364|NCT05543629|594057408|FG003|Overall Study|Physician Decision|0|||
164460365|NCT05543629|594057409|FG004|Overall Study|Physician Decision|0|||
164460366|NCT05543629|594057410|FG005|Overall Study|Physician Decision|0|||
164460367|NCT05543629|594057411|FG006|Overall Study|Physician Decision|1|||
164460368|NCT05543629|594057412|FG007|Overall Study|Physician Decision|0|||
164460369|NCT05543629|594057405|FG000|Overall Study|Study terminated by Sponsor|1|||
164460370|NCT05543629|594057406|FG001|Overall Study|Study terminated by Sponsor|0|||
164460371|NCT05543629|594057407|FG002|Overall Study|Study terminated by Sponsor|0|||
164460372|NCT05543629|594057408|FG003|Overall Study|Study terminated by Sponsor|1|||
164460373|NCT05543629|594057409|FG004|Overall Study|Study terminated by Sponsor|0|||
164460374|NCT05543629|594057410|FG005|Overall Study|Study terminated by Sponsor|4|||
164460375|NCT05543629|594057411|FG006|Overall Study|Study terminated by Sponsor|1|||
164460376|NCT05543629|594057412|FG007|Overall Study|Study terminated by Sponsor|0|||
164460377|NCT05543629|594057405|FG000|Overall Study|Withdrawal by Subject|1|||
164460378|NCT05543629|594057406|FG001|Overall Study|Withdrawal by Subject|1|||
164460379|NCT05543629|594057407|FG002|Overall Study|Withdrawal by Subject|0|||
164460380|NCT05543629|594057408|FG003|Overall Study|Withdrawal by Subject|2|||
164460381|NCT05543629|594057409|FG004|Overall Study|Withdrawal by Subject|1|||
164460382|NCT05543629|594057410|FG005|Overall Study|Withdrawal by Subject|1|||
164460383|NCT05543629|594057411|FG006|Overall Study|Withdrawal by Subject|1|||
164460384|NCT05543629|594057412|FG007|Overall Study|Withdrawal by Subject|1|||
164460385|NCT05543629|594057405|FG000|Overall Study|Not Reported|2|||
164460386|NCT05543629|594057406|FG001|Overall Study|Not Reported|2|||
164598766|NCT02883049|594554771|FG015|Induction|Inevaluable|0|||
164460387|NCT05543629|594057407|FG002|Overall Study|Not Reported|0|||
164460388|NCT05543629|594057408|FG003|Overall Study|Not Reported|0|||
164460389|NCT05543629|594057409|FG004|Overall Study|Not Reported|1|||
164460390|NCT05543629|594057410|FG005|Overall Study|Not Reported|1|||
164460391|NCT05543629|594057411|FG006|Overall Study|Not Reported|3|||
164460392|NCT05543629|594057412|FG007|Overall Study|Not Reported|0|||
164460393|NCT04568603|594057413|FG000|Overall Study|Physician Decision|1|||
164460394|NCT04564742|594057414|FG000|Overall Study|Lost to Follow-up|1|||
164460395|NCT04564742|594057415|FG001|Overall Study|Lost to Follow-up|0|||
164460396|NCT04564742|594057414|FG000|Overall Study|Consent Withdrawal|4|||
164460397|NCT04564742|594057415|FG001|Overall Study|Consent Withdrawal|4|||
164460398|NCT03313076|594057419|FG000|Overall Study|Withdrawal by Subject|2|||
164460399|NCT03313076|594057420|FG001|Overall Study|Withdrawal by Subject|0|||
164460400|NCT03313076|594057421|FG002|Overall Study|Withdrawal by Subject|0|||
164460401|NCT03313076|594057422|FG003|Overall Study|Withdrawal by Subject|0|||
164460402|NCT03313076|594057419|FG000|Overall Study|Lost to Follow-up|0|||
164460403|NCT03313076|594057420|FG001|Overall Study|Lost to Follow-up|2|||
164460404|NCT03313076|594057421|FG002|Overall Study|Lost to Follow-up|2|||
164460405|NCT03313076|594057422|FG003|Overall Study|Lost to Follow-up|2|||
164460406|NCT05869383|594057423|FG000|Overall Study|Withdrawal by Subject|2|||
164460407|NCT05869383|594057424|FG001|Overall Study|Withdrawal by Subject|0|||
164460408|NCT04137367|594057431|FG000|Overall Study|Lost to Follow-up|8|||
164460409|NCT04137367|594057432|FG001|Overall Study|Lost to Follow-up|6|||
164460410|NCT04137367|594057433|FG002|Overall Study|Lost to Follow-up|4|||
164460411|NCT05144009|594057434|FG000|Overall Study|Lost to Follow-up|0|||
164460412|NCT05144009|594057435|FG001|Overall Study|Lost to Follow-up|1|||
164460413|NCT05144009|594057434|FG000|Overall Study|Study Termination by the Sponsor|11|||
164460414|NCT05144009|594057435|FG001|Overall Study|Study Termination by the Sponsor|11|||
164460415|NCT05144009|594057434|FG000|Overall Study|Disease Progression|1|||
164460416|NCT05144009|594057435|FG001|Overall Study|Disease Progression|0|||
164460417|NCT05144009|594057434|FG000|Overall Study|Participant Decision|0|||
164460418|NCT05144009|594057435|FG001|Overall Study|Participant Decision|2|||
164460419|NCT05144009|594057434|FG000|Overall Study|Death|5|||
164460420|NCT05144009|594057435|FG001|Overall Study|Death|10|||
164460421|NCT03270501|594057436|FG000|Overall Study|Screen failure|6|||
164460422|NCT03270501|594057436|FG000|Overall Study|Lost to Follow-up|2|||
164460423|NCT03270501|594057436|FG000|Overall Study|Adverse Event|1|||
164460424|NCT05270408|594057445|FG000|Started Treatment|Withdrawal by Subject|0|||
164460425|NCT05270408|594057446|FG001|Started Treatment|Withdrawal by Subject|0|||
164460426|NCT05270408|594057447|FG002|Started Treatment|Withdrawal by Subject|3|||
164460427|NCT05270408|594057445|FG000|Started Treatment|Adverse Event|0|||
164460428|NCT05270408|594057446|FG001|Started Treatment|Adverse Event|0|||
164460429|NCT05270408|594057447|FG002|Started Treatment|Adverse Event|1|||
164460430|NCT05270408|594057445|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
164460431|NCT05270408|594057446|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
164460432|NCT05270408|594057447|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
164460433|NCT04338061|594057448|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
164460434|NCT04338061|594057449|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
164460435|NCT04338061|594057448|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
164460436|NCT04338061|594057449|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
164460437|NCT04338061|594057448|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
164460438|NCT04338061|594057449|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
164460439|NCT04338061|594057448|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
164460440|NCT04338061|594057449|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
164460441|NCT04338061|594057448|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
164460442|NCT04338061|594057449|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
164460443|NCT04338061|594057448|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
164460444|NCT04338061|594057449|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
164460445|NCT04338061|594057448|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
164460446|NCT04338061|594057449|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
164598767|NCT02883049|594554756|FG000|Induction|Identified as VHR at end of Induction|244|||
164598768|NCT02883049|594554757|FG001|Induction|Identified as VHR at end of Induction|0|||
164598769|NCT02883049|594554758|FG002|Induction|Identified as VHR at end of Induction|0|||
164598770|NCT02883049|594554759|FG003|Induction|Identified as VHR at end of Induction|0|||
164598771|NCT02883049|594554760|FG004|Induction|Identified as VHR at end of Induction|0|||
164598772|NCT02883049|594554761|FG005|Induction|Identified as VHR at end of Induction|0|||
164144661|NCT01495702|592891746|FG001|Randomized Phase|Lack of Efficacy|0|||
164460447|NCT04338061|594057448|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
164460448|NCT04338061|594057449|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
164460449|NCT04338061|594057448|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
164598773|NCT02883049|594554762|FG006|Induction|Identified as VHR at end of Induction|0|||
164598774|NCT02883049|594554763|FG007|Induction|Identified as VHR at end of Induction|0|||
164460450|NCT04338061|594057449|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
164460451|NCT04338061|594057448|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
164460452|NCT04338061|594057449|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
164460453|NCT04338061|594057448|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
164460454|NCT04338061|594057449|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
164460455|NCT04338061|594057448|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
164598775|NCT02883049|594554764|FG008|Induction|Identified as VHR at end of Induction|0|||
164460456|NCT04338061|594057449|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
164460457|NCT04492722|594057451|FG000|Overall Study|Adverse Event|7|||
164460458|NCT04492722|594057452|FG001|Overall Study|Adverse Event|2|||
164460459|NCT04492722|594057453|FG002|Overall Study|Adverse Event|3|||
164460460|NCT04492722|594057454|FG003|Overall Study|Adverse Event|0|||
164460461|NCT04492722|594057451|FG000|Overall Study|Death|0|||
164460462|NCT04492722|594057452|FG001|Overall Study|Death|0|||
164460463|NCT04492722|594057453|FG002|Overall Study|Death|0|||
164460464|NCT04492722|594057454|FG003|Overall Study|Death|1|||
164460465|NCT04492722|594057451|FG000|Overall Study|Lost to Follow-up|0|||
164460466|NCT04492722|594057452|FG001|Overall Study|Lost to Follow-up|1|||
164460467|NCT04492722|594057453|FG002|Overall Study|Lost to Follow-up|0|||
164460468|NCT04492722|594057454|FG003|Overall Study|Lost to Follow-up|1|||
164460469|NCT04492722|594057451|FG000|Overall Study|Physician Decision|0|||
164460470|NCT04492722|594057452|FG001|Overall Study|Physician Decision|3|||
164460471|NCT04492722|594057453|FG002|Overall Study|Physician Decision|1|||
164460472|NCT04492722|594057454|FG003|Overall Study|Physician Decision|1|||
164460473|NCT04492722|594057451|FG000|Overall Study|Withdrawal by Subject|6|||
164460474|NCT04492722|594057452|FG001|Overall Study|Withdrawal by Subject|6|||
164460475|NCT04492722|594057453|FG002|Overall Study|Withdrawal by Subject|0|||
164460476|NCT04492722|594057454|FG003|Overall Study|Withdrawal by Subject|3|||
164460477|NCT04492722|594057451|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
164460478|NCT04492722|594057452|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
164460479|NCT04492722|594057453|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
164460480|NCT04492722|594057454|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
164460481|NCT04492722|594057451|FG000|Overall Study|Due to Covid-19 pandemic|7|||
164460482|NCT04492722|594057452|FG001|Overall Study|Due to Covid-19 pandemic|3|||
164460483|NCT04492722|594057453|FG002|Overall Study|Due to Covid-19 pandemic|7|||
164460484|NCT04492722|594057454|FG003|Overall Study|Due to Covid-19 pandemic|6|||
164460485|NCT04492722|594057451|FG000|Overall Study|Failure to meet randomisation criteria|2|||
164460486|NCT04492722|594057452|FG001|Overall Study|Failure to meet randomisation criteria|3|||
164460487|NCT04492722|594057453|FG002|Overall Study|Failure to meet randomisation criteria|4|||
164460488|NCT04492722|594057454|FG003|Overall Study|Failure to meet randomisation criteria|2|||
164460489|NCT04492722|594057451|FG000|Overall Study|Early termination from the study|54|||
164460490|NCT04492722|594057452|FG001|Overall Study|Early termination from the study|51|||
164460491|NCT04492722|594057453|FG002|Overall Study|Early termination from the study|50|||
164460492|NCT04492722|594057454|FG003|Overall Study|Early termination from the study|50|||
164460493|NCT04492722|594057451|FG000|Overall Study|Missing|3|||
164460494|NCT04492722|594057452|FG001|Overall Study|Missing|0|||
164460495|NCT04492722|594057453|FG002|Overall Study|Missing|0|||
164460496|NCT04492722|594057454|FG003|Overall Study|Missing|5|||
164460497|NCT04492722|594057451|FG000|Overall Study|Participants who did not receive treatment|0|||
164460498|NCT04492722|594057452|FG001|Overall Study|Participants who did not receive treatment|1|||
164460499|NCT04492722|594057453|FG002|Overall Study|Participants who did not receive treatment|4|||
164460500|NCT04492722|594057454|FG003|Overall Study|Participants who did not receive treatment|0|||
164460501|NCT04074759|594057455|FG000|Overall Study|Withdrawal by Subject|0|||
164460502|NCT04074759|594057456|FG001|Overall Study|Withdrawal by Subject|0|||
164460503|NCT04074759|594057457|FG002|Overall Study|Withdrawal by Subject|0|||
164460504|NCT04074759|594057458|FG003|Overall Study|Withdrawal by Subject|0|||
164460505|NCT04074759|594057459|FG004|Overall Study|Withdrawal by Subject|0|||
164460506|NCT04074759|594057460|FG005|Overall Study|Withdrawal by Subject|2|||
164460507|NCT04074759|594057461|FG006|Overall Study|Withdrawal by Subject|0|||
164460508|NCT04074759|594057462|FG007|Overall Study|Withdrawal by Subject|2|||
164460509|NCT04074759|594057463|FG008|Overall Study|Withdrawal by Subject|1|||
164460510|NCT04074759|594057464|FG009|Overall Study|Withdrawal by Subject|2|||
164460511|NCT04074759|594057465|FG010|Overall Study|Withdrawal by Subject|9|||
164460512|NCT04074759|594057466|FG011|Overall Study|Withdrawal by Subject|2|||
164460513|NCT04074759|594057467|FG012|Overall Study|Withdrawal by Subject|1|||
164460514|NCT04074759|594057468|FG013|Overall Study|Withdrawal by Subject|3|||
164460515|NCT04074759|594057469|FG014|Overall Study|Withdrawal by Subject|2|||
164460516|NCT04074759|594057470|FG015|Overall Study|Withdrawal by Subject|0|||
164460517|NCT04074759|594057471|FG016|Overall Study|Withdrawal by Subject|0|||
164460518|NCT04074759|594057472|FG017|Overall Study|Withdrawal by Subject|3|||
164460519|NCT04074759|594057473|FG018|Overall Study|Withdrawal by Subject|1|||
164460520|NCT04074759|594057455|FG000|Overall Study|Death|1|||
164460521|NCT04074759|594057456|FG001|Overall Study|Death|0|||
164460522|NCT04074759|594057457|FG002|Overall Study|Death|1|||
164460523|NCT04074759|594057458|FG003|Overall Study|Death|1|||
164460524|NCT04074759|594057459|FG004|Overall Study|Death|2|||
164460525|NCT04074759|594057460|FG005|Overall Study|Death|0|||
164460526|NCT04074759|594057461|FG006|Overall Study|Death|1|||
164460527|NCT04074759|594057462|FG007|Overall Study|Death|0|||
164460528|NCT04074759|594057463|FG008|Overall Study|Death|3|||
164460529|NCT04074759|594057464|FG009|Overall Study|Death|2|||
164460530|NCT04074759|594057465|FG010|Overall Study|Death|4|||
164460531|NCT04074759|594057466|FG011|Overall Study|Death|1|||
164460532|NCT04074759|594057467|FG012|Overall Study|Death|0|||
164460533|NCT04074759|594057468|FG013|Overall Study|Death|2|||
164460534|NCT04074759|594057469|FG014|Overall Study|Death|1|||
164460535|NCT04074759|594057470|FG015|Overall Study|Death|0|||
164460536|NCT04074759|594057471|FG016|Overall Study|Death|1|||
164460537|NCT04074759|594057472|FG017|Overall Study|Death|0|||
164460538|NCT04074759|594057473|FG018|Overall Study|Death|1|||
164460539|NCT04074759|594057455|FG000|Overall Study|Lost to Follow-up|0|||
164460540|NCT04074759|594057456|FG001|Overall Study|Lost to Follow-up|0|||
164460541|NCT04074759|594057457|FG002|Overall Study|Lost to Follow-up|0|||
164460542|NCT04074759|594057458|FG003|Overall Study|Lost to Follow-up|0|||
164460543|NCT04074759|594057459|FG004|Overall Study|Lost to Follow-up|0|||
164460544|NCT04074759|594057460|FG005|Overall Study|Lost to Follow-up|0|||
164460545|NCT04074759|594057461|FG006|Overall Study|Lost to Follow-up|0|||
164460546|NCT04074759|594057462|FG007|Overall Study|Lost to Follow-up|0|||
164460547|NCT04074759|594057463|FG008|Overall Study|Lost to Follow-up|0|||
164460548|NCT04074759|594057464|FG009|Overall Study|Lost to Follow-up|0|||
164460549|NCT04074759|594057465|FG010|Overall Study|Lost to Follow-up|1|||
164460550|NCT04074759|594057466|FG011|Overall Study|Lost to Follow-up|0|||
164460551|NCT04074759|594057467|FG012|Overall Study|Lost to Follow-up|0|||
164460552|NCT04074759|594057468|FG013|Overall Study|Lost to Follow-up|0|||
164460553|NCT04074759|594057469|FG014|Overall Study|Lost to Follow-up|0|||
164460554|NCT04074759|594057470|FG015|Overall Study|Lost to Follow-up|0|||
164460555|NCT04074759|594057471|FG016|Overall Study|Lost to Follow-up|1|||
164460556|NCT04074759|594057472|FG017|Overall Study|Lost to Follow-up|0|||
164460557|NCT04074759|594057473|FG018|Overall Study|Lost to Follow-up|1|||
164460558|NCT04074759|594057455|FG000|Overall Study|Other|0|||
164460559|NCT04074759|594057456|FG001|Overall Study|Other|1|||
164460560|NCT04074759|594057457|FG002|Overall Study|Other|1|||
164460561|NCT04074759|594057458|FG003|Overall Study|Other|0|||
164460562|NCT04074759|594057459|FG004|Overall Study|Other|2|||
164460563|NCT04074759|594057460|FG005|Overall Study|Other|1|||
164460564|NCT04074759|594057461|FG006|Overall Study|Other|2|||
164460565|NCT04074759|594057462|FG007|Overall Study|Other|1|||
164460566|NCT04074759|594057463|FG008|Overall Study|Other|1|||
164460567|NCT04074759|594057464|FG009|Overall Study|Other|4|||
164460568|NCT04074759|594057465|FG010|Overall Study|Other|4|||
164460569|NCT04074759|594057466|FG011|Overall Study|Other|2|||
164460570|NCT04074759|594057467|FG012|Overall Study|Other|0|||
164460571|NCT04074759|594057468|FG013|Overall Study|Other|0|||
164460572|NCT04074759|594057469|FG014|Overall Study|Other|0|||
164460573|NCT04074759|594057470|FG015|Overall Study|Other|1|||
164460574|NCT04074759|594057471|FG016|Overall Study|Other|0|||
164460575|NCT04074759|594057472|FG017|Overall Study|Other|0|||
164460576|NCT04074759|594057473|FG018|Overall Study|Other|0|||
164460577|NCT04074759|594057455|FG000|Overall Study|Missing end of study status|0|||
164460578|NCT04074759|594057456|FG001|Overall Study|Missing end of study status|0|||
164460579|NCT04074759|594057457|FG002|Overall Study|Missing end of study status|0|||
164460580|NCT04074759|594057458|FG003|Overall Study|Missing end of study status|0|||
164460581|NCT04074759|594057459|FG004|Overall Study|Missing end of study status|0|||
164460582|NCT04074759|594057460|FG005|Overall Study|Missing end of study status|0|||
164460583|NCT04074759|594057461|FG006|Overall Study|Missing end of study status|0|||
164460584|NCT04074759|594057462|FG007|Overall Study|Missing end of study status|0|||
164460585|NCT04074759|594057463|FG008|Overall Study|Missing end of study status|0|||
164460586|NCT04074759|594057464|FG009|Overall Study|Missing end of study status|0|||
164460587|NCT04074759|594057465|FG010|Overall Study|Missing end of study status|2|||
164460588|NCT04074759|594057466|FG011|Overall Study|Missing end of study status|0|||
164460589|NCT04074759|594057467|FG012|Overall Study|Missing end of study status|0|||
164460590|NCT04074759|594057468|FG013|Overall Study|Missing end of study status|0|||
164460591|NCT04074759|594057469|FG014|Overall Study|Missing end of study status|0|||
164460592|NCT04074759|594057470|FG015|Overall Study|Missing end of study status|0|||
164460593|NCT04074759|594057471|FG016|Overall Study|Missing end of study status|1|||
164460594|NCT04074759|594057472|FG017|Overall Study|Missing end of study status|0|||
164460595|NCT04074759|594057473|FG018|Overall Study|Missing end of study status|0|||
164460596|NCT03631784|594057475|FG000|Overall Study|Participants Ongoing|1|||
164460597|NCT03631784|594057476|FG001|Overall Study|Participants Ongoing|0|||
164460598|NCT03631784|594057475|FG000|Overall Study|Withdrawal by Subject|3|||
164460599|NCT03631784|594057476|FG001|Overall Study|Withdrawal by Subject|3|||
164460600|NCT03631784|594057475|FG000|Overall Study|Sponsor's Decision|36|||
164460601|NCT03631784|594057476|FG001|Overall Study|Sponsor's Decision|52|||
164460602|NCT03631784|594057475|FG000|Overall Study|Lost to Follow-up|1|||
164460603|NCT03631784|594057476|FG001|Overall Study|Lost to Follow-up|0|||
164460604|NCT03631784|594057475|FG000|Overall Study|Death|71|||
164460605|NCT03631784|594057476|FG001|Overall Study|Death|49|||
164460606|NCT05329220|594057479|FG000|Active Trial Period|Adverse Event|0|||
164460607|NCT05329220|594057480|FG001|Active Trial Period|Adverse Event|0|||
164460608|NCT05329220|594057481|FG002|Active Trial Period|Adverse Event|0|||
164460609|NCT05329220|594057482|FG003|Active Trial Period|Adverse Event|0|||
164460610|NCT05329220|594057483|FG004|Active Trial Period|Adverse Event|1|||
164460611|NCT05329220|594057484|FG005|Active Trial Period|Adverse Event|0|||
164460612|NCT05329220|594057479|FG000|Active Trial Period|Lost to Follow-up|0|||
164460613|NCT05329220|594057480|FG001|Active Trial Period|Lost to Follow-up|0|||
164460614|NCT05329220|594057481|FG002|Active Trial Period|Lost to Follow-up|0|||
164460615|NCT05329220|594057482|FG003|Active Trial Period|Lost to Follow-up|0|||
164460616|NCT05329220|594057483|FG004|Active Trial Period|Lost to Follow-up|32|||
164460617|NCT05329220|594057484|FG005|Active Trial Period|Lost to Follow-up|28|||
164460618|NCT05329220|594057479|FG000|Active Trial Period|Physician Decision|0|||
164460619|NCT05329220|594057480|FG001|Active Trial Period|Physician Decision|0|||
164460620|NCT05329220|594057481|FG002|Active Trial Period|Physician Decision|0|||
164460621|NCT05329220|594057482|FG003|Active Trial Period|Physician Decision|0|||
164460622|NCT05329220|594057483|FG004|Active Trial Period|Physician Decision|2|||
164460623|NCT05329220|594057484|FG005|Active Trial Period|Physician Decision|0|||
164460624|NCT05329220|594057479|FG000|Active Trial Period|Protocol Violation|0|||
164460625|NCT05329220|594057480|FG001|Active Trial Period|Protocol Violation|0|||
164460626|NCT05329220|594057481|FG002|Active Trial Period|Protocol Violation|0|||
164460627|NCT05329220|594057482|FG003|Active Trial Period|Protocol Violation|0|||
164460628|NCT05329220|594057483|FG004|Active Trial Period|Protocol Violation|1|||
164460629|NCT05329220|594057484|FG005|Active Trial Period|Protocol Violation|3|||
164460630|NCT05329220|594057479|FG000|Active Trial Period|Withdrawal by Subject|0|||
164460631|NCT05329220|594057480|FG001|Active Trial Period|Withdrawal by Subject|0|||
164460632|NCT05329220|594057481|FG002|Active Trial Period|Withdrawal by Subject|0|||
164460633|NCT05329220|594057482|FG003|Active Trial Period|Withdrawal by Subject|1|||
164460634|NCT05329220|594057483|FG004|Active Trial Period|Withdrawal by Subject|12|||
164460635|NCT05329220|594057484|FG005|Active Trial Period|Withdrawal by Subject|13|||
164460636|NCT05329220|594057479|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
164460637|NCT05329220|594057480|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
164460638|NCT05329220|594057481|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
164460639|NCT05329220|594057482|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
164460640|NCT05329220|594057483|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
164460641|NCT05329220|594057484|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
164460642|NCT05329220|594057479|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
164460643|NCT05329220|594057480|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
164460644|NCT05329220|594057481|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
164460645|NCT05329220|594057482|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
164460646|NCT05329220|594057483|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
164460647|NCT05329220|594057484|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
164460648|NCT05329220|594057479|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
164460649|NCT05329220|594057480|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
164460650|NCT05329220|594057481|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
164460651|NCT05329220|594057482|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
164460652|NCT05329220|594057483|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
164460653|NCT05329220|594057484|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
164460654|NCT05329220|594057479|FG000|Follow-up Period|Adverse Event|0|||
164460655|NCT05329220|594057480|FG001|Follow-up Period|Adverse Event|0|||
164460656|NCT05329220|594057481|FG002|Follow-up Period|Adverse Event|0|||
164460657|NCT05329220|594057482|FG003|Follow-up Period|Adverse Event|0|||
164460658|NCT05329220|594057483|FG004|Follow-up Period|Adverse Event|2|||
164460659|NCT05329220|594057484|FG005|Follow-up Period|Adverse Event|1|||
164460660|NCT05329220|594057479|FG000|Follow-up Period|Death|0|||
164460661|NCT05329220|594057480|FG001|Follow-up Period|Death|0|||
164460662|NCT05329220|594057481|FG002|Follow-up Period|Death|1|||
164460663|NCT05329220|594057482|FG003|Follow-up Period|Death|1|||
164460664|NCT05329220|594057483|FG004|Follow-up Period|Death|0|||
164460665|NCT05329220|594057484|FG005|Follow-up Period|Death|1|||
164460666|NCT05329220|594057479|FG000|Follow-up Period|Lost to Follow-up|0|||
164460667|NCT05329220|594057480|FG001|Follow-up Period|Lost to Follow-up|1|||
164460668|NCT05329220|594057481|FG002|Follow-up Period|Lost to Follow-up|2|||
164460669|NCT05329220|594057482|FG003|Follow-up Period|Lost to Follow-up|2|||
164460670|NCT05329220|594057483|FG004|Follow-up Period|Lost to Follow-up|113|||
164460671|NCT05329220|594057484|FG005|Follow-up Period|Lost to Follow-up|89|||
164460672|NCT05329220|594057479|FG000|Follow-up Period|Physician Decision|0|||
164460673|NCT05329220|594057480|FG001|Follow-up Period|Physician Decision|0|||
164460674|NCT05329220|594057481|FG002|Follow-up Period|Physician Decision|0|||
164460675|NCT05329220|594057482|FG003|Follow-up Period|Physician Decision|0|||
164460676|NCT05329220|594057483|FG004|Follow-up Period|Physician Decision|2|||
164460677|NCT05329220|594057484|FG005|Follow-up Period|Physician Decision|2|||
164460678|NCT05329220|594057479|FG000|Follow-up Period|Protocol Violation|0|||
164460679|NCT05329220|594057480|FG001|Follow-up Period|Protocol Violation|0|||
164460680|NCT05329220|594057481|FG002|Follow-up Period|Protocol Violation|0|||
164598776|NCT02883049|594554765|FG009|Induction|Identified as VHR at end of Induction|0|||
164460681|NCT05329220|594057482|FG003|Follow-up Period|Protocol Violation|0|||
164460682|NCT05329220|594057483|FG004|Follow-up Period|Protocol Violation|0|||
164460683|NCT05329220|594057484|FG005|Follow-up Period|Protocol Violation|1|||
164460684|NCT05329220|594057479|FG000|Follow-up Period|Withdrawal by Subject|0|||
164460685|NCT05329220|594057480|FG001|Follow-up Period|Withdrawal by Subject|0|||
164460686|NCT05329220|594057481|FG002|Follow-up Period|Withdrawal by Subject|1|||
164460687|NCT05329220|594057482|FG003|Follow-up Period|Withdrawal by Subject|1|||
164460688|NCT05329220|594057483|FG004|Follow-up Period|Withdrawal by Subject|34|||
164460689|NCT05329220|594057484|FG005|Follow-up Period|Withdrawal by Subject|35|||
164460690|NCT05329220|594057479|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
164460691|NCT05329220|594057480|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
164460692|NCT05329220|594057481|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
164460693|NCT05329220|594057482|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
164460694|NCT05329220|594057483|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
164460695|NCT05329220|594057484|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
164460696|NCT05329220|594057479|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
164460697|NCT05329220|594057480|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
164460698|NCT05329220|594057481|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
164460699|NCT05329220|594057482|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
164460700|NCT05329220|594057483|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
164460701|NCT05329220|594057484|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
164460702|NCT05329220|594057479|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
164460703|NCT05329220|594057480|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
164460704|NCT05329220|594057481|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
164460705|NCT05329220|594057482|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
164460706|NCT05329220|594057483|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
164460707|NCT05329220|594057484|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
164460708|NCT05329220|594057479|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
164460709|NCT05329220|594057480|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
164460710|NCT05329220|594057481|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
164460711|NCT05329220|594057482|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
164460712|NCT05329220|594057483|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
164460713|NCT05329220|594057484|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
164460714|NCT05329220|594057479|FG000|Follow-up Period|EARLY TERMINATION|0|||
164460715|NCT05329220|594057480|FG001|Follow-up Period|EARLY TERMINATION|0|||
164460716|NCT05329220|594057481|FG002|Follow-up Period|EARLY TERMINATION|0|||
164460717|NCT05329220|594057482|FG003|Follow-up Period|EARLY TERMINATION|0|||
164460718|NCT05329220|594057483|FG004|Follow-up Period|EARLY TERMINATION|0|||
164460719|NCT05329220|594057484|FG005|Follow-up Period|EARLY TERMINATION|1|||
164460720|NCT05329220|594057479|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
164460721|NCT05329220|594057480|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
164460722|NCT05329220|594057481|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
164460723|NCT05329220|594057482|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
164460724|NCT05329220|594057483|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
164460725|NCT05329220|594057484|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
164460726|NCT05329220|594057479|FG000|Follow-up Period|DROPPED|0|||
164460727|NCT05329220|594057480|FG001|Follow-up Period|DROPPED|0|||
164460728|NCT05329220|594057481|FG002|Follow-up Period|DROPPED|0|||
164460729|NCT05329220|594057482|FG003|Follow-up Period|DROPPED|0|||
164460730|NCT05329220|594057483|FG004|Follow-up Period|DROPPED|0|||
164460731|NCT05329220|594057484|FG005|Follow-up Period|DROPPED|1|||
164460732|NCT05329220|594057479|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
164460733|NCT05329220|594057480|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
164460734|NCT05329220|594057481|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
164460735|NCT05329220|594057482|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
164460736|NCT05329220|594057483|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
164707686|NCT01523457|594955308|FG000|Overall Study|Withdrawal by Subject|7|||
164707687|NCT01523457|594955309|FG001|Overall Study|Withdrawal by Subject|2|||
164460737|NCT05329220|594057484|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
164460738|NCT02465268|594057486|FG000|Overall Study|Withdrawal by Subject|4|||
164460739|NCT02465268|594057487|FG001|Overall Study|Withdrawal by Subject|3|||
164460740|NCT02465268|594057488|FG002|Overall Study|Withdrawal by Subject|1|||
164707688|NCT02213510|594955310|FG000|Overall Study|Death|0|||
164707689|NCT02213510|594955311|FG001|Overall Study|Death|1|||
164707690|NCT02213510|594955310|FG000|Overall Study|Lost to Follow-up|1|||
164707691|NCT02213510|594955311|FG001|Overall Study|Lost to Follow-up|0|||
164707692|NCT03954834|594955312|FG000|Overall Study|Adverse Event|1|||
164460741|NCT02465268|594057486|FG000|Overall Study|Not evaluable per protocol criteria|3|||
164460742|NCT02465268|594057487|FG001|Overall Study|Not evaluable per protocol criteria|2|||
164460743|NCT02465268|594057488|FG002|Overall Study|Not evaluable per protocol criteria|1|||
164460744|NCT02465268|594057486|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
164460745|NCT02465268|594057487|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
164460746|NCT02465268|594057488|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
164460747|NCT02465268|594057486|FG000|Overall Study|Study drug did not pass QA/QC|1|||
164460748|NCT02465268|594057487|FG001|Overall Study|Study drug did not pass QA/QC|0|||
164460749|NCT02465268|594057488|FG002|Overall Study|Study drug did not pass QA/QC|0|||
164460750|NCT02465268|594057486|FG000|Overall Study|Adverse Event|0|||
164460751|NCT02465268|594057487|FG001|Overall Study|Adverse Event|1|||
164460752|NCT02465268|594057488|FG002|Overall Study|Adverse Event|0|||
164460753|NCT02465268|594057486|FG000|Overall Study|Physician Decision|0|||
164460754|NCT02465268|594057487|FG001|Overall Study|Physician Decision|1|||
164460755|NCT02465268|594057488|FG002|Overall Study|Physician Decision|0|||
164460756|NCT02547363|594057494|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
164460757|NCT02547363|594057495|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
164460758|NCT02547363|594057494|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
164460759|NCT02547363|594057495|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
164460760|NCT02547363|594057494|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
164460761|NCT02547363|594057495|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
164460762|NCT02547363|594057494|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
164460763|NCT02547363|594057495|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
164460764|NCT02547363|594057494|FG000|12-month Follow-up|Withdrawal by Subject|4|||
164460765|NCT02547363|594057495|FG001|12-month Follow-up|Withdrawal by Subject|3|||
164460766|NCT02547363|594057494|FG000|12-month Follow-up|Lost to Follow-up|4|||
164460767|NCT02547363|594057495|FG001|12-month Follow-up|Lost to Follow-up|1|||
164460768|NCT02547363|594057494|FG000|12-month Follow-up|Lack of Efficacy|1|||
164460769|NCT02547363|594057495|FG001|12-month Follow-up|Lack of Efficacy|1|||
164460770|NCT02547363|594057494|FG000|12-month Follow-up|Other|1|||
164460771|NCT02547363|594057495|FG001|12-month Follow-up|Other|0|||
164460772|NCT03322267|594057497|FG000|Overall Study|Lack of Efficacy|11|||
164460773|NCT03322267|594057497|FG000|Overall Study|Adverse Event|1|||
164460774|NCT03322267|594057497|FG000|Overall Study|Withdrawal by Subject|2|||
164460775|NCT03084536|594057500|FG000|Overall Study|Determined to be ineligible|0|||
164460776|NCT03084536|594057501|FG001|Overall Study|Determined to be ineligible|0|||
164460777|NCT03084536|594057502|FG002|Overall Study|Determined to be ineligible|16|||
164460778|NCT03084536|594057500|FG000|Overall Study|Withdrawal by Subject|0|||
164460779|NCT03084536|594057501|FG001|Overall Study|Withdrawal by Subject|0|||
164460780|NCT03084536|594057502|FG002|Overall Study|Withdrawal by Subject|4|||
164460781|NCT03084536|594057500|FG000|Overall Study|Physician Decision|0|||
164460782|NCT03084536|594057501|FG001|Overall Study|Physician Decision|0|||
164460783|NCT03084536|594057502|FG002|Overall Study|Physician Decision|3|||
164460784|NCT03084536|594057500|FG000|Overall Study|Death|0|||
164460785|NCT03084536|594057501|FG001|Overall Study|Death|0|||
164460786|NCT03084536|594057502|FG002|Overall Study|Death|1|||
164460787|NCT03084536|594057500|FG000|Overall Study|Lost to Follow-up|0|||
164460788|NCT03084536|594057501|FG001|Overall Study|Lost to Follow-up|0|||
164460789|NCT03084536|594057502|FG002|Overall Study|Lost to Follow-up|1|||
164460790|NCT03084536|594057500|FG000|Overall Study|Protocol Violation|0|||
164460791|NCT03084536|594057501|FG001|Overall Study|Protocol Violation|0|||
164460792|NCT03084536|594057502|FG002|Overall Study|Protocol Violation|1|||
164460793|NCT03084536|594057500|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
164460794|NCT03084536|594057501|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
164460795|NCT03084536|594057502|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
164460796|NCT05302596|594057514|FG000|Overall Study|Withdrawal by Subject|1|||
164460797|NCT05302596|594057515|FG001|Overall Study|Withdrawal by Subject|1|||
164460798|NCT04764448|594059676|FG000|Overall Study|Study terminated by sponsor|2|||
164460799|NCT04764448|594059677|FG001|Overall Study|Study terminated by sponsor|2|||
164460800|NCT04764448|594059678|FG002|Overall Study|Study terminated by sponsor|5|||
164460801|NCT04764448|594059676|FG000|Overall Study|Withdrawal by Subject|3|||
164460802|NCT04764448|594059677|FG001|Overall Study|Withdrawal by Subject|3|||
164460803|NCT04764448|594059678|FG002|Overall Study|Withdrawal by Subject|1|||
164460804|NCT04728347|594059679|FG000|Overall Study|Sponsor decision|0|||
164707693|NCT03954834|594955313|FG001|Overall Study|Adverse Event|3|||
164707694|NCT03954834|594955314|FG002|Overall Study|Adverse Event|1|||
164707695|NCT03954834|594955315|FG003|Overall Study|Adverse Event|1|||
164460805|NCT04728347|594059680|FG001|Overall Study|Sponsor decision|0|||
164460806|NCT04728347|594059681|FG002|Overall Study|Sponsor decision|1|||
164460807|NCT04728347|594059682|FG003|Overall Study|Sponsor decision|0|||
164460808|NCT04489771|594059684|FG000|Overall Study|Death|27|||
164460809|NCT04489771|594059685|FG001|Overall Study|Death|25|||
164460810|NCT04489771|594059684|FG000|Overall Study|Withdrawal by Subject|1|||
164460811|NCT04489771|594059685|FG001|Overall Study|Withdrawal by Subject|0|||
164460812|NCT04489771|594059684|FG000|Overall Study|Participants Ongoing in Study|50|||
164707696|NCT03954834|594955312|FG000|Overall Study|Death|0|||
164707697|NCT03954834|594955313|FG001|Overall Study|Death|0|||
164460813|NCT04489771|594059685|FG001|Overall Study|Participants Ongoing in Study|51|||
164460814|NCT04509674|594059690|FG000|Overall Study|Not treated|33|||
164460815|NCT04509674|594059691|FG001|Overall Study|Not treated|26|||
164460816|NCT04509674|594059690|FG000|Overall Study|Protocol Violation|9|||
164460817|NCT04509674|594059691|FG001|Overall Study|Protocol Violation|10|||
164460818|NCT04509674|594059690|FG000|Overall Study|Lost to Follow-up|31|||
164460819|NCT04509674|594059691|FG001|Overall Study|Lost to Follow-up|39|||
164460820|NCT04509674|594059690|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
164460821|NCT04509674|594059691|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
164460822|NCT04509674|594059690|FG000|Overall Study|Adverse event, serious fatal event|11|||
164460823|NCT04509674|594059691|FG001|Overall Study|Adverse event, serious fatal event|4|||
164460824|NCT04509674|594059690|FG000|Overall Study|Adverse event, non-fatal event|107|||
164460825|NCT04509674|594059691|FG001|Overall Study|Adverse event, non-fatal event|118|||
164460826|NCT04509674|594059690|FG000|Overall Study|Other reason than listed|106|||
164460827|NCT04509674|594059691|FG001|Overall Study|Other reason than listed|95|||
164460828|NCT05579899|594059694|FG000|Overall Study|Lost to Follow-up|3|||
164460829|NCT05579899|594059695|FG001|Overall Study|Lost to Follow-up|1|||
164460830|NCT05579899|594059694|FG000|Overall Study|Adverse Event|0|||
164460831|NCT05579899|594059695|FG001|Overall Study|Adverse Event|3|||
164460832|NCT05579899|594059694|FG000|Overall Study|Pregnancy|0|||
164460833|NCT05579899|594059695|FG001|Overall Study|Pregnancy|1|||
164460834|NCT05579899|594059694|FG000|Overall Study|Withdrawal by Subject|0|||
164460835|NCT05579899|594059695|FG001|Overall Study|Withdrawal by Subject|3|||
164460836|NCT04059484|594059697|FG000|Overall Study|Adverse Event|2|||
164460837|NCT04059484|594059698|FG001|Overall Study|Adverse Event|5|||
164460838|NCT04059484|594059697|FG000|Overall Study|Withdrawal by Subject|5|||
164460839|NCT04059484|594059698|FG001|Overall Study|Withdrawal by Subject|3|||
164460840|NCT04059484|594059697|FG000|Overall Study|Progressive disease|112|||
164460841|NCT04059484|594059698|FG001|Overall Study|Progressive disease|112|||
164460842|NCT04059484|594059697|FG000|Overall Study|Other|8|||
164460843|NCT04059484|594059698|FG001|Overall Study|Other|3|||
164460844|NCT04059484|594059697|FG000|Overall Study|Ongoing|20|||
164460845|NCT04059484|594059698|FG001|Overall Study|Ongoing|20|||
164460846|NCT04292223|594059699|FG000|Overall Study|Adverse Event|1|||
164460847|NCT04292223|594059699|FG000|Overall Study|Lost to Follow-up|1|||
164460848|NCT04292223|594059699|FG000|Overall Study|Noncompliance with study drug|2|||
164460849|NCT04292223|594059699|FG000|Overall Study|Patient moved out of the state|1|||
164460850|NCT00753545|594059700|FG000|Overall Study|Death|98|||
164460851|NCT00753545|594059701|FG001|Overall Study|Death|112|||
164460852|NCT00753545|594059700|FG000|Overall Study|Lost to Follow-up|2|||
164460853|NCT00753545|594059701|FG001|Overall Study|Lost to Follow-up|3|||
164460854|NCT00753545|594059700|FG000|Overall Study|Protocol Violation|1|||
164460855|NCT00753545|594059701|FG001|Overall Study|Protocol Violation|0|||
164460856|NCT00753545|594059700|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
164460857|NCT00753545|594059701|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
164460858|NCT06190691|594059702|FG000|Overall Study|Adverse Event|2|||
164460859|NCT06190691|594059703|FG001|Overall Study|Adverse Event|0|||
164460860|NCT06190691|594059704|FG002|Overall Study|Adverse Event|0|||
164460861|NCT06190691|594059705|FG003|Overall Study|Adverse Event|0|||
164460862|NCT05453773|594059706|FG000|Overall Study|Withdrawal by Subject|3|||
164460863|NCT05453773|594059706|FG000|Overall Study|Lost to Follow-up|3|||
164460864|NCT05453773|594059706|FG000|Overall Study|Difficult Blood Draw|3|||
164460865|NCT02485938|594059709|FG000|Overall Study|Withdrawal of consent|2|||
164460866|NCT02485938|594059710|FG001|Overall Study|Withdrawal of consent|0|||
164460867|NCT04633122|594059711|FG000|Overall Study|Remained on treatment|19|||
164460868|NCT04633122|594059712|FG001|Overall Study|Remained on treatment|14|||
164460869|NCT04633122|594059711|FG000|Overall Study|Survival follow-up stopped|22|||
164707698|NCT03954834|594955314|FG002|Overall Study|Death|0|||
164707699|NCT03954834|594955315|FG003|Overall Study|Death|1|||
164707700|NCT03954834|594955312|FG000|Overall Study|Physician Decision|0|||
164707701|NCT03954834|594955313|FG001|Overall Study|Physician Decision|1|||
164460870|NCT04633122|594059712|FG001|Overall Study|Survival follow-up stopped|25|||
164460871|NCT03839940|594059713|FG000|Overall Study|Withdrawal by Subject|3|||
164460872|NCT03839940|594059714|FG001|Overall Study|Withdrawal by Subject|0|||
164460873|NCT03839940|594059713|FG000|Overall Study|Protocol Violation|0|||
164460874|NCT03839940|594059714|FG001|Overall Study|Protocol Violation|1|||
164460875|NCT03839940|594059713|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
164460876|NCT03839940|594059714|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
164460877|NCT03241745|594059715|FG000|Overall Study|Adverse Event|7|||
164460878|NCT03241745|594059715|FG000|Overall Study|Death|1|||
164460879|NCT03241745|594059715|FG000|Overall Study|Withdrawal by Subject|5|||
164460880|NCT03241745|594059715|FG000|Overall Study|Treatment delay >28 days|2|||
164460881|NCT03241745|594059715|FG000|Overall Study|Lack of Efficacy|14|||
164460882|NCT00470704|594059716|FG000|Overall Study|Withdrawal by Subject|4|||
164707702|NCT03954834|594955314|FG002|Overall Study|Physician Decision|0|||
164707703|NCT03954834|594955315|FG003|Overall Study|Physician Decision|2|||
164460883|NCT00470704|594059717|FG001|Overall Study|Withdrawal by Subject|3|||
164460884|NCT00470704|594059716|FG000|Overall Study|Relapse/Progression|37|||
164460885|NCT00470704|594059717|FG001|Overall Study|Relapse/Progression|42|||
164460886|NCT00470704|594059716|FG000|Overall Study|toxicity|0|||
164460887|NCT00470704|594059717|FG001|Overall Study|toxicity|1|||
164460888|NCT02561247|594059718|FG000|Overall Study|Protocol Violation|1|||
164460889|NCT02561247|594059718|FG000|Overall Study|Withdrawal by Subject|1|||
164460890|NCT02561247|594059718|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
164460891|NCT04963270|594059719|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
164460892|NCT04963270|594059720|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
164460893|NCT04963270|594059721|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
164460894|NCT04963270|594059722|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
164460895|NCT04963270|594059719|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
164460896|NCT04963270|594059720|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
164460897|NCT04963270|594059721|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
164460898|NCT04963270|594059722|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
164460899|NCT04963270|594059719|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
164460900|NCT04963270|594059720|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
164460901|NCT04963270|594059721|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
164460902|NCT04963270|594059722|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
164460903|NCT04963270|594059719|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
164460904|NCT04963270|594059720|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
164460905|NCT04963270|594059721|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
164460906|NCT04963270|594059722|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
164460907|NCT04963270|594059719|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
164460908|NCT04963270|594059720|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
164460909|NCT04963270|594059721|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
164460910|NCT04963270|594059722|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
164460911|NCT04963270|594059719|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
164460912|NCT04963270|594059720|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
164460913|NCT04963270|594059721|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
164460914|NCT04963270|594059722|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
164460915|NCT04963270|594059719|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
164460916|NCT04963270|594059720|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
164460917|NCT04963270|594059721|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
164460918|NCT04963270|594059722|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
164460919|NCT04963270|594059719|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
164460920|NCT04963270|594059720|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
164460921|NCT04963270|594059721|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
164460922|NCT04963270|594059722|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
164460923|NCT04963270|594059719|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
164460924|NCT04963270|594059720|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
164460925|NCT04963270|594059721|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
164460926|NCT04963270|594059722|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
164460927|NCT04963270|594059719|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
164460928|NCT04963270|594059720|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
164460929|NCT04963270|594059721|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
164460930|NCT04963270|594059722|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
164460931|NCT04963270|594059719|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
164460932|NCT04963270|594059720|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
164460933|NCT04963270|594059721|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
164460934|NCT04963270|594059722|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
164460935|NCT04963270|594059719|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
164460936|NCT04963270|594059720|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
164460937|NCT04963270|594059721|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
164460938|NCT04963270|594059722|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
164460939|NCT04963270|594059719|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
164460940|NCT04963270|594059720|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
164460941|NCT04963270|594059721|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
164460942|NCT04963270|594059722|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
164460943|NCT04963270|594059719|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
164460944|NCT04963270|594059720|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
164460945|NCT04963270|594059721|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
164460946|NCT04963270|594059722|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
164460947|NCT04473222|594059727|FG000|Overall Study|Lost to Follow-up|13|||
164460948|NCT04473222|594059728|FG001|Overall Study|Lost to Follow-up|13|||
164460949|NCT04473222|594059727|FG000|Overall Study|Withdrawal by Subject|0|||
164460950|NCT04473222|594059728|FG001|Overall Study|Withdrawal by Subject|1|||
164460951|NCT04473222|594059727|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
164460952|NCT04473222|594059728|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
164460953|NCT01098812|594059729|FG000|Overall Study|Death|2|||
164460954|NCT01098812|594059730|FG001|Overall Study|Death|0|||
164460955|NCT01098812|594059731|FG002|Overall Study|Death|1|||
164460956|NCT01098812|594059729|FG000|Overall Study|Lost to Follow-up|0|||
164460957|NCT01098812|594059730|FG001|Overall Study|Lost to Follow-up|1|||
164460958|NCT01098812|594059731|FG002|Overall Study|Lost to Follow-up|0|||
164460959|NCT06424236|594059740|FG000|Overall Study|Adverse Event|0|||
164460960|NCT06424236|594059741|FG001|Overall Study|Adverse Event|1|||
164460961|NCT06424236|594059742|FG002|Overall Study|Adverse Event|0|||
164460962|NCT06424236|594059740|FG000|Overall Study|Withdrawal by Subject|3|||
164460963|NCT06424236|594059741|FG001|Overall Study|Withdrawal by Subject|1|||
164460964|NCT06424236|594059742|FG002|Overall Study|Withdrawal by Subject|2|||
164460965|NCT06424236|594059740|FG000|Overall Study|Physician Decision|0|||
164460966|NCT06424236|594059741|FG001|Overall Study|Physician Decision|1|||
164460967|NCT06424236|594059742|FG002|Overall Study|Physician Decision|0|||
164460968|NCT06424236|594059740|FG000|Overall Study|Study Terminated by Sponsor|11|||
164460969|NCT06424236|594059741|FG001|Overall Study|Study Terminated by Sponsor|20|||
164460970|NCT06424236|594059742|FG002|Overall Study|Study Terminated by Sponsor|16|||
164460971|NCT06424236|594059740|FG000|Overall Study|Lost to Follow-up|0|||
164460972|NCT06424236|594059741|FG001|Overall Study|Lost to Follow-up|1|||
164460973|NCT06424236|594059742|FG002|Overall Study|Lost to Follow-up|0|||
164460974|NCT06424236|594059740|FG000|Overall Study|Disease Progression|0|||
164460975|NCT06424236|594059741|FG001|Overall Study|Disease Progression|1|||
164460976|NCT06424236|594059742|FG002|Overall Study|Disease Progression|2|||
164460977|NCT06424236|594059740|FG000|Overall Study|Other|0|||
164460978|NCT06424236|594059741|FG001|Overall Study|Other|0|||
164460979|NCT06424236|594059742|FG002|Overall Study|Other|1|||
164460980|NCT03339713|594059743|FG000|Overall Study|Lost to Follow-up|2|||
164460981|NCT03339713|594059744|FG001|Overall Study|Lost to Follow-up|1|||
164460982|NCT03339713|594059743|FG000|Overall Study|Protocol Violation|1|||
164460983|NCT03339713|594059744|FG001|Overall Study|Protocol Violation|0|||
164460984|NCT03339713|594059743|FG000|Overall Study|Withdrawal by Subject|1|||
164460985|NCT03339713|594059744|FG001|Overall Study|Withdrawal by Subject|1|||
164460986|NCT01959425|594059745|FG000|Overall Study|Withdrawal by Subject|5|||
164460987|NCT01959425|594059746|FG001|Overall Study|Withdrawal by Subject|4|||
164460988|NCT01959425|594059745|FG000|Overall Study|Lost to Follow-up|1|||
164460989|NCT01959425|594059746|FG001|Overall Study|Lost to Follow-up|0|||
164460990|NCT01959425|594059745|FG000|Overall Study|Discontinued Subjects|6|||
164460991|NCT01959425|594059746|FG001|Overall Study|Discontinued Subjects|4|||
164460992|NCT05540665|594059747|FG000|Overall Study|Study terminated by sponsor|6|||
164460993|NCT05540665|594059748|FG001|Overall Study|Study terminated by sponsor|6|||
164460994|NCT05540665|594059749|FG002|Overall Study|Study terminated by sponsor|7|||
164460995|NCT03462030|594059750|FG000|Overall Study|Withdrawal by Subject|1|||
164460996|NCT03462030|594059751|FG001|Overall Study|Withdrawal by Subject|1|||
164460997|NCT03381196|594059752|FG000|Overall Study|Withdrawal by Subject|7|||
164460998|NCT03381196|594059753|FG001|Overall Study|Withdrawal by Subject|7|||
164460999|NCT03381196|594059752|FG000|Overall Study|Other|0|||
164461000|NCT03381196|594059753|FG001|Overall Study|Other|1|||
164461001|NCT03381196|594059752|FG000|Overall Study|Lost to Follow-up|5|||
164461002|NCT03381196|594059753|FG001|Overall Study|Lost to Follow-up|4|||
164461003|NCT03381196|594059752|FG000|Overall Study|Death|0|||
164461004|NCT03381196|594059753|FG001|Overall Study|Death|1|||
164461005|NCT03381196|594059752|FG000|Overall Study|Adverse Event|1|||
164461006|NCT03381196|594059753|FG001|Overall Study|Adverse Event|0|||
164461007|NCT03381196|594059752|FG000|Overall Study|Randomized, not treated|3|||
164461008|NCT03381196|594059753|FG001|Overall Study|Randomized, not treated|6|||
164461009|NCT00227344|594059754|FG000|Overall Study|study terminated early|12|||
164461010|NCT00227344|594059755|FG001|Overall Study|study terminated early|5|||
164461011|NCT03371381|594059756|FG000|Overall Study|Death|5|||
164461012|NCT03371381|594059756|FG000|Overall Study|Study terminated by sponsor|3|||
164461013|NCT03371381|594059756|FG000|Overall Study|Other|4|||
164461014|NCT03628924|594059762|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
164461015|NCT03628924|594059763|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
164461016|NCT03628924|594059764|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
164461017|NCT03628924|594059765|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
164461018|NCT03628924|594059766|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
164461019|NCT03628924|594059767|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
164461020|NCT03628924|594059768|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
164461021|NCT03628924|594059762|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
164461022|NCT03628924|594059763|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
164461023|NCT03628924|594059764|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
164461024|NCT03628924|594059765|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
164707704|NCT03954834|594955312|FG000|Overall Study|Protocol Violation|1|||
164598777|NCT02883049|594554766|FG010|Induction|Identified as VHR at end of Induction|0|||
164598778|NCT02883049|594554767|FG011|Induction|Identified as VHR at end of Induction|0|||
164461025|NCT03628924|594059766|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
164461026|NCT03628924|594059767|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
164461027|NCT03628924|594059768|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
164461028|NCT03628924|594059762|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
164461029|NCT03628924|594059763|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
164461030|NCT03628924|594059764|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
164461031|NCT03628924|594059765|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
164461032|NCT03628924|594059766|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
164461033|NCT03628924|594059767|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
164461034|NCT03628924|594059768|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
164461035|NCT03628924|594059762|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
164461036|NCT03628924|594059763|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
164461037|NCT03628924|594059764|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
164461038|NCT03628924|594059765|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
164461039|NCT03628924|594059766|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
164461040|NCT03628924|594059767|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
164461041|NCT03628924|594059768|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
164461042|NCT03628924|594059762|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
164461043|NCT03628924|594059763|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
164461044|NCT03628924|594059764|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
164461045|NCT03628924|594059765|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
164461046|NCT03628924|594059766|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
164461047|NCT03628924|594059767|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
164461048|NCT03628924|594059768|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
164461049|NCT03628924|594059762|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
164461050|NCT03628924|594059763|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
164461051|NCT03628924|594059764|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
164461052|NCT03628924|594059765|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
164461053|NCT03628924|594059766|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
164461054|NCT03628924|594059767|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
164461055|NCT03628924|594059768|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
164461056|NCT03628924|594059762|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
164461057|NCT03628924|594059763|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
164461058|NCT03628924|594059764|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
164461059|NCT03628924|594059765|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
164461060|NCT03628924|594059766|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
164461061|NCT03628924|594059767|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
164461062|NCT03628924|594059768|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
164461063|NCT03628924|594059762|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
164461064|NCT03628924|594059763|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
164461065|NCT03628924|594059764|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
164461066|NCT03628924|594059765|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
164461067|NCT03628924|594059766|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
164461068|NCT03628924|594059767|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
164461069|NCT03628924|594059768|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
164461070|NCT03628924|594059762|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
164461071|NCT03628924|594059763|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
164461072|NCT03628924|594059764|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
164461073|NCT03628924|594059765|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
164461074|NCT03628924|594059766|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
164461075|NCT03628924|594059767|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
164461076|NCT03628924|594059768|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
164461077|NCT03628924|594059762|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
164461078|NCT03628924|594059763|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
164461079|NCT03628924|594059764|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
164461080|NCT03628924|594059765|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
164598779|NCT02883049|594554768|FG012|Induction|Identified as VHR at end of Induction|0|||
164598780|NCT02883049|594554769|FG013|Induction|Identified as VHR at end of Induction|0|||
164598781|NCT02883049|594554770|FG014|Induction|Identified as VHR at end of Induction|0|||
164598782|NCT02883049|594554771|FG015|Induction|Identified as VHR at end of Induction|0|||
164598783|NCT02883049|594554756|FG000|Induction|Moved to another non-COG institution|3|||
164598784|NCT02883049|594554757|FG001|Induction|Moved to another non-COG institution|0|||
164598785|NCT02883049|594554758|FG002|Induction|Moved to another non-COG institution|0|||
164461081|NCT03628924|594059766|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
164461082|NCT03628924|594059767|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
164461083|NCT03628924|594059768|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
164461084|NCT01073566|594059769|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
164461085|NCT01073566|594059770|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
164461086|NCT05780437|594059773|FG000|Overall Study|Withdrawal by Subject|22|||
164461087|NCT05780437|594059774|FG001|Overall Study|Withdrawal by Subject|16|||
164461088|NCT05783102|594059777|FG000|Overall Study|Lost to Follow-up|1|||
164461089|NCT05783102|594059777|FG000|Overall Study|Withdrawal by Subject|2|||
164461090|NCT06019559|594059778|FG000|Overall Study|Withdrawal by Subject|7|||
164461091|NCT06019559|594059779|FG001|Overall Study|Withdrawal by Subject|6|||
164461092|NCT06019559|594059780|FG002|Overall Study|Withdrawal by Subject|5|||
164461093|NCT06019559|594059778|FG000|Overall Study|Lost to Follow-up|2|||
164461094|NCT06019559|594059779|FG001|Overall Study|Lost to Follow-up|0|||
164461095|NCT06019559|594059780|FG002|Overall Study|Lost to Follow-up|3|||
164461096|NCT05170009|594059782|FG000|Overall Study|Physician Decision|0|||
164461097|NCT05170009|594059783|FG001|Overall Study|Physician Decision|1|||
164461098|NCT04629716|594059784|FG000|Overall Study|Lost to Follow-up|7|||
164461099|NCT04629716|594059785|FG001|Overall Study|Lost to Follow-up|3|||
164461100|NCT00613106|594059787|FG000|Overall Study|Adverse Event|3|||
164461101|NCT00613106|594059788|FG001|Overall Study|Adverse Event|1|||
164461102|NCT00613106|594059787|FG000|Overall Study|Withdrawal by Subject|6|||
164461103|NCT00613106|594059788|FG001|Overall Study|Withdrawal by Subject|3|||
164461104|NCT00613106|594059787|FG000|Overall Study|Lost to Follow-up|7|||
164461105|NCT00613106|594059788|FG001|Overall Study|Lost to Follow-up|2|||
164461106|NCT00613106|594059787|FG000|Overall Study|misc|4|||
164461107|NCT00613106|594059788|FG001|Overall Study|misc|3|||
164461108|NCT03496168|594059795|FG000|Overall Study|Other Reasons|1|||
164461109|NCT03496168|594059795|FG000|Overall Study|Adverse Event|1|||
164461110|NCT05269667|594059796|FG000|Overall Study|Study Terminated by Sponsor|4|||
164461111|NCT03768505|594059798|FG000|Overall Study|sponsor decision|76|||
164461112|NCT03768505|594059798|FG000|Overall Study|Death|35|||
164461113|NCT03768505|594059798|FG000|Overall Study|Other -Various|30|||
164461114|NCT03768505|594059798|FG000|Overall Study|Withdrawal by Subject|22|||
164461115|NCT03768505|594059798|FG000|Overall Study|Lost to Follow-up|6|||
164461116|NCT02815566|594059803|FG000|Overall Study|Adverse Event|1|||
164461117|NCT02815566|594059804|FG001|Overall Study|Adverse Event|1|||
164461118|NCT02815566|594059803|FG000|Overall Study|Withdrawal by Subject|1|||
164461119|NCT02815566|594059804|FG001|Overall Study|Withdrawal by Subject|0|||
164461120|NCT02815566|594059803|FG000|Overall Study|Lost to Follow-up|0|||
164461121|NCT02815566|594059804|FG001|Overall Study|Lost to Follow-up|1|||
164461122|NCT02993159|594059805|FG000|Overall Study|Withdrawal by Subject|1|||
164461123|NCT02993159|594059806|FG001|Overall Study|Withdrawal by Subject|3|||
164461124|NCT02993159|594059805|FG000|Overall Study|Protocol Violation|1|||
164461125|NCT02993159|594059806|FG001|Overall Study|Protocol Violation|0|||
164461126|NCT02993159|594059805|FG000|Overall Study|Opted out of surgery|2|||
164461127|NCT02993159|594059806|FG001|Overall Study|Opted out of surgery|0|||
164461128|NCT02993159|594059805|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
164461129|NCT02993159|594059806|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
164461130|NCT02993159|594059805|FG000|Overall Study|Physician Decision|0|||
164461131|NCT02993159|594059806|FG001|Overall Study|Physician Decision|1|||
164461132|NCT02231164|594059807|FG000|Overall Study|Adverse Event|1|||
164461133|NCT02231164|594059808|FG001|Overall Study|Adverse Event|1|||
164461134|NCT02231164|594059807|FG000|Overall Study|Lack of Efficacy|4|||
164461135|NCT02231164|594059808|FG001|Overall Study|Lack of Efficacy|3|||
164461136|NCT02231164|594059807|FG000|Overall Study|Withdrawal by Subject|1|||
164461137|NCT02231164|594059808|FG001|Overall Study|Withdrawal by Subject|2|||
164598786|NCT02883049|594554759|FG003|Induction|Moved to another non-COG institution|0|||
164598787|NCT02883049|594554760|FG004|Induction|Moved to another non-COG institution|0|||
164598788|NCT02883049|594554761|FG005|Induction|Moved to another non-COG institution|0|||
164598789|NCT02883049|594554762|FG006|Induction|Moved to another non-COG institution|0|||
164598790|NCT02883049|594554763|FG007|Induction|Moved to another non-COG institution|0|||
164598791|NCT02883049|594554764|FG008|Induction|Moved to another non-COG institution|0|||
164598792|NCT02883049|594554765|FG009|Induction|Moved to another non-COG institution|0|||
164598793|NCT02883049|594554766|FG010|Induction|Moved to another non-COG institution|0|||
164707705|NCT03954834|594955313|FG001|Overall Study|Protocol Violation|0|||
164461138|NCT04313972|594059815|FG000|Overall Study|Withdrawal by Subject|0|||
164461139|NCT04313972|594059816|FG001|Overall Study|Withdrawal by Subject|1|||
164461140|NCT05201079|594059830|FG000|Overall Study|Adverse Event|7|||
164461141|NCT05201079|594059831|FG001|Overall Study|Adverse Event|11|||
164461142|NCT05201079|594059830|FG000|Overall Study|Death|1|||
164461143|NCT05201079|594059831|FG001|Overall Study|Death|1|||
164461144|NCT05201079|594059830|FG000|Overall Study|Lack of Efficacy|0|||
164461145|NCT05201079|594059831|FG001|Overall Study|Lack of Efficacy|2|||
164461146|NCT05201079|594059830|FG000|Overall Study|Lost to Follow-up|0|||
164461147|NCT05201079|594059831|FG001|Overall Study|Lost to Follow-up|1|||
164598794|NCT02883049|594554767|FG011|Induction|Moved to another non-COG institution|0|||
164461148|NCT05201079|594059830|FG000|Overall Study|Physician Decision|1|||
164461149|NCT05201079|594059831|FG001|Overall Study|Physician Decision|1|||
164461150|NCT05201079|594059830|FG000|Overall Study|Protocol Violation|1|||
164461151|NCT05201079|594059831|FG001|Overall Study|Protocol Violation|0|||
164461152|NCT05201079|594059830|FG000|Overall Study|Withdrawal by Subject|1|||
164461153|NCT05201079|594059831|FG001|Overall Study|Withdrawal by Subject|0|||
164461154|NCT05201079|594059830|FG000|Overall Study|Forbidden medication|9|||
164461155|NCT05201079|594059831|FG001|Overall Study|Forbidden medication|5|||
164461156|NCT05201079|594059830|FG000|Overall Study|Transfer to another hospital|0|||
164461157|NCT05201079|594059831|FG001|Overall Study|Transfer to another hospital|1|||
164461158|NCT05201079|594059830|FG000|Overall Study|Clinical condition|1|||
164461159|NCT05201079|594059831|FG001|Overall Study|Clinical condition|0|||
164461160|NCT05201079|594059830|FG000|Overall Study|SAE and sepsis|1|||
164461161|NCT05201079|594059831|FG001|Overall Study|SAE and sepsis|0|||
164461162|NCT04719832|594059840|FG000|Overall Study|Adverse Event|2|||
164461163|NCT04719832|594059841|FG001|Overall Study|Adverse Event|0|||
164461164|NCT04719832|594059840|FG000|Overall Study|Lack of Efficacy|2|||
164461165|NCT04719832|594059841|FG001|Overall Study|Lack of Efficacy|4|||
164461166|NCT04719832|594059840|FG000|Overall Study|Lost to Follow-up|0|||
164461167|NCT04719832|594059841|FG001|Overall Study|Lost to Follow-up|2|||
164461168|NCT04719832|594059840|FG000|Overall Study|Physician Decision|0|||
164461169|NCT04719832|594059841|FG001|Overall Study|Physician Decision|1|||
164461170|NCT04719832|594059840|FG000|Overall Study|Pregnancy|1|||
164461171|NCT04719832|594059841|FG001|Overall Study|Pregnancy|1|||
164461172|NCT04719832|594059840|FG000|Overall Study|Withdrawal by Subject|5|||
164461173|NCT04719832|594059841|FG001|Overall Study|Withdrawal by Subject|5|||
164461174|NCT04719832|594059840|FG000|Overall Study|Randomized, not treated|0|||
164461175|NCT04719832|594059841|FG001|Overall Study|Randomized, not treated|2|||
164461176|NCT04719832|594059840|FG000|Overall Study|GCP violations|4|||
164461177|NCT04719832|594059841|FG001|Overall Study|GCP violations|7|||
164461178|NCT03058289|594059842|FG000|Overall Study|Radiographic Deterioration|0|||
164461179|NCT03058289|594059843|FG001|Overall Study|Radiographic Deterioration|3|||
164461180|NCT03058289|594059844|FG002|Overall Study|Radiographic Deterioration|1|||
164461181|NCT03058289|594059845|FG003|Overall Study|Radiographic Deterioration|2|||
164461182|NCT03058289|594059846|FG004|Overall Study|Radiographic Deterioration|6|||
164461183|NCT03058289|594059847|FG005|Overall Study|Radiographic Deterioration|3|||
164461184|NCT03058289|594059848|FG006|Overall Study|Radiographic Deterioration|0|||
164461185|NCT03058289|594059849|FG007|Overall Study|Radiographic Deterioration|4|||
164461186|NCT03058289|594059850|FG008|Overall Study|Radiographic Deterioration|2|||
164461187|NCT03058289|594059842|FG000|Overall Study|Adverse Event|2|||
164461188|NCT03058289|594059843|FG001|Overall Study|Adverse Event|0|||
164461189|NCT03058289|594059844|FG002|Overall Study|Adverse Event|1|||
164461190|NCT03058289|594059845|FG003|Overall Study|Adverse Event|3|||
164461191|NCT03058289|594059846|FG004|Overall Study|Adverse Event|1|||
164461192|NCT03058289|594059847|FG005|Overall Study|Adverse Event|0|||
164461193|NCT03058289|594059848|FG006|Overall Study|Adverse Event|1|||
164461194|NCT03058289|594059849|FG007|Overall Study|Adverse Event|3|||
164461195|NCT03058289|594059850|FG008|Overall Study|Adverse Event|0|||
164461196|NCT03058289|594059842|FG000|Overall Study|Withdrawal by Subject|0|||
164461197|NCT03058289|594059843|FG001|Overall Study|Withdrawal by Subject|0|||
164461198|NCT03058289|594059844|FG002|Overall Study|Withdrawal by Subject|0|||
164461199|NCT03058289|594059845|FG003|Overall Study|Withdrawal by Subject|2|||
164461200|NCT03058289|594059846|FG004|Overall Study|Withdrawal by Subject|0|||
164461201|NCT03058289|594059847|FG005|Overall Study|Withdrawal by Subject|2|||
164461202|NCT03058289|594059848|FG006|Overall Study|Withdrawal by Subject|0|||
164461203|NCT03058289|594059849|FG007|Overall Study|Withdrawal by Subject|4|||
164461204|NCT03058289|594059850|FG008|Overall Study|Withdrawal by Subject|1|||
164461205|NCT03058289|594059842|FG000|Overall Study|Physician Decision|1|||
164461206|NCT03058289|594059843|FG001|Overall Study|Physician Decision|0|||
164461207|NCT03058289|594059844|FG002|Overall Study|Physician Decision|0|||
164461208|NCT03058289|594059845|FG003|Overall Study|Physician Decision|2|||
164461209|NCT03058289|594059846|FG004|Overall Study|Physician Decision|1|||
164461210|NCT03058289|594059847|FG005|Overall Study|Physician Decision|0|||
164461211|NCT03058289|594059848|FG006|Overall Study|Physician Decision|2|||
164707706|NCT03954834|594955314|FG002|Overall Study|Protocol Violation|0|||
164707707|NCT03954834|594955315|FG003|Overall Study|Protocol Violation|1|||
164461212|NCT03058289|594059849|FG007|Overall Study|Physician Decision|3|||
164461213|NCT03058289|594059850|FG008|Overall Study|Physician Decision|0|||
164461214|NCT03058289|594059842|FG000|Overall Study|Clinical Deterioration|2|||
164461215|NCT03058289|594059843|FG001|Overall Study|Clinical Deterioration|0|||
164461216|NCT03058289|594059844|FG002|Overall Study|Clinical Deterioration|0|||
164461217|NCT03058289|594059845|FG003|Overall Study|Clinical Deterioration|2|||
164461218|NCT03058289|594059846|FG004|Overall Study|Clinical Deterioration|1|||
164461219|NCT03058289|594059847|FG005|Overall Study|Clinical Deterioration|1|||
164461220|NCT03058289|594059848|FG006|Overall Study|Clinical Deterioration|0|||
164461221|NCT03058289|594059849|FG007|Overall Study|Clinical Deterioration|3|||
164461222|NCT03058289|594059850|FG008|Overall Study|Clinical Deterioration|2|||
164461223|NCT03058289|594059842|FG000|Overall Study|Lost to Follow-up|0|||
164461224|NCT03058289|594059843|FG001|Overall Study|Lost to Follow-up|0|||
164461225|NCT03058289|594059844|FG002|Overall Study|Lost to Follow-up|0|||
164461226|NCT03058289|594059845|FG003|Overall Study|Lost to Follow-up|0|||
164461227|NCT03058289|594059846|FG004|Overall Study|Lost to Follow-up|1|||
164461228|NCT03058289|594059847|FG005|Overall Study|Lost to Follow-up|0|||
164461229|NCT03058289|594059848|FG006|Overall Study|Lost to Follow-up|0|||
164461230|NCT03058289|594059849|FG007|Overall Study|Lost to Follow-up|0|||
164461231|NCT03058289|594059850|FG008|Overall Study|Lost to Follow-up|0|||
164461232|NCT03058289|594059842|FG000|Overall Study|Refused Further Treatment|0|||
164461233|NCT03058289|594059843|FG001|Overall Study|Refused Further Treatment|0|||
164461234|NCT03058289|594059844|FG002|Overall Study|Refused Further Treatment|1|||
164461235|NCT03058289|594059845|FG003|Overall Study|Refused Further Treatment|0|||
164461236|NCT03058289|594059846|FG004|Overall Study|Refused Further Treatment|1|||
164461237|NCT03058289|594059847|FG005|Overall Study|Refused Further Treatment|0|||
164461238|NCT03058289|594059848|FG006|Overall Study|Refused Further Treatment|0|||
164461239|NCT03058289|594059849|FG007|Overall Study|Refused Further Treatment|0|||
164461240|NCT03058289|594059850|FG008|Overall Study|Refused Further Treatment|0|||
164461241|NCT03058289|594059842|FG000|Overall Study|Rapid Progression of Disease|0|||
164461242|NCT03058289|594059843|FG001|Overall Study|Rapid Progression of Disease|0|||
164461243|NCT03058289|594059844|FG002|Overall Study|Rapid Progression of Disease|0|||
164461244|NCT03058289|594059845|FG003|Overall Study|Rapid Progression of Disease|1|||
164461245|NCT03058289|594059846|FG004|Overall Study|Rapid Progression of Disease|0|||
164461246|NCT03058289|594059847|FG005|Overall Study|Rapid Progression of Disease|0|||
164461247|NCT03058289|594059848|FG006|Overall Study|Rapid Progression of Disease|0|||
164461248|NCT03058289|594059849|FG007|Overall Study|Rapid Progression of Disease|0|||
164461249|NCT03058289|594059850|FG008|Overall Study|Rapid Progression of Disease|0|||
164461250|NCT03085810|594059851|FG000|Main Study|Withdrawal by Subject|77|||
164461251|NCT03085810|594059852|FG001|Main Study|Withdrawal by Subject|0|||
164461252|NCT03085810|594059853|FG002|Main Study|Withdrawal by Subject|0|||
164461253|NCT03085810|594059851|FG000|Main Study|Terminated By Sponsor|14|||
164461254|NCT03085810|594059852|FG001|Main Study|Terminated By Sponsor|0|||
164461255|NCT03085810|594059853|FG002|Main Study|Terminated By Sponsor|0|||
164461256|NCT03085810|594059851|FG000|Main Study|Protocol Violation|15|||
164461257|NCT03085810|594059852|FG001|Main Study|Protocol Violation|0|||
164461258|NCT03085810|594059853|FG002|Main Study|Protocol Violation|0|||
164461259|NCT03085810|594059851|FG000|Main Study|Physician Decision|13|||
164461260|NCT03085810|594059852|FG001|Main Study|Physician Decision|0|||
164461261|NCT03085810|594059853|FG002|Main Study|Physician Decision|0|||
164461262|NCT03085810|594059851|FG000|Main Study|Lost to Follow-up|17|||
164461263|NCT03085810|594059852|FG001|Main Study|Lost to Follow-up|0|||
164461264|NCT03085810|594059853|FG002|Main Study|Lost to Follow-up|0|||
164461265|NCT03085810|594059851|FG000|Main Study|Adverse Event|25|||
164461266|NCT03085810|594059852|FG001|Main Study|Adverse Event|0|||
164461267|NCT03085810|594059853|FG002|Main Study|Adverse Event|0|||
164461268|NCT03085810|594059851|FG000|Main Study|Pregnancy|7|||
164461269|NCT03085810|594059852|FG001|Main Study|Pregnancy|0|||
164461270|NCT03085810|594059853|FG002|Main Study|Pregnancy|0|||
164461271|NCT03085810|594059851|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
164461272|NCT03085810|594059852|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
164461273|NCT03085810|594059853|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
164461274|NCT03085810|594059851|FG000|Main Study|Lack of Efficacy|10|||
164461275|NCT03085810|594059852|FG001|Main Study|Lack of Efficacy|0|||
164461276|NCT03085810|594059853|FG002|Main Study|Lack of Efficacy|0|||
164461277|NCT03085810|594059851|FG000|Main Study|Death|12|||
164461278|NCT03085810|594059852|FG001|Main Study|Death|0|||
164461279|NCT03085810|594059853|FG002|Main Study|Death|0|||
164461280|NCT03085810|594059851|FG000|Main Study|Disease progression|1|||
164461281|NCT03085810|594059852|FG001|Main Study|Disease progression|0|||
164461282|NCT03085810|594059853|FG002|Main Study|Disease progression|0|||
164461283|NCT03085810|594059851|FG000|Main Study|Site Closure|3|||
164461284|NCT03085810|594059852|FG001|Main Study|Site Closure|0|||
164461285|NCT03085810|594059853|FG002|Main Study|Site Closure|0|||
164461286|NCT03085810|594059851|FG000|Main Study|Planned pregnancy|17|||
164461287|NCT03085810|594059852|FG001|Main Study|Planned pregnancy|0|||
164461288|NCT03085810|594059853|FG002|Main Study|Planned pregnancy|0|||
164461289|NCT03085810|594059851|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
164461290|NCT03085810|594059852|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
164461291|NCT03085810|594059853|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
164461292|NCT03085810|594059851|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
164461293|NCT03085810|594059852|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
164461294|NCT03085810|594059853|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
164461295|NCT03085810|594059851|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
164461296|NCT03085810|594059852|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
164461297|NCT03085810|594059853|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
164461298|NCT03085810|594059851|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
164461299|NCT03085810|594059852|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
164461300|NCT03085810|594059853|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
164461301|NCT02601313|594059854|FG000|Overall Study|Death|2|||
164461302|NCT02601313|594059855|FG001|Overall Study|Death|41|||
164461303|NCT02601313|594059856|FG002|Overall Study|Death|6|||
164461304|NCT02601313|594059854|FG000|Overall Study|Enrolled but never treated|0|||
164461305|NCT02601313|594059855|FG001|Overall Study|Enrolled but never treated|6|||
164461306|NCT02601313|594059856|FG002|Overall Study|Enrolled but never treated|3|||
164461307|NCT02601313|594059854|FG000|Overall Study|Enrolled, did not initiate AC|4|||
164461308|NCT02601313|594059855|FG001|Overall Study|Enrolled, did not initiate AC|0|||
164461309|NCT02601313|594059856|FG002|Overall Study|Enrolled, did not initiate AC|0|||
164461310|NCT02601313|594059854|FG000|Overall Study|Full consent withdrawal|0|||
164461311|NCT02601313|594059855|FG001|Overall Study|Full consent withdrawal|3|||
164461312|NCT02601313|594059856|FG002|Overall Study|Full consent withdrawal|2|||
164461313|NCT02601313|594059854|FG000|Overall Study|Lost to Follow-up|0|||
164461314|NCT02601313|594059855|FG001|Overall Study|Lost to Follow-up|1|||
164461315|NCT02601313|594059856|FG002|Overall Study|Lost to Follow-up|1|||
164461316|NCT05239455|594059858|FG000|Overall Study|Adverse Event|1|||
164461317|NCT05239455|594059858|FG000|Overall Study|Sponsor Decision|5|||
164461318|NCT05239455|594059858|FG000|Overall Study|Incomplete Blood Collection|1|||
164461319|NCT03701763|594059859|FG000|Placebo-controlled Phase|Adverse Event|1|||
164461320|NCT03701763|594059860|FG001|Placebo-controlled Phase|Adverse Event|5|||
164461321|NCT03701763|594059861|FG002|Placebo-controlled Phase|Adverse Event|0|||
164461322|NCT03701763|594059862|FG003|Placebo-controlled Phase|Adverse Event|0|||
164461323|NCT03701763|594059859|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
164461324|NCT03701763|594059860|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
164461325|NCT03701763|594059861|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
164461326|NCT03701763|594059862|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
164461327|NCT03701763|594059859|FG000|Placebo-controlled Phase|Miscellaneous|2|||
164461328|NCT03701763|594059860|FG001|Placebo-controlled Phase|Miscellaneous|0|||
164461329|NCT03701763|594059861|FG002|Placebo-controlled Phase|Miscellaneous|0|||
164461330|NCT03701763|594059862|FG003|Placebo-controlled Phase|Miscellaneous|0|||
164461331|NCT03701763|594059859|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
164461332|NCT03701763|594059860|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
164461333|NCT03701763|594059861|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
164461334|NCT03701763|594059862|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
164461335|NCT03701763|594059859|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
164461336|NCT03701763|594059860|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
164461337|NCT03701763|594059861|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
164461338|NCT03701763|594059862|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
164461339|NCT03701763|594059859|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
164461340|NCT03701763|594059860|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
164461341|NCT03701763|594059861|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
164461342|NCT03701763|594059862|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
164461343|NCT03701763|594059859|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
164461344|NCT03701763|594059860|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
164461345|NCT03701763|594059861|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
164461346|NCT03701763|594059862|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
164461347|NCT03701763|594059859|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
164461348|NCT03701763|594059860|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
164461349|NCT03701763|594059861|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
164461350|NCT03701763|594059862|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
164461351|NCT03701763|594059859|FG000|Apremilast Extension Phase|Adverse Event|0|||
164461352|NCT03701763|594059860|FG001|Apremilast Extension Phase|Adverse Event|0|||
164461353|NCT03701763|594059861|FG002|Apremilast Extension Phase|Adverse Event|3|||
164461354|NCT03701763|594059862|FG003|Apremilast Extension Phase|Adverse Event|1|||
164461355|NCT03701763|594059859|FG000|Apremilast Extension Phase|Miscellaneous|0|||
164461356|NCT03701763|594059860|FG001|Apremilast Extension Phase|Miscellaneous|0|||
164461357|NCT03701763|594059861|FG002|Apremilast Extension Phase|Miscellaneous|2|||
164461358|NCT03701763|594059862|FG003|Apremilast Extension Phase|Miscellaneous|1|||
164461359|NCT03701763|594059859|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
164461360|NCT03701763|594059860|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
164461361|NCT03701763|594059861|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
164461362|NCT03701763|594059862|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
164461363|NCT03701763|594059859|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
164461364|NCT03701763|594059860|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
164461365|NCT03701763|594059861|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
164461366|NCT03701763|594059862|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
164461367|NCT03701763|594059859|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
164461368|NCT03701763|594059860|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
164461369|NCT03701763|594059861|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
164461370|NCT03701763|594059862|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
164461371|NCT03701763|594059859|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
164461372|NCT03701763|594059860|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
164461373|NCT03701763|594059861|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
164461374|NCT03701763|594059862|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
164461375|NCT03701763|594059859|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
164461376|NCT03701763|594059860|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
164461377|NCT03701763|594059861|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
164461378|NCT03701763|594059862|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
164461379|NCT03701763|594059859|FG000|14-Week Observational Follow-up Phase|Other|0|||
164461380|NCT03701763|594059860|FG001|14-Week Observational Follow-up Phase|Other|0|||
164461381|NCT03701763|594059861|FG002|14-Week Observational Follow-up Phase|Other|1|||
164461382|NCT03701763|594059862|FG003|14-Week Observational Follow-up Phase|Other|0|||
164461383|NCT03701763|594059859|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
164461384|NCT03701763|594059860|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
164461385|NCT03701763|594059861|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
164461386|NCT03701763|594059862|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
164461387|NCT03701763|594059859|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
164461388|NCT03701763|594059860|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
164461389|NCT03701763|594059861|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
164461390|NCT03701763|594059862|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
164461391|NCT05623228|594059863|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
164461392|NCT05623228|594059864|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
164461393|NCT05623228|594059865|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
164461394|NCT05623228|594059866|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
164461395|NCT05623228|594059867|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
164461396|NCT05623228|594059868|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
164461397|NCT05623228|594059869|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
164461398|NCT05623228|594059870|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
164461399|NCT05623228|594059863|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
164461400|NCT05623228|594059864|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
164461401|NCT05623228|594059865|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
164461402|NCT05623228|594059866|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
164461403|NCT05623228|594059867|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
164461404|NCT05623228|594059868|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
164461405|NCT05623228|594059869|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
164461406|NCT05623228|594059870|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
164461407|NCT06516705|594062329|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
164461408|NCT06516705|594062330|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
164461409|NCT06516705|594062329|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
164461410|NCT06516705|594062330|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
164461411|NCT06516705|594062329|FG000|T3 ( 3 Month After Education)|covid-19|1|||
164461412|NCT06516705|594062330|FG001|T3 ( 3 Month After Education)|covid-19|2|||
164461413|NCT06516705|594062329|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
164461414|NCT06516705|594062330|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
164461415|NCT06516705|594062329|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
164461416|NCT06516705|594062330|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
164461417|NCT06516705|594062329|FG000|T4 ( 6 Month After Education)|covid-19|3|||
164461418|NCT06516705|594062330|FG001|T4 ( 6 Month After Education)|covid-19|2|||
164461419|NCT06516705|594062329|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
164461420|NCT06516705|594062330|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
164461421|NCT04802967|594062332|FG000|Part B|Withdrawal by Subject|0|||
164461422|NCT04802967|594062333|FG001|Part B|Withdrawal by Subject|0|||
164461423|NCT04802967|594062334|FG002|Part B|Withdrawal by Subject|0|||
164461424|NCT04802967|594062335|FG003|Part B|Withdrawal by Subject|0|||
164461425|NCT04802967|594062336|FG004|Part B|Withdrawal by Subject|0|||
164461426|NCT04802967|594062337|FG005|Part B|Withdrawal by Subject|1|||
164461427|NCT04802967|594062338|FG006|Part B|Withdrawal by Subject|0|||
164461428|NCT04802967|594062339|FG007|Part B|Withdrawal by Subject|0|||
164461429|NCT04802967|594062340|FG008|Part B|Withdrawal by Subject|0|||
164707708|NCT03954834|594955312|FG000|Overall Study|Withdrawal by Subject|2|||
164707709|NCT03954834|594955313|FG001|Overall Study|Withdrawal by Subject|3|||
164707710|NCT03954834|594955314|FG002|Overall Study|Withdrawal by Subject|13|||
164707711|NCT03954834|594955315|FG003|Overall Study|Withdrawal by Subject|6|||
164461430|NCT04802967|594062341|FG009|Part B|Withdrawal by Subject|0|||
164707712|NCT03954834|594955312|FG000|Overall Study|Participant left the country|0|||
164707713|NCT03954834|594955313|FG001|Overall Study|Participant left the country|0|||
164461431|NCT03560609|594062345|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
164461432|NCT03560609|594062346|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
164461433|NCT03544281|594062351|FG000|Main Study Phase|Death|3|||
164461434|NCT03544281|594062352|FG001|Main Study Phase|Death|2|||
164461435|NCT03544281|594062353|FG002|Main Study Phase|Death|6|||
164461436|NCT03544281|594062354|FG003|Main Study Phase|Death|8|||
164461437|NCT03544281|594062355|FG004|Main Study Phase|Death|4|||
164461438|NCT03544281|594062356|FG005|Main Study Phase|Death|2|||
164461439|NCT03544281|594062357|FG006|Main Study Phase|Death|4|||
164461440|NCT03544281|594062358|FG007|Main Study Phase|Death|5|||
164461441|NCT03544281|594062359|FG008|Main Study Phase|Death|5|||
164461442|NCT03544281|594062360|FG009|Main Study Phase|Death|8|||
164461443|NCT03544281|594062361|FG010|Main Study Phase|Death|6|||
164461444|NCT03544281|594062362|FG011|Main Study Phase|Death|4|||
164461445|NCT03544281|594062363|FG012|Main Study Phase|Death|0|||
164461446|NCT03544281|594062364|FG013|Main Study Phase|Death|0|||
164461447|NCT03544281|594062365|FG014|Main Study Phase|Death|0|||
164461448|NCT03544281|594062366|FG015|Main Study Phase|Death|0|||
164461449|NCT03544281|594062367|FG016|Main Study Phase|Death|0|||
164461450|NCT03544281|594062368|FG017|Main Study Phase|Death|0|||
164461451|NCT03544281|594062369|FG018|Main Study Phase|Death|0|||
164461452|NCT03544281|594062370|FG019|Main Study Phase|Death|0|||
164461453|NCT03544281|594062371|FG020|Main Study Phase|Death|0|||
164461454|NCT03544281|594062372|FG021|Main Study Phase|Death|0|||
164461455|NCT03544281|594062351|FG000|Main Study Phase|Lost to Follow-up|0|||
164461456|NCT03544281|594062352|FG001|Main Study Phase|Lost to Follow-up|0|||
164461457|NCT03544281|594062353|FG002|Main Study Phase|Lost to Follow-up|0|||
164461458|NCT03544281|594062354|FG003|Main Study Phase|Lost to Follow-up|0|||
164461459|NCT03544281|594062355|FG004|Main Study Phase|Lost to Follow-up|0|||
164461460|NCT03544281|594062356|FG005|Main Study Phase|Lost to Follow-up|0|||
164461461|NCT03544281|594062357|FG006|Main Study Phase|Lost to Follow-up|0|||
164461462|NCT03544281|594062358|FG007|Main Study Phase|Lost to Follow-up|0|||
164461463|NCT03544281|594062359|FG008|Main Study Phase|Lost to Follow-up|0|||
164461464|NCT03544281|594062360|FG009|Main Study Phase|Lost to Follow-up|0|||
164461465|NCT03544281|594062361|FG010|Main Study Phase|Lost to Follow-up|1|||
164461466|NCT03544281|594062362|FG011|Main Study Phase|Lost to Follow-up|0|||
164461467|NCT03544281|594062363|FG012|Main Study Phase|Lost to Follow-up|0|||
164461468|NCT03544281|594062364|FG013|Main Study Phase|Lost to Follow-up|0|||
164461469|NCT03544281|594062365|FG014|Main Study Phase|Lost to Follow-up|0|||
164461470|NCT03544281|594062366|FG015|Main Study Phase|Lost to Follow-up|0|||
164461471|NCT03544281|594062367|FG016|Main Study Phase|Lost to Follow-up|0|||
164461472|NCT03544281|594062368|FG017|Main Study Phase|Lost to Follow-up|0|||
164461473|NCT03544281|594062369|FG018|Main Study Phase|Lost to Follow-up|0|||
164461474|NCT03544281|594062370|FG019|Main Study Phase|Lost to Follow-up|0|||
164461475|NCT03544281|594062371|FG020|Main Study Phase|Lost to Follow-up|0|||
164461476|NCT03544281|594062372|FG021|Main Study Phase|Lost to Follow-up|0|||
164461477|NCT03544281|594062351|FG000|Main Study Phase|Physician Decision|0|||
164461478|NCT03544281|594062352|FG001|Main Study Phase|Physician Decision|0|||
164461479|NCT03544281|594062353|FG002|Main Study Phase|Physician Decision|0|||
164461480|NCT03544281|594062354|FG003|Main Study Phase|Physician Decision|0|||
164461481|NCT03544281|594062355|FG004|Main Study Phase|Physician Decision|0|||
164461482|NCT03544281|594062356|FG005|Main Study Phase|Physician Decision|0|||
164461483|NCT03544281|594062357|FG006|Main Study Phase|Physician Decision|0|||
164461484|NCT03544281|594062358|FG007|Main Study Phase|Physician Decision|1|||
164461485|NCT03544281|594062359|FG008|Main Study Phase|Physician Decision|0|||
164461486|NCT03544281|594062360|FG009|Main Study Phase|Physician Decision|0|||
164461487|NCT03544281|594062361|FG010|Main Study Phase|Physician Decision|0|||
164461488|NCT03544281|594062362|FG011|Main Study Phase|Physician Decision|0|||
164461489|NCT03544281|594062363|FG012|Main Study Phase|Physician Decision|0|||
164461490|NCT03544281|594062364|FG013|Main Study Phase|Physician Decision|0|||
164461491|NCT03544281|594062365|FG014|Main Study Phase|Physician Decision|0|||
164461492|NCT03544281|594062366|FG015|Main Study Phase|Physician Decision|0|||
164461493|NCT03544281|594062367|FG016|Main Study Phase|Physician Decision|0|||
164461494|NCT03544281|594062368|FG017|Main Study Phase|Physician Decision|0|||
164461495|NCT03544281|594062369|FG018|Main Study Phase|Physician Decision|0|||
164461496|NCT03544281|594062370|FG019|Main Study Phase|Physician Decision|0|||
164461497|NCT03544281|594062371|FG020|Main Study Phase|Physician Decision|0|||
164461498|NCT03544281|594062372|FG021|Main Study Phase|Physician Decision|0|||
164461499|NCT03544281|594062351|FG000|Main Study Phase|Withdrawal by Subject|2|||
164461500|NCT03544281|594062352|FG001|Main Study Phase|Withdrawal by Subject|0|||
164461501|NCT03544281|594062353|FG002|Main Study Phase|Withdrawal by Subject|1|||
164461502|NCT03544281|594062354|FG003|Main Study Phase|Withdrawal by Subject|2|||
164461503|NCT03544281|594062355|FG004|Main Study Phase|Withdrawal by Subject|0|||
164461504|NCT03544281|594062356|FG005|Main Study Phase|Withdrawal by Subject|0|||
164461505|NCT03544281|594062357|FG006|Main Study Phase|Withdrawal by Subject|0|||
164461506|NCT03544281|594062358|FG007|Main Study Phase|Withdrawal by Subject|0|||
164461507|NCT03544281|594062359|FG008|Main Study Phase|Withdrawal by Subject|2|||
164461508|NCT03544281|594062360|FG009|Main Study Phase|Withdrawal by Subject|3|||
164461509|NCT03544281|594062361|FG010|Main Study Phase|Withdrawal by Subject|0|||
164461510|NCT03544281|594062362|FG011|Main Study Phase|Withdrawal by Subject|4|||
164461511|NCT03544281|594062363|FG012|Main Study Phase|Withdrawal by Subject|0|||
164461512|NCT03544281|594062364|FG013|Main Study Phase|Withdrawal by Subject|0|||
164461513|NCT03544281|594062365|FG014|Main Study Phase|Withdrawal by Subject|0|||
164461514|NCT03544281|594062366|FG015|Main Study Phase|Withdrawal by Subject|0|||
164461515|NCT03544281|594062367|FG016|Main Study Phase|Withdrawal by Subject|0|||
164461516|NCT03544281|594062368|FG017|Main Study Phase|Withdrawal by Subject|0|||
164461517|NCT03544281|594062369|FG018|Main Study Phase|Withdrawal by Subject|0|||
164461518|NCT03544281|594062370|FG019|Main Study Phase|Withdrawal by Subject|0|||
164461519|NCT03544281|594062371|FG020|Main Study Phase|Withdrawal by Subject|0|||
164461520|NCT03544281|594062372|FG021|Main Study Phase|Withdrawal by Subject|0|||
164461521|NCT03544281|594062351|FG000|Main Study Phase|Ongoing|3|||
164461522|NCT03544281|594062352|FG001|Main Study Phase|Ongoing|1|||
164461523|NCT03544281|594062353|FG002|Main Study Phase|Ongoing|2|||
164598795|NCT02883049|594554768|FG012|Induction|Moved to another non-COG institution|0|||
164598796|NCT02883049|594554769|FG013|Induction|Moved to another non-COG institution|0|||
164598797|NCT02883049|594554770|FG014|Induction|Moved to another non-COG institution|0|||
164598798|NCT02883049|594554771|FG015|Induction|Moved to another non-COG institution|0|||
164598799|NCT02883049|594554756|FG000|Induction|Randomization closed|41|||
164598800|NCT02883049|594554757|FG001|Induction|Randomization closed|0|||
164598801|NCT02883049|594554758|FG002|Induction|Randomization closed|0|||
164598802|NCT02883049|594554759|FG003|Induction|Randomization closed|0|||
164598803|NCT02883049|594554760|FG004|Induction|Randomization closed|0|||
164598804|NCT02883049|594554761|FG005|Induction|Randomization closed|0|||
164598805|NCT02883049|594554762|FG006|Induction|Randomization closed|0|||
164598806|NCT02883049|594554763|FG007|Induction|Randomization closed|0|||
164598807|NCT02883049|594554764|FG008|Induction|Randomization closed|0|||
164598808|NCT02883049|594554765|FG009|Induction|Randomization closed|0|||
164598809|NCT02883049|594554766|FG010|Induction|Randomization closed|0|||
164598810|NCT02883049|594554767|FG011|Induction|Randomization closed|0|||
164598811|NCT02883049|594554768|FG012|Induction|Randomization closed|0|||
164598812|NCT02883049|594554769|FG013|Induction|Randomization closed|0|||
164598813|NCT02883049|594554770|FG014|Induction|Randomization closed|0|||
164598814|NCT02883049|594554771|FG015|Induction|Randomization closed|0|||
164598815|NCT02883049|594554756|FG000|Induction|MRD negative|36|||
164598816|NCT02883049|594554757|FG001|Induction|MRD negative|0|||
164598817|NCT02883049|594554758|FG002|Induction|MRD negative|0|||
164598818|NCT02883049|594554759|FG003|Induction|MRD negative|0|||
164598819|NCT02883049|594554760|FG004|Induction|MRD negative|0|||
164598820|NCT02883049|594554761|FG005|Induction|MRD negative|0|||
164598821|NCT02883049|594554762|FG006|Induction|MRD negative|0|||
164598822|NCT02883049|594554763|FG007|Induction|MRD negative|0|||
164598823|NCT02883049|594554764|FG008|Induction|MRD negative|0|||
164598824|NCT02883049|594554765|FG009|Induction|MRD negative|0|||
164598825|NCT02883049|594554766|FG010|Induction|MRD negative|0|||
164598826|NCT02883049|594554767|FG011|Induction|MRD negative|0|||
164598827|NCT02883049|594554768|FG012|Induction|MRD negative|0|||
164598828|NCT02883049|594554769|FG013|Induction|MRD negative|0|||
164598829|NCT02883049|594554770|FG014|Induction|MRD negative|0|||
164598830|NCT02883049|594554771|FG015|Induction|MRD negative|0|||
164598831|NCT02883049|594554756|FG000|Induction|Identified as HR patients|165|||
164598832|NCT02883049|594554757|FG001|Induction|Identified as HR patients|0|||
164598833|NCT02883049|594554758|FG002|Induction|Identified as HR patients|0|||
164598834|NCT02883049|594554759|FG003|Induction|Identified as HR patients|0|||
164598835|NCT02883049|594554760|FG004|Induction|Identified as HR patients|0|||
164598836|NCT02883049|594554761|FG005|Induction|Identified as HR patients|0|||
164598837|NCT02883049|594554762|FG006|Induction|Identified as HR patients|0|||
164598838|NCT02883049|594554763|FG007|Induction|Identified as HR patients|0|||
164598839|NCT02883049|594554764|FG008|Induction|Identified as HR patients|0|||
164598840|NCT02883049|594554765|FG009|Induction|Identified as HR patients|0|||
164598841|NCT02883049|594554766|FG010|Induction|Identified as HR patients|0|||
164598842|NCT02883049|594554767|FG011|Induction|Identified as HR patients|0|||
164598843|NCT02883049|594554768|FG012|Induction|Identified as HR patients|0|||
164598844|NCT02883049|594554769|FG013|Induction|Identified as HR patients|0|||
164598845|NCT02883049|594554770|FG014|Induction|Identified as HR patients|0|||
164598846|NCT02883049|594554771|FG015|Induction|Identified as HR patients|0|||
164598847|NCT02883049|594554756|FG000|Induction|Developed SMN|0|||
164461524|NCT03544281|594062354|FG003|Main Study Phase|Ongoing|4|||
164461525|NCT03544281|594062355|FG004|Main Study Phase|Ongoing|2|||
164461526|NCT03544281|594062356|FG005|Main Study Phase|Ongoing|4|||
164461527|NCT03544281|594062357|FG006|Main Study Phase|Ongoing|4|||
164461528|NCT03544281|594062358|FG007|Main Study Phase|Ongoing|0|||
164598848|NCT02883049|594554757|FG001|Induction|Developed SMN|1|||
164598849|NCT02883049|594554758|FG002|Induction|Developed SMN|0|||
164598850|NCT02883049|594554759|FG003|Induction|Developed SMN|0|||
164461529|NCT03544281|594062359|FG008|Main Study Phase|Ongoing|2|||
164598851|NCT02883049|594554760|FG004|Induction|Developed SMN|0|||
164598852|NCT02883049|594554761|FG005|Induction|Developed SMN|0|||
164598853|NCT02883049|594554762|FG006|Induction|Developed SMN|0|||
164598854|NCT02883049|594554763|FG007|Induction|Developed SMN|0|||
164598855|NCT02883049|594554764|FG008|Induction|Developed SMN|0|||
164598856|NCT02883049|594554765|FG009|Induction|Developed SMN|0|||
164707714|NCT03954834|594955314|FG002|Overall Study|Participant left the country|1|||
164707715|NCT03954834|594955315|FG003|Overall Study|Participant left the country|0|||
164707716|NCT03954834|594955312|FG000|Overall Study|Lost to Follow-up|3|||
164707717|NCT03954834|594955313|FG001|Overall Study|Lost to Follow-up|2|||
164707718|NCT03954834|594955314|FG002|Overall Study|Lost to Follow-up|3|||
164707719|NCT03954834|594955315|FG003|Overall Study|Lost to Follow-up|5|||
164707720|NCT00114166|594955317|FG000|Overall Study|Wrong primary|0|||
164707721|NCT00114166|594955318|FG001|Overall Study|Wrong primary|1|||
164707722|NCT03469336|594955319|FG000|Overall Study|Adverse Event|1|||
164707723|NCT02603393|594955322|FG000|Overall Study|Patient/guardian decision|32|||
164707724|NCT02603393|594955323|FG001|Overall Study|Patient/guardian decision|18|||
164707725|NCT02603393|594955322|FG000|Overall Study|Adverse Event|17|||
164707726|NCT02603393|594955323|FG001|Overall Study|Adverse Event|15|||
164707727|NCT02603393|594955322|FG000|Overall Study|Technical problems|4|||
164707728|NCT02603393|594955323|FG001|Overall Study|Technical problems|7|||
164707729|NCT02603393|594955322|FG000|Overall Study|Lack of Efficacy|7|||
164707730|NCT02603393|594955323|FG001|Overall Study|Lack of Efficacy|2|||
164707731|NCT02603393|594955322|FG000|Overall Study|Death|3|||
164407878|NCT01674621|593864476|FG001|Overall Study|Other than specified|1|||
164407879|NCT01674621|593864477|FG002|Overall Study|Other than specified|0|||
164407880|NCT01674621|593864478|FG003|Overall Study|Other than specified|0|||
164407881|NCT01674621|593864479|FG004|Overall Study|Other than specified|2|||
164407882|NCT01725386|593864480|FG000|Overall Study|Death|84|||
164407883|NCT01725386|593864481|FG001|Overall Study|Death|40|||
164407884|NCT01725386|593864480|FG000|Overall Study|Lost to Follow-up|81|||
164407885|NCT01725386|593864481|FG001|Overall Study|Lost to Follow-up|6|||
164407886|NCT01725386|593864480|FG000|Overall Study|Withdrawal by Subject|10|||
164407887|NCT01725386|593864481|FG001|Overall Study|Withdrawal by Subject|0|||
164407888|NCT01216163|593864489|FG000|Overall Study|Withdrawal by Subject|1|||
164407889|NCT01216163|593864490|FG001|Overall Study|Withdrawal by Subject|1|||
164407890|NCT01216163|593864491|FG002|Overall Study|Withdrawal by Subject|0|||
164407891|NCT02914314|593864492|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
164407892|NCT02914314|593864493|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
164407893|NCT02914314|593864494|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
164407894|NCT02914314|593864495|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
164407895|NCT02914314|593864492|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
164407896|NCT02914314|593864493|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
164407897|NCT02914314|593864494|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
164407898|NCT02914314|593864495|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
164407899|NCT02914314|593864492|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
164407900|NCT02914314|593864493|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
164407901|NCT02914314|593864494|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
164407902|NCT02914314|593864495|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
164407903|NCT02914314|593864492|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
164407904|NCT02914314|593864493|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
164407905|NCT02914314|593864494|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
164407906|NCT02914314|593864495|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
164407907|NCT02914314|593864492|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
164407908|NCT02914314|593864493|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
164407909|NCT02914314|593864494|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
164407910|NCT02914314|593864495|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
164407911|NCT01148862|593864498|FG000|Second Intervention|Withdrawal by Subject|0|||
164407912|NCT01148862|593864499|FG001|Second Intervention|Withdrawal by Subject|2|||
164407913|NCT04543188|593864500|FG000|Phase 1a|Adverse Event|0|||
164407914|NCT04543188|593864501|FG001|Phase 1a|Adverse Event|0|||
164407915|NCT04543188|593864502|FG002|Phase 1a|Adverse Event|0|||
164407916|NCT04543188|593864503|FG003|Phase 1a|Adverse Event|1|||
164407917|NCT04543188|593864504|FG004|Phase 1a|Adverse Event|0|||
164407918|NCT04543188|593864505|FG005|Phase 1a|Adverse Event|0|||
164407919|NCT04543188|593864506|FG006|Phase 1a|Adverse Event|1|||
164407920|NCT04543188|593864507|FG007|Phase 1a|Adverse Event|0|||
164407921|NCT04543188|593864508|FG008|Phase 1a|Adverse Event|0|||
164407922|NCT04543188|593864509|FG009|Phase 1a|Adverse Event|0|||
164407923|NCT04543188|593864510|FG010|Phase 1a|Adverse Event|0|||
164407924|NCT04543188|593864511|FG011|Phase 1a|Adverse Event|0|||
164407925|NCT04543188|593864512|FG012|Phase 1a|Adverse Event|0|||
164407926|NCT04543188|593864513|FG013|Phase 1a|Adverse Event|0|||
164407927|NCT04543188|593864514|FG014|Phase 1a|Adverse Event|0|||
164407928|NCT04543188|593864500|FG000|Phase 1a|Other (Death)|0|||
164407929|NCT04543188|593864501|FG001|Phase 1a|Other (Death)|1|||
164407930|NCT04543188|593864502|FG002|Phase 1a|Other (Death)|0|||
164407931|NCT04543188|593864503|FG003|Phase 1a|Other (Death)|0|||
164407932|NCT04543188|593864504|FG004|Phase 1a|Other (Death)|1|||
164407933|NCT04543188|593864505|FG005|Phase 1a|Other (Death)|0|||
164407934|NCT04543188|593864506|FG006|Phase 1a|Other (Death)|0|||
164407935|NCT04543188|593864507|FG007|Phase 1a|Other (Death)|0|||
164407936|NCT04543188|593864508|FG008|Phase 1a|Other (Death)|0|||
164407937|NCT04543188|593864509|FG009|Phase 1a|Other (Death)|1|||
164461530|NCT03544281|594062360|FG009|Main Study Phase|Ongoing|2|||
164461531|NCT03544281|594062361|FG010|Main Study Phase|Ongoing|1|||
164461532|NCT03544281|594062362|FG011|Main Study Phase|Ongoing|0|||
164461533|NCT03544281|594062363|FG012|Main Study Phase|Ongoing|0|||
164461534|NCT03544281|594062364|FG013|Main Study Phase|Ongoing|0|||
164461535|NCT03544281|594062365|FG014|Main Study Phase|Ongoing|0|||
164461536|NCT03544281|594062366|FG015|Main Study Phase|Ongoing|0|||
164461537|NCT03544281|594062367|FG016|Main Study Phase|Ongoing|0|||
164461538|NCT03544281|594062368|FG017|Main Study Phase|Ongoing|0|||
164461539|NCT03544281|594062369|FG018|Main Study Phase|Ongoing|0|||
164461540|NCT03544281|594062370|FG019|Main Study Phase|Ongoing|0|||
164461541|NCT03544281|594062371|FG020|Main Study Phase|Ongoing|0|||
164461542|NCT03544281|594062372|FG021|Main Study Phase|Ongoing|0|||
164461543|NCT03544281|594062351|FG000|Main Study Phase|Investigator Site Closed|0|||
164461544|NCT03544281|594062352|FG001|Main Study Phase|Investigator Site Closed|0|||
164461545|NCT03544281|594062353|FG002|Main Study Phase|Investigator Site Closed|0|||
164461546|NCT03544281|594062354|FG003|Main Study Phase|Investigator Site Closed|0|||
164461547|NCT03544281|594062355|FG004|Main Study Phase|Investigator Site Closed|0|||
164461548|NCT03544281|594062356|FG005|Main Study Phase|Investigator Site Closed|0|||
164461549|NCT03544281|594062357|FG006|Main Study Phase|Investigator Site Closed|0|||
164461550|NCT03544281|594062358|FG007|Main Study Phase|Investigator Site Closed|0|||
164461551|NCT03544281|594062359|FG008|Main Study Phase|Investigator Site Closed|0|||
164461552|NCT03544281|594062360|FG009|Main Study Phase|Investigator Site Closed|1|||
164461553|NCT03544281|594062361|FG010|Main Study Phase|Investigator Site Closed|0|||
164461554|NCT03544281|594062362|FG011|Main Study Phase|Investigator Site Closed|0|||
164461555|NCT03544281|594062363|FG012|Main Study Phase|Investigator Site Closed|0|||
164461556|NCT03544281|594062364|FG013|Main Study Phase|Investigator Site Closed|0|||
164461557|NCT03544281|594062365|FG014|Main Study Phase|Investigator Site Closed|0|||
164461558|NCT03544281|594062366|FG015|Main Study Phase|Investigator Site Closed|0|||
164461559|NCT03544281|594062367|FG016|Main Study Phase|Investigator Site Closed|0|||
164461560|NCT03544281|594062368|FG017|Main Study Phase|Investigator Site Closed|0|||
164461561|NCT03544281|594062369|FG018|Main Study Phase|Investigator Site Closed|0|||
164461562|NCT03544281|594062370|FG019|Main Study Phase|Investigator Site Closed|0|||
164461563|NCT03544281|594062371|FG020|Main Study Phase|Investigator Site Closed|0|||
164461564|NCT03544281|594062372|FG021|Main Study Phase|Investigator Site Closed|0|||
164461565|NCT03544281|594062351|FG000|Main Study Phase|Did not receive study treatment|0|||
164461566|NCT03544281|594062352|FG001|Main Study Phase|Did not receive study treatment|0|||
164461567|NCT03544281|594062353|FG002|Main Study Phase|Did not receive study treatment|0|||
164461568|NCT03544281|594062354|FG003|Main Study Phase|Did not receive study treatment|0|||
164461569|NCT03544281|594062355|FG004|Main Study Phase|Did not receive study treatment|0|||
164461570|NCT03544281|594062356|FG005|Main Study Phase|Did not receive study treatment|0|||
164461571|NCT03544281|594062357|FG006|Main Study Phase|Did not receive study treatment|1|||
164461572|NCT03544281|594062358|FG007|Main Study Phase|Did not receive study treatment|0|||
164461573|NCT03544281|594062359|FG008|Main Study Phase|Did not receive study treatment|0|||
164461574|NCT03544281|594062360|FG009|Main Study Phase|Did not receive study treatment|0|||
164461575|NCT03544281|594062361|FG010|Main Study Phase|Did not receive study treatment|0|||
164461576|NCT03544281|594062362|FG011|Main Study Phase|Did not receive study treatment|0|||
164461577|NCT03544281|594062363|FG012|Main Study Phase|Did not receive study treatment|0|||
164461578|NCT03544281|594062364|FG013|Main Study Phase|Did not receive study treatment|0|||
164461579|NCT03544281|594062365|FG014|Main Study Phase|Did not receive study treatment|0|||
164461580|NCT03544281|594062366|FG015|Main Study Phase|Did not receive study treatment|0|||
164461581|NCT03544281|594062367|FG016|Main Study Phase|Did not receive study treatment|0|||
164461582|NCT03544281|594062368|FG017|Main Study Phase|Did not receive study treatment|0|||
164461583|NCT03544281|594062369|FG018|Main Study Phase|Did not receive study treatment|0|||
164461584|NCT03544281|594062370|FG019|Main Study Phase|Did not receive study treatment|0|||
164461585|NCT03544281|594062371|FG020|Main Study Phase|Did not receive study treatment|0|||
164461586|NCT03544281|594062372|FG021|Main Study Phase|Did not receive study treatment|0|||
164461587|NCT03544281|594062351|FG000|PACT Phase|Adverse Event|0|||
164461588|NCT03544281|594062352|FG001|PACT Phase|Adverse Event|0|||
164461589|NCT03544281|594062353|FG002|PACT Phase|Adverse Event|0|||
164461590|NCT03544281|594062354|FG003|PACT Phase|Adverse Event|0|||
164461591|NCT03544281|594062355|FG004|PACT Phase|Adverse Event|0|||
164461592|NCT03544281|594062356|FG005|PACT Phase|Adverse Event|0|||
164461593|NCT03544281|594062357|FG006|PACT Phase|Adverse Event|0|||
164461594|NCT03544281|594062358|FG007|PACT Phase|Adverse Event|0|||
164598857|NCT02883049|594554766|FG010|Induction|Developed SMN|0|||
164598858|NCT02883049|594554767|FG011|Induction|Developed SMN|0|||
164461595|NCT03544281|594062359|FG008|PACT Phase|Adverse Event|0|||
164461596|NCT03544281|594062360|FG009|PACT Phase|Adverse Event|0|||
164461597|NCT03544281|594062361|FG010|PACT Phase|Adverse Event|0|||
164598859|NCT02883049|594554768|FG012|Induction|Developed SMN|0|||
164598860|NCT02883049|594554769|FG013|Induction|Developed SMN|0|||
164598861|NCT02883049|594554770|FG014|Induction|Developed SMN|0|||
164598862|NCT02883049|594554771|FG015|Induction|Developed SMN|0|||
164598863|NCT02883049|594554756|FG000|Induction|Enrolled onto another COG study|72|||
164598864|NCT02883049|594554757|FG001|Induction|Enrolled onto another COG study|0|||
164598865|NCT02883049|594554758|FG002|Induction|Enrolled onto another COG study|0|||
164461598|NCT03544281|594062362|FG011|PACT Phase|Adverse Event|0|||
164461599|NCT03544281|594062363|FG012|PACT Phase|Adverse Event|1|||
164461600|NCT03544281|594062364|FG013|PACT Phase|Adverse Event|0|||
164461601|NCT03544281|594062365|FG014|PACT Phase|Adverse Event|0|||
164461602|NCT03544281|594062366|FG015|PACT Phase|Adverse Event|0|||
164461603|NCT03544281|594062367|FG016|PACT Phase|Adverse Event|0|||
164461604|NCT03544281|594062368|FG017|PACT Phase|Adverse Event|1|||
164461605|NCT03544281|594062369|FG018|PACT Phase|Adverse Event|1|||
164461606|NCT03544281|594062370|FG019|PACT Phase|Adverse Event|0|||
164461607|NCT03544281|594062371|FG020|PACT Phase|Adverse Event|0|||
164461608|NCT03544281|594062372|FG021|PACT Phase|Adverse Event|0|||
164461609|NCT02547233|594062373|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
164461610|NCT02547233|594062374|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
164461611|NCT02547233|594062373|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
164461612|NCT02547233|594062374|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
164461613|NCT02547233|594062373|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
164461614|NCT02547233|594062374|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
164461615|NCT02547233|594062373|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
164461616|NCT02547233|594062374|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
164461617|NCT02547233|594062373|FG000|12-month Follow-up|Withdrawal by Subject|10|||
164461618|NCT02547233|594062374|FG001|12-month Follow-up|Withdrawal by Subject|10|||
164461619|NCT02547233|594062373|FG000|12-month Follow-up|Lost to Follow-up|3|||
164461620|NCT02547233|594062374|FG001|12-month Follow-up|Lost to Follow-up|3|||
164461621|NCT02547233|594062373|FG000|12-month Follow-up|Lack of Efficacy|1|||
164461622|NCT02547233|594062374|FG001|12-month Follow-up|Lack of Efficacy|2|||
164461623|NCT02547233|594062373|FG000|12-month Follow-up|Protocol Violation|0|||
164461624|NCT02547233|594062374|FG001|12-month Follow-up|Protocol Violation|1|||
164461625|NCT02547233|594062373|FG000|12-month Follow-up|Other|0|||
164461626|NCT02547233|594062374|FG001|12-month Follow-up|Other|1|||
164461627|NCT03603600|594062376|FG000|Overall Study|Withdrawal by Subject|5|||
164461628|NCT03603600|594062377|FG001|Overall Study|Withdrawal by Subject|7|||
164461629|NCT03603600|594062376|FG000|Overall Study|Lost to Follow-up|2|||
164461630|NCT03603600|594062377|FG001|Overall Study|Lost to Follow-up|3|||
164461631|NCT03603600|594062376|FG000|Overall Study|Death|3|||
164461632|NCT03603600|594062377|FG001|Overall Study|Death|1|||
164461633|NCT03603600|594062376|FG000|Overall Study|Physician Decision|2|||
164461634|NCT03603600|594062377|FG001|Overall Study|Physician Decision|1|||
164461635|NCT03603600|594062376|FG000|Overall Study|Other reason|1|||
164461636|NCT03603600|594062377|FG001|Overall Study|Other reason|0|||
164461637|NCT03461276|594062382|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
164461638|NCT03461276|594062383|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
164461639|NCT03461276|594062382|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
164461640|NCT03461276|594062383|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
164461641|NCT03461276|594062382|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
164461642|NCT03461276|594062383|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
164461643|NCT03461276|594062382|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
164461644|NCT03461276|594062383|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
164461645|NCT03461276|594062382|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
164461646|NCT03461276|594062383|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
164461647|NCT03461276|594062382|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
164461648|NCT03461276|594062383|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
164461649|NCT03461276|594062382|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
164461650|NCT03461276|594062383|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
164461651|NCT03461276|594062382|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
164461652|NCT03461276|594062383|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
164461653|NCT03461276|594062382|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
164461654|NCT03461276|594062383|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
164461655|NCT03461276|594062382|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
164461656|NCT03461276|594062383|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
164461657|NCT04016662|594062384|FG000|Run-In Phase|Death|1|||
164461658|NCT04016662|594062384|FG000|Run-In Phase|Withdrawal by Subject|11|||
164461659|NCT04016662|594062384|FG000|Run-In Phase|Not meeting screening eligibility|9|||
164461660|NCT04016662|594062384|FG000|Run-In Phase|Physician Decision|3|||
164461661|NCT04016662|594062384|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
164461662|NCT04016662|594062384|FG000|PLGS (12 Weeks)|Death|1|||
164461663|NCT04016662|594062384|FG000|SAP (12 Weeks)|Death|1|||
164461664|NCT02310646|594062385|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
164461665|NCT02310646|594062386|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
164461666|NCT02310646|594062385|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
164461667|NCT02310646|594062386|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
164461668|NCT03021096|594062387|FG000|Overall Study|Lost to Follow-up|4|||
164461669|NCT03021096|594062387|FG000|Overall Study|Protocol Violation|2|||
164461670|NCT02043678|594062392|FG000|Overall Study|Never treated|11|||
164461671|NCT02043678|594062393|FG001|Overall Study|Never treated|9|||
164461672|NCT02043678|594062392|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
164461673|NCT02043678|594062393|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
164461674|NCT02043678|594062392|FG000|Overall Study|AE without clinical PD|54|||
164461675|NCT02043678|594062393|FG001|Overall Study|AE without clinical PD|36|||
164707732|NCT02603393|594955323|FG001|Overall Study|Death|4|||
164707733|NCT02603393|594955322|FG000|Overall Study|Physician Decision|3|||
164707734|NCT02603393|594955323|FG001|Overall Study|Physician Decision|3|||
164707735|NCT02603393|594955322|FG000|Overall Study|Protocol deviation|2|||
164461676|NCT02043678|594062392|FG000|Overall Study|Lost to Follow-up|1|||
164461677|NCT02043678|594062393|FG001|Overall Study|Lost to Follow-up|1|||
164461678|NCT02043678|594062392|FG000|Overall Study|Other|10|||
164461679|NCT02043678|594062393|FG001|Overall Study|Other|14|||
164461680|NCT02043678|594062392|FG000|Overall Study|Clinical PD|114|||
164461681|NCT02043678|594062393|FG001|Overall Study|Clinical PD|148|||
164461682|NCT02043678|594062392|FG000|Overall Study|Radiological PD|100|||
164461683|NCT02043678|594062393|FG001|Overall Study|Radiological PD|90|||
164461684|NCT02043678|594062392|FG000|Overall Study|Protocol-driven decision point|59|||
164461685|NCT02043678|594062393|FG001|Overall Study|Protocol-driven decision point|58|||
164461686|NCT02043678|594062392|FG000|Overall Study|Withdrawal by Subject|16|||
164461687|NCT02043678|594062393|FG001|Overall Study|Withdrawal by Subject|20|||
164461688|NCT02043678|594062392|FG000|Overall Study|Protocol Violation|1|||
164461689|NCT02043678|594062393|FG001|Overall Study|Protocol Violation|0|||
164461690|NCT02043678|594062392|FG000|Overall Study|Deterioration of general conditions|1|||
164461691|NCT02043678|594062393|FG001|Overall Study|Deterioration of general conditions|1|||
164461692|NCT02043678|594062392|FG000|Overall Study|Logistical difficulties|2|||
164461693|NCT02043678|594062393|FG001|Overall Study|Logistical difficulties|0|||
164461694|NCT02043678|594062392|FG000|Overall Study|Non-compliance with study drug|3|||
164461695|NCT02043678|594062393|FG001|Overall Study|Non-compliance with study drug|1|||
164461696|NCT02043678|594062392|FG000|Overall Study|Physician Decision|4|||
164461697|NCT02043678|594062393|FG001|Overall Study|Physician Decision|3|||
164461698|NCT02043678|594062392|FG000|Overall Study|Subject decision|0|||
164461699|NCT02043678|594062393|FG001|Overall Study|Subject decision|1|||
164461700|NCT02043678|594062392|FG000|Overall Study|Switching to other therapy|3|||
164461701|NCT02043678|594062393|FG001|Overall Study|Switching to other therapy|2|||
164461702|NCT02043678|594062392|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
164461703|NCT02043678|594062393|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
164461704|NCT02043678|594062392|FG000|Overall Study|Missing|1|||
164461705|NCT02043678|594062393|FG001|Overall Study|Missing|0|||
164461706|NCT02043678|594062392|FG000|Overall Study|Adverse Event|0|||
164461707|NCT02043678|594062393|FG001|Overall Study|Adverse Event|1|||
164461708|NCT03907878|594062394|FG000|Treatment Period|Withdrawal by Subject|5|||
164461709|NCT03907878|594062394|FG000|Treatment Period|Adverse Event|4|||
164461710|NCT03907878|594062394|FG000|Treatment Period|Lack of Efficacy|1|||
164461711|NCT03907878|594062394|FG000|Treatment Period|Protocol Violation|1|||
164461712|NCT03907878|594062394|FG000|Follow-up Period|Adverse Event|3|||
164461713|NCT03907878|594062394|FG000|Follow-up Period|Withdrawal by Subject|3|||
164461714|NCT04307355|594062403|FG000|Overall Study|Non-Compliance|3|||
164461715|NCT04307355|594062404|FG001|Overall Study|Non-Compliance|3|||
164461716|NCT04307355|594062405|FG002|Overall Study|Non-Compliance|0|||
164461717|NCT04065841|594062406|FG000|Overall Study|Adverse Event|4|||
164461718|NCT04065841|594062407|FG001|Overall Study|Adverse Event|2|||
164461719|NCT04065841|594062408|FG002|Overall Study|Adverse Event|10|||
164461720|NCT04065841|594062409|FG003|Overall Study|Adverse Event|1|||
164461721|NCT04065841|594062406|FG000|Overall Study|Lost to Follow-up|1|||
164461722|NCT04065841|594062407|FG001|Overall Study|Lost to Follow-up|2|||
164461723|NCT04065841|594062408|FG002|Overall Study|Lost to Follow-up|2|||
164461724|NCT04065841|594062409|FG003|Overall Study|Lost to Follow-up|2|||
164461725|NCT04065841|594062406|FG000|Overall Study|Physician Decision|1|||
164461726|NCT04065841|594062407|FG001|Overall Study|Physician Decision|0|||
164461727|NCT04065841|594062408|FG002|Overall Study|Physician Decision|0|||
164461728|NCT04065841|594062409|FG003|Overall Study|Physician Decision|0|||
164461729|NCT04065841|594062406|FG000|Overall Study|Protocol Violation|0|||
164461730|NCT04065841|594062407|FG001|Overall Study|Protocol Violation|1|||
164707736|NCT02603393|594955323|FG001|Overall Study|Protocol deviation|3|||
164461731|NCT04065841|594062408|FG002|Overall Study|Protocol Violation|0|||
164461732|NCT04065841|594062409|FG003|Overall Study|Protocol Violation|0|||
164461733|NCT04065841|594062406|FG000|Overall Study|Study terminated by Sponsor|22|||
164461734|NCT04065841|594062407|FG001|Overall Study|Study terminated by Sponsor|16|||
164461735|NCT04065841|594062408|FG002|Overall Study|Study terminated by Sponsor|28|||
164461736|NCT04065841|594062409|FG003|Overall Study|Study terminated by Sponsor|17|||
164461737|NCT04065841|594062406|FG000|Overall Study|Withdrawal by Subject|1|||
164461738|NCT04065841|594062407|FG001|Overall Study|Withdrawal by Subject|1|||
164461739|NCT04065841|594062408|FG002|Overall Study|Withdrawal by Subject|2|||
164461740|NCT04065841|594062409|FG003|Overall Study|Withdrawal by Subject|0|||
164461741|NCT01420237|594062414|FG000|Overall Study|Death|13|||
164461742|NCT01420237|594062414|FG000|Overall Study|Withdrawal by Subject|41|||
164461743|NCT01420237|594062414|FG000|Overall Study|Lost to Follow-up|32|||
164461744|NCT01420237|594062414|FG000|Overall Study|Adverse Event|10|||
164461745|NCT01420237|594062414|FG000|Overall Study|Investigative Site Termination|43|||
164461746|NCT01420237|594062414|FG000|Overall Study|Censored because study device not implanted|21|||
164461747|NCT01420237|594062414|FG000|Overall Study|Censored because surgery not performed|2|||
164461748|NCT01420237|594062414|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
164461749|NCT01420237|594062414|FG000|Overall Study|Sponsor terminated study early|127|||
164461750|NCT02861300|594062415|FG000|Overall Study|Death|0|||
164461751|NCT02861300|594062416|FG001|Overall Study|Death|0|||
164461752|NCT02861300|594062417|FG002|Overall Study|Death|0|||
164461753|NCT02861300|594062418|FG003|Overall Study|Death|0|||
164461754|NCT02861300|594062419|FG004|Overall Study|Death|0|||
164461755|NCT02861300|594062420|FG005|Overall Study|Death|0|||
164461756|NCT02861300|594062421|FG006|Overall Study|Death|24|||
164461757|NCT02861300|594062415|FG000|Overall Study|Delay in treatment|0|||
164461758|NCT02861300|594062416|FG001|Overall Study|Delay in treatment|0|||
164461759|NCT02861300|594062417|FG002|Overall Study|Delay in treatment|0|||
164461760|NCT02861300|594062418|FG003|Overall Study|Delay in treatment|0|||
164461761|NCT02861300|594062419|FG004|Overall Study|Delay in treatment|0|||
164461762|NCT02861300|594062420|FG005|Overall Study|Delay in treatment|1|||
164461763|NCT02861300|594062421|FG006|Overall Study|Delay in treatment|0|||
164461764|NCT02861300|594062415|FG000|Overall Study|Disease Progression|0|||
164461765|NCT02861300|594062416|FG001|Overall Study|Disease Progression|1|||
164461766|NCT02861300|594062417|FG002|Overall Study|Disease Progression|0|||
164461767|NCT02861300|594062418|FG003|Overall Study|Disease Progression|0|||
164461768|NCT02861300|594062419|FG004|Overall Study|Disease Progression|0|||
164461769|NCT02861300|594062420|FG005|Overall Study|Disease Progression|0|||
164461770|NCT02861300|594062421|FG006|Overall Study|Disease Progression|2|||
164461771|NCT02861300|594062415|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
164461772|NCT02861300|594062416|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
164461773|NCT02861300|594062417|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
164461774|NCT02861300|594062418|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
164461775|NCT02861300|594062419|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
164461776|NCT02861300|594062420|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
164461777|NCT02861300|594062421|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
164461778|NCT02861300|594062415|FG000|Overall Study|Clinical Complications|0|||
164461779|NCT02861300|594062416|FG001|Overall Study|Clinical Complications|0|||
164461780|NCT02861300|594062417|FG002|Overall Study|Clinical Complications|0|||
164461781|NCT02861300|594062418|FG003|Overall Study|Clinical Complications|0|||
164461782|NCT02861300|594062419|FG004|Overall Study|Clinical Complications|0|||
164461783|NCT02861300|594062420|FG005|Overall Study|Clinical Complications|0|||
164461784|NCT02861300|594062421|FG006|Overall Study|Clinical Complications|1|||
164461785|NCT03133546|594062428|FG000|Overall Study|Death|46|||
164461786|NCT03133546|594062429|FG001|Overall Study|Death|43|||
164461787|NCT03133546|594062428|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
164461788|NCT03133546|594062429|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
164461789|NCT05034328|594062430|FG000|Overall Study|Protocol Violation|1|||
164461790|NCT05034328|594062431|FG001|Overall Study|Protocol Violation|0|||
164461791|NCT05034328|594062430|FG000|Overall Study|Lost to Follow-up|0|||
164461792|NCT05034328|594062431|FG001|Overall Study|Lost to Follow-up|10|||
164461793|NCT05808257|594062434|FG000|Overall Study|Lost to Follow-up|8|||
164461794|NCT05808257|594062435|FG001|Overall Study|Lost to Follow-up|8|||
164461795|NCT04568486|594062436|FG000|Overall Study|Withdrawal by Subject|26|||
164461796|NCT04568486|594062436|FG000|Overall Study|Lost to Follow-up|7|||
164461797|NCT04042233|594062437|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
164461798|NCT04042233|594062438|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
164461799|NCT04042233|594062437|FG000|Overall Study|Protocol Violation|0|||
164707737|NCT02603393|594955322|FG000|Overall Study|Lost to Follow-up|1|||
164461800|NCT04042233|594062438|FG001|Overall Study|Protocol Violation|2|||
164461801|NCT04907851|594062441|FG000|Overall Study|Consent withdrawn|1|||
164461802|NCT04907851|594062442|FG001|Overall Study|Consent withdrawn|2|||
164461803|NCT04907851|594062443|FG002|Overall Study|Consent withdrawn|0|||
164461804|NCT04907851|594062441|FG000|Overall Study|Death|5|||
164461805|NCT04907851|594062442|FG001|Overall Study|Death|15|||
164461806|NCT04907851|594062443|FG002|Overall Study|Death|10|||
164707738|NCT02603393|594955323|FG001|Overall Study|Lost to Follow-up|2|||
164707739|NCT02603393|594955322|FG000|Overall Study|Non-compliance with study treatment|1|||
164461807|NCT05281562|594062447|FG000|Overall Study|Ineligible patient|1|||
164461808|NCT05281562|594062448|FG001|Overall Study|Ineligible patient|0|||
164461809|NCT00324805|594062453|FG000|Overall Study|Adverse Event|62|||
164461810|NCT00324805|594062454|FG001|Overall Study|Adverse Event|203|||
164461811|NCT00324805|594062453|FG000|Overall Study|Progression|7|||
164461812|NCT00324805|594062454|FG001|Overall Study|Progression|35|||
164461813|NCT00324805|594062453|FG000|Overall Study|Withdrawal by Subject|51|||
164461814|NCT00324805|594062454|FG001|Overall Study|Withdrawal by Subject|174|||
164707740|NCT02603393|594955323|FG001|Overall Study|Non-compliance with study treatment|0|||
164707741|NCT02603393|594955322|FG000|Overall Study|Sponsor decision|1|||
164461815|NCT00324805|594062453|FG000|Overall Study|Death|6|||
164461816|NCT00324805|594062454|FG001|Overall Study|Death|9|||
164461817|NCT00324805|594062453|FG000|Overall Study|Alternative therapy|4|||
164461818|NCT00324805|594062454|FG001|Overall Study|Alternative therapy|8|||
164461819|NCT00324805|594062453|FG000|Overall Study|Other complicating disease|1|||
164461820|NCT00324805|594062454|FG001|Overall Study|Other complicating disease|9|||
164461821|NCT00324805|594062453|FG000|Overall Study|Other reasons|7|||
164461822|NCT00324805|594062454|FG001|Overall Study|Other reasons|26|||
164461823|NCT00324805|594062453|FG000|Overall Study|Other|0|||
164461824|NCT00324805|594062454|FG001|Overall Study|Other|2|||
164461825|NCT00324805|594062453|FG000|Overall Study|Did not start therapy|12|||
164461826|NCT00324805|594062454|FG001|Overall Study|Did not start therapy|17|||
164461827|NCT05792085|594062456|FG000|Overall Study|Death|0|||
164461828|NCT05792085|594062457|FG001|Overall Study|Death|0|||
164461829|NCT05792085|594062458|FG002|Overall Study|Death|0|||
164461830|NCT05792085|594062459|FG003|Overall Study|Death|0|||
164461831|NCT05792085|594062460|FG004|Overall Study|Death|1|||
164461832|NCT05496231|594062463|FG000|Overall Study|Adverse Event|1|||
164461833|NCT05496231|594062464|FG001|Overall Study|Adverse Event|1|||
164461834|NCT05496231|594062465|FG002|Overall Study|Adverse Event|0|||
164461835|NCT05496231|594062466|FG003|Overall Study|Adverse Event|4|||
164461836|NCT05496231|594062463|FG000|Overall Study|Withdrawal by Subject|5|||
164461837|NCT05496231|594062464|FG001|Overall Study|Withdrawal by Subject|5|||
164461838|NCT05496231|594062465|FG002|Overall Study|Withdrawal by Subject|4|||
164461839|NCT05496231|594062466|FG003|Overall Study|Withdrawal by Subject|11|||
164461840|NCT05496231|594062463|FG000|Overall Study|Migrated/moved from the study area|3|||
164461841|NCT05496231|594062464|FG001|Overall Study|Migrated/moved from the study area|5|||
164461842|NCT05496231|594062465|FG002|Overall Study|Migrated/moved from the study area|3|||
164461843|NCT05496231|594062466|FG003|Overall Study|Migrated/moved from the study area|3|||
164461844|NCT05496231|594062463|FG000|Overall Study|Lost to Follow-up|13|||
164461845|NCT05496231|594062464|FG001|Overall Study|Lost to Follow-up|6|||
164461846|NCT05496231|594062465|FG002|Overall Study|Lost to Follow-up|11|||
164461847|NCT05496231|594062466|FG003|Overall Study|Lost to Follow-up|6|||
164461848|NCT05496231|594062463|FG000|Overall Study|Other|9|||
164461849|NCT05496231|594062464|FG001|Overall Study|Other|7|||
164461850|NCT05496231|594062465|FG002|Overall Study|Other|7|||
164461851|NCT05496231|594062466|FG003|Overall Study|Other|8|||
164461852|NCT04524442|594062469|FG000|Overall Study|Subject Decision|1|||
164461853|NCT03819153|594062477|FG000|Overall Study|Withdrawal by Subject|20|||
164461854|NCT03819153|594062478|FG001|Overall Study|Withdrawal by Subject|28|||
164461855|NCT03819153|594062477|FG000|Overall Study|Lost to Follow-up|23|||
164461856|NCT03819153|594062478|FG001|Overall Study|Lost to Follow-up|30|||
164461857|NCT04898673|594062488|FG000|Overall Study|Screenfail|1|||
164461858|NCT04898673|594062489|FG001|Overall Study|Screenfail|0|||
164461859|NCT04797897|594062490|FG000|Overall Study|Study Termination by Sponsor|1|||
164461860|NCT04797897|594062491|FG001|Overall Study|Study Termination by Sponsor|1|||
164461861|NCT05526430|594062493|FG000|Overall Study|Withdrawal by Subject|0|||
164461862|NCT05526430|594062494|FG001|Overall Study|Withdrawal by Subject|2|||
164461863|NCT05526430|594062495|FG002|Overall Study|Withdrawal by Subject|0|||
164461864|NCT05526430|594062496|FG003|Overall Study|Withdrawal by Subject|0|||
164461865|NCT05192109|594062504|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
164461866|NCT05192109|594062505|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
164461867|NCT05192109|594062506|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
164461868|NCT05192109|594062507|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
164461869|NCT05192109|594062504|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
164461870|NCT05192109|594062505|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
164461871|NCT05192109|594062506|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
164461872|NCT05192109|594062507|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
164461873|NCT03365882|594062510|FG000|Randomization|Still Receiving Protocol Treatment|2|||
164461874|NCT03365882|594062511|FG001|Randomization|Still Receiving Protocol Treatment|0|||
164461875|NCT03365882|594062510|FG000|Randomization|Adverse Event|1|||
164461876|NCT03365882|594062511|FG001|Randomization|Adverse Event|2|||
164461877|NCT03365882|594062510|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
164461878|NCT03365882|594062511|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
164461879|NCT03365882|594062510|FG000|Randomization|Progression/Relapse|21|||
164461880|NCT03365882|594062511|FG001|Randomization|Progression/Relapse|3|||
164461881|NCT03365882|594062510|FG000|Randomization|Death|1|||
164461882|NCT03365882|594062511|FG001|Randomization|Death|0|||
164461883|NCT03365882|594062510|FG000|Randomization|Other - Not Protocol Specified|1|||
164461884|NCT03365882|594062511|FG001|Randomization|Other - Not Protocol Specified|1|||
164461885|NCT03365882|594062510|FG000|Randomization|Major Protocol Deviation|0|||
164461886|NCT03365882|594062511|FG001|Randomization|Major Protocol Deviation|1|||
164461887|NCT03365882|594062510|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
164461888|NCT03365882|594062511|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
164461889|NCT03365882|594062510|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
164461890|NCT03365882|594062511|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
164461891|NCT03365882|594062510|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
164461892|NCT03365882|594062511|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
164461893|NCT03365882|594062510|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
164461894|NCT03365882|594062511|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
164461895|NCT04437615|594062512|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
164461896|NCT04828005|594062513|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
164461897|NCT04828005|594062514|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
164461898|NCT04828005|594062515|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
164461899|NCT04828005|594062516|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
164461900|NCT04828005|594062513|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
164461901|NCT04828005|594062514|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
164461902|NCT04828005|594062515|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
164461903|NCT04828005|594062516|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
164461904|NCT04828005|594062513|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
164461905|NCT04828005|594062514|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
164461906|NCT04828005|594062515|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
164461907|NCT04828005|594062516|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
164461908|NCT04828005|594062513|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
164461909|NCT04828005|594062514|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
164461910|NCT04828005|594062515|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
164461911|NCT04828005|594062516|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
164461912|NCT04828005|594062513|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
164461913|NCT04828005|594062514|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
164461914|NCT04828005|594062515|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
164461915|NCT04828005|594062516|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
164461916|NCT04828005|594062513|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
164461917|NCT04828005|594062514|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
164461918|NCT04828005|594062515|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
164461919|NCT04828005|594062516|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
164461920|NCT04828005|594062513|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
164461921|NCT04828005|594062514|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
164461922|NCT04828005|594062515|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
164461923|NCT04828005|594062516|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
164461924|NCT04828005|594062513|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
164461925|NCT04828005|594062514|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
164461926|NCT04828005|594062515|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
164461927|NCT04828005|594062516|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
164461928|NCT04828005|594062513|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
164461929|NCT04828005|594062514|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
164461930|NCT04828005|594062515|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
164461931|NCT04828005|594062516|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
164461932|NCT02268253|594064341|FG000|Stage 1|Withdrawal by Subject|1|||
164461933|NCT02268253|594064342|FG001|Stage 1|Withdrawal by Subject|0|||
164461934|NCT02268253|594064343|FG002|Stage 1|Withdrawal by Subject|0|||
164461935|NCT02268253|594064344|FG003|Stage 1|Withdrawal by Subject|0|||
164461936|NCT02268253|594064345|FG004|Stage 1|Withdrawal by Subject|0|||
164461937|NCT02268253|594064346|FG005|Stage 1|Withdrawal by Subject|0|||
164461938|NCT02268253|594064347|FG006|Stage 1|Withdrawal by Subject|0|||
164461939|NCT02268253|594064341|FG000|Stage 1|Death|0|||
164461940|NCT02268253|594064342|FG001|Stage 1|Death|2|||
164461941|NCT02268253|594064343|FG002|Stage 1|Death|2|||
164461942|NCT02268253|594064344|FG003|Stage 1|Death|2|||
164461943|NCT02268253|594064345|FG004|Stage 1|Death|1|||
164461944|NCT02268253|594064346|FG005|Stage 1|Death|1|||
164461945|NCT02268253|594064347|FG006|Stage 1|Death|0|||
164461946|NCT02268253|594064341|FG000|Stage 2|Disease Recurrence/ Progression|0|||
164461947|NCT02268253|594064342|FG001|Stage 2|Disease Recurrence/ Progression|0|||
164461948|NCT02268253|594064343|FG002|Stage 2|Disease Recurrence/ Progression|1|||
164461949|NCT02268253|594064344|FG003|Stage 2|Disease Recurrence/ Progression|0|||
164461950|NCT02268253|594064345|FG004|Stage 2|Disease Recurrence/ Progression|0|||
164461951|NCT02268253|594064346|FG005|Stage 2|Disease Recurrence/ Progression|0|||
164461952|NCT02268253|594064347|FG006|Stage 2|Disease Recurrence/ Progression|0|||
164461953|NCT02268253|594064341|FG000|Stage 2|Withdrawal by Subject|0|||
164461954|NCT02268253|594064342|FG001|Stage 2|Withdrawal by Subject|0|||
164461955|NCT02268253|594064343|FG002|Stage 2|Withdrawal by Subject|2|||
164461956|NCT02268253|594064344|FG003|Stage 2|Withdrawal by Subject|0|||
164461957|NCT02268253|594064345|FG004|Stage 2|Withdrawal by Subject|0|||
164461958|NCT02268253|594064346|FG005|Stage 2|Withdrawal by Subject|2|||
164461959|NCT02268253|594064347|FG006|Stage 2|Withdrawal by Subject|0|||
164461960|NCT02268253|594064341|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
164461961|NCT02268253|594064342|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
164461962|NCT02268253|594064343|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
164461963|NCT02268253|594064344|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
164461964|NCT02268253|594064345|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
164461965|NCT02268253|594064346|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
164707742|NCT02603393|594955323|FG001|Overall Study|Sponsor decision|0|||
164461966|NCT02268253|594064347|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
164461967|NCT02268253|594064341|FG000|Stage 2|Death|0|||
164461968|NCT02268253|594064342|FG001|Stage 2|Death|0|||
164461969|NCT02268253|594064343|FG002|Stage 2|Death|19|||
164461970|NCT02268253|594064344|FG003|Stage 2|Death|0|||
164461971|NCT02268253|594064345|FG004|Stage 2|Death|0|||
164461972|NCT02268253|594064346|FG005|Stage 2|Death|20|||
164461973|NCT02268253|594064347|FG006|Stage 2|Death|1|||
164461974|NCT02268253|594064341|FG000|Stage 2|Lost to Follow-up|0|||
164461975|NCT02268253|594064342|FG001|Stage 2|Lost to Follow-up|0|||
164461976|NCT02268253|594064343|FG002|Stage 2|Lost to Follow-up|0|||
164461977|NCT02268253|594064344|FG003|Stage 2|Lost to Follow-up|0|||
164461978|NCT02268253|594064345|FG004|Stage 2|Lost to Follow-up|0|||
164461979|NCT02268253|594064346|FG005|Stage 2|Lost to Follow-up|4|||
164461980|NCT02268253|594064347|FG006|Stage 2|Lost to Follow-up|0|||
164461981|NCT02268253|594064341|FG000|Stage 2|Transferred to Hospice|0|||
164461982|NCT02268253|594064342|FG001|Stage 2|Transferred to Hospice|0|||
164461983|NCT02268253|594064343|FG002|Stage 2|Transferred to Hospice|0|||
164461984|NCT02268253|594064344|FG003|Stage 2|Transferred to Hospice|0|||
164461985|NCT02268253|594064345|FG004|Stage 2|Transferred to Hospice|0|||
164461986|NCT02268253|594064346|FG005|Stage 2|Transferred to Hospice|2|||
164461987|NCT02268253|594064347|FG006|Stage 2|Transferred to Hospice|0|||
164461988|NCT02268253|594064341|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
164461989|NCT02268253|594064342|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
164461990|NCT02268253|594064343|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
164461991|NCT02268253|594064344|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
164461992|NCT02268253|594064345|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
164461993|NCT02268253|594064346|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
164461994|NCT02268253|594064347|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
164461995|NCT02268253|594064341|FG000|Stage 3A|Withdrawal by Subject|0|||
164461996|NCT02268253|594064342|FG001|Stage 3A|Withdrawal by Subject|0|||
164461997|NCT02268253|594064343|FG002|Stage 3A|Withdrawal by Subject|2|||
164461998|NCT02268253|594064344|FG003|Stage 3A|Withdrawal by Subject|0|||
164461999|NCT02268253|594064345|FG004|Stage 3A|Withdrawal by Subject|0|||
164462000|NCT02268253|594064346|FG005|Stage 3A|Withdrawal by Subject|0|||
164462001|NCT02268253|594064347|FG006|Stage 3A|Withdrawal by Subject|0|||
164462002|NCT02268253|594064341|FG000|Stage 3A|Physician Decision|0|||
164462003|NCT02268253|594064342|FG001|Stage 3A|Physician Decision|0|||
164462004|NCT02268253|594064343|FG002|Stage 3A|Physician Decision|2|||
164462005|NCT02268253|594064344|FG003|Stage 3A|Physician Decision|0|||
164462006|NCT02268253|594064345|FG004|Stage 3A|Physician Decision|0|||
164462007|NCT02268253|594064346|FG005|Stage 3A|Physician Decision|0|||
164462008|NCT02268253|594064347|FG006|Stage 3A|Physician Decision|0|||
164462009|NCT02268253|594064341|FG000|Stage 3A|Study Terminated by Sponsor|0|||
164462010|NCT02268253|594064342|FG001|Stage 3A|Study Terminated by Sponsor|0|||
164462011|NCT02268253|594064343|FG002|Stage 3A|Study Terminated by Sponsor|2|||
164462012|NCT02268253|594064344|FG003|Stage 3A|Study Terminated by Sponsor|0|||
164462013|NCT02268253|594064345|FG004|Stage 3A|Study Terminated by Sponsor|0|||
164462014|NCT02268253|594064346|FG005|Stage 3A|Study Terminated by Sponsor|0|||
164462015|NCT02268253|594064347|FG006|Stage 3A|Study Terminated by Sponsor|0|||
164462016|NCT02268253|594064341|FG000|Stage 3A|Lost to Follow-up|0|||
164462017|NCT02268253|594064342|FG001|Stage 3A|Lost to Follow-up|0|||
164462018|NCT02268253|594064343|FG002|Stage 3A|Lost to Follow-up|1|||
164462019|NCT02268253|594064344|FG003|Stage 3A|Lost to Follow-up|0|||
164462020|NCT02268253|594064345|FG004|Stage 3A|Lost to Follow-up|0|||
164462021|NCT02268253|594064346|FG005|Stage 3A|Lost to Follow-up|0|||
164462022|NCT02268253|594064347|FG006|Stage 3A|Lost to Follow-up|0|||
164462023|NCT02268253|594064341|FG000|Stage 3A|Death|0|||
164462024|NCT02268253|594064342|FG001|Stage 3A|Death|0|||
164462025|NCT02268253|594064343|FG002|Stage 3A|Death|5|||
164462026|NCT02268253|594064344|FG003|Stage 3A|Death|0|||
164462027|NCT02268253|594064345|FG004|Stage 3A|Death|0|||
164462028|NCT02268253|594064346|FG005|Stage 3A|Death|0|||
164462029|NCT02268253|594064347|FG006|Stage 3A|Death|0|||
164462030|NCT05672069|594064348|FG000|Overall Study|Implant removal|1|||
164462031|NCT05672069|594064348|FG000|Overall Study|Lost to Follow-up|2|||
164462032|NCT03216057|594064351|FG000|Overall Study|Lost to Follow-up|2|||
164462033|NCT03216057|594064352|FG001|Overall Study|Lost to Follow-up|2|||
164462034|NCT05126433|594064353|FG000|Overall Study|Withdrawal by Subject|3|||
164462035|NCT05126433|594064354|FG001|Overall Study|Withdrawal by Subject|0|||
164462036|NCT05126433|594064355|FG002|Overall Study|Withdrawal by Subject|4|||
164462037|NCT05126433|594064353|FG000|Overall Study|Death|9|||
164462038|NCT05126433|594064354|FG001|Overall Study|Death|3|||
164462039|NCT05126433|594064355|FG002|Overall Study|Death|5|||
164462040|NCT05126433|594064353|FG000|Overall Study|Study Terminated by sponsor|0|||
164462041|NCT05126433|594064354|FG001|Overall Study|Study Terminated by sponsor|1|||
164462042|NCT05126433|594064355|FG002|Overall Study|Study Terminated by sponsor|2|||
164462043|NCT05126433|594064353|FG000|Overall Study|Progressive Disease|1|||
164462044|NCT05126433|594064354|FG001|Overall Study|Progressive Disease|4|||
164462045|NCT05126433|594064355|FG002|Overall Study|Progressive Disease|3|||
164462046|NCT05126433|594064353|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
164462047|NCT05126433|594064354|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
164462048|NCT05126433|594064355|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
164462049|NCT04413708|594064356|FG000|Overall Study|Lost to Follow-up|1|||
164462050|NCT04413708|594064357|FG001|Overall Study|Lost to Follow-up|2|||
164707743|NCT01359969|594955324|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
164707744|NCT00593736|594955328|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
164707745|NCT00593736|594955329|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
164707746|NCT00593736|594955330|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
164707747|NCT00593736|594955331|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
164707748|NCT00593736|594955328|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
164707749|NCT00593736|594955329|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
164707750|NCT00593736|594955330|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
164707751|NCT00593736|594955331|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
164707752|NCT00593736|594955328|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
164707753|NCT00593736|594955329|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
164707754|NCT00593736|594955330|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
164707755|NCT00593736|594955331|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
164707756|NCT00593736|594955328|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
164707757|NCT00593736|594955329|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
164707758|NCT00593736|594955330|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
164707759|NCT00593736|594955331|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
164707760|NCT00593736|594955328|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
164707761|NCT00593736|594955329|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
164707762|NCT00593736|594955330|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
164707763|NCT00593736|594955331|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
164707764|NCT00593736|594955328|FG000|Screening Period and Placebo Run-in|Various|0|||
164707765|NCT00593736|594955329|FG001|Screening Period and Placebo Run-in|Various|0|||
164707766|NCT00593736|594955330|FG002|Screening Period and Placebo Run-in|Various|0|||
164707767|NCT00593736|594955331|FG003|Screening Period and Placebo Run-in|Various|25|||
164707768|NCT00593736|594955328|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
164707769|NCT00593736|594955329|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
164707770|NCT00593736|594955330|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
164707771|NCT00593736|594955331|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
164707772|NCT00593736|594955328|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
164707773|NCT00593736|594955329|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
164707774|NCT00593736|594955330|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
164462051|NCT05399459|594064361|FG000|Overall Study|Randomized but not treated|29|||
164462052|NCT05399459|594064362|FG001|Overall Study|Randomized but not treated|30|||
164462053|NCT05399459|594064363|FG002|Overall Study|Randomized but not treated|38|||
164462054|NCT05399459|594064361|FG000|Overall Study|Lost to Follow-up|1|||
164462055|NCT05399459|594064362|FG001|Overall Study|Lost to Follow-up|0|||
164462056|NCT05399459|594064363|FG002|Overall Study|Lost to Follow-up|0|||
164462057|NCT04992520|594064364|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
164462058|NCT04992520|594064365|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
164462059|NCT04992520|594064366|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
164462060|NCT04992520|594064367|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
164462061|NCT04992520|594064368|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
164462062|NCT04992520|594064369|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
164462063|NCT04992520|594064364|FG000|Part A: First Challenge|Non-compliance|0|||
164462064|NCT04992520|594064365|FG001|Part A: First Challenge|Non-compliance|0|||
164462065|NCT04992520|594064366|FG002|Part A: First Challenge|Non-compliance|0|||
164462066|NCT04992520|594064367|FG003|Part A: First Challenge|Non-compliance|1|||
164462067|NCT04992520|594064368|FG004|Part A: First Challenge|Non-compliance|0|||
164462068|NCT04992520|594064369|FG005|Part A: First Challenge|Non-compliance|0|||
164462069|NCT04992520|594064364|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
164462070|NCT04992520|594064365|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
164462071|NCT04992520|594064366|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
164462072|NCT04992520|594064367|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
164707775|NCT00593736|594955331|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
164462073|NCT04992520|594064368|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
164462074|NCT04992520|594064369|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
164462075|NCT04992520|594064364|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
164462076|NCT04992520|594064365|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
164462077|NCT04992520|594064366|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
164462078|NCT04992520|594064367|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
164462079|NCT04992520|594064368|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
164462080|NCT04992520|594064369|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
164462081|NCT03625167|594064371|FG000|Overall Study|Protocol Violation|5|||
164462082|NCT06103188|594064372|FG000|Overall Study|Lost to Follow-up|1|||
164462083|NCT06103188|594064373|FG001|Overall Study|Lost to Follow-up|6|||
164462084|NCT06103188|594064374|FG002|Overall Study|Lost to Follow-up|4|||
164462085|NCT05583578|594064379|FG000|Overall Study|Withdrawal by Subject|2|||
164462086|NCT05583578|594064380|FG001|Overall Study|Withdrawal by Subject|0|||
164462087|NCT05877976|594064381|FG000|Overall Study|Lost to Follow-up|31|||
164462088|NCT00248287|594064384|FG000|Overall Study|Adverse Event|11|||
164462089|NCT00248287|594064385|FG001|Overall Study|Adverse Event|10|||
164462090|NCT00248287|594064384|FG000|Overall Study|Death|1|||
164462091|NCT00248287|594064385|FG001|Overall Study|Death|0|||
164462092|NCT00248287|594064384|FG000|Overall Study|Lost to Follow-up|0|||
164462093|NCT00248287|594064385|FG001|Overall Study|Lost to Follow-up|1|||
164462094|NCT00248287|594064384|FG000|Overall Study|Investigator Request|4|||
164462095|NCT00248287|594064385|FG001|Overall Study|Investigator Request|3|||
164462096|NCT00248287|594064384|FG000|Overall Study|Patient Request|5|||
164462097|NCT00248287|594064385|FG001|Overall Study|Patient Request|3|||
164462098|NCT00248287|594064384|FG000|Overall Study|Other|3|||
164462099|NCT00248287|594064385|FG001|Overall Study|Other|2|||
164462100|NCT04103580|594064388|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
164462101|NCT04103580|594064389|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
164462102|NCT04103580|594064388|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
164462103|NCT04103580|594064389|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
164462104|NCT04103580|594064388|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
164462105|NCT04103580|594064389|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
164462106|NCT04103580|594064388|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
164462107|NCT04103580|594064389|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
164462108|NCT04103580|594064388|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
164462109|NCT04103580|594064389|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
164462110|NCT04103580|594064388|FG000|Phase 1 Active Caregiving|Other|3|||
164462111|NCT04103580|594064389|FG001|Phase 1 Active Caregiving|Other|3|||
164462112|NCT04103580|594064388|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
164462113|NCT04103580|594064389|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
164462114|NCT04103580|594064388|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
164462115|NCT04103580|594064389|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
164462116|NCT04103580|594064388|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
164462117|NCT04103580|594064389|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
164462118|NCT04103580|594064388|FG000|Phase 2 Bereavement|Other|8|||
164462119|NCT04103580|594064389|FG001|Phase 2 Bereavement|Other|6|||
164462120|NCT04145440|594064390|FG000|Overall Study|Physician Decision|3|||
164462121|NCT04145440|594064391|FG001|Overall Study|Physician Decision|0|||
164462122|NCT04145440|594064390|FG000|Overall Study|Use of prohibited therapy|2|||
164462123|NCT04145440|594064391|FG001|Overall Study|Use of prohibited therapy|3|||
164462124|NCT04248725|594064405|FG000|Post-Treatment|Lost to Follow-up|6|||
164462125|NCT04248725|594064406|FG001|Post-Treatment|Lost to Follow-up|5|||
164462126|NCT04248725|594064405|FG000|6-Month Follow Up|Lost to Follow-up|9|||
164462127|NCT04248725|594064406|FG001|6-Month Follow Up|Lost to Follow-up|8|||
164462128|NCT01210807|594064415|FG000|Overall Study|Lost to Follow-up|1|||
164462129|NCT01210807|594064416|FG001|Overall Study|Lost to Follow-up|2|||
164462130|NCT01210807|594064415|FG000|Overall Study|Not implanted bilaterally|2|||
164462131|NCT01210807|594064416|FG001|Overall Study|Not implanted bilaterally|1|||
164462132|NCT04436276|594064418|FG000|Overall Study|Adverse Event|0|||
164462133|NCT04436276|594064419|FG001|Overall Study|Adverse Event|0|||
164462134|NCT04436276|594064420|FG002|Overall Study|Adverse Event|0|||
164462135|NCT04436276|594064421|FG003|Overall Study|Adverse Event|0|||
164462136|NCT04436276|594064422|FG004|Overall Study|Adverse Event|0|||
164462137|NCT04436276|594064423|FG005|Overall Study|Adverse Event|0|||
164462138|NCT04436276|594064424|FG006|Overall Study|Adverse Event|0|||
164462139|NCT04436276|594064425|FG007|Overall Study|Adverse Event|0|||
164462140|NCT04436276|594064426|FG008|Overall Study|Adverse Event|0|||
164462141|NCT04436276|594064427|FG009|Overall Study|Adverse Event|0|||
164462142|NCT04436276|594064428|FG010|Overall Study|Adverse Event|0|||
164462143|NCT04436276|594064429|FG011|Overall Study|Adverse Event|0|||
164462144|NCT04436276|594064430|FG012|Overall Study|Adverse Event|0|||
164462145|NCT04436276|594064431|FG013|Overall Study|Adverse Event|0|||
164462146|NCT04436276|594064432|FG014|Overall Study|Adverse Event|0|||
164462147|NCT04436276|594064433|FG015|Overall Study|Adverse Event|0|||
164462148|NCT04436276|594064434|FG016|Overall Study|Adverse Event|1|||
164462149|NCT04436276|594064435|FG017|Overall Study|Adverse Event|0|||
164462150|NCT04436276|594064436|FG018|Overall Study|Adverse Event|0|||
164462151|NCT04436276|594064437|FG019|Overall Study|Adverse Event|0|||
164462152|NCT04436276|594064438|FG020|Overall Study|Adverse Event|0|||
164462153|NCT04436276|594064439|FG021|Overall Study|Adverse Event|0|||
164462154|NCT04436276|594064440|FG022|Overall Study|Adverse Event|0|||
164462155|NCT04436276|594064418|FG000|Overall Study|Death|0|||
164462156|NCT04436276|594064419|FG001|Overall Study|Death|0|||
164462157|NCT04436276|594064420|FG002|Overall Study|Death|0|||
164462158|NCT04436276|594064421|FG003|Overall Study|Death|0|||
164462159|NCT04436276|594064422|FG004|Overall Study|Death|0|||
164462160|NCT04436276|594064423|FG005|Overall Study|Death|0|||
164462161|NCT04436276|594064424|FG006|Overall Study|Death|0|||
164462162|NCT04436276|594064425|FG007|Overall Study|Death|0|||
164462163|NCT04436276|594064426|FG008|Overall Study|Death|0|||
164462164|NCT04436276|594064427|FG009|Overall Study|Death|0|||
164462165|NCT04436276|594064428|FG010|Overall Study|Death|0|||
164462166|NCT04436276|594064429|FG011|Overall Study|Death|0|||
164462167|NCT04436276|594064430|FG012|Overall Study|Death|1|||
164462168|NCT04436276|594064431|FG013|Overall Study|Death|0|||
164462169|NCT04436276|594064432|FG014|Overall Study|Death|1|||
164462170|NCT04436276|594064433|FG015|Overall Study|Death|0|||
164462171|NCT04436276|594064434|FG016|Overall Study|Death|0|||
164462172|NCT04436276|594064435|FG017|Overall Study|Death|0|||
164462173|NCT04436276|594064436|FG018|Overall Study|Death|0|||
164462174|NCT04436276|594064437|FG019|Overall Study|Death|2|||
164462175|NCT04436276|594064438|FG020|Overall Study|Death|0|||
164462176|NCT04436276|594064439|FG021|Overall Study|Death|1|||
164462177|NCT04436276|594064440|FG022|Overall Study|Death|0|||
164462178|NCT04436276|594064418|FG000|Overall Study|Lost to Follow-up|0|||
164462179|NCT04436276|594064419|FG001|Overall Study|Lost to Follow-up|2|||
164462180|NCT04436276|594064420|FG002|Overall Study|Lost to Follow-up|2|||
164462181|NCT04436276|594064421|FG003|Overall Study|Lost to Follow-up|1|||
164462182|NCT04436276|594064422|FG004|Overall Study|Lost to Follow-up|4|||
164462183|NCT04436276|594064423|FG005|Overall Study|Lost to Follow-up|1|||
164462184|NCT04436276|594064424|FG006|Overall Study|Lost to Follow-up|0|||
164462185|NCT04436276|594064425|FG007|Overall Study|Lost to Follow-up|0|||
164462186|NCT04436276|594064426|FG008|Overall Study|Lost to Follow-up|1|||
164462187|NCT04436276|594064427|FG009|Overall Study|Lost to Follow-up|0|||
164462188|NCT04436276|594064428|FG010|Overall Study|Lost to Follow-up|5|||
164462189|NCT04436276|594064429|FG011|Overall Study|Lost to Follow-up|5|||
164462190|NCT04436276|594064430|FG012|Overall Study|Lost to Follow-up|4|||
164462191|NCT04436276|594064431|FG013|Overall Study|Lost to Follow-up|1|||
164462192|NCT04436276|594064432|FG014|Overall Study|Lost to Follow-up|7|||
164462193|NCT04436276|594064433|FG015|Overall Study|Lost to Follow-up|7|||
164462194|NCT04436276|594064434|FG016|Overall Study|Lost to Follow-up|1|||
164462195|NCT04436276|594064435|FG017|Overall Study|Lost to Follow-up|0|||
164462196|NCT04436276|594064436|FG018|Overall Study|Lost to Follow-up|1|||
164462197|NCT04436276|594064437|FG019|Overall Study|Lost to Follow-up|1|||
164462198|NCT04436276|594064438|FG020|Overall Study|Lost to Follow-up|2|||
164462199|NCT04436276|594064439|FG021|Overall Study|Lost to Follow-up|1|||
164462200|NCT04436276|594064440|FG022|Overall Study|Lost to Follow-up|1|||
164462201|NCT04436276|594064418|FG000|Overall Study|Physician Decision|1|||
164462202|NCT04436276|594064419|FG001|Overall Study|Physician Decision|0|||
164462203|NCT04436276|594064420|FG002|Overall Study|Physician Decision|2|||
164462204|NCT04436276|594064421|FG003|Overall Study|Physician Decision|1|||
164462205|NCT04436276|594064422|FG004|Overall Study|Physician Decision|0|||
164462206|NCT04436276|594064423|FG005|Overall Study|Physician Decision|0|||
164462207|NCT04436276|594064424|FG006|Overall Study|Physician Decision|0|||
164462208|NCT04436276|594064425|FG007|Overall Study|Physician Decision|0|||
164462209|NCT04436276|594064426|FG008|Overall Study|Physician Decision|0|||
164462210|NCT04436276|594064427|FG009|Overall Study|Physician Decision|0|||
164462211|NCT04436276|594064428|FG010|Overall Study|Physician Decision|0|||
164462212|NCT04436276|594064429|FG011|Overall Study|Physician Decision|1|||
164462213|NCT04436276|594064430|FG012|Overall Study|Physician Decision|2|||
164462214|NCT04436276|594064431|FG013|Overall Study|Physician Decision|0|||
164462215|NCT04436276|594064432|FG014|Overall Study|Physician Decision|0|||
164462216|NCT04436276|594064433|FG015|Overall Study|Physician Decision|0|||
164598866|NCT02883049|594554759|FG003|Induction|Enrolled onto another COG study|0|||
164598867|NCT02883049|594554760|FG004|Induction|Enrolled onto another COG study|0|||
164598868|NCT02883049|594554761|FG005|Induction|Enrolled onto another COG study|0|||
164598869|NCT02883049|594554762|FG006|Induction|Enrolled onto another COG study|0|||
164462217|NCT04436276|594064434|FG016|Overall Study|Physician Decision|0|||
164462218|NCT04436276|594064435|FG017|Overall Study|Physician Decision|0|||
164462219|NCT04436276|594064436|FG018|Overall Study|Physician Decision|0|||
164462220|NCT04436276|594064437|FG019|Overall Study|Physician Decision|0|||
164462221|NCT04436276|594064438|FG020|Overall Study|Physician Decision|1|||
164462222|NCT04436276|594064439|FG021|Overall Study|Physician Decision|2|||
164598870|NCT02883049|594554763|FG007|Induction|Enrolled onto another COG study|0|||
164598871|NCT02883049|594554764|FG008|Induction|Enrolled onto another COG study|0|||
164598872|NCT02883049|594554765|FG009|Induction|Enrolled onto another COG study|0|||
164462223|NCT04436276|594064440|FG022|Overall Study|Physician Decision|0|||
164462224|NCT04436276|594064418|FG000|Overall Study|Protocol Violation|0|||
164462225|NCT04436276|594064419|FG001|Overall Study|Protocol Violation|0|||
164462226|NCT04436276|594064420|FG002|Overall Study|Protocol Violation|0|||
164598873|NCT02883049|594554766|FG010|Induction|Enrolled onto another COG study|0|||
164462227|NCT04436276|594064421|FG003|Overall Study|Protocol Violation|0|||
164462228|NCT04436276|594064422|FG004|Overall Study|Protocol Violation|0|||
164462229|NCT04436276|594064423|FG005|Overall Study|Protocol Violation|0|||
164462230|NCT04436276|594064424|FG006|Overall Study|Protocol Violation|0|||
164462231|NCT04436276|594064425|FG007|Overall Study|Protocol Violation|0|||
164462232|NCT04436276|594064426|FG008|Overall Study|Protocol Violation|0|||
164462233|NCT04436276|594064427|FG009|Overall Study|Protocol Violation|0|||
164462234|NCT04436276|594064428|FG010|Overall Study|Protocol Violation|0|||
164462235|NCT04436276|594064429|FG011|Overall Study|Protocol Violation|0|||
164462236|NCT04436276|594064430|FG012|Overall Study|Protocol Violation|0|||
164462237|NCT04436276|594064431|FG013|Overall Study|Protocol Violation|1|||
164462238|NCT04436276|594064432|FG014|Overall Study|Protocol Violation|0|||
164462239|NCT04436276|594064433|FG015|Overall Study|Protocol Violation|1|||
164462240|NCT04436276|594064434|FG016|Overall Study|Protocol Violation|0|||
164462241|NCT04436276|594064435|FG017|Overall Study|Protocol Violation|0|||
164462242|NCT04436276|594064436|FG018|Overall Study|Protocol Violation|0|||
164462243|NCT04436276|594064437|FG019|Overall Study|Protocol Violation|0|||
164462244|NCT04436276|594064438|FG020|Overall Study|Protocol Violation|0|||
164462245|NCT04436276|594064439|FG021|Overall Study|Protocol Violation|0|||
164462246|NCT04436276|594064440|FG022|Overall Study|Protocol Violation|0|||
164462247|NCT04436276|594064418|FG000|Overall Study|Withdrawal by Subject|25|||
164462248|NCT04436276|594064419|FG001|Overall Study|Withdrawal by Subject|22|||
164462249|NCT04436276|594064420|FG002|Overall Study|Withdrawal by Subject|24|||
164462250|NCT04436276|594064421|FG003|Overall Study|Withdrawal by Subject|23|||
164462251|NCT04436276|594064422|FG004|Overall Study|Withdrawal by Subject|14|||
164462252|NCT04436276|594064423|FG005|Overall Study|Withdrawal by Subject|0|||
164462253|NCT04436276|594064424|FG006|Overall Study|Withdrawal by Subject|0|||
164462254|NCT04436276|594064425|FG007|Overall Study|Withdrawal by Subject|1|||
164462255|NCT04436276|594064426|FG008|Overall Study|Withdrawal by Subject|0|||
164462256|NCT04436276|594064427|FG009|Overall Study|Withdrawal by Subject|1|||
164462257|NCT04436276|594064428|FG010|Overall Study|Withdrawal by Subject|17|||
164462258|NCT04436276|594064429|FG011|Overall Study|Withdrawal by Subject|7|||
164462259|NCT04436276|594064430|FG012|Overall Study|Withdrawal by Subject|10|||
164462260|NCT04436276|594064431|FG013|Overall Study|Withdrawal by Subject|6|||
164462261|NCT04436276|594064432|FG014|Overall Study|Withdrawal by Subject|20|||
164462262|NCT04436276|594064433|FG015|Overall Study|Withdrawal by Subject|6|||
164462263|NCT04436276|594064434|FG016|Overall Study|Withdrawal by Subject|11|||
164462264|NCT04436276|594064435|FG017|Overall Study|Withdrawal by Subject|4|||
164598874|NCT02883049|594554767|FG011|Induction|Enrolled onto another COG study|0|||
164598875|NCT02883049|594554768|FG012|Induction|Enrolled onto another COG study|0|||
164598876|NCT02883049|594554769|FG013|Induction|Enrolled onto another COG study|0|||
164598877|NCT02883049|594554770|FG014|Induction|Enrolled onto another COG study|0|||
164598878|NCT02883049|594554771|FG015|Induction|Enrolled onto another COG study|0|||
164598879|NCT02883049|594554756|FG000|Induction|Incomplete induction data|17|||
164598880|NCT02883049|594554757|FG001|Induction|Incomplete induction data|0|||
164598881|NCT02883049|594554758|FG002|Induction|Incomplete induction data|0|||
164598882|NCT02883049|594554759|FG003|Induction|Incomplete induction data|0|||
164598883|NCT02883049|594554760|FG004|Induction|Incomplete induction data|0|||
164598884|NCT02883049|594554761|FG005|Induction|Incomplete induction data|0|||
164598885|NCT02883049|594554762|FG006|Induction|Incomplete induction data|0|||
164598886|NCT02883049|594554763|FG007|Induction|Incomplete induction data|0|||
164598887|NCT02883049|594554764|FG008|Induction|Incomplete induction data|0|||
164598888|NCT02883049|594554765|FG009|Induction|Incomplete induction data|0|||
164598889|NCT02883049|594554766|FG010|Induction|Incomplete induction data|0|||
164598890|NCT02883049|594554767|FG011|Induction|Incomplete induction data|0|||
164598891|NCT02883049|594554768|FG012|Induction|Incomplete induction data|0|||
164598892|NCT02883049|594554769|FG013|Induction|Incomplete induction data|0|||
164598893|NCT02883049|594554770|FG014|Induction|Incomplete induction data|0|||
164598894|NCT02883049|594554771|FG015|Induction|Incomplete induction data|0|||
164598895|NCT02883049|594554756|FG000|Post Induction|Adverse Event|0|||
164598896|NCT02883049|594554757|FG001|Post Induction|Adverse Event|0|||
164598897|NCT02883049|594554758|FG002|Post Induction|Adverse Event|0|||
164598898|NCT02883049|594554759|FG003|Post Induction|Adverse Event|7|||
164598899|NCT02883049|594554760|FG004|Post Induction|Adverse Event|8|||
164598900|NCT02883049|594554761|FG005|Post Induction|Adverse Event|3|||
164598901|NCT02883049|594554762|FG006|Post Induction|Adverse Event|4|||
164598902|NCT02883049|594554763|FG007|Post Induction|Adverse Event|5|||
164598903|NCT02883049|594554764|FG008|Post Induction|Adverse Event|6|||
164598904|NCT02883049|594554765|FG009|Post Induction|Adverse Event|7|||
164598905|NCT02883049|594554766|FG010|Post Induction|Adverse Event|2|||
164598906|NCT02883049|594554767|FG011|Post Induction|Adverse Event|2|||
164598907|NCT02883049|594554768|FG012|Post Induction|Adverse Event|0|||
164598908|NCT02883049|594554769|FG013|Post Induction|Adverse Event|0|||
164598909|NCT02883049|594554770|FG014|Post Induction|Adverse Event|5|||
164598910|NCT02883049|594554771|FG015|Post Induction|Adverse Event|2|||
164598911|NCT02883049|594554756|FG000|Post Induction|Death|0|||
164598912|NCT02883049|594554757|FG001|Post Induction|Death|0|||
164598913|NCT02883049|594554758|FG002|Post Induction|Death|0|||
164598914|NCT02883049|594554759|FG003|Post Induction|Death|9|||
164598915|NCT02883049|594554760|FG004|Post Induction|Death|9|||
164598916|NCT02883049|594554761|FG005|Post Induction|Death|0|||
164598917|NCT02883049|594554762|FG006|Post Induction|Death|1|||
164598918|NCT02883049|594554763|FG007|Post Induction|Death|6|||
164598919|NCT02883049|594554764|FG008|Post Induction|Death|5|||
164598920|NCT02883049|594554765|FG009|Post Induction|Death|3|||
164598921|NCT02883049|594554766|FG010|Post Induction|Death|1|||
164462265|NCT04436276|594064436|FG018|Overall Study|Withdrawal by Subject|14|||
164462266|NCT04436276|594064437|FG019|Overall Study|Withdrawal by Subject|24|||
164462267|NCT04436276|594064438|FG020|Overall Study|Withdrawal by Subject|24|||
164462268|NCT04436276|594064439|FG021|Overall Study|Withdrawal by Subject|16|||
164462269|NCT04436276|594064440|FG022|Overall Study|Withdrawal by Subject|14|||
164462270|NCT04436276|594064418|FG000|Overall Study|Other|3|||
164462271|NCT04436276|594064419|FG001|Overall Study|Other|2|||
164462272|NCT04436276|594064420|FG002|Overall Study|Other|5|||
164462273|NCT04436276|594064421|FG003|Overall Study|Other|9|||
164462274|NCT04436276|594064422|FG004|Overall Study|Other|23|||
164462275|NCT04436276|594064423|FG005|Overall Study|Other|1|||
164462276|NCT04436276|594064424|FG006|Overall Study|Other|0|||
164462277|NCT04436276|594064425|FG007|Overall Study|Other|0|||
164462278|NCT04436276|594064426|FG008|Overall Study|Other|0|||
164462279|NCT04436276|594064427|FG009|Overall Study|Other|0|||
164462280|NCT04436276|594064428|FG010|Overall Study|Other|3|||
164462281|NCT04436276|594064429|FG011|Overall Study|Other|1|||
164462282|NCT04436276|594064430|FG012|Overall Study|Other|1|||
164462283|NCT04436276|594064431|FG013|Overall Study|Other|2|||
164462284|NCT04436276|594064432|FG014|Overall Study|Other|3|||
164462285|NCT04436276|594064433|FG015|Overall Study|Other|0|||
164462286|NCT04436276|594064434|FG016|Overall Study|Other|0|||
164462287|NCT04436276|594064435|FG017|Overall Study|Other|6|||
164462288|NCT04436276|594064436|FG018|Overall Study|Other|1|||
164462289|NCT04436276|594064437|FG019|Overall Study|Other|0|||
164462290|NCT04436276|594064438|FG020|Overall Study|Other|2|||
164462291|NCT04436276|594064439|FG021|Overall Study|Other|2|||
164462292|NCT04436276|594064440|FG022|Overall Study|Other|60|||
164462293|NCT03656510|594064442|FG000|Overall Study|Lost to Follow-up|1|||
164462294|NCT03656510|594064443|FG001|Overall Study|Lost to Follow-up|0|||
164462295|NCT03656510|594064444|FG002|Overall Study|Lost to Follow-up|0|||
164462296|NCT03656510|594064445|FG003|Overall Study|Lost to Follow-up|0|||
164462297|NCT03656510|594064446|FG004|Overall Study|Lost to Follow-up|0|||
164462298|NCT03656510|594064447|FG005|Overall Study|Lost to Follow-up|0|||
164462299|NCT03656510|594064442|FG000|Overall Study|Withdrawal by Subject|1|||
164462300|NCT03656510|594064443|FG001|Overall Study|Withdrawal by Subject|1|||
164462301|NCT03656510|594064444|FG002|Overall Study|Withdrawal by Subject|0|||
164462302|NCT03656510|594064445|FG003|Overall Study|Withdrawal by Subject|1|||
164462303|NCT03656510|594064446|FG004|Overall Study|Withdrawal by Subject|0|||
164462304|NCT03656510|594064447|FG005|Overall Study|Withdrawal by Subject|0|||
164462305|NCT03852472|594064454|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
164462306|NCT03852472|594064455|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
164462307|NCT03852472|594064456|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
164462308|NCT03852472|594064457|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
164462309|NCT03852472|594064458|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
164462310|NCT03852472|594064454|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
164462311|NCT03852472|594064455|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
164462312|NCT03852472|594064456|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
164462313|NCT03852472|594064457|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
164462314|NCT03852472|594064458|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
164462315|NCT03852472|594064454|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
164462316|NCT03852472|594064455|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
164462317|NCT03852472|594064456|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
164462318|NCT03852472|594064457|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
164462319|NCT03852472|594064458|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
164462320|NCT03852472|594064454|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
164462321|NCT03852472|594064455|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
164598922|NCT02883049|594554767|FG011|Post Induction|Death|0|||
164598923|NCT02883049|594554768|FG012|Post Induction|Death|1|||
164462322|NCT03852472|594064456|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
164462323|NCT03852472|594064457|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
164462324|NCT03852472|594064458|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
164462325|NCT03852472|594064454|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
164462326|NCT03852472|594064455|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
164462327|NCT03852472|594064456|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
164462328|NCT03852472|594064457|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
164462329|NCT03852472|594064458|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
164462330|NCT03852472|594064454|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
164462331|NCT03852472|594064455|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
164462332|NCT03852472|594064456|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
164462333|NCT03852472|594064457|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
164462334|NCT03852472|594064458|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
164462335|NCT03852472|594064454|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
164462336|NCT03852472|594064455|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
164462337|NCT03852472|594064456|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
164462338|NCT03852472|594064457|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
164462339|NCT03852472|594064458|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
164462340|NCT03852472|594064454|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
164462341|NCT03852472|594064455|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
164462342|NCT03852472|594064456|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
164462343|NCT03852472|594064457|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
164462344|NCT03852472|594064458|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
164462345|NCT03852472|594064454|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
164462346|NCT03852472|594064455|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
164462347|NCT03852472|594064456|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
164462348|NCT03852472|594064457|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
164462349|NCT03852472|594064458|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
164462350|NCT03852472|594064454|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
164462351|NCT03852472|594064455|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
164462352|NCT03852472|594064456|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
164462353|NCT03852472|594064457|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
164462354|NCT03852472|594064458|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
164462355|NCT03852472|594064454|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
164462356|NCT03852472|594064455|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
164462357|NCT03852472|594064456|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
164462358|NCT03852472|594064457|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
164462359|NCT03852472|594064458|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
164462360|NCT03852472|594064454|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
164462361|NCT03852472|594064455|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
164462362|NCT03852472|594064456|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
164462363|NCT03852472|594064457|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
164462364|NCT03852472|594064458|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
164462365|NCT03852472|594064454|FG000|Period 2 - Week 44|Adverse Event|0|||
164462366|NCT03852472|594064455|FG001|Period 2 - Week 44|Adverse Event|3|||
164462367|NCT03852472|594064456|FG002|Period 2 - Week 44|Adverse Event|1|||
164462368|NCT03852472|594064457|FG003|Period 2 - Week 44|Adverse Event|2|||
164462369|NCT03852472|594064458|FG004|Period 2 - Week 44|Adverse Event|2|||
164462370|NCT03852472|594064454|FG000|Period 2 - Week 44|COVID-19 Related|0|||
164462371|NCT03852472|594064455|FG001|Period 2 - Week 44|COVID-19 Related|0|||
164462372|NCT03852472|594064456|FG002|Period 2 - Week 44|COVID-19 Related|0|||
164462373|NCT03852472|594064457|FG003|Period 2 - Week 44|COVID-19 Related|1|||
164462374|NCT03852472|594064458|FG004|Period 2 - Week 44|COVID-19 Related|0|||
164462375|NCT03852472|594064454|FG000|Period 2 - Week 44|Reason not stated|0|||
164462376|NCT03852472|594064455|FG001|Period 2 - Week 44|Reason not stated|0|||
164462377|NCT03852472|594064456|FG002|Period 2 - Week 44|Reason not stated|0|||
164462378|NCT03852472|594064457|FG003|Period 2 - Week 44|Reason not stated|0|||
164462379|NCT03852472|594064458|FG004|Period 2 - Week 44|Reason not stated|1|||
164462380|NCT05977530|594064459|FG000|Overall Study|Withdrawal by Subject|1|||
164462381|NCT05977530|594064459|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
164462382|NCT06457802|594064460|FG000|Overall Study|Early termination of study prior to participant completion|2|||
164462383|NCT06457802|594064461|FG001|Overall Study|Early termination of study prior to participant completion|2|||
164462384|NCT03974178|594064467|FG000|Overall Study|Death|0|||
164462385|NCT03974178|594064468|FG001|Overall Study|Death|1|||
164462386|NCT06182033|594064472|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
164462387|NCT06182033|594064473|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
164462388|NCT06182033|594064472|FG000|Overall Study|Target child relocation|1|||
164462389|NCT06182033|594064473|FG001|Overall Study|Target child relocation|1|||
164462390|NCT06182033|594064472|FG000|Overall Study|Withdrawal by Subject|1|||
164462391|NCT06182033|594064473|FG001|Overall Study|Withdrawal by Subject|0|||
164462392|NCT04568434|594064480|FG000|Overall Study|Voluntary Withdrawal|0|||
164462393|NCT04568434|594064481|FG001|Overall Study|Voluntary Withdrawal|1|||
164462394|NCT04568434|594064482|FG002|Overall Study|Voluntary Withdrawal|1|||
164462395|NCT04568434|594064480|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
164462396|NCT04568434|594064481|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
164462397|NCT04568434|594064482|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
164462398|NCT04568434|594064480|FG000|Overall Study|Investigator Judgement|1|||
164462399|NCT04568434|594064481|FG001|Overall Study|Investigator Judgement|0|||
164462400|NCT04568434|594064482|FG002|Overall Study|Investigator Judgement|0|||
164462401|NCT05576155|594064483|FG000|Overall Study|Withdrawal by Subject|1|||
164462402|NCT05576155|594064484|FG001|Overall Study|Withdrawal by Subject|1|||
164598924|NCT02883049|594554769|FG013|Post Induction|Death|1|||
164598925|NCT02883049|594554770|FG014|Post Induction|Death|10|||
164598926|NCT02883049|594554771|FG015|Post Induction|Death|2|||
164598927|NCT02883049|594554756|FG000|Post Induction|Lost to Follow-up|0|||
164462403|NCT04515849|594064485|FG000|Overall Study|Adverse Event|0|||
164462404|NCT04515849|594064486|FG001|Overall Study|Adverse Event|0|||
164462405|NCT04515849|594064487|FG002|Overall Study|Adverse Event|0|||
164462406|NCT04515849|594064488|FG003|Overall Study|Adverse Event|1|||
164462407|NCT04515849|594064489|FG004|Overall Study|Adverse Event|2|||
164462408|NCT04515849|594064485|FG000|Overall Study|Death|2|||
164462409|NCT04515849|594064486|FG001|Overall Study|Death|0|||
164462410|NCT04515849|594064487|FG002|Overall Study|Death|0|||
164462411|NCT04515849|594064488|FG003|Overall Study|Death|0|||
164462412|NCT04515849|594064489|FG004|Overall Study|Death|0|||
164462413|NCT04515849|594064485|FG000|Overall Study|Other:family emergency|0|||
164462414|NCT04515849|594064486|FG001|Overall Study|Other:family emergency|0|||
164462415|NCT04515849|594064487|FG002|Overall Study|Other:family emergency|0|||
164462416|NCT04515849|594064488|FG003|Overall Study|Other:family emergency|1|||
164462417|NCT04515849|594064489|FG004|Overall Study|Other:family emergency|0|||
164462418|NCT04515849|594064485|FG000|Overall Study|Other:randomised by error|0|||
164462419|NCT04515849|594064486|FG001|Overall Study|Other:randomised by error|1|||
164462420|NCT04515849|594064487|FG002|Overall Study|Other:randomised by error|0|||
164462421|NCT04515849|594064488|FG003|Overall Study|Other:randomised by error|0|||
164462422|NCT04515849|594064489|FG004|Overall Study|Other:randomised by error|0|||
164462423|NCT04515849|594064485|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
164462424|NCT04515849|594064486|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
164462425|NCT04515849|594064487|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
164462426|NCT04515849|594064488|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
164462427|NCT04515849|594064489|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
164462428|NCT04515849|594064485|FG000|Overall Study|Physician Decision|0|||
164462429|NCT04515849|594064486|FG001|Overall Study|Physician Decision|1|||
164462430|NCT04515849|594064487|FG002|Overall Study|Physician Decision|0|||
164462431|NCT04515849|594064488|FG003|Overall Study|Physician Decision|0|||
164462432|NCT04515849|594064489|FG004|Overall Study|Physician Decision|0|||
164598928|NCT02883049|594554757|FG001|Post Induction|Lost to Follow-up|0|||
164598929|NCT02883049|594554758|FG002|Post Induction|Lost to Follow-up|0|||
164462433|NCT04515849|594064485|FG000|Overall Study|Withdrawal by Subject|1|||
164462434|NCT04515849|594064486|FG001|Overall Study|Withdrawal by Subject|2|||
164462435|NCT04515849|594064487|FG002|Overall Study|Withdrawal by Subject|1|||
164462436|NCT04515849|594064488|FG003|Overall Study|Withdrawal by Subject|0|||
164462437|NCT04515849|594064489|FG004|Overall Study|Withdrawal by Subject|0|||
164462438|NCT04049643|594064498|FG000|Overall Study|Lack of Efficacy|1|||
164462439|NCT04049643|594064499|FG001|Overall Study|Lack of Efficacy|1|||
164462440|NCT04049643|594064500|FG002|Overall Study|Lack of Efficacy|0|||
164462441|NCT04049643|594064498|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
164462442|NCT04049643|594064499|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
164462443|NCT04049643|594064500|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
164462444|NCT04081103|594064501|FG000|Overall Study|Adverse Event|1|||
164462445|NCT04081103|594064502|FG001|Overall Study|Adverse Event|1|||
164462446|NCT04081103|594064503|FG002|Overall Study|Adverse Event|1|||
164462447|NCT04081103|594064501|FG000|Overall Study|Physician Decision|0|||
164462448|NCT04081103|594064502|FG001|Overall Study|Physician Decision|0|||
164144807|NCT01524978|592891777|FG003|Overall Study|Lost to Follow-up|0|||
164462449|NCT04081103|594064503|FG002|Overall Study|Physician Decision|1|||
164462450|NCT03023410|594065726|FG000|Overall Study|study termination|0|||
164462451|NCT03023410|594065727|FG001|Overall Study|study termination|1|||
164462452|NCT04799899|594065728|FG000|Overall Study|Lost to Follow-up|2|||
164462453|NCT04799899|594065729|FG001|Overall Study|Lost to Follow-up|4|||
164598930|NCT02883049|594554759|FG003|Post Induction|Lost to Follow-up|0|||
164598931|NCT02883049|594554760|FG004|Post Induction|Lost to Follow-up|1|||
164598932|NCT02883049|594554761|FG005|Post Induction|Lost to Follow-up|1|||
164598933|NCT02883049|594554762|FG006|Post Induction|Lost to Follow-up|0|||
164462454|NCT05459688|594065732|FG000|Overall Study|Lost to Follow-up|6|||
164462455|NCT05459688|594065732|FG000|Overall Study|Physician Decision|1|||
164598934|NCT02883049|594554763|FG007|Post Induction|Lost to Follow-up|0|||
164462456|NCT05459688|594065732|FG000|Overall Study|Withdrawal by Subject|19|||
164598935|NCT02883049|594554764|FG008|Post Induction|Lost to Follow-up|3|||
164598936|NCT02883049|594554765|FG009|Post Induction|Lost to Follow-up|0|||
164598937|NCT02883049|594554766|FG010|Post Induction|Lost to Follow-up|1|||
164598938|NCT02883049|594554767|FG011|Post Induction|Lost to Follow-up|0|||
164598939|NCT02883049|594554768|FG012|Post Induction|Lost to Follow-up|0|||
164598940|NCT02883049|594554769|FG013|Post Induction|Lost to Follow-up|0|||
164598941|NCT02883049|594554770|FG014|Post Induction|Lost to Follow-up|0|||
164598942|NCT02883049|594554771|FG015|Post Induction|Lost to Follow-up|0|||
164598943|NCT02883049|594554756|FG000|Post Induction|Physician Decision|0|||
164598944|NCT02883049|594554757|FG001|Post Induction|Physician Decision|0|||
164598945|NCT02883049|594554758|FG002|Post Induction|Physician Decision|0|||
164598946|NCT02883049|594554759|FG003|Post Induction|Physician Decision|27|||
164598947|NCT02883049|594554760|FG004|Post Induction|Physician Decision|27|||
164462457|NCT05459688|594065732|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
164462458|NCT03379675|594065735|FG000|Overall Study|Lost to Follow-up|0|||
164462459|NCT03379675|594065736|FG001|Overall Study|Lost to Follow-up|1|||
164462460|NCT03379675|594065737|FG002|Overall Study|Lost to Follow-up|0|||
164462461|NCT03379675|594065735|FG000|Overall Study|Adverse Event|2|||
164462462|NCT03379675|594065736|FG001|Overall Study|Adverse Event|0|||
164462463|NCT03379675|594065737|FG002|Overall Study|Adverse Event|0|||
164462464|NCT03379675|594065735|FG000|Overall Study|Withdrawal by Subject|2|||
164462465|NCT03379675|594065736|FG001|Overall Study|Withdrawal by Subject|1|||
164462466|NCT03379675|594065737|FG002|Overall Study|Withdrawal by Subject|2|||
164462467|NCT02817776|594065738|FG000|Overall Study|Excluded|33|||
164462468|NCT02817776|594065738|FG000|Overall Study|Lost to Follow-up|20|||
164462469|NCT02817776|594065738|FG000|Overall Study|Withdrawal by Subject|33|||
164462470|NCT02817776|594065738|FG000|Overall Study|Death|2|||
164462471|NCT02675751|594065741|FG000|Overall Study|Lost to Follow-up|16|||
164462472|NCT02359890|594065742|FG000|Overall Study|Not meeting eligibility|4|||
164462473|NCT02359890|594065742|FG000|Overall Study|Never treated with study catheter|6|||
164462474|NCT05714761|594065746|FG000|Overall Study|Lost to Follow-up|3|||
164462475|NCT05714761|594065746|FG000|Overall Study|Withdrawal by Subject|3|||
164462476|NCT05714761|594065746|FG000|Overall Study|unblinding of sensor data|1|||
164462477|NCT05714761|594065746|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
164462478|NCT05714761|594065746|FG000|Overall Study|did not return second CGM sensor|4|||
164462479|NCT05213390|594065747|FG000|Overall Study|Withdrawal by Subject|2|||
164462480|NCT05213390|594065747|FG000|Overall Study|Lost to Follow-up|12|||
164462481|NCT05213390|594065747|FG000|Overall Study|Protocol Violation|9|||
164462482|NCT01574274|594065748|FG000|Overall Study|Ineligible|0|||
164462483|NCT01574274|594065749|FG001|Overall Study|Ineligible|1|||
164462484|NCT01574274|594065748|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
164462485|NCT01574274|594065749|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
164462486|NCT01574274|594065748|FG000|Overall Study|Ph+ B-ALL|3|||
164462487|NCT01574274|594065749|FG001|Overall Study|Ph+ B-ALL|4|||
164462488|NCT01574274|594065748|FG000|Overall Study|Induction Death|2|||
164462489|NCT01574274|594065749|FG001|Overall Study|Induction Death|0|||
164462490|NCT01574274|594065748|FG000|Overall Study|Induction Failure|4|||
164462491|NCT01574274|594065749|FG001|Overall Study|Induction Failure|1|||
164462492|NCT01574274|594065748|FG000|Overall Study|Adverse Event|16|||
164462493|NCT01574274|594065749|FG001|Overall Study|Adverse Event|13|||
164462494|NCT01574274|594065748|FG000|Overall Study|Remission Death|1|||
164462495|NCT01574274|594065749|FG001|Overall Study|Remission Death|0|||
164462496|NCT01574274|594065748|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
164462497|NCT01574274|594065749|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
164462498|NCT01574274|594065748|FG000|Overall Study|Other, unknown|3|||
164462499|NCT01574274|594065749|FG001|Overall Study|Other, unknown|2|||
164462500|NCT02191618|594065758|FG000|Overall Study|Withdrawal by Subject|3|||
164462501|NCT02191618|594065758|FG000|Overall Study|Missed Visit|4|||
164462502|NCT03031470|594065760|FG000|Overall Study|Adverse Event|3|||
164462503|NCT03031470|594065761|FG001|Overall Study|Adverse Event|0|||
164462504|NCT03031470|594065760|FG000|Overall Study|Death|3|||
164462505|NCT03031470|594065761|FG001|Overall Study|Death|1|||
164462506|NCT03031470|594065760|FG000|Overall Study|Lost to Follow-up|1|||
164462507|NCT03031470|594065761|FG001|Overall Study|Lost to Follow-up|1|||
164462508|NCT03031470|594065760|FG000|Overall Study|Withdrawal by Subject|1|||
164462509|NCT03031470|594065761|FG001|Overall Study|Withdrawal by Subject|0|||
164462510|NCT03031470|594065760|FG000|Overall Study|Protocol entry criteria not met|0|||
164462511|NCT03031470|594065761|FG001|Overall Study|Protocol entry criteria not met|1|||
164462512|NCT03031470|594065760|FG000|Overall Study|Cancel the operation|0|||
164144808|NCT01524978|592891778|FG004|Overall Study|Lost to Follow-up|1|||
164462513|NCT03031470|594065761|FG001|Overall Study|Cancel the operation|1|||
164462514|NCT01593917|594065762|FG000|Overall Study|Death|67|||
164462515|NCT01593917|594065762|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
164462516|NCT01593917|594065762|FG000|Overall Study|Withdrawal by Subject|23|||
164462517|NCT01593917|594065762|FG000|Overall Study|Lost to Follow-up|12|||
164462518|NCT01593917|594065762|FG000|Overall Study|Protocol Violation|5|||
164462519|NCT01593917|594065762|FG000|Overall Study|Physician Decision|3|||
164462520|NCT02683447|594065766|FG000|Overall Study|Lost to Follow-up|2|||
164462521|NCT04663737|594065767|FG000|Overall Study|Withdrawal by Subject|2|||
164462522|NCT04663737|594065768|FG001|Overall Study|Withdrawal by Subject|0|||
164462523|NCT01943409|594065772|FG000|Overall Study|resumed oral/entral|24|||
164462524|NCT01943409|594065773|FG001|Overall Study|resumed oral/entral|20|||
164462525|NCT01943409|594065772|FG000|Overall Study|Protocol Violation|14|||
164462526|NCT01943409|594065773|FG001|Overall Study|Protocol Violation|24|||
164462527|NCT01943409|594065772|FG000|Overall Study|Death|3|||
164462528|NCT01943409|594065773|FG001|Overall Study|Death|1|||
164462529|NCT01943409|594065772|FG000|Overall Study|Withdrawal by Subject|4|||
164462530|NCT01943409|594065773|FG001|Overall Study|Withdrawal by Subject|3|||
164462531|NCT02489903|594065774|FG000|Screening|Screen Failure|24|||
164462532|NCT02489903|594065775|FG001|Screening|Screen Failure|0|||
164462533|NCT02489903|594065776|FG002|Screening|Screen Failure|0|||
164462534|NCT02489903|594065777|FG003|Screening|Screen Failure|8|||
164462535|NCT02489903|594065774|FG000|Randomized and Received Treatment|Protocol Violation|0|||
164462536|NCT02489903|594065775|FG001|Randomized and Received Treatment|Protocol Violation|1|||
164462537|NCT02489903|594065776|FG002|Randomized and Received Treatment|Protocol Violation|0|||
164462538|NCT02489903|594065777|FG003|Randomized and Received Treatment|Protocol Violation|0|||
164462539|NCT02489903|594065774|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
164462540|NCT02489903|594065775|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
164462541|NCT02489903|594065776|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
164462542|NCT02489903|594065777|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
164462543|NCT02489903|594065774|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
164462544|NCT02489903|594065775|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
164462545|NCT02489903|594065776|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
164462546|NCT02489903|594065777|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
164462547|NCT02489903|594065774|FG000|Randomized and Received Treatment|Death|10|||
164462548|NCT02489903|594065775|FG001|Randomized and Received Treatment|Death|1|||
164462549|NCT02489903|594065776|FG002|Randomized and Received Treatment|Death|0|||
164462550|NCT02489903|594065777|FG003|Randomized and Received Treatment|Death|0|||
164462551|NCT03904147|594065782|FG000|Overall Study|Death|15|||
164462552|NCT03904147|594065783|FG001|Overall Study|Death|13|||
164462553|NCT03904147|594065784|FG002|Overall Study|Death|15|||
164462554|NCT03904147|594065782|FG000|Overall Study|Withdrawal by Subject|7|||
164462555|NCT03904147|594065783|FG001|Overall Study|Withdrawal by Subject|12|||
164462556|NCT03904147|594065784|FG002|Overall Study|Withdrawal by Subject|1|||
164462557|NCT03904147|594065782|FG000|Overall Study|1Y visit completed after 365 days|1|||
164462558|NCT03904147|594065783|FG001|Overall Study|1Y visit completed after 365 days|1|||
164462559|NCT03904147|594065784|FG002|Overall Study|1Y visit completed after 365 days|0|||
164462560|NCT04599062|594065785|FG000|Overall Study|Physician Decision|1|||
164462561|NCT04599062|594065786|FG001|Overall Study|Physician Decision|0|||
164462562|NCT03020199|594065791|FG000|Treatment Period|Adverse Event|0|||
164462563|NCT03020199|594065792|FG001|Treatment Period|Adverse Event|2|||
164462564|NCT03020199|594065791|FG000|Treatment Period|Lack of Efficacy|1|||
164462565|NCT03020199|594065792|FG001|Treatment Period|Lack of Efficacy|6|||
164462566|NCT03020199|594065791|FG000|Treatment Period|Lost to Follow-up|1|||
164462567|NCT03020199|594065792|FG001|Treatment Period|Lost to Follow-up|6|||
164462568|NCT03020199|594065791|FG000|Treatment Period|Physician Decision|0|||
164462569|NCT03020199|594065792|FG001|Treatment Period|Physician Decision|1|||
164462570|NCT03020199|594065791|FG000|Treatment Period|Subject/guardian decision|8|||
164462571|NCT03020199|594065792|FG001|Treatment Period|Subject/guardian decision|15|||
164462572|NCT03020199|594065791|FG000|Treatment Period|Subjects not treated|3|||
164462573|NCT03020199|594065792|FG001|Treatment Period|Subjects not treated|4|||
164462574|NCT03020199|594065791|FG000|Follow-up Period|Disease relapse|32|||
164462575|NCT03020199|594065792|FG001|Follow-up Period|Disease relapse|7|||
164462576|NCT03020199|594065791|FG000|Follow-up Period|Lack of Efficacy|1|||
164462577|NCT03020199|594065792|FG001|Follow-up Period|Lack of Efficacy|2|||
164462578|NCT03020199|594065791|FG000|Follow-up Period|Lost to Follow-up|4|||
164462579|NCT03020199|594065792|FG001|Follow-up Period|Lost to Follow-up|6|||
164462580|NCT03020199|594065791|FG000|Follow-up Period|Physician Decision|2|||
164462581|NCT03020199|594065792|FG001|Follow-up Period|Physician Decision|2|||
164462582|NCT03020199|594065791|FG000|Follow-up Period|Protocol Violation|1|||
164462583|NCT03020199|594065792|FG001|Follow-up Period|Protocol Violation|2|||
164462584|NCT03020199|594065791|FG000|Follow-up Period|Study terminated by Sponsor|6|||
164462585|NCT03020199|594065792|FG001|Follow-up Period|Study terminated by Sponsor|3|||
164462586|NCT03020199|594065791|FG000|Follow-up Period|Subject/guardian decision|14|||
164462587|NCT03020199|594065792|FG001|Follow-up Period|Subject/guardian decision|9|||
164462588|NCT04880863|594065795|FG000|Overall Study|Adverse Event|1|||
164462589|NCT04880863|594065795|FG000|Overall Study|Patient decision|2|||
164462590|NCT04880863|594065795|FG000|Overall Study|Confirmed Disease Progression|15|||
164462591|NCT04880863|594065795|FG000|Overall Study|Death|3|||
164462592|NCT04880863|594065795|FG000|Overall Study|Physician Decision|4|||
164462593|NCT04880863|594065795|FG000|Overall Study|Unconfirmed Disease Progression|4|||
164462594|NCT04880863|594065795|FG000|Overall Study|Withdrawal by Subject|2|||
164462595|NCT04880863|594065795|FG000|Overall Study|Study discontinuation by the sponsor|4|||
164462596|NCT04880863|594065795|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
164462597|NCT04880863|594065795|FG000|Overall Study|Not received study drug NAP|2|||
164598948|NCT02883049|594554761|FG005|Post Induction|Physician Decision|23|||
164598949|NCT02883049|594554762|FG006|Post Induction|Physician Decision|30|||
164462598|NCT03899259|594065796|FG000|Overall Study|Adverse Event|5|||
164462599|NCT03899259|594065797|FG001|Overall Study|Adverse Event|4|||
164462600|NCT03899259|594065798|FG002|Overall Study|Adverse Event|6|||
164462601|NCT03899259|594065796|FG000|Overall Study|Lack of Efficacy|5|||
164462602|NCT03899259|594065797|FG001|Overall Study|Lack of Efficacy|0|||
164462603|NCT03899259|594065798|FG002|Overall Study|Lack of Efficacy|2|||
164462604|NCT03899259|594065796|FG000|Overall Study|Pregnancy|3|||
164462605|NCT03899259|594065797|FG001|Overall Study|Pregnancy|0|||
164462606|NCT03899259|594065798|FG002|Overall Study|Pregnancy|1|||
164707776|NCT00593736|594955328|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
164707777|NCT00593736|594955329|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
164707778|NCT00593736|594955330|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
164707779|NCT00593736|594955331|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
164707780|NCT00593736|594955328|FG000|Treatment Period and Placebo Run-out|Various|1|||
164707781|NCT00593736|594955329|FG001|Treatment Period and Placebo Run-out|Various|1|||
164707782|NCT00593736|594955330|FG002|Treatment Period and Placebo Run-out|Various|1|||
164707783|NCT00593736|594955331|FG003|Treatment Period and Placebo Run-out|Various|0|||
164707784|NCT01868893|594955332|FG000|Overall Study|Adverse Event|2|||
164707785|NCT01868893|594955332|FG000|Overall Study|Commercial availability of study drug|17|||
164707786|NCT01868893|594955332|FG000|Overall Study|Neutropenia|1|||
164707787|NCT01857271|594955333|FG000|Overall Study|Lost to Follow-up|1|||
164707788|NCT03825341|594955336|FG000|Overall Study|Withdrawal by Subject|0|||
164707789|NCT03825341|594955337|FG001|Overall Study|Withdrawal by Subject|1|||
164707790|NCT04283500|594955340|FG000|Overall Study|Lost to Follow-up|8|||
164707791|NCT04283500|594955340|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
164707792|NCT00470067|594955347|FG000|Overall Study|Death|1|||
164707793|NCT00470067|594955347|FG000|Overall Study|Disease Progression|6|||
164707794|NCT01460901|594955348|FG000|Overall Study|Withdrawal by Subject|2|||
164707795|NCT00338455|594955349|FG000|Overall Study|Death|2|||
164707796|NCT00338455|594955350|FG001|Overall Study|Death|1|||
164707797|NCT00338455|594955349|FG000|Overall Study|Physician Decision|1|||
164707798|NCT00338455|594955350|FG001|Overall Study|Physician Decision|0|||
164707799|NCT01517373|594955351|FG000|Run-in Period|Death|1|||
164707800|NCT01517373|594955352|FG001|Run-in Period|Death|0|||
164707801|NCT01517373|594955353|FG002|Run-in Period|Death|0|||
164707802|NCT01517373|594955354|FG003|Run-in Period|Death|0|||
164707803|NCT01517373|594955355|FG004|Run-in Period|Death|0|||
164707804|NCT01517373|594955356|FG005|Run-in Period|Death|0|||
164707805|NCT01517373|594955351|FG000|Run-in Period|Adverse Event|5|||
164707806|NCT01517373|594955352|FG001|Run-in Period|Adverse Event|0|||
164707807|NCT01517373|594955353|FG002|Run-in Period|Adverse Event|0|||
164707808|NCT01517373|594955354|FG003|Run-in Period|Adverse Event|0|||
164707809|NCT01517373|594955355|FG004|Run-in Period|Adverse Event|0|||
164707810|NCT01517373|594955356|FG005|Run-in Period|Adverse Event|0|||
164462607|NCT03899259|594065796|FG000|Overall Study|Physician Decision|0|||
164462608|NCT03899259|594065797|FG001|Overall Study|Physician Decision|1|||
164462609|NCT03899259|594065798|FG002|Overall Study|Physician Decision|0|||
164462610|NCT03899259|594065796|FG000|Overall Study|Protocol Deviation|1|||
164462611|NCT03899259|594065797|FG001|Overall Study|Protocol Deviation|1|||
164462612|NCT03899259|594065798|FG002|Overall Study|Protocol Deviation|1|||
164462613|NCT03899259|594065796|FG000|Overall Study|Withdrawal by Subject|8|||
164462614|NCT03899259|594065797|FG001|Overall Study|Withdrawal by Subject|10|||
164462615|NCT03899259|594065798|FG002|Overall Study|Withdrawal by Subject|12|||
164462616|NCT03899259|594065796|FG000|Overall Study|Lost to Follow-up|5|||
164462617|NCT03899259|594065797|FG001|Overall Study|Lost to Follow-up|6|||
164462618|NCT03899259|594065798|FG002|Overall Study|Lost to Follow-up|2|||
164462619|NCT03899259|594065796|FG000|Overall Study|Lack of Adherence|1|||
164462620|NCT03899259|594065797|FG001|Overall Study|Lack of Adherence|0|||
164462621|NCT03899259|594065798|FG002|Overall Study|Lack of Adherence|0|||
164462622|NCT03899259|594065796|FG000|Overall Study|Screen Failure|1|||
164462623|NCT03899259|594065797|FG001|Overall Study|Screen Failure|0|||
164462624|NCT03899259|594065798|FG002|Overall Study|Screen Failure|0|||
164462625|NCT03899259|594065796|FG000|Overall Study|Ongoing Study Participation|127|||
164462626|NCT03899259|594065797|FG001|Overall Study|Ongoing Study Participation|134|||
164462627|NCT03899259|594065798|FG002|Overall Study|Ongoing Study Participation|210|||
164462628|NCT01152450|594065799|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
164462629|NCT01152450|594065800|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
164462630|NCT01152450|594065801|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
164462631|NCT01152450|594065802|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
164707811|NCT01517373|594955351|FG000|Run-in Period|Did not meet eligibility criteria|34|||
164707812|NCT01517373|594955352|FG001|Run-in Period|Did not meet eligibility criteria|0|||
164462632|NCT01152450|594065803|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
164462633|NCT01152450|594065804|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
164707813|NCT01517373|594955353|FG002|Run-in Period|Did not meet eligibility criteria|0|||
164707814|NCT01517373|594955354|FG003|Run-in Period|Did not meet eligibility criteria|0|||
164707815|NCT01517373|594955355|FG004|Run-in Period|Did not meet eligibility criteria|0|||
164707816|NCT01517373|594955356|FG005|Run-in Period|Did not meet eligibility criteria|0|||
164707817|NCT01517373|594955351|FG000|Run-in Period|Lost to Follow-up|1|||
164707818|NCT01517373|594955352|FG001|Run-in Period|Lost to Follow-up|0|||
164707819|NCT01517373|594955353|FG002|Run-in Period|Lost to Follow-up|0|||
164707820|NCT01517373|594955354|FG003|Run-in Period|Lost to Follow-up|0|||
164462634|NCT01152450|594065799|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
164462635|NCT01152450|594065800|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
164462636|NCT01152450|594065801|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
164707821|NCT01517373|594955355|FG004|Run-in Period|Lost to Follow-up|0|||
164707822|NCT01517373|594955356|FG005|Run-in Period|Lost to Follow-up|0|||
164707823|NCT01517373|594955351|FG000|Run-in Period|Withdrawal by Subject|12|||
164707824|NCT01517373|594955352|FG001|Run-in Period|Withdrawal by Subject|0|||
164707825|NCT01517373|594955353|FG002|Run-in Period|Withdrawal by Subject|0|||
164707826|NCT01517373|594955354|FG003|Run-in Period|Withdrawal by Subject|0|||
164707827|NCT01517373|594955355|FG004|Run-in Period|Withdrawal by Subject|0|||
164707828|NCT01517373|594955356|FG005|Run-in Period|Withdrawal by Subject|0|||
164707829|NCT01517373|594955351|FG000|Run-in Period|Sponsor Decision|3|||
164707830|NCT01517373|594955352|FG001|Run-in Period|Sponsor Decision|0|||
164707831|NCT01517373|594955353|FG002|Run-in Period|Sponsor Decision|0|||
164707832|NCT01517373|594955354|FG003|Run-in Period|Sponsor Decision|0|||
164707833|NCT01517373|594955355|FG004|Run-in Period|Sponsor Decision|0|||
164707834|NCT01517373|594955356|FG005|Run-in Period|Sponsor Decision|0|||
164707835|NCT01517373|594955351|FG000|Run-in Period|Other|1|||
164707836|NCT01517373|594955352|FG001|Run-in Period|Other|0|||
164707837|NCT01517373|594955353|FG002|Run-in Period|Other|0|||
164707838|NCT01517373|594955354|FG003|Run-in Period|Other|0|||
164707839|NCT01517373|594955355|FG004|Run-in Period|Other|0|||
164707840|NCT01517373|594955356|FG005|Run-in Period|Other|0|||
164707841|NCT01517373|594955351|FG000|Treatment Period|Adverse Event|0|||
164707842|NCT01517373|594955352|FG001|Treatment Period|Adverse Event|0|||
164462637|NCT01152450|594065802|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
164462638|NCT01152450|594065803|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
164462639|NCT01152450|594065804|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
164462640|NCT01152450|594065799|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
164462641|NCT01152450|594065800|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
164462642|NCT01152450|594065801|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
164462643|NCT01152450|594065802|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
164462644|NCT01152450|594065803|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
164462645|NCT01152450|594065804|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
164462646|NCT05670587|594065805|FG000|Overall Study|Withdrawal by Subject|3|||
164462647|NCT01544114|594065809|FG000|Overall Study|Withdrawal by Subject|0|||
164462648|NCT01544114|594065810|FG001|Overall Study|Withdrawal by Subject|0|||
164462649|NCT01544114|594065811|FG002|Overall Study|Withdrawal by Subject|3|||
164462650|NCT01544114|594065809|FG000|Overall Study|Lost to Follow-up|0|||
164462651|NCT01544114|594065810|FG001|Overall Study|Lost to Follow-up|2|||
164462652|NCT01544114|594065811|FG002|Overall Study|Lost to Follow-up|0|||
164462653|NCT01544114|594065809|FG000|Overall Study|Adverse Event|1|||
164462654|NCT01544114|594065810|FG001|Overall Study|Adverse Event|1|||
164462655|NCT01544114|594065811|FG002|Overall Study|Adverse Event|2|||
164462656|NCT01544114|594065809|FG000|Overall Study|Protocol Violation|0|||
164462657|NCT01544114|594065810|FG001|Overall Study|Protocol Violation|1|||
164462658|NCT01544114|594065811|FG002|Overall Study|Protocol Violation|0|||
164462659|NCT04508309|594065816|FG000|Overall Study|Death|0|||
164462660|NCT04508309|594065817|FG001|Overall Study|Death|0|||
164462661|NCT04508309|594065818|FG002|Overall Study|Death|0|||
164462662|NCT04508309|594065819|FG003|Overall Study|Death|0|||
164462663|NCT04508309|594065820|FG004|Overall Study|Death|1|||
164462664|NCT04508309|594065816|FG000|Overall Study|Lost to Follow-up|0|||
164462665|NCT04508309|594065817|FG001|Overall Study|Lost to Follow-up|0|||
164462666|NCT04508309|594065818|FG002|Overall Study|Lost to Follow-up|1|||
164462667|NCT04508309|594065819|FG003|Overall Study|Lost to Follow-up|1|||
164462668|NCT04508309|594065820|FG004|Overall Study|Lost to Follow-up|0|||
164462669|NCT04508309|594065816|FG000|Overall Study|Withdrawal by Subject|0|||
164462670|NCT04508309|594065817|FG001|Overall Study|Withdrawal by Subject|0|||
164462671|NCT04508309|594065818|FG002|Overall Study|Withdrawal by Subject|0|||
164462672|NCT04508309|594065819|FG003|Overall Study|Withdrawal by Subject|0|||
164707843|NCT01517373|594955353|FG002|Treatment Period|Adverse Event|0|||
164707844|NCT01517373|594955354|FG003|Treatment Period|Adverse Event|0|||
164462673|NCT04508309|594065820|FG004|Overall Study|Withdrawal by Subject|1|||
164462674|NCT02305888|594065829|FG000|Overall Study|Lost to Follow-up|0|||
164462675|NCT02305888|594065830|FG001|Overall Study|Lost to Follow-up|0|||
164462676|NCT02305888|594065831|FG002|Overall Study|Lost to Follow-up|1|||
164462677|NCT02305888|594065829|FG000|Overall Study|Adverse Event|0|||
164462678|NCT02305888|594065830|FG001|Overall Study|Adverse Event|1|||
164462679|NCT02305888|594065831|FG002|Overall Study|Adverse Event|0|||
164598950|NCT02883049|594554763|FG007|Post Induction|Physician Decision|56|||
164598951|NCT02883049|594554764|FG008|Post Induction|Physician Decision|85|||
164598952|NCT02883049|594554765|FG009|Post Induction|Physician Decision|12|||
164598953|NCT02883049|594554766|FG010|Post Induction|Physician Decision|5|||
164598954|NCT02883049|594554767|FG011|Post Induction|Physician Decision|14|||
164598955|NCT02883049|594554768|FG012|Post Induction|Physician Decision|1|||
164598956|NCT02883049|594554769|FG013|Post Induction|Physician Decision|11|||
164598957|NCT02883049|594554770|FG014|Post Induction|Physician Decision|19|||
164598958|NCT02883049|594554771|FG015|Post Induction|Physician Decision|5|||
164462680|NCT05139810|594065832|FG000|Overall Study|Voluntary Withdrawal|2|||
164462681|NCT05139810|594065833|FG001|Overall Study|Voluntary Withdrawal|1|||
164462682|NCT05139810|594065834|FG002|Overall Study|Voluntary Withdrawal|0|||
164707845|NCT01517373|594955355|FG004|Treatment Period|Adverse Event|0|||
164462683|NCT05139810|594065832|FG000|Overall Study|Pregnancy|1|||
164462684|NCT05139810|594065833|FG001|Overall Study|Pregnancy|0|||
164462685|NCT05139810|594065834|FG002|Overall Study|Pregnancy|0|||
164462686|NCT05139810|594065832|FG000|Overall Study|Roll Over to CS7|19|||
164462687|NCT05139810|594065833|FG001|Overall Study|Roll Over to CS7|44|||
164462688|NCT05139810|594065834|FG002|Overall Study|Roll Over to CS7|20|||
164462689|NCT05940194|594065835|FG000|Overall Study|Adverse Event|0|||
164462690|NCT05940194|594065836|FG001|Overall Study|Adverse Event|1|||
164462691|NCT05940194|594065837|FG002|Overall Study|Adverse Event|0|||
164462692|NCT05940194|594065835|FG000|Overall Study|Migrated/Moved from the study area|2|||
164462693|NCT05940194|594065836|FG001|Overall Study|Migrated/Moved from the study area|2|||
164462694|NCT05940194|594065837|FG002|Overall Study|Migrated/Moved from the study area|4|||
164462695|NCT03800654|594065838|FG000|Overall Study|Time constraints|3|||
164462696|NCT03800654|594065839|FG001|Overall Study|Time constraints|3|||
164462697|NCT03800654|594065840|FG002|Overall Study|Time constraints|3|||
164462698|NCT03800654|594065838|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
164462699|NCT03800654|594065839|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
164462700|NCT03800654|594065840|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
164462701|NCT03800654|594065838|FG000|Overall Study|Lost to Follow-up|2|||
164462702|NCT03800654|594065839|FG001|Overall Study|Lost to Follow-up|1|||
164462703|NCT03800654|594065840|FG002|Overall Study|Lost to Follow-up|6|||
164462704|NCT03800654|594065838|FG000|Overall Study|Medical Health Issue|0|||
164462705|NCT03800654|594065839|FG001|Overall Study|Medical Health Issue|0|||
164462706|NCT03800654|594065840|FG002|Overall Study|Medical Health Issue|1|||
164462707|NCT03800654|594065838|FG000|Overall Study|Personal Issues|0|||
164462708|NCT03800654|594065839|FG001|Overall Study|Personal Issues|2|||
164462709|NCT03800654|594065840|FG002|Overall Study|Personal Issues|0|||
164462710|NCT03800654|594065838|FG000|Overall Study|Protocol Violation|0|||
164462711|NCT03800654|594065839|FG001|Overall Study|Protocol Violation|1|||
164462712|NCT03800654|594065840|FG002|Overall Study|Protocol Violation|0|||
164462713|NCT03459729|594065841|FG000|Overall Study|Physician Decision|2|||
164462714|NCT04498390|594065845|FG000|Overall Study|Adverse Event|0|||
164462715|NCT04498390|594065846|FG001|Overall Study|Adverse Event|0|||
164462716|NCT04498390|594065847|FG002|Overall Study|Adverse Event|1|||
164462717|NCT04498390|594065848|FG003|Overall Study|Adverse Event|0|||
164462718|NCT04498390|594065849|FG004|Overall Study|Adverse Event|0|||
164462719|NCT04498390|594065845|FG000|Overall Study|Withdrawal by Subject|0|||
164462720|NCT04498390|594065846|FG001|Overall Study|Withdrawal by Subject|0|||
164462721|NCT04498390|594065847|FG002|Overall Study|Withdrawal by Subject|0|||
164462722|NCT04498390|594065848|FG003|Overall Study|Withdrawal by Subject|1|||
164462723|NCT04498390|594065849|FG004|Overall Study|Withdrawal by Subject|0|||
164462724|NCT04721977|594065852|FG000|Overall Study|Death|15|||
164462725|NCT04721977|594065852|FG000|Overall Study|Ongoing|51|||
164462726|NCT05693935|594068510|FG000|Double-blind Period (8 Weeks)|Adverse Event|5|||
164462727|NCT05693935|594068511|FG001|Double-blind Period (8 Weeks)|Adverse Event|4|||
164598959|NCT02883049|594554756|FG000|Post Induction|Protocol Violation|0|||
164598960|NCT02883049|594554757|FG001|Post Induction|Protocol Violation|0|||
164598961|NCT02883049|594554758|FG002|Post Induction|Protocol Violation|0|||
164598962|NCT02883049|594554759|FG003|Post Induction|Protocol Violation|0|||
164598963|NCT02883049|594554760|FG004|Post Induction|Protocol Violation|0|||
164598964|NCT02883049|594554761|FG005|Post Induction|Protocol Violation|0|||
164598965|NCT02883049|594554762|FG006|Post Induction|Protocol Violation|0|||
164598966|NCT02883049|594554763|FG007|Post Induction|Protocol Violation|1|||
164598967|NCT02883049|594554764|FG008|Post Induction|Protocol Violation|0|||
164598968|NCT02883049|594554765|FG009|Post Induction|Protocol Violation|0|||
164598969|NCT02883049|594554766|FG010|Post Induction|Protocol Violation|0|||
164598970|NCT02883049|594554767|FG011|Post Induction|Protocol Violation|0|||
164598971|NCT02883049|594554768|FG012|Post Induction|Protocol Violation|0|||
164598972|NCT02883049|594554769|FG013|Post Induction|Protocol Violation|0|||
164598973|NCT02883049|594554770|FG014|Post Induction|Protocol Violation|0|||
164598974|NCT02883049|594554771|FG015|Post Induction|Protocol Violation|0|||
164598975|NCT02883049|594554756|FG000|Post Induction|Withdrawal by Subject|0|||
164462728|NCT05693935|594068512|FG002|Double-blind Period (8 Weeks)|Adverse Event|2|||
164462729|NCT05693935|594068513|FG003|Double-blind Period (8 Weeks)|Adverse Event|3|||
164462730|NCT05693935|594068514|FG004|Double-blind Period (8 Weeks)|Adverse Event|0|||
164462731|NCT05693935|594068515|FG005|Double-blind Period (8 Weeks)|Adverse Event|0|||
164462732|NCT05693935|594068516|FG006|Double-blind Period (8 Weeks)|Adverse Event|0|||
164462733|NCT05693935|594068510|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|26|||
164462734|NCT05693935|594068511|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|35|||
164598976|NCT02883049|594554757|FG001|Post Induction|Withdrawal by Subject|0|||
164462735|NCT05693935|594068512|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|31|||
164462736|NCT05693935|594068513|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|33|||
164462737|NCT05693935|594068514|FG004|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
164462738|NCT05693935|594068515|FG005|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
164462739|NCT05693935|594068516|FG006|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
164462740|NCT05693935|594068510|FG000|Double-blind Period (8 Weeks)|Lost to Follow-up|5|||
164462741|NCT05693935|594068511|FG001|Double-blind Period (8 Weeks)|Lost to Follow-up|4|||
164462742|NCT05693935|594068512|FG002|Double-blind Period (8 Weeks)|Lost to Follow-up|6|||
164462743|NCT05693935|594068513|FG003|Double-blind Period (8 Weeks)|Lost to Follow-up|4|||
164462744|NCT05693935|594068514|FG004|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
164462745|NCT05693935|594068515|FG005|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
164462746|NCT05693935|594068516|FG006|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
164462747|NCT05693935|594068510|FG000|Double-blind Period (8 Weeks)|Lack of Efficacy|1|||
164462748|NCT05693935|594068511|FG001|Double-blind Period (8 Weeks)|Lack of Efficacy|1|||
164462749|NCT05693935|594068512|FG002|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
164462750|NCT05693935|594068513|FG003|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
164462751|NCT05693935|594068514|FG004|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
164462752|NCT05693935|594068515|FG005|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
164462753|NCT05693935|594068516|FG006|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
164462754|NCT05693935|594068510|FG000|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
164462755|NCT05693935|594068511|FG001|Double-blind Period (8 Weeks)|Randomized But Not Treated|5|||
164462756|NCT05693935|594068512|FG002|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
164462757|NCT05693935|594068513|FG003|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
164462758|NCT05693935|594068514|FG004|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
164462759|NCT05693935|594068515|FG005|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
164462760|NCT05693935|594068516|FG006|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
164462761|NCT05693935|594068510|FG000|Double-blind Period (8 Weeks)|Other Than Specified|11|||
164462762|NCT05693935|594068511|FG001|Double-blind Period (8 Weeks)|Other Than Specified|5|||
164462763|NCT05693935|594068512|FG002|Double-blind Period (8 Weeks)|Other Than Specified|8|||
164462764|NCT05693935|594068513|FG003|Double-blind Period (8 Weeks)|Other Than Specified|7|||
164462765|NCT05693935|594068514|FG004|Double-blind Period (8 Weeks)|Other Than Specified|0|||
164462766|NCT05693935|594068515|FG005|Double-blind Period (8 Weeks)|Other Than Specified|0|||
164462767|NCT05693935|594068516|FG006|Double-blind Period (8 Weeks)|Other Than Specified|0|||
164462768|NCT05693935|594068510|FG000|Open-label Period (48 Weeks)|Adverse Event|0|||
164462769|NCT05693935|594068511|FG001|Open-label Period (48 Weeks)|Adverse Event|5|||
164462770|NCT05693935|594068512|FG002|Open-label Period (48 Weeks)|Adverse Event|6|||
164462771|NCT05693935|594068513|FG003|Open-label Period (48 Weeks)|Adverse Event|14|||
164462772|NCT05693935|594068514|FG004|Open-label Period (48 Weeks)|Adverse Event|4|||
164462773|NCT05693935|594068515|FG005|Open-label Period (48 Weeks)|Adverse Event|1|||
164462774|NCT05693935|594068516|FG006|Open-label Period (48 Weeks)|Adverse Event|3|||
164462775|NCT05693935|594068510|FG000|Open-label Period (48 Weeks)|Withdrawal by Subject|0|||
164462776|NCT05693935|594068511|FG001|Open-label Period (48 Weeks)|Withdrawal by Subject|32|||
164462777|NCT05693935|594068512|FG002|Open-label Period (48 Weeks)|Withdrawal by Subject|29|||
164462778|NCT05693935|594068513|FG003|Open-label Period (48 Weeks)|Withdrawal by Subject|39|||
164462779|NCT05693935|594068514|FG004|Open-label Period (48 Weeks)|Withdrawal by Subject|14|||
164462780|NCT05693935|594068515|FG005|Open-label Period (48 Weeks)|Withdrawal by Subject|15|||
164462781|NCT05693935|594068516|FG006|Open-label Period (48 Weeks)|Withdrawal by Subject|8|||
164462782|NCT05693935|594068510|FG000|Open-label Period (48 Weeks)|Protocol Violation|0|||
164462783|NCT05693935|594068511|FG001|Open-label Period (48 Weeks)|Protocol Violation|1|||
164462784|NCT05693935|594068512|FG002|Open-label Period (48 Weeks)|Protocol Violation|1|||
164462785|NCT05693935|594068513|FG003|Open-label Period (48 Weeks)|Protocol Violation|1|||
164462786|NCT05693935|594068514|FG004|Open-label Period (48 Weeks)|Protocol Violation|0|||
164462787|NCT05693935|594068515|FG005|Open-label Period (48 Weeks)|Protocol Violation|0|||
164462788|NCT05693935|594068516|FG006|Open-label Period (48 Weeks)|Protocol Violation|0|||
164462789|NCT05693935|594068510|FG000|Open-label Period (48 Weeks)|Lost to Follow-up|0|||
164462790|NCT05693935|594068511|FG001|Open-label Period (48 Weeks)|Lost to Follow-up|17|||
164462791|NCT05693935|594068512|FG002|Open-label Period (48 Weeks)|Lost to Follow-up|19|||
164462792|NCT05693935|594068513|FG003|Open-label Period (48 Weeks)|Lost to Follow-up|17|||
164462793|NCT05693935|594068514|FG004|Open-label Period (48 Weeks)|Lost to Follow-up|3|||
164462794|NCT05693935|594068515|FG005|Open-label Period (48 Weeks)|Lost to Follow-up|5|||
164462795|NCT05693935|594068516|FG006|Open-label Period (48 Weeks)|Lost to Follow-up|4|||
164462796|NCT05693935|594068510|FG000|Open-label Period (48 Weeks)|Lack of Efficacy|0|||
164462797|NCT05693935|594068511|FG001|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
164462798|NCT05693935|594068512|FG002|Open-label Period (48 Weeks)|Lack of Efficacy|2|||
164462799|NCT05693935|594068513|FG003|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
164462800|NCT05693935|594068514|FG004|Open-label Period (48 Weeks)|Lack of Efficacy|0|||
164462801|NCT05693935|594068515|FG005|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
164462802|NCT05693935|594068516|FG006|Open-label Period (48 Weeks)|Lack of Efficacy|2|||
164462803|NCT05693935|594068510|FG000|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
164407938|NCT04543188|593864510|FG010|Phase 1a|Other (Death)|0|||
164407939|NCT04543188|593864511|FG011|Phase 1a|Other (Death)|0|||
164407940|NCT04543188|593864512|FG012|Phase 1a|Other (Death)|0|||
164407941|NCT04543188|593864513|FG013|Phase 1a|Other (Death)|0|||
164407942|NCT04543188|593864514|FG014|Phase 1a|Other (Death)|0|||
164407943|NCT04543188|593864500|FG000|Phase 1a|Lost to Follow-up|0|||
164407944|NCT04543188|593864501|FG001|Phase 1a|Lost to Follow-up|0|||
164407945|NCT04543188|593864502|FG002|Phase 1a|Lost to Follow-up|0|||
164407946|NCT04543188|593864503|FG003|Phase 1a|Lost to Follow-up|0|||
164407947|NCT04543188|593864504|FG004|Phase 1a|Lost to Follow-up|0|||
164407948|NCT04543188|593864505|FG005|Phase 1a|Lost to Follow-up|0|||
164407949|NCT04543188|593864506|FG006|Phase 1a|Lost to Follow-up|0|||
164407950|NCT04543188|593864507|FG007|Phase 1a|Lost to Follow-up|0|||
164407951|NCT04543188|593864508|FG008|Phase 1a|Lost to Follow-up|0|||
164407952|NCT04543188|593864509|FG009|Phase 1a|Lost to Follow-up|0|||
164407953|NCT04543188|593864510|FG010|Phase 1a|Lost to Follow-up|1|||
164407954|NCT04543188|593864511|FG011|Phase 1a|Lost to Follow-up|0|||
164407955|NCT04543188|593864512|FG012|Phase 1a|Lost to Follow-up|0|||
164407956|NCT04543188|593864513|FG013|Phase 1a|Lost to Follow-up|0|||
164407957|NCT04543188|593864514|FG014|Phase 1a|Lost to Follow-up|0|||
164407958|NCT04543188|593864500|FG000|Phase 1a|Progressive Disease|2|||
164407959|NCT04543188|593864501|FG001|Phase 1a|Progressive Disease|2|||
164407960|NCT04543188|593864502|FG002|Phase 1a|Progressive Disease|3|||
164407961|NCT04543188|593864503|FG003|Phase 1a|Progressive Disease|1|||
164407962|NCT04543188|593864504|FG004|Phase 1a|Progressive Disease|4|||
164407963|NCT04543188|593864505|FG005|Phase 1a|Progressive Disease|2|||
164407964|NCT04543188|593864506|FG006|Phase 1a|Progressive Disease|3|||
164407965|NCT04543188|593864507|FG007|Phase 1a|Progressive Disease|4|||
164407966|NCT04543188|593864508|FG008|Phase 1a|Progressive Disease|1|||
164407967|NCT04543188|593864509|FG009|Phase 1a|Progressive Disease|0|||
164407968|NCT04543188|593864510|FG010|Phase 1a|Progressive Disease|4|||
164407969|NCT04543188|593864511|FG011|Phase 1a|Progressive Disease|0|||
164407970|NCT04543188|593864512|FG012|Phase 1a|Progressive Disease|0|||
164407971|NCT04543188|593864513|FG013|Phase 1a|Progressive Disease|0|||
164407972|NCT04543188|593864514|FG014|Phase 1a|Progressive Disease|0|||
164407973|NCT04543188|593864500|FG000|Phase 1a|Study terminated by sponsor|0|||
164407974|NCT04543188|593864501|FG001|Phase 1a|Study terminated by sponsor|0|||
164407975|NCT04543188|593864502|FG002|Phase 1a|Study terminated by sponsor|0|||
164407976|NCT04543188|593864503|FG003|Phase 1a|Study terminated by sponsor|0|||
164407977|NCT04543188|593864504|FG004|Phase 1a|Study terminated by sponsor|1|||
164407978|NCT04543188|593864505|FG005|Phase 1a|Study terminated by sponsor|0|||
164407979|NCT04543188|593864506|FG006|Phase 1a|Study terminated by sponsor|0|||
164407980|NCT04543188|593864507|FG007|Phase 1a|Study terminated by sponsor|0|||
164407981|NCT04543188|593864508|FG008|Phase 1a|Study terminated by sponsor|0|||
164407982|NCT04543188|593864509|FG009|Phase 1a|Study terminated by sponsor|0|||
164407983|NCT04543188|593864510|FG010|Phase 1a|Study terminated by sponsor|1|||
164407984|NCT04543188|593864511|FG011|Phase 1a|Study terminated by sponsor|0|||
164407985|NCT04543188|593864512|FG012|Phase 1a|Study terminated by sponsor|0|||
164407986|NCT04543188|593864513|FG013|Phase 1a|Study terminated by sponsor|0|||
164407987|NCT04543188|593864514|FG014|Phase 1a|Study terminated by sponsor|0|||
164407988|NCT04543188|593864500|FG000|Phase 1a|Withdrawal by Subject|0|||
164407989|NCT04543188|593864501|FG001|Phase 1a|Withdrawal by Subject|0|||
164407990|NCT04543188|593864502|FG002|Phase 1a|Withdrawal by Subject|0|||
164407991|NCT04543188|593864503|FG003|Phase 1a|Withdrawal by Subject|0|||
164707846|NCT01517373|594955356|FG005|Treatment Period|Adverse Event|2|||
164407992|NCT04543188|593864504|FG004|Phase 1a|Withdrawal by Subject|3|||
164407993|NCT04543188|593864505|FG005|Phase 1a|Withdrawal by Subject|0|||
164407994|NCT04543188|593864506|FG006|Phase 1a|Withdrawal by Subject|0|||
164462804|NCT05693935|594068511|FG001|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
164407995|NCT04543188|593864507|FG007|Phase 1a|Withdrawal by Subject|0|||
164407996|NCT04543188|593864508|FG008|Phase 1a|Withdrawal by Subject|1|||
164407997|NCT04543188|593864509|FG009|Phase 1a|Withdrawal by Subject|1|||
164407998|NCT04543188|593864510|FG010|Phase 1a|Withdrawal by Subject|2|||
164407999|NCT04543188|593864511|FG011|Phase 1a|Withdrawal by Subject|0|||
164408000|NCT04543188|593864512|FG012|Phase 1a|Withdrawal by Subject|0|||
164462805|NCT05693935|594068512|FG002|Open-label Period (48 Weeks)|Randomized But Not Treated|1|||
164408001|NCT04543188|593864513|FG013|Phase 1a|Withdrawal by Subject|0|||
164408002|NCT04543188|593864514|FG014|Phase 1a|Withdrawal by Subject|0|||
164408003|NCT04543188|593864500|FG000|Phase 1a|Global Deterioration Of Health Status|0|||
164408004|NCT04543188|593864501|FG001|Phase 1a|Global Deterioration Of Health Status|1|||
164408005|NCT04543188|593864502|FG002|Phase 1a|Global Deterioration Of Health Status|0|||
164462806|NCT05693935|594068513|FG003|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
164462807|NCT05693935|594068514|FG004|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
164408006|NCT04543188|593864503|FG003|Phase 1a|Global Deterioration Of Health Status|1|||
164408007|NCT04543188|593864504|FG004|Phase 1a|Global Deterioration Of Health Status|1|||
164408008|NCT04543188|593864505|FG005|Phase 1a|Global Deterioration Of Health Status|1|||
164408009|NCT04543188|593864506|FG006|Phase 1a|Global Deterioration Of Health Status|0|||
164408010|NCT04543188|593864507|FG007|Phase 1a|Global Deterioration Of Health Status|0|||
164408011|NCT04543188|593864508|FG008|Phase 1a|Global Deterioration Of Health Status|0|||
164408012|NCT04543188|593864509|FG009|Phase 1a|Global Deterioration Of Health Status|2|||
164408013|NCT04543188|593864510|FG010|Phase 1a|Global Deterioration Of Health Status|0|||
164408014|NCT04543188|593864511|FG011|Phase 1a|Global Deterioration Of Health Status|0|||
164408015|NCT04543188|593864512|FG012|Phase 1a|Global Deterioration Of Health Status|0|||
164408016|NCT04543188|593864513|FG013|Phase 1a|Global Deterioration Of Health Status|0|||
164408017|NCT04543188|593864514|FG014|Phase 1a|Global Deterioration Of Health Status|0|||
164408018|NCT04543188|593864500|FG000|Phase 1a|Other|0|||
164408019|NCT04543188|593864501|FG001|Phase 1a|Other|0|||
164408020|NCT04543188|593864502|FG002|Phase 1a|Other|0|||
164408021|NCT04543188|593864503|FG003|Phase 1a|Other|0|||
164408022|NCT04543188|593864504|FG004|Phase 1a|Other|0|||
164408023|NCT04543188|593864505|FG005|Phase 1a|Other|0|||
164408024|NCT04543188|593864506|FG006|Phase 1a|Other|0|||
164408025|NCT04543188|593864507|FG007|Phase 1a|Other|0|||
164408026|NCT04543188|593864508|FG008|Phase 1a|Other|0|||
164408027|NCT04543188|593864509|FG009|Phase 1a|Other|1|||
164408028|NCT04543188|593864510|FG010|Phase 1a|Other|0|||
164408029|NCT04543188|593864511|FG011|Phase 1a|Other|0|||
164408030|NCT04543188|593864512|FG012|Phase 1a|Other|0|||
164408031|NCT04543188|593864513|FG013|Phase 1a|Other|0|||
164408032|NCT04543188|593864514|FG014|Phase 1a|Other|0|||
164408033|NCT04543188|593864500|FG000|Phase 1b|Adverse Event|0|||
164408034|NCT04543188|593864501|FG001|Phase 1b|Adverse Event|0|||
164408035|NCT04543188|593864502|FG002|Phase 1b|Adverse Event|0|||
164408036|NCT04543188|593864503|FG003|Phase 1b|Adverse Event|0|||
164408037|NCT04543188|593864504|FG004|Phase 1b|Adverse Event|0|||
164408038|NCT04543188|593864505|FG005|Phase 1b|Adverse Event|0|||
164408039|NCT04543188|593864506|FG006|Phase 1b|Adverse Event|0|||
164598977|NCT02883049|594554758|FG002|Post Induction|Withdrawal by Subject|0|||
164598978|NCT02883049|594554759|FG003|Post Induction|Withdrawal by Subject|5|||
164598979|NCT02883049|594554760|FG004|Post Induction|Withdrawal by Subject|2|||
164408040|NCT04543188|593864507|FG007|Phase 1b|Adverse Event|0|||
164408041|NCT04543188|593864508|FG008|Phase 1b|Adverse Event|0|||
164408042|NCT04543188|593864509|FG009|Phase 1b|Adverse Event|0|||
164408043|NCT04543188|593864510|FG010|Phase 1b|Adverse Event|0|||
164408044|NCT04543188|593864511|FG011|Phase 1b|Adverse Event|0|||
164408045|NCT04543188|593864512|FG012|Phase 1b|Adverse Event|0|||
164408046|NCT04543188|593864513|FG013|Phase 1b|Adverse Event|0|||
164408047|NCT04543188|593864514|FG014|Phase 1b|Adverse Event|2|||
164408048|NCT04543188|593864500|FG000|Phase 1b|Other (Death)|0|||
164408049|NCT04543188|593864501|FG001|Phase 1b|Other (Death)|0|||
164408050|NCT04543188|593864502|FG002|Phase 1b|Other (Death)|0|||
164408051|NCT04543188|593864503|FG003|Phase 1b|Other (Death)|0|||
164408052|NCT04543188|593864504|FG004|Phase 1b|Other (Death)|0|||
164408053|NCT04543188|593864505|FG005|Phase 1b|Other (Death)|0|||
164408054|NCT04543188|593864506|FG006|Phase 1b|Other (Death)|0|||
164408055|NCT04543188|593864507|FG007|Phase 1b|Other (Death)|0|||
164408056|NCT04543188|593864508|FG008|Phase 1b|Other (Death)|0|||
164408057|NCT04543188|593864509|FG009|Phase 1b|Other (Death)|0|||
164408058|NCT04543188|593864510|FG010|Phase 1b|Other (Death)|0|||
164408059|NCT04543188|593864511|FG011|Phase 1b|Other (Death)|0|||
164408060|NCT04543188|593864512|FG012|Phase 1b|Other (Death)|1|||
164408061|NCT04543188|593864513|FG013|Phase 1b|Other (Death)|0|||
164408062|NCT04543188|593864514|FG014|Phase 1b|Other (Death)|1|||
164408063|NCT04543188|593864500|FG000|Phase 1b|Progressive Disease|0|||
164408064|NCT04543188|593864501|FG001|Phase 1b|Progressive Disease|0|||
164408065|NCT04543188|593864502|FG002|Phase 1b|Progressive Disease|0|||
164408066|NCT04543188|593864503|FG003|Phase 1b|Progressive Disease|0|||
164408067|NCT04543188|593864504|FG004|Phase 1b|Progressive Disease|0|||
164408068|NCT04543188|593864505|FG005|Phase 1b|Progressive Disease|0|||
164408069|NCT04543188|593864506|FG006|Phase 1b|Progressive Disease|0|||
164408070|NCT04543188|593864507|FG007|Phase 1b|Progressive Disease|0|||
164598980|NCT02883049|594554761|FG005|Post Induction|Withdrawal by Subject|1|||
164408071|NCT04543188|593864508|FG008|Phase 1b|Progressive Disease|0|||
164408072|NCT04543188|593864509|FG009|Phase 1b|Progressive Disease|0|||
164408073|NCT04543188|593864510|FG010|Phase 1b|Progressive Disease|0|||
164408074|NCT04543188|593864511|FG011|Phase 1b|Progressive Disease|0|||
164408075|NCT04543188|593864512|FG012|Phase 1b|Progressive Disease|2|||
164408076|NCT04543188|593864513|FG013|Phase 1b|Progressive Disease|1|||
164408077|NCT04543188|593864514|FG014|Phase 1b|Progressive Disease|5|||
164408078|NCT04543188|593864500|FG000|Phase 1b|Study Terminated By Sponsor|0|||
164408079|NCT04543188|593864501|FG001|Phase 1b|Study Terminated By Sponsor|0|||
164408080|NCT04543188|593864502|FG002|Phase 1b|Study Terminated By Sponsor|0|||
164408081|NCT04543188|593864503|FG003|Phase 1b|Study Terminated By Sponsor|0|||
164408082|NCT04543188|593864504|FG004|Phase 1b|Study Terminated By Sponsor|0|||
164408083|NCT04543188|593864505|FG005|Phase 1b|Study Terminated By Sponsor|0|||
164408084|NCT04543188|593864506|FG006|Phase 1b|Study Terminated By Sponsor|0|||
164408085|NCT04543188|593864507|FG007|Phase 1b|Study Terminated By Sponsor|0|||
164408086|NCT04543188|593864508|FG008|Phase 1b|Study Terminated By Sponsor|0|||
164408087|NCT04543188|593864509|FG009|Phase 1b|Study Terminated By Sponsor|0|||
164408088|NCT04543188|593864510|FG010|Phase 1b|Study Terminated By Sponsor|0|||
164408089|NCT04543188|593864511|FG011|Phase 1b|Study Terminated By Sponsor|1|||
164408090|NCT04543188|593864512|FG012|Phase 1b|Study Terminated By Sponsor|1|||
164408091|NCT04543188|593864513|FG013|Phase 1b|Study Terminated By Sponsor|0|||
164408092|NCT04543188|593864514|FG014|Phase 1b|Study Terminated By Sponsor|1|||
164408093|NCT04543188|593864500|FG000|Phase 1b|Withdrawal by Subject|0|||
164408094|NCT04543188|593864501|FG001|Phase 1b|Withdrawal by Subject|0|||
164408095|NCT04543188|593864502|FG002|Phase 1b|Withdrawal by Subject|0|||
164408096|NCT04543188|593864503|FG003|Phase 1b|Withdrawal by Subject|0|||
164408097|NCT04543188|593864504|FG004|Phase 1b|Withdrawal by Subject|0|||
164408098|NCT04543188|593864505|FG005|Phase 1b|Withdrawal by Subject|0|||
164408099|NCT04543188|593864506|FG006|Phase 1b|Withdrawal by Subject|0|||
164408100|NCT04543188|593864507|FG007|Phase 1b|Withdrawal by Subject|0|||
164408101|NCT04543188|593864508|FG008|Phase 1b|Withdrawal by Subject|0|||
164408102|NCT04543188|593864509|FG009|Phase 1b|Withdrawal by Subject|0|||
164408103|NCT04543188|593864510|FG010|Phase 1b|Withdrawal by Subject|0|||
164408104|NCT04543188|593864511|FG011|Phase 1b|Withdrawal by Subject|0|||
164408105|NCT04543188|593864512|FG012|Phase 1b|Withdrawal by Subject|0|||
164408106|NCT04543188|593864513|FG013|Phase 1b|Withdrawal by Subject|0|||
164408107|NCT04543188|593864514|FG014|Phase 1b|Withdrawal by Subject|2|||
164408108|NCT03815019|593864515|FG000|Overall Study|Withdrawal by Subject|6|||
164408109|NCT03815019|593864516|FG001|Overall Study|Withdrawal by Subject|8|||
164408110|NCT05398796|593864517|FG000|Overall Study|Participant moved from the area|0|||
164408111|NCT05398796|593864518|FG001|Overall Study|Participant moved from the area|1|||
164408112|NCT05398796|593864519|FG002|Overall Study|Participant moved from the area|0|||
164408113|NCT05398796|593864520|FG003|Overall Study|Participant moved from the area|0|||
164408114|NCT05960097|593864521|FG000|Overall Study|Lost to Follow-up|3|||
164408115|NCT05960097|593864522|FG001|Overall Study|Lost to Follow-up|1|||
164408116|NCT05960097|593864523|FG002|Overall Study|Lost to Follow-up|1|||
164408117|NCT05960097|593864524|FG003|Overall Study|Lost to Follow-up|2|||
164408118|NCT05960097|593864525|FG004|Overall Study|Lost to Follow-up|1|||
164408119|NCT05960097|593864526|FG005|Overall Study|Lost to Follow-up|1|||
164408120|NCT05960097|593864527|FG006|Overall Study|Lost to Follow-up|2|||
164408121|NCT05960097|593864528|FG007|Overall Study|Lost to Follow-up|3|||
164408122|NCT05960097|593864521|FG000|Overall Study|Physician Decision|0|||
164408123|NCT05960097|593864522|FG001|Overall Study|Physician Decision|0|||
164408124|NCT05960097|593864523|FG002|Overall Study|Physician Decision|0|||
164408125|NCT05960097|593864524|FG003|Overall Study|Physician Decision|0|||
164408126|NCT05960097|593864525|FG004|Overall Study|Physician Decision|0|||
164408127|NCT05960097|593864526|FG005|Overall Study|Physician Decision|0|||
164408128|NCT05960097|593864527|FG006|Overall Study|Physician Decision|1|||
164408129|NCT05960097|593864528|FG007|Overall Study|Physician Decision|0|||
164408130|NCT05960097|593864521|FG000|Overall Study|Withdrawal by Subject|1|||
164408131|NCT05960097|593864522|FG001|Overall Study|Withdrawal by Subject|0|||
164408132|NCT05960097|593864523|FG002|Overall Study|Withdrawal by Subject|0|||
164408133|NCT05960097|593864524|FG003|Overall Study|Withdrawal by Subject|1|||
164408134|NCT05960097|593864525|FG004|Overall Study|Withdrawal by Subject|1|||
164408135|NCT05960097|593864526|FG005|Overall Study|Withdrawal by Subject|0|||
164408136|NCT05960097|593864527|FG006|Overall Study|Withdrawal by Subject|0|||
164408137|NCT05960097|593864528|FG007|Overall Study|Withdrawal by Subject|0|||
164408138|NCT05960097|593864521|FG000|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
164598981|NCT02883049|594554762|FG006|Post Induction|Withdrawal by Subject|0|||
164598982|NCT02883049|594554763|FG007|Post Induction|Withdrawal by Subject|0|||
164598983|NCT02883049|594554764|FG008|Post Induction|Withdrawal by Subject|2|||
164598984|NCT02883049|594554765|FG009|Post Induction|Withdrawal by Subject|0|||
164598985|NCT02883049|594554766|FG010|Post Induction|Withdrawal by Subject|1|||
164598986|NCT02883049|594554767|FG011|Post Induction|Withdrawal by Subject|1|||
164598987|NCT02883049|594554768|FG012|Post Induction|Withdrawal by Subject|0|||
164598988|NCT02883049|594554769|FG013|Post Induction|Withdrawal by Subject|0|||
164598989|NCT02883049|594554770|FG014|Post Induction|Withdrawal by Subject|1|||
164598990|NCT02883049|594554771|FG015|Post Induction|Withdrawal by Subject|0|||
164598991|NCT02883049|594554756|FG000|Post Induction|Ineligible|0|||
164598992|NCT02883049|594554757|FG001|Post Induction|Ineligible|0|||
164598993|NCT02883049|594554758|FG002|Post Induction|Ineligible|2|||
164598994|NCT02883049|594554759|FG003|Post Induction|Ineligible|0|||
164598995|NCT02883049|594554760|FG004|Post Induction|Ineligible|0|||
164598996|NCT02883049|594554761|FG005|Post Induction|Ineligible|0|||
164598997|NCT02883049|594554762|FG006|Post Induction|Ineligible|1|||
164598998|NCT02883049|594554763|FG007|Post Induction|Ineligible|0|||
164598999|NCT02883049|594554764|FG008|Post Induction|Ineligible|0|||
164599000|NCT02883049|594554765|FG009|Post Induction|Ineligible|0|||
164599001|NCT02883049|594554766|FG010|Post Induction|Ineligible|1|||
164599002|NCT02883049|594554767|FG011|Post Induction|Ineligible|0|||
164599003|NCT02883049|594554768|FG012|Post Induction|Ineligible|0|||
164599004|NCT02883049|594554769|FG013|Post Induction|Ineligible|0|||
164599005|NCT02883049|594554770|FG014|Post Induction|Ineligible|0|||
164599006|NCT02883049|594554771|FG015|Post Induction|Ineligible|1|||
164599007|NCT02883049|594554756|FG000|Post Induction|Refusal of further protocol therapy|0|||
164599008|NCT02883049|594554757|FG001|Post Induction|Refusal of further protocol therapy|0|||
164599009|NCT02883049|594554758|FG002|Post Induction|Refusal of further protocol therapy|0|||
164408139|NCT05960097|593864522|FG001|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
164408140|NCT05960097|593864523|FG002|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|1|||
164408141|NCT05960097|593864524|FG003|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
164408142|NCT05960097|593864525|FG004|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
164408143|NCT05960097|593864526|FG005|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
164408144|NCT05960097|593864527|FG006|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
164408145|NCT05960097|593864528|FG007|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
164408146|NCT00532155|593864529|FG000|Overall Study|Adverse Event|66|||
164408147|NCT00532155|593864530|FG001|Overall Study|Adverse Event|123|||
164408148|NCT00532155|593864529|FG000|Overall Study|Lack of Efficacy|332|||
164408149|NCT00532155|593864530|FG001|Overall Study|Lack of Efficacy|255|||
164408150|NCT00532155|593864529|FG000|Overall Study|Protocol Violation|1|||
164408151|NCT00532155|593864530|FG001|Overall Study|Protocol Violation|3|||
164408152|NCT00532155|593864529|FG000|Overall Study|Lost to Follow-up|2|||
164408153|NCT00532155|593864530|FG001|Overall Study|Lost to Follow-up|0|||
164408154|NCT00532155|593864529|FG000|Overall Study|Physician Decision|16|||
164408155|NCT00532155|593864530|FG001|Overall Study|Physician Decision|15|||
164408156|NCT00532155|593864529|FG000|Overall Study|Withdrawal by Subject|23|||
164408157|NCT00532155|593864530|FG001|Overall Study|Withdrawal by Subject|44|||
164408158|NCT00532155|593864529|FG000|Overall Study|Consent withdrawn|5|||
164408159|NCT00532155|593864530|FG001|Overall Study|Consent withdrawn|7|||
164408160|NCT00532155|593864529|FG000|Overall Study|Moved|1|||
164408161|NCT00532155|593864530|FG001|Overall Study|Moved|0|||
164408162|NCT00532155|593864529|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
164408163|NCT00532155|593864530|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
164408164|NCT00532155|593864529|FG000|Overall Study|Occurence of a second cancer|0|||
164408165|NCT00532155|593864530|FG001|Overall Study|Occurence of a second cancer|1|||
164408166|NCT00532155|593864529|FG000|Overall Study|Occurence of a secondary cancer|0|||
164408167|NCT00532155|593864530|FG001|Overall Study|Occurence of a secondary cancer|1|||
164408168|NCT00532155|593864529|FG000|Overall Study|Promotor ended study|1|||
164408169|NCT00532155|593864530|FG001|Overall Study|Promotor ended study|0|||
164408170|NCT00532155|593864529|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
164408171|NCT00532155|593864530|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
164408172|NCT00532155|593864529|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
164408173|NCT00532155|593864530|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
164408174|NCT00532155|593864529|FG000|Overall Study|Study stopped|1|||
164408175|NCT00532155|593864530|FG001|Overall Study|Study stopped|0|||
164408176|NCT00532155|593864529|FG000|Overall Study|Study terminated by sponsor|1|||
164408177|NCT00532155|593864530|FG001|Overall Study|Study terminated by sponsor|0|||
164408178|NCT00532155|593864529|FG000|Overall Study|Study termination stop further treatment|4|||
164408179|NCT00532155|593864530|FG001|Overall Study|Study termination stop further treatment|0|||
164408180|NCT00532155|593864529|FG000|Overall Study|Did not receive study medication|2|||
164408181|NCT00532155|593864530|FG001|Overall Study|Did not receive study medication|6|||
164408182|NCT03483038|593864531|FG000|Overall Study|Subjects still in follow-up|18|||
164408183|NCT02134925|593864532|FG000|Overall Study|Withdrawal by Subject|1|||
164408184|NCT02134925|593864533|FG001|Overall Study|Withdrawal by Subject|0|||
164408185|NCT02134925|593864532|FG000|Overall Study|Cancel|1|||
164408186|NCT02134925|593864533|FG001|Overall Study|Cancel|6|||
164408187|NCT03635489|593864534|FG000|Overall Study|Death|19|||
164408188|NCT03635489|593864535|FG001|Overall Study|Death|13|||
164408189|NCT03635489|593864534|FG000|Overall Study|Lost to Follow-up|1|||
164408190|NCT03635489|593864535|FG001|Overall Study|Lost to Follow-up|2|||
164408191|NCT03635489|593864534|FG000|Overall Study|Withdrawal by Subject|1|||
164408192|NCT03635489|593864535|FG001|Overall Study|Withdrawal by Subject|2|||
164408193|NCT03635489|593864534|FG000|Overall Study|Study Ended by Sponsor|28|||
164408194|NCT03635489|593864535|FG001|Overall Study|Study Ended by Sponsor|34|||
164408195|NCT01368900|593864536|FG000|Overall Study|Lost to Follow-up|7|||
164408196|NCT02158884|593864539|FG000|Baseline Assessment|Missed performance assessment|3|||
164408197|NCT02158884|593864539|FG000|Baseline Assessment|Missed SMFA|1|||
164599010|NCT02883049|594554759|FG003|Post Induction|Refusal of further protocol therapy|11|||
164599011|NCT02883049|594554760|FG004|Post Induction|Refusal of further protocol therapy|15|||
164599012|NCT02883049|594554761|FG005|Post Induction|Refusal of further protocol therapy|9|||
164599013|NCT02883049|594554762|FG006|Post Induction|Refusal of further protocol therapy|13|||
164599014|NCT02883049|594554763|FG007|Post Induction|Refusal of further protocol therapy|5|||
164599015|NCT02883049|594554764|FG008|Post Induction|Refusal of further protocol therapy|21|||
164599016|NCT02883049|594554765|FG009|Post Induction|Refusal of further protocol therapy|7|||
164599017|NCT02883049|594554766|FG010|Post Induction|Refusal of further protocol therapy|0|||
164599018|NCT02883049|594554767|FG011|Post Induction|Refusal of further protocol therapy|7|||
164599019|NCT02883049|594554768|FG012|Post Induction|Refusal of further protocol therapy|3|||
164599020|NCT02883049|594554769|FG013|Post Induction|Refusal of further protocol therapy|0|||
164599021|NCT02883049|594554770|FG014|Post Induction|Refusal of further protocol therapy|4|||
164408198|NCT02158884|593864539|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
164408199|NCT02158884|593864539|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
164408200|NCT02158884|593864539|FG000|6 Month Assessment|Missed SMFA|20|||
164408201|NCT02158884|593864539|FG000|12 Month Assessment|Missed SMFA|17|||
164408202|NCT02487472|593864540|FG000|Overall Study|Did not complete telephonic interviews|9|||
164408203|NCT02487472|593864540|FG000|Overall Study|Other|2|||
164408204|NCT01313286|593864541|FG000|Period 1|Withdrawal by Subject|2|||
164408205|NCT01313286|593864542|FG001|Period 1|Withdrawal by Subject|0|||
164408206|NCT00654901|593864543|FG000|Overall Study|Lost to Follow-up|1|||
164408207|NCT00654901|593864544|FG001|Overall Study|Lost to Follow-up|0|||
164408208|NCT00654901|593864545|FG002|Overall Study|Lost to Follow-up|1|||
164408209|NCT00654901|593864546|FG003|Overall Study|Lost to Follow-up|0|||
164408210|NCT00654901|593864543|FG000|Overall Study|Withdrawal by Subject|3|||
164408211|NCT00654901|593864544|FG001|Overall Study|Withdrawal by Subject|0|||
164408212|NCT00654901|593864545|FG002|Overall Study|Withdrawal by Subject|1|||
164408213|NCT00654901|593864546|FG003|Overall Study|Withdrawal by Subject|0|||
164408214|NCT04843930|593864548|FG000|Randomization|Withdrawal by Subject|6|||
164408215|NCT04843930|593864549|FG001|Randomization|Withdrawal by Subject|6|||
164408216|NCT04843930|593864550|FG002|Randomization|Withdrawal by Subject|0|||
164408217|NCT04843930|593864551|FG003|Randomization|Withdrawal by Subject|0|||
164408218|NCT04843930|593864548|FG000|Week 6 Assessment|Adverse Event|3|||
164408219|NCT04843930|593864549|FG001|Week 6 Assessment|Adverse Event|0|||
164408220|NCT04843930|593864550|FG002|Week 6 Assessment|Adverse Event|0|||
164408221|NCT04843930|593864551|FG003|Week 6 Assessment|Adverse Event|0|||
164408222|NCT04843930|593864548|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
164408223|NCT04843930|593864549|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
164408224|NCT04843930|593864550|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
164408225|NCT04843930|593864551|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
164408226|NCT04843930|593864548|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
164408227|NCT04843930|593864549|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
164408228|NCT04843930|593864550|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
164408229|NCT04843930|593864551|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
164408230|NCT05158296|593864552|FG000|Overall Study|Sponsor Decision|2|||
164408231|NCT05158296|593864553|FG001|Overall Study|Sponsor Decision|3|||
164408232|NCT05158296|593864554|FG002|Overall Study|Sponsor Decision|2|||
164408233|NCT02010632|593864555|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
164408234|NCT02010632|593864556|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
164408235|NCT04631705|593864559|FG000|Overall Study|Withdrawal by Subject|0|||
164408236|NCT04631705|593864560|FG001|Overall Study|Withdrawal by Subject|0|||
164408237|NCT04631705|593864561|FG002|Overall Study|Withdrawal by Subject|0|||
164408238|NCT04631705|593864562|FG003|Overall Study|Withdrawal by Subject|0|||
164408239|NCT04631705|593864563|FG004|Overall Study|Withdrawal by Subject|0|||
164408240|NCT04631705|593864564|FG005|Overall Study|Withdrawal by Subject|0|||
164408241|NCT04631705|593864565|FG006|Overall Study|Withdrawal by Subject|1|||
164408242|NCT04631705|593864566|FG007|Overall Study|Withdrawal by Subject|0|||
164408243|NCT04631705|593864567|FG008|Overall Study|Withdrawal by Subject|0|||
164408244|NCT02070484|593864573|FG000|Overall Study|Withdrawal by Subject|1|||
164408245|NCT02070484|593864574|FG001|Overall Study|Withdrawal by Subject|0|||
164408246|NCT01521884|593864575|FG000|Overall Study|Non Responders|10|||
164408247|NCT01521884|593864575|FG000|Overall Study|Adverse Event|5|||
164408248|NCT01521884|593864575|FG000|Overall Study|Pregnancy|1|||
164408249|NCT01521884|593864575|FG000|Overall Study|Withdrawal by Subject|1|||
164408250|NCT01521884|593864575|FG000|Overall Study|Physician Decision|2|||
164408251|NCT01521884|593864575|FG000|Overall Study|Protocol Violation|3|||
164408252|NCT01521884|593864575|FG000|Overall Study|Participant non-eligible|1|||
164408253|NCT01521884|593864575|FG000|Overall Study|Lost to Follow-up|4|||
164408254|NCT02821819|593864576|FG000|Overall Study|Protocol Violation|1|||
164408255|NCT04098250|593864577|FG000|Overall Study|Withdrawal by Subject|1|||
164408256|NCT04098250|593864578|FG001|Overall Study|Withdrawal by Subject|0|||
164408257|NCT04098250|593864577|FG000|Overall Study|Lost to Follow-up|0|||
164408258|NCT04098250|593864578|FG001|Overall Study|Lost to Follow-up|1|||
164408259|NCT00633464|593864583|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
164408260|NCT00633464|593864584|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
164408261|NCT00633464|593864583|FG000|Overall Study|Never Treated (Randomized in error)|0|||
164408262|NCT00633464|593864584|FG001|Overall Study|Never Treated (Randomized in error)|1|||
164408263|NCT04241094|593864586|FG000|Overall Study|Dropped out of treatment|4|||
164408264|NCT04241094|593864586|FG000|Overall Study|Ineligible after clinical assessment|2|||
164408265|NCT04241094|593864586|FG000|Overall Study|Lost to Follow-up|2|||
164408266|NCT02612064|593864587|FG000|Overall Study|Withdrawal by Subject|1|||
164408267|NCT02612064|593864588|FG001|Overall Study|Withdrawal by Subject|1|||
164408268|NCT02612064|593864587|FG000|Overall Study|Other|0|||
164408269|NCT02612064|593864588|FG001|Overall Study|Other|2|||
164599022|NCT02883049|594554771|FG015|Post Induction|Refusal of further protocol therapy|1|||
164408270|NCT06387472|593864589|FG000|Overall Study|Withdrawal by Subject|1|||
164408271|NCT06387472|593864589|FG000|Overall Study|Lost to Follow-up|2|||
164408272|NCT06387472|593864589|FG000|Overall Study|Physician Decision|1|||
164707847|NCT01517373|594955351|FG000|Treatment Period|Lost to Follow-up|0|||
164707848|NCT01517373|594955352|FG001|Treatment Period|Lost to Follow-up|0|||
164707849|NCT01517373|594955353|FG002|Treatment Period|Lost to Follow-up|1|||
164408273|NCT04182880|593864590|FG000|Overall Study|Pregnancy|1|||
164408274|NCT04182880|593864591|FG001|Overall Study|Pregnancy|0|||
164408275|NCT02036645|593864592|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
164408276|NCT02036645|593864593|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
164408277|NCT02036645|593864594|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
164408278|NCT02036645|593864595|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
164408279|NCT02036645|593864596|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
164408280|NCT02036645|593864597|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
164408281|NCT02036645|593864598|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
164408282|NCT02036645|593864599|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
164408283|NCT02036645|593864600|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
164408284|NCT02036645|593864601|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
164408285|NCT02036645|593864602|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
164408286|NCT02036645|593864603|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
164408287|NCT02036645|593864592|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
164408288|NCT02036645|593864593|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
164408289|NCT02036645|593864594|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
164408290|NCT02036645|593864595|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
164408291|NCT02036645|593864596|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
164408292|NCT02036645|593864597|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
164408293|NCT02036645|593864598|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
164408294|NCT02036645|593864599|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
164408295|NCT02036645|593864600|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
164408296|NCT02036645|593864601|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
164408297|NCT02036645|593864602|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
164408298|NCT02036645|593864603|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
164408299|NCT00717860|593864608|FG000|Overall Study|Clinical adverse experience|5|||
164408300|NCT00717860|593864609|FG001|Overall Study|Clinical adverse experience|9|||
164408301|NCT00717860|593864608|FG000|Overall Study|Laboratory adverse experience|2|||
164408302|NCT00717860|593864609|FG001|Overall Study|Laboratory adverse experience|2|||
164408303|NCT00717860|593864608|FG000|Overall Study|Lack of Efficacy|7|||
164408304|NCT00717860|593864609|FG001|Overall Study|Lack of Efficacy|13|||
164408305|NCT00717860|593864608|FG000|Overall Study|Discontinued for other reason|6|||
164408306|NCT00717860|593864609|FG001|Overall Study|Discontinued for other reason|1|||
164408307|NCT00717860|593864608|FG000|Overall Study|Withdrew consent|7|||
164408308|NCT00717860|593864609|FG001|Overall Study|Withdrew consent|3|||
164408309|NCT02332590|593864610|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
164408310|NCT02332590|593864611|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
164408311|NCT02332590|593864610|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
164408312|NCT02332590|593864611|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
164408313|NCT02332590|593864610|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
164408314|NCT02332590|593864611|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
164408315|NCT02332590|593864610|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
164408316|NCT02332590|593864611|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
164408317|NCT02332590|593864610|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
164408318|NCT02332590|593864611|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
164408319|NCT02332590|593864610|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
164408320|NCT02332590|593864611|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
164408321|NCT02332590|593864610|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
164408322|NCT02332590|593864611|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
164408323|NCT02332590|593864610|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
164408324|NCT02332590|593864611|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
164408325|NCT02332590|593864610|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
164408326|NCT02332590|593864611|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
164408327|NCT00696384|593864612|FG000|Open Label Phase|Adverse Event|27|||
164408328|NCT00696384|593864613|FG001|Open Label Phase|Adverse Event|0|||
164408329|NCT00696384|593864614|FG002|Open Label Phase|Adverse Event|0|||
164408330|NCT00696384|593864612|FG000|Open Label Phase|Protocol Violation|18|||
164408331|NCT00696384|593864613|FG001|Open Label Phase|Protocol Violation|0|||
164707850|NCT01517373|594955354|FG003|Treatment Period|Lost to Follow-up|1|||
164408332|NCT00696384|593864614|FG002|Open Label Phase|Protocol Violation|0|||
164408333|NCT00696384|593864612|FG000|Open Label Phase|Lost to Follow-up|24|||
164408334|NCT00696384|593864613|FG001|Open Label Phase|Lost to Follow-up|0|||
164408335|NCT00696384|593864614|FG002|Open Label Phase|Lost to Follow-up|0|||
164408336|NCT00696384|593864612|FG000|Open Label Phase|Withdrawal by Subject|37|||
164408337|NCT00696384|593864613|FG001|Open Label Phase|Withdrawal by Subject|0|||
164408338|NCT00696384|593864614|FG002|Open Label Phase|Withdrawal by Subject|0|||
164707851|NCT01517373|594955355|FG004|Treatment Period|Lost to Follow-up|0|||
164707852|NCT01517373|594955356|FG005|Treatment Period|Lost to Follow-up|0|||
164408339|NCT00696384|593864612|FG000|Open Label Phase|Other|6|||
164408340|NCT00696384|593864613|FG001|Open Label Phase|Other|0|||
164408341|NCT00696384|593864614|FG002|Open Label Phase|Other|0|||
164408342|NCT00696384|593864612|FG000|Open Label Phase|Lack of Efficacy|3|||
164408343|NCT00696384|593864613|FG001|Open Label Phase|Lack of Efficacy|0|||
164408344|NCT00696384|593864614|FG002|Open Label Phase|Lack of Efficacy|0|||
164408345|NCT00696384|593864612|FG000|Open Label Phase|Physician Decision|4|||
164408346|NCT00696384|593864613|FG001|Open Label Phase|Physician Decision|0|||
164408347|NCT00696384|593864614|FG002|Open Label Phase|Physician Decision|0|||
164408348|NCT00696384|593864612|FG000|Double Blind Phase|Adverse Event|0|||
164408349|NCT00696384|593864613|FG001|Double Blind Phase|Adverse Event|2|||
164408350|NCT00696384|593864614|FG002|Double Blind Phase|Adverse Event|2|||
164408351|NCT00696384|593864612|FG000|Double Blind Phase|Lost to Follow-up|0|||
164408352|NCT00696384|593864613|FG001|Double Blind Phase|Lost to Follow-up|2|||
164408353|NCT00696384|593864614|FG002|Double Blind Phase|Lost to Follow-up|1|||
164408354|NCT00696384|593864612|FG000|Double Blind Phase|Withdrawal by Subject|0|||
164408355|NCT00696384|593864613|FG001|Double Blind Phase|Withdrawal by Subject|4|||
164408356|NCT00696384|593864614|FG002|Double Blind Phase|Withdrawal by Subject|3|||
164408357|NCT00696384|593864612|FG000|Double Blind Phase|Lack of Efficacy|0|||
164408358|NCT00696384|593864613|FG001|Double Blind Phase|Lack of Efficacy|1|||
164408359|NCT00696384|593864614|FG002|Double Blind Phase|Lack of Efficacy|0|||
164408360|NCT00696384|593864612|FG000|Double Blind Phase|Physician Decision|0|||
164408361|NCT00696384|593864613|FG001|Double Blind Phase|Physician Decision|2|||
164408362|NCT00696384|593864614|FG002|Double Blind Phase|Physician Decision|0|||
164408363|NCT03995784|593864615|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
164408364|NCT03015116|593865975|FG000|Overall Study|Lost to Follow-up|3|||
164408365|NCT03015116|593865976|FG001|Overall Study|Lost to Follow-up|0|||
164408366|NCT03015116|593865977|FG002|Overall Study|Lost to Follow-up|2|||
164408367|NCT03015116|593865975|FG000|Overall Study|Withdrawal by Subject|3|||
164408368|NCT03015116|593865976|FG001|Overall Study|Withdrawal by Subject|1|||
164408369|NCT03015116|593865977|FG002|Overall Study|Withdrawal by Subject|0|||
164408370|NCT03015116|593865975|FG000|Overall Study|Subject has New Medical Status|1|||
164408371|NCT03015116|593865976|FG001|Overall Study|Subject has New Medical Status|0|||
164408372|NCT03015116|593865977|FG002|Overall Study|Subject has New Medical Status|0|||
164408373|NCT03015116|593865975|FG000|Overall Study|Physician Decision|0|||
164408374|NCT03015116|593865976|FG001|Overall Study|Physician Decision|1|||
164408375|NCT03015116|593865977|FG002|Overall Study|Physician Decision|0|||
164408376|NCT01862991|593865978|FG000|Overall Study|Lost to Follow-up|2|||
164408377|NCT01862991|593865979|FG001|Overall Study|Lost to Follow-up|1|||
164408378|NCT01862991|593865980|FG002|Overall Study|Lost to Follow-up|1|||
164408379|NCT01862991|593865978|FG000|Overall Study|Protocol Violation|1|||
164408380|NCT01862991|593865979|FG001|Overall Study|Protocol Violation|0|||
164408381|NCT01862991|593865980|FG002|Overall Study|Protocol Violation|0|||
164408382|NCT04858802|593865981|FG000|Overall Study|Lost to Follow-up|1|||
164408383|NCT04858802|593865982|FG001|Overall Study|Lost to Follow-up|1|||
164408384|NCT04858802|593865981|FG000|Overall Study|Withdrawal by Subject|1|||
164408385|NCT04858802|593865982|FG001|Overall Study|Withdrawal by Subject|1|||
164408386|NCT00332332|593865983|FG000|Overall Study|Adverse Event|13|||
164408387|NCT00332332|593865983|FG000|Overall Study|Death|1|||
164408388|NCT00332332|593865983|FG000|Overall Study|Withdrawal by Subject|8|||
164408389|NCT00332332|593865983|FG000|Overall Study|Physician Decision|1|||
164408390|NCT00332332|593865983|FG000|Overall Study|Lost to Follow-up|3|||
164408391|NCT00332332|593865983|FG000|Overall Study|Protocol deviation|4|||
164408392|NCT00332332|593865983|FG000|Overall Study|Noncompliance|2|||
164408393|NCT00332332|593865983|FG000|Overall Study|Disease progression|2|||
164408394|NCT00332332|593865983|FG000|Overall Study|Other|18|||
164408395|NCT00332332|593865983|FG000|Overall Study|Did not receive study treatment|16|||
164408396|NCT01108458|593865984|FG000|Overall Study|Withdrawal by Subject|1|||
164408397|NCT03075501|593865985|FG000|Overall Study|Scheduling difficulties|15|||
164408398|NCT03075501|593865986|FG001|Overall Study|Scheduling difficulties|9|||
164408399|NCT00857805|593865987|FG000|Overall Study|Withdrawal by Subject|1|||
164408400|NCT00857805|593865988|FG001|Overall Study|Withdrawal by Subject|1|||
164408401|NCT03610737|593865991|FG000|Overall Study|Withdrawal by Subject|1|||
164408402|NCT03610737|593865992|FG001|Overall Study|Withdrawal by Subject|5|||
164408403|NCT03610737|593865991|FG000|Overall Study|Death|1|||
164408404|NCT03610737|593865992|FG001|Overall Study|Death|0|||
164408405|NCT03610737|593865991|FG000|Overall Study|Not treated|5|||
164408406|NCT03610737|593865992|FG001|Overall Study|Not treated|2|||
164408407|NCT03610737|593865991|FG000|Overall Study|Missed Visit|1|||
164408408|NCT03610737|593865992|FG001|Overall Study|Missed Visit|2|||
164408409|NCT02714868|593865993|FG000|Overall Study|Withdrawal by Subject|3|||
164408410|NCT02714868|593865994|FG001|Overall Study|Withdrawal by Subject|0|||
164408411|NCT02714868|593865993|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
164408412|NCT02714868|593865994|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
164408413|NCT02714868|593865993|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
164408414|NCT02714868|593865994|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
164408415|NCT00710606|593866001|FG000|Overall Study|Adverse Event|0|||
164408416|NCT00710606|593866002|FG001|Overall Study|Adverse Event|2|||
164408417|NCT05056870|593866003|FG000|Period 1|Site COVID-19 Related|3|||
164408418|NCT05056870|593866004|FG001|Period 1|Site COVID-19 Related|3|||
164408419|NCT05056870|593866003|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
164408420|NCT05056870|593866004|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
164408421|NCT05056870|593866003|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
164408422|NCT05056870|593866004|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
164408423|NCT05056870|593866003|FG000|Period 2|COVID-19 Related|1|||
164408424|NCT05056870|593866004|FG001|Period 2|COVID-19 Related|0|||
164408425|NCT05056870|593866003|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
164408426|NCT05056870|593866004|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
164408427|NCT02670538|593866007|FG000|Overall Study|Withdrawal of Consent|8|||
164408428|NCT02670538|593866008|FG001|Overall Study|Withdrawal of Consent|6|||
164408429|NCT02670538|593866009|FG002|Overall Study|Withdrawal of Consent|5|||
164408430|NCT02670538|593866007|FG000|Overall Study|Lost to Follow-up|8|||
164408431|NCT02670538|593866008|FG001|Overall Study|Lost to Follow-up|12|||
164408432|NCT02670538|593866009|FG002|Overall Study|Lost to Follow-up|7|||
164408433|NCT02670538|593866007|FG000|Overall Study|Adverse Event|5|||
164408434|NCT02670538|593866008|FG001|Overall Study|Adverse Event|5|||
164408435|NCT02670538|593866009|FG002|Overall Study|Adverse Event|11|||
164408436|NCT02670538|593866007|FG000|Overall Study|Lack of Efficacy|7|||
164408437|NCT02670538|593866008|FG001|Overall Study|Lack of Efficacy|1|||
164408438|NCT02670538|593866009|FG002|Overall Study|Lack of Efficacy|2|||
164408439|NCT02670538|593866007|FG000|Overall Study|Protocol Violation|3|||
164408440|NCT02670538|593866008|FG001|Overall Study|Protocol Violation|4|||
164408441|NCT02670538|593866009|FG002|Overall Study|Protocol Violation|1|||
164408442|NCT02670538|593866007|FG000|Overall Study|Noncompliance with Study Drug|1|||
164408443|NCT02670538|593866008|FG001|Overall Study|Noncompliance with Study Drug|3|||
164408444|NCT02670538|593866009|FG002|Overall Study|Noncompliance with Study Drug|2|||
164408445|NCT02670538|593866007|FG000|Overall Study|Other Miscellaneous Reasons|0|||
164408446|NCT02670538|593866008|FG001|Overall Study|Other Miscellaneous Reasons|1|||
164408447|NCT02670538|593866009|FG002|Overall Study|Other Miscellaneous Reasons|2|||
164408448|NCT01373931|593866010|FG000|Lead-in Period|Adverse Event|2|||
164408449|NCT01373931|593866011|FG001|Lead-in Period|Adverse Event|0|||
164408450|NCT01373931|593866010|FG000|Period 1|Adverse Event|2|||
164408451|NCT01373931|593866011|FG001|Period 1|Adverse Event|0|||
164408452|NCT01373931|593866010|FG000|Period 1|Withdrawal by Subject|0|||
164408453|NCT01373931|593866011|FG001|Period 1|Withdrawal by Subject|2|||
164408454|NCT00742079|593866012|FG000|Overall Study|Lost to Follow-up|0|||
164408455|NCT00742079|593866013|FG001|Overall Study|Lost to Follow-up|1|||
164408456|NCT01559454|593866018|FG000|Overall Study|Lost to Follow-up|3|||
164408457|NCT01559454|593866019|FG001|Overall Study|Lost to Follow-up|2|||
164408458|NCT01559454|593866018|FG000|Overall Study|Withdrawal by Subject|0|||
164408459|NCT01559454|593866019|FG001|Overall Study|Withdrawal by Subject|1|||
164408460|NCT01559454|593866018|FG000|Overall Study|Physician Decision|0|||
164408461|NCT01559454|593866019|FG001|Overall Study|Physician Decision|1|||
164408462|NCT01559454|593866018|FG000|Overall Study|Protocol Violation|0|||
164408463|NCT01559454|593866019|FG001|Overall Study|Protocol Violation|1|||
164408464|NCT01559454|593866018|FG000|Overall Study|Lack of Efficacy|0|||
164408465|NCT01559454|593866019|FG001|Overall Study|Lack of Efficacy|1|||
164408466|NCT01114204|593866020|FG000|Overall Study|Adverse Event|3|||
164408467|NCT01114204|593866021|FG001|Overall Study|Adverse Event|2|||
164408468|NCT01114204|593866020|FG000|Overall Study|Lost to Follow-up|1|||
164408469|NCT01114204|593866021|FG001|Overall Study|Lost to Follow-up|0|||
164408470|NCT01114204|593866020|FG000|Overall Study|Withdrawal by Subject|10|||
164408471|NCT01114204|593866021|FG001|Overall Study|Withdrawal by Subject|6|||
164408472|NCT01114204|593866020|FG000|Overall Study|Death|1|||
164462808|NCT05693935|594068515|FG005|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
164462809|NCT05693935|594068516|FG006|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
164707853|NCT01517373|594955351|FG000|Treatment Period|Withdrawal by Subject|0|||
164707854|NCT01517373|594955352|FG001|Treatment Period|Withdrawal by Subject|3|||
164707855|NCT01517373|594955353|FG002|Treatment Period|Withdrawal by Subject|2|||
164707856|NCT01517373|594955354|FG003|Treatment Period|Withdrawal by Subject|2|||
164707857|NCT01517373|594955355|FG004|Treatment Period|Withdrawal by Subject|2|||
164707858|NCT01517373|594955356|FG005|Treatment Period|Withdrawal by Subject|3|||
164408473|NCT01114204|593866021|FG001|Overall Study|Death|0|||
164408474|NCT01114204|593866020|FG000|Overall Study|Other-Personal reasons|2|||
164408475|NCT01114204|593866021|FG001|Overall Study|Other-Personal reasons|0|||
164408476|NCT01114204|593866020|FG000|Overall Study|Other-Medical monitor request|1|||
164408477|NCT01114204|593866021|FG001|Overall Study|Other-Medical monitor request|0|||
164408478|NCT01114204|593866020|FG000|Overall Study|Other-Participant request|2|||
164408479|NCT01114204|593866021|FG001|Overall Study|Other-Participant request|0|||
164408480|NCT01114204|593866020|FG000|Overall Study|Other-Protocol Violation|1|||
164408481|NCT01114204|593866021|FG001|Overall Study|Other-Protocol Violation|0|||
164408482|NCT03145766|593866032|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
164408483|NCT03145766|593866033|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
164408484|NCT03145766|593866034|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
164408485|NCT03145766|593866035|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
164408486|NCT03145766|593866036|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
164408487|NCT03145766|593866032|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
164408488|NCT03145766|593866033|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
164408489|NCT03145766|593866034|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
164408490|NCT03145766|593866035|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
164408491|NCT03145766|593866036|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
164408492|NCT03145766|593866032|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
164408493|NCT03145766|593866033|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
164408494|NCT03145766|593866034|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
164408495|NCT03145766|593866035|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
164408496|NCT03145766|593866036|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
164408497|NCT03145766|593866032|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
164408498|NCT03145766|593866033|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
164408499|NCT03145766|593866034|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
164408500|NCT03145766|593866035|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
164408501|NCT03145766|593866036|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
164408502|NCT03145766|593866032|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
164408503|NCT03145766|593866033|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
164408504|NCT03145766|593866034|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
164408505|NCT03145766|593866035|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
164408506|NCT03145766|593866036|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
164408507|NCT03145766|593866032|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
164408508|NCT03145766|593866033|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
164408509|NCT03145766|593866034|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
164408510|NCT03145766|593866035|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
164408511|NCT03145766|593866036|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
164408512|NCT03145766|593866032|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
164408513|NCT03145766|593866033|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
164408514|NCT03145766|593866034|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
164408515|NCT03145766|593866035|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
164408516|NCT03145766|593866036|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
164408517|NCT02799472|593866037|FG000|Overall Study|Withdrawal by Subject|2|||
164408518|NCT02799472|593866038|FG001|Overall Study|Withdrawal by Subject|4|||
164408519|NCT02799472|593866037|FG000|Overall Study|Lack of Efficacy|2|||
164408520|NCT02799472|593866038|FG001|Overall Study|Lack of Efficacy|0|||
164408521|NCT02799472|593866037|FG000|Overall Study|Lost to Follow-up|0|||
164408522|NCT02799472|593866038|FG001|Overall Study|Lost to Follow-up|1|||
164408523|NCT00462670|593866039|FG000|Overall Study|Adverse Event|3|||
164408524|NCT00462670|593866040|FG001|Overall Study|Adverse Event|5|||
164408525|NCT00462670|593866039|FG000|Overall Study|Lack of Efficacy|1|||
164408526|NCT00462670|593866040|FG001|Overall Study|Lack of Efficacy|0|||
164408527|NCT00462670|593866039|FG000|Overall Study|Protocol Violation|1|||
164599023|NCT02883049|594554756|FG000|Post Induction|Inevaluable|0|||
164599024|NCT02883049|594554757|FG001|Post Induction|Inevaluable|0|||
164599025|NCT02883049|594554758|FG002|Post Induction|Inevaluable|0|||
164599026|NCT02883049|594554759|FG003|Post Induction|Inevaluable|1|||
164599027|NCT02883049|594554760|FG004|Post Induction|Inevaluable|1|||
164599028|NCT02883049|594554761|FG005|Post Induction|Inevaluable|2|||
164599029|NCT02883049|594554762|FG006|Post Induction|Inevaluable|7|||
164599030|NCT02883049|594554763|FG007|Post Induction|Inevaluable|6|||
164599031|NCT02883049|594554764|FG008|Post Induction|Inevaluable|4|||
164599032|NCT02883049|594554765|FG009|Post Induction|Inevaluable|4|||
164599033|NCT02883049|594554766|FG010|Post Induction|Inevaluable|1|||
164599034|NCT02883049|594554767|FG011|Post Induction|Inevaluable|1|||
164599035|NCT02883049|594554768|FG012|Post Induction|Inevaluable|2|||
164599036|NCT02883049|594554769|FG013|Post Induction|Inevaluable|0|||
164599037|NCT02883049|594554770|FG014|Post Induction|Inevaluable|0|||
164599038|NCT02883049|594554771|FG015|Post Induction|Inevaluable|1|||
164599039|NCT02883049|594554756|FG000|Post Induction|Moved to another non-COG institution|0|||
164599040|NCT02883049|594554757|FG001|Post Induction|Moved to another non-COG institution|0|||
164599041|NCT02883049|594554758|FG002|Post Induction|Moved to another non-COG institution|0|||
164599042|NCT02883049|594554759|FG003|Post Induction|Moved to another non-COG institution|0|||
164408528|NCT00462670|593866040|FG001|Overall Study|Protocol Violation|0|||
164408529|NCT00462670|593866039|FG000|Overall Study|Resolution of signs and symptoms|0|||
164599043|NCT02883049|594554760|FG004|Post Induction|Moved to another non-COG institution|0|||
164599044|NCT02883049|594554761|FG005|Post Induction|Moved to another non-COG institution|0|||
164408530|NCT00462670|593866040|FG001|Overall Study|Resolution of signs and symptoms|2|||
164408531|NCT00633932|593866042|FG000|Overall Study|Adverse Event|1|||
164408532|NCT00633932|593866043|FG001|Overall Study|Adverse Event|3|||
164408533|NCT00633932|593866044|FG002|Overall Study|Adverse Event|4|||
164408534|NCT00633932|593866042|FG000|Overall Study|Withdrawal by Subject|3|||
164408535|NCT00633932|593866043|FG001|Overall Study|Withdrawal by Subject|9|||
164408536|NCT00633932|593866044|FG002|Overall Study|Withdrawal by Subject|1|||
164408537|NCT00633932|593866042|FG000|Overall Study|Lost to Follow-up|1|||
164408538|NCT00633932|593866043|FG001|Overall Study|Lost to Follow-up|0|||
164408539|NCT00633932|593866044|FG002|Overall Study|Lost to Follow-up|2|||
164408540|NCT00633932|593866042|FG000|Overall Study|Protocol Violation|5|||
164408541|NCT00633932|593866043|FG001|Overall Study|Protocol Violation|2|||
164408542|NCT00633932|593866044|FG002|Overall Study|Protocol Violation|3|||
164408543|NCT00633932|593866042|FG000|Overall Study|Physician Decision|0|||
164408544|NCT00633932|593866043|FG001|Overall Study|Physician Decision|0|||
164408545|NCT00633932|593866044|FG002|Overall Study|Physician Decision|1|||
164408546|NCT00633932|593866042|FG000|Overall Study|Doctor's judgement|1|||
164408547|NCT00633932|593866043|FG001|Overall Study|Doctor's judgement|0|||
164408548|NCT00633932|593866044|FG002|Overall Study|Doctor's judgement|0|||
164408549|NCT00633932|593866042|FG000|Overall Study|Moved Away|1|||
164408550|NCT00633932|593866043|FG001|Overall Study|Moved Away|0|||
164408551|NCT00633932|593866044|FG002|Overall Study|Moved Away|0|||
164408552|NCT00482274|593866045|FG000|Overall Study|Adverse Event|1|||
164408553|NCT04836858|593866046|FG000|Overall Study|Adverse Event|0|||
164408554|NCT04836858|593866047|FG001|Overall Study|Adverse Event|0|||
164408555|NCT04836858|593866048|FG002|Overall Study|Adverse Event|0|||
164408556|NCT04836858|593866049|FG003|Overall Study|Adverse Event|1|||
164408557|NCT04836858|593866046|FG000|Overall Study|Lost to Follow-up|1|||
164408558|NCT04836858|593866047|FG001|Overall Study|Lost to Follow-up|0|||
164408559|NCT04836858|593866048|FG002|Overall Study|Lost to Follow-up|0|||
164408560|NCT04836858|593866049|FG003|Overall Study|Lost to Follow-up|0|||
164408561|NCT04836858|593866046|FG000|Overall Study|Subject/Guardian decision|3|||
164408562|NCT04836858|593866047|FG001|Overall Study|Subject/Guardian decision|0|||
164408563|NCT04836858|593866048|FG002|Overall Study|Subject/Guardian decision|0|||
164408564|NCT04836858|593866049|FG003|Overall Study|Subject/Guardian decision|1|||
164408565|NCT04836858|593866046|FG000|Overall Study|Randomized but not treated|4|||
164408566|NCT04836858|593866047|FG001|Overall Study|Randomized but not treated|0|||
164408567|NCT04836858|593866048|FG002|Overall Study|Randomized but not treated|0|||
164408568|NCT04836858|593866049|FG003|Overall Study|Randomized but not treated|0|||
164408569|NCT00708435|593866052|FG000|Overall Study|Death / Serious Adverse Event|10|||
164408570|NCT00708435|593866053|FG001|Overall Study|Death / Serious Adverse Event|5|||
164408571|NCT00708435|593866052|FG000|Overall Study|Lost to Follow-up|9|||
164408572|NCT00708435|593866053|FG001|Overall Study|Lost to Follow-up|4|||
164408573|NCT00708435|593866052|FG000|Overall Study|Withdrawal by Subject|3|||
164408574|NCT00708435|593866053|FG001|Overall Study|Withdrawal by Subject|7|||
164408575|NCT00708435|593866052|FG000|Overall Study|Adverse Event|1|||
164408576|NCT00708435|593866053|FG001|Overall Study|Adverse Event|0|||
164408577|NCT00708435|593866052|FG000|Overall Study|Protocol Violation|0|||
164408578|NCT00708435|593866053|FG001|Overall Study|Protocol Violation|1|||
164408579|NCT00708435|593866052|FG000|Overall Study|Intervention by primary care physician|1|||
164408580|NCT00708435|593866053|FG001|Overall Study|Intervention by primary care physician|0|||
164408581|NCT00708435|593866052|FG000|Overall Study|Refused hospitalization|1|||
164408582|NCT00708435|593866053|FG001|Overall Study|Refused hospitalization|0|||
164408583|NCT04766086|593866054|FG000|Overall Study|Lost to Follow-up|3|||
164408584|NCT04766086|593866055|FG001|Overall Study|Lost to Follow-up|5|||
164408585|NCT04766086|593866056|FG002|Overall Study|Lost to Follow-up|3|||
164408586|NCT04766086|593866054|FG000|Overall Study|Withdrawal by Subject|1|||
164408587|NCT04766086|593866055|FG001|Overall Study|Withdrawal by Subject|1|||
164408588|NCT04766086|593866056|FG002|Overall Study|Withdrawal by Subject|2|||
164408589|NCT04766086|593866054|FG000|Overall Study|Other|0|||
164408590|NCT04766086|593866055|FG001|Overall Study|Other|0|||
164408591|NCT04766086|593866056|FG002|Overall Study|Other|1|||
164408592|NCT03954743|593866059|FG000|Overall Study|Adverse Event|1|||
164408593|NCT03954743|593866060|FG001|Overall Study|Adverse Event|0|||
164408594|NCT03954743|593866059|FG000|Overall Study|Lost to Follow-up|6|||
164408595|NCT03954743|593866060|FG001|Overall Study|Lost to Follow-up|4|||
164408596|NCT03954743|593866059|FG000|Overall Study|Protocol Violation|1|||
164408597|NCT03954743|593866060|FG001|Overall Study|Protocol Violation|0|||
164408598|NCT03954743|593866059|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
164599045|NCT02883049|594554762|FG006|Post Induction|Moved to another non-COG institution|0|||
164599046|NCT02883049|594554763|FG007|Post Induction|Moved to another non-COG institution|2|||
164599047|NCT02883049|594554764|FG008|Post Induction|Moved to another non-COG institution|2|||
164599048|NCT02883049|594554765|FG009|Post Induction|Moved to another non-COG institution|0|||
164599049|NCT02883049|594554766|FG010|Post Induction|Moved to another non-COG institution|0|||
164599050|NCT02883049|594554767|FG011|Post Induction|Moved to another non-COG institution|1|||
164599051|NCT02883049|594554768|FG012|Post Induction|Moved to another non-COG institution|0|||
164599052|NCT02883049|594554769|FG013|Post Induction|Moved to another non-COG institution|0|||
164408599|NCT03954743|593866060|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
164408600|NCT03954743|593866059|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
164707859|NCT01517373|594955351|FG000|Treatment Period|Other|0|||
164707860|NCT01517373|594955352|FG001|Treatment Period|Other|0|||
164408601|NCT03954743|593866060|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164408602|NCT01153269|593866061|FG000|Overall Study|Withdrawal by Subject|1|||
164408603|NCT01153269|593866061|FG000|Overall Study|Antiretroviral therapy break|1|||
164408604|NCT03541044|593866062|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
164408605|NCT03541044|593866063|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
164408606|NCT03541044|593866062|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
164408607|NCT03541044|593866063|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
164408608|NCT02281760|593866074|FG000|Overall Study|Withdrawal by Subject|1|||
164408609|NCT02635724|593866075|FG000|Overall Study|Withdrawal by Subject|0|||
164408610|NCT02635724|593866076|FG001|Overall Study|Withdrawal by Subject|1|||
164408611|NCT02635724|593866077|FG002|Overall Study|Withdrawal by Subject|0|||
164408612|NCT00860067|593866078|FG000|Overall Study|Lost to Follow-up|46|||
164408613|NCT00860067|593866079|FG001|Overall Study|Lost to Follow-up|9|||
164408614|NCT00860067|593866080|FG002|Overall Study|Lost to Follow-up|9|||
164408615|NCT00860067|593866078|FG000|Overall Study|Withdrawal by Subject|4|||
164408616|NCT00860067|593866079|FG001|Overall Study|Withdrawal by Subject|0|||
164408617|NCT00860067|593866080|FG002|Overall Study|Withdrawal by Subject|0|||
164408618|NCT00860067|593866078|FG000|Overall Study|Pregnancy|1|||
164408619|NCT00860067|593866079|FG001|Overall Study|Pregnancy|0|||
164408620|NCT00860067|593866080|FG002|Overall Study|Pregnancy|0|||
164408621|NCT00100932|593866085|FG000|Overall Study|Adverse Event|11|||
164408622|NCT00100932|593866086|FG001|Overall Study|Adverse Event|2|||
164408623|NCT00100932|593866085|FG000|Overall Study|Withdrawal by Subject|6|||
164408624|NCT00100932|593866086|FG001|Overall Study|Withdrawal by Subject|0|||
164408625|NCT00100932|593866085|FG000|Overall Study|Progressive Disease|44|||
164408626|NCT00100932|593866086|FG001|Overall Study|Progressive Disease|18|||
164408627|NCT00100932|593866085|FG000|Overall Study|Physician Decision|7|||
164408628|NCT00100932|593866086|FG001|Overall Study|Physician Decision|5|||
164408629|NCT00100932|593866085|FG000|Overall Study|Other|5|||
164408630|NCT00100932|593866086|FG001|Overall Study|Other|2|||
164408631|NCT02387996|593866089|FG000|Overall Study|Disease Progression|167|||
164408632|NCT02387996|593866089|FG000|Overall Study|Study Drug Toxicity|31|||
164408633|NCT02387996|593866089|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
164408634|NCT02387996|593866089|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
164408635|NCT02387996|593866089|FG000|Overall Study|Subject Withdrew Consent|5|||
164408636|NCT02387996|593866089|FG000|Overall Study|Lost to Follow-up|1|||
164408637|NCT02387996|593866089|FG000|Overall Study|Poor/Non-Compliance|1|||
164408638|NCT02387996|593866089|FG000|Overall Study|Other Reasons|5|||
164408639|NCT02387996|593866089|FG000|Overall Study|Death|1|||
164408640|NCT00770432|593866090|FG000|Overall Study|Other|4|||
164408641|NCT00770432|593866091|FG001|Overall Study|Other|6|||
164408642|NCT00770432|593866090|FG000|Overall Study|Non-compliance|0|||
164408643|NCT00770432|593866091|FG001|Overall Study|Non-compliance|1|||
164408644|NCT01453348|593866092|FG000|Overall Study|Death|0|||
164408645|NCT01453348|593866093|FG001|Overall Study|Death|0|||
164408646|NCT01453348|593866094|FG002|Overall Study|Death|1|||
164408647|NCT01453348|593866092|FG000|Overall Study|Withdrawal by Subject|0|||
164408648|NCT01453348|593866093|FG001|Overall Study|Withdrawal by Subject|1|||
164408649|NCT01453348|593866094|FG002|Overall Study|Withdrawal by Subject|0|||
164408650|NCT01453348|593866092|FG000|Overall Study|Protocol Violation|1|||
164408651|NCT01453348|593866093|FG001|Overall Study|Protocol Violation|0|||
164408652|NCT01453348|593866094|FG002|Overall Study|Protocol Violation|0|||
164408653|NCT02756832|593866095|FG000|Overall Study|Lost for Observation after Baseline|6|||
164408654|NCT02756832|593866095|FG000|Overall Study|Lost for Observation|13|||
164408655|NCT02756832|593866095|FG000|Overall Study|Patient's Unwillingness|12|||
164408656|NCT02756832|593866095|FG000|Overall Study|Insufficient Efficacy|2|||
164408657|NCT02756832|593866095|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
164408658|NCT02756832|593866095|FG000|Overall Study|Reason not Specified|9|||
164408659|NCT02756832|593866095|FG000|Overall Study|Protocol Deviation|10|||
164408660|NCT01498822|593866097|FG000|Overall Study|Protocol Violation|8|||
164408661|NCT01498822|593866098|FG001|Overall Study|Protocol Violation|4|||
164408662|NCT01498822|593866097|FG000|Overall Study|Other Reason|5|||
164408663|NCT01498822|593866098|FG001|Overall Study|Other Reason|2|||
164707861|NCT01517373|594955353|FG002|Treatment Period|Other|0|||
164707862|NCT01517373|594955354|FG003|Treatment Period|Other|0|||
164707863|NCT01517373|594955355|FG004|Treatment Period|Other|1|||
164408664|NCT01498822|593866097|FG000|Overall Study|Lack of Efficacy|7|||
164408665|NCT01498822|593866098|FG001|Overall Study|Lack of Efficacy|2|||
164408666|NCT01498822|593866097|FG000|Overall Study|AE, non-serious non-fatal|8|||
164408667|NCT01498822|593866098|FG001|Overall Study|AE, non-serious non-fatal|17|||
164408668|NCT01498822|593866097|FG000|Overall Study|SAE, non-fatal|2|||
164408669|NCT01498822|593866098|FG001|Overall Study|SAE, non-fatal|2|||
164408670|NCT01498822|593866097|FG000|Overall Study|Adverse Event, serious fatal|1|||
164707864|NCT01517373|594955356|FG005|Treatment Period|Other|0|||
164707865|NCT01517373|594955351|FG000|Treatment Period|Protocol Violation|0|||
164707866|NCT01517373|594955352|FG001|Treatment Period|Protocol Violation|0|||
164707867|NCT01517373|594955353|FG002|Treatment Period|Protocol Violation|0|||
164707868|NCT01517373|594955354|FG003|Treatment Period|Protocol Violation|0|||
164707869|NCT01517373|594955355|FG004|Treatment Period|Protocol Violation|1|||
164707870|NCT01517373|594955356|FG005|Treatment Period|Protocol Violation|0|||
164707871|NCT01517373|594955351|FG000|Treatment Period|Lack of Efficacy|0|||
164707872|NCT01517373|594955352|FG001|Treatment Period|Lack of Efficacy|1|||
164707873|NCT01517373|594955353|FG002|Treatment Period|Lack of Efficacy|1|||
164408671|NCT01498822|593866098|FG001|Overall Study|Adverse Event, serious fatal|1|||
164408672|NCT01498822|593866097|FG000|Overall Study|Withdrawal by Subject|15|||
164408673|NCT01498822|593866098|FG001|Overall Study|Withdrawal by Subject|25|||
164408674|NCT01498822|593866097|FG000|Overall Study|Lost to Follow-up|8|||
164408675|NCT01498822|593866098|FG001|Overall Study|Lost to Follow-up|3|||
164408676|NCT04027348|593866101|FG000|Overall Study|Adverse Event|2|||
164408677|NCT02552238|593866102|FG000|Overall Study|Withdrawal by Subject|2|||
164408678|NCT02552238|593866102|FG000|Overall Study|Adverse Event|2|||
164408679|NCT02404389|593866103|FG000|Overall Study|Adverse Event|1|||
164408680|NCT02404389|593866104|FG001|Overall Study|Adverse Event|0|||
164408681|NCT02404389|593866105|FG002|Overall Study|Adverse Event|1|||
164408682|NCT02404389|593866106|FG003|Overall Study|Adverse Event|0|||
164408683|NCT02404389|593866107|FG004|Overall Study|Adverse Event|2|||
164408684|NCT02404389|593866103|FG000|Overall Study|Subject/guardian decision|1|||
164408685|NCT02404389|593866104|FG001|Overall Study|Subject/guardian decision|0|||
164408686|NCT02404389|593866105|FG002|Overall Study|Subject/guardian decision|0|||
164408687|NCT02404389|593866106|FG003|Overall Study|Subject/guardian decision|1|||
164408688|NCT02404389|593866107|FG004|Overall Study|Subject/guardian decision|1|||
164408689|NCT01576718|593866108|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
164408690|NCT01576718|593866109|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
164408691|NCT01576718|593866110|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
164408692|NCT01576718|593866111|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
164408693|NCT01576718|593866112|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
164408694|NCT01576718|593866113|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
164408695|NCT01576718|593866114|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
164408696|NCT01576718|593866108|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
164408697|NCT01576718|593866109|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
164408698|NCT01576718|593866110|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
164408699|NCT01576718|593866111|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
164707874|NCT01517373|594955354|FG003|Treatment Period|Lack of Efficacy|3|||
164707875|NCT01517373|594955355|FG004|Treatment Period|Lack of Efficacy|2|||
164707876|NCT01517373|594955356|FG005|Treatment Period|Lack of Efficacy|0|||
164707877|NCT01517373|594955351|FG000|Treatment Period|Medication error without AEs|0|||
164707878|NCT01517373|594955352|FG001|Treatment Period|Medication error without AEs|0|||
164707879|NCT01517373|594955353|FG002|Treatment Period|Medication error without AEs|2|||
164707880|NCT01517373|594955354|FG003|Treatment Period|Medication error without AEs|1|||
164707881|NCT01517373|594955355|FG004|Treatment Period|Medication error without AEs|0|||
164707882|NCT01517373|594955356|FG005|Treatment Period|Medication error without AEs|2|||
164707883|NCT00851318|594955360|FG000|Overall Study|Withdrawal by Subject|7|||
164707884|NCT00851318|594955361|FG001|Overall Study|Withdrawal by Subject|1|||
164707885|NCT00851318|594955362|FG002|Overall Study|Withdrawal by Subject|5|||
164707886|NCT00851318|594955363|FG003|Overall Study|Withdrawal by Subject|3|||
164707887|NCT00851318|594955360|FG000|Overall Study|Adverse Event|13|||
164707888|NCT00851318|594955361|FG001|Overall Study|Adverse Event|2|||
164707889|NCT00851318|594955362|FG002|Overall Study|Adverse Event|9|||
164707890|NCT00851318|594955363|FG003|Overall Study|Adverse Event|12|||
164707891|NCT00851318|594955360|FG000|Overall Study|Pregnancy|0|||
164707892|NCT00851318|594955361|FG001|Overall Study|Pregnancy|0|||
164408700|NCT01576718|593866112|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
164707893|NCT00851318|594955362|FG002|Overall Study|Pregnancy|1|||
164707894|NCT00851318|594955363|FG003|Overall Study|Pregnancy|1|||
164707895|NCT00851318|594955360|FG000|Overall Study|Lack of Efficacy|8|||
164408701|NCT01576718|593866113|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
164408702|NCT01576718|593866114|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
164408703|NCT01576718|593866108|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
164408704|NCT01576718|593866109|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
164707896|NCT00851318|594955361|FG001|Overall Study|Lack of Efficacy|2|||
164707897|NCT00851318|594955362|FG002|Overall Study|Lack of Efficacy|4|||
164408705|NCT01576718|593866110|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
164408706|NCT01576718|593866111|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
164707898|NCT00851318|594955363|FG003|Overall Study|Lack of Efficacy|2|||
164707899|NCT00851318|594955360|FG000|Overall Study|Non-compliance with Study Procedures|2|||
164707900|NCT00851318|594955361|FG001|Overall Study|Non-compliance with Study Procedures|0|||
164408707|NCT01576718|593866112|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
164408708|NCT01576718|593866113|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
164408709|NCT01576718|593866114|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
164408710|NCT01576718|593866108|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
164408711|NCT01576718|593866109|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
164408712|NCT01576718|593866110|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
164408713|NCT01576718|593866111|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
164408714|NCT01576718|593866112|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
164408715|NCT01576718|593866113|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
164408716|NCT01576718|593866114|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
164408717|NCT01576718|593866108|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
164408718|NCT01576718|593866109|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
164408719|NCT01576718|593866110|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
164408720|NCT01576718|593866111|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
164408721|NCT01576718|593866112|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
164408722|NCT01576718|593866113|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
164408723|NCT01576718|593866114|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
164408724|NCT01576718|593866108|FG000|Treatment Period|Adverse Event|0|||
164408725|NCT01576718|593866109|FG001|Treatment Period|Adverse Event|1|||
164408726|NCT01576718|593866110|FG002|Treatment Period|Adverse Event|1|||
164408727|NCT01576718|593866111|FG003|Treatment Period|Adverse Event|1|||
164408728|NCT01576718|593866112|FG004|Treatment Period|Adverse Event|1|||
164408729|NCT01576718|593866113|FG005|Treatment Period|Adverse Event|1|||
164408730|NCT01576718|593866114|FG006|Treatment Period|Adverse Event|0|||
164408731|NCT01576718|593866108|FG000|Treatment Period|Withdrawal by Subject|0|||
164408732|NCT01576718|593866109|FG001|Treatment Period|Withdrawal by Subject|1|||
164408733|NCT01576718|593866110|FG002|Treatment Period|Withdrawal by Subject|1|||
164408734|NCT01576718|593866111|FG003|Treatment Period|Withdrawal by Subject|0|||
164408735|NCT01576718|593866112|FG004|Treatment Period|Withdrawal by Subject|2|||
164408736|NCT01576718|593866113|FG005|Treatment Period|Withdrawal by Subject|4|||
164408737|NCT01576718|593866114|FG006|Treatment Period|Withdrawal by Subject|2|||
164408738|NCT01576718|593866108|FG000|Treatment Period|Physician Decision|0|||
164408739|NCT01576718|593866109|FG001|Treatment Period|Physician Decision|1|||
164408740|NCT01576718|593866110|FG002|Treatment Period|Physician Decision|1|||
164408741|NCT01576718|593866111|FG003|Treatment Period|Physician Decision|1|||
164408742|NCT01576718|593866112|FG004|Treatment Period|Physician Decision|1|||
164408743|NCT01576718|593866113|FG005|Treatment Period|Physician Decision|0|||
164408744|NCT01576718|593866114|FG006|Treatment Period|Physician Decision|0|||
164408745|NCT01576718|593866108|FG000|Treatment Period|Protocol Violation|0|||
164408746|NCT01576718|593866109|FG001|Treatment Period|Protocol Violation|5|||
164408747|NCT01576718|593866110|FG002|Treatment Period|Protocol Violation|4|||
164408748|NCT01576718|593866111|FG003|Treatment Period|Protocol Violation|10|||
164408749|NCT01576718|593866112|FG004|Treatment Period|Protocol Violation|6|||
164408750|NCT01576718|593866113|FG005|Treatment Period|Protocol Violation|8|||
164408751|NCT01576718|593866114|FG006|Treatment Period|Protocol Violation|12|||
164408752|NCT01576718|593866108|FG000|Treatment Period|Sponsor request|0|||
164408753|NCT01576718|593866109|FG001|Treatment Period|Sponsor request|1|||
164408754|NCT01576718|593866110|FG002|Treatment Period|Sponsor request|0|||
164408755|NCT01576718|593866111|FG003|Treatment Period|Sponsor request|0|||
164408756|NCT01576718|593866112|FG004|Treatment Period|Sponsor request|0|||
164408757|NCT01576718|593866113|FG005|Treatment Period|Sponsor request|1|||
164408758|NCT01576718|593866114|FG006|Treatment Period|Sponsor request|0|||
164408759|NCT01576718|593866108|FG000|Treatment Period|Met stopping criteria|0|||
164408760|NCT01576718|593866109|FG001|Treatment Period|Met stopping criteria|16|||
164408761|NCT01576718|593866110|FG002|Treatment Period|Met stopping criteria|13|||
164408762|NCT01576718|593866111|FG003|Treatment Period|Met stopping criteria|19|||
164408763|NCT01576718|593866112|FG004|Treatment Period|Met stopping criteria|16|||
164408764|NCT01576718|593866113|FG005|Treatment Period|Met stopping criteria|33|||
164408765|NCT01576718|593866114|FG006|Treatment Period|Met stopping criteria|15|||
164408766|NCT01576718|593866108|FG000|Treatment Period|Lost to Follow-up|0|||
164408767|NCT01576718|593866109|FG001|Treatment Period|Lost to Follow-up|0|||
164408768|NCT01576718|593866110|FG002|Treatment Period|Lost to Follow-up|0|||
164408769|NCT01576718|593866111|FG003|Treatment Period|Lost to Follow-up|0|||
164408770|NCT01576718|593866112|FG004|Treatment Period|Lost to Follow-up|1|||
164408771|NCT01576718|593866113|FG005|Treatment Period|Lost to Follow-up|0|||
164408772|NCT01576718|593866114|FG006|Treatment Period|Lost to Follow-up|0|||
164408773|NCT01576718|593866108|FG000|Treatment Period|Noncompliance to study medication|0|||
164408774|NCT01576718|593866109|FG001|Treatment Period|Noncompliance to study medication|0|||
164408775|NCT01576718|593866110|FG002|Treatment Period|Noncompliance to study medication|0|||
164408776|NCT01576718|593866111|FG003|Treatment Period|Noncompliance to study medication|0|||
164408777|NCT01576718|593866112|FG004|Treatment Period|Noncompliance to study medication|0|||
164408778|NCT01576718|593866113|FG005|Treatment Period|Noncompliance to study medication|1|||
164408779|NCT01576718|593866114|FG006|Treatment Period|Noncompliance to study medication|1|||
164462810|NCT05693935|594068510|FG000|Open-label Period (48 Weeks)|Other Than Specified|0|||
164462811|NCT05693935|594068511|FG001|Open-label Period (48 Weeks)|Other Than Specified|12|||
164462812|NCT05693935|594068512|FG002|Open-label Period (48 Weeks)|Other Than Specified|9|||
164462813|NCT05693935|594068513|FG003|Open-label Period (48 Weeks)|Other Than Specified|10|||
164462814|NCT05693935|594068514|FG004|Open-label Period (48 Weeks)|Other Than Specified|4|||
164462815|NCT05693935|594068515|FG005|Open-label Period (48 Weeks)|Other Than Specified|3|||
164462816|NCT05693935|594068516|FG006|Open-label Period (48 Weeks)|Other Than Specified|4|||
164462817|NCT04221490|594068522|FG000|At 30 Days Follow-up|Death|7|||
164462818|NCT04221490|594068522|FG000|At 30 Days Follow-up|Physician Decision|1|||
164462819|NCT04221490|594068522|FG000|At 30 Days Follow-up|Missed Visit|4|||
164462820|NCT04221490|594068522|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
164462821|NCT04221490|594068522|FG000|At 6 Months Follow-up|Death|9|||
164462822|NCT04221490|594068522|FG000|At 6 Months Follow-up|Missed Visit|8|||
164462823|NCT04221490|594068522|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
164462824|NCT04221490|594068522|FG000|At 1 Year Follow-up|Death|7|||
164462825|NCT04221490|594068522|FG000|At 1 Year Follow-up|Withdrawal by Subject|2|||
164462826|NCT04221490|594068522|FG000|At 1 Year Follow-up|Missed Visit|9|||
164462827|NCT04221490|594068522|FG000|At 1 Year Follow-up|Exited for Other Reasons|1|||
164462828|NCT04987320|594068528|FG000|Overall Study|Withdrawal by Subject|0|||
164462829|NCT04987320|594068529|FG001|Overall Study|Withdrawal by Subject|1|||
164462830|NCT00085735|594068530|FG000|Overall Study|Adverse Event|1|||
164462831|NCT00085735|594068531|FG001|Overall Study|Adverse Event|0|||
164462832|NCT00085735|594068532|FG002|Overall Study|Adverse Event|0|||
164462833|NCT00085735|594068533|FG003|Overall Study|Adverse Event|0|||
164462834|NCT00085735|594068534|FG004|Overall Study|Adverse Event|0|||
164462835|NCT00085735|594068535|FG005|Overall Study|Adverse Event|0|||
164462836|NCT00085735|594068530|FG000|Overall Study|Lack of Efficacy|2|||
164462837|NCT00085735|594068531|FG001|Overall Study|Lack of Efficacy|4|||
164707901|NCT00851318|594955362|FG002|Overall Study|Non-compliance with Study Procedures|1|||
164707902|NCT00851318|594955363|FG003|Overall Study|Non-compliance with Study Procedures|0|||
164707903|NCT00851318|594955360|FG000|Overall Study|Physician Decision|0|||
164707904|NCT00851318|594955361|FG001|Overall Study|Physician Decision|0|||
164707905|NCT00851318|594955362|FG002|Overall Study|Physician Decision|1|||
164707906|NCT00851318|594955363|FG003|Overall Study|Physician Decision|1|||
164408780|NCT04225988|593866116|FG000|Overall Study|Withdrawal by Subject|2|||
164408781|NCT04225988|593866117|FG001|Overall Study|Withdrawal by Subject|0|||
164408782|NCT05619003|593866119|FG000|Overall Study|Adverse Event|1|||
164408783|NCT02272725|593866124|FG000|Overall Study|equipment malfunction|2|||
164408784|NCT02272725|593866125|FG001|Overall Study|equipment malfunction|0|||
164408785|NCT07018999|593866126|FG000|Overall Study|Protocol Violation|0|||
164408786|NCT07018999|593866127|FG001|Overall Study|Protocol Violation|1|||
164408787|NCT07018999|593866126|FG000|Overall Study|Incomplete data entry|4|||
164408788|NCT07018999|593866127|FG001|Overall Study|Incomplete data entry|7|||
164408789|NCT04739761|593866130|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
164408790|NCT04739761|593866131|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
164408791|NCT04739761|593866130|FG000|Overall Study|By complete response from the participant|1|||
164408792|NCT04739761|593866131|FG001|Overall Study|By complete response from the participant|0|||
164408793|NCT04739761|593866130|FG000|Overall Study|Lost to Follow-up|3|||
164408794|NCT04739761|593866131|FG001|Overall Study|Lost to Follow-up|3|||
164408795|NCT04739761|593866130|FG000|Overall Study|Death|13|||
164408796|NCT04739761|593866131|FG001|Overall Study|Death|13|||
164408797|NCT04739761|593866130|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
164408798|NCT04739761|593866131|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
164408799|NCT04739761|593866130|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
164408800|NCT04739761|593866131|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
164408801|NCT04739761|593866130|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
164408802|NCT04739761|593866131|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
164408803|NCT04739761|593866130|FG000|Overall Study|Adverse Event|0|||
164408804|NCT04739761|593866131|FG001|Overall Study|Adverse Event|3|||
164408805|NCT04739761|593866130|FG000|Overall Study|Participant decision|1|||
164408806|NCT04739761|593866131|FG001|Overall Study|Participant decision|0|||
164408807|NCT04739761|593866130|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
164408808|NCT04739761|593866131|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
164408809|NCT04739761|593866130|FG000|Overall Study|Participant immediately started next line of treatment|1|||
164462838|NCT00085735|594068532|FG002|Overall Study|Lack of Efficacy|6|||
164462839|NCT00085735|594068533|FG003|Overall Study|Lack of Efficacy|3|||
164462840|NCT00085735|594068534|FG004|Overall Study|Lack of Efficacy|4|||
164462841|NCT00085735|594068535|FG005|Overall Study|Lack of Efficacy|3|||
164462842|NCT00085735|594068530|FG000|Overall Study|Lost to Follow-up|0|||
164462843|NCT00085735|594068531|FG001|Overall Study|Lost to Follow-up|1|||
164462844|NCT00085735|594068532|FG002|Overall Study|Lost to Follow-up|0|||
164462845|NCT00085735|594068533|FG003|Overall Study|Lost to Follow-up|0|||
164707907|NCT03597529|594955368|FG000|Overall Study|Lost to Follow-up|10|||
164408810|NCT04739761|593866131|FG001|Overall Study|Participant immediately started next line of treatment|0|||
164408811|NCT04739761|593866130|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
164408812|NCT04739761|593866131|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
164408813|NCT04739761|593866130|FG000|Overall Study|Lack of clinical benefit|1|||
164408814|NCT04739761|593866131|FG001|Overall Study|Lack of clinical benefit|0|||
164408815|NCT04739761|593866130|FG000|Overall Study|Disease progression|5|||
164408816|NCT04739761|593866131|FG001|Overall Study|Disease progression|5|||
164408817|NCT04739761|593866130|FG000|Overall Study|Withdrawal by Subject|14|||
164408818|NCT04739761|593866131|FG001|Overall Study|Withdrawal by Subject|13|||
164408819|NCT04739761|593866130|FG000|Overall Study|Protocol Violation|1|||
164408820|NCT04739761|593866131|FG001|Overall Study|Protocol Violation|0|||
164408821|NCT04739761|593866130|FG000|Overall Study|Physician Decision|2|||
164408822|NCT04739761|593866131|FG001|Overall Study|Physician Decision|0|||
164408823|NCT00429494|593867777|FG000|Overall Study|Withdrawal by Subject|9|||
164408824|NCT00429494|593867777|FG000|Overall Study|Death|6|||
164408825|NCT00976703|593867780|FG000|Overall Study|Physician Decision|1|||
164408826|NCT00976703|593867781|FG001|Overall Study|Physician Decision|1|||
164408827|NCT00976703|593867780|FG000|Overall Study|ineligible for study|2|||
164408828|NCT00976703|593867781|FG001|Overall Study|ineligible for study|2|||
164408829|NCT01992549|593867786|FG000|Overall Study|Lost to Follow-up|2|||
164408830|NCT01992549|593867786|FG000|Overall Study|Serious Adverse Event|1|||
164408831|NCT01992549|593867786|FG000|Overall Study|Product Switch to Extend Half Life|1|||
164408832|NCT01590771|593867787|FG000|Overall Study|Other Protocol Specified Criteria|5|||
164408833|NCT01590771|593867788|FG001|Overall Study|Other Protocol Specified Criteria|14|||
164408834|NCT01590771|593867787|FG000|Overall Study|Withdrawal by Subject|8|||
164408835|NCT01590771|593867788|FG001|Overall Study|Withdrawal by Subject|15|||
164408836|NCT01590771|593867787|FG000|Overall Study|Protocol Violation|1|||
164408837|NCT01590771|593867788|FG001|Overall Study|Protocol Violation|2|||
164408838|NCT01590771|593867787|FG000|Overall Study|Lost to Follow-up|1|||
164408839|NCT01590771|593867788|FG001|Overall Study|Lost to Follow-up|1|||
164408840|NCT01590771|593867787|FG000|Overall Study|Lack of Efficacy|1|||
164408841|NCT01590771|593867788|FG001|Overall Study|Lack of Efficacy|0|||
164408842|NCT01590771|593867787|FG000|Overall Study|Adverse Event|3|||
164408843|NCT01590771|593867788|FG001|Overall Study|Adverse Event|7|||
164408844|NCT01785628|593867789|FG000|Overall Study|Lost to Follow-up|2|||
164408845|NCT01785628|593867790|FG001|Overall Study|Lost to Follow-up|3|||
164408846|NCT01289041|593867794|FG000|Overall Study|Adverse Event|24|||
164408847|NCT01289041|593867794|FG000|Overall Study|Physician Decision|1|||
164408848|NCT01289041|593867794|FG000|Overall Study|Progressive Disease|41|||
164408849|NCT01289041|593867794|FG000|Overall Study|Withdrawal by Subject|3|||
164408850|NCT01289041|593867794|FG000|Overall Study|Death|1|||
164408851|NCT00369681|593867799|FG000|Overall Study|Death|1|||
164408852|NCT05044325|593867811|FG000|Part A:Treatment Period 1|Adverse Event|0|||
164408853|NCT05044325|593867812|FG001|Part A:Treatment Period 1|Adverse Event|0|||
164408854|NCT05044325|593867813|FG002|Part A:Treatment Period 1|Adverse Event|0|||
164408855|NCT05044325|593867814|FG003|Part A:Treatment Period 1|Adverse Event|0|||
164408856|NCT05044325|593867815|FG004|Part A:Treatment Period 1|Adverse Event|0|||
164408857|NCT05044325|593867816|FG005|Part A:Treatment Period 1|Adverse Event|1|||
164408858|NCT05044325|593867817|FG006|Part A:Treatment Period 1|Adverse Event|0|||
164408859|NCT05044325|593867818|FG007|Part A:Treatment Period 1|Adverse Event|1|||
164408860|NCT05044325|593867819|FG008|Part A:Treatment Period 1|Adverse Event|0|||
164408861|NCT05044325|593867820|FG009|Part A:Treatment Period 1|Adverse Event|0|||
164408862|NCT05044325|593867811|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
164408863|NCT05044325|593867812|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
164408864|NCT05044325|593867813|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
164408865|NCT05044325|593867814|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
164408866|NCT05044325|593867815|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
164408867|NCT05044325|593867816|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
164408868|NCT05044325|593867817|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
164408869|NCT05044325|593867818|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
164408870|NCT05044325|593867819|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
164408871|NCT05044325|593867820|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
164408872|NCT05044325|593867811|FG000|Part A:Treatment Period 1|Physician Decision|0|||
164408873|NCT05044325|593867812|FG001|Part A:Treatment Period 1|Physician Decision|0|||
164408874|NCT05044325|593867813|FG002|Part A:Treatment Period 1|Physician Decision|0|||
164408875|NCT05044325|593867814|FG003|Part A:Treatment Period 1|Physician Decision|0|||
164408876|NCT05044325|593867815|FG004|Part A:Treatment Period 1|Physician Decision|0|||
164408877|NCT05044325|593867816|FG005|Part A:Treatment Period 1|Physician Decision|0|||
164408878|NCT05044325|593867817|FG006|Part A:Treatment Period 1|Physician Decision|1|||
164408879|NCT05044325|593867818|FG007|Part A:Treatment Period 1|Physician Decision|0|||
164408880|NCT05044325|593867819|FG008|Part A:Treatment Period 1|Physician Decision|0|||
164408881|NCT05044325|593867820|FG009|Part A:Treatment Period 1|Physician Decision|0|||
164707908|NCT03597529|594955369|FG001|Overall Study|Lost to Follow-up|12|||
164707909|NCT03597529|594955368|FG000|Overall Study|Physician Decision|3|||
164707910|NCT03597529|594955369|FG001|Overall Study|Physician Decision|1|||
164707911|NCT03597529|594955368|FG000|Overall Study|Withdrawal by Subject|6|||
164408882|NCT05044325|593867811|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
164408883|NCT05044325|593867812|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
164408884|NCT05044325|593867813|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
164408885|NCT05044325|593867814|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
164408886|NCT05044325|593867815|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
164408887|NCT05044325|593867816|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
164408888|NCT05044325|593867817|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
164408889|NCT05044325|593867818|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
164408890|NCT05044325|593867819|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
164408891|NCT05044325|593867820|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
164408892|NCT05044325|593867811|FG000|Part A:Treatment Period 2|Adverse Event|0|||
164408893|NCT05044325|593867812|FG001|Part A:Treatment Period 2|Adverse Event|1|||
164408894|NCT05044325|593867813|FG002|Part A:Treatment Period 2|Adverse Event|0|||
164408895|NCT05044325|593867814|FG003|Part A:Treatment Period 2|Adverse Event|0|||
164408896|NCT05044325|593867815|FG004|Part A:Treatment Period 2|Adverse Event|1|||
164408897|NCT05044325|593867816|FG005|Part A:Treatment Period 2|Adverse Event|1|||
164408898|NCT05044325|593867817|FG006|Part A:Treatment Period 2|Adverse Event|0|||
164408899|NCT05044325|593867818|FG007|Part A:Treatment Period 2|Adverse Event|0|||
164408900|NCT05044325|593867819|FG008|Part A:Treatment Period 2|Adverse Event|0|||
164408901|NCT05044325|593867820|FG009|Part A:Treatment Period 2|Adverse Event|0|||
164408902|NCT05044325|593867811|FG000|Part A:Treatment Period 2|Physician Decision|0|||
164408903|NCT05044325|593867812|FG001|Part A:Treatment Period 2|Physician Decision|0|||
164408904|NCT05044325|593867813|FG002|Part A:Treatment Period 2|Physician Decision|0|||
164408905|NCT05044325|593867814|FG003|Part A:Treatment Period 2|Physician Decision|0|||
164408906|NCT05044325|593867815|FG004|Part A:Treatment Period 2|Physician Decision|0|||
164408907|NCT05044325|593867816|FG005|Part A:Treatment Period 2|Physician Decision|1|||
164408908|NCT05044325|593867817|FG006|Part A:Treatment Period 2|Physician Decision|0|||
164408909|NCT05044325|593867818|FG007|Part A:Treatment Period 2|Physician Decision|0|||
164408910|NCT05044325|593867819|FG008|Part A:Treatment Period 2|Physician Decision|0|||
164408911|NCT05044325|593867820|FG009|Part A:Treatment Period 2|Physician Decision|0|||
164408912|NCT05044325|593867811|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
164408913|NCT05044325|593867812|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
164408914|NCT05044325|593867813|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
164408915|NCT05044325|593867814|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
164408916|NCT05044325|593867815|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
164408917|NCT05044325|593867816|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
164408918|NCT05044325|593867817|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
164408919|NCT05044325|593867818|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
164408920|NCT05044325|593867819|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
164408921|NCT05044325|593867820|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
164408922|NCT01250119|593867823|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
164408923|NCT01250119|593867824|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
164408924|NCT01250119|593867823|FG000|Diagnostic Phase|Participants Not Tested|44|||
164408925|NCT01250119|593867824|FG001|Diagnostic Phase|Participants Not Tested|0|||
164408926|NCT01250119|593867823|FG000|Treatment Phase|Progressive Disease|0|||
164408927|NCT01250119|593867824|FG001|Treatment Phase|Progressive Disease|32|||
164408928|NCT01250119|593867823|FG000|Treatment Phase|Death|0|||
164408929|NCT01250119|593867824|FG001|Treatment Phase|Death|2|||
164408930|NCT01250119|593867823|FG000|Treatment Phase|Withdrawal by Subject|0|||
164408931|NCT01250119|593867824|FG001|Treatment Phase|Withdrawal by Subject|1|||
164408932|NCT01250119|593867823|FG000|Treatment Phase|Adverse Event|0|||
164408933|NCT01250119|593867824|FG001|Treatment Phase|Adverse Event|2|||
164408934|NCT01250119|593867823|FG000|Treatment Phase|Unknown reason|0|||
164408935|NCT01250119|593867824|FG001|Treatment Phase|Unknown reason|4|||
164408936|NCT00674323|593867825|FG000|Overall Study|Adverse Event|0|||
164408937|NCT00674323|593867826|FG001|Overall Study|Adverse Event|1|||
164408938|NCT00674323|593867827|FG002|Overall Study|Adverse Event|0|||
164408939|NCT00674323|593867825|FG000|Overall Study|Protocol Violation|1|||
164408940|NCT00674323|593867826|FG001|Overall Study|Protocol Violation|0|||
164408941|NCT00674323|593867827|FG002|Overall Study|Protocol Violation|0|||
164408942|NCT02013388|593867832|FG000|Overall Study|work emergency|1|||
164707912|NCT03597529|594955369|FG001|Overall Study|Withdrawal by Subject|3|||
164707913|NCT03597529|594955368|FG000|Overall Study|Non-compliant with study activities|1|||
164707914|NCT03597529|594955369|FG001|Overall Study|Non-compliant with study activities|2|||
164144809|NCT01524978|592891779|FG005|Overall Study|Lost to Follow-up|1|||
164408943|NCT02013388|593867833|FG001|Overall Study|work emergency|0|||
164408944|NCT02013388|593867834|FG002|Overall Study|work emergency|0|||
164707915|NCT02196701|594955372|FG000|Overall Study|Adverse Event|1|||
164707916|NCT02196701|594955372|FG000|Overall Study|Lost to Follow-up|1|||
164408945|NCT02013388|593867835|FG003|Overall Study|work emergency|0|||
164408946|NCT02013388|593867836|FG004|Overall Study|work emergency|1|||
164408947|NCT02013388|593867837|FG005|Overall Study|work emergency|0|||
164408948|NCT02013388|593867838|FG006|Overall Study|work emergency|0|||
164408949|NCT02013388|593867839|FG007|Overall Study|work emergency|0|||
164408950|NCT00991341|593867844|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
164408951|NCT00991341|593867845|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
164408952|NCT00991341|593867844|FG000|Overall Study|Death|3|||
164408953|NCT00991341|593867845|FG001|Overall Study|Death|0|||
164408954|NCT00991341|593867844|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
164408955|NCT00991341|593867845|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
164408956|NCT00991341|593867844|FG000|Overall Study|Physician Decision|1|||
164408957|NCT00991341|593867845|FG001|Overall Study|Physician Decision|2|||
164408958|NCT00991341|593867844|FG000|Overall Study|Withdrawal by Subject|3|||
164408959|NCT00991341|593867845|FG001|Overall Study|Withdrawal by Subject|4|||
164408960|NCT02801669|593867848|FG000|Overall Study|Death|66|||
164408961|NCT02801669|593867849|FG001|Overall Study|Death|69|||
164408962|NCT02801669|593867848|FG000|Overall Study|Withdrawal by Subject|81|||
164408963|NCT02801669|593867849|FG001|Overall Study|Withdrawal by Subject|77|||
164408964|NCT02801669|593867848|FG000|Overall Study|Other|4|||
164408965|NCT02801669|593867849|FG001|Overall Study|Other|6|||
164408966|NCT04461795|593867851|FG000|Overall Study|Lost to Follow-up|2|||
164408967|NCT04461795|593867851|FG000|Overall Study|Withdrawal by Subject|2|||
164408968|NCT04461795|593867851|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
164408969|NCT00615264|593867852|FG000|Overall Study|Withdrawal by Subject|17|||
164408970|NCT00615264|593867853|FG001|Overall Study|Withdrawal by Subject|19|||
164408971|NCT00615264|593867852|FG000|Overall Study|Lost to Follow-up|6|||
164408972|NCT00615264|593867853|FG001|Overall Study|Lost to Follow-up|13|||
164408973|NCT00615264|593867852|FG000|Overall Study|Adverse Event|8|||
164408974|NCT00615264|593867853|FG001|Overall Study|Adverse Event|5|||
164408975|NCT00615264|593867852|FG000|Overall Study|Death|1|||
164408976|NCT00615264|593867853|FG001|Overall Study|Death|1|||
164408977|NCT00615264|593867852|FG000|Overall Study|Protocol Violation|11|||
164408978|NCT00615264|593867853|FG001|Overall Study|Protocol Violation|7|||
164408979|NCT00615264|593867852|FG000|Overall Study|Not defined|7|||
164408980|NCT00615264|593867853|FG001|Overall Study|Not defined|4|||
164408981|NCT00615264|593867852|FG000|Overall Study|Dermal Hypersensitivity|0|||
164408982|NCT00615264|593867853|FG001|Overall Study|Dermal Hypersensitivity|3|||
164408983|NCT02396537|593867858|FG000|Overall Study|Protocol Violation|0|||
164408984|NCT02396537|593867859|FG001|Overall Study|Protocol Violation|1|||
164408985|NCT01982435|593867860|FG000|Overall Study|Adverse Event|1|||
164408986|NCT01982435|593867861|FG001|Overall Study|Adverse Event|0|||
164408987|NCT00787319|593867865|FG000|Overall Study|Lost to Follow-up|2|||
164408988|NCT00787319|593867865|FG000|Overall Study|Withdrawal by Subject|15|||
164408989|NCT00787319|593867865|FG000|Overall Study|Adverse Event|3|||
164408990|NCT00787319|593867865|FG000|Overall Study|Objective progression or relapse|30|||
164408991|NCT00787319|593867865|FG000|Overall Study|Lack of Efficacy|1|||
164408992|NCT00787319|593867865|FG000|Overall Study|Budget exhausted/exceeded|1|||
164408993|NCT00787319|593867865|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
164408994|NCT00787319|593867865|FG000|Overall Study|No health insurance reimbursement|2|||
164408995|NCT00787319|593867865|FG000|Overall Study|Stabilized disease findings|3|||
164408996|NCT00787319|593867865|FG000|Overall Study|Inactive disease|5|||
164408997|NCT01932294|593867866|FG000|Overall Study|Death|43|||
164408998|NCT01932294|593867866|FG000|Overall Study|Lost to Follow-up|8|||
164408999|NCT01932294|593867866|FG000|Overall Study|VAD Implantation|20|||
164409000|NCT01932294|593867866|FG000|Overall Study|Heart Transplantation|16|||
164409001|NCT01932294|593867866|FG000|Overall Study|Transferred to other hospitals|12|||
164409002|NCT00409786|593867869|FG000|Overall Study|Withdrawal by Subject|3|||
164409003|NCT00312702|593867876|FG000|Immunization Phase|Lost to Follow-up|0|||
164409004|NCT00312702|593867877|FG001|Immunization Phase|Lost to Follow-up|1|||
164409005|NCT00312702|593867878|FG002|Immunization Phase|Lost to Follow-up|0|||
164409006|NCT03592277|593867879|FG000|Overall Study|Withdrawal by Subject|6|||
164599053|NCT02883049|594554770|FG014|Post Induction|Moved to another non-COG institution|0|||
164599054|NCT02883049|594554771|FG015|Post Induction|Moved to another non-COG institution|0|||
164599055|NCT02883049|594554756|FG000|Post Induction|Randomization closed|0|||
164599056|NCT02883049|594554757|FG001|Post Induction|Randomization closed|0|||
164599057|NCT02883049|594554758|FG002|Post Induction|Randomization closed|0|||
164599058|NCT02883049|594554759|FG003|Post Induction|Randomization closed|0|||
164599059|NCT02883049|594554760|FG004|Post Induction|Randomization closed|0|||
164599060|NCT02883049|594554761|FG005|Post Induction|Randomization closed|0|||
164599061|NCT02883049|594554762|FG006|Post Induction|Randomization closed|0|||
164599062|NCT02883049|594554763|FG007|Post Induction|Randomization closed|20|||
164599063|NCT02883049|594554764|FG008|Post Induction|Randomization closed|0|||
164599064|NCT02883049|594554765|FG009|Post Induction|Randomization closed|0|||
164599065|NCT02883049|594554766|FG010|Post Induction|Randomization closed|0|||
164599066|NCT02883049|594554767|FG011|Post Induction|Randomization closed|0|||
164599067|NCT02883049|594554768|FG012|Post Induction|Randomization closed|0|||
164409007|NCT03592277|593867880|FG001|Overall Study|Withdrawal by Subject|8|||
164409008|NCT02917265|593867883|FG000|Overall Study|Physician Decision|1|||
164409009|NCT02917265|593867884|FG001|Overall Study|Physician Decision|0|||
164409010|NCT02917265|593867883|FG000|Overall Study|Withdrawal by Subject|1|||
164409011|NCT02917265|593867884|FG001|Overall Study|Withdrawal by Subject|0|||
164409012|NCT00979602|593867897|FG000|Overall Study|Serious Adverse Event|5|||
164409013|NCT00979602|593867898|FG001|Overall Study|Serious Adverse Event|3|||
164707917|NCT02196701|594955372|FG000|Overall Study|Non-adherence to Protocol|1|||
164707918|NCT01341782|594955375|FG000|Overall Study|Adverse Event|1|||
164707919|NCT01341782|594955376|FG001|Overall Study|Adverse Event|1|||
164409014|NCT00979602|593867897|FG000|Overall Study|Protocol Violation|3|||
164409015|NCT00979602|593867898|FG001|Overall Study|Protocol Violation|0|||
164409016|NCT00979602|593867897|FG000|Overall Study|Withdrawal by Subject|31|||
164409017|NCT00979602|593867898|FG001|Overall Study|Withdrawal by Subject|25|||
164409018|NCT00979602|593867897|FG000|Overall Study|Lost to Follow-up|100|||
164409019|NCT00979602|593867898|FG001|Overall Study|Lost to Follow-up|96|||
164409020|NCT00979602|593867897|FG000|Overall Study|Migrated/moved from study area|3|||
164409021|NCT00979602|593867898|FG001|Overall Study|Migrated/moved from study area|6|||
164409022|NCT00979602|593867897|FG000|Overall Study|Others|3|||
164409023|NCT00979602|593867898|FG001|Overall Study|Others|3|||
164409024|NCT02002182|593867901|FG000|Overall Study|Withdraw from study|3|||
164409025|NCT02002182|593867902|FG001|Overall Study|Withdraw from study|1|||
164409026|NCT02002182|593867901|FG000|Overall Study|Health Reasons|1|||
164409027|NCT02002182|593867902|FG001|Overall Study|Health Reasons|0|||
164409028|NCT02002182|593867901|FG000|Overall Study|Death|1|||
164409029|NCT02002182|593867902|FG001|Overall Study|Death|0|||
164409030|NCT01320943|593867910|FG000|Overall Study|Lost to Follow-up|1|||
164409031|NCT01320943|593867911|FG001|Overall Study|Lost to Follow-up|0|||
164409032|NCT01320943|593867910|FG000|Overall Study|Physician Decision|0|||
164409033|NCT01320943|593867911|FG001|Overall Study|Physician Decision|1|||
164707920|NCT01341782|594955375|FG000|Overall Study|Withdrawal by Subject|6|||
164707921|NCT01341782|594955376|FG001|Overall Study|Withdrawal by Subject|5|||
164409034|NCT01320943|593867910|FG000|Overall Study|Randomized but not Treated|0|||
164409035|NCT01320943|593867911|FG001|Overall Study|Randomized but not Treated|1|||
164409036|NCT01669798|593867919|FG000|Overall Study|Physician Decision|5|||
164409037|NCT01806584|593867923|FG000|Overall Study|Adverse Event|2|||
164409038|NCT01806584|593867924|FG001|Overall Study|Adverse Event|1|||
164409039|NCT01806584|593867923|FG000|Overall Study|Death|1|||
164409040|NCT01806584|593867924|FG001|Overall Study|Death|0|||
164409041|NCT01806584|593867923|FG000|Overall Study|Lost to Follow-up|0|||
164409042|NCT01806584|593867924|FG001|Overall Study|Lost to Follow-up|2|||
164409043|NCT01806584|593867923|FG000|Overall Study|Study terminated by sponsor|9|||
164409044|NCT01806584|593867924|FG001|Overall Study|Study terminated by sponsor|14|||
164409045|NCT01806584|593867923|FG000|Overall Study|Withdrawal by Subject|1|||
164409046|NCT01806584|593867924|FG001|Overall Study|Withdrawal by Subject|1|||
164409047|NCT01806584|593867923|FG000|Overall Study|Other unspecified|1|||
164409048|NCT01806584|593867924|FG001|Overall Study|Other unspecified|0|||
164409049|NCT00311155|593869949|FG000|Overall Study|Adverse Event|21|||
164409050|NCT00311155|593869949|FG000|Overall Study|Withdrawal by Subject|17|||
164409051|NCT00311155|593869949|FG000|Overall Study|Did not meet entry criteria|55|||
164409052|NCT02243631|593869950|FG000|Overall Study|no synovial fluid on second aspirate|0|||
164409053|NCT02243631|593869951|FG001|Overall Study|no synovial fluid on second aspirate|1|||
164409054|NCT00767104|593869962|FG000|Overall Study|Lost to Follow-up|1|||
164409055|NCT00767104|593869963|FG001|Overall Study|Lost to Follow-up|2|||
164409056|NCT00840996|593869964|FG000|Overall Study|Withdrawal by Subject|1|||
164409057|NCT00840996|593869965|FG001|Overall Study|Withdrawal by Subject|0|||
164409058|NCT02200939|593869973|FG000|Overall Study|Participant withdrew consent|0|||
164409059|NCT02200939|593869974|FG001|Overall Study|Participant withdrew consent|1|||
164409060|NCT02200939|593869973|FG000|Overall Study|Lost to Follow-up|2|||
164409061|NCT02200939|593869974|FG001|Overall Study|Lost to Follow-up|9|||
164409062|NCT02200939|593869973|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
164409063|NCT02200939|593869974|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
164409064|NCT04567693|593869975|FG000|Overall Study|Death|0|||
164409065|NCT04567693|593869976|FG001|Overall Study|Death|0|||
164409066|NCT04567693|593869977|FG002|Overall Study|Death|2|||
164409067|NCT04567693|593869975|FG000|Overall Study|Lost to Follow-up|1|||
164409068|NCT04567693|593869976|FG001|Overall Study|Lost to Follow-up|0|||
164409069|NCT04567693|593869977|FG002|Overall Study|Lost to Follow-up|2|||
164409070|NCT04567693|593869975|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
164409071|NCT04567693|593869976|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
164409072|NCT04567693|593869977|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
164409073|NCT03722264|593869983|FG000|Overall Study|Physician Decision|3|||
164409074|NCT00957931|593869984|FG000|Overall Study|Death|4|||
164409075|NCT01486758|593869985|FG000|Overall Study|Lost to Follow-up|0|||
164409076|NCT01486758|593869986|FG001|Overall Study|Lost to Follow-up|1|||
164707922|NCT01341782|594955375|FG000|Overall Study|Missed 3 consecutive doses|0|||
164707923|NCT01341782|594955376|FG001|Overall Study|Missed 3 consecutive doses|4|||
164707924|NCT01341782|594955375|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
164707925|NCT01341782|594955376|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
164707926|NCT01341782|594955375|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
164707927|NCT01341782|594955376|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
164707928|NCT01341782|594955375|FG000|Overall Study|Other|5|||
164707929|NCT01341782|594955376|FG001|Overall Study|Other|0|||
164707930|NCT03796039|594955377|FG000|Overall Study|Death|2|||
164707931|NCT03796039|594955378|FG001|Overall Study|Death|1|||
164707932|NCT03796039|594955377|FG000|Overall Study|Withdrawal by Subject|7|||
164409077|NCT02392611|593869993|FG000|Overall Study|Adverse Event|0|||
164409078|NCT02392611|593869994|FG001|Overall Study|Adverse Event|0|||
164409079|NCT02392611|593869995|FG002|Overall Study|Adverse Event|0|||
164409080|NCT02392611|593869996|FG003|Overall Study|Adverse Event|1|||
164409081|NCT02392611|593869997|FG004|Overall Study|Adverse Event|0|||
164409082|NCT02392611|593869998|FG005|Overall Study|Adverse Event|0|||
164409083|NCT02392611|593869999|FG006|Overall Study|Adverse Event|0|||
164409084|NCT02392611|593870000|FG007|Overall Study|Adverse Event|0|||
164409085|NCT02392611|593870001|FG008|Overall Study|Adverse Event|0|||
164409086|NCT02392611|593869993|FG000|Overall Study|Progressive disease|0|||
164409087|NCT02392611|593869994|FG001|Overall Study|Progressive disease|0|||
164409088|NCT02392611|593869995|FG002|Overall Study|Progressive disease|0|||
164409089|NCT02392611|593869996|FG003|Overall Study|Progressive disease|2|||
164409090|NCT02392611|593869997|FG004|Overall Study|Progressive disease|1|||
164409091|NCT02392611|593869998|FG005|Overall Study|Progressive disease|0|||
164409092|NCT02392611|593869999|FG006|Overall Study|Progressive disease|0|||
164409093|NCT02392611|593870000|FG007|Overall Study|Progressive disease|0|||
164409094|NCT02392611|593870001|FG008|Overall Study|Progressive disease|0|||
164409095|NCT02392611|593869993|FG000|Overall Study|Death|1|||
164409096|NCT02392611|593869994|FG001|Overall Study|Death|0|||
164409097|NCT02392611|593869995|FG002|Overall Study|Death|0|||
164409098|NCT02392611|593869996|FG003|Overall Study|Death|0|||
164409099|NCT02392611|593869997|FG004|Overall Study|Death|0|||
164409100|NCT02392611|593869998|FG005|Overall Study|Death|1|||
164409101|NCT02392611|593869999|FG006|Overall Study|Death|0|||
164707933|NCT03796039|594955378|FG001|Overall Study|Withdrawal by Subject|4|||
164707934|NCT01140503|594955379|FG000|Overall Study|Withdrawal by Subject|1|||
164707935|NCT01157897|594955381|FG000|Overall Study|Lost to Follow-up|2|||
164409102|NCT02392611|593870000|FG007|Overall Study|Death|0|||
164409103|NCT02392611|593870001|FG008|Overall Study|Death|0|||
164409104|NCT02392611|593869993|FG000|Overall Study|Withdrawal by Subject|0|||
164409105|NCT02392611|593869994|FG001|Overall Study|Withdrawal by Subject|0|||
164409106|NCT02392611|593869995|FG002|Overall Study|Withdrawal by Subject|0|||
164409107|NCT02392611|593869996|FG003|Overall Study|Withdrawal by Subject|1|||
164462846|NCT00085735|594068534|FG004|Overall Study|Lost to Follow-up|1|||
164707936|NCT01157897|594955382|FG001|Overall Study|Lost to Follow-up|0|||
164707937|NCT01157897|594955383|FG002|Overall Study|Lost to Follow-up|0|||
164409108|NCT02392611|593869997|FG004|Overall Study|Withdrawal by Subject|0|||
164409109|NCT02392611|593869998|FG005|Overall Study|Withdrawal by Subject|0|||
164409110|NCT02392611|593869999|FG006|Overall Study|Withdrawal by Subject|0|||
164409111|NCT02392611|593870000|FG007|Overall Study|Withdrawal by Subject|0|||
164409112|NCT02392611|593870001|FG008|Overall Study|Withdrawal by Subject|0|||
164409113|NCT02392611|593869993|FG000|Overall Study|Lost to Follow-up|0|||
164409114|NCT02392611|593869994|FG001|Overall Study|Lost to Follow-up|0|||
164409115|NCT02392611|593869995|FG002|Overall Study|Lost to Follow-up|0|||
164409116|NCT02392611|593869996|FG003|Overall Study|Lost to Follow-up|0|||
164409117|NCT02392611|593869997|FG004|Overall Study|Lost to Follow-up|0|||
164409118|NCT02392611|593869998|FG005|Overall Study|Lost to Follow-up|0|||
164409119|NCT02392611|593869999|FG006|Overall Study|Lost to Follow-up|1|||
164409120|NCT02392611|593870000|FG007|Overall Study|Lost to Follow-up|0|||
164409121|NCT02392611|593870001|FG008|Overall Study|Lost to Follow-up|0|||
164409122|NCT02392611|593869993|FG000|Overall Study|Enrolled, not treated|0|||
164409123|NCT02392611|593869994|FG001|Overall Study|Enrolled, not treated|0|||
164409124|NCT02392611|593869995|FG002|Overall Study|Enrolled, not treated|0|||
164409125|NCT02392611|593869996|FG003|Overall Study|Enrolled, not treated|2|||
164409126|NCT02392611|593869997|FG004|Overall Study|Enrolled, not treated|0|||
164409127|NCT02392611|593869998|FG005|Overall Study|Enrolled, not treated|0|||
164409128|NCT02392611|593869999|FG006|Overall Study|Enrolled, not treated|0|||
164707938|NCT01157897|594955384|FG003|Overall Study|Lost to Follow-up|1|||
164707939|NCT01157897|594955381|FG000|Overall Study|Relocated|0|||
164707940|NCT01157897|594955382|FG001|Overall Study|Relocated|2|||
164707941|NCT01157897|594955383|FG002|Overall Study|Relocated|0|||
164707942|NCT01157897|594955384|FG003|Overall Study|Relocated|0|||
164707943|NCT00681590|594955385|FG000|Overall Study|Withdrawal by Subject|2|||
164707944|NCT00681590|594955386|FG001|Overall Study|Withdrawal by Subject|12|||
164409129|NCT02392611|593870000|FG007|Overall Study|Enrolled, not treated|0|||
164409130|NCT02392611|593870001|FG008|Overall Study|Enrolled, not treated|0|||
164409131|NCT00553202|593870008|FG000|Overall Study|Death|16|||
164409132|NCT00553202|593870008|FG000|Overall Study|Lost to Follow-up|1|||
164409133|NCT00553202|593870008|FG000|Overall Study|Physician Decision|28|||
164599068|NCT02883049|594554769|FG013|Post Induction|Randomization closed|0|||
164599069|NCT02883049|594554770|FG014|Post Induction|Randomization closed|0|||
164599070|NCT02883049|594554771|FG015|Post Induction|Randomization closed|0|||
164599071|NCT02883049|594554756|FG000|Post Induction|MRD negative|0|||
164599072|NCT02883049|594554757|FG001|Post Induction|MRD negative|0|||
164599073|NCT02883049|594554758|FG002|Post Induction|MRD negative|0|||
164599074|NCT02883049|594554759|FG003|Post Induction|MRD negative|0|||
164599075|NCT02883049|594554760|FG004|Post Induction|MRD negative|0|||
164599076|NCT02883049|594554761|FG005|Post Induction|MRD negative|0|||
164599077|NCT02883049|594554762|FG006|Post Induction|MRD negative|0|||
164599078|NCT02883049|594554763|FG007|Post Induction|MRD negative|11|||
164599079|NCT02883049|594554764|FG008|Post Induction|MRD negative|0|||
164599080|NCT02883049|594554765|FG009|Post Induction|MRD negative|0|||
164599081|NCT02883049|594554766|FG010|Post Induction|MRD negative|0|||
164599082|NCT02883049|594554767|FG011|Post Induction|MRD negative|0|||
164599083|NCT02883049|594554768|FG012|Post Induction|MRD negative|0|||
164599084|NCT02883049|594554769|FG013|Post Induction|MRD negative|0|||
164599085|NCT02883049|594554770|FG014|Post Induction|MRD negative|0|||
164599086|NCT02883049|594554771|FG015|Post Induction|MRD negative|0|||
164599087|NCT02883049|594554756|FG000|Post Induction|Developed SMN|0|||
164599088|NCT02883049|594554757|FG001|Post Induction|Developed SMN|0|||
164599089|NCT02883049|594554758|FG002|Post Induction|Developed SMN|0|||
164599090|NCT02883049|594554759|FG003|Post Induction|Developed SMN|0|||
164599091|NCT02883049|594554760|FG004|Post Induction|Developed SMN|1|||
164599092|NCT02883049|594554761|FG005|Post Induction|Developed SMN|0|||
164599093|NCT02883049|594554762|FG006|Post Induction|Developed SMN|1|||
164599094|NCT02883049|594554763|FG007|Post Induction|Developed SMN|0|||
164599095|NCT02883049|594554764|FG008|Post Induction|Developed SMN|0|||
164599096|NCT02883049|594554765|FG009|Post Induction|Developed SMN|0|||
164599097|NCT02883049|594554766|FG010|Post Induction|Developed SMN|1|||
164599098|NCT02883049|594554767|FG011|Post Induction|Developed SMN|1|||
164599099|NCT02883049|594554768|FG012|Post Induction|Developed SMN|0|||
164599100|NCT02883049|594554769|FG013|Post Induction|Developed SMN|0|||
164599101|NCT02883049|594554770|FG014|Post Induction|Developed SMN|1|||
164599102|NCT02883049|594554771|FG015|Post Induction|Developed SMN|0|||
164599103|NCT02883049|594554756|FG000|Post Induction|Enrolled onto another COG study|0|||
164599104|NCT02883049|594554757|FG001|Post Induction|Enrolled onto another COG study|0|||
164599105|NCT02883049|594554758|FG002|Post Induction|Enrolled onto another COG study|0|||
164599106|NCT02883049|594554759|FG003|Post Induction|Enrolled onto another COG study|1|||
164599107|NCT02883049|594554760|FG004|Post Induction|Enrolled onto another COG study|1|||
164599108|NCT02883049|594554761|FG005|Post Induction|Enrolled onto another COG study|0|||
164599109|NCT02883049|594554762|FG006|Post Induction|Enrolled onto another COG study|0|||
164599110|NCT02883049|594554763|FG007|Post Induction|Enrolled onto another COG study|4|||
164707945|NCT01791153|594955389|FG000|Part 1: Blinded Period|Adverse Event|7|||
164707946|NCT01791153|594955390|FG001|Part 1: Blinded Period|Adverse Event|3|||
164707947|NCT01791153|594955391|FG002|Part 1: Blinded Period|Adverse Event|2|||
164409134|NCT00553202|593870008|FG000|Overall Study|Withdrawal by Subject|1|||
164409135|NCT00553202|593870008|FG000|Overall Study|No donor identified|16|||
164409136|NCT00553202|593870008|FG000|Overall Study|Fails to meet organ function|6|||
164409137|NCT03239873|593870009|FG000|Overall Study|Lost to Follow-up|15|||
164409138|NCT03239873|593870010|FG001|Overall Study|Lost to Follow-up|16|||
164409139|NCT03239873|593870009|FG000|Overall Study|Physician Decision|1|||
164409140|NCT03239873|593870010|FG001|Overall Study|Physician Decision|0|||
164409141|NCT03239873|593870009|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
164409142|NCT03239873|593870010|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
164409143|NCT03239873|593870009|FG000|Overall Study|Withdrawal by Subject|2|||
164409144|NCT03239873|593870010|FG001|Overall Study|Withdrawal by Subject|0|||
164409145|NCT03239873|593870009|FG000|Overall Study|Contraindication to study medication|1|||
164409146|NCT03239873|593870010|FG001|Overall Study|Contraindication to study medication|0|||
164409147|NCT03239873|593870009|FG000|Overall Study|Protocol Violation|1|||
164409148|NCT03239873|593870010|FG001|Overall Study|Protocol Violation|0|||
164409149|NCT03075904|593870017|FG000|Overall Study|Physician Decision|3|||
164409150|NCT03075904|593870017|FG000|Overall Study|Need for Medication not Permitted|1|||
164409151|NCT00597714|593870018|FG000|Overall Study|Death|56|||
164409152|NCT00597714|593870019|FG001|Overall Study|Death|46|||
164409153|NCT00597714|593870020|FG002|Overall Study|Death|0|||
164409154|NCT00597714|593870018|FG000|Overall Study|Recipient death|0|||
164409155|NCT00597714|593870019|FG001|Overall Study|Recipient death|0|||
164409156|NCT00597714|593870020|FG002|Overall Study|Recipient death|10|||
164409157|NCT02228395|593870021|FG000|First Intervention Period|No longer willing to participate|1|||
164409158|NCT02228395|593870022|FG001|First Intervention Period|No longer willing to participate|0|||
164409159|NCT02228395|593870023|FG002|First Intervention Period|No longer willing to participate|0|||
164409160|NCT02228395|593870021|FG000|First Intervention Period|Unable to comply with study dates|0|||
164409161|NCT02228395|593870022|FG001|First Intervention Period|Unable to comply with study dates|1|||
164409162|NCT02228395|593870023|FG002|First Intervention Period|Unable to comply with study dates|1|||
164409163|NCT02424591|593870028|FG000|Overall Study|Protocol Violation|2|||
164409164|NCT02424591|593870029|FG001|Overall Study|Protocol Violation|3|||
164409165|NCT00988221|593870032|FG000|Part I|Adverse Event|0|||
164409166|NCT00988221|593870033|FG001|Part I|Adverse Event|1|||
164409167|NCT00988221|593870034|FG002|Part I|Adverse Event|2|||
164409168|NCT00988221|593870035|FG003|Part I|Adverse Event|0|||
164409169|NCT00988221|593870032|FG000|Part I|Insufficient Therapeutic Response|4|||
164409170|NCT00988221|593870033|FG001|Part I|Insufficient Therapeutic Response|6|||
164409171|NCT00988221|593870034|FG002|Part I|Insufficient Therapeutic Response|5|||
164409172|NCT00988221|593870035|FG003|Part I|Insufficient Therapeutic Response|0|||
164409173|NCT00988221|593870032|FG000|Part I|Refused Treatment|0|||
164409174|NCT00988221|593870033|FG001|Part I|Refused Treatment|2|||
164409175|NCT00988221|593870034|FG002|Part I|Refused Treatment|1|||
164409176|NCT00988221|593870035|FG003|Part I|Refused Treatment|0|||
164409177|NCT00988221|593870032|FG000|Part I|Lost to Follow-up|0|||
164409178|NCT00988221|593870033|FG001|Part I|Lost to Follow-up|1|||
164409179|NCT00988221|593870034|FG002|Part I|Lost to Follow-up|0|||
164409180|NCT00988221|593870035|FG003|Part I|Lost to Follow-up|0|||
164409181|NCT00988221|593870032|FG000|Part II|Adverse Event|1|||
164409182|NCT00988221|593870033|FG001|Part II|Adverse Event|0|||
164409183|NCT00988221|593870034|FG002|Part II|Adverse Event|0|||
164409184|NCT00988221|593870035|FG003|Part II|Adverse Event|1|||
164409185|NCT00988221|593870032|FG000|Part II|Withdrawal by Subject|0|||
164409186|NCT00988221|593870033|FG001|Part II|Withdrawal by Subject|0|||
164409187|NCT00988221|593870034|FG002|Part II|Withdrawal by Subject|2|||
164409188|NCT00988221|593870035|FG003|Part II|Withdrawal by Subject|2|||
164409189|NCT00988221|593870032|FG000|Part II|Reason not Specified|0|||
164409190|NCT00988221|593870033|FG001|Part II|Reason not Specified|0|||
164462847|NCT00085735|594068535|FG005|Overall Study|Lost to Follow-up|0|||
164462848|NCT00085735|594068530|FG000|Overall Study|Physician Decision|2|||
164462849|NCT00085735|594068531|FG001|Overall Study|Physician Decision|3|||
164462850|NCT00085735|594068532|FG002|Overall Study|Physician Decision|2|||
164409191|NCT00988221|593870034|FG002|Part II|Reason not Specified|1|||
164409192|NCT00988221|593870035|FG003|Part II|Reason not Specified|0|||
164409193|NCT00988221|593870032|FG000|Part III|Adverse Event|1|||
164409194|NCT00988221|593870033|FG001|Part III|Adverse Event|0|||
164409195|NCT00988221|593870034|FG002|Part III|Adverse Event|1|||
164409196|NCT00988221|593870035|FG003|Part III|Adverse Event|0|||
164409197|NCT00988221|593870032|FG000|Part III|Insufficient Therapeutic Response|0|||
164409198|NCT00988221|593870033|FG001|Part III|Insufficient Therapeutic Response|1|||
164409199|NCT00988221|593870034|FG002|Part III|Insufficient Therapeutic Response|1|||
164409200|NCT00988221|593870035|FG003|Part III|Insufficient Therapeutic Response|0|||
164409201|NCT00988221|593870032|FG000|Part III|Refused Treatment|0|||
164409202|NCT00988221|593870033|FG001|Part III|Refused Treatment|0|||
164409203|NCT00988221|593870034|FG002|Part III|Refused Treatment|1|||
164409204|NCT00988221|593870035|FG003|Part III|Refused Treatment|0|||
164409205|NCT02904902|593870042|FG000|Overall Study|Withdrawal by Subject|1|||
164409206|NCT01719237|593870046|FG000|Overall Study|Physician Decision|0|||
164462851|NCT00085735|594068533|FG003|Overall Study|Physician Decision|3|||
164462852|NCT00085735|594068534|FG004|Overall Study|Physician Decision|11|||
164409207|NCT01719237|593870047|FG001|Overall Study|Physician Decision|1|||
164409208|NCT02712398|593870048|FG000|Overall Study|Withdrawal by Subject|6|||
164409209|NCT02712398|593870048|FG000|Overall Study|Lost to Follow-up|6|||
164409210|NCT02712398|593870048|FG000|Overall Study|Sponsor Decision|1|||
164409211|NCT02712398|593870048|FG000|Overall Study|Physician Decision|1|||
164409212|NCT02712398|593870048|FG000|Overall Study|Death|2|||
164409213|NCT02712398|593870048|FG000|Overall Study|Re-operation|21|||
164409214|NCT04772053|593870059|FG000|Overall Study|Physician Decision|2|||
164409215|NCT04772053|593870059|FG000|Overall Study|Withdrawal by Subject|3|||
164409216|NCT04772053|593870059|FG000|Overall Study|Study Terminated by Sponsor|1|||
164409217|NCT04146896|593870064|FG000|Overall Study|Adverse Event|5|||
164409218|NCT04146896|593870065|FG001|Overall Study|Adverse Event|8|||
164409219|NCT04146896|593870064|FG000|Overall Study|Lack of Efficacy|3|||
164409220|NCT04146896|593870065|FG001|Overall Study|Lack of Efficacy|2|||
164409221|NCT04146896|593870064|FG000|Overall Study|Lost to Follow-up|0|||
164409222|NCT04146896|593870065|FG001|Overall Study|Lost to Follow-up|1|||
164409223|NCT04146896|593870064|FG000|Overall Study|Non-compliance|5|||
164409224|NCT04146896|593870065|FG001|Overall Study|Non-compliance|4|||
164409225|NCT04146896|593870064|FG000|Overall Study|Withdrawal by Subject|3|||
164409226|NCT04146896|593870065|FG001|Overall Study|Withdrawal by Subject|5|||
164409227|NCT04146896|593870064|FG000|Overall Study|Randomized in error|1|||
164409228|NCT04146896|593870065|FG001|Overall Study|Randomized in error|2|||
164409229|NCT03107377|593870066|FG000|Overall Study|Adverse Event|3|||
164409230|NCT03107377|593870067|FG001|Overall Study|Adverse Event|3|||
164409231|NCT03107377|593870066|FG000|Overall Study|Protocol Violation|9|||
164409232|NCT03107377|593870067|FG001|Overall Study|Protocol Violation|12|||
164409233|NCT03107377|593870066|FG000|Overall Study|Physician Decision|3|||
164409234|NCT03107377|593870067|FG001|Overall Study|Physician Decision|6|||
164409235|NCT03107377|593870066|FG000|Overall Study|Pregnancy|7|||
164409236|NCT03107377|593870067|FG001|Overall Study|Pregnancy|7|||
164409237|NCT03107377|593870066|FG000|Overall Study|Withdrawal by Subject|16|||
164409238|NCT03107377|593870067|FG001|Overall Study|Withdrawal by Subject|22|||
164409239|NCT03107377|593870066|FG000|Overall Study|Lost to Follow-up|37|||
164409240|NCT03107377|593870067|FG001|Overall Study|Lost to Follow-up|34|||
164409241|NCT03107377|593870066|FG000|Overall Study|Other reason not specified|16|||
164409242|NCT03107377|593870067|FG001|Overall Study|Other reason not specified|15|||
164409243|NCT01597505|593870068|FG000|Overall Study|Physician Decision|5|||
164409244|NCT01597505|593870069|FG001|Overall Study|Physician Decision|0|||
164409245|NCT01597505|593870068|FG000|Overall Study|Adverse Event|19|||
164409246|NCT01597505|593870069|FG001|Overall Study|Adverse Event|7|||
164409247|NCT01597505|593870068|FG000|Overall Study|Lost to Follow-up|4|||
164409248|NCT01597505|593870069|FG001|Overall Study|Lost to Follow-up|2|||
164409249|NCT01597505|593870068|FG000|Overall Study|Withdrawal by Subject|10|||
164409250|NCT01597505|593870069|FG001|Overall Study|Withdrawal by Subject|18|||
164409251|NCT01597505|593870068|FG000|Overall Study|Other|5|||
164409252|NCT01597505|593870069|FG001|Overall Study|Other|6|||
164409253|NCT01597505|593870068|FG000|Overall Study|Missing|1|||
164409254|NCT01597505|593870069|FG001|Overall Study|Missing|0|||
164409255|NCT02675465|593870071|FG000|Stage 3: 2 Year Treatment|Adverse Event|0|||
164409256|NCT02675465|593870072|FG001|Stage 3: 2 Year Treatment|Adverse Event|0|||
164409257|NCT02675465|593870073|FG002|Stage 3: 2 Year Treatment|Adverse Event|1|||
164409258|NCT02675465|593870074|FG003|Stage 3: 2 Year Treatment|Adverse Event|1|||
164409259|NCT02675465|593870075|FG004|Stage 3: 2 Year Treatment|Adverse Event|0|||
164409260|NCT02675465|593870076|FG005|Stage 3: 2 Year Treatment|Adverse Event|0|||
164409261|NCT02675465|593870071|FG000|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
164707948|NCT01791153|594955392|FG003|Part 1: Blinded Period|Adverse Event|0|||
164707949|NCT01791153|594955393|FG004|Part 1: Blinded Period|Adverse Event|0|||
164707950|NCT01791153|594955394|FG005|Part 1: Blinded Period|Adverse Event|0|||
164409262|NCT02675465|593870072|FG001|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
164409263|NCT02675465|593870073|FG002|Stage 3: 2 Year Treatment|Withdrawal by Subject|1|||
164409264|NCT02675465|593870074|FG003|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
164707951|NCT01791153|594955395|FG006|Part 1: Blinded Period|Adverse Event|0|||
164707952|NCT01791153|594955396|FG007|Part 1: Blinded Period|Adverse Event|0|||
164409265|NCT02675465|593870075|FG004|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
164409266|NCT02675465|593870076|FG005|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
164409267|NCT02675465|593870071|FG000|Stage 4: Long Term Extension|Physician Decision|0|||
164409268|NCT02675465|593870072|FG001|Stage 4: Long Term Extension|Physician Decision|0|||
164409269|NCT02675465|593870073|FG002|Stage 4: Long Term Extension|Physician Decision|1|||
164409270|NCT02675465|593870074|FG003|Stage 4: Long Term Extension|Physician Decision|0|||
164409271|NCT02675465|593870075|FG004|Stage 4: Long Term Extension|Physician Decision|0|||
164409272|NCT02675465|593870076|FG005|Stage 4: Long Term Extension|Physician Decision|0|||
164409273|NCT02675465|593870071|FG000|Stage 4: Long Term Extension|Death|0|||
164409274|NCT02675465|593870072|FG001|Stage 4: Long Term Extension|Death|0|||
164409275|NCT02675465|593870073|FG002|Stage 4: Long Term Extension|Death|0|||
164409276|NCT02675465|593870074|FG003|Stage 4: Long Term Extension|Death|1|||
164409277|NCT02675465|593870075|FG004|Stage 4: Long Term Extension|Death|0|||
164409278|NCT02675465|593870076|FG005|Stage 4: Long Term Extension|Death|0|||
164707953|NCT01791153|594955389|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
164409279|NCT00453102|593870077|FG000|Overall Study|Withdrawal by Subject|2|||
164409280|NCT05031078|593870078|FG000|Overall Study|Withdrawal by Subject|0|||
164409281|NCT05031078|593870079|FG001|Overall Study|Withdrawal by Subject|1|||
164409282|NCT05031078|593870080|FG002|Overall Study|Withdrawal by Subject|0|||
164409283|NCT03728972|593870081|FG000|Overall Study|Death|1|||
164409284|NCT03728972|593870082|FG001|Overall Study|Death|0|||
164409285|NCT03728972|593870081|FG000|Overall Study|Lack of Efficacy|1|||
164409286|NCT03728972|593870082|FG001|Overall Study|Lack of Efficacy|0|||
164409287|NCT03728972|593870081|FG000|Overall Study|Physician Decision|3|||
164409288|NCT03728972|593870082|FG001|Overall Study|Physician Decision|0|||
164409289|NCT03728972|593870081|FG000|Overall Study|Disease progression|4|||
164409290|NCT03728972|593870082|FG001|Overall Study|Disease progression|3|||
164409291|NCT03787680|593870087|FG000|Overall Study|Physician Decision|2|||
164409292|NCT03787680|593870088|FG001|Overall Study|Physician Decision|3|||
164409293|NCT03787680|593870087|FG000|Overall Study|Adverse Event|7|||
164409294|NCT03787680|593870088|FG001|Overall Study|Adverse Event|3|||
164409295|NCT03787680|593870087|FG000|Overall Study|Withdrawal by Subject|2|||
164409296|NCT03787680|593870088|FG001|Overall Study|Withdrawal by Subject|1|||
164409297|NCT05454410|593870091|FG000|Overall Study|Withdrawal by Subject|0|||
164409298|NCT05454410|593870092|FG001|Overall Study|Withdrawal by Subject|0|||
164409299|NCT05454410|593870093|FG002|Overall Study|Withdrawal by Subject|1|||
164409300|NCT05454410|593870094|FG003|Overall Study|Withdrawal by Subject|1|||
164409301|NCT00895622|593870095|FG000|Overall Study|Protocol Violation|5|||
164409302|NCT00895622|593870096|FG001|Overall Study|Protocol Violation|4|||
164409303|NCT00895622|593870097|FG002|Overall Study|Protocol Violation|4|||
164409304|NCT01490125|593870098|FG000|Period I|Adverse Event|4|||
164409305|NCT01490125|593870099|FG001|Period I|Adverse Event|1|||
164409306|NCT01490125|593870100|FG002|Period I|Adverse Event|1|||
164409307|NCT01490125|593870101|FG003|Period I|Adverse Event|3|||
164409308|NCT01490125|593870102|FG004|Period I|Adverse Event|2|||
164409309|NCT01490125|593870103|FG005|Period I|Adverse Event|4|||
164409310|NCT01490125|593870098|FG000|Period I|Protocol Violation|1|||
164409311|NCT01490125|593870099|FG001|Period I|Protocol Violation|1|||
164409312|NCT01490125|593870100|FG002|Period I|Protocol Violation|1|||
164409313|NCT01490125|593870101|FG003|Period I|Protocol Violation|1|||
164409314|NCT01490125|593870102|FG004|Period I|Protocol Violation|0|||
164409315|NCT01490125|593870103|FG005|Period I|Protocol Violation|0|||
164409316|NCT01490125|593870098|FG000|Period I|Withdrawal by Subject|1|||
164409317|NCT01490125|593870099|FG001|Period I|Withdrawal by Subject|3|||
164409318|NCT01490125|593870100|FG002|Period I|Withdrawal by Subject|2|||
164409319|NCT01490125|593870101|FG003|Period I|Withdrawal by Subject|1|||
164409320|NCT01490125|593870102|FG004|Period I|Withdrawal by Subject|2|||
164409321|NCT01490125|593870103|FG005|Period I|Withdrawal by Subject|1|||
164409322|NCT01490125|593870098|FG000|Period II|Adverse Event|2|||
164409323|NCT01490125|593870099|FG001|Period II|Adverse Event|3|||
164409324|NCT01490125|593870100|FG002|Period II|Adverse Event|2|||
164409325|NCT01490125|593870101|FG003|Period II|Adverse Event|2|||
164409326|NCT01490125|593870102|FG004|Period II|Adverse Event|4|||
164409327|NCT01490125|593870103|FG005|Period II|Adverse Event|2|||
164409328|NCT01490125|593870098|FG000|Period II|Protocol Violation|0|||
164409329|NCT01490125|593870099|FG001|Period II|Protocol Violation|0|||
164409330|NCT01490125|593870100|FG002|Period II|Protocol Violation|1|||
164409331|NCT01490125|593870101|FG003|Period II|Protocol Violation|1|||
164409332|NCT01490125|593870102|FG004|Period II|Protocol Violation|0|||
164462853|NCT00085735|594068535|FG005|Overall Study|Physician Decision|8|||
164409333|NCT01490125|593870103|FG005|Period II|Protocol Violation|0|||
164409334|NCT01490125|593870098|FG000|Period II|Lost to Follow-up|0|||
164409335|NCT01490125|593870099|FG001|Period II|Lost to Follow-up|1|||
164462854|NCT00085735|594068530|FG000|Overall Study|Protocol Violation|1|||
164462855|NCT00085735|594068531|FG001|Overall Study|Protocol Violation|0|||
164462856|NCT00085735|594068532|FG002|Overall Study|Protocol Violation|0|||
164599111|NCT02883049|594554764|FG008|Post Induction|Enrolled onto another COG study|0|||
164599112|NCT02883049|594554765|FG009|Post Induction|Enrolled onto another COG study|0|||
164599113|NCT02883049|594554766|FG010|Post Induction|Enrolled onto another COG study|0|||
164599114|NCT02883049|594554767|FG011|Post Induction|Enrolled onto another COG study|2|||
164599115|NCT02883049|594554768|FG012|Post Induction|Enrolled onto another COG study|0|||
164599116|NCT02883049|594554769|FG013|Post Induction|Enrolled onto another COG study|1|||
164409336|NCT01490125|593870100|FG002|Period II|Lost to Follow-up|0|||
164409337|NCT01490125|593870101|FG003|Period II|Lost to Follow-up|0|||
164409338|NCT01490125|593870102|FG004|Period II|Lost to Follow-up|0|||
164409339|NCT01490125|593870103|FG005|Period II|Lost to Follow-up|0|||
164409340|NCT01490125|593870098|FG000|Period II|Withdrawal by Subject|1|||
164409341|NCT01490125|593870099|FG001|Period II|Withdrawal by Subject|0|||
164409342|NCT01490125|593870100|FG002|Period II|Withdrawal by Subject|0|||
164409343|NCT01490125|593870101|FG003|Period II|Withdrawal by Subject|0|||
164409344|NCT01490125|593870102|FG004|Period II|Withdrawal by Subject|0|||
164409345|NCT01490125|593870103|FG005|Period II|Withdrawal by Subject|0|||
164409346|NCT01490125|593870098|FG000|Period III|Adverse Event|3|||
164409347|NCT01490125|593870099|FG001|Period III|Adverse Event|1|||
164409348|NCT01490125|593870100|FG002|Period III|Adverse Event|0|||
164409349|NCT01490125|593870101|FG003|Period III|Adverse Event|1|||
164144810|NCT01524978|592891780|FG006|Overall Study|Lost to Follow-up|2|||
164409350|NCT01490125|593870102|FG004|Period III|Adverse Event|0|||
164409351|NCT01490125|593870103|FG005|Period III|Adverse Event|0|||
164409352|NCT01490125|593870098|FG000|Period III|Death|0|||
164409353|NCT01490125|593870099|FG001|Period III|Death|0|||
164409354|NCT01490125|593870100|FG002|Period III|Death|0|||
164409355|NCT01490125|593870101|FG003|Period III|Death|1|||
164409356|NCT01490125|593870102|FG004|Period III|Death|0|||
164409357|NCT01490125|593870103|FG005|Period III|Death|0|||
164409358|NCT01490125|593870098|FG000|Period III|Lack of Efficacy|0|||
164409359|NCT01490125|593870099|FG001|Period III|Lack of Efficacy|0|||
164409360|NCT01490125|593870100|FG002|Period III|Lack of Efficacy|0|||
164409361|NCT01490125|593870101|FG003|Period III|Lack of Efficacy|0|||
164409362|NCT01490125|593870102|FG004|Period III|Lack of Efficacy|1|||
164409363|NCT01490125|593870103|FG005|Period III|Lack of Efficacy|0|||
164409364|NCT01224158|593870104|FG000|Overall Study|Withdrawal by Subject|1|||
164409365|NCT01224158|593870105|FG001|Overall Study|Withdrawal by Subject|0|||
164409366|NCT01412801|593870111|FG000|Overall Study|Death|0|||
164409367|NCT01412801|593870112|FG001|Overall Study|Death|1|||
164409368|NCT01412801|593870113|FG002|Overall Study|Death|0|||
164409369|NCT01412801|593870114|FG003|Overall Study|Death|4|||
164409370|NCT01412801|593870115|FG004|Overall Study|Death|2|||
164409371|NCT01412801|593870116|FG005|Overall Study|Death|2|||
164409372|NCT01412801|593870111|FG000|Overall Study|Lost to Follow-up|1|||
164409373|NCT01412801|593870112|FG001|Overall Study|Lost to Follow-up|2|||
164599117|NCT02883049|594554770|FG014|Post Induction|Enrolled onto another COG study|0|||
164599118|NCT02883049|594554771|FG015|Post Induction|Enrolled onto another COG study|0|||
164599119|NCT02883049|594554756|FG000|Post Induction|Recurrent leukemia|0|||
164599120|NCT02883049|594554757|FG001|Post Induction|Recurrent leukemia|0|||
164599121|NCT02883049|594554758|FG002|Post Induction|Recurrent leukemia|0|||
164599122|NCT02883049|594554759|FG003|Post Induction|Recurrent leukemia|17|||
164599123|NCT02883049|594554760|FG004|Post Induction|Recurrent leukemia|12|||
164599124|NCT02883049|594554761|FG005|Post Induction|Recurrent leukemia|4|||
164599125|NCT02883049|594554762|FG006|Post Induction|Recurrent leukemia|1|||
164599126|NCT02883049|594554763|FG007|Post Induction|Recurrent leukemia|13|||
164599127|NCT02883049|594554764|FG008|Post Induction|Recurrent leukemia|27|||
164599128|NCT02883049|594554765|FG009|Post Induction|Recurrent leukemia|5|||
164599129|NCT02883049|594554766|FG010|Post Induction|Recurrent leukemia|3|||
164599130|NCT02883049|594554767|FG011|Post Induction|Recurrent leukemia|12|||
164599131|NCT02883049|594554768|FG012|Post Induction|Recurrent leukemia|1|||
164599132|NCT02883049|594554769|FG013|Post Induction|Recurrent leukemia|1|||
164599133|NCT02883049|594554770|FG014|Post Induction|Recurrent leukemia|9|||
164599134|NCT02883049|594554771|FG015|Post Induction|Recurrent leukemia|3|||
164599135|NCT02883049|594554756|FG000|Post Induction|Induction Failure|0|||
164599136|NCT02883049|594554757|FG001|Post Induction|Induction Failure|0|||
164599137|NCT02883049|594554758|FG002|Post Induction|Induction Failure|0|||
164599138|NCT02883049|594554759|FG003|Post Induction|Induction Failure|0|||
164599139|NCT02883049|594554760|FG004|Post Induction|Induction Failure|0|||
164599140|NCT02883049|594554761|FG005|Post Induction|Induction Failure|0|||
164599141|NCT02883049|594554762|FG006|Post Induction|Induction Failure|0|||
164599142|NCT02883049|594554763|FG007|Post Induction|Induction Failure|2|||
164599143|NCT02883049|594554764|FG008|Post Induction|Induction Failure|2|||
164599144|NCT02883049|594554765|FG009|Post Induction|Induction Failure|0|||
164599145|NCT02883049|594554766|FG010|Post Induction|Induction Failure|0|||
164599146|NCT02883049|594554767|FG011|Post Induction|Induction Failure|0|||
164599147|NCT02883049|594554768|FG012|Post Induction|Induction Failure|0|||
164599148|NCT02883049|594554769|FG013|Post Induction|Induction Failure|2|||
164599149|NCT02883049|594554770|FG014|Post Induction|Induction Failure|0|||
164599150|NCT02883049|594554771|FG015|Post Induction|Induction Failure|0|||
164599151|NCT02938585|594554774|FG000|Overall Study|Withdrawal by parent or guardian|0|||
164599152|NCT02938585|594554775|FG001|Overall Study|Withdrawal by parent or guardian|1|||
164599153|NCT02938585|594554776|FG002|Overall Study|Withdrawal by parent or guardian|0|||
164599154|NCT02938585|594554777|FG003|Overall Study|Withdrawal by parent or guardian|0|||
164599155|NCT02938585|594554774|FG000|Overall Study|Withdrawal by Subject|0|||
164409374|NCT01412801|593870113|FG002|Overall Study|Lost to Follow-up|4|||
164409375|NCT01412801|593870114|FG003|Overall Study|Lost to Follow-up|0|||
164409376|NCT01412801|593870115|FG004|Overall Study|Lost to Follow-up|1|||
164409377|NCT01412801|593870116|FG005|Overall Study|Lost to Follow-up|1|||
164409378|NCT01412801|593870111|FG000|Overall Study|Withdrawal by Subject|3|||
164409379|NCT01412801|593870112|FG001|Overall Study|Withdrawal by Subject|2|||
164409380|NCT01412801|593870113|FG002|Overall Study|Withdrawal by Subject|1|||
164409381|NCT01412801|593870114|FG003|Overall Study|Withdrawal by Subject|0|||
164409382|NCT01412801|593870115|FG004|Overall Study|Withdrawal by Subject|0|||
164599156|NCT02938585|594554775|FG001|Overall Study|Withdrawal by Subject|0|||
164599157|NCT02938585|594554776|FG002|Overall Study|Withdrawal by Subject|0|||
164599158|NCT02938585|594554777|FG003|Overall Study|Withdrawal by Subject|5|||
164599159|NCT02106455|594554785|FG000|Overall Study|Case Report Form Uncollected|6|||
164599160|NCT02106455|594554785|FG000|Overall Study|Protocol Deviation|2|||
164599161|NCT00213980|594554786|FG000|Overall Study|Withdrawal by Subject|3|||
164599162|NCT00213980|594554787|FG001|Overall Study|Withdrawal by Subject|1|||
164599163|NCT00213980|594554786|FG000|Overall Study|Adverse Event|1|||
164462857|NCT00085735|594068533|FG003|Overall Study|Protocol Violation|0|||
164462858|NCT00085735|594068534|FG004|Overall Study|Protocol Violation|0|||
164462859|NCT00085735|594068535|FG005|Overall Study|Protocol Violation|0|||
164462860|NCT00085735|594068530|FG000|Overall Study|Withdrawal by Subject|1|||
164462861|NCT00085735|594068531|FG001|Overall Study|Withdrawal by Subject|0|||
164462862|NCT00085735|594068532|FG002|Overall Study|Withdrawal by Subject|4|||
164462863|NCT00085735|594068533|FG003|Overall Study|Withdrawal by Subject|5|||
164462864|NCT00085735|594068534|FG004|Overall Study|Withdrawal by Subject|7|||
164462865|NCT00085735|594068535|FG005|Overall Study|Withdrawal by Subject|8|||
164462866|NCT00085735|594068530|FG000|Overall Study|Patient ineligible|1|||
164462867|NCT00085735|594068531|FG001|Overall Study|Patient ineligible|0|||
164707954|NCT01791153|594955390|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
164707955|NCT01791153|594955391|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
164707956|NCT01791153|594955392|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
164707957|NCT01791153|594955393|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
164707958|NCT01791153|594955394|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
164707959|NCT01791153|594955395|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
164409383|NCT01412801|593870116|FG005|Overall Study|Withdrawal by Subject|0|||
164409384|NCT01412801|593870111|FG000|Overall Study|Relocated to another area|0|||
164409385|NCT01412801|593870112|FG001|Overall Study|Relocated to another area|0|||
164409386|NCT01412801|593870113|FG002|Overall Study|Relocated to another area|2|||
164409387|NCT01412801|593870114|FG003|Overall Study|Relocated to another area|0|||
164409388|NCT01412801|593870115|FG004|Overall Study|Relocated to another area|0|||
164409389|NCT01412801|593870116|FG005|Overall Study|Relocated to another area|0|||
164409390|NCT01919970|593870117|FG000|Overall Study|Withdrawal by Subject|3|||
164409391|NCT01919970|593870118|FG001|Overall Study|Withdrawal by Subject|0|||
164409392|NCT00990340|593870119|FG000|First 14-day Treatment|Not Compliant|2|||
164409393|NCT00990340|593870120|FG001|First 14-day Treatment|Not Compliant|1|||
164409394|NCT00990340|593870119|FG000|First 14-day Treatment|Lost to Follow-up|2|||
164409395|NCT00990340|593870120|FG001|First 14-day Treatment|Lost to Follow-up|1|||
164409396|NCT00990340|593870119|FG000|First 14-day Treatment|Protocol Violation|2|||
164409397|NCT00990340|593870120|FG001|First 14-day Treatment|Protocol Violation|2|||
164409398|NCT04615182|593870121|FG000|Overall Study|Re-transplanted|2|||
164409399|NCT04615182|593870121|FG000|Overall Study|Protocol Violation|6|||
164409400|NCT04615182|593870121|FG000|Overall Study|Death|6|||
164409401|NCT04615182|593870121|FG000|Overall Study|Death and protocol violation|1|||
164409402|NCT01126060|593870122|FG000|Overall Study|Protocol Violation|0|||
164409403|NCT01126060|593870123|FG001|Overall Study|Protocol Violation|2|||
164409404|NCT01874145|593870124|FG000|Core Period|Non-compliance|1|||
164409405|NCT01874145|593870125|FG001|Core Period|Non-compliance|0|||
164409406|NCT01874145|593870124|FG000|Core Period|Protocol Violation|1|||
164409407|NCT01874145|593870125|FG001|Core Period|Protocol Violation|1|||
164409408|NCT01874145|593870124|FG000|Core Period|Physician Decision|1|||
164409409|NCT01874145|593870125|FG001|Core Period|Physician Decision|1|||
164409410|NCT01874145|593870124|FG000|Core Period|Adverse Event|0|||
164409411|NCT01874145|593870125|FG001|Core Period|Adverse Event|1|||
164409412|NCT01874145|593870124|FG000|Core Period|Withdrawal by Subject|0|||
164409413|NCT01874145|593870125|FG001|Core Period|Withdrawal by Subject|4|||
164409414|NCT01874145|593870124|FG000|Extension Period|Adverse Event|3|||
164409415|NCT01874145|593870125|FG001|Extension Period|Adverse Event|2|||
164409416|NCT01874145|593870124|FG000|Extension Period|Withdrawal by Subject|2|||
164409417|NCT01874145|593870125|FG001|Extension Period|Withdrawal by Subject|1|||
164409418|NCT01874145|593870124|FG000|Extension Period|Lost to Follow-up|1|||
164409419|NCT01874145|593870125|FG001|Extension Period|Lost to Follow-up|1|||
164409420|NCT00402337|593870126|FG000|Overall Study|Adverse Event|0|||
164409421|NCT00402337|593870127|FG001|Overall Study|Adverse Event|2|||
164409422|NCT00402337|593870128|FG002|Overall Study|Adverse Event|2|||
164409423|NCT00402337|593870129|FG003|Overall Study|Adverse Event|3|||
164409424|NCT00402337|593870130|FG004|Overall Study|Adverse Event|2|||
164409425|NCT00402337|593870126|FG000|Overall Study|Noncompliance|0|||
164409426|NCT00402337|593870127|FG001|Overall Study|Noncompliance|0|||
164409427|NCT00402337|593870128|FG002|Overall Study|Noncompliance|0|||
164462868|NCT00085735|594068532|FG002|Overall Study|Patient ineligible|3|||
164462869|NCT00085735|594068533|FG003|Overall Study|Patient ineligible|7|||
164462870|NCT00085735|594068534|FG004|Overall Study|Patient ineligible|17|||
164707960|NCT01791153|594955396|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
164409428|NCT00402337|593870129|FG003|Overall Study|Noncompliance|0|||
164409429|NCT00402337|593870130|FG004|Overall Study|Noncompliance|2|||
164409430|NCT00402337|593870126|FG000|Overall Study|Withdrawal by Subject|5|||
164409431|NCT00402337|593870127|FG001|Overall Study|Withdrawal by Subject|3|||
164409432|NCT00402337|593870128|FG002|Overall Study|Withdrawal by Subject|1|||
164409433|NCT00402337|593870129|FG003|Overall Study|Withdrawal by Subject|6|||
164409434|NCT00402337|593870130|FG004|Overall Study|Withdrawal by Subject|4|||
164409435|NCT00402337|593870126|FG000|Overall Study|Lost to Follow-up|0|||
164409436|NCT00402337|593870127|FG001|Overall Study|Lost to Follow-up|0|||
164409437|NCT00402337|593870128|FG002|Overall Study|Lost to Follow-up|1|||
164409438|NCT00402337|593870129|FG003|Overall Study|Lost to Follow-up|2|||
164462871|NCT00085735|594068535|FG005|Overall Study|Patient ineligible|8|||
164409439|NCT00402337|593870130|FG004|Overall Study|Lost to Follow-up|0|||
164409440|NCT00402337|593870126|FG000|Overall Study|Physician Decision|0|||
164409441|NCT00402337|593870127|FG001|Overall Study|Physician Decision|0|||
164409442|NCT00402337|593870128|FG002|Overall Study|Physician Decision|0|||
164409443|NCT00402337|593870129|FG003|Overall Study|Physician Decision|1|||
164409444|NCT00402337|593870130|FG004|Overall Study|Physician Decision|0|||
164409445|NCT00402337|593870126|FG000|Overall Study|Other Reason|0|||
164409446|NCT00402337|593870127|FG001|Overall Study|Other Reason|1|||
164409447|NCT00402337|593870128|FG002|Overall Study|Other Reason|0|||
164409448|NCT00402337|593870129|FG003|Overall Study|Other Reason|0|||
164409449|NCT00402337|593870130|FG004|Overall Study|Other Reason|0|||
164409450|NCT03565068|593870131|FG000|Overall Study|Protocol Violation|0|||
164409451|NCT03565068|593870132|FG001|Overall Study|Protocol Violation|0|||
164409452|NCT03565068|593870133|FG002|Overall Study|Protocol Violation|0|||
164409453|NCT03565068|593870134|FG003|Overall Study|Protocol Violation|0|||
164409454|NCT03565068|593870135|FG004|Overall Study|Protocol Violation|1|||
164409455|NCT03565068|593870136|FG005|Overall Study|Protocol Violation|0|||
164409456|NCT03565068|593870137|FG006|Overall Study|Protocol Violation|0|||
164409457|NCT03565068|593870138|FG007|Overall Study|Protocol Violation|1|||
164409458|NCT03565068|593870139|FG008|Overall Study|Protocol Violation|0|||
164409459|NCT03565068|593870131|FG000|Overall Study|Sponsor decision|0|||
164409460|NCT03565068|593870132|FG001|Overall Study|Sponsor decision|0|||
164409461|NCT03565068|593870133|FG002|Overall Study|Sponsor decision|0|||
164409462|NCT03565068|593870134|FG003|Overall Study|Sponsor decision|0|||
164409463|NCT03565068|593870135|FG004|Overall Study|Sponsor decision|1|||
164409464|NCT03565068|593870136|FG005|Overall Study|Sponsor decision|1|||
164409465|NCT03565068|593870137|FG006|Overall Study|Sponsor decision|0|||
164409466|NCT03565068|593870138|FG007|Overall Study|Sponsor decision|0|||
164409467|NCT03565068|593870139|FG008|Overall Study|Sponsor decision|0|||
164409468|NCT03565068|593870131|FG000|Overall Study|Withdrawal by Subject|0|||
164409469|NCT03565068|593870132|FG001|Overall Study|Withdrawal by Subject|0|||
164409470|NCT03565068|593870133|FG002|Overall Study|Withdrawal by Subject|1|||
164409471|NCT03565068|593870134|FG003|Overall Study|Withdrawal by Subject|0|||
164409472|NCT03565068|593870135|FG004|Overall Study|Withdrawal by Subject|2|||
164409473|NCT03565068|593870136|FG005|Overall Study|Withdrawal by Subject|0|||
164409474|NCT03565068|593870137|FG006|Overall Study|Withdrawal by Subject|1|||
164409475|NCT03565068|593870138|FG007|Overall Study|Withdrawal by Subject|5|||
164409476|NCT03565068|593870139|FG008|Overall Study|Withdrawal by Subject|1|||
164409477|NCT03565068|593870131|FG000|Overall Study|Physician Decision|0|||
164409478|NCT03565068|593870132|FG001|Overall Study|Physician Decision|0|||
164409479|NCT03565068|593870133|FG002|Overall Study|Physician Decision|0|||
164409480|NCT03565068|593870134|FG003|Overall Study|Physician Decision|0|||
164409481|NCT03565068|593870135|FG004|Overall Study|Physician Decision|0|||
164409482|NCT03565068|593870136|FG005|Overall Study|Physician Decision|0|||
164409483|NCT03565068|593870137|FG006|Overall Study|Physician Decision|0|||
164409484|NCT03565068|593870138|FG007|Overall Study|Physician Decision|1|||
164409485|NCT03565068|593870139|FG008|Overall Study|Physician Decision|0|||
164409486|NCT03565068|593870131|FG000|Overall Study|Lost to Follow-up|0|||
164409487|NCT03565068|593870132|FG001|Overall Study|Lost to Follow-up|0|||
164409488|NCT03565068|593870133|FG002|Overall Study|Lost to Follow-up|0|||
164409489|NCT03565068|593870134|FG003|Overall Study|Lost to Follow-up|0|||
164409490|NCT03565068|593870135|FG004|Overall Study|Lost to Follow-up|0|||
164409491|NCT03565068|593870136|FG005|Overall Study|Lost to Follow-up|0|||
164409492|NCT03565068|593870137|FG006|Overall Study|Lost to Follow-up|0|||
164599164|NCT00213980|594554787|FG001|Overall Study|Adverse Event|1|||
164409493|NCT03565068|593870138|FG007|Overall Study|Lost to Follow-up|1|||
164409494|NCT03565068|593870139|FG008|Overall Study|Lost to Follow-up|0|||
164409495|NCT03285295|593872313|FG000|Alinity s HBsAg|Protocol Violation|11|||
164409496|NCT03285295|593872314|FG001|Alinity s HBsAg|Protocol Violation|0|||
164409497|NCT03285295|593872315|FG002|Alinity s HBsAg|Protocol Violation|0|||
164409498|NCT03285295|593872316|FG003|Alinity s HBsAg|Protocol Violation|0|||
164409499|NCT03285295|593872317|FG004|Alinity s HBsAg|Protocol Violation|0|||
164409500|NCT03285295|593872313|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
164409501|NCT03285295|593872314|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
164409502|NCT03285295|593872315|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
164409503|NCT03285295|593872316|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
164409504|NCT03285295|593872317|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
164409505|NCT03285295|593872313|FG000|Alinity s HBsAg|No Results Generated|74|||
164409506|NCT03285295|593872314|FG001|Alinity s HBsAg|No Results Generated|6|||
164599165|NCT00213980|594554786|FG000|Overall Study|Disease progression|0|||
164599166|NCT00213980|594554787|FG001|Overall Study|Disease progression|2|||
164599167|NCT00213980|594554786|FG000|Overall Study|Developed ovarian cancer|1|||
164599168|NCT00213980|594554787|FG001|Overall Study|Developed ovarian cancer|0|||
164599169|NCT00213980|594554786|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
164599170|NCT00213980|594554787|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
164599171|NCT03607838|594554788|FG000|Overall Study|Lack of Efficacy|14|||
164599172|NCT03607838|594554789|FG001|Overall Study|Lack of Efficacy|20|||
164599173|NCT03607838|594554788|FG000|Overall Study|Withdrawal by Subject|13|||
164707961|NCT01791153|594955389|FG000|Part 1: Blinded Period|Non-Compliance|1|||
164707962|NCT01791153|594955390|FG001|Part 1: Blinded Period|Non-Compliance|0|||
164707963|NCT01791153|594955391|FG002|Part 1: Blinded Period|Non-Compliance|0|||
164707964|NCT01791153|594955392|FG003|Part 1: Blinded Period|Non-Compliance|0|||
164707965|NCT01791153|594955393|FG004|Part 1: Blinded Period|Non-Compliance|0|||
164707966|NCT01791153|594955394|FG005|Part 1: Blinded Period|Non-Compliance|0|||
164707967|NCT01791153|594955395|FG006|Part 1: Blinded Period|Non-Compliance|0|||
164707968|NCT01791153|594955396|FG007|Part 1: Blinded Period|Non-Compliance|0|||
164707969|NCT01791153|594955389|FG000|Part 1: Blinded Period|Physician Decision|0|||
164707970|NCT01791153|594955390|FG001|Part 1: Blinded Period|Physician Decision|0|||
164707971|NCT01791153|594955391|FG002|Part 1: Blinded Period|Physician Decision|0|||
164707972|NCT01791153|594955392|FG003|Part 1: Blinded Period|Physician Decision|1|||
164707973|NCT01791153|594955393|FG004|Part 1: Blinded Period|Physician Decision|0|||
164409507|NCT03285295|593872315|FG002|Alinity s HBsAg|No Results Generated|0|||
164409508|NCT03285295|593872316|FG003|Alinity s HBsAg|No Results Generated|0|||
164409509|NCT03285295|593872317|FG004|Alinity s HBsAg|No Results Generated|0|||
164707974|NCT01791153|594955394|FG005|Part 1: Blinded Period|Physician Decision|0|||
164409510|NCT03285295|593872313|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
164409511|NCT03285295|593872314|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
164409512|NCT03285295|593872315|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
164409513|NCT03285295|593872316|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
164409514|NCT03285295|593872317|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
164409515|NCT03285295|593872313|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
164409516|NCT03285295|593872314|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
164409517|NCT03285295|593872315|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
164409518|NCT03285295|593872316|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
164409519|NCT03285295|593872317|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
164409520|NCT03285295|593872313|FG000|Alinity s HTLV I/II|No Results Generated|70|||
164409521|NCT03285295|593872314|FG001|Alinity s HTLV I/II|No Results Generated|0|||
164409522|NCT03285295|593872315|FG002|Alinity s HTLV I/II|No Results Generated|0|||
164409523|NCT03285295|593872316|FG003|Alinity s HTLV I/II|No Results Generated|0|||
164409524|NCT03285295|593872317|FG004|Alinity s HTLV I/II|No Results Generated|0|||
164409525|NCT03285295|593872313|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
164409526|NCT03285295|593872314|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
164409527|NCT03285295|593872315|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
164409528|NCT03285295|593872316|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
164409529|NCT03285295|593872317|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
164409530|NCT03285295|593872313|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
164409531|NCT03285295|593872314|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
164409532|NCT03285295|593872315|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
164409533|NCT03285295|593872316|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
164409534|NCT03285295|593872317|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
164409535|NCT03285295|593872313|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
164409536|NCT03285295|593872314|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
164409537|NCT03285295|593872315|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
164409538|NCT03285295|593872316|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
164409539|NCT03285295|593872317|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
164409540|NCT03285295|593872313|FG000|Alinity s Anti-HCV|No Results Generated|71|||
164409541|NCT03285295|593872314|FG001|Alinity s Anti-HCV|No Results Generated|0|||
164409542|NCT03285295|593872315|FG002|Alinity s Anti-HCV|No Results Generated|0|||
164409543|NCT03285295|593872316|FG003|Alinity s Anti-HCV|No Results Generated|0|||
164409544|NCT03285295|593872317|FG004|Alinity s Anti-HCV|No Results Generated|0|||
164409545|NCT03285295|593872313|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
164409546|NCT03285295|593872314|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
164409547|NCT03285295|593872315|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
164409548|NCT03285295|593872316|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
164409549|NCT03285295|593872317|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
164409550|NCT03285295|593872313|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
164409551|NCT03285295|593872314|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
164409552|NCT03285295|593872315|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
164409553|NCT03285295|593872316|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
164409554|NCT03285295|593872317|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
164409555|NCT03285295|593872313|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
164409556|NCT03285295|593872314|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
164707975|NCT01791153|594955395|FG006|Part 1: Blinded Period|Physician Decision|0|||
164707976|NCT01791153|594955396|FG007|Part 1: Blinded Period|Physician Decision|0|||
164409557|NCT03285295|593872315|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
164409558|NCT03285295|593872316|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
164409559|NCT03285295|593872317|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
164409560|NCT03285295|593872313|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
164707977|NCT01791153|594955389|FG000|Part 1: Blinded Period|Protocol Violation|0|||
164707978|NCT01791153|594955390|FG001|Part 1: Blinded Period|Protocol Violation|0|||
164409561|NCT03285295|593872314|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
164409562|NCT03285295|593872315|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
164409563|NCT03285295|593872316|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
164409564|NCT03285295|593872317|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
164409565|NCT03285295|593872313|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
164409566|NCT03285295|593872314|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
164409567|NCT03285295|593872315|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
164409568|NCT03285295|593872316|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
164409569|NCT03285295|593872317|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
164409570|NCT03285295|593872313|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
164409571|NCT03285295|593872314|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
164409572|NCT03285295|593872315|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
164409573|NCT03285295|593872316|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
164409574|NCT03285295|593872317|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
164409575|NCT03285295|593872313|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
164409576|NCT03285295|593872314|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
164409577|NCT03285295|593872315|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
164409578|NCT03285295|593872316|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
164409579|NCT03285295|593872317|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
164409580|NCT03285295|593872313|FG000|Alinity s Anti-HBc|No Results Generated|70|||
164409581|NCT03285295|593872314|FG001|Alinity s Anti-HBc|No Results Generated|0|||
164409582|NCT03285295|593872315|FG002|Alinity s Anti-HBc|No Results Generated|0|||
164409583|NCT03285295|593872316|FG003|Alinity s Anti-HBc|No Results Generated|0|||
164409584|NCT03285295|593872317|FG004|Alinity s Anti-HBc|No Results Generated|0|||
164409585|NCT03285295|593872313|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
164409586|NCT03285295|593872314|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
164409587|NCT03285295|593872315|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
164409588|NCT03285295|593872316|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
164409589|NCT03285295|593872317|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
164409590|NCT03285295|593872313|FG000|Alinity s Chagas|Protocol Violation|76|||
164409591|NCT03285295|593872314|FG001|Alinity s Chagas|Protocol Violation|0|||
164409592|NCT03285295|593872315|FG002|Alinity s Chagas|Protocol Violation|0|||
164409593|NCT03285295|593872316|FG003|Alinity s Chagas|Protocol Violation|0|||
164409594|NCT03285295|593872317|FG004|Alinity s Chagas|Protocol Violation|0|||
164409595|NCT03285295|593872313|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
164409596|NCT03285295|593872314|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
164409597|NCT03285295|593872315|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
164409598|NCT03285295|593872316|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
164409599|NCT03285295|593872317|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
164409600|NCT03285295|593872313|FG000|Alinity s Chagas|No Results Generated|105|||
164409601|NCT03285295|593872314|FG001|Alinity s Chagas|No Results Generated|0|||
164409602|NCT03285295|593872315|FG002|Alinity s Chagas|No Results Generated|0|||
164409603|NCT03285295|593872316|FG003|Alinity s Chagas|No Results Generated|0|||
164409604|NCT03285295|593872317|FG004|Alinity s Chagas|No Results Generated|0|||
164409605|NCT03285295|593872313|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
164409606|NCT03285295|593872314|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
164409607|NCT03285295|593872315|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
164409608|NCT03285295|593872316|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
164409609|NCT03285295|593872317|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
164409610|NCT02762981|593872318|FG000|Overall Study|Adverse Event|2|||
164462872|NCT00085735|594068530|FG000|Overall Study|Excess residual disease|2|||
164462873|NCT00085735|594068531|FG001|Overall Study|Excess residual disease|2|||
164462874|NCT00085735|594068532|FG002|Overall Study|Excess residual disease|1|||
164462875|NCT00085735|594068533|FG003|Overall Study|Excess residual disease|1|||
164462876|NCT00085735|594068534|FG004|Overall Study|Excess residual disease|1|||
164462877|NCT00085735|594068535|FG005|Overall Study|Excess residual disease|4|||
164707979|NCT01791153|594955391|FG002|Part 1: Blinded Period|Protocol Violation|0|||
164707980|NCT01791153|594955392|FG003|Part 1: Blinded Period|Protocol Violation|1|||
164707981|NCT01791153|594955393|FG004|Part 1: Blinded Period|Protocol Violation|0|||
164707982|NCT01791153|594955394|FG005|Part 1: Blinded Period|Protocol Violation|0|||
164707983|NCT01791153|594955395|FG006|Part 1: Blinded Period|Protocol Violation|0|||
164462878|NCT00085735|594068530|FG000|Overall Study|Reason not documented|1|||
164462879|NCT00085735|594068531|FG001|Overall Study|Reason not documented|0|||
164462880|NCT00085735|594068532|FG002|Overall Study|Reason not documented|1|||
164707984|NCT01791153|594955396|FG007|Part 1: Blinded Period|Protocol Violation|0|||
164707985|NCT01791153|594955389|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
164707986|NCT01791153|594955390|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
164707987|NCT01791153|594955391|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
164409611|NCT02762981|593872319|FG001|Overall Study|Adverse Event|3|||
164409612|NCT02762981|593872320|FG002|Overall Study|Adverse Event|1|||
164409613|NCT02762981|593872321|FG003|Overall Study|Adverse Event|1|||
164707988|NCT01791153|594955392|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
164707989|NCT01791153|594955393|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
164462881|NCT00085735|594068533|FG003|Overall Study|Reason not documented|0|||
164462882|NCT00085735|594068534|FG004|Overall Study|Reason not documented|1|||
164462883|NCT00085735|594068535|FG005|Overall Study|Reason not documented|0|||
164462884|NCT00085735|594068530|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
164462885|NCT00085735|594068531|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
164462886|NCT00085735|594068532|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
164462887|NCT00085735|594068533|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
164599174|NCT03607838|594554789|FG001|Overall Study|Withdrawal by Subject|8|||
164409614|NCT02762981|593872322|FG004|Overall Study|Adverse Event|3|||
164409615|NCT02762981|593872318|FG000|Overall Study|Physician Decision|0|||
164409616|NCT02762981|593872319|FG001|Overall Study|Physician Decision|1|||
164409617|NCT02762981|593872320|FG002|Overall Study|Physician Decision|0|||
164409618|NCT02762981|593872321|FG003|Overall Study|Physician Decision|0|||
164409619|NCT02762981|593872322|FG004|Overall Study|Physician Decision|1|||
164409620|NCT02762981|593872318|FG000|Overall Study|Disease progression|11|||
164409621|NCT02762981|593872319|FG001|Overall Study|Disease progression|23|||
164409622|NCT02762981|593872320|FG002|Overall Study|Disease progression|4|||
164409623|NCT02762981|593872321|FG003|Overall Study|Disease progression|10|||
164409624|NCT02762981|593872322|FG004|Overall Study|Disease progression|1|||
164409625|NCT02762981|593872318|FG000|Overall Study|Enrolled not treated|1|||
164409626|NCT02762981|593872319|FG001|Overall Study|Enrolled not treated|5|||
164409627|NCT02762981|593872320|FG002|Overall Study|Enrolled not treated|0|||
164409628|NCT02762981|593872321|FG003|Overall Study|Enrolled not treated|2|||
164409629|NCT02762981|593872322|FG004|Overall Study|Enrolled not treated|0|||
164409630|NCT02762981|593872318|FG000|Overall Study|Other|2|||
164409631|NCT02762981|593872319|FG001|Overall Study|Other|3|||
164409632|NCT02762981|593872320|FG002|Overall Study|Other|1|||
164409633|NCT02762981|593872321|FG003|Overall Study|Other|0|||
164409634|NCT02762981|593872322|FG004|Overall Study|Other|0|||
164409635|NCT02762981|593872318|FG000|Overall Study|Missing|1|||
164409636|NCT02762981|593872319|FG001|Overall Study|Missing|0|||
164409637|NCT02762981|593872320|FG002|Overall Study|Missing|0|||
164409638|NCT02762981|593872321|FG003|Overall Study|Missing|0|||
164409639|NCT02762981|593872322|FG004|Overall Study|Missing|0|||
164409640|NCT02762981|593872318|FG000|Overall Study|Withdrawal by Subject|0|||
164409641|NCT02762981|593872319|FG001|Overall Study|Withdrawal by Subject|5|||
164409642|NCT02762981|593872320|FG002|Overall Study|Withdrawal by Subject|1|||
164409643|NCT02762981|593872321|FG003|Overall Study|Withdrawal by Subject|3|||
164409644|NCT02762981|593872322|FG004|Overall Study|Withdrawal by Subject|0|||
164409645|NCT00976482|593872323|FG000|Overall Study|Death|208|||
164409646|NCT00976482|593872323|FG000|Overall Study|Withdrawal by Subject|45|||
164409647|NCT00976482|593872323|FG000|Overall Study|Center terminated|1|||
164409648|NCT00976482|593872323|FG000|Overall Study|Protocol Violation|5|||
164409649|NCT04867785|593872325|FG000|Overall Study|Adverse Event|1|||
164409650|NCT04867785|593872326|FG001|Overall Study|Adverse Event|0|||
164409651|NCT04867785|593872327|FG002|Overall Study|Adverse Event|1|||
164409652|NCT04867785|593872328|FG003|Overall Study|Adverse Event|0|||
164409653|NCT04867785|593872329|FG004|Overall Study|Adverse Event|0|||
164409654|NCT04867785|593872330|FG005|Overall Study|Adverse Event|0|||
164409655|NCT04867785|593872331|FG006|Overall Study|Adverse Event|0|||
164409656|NCT04867785|593872332|FG007|Overall Study|Adverse Event|2|||
164409657|NCT04867785|593872325|FG000|Overall Study|Lost to Follow-up|4|||
164409658|NCT04867785|593872326|FG001|Overall Study|Lost to Follow-up|4|||
164409659|NCT04867785|593872327|FG002|Overall Study|Lost to Follow-up|3|||
164409660|NCT04867785|593872328|FG003|Overall Study|Lost to Follow-up|2|||
164409661|NCT04867785|593872329|FG004|Overall Study|Lost to Follow-up|0|||
164409662|NCT04867785|593872330|FG005|Overall Study|Lost to Follow-up|1|||
164409663|NCT04867785|593872331|FG006|Overall Study|Lost to Follow-up|0|||
164409664|NCT04867785|593872332|FG007|Overall Study|Lost to Follow-up|1|||
164409665|NCT04867785|593872325|FG000|Overall Study|Withdrawal by Subject|6|||
164409666|NCT04867785|593872326|FG001|Overall Study|Withdrawal by Subject|2|||
164409667|NCT04867785|593872327|FG002|Overall Study|Withdrawal by Subject|2|||
164409668|NCT04867785|593872328|FG003|Overall Study|Withdrawal by Subject|1|||
164409669|NCT04867785|593872329|FG004|Overall Study|Withdrawal by Subject|2|||
164409670|NCT04867785|593872330|FG005|Overall Study|Withdrawal by Subject|0|||
164409671|NCT04867785|593872331|FG006|Overall Study|Withdrawal by Subject|2|||
164409672|NCT04867785|593872332|FG007|Overall Study|Withdrawal by Subject|5|||
164409673|NCT04867785|593872325|FG000|Overall Study|Physician Decision|0|||
164409674|NCT04867785|593872326|FG001|Overall Study|Physician Decision|0|||
164462888|NCT00085735|594068534|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
164599175|NCT03607838|594554788|FG000|Overall Study|Lost to Follow-up|6|||
164409675|NCT04867785|593872327|FG002|Overall Study|Physician Decision|0|||
164409676|NCT04867785|593872328|FG003|Overall Study|Physician Decision|0|||
164409677|NCT04867785|593872329|FG004|Overall Study|Physician Decision|0|||
164409678|NCT04867785|593872330|FG005|Overall Study|Physician Decision|0|||
164409679|NCT04867785|593872331|FG006|Overall Study|Physician Decision|0|||
164409680|NCT04867785|593872332|FG007|Overall Study|Physician Decision|1|||
164409681|NCT04867785|593872325|FG000|Overall Study|Inadvertent Enrollment|0|||
164409682|NCT04867785|593872326|FG001|Overall Study|Inadvertent Enrollment|0|||
164409683|NCT04867785|593872327|FG002|Overall Study|Inadvertent Enrollment|0|||
164409684|NCT04867785|593872328|FG003|Overall Study|Inadvertent Enrollment|1|||
164409685|NCT04867785|593872329|FG004|Overall Study|Inadvertent Enrollment|1|||
164409686|NCT04867785|593872330|FG005|Overall Study|Inadvertent Enrollment|0|||
164409687|NCT04867785|593872331|FG006|Overall Study|Inadvertent Enrollment|0|||
164409688|NCT04867785|593872332|FG007|Overall Study|Inadvertent Enrollment|1|||
164409689|NCT04867785|593872325|FG000|Overall Study|Eligibility Criteria Not Met|0|||
164409690|NCT04867785|593872326|FG001|Overall Study|Eligibility Criteria Not Met|0|||
164409691|NCT04867785|593872327|FG002|Overall Study|Eligibility Criteria Not Met|0|||
164409692|NCT04867785|593872328|FG003|Overall Study|Eligibility Criteria Not Met|0|||
164409693|NCT04867785|593872329|FG004|Overall Study|Eligibility Criteria Not Met|0|||
164409694|NCT04867785|593872330|FG005|Overall Study|Eligibility Criteria Not Met|0|||
164409695|NCT04867785|593872331|FG006|Overall Study|Eligibility Criteria Not Met|0|||
164409696|NCT04867785|593872332|FG007|Overall Study|Eligibility Criteria Not Met|1|||
164409697|NCT02959671|593872333|FG000|Overall Study|Adverse Event|2|||
164409698|NCT02959671|593872333|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
164409699|NCT01062763|593872334|FG000|Overall Study|Adverse Event|3|||
164409700|NCT01062763|593872335|FG001|Overall Study|Adverse Event|4|||
164409701|NCT02494921|593872336|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
164409702|NCT02494921|593872337|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
164409703|NCT02494921|593872338|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
164409704|NCT02494921|593872339|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
164409705|NCT02494921|593872340|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
164409706|NCT02494921|593872336|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
164409707|NCT02494921|593872337|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
164409708|NCT02494921|593872338|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
164409709|NCT02494921|593872339|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
164409710|NCT02494921|593872340|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
164409711|NCT02494921|593872336|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
164409712|NCT02494921|593872337|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
164409713|NCT02494921|593872338|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
164409714|NCT02494921|593872339|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
164409715|NCT02494921|593872340|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
164409716|NCT00605319|593872345|FG000|Overall Study|Adverse Event|6|||
164409717|NCT02991482|593872346|FG000|Overall Study|Disease progression|56|||
164409718|NCT02991482|593872347|FG001|Overall Study|Disease progression|47|||
164409719|NCT02991482|593872346|FG000|Overall Study|Death|4|||
164409720|NCT02991482|593872347|FG001|Overall Study|Death|4|||
164409721|NCT02991482|593872346|FG000|Overall Study|Adverse Event|1|||
164409722|NCT02991482|593872347|FG001|Overall Study|Adverse Event|6|||
164409723|NCT02991482|593872346|FG000|Overall Study|Patient decision|1|||
164409724|NCT02991482|593872347|FG001|Overall Study|Patient decision|1|||
164409725|NCT02991482|593872346|FG000|Overall Study|Physician Decision|0|||
164409726|NCT02991482|593872347|FG001|Overall Study|Physician Decision|6|||
164409727|NCT02991482|593872346|FG000|Overall Study|Clinical deterioration|1|||
164409728|NCT02991482|593872347|FG001|Overall Study|Clinical deterioration|0|||
164409729|NCT02991482|593872346|FG000|Overall Study|Patient feeling too unwell|1|||
164409730|NCT02991482|593872347|FG001|Overall Study|Patient feeling too unwell|0|||
164409731|NCT02991482|593872346|FG000|Overall Study|Worsening of performance status|0|||
164409732|NCT02991482|593872347|FG001|Overall Study|Worsening of performance status|1|||
164409733|NCT02991482|593872346|FG000|Overall Study|Death prior to study drug initiation|1|||
164409734|NCT02991482|593872347|FG001|Overall Study|Death prior to study drug initiation|0|||
164409735|NCT02991482|593872346|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
164409736|NCT02991482|593872347|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
164409737|NCT02887989|593872353|FG000|Overall Study|Withdrawal by Subject|8|||
164409738|NCT02887989|593872354|FG001|Overall Study|Withdrawal by Subject|11|||
164409739|NCT02887989|593872353|FG000|Overall Study|Death|1|||
164409740|NCT02887989|593872354|FG001|Overall Study|Death|0|||
164409741|NCT05648357|593872358|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
164409742|NCT02045433|593872359|FG000|Overall Study|Withdrawal by Subject|1|||
164409743|NCT03585296|593872360|FG000|Overall Study|Adverse Event|1|||
164409744|NCT03585296|593872360|FG000|Overall Study|Lost to Follow-up|2|||
164409745|NCT03585296|593872360|FG000|Overall Study|Withdrawal by Subject|2|||
164409746|NCT00041756|593872361|FG000|Overall Study|Adverse Event|4|||
164409747|NCT00041756|593872362|FG001|Overall Study|Adverse Event|10|||
164409748|NCT00041756|593872363|FG002|Overall Study|Adverse Event|6|||
164409749|NCT00041756|593872364|FG003|Overall Study|Adverse Event|11|||
164409750|NCT00041756|593872365|FG004|Overall Study|Adverse Event|34|||
164409751|NCT00041756|593872361|FG000|Overall Study|Protocol Violation|1|||
164409752|NCT00041756|593872362|FG001|Overall Study|Protocol Violation|1|||
164409753|NCT00041756|593872363|FG002|Overall Study|Protocol Violation|2|||
164409754|NCT00041756|593872364|FG003|Overall Study|Protocol Violation|2|||
164409755|NCT00041756|593872365|FG004|Overall Study|Protocol Violation|1|||
164409756|NCT00041756|593872361|FG000|Overall Study|Withdrawal by Subject|3|||
164707990|NCT01791153|594955394|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
164409757|NCT00041756|593872362|FG001|Overall Study|Withdrawal by Subject|3|||
164409758|NCT00041756|593872363|FG002|Overall Study|Withdrawal by Subject|4|||
164409759|NCT00041756|593872364|FG003|Overall Study|Withdrawal by Subject|2|||
164409760|NCT00041756|593872365|FG004|Overall Study|Withdrawal by Subject|3|||
164409761|NCT00041756|593872361|FG000|Overall Study|Lost to Follow-up|0|||
164409762|NCT00041756|593872362|FG001|Overall Study|Lost to Follow-up|1|||
164409763|NCT00041756|593872363|FG002|Overall Study|Lost to Follow-up|0|||
164409764|NCT00041756|593872364|FG003|Overall Study|Lost to Follow-up|1|||
164409765|NCT00041756|593872365|FG004|Overall Study|Lost to Follow-up|0|||
164409766|NCT00041756|593872361|FG000|Overall Study|Unable to meet protocol criteria|0|||
164409767|NCT00041756|593872362|FG001|Overall Study|Unable to meet protocol criteria|0|||
164409768|NCT00041756|593872363|FG002|Overall Study|Unable to meet protocol criteria|1|||
164409769|NCT00041756|593872364|FG003|Overall Study|Unable to meet protocol criteria|0|||
164409770|NCT00041756|593872365|FG004|Overall Study|Unable to meet protocol criteria|1|||
164409771|NCT00041756|593872361|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
164409772|NCT00041756|593872362|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
164409773|NCT00041756|593872363|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
164409774|NCT00041756|593872364|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
164409775|NCT00041756|593872365|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
164409776|NCT02002884|593872368|FG000|Main Period (MP)|Other|0|||
164409777|NCT02002884|593872369|FG001|Main Period (MP)|Other|3|||
164409778|NCT02002884|593872370|FG002|Main Period (MP)|Other|3|||
164409779|NCT02002884|593872371|FG003|Main Period (MP)|Other|0|||
164409780|NCT02002884|593872368|FG000|Main Period (MP)|Adverse Event|0|||
164409781|NCT02002884|593872369|FG001|Main Period (MP)|Adverse Event|1|||
164409782|NCT02002884|593872370|FG002|Main Period (MP)|Adverse Event|1|||
164409783|NCT02002884|593872371|FG003|Main Period (MP)|Adverse Event|0|||
164409784|NCT02002884|593872368|FG000|Main Period (MP)|Withdrawal by Subject|6|||
164409785|NCT02002884|593872369|FG001|Main Period (MP)|Withdrawal by Subject|2|||
164409786|NCT02002884|593872370|FG002|Main Period (MP)|Withdrawal by Subject|2|||
164409787|NCT02002884|593872371|FG003|Main Period (MP)|Withdrawal by Subject|0|||
164409788|NCT02002884|593872368|FG000|Main Period (MP)|Lost to Follow-up|0|||
164409789|NCT02002884|593872369|FG001|Main Period (MP)|Lost to Follow-up|0|||
164409790|NCT02002884|593872370|FG002|Main Period (MP)|Lost to Follow-up|2|||
164409791|NCT02002884|593872371|FG003|Main Period (MP)|Lost to Follow-up|0|||
164409792|NCT02002884|593872368|FG000|Open-Label Extension Period (OLEX)|Other|0|||
164409793|NCT02002884|593872369|FG001|Open-Label Extension Period (OLEX)|Other|0|||
164409794|NCT02002884|593872370|FG002|Open-Label Extension Period (OLEX)|Other|0|||
164409795|NCT02002884|593872371|FG003|Open-Label Extension Period (OLEX)|Other|24|||
164409796|NCT02002884|593872368|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
164409797|NCT02002884|593872369|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
164409798|NCT02002884|593872370|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
164409799|NCT02002884|593872371|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
164409800|NCT02002884|593872368|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
164409801|NCT02002884|593872369|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
164409802|NCT02002884|593872370|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
164409803|NCT02002884|593872371|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
164409804|NCT02002884|593872368|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
164462889|NCT00085735|594068535|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
164462890|NCT01824875|594068536|FG000|Overall Study|Disease progression|22|||
164462891|NCT01824875|594068537|FG001|Overall Study|Disease progression|15|||
164462892|NCT01824875|594068536|FG000|Overall Study|Withdrawal by Subject|5|||
164462893|NCT01824875|594068537|FG001|Overall Study|Withdrawal by Subject|4|||
164462894|NCT01824875|594068536|FG000|Overall Study|Adverse Event|4|||
164462895|NCT01824875|594068537|FG001|Overall Study|Adverse Event|10|||
164462896|NCT01824875|594068536|FG000|Overall Study|Alternative therapy|3|||
164462897|NCT01824875|594068537|FG001|Overall Study|Alternative therapy|0|||
164462898|NCT01824875|594068536|FG000|Overall Study|Complicating disease|1|||
164462899|NCT01824875|594068537|FG001|Overall Study|Complicating disease|0|||
164462900|NCT01824875|594068536|FG000|Overall Study|Physician Decision|0|||
164462901|NCT01824875|594068537|FG001|Overall Study|Physician Decision|1|||
164462902|NCT01824875|594068536|FG000|Overall Study|Non-compliance|1|||
164462903|NCT01824875|594068537|FG001|Overall Study|Non-compliance|1|||
164462904|NCT01824875|594068536|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
164599176|NCT03607838|594554789|FG001|Overall Study|Lost to Follow-up|11|||
164409805|NCT02002884|593872369|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
164409806|NCT02002884|593872370|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
164409807|NCT02002884|593872371|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
164409808|NCT02002884|593872368|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
164409809|NCT02002884|593872369|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
164409810|NCT02002884|593872370|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
164409811|NCT02002884|593872371|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
164409812|NCT02110732|593872372|FG000|Overall Study|Physician Decision|5|||
164409813|NCT02110732|593872373|FG001|Overall Study|Physician Decision|2|||
164462905|NCT01824875|594068537|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
164409814|NCT02110732|593872372|FG000|Overall Study|Lost to Follow-up|1|||
164409815|NCT02110732|593872373|FG001|Overall Study|Lost to Follow-up|1|||
164409816|NCT02948959|593872374|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
164409817|NCT02948959|593872375|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
164409818|NCT02948959|593872374|FG000|52 Weeks Treatment Period|Adverse Event|2|||
164409819|NCT02948959|593872375|FG001|52 Weeks Treatment Period|Adverse Event|5|||
164409820|NCT02948959|593872374|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
164409821|NCT02948959|593872375|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
164409822|NCT02948959|593872374|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
164409823|NCT02948959|593872375|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
164409824|NCT02948959|593872374|FG000|52 Weeks Treatment Period|Randomized by error|0|||
164409825|NCT02948959|593872375|FG001|52 Weeks Treatment Period|Randomized by error|5|||
164409826|NCT02948959|593872374|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
164409827|NCT02948959|593872375|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
164409828|NCT02948959|593872374|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
164409829|NCT02948959|593872375|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
164409830|NCT02948959|593872374|FG000|52 Weeks Treatment Period|Change of residence location|0|||
164409831|NCT02948959|593872375|FG001|52 Weeks Treatment Period|Change of residence location|1|||
164409832|NCT02948959|593872374|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
164409833|NCT02948959|593872375|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
164409834|NCT02948959|593872374|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
164409835|NCT02948959|593872375|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
164409836|NCT02948959|593872374|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
164409837|NCT02948959|593872375|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
164409838|NCT02948959|593872374|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
164409839|NCT02948959|593872375|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
164409840|NCT02948959|593872374|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
164409841|NCT02948959|593872375|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
164409842|NCT02948959|593872374|FG000|12 Weeks Follow-up Period|Study site closure|1|||
164409843|NCT02948959|593872375|FG001|12 Weeks Follow-up Period|Study site closure|0|||
164409844|NCT01800201|593872379|FG000|Overall Study|Withdrawal by Subject|2|||
164409845|NCT01800201|593872380|FG001|Overall Study|Withdrawal by Subject|0|||
164409846|NCT01800201|593872379|FG000|Overall Study|patient privacy concerns|1|||
164409847|NCT01800201|593872380|FG001|Overall Study|patient privacy concerns|1|||
164409848|NCT01800201|593872379|FG000|Overall Study|did not want to use device|0|||
164409849|NCT01800201|593872380|FG001|Overall Study|did not want to use device|1|||
164409850|NCT01800201|593872379|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
164409851|NCT01800201|593872380|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
164409852|NCT01480596|593872381|FG000|Overall Study|Adverse Event|3|||
164409853|NCT01480596|593872382|FG001|Overall Study|Adverse Event|0|||
164409854|NCT01480596|593872381|FG000|Overall Study|MG exacerbation or change in medication|2|||
164409855|NCT01480596|593872382|FG001|Overall Study|MG exacerbation or change in medication|2|||
164409856|NCT03812536|593872386|FG000|Overall Study|Protocol Violation|2|||
164409857|NCT03812536|593872387|FG001|Overall Study|Protocol Violation|0|||
164409858|NCT03812536|593872386|FG000|Overall Study|Withdrawal by Subject|1|||
164409859|NCT03812536|593872387|FG001|Overall Study|Withdrawal by Subject|1|||
164409860|NCT00152009|593872388|FG000|Overall Study|Adverse Event|9|||
164409861|NCT00152009|593872389|FG001|Overall Study|Adverse Event|13|||
164409862|NCT00152009|593872390|FG002|Overall Study|Adverse Event|20|||
164409863|NCT00152009|593872391|FG003|Overall Study|Adverse Event|1|||
164409864|NCT00152009|593872388|FG000|Overall Study|Protocol Violation|3|||
164409865|NCT00152009|593872389|FG001|Overall Study|Protocol Violation|0|||
164409866|NCT00152009|593872390|FG002|Overall Study|Protocol Violation|0|||
164409867|NCT00152009|593872391|FG003|Overall Study|Protocol Violation|1|||
164409868|NCT00152009|593872388|FG000|Overall Study|Withdrawal by Subject|2|||
164409869|NCT00152009|593872389|FG001|Overall Study|Withdrawal by Subject|3|||
164409870|NCT00152009|593872390|FG002|Overall Study|Withdrawal by Subject|4|||
164409871|NCT00152009|593872391|FG003|Overall Study|Withdrawal by Subject|9|||
164409872|NCT00152009|593872388|FG000|Overall Study|Lost to Follow-up|2|||
164409873|NCT00152009|593872389|FG001|Overall Study|Lost to Follow-up|4|||
164409874|NCT00152009|593872390|FG002|Overall Study|Lost to Follow-up|3|||
164409875|NCT00152009|593872391|FG003|Overall Study|Lost to Follow-up|3|||
164409876|NCT00152009|593872388|FG000|Overall Study|Lack of Efficacy|8|||
164462906|NCT01824875|594068536|FG000|Overall Study|Administrative issues|0|||
164462907|NCT01824875|594068537|FG001|Overall Study|Administrative issues|2|||
164409877|NCT00152009|593872389|FG001|Overall Study|Lack of Efficacy|6|||
164409878|NCT00152009|593872390|FG002|Overall Study|Lack of Efficacy|7|||
164409879|NCT00152009|593872391|FG003|Overall Study|Lack of Efficacy|15|||
164409880|NCT00152009|593872388|FG000|Overall Study|ECG abnormalities|2|||
164707991|NCT01791153|594955395|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
164707992|NCT01791153|594955396|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
164144811|NCT01524978|592891781|FG007|Overall Study|Lost to Follow-up|0|||
164409881|NCT00152009|593872389|FG001|Overall Study|ECG abnormalities|2|||
164409882|NCT00152009|593872390|FG002|Overall Study|ECG abnormalities|2|||
164409883|NCT00152009|593872391|FG003|Overall Study|ECG abnormalities|1|||
164409884|NCT00152009|593872388|FG000|Overall Study|Sponsor's decision|3|||
164409885|NCT00152009|593872389|FG001|Overall Study|Sponsor's decision|3|||
164409886|NCT00152009|593872390|FG002|Overall Study|Sponsor's decision|1|||
164409887|NCT00152009|593872391|FG003|Overall Study|Sponsor's decision|3|||
164409888|NCT01306201|593872392|FG000|Overall Study|Arrhythmia|4|||
164409889|NCT01306201|593872392|FG000|Overall Study|Files could not be processed|3|||
164409890|NCT01306201|593872392|FG000|Overall Study|Files unreadable|3|||
164409891|NCT00980005|593872395|FG000|Overall Study|Withdrawal by Subject|6|||
164409892|NCT00980005|593872396|FG001|Overall Study|Withdrawal by Subject|17|||
164409893|NCT00980005|593872395|FG000|Overall Study|Lost to Follow-up|37|||
164409894|NCT00980005|593872396|FG001|Overall Study|Lost to Follow-up|43|||
164409895|NCT00980005|593872395|FG000|Overall Study|Other|4|||
164707993|NCT01791153|594955389|FG000|Part 2: Open-label Period|Adverse Event|0|||
164707994|NCT01791153|594955390|FG001|Part 2: Open-label Period|Adverse Event|0|||
164707995|NCT01791153|594955391|FG002|Part 2: Open-label Period|Adverse Event|0|||
164707996|NCT01791153|594955392|FG003|Part 2: Open-label Period|Adverse Event|0|||
164707997|NCT01791153|594955393|FG004|Part 2: Open-label Period|Adverse Event|0|||
164707998|NCT01791153|594955394|FG005|Part 2: Open-label Period|Adverse Event|1|||
164707999|NCT01791153|594955395|FG006|Part 2: Open-label Period|Adverse Event|1|||
164708000|NCT01791153|594955396|FG007|Part 2: Open-label Period|Adverse Event|2|||
164708001|NCT01791153|594955389|FG000|Part 2: Open-label Period|Death|0|||
164708002|NCT01791153|594955390|FG001|Part 2: Open-label Period|Death|0|||
164708003|NCT01791153|594955391|FG002|Part 2: Open-label Period|Death|0|||
164708004|NCT01791153|594955392|FG003|Part 2: Open-label Period|Death|0|||
164708005|NCT01791153|594955393|FG004|Part 2: Open-label Period|Death|0|||
164708006|NCT01791153|594955394|FG005|Part 2: Open-label Period|Death|1|||
164708007|NCT01791153|594955395|FG006|Part 2: Open-label Period|Death|1|||
164708008|NCT01791153|594955396|FG007|Part 2: Open-label Period|Death|1|||
164708009|NCT01791153|594955389|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
164708010|NCT01791153|594955390|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
164708011|NCT01791153|594955391|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
164708012|NCT01791153|594955392|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
164708013|NCT01791153|594955393|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
164708014|NCT01791153|594955394|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
164708015|NCT01791153|594955395|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
164708016|NCT01791153|594955396|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
164708017|NCT01791153|594955389|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
164708018|NCT01791153|594955390|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
164708019|NCT01791153|594955391|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
164708020|NCT01791153|594955392|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
164708021|NCT01791153|594955393|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
164708022|NCT01791153|594955394|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
164708023|NCT01791153|594955395|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
164708024|NCT01791153|594955396|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
164708025|NCT01791153|594955389|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
164708026|NCT01791153|594955390|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
164708027|NCT01791153|594955391|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
164708028|NCT01791153|594955392|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
164708029|NCT01791153|594955393|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
164708030|NCT01791153|594955394|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
164708031|NCT01791153|594955395|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
164708032|NCT01791153|594955396|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
164708033|NCT01791153|594955389|FG000|Part 2: Open-label Period|Physician Decision|0|||
164708034|NCT01791153|594955390|FG001|Part 2: Open-label Period|Physician Decision|0|||
164708035|NCT01791153|594955391|FG002|Part 2: Open-label Period|Physician Decision|0|||
164708036|NCT01791153|594955392|FG003|Part 2: Open-label Period|Physician Decision|0|||
164409896|NCT00980005|593872396|FG001|Overall Study|Other|3|||
164409897|NCT00572624|593872397|FG000|Overall Study|Lost to Follow-up|10|||
164409898|NCT00572624|593872398|FG001|Overall Study|Lost to Follow-up|4|||
164409899|NCT00572624|593872397|FG000|Overall Study|Wanted to do a different diet program|1|||
164409900|NCT00572624|593872398|FG001|Overall Study|Wanted to do a different diet program|0|||
164409901|NCT00572624|593872397|FG000|Overall Study|Medication change|1|||
164708037|NCT01791153|594955393|FG004|Part 2: Open-label Period|Physician Decision|1|||
164409902|NCT00572624|593872398|FG001|Overall Study|Medication change|0|||
164409903|NCT00572624|593872397|FG000|Overall Study|Started a new job-- no time for study|1|||
164409904|NCT00572624|593872398|FG001|Overall Study|Started a new job-- no time for study|0|||
164409905|NCT00572624|593872397|FG000|Overall Study|Admitted to being a smoker|1|||
164409906|NCT00572624|593872398|FG001|Overall Study|Admitted to being a smoker|0|||
164462908|NCT01824875|594068536|FG000|Overall Study|Ineligible or never started treatment|9|||
164708038|NCT01791153|594955394|FG005|Part 2: Open-label Period|Physician Decision|1|||
164409907|NCT00572624|593872397|FG000|Overall Study|Refused to do the stress test|1|||
164409908|NCT00572624|593872398|FG001|Overall Study|Refused to do the stress test|0|||
164409909|NCT00572624|593872397|FG000|Overall Study|Problem with vascular access|1|||
164409910|NCT00572624|593872398|FG001|Overall Study|Problem with vascular access|0|||
164409911|NCT00572624|593872397|FG000|Overall Study|Health issues unrelated to the study|1|||
164409912|NCT00572624|593872398|FG001|Overall Study|Health issues unrelated to the study|0|||
164409913|NCT05400746|593872403|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
164409914|NCT05400746|593872404|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
164409915|NCT05400746|593872405|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
164409916|NCT05375955|593872406|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
164409917|NCT05375955|593872407|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
164409918|NCT05375955|593872408|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
164409919|NCT05375955|593872409|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
164409920|NCT05375955|593872410|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
164409921|NCT05375955|593872411|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
164409922|NCT05375955|593872412|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
164409923|NCT05375955|593872406|FG000|Treatment (12 Weeks)|Physician Decision|4|||
164409924|NCT05375955|593872407|FG001|Treatment (12 Weeks)|Physician Decision|1|||
164409925|NCT05375955|593872408|FG002|Treatment (12 Weeks)|Physician Decision|3|||
164409926|NCT05375955|593872409|FG003|Treatment (12 Weeks)|Physician Decision|0|||
164409927|NCT05375955|593872410|FG004|Treatment (12 Weeks)|Physician Decision|0|||
164409928|NCT05375955|593872411|FG005|Treatment (12 Weeks)|Physician Decision|1|||
164409929|NCT05375955|593872412|FG006|Treatment (12 Weeks)|Physician Decision|0|||
164409930|NCT05375955|593872406|FG000|Treatment (12 Weeks)|Other|0|||
164409931|NCT05375955|593872407|FG001|Treatment (12 Weeks)|Other|1|||
164409932|NCT05375955|593872408|FG002|Treatment (12 Weeks)|Other|0|||
164409933|NCT05375955|593872409|FG003|Treatment (12 Weeks)|Other|0|||
164409934|NCT05375955|593872410|FG004|Treatment (12 Weeks)|Other|0|||
164409935|NCT05375955|593872411|FG005|Treatment (12 Weeks)|Other|0|||
164409936|NCT05375955|593872412|FG006|Treatment (12 Weeks)|Other|0|||
164409937|NCT05375955|593872406|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
164409938|NCT05375955|593872407|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
164409939|NCT05375955|593872408|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
164409940|NCT05375955|593872409|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
164409941|NCT05375955|593872410|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
164409942|NCT05375955|593872411|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
164409943|NCT05375955|593872412|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
164409944|NCT05375955|593872406|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
164409945|NCT05375955|593872407|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
164409946|NCT05375955|593872408|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
164409947|NCT05375955|593872409|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
164409948|NCT05375955|593872410|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
164409949|NCT05375955|593872411|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
164409950|NCT05375955|593872412|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
164409951|NCT05375955|593872406|FG000|Treatment (12 Weeks)|Pregnancy|0|||
164409952|NCT05375955|593872407|FG001|Treatment (12 Weeks)|Pregnancy|0|||
164409953|NCT05375955|593872408|FG002|Treatment (12 Weeks)|Pregnancy|1|||
164409954|NCT05375955|593872409|FG003|Treatment (12 Weeks)|Pregnancy|0|||
164409955|NCT05375955|593872410|FG004|Treatment (12 Weeks)|Pregnancy|0|||
164409956|NCT05375955|593872411|FG005|Treatment (12 Weeks)|Pregnancy|0|||
164409957|NCT05375955|593872412|FG006|Treatment (12 Weeks)|Pregnancy|0|||
164409958|NCT05375955|593872406|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
164409959|NCT05375955|593872407|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
164409960|NCT05375955|593872408|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
164409961|NCT05375955|593872409|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
164409962|NCT05375955|593872410|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
164409963|NCT05375955|593872411|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
164409964|NCT05375955|593872412|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
164409965|NCT05375955|593872406|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
164409966|NCT05375955|593872407|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
164409967|NCT05375955|593872408|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
164409968|NCT05375955|593872409|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
164409969|NCT05375955|593872410|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
164409970|NCT05375955|593872411|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
164409971|NCT05375955|593872412|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
164409972|NCT05375955|593872406|FG000|Follow-up (up to 5 Weeks)|Other|0|||
164409973|NCT05375955|593872407|FG001|Follow-up (up to 5 Weeks)|Other|1|||
164409974|NCT05375955|593872408|FG002|Follow-up (up to 5 Weeks)|Other|0|||
164409975|NCT05375955|593872409|FG003|Follow-up (up to 5 Weeks)|Other|0|||
164409976|NCT05375955|593872410|FG004|Follow-up (up to 5 Weeks)|Other|0|||
164409977|NCT05375955|593872411|FG005|Follow-up (up to 5 Weeks)|Other|0|||
164409978|NCT05375955|593872412|FG006|Follow-up (up to 5 Weeks)|Other|0|||
164409979|NCT05375955|593872406|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
164409980|NCT05375955|593872407|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
164409981|NCT05375955|593872408|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
164409982|NCT05375955|593872409|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
164409983|NCT05375955|593872410|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
164409984|NCT05375955|593872411|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
164409985|NCT05375955|593872412|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
164409986|NCT05375955|593872406|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
164409987|NCT05375955|593872407|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
164409988|NCT05375955|593872408|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
164409989|NCT05375955|593872409|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
164409990|NCT05375955|593872410|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
164409991|NCT05375955|593872411|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
164409992|NCT05375955|593872412|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
164409993|NCT03879408|593872422|FG000|Overall Study|Lost to Follow-up|0|||
164409994|NCT03879408|593872423|FG001|Overall Study|Lost to Follow-up|3|||
164409995|NCT03879408|593872424|FG002|Overall Study|Lost to Follow-up|2|||
164409996|NCT03879408|593872425|FG003|Overall Study|Lost to Follow-up|1|||
164409997|NCT03879408|593872426|FG004|Overall Study|Lost to Follow-up|0|||
164409998|NCT03879408|593872422|FG000|Overall Study|Withdrawal by Subject|2|||
164409999|NCT03879408|593872423|FG001|Overall Study|Withdrawal by Subject|1|||
164462909|NCT01824875|594068537|FG001|Overall Study|Ineligible or never started treatment|5|||
164462910|NCT01824875|594068536|FG000|Overall Study|Other|0|||
164462911|NCT01824875|594068537|FG001|Overall Study|Other|2|||
164462912|NCT04195698|594068538|FG000|Overall Study|Adverse Event|4|||
164462913|NCT04195698|594068539|FG001|Overall Study|Adverse Event|11|||
164462914|NCT04195698|594068538|FG000|Overall Study|Withdrawal by Subject|9|||
164462915|NCT04195698|594068539|FG001|Overall Study|Withdrawal by Subject|10|||
164708039|NCT01791153|594955395|FG006|Part 2: Open-label Period|Physician Decision|0|||
164708040|NCT01791153|594955396|FG007|Part 2: Open-label Period|Physician Decision|0|||
164708041|NCT02562482|594955400|FG000|Overall Study|Enrolled, but did not receive product|4|||
164708042|NCT02562482|594955401|FG001|Overall Study|Enrolled, but did not receive product|0|||
164708043|NCT02562482|594955400|FG000|Overall Study|Lost to Follow-up|9|||
164708044|NCT02562482|594955401|FG001|Overall Study|Lost to Follow-up|6|||
164708045|NCT02562482|594955400|FG000|Overall Study|Moved from area|2|||
164708046|NCT02562482|594955401|FG001|Overall Study|Moved from area|3|||
164708047|NCT02562482|594955400|FG000|Overall Study|Withdrawal by Subject|5|||
164708048|NCT02562482|594955401|FG001|Overall Study|Withdrawal by Subject|3|||
164708049|NCT02562482|594955400|FG000|Overall Study|Physician Decision|1|||
164708050|NCT02562482|594955401|FG001|Overall Study|Physician Decision|3|||
164708051|NCT02562482|594955400|FG000|Overall Study|Illness/Injury unrelated to product|0|||
164708052|NCT02562482|594955401|FG001|Overall Study|Illness/Injury unrelated to product|1|||
164708053|NCT04669691|594955402|FG000|Overall Study|Death|0|||
164708054|NCT04669691|594955403|FG001|Overall Study|Death|1|||
164708055|NCT04669691|594955404|FG002|Overall Study|Death|0|||
164708056|NCT04669691|594955405|FG003|Overall Study|Death|0|||
164708057|NCT04669691|594955406|FG004|Overall Study|Death|0|||
164708058|NCT04669691|594955407|FG005|Overall Study|Death|0|||
164708059|NCT04156620|594955408|FG000|Overall Study|Adverse event - TP 1|5|||
164708060|NCT04156620|594955409|FG001|Overall Study|Adverse event - TP 1|2|||
164708061|NCT04156620|594955408|FG000|Overall Study|Lost to follow-up TP 1|1|||
164708062|NCT04156620|594955409|FG001|Overall Study|Lost to follow-up TP 1|1|||
164708063|NCT04156620|594955408|FG000|Overall Study|Progressive disease - TP 1|0|||
164708064|NCT04156620|594955409|FG001|Overall Study|Progressive disease - TP 1|1|||
164708065|NCT04156620|594955408|FG000|Overall Study|Subject decision - TP 1|3|||
164708066|NCT04156620|594955409|FG001|Overall Study|Subject decision - TP 1|5|||
164708067|NCT04156620|594955408|FG000|Overall Study|Adverse event - TP 2|5|||
164708068|NCT04156620|594955409|FG001|Overall Study|Adverse event - TP 2|6|||
164708069|NCT04156620|594955408|FG000|Overall Study|Death - TP 2|1|||
164708070|NCT04156620|594955409|FG001|Overall Study|Death - TP 2|0|||
164708071|NCT04156620|594955408|FG000|Overall Study|Lost to follow-up - TP 2|5|||
164708072|NCT04156620|594955409|FG001|Overall Study|Lost to follow-up - TP 2|2|||
164708073|NCT04156620|594955408|FG000|Overall Study|Physician decision - TP 2|4|||
164410000|NCT03879408|593872424|FG002|Overall Study|Withdrawal by Subject|1|||
164410001|NCT03879408|593872425|FG003|Overall Study|Withdrawal by Subject|0|||
164462916|NCT04195698|594068538|FG000|Overall Study|Lost to Follow-up|5|||
164462917|NCT04195698|594068539|FG001|Overall Study|Lost to Follow-up|4|||
164410002|NCT03879408|593872426|FG004|Overall Study|Withdrawal by Subject|1|||
164410003|NCT04522180|593872427|FG000|Overall Study|Investigator judgement|3|||
164462918|NCT04195698|594068538|FG000|Overall Study|Lack of Efficacy|2|||
164708074|NCT04156620|594955409|FG001|Overall Study|Physician decision - TP 2|2|||
164708075|NCT04156620|594955408|FG000|Overall Study|Pregnancy - TP 2|1|||
164708076|NCT04156620|594955409|FG001|Overall Study|Pregnancy - TP 2|1|||
164708077|NCT04156620|594955408|FG000|Overall Study|Subject decision - TP 2|11|||
164708078|NCT04156620|594955409|FG001|Overall Study|Subject decision - TP 2|9|||
164708079|NCT04156620|594955408|FG000|Overall Study|New therapy for study indication - TP 2|1|||
164708080|NCT04156620|594955409|FG001|Overall Study|New therapy for study indication - TP 2|0|||
164462919|NCT04195698|594068539|FG001|Overall Study|Lack of Efficacy|10|||
164462920|NCT04195698|594068538|FG000|Overall Study|Other|5|||
164462921|NCT04195698|594068539|FG001|Overall Study|Other|4|||
164462922|NCT00433329|594068540|FG000|Overall Study|Adverse Event|9|||
164462923|NCT00433329|594068540|FG000|Overall Study|Death|4|||
164462924|NCT00433329|594068540|FG000|Overall Study|Withdrew consent|3|||
164462925|NCT00433329|594068540|FG000|Overall Study|Discontinued sildenafil|2|||
164462926|NCT00433329|594068540|FG000|Overall Study|Moved out of state|1|||
164462927|NCT00433329|594068540|FG000|Overall Study|Lost to Follow-up|1|||
164462928|NCT00433329|594068540|FG000|Overall Study|Physician Decision|1|||
164410004|NCT04522180|593872428|FG001|Overall Study|Investigator judgement|4|||
164410005|NCT04522180|593872427|FG000|Overall Study|Voluntary withdrawal|1|||
164410006|NCT04522180|593872428|FG001|Overall Study|Voluntary withdrawal|0|||
164410007|NCT04522180|593872427|FG000|Overall Study|Pregnancy|0|||
164410008|NCT04522180|593872428|FG001|Overall Study|Pregnancy|1|||
164410009|NCT04522180|593872427|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
164410010|NCT04522180|593872428|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
164410011|NCT04522180|593872427|FG000|Overall Study|Reason not specified|8|||
164410012|NCT04522180|593872428|FG001|Overall Study|Reason not specified|5|||
164410013|NCT03976466|593872435|FG000|Overall Study|Lost to Follow-up|1|||
164410014|NCT03976466|593872436|FG001|Overall Study|Lost to Follow-up|3|||
164410015|NCT02055157|593872437|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
164410016|NCT02055157|593872438|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
164410017|NCT02055157|593872439|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
164410018|NCT02055157|593872440|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
164410019|NCT02055157|593872437|FG000|Initial 6 Months|Adverse Event|0|||
164410020|NCT02055157|593872438|FG001|Initial 6 Months|Adverse Event|0|||
164410021|NCT02055157|593872439|FG002|Initial 6 Months|Adverse Event|0|||
164410022|NCT02055157|593872440|FG003|Initial 6 Months|Adverse Event|1|||
164410023|NCT02055157|593872437|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
164410024|NCT02055157|593872438|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
164410025|NCT02055157|593872439|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
164410026|NCT02055157|593872440|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
164410027|NCT02055157|593872437|FG000|18-month Extension|Investigator decision|0|||
164410028|NCT02055157|593872438|FG001|18-month Extension|Investigator decision|1|||
164410029|NCT02055157|593872439|FG002|18-month Extension|Investigator decision|0|||
164410030|NCT02055157|593872440|FG003|18-month Extension|Investigator decision|0|||
164410031|NCT02055157|593872437|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
164410032|NCT02055157|593872438|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
164410033|NCT02055157|593872439|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
164410034|NCT02055157|593872440|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
164410035|NCT02034708|593872441|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
164410036|NCT02034708|593872442|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
164410037|NCT02034708|593872441|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
164410038|NCT02034708|593872442|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
164410039|NCT02034708|593872441|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
164410040|NCT02034708|593872442|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
164410041|NCT02034708|593872441|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
164410042|NCT02034708|593872442|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
164410043|NCT00733499|593872445|FG000|Pre-operative|Protocol Violation|0|||
164410044|NCT00733499|593872446|FG001|Pre-operative|Protocol Violation|1|||
164410045|NCT00733499|593872445|FG000|3 Months Follow-up|Death|1|||
164410046|NCT00733499|593872446|FG001|3 Months Follow-up|Death|2|||
164410047|NCT00733499|593872445|FG000|6 Months Follow-up|Death|0|||
164410048|NCT00733499|593872446|FG001|6 Months Follow-up|Death|2|||
164410049|NCT00733499|593872445|FG000|6 Months Follow-up|Adverse Event|0|||
164410050|NCT00733499|593872446|FG001|6 Months Follow-up|Adverse Event|1|||
164410051|NCT00733499|593872445|FG000|12 Months Follow-up|Death|2|||
164410052|NCT00733499|593872446|FG001|12 Months Follow-up|Death|1|||
164410053|NCT00733499|593872445|FG000|24 Months Follow-up|Death|0|||
164410054|NCT00733499|593872446|FG001|24 Months Follow-up|Death|1|||
164410055|NCT00733499|593872445|FG000|5 Year Followup|Adverse Event|2|||
164462929|NCT01129102|594068541|FG000|Overall Study|No study drug treatment|2|||
164462930|NCT01129102|594068542|FG001|Overall Study|No study drug treatment|3|||
164462931|NCT01129102|594068543|FG002|Overall Study|No study drug treatment|1|||
164708081|NCT00390221|594955415|FG000|Overall Study|Lost to Follow-up|0|||
164708082|NCT00390221|594955416|FG001|Overall Study|Lost to Follow-up|3|||
164708083|NCT00390221|594955417|FG002|Overall Study|Lost to Follow-up|0|||
164410056|NCT00733499|593872446|FG001|5 Year Followup|Adverse Event|2|||
164410057|NCT00733499|593872445|FG000|5 Year Followup|Non device related AE|0|||
164410058|NCT00733499|593872446|FG001|5 Year Followup|Non device related AE|1|||
164410059|NCT00733499|593872445|FG000|5 Year Followup|Revision of Study Implant|0|||
164410060|NCT00733499|593872446|FG001|5 Year Followup|Revision of Study Implant|1|||
164462932|NCT01129102|594068541|FG000|Overall Study|Withdrawal by Subject|2|||
164708084|NCT00390221|594955415|FG000|Overall Study|Adverse Event|1|||
164708085|NCT00390221|594955416|FG001|Overall Study|Adverse Event|4|||
164599177|NCT03607838|594554788|FG000|Overall Study|Adverse Event|2|||
164599178|NCT03607838|594554789|FG001|Overall Study|Adverse Event|2|||
164599179|NCT03607838|594554788|FG000|Overall Study|Physician Decision|2|||
164599180|NCT03607838|594554789|FG001|Overall Study|Physician Decision|0|||
164599181|NCT03607838|594554788|FG000|Overall Study|Failure to meet randomization criteria|1|||
164599182|NCT03607838|594554789|FG001|Overall Study|Failure to meet randomization criteria|2|||
164599183|NCT03607838|594554788|FG000|Overall Study|Pregnancy|1|||
164599184|NCT03607838|594554789|FG001|Overall Study|Pregnancy|0|||
164599185|NCT03607838|594554788|FG000|Overall Study|Protocol Violation|1|||
164599186|NCT03607838|594554789|FG001|Overall Study|Protocol Violation|0|||
164599187|NCT03607838|594554788|FG000|Overall Study|Due to work|1|||
164599188|NCT03607838|594554789|FG001|Overall Study|Due to work|0|||
164410061|NCT00733499|593872445|FG000|5 Year Followup|Lost to Follow-up|2|||
164410062|NCT00733499|593872446|FG001|5 Year Followup|Lost to Follow-up|0|||
164410063|NCT00733499|593872445|FG000|5 Year Followup|Death|13|||
164410064|NCT00733499|593872446|FG001|5 Year Followup|Death|19|||
164410065|NCT00733499|593872445|FG000|5 Year Followup|missing, unable to locate|0|||
164410066|NCT00733499|593872446|FG001|5 Year Followup|missing, unable to locate|1|||
164410067|NCT00733499|593872445|FG000|5 Year Followup|Withdrawal by Subject|4|||
164410068|NCT00733499|593872446|FG001|5 Year Followup|Withdrawal by Subject|1|||
164410069|NCT00733499|593872445|FG000|10 Year Followup|Death|9|||
164410070|NCT00733499|593872446|FG001|10 Year Followup|Death|7|||
164410071|NCT00733499|593872445|FG000|10 Year Followup|Adverse Event|3|||
164410072|NCT00733499|593872446|FG001|10 Year Followup|Adverse Event|3|||
164410073|NCT00733499|593872445|FG000|10 Year Followup|Lost to Follow-up|3|||
164410074|NCT00733499|593872446|FG001|10 Year Followup|Lost to Follow-up|2|||
164410075|NCT00733499|593872445|FG000|10 Year Followup|Withdrawal by Subject|5|||
164410076|NCT00733499|593872446|FG001|10 Year Followup|Withdrawal by Subject|5|||
164410077|NCT00733499|593872445|FG000|10 Year Followup|missing, unable to locate|0|||
164410078|NCT00733499|593872446|FG001|10 Year Followup|missing, unable to locate|2|||
164410079|NCT00733980|593872447|FG000|Overall Study|Adverse Event|5|||
164410080|NCT00733980|593872448|FG001|Overall Study|Adverse Event|2|||
164410081|NCT00733980|593872447|FG000|Overall Study|Lack of Efficacy|0|||
164410082|NCT00733980|593872448|FG001|Overall Study|Lack of Efficacy|1|||
164410083|NCT00733980|593872447|FG000|Overall Study|Protocol Violation|2|||
164410084|NCT00733980|593872448|FG001|Overall Study|Protocol Violation|1|||
164410085|NCT00733980|593872447|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
164410086|NCT00733980|593872448|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
164410087|NCT00733980|593872447|FG000|Overall Study|Lost to Follow-up|6|||
164410088|NCT00733980|593872448|FG001|Overall Study|Lost to Follow-up|11|||
164410089|NCT00733980|593872447|FG000|Overall Study|Physician Decision|2|||
164410090|NCT00733980|593872448|FG001|Overall Study|Physician Decision|3|||
164410091|NCT00733980|593872447|FG000|Overall Study|Withdrawal by Subject|6|||
164410092|NCT00733980|593872448|FG001|Overall Study|Withdrawal by Subject|2|||
164410093|NCT01931735|593872449|FG000|Randomized Phase|Lost to Follow-up|2|||
164410094|NCT01931735|593872450|FG001|Randomized Phase|Lost to Follow-up|2|||
164410095|NCT01931735|593872451|FG002|Randomized Phase|Lost to Follow-up|5|||
164410096|NCT01931735|593872452|FG003|Randomized Phase|Lost to Follow-up|0|||
164410097|NCT01931735|593872449|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
164410098|NCT01931735|593872450|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
164410099|NCT01931735|593872451|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
164410100|NCT01931735|593872452|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
164410101|NCT01931735|593872449|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
164599189|NCT03607838|594554788|FG000|Overall Study|Litigation|0|||
164599190|NCT03607838|594554789|FG001|Overall Study|Litigation|1|||
164599191|NCT03607838|594554788|FG000|Overall Study|Temperature excursion for study drug|0|||
164599192|NCT03607838|594554789|FG001|Overall Study|Temperature excursion for study drug|1|||
164599193|NCT03607838|594554788|FG000|Overall Study|Change of mind|0|||
164599194|NCT03607838|594554789|FG001|Overall Study|Change of mind|1|||
164599195|NCT01576016|594554790|FG000|Lead Safety|Death|132|||
164599196|NCT01576016|594554791|FG001|Lead Safety|Death|0|||
164599197|NCT01576016|594554790|FG000|Lead Safety|Withdrawal by Subject|81|||
164599198|NCT01576016|594554791|FG001|Lead Safety|Withdrawal by Subject|0|||
164144812|NCT01524978|592891782|FG008|Overall Study|Lost to Follow-up|1|||
164410102|NCT01931735|593872450|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
164410103|NCT01931735|593872451|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
164410104|NCT01931735|593872452|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
164410105|NCT02719990|593872456|FG000|Overall Study|Physician Decision|2|||
164410106|NCT02719990|593872456|FG000|Overall Study|Withdrawal by Subject|2|||
164410107|NCT02719990|593872456|FG000|Overall Study|Study Terminated By Sponsor|32|||
164410108|NCT00652938|593872460|FG000|Overall Study|Adverse Event|1|||
164599199|NCT01576016|594554790|FG000|Lead Safety|System Explanted without Replacement|24|||
164599200|NCT01576016|594554791|FG001|Lead Safety|System Explanted without Replacement|0|||
164599201|NCT01576016|594554790|FG000|Lead Safety|Physician Decision|14|||
164410109|NCT00652938|593872461|FG001|Overall Study|Adverse Event|0|||
164410110|NCT00652938|593872462|FG002|Overall Study|Adverse Event|2|||
164599202|NCT01576016|594554791|FG001|Lead Safety|Physician Decision|0|||
164410111|NCT00652938|593872460|FG000|Overall Study|Withdrawal by Subject|0|||
164410112|NCT00652938|593872461|FG001|Overall Study|Withdrawal by Subject|6|||
164410113|NCT00652938|593872462|FG002|Overall Study|Withdrawal by Subject|1|||
164410114|NCT00652938|593872460|FG000|Overall Study|Lost to Follow-up|0|||
164410115|NCT00652938|593872461|FG001|Overall Study|Lost to Follow-up|0|||
164410116|NCT00652938|593872462|FG002|Overall Study|Lost to Follow-up|2|||
164410117|NCT00652938|593872460|FG000|Overall Study|fear of blood sampling|0|||
164410118|NCT00652938|593872461|FG001|Overall Study|fear of blood sampling|1|||
164410119|NCT00652938|593872462|FG002|Overall Study|fear of blood sampling|0|||
164410120|NCT03324880|593872463|FG000|Overall Study|Adverse Event|0|||
164410121|NCT03324880|593872464|FG001|Overall Study|Adverse Event|2|||
164410122|NCT03324880|593872463|FG000|Overall Study|Withdrawal by Subject|2|||
164410123|NCT03324880|593872464|FG001|Overall Study|Withdrawal by Subject|2|||
164410124|NCT03324880|593872463|FG000|Overall Study|Lost to Follow-up|0|||
164410125|NCT03324880|593872464|FG001|Overall Study|Lost to Follow-up|1|||
164410126|NCT03324880|593872463|FG000|Overall Study|Product Recall|0|||
164410127|NCT03324880|593872464|FG001|Overall Study|Product Recall|1|||
164410128|NCT01547299|593872467|FG000|Overall Study|Withdrawal by Subject|2|||
164410129|NCT01547299|593872468|FG001|Overall Study|Withdrawal by Subject|2|||
164410130|NCT05076149|593872469|FG000|Overall Study|Adverse Event|3|||
164410131|NCT05076149|593872470|FG001|Overall Study|Adverse Event|9|||
164410132|NCT05076149|593872469|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
164462933|NCT01129102|594068542|FG001|Overall Study|Withdrawal by Subject|0|||
164462934|NCT01129102|594068543|FG002|Overall Study|Withdrawal by Subject|3|||
164462935|NCT01129102|594068541|FG000|Overall Study|Protocol Violation|0|||
164462936|NCT01129102|594068542|FG001|Overall Study|Protocol Violation|1|||
164462937|NCT01129102|594068543|FG002|Overall Study|Protocol Violation|1|||
164462938|NCT01129102|594068541|FG000|Overall Study|Pregnancy|0|||
164410133|NCT05076149|593872470|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
164410134|NCT05076149|593872469|FG000|Overall Study|Lost to Follow-up|0|||
164410135|NCT05076149|593872470|FG001|Overall Study|Lost to Follow-up|1|||
164410136|NCT05076149|593872469|FG000|Overall Study|Commercial drug is available for participant|0|||
164410137|NCT05076149|593872470|FG001|Overall Study|Commercial drug is available for participant|1|||
164410138|NCT05076149|593872469|FG000|Overall Study|Other non compliance|1|||
164410139|NCT05076149|593872470|FG001|Overall Study|Other non compliance|1|||
164410140|NCT05076149|593872469|FG000|Overall Study|Physician Decision|0|||
164410141|NCT05076149|593872470|FG001|Overall Study|Physician Decision|1|||
164410142|NCT05076149|593872469|FG000|Overall Study|Other|5|||
164410143|NCT05076149|593872470|FG001|Overall Study|Other|4|||
164410144|NCT02087501|593872471|FG000|Overall Study|Death|7|||
164410145|NCT02087501|593872471|FG000|Overall Study|Open repair of aneurysm|1|||
164410146|NCT02087501|593872471|FG000|Overall Study|Lost to Follow-up|2|||
164410147|NCT03682705|593872472|FG000|Overall Study|Adverse Event|1|||
164410148|NCT03682705|593872473|FG001|Overall Study|Adverse Event|1|||
164410149|NCT03682705|593872474|FG002|Overall Study|Adverse Event|1|||
164410150|NCT03682705|593872475|FG003|Overall Study|Adverse Event|0|||
164410151|NCT03682705|593872476|FG004|Overall Study|Adverse Event|1|||
164410152|NCT03682705|593872477|FG005|Overall Study|Adverse Event|1|||
164410153|NCT03682705|593872472|FG000|Overall Study|Withdrawal by Subject|1|||
164410154|NCT03682705|593872473|FG001|Overall Study|Withdrawal by Subject|3|||
164410155|NCT03682705|593872474|FG002|Overall Study|Withdrawal by Subject|2|||
164410156|NCT03682705|593872475|FG003|Overall Study|Withdrawal by Subject|4|||
164410157|NCT03682705|593872476|FG004|Overall Study|Withdrawal by Subject|0|||
164410158|NCT03682705|593872477|FG005|Overall Study|Withdrawal by Subject|1|||
164410159|NCT03682705|593872472|FG000|Overall Study|Other, not specified|0|||
164410160|NCT03682705|593872473|FG001|Overall Study|Other, not specified|0|||
164410161|NCT03682705|593872474|FG002|Overall Study|Other, not specified|0|||
164410162|NCT03682705|593872475|FG003|Overall Study|Other, not specified|1|||
164410163|NCT03682705|593872476|FG004|Overall Study|Other, not specified|2|||
164410164|NCT03682705|593872477|FG005|Overall Study|Other, not specified|0|||
164410165|NCT03682705|593872472|FG000|Overall Study|Lost to Follow-up|0|||
164410166|NCT03682705|593872473|FG001|Overall Study|Lost to Follow-up|0|||
164410167|NCT03682705|593872474|FG002|Overall Study|Lost to Follow-up|0|||
164410168|NCT03682705|593872475|FG003|Overall Study|Lost to Follow-up|0|||
164410169|NCT03682705|593872476|FG004|Overall Study|Lost to Follow-up|3|||
164462939|NCT01129102|594068542|FG001|Overall Study|Pregnancy|0|||
164462940|NCT01129102|594068543|FG002|Overall Study|Pregnancy|1|||
164410170|NCT03682705|593872477|FG005|Overall Study|Lost to Follow-up|0|||
164410171|NCT00094328|593872480|FG000|Overall Study|Lost to Follow-up|1|||
164410172|NCT00117156|593872481|FG000|Overall Study|Adverse Event|9|||
164410173|NCT00117156|593872481|FG000|Overall Study|Physician Decision|1|||
164410174|NCT00117156|593872481|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
164410175|NCT02213328|593872482|FG000|Overall Study|Withdrawal by Subject|10|||
164410176|NCT02213328|593872482|FG000|Overall Study|Physician Decision|2|||
164410177|NCT02213328|593872482|FG000|Overall Study|Lost to Follow-up|16|||
164410178|NCT04043962|593872483|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
164410179|NCT04043962|593872483|FG000|Post-Treatment|Withdrawal by Subject|5|||
164410180|NCT04043962|593872483|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
164410181|NCT01654601|593872484|FG000|1st Administration|Withdrawal by Subject|2|||
164410182|NCT01654601|593872485|FG001|1st Administration|Withdrawal by Subject|0|||
164410183|NCT01654601|593872484|FG000|1st Administration|Protocol Violation|0|||
164410184|NCT01654601|593872485|FG001|1st Administration|Protocol Violation|2|||
164410185|NCT01654601|593872484|FG000|2nd Administration|Adverse Event|1|||
164410186|NCT01654601|593872485|FG001|2nd Administration|Adverse Event|0|||
164410187|NCT01654601|593872484|FG000|2nd Administration|Protocol Violation|0|||
164410188|NCT01654601|593872485|FG001|2nd Administration|Protocol Violation|1|||
164410189|NCT02636270|593872486|FG000|Overall Study|Adverse Event|1|||
164410190|NCT02636270|593872487|FG001|Overall Study|Adverse Event|0|||
164410191|NCT02636270|593872488|FG002|Overall Study|Adverse Event|0|||
164410192|NCT02636270|593872486|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
164410193|NCT02636270|593872487|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
164410194|NCT02636270|593872488|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
164410195|NCT00386308|593875091|FG000|Overall Study|Adverse Event|3|||
164410196|NCT00386308|593875092|FG001|Overall Study|Adverse Event|3|||
164410197|NCT00386308|593875091|FG000|Overall Study|Protocol Violation|2|||
164410198|NCT00386308|593875092|FG001|Overall Study|Protocol Violation|5|||
164410199|NCT00386308|593875091|FG000|Overall Study|Lack of Efficacy|0|||
164410200|NCT00386308|593875092|FG001|Overall Study|Lack of Efficacy|2|||
164410201|NCT00386308|593875091|FG000|Overall Study|Lost to Follow-up|10|||
164410202|NCT00386308|593875092|FG001|Overall Study|Lost to Follow-up|6|||
164410203|NCT00386308|593875091|FG000|Overall Study|Withdrawal by Subject|6|||
164410204|NCT00386308|593875092|FG001|Overall Study|Withdrawal by Subject|2|||
164410205|NCT00386308|593875091|FG000|Overall Study|Other Event|8|||
164410206|NCT00386308|593875092|FG001|Overall Study|Other Event|1|||
164410207|NCT01167179|593875093|FG000|Overall Study|disease recurrence|4|||
164410208|NCT01167179|593875094|FG001|Overall Study|disease recurrence|4|||
164410209|NCT01167179|593875093|FG000|Overall Study|Death|4|||
164410210|NCT01167179|593875094|FG001|Overall Study|Death|10|||
164410211|NCT01167179|593875093|FG000|Overall Study|Withdrawal by Subject|1|||
164410212|NCT01167179|593875094|FG001|Overall Study|Withdrawal by Subject|2|||
164410213|NCT01167179|593875093|FG000|Overall Study|diverse|6|||
164410214|NCT01167179|593875094|FG001|Overall Study|diverse|5|||
164410215|NCT02769065|593875095|FG000|Overall Study|Voluntary Withdrawal|1|||
164410216|NCT02769065|593875096|FG001|Overall Study|Voluntary Withdrawal|0|||
164410217|NCT02769065|593875097|FG002|Overall Study|Voluntary Withdrawal|0|||
164410218|NCT02769065|593875098|FG003|Overall Study|Voluntary Withdrawal|0|||
164410219|NCT02769065|593875099|FG004|Overall Study|Voluntary Withdrawal|0|||
164410220|NCT02769065|593875100|FG005|Overall Study|Voluntary Withdrawal|0|||
164410221|NCT02769065|593875101|FG006|Overall Study|Voluntary Withdrawal|0|||
164410222|NCT02769065|593875102|FG007|Overall Study|Voluntary Withdrawal|0|||
164410223|NCT02769065|593875103|FG008|Overall Study|Voluntary Withdrawal|0|||
164410224|NCT02769065|593875104|FG009|Overall Study|Voluntary Withdrawal|0|||
164410225|NCT02769065|593875105|FG010|Overall Study|Voluntary Withdrawal|0|||
164410226|NCT02769065|593875106|FG011|Overall Study|Voluntary Withdrawal|0|||
164410227|NCT02769065|593875107|FG012|Overall Study|Voluntary Withdrawal|0|||
164410228|NCT02769065|593875108|FG013|Overall Study|Voluntary Withdrawal|0|||
164410229|NCT02769065|593875109|FG014|Overall Study|Voluntary Withdrawal|0|||
164410230|NCT02769065|593875110|FG015|Overall Study|Voluntary Withdrawal|0|||
164410231|NCT02769065|593875111|FG016|Overall Study|Voluntary Withdrawal|0|||
164410232|NCT02769065|593875112|FG017|Overall Study|Voluntary Withdrawal|0|||
164410233|NCT02769065|593875113|FG018|Overall Study|Voluntary Withdrawal|0|||
164410234|NCT02769065|593875114|FG019|Overall Study|Voluntary Withdrawal|0|||
164410235|NCT02769065|593875115|FG020|Overall Study|Voluntary Withdrawal|0|||
164410236|NCT02769065|593875116|FG021|Overall Study|Voluntary Withdrawal|0|||
164410237|NCT02769065|593875117|FG022|Overall Study|Voluntary Withdrawal|0|||
164410238|NCT02769065|593875118|FG023|Overall Study|Voluntary Withdrawal|0|||
164410239|NCT02769065|593875119|FG024|Overall Study|Voluntary Withdrawal|0|||
164410240|NCT02769065|593875120|FG025|Overall Study|Voluntary Withdrawal|0|||
164410241|NCT02769065|593875121|FG026|Overall Study|Voluntary Withdrawal|0|||
164410242|NCT02769065|593875122|FG027|Overall Study|Voluntary Withdrawal|0|||
164410243|NCT02769065|593875123|FG028|Overall Study|Voluntary Withdrawal|0|||
164410244|NCT02769065|593875124|FG029|Overall Study|Voluntary Withdrawal|0|||
164410245|NCT02769065|593875095|FG000|Overall Study|Reason Not Specified|0|||
164410246|NCT02769065|593875096|FG001|Overall Study|Reason Not Specified|0|||
164410247|NCT02769065|593875097|FG002|Overall Study|Reason Not Specified|0|||
164410248|NCT02769065|593875098|FG003|Overall Study|Reason Not Specified|0|||
164410249|NCT02769065|593875099|FG004|Overall Study|Reason Not Specified|0|||
164410250|NCT02769065|593875100|FG005|Overall Study|Reason Not Specified|0|||
164410251|NCT02769065|593875101|FG006|Overall Study|Reason Not Specified|1|||
164410252|NCT02769065|593875102|FG007|Overall Study|Reason Not Specified|0|||
164410253|NCT02769065|593875103|FG008|Overall Study|Reason Not Specified|0|||
164410254|NCT02769065|593875104|FG009|Overall Study|Reason Not Specified|0|||
164410255|NCT02769065|593875105|FG010|Overall Study|Reason Not Specified|0|||
164410256|NCT02769065|593875106|FG011|Overall Study|Reason Not Specified|0|||
164410257|NCT02769065|593875107|FG012|Overall Study|Reason Not Specified|0|||
164410258|NCT02769065|593875108|FG013|Overall Study|Reason Not Specified|0|||
164410259|NCT02769065|593875109|FG014|Overall Study|Reason Not Specified|0|||
164410260|NCT02769065|593875110|FG015|Overall Study|Reason Not Specified|0|||
164410261|NCT02769065|593875111|FG016|Overall Study|Reason Not Specified|0|||
164410262|NCT02769065|593875112|FG017|Overall Study|Reason Not Specified|0|||
164410263|NCT02769065|593875113|FG018|Overall Study|Reason Not Specified|0|||
164410264|NCT02769065|593875114|FG019|Overall Study|Reason Not Specified|0|||
164410265|NCT02769065|593875115|FG020|Overall Study|Reason Not Specified|0|||
164410266|NCT02769065|593875116|FG021|Overall Study|Reason Not Specified|0|||
164410267|NCT02769065|593875117|FG022|Overall Study|Reason Not Specified|0|||
164410268|NCT02769065|593875118|FG023|Overall Study|Reason Not Specified|0|||
164410269|NCT02769065|593875119|FG024|Overall Study|Reason Not Specified|0|||
164410270|NCT02769065|593875120|FG025|Overall Study|Reason Not Specified|0|||
164410271|NCT02769065|593875121|FG026|Overall Study|Reason Not Specified|0|||
164410272|NCT02769065|593875122|FG027|Overall Study|Reason Not Specified|0|||
164410273|NCT02769065|593875123|FG028|Overall Study|Reason Not Specified|0|||
164410274|NCT02769065|593875124|FG029|Overall Study|Reason Not Specified|0|||
164410275|NCT02769065|593875095|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410276|NCT02769065|593875096|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410277|NCT02769065|593875097|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410278|NCT02769065|593875098|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410279|NCT02769065|593875099|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410280|NCT02769065|593875100|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410281|NCT02769065|593875101|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410282|NCT02769065|593875102|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410283|NCT02769065|593875103|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410284|NCT02769065|593875104|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410285|NCT02769065|593875105|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
164410286|NCT02769065|593875106|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410287|NCT02769065|593875107|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410288|NCT02769065|593875108|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410289|NCT02769065|593875109|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410290|NCT02769065|593875110|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410291|NCT02769065|593875111|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410292|NCT02769065|593875112|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410293|NCT02769065|593875113|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410294|NCT02769065|593875114|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410295|NCT02769065|593875115|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410296|NCT02769065|593875116|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410297|NCT02769065|593875117|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410298|NCT02769065|593875118|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410299|NCT02769065|593875119|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410300|NCT02769065|593875120|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410301|NCT02769065|593875121|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410302|NCT02769065|593875122|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410303|NCT02769065|593875123|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410304|NCT02769065|593875124|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
164410305|NCT03017235|593875125|FG000|Overall Study|Withdrawal by Subject|4|||
164410306|NCT03017235|593875126|FG001|Overall Study|Withdrawal by Subject|3|||
164410307|NCT03017235|593875125|FG000|Overall Study|Lost to Follow-up|2|||
164410308|NCT03017235|593875126|FG001|Overall Study|Lost to Follow-up|7|||
164708086|NCT00390221|594955417|FG002|Overall Study|Adverse Event|3|||
164708087|NCT00390221|594955415|FG000|Overall Study|Investigator Decision|0|||
164410309|NCT03017235|593875125|FG000|Overall Study|Adverse Event|0|||
164410310|NCT03017235|593875126|FG001|Overall Study|Adverse Event|1|||
164410311|NCT03017235|593875125|FG000|Overall Study|Protocol Violation|2|||
164410312|NCT03017235|593875126|FG001|Overall Study|Protocol Violation|1|||
164410313|NCT03017235|593875125|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
164410314|NCT03017235|593875126|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
164599203|NCT01576016|594554790|FG000|Lead Safety|Lost to Follow-up|13|||
164599204|NCT01576016|594554791|FG001|Lead Safety|Lost to Follow-up|0|||
164599205|NCT01576016|594554790|FG000|Lead Safety|Unsuccessful implant|2|||
164599206|NCT01576016|594554791|FG001|Lead Safety|Unsuccessful implant|0|||
164599207|NCT01576016|594554790|FG000|Lead Safety|Sponsor request|1|||
164599208|NCT01576016|594554791|FG001|Lead Safety|Sponsor request|0|||
164599209|NCT01576016|594554790|FG000|Lead Safety|Device replaced with CRT-D|1|||
164599210|NCT01576016|594554791|FG001|Lead Safety|Device replaced with CRT-D|0|||
164599211|NCT01576016|594554790|FG000|Lead Safety|Patient on Palliative Care|1|||
164708088|NCT00390221|594955416|FG001|Overall Study|Investigator Decision|0|||
164599212|NCT01576016|594554791|FG001|Lead Safety|Patient on Palliative Care|0|||
164410315|NCT03518658|593875127|FG000|Overall Study|Other|51|||
164410316|NCT03518658|593875128|FG001|Overall Study|Other|0|||
164410317|NCT00649389|593875129|FG000|Overall Study|Adverse Event|22|||
164410318|NCT00649389|593875130|FG001|Overall Study|Adverse Event|46|||
164410319|NCT00649389|593875131|FG002|Overall Study|Adverse Event|38|||
164410320|NCT00649389|593875132|FG003|Overall Study|Adverse Event|48|||
164410321|NCT00649389|593875129|FG000|Overall Study|Lost to Follow-up|15|||
164410322|NCT00649389|593875130|FG001|Overall Study|Lost to Follow-up|17|||
164410323|NCT00649389|593875131|FG002|Overall Study|Lost to Follow-up|21|||
164410324|NCT00649389|593875132|FG003|Overall Study|Lost to Follow-up|26|||
164410325|NCT00649389|593875129|FG000|Overall Study|Protocol Violation|11|||
164410326|NCT00649389|593875130|FG001|Overall Study|Protocol Violation|13|||
164410327|NCT00649389|593875131|FG002|Overall Study|Protocol Violation|9|||
164410328|NCT00649389|593875132|FG003|Overall Study|Protocol Violation|8|||
164410329|NCT00649389|593875129|FG000|Overall Study|Withdrawal by Subject|20|||
164410330|NCT00649389|593875130|FG001|Overall Study|Withdrawal by Subject|21|||
164410331|NCT00649389|593875131|FG002|Overall Study|Withdrawal by Subject|19|||
164410332|NCT00649389|593875132|FG003|Overall Study|Withdrawal by Subject|23|||
164410333|NCT00649389|593875129|FG000|Overall Study|Other|3|||
164410334|NCT00649389|593875130|FG001|Overall Study|Other|9|||
164410335|NCT00649389|593875131|FG002|Overall Study|Other|1|||
164410336|NCT00649389|593875132|FG003|Overall Study|Other|6|||
164410337|NCT02746575|593875135|FG000|Overall Study|Surgery cancelled or time chaned|13|||
164410338|NCT02746575|593875135|FG000|Overall Study|Received epidural|10|||
164410339|NCT02746575|593875135|FG000|Overall Study|Withdrawal by Subject|3|||
164410340|NCT02746575|593875135|FG000|Overall Study|Bradycardia/hypotension|9|||
164410341|NCT02746575|593875135|FG000|Overall Study|Study paused|8|||
164410342|NCT02746575|593875135|FG000|Overall Study|put on beta-blocker|3|||
164410343|NCT02746575|593875135|FG000|Overall Study|type of surgery|1|||
164410344|NCT02746575|593875135|FG000|Overall Study|typ of surgery|1|||
164410345|NCT02746575|593875135|FG000|Overall Study|PI unavailable|1|||
164410346|NCT02746575|593875135|FG000|Overall Study|Unknown history of CVA|1|||
164410347|NCT00768430|593875141|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
164410348|NCT00768430|593875142|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
164410349|NCT00432835|593875145|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
164410350|NCT00432835|593875146|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
164410351|NCT04887948|593875152|FG000|Overall Study|Death|1|||
164410352|NCT04887948|593875153|FG001|Overall Study|Death|0|||
164410353|NCT04887948|593875154|FG002|Overall Study|Death|0|||
164410354|NCT04887948|593875152|FG000|Overall Study|Lost to Follow-up|1|||
164410355|NCT04887948|593875153|FG001|Overall Study|Lost to Follow-up|0|||
164410356|NCT04887948|593875154|FG002|Overall Study|Lost to Follow-up|3|||
164410357|NCT04887948|593875152|FG000|Overall Study|Physician Decision|0|||
164410358|NCT04887948|593875153|FG001|Overall Study|Physician Decision|4|||
164410359|NCT04887948|593875154|FG002|Overall Study|Physician Decision|1|||
164410360|NCT04887948|593875152|FG000|Overall Study|Protocol Violation|1|||
164410361|NCT04887948|593875153|FG001|Overall Study|Protocol Violation|1|||
164410362|NCT04887948|593875154|FG002|Overall Study|Protocol Violation|0|||
164410363|NCT04887948|593875152|FG000|Overall Study|Withdrawal by Subject|0|||
164410364|NCT04887948|593875153|FG001|Overall Study|Withdrawal by Subject|6|||
164410365|NCT04887948|593875154|FG002|Overall Study|Withdrawal by Subject|1|||
164410366|NCT04887948|593875152|FG000|Overall Study|No longer met eligibility criteria|1|||
164410367|NCT04887948|593875153|FG001|Overall Study|No longer met eligibility criteria|2|||
164410368|NCT04887948|593875154|FG002|Overall Study|No longer met eligibility criteria|1|||
164410369|NCT04887948|593875152|FG000|Overall Study|Other|2|||
164410370|NCT04887948|593875153|FG001|Overall Study|Other|1|||
164410371|NCT04887948|593875154|FG002|Overall Study|Other|1|||
164410372|NCT02312856|593875155|FG000|Overall Study|Death|1|||
164462941|NCT01129102|594068541|FG000|Overall Study|Adverse Event|2|||
164599213|NCT01576016|594554790|FG000|Lead Safety|Patient noncompliance|1|||
164599214|NCT01576016|594554791|FG001|Lead Safety|Patient noncompliance|0|||
164599215|NCT01576016|594554790|FG000|Lead Safety|Too far from study site|1|||
164599216|NCT01576016|594554791|FG001|Lead Safety|Too far from study site|0|||
164599217|NCT01576016|594554790|FG000|Lead Safety|System deactivated|1|||
164599218|NCT01576016|594554791|FG001|Lead Safety|System deactivated|0|||
164599219|NCT01576016|594554790|FG000|Lead Safety|Patient no longer followed by study PI|1|||
164599220|NCT01576016|594554791|FG001|Lead Safety|Patient no longer followed by study PI|0|||
164599221|NCT01576016|594554790|FG000|MRI Safety|Withdrawal by Subject|0|||
164599222|NCT01576016|594554791|FG001|MRI Safety|Withdrawal by Subject|10|||
164599223|NCT01576016|594554790|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
164599224|NCT01576016|594554791|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
164599225|NCT01576016|594554790|FG000|MRI Safety|Has not yet completed MRI scan|0|||
164599226|NCT01576016|594554791|FG001|MRI Safety|Has not yet completed MRI scan|56|||
164599227|NCT01576016|594554790|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
164599228|NCT01576016|594554791|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
164410373|NCT02312856|593875155|FG000|Overall Study|Lost to Follow-up|3|||
164410374|NCT04415151|593875156|FG000|Overall Study|Death|1|||
164410375|NCT04415151|593875157|FG001|Overall Study|Death|1|||
164410376|NCT04415151|593875156|FG000|Overall Study|Withdrawal by Subject|1|||
164410377|NCT04415151|593875157|FG001|Overall Study|Withdrawal by Subject|0|||
164410378|NCT00638235|593875158|FG000|Overall Study|Lost to Follow-up|31|||
164410379|NCT00638235|593875159|FG001|Overall Study|Lost to Follow-up|3|||
164410380|NCT00638235|593875160|FG002|Overall Study|Lost to Follow-up|18|||
164410381|NCT00638235|593875161|FG003|Overall Study|Lost to Follow-up|10|||
164410382|NCT00638235|593875162|FG004|Overall Study|Lost to Follow-up|13|||
164410383|NCT00638235|593875163|FG005|Overall Study|Lost to Follow-up|26|||
164410384|NCT00638235|593875164|FG006|Overall Study|Lost to Follow-up|0|||
164410385|NCT00638235|593875165|FG007|Overall Study|Lost to Follow-up|1|||
164410386|NCT00638235|593875166|FG008|Overall Study|Lost to Follow-up|18|||
164410387|NCT01588990|593875167|FG000|Phase A|Withdrawal by Subject|5|||
164410388|NCT01588990|593875167|FG000|Phase A|Physician Decision|11|||
164410389|NCT01588990|593875167|FG000|Phase A|Other|14|||
164410390|NCT01588990|593875167|FG000|Phase A|Lost to Follow-up|1|||
164410391|NCT01588990|593875167|FG000|Phase A|Death|5|||
164410392|NCT01588990|593875167|FG000|Phase A|Adverse Event|28|||
164410393|NCT01588990|593875167|FG000|Phase A|Still on therapy at end of study|6|||
164410394|NCT01588990|593875167|FG000|Phase B|Adverse Event|2|||
164410395|NCT01588990|593875167|FG000|Phase B|Still on therapy at end of study|5|||
164410396|NCT01588990|593875167|FG000|Phase B|Withdrawal by Subject|3|||
164410397|NCT01588990|593875167|FG000|Phase B|Physician Decision|4|||
164410398|NCT01588990|593875167|FG000|Phase B|Other|2|||
164410399|NCT02367716|593875170|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
164410400|NCT01473381|593875171|FG000|Overall Study|Adverse Event|8|||
164410401|NCT01473381|593875172|FG001|Overall Study|Adverse Event|20|||
164410402|NCT01473381|593875173|FG002|Overall Study|Adverse Event|25|||
164410403|NCT01473381|593875174|FG003|Overall Study|Adverse Event|17|||
164410404|NCT01473381|593875171|FG000|Overall Study|Insufficient Therapeutic Response|10|||
164410405|NCT01473381|593875172|FG001|Overall Study|Insufficient Therapeutic Response|1|||
164410406|NCT01473381|593875173|FG002|Overall Study|Insufficient Therapeutic Response|2|||
164410407|NCT01473381|593875174|FG003|Overall Study|Insufficient Therapeutic Response|3|||
164410408|NCT01473381|593875171|FG000|Overall Study|Protocol Violation|17|||
164410409|NCT01473381|593875172|FG001|Overall Study|Protocol Violation|23|||
164410410|NCT01473381|593875173|FG002|Overall Study|Protocol Violation|19|||
164410411|NCT01473381|593875174|FG003|Overall Study|Protocol Violation|17|||
164410412|NCT01473381|593875171|FG000|Overall Study|Withdrawal of Consent|20|||
164410413|NCT01473381|593875172|FG001|Overall Study|Withdrawal of Consent|21|||
164410414|NCT01473381|593875173|FG002|Overall Study|Withdrawal of Consent|20|||
164410415|NCT01473381|593875174|FG003|Overall Study|Withdrawal of Consent|26|||
164410416|NCT01473381|593875171|FG000|Overall Study|Lost to Follow-up|25|||
164410417|NCT01473381|593875172|FG001|Overall Study|Lost to Follow-up|28|||
164410418|NCT01473381|593875173|FG002|Overall Study|Lost to Follow-up|35|||
164410419|NCT01473381|593875174|FG003|Overall Study|Lost to Follow-up|23|||
164410420|NCT01473381|593875171|FG000|Overall Study|Other Reasons|0|||
164599229|NCT03654755|594554794|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
164599230|NCT03654755|594554795|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
164599231|NCT03654755|594554796|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
164599232|NCT03654755|594554794|FG000|Overall Study|Withdrawal by Subject|2|||
164599233|NCT03654755|594554795|FG001|Overall Study|Withdrawal by Subject|4|||
164599234|NCT03654755|594554796|FG002|Overall Study|Withdrawal by Subject|8|||
164599235|NCT03654755|594554794|FG000|Overall Study|Lost to Follow-up|1|||
164599236|NCT03654755|594554795|FG001|Overall Study|Lost to Follow-up|3|||
164599237|NCT03654755|594554796|FG002|Overall Study|Lost to Follow-up|7|||
164599238|NCT03654755|594554794|FG000|Overall Study|Physician Decision|0|||
164599239|NCT03654755|594554795|FG001|Overall Study|Physician Decision|1|||
164599240|NCT03654755|594554796|FG002|Overall Study|Physician Decision|0|||
164599241|NCT03654755|594554794|FG000|Overall Study|Adverse Event|0|||
164599242|NCT03654755|594554795|FG001|Overall Study|Adverse Event|0|||
164599243|NCT03654755|594554796|FG002|Overall Study|Adverse Event|4|||
164410421|NCT01473381|593875172|FG001|Overall Study|Other Reasons|0|||
164410422|NCT01473381|593875173|FG002|Overall Study|Other Reasons|1|||
164410423|NCT01473381|593875174|FG003|Overall Study|Other Reasons|3|||
164599244|NCT03654755|594554794|FG000|Overall Study|Lack of Efficacy|0|||
164599245|NCT03654755|594554795|FG001|Overall Study|Lack of Efficacy|0|||
164410424|NCT00539643|593875175|FG000|Overall Study|Adverse Event|1|||
164410425|NCT00539643|593875176|FG001|Overall Study|Adverse Event|0|||
164410426|NCT00539643|593875175|FG000|Overall Study|Death|2|||
164599246|NCT03654755|594554796|FG002|Overall Study|Lack of Efficacy|1|||
164599247|NCT01952730|594554801|FG000|Overall Study|FDA shut down core lab used by study|1|||
164599248|NCT01514188|594554808|FG000|Overall Study|Adverse Event|3|||
164599249|NCT01514188|594554809|FG001|Overall Study|Adverse Event|5|||
164410427|NCT00539643|593875176|FG001|Overall Study|Death|1|||
164410428|NCT00539643|593875175|FG000|Overall Study|Physician Decision|3|||
164410429|NCT00539643|593875176|FG001|Overall Study|Physician Decision|1|||
164410430|NCT00539643|593875175|FG000|Overall Study|Withdrawal by Subject|0|||
164410431|NCT00539643|593875176|FG001|Overall Study|Withdrawal by Subject|1|||
164410432|NCT02508532|593875179|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
164462942|NCT01129102|594068542|FG001|Overall Study|Adverse Event|2|||
164410433|NCT02508532|593875180|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
164410434|NCT02508532|593875181|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
164410435|NCT02508532|593875182|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
164410436|NCT02508532|593875183|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
164410437|NCT02508532|593875184|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
164410438|NCT02508532|593875185|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
164410439|NCT02508532|593875186|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
164410440|NCT02508532|593875187|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
164410441|NCT02508532|593875179|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
164410442|NCT02508532|593875180|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
164410443|NCT02508532|593875181|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
164410444|NCT02508532|593875182|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
164410445|NCT02508532|593875183|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
164410446|NCT02508532|593875184|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
164410447|NCT02508532|593875185|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
164410448|NCT02508532|593875186|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
164410449|NCT02508532|593875187|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
164410450|NCT02508532|593875179|FG000|Part 2 - Treatment|Disease Progression|0|||
164410451|NCT02508532|593875180|FG001|Part 2 - Treatment|Disease Progression|0|||
164410452|NCT02508532|593875181|FG002|Part 2 - Treatment|Disease Progression|0|||
164410453|NCT02508532|593875182|FG003|Part 2 - Treatment|Disease Progression|0|||
164410454|NCT02508532|593875183|FG004|Part 2 - Treatment|Disease Progression|0|||
164410455|NCT02508532|593875184|FG005|Part 2 - Treatment|Disease Progression|0|||
164599250|NCT01514188|594554808|FG000|Overall Study|Withdrawal by Subject|2|||
164410456|NCT02508532|593875185|FG006|Part 2 - Treatment|Disease Progression|0|||
164410457|NCT02508532|593875186|FG007|Part 2 - Treatment|Disease Progression|0|||
164410458|NCT02508532|593875187|FG008|Part 2 - Treatment|Disease Progression|118|||
164410459|NCT02508532|593875179|FG000|Part 2 - Treatment|Adverse Event|0|||
164410460|NCT02508532|593875180|FG001|Part 2 - Treatment|Adverse Event|0|||
164410461|NCT02508532|593875181|FG002|Part 2 - Treatment|Adverse Event|0|||
164410462|NCT02508532|593875182|FG003|Part 2 - Treatment|Adverse Event|0|||
164410463|NCT02508532|593875183|FG004|Part 2 - Treatment|Adverse Event|0|||
164462943|NCT01129102|594068543|FG002|Overall Study|Adverse Event|1|||
164599251|NCT01514188|594554809|FG001|Overall Study|Withdrawal by Subject|4|||
164599252|NCT01514188|594554808|FG000|Overall Study|Protocol Violation|2|||
164599253|NCT01514188|594554809|FG001|Overall Study|Protocol Violation|4|||
164599254|NCT01514188|594554808|FG000|Overall Study|Physician Decision|0|||
164599255|NCT01514188|594554809|FG001|Overall Study|Physician Decision|2|||
164599256|NCT01514188|594554808|FG000|Overall Study|Disease Progression|13|||
164599257|NCT01514188|594554809|FG001|Overall Study|Disease Progression|14|||
164599258|NCT01514188|594554808|FG000|Overall Study|Death|1|||
164599259|NCT01514188|594554809|FG001|Overall Study|Death|3|||
164599260|NCT01514188|594554808|FG000|Overall Study|Other|2|||
164599261|NCT01514188|594554809|FG001|Overall Study|Other|1|||
164599262|NCT03442829|594554812|FG000|Overall Study|Scheduling clash|3|||
164599263|NCT03442829|594554813|FG001|Overall Study|Scheduling clash|1|||
164599264|NCT03442829|594554812|FG000|Overall Study|Illness unrelated to study|1|||
164599265|NCT03442829|594554813|FG001|Overall Study|Illness unrelated to study|1|||
164599266|NCT01486784|594554814|FG000|Overall Study|Withdrawal by Subject|0|||
164599267|NCT01486784|594554815|FG001|Overall Study|Withdrawal by Subject|0|||
164599268|NCT01486784|594554816|FG002|Overall Study|Withdrawal by Subject|1|||
164599269|NCT01486784|594554817|FG003|Overall Study|Withdrawal by Subject|0|||
164599270|NCT01486784|594554818|FG004|Overall Study|Withdrawal by Subject|1|||
164599271|NCT01486784|594554819|FG005|Overall Study|Withdrawal by Subject|2|||
164599272|NCT01486784|594554814|FG000|Overall Study|Subject did not meet entry criteria|0|||
164599273|NCT01486784|594554815|FG001|Overall Study|Subject did not meet entry criteria|0|||
164599274|NCT01486784|594554816|FG002|Overall Study|Subject did not meet entry criteria|0|||
164599275|NCT01486784|594554817|FG003|Overall Study|Subject did not meet entry criteria|0|||
164599276|NCT01486784|594554818|FG004|Overall Study|Subject did not meet entry criteria|1|||
164599277|NCT01486784|594554819|FG005|Overall Study|Subject did not meet entry criteria|0|||
164599278|NCT01486784|594554814|FG000|Overall Study|Death|0|||
164599279|NCT01486784|594554815|FG001|Overall Study|Death|0|||
164599280|NCT01486784|594554816|FG002|Overall Study|Death|0|||
164599281|NCT01486784|594554817|FG003|Overall Study|Death|0|||
164599282|NCT01486784|594554818|FG004|Overall Study|Death|0|||
164599283|NCT01486784|594554819|FG005|Overall Study|Death|1|||
164599284|NCT02605447|594554822|FG000|Overall Study|Death|66|||
164599285|NCT02605447|594554822|FG000|Overall Study|Physician Decision|1|||
164599286|NCT02605447|594554822|FG000|Overall Study|Lost to Follow-up|24|||
164599287|NCT02605447|594554822|FG000|Overall Study|Withdrawal by Subject|10|||
164599288|NCT02605447|594554822|FG000|Overall Study|Not disclosed|1|||
164599289|NCT02237157|594554823|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
164599290|NCT02237157|594554824|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
164599291|NCT02237157|594554825|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
164599292|NCT02237157|594554826|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
164599293|NCT02237157|594554823|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
164599294|NCT02237157|594554824|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
164599295|NCT02237157|594554825|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
164599296|NCT02237157|594554826|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
164599297|NCT04533815|594554828|FG000|Overall Study|Adverse Event|2|||
164599298|NCT04533815|594554828|FG000|Overall Study|Site withdrew|5|||
164410464|NCT02508532|593875184|FG005|Part 2 - Treatment|Adverse Event|0|||
164410465|NCT02508532|593875185|FG006|Part 2 - Treatment|Adverse Event|0|||
164410466|NCT02508532|593875186|FG007|Part 2 - Treatment|Adverse Event|0|||
164410467|NCT02508532|593875187|FG008|Part 2 - Treatment|Adverse Event|49|||
164410468|NCT02508532|593875179|FG000|Part 2 - Treatment|Physician Decision|0|||
164410469|NCT02508532|593875180|FG001|Part 2 - Treatment|Physician Decision|0|||
164410470|NCT02508532|593875181|FG002|Part 2 - Treatment|Physician Decision|0|||
164410471|NCT02508532|593875182|FG003|Part 2 - Treatment|Physician Decision|0|||
164410472|NCT02508532|593875183|FG004|Part 2 - Treatment|Physician Decision|0|||
164410473|NCT02508532|593875184|FG005|Part 2 - Treatment|Physician Decision|0|||
164410474|NCT02508532|593875185|FG006|Part 2 - Treatment|Physician Decision|0|||
164410475|NCT02508532|593875186|FG007|Part 2 - Treatment|Physician Decision|0|||
164410476|NCT02508532|593875187|FG008|Part 2 - Treatment|Physician Decision|12|||
164410477|NCT02508532|593875179|FG000|Part 2 - Treatment|Administrative|0|||
164410478|NCT02508532|593875180|FG001|Part 2 - Treatment|Administrative|0|||
164410479|NCT02508532|593875181|FG002|Part 2 - Treatment|Administrative|0|||
164410480|NCT02508532|593875182|FG003|Part 2 - Treatment|Administrative|0|||
164410481|NCT02508532|593875183|FG004|Part 2 - Treatment|Administrative|0|||
164410482|NCT02508532|593875184|FG005|Part 2 - Treatment|Administrative|0|||
164410483|NCT02508532|593875185|FG006|Part 2 - Treatment|Administrative|0|||
164410484|NCT02508532|593875186|FG007|Part 2 - Treatment|Administrative|0|||
164410485|NCT02508532|593875187|FG008|Part 2 - Treatment|Administrative|3|||
164410486|NCT02508532|593875179|FG000|Part 2 - Treatment|Sponsor Decision|0|||
164410487|NCT02508532|593875180|FG001|Part 2 - Treatment|Sponsor Decision|0|||
164410488|NCT02508532|593875181|FG002|Part 2 - Treatment|Sponsor Decision|0|||
164410489|NCT02508532|593875182|FG003|Part 2 - Treatment|Sponsor Decision|0|||
164410490|NCT02508532|593875183|FG004|Part 2 - Treatment|Sponsor Decision|0|||
164410491|NCT02508532|593875184|FG005|Part 2 - Treatment|Sponsor Decision|0|||
164410492|NCT02508532|593875185|FG006|Part 2 - Treatment|Sponsor Decision|0|||
164410493|NCT02508532|593875186|FG007|Part 2 - Treatment|Sponsor Decision|0|||
164410494|NCT02508532|593875187|FG008|Part 2 - Treatment|Sponsor Decision|28|||
164410495|NCT02508532|593875179|FG000|Part 2 - Treatment|Death|0|||
164410496|NCT02508532|593875180|FG001|Part 2 - Treatment|Death|0|||
164410497|NCT02508532|593875181|FG002|Part 2 - Treatment|Death|0|||
164410498|NCT02508532|593875182|FG003|Part 2 - Treatment|Death|0|||
164410499|NCT02508532|593875183|FG004|Part 2 - Treatment|Death|0|||
164410500|NCT02508532|593875184|FG005|Part 2 - Treatment|Death|0|||
164410501|NCT02508532|593875185|FG006|Part 2 - Treatment|Death|0|||
164410502|NCT02508532|593875186|FG007|Part 2 - Treatment|Death|0|||
164410503|NCT02508532|593875187|FG008|Part 2 - Treatment|Death|1|||
164410504|NCT02508532|593875179|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
164410505|NCT02508532|593875180|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
164410506|NCT02508532|593875181|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
164410507|NCT02508532|593875182|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
164410508|NCT02508532|593875183|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
164410509|NCT02508532|593875184|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
164410510|NCT02508532|593875185|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
164410511|NCT02508532|593875186|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
164410512|NCT02508532|593875187|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
164599299|NCT00488592|594554829|FG000|Overall Study|Withdrawal by Subject|1|||
164599300|NCT00488592|594554829|FG000|Overall Study|Disease progression|1|||
164599301|NCT00488592|594554829|FG000|Overall Study|Enrolled but not treated|1|||
164599302|NCT00441103|594554830|FG000|Overall Study|Adverse Event|2|||
164708089|NCT00390221|594955417|FG002|Overall Study|Investigator Decision|1|||
164708090|NCT00390221|594955415|FG000|Overall Study|Withdrawal by Subject|13|||
164708091|NCT00390221|594955416|FG001|Overall Study|Withdrawal by Subject|9|||
164410513|NCT02508532|593875179|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
164410514|NCT02508532|593875180|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
164410515|NCT02508532|593875181|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
164410516|NCT02508532|593875182|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
164410517|NCT02508532|593875183|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
164410518|NCT02508532|593875184|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
164410519|NCT02508532|593875185|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
164410520|NCT02508532|593875186|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
164410521|NCT02508532|593875187|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
164599303|NCT00441103|594554831|FG001|Overall Study|Adverse Event|1|||
164708092|NCT00390221|594955417|FG002|Overall Study|Withdrawal by Subject|7|||
164708093|NCT00390221|594955415|FG000|Overall Study|Subject Non-compliance|1|||
164410522|NCT02508532|593875179|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
164410523|NCT02508532|593875180|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
164410524|NCT02508532|593875181|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
164410525|NCT02508532|593875182|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
164410526|NCT02508532|593875183|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
164410527|NCT02508532|593875184|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
164410528|NCT02508532|593875185|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
164410529|NCT02508532|593875186|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
164410530|NCT02508532|593875187|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
164410531|NCT02508532|593875179|FG000|Part 1 and Part 2 End of Study|Death|0|||
164410532|NCT02508532|593875180|FG001|Part 1 and Part 2 End of Study|Death|4|||
164410533|NCT02508532|593875181|FG002|Part 1 and Part 2 End of Study|Death|2|||
164410534|NCT02508532|593875182|FG003|Part 1 and Part 2 End of Study|Death|4|||
164410535|NCT02508532|593875183|FG004|Part 1 and Part 2 End of Study|Death|3|||
164410536|NCT02508532|593875184|FG005|Part 1 and Part 2 End of Study|Death|0|||
164410537|NCT02508532|593875185|FG006|Part 1 and Part 2 End of Study|Death|0|||
164410538|NCT02508532|593875186|FG007|Part 1 and Part 2 End of Study|Death|1|||
164410539|NCT02508532|593875187|FG008|Part 1 and Part 2 End of Study|Death|111|||
164410540|NCT02508532|593875179|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
164410541|NCT02508532|593875180|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
164410542|NCT02508532|593875181|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
164462944|NCT01129102|594068541|FG000|Overall Study|Lost to Follow-up|2|||
164462945|NCT01129102|594068542|FG001|Overall Study|Lost to Follow-up|0|||
164462946|NCT01129102|594068543|FG002|Overall Study|Lost to Follow-up|0|||
164708094|NCT00390221|594955416|FG001|Overall Study|Subject Non-compliance|0|||
164708095|NCT00390221|594955417|FG002|Overall Study|Subject Non-compliance|2|||
164708096|NCT00390221|594955415|FG000|Overall Study|Other|3|||
164708097|NCT00390221|594955416|FG001|Overall Study|Other|4|||
164708098|NCT00390221|594955417|FG002|Overall Study|Other|2|||
164708099|NCT02011386|594955422|FG000|Overall Study|Non-compliance|2|||
164708100|NCT02011386|594955422|FG000|Overall Study|Lack of Efficacy|3|||
164708101|NCT04555720|594955423|FG000|Overall Study|Lost to Follow-up|2|||
164708102|NCT04555720|594955424|FG001|Overall Study|Lost to Follow-up|0|||
164708103|NCT04555720|594955425|FG002|Overall Study|Lost to Follow-up|0|||
164708104|NCT04555720|594955426|FG003|Overall Study|Lost to Follow-up|0|||
164708105|NCT04555720|594955423|FG000|Overall Study|Withdrawal by Subject|4|||
164708106|NCT04555720|594955424|FG001|Overall Study|Withdrawal by Subject|6|||
164708107|NCT04555720|594955425|FG002|Overall Study|Withdrawal by Subject|0|||
164708108|NCT04555720|594955426|FG003|Overall Study|Withdrawal by Subject|0|||
164708109|NCT00633243|594958149|FG000|Overall Study|Withdrawal by Subject|0|||
164708110|NCT00633243|594958150|FG001|Overall Study|Withdrawal by Subject|1|||
164708111|NCT00633243|594958149|FG000|Overall Study|incarceration|0|||
164708112|NCT00633243|594958150|FG001|Overall Study|incarceration|2|||
164708113|NCT00633243|594958149|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
164708114|NCT00633243|594958150|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
164708115|NCT00633243|594958149|FG000|Overall Study|Not comfortable with self-injecting|0|||
164708116|NCT00633243|594958150|FG001|Overall Study|Not comfortable with self-injecting|1|||
164708117|NCT00633243|594958149|FG000|Overall Study|Mental Health--Depression|0|||
164708118|NCT00633243|594958150|FG001|Overall Study|Mental Health--Depression|1|||
164708119|NCT00633243|594958149|FG000|Overall Study|Couldn't tolerate side-effects|1|||
164708120|NCT00633243|594958150|FG001|Overall Study|Couldn't tolerate side-effects|1|||
164708121|NCT02799095|594958151|FG000|Part A|Adverse Event|1|||
164708122|NCT02799095|594958152|FG001|Part A|Adverse Event|0|||
164708123|NCT02799095|594958153|FG002|Part A|Adverse Event|1|||
164708124|NCT02799095|594958154|FG003|Part A|Adverse Event|4|||
164708125|NCT02799095|594958155|FG004|Part A|Adverse Event|1|||
164708126|NCT02799095|594958156|FG005|Part A|Adverse Event|0|||
164708127|NCT02799095|594958157|FG006|Part A|Adverse Event|0|||
164708128|NCT02799095|594958158|FG007|Part A|Adverse Event|0|||
164708129|NCT02799095|594958159|FG008|Part A|Adverse Event|0|||
164708130|NCT02799095|594958160|FG009|Part A|Adverse Event|0|||
164708131|NCT02799095|594958161|FG010|Part A|Adverse Event|0|||
164708132|NCT02799095|594958162|FG011|Part A|Adverse Event|0|||
164708133|NCT02799095|594958163|FG012|Part A|Adverse Event|0|||
164410543|NCT02508532|593875182|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
164410544|NCT02508532|593875183|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
164462947|NCT05256017|594068546|FG000|Treatment Period|Withdrawal by Subject|1|||
164708134|NCT02799095|594958164|FG013|Part A|Adverse Event|0|||
164708135|NCT02799095|594958165|FG014|Part A|Adverse Event|0|||
164708136|NCT02799095|594958166|FG015|Part A|Adverse Event|0|||
164708137|NCT02799095|594958167|FG016|Part A|Adverse Event|0|||
164708138|NCT02799095|594958151|FG000|Part A|Death|0|||
164708139|NCT02799095|594958152|FG001|Part A|Death|0|||
164708140|NCT02799095|594958153|FG002|Part A|Death|0|||
164708141|NCT02799095|594958154|FG003|Part A|Death|0|||
164708142|NCT02799095|594958155|FG004|Part A|Death|0|||
164708143|NCT02799095|594958156|FG005|Part A|Death|0|||
164708144|NCT02799095|594958157|FG006|Part A|Death|3|||
164410545|NCT02508532|593875184|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
164410546|NCT02508532|593875185|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
164410547|NCT02508532|593875186|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
164410548|NCT02508532|593875187|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
164410549|NCT02508532|593875179|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
164410550|NCT02508532|593875180|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
164410551|NCT02508532|593875181|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
164410552|NCT02508532|593875182|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
164410553|NCT02508532|593875183|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
164410554|NCT02508532|593875184|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
164410555|NCT02508532|593875185|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
164410556|NCT02508532|593875186|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
164410557|NCT02508532|593875187|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
164410558|NCT02508532|593875179|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
164410559|NCT02508532|593875180|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
164410560|NCT02508532|593875181|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
164410561|NCT02508532|593875182|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
164410562|NCT02508532|593875183|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
164410563|NCT02508532|593875184|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
164410564|NCT02508532|593875185|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
164410565|NCT02508532|593875186|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
164410566|NCT02508532|593875187|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
164410567|NCT02508532|593875179|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
164410568|NCT02508532|593875180|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
164410569|NCT02508532|593875181|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
164410570|NCT02508532|593875182|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
164410571|NCT02508532|593875183|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
164410572|NCT02508532|593875184|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
164410573|NCT02508532|593875185|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
164410574|NCT02508532|593875186|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
164410575|NCT02508532|593875187|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
164410576|NCT02508532|593875179|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
164410577|NCT02508532|593875180|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
164410578|NCT02508532|593875181|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
164410579|NCT02508532|593875182|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
164410580|NCT02508532|593875183|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
164410581|NCT02508532|593875184|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
164410582|NCT02508532|593875185|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
164410583|NCT02508532|593875186|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
164410584|NCT02508532|593875187|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
164410585|NCT01641926|593875188|FG000|Overall Study|Adverse Event|5|||
164410586|NCT01641926|593875189|FG001|Overall Study|Adverse Event|2|||
164410587|NCT01641926|593875190|FG002|Overall Study|Adverse Event|3|||
164410588|NCT01641926|593875191|FG003|Overall Study|Adverse Event|1|||
164410589|NCT01641926|593875188|FG000|Overall Study|Lost to Follow-up|2|||
164410590|NCT01641926|593875189|FG001|Overall Study|Lost to Follow-up|2|||
164410591|NCT01641926|593875190|FG002|Overall Study|Lost to Follow-up|1|||
164410592|NCT01641926|593875191|FG003|Overall Study|Lost to Follow-up|0|||
164410593|NCT01641926|593875188|FG000|Overall Study|Physician Decision|6|||
164410594|NCT01641926|593875189|FG001|Overall Study|Physician Decision|5|||
164410595|NCT01641926|593875190|FG002|Overall Study|Physician Decision|0|||
164410596|NCT01641926|593875191|FG003|Overall Study|Physician Decision|1|||
164410597|NCT01641926|593875188|FG000|Overall Study|Protocol Violation|1|||
164410598|NCT01641926|593875189|FG001|Overall Study|Protocol Violation|0|||
164410599|NCT01641926|593875190|FG002|Overall Study|Protocol Violation|0|||
164410600|NCT01641926|593875191|FG003|Overall Study|Protocol Violation|1|||
164410601|NCT01641926|593875188|FG000|Overall Study|Withdrawal by Subject|13|||
164410602|NCT01641926|593875189|FG001|Overall Study|Withdrawal by Subject|5|||
164410603|NCT01641926|593875190|FG002|Overall Study|Withdrawal by Subject|6|||
164410604|NCT01641926|593875191|FG003|Overall Study|Withdrawal by Subject|1|||
164410605|NCT01641926|593875188|FG000|Overall Study|Not Treated|1|||
164410606|NCT01641926|593875189|FG001|Overall Study|Not Treated|1|||
164410607|NCT01641926|593875190|FG002|Overall Study|Not Treated|1|||
164410608|NCT01641926|593875191|FG003|Overall Study|Not Treated|0|||
164410609|NCT01111838|593875192|FG000|Overall Study|Patient Ineligible|2|||
164410610|NCT01111838|593875192|FG000|Overall Study|Not Treated|3|||
164410611|NCT01111838|593875192|FG000|Overall Study|Clinical deterioration|1|||
164410612|NCT01111838|593875192|FG000|Overall Study|Other Complicating Disease|1|||
164410613|NCT04399356|593875193|FG000|Overall Study|Lost to Follow-up|1|||
164410614|NCT04399356|593875194|FG001|Overall Study|Lost to Follow-up|1|||
164410615|NCT04399356|593875193|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
164410616|NCT04399356|593875194|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
164410617|NCT04399356|593875193|FG000|Overall Study|Withdrawal by Subject|1|||
164410618|NCT04399356|593875194|FG001|Overall Study|Withdrawal by Subject|0|||
164410619|NCT00098254|593875197|FG000|Overall Study|Adverse Event|2|||
164410620|NCT00098254|593875197|FG000|Overall Study|Death|1|||
164410621|NCT02118337|593875198|FG000|Overall Study|Other|1|||
164410622|NCT02118337|593875199|FG001|Overall Study|Other|0|||
164410623|NCT02118337|593875200|FG002|Overall Study|Other|0|||
164410624|NCT02118337|593875201|FG003|Overall Study|Other|0|||
164410625|NCT02118337|593875202|FG004|Overall Study|Other|2|||
164410626|NCT02118337|593875203|FG005|Overall Study|Other|3|||
164410627|NCT02118337|593875204|FG006|Overall Study|Other|1|||
164462948|NCT05256017|594068547|FG001|Treatment Period|Withdrawal by Subject|1|||
164462949|NCT05256017|594068546|FG000|Follow-up|Lost to Follow-up|7|||
164462950|NCT05256017|594068547|FG001|Follow-up|Lost to Follow-up|1|||
164410628|NCT02118337|593875205|FG007|Overall Study|Other|28|||
164462951|NCT05256017|594068546|FG000|Follow-up|Withdrawal by Subject|1|||
164462952|NCT05256017|594068547|FG001|Follow-up|Withdrawal by Subject|0|||
164410629|NCT02118337|593875206|FG008|Overall Study|Other|15|||
164410630|NCT02118337|593875198|FG000|Overall Study|Lost to Follow-up|0|||
164462953|NCT05256017|594068546|FG000|Follow-up|Death|0|||
164410631|NCT02118337|593875199|FG001|Overall Study|Lost to Follow-up|0|||
164410632|NCT02118337|593875200|FG002|Overall Study|Lost to Follow-up|0|||
164410633|NCT02118337|593875201|FG003|Overall Study|Lost to Follow-up|0|||
164410634|NCT02118337|593875202|FG004|Overall Study|Lost to Follow-up|0|||
164410635|NCT02118337|593875203|FG005|Overall Study|Lost to Follow-up|0|||
164410636|NCT02118337|593875204|FG006|Overall Study|Lost to Follow-up|0|||
164410637|NCT02118337|593875205|FG007|Overall Study|Lost to Follow-up|1|||
164410638|NCT02118337|593875206|FG008|Overall Study|Lost to Follow-up|0|||
164410639|NCT02118337|593875198|FG000|Overall Study|Withdrawal by Subject|1|||
164410640|NCT02118337|593875199|FG001|Overall Study|Withdrawal by Subject|3|||
164410641|NCT02118337|593875200|FG002|Overall Study|Withdrawal by Subject|2|||
164410642|NCT02118337|593875201|FG003|Overall Study|Withdrawal by Subject|1|||
164410643|NCT02118337|593875202|FG004|Overall Study|Withdrawal by Subject|2|||
164410644|NCT02118337|593875203|FG005|Overall Study|Withdrawal by Subject|2|||
164410645|NCT02118337|593875204|FG006|Overall Study|Withdrawal by Subject|1|||
164410646|NCT02118337|593875205|FG007|Overall Study|Withdrawal by Subject|4|||
164410647|NCT02118337|593875206|FG008|Overall Study|Withdrawal by Subject|2|||
164410648|NCT02118337|593875198|FG000|Overall Study|Death|2|||
164410649|NCT02118337|593875199|FG001|Overall Study|Death|2|||
164410650|NCT02118337|593875200|FG002|Overall Study|Death|1|||
164410651|NCT02118337|593875201|FG003|Overall Study|Death|2|||
164410652|NCT02118337|593875202|FG004|Overall Study|Death|5|||
164410653|NCT02118337|593875203|FG005|Overall Study|Death|1|||
164410654|NCT02118337|593875204|FG006|Overall Study|Death|2|||
164410655|NCT02118337|593875205|FG007|Overall Study|Death|9|||
164410656|NCT02118337|593875206|FG008|Overall Study|Death|4|||
164410657|NCT00130793|593875208|FG000|Overall Study|Lost to Follow-up|1|||
164410658|NCT00130793|593875209|FG001|Overall Study|Lost to Follow-up|4|||
164410659|NCT00130793|593875208|FG000|Overall Study|Withdrew consent|2|||
164410660|NCT00130793|593875209|FG001|Overall Study|Withdrew consent|0|||
164410661|NCT00211237|593875210|FG000|Baseline|Withdrew|1|||
164410662|NCT00211237|593875211|FG001|Baseline|Withdrew|3|||
164410663|NCT00211237|593875212|FG002|Baseline|Withdrew|0|||
164410664|NCT00211237|593875210|FG000|Baseline|Refused random assignment|1|||
164410665|NCT00211237|593875211|FG001|Baseline|Refused random assignment|0|||
164410666|NCT00211237|593875212|FG002|Baseline|Refused random assignment|0|||
164410667|NCT00211237|593875210|FG000|1 Month|Death|2|||
164410668|NCT00211237|593875211|FG001|1 Month|Death|1|||
164410669|NCT00211237|593875212|FG002|1 Month|Death|0|||
164410670|NCT00211237|593875210|FG000|1 Month|Lost to Follow-up|0|||
164410671|NCT00211237|593875211|FG001|1 Month|Lost to Follow-up|2|||
164410672|NCT00211237|593875212|FG002|1 Month|Lost to Follow-up|0|||
164410673|NCT00211237|593875210|FG000|1 Month|Withdrew|0|||
164410674|NCT00211237|593875211|FG001|1 Month|Withdrew|4|||
164410675|NCT00211237|593875212|FG002|1 Month|Withdrew|0|||
164410676|NCT00211237|593875210|FG000|1 Month|Additional surgery needed|1|||
164410677|NCT00211237|593875211|FG001|1 Month|Additional surgery needed|0|||
164410678|NCT00211237|593875212|FG002|1 Month|Additional surgery needed|0|||
164410679|NCT00211237|593875210|FG000|1 Month|Non-medical problem|0|||
164410680|NCT00211237|593875211|FG001|1 Month|Non-medical problem|2|||
164410681|NCT00211237|593875212|FG002|1 Month|Non-medical problem|0|||
164410682|NCT00211237|593875210|FG000|3 Months|Death|7|||
164410683|NCT00211237|593875211|FG001|3 Months|Death|3|||
164410684|NCT00211237|593875212|FG002|3 Months|Death|0|||
164410685|NCT00211237|593875210|FG000|3 Months|Could not comply with protocol|1|||
164410686|NCT00211237|593875211|FG001|3 Months|Could not comply with protocol|0|||
164410687|NCT00211237|593875212|FG002|3 Months|Could not comply with protocol|0|||
164410688|NCT00211237|593875210|FG000|3 Months|Withdrew|0|||
164410689|NCT00211237|593875211|FG001|3 Months|Withdrew|1|||
164410690|NCT00211237|593875212|FG002|3 Months|Withdrew|0|||
164410691|NCT00211237|593875210|FG000|3 Months|Non-medical problem|0|||
164410692|NCT00211237|593875211|FG001|3 Months|Non-medical problem|0|||
164410693|NCT00211237|593875212|FG002|3 Months|Non-medical problem|1|||
164410694|NCT00211237|593875210|FG000|6 Months|Death|6|||
164410695|NCT00211237|593875211|FG001|6 Months|Death|0|||
164410696|NCT00211237|593875212|FG002|6 Months|Death|3|||
164410697|NCT00211237|593875210|FG000|6 Months|Lost to Follow-up|2|||
164410698|NCT00211237|593875211|FG001|6 Months|Lost to Follow-up|0|||
164410699|NCT00211237|593875212|FG002|6 Months|Lost to Follow-up|0|||
164410700|NCT00211237|593875210|FG000|6 Months|Could not comply with protocol|0|||
164410701|NCT00211237|593875211|FG001|6 Months|Could not comply with protocol|2|||
164410702|NCT00211237|593875212|FG002|6 Months|Could not comply with protocol|0|||
164410703|NCT00211237|593875210|FG000|12 Months|Death|8|||
164410704|NCT00211237|593875211|FG001|12 Months|Death|2|||
164410705|NCT00211237|593875212|FG002|12 Months|Death|3|||
164410706|NCT00211237|593875210|FG000|12 Months|Lost to Follow-up|1|||
164410707|NCT00211237|593875211|FG001|12 Months|Lost to Follow-up|0|||
164410708|NCT00211237|593875212|FG002|12 Months|Lost to Follow-up|1|||
164410709|NCT00211237|593875210|FG000|12 Months|Withdrew|0|||
164410710|NCT00211237|593875211|FG001|12 Months|Withdrew|0|||
164410711|NCT00211237|593875212|FG002|12 Months|Withdrew|1|||
164410712|NCT00211237|593875210|FG000|12 Months|unrelated medical problem|0|||
164410713|NCT00211237|593875211|FG001|12 Months|unrelated medical problem|0|||
164410714|NCT00211237|593875212|FG002|12 Months|unrelated medical problem|1|||
164599304|NCT00441103|594554830|FG000|Overall Study|Death|1|||
164599305|NCT00441103|594554831|FG001|Overall Study|Death|0|||
164599306|NCT00441103|594554830|FG000|Overall Study|Disease Progression|2|||
164599307|NCT00441103|594554831|FG001|Overall Study|Disease Progression|0|||
164599308|NCT00441103|594554830|FG000|Overall Study|Lost to Follow-up|1|||
164599309|NCT00441103|594554831|FG001|Overall Study|Lost to Follow-up|0|||
164599310|NCT00441103|594554830|FG000|Overall Study|Protocol Violation|1|||
164599311|NCT00441103|594554831|FG001|Overall Study|Protocol Violation|0|||
164599312|NCT00441103|594554830|FG000|Overall Study|Participant unable to use Rebiject II|1|||
164599313|NCT00441103|594554831|FG001|Overall Study|Participant unable to use Rebiject II|0|||
164599314|NCT00441103|594554830|FG000|Overall Study|Participant refused MRI|1|||
164599315|NCT00441103|594554831|FG001|Overall Study|Participant refused MRI|0|||
164599316|NCT00441103|594554830|FG000|Overall Study|Inclusion criteria absent|1|||
164599317|NCT00441103|594554831|FG001|Overall Study|Inclusion criteria absent|0|||
164599318|NCT00441103|594554830|FG000|Overall Study|Non-compliant|0|||
164599319|NCT00441103|594554831|FG001|Overall Study|Non-compliant|1|||
164599320|NCT00441103|594554830|FG000|Overall Study|Participant decided to withdraw|1|||
164599321|NCT00441103|594554831|FG001|Overall Study|Participant decided to withdraw|0|||
164599322|NCT00441103|594554830|FG000|Overall Study|Participant's reason|0|||
164599323|NCT00441103|594554831|FG001|Overall Study|Participant's reason|1|||
164599324|NCT00441103|594554830|FG000|Overall Study|Participant decided to stop|0|||
164599325|NCT00441103|594554831|FG001|Overall Study|Participant decided to stop|1|||
164599326|NCT00243230|594554833|FG000|Double-Blind Period|Adverse Event|0|||
164599327|NCT00243230|594554834|FG001|Double-Blind Period|Adverse Event|2|||
164599328|NCT00243230|594554835|FG002|Double-Blind Period|Adverse Event|2|||
164599329|NCT00243230|594554836|FG003|Double-Blind Period|Adverse Event|0|||
164599330|NCT00243230|594554833|FG000|Double-Blind Period|Withdrawal by Subject|1|||
164599331|NCT00243230|594554834|FG001|Double-Blind Period|Withdrawal by Subject|0|||
164599332|NCT00243230|594554835|FG002|Double-Blind Period|Withdrawal by Subject|0|||
164599333|NCT00243230|594554836|FG003|Double-Blind Period|Withdrawal by Subject|0|||
164599334|NCT00243230|594554833|FG000|Double-Blind Period|Protocol Violation|0|||
164599335|NCT00243230|594554834|FG001|Double-Blind Period|Protocol Violation|0|||
164599336|NCT00243230|594554835|FG002|Double-Blind Period|Protocol Violation|1|||
164708145|NCT02799095|594958158|FG007|Part A|Death|0|||
164708146|NCT02799095|594958159|FG008|Part A|Death|0|||
164708147|NCT02799095|594958160|FG009|Part A|Death|0|||
164708148|NCT02799095|594958161|FG010|Part A|Death|0|||
164708149|NCT02799095|594958162|FG011|Part A|Death|0|||
164708150|NCT02799095|594958163|FG012|Part A|Death|0|||
164462954|NCT05256017|594068547|FG001|Follow-up|Death|1|||
164462955|NCT05082025|594068550|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
164462956|NCT03854227|594068552|FG000|Overall Study|Adverse Event|0|||
164462957|NCT03854227|594068553|FG001|Overall Study|Adverse Event|0|||
164462958|NCT03854227|594068554|FG002|Overall Study|Adverse Event|0|||
164462959|NCT03854227|594068555|FG003|Overall Study|Adverse Event|1|||
164462960|NCT03854227|594068556|FG004|Overall Study|Adverse Event|0|||
164462961|NCT03854227|594068557|FG005|Overall Study|Adverse Event|0|||
164462962|NCT03854227|594068558|FG006|Overall Study|Adverse Event|1|||
164462963|NCT03854227|594068559|FG007|Overall Study|Adverse Event|0|||
164462964|NCT03854227|594068560|FG008|Overall Study|Adverse Event|0|||
164462965|NCT03854227|594068561|FG009|Overall Study|Adverse Event|3|||
164462966|NCT03854227|594068562|FG010|Overall Study|Adverse Event|0|||
164462967|NCT03854227|594068563|FG011|Overall Study|Adverse Event|1|||
164599337|NCT00243230|594554836|FG003|Double-Blind Period|Protocol Violation|0|||
164708151|NCT02799095|594958164|FG013|Part A|Death|0|||
164708152|NCT02799095|594958165|FG014|Part A|Death|0|||
164708153|NCT02799095|594958166|FG015|Part A|Death|0|||
164708154|NCT02799095|594958167|FG016|Part A|Death|0|||
164708155|NCT02799095|594958151|FG000|Part A|Lost to Follow-up|0|||
164708156|NCT02799095|594958152|FG001|Part A|Lost to Follow-up|1|||
164708157|NCT02799095|594958153|FG002|Part A|Lost to Follow-up|0|||
164708158|NCT02799095|594958154|FG003|Part A|Lost to Follow-up|0|||
164599338|NCT00243230|594554833|FG000|Double-Blind Period|Randomized but Not Treated|0|||
164599339|NCT00243230|594554834|FG001|Double-Blind Period|Randomized but Not Treated|0|||
164708159|NCT02799095|594958155|FG004|Part A|Lost to Follow-up|0|||
164708160|NCT02799095|594958156|FG005|Part A|Lost to Follow-up|0|||
164708161|NCT02799095|594958157|FG006|Part A|Lost to Follow-up|1|||
164599340|NCT00243230|594554835|FG002|Double-Blind Period|Randomized but Not Treated|2|||
164599341|NCT00243230|594554836|FG003|Double-Blind Period|Randomized but Not Treated|0|||
164599342|NCT00243230|594554833|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
164708162|NCT02799095|594958158|FG007|Part A|Lost to Follow-up|0|||
164462968|NCT03854227|594068552|FG000|Overall Study|Death|0|||
164462969|NCT03854227|594068553|FG001|Overall Study|Death|0|||
164462970|NCT03854227|594068554|FG002|Overall Study|Death|0|||
164462971|NCT03854227|594068555|FG003|Overall Study|Death|0|||
164462972|NCT03854227|594068556|FG004|Overall Study|Death|0|||
164708163|NCT02799095|594958159|FG008|Part A|Lost to Follow-up|0|||
164708164|NCT02799095|594958160|FG009|Part A|Lost to Follow-up|0|||
164708165|NCT02799095|594958161|FG010|Part A|Lost to Follow-up|0|||
164708166|NCT02799095|594958162|FG011|Part A|Lost to Follow-up|0|||
164708167|NCT02799095|594958163|FG012|Part A|Lost to Follow-up|0|||
164708168|NCT02799095|594958164|FG013|Part A|Lost to Follow-up|0|||
164708169|NCT02799095|594958165|FG014|Part A|Lost to Follow-up|0|||
164708170|NCT02799095|594958166|FG015|Part A|Lost to Follow-up|0|||
164708171|NCT02799095|594958167|FG016|Part A|Lost to Follow-up|0|||
164708172|NCT02799095|594958151|FG000|Part A|Progressive Disease|3|||
164708173|NCT02799095|594958152|FG001|Part A|Progressive Disease|3|||
164708174|NCT02799095|594958153|FG002|Part A|Progressive Disease|3|||
164708175|NCT02799095|594958154|FG003|Part A|Progressive Disease|2|||
164708176|NCT02799095|594958155|FG004|Part A|Progressive Disease|2|||
164708177|NCT02799095|594958156|FG005|Part A|Progressive Disease|0|||
164708178|NCT02799095|594958157|FG006|Part A|Progressive Disease|0|||
164708179|NCT02799095|594958158|FG007|Part A|Progressive Disease|0|||
164708180|NCT02799095|594958159|FG008|Part A|Progressive Disease|0|||
164708181|NCT02799095|594958160|FG009|Part A|Progressive Disease|0|||
164708182|NCT02799095|594958161|FG010|Part A|Progressive Disease|0|||
164708183|NCT02799095|594958162|FG011|Part A|Progressive Disease|0|||
164708184|NCT02799095|594958163|FG012|Part A|Progressive Disease|0|||
164708185|NCT02799095|594958164|FG013|Part A|Progressive Disease|0|||
164708186|NCT02799095|594958165|FG014|Part A|Progressive Disease|0|||
164708187|NCT02799095|594958166|FG015|Part A|Progressive Disease|0|||
164708188|NCT02799095|594958167|FG016|Part A|Progressive Disease|0|||
164708189|NCT02799095|594958151|FG000|Part A|Clinical Progression|1|||
164708190|NCT02799095|594958152|FG001|Part A|Clinical Progression|0|||
164708191|NCT02799095|594958153|FG002|Part A|Clinical Progression|2|||
164708192|NCT02799095|594958154|FG003|Part A|Clinical Progression|1|||
164708193|NCT02799095|594958155|FG004|Part A|Clinical Progression|5|||
164708194|NCT02799095|594958156|FG005|Part A|Clinical Progression|0|||
164708195|NCT02799095|594958157|FG006|Part A|Clinical Progression|0|||
164708196|NCT02799095|594958158|FG007|Part A|Clinical Progression|0|||
164708197|NCT02799095|594958159|FG008|Part A|Clinical Progression|0|||
164708198|NCT02799095|594958160|FG009|Part A|Clinical Progression|0|||
164708199|NCT02799095|594958161|FG010|Part A|Clinical Progression|0|||
164708200|NCT02799095|594958162|FG011|Part A|Clinical Progression|0|||
164708201|NCT02799095|594958163|FG012|Part A|Clinical Progression|0|||
164708202|NCT02799095|594958164|FG013|Part A|Clinical Progression|0|||
164708203|NCT02799095|594958165|FG014|Part A|Clinical Progression|0|||
164708204|NCT02799095|594958166|FG015|Part A|Clinical Progression|0|||
164708205|NCT02799095|594958167|FG016|Part A|Clinical Progression|0|||
164708206|NCT02799095|594958151|FG000|Part A|Protocol Deviation|0|||
164708207|NCT02799095|594958152|FG001|Part A|Protocol Deviation|0|||
164708208|NCT02799095|594958153|FG002|Part A|Protocol Deviation|1|||
164708209|NCT02799095|594958154|FG003|Part A|Protocol Deviation|0|||
164708210|NCT02799095|594958155|FG004|Part A|Protocol Deviation|0|||
164708211|NCT02799095|594958156|FG005|Part A|Protocol Deviation|0|||
164708212|NCT02799095|594958157|FG006|Part A|Protocol Deviation|0|||
164708213|NCT02799095|594958158|FG007|Part A|Protocol Deviation|0|||
164708214|NCT02799095|594958159|FG008|Part A|Protocol Deviation|0|||
164708215|NCT02799095|594958160|FG009|Part A|Protocol Deviation|0|||
164708216|NCT02799095|594958161|FG010|Part A|Protocol Deviation|0|||
164708217|NCT02799095|594958162|FG011|Part A|Protocol Deviation|0|||
164708218|NCT02799095|594958163|FG012|Part A|Protocol Deviation|0|||
164708219|NCT02799095|594958164|FG013|Part A|Protocol Deviation|0|||
164708220|NCT02799095|594958165|FG014|Part A|Protocol Deviation|0|||
164708221|NCT02799095|594958166|FG015|Part A|Protocol Deviation|0|||
164462973|NCT03854227|594068557|FG005|Overall Study|Death|1|||
164462974|NCT03854227|594068558|FG006|Overall Study|Death|0|||
164708222|NCT02799095|594958167|FG016|Part A|Protocol Deviation|0|||
164708223|NCT02799095|594958151|FG000|Part A|Withdrawal by Subject|0|||
164708224|NCT02799095|594958152|FG001|Part A|Withdrawal by Subject|0|||
164462975|NCT03854227|594068559|FG007|Overall Study|Death|0|||
164462976|NCT03854227|594068560|FG008|Overall Study|Death|0|||
164462977|NCT03854227|594068561|FG009|Overall Study|Death|1|||
164462978|NCT03854227|594068562|FG010|Overall Study|Death|0|||
164708225|NCT02799095|594958153|FG002|Part A|Withdrawal by Subject|0|||
164708226|NCT02799095|594958154|FG003|Part A|Withdrawal by Subject|1|||
164708227|NCT02799095|594958155|FG004|Part A|Withdrawal by Subject|3|||
164708228|NCT02799095|594958156|FG005|Part A|Withdrawal by Subject|1|||
164708229|NCT02799095|594958157|FG006|Part A|Withdrawal by Subject|1|||
164708230|NCT02799095|594958158|FG007|Part A|Withdrawal by Subject|0|||
164708231|NCT02799095|594958159|FG008|Part A|Withdrawal by Subject|0|||
164462979|NCT03854227|594068563|FG011|Overall Study|Death|1|||
164462980|NCT03854227|594068552|FG000|Overall Study|Physician Decision|0|||
164708232|NCT02799095|594958160|FG009|Part A|Withdrawal by Subject|0|||
164708233|NCT02799095|594958161|FG010|Part A|Withdrawal by Subject|0|||
164708234|NCT02799095|594958162|FG011|Part A|Withdrawal by Subject|0|||
164708235|NCT02799095|594958163|FG012|Part A|Withdrawal by Subject|0|||
164708236|NCT02799095|594958164|FG013|Part A|Withdrawal by Subject|0|||
164708237|NCT02799095|594958165|FG014|Part A|Withdrawal by Subject|0|||
164708238|NCT02799095|594958166|FG015|Part A|Withdrawal by Subject|0|||
164708239|NCT02799095|594958167|FG016|Part A|Withdrawal by Subject|0|||
164708240|NCT02799095|594958151|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
164708241|NCT02799095|594958152|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
164462981|NCT03854227|594068553|FG001|Overall Study|Physician Decision|0|||
164462982|NCT03854227|594068554|FG002|Overall Study|Physician Decision|0|||
164462983|NCT03854227|594068555|FG003|Overall Study|Physician Decision|0|||
164462984|NCT03854227|594068556|FG004|Overall Study|Physician Decision|0|||
164462985|NCT03854227|594068557|FG005|Overall Study|Physician Decision|1|||
164462986|NCT03854227|594068558|FG006|Overall Study|Physician Decision|0|||
164462987|NCT03854227|594068559|FG007|Overall Study|Physician Decision|0|||
164462988|NCT03854227|594068560|FG008|Overall Study|Physician Decision|1|||
164462989|NCT03854227|594068561|FG009|Overall Study|Physician Decision|1|||
164462990|NCT03854227|594068562|FG010|Overall Study|Physician Decision|0|||
164462991|NCT03854227|594068563|FG011|Overall Study|Physician Decision|1|||
164708242|NCT02799095|594958153|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
164708243|NCT02799095|594958154|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
164708244|NCT02799095|594958155|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
164708245|NCT02799095|594958156|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
164708246|NCT02799095|594958157|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
164708247|NCT02799095|594958158|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
164708248|NCT02799095|594958159|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
164708249|NCT02799095|594958160|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
164708250|NCT02799095|594958161|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
164708251|NCT02799095|594958162|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
164708252|NCT02799095|594958163|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
164708253|NCT02799095|594958164|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
164708254|NCT02799095|594958165|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
164708255|NCT02799095|594958166|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
164708256|NCT02799095|594958167|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
164708257|NCT02799095|594958151|FG000|Part B|Death|0|||
164708258|NCT02799095|594958152|FG001|Part B|Death|0|||
164708259|NCT02799095|594958153|FG002|Part B|Death|0|||
164708260|NCT02799095|594958154|FG003|Part B|Death|0|||
164708261|NCT02799095|594958155|FG004|Part B|Death|0|||
164708262|NCT02799095|594958156|FG005|Part B|Death|0|||
164708263|NCT02799095|594958157|FG006|Part B|Death|0|||
164708264|NCT02799095|594958158|FG007|Part B|Death|7|||
164708265|NCT02799095|594958159|FG008|Part B|Death|7|||
164708266|NCT02799095|594958160|FG009|Part B|Death|0|||
164708267|NCT02799095|594958161|FG010|Part B|Death|0|||
164708268|NCT02799095|594958162|FG011|Part B|Death|0|||
164708269|NCT02799095|594958163|FG012|Part B|Death|0|||
164708270|NCT02799095|594958164|FG013|Part B|Death|0|||
164708271|NCT02799095|594958165|FG014|Part B|Death|0|||
164708272|NCT02799095|594958166|FG015|Part B|Death|0|||
164708273|NCT02799095|594958167|FG016|Part B|Death|0|||
164708274|NCT02799095|594958151|FG000|Part B|Progressive Disease|0|||
164708275|NCT02799095|594958152|FG001|Part B|Progressive Disease|0|||
164708276|NCT02799095|594958153|FG002|Part B|Progressive Disease|0|||
164708277|NCT02799095|594958154|FG003|Part B|Progressive Disease|0|||
164708278|NCT02799095|594958155|FG004|Part B|Progressive Disease|0|||
164462992|NCT03854227|594068552|FG000|Overall Study|Progressive disease|1|||
164462993|NCT03854227|594068553|FG001|Overall Study|Progressive disease|1|||
164462994|NCT03854227|594068554|FG002|Overall Study|Progressive disease|1|||
164462995|NCT03854227|594068555|FG003|Overall Study|Progressive disease|2|||
164462996|NCT03854227|594068556|FG004|Overall Study|Progressive disease|3|||
164462997|NCT03854227|594068557|FG005|Overall Study|Progressive disease|1|||
164708279|NCT02799095|594958156|FG005|Part B|Progressive Disease|0|||
164708280|NCT02799095|594958157|FG006|Part B|Progressive Disease|0|||
164708281|NCT02799095|594958158|FG007|Part B|Progressive Disease|1|||
164708282|NCT02799095|594958159|FG008|Part B|Progressive Disease|0|||
164410715|NCT01003639|593875215|FG000|Overall Study|Lost to Follow-up|6|||
164410716|NCT01003639|593875216|FG001|Overall Study|Lost to Follow-up|9|||
164410717|NCT01003639|593875215|FG000|Overall Study|Withdrawal by Subject|9|||
164410718|NCT01003639|593875216|FG001|Overall Study|Withdrawal by Subject|5|||
164410719|NCT01003639|593875215|FG000|Overall Study|Lack of Efficacy|1|||
164410720|NCT01003639|593875216|FG001|Overall Study|Lack of Efficacy|6|||
164410721|NCT01003639|593875215|FG000|Overall Study|Adverse Event|0|||
164410722|NCT01003639|593875216|FG001|Overall Study|Adverse Event|1|||
164410723|NCT01003639|593875215|FG000|Overall Study|Protocol Violation|0|||
164410724|NCT01003639|593875216|FG001|Overall Study|Protocol Violation|1|||
164410725|NCT01003639|593875215|FG000|Overall Study|Physician Decision|1|||
164599343|NCT00243230|594554834|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
164599344|NCT00243230|594554835|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
164599345|NCT00243230|594554836|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
164599346|NCT00243230|594554833|FG000|Open Label Period|Adverse Event|0|||
164599347|NCT00243230|594554834|FG001|Open Label Period|Adverse Event|0|||
164599348|NCT00243230|594554835|FG002|Open Label Period|Adverse Event|0|||
164599349|NCT00243230|594554836|FG003|Open Label Period|Adverse Event|2|||
164599350|NCT00243230|594554833|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
164599351|NCT00243230|594554834|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
164599352|NCT00243230|594554835|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
164599353|NCT00243230|594554836|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
164599354|NCT00243230|594554833|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
164599355|NCT00243230|594554834|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
164599356|NCT00243230|594554835|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
164599357|NCT00243230|594554836|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
164599358|NCT00243230|594554833|FG000|Open Label Period|Lost to Follow-up|0|||
164599359|NCT00243230|594554834|FG001|Open Label Period|Lost to Follow-up|0|||
164599360|NCT00243230|594554835|FG002|Open Label Period|Lost to Follow-up|0|||
164599361|NCT00243230|594554836|FG003|Open Label Period|Lost to Follow-up|2|||
164599362|NCT00243230|594554833|FG000|Open Label Period|Withdrawal by Subject|0|||
164599363|NCT00243230|594554834|FG001|Open Label Period|Withdrawal by Subject|0|||
164599364|NCT00243230|594554835|FG002|Open Label Period|Withdrawal by Subject|0|||
164599365|NCT00243230|594554836|FG003|Open Label Period|Withdrawal by Subject|2|||
164599366|NCT00243230|594554833|FG000|Open Label Period|Protocol Violation|0|||
164599367|NCT00243230|594554834|FG001|Open Label Period|Protocol Violation|0|||
164599368|NCT00243230|594554835|FG002|Open Label Period|Protocol Violation|0|||
164708283|NCT02799095|594958160|FG009|Part B|Progressive Disease|0|||
164708284|NCT02799095|594958161|FG010|Part B|Progressive Disease|0|||
164410726|NCT01003639|593875216|FG001|Overall Study|Physician Decision|0|||
164410727|NCT02237508|593875217|FG000|Overall Study|Withdrawal by Subject|0|||
164410728|NCT02237508|593875218|FG001|Overall Study|Withdrawal by Subject|2|||
164410729|NCT02237508|593875219|FG002|Overall Study|Withdrawal by Subject|0|||
164410730|NCT02237508|593875220|FG003|Overall Study|Withdrawal by Subject|1|||
164410731|NCT02237508|593875221|FG004|Overall Study|Withdrawal by Subject|0|||
164410732|NCT02237508|593875222|FG005|Overall Study|Withdrawal by Subject|1|||
164410733|NCT02237508|593875223|FG006|Overall Study|Withdrawal by Subject|1|||
164410734|NCT02237508|593875224|FG007|Overall Study|Withdrawal by Subject|0|||
164410735|NCT02237508|593875225|FG008|Overall Study|Withdrawal by Subject|1|||
164410736|NCT02237508|593875226|FG009|Overall Study|Withdrawal by Subject|0|||
164410737|NCT02237508|593875217|FG000|Overall Study|Physician Decision|0|||
164410738|NCT02237508|593875218|FG001|Overall Study|Physician Decision|1|||
164410739|NCT02237508|593875219|FG002|Overall Study|Physician Decision|0|||
164410740|NCT02237508|593875220|FG003|Overall Study|Physician Decision|0|||
164410741|NCT02237508|593875221|FG004|Overall Study|Physician Decision|0|||
164410742|NCT02237508|593875222|FG005|Overall Study|Physician Decision|0|||
164462998|NCT03854227|594068558|FG006|Overall Study|Progressive disease|2|||
164462999|NCT03854227|594068559|FG007|Overall Study|Progressive disease|5|||
164463000|NCT03854227|594068560|FG008|Overall Study|Progressive disease|2|||
164463001|NCT03854227|594068561|FG009|Overall Study|Progressive disease|5|||
164463002|NCT03854227|594068562|FG010|Overall Study|Progressive disease|1|||
164463003|NCT03854227|594068563|FG011|Overall Study|Progressive disease|6|||
164463004|NCT03854227|594068552|FG000|Overall Study|Study terminated by sponsor|0|||
164463005|NCT03854227|594068553|FG001|Overall Study|Study terminated by sponsor|0|||
164463006|NCT03854227|594068554|FG002|Overall Study|Study terminated by sponsor|0|||
164463007|NCT03854227|594068555|FG003|Overall Study|Study terminated by sponsor|0|||
164463008|NCT03854227|594068556|FG004|Overall Study|Study terminated by sponsor|0|||
164463009|NCT03854227|594068557|FG005|Overall Study|Study terminated by sponsor|0|||
164463010|NCT03854227|594068558|FG006|Overall Study|Study terminated by sponsor|0|||
164463011|NCT03854227|594068559|FG007|Overall Study|Study terminated by sponsor|0|||
164463012|NCT03854227|594068560|FG008|Overall Study|Study terminated by sponsor|0|||
164708285|NCT02799095|594958162|FG011|Part B|Progressive Disease|0|||
164410743|NCT02237508|593875223|FG006|Overall Study|Physician Decision|0|||
164410744|NCT02237508|593875224|FG007|Overall Study|Physician Decision|0|||
164410745|NCT02237508|593875225|FG008|Overall Study|Physician Decision|0|||
164410746|NCT02237508|593875226|FG009|Overall Study|Physician Decision|0|||
164463013|NCT03854227|594068561|FG009|Overall Study|Study terminated by sponsor|1|||
164463014|NCT03854227|594068562|FG010|Overall Study|Study terminated by sponsor|0|||
164463015|NCT03854227|594068563|FG011|Overall Study|Study terminated by sponsor|0|||
164463016|NCT03854227|594068552|FG000|Overall Study|Withdrawal by Subject|0|||
164463017|NCT03854227|594068553|FG001|Overall Study|Withdrawal by Subject|0|||
164463018|NCT03854227|594068554|FG002|Overall Study|Withdrawal by Subject|1|||
164463019|NCT03854227|594068555|FG003|Overall Study|Withdrawal by Subject|0|||
164463020|NCT03854227|594068556|FG004|Overall Study|Withdrawal by Subject|0|||
164463021|NCT03854227|594068557|FG005|Overall Study|Withdrawal by Subject|0|||
164463022|NCT03854227|594068558|FG006|Overall Study|Withdrawal by Subject|0|||
164410747|NCT02237508|593875217|FG000|Overall Study|Protocol Violation|0|||
164410748|NCT02237508|593875218|FG001|Overall Study|Protocol Violation|0|||
164410749|NCT02237508|593875219|FG002|Overall Study|Protocol Violation|1|||
164410750|NCT02237508|593875220|FG003|Overall Study|Protocol Violation|0|||
164410751|NCT02237508|593875221|FG004|Overall Study|Protocol Violation|0|||
164410752|NCT02237508|593875222|FG005|Overall Study|Protocol Violation|0|||
164410753|NCT02237508|593875223|FG006|Overall Study|Protocol Violation|0|||
164410754|NCT02237508|593875224|FG007|Overall Study|Protocol Violation|0|||
164410755|NCT02237508|593875225|FG008|Overall Study|Protocol Violation|0|||
164410756|NCT02237508|593875226|FG009|Overall Study|Protocol Violation|0|||
164410757|NCT01650519|593875227|FG000|Overall Study|Withdrawal by Subject|1|||
164410758|NCT01650519|593875228|FG001|Overall Study|Withdrawal by Subject|0|||
164410759|NCT05458024|593875229|FG000|Overall Study|Withdrawal by Subject|1|||
164410760|NCT05458024|593875230|FG001|Overall Study|Withdrawal by Subject|1|||
164410761|NCT04000594|593875232|FG000|Overall Study|Withdrawal by Subject|1|||
164410762|NCT04000594|593875233|FG001|Overall Study|Withdrawal by Subject|0|||
164410763|NCT04000594|593875234|FG002|Overall Study|Withdrawal by Subject|0|||
164410764|NCT05807919|593875235|FG000|Overall Study|Received antibiotics - excluded|0|||
164410765|NCT05807919|593875236|FG001|Overall Study|Received antibiotics - excluded|1|||
164410766|NCT05807919|593875235|FG000|Overall Study|Withdrawal by Subject|0|||
164410767|NCT05807919|593875236|FG001|Overall Study|Withdrawal by Subject|3|||
164410768|NCT05807919|593875235|FG000|Overall Study|Adverse Event|1|||
164410769|NCT05807919|593875236|FG001|Overall Study|Adverse Event|1|||
164410770|NCT00747123|593875237|FG000|Overall Study|Investigator's request|0|||
164410771|NCT00747123|593875238|FG001|Overall Study|Investigator's request|0|||
164708286|NCT02799095|594958163|FG012|Part B|Progressive Disease|0|||
164708287|NCT02799095|594958164|FG013|Part B|Progressive Disease|0|||
164708288|NCT02799095|594958165|FG014|Part B|Progressive Disease|0|||
164708289|NCT02799095|594958166|FG015|Part B|Progressive Disease|0|||
164708290|NCT02799095|594958167|FG016|Part B|Progressive Disease|0|||
164708291|NCT02799095|594958151|FG000|Part B|Withdrawal by Subject|0|||
164708292|NCT02799095|594958152|FG001|Part B|Withdrawal by Subject|0|||
164708293|NCT02799095|594958153|FG002|Part B|Withdrawal by Subject|0|||
164708294|NCT02799095|594958154|FG003|Part B|Withdrawal by Subject|0|||
164708295|NCT02799095|594958155|FG004|Part B|Withdrawal by Subject|0|||
164708296|NCT02799095|594958156|FG005|Part B|Withdrawal by Subject|0|||
164708297|NCT02799095|594958157|FG006|Part B|Withdrawal by Subject|0|||
164708298|NCT02799095|594958158|FG007|Part B|Withdrawal by Subject|10|||
164708299|NCT02799095|594958159|FG008|Part B|Withdrawal by Subject|7|||
164708300|NCT02799095|594958160|FG009|Part B|Withdrawal by Subject|0|||
164708301|NCT02799095|594958161|FG010|Part B|Withdrawal by Subject|0|||
164708302|NCT02799095|594958162|FG011|Part B|Withdrawal by Subject|0|||
164708303|NCT02799095|594958163|FG012|Part B|Withdrawal by Subject|0|||
164708304|NCT02799095|594958164|FG013|Part B|Withdrawal by Subject|0|||
164708305|NCT02799095|594958165|FG014|Part B|Withdrawal by Subject|0|||
164708306|NCT02799095|594958166|FG015|Part B|Withdrawal by Subject|0|||
164708307|NCT02799095|594958167|FG016|Part B|Withdrawal by Subject|0|||
164708308|NCT02799095|594958151|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
164708309|NCT02799095|594958152|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
164708310|NCT02799095|594958153|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
164708311|NCT02799095|594958154|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
164708312|NCT02799095|594958155|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
164708313|NCT02799095|594958156|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
164708314|NCT02799095|594958157|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
164708315|NCT02799095|594958158|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
164708316|NCT02799095|594958159|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
164708317|NCT02799095|594958160|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
164708318|NCT02799095|594958161|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
164708319|NCT02799095|594958162|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
164708320|NCT02799095|594958163|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
164708321|NCT02799095|594958164|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
164708322|NCT02799095|594958165|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
164708323|NCT02799095|594958166|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
164708324|NCT02799095|594958167|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
164708325|NCT02799095|594958151|FG000|Part C|Adverse Event|0|||
164708326|NCT02799095|594958152|FG001|Part C|Adverse Event|0|||
164708327|NCT02799095|594958153|FG002|Part C|Adverse Event|0|||
164708328|NCT02799095|594958154|FG003|Part C|Adverse Event|0|||
164708329|NCT02799095|594958155|FG004|Part C|Adverse Event|0|||
164708330|NCT02799095|594958156|FG005|Part C|Adverse Event|0|||
164410772|NCT00747123|593875239|FG002|Overall Study|Investigator's request|1|||
164410773|NCT00747123|593875240|FG003|Overall Study|Investigator's request|0|||
164410774|NCT00747123|593875237|FG000|Overall Study|Withdrew consent|0|||
164708331|NCT02799095|594958157|FG006|Part C|Adverse Event|0|||
164708332|NCT02799095|594958158|FG007|Part C|Adverse Event|0|||
164708333|NCT02799095|594958159|FG008|Part C|Adverse Event|0|||
164708334|NCT02799095|594958160|FG009|Part C|Adverse Event|0|||
164708335|NCT02799095|594958161|FG010|Part C|Adverse Event|3|||
164708336|NCT02799095|594958162|FG011|Part C|Adverse Event|1|||
164708337|NCT02799095|594958163|FG012|Part C|Adverse Event|0|||
164463023|NCT03854227|594068559|FG007|Overall Study|Withdrawal by Subject|0|||
164463024|NCT03854227|594068560|FG008|Overall Study|Withdrawal by Subject|0|||
164463025|NCT03854227|594068561|FG009|Overall Study|Withdrawal by Subject|1|||
164708338|NCT02799095|594958164|FG013|Part C|Adverse Event|1|||
164708339|NCT02799095|594958165|FG014|Part C|Adverse Event|0|||
164708340|NCT02799095|594958166|FG015|Part C|Adverse Event|0|||
164708341|NCT02799095|594958167|FG016|Part C|Adverse Event|0|||
164708342|NCT02799095|594958151|FG000|Part C|Death|0|||
164708343|NCT02799095|594958152|FG001|Part C|Death|0|||
164708344|NCT02799095|594958153|FG002|Part C|Death|0|||
164708345|NCT02799095|594958154|FG003|Part C|Death|0|||
164708346|NCT02799095|594958155|FG004|Part C|Death|0|||
164708347|NCT02799095|594958156|FG005|Part C|Death|0|||
164708348|NCT02799095|594958157|FG006|Part C|Death|0|||
164708349|NCT02799095|594958158|FG007|Part C|Death|0|||
164708350|NCT02799095|594958159|FG008|Part C|Death|0|||
164708351|NCT02799095|594958160|FG009|Part C|Death|0|||
164708352|NCT02799095|594958161|FG010|Part C|Death|7|||
164708353|NCT02799095|594958162|FG011|Part C|Death|5|||
164708354|NCT02799095|594958163|FG012|Part C|Death|6|||
164708355|NCT02799095|594958164|FG013|Part C|Death|8|||
164708356|NCT02799095|594958165|FG014|Part C|Death|1|||
164708357|NCT02799095|594958166|FG015|Part C|Death|8|||
164708358|NCT02799095|594958167|FG016|Part C|Death|1|||
164708359|NCT02799095|594958151|FG000|Part C|Lost to Follow-up|0|||
164708360|NCT02799095|594958152|FG001|Part C|Lost to Follow-up|0|||
164708361|NCT02799095|594958153|FG002|Part C|Lost to Follow-up|0|||
164708362|NCT02799095|594958154|FG003|Part C|Lost to Follow-up|0|||
164708363|NCT02799095|594958155|FG004|Part C|Lost to Follow-up|0|||
164708364|NCT02799095|594958156|FG005|Part C|Lost to Follow-up|0|||
164708365|NCT02799095|594958157|FG006|Part C|Lost to Follow-up|0|||
164708366|NCT02799095|594958158|FG007|Part C|Lost to Follow-up|0|||
164708367|NCT02799095|594958159|FG008|Part C|Lost to Follow-up|0|||
164708368|NCT02799095|594958160|FG009|Part C|Lost to Follow-up|0|||
164708369|NCT02799095|594958161|FG010|Part C|Lost to Follow-up|1|||
164708370|NCT02799095|594958162|FG011|Part C|Lost to Follow-up|1|||
164708371|NCT02799095|594958163|FG012|Part C|Lost to Follow-up|1|||
164708372|NCT02799095|594958164|FG013|Part C|Lost to Follow-up|3|||
164708373|NCT02799095|594958165|FG014|Part C|Lost to Follow-up|0|||
164708374|NCT02799095|594958166|FG015|Part C|Lost to Follow-up|0|||
164708375|NCT02799095|594958167|FG016|Part C|Lost to Follow-up|0|||
164708376|NCT02799095|594958151|FG000|Part C|Progressive Disease|0|||
164708377|NCT02799095|594958152|FG001|Part C|Progressive Disease|0|||
164708378|NCT02799095|594958153|FG002|Part C|Progressive Disease|0|||
164708379|NCT02799095|594958154|FG003|Part C|Progressive Disease|0|||
164708380|NCT02799095|594958155|FG004|Part C|Progressive Disease|0|||
164708381|NCT02799095|594958156|FG005|Part C|Progressive Disease|0|||
164708382|NCT02799095|594958157|FG006|Part C|Progressive Disease|0|||
164708383|NCT02799095|594958158|FG007|Part C|Progressive Disease|0|||
164708384|NCT02799095|594958159|FG008|Part C|Progressive Disease|0|||
164708385|NCT02799095|594958160|FG009|Part C|Progressive Disease|2|||
164708386|NCT02799095|594958161|FG010|Part C|Progressive Disease|13|||
164708387|NCT02799095|594958162|FG011|Part C|Progressive Disease|2|||
164708388|NCT02799095|594958163|FG012|Part C|Progressive Disease|0|||
164708389|NCT02799095|594958164|FG013|Part C|Progressive Disease|1|||
164708390|NCT02799095|594958165|FG014|Part C|Progressive Disease|0|||
164708391|NCT02799095|594958166|FG015|Part C|Progressive Disease|0|||
164708392|NCT02799095|594958167|FG016|Part C|Progressive Disease|0|||
164708393|NCT02799095|594958151|FG000|Part C|Clinical Progression|0|||
164708394|NCT02799095|594958152|FG001|Part C|Clinical Progression|0|||
164708395|NCT02799095|594958153|FG002|Part C|Clinical Progression|0|||
164708396|NCT02799095|594958154|FG003|Part C|Clinical Progression|0|||
164463026|NCT03854227|594068562|FG010|Overall Study|Withdrawal by Subject|1|||
164463027|NCT03854227|594068563|FG011|Overall Study|Withdrawal by Subject|0|||
164463028|NCT03854227|594068552|FG000|Overall Study|Disease relapse|0|||
164708397|NCT02799095|594958155|FG004|Part C|Clinical Progression|0|||
164708398|NCT02799095|594958156|FG005|Part C|Clinical Progression|0|||
164708399|NCT02799095|594958157|FG006|Part C|Clinical Progression|0|||
164708400|NCT02799095|594958158|FG007|Part C|Clinical Progression|0|||
164708401|NCT02799095|594958159|FG008|Part C|Clinical Progression|0|||
164708402|NCT02799095|594958160|FG009|Part C|Clinical Progression|1|||
164708403|NCT02799095|594958161|FG010|Part C|Clinical Progression|3|||
164708404|NCT02799095|594958162|FG011|Part C|Clinical Progression|0|||
164708405|NCT02799095|594958163|FG012|Part C|Clinical Progression|0|||
164708406|NCT02799095|594958164|FG013|Part C|Clinical Progression|1|||
164708407|NCT02799095|594958165|FG014|Part C|Clinical Progression|0|||
164708408|NCT02799095|594958166|FG015|Part C|Clinical Progression|0|||
164708409|NCT02799095|594958167|FG016|Part C|Clinical Progression|0|||
164708410|NCT02799095|594958151|FG000|Part C|Withdrawal by Subject|0|||
164708411|NCT02799095|594958152|FG001|Part C|Withdrawal by Subject|0|||
164708412|NCT02799095|594958153|FG002|Part C|Withdrawal by Subject|0|||
164708413|NCT02799095|594958154|FG003|Part C|Withdrawal by Subject|0|||
164708414|NCT02799095|594958155|FG004|Part C|Withdrawal by Subject|0|||
164410775|NCT00747123|593875238|FG001|Overall Study|Withdrew consent|1|||
164410776|NCT00747123|593875239|FG002|Overall Study|Withdrew consent|0|||
164410777|NCT00747123|593875240|FG003|Overall Study|Withdrew consent|0|||
164410778|NCT00747123|593875237|FG000|Overall Study|Adverse Event|0|||
164410779|NCT00747123|593875238|FG001|Overall Study|Adverse Event|1|||
164410780|NCT00747123|593875239|FG002|Overall Study|Adverse Event|0|||
164410781|NCT00747123|593875240|FG003|Overall Study|Adverse Event|1|||
164410782|NCT03489057|593875241|FG000|Overall Study|Lost to Follow-up|16|||
164410783|NCT03489057|593875242|FG001|Overall Study|Lost to Follow-up|16|||
164410784|NCT03489057|593875243|FG002|Overall Study|Lost to Follow-up|14|||
164410785|NCT03489057|593875244|FG003|Overall Study|Lost to Follow-up|14|||
164410786|NCT03489057|593875241|FG000|Overall Study|Withdrawal by Subject|12|||
164410787|NCT03489057|593875242|FG001|Overall Study|Withdrawal by Subject|12|||
164410788|NCT03489057|593875243|FG002|Overall Study|Withdrawal by Subject|8|||
164410789|NCT03489057|593875244|FG003|Overall Study|Withdrawal by Subject|8|||
164410790|NCT03489057|593875241|FG000|Overall Study|Protocol Violation|7|||
164410791|NCT03489057|593875242|FG001|Overall Study|Protocol Violation|7|||
164410792|NCT03489057|593875243|FG002|Overall Study|Protocol Violation|2|||
164410793|NCT03489057|593875244|FG003|Overall Study|Protocol Violation|2|||
164410794|NCT02277743|593875250|FG000|Overall Study|Protocol Violation|1|||
164410795|NCT02277743|593875251|FG001|Overall Study|Protocol Violation|1|||
164410796|NCT02277743|593875252|FG002|Overall Study|Protocol Violation|1|||
164410797|NCT02277743|593875250|FG000|Overall Study|Adverse Event|10|||
164410798|NCT02277743|593875251|FG001|Overall Study|Adverse Event|6|||
164410799|NCT02277743|593875252|FG002|Overall Study|Adverse Event|6|||
164410800|NCT02277743|593875250|FG000|Overall Study|Lack of Efficacy|11|||
164410801|NCT02277743|593875251|FG001|Overall Study|Lack of Efficacy|4|||
164410802|NCT02277743|593875252|FG002|Overall Study|Lack of Efficacy|3|||
164410803|NCT02277743|593875250|FG000|Overall Study|Other than specified above|18|||
164410804|NCT02277743|593875251|FG001|Overall Study|Other than specified above|5|||
164410805|NCT02277743|593875252|FG002|Overall Study|Other than specified above|16|||
164410806|NCT00943306|593875255|FG000|Overall Study|Physician Decision|1|||
164410807|NCT00943306|593875255|FG000|Overall Study|Death|1|||
164410808|NCT00943306|593875255|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
164410809|NCT02739347|593875256|FG000|Overall Study|Adverse Event|3|||
164410810|NCT02739347|593875257|FG001|Overall Study|Adverse Event|0|||
164410811|NCT02739347|593875256|FG000|Overall Study|Protocol Violation|0|||
164410812|NCT02739347|593875257|FG001|Overall Study|Protocol Violation|1|||
164410813|NCT02739347|593875256|FG000|Overall Study|Lost to Follow-up|0|||
164410814|NCT02739347|593875257|FG001|Overall Study|Lost to Follow-up|2|||
164410815|NCT01552954|593875258|FG000|Overall Study|Adverse Event|1|||
164410816|NCT01552954|593875259|FG001|Overall Study|Adverse Event|2|||
164410817|NCT01552954|593875258|FG000|Overall Study|Lost to Follow-up|1|||
164410818|NCT01552954|593875259|FG001|Overall Study|Lost to Follow-up|1|||
164410819|NCT01552954|593875258|FG000|Overall Study|Withdrawal by Subject|1|||
164410820|NCT01552954|593875259|FG001|Overall Study|Withdrawal by Subject|1|||
164410821|NCT01552954|593875258|FG000|Overall Study|Protocol Violation|1|||
164410822|NCT01552954|593875259|FG001|Overall Study|Protocol Violation|2|||
164410823|NCT01552954|593875258|FG000|Overall Study|diagnosed DM|1|||
164410824|NCT01552954|593875259|FG001|Overall Study|diagnosed DM|0|||
164410825|NCT00779779|593875260|FG000|Overall Study|Adverse Event|1|||
164410826|NCT00779779|593875260|FG000|Overall Study|Protocol Violation|14|||
164410827|NCT00779779|593875260|FG000|Overall Study|Withdrawal by Subject|4|||
164410828|NCT00779779|593875260|FG000|Overall Study|Lost to Follow-up|5|||
164410829|NCT01395823|593875261|FG000|Overall Study|Death|4|||
164410830|NCT01395823|593875262|FG001|Overall Study|Death|4|||
164410831|NCT01395823|593875261|FG000|Overall Study|Physician Decision|3|||
164410832|NCT01395823|593875262|FG001|Overall Study|Physician Decision|1|||
164410833|NCT01395823|593875261|FG000|Overall Study|Lost to Follow-up|1|||
164410834|NCT01395823|593875262|FG001|Overall Study|Lost to Follow-up|0|||
164410835|NCT01395823|593875261|FG000|Overall Study|Transplant|1|||
164410836|NCT01395823|593875262|FG001|Overall Study|Transplant|0|||
164410837|NCT01395823|593875261|FG000|Overall Study|GI symptoms|1|||
164410838|NCT01395823|593875262|FG001|Overall Study|GI symptoms|0|||
164410839|NCT01395823|593875261|FG000|Overall Study|Withdrawal by Subject|5|||
164410840|NCT01395823|593875262|FG001|Overall Study|Withdrawal by Subject|4|||
164410841|NCT03300570|593875264|FG000|Overall Study|Adverse Event|0|||
164410842|NCT03300570|593875265|FG001|Overall Study|Adverse Event|1|||
164410843|NCT03300570|593875264|FG000|Overall Study|Withdrawal by Subject|1|||
164410844|NCT03300570|593875265|FG001|Overall Study|Withdrawal by Subject|0|||
164410845|NCT03300570|593875264|FG000|Overall Study|Inadequate bowel prep|1|||
164410846|NCT03300570|593875265|FG001|Overall Study|Inadequate bowel prep|0|||
164410847|NCT00116272|593875266|FG000|Overall Study|Lost to Follow-up|11|||
164708415|NCT02799095|594958156|FG005|Part C|Withdrawal by Subject|0|||
164708416|NCT02799095|594958157|FG006|Part C|Withdrawal by Subject|0|||
164410848|NCT00116272|593875267|FG001|Overall Study|Lost to Follow-up|6|||
164410849|NCT03188120|593875269|FG000|Overall Study|Adverse Event|4|||
164410850|NCT03188120|593875269|FG000|Overall Study|Insufficient Effectiveness|8|||
164410851|NCT03188120|593875269|FG000|Overall Study|Improved|12|||
164410852|NCT03188120|593875269|FG000|Overall Study|Lost to Follow-up|7|||
164410853|NCT03188120|593875269|FG000|Overall Study|Other than specified|3|||
164410854|NCT03188120|593875269|FG000|Overall Study|No visit after the first visit|13|||
164410855|NCT01235403|593875270|FG000|Overall Study|Adverse Event|14|||
164410856|NCT01235403|593875270|FG000|Overall Study|Lost to Follow-up|2|||
164410857|NCT01235403|593875270|FG000|Overall Study|Withdrawal by Subject|4|||
164410858|NCT01235403|593875270|FG000|Overall Study|Lack of Efficacy|2|||
164410859|NCT01235403|593875270|FG000|Overall Study|Other reasons for premature termination|4|||
164410860|NCT02296190|593875271|FG000|Overall Study|Lost to Follow-up|0|||
164410861|NCT02296190|593875272|FG001|Overall Study|Lost to Follow-up|0|||
164410862|NCT02296190|593875273|FG002|Overall Study|Lost to Follow-up|0|||
164410863|NCT02296190|593875274|FG003|Overall Study|Lost to Follow-up|0|||
164410864|NCT02296190|593875275|FG004|Overall Study|Lost to Follow-up|1|||
164410865|NCT02296190|593875276|FG005|Overall Study|Lost to Follow-up|0|||
164410866|NCT02296190|593875271|FG000|Overall Study|Failure to induce PSVT|6|||
164410867|NCT02296190|593875272|FG001|Overall Study|Failure to induce PSVT|10|||
164410868|NCT02296190|593875273|FG002|Overall Study|Failure to induce PSVT|5|||
164410869|NCT02296190|593875274|FG003|Overall Study|Failure to induce PSVT|13|||
164410870|NCT02296190|593875275|FG004|Overall Study|Failure to induce PSVT|8|||
164410871|NCT02296190|593875276|FG005|Overall Study|Failure to induce PSVT|0|||
164410872|NCT02296190|593875271|FG000|Overall Study|Physician Decision|1|||
164410873|NCT02296190|593875272|FG001|Overall Study|Physician Decision|1|||
164410874|NCT02296190|593875273|FG002|Overall Study|Physician Decision|0|||
164410875|NCT02296190|593875274|FG003|Overall Study|Physician Decision|1|||
164410876|NCT02296190|593875275|FG004|Overall Study|Physician Decision|2|||
164410877|NCT02296190|593875276|FG005|Overall Study|Physician Decision|0|||
164410878|NCT02296190|593875271|FG000|Overall Study|Withdrawal by Subject|0|||
164410879|NCT02296190|593875272|FG001|Overall Study|Withdrawal by Subject|1|||
164410880|NCT02296190|593875273|FG002|Overall Study|Withdrawal by Subject|0|||
164410881|NCT02296190|593875274|FG003|Overall Study|Withdrawal by Subject|0|||
164410882|NCT02296190|593875275|FG004|Overall Study|Withdrawal by Subject|0|||
164410883|NCT02296190|593875276|FG005|Overall Study|Withdrawal by Subject|0|||
164410884|NCT02296190|593875271|FG000|Overall Study|PSVT < 5 minutes|5|||
164410885|NCT02296190|593875272|FG001|Overall Study|PSVT < 5 minutes|6|||
164410886|NCT02296190|593875273|FG002|Overall Study|PSVT < 5 minutes|6|||
164410887|NCT02296190|593875274|FG003|Overall Study|PSVT < 5 minutes|6|||
164410888|NCT02296190|593875275|FG004|Overall Study|PSVT < 5 minutes|5|||
164410889|NCT02296190|593875276|FG005|Overall Study|PSVT < 5 minutes|0|||
164410890|NCT02296190|593875271|FG000|Overall Study|Patient was given Propofol|0|||
164410891|NCT02296190|593875272|FG001|Overall Study|Patient was given Propofol|1|||
164410892|NCT02296190|593875273|FG002|Overall Study|Patient was given Propofol|0|||
164410893|NCT02296190|593875274|FG003|Overall Study|Patient was given Propofol|1|||
164410894|NCT02296190|593875275|FG004|Overall Study|Patient was given Propofol|0|||
164410895|NCT02296190|593875276|FG005|Overall Study|Patient was given Propofol|0|||
164410896|NCT02296190|593875271|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
164410897|NCT02296190|593875272|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
164410898|NCT02296190|593875273|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
164410899|NCT02296190|593875274|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
164410900|NCT02296190|593875275|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
164410901|NCT02296190|593875276|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
164410902|NCT02296190|593875271|FG000|Overall Study|Blood pressure <100 after sedation|0|||
164410903|NCT02296190|593875272|FG001|Overall Study|Blood pressure <100 after sedation|0|||
164463029|NCT03854227|594068553|FG001|Overall Study|Disease relapse|0|||
164463030|NCT03854227|594068554|FG002|Overall Study|Disease relapse|0|||
164463031|NCT03854227|594068555|FG003|Overall Study|Disease relapse|0|||
164463032|NCT03854227|594068556|FG004|Overall Study|Disease relapse|0|||
164463033|NCT03854227|594068557|FG005|Overall Study|Disease relapse|0|||
164463034|NCT03854227|594068558|FG006|Overall Study|Disease relapse|0|||
164463035|NCT03854227|594068559|FG007|Overall Study|Disease relapse|0|||
164463036|NCT03854227|594068560|FG008|Overall Study|Disease relapse|1|||
164463037|NCT03854227|594068561|FG009|Overall Study|Disease relapse|0|||
164463038|NCT03854227|594068562|FG010|Overall Study|Disease relapse|0|||
164463039|NCT03854227|594068563|FG011|Overall Study|Disease relapse|0|||
164463040|NCT03854227|594068552|FG000|Overall Study|Global deterioration of health status|0|||
164463041|NCT03854227|594068553|FG001|Overall Study|Global deterioration of health status|0|||
164463042|NCT03854227|594068554|FG002|Overall Study|Global deterioration of health status|0|||
164463043|NCT03854227|594068555|FG003|Overall Study|Global deterioration of health status|0|||
164463044|NCT03854227|594068556|FG004|Overall Study|Global deterioration of health status|0|||
164463045|NCT03854227|594068557|FG005|Overall Study|Global deterioration of health status|1|||
164463046|NCT03854227|594068558|FG006|Overall Study|Global deterioration of health status|0|||
164463047|NCT03854227|594068559|FG007|Overall Study|Global deterioration of health status|1|||
164463048|NCT03854227|594068560|FG008|Overall Study|Global deterioration of health status|0|||
164463049|NCT03854227|594068561|FG009|Overall Study|Global deterioration of health status|0|||
164410904|NCT02296190|593875273|FG002|Overall Study|Blood pressure <100 after sedation|0|||
164410905|NCT02296190|593875274|FG003|Overall Study|Blood pressure <100 after sedation|1|||
164410906|NCT02296190|593875275|FG004|Overall Study|Blood pressure <100 after sedation|0|||
164410907|NCT02296190|593875276|FG005|Overall Study|Blood pressure <100 after sedation|0|||
164410908|NCT02296190|593875271|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
164410909|NCT02296190|593875272|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
164410910|NCT02296190|593875273|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
164410911|NCT02296190|593875274|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
164410912|NCT02296190|593875275|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
164410913|NCT02296190|593875276|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
164410914|NCT02296190|593875271|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
164410915|NCT02296190|593875272|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
164410916|NCT02296190|593875273|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
164410917|NCT02296190|593875274|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
164410918|NCT02296190|593875275|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
164410919|NCT02296190|593875276|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
164410920|NCT02296190|593875271|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
164410921|NCT02296190|593875272|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
164410922|NCT02296190|593875273|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
164410923|NCT02296190|593875274|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
164410924|NCT02296190|593875275|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
164410925|NCT02296190|593875276|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
164410926|NCT02296190|593875271|FG000|Overall Study|Lab result not available in time|1|||
164410927|NCT02296190|593875272|FG001|Overall Study|Lab result not available in time|0|||
164410928|NCT02296190|593875273|FG002|Overall Study|Lab result not available in time|0|||
164410929|NCT02296190|593875274|FG003|Overall Study|Lab result not available in time|0|||
164410930|NCT02296190|593875275|FG004|Overall Study|Lab result not available in time|0|||
164410931|NCT02296190|593875276|FG005|Overall Study|Lab result not available in time|0|||
164410932|NCT00717314|593875278|FG000|Overall Study|Adverse Event|3|||
164410933|NCT00717314|593875279|FG001|Overall Study|Adverse Event|2|||
164410934|NCT00717314|593875278|FG000|Overall Study|Protocol Violation|1|||
164410935|NCT00717314|593875279|FG001|Overall Study|Protocol Violation|0|||
164410936|NCT00717314|593875278|FG000|Overall Study|Lost to Follow-up|1|||
164410937|NCT00717314|593875279|FG001|Overall Study|Lost to Follow-up|5|||
164410938|NCT00717314|593875278|FG000|Overall Study|Withdrawal by Subject|1|||
164410939|NCT00717314|593875279|FG001|Overall Study|Withdrawal by Subject|3|||
164410940|NCT05096208|593875280|FG000|Overall Study|Lost to Follow-up|3|||
164410941|NCT05096208|593875281|FG001|Overall Study|Lost to Follow-up|5|||
164410942|NCT05096208|593875282|FG002|Overall Study|Lost to Follow-up|5|||
164410943|NCT05096208|593875283|FG003|Overall Study|Lost to Follow-up|2|||
164410944|NCT05096208|593875280|FG000|Overall Study|Withdrawal by Subject|0|||
164410945|NCT05096208|593875281|FG001|Overall Study|Withdrawal by Subject|1|||
164410946|NCT05096208|593875282|FG002|Overall Study|Withdrawal by Subject|2|||
164410947|NCT05096208|593875283|FG003|Overall Study|Withdrawal by Subject|3|||
164410948|NCT05096208|593875280|FG000|Overall Study|No longer met eligibility criteria|1|||
164410949|NCT05096208|593875281|FG001|Overall Study|No longer met eligibility criteria|0|||
164410950|NCT05096208|593875282|FG002|Overall Study|No longer met eligibility criteria|0|||
164410951|NCT05096208|593875283|FG003|Overall Study|No longer met eligibility criteria|0|||
164410952|NCT05096208|593875280|FG000|Overall Study|Other|0|||
164410953|NCT05096208|593875281|FG001|Overall Study|Other|0|||
164410954|NCT05096208|593875282|FG002|Overall Study|Other|1|||
164410955|NCT05096208|593875283|FG003|Overall Study|Other|0|||
164410956|NCT00782496|593875284|FG000|Overall Study|Lost to Follow-up|14|||
164410957|NCT00782496|593875285|FG001|Overall Study|Lost to Follow-up|15|||
164410958|NCT01483937|593875287|FG000|Overall Study|Withdrawal by Subject|4|||
164410959|NCT01483937|593875288|FG001|Overall Study|Withdrawal by Subject|3|||
164410960|NCT00399763|593875289|FG000|Overall Study|Lost to Follow-up|2|||
164410961|NCT00399763|593875290|FG001|Overall Study|Lost to Follow-up|3|||
164410962|NCT03389477|593875291|FG000|Step 1|Withdrawal by Subject|1|||
164410963|NCT03389477|593875292|FG001|Step 1|Withdrawal by Subject|0|||
164410964|NCT03389477|593875291|FG000|Step 2|Withdrawal by Subject|1|||
164410965|NCT03389477|593875292|FG001|Step 2|Withdrawal by Subject|2|||
164410966|NCT03389477|593875291|FG000|Step 2|Disease progression|1|||
164410967|NCT03389477|593875292|FG001|Step 2|Disease progression|0|||
164410968|NCT03389477|593875291|FG000|Step 2|Death|0|||
164410969|NCT03389477|593875292|FG001|Step 2|Death|1|||
164410970|NCT03389477|593875291|FG000|Step 2|Poor performance status and nutrition|0|||
164410971|NCT03389477|593875292|FG001|Step 2|Poor performance status and nutrition|1|||
164410972|NCT03389477|593875291|FG000|Step 3|Withdrawal after 3 cycles|0|||
164410973|NCT03389477|593875292|FG001|Step 3|Withdrawal after 3 cycles|1|||
164410974|NCT03389477|593875291|FG000|Step 3|Still receiving active treatment|4|||
164410975|NCT03389477|593875292|FG001|Step 3|Still receiving active treatment|0|||
164410976|NCT03389477|593875291|FG000|Step 3|Progressive disease after 2 cycles|1|||
164463050|NCT03854227|594068562|FG010|Overall Study|Global deterioration of health status|0|||
164708417|NCT02799095|594958158|FG007|Part C|Withdrawal by Subject|0|||
164708418|NCT02799095|594958159|FG008|Part C|Withdrawal by Subject|0|||
164708419|NCT02799095|594958160|FG009|Part C|Withdrawal by Subject|0|||
164708420|NCT02799095|594958161|FG010|Part C|Withdrawal by Subject|13|||
164708421|NCT02799095|594958162|FG011|Part C|Withdrawal by Subject|15|||
164708422|NCT02799095|594958163|FG012|Part C|Withdrawal by Subject|13|||
164708423|NCT02799095|594958164|FG013|Part C|Withdrawal by Subject|21|||
164708424|NCT02799095|594958165|FG014|Part C|Withdrawal by Subject|0|||
164708425|NCT02799095|594958166|FG015|Part C|Withdrawal by Subject|12|||
164708426|NCT02799095|594958167|FG016|Part C|Withdrawal by Subject|1|||
164708427|NCT02799095|594958151|FG000|Part C|Physician Decision|0|||
164708428|NCT02799095|594958152|FG001|Part C|Physician Decision|0|||
164708429|NCT02799095|594958153|FG002|Part C|Physician Decision|0|||
164708430|NCT02799095|594958154|FG003|Part C|Physician Decision|0|||
164708431|NCT02799095|594958155|FG004|Part C|Physician Decision|0|||
164708432|NCT02799095|594958156|FG005|Part C|Physician Decision|0|||
164708433|NCT02799095|594958157|FG006|Part C|Physician Decision|0|||
164708434|NCT02799095|594958158|FG007|Part C|Physician Decision|0|||
164708435|NCT02799095|594958159|FG008|Part C|Physician Decision|0|||
164708436|NCT02799095|594958160|FG009|Part C|Physician Decision|0|||
164708437|NCT02799095|594958161|FG010|Part C|Physician Decision|1|||
164708438|NCT02799095|594958162|FG011|Part C|Physician Decision|0|||
164708439|NCT02799095|594958163|FG012|Part C|Physician Decision|0|||
164708440|NCT02799095|594958164|FG013|Part C|Physician Decision|0|||
164708441|NCT02799095|594958165|FG014|Part C|Physician Decision|0|||
164708442|NCT02799095|594958166|FG015|Part C|Physician Decision|0|||
164708443|NCT02799095|594958167|FG016|Part C|Physician Decision|0|||
164708444|NCT02799095|594958151|FG000|Part C|Other|0|||
164708445|NCT02799095|594958152|FG001|Part C|Other|0|||
164708446|NCT02799095|594958153|FG002|Part C|Other|0|||
164708447|NCT02799095|594958154|FG003|Part C|Other|0|||
164708448|NCT02799095|594958155|FG004|Part C|Other|0|||
164708449|NCT02799095|594958156|FG005|Part C|Other|0|||
164708450|NCT02799095|594958157|FG006|Part C|Other|0|||
164410977|NCT03389477|593875292|FG001|Step 3|Progressive disease after 2 cycles|0|||
164410978|NCT01833143|593875295|FG000|Overall Study|Not Treated|1|||
164410979|NCT00116844|593875296|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
164410980|NCT00116844|593875297|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
164410981|NCT00116844|593875296|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
164410982|NCT00116844|593875297|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
164410983|NCT00116844|593875296|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
164410984|NCT00116844|593875297|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
164410985|NCT00116844|593875296|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
164410986|NCT00116844|593875297|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
164410987|NCT00116844|593875296|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
164410988|NCT00116844|593875297|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
164410989|NCT00116844|593875296|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
164410990|NCT00116844|593875297|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
164410991|NCT00116844|593875296|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
164410992|NCT00116844|593875297|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
164410993|NCT00116844|593875296|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
164410994|NCT00116844|593875297|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
164410995|NCT00116844|593875296|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
164410996|NCT00116844|593875297|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
164410997|NCT03474549|593875298|FG000|Overall Study|Death|31|||
164410998|NCT03474549|593875298|FG000|Overall Study|Lost to Follow-up|4|||
164410999|NCT03474549|593875298|FG000|Overall Study|Withdrawal by Subject|2|||
164411000|NCT00926003|593875299|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
164411001|NCT00926003|593875300|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
164411002|NCT00926003|593875301|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
164411003|NCT00926003|593875299|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
164411004|NCT00926003|593875300|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
164411005|NCT00926003|593875301|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
164411006|NCT01786330|593875303|FG000|Overall Study|Withdrawal by Subject|0|||
164411007|NCT01786330|593875304|FG001|Overall Study|Withdrawal by Subject|1|||
164411008|NCT01786330|593875303|FG000|Overall Study|Lost to Follow-up|0|||
164411009|NCT01786330|593875304|FG001|Overall Study|Lost to Follow-up|1|||
164411010|NCT01786330|593875303|FG000|Overall Study|Excluded intraoperatively|0|||
164411011|NCT01786330|593875304|FG001|Overall Study|Excluded intraoperatively|1|||
164708451|NCT02799095|594958158|FG007|Part C|Other|0|||
164708452|NCT02799095|594958159|FG008|Part C|Other|0|||
164708453|NCT02799095|594958160|FG009|Part C|Other|0|||
164708454|NCT02799095|594958161|FG010|Part C|Other|0|||
164708455|NCT02799095|594958162|FG011|Part C|Other|2|||
164708456|NCT02799095|594958163|FG012|Part C|Other|2|||
164708457|NCT02799095|594958164|FG013|Part C|Other|0|||
164708458|NCT02799095|594958165|FG014|Part C|Other|0|||
164708459|NCT02799095|594958166|FG015|Part C|Other|0|||
164708460|NCT02799095|594958167|FG016|Part C|Other|0|||
164411012|NCT01786330|593875303|FG000|Overall Study|Protocol Violation|1|||
164411013|NCT01786330|593875304|FG001|Overall Study|Protocol Violation|0|||
164411014|NCT02966002|593877069|FG000|Overall Study|Withdrawal by Subject|2|||
164411015|NCT02966002|593877069|FG000|Overall Study|Adverse Event|1|||
164411016|NCT02966002|593877069|FG000|Overall Study|Lost to Follow-up|1|||
164411017|NCT00067990|593877070|FG000|Overall Study|Death|5|||
164411018|NCT00067990|593877071|FG001|Overall Study|Death|7|||
164411019|NCT00067990|593877070|FG000|Overall Study|ESRD, Non IF/TA|1|||
164411020|NCT00067990|593877071|FG001|Overall Study|ESRD, Non IF/TA|3|||
164411021|NCT00067990|593877070|FG000|Overall Study|Withdrawal by Subject|4|||
164411022|NCT00067990|593877071|FG001|Overall Study|Withdrawal by Subject|12|||
164411023|NCT02291432|593877072|FG000|Overall Study|Withdrawal by Subject|2|||
164411024|NCT01350141|593877073|FG000|Overall Study|Lost to Follow-up|1|||
164411025|NCT01350141|593877074|FG001|Overall Study|Lost to Follow-up|0|||
164411026|NCT01350141|593877075|FG002|Overall Study|Lost to Follow-up|1|||
164411027|NCT01350141|593877073|FG000|Overall Study|Withdrawal by Subject|1|||
164411028|NCT01350141|593877074|FG001|Overall Study|Withdrawal by Subject|0|||
164411029|NCT01350141|593877075|FG002|Overall Study|Withdrawal by Subject|0|||
164411030|NCT01350141|593877073|FG000|Overall Study|Randomized but not treated|1|||
164411031|NCT01350141|593877074|FG001|Overall Study|Randomized but not treated|0|||
164411032|NCT01350141|593877075|FG002|Overall Study|Randomized but not treated|0|||
164411033|NCT00810082|593877076|FG000|Overall Study|Lost to Follow-up|0|||
164411034|NCT00810082|593877077|FG001|Overall Study|Lost to Follow-up|4|||
164411035|NCT03327402|593877078|FG000|Overall Study|Withdrawal by Subject|1|||
164411036|NCT03327402|593877078|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
164411037|NCT01454830|593877085|FG000|Overall Study|Withdrawal by Subject|4|||
164411038|NCT01454830|593877086|FG001|Overall Study|Withdrawal by Subject|4|||
164411039|NCT01454830|593877085|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
164411040|NCT01454830|593877086|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
164411041|NCT01454830|593877085|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
164411042|NCT01454830|593877086|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
164411043|NCT01454830|593877085|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
164411044|NCT01454830|593877086|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
164411045|NCT01454830|593877085|FG000|Overall Study|Withdrawal - no polysomnography|3|||
164411046|NCT01454830|593877086|FG001|Overall Study|Withdrawal - no polysomnography|2|||
164411047|NCT03810313|593877087|FG000|Overall Study|Study terminated by sponsor|164|||
164411048|NCT03810313|593877088|FG001|Overall Study|Study terminated by sponsor|159|||
164411049|NCT03810313|593877087|FG000|Overall Study|Subject decision|10|||
164411050|NCT03810313|593877088|FG001|Overall Study|Subject decision|11|||
164411051|NCT03810313|593877087|FG000|Overall Study|Lost to Follow-up|3|||
164411052|NCT03810313|593877088|FG001|Overall Study|Lost to Follow-up|3|||
164411053|NCT03810313|593877087|FG000|Overall Study|Adverse Event|2|||
164411054|NCT03810313|593877088|FG001|Overall Study|Adverse Event|1|||
164411055|NCT03810313|593877087|FG000|Overall Study|Death|2|||
164411056|NCT03810313|593877088|FG001|Overall Study|Death|1|||
164411057|NCT03810313|593877087|FG000|Overall Study|Physician Decision|0|||
164411058|NCT03810313|593877088|FG001|Overall Study|Physician Decision|1|||
164411059|NCT00584805|593877091|FG000|Overall Study|No longer at risk of exposure|39|||
164411060|NCT00584805|593877091|FG000|Overall Study|Relocation|36|||
164411061|NCT00584805|593877091|FG000|Overall Study|Withdrawal by Subject|18|||
164411062|NCT00584805|593877091|FG000|Overall Study|Non-compliance|1|||
164411063|NCT00584805|593877091|FG000|Overall Study|Lost to follow up|3|||
164411064|NCT00584805|593877091|FG000|Overall Study|Screen failures|2|||
164411065|NCT02341456|593877092|FG000|Overall Study|Disease progression|2|||
164411066|NCT02341456|593877093|FG001|Overall Study|Disease progression|3|||
164411067|NCT02341456|593877094|FG002|Overall Study|Disease progression|1|||
164411068|NCT02341456|593877092|FG000|Overall Study|Death|1|||
164411069|NCT02341456|593877093|FG001|Overall Study|Death|1|||
164411070|NCT02341456|593877094|FG002|Overall Study|Death|1|||
164411071|NCT02341456|593877092|FG000|Overall Study|Withdrawal by Subject|0|||
164411072|NCT02341456|593877093|FG001|Overall Study|Withdrawal by Subject|1|||
164411073|NCT02341456|593877094|FG002|Overall Study|Withdrawal by Subject|1|||
164411074|NCT02341456|593877092|FG000|Overall Study|Moved to local access programme.|0|||
164411075|NCT02341456|593877093|FG001|Overall Study|Moved to local access programme.|1|||
164411076|NCT02341456|593877094|FG002|Overall Study|Moved to local access programme.|1|||
164411077|NCT02341456|593877092|FG000|Overall Study|Physician Decision|1|||
164411078|NCT02341456|593877093|FG001|Overall Study|Physician Decision|0|||
164411079|NCT02341456|593877094|FG002|Overall Study|Physician Decision|0|||
164411080|NCT01077362|593877095|FG000|Overall Study|Lack of Efficacy|13|||
164411081|NCT01077362|593877096|FG001|Overall Study|Lack of Efficacy|8|||
164411082|NCT01077362|593877097|FG002|Overall Study|Lack of Efficacy|10|||
164411083|NCT01077362|593877095|FG000|Overall Study|Lost to Follow-up|1|||
164411084|NCT01077362|593877096|FG001|Overall Study|Lost to Follow-up|0|||
164411085|NCT01077362|593877097|FG002|Overall Study|Lost to Follow-up|3|||
164411086|NCT01077362|593877095|FG000|Overall Study|Adverse Event|12|||
164411087|NCT01077362|593877096|FG001|Overall Study|Adverse Event|7|||
164411088|NCT01077362|593877097|FG002|Overall Study|Adverse Event|4|||
164411089|NCT01077362|593877095|FG000|Overall Study|Withdrawal by Subject|5|||
164463051|NCT03854227|594068563|FG011|Overall Study|Global deterioration of health status|0|||
164463052|NCT03854227|594068552|FG000|Overall Study|Refused further treatment|0|||
164463053|NCT03854227|594068553|FG001|Overall Study|Refused further treatment|0|||
164463054|NCT03854227|594068554|FG002|Overall Study|Refused further treatment|0|||
164463055|NCT03854227|594068555|FG003|Overall Study|Refused further treatment|0|||
164463056|NCT03854227|594068556|FG004|Overall Study|Refused further treatment|0|||
164463057|NCT03854227|594068557|FG005|Overall Study|Refused further treatment|0|||
164463058|NCT03854227|594068558|FG006|Overall Study|Refused further treatment|0|||
164463059|NCT03854227|594068559|FG007|Overall Study|Refused further treatment|0|||
164463060|NCT03854227|594068560|FG008|Overall Study|Refused further treatment|0|||
164708461|NCT02903030|594958168|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
164708462|NCT02903030|594958169|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
164708463|NCT03700385|594958176|FG000|Overall Study|Lost to Follow-up|1|||
164708464|NCT00699283|594958177|FG000|Overall Study|Lack of Efficacy|15|||
164708465|NCT00699283|594958178|FG001|Overall Study|Lack of Efficacy|5|||
164708466|NCT00699283|594958177|FG000|Overall Study|Lost to Follow-up|2|||
164708467|NCT00699283|594958178|FG001|Overall Study|Lost to Follow-up|0|||
164708468|NCT00699283|594958177|FG000|Overall Study|Withdrawal by Subject|1|||
164708469|NCT00699283|594958178|FG001|Overall Study|Withdrawal by Subject|0|||
164708470|NCT00699283|594958177|FG000|Overall Study|Other Reason|5|||
164708471|NCT00699283|594958178|FG001|Overall Study|Other Reason|1|||
164708472|NCT00699283|594958177|FG000|Overall Study|SAE, non-fatal|1|||
164708473|NCT00699283|594958178|FG001|Overall Study|SAE, non-fatal|1|||
164708474|NCT00699283|594958177|FG000|Overall Study|AE, non-serious non-fatal|8|||
164708475|NCT00699283|594958178|FG001|Overall Study|AE, non-serious non-fatal|1|||
164708476|NCT00699283|594958177|FG000|Overall Study|AE of unknown type|1|||
164708477|NCT00699283|594958178|FG001|Overall Study|AE of unknown type|0|||
164708478|NCT04590040|594958184|FG000|Treatment Period|Lost to Follow-up|2|||
164708479|NCT04590040|594958185|FG001|Treatment Period|Lost to Follow-up|5|||
164708480|NCT04590040|594958186|FG002|Treatment Period|Lost to Follow-up|0|||
164708481|NCT04590040|594958184|FG000|Treatment Period|Physician Decision|0|||
164708482|NCT04590040|594958185|FG001|Treatment Period|Physician Decision|0|||
164708483|NCT04590040|594958186|FG002|Treatment Period|Physician Decision|2|||
164708484|NCT00000378|594958189|FG000|Overall Study|Lack of Efficacy|16|||
164708485|NCT00000378|594958190|FG001|Overall Study|Lack of Efficacy|14|||
164708486|NCT01284361|594958195|FG000|Overall Study|Withdrawal by Subject|1|||
164708487|NCT01284361|594958195|FG000|Overall Study|Protocol Violation|5|||
164708488|NCT01284361|594958195|FG000|Overall Study|Adverse Event|1|||
164708489|NCT01284361|594958195|FG000|Overall Study|Lost to Follow-up|2|||
164708490|NCT00805675|594958198|FG000|Overall Study|Adverse Event|0|||
164708491|NCT00805675|594958199|FG001|Overall Study|Adverse Event|0|||
164708492|NCT00805675|594958200|FG002|Overall Study|Adverse Event|1|||
164708493|NCT02771795|594958202|FG000|Overall Study|Withdrawal by Subject|47|||
164708494|NCT02771795|594958203|FG001|Overall Study|Withdrawal by Subject|37|||
164708495|NCT02771795|594958202|FG000|Overall Study|Termination by premature discontinuation of study|168|||
164708496|NCT02771795|594958203|FG001|Overall Study|Termination by premature discontinuation of study|185|||
164708497|NCT01957397|594958205|FG000|Test Period 1|sudden leakage/small bag|1|||
164708498|NCT01957397|594958206|FG001|Test Period 1|sudden leakage/small bag|1|||
164708499|NCT01957397|594958205|FG000|Test Period 1|Withdrawal by Subject|1|||
164708500|NCT01957397|594958206|FG001|Test Period 1|Withdrawal by Subject|0|||
164708501|NCT01957397|594958205|FG000|Test Period 2|Adverse Event|0|||
164708502|NCT01957397|594958206|FG001|Test Period 2|Adverse Event|1|||
164708503|NCT01957397|594958205|FG000|Test Period 3|Adverse Event|1|||
164708504|NCT01957397|594958206|FG001|Test Period 3|Adverse Event|2|||
164708505|NCT01957397|594958205|FG000|Test Period 3|the adhesive did not work|1|||
164708506|NCT01957397|594958206|FG001|Test Period 3|the adhesive did not work|0|||
164708507|NCT00505375|594958207|FG000|Overall Study|Death|1|||
164708508|NCT00505375|594958208|FG001|Overall Study|Death|0|||
164708509|NCT00505375|594958207|FG000|Overall Study|Withdrawal by Subject|2|||
164708510|NCT00505375|594958208|FG001|Overall Study|Withdrawal by Subject|2|||
164708511|NCT00505375|594958207|FG000|Overall Study|Lost to Follow-up|0|||
164708512|NCT00505375|594958208|FG001|Overall Study|Lost to Follow-up|2|||
164708513|NCT00505375|594958207|FG000|Overall Study|Pregnancy|1|||
164708514|NCT00505375|594958208|FG001|Overall Study|Pregnancy|0|||
164708515|NCT00505375|594958207|FG000|Overall Study|Travel issues|0|||
164708516|NCT00505375|594958208|FG001|Overall Study|Travel issues|1|||
164708517|NCT02906930|594958209|FG000|Overall Study|Withdrawal by Subject|0|||
164708518|NCT02906930|594958210|FG001|Overall Study|Withdrawal by Subject|5|||
164708519|NCT02906930|594958211|FG002|Overall Study|Withdrawal by Subject|5|||
164708520|NCT02906930|594958212|FG003|Overall Study|Withdrawal by Subject|4|||
164708521|NCT02906930|594958209|FG000|Overall Study|Lost to Follow-up|5|||
164708522|NCT02906930|594958210|FG001|Overall Study|Lost to Follow-up|7|||
164708523|NCT02906930|594958211|FG002|Overall Study|Lost to Follow-up|5|||
164708524|NCT02906930|594958212|FG003|Overall Study|Lost to Follow-up|2|||
164708525|NCT02906930|594958209|FG000|Overall Study|Death|0|||
164708526|NCT02906930|594958210|FG001|Overall Study|Death|0|||
164463061|NCT03854227|594068561|FG009|Overall Study|Refused further treatment|1|||
164708527|NCT02906930|594958211|FG002|Overall Study|Death|1|||
164463062|NCT03854227|594068562|FG010|Overall Study|Refused further treatment|0|||
164708528|NCT02906930|594958212|FG003|Overall Study|Death|0|||
164708529|NCT02906930|594958209|FG000|Overall Study|Other|1|||
164708530|NCT02906930|594958210|FG001|Overall Study|Other|2|||
164708531|NCT02906930|594958211|FG002|Overall Study|Other|1|||
164708532|NCT02906930|594958212|FG003|Overall Study|Other|2|||
164708533|NCT00540293|594958213|FG000|Overall Study|Adverse event related to study drug|10|||
164708534|NCT00540293|594958213|FG000|Overall Study|Adverse event not related to study drug|7|||
164708535|NCT00540293|594958213|FG000|Overall Study|Withdrawal by Subject|6|||
164708536|NCT00540293|594958213|FG000|Overall Study|Protocol violation, & subject schedule|12|||
164708537|NCT03537599|594958214|FG000|Overall Study|Disease Progression|2|||
164708538|NCT03537599|594958215|FG001|Overall Study|Disease Progression|1|||
164708539|NCT03537599|594958214|FG000|Overall Study|Death|0|||
164708540|NCT03537599|594958215|FG001|Overall Study|Death|1|||
164708541|NCT04713553|594958216|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
164708542|NCT04713553|594958217|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
164708543|NCT04713553|594958218|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
164708544|NCT04713553|594958219|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
164708545|NCT04713553|594958220|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
164708546|NCT04713553|594958221|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
164708547|NCT04713553|594958222|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
164708548|NCT04713553|594958216|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
164708549|NCT04713553|594958217|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
164708550|NCT04713553|594958218|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
164708551|NCT04713553|594958219|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
164708552|NCT04713553|594958220|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
164708553|NCT04713553|594958221|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
164708554|NCT04713553|594958222|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
164708555|NCT04713553|594958216|FG000|Primary Study (2 Months)|Other|1|||
164708556|NCT04713553|594958217|FG001|Primary Study (2 Months)|Other|2|||
164708557|NCT04713553|594958218|FG002|Primary Study (2 Months)|Other|0|||
164463063|NCT03854227|594068563|FG011|Overall Study|Refused further treatment|1|||
164708558|NCT04713553|594958219|FG003|Primary Study (2 Months)|Other|0|||
164708559|NCT04713553|594958220|FG004|Primary Study (2 Months)|Other|1|||
164708560|NCT04713553|594958221|FG005|Primary Study (2 Months)|Other|0|||
164463064|NCT03854227|594068552|FG000|Overall Study|Other|0|||
164463065|NCT03854227|594068553|FG001|Overall Study|Other|0|||
164463066|NCT03854227|594068554|FG002|Overall Study|Other|0|||
164463067|NCT03854227|594068555|FG003|Overall Study|Other|0|||
164463068|NCT03854227|594068556|FG004|Overall Study|Other|0|||
164463069|NCT03854227|594068557|FG005|Overall Study|Other|0|||
164463070|NCT03854227|594068558|FG006|Overall Study|Other|0|||
164463071|NCT03854227|594068559|FG007|Overall Study|Other|0|||
164463072|NCT03854227|594068560|FG008|Overall Study|Other|1|||
164463073|NCT03854227|594068561|FG009|Overall Study|Other|1|||
164463074|NCT03854227|594068562|FG010|Overall Study|Other|0|||
164463075|NCT03854227|594068563|FG011|Overall Study|Other|0|||
164463076|NCT06504862|594068564|FG000|Transition period|Adverse Event|1|||
164463077|NCT06504862|594068565|FG001|Transition period|Adverse Event|0|||
164463078|NCT05949788|594068566|FG000|Overall Study|severe birth deformity|2|||
164463079|NCT05949788|594068567|FG001|Overall Study|severe birth deformity|7|||
164463080|NCT05949788|594068566|FG000|Overall Study|twin-twin transfusion syndrome|2|||
164463081|NCT05949788|594068567|FG001|Overall Study|twin-twin transfusion syndrome|7|||
164463082|NCT05949788|594068566|FG000|Overall Study|neonatal hemolytic disease|3|||
164463083|NCT05949788|594068567|FG001|Overall Study|neonatal hemolytic disease|8|||
164463084|NCT05949788|594068566|FG000|Overall Study|death within 14 days after birth|2|||
164463085|NCT05949788|594068567|FG001|Overall Study|death within 14 days after birth|6|||
164463086|NCT05949788|594068566|FG000|Overall Study|transfer to another hospital|2|||
164463087|NCT05949788|594068567|FG001|Overall Study|transfer to another hospital|6|||
164463088|NCT04192266|594068571|FG000|Overall Study|Withdrawal by Subject|3|||
164463089|NCT04192266|594068572|FG001|Overall Study|Withdrawal by Subject|2|||
164463090|NCT04948697|594068573|FG000|Overall Study|Progressive disease|27|||
164463091|NCT04948697|594068574|FG001|Overall Study|Progressive disease|18|||
164463092|NCT04948697|594068573|FG000|Overall Study|Adverse Event|14|||
164463093|NCT04948697|594068574|FG001|Overall Study|Adverse Event|4|||
164463094|NCT04948697|594068573|FG000|Overall Study|Participant moved to long term extension study|7|||
164411090|NCT01077362|593877096|FG001|Overall Study|Withdrawal by Subject|3|||
164411091|NCT01077362|593877097|FG002|Overall Study|Withdrawal by Subject|5|||
164411092|NCT01077362|593877095|FG000|Overall Study|Other|0|||
164411093|NCT01077362|593877096|FG001|Overall Study|Other|1|||
164411094|NCT01077362|593877097|FG002|Overall Study|Other|2|||
164411095|NCT00301080|593877102|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
164411096|NCT00301080|593877103|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
164411097|NCT00301080|593877104|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
164411098|NCT00301080|593877105|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
164411099|NCT00301080|593877106|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
164411100|NCT01287520|593877109|FG000|Overall Study|Adverse Event|2|||
164411101|NCT01287520|593877110|FG001|Overall Study|Adverse Event|2|||
164411102|NCT01287520|593877111|FG002|Overall Study|Adverse Event|2|||
164411103|NCT01287520|593877112|FG003|Overall Study|Adverse Event|1|||
164411104|NCT01287520|593877113|FG004|Overall Study|Adverse Event|1|||
164411105|NCT01287520|593877114|FG005|Overall Study|Adverse Event|2|||
164411106|NCT01287520|593877115|FG006|Overall Study|Adverse Event|0|||
164411107|NCT01287520|593877116|FG007|Overall Study|Adverse Event|2|||
164411108|NCT01287520|593877117|FG008|Overall Study|Adverse Event|0|||
164411109|NCT01287520|593877109|FG000|Overall Study|Physician Decision|1|||
164411110|NCT01287520|593877110|FG001|Overall Study|Physician Decision|1|||
164411111|NCT01287520|593877111|FG002|Overall Study|Physician Decision|2|||
164411112|NCT01287520|593877112|FG003|Overall Study|Physician Decision|0|||
164411113|NCT01287520|593877113|FG004|Overall Study|Physician Decision|1|||
164411114|NCT01287520|593877114|FG005|Overall Study|Physician Decision|1|||
164411115|NCT01287520|593877115|FG006|Overall Study|Physician Decision|0|||
164411116|NCT01287520|593877116|FG007|Overall Study|Physician Decision|1|||
164411117|NCT01287520|593877117|FG008|Overall Study|Physician Decision|0|||
164411118|NCT01287520|593877109|FG000|Overall Study|Progressive disease|0|||
164411119|NCT01287520|593877110|FG001|Overall Study|Progressive disease|4|||
164463095|NCT04948697|594068574|FG001|Overall Study|Participant moved to long term extension study|4|||
164463096|NCT04948697|594068573|FG000|Overall Study|Withdrawal by Subject|10|||
164708561|NCT04713553|594958222|FG006|Primary Study (2 Months)|Other|0|||
164708562|NCT04713553|594958216|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
164463097|NCT04948697|594068574|FG001|Overall Study|Withdrawal by Subject|0|||
164463098|NCT04948697|594068573|FG000|Overall Study|Closed by Sponsor|3|||
164463099|NCT04948697|594068574|FG001|Overall Study|Closed by Sponsor|2|||
164708563|NCT04713553|594958217|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
164463100|NCT04948697|594068573|FG000|Overall Study|Physician Decision|0|||
164411120|NCT01287520|593877111|FG002|Overall Study|Progressive disease|1|||
164411121|NCT01287520|593877112|FG003|Overall Study|Progressive disease|6|||
164411122|NCT01287520|593877113|FG004|Overall Study|Progressive disease|1|||
164411123|NCT01287520|593877114|FG005|Overall Study|Progressive disease|0|||
164411124|NCT01287520|593877115|FG006|Overall Study|Progressive disease|2|||
164411125|NCT01287520|593877116|FG007|Overall Study|Progressive disease|2|||
164411126|NCT01287520|593877117|FG008|Overall Study|Progressive disease|4|||
164463101|NCT04948697|594068574|FG001|Overall Study|Physician Decision|2|||
164463102|NCT04948697|594068573|FG000|Overall Study|Lost to Follow-up|0|||
164411127|NCT01287520|593877109|FG000|Overall Study|Withdrawal by Subject|0|||
164708564|NCT04713553|594958218|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
164708565|NCT04713553|594958219|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
164708566|NCT04713553|594958220|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
164708567|NCT04713553|594958221|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
164708568|NCT04713553|594958222|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
164708569|NCT04713553|594958216|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
164708570|NCT04713553|594958217|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
164708571|NCT04713553|594958218|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
164708572|NCT04713553|594958219|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
164708573|NCT04713553|594958220|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
164708574|NCT04713553|594958221|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
164708575|NCT04713553|594958222|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
164708576|NCT01682863|594958223|FG000|Overall Study|Subject/guardian decision|19|||
164411128|NCT01287520|593877110|FG001|Overall Study|Withdrawal by Subject|0|||
164411129|NCT01287520|593877111|FG002|Overall Study|Withdrawal by Subject|0|||
164411130|NCT01287520|593877112|FG003|Overall Study|Withdrawal by Subject|0|||
164411131|NCT01287520|593877113|FG004|Overall Study|Withdrawal by Subject|0|||
164411132|NCT01287520|593877114|FG005|Overall Study|Withdrawal by Subject|1|||
164411133|NCT01287520|593877115|FG006|Overall Study|Withdrawal by Subject|0|||
164411134|NCT01287520|593877116|FG007|Overall Study|Withdrawal by Subject|0|||
164411135|NCT01287520|593877117|FG008|Overall Study|Withdrawal by Subject|1|||
164411136|NCT03587142|593877118|FG000|Overall Study|Lost to Follow-up|5|||
164411137|NCT03587142|593877119|FG001|Overall Study|Lost to Follow-up|3|||
164411138|NCT03587142|593877118|FG000|Overall Study|Did not complete the f4 visit|3|||
164411139|NCT03587142|593877119|FG001|Overall Study|Did not complete the f4 visit|7|||
164411140|NCT02768662|593877120|FG000|Overall Study|Adverse Event|1|||
164411141|NCT02768662|593877120|FG000|Overall Study|Lost to Follow-up|4|||
164411142|NCT02768662|593877120|FG000|Overall Study|Withdrawal by Subject|3|||
164411143|NCT02768662|593877120|FG000|Overall Study|Study terminated by Sponsor|78|||
164411144|NCT03673462|593877121|FG000|Overall Study|Adverse Event|11|||
164411145|NCT03673462|593877122|FG001|Overall Study|Adverse Event|1|||
164411146|NCT03673462|593877121|FG000|Overall Study|Protocol Violation|25|||
164411147|NCT03673462|593877122|FG001|Overall Study|Protocol Violation|11|||
164411148|NCT03673462|593877121|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
164411149|NCT03673462|593877122|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
164411150|NCT03673462|593877121|FG000|Overall Study|Lost to Follow-up|102|||
164411151|NCT03673462|593877122|FG001|Overall Study|Lost to Follow-up|19|||
164411152|NCT02567825|593877127|FG000|Overall Study|No follow-up post-randomization|5|||
164411153|NCT02567825|593877128|FG001|Overall Study|No follow-up post-randomization|1|||
164411154|NCT02567825|593877127|FG000|Overall Study|Follow-up less than 23 months|16|||
164411155|NCT02567825|593877128|FG001|Overall Study|Follow-up less than 23 months|20|||
164411156|NCT01616771|593877137|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
164411157|NCT04359771|593877142|FG000|Overall Study|Lack of Efficacy|2|||
164411158|NCT04359771|593877143|FG001|Overall Study|Lack of Efficacy|2|||
164411159|NCT04041440|593877145|FG000|Overall Study|Withdrawal by Subject|0|||
164411160|NCT04041440|593877146|FG001|Overall Study|Withdrawal by Subject|1|||
164411161|NCT04041440|593877145|FG000|Overall Study|Lost to Follow-up|0|||
164411162|NCT04041440|593877146|FG001|Overall Study|Lost to Follow-up|1|||
164411163|NCT02306265|593877147|FG000|Overall Study|Withdrawal by Subject|1|||
164411164|NCT02247804|593877152|FG000|Treatment Period 1|Adverse Event|9|||
164411165|NCT02247804|593877153|FG001|Treatment Period 1|Adverse Event|2|||
164411166|NCT02247804|593877154|FG002|Treatment Period 1|Adverse Event|0|||
164411167|NCT02247804|593877152|FG000|Treatment Period 1|Lack of Efficacy|0|||
164411168|NCT02247804|593877153|FG001|Treatment Period 1|Lack of Efficacy|0|||
164411169|NCT02247804|593877154|FG002|Treatment Period 1|Lack of Efficacy|2|||
164411170|NCT02247804|593877152|FG000|Treatment Period 1|Lost to Follow-up|1|||
164411171|NCT02247804|593877153|FG001|Treatment Period 1|Lost to Follow-up|0|||
164411172|NCT02247804|593877154|FG002|Treatment Period 1|Lost to Follow-up|2|||
164411173|NCT02247804|593877152|FG000|Treatment Period 1|Personal Reasons|7|||
164411174|NCT02247804|593877153|FG001|Treatment Period 1|Personal Reasons|1|||
164411175|NCT02247804|593877154|FG002|Treatment Period 1|Personal Reasons|2|||
164411176|NCT02247804|593877152|FG000|Treatment Period 1|Protocol Deviation|0|||
164411177|NCT02247804|593877153|FG001|Treatment Period 1|Protocol Deviation|0|||
164411178|NCT02247804|593877154|FG002|Treatment Period 1|Protocol Deviation|1|||
164411179|NCT02247804|593877152|FG000|Treatment Period 1|Randomized but not Treated|5|||
164411180|NCT02247804|593877153|FG001|Treatment Period 1|Randomized but not Treated|1|||
164411181|NCT02247804|593877154|FG002|Treatment Period 1|Randomized but not Treated|1|||
164411182|NCT02247804|593877152|FG000|Treatment Period 2|Adverse Event|6|||
164411183|NCT02247804|593877153|FG001|Treatment Period 2|Adverse Event|3|||
164411184|NCT02247804|593877154|FG002|Treatment Period 2|Adverse Event|3|||
164411185|NCT02247804|593877152|FG000|Treatment Period 2|Lack of Efficacy|0|||
164411186|NCT02247804|593877153|FG001|Treatment Period 2|Lack of Efficacy|0|||
164411187|NCT02247804|593877154|FG002|Treatment Period 2|Lack of Efficacy|1|||
164463103|NCT04948697|594068574|FG001|Overall Study|Lost to Follow-up|1|||
164463104|NCT04948697|594068573|FG000|Overall Study|Other-Miscellaneous|1|||
164463105|NCT04948697|594068574|FG001|Overall Study|Other-Miscellaneous|0|||
164463106|NCT04948697|594068573|FG000|Overall Study|Randomized but not treated|0|||
164463107|NCT04948697|594068574|FG001|Overall Study|Randomized but not treated|1|||
164463108|NCT04870515|594068575|FG000|Overall Study|Lost to Follow-up|0|||
164463109|NCT04870515|594068576|FG001|Overall Study|Lost to Follow-up|2|||
164463110|NCT04870515|594068575|FG000|Overall Study|Withdrawal by Subject|0|||
164463111|NCT04870515|594068576|FG001|Overall Study|Withdrawal by Subject|1|||
164463112|NCT04870515|594068575|FG000|Overall Study|Withdrawal due to complications with standard of care treatment|2|||
164463113|NCT04870515|594068576|FG001|Overall Study|Withdrawal due to complications with standard of care treatment|0|||
164463114|NCT04032704|594068577|FG000|Part A|Withdrawal by Subject|0|||
164463115|NCT04032704|594068578|FG001|Part A|Withdrawal by Subject|0|||
164463116|NCT04032704|594068579|FG002|Part A|Withdrawal by Subject|3|||
164463117|NCT04032704|594068580|FG003|Part A|Withdrawal by Subject|0|||
164463118|NCT04032704|594068581|FG004|Part A|Withdrawal by Subject|1|||
164463119|NCT04032704|594068582|FG005|Part A|Withdrawal by Subject|7|||
164463120|NCT04032704|594068583|FG006|Part A|Withdrawal by Subject|0|||
164463121|NCT04032704|594068584|FG007|Part A|Withdrawal by Subject|0|||
164463122|NCT04032704|594068585|FG008|Part A|Withdrawal by Subject|0|||
164463123|NCT04032704|594068586|FG009|Part A|Withdrawal by Subject|0|||
164463124|NCT04032704|594068587|FG010|Part A|Withdrawal by Subject|0|||
164463125|NCT04032704|594068588|FG011|Part A|Withdrawal by Subject|0|||
164463126|NCT04032704|594068589|FG012|Part A|Withdrawal by Subject|0|||
164463127|NCT04032704|594068590|FG013|Part A|Withdrawal by Subject|0|||
164463128|NCT04032704|594068591|FG014|Part A|Withdrawal by Subject|0|||
164463129|NCT04032704|594068592|FG015|Part A|Withdrawal by Subject|0|||
164463130|NCT04032704|594068593|FG016|Part A|Withdrawal by Subject|0|||
164463131|NCT04032704|594068594|FG017|Part A|Withdrawal by Subject|0|||
164463132|NCT04032704|594068577|FG000|Part A|Lost to Follow-up|1|||
164463133|NCT04032704|594068578|FG001|Part A|Lost to Follow-up|0|||
164463134|NCT04032704|594068579|FG002|Part A|Lost to Follow-up|0|||
164463135|NCT04032704|594068580|FG003|Part A|Lost to Follow-up|0|||
164463136|NCT04032704|594068581|FG004|Part A|Lost to Follow-up|0|||
164463137|NCT04032704|594068582|FG005|Part A|Lost to Follow-up|0|||
164463138|NCT04032704|594068583|FG006|Part A|Lost to Follow-up|0|||
164463139|NCT04032704|594068584|FG007|Part A|Lost to Follow-up|0|||
164463140|NCT04032704|594068585|FG008|Part A|Lost to Follow-up|0|||
164463141|NCT04032704|594068586|FG009|Part A|Lost to Follow-up|0|||
164463142|NCT04032704|594068587|FG010|Part A|Lost to Follow-up|0|||
164463143|NCT04032704|594068588|FG011|Part A|Lost to Follow-up|0|||
164463144|NCT04032704|594068589|FG012|Part A|Lost to Follow-up|0|||
164463145|NCT04032704|594068590|FG013|Part A|Lost to Follow-up|0|||
164463146|NCT04032704|594068591|FG014|Part A|Lost to Follow-up|0|||
164463147|NCT04032704|594068592|FG015|Part A|Lost to Follow-up|0|||
164463148|NCT04032704|594068593|FG016|Part A|Lost to Follow-up|0|||
164463149|NCT04032704|594068594|FG017|Part A|Lost to Follow-up|0|||
164463150|NCT04032704|594068577|FG000|Part A|Death|9|||
164463151|NCT04032704|594068578|FG001|Part A|Death|2|||
164463152|NCT04032704|594068579|FG002|Part A|Death|10|||
164463153|NCT04032704|594068580|FG003|Part A|Death|7|||
164463154|NCT04032704|594068581|FG004|Part A|Death|4|||
164463155|NCT04032704|594068582|FG005|Part A|Death|5|||
164463156|NCT04032704|594068583|FG006|Part A|Death|0|||
164463157|NCT04032704|594068584|FG007|Part A|Death|0|||
164463158|NCT04032704|594068585|FG008|Part A|Death|0|||
164463159|NCT04032704|594068586|FG009|Part A|Death|0|||
164463160|NCT04032704|594068587|FG010|Part A|Death|0|||
164463161|NCT04032704|594068588|FG011|Part A|Death|0|||
164463162|NCT04032704|594068589|FG012|Part A|Death|0|||
164463163|NCT04032704|594068590|FG013|Part A|Death|0|||
164463164|NCT04032704|594068591|FG014|Part A|Death|0|||
164463165|NCT04032704|594068592|FG015|Part A|Death|0|||
164463166|NCT04032704|594068593|FG016|Part A|Death|0|||
164463167|NCT04032704|594068594|FG017|Part A|Death|0|||
164463168|NCT04032704|594068577|FG000|Part B|Other|0|||
164463169|NCT04032704|594068578|FG001|Part B|Other|0|||
164463170|NCT04032704|594068579|FG002|Part B|Other|0|||
164463171|NCT04032704|594068580|FG003|Part B|Other|0|||
164463172|NCT04032704|594068581|FG004|Part B|Other|0|||
164463173|NCT04032704|594068582|FG005|Part B|Other|0|||
164463174|NCT04032704|594068583|FG006|Part B|Other|0|||
164463175|NCT04032704|594068584|FG007|Part B|Other|1|||
164463176|NCT04032704|594068585|FG008|Part B|Other|2|||
164463177|NCT04032704|594068586|FG009|Part B|Other|1|||
164463178|NCT04032704|594068587|FG010|Part B|Other|1|||
164463179|NCT04032704|594068588|FG011|Part B|Other|1|||
164463180|NCT04032704|594068589|FG012|Part B|Other|5|||
164463181|NCT04032704|594068590|FG013|Part B|Other|13|||
164463182|NCT04032704|594068591|FG014|Part B|Other|0|||
164463183|NCT04032704|594068592|FG015|Part B|Other|0|||
164463184|NCT04032704|594068593|FG016|Part B|Other|0|||
164463185|NCT04032704|594068594|FG017|Part B|Other|0|||
164463186|NCT04032704|594068577|FG000|Part B|Study termination by Sponsor|0|||
164463187|NCT04032704|594068578|FG001|Part B|Study termination by Sponsor|0|||
164463188|NCT04032704|594068579|FG002|Part B|Study termination by Sponsor|0|||
164463189|NCT04032704|594068580|FG003|Part B|Study termination by Sponsor|0|||
164411188|NCT02247804|593877152|FG000|Treatment Period 2|Lost to Follow-up|0|||
164411189|NCT02247804|593877153|FG001|Treatment Period 2|Lost to Follow-up|1|||
164411190|NCT02247804|593877154|FG002|Treatment Period 2|Lost to Follow-up|1|||
164411191|NCT02247804|593877152|FG000|Treatment Period 2|Personal Reasons|2|||
164411192|NCT02247804|593877153|FG001|Treatment Period 2|Personal Reasons|1|||
164411193|NCT02247804|593877154|FG002|Treatment Period 2|Personal Reasons|1|||
164411194|NCT02247804|593877152|FG000|Treatment Period 2|Reason not Specified|0|||
164411195|NCT02247804|593877153|FG001|Treatment Period 2|Reason not Specified|0|||
164411196|NCT02247804|593877154|FG002|Treatment Period 2|Reason not Specified|2|||
164411197|NCT02247804|593877152|FG000|Treatment Period 3|Adverse Event|4|||
164411198|NCT02247804|593877153|FG001|Treatment Period 3|Adverse Event|3|||
164411199|NCT02247804|593877154|FG002|Treatment Period 3|Adverse Event|3|||
164411200|NCT02247804|593877152|FG000|Treatment Period 3|Lack of Efficacy|0|||
164411201|NCT02247804|593877153|FG001|Treatment Period 3|Lack of Efficacy|1|||
164411202|NCT02247804|593877154|FG002|Treatment Period 3|Lack of Efficacy|0|||
164411203|NCT02247804|593877152|FG000|Treatment Period 3|Lost to Follow-up|1|||
164411204|NCT02247804|593877153|FG001|Treatment Period 3|Lost to Follow-up|2|||
164411205|NCT02247804|593877154|FG002|Treatment Period 3|Lost to Follow-up|2|||
164411206|NCT02247804|593877152|FG000|Treatment Period 3|Personal Reasons|4|||
164411207|NCT02247804|593877153|FG001|Treatment Period 3|Personal Reasons|3|||
164411208|NCT02247804|593877154|FG002|Treatment Period 3|Personal Reasons|2|||
164411209|NCT02247804|593877152|FG000|Treatment Period 3|Reason not Specified|2|||
164411210|NCT02247804|593877153|FG001|Treatment Period 3|Reason not Specified|1|||
164411211|NCT02247804|593877154|FG002|Treatment Period 3|Reason not Specified|3|||
164411212|NCT01346514|593877157|FG000|Overall Study|Lost to Follow-up|19|||
164411213|NCT01346514|593877158|FG001|Overall Study|Lost to Follow-up|30|||
164411214|NCT01346514|593877157|FG000|Overall Study|Withdrawal by Subject|7|||
164411215|NCT01346514|593877158|FG001|Overall Study|Withdrawal by Subject|3|||
164411216|NCT01346514|593877157|FG000|Overall Study|Death|3|||
164411217|NCT01346514|593877158|FG001|Overall Study|Death|4|||
164411218|NCT00909480|593877159|FG000|Overall Study|Adverse Event|5|||
164411219|NCT00909480|593877160|FG001|Overall Study|Adverse Event|3|||
164411220|NCT00909480|593877159|FG000|Overall Study|Protocol Violation|6|||
164411221|NCT00909480|593877160|FG001|Overall Study|Protocol Violation|8|||
164411222|NCT00909480|593877159|FG000|Overall Study|Withdrawal criteria|9|||
164411223|NCT00909480|593877160|FG001|Overall Study|Withdrawal criteria|11|||
164411224|NCT00909480|593877159|FG000|Overall Study|Unclassified|18|||
164411225|NCT00909480|593877160|FG001|Overall Study|Unclassified|19|||
164411226|NCT03002038|593877164|FG000|Overall Study|Adverse Event|3|||
164411227|NCT03002038|593877165|FG001|Overall Study|Adverse Event|1|||
164411228|NCT03002038|593877164|FG000|Overall Study|Withdrawal by Subject|8|||
164411229|NCT03002038|593877165|FG001|Overall Study|Withdrawal by Subject|4|||
164411230|NCT03002038|593877164|FG000|Overall Study|Immigration to another region|0|||
164411231|NCT03002038|593877165|FG001|Overall Study|Immigration to another region|2|||
164411232|NCT01054573|593877166|FG000|Overall Study|Adverse Event|1|||
164411233|NCT01054573|593877167|FG001|Overall Study|Adverse Event|0|||
164411234|NCT01054573|593877168|FG002|Overall Study|Adverse Event|1|||
164411235|NCT01054573|593877169|FG003|Overall Study|Adverse Event|1|||
164463190|NCT04032704|594068581|FG004|Part B|Study termination by Sponsor|0|||
164463191|NCT04032704|594068582|FG005|Part B|Study termination by Sponsor|0|||
164411236|NCT01054573|593877166|FG000|Overall Study|Lost to Follow-up|0|||
164411237|NCT01054573|593877167|FG001|Overall Study|Lost to Follow-up|2|||
164411238|NCT01054573|593877168|FG002|Overall Study|Lost to Follow-up|0|||
164411239|NCT01054573|593877169|FG003|Overall Study|Lost to Follow-up|0|||
164411240|NCT01054573|593877166|FG000|Overall Study|Withdrawal by Subject|0|||
164411241|NCT01054573|593877167|FG001|Overall Study|Withdrawal by Subject|2|||
164463192|NCT04032704|594068583|FG006|Part B|Study termination by Sponsor|0|||
164463193|NCT04032704|594068584|FG007|Part B|Study termination by Sponsor|0|||
164463194|NCT04032704|594068585|FG008|Part B|Study termination by Sponsor|1|||
164463195|NCT04032704|594068586|FG009|Part B|Study termination by Sponsor|0|||
164463196|NCT04032704|594068587|FG010|Part B|Study termination by Sponsor|0|||
164463197|NCT04032704|594068588|FG011|Part B|Study termination by Sponsor|0|||
164708577|NCT01682863|594958224|FG001|Overall Study|Subject/guardian decision|12|||
164708578|NCT01682863|594958225|FG002|Overall Study|Subject/guardian decision|10|||
164708579|NCT01682863|594958223|FG000|Overall Study|Lost to Follow-up|5|||
164708580|NCT01682863|594958224|FG001|Overall Study|Lost to Follow-up|1|||
164708581|NCT01682863|594958225|FG002|Overall Study|Lost to Follow-up|6|||
164708582|NCT01682863|594958223|FG000|Overall Study|Death|1|||
164708583|NCT01682863|594958224|FG001|Overall Study|Death|3|||
164708584|NCT01682863|594958225|FG002|Overall Study|Death|4|||
164708585|NCT01682863|594958223|FG000|Overall Study|Protocol deviation|1|||
164708586|NCT01682863|594958224|FG001|Overall Study|Protocol deviation|0|||
164708587|NCT01682863|594958225|FG002|Overall Study|Protocol deviation|1|||
164708588|NCT01682863|594958223|FG000|Overall Study|Technical problems|1|||
164708589|NCT01682863|594958224|FG001|Overall Study|Technical problems|0|||
164708590|NCT01682863|594958225|FG002|Overall Study|Technical problems|0|||
164708591|NCT01682863|594958223|FG000|Overall Study|Adverse Event|0|||
164708592|NCT01682863|594958224|FG001|Overall Study|Adverse Event|1|||
164708593|NCT01682863|594958225|FG002|Overall Study|Adverse Event|2|||
164708594|NCT01682863|594958223|FG000|Overall Study|Physician Decision|0|||
164708595|NCT01682863|594958224|FG001|Overall Study|Physician Decision|0|||
164708596|NCT01682863|594958225|FG002|Overall Study|Physician Decision|1|||
164708597|NCT00977379|594958226|FG000|Overall Study|Withdrawal by Subject|1|||
164708598|NCT00977379|594958227|FG001|Overall Study|Withdrawal by Subject|1|||
164708599|NCT00977379|594958226|FG000|Overall Study|Death|7|||
164708600|NCT00977379|594958227|FG001|Overall Study|Death|9|||
164708601|NCT00977379|594958226|FG000|Overall Study|Premature Study Termination|4|||
164708602|NCT00977379|594958227|FG001|Overall Study|Premature Study Termination|0|||
164708603|NCT00977379|594958226|FG000|Overall Study|Participant Moving House|0|||
164708604|NCT00977379|594958227|FG001|Overall Study|Participant Moving House|1|||
164463198|NCT04032704|594068589|FG012|Part B|Study termination by Sponsor|0|||
164463199|NCT04032704|594068590|FG013|Part B|Study termination by Sponsor|0|||
164463200|NCT04032704|594068591|FG014|Part B|Study termination by Sponsor|0|||
164463201|NCT04032704|594068592|FG015|Part B|Study termination by Sponsor|0|||
164463202|NCT04032704|594068593|FG016|Part B|Study termination by Sponsor|0|||
164463203|NCT04032704|594068594|FG017|Part B|Study termination by Sponsor|0|||
164463204|NCT04032704|594068577|FG000|Part B|Withdrawal by Subject|0|||
164463205|NCT04032704|594068578|FG001|Part B|Withdrawal by Subject|0|||
164463206|NCT04032704|594068579|FG002|Part B|Withdrawal by Subject|0|||
164463207|NCT04032704|594068580|FG003|Part B|Withdrawal by Subject|0|||
164463208|NCT04032704|594068581|FG004|Part B|Withdrawal by Subject|0|||
164463209|NCT04032704|594068582|FG005|Part B|Withdrawal by Subject|0|||
164463210|NCT04032704|594068583|FG006|Part B|Withdrawal by Subject|3|||
164708605|NCT00977379|594958226|FG000|Overall Study|Randomization Error|0|||
164708606|NCT00977379|594958227|FG001|Overall Study|Randomization Error|1|||
164708607|NCT00918138|594958228|FG000|Overall Study|Subject withdrew consent|1|||
164708608|NCT00918138|594958229|FG001|Overall Study|Subject withdrew consent|1|||
164708609|NCT00918138|594958228|FG000|Overall Study|Death|1|||
164708610|NCT00918138|594958229|FG001|Overall Study|Death|0|||
164708611|NCT03972163|594958230|FG000|Overall Study|Death|0|||
164708612|NCT03972163|594958231|FG001|Overall Study|Death|1|||
164708613|NCT01199471|594958232|FG000|Overall Study|Protocol Violation|4|||
164708614|NCT01199471|594958232|FG000|Overall Study|Withdrawal by Subject|1|||
164708615|NCT01199471|594958232|FG000|Overall Study|Physician Decision|1|||
164708616|NCT04053465|594958235|FG000|Overall Study|Withdrawal by Subject|4|||
164708617|NCT04053465|594958236|FG001|Overall Study|Withdrawal by Subject|4|||
164708618|NCT02085135|594958237|FG000|Overall Study|Adverse Event|4|||
164708619|NCT02085135|594958238|FG001|Overall Study|Adverse Event|7|||
164708620|NCT02085135|594958237|FG000|Overall Study|Lost to Follow-up|2|||
164708621|NCT02085135|594958238|FG001|Overall Study|Lost to Follow-up|2|||
164708622|NCT02085135|594958237|FG000|Overall Study|Withdrawal by Subject|3|||
164708623|NCT02085135|594958238|FG001|Overall Study|Withdrawal by Subject|0|||
164708624|NCT02085135|594958237|FG000|Overall Study|Lack of Efficacy|2|||
164708625|NCT02085135|594958238|FG001|Overall Study|Lack of Efficacy|0|||
164708626|NCT01212588|594958241|FG000|Overall Study|Physician Decision|0|||
164708627|NCT01212588|594958242|FG001|Overall Study|Physician Decision|1|||
164708628|NCT01212588|594958241|FG000|Overall Study|Protocol Violation|1|||
164708629|NCT01212588|594958242|FG001|Overall Study|Protocol Violation|1|||
164708630|NCT02885181|594958243|FG000|Overall Study|Investigator's Discretion|0|||
164708631|NCT02885181|594958244|FG001|Overall Study|Investigator's Discretion|1|||
164463211|NCT04032704|594068584|FG007|Part B|Withdrawal by Subject|2|||
164463212|NCT04032704|594068585|FG008|Part B|Withdrawal by Subject|2|||
164463213|NCT04032704|594068586|FG009|Part B|Withdrawal by Subject|1|||
164708632|NCT02885181|594958245|FG002|Overall Study|Investigator's Discretion|0|||
164708633|NCT02885181|594958246|FG003|Overall Study|Investigator's Discretion|1|||
164708634|NCT02885181|594958243|FG000|Overall Study|Adverse Event|0|||
164708635|NCT02885181|594958244|FG001|Overall Study|Adverse Event|0|||
164708636|NCT02885181|594958245|FG002|Overall Study|Adverse Event|0|||
164708637|NCT02885181|594958246|FG003|Overall Study|Adverse Event|1|||
164708638|NCT02885181|594958243|FG000|Overall Study|Withdrawal by Subject|0|||
164708639|NCT02885181|594958244|FG001|Overall Study|Withdrawal by Subject|0|||
164708640|NCT02885181|594958245|FG002|Overall Study|Withdrawal by Subject|0|||
164708641|NCT02885181|594958246|FG003|Overall Study|Withdrawal by Subject|1|||
164708642|NCT00742924|594958251|FG000|Overall Study|Adverse Event|0|||
164708643|NCT00742924|594958252|FG001|Overall Study|Adverse Event|0|||
164708644|NCT00742924|594958253|FG002|Overall Study|Adverse Event|1|||
164708645|NCT00742924|594958254|FG003|Overall Study|Adverse Event|1|||
164708646|NCT00742924|594958251|FG000|Overall Study|Lack of Efficacy|5|||
164708647|NCT00742924|594958252|FG001|Overall Study|Lack of Efficacy|1|||
164708648|NCT00742924|594958253|FG002|Overall Study|Lack of Efficacy|2|||
164708649|NCT00742924|594958254|FG003|Overall Study|Lack of Efficacy|4|||
164708650|NCT00742924|594958251|FG000|Overall Study|Physician Decision|0|||
164708651|NCT00742924|594958252|FG001|Overall Study|Physician Decision|0|||
164708652|NCT00742924|594958253|FG002|Overall Study|Physician Decision|0|||
164708653|NCT00742924|594958254|FG003|Overall Study|Physician Decision|1|||
164708654|NCT00742924|594958251|FG000|Overall Study|Withdrawal by Subject|0|||
164708655|NCT00742924|594958252|FG001|Overall Study|Withdrawal by Subject|1|||
164708656|NCT00742924|594958253|FG002|Overall Study|Withdrawal by Subject|1|||
164708657|NCT00742924|594958254|FG003|Overall Study|Withdrawal by Subject|0|||
164708658|NCT05005312|594958268|FG000|Overall Study|Enrolled, but not treated|0|||
164708659|NCT05005312|594958269|FG001|Overall Study|Enrolled, but not treated|1|||
164708660|NCT01755767|594958272|FG000|Overall Study|Progressive Disease|8|||
164708661|NCT01755767|594958273|FG001|Overall Study|Progressive Disease|7|||
164708662|NCT01755767|594958274|FG002|Overall Study|Progressive Disease|91|||
164411242|NCT01054573|593877168|FG002|Overall Study|Withdrawal by Subject|2|||
164411243|NCT01054573|593877169|FG003|Overall Study|Withdrawal by Subject|1|||
164411244|NCT00393523|593877170|FG000|Overall Study|Lost to Follow-up|0|||
164411245|NCT00393523|593877171|FG001|Overall Study|Lost to Follow-up|0|||
164411246|NCT00393523|593877172|FG002|Overall Study|Lost to Follow-up|0|||
164411247|NCT00393523|593877173|FG003|Overall Study|Lost to Follow-up|2|||
164411248|NCT00393523|593877174|FG004|Overall Study|Lost to Follow-up|1|||
164411249|NCT00393523|593877170|FG000|Overall Study|Protocol Violation|6|||
164411250|NCT00393523|593877171|FG001|Overall Study|Protocol Violation|2|||
164411251|NCT00393523|593877172|FG002|Overall Study|Protocol Violation|0|||
164411252|NCT00393523|593877173|FG003|Overall Study|Protocol Violation|1|||
164411253|NCT00393523|593877174|FG004|Overall Study|Protocol Violation|0|||
164411254|NCT00393523|593877170|FG000|Overall Study|Withdrawal by Subject|6|||
164411255|NCT00393523|593877171|FG001|Overall Study|Withdrawal by Subject|7|||
164411256|NCT00393523|593877172|FG002|Overall Study|Withdrawal by Subject|2|||
164411257|NCT00393523|593877173|FG003|Overall Study|Withdrawal by Subject|3|||
164411258|NCT00393523|593877174|FG004|Overall Study|Withdrawal by Subject|0|||
164411259|NCT00393523|593877170|FG000|Overall Study|Difficulties in specimen collection|0|||
164411260|NCT00393523|593877171|FG001|Overall Study|Difficulties in specimen collection|0|||
164411261|NCT00393523|593877172|FG002|Overall Study|Difficulties in specimen collection|1|||
164411262|NCT00393523|593877173|FG003|Overall Study|Difficulties in specimen collection|0|||
164411263|NCT00393523|593877174|FG004|Overall Study|Difficulties in specimen collection|0|||
164411264|NCT00393523|593877170|FG000|Overall Study|Vaccine supply issue|0|||
164411265|NCT00393523|593877171|FG001|Overall Study|Vaccine supply issue|0|||
164411266|NCT00393523|593877172|FG002|Overall Study|Vaccine supply issue|1|||
164411267|NCT00393523|593877173|FG003|Overall Study|Vaccine supply issue|0|||
164411268|NCT00393523|593877174|FG004|Overall Study|Vaccine supply issue|0|||
164411269|NCT01735396|593877178|FG000|Overall Study|not evaluable|1|||
164411270|NCT03724396|593877181|FG000|Overall Study|Lost to Follow-up|1|||
164411271|NCT03724396|593877182|FG001|Overall Study|Lost to Follow-up|1|||
164411272|NCT03724396|593877181|FG000|Overall Study|Withdrawal by Subject|1|||
164411273|NCT03724396|593877182|FG001|Overall Study|Withdrawal by Subject|0|||
164411274|NCT00682643|593877185|FG000|Overall Study|Adverse Event|12|||
164411275|NCT00682643|593877186|FG001|Overall Study|Adverse Event|23|||
164411276|NCT00682643|593877185|FG000|Overall Study|Lack of Efficacy|2|||
164411277|NCT00682643|593877186|FG001|Overall Study|Lack of Efficacy|0|||
164411278|NCT00682643|593877185|FG000|Overall Study|Protocol Violation|38|||
164411279|NCT00682643|593877186|FG001|Overall Study|Protocol Violation|76|||
164411280|NCT00682643|593877185|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
164411281|NCT00682643|593877186|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
164411282|NCT00682643|593877185|FG000|Overall Study|Lost to Follow-up|1|||
164411283|NCT00682643|593877186|FG001|Overall Study|Lost to Follow-up|6|||
164411284|NCT00682643|593877185|FG000|Overall Study|Physician Decision|2|||
164411285|NCT00682643|593877186|FG001|Overall Study|Physician Decision|6|||
164708663|NCT01755767|594958275|FG003|Overall Study|Progressive Disease|43|||
164708664|NCT01755767|594958272|FG000|Overall Study|Clinical Disease Progression|4|||
164411286|NCT00682643|593877185|FG000|Overall Study|Withdrawal by Subject|19|||
164411287|NCT00682643|593877186|FG001|Overall Study|Withdrawal by Subject|53|||
164708665|NCT01755767|594958273|FG001|Overall Study|Clinical Disease Progression|2|||
164708666|NCT01755767|594958274|FG002|Overall Study|Clinical Disease Progression|29|||
164708667|NCT01755767|594958275|FG003|Overall Study|Clinical Disease Progression|20|||
164708668|NCT01755767|594958272|FG000|Overall Study|Radiographic Disease Progression|9|||
164708669|NCT01755767|594958273|FG001|Overall Study|Radiographic Disease Progression|4|||
164708670|NCT01755767|594958274|FG002|Overall Study|Radiographic Disease Progression|44|||
164708671|NCT01755767|594958275|FG003|Overall Study|Radiographic Disease Progression|27|||
164708672|NCT01755767|594958272|FG000|Overall Study|Adverse Event|6|||
164708673|NCT01755767|594958273|FG001|Overall Study|Adverse Event|0|||
164708674|NCT01755767|594958274|FG002|Overall Study|Adverse Event|28|||
164708675|NCT01755767|594958275|FG003|Overall Study|Adverse Event|11|||
164708676|NCT01755767|594958272|FG000|Overall Study|Death|1|||
164708677|NCT01755767|594958273|FG001|Overall Study|Death|2|||
164708678|NCT01755767|594958274|FG002|Overall Study|Death|15|||
164708679|NCT01755767|594958275|FG003|Overall Study|Death|4|||
164708680|NCT01755767|594958272|FG000|Overall Study|Subject Decision|0|||
164708681|NCT01755767|594958273|FG001|Overall Study|Subject Decision|0|||
164708682|NCT01755767|594958274|FG002|Overall Study|Subject Decision|10|||
164708683|NCT01755767|594958275|FG003|Overall Study|Subject Decision|3|||
164708684|NCT01755767|594958272|FG000|Overall Study|Withdrawal by Subject|0|||
164708685|NCT01755767|594958273|FG001|Overall Study|Withdrawal by Subject|0|||
164708686|NCT01755767|594958274|FG002|Overall Study|Withdrawal by Subject|2|||
164708687|NCT01755767|594958275|FG003|Overall Study|Withdrawal by Subject|1|||
164708688|NCT01755767|594958272|FG000|Overall Study|Other|0|||
164708689|NCT01755767|594958273|FG001|Overall Study|Other|0|||
164708690|NCT01755767|594958274|FG002|Overall Study|Other|2|||
164708691|NCT01755767|594958275|FG003|Overall Study|Other|3|||
164708692|NCT01755767|594958272|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
164708693|NCT01755767|594958273|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
164708694|NCT01755767|594958274|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
164708695|NCT01755767|594958275|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
164708696|NCT06077149|594958276|FG000|Overall Study|Death|1|||
164708697|NCT06077149|594958277|FG001|Overall Study|Death|0|||
164708698|NCT06077149|594958276|FG000|Overall Study|Withdrawal by Subject|2|||
164708699|NCT06077149|594958277|FG001|Overall Study|Withdrawal by Subject|0|||
164708700|NCT06077149|594958276|FG000|Overall Study|RSV infection before vaccination|3|||
164708701|NCT06077149|594958277|FG001|Overall Study|RSV infection before vaccination|0|||
164708702|NCT04658095|594958278|FG000|Overall Study|Study terminated|5|||
164708703|NCT04658095|594958279|FG001|Overall Study|Study terminated|1|||
164708704|NCT04658095|594958280|FG002|Overall Study|Study terminated|4|||
164708705|NCT01441947|594958281|FG000|Overall Study|Withdrawal by Subject|3|||
164463214|NCT04032704|594068587|FG010|Part B|Withdrawal by Subject|4|||
164463215|NCT04032704|594068588|FG011|Part B|Withdrawal by Subject|6|||
164463216|NCT04032704|594068589|FG012|Part B|Withdrawal by Subject|2|||
164463217|NCT04032704|594068590|FG013|Part B|Withdrawal by Subject|1|||
164463218|NCT04032704|594068591|FG014|Part B|Withdrawal by Subject|0|||
164463219|NCT04032704|594068592|FG015|Part B|Withdrawal by Subject|1|||
164463220|NCT04032704|594068593|FG016|Part B|Withdrawal by Subject|0|||
164463221|NCT04032704|594068594|FG017|Part B|Withdrawal by Subject|0|||
164463222|NCT04032704|594068577|FG000|Part B|Lost to Follow-up|0|||
164463223|NCT04032704|594068578|FG001|Part B|Lost to Follow-up|0|||
164463224|NCT04032704|594068579|FG002|Part B|Lost to Follow-up|0|||
164463225|NCT04032704|594068580|FG003|Part B|Lost to Follow-up|0|||
164463226|NCT04032704|594068581|FG004|Part B|Lost to Follow-up|0|||
164463227|NCT04032704|594068582|FG005|Part B|Lost to Follow-up|0|||
164463228|NCT04032704|594068583|FG006|Part B|Lost to Follow-up|0|||
164463229|NCT04032704|594068584|FG007|Part B|Lost to Follow-up|0|||
164463230|NCT04032704|594068585|FG008|Part B|Lost to Follow-up|0|||
164463231|NCT04032704|594068586|FG009|Part B|Lost to Follow-up|0|||
164463232|NCT04032704|594068587|FG010|Part B|Lost to Follow-up|0|||
164463233|NCT04032704|594068588|FG011|Part B|Lost to Follow-up|1|||
164463234|NCT04032704|594068589|FG012|Part B|Lost to Follow-up|0|||
164708706|NCT01441947|594958282|FG001|Overall Study|Withdrawal by Subject|0|||
164708707|NCT02970318|594958284|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
164463235|NCT04032704|594068590|FG013|Part B|Lost to Follow-up|0|||
164463236|NCT04032704|594068591|FG014|Part B|Lost to Follow-up|0|||
164463237|NCT04032704|594068592|FG015|Part B|Lost to Follow-up|0|||
164463238|NCT04032704|594068593|FG016|Part B|Lost to Follow-up|0|||
164708708|NCT02970318|594958285|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
164708709|NCT02970318|594958286|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
164708710|NCT02970318|594958287|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
164708711|NCT02970318|594958284|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
164463239|NCT04032704|594068594|FG017|Part B|Lost to Follow-up|0|||
164463240|NCT04032704|594068577|FG000|Part B|Death|0|||
164463241|NCT04032704|594068578|FG001|Part B|Death|0|||
164463242|NCT04032704|594068579|FG002|Part B|Death|0|||
164463243|NCT04032704|594068580|FG003|Part B|Death|0|||
164463244|NCT04032704|594068581|FG004|Part B|Death|0|||
164463245|NCT04032704|594068582|FG005|Part B|Death|0|||
164463246|NCT04032704|594068583|FG006|Part B|Death|13|||
164708712|NCT02970318|594958285|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
164708713|NCT02970318|594958286|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
164708714|NCT02970318|594958287|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
164708715|NCT02970318|594958284|FG000|Overall for Arm A & Main for Arm B|Death|41|||
164708716|NCT02970318|594958285|FG001|Overall for Arm A & Main for Arm B|Death|33|||
164708717|NCT02970318|594958286|FG002|Overall for Arm A & Main for Arm B|Death|0|||
164708718|NCT02970318|594958287|FG003|Overall for Arm A & Main for Arm B|Death|0|||
164708719|NCT02970318|594958284|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
164708720|NCT02970318|594958285|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
164708721|NCT02970318|594958286|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
164708722|NCT02970318|594958287|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
164708723|NCT02970318|594958284|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
164708724|NCT02970318|594958285|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
164708725|NCT02970318|594958286|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
164708726|NCT02970318|594958287|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
164708727|NCT02970318|594958284|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
164708728|NCT02970318|594958285|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
164708729|NCT02970318|594958286|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
164708730|NCT02970318|594958287|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
164708731|NCT02970318|594958284|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
164708732|NCT02970318|594958285|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
164708733|NCT02970318|594958286|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
164708734|NCT02970318|594958287|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
164708735|NCT03384654|594958288|FG000|Overall Study|Withdrawal by Subject|0|||
164708736|NCT03384654|594958289|FG001|Overall Study|Withdrawal by Subject|0|||
164708737|NCT03384654|594958290|FG002|Overall Study|Withdrawal by Subject|1|||
164708738|NCT03384654|594958291|FG003|Overall Study|Withdrawal by Subject|0|||
164708739|NCT01616953|594958292|FG000|Overall Study|Lost to Follow-up|1|||
164708740|NCT01616953|594958293|FG001|Overall Study|Lost to Follow-up|0|||
164708741|NCT01616953|594958292|FG000|Overall Study|lack of bone and soft tissue|1|||
164708742|NCT01616953|594958293|FG001|Overall Study|lack of bone and soft tissue|0|||
164708743|NCT02036775|594958295|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
164708744|NCT02036775|594958296|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
164708745|NCT02036775|594958297|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
164708746|NCT02036775|594958298|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
164708747|NCT02036775|594958299|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
164708748|NCT02036775|594958300|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
164708749|NCT03496610|594958304|FG000|Overall Study|Lost to Follow-up|3|||
164708750|NCT03496610|594958305|FG001|Overall Study|Lost to Follow-up|2|||
164708751|NCT03496610|594958304|FG000|Overall Study|Physician Decision|1|||
164708752|NCT03496610|594958305|FG001|Overall Study|Physician Decision|0|||
164708753|NCT03496610|594958304|FG000|Overall Study|Withdrawal by Subject|1|||
164708754|NCT03496610|594958305|FG001|Overall Study|Withdrawal by Subject|0|||
164708755|NCT00426361|594958306|FG000|Overall Study|Lost to Follow-up|3|||
164708756|NCT00426361|594958307|FG001|Overall Study|Lost to Follow-up|2|||
164708757|NCT00426361|594958308|FG002|Overall Study|Lost to Follow-up|5|||
164708758|NCT00426361|594958306|FG000|Overall Study|Withdrawal by Subject|1|||
164708759|NCT00426361|594958307|FG001|Overall Study|Withdrawal by Subject|3|||
164708760|NCT00426361|594958308|FG002|Overall Study|Withdrawal by Subject|0|||
164708761|NCT01408628|594958309|FG000|Consented|Withdrawal by Subject|12|||
164708762|NCT01408628|594958309|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
164708763|NCT01408628|594958309|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
164708764|NCT01408628|594958309|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
164708765|NCT01970865|594958310|FG000|Overall Study|Death|3|||
164708766|NCT01970865|594958311|FG001|Overall Study|Death|2|||
164708767|NCT01970865|594958312|FG002|Overall Study|Death|3|||
164708768|NCT01970865|594958313|FG003|Overall Study|Death|6|||
164708769|NCT01970865|594958314|FG004|Overall Study|Death|9|||
164708770|NCT01970865|594958315|FG005|Overall Study|Death|3|||
164708771|NCT01970865|594958316|FG006|Overall Study|Death|2|||
164708772|NCT01970865|594958317|FG007|Overall Study|Death|3|||
164708773|NCT01970865|594958318|FG008|Overall Study|Death|2|||
164411288|NCT00682643|593877185|FG000|Overall Study|Did Not Receive Study Drug|1|||
164708774|NCT01970865|594958319|FG009|Overall Study|Death|2|||
164708775|NCT01970865|594958320|FG010|Overall Study|Death|8|||
164708776|NCT01970865|594958321|FG011|Overall Study|Death|13|||
164708777|NCT01970865|594958322|FG012|Overall Study|Death|25|||
164708778|NCT01970865|594958323|FG013|Overall Study|Death|46|||
164708779|NCT01970865|594958324|FG014|Overall Study|Death|37|||
164708780|NCT01970865|594958325|FG015|Overall Study|Death|22|||
164708781|NCT01970865|594958326|FG016|Overall Study|Death|1|||
164463247|NCT04032704|594068584|FG007|Part B|Death|13|||
164463248|NCT04032704|594068585|FG008|Part B|Death|14|||
164463249|NCT04032704|594068586|FG009|Part B|Death|12|||
164463250|NCT04032704|594068587|FG010|Part B|Death|12|||
164463251|NCT04032704|594068588|FG011|Part B|Death|13|||
164463252|NCT04032704|594068589|FG012|Part B|Death|7|||
164463253|NCT04032704|594068590|FG013|Part B|Death|17|||
164463254|NCT04032704|594068591|FG014|Part B|Death|2|||
164463255|NCT04032704|594068592|FG015|Part B|Death|1|||
164463256|NCT04032704|594068593|FG016|Part B|Death|2|||
164463257|NCT04032704|594068594|FG017|Part B|Death|2|||
164463258|NCT01501955|594068595|FG000|Overall Study|Withdrawal by Subject|1|||
164463259|NCT01501955|594068596|FG001|Overall Study|Withdrawal by Subject|0|||
164463260|NCT01501955|594068595|FG000|Overall Study|Adverse Event|1|||
164463261|NCT01501955|594068596|FG001|Overall Study|Adverse Event|3|||
164463262|NCT02969707|594068597|FG000|Overall Study|Withdrawal by Subject|6|||
164463263|NCT02969707|594068598|FG001|Overall Study|Withdrawal by Subject|5|||
164463264|NCT02969707|594068597|FG000|Overall Study|Severe anxiety|0|||
164463265|NCT02969707|594068598|FG001|Overall Study|Severe anxiety|1|||
164463266|NCT02969707|594068597|FG000|Overall Study|Positive toxicology screen|0|||
164463267|NCT02969707|594068598|FG001|Overall Study|Positive toxicology screen|2|||
164463268|NCT02969707|594068597|FG000|Overall Study|Claustrophobia|2|||
164463269|NCT02969707|594068598|FG001|Overall Study|Claustrophobia|2|||
164463270|NCT02969707|594068597|FG000|Overall Study|Non-compliance|1|||
164463271|NCT02969707|594068598|FG001|Overall Study|Non-compliance|2|||
164463272|NCT04298983|594068599|FG000|Overall Study|Adverse Event|4|||
164463273|NCT04298983|594068599|FG000|Overall Study|Lack of Efficacy|3|||
164463274|NCT04314713|594068600|FG000|Overall Study|Lost to Follow-up|0|||
164463275|NCT04314713|594068601|FG001|Overall Study|Lost to Follow-up|0|||
164463276|NCT04314713|594068602|FG002|Overall Study|Lost to Follow-up|0|||
164463277|NCT04314713|594068603|FG003|Overall Study|Lost to Follow-up|1|||
164463278|NCT04314713|594068604|FG004|Overall Study|Lost to Follow-up|0|||
164463279|NCT04314713|594068605|FG005|Overall Study|Lost to Follow-up|0|||
164463280|NCT02714257|594068606|FG000|Overall Study|Withdrawal by Subject|6|||
164463281|NCT02714257|594068607|FG001|Overall Study|Withdrawal by Subject|11|||
164463282|NCT02714257|594068606|FG000|Overall Study|Death|3|||
164708782|NCT01970865|594958327|FG017|Overall Study|Death|17|||
164708783|NCT01970865|594958310|FG000|Overall Study|Lost to Follow-up|0|||
164708784|NCT01970865|594958311|FG001|Overall Study|Lost to Follow-up|0|||
164411289|NCT00682643|593877186|FG001|Overall Study|Did Not Receive Study Drug|1|||
164411290|NCT01875185|593877187|FG000|Overall Study|study was terminated|52|||
164411291|NCT01875185|593877188|FG001|Overall Study|study was terminated|48|||
164411292|NCT03238300|593877189|FG000|Baseline (Before Intervention)|Physician Decision|0|||
164411293|NCT03238300|593877190|FG001|Baseline (Before Intervention)|Physician Decision|1|||
164411294|NCT03238300|593877189|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
164411295|NCT03238300|593877190|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
164411296|NCT03238300|593877189|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
164411297|NCT03238300|593877190|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
164411298|NCT03238300|593877189|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
164411299|NCT03238300|593877190|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
164411300|NCT04512066|593877201|FG000|Double-blind Treatment Period|Adverse Event|6|||
164411301|NCT04512066|593877202|FG001|Double-blind Treatment Period|Adverse Event|4|||
164411302|NCT04512066|593877203|FG002|Double-blind Treatment Period|Adverse Event|5|||
164411303|NCT04512066|593877204|FG003|Double-blind Treatment Period|Adverse Event|1|||
164411304|NCT04512066|593877205|FG004|Double-blind Treatment Period|Adverse Event|0|||
164411305|NCT04512066|593877206|FG005|Double-blind Treatment Period|Adverse Event|0|||
164411306|NCT04512066|593877201|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
164708785|NCT01970865|594958312|FG002|Overall Study|Lost to Follow-up|0|||
164708786|NCT01970865|594958313|FG003|Overall Study|Lost to Follow-up|1|||
164708787|NCT01970865|594958314|FG004|Overall Study|Lost to Follow-up|1|||
164708788|NCT01970865|594958315|FG005|Overall Study|Lost to Follow-up|0|||
164411307|NCT04512066|593877202|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
164411308|NCT04512066|593877203|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
164411309|NCT04512066|593877204|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
164411310|NCT04512066|593877205|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
164411311|NCT04512066|593877206|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
164411312|NCT04512066|593877201|FG000|Double-blind Treatment Period|Physician Decision|1|||
164411313|NCT04512066|593877202|FG001|Double-blind Treatment Period|Physician Decision|0|||
164411314|NCT04512066|593877203|FG002|Double-blind Treatment Period|Physician Decision|1|||
164411315|NCT04512066|593877204|FG003|Double-blind Treatment Period|Physician Decision|0|||
164463283|NCT02714257|594068607|FG001|Overall Study|Death|4|||
164463284|NCT02714257|594068606|FG000|Overall Study|Lost to Follow-up|1|||
164463285|NCT02714257|594068607|FG001|Overall Study|Lost to Follow-up|6|||
164463286|NCT05477186|594068610|FG000|Overall Study|Vaccine not administered|0|||
164463287|NCT05477186|594068611|FG001|Overall Study|Vaccine not administered|2|||
164463288|NCT05477186|594068612|FG002|Overall Study|Vaccine not administered|1|||
164463289|NCT05477186|594068613|FG003|Overall Study|Vaccine not administered|0|||
164708789|NCT01970865|594958316|FG006|Overall Study|Lost to Follow-up|0|||
164411316|NCT04512066|593877205|FG004|Double-blind Treatment Period|Physician Decision|0|||
164411317|NCT04512066|593877206|FG005|Double-blind Treatment Period|Physician Decision|0|||
164411318|NCT04512066|593877201|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
164411319|NCT04512066|593877202|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
164411320|NCT04512066|593877203|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
164411321|NCT04512066|593877204|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
164411322|NCT04512066|593877205|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
164708790|NCT01970865|594958317|FG007|Overall Study|Lost to Follow-up|0|||
164708791|NCT01970865|594958318|FG008|Overall Study|Lost to Follow-up|0|||
164708792|NCT01970865|594958319|FG009|Overall Study|Lost to Follow-up|0|||
164708793|NCT01970865|594958320|FG010|Overall Study|Lost to Follow-up|1|||
164708794|NCT01970865|594958321|FG011|Overall Study|Lost to Follow-up|0|||
164708795|NCT01970865|594958322|FG012|Overall Study|Lost to Follow-up|2|||
164708796|NCT01970865|594958323|FG013|Overall Study|Lost to Follow-up|0|||
164708797|NCT01970865|594958324|FG014|Overall Study|Lost to Follow-up|1|||
164708798|NCT01970865|594958325|FG015|Overall Study|Lost to Follow-up|4|||
164708799|NCT01970865|594958326|FG016|Overall Study|Lost to Follow-up|0|||
164708800|NCT01970865|594958327|FG017|Overall Study|Lost to Follow-up|1|||
164708801|NCT01970865|594958310|FG000|Overall Study|Other|0|||
164708802|NCT01970865|594958311|FG001|Overall Study|Other|1|||
164708803|NCT01970865|594958312|FG002|Overall Study|Other|0|||
164708804|NCT01970865|594958313|FG003|Overall Study|Other|1|||
164708805|NCT01970865|594958314|FG004|Overall Study|Other|1|||
164708806|NCT01970865|594958315|FG005|Overall Study|Other|0|||
164708807|NCT01970865|594958316|FG006|Overall Study|Other|1|||
164708808|NCT01970865|594958317|FG007|Overall Study|Other|0|||
164708809|NCT01970865|594958318|FG008|Overall Study|Other|0|||
164708810|NCT01970865|594958319|FG009|Overall Study|Other|0|||
164708811|NCT01970865|594958320|FG010|Overall Study|Other|2|||
164708812|NCT01970865|594958321|FG011|Overall Study|Other|3|||
164708813|NCT01970865|594958322|FG012|Overall Study|Other|8|||
164708814|NCT01970865|594958323|FG013|Overall Study|Other|3|||
164708815|NCT01970865|594958324|FG014|Overall Study|Other|2|||
164708816|NCT01970865|594958325|FG015|Overall Study|Other|3|||
164708817|NCT01970865|594958326|FG016|Overall Study|Other|0|||
164708818|NCT01970865|594958327|FG017|Overall Study|Other|2|||
164708819|NCT01970865|594958310|FG000|Overall Study|Participant refused further follow-up|0|||
164708820|NCT01970865|594958311|FG001|Overall Study|Participant refused further follow-up|0|||
164708821|NCT01970865|594958312|FG002|Overall Study|Participant refused further follow-up|0|||
164144813|NCT01524978|592891783|FG009|Overall Study|Lost to Follow-up|1|||
164411323|NCT04512066|593877206|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
164411324|NCT04512066|593877201|FG000|Extension Period|Adverse Event|0|||
164411325|NCT04512066|593877202|FG001|Extension Period|Adverse Event|1|||
164411326|NCT04512066|593877203|FG002|Extension Period|Adverse Event|4|||
164411327|NCT04512066|593877204|FG003|Extension Period|Adverse Event|3|||
164411328|NCT04512066|593877205|FG004|Extension Period|Adverse Event|1|||
164411329|NCT04512066|593877206|FG005|Extension Period|Adverse Event|3|||
164411330|NCT04512066|593877201|FG000|Extension Period|Death|0|||
164411331|NCT04512066|593877202|FG001|Extension Period|Death|0|||
164411332|NCT04512066|593877203|FG002|Extension Period|Death|0|||
164411333|NCT04512066|593877204|FG003|Extension Period|Death|0|||
164411334|NCT04512066|593877205|FG004|Extension Period|Death|0|||
164411335|NCT04512066|593877206|FG005|Extension Period|Death|1|||
164411336|NCT04512066|593877201|FG000|Extension Period|Lack of Efficacy|0|||
164411337|NCT04512066|593877202|FG001|Extension Period|Lack of Efficacy|4|||
164411338|NCT04512066|593877203|FG002|Extension Period|Lack of Efficacy|4|||
164411339|NCT04512066|593877204|FG003|Extension Period|Lack of Efficacy|1|||
164411340|NCT04512066|593877205|FG004|Extension Period|Lack of Efficacy|3|||
164411341|NCT04512066|593877206|FG005|Extension Period|Lack of Efficacy|3|||
164411342|NCT04512066|593877201|FG000|Extension Period|Lost to Follow-up|0|||
164411343|NCT04512066|593877202|FG001|Extension Period|Lost to Follow-up|1|||
164411344|NCT04512066|593877203|FG002|Extension Period|Lost to Follow-up|5|||
164411345|NCT04512066|593877204|FG003|Extension Period|Lost to Follow-up|2|||
164411346|NCT04512066|593877205|FG004|Extension Period|Lost to Follow-up|3|||
164411347|NCT04512066|593877206|FG005|Extension Period|Lost to Follow-up|2|||
164411348|NCT04512066|593877201|FG000|Extension Period|Non-compliance with study drug|0|||
164411349|NCT04512066|593877202|FG001|Extension Period|Non-compliance with study drug|1|||
164411350|NCT04512066|593877203|FG002|Extension Period|Non-compliance with study drug|0|||
164411351|NCT04512066|593877204|FG003|Extension Period|Non-compliance with study drug|0|||
164411352|NCT04512066|593877205|FG004|Extension Period|Non-compliance with study drug|0|||
164411353|NCT04512066|593877206|FG005|Extension Period|Non-compliance with study drug|1|||
164411354|NCT04512066|593877201|FG000|Extension Period|Other|0|||
164411355|NCT04512066|593877202|FG001|Extension Period|Other|2|||
164708822|NCT01970865|594958313|FG003|Overall Study|Participant refused further follow-up|2|||
164708823|NCT01970865|594958314|FG004|Overall Study|Participant refused further follow-up|3|||
164708824|NCT01970865|594958315|FG005|Overall Study|Participant refused further follow-up|0|||
164708825|NCT01970865|594958316|FG006|Overall Study|Participant refused further follow-up|0|||
164708826|NCT01970865|594958317|FG007|Overall Study|Participant refused further follow-up|0|||
164411356|NCT04512066|593877203|FG002|Extension Period|Other|0|||
164463290|NCT05477186|594068614|FG004|Overall Study|Vaccine not administered|1|||
164463291|NCT05477186|594068615|FG005|Overall Study|Vaccine not administered|0|||
164463292|NCT05477186|594068616|FG006|Overall Study|Vaccine not administered|0|||
164463293|NCT05477186|594068610|FG000|Overall Study|Withdrawal by Subject|1|||
164463294|NCT05477186|594068611|FG001|Overall Study|Withdrawal by Subject|0|||
164463295|NCT05477186|594068612|FG002|Overall Study|Withdrawal by Subject|0|||
164463296|NCT05477186|594068613|FG003|Overall Study|Withdrawal by Subject|0|||
164463297|NCT05477186|594068614|FG004|Overall Study|Withdrawal by Subject|0|||
164463298|NCT05477186|594068615|FG005|Overall Study|Withdrawal by Subject|1|||
164463299|NCT05477186|594068616|FG006|Overall Study|Withdrawal by Subject|0|||
164463300|NCT05477186|594068610|FG000|Overall Study|Lost to Follow-up|1|||
164463301|NCT05477186|594068611|FG001|Overall Study|Lost to Follow-up|0|||
164463302|NCT05477186|594068612|FG002|Overall Study|Lost to Follow-up|2|||
164411357|NCT04512066|593877204|FG003|Extension Period|Other|0|||
164411358|NCT04512066|593877205|FG004|Extension Period|Other|0|||
164463303|NCT05477186|594068613|FG003|Overall Study|Lost to Follow-up|1|||
164463304|NCT05477186|594068614|FG004|Overall Study|Lost to Follow-up|1|||
164463305|NCT05477186|594068615|FG005|Overall Study|Lost to Follow-up|0|||
164463306|NCT05477186|594068616|FG006|Overall Study|Lost to Follow-up|2|||
164463307|NCT01733316|594068618|FG000|RP103 Phase|Non-compliance|1|||
164411359|NCT04512066|593877206|FG005|Extension Period|Other|0|||
164411360|NCT04512066|593877201|FG000|Extension Period|Physician Decision|0|||
164463308|NCT01733316|594068618|FG000|Long Term Extension Phase|Adverse Event|1|||
164463309|NCT01733316|594068618|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
164463310|NCT01733316|594068618|FG000|Long Term Extension Phase|Sponsor Decision|2|||
164463311|NCT02626533|594068622|FG000|Overall Study|Protocol Violation|14|||
164463312|NCT02626533|594068622|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
164463313|NCT02626533|594068622|FG000|Overall Study|Withdrawal by Subject|1|||
164463314|NCT04068181|594068623|FG000|Overall Study|Death|17|||
164463315|NCT04068181|594068624|FG001|Overall Study|Death|12|||
164463316|NCT04068181|594068625|FG002|Overall Study|Death|4|||
164463317|NCT04068181|594068626|FG003|Overall Study|Death|7|||
164463318|NCT04068181|594068623|FG000|Overall Study|Lost to Follow-up|1|||
164463319|NCT04068181|594068624|FG001|Overall Study|Lost to Follow-up|0|||
164463320|NCT04068181|594068625|FG002|Overall Study|Lost to Follow-up|0|||
164463321|NCT04068181|594068626|FG003|Overall Study|Lost to Follow-up|0|||
164463322|NCT04068181|594068623|FG000|Overall Study|Withdrawal of consent from study|3|||
164463323|NCT04068181|594068624|FG001|Overall Study|Withdrawal of consent from study|0|||
164463324|NCT04068181|594068625|FG002|Overall Study|Withdrawal of consent from study|0|||
164463325|NCT04068181|594068626|FG003|Overall Study|Withdrawal of consent from study|0|||
164463326|NCT03785964|594068629|FG000|Overall Study|Adverse Event|14|||
164463327|NCT03785964|594068630|FG001|Overall Study|Adverse Event|1|||
164463328|NCT03785964|594068629|FG000|Overall Study|Unqualified Clinical Progression|1|||
164463329|NCT03785964|594068630|FG001|Overall Study|Unqualified Clinical Progression|1|||
164411361|NCT04512066|593877202|FG001|Extension Period|Physician Decision|2|||
164411362|NCT04512066|593877203|FG002|Extension Period|Physician Decision|0|||
164411363|NCT04512066|593877204|FG003|Extension Period|Physician Decision|1|||
164411364|NCT04512066|593877205|FG004|Extension Period|Physician Decision|1|||
164411365|NCT04512066|593877206|FG005|Extension Period|Physician Decision|0|||
164411366|NCT04512066|593877201|FG000|Extension Period|Withdrawal by Subject|0|||
164411367|NCT04512066|593877202|FG001|Extension Period|Withdrawal by Subject|3|||
164411368|NCT04512066|593877203|FG002|Extension Period|Withdrawal by Subject|7|||
164411369|NCT04512066|593877204|FG003|Extension Period|Withdrawal by Subject|11|||
164411370|NCT04512066|593877205|FG004|Extension Period|Withdrawal by Subject|8|||
164411371|NCT04512066|593877206|FG005|Extension Period|Withdrawal by Subject|4|||
164411372|NCT03403426|593877208|FG000|Overall Study|Death|1|||
164411373|NCT03403426|593877208|FG000|Overall Study|Lost to Follow-up|2|||
164411374|NCT01657266|593877212|FG000|Overall Study|Lost to Follow-up|2|||
164411375|NCT01657266|593877213|FG001|Overall Study|Lost to Follow-up|2|||
164411376|NCT01657266|593877212|FG000|Overall Study|Adverse Event|2|||
164463330|NCT03785964|594068629|FG000|Overall Study|Participant non-compliance|1|||
164463331|NCT03785964|594068630|FG001|Overall Study|Participant non-compliance|1|||
164463332|NCT03785964|594068629|FG000|Overall Study|Not treated|1|||
164463333|NCT03785964|594068630|FG001|Overall Study|Not treated|0|||
164463334|NCT03785964|594068629|FG000|Overall Study|Other reason|5|||
164463335|NCT03785964|594068630|FG001|Overall Study|Other reason|11|||
164463336|NCT03785964|594068629|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
164463337|NCT03785964|594068630|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
164411377|NCT01657266|593877213|FG001|Overall Study|Adverse Event|3|||
164411378|NCT03520400|593877214|FG000|Overall Study|Physician Decision|15|||
164411379|NCT03520400|593877215|FG001|Overall Study|Physician Decision|7|||
164463338|NCT02723591|594068631|FG000|Overall Study|Adverse Event|48|||
164463339|NCT02723591|594068632|FG001|Overall Study|Adverse Event|40|||
164463340|NCT02723591|594068631|FG000|Overall Study|Death|2|||
164463341|NCT02723591|594068632|FG001|Overall Study|Death|2|||
164463342|NCT02723591|594068631|FG000|Overall Study|Lack of Efficacy|4|||
164463343|NCT02723591|594068632|FG001|Overall Study|Lack of Efficacy|3|||
164463344|NCT02723591|594068631|FG000|Overall Study|Lost to Follow-up|1|||
164463345|NCT02723591|594068632|FG001|Overall Study|Lost to Follow-up|7|||
164463346|NCT02723591|594068631|FG000|Overall Study|Protocol Violation|20|||
164463347|NCT02723591|594068632|FG001|Overall Study|Protocol Violation|23|||
164463348|NCT02723591|594068631|FG000|Overall Study|Withdrawal by Subject|4|||
164463349|NCT02723591|594068632|FG001|Overall Study|Withdrawal by Subject|8|||
164463350|NCT02723591|594068631|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
164463351|NCT02723591|594068632|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
164463352|NCT02723591|594068631|FG000|Overall Study|Miscellaneous|5|||
164463353|NCT02723591|594068632|FG001|Overall Study|Miscellaneous|6|||
164463354|NCT05070728|594068633|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
164463355|NCT05070728|594068634|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
164411380|NCT00445679|593877216|FG000|Overall Study|Adverse Event|22|||
164411381|NCT00445679|593877217|FG001|Overall Study|Adverse Event|12|||
164411382|NCT00445679|593877218|FG002|Overall Study|Adverse Event|30|||
164411383|NCT00445679|593877219|FG003|Overall Study|Adverse Event|19|||
164411384|NCT00445679|593877216|FG000|Overall Study|Failed to return|1|||
164411385|NCT00445679|593877217|FG001|Overall Study|Failed to return|3|||
164411386|NCT00445679|593877218|FG002|Overall Study|Failed to return|2|||
164411387|NCT00445679|593877219|FG003|Overall Study|Failed to return|2|||
164411388|NCT00445679|593877216|FG000|Overall Study|Physician Decision|0|||
164411389|NCT00445679|593877217|FG001|Overall Study|Physician Decision|0|||
164411390|NCT00445679|593877218|FG002|Overall Study|Physician Decision|1|||
164411391|NCT00445679|593877219|FG003|Overall Study|Physician Decision|0|||
164411392|NCT00445679|593877216|FG000|Overall Study|Lost to Follow-up|10|||
164411393|NCT00445679|593877217|FG001|Overall Study|Lost to Follow-up|6|||
164411394|NCT00445679|593877218|FG002|Overall Study|Lost to Follow-up|6|||
164411395|NCT00445679|593877219|FG003|Overall Study|Lost to Follow-up|5|||
164411396|NCT00445679|593877216|FG000|Overall Study|Compliance|3|||
164411397|NCT00445679|593877217|FG001|Overall Study|Compliance|2|||
164411398|NCT00445679|593877218|FG002|Overall Study|Compliance|1|||
164411399|NCT00445679|593877219|FG003|Overall Study|Compliance|2|||
164411400|NCT00445679|593877216|FG000|Overall Study|Withdrawal of Informed Consent|0|||
164411401|NCT00445679|593877217|FG001|Overall Study|Withdrawal of Informed Consent|0|||
164411402|NCT00445679|593877218|FG002|Overall Study|Withdrawal of Informed Consent|1|||
164411403|NCT00445679|593877219|FG003|Overall Study|Withdrawal of Informed Consent|0|||
164411404|NCT00445679|593877216|FG000|Overall Study|Protocol Violation|2|||
164411405|NCT00445679|593877217|FG001|Overall Study|Protocol Violation|3|||
164411406|NCT00445679|593877218|FG002|Overall Study|Protocol Violation|3|||
164411407|NCT00445679|593877219|FG003|Overall Study|Protocol Violation|1|||
164411408|NCT00445679|593877216|FG000|Overall Study|Withdrawal by Subject|8|||
164411409|NCT00445679|593877217|FG001|Overall Study|Withdrawal by Subject|14|||
164411410|NCT00445679|593877218|FG002|Overall Study|Withdrawal by Subject|20|||
164411411|NCT00445679|593877219|FG003|Overall Study|Withdrawal by Subject|18|||
164411412|NCT00445679|593877216|FG000|Overall Study|Lack of Efficacy|2|||
164411413|NCT00445679|593877217|FG001|Overall Study|Lack of Efficacy|6|||
164411414|NCT00445679|593877218|FG002|Overall Study|Lack of Efficacy|2|||
164411415|NCT00445679|593877219|FG003|Overall Study|Lack of Efficacy|0|||
164411416|NCT00909428|593877223|FG000|Overall Study|Lost to Follow-up|13|||
164411417|NCT00909428|593877224|FG001|Overall Study|Lost to Follow-up|10|||
164411418|NCT00909428|593877225|FG002|Overall Study|Lost to Follow-up|9|||
164411419|NCT01933880|593877228|FG000|Overall Study|Withdrawal by Subject|5|||
164411420|NCT01933880|593877229|FG001|Overall Study|Withdrawal by Subject|0|||
164411421|NCT01933880|593877228|FG000|Overall Study|Lack of Efficacy|1|||
164411422|NCT01933880|593877229|FG001|Overall Study|Lack of Efficacy|0|||
164411423|NCT01933880|593877228|FG000|Overall Study|Concomitant medication Interference|0|||
164411424|NCT01933880|593877229|FG001|Overall Study|Concomitant medication Interference|1|||
164411425|NCT01933880|593877228|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
164411426|NCT01933880|593877229|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
164411427|NCT01933880|593877228|FG000|Overall Study|Other|4|||
164411428|NCT01933880|593877229|FG001|Overall Study|Other|0|||
164411429|NCT01933880|593877228|FG000|Overall Study|Protocol Violation|1|||
164411430|NCT01933880|593877229|FG001|Overall Study|Protocol Violation|0|||
164411431|NCT01125722|593877230|FG000|Overall Study|Withdrawal by Subject|2|||
164411432|NCT01125722|593877231|FG001|Overall Study|Withdrawal by Subject|1|||
164411433|NCT01125722|593877230|FG000|Overall Study|Lost to Follow-up|1|||
164411434|NCT01125722|593877231|FG001|Overall Study|Lost to Follow-up|0|||
164411435|NCT00069784|593877232|FG000|Overall Study|Adverse Event|105|||
164411436|NCT00069784|593877233|FG001|Overall Study|Adverse Event|0|||
164411437|NCT00069784|593877232|FG000|Overall Study|Withdrawal by Subject|1090|||
164411438|NCT00069784|593877233|FG001|Overall Study|Withdrawal by Subject|0|||
164463356|NCT02151981|594068635|FG000|Overall Study|Death|184|||
164599369|NCT00243230|594554836|FG003|Open Label Period|Protocol Violation|2|||
164411439|NCT00069784|593877232|FG000|Overall Study|Other|17|||
164411440|NCT00069784|593877233|FG001|Overall Study|Other|0|||
164411441|NCT00709059|593877238|FG000|Overall Study|Lost to Follow-up|34|||
164411442|NCT00709059|593877238|FG000|Overall Study|Withdrawal by Subject|19|||
164411443|NCT00709059|593877238|FG000|Overall Study|Physician Decision|7|||
164411444|NCT00709059|593877238|FG000|Overall Study|Disease complication|3|||
164411445|NCT00709059|593877238|FG000|Overall Study|Side effects|20|||
164411446|NCT00709059|593877238|FG000|Overall Study|Serious side effects|11|||
164411447|NCT01382940|593878889|FG000|Overall Study|Adverse Event|19|||
164411448|NCT01382940|593878889|FG000|Overall Study|Lost to Follow-up|4|||
164411449|NCT01382940|593878889|FG000|Overall Study|Physician Decision|7|||
164411450|NCT01382940|593878889|FG000|Overall Study|Withdrawal by Subject|23|||
164411451|NCT01382940|593878889|FG000|Overall Study|Protocol Violation|20|||
164411452|NCT02105636|593878890|FG000|Pre-Treatment|Disease Progression|1|||
164411453|NCT02105636|593878891|FG001|Pre-Treatment|Disease Progression|0|||
164411454|NCT02105636|593878890|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
164411455|NCT02105636|593878891|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
164411456|NCT02105636|593878890|FG000|Pre-Treatment|Participant withdrew consent|0|||
164411457|NCT02105636|593878891|FG001|Pre-Treatment|Participant withdrew consent|6|||
164411458|NCT02105636|593878890|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
164411459|NCT02105636|593878891|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
164411460|NCT02105636|593878890|FG000|Treatment|Study Drug Toxicity|14|||
164411461|NCT02105636|593878891|FG001|Treatment|Study Drug Toxicity|10|||
164411462|NCT02105636|593878890|FG000|Treatment|Adverse event unrelated to study drug|19|||
164411463|NCT02105636|593878891|FG001|Treatment|Adverse event unrelated to study drug|3|||
164411464|NCT02105636|593878890|FG000|Treatment|Participant request to discontinue study treatment|8|||
164411465|NCT02105636|593878891|FG001|Treatment|Participant request to discontinue study treatment|6|||
164411466|NCT02105636|593878890|FG000|Treatment|Participant withdrew consent|5|||
164411467|NCT02105636|593878891|FG001|Treatment|Participant withdrew consent|1|||
164411468|NCT02105636|593878890|FG000|Treatment|Lost to Follow-up|1|||
164411469|NCT02105636|593878891|FG001|Treatment|Lost to Follow-up|0|||
164411470|NCT02105636|593878890|FG000|Treatment|Maximum Clinical Benefit|1|||
164411471|NCT02105636|593878891|FG001|Treatment|Maximum Clinical Benefit|3|||
164411472|NCT02105636|593878890|FG000|Treatment|Poor/Non-compliance|0|||
164411473|NCT02105636|593878891|FG001|Treatment|Poor/Non-compliance|1|||
164411474|NCT02105636|593878890|FG000|Treatment|Participant no longer meets study criteria|1|||
164411475|NCT02105636|593878891|FG001|Treatment|Participant no longer meets study criteria|0|||
164411476|NCT02105636|593878890|FG000|Treatment|Other reasons|1|||
164411477|NCT02105636|593878891|FG001|Treatment|Other reasons|0|||
164411478|NCT02105636|593878890|FG000|Treatment|Disease Progression|185|||
164411479|NCT02105636|593878891|FG001|Treatment|Disease Progression|87|||
164411480|NCT00720902|593878892|FG000|Overall Study|Withdrawal by Subject|1|||
164411481|NCT00720902|593878893|FG001|Overall Study|Withdrawal by Subject|0|||
164411482|NCT00720902|593878892|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
164411483|NCT00720902|593878893|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
164411484|NCT01478113|593878896|FG000|Overall Study|Withdrawal by Subject|0|||
164411485|NCT01478113|593878897|FG001|Overall Study|Withdrawal by Subject|1|||
164411486|NCT01478113|593878896|FG000|Overall Study|Physician Decision|1|||
164411487|NCT01478113|593878897|FG001|Overall Study|Physician Decision|0|||
164411488|NCT00289770|593878898|FG000|Year 15|Withdrawal by Subject|1|||
164411489|NCT02145078|593878899|FG000|Overall Study|Death|1|||
164411490|NCT02145078|593878899|FG000|Overall Study|Reason not given|3|||
164411491|NCT03097861|593878903|FG000|Overall Study|Adverse Event|3|||
164411492|NCT03097861|593878904|FG001|Overall Study|Adverse Event|8|||
164411493|NCT03097861|593878905|FG002|Overall Study|Adverse Event|4|||
164411494|NCT03097861|593878903|FG000|Overall Study|Investigator Decision|0|||
164411495|NCT03097861|593878904|FG001|Overall Study|Investigator Decision|1|||
164411496|NCT03097861|593878905|FG002|Overall Study|Investigator Decision|0|||
164411497|NCT03097861|593878903|FG000|Overall Study|Lost to Follow-up|0|||
164411498|NCT03097861|593878904|FG001|Overall Study|Lost to Follow-up|7|||
164411499|NCT03097861|593878905|FG002|Overall Study|Lost to Follow-up|1|||
164411500|NCT03097861|593878903|FG000|Overall Study|Withdrawal by Subject|1|||
164411501|NCT03097861|593878904|FG001|Overall Study|Withdrawal by Subject|5|||
164411502|NCT03097861|593878905|FG002|Overall Study|Withdrawal by Subject|3|||
164411503|NCT03097861|593878903|FG000|Overall Study|Reason not provided|3|||
164411504|NCT03097861|593878904|FG001|Overall Study|Reason not provided|1|||
164411505|NCT03097861|593878905|FG002|Overall Study|Reason not provided|1|||
164411506|NCT05061537|593878907|FG000|Treatment Phase|Progressive disease|0|||
164411507|NCT05061537|593878908|FG001|Treatment Phase|Progressive disease|1|||
164411508|NCT05061537|593878909|FG002|Treatment Phase|Progressive disease|2|||
164411509|NCT05061537|593878910|FG003|Treatment Phase|Progressive disease|0|||
164411510|NCT05061537|593878911|FG004|Treatment Phase|Progressive disease|0|||
164411511|NCT05061537|593878907|FG000|Treatment Phase|Adverse Event|0|||
164411512|NCT05061537|593878908|FG001|Treatment Phase|Adverse Event|0|||
164411513|NCT05061537|593878909|FG002|Treatment Phase|Adverse Event|2|||
164411514|NCT05061537|593878910|FG003|Treatment Phase|Adverse Event|0|||
164411515|NCT05061537|593878911|FG004|Treatment Phase|Adverse Event|0|||
164411516|NCT05061537|593878907|FG000|Treatment Phase|Global deterioration of health status|0|||
164411517|NCT05061537|593878908|FG001|Treatment Phase|Global deterioration of health status|1|||
164411518|NCT05061537|593878909|FG002|Treatment Phase|Global deterioration of health status|0|||
164411519|NCT05061537|593878910|FG003|Treatment Phase|Global deterioration of health status|0|||
164411520|NCT05061537|593878911|FG004|Treatment Phase|Global deterioration of health status|0|||
164411521|NCT05061537|593878907|FG000|Follow up|Other|2|||
164411522|NCT05061537|593878908|FG001|Follow up|Other|0|||
164411523|NCT05061537|593878909|FG002|Follow up|Other|2|||
164411524|NCT05061537|593878910|FG003|Follow up|Other|0|||
164411525|NCT05061537|593878911|FG004|Follow up|Other|0|||
164411526|NCT05061537|593878907|FG000|Follow up|Study terminated by sponsor|0|||
164411527|NCT05061537|593878908|FG001|Follow up|Study terminated by sponsor|0|||
164411528|NCT05061537|593878909|FG002|Follow up|Study terminated by sponsor|2|||
164411529|NCT05061537|593878910|FG003|Follow up|Study terminated by sponsor|0|||
164411530|NCT05061537|593878911|FG004|Follow up|Study terminated by sponsor|0|||
164411531|NCT05061537|593878907|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
164411532|NCT05061537|593878908|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
164411533|NCT05061537|593878909|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
164411534|NCT05061537|593878910|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
164411535|NCT05061537|593878911|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
164411536|NCT05061537|593878907|FG000|Long-term Follow-up|Death|0|||
164411537|NCT05061537|593878908|FG001|Long-term Follow-up|Death|1|||
164411538|NCT05061537|593878909|FG002|Long-term Follow-up|Death|0|||
164411539|NCT05061537|593878910|FG003|Long-term Follow-up|Death|0|||
164411540|NCT05061537|593878911|FG004|Long-term Follow-up|Death|0|||
164411541|NCT03502616|593878912|FG000|Up to Week 16|Withdrawal by Subject|1|||
164411542|NCT03502616|593878913|FG001|Up to Week 16|Withdrawal by Subject|2|||
164411543|NCT03502616|593878912|FG000|Up to Week 16|Lost to Follow-up|0|||
164411544|NCT03502616|593878913|FG001|Up to Week 16|Lost to Follow-up|1|||
164411545|NCT03502616|593878912|FG000|Up to Week 16|Randomized, but not treated|1|||
164411546|NCT03502616|593878913|FG001|Up to Week 16|Randomized, but not treated|0|||
164411547|NCT03502616|593878912|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
164411548|NCT03502616|593878913|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
164411549|NCT03502616|593878912|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
164411550|NCT03502616|593878913|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
164411551|NCT04503096|593878914|FG000|Overall Study|Withdrawal by Subject|3|||
164708827|NCT01970865|594958318|FG008|Overall Study|Participant refused further follow-up|0|||
164708828|NCT01970865|594958319|FG009|Overall Study|Participant refused further follow-up|0|||
164708829|NCT01970865|594958320|FG010|Overall Study|Participant refused further follow-up|1|||
164708830|NCT01970865|594958321|FG011|Overall Study|Participant refused further follow-up|4|||
164708831|NCT01970865|594958322|FG012|Overall Study|Participant refused further follow-up|7|||
164708832|NCT01970865|594958323|FG013|Overall Study|Participant refused further follow-up|8|||
164708833|NCT01970865|594958324|FG014|Overall Study|Participant refused further follow-up|3|||
164708834|NCT01970865|594958325|FG015|Overall Study|Participant refused further follow-up|11|||
164708835|NCT01970865|594958326|FG016|Overall Study|Participant refused further follow-up|0|||
164708836|NCT01970865|594958327|FG017|Overall Study|Participant refused further follow-up|6|||
164708837|NCT01629966|594958328|FG000|Overall Study|Pregnancy|0|||
164708838|NCT01629966|594958329|FG001|Overall Study|Pregnancy|1|||
164708839|NCT01629966|594958330|FG002|Overall Study|Pregnancy|0|||
164708840|NCT01629966|594958328|FG000|Overall Study|Lost to Follow-up|10|||
164708841|NCT01629966|594958329|FG001|Overall Study|Lost to Follow-up|13|||
164708842|NCT01629966|594958330|FG002|Overall Study|Lost to Follow-up|9|||
164708843|NCT01629966|594958328|FG000|Overall Study|Withdrawal by Subject|8|||
164708844|NCT01629966|594958329|FG001|Overall Study|Withdrawal by Subject|9|||
164708845|NCT01629966|594958330|FG002|Overall Study|Withdrawal by Subject|16|||
164708846|NCT01629966|594958328|FG000|Overall Study|Protocol Violation|7|||
164411552|NCT01785563|593878915|FG000|Overall Study|Physician Decision|10|||
164411553|NCT01785563|593878915|FG000|Overall Study|Withdrawal by Subject|1|||
164411554|NCT01785563|593878915|FG000|Overall Study|Protocol Violation|2|||
164411555|NCT01872910|593878916|FG000|Overall Study|Lost to Follow-up|2|||
164411556|NCT01872910|593878917|FG001|Overall Study|Lost to Follow-up|0|||
164411557|NCT01872910|593878918|FG002|Overall Study|Lost to Follow-up|2|||
164708847|NCT01629966|594958329|FG001|Overall Study|Protocol Violation|9|||
164708848|NCT01629966|594958330|FG002|Overall Study|Protocol Violation|7|||
164708849|NCT01629966|594958328|FG000|Overall Study|Lack of Efficacy|5|||
164708850|NCT01629966|594958329|FG001|Overall Study|Lack of Efficacy|2|||
164708851|NCT01629966|594958330|FG002|Overall Study|Lack of Efficacy|4|||
164708852|NCT01629966|594958328|FG000|Overall Study|Adverse Event|11|||
164708853|NCT01629966|594958329|FG001|Overall Study|Adverse Event|18|||
164708854|NCT01629966|594958330|FG002|Overall Study|Adverse Event|30|||
164411558|NCT01872910|593878919|FG003|Overall Study|Lost to Follow-up|0|||
164463357|NCT02151981|594068636|FG001|Overall Study|Death|88|||
164411559|NCT01872910|593878920|FG004|Overall Study|Lost to Follow-up|0|||
164411560|NCT01872910|593878921|FG005|Overall Study|Lost to Follow-up|0|||
164411561|NCT00744328|593878924|FG000|Overall Study|Lost to Follow-up|2|||
164411562|NCT00744328|593878925|FG001|Overall Study|Lost to Follow-up|5|||
164411563|NCT00744328|593878926|FG002|Overall Study|Lost to Follow-up|3|||
164411564|NCT00744328|593878924|FG000|Overall Study|Withdrawal by Subject|5|||
164411565|NCT00744328|593878925|FG001|Overall Study|Withdrawal by Subject|3|||
164708855|NCT01150890|594958331|FG000|Overall Study|Other|0|||
164708856|NCT01150890|594958332|FG001|Overall Study|Other|1|||
164708857|NCT01150890|594958333|FG002|Overall Study|Other|0|||
164708858|NCT01150890|594958334|FG003|Overall Study|Other|2|||
164708859|NCT01150890|594958331|FG000|Overall Study|Pregnancy|0|||
164708860|NCT01150890|594958332|FG001|Overall Study|Pregnancy|0|||
164708861|NCT01150890|594958333|FG002|Overall Study|Pregnancy|0|||
164708862|NCT01150890|594958334|FG003|Overall Study|Pregnancy|1|||
164708863|NCT01150890|594958331|FG000|Overall Study|Administrative Decision|4|||
164708864|NCT01150890|594958332|FG001|Overall Study|Administrative Decision|4|||
164708865|NCT01150890|594958333|FG002|Overall Study|Administrative Decision|5|||
164708866|NCT01150890|594958334|FG003|Overall Study|Administrative Decision|6|||
164708867|NCT01150890|594958331|FG000|Overall Study|Ineligibility determined|0|||
164708868|NCT01150890|594958332|FG001|Overall Study|Ineligibility determined|1|||
164708869|NCT01150890|594958333|FG002|Overall Study|Ineligibility determined|0|||
164708870|NCT01150890|594958334|FG003|Overall Study|Ineligibility determined|0|||
164708871|NCT01150890|594958331|FG000|Overall Study|Adverse Event|0|||
164708872|NCT01150890|594958332|FG001|Overall Study|Adverse Event|0|||
164708873|NCT01150890|594958333|FG002|Overall Study|Adverse Event|2|||
164708874|NCT01150890|594958334|FG003|Overall Study|Adverse Event|0|||
164708875|NCT01150890|594958331|FG000|Overall Study|Withdrawal by Subject|0|||
164708876|NCT01150890|594958332|FG001|Overall Study|Withdrawal by Subject|0|||
164708877|NCT01150890|594958333|FG002|Overall Study|Withdrawal by Subject|2|||
164708878|NCT01150890|594958334|FG003|Overall Study|Withdrawal by Subject|1|||
164708879|NCT01150890|594958331|FG000|Overall Study|Disease progression|0|||
164708880|NCT01150890|594958332|FG001|Overall Study|Disease progression|7|||
164708881|NCT01150890|594958333|FG002|Overall Study|Disease progression|3|||
164708882|NCT01150890|594958334|FG003|Overall Study|Disease progression|7|||
164708883|NCT03118570|594958335|FG000|Overall Study|Adverse Event|2|||
164708884|NCT03118570|594958336|FG001|Overall Study|Adverse Event|0|||
164708885|NCT03118570|594958337|FG002|Overall Study|Adverse Event|0|||
164708886|NCT03118570|594958338|FG003|Overall Study|Adverse Event|0|||
164708887|NCT03118570|594958339|FG004|Overall Study|Adverse Event|3|||
164708888|NCT03118570|594958335|FG000|Overall Study|Withdrawal by Subject|0|||
164708889|NCT03118570|594958336|FG001|Overall Study|Withdrawal by Subject|1|||
164708890|NCT03118570|594958337|FG002|Overall Study|Withdrawal by Subject|4|||
164708891|NCT03118570|594958338|FG003|Overall Study|Withdrawal by Subject|0|||
164708892|NCT03118570|594958339|FG004|Overall Study|Withdrawal by Subject|1|||
164708893|NCT03118570|594958335|FG000|Overall Study|Lost to Follow-up|2|||
164708894|NCT03118570|594958336|FG001|Overall Study|Lost to Follow-up|3|||
164708895|NCT03118570|594958337|FG002|Overall Study|Lost to Follow-up|1|||
164708896|NCT03118570|594958338|FG003|Overall Study|Lost to Follow-up|0|||
164708897|NCT03118570|594958339|FG004|Overall Study|Lost to Follow-up|1|||
164708898|NCT03118570|594958335|FG000|Overall Study|Other, Not Specified|1|||
164708899|NCT03118570|594958336|FG001|Overall Study|Other, Not Specified|3|||
164708900|NCT03118570|594958337|FG002|Overall Study|Other, Not Specified|0|||
164708901|NCT03118570|594958338|FG003|Overall Study|Other, Not Specified|0|||
164708902|NCT03118570|594958339|FG004|Overall Study|Other, Not Specified|0|||
164708903|NCT01672970|594958340|FG000|Overall Study|Lack of Efficacy|12|||
164708904|NCT01672970|594958340|FG000|Overall Study|Adverse Event|18|||
164708905|NCT01672970|594958340|FG000|Overall Study|Withdrawal by Subject|2|||
164708906|NCT01672970|594958340|FG000|Overall Study|Lost to Follow-up|5|||
164708907|NCT01672970|594958340|FG000|Overall Study|Other|9|||
164708908|NCT01672970|594958340|FG000|Overall Study|Enrolled but not treated|1|||
164708909|NCT04568031|594958343|FG000|Overall Study|Lost to Follow-up|1|||
164708910|NCT04568031|594958344|FG001|Overall Study|Lost to Follow-up|0|||
164708911|NCT04568031|594958345|FG002|Overall Study|Lost to Follow-up|0|||
164708912|NCT04568031|594958346|FG003|Overall Study|Lost to Follow-up|0|||
164708913|NCT04568031|594958343|FG000|Overall Study|Physician Decision|1|||
164708914|NCT04568031|594958344|FG001|Overall Study|Physician Decision|0|||
164708915|NCT04568031|594958345|FG002|Overall Study|Physician Decision|1|||
164411566|NCT00744328|593878926|FG002|Overall Study|Withdrawal by Subject|4|||
164411567|NCT00744328|593878924|FG000|Overall Study|Found ineligible after randomization|0|||
164411568|NCT00744328|593878925|FG001|Overall Study|Found ineligible after randomization|0|||
164411569|NCT00744328|593878926|FG002|Overall Study|Found ineligible after randomization|1|||
164708916|NCT04568031|594958346|FG003|Overall Study|Physician Decision|0|||
164708917|NCT04568031|594958343|FG000|Overall Study|Withdrawal by Subject|1|||
164708918|NCT04568031|594958344|FG001|Overall Study|Withdrawal by Subject|0|||
164708919|NCT04568031|594958345|FG002|Overall Study|Withdrawal by Subject|4|||
164708920|NCT04568031|594958346|FG003|Overall Study|Withdrawal by Subject|1|||
164708921|NCT04430855|594958347|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
164708922|NCT04430855|594958348|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
164411570|NCT01576367|593878927|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164708923|NCT04430855|594958347|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
164708924|NCT04430855|594958348|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
164708925|NCT04430855|594958347|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
164708926|NCT04430855|594958348|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
164708927|NCT04430855|594958347|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
164411571|NCT01576367|593878927|FG000|Overall Study|Moved to commercial use after 6 months|1|||
164411572|NCT02387216|593878931|FG000|Overall Study|Progressive disease|2|||
164411573|NCT02387216|593878932|FG001|Overall Study|Progressive disease|0|||
164708928|NCT04430855|594958348|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
164708929|NCT04430855|594958347|FG000|Period 1 (Weeks 1-12)|Other|0|||
164708930|NCT04430855|594958348|FG001|Period 1 (Weeks 1-12)|Other|1|||
164708931|NCT04430855|594958347|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
164708932|NCT04430855|594958348|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
164708933|NCT04430855|594958347|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
164708934|NCT04430855|594958348|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
164708935|NCT04430855|594958347|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
164708936|NCT04430855|594958348|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
164708937|NCT00186043|594958349|FG000|Overall Study|Lack of Efficacy|1|||
164708938|NCT00186043|594958350|FG001|Overall Study|Lack of Efficacy|3|||
164708939|NCT00186043|594958349|FG000|Overall Study|Lost to Follow-up|4|||
164708940|NCT00186043|594958350|FG001|Overall Study|Lost to Follow-up|6|||
164708941|NCT00186043|594958349|FG000|Overall Study|Withdrawal by Subject|1|||
164708942|NCT00186043|594958350|FG001|Overall Study|Withdrawal by Subject|0|||
164708943|NCT00186043|594958349|FG000|Overall Study|Adverse Event|7|||
164708944|NCT00186043|594958350|FG001|Overall Study|Adverse Event|3|||
164708945|NCT00186043|594958349|FG000|Overall Study|Protocol Violation|2|||
164708946|NCT00186043|594958350|FG001|Overall Study|Protocol Violation|1|||
164708947|NCT04874636|594958351|FG000|Overall Study|Adverse Event|17|||
164708948|NCT04874636|594958352|FG001|Overall Study|Adverse Event|7|||
164708949|NCT04874636|594958351|FG000|Overall Study|Lost to Follow-up|1|||
164708950|NCT04874636|594958352|FG001|Overall Study|Lost to Follow-up|0|||
164708951|NCT04874636|594958351|FG000|Overall Study|Non-Compliance with Study Drug|2|||
164708952|NCT04874636|594958352|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164708953|NCT04874636|594958351|FG000|Overall Study|Physician Decision|1|||
164708954|NCT04874636|594958352|FG001|Overall Study|Physician Decision|0|||
164708955|NCT04874636|594958351|FG000|Overall Study|Withdrawal by Subject|6|||
164708956|NCT04874636|594958352|FG001|Overall Study|Withdrawal by Subject|5|||
164708957|NCT00620659|594958361|FG000|Treatment Period 1|Adverse Event|1|||
164708958|NCT00620659|594958362|FG001|Treatment Period 1|Adverse Event|0|||
164708959|NCT00620659|594958363|FG002|Treatment Period 1|Adverse Event|0|||
164708960|NCT00620659|594958364|FG003|Treatment Period 1|Adverse Event|3|||
164708961|NCT00620659|594958365|FG004|Treatment Period 1|Adverse Event|0|||
164708962|NCT00620659|594958366|FG005|Treatment Period 1|Adverse Event|0|||
164708963|NCT00620659|594958361|FG000|Treatment Period 1|Protocol Violation|1|||
164708964|NCT00620659|594958362|FG001|Treatment Period 1|Protocol Violation|0|||
164708965|NCT00620659|594958363|FG002|Treatment Period 1|Protocol Violation|0|||
164708966|NCT00620659|594958364|FG003|Treatment Period 1|Protocol Violation|0|||
164708967|NCT00620659|594958365|FG004|Treatment Period 1|Protocol Violation|0|||
164708968|NCT00620659|594958366|FG005|Treatment Period 1|Protocol Violation|0|||
164708969|NCT00620659|594958361|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164708970|NCT00620659|594958362|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164708971|NCT00620659|594958363|FG002|Treatment Period 1|Withdrawal by Subject|1|||
164708972|NCT00620659|594958364|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164708973|NCT00620659|594958365|FG004|Treatment Period 1|Withdrawal by Subject|1|||
164708974|NCT00620659|594958366|FG005|Treatment Period 1|Withdrawal by Subject|0|||
164708975|NCT00620659|594958361|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
164708976|NCT00620659|594958362|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
164708977|NCT00620659|594958363|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
164708978|NCT00620659|594958364|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
164708979|NCT00620659|594958365|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
164708980|NCT00620659|594958366|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
164708981|NCT00620659|594958361|FG000|Treatment Period 2|Adverse Event|0|||
164708982|NCT00620659|594958362|FG001|Treatment Period 2|Adverse Event|3|||
164708983|NCT00620659|594958363|FG002|Treatment Period 2|Adverse Event|0|||
164708984|NCT00620659|594958364|FG003|Treatment Period 2|Adverse Event|0|||
164708985|NCT00620659|594958365|FG004|Treatment Period 2|Adverse Event|2|||
164708986|NCT00620659|594958366|FG005|Treatment Period 2|Adverse Event|0|||
164708987|NCT00620659|594958361|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164708988|NCT00620659|594958362|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164708989|NCT00620659|594958363|FG002|Treatment Period 2|Withdrawal by Subject|1|||
164708990|NCT00620659|594958364|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164708991|NCT00620659|594958365|FG004|Treatment Period 2|Withdrawal by Subject|3|||
164708992|NCT00620659|594958366|FG005|Treatment Period 2|Withdrawal by Subject|0|||
164411574|NCT02387216|593878931|FG000|Overall Study|Withdrawal by Subject|3|||
164708993|NCT00620659|594958361|FG000|Placebo Washout Period 2|Adverse Event|2|||
164708994|NCT00620659|594958362|FG001|Placebo Washout Period 2|Adverse Event|0|||
164708995|NCT00620659|594958363|FG002|Placebo Washout Period 2|Adverse Event|0|||
164708996|NCT00620659|594958364|FG003|Placebo Washout Period 2|Adverse Event|0|||
164708997|NCT00620659|594958365|FG004|Placebo Washout Period 2|Adverse Event|0|||
164411575|NCT02387216|593878932|FG001|Overall Study|Withdrawal by Subject|5|||
164708998|NCT00620659|594958366|FG005|Placebo Washout Period 2|Adverse Event|0|||
164708999|NCT00620659|594958361|FG000|Treatment Period 3|Adverse Event|0|||
164411576|NCT02387216|593878931|FG000|Overall Study|Physician Decision|2|||
164411577|NCT02387216|593878932|FG001|Overall Study|Physician Decision|0|||
164411578|NCT02387216|593878931|FG000|Overall Study|Sponsor Decision|28|||
164411579|NCT02387216|593878932|FG001|Overall Study|Sponsor Decision|12|||
164411580|NCT02387216|593878931|FG000|Overall Study|Death|60|||
164411581|NCT02387216|593878932|FG001|Overall Study|Death|23|||
164411582|NCT02387216|593878931|FG000|Overall Study|Other|5|||
164411583|NCT02387216|593878932|FG001|Overall Study|Other|4|||
164411584|NCT02387216|593878931|FG000|Overall Study|Lost to Follow-up|0|||
164411585|NCT02387216|593878932|FG001|Overall Study|Lost to Follow-up|3|||
164411586|NCT02091739|593878933|FG000|MP: 16 Weeks|Adverse Event|1|||
164411587|NCT02091739|593878934|FG001|MP: 16 Weeks|Adverse Event|1|||
164411588|NCT02091739|593878935|FG002|MP: 16 Weeks|Adverse Event|1|||
164411589|NCT02091739|593878936|FG003|MP: 16 Weeks|Adverse Event|0|||
164411590|NCT02091739|593878937|FG004|MP: 16 Weeks|Adverse Event|0|||
164411591|NCT02091739|593878933|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
164411592|NCT02091739|593878934|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
164411593|NCT02091739|593878935|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
164411594|NCT02091739|593878936|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
164411595|NCT02091739|593878937|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
164411596|NCT02091739|593878933|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
164411597|NCT02091739|593878934|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
164411598|NCT02091739|593878935|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
164411599|NCT02091739|593878936|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
164411600|NCT02091739|593878937|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
164411601|NCT02091739|593878933|FG000|EP: 48 Weeks|Other|0|||
164411602|NCT02091739|593878934|FG001|EP: 48 Weeks|Other|0|||
164411603|NCT02091739|593878935|FG002|EP: 48 Weeks|Other|0|||
164411604|NCT02091739|593878936|FG003|EP: 48 Weeks|Other|1|||
164411605|NCT02091739|593878937|FG004|EP: 48 Weeks|Other|0|||
164411606|NCT02091739|593878933|FG000|EP: 48 Weeks|Death|0|||
164411607|NCT02091739|593878934|FG001|EP: 48 Weeks|Death|0|||
164411608|NCT02091739|593878935|FG002|EP: 48 Weeks|Death|0|||
164411609|NCT02091739|593878936|FG003|EP: 48 Weeks|Death|3|||
164411610|NCT02091739|593878937|FG004|EP: 48 Weeks|Death|2|||
164411611|NCT02091739|593878933|FG000|EP: 48 Weeks|Adverse Event|0|||
164411612|NCT02091739|593878934|FG001|EP: 48 Weeks|Adverse Event|0|||
164411613|NCT02091739|593878935|FG002|EP: 48 Weeks|Adverse Event|0|||
164411614|NCT02091739|593878936|FG003|EP: 48 Weeks|Adverse Event|2|||
164411615|NCT02091739|593878937|FG004|EP: 48 Weeks|Adverse Event|6|||
164411616|NCT02091739|593878933|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
164411617|NCT02091739|593878934|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
164411618|NCT02091739|593878935|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
164411619|NCT02091739|593878936|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
164411620|NCT02091739|593878937|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
164411621|NCT03469349|593878938|FG000|Overall Study|Withdrawal by Subject|1|||
164411622|NCT03469349|593878939|FG001|Overall Study|Withdrawal by Subject|3|||
164411623|NCT03469349|593878938|FG000|Overall Study|Progressive Disease|0|||
164411624|NCT03469349|593878939|FG001|Overall Study|Progressive Disease|1|||
164411625|NCT03469349|593878938|FG000|Overall Study|Lost to Follow-up|2|||
164411626|NCT03469349|593878939|FG001|Overall Study|Lost to Follow-up|2|||
164411627|NCT03469349|593878938|FG000|Overall Study|Adverse Event|2|||
164411628|NCT03469349|593878939|FG001|Overall Study|Adverse Event|4|||
164709000|NCT00620659|594958362|FG001|Treatment Period 3|Adverse Event|2|||
164411629|NCT03528174|593878940|FG000|Overall Study|Adverse Event|1|||
164411630|NCT03528174|593878940|FG000|Overall Study|sensors dislodged|1|||
164411631|NCT04251065|593878944|FG000|Overall Study|Death|2|||
164411632|NCT04251065|593878944|FG000|Overall Study|Lack of Efficacy|3|||
164411633|NCT04251065|593878944|FG000|Overall Study|Death|1|||
164411634|NCT00525265|593878953|FG000|Overall Study|Protocol Violation|1|||
164411635|NCT00525265|593878954|FG001|Overall Study|Protocol Violation|0|||
164411636|NCT04986982|593878956|FG000|Overall Study|Withdrawal by Subject|3|||
164411637|NCT04986982|593878957|FG001|Overall Study|Withdrawal by Subject|1|||
164411638|NCT04986982|593878956|FG000|Overall Study|Lack of Efficacy|0|||
164411639|NCT04986982|593878957|FG001|Overall Study|Lack of Efficacy|2|||
164709001|NCT00620659|594958363|FG002|Treatment Period 3|Adverse Event|0|||
164709002|NCT00620659|594958364|FG003|Treatment Period 3|Adverse Event|0|||
164411640|NCT04986982|593878956|FG000|Overall Study|Ineligibility|3|||
164411641|NCT04986982|593878957|FG001|Overall Study|Ineligibility|0|||
164411642|NCT04986982|593878956|FG000|Overall Study|Adverse Event|4|||
164411643|NCT04986982|593878957|FG001|Overall Study|Adverse Event|4|||
164411644|NCT04986982|593878956|FG000|Overall Study|Lost to Follow-up|0|||
164411645|NCT04986982|593878957|FG001|Overall Study|Lost to Follow-up|1|||
164411646|NCT04986982|593878956|FG000|Overall Study|Sponsor's discretion|1|||
164411647|NCT04986982|593878957|FG001|Overall Study|Sponsor's discretion|0|||
164411648|NCT03500640|593878958|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
164411649|NCT03500640|593878959|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
164411650|NCT03500640|593878960|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
164411651|NCT03500640|593878958|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
164463358|NCT02151981|594068635|FG000|Overall Study|Lost to Follow-up|7|||
164709003|NCT00620659|594958365|FG004|Treatment Period 3|Adverse Event|0|||
164709004|NCT00620659|594958366|FG005|Treatment Period 3|Adverse Event|0|||
164709005|NCT00620659|594958361|FG000|Treatment Period 3|Withdrawal by Subject|0|||
164709006|NCT00620659|594958362|FG001|Treatment Period 3|Withdrawal by Subject|0|||
164709007|NCT00620659|594958363|FG002|Treatment Period 3|Withdrawal by Subject|0|||
164411652|NCT03500640|593878959|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
164411653|NCT03500640|593878960|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
164411654|NCT03500640|593878958|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
164411655|NCT03500640|593878959|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
164411656|NCT03500640|593878960|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
164411657|NCT03500640|593878958|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
164411658|NCT03500640|593878959|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
164411659|NCT03500640|593878960|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
164411660|NCT03500640|593878958|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
164411661|NCT03500640|593878959|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
164411662|NCT03500640|593878960|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
164411663|NCT03500640|593878958|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
164411664|NCT03500640|593878959|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
164411665|NCT03500640|593878960|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
164411666|NCT03500640|593878958|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
164411667|NCT03500640|593878959|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
164411668|NCT03500640|593878960|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
164411669|NCT03500640|593878958|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
164411670|NCT03500640|593878959|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
164411671|NCT03500640|593878960|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
164411672|NCT03500640|593878958|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
164411673|NCT03500640|593878959|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
164411674|NCT03500640|593878960|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
164411675|NCT03500640|593878958|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
164411676|NCT03500640|593878959|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
164411677|NCT03500640|593878960|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
164411678|NCT01778556|593878961|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
164411679|NCT01778556|593878962|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
164411680|NCT01778556|593878961|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
164411681|NCT01778556|593878962|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
164411682|NCT01778556|593878961|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
164411683|NCT01778556|593878962|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
164411684|NCT01778556|593878961|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
164411685|NCT01778556|593878962|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
164411686|NCT00576732|593878963|FG000|DOUBLE BLIND|Adverse Event|0|||
164411687|NCT00576732|593878964|FG001|DOUBLE BLIND|Adverse Event|0|||
164411688|NCT00576732|593878965|FG002|DOUBLE BLIND|Adverse Event|1|||
164411689|NCT00576732|593878966|FG003|DOUBLE BLIND|Adverse Event|0|||
164411690|NCT00576732|593878967|FG004|DOUBLE BLIND|Adverse Event|0|||
164411691|NCT00576732|593878968|FG005|DOUBLE BLIND|Adverse Event|0|||
164411692|NCT00576732|593878963|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
164411693|NCT00576732|593878964|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
164411694|NCT00576732|593878965|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
164411695|NCT00576732|593878966|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
164411696|NCT00576732|593878967|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
164411697|NCT00576732|593878968|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
164411698|NCT00576732|593878963|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
164411699|NCT00576732|593878964|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
164411700|NCT00576732|593878965|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
164411701|NCT00576732|593878966|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
164411702|NCT00576732|593878967|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
164411703|NCT00576732|593878968|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
164411704|NCT00576732|593878963|FG000|DOUBLE BLIND|OTHER|0|||
164411705|NCT00576732|593878964|FG001|DOUBLE BLIND|OTHER|2|||
164411706|NCT00576732|593878965|FG002|DOUBLE BLIND|OTHER|1|||
164411707|NCT00576732|593878966|FG003|DOUBLE BLIND|OTHER|0|||
164411708|NCT00576732|593878967|FG004|DOUBLE BLIND|OTHER|0|||
164411709|NCT00576732|593878968|FG005|DOUBLE BLIND|OTHER|0|||
164411710|NCT00576732|593878963|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
164411711|NCT00576732|593878964|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
164411712|NCT00576732|593878965|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
164411713|NCT00576732|593878966|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
164411714|NCT00576732|593878967|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
164463359|NCT02151981|594068636|FG001|Overall Study|Lost to Follow-up|1|||
164709008|NCT00620659|594958364|FG003|Treatment Period 3|Withdrawal by Subject|1|||
164709009|NCT00620659|594958365|FG004|Treatment Period 3|Withdrawal by Subject|0|||
164411715|NCT00576732|593878968|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
164463360|NCT02151981|594068635|FG000|Overall Study|Withdrawal by Subject|27|||
164709010|NCT00620659|594958366|FG005|Treatment Period 3|Withdrawal by Subject|0|||
164709011|NCT01709838|594958367|FG000|Overall Study|Withdrawal by Subject|21|||
164709012|NCT01709838|594958367|FG000|Overall Study|Lost to Follow-up|16|||
164709013|NCT01709838|594958367|FG000|Overall Study|Pregnancy|10|||
164709014|NCT01709838|594958367|FG000|Overall Study|Subject/guardian decision|8|||
164709015|NCT01709838|594958367|FG000|Overall Study|Adverse Event|4|||
164709016|NCT01709838|594958367|FG000|Overall Study|Physician Decision|4|||
164709017|NCT01709838|594958367|FG000|Overall Study|Death|3|||
164709018|NCT01709838|594958367|FG000|Overall Study|Protocol Violation|1|||
164709019|NCT02352779|594958368|FG000|Overall Study|Personal Issues|1|||
164709020|NCT02352779|594958369|FG001|Overall Study|Personal Issues|1|||
164709021|NCT02352779|594958370|FG002|Overall Study|Personal Issues|0|||
164709022|NCT02352779|594958368|FG000|Overall Study|Too Many Forms|2|||
164709023|NCT02352779|594958369|FG001|Overall Study|Too Many Forms|0|||
164709024|NCT02352779|594958370|FG002|Overall Study|Too Many Forms|0|||
164709025|NCT02352779|594958368|FG000|Overall Study|Feeling Overwhelmed|1|||
164709026|NCT02352779|594958369|FG001|Overall Study|Feeling Overwhelmed|0|||
164709027|NCT02352779|594958370|FG002|Overall Study|Feeling Overwhelmed|0|||
164709028|NCT02352779|594958368|FG000|Overall Study|Disliked Intervention|1|||
164709029|NCT02352779|594958369|FG001|Overall Study|Disliked Intervention|0|||
164709030|NCT02352779|594958370|FG002|Overall Study|Disliked Intervention|0|||
164709031|NCT02352779|594958368|FG000|Overall Study|Changed Mind|1|||
164709032|NCT02352779|594958369|FG001|Overall Study|Changed Mind|0|||
164709033|NCT02352779|594958370|FG002|Overall Study|Changed Mind|0|||
164709034|NCT02352779|594958368|FG000|Overall Study|Study Related Symptoms|1|||
164709035|NCT02352779|594958369|FG001|Overall Study|Study Related Symptoms|0|||
164709036|NCT02352779|594958370|FG002|Overall Study|Study Related Symptoms|0|||
164709037|NCT02352779|594958368|FG000|Overall Study|Absence of Symptoms|1|||
164709038|NCT02352779|594958369|FG001|Overall Study|Absence of Symptoms|0|||
164709039|NCT02352779|594958370|FG002|Overall Study|Absence of Symptoms|0|||
164709040|NCT02352779|594958368|FG000|Overall Study|Other Medical Reason|0|||
164709041|NCT02352779|594958369|FG001|Overall Study|Other Medical Reason|0|||
164709042|NCT02352779|594958370|FG002|Overall Study|Other Medical Reason|1|||
164709043|NCT02352779|594958368|FG000|Overall Study|No Reason|0|||
164709044|NCT02352779|594958369|FG001|Overall Study|No Reason|0|||
164709045|NCT02352779|594958370|FG002|Overall Study|No Reason|1|||
164709046|NCT00968799|594958373|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
164709047|NCT00719849|594958374|FG000|Overall Study|Death|0|||
164709048|NCT00719849|594958375|FG001|Overall Study|Death|1|||
164709049|NCT00389831|594958376|FG000|Overall Study|Lack of Efficacy|0|||
164709050|NCT00389831|594958377|FG001|Overall Study|Lack of Efficacy|2|||
164709051|NCT00389831|594958376|FG000|Overall Study|Did not receive treatment.|0|||
164709052|NCT00389831|594958377|FG001|Overall Study|Did not receive treatment.|2|||
164709053|NCT00389831|594958376|FG000|Overall Study|Other reasons|0|||
164709054|NCT00389831|594958377|FG001|Overall Study|Other reasons|2|||
164709055|NCT00389831|594958376|FG000|Overall Study|Lost to Follow-up|0|||
164709056|NCT00389831|594958377|FG001|Overall Study|Lost to Follow-up|1|||
164709057|NCT00321737|594958378|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
164709058|NCT00321737|594958379|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
164709059|NCT00321737|594958380|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
164709060|NCT00321737|594958378|FG000|Overall Study|Adverse Event|11|||
164709061|NCT00321737|594958379|FG001|Overall Study|Adverse Event|3|||
164709062|NCT00321737|594958380|FG002|Overall Study|Adverse Event|6|||
164411716|NCT00576732|593878963|FG000|DOUBLE BLIND|Protocol Violation|1|||
164709063|NCT00321737|594958378|FG000|Overall Study|Lost to Follow-up|5|||
164709064|NCT00321737|594958379|FG001|Overall Study|Lost to Follow-up|5|||
164709065|NCT00321737|594958380|FG002|Overall Study|Lost to Follow-up|6|||
164709066|NCT00321737|594958378|FG000|Overall Study|Withdrawal by Subject|19|||
164709067|NCT00321737|594958379|FG001|Overall Study|Withdrawal by Subject|12|||
164709068|NCT00321737|594958380|FG002|Overall Study|Withdrawal by Subject|17|||
164709069|NCT00321737|594958378|FG000|Overall Study|Protocol Violation|0|||
164709070|NCT00321737|594958379|FG001|Overall Study|Protocol Violation|0|||
164709071|NCT00321737|594958380|FG002|Overall Study|Protocol Violation|1|||
164709072|NCT00321737|594958378|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
164709073|NCT00321737|594958379|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
164709074|NCT00321737|594958380|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
164709075|NCT00321737|594958378|FG000|Overall Study|Possible Barrett's Esophagus|2|||
164411717|NCT00576732|593878964|FG001|DOUBLE BLIND|Protocol Violation|0|||
164411718|NCT00576732|593878965|FG002|DOUBLE BLIND|Protocol Violation|0|||
164411719|NCT00576732|593878966|FG003|DOUBLE BLIND|Protocol Violation|0|||
164411720|NCT00576732|593878967|FG004|DOUBLE BLIND|Protocol Violation|0|||
164411721|NCT00576732|593878968|FG005|DOUBLE BLIND|Protocol Violation|0|||
164411722|NCT00576732|593878963|FG000|OPEN LABEL|Adverse Event|0|||
164411723|NCT00576732|593878964|FG001|OPEN LABEL|Adverse Event|0|||
164709076|NCT00321737|594958379|FG001|Overall Study|Possible Barrett's Esophagus|1|||
164709077|NCT00321737|594958380|FG002|Overall Study|Possible Barrett's Esophagus|1|||
164709078|NCT00321737|594958378|FG000|Overall Study|Therapeutic Failure|6|||
164411724|NCT00576732|593878965|FG002|OPEN LABEL|Adverse Event|0|||
164709079|NCT00321737|594958379|FG001|Overall Study|Therapeutic Failure|0|||
164709080|NCT00321737|594958380|FG002|Overall Study|Therapeutic Failure|2|||
164709081|NCT00321737|594958378|FG000|Overall Study|Pregnancy|0|||
164709082|NCT00321737|594958379|FG001|Overall Study|Pregnancy|2|||
164709083|NCT00321737|594958380|FG002|Overall Study|Pregnancy|0|||
164709084|NCT00321737|594958378|FG000|Overall Study|Noncompliance|2|||
164709085|NCT00321737|594958379|FG001|Overall Study|Noncompliance|0|||
164709086|NCT00321737|594958380|FG002|Overall Study|Noncompliance|0|||
164709087|NCT00321737|594958378|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
164709088|NCT00321737|594958379|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
164709089|NCT00321737|594958380|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
164709090|NCT02283294|594958385|FG000|Overall Study|Lost to Follow-up|1|||
164709091|NCT02283294|594958386|FG001|Overall Study|Lost to Follow-up|1|||
164709092|NCT02283294|594958385|FG000|Overall Study|Withdrawal by Subject|1|||
164709093|NCT02283294|594958386|FG001|Overall Study|Withdrawal by Subject|6|||
164709094|NCT02283294|594958385|FG000|Overall Study|Protocol Violation|1|||
164709095|NCT02283294|594958386|FG001|Overall Study|Protocol Violation|0|||
164709096|NCT02283294|594958385|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
164709097|NCT02283294|594958386|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
164709098|NCT00594646|594958387|FG000|Overall Study|Withdrawal by Subject|1|||
164709099|NCT00594646|594958387|FG000|Overall Study|Lost to Follow-up|15|||
164709100|NCT03907462|594958388|FG000|Overall Study|Physician Decision|1|||
164709101|NCT03907462|594958389|FG001|Overall Study|Physician Decision|3|||
164709102|NCT03907462|594958390|FG002|Overall Study|Physician Decision|1|||
164709103|NCT03907462|594958388|FG000|Overall Study|Withdrawal by Subject|6|||
164709104|NCT03907462|594958389|FG001|Overall Study|Withdrawal by Subject|3|||
164709105|NCT03907462|594958390|FG002|Overall Study|Withdrawal by Subject|3|||
164709106|NCT03907462|594958388|FG000|Overall Study|Pregnancy|4|||
164709107|NCT03907462|594958389|FG001|Overall Study|Pregnancy|2|||
164709108|NCT03907462|594958390|FG002|Overall Study|Pregnancy|6|||
164709109|NCT03907462|594958388|FG000|Overall Study|Lost to Follow-up|16|||
164709110|NCT03907462|594958389|FG001|Overall Study|Lost to Follow-up|18|||
164709111|NCT03907462|594958390|FG002|Overall Study|Lost to Follow-up|22|||
164709112|NCT04994483|594960965|FG000|Overall Study|Adverse Event|26|||
164709113|NCT04994483|594960966|FG001|Overall Study|Adverse Event|17|||
164709114|NCT04994483|594960965|FG000|Overall Study|Lost to Follow-up|6|||
164709115|NCT04994483|594960966|FG001|Overall Study|Lost to Follow-up|10|||
164709116|NCT04994483|594960965|FG000|Overall Study|Noncompliance with study drug|8|||
164709117|NCT04994483|594960966|FG001|Overall Study|Noncompliance with study drug|5|||
164709118|NCT04994483|594960965|FG000|Overall Study|Physician Decision|5|||
164709119|NCT04994483|594960966|FG001|Overall Study|Physician Decision|0|||
164709120|NCT04994483|594960965|FG000|Overall Study|Withdrawal by Subject|41|||
164709121|NCT04994483|594960966|FG001|Overall Study|Withdrawal by Subject|38|||
164411725|NCT00576732|593878966|FG003|OPEN LABEL|Adverse Event|4|||
164411726|NCT00576732|593878967|FG004|OPEN LABEL|Adverse Event|0|||
164411727|NCT00576732|593878968|FG005|OPEN LABEL|Adverse Event|1|||
164411728|NCT00576732|593878963|FG000|OPEN LABEL|Lost to Follow-up|0|||
164411729|NCT00576732|593878964|FG001|OPEN LABEL|Lost to Follow-up|0|||
164411730|NCT00576732|593878965|FG002|OPEN LABEL|Lost to Follow-up|0|||
164411731|NCT00576732|593878966|FG003|OPEN LABEL|Lost to Follow-up|2|||
164411732|NCT00576732|593878967|FG004|OPEN LABEL|Lost to Follow-up|1|||
164411733|NCT00576732|593878968|FG005|OPEN LABEL|Lost to Follow-up|1|||
164411734|NCT00576732|593878963|FG000|OPEN LABEL|Withdrawal by Subject|0|||
164411735|NCT00576732|593878964|FG001|OPEN LABEL|Withdrawal by Subject|0|||
164411736|NCT00576732|593878965|FG002|OPEN LABEL|Withdrawal by Subject|0|||
164411737|NCT00576732|593878966|FG003|OPEN LABEL|Withdrawal by Subject|1|||
164411738|NCT00576732|593878967|FG004|OPEN LABEL|Withdrawal by Subject|0|||
164411739|NCT00576732|593878968|FG005|OPEN LABEL|Withdrawal by Subject|1|||
164411740|NCT00576732|593878963|FG000|OPEN LABEL|OTHER|0|||
164411741|NCT00576732|593878964|FG001|OPEN LABEL|OTHER|0|||
164411742|NCT00576732|593878965|FG002|OPEN LABEL|OTHER|0|||
164411743|NCT00576732|593878966|FG003|OPEN LABEL|OTHER|0|||
164411744|NCT00576732|593878967|FG004|OPEN LABEL|OTHER|0|||
164411745|NCT00576732|593878968|FG005|OPEN LABEL|OTHER|2|||
164411746|NCT00576732|593878963|FG000|OPEN LABEL|Lack of Efficacy|0|||
164411747|NCT00576732|593878964|FG001|OPEN LABEL|Lack of Efficacy|0|||
164709122|NCT04994483|594960965|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
164411748|NCT00576732|593878965|FG002|OPEN LABEL|Lack of Efficacy|0|||
164411749|NCT00576732|593878966|FG003|OPEN LABEL|Lack of Efficacy|2|||
164411750|NCT00576732|593878967|FG004|OPEN LABEL|Lack of Efficacy|2|||
164411751|NCT00576732|593878968|FG005|OPEN LABEL|Lack of Efficacy|3|||
164411752|NCT00576732|593878963|FG000|OPEN LABEL|Protocol Violation|0|||
164411753|NCT00576732|593878964|FG001|OPEN LABEL|Protocol Violation|0|||
164411754|NCT00576732|593878965|FG002|OPEN LABEL|Protocol Violation|0|||
164411755|NCT00576732|593878966|FG003|OPEN LABEL|Protocol Violation|2|||
164709123|NCT04994483|594960966|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
164411756|NCT00576732|593878967|FG004|OPEN LABEL|Protocol Violation|1|||
164411757|NCT00576732|593878968|FG005|OPEN LABEL|Protocol Violation|0|||
164411758|NCT00265330|593878969|FG000|Overall Study|Adverse Event|41|||
164411759|NCT00265330|593878969|FG000|Overall Study|Lost to Follow-up|8|||
164411760|NCT00265330|593878969|FG000|Overall Study|Withdrawal by Subject|34|||
164411761|NCT00265330|593878969|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
164411762|NCT00265330|593878969|FG000|Overall Study|Lack of Efficacy|4|||
164411763|NCT00265330|593878969|FG000|Overall Study|Family Scheduling Conflicts|1|||
164411764|NCT00265330|593878969|FG000|Overall Study|Began Taking Formulary Geodon|1|||
164411765|NCT00265330|593878969|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
164411766|NCT00265330|593878969|FG000|Overall Study|Site Closed by Sponsor|1|||
164411767|NCT00265330|593878969|FG000|Overall Study|Principal Investigators Request|1|||
164411768|NCT00265330|593878969|FG000|Overall Study|Withdrew Consent|1|||
164411769|NCT00265330|593878969|FG000|Overall Study|Protocol Violation|1|||
164411770|NCT02178566|593878977|FG000|Overall Study|patient did not complete due to noncompliance|0|||
164411771|NCT02178566|593878978|FG001|Overall Study|patient did not complete due to noncompliance|1|||
164411772|NCT02658630|593878979|FG000|Overall Study|Withdrawal by Subject|4|||
164411773|NCT00085202|593878980|FG000|Overall Study|Still on therapy|2|||
164411774|NCT00085202|593878981|FG001|Overall Study|Still on therapy|0|||
164411775|NCT00085202|593878980|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
164411776|NCT00085202|593878981|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
164411777|NCT00085202|593878980|FG000|Overall Study|Excessive toxicity|6|||
164411778|NCT00085202|593878981|FG001|Overall Study|Excessive toxicity|5|||
164709124|NCT04994483|594960965|FG000|Overall Study|Met stopping criteria|1|||
164411779|NCT00085202|593878980|FG000|Overall Study|Non-specified|3|||
164411780|NCT00085202|593878981|FG001|Overall Study|Non-specified|5|||
164411781|NCT00085202|593878980|FG000|Overall Study|Withdrawal by Subject|2|||
164411782|NCT00085202|593878981|FG001|Overall Study|Withdrawal by Subject|1|||
164411783|NCT00085202|593878980|FG000|Overall Study|Physician Decision|4|||
164411784|NCT00085202|593878981|FG001|Overall Study|Physician Decision|1|||
164411785|NCT00085202|593878980|FG000|Overall Study|Progressive disease|1|||
164411786|NCT00085202|593878981|FG001|Overall Study|Progressive disease|11|||
164411787|NCT01436201|593878983|FG000|Overall Study|Adverse Event|2|||
164411788|NCT01436201|593878983|FG000|Overall Study|Withdrawal by Subject|1|||
164411789|NCT01436201|593878983|FG000|Overall Study|Protocol Violation|1|||
164411790|NCT00110890|593878984|FG000|Overall Study|Adverse Event|30|||
164411791|NCT00110890|593878985|FG001|Overall Study|Adverse Event|7|||
164411792|NCT00110890|593878984|FG000|Overall Study|Death|16|||
164411793|NCT00110890|593878985|FG001|Overall Study|Death|9|||
164411794|NCT00110890|593878984|FG000|Overall Study|Lost to Follow-up|3|||
164411795|NCT00110890|593878985|FG001|Overall Study|Lost to Follow-up|1|||
164411796|NCT00110890|593878984|FG000|Overall Study|Physician Decision|4|||
164411797|NCT00110890|593878985|FG001|Overall Study|Physician Decision|5|||
164411798|NCT00110890|593878984|FG000|Overall Study|Withdrawal by Subject|17|||
164411799|NCT00110890|593878985|FG001|Overall Study|Withdrawal by Subject|5|||
164411800|NCT00110890|593878984|FG000|Overall Study|Protocol Deviation|1|||
164411801|NCT00110890|593878985|FG001|Overall Study|Protocol Deviation|0|||
164411802|NCT00110890|593878984|FG000|Overall Study|Noncompliance|10|||
164411803|NCT00110890|593878985|FG001|Overall Study|Noncompliance|0|||
164411804|NCT00110890|593878984|FG000|Overall Study|Kidney Transplant|16|||
164411805|NCT00110890|593878985|FG001|Overall Study|Kidney Transplant|12|||
164411806|NCT00110890|593878984|FG000|Overall Study|Invest. Product Commercially Available|217|||
164411807|NCT00110890|593878985|FG001|Overall Study|Invest. Product Commercially Available|110|||
164411808|NCT00110890|593878984|FG000|Overall Study|Other|34|||
164411809|NCT00110890|593878985|FG001|Overall Study|Other|23|||
164411810|NCT00110890|593878984|FG000|Overall Study|Ineligibility determined|3|||
164411811|NCT00110890|593878985|FG001|Overall Study|Ineligibility determined|0|||
164411812|NCT00110890|593878984|FG000|Overall Study|Requirement for alternative therapy|0|||
164411813|NCT00110890|593878985|FG001|Overall Study|Requirement for alternative therapy|1|||
164411814|NCT00110890|593878984|FG000|Overall Study|Disease progression|0|||
164411815|NCT00110890|593878985|FG001|Overall Study|Disease progression|1|||
164463361|NCT02151981|594068636|FG001|Overall Study|Withdrawal by Subject|21|||
164411816|NCT00110890|593878984|FG000|Overall Study|Parathyroidectomy|0|||
164411817|NCT00110890|593878985|FG001|Overall Study|Parathyroidectomy|1|||
164411818|NCT00110890|593878984|FG000|Overall Study|Did not enter follow-up phase|10|||
164411819|NCT00110890|593878985|FG001|Overall Study|Did not enter follow-up phase|4|||
164411820|NCT01686581|593878986|FG000|Overall Study|Side-effects or Health Problems|15|||
164411821|NCT01686581|593878986|FG000|Overall Study|Lack of Efficacy|90|||
164411822|NCT01686581|593878986|FG000|Overall Study|Participant Concerned about Risks|6|||
164411823|NCT01686581|593878986|FG000|Overall Study|Thinks Injections Too Painful|8|||
164411824|NCT01686581|593878986|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
164411825|NCT01686581|593878986|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
164411826|NCT01686581|593878986|FG000|Overall Study|Thinks it is Inconvenient|17|||
164411827|NCT01686581|593878986|FG000|Overall Study|Other Miscellaneous Reasons|36|||
164411828|NCT01686581|593878986|FG000|Overall Study|Reason Missing|1|||
164411829|NCT01975220|593878987|FG000|Test Period 1|Not treated|0|||
164411830|NCT01975220|593878988|FG001|Test Period 1|Not treated|1|||
164411831|NCT01975220|593878989|FG002|Test Period 1|Not treated|0|||
164411832|NCT01975220|593878990|FG003|Test Period 1|Not treated|0|||
164411833|NCT01975220|593878991|FG004|Test Period 1|Not treated|0|||
164709125|NCT04994483|594960966|FG001|Overall Study|Met stopping criteria|0|||
164709126|NCT04994483|594960965|FG000|Overall Study|Randomized in error, not treated|4|||
164709127|NCT04994483|594960966|FG001|Overall Study|Randomized in error, not treated|3|||
164709128|NCT04994483|594960965|FG000|Overall Study|Lack of a reliable study partner|0|||
164709129|NCT04994483|594960966|FG001|Overall Study|Lack of a reliable study partner|1|||
164709130|NCT04994483|594960965|FG000|Overall Study|Met MRI exclusion criteria|0|||
164709131|NCT04994483|594960966|FG001|Overall Study|Met MRI exclusion criteria|1|||
164709132|NCT00759902|594960967|FG000|Overall Study|Adverse Event|0|||
164709133|NCT00759902|594960968|FG001|Overall Study|Adverse Event|1|||
164709134|NCT00663026|594960969|FG000|Overall Study|Lost to Follow-up|1|||
164709135|NCT00663026|594960970|FG001|Overall Study|Lost to Follow-up|0|||
164709136|NCT00663026|594960971|FG002|Overall Study|Lost to Follow-up|0|||
164709137|NCT00663026|594960969|FG000|Overall Study|Other|1|||
164709138|NCT00663026|594960970|FG001|Overall Study|Other|2|||
164709139|NCT00663026|594960971|FG002|Overall Study|Other|0|||
164709140|NCT00663026|594960969|FG000|Overall Study|Adverse Event|0|||
164709141|NCT00663026|594960970|FG001|Overall Study|Adverse Event|2|||
164709142|NCT00663026|594960971|FG002|Overall Study|Adverse Event|3|||
164709143|NCT00663026|594960969|FG000|Overall Study|Caregiver Request|0|||
164709144|NCT00663026|594960970|FG001|Overall Study|Caregiver Request|2|||
164709145|NCT00663026|594960971|FG002|Overall Study|Caregiver Request|0|||
164709146|NCT00663026|594960969|FG000|Overall Study|Withdrawal by Subject|0|||
164709147|NCT00663026|594960970|FG001|Overall Study|Withdrawal by Subject|0|||
164709148|NCT00663026|594960971|FG002|Overall Study|Withdrawal by Subject|1|||
164709149|NCT04003896|594960972|FG000|Overall Study|Withdrawal by Subject|3|||
164709150|NCT04003896|594960972|FG000|Overall Study|Physician Decision|1|||
164709151|NCT00806286|594960975|FG000|Overall Study|Adverse Event|5|||
164709152|NCT00806286|594960976|FG001|Overall Study|Adverse Event|2|||
164709153|NCT00806286|594960977|FG002|Overall Study|Adverse Event|0|||
164709154|NCT00806286|594960975|FG000|Overall Study|Disease progression|31|||
164709155|NCT00806286|594960976|FG001|Overall Study|Disease progression|38|||
164709156|NCT00806286|594960977|FG002|Overall Study|Disease progression|1|||
164709157|NCT00806286|594960975|FG000|Overall Study|Death|1|||
164709158|NCT00806286|594960976|FG001|Overall Study|Death|6|||
164709159|NCT00806286|594960977|FG002|Overall Study|Death|0|||
164709160|NCT00806286|594960975|FG000|Overall Study|Lost to Follow-up|0|||
164709161|NCT00806286|594960976|FG001|Overall Study|Lost to Follow-up|1|||
164709162|NCT00806286|594960977|FG002|Overall Study|Lost to Follow-up|0|||
164709163|NCT00806286|594960975|FG000|Overall Study|Withdrawal by Subject|8|||
164709164|NCT00806286|594960976|FG001|Overall Study|Withdrawal by Subject|3|||
164709165|NCT00806286|594960977|FG002|Overall Study|Withdrawal by Subject|1|||
164709166|NCT00806286|594960975|FG000|Overall Study|Physician Decision|2|||
164709167|NCT00806286|594960976|FG001|Overall Study|Physician Decision|2|||
164709168|NCT00806286|594960977|FG002|Overall Study|Physician Decision|0|||
164709169|NCT00806286|594960975|FG000|Overall Study|Due to a variety of reasons|7|||
164709170|NCT00806286|594960976|FG001|Overall Study|Due to a variety of reasons|2|||
164709171|NCT00806286|594960977|FG002|Overall Study|Due to a variety of reasons|1|||
164709172|NCT02006693|594960978|FG000|Overall Study|No Reason Specified|6|||
164709173|NCT02006693|594960979|FG001|Overall Study|No Reason Specified|8|||
164709174|NCT02006693|594960978|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
164709175|NCT02006693|594960979|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
164709176|NCT02006693|594960978|FG000|Overall Study|XEN Implant Explantation|0|||
164709177|NCT02006693|594960979|FG001|Overall Study|XEN Implant Explantation|1|||
164709178|NCT02006693|594960978|FG000|Overall Study|Death|2|||
164709179|NCT02006693|594960979|FG001|Overall Study|Death|2|||
164709180|NCT02006693|594960978|FG000|Overall Study|Lost to Follow-up|4|||
164709181|NCT02006693|594960979|FG001|Overall Study|Lost to Follow-up|1|||
164709182|NCT02006693|594960978|FG000|Overall Study|Patient Decision|4|||
164709183|NCT02006693|594960979|FG001|Overall Study|Patient Decision|0|||
164709184|NCT03151408|594960980|FG000|Overall Study|Adverse Event|24|||
164709185|NCT03151408|594960981|FG001|Overall Study|Adverse Event|23|||
164411834|NCT01975220|593878992|FG005|Test Period 1|Not treated|0|||
164411835|NCT00263328|593878995|FG000|Overall Study|Death|0|||
164709186|NCT03151408|594960980|FG000|Overall Study|Death|46|||
164709187|NCT03151408|594960981|FG001|Overall Study|Death|26|||
164709188|NCT03151408|594960980|FG000|Overall Study|Physician Decision|13|||
164709189|NCT03151408|594960981|FG001|Overall Study|Physician Decision|19|||
164709190|NCT03151408|594960980|FG000|Overall Study|Withdrawal by Subject|16|||
164709191|NCT03151408|594960981|FG001|Overall Study|Withdrawal by Subject|20|||
164709192|NCT03151408|594960980|FG000|Overall Study|Progressive disease|45|||
164709193|NCT03151408|594960981|FG001|Overall Study|Progressive disease|61|||
164709194|NCT03151408|594960980|FG000|Overall Study|non-compliance by patient|1|||
164709195|NCT03151408|594960981|FG001|Overall Study|non-compliance by patient|0|||
164709196|NCT03151408|594960980|FG000|Overall Study|other reasons|56|||
164709197|NCT03151408|594960981|FG001|Overall Study|other reasons|52|||
164709198|NCT03151408|594960980|FG000|Overall Study|randomized and not treated|2|||
164709199|NCT03151408|594960981|FG001|Overall Study|randomized and not treated|2|||
164709200|NCT00265395|594960982|FG000|Overall Study|Adverse Event|3|||
164709201|NCT00265395|594960983|FG001|Overall Study|Adverse Event|6|||
164709202|NCT00265395|594960982|FG000|Overall Study|Lost to Follow-up|2|||
164709203|NCT00265395|594960983|FG001|Overall Study|Lost to Follow-up|1|||
164709204|NCT00265395|594960982|FG000|Overall Study|Withdrawal by Subject|1|||
164709205|NCT00265395|594960983|FG001|Overall Study|Withdrawal by Subject|6|||
164709206|NCT00265395|594960982|FG000|Overall Study|Protocol Violation|2|||
164709207|NCT00265395|594960983|FG001|Overall Study|Protocol Violation|2|||
164709208|NCT00265395|594960982|FG000|Overall Study|Lack of Efficacy|0|||
164709209|NCT00265395|594960983|FG001|Overall Study|Lack of Efficacy|1|||
164709210|NCT00265395|594960982|FG000|Overall Study|Administrative|0|||
164709211|NCT00265395|594960983|FG001|Overall Study|Administrative|1|||
164709212|NCT03400943|594960984|FG000|Treatment Period 1|Adverse Event|0|||
164709213|NCT03400943|594960985|FG001|Treatment Period 1|Adverse Event|0|||
164709214|NCT03400943|594960986|FG002|Treatment Period 1|Adverse Event|0|||
164709215|NCT03400943|594960987|FG003|Treatment Period 1|Adverse Event|1|||
164709216|NCT03400943|594960984|FG000|Treatment Period 1|Lost to Follow-up|1|||
164709217|NCT03400943|594960985|FG001|Treatment Period 1|Lost to Follow-up|0|||
164709218|NCT03400943|594960986|FG002|Treatment Period 1|Lost to Follow-up|0|||
164709219|NCT03400943|594960987|FG003|Treatment Period 1|Lost to Follow-up|0|||
164709220|NCT03400943|594960984|FG000|Treatment Period 1|Protocol Violation|0|||
164709221|NCT03400943|594960985|FG001|Treatment Period 1|Protocol Violation|1|||
164709222|NCT03400943|594960986|FG002|Treatment Period 1|Protocol Violation|1|||
164709223|NCT03400943|594960987|FG003|Treatment Period 1|Protocol Violation|0|||
164709224|NCT03400943|594960984|FG000|Treatment Period 1|Study terminated by sponsor|2|||
164709225|NCT03400943|594960985|FG001|Treatment Period 1|Study terminated by sponsor|0|||
164709226|NCT03400943|594960986|FG002|Treatment Period 1|Study terminated by sponsor|0|||
164709227|NCT03400943|594960987|FG003|Treatment Period 1|Study terminated by sponsor|1|||
164709228|NCT03400943|594960984|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164709229|NCT03400943|594960985|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164709230|NCT03400943|594960986|FG002|Treatment Period 1|Withdrawal by Subject|3|||
164709231|NCT03400943|594960987|FG003|Treatment Period 1|Withdrawal by Subject|1|||
164709232|NCT03400943|594960984|FG000|Treatment Period 1|Other|2|||
164709233|NCT03400943|594960985|FG001|Treatment Period 1|Other|1|||
164709234|NCT03400943|594960986|FG002|Treatment Period 1|Other|2|||
164709235|NCT03400943|594960987|FG003|Treatment Period 1|Other|2|||
164411836|NCT00263328|593878996|FG001|Overall Study|Death|0|||
164411837|NCT00263328|593878997|FG002|Overall Study|Death|1|||
164411838|NCT00263328|593878995|FG000|Overall Study|Lost to Follow-up|1|||
164411839|NCT00263328|593878996|FG001|Overall Study|Lost to Follow-up|1|||
164411840|NCT00263328|593878997|FG002|Overall Study|Lost to Follow-up|0|||
164411841|NCT00263328|593878995|FG000|Overall Study|Withdrawal by Subject|3|||
164411842|NCT00263328|593878996|FG001|Overall Study|Withdrawal by Subject|0|||
164411843|NCT00263328|593878997|FG002|Overall Study|Withdrawal by Subject|1|||
164411844|NCT00263328|593878995|FG000|Overall Study|Other|3|||
164411845|NCT00263328|593878996|FG001|Overall Study|Other|0|||
164411846|NCT00263328|593878997|FG002|Overall Study|Other|1|||
164411847|NCT00263328|593878995|FG000|Overall Study|Adverse Event|1|||
164411848|NCT00263328|593878996|FG001|Overall Study|Adverse Event|1|||
164411849|NCT00263328|593878997|FG002|Overall Study|Adverse Event|4|||
164411850|NCT02613221|593879000|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
164411851|NCT02613221|593879000|FG000|Overall Study|Adverse Event|2|||
164411852|NCT02613221|593879000|FG000|Overall Study|Voluntary Discontinuation|1|||
164411853|NCT02613221|593879000|FG000|Overall Study|Delayed Treatment|1|||
164411854|NCT02613221|593879000|FG000|Overall Study|Enrolled but Not Treated|1|||
164411855|NCT01008475|593879003|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
164411856|NCT01008475|593879004|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
164411857|NCT01008475|593879005|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
164411858|NCT01008475|593879006|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
164411859|NCT01008475|593879007|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
164411860|NCT01008475|593879008|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
164411861|NCT01008475|593879009|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
164411862|NCT01301274|593879010|FG000|Overall Study|Physician Decision|2|||
164411863|NCT01301274|593879011|FG001|Overall Study|Physician Decision|1|||
164709236|NCT03400943|594960984|FG000|Post-treatment Period 1|Adverse Event|2|||
164709237|NCT03400943|594960985|FG001|Post-treatment Period 1|Adverse Event|0|||
164411864|NCT00661661|593879012|FG000|Overall Study|Adverse Event|99|||
164411865|NCT00661661|593879013|FG001|Overall Study|Adverse Event|24|||
164709238|NCT03400943|594960986|FG002|Post-treatment Period 1|Adverse Event|0|||
164709239|NCT03400943|594960987|FG003|Post-treatment Period 1|Adverse Event|0|||
164709240|NCT03400943|594960984|FG000|Post-treatment Period 1|Protocol Violation|1|||
164411866|NCT00661661|593879012|FG000|Overall Study|Lack of Efficacy|3|||
164709241|NCT03400943|594960985|FG001|Post-treatment Period 1|Protocol Violation|0|||
164709242|NCT03400943|594960986|FG002|Post-treatment Period 1|Protocol Violation|0|||
164709243|NCT03400943|594960987|FG003|Post-treatment Period 1|Protocol Violation|0|||
164709244|NCT03400943|594960984|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
164709245|NCT03400943|594960985|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
164709246|NCT03400943|594960986|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
164411867|NCT00661661|593879013|FG001|Overall Study|Lack of Efficacy|2|||
164411868|NCT00661661|593879012|FG000|Overall Study|Lost to Follow-up|0|||
164709247|NCT03400943|594960987|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
164709248|NCT03400943|594960984|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
164411869|NCT00661661|593879013|FG001|Overall Study|Lost to Follow-up|1|||
164411870|NCT00661661|593879012|FG000|Overall Study|Withdrawal by Subject|15|||
164411871|NCT00661661|593879013|FG001|Overall Study|Withdrawal by Subject|5|||
164411872|NCT00661661|593879012|FG000|Overall Study|Other|22|||
164411873|NCT00661661|593879013|FG001|Overall Study|Other|7|||
164411874|NCT00661661|593879012|FG000|Overall Study|Not assigned treatment|1|||
164411875|NCT00661661|593879013|FG001|Overall Study|Not assigned treatment|0|||
164599370|NCT00243230|594554833|FG000|Open Label Period|Administrative Reason|0|||
164599371|NCT00243230|594554834|FG001|Open Label Period|Administrative Reason|0|||
164599372|NCT00243230|594554835|FG002|Open Label Period|Administrative Reason|0|||
164599373|NCT00243230|594554836|FG003|Open Label Period|Administrative Reason|63|||
164599374|NCT05836818|594554837|FG000|Overall Study|Physician Decision|1|||
164599375|NCT05836818|594554838|FG001|Overall Study|Physician Decision|1|||
164599376|NCT05836818|594554839|FG002|Overall Study|Physician Decision|0|||
164599377|NCT05836818|594554837|FG000|Overall Study|Withdrawal by Subject|0|||
164599378|NCT05836818|594554838|FG001|Overall Study|Withdrawal by Subject|0|||
164599379|NCT05836818|594554839|FG002|Overall Study|Withdrawal by Subject|1|||
164599380|NCT05836818|594554837|FG000|Overall Study|Later found to be previously vaccinated|0|||
164599381|NCT05836818|594554838|FG001|Overall Study|Later found to be previously vaccinated|1|||
164599382|NCT05836818|594554839|FG002|Overall Study|Later found to be previously vaccinated|3|||
164599383|NCT05836818|594554837|FG000|Overall Study|Pregnancy|0|||
164599384|NCT05836818|594554838|FG001|Overall Study|Pregnancy|1|||
164599385|NCT05836818|594554839|FG002|Overall Study|Pregnancy|0|||
164599386|NCT05836818|594554837|FG000|Overall Study|Allergic to vaccines|0|||
164599387|NCT05836818|594554838|FG001|Overall Study|Allergic to vaccines|1|||
164599388|NCT05836818|594554839|FG002|Overall Study|Allergic to vaccines|0|||
164599389|NCT03738566|594554840|FG000|Initial Study Phase|Withdrawal by Subject|1|||
164599390|NCT03738566|594554841|FG001|Initial Study Phase|Withdrawal by Subject|1|||
164599391|NCT03738566|594554842|FG002|Initial Study Phase|Withdrawal by Subject|2|||
164599392|NCT03738566|594554843|FG003|Initial Study Phase|Withdrawal by Subject|0|||
164599393|NCT03738566|594554840|FG000|Initial Study Phase|Death|0|||
164599394|NCT03738566|594554841|FG001|Initial Study Phase|Death|1|||
164599395|NCT03738566|594554842|FG002|Initial Study Phase|Death|0|||
164599396|NCT03738566|594554843|FG003|Initial Study Phase|Death|0|||
164599397|NCT03738566|594554840|FG000|Initial Study Phase|Treatment failure|5|||
164599398|NCT03738566|594554841|FG001|Initial Study Phase|Treatment failure|0|||
164599399|NCT03738566|594554842|FG002|Initial Study Phase|Treatment failure|0|||
164599400|NCT03738566|594554843|FG003|Initial Study Phase|Treatment failure|0|||
164599401|NCT03738566|594554840|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
164599402|NCT03738566|594554841|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
164599403|NCT03738566|594554842|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
164599404|NCT03738566|594554843|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
164599405|NCT03126539|594554849|FG000|Overall Study|Lost to Follow-up|1|||
164599406|NCT03126539|594554850|FG001|Overall Study|Lost to Follow-up|1|||
164599407|NCT03126539|594554851|FG002|Overall Study|Lost to Follow-up|1|||
164599408|NCT03126539|594554852|FG003|Overall Study|Lost to Follow-up|0|||
164599409|NCT03126539|594554853|FG004|Overall Study|Lost to Follow-up|0|||
164599410|NCT01627067|594554854|FG000|Overall Study|Screen Failure|1|||
164599411|NCT00926796|594554855|FG000|Overall Study|Did not receive randomized treatment|4|||
164599412|NCT00926796|594554856|FG001|Overall Study|Did not receive randomized treatment|7|||
164599413|NCT00926796|594554855|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
164599414|NCT00926796|594554856|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
164599415|NCT00926796|594554855|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
164599416|NCT00926796|594554856|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
164599417|NCT00926796|594554855|FG000|Overall Study|Adverse Event|7|||
164599418|NCT00926796|594554856|FG001|Overall Study|Adverse Event|14|||
164599419|NCT00926796|594554855|FG000|Overall Study|Lost to Follow-up|22|||
164599420|NCT00926796|594554856|FG001|Overall Study|Lost to Follow-up|13|||
164599421|NCT00926796|594554855|FG000|Overall Study|Protocol Violation|15|||
164599422|NCT00926796|594554856|FG001|Overall Study|Protocol Violation|11|||
164599423|NCT00926796|594554855|FG000|Overall Study|Withdrawal by Subject|1|||
164599424|NCT00926796|594554856|FG001|Overall Study|Withdrawal by Subject|0|||
164599425|NCT02596711|594554862|FG000|Overall Study|Lost to Follow-up|1|||
164599426|NCT02596711|594554863|FG001|Overall Study|Lost to Follow-up|2|||
164599427|NCT02596711|594554864|FG002|Overall Study|Lost to Follow-up|3|||
164599428|NCT00586924|594554865|FG000|Overall Study|Adverse event/serious adverse event|0|||
164599429|NCT00586924|594554866|FG001|Overall Study|Adverse event/serious adverse event|0|||
164709249|NCT03400943|594960985|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
164709250|NCT03400943|594960986|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
164709251|NCT03400943|594960987|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
164709252|NCT03400943|594960984|FG000|Post-treatment Period 1|Other|2|||
164709253|NCT03400943|594960985|FG001|Post-treatment Period 1|Other|0|||
164709254|NCT03400943|594960986|FG002|Post-treatment Period 1|Other|4|||
164709255|NCT03400943|594960987|FG003|Post-treatment Period 1|Other|5|||
164709256|NCT03400943|594960984|FG000|Treatment Period 2|Study terminated by sponsor|0|||
164709257|NCT03400943|594960985|FG001|Treatment Period 2|Study terminated by sponsor|1|||
164709258|NCT03400943|594960986|FG002|Treatment Period 2|Study terminated by sponsor|0|||
164709259|NCT03400943|594960987|FG003|Treatment Period 2|Study terminated by sponsor|0|||
164709260|NCT03400943|594960984|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164709261|NCT03400943|594960985|FG001|Treatment Period 2|Withdrawal by Subject|1|||
164709262|NCT03400943|594960986|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164709263|NCT03400943|594960987|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164709264|NCT03400943|594960984|FG000|Treatment Period 2|Other|1|||
164709265|NCT03400943|594960985|FG001|Treatment Period 2|Other|6|||
164709266|NCT03400943|594960986|FG002|Treatment Period 2|Other|0|||
164709267|NCT03400943|594960987|FG003|Treatment Period 2|Other|0|||
164709268|NCT03400943|594960984|FG000|Follow-up Period|Withdrawal by Subject|1|||
164709269|NCT03400943|594960985|FG001|Follow-up Period|Withdrawal by Subject|0|||
164709270|NCT03400943|594960986|FG002|Follow-up Period|Withdrawal by Subject|0|||
164709271|NCT03400943|594960987|FG003|Follow-up Period|Withdrawal by Subject|0|||
164709272|NCT03317834|594960988|FG000|Overall Study|Death|2|||
164709273|NCT03317834|594960988|FG000|Overall Study|Device Revision|5|||
164709274|NCT03317834|594960988|FG000|Overall Study|Withdrawal by Subject|13|||
164709275|NCT03317834|594960988|FG000|Overall Study|Lost to Follow-up|13|||
164709276|NCT03839823|594960992|FG000|Overall Study|Adverse Event|8|||
164709277|NCT03839823|594960993|FG001|Overall Study|Adverse Event|4|||
164709278|NCT03839823|594960992|FG000|Overall Study|Death|1|||
164709279|NCT03839823|594960993|FG001|Overall Study|Death|0|||
164709280|NCT03839823|594960992|FG000|Overall Study|Physician Decision|1|||
164709281|NCT03839823|594960993|FG001|Overall Study|Physician Decision|5|||
164709282|NCT03839823|594960992|FG000|Overall Study|Progressive Disease (PD)|65|||
164709283|NCT03839823|594960993|FG001|Overall Study|Progressive Disease (PD)|65|||
164709284|NCT03839823|594960992|FG000|Overall Study|Subject Decision|2|||
164709285|NCT03839823|594960993|FG001|Overall Study|Subject Decision|9|||
164709286|NCT03839823|594960992|FG000|Overall Study|Not Treated|0|||
164709287|NCT03839823|594960993|FG001|Overall Study|Not Treated|10|||
164709288|NCT01716715|594960994|FG000|Overall Study|Never Treated|2|||
164709289|NCT01716715|594960995|FG001|Overall Study|Never Treated|4|||
164709290|NCT00660400|594960996|FG000|Overall Study|Lack of insurance approval|1|||
164709291|NCT00660400|594960996|FG000|Overall Study|Suboptimal organ function|1|||
164709292|NCT00660400|594960996|FG000|Overall Study|Intracranial hemorrhage|1|||
164709293|NCT00660400|594960996|FG000|Overall Study|Withdrawal by Subject|1|||
164709294|NCT01161407|594960997|FG000|Overall Study|Protocol Violation|3|||
164709295|NCT01161407|594960998|FG001|Overall Study|Protocol Violation|1|||
164709296|NCT01777620|594960999|FG000|Overall Study|Subject Withdrawal|1|||
164709297|NCT01777620|594961000|FG001|Overall Study|Subject Withdrawal|0|||
164709298|NCT04562155|594961001|FG000|Overall Study|COVID-19 pandemic|0|||
164709299|NCT04562155|594961002|FG001|Overall Study|COVID-19 pandemic|0|||
164709300|NCT04562155|594961003|FG002|Overall Study|COVID-19 pandemic|0|||
164411876|NCT02917941|593879014|FG000|Treatment Period|Adverse Event|11|||
164411877|NCT02917941|593879014|FG000|Treatment Period|Progressive Disease|11|||
164411878|NCT02917941|593879014|FG000|Treatment Period|Reason not Specified|2|||
164411879|NCT02917941|593879014|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
164463362|NCT02151981|594068635|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164463363|NCT02151981|594068636|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
164463364|NCT02151981|594068635|FG000|Overall Study|Other reasons|1|||
164463365|NCT02151981|594068636|FG001|Overall Study|Other reasons|2|||
164411880|NCT02917941|593879014|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
164411881|NCT01893827|593879015|FG000|Overall Study|Lost to Follow-up|19|||
164411882|NCT01893827|593879016|FG001|Overall Study|Lost to Follow-up|26|||
164709301|NCT04562155|594961004|FG003|Overall Study|COVID-19 pandemic|1|||
164709302|NCT04562155|594961001|FG000|Overall Study|Adverse Event|7|||
164709303|NCT04562155|594961002|FG001|Overall Study|Adverse Event|3|||
164411883|NCT01353222|593879019|FG000|Overall Study|Death|30|||
164411884|NCT01353222|593879020|FG001|Overall Study|Death|30|||
164411885|NCT01353222|593879019|FG000|Overall Study|Withdrawal by Subject|8|||
164709304|NCT04562155|594961003|FG002|Overall Study|Adverse Event|8|||
164709305|NCT04562155|594961004|FG003|Overall Study|Adverse Event|1|||
164463366|NCT05645757|594068656|FG000|Overall Study|Enrolled but treatment not administered|0|||
164709306|NCT04562155|594961001|FG000|Overall Study|Withdrawal by Subject|3|||
164709307|NCT04562155|594961002|FG001|Overall Study|Withdrawal by Subject|6|||
164709308|NCT04562155|594961003|FG002|Overall Study|Withdrawal by Subject|3|||
164709309|NCT04562155|594961004|FG003|Overall Study|Withdrawal by Subject|3|||
164709310|NCT04562155|594961001|FG000|Overall Study|Participant personal reason|1|||
164709311|NCT04562155|594961002|FG001|Overall Study|Participant personal reason|0|||
164709312|NCT04562155|594961003|FG002|Overall Study|Participant personal reason|2|||
164709313|NCT04562155|594961004|FG003|Overall Study|Participant personal reason|1|||
164709314|NCT04005352|594961015|FG000|Overall Study|Adverse Event|4|||
164709315|NCT04005352|594961016|FG001|Overall Study|Adverse Event|5|||
164709316|NCT04005352|594961015|FG000|Overall Study|Death|4|||
164709317|NCT04005352|594961016|FG001|Overall Study|Death|2|||
164709318|NCT04005352|594961015|FG000|Overall Study|Lost to Follow-up|6|||
164709319|NCT04005352|594961016|FG001|Overall Study|Lost to Follow-up|2|||
164709320|NCT04005352|594961015|FG000|Overall Study|Physician Decision|7|||
164709321|NCT04005352|594961016|FG001|Overall Study|Physician Decision|13|||
164709322|NCT04005352|594961015|FG000|Overall Study|Protocol Violation|0|||
164709323|NCT04005352|594961016|FG001|Overall Study|Protocol Violation|1|||
164709324|NCT04005352|594961015|FG000|Overall Study|Withdrawal by Subject|28|||
164709325|NCT04005352|594961016|FG001|Overall Study|Withdrawal by Subject|38|||
164709326|NCT00849186|594961017|FG000|Overall Study|Adverse Event|2|||
164709327|NCT00849186|594961017|FG000|Overall Study|Withdrawal by Subject|1|||
164709328|NCT00849186|594961017|FG000|Overall Study|not treated|6|||
164709329|NCT00849186|594961017|FG000|Overall Study|Other|1|||
164709330|NCT00936897|594961020|FG000|Overall Study|Withdrawal by Subject|9|||
164709331|NCT00936897|594961021|FG001|Overall Study|Withdrawal by Subject|19|||
164709332|NCT00936897|594961020|FG000|Overall Study|Adverse Event|4|||
164709333|NCT00936897|594961021|FG001|Overall Study|Adverse Event|13|||
164709334|NCT00936897|594961020|FG000|Overall Study|Other|3|||
164709335|NCT00936897|594961021|FG001|Overall Study|Other|9|||
164709336|NCT00936897|594961020|FG000|Overall Study|Lost to Follow-up|1|||
164709337|NCT00936897|594961021|FG001|Overall Study|Lost to Follow-up|10|||
164709338|NCT00936897|594961020|FG000|Overall Study|Administrative Decision|1|||
164709339|NCT00936897|594961021|FG001|Overall Study|Administrative Decision|2|||
164709340|NCT00936897|594961020|FG000|Overall Study|Protocol Violation|1|||
164709341|NCT00936897|594961021|FG001|Overall Study|Protocol Violation|1|||
164709342|NCT00936897|594961020|FG000|Overall Study|Ineligibility Determined|0|||
164709343|NCT00936897|594961021|FG001|Overall Study|Ineligibility Determined|3|||
164709344|NCT00936897|594961020|FG000|Overall Study|Noncompliance|0|||
164709345|NCT00936897|594961021|FG001|Overall Study|Noncompliance|2|||
164709346|NCT00936897|594961020|FG000|Overall Study|Death|0|||
164709347|NCT00936897|594961021|FG001|Overall Study|Death|1|||
164709348|NCT04058067|594961022|FG000|Overall Study|Adverse Event|2|||
164411886|NCT01353222|593879020|FG001|Overall Study|Withdrawal by Subject|5|||
164411887|NCT01353222|593879019|FG000|Overall Study|Study Terminated|31|||
164411888|NCT01353222|593879020|FG001|Overall Study|Study Terminated|37|||
164411889|NCT01353222|593879019|FG000|Overall Study|Site closed research department|1|||
164411890|NCT01353222|593879020|FG001|Overall Study|Site closed research department|0|||
164411891|NCT01119898|593879021|FG000|Overall Study|Adverse Event|4|||
164411892|NCT01119898|593879022|FG001|Overall Study|Adverse Event|5|||
164411893|NCT01119898|593879021|FG000|Overall Study|Withdrawal by Subject|1|||
164411894|NCT01119898|593879022|FG001|Overall Study|Withdrawal by Subject|4|||
164411895|NCT01119898|593879021|FG000|Overall Study|Lack of Efficacy|0|||
164411896|NCT01119898|593879022|FG001|Overall Study|Lack of Efficacy|2|||
164411897|NCT01119898|593879021|FG000|Overall Study|Protocol Violation|1|||
164411898|NCT01119898|593879022|FG001|Overall Study|Protocol Violation|1|||
164411899|NCT01119898|593879021|FG000|Overall Study|Medical procedure|1|||
164411900|NCT01119898|593879022|FG001|Overall Study|Medical procedure|0|||
164411901|NCT01119898|593879021|FG000|Overall Study|Randomized in error did not participate|1|||
164411902|NCT01119898|593879022|FG001|Overall Study|Randomized in error did not participate|0|||
164411903|NCT01807650|593879025|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
164411904|NCT01807650|593879025|FG000|Overall Study|Adverse Event|5|||
164411905|NCT01807650|593879025|FG000|Overall Study|Other|2|||
164411906|NCT03021668|593879026|FG000|Overall Study|Physician Decision|0|||
164411907|NCT03021668|593879027|FG001|Overall Study|Physician Decision|1|||
164411908|NCT01122381|593879028|FG000|Overall Study|study terminated early|0|||
164411909|NCT01122381|593879029|FG001|Overall Study|study terminated early|1|||
164411910|NCT02217280|593879030|FG000|Overall Study|Withdrawal by Subject|2|||
164411911|NCT02217280|593879030|FG000|Overall Study|Post-consent sceen fail|2|||
164411912|NCT00736489|593879031|FG000|Period 1|Lost to Follow-up|1|||
164411913|NCT00736489|593879032|FG001|Period 1|Lost to Follow-up|0|||
164709349|NCT04058067|594961023|FG001|Overall Study|Adverse Event|0|||
164709350|NCT04058067|594961022|FG000|Overall Study|Death|0|||
164709351|NCT04058067|594961023|FG001|Overall Study|Death|1|||
164709352|NCT04058067|594961022|FG000|Overall Study|Physician Decision|3|||
164411914|NCT00736489|593879033|FG002|Period 1|Lost to Follow-up|0|||
164411915|NCT00736489|593879034|FG003|Period 1|Lost to Follow-up|0|||
164709353|NCT04058067|594961023|FG001|Overall Study|Physician Decision|1|||
164411916|NCT00736489|593879035|FG004|Period 1|Lost to Follow-up|0|||
164709354|NCT04058067|594961022|FG000|Overall Study|Protocol Violation|0|||
164709355|NCT04058067|594961023|FG001|Overall Study|Protocol Violation|1|||
164709356|NCT04058067|594961022|FG000|Overall Study|Withdrawal by Subject|7|||
164709357|NCT04058067|594961023|FG001|Overall Study|Withdrawal by Subject|8|||
164709358|NCT01283035|594961024|FG000|Overall Study|Subject later found ineligible|1|||
164709359|NCT04628793|594961027|FG000|Overall Study|Study terminated by sponsor|0|||
164709360|NCT04628793|594961028|FG001|Overall Study|Study terminated by sponsor|0|||
164709361|NCT04628793|594961029|FG002|Overall Study|Study terminated by sponsor|8|||
164709362|NCT04628793|594961027|FG000|Overall Study|Withdrawal by Subject|2|||
164709363|NCT04628793|594961028|FG001|Overall Study|Withdrawal by Subject|3|||
164709364|NCT04628793|594961029|FG002|Overall Study|Withdrawal by Subject|0|||
164709365|NCT04628793|594961027|FG000|Overall Study|Lost to Follow-up|0|||
164709366|NCT04628793|594961028|FG001|Overall Study|Lost to Follow-up|1|||
164709367|NCT04628793|594961029|FG002|Overall Study|Lost to Follow-up|0|||
164709368|NCT00191165|594961031|FG000|Overall Study|Adverse Event|2|||
164709369|NCT00191165|594961032|FG001|Overall Study|Adverse Event|0|||
164709370|NCT00191165|594961031|FG000|Overall Study|Protocol Violation|0|||
164709371|NCT00191165|594961032|FG001|Overall Study|Protocol Violation|1|||
164709372|NCT00191165|594961031|FG000|Overall Study|Participant Moved Away|0|||
164709373|NCT00191165|594961032|FG001|Overall Study|Participant Moved Away|1|||
164709374|NCT00998309|594961035|FG000|Overall Study|Protocol Violation|4|||
164709375|NCT03421730|594961036|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
164709376|NCT03421730|594961037|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
164709377|NCT03421730|594961038|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
164709378|NCT03421730|594961039|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
164709379|NCT03421730|594961040|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
164709380|NCT03421730|594961041|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
164709381|NCT03421730|594961042|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
164709382|NCT03421730|594961043|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
164709383|NCT03421730|594961044|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
164709384|NCT03421730|594961045|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
164709385|NCT03421730|594961046|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
164709386|NCT03421730|594961047|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
164411917|NCT00736489|593879036|FG005|Period 1|Lost to Follow-up|0|||
164411918|NCT00736489|593879031|FG000|Period 1|Withdrawal by Subject|0|||
164411919|NCT00736489|593879032|FG001|Period 1|Withdrawal by Subject|0|||
164411920|NCT00736489|593879033|FG002|Period 1|Withdrawal by Subject|0|||
164411921|NCT00736489|593879034|FG003|Period 1|Withdrawal by Subject|0|||
164411922|NCT00736489|593879035|FG004|Period 1|Withdrawal by Subject|0|||
164411923|NCT00736489|593879036|FG005|Period 1|Withdrawal by Subject|1|||
164411924|NCT02531295|593880394|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
164411925|NCT02531295|593880395|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
164411926|NCT02531295|593880396|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
164411927|NCT02531295|593880397|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
164411928|NCT02531295|593880398|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
164411929|NCT02531295|593880399|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
164411930|NCT02254408|593880405|FG000|Overall Study|Randomized But Not Treated|1|||
164411931|NCT02254408|593880406|FG001|Overall Study|Randomized But Not Treated|3|||
164411932|NCT02254408|593880405|FG000|Overall Study|Adverse Event|1|||
164463367|NCT05645757|594068657|FG001|Overall Study|Enrolled but treatment not administered|0|||
164463368|NCT05645757|594068658|FG002|Overall Study|Enrolled but treatment not administered|0|||
164463369|NCT05645757|594068659|FG003|Overall Study|Enrolled but treatment not administered|0|||
164463370|NCT05645757|594068660|FG004|Overall Study|Enrolled but treatment not administered|1|||
164463371|NCT05645757|594068661|FG005|Overall Study|Enrolled but treatment not administered|1|||
164463372|NCT05645757|594068662|FG006|Overall Study|Enrolled but treatment not administered|0|||
164463373|NCT05645757|594068663|FG007|Overall Study|Enrolled but treatment not administered|0|||
164463374|NCT03905798|594068664|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
164463375|NCT03463044|594068665|FG000|Overall Study|Lost to Follow-up|0|||
164463376|NCT03463044|594068666|FG001|Overall Study|Lost to Follow-up|0|||
164463377|NCT03463044|594068667|FG002|Overall Study|Lost to Follow-up|0|||
164463378|NCT03463044|594068668|FG003|Overall Study|Lost to Follow-up|0|||
164709387|NCT03421730|594961036|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
164411933|NCT02254408|593880406|FG001|Overall Study|Adverse Event|0|||
164463379|NCT03463044|594068669|FG004|Overall Study|Lost to Follow-up|0|||
164411934|NCT02254408|593880405|FG000|Overall Study|Death|2|||
164411935|NCT02254408|593880406|FG001|Overall Study|Death|3|||
164463380|NCT03463044|594068670|FG005|Overall Study|Lost to Follow-up|0|||
164411936|NCT02254408|593880405|FG000|Overall Study|Investigator's Discretion|0|||
164709388|NCT03421730|594961037|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
164709389|NCT03421730|594961038|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
164709390|NCT03421730|594961039|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
164709391|NCT03421730|594961040|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
164709392|NCT03421730|594961041|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
164709393|NCT03421730|594961042|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
164709394|NCT03421730|594961043|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
164709395|NCT03421730|594961044|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
164709396|NCT03421730|594961045|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
164709397|NCT03421730|594961046|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
164709398|NCT03421730|594961047|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
164411937|NCT02254408|593880406|FG001|Overall Study|Investigator's Discretion|1|||
164411938|NCT02254408|593880405|FG000|Overall Study|Withdrawal by Subject|3|||
164411939|NCT02254408|593880406|FG001|Overall Study|Withdrawal by Subject|3|||
164411940|NCT02254408|593880405|FG000|Overall Study|Lost to Follow-up|1|||
164411941|NCT02254408|593880406|FG001|Overall Study|Lost to Follow-up|0|||
164411942|NCT04651114|593880407|FG000|Overall Study|Withdrawal by Subject|8|||
164411943|NCT01993017|593880408|FG000|Overall Study|Death|23|||
164411944|NCT01993017|593880409|FG001|Overall Study|Death|26|||
164411945|NCT01993017|593880410|FG002|Overall Study|Death|18|||
164411946|NCT01993017|593880408|FG000|Overall Study|Could not be contacted|43|||
164411947|NCT01993017|593880409|FG001|Overall Study|Could not be contacted|42|||
164411948|NCT01993017|593880410|FG002|Overall Study|Could not be contacted|38|||
164411949|NCT01993017|593880408|FG000|Overall Study|Dropped out|19|||
164411950|NCT01993017|593880409|FG001|Overall Study|Dropped out|6|||
164411951|NCT01993017|593880410|FG002|Overall Study|Dropped out|11|||
164411952|NCT01993017|593880408|FG000|Overall Study|Other reasons|17|||
164411953|NCT01993017|593880409|FG001|Overall Study|Other reasons|11|||
164411954|NCT01993017|593880410|FG002|Overall Study|Other reasons|7|||
164411955|NCT01993017|593880408|FG000|Overall Study|Ineligible after randomization|4|||
164411956|NCT01993017|593880409|FG001|Overall Study|Ineligible after randomization|5|||
164411957|NCT01993017|593880410|FG002|Overall Study|Ineligible after randomization|5|||
164411958|NCT01161472|593880411|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
164411959|NCT01161472|593880412|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
164411960|NCT01161472|593880413|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
164411961|NCT01161472|593880414|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
164411962|NCT00003511|593880415|FG000|Overall Study|Not evaluable|4|||
164411963|NCT00917267|593880416|FG000|Overall Study|Adverse Event|15|||
164411964|NCT00917267|593880417|FG001|Overall Study|Adverse Event|36|||
164411965|NCT00917267|593880416|FG000|Overall Study|Physician Decision|2|||
164411966|NCT00917267|593880417|FG001|Overall Study|Physician Decision|4|||
164463381|NCT03463044|594068671|FG006|Overall Study|Lost to Follow-up|0|||
164463382|NCT03463044|594068672|FG007|Overall Study|Lost to Follow-up|1|||
164463383|NCT03463044|594068673|FG008|Overall Study|Lost to Follow-up|0|||
164463384|NCT03334630|594068674|FG000|Overall Study|Withdrawal by Subject|7|||
164463385|NCT03334630|594068675|FG001|Overall Study|Withdrawal by Subject|7|||
164463386|NCT03334630|594068674|FG000|Overall Study|Lost to Follow-up|3|||
164463387|NCT03334630|594068675|FG001|Overall Study|Lost to Follow-up|1|||
164463388|NCT03334630|594068674|FG000|Overall Study|Adverse Event|0|||
164463389|NCT03334630|594068675|FG001|Overall Study|Adverse Event|1|||
164463390|NCT03334630|594068674|FG000|Overall Study|Physician Decision|1|||
164463391|NCT03334630|594068675|FG001|Overall Study|Physician Decision|1|||
164463392|NCT03334630|594068674|FG000|Overall Study|Enrollment closed|2|||
164411967|NCT00917267|593880416|FG000|Overall Study|Protocol Violation|9|||
164411968|NCT00917267|593880417|FG001|Overall Study|Protocol Violation|18|||
164411969|NCT00917267|593880416|FG000|Overall Study|Withdrawal by Subject|5|||
164411970|NCT00917267|593880417|FG001|Overall Study|Withdrawal by Subject|12|||
164411971|NCT00917267|593880416|FG000|Overall Study|Lost to follow up|0|||
164411972|NCT00917267|593880417|FG001|Overall Study|Lost to follow up|2|||
164411973|NCT00917267|593880416|FG000|Overall Study|Entry Criteria Not Met|1|||
164411974|NCT00917267|593880417|FG001|Overall Study|Entry Criteria Not Met|0|||
164463393|NCT03334630|594068675|FG001|Overall Study|Enrollment closed|1|||
164463394|NCT03334630|594068674|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
164463395|NCT03334630|594068675|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
164463396|NCT03334630|594068674|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
164411975|NCT00917267|593880416|FG000|Overall Study|Sponsor Decision|5|||
164411976|NCT00917267|593880417|FG001|Overall Study|Sponsor Decision|5|||
164411977|NCT00917267|593880416|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
164411978|NCT00917267|593880417|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
164411979|NCT03638635|593880418|FG000|Initial Hospitalization|Study terminated prematurely|0|||
164411980|NCT03638635|593880419|FG001|Initial Hospitalization|Study terminated prematurely|1|||
164411981|NCT03638635|593880418|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
164411982|NCT03638635|593880419|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
164411983|NCT03638635|593880418|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
164411984|NCT03638635|593880419|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
164411985|NCT00423293|593880420|FG000|Overall Study|Ineligible / No protocol treatment|11|||
164411986|NCT00519896|593880427|FG000|Overall Study|Protocol Violation|1|||
164411987|NCT00519896|593880427|FG000|Overall Study|Adverse Event|1|||
164411988|NCT01129336|593880428|FG000|Overall Study|Protocol Violation|1|||
164411989|NCT01129336|593880429|FG001|Overall Study|Protocol Violation|0|||
164411990|NCT01129336|593880428|FG000|Overall Study|Disease Progression|1|||
164411991|NCT01129336|593880429|FG001|Overall Study|Disease Progression|4|||
164411992|NCT01129336|593880428|FG000|Overall Study|Lost to Follow-up|1|||
164411993|NCT01129336|593880429|FG001|Overall Study|Lost to Follow-up|0|||
164411994|NCT01129336|593880428|FG000|Overall Study|Withdrawal by Subject|7|||
164411995|NCT01129336|593880429|FG001|Overall Study|Withdrawal by Subject|4|||
164411996|NCT01129336|593880428|FG000|Overall Study|Adverse Event|0|||
164411997|NCT01129336|593880429|FG001|Overall Study|Adverse Event|1|||
164411998|NCT01129336|593880428|FG000|Overall Study|Missing Study Completion Status|2|||
164411999|NCT01129336|593880429|FG001|Overall Study|Missing Study Completion Status|3|||
164412000|NCT01129336|593880428|FG000|Overall Study|Death|0|||
164412001|NCT01129336|593880429|FG001|Overall Study|Death|4|||
164412002|NCT00791921|593880432|FG000|Overall Study|Protocol planed|24|||
164412003|NCT00791921|593880433|FG001|Overall Study|Protocol planed|88|||
164412004|NCT00791921|593880432|FG000|Overall Study|Withdrawal by Subject|1|||
164412005|NCT00791921|593880433|FG001|Overall Study|Withdrawal by Subject|2|||
164412006|NCT00791921|593880432|FG000|Overall Study|Adverse Event|8|||
164412007|NCT00791921|593880433|FG001|Overall Study|Adverse Event|2|||
164412008|NCT00791921|593880432|FG000|Overall Study|Lack of Efficacy|0|||
164412009|NCT00791921|593880433|FG001|Overall Study|Lack of Efficacy|2|||
164412010|NCT00791921|593880432|FG000|Overall Study|Lack of study drug administration|1|||
164412011|NCT00791921|593880433|FG001|Overall Study|Lack of study drug administration|1|||
164412012|NCT00791921|593880432|FG000|Overall Study|Reason other than those above|0|||
164412013|NCT00791921|593880433|FG001|Overall Study|Reason other than those above|1|||
164412014|NCT01540565|593880437|FG000|Overall Study|Ineligible|2|||
164412015|NCT01827254|593880439|FG000|Overall Study|Death|10|||
164412016|NCT01827254|593880439|FG000|Overall Study|Case report form not completed|4|||
164412017|NCT01827254|593880439|FG000|Overall Study|Invalidated centre|3|||
164412018|NCT01827254|593880439|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
164412019|NCT01827254|593880439|FG000|Overall Study|Did not complete re-challenge|1|||
164412020|NCT01827254|593880439|FG000|Overall Study|Disease progression|36|||
164412021|NCT01827254|593880439|FG000|Overall Study|Intolerance to treatment|4|||
164412022|NCT04145037|593880440|FG000|Overall Study|Study terminated|2|||
164412023|NCT04145037|593880441|FG001|Overall Study|Study terminated|0|||
164412024|NCT04145037|593880440|FG000|Overall Study|Withdrawal by Subject|1|||
164412025|NCT04145037|593880441|FG001|Overall Study|Withdrawal by Subject|0|||
164412026|NCT04145037|593880440|FG000|Overall Study|Lost to Follow-up|1|||
164412027|NCT04145037|593880441|FG001|Overall Study|Lost to Follow-up|0|||
164412028|NCT02307513|593880444|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
164412029|NCT02307513|593880445|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
164412030|NCT02307513|593880444|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
164412031|NCT02307513|593880445|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
164412032|NCT02307513|593880444|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
164709399|NCT02865460|594961048|FG000|Overall Study|Adverse Event|1|||
164709400|NCT02865460|594961049|FG001|Overall Study|Adverse Event|0|||
164709401|NCT02865460|594961048|FG000|Overall Study|Withdrawal by Subject|1|||
164709402|NCT02865460|594961049|FG001|Overall Study|Withdrawal by Subject|1|||
164709403|NCT02865460|594961048|FG000|Overall Study|Lost to Follow-up|7|||
164709404|NCT02865460|594961049|FG001|Overall Study|Lost to Follow-up|4|||
164709405|NCT02865460|594961048|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
164709406|NCT02865460|594961049|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
164412033|NCT02307513|593880445|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
164412034|NCT02307513|593880444|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
164412035|NCT02307513|593880445|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
164412036|NCT02307513|593880444|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
164412037|NCT02307513|593880445|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
164709407|NCT00901576|594961056|FG000|Second Intervention|Withdrawal by Subject|0|||
164412038|NCT02307513|593880444|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
164412039|NCT02307513|593880445|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
164412040|NCT02307513|593880444|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
164412041|NCT02307513|593880445|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
164412042|NCT02307513|593880444|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
164412043|NCT02307513|593880445|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
164412044|NCT02307513|593880444|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
164412045|NCT02307513|593880445|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
164709408|NCT00901576|594961057|FG001|Second Intervention|Withdrawal by Subject|0|||
164709409|NCT00901576|594961058|FG002|Second Intervention|Withdrawal by Subject|0|||
164709410|NCT00901576|594961059|FG003|Second Intervention|Withdrawal by Subject|1|||
164709411|NCT00901576|594961060|FG004|Second Intervention|Withdrawal by Subject|0|||
164709412|NCT00901576|594961061|FG005|Second Intervention|Withdrawal by Subject|1|||
164709413|NCT00901576|594961056|FG000|Second Intervention|Physician Decision|1|||
164709414|NCT00901576|594961057|FG001|Second Intervention|Physician Decision|0|||
164709415|NCT00901576|594961058|FG002|Second Intervention|Physician Decision|0|||
164709416|NCT00901576|594961059|FG003|Second Intervention|Physician Decision|0|||
164709417|NCT00901576|594961060|FG004|Second Intervention|Physician Decision|0|||
164709418|NCT00901576|594961061|FG005|Second Intervention|Physician Decision|0|||
164709419|NCT01696279|594961062|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
164709420|NCT01696279|594961063|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
164709421|NCT01696279|594961064|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
164709422|NCT01696279|594961065|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
164709423|NCT01696279|594961062|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
164709424|NCT01696279|594961063|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
164709425|NCT01696279|594961064|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
164709426|NCT01696279|594961065|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
164709427|NCT01696279|594961062|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
164709428|NCT01696279|594961063|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
164709429|NCT01696279|594961064|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
164709430|NCT01696279|594961065|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
164709431|NCT01696279|594961062|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
164709432|NCT01696279|594961063|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
164709433|NCT01696279|594961064|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
164709434|NCT01696279|594961065|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
164709435|NCT01696279|594961062|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
164709436|NCT01696279|594961063|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
164709437|NCT01696279|594961064|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
164709438|NCT01696279|594961065|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
164709439|NCT01696279|594961062|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
164709440|NCT01696279|594961063|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
164709441|NCT01696279|594961064|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
164709442|NCT01696279|594961065|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
164709443|NCT01696279|594961062|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
164709444|NCT01696279|594961063|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
164709445|NCT01696279|594961064|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
164709446|NCT01696279|594961065|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
164709447|NCT01696279|594961062|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
164709448|NCT01696279|594961063|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
164709449|NCT01696279|594961064|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
164709450|NCT01696279|594961065|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
164709451|NCT01696279|594961062|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
164709452|NCT01696279|594961063|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
164709453|NCT01696279|594961064|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
164709454|NCT01696279|594961065|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
164709455|NCT01696279|594961062|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
164709456|NCT01696279|594961063|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
164709457|NCT01696279|594961064|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
164709458|NCT01696279|594961065|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
164709459|NCT01696279|594961062|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
164709460|NCT01696279|594961063|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
164709461|NCT01696279|594961064|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
164709462|NCT01696279|594961065|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
164709463|NCT00171951|594961066|FG000|Overall Study|Adverse Event|1|||
164709464|NCT00171951|594961066|FG000|Overall Study|Abnormal Laboratory Values|2|||
164709465|NCT00171951|594961066|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
164709466|NCT00171951|594961066|FG000|Overall Study|Participants Withdrew Consent|3|||
164709467|NCT00171951|594961066|FG000|Overall Study|New Cancer Therapy|5|||
164412046|NCT02307513|593880444|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
164412047|NCT02307513|593880445|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
164412048|NCT02307513|593880444|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
164709468|NCT00171951|594961066|FG000|Overall Study|Reason not Specified|2|||
164709469|NCT01661062|594961067|FG000|Overall Study|Completed Treatment Off Study|3|||
164709470|NCT01661062|594961067|FG000|Overall Study|Withdrawal by Subject|2|||
164709471|NCT05788289|594961068|FG000|Overall Study|Death|3|||
164709472|NCT04154631|594961070|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
164709473|NCT04154631|594961071|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
164412049|NCT02307513|593880445|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
164412050|NCT02307513|593880444|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
164412051|NCT02307513|593880445|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
164412052|NCT02307513|593880444|FG000|Long-term Extension|Physician Decision|1|||
164412053|NCT02307513|593880445|FG001|Long-term Extension|Physician Decision|0|||
164412054|NCT01107743|593880447|FG000|Overall Study|Protocol Violation|46|||
164412055|NCT00744263|593880450|FG000|Overall Study|Death|3006|||
164412056|NCT00744263|593880451|FG001|Overall Study|Death|3005|||
164412057|NCT00744263|593880450|FG000|Overall Study|Lost to Follow-up|2038|||
164412058|NCT00744263|593880451|FG001|Overall Study|Lost to Follow-up|2135|||
164412059|NCT00744263|593880450|FG000|Overall Study|Withdrawal by Subject|166|||
164412060|NCT00744263|593880451|FG001|Overall Study|Withdrawal by Subject|150|||
164412061|NCT00744263|593880450|FG000|Overall Study|Physician Decision|20|||
164412062|NCT00744263|593880451|FG001|Overall Study|Physician Decision|23|||
164412063|NCT00744263|593880450|FG000|Overall Study|Protocol Violation|3|||
164412064|NCT00744263|593880451|FG001|Overall Study|Protocol Violation|5|||
164412065|NCT00744263|593880450|FG000|Overall Study|Adverse Event|1|||
164412066|NCT00744263|593880451|FG001|Overall Study|Adverse Event|0|||
164412067|NCT00744263|593880450|FG000|Overall Study|Other|2|||
164412068|NCT00744263|593880451|FG001|Overall Study|Other|2|||
164412069|NCT01913639|593880452|FG000|Overall Study|Not Eligible|3|||
164412070|NCT01290822|593880455|FG000|Overall Study|Withdrawal by Subject|1|||
164412071|NCT01290822|593880455|FG000|Overall Study|Physician Decision|10|||
164412072|NCT04078035|593880456|FG000|Session 2|Lost to Follow-up|3|||
164412073|NCT04078035|593880457|FG001|Session 2|Lost to Follow-up|1|||
164412074|NCT04078035|593880456|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
164412075|NCT04078035|593880457|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
164412076|NCT04296890|593880460|FG000|Overall Study|Withdrawal by Subject|1|||
164412077|NCT04296890|593880460|FG000|Overall Study|Death|62|||
164412078|NCT04296890|593880460|FG000|Overall Study|Lost to Follow-up|3|||
164412079|NCT04296890|593880460|FG000|Overall Study|Other than specified|2|||
164412080|NCT02100722|593880461|FG000|Overall Study|Withdrawal pre-procedure|4|||
164412081|NCT02100722|593880462|FG001|Overall Study|Withdrawal pre-procedure|9|||
164412082|NCT02100722|593880461|FG000|Overall Study|Withdrawal post-procedure|0|||
164412083|NCT02100722|593880462|FG001|Overall Study|Withdrawal post-procedure|3|||
164412084|NCT02100722|593880461|FG000|Overall Study|Lost to Follow-up|2|||
164412085|NCT02100722|593880462|FG001|Overall Study|Lost to Follow-up|2|||
164412086|NCT02100722|593880461|FG000|Overall Study|Continuing on study|751|||
164412087|NCT02100722|593880462|FG001|Overall Study|Continuing on study|729|||
164709474|NCT02238795|594961072|FG000|Overall Study|Patient without purpura fulminans|1|||
164709475|NCT05187013|594961074|FG000|Overall Study|Withdrawal by Subject|1|||
164709476|NCT05187013|594961075|FG001|Overall Study|Withdrawal by Subject|1|||
164709477|NCT05187013|594961076|FG002|Overall Study|Withdrawal by Subject|0|||
164709478|NCT05187013|594961074|FG000|Overall Study|Death|0|||
164709479|NCT05187013|594961075|FG001|Overall Study|Death|1|||
164709480|NCT05187013|594961076|FG002|Overall Study|Death|0|||
164709481|NCT05187013|594961074|FG000|Overall Study|Lost to Follow-up|20|||
164709482|NCT05187013|594961075|FG001|Overall Study|Lost to Follow-up|17|||
164709483|NCT05187013|594961076|FG002|Overall Study|Lost to Follow-up|0|||
164412088|NCT01845974|593880463|FG000|Overall Study|screen failure|1|||
164709484|NCT05187013|594961074|FG000|Overall Study|Ongoing Participants|3|||
164709485|NCT05187013|594961075|FG001|Overall Study|Ongoing Participants|5|||
164709486|NCT05187013|594961076|FG002|Overall Study|Ongoing Participants|0|||
164709487|NCT01096368|594961078|FG000|Overall Study|Death|0|||
164709488|NCT01096368|594961079|FG001|Overall Study|Death|1|||
164709489|NCT01096368|594961080|FG002|Overall Study|Death|0|||
164709490|NCT01096368|594961081|FG003|Overall Study|Death|0|||
164412089|NCT01845974|593880464|FG001|Overall Study|screen failure|0|||
164412090|NCT02667886|593880465|FG000|Dose Escalation (Part A)|Adverse Event|1|||
164412091|NCT02667886|593880466|FG001|Dose Escalation (Part A)|Adverse Event|3|||
164412092|NCT02667886|593880467|FG002|Dose Escalation (Part A)|Adverse Event|1|||
164412093|NCT02667886|593880468|FG003|Dose Escalation (Part A)|Adverse Event|0|||
164412094|NCT02667886|593880469|FG004|Dose Escalation (Part A)|Adverse Event|0|||
164412095|NCT02667886|593880465|FG000|Dose Escalation (Part A)|Disease Progression|1|||
164412096|NCT02667886|593880466|FG001|Dose Escalation (Part A)|Disease Progression|4|||
164412097|NCT02667886|593880467|FG002|Dose Escalation (Part A)|Disease Progression|3|||
164412098|NCT02667886|593880468|FG003|Dose Escalation (Part A)|Disease Progression|0|||
164412099|NCT02667886|593880469|FG004|Dose Escalation (Part A)|Disease Progression|0|||
164412100|NCT02667886|593880465|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
164412101|NCT02667886|593880466|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
164412102|NCT02667886|593880467|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
164709491|NCT01096368|594961082|FG004|Overall Study|Death|0|||
164709492|NCT01096368|594961078|FG000|Overall Study|Physician Decision|0|||
164709493|NCT01096368|594961079|FG001|Overall Study|Physician Decision|13|||
164412103|NCT02667886|593880468|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
164412104|NCT02667886|593880469|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
164412105|NCT02667886|593880465|FG000|Dose Expansion (Part B)|Adverse Event|0|||
164412106|NCT02667886|593880466|FG001|Dose Expansion (Part B)|Adverse Event|0|||
164412107|NCT02667886|593880467|FG002|Dose Expansion (Part B)|Adverse Event|0|||
164412108|NCT02667886|593880468|FG003|Dose Expansion (Part B)|Adverse Event|9|||
164412109|NCT02667886|593880469|FG004|Dose Expansion (Part B)|Adverse Event|0|||
164412110|NCT02667886|593880465|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
164412111|NCT02667886|593880466|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
164412112|NCT02667886|593880467|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
164412113|NCT02667886|593880468|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
164412114|NCT02667886|593880469|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
164412115|NCT02667886|593880465|FG000|Dose Expansion (Part B)|Disease Progression|0|||
164412116|NCT02667886|593880466|FG001|Dose Expansion (Part B)|Disease Progression|0|||
164412117|NCT02667886|593880467|FG002|Dose Expansion (Part B)|Disease Progression|0|||
164412118|NCT02667886|593880468|FG003|Dose Expansion (Part B)|Disease Progression|38|||
164412119|NCT02667886|593880469|FG004|Dose Expansion (Part B)|Disease Progression|0|||
164412120|NCT02667886|593880465|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
164412121|NCT02667886|593880466|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
164412122|NCT02667886|593880467|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
164412123|NCT02667886|593880468|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
164412124|NCT02667886|593880469|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
164412125|NCT02667886|593880465|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
164412126|NCT02667886|593880466|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
164412127|NCT02667886|593880467|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
164412128|NCT02667886|593880468|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
164412129|NCT02667886|593880469|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
164412130|NCT02667886|593880465|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
164412131|NCT02667886|593880466|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
164412132|NCT02667886|593880467|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
164412133|NCT02667886|593880468|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
164412134|NCT02667886|593880469|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
164412135|NCT01905046|593880470|FG000|Months 13-24|Withdrawal by Subject|10|||
164412136|NCT01905046|593880471|FG001|Months 13-24|Withdrawal by Subject|10|||
164412137|NCT01905046|593880470|FG000|Months 13-24|Adverse Event|3|||
164412138|NCT01905046|593880471|FG001|Months 13-24|Adverse Event|2|||
164412139|NCT01905046|593880470|FG000|Months 13-24|Protocol Violation|3|||
164412140|NCT01905046|593880471|FG001|Months 13-24|Protocol Violation|3|||
164412141|NCT01905046|593880470|FG000|Months 13-24|Physician Decision|1|||
164412142|NCT01905046|593880471|FG001|Months 13-24|Physician Decision|0|||
164412143|NCT05672680|593880472|FG000|Overall Study|Patient Did Not Complete the Form|5|||
164412144|NCT05672680|593880473|FG001|Overall Study|Patient Did Not Complete the Form|4|||
164412145|NCT05672680|593880472|FG000|Overall Study|Procedure Aborted|1|||
164412146|NCT05672680|593880473|FG001|Overall Study|Procedure Aborted|0|||
164412147|NCT03929562|593880474|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
164412148|NCT03929562|593880475|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
164412149|NCT03929562|593880474|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
164412150|NCT03929562|593880475|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
164412151|NCT03929562|593880474|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
164412152|NCT03929562|593880475|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
164412153|NCT02778399|593880484|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
164412154|NCT02778399|593880485|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
164412155|NCT02778399|593880486|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
164412156|NCT02778399|593880487|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
164412157|NCT02778399|593880488|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
164412158|NCT02778399|593880489|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
164412159|NCT02778399|593880484|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
164412160|NCT02778399|593880485|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
164412161|NCT02778399|593880486|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
164412162|NCT02778399|593880487|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
164412163|NCT02778399|593880488|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
164412164|NCT02778399|593880489|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
164412165|NCT02778399|593880484|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
164412166|NCT02778399|593880485|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
164412167|NCT02778399|593880486|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
164412168|NCT02778399|593880487|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
164412169|NCT02778399|593880488|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
164412170|NCT02778399|593880489|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
164412171|NCT02778399|593880484|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
164412172|NCT02778399|593880485|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
164709494|NCT01096368|594961080|FG002|Overall Study|Physician Decision|2|||
164709495|NCT01096368|594961081|FG003|Overall Study|Physician Decision|4|||
164709496|NCT01096368|594961082|FG004|Overall Study|Physician Decision|6|||
164709497|NCT01096368|594961078|FG000|Overall Study|Withdrawal by Subject|0|||
164709498|NCT01096368|594961079|FG001|Overall Study|Withdrawal by Subject|52|||
164709499|NCT01096368|594961080|FG002|Overall Study|Withdrawal by Subject|0|||
164709500|NCT01096368|594961081|FG003|Overall Study|Withdrawal by Subject|10|||
164709501|NCT01096368|594961082|FG004|Overall Study|Withdrawal by Subject|14|||
164709502|NCT01096368|594961078|FG000|Overall Study|Ineligible|0|||
164709503|NCT01096368|594961079|FG001|Overall Study|Ineligible|3|||
164709504|NCT01096368|594961080|FG002|Overall Study|Ineligible|2|||
164709505|NCT01096368|594961081|FG003|Overall Study|Ineligible|0|||
164709506|NCT01096368|594961082|FG004|Overall Study|Ineligible|25|||
164709507|NCT01096368|594961078|FG000|Overall Study|Did not start treatment|0|||
164709508|NCT01096368|594961079|FG001|Overall Study|Did not start treatment|4|||
164709509|NCT01096368|594961080|FG002|Overall Study|Did not start treatment|4|||
164709510|NCT01096368|594961081|FG003|Overall Study|Did not start treatment|0|||
164709511|NCT01096368|594961082|FG004|Overall Study|Did not start treatment|0|||
164709512|NCT01096368|594961078|FG000|Overall Study|Progressive disease|0|||
164709513|NCT01096368|594961079|FG001|Overall Study|Progressive disease|6|||
164709514|NCT01096368|594961080|FG002|Overall Study|Progressive disease|0|||
164709515|NCT01096368|594961081|FG003|Overall Study|Progressive disease|10|||
164709516|NCT01096368|594961082|FG004|Overall Study|Progressive disease|3|||
164709517|NCT01096368|594961078|FG000|Overall Study|Other|0|||
164709518|NCT01096368|594961079|FG001|Overall Study|Other|0|||
164709519|NCT01096368|594961080|FG002|Overall Study|Other|1|||
164709520|NCT01096368|594961081|FG003|Overall Study|Other|0|||
164709521|NCT01096368|594961082|FG004|Overall Study|Other|0|||
164709522|NCT01096368|594961078|FG000|Overall Study|Treated with institutional review|0|||
164709523|NCT01096368|594961079|FG001|Overall Study|Treated with institutional review|0|||
164709524|NCT01096368|594961080|FG002|Overall Study|Treated with institutional review|0|||
164709525|NCT01096368|594961081|FG003|Overall Study|Treated with institutional review|0|||
164709526|NCT01096368|594961082|FG004|Overall Study|Treated with institutional review|1|||
164709527|NCT01568320|594961084|FG000|Overall Study|Death|20|||
164709528|NCT01568320|594961084|FG000|Overall Study|Lost to Follow-up|9|||
164709529|NCT01568320|594961084|FG000|Overall Study|Withdrawal by Subject|10|||
164709530|NCT01568320|594961084|FG000|Overall Study|Conversion to open repair|1|||
164709531|NCT01568320|594961084|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
164709532|NCT03233230|594961085|FG000|Overall Study|Adverse Event|6|||
164709533|NCT03233230|594961086|FG001|Overall Study|Adverse Event|3|||
164709534|NCT03233230|594961087|FG002|Overall Study|Adverse Event|6|||
164709535|NCT03233230|594961088|FG003|Overall Study|Adverse Event|3|||
164709536|NCT03233230|594961085|FG000|Overall Study|Protocol Violation|1|||
164709537|NCT03233230|594961086|FG001|Overall Study|Protocol Violation|2|||
164709538|NCT03233230|594961087|FG002|Overall Study|Protocol Violation|1|||
164709539|NCT03233230|594961088|FG003|Overall Study|Protocol Violation|1|||
164709540|NCT03233230|594961085|FG000|Overall Study|Lack of Efficacy|1|||
164709541|NCT03233230|594961086|FG001|Overall Study|Lack of Efficacy|0|||
164709542|NCT03233230|594961087|FG002|Overall Study|Lack of Efficacy|0|||
164709543|NCT03233230|594961088|FG003|Overall Study|Lack of Efficacy|0|||
164709544|NCT03233230|594961085|FG000|Overall Study|Other|5|||
164709545|NCT03233230|594961086|FG001|Overall Study|Other|5|||
164709546|NCT03233230|594961087|FG002|Overall Study|Other|5|||
164709547|NCT03233230|594961088|FG003|Overall Study|Other|3|||
164709548|NCT03233230|594961085|FG000|Overall Study|Withdrawal by Subject|2|||
164709549|NCT03233230|594961086|FG001|Overall Study|Withdrawal by Subject|2|||
164709550|NCT03233230|594961087|FG002|Overall Study|Withdrawal by Subject|0|||
164709551|NCT03233230|594961088|FG003|Overall Study|Withdrawal by Subject|1|||
164709552|NCT03233230|594961085|FG000|Overall Study|Lost to Follow-up|0|||
164709553|NCT03233230|594961086|FG001|Overall Study|Lost to Follow-up|3|||
164709554|NCT03233230|594961087|FG002|Overall Study|Lost to Follow-up|0|||
164709555|NCT03233230|594961088|FG003|Overall Study|Lost to Follow-up|0|||
164709556|NCT04159935|594961089|FG000|Overall Study|Study terminated due to COVID-19|1|||
164709557|NCT04159935|594961090|FG001|Overall Study|Study terminated due to COVID-19|3|||
164709558|NCT02927366|594961091|FG000|Overall Study|Adverse Event|1|||
164709559|NCT02927366|594961092|FG001|Overall Study|Adverse Event|0|||
164412173|NCT02778399|593880486|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
164709560|NCT02927366|594961091|FG000|Overall Study|Patient schedule|1|||
164709561|NCT02927366|594961092|FG001|Overall Study|Patient schedule|0|||
164709562|NCT00587990|594961097|FG000|Overall Study|Death|0|||
164709563|NCT00587990|594961098|FG001|Overall Study|Death|0|||
164709564|NCT00587990|594961099|FG002|Overall Study|Death|1|||
164709565|NCT00206323|594961100|FG000|Overall Study|Lack of Efficacy|4|||
164709566|NCT00206323|594961101|FG001|Overall Study|Lack of Efficacy|1|||
164709567|NCT00206323|594961100|FG000|Overall Study|Adverse Event|1|||
164709568|NCT00206323|594961101|FG001|Overall Study|Adverse Event|1|||
164709569|NCT00206323|594961100|FG000|Overall Study|Lost to Follow-up|1|||
164709570|NCT00206323|594961101|FG001|Overall Study|Lost to Follow-up|1|||
164709571|NCT02910063|594961102|FG000|Phase 2|Withdrawal by Subject|3|||
164709572|NCT02910063|594961103|FG001|Phase 2|Withdrawal by Subject|0|||
164709573|NCT02910063|594961104|FG002|Phase 2|Withdrawal by Subject|0|||
164709574|NCT02910063|594961102|FG000|Phase 2|Lost to Follow-up|1|||
164709575|NCT02910063|594961103|FG001|Phase 2|Lost to Follow-up|0|||
164709576|NCT02910063|594961104|FG002|Phase 2|Lost to Follow-up|0|||
164709577|NCT02910063|594961102|FG000|Phase 2|Death|24|||
164709578|NCT02910063|594961103|FG001|Phase 2|Death|0|||
164709579|NCT02910063|594961104|FG002|Phase 2|Death|0|||
164709580|NCT03334617|594961107|FG000|Overall Study|Adverse Event|0|||
164709581|NCT03334617|594961108|FG001|Overall Study|Adverse Event|0|||
164709582|NCT03334617|594961109|FG002|Overall Study|Adverse Event|0|||
164709583|NCT03334617|594961110|FG003|Overall Study|Adverse Event|0|||
164709584|NCT03334617|594961111|FG004|Overall Study|Adverse Event|0|||
164709585|NCT03334617|594961112|FG005|Overall Study|Adverse Event|0|||
164709586|NCT03334617|594961113|FG006|Overall Study|Adverse Event|0|||
164709587|NCT03334617|594961114|FG007|Overall Study|Adverse Event|0|||
164709588|NCT03334617|594961115|FG008|Overall Study|Adverse Event|1|||
164709589|NCT03334617|594961116|FG009|Overall Study|Adverse Event|0|||
164709590|NCT03334617|594961117|FG010|Overall Study|Adverse Event|0|||
164709591|NCT03334617|594961118|FG011|Overall Study|Adverse Event|0|||
164709592|NCT03334617|594961119|FG012|Overall Study|Adverse Event|1|||
164709593|NCT03334617|594961120|FG013|Overall Study|Adverse Event|0|||
164709594|NCT03334617|594961121|FG014|Overall Study|Adverse Event|0|||
164709595|NCT03334617|594961122|FG015|Overall Study|Adverse Event|0|||
164709596|NCT03334617|594961123|FG016|Overall Study|Adverse Event|0|||
164709597|NCT03334617|594961124|FG017|Overall Study|Adverse Event|0|||
164709598|NCT03334617|594961125|FG018|Overall Study|Adverse Event|0|||
164709599|NCT03334617|594961126|FG019|Overall Study|Adverse Event|0|||
164709600|NCT03334617|594961127|FG020|Overall Study|Adverse Event|0|||
164709601|NCT03334617|594961128|FG021|Overall Study|Adverse Event|0|||
164709602|NCT03334617|594961107|FG000|Overall Study|Death|18|||
164709603|NCT03334617|594961108|FG001|Overall Study|Death|18|||
164709604|NCT03334617|594961109|FG002|Overall Study|Death|20|||
164709605|NCT03334617|594961110|FG003|Overall Study|Death|21|||
164709606|NCT03334617|594961111|FG004|Overall Study|Death|20|||
164709607|NCT03334617|594961112|FG005|Overall Study|Death|16|||
164709608|NCT03334617|594961113|FG006|Overall Study|Death|28|||
164709609|NCT03334617|594961114|FG007|Overall Study|Death|35|||
164709610|NCT03334617|594961115|FG008|Overall Study|Death|47|||
164709611|NCT03334617|594961116|FG009|Overall Study|Death|0|||
164709612|NCT03334617|594961117|FG010|Overall Study|Death|19|||
164709613|NCT03334617|594961118|FG011|Overall Study|Death|6|||
164709614|NCT03334617|594961119|FG012|Overall Study|Death|20|||
164709615|NCT03334617|594961120|FG013|Overall Study|Death|22|||
164709616|NCT03334617|594961121|FG014|Overall Study|Death|17|||
164709617|NCT03334617|594961122|FG015|Overall Study|Death|18|||
164709618|NCT03334617|594961123|FG016|Overall Study|Death|12|||
164709619|NCT03334617|594961124|FG017|Overall Study|Death|15|||
164709620|NCT03334617|594961125|FG018|Overall Study|Death|16|||
164709621|NCT03334617|594961126|FG019|Overall Study|Death|27|||
164709622|NCT03334617|594961127|FG020|Overall Study|Death|14|||
164709623|NCT03334617|594961128|FG021|Overall Study|Death|27|||
164709624|NCT03334617|594961107|FG000|Overall Study|Lost to Follow-up|0|||
164709625|NCT03334617|594961108|FG001|Overall Study|Lost to Follow-up|0|||
164709626|NCT03334617|594961109|FG002|Overall Study|Lost to Follow-up|0|||
164709627|NCT03334617|594961110|FG003|Overall Study|Lost to Follow-up|1|||
164412174|NCT02778399|593880487|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
164412175|NCT02778399|593880488|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
164709628|NCT03334617|594961111|FG004|Overall Study|Lost to Follow-up|0|||
164709629|NCT03334617|594961112|FG005|Overall Study|Lost to Follow-up|1|||
164709630|NCT03334617|594961113|FG006|Overall Study|Lost to Follow-up|0|||
164709631|NCT03334617|594961114|FG007|Overall Study|Lost to Follow-up|0|||
164709632|NCT03334617|594961115|FG008|Overall Study|Lost to Follow-up|1|||
164709633|NCT03334617|594961116|FG009|Overall Study|Lost to Follow-up|0|||
164709634|NCT03334617|594961117|FG010|Overall Study|Lost to Follow-up|0|||
164709635|NCT03334617|594961118|FG011|Overall Study|Lost to Follow-up|0|||
164709636|NCT03334617|594961119|FG012|Overall Study|Lost to Follow-up|0|||
164412176|NCT02778399|593880489|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
164709637|NCT03334617|594961120|FG013|Overall Study|Lost to Follow-up|0|||
164709638|NCT03334617|594961121|FG014|Overall Study|Lost to Follow-up|0|||
164709639|NCT03334617|594961122|FG015|Overall Study|Lost to Follow-up|0|||
164709640|NCT03334617|594961123|FG016|Overall Study|Lost to Follow-up|0|||
164709641|NCT03334617|594961124|FG017|Overall Study|Lost to Follow-up|0|||
164709642|NCT03334617|594961125|FG018|Overall Study|Lost to Follow-up|0|||
164709643|NCT03334617|594961126|FG019|Overall Study|Lost to Follow-up|0|||
164709644|NCT03334617|594961127|FG020|Overall Study|Lost to Follow-up|0|||
164412177|NCT02778399|593880484|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
164412178|NCT02778399|593880485|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
164412179|NCT02778399|593880486|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
164412180|NCT02778399|593880487|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
164412181|NCT02778399|593880488|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
164412182|NCT02778399|593880489|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
164412183|NCT02778399|593880484|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
164412184|NCT02778399|593880485|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
164412185|NCT02778399|593880486|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
164412186|NCT02778399|593880487|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
164412187|NCT02778399|593880488|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
164412188|NCT02778399|593880489|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
164412189|NCT02778399|593880484|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
164412190|NCT02778399|593880485|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
164412191|NCT02778399|593880486|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
164412192|NCT02778399|593880487|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
164412193|NCT02778399|593880488|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
164412194|NCT02778399|593880489|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
164412195|NCT02778399|593880484|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
164412196|NCT02778399|593880485|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
164412197|NCT02778399|593880486|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
164412198|NCT02778399|593880487|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
164412199|NCT02778399|593880488|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
164412200|NCT02778399|593880489|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
164412201|NCT02778399|593880484|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
164412202|NCT02778399|593880485|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
164412203|NCT02778399|593880486|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
164412204|NCT02778399|593880487|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
164412205|NCT02778399|593880488|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
164412206|NCT02778399|593880489|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
164412207|NCT02778399|593880484|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
164412208|NCT02778399|593880485|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
164412209|NCT02778399|593880486|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
164412210|NCT02778399|593880487|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
164412211|NCT02778399|593880488|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
164412212|NCT02778399|593880489|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
164412213|NCT02778399|593880484|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
164412214|NCT02778399|593880485|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
164412215|NCT02778399|593880486|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
164412216|NCT02778399|593880487|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
164412217|NCT02778399|593880488|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
164412218|NCT02778399|593880489|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
164412219|NCT02978443|593880491|FG000|Overall Study|Withdrawal by Subject|1|||
164412220|NCT02978443|593880491|FG000|Overall Study|Adverse Event|3|||
164412221|NCT02978443|593880491|FG000|Overall Study|Disease Progression on study|6|||
164412222|NCT02978443|593880491|FG000|Overall Study|Death|1|||
164412223|NCT02978443|593880491|FG000|Overall Study|Physician Decision|1|||
164412224|NCT02978443|593880491|FG000|Overall Study|Switch to alternative therapy|1|||
164412225|NCT02978443|593880491|FG000|Overall Study|Refused further treatment|1|||
164412226|NCT00405639|593880492|FG000|Overall Study|Withdrawal by Subject|1|||
164412227|NCT00405639|593880493|FG001|Overall Study|Withdrawal by Subject|0|||
164412228|NCT00405639|593880492|FG000|Overall Study|Adverse Event|1|||
164412229|NCT00405639|593880493|FG001|Overall Study|Adverse Event|0|||
164412230|NCT00405639|593880492|FG000|Overall Study|Seizure prior to receiving BNP|1|||
164412231|NCT00405639|593880493|FG001|Overall Study|Seizure prior to receiving BNP|0|||
164412232|NCT00612534|593880497|FG000|Overall Study|Adverse Event|0|||
164412233|NCT00612534|593880498|FG001|Overall Study|Adverse Event|4|||
164412234|NCT00612534|593880499|FG002|Overall Study|Adverse Event|2|||
164412235|NCT00612534|593880500|FG003|Overall Study|Adverse Event|1|||
164412236|NCT00612534|593880497|FG000|Overall Study|Lack of Efficacy|13|||
164412237|NCT00612534|593880498|FG001|Overall Study|Lack of Efficacy|12|||
164412238|NCT00612534|593880499|FG002|Overall Study|Lack of Efficacy|5|||
164412239|NCT00612534|593880500|FG003|Overall Study|Lack of Efficacy|16|||
164412240|NCT00612534|593880497|FG000|Overall Study|Other Reason|0|||
164412241|NCT00612534|593880498|FG001|Overall Study|Other Reason|1|||
164412242|NCT00612534|593880499|FG002|Overall Study|Other Reason|0|||
164412243|NCT00612534|593880500|FG003|Overall Study|Other Reason|0|||
164412244|NCT02395133|593880507|FG000|Overall Study|Adverse Event|4|||
164412245|NCT02395133|593880508|FG001|Overall Study|Adverse Event|1|||
164412246|NCT02395133|593880509|FG002|Overall Study|Adverse Event|3|||
164412247|NCT02395133|593880510|FG003|Overall Study|Adverse Event|0|||
164412248|NCT02395133|593880507|FG000|Overall Study|Lack of Efficacy|1|||
164412249|NCT02395133|593880508|FG001|Overall Study|Lack of Efficacy|0|||
164412250|NCT02395133|593880509|FG002|Overall Study|Lack of Efficacy|1|||
164412251|NCT02395133|593880510|FG003|Overall Study|Lack of Efficacy|1|||
164412252|NCT02395133|593880507|FG000|Overall Study|Protocol Violation|1|||
164412253|NCT02395133|593880508|FG001|Overall Study|Protocol Violation|1|||
164412254|NCT02395133|593880509|FG002|Overall Study|Protocol Violation|0|||
164412255|NCT02395133|593880510|FG003|Overall Study|Protocol Violation|3|||
164412256|NCT02395133|593880507|FG000|Overall Study|Lost to Follow-up|0|||
164412257|NCT02395133|593880508|FG001|Overall Study|Lost to Follow-up|1|||
164412258|NCT02395133|593880509|FG002|Overall Study|Lost to Follow-up|1|||
164412259|NCT02395133|593880510|FG003|Overall Study|Lost to Follow-up|0|||
164412260|NCT02395133|593880507|FG000|Overall Study|Pregnancy|0|||
164412261|NCT02395133|593880508|FG001|Overall Study|Pregnancy|0|||
164412262|NCT02395133|593880509|FG002|Overall Study|Pregnancy|3|||
164412263|NCT02395133|593880510|FG003|Overall Study|Pregnancy|0|||
164412264|NCT02395133|593880507|FG000|Overall Study|Consent withdrawn with no reason given|1|||
164412265|NCT02395133|593880508|FG001|Overall Study|Consent withdrawn with no reason given|3|||
164709645|NCT03334617|594961128|FG021|Overall Study|Lost to Follow-up|0|||
164709646|NCT03334617|594961107|FG000|Overall Study|Withdrawal by Subject|0|||
164709647|NCT03334617|594961108|FG001|Overall Study|Withdrawal by Subject|1|||
164709648|NCT03334617|594961109|FG002|Overall Study|Withdrawal by Subject|0|||
164709649|NCT03334617|594961110|FG003|Overall Study|Withdrawal by Subject|0|||
164709650|NCT03334617|594961111|FG004|Overall Study|Withdrawal by Subject|1|||
164709651|NCT03334617|594961112|FG005|Overall Study|Withdrawal by Subject|1|||
164709652|NCT03334617|594961113|FG006|Overall Study|Withdrawal by Subject|1|||
164709653|NCT03334617|594961114|FG007|Overall Study|Withdrawal by Subject|2|||
164709654|NCT03334617|594961115|FG008|Overall Study|Withdrawal by Subject|0|||
164412266|NCT02395133|593880509|FG002|Overall Study|Consent withdrawn with no reason given|0|||
164412267|NCT02395133|593880510|FG003|Overall Study|Consent withdrawn with no reason given|2|||
164412268|NCT02395133|593880507|FG000|Overall Study|Consent withdrawn with personal reason|0|||
164412269|NCT02395133|593880508|FG001|Overall Study|Consent withdrawn with personal reason|1|||
164412270|NCT02395133|593880509|FG002|Overall Study|Consent withdrawn with personal reason|0|||
164412271|NCT02395133|593880510|FG003|Overall Study|Consent withdrawn with personal reason|3|||
164412272|NCT02395133|593880507|FG000|Overall Study|Sponsor decision|2|||
164412273|NCT02395133|593880508|FG001|Overall Study|Sponsor decision|0|||
164412274|NCT02395133|593880509|FG002|Overall Study|Sponsor decision|0|||
164709655|NCT03334617|594961116|FG009|Overall Study|Withdrawal by Subject|0|||
164709656|NCT03334617|594961117|FG010|Overall Study|Withdrawal by Subject|0|||
164709657|NCT03334617|594961118|FG011|Overall Study|Withdrawal by Subject|1|||
164709658|NCT03334617|594961119|FG012|Overall Study|Withdrawal by Subject|1|||
164709659|NCT03334617|594961120|FG013|Overall Study|Withdrawal by Subject|0|||
164709660|NCT03334617|594961121|FG014|Overall Study|Withdrawal by Subject|2|||
164709661|NCT03334617|594961122|FG015|Overall Study|Withdrawal by Subject|1|||
164412275|NCT02395133|593880510|FG003|Overall Study|Sponsor decision|1|||
164412276|NCT02395133|593880507|FG000|Overall Study|Other than specified above|5|||
164412277|NCT02395133|593880508|FG001|Overall Study|Other than specified above|2|||
164412278|NCT02395133|593880509|FG002|Overall Study|Other than specified above|2|||
164412279|NCT02395133|593880510|FG003|Overall Study|Other than specified above|4|||
164412280|NCT03573908|593880516|FG000|Treatment Period|Adverse Event|4|||
164709662|NCT03334617|594961123|FG016|Overall Study|Withdrawal by Subject|0|||
164412281|NCT03573908|593880517|FG001|Treatment Period|Adverse Event|9|||
164412282|NCT03573908|593880518|FG002|Treatment Period|Adverse Event|0|||
164412283|NCT03573908|593880519|FG003|Treatment Period|Adverse Event|0|||
164412284|NCT03573908|593880520|FG004|Treatment Period|Adverse Event|0|||
164412285|NCT03573908|593880516|FG000|Treatment Period|Protocol Violation|1|||
164412286|NCT03573908|593880517|FG001|Treatment Period|Protocol Violation|0|||
164412287|NCT03573908|593880518|FG002|Treatment Period|Protocol Violation|0|||
164412288|NCT03573908|593880519|FG003|Treatment Period|Protocol Violation|0|||
164412289|NCT03573908|593880520|FG004|Treatment Period|Protocol Violation|0|||
164412290|NCT03573908|593880516|FG000|Treatment Period|Withdrawal by Subject|7|||
164412291|NCT03573908|593880517|FG001|Treatment Period|Withdrawal by Subject|5|||
164412292|NCT03573908|593880518|FG002|Treatment Period|Withdrawal by Subject|0|||
164412293|NCT03573908|593880519|FG003|Treatment Period|Withdrawal by Subject|0|||
164412294|NCT03573908|593880520|FG004|Treatment Period|Withdrawal by Subject|0|||
164412295|NCT03573908|593880516|FG000|Treatment Period|Lost to Follow-up|7|||
164412296|NCT03573908|593880517|FG001|Treatment Period|Lost to Follow-up|6|||
164463397|NCT03334630|594068675|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
164463398|NCT04585815|594068678|FG000|Sub-study A- Treatment Phase|Adverse Event|1|||
164463399|NCT04585815|594068679|FG001|Sub-study A- Treatment Phase|Adverse Event|4|||
164463400|NCT04585815|594068680|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
164463401|NCT04585815|594068681|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
164463402|NCT04585815|594068682|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
164463403|NCT04585815|594068683|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
164463404|NCT04585815|594068684|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
164463405|NCT04585815|594068678|FG000|Sub-study A- Treatment Phase|Death|0|||
164463406|NCT04585815|594068679|FG001|Sub-study A- Treatment Phase|Death|2|||
164709663|NCT03334617|594961124|FG017|Overall Study|Withdrawal by Subject|1|||
164709664|NCT03334617|594961125|FG018|Overall Study|Withdrawal by Subject|1|||
164709665|NCT03334617|594961126|FG019|Overall Study|Withdrawal by Subject|1|||
164412297|NCT03573908|593880518|FG002|Treatment Period|Lost to Follow-up|0|||
164412298|NCT03573908|593880519|FG003|Treatment Period|Lost to Follow-up|0|||
164412299|NCT03573908|593880520|FG004|Treatment Period|Lost to Follow-up|0|||
164412300|NCT03573908|593880516|FG000|Treatment Period|Pregnancy|1|||
164412301|NCT03573908|593880517|FG001|Treatment Period|Pregnancy|0|||
164412302|NCT03573908|593880518|FG002|Treatment Period|Pregnancy|0|||
164412303|NCT03573908|593880519|FG003|Treatment Period|Pregnancy|0|||
164412304|NCT03573908|593880520|FG004|Treatment Period|Pregnancy|0|||
164412305|NCT03573908|593880516|FG000|Treatment Period|Other, Not Specified|4|||
164412306|NCT03573908|593880517|FG001|Treatment Period|Other, Not Specified|6|||
164412307|NCT03573908|593880518|FG002|Treatment Period|Other, Not Specified|0|||
164412308|NCT03573908|593880519|FG003|Treatment Period|Other, Not Specified|0|||
164412309|NCT03573908|593880520|FG004|Treatment Period|Other, Not Specified|0|||
164412310|NCT03573908|593880516|FG000|Randomized Withdrawal Period|Adverse Event|0|||
164412311|NCT03573908|593880517|FG001|Randomized Withdrawal Period|Adverse Event|0|||
164412312|NCT03573908|593880518|FG002|Randomized Withdrawal Period|Adverse Event|3|||
164412313|NCT03573908|593880519|FG003|Randomized Withdrawal Period|Adverse Event|0|||
164412314|NCT03573908|593880520|FG004|Randomized Withdrawal Period|Adverse Event|0|||
164709666|NCT03334617|594961127|FG020|Overall Study|Withdrawal by Subject|0|||
164709667|NCT03334617|594961128|FG021|Overall Study|Withdrawal by Subject|1|||
164412315|NCT03573908|593880516|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164412316|NCT03573908|593880517|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164412317|NCT03573908|593880518|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164412318|NCT03573908|593880519|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164412319|NCT03573908|593880520|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
164412320|NCT03573908|593880516|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
164412321|NCT03573908|593880517|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
164463407|NCT04585815|594068680|FG002|Sub-study A- Treatment Phase|Death|0|||
164412322|NCT03573908|593880518|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
164412323|NCT03573908|593880519|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
164412324|NCT03573908|593880520|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
164709668|NCT03334617|594961107|FG000|Overall Study|Other|1|||
164709669|NCT03334617|594961108|FG001|Overall Study|Other|2|||
164709670|NCT03334617|594961109|FG002|Overall Study|Other|0|||
164709671|NCT03334617|594961110|FG003|Overall Study|Other|1|||
164709672|NCT03334617|594961111|FG004|Overall Study|Other|1|||
164709673|NCT03334617|594961112|FG005|Overall Study|Other|0|||
164709674|NCT03334617|594961113|FG006|Overall Study|Other|2|||
164709675|NCT03334617|594961114|FG007|Overall Study|Other|1|||
164412325|NCT03573908|593880516|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
164412326|NCT03573908|593880517|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
164412327|NCT03573908|593880518|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
164412328|NCT03573908|593880519|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
164412329|NCT03573908|593880520|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
164412330|NCT04006925|593880521|FG000|Overall Study|Side effects|2|||
164412331|NCT04006925|593880522|FG001|Overall Study|Side effects|0|||
164412332|NCT02669095|593880524|FG000|Overall Study|Adverse Event|1|||
164412333|NCT02669095|593880525|FG001|Overall Study|Adverse Event|0|||
164412334|NCT02669095|593880524|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
164412335|NCT02669095|593880525|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
164412336|NCT02669095|593880524|FG000|Overall Study|Torn Lens|0|||
164412337|NCT02669095|593880525|FG001|Overall Study|Torn Lens|1|||
164412338|NCT02669095|593880524|FG000|Overall Study|Visit 5 assessments not completed|0|||
164412339|NCT02669095|593880525|FG001|Overall Study|Visit 5 assessments not completed|1|||
164412340|NCT00738101|593880527|FG000|Overall Study|Physician Decision|5|||
164412341|NCT00738101|593880527|FG000|Overall Study|Death|1|||
164412342|NCT00738101|593880527|FG000|Overall Study|Repeat enrollment|1|||
164412343|NCT01396317|593880528|FG000|Overall Study|Adverse Event|1|||
164412344|NCT01396317|593880529|FG001|Overall Study|Adverse Event|0|||
164412345|NCT02906683|593882178|FG000|Overall Study|Adverse Event|0|||
164412346|NCT02906683|593882179|FG001|Overall Study|Adverse Event|1|||
164412347|NCT02906683|593882180|FG002|Overall Study|Adverse Event|0|||
164412348|NCT02906683|593882178|FG000|Overall Study|Physician Decision|0|||
164412349|NCT02906683|593882179|FG001|Overall Study|Physician Decision|1|||
164412350|NCT02906683|593882180|FG002|Overall Study|Physician Decision|1|||
164412351|NCT02906683|593882178|FG000|Overall Study|Withdrawal by Subject|0|||
164412352|NCT02906683|593882179|FG001|Overall Study|Withdrawal by Subject|2|||
164412353|NCT02906683|593882180|FG002|Overall Study|Withdrawal by Subject|1|||
164412354|NCT02906683|593882178|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
164412355|NCT02906683|593882179|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
164412356|NCT02906683|593882180|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
164412357|NCT02906683|593882178|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
164412358|NCT02906683|593882179|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
164412359|NCT02906683|593882180|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
164412360|NCT00663117|593882183|FG000|Overall Study|Lack of Efficacy|1|||
164412361|NCT00663117|593882184|FG001|Overall Study|Lack of Efficacy|0|||
164412362|NCT02781506|593882185|FG000|Overall Study|Adverse Event|5|||
164412363|NCT01158378|593882186|FG000|Overall Study|Death|4|||
164412364|NCT01158378|593882187|FG001|Overall Study|Death|5|||
164412365|NCT01158378|593882186|FG000|Overall Study|Lost to Follow-up|2|||
164412366|NCT01158378|593882187|FG001|Overall Study|Lost to Follow-up|4|||
164412367|NCT01158378|593882186|FG000|Overall Study|Withdrawal by Subject|4|||
164412368|NCT01158378|593882187|FG001|Overall Study|Withdrawal by Subject|0|||
164412369|NCT02593539|593882192|FG000|Overall Study|Adverse Event|1|||
164412370|NCT00437125|593882193|FG000|Overall Study|Adverse Event|12|||
164412371|NCT00437125|593882193|FG000|Overall Study|Death|1|||
164412372|NCT00437125|593882193|FG000|Overall Study|Clinical Relapse|1|||
164412373|NCT00437125|593882193|FG000|Overall Study|Lack of Efficacy|1|||
164412374|NCT00437125|593882193|FG000|Overall Study|Lost to Follow-up|1|||
164412375|NCT00437125|593882193|FG000|Overall Study|Withdrawal by Subject|13|||
164412376|NCT00437125|593882193|FG000|Overall Study|Withdrawal by Caregiver|2|||
164412377|NCT00437125|593882193|FG000|Overall Study|Physician Decision|1|||
164412378|NCT02248961|593882196|FG000|Overall Study|Adverse Event|1|||
164709676|NCT03334617|594961115|FG008|Overall Study|Other|8|||
164709677|NCT03334617|594961116|FG009|Overall Study|Other|0|||
164709678|NCT03334617|594961117|FG010|Overall Study|Other|3|||
164709679|NCT03334617|594961118|FG011|Overall Study|Other|1|||
164412379|NCT02248961|593882197|FG001|Overall Study|Adverse Event|0|||
164709680|NCT03334617|594961119|FG012|Overall Study|Other|3|||
164412380|NCT02248961|593882196|FG000|Overall Study|Withdrawal by Subject|1|||
164412381|NCT02248961|593882197|FG001|Overall Study|Withdrawal by Subject|2|||
164412382|NCT02248961|593882196|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
164412383|NCT02248961|593882197|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
164412384|NCT00453310|593882201|FG000|Overall Study|Progression of Disease|10|||
164412385|NCT01806740|593882202|FG000|Overall Study|Withdrawal by Subject|4|||
164709681|NCT03334617|594961120|FG013|Overall Study|Other|1|||
164709682|NCT03334617|594961121|FG014|Overall Study|Other|1|||
164709683|NCT03334617|594961122|FG015|Overall Study|Other|3|||
164709684|NCT03334617|594961123|FG016|Overall Study|Other|3|||
164709685|NCT03334617|594961124|FG017|Overall Study|Other|3|||
164709686|NCT03334617|594961125|FG018|Overall Study|Other|7|||
164709687|NCT03334617|594961126|FG019|Overall Study|Other|4|||
164709688|NCT03334617|594961127|FG020|Overall Study|Other|1|||
164709689|NCT03334617|594961128|FG021|Overall Study|Other|4|||
164709690|NCT03334617|594961107|FG000|Overall Study|Continuing study off treatment at data cut-off|0|||
164709691|NCT03334617|594961108|FG001|Overall Study|Continuing study off treatment at data cut-off|0|||
164709692|NCT03334617|594961109|FG002|Overall Study|Continuing study off treatment at data cut-off|0|||
164709693|NCT03334617|594961110|FG003|Overall Study|Continuing study off treatment at data cut-off|0|||
164709694|NCT03334617|594961111|FG004|Overall Study|Continuing study off treatment at data cut-off|0|||
164709695|NCT03334617|594961112|FG005|Overall Study|Continuing study off treatment at data cut-off|2|||
164709696|NCT03334617|594961113|FG006|Overall Study|Continuing study off treatment at data cut-off|0|||
164709697|NCT03334617|594961114|FG007|Overall Study|Continuing study off treatment at data cut-off|0|||
164709698|NCT03334617|594961115|FG008|Overall Study|Continuing study off treatment at data cut-off|0|||
164709699|NCT03334617|594961116|FG009|Overall Study|Continuing study off treatment at data cut-off|0|||
164709700|NCT03334617|594961117|FG010|Overall Study|Continuing study off treatment at data cut-off|1|||
164709701|NCT03334617|594961118|FG011|Overall Study|Continuing study off treatment at data cut-off|0|||
164709702|NCT03334617|594961119|FG012|Overall Study|Continuing study off treatment at data cut-off|0|||
164709703|NCT03334617|594961120|FG013|Overall Study|Continuing study off treatment at data cut-off|0|||
164709704|NCT03334617|594961121|FG014|Overall Study|Continuing study off treatment at data cut-off|0|||
164412386|NCT01806740|593882202|FG000|Overall Study|Physician Decision|1|||
164412387|NCT01806740|593882202|FG000|Overall Study|Patient's refusal of treatment|1|||
164412388|NCT04666922|593882203|FG000|Overall Study|Withdrawal by Subject|1|||
164412389|NCT04666922|593882204|FG001|Overall Study|Withdrawal by Subject|0|||
164412390|NCT04666922|593882205|FG002|Overall Study|Withdrawal by Subject|0|||
164412391|NCT04666922|593882206|FG003|Overall Study|Withdrawal by Subject|0|||
164412392|NCT04666922|593882207|FG004|Overall Study|Withdrawal by Subject|0|||
164412393|NCT04666922|593882208|FG005|Overall Study|Withdrawal by Subject|0|||
164412394|NCT04666922|593882209|FG006|Overall Study|Withdrawal by Subject|0|||
164412395|NCT00244374|593882213|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
164412396|NCT00244374|593882214|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
164412397|NCT00244374|593882215|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
164412398|NCT00244374|593882216|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
164412399|NCT00244374|593882217|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
164412400|NCT00244374|593882213|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
164412401|NCT00244374|593882214|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
164412402|NCT00244374|593882215|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
164412403|NCT00244374|593882216|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
164412404|NCT00244374|593882217|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
164412405|NCT00244374|593882213|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
164412406|NCT00244374|593882214|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
164412407|NCT00244374|593882215|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
164412408|NCT00244374|593882216|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
164412409|NCT00244374|593882217|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
164412410|NCT00244374|593882213|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
164412411|NCT00244374|593882214|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
164412412|NCT00244374|593882215|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
164412413|NCT00244374|593882216|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
164412414|NCT00244374|593882217|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
164412415|NCT00244374|593882213|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
164412416|NCT00244374|593882214|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
164412417|NCT00244374|593882215|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
164412418|NCT00244374|593882216|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
164412419|NCT00244374|593882217|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
164412420|NCT00244374|593882213|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
164412421|NCT00244374|593882214|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
164412422|NCT00244374|593882215|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
164412423|NCT00244374|593882216|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
164412424|NCT00244374|593882217|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
164709705|NCT03334617|594961122|FG015|Overall Study|Continuing study off treatment at data cut-off|0|||
164709706|NCT03334617|594961123|FG016|Overall Study|Continuing study off treatment at data cut-off|0|||
164412425|NCT00244374|593882213|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
164412426|NCT00244374|593882214|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
164412427|NCT00244374|593882215|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
164412428|NCT00244374|593882216|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
164412429|NCT00244374|593882217|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
164412430|NCT00244374|593882213|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
164412431|NCT00244374|593882214|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
164709707|NCT03334617|594961124|FG017|Overall Study|Continuing study off treatment at data cut-off|0|||
164709708|NCT03334617|594961125|FG018|Overall Study|Continuing study off treatment at data cut-off|0|||
164709709|NCT03334617|594961126|FG019|Overall Study|Continuing study off treatment at data cut-off|1|||
164709710|NCT03334617|594961127|FG020|Overall Study|Continuing study off treatment at data cut-off|2|||
164709711|NCT03334617|594961128|FG021|Overall Study|Continuing study off treatment at data cut-off|4|||
164709712|NCT03657342|594961130|FG000|Overall Study|Adverse Event, including SAE/Death|6|||
164709713|NCT03657342|594961131|FG001|Overall Study|Adverse Event, including SAE/Death|3|||
164709714|NCT03657342|594961130|FG000|Overall Study|Withdrawal by Subject|4|||
164709715|NCT03657342|594961131|FG001|Overall Study|Withdrawal by Subject|4|||
164709716|NCT03657342|594961130|FG000|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|1|||
164709717|NCT03657342|594961131|FG001|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|0|||
164709718|NCT03657342|594961130|FG000|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|1|||
164709719|NCT03657342|594961131|FG001|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|0|||
164709720|NCT00827632|594961132|FG000|Overall Study|Lost to Follow-up|8|||
164709721|NCT00827632|594961133|FG001|Overall Study|Lost to Follow-up|12|||
164709722|NCT00827632|594961132|FG000|Overall Study|Early withdrawal|14|||
164709723|NCT00827632|594961133|FG001|Overall Study|Early withdrawal|11|||
164709724|NCT00911807|594961148|FG000|Overall Study|Adverse Event|2|||
164709725|NCT00911807|594961149|FG001|Overall Study|Adverse Event|1|||
164709726|NCT00911807|594961150|FG002|Overall Study|Adverse Event|5|||
164709727|NCT00911807|594961148|FG000|Overall Study|Death|0|||
164709728|NCT00911807|594961149|FG001|Overall Study|Death|0|||
164709729|NCT00911807|594961150|FG002|Overall Study|Death|1|||
164709730|NCT00911807|594961148|FG000|Overall Study|Protocol Violation|6|||
164709731|NCT00911807|594961149|FG001|Overall Study|Protocol Violation|4|||
164709732|NCT00911807|594961150|FG002|Overall Study|Protocol Violation|9|||
164709733|NCT00911807|594961148|FG000|Overall Study|Withdrawal by Subject|8|||
164709734|NCT00911807|594961149|FG001|Overall Study|Withdrawal by Subject|10|||
164709735|NCT00911807|594961150|FG002|Overall Study|Withdrawal by Subject|7|||
164709736|NCT00911807|594961148|FG000|Overall Study|Organizational reasons|1|||
164709737|NCT00911807|594961149|FG001|Overall Study|Organizational reasons|3|||
164709738|NCT00911807|594961150|FG002|Overall Study|Organizational reasons|1|||
164709739|NCT01753336|594961152|FG000|Overall Study|Patient decision|12|||
164709740|NCT01753336|594961152|FG000|Overall Study|Lost to Follow-up|3|||
164709741|NCT01753336|594961152|FG000|Overall Study|Physician Decision|2|||
164709742|NCT01753336|594961152|FG000|Overall Study|Sponsor's decision|2|||
164709743|NCT01753336|594961152|FG000|Overall Study|Withdrawal by Subject|1|||
164709744|NCT00855803|594961153|FG000|Overall Study|Death|2|||
164709745|NCT00855803|594961153|FG000|Overall Study|Lost to Follow-up|2|||
164709746|NCT00855803|594961153|FG000|Overall Study|Technical inability to undergo procedure|2|||
164709747|NCT00855803|594961153|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
164709748|NCT00855803|594961153|FG000|Overall Study|Withdrawal by Subject|3|||
164709749|NCT00855803|594961153|FG000|Overall Study|Physician Decision|3|||
164709750|NCT00809159|594961154|FG000|Part 1|Adverse Event|1|||
164709751|NCT00809159|594961155|FG001|Part 1|Adverse Event|1|||
164709752|NCT00809159|594961156|FG002|Part 1|Adverse Event|0|||
164709753|NCT00809159|594961157|FG003|Part 1|Adverse Event|0|||
164709754|NCT00809159|594961158|FG004|Part 1|Adverse Event|0|||
164709755|NCT00809159|594961159|FG005|Part 1|Adverse Event|0|||
164709756|NCT00809159|594961154|FG000|Part 1|Lost to Follow-up|1|||
164709757|NCT00809159|594961155|FG001|Part 1|Lost to Follow-up|0|||
164709758|NCT00809159|594961156|FG002|Part 1|Lost to Follow-up|0|||
164709759|NCT00809159|594961157|FG003|Part 1|Lost to Follow-up|0|||
164709760|NCT00809159|594961158|FG004|Part 1|Lost to Follow-up|0|||
164709761|NCT00809159|594961159|FG005|Part 1|Lost to Follow-up|0|||
164709762|NCT00809159|594961154|FG000|Part 1|Withdrawal by Subject|3|||
164709763|NCT00809159|594961155|FG001|Part 1|Withdrawal by Subject|1|||
164709764|NCT00809159|594961156|FG002|Part 1|Withdrawal by Subject|0|||
164709765|NCT00809159|594961157|FG003|Part 1|Withdrawal by Subject|0|||
164709766|NCT00809159|594961158|FG004|Part 1|Withdrawal by Subject|0|||
164709767|NCT00809159|594961159|FG005|Part 1|Withdrawal by Subject|0|||
164709768|NCT00809159|594961154|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
164709769|NCT00809159|594961155|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
164709770|NCT00809159|594961156|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
164709771|NCT00809159|594961157|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
164709772|NCT00809159|594961158|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
164412432|NCT00244374|593882215|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
164412433|NCT00244374|593882216|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
164412434|NCT00244374|593882217|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
164412435|NCT00244374|593882213|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
164412436|NCT00244374|593882214|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
164412437|NCT00244374|593882215|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
164412438|NCT00244374|593882216|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
164412439|NCT00244374|593882217|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
164412440|NCT03462706|593882219|FG000|Overall Study|Polyp was pedunculated|1|||
164412441|NCT03462706|593882220|FG001|Overall Study|Polyp was pedunculated|0|||
164412442|NCT03462706|593882221|FG002|Overall Study|Polyp was pedunculated|1|||
164412443|NCT03462706|593882222|FG003|Overall Study|Polyp was pedunculated|0|||
164412444|NCT03462706|593882219|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
164412445|NCT03462706|593882220|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
164412446|NCT03462706|593882221|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
164412447|NCT03462706|593882222|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
164412448|NCT04105972|593882233|FG000|Overall Study|Adverse Event|2|||
164412449|NCT04105972|593882234|FG001|Overall Study|Adverse Event|1|||
164412450|NCT02802319|593882235|FG000|Overall Study|Physician Decision|2|||
164412451|NCT02802319|593882236|FG001|Overall Study|Physician Decision|1|||
164412452|NCT02802319|593882235|FG000|Overall Study|Lost to Follow-up|0|||
164412453|NCT02802319|593882236|FG001|Overall Study|Lost to Follow-up|4|||
164412454|NCT03661996|593882237|FG000|Overall Study|Adverse Event|0|||
164412455|NCT03661996|593882238|FG001|Overall Study|Adverse Event|0|||
164463408|NCT04585815|594068681|FG003|Sub-study A- Treatment Phase|Death|0|||
164463409|NCT04585815|594068682|FG004|Sub-study A- Treatment Phase|Death|0|||
164463410|NCT04585815|594068683|FG005|Sub-study A- Treatment Phase|Death|0|||
164463411|NCT04585815|594068684|FG006|Sub-study A- Treatment Phase|Death|0|||
164463412|NCT04585815|594068678|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
164412456|NCT03661996|593882239|FG002|Overall Study|Adverse Event|1|||
164412457|NCT03661996|593882240|FG003|Overall Study|Adverse Event|1|||
164412458|NCT03661996|593882241|FG004|Overall Study|Adverse Event|0|||
164412459|NCT03661996|593882237|FG000|Overall Study|Lost to Follow-up|5|||
164412460|NCT03661996|593882238|FG001|Overall Study|Lost to Follow-up|1|||
164412461|NCT03661996|593882239|FG002|Overall Study|Lost to Follow-up|2|||
164412462|NCT03661996|593882240|FG003|Overall Study|Lost to Follow-up|2|||
164412463|NCT03661996|593882241|FG004|Overall Study|Lost to Follow-up|6|||
164412464|NCT03661996|593882237|FG000|Overall Study|Physician Decision|1|||
164412465|NCT03661996|593882238|FG001|Overall Study|Physician Decision|1|||
164412466|NCT03661996|593882239|FG002|Overall Study|Physician Decision|1|||
164412467|NCT03661996|593882240|FG003|Overall Study|Physician Decision|2|||
164412468|NCT03661996|593882241|FG004|Overall Study|Physician Decision|0|||
164412469|NCT03661996|593882237|FG000|Overall Study|Protocol Violation|0|||
164412470|NCT03661996|593882238|FG001|Overall Study|Protocol Violation|0|||
164412471|NCT03661996|593882239|FG002|Overall Study|Protocol Violation|0|||
164412472|NCT03661996|593882240|FG003|Overall Study|Protocol Violation|0|||
164412473|NCT03661996|593882241|FG004|Overall Study|Protocol Violation|1|||
164412474|NCT03661996|593882237|FG000|Overall Study|Withdrawal by Subject|3|||
164412475|NCT03661996|593882238|FG001|Overall Study|Withdrawal by Subject|5|||
164412476|NCT03661996|593882239|FG002|Overall Study|Withdrawal by Subject|1|||
164412477|NCT03661996|593882240|FG003|Overall Study|Withdrawal by Subject|7|||
164412478|NCT03661996|593882241|FG004|Overall Study|Withdrawal by Subject|7|||
164412479|NCT03661996|593882237|FG000|Overall Study|Sponsors Decision|2|||
164412480|NCT03661996|593882238|FG001|Overall Study|Sponsors Decision|0|||
164412481|NCT03661996|593882239|FG002|Overall Study|Sponsors Decision|0|||
164412482|NCT03661996|593882240|FG003|Overall Study|Sponsors Decision|0|||
164463413|NCT04585815|594068679|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
164463414|NCT04585815|594068680|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
164412483|NCT03661996|593882241|FG004|Overall Study|Sponsors Decision|0|||
164412484|NCT03661996|593882237|FG000|Overall Study|Other|1|||
164412485|NCT03661996|593882238|FG001|Overall Study|Other|1|||
164412486|NCT03661996|593882239|FG002|Overall Study|Other|1|||
164412487|NCT03661996|593882240|FG003|Overall Study|Other|1|||
164412488|NCT03661996|593882241|FG004|Overall Study|Other|0|||
164412489|NCT03980184|593882244|FG000|Overall Study|Dropped out before treatment|2|||
164412490|NCT03980184|593882245|FG001|Overall Study|Dropped out before treatment|2|||
164412491|NCT03980184|593882244|FG000|Overall Study|Lost to Follow-up|11|||
164412492|NCT03980184|593882245|FG001|Overall Study|Lost to Follow-up|13|||
164412493|NCT02176421|593882246|FG000|Overall Study|Lost to Follow-up|4|||
164412494|NCT02176421|593882246|FG000|Overall Study|Adverse Event|1|||
164412495|NCT01965158|593882250|FG000|Overall Study|Adverse Event|14|||
164412496|NCT01965158|593882251|FG001|Overall Study|Adverse Event|5|||
164412497|NCT01965158|593882250|FG000|Overall Study|Withdrawal by Subject|16|||
164412498|NCT01965158|593882251|FG001|Overall Study|Withdrawal by Subject|24|||
164412499|NCT01965158|593882250|FG000|Overall Study|Lost to Follow-up|7|||
164412500|NCT01965158|593882251|FG001|Overall Study|Lost to Follow-up|5|||
164412501|NCT01965158|593882250|FG000|Overall Study|Protocol Violation|1|||
164412502|NCT01965158|593882251|FG001|Overall Study|Protocol Violation|1|||
164412503|NCT01965158|593882250|FG000|Overall Study|Other - Miscellaneous|3|||
164412504|NCT01965158|593882251|FG001|Overall Study|Other - Miscellaneous|0|||
164412505|NCT00467142|593882252|FG000|Overall Study|Withdrawal by Subject|1|||
164412506|NCT00467142|593882252|FG000|Overall Study|Adverse Event|1|||
164412507|NCT00467142|593882252|FG000|Overall Study|Protocol Violation|1|||
164463415|NCT04585815|594068681|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
164463416|NCT04585815|594068682|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
164463417|NCT04585815|594068683|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
164463418|NCT04585815|594068684|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
164463419|NCT04585815|594068678|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
164463420|NCT04585815|594068679|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
164463421|NCT04585815|594068680|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
164463422|NCT04585815|594068681|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
164463423|NCT04585815|594068682|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
164463424|NCT04585815|594068683|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
164463425|NCT04585815|594068684|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
164463426|NCT04585815|594068678|FG000|Sub-study A- Treatment Phase|Progressive disease|0|||
164463427|NCT04585815|594068679|FG001|Sub-study A- Treatment Phase|Progressive disease|1|||
164463428|NCT04585815|594068680|FG002|Sub-study A- Treatment Phase|Progressive disease|0|||
164463429|NCT04585815|594068681|FG003|Sub-study A- Treatment Phase|Progressive disease|0|||
164463430|NCT04585815|594068682|FG004|Sub-study A- Treatment Phase|Progressive disease|0|||
164463431|NCT04585815|594068683|FG005|Sub-study A- Treatment Phase|Progressive disease|0|||
164463432|NCT04585815|594068684|FG006|Sub-study A- Treatment Phase|Progressive disease|0|||
164463433|NCT04585815|594068678|FG000|Sub-study A- Treatment Phase|Study terminated by sponsor|1|||
164463434|NCT04585815|594068679|FG001|Sub-study A- Treatment Phase|Study terminated by sponsor|1|||
164412508|NCT00154310|593882253|FG000|Overall Study|Adverse Event|19|||
164412509|NCT00154310|593882254|FG001|Overall Study|Adverse Event|9|||
164412510|NCT00154310|593882253|FG000|Overall Study|Lack of Efficacy|5|||
164412511|NCT00154310|593882254|FG001|Overall Study|Lack of Efficacy|4|||
164412512|NCT00154310|593882253|FG000|Overall Study|Protocol Violation|4|||
164412513|NCT00154310|593882254|FG001|Overall Study|Protocol Violation|2|||
164412514|NCT00154310|593882253|FG000|Overall Study|Withdrawal by Subject|9|||
164412515|NCT00154310|593882254|FG001|Overall Study|Withdrawal by Subject|3|||
164412516|NCT00154310|593882253|FG000|Overall Study|Lost to Follow-up|0|||
164412517|NCT00154310|593882254|FG001|Overall Study|Lost to Follow-up|8|||
164412518|NCT00154310|593882253|FG000|Overall Study|Administrative problems|0|||
164412519|NCT00154310|593882254|FG001|Overall Study|Administrative problems|1|||
164412520|NCT00154310|593882253|FG000|Overall Study|Death|0|||
164412521|NCT00154310|593882254|FG001|Overall Study|Death|1|||
164412522|NCT03447730|593882256|FG000|Overall Study|Adverse Event|0|||
164412523|NCT03447730|593882257|FG001|Overall Study|Adverse Event|2|||
164412524|NCT03447730|593882258|FG002|Overall Study|Adverse Event|0|||
164412525|NCT02086162|593882259|FG000|Overall Study|Withdrawal by Subject|4|||
164412526|NCT02086162|593882260|FG001|Overall Study|Withdrawal by Subject|4|||
164412527|NCT02086162|593882259|FG000|Overall Study|moved|1|||
164412528|NCT02086162|593882260|FG001|Overall Study|moved|1|||
164463435|NCT04585815|594068680|FG002|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
164463436|NCT04585815|594068681|FG003|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
164412529|NCT02086162|593882259|FG000|Overall Study|Lost to Follow-up|4|||
164412530|NCT02086162|593882260|FG001|Overall Study|Lost to Follow-up|2|||
164412531|NCT02086162|593882259|FG000|Overall Study|Death|1|||
164412532|NCT02086162|593882260|FG001|Overall Study|Death|0|||
164412533|NCT01248962|593882264|FG000|Overall Study|Withdrawal by Subject|1|||
164412534|NCT01248962|593882265|FG001|Overall Study|Withdrawal by Subject|1|||
164412535|NCT01248962|593882264|FG000|Overall Study|Adverse Event|2|||
164412536|NCT01248962|593882265|FG001|Overall Study|Adverse Event|1|||
164412537|NCT01248962|593882264|FG000|Overall Study|Complete Response after 4 Cycles|1|||
164412538|NCT01248962|593882265|FG001|Overall Study|Complete Response after 4 Cycles|0|||
164412539|NCT01248962|593882264|FG000|Overall Study|Complete Response after 3 Cycles|0|||
164463437|NCT04585815|594068682|FG004|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
164463438|NCT04585815|594068683|FG005|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
164463439|NCT04585815|594068684|FG006|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
164709773|NCT00809159|594961159|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
164412540|NCT01248962|593882265|FG001|Overall Study|Complete Response after 3 Cycles|1|||
164412541|NCT01248962|593882264|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
164412542|NCT01248962|593882265|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
164412543|NCT04848662|593882266|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
164412544|NCT04848662|593882267|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
164412545|NCT01350505|593882268|FG000|Overall Study|Lost to Follow-up|4|||
164412546|NCT01834222|593882269|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
164412547|NCT04702568|593882270|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
164412548|NCT04702568|593882271|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
164412549|NCT04702568|593882270|FG000|Overall Study|Pregnancy|1|||
164412550|NCT04702568|593882271|FG001|Overall Study|Pregnancy|0|||
164412551|NCT04702568|593882270|FG000|Overall Study|Bone marrow transplant|1|||
164709774|NCT00809159|594961154|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
164709775|NCT00809159|594961155|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
164709776|NCT00809159|594961156|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
164709777|NCT00809159|594961157|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
164709778|NCT00809159|594961158|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
164709779|NCT00809159|594961159|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
164709780|NCT00809159|594961154|FG000|Part 1 and 2|Administrative problems|0|||
164709781|NCT00809159|594961155|FG001|Part 1 and 2|Administrative problems|0|||
164709782|NCT00809159|594961156|FG002|Part 1 and 2|Administrative problems|0|||
164709783|NCT00809159|594961157|FG003|Part 1 and 2|Administrative problems|1|||
164709784|NCT00809159|594961158|FG004|Part 1 and 2|Administrative problems|0|||
164709785|NCT00809159|594961159|FG005|Part 1 and 2|Administrative problems|0|||
164709786|NCT00809159|594961154|FG000|Part 1 and 2|Adverse Event|0|||
164709787|NCT00809159|594961155|FG001|Part 1 and 2|Adverse Event|0|||
164709788|NCT00809159|594961156|FG002|Part 1 and 2|Adverse Event|1|||
164709789|NCT00809159|594961157|FG003|Part 1 and 2|Adverse Event|0|||
164709790|NCT00809159|594961158|FG004|Part 1 and 2|Adverse Event|1|||
164709791|NCT00809159|594961159|FG005|Part 1 and 2|Adverse Event|1|||
164709792|NCT00809159|594961154|FG000|Part 1 and 2|Lost to Follow-up|0|||
164709793|NCT00809159|594961155|FG001|Part 1 and 2|Lost to Follow-up|0|||
164709794|NCT00809159|594961156|FG002|Part 1 and 2|Lost to Follow-up|1|||
164709795|NCT00809159|594961157|FG003|Part 1 and 2|Lost to Follow-up|1|||
164709796|NCT00809159|594961158|FG004|Part 1 and 2|Lost to Follow-up|0|||
164709797|NCT00809159|594961159|FG005|Part 1 and 2|Lost to Follow-up|0|||
164709798|NCT00809159|594961154|FG000|Part 1 and 2|Withdrawal by Subject|0|||
164709799|NCT00809159|594961155|FG001|Part 1 and 2|Withdrawal by Subject|0|||
164709800|NCT00809159|594961156|FG002|Part 1 and 2|Withdrawal by Subject|4|||
164709801|NCT00809159|594961157|FG003|Part 1 and 2|Withdrawal by Subject|0|||
164709802|NCT00809159|594961158|FG004|Part 1 and 2|Withdrawal by Subject|0|||
164709803|NCT00809159|594961159|FG005|Part 1 and 2|Withdrawal by Subject|1|||
164709804|NCT03201211|594961160|FG000|Overall Study|Adverse Event|1|||
164709805|NCT03201211|594961161|FG001|Overall Study|Adverse Event|0|||
164709806|NCT03201211|594961162|FG002|Overall Study|Adverse Event|0|||
164709807|NCT03201211|594961160|FG000|Overall Study|Protocol Violation|1|||
164709808|NCT03201211|594961161|FG001|Overall Study|Protocol Violation|0|||
164709809|NCT03201211|594961162|FG002|Overall Study|Protocol Violation|0|||
164709810|NCT03201211|594961160|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
164709811|NCT03201211|594961161|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
164709812|NCT03201211|594961162|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
164709813|NCT03201211|594961160|FG000|Overall Study|OTHER unknown reasons|0|||
164709814|NCT03201211|594961161|FG001|Overall Study|OTHER unknown reasons|1|||
164709815|NCT03201211|594961162|FG002|Overall Study|OTHER unknown reasons|0|||
164709816|NCT03918109|594961167|FG000|Overall Study|Withdrawal by Subject|0|||
164709817|NCT03918109|594961168|FG001|Overall Study|Withdrawal by Subject|0|||
164709818|NCT03918109|594961169|FG002|Overall Study|Withdrawal by Subject|2|||
164709819|NCT03918109|594961170|FG003|Overall Study|Withdrawal by Subject|1|||
164709820|NCT03918109|594961167|FG000|Overall Study|Lost to Follow-up|0|||
164709821|NCT03918109|594961168|FG001|Overall Study|Lost to Follow-up|0|||
164709822|NCT03918109|594961169|FG002|Overall Study|Lost to Follow-up|0|||
164709823|NCT03918109|594961170|FG003|Overall Study|Lost to Follow-up|1|||
164709824|NCT03050060|594961173|FG000|Overall Study|Adverse Event|7|||
164709825|NCT03050060|594961173|FG000|Overall Study|Withdrawal by Subject|1|||
164709826|NCT03050060|594961173|FG000|Overall Study|Progression|7|||
164709827|NCT02304458|594961174|FG000|Overall Study|Adverse Event|0|||
164709828|NCT02304458|594961175|FG001|Overall Study|Adverse Event|0|||
164709829|NCT02304458|594961176|FG002|Overall Study|Adverse Event|7|||
164709830|NCT02304458|594961177|FG003|Overall Study|Adverse Event|0|||
164709831|NCT02304458|594961178|FG004|Overall Study|Adverse Event|0|||
164709832|NCT02304458|594961179|FG005|Overall Study|Adverse Event|0|||
164709833|NCT02304458|594961180|FG006|Overall Study|Adverse Event|3|||
164709834|NCT02304458|594961181|FG007|Overall Study|Adverse Event|4|||
164709835|NCT02304458|594961174|FG000|Overall Study|Death|0|||
164709836|NCT02304458|594961175|FG001|Overall Study|Death|0|||
164709837|NCT02304458|594961176|FG002|Overall Study|Death|2|||
164709838|NCT02304458|594961177|FG003|Overall Study|Death|0|||
164709839|NCT02304458|594961178|FG004|Overall Study|Death|0|||
164709840|NCT02304458|594961179|FG005|Overall Study|Death|0|||
164709841|NCT02304458|594961180|FG006|Overall Study|Death|1|||
164412552|NCT04702568|593882271|FG001|Overall Study|Bone marrow transplant|0|||
164709842|NCT02304458|594961181|FG007|Overall Study|Death|0|||
164709843|NCT02304458|594961174|FG000|Overall Study|Lack of Efficacy|4|||
164709844|NCT02304458|594961175|FG001|Overall Study|Lack of Efficacy|6|||
164412553|NCT04702568|593882270|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
164412554|NCT04702568|593882271|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
164412555|NCT04702568|593882270|FG000|Overall Study|Withdrawal by Subject|0|||
164412556|NCT04702568|593882271|FG001|Overall Study|Withdrawal by Subject|2|||
164412557|NCT00423852|593882274|FG000|Overall Study|Removed pior to the high-dose portion|3|||
164412558|NCT00308737|593882277|FG000|Overall Study|Adverse Event|104|||
164412559|NCT00308737|593882278|FG001|Overall Study|Adverse Event|9|||
164412560|NCT00308737|593882279|FG002|Overall Study|Adverse Event|0|||
164412561|NCT00308737|593882277|FG000|Overall Study|Death|4|||
164412562|NCT00308737|593882278|FG001|Overall Study|Death|3|||
164412563|NCT00308737|593882279|FG002|Overall Study|Death|0|||
164412564|NCT00308737|593882277|FG000|Overall Study|Lost to Follow-up|56|||
164412565|NCT00308737|593882278|FG001|Overall Study|Lost to Follow-up|80|||
164412566|NCT00308737|593882279|FG002|Overall Study|Lost to Follow-up|5|||
164412567|NCT00308737|593882277|FG000|Overall Study|Physician Decision|15|||
164412568|NCT00308737|593882278|FG001|Overall Study|Physician Decision|2|||
164412569|NCT00308737|593882279|FG002|Overall Study|Physician Decision|1|||
164412570|NCT00308737|593882277|FG000|Overall Study|Protocol Violation|34|||
164412571|NCT00308737|593882278|FG001|Overall Study|Protocol Violation|9|||
164412572|NCT00308737|593882279|FG002|Overall Study|Protocol Violation|5|||
164412573|NCT00308737|593882277|FG000|Overall Study|Withdrawal by Subject|218|||
164412574|NCT00308737|593882278|FG001|Overall Study|Withdrawal by Subject|166|||
164412575|NCT00308737|593882279|FG002|Overall Study|Withdrawal by Subject|18|||
164412576|NCT00308737|593882277|FG000|Overall Study|Various|32|||
164412577|NCT00308737|593882278|FG001|Overall Study|Various|20|||
164412578|NCT00308737|593882279|FG002|Overall Study|Various|8|||
164412579|NCT01225822|593882289|FG000|Overall Study|Adverse Event|13|||
164412580|NCT01225822|593882290|FG001|Overall Study|Adverse Event|31|||
164412581|NCT01225822|593882291|FG002|Overall Study|Adverse Event|18|||
164412582|NCT01225822|593882292|FG003|Overall Study|Adverse Event|23|||
164412583|NCT01225822|593882293|FG004|Overall Study|Adverse Event|14|||
164412584|NCT01225822|593882289|FG000|Overall Study|Protocol Violation|6|||
164412585|NCT01225822|593882290|FG001|Overall Study|Protocol Violation|8|||
164412586|NCT01225822|593882291|FG002|Overall Study|Protocol Violation|6|||
164412587|NCT01225822|593882292|FG003|Overall Study|Protocol Violation|7|||
164412588|NCT01225822|593882293|FG004|Overall Study|Protocol Violation|4|||
164412589|NCT01225822|593882289|FG000|Overall Study|Lost to Follow-up|0|||
164412590|NCT01225822|593882290|FG001|Overall Study|Lost to Follow-up|0|||
164412591|NCT01225822|593882291|FG002|Overall Study|Lost to Follow-up|0|||
164412592|NCT01225822|593882292|FG003|Overall Study|Lost to Follow-up|1|||
164412593|NCT01225822|593882293|FG004|Overall Study|Lost to Follow-up|0|||
164412594|NCT01225822|593882289|FG000|Overall Study|Withdrawal by Subject|6|||
164412595|NCT01225822|593882290|FG001|Overall Study|Withdrawal by Subject|7|||
164412596|NCT01225822|593882291|FG002|Overall Study|Withdrawal by Subject|7|||
164412597|NCT01225822|593882292|FG003|Overall Study|Withdrawal by Subject|11|||
164412598|NCT01225822|593882293|FG004|Overall Study|Withdrawal by Subject|6|||
164412599|NCT01225822|593882289|FG000|Overall Study|Other|13|||
164412600|NCT01225822|593882290|FG001|Overall Study|Other|10|||
164412601|NCT01225822|593882291|FG002|Overall Study|Other|7|||
164412602|NCT01225822|593882292|FG003|Overall Study|Other|10|||
164412603|NCT01225822|593882293|FG004|Overall Study|Other|7|||
164412604|NCT00089895|593882294|FG000|Overall Study|Consent Withdrawn|11|||
164412605|NCT00089895|593882295|FG001|Overall Study|Consent Withdrawn|14|||
164412606|NCT00089895|593882294|FG000|Overall Study|Technical reason|7|||
164412607|NCT00089895|593882295|FG001|Overall Study|Technical reason|2|||
164412608|NCT00089895|593882294|FG000|Overall Study|Surgery|0|||
164412609|NCT00089895|593882295|FG001|Overall Study|Surgery|1|||
164412610|NCT00089895|593882294|FG000|Overall Study|Bleeding|0|||
164412611|NCT00089895|593882295|FG001|Overall Study|Bleeding|2|||
164412612|NCT00089895|593882294|FG000|Overall Study|Physician Decision|3|||
164412613|NCT00089895|593882295|FG001|Overall Study|Physician Decision|7|||
164412614|NCT00089895|593882294|FG000|Overall Study|Exclusion criteria met|6|||
164412615|NCT00089895|593882295|FG001|Overall Study|Exclusion criteria met|6|||
164412616|NCT00089895|593882294|FG000|Overall Study|Not otherwise specified|4|||
164412617|NCT00089895|593882295|FG001|Overall Study|Not otherwise specified|8|||
164412618|NCT00089895|593882294|FG000|Overall Study|Missing|4|||
164412619|NCT00089895|593882295|FG001|Overall Study|Missing|2|||
164412620|NCT05644353|593882296|FG000|Overall Study|Physician Decision|1|||
164412621|NCT05644353|593882297|FG001|Overall Study|Physician Decision|0|||
164412622|NCT05644353|593882298|FG002|Overall Study|Physician Decision|0|||
164412623|NCT05644353|593882299|FG003|Overall Study|Physician Decision|0|||
164412624|NCT05644353|593882300|FG004|Overall Study|Physician Decision|0|||
164412625|NCT05644353|593882301|FG005|Overall Study|Physician Decision|0|||
164412626|NCT05644353|593882296|FG000|Overall Study|Protocol Violation|1|||
164412627|NCT05644353|593882297|FG001|Overall Study|Protocol Violation|0|||
164412628|NCT05644353|593882298|FG002|Overall Study|Protocol Violation|0|||
164412629|NCT05644353|593882299|FG003|Overall Study|Protocol Violation|0|||
164412630|NCT05644353|593882300|FG004|Overall Study|Protocol Violation|0|||
164412631|NCT05644353|593882301|FG005|Overall Study|Protocol Violation|0|||
164412632|NCT05644353|593882296|FG000|Overall Study|Withdrawal by Subject|0|||
164412633|NCT05644353|593882297|FG001|Overall Study|Withdrawal by Subject|2|||
164412634|NCT05644353|593882298|FG002|Overall Study|Withdrawal by Subject|0|||
164412635|NCT05644353|593882299|FG003|Overall Study|Withdrawal by Subject|0|||
164412636|NCT05644353|593882300|FG004|Overall Study|Withdrawal by Subject|1|||
164412637|NCT05644353|593882301|FG005|Overall Study|Withdrawal by Subject|0|||
164412638|NCT05644353|593882296|FG000|Overall Study|Lost to Follow-up|0|||
164412639|NCT05644353|593882297|FG001|Overall Study|Lost to Follow-up|0|||
164412640|NCT05644353|593882298|FG002|Overall Study|Lost to Follow-up|1|||
164463440|NCT04585815|594068678|FG000|Sub-study A- Treatment Phase|Other|1|||
164463441|NCT04585815|594068679|FG001|Sub-study A- Treatment Phase|Other|0|||
164463442|NCT04585815|594068680|FG002|Sub-study A- Treatment Phase|Other|0|||
164463443|NCT04585815|594068681|FG003|Sub-study A- Treatment Phase|Other|0|||
164463444|NCT04585815|594068682|FG004|Sub-study A- Treatment Phase|Other|0|||
164463445|NCT04585815|594068683|FG005|Sub-study A- Treatment Phase|Other|0|||
164463446|NCT04585815|594068684|FG006|Sub-study A- Treatment Phase|Other|0|||
164709845|NCT02304458|594961176|FG002|Overall Study|Lack of Efficacy|38|||
164412641|NCT05644353|593882299|FG003|Overall Study|Lost to Follow-up|0|||
164412642|NCT05644353|593882300|FG004|Overall Study|Lost to Follow-up|0|||
164412643|NCT05644353|593882301|FG005|Overall Study|Lost to Follow-up|0|||
164412644|NCT01535274|593882302|FG000|Overall Study|Determined to be ineligible|0|||
164412645|NCT01535274|593882303|FG001|Overall Study|Determined to be ineligible|1|||
164412646|NCT01535274|593882302|FG000|Overall Study|Misallocated to propofol intervention|0|||
164412647|NCT01535274|593882303|FG001|Overall Study|Misallocated to propofol intervention|1|||
164412648|NCT02954458|593882306|FG000|Overall Study|Adverse Event|0|||
164412649|NCT02954458|593882307|FG001|Overall Study|Adverse Event|0|||
164412650|NCT02954458|593882308|FG002|Overall Study|Adverse Event|0|||
164412651|NCT02954458|593882309|FG003|Overall Study|Adverse Event|1|||
164412652|NCT02954458|593882306|FG000|Overall Study|Withdrawal by Subject|0|||
164412653|NCT02954458|593882307|FG001|Overall Study|Withdrawal by Subject|0|||
164412654|NCT02954458|593882308|FG002|Overall Study|Withdrawal by Subject|0|||
164412655|NCT02954458|593882309|FG003|Overall Study|Withdrawal by Subject|1|||
164412656|NCT02954458|593882306|FG000|Overall Study|Physician Decision|0|||
164412657|NCT02954458|593882307|FG001|Overall Study|Physician Decision|0|||
164412658|NCT02954458|593882308|FG002|Overall Study|Physician Decision|1|||
164412659|NCT02954458|593882309|FG003|Overall Study|Physician Decision|1|||
164412660|NCT02954458|593882306|FG000|Overall Study|Lost to Follow-up|1|||
164412661|NCT02954458|593882307|FG001|Overall Study|Lost to Follow-up|0|||
164412662|NCT02954458|593882308|FG002|Overall Study|Lost to Follow-up|0|||
164412663|NCT02954458|593882309|FG003|Overall Study|Lost to Follow-up|1|||
164412664|NCT02954458|593882306|FG000|Overall Study|Death|0|||
164412665|NCT02954458|593882307|FG001|Overall Study|Death|0|||
164412666|NCT02954458|593882308|FG002|Overall Study|Death|0|||
164412667|NCT02954458|593882309|FG003|Overall Study|Death|1|||
164412668|NCT02954458|593882306|FG000|Overall Study|Other|0|||
164412669|NCT02954458|593882307|FG001|Overall Study|Other|0|||
164412670|NCT02954458|593882308|FG002|Overall Study|Other|0|||
164412671|NCT02954458|593882309|FG003|Overall Study|Other|7|||
164412672|NCT02690077|593882312|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
164412673|NCT02690077|593882313|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
164412674|NCT02690077|593882312|FG000|Overall Study|Withdrawal by Subject|0|||
164709846|NCT02304458|594961177|FG003|Overall Study|Lack of Efficacy|5|||
164709847|NCT02304458|594961178|FG004|Overall Study|Lack of Efficacy|6|||
164709848|NCT02304458|594961179|FG005|Overall Study|Lack of Efficacy|6|||
164709849|NCT02304458|594961180|FG006|Overall Study|Lack of Efficacy|21|||
164709850|NCT02304458|594961181|FG007|Overall Study|Lack of Efficacy|4|||
164709851|NCT02304458|594961174|FG000|Overall Study|Physician Decision|2|||
164709852|NCT02304458|594961175|FG001|Overall Study|Physician Decision|0|||
164709853|NCT02304458|594961176|FG002|Overall Study|Physician Decision|16|||
164709854|NCT02304458|594961177|FG003|Overall Study|Physician Decision|1|||
164709855|NCT02304458|594961178|FG004|Overall Study|Physician Decision|0|||
164709856|NCT02304458|594961179|FG005|Overall Study|Physician Decision|0|||
164412675|NCT02690077|593882313|FG001|Overall Study|Withdrawal by Subject|5|||
164412676|NCT02690077|593882312|FG000|Overall Study|Excluded by IRB|0|||
164412677|NCT02690077|593882313|FG001|Overall Study|Excluded by IRB|2|||
164412678|NCT02130284|593882314|FG000|Overall Study|Withdrawal by Subject|3|||
164412679|NCT02130284|593882314|FG000|Overall Study|Subject Withdrew Consent|1|||
164412680|NCT02130284|593882314|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
164412681|NCT02130284|593882314|FG000|Overall Study|Subject was screened as backup for study|3|||
164412682|NCT02130284|593882314|FG000|Overall Study|Screen Failure|1|||
164412683|NCT01852058|593882316|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
164412684|NCT01852058|593882317|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
164412685|NCT01852058|593882318|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
164709857|NCT02304458|594961180|FG006|Overall Study|Physician Decision|3|||
164709858|NCT02304458|594961181|FG007|Overall Study|Physician Decision|0|||
164709859|NCT02304458|594961174|FG000|Overall Study|Protocol Violation|0|||
164412686|NCT01852058|593882319|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
164463447|NCT04585815|594068678|FG000|Sub-study A- Follow-up Phase|Death|0|||
164709860|NCT02304458|594961175|FG001|Overall Study|Protocol Violation|0|||
164412687|NCT01852058|593882320|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
164412688|NCT01852058|593882321|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
164412689|NCT01852058|593882322|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
164412690|NCT01852058|593882323|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
164412691|NCT01852058|593882324|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
164412692|NCT01852058|593882325|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
164412693|NCT01852058|593882326|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
164412694|NCT01852058|593882327|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
164412695|NCT01852058|593882316|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
164412696|NCT01852058|593882317|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
164412697|NCT01852058|593882318|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
164412698|NCT01852058|593882319|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
164412699|NCT01852058|593882320|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
164412700|NCT01852058|593882321|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
164412701|NCT01852058|593882322|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
164412702|NCT01852058|593882323|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
164412703|NCT01852058|593882324|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
164412704|NCT01852058|593882325|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
164412705|NCT01852058|593882326|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
164412706|NCT01852058|593882327|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
164412707|NCT01852058|593882316|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
164412708|NCT01852058|593882317|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
164412709|NCT01852058|593882318|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
164412710|NCT01852058|593882319|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
164412711|NCT01852058|593882320|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
164412712|NCT01852058|593882321|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
164412713|NCT01852058|593882322|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
164412714|NCT01852058|593882323|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
164412715|NCT01852058|593882324|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
164412716|NCT01852058|593882325|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
164412717|NCT01852058|593882326|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
164412718|NCT01852058|593882327|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
164412719|NCT01852058|593882316|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
164412720|NCT01852058|593882317|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
164412721|NCT01852058|593882318|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
164412722|NCT01852058|593882319|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
164412723|NCT01852058|593882320|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
164412724|NCT01852058|593882321|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
164412725|NCT01852058|593882322|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
164412726|NCT01852058|593882323|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
164412727|NCT01852058|593882324|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
164412728|NCT01852058|593882325|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
164412729|NCT01852058|593882326|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
164412730|NCT01852058|593882327|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
164412731|NCT01852058|593882316|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
164412732|NCT01852058|593882317|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
164412733|NCT01852058|593882318|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
164412734|NCT01852058|593882319|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
164412735|NCT01852058|593882320|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
164412736|NCT01852058|593882321|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
164412737|NCT01852058|593882322|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
164412738|NCT01852058|593882323|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
164412739|NCT01852058|593882324|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
164412740|NCT01852058|593882325|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
164412741|NCT01852058|593882326|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
164412742|NCT01852058|593882327|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
164412743|NCT01852058|593882316|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
164412744|NCT01852058|593882317|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
164412745|NCT01852058|593882318|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
164412746|NCT01852058|593882319|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
164412747|NCT01852058|593882320|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
164412748|NCT01852058|593882321|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
164412749|NCT01852058|593882322|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
164412750|NCT01852058|593882323|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
164412751|NCT01852058|593882324|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
164412752|NCT01852058|593882325|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
164412753|NCT01852058|593882326|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
164412754|NCT01852058|593882327|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
164412755|NCT01852058|593882316|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
164412756|NCT01852058|593882317|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
164412757|NCT01852058|593882318|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
164412758|NCT01852058|593882319|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
164412759|NCT01852058|593882320|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
164412760|NCT01852058|593882321|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
164412761|NCT01852058|593882322|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
164412762|NCT01852058|593882323|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
164412763|NCT01852058|593882324|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
164412764|NCT01852058|593882325|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
164412765|NCT01852058|593882326|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
164412766|NCT01852058|593882327|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
164412767|NCT01852058|593882316|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
164412768|NCT01852058|593882317|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
164412769|NCT01852058|593882318|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
164412770|NCT01852058|593882319|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
164412771|NCT01852058|593882320|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
164412772|NCT01852058|593882321|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
164412773|NCT01852058|593882322|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
164412774|NCT01852058|593882323|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
164412775|NCT01852058|593882324|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
164412776|NCT01852058|593882325|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
164412777|NCT01852058|593882326|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
164412778|NCT01852058|593882327|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
164412779|NCT01852058|593882316|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
164412780|NCT01852058|593882317|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
164412781|NCT01852058|593882318|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
164412782|NCT01852058|593882319|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
164412783|NCT01852058|593882320|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
164412784|NCT01852058|593882321|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
164412785|NCT01852058|593882322|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
164412786|NCT01852058|593882323|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
164412787|NCT01852058|593882324|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
164412788|NCT01852058|593882325|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
164412789|NCT01852058|593882326|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
164412790|NCT01852058|593882327|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
164412791|NCT01279343|593882328|FG000|Overall Study|Did not receive treatment|2|||
164412792|NCT01279343|593882329|FG001|Overall Study|Did not receive treatment|6|||
164412793|NCT03287414|593882330|FG000|Treatment Epoch|Adverse Event|0|||
164412794|NCT03287414|593882331|FG001|Treatment Epoch|Adverse Event|1|||
164412795|NCT03287414|593882330|FG000|Treatment Epoch|Study terminated by sponsor|2|||
164709861|NCT02304458|594961176|FG002|Overall Study|Protocol Violation|1|||
164709862|NCT02304458|594961177|FG003|Overall Study|Protocol Violation|0|||
164709863|NCT02304458|594961178|FG004|Overall Study|Protocol Violation|0|||
164709864|NCT02304458|594961179|FG005|Overall Study|Protocol Violation|0|||
164709865|NCT02304458|594961180|FG006|Overall Study|Protocol Violation|0|||
164709866|NCT02304458|594961181|FG007|Overall Study|Protocol Violation|0|||
164709867|NCT02304458|594961174|FG000|Overall Study|Withdrawal by Subject|1|||
164709868|NCT02304458|594961175|FG001|Overall Study|Withdrawal by Subject|0|||
164709869|NCT02304458|594961176|FG002|Overall Study|Withdrawal by Subject|7|||
164709870|NCT02304458|594961177|FG003|Overall Study|Withdrawal by Subject|0|||
164709871|NCT02304458|594961178|FG004|Overall Study|Withdrawal by Subject|0|||
164709872|NCT02304458|594961179|FG005|Overall Study|Withdrawal by Subject|0|||
164709873|NCT02304458|594961180|FG006|Overall Study|Withdrawal by Subject|1|||
164709874|NCT02304458|594961181|FG007|Overall Study|Withdrawal by Subject|0|||
164709875|NCT04188301|594961182|FG000|Month 3|Lost to Follow-up|0|||
164709876|NCT04188301|594961183|FG001|Month 3|Lost to Follow-up|0|||
164709877|NCT04188301|594961184|FG002|Month 3|Lost to Follow-up|1|||
164709878|NCT04188301|594961182|FG000|Month 12|Lost to Follow-up|0|||
164709879|NCT04188301|594961183|FG001|Month 12|Lost to Follow-up|0|||
164709880|NCT04188301|594961184|FG002|Month 12|Lost to Follow-up|2|||
164709881|NCT04188301|594961182|FG000|Month 12|Death|1|||
164709882|NCT04188301|594961183|FG001|Month 12|Death|1|||
164463448|NCT04585815|594068679|FG001|Sub-study A- Follow-up Phase|Death|1|||
164463449|NCT04585815|594068680|FG002|Sub-study A- Follow-up Phase|Death|0|||
164463450|NCT04585815|594068681|FG003|Sub-study A- Follow-up Phase|Death|0|||
164463451|NCT04585815|594068682|FG004|Sub-study A- Follow-up Phase|Death|0|||
164463452|NCT04585815|594068683|FG005|Sub-study A- Follow-up Phase|Death|0|||
164463453|NCT04585815|594068684|FG006|Sub-study A- Follow-up Phase|Death|0|||
164463454|NCT04585815|594068678|FG000|Sub-study A- Follow-up Phase|Study terminated by sponsor|1|||
164463455|NCT04585815|594068679|FG001|Sub-study A- Follow-up Phase|Study terminated by sponsor|3|||
164463456|NCT04585815|594068680|FG002|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
164463457|NCT04585815|594068681|FG003|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
164412796|NCT03287414|593882331|FG001|Treatment Epoch|Study terminated by sponsor|2|||
164463458|NCT04585815|594068682|FG004|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
164412797|NCT03287414|593882330|FG000|Treatment Epoch|Subject/Guardian decision|4|||
164412798|NCT03287414|593882331|FG001|Treatment Epoch|Subject/Guardian decision|0|||
164412799|NCT03287414|593882330|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
164412800|NCT03287414|593882331|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
164412801|NCT03287414|593882330|FG000|Treatment Epoch|Withdrawal by Subject|1|||
164412802|NCT03287414|593882331|FG001|Treatment Epoch|Withdrawal by Subject|0|||
164412803|NCT03287414|593882330|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
164412804|NCT03287414|593882331|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
164412805|NCT03287414|593882330|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
164412806|NCT03287414|593882331|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
164412807|NCT02569710|593882336|FG000|Overall Study|Adverse Event|1|||
164412808|NCT02569710|593882337|FG001|Overall Study|Adverse Event|0|||
164412809|NCT02569710|593882338|FG002|Overall Study|Adverse Event|0|||
164412810|NCT02569710|593882339|FG003|Overall Study|Adverse Event|0|||
164412811|NCT02569710|593882340|FG004|Overall Study|Adverse Event|0|||
164412812|NCT02569710|593882341|FG005|Overall Study|Adverse Event|0|||
164412813|NCT02569710|593882342|FG006|Overall Study|Adverse Event|0|||
164412814|NCT02569710|593882343|FG007|Overall Study|Adverse Event|0|||
164412815|NCT02569710|593882344|FG008|Overall Study|Adverse Event|0|||
164412816|NCT02569710|593882345|FG009|Overall Study|Adverse Event|0|||
164412817|NCT02569710|593882336|FG000|Overall Study|Lost to Follow-up|0|||
164412818|NCT02569710|593882337|FG001|Overall Study|Lost to Follow-up|0|||
164412819|NCT02569710|593882338|FG002|Overall Study|Lost to Follow-up|0|||
164412820|NCT02569710|593882339|FG003|Overall Study|Lost to Follow-up|0|||
164412821|NCT02569710|593882340|FG004|Overall Study|Lost to Follow-up|0|||
164412822|NCT02569710|593882341|FG005|Overall Study|Lost to Follow-up|0|||
164412823|NCT02569710|593882342|FG006|Overall Study|Lost to Follow-up|1|||
164412824|NCT02569710|593882343|FG007|Overall Study|Lost to Follow-up|0|||
164412825|NCT02569710|593882344|FG008|Overall Study|Lost to Follow-up|1|||
164412826|NCT02569710|593882345|FG009|Overall Study|Lost to Follow-up|0|||
164412827|NCT02569710|593882336|FG000|Overall Study|Virologic failure|0|||
164412828|NCT02569710|593882337|FG001|Overall Study|Virologic failure|0|||
164412829|NCT02569710|593882338|FG002|Overall Study|Virologic failure|0|||
164412830|NCT02569710|593882339|FG003|Overall Study|Virologic failure|0|||
164412831|NCT02569710|593882340|FG004|Overall Study|Virologic failure|1|||
164412832|NCT02569710|593882341|FG005|Overall Study|Virologic failure|0|||
164412833|NCT02569710|593882342|FG006|Overall Study|Virologic failure|1|||
164412834|NCT02569710|593882343|FG007|Overall Study|Virologic failure|0|||
164412835|NCT02569710|593882344|FG008|Overall Study|Virologic failure|0|||
164412836|NCT02569710|593882345|FG009|Overall Study|Virologic failure|0|||
164412837|NCT02569710|593882336|FG000|Overall Study|Withdrawal by Subject|0|||
164412838|NCT02569710|593882337|FG001|Overall Study|Withdrawal by Subject|0|||
164412839|NCT02569710|593882338|FG002|Overall Study|Withdrawal by Subject|0|||
164412840|NCT02569710|593882339|FG003|Overall Study|Withdrawal by Subject|0|||
164412841|NCT02569710|593882340|FG004|Overall Study|Withdrawal by Subject|0|||
164412842|NCT02569710|593882341|FG005|Overall Study|Withdrawal by Subject|1|||
164412843|NCT02569710|593882342|FG006|Overall Study|Withdrawal by Subject|0|||
164412844|NCT02569710|593882343|FG007|Overall Study|Withdrawal by Subject|0|||
164412845|NCT02569710|593882344|FG008|Overall Study|Withdrawal by Subject|0|||
164463459|NCT04585815|594068683|FG005|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
164463460|NCT04585815|594068684|FG006|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
164463461|NCT04585815|594068678|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
164463462|NCT04585815|594068679|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
164463463|NCT04585815|594068680|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
164412846|NCT02569710|593882345|FG009|Overall Study|Withdrawal by Subject|0|||
164412847|NCT02946918|593882346|FG000|Overall Study|Patient unblinded himself|1|||
164412848|NCT02946918|593882347|FG001|Overall Study|Patient unblinded himself|0|||
164412849|NCT02946918|593882346|FG000|Overall Study|Physician Decision|0|||
164412850|NCT02946918|593882347|FG001|Overall Study|Physician Decision|2|||
164412851|NCT02946918|593882346|FG000|Overall Study|Ran out of study medication|0|||
164412852|NCT02946918|593882347|FG001|Overall Study|Ran out of study medication|1|||
164412853|NCT03203694|593882354|FG000|Overall Study|Withdrawal by Subject|2|||
164412854|NCT03203694|593882355|FG001|Overall Study|Withdrawal by Subject|0|||
164709883|NCT04188301|594961184|FG002|Month 12|Death|0|||
164709884|NCT04188301|594961182|FG000|Month 18|Lost to Follow-up|6|||
164709885|NCT04188301|594961183|FG001|Month 18|Lost to Follow-up|0|||
164709886|NCT04188301|594961184|FG002|Month 18|Lost to Follow-up|0|||
164709887|NCT01770392|594961185|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
164709888|NCT03401450|594961186|FG000|Overall Study|Lost to Follow-up|4|||
164709889|NCT03401450|594961187|FG001|Overall Study|Lost to Follow-up|6|||
164709890|NCT03401450|594961186|FG000|Overall Study|Anesthesia plan changed|2|||
164709891|NCT03401450|594961187|FG001|Overall Study|Anesthesia plan changed|2|||
164709892|NCT03401450|594961186|FG000|Overall Study|Did not complete medication diary|4|||
164709893|NCT03401450|594961187|FG001|Overall Study|Did not complete medication diary|2|||
164709894|NCT03401450|594961186|FG000|Overall Study|post surgery medication change|2|||
164709895|NCT03401450|594961187|FG001|Overall Study|post surgery medication change|1|||
164709896|NCT03401450|594961186|FG000|Overall Study|Cancelled surgery|0|||
164709897|NCT03401450|594961187|FG001|Overall Study|Cancelled surgery|2|||
164709898|NCT00228423|594961188|FG000|Overall Study|Adverse Event|2|||
164709899|NCT00228423|594961189|FG001|Overall Study|Adverse Event|5|||
164709900|NCT00228423|594961188|FG000|Overall Study|Withdrawal by Subject|7|||
164412855|NCT03203694|593882356|FG002|Overall Study|Withdrawal by Subject|0|||
164412856|NCT03203694|593882357|FG003|Overall Study|Withdrawal by Subject|0|||
164412857|NCT03203694|593882358|FG004|Overall Study|Withdrawal by Subject|0|||
164412858|NCT03203694|593882359|FG005|Overall Study|Withdrawal by Subject|0|||
164412859|NCT01923896|593884151|FG000|Overall Study|Adverse Event|1|||
164412860|NCT01923896|593884152|FG001|Overall Study|Adverse Event|0|||
164412861|NCT03545113|593884155|FG000|Overall Study|Surgery Cancelled|1|||
164412862|NCT03545113|593884156|FG001|Overall Study|Surgery Cancelled|0|||
164412863|NCT03545113|593884155|FG000|Overall Study|Death|1|||
164412864|NCT03545113|593884156|FG001|Overall Study|Death|0|||
164412865|NCT03545113|593884155|FG000|Overall Study|Adverse Event|2|||
164412866|NCT03545113|593884156|FG001|Overall Study|Adverse Event|0|||
164412867|NCT03545113|593884155|FG000|Overall Study|Received different surgery|1|||
164412868|NCT03545113|593884156|FG001|Overall Study|Received different surgery|0|||
164412869|NCT00235443|593884157|FG000|Overall Study|Adverse Event|4|||
164412870|NCT00235443|593884158|FG001|Overall Study|Adverse Event|12|||
164412871|NCT00235443|593884159|FG002|Overall Study|Adverse Event|17|||
164412872|NCT00235443|593884160|FG003|Overall Study|Adverse Event|44|||
164412873|NCT00235443|593884161|FG004|Overall Study|Adverse Event|10|||
164412874|NCT00235443|593884162|FG005|Overall Study|Adverse Event|15|||
164412875|NCT00235443|593884157|FG000|Overall Study|Lack of Efficacy|0|||
164412876|NCT00235443|593884158|FG001|Overall Study|Lack of Efficacy|1|||
164412877|NCT00235443|593884159|FG002|Overall Study|Lack of Efficacy|5|||
164412878|NCT00235443|593884160|FG003|Overall Study|Lack of Efficacy|12|||
164412879|NCT00235443|593884161|FG004|Overall Study|Lack of Efficacy|2|||
164412880|NCT00235443|593884162|FG005|Overall Study|Lack of Efficacy|9|||
164412881|NCT00235443|593884157|FG000|Overall Study|Withdrawal by Subject|3|||
164412882|NCT00235443|593884158|FG001|Overall Study|Withdrawal by Subject|9|||
164412883|NCT00235443|593884159|FG002|Overall Study|Withdrawal by Subject|25|||
164412884|NCT00235443|593884160|FG003|Overall Study|Withdrawal by Subject|24|||
164412885|NCT00235443|593884161|FG004|Overall Study|Withdrawal by Subject|10|||
164412886|NCT00235443|593884162|FG005|Overall Study|Withdrawal by Subject|12|||
164412887|NCT00235443|593884157|FG000|Overall Study|Lost to Follow-up|0|||
164412888|NCT00235443|593884158|FG001|Overall Study|Lost to Follow-up|8|||
164412889|NCT00235443|593884159|FG002|Overall Study|Lost to Follow-up|6|||
164412890|NCT00235443|593884160|FG003|Overall Study|Lost to Follow-up|6|||
164412891|NCT00235443|593884161|FG004|Overall Study|Lost to Follow-up|4|||
164412892|NCT00235443|593884162|FG005|Overall Study|Lost to Follow-up|3|||
164412893|NCT00235443|593884157|FG000|Overall Study|Unsatisfactory compliance|0|||
164412894|NCT00235443|593884158|FG001|Overall Study|Unsatisfactory compliance|2|||
164412895|NCT00235443|593884159|FG002|Overall Study|Unsatisfactory compliance|3|||
164412896|NCT00235443|593884160|FG003|Overall Study|Unsatisfactory compliance|4|||
164412897|NCT00235443|593884161|FG004|Overall Study|Unsatisfactory compliance|1|||
164412898|NCT00235443|593884162|FG005|Overall Study|Unsatisfactory compliance|0|||
164412899|NCT00235443|593884157|FG000|Overall Study|Other reasons for premature termination|1|||
164412900|NCT00235443|593884158|FG001|Overall Study|Other reasons for premature termination|6|||
164412901|NCT00235443|593884159|FG002|Overall Study|Other reasons for premature termination|6|||
164412902|NCT00235443|593884160|FG003|Overall Study|Other reasons for premature termination|7|||
164412903|NCT00235443|593884161|FG004|Overall Study|Other reasons for premature termination|3|||
164412904|NCT00235443|593884162|FG005|Overall Study|Other reasons for premature termination|6|||
164412905|NCT00474929|593884166|FG000|Overall Study|Withdrawal by Subject|0|||
164412906|NCT00474929|593884167|FG001|Overall Study|Withdrawal by Subject|1|||
164412907|NCT00474929|593884168|FG002|Overall Study|Withdrawal by Subject|0|||
164709901|NCT00228423|594961189|FG001|Overall Study|Withdrawal by Subject|3|||
164709902|NCT00228423|594961188|FG000|Overall Study|Protocol Violation|1|||
164412908|NCT00474929|593884169|FG003|Overall Study|Withdrawal by Subject|0|||
164412909|NCT00474929|593884170|FG004|Overall Study|Withdrawal by Subject|0|||
164463464|NCT04585815|594068681|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
164463465|NCT04585815|594068682|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
164463466|NCT04585815|594068683|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
164463467|NCT04585815|594068684|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
164463468|NCT04585815|594068678|FG000|Sub-study B- Treatment Phase|Death|0|||
164463469|NCT04585815|594068679|FG001|Sub-study B- Treatment Phase|Death|0|||
164463470|NCT04585815|594068680|FG002|Sub-study B- Treatment Phase|Death|0|||
164463471|NCT04585815|594068681|FG003|Sub-study B- Treatment Phase|Death|1|||
164463472|NCT04585815|594068682|FG004|Sub-study B- Treatment Phase|Death|0|||
164463473|NCT04585815|594068683|FG005|Sub-study B- Treatment Phase|Death|0|||
164463474|NCT04585815|594068684|FG006|Sub-study B- Treatment Phase|Death|0|||
164463475|NCT04585815|594068678|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
164463476|NCT04585815|594068679|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
164463477|NCT04585815|594068680|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
164463478|NCT04585815|594068681|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
164463479|NCT04585815|594068682|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
164463480|NCT04585815|594068683|FG005|Sub-study B- Treatment Phase|Progressive disease|1|||
164463481|NCT04585815|594068684|FG006|Sub-study B- Treatment Phase|Progressive disease|5|||
164463482|NCT04585815|594068678|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
164463483|NCT04585815|594068679|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
164463484|NCT04585815|594068680|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
164463485|NCT04585815|594068681|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
164463486|NCT04585815|594068682|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
164463487|NCT04585815|594068683|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
164463488|NCT04585815|594068684|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
164463489|NCT04585815|594068678|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
164463490|NCT04585815|594068679|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
164463491|NCT04585815|594068680|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
164463492|NCT04585815|594068681|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
164463493|NCT04585815|594068682|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
164463494|NCT04585815|594068683|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
164463495|NCT04585815|594068684|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
164463496|NCT04585815|594068678|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
164463497|NCT04585815|594068679|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
164463498|NCT04585815|594068680|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
164463499|NCT04585815|594068681|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
164463500|NCT04585815|594068682|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
164463501|NCT04585815|594068683|FG005|Sub-study B- Treatment Phase|Physician Decision|0|||
164463502|NCT04585815|594068684|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
164463503|NCT04585815|594068678|FG000|Sub-study B- Follow-up Phase|Death|0|||
164463504|NCT04585815|594068679|FG001|Sub-study B- Follow-up Phase|Death|0|||
164463505|NCT04585815|594068680|FG002|Sub-study B- Follow-up Phase|Death|1|||
164463506|NCT04585815|594068681|FG003|Sub-study B- Follow-up Phase|Death|3|||
164463507|NCT04585815|594068682|FG004|Sub-study B- Follow-up Phase|Death|1|||
164463508|NCT04585815|594068683|FG005|Sub-study B- Follow-up Phase|Death|0|||
164463509|NCT04585815|594068684|FG006|Sub-study B- Follow-up Phase|Death|3|||
164463510|NCT04585815|594068678|FG000|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
164463511|NCT04585815|594068679|FG001|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
164463512|NCT04585815|594068680|FG002|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
164709903|NCT00228423|594961189|FG001|Overall Study|Protocol Violation|3|||
164709904|NCT00228423|594961188|FG000|Overall Study|Physician Decision|0|||
164709905|NCT00228423|594961189|FG001|Overall Study|Physician Decision|1|||
164709906|NCT04639713|594961204|FG000|Overall Study|Protocol Noncompliance|2|||
164412910|NCT00474929|593884166|FG000|Overall Study|Unrelated medical condition|0|||
164412911|NCT00474929|593884167|FG001|Overall Study|Unrelated medical condition|0|||
164412912|NCT00474929|593884168|FG002|Overall Study|Unrelated medical condition|1|||
164412913|NCT00474929|593884169|FG003|Overall Study|Unrelated medical condition|0|||
164709907|NCT04639713|594961204|FG000|Overall Study|Withdrawal by Subject|1|||
164709908|NCT00191113|594962799|FG000|Core Study|Withdrawal by Subject|25|||
164412914|NCT00474929|593884170|FG004|Overall Study|Unrelated medical condition|0|||
164412915|NCT00474929|593884166|FG000|Overall Study|Physician Decision|0|||
164412916|NCT00474929|593884167|FG001|Overall Study|Physician Decision|0|||
164412917|NCT00474929|593884168|FG002|Overall Study|Physician Decision|1|||
164412918|NCT00474929|593884169|FG003|Overall Study|Physician Decision|2|||
164463513|NCT04585815|594068681|FG003|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
164463514|NCT04585815|594068682|FG004|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
164463515|NCT04585815|594068683|FG005|Sub-study B- Follow-up Phase|Study terminated by sponsor|1|||
164463516|NCT04585815|594068684|FG006|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
164463517|NCT01854775|594068685|FG000|Treatment Phase (48 Weeks)|Withdrew consent|1|||
164412919|NCT00474929|593884170|FG004|Overall Study|Physician Decision|0|||
164412920|NCT03321513|593884173|FG000|Overall Study|Death|11|||
164412921|NCT03321513|593884174|FG001|Overall Study|Death|5|||
164412922|NCT03321513|593884173|FG000|Overall Study|Withdrawal by Subject|5|||
164412923|NCT03321513|593884174|FG001|Overall Study|Withdrawal by Subject|10|||
164412924|NCT03321513|593884173|FG000|Overall Study|Lost to Follow-up|10|||
164412925|NCT03321513|593884174|FG001|Overall Study|Lost to Follow-up|11|||
164412926|NCT03029247|593884175|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
164412927|NCT03029247|593884176|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
164412928|NCT03029247|593884175|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
164412929|NCT03029247|593884176|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
164412930|NCT03029247|593884175|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
164412931|NCT03029247|593884176|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
164412932|NCT03029247|593884175|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
164412933|NCT03029247|593884176|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
164412934|NCT02593305|593884177|FG000|Post 1|Comparison only group. No intervention.|0|||
164412935|NCT02593305|593884178|FG001|Post 1|Comparison only group. No intervention.|0|||
164412936|NCT02593305|593884179|FG002|Post 1|Comparison only group. No intervention.|10|||
164412937|NCT02757521|593884180|FG000|Overall Study|Adverse Event|1|||
164412938|NCT02757521|593884181|FG001|Overall Study|Adverse Event|0|||
164412939|NCT00798174|593884185|FG000|Overall Study|inability to implant azygos coil|3|||
164412940|NCT00798174|593884186|FG001|Overall Study|inability to implant azygos coil|3|||
164412941|NCT00798174|593884185|FG000|Overall Study|Inability to sedate for DFT testing|1|||
164412942|NCT00798174|593884186|FG001|Overall Study|Inability to sedate for DFT testing|0|||
164463518|NCT01854775|594068686|FG001|Treatment Phase (48 Weeks)|Withdrew consent|1|||
164463519|NCT01854775|594068687|FG002|Treatment Phase (48 Weeks)|Withdrew consent|0|||
164463520|NCT01854775|594068685|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
164463521|NCT01854775|594068686|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
164463522|NCT01854775|594068687|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
164463523|NCT01854775|594068685|FG000|Extension Phase|Pregnancy|1|||
164463524|NCT01854775|594068686|FG001|Extension Phase|Pregnancy|0|||
164463525|NCT01854775|594068687|FG002|Extension Phase|Pregnancy|0|||
164463526|NCT01854775|594068685|FG000|Extension Phase|Investigator's Discretion|1|||
164463527|NCT01854775|594068686|FG001|Extension Phase|Investigator's Discretion|0|||
164463528|NCT01854775|594068687|FG002|Extension Phase|Investigator's Discretion|0|||
164463529|NCT01854775|594068685|FG000|Extension Phase|Non-Compliance with study drug|1|||
164463530|NCT01854775|594068686|FG001|Extension Phase|Non-Compliance with study drug|0|||
164463531|NCT01854775|594068687|FG002|Extension Phase|Non-Compliance with study drug|0|||
164463532|NCT01854775|594068685|FG000|Extension Phase|Lost to Follow-up|1|||
164463533|NCT01854775|594068686|FG001|Extension Phase|Lost to Follow-up|0|||
164463534|NCT01854775|594068687|FG002|Extension Phase|Lost to Follow-up|0|||
164463535|NCT01854775|594068685|FG000|Extension Phase|Withdrew consent|0|||
164463536|NCT01854775|594068686|FG001|Extension Phase|Withdrew consent|1|||
164463537|NCT01854775|594068687|FG002|Extension Phase|Withdrew consent|0|||
164709909|NCT00191113|594962800|FG001|Core Study|Withdrawal by Subject|9|||
164709910|NCT00191113|594962799|FG000|Core Study|Protocol Violation|6|||
164709911|NCT00191113|594962800|FG001|Core Study|Protocol Violation|2|||
164709912|NCT00191113|594962799|FG000|Core Study|Lost to Follow-up|3|||
164709913|NCT00191113|594962800|FG001|Core Study|Lost to Follow-up|0|||
164709914|NCT00191113|594962799|FG000|Core Study|Adverse Event|0|||
164709915|NCT00191113|594962800|FG001|Core Study|Adverse Event|2|||
164709916|NCT00191113|594962799|FG000|Core Study|Lack of Efficacy|0|||
164709917|NCT00191113|594962800|FG001|Core Study|Lack of Efficacy|2|||
164709918|NCT00191113|594962799|FG000|Core Study|Death|1|||
164709919|NCT00191113|594962800|FG001|Core Study|Death|0|||
164709920|NCT01555671|594962801|FG000|Overall Study|Physician Decision|20|||
164709921|NCT01555671|594962802|FG001|Overall Study|Physician Decision|25|||
164709922|NCT00631657|594962803|FG000|6-Month Treatment Period|Adverse Event|47|||
164709923|NCT00631657|594962804|FG001|6-Month Treatment Period|Adverse Event|0|||
164412943|NCT01683994|593884205|FG000|Overall Study|Withdrawal by Subject|1|||
164463538|NCT02068885|594068688|FG000|Overall Study|Withdrew|3|||
164463539|NCT02068885|594068689|FG001|Overall Study|Withdrew|5|||
164463540|NCT02068885|594068690|FG002|Overall Study|Withdrew|8|||
164709924|NCT00631657|594962805|FG002|6-Month Treatment Period|Adverse Event|7|||
164709925|NCT00631657|594962803|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
164709926|NCT00631657|594962804|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
164412944|NCT01683994|593884206|FG001|Overall Study|Withdrawal by Subject|0|||
164463541|NCT03100149|594068695|FG000|Overall Study|Adverse Event|0|||
164463542|NCT03100149|594068696|FG001|Overall Study|Adverse Event|1|||
164463543|NCT03100149|594068697|FG002|Overall Study|Adverse Event|0|||
164463544|NCT03100149|594068695|FG000|Overall Study|Participant Moved out of Country|0|||
164463545|NCT03100149|594068696|FG001|Overall Study|Participant Moved out of Country|0|||
164412945|NCT01683994|593884207|FG002|Overall Study|Withdrawal by Subject|0|||
164412946|NCT01683994|593884208|FG003|Overall Study|Withdrawal by Subject|1|||
164412947|NCT01683994|593884209|FG004|Overall Study|Withdrawal by Subject|0|||
164709927|NCT00631657|594962805|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
164412948|NCT01683994|593884205|FG000|Overall Study|Intercurrent illness|0|||
164412949|NCT01683994|593884206|FG001|Overall Study|Intercurrent illness|0|||
164412950|NCT01683994|593884207|FG002|Overall Study|Intercurrent illness|0|||
164412951|NCT01683994|593884208|FG003|Overall Study|Intercurrent illness|2|||
164412952|NCT01683994|593884209|FG004|Overall Study|Intercurrent illness|1|||
164412953|NCT00999661|593884210|FG000|Overall Study|Lost to Follow-up|59|||
164412954|NCT00999661|593884210|FG000|Overall Study|Adverse Event|1|||
164412955|NCT00999661|593884210|FG000|Overall Study|Withdrawal by Subject|1|||
164412956|NCT00999661|593884210|FG000|Overall Study|Not meeting eligibility criteria|9|||
164412957|NCT00312858|593884214|FG000|Overall Study|Adverse Event|0|||
164412958|NCT00312858|593884215|FG001|Overall Study|Adverse Event|1|||
164412959|NCT00312858|593884214|FG000|Overall Study|Lost to Follow-up|25|||
164412960|NCT00312858|593884215|FG001|Overall Study|Lost to Follow-up|42|||
164412961|NCT00312858|593884214|FG000|Overall Study|Protocol Violation|3|||
164412962|NCT00312858|593884215|FG001|Overall Study|Protocol Violation|8|||
164412963|NCT00312858|593884214|FG000|Overall Study|Withdraw by Participant|20|||
164412964|NCT00312858|593884215|FG001|Overall Study|Withdraw by Participant|20|||
164412965|NCT00312858|593884214|FG000|Overall Study|Participant Moved|11|||
164412966|NCT00312858|593884215|FG001|Overall Study|Participant Moved|10|||
164412967|NCT00312858|593884214|FG000|Overall Study|Other|9|||
164412968|NCT00312858|593884215|FG001|Overall Study|Other|12|||
164412969|NCT02318719|593884218|FG000|Double-blind Phase|Adverse Event|7|||
164412970|NCT02318719|593884219|FG001|Double-blind Phase|Adverse Event|6|||
164709928|NCT00631657|594962803|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
164709929|NCT00631657|594962804|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
164709930|NCT00631657|594962805|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
164412971|NCT02318719|593884220|FG002|Double-blind Phase|Adverse Event|12|||
164412972|NCT02318719|593884221|FG003|Double-blind Phase|Adverse Event|4|||
164412973|NCT02318719|593884222|FG004|Double-blind Phase|Adverse Event|0|||
164412974|NCT02318719|593884218|FG000|Double-blind Phase|Lack of Efficacy|5|||
164412975|NCT02318719|593884219|FG001|Double-blind Phase|Lack of Efficacy|0|||
164412976|NCT02318719|593884220|FG002|Double-blind Phase|Lack of Efficacy|1|||
164412977|NCT02318719|593884221|FG003|Double-blind Phase|Lack of Efficacy|1|||
164412978|NCT02318719|593884222|FG004|Double-blind Phase|Lack of Efficacy|0|||
164412979|NCT02318719|593884218|FG000|Double-blind Phase|Protocol Violation|0|||
164412980|NCT02318719|593884219|FG001|Double-blind Phase|Protocol Violation|1|||
164412981|NCT02318719|593884220|FG002|Double-blind Phase|Protocol Violation|3|||
164412982|NCT02318719|593884221|FG003|Double-blind Phase|Protocol Violation|0|||
164412983|NCT02318719|593884222|FG004|Double-blind Phase|Protocol Violation|0|||
164412984|NCT02318719|593884218|FG000|Double-blind Phase|Withdrawal by Subject|25|||
164412985|NCT02318719|593884219|FG001|Double-blind Phase|Withdrawal by Subject|7|||
164412986|NCT02318719|593884220|FG002|Double-blind Phase|Withdrawal by Subject|9|||
164412987|NCT02318719|593884221|FG003|Double-blind Phase|Withdrawal by Subject|10|||
164412988|NCT02318719|593884222|FG004|Double-blind Phase|Withdrawal by Subject|0|||
164412989|NCT02318719|593884218|FG000|Double-blind Phase|Other|1|||
164412990|NCT02318719|593884219|FG001|Double-blind Phase|Other|2|||
164412991|NCT02318719|593884220|FG002|Double-blind Phase|Other|0|||
164412992|NCT02318719|593884221|FG003|Double-blind Phase|Other|0|||
164412993|NCT02318719|593884222|FG004|Double-blind Phase|Other|0|||
164412994|NCT02318719|593884218|FG000|Open-label Extension Phase|Adverse Event|0|||
164412995|NCT02318719|593884219|FG001|Open-label Extension Phase|Adverse Event|0|||
164412996|NCT02318719|593884220|FG002|Open-label Extension Phase|Adverse Event|0|||
164412997|NCT02318719|593884221|FG003|Open-label Extension Phase|Adverse Event|0|||
164412998|NCT02318719|593884222|FG004|Open-label Extension Phase|Adverse Event|15|||
164412999|NCT02318719|593884218|FG000|Open-label Extension Phase|Death|0|||
164413000|NCT02318719|593884219|FG001|Open-label Extension Phase|Death|0|||
164413001|NCT02318719|593884220|FG002|Open-label Extension Phase|Death|0|||
164413002|NCT02318719|593884221|FG003|Open-label Extension Phase|Death|0|||
164413003|NCT02318719|593884222|FG004|Open-label Extension Phase|Death|1|||
164413004|NCT02318719|593884218|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
164709931|NCT00631657|594962803|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
164709932|NCT00631657|594962804|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
164413005|NCT02318719|593884219|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
164413006|NCT02318719|593884220|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
164413007|NCT02318719|593884221|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
164413008|NCT02318719|593884222|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
164413009|NCT02318719|593884218|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
164709933|NCT00631657|594962805|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
164413010|NCT02318719|593884219|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
164413011|NCT02318719|593884220|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
164413012|NCT02318719|593884221|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
164413013|NCT02318719|593884222|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
164709934|NCT00631657|594962803|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
164413014|NCT02318719|593884218|FG000|Open-label Extension Phase|Other|0|||
164413015|NCT02318719|593884219|FG001|Open-label Extension Phase|Other|0|||
164413016|NCT02318719|593884220|FG002|Open-label Extension Phase|Other|0|||
164413017|NCT02318719|593884221|FG003|Open-label Extension Phase|Other|0|||
164709935|NCT00631657|594962804|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
164709936|NCT00631657|594962805|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
164709937|NCT00631657|594962803|FG000|6-Month Treatment Period|Other|16|||
164709938|NCT00631657|594962804|FG001|6-Month Treatment Period|Other|0|||
164709939|NCT00631657|594962805|FG002|6-Month Treatment Period|Other|4|||
164413018|NCT02318719|593884222|FG004|Open-label Extension Phase|Other|7|||
164413019|NCT00854295|593884226|FG000|Overall Study|Death|7|||
164413020|NCT00854295|593884227|FG001|Overall Study|Death|0|||
164413021|NCT00854295|593884228|FG002|Overall Study|Death|1|||
164413022|NCT00854295|593884229|FG003|Overall Study|Death|1|||
164413023|NCT00854295|593884226|FG000|Overall Study|Adverse Event|6|||
164413024|NCT00854295|593884227|FG001|Overall Study|Adverse Event|1|||
164413025|NCT00854295|593884228|FG002|Overall Study|Adverse Event|1|||
164413026|NCT00854295|593884229|FG003|Overall Study|Adverse Event|3|||
164413027|NCT00854295|593884226|FG000|Overall Study|Lost to Follow-up|18|||
164413028|NCT00854295|593884227|FG001|Overall Study|Lost to Follow-up|5|||
164413029|NCT00854295|593884228|FG002|Overall Study|Lost to Follow-up|21|||
164413030|NCT00854295|593884229|FG003|Overall Study|Lost to Follow-up|21|||
164413031|NCT00854295|593884226|FG000|Overall Study|Physician Decision|10|||
164413032|NCT00854295|593884227|FG001|Overall Study|Physician Decision|0|||
164413033|NCT00854295|593884228|FG002|Overall Study|Physician Decision|0|||
164413034|NCT00854295|593884229|FG003|Overall Study|Physician Decision|0|||
164413035|NCT02440594|593884230|FG000|Overall Study|Lost to Follow-up|34|||
164413036|NCT02440594|593884231|FG001|Overall Study|Lost to Follow-up|33|||
164413037|NCT02440594|593884232|FG002|Overall Study|Lost to Follow-up|54|||
164413038|NCT02440594|593884233|FG003|Overall Study|Lost to Follow-up|47|||
164413039|NCT02440594|593884234|FG004|Overall Study|Lost to Follow-up|5|||
164413040|NCT02440594|593884235|FG005|Overall Study|Lost to Follow-up|4|||
164413041|NCT02440594|593884236|FG006|Overall Study|Lost to Follow-up|28|||
164413042|NCT02440594|593884237|FG007|Overall Study|Lost to Follow-up|48|||
164413043|NCT02440594|593884230|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
164413044|NCT02440594|593884231|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
164413045|NCT02440594|593884232|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
164413046|NCT02440594|593884233|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
164413047|NCT02440594|593884234|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
164413048|NCT02440594|593884235|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
164413049|NCT02440594|593884236|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
164413050|NCT02440594|593884237|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
164413051|NCT02440594|593884230|FG000|Overall Study|Withdrawal by Subject|81|||
164413052|NCT02440594|593884231|FG001|Overall Study|Withdrawal by Subject|67|||
164413053|NCT02440594|593884232|FG002|Overall Study|Withdrawal by Subject|59|||
164413054|NCT02440594|593884233|FG003|Overall Study|Withdrawal by Subject|38|||
164413055|NCT02440594|593884234|FG004|Overall Study|Withdrawal by Subject|2|||
164413056|NCT02440594|593884235|FG005|Overall Study|Withdrawal by Subject|2|||
164413057|NCT02440594|593884236|FG006|Overall Study|Withdrawal by Subject|7|||
164413058|NCT02440594|593884237|FG007|Overall Study|Withdrawal by Subject|7|||
164413059|NCT02440594|593884230|FG000|Overall Study|Administratively w/drawn|3|||
164413060|NCT02440594|593884231|FG001|Overall Study|Administratively w/drawn|2|||
164413061|NCT02440594|593884232|FG002|Overall Study|Administratively w/drawn|0|||
164413062|NCT02440594|593884233|FG003|Overall Study|Administratively w/drawn|0|||
164413063|NCT02440594|593884234|FG004|Overall Study|Administratively w/drawn|0|||
164413064|NCT02440594|593884235|FG005|Overall Study|Administratively w/drawn|0|||
164413065|NCT02440594|593884236|FG006|Overall Study|Administratively w/drawn|2|||
164413066|NCT02440594|593884237|FG007|Overall Study|Administratively w/drawn|1|||
164413067|NCT00152763|593884238|FG000|Overall Study|Death|4|||
164413068|NCT00152763|593884239|FG001|Overall Study|Death|1|||
164413069|NCT00152763|593884240|FG002|Overall Study|Death|2|||
164413070|NCT00152763|593884241|FG003|Overall Study|Death|1|||
164413071|NCT00152763|593884238|FG000|Overall Study|Lost to Follow-up|6|||
164413072|NCT00152763|593884239|FG001|Overall Study|Lost to Follow-up|4|||
164413073|NCT00152763|593884240|FG002|Overall Study|Lost to Follow-up|2|||
164413074|NCT00152763|593884241|FG003|Overall Study|Lost to Follow-up|13|||
164413075|NCT01622348|593884242|FG000|Overall Study|Withdrawal by Subject|1|||
164413076|NCT01622348|593884243|FG001|Overall Study|Withdrawal by Subject|0|||
164413077|NCT01622348|593884244|FG002|Overall Study|Withdrawal by Subject|1|||
164413078|NCT00474175|593884247|FG000|Overall Study|Lack of Efficacy|0|||
164413079|NCT00474175|593884248|FG001|Overall Study|Lack of Efficacy|0|||
164413080|NCT00474175|593884249|FG002|Overall Study|Lack of Efficacy|1|||
164413081|NCT00474175|593884247|FG000|Overall Study|Withdrawal by Subject|0|||
164413082|NCT00474175|593884248|FG001|Overall Study|Withdrawal by Subject|1|||
164413083|NCT00474175|593884249|FG002|Overall Study|Withdrawal by Subject|1|||
164413084|NCT00474175|593884247|FG000|Overall Study|Ineligible|1|||
164413085|NCT00474175|593884248|FG001|Overall Study|Ineligible|3|||
164413086|NCT00474175|593884249|FG002|Overall Study|Ineligible|1|||
164413087|NCT00474175|593884247|FG000|Overall Study|Protocol Violation|0|||
164413088|NCT00474175|593884248|FG001|Overall Study|Protocol Violation|2|||
164413089|NCT00474175|593884249|FG002|Overall Study|Protocol Violation|1|||
164709940|NCT00631657|594962803|FG000|6-Month Treatment Period|Not Treated|2|||
164709941|NCT00631657|594962804|FG001|6-Month Treatment Period|Not Treated|0|||
164709942|NCT00631657|594962805|FG002|6-Month Treatment Period|Not Treated|1|||
164709943|NCT00631657|594962803|FG000|7-Day Discontinuation Period|Not Treated|1|||
164709944|NCT00631657|594962804|FG001|7-Day Discontinuation Period|Not Treated|1|||
164709945|NCT00631657|594962805|FG002|7-Day Discontinuation Period|Not Treated|1|||
164709946|NCT00631657|594962803|FG000|7-Day Discontinuation Period|Other|1|||
164413090|NCT00474175|593884247|FG000|Overall Study|Administrative|0|||
164413091|NCT00474175|593884248|FG001|Overall Study|Administrative|1|||
164413092|NCT00474175|593884249|FG002|Overall Study|Administrative|0|||
164413093|NCT01619787|593884250|FG000|Overall Study|Lost to Follow-up|5|||
164413094|NCT04537897|593884251|FG000|Overall Study|Other than listed|0|||
164413095|NCT04537897|593884252|FG001|Overall Study|Other than listed|0|||
164413096|NCT04537897|593884253|FG002|Overall Study|Other than listed|0|||
164413097|NCT04537897|593884254|FG003|Overall Study|Other than listed|0|||
164413098|NCT04537897|593884255|FG004|Overall Study|Other than listed|0|||
164413099|NCT04537897|593884256|FG005|Overall Study|Other than listed|0|||
164413100|NCT04537897|593884257|FG006|Overall Study|Other than listed|1|||
164413101|NCT04537897|593884258|FG007|Overall Study|Other than listed|0|||
164413102|NCT04537897|593884259|FG008|Overall Study|Other than listed|0|||
164413103|NCT04537897|593884251|FG000|Overall Study|Adverse Event|0|||
164413104|NCT04537897|593884252|FG001|Overall Study|Adverse Event|0|||
164413105|NCT04537897|593884253|FG002|Overall Study|Adverse Event|0|||
164413106|NCT04537897|593884254|FG003|Overall Study|Adverse Event|1|||
164413107|NCT04537897|593884255|FG004|Overall Study|Adverse Event|0|||
164413108|NCT04537897|593884256|FG005|Overall Study|Adverse Event|0|||
164413109|NCT04537897|593884257|FG006|Overall Study|Adverse Event|0|||
164413110|NCT04537897|593884258|FG007|Overall Study|Adverse Event|0|||
164413111|NCT04537897|593884259|FG008|Overall Study|Adverse Event|0|||
164413112|NCT04537897|593884251|FG000|Overall Study|Withdrawal by Subject|0|||
164413113|NCT04537897|593884252|FG001|Overall Study|Withdrawal by Subject|1|||
164413114|NCT04537897|593884253|FG002|Overall Study|Withdrawal by Subject|0|||
164413115|NCT04537897|593884254|FG003|Overall Study|Withdrawal by Subject|0|||
164413116|NCT04537897|593884255|FG004|Overall Study|Withdrawal by Subject|0|||
164413117|NCT04537897|593884256|FG005|Overall Study|Withdrawal by Subject|0|||
164413118|NCT04537897|593884257|FG006|Overall Study|Withdrawal by Subject|0|||
164413119|NCT04537897|593884258|FG007|Overall Study|Withdrawal by Subject|0|||
164413120|NCT04537897|593884259|FG008|Overall Study|Withdrawal by Subject|0|||
164413121|NCT00197028|593884261|FG000|Overall Study|Adverse Event|2|||
164413122|NCT00197028|593884262|FG001|Overall Study|Adverse Event|2|||
164413123|NCT00197028|593884261|FG000|Overall Study|Protocol Violation|2|||
164413124|NCT00197028|593884262|FG001|Overall Study|Protocol Violation|1|||
164413125|NCT00197028|593884261|FG000|Overall Study|Withdrawal by Subject|8|||
164413126|NCT00197028|593884262|FG001|Overall Study|Withdrawal by Subject|12|||
164413127|NCT00197028|593884261|FG000|Overall Study|Lost to Follow-up|1|||
164413128|NCT00197028|593884262|FG001|Overall Study|Lost to Follow-up|0|||
164413129|NCT00197028|593884261|FG000|Overall Study|Other|3|||
164413130|NCT00197028|593884262|FG001|Overall Study|Other|6|||
164413131|NCT03893825|593884263|FG000|Overall Study|Death|2|||
164413132|NCT03893825|593884264|FG001|Overall Study|Death|1|||
164413133|NCT03893825|593884263|FG000|Overall Study|Adverse Event|0|||
164413134|NCT03893825|593884264|FG001|Overall Study|Adverse Event|2|||
164413135|NCT03893825|593884263|FG000|Overall Study|Withdrawal by Subject|19|||
164413136|NCT03893825|593884264|FG001|Overall Study|Withdrawal by Subject|21|||
164413137|NCT03893825|593884263|FG000|Overall Study|Protocol deviation|1|||
164413138|NCT03893825|593884264|FG001|Overall Study|Protocol deviation|0|||
164413139|NCT03893825|593884263|FG000|Overall Study|Lost to Follow-up|10|||
164413140|NCT03893825|593884264|FG001|Overall Study|Lost to Follow-up|10|||
164413141|NCT03893825|593884263|FG000|Overall Study|Other than specified|7|||
164413142|NCT03893825|593884264|FG001|Overall Study|Other than specified|6|||
164413143|NCT04488003|593884267|FG000|Assessed for Eligibility|Screen Failure|24|||
164413144|NCT04488003|593884268|FG001|Assessed for Eligibility|Screen Failure|0|||
164413145|NCT04488003|593884269|FG002|Assessed for Eligibility|Screen Failure|0|||
164413146|NCT04488003|593884267|FG000|Assessed for Eligibility|Adverse Event|1|||
164413147|NCT04488003|593884268|FG001|Assessed for Eligibility|Adverse Event|0|||
164413148|NCT04488003|593884269|FG002|Assessed for Eligibility|Adverse Event|0|||
164413149|NCT04488003|593884267|FG000|Assessed for Eligibility|Death|1|||
164413150|NCT04488003|593884268|FG001|Assessed for Eligibility|Death|0|||
164413151|NCT04488003|593884269|FG002|Assessed for Eligibility|Death|0|||
164413152|NCT04488003|593884267|FG000|Assessed for Eligibility|Physician Decision|1|||
164709947|NCT00631657|594962804|FG001|7-Day Discontinuation Period|Other|0|||
164709948|NCT00631657|594962805|FG002|7-Day Discontinuation Period|Other|0|||
164413153|NCT04488003|593884268|FG001|Assessed for Eligibility|Physician Decision|0|||
164413154|NCT04488003|593884269|FG002|Assessed for Eligibility|Physician Decision|0|||
164413155|NCT04488003|593884267|FG000|Allocated to Treatment|Progressive Disease|51|||
164413156|NCT04488003|593884268|FG001|Allocated to Treatment|Progressive Disease|0|||
164413157|NCT04488003|593884269|FG002|Allocated to Treatment|Progressive Disease|0|||
164709949|NCT02563106|594962806|FG000|Overall Study|Withdrawal by Subject|7|||
164413158|NCT04488003|593884267|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
164413159|NCT04488003|593884268|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
164413160|NCT04488003|593884269|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
164413161|NCT04488003|593884267|FG000|Allocated to Treatment|Adverse Event|6|||
164413162|NCT04488003|593884268|FG001|Allocated to Treatment|Adverse Event|0|||
164413163|NCT04488003|593884269|FG002|Allocated to Treatment|Adverse Event|0|||
164413164|NCT04488003|593884267|FG000|Allocated to Treatment|Other|5|||
164413165|NCT04488003|593884268|FG001|Allocated to Treatment|Other|0|||
164413166|NCT04488003|593884269|FG002|Allocated to Treatment|Other|0|||
164413167|NCT04488003|593884267|FG000|Allocated to Treatment|Physician Decision|4|||
164413168|NCT04488003|593884268|FG001|Allocated to Treatment|Physician Decision|0|||
164413169|NCT04488003|593884269|FG002|Allocated to Treatment|Physician Decision|0|||
164413170|NCT04488003|593884267|FG000|Allocated to Treatment|Death|4|||
164413171|NCT04488003|593884268|FG001|Allocated to Treatment|Death|0|||
164413172|NCT04488003|593884269|FG002|Allocated to Treatment|Death|0|||
164413173|NCT02912468|593884272|FG000|Overall Study|Adverse Event|3|||
164413174|NCT02912468|593884273|FG001|Overall Study|Adverse Event|2|||
164413175|NCT02912468|593884272|FG000|Overall Study|Withdrawal by Subject|6|||
164413176|NCT02912468|593884273|FG001|Overall Study|Withdrawal by Subject|2|||
164413177|NCT02912468|593884272|FG000|Overall Study|Randomized and not treated|0|||
164413178|NCT02912468|593884273|FG001|Overall Study|Randomized and not treated|1|||
164413179|NCT01515189|593884274|FG000|Induction|Disease Progression|109|||
164413180|NCT01515189|593884275|FG001|Induction|Disease Progression|155|||
164413181|NCT01515189|593884274|FG000|Induction|Study drug toxicity|86|||
164413182|NCT01515189|593884275|FG001|Induction|Study drug toxicity|36|||
164413183|NCT01515189|593884274|FG000|Induction|Death|24|||
164413184|NCT01515189|593884275|FG001|Induction|Death|17|||
164413185|NCT01515189|593884274|FG000|Induction|Adverse Event|14|||
164413186|NCT01515189|593884275|FG001|Induction|Adverse Event|9|||
164413187|NCT01515189|593884274|FG000|Induction|Withdrawal by Subject|3|||
164413188|NCT01515189|593884275|FG001|Induction|Withdrawal by Subject|9|||
164413189|NCT01515189|593884274|FG000|Induction|No longer meets study criteria|0|||
164413190|NCT01515189|593884275|FG001|Induction|No longer meets study criteria|2|||
164413191|NCT01515189|593884274|FG000|Induction|Lost to Follow-up|1|||
164413192|NCT01515189|593884275|FG001|Induction|Lost to Follow-up|0|||
164413193|NCT01515189|593884274|FG000|Induction|Other|0|||
164413194|NCT01515189|593884275|FG001|Induction|Other|4|||
164413195|NCT01515189|593884274|FG000|First Re-Induction Phase|Disease progression|6|||
164413196|NCT01515189|593884275|FG001|First Re-Induction Phase|Disease progression|14|||
164413197|NCT01515189|593884274|FG000|First Re-Induction Phase|Study drug toxicity|5|||
164413198|NCT01515189|593884275|FG001|First Re-Induction Phase|Study drug toxicity|0|||
164413199|NCT01515189|593884274|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
164413200|NCT01515189|593884275|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
164413201|NCT01515189|593884274|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
164413202|NCT01515189|593884275|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
164413203|NCT01515189|593884274|FG000|First Re-Induction Phase|Other|1|||
164413204|NCT01515189|593884275|FG001|First Re-Induction Phase|Other|0|||
164413205|NCT00284089|593884276|FG000|Multiple Dose Phase|Adverse Event|1|||
164413206|NCT00284089|593884277|FG001|Multiple Dose Phase|Adverse Event|0|||
164413207|NCT00284089|593884278|FG002|Multiple Dose Phase|Adverse Event|1|||
164413208|NCT00284089|593884279|FG003|Multiple Dose Phase|Adverse Event|1|||
164413209|NCT00284089|593884276|FG000|Multiple Dose Phase|Protocol Violation|0|||
164413210|NCT00284089|593884277|FG001|Multiple Dose Phase|Protocol Violation|0|||
164413211|NCT00284089|593884278|FG002|Multiple Dose Phase|Protocol Violation|1|||
164413212|NCT00284089|593884279|FG003|Multiple Dose Phase|Protocol Violation|0|||
164413213|NCT00284089|593884276|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
164413214|NCT00284089|593884277|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
164413215|NCT00284089|593884278|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
164413216|NCT00284089|593884279|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
164413217|NCT00284089|593884276|FG000|Multiple Dose Phase|Death|0|||
164413218|NCT00284089|593884277|FG001|Multiple Dose Phase|Death|0|||
164413219|NCT00284089|593884278|FG002|Multiple Dose Phase|Death|1|||
164413220|NCT00284089|593884279|FG003|Multiple Dose Phase|Death|1|||
164413221|NCT00284089|593884276|FG000|Extension Phase|Adverse Event|0|||
164413222|NCT00284089|593884277|FG001|Extension Phase|Adverse Event|0|||
164413223|NCT00284089|593884278|FG002|Extension Phase|Adverse Event|2|||
164413224|NCT00284089|593884279|FG003|Extension Phase|Adverse Event|2|||
164413225|NCT00284089|593884276|FG000|Extension Phase|condition no longer requires study drug|2|||
164413226|NCT00284089|593884277|FG001|Extension Phase|condition no longer requires study drug|0|||
164413227|NCT00284089|593884278|FG002|Extension Phase|condition no longer requires study drug|2|||
164463546|NCT03100149|594068697|FG002|Overall Study|Participant Moved out of Country|1|||
164413228|NCT00284089|593884279|FG003|Extension Phase|condition no longer requires study drug|7|||
164413229|NCT00284089|593884276|FG000|Extension Phase|Protocol Violation|0|||
164413230|NCT00284089|593884277|FG001|Extension Phase|Protocol Violation|0|||
164413231|NCT00284089|593884278|FG002|Extension Phase|Protocol Violation|1|||
164413232|NCT00284089|593884279|FG003|Extension Phase|Protocol Violation|0|||
164413233|NCT00284089|593884276|FG000|Extension Phase|Withdrawal by Subject|0|||
164709950|NCT02563106|594962807|FG001|Overall Study|Withdrawal by Subject|8|||
164709951|NCT02563106|594962806|FG000|Overall Study|Adverse Event|17|||
164709952|NCT02563106|594962807|FG001|Overall Study|Adverse Event|15|||
164709953|NCT02563106|594962806|FG000|Overall Study|Protocol Violation|1|||
164709954|NCT02563106|594962807|FG001|Overall Study|Protocol Violation|0|||
164709955|NCT02563106|594962806|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
164709956|NCT02563106|594962807|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
164709957|NCT02563106|594962806|FG000|Overall Study|Lost to Follow-up|3|||
164709958|NCT02563106|594962807|FG001|Overall Study|Lost to Follow-up|2|||
164709959|NCT02563106|594962806|FG000|Overall Study|Physician Decision|3|||
164709960|NCT02563106|594962807|FG001|Overall Study|Physician Decision|1|||
164709961|NCT02563106|594962806|FG000|Overall Study|Other reason - not specified|2|||
164709962|NCT02563106|594962807|FG001|Overall Study|Other reason - not specified|1|||
164709963|NCT01136967|594962812|FG000|Overall Study|Adverse Event|9|||
164709964|NCT01136967|594962813|FG001|Overall Study|Adverse Event|12|||
164709965|NCT01136967|594962812|FG000|Overall Study|Participant Choice|8|||
164709966|NCT01136967|594962813|FG001|Overall Study|Participant Choice|3|||
164709967|NCT01136967|594962812|FG000|Overall Study|Lost to Follow-up|0|||
164709968|NCT01136967|594962813|FG001|Overall Study|Lost to Follow-up|1|||
164709969|NCT01136967|594962812|FG000|Overall Study|Withdrawal by Subject|1|||
164709970|NCT01136967|594962813|FG001|Overall Study|Withdrawal by Subject|2|||
164709971|NCT01136967|594962812|FG000|Overall Study|Clinical Progression|3|||
164413234|NCT00284089|593884277|FG001|Extension Phase|Withdrawal by Subject|0|||
164413235|NCT00284089|593884278|FG002|Extension Phase|Withdrawal by Subject|1|||
164413236|NCT00284089|593884279|FG003|Extension Phase|Withdrawal by Subject|3|||
164413237|NCT02541383|593884280|FG000|Overall Study|Death|50|||
164413238|NCT02541383|593884281|FG001|Overall Study|Death|37|||
164413239|NCT02541383|593884282|FG002|Overall Study|Death|48|||
164413240|NCT02541383|593884283|FG003|Overall Study|Death|41|||
164413241|NCT02541383|593884284|FG004|Overall Study|Death|21|||
164413242|NCT02541383|593884285|FG005|Overall Study|Death|25|||
164413243|NCT02541383|593884280|FG000|Overall Study|Lost to Follow-up|5|||
164413244|NCT02541383|593884281|FG001|Overall Study|Lost to Follow-up|3|||
164413245|NCT02541383|593884282|FG002|Overall Study|Lost to Follow-up|1|||
164413246|NCT02541383|593884283|FG003|Overall Study|Lost to Follow-up|1|||
164413247|NCT02541383|593884284|FG004|Overall Study|Lost to Follow-up|3|||
164413248|NCT02541383|593884285|FG005|Overall Study|Lost to Follow-up|0|||
164413249|NCT02541383|593884280|FG000|Overall Study|Consent withdrawn|5|||
164413250|NCT02541383|593884281|FG001|Overall Study|Consent withdrawn|6|||
164413251|NCT02541383|593884282|FG002|Overall Study|Consent withdrawn|1|||
164413252|NCT02541383|593884283|FG003|Overall Study|Consent withdrawn|1|||
164413253|NCT02541383|593884284|FG004|Overall Study|Consent withdrawn|0|||
164413254|NCT02541383|593884285|FG005|Overall Study|Consent withdrawn|0|||
164413255|NCT02541383|593884280|FG000|Overall Study|Sponsor's decision|1|||
164413256|NCT02541383|593884281|FG001|Overall Study|Sponsor's decision|1|||
164413257|NCT02541383|593884282|FG002|Overall Study|Sponsor's decision|0|||
164413258|NCT02541383|593884283|FG003|Overall Study|Sponsor's decision|0|||
164413259|NCT02541383|593884284|FG004|Overall Study|Sponsor's decision|0|||
164413260|NCT02541383|593884285|FG005|Overall Study|Sponsor's decision|0|||
164413261|NCT05796518|593884286|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
164413262|NCT00594217|593884287|FG000|Overall Study|Withdrawal by Subject|1|||
164413263|NCT00594217|593884288|FG001|Overall Study|Withdrawal by Subject|3|||
164413264|NCT05778526|593884291|FG000|Overall Study|Lost to Follow-up|0|||
164413265|NCT05778526|593884292|FG001|Overall Study|Lost to Follow-up|1|||
164413266|NCT05778526|593884293|FG002|Overall Study|Lost to Follow-up|3|||
164413267|NCT05778526|593884291|FG000|Overall Study|Protocol Violation|0|||
164413268|NCT05778526|593884292|FG001|Overall Study|Protocol Violation|0|||
164413269|NCT05778526|593884293|FG002|Overall Study|Protocol Violation|8|||
164413270|NCT03108157|593884296|FG000|Overall Study|Protocol Violation|15|||
164413271|NCT03108157|593884297|FG001|Overall Study|Protocol Violation|4|||
164413272|NCT01435655|593884298|FG000|Overall Study|Death|2|||
164413273|NCT01435655|593884298|FG000|Overall Study|Other|1|||
164413274|NCT02839343|593884301|FG000|Overall Study|Withdrawal by Subject|3|||
164413275|NCT02839343|593884302|FG001|Overall Study|Withdrawal by Subject|1|||
164413276|NCT02839343|593884301|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
164413277|NCT02839343|593884302|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
164413278|NCT02839343|593884301|FG000|Overall Study|Adverse Event|1|||
164413279|NCT02839343|593884302|FG001|Overall Study|Adverse Event|0|||
164413280|NCT02223754|593884303|FG000|Period 1|Adverse Event|1|||
164413281|NCT02223754|593884304|FG001|Period 1|Adverse Event|0|||
164413282|NCT02223754|593884303|FG000|Period 1|Lost to Follow-up|0|||
164413283|NCT02223754|593884304|FG001|Period 1|Lost to Follow-up|1|||
164413284|NCT02223754|593884303|FG000|Period 1|Protocol Violation|2|||
164413285|NCT02223754|593884304|FG001|Period 1|Protocol Violation|4|||
164413286|NCT02223754|593884303|FG000|Period 1|Withdrawal by Subject|0|||
164709972|NCT01136967|594962813|FG001|Overall Study|Clinical Progression|5|||
164709973|NCT01136967|594962812|FG000|Overall Study|Radiation|1|||
164709974|NCT01136967|594962813|FG001|Overall Study|Radiation|0|||
164709975|NCT01136967|594962812|FG000|Overall Study|Non-compliance|1|||
164709976|NCT01136967|594962813|FG001|Overall Study|Non-compliance|0|||
164413287|NCT02223754|593884304|FG001|Period 1|Withdrawal by Subject|4|||
164413288|NCT02223754|593884303|FG000|Period 1|Test Article No Longer Available|1|||
164413289|NCT02223754|593884304|FG001|Period 1|Test Article No Longer Available|5|||
164413290|NCT02223754|593884303|FG000|Period 1|Unsatisfactory Visual Response|0|||
164413291|NCT02223754|593884304|FG001|Period 1|Unsatisfactory Visual Response|1|||
164413292|NCT02223754|593884303|FG000|Period 2|Adverse Event|0|||
164413293|NCT02223754|593884304|FG001|Period 2|Adverse Event|1|||
164413294|NCT02223754|593884303|FG000|Period 2|Protocol Violation|1|||
164413295|NCT02223754|593884304|FG001|Period 2|Protocol Violation|0|||
164413296|NCT02223754|593884303|FG000|Period 2|Lens Discomfort|1|||
164413297|NCT02223754|593884304|FG001|Period 2|Lens Discomfort|1|||
164413298|NCT02223754|593884303|FG000|Period 2|Lost to Follow-up|1|||
164413299|NCT02223754|593884304|FG001|Period 2|Lost to Follow-up|0|||
164413300|NCT02223754|593884303|FG000|Period 2|Test Article No Longer Available|0|||
164413301|NCT02223754|593884304|FG001|Period 2|Test Article No Longer Available|1|||
164413302|NCT04395183|593884306|FG000|Overall Study|Withdrawal by Subject|1|||
164413303|NCT04395183|593884307|FG001|Overall Study|Withdrawal by Subject|0|||
164413304|NCT04395183|593884308|FG002|Overall Study|Withdrawal by Subject|2|||
164413305|NCT04395183|593884309|FG003|Overall Study|Withdrawal by Subject|2|||
164413306|NCT02668016|593884310|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
164413307|NCT02668016|593884310|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
164413308|NCT02668016|593884310|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
164413309|NCT02668016|593884310|FG000|Month 4|Withdrawal due to severe symptoms|1|||
164413310|NCT02668016|593884310|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
164413311|NCT02668016|593884310|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
164413312|NCT02668016|593884310|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
164413313|NCT02668016|593884310|FG000|Month 6|Withdrawal due to severe symptoms|2|||
164413314|NCT02668016|593884310|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
164413315|NCT02668016|593884310|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
164413316|NCT02668016|593884310|FG000|Month 8|Withdrawal due to severe symptoms|1|||
164413317|NCT02668016|593884310|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
164413318|NCT02668016|593884310|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
164413319|NCT02668016|593884310|FG000|Month 10|Withdrawal due to severe symptoms|1|||
164413320|NCT02668016|593884310|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
164413321|NCT01065350|593884314|FG000|Overall Study|Received incorrect drug allocation|0|||
164413322|NCT01065350|593884315|FG001|Overall Study|Received incorrect drug allocation|1|||
164413323|NCT00962247|593884321|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
164413324|NCT00962247|593884321|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
164413325|NCT02234063|593884324|FG000|Overall Study|Lost to Follow-up|235|||
164413326|NCT02234063|593884325|FG001|Overall Study|Lost to Follow-up|42|||
164413327|NCT02234063|593884324|FG000|Overall Study|Withdrawal by Subject|20|||
164413328|NCT02234063|593884325|FG001|Overall Study|Withdrawal by Subject|1|||
164413329|NCT00510458|593884328|FG000|Overall Study|5 year not evaluable/missed|21|||
164413330|NCT00510458|593884328|FG000|Overall Study|Death|1|||
164413331|NCT00510458|593884328|FG000|Overall Study|Terminated|14|||
164413332|NCT00510458|593884328|FG000|Overall Study|Lost to Follow-up|6|||
164413333|NCT00510458|593884328|FG000|Overall Study|Withdrawal by Subject|3|||
164413334|NCT00510458|593884328|FG000|Overall Study|Revision|2|||
164413335|NCT03535337|593884332|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
164413336|NCT03535337|593884333|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
164709977|NCT01136967|594962812|FG000|Overall Study|Investigator's Choice|1|||
164413337|NCT03535337|593884334|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
164413338|NCT03535337|593884335|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
164413339|NCT03535337|593884336|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
164413340|NCT03535337|593884337|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
164413341|NCT03535337|593884338|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
164413342|NCT03535337|593884339|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
164413343|NCT03535337|593884340|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
164413344|NCT03535337|593884341|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
164413345|NCT05879198|593884342|FG000|Overall Study|Lost to Follow-up|1|||
164413346|NCT01598298|593884343|FG000|Overall Study|Not eligible|5|||
164413347|NCT01598298|593884344|FG001|Overall Study|Not eligible|5|||
164413348|NCT01598298|593884343|FG000|Overall Study|Adverse Event|21|||
164413349|NCT01598298|593884344|FG001|Overall Study|Adverse Event|19|||
164413350|NCT01598298|593884343|FG000|Overall Study|Progression/relapse|0|||
164413351|NCT01598298|593884344|FG001|Overall Study|Progression/relapse|2|||
164413352|NCT01598298|593884343|FG000|Overall Study|Withdrawal by Subject|10|||
164413353|NCT01598298|593884344|FG001|Overall Study|Withdrawal by Subject|15|||
164413354|NCT01598298|593884343|FG000|Overall Study|Other reason (not protocol specified)|4|||
164413355|NCT01598298|593884344|FG001|Overall Study|Other reason (not protocol specified)|0|||
164413356|NCT01811563|593886422|FG000|Overall Study|Lost to Follow-up|5|||
164413357|NCT01811563|593886423|FG001|Overall Study|Lost to Follow-up|2|||
164413358|NCT01811563|593886422|FG000|Overall Study|Incorrect Randomization procedure|0|||
164413359|NCT01811563|593886423|FG001|Overall Study|Incorrect Randomization procedure|1|||
164463547|NCT03100149|594068695|FG000|Overall Study|Withdrawal by Subject|0|||
164463548|NCT03100149|594068696|FG001|Overall Study|Withdrawal by Subject|3|||
164463549|NCT03100149|594068697|FG002|Overall Study|Withdrawal by Subject|1|||
164413360|NCT04424290|593886424|FG000|Overall Study|Not treated|0|||
164413361|NCT04424290|593886425|FG001|Overall Study|Not treated|0|||
164413362|NCT04424290|593886426|FG002|Overall Study|Not treated|1|||
164413363|NCT04424290|593886427|FG003|Overall Study|Not treated|0|||
164413364|NCT04424290|593886428|FG004|Overall Study|Not treated|1|||
164413365|NCT04424290|593886424|FG000|Overall Study|Adverse Event|0|||
164413366|NCT04424290|593886425|FG001|Overall Study|Adverse Event|0|||
164413367|NCT04424290|593886426|FG002|Overall Study|Adverse Event|0|||
164413368|NCT04424290|593886427|FG003|Overall Study|Adverse Event|2|||
164413369|NCT04424290|593886428|FG004|Overall Study|Adverse Event|0|||
164413370|NCT04424290|593886424|FG000|Overall Study|Withdrawal by Subject|0|||
164413371|NCT04424290|593886425|FG001|Overall Study|Withdrawal by Subject|0|||
164413372|NCT04424290|593886426|FG002|Overall Study|Withdrawal by Subject|0|||
164413373|NCT04424290|593886427|FG003|Overall Study|Withdrawal by Subject|0|||
164413374|NCT04424290|593886428|FG004|Overall Study|Withdrawal by Subject|1|||
164413375|NCT04424290|593886424|FG000|Overall Study|Other than listed|0|||
164413376|NCT04424290|593886425|FG001|Overall Study|Other than listed|0|||
164413377|NCT04424290|593886426|FG002|Overall Study|Other than listed|0|||
164413378|NCT04424290|593886427|FG003|Overall Study|Other than listed|1|||
164413379|NCT04424290|593886428|FG004|Overall Study|Other than listed|0|||
164413380|NCT02936037|593886429|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
164413381|NCT02936037|593886430|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
164413382|NCT02936037|593886429|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
164413383|NCT02936037|593886430|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
164413384|NCT02936037|593886429|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
164413385|NCT02936037|593886430|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
164413386|NCT02936037|593886429|FG000|Double-Blind Treatment Period|Death|0|||
164413387|NCT02936037|593886430|FG001|Double-Blind Treatment Period|Death|1|||
164413388|NCT02936037|593886429|FG000|Double-Blind Treatment Period|Adverse Event|11|||
164413389|NCT02936037|593886430|FG001|Double-Blind Treatment Period|Adverse Event|11|||
164413390|NCT02936037|593886429|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
164413391|NCT02936037|593886430|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
164413392|NCT02936037|593886429|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
164413393|NCT02936037|593886430|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
164413394|NCT02936037|593886429|FG000|Open Label Extension|Adverse Event|0|||
164413395|NCT02936037|593886430|FG001|Open Label Extension|Adverse Event|3|||
164413396|NCT02936037|593886429|FG000|Open Label Extension|Other|0|||
164463550|NCT02670525|594068698|FG000|Overall Study|Death|94|||
164463551|NCT02670525|594068699|FG001|Overall Study|Death|14|||
164463552|NCT02670525|594068698|FG000|Overall Study|Lost to Follow-up|4|||
164463553|NCT02670525|594068699|FG001|Overall Study|Lost to Follow-up|1|||
164463554|NCT02670525|594068698|FG000|Overall Study|Subject withdrew consent|1|||
164463555|NCT02670525|594068699|FG001|Overall Study|Subject withdrew consent|0|||
164463556|NCT02670525|594068698|FG000|Overall Study|Unknown, data entry delayed|123|||
164463557|NCT02670525|594068699|FG001|Overall Study|Unknown, data entry delayed|78|||
164463558|NCT04304820|594070350|FG000|Overall Study|Death|1|||
164463559|NCT04304820|594070350|FG000|Overall Study|Lost to Follow-up|1|||
164463560|NCT04304820|594070350|FG000|Overall Study|Pursuing Stem Cell Transplant|4|||
164463561|NCT04304820|594070350|FG000|Overall Study|Pursuing Additional Immunosuppressive therapy|4|||
164463562|NCT04304820|594070350|FG000|Overall Study|Evolution to Myeloid Malignancy|1|||
164463563|NCT03873818|594070351|FG000|Overall Study|Death|9|||
164463564|NCT03873818|594070352|FG001|Overall Study|Death|3|||
164463565|NCT03873818|594070351|FG000|Overall Study|Lost to Follow-up|1|||
164463566|NCT03873818|594070352|FG001|Overall Study|Lost to Follow-up|0|||
164463567|NCT03474107|594070353|FG000|Overall Study|Adverse Event|42|||
164463568|NCT03474107|594070354|FG001|Overall Study|Adverse Event|46|||
164463569|NCT03474107|594070353|FG000|Overall Study|Death|2|||
164463570|NCT03474107|594070354|FG001|Overall Study|Death|2|||
164463571|NCT03474107|594070353|FG000|Overall Study|Lost to Follow-up|0|||
164463572|NCT03474107|594070354|FG001|Overall Study|Lost to Follow-up|1|||
164413397|NCT02936037|593886430|FG001|Open Label Extension|Other|3|||
164413398|NCT02936037|593886429|FG000|Open Label Extension|Withdrawal by Subject|0|||
164413399|NCT02936037|593886430|FG001|Open Label Extension|Withdrawal by Subject|4|||
164463573|NCT03474107|594070353|FG000|Overall Study|Progressive Disease|177|||
164463574|NCT03474107|594070354|FG001|Overall Study|Progressive Disease|180|||
164463575|NCT03474107|594070353|FG000|Overall Study|Protocol Violation|1|||
164463576|NCT03474107|594070354|FG001|Overall Study|Protocol Violation|1|||
164413400|NCT01267825|593886431|FG000|Overall Study|study terminated. no data collected.|1|||
164413401|NCT01267825|593886432|FG001|Overall Study|study terminated. no data collected.|0|||
164413402|NCT04249336|593886433|FG000|Overall Study|Lost to Follow-up|3|||
164413403|NCT04249336|593886434|FG001|Overall Study|Lost to Follow-up|3|||
164413404|NCT04249336|593886435|FG002|Overall Study|Lost to Follow-up|3|||
164413405|NCT04249336|593886436|FG003|Overall Study|Lost to Follow-up|3|||
164413406|NCT01189890|593886440|FG000|Overall Study|Adverse Event|3|||
164413407|NCT01189890|593886441|FG001|Overall Study|Adverse Event|4|||
164413408|NCT01189890|593886440|FG000|Overall Study|Lack of Efficacy|7|||
164413409|NCT01189890|593886441|FG001|Overall Study|Lack of Efficacy|2|||
164413410|NCT01189890|593886440|FG000|Overall Study|Lost to Follow-up|1|||
164413411|NCT01189890|593886441|FG001|Overall Study|Lost to Follow-up|7|||
164413412|NCT01189890|593886440|FG000|Overall Study|Protocol Violation|1|||
164413413|NCT01189890|593886441|FG001|Overall Study|Protocol Violation|5|||
164413414|NCT01189890|593886440|FG000|Overall Study|Withdrawal by Subject|15|||
164413415|NCT01189890|593886441|FG001|Overall Study|Withdrawal by Subject|11|||
164413416|NCT01189890|593886440|FG000|Overall Study|Non Compliance|0|||
164413417|NCT01189890|593886441|FG001|Overall Study|Non Compliance|1|||
164413418|NCT01189890|593886440|FG000|Overall Study|Physician Decision|5|||
164413419|NCT01189890|593886441|FG001|Overall Study|Physician Decision|4|||
164413420|NCT01189890|593886440|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
164413421|NCT01189890|593886441|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
164413422|NCT00077636|593886442|FG000|Overall Study|Refused Treatment|9|||
164413423|NCT00077636|593886443|FG001|Overall Study|Refused Treatment|31|||
164413424|NCT00077636|593886442|FG000|Overall Study|Admin|3|||
164413425|NCT00077636|593886443|FG001|Overall Study|Admin|3|||
164413426|NCT00077636|593886442|FG000|Overall Study|Withdrawal by Subject|2|||
164413427|NCT00077636|593886443|FG001|Overall Study|Withdrawal by Subject|2|||
164413428|NCT00077636|593886442|FG000|Overall Study|Adverse Event|17|||
164413429|NCT00077636|593886443|FG001|Overall Study|Adverse Event|34|||
164413430|NCT00077636|593886442|FG000|Overall Study|Protocol Violation|0|||
164413431|NCT00077636|593886443|FG001|Overall Study|Protocol Violation|2|||
164413432|NCT00077636|593886442|FG000|Overall Study|Lost to Follow-up|10|||
164413433|NCT00077636|593886443|FG001|Overall Study|Lost to Follow-up|18|||
164413434|NCT00077636|593886442|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
164413435|NCT00077636|593886443|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
164413436|NCT00068380|593886446|FG000|Overall Study|Withdrawal by Subject|3|||
164413437|NCT00068380|593886446|FG000|Overall Study|Adverse Event|2|||
164413438|NCT01976364|593886447|FG000|Main Study (36 Months)|Adverse Event|63|||
164413439|NCT01976364|593886448|FG001|Main Study (36 Months)|Adverse Event|0|||
164413440|NCT01976364|593886449|FG002|Main Study (36 Months)|Adverse Event|0|||
164413441|NCT01976364|593886447|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
164413442|NCT01976364|593886448|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
164413443|NCT01976364|593886449|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
164413444|NCT01976364|593886447|FG000|Main Study (36 Months)|Other|13|||
164413445|NCT01976364|593886448|FG001|Main Study (36 Months)|Other|0|||
164413446|NCT01976364|593886449|FG002|Main Study (36 Months)|Other|0|||
164413447|NCT01976364|593886447|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
164413448|NCT01976364|593886448|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
164413449|NCT01976364|593886449|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
164413450|NCT01976364|593886447|FG000|Main Study (36 Months)|Medication error|1|||
164413451|NCT01976364|593886448|FG001|Main Study (36 Months)|Medication error|0|||
164413452|NCT01976364|593886449|FG002|Main Study (36 Months)|Medication error|0|||
164413453|NCT01976364|593886447|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
164413454|NCT01976364|593886448|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
164413455|NCT01976364|593886449|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
164413456|NCT01976364|593886447|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
164413457|NCT01976364|593886448|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
164413458|NCT01976364|593886449|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
164413459|NCT01976364|593886447|FG000|Main Study (36 Months)|Protocol Violation|13|||
164413460|NCT01976364|593886448|FG001|Main Study (36 Months)|Protocol Violation|0|||
164413461|NCT01976364|593886449|FG002|Main Study (36 Months)|Protocol Violation|0|||
164413462|NCT01976364|593886447|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
164413463|NCT01976364|593886448|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
164413464|NCT01976364|593886449|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
164413465|NCT01976364|593886447|FG000|Main Study (36 Months)|Death|5|||
164413466|NCT01976364|593886448|FG001|Main Study (36 Months)|Death|0|||
164463577|NCT03474107|594070353|FG000|Overall Study|Withdrawal by Subject|15|||
164709978|NCT01136967|594962813|FG001|Overall Study|Investigator's Choice|1|||
164709979|NCT01136967|594962812|FG000|Overall Study|Increase in Lesion Size|0|||
164709980|NCT01136967|594962813|FG001|Overall Study|Increase in Lesion Size|2|||
164709981|NCT01136967|594962812|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
164463578|NCT03474107|594070354|FG001|Overall Study|Withdrawal by Subject|27|||
164463579|NCT03474107|594070353|FG000|Overall Study|Physician Decision|7|||
164463580|NCT03474107|594070354|FG001|Overall Study|Physician Decision|22|||
164463581|NCT03474107|594070353|FG000|Overall Study|Miscellaneous|1|||
164413467|NCT01976364|593886449|FG002|Main Study (36 Months)|Death|0|||
164413468|NCT01976364|593886447|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
164413469|NCT01976364|593886448|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
164463582|NCT03474107|594070354|FG001|Overall Study|Miscellaneous|6|||
164709982|NCT01136967|594962813|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
164413470|NCT01976364|593886449|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
164413471|NCT01976364|593886447|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
164413472|NCT01976364|593886448|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
164413473|NCT01976364|593886449|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
164413474|NCT01976364|593886447|FG000|Sub-study (12 Months)|Protocol Violation|0|||
164413475|NCT01976364|593886448|FG001|Sub-study (12 Months)|Protocol Violation|1|||
164413476|NCT01976364|593886449|FG002|Sub-study (12 Months)|Protocol Violation|1|||
164413477|NCT01976364|593886447|FG000|Sub-study (12 Months)|Adverse Event|0|||
164413478|NCT01976364|593886448|FG001|Sub-study (12 Months)|Adverse Event|4|||
164413479|NCT01976364|593886449|FG002|Sub-study (12 Months)|Adverse Event|3|||
164413480|NCT01190215|593886450|FG000|Up to Month 6|Lost to Follow-up|2|||
164413481|NCT01190215|593886451|FG001|Up to Month 6|Lost to Follow-up|0|||
164413482|NCT02914184|593886453|FG000|Overall Study|Lost to Follow-up|7|||
164413483|NCT02914184|593886454|FG001|Overall Study|Lost to Follow-up|10|||
164413484|NCT02914184|593886455|FG002|Overall Study|Lost to Follow-up|8|||
164413485|NCT02914184|593886456|FG003|Overall Study|Lost to Follow-up|7|||
164413486|NCT02914184|593886453|FG000|Overall Study|Withdrawal by Subject|4|||
164413487|NCT02914184|593886454|FG001|Overall Study|Withdrawal by Subject|2|||
164413488|NCT02914184|593886455|FG002|Overall Study|Withdrawal by Subject|7|||
164413489|NCT02914184|593886456|FG003|Overall Study|Withdrawal by Subject|3|||
164413490|NCT02914184|593886453|FG000|Overall Study|Other|1|||
164413491|NCT02914184|593886454|FG001|Overall Study|Other|0|||
164413492|NCT02914184|593886455|FG002|Overall Study|Other|0|||
164413493|NCT02914184|593886456|FG003|Overall Study|Other|0|||
164413494|NCT02914184|593886453|FG000|Overall Study|Migrated/moved from the study area|2|||
164413495|NCT02914184|593886454|FG001|Overall Study|Migrated/moved from the study area|1|||
164413496|NCT02914184|593886455|FG002|Overall Study|Migrated/moved from the study area|2|||
164413497|NCT02914184|593886456|FG003|Overall Study|Migrated/moved from the study area|1|||
164413498|NCT00802659|593886457|FG000|Overall Study|Physician Decision|0|||
164413499|NCT00802659|593886458|FG001|Overall Study|Physician Decision|1|||
164413500|NCT00802659|593886459|FG002|Overall Study|Physician Decision|0|||
164413501|NCT00802659|593886460|FG003|Overall Study|Physician Decision|0|||
164413502|NCT00806624|593886461|FG000|Overall Study|Adverse Event|2|||
164413503|NCT00806624|593886462|FG001|Overall Study|Adverse Event|8|||
164413504|NCT00806624|593886463|FG002|Overall Study|Adverse Event|0|||
164413505|NCT00806624|593886461|FG000|Overall Study|Death|0|||
164413506|NCT00806624|593886462|FG001|Overall Study|Death|1|||
164413507|NCT00806624|593886463|FG002|Overall Study|Death|1|||
164413508|NCT00806624|593886461|FG000|Overall Study|Lost to Follow-up|1|||
164413509|NCT00806624|593886462|FG001|Overall Study|Lost to Follow-up|0|||
164413510|NCT00806624|593886463|FG002|Overall Study|Lost to Follow-up|1|||
164413511|NCT00806624|593886461|FG000|Overall Study|Withdrawal by Subject|6|||
164413512|NCT00806624|593886462|FG001|Overall Study|Withdrawal by Subject|3|||
164413513|NCT00806624|593886463|FG002|Overall Study|Withdrawal by Subject|3|||
164413514|NCT00806624|593886461|FG000|Overall Study|discontinued before start of treatment|0|||
164413515|NCT00806624|593886462|FG001|Overall Study|discontinued before start of treatment|0|||
164413516|NCT00806624|593886463|FG002|Overall Study|discontinued before start of treatment|1|||
164413517|NCT03093428|593886464|FG000|Overall Study|Not eligible for treatment|2|||
164413518|NCT03093428|593886465|FG001|Overall Study|Not eligible for treatment|1|||
164413519|NCT03093428|593886464|FG000|Overall Study|Progression|14|||
164413520|NCT03093428|593886465|FG001|Overall Study|Progression|4|||
164413521|NCT03093428|593886464|FG000|Overall Study|Death|1|||
164413522|NCT03093428|593886465|FG001|Overall Study|Death|0|||
164413523|NCT03093428|593886464|FG000|Overall Study|Adverse Event|1|||
164413524|NCT03093428|593886465|FG001|Overall Study|Adverse Event|0|||
164413525|NCT03093428|593886464|FG000|Overall Study|Withdrawal by Subject|1|||
164413526|NCT03093428|593886465|FG001|Overall Study|Withdrawal by Subject|1|||
164413527|NCT01336634|593886469|FG000|Overall Study|Study closed/terminated|5|||
164413528|NCT01336634|593886470|FG001|Overall Study|Study closed/terminated|6|||
164413529|NCT01336634|593886471|FG002|Overall Study|Study closed/terminated|6|||
164413530|NCT01336634|593886469|FG000|Overall Study|Lost to Follow-up|2|||
164413531|NCT01336634|593886470|FG001|Overall Study|Lost to Follow-up|1|||
164413532|NCT01336634|593886471|FG002|Overall Study|Lost to Follow-up|1|||
164413533|NCT01336634|593886469|FG000|Overall Study|Physician Decision|1|||
164413534|NCT01336634|593886470|FG001|Overall Study|Physician Decision|1|||
164413535|NCT01336634|593886471|FG002|Overall Study|Physician Decision|0|||
164413536|NCT01336634|593886469|FG000|Overall Study|Withdrawal by Subject|6|||
164413537|NCT01336634|593886470|FG001|Overall Study|Withdrawal by Subject|0|||
164413538|NCT01336634|593886471|FG002|Overall Study|Withdrawal by Subject|2|||
164413539|NCT01973491|593886472|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
164413540|NCT01973491|593886472|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
164413541|NCT01973491|593886472|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
164413542|NCT01863043|593886476|FG000|Overall Study|Death|6|||
164413543|NCT01863043|593886477|FG001|Overall Study|Death|1|||
164413544|NCT01863043|593886476|FG000|Overall Study|Withdrawal by Subject|0|||
164413545|NCT01863043|593886477|FG001|Overall Study|Withdrawal by Subject|2|||
164413546|NCT01863043|593886476|FG000|Overall Study|Adverse Event|7|||
164413547|NCT01863043|593886477|FG001|Overall Study|Adverse Event|8|||
164463583|NCT05171855|594070355|FG000|Overall Study|Death|1|||
164463584|NCT05171855|594070356|FG001|Overall Study|Death|0|||
164413548|NCT01863043|593886476|FG000|Overall Study|exclusion criteria found after enrollment|0|||
164413549|NCT01863043|593886477|FG001|Overall Study|exclusion criteria found after enrollment|1|||
164413550|NCT00313911|593886478|FG000|Overall Study|Serious adverse event|6|||
164413551|NCT00313911|593886479|FG001|Overall Study|Serious adverse event|1|||
164413552|NCT00313911|593886478|FG000|Overall Study|Adverse Event|2|||
164413553|NCT00313911|593886479|FG001|Overall Study|Adverse Event|3|||
164413554|NCT00313911|593886478|FG000|Overall Study|Protocol Violation|19|||
164413555|NCT00313911|593886479|FG001|Overall Study|Protocol Violation|10|||
164413556|NCT00313911|593886478|FG000|Overall Study|Lost to Follow-up|27|||
164413557|NCT00313911|593886479|FG001|Overall Study|Lost to Follow-up|14|||
164413558|NCT00313911|593886478|FG000|Overall Study|Withdrawal by Subject|39|||
164413559|NCT00313911|593886479|FG001|Overall Study|Withdrawal by Subject|12|||
164413560|NCT00313911|593886478|FG000|Overall Study|Did not meet age criteria|1|||
164413561|NCT00313911|593886479|FG001|Overall Study|Did not meet age criteria|1|||
164413562|NCT04668989|593886480|FG000|First Intervention|Covid-19 related self-isolation|0|||
164413563|NCT04668989|593886481|FG001|First Intervention|Covid-19 related self-isolation|1|||
164413564|NCT04668989|593886480|FG000|Second Intervention|Adverse Event|0|||
164413565|NCT04668989|593886481|FG001|Second Intervention|Adverse Event|1|||
164413566|NCT01468922|593886490|FG000|Overall Study|Screening failure|0|||
164413567|NCT01468922|593886491|FG001|Overall Study|Screening failure|0|||
164413568|NCT01468922|593886492|FG002|Overall Study|Screening failure|0|||
164413569|NCT01468922|593886493|FG003|Overall Study|Screening failure|0|||
164413570|NCT01468922|593886494|FG004|Overall Study|Screening failure|0|||
164413571|NCT01468922|593886495|FG005|Overall Study|Screening failure|0|||
164413572|NCT01468922|593886496|FG006|Overall Study|Screening failure|0|||
164413573|NCT01468922|593886497|FG007|Overall Study|Screening failure|0|||
164413574|NCT01468922|593886498|FG008|Overall Study|Screening failure|1|||
164413575|NCT01468922|593886490|FG000|Overall Study|Per patient choice|1|||
164413576|NCT01468922|593886491|FG001|Overall Study|Per patient choice|0|||
164413577|NCT01468922|593886492|FG002|Overall Study|Per patient choice|0|||
164413578|NCT01468922|593886493|FG003|Overall Study|Per patient choice|0|||
164413579|NCT01468922|593886494|FG004|Overall Study|Per patient choice|0|||
164413580|NCT01468922|593886495|FG005|Overall Study|Per patient choice|0|||
164413581|NCT01468922|593886496|FG006|Overall Study|Per patient choice|0|||
164413582|NCT01468922|593886497|FG007|Overall Study|Per patient choice|0|||
164413583|NCT01468922|593886498|FG008|Overall Study|Per patient choice|0|||
164413584|NCT01468922|593886490|FG000|Overall Study|Switched to alternative treatment|1|||
164413585|NCT01468922|593886491|FG001|Overall Study|Switched to alternative treatment|0|||
164413586|NCT01468922|593886492|FG002|Overall Study|Switched to alternative treatment|0|||
164413587|NCT01468922|593886493|FG003|Overall Study|Switched to alternative treatment|0|||
164413588|NCT01468922|593886494|FG004|Overall Study|Switched to alternative treatment|1|||
164413589|NCT01468922|593886495|FG005|Overall Study|Switched to alternative treatment|0|||
164413590|NCT01468922|593886496|FG006|Overall Study|Switched to alternative treatment|0|||
164413591|NCT01468922|593886497|FG007|Overall Study|Switched to alternative treatment|0|||
164413592|NCT01468922|593886498|FG008|Overall Study|Switched to alternative treatment|0|||
164413593|NCT01468922|593886490|FG000|Overall Study|Enrolled on new protocol|0|||
164413594|NCT01468922|593886491|FG001|Overall Study|Enrolled on new protocol|0|||
164413595|NCT01468922|593886492|FG002|Overall Study|Enrolled on new protocol|0|||
164413596|NCT01468922|593886493|FG003|Overall Study|Enrolled on new protocol|0|||
164413597|NCT01468922|593886494|FG004|Overall Study|Enrolled on new protocol|1|||
164413598|NCT01468922|593886495|FG005|Overall Study|Enrolled on new protocol|0|||
164463585|NCT05171855|594070357|FG002|Overall Study|Death|0|||
164413599|NCT01468922|593886496|FG006|Overall Study|Enrolled on new protocol|0|||
164413600|NCT01468922|593886497|FG007|Overall Study|Enrolled on new protocol|0|||
164413601|NCT01468922|593886498|FG008|Overall Study|Enrolled on new protocol|0|||
164413602|NCT01468922|593886490|FG000|Overall Study|Adverse Event|0|||
164413603|NCT01468922|593886491|FG001|Overall Study|Adverse Event|0|||
164413604|NCT01468922|593886492|FG002|Overall Study|Adverse Event|0|||
164413605|NCT01468922|593886493|FG003|Overall Study|Adverse Event|0|||
164413606|NCT01468922|593886494|FG004|Overall Study|Adverse Event|0|||
164413607|NCT01468922|593886495|FG005|Overall Study|Adverse Event|0|||
164413608|NCT01468922|593886496|FG006|Overall Study|Adverse Event|0|||
164413609|NCT01468922|593886497|FG007|Overall Study|Adverse Event|1|||
164413610|NCT01468922|593886498|FG008|Overall Study|Adverse Event|0|||
164413611|NCT01468922|593886490|FG000|Overall Study|Infection of blood|0|||
164413612|NCT01468922|593886491|FG001|Overall Study|Infection of blood|0|||
164413613|NCT01468922|593886492|FG002|Overall Study|Infection of blood|0|||
164413614|NCT01468922|593886493|FG003|Overall Study|Infection of blood|0|||
164413615|NCT01468922|593886494|FG004|Overall Study|Infection of blood|0|||
164413616|NCT01468922|593886495|FG005|Overall Study|Infection of blood|0|||
164413617|NCT01468922|593886496|FG006|Overall Study|Infection of blood|0|||
164413618|NCT01468922|593886497|FG007|Overall Study|Infection of blood|1|||
164413619|NCT01468922|593886498|FG008|Overall Study|Infection of blood|0|||
164413620|NCT01468922|593886490|FG000|Overall Study|Patient choice - surgery|0|||
164413621|NCT01468922|593886491|FG001|Overall Study|Patient choice - surgery|0|||
164413622|NCT01468922|593886492|FG002|Overall Study|Patient choice - surgery|0|||
164413623|NCT01468922|593886493|FG003|Overall Study|Patient choice - surgery|0|||
164413624|NCT01468922|593886494|FG004|Overall Study|Patient choice - surgery|0|||
164413625|NCT01468922|593886495|FG005|Overall Study|Patient choice - surgery|0|||
164413626|NCT01468922|593886496|FG006|Overall Study|Patient choice - surgery|0|||
164413627|NCT01468922|593886497|FG007|Overall Study|Patient choice - surgery|1|||
164413628|NCT01468922|593886498|FG008|Overall Study|Patient choice - surgery|0|||
164413629|NCT01468922|593886490|FG000|Overall Study|Refused further treatment|0|||
164413630|NCT01468922|593886491|FG001|Overall Study|Refused further treatment|0|||
164413631|NCT01468922|593886492|FG002|Overall Study|Refused further treatment|0|||
164413632|NCT01468922|593886493|FG003|Overall Study|Refused further treatment|0|||
164413633|NCT01468922|593886494|FG004|Overall Study|Refused further treatment|0|||
164413634|NCT01468922|593886495|FG005|Overall Study|Refused further treatment|0|||
164413635|NCT01468922|593886496|FG006|Overall Study|Refused further treatment|0|||
164413636|NCT01468922|593886497|FG007|Overall Study|Refused further treatment|1|||
164413637|NCT01468922|593886498|FG008|Overall Study|Refused further treatment|0|||
164413638|NCT00007475|593886501|FG000|Overall Study|Withdrawal by Subject|1|||
164413639|NCT00007475|593886502|FG001|Overall Study|Withdrawal by Subject|0|||
164413640|NCT00007475|593886503|FG002|Overall Study|Withdrawal by Subject|0|||
164413641|NCT00007475|593886504|FG003|Overall Study|Withdrawal by Subject|0|||
164413642|NCT00007475|593886501|FG000|Overall Study|Adverse Event|3|||
164413643|NCT00007475|593886502|FG001|Overall Study|Adverse Event|0|||
164413644|NCT00007475|593886503|FG002|Overall Study|Adverse Event|0|||
164413645|NCT00007475|593886504|FG003|Overall Study|Adverse Event|0|||
164413646|NCT01719224|593886505|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
164413647|NCT01719224|593886506|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
164413648|NCT00258440|593886507|FG000|Overall Study|Withdrawal by Subject|0|||
164413649|NCT00258440|593886508|FG001|Overall Study|Withdrawal by Subject|0|||
164413650|NCT00258440|593886509|FG002|Overall Study|Withdrawal by Subject|1|||
164413651|NCT00737061|593886510|FG000|Waiting Period|Lost to Follow-up|6|||
164413652|NCT00737061|593886510|FG000|Waiting Period|Withdrawal by Subject|1|||
164413653|NCT00737061|593886510|FG000|Waiting Period|Bilateral placement failure|34|||
164413654|NCT00737061|593886510|FG000|Waiting Period|Deemed patent following HSG|26|||
164413655|NCT00737061|593886510|FG000|Waiting Period|Alternative contraception failure|3|||
164413656|NCT00737061|593886510|FG000|Waiting Period|Elected surgical tubal ligation|5|||
164413657|NCT00737061|593886510|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
164413658|NCT00737061|593886510|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
164413659|NCT00737061|593886510|FG000|1 Year Wearing Period|Discontinued reilance|3|||
164413660|NCT00737061|593886510|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
164413661|NCT03000673|593886511|FG000|Overall Study|Withdrawal by Subject|1|||
164413662|NCT03000673|593886512|FG001|Overall Study|Withdrawal by Subject|0|||
164413663|NCT03000673|593886513|FG002|Overall Study|Withdrawal by Subject|0|||
164413664|NCT03000673|593886514|FG003|Overall Study|Withdrawal by Subject|0|||
164413665|NCT00692406|593886515|FG000|Overall Study|PI dropped, bad data|57|||
164413666|NCT04186403|593886520|FG000|Overall Study|Adverse Event|1|||
164413667|NCT04186403|593886521|FG001|Overall Study|Adverse Event|8|||
164413668|NCT04186403|593886520|FG000|Overall Study|Lost to Follow-up|7|||
164413669|NCT04186403|593886521|FG001|Overall Study|Lost to Follow-up|3|||
164413670|NCT04186403|593886520|FG000|Overall Study|Physician Decision|1|||
164413671|NCT04186403|593886521|FG001|Overall Study|Physician Decision|0|||
164413672|NCT04186403|593886520|FG000|Overall Study|Withdrawal by Subject|7|||
164413673|NCT04186403|593886521|FG001|Overall Study|Withdrawal by Subject|8|||
164413674|NCT04186403|593886520|FG000|Overall Study|Other: Not Related to Covid-19|3|||
164413675|NCT04186403|593886521|FG001|Overall Study|Other: Not Related to Covid-19|0|||
164413676|NCT01407354|593886526|FG000|First Intervention|Withdrawal by Subject|0|||
164413677|NCT01407354|593886527|FG001|First Intervention|Withdrawal by Subject|2|||
164413678|NCT01407354|593886526|FG000|First Intervention|Adverse Event|1|||
164413679|NCT01407354|593886527|FG001|First Intervention|Adverse Event|0|||
164413680|NCT01407354|593886526|FG000|First Intervention|Physician Decision|1|||
164413681|NCT01407354|593886527|FG001|First Intervention|Physician Decision|0|||
164413682|NCT01036022|593886528|FG000|Overall Study|Adverse Event|1|||
164413683|NCT01036022|593886529|FG001|Overall Study|Adverse Event|3|||
164413684|NCT01036022|593886530|FG002|Overall Study|Adverse Event|2|||
164413685|NCT01036022|593886531|FG003|Overall Study|Adverse Event|1|||
164413686|NCT01036022|593886532|FG004|Overall Study|Adverse Event|0|||
164413687|NCT01036022|593886533|FG005|Overall Study|Adverse Event|2|||
164413688|NCT01036022|593886528|FG000|Overall Study|Lack of Efficacy|1|||
164413689|NCT01036022|593886529|FG001|Overall Study|Lack of Efficacy|1|||
164413690|NCT01036022|593886530|FG002|Overall Study|Lack of Efficacy|1|||
164413691|NCT01036022|593886531|FG003|Overall Study|Lack of Efficacy|0|||
164413692|NCT01036022|593886532|FG004|Overall Study|Lack of Efficacy|1|||
164413693|NCT01036022|593886533|FG005|Overall Study|Lack of Efficacy|1|||
164413694|NCT01036022|593886528|FG000|Overall Study|Physician Decision|0|||
164413695|NCT01036022|593886529|FG001|Overall Study|Physician Decision|0|||
164413696|NCT01036022|593886530|FG002|Overall Study|Physician Decision|1|||
164413697|NCT01036022|593886531|FG003|Overall Study|Physician Decision|0|||
164413698|NCT01036022|593886532|FG004|Overall Study|Physician Decision|0|||
164413699|NCT01036022|593886533|FG005|Overall Study|Physician Decision|0|||
164413700|NCT01036022|593886528|FG000|Overall Study|Withdrawal by Subject|0|||
164413701|NCT01036022|593886529|FG001|Overall Study|Withdrawal by Subject|0|||
164413702|NCT01036022|593886530|FG002|Overall Study|Withdrawal by Subject|0|||
164413703|NCT01036022|593886531|FG003|Overall Study|Withdrawal by Subject|1|||
164413704|NCT01036022|593886532|FG004|Overall Study|Withdrawal by Subject|2|||
164413705|NCT01036022|593886533|FG005|Overall Study|Withdrawal by Subject|0|||
164413706|NCT02487095|593886535|FG000|Dose Expansion|Unable to scan/restage participant|0|||
164413707|NCT02487095|593886536|FG001|Dose Expansion|Unable to scan/restage participant|0|||
164413708|NCT02487095|593886537|FG002|Dose Expansion|Unable to scan/restage participant|0|||
164413709|NCT02487095|593886538|FG003|Dose Expansion|Unable to scan/restage participant|0|||
164413710|NCT02487095|593886539|FG004|Dose Expansion|Unable to scan/restage participant|1|||
164413711|NCT01555164|593886542|FG000|Overall Study|Adverse Event|5|||
164413712|NCT01555164|593886543|FG001|Overall Study|Adverse Event|7|||
164413713|NCT01555164|593886542|FG000|Overall Study|Hyperglycemia|0|||
164413714|NCT01555164|593886543|FG001|Overall Study|Hyperglycemia|1|||
164413715|NCT01555164|593886542|FG000|Overall Study|Investigator's Discretion|2|||
164413716|NCT01555164|593886543|FG001|Overall Study|Investigator's Discretion|2|||
164413717|NCT01555164|593886542|FG000|Overall Study|Lost to Follow-up|4|||
164413718|NCT01555164|593886543|FG001|Overall Study|Lost to Follow-up|3|||
164413719|NCT01555164|593886542|FG000|Overall Study|Protocol Violation|9|||
164413720|NCT01555164|593886543|FG001|Overall Study|Protocol Violation|5|||
164413721|NCT01555164|593886542|FG000|Overall Study|Subject Non-compliance|14|||
164413722|NCT01555164|593886543|FG001|Overall Study|Subject Non-compliance|6|||
164413723|NCT01555164|593886542|FG000|Overall Study|Subject Withdrew Consent|6|||
164413724|NCT01555164|593886543|FG001|Overall Study|Subject Withdrew Consent|11|||
164413725|NCT00886639|593886546|FG000|Overall Study|acute exacerbation|14|||
164413726|NCT00886639|593886546|FG000|Overall Study|non-compliance|2|||
164413727|NCT01871558|593886547|FG000|Overall Study|Other reason|0|||
164413728|NCT01871558|593886548|FG001|Overall Study|Other reason|1|||
164413729|NCT01871558|593886547|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
164413730|NCT01871558|593886548|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
164413731|NCT01871558|593886547|FG000|Overall Study|Withdrawal by Subject|2|||
164413732|NCT01871558|593886548|FG001|Overall Study|Withdrawal by Subject|0|||
164413733|NCT01709305|593886551|FG000|Phase 1|Clinical Adverse Event|80|||
164413734|NCT01709305|593886552|FG001|Phase 1|Clinical Adverse Event|0|||
164413735|NCT01709305|593886553|FG002|Phase 1|Clinical Adverse Event|0|||
164413736|NCT01709305|593886554|FG003|Phase 1|Clinical Adverse Event|0|||
164413737|NCT01709305|593886555|FG004|Phase 1|Clinical Adverse Event|0|||
164413738|NCT01709305|593886551|FG000|Phase 1|Death|2|||
164413739|NCT01709305|593886552|FG001|Phase 1|Death|0|||
164413740|NCT01709305|593886553|FG002|Phase 1|Death|0|||
164413741|NCT01709305|593886554|FG003|Phase 1|Death|0|||
164413742|NCT01709305|593886555|FG004|Phase 1|Death|0|||
164413743|NCT01709305|593886551|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
164413744|NCT01709305|593886552|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
164413745|NCT01709305|593886553|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
164413746|NCT01709305|593886554|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
164413747|NCT01709305|593886555|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
164413748|NCT01709305|593886551|FG000|Phase 1|Laboratory Adverse Event|16|||
164413749|NCT01709305|593886552|FG001|Phase 1|Laboratory Adverse Event|0|||
164413750|NCT01709305|593886553|FG002|Phase 1|Laboratory Adverse Event|0|||
164413751|NCT01709305|593886554|FG003|Phase 1|Laboratory Adverse Event|0|||
164413752|NCT01709305|593886555|FG004|Phase 1|Laboratory Adverse Event|0|||
164413753|NCT01709305|593886551|FG000|Phase 1|Lost to Follow-up|147|||
164709983|NCT01735955|594962814|FG000|Overall Study|Administrative problems|1|||
164709984|NCT01735955|594962814|FG000|Overall Study|Patient/guardian decision|1|||
164709985|NCT01735955|594962814|FG000|Overall Study|Patient withdrew consent|2|||
164709986|NCT01735955|594962814|FG000|Overall Study|Physician Decision|4|||
164709987|NCT01735955|594962814|FG000|Overall Study|Disease progression|24|||
164709988|NCT01735955|594962814|FG000|Overall Study|Adverse Event|5|||
164709989|NCT04228783|594962815|FG000|Overall Study|Adverse Event|1|||
164709990|NCT04228783|594962816|FG001|Overall Study|Adverse Event|0|||
164709991|NCT04228783|594962817|FG002|Overall Study|Adverse Event|2|||
164709992|NCT04228783|594962818|FG003|Overall Study|Adverse Event|0|||
164709993|NCT04228783|594962819|FG004|Overall Study|Adverse Event|0|||
164413754|NCT01709305|593886552|FG001|Phase 1|Lost to Follow-up|0|||
164413755|NCT01709305|593886553|FG002|Phase 1|Lost to Follow-up|0|||
164413756|NCT01709305|593886554|FG003|Phase 1|Lost to Follow-up|0|||
164413757|NCT01709305|593886555|FG004|Phase 1|Lost to Follow-up|0|||
164413758|NCT01709305|593886551|FG000|Phase 1|Travel, moving, etc.|30|||
164413759|NCT01709305|593886552|FG001|Phase 1|Travel, moving, etc.|0|||
164413760|NCT01709305|593886553|FG002|Phase 1|Travel, moving, etc.|0|||
164413761|NCT01709305|593886554|FG003|Phase 1|Travel, moving, etc.|0|||
164413762|NCT01709305|593886555|FG004|Phase 1|Travel, moving, etc.|0|||
164413763|NCT01709305|593886551|FG000|Phase 1|Physician Decision|13|||
164413764|NCT01709305|593886552|FG001|Phase 1|Physician Decision|0|||
164413765|NCT01709305|593886553|FG002|Phase 1|Physician Decision|0|||
164413766|NCT01709305|593886554|FG003|Phase 1|Physician Decision|0|||
164413767|NCT01709305|593886555|FG004|Phase 1|Physician Decision|0|||
164413768|NCT01709305|593886551|FG000|Phase 1|Protocol Violation|118|||
164413769|NCT01709305|593886552|FG001|Phase 1|Protocol Violation|0|||
164413770|NCT01709305|593886553|FG002|Phase 1|Protocol Violation|0|||
164413771|NCT01709305|593886554|FG003|Phase 1|Protocol Violation|0|||
164413772|NCT01709305|593886555|FG004|Phase 1|Protocol Violation|0|||
164413773|NCT01709305|593886551|FG000|Phase 1|Withdrawal by Subject|218|||
164413774|NCT01709305|593886552|FG001|Phase 1|Withdrawal by Subject|0|||
164413775|NCT01709305|593886553|FG002|Phase 1|Withdrawal by Subject|0|||
164413776|NCT01709305|593886554|FG003|Phase 1|Withdrawal by Subject|0|||
164413777|NCT01709305|593886555|FG004|Phase 1|Withdrawal by Subject|0|||
164413778|NCT01709305|593886551|FG000|Phase 2|Clinical Adverse Event|0|||
164413779|NCT01709305|593886552|FG001|Phase 2|Clinical Adverse Event|10|||
164413780|NCT01709305|593886553|FG002|Phase 2|Clinical Adverse Event|10|||
164413781|NCT01709305|593886554|FG003|Phase 2|Clinical Adverse Event|6|||
164413782|NCT01709305|593886555|FG004|Phase 2|Clinical Adverse Event|11|||
164413783|NCT01709305|593886551|FG000|Phase 2|Death|0|||
164413784|NCT01709305|593886552|FG001|Phase 2|Death|0|||
164413785|NCT01709305|593886553|FG002|Phase 2|Death|1|||
164413786|NCT01709305|593886554|FG003|Phase 2|Death|0|||
164413787|NCT01709305|593886555|FG004|Phase 2|Death|0|||
164413788|NCT01709305|593886551|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
164413789|NCT01709305|593886552|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
164413790|NCT01709305|593886553|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
164413791|NCT01709305|593886554|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
164413792|NCT01709305|593886555|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
164413793|NCT01709305|593886551|FG000|Phase 2|Laboratory Adverse Event|0|||
164413794|NCT01709305|593886552|FG001|Phase 2|Laboratory Adverse Event|1|||
164413795|NCT01709305|593886553|FG002|Phase 2|Laboratory Adverse Event|0|||
164413796|NCT01709305|593886554|FG003|Phase 2|Laboratory Adverse Event|1|||
164413797|NCT01709305|593886555|FG004|Phase 2|Laboratory Adverse Event|1|||
164413798|NCT01709305|593886551|FG000|Phase 2|Lost to Follow-up|0|||
164413799|NCT01709305|593886552|FG001|Phase 2|Lost to Follow-up|10|||
164413800|NCT01709305|593886553|FG002|Phase 2|Lost to Follow-up|6|||
164413801|NCT01709305|593886554|FG003|Phase 2|Lost to Follow-up|9|||
164413802|NCT01709305|593886555|FG004|Phase 2|Lost to Follow-up|5|||
164413803|NCT01709305|593886551|FG000|Phase 2|Travel, moving, etc.|0|||
164413804|NCT01709305|593886552|FG001|Phase 2|Travel, moving, etc.|2|||
164413805|NCT01709305|593886553|FG002|Phase 2|Travel, moving, etc.|3|||
164413806|NCT01709305|593886554|FG003|Phase 2|Travel, moving, etc.|3|||
164413807|NCT01709305|593886555|FG004|Phase 2|Travel, moving, etc.|5|||
164413808|NCT01709305|593886551|FG000|Phase 2|Physician Decision|0|||
164413809|NCT01709305|593886552|FG001|Phase 2|Physician Decision|2|||
164413810|NCT01709305|593886553|FG002|Phase 2|Physician Decision|0|||
164413811|NCT01709305|593886554|FG003|Phase 2|Physician Decision|1|||
164413812|NCT01709305|593886555|FG004|Phase 2|Physician Decision|2|||
164413813|NCT01709305|593886551|FG000|Phase 2|Protocol Violation|0|||
164413814|NCT01709305|593886552|FG001|Phase 2|Protocol Violation|19|||
164413815|NCT01709305|593886553|FG002|Phase 2|Protocol Violation|19|||
164413816|NCT01709305|593886554|FG003|Phase 2|Protocol Violation|13|||
164413817|NCT01709305|593886555|FG004|Phase 2|Protocol Violation|9|||
164413818|NCT01709305|593886551|FG000|Phase 2|Withdrawal by Subject|0|||
164413819|NCT01709305|593886552|FG001|Phase 2|Withdrawal by Subject|8|||
164413820|NCT01709305|593886553|FG002|Phase 2|Withdrawal by Subject|6|||
164413821|NCT01709305|593886554|FG003|Phase 2|Withdrawal by Subject|15|||
164709994|NCT04228783|594962820|FG005|Overall Study|Adverse Event|1|||
164709995|NCT04228783|594962815|FG000|Overall Study|Death|0|||
164709996|NCT04228783|594962816|FG001|Overall Study|Death|0|||
164463586|NCT05171855|594070355|FG000|Overall Study|Withdrawal by Subject|2|||
164463587|NCT05171855|594070356|FG001|Overall Study|Withdrawal by Subject|0|||
164463588|NCT05171855|594070357|FG002|Overall Study|Withdrawal by Subject|5|||
164463589|NCT05171855|594070355|FG000|Overall Study|Physician Decision|1|||
164463590|NCT05171855|594070356|FG001|Overall Study|Physician Decision|0|||
164463591|NCT05171855|594070357|FG002|Overall Study|Physician Decision|0|||
164463592|NCT05171855|594070355|FG000|Overall Study|Adverse Event|2|||
164463593|NCT05171855|594070356|FG001|Overall Study|Adverse Event|4|||
164463594|NCT05171855|594070357|FG002|Overall Study|Adverse Event|2|||
164463595|NCT05171855|594070355|FG000|Overall Study|Other|0|||
164463596|NCT05171855|594070356|FG001|Overall Study|Other|0|||
164463597|NCT05171855|594070357|FG002|Overall Study|Other|1|||
164463598|NCT05041257|594070358|FG000|Overall Study|Death|37|||
164463599|NCT05041257|594070358|FG000|Overall Study|Lost to Follow-up|3|||
164463600|NCT05041257|594070358|FG000|Overall Study|Sponsor decision|39|||
164463601|NCT03067480|594070359|FG000|Overall Study|Lost to Follow-up|2|||
164463602|NCT03067480|594070360|FG001|Overall Study|Lost to Follow-up|4|||
164463603|NCT03067480|594070359|FG000|Overall Study|started insulin|1|||
164463604|NCT03067480|594070360|FG001|Overall Study|started insulin|1|||
164463605|NCT05782816|594070361|FG000|Overall Study|Withdrawal by Subject|1|||
164463606|NCT05782816|594070362|FG001|Overall Study|Withdrawal by Subject|0|||
164463607|NCT02442349|594070363|FG000|Overall Study|Death|95|||
164463608|NCT02442349|594070363|FG000|Overall Study|Withdrawal by Subject|27|||
164463609|NCT02442349|594070363|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
164463610|NCT02442349|594070363|FG000|Overall Study|Lost to Follow-up|1|||
164463611|NCT03748953|594070364|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
164463612|NCT03748953|594070365|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
164463613|NCT03748953|594070364|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
164463614|NCT03748953|594070365|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
164463615|NCT03748953|594070364|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
164463616|NCT03748953|594070365|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
164463617|NCT03748953|594070364|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
164463618|NCT03748953|594070365|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
164463619|NCT03748953|594070364|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
164463620|NCT03748953|594070365|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
164463621|NCT04676763|594070366|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
164463622|NCT04676763|594070367|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
164463623|NCT04676763|594070368|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
164463624|NCT04676763|594070366|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
164463625|NCT04676763|594070367|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
164463626|NCT04676763|594070368|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
164463627|NCT04676763|594070366|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
164463628|NCT04676763|594070367|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
164463629|NCT04676763|594070368|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
164463630|NCT02296125|594070369|FG000|Overall Study|Withdrawal by Subject|18|||
164463631|NCT02296125|594070370|FG001|Overall Study|Withdrawal by Subject|8|||
164463632|NCT02296125|594070371|FG002|Overall Study|Withdrawal by Subject|6|||
164463633|NCT02296125|594070372|FG003|Overall Study|Withdrawal by Subject|2|||
164463634|NCT02296125|594070369|FG000|Overall Study|Adverse Event|41|||
164463635|NCT02296125|594070370|FG001|Overall Study|Adverse Event|52|||
164463636|NCT02296125|594070371|FG002|Overall Study|Adverse Event|9|||
164463637|NCT02296125|594070372|FG003|Overall Study|Adverse Event|4|||
164463638|NCT02296125|594070369|FG000|Overall Study|Severe non-compliance to protocol|0|||
164463639|NCT02296125|594070370|FG001|Overall Study|Severe non-compliance to protocol|1|||
164463640|NCT02296125|594070371|FG002|Overall Study|Severe non-compliance to protocol|0|||
164463641|NCT02296125|594070372|FG003|Overall Study|Severe non-compliance to protocol|0|||
164463642|NCT02296125|594070369|FG000|Overall Study|Condition under investigation worsened|153|||
164463643|NCT02296125|594070370|FG001|Overall Study|Condition under investigation worsened|199|||
164463644|NCT02296125|594070371|FG002|Overall Study|Condition under investigation worsened|39|||
164463645|NCT02296125|594070372|FG003|Overall Study|Condition under investigation worsened|56|||
164463646|NCT02296125|594070369|FG000|Overall Study|Any reason not specifically recorded|6|||
164463647|NCT02296125|594070370|FG001|Overall Study|Any reason not specifically recorded|4|||
164463648|NCT02296125|594070371|FG002|Overall Study|Any reason not specifically recorded|2|||
164463649|NCT02296125|594070372|FG003|Overall Study|Any reason not specifically recorded|0|||
164463650|NCT04225273|594070373|FG000|Overall Study|Lost to Follow-up|3|||
164463651|NCT02927236|594070374|FG000|Characterization Phase|Physician Decision|0|||
164463652|NCT02927236|594070375|FG001|Characterization Phase|Physician Decision|3|||
164463653|NCT02927236|594070376|FG002|Characterization Phase|Physician Decision|0|||
164463654|NCT02927236|594070377|FG003|Characterization Phase|Physician Decision|2|||
164463655|NCT02927236|594070374|FG000|Characterization Phase|Lost to Follow-up|0|||
164463656|NCT02927236|594070375|FG001|Characterization Phase|Lost to Follow-up|0|||
164463657|NCT02927236|594070376|FG002|Characterization Phase|Lost to Follow-up|0|||
164463658|NCT02927236|594070377|FG003|Characterization Phase|Lost to Follow-up|3|||
164463659|NCT02927236|594070374|FG000|Characterization Phase|Withdrawal by Subject|1|||
164413822|NCT01709305|593886555|FG004|Phase 2|Withdrawal by Subject|12|||
164413823|NCT02875834|593886556|FG000|Open-label Phase|Withdrawal by Subject|3|||
164463660|NCT02927236|594070375|FG001|Characterization Phase|Withdrawal by Subject|0|||
164463661|NCT02927236|594070376|FG002|Characterization Phase|Withdrawal by Subject|0|||
164463662|NCT02927236|594070377|FG003|Characterization Phase|Withdrawal by Subject|1|||
164463663|NCT02927236|594070374|FG000|Treatment Phase|Adverse Event|1|||
164463664|NCT02927236|594070375|FG001|Treatment Phase|Adverse Event|0|||
164463665|NCT02927236|594070376|FG002|Treatment Phase|Adverse Event|1|||
164463666|NCT02927236|594070377|FG003|Treatment Phase|Adverse Event|1|||
164463667|NCT02927236|594070374|FG000|Treatment Phase|Protocol Violation|3|||
164463668|NCT02927236|594070375|FG001|Treatment Phase|Protocol Violation|0|||
164463669|NCT02927236|594070376|FG002|Treatment Phase|Protocol Violation|0|||
164463670|NCT02927236|594070377|FG003|Treatment Phase|Protocol Violation|1|||
164463671|NCT02927236|594070374|FG000|Treatment Phase|Lost to Follow-up|1|||
164463672|NCT02927236|594070375|FG001|Treatment Phase|Lost to Follow-up|0|||
164463673|NCT02927236|594070376|FG002|Treatment Phase|Lost to Follow-up|0|||
164463674|NCT02927236|594070377|FG003|Treatment Phase|Lost to Follow-up|0|||
164463675|NCT02927236|594070374|FG000|Follow-up Phase|Lost to Follow-up|1|||
164463676|NCT02927236|594070375|FG001|Follow-up Phase|Lost to Follow-up|0|||
164463677|NCT02927236|594070376|FG002|Follow-up Phase|Lost to Follow-up|1|||
164463678|NCT02927236|594070377|FG003|Follow-up Phase|Lost to Follow-up|0|||
164463679|NCT01919554|594070379|FG000|Overall Study|Withdrawal by Subject|0|||
164463680|NCT01919554|594070380|FG001|Overall Study|Withdrawal by Subject|0|||
164463681|NCT01919554|594070381|FG002|Overall Study|Withdrawal by Subject|1|||
164463682|NCT01919554|594070382|FG003|Overall Study|Withdrawal by Subject|1|||
164463683|NCT02838420|594070388|FG000|Overall Study|Ongoing in Study|113|||
164463684|NCT02838420|594070389|FG001|Overall Study|Ongoing in Study|45|||
164463685|NCT02838420|594070388|FG000|Overall Study|Lost to Follow-up|1|||
164463686|NCT02838420|594070389|FG001|Overall Study|Lost to Follow-up|0|||
164413824|NCT02875834|593886557|FG001|Open-label Phase|Withdrawal by Subject|0|||
164413825|NCT02875834|593886558|FG002|Open-label Phase|Withdrawal by Subject|0|||
164413826|NCT02875834|593886559|FG003|Open-label Phase|Withdrawal by Subject|0|||
164413827|NCT02875834|593886556|FG000|Open-label Phase|(Not collected)|4|||
164413828|NCT02875834|593886557|FG001|Open-label Phase|(Not collected)|0|||
164413829|NCT02875834|593886558|FG002|Open-label Phase|(Not collected)|0|||
164413830|NCT02875834|593886559|FG003|Open-label Phase|(Not collected)|0|||
164413831|NCT02875834|593886556|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
164413832|NCT02875834|593886557|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
164413833|NCT02875834|593886558|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
164413834|NCT02875834|593886559|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
164413835|NCT02875834|593886556|FG000|Randomized Treatment Phase|Protocol Violation|0|||
164413836|NCT02875834|593886557|FG001|Randomized Treatment Phase|Protocol Violation|2|||
164463687|NCT02838420|594070388|FG000|Overall Study|Withdrawal by Subject|3|||
164463688|NCT02838420|594070389|FG001|Overall Study|Withdrawal by Subject|4|||
164413837|NCT02875834|593886558|FG002|Randomized Treatment Phase|Protocol Violation|0|||
164463689|NCT02838420|594070388|FG000|Overall Study|Death|8|||
164463690|NCT02838420|594070389|FG001|Overall Study|Death|13|||
164463691|NCT03024437|594070390|FG000|Overall Study|Adverse Event|0|||
164463692|NCT03024437|594070391|FG001|Overall Study|Adverse Event|1|||
164709997|NCT04228783|594962817|FG002|Overall Study|Death|0|||
164709998|NCT04228783|594962818|FG003|Overall Study|Death|0|||
164709999|NCT04228783|594962819|FG004|Overall Study|Death|1|||
164710000|NCT04228783|594962820|FG005|Overall Study|Death|0|||
164710001|NCT04228783|594962815|FG000|Overall Study|Lost to Follow-up|36|||
164710002|NCT04228783|594962816|FG001|Overall Study|Lost to Follow-up|36|||
164710003|NCT04228783|594962817|FG002|Overall Study|Lost to Follow-up|28|||
164710004|NCT04228783|594962818|FG003|Overall Study|Lost to Follow-up|6|||
164710005|NCT04228783|594962819|FG004|Overall Study|Lost to Follow-up|14|||
164710006|NCT04228783|594962820|FG005|Overall Study|Lost to Follow-up|3|||
164710007|NCT04228783|594962815|FG000|Overall Study|Physician Decision|1|||
164710008|NCT04228783|594962816|FG001|Overall Study|Physician Decision|2|||
164710009|NCT04228783|594962817|FG002|Overall Study|Physician Decision|0|||
164710010|NCT04228783|594962818|FG003|Overall Study|Physician Decision|0|||
164710011|NCT04228783|594962819|FG004|Overall Study|Physician Decision|0|||
164710012|NCT04228783|594962820|FG005|Overall Study|Physician Decision|0|||
164710013|NCT04228783|594962815|FG000|Overall Study|Protocol Violation|0|||
164710014|NCT04228783|594962816|FG001|Overall Study|Protocol Violation|0|||
164710015|NCT04228783|594962817|FG002|Overall Study|Protocol Violation|0|||
164710016|NCT04228783|594962818|FG003|Overall Study|Protocol Violation|1|||
164710017|NCT04228783|594962819|FG004|Overall Study|Protocol Violation|0|||
164710018|NCT04228783|594962820|FG005|Overall Study|Protocol Violation|0|||
164413838|NCT02875834|593886559|FG003|Randomized Treatment Phase|Protocol Violation|0|||
164710019|NCT04228783|594962815|FG000|Overall Study|Withdrawal by Subject|6|||
164710020|NCT04228783|594962816|FG001|Overall Study|Withdrawal by Subject|10|||
164710021|NCT04228783|594962817|FG002|Overall Study|Withdrawal by Subject|19|||
164710022|NCT04228783|594962818|FG003|Overall Study|Withdrawal by Subject|1|||
164710023|NCT04228783|594962819|FG004|Overall Study|Withdrawal by Subject|2|||
164710024|NCT04228783|594962820|FG005|Overall Study|Withdrawal by Subject|0|||
164710025|NCT04228783|594962815|FG000|Overall Study|Other|4|||
164710026|NCT04228783|594962816|FG001|Overall Study|Other|3|||
164413839|NCT02875834|593886556|FG000|Randomized Treatment Phase|(Not collected)|0|||
164413840|NCT02875834|593886557|FG001|Randomized Treatment Phase|(Not collected)|9|||
164413841|NCT02875834|593886558|FG002|Randomized Treatment Phase|(Not collected)|10|||
164413842|NCT02875834|593886559|FG003|Randomized Treatment Phase|(Not collected)|9|||
164413843|NCT01302938|593886560|FG000|Overall Study|Withdrawal by Subject|1|||
164413844|NCT01302938|593886561|FG001|Overall Study|Withdrawal by Subject|0|||
164413845|NCT01302938|593886560|FG000|Overall Study|Adverse Event|1|||
164413846|NCT01302938|593886561|FG001|Overall Study|Adverse Event|0|||
164413847|NCT03443713|593886563|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
164413848|NCT03443713|593886564|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
164413849|NCT03443713|593886565|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
164413850|NCT01672853|593886566|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
164413851|NCT01672853|593886567|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
164413852|NCT01672853|593886568|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
164413853|NCT01672853|593886566|FG000|Overall Study|Pregnancy|0|||
164413854|NCT01672853|593886567|FG001|Overall Study|Pregnancy|1|||
164413855|NCT01672853|593886568|FG002|Overall Study|Pregnancy|0|||
164413856|NCT01672853|593886566|FG000|Overall Study|Investigator's Discretion|1|||
164413857|NCT01672853|593886567|FG001|Overall Study|Investigator's Discretion|0|||
164413858|NCT01672853|593886568|FG002|Overall Study|Investigator's Discretion|0|||
164413859|NCT01672853|593886566|FG000|Overall Study|Withdrew Consent|5|||
164413860|NCT01672853|593886567|FG001|Overall Study|Withdrew Consent|5|||
164413861|NCT01672853|593886568|FG002|Overall Study|Withdrew Consent|5|||
164413862|NCT01672853|593886566|FG000|Overall Study|Adverse Event|4|||
164413863|NCT01672853|593886567|FG001|Overall Study|Adverse Event|6|||
164413864|NCT01672853|593886568|FG002|Overall Study|Adverse Event|8|||
164413865|NCT01672853|593886566|FG000|Overall Study|Lost to Follow-up|0|||
164413866|NCT01672853|593886567|FG001|Overall Study|Lost to Follow-up|1|||
164413867|NCT01672853|593886568|FG002|Overall Study|Lost to Follow-up|0|||
164413868|NCT01672853|593886566|FG000|Overall Study|Randomized but Never Treated|0|||
164413869|NCT01672853|593886567|FG001|Overall Study|Randomized but Never Treated|0|||
164413870|NCT01672853|593886568|FG002|Overall Study|Randomized but Never Treated|1|||
164413871|NCT02969525|593886569|FG000|Double-Blind Period|Adverse Event|0|||
164413872|NCT02969525|593886570|FG001|Double-Blind Period|Adverse Event|0|||
164413873|NCT02969525|593886571|FG002|Double-Blind Period|Adverse Event|1|||
164413874|NCT02969525|593886572|FG003|Double-Blind Period|Adverse Event|1|||
164413875|NCT02969525|593886573|FG004|Double-Blind Period|Adverse Event|0|||
164413876|NCT02969525|593886574|FG005|Double-Blind Period|Adverse Event|0|||
164413877|NCT02969525|593886575|FG006|Double-Blind Period|Adverse Event|0|||
164710027|NCT04228783|594962817|FG002|Overall Study|Other|2|||
164710028|NCT04228783|594962818|FG003|Overall Study|Other|1|||
164413878|NCT02969525|593886576|FG007|Double-Blind Period|Adverse Event|0|||
164413879|NCT02969525|593886577|FG008|Double-Blind Period|Adverse Event|0|||
164413880|NCT02969525|593886578|FG009|Double-Blind Period|Adverse Event|0|||
164710029|NCT04228783|594962819|FG004|Overall Study|Other|0|||
164710030|NCT04228783|594962820|FG005|Overall Study|Other|0|||
164710031|NCT03327792|594962821|FG000|Overall Study|Adverse Event|4|||
164710032|NCT03327792|594962822|FG001|Overall Study|Adverse Event|0|||
164413881|NCT02969525|593886579|FG010|Double-Blind Period|Adverse Event|0|||
164413882|NCT02969525|593886580|FG011|Double-Blind Period|Adverse Event|0|||
164413883|NCT02969525|593886569|FG000|Double-Blind Period|LOW EGFR|0|||
164413884|NCT02969525|593886570|FG001|Double-Blind Period|LOW EGFR|0|||
164413885|NCT02969525|593886571|FG002|Double-Blind Period|LOW EGFR|0|||
164413886|NCT02969525|593886572|FG003|Double-Blind Period|LOW EGFR|1|||
164413887|NCT02969525|593886573|FG004|Double-Blind Period|LOW EGFR|0|||
164413888|NCT02969525|593886574|FG005|Double-Blind Period|LOW EGFR|0|||
164413889|NCT02969525|593886575|FG006|Double-Blind Period|LOW EGFR|0|||
164413890|NCT02969525|593886576|FG007|Double-Blind Period|LOW EGFR|0|||
164413891|NCT02969525|593886577|FG008|Double-Blind Period|LOW EGFR|0|||
164413892|NCT02969525|593886578|FG009|Double-Blind Period|LOW EGFR|0|||
164413893|NCT02969525|593886579|FG010|Double-Blind Period|LOW EGFR|0|||
164413894|NCT02969525|593886580|FG011|Double-Blind Period|LOW EGFR|0|||
164413895|NCT02969525|593886569|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
164413896|NCT02969525|593886570|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
164413897|NCT02969525|593886571|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
164413898|NCT02969525|593886572|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
164413899|NCT02969525|593886573|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
164413900|NCT02969525|593886574|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
164413901|NCT02969525|593886575|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
164413902|NCT02969525|593886576|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
164413903|NCT02969525|593886577|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
164413904|NCT02969525|593886578|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
164413905|NCT02969525|593886579|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
164413906|NCT02969525|593886580|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
164413907|NCT02969525|593886569|FG000|Dose-Blind Period|Adverse Event|0|||
164413908|NCT02969525|593886570|FG001|Dose-Blind Period|Adverse Event|0|||
164413909|NCT02969525|593886571|FG002|Dose-Blind Period|Adverse Event|0|||
164413910|NCT02969525|593886572|FG003|Dose-Blind Period|Adverse Event|0|||
164413911|NCT02969525|593886573|FG004|Dose-Blind Period|Adverse Event|0|||
164413912|NCT02969525|593886574|FG005|Dose-Blind Period|Adverse Event|0|||
164413913|NCT02969525|593886575|FG006|Dose-Blind Period|Adverse Event|0|||
164413914|NCT02969525|593886576|FG007|Dose-Blind Period|Adverse Event|0|||
164413915|NCT02969525|593886577|FG008|Dose-Blind Period|Adverse Event|0|||
164413916|NCT02969525|593886578|FG009|Dose-Blind Period|Adverse Event|1|||
164413917|NCT02969525|593886579|FG010|Dose-Blind Period|Adverse Event|1|||
164413918|NCT02969525|593886580|FG011|Dose-Blind Period|Adverse Event|1|||
164413919|NCT02969525|593886569|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
164413920|NCT02969525|593886570|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
164463693|NCT03024437|594070392|FG002|Overall Study|Adverse Event|3|||
164463694|NCT03024437|594070393|FG003|Overall Study|Adverse Event|5|||
164463695|NCT03024437|594070394|FG004|Overall Study|Adverse Event|0|||
164463696|NCT03024437|594070390|FG000|Overall Study|Physician Decision|1|||
164463697|NCT03024437|594070391|FG001|Overall Study|Physician Decision|0|||
164463698|NCT03024437|594070392|FG002|Overall Study|Physician Decision|0|||
164463699|NCT03024437|594070393|FG003|Overall Study|Physician Decision|1|||
164463700|NCT03024437|594070394|FG004|Overall Study|Physician Decision|0|||
164463701|NCT03024437|594070390|FG000|Overall Study|Disease progression, relapse|1|||
164463702|NCT03024437|594070391|FG001|Overall Study|Disease progression, relapse|0|||
164463703|NCT03024437|594070392|FG002|Overall Study|Disease progression, relapse|0|||
164463704|NCT03024437|594070393|FG003|Overall Study|Disease progression, relapse|3|||
164463705|NCT03024437|594070394|FG004|Overall Study|Disease progression, relapse|0|||
164463706|NCT03024437|594070390|FG000|Overall Study|Disease progression, refractory disease|4|||
164463707|NCT03024437|594070391|FG001|Overall Study|Disease progression, refractory disease|4|||
164463708|NCT03024437|594070392|FG002|Overall Study|Disease progression, refractory disease|2|||
164413921|NCT02969525|593886571|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
164413922|NCT02969525|593886572|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
164463709|NCT03024437|594070393|FG003|Overall Study|Disease progression, refractory disease|2|||
164463710|NCT03024437|594070394|FG004|Overall Study|Disease progression, refractory disease|1|||
164413923|NCT02969525|593886573|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
164413924|NCT02969525|593886574|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
164413925|NCT02969525|593886575|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
164413926|NCT02969525|593886576|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
164413927|NCT02969525|593886577|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
164413928|NCT02969525|593886578|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
164413929|NCT02969525|593886579|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
164463711|NCT03024437|594070390|FG000|Overall Study|Newly diagnosed cancer|0|||
164463712|NCT03024437|594070391|FG001|Overall Study|Newly diagnosed cancer|0|||
164710033|NCT03327792|594962821|FG000|Overall Study|Family/Personal issues|3|||
164710034|NCT03327792|594962822|FG001|Overall Study|Family/Personal issues|2|||
164463713|NCT03024437|594070392|FG002|Overall Study|Newly diagnosed cancer|0|||
164463714|NCT03024437|594070393|FG003|Overall Study|Newly diagnosed cancer|1|||
164463715|NCT03024437|594070394|FG004|Overall Study|Newly diagnosed cancer|0|||
164463716|NCT03024437|594070390|FG000|Overall Study|Moved out of state|0|||
164463717|NCT03024437|594070391|FG001|Overall Study|Moved out of state|1|||
164463718|NCT03024437|594070392|FG002|Overall Study|Moved out of state|0|||
164463719|NCT03024437|594070393|FG003|Overall Study|Moved out of state|0|||
164463720|NCT03024437|594070394|FG004|Overall Study|Moved out of state|0|||
164463721|NCT03024437|594070390|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
164463722|NCT03024437|594070391|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
164463723|NCT03024437|594070392|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
164463724|NCT03024437|594070393|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
164463725|NCT03024437|594070394|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
164463726|NCT03240016|594070397|FG000|Overall Study|Adverse Event|9|||
164463727|NCT03240016|594070397|FG000|Overall Study|Withdrawal by Subject|7|||
164463728|NCT03240016|594070397|FG000|Overall Study|Death|1|||
164463729|NCT03240016|594070397|FG000|Overall Study|Physician Decision|2|||
164463730|NCT05200403|594070398|FG000|Overall Study|Withdrawal by Subject|4|||
164463731|NCT05200403|594070399|FG001|Overall Study|Withdrawal by Subject|2|||
164463732|NCT05200403|594070400|FG002|Overall Study|Withdrawal by Subject|6|||
164463733|NCT05546411|594070401|FG000|Overall Study|Progressive Disease|1|||
164463734|NCT05546411|594070402|FG001|Overall Study|Progressive Disease|0|||
164463735|NCT05546411|594070401|FG000|Overall Study|Adverse Event|0|||
164463736|NCT05546411|594070402|FG001|Overall Study|Adverse Event|1|||
164463737|NCT05546411|594070401|FG000|Overall Study|Metastatic disease|1|||
164463738|NCT05546411|594070402|FG001|Overall Study|Metastatic disease|0|||
164463739|NCT02606422|594070403|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
164463740|NCT02606422|594070404|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
164463741|NCT02606422|594070403|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
164463742|NCT02606422|594070404|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
164463743|NCT02606422|594070403|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
164463744|NCT02606422|594070404|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
164463745|NCT02606422|594070403|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
164463746|NCT02606422|594070404|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
164463747|NCT04625465|594070405|FG000|Overall Study|Lost to Follow-up|2|||
164463748|NCT04625465|594070406|FG001|Overall Study|Lost to Follow-up|2|||
164413930|NCT02969525|593886580|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
164413931|NCT02969525|593886569|FG000|Dose-Blind Period|Non-cooperating patient|0|||
164413932|NCT02969525|593886570|FG001|Dose-Blind Period|Non-cooperating patient|0|||
164413933|NCT02969525|593886571|FG002|Dose-Blind Period|Non-cooperating patient|0|||
164413934|NCT02969525|593886572|FG003|Dose-Blind Period|Non-cooperating patient|0|||
164413935|NCT02969525|593886573|FG004|Dose-Blind Period|Non-cooperating patient|0|||
164413936|NCT02969525|593886574|FG005|Dose-Blind Period|Non-cooperating patient|0|||
164413937|NCT02969525|593886575|FG006|Dose-Blind Period|Non-cooperating patient|0|||
164413938|NCT02969525|593886576|FG007|Dose-Blind Period|Non-cooperating patient|0|||
164413939|NCT02969525|593886577|FG008|Dose-Blind Period|Non-cooperating patient|0|||
164413940|NCT02969525|593886578|FG009|Dose-Blind Period|Non-cooperating patient|0|||
164413941|NCT02969525|593886579|FG010|Dose-Blind Period|Non-cooperating patient|0|||
164413942|NCT02969525|593886580|FG011|Dose-Blind Period|Non-cooperating patient|1|||
164413943|NCT02969525|593886569|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
164413944|NCT02969525|593886570|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
164413945|NCT02969525|593886571|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
164413946|NCT02969525|593886572|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
164413947|NCT02969525|593886573|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
164413948|NCT02969525|593886574|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
164413949|NCT02969525|593886575|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
164413950|NCT02969525|593886576|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
164413951|NCT02969525|593886577|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
164413952|NCT02969525|593886578|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
164413953|NCT02969525|593886579|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
164413954|NCT02969525|593886580|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
164413955|NCT03445065|593886581|FG000|Overall Study|Withdrawal by Subject|3|||
164413956|NCT03445065|593886582|FG001|Overall Study|Withdrawal by Subject|6|||
164413957|NCT03445065|593886583|FG002|Overall Study|Withdrawal by Subject|2|||
164413958|NCT03445065|593886584|FG003|Overall Study|Withdrawal by Subject|2|||
164413959|NCT03445065|593886581|FG000|Overall Study|Other|4|||
164413960|NCT03445065|593886582|FG001|Overall Study|Other|3|||
164413961|NCT03445065|593886583|FG002|Overall Study|Other|3|||
164413962|NCT03445065|593886584|FG003|Overall Study|Other|1|||
164413963|NCT02172625|593886585|FG000|Overall Study|Adverse Event|0|||
164413964|NCT02172625|593886586|FG001|Overall Study|Adverse Event|1|||
164413965|NCT02172625|593886585|FG000|Overall Study|Pregnancy|0|||
164413966|NCT02172625|593886586|FG001|Overall Study|Pregnancy|1|||
164413967|NCT02172625|593886585|FG000|Overall Study|car accident|0|||
164463749|NCT04625465|594070407|FG002|Overall Study|Lost to Follow-up|1|||
164463750|NCT04625465|594070408|FG003|Overall Study|Lost to Follow-up|0|||
164413968|NCT02172625|593886586|FG001|Overall Study|car accident|1|||
164413969|NCT03315130|593886587|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
164413970|NCT03315130|593886588|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
164413971|NCT03315130|593886589|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
164413972|NCT03315130|593886590|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
164413973|NCT03315130|593886587|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
164413974|NCT03315130|593886588|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
164413975|NCT03315130|593886589|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
164413976|NCT03315130|593886590|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
164413977|NCT03315130|593886587|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
164413978|NCT03315130|593886588|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
164413979|NCT03315130|593886589|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
164413980|NCT03315130|593886590|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
164413981|NCT03315130|593886587|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
164413982|NCT03315130|593886588|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
164413983|NCT03315130|593886589|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
164413984|NCT03315130|593886590|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
164413985|NCT03315130|593886587|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
164413986|NCT03315130|593886588|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
164413987|NCT03315130|593886589|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
164413988|NCT03315130|593886590|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
164413989|NCT03315130|593886587|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
164413990|NCT03315130|593886588|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
164413991|NCT03315130|593886589|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
164413992|NCT03315130|593886590|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
164413993|NCT00524030|593886591|FG000|Overall Study|Lack of Efficacy|10|||
164413994|NCT00524030|593886592|FG001|Overall Study|Lack of Efficacy|24|||
164413995|NCT00524030|593886591|FG000|Overall Study|Lost to Follow-up|0|||
164413996|NCT00524030|593886592|FG001|Overall Study|Lost to Follow-up|2|||
164413997|NCT00524030|593886591|FG000|Overall Study|Withdrawal by Subject|3|||
164413998|NCT00524030|593886592|FG001|Overall Study|Withdrawal by Subject|8|||
164413999|NCT00524030|593886591|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
164414000|NCT00524030|593886592|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
164414001|NCT00524030|593886591|FG000|Overall Study|Protocol Violation|0|||
164414002|NCT00524030|593886592|FG001|Overall Study|Protocol Violation|1|||
164414003|NCT00524030|593886591|FG000|Overall Study|Pregnancy|1|||
164414004|NCT00524030|593886592|FG001|Overall Study|Pregnancy|0|||
164414005|NCT00524030|593886591|FG000|Overall Study|Adverse Event|3|||
164414006|NCT00524030|593886592|FG001|Overall Study|Adverse Event|21|||
164414007|NCT00524030|593886591|FG000|Overall Study|Death|0|||
164414008|NCT00524030|593886592|FG001|Overall Study|Death|1|||
164414009|NCT02944656|593886593|FG000|Overall Study|No longer eligible|3|||
164414010|NCT02944656|593886594|FG001|Overall Study|No longer eligible|0|||
164414011|NCT02944656|593886593|FG000|Overall Study|Lost to Follow-up|7|||
164414012|NCT02944656|593886594|FG001|Overall Study|Lost to Follow-up|10|||
164414013|NCT04398537|593886595|FG000|Overall Study|Physician Decision|10|||
164414014|NCT04398537|593886596|FG001|Overall Study|Physician Decision|15|||
164414015|NCT00118898|593886597|FG000|Overall Study|Death|6|||
164414016|NCT00118898|593886598|FG001|Overall Study|Death|11|||
164414017|NCT00118898|593886599|FG002|Overall Study|Death|6|||
164414018|NCT00118898|593886600|FG003|Overall Study|Death|8|||
164414019|NCT00118898|593886597|FG000|Overall Study|Lost to Follow-up|26|||
164414020|NCT00118898|593886598|FG001|Overall Study|Lost to Follow-up|34|||
164414021|NCT00118898|593886599|FG002|Overall Study|Lost to Follow-up|33|||
164414022|NCT00118898|593886600|FG003|Overall Study|Lost to Follow-up|33|||
164414023|NCT00118898|593886597|FG000|Overall Study|Withdrawal by Subject|10|||
164414024|NCT00118898|593886598|FG001|Overall Study|Withdrawal by Subject|5|||
164414025|NCT00118898|593886599|FG002|Overall Study|Withdrawal by Subject|8|||
164414026|NCT00118898|593886600|FG003|Overall Study|Withdrawal by Subject|8|||
164414027|NCT00118898|593886597|FG000|Overall Study|Site Closure|33|||
164414028|NCT00118898|593886598|FG001|Overall Study|Site Closure|31|||
164414029|NCT00118898|593886599|FG002|Overall Study|Site Closure|28|||
164414030|NCT00118898|593886600|FG003|Overall Study|Site Closure|37|||
164414031|NCT00118898|593886597|FG000|Overall Study|Severe debilitation|1|||
164414032|NCT00118898|593886598|FG001|Overall Study|Severe debilitation|4|||
164414033|NCT00118898|593886599|FG002|Overall Study|Severe debilitation|6|||
164414034|NCT00118898|593886600|FG003|Overall Study|Severe debilitation|4|||
164414035|NCT00118898|593886597|FG000|Overall Study|Not compliant with requirements|11|||
164414036|NCT00118898|593886598|FG001|Overall Study|Not compliant with requirements|13|||
164414037|NCT00118898|593886599|FG002|Overall Study|Not compliant with requirements|11|||
164414038|NCT00118898|593886600|FG003|Overall Study|Not compliant with requirements|11|||
164414039|NCT00118898|593886597|FG000|Overall Study|Not able to get to clinic|34|||
164414040|NCT00118898|593886598|FG001|Overall Study|Not able to get to clinic|43|||
164414041|NCT00118898|593886599|FG002|Overall Study|Not able to get to clinic|31|||
164463751|NCT04625465|594070409|FG004|Overall Study|Lost to Follow-up|0|||
164463752|NCT04625465|594070410|FG005|Overall Study|Lost to Follow-up|2|||
164463753|NCT04625465|594070411|FG006|Overall Study|Lost to Follow-up|0|||
164463754|NCT04625465|594070412|FG007|Overall Study|Lost to Follow-up|0|||
164463755|NCT04625465|594070405|FG000|Overall Study|Death|1|||
164463756|NCT04625465|594070406|FG001|Overall Study|Death|0|||
164463757|NCT04625465|594070407|FG002|Overall Study|Death|0|||
164463758|NCT04625465|594070408|FG003|Overall Study|Death|0|||
164463759|NCT04625465|594070409|FG004|Overall Study|Death|0|||
164463760|NCT04625465|594070410|FG005|Overall Study|Death|0|||
164463761|NCT04625465|594070411|FG006|Overall Study|Death|0|||
164463762|NCT04625465|594070412|FG007|Overall Study|Death|0|||
164463763|NCT04625465|594070405|FG000|Overall Study|Withdrawal by Subject|1|||
164463764|NCT04625465|594070406|FG001|Overall Study|Withdrawal by Subject|0|||
164463765|NCT04625465|594070407|FG002|Overall Study|Withdrawal by Subject|4|||
164463766|NCT04625465|594070408|FG003|Overall Study|Withdrawal by Subject|4|||
164463767|NCT04625465|594070409|FG004|Overall Study|Withdrawal by Subject|4|||
164463768|NCT04625465|594070410|FG005|Overall Study|Withdrawal by Subject|0|||
164463769|NCT04625465|594070411|FG006|Overall Study|Withdrawal by Subject|0|||
164463770|NCT04625465|594070412|FG007|Overall Study|Withdrawal by Subject|0|||
164463771|NCT05566639|594070416|FG000|Overall Study|Adverse Event|1|||
164463772|NCT05566639|594070417|FG001|Overall Study|Adverse Event|1|||
164463773|NCT05566639|594070416|FG000|Overall Study|Serious Adverse Event|1|||
164463774|NCT05566639|594070417|FG001|Overall Study|Serious Adverse Event|3|||
164463775|NCT05566639|594070416|FG000|Overall Study|Death|44|||
164463776|NCT05566639|594070417|FG001|Overall Study|Death|45|||
164463777|NCT05566639|594070416|FG000|Overall Study|Lost to Follow-up|467|||
164463778|NCT05566639|594070417|FG001|Overall Study|Lost to Follow-up|461|||
164463779|NCT05566639|594070416|FG000|Overall Study|Physician Decision|45|||
164463780|NCT05566639|594070417|FG001|Overall Study|Physician Decision|44|||
164463781|NCT05566639|594070416|FG000|Overall Study|Protocol Deviation|4|||
164463782|NCT05566639|594070417|FG001|Overall Study|Protocol Deviation|4|||
164463783|NCT05566639|594070416|FG000|Overall Study|Withdrawal by Subject|277|||
164463784|NCT05566639|594070417|FG001|Overall Study|Withdrawal by Subject|271|||
164463785|NCT05566639|594070416|FG000|Overall Study|Other Than Specified|52|||
164463786|NCT05566639|594070417|FG001|Overall Study|Other Than Specified|64|||
164463787|NCT04054193|594070425|FG000|Cycle 1|Physician Decision|1|||
164463788|NCT04054193|594070425|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
164463789|NCT04054193|594070425|FG000|Cycle 1|Allocated but not treated|3|||
164463790|NCT04054193|594070425|FG000|Cycles 2-3|Physician Decision|2|||
164463791|NCT04054193|594070425|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
164463792|NCT04054193|594070425|FG000|Cycles 2-3|Various reasons|17|||
164463793|NCT02966873|594070426|FG000|Overall Study|Lost to Follow-up|16|||
164463794|NCT02966873|594070427|FG001|Overall Study|Lost to Follow-up|15|||
164463795|NCT05436262|594070431|FG000|Pre-Randomization|Withdrawal by Subject|1|||
164463796|NCT05436262|594070432|FG001|Pre-Randomization|Withdrawal by Subject|0|||
164463797|NCT05436262|594070433|FG002|Pre-Randomization|Withdrawal by Subject|0|||
164463798|NCT05436262|594070431|FG000|Randomization|Withdrawal by Subject|0|||
164463799|NCT05436262|594070432|FG001|Randomization|Withdrawal by Subject|1|||
164463800|NCT05436262|594070433|FG002|Randomization|Withdrawal by Subject|0|||
164463801|NCT05299073|594070434|FG000|Overall Study|Withdrawal by Subject|0|||
164463802|NCT05299073|594070435|FG001|Overall Study|Withdrawal by Subject|0|||
164463803|NCT05299073|594070436|FG002|Overall Study|Withdrawal by Subject|1|||
164463804|NCT05299073|594070434|FG000|Overall Study|Adverse Event|0|||
164463805|NCT05299073|594070435|FG001|Overall Study|Adverse Event|1|||
164463806|NCT05299073|594070436|FG002|Overall Study|Adverse Event|0|||
164463807|NCT05299073|594070434|FG000|Overall Study|Lost to Follow-up|0|||
164463808|NCT05299073|594070435|FG001|Overall Study|Lost to Follow-up|1|||
164463809|NCT05299073|594070436|FG002|Overall Study|Lost to Follow-up|0|||
164463810|NCT03952338|594070437|FG000|Overall Study|Lost to Follow-up|11|||
164463811|NCT03952338|594070438|FG001|Overall Study|Lost to Follow-up|17|||
164463812|NCT03952338|594070437|FG000|Overall Study|Withdrawal by Subject|1|||
164463813|NCT03952338|594070438|FG001|Overall Study|Withdrawal by Subject|1|||
164414042|NCT00118898|593886600|FG003|Overall Study|Not able to get to clinic|40|||
164414043|NCT02714205|593886606|FG000|Overall Study|Cannot tolerate medication|1|||
164414044|NCT02714205|593886607|FG001|Overall Study|Cannot tolerate medication|0|||
164414045|NCT02714205|593886606|FG000|Overall Study|Adverse Event|2|||
164414046|NCT02714205|593886607|FG001|Overall Study|Adverse Event|0|||
164414047|NCT02714205|593886606|FG000|Overall Study|Too busy|1|||
164414048|NCT02714205|593886607|FG001|Overall Study|Too busy|0|||
164414049|NCT02714205|593886606|FG000|Overall Study|Incomplete outcome data|0|||
164414050|NCT02714205|593886607|FG001|Overall Study|Incomplete outcome data|1|||
164463814|NCT03952338|594070437|FG000|Overall Study|Protocol Violation|1|||
164463815|NCT03952338|594070438|FG001|Overall Study|Protocol Violation|0|||
164463816|NCT04770402|594070441|FG000|Overall Study|Lost to Follow-up|1|||
164463817|NCT04770402|594070442|FG001|Overall Study|Lost to Follow-up|2|||
164463818|NCT04770402|594070441|FG000|Overall Study|Non-compliance|1|||
164463819|NCT04770402|594070442|FG001|Overall Study|Non-compliance|0|||
164463820|NCT04770402|594070441|FG000|Overall Study|Withdrawal by Subject|0|||
164414051|NCT02073097|593886608|FG000|Overall Study|Adverse Event|0|||
164463821|NCT04770402|594070442|FG001|Overall Study|Withdrawal by Subject|1|||
164463822|NCT03599661|594070443|FG000|Overall Study|Lost to Follow-up|9|||
164463823|NCT04811040|594070444|FG000|Overall Study|Lost to Follow-up|2|||
164463824|NCT04811040|594070445|FG001|Overall Study|Lost to Follow-up|0|||
164463825|NCT04811040|594070446|FG002|Overall Study|Lost to Follow-up|0|||
164463826|NCT04811040|594070447|FG003|Overall Study|Lost to Follow-up|0|||
164463827|NCT04811040|594070444|FG000|Overall Study|Withdrew consent|1|||
164463828|NCT04811040|594070445|FG001|Overall Study|Withdrew consent|1|||
164463829|NCT04811040|594070446|FG002|Overall Study|Withdrew consent|0|||
164463830|NCT04811040|594070447|FG003|Overall Study|Withdrew consent|0|||
164463831|NCT05934942|594070452|FG000|Run-in Period|Not treated|1|||
164463832|NCT05934942|594070452|FG000|Run-in Period|Withdrawal by Subject|1|||
164463833|NCT03924635|594070453|FG000|Overall Study|Withdrawal by Subject|2|||
164463834|NCT03924635|594070454|FG001|Overall Study|Withdrawal by Subject|4|||
164463835|NCT05469464|594070455|FG000|Overall Study|Withdrawal by Subject|8|||
164463836|NCT05469464|594070456|FG001|Overall Study|Withdrawal by Subject|7|||
164463837|NCT05469464|594070457|FG002|Overall Study|Withdrawal by Subject|4|||
164463838|NCT05469464|594070458|FG003|Overall Study|Withdrawal by Subject|5|||
164463839|NCT05469464|594070455|FG000|Overall Study|Adverse Event|8|||
164463840|NCT05469464|594070456|FG001|Overall Study|Adverse Event|14|||
164463841|NCT05469464|594070457|FG002|Overall Study|Adverse Event|13|||
164463842|NCT05469464|594070458|FG003|Overall Study|Adverse Event|2|||
164463843|NCT05469464|594070455|FG000|Overall Study|Lost to Follow-up|2|||
164463844|NCT05469464|594070456|FG001|Overall Study|Lost to Follow-up|5|||
164463845|NCT05469464|594070457|FG002|Overall Study|Lost to Follow-up|3|||
164463846|NCT05469464|594070458|FG003|Overall Study|Lost to Follow-up|3|||
164463847|NCT05469464|594070455|FG000|Overall Study|Lack of Efficacy|4|||
164463848|NCT05469464|594070456|FG001|Overall Study|Lack of Efficacy|1|||
164463849|NCT05469464|594070457|FG002|Overall Study|Lack of Efficacy|2|||
164463850|NCT05469464|594070458|FG003|Overall Study|Lack of Efficacy|2|||
164463851|NCT05469464|594070455|FG000|Overall Study|Physician Decision|0|||
164463852|NCT05469464|594070456|FG001|Overall Study|Physician Decision|0|||
164463853|NCT05469464|594070457|FG002|Overall Study|Physician Decision|0|||
164463854|NCT05469464|594070458|FG003|Overall Study|Physician Decision|1|||
164463855|NCT05374798|594070461|FG000|Overall Study|Lost to Follow-up|2|||
164463856|NCT05374798|594070461|FG000|Overall Study|Withdrawal by Subject|2|||
164463857|NCT05374798|594070461|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
164463858|NCT06473662|594070462|FG000|Overall Study|Withdrawal by Subject|1|||
164463859|NCT06473662|594070463|FG001|Overall Study|Withdrawal by Subject|6|||
164463860|NCT06473662|594070464|FG002|Overall Study|Withdrawal by Subject|5|||
164463861|NCT06473662|594070462|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
164463862|NCT06473662|594070463|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
164463863|NCT06473662|594070464|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
164463864|NCT06473662|594070462|FG000|Overall Study|Starting HbA1c below 7%|0|||
164463865|NCT06473662|594070463|FG001|Overall Study|Starting HbA1c below 7%|1|||
164463866|NCT06473662|594070464|FG002|Overall Study|Starting HbA1c below 7%|1|||
164463867|NCT06473662|594070462|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
164463868|NCT06473662|594070463|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
164463869|NCT06473662|594070464|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
164463870|NCT06473662|594070462|FG000|Overall Study|Did not take medication|2|||
164463871|NCT06473662|594070463|FG001|Overall Study|Did not take medication|3|||
164463872|NCT06473662|594070464|FG002|Overall Study|Did not take medication|2|||
164463873|NCT04471246|594070469|FG000|Overall Study|Lost to Follow-up|2|||
164463874|NCT04471246|594070470|FG001|Overall Study|Lost to Follow-up|2|||
164463875|NCT04826471|594070471|FG000|Overall Study|Lost to Follow-up|2|||
164463876|NCT04826471|594070471|FG000|Overall Study|Protocol Violation|3|||
164710035|NCT03327792|594962821|FG000|Overall Study|Lost to Follow-up|0|||
164710036|NCT03327792|594962822|FG001|Overall Study|Lost to Follow-up|1|||
164710037|NCT00626392|594962823|FG000|Run-in Period|Adverse Event|0|||
164710038|NCT00626392|594962824|FG001|Run-in Period|Adverse Event|0|||
164710039|NCT00626392|594962825|FG002|Run-in Period|Adverse Event|1|||
164710040|NCT00626392|594962826|FG003|Run-in Period|Adverse Event|0|||
164710041|NCT00626392|594962827|FG004|Run-in Period|Adverse Event|1|||
164463877|NCT04826471|594070471|FG000|Overall Study|Withdrawal by Subject|1|||
164463878|NCT05764525|594070472|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
164463879|NCT05764525|594070473|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
164463880|NCT05764525|594070472|FG000|Overall Study|Withdrawal by Subject|4|||
164463881|NCT05764525|594070473|FG001|Overall Study|Withdrawal by Subject|8|||
164463882|NCT05764525|594070472|FG000|Overall Study|Physician Decision|1|||
164463883|NCT05764525|594070473|FG001|Overall Study|Physician Decision|0|||
164463884|NCT04079218|594070478|FG000|Overall Study|Death|1|||
164463885|NCT04079218|594070479|FG001|Overall Study|Death|0|||
164463886|NCT04079218|594070478|FG000|Overall Study|Withdrawal by Subject|3|||
164710042|NCT00626392|594962828|FG005|Run-in Period|Adverse Event|0|||
164710043|NCT00626392|594962823|FG000|Run-in Period|Withdrawal by Subject|0|||
164463887|NCT04079218|594070479|FG001|Overall Study|Withdrawal by Subject|0|||
164463888|NCT04079218|594070478|FG000|Overall Study|Physician Decision|4|||
164463889|NCT04079218|594070479|FG001|Overall Study|Physician Decision|0|||
164414052|NCT02073097|593886609|FG001|Overall Study|Adverse Event|0|||
164414053|NCT02073097|593886610|FG002|Overall Study|Adverse Event|0|||
164414054|NCT02073097|593886611|FG003|Overall Study|Adverse Event|0|||
164414055|NCT02073097|593886612|FG004|Overall Study|Adverse Event|0|||
164414056|NCT02073097|593886613|FG005|Overall Study|Adverse Event|0|||
164414057|NCT02073097|593886614|FG006|Overall Study|Adverse Event|0|||
164414058|NCT02073097|593886615|FG007|Overall Study|Adverse Event|2|||
164414059|NCT02073097|593886608|FG000|Overall Study|Withdrawal by Subject|0|||
164414060|NCT02073097|593886609|FG001|Overall Study|Withdrawal by Subject|0|||
164414061|NCT02073097|593886610|FG002|Overall Study|Withdrawal by Subject|0|||
164414062|NCT02073097|593886611|FG003|Overall Study|Withdrawal by Subject|0|||
164414063|NCT02073097|593886612|FG004|Overall Study|Withdrawal by Subject|0|||
164414064|NCT02073097|593886613|FG005|Overall Study|Withdrawal by Subject|0|||
164414065|NCT02073097|593886614|FG006|Overall Study|Withdrawal by Subject|0|||
164414066|NCT02073097|593886615|FG007|Overall Study|Withdrawal by Subject|2|||
164414067|NCT02073097|593886608|FG000|Overall Study|Death|0|||
164414068|NCT02073097|593886609|FG001|Overall Study|Death|0|||
164414069|NCT02073097|593886610|FG002|Overall Study|Death|0|||
164414070|NCT02073097|593886611|FG003|Overall Study|Death|0|||
164414071|NCT02073097|593886612|FG004|Overall Study|Death|0|||
164414072|NCT02073097|593886613|FG005|Overall Study|Death|0|||
164414073|NCT02073097|593886614|FG006|Overall Study|Death|0|||
164414074|NCT02073097|593886615|FG007|Overall Study|Death|1|||
164414075|NCT02073097|593886608|FG000|Overall Study|Physician Decision|0|||
164414076|NCT02073097|593886609|FG001|Overall Study|Physician Decision|0|||
164414077|NCT02073097|593886610|FG002|Overall Study|Physician Decision|0|||
164414078|NCT02073097|593886611|FG003|Overall Study|Physician Decision|0|||
164414079|NCT02073097|593886612|FG004|Overall Study|Physician Decision|0|||
164414080|NCT02073097|593886613|FG005|Overall Study|Physician Decision|0|||
164414081|NCT02073097|593886614|FG006|Overall Study|Physician Decision|0|||
164414082|NCT02073097|593886615|FG007|Overall Study|Physician Decision|1|||
164414083|NCT03813147|593886618|FG000|Overall Study|Lack of Efficacy|4|||
164414084|NCT03813147|593886619|FG001|Overall Study|Lack of Efficacy|4|||
164414085|NCT03813147|593886618|FG000|Overall Study|Physician Decision|2|||
164414086|NCT03813147|593886619|FG001|Overall Study|Physician Decision|1|||
164414087|NCT01693692|593886620|FG000|Overall Study|Withdrawal by Subject|12|||
164414088|NCT01693692|593886621|FG001|Overall Study|Withdrawal by Subject|10|||
164414089|NCT01693692|593886622|FG002|Overall Study|Withdrawal by Subject|11|||
164414090|NCT01693692|593886620|FG000|Overall Study|Adverse Event|7|||
164414091|NCT01693692|593886621|FG001|Overall Study|Adverse Event|14|||
164414092|NCT01693692|593886622|FG002|Overall Study|Adverse Event|9|||
164414093|NCT01693692|593886620|FG000|Overall Study|Physician Decision|0|||
164414094|NCT01693692|593886621|FG001|Overall Study|Physician Decision|0|||
164414095|NCT01693692|593886622|FG002|Overall Study|Physician Decision|1|||
164414096|NCT01693692|593886620|FG000|Overall Study|Protocol Violation|5|||
164414097|NCT01693692|593886621|FG001|Overall Study|Protocol Violation|4|||
164414098|NCT01693692|593886622|FG002|Overall Study|Protocol Violation|6|||
164414099|NCT01693692|593886620|FG000|Overall Study|Lost to Follow-up|2|||
164414100|NCT01693692|593886621|FG001|Overall Study|Lost to Follow-up|2|||
164414101|NCT01693692|593886622|FG002|Overall Study|Lost to Follow-up|3|||
164414102|NCT01693692|593886620|FG000|Overall Study|Other|4|||
164414103|NCT01693692|593886621|FG001|Overall Study|Other|4|||
164414104|NCT01693692|593886622|FG002|Overall Study|Other|6|||
164414105|NCT01987596|593888397|FG000|Overall Study|Physician Decision|1|||
164414106|NCT01987596|593888398|FG001|Overall Study|Physician Decision|0|||
164414107|NCT01987596|593888397|FG000|Overall Study|Progressive Disease; missing all period|0|||
164414108|NCT01987596|593888398|FG001|Overall Study|Progressive Disease; missing all period|1|||
164414109|NCT02632786|593888401|FG000|Overall Study|Adverse Event|2|||
164414110|NCT02632786|593888402|FG001|Overall Study|Adverse Event|1|||
164414111|NCT02632786|593888401|FG000|Overall Study|Death|3|||
164414112|NCT02632786|593888402|FG001|Overall Study|Death|2|||
164414113|NCT02632786|593888401|FG000|Overall Study|Physician Decision|5|||
164414114|NCT02632786|593888402|FG001|Overall Study|Physician Decision|4|||
164414115|NCT02632786|593888401|FG000|Overall Study|Withdrawal by Subject|1|||
164414116|NCT02632786|593888402|FG001|Overall Study|Withdrawal by Subject|0|||
164414117|NCT00709592|593888403|FG000|Overall Study|Unable to proceed to transplant|0|||
164414118|NCT00709592|593888404|FG001|Overall Study|Unable to proceed to transplant|1|||
164414119|NCT00451217|593888406|FG000|Overall Study|Lost to Follow-up|0|||
164414120|NCT00451217|593888407|FG001|Overall Study|Lost to Follow-up|1|||
164414121|NCT00451217|593888408|FG002|Overall Study|Lost to Follow-up|1|||
164414122|NCT00451217|593888409|FG003|Overall Study|Lost to Follow-up|1|||
164414123|NCT00451217|593888406|FG000|Overall Study|Withdrawal by Subject|1|||
164414124|NCT00451217|593888407|FG001|Overall Study|Withdrawal by Subject|0|||
164414125|NCT00451217|593888408|FG002|Overall Study|Withdrawal by Subject|0|||
164414126|NCT00451217|593888409|FG003|Overall Study|Withdrawal by Subject|0|||
164414127|NCT00451217|593888406|FG000|Overall Study|Not Treated|1|||
164414128|NCT00451217|593888407|FG001|Overall Study|Not Treated|1|||
164414129|NCT00451217|593888408|FG002|Overall Study|Not Treated|3|||
164414130|NCT00451217|593888409|FG003|Overall Study|Not Treated|4|||
164414131|NCT03154359|593888413|FG000|Overall Study|Adverse Event|1|||
164414132|NCT03154359|593888413|FG000|Overall Study|Lack of Efficacy|2|||
164414133|NCT03154359|593888413|FG000|Overall Study|Lost to Follow-up|3|||
164414134|NCT03154359|593888413|FG000|Overall Study|Physician Decision|3|||
164414135|NCT03154359|593888413|FG000|Overall Study|Protocol Violation|4|||
164414136|NCT03154359|593888413|FG000|Overall Study|Withdrawal by Subject|5|||
164414137|NCT03154359|593888413|FG000|Overall Study|Disruption of study due to COVID-19|4|||
164414138|NCT04250337|593888414|FG000|Overall Study|Adverse Event|0|||
164463890|NCT04079218|594070478|FG000|Overall Study|Lost to Follow-up|0|||
164463891|NCT04079218|594070479|FG001|Overall Study|Lost to Follow-up|1|||
164463892|NCT04066205|594070482|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
164463893|NCT04066205|594070483|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
164463894|NCT04066205|594070482|FG000|T2 Immediate Post-Intervention|did not respond|5|||
164463895|NCT04066205|594070483|FG001|T2 Immediate Post-Intervention|did not respond|3|||
164463896|NCT02052882|594070484|FG000|Overall Study|Not treated|11|||
164463897|NCT02052882|594070484|FG000|Overall Study|Protocol Violation|1|||
164463898|NCT02052882|594070484|FG000|Overall Study|Inadequate testing|1|||
164463899|NCT03734679|594070485|FG000|Overall Study|Missed Visit|1|||
164463900|NCT05218096|594070489|FG000|Primary Evaluation|Withdrawal by Subject|0|||
164463901|NCT05218096|594070490|FG001|Primary Evaluation|Withdrawal by Subject|0|||
164463902|NCT05218096|594070491|FG002|Primary Evaluation|Withdrawal by Subject|2|||
164463903|NCT05218096|594070492|FG003|Primary Evaluation|Withdrawal by Subject|0|||
164463904|NCT05218096|594070493|FG004|Primary Evaluation|Withdrawal by Subject|0|||
164463905|NCT05218096|594070489|FG000|Primary Evaluation|Physician Decision|1|||
164463906|NCT05218096|594070490|FG001|Primary Evaluation|Physician Decision|0|||
164463907|NCT05218096|594070491|FG002|Primary Evaluation|Physician Decision|0|||
164463908|NCT05218096|594070492|FG003|Primary Evaluation|Physician Decision|0|||
164463909|NCT05218096|594070493|FG004|Primary Evaluation|Physician Decision|0|||
164463910|NCT05218096|594070489|FG000|Extended Treatment|Clinical Deterioration|1|||
164463911|NCT05218096|594070490|FG001|Extended Treatment|Clinical Deterioration|1|||
164463912|NCT05218096|594070491|FG002|Extended Treatment|Clinical Deterioration|0|||
164463913|NCT05218096|594070492|FG003|Extended Treatment|Clinical Deterioration|0|||
164463914|NCT05218096|594070493|FG004|Extended Treatment|Clinical Deterioration|0|||
164463915|NCT05218096|594070489|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
164463916|NCT05218096|594070490|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
164463917|NCT05218096|594070491|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
164463918|NCT05218096|594070492|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
164463919|NCT05218096|594070493|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
164463920|NCT05218096|594070489|FG000|Extended Treatment|Withdrawal by Subject|1|||
164463921|NCT05218096|594070490|FG001|Extended Treatment|Withdrawal by Subject|3|||
164463922|NCT05218096|594070491|FG002|Extended Treatment|Withdrawal by Subject|0|||
164463923|NCT05218096|594070492|FG003|Extended Treatment|Withdrawal by Subject|2|||
164463924|NCT05218096|594070493|FG004|Extended Treatment|Withdrawal by Subject|2|||
164463925|NCT05218096|594070489|FG000|Extended Treatment|Lack of Efficacy|3|||
164463926|NCT05218096|594070490|FG001|Extended Treatment|Lack of Efficacy|0|||
164463927|NCT05218096|594070491|FG002|Extended Treatment|Lack of Efficacy|0|||
164463928|NCT05218096|594070492|FG003|Extended Treatment|Lack of Efficacy|0|||
164463929|NCT05218096|594070493|FG004|Extended Treatment|Lack of Efficacy|0|||
164463930|NCT05218096|594070489|FG000|Extended Treatment|Physician Decision|0|||
164463931|NCT05218096|594070490|FG001|Extended Treatment|Physician Decision|1|||
164463932|NCT05218096|594070491|FG002|Extended Treatment|Physician Decision|0|||
164463933|NCT05218096|594070492|FG003|Extended Treatment|Physician Decision|0|||
164463934|NCT05218096|594070493|FG004|Extended Treatment|Physician Decision|0|||
164463935|NCT05218096|594070489|FG000|Open-label Extension|Adverse Event|1|||
164463936|NCT05218096|594070490|FG001|Open-label Extension|Adverse Event|0|||
164463937|NCT05218096|594070491|FG002|Open-label Extension|Adverse Event|0|||
164463938|NCT05218096|594070492|FG003|Open-label Extension|Adverse Event|0|||
164463939|NCT05218096|594070493|FG004|Open-label Extension|Adverse Event|1|||
164463940|NCT05218096|594070489|FG000|Open-label Extension|Pregnancy|0|||
164463941|NCT05218096|594070490|FG001|Open-label Extension|Pregnancy|0|||
164463942|NCT05218096|594070491|FG002|Open-label Extension|Pregnancy|0|||
164463943|NCT05218096|594070492|FG003|Open-label Extension|Pregnancy|0|||
164463944|NCT05218096|594070493|FG004|Open-label Extension|Pregnancy|1|||
164463945|NCT05218096|594070489|FG000|Open-label Extension|Lack of Efficacy|1|||
164463946|NCT05218096|594070490|FG001|Open-label Extension|Lack of Efficacy|2|||
164463947|NCT05218096|594070491|FG002|Open-label Extension|Lack of Efficacy|0|||
164463948|NCT05218096|594070492|FG003|Open-label Extension|Lack of Efficacy|0|||
164463949|NCT05218096|594070493|FG004|Open-label Extension|Lack of Efficacy|0|||
164463950|NCT05218096|594070489|FG000|Open-label Extension|Lost to Follow-up|1|||
164463951|NCT05218096|594070490|FG001|Open-label Extension|Lost to Follow-up|0|||
164463952|NCT05218096|594070491|FG002|Open-label Extension|Lost to Follow-up|0|||
164463953|NCT05218096|594070492|FG003|Open-label Extension|Lost to Follow-up|0|||
164463954|NCT05218096|594070493|FG004|Open-label Extension|Lost to Follow-up|0|||
164463955|NCT05218096|594070489|FG000|Open-label Extension|Death|0|||
164463956|NCT05218096|594070490|FG001|Open-label Extension|Death|0|||
164463957|NCT05218096|594070491|FG002|Open-label Extension|Death|0|||
164463958|NCT05218096|594070492|FG003|Open-label Extension|Death|1|||
164463959|NCT05218096|594070493|FG004|Open-label Extension|Death|0|||
164463960|NCT05218096|594070489|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
164463961|NCT05218096|594070490|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
164463962|NCT05218096|594070491|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
164463963|NCT05218096|594070492|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
164710044|NCT00626392|594962824|FG001|Run-in Period|Withdrawal by Subject|1|||
164710045|NCT00626392|594962825|FG002|Run-in Period|Withdrawal by Subject|1|||
164710046|NCT00626392|594962826|FG003|Run-in Period|Withdrawal by Subject|1|||
164710047|NCT00626392|594962827|FG004|Run-in Period|Withdrawal by Subject|3|||
164710048|NCT00626392|594962828|FG005|Run-in Period|Withdrawal by Subject|1|||
164710049|NCT00626392|594962823|FG000|Run-in Period|Noncompliance|1|||
164710050|NCT00626392|594962824|FG001|Run-in Period|Noncompliance|0|||
164414139|NCT04250337|593888415|FG001|Overall Study|Adverse Event|3|||
164414140|NCT04250337|593888414|FG000|Overall Study|Lack of Efficacy|1|||
164414141|NCT04250337|593888415|FG001|Overall Study|Lack of Efficacy|3|||
164414142|NCT04250337|593888414|FG000|Overall Study|Physician Decision|1|||
164414143|NCT04250337|593888415|FG001|Overall Study|Physician Decision|0|||
164414144|NCT04250337|593888414|FG000|Overall Study|Protocol Deviation|2|||
164414145|NCT04250337|593888415|FG001|Overall Study|Protocol Deviation|2|||
164414146|NCT04250337|593888414|FG000|Overall Study|Withdrawal by Subject|4|||
164414147|NCT04250337|593888415|FG001|Overall Study|Withdrawal by Subject|3|||
164414148|NCT00569803|593888418|FG000|Overall Study|Lost to Follow-up|1|||
164414149|NCT00569803|593888419|FG001|Overall Study|Lost to Follow-up|0|||
164414150|NCT00569803|593888420|FG002|Overall Study|Lost to Follow-up|0|||
164414151|NCT00569803|593888421|FG003|Overall Study|Lost to Follow-up|0|||
164414152|NCT00569803|593888422|FG004|Overall Study|Lost to Follow-up|0|||
164414153|NCT00569803|593888423|FG005|Overall Study|Lost to Follow-up|0|||
164414154|NCT00569803|593888424|FG006|Overall Study|Lost to Follow-up|0|||
164414155|NCT00569803|593888425|FG007|Overall Study|Lost to Follow-up|0|||
164414156|NCT00569803|593888418|FG000|Overall Study|injection syringe leaked during dosing|0|||
164414157|NCT00569803|593888419|FG001|Overall Study|injection syringe leaked during dosing|0|||
164414158|NCT00569803|593888420|FG002|Overall Study|injection syringe leaked during dosing|0|||
164414159|NCT00569803|593888421|FG003|Overall Study|injection syringe leaked during dosing|1|||
164414160|NCT00569803|593888422|FG004|Overall Study|injection syringe leaked during dosing|0|||
164414161|NCT00569803|593888423|FG005|Overall Study|injection syringe leaked during dosing|0|||
164414162|NCT00569803|593888424|FG006|Overall Study|injection syringe leaked during dosing|0|||
164414163|NCT00569803|593888425|FG007|Overall Study|injection syringe leaked during dosing|0|||
164414164|NCT00569803|593888418|FG000|Overall Study|Withdrawal by Subject|0|||
164414165|NCT00569803|593888419|FG001|Overall Study|Withdrawal by Subject|0|||
164414166|NCT00569803|593888420|FG002|Overall Study|Withdrawal by Subject|0|||
164414167|NCT00569803|593888421|FG003|Overall Study|Withdrawal by Subject|0|||
164414168|NCT00569803|593888422|FG004|Overall Study|Withdrawal by Subject|0|||
164414169|NCT00569803|593888423|FG005|Overall Study|Withdrawal by Subject|0|||
164414170|NCT00569803|593888424|FG006|Overall Study|Withdrawal by Subject|0|||
164414171|NCT00569803|593888425|FG007|Overall Study|Withdrawal by Subject|1|||
164414172|NCT01993823|593888426|FG000|Overall Study|Requested by the patient|6|||
164414173|NCT01993823|593888427|FG001|Overall Study|Requested by the patient|11|||
164414174|NCT01993823|593888426|FG000|Overall Study|Protocol Violation|0|||
164414175|NCT01993823|593888427|FG001|Overall Study|Protocol Violation|1|||
164414176|NCT01993823|593888426|FG000|Overall Study|Lost to Follow-up|1|||
164414177|NCT01993823|593888427|FG001|Overall Study|Lost to Follow-up|4|||
164414178|NCT01592695|593888433|FG000|Overall Study|Lost to Follow-up|8|||
164414179|NCT01592695|593888434|FG001|Overall Study|Lost to Follow-up|4|||
164414180|NCT00422799|593888435|FG000|Overall Study|Withdrawal by Subject|6|||
164414181|NCT00422799|593888435|FG000|Overall Study|Adverse Event|7|||
164414182|NCT03029780|593888439|FG000|Overall Study|Disease Progression|20|||
164414183|NCT03029780|593888440|FG001|Overall Study|Disease Progression|22|||
164414184|NCT03029780|593888439|FG000|Overall Study|Study Drug Toxicity|15|||
164414185|NCT03029780|593888440|FG001|Overall Study|Study Drug Toxicity|11|||
164414186|NCT03029780|593888439|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
164414187|NCT03029780|593888440|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
164414188|NCT03029780|593888439|FG000|Overall Study|Participant request to discontinue study treatment|4|||
164414189|NCT03029780|593888440|FG001|Overall Study|Participant request to discontinue study treatment|1|||
164414190|NCT03029780|593888439|FG000|Overall Study|Maximum clinical benefit|1|||
164414191|NCT03029780|593888440|FG001|Overall Study|Maximum clinical benefit|0|||
164414192|NCT03029780|593888439|FG000|Overall Study|Participant no longer meets study criteria|0|||
164414193|NCT03029780|593888440|FG001|Overall Study|Participant no longer meets study criteria|1|||
164414194|NCT03029780|593888439|FG000|Overall Study|Other reasons|6|||
164414195|NCT03029780|593888440|FG001|Overall Study|Other reasons|6|||
164414196|NCT03029780|593888439|FG000|Overall Study|Not reported|1|||
164414197|NCT03029780|593888440|FG001|Overall Study|Not reported|1|||
164414198|NCT03029780|593888439|FG000|Overall Study|Death|2|||
164414199|NCT03029780|593888440|FG001|Overall Study|Death|6|||
164414200|NCT00178256|593888441|FG000|Overall Study|Adverse Event|2|||
164414201|NCT00178256|593888442|FG001|Overall Study|Adverse Event|0|||
164414202|NCT00178256|593888443|FG002|Overall Study|Adverse Event|0|||
164414203|NCT00178256|593888444|FG003|Overall Study|Adverse Event|0|||
164414204|NCT00178256|593888441|FG000|Overall Study|Death|0|||
164414205|NCT00178256|593888442|FG001|Overall Study|Death|1|||
164414206|NCT00178256|593888443|FG002|Overall Study|Death|0|||
164414207|NCT00178256|593888444|FG003|Overall Study|Death|1|||
164710051|NCT00626392|594962825|FG002|Run-in Period|Noncompliance|1|||
164463964|NCT05218096|594070493|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
164463965|NCT04068311|594070503|FG000|Overall Study|Death|3|||
164463966|NCT04068311|594070504|FG001|Overall Study|Death|3|||
164463967|NCT04068311|594070503|FG000|Overall Study|Lost to Follow-up|24|||
164463968|NCT04068311|594070504|FG001|Overall Study|Lost to Follow-up|68|||
164463969|NCT04068311|594070503|FG000|Overall Study|Withdrawal by Subject|5|||
164463970|NCT04068311|594070504|FG001|Overall Study|Withdrawal by Subject|0|||
164463971|NCT03697876|594070505|FG000|Overall Study|Lost to Follow-up|0|||
164463972|NCT03697876|594070506|FG001|Overall Study|Lost to Follow-up|1|||
164463973|NCT03697876|594070505|FG000|Overall Study|Adverse Event|1|||
164463974|NCT03697876|594070506|FG001|Overall Study|Adverse Event|0|||
164463975|NCT04858451|594071961|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
164463976|NCT04858451|594071962|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
164463977|NCT04858451|594071963|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
164463978|NCT04858451|594071964|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
164463979|NCT04858451|594071965|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
164463980|NCT04858451|594071966|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
164463981|NCT04858451|594071967|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
164463982|NCT04858451|594071968|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
164463983|NCT04858451|594071969|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
164463984|NCT04858451|594071961|FG000|Part 2|Discontinued|0|||
164463985|NCT04858451|594071962|FG001|Part 2|Discontinued|0|||
164463986|NCT04858451|594071963|FG002|Part 2|Discontinued|0|||
164463987|NCT04858451|594071964|FG003|Part 2|Discontinued|0|||
164463988|NCT04858451|594071965|FG004|Part 2|Discontinued|0|||
164463989|NCT04858451|594071966|FG005|Part 2|Discontinued|0|||
164463990|NCT04858451|594071967|FG006|Part 2|Discontinued|0|||
164463991|NCT04858451|594071968|FG007|Part 2|Discontinued|0|||
164463992|NCT04858451|594071969|FG008|Part 2|Discontinued|63|||
164463993|NCT02998268|594071970|FG000|Overall Study|Adverse Event|0|||
164463994|NCT02998268|594071971|FG001|Overall Study|Adverse Event|2|||
164463995|NCT02998268|594071970|FG000|Overall Study|Withdrawal by Subject|0|||
164463996|NCT02998268|594071971|FG001|Overall Study|Withdrawal by Subject|1|||
164463997|NCT04231149|594071972|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
164463998|NCT04231149|594071973|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
164463999|NCT04231149|594071974|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
164464000|NCT04231149|594071975|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
164464001|NCT04231149|594071976|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
164464002|NCT03252847|594071977|FG000|Overall Study|Withdrawal by Subject|0|||
164464003|NCT03252847|594071978|FG001|Overall Study|Withdrawal by Subject|0|||
164464004|NCT03252847|594071979|FG002|Overall Study|Withdrawal by Subject|1|||
164464005|NCT03252847|594071980|FG003|Overall Study|Withdrawal by Subject|0|||
164464006|NCT03252847|594071981|FG004|Overall Study|Withdrawal by Subject|0|||
164464007|NCT03252847|594071982|FG005|Overall Study|Withdrawal by Subject|0|||
164464008|NCT03252847|594071983|FG006|Overall Study|Withdrawal by Subject|0|||
164464009|NCT03252847|594071977|FG000|Overall Study|Other: Patient decision|0|||
164464010|NCT03252847|594071978|FG001|Overall Study|Other: Patient decision|0|||
164464011|NCT03252847|594071979|FG002|Overall Study|Other: Patient decision|0|||
164464012|NCT03252847|594071980|FG003|Overall Study|Other: Patient decision|0|||
164464013|NCT03252847|594071981|FG004|Overall Study|Other: Patient decision|1|||
164464014|NCT03252847|594071982|FG005|Overall Study|Other: Patient decision|0|||
164464015|NCT03252847|594071983|FG006|Overall Study|Other: Patient decision|0|||
164464016|NCT03235544|594071984|FG000|Overall Study|Death|11|||
164464017|NCT03235544|594071985|FG001|Overall Study|Death|31|||
164464018|NCT03235544|594071986|FG002|Overall Study|Death|19|||
164464019|NCT03235544|594071987|FG003|Overall Study|Death|34|||
164464020|NCT03235544|594071984|FG000|Overall Study|Lost to Follow-up|0|||
164464021|NCT03235544|594071985|FG001|Overall Study|Lost to Follow-up|1|||
164464022|NCT03235544|594071986|FG002|Overall Study|Lost to Follow-up|1|||
164464023|NCT03235544|594071987|FG003|Overall Study|Lost to Follow-up|1|||
164464024|NCT03235544|594071984|FG000|Overall Study|Withdrawal by Subject|0|||
164464025|NCT03235544|594071985|FG001|Overall Study|Withdrawal by Subject|3|||
164464026|NCT03235544|594071986|FG002|Overall Study|Withdrawal by Subject|1|||
164710052|NCT00626392|594962826|FG003|Run-in Period|Noncompliance|0|||
164710053|NCT00626392|594962827|FG004|Run-in Period|Noncompliance|0|||
164710054|NCT00626392|594962828|FG005|Run-in Period|Noncompliance|0|||
164710055|NCT00626392|594962823|FG000|Coadministration Period|Adverse Event|3|||
164710056|NCT00626392|594962824|FG001|Coadministration Period|Adverse Event|1|||
164710057|NCT00626392|594962825|FG002|Coadministration Period|Adverse Event|7|||
164710058|NCT00626392|594962826|FG003|Coadministration Period|Adverse Event|4|||
164464027|NCT03235544|594071987|FG003|Overall Study|Withdrawal by Subject|5|||
164464028|NCT03235544|594071984|FG000|Overall Study|Disease Progression|0|||
164464029|NCT03235544|594071985|FG001|Overall Study|Disease Progression|1|||
164464030|NCT03235544|594071986|FG002|Overall Study|Disease Progression|0|||
164464031|NCT03235544|594071987|FG003|Overall Study|Disease Progression|2|||
164464032|NCT03235544|594071984|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
164464033|NCT03235544|594071985|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
164464034|NCT03235544|594071986|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
164464035|NCT03235544|594071987|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
164464036|NCT03235544|594071984|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
164464037|NCT03235544|594071985|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
164464038|NCT03235544|594071986|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
164464039|NCT03235544|594071987|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
164464040|NCT00950742|594071988|FG000|Overall Study|Other Adverse Event|1|||
164464041|NCT00950742|594071989|FG001|Overall Study|Other Adverse Event|0|||
164464042|NCT00950742|594071988|FG000|Overall Study|Withdrawal by Subject|3|||
164464043|NCT00950742|594071989|FG001|Overall Study|Withdrawal by Subject|0|||
164464044|NCT00950742|594071988|FG000|Overall Study|Progressive Disease|6|||
164464045|NCT00950742|594071989|FG001|Overall Study|Progressive Disease|2|||
164464046|NCT00950742|594071988|FG000|Overall Study|Dose limiting toxicity|6|||
164464047|NCT00950742|594071989|FG001|Overall Study|Dose limiting toxicity|0|||
164464048|NCT01456949|594071991|FG000|Enrollment|PI death- incomplete data|6|||
164464049|NCT01456949|594071991|FG000|Enrollment|Death|1|||
164464050|NCT01456949|594071991|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
164464051|NCT01456949|594071991|FG000|Enrollment|Physician Decision|10|||
164464052|NCT01456949|594071991|FG000|Enrollment|Withdrawal by Subject|7|||
164464053|NCT01456949|594071991|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
164464054|NCT01456949|594071991|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
164464055|NCT01456949|594071991|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
164464056|NCT01456949|594071991|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
164464057|NCT01456949|594071991|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
164464058|NCT01456949|594071991|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
164464059|NCT01456949|594071991|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
164464060|NCT01456949|594071991|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
164464061|NCT04753697|594071992|FG000|Induction Phase|Withdrawal by Subject|12|||
164464062|NCT04753697|594071993|FG001|Induction Phase|Withdrawal by Subject|5|||
164464063|NCT04753697|594071994|FG002|Induction Phase|Withdrawal by Subject|6|||
164464064|NCT04753697|594071992|FG000|Induction Phase|Physician Decision|1|||
164464065|NCT04753697|594071993|FG001|Induction Phase|Physician Decision|0|||
164464066|NCT04753697|594071994|FG002|Induction Phase|Physician Decision|0|||
164464067|NCT04753697|594071992|FG000|Induction Phase|Lost to Follow-up|2|||
164464068|NCT04753697|594071993|FG001|Induction Phase|Lost to Follow-up|2|||
164464069|NCT04753697|594071994|FG002|Induction Phase|Lost to Follow-up|1|||
164464070|NCT04753697|594071992|FG000|Induction Phase|Lack of Efficacy|1|||
164464071|NCT04753697|594071993|FG001|Induction Phase|Lack of Efficacy|0|||
164464072|NCT04753697|594071994|FG002|Induction Phase|Lack of Efficacy|0|||
164464073|NCT04753697|594071992|FG000|Maintenance Phase|Physician Decision|0|||
164464074|NCT04753697|594071993|FG001|Maintenance Phase|Physician Decision|0|||
164464075|NCT04753697|594071994|FG002|Maintenance Phase|Physician Decision|1|||
164464076|NCT04753697|594071992|FG000|Maintenance Phase|Withdrawal by Subject|3|||
164464077|NCT04753697|594071993|FG001|Maintenance Phase|Withdrawal by Subject|4|||
164464078|NCT04753697|594071994|FG002|Maintenance Phase|Withdrawal by Subject|6|||
164464079|NCT04753697|594071992|FG000|Maintenance Phase|Lost to Follow-up|2|||
164464080|NCT04753697|594071993|FG001|Maintenance Phase|Lost to Follow-up|2|||
164464081|NCT04753697|594071994|FG002|Maintenance Phase|Lost to Follow-up|0|||
164464082|NCT04753697|594071992|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
164464083|NCT04753697|594071993|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
164464084|NCT04753697|594071994|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
164464085|NCT04753697|594071992|FG000|Maintenance Phase|Adverse Event|0|||
164464086|NCT04753697|594071993|FG001|Maintenance Phase|Adverse Event|1|||
164464087|NCT04753697|594071994|FG002|Maintenance Phase|Adverse Event|1|||
164464088|NCT04753697|594071992|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
164464089|NCT04753697|594071993|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
164464090|NCT04753697|594071994|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
164464091|NCT00592852|594071995|FG000|Overall Study|Non-compliance|1|||
164464092|NCT00592852|594071995|FG000|Overall Study|Adverse Event|3|||
164464093|NCT00592852|594071995|FG000|Overall Study|Found ineligible|1|||
164464094|NCT00592852|594071995|FG000|Overall Study|Withdrawal by Subject|1|||
164464095|NCT05002088|594071996|FG000|Overall Study|Withdrawal by Subject|9|||
164464096|NCT05002088|594071997|FG001|Overall Study|Withdrawal by Subject|0|||
164464097|NCT05002088|594071996|FG000|Overall Study|Lost to Follow-up|0|||
164464098|NCT05002088|594071997|FG001|Overall Study|Lost to Follow-up|1|||
164464099|NCT05002088|594071996|FG000|Overall Study|Death|16|||
164464100|NCT05002088|594071997|FG001|Overall Study|Death|2|||
164464101|NCT05002088|594071996|FG000|Overall Study|Protocol Violation|25|||
164464102|NCT05002088|594071997|FG001|Overall Study|Protocol Violation|7|||
164464103|NCT05446168|594072001|FG000|Overall Study|Physician Decision|0|||
164464104|NCT05446168|594072002|FG001|Overall Study|Physician Decision|1|||
164464105|NCT01828099|594072005|FG000|Treatment Period|Adverse Event|24|||
164464106|NCT01828099|594072006|FG001|Treatment Period|Adverse Event|23|||
164464107|NCT01828099|594072005|FG000|Treatment Period|Death|10|||
164414208|NCT00178256|593888441|FG000|Overall Study|Cancer progression|2|||
164414209|NCT00178256|593888442|FG001|Overall Study|Cancer progression|0|||
164414210|NCT00178256|593888443|FG002|Overall Study|Cancer progression|0|||
164414211|NCT00178256|593888444|FG003|Overall Study|Cancer progression|1|||
164414212|NCT03066622|593888445|FG000|Overall Study|Lost to Follow-up|24|||
164414213|NCT03066622|593888446|FG001|Overall Study|Lost to Follow-up|25|||
164414214|NCT03066622|593888445|FG000|Overall Study|Withdrawal by Subject|2|||
164414215|NCT03066622|593888446|FG001|Overall Study|Withdrawal by Subject|1|||
164414216|NCT01763788|593888447|FG000|Overall Study|Lost to Follow-up|0|||
164414217|NCT01763788|593888448|FG001|Overall Study|Lost to Follow-up|0|||
164414218|NCT01763788|593888449|FG002|Overall Study|Lost to Follow-up|1|||
164414219|NCT01763788|593888450|FG003|Overall Study|Lost to Follow-up|0|||
164414220|NCT00641719|593888451|FG000|Overall Study|Lack of Efficacy|1|||
164414221|NCT00641719|593888452|FG001|Overall Study|Lack of Efficacy|2|||
164414222|NCT00641719|593888451|FG000|Overall Study|Adverse Event|24|||
164414223|NCT00641719|593888452|FG001|Overall Study|Adverse Event|29|||
164414224|NCT00641719|593888451|FG000|Overall Study|Withdrawal by Subject|4|||
164414225|NCT00641719|593888452|FG001|Overall Study|Withdrawal by Subject|4|||
164414226|NCT00641719|593888451|FG000|Overall Study|Reason Not Specified|1|||
164414227|NCT00641719|593888452|FG001|Overall Study|Reason Not Specified|2|||
164414228|NCT03321006|593888453|FG000|Overall Study|Death|1|||
164414229|NCT03321006|593888454|FG001|Overall Study|Death|0|||
164414230|NCT03321006|593888453|FG000|Overall Study|Lack of Efficacy|1|||
164414231|NCT03321006|593888454|FG001|Overall Study|Lack of Efficacy|0|||
164414232|NCT03303469|593888455|FG000|Overall Study|Lost to Follow-up|2|||
164414233|NCT00885352|593888458|FG000|Overall Study|Adverse Event|2|||
164414234|NCT00885352|593888459|FG001|Overall Study|Adverse Event|3|||
164414235|NCT00885352|593888458|FG000|Overall Study|Lost to Follow-up|2|||
164414236|NCT00885352|593888459|FG001|Overall Study|Lost to Follow-up|2|||
164414237|NCT00885352|593888458|FG000|Overall Study|Physician Decision|0|||
164414238|NCT00885352|593888459|FG001|Overall Study|Physician Decision|3|||
164414239|NCT00885352|593888458|FG000|Overall Study|Protocol Violation|0|||
164414240|NCT00885352|593888459|FG001|Overall Study|Protocol Violation|2|||
164414241|NCT00885352|593888458|FG000|Overall Study|Withdrawal by Subject|1|||
164414242|NCT00885352|593888459|FG001|Overall Study|Withdrawal by Subject|5|||
164414243|NCT00885352|593888458|FG000|Overall Study|Contradiction to study medication|0|||
164414244|NCT00885352|593888459|FG001|Overall Study|Contradiction to study medication|2|||
164414245|NCT00885352|593888458|FG000|Overall Study|Excluded medication|2|||
164414246|NCT00885352|593888459|FG001|Overall Study|Excluded medication|2|||
164414247|NCT00885352|593888458|FG000|Overall Study|Lab abnormalities|1|||
164414248|NCT00885352|593888459|FG001|Overall Study|Lab abnormalities|1|||
164414249|NCT03560258|593888460|FG000|Overall Study|Lost to Follow-up|3|||
164414250|NCT03560258|593888461|FG001|Overall Study|Lost to Follow-up|0|||
164414251|NCT03560258|593888462|FG002|Overall Study|Lost to Follow-up|0|||
164414252|NCT03560258|593888460|FG000|Overall Study|Protocol Violation|0|||
164414253|NCT03560258|593888461|FG001|Overall Study|Protocol Violation|1|||
164414254|NCT03560258|593888462|FG002|Overall Study|Protocol Violation|0|||
164414255|NCT03560258|593888460|FG000|Overall Study|Withdrawal by Subject|0|||
164414256|NCT03560258|593888461|FG001|Overall Study|Withdrawal by Subject|0|||
164414257|NCT03560258|593888462|FG002|Overall Study|Withdrawal by Subject|1|||
164414258|NCT01460160|593888463|FG000|Treatment Phase|Lack of Efficacy|3|||
164414259|NCT01460160|593888463|FG000|Treatment Phase|Study Drug Toxicity|2|||
164414260|NCT01460160|593888463|FG000|Treatment Phase|Adverse Event|8|||
164414261|NCT01460160|593888463|FG000|Treatment Phase|Withdrawal by Subject|4|||
164414262|NCT01460160|593888463|FG000|Treatment Phase|Death|2|||
164414263|NCT01460160|593888463|FG000|Treatment Phase|Other reasons|9|||
164414264|NCT01460160|593888463|FG000|Follow-up Phase|Withdrawal by Subject|4|||
164414265|NCT01460160|593888463|FG000|Follow-up Phase|Death|14|||
164414266|NCT01460160|593888463|FG000|Follow-up Phase|Lost to Follow-up|7|||
164414267|NCT01460160|593888463|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
164414268|NCT01460160|593888463|FG000|Follow-up Phase|Other and not reported reasons|5|||
164414269|NCT02006121|593888464|FG000|Double Blind Phase|Adverse Event|6|||
164414270|NCT02006121|593888465|FG001|Double Blind Phase|Adverse Event|0|||
164414271|NCT02006121|593888464|FG000|Double Blind Phase|Lack of Efficacy|1|||
164710059|NCT00626392|594962827|FG004|Coadministration Period|Adverse Event|3|||
164414272|NCT02006121|593888465|FG001|Double Blind Phase|Lack of Efficacy|16|||
164414273|NCT02006121|593888464|FG000|Double Blind Phase|Withdrawal by Subject|3|||
164414274|NCT02006121|593888465|FG001|Double Blind Phase|Withdrawal by Subject|4|||
164414275|NCT02006121|593888464|FG000|Double Blind Phase|Non-compliance with study drug|1|||
164414276|NCT02006121|593888465|FG001|Double Blind Phase|Non-compliance with study drug|3|||
164414277|NCT02006121|593888464|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
164414278|NCT02006121|593888465|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
164414279|NCT02006121|593888464|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
164414280|NCT02006121|593888465|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
164414281|NCT02006121|593888464|FG000|Open Label Phase|Adverse Event|15|||
164414282|NCT02006121|593888465|FG001|Open Label Phase|Adverse Event|0|||
164414283|NCT02006121|593888464|FG000|Open Label Phase|Lack of Efficacy|2|||
164414284|NCT02006121|593888465|FG001|Open Label Phase|Lack of Efficacy|0|||
164464108|NCT01828099|594072006|FG001|Treatment Period|Death|12|||
164464109|NCT01828099|594072005|FG000|Treatment Period|Lost to Follow-up|2|||
164464110|NCT01828099|594072006|FG001|Treatment Period|Lost to Follow-up|1|||
164464111|NCT01828099|594072005|FG000|Treatment Period|Non-compliance with study treatment|1|||
164464112|NCT01828099|594072006|FG001|Treatment Period|Non-compliance with study treatment|0|||
164464113|NCT01828099|594072005|FG000|Treatment Period|Physician Decision|17|||
164464114|NCT01828099|594072006|FG001|Treatment Period|Physician Decision|16|||
164464115|NCT01828099|594072005|FG000|Treatment Period|Progressive disease|99|||
164464116|NCT01828099|594072006|FG001|Treatment Period|Progressive disease|107|||
164464117|NCT01828099|594072005|FG000|Treatment Period|Subject/guardian decision|22|||
164464118|NCT01828099|594072006|FG001|Treatment Period|Subject/guardian decision|26|||
164464119|NCT01828099|594072005|FG000|Treatment Period|Study terminated by Sponsor|13|||
164464120|NCT01828099|594072006|FG001|Treatment Period|Study terminated by Sponsor|1|||
164464121|NCT01828099|594072005|FG000|Treatment Period|Protocol deviation|1|||
164464122|NCT01828099|594072006|FG001|Treatment Period|Protocol deviation|0|||
164464123|NCT01828099|594072005|FG000|Treatment Period|No longer requires treatment|0|||
164464124|NCT01828099|594072006|FG001|Treatment Period|No longer requires treatment|1|||
164464125|NCT01828099|594072005|FG000|Extension-treatment Phase|Adverse Event|0|||
164464126|NCT01828099|594072006|FG001|Extension-treatment Phase|Adverse Event|17|||
164464127|NCT01828099|594072005|FG000|Extension-treatment Phase|Death|0|||
164464128|NCT01828099|594072006|FG001|Extension-treatment Phase|Death|11|||
164464129|NCT01828099|594072005|FG000|Extension-treatment Phase|Physician Decision|0|||
164464130|NCT01828099|594072006|FG001|Extension-treatment Phase|Physician Decision|5|||
164464131|NCT01828099|594072005|FG000|Extension-treatment Phase|Progressive disease|0|||
164464132|NCT01828099|594072006|FG001|Extension-treatment Phase|Progressive disease|54|||
164464133|NCT01828099|594072005|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
164464134|NCT01828099|594072006|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
164464135|NCT01828099|594072005|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
164464136|NCT01828099|594072006|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
164464137|NCT03910478|594072016|FG000|Overall Study|Death|13|||
164464138|NCT03910478|594072017|FG001|Overall Study|Death|6|||
164464139|NCT03910478|594072016|FG000|Overall Study|Withdrawal by Subject|23|||
164464140|NCT03910478|594072017|FG001|Overall Study|Withdrawal by Subject|2|||
164464141|NCT03910478|594072016|FG000|Overall Study|Physician Decision|5|||
164464142|NCT03910478|594072017|FG001|Overall Study|Physician Decision|0|||
164464143|NCT03910478|594072016|FG000|Overall Study|Protocol Violation|1|||
164464144|NCT03910478|594072017|FG001|Overall Study|Protocol Violation|0|||
164464145|NCT03910478|594072016|FG000|Overall Study|Failure to meet continuation criteria|2|||
164464146|NCT03910478|594072017|FG001|Overall Study|Failure to meet continuation criteria|0|||
164464147|NCT03910478|594072016|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
164464148|NCT03910478|594072017|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
164464149|NCT05293171|594072019|FG000|Washout 5 to 7 Days|Adverse Event|1|||
164464150|NCT05293171|594072020|FG001|Washout 5 to 7 Days|Adverse Event|1|||
164464151|NCT05293171|594072021|FG002|Washout 5 to 7 Days|Adverse Event|0|||
164464152|NCT05293171|594072022|FG003|Washout 5 to 7 Days|Adverse Event|0|||
164464153|NCT05293171|594072023|FG004|Washout 5 to 7 Days|Adverse Event|0|||
164464154|NCT05293171|594072024|FG005|Washout 5 to 7 Days|Adverse Event|0|||
164464155|NCT05293171|594072025|FG006|Washout 5 to 7 Days|Adverse Event|0|||
164464156|NCT05293171|594072026|FG007|Washout 5 to 7 Days|Adverse Event|0|||
164464157|NCT05293171|594072027|FG008|Washout 5 to 7 Days|Adverse Event|0|||
164464158|NCT05293171|594072028|FG009|Washout 5 to 7 Days|Adverse Event|0|||
164464159|NCT05293171|594072029|FG010|Washout 5 to 7 Days|Adverse Event|0|||
164464160|NCT05293171|594072030|FG011|Washout 5 to 7 Days|Adverse Event|0|||
164464161|NCT05293171|594072019|FG000|Washout 5 to 7 Days|Adverse Event|0|||
164464162|NCT05293171|594072020|FG001|Washout 5 to 7 Days|Adverse Event|0|||
164464163|NCT05293171|594072021|FG002|Washout 5 to 7 Days|Adverse Event|0|||
164464164|NCT05293171|594072022|FG003|Washout 5 to 7 Days|Adverse Event|0|||
164464165|NCT05293171|594072023|FG004|Washout 5 to 7 Days|Adverse Event|0|||
164464166|NCT05293171|594072024|FG005|Washout 5 to 7 Days|Adverse Event|1|||
164464167|NCT05293171|594072025|FG006|Washout 5 to 7 Days|Adverse Event|0|||
164464168|NCT05293171|594072026|FG007|Washout 5 to 7 Days|Adverse Event|0|||
164464169|NCT05293171|594072027|FG008|Washout 5 to 7 Days|Adverse Event|0|||
164464170|NCT05293171|594072028|FG009|Washout 5 to 7 Days|Adverse Event|0|||
164710060|NCT00626392|594962828|FG005|Coadministration Period|Adverse Event|4|||
164464171|NCT05293171|594072029|FG010|Washout 5 to 7 Days|Adverse Event|0|||
164464172|NCT05293171|594072030|FG011|Washout 5 to 7 Days|Adverse Event|0|||
164464173|NCT03209973|594072031|FG000|Overall Study|Withdrawal by Subject|7|||
164464174|NCT03209973|594072031|FG000|Overall Study|Lost to Follow-up|2|||
164464175|NCT03209973|594072031|FG000|Overall Study|Death|8|||
164464176|NCT03209973|594072031|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
164464177|NCT03209973|594072031|FG000|Overall Study|Sponsor Decision|18|||
164464178|NCT03209973|594072031|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
164464179|NCT03209973|594072031|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
164464180|NCT04800211|594072036|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
164464181|NCT04800211|594072037|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
164414285|NCT02006121|593888464|FG000|Open Label Phase|Protocol Violation|2|||
164414286|NCT02006121|593888465|FG001|Open Label Phase|Protocol Violation|0|||
164414287|NCT02006121|593888464|FG000|Open Label Phase|Withdrawal by Subject|3|||
164414288|NCT02006121|593888465|FG001|Open Label Phase|Withdrawal by Subject|0|||
164414289|NCT02006121|593888464|FG000|Open Label Phase|Non-compliance with study drug|3|||
164414290|NCT02006121|593888465|FG001|Open Label Phase|Non-compliance with study drug|0|||
164414291|NCT03101241|593888469|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
164414292|NCT03101241|593888470|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
164414293|NCT03101241|593888469|FG000|Overall Study|Participant withdrew consent|3|||
164414294|NCT03101241|593888470|FG001|Overall Study|Participant withdrew consent|1|||
164414295|NCT03101241|593888469|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
164414296|NCT03101241|593888470|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
164414297|NCT03101241|593888469|FG000|Overall Study|Lost to Follow-up|2|||
164414298|NCT03101241|593888470|FG001|Overall Study|Lost to Follow-up|0|||
164414299|NCT03101241|593888469|FG000|Overall Study|Lack of Efficacy|0|||
164414300|NCT03101241|593888470|FG001|Overall Study|Lack of Efficacy|1|||
164414301|NCT03101241|593888469|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
164414302|NCT03101241|593888470|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
164414303|NCT04498247|593888471|FG000|Overall Study|Lost to Follow-up|0|||
164414304|NCT04498247|593888472|FG001|Overall Study|Lost to Follow-up|0|||
164414305|NCT04498247|593888473|FG002|Overall Study|Lost to Follow-up|0|||
164414306|NCT04498247|593888474|FG003|Overall Study|Lost to Follow-up|1|||
164414307|NCT04498247|593888475|FG004|Overall Study|Lost to Follow-up|0|||
164414308|NCT04498247|593888476|FG005|Overall Study|Lost to Follow-up|0|||
164414309|NCT04498247|593888477|FG006|Overall Study|Lost to Follow-up|0|||
164464182|NCT04800211|594072038|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
164464183|NCT04800211|594072036|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
164464184|NCT04800211|594072037|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
164464185|NCT04800211|594072038|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
164464186|NCT04800211|594072036|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
164464187|NCT04800211|594072037|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
164464188|NCT04800211|594072038|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
164464189|NCT04800211|594072036|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
164464190|NCT04800211|594072037|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
164464191|NCT04800211|594072038|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
164464192|NCT04800211|594072036|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
164464193|NCT04800211|594072037|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
164464194|NCT04800211|594072038|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
164464195|NCT04800211|594072036|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
164464196|NCT04800211|594072037|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
164464197|NCT04800211|594072038|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
164464198|NCT04800211|594072036|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
164414310|NCT04498247|593888478|FG007|Overall Study|Lost to Follow-up|0|||
164414311|NCT04498247|593888471|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
164414312|NCT04498247|593888472|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
164414313|NCT04498247|593888473|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
164414314|NCT04498247|593888474|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
164414315|NCT04498247|593888475|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
164414316|NCT04498247|593888476|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
164414317|NCT04498247|593888477|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
164414318|NCT04498247|593888478|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
164414319|NCT04498247|593888471|FG000|Overall Study|Withdrawal by Subject|0|||
164464199|NCT04800211|594072037|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
164464200|NCT04800211|594072038|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
164464201|NCT04800211|594072036|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
164464202|NCT04800211|594072037|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
164414320|NCT04498247|593888472|FG001|Overall Study|Withdrawal by Subject|8|||
164414321|NCT04498247|593888473|FG002|Overall Study|Withdrawal by Subject|0|||
164464203|NCT04800211|594072038|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
164464204|NCT04800211|594072036|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
164464205|NCT04800211|594072037|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
164464206|NCT04800211|594072038|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
164464207|NCT04800211|594072036|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
164464208|NCT04800211|594072037|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
164464209|NCT04800211|594072038|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
164464210|NCT04800211|594072036|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
164464211|NCT04800211|594072037|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
164464212|NCT04800211|594072038|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
164464213|NCT05170841|594072039|FG000|Single Dose Phase|Adverse Event|1|||
164464214|NCT05170841|594072040|FG001|Single Dose Phase|Adverse Event|2|||
164464215|NCT05170841|594072041|FG002|Single Dose Phase|Adverse Event|0|||
164464216|NCT05170841|594072042|FG003|Single Dose Phase|Adverse Event|2|||
164464217|NCT05170841|594072039|FG000|Multiple Dose Phase|Adverse Event|1|||
164464218|NCT05170841|594072040|FG001|Multiple Dose Phase|Adverse Event|2|||
164464219|NCT05170841|594072041|FG002|Multiple Dose Phase|Adverse Event|1|||
164464220|NCT05170841|594072042|FG003|Multiple Dose Phase|Adverse Event|4|||
164464221|NCT05170841|594072039|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
164414322|NCT04498247|593888474|FG003|Overall Study|Withdrawal by Subject|7|||
164414323|NCT04498247|593888475|FG004|Overall Study|Withdrawal by Subject|0|||
164414324|NCT04498247|593888476|FG005|Overall Study|Withdrawal by Subject|0|||
164414325|NCT04498247|593888477|FG006|Overall Study|Withdrawal by Subject|1|||
164414326|NCT04498247|593888478|FG007|Overall Study|Withdrawal by Subject|0|||
164414327|NCT04498247|593888471|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
164414328|NCT04498247|593888472|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
164414329|NCT04498247|593888473|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
164414330|NCT04498247|593888474|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
164414331|NCT04498247|593888475|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
164414332|NCT04498247|593888476|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
164414333|NCT04498247|593888477|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
164414334|NCT04498247|593888478|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
164414335|NCT00669903|593888479|FG000|Overall Study|Adverse Event|0|||
164464222|NCT05170841|594072040|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
164464223|NCT05170841|594072041|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
164464224|NCT05170841|594072042|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
164710061|NCT00626392|594962823|FG000|Coadministration Period|Withdrawal by Subject|1|||
164464225|NCT05123586|594072045|FG000|Overall Study|Physician Decision|1|||
164464226|NCT05123586|594072046|FG001|Overall Study|Physician Decision|1|||
164464227|NCT05123586|594072045|FG000|Overall Study|Withdrawal by Subject|0|||
164464228|NCT05123586|594072046|FG001|Overall Study|Withdrawal by Subject|3|||
164464229|NCT04690582|594072072|FG000|Overall Study|Withdrawal by Subject|6|||
164464230|NCT04690582|594072073|FG001|Overall Study|Withdrawal by Subject|4|||
164464231|NCT04032847|594072079|FG000|Overall Study|Study termination by sponsor|8|||
164464232|NCT04032847|594072080|FG001|Overall Study|Study termination by sponsor|0|||
164464233|NCT04032847|594072081|FG002|Overall Study|Study termination by sponsor|4|||
164464234|NCT04032847|594072079|FG000|Overall Study|Death|12|||
164464235|NCT04032847|594072080|FG001|Overall Study|Death|0|||
164710062|NCT00626392|594962824|FG001|Coadministration Period|Withdrawal by Subject|1|||
164710063|NCT00626392|594962825|FG002|Coadministration Period|Withdrawal by Subject|0|||
164710064|NCT00626392|594962826|FG003|Coadministration Period|Withdrawal by Subject|1|||
164710065|NCT00626392|594962827|FG004|Coadministration Period|Withdrawal by Subject|0|||
164710066|NCT00626392|594962828|FG005|Coadministration Period|Withdrawal by Subject|1|||
164710067|NCT00626392|594962823|FG000|Coadministration Period|Protocol Violation|0|||
164710068|NCT00626392|594962824|FG001|Coadministration Period|Protocol Violation|1|||
164710069|NCT00626392|594962825|FG002|Coadministration Period|Protocol Violation|0|||
164710070|NCT00626392|594962826|FG003|Coadministration Period|Protocol Violation|1|||
164710071|NCT00626392|594962827|FG004|Coadministration Period|Protocol Violation|1|||
164710072|NCT00626392|594962828|FG005|Coadministration Period|Protocol Violation|0|||
164710073|NCT00626392|594962823|FG000|Coadministration Period|Other|0|||
164710074|NCT00626392|594962824|FG001|Coadministration Period|Other|2|||
164710075|NCT00626392|594962825|FG002|Coadministration Period|Other|3|||
164710076|NCT00626392|594962826|FG003|Coadministration Period|Other|1|||
164710077|NCT00626392|594962827|FG004|Coadministration Period|Other|1|||
164710078|NCT00626392|594962828|FG005|Coadministration Period|Other|1|||
164710079|NCT04576923|594962829|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
164710080|NCT03151811|594962835|FG000|Overall Study|Randomized But Not Treated|18|||
164710081|NCT03151811|594962836|FG001|Overall Study|Randomized But Not Treated|3|||
164710082|NCT03151811|594962835|FG000|Overall Study|Progressive Disease|130|||
164710083|NCT03151811|594962836|FG001|Overall Study|Progressive Disease|170|||
164710084|NCT03151811|594962835|FG000|Overall Study|Adverse Event|49|||
164710085|NCT03151811|594962836|FG001|Overall Study|Adverse Event|40|||
164710086|NCT03151811|594962835|FG000|Overall Study|Lack of Efficacy|6|||
164710087|NCT03151811|594962836|FG001|Overall Study|Lack of Efficacy|8|||
164710088|NCT03151811|594962835|FG000|Overall Study|Physician Decision|21|||
164710089|NCT03151811|594962836|FG001|Overall Study|Physician Decision|9|||
164710090|NCT03151811|594962835|FG000|Overall Study|Withdrawal by Subject|17|||
164710091|NCT03151811|594962836|FG001|Overall Study|Withdrawal by Subject|7|||
164710092|NCT03151811|594962835|FG000|Overall Study|Lost to Follow-up|0|||
164710093|NCT03151811|594962836|FG001|Overall Study|Lost to Follow-up|1|||
164710094|NCT03151811|594962835|FG000|Overall Study|Study Terminated by Sponsor|5|||
164710095|NCT03151811|594962836|FG001|Overall Study|Study Terminated by Sponsor|11|||
164710096|NCT01081834|594962839|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
164710097|NCT01081834|594962840|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
164710098|NCT01081834|594962841|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
164710099|NCT01081834|594962842|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
164710100|NCT01081834|594962843|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
164710101|NCT01081834|594962839|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
164710102|NCT01081834|594962840|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
164710103|NCT01081834|594962841|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
164710104|NCT01081834|594962842|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
164710105|NCT01081834|594962843|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
164710106|NCT01081834|594962839|FG000|Core Period: Baseline to Week 26|Death|1|||
164710107|NCT01081834|594962840|FG001|Core Period: Baseline to Week 26|Death|0|||
164710108|NCT01081834|594962841|FG002|Core Period: Baseline to Week 26|Death|0|||
164464236|NCT04032847|594072081|FG002|Overall Study|Death|0|||
164710109|NCT01081834|594962842|FG003|Core Period: Baseline to Week 26|Death|0|||
164710110|NCT01081834|594962843|FG004|Core Period: Baseline to Week 26|Death|0|||
164710111|NCT01081834|594962839|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
164710112|NCT01081834|594962840|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
164710113|NCT01081834|594962841|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
164710114|NCT01081834|594962842|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
164710115|NCT01081834|594962843|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
164710116|NCT01081834|594962839|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
164710117|NCT01081834|594962840|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
164710118|NCT01081834|594962841|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
164464237|NCT04032847|594072079|FG000|Overall Study|Progressive disease|2|||
164464238|NCT04032847|594072080|FG001|Overall Study|Progressive disease|0|||
164464239|NCT04032847|594072081|FG002|Overall Study|Progressive disease|1|||
164414336|NCT00669903|593888480|FG001|Overall Study|Adverse Event|1|||
164414337|NCT00669903|593888481|FG002|Overall Study|Adverse Event|3|||
164414338|NCT00669903|593888482|FG003|Overall Study|Adverse Event|1|||
164414339|NCT00669903|593888479|FG000|Overall Study|Withdrawal by Subject|0|||
164414340|NCT00669903|593888480|FG001|Overall Study|Withdrawal by Subject|2|||
164414341|NCT00669903|593888481|FG002|Overall Study|Withdrawal by Subject|2|||
164414342|NCT00669903|593888482|FG003|Overall Study|Withdrawal by Subject|2|||
164414343|NCT00669903|593888479|FG000|Overall Study|Lost to Follow-up|1|||
164599430|NCT00586924|594554867|FG002|Overall Study|Adverse event/serious adverse event|0|||
164599431|NCT00586924|594554868|FG003|Overall Study|Adverse event/serious adverse event|1|||
164599432|NCT00586924|594554869|FG004|Overall Study|Adverse event/serious adverse event|0|||
164599433|NCT00586924|594554870|FG005|Overall Study|Adverse event/serious adverse event|2|||
164599434|NCT00586924|594554865|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
164599435|NCT00586924|594554866|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
164599436|NCT00586924|594554867|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
164599437|NCT00586924|594554868|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
164599438|NCT00586924|594554869|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
164599439|NCT00586924|594554870|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
164599440|NCT00586924|594554865|FG000|Overall Study|Disease progression|0|||
164599441|NCT00586924|594554866|FG001|Overall Study|Disease progression|0|||
164599442|NCT00586924|594554867|FG002|Overall Study|Disease progression|0|||
164599443|NCT00586924|594554868|FG003|Overall Study|Disease progression|1|||
164599444|NCT00586924|594554869|FG004|Overall Study|Disease progression|1|||
164599445|NCT00586924|594554870|FG005|Overall Study|Disease progression|0|||
164599446|NCT00586924|594554865|FG000|Overall Study|Development of neutralizing antibodies|2|||
164599447|NCT00586924|594554866|FG001|Overall Study|Development of neutralizing antibodies|2|||
164599448|NCT00586924|594554867|FG002|Overall Study|Development of neutralizing antibodies|2|||
164599449|NCT00586924|594554868|FG003|Overall Study|Development of neutralizing antibodies|0|||
164599450|NCT00586924|594554869|FG004|Overall Study|Development of neutralizing antibodies|0|||
164599451|NCT00586924|594554870|FG005|Overall Study|Development of neutralizing antibodies|22|||
164599452|NCT00586924|594554865|FG000|Overall Study|Complete response|0|||
164599453|NCT00586924|594554866|FG001|Overall Study|Complete response|1|||
164599454|NCT00586924|594554867|FG002|Overall Study|Complete response|0|||
164599455|NCT00586924|594554868|FG003|Overall Study|Complete response|0|||
164599456|NCT00586924|594554869|FG004|Overall Study|Complete response|2|||
164599457|NCT00586924|594554870|FG005|Overall Study|Complete response|2|||
164599458|NCT00586924|594554865|FG000|Overall Study|Other|1|||
164599459|NCT00586924|594554866|FG001|Overall Study|Other|0|||
164599460|NCT00586924|594554867|FG002|Overall Study|Other|1|||
164599461|NCT00586924|594554868|FG003|Overall Study|Other|1|||
164599462|NCT00586924|594554869|FG004|Overall Study|Other|1|||
164599463|NCT00586924|594554870|FG005|Overall Study|Other|6|||
164599464|NCT01331239|594554871|FG000|Part II: Core Study|Adverse Event|0|||
164599465|NCT01331239|594554872|FG001|Part II: Core Study|Adverse Event|3|||
164599466|NCT01331239|594554873|FG002|Part II: Core Study|Adverse Event|0|||
164599467|NCT01331239|594554871|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
164599468|NCT01331239|594554872|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
164599469|NCT01331239|594554873|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
164599470|NCT01331239|594554871|FG000|Part II: Core Study|Withdrawal by Subject|0|||
164599471|NCT01331239|594554872|FG001|Part II: Core Study|Withdrawal by Subject|2|||
164599472|NCT01331239|594554873|FG002|Part II: Core Study|Withdrawal by Subject|0|||
164599473|NCT01331239|594554871|FG000|Part II: Core Study|Administrative problems|0|||
164599474|NCT01331239|594554872|FG001|Part II: Core Study|Administrative problems|1|||
164599475|NCT01331239|594554873|FG002|Part II: Core Study|Administrative problems|0|||
164599476|NCT01767194|594554875|FG000|Overall Study|Adverse Event|1|||
164599477|NCT01767194|594554876|FG001|Overall Study|Adverse Event|1|||
164599478|NCT01767194|594554875|FG000|Overall Study|Death|0|||
164599479|NCT01767194|594554876|FG001|Overall Study|Death|1|||
164599480|NCT01767194|594554875|FG000|Overall Study|Lack of Efficacy|12|||
164599481|NCT01767194|594554876|FG001|Overall Study|Lack of Efficacy|11|||
164599482|NCT01767194|594554875|FG000|Overall Study|Physician Decision|2|||
164599483|NCT01767194|594554876|FG001|Overall Study|Physician Decision|23|||
164599484|NCT01767194|594554875|FG000|Overall Study|Withdrawal by Subject|0|||
164599485|NCT01767194|594554876|FG001|Overall Study|Withdrawal by Subject|1|||
164599486|NCT01767194|594554875|FG000|Overall Study|Ineligible|1|||
164599487|NCT01767194|594554876|FG001|Overall Study|Ineligible|1|||
164599488|NCT01767194|594554875|FG000|Overall Study|Refusal by patient/parent|2|||
164599489|NCT01767194|594554876|FG001|Overall Study|Refusal by patient/parent|4|||
164599490|NCT01767194|594554875|FG000|Overall Study|Criteria not met on time for next cycle|0|||
164414344|NCT00669903|593888480|FG001|Overall Study|Lost to Follow-up|1|||
164414345|NCT00669903|593888481|FG002|Overall Study|Lost to Follow-up|0|||
164414346|NCT00669903|593888482|FG003|Overall Study|Lost to Follow-up|1|||
164414347|NCT00669903|593888479|FG000|Overall Study|Protocol Violation|0|||
164414348|NCT00669903|593888480|FG001|Overall Study|Protocol Violation|1|||
164414349|NCT00669903|593888481|FG002|Overall Study|Protocol Violation|0|||
164414350|NCT00669903|593888482|FG003|Overall Study|Protocol Violation|0|||
164414351|NCT00251927|593888483|FG000|Overall Study|Adverse Event|3|||
164414352|NCT00251927|593888484|FG001|Overall Study|Adverse Event|15|||
164414353|NCT00251927|593888483|FG000|Overall Study|Lack of Efficacy|22|||
164414354|NCT00251927|593888484|FG001|Overall Study|Lack of Efficacy|16|||
164414355|NCT00251927|593888483|FG000|Overall Study|Lost to Follow-up|22|||
164414356|NCT00251927|593888484|FG001|Overall Study|Lost to Follow-up|8|||
164414357|NCT00251927|593888483|FG000|Overall Study|Protocol Violation|1|||
164414358|NCT00251927|593888484|FG001|Overall Study|Protocol Violation|2|||
164414359|NCT00251927|593888483|FG000|Overall Study|Pregnancy|2|||
164414360|NCT00251927|593888484|FG001|Overall Study|Pregnancy|0|||
164414361|NCT00251927|593888483|FG000|Overall Study|Withdrawal by Subject|40|||
164414362|NCT00251927|593888484|FG001|Overall Study|Withdrawal by Subject|25|||
164414363|NCT00251927|593888483|FG000|Overall Study|Study-specific discont. achieved|13|||
164414364|NCT00251927|593888484|FG001|Overall Study|Study-specific discont. achieved|2|||
164414365|NCT00251927|593888483|FG000|Overall Study|Study procedure non-compliance|5|||
164414366|NCT00251927|593888484|FG001|Overall Study|Study procedure non-compliance|6|||
164414367|NCT01678820|593888485|FG000|Overall Study|Study Terminated by Sponsor|45|||
164414368|NCT01678820|593888486|FG001|Overall Study|Study Terminated by Sponsor|43|||
164414369|NCT01678820|593888487|FG002|Overall Study|Study Terminated by Sponsor|43|||
164414370|NCT01678820|593888485|FG000|Overall Study|Withdrawal by Subject|2|||
164414371|NCT01678820|593888486|FG001|Overall Study|Withdrawal by Subject|5|||
164414372|NCT01678820|593888487|FG002|Overall Study|Withdrawal by Subject|2|||
164414373|NCT01678820|593888485|FG000|Overall Study|Protocol Specified Criteria|2|||
164414374|NCT01678820|593888486|FG001|Overall Study|Protocol Specified Criteria|3|||
164414375|NCT01678820|593888487|FG002|Overall Study|Protocol Specified Criteria|1|||
164414376|NCT01678820|593888485|FG000|Overall Study|Adverse Event|2|||
164414377|NCT01678820|593888486|FG001|Overall Study|Adverse Event|2|||
164414378|NCT01678820|593888487|FG002|Overall Study|Adverse Event|2|||
164414379|NCT01678820|593888485|FG000|Overall Study|Lost to Follow-up|7|||
164414380|NCT01678820|593888486|FG001|Overall Study|Lost to Follow-up|2|||
164414381|NCT01678820|593888487|FG002|Overall Study|Lost to Follow-up|2|||
164414382|NCT01678820|593888485|FG000|Overall Study|Non-compliance with study drug|0|||
164414383|NCT01678820|593888486|FG001|Overall Study|Non-compliance with study drug|1|||
164414384|NCT01678820|593888487|FG002|Overall Study|Non-compliance with study drug|0|||
164414385|NCT01678820|593888485|FG000|Overall Study|Physician Decision|0|||
164414386|NCT01678820|593888486|FG001|Overall Study|Physician Decision|0|||
164414387|NCT01678820|593888487|FG002|Overall Study|Physician Decision|1|||
164414388|NCT01678820|593888485|FG000|Overall Study|Protocol Violation|4|||
164414389|NCT01678820|593888486|FG001|Overall Study|Protocol Violation|5|||
164414390|NCT01678820|593888487|FG002|Overall Study|Protocol Violation|4|||
164414391|NCT01678820|593888485|FG000|Overall Study|Not treated with double-blind study drug|0|||
164414392|NCT01678820|593888486|FG001|Overall Study|Not treated with double-blind study drug|2|||
164414393|NCT01678820|593888487|FG002|Overall Study|Not treated with double-blind study drug|2|||
164414394|NCT01381874|593888488|FG000|Overall Study|Lost to Follow-up|1|||
164414395|NCT01381874|593888489|FG001|Overall Study|Lost to Follow-up|1|||
164414396|NCT01381874|593888490|FG002|Overall Study|Lost to Follow-up|0|||
164414397|NCT01381874|593888488|FG000|Overall Study|Withdrawal by Subject|9|||
164414398|NCT01381874|593888489|FG001|Overall Study|Withdrawal by Subject|10|||
164414399|NCT01381874|593888490|FG002|Overall Study|Withdrawal by Subject|9|||
164414400|NCT01381874|593888488|FG000|Overall Study|Other|67|||
164414401|NCT01381874|593888489|FG001|Overall Study|Other|52|||
164414402|NCT01381874|593888490|FG002|Overall Study|Other|67|||
164414403|NCT01737996|593888491|FG000|Overall Study|Adverse Event|0|||
164414404|NCT01737996|593888492|FG001|Overall Study|Adverse Event|1|||
164414405|NCT01737996|593888493|FG002|Overall Study|Adverse Event|1|||
164414406|NCT01737996|593888491|FG000|Overall Study|Withdrawal by Subject|0|||
164414407|NCT01737996|593888492|FG001|Overall Study|Withdrawal by Subject|0|||
164414408|NCT01737996|593888493|FG002|Overall Study|Withdrawal by Subject|1|||
164414409|NCT03283696|593888494|FG000|Overall Study|Physician Decision|5|||
164414410|NCT03283696|593888495|FG001|Overall Study|Physician Decision|6|||
164414411|NCT03283696|593888494|FG000|Overall Study|Withdrawal by Subject|2|||
164414412|NCT03283696|593888495|FG001|Overall Study|Withdrawal by Subject|0|||
164414413|NCT00245856|593888496|FG000|Period Two|Withdrawal by Subject|0|||
164414414|NCT00245856|593888497|FG001|Period Two|Withdrawal by Subject|1|||
164414415|NCT01003184|593888498|FG000|Overall Study|Adverse Event|12|||
164414416|NCT01003184|593888499|FG001|Overall Study|Adverse Event|5|||
164414417|NCT01003184|593888498|FG000|Overall Study|Lost to Follow-up|1|||
164414418|NCT01003184|593888499|FG001|Overall Study|Lost to Follow-up|0|||
164414419|NCT01003184|593888498|FG000|Overall Study|Loss of glucose control|1|||
164414420|NCT01003184|593888499|FG001|Overall Study|Loss of glucose control|1|||
164414421|NCT01003184|593888498|FG000|Overall Study|Protocol Violation|3|||
164414422|NCT01003184|593888499|FG001|Overall Study|Protocol Violation|0|||
164414423|NCT01003184|593888498|FG000|Overall Study|Withdrawal by Subject|1|||
164414424|NCT01003184|593888499|FG001|Overall Study|Withdrawal by Subject|6|||
164414425|NCT01003184|593888498|FG000|Overall Study|Physician Decision|1|||
164414426|NCT01003184|593888499|FG001|Overall Study|Physician Decision|0|||
164414427|NCT00557622|593888500|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
164464240|NCT03056573|594072082|FG000|Overall Study|Death|2|||
164464241|NCT03056573|594072083|FG001|Overall Study|Death|4|||
164464242|NCT03056573|594072082|FG000|Overall Study|Withdrawal by Subject|2|||
164464243|NCT03056573|594072083|FG001|Overall Study|Withdrawal by Subject|0|||
164464244|NCT03056573|594072082|FG000|Overall Study|Lost to Follow-up|1|||
164464245|NCT03056573|594072083|FG001|Overall Study|Lost to Follow-up|1|||
164464246|NCT05267470|594072084|FG000|Overall Study|Decision by sponsor|0|||
164464247|NCT05267470|594072085|FG001|Overall Study|Decision by sponsor|3|||
164464248|NCT05267470|594072086|FG002|Overall Study|Decision by sponsor|19|||
164464249|NCT05267470|594072087|FG003|Overall Study|Decision by sponsor|7|||
164464250|NCT05267470|594072088|FG004|Overall Study|Decision by sponsor|3|||
164464251|NCT05267470|594072084|FG000|Overall Study|Withdrawal by Subject|1|||
164464252|NCT05267470|594072085|FG001|Overall Study|Withdrawal by Subject|1|||
164464253|NCT05267470|594072086|FG002|Overall Study|Withdrawal by Subject|2|||
164464254|NCT05267470|594072087|FG003|Overall Study|Withdrawal by Subject|2|||
164464255|NCT05267470|594072088|FG004|Overall Study|Withdrawal by Subject|0|||
164464256|NCT05267470|594072084|FG000|Overall Study|Death|3|||
164464257|NCT05267470|594072085|FG001|Overall Study|Death|5|||
164464258|NCT05267470|594072086|FG002|Overall Study|Death|8|||
164464259|NCT05267470|594072087|FG003|Overall Study|Death|18|||
164464260|NCT05267470|594072088|FG004|Overall Study|Death|1|||
164464261|NCT05267470|594072084|FG000|Overall Study|Lost to Follow-up|0|||
164464262|NCT05267470|594072085|FG001|Overall Study|Lost to Follow-up|0|||
164464263|NCT05267470|594072086|FG002|Overall Study|Lost to Follow-up|0|||
164464264|NCT05267470|594072087|FG003|Overall Study|Lost to Follow-up|1|||
164464265|NCT05267470|594072088|FG004|Overall Study|Lost to Follow-up|0|||
164464266|NCT04622046|594072089|FG000|Intervention Period|Adverse Event|1|||
164464267|NCT04622046|594072089|FG000|Intervention Period|Withdrawal by Subject|2|||
164599491|NCT01767194|594554876|FG001|Overall Study|Criteria not met on time for next cycle|1|||
164464268|NCT04622046|594072089|FG000|Extension Period|Ongoing in the Extension Period|21|||
164464269|NCT05321082|594072090|FG000|Overall Study|Other than listed|40|||
164464270|NCT05321082|594072091|FG001|Overall Study|Other than listed|26|||
164464271|NCT05321082|594072092|FG002|Overall Study|Other than listed|27|||
164464272|NCT05321082|594072090|FG000|Overall Study|Lost to Follow-up|0|||
164464273|NCT05321082|594072091|FG001|Overall Study|Lost to Follow-up|1|||
164464274|NCT05321082|594072092|FG002|Overall Study|Lost to Follow-up|0|||
164464275|NCT05321082|594072090|FG000|Overall Study|Withdrawal by Subject|30|||
164464276|NCT05321082|594072091|FG001|Overall Study|Withdrawal by Subject|34|||
164464277|NCT05321082|594072092|FG002|Overall Study|Withdrawal by Subject|42|||
164464278|NCT05321082|594072090|FG000|Overall Study|Protocol Violation|0|||
164464279|NCT05321082|594072091|FG001|Overall Study|Protocol Violation|0|||
164464280|NCT05321082|594072092|FG002|Overall Study|Protocol Violation|1|||
164464281|NCT05321082|594072090|FG000|Overall Study|Adverse Event|49|||
164464282|NCT05321082|594072091|FG001|Overall Study|Adverse Event|49|||
164464283|NCT05321082|594072092|FG002|Overall Study|Adverse Event|48|||
164464284|NCT05321082|594072090|FG000|Overall Study|Lack of Efficacy|2|||
164464285|NCT05321082|594072091|FG001|Overall Study|Lack of Efficacy|0|||
164464286|NCT05321082|594072092|FG002|Overall Study|Lack of Efficacy|1|||
164464287|NCT05321082|594072090|FG000|Overall Study|Not treated|1|||
164464288|NCT05321082|594072091|FG001|Overall Study|Not treated|0|||
164464289|NCT05321082|594072092|FG002|Overall Study|Not treated|1|||
164464290|NCT07147257|594072093|FG000|Overall Study|Pregnancy|1|||
164464291|NCT07147257|594072094|FG001|Overall Study|Pregnancy|0|||
164464292|NCT07147257|594072093|FG000|Overall Study|Physician Decision|0|||
164464293|NCT07147257|594072094|FG001|Overall Study|Physician Decision|1|||
164464294|NCT07147257|594072093|FG000|Overall Study|Withdrawal by Subject|0|||
164464295|NCT07147257|594072094|FG001|Overall Study|Withdrawal by Subject|1|||
164464296|NCT07147257|594072093|FG000|Overall Study|Drug administration failure|0|||
164464297|NCT07147257|594072094|FG001|Overall Study|Drug administration failure|1|||
164464298|NCT03314454|594073752|FG000|Overall Study|Protocol Violation|1|||
164464299|NCT02841579|594073760|FG000|Overall Study|Death|1|||
164464300|NCT02841579|594073760|FG000|Overall Study|Adverse Event|1|||
164464301|NCT02841579|594073760|FG000|Overall Study|Lack of Efficacy|9|||
164464302|NCT04233216|594073763|FG000|Overall Study|Lost to Follow-up|1|||
164464303|NCT04233216|594073764|FG001|Overall Study|Lost to Follow-up|0|||
164464304|NCT04233216|594073765|FG002|Overall Study|Lost to Follow-up|2|||
164464305|NCT04233216|594073766|FG003|Overall Study|Lost to Follow-up|0|||
164464306|NCT04233216|594073763|FG000|Overall Study|Physician Decision|0|||
164464307|NCT04233216|594073764|FG001|Overall Study|Physician Decision|3|||
164464308|NCT04233216|594073765|FG002|Overall Study|Physician Decision|0|||
164464309|NCT04233216|594073766|FG003|Overall Study|Physician Decision|2|||
164464310|NCT04233216|594073763|FG000|Overall Study|Withdrawal by Subject|0|||
164464311|NCT04233216|594073764|FG001|Overall Study|Withdrawal by Subject|2|||
164464312|NCT04233216|594073765|FG002|Overall Study|Withdrawal by Subject|1|||
164464313|NCT04233216|594073766|FG003|Overall Study|Withdrawal by Subject|0|||
164464314|NCT03652389|594073767|FG000|Overall Study|Lost to Follow-up|1|||
164464315|NCT03652389|594073768|FG001|Overall Study|Lost to Follow-up|5|||
164464316|NCT03652389|594073767|FG000|Overall Study|Withdrawal by Subject|5|||
164464317|NCT03652389|594073768|FG001|Overall Study|Withdrawal by Subject|1|||
164464318|NCT03652389|594073767|FG000|Overall Study|New diagnosis|2|||
164464319|NCT03652389|594073768|FG001|Overall Study|New diagnosis|0|||
164464320|NCT03766685|594073773|FG000|Overall Study|Lost to Follow-up|1|||
164464321|NCT03766685|594073774|FG001|Overall Study|Lost to Follow-up|1|||
164464322|NCT03766685|594073775|FG002|Overall Study|Lost to Follow-up|0|||
164464323|NCT03766685|594073776|FG003|Overall Study|Lost to Follow-up|0|||
164464324|NCT03766685|594073773|FG000|Overall Study|Adverse Event, not fatal|0|||
164464325|NCT03766685|594073774|FG001|Overall Study|Adverse Event, not fatal|1|||
164464326|NCT03766685|594073775|FG002|Overall Study|Adverse Event, not fatal|0|||
164464327|NCT03766685|594073776|FG003|Overall Study|Adverse Event, not fatal|1|||
164464328|NCT03766685|594073773|FG000|Overall Study|Withdrawal by Subject|0|||
164464329|NCT03766685|594073774|FG001|Overall Study|Withdrawal by Subject|2|||
164464330|NCT03766685|594073775|FG002|Overall Study|Withdrawal by Subject|0|||
164464331|NCT03766685|594073776|FG003|Overall Study|Withdrawal by Subject|0|||
164464332|NCT03766685|594073773|FG000|Overall Study|Protocol Violation|0|||
164464333|NCT03766685|594073774|FG001|Overall Study|Protocol Violation|1|||
164464334|NCT03766685|594073775|FG002|Overall Study|Protocol Violation|0|||
164710119|NCT01081834|594962842|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
164710120|NCT01081834|594962843|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
164710121|NCT01081834|594962839|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
164710122|NCT01081834|594962840|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
164710123|NCT01081834|594962841|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
164144814|NCT01524978|592891784|FG010|Overall Study|Lost to Follow-up|1|||
164464335|NCT03766685|594073776|FG003|Overall Study|Protocol Violation|0|||
164464336|NCT03766685|594073773|FG000|Overall Study|Non-compliance|0|||
164464337|NCT03766685|594073774|FG001|Overall Study|Non-compliance|2|||
164464338|NCT03766685|594073775|FG002|Overall Study|Non-compliance|0|||
164464339|NCT03766685|594073776|FG003|Overall Study|Non-compliance|0|||
164464340|NCT02116530|594073777|FG000|Overall Study|Withdrawal by Subject|1|||
164464341|NCT02116530|594073778|FG001|Overall Study|Withdrawal by Subject|2|||
164464342|NCT02116530|594073777|FG000|Overall Study|Adverse Event|4|||
164464343|NCT02116530|594073778|FG001|Overall Study|Adverse Event|0|||
164464344|NCT02116530|594073777|FG000|Overall Study|Physician Decision|1|||
164464345|NCT02116530|594073778|FG001|Overall Study|Physician Decision|0|||
164464346|NCT02116530|594073777|FG000|Overall Study|Lost to Follow-up|1|||
164464347|NCT02116530|594073778|FG001|Overall Study|Lost to Follow-up|0|||
164464348|NCT02116530|594073777|FG000|Overall Study|Other Medical Problems|2|||
164464349|NCT02116530|594073778|FG001|Overall Study|Other Medical Problems|2|||
164464350|NCT06232590|594073781|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
164464351|NCT06232590|594073782|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
164464352|NCT04914676|594073783|FG000|Overall Study|Study termination|3|||
164464353|NCT04914676|594073784|FG001|Overall Study|Study termination|0|||
164464354|NCT02433379|594073785|FG000|Overall Study|Screen Failures|55|||
164464355|NCT02433379|594073785|FG000|Overall Study|Death|57|||
164464356|NCT02433379|594073785|FG000|Overall Study|Total Withdrawals|209|||
164464357|NCT04200456|594073786|FG000|Overall Study|Physician Decision|0|||
164464358|NCT04200456|594073787|FG001|Overall Study|Physician Decision|1|||
164464359|NCT04200456|594073786|FG000|Overall Study|Withdrawal by Subject|2|||
164464360|NCT04200456|594073787|FG001|Overall Study|Withdrawal by Subject|2|||
164464361|NCT04200456|594073786|FG000|Overall Study|Lack of Efficacy|1|||
164464362|NCT04200456|594073787|FG001|Overall Study|Lack of Efficacy|1|||
164464363|NCT04200456|594073786|FG000|Overall Study|Adverse event, non-fatal|0|||
164464364|NCT04200456|594073787|FG001|Overall Study|Adverse event, non-fatal|1|||
164464365|NCT04200456|594073786|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
164464366|NCT04200456|594073787|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
164464367|NCT02505984|594073790|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
164464368|NCT02505984|594073791|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
164464369|NCT02505984|594073790|FG000|Overall Study|Unreliable self-report data|1|||
164464370|NCT02505984|594073791|FG001|Overall Study|Unreliable self-report data|0|||
164464371|NCT02505984|594073790|FG000|Overall Study|Study blind opened during assessment|0|||
164464372|NCT02505984|594073791|FG001|Overall Study|Study blind opened during assessment|1|||
164464373|NCT02505984|594073790|FG000|Overall Study|Noncompliance with study protocol|0|||
164464374|NCT02505984|594073791|FG001|Overall Study|Noncompliance with study protocol|1|||
164464375|NCT03511664|594073802|FG000|Overall Study|Death|457|||
164464376|NCT03511664|594073803|FG001|Overall Study|Death|201|||
164464377|NCT03511664|594073804|FG002|Overall Study|Death|21|||
164464378|NCT03511664|594073802|FG000|Overall Study|Withdrew consent|40|||
164464379|NCT03511664|594073803|FG001|Overall Study|Withdrew consent|63|||
164464380|NCT03511664|594073804|FG002|Overall Study|Withdrew consent|3|||
164464381|NCT03511664|594073802|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
164464382|NCT03511664|594073803|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
164464383|NCT03511664|594073804|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
164464384|NCT03511664|594073802|FG000|Overall Study|Lost to Follow-up|8|||
164464385|NCT03511664|594073803|FG001|Overall Study|Lost to Follow-up|5|||
164464386|NCT03511664|594073804|FG002|Overall Study|Lost to Follow-up|0|||
164464387|NCT03511664|594073802|FG000|Overall Study|Physician Decision|2|||
164464388|NCT03511664|594073803|FG001|Overall Study|Physician Decision|1|||
164464389|NCT03511664|594073804|FG002|Overall Study|Physician Decision|0|||
164464390|NCT03511664|594073802|FG000|Overall Study|Patient non-compliance|1|||
164464391|NCT03511664|594073803|FG001|Overall Study|Patient non-compliance|0|||
164464392|NCT03511664|594073804|FG002|Overall Study|Patient non-compliance|0|||
164464393|NCT01946789|594073805|FG000|Overall Study|Death|0|||
164464394|NCT01946789|594073806|FG001|Overall Study|Death|2|||
164464395|NCT01946789|594073807|FG002|Overall Study|Death|1|||
164464396|NCT01946789|594073808|FG003|Overall Study|Death|1|||
164464397|NCT01946789|594073809|FG004|Overall Study|Death|1|||
164464398|NCT01946789|594073810|FG005|Overall Study|Death|1|||
164464399|NCT01946789|594073811|FG006|Overall Study|Death|3|||
164464400|NCT01946789|594073812|FG007|Overall Study|Death|1|||
164464401|NCT01946789|594073813|FG008|Overall Study|Death|2|||
164464402|NCT01946789|594073805|FG000|Overall Study|Progressive Disease|0|||
164464403|NCT01946789|594073806|FG001|Overall Study|Progressive Disease|0|||
164464404|NCT01946789|594073807|FG002|Overall Study|Progressive Disease|1|||
164464405|NCT01946789|594073808|FG003|Overall Study|Progressive Disease|0|||
164464406|NCT01946789|594073809|FG004|Overall Study|Progressive Disease|0|||
164464407|NCT01946789|594073810|FG005|Overall Study|Progressive Disease|2|||
164464408|NCT01946789|594073811|FG006|Overall Study|Progressive Disease|0|||
164464409|NCT01946789|594073812|FG007|Overall Study|Progressive Disease|0|||
164464410|NCT01946789|594073813|FG008|Overall Study|Progressive Disease|0|||
164464411|NCT01946789|594073805|FG000|Overall Study|Withdrawal by Subject|0|||
164464412|NCT01946789|594073806|FG001|Overall Study|Withdrawal by Subject|0|||
164464413|NCT01946789|594073807|FG002|Overall Study|Withdrawal by Subject|0|||
164464414|NCT01946789|594073808|FG003|Overall Study|Withdrawal by Subject|2|||
164464415|NCT01946789|594073809|FG004|Overall Study|Withdrawal by Subject|1|||
164464416|NCT01946789|594073810|FG005|Overall Study|Withdrawal by Subject|0|||
164464417|NCT01946789|594073811|FG006|Overall Study|Withdrawal by Subject|1|||
164464418|NCT01946789|594073812|FG007|Overall Study|Withdrawal by Subject|0|||
164464419|NCT01946789|594073813|FG008|Overall Study|Withdrawal by Subject|0|||
164464420|NCT04076618|594073814|FG000|Overall Study|Lost to Follow-up|2|||
164464421|NCT04076618|594073815|FG001|Overall Study|Lost to Follow-up|1|||
164464422|NCT04076618|594073816|FG002|Overall Study|Lost to Follow-up|3|||
164464423|NCT04076618|594073814|FG000|Overall Study|Withdrawal by Subject|3|||
164464424|NCT04076618|594073815|FG001|Overall Study|Withdrawal by Subject|1|||
164464425|NCT04076618|594073816|FG002|Overall Study|Withdrawal by Subject|2|||
164414428|NCT00557622|593888501|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
164414429|NCT00557622|593888500|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
164414430|NCT00557622|593888501|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
164414431|NCT00557622|593888500|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
164414432|NCT00557622|593888501|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
164414433|NCT02765490|593888502|FG000|Overall Study|Lost to Follow-up|1|||
164414434|NCT02765490|593888503|FG001|Overall Study|Lost to Follow-up|1|||
164414435|NCT02765490|593888502|FG000|Overall Study|Other|0|||
164414436|NCT02765490|593888503|FG001|Overall Study|Other|1|||
164414437|NCT02765490|593888502|FG000|Overall Study|Death|0|||
164414438|NCT02765490|593888503|FG001|Overall Study|Death|1|||
164414439|NCT01923389|593888504|FG000|Overall Study|Protocol Violation|1|||
164414440|NCT01923389|593888505|FG001|Overall Study|Protocol Violation|0|||
164414441|NCT03237013|593888506|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
164414442|NCT03237013|593888507|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
164414443|NCT03237013|593888508|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
164414444|NCT05266963|593888510|FG000|Drug Period A|Withdrawal by Subject|0|||
164414445|NCT05266963|593888511|FG001|Drug Period A|Withdrawal by Subject|1|||
164414446|NCT00152971|593888512|FG000|Overall Study|Adverse Event|12|||
164414447|NCT00152971|593888513|FG001|Overall Study|Adverse Event|10|||
164414448|NCT00152971|593888514|FG002|Overall Study|Adverse Event|9|||
164414449|NCT00152971|593888512|FG000|Overall Study|Protocol Violation|10|||
164414450|NCT00152971|593888513|FG001|Overall Study|Protocol Violation|11|||
164414451|NCT00152971|593888514|FG002|Overall Study|Protocol Violation|8|||
164414452|NCT00152971|593888512|FG000|Overall Study|Lost to Follow-up|17|||
164414453|NCT00152971|593888513|FG001|Overall Study|Lost to Follow-up|14|||
164414454|NCT00152971|593888514|FG002|Overall Study|Lost to Follow-up|13|||
164414455|NCT00152971|593888512|FG000|Overall Study|Withdrawal by Subject|9|||
164414456|NCT00152971|593888513|FG001|Overall Study|Withdrawal by Subject|8|||
164414457|NCT00152971|593888514|FG002|Overall Study|Withdrawal by Subject|14|||
164414458|NCT00152971|593888512|FG000|Overall Study|Other|3|||
164414459|NCT00152971|593888513|FG001|Overall Study|Other|5|||
164414460|NCT00152971|593888514|FG002|Overall Study|Other|5|||
164414461|NCT00152971|593888512|FG000|Treatment|Adverse Event|49|||
164414462|NCT00152971|593888513|FG001|Treatment|Adverse Event|40|||
164414463|NCT00152971|593888514|FG002|Treatment|Adverse Event|54|||
164414464|NCT00152971|593888512|FG000|Treatment|Protocol Violation|8|||
164414465|NCT00152971|593888513|FG001|Treatment|Protocol Violation|6|||
164414466|NCT00152971|593888514|FG002|Treatment|Protocol Violation|10|||
164414467|NCT00152971|593888512|FG000|Treatment|Lost to Follow-up|1|||
164414468|NCT00152971|593888513|FG001|Treatment|Lost to Follow-up|2|||
164414469|NCT00152971|593888514|FG002|Treatment|Lost to Follow-up|1|||
164414470|NCT00152971|593888512|FG000|Treatment|Withdrawal by Subject|4|||
164414471|NCT00152971|593888513|FG001|Treatment|Withdrawal by Subject|4|||
164414472|NCT00152971|593888514|FG002|Treatment|Withdrawal by Subject|5|||
164414473|NCT00152971|593888512|FG000|Treatment|Other|9|||
164414474|NCT00152971|593888513|FG001|Treatment|Other|11|||
164414475|NCT00152971|593888514|FG002|Treatment|Other|10|||
164414476|NCT06173570|593888515|FG000|Overall Study|Adverse Event|1|||
164414477|NCT06173570|593888516|FG001|Overall Study|Adverse Event|0|||
164414478|NCT06173570|593888517|FG002|Overall Study|Adverse Event|0|||
164414479|NCT06173570|593888518|FG003|Overall Study|Adverse Event|2|||
164414480|NCT06173570|593888519|FG004|Overall Study|Adverse Event|0|||
164414481|NCT06173570|593888515|FG000|Overall Study|Lost to Follow-up|1|||
164414482|NCT06173570|593888516|FG001|Overall Study|Lost to Follow-up|0|||
164414483|NCT06173570|593888517|FG002|Overall Study|Lost to Follow-up|0|||
164414484|NCT06173570|593888518|FG003|Overall Study|Lost to Follow-up|0|||
164414485|NCT06173570|593888519|FG004|Overall Study|Lost to Follow-up|2|||
164414486|NCT06173570|593888515|FG000|Overall Study|Protocol Violation|0|||
164414487|NCT06173570|593888516|FG001|Overall Study|Protocol Violation|2|||
164414488|NCT06173570|593888517|FG002|Overall Study|Protocol Violation|0|||
164414489|NCT06173570|593888518|FG003|Overall Study|Protocol Violation|0|||
164414490|NCT06173570|593888519|FG004|Overall Study|Protocol Violation|1|||
164414491|NCT06173570|593888515|FG000|Overall Study|Withdrawal by Subject|0|||
164414492|NCT06173570|593888516|FG001|Overall Study|Withdrawal by Subject|1|||
164414493|NCT06173570|593888517|FG002|Overall Study|Withdrawal by Subject|1|||
164414494|NCT06173570|593888518|FG003|Overall Study|Withdrawal by Subject|1|||
164414495|NCT06173570|593888519|FG004|Overall Study|Withdrawal by Subject|1|||
164414496|NCT06173570|593888515|FG000|Overall Study|Non-compliance with Study Drug|1|||
164414497|NCT06173570|593888516|FG001|Overall Study|Non-compliance with Study Drug|0|||
164414498|NCT06173570|593888517|FG002|Overall Study|Non-compliance with Study Drug|0|||
164414499|NCT06173570|593888518|FG003|Overall Study|Non-compliance with Study Drug|0|||
164414500|NCT06173570|593888519|FG004|Overall Study|Non-compliance with Study Drug|0|||
164414501|NCT06173570|593888515|FG000|Overall Study|Screen Failure|0|||
164414502|NCT06173570|593888516|FG001|Overall Study|Screen Failure|0|||
164414503|NCT06173570|593888517|FG002|Overall Study|Screen Failure|0|||
164414504|NCT06173570|593888518|FG003|Overall Study|Screen Failure|0|||
164414505|NCT06173570|593888519|FG004|Overall Study|Screen Failure|1|||
164414506|NCT06173570|593888515|FG000|Overall Study|Other|2|||
164414507|NCT06173570|593888516|FG001|Overall Study|Other|1|||
164464426|NCT04076618|594073814|FG000|Overall Study|Relocated out of state|0|||
164464427|NCT04076618|594073815|FG001|Overall Study|Relocated out of state|2|||
164464428|NCT04076618|594073816|FG002|Overall Study|Relocated out of state|0|||
164464429|NCT04076618|594073814|FG000|Overall Study|COVID concerns|0|||
164464430|NCT04076618|594073815|FG001|Overall Study|COVID concerns|1|||
164464431|NCT04076618|594073816|FG002|Overall Study|COVID concerns|0|||
164464432|NCT04076618|594073814|FG000|Overall Study|Adverse Event|0|||
164464433|NCT04076618|594073815|FG001|Overall Study|Adverse Event|0|||
164464434|NCT04076618|594073816|FG002|Overall Study|Adverse Event|2|||
164464435|NCT01928394|594073817|FG000|Treatment Period|Disease progression|17|||
164464436|NCT01928394|594073818|FG001|Treatment Period|Disease progression|2|||
164464437|NCT01928394|594073819|FG002|Treatment Period|Disease progression|12|||
164464438|NCT01928394|594073820|FG003|Treatment Period|Disease progression|48|||
164464439|NCT01928394|594073821|FG004|Treatment Period|Disease progression|3|||
164464440|NCT01928394|594073822|FG005|Treatment Period|Disease progression|25|||
164464441|NCT01928394|594073823|FG006|Treatment Period|Disease progression|38|||
164464442|NCT01928394|594073824|FG007|Treatment Period|Disease progression|16|||
164464443|NCT01928394|594073825|FG008|Treatment Period|Disease progression|3|||
164464444|NCT01928394|594073826|FG009|Treatment Period|Disease progression|11|||
164464445|NCT01928394|594073827|FG010|Treatment Period|Disease progression|22|||
164464446|NCT01928394|594073828|FG011|Treatment Period|Disease progression|73|||
164464447|NCT01928394|594073829|FG012|Treatment Period|Disease progression|38|||
164464448|NCT01928394|594073830|FG013|Treatment Period|Disease progression|118|||
164464449|NCT01928394|594073831|FG014|Treatment Period|Disease progression|59|||
164464450|NCT01928394|594073832|FG015|Treatment Period|Disease progression|1|||
164464451|NCT01928394|594073833|FG016|Treatment Period|Disease progression|43|||
164464452|NCT01928394|594073834|FG017|Treatment Period|Disease progression|56|||
164464453|NCT01928394|594073835|FG018|Treatment Period|Disease progression|50|||
164464454|NCT01928394|594073836|FG019|Treatment Period|Disease progression|71|||
164464455|NCT01928394|594073837|FG020|Treatment Period|Disease progression|30|||
164464456|NCT01928394|594073838|FG021|Treatment Period|Disease progression|31|||
164464457|NCT01928394|594073839|FG022|Treatment Period|Disease progression|31|||
164464458|NCT01928394|594073817|FG000|Treatment Period|Study drug toxicity|1|||
164464459|NCT01928394|594073818|FG001|Treatment Period|Study drug toxicity|1|||
164464460|NCT01928394|594073819|FG002|Treatment Period|Study drug toxicity|3|||
164464461|NCT01928394|594073820|FG003|Treatment Period|Study drug toxicity|3|||
164464462|NCT01928394|594073821|FG004|Treatment Period|Study drug toxicity|0|||
164464463|NCT01928394|594073822|FG005|Treatment Period|Study drug toxicity|9|||
164464464|NCT01928394|594073823|FG006|Treatment Period|Study drug toxicity|7|||
164464465|NCT01928394|594073824|FG007|Treatment Period|Study drug toxicity|1|||
164464466|NCT01928394|594073825|FG008|Treatment Period|Study drug toxicity|0|||
164464467|NCT01928394|594073826|FG009|Treatment Period|Study drug toxicity|5|||
164464468|NCT01928394|594073827|FG010|Treatment Period|Study drug toxicity|2|||
164464469|NCT01928394|594073828|FG011|Treatment Period|Study drug toxicity|3|||
164464470|NCT01928394|594073829|FG012|Treatment Period|Study drug toxicity|7|||
164464471|NCT01928394|594073830|FG013|Treatment Period|Study drug toxicity|5|||
164464472|NCT01928394|594073831|FG014|Treatment Period|Study drug toxicity|12|||
164464473|NCT01928394|594073832|FG015|Treatment Period|Study drug toxicity|0|||
164464474|NCT01928394|594073833|FG016|Treatment Period|Study drug toxicity|3|||
164464475|NCT01928394|594073834|FG017|Treatment Period|Study drug toxicity|3|||
164464476|NCT01928394|594073835|FG018|Treatment Period|Study drug toxicity|12|||
164464477|NCT01928394|594073836|FG019|Treatment Period|Study drug toxicity|15|||
164464478|NCT01928394|594073837|FG020|Treatment Period|Study drug toxicity|4|||
164464479|NCT01928394|594073838|FG021|Treatment Period|Study drug toxicity|7|||
164464480|NCT01928394|594073839|FG022|Treatment Period|Study drug toxicity|4|||
164464481|NCT01928394|594073817|FG000|Treatment Period|AE unrelated to study drug|0|||
164464482|NCT01928394|594073818|FG001|Treatment Period|AE unrelated to study drug|0|||
164464483|NCT01928394|594073819|FG002|Treatment Period|AE unrelated to study drug|2|||
164464484|NCT01928394|594073820|FG003|Treatment Period|AE unrelated to study drug|3|||
164464485|NCT01928394|594073821|FG004|Treatment Period|AE unrelated to study drug|0|||
164464486|NCT01928394|594073822|FG005|Treatment Period|AE unrelated to study drug|5|||
164464487|NCT01928394|594073823|FG006|Treatment Period|AE unrelated to study drug|1|||
164464488|NCT01928394|594073824|FG007|Treatment Period|AE unrelated to study drug|0|||
164464489|NCT01928394|594073825|FG008|Treatment Period|AE unrelated to study drug|0|||
164464490|NCT01928394|594073826|FG009|Treatment Period|AE unrelated to study drug|2|||
164464491|NCT01928394|594073827|FG010|Treatment Period|AE unrelated to study drug|0|||
164464492|NCT01928394|594073828|FG011|Treatment Period|AE unrelated to study drug|12|||
164464493|NCT01928394|594073829|FG012|Treatment Period|AE unrelated to study drug|6|||
164464494|NCT01928394|594073830|FG013|Treatment Period|AE unrelated to study drug|13|||
164464495|NCT01928394|594073831|FG014|Treatment Period|AE unrelated to study drug|6|||
164464496|NCT01928394|594073832|FG015|Treatment Period|AE unrelated to study drug|1|||
164464497|NCT01928394|594073833|FG016|Treatment Period|AE unrelated to study drug|1|||
164464498|NCT01928394|594073834|FG017|Treatment Period|AE unrelated to study drug|6|||
164464499|NCT01928394|594073835|FG018|Treatment Period|AE unrelated to study drug|3|||
164414508|NCT06173570|593888517|FG002|Overall Study|Other|0|||
164414509|NCT06173570|593888518|FG003|Overall Study|Other|2|||
164414510|NCT06173570|593888519|FG004|Overall Study|Other|0|||
164414511|NCT03151395|593888520|FG000|Overall Study|Adverse Event|2|||
164414512|NCT03151395|593888520|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
164414513|NCT03151395|593888520|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
164414514|NCT03151395|593888520|FG000|Overall Study|Unspecified reason|4|||
164414515|NCT00366301|593888521|FG000|Overall Study|Lost to Follow-up|4|||
164414516|NCT00366301|593888522|FG001|Overall Study|Lost to Follow-up|4|||
164414517|NCT00366301|593888523|FG002|Overall Study|Lost to Follow-up|3|||
164414518|NCT00366301|593888524|FG003|Overall Study|Lost to Follow-up|7|||
164414519|NCT00366301|593888521|FG000|Overall Study|Withdrawal by Subject|4|||
164414520|NCT00366301|593888522|FG001|Overall Study|Withdrawal by Subject|2|||
164414521|NCT00366301|593888523|FG002|Overall Study|Withdrawal by Subject|1|||
164414522|NCT00366301|593888524|FG003|Overall Study|Withdrawal by Subject|1|||
164414523|NCT04091360|593888525|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
164414524|NCT04091360|593888526|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
164414525|NCT04091360|593888527|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
164414526|NCT04091360|593888528|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
164414527|NCT04091360|593888529|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
164414528|NCT04091360|593888530|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
164414529|NCT04091360|593888531|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
164414530|NCT04091360|593888532|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
164414531|NCT04091360|593888533|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
164414532|NCT04091360|593888534|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
164414533|NCT04091360|593888525|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
164414534|NCT04091360|593888526|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
164414535|NCT04091360|593888527|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
164414536|NCT04091360|593888528|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
164414537|NCT04091360|593888529|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
164414538|NCT04091360|593888530|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
164414539|NCT04091360|593888531|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
164414540|NCT04091360|593888532|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
164414541|NCT04091360|593888533|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
164414542|NCT04091360|593888534|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
164414543|NCT04091360|593888525|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
164414544|NCT04091360|593888526|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
164414545|NCT04091360|593888527|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
164414546|NCT04091360|593888528|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
164414547|NCT04091360|593888529|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
164414548|NCT04091360|593888530|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
164414549|NCT04091360|593888531|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
164414550|NCT04091360|593888532|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
164464500|NCT01928394|594073836|FG019|Treatment Period|AE unrelated to study drug|5|||
164464501|NCT01928394|594073837|FG020|Treatment Period|AE unrelated to study drug|1|||
164464502|NCT01928394|594073838|FG021|Treatment Period|AE unrelated to study drug|1|||
164464503|NCT01928394|594073839|FG022|Treatment Period|AE unrelated to study drug|0|||
164464504|NCT01928394|594073817|FG000|Treatment Period|Participant request to stop therapy|0|||
164464505|NCT01928394|594073818|FG001|Treatment Period|Participant request to stop therapy|0|||
164464506|NCT01928394|594073819|FG002|Treatment Period|Participant request to stop therapy|0|||
164464507|NCT01928394|594073820|FG003|Treatment Period|Participant request to stop therapy|0|||
164464508|NCT01928394|594073821|FG004|Treatment Period|Participant request to stop therapy|0|||
164464509|NCT01928394|594073822|FG005|Treatment Period|Participant request to stop therapy|3|||
164464510|NCT01928394|594073823|FG006|Treatment Period|Participant request to stop therapy|3|||
164464511|NCT01928394|594073824|FG007|Treatment Period|Participant request to stop therapy|0|||
164464512|NCT01928394|594073825|FG008|Treatment Period|Participant request to stop therapy|0|||
164464513|NCT01928394|594073826|FG009|Treatment Period|Participant request to stop therapy|0|||
164464514|NCT01928394|594073827|FG010|Treatment Period|Participant request to stop therapy|3|||
164464515|NCT01928394|594073828|FG011|Treatment Period|Participant request to stop therapy|2|||
164464516|NCT01928394|594073829|FG012|Treatment Period|Participant request to stop therapy|1|||
164464517|NCT01928394|594073830|FG013|Treatment Period|Participant request to stop therapy|2|||
164464518|NCT01928394|594073831|FG014|Treatment Period|Participant request to stop therapy|4|||
164464519|NCT01928394|594073832|FG015|Treatment Period|Participant request to stop therapy|0|||
164464520|NCT01928394|594073833|FG016|Treatment Period|Participant request to stop therapy|1|||
164464521|NCT01928394|594073834|FG017|Treatment Period|Participant request to stop therapy|3|||
164464522|NCT01928394|594073835|FG018|Treatment Period|Participant request to stop therapy|1|||
164464523|NCT01928394|594073836|FG019|Treatment Period|Participant request to stop therapy|1|||
164464524|NCT01928394|594073837|FG020|Treatment Period|Participant request to stop therapy|3|||
164464525|NCT01928394|594073838|FG021|Treatment Period|Participant request to stop therapy|1|||
164464526|NCT01928394|594073839|FG022|Treatment Period|Participant request to stop therapy|3|||
164464527|NCT01928394|594073817|FG000|Treatment Period|Participant withdrew consent|0|||
164464528|NCT01928394|594073818|FG001|Treatment Period|Participant withdrew consent|0|||
164464529|NCT01928394|594073819|FG002|Treatment Period|Participant withdrew consent|1|||
164464530|NCT01928394|594073820|FG003|Treatment Period|Participant withdrew consent|1|||
164464531|NCT01928394|594073821|FG004|Treatment Period|Participant withdrew consent|0|||
164464532|NCT01928394|594073822|FG005|Treatment Period|Participant withdrew consent|1|||
164464533|NCT01928394|594073823|FG006|Treatment Period|Participant withdrew consent|0|||
164464534|NCT01928394|594073824|FG007|Treatment Period|Participant withdrew consent|1|||
164464535|NCT01928394|594073825|FG008|Treatment Period|Participant withdrew consent|0|||
164464536|NCT01928394|594073826|FG009|Treatment Period|Participant withdrew consent|0|||
164464537|NCT01928394|594073827|FG010|Treatment Period|Participant withdrew consent|1|||
164464538|NCT01928394|594073828|FG011|Treatment Period|Participant withdrew consent|1|||
164464539|NCT01928394|594073829|FG012|Treatment Period|Participant withdrew consent|1|||
164464540|NCT01928394|594073830|FG013|Treatment Period|Participant withdrew consent|0|||
164464541|NCT01928394|594073831|FG014|Treatment Period|Participant withdrew consent|2|||
164464542|NCT01928394|594073832|FG015|Treatment Period|Participant withdrew consent|0|||
164464543|NCT01928394|594073833|FG016|Treatment Period|Participant withdrew consent|2|||
164464544|NCT01928394|594073834|FG017|Treatment Period|Participant withdrew consent|1|||
164464545|NCT01928394|594073835|FG018|Treatment Period|Participant withdrew consent|1|||
164464546|NCT01928394|594073836|FG019|Treatment Period|Participant withdrew consent|1|||
164464547|NCT01928394|594073837|FG020|Treatment Period|Participant withdrew consent|0|||
164464548|NCT01928394|594073838|FG021|Treatment Period|Participant withdrew consent|2|||
164464549|NCT01928394|594073839|FG022|Treatment Period|Participant withdrew consent|0|||
164464550|NCT01928394|594073817|FG000|Treatment Period|Poor/non-compliance|0|||
164464551|NCT01928394|594073818|FG001|Treatment Period|Poor/non-compliance|0|||
164464552|NCT01928394|594073819|FG002|Treatment Period|Poor/non-compliance|0|||
164464553|NCT01928394|594073820|FG003|Treatment Period|Poor/non-compliance|1|||
164464554|NCT01928394|594073821|FG004|Treatment Period|Poor/non-compliance|0|||
164464555|NCT01928394|594073822|FG005|Treatment Period|Poor/non-compliance|0|||
164464556|NCT01928394|594073823|FG006|Treatment Period|Poor/non-compliance|0|||
164464557|NCT01928394|594073824|FG007|Treatment Period|Poor/non-compliance|0|||
164464558|NCT01928394|594073825|FG008|Treatment Period|Poor/non-compliance|0|||
164464559|NCT01928394|594073826|FG009|Treatment Period|Poor/non-compliance|0|||
164464560|NCT01928394|594073827|FG010|Treatment Period|Poor/non-compliance|0|||
164464561|NCT01928394|594073828|FG011|Treatment Period|Poor/non-compliance|0|||
164464562|NCT01928394|594073829|FG012|Treatment Period|Poor/non-compliance|1|||
164464563|NCT01928394|594073830|FG013|Treatment Period|Poor/non-compliance|0|||
164464564|NCT01928394|594073831|FG014|Treatment Period|Poor/non-compliance|1|||
164464565|NCT01928394|594073832|FG015|Treatment Period|Poor/non-compliance|0|||
164464566|NCT01928394|594073833|FG016|Treatment Period|Poor/non-compliance|0|||
164464567|NCT01928394|594073834|FG017|Treatment Period|Poor/non-compliance|1|||
164464568|NCT01928394|594073835|FG018|Treatment Period|Poor/non-compliance|0|||
164464569|NCT01928394|594073836|FG019|Treatment Period|Poor/non-compliance|1|||
164464570|NCT01928394|594073837|FG020|Treatment Period|Poor/non-compliance|0|||
164464571|NCT01928394|594073838|FG021|Treatment Period|Poor/non-compliance|0|||
164464572|NCT01928394|594073839|FG022|Treatment Period|Poor/non-compliance|0|||
164464573|NCT01928394|594073817|FG000|Treatment Period|other reason|0|||
164464574|NCT01928394|594073818|FG001|Treatment Period|other reason|0|||
164464575|NCT01928394|594073819|FG002|Treatment Period|other reason|0|||
164464576|NCT01928394|594073820|FG003|Treatment Period|other reason|0|||
164464577|NCT01928394|594073821|FG004|Treatment Period|other reason|0|||
164464578|NCT01928394|594073822|FG005|Treatment Period|other reason|0|||
164464579|NCT01928394|594073823|FG006|Treatment Period|other reason|0|||
164464580|NCT01928394|594073824|FG007|Treatment Period|other reason|0|||
164464581|NCT01928394|594073825|FG008|Treatment Period|other reason|0|||
164464582|NCT01928394|594073826|FG009|Treatment Period|other reason|0|||
164464583|NCT01928394|594073827|FG010|Treatment Period|other reason|1|||
164464584|NCT01928394|594073828|FG011|Treatment Period|other reason|1|||
164464585|NCT01928394|594073829|FG012|Treatment Period|other reason|1|||
164464586|NCT01928394|594073830|FG013|Treatment Period|other reason|0|||
164464587|NCT01928394|594073831|FG014|Treatment Period|other reason|1|||
164464588|NCT01928394|594073832|FG015|Treatment Period|other reason|0|||
164464589|NCT01928394|594073833|FG016|Treatment Period|other reason|0|||
164464590|NCT01928394|594073834|FG017|Treatment Period|other reason|0|||
164464591|NCT01928394|594073835|FG018|Treatment Period|other reason|2|||
164464592|NCT01928394|594073836|FG019|Treatment Period|other reason|2|||
164464593|NCT01928394|594073837|FG020|Treatment Period|other reason|0|||
164464594|NCT01928394|594073838|FG021|Treatment Period|other reason|0|||
164464595|NCT01928394|594073839|FG022|Treatment Period|other reason|0|||
164464596|NCT01928394|594073817|FG000|Treatment Period|Maximum clinical benefit|0|||
164464597|NCT01928394|594073818|FG001|Treatment Period|Maximum clinical benefit|0|||
164464598|NCT01928394|594073819|FG002|Treatment Period|Maximum clinical benefit|0|||
164464599|NCT01928394|594073820|FG003|Treatment Period|Maximum clinical benefit|0|||
164464600|NCT01928394|594073821|FG004|Treatment Period|Maximum clinical benefit|0|||
164464601|NCT01928394|594073822|FG005|Treatment Period|Maximum clinical benefit|0|||
164464602|NCT01928394|594073823|FG006|Treatment Period|Maximum clinical benefit|0|||
164464603|NCT01928394|594073824|FG007|Treatment Period|Maximum clinical benefit|0|||
164464604|NCT01928394|594073825|FG008|Treatment Period|Maximum clinical benefit|0|||
164464605|NCT01928394|594073826|FG009|Treatment Period|Maximum clinical benefit|0|||
164464606|NCT01928394|594073827|FG010|Treatment Period|Maximum clinical benefit|1|||
164464607|NCT01928394|594073828|FG011|Treatment Period|Maximum clinical benefit|1|||
164464608|NCT01928394|594073829|FG012|Treatment Period|Maximum clinical benefit|0|||
164464609|NCT01928394|594073830|FG013|Treatment Period|Maximum clinical benefit|0|||
164464610|NCT01928394|594073831|FG014|Treatment Period|Maximum clinical benefit|1|||
164464611|NCT01928394|594073832|FG015|Treatment Period|Maximum clinical benefit|0|||
164464612|NCT01928394|594073833|FG016|Treatment Period|Maximum clinical benefit|0|||
164464613|NCT01928394|594073834|FG017|Treatment Period|Maximum clinical benefit|1|||
164464614|NCT01928394|594073835|FG018|Treatment Period|Maximum clinical benefit|1|||
164464615|NCT01928394|594073836|FG019|Treatment Period|Maximum clinical benefit|0|||
164464616|NCT01928394|594073837|FG020|Treatment Period|Maximum clinical benefit|2|||
164464617|NCT01928394|594073838|FG021|Treatment Period|Maximum clinical benefit|0|||
164464618|NCT01928394|594073839|FG022|Treatment Period|Maximum clinical benefit|0|||
164464619|NCT01928394|594073817|FG000|Treatment Period|Lost to Follow-up|0|||
164464620|NCT01928394|594073818|FG001|Treatment Period|Lost to Follow-up|0|||
164464621|NCT01928394|594073819|FG002|Treatment Period|Lost to Follow-up|0|||
164464622|NCT01928394|594073820|FG003|Treatment Period|Lost to Follow-up|0|||
164464623|NCT01928394|594073821|FG004|Treatment Period|Lost to Follow-up|0|||
164464624|NCT01928394|594073822|FG005|Treatment Period|Lost to Follow-up|0|||
164710124|NCT01081834|594962842|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
164710125|NCT01081834|594962843|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
164710126|NCT01081834|594962839|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
164710127|NCT01081834|594962840|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
164710128|NCT01081834|594962841|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
164464625|NCT01928394|594073823|FG006|Treatment Period|Lost to Follow-up|0|||
164710129|NCT01081834|594962842|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
164464626|NCT01928394|594073824|FG007|Treatment Period|Lost to Follow-up|0|||
164464627|NCT01928394|594073825|FG008|Treatment Period|Lost to Follow-up|0|||
164464628|NCT01928394|594073826|FG009|Treatment Period|Lost to Follow-up|0|||
164464629|NCT01928394|594073827|FG010|Treatment Period|Lost to Follow-up|0|||
164464630|NCT01928394|594073828|FG011|Treatment Period|Lost to Follow-up|0|||
164464631|NCT01928394|594073829|FG012|Treatment Period|Lost to Follow-up|0|||
164710130|NCT01081834|594962843|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
164464632|NCT01928394|594073830|FG013|Treatment Period|Lost to Follow-up|0|||
164464633|NCT01928394|594073831|FG014|Treatment Period|Lost to Follow-up|0|||
164464634|NCT01928394|594073832|FG015|Treatment Period|Lost to Follow-up|0|||
164464635|NCT01928394|594073833|FG016|Treatment Period|Lost to Follow-up|0|||
164464636|NCT01928394|594073834|FG017|Treatment Period|Lost to Follow-up|0|||
164464637|NCT01928394|594073835|FG018|Treatment Period|Lost to Follow-up|0|||
164464638|NCT01928394|594073836|FG019|Treatment Period|Lost to Follow-up|0|||
164464639|NCT01928394|594073837|FG020|Treatment Period|Lost to Follow-up|0|||
164464640|NCT01928394|594073838|FG021|Treatment Period|Lost to Follow-up|0|||
164464641|NCT01928394|594073839|FG022|Treatment Period|Lost to Follow-up|1|||
164464642|NCT01928394|594073817|FG000|Treatment Period|Death|0|||
164464643|NCT01928394|594073818|FG001|Treatment Period|Death|0|||
164464644|NCT01928394|594073819|FG002|Treatment Period|Death|0|||
164464645|NCT01928394|594073820|FG003|Treatment Period|Death|0|||
164464646|NCT01928394|594073821|FG004|Treatment Period|Death|0|||
164464647|NCT01928394|594073822|FG005|Treatment Period|Death|0|||
164464648|NCT01928394|594073823|FG006|Treatment Period|Death|0|||
164464649|NCT01928394|594073824|FG007|Treatment Period|Death|0|||
164464650|NCT01928394|594073825|FG008|Treatment Period|Death|0|||
164464651|NCT01928394|594073826|FG009|Treatment Period|Death|0|||
164464652|NCT01928394|594073827|FG010|Treatment Period|Death|0|||
164464653|NCT01928394|594073828|FG011|Treatment Period|Death|0|||
164464654|NCT01928394|594073829|FG012|Treatment Period|Death|0|||
164464655|NCT01928394|594073830|FG013|Treatment Period|Death|1|||
164464656|NCT01928394|594073831|FG014|Treatment Period|Death|2|||
164464657|NCT01928394|594073832|FG015|Treatment Period|Death|0|||
164464658|NCT01928394|594073833|FG016|Treatment Period|Death|0|||
164464659|NCT01928394|594073834|FG017|Treatment Period|Death|0|||
164464660|NCT01928394|594073835|FG018|Treatment Period|Death|0|||
164464661|NCT01928394|594073836|FG019|Treatment Period|Death|0|||
164464662|NCT01928394|594073837|FG020|Treatment Period|Death|0|||
164464663|NCT01928394|594073838|FG021|Treatment Period|Death|0|||
164464664|NCT01928394|594073839|FG022|Treatment Period|Death|0|||
164464665|NCT01928394|594073817|FG000|Follow-up Period|Participant withdrew consent|3|||
164464666|NCT01928394|594073818|FG001|Follow-up Period|Participant withdrew consent|0|||
164464667|NCT01928394|594073819|FG002|Follow-up Period|Participant withdrew consent|1|||
164464668|NCT01928394|594073820|FG003|Follow-up Period|Participant withdrew consent|4|||
164464669|NCT01928394|594073821|FG004|Follow-up Period|Participant withdrew consent|0|||
164464670|NCT01928394|594073822|FG005|Follow-up Period|Participant withdrew consent|2|||
164464671|NCT01928394|594073823|FG006|Follow-up Period|Participant withdrew consent|5|||
164464672|NCT01928394|594073824|FG007|Follow-up Period|Participant withdrew consent|1|||
164464673|NCT01928394|594073825|FG008|Follow-up Period|Participant withdrew consent|0|||
164464674|NCT01928394|594073826|FG009|Follow-up Period|Participant withdrew consent|0|||
164464675|NCT01928394|594073827|FG010|Follow-up Period|Participant withdrew consent|5|||
164464676|NCT01928394|594073828|FG011|Follow-up Period|Participant withdrew consent|8|||
164464677|NCT01928394|594073829|FG012|Follow-up Period|Participant withdrew consent|2|||
164464678|NCT01928394|594073830|FG013|Follow-up Period|Participant withdrew consent|12|||
164464679|NCT01928394|594073831|FG014|Follow-up Period|Participant withdrew consent|7|||
164464680|NCT01928394|594073832|FG015|Follow-up Period|Participant withdrew consent|0|||
164464681|NCT01928394|594073833|FG016|Follow-up Period|Participant withdrew consent|5|||
164464682|NCT01928394|594073834|FG017|Follow-up Period|Participant withdrew consent|3|||
164464683|NCT01928394|594073835|FG018|Follow-up Period|Participant withdrew consent|2|||
164464684|NCT01928394|594073836|FG019|Follow-up Period|Participant withdrew consent|7|||
164464685|NCT01928394|594073837|FG020|Follow-up Period|Participant withdrew consent|4|||
164464686|NCT01928394|594073838|FG021|Follow-up Period|Participant withdrew consent|6|||
164464687|NCT01928394|594073839|FG022|Follow-up Period|Participant withdrew consent|2|||
164464688|NCT01928394|594073817|FG000|Follow-up Period|Death|0|||
164464689|NCT01928394|594073818|FG001|Follow-up Period|Death|0|||
164464690|NCT01928394|594073819|FG002|Follow-up Period|Death|2|||
164464691|NCT01928394|594073820|FG003|Follow-up Period|Death|6|||
164464692|NCT01928394|594073821|FG004|Follow-up Period|Death|0|||
164464693|NCT01928394|594073822|FG005|Follow-up Period|Death|6|||
164464694|NCT01928394|594073823|FG006|Follow-up Period|Death|6|||
164464695|NCT01928394|594073824|FG007|Follow-up Period|Death|2|||
164464696|NCT01928394|594073825|FG008|Follow-up Period|Death|1|||
164464697|NCT01928394|594073826|FG009|Follow-up Period|Death|2|||
164464698|NCT01928394|594073827|FG010|Follow-up Period|Death|4|||
164464699|NCT01928394|594073828|FG011|Follow-up Period|Death|12|||
164464700|NCT01928394|594073829|FG012|Follow-up Period|Death|11|||
164464701|NCT01928394|594073830|FG013|Follow-up Period|Death|25|||
164464702|NCT01928394|594073831|FG014|Follow-up Period|Death|18|||
164599492|NCT04191577|594554880|FG000|Overall Study|Withdrawal by Subject|2|||
164464703|NCT01928394|594073832|FG015|Follow-up Period|Death|0|||
164464704|NCT01928394|594073833|FG016|Follow-up Period|Death|6|||
164464705|NCT01928394|594073834|FG017|Follow-up Period|Death|5|||
164464706|NCT01928394|594073835|FG018|Follow-up Period|Death|13|||
164464707|NCT01928394|594073836|FG019|Follow-up Period|Death|13|||
164464708|NCT01928394|594073837|FG020|Follow-up Period|Death|5|||
164464709|NCT01928394|594073838|FG021|Follow-up Period|Death|3|||
164464710|NCT01928394|594073839|FG022|Follow-up Period|Death|2|||
164464711|NCT01928394|594073817|FG000|Follow-up Period|other reason|0|||
164464712|NCT01928394|594073818|FG001|Follow-up Period|other reason|0|||
164464713|NCT01928394|594073819|FG002|Follow-up Period|other reason|0|||
164464714|NCT01928394|594073820|FG003|Follow-up Period|other reason|0|||
164464715|NCT01928394|594073821|FG004|Follow-up Period|other reason|0|||
164464716|NCT01928394|594073822|FG005|Follow-up Period|other reason|0|||
164464717|NCT01928394|594073823|FG006|Follow-up Period|other reason|1|||
164414551|NCT04091360|593888533|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
164464718|NCT01928394|594073824|FG007|Follow-up Period|other reason|3|||
164464719|NCT01928394|594073825|FG008|Follow-up Period|other reason|0|||
164464720|NCT01928394|594073826|FG009|Follow-up Period|other reason|0|||
164464721|NCT01928394|594073827|FG010|Follow-up Period|other reason|2|||
164464722|NCT01928394|594073828|FG011|Follow-up Period|other reason|1|||
164464723|NCT01928394|594073829|FG012|Follow-up Period|other reason|0|||
164464724|NCT01928394|594073830|FG013|Follow-up Period|other reason|1|||
164464725|NCT01928394|594073831|FG014|Follow-up Period|other reason|4|||
164464726|NCT01928394|594073832|FG015|Follow-up Period|other reason|0|||
164464727|NCT01928394|594073833|FG016|Follow-up Period|other reason|2|||
164464728|NCT01928394|594073834|FG017|Follow-up Period|other reason|0|||
164464729|NCT01928394|594073835|FG018|Follow-up Period|other reason|1|||
164464730|NCT01928394|594073836|FG019|Follow-up Period|other reason|1|||
164464731|NCT01928394|594073837|FG020|Follow-up Period|other reason|0|||
164464732|NCT01928394|594073838|FG021|Follow-up Period|other reason|0|||
164464733|NCT01928394|594073839|FG022|Follow-up Period|other reason|1|||
164464734|NCT01928394|594073817|FG000|Follow-up Period|Lost to Follow-up|0|||
164464735|NCT01928394|594073818|FG001|Follow-up Period|Lost to Follow-up|0|||
164464736|NCT01928394|594073819|FG002|Follow-up Period|Lost to Follow-up|0|||
164464737|NCT01928394|594073820|FG003|Follow-up Period|Lost to Follow-up|0|||
164464738|NCT01928394|594073821|FG004|Follow-up Period|Lost to Follow-up|0|||
164464739|NCT01928394|594073822|FG005|Follow-up Period|Lost to Follow-up|0|||
164464740|NCT01928394|594073823|FG006|Follow-up Period|Lost to Follow-up|0|||
164464741|NCT01928394|594073824|FG007|Follow-up Period|Lost to Follow-up|0|||
164464742|NCT01928394|594073825|FG008|Follow-up Period|Lost to Follow-up|0|||
164464743|NCT01928394|594073826|FG009|Follow-up Period|Lost to Follow-up|0|||
164464744|NCT01928394|594073827|FG010|Follow-up Period|Lost to Follow-up|0|||
164464745|NCT01928394|594073828|FG011|Follow-up Period|Lost to Follow-up|1|||
164464746|NCT01928394|594073829|FG012|Follow-up Period|Lost to Follow-up|1|||
164464747|NCT01928394|594073830|FG013|Follow-up Period|Lost to Follow-up|0|||
164464748|NCT01928394|594073831|FG014|Follow-up Period|Lost to Follow-up|1|||
164464749|NCT01928394|594073832|FG015|Follow-up Period|Lost to Follow-up|0|||
164464750|NCT01928394|594073833|FG016|Follow-up Period|Lost to Follow-up|1|||
164464751|NCT01928394|594073834|FG017|Follow-up Period|Lost to Follow-up|0|||
164464752|NCT01928394|594073835|FG018|Follow-up Period|Lost to Follow-up|0|||
164464753|NCT01928394|594073836|FG019|Follow-up Period|Lost to Follow-up|0|||
164464754|NCT01928394|594073837|FG020|Follow-up Period|Lost to Follow-up|0|||
164464755|NCT01928394|594073838|FG021|Follow-up Period|Lost to Follow-up|0|||
164464756|NCT01928394|594073839|FG022|Follow-up Period|Lost to Follow-up|1|||
164464757|NCT04299464|594073840|FG000|Overall Study|Adverse Event|1|||
164464758|NCT04299464|594073841|FG001|Overall Study|Adverse Event|0|||
164414552|NCT04091360|593888534|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
164414553|NCT02597933|593888537|FG000|Overall Study|Withdrawal by Subject|7|||
164414554|NCT02597933|593888538|FG001|Overall Study|Withdrawal by Subject|5|||
164414555|NCT02597933|593888537|FG000|Overall Study|Protocol Violation|2|||
164414556|NCT02597933|593888538|FG001|Overall Study|Protocol Violation|2|||
164414557|NCT02597933|593888537|FG000|Overall Study|Adverse Event|20|||
164414558|NCT02597933|593888538|FG001|Overall Study|Adverse Event|28|||
164414559|NCT02597933|593888537|FG000|Overall Study|Not treated|2|||
164414560|NCT02597933|593888538|FG001|Overall Study|Not treated|2|||
164414561|NCT02597933|593888537|FG000|Overall Study|Other than stated above|7|||
164414562|NCT02597933|593888538|FG001|Overall Study|Other than stated above|14|||
164414563|NCT01617005|593888539|FG000|Overall Study|Pregnancy|1|||
164414564|NCT01617005|593888539|FG000|Overall Study|Lack of motivation for treatment|1|||
164414565|NCT01336621|593888544|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
164414566|NCT01336621|593888544|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
164414567|NCT01336621|593888544|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
164414568|NCT01336621|593888544|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
164414569|NCT01336621|593888544|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
164414570|NCT01336621|593888544|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
164414571|NCT01336621|593888544|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
164414572|NCT01336621|593888544|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
164414573|NCT01336621|593888544|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
164414574|NCT01336621|593888544|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
164414575|NCT01336621|593888544|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
164464759|NCT04299464|594073842|FG002|Overall Study|Adverse Event|2|||
164464760|NCT04299464|594073840|FG000|Overall Study|Non-compliance with Study Drug|1|||
164464761|NCT04299464|594073841|FG001|Overall Study|Non-compliance with Study Drug|0|||
164464762|NCT04299464|594073842|FG002|Overall Study|Non-compliance with Study Drug|0|||
164464763|NCT04299464|594073840|FG000|Overall Study|Reason not Specified|0|||
164464764|NCT04299464|594073841|FG001|Overall Study|Reason not Specified|1|||
164464765|NCT04299464|594073842|FG002|Overall Study|Reason not Specified|3|||
164464766|NCT04299464|594073840|FG000|Overall Study|Physician Decision|0|||
164464767|NCT04299464|594073841|FG001|Overall Study|Physician Decision|1|||
164710131|NCT01081834|594962839|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
164464768|NCT04299464|594073842|FG002|Overall Study|Physician Decision|1|||
164464769|NCT04299464|594073840|FG000|Overall Study|Withdrawal by Subject|0|||
164464770|NCT04299464|594073841|FG001|Overall Study|Withdrawal by Subject|2|||
164464771|NCT04299464|594073842|FG002|Overall Study|Withdrawal by Subject|1|||
164464772|NCT05907174|594073848|FG000|3-Month Assessment|Withdrawal by Subject|0|||
164464773|NCT05907174|594073849|FG001|3-Month Assessment|Withdrawal by Subject|0|||
164464774|NCT05907174|594073850|FG002|3-Month Assessment|Withdrawal by Subject|0|||
164464775|NCT05907174|594073851|FG003|3-Month Assessment|Withdrawal by Subject|1|||
164464776|NCT05907174|594073848|FG000|3-Month Assessment|Lost to Follow-up|1|||
164464777|NCT05907174|594073849|FG001|3-Month Assessment|Lost to Follow-up|1|||
164464778|NCT05907174|594073850|FG002|3-Month Assessment|Lost to Follow-up|1|||
164464779|NCT05907174|594073851|FG003|3-Month Assessment|Lost to Follow-up|1|||
164464780|NCT05907174|594073848|FG000|6-Month Assessment|Death|0|||
164464781|NCT05907174|594073849|FG001|6-Month Assessment|Death|0|||
164464782|NCT05907174|594073850|FG002|6-Month Assessment|Death|3|||
164464783|NCT05907174|594073851|FG003|6-Month Assessment|Death|0|||
164464784|NCT05907174|594073848|FG000|6-Month Assessment|Withdrawal by Subject|0|||
164464785|NCT05907174|594073849|FG001|6-Month Assessment|Withdrawal by Subject|0|||
164464786|NCT05907174|594073850|FG002|6-Month Assessment|Withdrawal by Subject|1|||
164464787|NCT05907174|594073851|FG003|6-Month Assessment|Withdrawal by Subject|1|||
164464788|NCT05907174|594073848|FG000|6-Month Assessment|Lost to Follow-up|0|||
164464789|NCT05907174|594073849|FG001|6-Month Assessment|Lost to Follow-up|1|||
164464790|NCT05907174|594073850|FG002|6-Month Assessment|Lost to Follow-up|1|||
164464791|NCT05907174|594073851|FG003|6-Month Assessment|Lost to Follow-up|1|||
164464792|NCT01868997|594073856|FG000|Overall Study|Adverse Event|2|||
164464793|NCT01868997|594073857|FG001|Overall Study|Adverse Event|5|||
164464794|NCT01868997|594073856|FG000|Overall Study|Lack of Efficacy|2|||
164464795|NCT01868997|594073857|FG001|Overall Study|Lack of Efficacy|0|||
164464796|NCT01868997|594073856|FG000|Overall Study|Other|3|||
164464797|NCT01868997|594073857|FG001|Overall Study|Other|1|||
164464798|NCT05093842|594073860|FG000|Overall Study|Pregnancy loss|1|||
164464799|NCT05093842|594073861|FG001|Overall Study|Pregnancy loss|1|||
164464800|NCT05093842|594073860|FG000|Overall Study|Lost to Follow-up|6|||
164464801|NCT05093842|594073861|FG001|Overall Study|Lost to Follow-up|0|||
164464802|NCT05093842|594073860|FG000|Overall Study|Physician Decision|0|||
164464803|NCT05093842|594073861|FG001|Overall Study|Physician Decision|1|||
164464804|NCT01275677|594073866|FG000|Overall Study|Not at risk for recurrence.|1|||
164464805|NCT01275677|594073867|FG001|Overall Study|Not at risk for recurrence.|1|||
164464806|NCT01275677|594073866|FG000|Overall Study|No follow-up|26|||
164464807|NCT01275677|594073867|FG001|Overall Study|No follow-up|37|||
164464808|NCT01275677|594073866|FG000|Overall Study|No clinical follow up.|1|||
164464809|NCT01275677|594073867|FG001|Overall Study|No clinical follow up.|4|||
164464810|NCT06122194|594073871|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
164464811|NCT06122194|594073872|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
164464812|NCT06122194|594073873|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
164464813|NCT06122194|594073874|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
164464814|NCT03088878|594073878|FG000|Overall Study|Adverse Event|0|||
164464815|NCT03088878|594073879|FG001|Overall Study|Adverse Event|0|||
164464816|NCT03088878|594073880|FG002|Overall Study|Adverse Event|0|||
164464817|NCT03088878|594073881|FG003|Overall Study|Adverse Event|0|||
164464818|NCT03088878|594073882|FG004|Overall Study|Adverse Event|4|||
164464819|NCT03088878|594073883|FG005|Overall Study|Adverse Event|2|||
164464820|NCT03088878|594073884|FG006|Overall Study|Adverse Event|1|||
164464821|NCT03088878|594073885|FG007|Overall Study|Adverse Event|0|||
164464822|NCT03088878|594073886|FG008|Overall Study|Adverse Event|0|||
164464823|NCT03088878|594073887|FG009|Overall Study|Adverse Event|0|||
164464824|NCT03088878|594073888|FG010|Overall Study|Adverse Event|0|||
164464825|NCT03088878|594073889|FG011|Overall Study|Adverse Event|0|||
164464826|NCT03088878|594073890|FG012|Overall Study|Adverse Event|5|||
164464827|NCT03088878|594073891|FG013|Overall Study|Adverse Event|3|||
164710132|NCT01081834|594962840|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
164710133|NCT01081834|594962841|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
164464828|NCT03088878|594073878|FG000|Overall Study|Clinical Progression|0|||
164464829|NCT03088878|594073879|FG001|Overall Study|Clinical Progression|0|||
164464830|NCT03088878|594073880|FG002|Overall Study|Clinical Progression|0|||
164464831|NCT03088878|594073881|FG003|Overall Study|Clinical Progression|0|||
164464832|NCT03088878|594073882|FG004|Overall Study|Clinical Progression|2|||
164464833|NCT03088878|594073883|FG005|Overall Study|Clinical Progression|0|||
164464834|NCT03088878|594073884|FG006|Overall Study|Clinical Progression|0|||
164464835|NCT03088878|594073885|FG007|Overall Study|Clinical Progression|0|||
164464836|NCT03088878|594073886|FG008|Overall Study|Clinical Progression|0|||
164710134|NCT01081834|594962842|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
164710135|NCT01081834|594962843|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
164464837|NCT03088878|594073887|FG009|Overall Study|Clinical Progression|0|||
164464838|NCT03088878|594073888|FG010|Overall Study|Clinical Progression|0|||
164464839|NCT03088878|594073889|FG011|Overall Study|Clinical Progression|0|||
164464840|NCT03088878|594073890|FG012|Overall Study|Clinical Progression|0|||
164464841|NCT03088878|594073891|FG013|Overall Study|Clinical Progression|0|||
164464842|NCT03088878|594073878|FG000|Overall Study|Death|0|||
164464843|NCT03088878|594073879|FG001|Overall Study|Death|0|||
164464844|NCT03088878|594073880|FG002|Overall Study|Death|0|||
164464845|NCT03088878|594073881|FG003|Overall Study|Death|0|||
164464846|NCT03088878|594073882|FG004|Overall Study|Death|2|||
164464847|NCT03088878|594073883|FG005|Overall Study|Death|0|||
164464848|NCT03088878|594073884|FG006|Overall Study|Death|0|||
164464849|NCT03088878|594073885|FG007|Overall Study|Death|0|||
164464850|NCT03088878|594073886|FG008|Overall Study|Death|0|||
164464851|NCT03088878|594073887|FG009|Overall Study|Death|0|||
164464852|NCT03088878|594073888|FG010|Overall Study|Death|0|||
164464853|NCT03088878|594073889|FG011|Overall Study|Death|1|||
164464854|NCT03088878|594073890|FG012|Overall Study|Death|0|||
164464855|NCT03088878|594073891|FG013|Overall Study|Death|0|||
164464856|NCT03088878|594073878|FG000|Overall Study|Disease Progression|1|||
164464857|NCT03088878|594073879|FG001|Overall Study|Disease Progression|2|||
164464858|NCT03088878|594073880|FG002|Overall Study|Disease Progression|3|||
164464859|NCT03088878|594073881|FG003|Overall Study|Disease Progression|0|||
164464860|NCT03088878|594073882|FG004|Overall Study|Disease Progression|3|||
164464861|NCT03088878|594073883|FG005|Overall Study|Disease Progression|0|||
164464862|NCT03088878|594073884|FG006|Overall Study|Disease Progression|0|||
164464863|NCT03088878|594073885|FG007|Overall Study|Disease Progression|0|||
164464864|NCT03088878|594073886|FG008|Overall Study|Disease Progression|0|||
164464865|NCT03088878|594073887|FG009|Overall Study|Disease Progression|0|||
164464866|NCT03088878|594073888|FG010|Overall Study|Disease Progression|0|||
164464867|NCT03088878|594073889|FG011|Overall Study|Disease Progression|0|||
164464868|NCT03088878|594073890|FG012|Overall Study|Disease Progression|1|||
164464869|NCT03088878|594073891|FG013|Overall Study|Disease Progression|1|||
164464870|NCT03088878|594073878|FG000|Overall Study|Initiation of Alternative Treatment|0|||
164464871|NCT03088878|594073879|FG001|Overall Study|Initiation of Alternative Treatment|0|||
164464872|NCT03088878|594073880|FG002|Overall Study|Initiation of Alternative Treatment|0|||
164464873|NCT03088878|594073881|FG003|Overall Study|Initiation of Alternative Treatment|1|||
164464874|NCT03088878|594073882|FG004|Overall Study|Initiation of Alternative Treatment|0|||
164464875|NCT03088878|594073883|FG005|Overall Study|Initiation of Alternative Treatment|0|||
164464876|NCT03088878|594073884|FG006|Overall Study|Initiation of Alternative Treatment|0|||
164464877|NCT03088878|594073885|FG007|Overall Study|Initiation of Alternative Treatment|1|||
164464878|NCT03088878|594073886|FG008|Overall Study|Initiation of Alternative Treatment|1|||
164464879|NCT03088878|594073887|FG009|Overall Study|Initiation of Alternative Treatment|0|||
164464880|NCT03088878|594073888|FG010|Overall Study|Initiation of Alternative Treatment|0|||
164464881|NCT03088878|594073889|FG011|Overall Study|Initiation of Alternative Treatment|0|||
164464882|NCT03088878|594073890|FG012|Overall Study|Initiation of Alternative Treatment|0|||
164464883|NCT03088878|594073891|FG013|Overall Study|Initiation of Alternative Treatment|0|||
164464884|NCT03088878|594073878|FG000|Overall Study|Withdrawal by Subject|0|||
164464885|NCT03088878|594073879|FG001|Overall Study|Withdrawal by Subject|0|||
164464886|NCT03088878|594073880|FG002|Overall Study|Withdrawal by Subject|0|||
164464887|NCT03088878|594073881|FG003|Overall Study|Withdrawal by Subject|1|||
164414576|NCT01336621|593888544|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
164414577|NCT01336621|593888544|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
164414578|NCT01336621|593888544|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
164414579|NCT04534114|593888545|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
164414580|NCT04534114|593888546|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
164414581|NCT04534114|593888547|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
164414582|NCT04534114|593888548|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
164414583|NCT04534114|593888545|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
164414584|NCT04534114|593888546|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
164414585|NCT04534114|593888547|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
164414586|NCT04534114|593888548|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
164414587|NCT04534114|593888545|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
164414588|NCT04534114|593888546|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
164710136|NCT01081834|594962839|FG000|Core Period: Baseline to Week 26|Other|4|||
164414589|NCT04534114|593888547|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
164414590|NCT04534114|593888548|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
164464888|NCT03088878|594073882|FG004|Overall Study|Withdrawal by Subject|4|||
164464889|NCT03088878|594073883|FG005|Overall Study|Withdrawal by Subject|1|||
164464890|NCT03088878|594073884|FG006|Overall Study|Withdrawal by Subject|1|||
164464891|NCT03088878|594073885|FG007|Overall Study|Withdrawal by Subject|0|||
164464892|NCT03088878|594073886|FG008|Overall Study|Withdrawal by Subject|1|||
164464893|NCT03088878|594073887|FG009|Overall Study|Withdrawal by Subject|2|||
164464894|NCT03088878|594073888|FG010|Overall Study|Withdrawal by Subject|0|||
164464895|NCT03088878|594073889|FG011|Overall Study|Withdrawal by Subject|2|||
164464896|NCT03088878|594073890|FG012|Overall Study|Withdrawal by Subject|1|||
164464897|NCT03088878|594073891|FG013|Overall Study|Withdrawal by Subject|0|||
164464898|NCT03088878|594073878|FG000|Overall Study|Terminated by Sponsor|2|||
164710137|NCT01081834|594962840|FG001|Core Period: Baseline to Week 26|Other|4|||
164464899|NCT03088878|594073879|FG001|Overall Study|Terminated by Sponsor|1|||
164464900|NCT03088878|594073880|FG002|Overall Study|Terminated by Sponsor|0|||
164464901|NCT03088878|594073881|FG003|Overall Study|Terminated by Sponsor|1|||
164464902|NCT03088878|594073882|FG004|Overall Study|Terminated by Sponsor|6|||
164464903|NCT03088878|594073883|FG005|Overall Study|Terminated by Sponsor|0|||
164464904|NCT03088878|594073884|FG006|Overall Study|Terminated by Sponsor|0|||
164464905|NCT03088878|594073885|FG007|Overall Study|Terminated by Sponsor|0|||
164464906|NCT03088878|594073886|FG008|Overall Study|Terminated by Sponsor|0|||
164464907|NCT03088878|594073887|FG009|Overall Study|Terminated by Sponsor|0|||
164464908|NCT03088878|594073888|FG010|Overall Study|Terminated by Sponsor|3|||
164464909|NCT03088878|594073889|FG011|Overall Study|Terminated by Sponsor|13|||
164464910|NCT03088878|594073890|FG012|Overall Study|Terminated by Sponsor|2|||
164464911|NCT03088878|594073891|FG013|Overall Study|Terminated by Sponsor|1|||
164464912|NCT03088878|594073878|FG000|Overall Study|Completed 2 years of Treatment|0|||
164464913|NCT03088878|594073879|FG001|Overall Study|Completed 2 years of Treatment|0|||
164464914|NCT03088878|594073880|FG002|Overall Study|Completed 2 years of Treatment|0|||
164464915|NCT03088878|594073881|FG003|Overall Study|Completed 2 years of Treatment|0|||
164464916|NCT03088878|594073882|FG004|Overall Study|Completed 2 years of Treatment|0|||
164464917|NCT03088878|594073883|FG005|Overall Study|Completed 2 years of Treatment|0|||
164464918|NCT03088878|594073884|FG006|Overall Study|Completed 2 years of Treatment|1|||
164464919|NCT03088878|594073885|FG007|Overall Study|Completed 2 years of Treatment|0|||
164464920|NCT03088878|594073886|FG008|Overall Study|Completed 2 years of Treatment|0|||
164464921|NCT03088878|594073887|FG009|Overall Study|Completed 2 years of Treatment|1|||
164464922|NCT03088878|594073888|FG010|Overall Study|Completed 2 years of Treatment|0|||
164464923|NCT03088878|594073889|FG011|Overall Study|Completed 2 years of Treatment|0|||
164464924|NCT03088878|594073890|FG012|Overall Study|Completed 2 years of Treatment|8|||
164464925|NCT03088878|594073891|FG013|Overall Study|Completed 2 years of Treatment|3|||
164464926|NCT03088878|594073878|FG000|Overall Study|Physician Decision|0|||
164464927|NCT03088878|594073879|FG001|Overall Study|Physician Decision|0|||
164464928|NCT03088878|594073880|FG002|Overall Study|Physician Decision|0|||
164464929|NCT03088878|594073881|FG003|Overall Study|Physician Decision|0|||
164464930|NCT03088878|594073882|FG004|Overall Study|Physician Decision|0|||
164464931|NCT03088878|594073883|FG005|Overall Study|Physician Decision|0|||
164464932|NCT03088878|594073884|FG006|Overall Study|Physician Decision|0|||
164464933|NCT03088878|594073885|FG007|Overall Study|Physician Decision|2|||
164464934|NCT03088878|594073886|FG008|Overall Study|Physician Decision|1|||
164464935|NCT03088878|594073887|FG009|Overall Study|Physician Decision|0|||
164464936|NCT03088878|594073888|FG010|Overall Study|Physician Decision|0|||
164464937|NCT03088878|594073889|FG011|Overall Study|Physician Decision|0|||
164464938|NCT03088878|594073890|FG012|Overall Study|Physician Decision|0|||
164464939|NCT03088878|594073891|FG013|Overall Study|Physician Decision|1|||
164464940|NCT03088878|594073878|FG000|Overall Study|COVID Related noncompliance|0|||
164464941|NCT03088878|594073879|FG001|Overall Study|COVID Related noncompliance|0|||
164464942|NCT03088878|594073880|FG002|Overall Study|COVID Related noncompliance|0|||
164464943|NCT03088878|594073881|FG003|Overall Study|COVID Related noncompliance|0|||
164464944|NCT03088878|594073882|FG004|Overall Study|COVID Related noncompliance|0|||
164464945|NCT03088878|594073883|FG005|Overall Study|COVID Related noncompliance|0|||
164464946|NCT03088878|594073884|FG006|Overall Study|COVID Related noncompliance|0|||
164464947|NCT03088878|594073885|FG007|Overall Study|COVID Related noncompliance|0|||
164464948|NCT03088878|594073886|FG008|Overall Study|COVID Related noncompliance|0|||
164464949|NCT03088878|594073887|FG009|Overall Study|COVID Related noncompliance|0|||
164464950|NCT03088878|594073888|FG010|Overall Study|COVID Related noncompliance|0|||
164464951|NCT03088878|594073889|FG011|Overall Study|COVID Related noncompliance|0|||
164464952|NCT03088878|594073890|FG012|Overall Study|COVID Related noncompliance|0|||
164464953|NCT03088878|594073891|FG013|Overall Study|COVID Related noncompliance|1|||
164464954|NCT03088878|594073878|FG000|Overall Study|Drug or Study Noncompliance|0|||
164464955|NCT03088878|594073879|FG001|Overall Study|Drug or Study Noncompliance|0|||
164464956|NCT03088878|594073880|FG002|Overall Study|Drug or Study Noncompliance|0|||
164464957|NCT03088878|594073881|FG003|Overall Study|Drug or Study Noncompliance|0|||
164464958|NCT03088878|594073882|FG004|Overall Study|Drug or Study Noncompliance|0|||
164464959|NCT03088878|594073883|FG005|Overall Study|Drug or Study Noncompliance|0|||
164464960|NCT03088878|594073884|FG006|Overall Study|Drug or Study Noncompliance|0|||
164464961|NCT03088878|594073885|FG007|Overall Study|Drug or Study Noncompliance|0|||
164464962|NCT03088878|594073886|FG008|Overall Study|Drug or Study Noncompliance|0|||
164464963|NCT03088878|594073887|FG009|Overall Study|Drug or Study Noncompliance|0|||
164464964|NCT03088878|594073888|FG010|Overall Study|Drug or Study Noncompliance|0|||
164464965|NCT03088878|594073889|FG011|Overall Study|Drug or Study Noncompliance|0|||
164464966|NCT03088878|594073890|FG012|Overall Study|Drug or Study Noncompliance|1|||
164464967|NCT03088878|594073891|FG013|Overall Study|Drug or Study Noncompliance|0|||
164464968|NCT05104463|594073901|FG000|Overall Study|Adverse Event|1|||
164464969|NCT05104463|594073902|FG001|Overall Study|Adverse Event|1|||
164464970|NCT05104463|594073901|FG000|Overall Study|Lost to Follow-up|1|||
164464971|NCT05104463|594073902|FG001|Overall Study|Lost to Follow-up|1|||
164464972|NCT05104463|594073901|FG000|Overall Study|Physician Decision|1|||
164710138|NCT01081834|594962841|FG002|Core Period: Baseline to Week 26|Other|3|||
164464973|NCT05104463|594073902|FG001|Overall Study|Physician Decision|0|||
164464974|NCT05104463|594073901|FG000|Overall Study|Protocol Violation|0|||
164464975|NCT05104463|594073902|FG001|Overall Study|Protocol Violation|2|||
164464976|NCT05104463|594073901|FG000|Overall Study|Withdrawal by Subject|1|||
164464977|NCT05104463|594073902|FG001|Overall Study|Withdrawal by Subject|1|||
164464978|NCT04428203|594073903|FG000|Overall Study|Adverse Event|1|||
164464979|NCT04428203|594073904|FG001|Overall Study|Adverse Event|0|||
164464980|NCT04428203|594073905|FG002|Overall Study|Adverse Event|0|||
164464981|NCT04428203|594073903|FG000|Overall Study|Withdrawal by Subject|1|||
164464982|NCT04428203|594073904|FG001|Overall Study|Withdrawal by Subject|0|||
164464983|NCT04428203|594073905|FG002|Overall Study|Withdrawal by Subject|1|||
164464984|NCT02823145|594073906|FG000|Enrollment|Other|1|||
164464985|NCT02823145|594073907|FG001|Enrollment|Other|0|||
164464986|NCT02823145|594073906|FG000|Treatment|Adverse Event|0|||
164464987|NCT02823145|594073907|FG001|Treatment|Adverse Event|11|||
164464988|NCT02823145|594073906|FG000|Treatment|Death|0|||
164464989|NCT02823145|594073907|FG001|Treatment|Death|3|||
164710139|NCT01081834|594962842|FG003|Core Period: Baseline to Week 26|Other|1|||
164710140|NCT01081834|594962843|FG004|Core Period: Baseline to Week 26|Other|0|||
164710141|NCT01081834|594962839|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
164710142|NCT01081834|594962840|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
164710143|NCT01081834|594962841|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
164710144|NCT01081834|594962842|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
164710145|NCT01081834|594962843|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
164710146|NCT01081834|594962839|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
164710147|NCT01081834|594962840|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
164710148|NCT01081834|594962841|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
164710149|NCT01081834|594962842|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
164710150|NCT01081834|594962843|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
164710151|NCT01081834|594962839|FG000|Extension Period: Week 26 to Week 52|Death|1|||
164710152|NCT01081834|594962840|FG001|Extension Period: Week 26 to Week 52|Death|0|||
164710153|NCT01081834|594962841|FG002|Extension Period: Week 26 to Week 52|Death|0|||
164710154|NCT01081834|594962842|FG003|Extension Period: Week 26 to Week 52|Death|0|||
164710155|NCT01081834|594962843|FG004|Extension Period: Week 26 to Week 52|Death|0|||
164710156|NCT01081834|594962839|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
164710157|NCT01081834|594962840|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
164710158|NCT01081834|594962841|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
164710159|NCT01081834|594962842|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
164710160|NCT01081834|594962843|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
164710161|NCT01081834|594962839|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
164710162|NCT01081834|594962840|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
164710163|NCT01081834|594962841|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
164710164|NCT01081834|594962842|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
164710165|NCT01081834|594962843|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
164710166|NCT01081834|594962839|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
164710167|NCT01081834|594962840|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
164710168|NCT01081834|594962841|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
164710169|NCT01081834|594962842|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
164710170|NCT01081834|594962843|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
164710171|NCT01081834|594962839|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
164710172|NCT01081834|594962840|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
164710173|NCT01081834|594962841|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
164710174|NCT01081834|594962842|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
164710175|NCT01081834|594962843|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
164710176|NCT01081834|594962839|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
164710177|NCT01081834|594962840|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
164710178|NCT01081834|594962841|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
164710179|NCT01081834|594962842|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
164710180|NCT01081834|594962843|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
164710181|NCT01081834|594962839|FG000|Extension Period: Week 26 to Week 52|Other|4|||
164710182|NCT01081834|594962840|FG001|Extension Period: Week 26 to Week 52|Other|5|||
164710183|NCT01081834|594962841|FG002|Extension Period: Week 26 to Week 52|Other|4|||
164710184|NCT01081834|594962842|FG003|Extension Period: Week 26 to Week 52|Other|0|||
164464990|NCT02823145|594073906|FG000|Treatment|Family Decision|0|||
164464991|NCT02823145|594073907|FG001|Treatment|Family Decision|1|||
164464992|NCT02823145|594073906|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
164464993|NCT02823145|594073907|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
164464994|NCT02823145|594073906|FG000|Treatment|Lack of Efficacy|0|||
164464995|NCT02823145|594073907|FG001|Treatment|Lack of Efficacy|48|||
164464996|NCT02823145|594073906|FG000|Treatment|Non-Compliance With E-Diary|0|||
164464997|NCT02823145|594073907|FG001|Treatment|Non-Compliance With E-Diary|1|||
164464998|NCT02823145|594073906|FG000|Treatment|Physician Decision|0|||
164464999|NCT02823145|594073907|FG001|Treatment|Physician Decision|2|||
164465000|NCT02823145|594073906|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
164465001|NCT02823145|594073907|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
164465002|NCT02823145|594073906|FG000|Treatment|Subject needed to take prohibited medication|0|||
164465003|NCT02823145|594073907|FG001|Treatment|Subject needed to take prohibited medication|1|||
164465004|NCT02823145|594073906|FG000|Treatment|Subject transferred to direct access programme|0|||
164465005|NCT02823145|594073907|FG001|Treatment|Subject transferred to direct access programme|1|||
164465006|NCT02823145|594073906|FG000|Treatment|Switching to commercially available drug|0|||
164465007|NCT02823145|594073907|FG001|Treatment|Switching to commercially available drug|11|||
164414591|NCT04534114|593888545|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
164414592|NCT04534114|593888546|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
164414593|NCT04534114|593888547|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
164414594|NCT04534114|593888548|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
164414595|NCT04534114|593888545|FG000|Main Treatment Period|Physician Decision|0|||
164414596|NCT04534114|593888546|FG001|Main Treatment Period|Physician Decision|0|||
164414597|NCT04534114|593888547|FG002|Main Treatment Period|Physician Decision|0|||
164414598|NCT04534114|593888548|FG003|Main Treatment Period|Physician Decision|1|||
164414599|NCT04534114|593888545|FG000|Main Treatment Period|Death|1|||
164414600|NCT04534114|593888546|FG001|Main Treatment Period|Death|0|||
164414601|NCT04534114|593888547|FG002|Main Treatment Period|Death|0|||
164414602|NCT04534114|593888548|FG003|Main Treatment Period|Death|1|||
164414603|NCT04534114|593888545|FG000|Main Treatment Period|Other reason|1|||
164414604|NCT04534114|593888546|FG001|Main Treatment Period|Other reason|1|||
164414605|NCT04534114|593888547|FG002|Main Treatment Period|Other reason|0|||
164414606|NCT04534114|593888548|FG003|Main Treatment Period|Other reason|0|||
164414607|NCT04534114|593888545|FG000|Main Treatment Period|Participant decision|1|||
164414608|NCT04534114|593888546|FG001|Main Treatment Period|Participant decision|3|||
164414609|NCT04534114|593888547|FG002|Main Treatment Period|Participant decision|3|||
164414610|NCT04534114|593888548|FG003|Main Treatment Period|Participant decision|1|||
164414611|NCT04534114|593888545|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
164414612|NCT04534114|593888546|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
164414613|NCT04534114|593888547|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
164414614|NCT04534114|593888548|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
164414615|NCT04534114|593888545|FG000|Main Treatment Period|Adverse Event|4|||
164414616|NCT04534114|593888546|FG001|Main Treatment Period|Adverse Event|2|||
164414617|NCT04534114|593888547|FG002|Main Treatment Period|Adverse Event|1|||
164414618|NCT04534114|593888548|FG003|Main Treatment Period|Adverse Event|2|||
164414619|NCT04534114|593888545|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
164414620|NCT04534114|593888546|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
164414621|NCT04534114|593888547|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
164414622|NCT04534114|593888548|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
164414623|NCT04534114|593888545|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
164414624|NCT04534114|593888546|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
164414625|NCT04534114|593888547|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
164414626|NCT04534114|593888548|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
164414627|NCT04534114|593888545|FG000|Extension Treatment Period|Other reason|0|||
164414628|NCT04534114|593888546|FG001|Extension Treatment Period|Other reason|1|||
164414629|NCT04534114|593888547|FG002|Extension Treatment Period|Other reason|0|||
164414630|NCT04534114|593888548|FG003|Extension Treatment Period|Other reason|0|||
164414631|NCT04534114|593888545|FG000|Extension Treatment Period|Death|0|||
164414632|NCT04534114|593888546|FG001|Extension Treatment Period|Death|0|||
164414633|NCT04534114|593888547|FG002|Extension Treatment Period|Death|1|||
164414634|NCT04534114|593888548|FG003|Extension Treatment Period|Death|2|||
164414635|NCT04534114|593888545|FG000|Extension Treatment Period|Adverse Event|0|||
164414636|NCT04534114|593888546|FG001|Extension Treatment Period|Adverse Event|1|||
164414637|NCT04534114|593888547|FG002|Extension Treatment Period|Adverse Event|0|||
164414638|NCT04534114|593888548|FG003|Extension Treatment Period|Adverse Event|1|||
164414639|NCT04534114|593888545|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
164414640|NCT04534114|593888546|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
164414641|NCT04534114|593888547|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
164414642|NCT04534114|593888548|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
164465008|NCT02823145|594073906|FG000|Treatment|Transitioned to commercial supply of medication|0|||
164414643|NCT02759185|593888549|FG000|Stage 1|Adverse Event|0|||
164414644|NCT02759185|593888550|FG001|Stage 1|Adverse Event|1|||
164465009|NCT02823145|594073907|FG001|Treatment|Transitioned to commercial supply of medication|1|||
164465010|NCT02823145|594073906|FG000|Treatment|Withdrawal By Caregiver|0|||
164710185|NCT01081834|594962843|FG004|Extension Period: Week 26 to Week 52|Other|0|||
164710186|NCT01081834|594962839|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
164710187|NCT01081834|594962840|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
164710188|NCT01081834|594962841|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
164710189|NCT01081834|594962842|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
164710190|NCT01081834|594962843|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
164710191|NCT01081834|594962839|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
164710192|NCT01081834|594962840|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
164465011|NCT02823145|594073907|FG001|Treatment|Withdrawal By Caregiver|1|||
164465012|NCT02823145|594073906|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
164465013|NCT02823145|594073907|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
164465014|NCT02823145|594073906|FG000|Treatment|Withdrawal by Subject|0|||
164465015|NCT02823145|594073907|FG001|Treatment|Withdrawal by Subject|16|||
164465016|NCT02823145|594073906|FG000|Treatment|Reason unknown|0|||
164465017|NCT02823145|594073907|FG001|Treatment|Reason unknown|1|||
164465018|NCT04741776|594073908|FG000|Overall Study|Withdrawal by Subject|7|||
164465019|NCT04741776|594073909|FG001|Overall Study|Withdrawal by Subject|10|||
164465020|NCT04741776|594073910|FG002|Overall Study|Withdrawal by Subject|10|||
164465021|NCT04741776|594073911|FG003|Overall Study|Withdrawal by Subject|17|||
164465022|NCT04741776|594073908|FG000|Overall Study|Death|0|||
164465023|NCT04741776|594073909|FG001|Overall Study|Death|0|||
164710193|NCT01081834|594962841|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
164710194|NCT01081834|594962842|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
164710195|NCT01081834|594962843|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
164710196|NCT01085734|594962844|FG000|Overall Study|Adverse Event|0|||
164710197|NCT01085734|594962845|FG001|Overall Study|Adverse Event|2|||
164710198|NCT01085734|594962844|FG000|Overall Study|Death|1|||
164710199|NCT01085734|594962845|FG001|Overall Study|Death|0|||
164710200|NCT01085734|594962844|FG000|Overall Study|Lost to Follow-up|0|||
164710201|NCT01085734|594962845|FG001|Overall Study|Lost to Follow-up|1|||
164710202|NCT01085734|594962844|FG000|Overall Study|Withdrawal by Subject|0|||
164710203|NCT01085734|594962845|FG001|Overall Study|Withdrawal by Subject|1|||
164710204|NCT02045147|594962848|FG000|Overall Study|Withdrawal by Subject|2|||
164710205|NCT02045147|594962849|FG001|Overall Study|Withdrawal by Subject|0|||
164710206|NCT02045147|594962850|FG002|Overall Study|Withdrawal by Subject|0|||
164710207|NCT02045147|594962851|FG003|Overall Study|Withdrawal by Subject|0|||
164710208|NCT02045147|594962852|FG004|Overall Study|Withdrawal by Subject|0|||
164710209|NCT02045147|594962853|FG005|Overall Study|Withdrawal by Subject|0|||
164710210|NCT02045147|594962854|FG006|Overall Study|Withdrawal by Subject|0|||
164710211|NCT02045147|594962855|FG007|Overall Study|Withdrawal by Subject|1|||
164710212|NCT02045147|594962848|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
164710213|NCT02045147|594962849|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
164710214|NCT02045147|594962850|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
164710215|NCT02045147|594962851|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
164710216|NCT02045147|594962852|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
164710217|NCT02045147|594962853|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
164465024|NCT04741776|594073910|FG002|Overall Study|Death|1|||
164465025|NCT04741776|594073911|FG003|Overall Study|Death|0|||
164465026|NCT02852655|594073927|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
164465027|NCT02852655|594073928|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
164465028|NCT02852655|594073929|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
164465029|NCT02852655|594073927|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
164465030|NCT02852655|594073928|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
164465031|NCT02852655|594073929|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
164465032|NCT02852655|594073927|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
164465033|NCT02852655|594073928|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
164465034|NCT02852655|594073929|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
164465035|NCT02852655|594073927|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
164465036|NCT02852655|594073928|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
164465037|NCT02852655|594073929|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
164465038|NCT02852655|594073927|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
164465039|NCT02852655|594073928|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
164465040|NCT02852655|594073929|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
164710218|NCT02045147|594962854|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
164465041|NCT02852655|594073927|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
164465042|NCT02852655|594073928|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
164710219|NCT02045147|594962855|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
164710220|NCT01475097|594962856|FG000|Overall Study|Protocol Violation|1|||
164710221|NCT01475097|594962857|FG001|Overall Study|Protocol Violation|1|||
164710222|NCT04839692|594962858|FG000|Overall Study|Withdrawal by Subject|0|||
164710223|NCT04839692|594962859|FG001|Overall Study|Withdrawal by Subject|3|||
164710224|NCT04839692|594962858|FG000|Overall Study|Physician Decision|1|||
164710225|NCT04839692|594962859|FG001|Overall Study|Physician Decision|0|||
164710226|NCT00049530|594962860|FG000|Overall Study|Lack of Efficacy|25|||
164710227|NCT00049530|594962860|FG000|Overall Study|Adverse Event|2|||
164710228|NCT00049530|594962860|FG000|Overall Study|Death|1|||
164710229|NCT00049530|594962860|FG000|Overall Study|symptomatic deterioration|1|||
164710230|NCT00049530|594962860|FG000|Overall Study|ineligible|3|||
164710231|NCT03511326|594962862|FG000|Overall Study|Withdrawal by Subject|1|||
164710232|NCT01305044|594962865|FG000|Overall Study|Withdrawal by Subject|3|||
164710233|NCT01305044|594962866|FG001|Overall Study|Withdrawal by Subject|6|||
164710234|NCT00492024|594962871|FG000|Treatment|Adverse Event|3|||
164710235|NCT00492024|594962872|FG001|Treatment|Adverse Event|1|||
164710236|NCT00492024|594962871|FG000|Treatment|Lack of Efficacy|21|||
164710237|NCT00492024|594962872|FG001|Treatment|Lack of Efficacy|20|||
164710238|NCT00492024|594962871|FG000|Treatment|Lost to Follow-up|3|||
164710239|NCT00492024|594962872|FG001|Treatment|Lost to Follow-up|1|||
164710240|NCT00492024|594962871|FG000|Treatment|Withdrawal by Subject|2|||
164710241|NCT00492024|594962872|FG001|Treatment|Withdrawal by Subject|0|||
164710242|NCT00492024|594962871|FG000|Follow up|Lack of Efficacy|0|||
164710243|NCT00492024|594962872|FG001|Follow up|Lack of Efficacy|1|||
164710244|NCT00492024|594962871|FG000|Follow up|Lost to Follow-up|1|||
164710245|NCT00492024|594962872|FG001|Follow up|Lost to Follow-up|1|||
164710246|NCT03247816|594962873|FG000|Overall Study|Adverse Event|12|||
164710247|NCT03247816|594962873|FG000|Overall Study|Physician Decision|3|||
164710248|NCT03247816|594962873|FG000|Overall Study|Lack of Efficacy|1|||
164710249|NCT03247816|594962873|FG000|Overall Study|Lost to Follow-up|10|||
164710250|NCT03247816|594962873|FG000|Overall Study|Missing Feraccru stop date|3|||
164710251|NCT01439009|594962876|FG000|Overall Study|Physician Decision|5|||
164710252|NCT01439009|594962877|FG001|Overall Study|Physician Decision|3|||
164710253|NCT01439009|594962876|FG000|Overall Study|Protocol Violation|2|||
164710254|NCT01439009|594962877|FG001|Overall Study|Protocol Violation|0|||
164710255|NCT01439009|594962876|FG000|Overall Study|Deviation of exclusion criteria|1|||
164710256|NCT01439009|594962877|FG001|Overall Study|Deviation of exclusion criteria|0|||
164710257|NCT00926783|594962878|FG000|Overall Study|Incomplete CFAE Procedures|3|||
164710258|NCT00926783|594962879|FG001|Overall Study|Incomplete CFAE Procedures|3|||
164710259|NCT00417170|594962880|FG000|Overall Study|Adverse Event|1|||
164710260|NCT00417170|594962881|FG001|Overall Study|Adverse Event|1|||
164710261|NCT00417170|594962880|FG000|Overall Study|Withdrawal by Subject|1|||
164710262|NCT00417170|594962881|FG001|Overall Study|Withdrawal by Subject|1|||
164710263|NCT00417170|594962880|FG000|Overall Study|Lost to Follow-up|0|||
164710264|NCT00417170|594962881|FG001|Overall Study|Lost to Follow-up|1|||
164710265|NCT00696787|594962882|FG000|Overall Study|Adverse Event|1|||
164710266|NCT00696787|594962883|FG001|Overall Study|Adverse Event|0|||
164710267|NCT00696787|594962884|FG002|Overall Study|Adverse Event|6|||
164710268|NCT00696787|594962882|FG000|Overall Study|Discontinuation by Sponsor|9|||
164710269|NCT00696787|594962883|FG001|Overall Study|Discontinuation by Sponsor|13|||
164710270|NCT00696787|594962884|FG002|Overall Study|Discontinuation by Sponsor|14|||
164414645|NCT02759185|593888551|FG002|Stage 1|Adverse Event|3|||
164414646|NCT02759185|593888552|FG003|Stage 1|Adverse Event|0|||
164414647|NCT02759185|593888553|FG004|Stage 1|Adverse Event|0|||
164414648|NCT02759185|593888554|FG005|Stage 1|Adverse Event|0|||
164414649|NCT02759185|593888555|FG006|Stage 1|Adverse Event|0|||
164414650|NCT02759185|593888549|FG000|Stage 1|Withdrawal by Subject|1|||
164414651|NCT02759185|593888550|FG001|Stage 1|Withdrawal by Subject|0|||
164414652|NCT02759185|593888551|FG002|Stage 1|Withdrawal by Subject|0|||
164414653|NCT02759185|593888552|FG003|Stage 1|Withdrawal by Subject|0|||
164414654|NCT02759185|593888553|FG004|Stage 1|Withdrawal by Subject|0|||
164414655|NCT02759185|593888554|FG005|Stage 1|Withdrawal by Subject|0|||
164414656|NCT02759185|593888555|FG006|Stage 1|Withdrawal by Subject|0|||
164465043|NCT02852655|594073929|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
164710271|NCT00696787|594962882|FG000|Overall Study|Lack of Efficacy|0|||
164710272|NCT00696787|594962883|FG001|Overall Study|Lack of Efficacy|1|||
164710273|NCT00696787|594962884|FG002|Overall Study|Lack of Efficacy|0|||
164710274|NCT00696787|594962882|FG000|Overall Study|Lost to Follow-up|4|||
164710275|NCT00696787|594962883|FG001|Overall Study|Lost to Follow-up|0|||
164710276|NCT00696787|594962884|FG002|Overall Study|Lost to Follow-up|3|||
164710277|NCT00696787|594962882|FG000|Overall Study|Withdrawal by Subject|0|||
164414657|NCT02759185|593888549|FG000|Stage 2|Adverse Event|0|||
164414658|NCT02759185|593888550|FG001|Stage 2|Adverse Event|0|||
164414659|NCT02759185|593888551|FG002|Stage 2|Adverse Event|0|||
164414660|NCT02759185|593888552|FG003|Stage 2|Adverse Event|0|||
164710278|NCT00696787|594962883|FG001|Overall Study|Withdrawal by Subject|3|||
164710279|NCT00696787|594962884|FG002|Overall Study|Withdrawal by Subject|2|||
164710280|NCT00696787|594962882|FG000|Overall Study|Failed to return|1|||
164710281|NCT00696787|594962883|FG001|Overall Study|Failed to return|3|||
164465044|NCT02852655|594073927|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
164465045|NCT02852655|594073928|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
164465046|NCT02852655|594073929|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
164465047|NCT02852655|594073927|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
164465048|NCT02852655|594073928|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
164465049|NCT02852655|594073929|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
164465050|NCT02852655|594073927|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
164465051|NCT02852655|594073928|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
164465052|NCT02852655|594073929|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
164465053|NCT05809453|594075807|FG000|Overall Study|Withdrawal by Subject|1|||
164465054|NCT05809453|594075808|FG001|Overall Study|Withdrawal by Subject|0|||
164465055|NCT05809453|594075809|FG002|Overall Study|Withdrawal by Subject|0|||
164465056|NCT05809453|594075810|FG003|Overall Study|Withdrawal by Subject|0|||
164465057|NCT04171141|594075811|FG000|Overall Study|Adverse Event|0|||
164465058|NCT04171141|594075812|FG001|Overall Study|Adverse Event|0|||
164465059|NCT04171141|594075813|FG002|Overall Study|Adverse Event|2|||
164465060|NCT04171141|594075814|FG003|Overall Study|Adverse Event|0|||
164465061|NCT04171141|594075815|FG004|Overall Study|Adverse Event|0|||
164465062|NCT04171141|594075816|FG005|Overall Study|Adverse Event|0|||
164465063|NCT04171141|594075817|FG006|Overall Study|Adverse Event|0|||
164465064|NCT04171141|594075818|FG007|Overall Study|Adverse Event|0|||
164465065|NCT04171141|594075819|FG008|Overall Study|Adverse Event|0|||
164465066|NCT04171141|594075820|FG009|Overall Study|Adverse Event|0|||
164465067|NCT04171141|594075821|FG010|Overall Study|Adverse Event|0|||
164465068|NCT04171141|594075822|FG011|Overall Study|Adverse Event|0|||
164465069|NCT04171141|594075823|FG012|Overall Study|Adverse Event|0|||
164465070|NCT04171141|594075824|FG013|Overall Study|Adverse Event|2|||
164465071|NCT04171141|594075825|FG014|Overall Study|Adverse Event|0|||
164465072|NCT04171141|594075826|FG015|Overall Study|Adverse Event|0|||
164465073|NCT04171141|594075811|FG000|Overall Study|Physician Decision|0|||
164465074|NCT04171141|594075812|FG001|Overall Study|Physician Decision|0|||
164465075|NCT04171141|594075813|FG002|Overall Study|Physician Decision|0|||
164465076|NCT04171141|594075814|FG003|Overall Study|Physician Decision|0|||
164465077|NCT04171141|594075815|FG004|Overall Study|Physician Decision|1|||
164465078|NCT04171141|594075816|FG005|Overall Study|Physician Decision|0|||
164465079|NCT04171141|594075817|FG006|Overall Study|Physician Decision|0|||
164465080|NCT04171141|594075818|FG007|Overall Study|Physician Decision|0|||
164465081|NCT04171141|594075819|FG008|Overall Study|Physician Decision|0|||
164465082|NCT04171141|594075820|FG009|Overall Study|Physician Decision|0|||
164465083|NCT04171141|594075821|FG010|Overall Study|Physician Decision|0|||
164465084|NCT04171141|594075822|FG011|Overall Study|Physician Decision|0|||
164465085|NCT04171141|594075823|FG012|Overall Study|Physician Decision|0|||
164465086|NCT04171141|594075824|FG013|Overall Study|Physician Decision|0|||
164465087|NCT04171141|594075825|FG014|Overall Study|Physician Decision|0|||
164465088|NCT04171141|594075826|FG015|Overall Study|Physician Decision|1|||
164465089|NCT04171141|594075811|FG000|Overall Study|Progressive disease|2|||
164465090|NCT04171141|594075812|FG001|Overall Study|Progressive disease|3|||
164465091|NCT04171141|594075813|FG002|Overall Study|Progressive disease|4|||
164465092|NCT04171141|594075814|FG003|Overall Study|Progressive disease|7|||
164465093|NCT04171141|594075815|FG004|Overall Study|Progressive disease|1|||
164465094|NCT04171141|594075816|FG005|Overall Study|Progressive disease|8|||
164465095|NCT04171141|594075817|FG006|Overall Study|Progressive disease|4|||
164465096|NCT04171141|594075818|FG007|Overall Study|Progressive disease|6|||
164465097|NCT04171141|594075819|FG008|Overall Study|Progressive disease|7|||
164465098|NCT04171141|594075820|FG009|Overall Study|Progressive disease|3|||
164465099|NCT04171141|594075821|FG010|Overall Study|Progressive disease|4|||
164465100|NCT04171141|594075822|FG011|Overall Study|Progressive disease|3|||
164465101|NCT04171141|594075823|FG012|Overall Study|Progressive disease|4|||
164465102|NCT04171141|594075824|FG013|Overall Study|Progressive disease|2|||
164465103|NCT04171141|594075825|FG014|Overall Study|Progressive disease|4|||
164465104|NCT04171141|594075826|FG015|Overall Study|Progressive disease|1|||
164465105|NCT04171141|594075811|FG000|Overall Study|Withdrawal by Subject|0|||
164465106|NCT04171141|594075812|FG001|Overall Study|Withdrawal by Subject|0|||
164465107|NCT04171141|594075813|FG002|Overall Study|Withdrawal by Subject|0|||
164465108|NCT04171141|594075814|FG003|Overall Study|Withdrawal by Subject|1|||
164465109|NCT04171141|594075815|FG004|Overall Study|Withdrawal by Subject|0|||
164465110|NCT04171141|594075816|FG005|Overall Study|Withdrawal by Subject|0|||
164465111|NCT04171141|594075817|FG006|Overall Study|Withdrawal by Subject|1|||
164465112|NCT04171141|594075818|FG007|Overall Study|Withdrawal by Subject|0|||
164465113|NCT04171141|594075819|FG008|Overall Study|Withdrawal by Subject|0|||
164465114|NCT04171141|594075820|FG009|Overall Study|Withdrawal by Subject|1|||
164465115|NCT04171141|594075821|FG010|Overall Study|Withdrawal by Subject|0|||
164465116|NCT04171141|594075822|FG011|Overall Study|Withdrawal by Subject|0|||
164465117|NCT04171141|594075823|FG012|Overall Study|Withdrawal by Subject|0|||
164465118|NCT04171141|594075824|FG013|Overall Study|Withdrawal by Subject|0|||
164465119|NCT04171141|594075825|FG014|Overall Study|Withdrawal by Subject|0|||
164465120|NCT04171141|594075826|FG015|Overall Study|Withdrawal by Subject|0|||
164465121|NCT04171141|594075811|FG000|Overall Study|Global deterioration of health status|0|||
164465122|NCT04171141|594075812|FG001|Overall Study|Global deterioration of health status|0|||
164465123|NCT04171141|594075813|FG002|Overall Study|Global deterioration of health status|0|||
164465124|NCT04171141|594075814|FG003|Overall Study|Global deterioration of health status|1|||
164465125|NCT04171141|594075815|FG004|Overall Study|Global deterioration of health status|0|||
164465126|NCT04171141|594075816|FG005|Overall Study|Global deterioration of health status|2|||
164465127|NCT04171141|594075817|FG006|Overall Study|Global deterioration of health status|1|||
164465128|NCT04171141|594075818|FG007|Overall Study|Global deterioration of health status|0|||
164465129|NCT04171141|594075819|FG008|Overall Study|Global deterioration of health status|1|||
164465130|NCT04171141|594075820|FG009|Overall Study|Global deterioration of health status|0|||
164465131|NCT04171141|594075821|FG010|Overall Study|Global deterioration of health status|0|||
164465132|NCT04171141|594075822|FG011|Overall Study|Global deterioration of health status|0|||
164465133|NCT04171141|594075823|FG012|Overall Study|Global deterioration of health status|0|||
164465134|NCT04171141|594075824|FG013|Overall Study|Global deterioration of health status|0|||
164465135|NCT04171141|594075825|FG014|Overall Study|Global deterioration of health status|1|||
164465136|NCT04171141|594075826|FG015|Overall Study|Global deterioration of health status|1|||
164465137|NCT04119843|594075827|FG000|Overall Study|Adverse Event|3|||
164465138|NCT04119843|594075827|FG000|Overall Study|Death|1|||
164465139|NCT03663569|594075829|FG000|Overall Study|Discontinuation of study|11|||
164465140|NCT03663569|594075829|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
164465141|NCT03663569|594075829|FG000|Overall Study|Deceased patient|6|||
164465142|NCT03663569|594075829|FG000|Overall Study|Lost to Follow-up|18|||
164465143|NCT03663569|594075829|FG000|Overall Study|Withdrawal of consent|5|||
164465144|NCT03663569|594075829|FG000|Overall Study|Patient's request|11|||
164465145|NCT03663569|594075829|FG000|Overall Study|Adverse Event|4|||
164465146|NCT03663569|594075829|FG000|Overall Study|Not come to second visit|3|||
164465147|NCT03663569|594075829|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
164465148|NCT03663569|594075829|FG000|Overall Study|Serious adverse event|1|||
164465149|NCT04979442|594075830|FG000|Overall Study|Death|43|||
164465150|NCT04979442|594075831|FG001|Overall Study|Death|30|||
164465151|NCT04979442|594075830|FG000|Overall Study|Withdrawal by Subject|8|||
164465152|NCT04979442|594075831|FG001|Overall Study|Withdrawal by Subject|13|||
164465153|NCT04979442|594075830|FG000|Overall Study|Physician Decision|1|||
164465154|NCT04979442|594075831|FG001|Overall Study|Physician Decision|1|||
164465155|NCT04979442|594075830|FG000|Overall Study|Lost to Follow-up|0|||
164465156|NCT04979442|594075831|FG001|Overall Study|Lost to Follow-up|2|||
164465157|NCT04979442|594075830|FG000|Overall Study|do not want to continue|0|||
164465158|NCT04979442|594075831|FG001|Overall Study|do not want to continue|1|||
164465159|NCT04005794|594075832|FG000|Overall Study|Lost to Follow-up|0|||
164465160|NCT04005794|594075833|FG001|Overall Study|Lost to Follow-up|4|||
164465161|NCT04005794|594075834|FG002|Overall Study|Lost to Follow-up|0|||
164465162|NCT03916185|594075838|FG000|Overall Study|Lost to Follow-up|0|||
164465163|NCT03916185|594075839|FG001|Overall Study|Lost to Follow-up|1|||
164465164|NCT03916185|594075840|FG002|Overall Study|Lost to Follow-up|0|||
164465165|NCT03916185|594075841|FG003|Overall Study|Lost to Follow-up|0|||
164465166|NCT03916185|594075838|FG000|Overall Study|Moved|1|||
164465167|NCT03916185|594075839|FG001|Overall Study|Moved|0|||
164414661|NCT02759185|593888553|FG004|Stage 2|Adverse Event|1|||
164414662|NCT02759185|593888554|FG005|Stage 2|Adverse Event|2|||
164414663|NCT02759185|593888555|FG006|Stage 2|Adverse Event|0|||
164414664|NCT02759185|593888549|FG000|Stage 2|Withdrawal by Subject|0|||
164414665|NCT02759185|593888550|FG001|Stage 2|Withdrawal by Subject|0|||
164414666|NCT02759185|593888551|FG002|Stage 2|Withdrawal by Subject|0|||
164414667|NCT02759185|593888552|FG003|Stage 2|Withdrawal by Subject|0|||
164414668|NCT02759185|593888553|FG004|Stage 2|Withdrawal by Subject|1|||
164414669|NCT02759185|593888554|FG005|Stage 2|Withdrawal by Subject|1|||
164414670|NCT02759185|593888555|FG006|Stage 2|Withdrawal by Subject|1|||
164465168|NCT03916185|594075840|FG002|Overall Study|Moved|0|||
164465169|NCT03916185|594075841|FG003|Overall Study|Moved|1|||
164465170|NCT03916185|594075838|FG000|Overall Study|Not Able to Get to Clinic|1|||
164465171|NCT03916185|594075839|FG001|Overall Study|Not Able to Get to Clinic|0|||
164465172|NCT03916185|594075840|FG002|Overall Study|Not Able to Get to Clinic|0|||
164414671|NCT00539279|593888560|FG000|Treatment|Withdrawal by Subject|10|||
164414672|NCT00539279|593888561|FG001|Treatment|Withdrawal by Subject|8|||
164414673|NCT00539279|593888560|FG000|Treatment|Death|1|||
164465173|NCT03916185|594075841|FG003|Overall Study|Not Able to Get to Clinic|0|||
164465174|NCT02844465|594075845|FG000|Overall Study|Screen Failure|36|||
164465175|NCT02844465|594075845|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
164465176|NCT02844465|594075845|FG000|Overall Study|Withdrawal by Subject|5|||
164465177|NCT02844465|594075845|FG000|Overall Study|Lost to Follow-up|1|||
164465178|NCT02844465|594075845|FG000|Overall Study|Retreatment|1|||
164465179|NCT05297565|594075846|FG000|Overall Study|Other Reasons|0|||
164465180|NCT05297565|594075847|FG001|Overall Study|Other Reasons|1|||
164465181|NCT05297565|594075846|FG000|Overall Study|Physician Decision|0|||
164465182|NCT05297565|594075847|FG001|Overall Study|Physician Decision|1|||
164465183|NCT05297565|594075846|FG000|Overall Study|Disease recurrence|1|||
164465184|NCT05297565|594075847|FG001|Overall Study|Disease recurrence|0|||
164465185|NCT05029622|594075851|FG000|Overall Study|Lost to Follow-up|1|||
164465186|NCT05671653|594075852|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
164465187|NCT05671653|594075853|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
164465188|NCT05671653|594075854|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
164465189|NCT05671653|594075855|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
164465190|NCT05671653|594075856|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
164465191|NCT05671653|594075857|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
164465192|NCT05671653|594075858|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
164465193|NCT05671653|594075859|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
164465194|NCT05671653|594075860|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
164465195|NCT05671653|594075861|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
164465196|NCT05671653|594075862|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
164465197|NCT05671653|594075863|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
164465198|NCT05671653|594075864|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
164465199|NCT05671653|594075852|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
164465200|NCT05671653|594075853|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
164465201|NCT05671653|594075854|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
164465202|NCT05671653|594075855|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
164465203|NCT05671653|594075856|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
164465204|NCT05671653|594075857|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
164465205|NCT05671653|594075858|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
164465206|NCT05671653|594075859|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
164465207|NCT05671653|594075860|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
164465208|NCT05671653|594075861|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
164465209|NCT05671653|594075862|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
164465210|NCT05671653|594075863|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
164465211|NCT05671653|594075864|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
164465212|NCT05671653|594075852|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
164465213|NCT05671653|594075853|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
164465214|NCT05671653|594075854|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
164465215|NCT05671653|594075855|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
164465216|NCT05671653|594075856|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
164465217|NCT05671653|594075857|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
164465218|NCT05671653|594075858|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
164465219|NCT05671653|594075859|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
164465220|NCT05671653|594075860|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
164465221|NCT05671653|594075861|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
164465222|NCT05671653|594075862|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
164465223|NCT05671653|594075863|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
164465224|NCT05671653|594075864|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
164465225|NCT05671653|594075852|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
164465226|NCT05671653|594075853|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
164465227|NCT05671653|594075854|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
164465228|NCT05671653|594075855|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
164465229|NCT05671653|594075856|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
164465230|NCT05671653|594075857|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
164465231|NCT05671653|594075858|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
164465232|NCT05671653|594075859|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
164465233|NCT05671653|594075860|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
164465234|NCT05671653|594075861|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
164465235|NCT05671653|594075862|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
164465236|NCT05671653|594075863|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
164465237|NCT05671653|594075864|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
164465238|NCT05671653|594075852|FG000|Cohort 2 Period 2|Adverse Event|0|||
164465239|NCT05671653|594075853|FG001|Cohort 2 Period 2|Adverse Event|0|||
164465240|NCT05671653|594075854|FG002|Cohort 2 Period 2|Adverse Event|0|||
164465241|NCT05671653|594075855|FG003|Cohort 2 Period 2|Adverse Event|0|||
164465242|NCT05671653|594075856|FG004|Cohort 2 Period 2|Adverse Event|0|||
164465243|NCT05671653|594075857|FG005|Cohort 2 Period 2|Adverse Event|0|||
164465244|NCT05671653|594075858|FG006|Cohort 2 Period 2|Adverse Event|0|||
164710282|NCT00696787|594962884|FG002|Overall Study|Failed to return|1|||
164710283|NCT01001988|594962885|FG000|Overall Study|Protocol Violation|84|||
164710284|NCT01001988|594962885|FG000|Overall Study|Withdrawal by Subject|18|||
164710285|NCT01001988|594962885|FG000|Overall Study|Lost to Follow-up|15|||
164710286|NCT01329549|594962891|FG000|Overall Study|Withdrawal by Subject|1|||
164710287|NCT01329549|594962891|FG000|Overall Study|Adverse Event|1|||
164710288|NCT03200912|594962892|FG000|Overall Study|Adverse Event|3|||
164710289|NCT03200912|594962893|FG001|Overall Study|Adverse Event|0|||
164710290|NCT03200912|594962894|FG002|Overall Study|Adverse Event|0|||
164710291|NCT03200912|594962892|FG000|Overall Study|Withdrawal by Subject|1|||
164710292|NCT03200912|594962893|FG001|Overall Study|Withdrawal by Subject|2|||
164710293|NCT03200912|594962894|FG002|Overall Study|Withdrawal by Subject|4|||
164710294|NCT03200912|594962892|FG000|Overall Study|Non-compliance with study drug|0|||
164710295|NCT03200912|594962893|FG001|Overall Study|Non-compliance with study drug|1|||
164710296|NCT03200912|594962894|FG002|Overall Study|Non-compliance with study drug|0|||
164710297|NCT03196635|594962895|FG000|Overall Study|Withdrawal by Subject|1|||
164710298|NCT01346293|594962896|FG000|Overall Study|Protocol Violation|30|||
164710299|NCT01346293|594962897|FG001|Overall Study|Protocol Violation|9|||
164710300|NCT01346293|594962896|FG000|Overall Study|Lost to Follow-up|21|||
164710301|NCT01346293|594962897|FG001|Overall Study|Lost to Follow-up|8|||
164710302|NCT01346293|594962896|FG000|Overall Study|Withdrawal by Subject|15|||
164710303|NCT01346293|594962897|FG001|Overall Study|Withdrawal by Subject|4|||
164710304|NCT01346293|594962896|FG000|Overall Study|Other|1|||
164710305|NCT01346293|594962897|FG001|Overall Study|Other|0|||
164710306|NCT01844505|594962898|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
164710307|NCT01844505|594962899|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
164710308|NCT01844505|594962900|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
164710309|NCT01844505|594962898|FG000|Treatment Period|Other Reasons|120|||
164710310|NCT01844505|594962899|FG001|Treatment Period|Other Reasons|136|||
164710311|NCT01844505|594962900|FG002|Treatment Period|Other Reasons|58|||
164710312|NCT01844505|594962898|FG000|Treatment Period|Lost to Follow-up|9|||
164710313|NCT01844505|594962899|FG001|Treatment Period|Lost to Follow-up|11|||
164710314|NCT01844505|594962900|FG002|Treatment Period|Lost to Follow-up|6|||
164710315|NCT01844505|594962898|FG000|Treatment Period|Death|175|||
164710316|NCT01844505|594962899|FG001|Treatment Period|Death|154|||
164710317|NCT01844505|594962900|FG002|Treatment Period|Death|228|||
164710318|NCT02730351|594962901|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
164710319|NCT02730351|594962902|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
164710320|NCT02730351|594962901|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
164710321|NCT02730351|594962902|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
164710322|NCT02730351|594962901|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
164710323|NCT02730351|594962902|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
164710324|NCT02730351|594962901|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
164710325|NCT02730351|594962902|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
164710326|NCT02730351|594962901|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
164414674|NCT00539279|593888561|FG001|Treatment|Death|0|||
164414675|NCT00539279|593888560|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
164414676|NCT00539279|593888561|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
164414677|NCT00539279|593888560|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
164414678|NCT00539279|593888561|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
164414679|NCT02791490|593889856|FG000|Overall Study|Lost to Follow-up|1|||
164414680|NCT02791490|593889857|FG001|Overall Study|Lost to Follow-up|2|||
164414681|NCT02791490|593889856|FG000|Overall Study|Withdrawal by Subject|2|||
164414682|NCT02791490|593889857|FG001|Overall Study|Withdrawal by Subject|6|||
164414683|NCT02960763|593889858|FG000|Step 1|Withdrawal by Subject|10|||
164414684|NCT02960763|593889859|FG001|Step 1|Withdrawal by Subject|8|||
164414685|NCT02960763|593889860|FG002|Step 1|Withdrawal by Subject|13|||
164414686|NCT02960763|593889861|FG003|Step 1|Withdrawal by Subject|0|||
164414687|NCT02960763|593889862|FG004|Step 1|Withdrawal by Subject|0|||
164414688|NCT02960763|593889858|FG000|Step 1|Lost to Follow-up|7|||
164414689|NCT02960763|593889859|FG001|Step 1|Lost to Follow-up|9|||
164414690|NCT02960763|593889860|FG002|Step 1|Lost to Follow-up|12|||
164414691|NCT02960763|593889861|FG003|Step 1|Lost to Follow-up|0|||
164414692|NCT02960763|593889862|FG004|Step 1|Lost to Follow-up|0|||
164414693|NCT02960763|593889858|FG000|Step 1|Death|1|||
164414694|NCT02960763|593889859|FG001|Step 1|Death|1|||
164414695|NCT02960763|593889860|FG002|Step 1|Death|1|||
164414696|NCT02960763|593889861|FG003|Step 1|Death|0|||
164414697|NCT02960763|593889862|FG004|Step 1|Death|0|||
164414698|NCT02960763|593889858|FG000|Step 1|Investigator discretion|1|||
164414699|NCT02960763|593889859|FG001|Step 1|Investigator discretion|0|||
164414700|NCT02960763|593889860|FG002|Step 1|Investigator discretion|1|||
164414701|NCT02960763|593889861|FG003|Step 1|Investigator discretion|0|||
164414702|NCT02960763|593889862|FG004|Step 1|Investigator discretion|0|||
164414703|NCT02960763|593889858|FG000|Step 1|Other|0|||
164414704|NCT02960763|593889859|FG001|Step 1|Other|0|||
164710327|NCT02730351|594962902|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
164414705|NCT02960763|593889860|FG002|Step 1|Other|1|||
164414706|NCT02960763|593889861|FG003|Step 1|Other|0|||
164414707|NCT02960763|593889862|FG004|Step 1|Other|0|||
164465245|NCT05671653|594075859|FG007|Cohort 2 Period 2|Adverse Event|0|||
164465246|NCT05671653|594075860|FG008|Cohort 2 Period 2|Adverse Event|0|||
164465247|NCT05671653|594075861|FG009|Cohort 2 Period 2|Adverse Event|0|||
164465248|NCT05671653|594075862|FG010|Cohort 2 Period 2|Adverse Event|1|||
164465249|NCT05671653|594075863|FG011|Cohort 2 Period 2|Adverse Event|0|||
164465250|NCT05671653|594075864|FG012|Cohort 2 Period 2|Adverse Event|0|||
164465251|NCT05671653|594075852|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
164465252|NCT05671653|594075853|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
164465253|NCT05671653|594075854|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
164465254|NCT05671653|594075855|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
164465255|NCT05671653|594075856|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
164465256|NCT05671653|594075857|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
164465257|NCT05671653|594075858|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
164465258|NCT05671653|594075859|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
164465259|NCT05671653|594075860|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
164465260|NCT05671653|594075861|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
164465261|NCT05671653|594075862|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
164465262|NCT05671653|594075863|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
164465263|NCT05671653|594075864|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
164465264|NCT05671653|594075852|FG000|Cohort 2 Period 2|Pregnancy|0|||
164465265|NCT05671653|594075853|FG001|Cohort 2 Period 2|Pregnancy|0|||
164465266|NCT05671653|594075854|FG002|Cohort 2 Period 2|Pregnancy|0|||
164465267|NCT05671653|594075855|FG003|Cohort 2 Period 2|Pregnancy|0|||
164465268|NCT05671653|594075856|FG004|Cohort 2 Period 2|Pregnancy|0|||
164465269|NCT05671653|594075857|FG005|Cohort 2 Period 2|Pregnancy|0|||
164465270|NCT05671653|594075858|FG006|Cohort 2 Period 2|Pregnancy|0|||
164465271|NCT05671653|594075859|FG007|Cohort 2 Period 2|Pregnancy|0|||
164465272|NCT05671653|594075860|FG008|Cohort 2 Period 2|Pregnancy|0|||
164465273|NCT05671653|594075861|FG009|Cohort 2 Period 2|Pregnancy|0|||
164465274|NCT05671653|594075862|FG010|Cohort 2 Period 2|Pregnancy|1|||
164465275|NCT05671653|594075863|FG011|Cohort 2 Period 2|Pregnancy|0|||
164465276|NCT05671653|594075864|FG012|Cohort 2 Period 2|Pregnancy|0|||
164465277|NCT05671653|594075852|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
164465278|NCT05671653|594075853|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
164465279|NCT05671653|594075854|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
164465280|NCT05671653|594075855|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
164465281|NCT05671653|594075856|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
164465282|NCT05671653|594075857|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
164465283|NCT05671653|594075858|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
164465284|NCT05671653|594075859|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
164465285|NCT05671653|594075860|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
164465286|NCT05671653|594075861|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
164465287|NCT05671653|594075862|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
164465288|NCT05671653|594075863|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
164465289|NCT05671653|594075864|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
164465290|NCT05671653|594075852|FG000|Cohort 2 Period 2|Other|0|||
164465291|NCT05671653|594075853|FG001|Cohort 2 Period 2|Other|0|||
164465292|NCT05671653|594075854|FG002|Cohort 2 Period 2|Other|0|||
164465293|NCT05671653|594075855|FG003|Cohort 2 Period 2|Other|0|||
164465294|NCT05671653|594075856|FG004|Cohort 2 Period 2|Other|0|||
164465295|NCT05671653|594075857|FG005|Cohort 2 Period 2|Other|0|||
164465296|NCT05671653|594075858|FG006|Cohort 2 Period 2|Other|0|||
164465297|NCT05671653|594075859|FG007|Cohort 2 Period 2|Other|0|||
164465298|NCT05671653|594075860|FG008|Cohort 2 Period 2|Other|0|||
164465299|NCT05671653|594075861|FG009|Cohort 2 Period 2|Other|0|||
164465300|NCT05671653|594075862|FG010|Cohort 2 Period 2|Other|1|||
164465301|NCT05671653|594075863|FG011|Cohort 2 Period 2|Other|0|||
164465302|NCT05671653|594075864|FG012|Cohort 2 Period 2|Other|0|||
164465303|NCT05671653|594075852|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
164465304|NCT05671653|594075853|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
164465305|NCT05671653|594075854|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
164465306|NCT05671653|594075855|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
164465307|NCT05671653|594075856|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
164465308|NCT05671653|594075857|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
164465309|NCT05671653|594075858|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
164465310|NCT05671653|594075859|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
164465311|NCT05671653|594075860|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
164465312|NCT05671653|594075861|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
164465313|NCT05671653|594075862|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
164465314|NCT05671653|594075863|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
164465315|NCT05671653|594075864|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
164465316|NCT01197378|594075868|FG000|Overall Study|Adverse Event|3|||
164465317|NCT01197378|594075868|FG000|Overall Study|Withdrawal by Subject|1|||
164465318|NCT01197378|594075868|FG000|Overall Study|Physician Decision|1|||
164465319|NCT01197378|594075868|FG000|Overall Study|Other|2|||
164465320|NCT05299723|594075875|FG000|Overall Study|Withdrawal by Subject|0|||
164465321|NCT05299723|594075876|FG001|Overall Study|Withdrawal by Subject|2|||
164465322|NCT05299723|594075877|FG002|Overall Study|Withdrawal by Subject|0|||
164465323|NCT01959607|594075878|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
164465324|NCT01959607|594075879|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
164465325|NCT01959607|594075880|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
164465326|NCT01959607|594075881|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
164465327|NCT03913442|594075882|FG000|Overall Study|Adverse Event|0|||
164465328|NCT03913442|594075883|FG001|Overall Study|Adverse Event|3|||
164465329|NCT03913442|594075882|FG000|Overall Study|Withdrawal by Subject|5|||
164465330|NCT03913442|594075883|FG001|Overall Study|Withdrawal by Subject|5|||
164465331|NCT03913442|594075882|FG000|Overall Study|Terminations|2|||
164465332|NCT03913442|594075883|FG001|Overall Study|Terminations|1|||
164465333|NCT03913442|594075882|FG000|Overall Study|Lost to Follow-up|2|||
164465334|NCT03913442|594075883|FG001|Overall Study|Lost to Follow-up|2|||
164465335|NCT02460458|594075884|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
164465336|NCT02460458|594075884|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
164465337|NCT02460458|594075884|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
164465338|NCT02460458|594075884|FG000|First Prospective Phase|Lost to Follow-up|84|||
164465339|NCT02460458|594075884|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
164465340|NCT00696111|594075885|FG000|Overall Study|Withdrawal by Subject|17|||
164465341|NCT03710603|594075889|FG000|Overall Study|Adverse Event|1|||
164465342|NCT03710603|594075890|FG001|Overall Study|Adverse Event|0|||
164465343|NCT03710603|594075889|FG000|Overall Study|Death|44|||
164465344|NCT03710603|594075890|FG001|Overall Study|Death|34|||
164465345|NCT03710603|594075889|FG000|Overall Study|Lost to Follow-up|3|||
164465346|NCT03710603|594075890|FG001|Overall Study|Lost to Follow-up|5|||
164465347|NCT03710603|594075889|FG000|Overall Study|Withdrawal by Subject|11|||
164465348|NCT03710603|594075890|FG001|Overall Study|Withdrawal by Subject|10|||
164465349|NCT02589795|594075900|FG000|Overall Study|Lost to Follow-up|1|||
164465350|NCT02589795|594075901|FG001|Overall Study|Lost to Follow-up|0|||
164465351|NCT02589795|594075902|FG002|Overall Study|Lost to Follow-up|0|||
164465352|NCT02589795|594075900|FG000|Overall Study|Withdrawal by Subject|0|||
164465353|NCT02589795|594075901|FG001|Overall Study|Withdrawal by Subject|0|||
164465354|NCT02589795|594075902|FG002|Overall Study|Withdrawal by Subject|2|||
164465355|NCT02589795|594075900|FG000|Overall Study|Protocol Violation|0|||
164465356|NCT02589795|594075901|FG001|Overall Study|Protocol Violation|0|||
164465357|NCT02589795|594075902|FG002|Overall Study|Protocol Violation|1|||
164465358|NCT03687086|594075904|FG000|Overall Study|Withdrawal by Subject|3|||
164465359|NCT03687086|594075905|FG001|Overall Study|Withdrawal by Subject|4|||
164465360|NCT03687086|594075904|FG000|Overall Study|Lost to Follow-up|1|||
164465361|NCT03687086|594075905|FG001|Overall Study|Lost to Follow-up|1|||
164465362|NCT03687086|594075904|FG000|Overall Study|Death|1|||
164465363|NCT03687086|594075905|FG001|Overall Study|Death|0|||
164465364|NCT03687086|594075904|FG000|Overall Study|Incomplete assessment|0|||
164465365|NCT03687086|594075905|FG001|Overall Study|Incomplete assessment|2|||
164465366|NCT03691935|594075906|FG000|Overall Study|Physician Decision|2|||
164465367|NCT03691935|594075907|FG001|Overall Study|Physician Decision|1|||
164465368|NCT03691935|594075906|FG000|Overall Study|Adverse Event|3|||
164465369|NCT03691935|594075907|FG001|Overall Study|Adverse Event|0|||
164465370|NCT03478956|594075913|FG000|Randomized Treatment Period|Adverse Event|1|||
164465371|NCT03478956|594075914|FG001|Randomized Treatment Period|Adverse Event|0|||
164465372|NCT03478956|594075915|FG002|Randomized Treatment Period|Adverse Event|0|||
164465373|NCT03478956|594075916|FG003|Randomized Treatment Period|Adverse Event|0|||
164465374|NCT03478956|594075913|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
164465375|NCT03478956|594075914|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
164465376|NCT03478956|594075915|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
164465377|NCT03478956|594075916|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
164465378|NCT03478956|594075913|FG000|Open Label Extension Period|Adverse Event|0|||
164465379|NCT03478956|594075914|FG001|Open Label Extension Period|Adverse Event|0|||
164465380|NCT03478956|594075915|FG002|Open Label Extension Period|Adverse Event|4|||
164465381|NCT03478956|594075916|FG003|Open Label Extension Period|Adverse Event|0|||
164465382|NCT03478956|594075913|FG000|Open Label Extension Period|Lack of Efficacy|0|||
164465383|NCT03478956|594075914|FG001|Open Label Extension Period|Lack of Efficacy|0|||
164465384|NCT03478956|594075915|FG002|Open Label Extension Period|Lack of Efficacy|8|||
164465385|NCT03478956|594075916|FG003|Open Label Extension Period|Lack of Efficacy|0|||
164465386|NCT03478956|594075913|FG000|Open Label Extension Period|Reason Not Provided|0|||
164465387|NCT03478956|594075914|FG001|Open Label Extension Period|Reason Not Provided|0|||
164465388|NCT03478956|594075915|FG002|Open Label Extension Period|Reason Not Provided|1|||
164710328|NCT00128830|594962903|FG000|Overall Study|Adverse Event|10|||
164465389|NCT03478956|594075916|FG003|Open Label Extension Period|Reason Not Provided|0|||
164465390|NCT03478956|594075913|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
164465391|NCT03478956|594075914|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
164465392|NCT03478956|594075915|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
164465393|NCT03478956|594075916|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
164465394|NCT03478956|594075913|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
164465395|NCT03478956|594075914|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
164465396|NCT03478956|594075915|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
164465397|NCT03478956|594075916|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
164465398|NCT03478956|594075913|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
164465399|NCT03478956|594075914|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
164465400|NCT03478956|594075915|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
164465401|NCT03478956|594075916|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
164465402|NCT04730739|594075917|FG000|Overall Study|Death|1|||
164465403|NCT02733159|594075921|FG000|Overall Study|Adverse Event|1|||
164465404|NCT02733159|594075921|FG000|Overall Study|Lack of disease progression|1|||
164465405|NCT05646355|594075928|FG000|Overall Study|Lost to Follow-up|1|||
164465406|NCT05646355|594075929|FG001|Overall Study|Lost to Follow-up|0|||
164465407|NCT05646355|594075928|FG000|Overall Study|translated materials not available for pilot|2|||
164465408|NCT05646355|594075929|FG001|Overall Study|translated materials not available for pilot|0|||
164465409|NCT05646355|594075928|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
164465410|NCT05646355|594075929|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
164465411|NCT03362476|594075930|FG000|Overall Study|Withdrawal by Subject|0|||
164465412|NCT03362476|594075931|FG001|Overall Study|Withdrawal by Subject|1|||
164465413|NCT05216406|594075932|FG000|Overall Study|Lost to Follow-up|8|||
164465414|NCT05216406|594075933|FG001|Overall Study|Lost to Follow-up|9|||
164465415|NCT04270942|594075936|FG000|Overall Study|Death|1|||
164465416|NCT03625115|594075938|FG000|Overall Study|Withdrawal by Subject|4|||
164465417|NCT03625115|594075939|FG001|Overall Study|Withdrawal by Subject|7|||
164465418|NCT03625115|594075938|FG000|Overall Study|Lost to Follow-up|17|||
164465419|NCT03625115|594075939|FG001|Overall Study|Lost to Follow-up|24|||
164465420|NCT04797195|594075940|FG000|Overall Study|Death|8|||
164465421|NCT04797195|594075941|FG001|Overall Study|Death|15|||
164465422|NCT04797195|594075940|FG000|Overall Study|Change from PD|15|||
164465423|NCT04797195|594075941|FG001|Overall Study|Change from PD|15|||
164465424|NCT04797195|594075940|FG000|Overall Study|Withdrawal by Subject|3|||
164465425|NCT04797195|594075941|FG001|Overall Study|Withdrawal by Subject|2|||
164465426|NCT05868382|594075942|FG000|Overall Study|Lost to Follow-up|5|||
164465427|NCT05868382|594075943|FG001|Overall Study|Lost to Follow-up|0|||
164465428|NCT05868382|594075944|FG002|Overall Study|Lost to Follow-up|6|||
164465429|NCT05868382|594075945|FG003|Overall Study|Lost to Follow-up|4|||
164465430|NCT05868382|594075946|FG004|Overall Study|Lost to Follow-up|2|||
164465431|NCT05868382|594075947|FG005|Overall Study|Lost to Follow-up|6|||
164465432|NCT05868382|594075942|FG000|Overall Study|Withdrawal by Subject|1|||
164465433|NCT05868382|594075943|FG001|Overall Study|Withdrawal by Subject|0|||
164465434|NCT05868382|594075944|FG002|Overall Study|Withdrawal by Subject|0|||
164465435|NCT05868382|594075945|FG003|Overall Study|Withdrawal by Subject|0|||
164465436|NCT05868382|594075946|FG004|Overall Study|Withdrawal by Subject|1|||
164465437|NCT05868382|594075947|FG005|Overall Study|Withdrawal by Subject|0|||
164465438|NCT03655028|594075948|FG000|12-weeks Follow up|Death|1|||
164465439|NCT03655028|594075949|FG001|12-weeks Follow up|Death|0|||
164465440|NCT03655028|594075948|FG000|12-weeks Follow up|Physician Decision|3|||
164465441|NCT03655028|594075949|FG001|12-weeks Follow up|Physician Decision|3|||
164465442|NCT03655028|594075948|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
164465443|NCT03655028|594075949|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
164465444|NCT03655028|594075948|FG000|12-weeks Follow up|Lost to Follow-up|4|||
164465445|NCT03655028|594075949|FG001|12-weeks Follow up|Lost to Follow-up|4|||
164465446|NCT03655028|594075948|FG000|24-weeks|Lost to Follow-up|1|||
164465447|NCT03655028|594075949|FG001|24-weeks|Lost to Follow-up|1|||
164465448|NCT03655028|594075948|FG000|24-weeks|Death|0|||
164465449|NCT03655028|594075949|FG001|24-weeks|Death|1|||
164465450|NCT03513302|594075950|FG000|First Intervention (14 Days)|Screen failure|15|||
164465451|NCT03513302|594075951|FG001|First Intervention (14 Days)|Screen failure|16|||
164465452|NCT01236781|594075952|FG000|Overall Study|Ineligible|2|||
164465453|NCT01236781|594075953|FG001|Overall Study|Ineligible|1|||
164465454|NCT01236781|594075952|FG000|Overall Study|Did not complete study imaging|5|||
164465455|NCT01236781|594075953|FG001|Overall Study|Did not complete study imaging|0|||
164465456|NCT04577963|594075954|FG000|Part 2|Death|0|||
164465457|NCT04577963|594075955|FG001|Part 2|Death|1|||
164465458|NCT04577963|594075956|FG002|Part 2|Death|8|||
164465459|NCT04577963|594075957|FG003|Part 2|Death|0|||
164465460|NCT04577963|594075958|FG004|Part 2|Death|20|||
164465461|NCT04577963|594075954|FG000|Part 2|Lost to Follow-up|0|||
164465462|NCT04577963|594075955|FG001|Part 2|Lost to Follow-up|0|||
164465463|NCT04577963|594075956|FG002|Part 2|Lost to Follow-up|0|||
164465464|NCT04577963|594075957|FG003|Part 2|Lost to Follow-up|0|||
164465465|NCT04577963|594075958|FG004|Part 2|Lost to Follow-up|2|||
164465466|NCT04577963|594075954|FG000|Part 2|Withdrawal by Subject|0|||
164465467|NCT04577963|594075955|FG001|Part 2|Withdrawal by Subject|0|||
164465468|NCT04577963|594075956|FG002|Part 2|Withdrawal by Subject|0|||
164465469|NCT04577963|594075957|FG003|Part 2|Withdrawal by Subject|0|||
164465470|NCT04577963|594075958|FG004|Part 2|Withdrawal by Subject|10|||
164465471|NCT04577963|594075954|FG000|Part 2|Progressive disease|0|||
164465472|NCT04577963|594075955|FG001|Part 2|Progressive disease|0|||
164465473|NCT04577963|594075956|FG002|Part 2|Progressive disease|0|||
164465474|NCT04577963|594075957|FG003|Part 2|Progressive disease|0|||
164465475|NCT04577963|594075958|FG004|Part 2|Progressive disease|2|||
164465476|NCT04577963|594075954|FG000|Part 2|Investigator decision|0|||
164465477|NCT04577963|594075955|FG001|Part 2|Investigator decision|0|||
164599493|NCT04191577|594554881|FG001|Overall Study|Withdrawal by Subject|2|||
164599494|NCT04191577|594554882|FG002|Overall Study|Withdrawal by Subject|1|||
164599495|NCT04191577|594554880|FG000|Overall Study|Physician Decision|1|||
164710329|NCT00128830|594962903|FG000|Overall Study|Withdrawal by Subject|14|||
164710330|NCT00128830|594962903|FG000|Overall Study|Lost to Follow-up|4|||
164710331|NCT00128830|594962903|FG000|Overall Study|Reached a virologic endpoint|29|||
164710332|NCT00128830|594962903|FG000|Overall Study|Non-compliant|4|||
164710333|NCT00128830|594962903|FG000|Overall Study|Discontinued or ineligible for study|2|||
164414708|NCT02960763|593889858|FG000|Step 2|Withdrawal by Subject|0|||
164414709|NCT02960763|593889859|FG001|Step 2|Withdrawal by Subject|0|||
164414710|NCT02960763|593889860|FG002|Step 2|Withdrawal by Subject|0|||
164414711|NCT02960763|593889861|FG003|Step 2|Withdrawal by Subject|7|||
164414712|NCT02960763|593889862|FG004|Step 2|Withdrawal by Subject|3|||
164414713|NCT02960763|593889858|FG000|Step 2|Lost to Follow-up|0|||
164414714|NCT02960763|593889859|FG001|Step 2|Lost to Follow-up|0|||
164414715|NCT02960763|593889860|FG002|Step 2|Lost to Follow-up|0|||
164414716|NCT02960763|593889861|FG003|Step 2|Lost to Follow-up|4|||
164414717|NCT02960763|593889862|FG004|Step 2|Lost to Follow-up|1|||
164414718|NCT02960763|593889858|FG000|Step 2|Investigator discretion|0|||
164414719|NCT02960763|593889859|FG001|Step 2|Investigator discretion|0|||
164599496|NCT04191577|594554881|FG001|Overall Study|Physician Decision|1|||
164599497|NCT04191577|594554882|FG002|Overall Study|Physician Decision|0|||
164599498|NCT04191577|594554880|FG000|Overall Study|Adverse Event|0|||
164599499|NCT04191577|594554881|FG001|Overall Study|Adverse Event|0|||
164599500|NCT04191577|594554882|FG002|Overall Study|Adverse Event|1|||
164599501|NCT04191577|594554880|FG000|Overall Study|Death|0|||
164710334|NCT00128830|594962903|FG000|Overall Study|Other|9|||
164414720|NCT02960763|593889860|FG002|Step 2|Investigator discretion|0|||
164414721|NCT02960763|593889861|FG003|Step 2|Investigator discretion|0|||
164414722|NCT02960763|593889862|FG004|Step 2|Investigator discretion|1|||
164414723|NCT01017120|593889863|FG000|Overall Study|Adverse Event|9|||
164414724|NCT01017120|593889864|FG001|Overall Study|Adverse Event|0|||
164414725|NCT01017120|593889863|FG000|Overall Study|Lost to Follow-up|13|||
164414726|NCT01017120|593889864|FG001|Overall Study|Lost to Follow-up|11|||
164414727|NCT01017120|593889863|FG000|Overall Study|Lack of Efficacy|1|||
164414728|NCT01017120|593889864|FG001|Overall Study|Lack of Efficacy|0|||
164414729|NCT01017120|593889863|FG000|Overall Study|Withdrawal by Subject|39|||
164414730|NCT01017120|593889864|FG001|Overall Study|Withdrawal by Subject|21|||
164414731|NCT01017120|593889863|FG000|Overall Study|Pregnancy|1|||
164414732|NCT01017120|593889864|FG001|Overall Study|Pregnancy|1|||
164414733|NCT01017120|593889863|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
164414734|NCT01017120|593889864|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
164414735|NCT01017120|593889863|FG000|Overall Study|Relocated Out of Town|0|||
164414736|NCT01017120|593889864|FG001|Overall Study|Relocated Out of Town|2|||
164414737|NCT01017120|593889863|FG000|Overall Study|Protocol Violation|1|||
164414738|NCT01017120|593889864|FG001|Overall Study|Protocol Violation|0|||
164414739|NCT01017120|593889863|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
164414740|NCT01017120|593889864|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
164414741|NCT05340751|593889865|FG000|Overall Study|Physician Decision|3|||
164414742|NCT01014975|593889878|FG000|Overall Study|Withdrawal by Subject|1|||
164414743|NCT01014975|593889879|FG001|Overall Study|Withdrawal by Subject|0|||
164414744|NCT01014975|593889880|FG002|Overall Study|Withdrawal by Subject|1|||
164414745|NCT01014975|593889878|FG000|Overall Study|Death|3|||
164414746|NCT01014975|593889879|FG001|Overall Study|Death|3|||
164414747|NCT01014975|593889880|FG002|Overall Study|Death|4|||
164414748|NCT01014975|593889878|FG000|Overall Study|Lost to Follow-up|0|||
164414749|NCT01014975|593889879|FG001|Overall Study|Lost to Follow-up|0|||
164414750|NCT01014975|593889880|FG002|Overall Study|Lost to Follow-up|1|||
164414751|NCT01642602|593889881|FG000|Overall Study|Adverse Event|2|||
164414752|NCT01112514|593889882|FG000|Overall Study|Lost to Follow-up|1|||
164414753|NCT01024959|593889883|FG000|Overall Study|ineligible|12|||
164414754|NCT01024959|593889883|FG000|Overall Study|results not evaluable|12|||
164414755|NCT01024959|593889883|FG000|Overall Study|missing results required for analysis|17|||
164414756|NCT02961881|593889884|FG000|Overall Study|Adverse Event|1|||
164465478|NCT04577963|594075956|FG002|Part 2|Investigator decision|0|||
164465479|NCT04577963|594075957|FG003|Part 2|Investigator decision|0|||
164465480|NCT04577963|594075958|FG004|Part 2|Investigator decision|1|||
164465481|NCT04577963|594075954|FG000|Part 2|Sponsor terminated study|0|||
164414757|NCT02961881|593889885|FG001|Overall Study|Adverse Event|2|||
164465482|NCT04577963|594075955|FG001|Part 2|Sponsor terminated study|0|||
164465483|NCT04577963|594075956|FG002|Part 2|Sponsor terminated study|3|||
164465484|NCT04577963|594075957|FG003|Part 2|Sponsor terminated study|1|||
164465485|NCT04577963|594075958|FG004|Part 2|Sponsor terminated study|4|||
164465486|NCT05256654|594075959|FG000|Overall Study|Adverse Event|0|||
164465487|NCT05256654|594075960|FG001|Overall Study|Adverse Event|0|||
164465488|NCT05256654|594075961|FG002|Overall Study|Adverse Event|1|||
164465489|NCT05256654|594075962|FG003|Overall Study|Adverse Event|0|||
164465490|NCT05256654|594075959|FG000|Overall Study|Lost to Follow-up|0|||
164465491|NCT05256654|594075960|FG001|Overall Study|Lost to Follow-up|0|||
164465492|NCT05256654|594075961|FG002|Overall Study|Lost to Follow-up|0|||
164465493|NCT05256654|594075962|FG003|Overall Study|Lost to Follow-up|1|||
164465494|NCT05256654|594075959|FG000|Overall Study|Withdrawal by Subject|1|||
164465495|NCT05256654|594075960|FG001|Overall Study|Withdrawal by Subject|2|||
164465496|NCT05256654|594075961|FG002|Overall Study|Withdrawal by Subject|1|||
164465497|NCT05256654|594075962|FG003|Overall Study|Withdrawal by Subject|3|||
164465498|NCT05256654|594075959|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
164465499|NCT05256654|594075960|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
164465500|NCT05256654|594075961|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
164465501|NCT05256654|594075962|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
164465502|NCT05256654|594075959|FG000|Overall Study|Other|0|||
164465503|NCT05256654|594075960|FG001|Overall Study|Other|0|||
164465504|NCT05256654|594075961|FG002|Overall Study|Other|0|||
164465505|NCT05256654|594075962|FG003|Overall Study|Other|1|||
164465506|NCT02709161|594075967|FG000|Overall Study|Withdrawal by Subject|1|||
164465507|NCT02709161|594075968|FG001|Overall Study|Withdrawal by Subject|0|||
164465508|NCT04862416|594075974|FG000|Overall Study|Withdrawal by Subject|0|||
164465509|NCT04862416|594075975|FG001|Overall Study|Withdrawal by Subject|1|||
164465510|NCT04862416|594075976|FG002|Overall Study|Withdrawal by Subject|0|||
164465511|NCT04862416|594075977|FG003|Overall Study|Withdrawal by Subject|1|||
164465512|NCT04862416|594075978|FG004|Overall Study|Withdrawal by Subject|0|||
164465513|NCT04862416|594075979|FG005|Overall Study|Withdrawal by Subject|0|||
164465514|NCT04862416|594075980|FG006|Overall Study|Withdrawal by Subject|0|||
164465515|NCT04862416|594075981|FG007|Overall Study|Withdrawal by Subject|0|||
164465516|NCT04059185|594075984|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
164465517|NCT04059185|594075985|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
164465518|NCT04059185|594075986|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
164465519|NCT04059185|594075984|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
164465520|NCT04059185|594075985|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
164465521|NCT04059185|594075986|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
164465522|NCT04059185|594075984|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
164465523|NCT04059185|594075985|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
164465524|NCT04059185|594075986|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
164465525|NCT04059185|594075984|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
164465526|NCT04059185|594075985|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
164414758|NCT02961881|593889886|FG002|Overall Study|Adverse Event|2|||
164414759|NCT02961881|593889887|FG003|Overall Study|Adverse Event|0|||
164414760|NCT02961881|593889888|FG004|Overall Study|Adverse Event|1|||
164414761|NCT02961881|593889884|FG000|Overall Study|Participant request|0|||
164414762|NCT02961881|593889885|FG001|Overall Study|Participant request|2|||
164414763|NCT02961881|593889886|FG002|Overall Study|Participant request|0|||
164414764|NCT02961881|593889887|FG003|Overall Study|Participant request|0|||
164414765|NCT02961881|593889888|FG004|Overall Study|Participant request|0|||
164414766|NCT02961881|593889884|FG000|Overall Study|Disease progression|1|||
164414767|NCT02961881|593889885|FG001|Overall Study|Disease progression|0|||
164414768|NCT02961881|593889886|FG002|Overall Study|Disease progression|1|||
164414769|NCT02961881|593889887|FG003|Overall Study|Disease progression|0|||
164414770|NCT02961881|593889888|FG004|Overall Study|Disease progression|0|||
164414771|NCT00636792|593889893|FG000|Overall Study|Adverse Event|16|||
164414772|NCT00636792|593889893|FG000|Overall Study|Physician Decision|7|||
164414773|NCT00636792|593889893|FG000|Overall Study|Progressive Disease|4|||
164414774|NCT00636792|593889893|FG000|Overall Study|Withdrawal by Subject|3|||
164414775|NCT00636792|593889893|FG000|Overall Study|Other|3|||
164414776|NCT01928225|593889894|FG000|Overall Study|Pregnancy|1|||
164414777|NCT01928225|593889895|FG001|Overall Study|Pregnancy|0|||
164414778|NCT01928225|593889894|FG000|Overall Study|basaloid cervical cancer|1|||
164414779|NCT01928225|593889895|FG001|Overall Study|basaloid cervical cancer|0|||
164414780|NCT01928225|593889894|FG000|Overall Study|Lost to Follow-up|1|||
164414781|NCT01928225|593889895|FG001|Overall Study|Lost to Follow-up|3|||
164414782|NCT01235975|593889900|FG000|Overall Study|Serious Adverse Event|0|||
164465527|NCT04059185|594075986|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
164465528|NCT04059185|594075984|FG000|Longitudinal Assessment-Adults Only|Death|4|||
164465529|NCT04059185|594075985|FG001|Longitudinal Assessment-Adults Only|Death|4|||
164465530|NCT04059185|594075986|FG002|Longitudinal Assessment-Adults Only|Death|3|||
164710335|NCT00311402|594962904|FG000|Overall Study|Adverse Event|118|||
164465531|NCT01009788|594075996|FG000|Overall Study|Withdrawal by Subject|1|||
164465532|NCT01009788|594075997|FG001|Overall Study|Withdrawal by Subject|0|||
164465533|NCT03257410|594077753|FG000|Overall Study|Adverse Event|2|||
164465534|NCT03257410|594077754|FG001|Overall Study|Adverse Event|3|||
164465535|NCT03257410|594077753|FG000|Overall Study|Protocol Violation|1|||
164465536|NCT03257410|594077754|FG001|Overall Study|Protocol Violation|2|||
164465537|NCT03257410|594077753|FG000|Overall Study|Lost to Follow-up|1|||
164465538|NCT03257410|594077754|FG001|Overall Study|Lost to Follow-up|0|||
164465539|NCT03257410|594077753|FG000|Overall Study|Withdrawal by Subject|1|||
164465540|NCT03257410|594077754|FG001|Overall Study|Withdrawal by Subject|2|||
164465541|NCT03257410|594077753|FG000|Overall Study|Physician Decision|1|||
164465542|NCT03257410|594077754|FG001|Overall Study|Physician Decision|1|||
164465543|NCT03257410|594077753|FG000|Overall Study|Renal transplantation|2|||
164465544|NCT03257410|594077754|FG001|Overall Study|Renal transplantation|0|||
164465545|NCT03257410|594077753|FG000|Overall Study|Switch to peritoneal dialysis|1|||
164465546|NCT03257410|594077754|FG001|Overall Study|Switch to peritoneal dialysis|0|||
164465547|NCT03257410|594077753|FG000|Overall Study|Death|3|||
164465548|NCT03257410|594077754|FG001|Overall Study|Death|2|||
164465549|NCT03257410|594077753|FG000|Overall Study|Change to another dialysis center|2|||
164465550|NCT03257410|594077754|FG001|Overall Study|Change to another dialysis center|2|||
164465551|NCT03257410|594077753|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
164465552|NCT03257410|594077754|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
164465553|NCT03257410|594077753|FG000|Overall Study|Miscellaneous|2|||
164465554|NCT03257410|594077754|FG001|Overall Study|Miscellaneous|2|||
164465555|NCT03257410|594077753|FG000|Overall Study|Other|0|||
164465556|NCT03257410|594077754|FG001|Overall Study|Other|1|||
164465557|NCT02598388|594077755|FG000|Overall Study|Lost to Follow-up|1|||
164465558|NCT02598388|594077756|FG001|Overall Study|Lost to Follow-up|0|||
164465559|NCT02598388|594077757|FG002|Overall Study|Lost to Follow-up|1|||
164465560|NCT02598388|594077758|FG003|Overall Study|Lost to Follow-up|0|||
164465561|NCT02598388|594077759|FG004|Overall Study|Lost to Follow-up|5|||
164465562|NCT02598388|594077760|FG005|Overall Study|Lost to Follow-up|1|||
164465563|NCT02598388|594077761|FG006|Overall Study|Lost to Follow-up|2|||
164465564|NCT02598388|594077762|FG007|Overall Study|Lost to Follow-up|1|||
164465565|NCT02598388|594077763|FG008|Overall Study|Lost to Follow-up|0|||
164465566|NCT02598388|594077764|FG009|Overall Study|Lost to Follow-up|0|||
164465567|NCT02598388|594077765|FG010|Overall Study|Lost to Follow-up|1|||
164465568|NCT02598388|594077766|FG011|Overall Study|Lost to Follow-up|0|||
164465569|NCT02598388|594077755|FG000|Overall Study|Withdrawal by Subject|0|||
164465570|NCT02598388|594077756|FG001|Overall Study|Withdrawal by Subject|0|||
164710336|NCT00311402|594962905|FG001|Overall Study|Adverse Event|105|||
164710337|NCT00311402|594962904|FG000|Overall Study|Lost to Follow-up|0|||
164710338|NCT00311402|594962905|FG001|Overall Study|Lost to Follow-up|3|||
164710339|NCT00311402|594962904|FG000|Overall Study|Withdrawal by Subject|17|||
164710340|NCT00311402|594962905|FG001|Overall Study|Withdrawal by Subject|18|||
164710341|NCT00311402|594962904|FG000|Overall Study|Lack of Efficacy|58|||
164710342|NCT00311402|594962905|FG001|Overall Study|Lack of Efficacy|42|||
164710343|NCT00311402|594962904|FG000|Overall Study|Protocol Violation|7|||
164710344|NCT00311402|594962905|FG001|Overall Study|Protocol Violation|6|||
164710345|NCT00311402|594962904|FG000|Overall Study|IRB's rejection etc.|10|||
164710346|NCT00311402|594962905|FG001|Overall Study|IRB's rejection etc.|3|||
164710347|NCT02640053|594962906|FG000|Overall Study|Withdrawal by Subject|2|||
164710348|NCT02640053|594962907|FG001|Overall Study|Withdrawal by Subject|1|||
164710349|NCT02640053|594962906|FG000|Overall Study|Adverse Event|1|||
164710350|NCT02640053|594962907|FG001|Overall Study|Adverse Event|1|||
164710351|NCT02640053|594962906|FG000|Overall Study|Alternative Therapy|1|||
164710352|NCT02640053|594962907|FG001|Overall Study|Alternative Therapy|1|||
164710353|NCT02640053|594962906|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
164465571|NCT02598388|594077757|FG002|Overall Study|Withdrawal by Subject|0|||
164465572|NCT02598388|594077758|FG003|Overall Study|Withdrawal by Subject|0|||
164465573|NCT02598388|594077759|FG004|Overall Study|Withdrawal by Subject|2|||
164465574|NCT02598388|594077760|FG005|Overall Study|Withdrawal by Subject|0|||
164465575|NCT02598388|594077761|FG006|Overall Study|Withdrawal by Subject|2|||
164465576|NCT02598388|594077762|FG007|Overall Study|Withdrawal by Subject|0|||
164710354|NCT02640053|594962907|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
164710355|NCT02754856|594962909|FG000|Overall Study|Withdrawal by Subject|1|||
164710356|NCT00530218|594962910|FG000|Overall Study|CMV Not Detected|13|||
164710357|NCT00530218|594962910|FG000|Overall Study|Death|12|||
164144815|NCT01524978|592891774|FG000|Overall Study|Death|34|||
164465577|NCT02598388|594077763|FG008|Overall Study|Withdrawal by Subject|0|||
164465578|NCT02598388|594077764|FG009|Overall Study|Withdrawal by Subject|1|||
164465579|NCT02598388|594077765|FG010|Overall Study|Withdrawal by Subject|0|||
164465580|NCT02598388|594077766|FG011|Overall Study|Withdrawal by Subject|0|||
164465581|NCT02598388|594077755|FG000|Overall Study|Other|0|||
164465582|NCT02598388|594077756|FG001|Overall Study|Other|0|||
164465583|NCT02598388|594077757|FG002|Overall Study|Other|1|||
164465584|NCT02598388|594077758|FG003|Overall Study|Other|0|||
164465585|NCT02598388|594077759|FG004|Overall Study|Other|3|||
164414783|NCT01235975|593889901|FG001|Overall Study|Serious Adverse Event|1|||
164414784|NCT01235975|593889900|FG000|Overall Study|Withdrawal by Subject|8|||
164414785|NCT01235975|593889901|FG001|Overall Study|Withdrawal by Subject|2|||
164414786|NCT01235975|593889900|FG000|Overall Study|Migrated/moved from study area|2|||
164414787|NCT01235975|593889901|FG001|Overall Study|Migrated/moved from study area|1|||
164414788|NCT01235975|593889900|FG000|Overall Study|Lost to Follow-up|7|||
164414789|NCT01235975|593889901|FG001|Overall Study|Lost to Follow-up|3|||
164414790|NCT01512745|593889903|FG000|Overall Study|Adverse Event|22|||
164414791|NCT01512745|593889904|FG001|Overall Study|Adverse Event|3|||
164414792|NCT01512745|593889903|FG000|Overall Study|Death|9|||
164414793|NCT01512745|593889904|FG001|Overall Study|Death|13|||
164414794|NCT01512745|593889903|FG000|Overall Study|Withdrawal by Subject|2|||
164414795|NCT01512745|593889904|FG001|Overall Study|Withdrawal by Subject|2|||
164414796|NCT01512745|593889903|FG000|Overall Study|Lost to Follow-up|4|||
164414797|NCT01512745|593889904|FG001|Overall Study|Lost to Follow-up|0|||
164414798|NCT01512745|593889903|FG000|Overall Study|Lack of Efficacy|2|||
164414799|NCT01512745|593889904|FG001|Overall Study|Lack of Efficacy|2|||
164414800|NCT01512745|593889903|FG000|Overall Study|Protocol Violation|1|||
164414801|NCT01512745|593889904|FG001|Overall Study|Protocol Violation|0|||
164414802|NCT00439179|593889905|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
164414803|NCT00439179|593889906|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
164414804|NCT00439179|593889907|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
164414805|NCT00439179|593889908|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
164414806|NCT02761629|593889909|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
164414807|NCT02761629|593889910|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
164414808|NCT02761629|593889909|FG000|Overall Study|Insufficient Therapeutic Response|2|||
164465586|NCT02598388|594077760|FG005|Overall Study|Other|0|||
164465587|NCT02598388|594077761|FG006|Overall Study|Other|1|||
164465588|NCT02598388|594077762|FG007|Overall Study|Other|0|||
164465589|NCT02598388|594077763|FG008|Overall Study|Other|0|||
164465590|NCT02598388|594077764|FG009|Overall Study|Other|0|||
164465591|NCT02598388|594077765|FG010|Overall Study|Other|0|||
164465592|NCT02598388|594077766|FG011|Overall Study|Other|0|||
164465593|NCT03668236|594077769|FG000|90-day Follow-up|Withdrawal by Subject|3|||
164465594|NCT03668236|594077770|FG001|90-day Follow-up|Withdrawal by Subject|2|||
164465595|NCT03668236|594077769|FG000|90-day Follow-up|Lost to Follow-up|3|||
164465596|NCT03668236|594077770|FG001|90-day Follow-up|Lost to Follow-up|1|||
164465597|NCT03668236|594077769|FG000|Baseline Characteristics|Lost to Follow-up|9|||
164465598|NCT03668236|594077770|FG001|Baseline Characteristics|Lost to Follow-up|5|||
164465599|NCT03668236|594077769|FG000|1-year Follow-up|Withdrawal by Subject|17|||
164465600|NCT03668236|594077770|FG001|1-year Follow-up|Withdrawal by Subject|15|||
164465601|NCT06132282|594077771|FG000|Overall Study|Lost to Follow-up|31|||
164465602|NCT03011333|594077774|FG000|Overall Study|Lost to Follow-up|0|||
164465603|NCT03011333|594077775|FG001|Overall Study|Lost to Follow-up|1|||
164465604|NCT03011333|594077776|FG002|Overall Study|Lost to Follow-up|0|||
164465605|NCT03011333|594077777|FG003|Overall Study|Lost to Follow-up|1|||
164465606|NCT03011333|594077778|FG004|Overall Study|Lost to Follow-up|4|||
164465607|NCT03011333|594077779|FG005|Overall Study|Lost to Follow-up|4|||
164465608|NCT03011333|594077780|FG006|Overall Study|Lost to Follow-up|5|||
164465609|NCT04183283|594077781|FG000|Period 1|Withdrawal by Subject|0|||
164465610|NCT04183283|594077782|FG001|Period 1|Withdrawal by Subject|1|||
164465611|NCT04183283|594077783|FG002|Period 1|Withdrawal by Subject|0|||
164465612|NCT04183283|594077784|FG003|Period 1|Withdrawal by Subject|0|||
164465613|NCT04183283|594077781|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
164414809|NCT02761629|593889910|FG001|Overall Study|Insufficient Therapeutic Response|7|||
164414810|NCT02761629|593889909|FG000|Overall Study|Failure to Return|2|||
164414811|NCT02761629|593889910|FG001|Overall Study|Failure to Return|4|||
164414812|NCT02761629|593889909|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
164414813|NCT02761629|593889910|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
164414814|NCT02761629|593889909|FG000|Overall Study|Protocol Violation|2|||
164710358|NCT03477903|594962915|FG000|Overall Study|Study Terminated by Sponsor|1|||
164710359|NCT00407758|594962916|FG000|Overall Study|ineligible -improper prior treatment|1|||
164710360|NCT02980874|594962929|FG000|Overall Study|Adverse Event|2|||
164710361|NCT02980874|594962930|FG001|Overall Study|Adverse Event|7|||
164710362|NCT02980874|594962929|FG000|Overall Study|Withdrawal by Subject|7|||
164710363|NCT02980874|594962930|FG001|Overall Study|Withdrawal by Subject|2|||
164710364|NCT02980874|594962929|FG000|Overall Study|Lost to Follow-up|5|||
164710365|NCT02980874|594962930|FG001|Overall Study|Lost to Follow-up|5|||
164710366|NCT02980874|594962929|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
164710367|NCT02980874|594962930|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
164710368|NCT02980874|594962929|FG000|Overall Study|Unknown study completion status|1|||
164710369|NCT02980874|594962930|FG001|Overall Study|Unknown study completion status|0|||
164710370|NCT00513682|594962931|FG000|Washout Phase|Adverse Event|2|||
164710371|NCT02450526|594962932|FG000|DB Period (Cycle 1)|Adverse Event|0|||
164710372|NCT02450526|594962933|FG001|DB Period (Cycle 1)|Adverse Event|0|||
164710373|NCT02450526|594962934|FG002|DB Period (Cycle 1)|Adverse Event|2|||
164710374|NCT02450526|594962935|FG003|DB Period (Cycle 1)|Adverse Event|0|||
164710375|NCT02450526|594962936|FG004|DB Period (Cycle 1)|Adverse Event|0|||
164710376|NCT02450526|594962932|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
164710377|NCT02450526|594962933|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
164710378|NCT02450526|594962934|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
164710379|NCT02450526|594962935|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
164710380|NCT02450526|594962936|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
164710381|NCT02450526|594962932|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
164710382|NCT02450526|594962933|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
164710383|NCT02450526|594962934|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
164710384|NCT02450526|594962935|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
164710385|NCT02450526|594962936|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
164710386|NCT02450526|594962932|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
164414815|NCT02761629|593889910|FG001|Overall Study|Protocol Violation|2|||
164414816|NCT02761629|593889909|FG000|Overall Study|Withdrawal by Subject|0|||
164465614|NCT04183283|594077782|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
164465615|NCT04183283|594077783|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
164710387|NCT02450526|594962933|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
164710388|NCT02450526|594962934|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
164710389|NCT02450526|594962935|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
164710390|NCT02450526|594962936|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
164465616|NCT04183283|594077784|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
164465617|NCT00104676|594077789|FG000|Overall Study|Death|3|||
164465618|NCT00104676|594077790|FG001|Overall Study|Death|2|||
164465619|NCT00104676|594077789|FG000|Overall Study|Withdrawal by Subject|0|||
164465620|NCT00104676|594077790|FG001|Overall Study|Withdrawal by Subject|2|||
164465621|NCT00104676|594077789|FG000|Overall Study|treatment interruption|4|||
164465622|NCT00104676|594077790|FG001|Overall Study|treatment interruption|10|||
164465623|NCT05622812|594077791|FG000|Overall Study|Withdrawal by Subject|1|||
164465624|NCT05622812|594077792|FG001|Overall Study|Withdrawal by Subject|4|||
164465625|NCT05622812|594077791|FG000|Overall Study|Lost to Follow-up|2|||
164465626|NCT05622812|594077792|FG001|Overall Study|Lost to Follow-up|1|||
164465627|NCT04362254|594077793|FG000|Overall Study|Adverse Event|1|||
164465628|NCT04362254|594077793|FG000|Overall Study|Protocol Violation|1|||
164465629|NCT04362254|594077793|FG000|Overall Study|Due to early termination of the trial|10|||
164465630|NCT04707625|594077794|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
164465631|NCT00321048|594077795|FG000|Overall Study|Withdrawal by Subject|6|||
164465632|NCT00321048|594077796|FG001|Overall Study|Withdrawal by Subject|8|||
164465633|NCT03676192|594077797|FG000|Induction Study Period|Adverse Event|21|||
164465634|NCT03676192|594077798|FG001|Induction Study Period|Adverse Event|20|||
164465635|NCT03676192|594077797|FG000|Induction Study Period|Death|23|||
164465636|NCT03676192|594077798|FG001|Induction Study Period|Death|20|||
164465637|NCT03676192|594077797|FG000|Induction Study Period|Lost to Follow-up|3|||
164465638|NCT03676192|594077798|FG001|Induction Study Period|Lost to Follow-up|3|||
164465639|NCT03676192|594077797|FG000|Induction Study Period|Physician Decision|6|||
164465640|NCT03676192|594077798|FG001|Induction Study Period|Physician Decision|3|||
164465641|NCT03676192|594077797|FG000|Induction Study Period|Progressive Disease|32|||
164465642|NCT03676192|594077798|FG001|Induction Study Period|Progressive Disease|21|||
164465643|NCT03676192|594077797|FG000|Induction Study Period|Protocol Violation|1|||
164465644|NCT03676192|594077798|FG001|Induction Study Period|Protocol Violation|2|||
164465645|NCT03676192|594077797|FG000|Induction Study Period|Withdrawal by Subject|20|||
164465646|NCT03676192|594077798|FG001|Induction Study Period|Withdrawal by Subject|15|||
164465647|NCT03386578|594077799|FG000|PK Component|Lost to Follow-up|0|||
164465648|NCT03386578|594077800|FG001|PK Component|Lost to Follow-up|1|||
164465649|NCT03386578|594077801|FG002|PK Component|Lost to Follow-up|0|||
164465650|NCT03386578|594077802|FG003|PK Component|Lost to Follow-up|0|||
164465651|NCT03386578|594077803|FG004|PK Component|Lost to Follow-up|0|||
164465652|NCT03386578|594077804|FG005|PK Component|Lost to Follow-up|0|||
164465653|NCT03386578|594077805|FG006|PK Component|Lost to Follow-up|1|||
164465654|NCT03386578|594077806|FG007|PK Component|Lost to Follow-up|0|||
164465655|NCT03386578|594077807|FG008|PK Component|Lost to Follow-up|0|||
164465656|NCT03386578|594077808|FG009|PK Component|Lost to Follow-up|0|||
164465657|NCT03386578|594077799|FG000|PK Component|Stillbirth/Abortion|0|||
164465658|NCT03386578|594077800|FG001|PK Component|Stillbirth/Abortion|0|||
164465659|NCT03386578|594077801|FG002|PK Component|Stillbirth/Abortion|0|||
164465660|NCT03386578|594077802|FG003|PK Component|Stillbirth/Abortion|0|||
164465661|NCT03386578|594077803|FG004|PK Component|Stillbirth/Abortion|0|||
164465662|NCT03386578|594077804|FG005|PK Component|Stillbirth/Abortion|2|||
164465663|NCT03386578|594077805|FG006|PK Component|Stillbirth/Abortion|0|||
164465664|NCT03386578|594077806|FG007|PK Component|Stillbirth/Abortion|0|||
164465665|NCT03386578|594077807|FG008|PK Component|Stillbirth/Abortion|0|||
164465666|NCT03386578|594077808|FG009|PK Component|Stillbirth/Abortion|0|||
164465667|NCT03386578|594077799|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
164465668|NCT03386578|594077800|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
164465669|NCT03386578|594077801|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
164465670|NCT03386578|594077802|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
164465671|NCT03386578|594077803|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
164465672|NCT03386578|594077804|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
164465673|NCT03386578|594077805|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
164465674|NCT03386578|594077806|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
164465675|NCT03386578|594077807|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
164465676|NCT03386578|594077808|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
164465677|NCT03386578|594077799|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
164465678|NCT03386578|594077800|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
164465679|NCT03386578|594077801|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
164465680|NCT03386578|594077802|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
164465681|NCT03386578|594077803|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
164465682|NCT03386578|594077804|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
164465683|NCT03386578|594077805|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
164465684|NCT03386578|594077806|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
164599502|NCT04191577|594554881|FG001|Overall Study|Death|0|||
164465685|NCT03386578|594077807|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
164465686|NCT03386578|594077808|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
164465687|NCT03386578|594077799|FG000|PrEP Comparison Component Step 1|Death|0|||
164465688|NCT03386578|594077800|FG001|PrEP Comparison Component Step 1|Death|0|||
164465689|NCT03386578|594077801|FG002|PrEP Comparison Component Step 1|Death|1|||
164465690|NCT03386578|594077802|FG003|PrEP Comparison Component Step 1|Death|0|||
164465691|NCT03386578|594077803|FG004|PrEP Comparison Component Step 1|Death|0|||
164465692|NCT03386578|594077804|FG005|PrEP Comparison Component Step 1|Death|0|||
164599503|NCT04191577|594554882|FG002|Overall Study|Death|1|||
164465693|NCT03386578|594077805|FG006|PrEP Comparison Component Step 1|Death|0|||
164465694|NCT03386578|594077806|FG007|PrEP Comparison Component Step 1|Death|9|||
164465695|NCT03386578|594077807|FG008|PrEP Comparison Component Step 1|Death|5|||
164465696|NCT03386578|594077808|FG009|PrEP Comparison Component Step 1|Death|0|||
164465697|NCT03386578|594077799|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
164465698|NCT03386578|594077800|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
164465699|NCT03386578|594077801|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
164465700|NCT03386578|594077802|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
164465701|NCT03386578|594077803|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
164465702|NCT03386578|594077804|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
164465703|NCT03386578|594077805|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
164465704|NCT03386578|594077806|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
164465705|NCT03386578|594077807|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
164465706|NCT03386578|594077808|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
164465707|NCT03386578|594077799|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
164465708|NCT03386578|594077800|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
164465709|NCT03386578|594077801|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
164465710|NCT03386578|594077802|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
164465711|NCT03386578|594077803|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
164465712|NCT03386578|594077804|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
164465713|NCT03386578|594077805|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
164465714|NCT03386578|594077806|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
164465715|NCT03386578|594077807|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
164465716|NCT03386578|594077808|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
164465717|NCT03386578|594077799|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
164465718|NCT03386578|594077800|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
164465719|NCT03386578|594077801|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
164465720|NCT03386578|594077802|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
164465721|NCT03386578|594077803|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
164465722|NCT03386578|594077804|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
164465723|NCT03386578|594077805|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
164465724|NCT03386578|594077806|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
164465725|NCT03386578|594077807|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
164465726|NCT03386578|594077808|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
164465727|NCT02424617|594077811|FG000|Overall Study|Adverse Event|0|||
164465728|NCT02424617|594077812|FG001|Overall Study|Adverse Event|1|||
164465729|NCT02424617|594077813|FG002|Overall Study|Adverse Event|0|||
164465730|NCT02424617|594077814|FG003|Overall Study|Adverse Event|0|||
164465731|NCT02424617|594077811|FG000|Overall Study|Investigator Decision|0|||
164465732|NCT02424617|594077812|FG001|Overall Study|Investigator Decision|0|||
164465733|NCT02424617|594077813|FG002|Overall Study|Investigator Decision|0|||
164465734|NCT02424617|594077814|FG003|Overall Study|Investigator Decision|1|||
164465735|NCT02424617|594077811|FG000|Overall Study|Withdrawal by Subject|1|||
164465736|NCT02424617|594077812|FG001|Overall Study|Withdrawal by Subject|1|||
164465737|NCT02424617|594077813|FG002|Overall Study|Withdrawal by Subject|0|||
164465738|NCT02424617|594077814|FG003|Overall Study|Withdrawal by Subject|1|||
164465739|NCT02424617|594077811|FG000|Overall Study|Progressive Disease|7|||
164465740|NCT02424617|594077812|FG001|Overall Study|Progressive Disease|6|||
164465741|NCT02424617|594077813|FG002|Overall Study|Progressive Disease|11|||
164465742|NCT02424617|594077814|FG003|Overall Study|Progressive Disease|10|||
164465743|NCT02424617|594077811|FG000|Overall Study|Other|0|||
164465744|NCT02424617|594077812|FG001|Overall Study|Other|0|||
164465745|NCT02424617|594077813|FG002|Overall Study|Other|0|||
164465746|NCT02424617|594077814|FG003|Overall Study|Other|1|||
164465747|NCT04778397|594077819|FG000|Overall Study|Death|59|||
164465748|NCT04778397|594077820|FG001|Overall Study|Death|54|||
164465749|NCT04778397|594077821|FG002|Overall Study|Death|11|||
164465750|NCT04778397|594077822|FG003|Overall Study|Death|9|||
164465751|NCT04778397|594077819|FG000|Overall Study|Study Terminated by Sponsor|34|||
164465752|NCT04778397|594077820|FG001|Overall Study|Study Terminated by Sponsor|42|||
164710391|NCT02450526|594962932|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
164710392|NCT02450526|594962933|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
164710393|NCT02450526|594962934|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
164465753|NCT04778397|594077821|FG002|Overall Study|Study Terminated by Sponsor|15|||
164710394|NCT02450526|594962935|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
164465754|NCT04778397|594077822|FG003|Overall Study|Study Terminated by Sponsor|12|||
164465755|NCT04778397|594077819|FG000|Overall Study|Withdrew Consent|5|||
164465756|NCT04778397|594077820|FG001|Overall Study|Withdrew Consent|4|||
164465757|NCT04778397|594077821|FG002|Overall Study|Withdrew Consent|1|||
164465758|NCT04778397|594077822|FG003|Overall Study|Withdrew Consent|1|||
164465759|NCT04778397|594077819|FG000|Overall Study|Reason Not Specified|1|||
164465760|NCT04778397|594077820|FG001|Overall Study|Reason Not Specified|3|||
164465761|NCT04778397|594077821|FG002|Overall Study|Reason Not Specified|0|||
164465762|NCT04778397|594077822|FG003|Overall Study|Reason Not Specified|2|||
164465763|NCT04778397|594077819|FG000|Overall Study|Lost to Follow-up|2|||
164465764|NCT04778397|594077820|FG001|Overall Study|Lost to Follow-up|1|||
164465765|NCT04778397|594077821|FG002|Overall Study|Lost to Follow-up|0|||
164465766|NCT04778397|594077822|FG003|Overall Study|Lost to Follow-up|1|||
164465767|NCT01627574|594077823|FG000|Overall Study|Withdrawal by Subject|8|||
164465768|NCT01627574|594077824|FG001|Overall Study|Withdrawal by Subject|5|||
164465769|NCT01627574|594077823|FG000|Overall Study|Lost to Follow-up|13|||
164465770|NCT01627574|594077824|FG001|Overall Study|Lost to Follow-up|13|||
164465771|NCT03308877|594077825|FG000|Overall Study|Lost to Follow-up|32|||
164465772|NCT03308877|594077826|FG001|Overall Study|Lost to Follow-up|28|||
164465773|NCT04314778|594077828|FG000|Overall Study|Lost to Follow-up|5|||
164465774|NCT04314778|594077829|FG001|Overall Study|Lost to Follow-up|3|||
164465775|NCT03523572|594077830|FG000|Dose Escalation|Progressive disease|1|||
164465776|NCT03523572|594077831|FG001|Dose Escalation|Progressive disease|0|||
164465777|NCT03523572|594077832|FG002|Dose Escalation|Progressive disease|0|||
164465778|NCT03523572|594077833|FG003|Dose Escalation|Progressive disease|0|||
164465779|NCT03523572|594077834|FG004|Dose Escalation|Progressive disease|0|||
164465780|NCT03523572|594077835|FG005|Dose Escalation|Progressive disease|0|||
164465781|NCT03523572|594077830|FG000|Dose Escalation|Clinical Progression|0|||
164465782|NCT03523572|594077831|FG001|Dose Escalation|Clinical Progression|1|||
164465783|NCT03523572|594077832|FG002|Dose Escalation|Clinical Progression|0|||
164465784|NCT03523572|594077833|FG003|Dose Escalation|Clinical Progression|0|||
164465785|NCT03523572|594077834|FG004|Dose Escalation|Clinical Progression|0|||
164465786|NCT03523572|594077835|FG005|Dose Escalation|Clinical Progression|0|||
164465787|NCT03523572|594077830|FG000|Dose Escalation|Adverse Event|2|||
164465788|NCT03523572|594077831|FG001|Dose Escalation|Adverse Event|0|||
164465789|NCT03523572|594077832|FG002|Dose Escalation|Adverse Event|0|||
164465790|NCT03523572|594077833|FG003|Dose Escalation|Adverse Event|0|||
164465791|NCT03523572|594077834|FG004|Dose Escalation|Adverse Event|0|||
164465792|NCT03523572|594077835|FG005|Dose Escalation|Adverse Event|0|||
164465793|NCT03523572|594077830|FG000|Dose Escalation|Physician Decision|1|||
164465794|NCT03523572|594077831|FG001|Dose Escalation|Physician Decision|1|||
164465795|NCT03523572|594077832|FG002|Dose Escalation|Physician Decision|0|||
164465796|NCT03523572|594077833|FG003|Dose Escalation|Physician Decision|0|||
164465797|NCT03523572|594077834|FG004|Dose Escalation|Physician Decision|0|||
164465798|NCT03523572|594077835|FG005|Dose Escalation|Physician Decision|0|||
164465799|NCT03523572|594077830|FG000|Dose Expansion|Progressive Disease|0|||
164465800|NCT03523572|594077831|FG001|Dose Expansion|Progressive Disease|0|||
164465801|NCT03523572|594077832|FG002|Dose Expansion|Progressive Disease|9|||
164465802|NCT03523572|594077833|FG003|Dose Expansion|Progressive Disease|11|||
164465803|NCT03523572|594077834|FG004|Dose Expansion|Progressive Disease|15|||
164465804|NCT03523572|594077835|FG005|Dose Expansion|Progressive Disease|2|||
164465805|NCT03523572|594077830|FG000|Dose Expansion|Clinical Progression|0|||
164465806|NCT03523572|594077831|FG001|Dose Expansion|Clinical Progression|0|||
164465807|NCT03523572|594077832|FG002|Dose Expansion|Clinical Progression|2|||
164465808|NCT03523572|594077833|FG003|Dose Expansion|Clinical Progression|2|||
164465809|NCT03523572|594077834|FG004|Dose Expansion|Clinical Progression|2|||
164465810|NCT03523572|594077835|FG005|Dose Expansion|Clinical Progression|0|||
164465811|NCT03523572|594077830|FG000|Dose Expansion|Adverse Event|0|||
164465812|NCT03523572|594077831|FG001|Dose Expansion|Adverse Event|0|||
164465813|NCT03523572|594077832|FG002|Dose Expansion|Adverse Event|10|||
164465814|NCT03523572|594077833|FG003|Dose Expansion|Adverse Event|1|||
164465815|NCT03523572|594077834|FG004|Dose Expansion|Adverse Event|5|||
164465816|NCT03523572|594077835|FG005|Dose Expansion|Adverse Event|2|||
164465817|NCT03523572|594077830|FG000|Dose Expansion|Withdrawal by Subject|0|||
164465818|NCT03523572|594077831|FG001|Dose Expansion|Withdrawal by Subject|0|||
164465819|NCT03523572|594077832|FG002|Dose Expansion|Withdrawal by Subject|1|||
164465820|NCT03523572|594077833|FG003|Dose Expansion|Withdrawal by Subject|1|||
164465821|NCT03523572|594077834|FG004|Dose Expansion|Withdrawal by Subject|0|||
164465822|NCT03523572|594077835|FG005|Dose Expansion|Withdrawal by Subject|0|||
164465823|NCT03523572|594077830|FG000|Dose Expansion|Physician Decision|0|||
164465824|NCT03523572|594077831|FG001|Dose Expansion|Physician Decision|0|||
164465825|NCT03523572|594077832|FG002|Dose Expansion|Physician Decision|1|||
164465826|NCT03523572|594077833|FG003|Dose Expansion|Physician Decision|0|||
164465827|NCT03523572|594077834|FG004|Dose Expansion|Physician Decision|1|||
164465828|NCT03523572|594077835|FG005|Dose Expansion|Physician Decision|0|||
164465829|NCT03523572|594077830|FG000|Dose Expansion|Miscellaneous|0|||
164465830|NCT03523572|594077831|FG001|Dose Expansion|Miscellaneous|0|||
164710395|NCT02450526|594962936|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
164710396|NCT02450526|594962932|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
164710397|NCT02450526|594962933|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
164710398|NCT02450526|594962934|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
164710399|NCT02450526|594962935|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
164710400|NCT02450526|594962936|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
164710401|NCT02450526|594962932|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
164710402|NCT02450526|594962933|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
164710403|NCT02450526|594962934|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
164710404|NCT02450526|594962935|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
164710405|NCT02450526|594962936|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
164710406|NCT02450526|594962932|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
164710407|NCT02450526|594962933|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
164710408|NCT02450526|594962934|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
164710409|NCT02450526|594962935|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
164710410|NCT02450526|594962936|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
164710411|NCT02582866|594962939|FG000|Overall Study|Death|1|||
164710412|NCT02582866|594962939|FG000|Overall Study|Lack of Efficacy|2|||
164710413|NCT02582866|594962939|FG000|Overall Study|Lost to Follow-up|2|||
164710414|NCT02582866|594962939|FG000|Overall Study|Withdrawal by Subject|7|||
164710415|NCT02582866|594962939|FG000|Overall Study|Investigator decision|5|||
164710416|NCT02582866|594962939|FG000|Overall Study|Participant wants to get pregnant|1|||
164710417|NCT02582866|594962939|FG000|Overall Study|Pregnancy|2|||
164710418|NCT02582866|594962939|FG000|Overall Study|Sponsor decision|1|||
164710419|NCT02582866|594962939|FG000|Overall Study|Withdrawal due to personal reasons|1|||
164710420|NCT03567382|594962940|FG000|Overall Study|Lost to Follow-up|1|||
164710421|NCT03567382|594962941|FG001|Overall Study|Lost to Follow-up|21|||
164710422|NCT03567382|594962942|FG002|Overall Study|Lost to Follow-up|1|||
164465831|NCT03523572|594077832|FG002|Dose Expansion|Miscellaneous|0|||
164465832|NCT03523572|594077833|FG003|Dose Expansion|Miscellaneous|0|||
164465833|NCT03523572|594077834|FG004|Dose Expansion|Miscellaneous|3|||
164465834|NCT03523572|594077835|FG005|Dose Expansion|Miscellaneous|0|||
164465835|NCT04685135|594077836|FG000|Overall Study|Death|126|||
164465836|NCT04685135|594077837|FG001|Overall Study|Death|53|||
164465837|NCT04685135|594077836|FG000|Overall Study|Withdrawal by Subject|12|||
164465838|NCT04685135|594077837|FG001|Overall Study|Withdrawal by Subject|16|||
164465839|NCT02240238|594077840|FG000|Phase 1|Adverse Event|0|||
164465840|NCT02240238|594077841|FG001|Phase 1|Adverse Event|0|||
164465841|NCT02240238|594077842|FG002|Phase 1|Adverse Event|0|||
164465842|NCT02240238|594077843|FG003|Phase 1|Adverse Event|0|||
164465843|NCT02240238|594077844|FG004|Phase 1|Adverse Event|0|||
164465844|NCT02240238|594077845|FG005|Phase 1|Adverse Event|0|||
164465845|NCT02240238|594077846|FG006|Phase 1|Adverse Event|3|||
164465846|NCT02240238|594077847|FG007|Phase 1|Adverse Event|1|||
164465847|NCT02240238|594077848|FG008|Phase 1|Adverse Event|0|||
164465848|NCT02240238|594077849|FG009|Phase 1|Adverse Event|0|||
164465849|NCT02240238|594077850|FG010|Phase 1|Adverse Event|0|||
164465850|NCT02240238|594077851|FG011|Phase 1|Adverse Event|0|||
164465851|NCT02240238|594077840|FG000|Phase 1|Death|0|||
164465852|NCT02240238|594077841|FG001|Phase 1|Death|0|||
164465853|NCT02240238|594077842|FG002|Phase 1|Death|0|||
164465854|NCT02240238|594077843|FG003|Phase 1|Death|0|||
164465855|NCT02240238|594077844|FG004|Phase 1|Death|0|||
164465856|NCT02240238|594077845|FG005|Phase 1|Death|1|||
164465857|NCT02240238|594077846|FG006|Phase 1|Death|0|||
164465858|NCT02240238|594077847|FG007|Phase 1|Death|0|||
164465859|NCT02240238|594077848|FG008|Phase 1|Death|0|||
164465860|NCT02240238|594077849|FG009|Phase 1|Death|0|||
164465861|NCT02240238|594077850|FG010|Phase 1|Death|0|||
164465862|NCT02240238|594077851|FG011|Phase 1|Death|0|||
164465863|NCT02240238|594077840|FG000|Phase 1|Sponsor termination|0|||
164465864|NCT02240238|594077841|FG001|Phase 1|Sponsor termination|0|||
164710423|NCT03567382|594962943|FG003|Overall Study|Lost to Follow-up|21|||
164710424|NCT03567382|594962940|FG000|Overall Study|Withdrawal by Subject|2|||
164465865|NCT02240238|594077842|FG002|Phase 1|Sponsor termination|0|||
164710425|NCT03567382|594962941|FG001|Overall Study|Withdrawal by Subject|14|||
164710426|NCT03567382|594962942|FG002|Overall Study|Withdrawal by Subject|1|||
164710427|NCT03567382|594962943|FG003|Overall Study|Withdrawal by Subject|12|||
164465866|NCT02240238|594077843|FG003|Phase 1|Sponsor termination|0|||
164465867|NCT02240238|594077844|FG004|Phase 1|Sponsor termination|0|||
164465868|NCT02240238|594077845|FG005|Phase 1|Sponsor termination|1|||
164465869|NCT02240238|594077846|FG006|Phase 1|Sponsor termination|0|||
164465870|NCT02240238|594077847|FG007|Phase 1|Sponsor termination|0|||
164465871|NCT02240238|594077848|FG008|Phase 1|Sponsor termination|0|||
164465872|NCT02240238|594077849|FG009|Phase 1|Sponsor termination|0|||
164465873|NCT02240238|594077850|FG010|Phase 1|Sponsor termination|0|||
164710428|NCT03246646|594962944|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
164710429|NCT03246646|594962945|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
164710430|NCT03246646|594962944|FG000|Overall Study|Withdrawal by Subject|3|||
164710431|NCT03246646|594962945|FG001|Overall Study|Withdrawal by Subject|0|||
164710432|NCT03246646|594962944|FG000|Overall Study|Lost to Follow-up|7|||
164710433|NCT03246646|594962945|FG001|Overall Study|Lost to Follow-up|0|||
164710434|NCT00758680|594962948|FG000|Overall Study|Adverse Event|0|||
164710435|NCT00758680|594962949|FG001|Overall Study|Adverse Event|0|||
164710436|NCT00758680|594962950|FG002|Overall Study|Adverse Event|0|||
164710437|NCT00758680|594962951|FG003|Overall Study|Adverse Event|0|||
164710438|NCT00758680|594962952|FG004|Overall Study|Adverse Event|0|||
164710439|NCT00758680|594962953|FG005|Overall Study|Adverse Event|0|||
164710440|NCT00758680|594962954|FG006|Overall Study|Adverse Event|0|||
164710441|NCT00758680|594962955|FG007|Overall Study|Adverse Event|1|||
164465874|NCT02240238|594077851|FG011|Phase 1|Sponsor termination|0|||
164465875|NCT02240238|594077840|FG000|Phase 1|Withdrawal by Subject|0|||
164465876|NCT02240238|594077841|FG001|Phase 1|Withdrawal by Subject|0|||
164465877|NCT02240238|594077842|FG002|Phase 1|Withdrawal by Subject|0|||
164465878|NCT02240238|594077843|FG003|Phase 1|Withdrawal by Subject|0|||
164465879|NCT02240238|594077844|FG004|Phase 1|Withdrawal by Subject|0|||
164465880|NCT02240238|594077845|FG005|Phase 1|Withdrawal by Subject|2|||
164465881|NCT02240238|594077846|FG006|Phase 1|Withdrawal by Subject|0|||
164465882|NCT02240238|594077847|FG007|Phase 1|Withdrawal by Subject|0|||
164465883|NCT02240238|594077848|FG008|Phase 1|Withdrawal by Subject|0|||
164465884|NCT02240238|594077849|FG009|Phase 1|Withdrawal by Subject|0|||
164465885|NCT02240238|594077850|FG010|Phase 1|Withdrawal by Subject|0|||
164465886|NCT02240238|594077851|FG011|Phase 1|Withdrawal by Subject|0|||
164465887|NCT02240238|594077840|FG000|Phase 1|Physician Decision|0|||
164465888|NCT02240238|594077841|FG001|Phase 1|Physician Decision|0|||
164465889|NCT02240238|594077842|FG002|Phase 1|Physician Decision|0|||
164465890|NCT02240238|594077843|FG003|Phase 1|Physician Decision|0|||
164465891|NCT02240238|594077844|FG004|Phase 1|Physician Decision|0|||
164465892|NCT02240238|594077845|FG005|Phase 1|Physician Decision|2|||
164465893|NCT02240238|594077846|FG006|Phase 1|Physician Decision|0|||
164465894|NCT02240238|594077847|FG007|Phase 1|Physician Decision|0|||
164465895|NCT02240238|594077848|FG008|Phase 1|Physician Decision|0|||
164465896|NCT02240238|594077849|FG009|Phase 1|Physician Decision|0|||
164465897|NCT02240238|594077850|FG010|Phase 1|Physician Decision|0|||
164465898|NCT02240238|594077851|FG011|Phase 1|Physician Decision|0|||
164465899|NCT02240238|594077840|FG000|Phase 2|Adverse Event|0|||
164465900|NCT02240238|594077841|FG001|Phase 2|Adverse Event|0|||
164465901|NCT02240238|594077842|FG002|Phase 2|Adverse Event|0|||
164465902|NCT02240238|594077843|FG003|Phase 2|Adverse Event|0|||
164465903|NCT02240238|594077844|FG004|Phase 2|Adverse Event|0|||
164465904|NCT02240238|594077845|FG005|Phase 2|Adverse Event|0|||
164465905|NCT02240238|594077846|FG006|Phase 2|Adverse Event|0|||
164465906|NCT02240238|594077847|FG007|Phase 2|Adverse Event|0|||
164465907|NCT02240238|594077848|FG008|Phase 2|Adverse Event|0|||
164465908|NCT02240238|594077849|FG009|Phase 2|Adverse Event|7|||
164465909|NCT02240238|594077850|FG010|Phase 2|Adverse Event|14|||
164465910|NCT02240238|594077851|FG011|Phase 2|Adverse Event|2|||
164465911|NCT02240238|594077840|FG000|Phase 2|Death|0|||
164465912|NCT02240238|594077841|FG001|Phase 2|Death|0|||
164465913|NCT02240238|594077842|FG002|Phase 2|Death|0|||
164465914|NCT02240238|594077843|FG003|Phase 2|Death|0|||
164465915|NCT02240238|594077844|FG004|Phase 2|Death|0|||
164465916|NCT02240238|594077845|FG005|Phase 2|Death|0|||
164465917|NCT02240238|594077846|FG006|Phase 2|Death|0|||
164465918|NCT02240238|594077847|FG007|Phase 2|Death|0|||
164465919|NCT02240238|594077848|FG008|Phase 2|Death|0|||
164465920|NCT02240238|594077849|FG009|Phase 2|Death|3|||
164465921|NCT02240238|594077850|FG010|Phase 2|Death|2|||
164465922|NCT02240238|594077851|FG011|Phase 2|Death|1|||
164465923|NCT02240238|594077840|FG000|Phase 2|Disease progression|0|||
164465924|NCT02240238|594077841|FG001|Phase 2|Disease progression|0|||
164465925|NCT02240238|594077842|FG002|Phase 2|Disease progression|0|||
164465926|NCT02240238|594077843|FG003|Phase 2|Disease progression|0|||
164465927|NCT02240238|594077844|FG004|Phase 2|Disease progression|0|||
164465928|NCT02240238|594077845|FG005|Phase 2|Disease progression|0|||
164465929|NCT02240238|594077846|FG006|Phase 2|Disease progression|0|||
164465930|NCT02240238|594077847|FG007|Phase 2|Disease progression|0|||
164710442|NCT00758680|594962956|FG008|Overall Study|Adverse Event|0|||
164465931|NCT02240238|594077848|FG008|Phase 2|Disease progression|0|||
164465932|NCT02240238|594077849|FG009|Phase 2|Disease progression|5|||
164465933|NCT02240238|594077850|FG010|Phase 2|Disease progression|11|||
164465934|NCT02240238|594077851|FG011|Phase 2|Disease progression|1|||
164465935|NCT02240238|594077840|FG000|Phase 2|Withdrawal by Subject|0|||
164465936|NCT02240238|594077841|FG001|Phase 2|Withdrawal by Subject|0|||
164465937|NCT02240238|594077842|FG002|Phase 2|Withdrawal by Subject|0|||
164465938|NCT02240238|594077843|FG003|Phase 2|Withdrawal by Subject|0|||
164465939|NCT02240238|594077844|FG004|Phase 2|Withdrawal by Subject|0|||
164465940|NCT02240238|594077845|FG005|Phase 2|Withdrawal by Subject|0|||
164465941|NCT02240238|594077846|FG006|Phase 2|Withdrawal by Subject|0|||
164465942|NCT02240238|594077847|FG007|Phase 2|Withdrawal by Subject|0|||
164465943|NCT02240238|594077848|FG008|Phase 2|Withdrawal by Subject|0|||
164465944|NCT02240238|594077849|FG009|Phase 2|Withdrawal by Subject|1|||
164465945|NCT02240238|594077850|FG010|Phase 2|Withdrawal by Subject|1|||
164465946|NCT02240238|594077851|FG011|Phase 2|Withdrawal by Subject|0|||
164465947|NCT02240238|594077840|FG000|Phase 2|Physician Decision|0|||
164465948|NCT02240238|594077841|FG001|Phase 2|Physician Decision|0|||
164465949|NCT02240238|594077842|FG002|Phase 2|Physician Decision|0|||
164465950|NCT02240238|594077843|FG003|Phase 2|Physician Decision|0|||
164465951|NCT02240238|594077844|FG004|Phase 2|Physician Decision|0|||
164465952|NCT02240238|594077845|FG005|Phase 2|Physician Decision|0|||
164465953|NCT02240238|594077846|FG006|Phase 2|Physician Decision|0|||
164465954|NCT02240238|594077847|FG007|Phase 2|Physician Decision|0|||
164465955|NCT02240238|594077848|FG008|Phase 2|Physician Decision|0|||
164465956|NCT02240238|594077849|FG009|Phase 2|Physician Decision|1|||
164465957|NCT02240238|594077850|FG010|Phase 2|Physician Decision|3|||
164465958|NCT02240238|594077851|FG011|Phase 2|Physician Decision|0|||
164465959|NCT02240238|594077840|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
164465960|NCT02240238|594077841|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
164465961|NCT02240238|594077842|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
164465962|NCT02240238|594077843|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
164465963|NCT02240238|594077844|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
164465964|NCT02240238|594077845|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
164465965|NCT02240238|594077846|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
164465966|NCT02240238|594077847|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
164465967|NCT02240238|594077848|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
164465968|NCT02240238|594077849|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
164465969|NCT02240238|594077850|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
164465970|NCT02240238|594077851|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
164465971|NCT02240238|594077840|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
164465972|NCT02240238|594077841|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
164465973|NCT02240238|594077842|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
164465974|NCT02240238|594077843|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
164465975|NCT02240238|594077844|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
164465976|NCT02240238|594077845|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
164465977|NCT02240238|594077846|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
164465978|NCT02240238|594077847|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
164465979|NCT02240238|594077848|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
164465980|NCT02240238|594077849|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
164465981|NCT02240238|594077850|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
164465982|NCT02240238|594077851|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
164465983|NCT02240238|594077840|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
164465984|NCT02240238|594077841|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
164465985|NCT02240238|594077842|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
164465986|NCT02240238|594077843|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
164465987|NCT02240238|594077844|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
164465988|NCT02240238|594077845|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
164465989|NCT02240238|594077846|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
164465990|NCT02240238|594077847|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
164465991|NCT02240238|594077848|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
164465992|NCT02240238|594077849|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
164465993|NCT02240238|594077850|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
164465994|NCT02240238|594077851|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
164465995|NCT02240238|594077840|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
164465996|NCT02240238|594077841|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
164465997|NCT02240238|594077842|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
164465998|NCT02240238|594077843|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
164465999|NCT02240238|594077844|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
164466000|NCT02240238|594077845|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
164466001|NCT02240238|594077846|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
164466002|NCT02240238|594077847|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
164466003|NCT02240238|594077848|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
164466004|NCT02240238|594077849|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
164466005|NCT02240238|594077850|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
164466006|NCT02240238|594077851|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
164466007|NCT02240238|594077840|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
164466008|NCT02240238|594077841|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
164466009|NCT02240238|594077842|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
164466010|NCT02240238|594077843|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
164466011|NCT02240238|594077844|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
164466012|NCT02240238|594077845|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
164466013|NCT02240238|594077846|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
164466014|NCT02240238|594077847|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
164466015|NCT02240238|594077848|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
164466016|NCT02240238|594077849|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
164466017|NCT02240238|594077850|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
164466018|NCT02240238|594077851|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
164466019|NCT02240238|594077840|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
164466020|NCT02240238|594077841|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
164466021|NCT02240238|594077842|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
164466022|NCT02240238|594077843|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
164466023|NCT02240238|594077844|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
164466024|NCT02240238|594077845|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
164466025|NCT02240238|594077846|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
164466026|NCT02240238|594077847|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
164466027|NCT02240238|594077848|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
164466028|NCT02240238|594077849|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
164466029|NCT02240238|594077850|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
164466030|NCT02240238|594077851|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
164466031|NCT02240238|594077840|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
164466032|NCT02240238|594077841|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
164466033|NCT02240238|594077842|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
164466034|NCT02240238|594077843|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
164466035|NCT02240238|594077844|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
164466036|NCT02240238|594077845|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
164466037|NCT02240238|594077846|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
164466038|NCT02240238|594077847|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
164466039|NCT02240238|594077848|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
164466040|NCT02240238|594077849|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
164466041|NCT02240238|594077850|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
164466042|NCT02240238|594077851|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
164466043|NCT02240238|594077840|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
164466044|NCT02240238|594077841|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
164466045|NCT02240238|594077842|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
164466046|NCT02240238|594077843|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
164466047|NCT02240238|594077844|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
164466048|NCT02240238|594077845|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
164466049|NCT02240238|594077846|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
164466050|NCT02240238|594077847|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
164466051|NCT02240238|594077848|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
164466052|NCT02240238|594077849|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
164466053|NCT02240238|594077850|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
164466054|NCT02240238|594077851|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
164466055|NCT02315703|594077852|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
164466056|NCT02315703|594077853|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
164466057|NCT02315703|594077854|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
164466058|NCT02315703|594077855|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
164599504|NCT00992446|594554885|FG000|Overall Study|Disease Progression|1|||
164599505|NCT00992446|594554885|FG000|Overall Study|Withdrawal by Subject|2|||
164599506|NCT00992446|594554885|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
164599507|NCT01274338|594556272|FG000|Overall Study|Lack of Efficacy|72|||
164466059|NCT02315703|594077856|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
164710443|NCT00758680|594962957|FG009|Overall Study|Adverse Event|1|||
164710444|NCT00758680|594962948|FG000|Overall Study|Laboratory Adverse Event|0|||
164710445|NCT00758680|594962949|FG001|Overall Study|Laboratory Adverse Event|0|||
164710446|NCT00758680|594962950|FG002|Overall Study|Laboratory Adverse Event|0|||
164710447|NCT00758680|594962951|FG003|Overall Study|Laboratory Adverse Event|0|||
164710448|NCT00758680|594962952|FG004|Overall Study|Laboratory Adverse Event|0|||
164710449|NCT00758680|594962953|FG005|Overall Study|Laboratory Adverse Event|0|||
164710450|NCT00758680|594962954|FG006|Overall Study|Laboratory Adverse Event|0|||
164710451|NCT00758680|594962955|FG007|Overall Study|Laboratory Adverse Event|0|||
164710452|NCT00758680|594962956|FG008|Overall Study|Laboratory Adverse Event|1|||
164710453|NCT00758680|594962957|FG009|Overall Study|Laboratory Adverse Event|0|||
164710454|NCT00758680|594962948|FG000|Overall Study|Withdrawal by Subject|0|||
164710455|NCT00758680|594962949|FG001|Overall Study|Withdrawal by Subject|0|||
164710456|NCT00758680|594962950|FG002|Overall Study|Withdrawal by Subject|0|||
164710457|NCT00758680|594962951|FG003|Overall Study|Withdrawal by Subject|0|||
164710458|NCT00758680|594962952|FG004|Overall Study|Withdrawal by Subject|0|||
164710459|NCT00758680|594962953|FG005|Overall Study|Withdrawal by Subject|0|||
164710460|NCT00758680|594962954|FG006|Overall Study|Withdrawal by Subject|1|||
164710461|NCT00758680|594962955|FG007|Overall Study|Withdrawal by Subject|0|||
164710462|NCT00758680|594962956|FG008|Overall Study|Withdrawal by Subject|1|||
164710463|NCT00758680|594962957|FG009|Overall Study|Withdrawal by Subject|0|||
164466060|NCT02315703|594077857|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
164466061|NCT02315703|594077858|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
164466062|NCT02315703|594077859|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
164466063|NCT02315703|594077852|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
164466064|NCT02315703|594077853|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
164466065|NCT02315703|594077854|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
164466066|NCT02315703|594077855|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
164466067|NCT02315703|594077856|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
164466068|NCT02315703|594077857|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
164466069|NCT02315703|594077858|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
164466070|NCT02315703|594077859|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
164466071|NCT02315703|594077852|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
164466072|NCT02315703|594077853|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
164466073|NCT02315703|594077854|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
164466074|NCT02315703|594077855|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
164466075|NCT02315703|594077856|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
164466076|NCT02315703|594077857|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
164466077|NCT02315703|594077858|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
164466078|NCT02315703|594077859|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
164466079|NCT02315703|594077852|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
164466080|NCT02315703|594077853|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
164466081|NCT02315703|594077854|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
164466082|NCT02315703|594077855|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
164466083|NCT02315703|594077856|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
164466084|NCT02315703|594077857|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
164466085|NCT02315703|594077858|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
164466086|NCT02315703|594077859|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
164466087|NCT02315703|594077852|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
164466088|NCT02315703|594077853|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
164466089|NCT02315703|594077854|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
164466090|NCT02315703|594077855|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
164466091|NCT02315703|594077856|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
164466092|NCT02315703|594077857|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
164466093|NCT02315703|594077858|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
164466094|NCT02315703|594077859|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
164466095|NCT02315703|594077852|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
164466096|NCT02315703|594077853|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
164466097|NCT02315703|594077854|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
164710464|NCT00319982|594962958|FG000|Overall Study|Withdrawal by Subject|1|||
164710465|NCT00319982|594962959|FG001|Overall Study|Withdrawal by Subject|0|||
164710466|NCT03480386|594962960|FG000|Overall Study|Did not complete measures at 3-months|17|||
164466098|NCT02315703|594077855|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
164466099|NCT02315703|594077856|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
164466100|NCT02315703|594077857|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
164710467|NCT03480386|594962961|FG001|Overall Study|Did not complete measures at 3-months|14|||
164710468|NCT03480386|594962960|FG000|Overall Study|No baseline measures|11|||
164466101|NCT02315703|594077858|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
164466102|NCT02315703|594077859|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
164466103|NCT02315703|594077852|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
164414817|NCT02761629|593889910|FG001|Overall Study|Withdrawal by Subject|3|||
164414818|NCT02761629|593889909|FG000|Overall Study|Other|0|||
164414819|NCT02761629|593889910|FG001|Overall Study|Other|2|||
164466104|NCT02315703|594077853|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
164466105|NCT02315703|594077854|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
164466106|NCT02315703|594077855|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
164466107|NCT02315703|594077856|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
164710469|NCT03480386|594962961|FG001|Overall Study|No baseline measures|14|||
164414820|NCT02761629|593889909|FG000|Overall Study|Lost to Follow-up|4|||
164414821|NCT02761629|593889910|FG001|Overall Study|Lost to Follow-up|1|||
164414822|NCT02761629|593889909|FG000|Overall Study|Randomized But Not Treated|8|||
164414823|NCT02761629|593889910|FG001|Overall Study|Randomized But Not Treated|4|||
164414824|NCT02357810|593889911|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
164414825|NCT02357810|593889911|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
164414826|NCT02357810|593889911|FG000|Reached 12 Weeks Response|Adverse Event|5|||
164414827|NCT02357810|593889911|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
164414828|NCT02357810|593889911|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
164414829|NCT02357810|593889911|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
164414830|NCT02357810|593889911|FG000|Reached 12 Weeks Response|Death|1|||
164414831|NCT02357810|593889911|FG000|Reached 12 Weeks Response|Physician Decision|1|||
164414832|NCT02357810|593889911|FG000|Reached 12 Weeks Response|Other|1|||
164414833|NCT02357810|593889911|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
164414834|NCT02357810|593889911|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
164414835|NCT02357810|593889911|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
164414836|NCT02357810|593889911|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
164414837|NCT02357810|593889911|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
164414838|NCT02357810|593889911|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
164414839|NCT00562978|593889912|FG000|Overall Study|Patient had imaging dose only|1|||
164414840|NCT00562978|593889913|FG001|Overall Study|Patient had imaging dose only|11|||
164414841|NCT00675506|593889914|FG000|Overall Study|Lost to Follow-up|1|||
164414842|NCT00675506|593889915|FG001|Overall Study|Lost to Follow-up|5|||
164414843|NCT00675506|593889914|FG000|Overall Study|Lost interest|3|||
164414844|NCT00675506|593889915|FG001|Overall Study|Lost interest|5|||
164414845|NCT00675506|593889914|FG000|Overall Study|Elevated fasting glucose|2|||
164414846|NCT00675506|593889915|FG001|Overall Study|Elevated fasting glucose|1|||
164414847|NCT00675506|593889914|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
164414848|NCT00675506|593889915|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
164414849|NCT00675506|593889914|FG000|Overall Study|Elevated IGF-1|2|||
164414850|NCT00675506|593889915|FG001|Overall Study|Elevated IGF-1|0|||
164414851|NCT00675506|593889914|FG000|Overall Study|Hypersensitivity Reaction|1|||
164414852|NCT00675506|593889915|FG001|Overall Study|Hypersensitivity Reaction|0|||
164414853|NCT00675506|593889914|FG000|Overall Study|Disclosed history of cancer|1|||
164414854|NCT00675506|593889915|FG001|Overall Study|Disclosed history of cancer|0|||
164414855|NCT00675506|593889914|FG000|Overall Study|Declined participation|1|||
164414856|NCT00675506|593889915|FG001|Overall Study|Declined participation|0|||
164414857|NCT00675506|593889914|FG000|Overall Study|Schedule conflict|0|||
164414858|NCT00675506|593889915|FG001|Overall Study|Schedule conflict|1|||
164414859|NCT03820323|593889916|FG000|Overall Study|Lost to Follow-up|2|||
164414860|NCT03820323|593889917|FG001|Overall Study|Lost to Follow-up|1|||
164414861|NCT03820323|593889916|FG000|Overall Study|Missed 12-month visit|22|||
164414862|NCT03820323|593889917|FG001|Overall Study|Missed 12-month visit|14|||
164414863|NCT03820323|593889916|FG000|Overall Study|Death|2|||
164414864|NCT03820323|593889917|FG001|Overall Study|Death|1|||
164414865|NCT03820323|593889916|FG000|Overall Study|Transferred out|13|||
164414866|NCT03820323|593889917|FG001|Overall Study|Transferred out|11|||
164414867|NCT03820323|593889916|FG000|Overall Study|Terminated|0|||
164414868|NCT03820323|593889917|FG001|Overall Study|Terminated|3|||
164414869|NCT03820323|593889916|FG000|Overall Study|Withdrawal by Subject|1|||
164414870|NCT03820323|593889917|FG001|Overall Study|Withdrawal by Subject|6|||
164414871|NCT02153359|593889918|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
164710470|NCT03480386|594962960|FG000|Overall Study|Death|0|||
164414872|NCT02153359|593889919|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
164414873|NCT01348776|593889920|FG000|Overall Study|Lost to Follow-up|3|||
164414874|NCT01372605|593889921|FG000|Overall Study|Death|1|||
164414875|NCT01372605|593889922|FG001|Overall Study|Death|2|||
164414876|NCT01372605|593889921|FG000|Overall Study|Lost to Follow-up|2|||
164414877|NCT01372605|593889922|FG001|Overall Study|Lost to Follow-up|1|||
164414878|NCT01372605|593889921|FG000|Overall Study|Withdrawal by Subject|4|||
164414879|NCT01372605|593889922|FG001|Overall Study|Withdrawal by Subject|7|||
164414880|NCT01372605|593889921|FG000|Overall Study|Moved|3|||
164414881|NCT01372605|593889922|FG001|Overall Study|Moved|0|||
164414882|NCT01372605|593889921|FG000|Overall Study|Changed medical home|2|||
164710471|NCT03480386|594962961|FG001|Overall Study|Death|5|||
164710472|NCT03480386|594962960|FG000|Overall Study|Withdrawal by Subject|12|||
164710473|NCT03480386|594962961|FG001|Overall Study|Withdrawal by Subject|8|||
164710474|NCT03480386|594962960|FG000|Overall Study|Lost to Follow-up|2|||
164710475|NCT03480386|594962961|FG001|Overall Study|Lost to Follow-up|1|||
164710476|NCT03480386|594962960|FG000|Overall Study|Complicating disease|0|||
164710477|NCT03480386|594962961|FG001|Overall Study|Complicating disease|1|||
164710478|NCT03480386|594962960|FG000|Overall Study|Disease progression|3|||
164710479|NCT03480386|594962961|FG001|Overall Study|Disease progression|0|||
164710480|NCT03480386|594962960|FG000|Overall Study|Became ineligible|0|||
164710481|NCT03480386|594962961|FG001|Overall Study|Became ineligible|2|||
164710482|NCT02201290|594962962|FG000|Overall Study|Withdrawal by Subject|2|||
164710483|NCT02201290|594962962|FG000|Overall Study|Lack of Efficacy|2|||
164710484|NCT02201290|594962962|FG000|Overall Study|Adverse Event|1|||
164710485|NCT00805467|594964505|FG000|Overall Study|Lack of Efficacy|0|||
164710486|NCT00805467|594964506|FG001|Overall Study|Lack of Efficacy|8|||
164710487|NCT00805467|594964507|FG002|Overall Study|Lack of Efficacy|13|||
164710488|NCT00805467|594964508|FG003|Overall Study|Lack of Efficacy|86|||
164710489|NCT00805467|594964505|FG000|Overall Study|Lost to Follow-up|0|||
164710490|NCT00805467|594964506|FG001|Overall Study|Lost to Follow-up|1|||
164710491|NCT00805467|594964507|FG002|Overall Study|Lost to Follow-up|7|||
164710492|NCT00805467|594964508|FG003|Overall Study|Lost to Follow-up|21|||
164710493|NCT00805467|594964505|FG000|Overall Study|Withdrawal by Subject|0|||
164710494|NCT00805467|594964506|FG001|Overall Study|Withdrawal by Subject|6|||
164710495|NCT00805467|594964507|FG002|Overall Study|Withdrawal by Subject|45|||
164710496|NCT00805467|594964508|FG003|Overall Study|Withdrawal by Subject|50|||
164710497|NCT00805467|594964505|FG000|Overall Study|Protocol Violation|0|||
164710498|NCT00805467|594964506|FG001|Overall Study|Protocol Violation|3|||
164710499|NCT00805467|594964507|FG002|Overall Study|Protocol Violation|0|||
164710500|NCT00805467|594964508|FG003|Overall Study|Protocol Violation|5|||
164710501|NCT00805467|594964505|FG000|Overall Study|Adverse Event|0|||
164710502|NCT00805467|594964506|FG001|Overall Study|Adverse Event|13|||
164710503|NCT00805467|594964507|FG002|Overall Study|Adverse Event|26|||
164710504|NCT00805467|594964508|FG003|Overall Study|Adverse Event|57|||
164710505|NCT00805467|594964505|FG000|Overall Study|Death|0|||
164710506|NCT00805467|594964506|FG001|Overall Study|Death|2|||
164710507|NCT00805467|594964507|FG002|Overall Study|Death|7|||
164710508|NCT00805467|594964508|FG003|Overall Study|Death|5|||
164710509|NCT00805467|594964505|FG000|Overall Study|Physician Decision|0|||
164710510|NCT00805467|594964506|FG001|Overall Study|Physician Decision|1|||
164710511|NCT00805467|594964507|FG002|Overall Study|Physician Decision|2|||
164414883|NCT01372605|593889922|FG001|Overall Study|Changed medical home|0|||
164414884|NCT01830881|593889924|FG000|Overall Study|Changed decision to have an abortion|0|||
164414885|NCT01830881|593889925|FG001|Overall Study|Changed decision to have an abortion|1|||
164414886|NCT00734214|593889926|FG000|Overall Study|Withdrawal by Subject|3|||
164414887|NCT00734214|593889927|FG001|Overall Study|Withdrawal by Subject|4|||
164414888|NCT00734214|593889926|FG000|Overall Study|MD withdrawal|1|||
164414889|NCT00734214|593889927|FG001|Overall Study|MD withdrawal|0|||
164414890|NCT01320735|593889928|FG000|Overall Study|Adverse Event|3|||
164414891|NCT01320735|593889928|FG000|Overall Study|Withdrawal by Subject|3|||
164414892|NCT01320735|593889928|FG000|Overall Study|Lost to Follow-up|13|||
164414893|NCT01320735|593889928|FG000|Overall Study|Administrative Reason|6|||
164414894|NCT01320735|593889928|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
164414895|NCT01320735|593889928|FG000|Overall Study|Protocol Violation|1|||
164414896|NCT01320735|593889928|FG000|Overall Study|Other|1|||
164414897|NCT01320735|593889928|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
164414898|NCT01320735|593889928|FG000|Overall Study|Investigator Unable to be Contacted|17|||
164414899|NCT04599101|593889929|FG000|Overall Study|Lost to Follow-up|5|||
164414900|NCT04599101|593889930|FG001|Overall Study|Lost to Follow-up|5|||
164414901|NCT05952297|593889931|FG000|Overall Study|Withdrawal by Subject|1|||
164414902|NCT05952297|593889932|FG001|Overall Study|Withdrawal by Subject|0|||
164414903|NCT00406419|593889933|FG000|Overall Study|Death|3|||
164414904|NCT00406419|593889934|FG001|Overall Study|Death|1|||
164414905|NCT00406419|593889935|FG002|Overall Study|Death|4|||
164414906|NCT00406419|593889933|FG000|Overall Study|Protocol Violation|6|||
164414907|NCT00406419|593889934|FG001|Overall Study|Protocol Violation|2|||
164414908|NCT00406419|593889935|FG002|Overall Study|Protocol Violation|5|||
164710512|NCT00805467|594964508|FG003|Overall Study|Physician Decision|6|||
164710513|NCT00805467|594964505|FG000|Overall Study|Not reported|0|||
164710514|NCT00805467|594964506|FG001|Overall Study|Not reported|0|||
164710515|NCT00805467|594964507|FG002|Overall Study|Not reported|3|||
164710516|NCT00805467|594964508|FG003|Overall Study|Not reported|7|||
164710517|NCT04240392|594964510|FG000|Overall Study|Withdrawal by Subject|13|||
164414909|NCT00406419|593889933|FG000|Overall Study|Study Terminated by Sponsor|260|||
164710518|NCT04240392|594964511|FG001|Overall Study|Withdrawal by Subject|4|||
164710519|NCT04240392|594964510|FG000|Overall Study|Lost to Follow-up|11|||
164710520|NCT04240392|594964511|FG001|Overall Study|Lost to Follow-up|12|||
164710521|NCT03589768|594964512|FG000|Overall Study|Death|1|||
164710522|NCT03589768|594964513|FG001|Overall Study|Death|0|||
164710523|NCT03589768|594964514|FG002|Overall Study|Death|8|||
164414910|NCT00406419|593889934|FG001|Overall Study|Study Terminated by Sponsor|288|||
164414911|NCT00406419|593889935|FG002|Overall Study|Study Terminated by Sponsor|282|||
164414912|NCT00406419|593889933|FG000|Overall Study|Withdrawal by Subject|17|||
164414913|NCT00406419|593889934|FG001|Overall Study|Withdrawal by Subject|24|||
164414914|NCT00406419|593889935|FG002|Overall Study|Withdrawal by Subject|26|||
164414915|NCT00406419|593889933|FG000|Overall Study|Lack of Efficacy|12|||
164414916|NCT00406419|593889934|FG001|Overall Study|Lack of Efficacy|1|||
164414917|NCT00406419|593889935|FG002|Overall Study|Lack of Efficacy|6|||
164414918|NCT00406419|593889933|FG000|Overall Study|Non-Compliance with Study Drug|5|||
164414919|NCT00406419|593889934|FG001|Overall Study|Non-Compliance with Study Drug|6|||
164414920|NCT00406419|593889935|FG002|Overall Study|Non-Compliance with Study Drug|3|||
164414921|NCT00406419|593889933|FG000|Overall Study|Adverse Event|10|||
164414922|NCT00406419|593889934|FG001|Overall Study|Adverse Event|12|||
164414923|NCT00406419|593889935|FG002|Overall Study|Adverse Event|16|||
164414924|NCT00406419|593889933|FG000|Overall Study|Lost to Follow-up|11|||
164414925|NCT00406419|593889934|FG001|Overall Study|Lost to Follow-up|10|||
164414926|NCT00406419|593889935|FG002|Overall Study|Lost to Follow-up|5|||
164414927|NCT03856996|593889936|FG000|Overall Study|Withdrawal by Subject|1|||
164414928|NCT03856996|593889937|FG001|Overall Study|Withdrawal by Subject|0|||
164414929|NCT03856996|593889936|FG000|Overall Study|Lost to Follow-up|0|||
164414930|NCT03856996|593889937|FG001|Overall Study|Lost to Follow-up|1|||
164414931|NCT03856996|593889936|FG000|Overall Study|Adverse Event|1|||
164414932|NCT03856996|593889937|FG001|Overall Study|Adverse Event|1|||
164414933|NCT03856996|593889936|FG000|Overall Study|Other|1|||
164414934|NCT03856996|593889937|FG001|Overall Study|Other|0|||
164414935|NCT04362137|593889940|FG000|Overall Study|Death|9|||
164414936|NCT04362137|593889941|FG001|Overall Study|Death|3|||
164414937|NCT04362137|593889940|FG000|Overall Study|Patient decision|6|||
164414938|NCT04362137|593889941|FG001|Overall Study|Patient decision|3|||
164414939|NCT04362137|593889940|FG000|Overall Study|Adverse Event|1|||
164414940|NCT04362137|593889941|FG001|Overall Study|Adverse Event|0|||
164414941|NCT04362137|593889940|FG000|Overall Study|Lost to Follow-up|1|||
164414942|NCT04362137|593889941|FG001|Overall Study|Lost to Follow-up|0|||
164414943|NCT04362137|593889940|FG000|Overall Study|Protocol deviation|1|||
164414944|NCT04362137|593889941|FG001|Overall Study|Protocol deviation|0|||
164414945|NCT03556358|593889949|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
164414946|NCT03556358|593889950|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
164414947|NCT03556358|593889949|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
164414948|NCT03556358|593889950|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
164414949|NCT03556358|593889949|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
164414950|NCT03556358|593889950|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
164414951|NCT03556358|593889949|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
164414952|NCT03556358|593889950|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
164414953|NCT03556358|593889949|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
164414954|NCT03556358|593889950|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
164414955|NCT03556358|593889949|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
164414956|NCT03556358|593889950|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
164414957|NCT03556358|593889949|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
164414958|NCT03556358|593889950|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
164414959|NCT05067933|593889961|FG000|Overall Study|Withdrawal by Subject|2|||
164414960|NCT05067933|593889962|FG001|Overall Study|Withdrawal by Subject|0|||
164414961|NCT05067933|593889963|FG002|Overall Study|Withdrawal by Subject|0|||
164414962|NCT05067933|593889964|FG003|Overall Study|Withdrawal by Subject|0|||
164414963|NCT05067933|593889965|FG004|Overall Study|Withdrawal by Subject|0|||
164414964|NCT05067933|593889966|FG005|Overall Study|Withdrawal by Subject|0|||
164414965|NCT05067933|593889961|FG000|Overall Study|Lost to Follow-up|1|||
164414966|NCT05067933|593889962|FG001|Overall Study|Lost to Follow-up|1|||
164414967|NCT05067933|593889963|FG002|Overall Study|Lost to Follow-up|1|||
164414968|NCT05067933|593889964|FG003|Overall Study|Lost to Follow-up|2|||
164414969|NCT05067933|593889965|FG004|Overall Study|Lost to Follow-up|1|||
164414970|NCT05067933|593889966|FG005|Overall Study|Lost to Follow-up|0|||
164414971|NCT05067933|593889961|FG000|Overall Study|Miscellaneous|1|||
164414972|NCT05067933|593889962|FG001|Overall Study|Miscellaneous|0|||
164414973|NCT05067933|593889963|FG002|Overall Study|Miscellaneous|0|||
164414974|NCT05067933|593889964|FG003|Overall Study|Miscellaneous|0|||
164414975|NCT05067933|593889965|FG004|Overall Study|Miscellaneous|0|||
164414976|NCT05067933|593889966|FG005|Overall Study|Miscellaneous|0|||
164414977|NCT05067933|593889961|FG000|Overall Study|Death|0|||
164414978|NCT05067933|593889962|FG001|Overall Study|Death|0|||
164414979|NCT05067933|593889963|FG002|Overall Study|Death|0|||
164414980|NCT05067933|593889964|FG003|Overall Study|Death|1|||
164414981|NCT05067933|593889965|FG004|Overall Study|Death|0|||
164414982|NCT05067933|593889966|FG005|Overall Study|Death|0|||
164414983|NCT02716038|593889973|FG000|Overall Study|Not evaluable|1|||
164414984|NCT02716038|593889973|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
164414985|NCT02716038|593889973|FG000|Overall Study|Unresectable|3|||
164414986|NCT00550550|593889974|FG000|Overall Study|Adverse Event|13|||
164414987|NCT00550550|593889975|FG001|Overall Study|Adverse Event|5|||
164414988|NCT00550550|593889974|FG000|Overall Study|Treatment Failure|0|||
164710524|NCT03589768|594964515|FG003|Overall Study|Death|3|||
164710525|NCT03589768|594964512|FG000|Overall Study|Withdrawal by Subject|2|||
164710526|NCT03589768|594964513|FG001|Overall Study|Withdrawal by Subject|0|||
164710527|NCT03589768|594964514|FG002|Overall Study|Withdrawal by Subject|0|||
164710528|NCT03589768|594964515|FG003|Overall Study|Withdrawal by Subject|0|||
164710529|NCT03589768|594964512|FG000|Overall Study|Protocol Violation|1|||
164710530|NCT03589768|594964513|FG001|Overall Study|Protocol Violation|0|||
164710531|NCT03589768|594964514|FG002|Overall Study|Protocol Violation|0|||
164710532|NCT03589768|594964515|FG003|Overall Study|Protocol Violation|0|||
164710533|NCT05307510|594964525|FG000|Overall Study|Lost to Follow-up|3|||
164710534|NCT05307510|594964526|FG001|Overall Study|Lost to Follow-up|6|||
164710535|NCT05307510|594964525|FG000|Overall Study|Withdrawal by Subject|0|||
164710536|NCT05307510|594964526|FG001|Overall Study|Withdrawal by Subject|1|||
164710537|NCT04345601|594964528|FG000|Overall Study|Death|0|||
164710538|NCT04345601|594964529|FG001|Overall Study|Death|3|||
164710539|NCT04345601|594964530|FG002|Overall Study|Death|2|||
164710540|NCT04345601|594964528|FG000|Overall Study|Lost to Follow-up|0|||
164710541|NCT04345601|594964529|FG001|Overall Study|Lost to Follow-up|0|||
164710542|NCT04345601|594964530|FG002|Overall Study|Lost to Follow-up|2|||
164710543|NCT04241315|594964537|FG000|Overall Study|Withdrawal by Subject|0|||
164710544|NCT04241315|594964538|FG001|Overall Study|Withdrawal by Subject|1|||
164710545|NCT03047330|594964539|FG000|Sleep Block 1|Withdrawal by Subject|3|||
164710546|NCT01908907|594964540|FG000|Overall Study|Physician Decision|1|||
164710547|NCT01908907|594964541|FG001|Overall Study|Physician Decision|0|||
164710548|NCT01908907|594964540|FG000|Overall Study|Protocol Violation|1|||
164710549|NCT01908907|594964541|FG001|Overall Study|Protocol Violation|0|||
164710550|NCT01392963|594964551|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
164710551|NCT01392963|594964552|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
164710552|NCT01392963|594964551|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
164710553|NCT01392963|594964552|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
164710554|NCT01392963|594964551|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
164710555|NCT01392963|594964552|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
164710556|NCT03929757|594964553|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
164710557|NCT03929757|594964554|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
164710558|NCT03929757|594964555|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
164710559|NCT03929757|594964553|FG000|Main Study: Up to Day 365|Other|1|||
164710560|NCT03929757|594964554|FG001|Main Study: Up to Day 365|Other|0|||
164710561|NCT03929757|594964555|FG002|Main Study: Up to Day 365|Other|0|||
164710562|NCT03929757|594964553|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
164710563|NCT03929757|594964554|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
164710564|NCT03929757|594964555|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
164710565|NCT01154816|594964556|FG000|Overall Study|Withdrawal by Subject|1|||
164710566|NCT01154816|594964557|FG001|Overall Study|Withdrawal by Subject|0|||
164710567|NCT01154816|594964558|FG002|Overall Study|Withdrawal by Subject|0|||
164710568|NCT01154816|594964559|FG003|Overall Study|Withdrawal by Subject|1|||
164710569|NCT01154816|594964560|FG004|Overall Study|Withdrawal by Subject|0|||
164710570|NCT01154816|594964561|FG005|Overall Study|Withdrawal by Subject|0|||
164710571|NCT01154816|594964562|FG006|Overall Study|Withdrawal by Subject|0|||
164710572|NCT01154816|594964563|FG007|Overall Study|Withdrawal by Subject|0|||
164710573|NCT01154816|594964564|FG008|Overall Study|Withdrawal by Subject|1|||
164710574|NCT01154816|594964565|FG009|Overall Study|Withdrawal by Subject|3|||
164710575|NCT01154816|594964566|FG010|Overall Study|Withdrawal by Subject|0|||
164710576|NCT01154816|594964567|FG011|Overall Study|Withdrawal by Subject|0|||
164710577|NCT01154816|594964556|FG000|Overall Study|Progressive Disease|13|||
164710578|NCT01154816|594964557|FG001|Overall Study|Progressive Disease|8|||
164414989|NCT00550550|593889975|FG001|Overall Study|Treatment Failure|1|||
164414990|NCT00550550|593889974|FG000|Overall Study|Lost to Follow-up|4|||
164710579|NCT01154816|594964558|FG002|Overall Study|Progressive Disease|9|||
164710580|NCT01154816|594964559|FG003|Overall Study|Progressive Disease|9|||
164710581|NCT01154816|594964560|FG004|Overall Study|Progressive Disease|8|||
164710582|NCT01154816|594964561|FG005|Overall Study|Progressive Disease|8|||
164710583|NCT01154816|594964562|FG006|Overall Study|Progressive Disease|5|||
164710584|NCT01154816|594964563|FG007|Overall Study|Progressive Disease|6|||
164710585|NCT01154816|594964564|FG008|Overall Study|Progressive Disease|8|||
164710586|NCT01154816|594964565|FG009|Overall Study|Progressive Disease|6|||
164710587|NCT01154816|594964566|FG010|Overall Study|Progressive Disease|10|||
164710588|NCT01154816|594964567|FG011|Overall Study|Progressive Disease|3|||
164710589|NCT01154816|594964556|FG000|Overall Study|Physician Decision|1|||
164710590|NCT01154816|594964557|FG001|Overall Study|Physician Decision|0|||
164710591|NCT01154816|594964558|FG002|Overall Study|Physician Decision|1|||
164710592|NCT01154816|594964559|FG003|Overall Study|Physician Decision|0|||
164414991|NCT00550550|593889975|FG001|Overall Study|Lost to Follow-up|0|||
164414992|NCT00550550|593889974|FG000|Overall Study|Withdrawal by Subject|10|||
164414993|NCT00550550|593889975|FG001|Overall Study|Withdrawal by Subject|8|||
164414994|NCT00550550|593889974|FG000|Overall Study|Protocol Violation|5|||
164414995|NCT00550550|593889975|FG001|Overall Study|Protocol Violation|14|||
164414996|NCT00550550|593889974|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
164414997|NCT00550550|593889975|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
164414998|NCT00550550|593889974|FG000|Overall Study|Randomized But Not Treated|1|||
164414999|NCT00550550|593889975|FG001|Overall Study|Randomized But Not Treated|0|||
164415000|NCT00591864|593889976|FG000|Overall Study|Incomplete Imaging|5|||
164415001|NCT02459093|593889981|FG000|Overall Study|Protocol Violation|6|||
164415002|NCT02459093|593889982|FG001|Overall Study|Protocol Violation|11|||
164415003|NCT02459093|593889981|FG000|Overall Study|Lost to Follow-up|6|||
164415004|NCT02459093|593889982|FG001|Overall Study|Lost to Follow-up|7|||
164415005|NCT00118092|593889983|FG000|Overall Study|Withdrawal by Subject|1|||
164415006|NCT00118092|593889983|FG000|Overall Study|Protocol Violation|1|||
164415007|NCT01103960|593889988|FG000|Overall Study|Adverse Event|2|||
164415008|NCT01103960|593889989|FG001|Overall Study|Adverse Event|1|||
164415009|NCT01103960|593889988|FG000|Overall Study|Withdrawal by Subject|2|||
164415010|NCT01103960|593889989|FG001|Overall Study|Withdrawal by Subject|1|||
164415011|NCT01103960|593889988|FG000|Overall Study|Other|1|||
164415012|NCT01103960|593889989|FG001|Overall Study|Other|0|||
164415013|NCT02089230|593889991|FG000|Overall Study|Death|0|||
164415014|NCT02089230|593889992|FG001|Overall Study|Death|0|||
164415015|NCT02089230|593889993|FG002|Overall Study|Death|2|||
164415016|NCT02089230|593889991|FG000|Overall Study|Seeking Alternative Therapy|0|||
164415017|NCT02089230|593889992|FG001|Overall Study|Seeking Alternative Therapy|0|||
164415018|NCT02089230|593889993|FG002|Overall Study|Seeking Alternative Therapy|4|||
164415019|NCT04921969|593889994|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
164415020|NCT04921969|593889995|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
164415021|NCT04921969|593889996|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
164415022|NCT04921969|593889997|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
164415023|NCT04921969|593889998|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
164415024|NCT04921969|593889999|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
164415025|NCT04921969|593890000|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
164415026|NCT04921969|593889994|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
164415027|NCT04921969|593889995|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164415028|NCT04921969|593889996|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164415029|NCT04921969|593889997|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164415030|NCT04921969|593889998|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164415031|NCT04921969|593889999|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164415032|NCT04921969|593890000|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164415033|NCT04921969|593889994|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
164415034|NCT04921969|593889995|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
164415035|NCT04921969|593889996|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
164415036|NCT04921969|593889997|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164415037|NCT04921969|593889998|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164415038|NCT04921969|593889999|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164415039|NCT04921969|593890000|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164415040|NCT04921969|593889994|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
164415041|NCT04921969|593889995|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
164415042|NCT04921969|593889996|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
164415043|NCT04921969|593889997|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
164415044|NCT04921969|593889998|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
164415045|NCT04921969|593889999|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
164415046|NCT04921969|593890000|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
164415047|NCT04921969|593889994|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
164415048|NCT04921969|593889995|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
164415049|NCT04921969|593889996|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
164415050|NCT04921969|593889997|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
164415051|NCT04921969|593889998|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
164415052|NCT04921969|593889999|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
164415053|NCT04921969|593890000|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
164415054|NCT04921969|593889994|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
164415055|NCT04921969|593889995|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
164415056|NCT04921969|593889996|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
164415057|NCT04921969|593889997|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164415058|NCT04921969|593889998|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164415059|NCT04921969|593889999|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164415060|NCT04921969|593890000|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164415061|NCT04921969|593889994|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
164415062|NCT04921969|593889995|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
164415063|NCT04921969|593889996|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
164415064|NCT04921969|593889997|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
164415065|NCT04921969|593889998|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
164415066|NCT04921969|593889999|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
164415067|NCT04921969|593890000|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
164415068|NCT04921969|593889994|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
164415069|NCT04921969|593889995|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
164415070|NCT04921969|593889996|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
164415071|NCT04921969|593889997|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
164415072|NCT04921969|593889998|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
164415073|NCT04921969|593889999|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
164415074|NCT04921969|593890000|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
164415075|NCT04921969|593889994|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
164415076|NCT04921969|593889995|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
164415077|NCT04921969|593889996|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
164415078|NCT04921969|593889997|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
164415079|NCT04921969|593889998|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
164415080|NCT04921969|593889999|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
164415081|NCT04921969|593890000|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
164415082|NCT04921969|593889994|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
164415083|NCT04921969|593889995|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
164415084|NCT04921969|593889996|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
164415085|NCT04921969|593889997|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
164415086|NCT04921969|593889998|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
164415087|NCT04921969|593889999|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
164415088|NCT04921969|593890000|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
164466108|NCT02315703|594077857|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
164466109|NCT02315703|594077858|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
164466110|NCT02315703|594077859|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
164466111|NCT02315703|594077852|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
164466112|NCT02315703|594077853|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
164466113|NCT02315703|594077854|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
164466114|NCT02315703|594077855|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
164466115|NCT02315703|594077856|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
164466116|NCT02315703|594077857|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
164466117|NCT02315703|594077858|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
164466118|NCT02315703|594077859|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
164466119|NCT02315703|594077852|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
164466120|NCT02315703|594077853|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
164466121|NCT02315703|594077854|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
164466122|NCT02315703|594077855|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
164466123|NCT02315703|594077856|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
164466124|NCT02315703|594077857|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
164466125|NCT02315703|594077858|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
164466126|NCT02315703|594077859|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
164466127|NCT02724969|594077872|FG000|Overall Study|Lost to Follow-up|12|||
164466128|NCT02724969|594077873|FG001|Overall Study|Lost to Follow-up|6|||
164466129|NCT02724969|594077872|FG000|Overall Study|Withdrawal by Subject|3|||
164466130|NCT02724969|594077873|FG001|Overall Study|Withdrawal by Subject|3|||
164466131|NCT02724969|594077872|FG000|Overall Study|Infant demise|0|||
164466132|NCT02724969|594077873|FG001|Overall Study|Infant demise|2|||
164466133|NCT05863156|594077874|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
164466134|NCT05863156|594077875|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
164466135|NCT05863156|594077876|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
164466136|NCT01346540|594077877|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
164466137|NCT01346540|594077878|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
164466138|NCT01346540|594077877|FG000|Overall Study|Adverse Event|0|||
164466139|NCT01346540|594077878|FG001|Overall Study|Adverse Event|4|||
164466140|NCT05974501|594077880|FG000|Overall Study|Physician Decision|0|||
164466141|NCT05974501|594077881|FG001|Overall Study|Physician Decision|1|||
164466142|NCT01221948|594077886|FG000|Overall Study|Physician Decision|5|||
164466143|NCT01221948|594077886|FG000|Overall Study|Withdrawal by Subject|2|||
164415089|NCT04921969|593889994|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
164415090|NCT04921969|593889995|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
164415091|NCT04921969|593889996|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
164415092|NCT04921969|593889997|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
164466144|NCT01221948|594077886|FG000|Overall Study|not disclosed|2|||
164466145|NCT01221948|594077886|FG000|Overall Study|Death|1|||
164466146|NCT01221948|594077886|FG000|Overall Study|Protocol Violation|4|||
164466147|NCT00746096|594077887|FG000|Overall Study|Adverse Event|1|||
164466148|NCT00746096|594077888|FG001|Overall Study|Adverse Event|0|||
164466149|NCT00746096|594077887|FG000|Overall Study|Withdrawal by Subject|5|||
164466150|NCT00746096|594077888|FG001|Overall Study|Withdrawal by Subject|1|||
164466151|NCT00746096|594077887|FG000|Overall Study|Lost to Follow-up|2|||
164466152|NCT00746096|594077888|FG001|Overall Study|Lost to Follow-up|1|||
164466153|NCT00746096|594077887|FG000|Overall Study|Protocol Violation|1|||
164466154|NCT00746096|594077888|FG001|Overall Study|Protocol Violation|0|||
164466155|NCT00746096|594077887|FG000|Overall Study|No study drug treatment|1|||
164466156|NCT00746096|594077888|FG001|Overall Study|No study drug treatment|1|||
164466157|NCT05207956|594077891|FG000|Overall Study|Lost to follow up|1|||
164466158|NCT05207956|594077892|FG001|Overall Study|Lost to follow up|2|||
164466159|NCT04587453|594077895|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
164466160|NCT04587453|594077896|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
164466161|NCT03571581|594077897|FG000|Overall Study|Death|2|||
164466162|NCT03571581|594077897|FG000|Overall Study|Withdrawal by Subject|2|||
164466163|NCT01309672|594077899|FG000|Overall Study|Lack of Efficacy|20|||
164466164|NCT01309672|594077899|FG000|Overall Study|Other|9|||
164466165|NCT01309672|594077899|FG000|Overall Study|Adverse Event|5|||
164466166|NCT01309672|594077899|FG000|Overall Study|Withdrawal by Subject|3|||
164466167|NCT01254864|594077900|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
164466168|NCT01254864|594077901|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
164466169|NCT01254864|594077902|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
164466170|NCT01254864|594077900|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
164466171|NCT01254864|594077901|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
164466172|NCT01254864|594077902|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
164466173|NCT01254864|594077900|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
164466174|NCT01254864|594077901|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
164466175|NCT01254864|594077902|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
164466176|NCT01254864|594077900|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
164466177|NCT01254864|594077901|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
164466178|NCT01254864|594077902|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
164466179|NCT01254864|594077900|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
164466180|NCT01254864|594077901|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
164466181|NCT01254864|594077902|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
164466182|NCT01254864|594077900|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
164466183|NCT01254864|594077901|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
164599508|NCT01274338|594556273|FG001|Overall Study|Lack of Efficacy|108|||
164415093|NCT04921969|593889998|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
164415094|NCT04921969|593889999|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
164415095|NCT04921969|593890000|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
164415096|NCT04921969|593889994|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
164415097|NCT04921969|593889995|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
164415098|NCT04921969|593889996|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
164415099|NCT04921969|593889997|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
164415100|NCT04921969|593889998|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
164415101|NCT04921969|593889999|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
164415102|NCT04921969|593890000|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
164415103|NCT04921969|593889994|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
164415104|NCT04921969|593889995|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
164415105|NCT04921969|593889996|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
164415106|NCT04921969|593889997|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
164415107|NCT04921969|593889998|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
164415108|NCT04921969|593889999|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
164415109|NCT04921969|593890000|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
164415110|NCT04921969|593889994|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
164415111|NCT04921969|593889995|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
164415112|NCT04921969|593889996|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
164415113|NCT04921969|593889997|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
164415114|NCT04921969|593889998|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
164415115|NCT04921969|593889999|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
164415116|NCT04921969|593890000|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
164415117|NCT04921969|593889994|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
164415118|NCT04921969|593889995|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
164415119|NCT04921969|593889996|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
164415120|NCT04921969|593889997|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
164599509|NCT01274338|594556274|FG002|Overall Study|Lack of Efficacy|116|||
164599510|NCT01274338|594556275|FG003|Overall Study|Lack of Efficacy|0|||
164599511|NCT01274338|594556276|FG004|Overall Study|Lack of Efficacy|0|||
164599512|NCT01274338|594556277|FG005|Overall Study|Lack of Efficacy|0|||
164466184|NCT01254864|594077902|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
164466185|NCT01254864|594077900|FG000|Randomization Phase|Adverse Event|0|||
164415121|NCT04921969|593889998|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
164415122|NCT04921969|593889999|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
164415123|NCT04921969|593890000|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
164415124|NCT04287868|593890001|FG000|Overall Study|Screening fail|1|||
164415125|NCT04287868|593890002|FG001|Overall Study|Screening fail|0|||
164415126|NCT01242176|593891588|FG000|Washout Period of 7 Days|Adverse Event|0|||
164415127|NCT01242176|593891589|FG001|Washout Period of 7 Days|Adverse Event|2|||
164415128|NCT01242176|593891588|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
164415129|NCT01242176|593891589|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
164415130|NCT00358215|593891590|FG000|Overall Study|Ineligibility determined|4|||
164415131|NCT00358215|593891591|FG001|Overall Study|Ineligibility determined|3|||
164415132|NCT00358215|593891590|FG000|Overall Study|Adverse Event|83|||
164415133|NCT00358215|593891591|FG001|Overall Study|Adverse Event|65|||
164415134|NCT00358215|593891590|FG000|Overall Study|Withdrawal by Subject|111|||
164415135|NCT00358215|593891591|FG001|Overall Study|Withdrawal by Subject|102|||
164415136|NCT00358215|593891590|FG000|Overall Study|Participant request|65|||
164415137|NCT00358215|593891591|FG001|Overall Study|Participant request|64|||
164415138|NCT00358215|593891590|FG000|Overall Study|Physician Decision|47|||
164415139|NCT00358215|593891591|FG001|Overall Study|Physician Decision|39|||
164415140|NCT00358215|593891590|FG000|Overall Study|Lost to Follow-up|16|||
164415141|NCT00358215|593891591|FG001|Overall Study|Lost to Follow-up|22|||
164415142|NCT00358215|593891590|FG000|Overall Study|Death|265|||
164415143|NCT00358215|593891591|FG001|Overall Study|Death|281|||
164415144|NCT00358215|593891590|FG000|Overall Study|Protocol Violation|64|||
164415145|NCT00358215|593891591|FG001|Overall Study|Protocol Violation|59|||
164415146|NCT00358215|593891590|FG000|Overall Study|Pregnancy|1|||
164415147|NCT00358215|593891591|FG001|Overall Study|Pregnancy|0|||
164415148|NCT00358215|593891590|FG000|Overall Study|Other|21|||
164415149|NCT00358215|593891591|FG001|Overall Study|Other|14|||
164415150|NCT00358215|593891590|FG000|Overall Study|Did not receive investigational product|2|||
164415151|NCT00358215|593891591|FG001|Overall Study|Did not receive investigational product|3|||
164415152|NCT00871351|593891592|FG000|Overall Study|Withdrawal by Subject|1|||
164415153|NCT00871351|593891593|FG001|Overall Study|Withdrawal by Subject|0|||
164415154|NCT00871351|593891594|FG002|Overall Study|Withdrawal by Subject|0|||
164415155|NCT00871351|593891592|FG000|Overall Study|Adverse Event|3|||
164415156|NCT00871351|593891593|FG001|Overall Study|Adverse Event|1|||
164415157|NCT00871351|593891594|FG002|Overall Study|Adverse Event|0|||
164415158|NCT00744237|593891595|FG000|Overall Study|Lack of Efficacy|1|||
164415159|NCT00744237|593891596|FG001|Overall Study|Lack of Efficacy|1|||
164415160|NCT00744237|593891597|FG002|Overall Study|Lack of Efficacy|0|||
164415161|NCT00744237|593891595|FG000|Overall Study|Withdrawal by Subject|9|||
164415162|NCT00744237|593891596|FG001|Overall Study|Withdrawal by Subject|5|||
164415163|NCT00744237|593891597|FG002|Overall Study|Withdrawal by Subject|3|||
164415164|NCT00744237|593891595|FG000|Overall Study|Lost to Follow-up|1|||
164415165|NCT00744237|593891596|FG001|Overall Study|Lost to Follow-up|1|||
164415166|NCT00744237|593891597|FG002|Overall Study|Lost to Follow-up|1|||
164415167|NCT00744237|593891595|FG000|Overall Study|Protocol Violation|3|||
164415168|NCT00744237|593891596|FG001|Overall Study|Protocol Violation|4|||
164415169|NCT00744237|593891597|FG002|Overall Study|Protocol Violation|3|||
164415170|NCT00744237|593891595|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
164415171|NCT00744237|593891596|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
164415172|NCT00744237|593891597|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
164415173|NCT00744237|593891595|FG000|Overall Study|Dosing Error|1|||
164415174|NCT00744237|593891596|FG001|Overall Study|Dosing Error|0|||
164415175|NCT00744237|593891597|FG002|Overall Study|Dosing Error|1|||
164415176|NCT00744237|593891595|FG000|Overall Study|Study Drug Error|1|||
164415177|NCT00744237|593891596|FG001|Overall Study|Study Drug Error|0|||
164415178|NCT00744237|593891597|FG002|Overall Study|Study Drug Error|0|||
164415179|NCT00744237|593891595|FG000|Overall Study|Prohibited Concomitant Medication|0|||
164415180|NCT00744237|593891596|FG001|Overall Study|Prohibited Concomitant Medication|0|||
164415181|NCT00744237|593891597|FG002|Overall Study|Prohibited Concomitant Medication|1|||
164415182|NCT00744237|593891595|FG000|Overall Study|Poor Compliance|0|||
164415183|NCT00744237|593891596|FG001|Overall Study|Poor Compliance|2|||
164415184|NCT00744237|593891597|FG002|Overall Study|Poor Compliance|0|||
164415185|NCT00744237|593891595|FG000|Overall Study|Administrative. Site Closed|1|||
164415186|NCT00744237|593891596|FG001|Overall Study|Administrative. Site Closed|1|||
164415187|NCT00744237|593891597|FG002|Overall Study|Administrative. Site Closed|1|||
164415188|NCT00744237|593891595|FG000|Overall Study|Adverse Event|9|||
164415189|NCT00744237|593891596|FG001|Overall Study|Adverse Event|13|||
164415190|NCT00744237|593891597|FG002|Overall Study|Adverse Event|5|||
164415191|NCT01118455|593891598|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
164415192|NCT01118455|593891599|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
164415193|NCT05033743|593891600|FG000|Overall Study|Lost to Follow-up|1|||
164466186|NCT01254864|594077901|FG001|Randomization Phase|Adverse Event|5|||
164466187|NCT01254864|594077902|FG002|Randomization Phase|Adverse Event|17|||
164466188|NCT01254864|594077900|FG000|Randomization Phase|Death|0|||
164466189|NCT01254864|594077901|FG001|Randomization Phase|Death|1|||
164466190|NCT01254864|594077902|FG002|Randomization Phase|Death|0|||
164466191|NCT01254864|594077900|FG000|Randomization Phase|Lost to Follow-up|0|||
164466192|NCT01254864|594077901|FG001|Randomization Phase|Lost to Follow-up|0|||
164466193|NCT01254864|594077902|FG002|Randomization Phase|Lost to Follow-up|1|||
164466194|NCT01254864|594077900|FG000|Randomization Phase|Physician Decision|0|||
164466195|NCT01254864|594077901|FG001|Randomization Phase|Physician Decision|20|||
164466196|NCT01254864|594077902|FG002|Randomization Phase|Physician Decision|25|||
164466197|NCT01254864|594077900|FG000|Randomization Phase|Withdrawal by Subject|0|||
164466198|NCT01254864|594077901|FG001|Randomization Phase|Withdrawal by Subject|4|||
164466199|NCT01254864|594077902|FG002|Randomization Phase|Withdrawal by Subject|2|||
164466200|NCT01254864|594077900|FG000|Randomization Phase|Non-Compliance|0|||
164466201|NCT01254864|594077901|FG001|Randomization Phase|Non-Compliance|1|||
164466202|NCT01254864|594077902|FG002|Randomization Phase|Non-Compliance|0|||
164466203|NCT01254864|594077900|FG000|Randomization Phase|Comorbidities|0|||
164466204|NCT01254864|594077901|FG001|Randomization Phase|Comorbidities|2|||
164466205|NCT01254864|594077902|FG002|Randomization Phase|Comorbidities|1|||
164466206|NCT04141891|594077905|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
164466207|NCT04141891|594077906|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
164466208|NCT04141891|594077905|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
164466209|NCT04141891|594077906|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
164466210|NCT04141891|594077905|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
164466211|NCT04141891|594077906|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
164466212|NCT04141891|594077905|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
164466213|NCT04141891|594077906|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
164466214|NCT04141891|594077905|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
164466215|NCT04141891|594077906|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
164466216|NCT04141891|594077905|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
164466217|NCT04141891|594077906|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
164466218|NCT04141891|594077905|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
164466219|NCT04141891|594077906|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
164466220|NCT04141891|594077905|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
164466221|NCT04141891|594077906|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
164466222|NCT04141891|594077905|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
164466223|NCT04141891|594077906|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
164466224|NCT04141891|594077905|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
164466225|NCT04141891|594077906|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
164466226|NCT04141891|594077905|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
164466227|NCT04141891|594077906|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
164466228|NCT04141891|594077905|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
164466229|NCT04141891|594077906|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
164466230|NCT04141891|594077905|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
164466231|NCT04141891|594077906|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
164466232|NCT04141891|594077905|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
164466233|NCT04141891|594077906|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
164466234|NCT03626220|594077907|FG000|Overall Study|Withdrawal by Subject|2|||
164466235|NCT03626220|594077908|FG001|Overall Study|Withdrawal by Subject|0|||
164466236|NCT04737330|594077909|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
164466237|NCT04737330|594077910|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
164466238|NCT04737330|594077909|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
164466239|NCT04737330|594077910|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
164466240|NCT04737330|594077909|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
164466241|NCT04737330|594077910|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
164466242|NCT04737330|594077909|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
164466243|NCT04737330|594077910|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
164466244|NCT04737330|594077909|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
164466245|NCT04737330|594077910|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
164466246|NCT04737330|594077909|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
164466247|NCT04737330|594077910|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
164466248|NCT03295721|594077914|FG000|Overall Study|Adverse Event|1|||
164466249|NCT03295721|594077915|FG001|Overall Study|Adverse Event|0|||
164466250|NCT03295721|594077916|FG002|Overall Study|Adverse Event|0|||
164599513|NCT01274338|594556272|FG000|Overall Study|Adverse Event|272|||
164466251|NCT03295721|594077914|FG000|Overall Study|Lost to Follow-up|1|||
164466252|NCT03295721|594077915|FG001|Overall Study|Lost to Follow-up|1|||
164599514|NCT01274338|594556273|FG001|Overall Study|Adverse Event|105|||
164466253|NCT03295721|594077916|FG002|Overall Study|Lost to Follow-up|1|||
164466254|NCT03295721|594077914|FG000|Overall Study|Withdrawal by Subject|1|||
164466255|NCT03295721|594077915|FG001|Overall Study|Withdrawal by Subject|0|||
164466256|NCT03295721|594077916|FG002|Overall Study|Withdrawal by Subject|1|||
164466257|NCT03295721|594077914|FG000|Overall Study|Death|0|||
164466258|NCT03295721|594077915|FG001|Overall Study|Death|0|||
164466259|NCT03295721|594077916|FG002|Overall Study|Death|1|||
164466260|NCT01651403|594077924|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
164466261|NCT01651403|594077925|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
164466262|NCT01651403|594077924|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
164466263|NCT01651403|594077925|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
164466264|NCT01651403|594077924|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
164466265|NCT01651403|594077925|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
164466266|NCT01651403|594077924|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
164466267|NCT01651403|594077925|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
164466268|NCT01651403|594077924|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
164466269|NCT01651403|594077925|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
164466270|NCT01651403|594077924|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
164466271|NCT01651403|594077925|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
164466272|NCT05090683|594077926|FG000|Overall Study|Lost to Follow-up|10|||
164466273|NCT05090683|594077927|FG001|Overall Study|Lost to Follow-up|2|||
164466274|NCT05090683|594077926|FG000|Overall Study|Withdrawal by Subject|15|||
164466275|NCT05090683|594077927|FG001|Overall Study|Withdrawal by Subject|0|||
164466276|NCT03213665|594077928|FG000|Overall Study|Adverse Event|1|||
164466277|NCT03213665|594077928|FG000|Overall Study|Physician Decision|2|||
164466278|NCT03213665|594077928|FG000|Overall Study|Withdrawal by Subject|3|||
164466279|NCT03213665|594077928|FG000|Overall Study|Progressive Disease|13|||
164466280|NCT03325985|594077929|FG000|Overall Study|Lost to Follow-up|122|||
164466281|NCT03325985|594077930|FG001|Overall Study|Lost to Follow-up|26|||
164466282|NCT03325985|594077931|FG002|Overall Study|Lost to Follow-up|141|||
164466283|NCT03325985|594077932|FG003|Overall Study|Lost to Follow-up|28|||
164466284|NCT03325985|594077929|FG000|Overall Study|Death|99|||
164466285|NCT03325985|594077930|FG001|Overall Study|Death|36|||
164466286|NCT03325985|594077931|FG002|Overall Study|Death|94|||
164466287|NCT03325985|594077932|FG003|Overall Study|Death|32|||
164466288|NCT03034356|594077933|FG000|Baseline|Lost to Follow-up|2|||
164466289|NCT03034356|594077934|FG001|Baseline|Lost to Follow-up|4|||
164466290|NCT03034356|594077933|FG000|Baseline|Withdrawal by Subject|2|||
164466291|NCT03034356|594077934|FG001|Baseline|Withdrawal by Subject|0|||
164466292|NCT03034356|594077933|FG000|Baseline|Physician Decision|0|||
164466293|NCT03034356|594077934|FG001|Baseline|Physician Decision|1|||
164466294|NCT03034356|594077933|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
164466295|NCT03034356|594077934|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
164466296|NCT03034356|594077933|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
164466297|NCT03034356|594077934|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
164466298|NCT03034356|594077933|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
164466299|NCT03034356|594077934|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
164466300|NCT03034356|594077933|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
164710593|NCT01154816|594964560|FG004|Overall Study|Physician Decision|2|||
164710594|NCT01154816|594964561|FG005|Overall Study|Physician Decision|0|||
164710595|NCT01154816|594964562|FG006|Overall Study|Physician Decision|0|||
164710596|NCT01154816|594964563|FG007|Overall Study|Physician Decision|0|||
164710597|NCT01154816|594964564|FG008|Overall Study|Physician Decision|0|||
164710598|NCT01154816|594964565|FG009|Overall Study|Physician Decision|1|||
164710599|NCT01154816|594964566|FG010|Overall Study|Physician Decision|1|||
164710600|NCT01154816|594964567|FG011|Overall Study|Physician Decision|1|||
164710601|NCT01154816|594964556|FG000|Overall Study|Adverse Event|5|||
164710602|NCT01154816|594964557|FG001|Overall Study|Adverse Event|2|||
164710603|NCT01154816|594964558|FG002|Overall Study|Adverse Event|0|||
164710604|NCT01154816|594964559|FG003|Overall Study|Adverse Event|0|||
164710605|NCT01154816|594964560|FG004|Overall Study|Adverse Event|0|||
164710606|NCT01154816|594964561|FG005|Overall Study|Adverse Event|0|||
164710607|NCT01154816|594964562|FG006|Overall Study|Adverse Event|1|||
164710608|NCT01154816|594964563|FG007|Overall Study|Adverse Event|1|||
164710609|NCT01154816|594964564|FG008|Overall Study|Adverse Event|0|||
164710610|NCT01154816|594964565|FG009|Overall Study|Adverse Event|0|||
164710611|NCT01154816|594964566|FG010|Overall Study|Adverse Event|0|||
164710612|NCT01154816|594964567|FG011|Overall Study|Adverse Event|0|||
164710613|NCT00686075|594964568|FG000|Overall Study|Withdrawal by Subject|4|||
164710614|NCT00686075|594964569|FG001|Overall Study|Withdrawal by Subject|3|||
164710615|NCT00686075|594964570|FG002|Overall Study|Withdrawal by Subject|3|||
164466301|NCT03034356|594077934|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
164710616|NCT00686075|594964571|FG003|Overall Study|Withdrawal by Subject|7|||
164710617|NCT00686075|594964572|FG004|Overall Study|Withdrawal by Subject|1|||
164710618|NCT00686075|594964573|FG005|Overall Study|Withdrawal by Subject|0|||
164710619|NCT00686075|594964574|FG006|Overall Study|Withdrawal by Subject|0|||
164710620|NCT00686075|594964575|FG007|Overall Study|Withdrawal by Subject|2|||
164710621|NCT00686075|594964576|FG008|Overall Study|Withdrawal by Subject|4|||
164710622|NCT00686075|594964577|FG009|Overall Study|Withdrawal by Subject|6|||
164710623|NCT00686075|594964568|FG000|Overall Study|Lost to Follow-up|3|||
164710624|NCT00686075|594964569|FG001|Overall Study|Lost to Follow-up|6|||
164710625|NCT00686075|594964570|FG002|Overall Study|Lost to Follow-up|3|||
164710626|NCT00686075|594964571|FG003|Overall Study|Lost to Follow-up|2|||
164710627|NCT00686075|594964572|FG004|Overall Study|Lost to Follow-up|3|||
164710628|NCT00686075|594964573|FG005|Overall Study|Lost to Follow-up|3|||
164710629|NCT00686075|594964574|FG006|Overall Study|Lost to Follow-up|0|||
164710630|NCT00686075|594964575|FG007|Overall Study|Lost to Follow-up|0|||
164710631|NCT00686075|594964576|FG008|Overall Study|Lost to Follow-up|2|||
164144816|NCT01524978|592891775|FG001|Overall Study|Death|2|||
164415194|NCT05033743|593891600|FG000|Overall Study|Protocol Violation|2|||
164415195|NCT05033743|593891600|FG000|Overall Study|Withdrawal by Subject|1|||
164415196|NCT00452413|593891613|FG000|Overall Study|Progressive Disease|4|||
164415197|NCT00452413|593891614|FG001|Overall Study|Progressive Disease|11|||
164415198|NCT00452413|593891615|FG002|Overall Study|Progressive Disease|30|||
164415199|NCT00452413|593891613|FG000|Overall Study|Withdrawal by Subject|0|||
164415200|NCT00452413|593891614|FG001|Overall Study|Withdrawal by Subject|1|||
164415201|NCT00452413|593891615|FG002|Overall Study|Withdrawal by Subject|4|||
164415202|NCT00452413|593891613|FG000|Overall Study|Adverse Event|0|||
164415203|NCT00452413|593891614|FG001|Overall Study|Adverse Event|0|||
164415204|NCT00452413|593891615|FG002|Overall Study|Adverse Event|5|||
164415205|NCT00452413|593891613|FG000|Overall Study|Physician Decision|0|||
164415206|NCT00452413|593891614|FG001|Overall Study|Physician Decision|0|||
164415207|NCT00452413|593891615|FG002|Overall Study|Physician Decision|4|||
164415208|NCT00452413|593891613|FG000|Overall Study|Death due to study disease|0|||
164415209|NCT00452413|593891614|FG001|Overall Study|Death due to study disease|0|||
164415210|NCT00452413|593891615|FG002|Overall Study|Death due to study disease|2|||
164415211|NCT00452413|593891613|FG000|Overall Study|Death due to adverse event (AE)|0|||
164415212|NCT00452413|593891614|FG001|Overall Study|Death due to adverse event (AE)|0|||
164415213|NCT00452413|593891615|FG002|Overall Study|Death due to adverse event (AE)|1|||
164415214|NCT00452413|593891613|FG000|Overall Study|On treatment|0|||
164415215|NCT00452413|593891614|FG001|Overall Study|On treatment|0|||
164415216|NCT00452413|593891615|FG002|Overall Study|On treatment|3|||
164415217|NCT03119610|593891617|FG000|Overall Study|Adverse Event|1|||
164415218|NCT03119610|593891618|FG001|Overall Study|Adverse Event|0|||
164415219|NCT03119610|593891617|FG000|Overall Study|Lost to Follow-up|0|||
164415220|NCT03119610|593891618|FG001|Overall Study|Lost to Follow-up|1|||
164415221|NCT00114634|593891619|FG000|Overall Study|failure to return forms|3|||
164415222|NCT00684762|593891622|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
164415223|NCT00684762|593891623|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
164415224|NCT03662997|593891645|FG000|Overall Study|Adverse Event|0|||
164415225|NCT03662997|593891646|FG001|Overall Study|Adverse Event|2|||
164415226|NCT03662997|593891647|FG002|Overall Study|Adverse Event|0|||
164415227|NCT03662997|593891648|FG003|Overall Study|Adverse Event|0|||
164415228|NCT00936221|593891657|FG000|Overall Study|Withdrawal by Subject|1|||
164415229|NCT00936221|593891658|FG001|Overall Study|Withdrawal by Subject|1|||
164415230|NCT01844115|593891661|FG000|Overall Study|Adverse Event|4|||
164415231|NCT01844115|593891662|FG001|Overall Study|Adverse Event|22|||
164415232|NCT01844115|593891661|FG000|Overall Study|Lack of Efficacy|1|||
164415233|NCT01844115|593891662|FG001|Overall Study|Lack of Efficacy|4|||
164415234|NCT01844115|593891661|FG000|Overall Study|Protocol Violation|12|||
164415235|NCT01844115|593891662|FG001|Overall Study|Protocol Violation|10|||
164415236|NCT01844115|593891661|FG000|Overall Study|Withdrawal by Subject|11|||
164415237|NCT01844115|593891662|FG001|Overall Study|Withdrawal by Subject|11|||
164415238|NCT01844115|593891661|FG000|Overall Study|Lost to Follow-up|11|||
164415239|NCT01844115|593891662|FG001|Overall Study|Lost to Follow-up|10|||
164415240|NCT01844115|593891661|FG000|Overall Study|Pregnancy|0|||
164415241|NCT01844115|593891662|FG001|Overall Study|Pregnancy|1|||
164415242|NCT00545363|593891663|FG000|Overall Study|Adverse Event|6|||
164415243|NCT00545363|593891664|FG001|Overall Study|Adverse Event|7|||
164415244|NCT00545363|593891663|FG000|Overall Study|Withdrawal by Subject|6|||
164415245|NCT00545363|593891664|FG001|Overall Study|Withdrawal by Subject|5|||
164415246|NCT00545363|593891663|FG000|Overall Study|Non-compliance|3|||
164415247|NCT00545363|593891664|FG001|Overall Study|Non-compliance|1|||
164415248|NCT00545363|593891663|FG000|Overall Study|Did not meet entry criteria|1|||
164415249|NCT00545363|593891664|FG001|Overall Study|Did not meet entry criteria|1|||
164415250|NCT00545363|593891663|FG000|Overall Study|Lost to Follow-up|2|||
164415251|NCT00545363|593891664|FG001|Overall Study|Lost to Follow-up|0|||
164710632|NCT00686075|594964577|FG009|Overall Study|Lost to Follow-up|3|||
164710633|NCT00686075|594964568|FG000|Overall Study|Other|1|||
164710634|NCT00686075|594964569|FG001|Overall Study|Other|1|||
164710635|NCT00686075|594964570|FG002|Overall Study|Other|0|||
164710636|NCT00686075|594964571|FG003|Overall Study|Other|0|||
164466302|NCT02684227|594077935|FG000|Overall Study|Adverse Event|1|||
164466303|NCT02684227|594077936|FG001|Overall Study|Adverse Event|7|||
164466304|NCT02684227|594077935|FG000|Overall Study|Death|0|||
164466305|NCT02684227|594077936|FG001|Overall Study|Death|2|||
164710637|NCT00686075|594964572|FG004|Overall Study|Other|0|||
164710638|NCT00686075|594964573|FG005|Overall Study|Other|0|||
164710639|NCT00686075|594964574|FG006|Overall Study|Other|0|||
164710640|NCT00686075|594964575|FG007|Overall Study|Other|0|||
164710641|NCT00686075|594964576|FG008|Overall Study|Other|0|||
164710642|NCT00686075|594964577|FG009|Overall Study|Other|1|||
164710643|NCT03783039|594964578|FG000|Overall Study|Death|2|||
164710644|NCT03783039|594964579|FG001|Overall Study|Death|1|||
164710645|NCT01119508|594964580|FG000|Overall Study|Adverse Event|56|||
164710646|NCT01119508|594964580|FG000|Overall Study|Withdrawal by Subject|2|||
164710647|NCT01119508|594964580|FG000|Overall Study|Died before tumor response evaluation|1|||
164710648|NCT00837473|594964583|FG000|Overall Study|Lost to Follow-up|1|||
164710649|NCT00837473|594964583|FG000|Overall Study|Withdrawal by Subject|2|||
164710650|NCT02338193|594964584|FG000|Overall Study|Withdrawal by Subject|0|||
164710651|NCT02338193|594964585|FG001|Overall Study|Withdrawal by Subject|0|||
164710652|NCT02338193|594964586|FG002|Overall Study|Withdrawal by Subject|2|||
164710653|NCT02338193|594964584|FG000|Overall Study|Pregnancy|0|||
164710654|NCT02338193|594964585|FG001|Overall Study|Pregnancy|1|||
164710655|NCT02338193|594964586|FG002|Overall Study|Pregnancy|1|||
164710656|NCT02338193|594964584|FG000|Overall Study|Noncompliant with visits|2|||
164710657|NCT02338193|594964585|FG001|Overall Study|Noncompliant with visits|2|||
164710658|NCT02338193|594964586|FG002|Overall Study|Noncompliant with visits|7|||
164710659|NCT02338193|594964584|FG000|Overall Study|moved out of state|0|||
164710660|NCT02338193|594964585|FG001|Overall Study|moved out of state|1|||
164710661|NCT02338193|594964586|FG002|Overall Study|moved out of state|0|||
164710662|NCT02338193|594964584|FG000|Overall Study|intolerant of side effects|1|||
164710663|NCT02338193|594964585|FG001|Overall Study|intolerant of side effects|0|||
164710664|NCT02338193|594964586|FG002|Overall Study|intolerant of side effects|0|||
164710665|NCT01724489|594964587|FG000|Overall Study|Adverse Event|8|||
164710666|NCT01724489|594964588|FG001|Overall Study|Adverse Event|3|||
164710667|NCT01724489|594964587|FG000|Overall Study|Surgery, medication|1|||
164710668|NCT01724489|594964588|FG001|Overall Study|Surgery, medication|1|||
164710669|NCT01724489|594964587|FG000|Overall Study|Lost to Follow-up|1|||
164710670|NCT01724489|594964588|FG001|Overall Study|Lost to Follow-up|2|||
164710671|NCT01724489|594964587|FG000|Overall Study|Withdrawal by Subject|6|||
164710672|NCT01724489|594964588|FG001|Overall Study|Withdrawal by Subject|6|||
164710673|NCT00867503|594964591|FG000|Overall Study|Withdrawal by Subject|1|||
164710674|NCT02704403|594964592|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
164710675|NCT02704403|594964593|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
164710676|NCT02704403|594964592|FG000|Overall Study|Administrative reasons by sponsor|1251|||
164710677|NCT02704403|594964593|FG001|Overall Study|Administrative reasons by sponsor|616|||
164710678|NCT02704403|594964592|FG000|Overall Study|Death|4|||
164710679|NCT02704403|594964593|FG001|Overall Study|Death|3|||
164710680|NCT02704403|594964592|FG000|Overall Study|Endpoint event|52|||
164710681|NCT02704403|594964593|FG001|Overall Study|Endpoint event|24|||
164710682|NCT02704403|594964592|FG000|Overall Study|Lost to Follow-up|22|||
164710683|NCT02704403|594964593|FG001|Overall Study|Lost to Follow-up|11|||
164710684|NCT02704403|594964592|FG000|Overall Study|Protocol Violation|15|||
164710685|NCT02704403|594964593|FG001|Overall Study|Protocol Violation|15|||
164710686|NCT02704403|594964592|FG000|Overall Study|Adverse Event|2|||
164710687|NCT02704403|594964593|FG001|Overall Study|Adverse Event|0|||
164710688|NCT02704403|594964592|FG000|Overall Study|Withdrawal by Subject|85|||
164710689|NCT02704403|594964593|FG001|Overall Study|Withdrawal by Subject|45|||
164710690|NCT02704403|594964592|FG000|Overall Study|Investigator decision|1|||
164710691|NCT02704403|594964593|FG001|Overall Study|Investigator decision|1|||
164710692|NCT02704403|594964592|FG000|Overall Study|Follow-up not possible|1|||
164144817|NCT01524978|592891776|FG002|Overall Study|Death|5|||
164466306|NCT02684227|594077935|FG000|Overall Study|Withdrawal by Subject|0|||
164710693|NCT02704403|594964593|FG001|Overall Study|Follow-up not possible|2|||
164710694|NCT01844856|594964600|FG000|Overall Study|Lost to Follow-up|15|||
164710695|NCT01844856|594964601|FG001|Overall Study|Lost to Follow-up|3|||
164710696|NCT01844856|594964600|FG000|Overall Study|Adverse Event|3|||
164710697|NCT01844856|594964601|FG001|Overall Study|Adverse Event|6|||
164710698|NCT01844856|594964600|FG000|Overall Study|Withdrawal by Subject|3|||
164710699|NCT01844856|594964601|FG001|Overall Study|Withdrawal by Subject|2|||
164710700|NCT01844856|594964600|FG000|Overall Study|Noncompliance|2|||
164710701|NCT01844856|594964601|FG001|Overall Study|Noncompliance|3|||
164710702|NCT01844856|594964600|FG000|Overall Study|Enterococcus Resistant|0|||
164710703|NCT01844856|594964601|FG001|Overall Study|Enterococcus Resistant|1|||
164710704|NCT01844856|594964600|FG000|Overall Study|Inadvertently Not Scheduled|1|||
164710705|NCT01844856|594964601|FG001|Overall Study|Inadvertently Not Scheduled|0|||
164710706|NCT01844856|594964600|FG000|Overall Study|Randomized but was a Screen Failure|0|||
164710707|NCT01844856|594964601|FG001|Overall Study|Randomized but was a Screen Failure|1|||
164710708|NCT00927394|594964604|FG000|Overall Study|Adverse Event|14|||
164466307|NCT02684227|594077936|FG001|Overall Study|Withdrawal by Subject|1|||
164466308|NCT02684227|594077935|FG000|Overall Study|Progressive Disease|0|||
164466309|NCT02684227|594077936|FG001|Overall Study|Progressive Disease|2|||
164466310|NCT04571619|594077939|FG000|Phase 1|Death|22|||
164466311|NCT04571619|594077940|FG001|Phase 1|Death|18|||
164466312|NCT04571619|594077939|FG000|Phase 1|Withdrawal by Subject|7|||
164466313|NCT04571619|594077940|FG001|Phase 1|Withdrawal by Subject|2|||
164466314|NCT04571619|594077939|FG000|Phase 2|Death|13|||
164466315|NCT04571619|594077940|FG001|Phase 2|Death|16|||
164466316|NCT04571619|594077939|FG000|Phase 2|Withdrawal by Subject|6|||
164466317|NCT04571619|594077940|FG001|Phase 2|Withdrawal by Subject|4|||
164466318|NCT04479761|594077942|FG000|Overall Study|could not perform the balance tasks|1|||
164466319|NCT04479761|594077943|FG001|Overall Study|could not perform the balance tasks|0|||
164466320|NCT04479761|594077944|FG002|Overall Study|could not perform the balance tasks|0|||
164466321|NCT04479761|594077942|FG000|Overall Study|Adverse Event|1|||
164466322|NCT04479761|594077943|FG001|Overall Study|Adverse Event|0|||
164466323|NCT04479761|594077944|FG002|Overall Study|Adverse Event|0|||
164466324|NCT04479761|594077942|FG000|Overall Study|one control did not meet screening criteria|0|||
164466325|NCT04479761|594077943|FG001|Overall Study|one control did not meet screening criteria|0|||
164466326|NCT04479761|594077944|FG002|Overall Study|one control did not meet screening criteria|1|||
164466327|NCT04479761|594077942|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
164466328|NCT04479761|594077943|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
164466329|NCT04479761|594077944|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
164466330|NCT04499924|594079856|FG000|Overall Study|Study termination by sponsor|4|||
164466331|NCT04499924|594079857|FG001|Overall Study|Study termination by sponsor|6|||
164466332|NCT04499924|594079856|FG000|Overall Study|Withdrawal by Subject|1|||
164466333|NCT04499924|594079857|FG001|Overall Study|Withdrawal by Subject|3|||
164466334|NCT04850898|594079858|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
164466335|NCT04850898|594079859|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
164466336|NCT04909801|594079868|FG000|Overall Study|Lack of Efficacy|2|||
164466337|NCT04909801|594079869|FG001|Overall Study|Lack of Efficacy|1|||
164466338|NCT04909801|594079868|FG000|Overall Study|Adverse Event|1|||
164466339|NCT04909801|594079869|FG001|Overall Study|Adverse Event|2|||
164466340|NCT04909801|594079868|FG000|Overall Study|Participant request to discontinue study treatment|1|||
164466341|NCT04909801|594079869|FG001|Overall Study|Participant request to discontinue study treatment|2|||
164466342|NCT04909801|594079868|FG000|Overall Study|Withdrawal by Subject|2|||
164466343|NCT04909801|594079869|FG001|Overall Study|Withdrawal by Subject|1|||
164466344|NCT04909801|594079868|FG000|Overall Study|other reasons|1|||
164466345|NCT04909801|594079869|FG001|Overall Study|other reasons|1|||
164466346|NCT04550221|594079870|FG000|Overall Study|Lost to Follow-up|0|||
164466347|NCT04550221|594079871|FG001|Overall Study|Lost to Follow-up|4|||
164466348|NCT04550221|594079870|FG000|Overall Study|Withdrawn|3|||
164466349|NCT04550221|594079871|FG001|Overall Study|Withdrawn|0|||
164466350|NCT04550221|594079870|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
164466351|NCT04550221|594079871|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
164466352|NCT05274074|594079872|FG000|Overall Study|Lost to Follow-up|2|||
164466353|NCT05274074|594079873|FG001|Overall Study|Lost to Follow-up|3|||
164466354|NCT05274074|594079872|FG000|Overall Study|Withdrawal by Subject|1|||
164466355|NCT05274074|594079873|FG001|Overall Study|Withdrawal by Subject|2|||
164466356|NCT04117347|594079874|FG000|Overall Study|Adverse Event|0|||
164466357|NCT04117347|594079875|FG001|Overall Study|Adverse Event|0|||
164466358|NCT04117347|594079876|FG002|Overall Study|Adverse Event|1|||
164466359|NCT04117347|594079874|FG000|Overall Study|No time for study|0|||
164466360|NCT04117347|594079875|FG001|Overall Study|No time for study|2|||
164466361|NCT04117347|594079876|FG002|Overall Study|No time for study|0|||
164466362|NCT04117347|594079874|FG000|Overall Study|Family emergency|1|||
164466363|NCT04117347|594079875|FG001|Overall Study|Family emergency|0|||
164466364|NCT04117347|594079876|FG002|Overall Study|Family emergency|0|||
164466365|NCT05194956|594079877|FG000|Washout Period|Withdrawal by Subject|0|||
164466366|NCT05194956|594079878|FG001|Washout Period|Withdrawal by Subject|2|||
164466367|NCT05452460|594079879|FG000|Overall Study|Lost to Follow-up|3|||
164466368|NCT05452460|594079880|FG001|Overall Study|Lost to Follow-up|3|||
164466369|NCT05452460|594079879|FG000|Overall Study|Did not receive intervention|1|||
164466370|NCT05452460|594079880|FG001|Overall Study|Did not receive intervention|0|||
164466371|NCT04447040|594079882|FG000|Overall Study|Lost to Follow-up|2|||
164466372|NCT04447040|594079883|FG001|Overall Study|Lost to Follow-up|1|||
164466373|NCT04447040|594079884|FG002|Overall Study|Lost to Follow-up|3|||
164466374|NCT04447040|594079885|FG003|Overall Study|Lost to Follow-up|3|||
164466375|NCT04447040|594079886|FG004|Overall Study|Lost to Follow-up|1|||
164466376|NCT04447040|594079887|FG005|Overall Study|Lost to Follow-up|3|||
164466377|NCT04447040|594079882|FG000|Overall Study|Withdrawal by Subject|0|||
164466378|NCT04447040|594079883|FG001|Overall Study|Withdrawal by Subject|1|||
164466379|NCT04447040|594079884|FG002|Overall Study|Withdrawal by Subject|1|||
164466380|NCT04447040|594079885|FG003|Overall Study|Withdrawal by Subject|1|||
164415252|NCT00545363|593891663|FG000|Overall Study|Other|1|||
164415253|NCT00545363|593891664|FG001|Overall Study|Other|1|||
164415254|NCT00210119|593891665|FG000|Overall Study|Protocol Violation|1|||
164415255|NCT00210119|593891665|FG000|Overall Study|Withdrawal by Subject|1|||
164415256|NCT00951509|593891666|FG000|Overall Study|Withdrawal by Subject|2|||
164415257|NCT03125941|593891668|FG000|Overall Study|did not receive intervention|1|||
164415258|NCT03125941|593891669|FG001|Overall Study|did not receive intervention|2|||
164415259|NCT00582491|593891670|FG000|Overall Study|Withdrawal by Subject|1|||
164415260|NCT00582491|593891671|FG001|Overall Study|Withdrawal by Subject|0|||
164415261|NCT01461993|593891680|FG000|Overall Study|Withdrawal by Subject|60|||
164415262|NCT01461993|593891681|FG001|Overall Study|Withdrawal by Subject|53|||
164415263|NCT01461993|593891682|FG002|Overall Study|Withdrawal by Subject|16|||
164415264|NCT01461993|593891680|FG000|Overall Study|Lost to Follow-up|44|||
164415265|NCT01461993|593891681|FG001|Overall Study|Lost to Follow-up|48|||
164415266|NCT01461993|593891682|FG002|Overall Study|Lost to Follow-up|22|||
164415267|NCT01461993|593891680|FG000|Overall Study|Protocol Violation|10|||
164415268|NCT01461993|593891681|FG001|Overall Study|Protocol Violation|9|||
164415269|NCT01461993|593891682|FG002|Overall Study|Protocol Violation|7|||
164415270|NCT01461993|593891680|FG000|Overall Study|Adverse Event|9|||
164415271|NCT01461993|593891681|FG001|Overall Study|Adverse Event|11|||
164415272|NCT01461993|593891682|FG002|Overall Study|Adverse Event|3|||
164415273|NCT01461993|593891680|FG000|Overall Study|No longer met eligibility criteria|13|||
164415274|NCT01461993|593891681|FG001|Overall Study|No longer met eligibility criteria|18|||
164415275|NCT01461993|593891682|FG002|Overall Study|No longer met eligibility criteria|10|||
164415276|NCT01461993|593891680|FG000|Overall Study|Did not meet entrance criteria|2|||
164415277|NCT01461993|593891681|FG001|Overall Study|Did not meet entrance criteria|3|||
164415278|NCT01461993|593891682|FG002|Overall Study|Did not meet entrance criteria|0|||
164415279|NCT01461993|593891680|FG000|Overall Study|Other|13|||
164415280|NCT01461993|593891681|FG001|Overall Study|Other|15|||
164415281|NCT01461993|593891682|FG002|Overall Study|Other|6|||
164415282|NCT00680056|593891683|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
164415283|NCT00680056|593891684|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
164415284|NCT00680056|593891683|FG000|Second Intervention|Protocol Violation|3|||
164415285|NCT00680056|593891684|FG001|Second Intervention|Protocol Violation|1|||
164415286|NCT01821898|593891686|FG000|Overall Study|Withdrawal by Subject|2|||
164415287|NCT01821898|593891687|FG001|Overall Study|Withdrawal by Subject|1|||
164415288|NCT01121484|593891689|FG000|Overall Study|Adverse Event|12|||
164415289|NCT01121484|593891690|FG001|Overall Study|Adverse Event|5|||
164415290|NCT01121484|593891689|FG000|Overall Study|Lack of Efficacy|3|||
164415291|NCT01121484|593891690|FG001|Overall Study|Lack of Efficacy|11|||
164415292|NCT01121484|593891689|FG000|Overall Study|Lost to Follow-up|5|||
164415293|NCT01121484|593891690|FG001|Overall Study|Lost to Follow-up|9|||
164415294|NCT01121484|593891689|FG000|Overall Study|Physician Decision|0|||
164415295|NCT01121484|593891690|FG001|Overall Study|Physician Decision|3|||
164415296|NCT01121484|593891689|FG000|Overall Study|Protocol Violation|1|||
164415297|NCT01121484|593891690|FG001|Overall Study|Protocol Violation|0|||
164415298|NCT01121484|593891689|FG000|Overall Study|Withdrawal by Subject|8|||
164415299|NCT01121484|593891690|FG001|Overall Study|Withdrawal by Subject|7|||
164415300|NCT01121484|593891689|FG000|Overall Study|Discontinuation of study by sponsor|0|||
164415301|NCT01121484|593891690|FG001|Overall Study|Discontinuation of study by sponsor|1|||
164415302|NCT01121484|593891689|FG000|Overall Study|Other|3|||
164415303|NCT01121484|593891690|FG001|Overall Study|Other|3|||
164415304|NCT01121484|593891689|FG000|Overall Study|Randomized, not treated|1|||
164415305|NCT01121484|593891690|FG001|Overall Study|Randomized, not treated|4|||
164415306|NCT06390826|593891692|FG000|Overall Study|Never Start Protocol Therapy|1|||
164415307|NCT06390826|593891692|FG000|Overall Study|Adverse Event|1|||
164415308|NCT06390826|593891692|FG000|Overall Study|Disease Progression|8|||
164415309|NCT03679767|593891693|FG000|Overall Study|Death|16|||
164415310|NCT03679767|593891694|FG001|Overall Study|Death|11|||
164415311|NCT03679767|593891695|FG002|Overall Study|Death|17|||
164415312|NCT03679767|593891696|FG003|Overall Study|Death|10|||
164415313|NCT03679767|593891693|FG000|Overall Study|Lost to Follow-up|1|||
164415314|NCT03679767|593891694|FG001|Overall Study|Lost to Follow-up|1|||
164415315|NCT03679767|593891695|FG002|Overall Study|Lost to Follow-up|1|||
164415316|NCT03679767|593891696|FG003|Overall Study|Lost to Follow-up|1|||
164415317|NCT03679767|593891693|FG000|Overall Study|Withdrawal by Subject|0|||
164415318|NCT03679767|593891694|FG001|Overall Study|Withdrawal by Subject|0|||
164415319|NCT03679767|593891695|FG002|Overall Study|Withdrawal by Subject|0|||
164415320|NCT03679767|593891696|FG003|Overall Study|Withdrawal by Subject|1|||
164415321|NCT03679767|593891693|FG000|Overall Study|Follow-up Completed|18|||
164415322|NCT03679767|593891694|FG001|Overall Study|Follow-up Completed|11|||
164415323|NCT03679767|593891695|FG002|Overall Study|Follow-up Completed|11|||
164415324|NCT03679767|593891696|FG003|Overall Study|Follow-up Completed|20|||
164415325|NCT03679767|593891693|FG000|Overall Study|Entered Hospice Care|0|||
164415326|NCT03679767|593891694|FG001|Overall Study|Entered Hospice Care|0|||
164415327|NCT03679767|593891695|FG002|Overall Study|Entered Hospice Care|0|||
164415328|NCT03679767|593891696|FG003|Overall Study|Entered Hospice Care|1|||
164415329|NCT03679767|593891693|FG000|Overall Study|Progressive Disease|0|||
164710709|NCT00927394|594964605|FG001|Overall Study|Adverse Event|9|||
164710710|NCT00927394|594964604|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
164710711|NCT00927394|594964605|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
164710712|NCT00927394|594964604|FG000|Overall Study|Withdrawal by Subject|20|||
164710713|NCT00927394|594964605|FG001|Overall Study|Withdrawal by Subject|24|||
164710714|NCT00927394|594964604|FG000|Overall Study|Lost to Follow-up|8|||
164710715|NCT00927394|594964605|FG001|Overall Study|Lost to Follow-up|14|||
164415330|NCT03679767|593891694|FG001|Overall Study|Progressive Disease|0|||
164415331|NCT03679767|593891695|FG002|Overall Study|Progressive Disease|0|||
164415332|NCT03679767|593891696|FG003|Overall Study|Progressive Disease|1|||
164415333|NCT05229653|593891697|FG000|Overall Study|Lost to Follow-up|1|||
164415334|NCT05229653|593891698|FG001|Overall Study|Lost to Follow-up|0|||
164415335|NCT03915951|593891699|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
164415336|NCT03915951|593891700|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
164415337|NCT03915951|593891699|FG000|Overall Study|Adverse Event|12|||
164415338|NCT03915951|593891700|FG001|Overall Study|Adverse Event|6|||
164415339|NCT03915951|593891699|FG000|Overall Study|Disease progression (radiological)|17|||
164415340|NCT03915951|593891700|FG001|Overall Study|Disease progression (radiological)|15|||
164415341|NCT03915951|593891699|FG000|Overall Study|Disease progression (clinical)|4|||
164415342|NCT03915951|593891700|FG001|Overall Study|Disease progression (clinical)|1|||
164415343|NCT03915951|593891699|FG000|Overall Study|Patient decision|0|||
164415344|NCT03915951|593891700|FG001|Overall Study|Patient decision|4|||
164415345|NCT03915951|593891699|FG000|Overall Study|Investigator decision|0|||
164415346|NCT03915951|593891700|FG001|Overall Study|Investigator decision|1|||
164415347|NCT03915951|593891699|FG000|Overall Study|Consent withdrawn|1|||
164415348|NCT03915951|593891700|FG001|Overall Study|Consent withdrawn|1|||
164415349|NCT03915951|593891699|FG000|Overall Study|Death|0|||
164415350|NCT03915951|593891700|FG001|Overall Study|Death|3|||
164415351|NCT05408468|593891701|FG000|Overall Study|Lost to Follow-up|3|||
164415352|NCT05408468|593891702|FG001|Overall Study|Lost to Follow-up|1|||
164415353|NCT05408468|593891701|FG000|Overall Study|Physician Decision|1|||
164415354|NCT05408468|593891702|FG001|Overall Study|Physician Decision|0|||
164415355|NCT05408468|593891701|FG000|Overall Study|Overwhelmed by clinical situation|3|||
164415356|NCT05408468|593891702|FG001|Overall Study|Overwhelmed by clinical situation|0|||
164415357|NCT05408468|593891701|FG000|Overall Study|Personal illness precluding participation|1|||
164415358|NCT05408468|593891702|FG001|Overall Study|Personal illness precluding participation|0|||
164415359|NCT05408468|593891701|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
164415360|NCT05408468|593891702|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
164415361|NCT02204579|593891707|FG000|Overall Study|Screen failures|2|||
164415362|NCT01396395|593891708|FG000|Overall Study|Withdrawal by Subject|10|||
164415363|NCT01396395|593891709|FG001|Overall Study|Withdrawal by Subject|12|||
164415364|NCT01396395|593891708|FG000|Overall Study|Protocol Violation|3|||
164415365|NCT01396395|593891709|FG001|Overall Study|Protocol Violation|1|||
164415366|NCT01396395|593891708|FG000|Overall Study|Adverse Event|10|||
164415367|NCT01396395|593891709|FG001|Overall Study|Adverse Event|2|||
164415368|NCT01396395|593891708|FG000|Overall Study|Lost to Follow-up|17|||
164415369|NCT01396395|593891709|FG001|Overall Study|Lost to Follow-up|11|||
164415370|NCT01396395|593891708|FG000|Overall Study|Other|0|||
164415371|NCT01396395|593891709|FG001|Overall Study|Other|1|||
164415372|NCT01370005|593891710|FG000|Overall Study|Not treated|1|||
164415373|NCT01370005|593891711|FG001|Overall Study|Not treated|0|||
164415374|NCT01370005|593891712|FG002|Overall Study|Not treated|0|||
164415375|NCT01370005|593891710|FG000|Overall Study|Adverse Event|5|||
164415376|NCT01370005|593891711|FG001|Overall Study|Adverse Event|5|||
164415377|NCT01370005|593891712|FG002|Overall Study|Adverse Event|6|||
164415378|NCT01370005|593891710|FG000|Overall Study|Lack of Efficacy|1|||
164415379|NCT01370005|593891711|FG001|Overall Study|Lack of Efficacy|0|||
164415380|NCT01370005|593891712|FG002|Overall Study|Lack of Efficacy|0|||
164415381|NCT01370005|593891710|FG000|Overall Study|Non compliant with protocol|0|||
164415382|NCT01370005|593891711|FG001|Overall Study|Non compliant with protocol|1|||
164415383|NCT01370005|593891712|FG002|Overall Study|Non compliant with protocol|2|||
164415384|NCT01370005|593891710|FG000|Overall Study|Lost to Follow-up|1|||
164415385|NCT01370005|593891711|FG001|Overall Study|Lost to Follow-up|1|||
164415386|NCT01370005|593891712|FG002|Overall Study|Lost to Follow-up|1|||
164415387|NCT01370005|593891710|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
164415388|NCT01370005|593891711|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
164415389|NCT01370005|593891712|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
164415390|NCT01370005|593891710|FG000|Overall Study|Other reason not defined above|3|||
164415391|NCT01370005|593891711|FG001|Overall Study|Other reason not defined above|0|||
164415392|NCT01370005|593891712|FG002|Overall Study|Other reason not defined above|2|||
164415393|NCT02009696|593891713|FG000|Overall Study|Withdrawal by Subject|2|||
164415394|NCT01018563|593891715|FG000|Overall Study|Termination of the study by Sponsor|2|||
164415395|NCT01018563|593891716|FG001|Overall Study|Termination of the study by Sponsor|1|||
164710716|NCT00927394|594964604|FG000|Overall Study|Administrative Problem|1|||
164710717|NCT00927394|594964605|FG001|Overall Study|Administrative Problem|0|||
164466381|NCT04447040|594079886|FG004|Overall Study|Withdrawal by Subject|0|||
164415396|NCT02344537|593891717|FG000|Overall Study|Protocol Violation|1|||
164415397|NCT02344537|593891718|FG001|Overall Study|Protocol Violation|1|||
164415398|NCT02344537|593891717|FG000|Overall Study|Subject started another treatment after wk 6|1|||
164415399|NCT02344537|593891718|FG001|Overall Study|Subject started another treatment after wk 6|0|||
164415400|NCT02344537|593891717|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
164415401|NCT02344537|593891718|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
164415402|NCT05490329|593891721|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
164415403|NCT05490329|593891722|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
164415404|NCT05490329|593891721|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
164415405|NCT05490329|593891722|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
164415406|NCT05490329|593891721|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
164415407|NCT05490329|593891722|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
164415408|NCT02120664|593891723|FG000|Overall Study|Withdrawal by Subject|0|||
164415409|NCT02120664|593891724|FG001|Overall Study|Withdrawal by Subject|0|||
164415410|NCT02120664|593891725|FG002|Overall Study|Withdrawal by Subject|0|||
164415411|NCT02120664|593891726|FG003|Overall Study|Withdrawal by Subject|1|||
164415412|NCT02120664|593891727|FG004|Overall Study|Withdrawal by Subject|0|||
164415413|NCT02460263|593891728|FG000|Transition Period|Withdrawal by Subject|1|||
164415414|NCT02460263|593891728|FG000|Transition Period|Death|1|||
164415415|NCT03916744|593891729|FG000|Overall Study|Withdrawal by Subject|0|||
164415416|NCT03916744|593891730|FG001|Overall Study|Withdrawal by Subject|1|||
164415417|NCT03916744|593891731|FG002|Overall Study|Withdrawal by Subject|2|||
164415418|NCT03176238|593891734|FG000|Overall Study|Unacceptable AEs|15|||
164415419|NCT03176238|593891735|FG001|Overall Study|Unacceptable AEs|8|||
164415420|NCT03176238|593891734|FG000|Overall Study|Abnormal lab value(s)|2|||
164415421|NCT03176238|593891735|FG001|Overall Study|Abnormal lab value(s)|0|||
164415422|NCT03176238|593891734|FG000|Overall Study|Inter-current illness|0|||
164415423|NCT03176238|593891735|FG001|Overall Study|Inter-current illness|1|||
164415424|NCT03176238|593891734|FG000|Overall Study|Consent withdrawal|14|||
164415425|NCT03176238|593891735|FG001|Overall Study|Consent withdrawal|2|||
164415426|NCT03176238|593891734|FG000|Overall Study|Lost to Follow-up|3|||
164415427|NCT03176238|593891735|FG001|Overall Study|Lost to Follow-up|0|||
164415428|NCT03176238|593891734|FG000|Overall Study|Administrative problems|1|||
164415429|NCT03176238|593891735|FG001|Overall Study|Administrative problems|0|||
164415430|NCT03176238|593891734|FG000|Overall Study|Death|3|||
164415431|NCT03176238|593891735|FG001|Overall Study|Death|0|||
164415432|NCT03176238|593891734|FG000|Overall Study|Disease Progression|133|||
164415433|NCT03176238|593891735|FG001|Overall Study|Disease Progression|22|||
164415434|NCT03176238|593891734|FG000|Overall Study|Tx duration completed per EAP|0|||
164415435|NCT03176238|593891735|FG001|Overall Study|Tx duration completed per EAP|1|||
164415436|NCT03176238|593891734|FG000|Overall Study|Patient is switched to commercial drug|16|||
164415437|NCT03176238|593891735|FG001|Overall Study|Patient is switched to commercial drug|1|||
164415438|NCT03176238|593891734|FG000|Overall Study|Protocol Violation|1|||
164415439|NCT03176238|593891735|FG001|Overall Study|Protocol Violation|0|||
164415440|NCT03176238|593891734|FG000|Overall Study|Changes in the patient's condition|2|||
164415441|NCT03176238|593891735|FG001|Overall Study|Changes in the patient's condition|1|||
164415442|NCT03176238|593891734|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
164415443|NCT03176238|593891735|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
164415444|NCT04524598|593891736|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
164415445|NCT04524598|593891737|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
164415446|NCT04524598|593891738|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
164415447|NCT04524598|593891739|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
164415448|NCT04524598|593891740|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
164415449|NCT04524598|593891736|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
164415450|NCT04524598|593891737|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
164415451|NCT04524598|593891738|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
164415452|NCT04524598|593891739|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
164415453|NCT04524598|593891740|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
164415454|NCT04524598|593891736|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
164415455|NCT04524598|593891737|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
164415456|NCT04524598|593891738|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
164415457|NCT04524598|593891739|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
164415458|NCT04524598|593891740|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
164415459|NCT04524598|593891736|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
164415460|NCT04524598|593891737|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
164415461|NCT04524598|593891738|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
164415462|NCT04524598|593891739|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
164466382|NCT04447040|594079887|FG005|Overall Study|Withdrawal by Subject|0|||
164466383|NCT04433208|594079888|FG000|Overall Study|Withdrawal by Subject|0|||
164415463|NCT04524598|593891740|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
164599515|NCT01274338|594556274|FG002|Overall Study|Adverse Event|180|||
164710718|NCT00927394|594964604|FG000|Overall Study|Death|1|||
164710719|NCT00927394|594964605|FG001|Overall Study|Death|1|||
164710720|NCT00927394|594964604|FG000|Overall Study|Protocol deviation|16|||
164710721|NCT00927394|594964605|FG001|Overall Study|Protocol deviation|13|||
164710722|NCT00927394|594964604|FG000|Overall Study|Randomized in error|0|||
164710723|NCT00927394|594964605|FG001|Overall Study|Randomized in error|1|||
164710724|NCT01221363|594964606|FG000|Overall Study|Pregnancy|1|||
164710725|NCT01221363|594964607|FG001|Overall Study|Pregnancy|0|||
164710726|NCT01221363|594964606|FG000|Overall Study|Withdrawal by Subject|11|||
164710727|NCT01221363|594964607|FG001|Overall Study|Withdrawal by Subject|5|||
164710728|NCT01756079|594964608|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
164710729|NCT01756079|594964608|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
164710730|NCT01756079|594964608|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
164710731|NCT01756079|594964608|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
164710732|NCT01756079|594964608|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
164710733|NCT04623086|594964609|FG000|Overall Study|Withdrawal by Subject|0|||
164710734|NCT04623086|594964610|FG001|Overall Study|Withdrawal by Subject|0|||
164710735|NCT04623086|594964611|FG002|Overall Study|Withdrawal by Subject|10|||
164710736|NCT03464630|594964612|FG000|Overall Study|Lost to Follow-up|62|||
164710737|NCT03464630|594964613|FG001|Overall Study|Lost to Follow-up|52|||
164710738|NCT03464630|594964612|FG000|Overall Study|Withdrawal by Subject|16|||
164710739|NCT03464630|594964613|FG001|Overall Study|Withdrawal by Subject|10|||
164710740|NCT03464630|594964612|FG000|Overall Study|Passive Disengagement|8|||
164710741|NCT03464630|594964613|FG001|Overall Study|Passive Disengagement|4|||
164710742|NCT00715624|594964614|FG000|Overall Study|Adverse Event|12|||
164710743|NCT00715624|594964615|FG001|Overall Study|Adverse Event|37|||
164710744|NCT00715624|594964614|FG000|Overall Study|Lack of Efficacy|11|||
164710745|NCT00715624|594964615|FG001|Overall Study|Lack of Efficacy|11|||
164710746|NCT00715624|594964614|FG000|Overall Study|Lost to Follow-up|1|||
164710747|NCT00715624|594964615|FG001|Overall Study|Lost to Follow-up|2|||
164710748|NCT00715624|594964614|FG000|Overall Study|Protocol Violation|1|||
164710749|NCT00715624|594964615|FG001|Overall Study|Protocol Violation|0|||
164710750|NCT00715624|594964614|FG000|Overall Study|Withdrawal by Subject|11|||
164710751|NCT00715624|594964615|FG001|Overall Study|Withdrawal by Subject|25|||
164710752|NCT00715624|594964614|FG000|Overall Study|Familial and personal reasons|10|||
164710753|NCT00715624|594964615|FG001|Overall Study|Familial and personal reasons|22|||
164710754|NCT00715624|594964614|FG000|Overall Study|Poor compliance|6|||
164710755|NCT00715624|594964615|FG001|Overall Study|Poor compliance|13|||
164710756|NCT00715624|594964614|FG000|Overall Study|Sponsor decision|0|||
164710757|NCT00715624|594964615|FG001|Overall Study|Sponsor decision|4|||
164710758|NCT00715624|594964614|FG000|Overall Study|Incorrect randomization (not treated)|0|||
164710759|NCT00715624|594964615|FG001|Overall Study|Incorrect randomization (not treated)|1|||
164710760|NCT00715624|594964614|FG000|Overall Study|Other|0|||
164710761|NCT00715624|594964615|FG001|Overall Study|Other|1|||
164710762|NCT04524364|594964618|FG000|Overall Study|Physician Decision|3|||
164710763|NCT04524364|594964619|FG001|Overall Study|Physician Decision|6|||
164710764|NCT04524364|594964618|FG000|Overall Study|Adverse Event|0|||
164466384|NCT04433208|594079889|FG001|Overall Study|Withdrawal by Subject|1|||
164466385|NCT04433208|594079890|FG002|Overall Study|Withdrawal by Subject|1|||
164466386|NCT04433208|594079891|FG003|Overall Study|Withdrawal by Subject|0|||
164466387|NCT04433208|594079892|FG004|Overall Study|Withdrawal by Subject|2|||
164466388|NCT04433208|594079893|FG005|Overall Study|Withdrawal by Subject|1|||
164466389|NCT04433208|594079888|FG000|Overall Study|Lost to Follow-up|0|||
164466390|NCT04433208|594079889|FG001|Overall Study|Lost to Follow-up|0|||
164466391|NCT04433208|594079890|FG002|Overall Study|Lost to Follow-up|0|||
164466392|NCT04433208|594079891|FG003|Overall Study|Lost to Follow-up|0|||
164466393|NCT04433208|594079892|FG004|Overall Study|Lost to Follow-up|0|||
164466394|NCT04433208|594079893|FG005|Overall Study|Lost to Follow-up|1|||
164466395|NCT05485779|594079896|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
164466396|NCT05485779|594079897|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
164466397|NCT05485779|594079898|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
164466398|NCT05485779|594079899|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
164466399|NCT05485779|594079900|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
164466400|NCT05485779|594079901|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
164466401|NCT05485779|594079902|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
164466402|NCT05485779|594079903|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
164710765|NCT04524364|594964619|FG001|Overall Study|Adverse Event|1|||
164710766|NCT04524364|594964618|FG000|Overall Study|Investigational device deficiency|0|||
164710767|NCT04524364|594964619|FG001|Overall Study|Investigational device deficiency|1|||
164710768|NCT04524364|594964618|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
164710769|NCT04524364|594964619|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
164710770|NCT04524364|594964618|FG000|Overall Study|Device unavailability|0|||
164710771|NCT04524364|594964619|FG001|Overall Study|Device unavailability|2|||
164710772|NCT04524364|594964618|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
164710773|NCT04524364|594964619|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
164710774|NCT04524364|594964618|FG000|Overall Study|Low International normalized ratio (INR)|1|||
164710775|NCT04524364|594964619|FG001|Overall Study|Low International normalized ratio (INR)|0|||
164710776|NCT02309138|594964620|FG000|Overall Study|Withdrawal by Subject|44|||
164144818|NCT01524978|592891777|FG003|Overall Study|Death|24|||
164415464|NCT04524598|593891736|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
164415465|NCT04524598|593891737|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
164415466|NCT04524598|593891738|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
164415467|NCT04524598|593891739|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
164415468|NCT04524598|593891740|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
164415469|NCT04524598|593891736|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
164415470|NCT04524598|593891737|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
164415471|NCT04524598|593891738|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
164415472|NCT04524598|593891739|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
164415473|NCT04524598|593891740|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
164415474|NCT04524598|593891736|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
164415475|NCT04524598|593891737|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
164415476|NCT04524598|593891738|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
164415477|NCT04524598|593891739|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
164415478|NCT04524598|593891740|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
164415479|NCT03936777|593891741|FG000|Overall Study|Adverse Event|3|||
164415480|NCT03936777|593891741|FG000|Overall Study|Death|3|||
164415481|NCT03936777|593891741|FG000|Overall Study|Lack of Efficacy|24|||
164415482|NCT03936777|593891741|FG000|Overall Study|Lost to Follow-up|3|||
164415483|NCT03936777|593891741|FG000|Overall Study|Physician Decision|1|||
164415484|NCT03936777|593891741|FG000|Overall Study|Withdrawal by Subject|11|||
164415485|NCT03936777|593891741|FG000|Overall Study|Subjected Weaned of ZX008|1|||
164415486|NCT03936777|593891741|FG000|Overall Study|Missing|6|||
164415487|NCT02306122|593891745|FG000|Initial Physician Randomization|Physician Decision|0|||
164415488|NCT02306122|593891746|FG001|Initial Physician Randomization|Physician Decision|0|||
164415489|NCT02306122|593891747|FG002|Initial Physician Randomization|Physician Decision|0|||
164415490|NCT02306122|593891748|FG003|Initial Physician Randomization|Physician Decision|0|||
164415491|NCT02306122|593891749|FG004|Initial Physician Randomization|Physician Decision|0|||
164415492|NCT02306122|593891750|FG005|Initial Physician Randomization|Physician Decision|0|||
164415493|NCT02306122|593891751|FG006|Initial Physician Randomization|Physician Decision|0|||
164415494|NCT02306122|593891752|FG007|Initial Physician Randomization|Physician Decision|0|||
164415495|NCT02306122|593891753|FG008|Initial Physician Randomization|Physician Decision|1|||
164415496|NCT02306122|593891754|FG009|Initial Physician Randomization|Physician Decision|0|||
164415497|NCT02306122|593891755|FG010|Initial Physician Randomization|Physician Decision|0|||
164415498|NCT01351025|593891757|FG000|Week 0 - 20|Lost to Follow-up|2|||
164415499|NCT01351025|593891758|FG001|Week 0 - 20|Lost to Follow-up|1|||
164415500|NCT01351025|593891757|FG000|Week 0 - 20|Withdrawal by Subject|1|||
164415501|NCT01351025|593891758|FG001|Week 0 - 20|Withdrawal by Subject|0|||
164415502|NCT01351025|593891757|FG000|Week 24 - 44|Lost to Follow-up|0|||
164415503|NCT01351025|593891758|FG001|Week 24 - 44|Lost to Follow-up|2|||
164415504|NCT01351025|593891757|FG000|Week 24 - 44|Site closed|0|||
164415505|NCT01351025|593891758|FG001|Week 24 - 44|Site closed|1|||
164415506|NCT01351025|593891757|FG000|Week 24 - 44|unable to get to clinic|1|||
164415507|NCT01351025|593891758|FG001|Week 24 - 44|unable to get to clinic|1|||
164415508|NCT02638623|593891759|FG000|Overall Study|Surgery timing|5|||
164415509|NCT02638623|593891760|FG001|Overall Study|Surgery timing|6|||
164415510|NCT02638623|593891759|FG000|Overall Study|Not given intervention|2|||
164415511|NCT02638623|593891760|FG001|Overall Study|Not given intervention|0|||
164415512|NCT00180713|593891761|FG000|Overall Study|Withdrawal by Subject|2|||
164415513|NCT00180713|593891762|FG001|Overall Study|Withdrawal by Subject|0|||
164415514|NCT00180713|593891761|FG000|Overall Study|Adverse Event|3|||
164415515|NCT00180713|593891762|FG001|Overall Study|Adverse Event|3|||
164415516|NCT05295732|593891763|FG000|Phase 3: Double-blind / MUsT: Treatment|Various reasons|14|||
164415517|NCT05295732|593891764|FG001|Phase 3: Double-blind / MUsT: Treatment|Various reasons|4|||
164415518|NCT05295732|593891765|FG002|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
164415519|NCT05295732|593891766|FG003|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
164415520|NCT05295732|593891767|FG004|Phase 3: Double-blind / MUsT: Treatment|Various reasons|2|||
164415521|NCT05295732|593891763|FG000|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
164415522|NCT05295732|593891764|FG001|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
164415523|NCT05295732|593891765|FG002|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
164415524|NCT05295732|593891766|FG003|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
164415525|NCT05295732|593891767|FG004|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
164415526|NCT02322814|593891768|FG000|Overall Study|Death|7|||
164415527|NCT02322814|593891769|FG001|Overall Study|Death|29|||
164415528|NCT02322814|593891770|FG002|Overall Study|Death|32|||
164710777|NCT02309138|594964621|FG001|Overall Study|Withdrawal by Subject|15|||
164466403|NCT05485779|594079904|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
164466404|NCT05485779|594079905|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
164466405|NCT05485779|594079906|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
164466406|NCT05485779|594079896|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
164466407|NCT05485779|594079897|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
164466408|NCT05485779|594079898|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
164466409|NCT05485779|594079899|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
164466410|NCT05485779|594079900|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
164466411|NCT05485779|594079901|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
164466412|NCT05485779|594079902|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
164466413|NCT05485779|594079903|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
164466414|NCT05485779|594079904|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
164466415|NCT05485779|594079905|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
164466416|NCT05485779|594079906|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
164466417|NCT05485779|594079896|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
164466418|NCT05485779|594079897|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
164466419|NCT05485779|594079898|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
164466420|NCT05485779|594079899|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
164466421|NCT05485779|594079900|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
164466422|NCT05485779|594079901|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
164466423|NCT05485779|594079902|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
164466424|NCT05485779|594079903|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
164466425|NCT05485779|594079904|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
164466426|NCT05485779|594079905|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
164466427|NCT05485779|594079906|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
164466428|NCT02038777|594079907|FG000|Overall Study|Death|0|||
164466429|NCT02038777|594079908|FG001|Overall Study|Death|2|||
164466430|NCT02038777|594079909|FG002|Overall Study|Death|0|||
164466431|NCT02038777|594079910|FG003|Overall Study|Death|1|||
164466432|NCT02038777|594079911|FG004|Overall Study|Death|2|||
164466433|NCT02038777|594079912|FG005|Overall Study|Death|4|||
164466434|NCT02038777|594079913|FG006|Overall Study|Death|0|||
164466435|NCT02038777|594079914|FG007|Overall Study|Death|11|||
164466436|NCT02038777|594079907|FG000|Overall Study|Lost to Follow-up|0|||
164466437|NCT02038777|594079908|FG001|Overall Study|Lost to Follow-up|0|||
164466438|NCT02038777|594079909|FG002|Overall Study|Lost to Follow-up|0|||
164466439|NCT02038777|594079910|FG003|Overall Study|Lost to Follow-up|1|||
164466440|NCT02038777|594079911|FG004|Overall Study|Lost to Follow-up|0|||
164466441|NCT02038777|594079912|FG005|Overall Study|Lost to Follow-up|0|||
164466442|NCT02038777|594079913|FG006|Overall Study|Lost to Follow-up|0|||
164466443|NCT02038777|594079914|FG007|Overall Study|Lost to Follow-up|0|||
164466444|NCT02038777|594079907|FG000|Overall Study|Other|0|||
164466445|NCT02038777|594079908|FG001|Overall Study|Other|1|||
164466446|NCT02038777|594079909|FG002|Overall Study|Other|0|||
164466447|NCT02038777|594079910|FG003|Overall Study|Other|2|||
164466448|NCT02038777|594079911|FG004|Overall Study|Other|1|||
164466449|NCT02038777|594079912|FG005|Overall Study|Other|0|||
164466450|NCT02038777|594079913|FG006|Overall Study|Other|0|||
164466451|NCT02038777|594079914|FG007|Overall Study|Other|0|||
164466452|NCT02038777|594079907|FG000|Overall Study|Randomized but not treated|0|||
164466453|NCT02038777|594079908|FG001|Overall Study|Randomized but not treated|1|||
164466454|NCT02038777|594079909|FG002|Overall Study|Randomized but not treated|0|||
164466455|NCT02038777|594079910|FG003|Overall Study|Randomized but not treated|0|||
164466456|NCT02038777|594079911|FG004|Overall Study|Randomized but not treated|0|||
164466457|NCT02038777|594079912|FG005|Overall Study|Randomized but not treated|0|||
164466458|NCT02038777|594079913|FG006|Overall Study|Randomized but not treated|0|||
164466459|NCT02038777|594079914|FG007|Overall Study|Randomized but not treated|0|||
164466460|NCT02038777|594079907|FG000|Overall Study|Started Chemotherapy|1|||
164466461|NCT02038777|594079908|FG001|Overall Study|Started Chemotherapy|0|||
164466462|NCT02038777|594079909|FG002|Overall Study|Started Chemotherapy|3|||
164466463|NCT02038777|594079910|FG003|Overall Study|Started Chemotherapy|0|||
164466464|NCT02038777|594079911|FG004|Overall Study|Started Chemotherapy|0|||
164466465|NCT02038777|594079912|FG005|Overall Study|Started Chemotherapy|0|||
164466466|NCT02038777|594079913|FG006|Overall Study|Started Chemotherapy|0|||
164599516|NCT01274338|594556275|FG003|Overall Study|Adverse Event|1|||
164599517|NCT01274338|594556276|FG004|Overall Study|Adverse Event|0|||
164599518|NCT01274338|594556277|FG005|Overall Study|Adverse Event|0|||
164599519|NCT01274338|594556272|FG000|Overall Study|Death|8|||
164599520|NCT01274338|594556273|FG001|Overall Study|Death|1|||
164599521|NCT01274338|594556274|FG002|Overall Study|Death|0|||
164466467|NCT02038777|594079914|FG007|Overall Study|Started Chemotherapy|0|||
164466468|NCT02038777|594079907|FG000|Overall Study|participation terminated by sponsor|0|||
164466469|NCT02038777|594079908|FG001|Overall Study|participation terminated by sponsor|0|||
164466470|NCT02038777|594079909|FG002|Overall Study|participation terminated by sponsor|0|||
164466471|NCT02038777|594079910|FG003|Overall Study|participation terminated by sponsor|0|||
164466472|NCT02038777|594079911|FG004|Overall Study|participation terminated by sponsor|0|||
164466473|NCT02038777|594079912|FG005|Overall Study|participation terminated by sponsor|0|||
164466474|NCT02038777|594079913|FG006|Overall Study|participation terminated by sponsor|1|||
164466475|NCT02038777|594079914|FG007|Overall Study|participation terminated by sponsor|1|||
164466476|NCT02694822|594079920|FG000|Phase 1|Death|2|||
164466477|NCT02694822|594079921|FG001|Phase 1|Death|1|||
164466478|NCT02694822|594079922|FG002|Phase 1|Death|6|||
164466479|NCT02694822|594079923|FG003|Phase 1|Death|6|||
164466480|NCT02694822|594079924|FG004|Phase 1|Death|3|||
164466481|NCT02694822|594079925|FG005|Phase 1|Death|0|||
164466482|NCT02694822|594079920|FG000|Phase 1|Withdrawal by Subject|2|||
164466483|NCT02694822|594079921|FG001|Phase 1|Withdrawal by Subject|2|||
164466484|NCT02694822|594079922|FG002|Phase 1|Withdrawal by Subject|4|||
164466485|NCT02694822|594079923|FG003|Phase 1|Withdrawal by Subject|8|||
164466486|NCT02694822|594079924|FG004|Phase 1|Withdrawal by Subject|1|||
164466487|NCT02694822|594079925|FG005|Phase 1|Withdrawal by Subject|0|||
164466488|NCT02694822|594079920|FG000|Phase 2|Death|0|||
164466489|NCT02694822|594079921|FG001|Phase 2|Death|0|||
164466490|NCT02694822|594079922|FG002|Phase 2|Death|0|||
164466491|NCT02694822|594079923|FG003|Phase 2|Death|0|||
164466492|NCT02694822|594079924|FG004|Phase 2|Death|0|||
164466493|NCT02694822|594079925|FG005|Phase 2|Death|26|||
164466494|NCT02694822|594079920|FG000|Phase 2|Withdrawal by Subject|0|||
164466495|NCT02694822|594079921|FG001|Phase 2|Withdrawal by Subject|0|||
164466496|NCT02694822|594079922|FG002|Phase 2|Withdrawal by Subject|0|||
164466497|NCT02694822|594079923|FG003|Phase 2|Withdrawal by Subject|0|||
164466498|NCT02694822|594079924|FG004|Phase 2|Withdrawal by Subject|0|||
164466499|NCT02694822|594079925|FG005|Phase 2|Withdrawal by Subject|13|||
164466500|NCT02694822|594079920|FG000|Phase 2|Administrative Study Closure|0|||
164466501|NCT02694822|594079921|FG001|Phase 2|Administrative Study Closure|0|||
164466502|NCT02694822|594079922|FG002|Phase 2|Administrative Study Closure|0|||
164466503|NCT02694822|594079923|FG003|Phase 2|Administrative Study Closure|0|||
164466504|NCT02694822|594079924|FG004|Phase 2|Administrative Study Closure|0|||
164466505|NCT02694822|594079925|FG005|Phase 2|Administrative Study Closure|2|||
164466506|NCT02694822|594079920|FG000|Phase 2|Lost to Follow-up|0|||
164466507|NCT02694822|594079921|FG001|Phase 2|Lost to Follow-up|0|||
164466508|NCT02694822|594079922|FG002|Phase 2|Lost to Follow-up|0|||
164466509|NCT02694822|594079923|FG003|Phase 2|Lost to Follow-up|0|||
164466510|NCT02694822|594079924|FG004|Phase 2|Lost to Follow-up|0|||
164466511|NCT02694822|594079925|FG005|Phase 2|Lost to Follow-up|1|||
164466512|NCT02694822|594079920|FG000|Phase 2|Participant Transferred to Another Site|0|||
164466513|NCT02694822|594079921|FG001|Phase 2|Participant Transferred to Another Site|0|||
164466514|NCT02694822|594079922|FG002|Phase 2|Participant Transferred to Another Site|0|||
164466515|NCT02694822|594079923|FG003|Phase 2|Participant Transferred to Another Site|0|||
164466516|NCT02694822|594079924|FG004|Phase 2|Participant Transferred to Another Site|0|||
164466517|NCT02694822|594079925|FG005|Phase 2|Participant Transferred to Another Site|1|||
164466518|NCT05370040|594079926|FG000|Overall Study|Lost to Follow-up|0|||
164466519|NCT05370040|594079927|FG001|Overall Study|Lost to Follow-up|0|||
164466520|NCT05370040|594079928|FG002|Overall Study|Lost to Follow-up|1|||
164466521|NCT05370040|594079929|FG003|Overall Study|Lost to Follow-up|0|||
164466522|NCT05370040|594079930|FG004|Overall Study|Lost to Follow-up|1|||
164466523|NCT05370040|594079931|FG005|Overall Study|Lost to Follow-up|0|||
164466524|NCT04971109|594079932|FG000|Overall Study|Adverse Event|4|||
164466525|NCT04971109|594079933|FG001|Overall Study|Adverse Event|3|||
164466526|NCT04971109|594079932|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
164466527|NCT04971109|594079933|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
164466528|NCT04971109|594079932|FG000|Overall Study|Lost to Follow-up|8|||
164466529|NCT04971109|594079933|FG001|Overall Study|Lost to Follow-up|2|||
164466530|NCT04971109|594079932|FG000|Overall Study|Physician Decision|5|||
164466531|NCT04971109|594079933|FG001|Overall Study|Physician Decision|0|||
164466532|NCT04971109|594079932|FG000|Overall Study|Protocol Violation|0|||
164466533|NCT04971109|594079933|FG001|Overall Study|Protocol Violation|1|||
164466534|NCT04971109|594079932|FG000|Overall Study|Withdrawal by Subject|18|||
164466535|NCT04971109|594079933|FG001|Overall Study|Withdrawal by Subject|3|||
164466536|NCT04971109|594079932|FG000|Overall Study|Subject was randomized in error|1|||
164466537|NCT04971109|594079933|FG001|Overall Study|Subject was randomized in error|0|||
164466538|NCT05906784|594079935|FG000|Overall Study|Lost to Follow-up|2|||
164466539|NCT05906784|594079936|FG001|Overall Study|Lost to Follow-up|1|||
164599522|NCT01274338|594556275|FG003|Overall Study|Death|0|||
164599523|NCT01274338|594556276|FG004|Overall Study|Death|0|||
164599524|NCT01274338|594556277|FG005|Overall Study|Death|0|||
164599525|NCT01274338|594556272|FG000|Overall Study|Withdrawal by Subject|27|||
164599526|NCT01274338|594556273|FG001|Overall Study|Withdrawal by Subject|99|||
164599527|NCT01274338|594556274|FG002|Overall Study|Withdrawal by Subject|17|||
164599528|NCT01274338|594556275|FG003|Overall Study|Withdrawal by Subject|0|||
164466540|NCT05906784|594079937|FG002|Overall Study|Lost to Follow-up|1|||
164466541|NCT05906784|594079938|FG003|Overall Study|Lost to Follow-up|1|||
164466542|NCT03987022|594079940|FG000|Overall Study|Lost to Follow-up|2|||
164466543|NCT03987022|594079941|FG001|Overall Study|Lost to Follow-up|2|||
164466544|NCT03987022|594079940|FG000|Overall Study|Withdrawal by Subject|1|||
164466545|NCT03987022|594079941|FG001|Overall Study|Withdrawal by Subject|0|||
164466546|NCT03249090|594079951|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
164466547|NCT03249090|594079952|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
164466548|NCT03249090|594079951|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
164466549|NCT03249090|594079952|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
164466550|NCT03249090|594079951|FG000|3 Month Time Point|Voluntary withdrawal|6|||
164466551|NCT03249090|594079952|FG001|3 Month Time Point|Voluntary withdrawal|3|||
164466552|NCT03249090|594079951|FG000|3 Month Time Point|Changed oncology practice|4|||
164466553|NCT03249090|594079952|FG001|3 Month Time Point|Changed oncology practice|2|||
164466554|NCT03249090|594079951|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
164466555|NCT03249090|594079952|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
164466556|NCT03249090|594079951|FG000|12 Month Time Point|Voluntary withdrawal|35|||
164466557|NCT03249090|594079952|FG001|12 Month Time Point|Voluntary withdrawal|4|||
164466558|NCT03249090|594079951|FG000|12 Month Time Point|Changed oncology practice|20|||
164466559|NCT03249090|594079952|FG001|12 Month Time Point|Changed oncology practice|9|||
164466560|NCT03476343|594079961|FG000|Overall Study|Clinical exam moved to another scanner|7|||
164466561|NCT03476343|594079961|FG000|Overall Study|Clinical order cancelled|4|||
164466562|NCT03476343|594079961|FG000|Overall Study|Neonate did not settle down for the scan|1|||
164466563|NCT05147116|594079963|FG000|Overall Study|Withdrawal by Subject|0|||
164466564|NCT05147116|594079964|FG001|Overall Study|Withdrawal by Subject|1|||
164466565|NCT03672916|594079965|FG000|Overall Study|Death|6|||
164466566|NCT03672916|594079965|FG000|Overall Study|Lost to Follow-up|29|||
164466567|NCT03672916|594079965|FG000|Overall Study|Adverse Event|6|||
164466568|NCT03672916|594079965|FG000|Overall Study|Withdrawal by Subject|11|||
164710778|NCT02309138|594964620|FG000|Overall Study|Protocol Violation|4|||
164710779|NCT02309138|594964621|FG001|Overall Study|Protocol Violation|2|||
164710780|NCT02309138|594964620|FG000|Overall Study|delivered before visit 2|0|||
164710781|NCT02309138|594964621|FG001|Overall Study|delivered before visit 2|1|||
164710782|NCT00735397|594964624|FG000|Overall Study|Adverse Event|194|||
164710783|NCT00735397|594964624|FG000|Overall Study|Lost to Follow-up|33|||
164710784|NCT00735397|594964624|FG000|Overall Study|Participant choice|252|||
164710785|NCT00735397|594964624|FG000|Overall Study|Inadequate therapeutic effect|202|||
164710786|NCT00735397|594964624|FG000|Overall Study|Administrative/Other|502|||
164710787|NCT02677714|594964625|FG000|Overall Study|Withdrawal by Subject|2|||
164710788|NCT02677714|594964626|FG001|Overall Study|Withdrawal by Subject|0|||
164710789|NCT00380744|594964627|FG000|Overall Study|Death|0|||
164710790|NCT00380744|594964628|FG001|Overall Study|Death|0|||
164710791|NCT00380744|594964629|FG002|Overall Study|Death|0|||
164710792|NCT00380744|594964630|FG003|Overall Study|Death|0|||
164710793|NCT00380744|594964631|FG004|Overall Study|Death|0|||
164710794|NCT00380744|594964632|FG005|Overall Study|Death|0|||
164710795|NCT00380744|594964633|FG006|Overall Study|Death|1|||
164710796|NCT00380744|594964627|FG000|Overall Study|Withdrawal by Subject|1|||
164710797|NCT00380744|594964628|FG001|Overall Study|Withdrawal by Subject|0|||
164710798|NCT00380744|594964629|FG002|Overall Study|Withdrawal by Subject|0|||
164710799|NCT00380744|594964630|FG003|Overall Study|Withdrawal by Subject|0|||
164710800|NCT00380744|594964631|FG004|Overall Study|Withdrawal by Subject|0|||
164710801|NCT00380744|594964632|FG005|Overall Study|Withdrawal by Subject|0|||
164710802|NCT00380744|594964633|FG006|Overall Study|Withdrawal by Subject|0|||
164710803|NCT01955083|594964643|FG000|Overall Study|Lost to Follow-up|1|||
164710804|NCT01955083|594964644|FG001|Overall Study|Lost to Follow-up|1|||
164710805|NCT01559389|594964653|FG000|Overall Study|Withdrawal by Subject|20|||
164710806|NCT01559389|594964654|FG001|Overall Study|Withdrawal by Subject|20|||
164710807|NCT02871492|594964655|FG000|Overall Study|Lost to Follow-up|6|||
164710808|NCT02871492|594964656|FG001|Overall Study|Lost to Follow-up|3|||
164710809|NCT02871492|594964657|FG002|Overall Study|Lost to Follow-up|5|||
164710810|NCT02871492|594964655|FG000|Overall Study|Withdrawal by Subject|0|||
164144819|NCT01524978|592891778|FG004|Overall Study|Death|4|||
164466569|NCT04197336|594079966|FG000|Overall Study|Withdrawal by Subject|1|||
164466570|NCT02497950|594079970|FG000|Overall Study|Death|209|||
164466571|NCT02497950|594079970|FG000|Overall Study|Transplanted|85|||
164466572|NCT02497950|594079970|FG000|Overall Study|Explanted|8|||
164710811|NCT02871492|594964656|FG001|Overall Study|Withdrawal by Subject|0|||
164710812|NCT02871492|594964657|FG002|Overall Study|Withdrawal by Subject|1|||
164710813|NCT04546724|594964658|FG000|Overall Study|Withdrawal by Subject|145|||
164710814|NCT04546724|594964659|FG001|Overall Study|Withdrawal by Subject|41|||
164710815|NCT04546724|594964658|FG000|Overall Study|Adverse Event|1|||
164710816|NCT04546724|594964659|FG001|Overall Study|Adverse Event|1|||
164710817|NCT04546724|594964658|FG000|Overall Study|Lost to Follow-up|186|||
164710818|NCT04546724|594964659|FG001|Overall Study|Lost to Follow-up|63|||
164710819|NCT04546724|594964658|FG000|Overall Study|Physician Decision|8|||
164710820|NCT04546724|594964659|FG001|Overall Study|Physician Decision|2|||
164710821|NCT04546724|594964658|FG000|Overall Study|Death|2|||
164710822|NCT04546724|594964659|FG001|Overall Study|Death|1|||
164710823|NCT04546724|594964658|FG000|Overall Study|subject has been out of town|1|||
164415529|NCT02322814|593891771|FG003|Overall Study|Death|23|||
164415530|NCT02322814|593891772|FG004|Overall Study|Death|14|||
164415531|NCT02322814|593891768|FG000|Overall Study|Lost to Follow-up|1|||
164415532|NCT02322814|593891769|FG001|Overall Study|Lost to Follow-up|3|||
164415533|NCT02322814|593891770|FG002|Overall Study|Lost to Follow-up|3|||
164415534|NCT02322814|593891771|FG003|Overall Study|Lost to Follow-up|1|||
164415535|NCT02322814|593891772|FG004|Overall Study|Lost to Follow-up|0|||
164415536|NCT02322814|593891768|FG000|Overall Study|Various Reasons|2|||
164415537|NCT02322814|593891769|FG001|Overall Study|Various Reasons|0|||
164415538|NCT02322814|593891770|FG002|Overall Study|Various Reasons|1|||
164415539|NCT02322814|593891771|FG003|Overall Study|Various Reasons|1|||
164415540|NCT02322814|593891772|FG004|Overall Study|Various Reasons|0|||
164415541|NCT02322814|593891768|FG000|Overall Study|Progressive Disease|0|||
164415542|NCT02322814|593891769|FG001|Overall Study|Progressive Disease|0|||
164415543|NCT02322814|593891770|FG002|Overall Study|Progressive Disease|0|||
164415544|NCT02322814|593891771|FG003|Overall Study|Progressive Disease|1|||
164415545|NCT02322814|593891772|FG004|Overall Study|Progressive Disease|1|||
164415546|NCT02322814|593891768|FG000|Overall Study|Protocol Violation|1|||
164415547|NCT02322814|593891769|FG001|Overall Study|Protocol Violation|0|||
164415548|NCT02322814|593891770|FG002|Overall Study|Protocol Violation|0|||
164415549|NCT02322814|593891771|FG003|Overall Study|Protocol Violation|0|||
164415550|NCT02322814|593891772|FG004|Overall Study|Protocol Violation|0|||
164415551|NCT02322814|593891768|FG000|Overall Study|Study Terminated by Sponsor|0|||
164415552|NCT02322814|593891769|FG001|Overall Study|Study Terminated by Sponsor|7|||
164415553|NCT02322814|593891770|FG002|Overall Study|Study Terminated by Sponsor|9|||
164415554|NCT02322814|593891771|FG003|Overall Study|Study Terminated by Sponsor|5|||
164415555|NCT02322814|593891772|FG004|Overall Study|Study Terminated by Sponsor|13|||
164415556|NCT02322814|593891768|FG000|Overall Study|Withdrawal by Subject|5|||
164415557|NCT02322814|593891769|FG001|Overall Study|Withdrawal by Subject|4|||
164415558|NCT02322814|593891770|FG002|Overall Study|Withdrawal by Subject|2|||
164415559|NCT02322814|593891771|FG003|Overall Study|Withdrawal by Subject|1|||
164415560|NCT02322814|593891772|FG004|Overall Study|Withdrawal by Subject|3|||
164415561|NCT03311230|593891774|FG000|Overall Study|Withdrawal by Subject|1|||
164415562|NCT03311230|593891775|FG001|Overall Study|Withdrawal by Subject|4|||
164415563|NCT03311230|593891776|FG002|Overall Study|Withdrawal by Subject|2|||
164415564|NCT03311230|593891777|FG003|Overall Study|Withdrawal by Subject|7|||
164415565|NCT03311230|593891774|FG000|Overall Study|Unrelated injury|0|||
164415566|NCT03311230|593891775|FG001|Overall Study|Unrelated injury|1|||
164415567|NCT03311230|593891776|FG002|Overall Study|Unrelated injury|0|||
164415568|NCT03311230|593891777|FG003|Overall Study|Unrelated injury|0|||
164415569|NCT02998021|593891778|FG000|Overall Study|Withdrawal by Subject|3|||
164415570|NCT02998021|593891779|FG001|Overall Study|Withdrawal by Subject|1|||
164415571|NCT02998021|593891778|FG000|Overall Study|unsafe home|0|||
164415572|NCT02998021|593891779|FG001|Overall Study|unsafe home|1|||
164415573|NCT02032173|593893398|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
164415574|NCT02291289|593893402|FG000|Induction Treatment|Withdrawal by Subject|0|||
164415575|NCT02291289|593893403|FG001|Induction Treatment|Withdrawal by Subject|0|||
164415576|NCT02291289|593893404|FG002|Induction Treatment|Withdrawal by Subject|0|||
164415577|NCT02291289|593893405|FG003|Induction Treatment|Withdrawal by Subject|24|||
164415578|NCT02291289|593893406|FG004|Induction Treatment|Withdrawal by Subject|0|||
164415579|NCT02291289|593893407|FG005|Induction Treatment|Withdrawal by Subject|0|||
164415580|NCT02291289|593893408|FG006|Induction Treatment|Withdrawal by Subject|0|||
164415581|NCT02291289|593893409|FG007|Induction Treatment|Withdrawal by Subject|0|||
164415582|NCT02291289|593893410|FG008|Induction Treatment|Withdrawal by Subject|0|||
164415583|NCT02291289|593893411|FG009|Induction Treatment|Withdrawal by Subject|18|||
164415584|NCT02291289|593893412|FG010|Induction Treatment|Withdrawal by Subject|0|||
164415585|NCT02291289|593893413|FG011|Induction Treatment|Withdrawal by Subject|0|||
164415586|NCT02291289|593893414|FG012|Induction Treatment|Withdrawal by Subject|0|||
164415587|NCT02291289|593893402|FG000|Induction Treatment|Adverse Event|0|||
164415588|NCT02291289|593893403|FG001|Induction Treatment|Adverse Event|0|||
164415589|NCT02291289|593893404|FG002|Induction Treatment|Adverse Event|0|||
164415590|NCT02291289|593893405|FG003|Induction Treatment|Adverse Event|3|||
164415591|NCT02291289|593893406|FG004|Induction Treatment|Adverse Event|0|||
164415592|NCT02291289|593893407|FG005|Induction Treatment|Adverse Event|0|||
164415593|NCT02291289|593893408|FG006|Induction Treatment|Adverse Event|0|||
164415594|NCT02291289|593893409|FG007|Induction Treatment|Adverse Event|0|||
164415595|NCT02291289|593893410|FG008|Induction Treatment|Adverse Event|0|||
164415596|NCT02291289|593893411|FG009|Induction Treatment|Adverse Event|1|||
164415597|NCT02291289|593893412|FG010|Induction Treatment|Adverse Event|0|||
164415598|NCT02291289|593893413|FG011|Induction Treatment|Adverse Event|0|||
164415599|NCT02291289|593893414|FG012|Induction Treatment|Adverse Event|0|||
164415600|NCT02291289|593893402|FG000|Induction Treatment|Death|25|||
164415601|NCT02291289|593893403|FG001|Induction Treatment|Death|0|||
164415602|NCT02291289|593893404|FG002|Induction Treatment|Death|0|||
164415603|NCT02291289|593893405|FG003|Induction Treatment|Death|111|||
164710824|NCT04546724|594964659|FG001|Overall Study|subject has been out of town|0|||
164466573|NCT02497950|594079970|FG000|Overall Study|Device Permanently Deactivated|4|||
164710825|NCT04546724|594964658|FG000|Overall Study|subject is incarcerated|2|||
164710826|NCT04546724|594964659|FG001|Overall Study|subject is incarcerated|0|||
164710827|NCT04546724|594964658|FG000|Overall Study|subject is relocating|12|||
164710828|NCT04546724|594964659|FG001|Overall Study|subject is relocating|4|||
164710829|NCT04546724|594964658|FG000|Overall Study|Subject in another study|1|||
164710830|NCT04546724|594964659|FG001|Overall Study|Subject in another study|1|||
164710831|NCT03583086|594964662|FG000|Overall Study|Death|2|||
164710832|NCT03583086|594964663|FG001|Overall Study|Death|6|||
164710833|NCT03583086|594964664|FG002|Overall Study|Death|12|||
164710834|NCT03583086|594964665|FG003|Overall Study|Death|10|||
164710835|NCT03583086|594964666|FG004|Overall Study|Death|14|||
164710836|NCT03583086|594964667|FG005|Overall Study|Death|14|||
164710837|NCT03583086|594964668|FG006|Overall Study|Death|4|||
164710838|NCT03583086|594964662|FG000|Overall Study|Withdrawal by Subject|0|||
164710839|NCT03583086|594964663|FG001|Overall Study|Withdrawal by Subject|0|||
164710840|NCT03583086|594964664|FG002|Overall Study|Withdrawal by Subject|1|||
164710841|NCT03583086|594964665|FG003|Overall Study|Withdrawal by Subject|0|||
164710842|NCT03583086|594964666|FG004|Overall Study|Withdrawal by Subject|0|||
164710843|NCT03583086|594964667|FG005|Overall Study|Withdrawal by Subject|0|||
164710844|NCT03583086|594964668|FG006|Overall Study|Withdrawal by Subject|1|||
164710845|NCT03583086|594964662|FG000|Overall Study|Refused follow-up|0|||
164710846|NCT03583086|594964663|FG001|Overall Study|Refused follow-up|0|||
164710847|NCT03583086|594964664|FG002|Overall Study|Refused follow-up|1|||
164710848|NCT03583086|594964665|FG003|Overall Study|Refused follow-up|0|||
164710849|NCT03583086|594964666|FG004|Overall Study|Refused follow-up|1|||
164710850|NCT03583086|594964667|FG005|Overall Study|Refused follow-up|0|||
164710851|NCT03583086|594964668|FG006|Overall Study|Refused follow-up|0|||
164710852|NCT03583086|594964662|FG000|Overall Study|Declining Performance Status|0|||
164466574|NCT02497950|594079970|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
164466575|NCT02497950|594079970|FG000|Overall Study|Lost to Follow-up|6|||
164466576|NCT02497950|594079970|FG000|Overall Study|Withdrawal by Subject|2|||
164466577|NCT02497950|594079970|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
164466578|NCT02497950|594079970|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
164466579|NCT03756662|594079977|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
164466580|NCT04295512|594079982|FG000|Overall Study|Lack of family response to schedule assessment|0|||
164466581|NCT04295512|594079983|FG001|Overall Study|Lack of family response to schedule assessment|0|||
164466582|NCT04295512|594079984|FG002|Overall Study|Lack of family response to schedule assessment|0|||
164466583|NCT04295512|594079985|FG003|Overall Study|Lack of family response to schedule assessment|2|||
164466584|NCT04295512|594079982|FG000|Overall Study|Therapist did not refer eligible family|7|||
164466585|NCT04295512|594079983|FG001|Overall Study|Therapist did not refer eligible family|7|||
164466586|NCT04295512|594079984|FG002|Overall Study|Therapist did not refer eligible family|0|||
164466587|NCT04295512|594079985|FG003|Overall Study|Therapist did not refer eligible family|0|||
164466588|NCT04625725|594079989|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
164466589|NCT04625725|594079990|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
164466590|NCT04625725|594079991|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
164466591|NCT04625725|594079992|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
164466592|NCT04625725|594079993|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
164466593|NCT04625725|594079994|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
164466594|NCT04625725|594079989|FG000|Provent Main Study|Withdrawal by Subject|242|||
164466595|NCT04625725|594079990|FG001|Provent Main Study|Withdrawal by Subject|144|||
164466596|NCT04625725|594079991|FG002|Provent Main Study|Withdrawal by Subject|0|||
164466597|NCT04625725|594079992|FG003|Provent Main Study|Withdrawal by Subject|0|||
164466598|NCT04625725|594079993|FG004|Provent Main Study|Withdrawal by Subject|0|||
164466599|NCT04625725|594079994|FG005|Provent Main Study|Withdrawal by Subject|0|||
164466600|NCT04625725|594079989|FG000|Provent Main Study|Physician Decision|5|||
164466601|NCT04625725|594079990|FG001|Provent Main Study|Physician Decision|0|||
164466602|NCT04625725|594079991|FG002|Provent Main Study|Physician Decision|0|||
164466603|NCT04625725|594079992|FG003|Provent Main Study|Physician Decision|0|||
164466604|NCT04625725|594079993|FG004|Provent Main Study|Physician Decision|0|||
164466605|NCT04625725|594079994|FG005|Provent Main Study|Physician Decision|0|||
164466606|NCT04625725|594079989|FG000|Provent Main Study|Protocol Violation|1|||
164466607|NCT04625725|594079990|FG001|Provent Main Study|Protocol Violation|0|||
164710853|NCT03583086|594964663|FG001|Overall Study|Declining Performance Status|0|||
164466608|NCT04625725|594079991|FG002|Provent Main Study|Protocol Violation|0|||
164466609|NCT04625725|594079992|FG003|Provent Main Study|Protocol Violation|0|||
164466610|NCT04625725|594079993|FG004|Provent Main Study|Protocol Violation|0|||
164710854|NCT03583086|594964664|FG002|Overall Study|Declining Performance Status|1|||
164466611|NCT04625725|594079994|FG005|Provent Main Study|Protocol Violation|0|||
164710855|NCT03583086|594964665|FG003|Overall Study|Declining Performance Status|0|||
164710856|NCT03583086|594964666|FG004|Overall Study|Declining Performance Status|0|||
164710857|NCT03583086|594964667|FG005|Overall Study|Declining Performance Status|0|||
164466612|NCT04625725|594079989|FG000|Provent Main Study|Lost to Follow-up|357|||
164466613|NCT04625725|594079990|FG001|Provent Main Study|Lost to Follow-up|200|||
164466614|NCT04625725|594079991|FG002|Provent Main Study|Lost to Follow-up|0|||
164466615|NCT04625725|594079992|FG003|Provent Main Study|Lost to Follow-up|0|||
164466616|NCT04625725|594079993|FG004|Provent Main Study|Lost to Follow-up|0|||
164466617|NCT04625725|594079994|FG005|Provent Main Study|Lost to Follow-up|0|||
164466618|NCT04625725|594079989|FG000|Provent Main Study|Death|22|||
164466619|NCT04625725|594079990|FG001|Provent Main Study|Death|10|||
164466620|NCT04625725|594079991|FG002|Provent Main Study|Death|0|||
164466621|NCT04625725|594079992|FG003|Provent Main Study|Death|0|||
164466622|NCT04625725|594079993|FG004|Provent Main Study|Death|0|||
164466623|NCT04625725|594079994|FG005|Provent Main Study|Death|0|||
164466624|NCT04625725|594079989|FG000|Provent Main Study|Adverse Event|2|||
164466625|NCT04625725|594079990|FG001|Provent Main Study|Adverse Event|1|||
164466626|NCT04625725|594079991|FG002|Provent Main Study|Adverse Event|0|||
164466627|NCT04625725|594079992|FG003|Provent Main Study|Adverse Event|0|||
164466628|NCT04625725|594079993|FG004|Provent Main Study|Adverse Event|0|||
164466629|NCT04625725|594079994|FG005|Provent Main Study|Adverse Event|0|||
164466630|NCT04625725|594079989|FG000|Provent Main Study|Participants dosed in sub-study|310|||
164466631|NCT04625725|594079990|FG001|Provent Main Study|Participants dosed in sub-study|193|||
164466632|NCT04625725|594079991|FG002|Provent Main Study|Participants dosed in sub-study|0|||
164466633|NCT04625725|594079992|FG003|Provent Main Study|Participants dosed in sub-study|0|||
164466634|NCT04625725|594079993|FG004|Provent Main Study|Participants dosed in sub-study|0|||
164466635|NCT04625725|594079994|FG005|Provent Main Study|Participants dosed in sub-study|0|||
164466636|NCT04625725|594079989|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
164466637|NCT04625725|594079990|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
164466638|NCT04625725|594079991|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
164466639|NCT04625725|594079992|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
164466640|NCT04625725|594079993|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
164466641|NCT04625725|594079994|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
164466642|NCT04625725|594079989|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
164466643|NCT04625725|594079990|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
164466644|NCT04625725|594079991|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
164466645|NCT04625725|594079992|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
164466646|NCT04625725|594079993|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
164466647|NCT04625725|594079994|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
164466648|NCT04625725|594079989|FG000|Provent Main Study|INCARCERATION|3|||
164466649|NCT04625725|594079990|FG001|Provent Main Study|INCARCERATION|0|||
164466650|NCT04625725|594079991|FG002|Provent Main Study|INCARCERATION|0|||
164466651|NCT04625725|594079992|FG003|Provent Main Study|INCARCERATION|0|||
164466652|NCT04625725|594079993|FG004|Provent Main Study|INCARCERATION|0|||
164466653|NCT04625725|594079994|FG005|Provent Main Study|INCARCERATION|0|||
164466654|NCT04625725|594079989|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
164466655|NCT04625725|594079990|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
164466656|NCT04625725|594079991|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
164466657|NCT04625725|594079992|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
164466658|NCT04625725|594079993|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
164466659|NCT04625725|594079994|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
164466660|NCT04625725|594079989|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
164466661|NCT04625725|594079990|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
164466662|NCT04625725|594079991|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
164466663|NCT04625725|594079992|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
164466664|NCT04625725|594079993|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
164466665|NCT04625725|594079994|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
164466666|NCT04625725|594079989|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
164466667|NCT04625725|594079990|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
164466668|NCT04625725|594079991|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
164466669|NCT04625725|594079992|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
164466670|NCT04625725|594079993|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
164599529|NCT01274338|594556276|FG004|Overall Study|Withdrawal by Subject|0|||
164599530|NCT01274338|594556277|FG005|Overall Study|Withdrawal by Subject|0|||
164466671|NCT04625725|594079994|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
164466672|NCT04625725|594079989|FG000|Provent Main Study|MISSING REASON|0|||
164466673|NCT04625725|594079990|FG001|Provent Main Study|MISSING REASON|1|||
164466674|NCT04625725|594079991|FG002|Provent Main Study|MISSING REASON|0|||
164466675|NCT04625725|594079992|FG003|Provent Main Study|MISSING REASON|0|||
164466676|NCT04625725|594079993|FG004|Provent Main Study|MISSING REASON|0|||
164466677|NCT04625725|594079994|FG005|Provent Main Study|MISSING REASON|0|||
164466678|NCT04625725|594079989|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
164466679|NCT04625725|594079990|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
164466680|NCT04625725|594079991|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
164466681|NCT04625725|594079992|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
164599531|NCT01274338|594556272|FG000|Overall Study|Did not start treatment|8|||
164466682|NCT04625725|594079993|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
164466683|NCT04625725|594079994|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
164466684|NCT04625725|594079989|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
164466685|NCT04625725|594079990|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
164466686|NCT04625725|594079991|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
164466687|NCT04625725|594079992|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
164466688|NCT04625725|594079993|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
164466689|NCT04625725|594079994|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
164466690|NCT04625725|594079989|FG000|Provent Sub Study|Lost to Follow-up|0|||
164466691|NCT04625725|594079990|FG001|Provent Sub Study|Lost to Follow-up|0|||
164466692|NCT04625725|594079991|FG002|Provent Sub Study|Lost to Follow-up|20|||
164466693|NCT04625725|594079992|FG003|Provent Sub Study|Lost to Follow-up|10|||
164466694|NCT04625725|594079993|FG004|Provent Sub Study|Lost to Follow-up|6|||
164466695|NCT04625725|594079994|FG005|Provent Sub Study|Lost to Follow-up|4|||
164466696|NCT04625725|594079989|FG000|Provent Sub Study|Death|0|||
164466697|NCT04625725|594079990|FG001|Provent Sub Study|Death|0|||
164466698|NCT04625725|594079991|FG002|Provent Sub Study|Death|8|||
164466699|NCT04625725|594079992|FG003|Provent Sub Study|Death|5|||
164466700|NCT04625725|594079993|FG004|Provent Sub Study|Death|0|||
164466701|NCT04625725|594079994|FG005|Provent Sub Study|Death|1|||
164466702|NCT04625725|594079989|FG000|Provent Sub Study|Adverse Event|0|||
164466703|NCT04625725|594079990|FG001|Provent Sub Study|Adverse Event|0|||
164466704|NCT04625725|594079991|FG002|Provent Sub Study|Adverse Event|0|||
164466705|NCT04625725|594079992|FG003|Provent Sub Study|Adverse Event|0|||
164466706|NCT04625725|594079993|FG004|Provent Sub Study|Adverse Event|0|||
164466707|NCT04625725|594079994|FG005|Provent Sub Study|Adverse Event|1|||
164466708|NCT04625725|594079989|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
164466709|NCT04625725|594079990|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
164466710|NCT04625725|594079991|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
164466711|NCT04625725|594079992|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
164466712|NCT04625725|594079993|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
164466713|NCT04625725|594079994|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
164466714|NCT04625725|594079989|FG000|Provent Sub Study|Withdrawal by Subject|0|||
164466715|NCT04625725|594079990|FG001|Provent Sub Study|Withdrawal by Subject|0|||
164466716|NCT04625725|594079991|FG002|Provent Sub Study|Withdrawal by Subject|11|||
164466717|NCT04625725|594079992|FG003|Provent Sub Study|Withdrawal by Subject|13|||
164710858|NCT03583086|594964668|FG006|Overall Study|Declining Performance Status|0|||
164710859|NCT03583086|594964662|FG000|Overall Study|Still on study|0|||
164710860|NCT03583086|594964663|FG001|Overall Study|Still on study|0|||
164415604|NCT02291289|593893406|FG004|Induction Treatment|Death|0|||
164415605|NCT02291289|593893407|FG005|Induction Treatment|Death|0|||
164415606|NCT02291289|593893408|FG006|Induction Treatment|Death|1|||
164415607|NCT02291289|593893409|FG007|Induction Treatment|Death|0|||
164415608|NCT02291289|593893410|FG008|Induction Treatment|Death|0|||
164415609|NCT02291289|593893411|FG009|Induction Treatment|Death|82|||
164415610|NCT02291289|593893412|FG010|Induction Treatment|Death|0|||
164415611|NCT02291289|593893413|FG011|Induction Treatment|Death|0|||
164415612|NCT02291289|593893414|FG012|Induction Treatment|Death|0|||
164415613|NCT02291289|593893402|FG000|Induction Treatment|Lost to Follow-up|1|||
164415614|NCT02291289|593893403|FG001|Induction Treatment|Lost to Follow-up|0|||
164415615|NCT02291289|593893404|FG002|Induction Treatment|Lost to Follow-up|0|||
164415616|NCT02291289|593893405|FG003|Induction Treatment|Lost to Follow-up|12|||
164415617|NCT02291289|593893406|FG004|Induction Treatment|Lost to Follow-up|0|||
164415618|NCT02291289|593893407|FG005|Induction Treatment|Lost to Follow-up|0|||
164415619|NCT02291289|593893408|FG006|Induction Treatment|Lost to Follow-up|0|||
164415620|NCT02291289|593893409|FG007|Induction Treatment|Lost to Follow-up|0|||
164415621|NCT02291289|593893410|FG008|Induction Treatment|Lost to Follow-up|0|||
164415622|NCT02291289|593893411|FG009|Induction Treatment|Lost to Follow-up|9|||
164415623|NCT02291289|593893412|FG010|Induction Treatment|Lost to Follow-up|0|||
164415624|NCT02291289|593893413|FG011|Induction Treatment|Lost to Follow-up|0|||
164415625|NCT02291289|593893414|FG012|Induction Treatment|Lost to Follow-up|0|||
164415626|NCT02291289|593893402|FG000|Induction Treatment|Non-Compliance|0|||
164415627|NCT02291289|593893403|FG001|Induction Treatment|Non-Compliance|0|||
164415628|NCT02291289|593893404|FG002|Induction Treatment|Non-Compliance|0|||
164415629|NCT02291289|593893405|FG003|Induction Treatment|Non-Compliance|1|||
164415630|NCT02291289|593893406|FG004|Induction Treatment|Non-Compliance|0|||
164466718|NCT04625725|594079993|FG004|Provent Sub Study|Withdrawal by Subject|5|||
164466719|NCT04625725|594079994|FG005|Provent Sub Study|Withdrawal by Subject|6|||
164466720|NCT04625725|594079989|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
164466721|NCT04625725|594079990|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
164710861|NCT03583086|594964664|FG002|Overall Study|Still on study|0|||
164415631|NCT02291289|593893407|FG005|Induction Treatment|Non-Compliance|0|||
164466722|NCT04625725|594079991|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
164466723|NCT04625725|594079992|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
164466724|NCT04625725|594079993|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
164466725|NCT04625725|594079994|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
164466726|NCT04308681|594079998|FG000|Pre-Treatment|Not reported|1|||
164466727|NCT04308681|594079999|FG001|Pre-Treatment|Not reported|1|||
164466728|NCT04308681|594080000|FG002|Pre-Treatment|Not reported|0|||
164466729|NCT04308681|594080001|FG003|Pre-Treatment|Not reported|0|||
164466730|NCT04308681|594080002|FG004|Pre-Treatment|Not reported|0|||
164466731|NCT04308681|594080003|FG005|Pre-Treatment|Not reported|2|||
164466732|NCT04308681|594080004|FG006|Pre-Treatment|Not reported|0|||
164415632|NCT02291289|593893408|FG006|Induction Treatment|Non-Compliance|0|||
164415633|NCT02291289|593893409|FG007|Induction Treatment|Non-Compliance|0|||
164415634|NCT02291289|593893410|FG008|Induction Treatment|Non-Compliance|0|||
164415635|NCT02291289|593893411|FG009|Induction Treatment|Non-Compliance|1|||
164415636|NCT02291289|593893412|FG010|Induction Treatment|Non-Compliance|0|||
164415637|NCT02291289|593893413|FG011|Induction Treatment|Non-Compliance|0|||
164415638|NCT02291289|593893414|FG012|Induction Treatment|Non-Compliance|0|||
164415639|NCT02291289|593893402|FG000|Induction Treatment|Reason Not Specified|0|||
164415640|NCT02291289|593893403|FG001|Induction Treatment|Reason Not Specified|0|||
164415641|NCT02291289|593893404|FG002|Induction Treatment|Reason Not Specified|0|||
164415642|NCT02291289|593893405|FG003|Induction Treatment|Reason Not Specified|4|||
164415643|NCT02291289|593893406|FG004|Induction Treatment|Reason Not Specified|0|||
164415644|NCT02291289|593893407|FG005|Induction Treatment|Reason Not Specified|0|||
164415645|NCT02291289|593893408|FG006|Induction Treatment|Reason Not Specified|0|||
164415646|NCT02291289|593893409|FG007|Induction Treatment|Reason Not Specified|0|||
164415647|NCT02291289|593893410|FG008|Induction Treatment|Reason Not Specified|0|||
164415648|NCT02291289|593893411|FG009|Induction Treatment|Reason Not Specified|7|||
164415649|NCT02291289|593893412|FG010|Induction Treatment|Reason Not Specified|0|||
164415650|NCT02291289|593893413|FG011|Induction Treatment|Reason Not Specified|0|||
164415651|NCT02291289|593893414|FG012|Induction Treatment|Reason Not Specified|0|||
164415652|NCT02291289|593893402|FG000|Induction Treatment|Physician Decision|0|||
164415653|NCT02291289|593893403|FG001|Induction Treatment|Physician Decision|0|||
164415654|NCT02291289|593893404|FG002|Induction Treatment|Physician Decision|0|||
164415655|NCT02291289|593893405|FG003|Induction Treatment|Physician Decision|3|||
164415656|NCT02291289|593893406|FG004|Induction Treatment|Physician Decision|0|||
164415657|NCT02291289|593893407|FG005|Induction Treatment|Physician Decision|0|||
164415658|NCT02291289|593893408|FG006|Induction Treatment|Physician Decision|0|||
164415659|NCT02291289|593893409|FG007|Induction Treatment|Physician Decision|0|||
164415660|NCT02291289|593893410|FG008|Induction Treatment|Physician Decision|0|||
164415661|NCT02291289|593893411|FG009|Induction Treatment|Physician Decision|1|||
164415662|NCT02291289|593893412|FG010|Induction Treatment|Physician Decision|0|||
164415663|NCT02291289|593893413|FG011|Induction Treatment|Physician Decision|0|||
164415664|NCT02291289|593893414|FG012|Induction Treatment|Physician Decision|0|||
164415665|NCT02291289|593893402|FG000|Induction Treatment|Protocol Violation|0|||
164415666|NCT02291289|593893403|FG001|Induction Treatment|Protocol Violation|0|||
164415667|NCT02291289|593893404|FG002|Induction Treatment|Protocol Violation|0|||
164415668|NCT02291289|593893405|FG003|Induction Treatment|Protocol Violation|3|||
164415669|NCT02291289|593893406|FG004|Induction Treatment|Protocol Violation|0|||
164415670|NCT02291289|593893407|FG005|Induction Treatment|Protocol Violation|0|||
164415671|NCT02291289|593893408|FG006|Induction Treatment|Protocol Violation|0|||
164415672|NCT02291289|593893409|FG007|Induction Treatment|Protocol Violation|0|||
164415673|NCT02291289|593893410|FG008|Induction Treatment|Protocol Violation|0|||
164415674|NCT02291289|593893411|FG009|Induction Treatment|Protocol Violation|2|||
164415675|NCT02291289|593893412|FG010|Induction Treatment|Protocol Violation|0|||
164415676|NCT02291289|593893413|FG011|Induction Treatment|Protocol Violation|0|||
164415677|NCT02291289|593893414|FG012|Induction Treatment|Protocol Violation|0|||
164415678|NCT02291289|593893402|FG000|Induction Treatment|Missing|4|||
164415679|NCT02291289|593893403|FG001|Induction Treatment|Missing|0|||
164415680|NCT02291289|593893404|FG002|Induction Treatment|Missing|0|||
164415681|NCT02291289|593893405|FG003|Induction Treatment|Missing|14|||
164415682|NCT02291289|593893406|FG004|Induction Treatment|Missing|0|||
164415683|NCT02291289|593893407|FG005|Induction Treatment|Missing|0|||
164415684|NCT02291289|593893408|FG006|Induction Treatment|Missing|0|||
164415685|NCT02291289|593893409|FG007|Induction Treatment|Missing|0|||
164415686|NCT02291289|593893410|FG008|Induction Treatment|Missing|0|||
164415687|NCT02291289|593893411|FG009|Induction Treatment|Missing|54|||
164415688|NCT02291289|593893412|FG010|Induction Treatment|Missing|0|||
164415689|NCT02291289|593893413|FG011|Induction Treatment|Missing|0|||
164415690|NCT02291289|593893414|FG012|Induction Treatment|Missing|0|||
164415691|NCT02291289|593893402|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
164415692|NCT02291289|593893403|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
164415693|NCT02291289|593893404|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
164466733|NCT04308681|594080005|FG007|Pre-Treatment|Not reported|0|||
164466734|NCT04308681|594079998|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
164466735|NCT04308681|594079999|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
164710862|NCT03583086|594964665|FG003|Overall Study|Still on study|1|||
164710863|NCT03583086|594964666|FG004|Overall Study|Still on study|0|||
164710864|NCT03583086|594964667|FG005|Overall Study|Still on study|0|||
164710865|NCT03583086|594964668|FG006|Overall Study|Still on study|1|||
164710866|NCT03583086|594964662|FG000|Overall Study|Disease progression|0|||
164710867|NCT03583086|594964663|FG001|Overall Study|Disease progression|0|||
164710868|NCT03583086|594964664|FG002|Overall Study|Disease progression|0|||
164710869|NCT03583086|594964665|FG003|Overall Study|Disease progression|0|||
164710870|NCT03583086|594964666|FG004|Overall Study|Disease progression|0|||
164710871|NCT03583086|594964667|FG005|Overall Study|Disease progression|0|||
164710872|NCT03583086|594964668|FG006|Overall Study|Disease progression|1|||
164710873|NCT03583086|594964662|FG000|Overall Study|Undergoing radiation therapy|0|||
164710874|NCT03583086|594964663|FG001|Overall Study|Undergoing radiation therapy|0|||
164710875|NCT03583086|594964664|FG002|Overall Study|Undergoing radiation therapy|0|||
164710876|NCT03583086|594964665|FG003|Overall Study|Undergoing radiation therapy|0|||
164710877|NCT03583086|594964666|FG004|Overall Study|Undergoing radiation therapy|0|||
164710878|NCT03583086|594964667|FG005|Overall Study|Undergoing radiation therapy|0|||
164710879|NCT03583086|594964668|FG006|Overall Study|Undergoing radiation therapy|1|||
164710880|NCT03583086|594964662|FG000|Overall Study|Lost to Follow-up|0|||
164710881|NCT03583086|594964663|FG001|Overall Study|Lost to Follow-up|0|||
164710882|NCT03583086|594964664|FG002|Overall Study|Lost to Follow-up|0|||
164710883|NCT03583086|594964665|FG003|Overall Study|Lost to Follow-up|0|||
164710884|NCT03583086|594964666|FG004|Overall Study|Lost to Follow-up|0|||
164710885|NCT03583086|594964667|FG005|Overall Study|Lost to Follow-up|1|||
164710886|NCT03583086|594964668|FG006|Overall Study|Lost to Follow-up|0|||
164710887|NCT03583086|594964662|FG000|Overall Study|Adverse Event|0|||
164710888|NCT03583086|594964663|FG001|Overall Study|Adverse Event|0|||
164710889|NCT03583086|594964664|FG002|Overall Study|Adverse Event|0|||
164710890|NCT03583086|594964665|FG003|Overall Study|Adverse Event|0|||
164710891|NCT03583086|594964666|FG004|Overall Study|Adverse Event|0|||
164710892|NCT03583086|594964667|FG005|Overall Study|Adverse Event|1|||
164710893|NCT03583086|594964668|FG006|Overall Study|Adverse Event|0|||
164710894|NCT00396812|594964672|FG000|Overall Study|Physician Decision|1|||
164710895|NCT02387983|594964675|FG000|Overall Study|Adverse Event|4|||
164710896|NCT02387983|594964675|FG000|Overall Study|Protocol Violation|1|||
164710897|NCT02387983|594964675|FG000|Overall Study|Withdrawal by Subject|2|||
164710898|NCT00724048|594964679|FG000|Overall Study|Adverse Event|1|||
164710899|NCT00724048|594964680|FG001|Overall Study|Adverse Event|1|||
164710900|NCT00724048|594964681|FG002|Overall Study|Adverse Event|1|||
164710901|NCT00724048|594964682|FG003|Overall Study|Adverse Event|0|||
164710902|NCT00724048|594964679|FG000|Overall Study|Lost to Follow-up|0|||
164710903|NCT00724048|594964680|FG001|Overall Study|Lost to Follow-up|1|||
164710904|NCT00724048|594964681|FG002|Overall Study|Lost to Follow-up|0|||
164710905|NCT00724048|594964682|FG003|Overall Study|Lost to Follow-up|0|||
164710906|NCT00724048|594964679|FG000|Overall Study|Withdrawal by Subject|1|||
164710907|NCT00724048|594964680|FG001|Overall Study|Withdrawal by Subject|2|||
164710908|NCT00724048|594964681|FG002|Overall Study|Withdrawal by Subject|1|||
164710909|NCT00724048|594964682|FG003|Overall Study|Withdrawal by Subject|2|||
164710910|NCT00724048|594964679|FG000|Overall Study|Investigator decision|0|||
164710911|NCT00724048|594964680|FG001|Overall Study|Investigator decision|0|||
164710912|NCT00724048|594964681|FG002|Overall Study|Investigator decision|1|||
164710913|NCT00724048|594964682|FG003|Overall Study|Investigator decision|0|||
164710914|NCT00724048|594964679|FG000|Overall Study|Did not tolerate study drug|0|||
164710915|NCT00724048|594964680|FG001|Overall Study|Did not tolerate study drug|0|||
164710916|NCT00724048|594964681|FG002|Overall Study|Did not tolerate study drug|0|||
164710917|NCT00724048|594964682|FG003|Overall Study|Did not tolerate study drug|1|||
164710918|NCT00724048|594964679|FG000|Overall Study|Other than specified|1|||
164710919|NCT00724048|594964680|FG001|Overall Study|Other than specified|1|||
164710920|NCT00724048|594964681|FG002|Overall Study|Other than specified|0|||
164710921|NCT00724048|594964682|FG003|Overall Study|Other than specified|0|||
164710922|NCT04874155|594964683|FG000|Overall Study|Lost to Follow-up|1|||
164710923|NCT04874155|594964684|FG001|Overall Study|Lost to Follow-up|1|||
164710924|NCT04874155|594964683|FG000|Overall Study|Withdrawal by Subject|2|||
164710925|NCT04874155|594964684|FG001|Overall Study|Withdrawal by Subject|2|||
164144820|NCT01524978|592891779|FG005|Overall Study|Death|4|||
164415694|NCT02291289|593893405|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
164710926|NCT06281171|594964687|FG000|Timepoint 2|Lost to Follow-up|6|||
164710927|NCT06281171|594964688|FG001|Timepoint 2|Lost to Follow-up|4|||
164710928|NCT06281171|594964687|FG000|Timepoint 3|Lost to Follow-up|0|||
164710929|NCT06281171|594964688|FG001|Timepoint 3|Lost to Follow-up|5|||
164710930|NCT00750308|594964689|FG000|First Treatment|Adverse Event|0|||
164710931|NCT00750308|594964690|FG001|First Treatment|Adverse Event|1|||
164710932|NCT00750308|594964691|FG002|First Treatment|Adverse Event|0|||
164710933|NCT00750308|594964692|FG003|First Treatment|Adverse Event|0|||
164710934|NCT00750308|594964693|FG004|First Treatment|Adverse Event|0|||
164710935|NCT00750308|594964694|FG005|First Treatment|Adverse Event|0|||
164710936|NCT00750308|594964695|FG006|First Treatment|Adverse Event|0|||
164415695|NCT02291289|593893406|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
164415696|NCT02291289|593893407|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
164415697|NCT02291289|593893408|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
164415698|NCT02291289|593893409|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
164415699|NCT02291289|593893410|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
164415700|NCT02291289|593893411|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
164415701|NCT02291289|593893412|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
164415702|NCT02291289|593893413|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
164415703|NCT02291289|593893414|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
164415704|NCT02291289|593893402|FG000|Maintenance Treatment Phase|Death|0|||
164415705|NCT02291289|593893403|FG001|Maintenance Treatment Phase|Death|29|||
164415706|NCT02291289|593893404|FG002|Maintenance Treatment Phase|Death|16|||
164415707|NCT02291289|593893405|FG003|Maintenance Treatment Phase|Death|0|||
164415708|NCT02291289|593893406|FG004|Maintenance Treatment Phase|Death|188|||
164415709|NCT02291289|593893407|FG005|Maintenance Treatment Phase|Death|107|||
164415710|NCT02291289|593893408|FG006|Maintenance Treatment Phase|Death|0|||
164415711|NCT02291289|593893409|FG007|Maintenance Treatment Phase|Death|1|||
164415712|NCT02291289|593893410|FG008|Maintenance Treatment Phase|Death|1|||
164415713|NCT02291289|593893411|FG009|Maintenance Treatment Phase|Death|0|||
164415714|NCT02291289|593893412|FG010|Maintenance Treatment Phase|Death|46|||
164415715|NCT02291289|593893413|FG011|Maintenance Treatment Phase|Death|19|||
164415716|NCT02291289|593893414|FG012|Maintenance Treatment Phase|Death|0|||
164415717|NCT02291289|593893402|FG000|Maintenance Treatment Phase|Adverse Event|0|||
164415718|NCT02291289|593893403|FG001|Maintenance Treatment Phase|Adverse Event|0|||
164415719|NCT02291289|593893404|FG002|Maintenance Treatment Phase|Adverse Event|0|||
164415720|NCT02291289|593893405|FG003|Maintenance Treatment Phase|Adverse Event|0|||
164415721|NCT02291289|593893406|FG004|Maintenance Treatment Phase|Adverse Event|1|||
164415722|NCT02291289|593893407|FG005|Maintenance Treatment Phase|Adverse Event|1|||
164415723|NCT02291289|593893408|FG006|Maintenance Treatment Phase|Adverse Event|0|||
164415724|NCT02291289|593893409|FG007|Maintenance Treatment Phase|Adverse Event|0|||
164415725|NCT02291289|593893410|FG008|Maintenance Treatment Phase|Adverse Event|0|||
164466736|NCT04308681|594080000|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
164710937|NCT00750308|594964696|FG007|First Treatment|Adverse Event|0|||
164710938|NCT00750308|594964697|FG008|First Treatment|Adverse Event|0|||
164710939|NCT00750308|594964698|FG009|First Treatment|Adverse Event|0|||
164710940|NCT00750308|594964699|FG010|First Treatment|Adverse Event|1|||
164710941|NCT00750308|594964700|FG011|First Treatment|Adverse Event|1|||
164710942|NCT00750308|594964689|FG000|First Treatment|Withdrawal by Subject|0|||
164710943|NCT00750308|594964690|FG001|First Treatment|Withdrawal by Subject|0|||
164710944|NCT00750308|594964691|FG002|First Treatment|Withdrawal by Subject|0|||
164710945|NCT00750308|594964692|FG003|First Treatment|Withdrawal by Subject|1|||
164710946|NCT00750308|594964693|FG004|First Treatment|Withdrawal by Subject|0|||
164710947|NCT00750308|594964694|FG005|First Treatment|Withdrawal by Subject|0|||
164710948|NCT00750308|594964695|FG006|First Treatment|Withdrawal by Subject|0|||
164710949|NCT00750308|594964696|FG007|First Treatment|Withdrawal by Subject|1|||
164710950|NCT00750308|594964697|FG008|First Treatment|Withdrawal by Subject|0|||
164710951|NCT00750308|594964698|FG009|First Treatment|Withdrawal by Subject|0|||
164710952|NCT00750308|594964699|FG010|First Treatment|Withdrawal by Subject|0|||
164710953|NCT00750308|594964700|FG011|First Treatment|Withdrawal by Subject|0|||
164710954|NCT00750308|594964689|FG000|Second Treatment|Adverse Event|0|||
164710955|NCT00750308|594964690|FG001|Second Treatment|Adverse Event|0|||
164710956|NCT00750308|594964691|FG002|Second Treatment|Adverse Event|0|||
164710957|NCT00750308|594964692|FG003|Second Treatment|Adverse Event|0|||
164710958|NCT00750308|594964693|FG004|Second Treatment|Adverse Event|0|||
164710959|NCT00750308|594964694|FG005|Second Treatment|Adverse Event|1|||
164710960|NCT00750308|594964695|FG006|Second Treatment|Adverse Event|0|||
164710961|NCT00750308|594964696|FG007|Second Treatment|Adverse Event|0|||
164710962|NCT00750308|594964697|FG008|Second Treatment|Adverse Event|1|||
164710963|NCT00750308|594964698|FG009|Second Treatment|Adverse Event|0|||
164710964|NCT00750308|594964699|FG010|Second Treatment|Adverse Event|0|||
164710965|NCT00750308|594964700|FG011|Second Treatment|Adverse Event|0|||
164710966|NCT00750308|594964689|FG000|Second Treatment|Withdrawal by Subject|0|||
164710967|NCT00750308|594964690|FG001|Second Treatment|Withdrawal by Subject|0|||
164415726|NCT02291289|593893411|FG009|Maintenance Treatment Phase|Adverse Event|0|||
164415727|NCT02291289|593893412|FG010|Maintenance Treatment Phase|Adverse Event|0|||
164415728|NCT02291289|593893413|FG011|Maintenance Treatment Phase|Adverse Event|0|||
164415729|NCT02291289|593893414|FG012|Maintenance Treatment Phase|Adverse Event|0|||
164415730|NCT02291289|593893402|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
164415731|NCT02291289|593893403|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
164710968|NCT00750308|594964691|FG002|Second Treatment|Withdrawal by Subject|0|||
164710969|NCT00750308|594964692|FG003|Second Treatment|Withdrawal by Subject|0|||
164710970|NCT00750308|594964693|FG004|Second Treatment|Withdrawal by Subject|1|||
164710971|NCT00750308|594964694|FG005|Second Treatment|Withdrawal by Subject|0|||
164710972|NCT00750308|594964695|FG006|Second Treatment|Withdrawal by Subject|0|||
164710973|NCT00750308|594964696|FG007|Second Treatment|Withdrawal by Subject|0|||
164710974|NCT00750308|594964697|FG008|Second Treatment|Withdrawal by Subject|0|||
164466737|NCT04308681|594080001|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
164466738|NCT04308681|594080002|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
164466739|NCT04308681|594080003|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
164466740|NCT04308681|594080004|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
164466741|NCT04308681|594080005|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
164466742|NCT04308681|594079998|FG000|Treatment up to Week 26|Other reasons|2|||
164710975|NCT00750308|594964698|FG009|Second Treatment|Withdrawal by Subject|0|||
164710976|NCT00750308|594964699|FG010|Second Treatment|Withdrawal by Subject|0|||
164710977|NCT00750308|594964700|FG011|Second Treatment|Withdrawal by Subject|0|||
164710978|NCT00750308|594964689|FG000|Third Treatment|Withdrawal by Subject|0|||
164710979|NCT00750308|594964690|FG001|Third Treatment|Withdrawal by Subject|1|||
164710980|NCT00750308|594964691|FG002|Third Treatment|Withdrawal by Subject|0|||
164710981|NCT00750308|594964692|FG003|Third Treatment|Withdrawal by Subject|0|||
164710982|NCT00750308|594964693|FG004|Third Treatment|Withdrawal by Subject|0|||
164710983|NCT00750308|594964694|FG005|Third Treatment|Withdrawal by Subject|0|||
164710984|NCT00750308|594964695|FG006|Third Treatment|Withdrawal by Subject|0|||
164710985|NCT00750308|594964696|FG007|Third Treatment|Withdrawal by Subject|0|||
164710986|NCT00750308|594964697|FG008|Third Treatment|Withdrawal by Subject|0|||
164710987|NCT00750308|594964698|FG009|Third Treatment|Withdrawal by Subject|0|||
164710988|NCT00750308|594964699|FG010|Third Treatment|Withdrawal by Subject|0|||
164710989|NCT00750308|594964700|FG011|Third Treatment|Withdrawal by Subject|0|||
164710990|NCT01822275|594964701|FG000|Overall Study|Withdrawal by Subject|3|||
164710991|NCT01822275|594964701|FG000|Overall Study|Adverse Event|3|||
164710992|NCT01822275|594964701|FG000|Overall Study|Progression|14|||
164710993|NCT01822275|594964701|FG000|Overall Study|Physician Decision|2|||
164710994|NCT03258853|594964703|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
164710995|NCT03258853|594964704|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
164710996|NCT04730349|594964710|FG000|Overall Study|Participant withdrew consent|1|||
164710997|NCT04730349|594964711|FG001|Overall Study|Participant withdrew consent|0|||
164710998|NCT04730349|594964710|FG000|Overall Study|Disease progression|6|||
164710999|NCT04730349|594964711|FG001|Overall Study|Disease progression|4|||
164711000|NCT04730349|594964710|FG000|Overall Study|Study drug toxicity|0|||
164711001|NCT04730349|594964711|FG001|Overall Study|Study drug toxicity|1|||
164711002|NCT03395405|594966241|FG000|Overall Study|Death|0|||
164711003|NCT03395405|594966242|FG001|Overall Study|Death|2|||
164711004|NCT03395405|594966241|FG000|Overall Study|Lost to Follow-up|0|||
164711005|NCT03395405|594966242|FG001|Overall Study|Lost to Follow-up|1|||
164711006|NCT03395405|594966241|FG000|Overall Study|Protocol Violation|0|||
164711007|NCT03395405|594966242|FG001|Overall Study|Protocol Violation|1|||
164711008|NCT03395405|594966241|FG000|Overall Study|Withdrawal by Subject|3|||
164711009|NCT03395405|594966242|FG001|Overall Study|Withdrawal by Subject|1|||
164711010|NCT03395405|594966241|FG000|Overall Study|COVID-19 Pandemic|1|||
164711011|NCT03395405|594966242|FG001|Overall Study|COVID-19 Pandemic|0|||
164711012|NCT00070499|594966248|FG000|Overall Study|Adverse Event|6|||
164711013|NCT00070499|594966249|FG001|Overall Study|Adverse Event|6|||
164711014|NCT00070499|594966250|FG002|Overall Study|Adverse Event|19|||
164711015|NCT00070499|594966251|FG003|Overall Study|Adverse Event|15|||
164711016|NCT00070499|594966248|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
164711017|NCT00070499|594966249|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
164711018|NCT00070499|594966250|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
164711019|NCT00070499|594966251|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
164711020|NCT00070499|594966248|FG000|Overall Study|Progression/relapse|4|||
164711021|NCT00070499|594966249|FG001|Overall Study|Progression/relapse|2|||
164711022|NCT00070499|594966250|FG002|Overall Study|Progression/relapse|1|||
164711023|NCT00070499|594966251|FG003|Overall Study|Progression/relapse|4|||
164711024|NCT00070499|594966248|FG000|Overall Study|Death|1|||
164711025|NCT00070499|594966249|FG001|Overall Study|Death|1|||
164711026|NCT00070499|594966250|FG002|Overall Study|Death|1|||
164711027|NCT00070499|594966251|FG003|Overall Study|Death|2|||
164711028|NCT00070499|594966248|FG000|Overall Study|Other - not protocol specified|7|||
164711029|NCT00070499|594966249|FG001|Overall Study|Other - not protocol specified|3|||
164711030|NCT00070499|594966250|FG002|Overall Study|Other - not protocol specified|12|||
164711031|NCT00070499|594966251|FG003|Overall Study|Other - not protocol specified|20|||
164711032|NCT00070499|594966248|FG000|Overall Study|Still on protocol treatment|10|||
164711033|NCT00070499|594966249|FG001|Overall Study|Still on protocol treatment|4|||
164711034|NCT00070499|594966250|FG002|Overall Study|Still on protocol treatment|79|||
164144821|NCT01524978|592891780|FG006|Overall Study|Death|1|||
164466743|NCT04308681|594079999|FG001|Treatment up to Week 26|Other reasons|0|||
164466744|NCT04308681|594080000|FG002|Treatment up to Week 26|Other reasons|0|||
164711035|NCT00070499|594966251|FG003|Overall Study|Still on protocol treatment|57|||
164711036|NCT00070499|594966248|FG000|Overall Study|Did not start treatment|1|||
164711037|NCT00070499|594966249|FG001|Overall Study|Did not start treatment|0|||
164711038|NCT00070499|594966250|FG002|Overall Study|Did not start treatment|0|||
164711039|NCT00070499|594966251|FG003|Overall Study|Did not start treatment|2|||
164711040|NCT00070499|594966248|FG000|Overall Study|Not eligible|2|||
164711041|NCT00070499|594966249|FG001|Overall Study|Not eligible|5|||
164466745|NCT04308681|594080001|FG003|Treatment up to Week 26|Other reasons|0|||
164466746|NCT04308681|594080002|FG004|Treatment up to Week 26|Other reasons|1|||
164466747|NCT04308681|594080003|FG005|Treatment up to Week 26|Other reasons|1|||
164466748|NCT04308681|594080004|FG006|Treatment up to Week 26|Other reasons|0|||
164711042|NCT00070499|594966250|FG002|Overall Study|Not eligible|3|||
164711043|NCT00070499|594966251|FG003|Overall Study|Not eligible|2|||
164711044|NCT00660907|594966256|FG000|Overall Study|Incorrect Enrollment|1|||
164711045|NCT00660907|594966257|FG001|Overall Study|Incorrect Enrollment|1|||
164711046|NCT00660907|594966256|FG000|Overall Study|Adverse Event|33|||
164711047|NCT00660907|594966257|FG001|Overall Study|Adverse Event|19|||
164711048|NCT00660907|594966256|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
164711049|NCT00660907|594966257|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
164711050|NCT00660907|594966256|FG000|Overall Study|Withdrawal by Subject|23|||
164711051|NCT00660907|594966257|FG001|Overall Study|Withdrawal by Subject|32|||
164711052|NCT00660907|594966256|FG000|Overall Study|Lost to Follow-up|3|||
164711053|NCT00660907|594966257|FG001|Overall Study|Lost to Follow-up|3|||
164711054|NCT00660907|594966256|FG000|Overall Study|Poor/Non-Compliance|5|||
164711055|NCT00660907|594966257|FG001|Overall Study|Poor/Non-Compliance|1|||
164711056|NCT00660907|594966256|FG000|Overall Study|Safety|1|||
164711057|NCT00660907|594966257|FG001|Overall Study|Safety|0|||
164711058|NCT00660907|594966256|FG000|Overall Study|Death|1|||
164711059|NCT00660907|594966257|FG001|Overall Study|Death|3|||
164711060|NCT00660907|594966256|FG000|Overall Study|Various|11|||
164711061|NCT00660907|594966257|FG001|Overall Study|Various|8|||
164711062|NCT04975191|594966258|FG000|Overall Study|Protocol Violation|1|||
164711063|NCT04975191|594966259|FG001|Overall Study|Protocol Violation|2|||
164711064|NCT04975191|594966260|FG002|Overall Study|Protocol Violation|2|||
164711065|NCT04975191|594966261|FG003|Overall Study|Protocol Violation|2|||
164711066|NCT04975191|594966258|FG000|Overall Study|Lost to Follow-up|13|||
164711067|NCT04975191|594966259|FG001|Overall Study|Lost to Follow-up|3|||
164711068|NCT04975191|594966260|FG002|Overall Study|Lost to Follow-up|8|||
164711069|NCT04975191|594966261|FG003|Overall Study|Lost to Follow-up|8|||
164711070|NCT00537303|594966272|FG000|Overall Study|Adverse Event|1|||
164711071|NCT00537303|594966273|FG001|Overall Study|Adverse Event|4|||
164711072|NCT00537303|594966272|FG000|Overall Study|Lack of Efficacy|6|||
164711073|NCT00537303|594966273|FG001|Overall Study|Lack of Efficacy|7|||
164711074|NCT00537303|594966272|FG000|Overall Study|Protocol Violation|8|||
164711075|NCT00537303|594966273|FG001|Overall Study|Protocol Violation|4|||
164711076|NCT00537303|594966272|FG000|Overall Study|Withdrawal criteria|3|||
164711077|NCT00537303|594966273|FG001|Overall Study|Withdrawal criteria|3|||
164711078|NCT00537303|594966272|FG000|Overall Study|Unclassified|8|||
164711079|NCT00537303|594966273|FG001|Overall Study|Unclassified|7|||
164711080|NCT01473524|594966278|FG000|DB Phase|Adverse Event|4|||
164711081|NCT01473524|594966279|FG001|DB Phase|Adverse Event|8|||
164711082|NCT01473524|594966280|FG002|DB Phase|Adverse Event|2|||
164711083|NCT01473524|594966281|FG003|DB Phase|Adverse Event|0|||
164711084|NCT01473524|594966282|FG004|DB Phase|Adverse Event|0|||
164711085|NCT01473524|594966283|FG005|DB Phase|Adverse Event|0|||
164711086|NCT01473524|594966278|FG000|DB Phase|Death|1|||
164711087|NCT01473524|594966279|FG001|DB Phase|Death|0|||
164711088|NCT01473524|594966280|FG002|DB Phase|Death|0|||
164711089|NCT01473524|594966281|FG003|DB Phase|Death|0|||
164711090|NCT01473524|594966282|FG004|DB Phase|Death|0|||
164711091|NCT01473524|594966283|FG005|DB Phase|Death|0|||
164711092|NCT01473524|594966278|FG000|DB Phase|Withdrawal by Subject|2|||
164711093|NCT01473524|594966279|FG001|DB Phase|Withdrawal by Subject|1|||
164711094|NCT01473524|594966280|FG002|DB Phase|Withdrawal by Subject|1|||
164466749|NCT04308681|594080005|FG007|Treatment up to Week 26|Other reasons|0|||
164466750|NCT04308681|594079998|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
164466751|NCT04308681|594079999|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
164711095|NCT01473524|594966281|FG003|DB Phase|Withdrawal by Subject|0|||
164711096|NCT01473524|594966282|FG004|DB Phase|Withdrawal by Subject|0|||
164711097|NCT01473524|594966283|FG005|DB Phase|Withdrawal by Subject|0|||
164711098|NCT01473524|594966278|FG000|LTSE Phase|Withdrawal by Subject|0|||
164711099|NCT01473524|594966279|FG001|LTSE Phase|Withdrawal by Subject|0|||
164711100|NCT01473524|594966280|FG002|LTSE Phase|Withdrawal by Subject|0|||
164711101|NCT01473524|594966281|FG003|LTSE Phase|Withdrawal by Subject|3|||
164711102|NCT01473524|594966282|FG004|LTSE Phase|Withdrawal by Subject|3|||
164711103|NCT01473524|594966283|FG005|LTSE Phase|Withdrawal by Subject|6|||
164711104|NCT01473524|594966278|FG000|LTSE Phase|Death|0|||
164711105|NCT01473524|594966279|FG001|LTSE Phase|Death|0|||
164711106|NCT01473524|594966280|FG002|LTSE Phase|Death|0|||
164711107|NCT01473524|594966281|FG003|LTSE Phase|Death|0|||
164711108|NCT01473524|594966282|FG004|LTSE Phase|Death|1|||
164711109|NCT01473524|594966283|FG005|LTSE Phase|Death|0|||
164711110|NCT01473524|594966278|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
164711111|NCT01473524|594966279|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
164711112|NCT01473524|594966280|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
164711113|NCT01473524|594966281|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
164711114|NCT01473524|594966282|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
164711115|NCT01473524|594966283|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
164466752|NCT04308681|594080000|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
164466753|NCT04308681|594080001|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
164466754|NCT04308681|594080002|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
164466755|NCT04308681|594080003|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
164466756|NCT04308681|594080004|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
164466757|NCT04308681|594080005|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
164466758|NCT04308681|594079998|FG000|Treatment up to Week 26|Adverse Event|6|||
164466759|NCT04308681|594079999|FG001|Treatment up to Week 26|Adverse Event|5|||
164466760|NCT04308681|594080000|FG002|Treatment up to Week 26|Adverse Event|5|||
164466761|NCT04308681|594080001|FG003|Treatment up to Week 26|Adverse Event|0|||
164466762|NCT04308681|594080002|FG004|Treatment up to Week 26|Adverse Event|6|||
164466763|NCT04308681|594080003|FG005|Treatment up to Week 26|Adverse Event|1|||
164466764|NCT04308681|594080004|FG006|Treatment up to Week 26|Adverse Event|0|||
164466765|NCT04308681|594080005|FG007|Treatment up to Week 26|Adverse Event|0|||
164466766|NCT04308681|594079998|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
164466767|NCT04308681|594079999|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
164466768|NCT04308681|594080000|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
164466769|NCT04308681|594080001|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
164466770|NCT04308681|594080002|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
164466771|NCT04308681|594080003|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
164466772|NCT04308681|594080004|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
164466773|NCT04308681|594080005|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
164466774|NCT04308681|594079998|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
164466775|NCT04308681|594079999|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
164466776|NCT04308681|594080000|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
164466777|NCT04308681|594080001|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
164466778|NCT04308681|594080002|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
164466779|NCT04308681|594080003|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
164466780|NCT04308681|594080004|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
164466781|NCT04308681|594080005|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
164466782|NCT04308681|594079998|FG000|OTE - 26 Weeks|Death|0|||
164466783|NCT04308681|594079999|FG001|OTE - 26 Weeks|Death|1|||
164466784|NCT04308681|594080000|FG002|OTE - 26 Weeks|Death|0|||
164466785|NCT04308681|594080001|FG003|OTE - 26 Weeks|Death|0|||
164466786|NCT04308681|594080002|FG004|OTE - 26 Weeks|Death|0|||
164466787|NCT04308681|594080003|FG005|OTE - 26 Weeks|Death|0|||
164466788|NCT04308681|594080004|FG006|OTE - 26 Weeks|Death|1|||
164466789|NCT04308681|594080005|FG007|OTE - 26 Weeks|Death|0|||
164466790|NCT04308681|594079998|FG000|OTE - 26 Weeks|Adverse Event|0|||
164466791|NCT04308681|594079999|FG001|OTE - 26 Weeks|Adverse Event|2|||
164466792|NCT04308681|594080000|FG002|OTE - 26 Weeks|Adverse Event|8|||
164466793|NCT04308681|594080001|FG003|OTE - 26 Weeks|Adverse Event|3|||
164466794|NCT04308681|594080002|FG004|OTE - 26 Weeks|Adverse Event|0|||
164466795|NCT04308681|594080003|FG005|OTE - 26 Weeks|Adverse Event|1|||
164466796|NCT04308681|594080004|FG006|OTE - 26 Weeks|Adverse Event|2|||
164466797|NCT04308681|594080005|FG007|OTE - 26 Weeks|Adverse Event|0|||
164466798|NCT04308681|594079998|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
164466799|NCT04308681|594079999|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
164466800|NCT04308681|594080000|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
164466801|NCT04308681|594080001|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
164466802|NCT04308681|594080002|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
164466803|NCT04308681|594080003|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
164415732|NCT02291289|593893404|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
164415733|NCT02291289|593893405|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
164415734|NCT02291289|593893406|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
164415735|NCT02291289|593893407|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
164415736|NCT02291289|593893408|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
164415737|NCT02291289|593893409|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
164415738|NCT02291289|593893410|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
164415739|NCT02291289|593893411|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
164415740|NCT02291289|593893412|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
164415741|NCT02291289|593893413|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
164415742|NCT02291289|593893414|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
164415743|NCT02291289|593893402|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
164415744|NCT02291289|593893403|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
164466804|NCT04308681|594080004|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
164466805|NCT04308681|594080005|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
164466806|NCT00429364|594080008|FG000|Overall Study|Withdrawal by Subject|11|||
164466807|NCT00429364|594080009|FG001|Overall Study|Withdrawal by Subject|5|||
164466808|NCT00429364|594080008|FG000|Overall Study|Physician Decision|4|||
164466809|NCT00429364|594080009|FG001|Overall Study|Physician Decision|2|||
164711116|NCT01473524|594966278|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
164711117|NCT01473524|594966279|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
164711118|NCT01473524|594966280|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
164711119|NCT01473524|594966281|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
164711120|NCT01473524|594966282|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
164711121|NCT01473524|594966283|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
164711122|NCT01473524|594966278|FG000|LTSE Phase|Lost to Follow-up|0|||
164711123|NCT01473524|594966279|FG001|LTSE Phase|Lost to Follow-up|0|||
164711124|NCT01473524|594966280|FG002|LTSE Phase|Lost to Follow-up|0|||
164711125|NCT01473524|594966281|FG003|LTSE Phase|Lost to Follow-up|1|||
164711126|NCT01473524|594966282|FG004|LTSE Phase|Lost to Follow-up|3|||
164711127|NCT01473524|594966283|FG005|LTSE Phase|Lost to Follow-up|2|||
164711128|NCT01473524|594966278|FG000|LTSE Phase|Principal Investigator Decision|0|||
164711129|NCT01473524|594966279|FG001|LTSE Phase|Principal Investigator Decision|0|||
164711130|NCT01473524|594966280|FG002|LTSE Phase|Principal Investigator Decision|0|||
164711131|NCT01473524|594966281|FG003|LTSE Phase|Principal Investigator Decision|1|||
164711132|NCT01473524|594966282|FG004|LTSE Phase|Principal Investigator Decision|1|||
164711133|NCT01473524|594966283|FG005|LTSE Phase|Principal Investigator Decision|3|||
164711134|NCT01473524|594966278|FG000|LTSE Phase|Liver Transplantation|0|||
164711135|NCT01473524|594966279|FG001|LTSE Phase|Liver Transplantation|0|||
164711136|NCT01473524|594966280|FG002|LTSE Phase|Liver Transplantation|0|||
164415745|NCT02291289|593893404|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
164415746|NCT02291289|593893405|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
164415747|NCT02291289|593893406|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
164415748|NCT02291289|593893407|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
164415749|NCT02291289|593893408|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
164415750|NCT02291289|593893409|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
164415751|NCT02291289|593893410|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
164415752|NCT02291289|593893411|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
164415753|NCT02291289|593893412|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
164415754|NCT02291289|593893413|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
164415755|NCT02291289|593893414|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
164415756|NCT02291289|593893402|FG000|Maintenance Treatment Phase|Physician Decision|0|||
164415757|NCT02291289|593893403|FG001|Maintenance Treatment Phase|Physician Decision|2|||
164415758|NCT02291289|593893404|FG002|Maintenance Treatment Phase|Physician Decision|0|||
164415759|NCT02291289|593893405|FG003|Maintenance Treatment Phase|Physician Decision|0|||
164415760|NCT02291289|593893406|FG004|Maintenance Treatment Phase|Physician Decision|3|||
164415761|NCT02291289|593893407|FG005|Maintenance Treatment Phase|Physician Decision|0|||
164415762|NCT02291289|593893408|FG006|Maintenance Treatment Phase|Physician Decision|0|||
164415763|NCT02291289|593893409|FG007|Maintenance Treatment Phase|Physician Decision|0|||
164415764|NCT02291289|593893410|FG008|Maintenance Treatment Phase|Physician Decision|0|||
164415765|NCT02291289|593893411|FG009|Maintenance Treatment Phase|Physician Decision|0|||
164415766|NCT02291289|593893412|FG010|Maintenance Treatment Phase|Physician Decision|1|||
164415767|NCT02291289|593893413|FG011|Maintenance Treatment Phase|Physician Decision|3|||
164415768|NCT02291289|593893414|FG012|Maintenance Treatment Phase|Physician Decision|0|||
164415769|NCT02291289|593893402|FG000|Maintenance Treatment Phase|Not Treated|0|||
164415770|NCT02291289|593893403|FG001|Maintenance Treatment Phase|Not Treated|0|||
164415771|NCT02291289|593893404|FG002|Maintenance Treatment Phase|Not Treated|2|||
164415772|NCT02291289|593893405|FG003|Maintenance Treatment Phase|Not Treated|0|||
164415773|NCT02291289|593893406|FG004|Maintenance Treatment Phase|Not Treated|0|||
164415774|NCT02291289|593893407|FG005|Maintenance Treatment Phase|Not Treated|0|||
164415775|NCT02291289|593893408|FG006|Maintenance Treatment Phase|Not Treated|0|||
164415776|NCT02291289|593893409|FG007|Maintenance Treatment Phase|Not Treated|0|||
164415777|NCT02291289|593893410|FG008|Maintenance Treatment Phase|Not Treated|0|||
164415778|NCT02291289|593893411|FG009|Maintenance Treatment Phase|Not Treated|0|||
164415779|NCT02291289|593893412|FG010|Maintenance Treatment Phase|Not Treated|0|||
164415780|NCT02291289|593893413|FG011|Maintenance Treatment Phase|Not Treated|0|||
164415781|NCT02291289|593893414|FG012|Maintenance Treatment Phase|Not Treated|0|||
164415782|NCT02291289|593893402|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
164415783|NCT02291289|593893403|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
164415784|NCT02291289|593893404|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
164415785|NCT02291289|593893405|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
164415786|NCT02291289|593893406|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
164415787|NCT02291289|593893407|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
164415788|NCT02291289|593893408|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
164415789|NCT02291289|593893409|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
164415790|NCT02291289|593893410|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
164415791|NCT02291289|593893411|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
164415792|NCT02291289|593893412|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
164415793|NCT02291289|593893413|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
164415794|NCT02291289|593893414|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
164466810|NCT00429364|594080008|FG000|Overall Study|Lost to Follow-up|7|||
164466811|NCT00429364|594080009|FG001|Overall Study|Lost to Follow-up|6|||
164466812|NCT00429364|594080008|FG000|Overall Study|Death|0|||
164466813|NCT00429364|594080009|FG001|Overall Study|Death|1|||
164466814|NCT00429364|594080008|FG000|Overall Study|Underwent aortic root surgery|10|||
164466815|NCT00429364|594080009|FG001|Overall Study|Underwent aortic root surgery|18|||
164466816|NCT00429364|594080008|FG000|Overall Study|Pregnancy|0|||
164466817|NCT00429364|594080009|FG001|Overall Study|Pregnancy|1|||
164466818|NCT05873556|594080010|FG000|Overall Study|Lost to Follow-up|4|||
164466819|NCT05873556|594080011|FG001|Overall Study|Lost to Follow-up|1|||
164711137|NCT01473524|594966281|FG003|LTSE Phase|Liver Transplantation|0|||
164711138|NCT01473524|594966282|FG004|LTSE Phase|Liver Transplantation|0|||
164711139|NCT01473524|594966283|FG005|LTSE Phase|Liver Transplantation|1|||
164711140|NCT01473524|594966278|FG000|LTSE Phase|Pregnancy|0|||
164466820|NCT04689256|594080013|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
164466821|NCT04689256|594080014|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
164466822|NCT04167553|594080019|FG000|Overall Study|Withdrawal by Subject|1|||
164466823|NCT04167553|594080020|FG001|Overall Study|Withdrawal by Subject|0|||
164466824|NCT04167553|594080021|FG002|Overall Study|Withdrawal by Subject|1|||
164466825|NCT04167553|594080022|FG003|Overall Study|Withdrawal by Subject|2|||
164466826|NCT04167553|594080023|FG004|Overall Study|Withdrawal by Subject|1|||
164466827|NCT04167553|594080024|FG005|Overall Study|Withdrawal by Subject|0|||
164466828|NCT04167553|594080025|FG006|Overall Study|Withdrawal by Subject|0|||
164466829|NCT04167553|594080019|FG000|Overall Study|Physician Decision|0|||
164466830|NCT04167553|594080020|FG001|Overall Study|Physician Decision|0|||
164466831|NCT04167553|594080021|FG002|Overall Study|Physician Decision|0|||
164466832|NCT04167553|594080022|FG003|Overall Study|Physician Decision|0|||
164466833|NCT04167553|594080023|FG004|Overall Study|Physician Decision|2|||
164466834|NCT04167553|594080024|FG005|Overall Study|Physician Decision|2|||
164466835|NCT04167553|594080025|FG006|Overall Study|Physician Decision|0|||
164466836|NCT04167553|594080019|FG000|Overall Study|Lost to Follow-up|0|||
164466837|NCT04167553|594080020|FG001|Overall Study|Lost to Follow-up|0|||
164466838|NCT04167553|594080021|FG002|Overall Study|Lost to Follow-up|2|||
164466839|NCT04167553|594080022|FG003|Overall Study|Lost to Follow-up|0|||
164466840|NCT04167553|594080023|FG004|Overall Study|Lost to Follow-up|0|||
164466841|NCT04167553|594080024|FG005|Overall Study|Lost to Follow-up|0|||
164466842|NCT04167553|594080025|FG006|Overall Study|Lost to Follow-up|0|||
164466843|NCT05209152|594080028|FG000|Overall Study|Sponsor decision|1|||
164466844|NCT05209152|594080029|FG001|Overall Study|Sponsor decision|2|||
164466845|NCT05209152|594080028|FG000|Overall Study|Death|3|||
164466846|NCT05209152|594080029|FG001|Overall Study|Death|1|||
164466847|NCT04024020|594081997|FG000|Overall Study|Withdrawal by Subject|2|||
164466848|NCT04024020|594081998|FG001|Overall Study|Withdrawal by Subject|2|||
164466849|NCT05269966|594081999|FG000|Overall Study|Adverse Event|4|||
164466850|NCT05269966|594081999|FG000|Overall Study|Withdrawal by Subject|1|||
164466851|NCT05269966|594081999|FG000|Overall Study|Lost to Follow-up|4|||
164466852|NCT05269966|594081999|FG000|Overall Study|Physician Decision|1|||
164466853|NCT06262347|594082002|FG000|Overall Study|Lost to Follow-up|4|||
164466854|NCT06262347|594082003|FG001|Overall Study|Lost to Follow-up|3|||
164711141|NCT01473524|594966279|FG001|LTSE Phase|Pregnancy|0|||
164711142|NCT01473524|594966280|FG002|LTSE Phase|Pregnancy|0|||
164711143|NCT01473524|594966281|FG003|LTSE Phase|Pregnancy|1|||
164711144|NCT01473524|594966282|FG004|LTSE Phase|Pregnancy|0|||
164711145|NCT01473524|594966283|FG005|LTSE Phase|Pregnancy|0|||
164711146|NCT01473524|594966278|FG000|LTSE Phase|Protocol Violation|0|||
164711147|NCT01473524|594966279|FG001|LTSE Phase|Protocol Violation|0|||
164711148|NCT01473524|594966280|FG002|LTSE Phase|Protocol Violation|0|||
164711149|NCT01473524|594966281|FG003|LTSE Phase|Protocol Violation|0|||
164711150|NCT01473524|594966282|FG004|LTSE Phase|Protocol Violation|0|||
164711151|NCT01473524|594966283|FG005|LTSE Phase|Protocol Violation|1|||
164466855|NCT06262347|594082002|FG000|Overall Study|Withdrawal by Subject|0|||
164466856|NCT06262347|594082003|FG001|Overall Study|Withdrawal by Subject|1|||
164466857|NCT04660539|594082018|FG000|Overall Study|Adverse Event|10|||
164466858|NCT04660539|594082018|FG000|Overall Study|Lack of Efficacy|4|||
164466859|NCT04660539|594082018|FG000|Overall Study|Lost to Follow-up|5|||
164466860|NCT04660539|594082018|FG000|Overall Study|Non-Compliance With Study Drug|3|||
164466861|NCT04660539|594082018|FG000|Overall Study|Reason not Specified|12|||
164466862|NCT04660539|594082018|FG000|Overall Study|Pregnancy|2|||
164466863|NCT04660539|594082018|FG000|Overall Study|Protocol Violation|2|||
164466864|NCT04660539|594082018|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
164466865|NCT04660539|594082018|FG000|Overall Study|Withdrawal by Subject|21|||
164711152|NCT01544179|594966284|FG000|Overall Study|Death|50|||
164711153|NCT01544179|594966285|FG001|Overall Study|Death|37|||
164144822|NCT01524978|592891781|FG007|Overall Study|Death|9|||
164466866|NCT05618587|594082019|FG000|Overall Study|Lost to Follow-up|2|||
164466867|NCT05618587|594082020|FG001|Overall Study|Lost to Follow-up|0|||
164466868|NCT03852550|594082023|FG000|Overall Study|Lost to Follow-up|4|||
164711154|NCT01544179|594966284|FG000|Overall Study|Lost to Follow-up|0|||
164711155|NCT01544179|594966285|FG001|Overall Study|Lost to Follow-up|1|||
164711156|NCT01544179|594966284|FG000|Overall Study|Adverse Event|0|||
164466869|NCT03852550|594082024|FG001|Overall Study|Lost to Follow-up|3|||
164466870|NCT03852550|594082023|FG000|Overall Study|Only parent outcomes completed|0|||
164466871|NCT03852550|594082024|FG001|Overall Study|Only parent outcomes completed|1|||
164466872|NCT03852550|594082023|FG000|Overall Study|Withdrawal by Subject|1|||
164711157|NCT01544179|594966285|FG001|Overall Study|Adverse Event|1|||
164711158|NCT01544179|594966284|FG000|Overall Study|Withdrawal by Subject|12|||
164711159|NCT01544179|594966285|FG001|Overall Study|Withdrawal by Subject|7|||
164711160|NCT01544179|594966284|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
164711161|NCT01544179|594966285|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164711162|NCT01635283|594966288|FG000|Overall Study|Tumor Progression|3|||
164711163|NCT01635283|594966288|FG000|Overall Study|Lost to Follow-up|1|||
164711164|NCT01438996|594966291|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
164711165|NCT01438996|594966292|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
164711166|NCT01438996|594966293|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
164711167|NCT04516759|594966294|FG000|Overall Study|Withdrawal by Subject|1|||
164711168|NCT04516759|594966295|FG001|Overall Study|Withdrawal by Subject|1|||
164711169|NCT04516759|594966294|FG000|Overall Study|Other|0|||
164711170|NCT04516759|594966295|FG001|Overall Study|Other|1|||
164711171|NCT02246114|594966296|FG000|Overall Study|miscarriage|1|||
164711172|NCT02246114|594966297|FG001|Overall Study|miscarriage|0|||
164711173|NCT02861014|594966299|FG000|Primary Analysis|Adverse Event|7|||
164711174|NCT02861014|594966299|FG000|Primary Analysis|Death|1|||
164711175|NCT02861014|594966299|FG000|Primary Analysis|Lack of Efficacy|3|||
164711176|NCT02861014|594966299|FG000|Primary Analysis|Physician Decision|2|||
164711177|NCT02861014|594966299|FG000|Primary Analysis|Pregnancy|4|||
164711178|NCT02861014|594966299|FG000|Primary Analysis|Protocol Violation|2|||
164711179|NCT02861014|594966299|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
164711180|NCT02861014|594966299|FG000|Primary Analysis|Withdrawal by Subject|14|||
164711181|NCT02861014|594966299|FG000|Primary Analysis|Commercial ocrelizumab|3|||
164711182|NCT02861014|594966299|FG000|Safety Follow-up|Adverse Event|1|||
164711183|NCT02861014|594966299|FG000|Safety Follow-up|Pregnancy|1|||
164711184|NCT02861014|594966299|FG000|Safety Follow-up|Withdrawal by Subject|9|||
164711185|NCT02861014|594966299|FG000|Safety Follow-up|Study terminated by sponsor|1|||
164711186|NCT02861014|594966299|FG000|Safety Follow-up|Physician Decision|1|||
164711187|NCT02861014|594966299|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
164711188|NCT02861014|594966299|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
164711189|NCT00229723|594966306|FG000|Concomitant Phase|Adverse Event|4|||
164711190|NCT00229723|594966307|FG001|Concomitant Phase|Adverse Event|2|||
164711191|NCT00229723|594966308|FG002|Concomitant Phase|Adverse Event|5|||
164711192|NCT00229723|594966309|FG003|Concomitant Phase|Adverse Event|2|||
164711193|NCT00229723|594966310|FG004|Concomitant Phase|Adverse Event|0|||
164711194|NCT00229723|594966311|FG005|Concomitant Phase|Adverse Event|1|||
164711195|NCT00229723|594966312|FG006|Concomitant Phase|Adverse Event|2|||
164711196|NCT00229723|594966306|FG000|Concomitant Phase|Objective disease progression|0|||
164711197|NCT00229723|594966307|FG001|Concomitant Phase|Objective disease progression|0|||
164711198|NCT00229723|594966308|FG002|Concomitant Phase|Objective disease progression|0|||
164711199|NCT00229723|594966309|FG003|Concomitant Phase|Objective disease progression|0|||
164711200|NCT00229723|594966310|FG004|Concomitant Phase|Objective disease progression|0|||
164711201|NCT00229723|594966311|FG005|Concomitant Phase|Objective disease progression|0|||
164711202|NCT00229723|594966312|FG006|Concomitant Phase|Objective disease progression|0|||
164711203|NCT00229723|594966306|FG000|Concomitant Phase|Clinical progression|0|||
164711204|NCT00229723|594966307|FG001|Concomitant Phase|Clinical progression|0|||
164711205|NCT00229723|594966308|FG002|Concomitant Phase|Clinical progression|0|||
164711206|NCT00229723|594966309|FG003|Concomitant Phase|Clinical progression|0|||
164711207|NCT00229723|594966310|FG004|Concomitant Phase|Clinical progression|0|||
164466873|NCT03852550|594082024|FG001|Overall Study|Withdrawal by Subject|0|||
164466874|NCT05204654|594082025|FG000|Overall Study|Study terminated due to time restraint|2|||
164466875|NCT05204654|594082026|FG001|Overall Study|Study terminated due to time restraint|2|||
164711208|NCT00229723|594966311|FG005|Concomitant Phase|Clinical progression|0|||
164711209|NCT00229723|594966312|FG006|Concomitant Phase|Clinical progression|1|||
164711210|NCT00229723|594966306|FG000|Concomitant Phase|Lost to Follow-up|0|||
164711211|NCT00229723|594966307|FG001|Concomitant Phase|Lost to Follow-up|0|||
164711212|NCT00229723|594966308|FG002|Concomitant Phase|Lost to Follow-up|0|||
164466876|NCT04862234|594082036|FG000|Overall Study|Surgery cancellation|1|||
164466877|NCT04862234|594082037|FG001|Overall Study|Surgery cancellation|2|||
164711213|NCT00229723|594966309|FG003|Concomitant Phase|Lost to Follow-up|0|||
164711214|NCT00229723|594966310|FG004|Concomitant Phase|Lost to Follow-up|1|||
164711215|NCT00229723|594966311|FG005|Concomitant Phase|Lost to Follow-up|0|||
164711216|NCT00229723|594966312|FG006|Concomitant Phase|Lost to Follow-up|0|||
164711217|NCT00229723|594966306|FG000|Concomitant Phase|Informed consent withdrawn|3|||
164711218|NCT00229723|594966307|FG001|Concomitant Phase|Informed consent withdrawn|2|||
164711219|NCT00229723|594966308|FG002|Concomitant Phase|Informed consent withdrawn|0|||
164711220|NCT00229723|594966309|FG003|Concomitant Phase|Informed consent withdrawn|2|||
164711221|NCT00229723|594966310|FG004|Concomitant Phase|Informed consent withdrawn|0|||
164711222|NCT00229723|594966311|FG005|Concomitant Phase|Informed consent withdrawn|0|||
164466878|NCT04862234|594082036|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
164466879|NCT04862234|594082037|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
164466880|NCT04862234|594082036|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
164466881|NCT04862234|594082037|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
164466882|NCT05828017|594082046|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
164466883|NCT05012163|594082047|FG000|Overall Study|Protocol Violation|0|||
164466884|NCT05012163|594082048|FG001|Overall Study|Protocol Violation|0|||
164466885|NCT05012163|594082049|FG002|Overall Study|Protocol Violation|1|||
164466886|NCT05012163|594082050|FG003|Overall Study|Protocol Violation|1|||
164466887|NCT04132518|594082055|FG000|Overall Study|Prematurely withdrawn from the study|0|||
164466888|NCT04132518|594082056|FG001|Overall Study|Prematurely withdrawn from the study|9|||
164466889|NCT04132518|594082057|FG002|Overall Study|Prematurely withdrawn from the study|1|||
164466890|NCT05425420|594082059|FG000|Overall Study|Physician Decision|1|||
164466891|NCT05425420|594082059|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
164466892|NCT05524402|594082060|FG000|Overall Study|Withdrawal by Subject|3|||
164466893|NCT05524402|594082061|FG001|Overall Study|Withdrawal by Subject|1|||
164466894|NCT05524402|594082060|FG000|Overall Study|Lost to Follow-up|2|||
164466895|NCT05524402|594082061|FG001|Overall Study|Lost to Follow-up|1|||
164466896|NCT05976334|594082062|FG000|Part B|Death|0|||
164466897|NCT05976334|594082063|FG001|Part B|Death|1|||
164466898|NCT05976334|594082062|FG000|Part B|Study Terminated by Sponsor|0|||
164466899|NCT05976334|594082063|FG001|Part B|Study Terminated by Sponsor|1|||
164466900|NCT05976334|594082062|FG000|Part B|Reason Not Specified|0|||
164466901|NCT05976334|594082063|FG001|Part B|Reason Not Specified|1|||
164466902|NCT03381586|594082064|FG000|Overall Study|Adverse Event|1|||
164466903|NCT03381586|594082065|FG001|Overall Study|Adverse Event|1|||
164466904|NCT03381586|594082064|FG000|Overall Study|Protocol Violation|1|||
164466905|NCT03381586|594082065|FG001|Overall Study|Protocol Violation|0|||
164466906|NCT03381586|594082064|FG000|Overall Study|Withdrawal by Subject|1|||
164466907|NCT03381586|594082065|FG001|Overall Study|Withdrawal by Subject|2|||
164466908|NCT05280574|594082071|FG000|Overall Study|Withdrawal by Subject|0|||
164466909|NCT05280574|594082072|FG001|Overall Study|Withdrawal by Subject|2|||
164466910|NCT05280574|594082073|FG002|Overall Study|Withdrawal by Subject|0|||
164466911|NCT03714815|594082076|FG000|Overall Study|Physician Decision|2|||
164466912|NCT03714815|594082076|FG000|Overall Study|Withdrawal by Subject|2|||
164466913|NCT03714815|594082076|FG000|Overall Study|Death|11|||
164466914|NCT04999111|594082077|FG000|Overall Study|Lost to Follow-up|21|||
164466915|NCT04999111|594082078|FG001|Overall Study|Lost to Follow-up|16|||
164466916|NCT04999111|594082079|FG002|Overall Study|Lost to Follow-up|2|||
164466917|NCT04999111|594082080|FG003|Overall Study|Lost to Follow-up|26|||
164466918|NCT04999111|594082081|FG004|Overall Study|Lost to Follow-up|30|||
164466919|NCT04999111|594082082|FG005|Overall Study|Lost to Follow-up|6|||
164466920|NCT04999111|594082077|FG000|Overall Study|Physician Decision|1|||
164466921|NCT04999111|594082078|FG001|Overall Study|Physician Decision|3|||
164466922|NCT04999111|594082079|FG002|Overall Study|Physician Decision|0|||
164466923|NCT04999111|594082080|FG003|Overall Study|Physician Decision|1|||
164466924|NCT04999111|594082081|FG004|Overall Study|Physician Decision|2|||
164466925|NCT04999111|594082082|FG005|Overall Study|Physician Decision|0|||
164466926|NCT04999111|594082077|FG000|Overall Study|Withdrawal by Subject|23|||
164466927|NCT04999111|594082078|FG001|Overall Study|Withdrawal by Subject|29|||
164466928|NCT04999111|594082079|FG002|Overall Study|Withdrawal by Subject|15|||
164466929|NCT04999111|594082080|FG003|Overall Study|Withdrawal by Subject|30|||
164466930|NCT04999111|594082081|FG004|Overall Study|Withdrawal by Subject|35|||
164466931|NCT04999111|594082082|FG005|Overall Study|Withdrawal by Subject|10|||
164466932|NCT04999111|594082077|FG000|Overall Study|Other|6|||
164466933|NCT04999111|594082078|FG001|Overall Study|Other|6|||
164466934|NCT04999111|594082079|FG002|Overall Study|Other|3|||
164466935|NCT04999111|594082080|FG003|Overall Study|Other|8|||
164466936|NCT04999111|594082081|FG004|Overall Study|Other|8|||
164466937|NCT04999111|594082082|FG005|Overall Study|Other|5|||
164466938|NCT04999111|594082077|FG000|Overall Study|Non-compliance with study schedule|1|||
164466939|NCT04999111|594082078|FG001|Overall Study|Non-compliance with study schedule|0|||
164466940|NCT04999111|594082079|FG002|Overall Study|Non-compliance with study schedule|0|||
164466941|NCT04999111|594082080|FG003|Overall Study|Non-compliance with study schedule|1|||
164466942|NCT04999111|594082081|FG004|Overall Study|Non-compliance with study schedule|1|||
164466943|NCT04999111|594082082|FG005|Overall Study|Non-compliance with study schedule|1|||
164466944|NCT04999111|594082077|FG000|Overall Study|Randomized but not vaccinated|1|||
164466945|NCT04999111|594082078|FG001|Overall Study|Randomized but not vaccinated|2|||
164466946|NCT04999111|594082079|FG002|Overall Study|Randomized but not vaccinated|0|||
164144823|NCT01524978|592891782|FG008|Overall Study|Death|5|||
164466947|NCT04999111|594082080|FG003|Overall Study|Randomized but not vaccinated|3|||
164466948|NCT04999111|594082081|FG004|Overall Study|Randomized but not vaccinated|3|||
164466949|NCT04999111|594082082|FG005|Overall Study|Randomized but not vaccinated|0|||
164466950|NCT04999111|594082077|FG000|Overall Study|Adverse Event|1|||
164466951|NCT04999111|594082078|FG001|Overall Study|Adverse Event|1|||
164711223|NCT00229723|594966312|FG006|Concomitant Phase|Informed consent withdrawn|0|||
164711224|NCT00229723|594966306|FG000|Concomitant Phase|Severe non-compliance|0|||
164711225|NCT00229723|594966307|FG001|Concomitant Phase|Severe non-compliance|1|||
164711226|NCT00229723|594966308|FG002|Concomitant Phase|Severe non-compliance|0|||
164711227|NCT00229723|594966309|FG003|Concomitant Phase|Severe non-compliance|0|||
164711228|NCT00229723|594966310|FG004|Concomitant Phase|Severe non-compliance|1|||
164711229|NCT00229723|594966311|FG005|Concomitant Phase|Severe non-compliance|0|||
164711230|NCT00229723|594966312|FG006|Concomitant Phase|Severe non-compliance|0|||
164711231|NCT00229723|594966306|FG000|Concomitant Phase|Other|3|||
164711232|NCT00229723|594966307|FG001|Concomitant Phase|Other|0|||
164711233|NCT00229723|594966308|FG002|Concomitant Phase|Other|1|||
164711234|NCT00229723|594966309|FG003|Concomitant Phase|Other|1|||
164711235|NCT00229723|594966310|FG004|Concomitant Phase|Other|0|||
164711236|NCT00229723|594966311|FG005|Concomitant Phase|Other|2|||
164711237|NCT00229723|594966312|FG006|Concomitant Phase|Other|0|||
164711238|NCT00229723|594966306|FG000|Maintenance Phase|Adverse Event|7|||
164711239|NCT00229723|594966307|FG001|Maintenance Phase|Adverse Event|2|||
164711240|NCT00229723|594966308|FG002|Maintenance Phase|Adverse Event|1|||
164711241|NCT00229723|594966309|FG003|Maintenance Phase|Adverse Event|4|||
164711242|NCT00229723|594966310|FG004|Maintenance Phase|Adverse Event|7|||
164711243|NCT00229723|594966311|FG005|Maintenance Phase|Adverse Event|5|||
164711244|NCT00229723|594966312|FG006|Maintenance Phase|Adverse Event|2|||
164711245|NCT00229723|594966306|FG000|Maintenance Phase|Objective disease progression|5|||
164144824|NCT01524978|592891783|FG009|Overall Study|Death|6|||
164415795|NCT02291289|593893402|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
164415796|NCT02291289|593893403|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
164415797|NCT02291289|593893404|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
164415798|NCT02291289|593893405|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
164415799|NCT02291289|593893406|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
164415800|NCT02291289|593893407|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
164415801|NCT02291289|593893408|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
164415802|NCT02291289|593893409|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
164415803|NCT02291289|593893410|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
164415804|NCT02291289|593893411|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
164415805|NCT02291289|593893412|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
164415806|NCT02291289|593893413|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
164415807|NCT02291289|593893414|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
164415808|NCT02291289|593893402|FG000|Early Disease Progression|Death|0|||
164415809|NCT02291289|593893403|FG001|Early Disease Progression|Death|0|||
164415810|NCT02291289|593893404|FG002|Early Disease Progression|Death|0|||
164415811|NCT02291289|593893405|FG003|Early Disease Progression|Death|0|||
164415812|NCT02291289|593893406|FG004|Early Disease Progression|Death|0|||
164415813|NCT02291289|593893407|FG005|Early Disease Progression|Death|0|||
164415814|NCT02291289|593893408|FG006|Early Disease Progression|Death|0|||
164415815|NCT02291289|593893409|FG007|Early Disease Progression|Death|0|||
164415816|NCT02291289|593893410|FG008|Early Disease Progression|Death|0|||
164415817|NCT02291289|593893411|FG009|Early Disease Progression|Death|0|||
164415818|NCT02291289|593893412|FG010|Early Disease Progression|Death|0|||
164415819|NCT02291289|593893413|FG011|Early Disease Progression|Death|0|||
164415820|NCT02291289|593893414|FG012|Early Disease Progression|Death|10|||
164415821|NCT02291289|593893402|FG000|Early Disease Progression|Lost to Follow-up|0|||
164415822|NCT02291289|593893403|FG001|Early Disease Progression|Lost to Follow-up|0|||
164415823|NCT02291289|593893404|FG002|Early Disease Progression|Lost to Follow-up|0|||
164415824|NCT02291289|593893405|FG003|Early Disease Progression|Lost to Follow-up|0|||
164415825|NCT02291289|593893406|FG004|Early Disease Progression|Lost to Follow-up|0|||
164415826|NCT02291289|593893407|FG005|Early Disease Progression|Lost to Follow-up|0|||
164415827|NCT02291289|593893408|FG006|Early Disease Progression|Lost to Follow-up|0|||
164415828|NCT02291289|593893409|FG007|Early Disease Progression|Lost to Follow-up|0|||
164415829|NCT02291289|593893410|FG008|Early Disease Progression|Lost to Follow-up|0|||
164415830|NCT02291289|593893411|FG009|Early Disease Progression|Lost to Follow-up|0|||
164415831|NCT02291289|593893412|FG010|Early Disease Progression|Lost to Follow-up|0|||
164415832|NCT02291289|593893413|FG011|Early Disease Progression|Lost to Follow-up|0|||
164415833|NCT02291289|593893414|FG012|Early Disease Progression|Lost to Follow-up|1|||
164415834|NCT04399551|593893415|FG000|Overall Study|Adverse Event|15|||
164415835|NCT04399551|593893415|FG000|Overall Study|Withdrawal by Subject|6|||
164415836|NCT04399551|593893415|FG000|Overall Study|Physician Decision|3|||
164415837|NCT04399551|593893415|FG000|Overall Study|Lost to Follow-up|2|||
164415838|NCT04399551|593893415|FG000|Overall Study|Protocol Deviation|2|||
164415839|NCT01533714|593893418|FG000|Overall Study|Adverse Event|0|||
164415840|NCT01533714|593893419|FG001|Overall Study|Adverse Event|1|||
164415841|NCT01533714|593893420|FG002|Overall Study|Adverse Event|2|||
164415842|NCT01533714|593893421|FG003|Overall Study|Adverse Event|2|||
164415843|NCT01533714|593893422|FG004|Overall Study|Adverse Event|2|||
164711246|NCT00229723|594966307|FG001|Maintenance Phase|Objective disease progression|5|||
164711247|NCT00229723|594966308|FG002|Maintenance Phase|Objective disease progression|3|||
164711248|NCT00229723|594966309|FG003|Maintenance Phase|Objective disease progression|6|||
164711249|NCT00229723|594966310|FG004|Maintenance Phase|Objective disease progression|2|||
164711250|NCT00229723|594966311|FG005|Maintenance Phase|Objective disease progression|9|||
164711251|NCT00229723|594966312|FG006|Maintenance Phase|Objective disease progression|5|||
164415844|NCT01533714|593893423|FG005|Overall Study|Adverse Event|1|||
164415845|NCT01533714|593893418|FG000|Overall Study|Lack of Efficacy|0|||
164415846|NCT01533714|593893419|FG001|Overall Study|Lack of Efficacy|0|||
164415847|NCT01533714|593893420|FG002|Overall Study|Lack of Efficacy|0|||
164415848|NCT01533714|593893421|FG003|Overall Study|Lack of Efficacy|0|||
164415849|NCT01533714|593893422|FG004|Overall Study|Lack of Efficacy|0|||
164415850|NCT01533714|593893423|FG005|Overall Study|Lack of Efficacy|1|||
164415851|NCT01533714|593893418|FG000|Overall Study|Withdrawal by Subject|0|||
164415852|NCT01533714|593893419|FG001|Overall Study|Withdrawal by Subject|1|||
164415853|NCT01533714|593893420|FG002|Overall Study|Withdrawal by Subject|0|||
164415854|NCT01533714|593893421|FG003|Overall Study|Withdrawal by Subject|1|||
164415855|NCT01533714|593893422|FG004|Overall Study|Withdrawal by Subject|1|||
164415856|NCT01533714|593893423|FG005|Overall Study|Withdrawal by Subject|0|||
164415857|NCT01533714|593893418|FG000|Overall Study|Exclusion criteria|0|||
164415858|NCT01533714|593893419|FG001|Overall Study|Exclusion criteria|1|||
164415859|NCT01533714|593893420|FG002|Overall Study|Exclusion criteria|0|||
164415860|NCT01533714|593893421|FG003|Overall Study|Exclusion criteria|0|||
164415861|NCT01533714|593893422|FG004|Overall Study|Exclusion criteria|0|||
164415862|NCT01533714|593893423|FG005|Overall Study|Exclusion criteria|0|||
164415863|NCT01533714|593893418|FG000|Overall Study|Positive for purified protein derivative|0|||
164415864|NCT01533714|593893419|FG001|Overall Study|Positive for purified protein derivative|0|||
164415865|NCT01533714|593893420|FG002|Overall Study|Positive for purified protein derivative|1|||
164415866|NCT01533714|593893421|FG003|Overall Study|Positive for purified protein derivative|0|||
164415867|NCT01533714|593893422|FG004|Overall Study|Positive for purified protein derivative|1|||
164415868|NCT01533714|593893423|FG005|Overall Study|Positive for purified protein derivative|0|||
164415869|NCT01533714|593893418|FG000|Overall Study|Withdrawal criteria|0|||
164415870|NCT01533714|593893419|FG001|Overall Study|Withdrawal criteria|0|||
164415871|NCT01533714|593893420|FG002|Overall Study|Withdrawal criteria|1|||
164415872|NCT01533714|593893421|FG003|Overall Study|Withdrawal criteria|0|||
164415873|NCT01533714|593893422|FG004|Overall Study|Withdrawal criteria|3|||
164415874|NCT01533714|593893423|FG005|Overall Study|Withdrawal criteria|1|||
164415875|NCT01533714|593893418|FG000|Overall Study|Ineligibility reason|0|||
164415876|NCT01533714|593893419|FG001|Overall Study|Ineligibility reason|0|||
164415877|NCT01533714|593893420|FG002|Overall Study|Ineligibility reason|0|||
164415878|NCT01533714|593893421|FG003|Overall Study|Ineligibility reason|1|||
164415879|NCT01533714|593893422|FG004|Overall Study|Ineligibility reason|0|||
164415880|NCT01533714|593893423|FG005|Overall Study|Ineligibility reason|0|||
164415881|NCT01375959|593893426|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
164415882|NCT01375959|593893427|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
164415883|NCT01375959|593893426|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
164415884|NCT01375959|593893427|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
164415885|NCT01375959|593893426|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
164415886|NCT01375959|593893427|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
164415887|NCT02310126|593893430|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
164415888|NCT02310126|593893431|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
164415889|NCT02310126|593893430|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
164415890|NCT02310126|593893431|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
164415891|NCT01539863|593893432|FG000|Overall Study|Lost to Follow-up|5|||
164415892|NCT01539863|593893433|FG001|Overall Study|Lost to Follow-up|4|||
164415893|NCT02693834|593893437|FG000|Baseline Measurement|Withdrawal by Subject|1|||
164415894|NCT02693834|593893438|FG001|Baseline Measurement|Withdrawal by Subject|0|||
164415895|NCT02693834|593893437|FG000|Baseline Measurement|Adverse Event|1|||
164415896|NCT02693834|593893438|FG001|Baseline Measurement|Adverse Event|0|||
164415897|NCT02693834|593893437|FG000|Week 2 Practice|Adverse Event|0|||
164415898|NCT02693834|593893438|FG001|Week 2 Practice|Adverse Event|1|||
164415899|NCT02111213|593893439|FG000|Overall Study|Withdrawal by Subject|3|||
164415900|NCT02111213|593893440|FG001|Overall Study|Withdrawal by Subject|2|||
164415901|NCT02111213|593893439|FG000|Overall Study|Lost to Follow-up|3|||
164415902|NCT02111213|593893440|FG001|Overall Study|Lost to Follow-up|4|||
164415903|NCT02226172|593893443|FG000|Overall Study|Participant refused further follow-up|4|||
164415904|NCT02226172|593893443|FG000|Overall Study|Other|5|||
164415905|NCT02226172|593893443|FG000|Overall Study|Death|1|||
164415906|NCT02226172|593893443|FG000|Overall Study|Study terminated by sponsor|1|||
164415907|NCT02226172|593893443|FG000|Overall Study|Adverse Event|6|||
164415908|NCT00758160|593893450|FG000|Overall Study|No Longer Requires Study Medication|4|||
164415909|NCT00758160|593893450|FG000|Overall Study|Administration Problems|3|||
164415910|NCT00758160|593893450|FG000|Overall Study|Adverse Event|15|||
164415911|NCT00758160|593893450|FG000|Overall Study|Lack of Efficacy|10|||
164415912|NCT00758160|593893450|FG000|Overall Study|Lost to Follow-up|14|||
164415913|NCT00758160|593893450|FG000|Overall Study|Protocol Violation|12|||
164415914|NCT00758160|593893450|FG000|Overall Study|Withdrawal by Subject|8|||
164415915|NCT01108510|593893454|FG000|Overall Study|Randomized but Not Treated|5|||
164415916|NCT01108510|593893455|FG001|Overall Study|Randomized but Not Treated|1|||
164466952|NCT04999111|594082079|FG002|Overall Study|Adverse Event|0|||
164466953|NCT04999111|594082080|FG003|Overall Study|Adverse Event|0|||
164466954|NCT04999111|594082081|FG004|Overall Study|Adverse Event|0|||
164466955|NCT04999111|594082082|FG005|Overall Study|Adverse Event|0|||
164466956|NCT04999111|594082077|FG000|Overall Study|Initiated prohibited medication|0|||
164466957|NCT04999111|594082078|FG001|Overall Study|Initiated prohibited medication|0|||
164466958|NCT04999111|594082079|FG002|Overall Study|Initiated prohibited medication|0|||
164466959|NCT04999111|594082080|FG003|Overall Study|Initiated prohibited medication|0|||
164466960|NCT04999111|594082081|FG004|Overall Study|Initiated prohibited medication|1|||
164466961|NCT04999111|594082082|FG005|Overall Study|Initiated prohibited medication|0|||
164466962|NCT04056611|594082091|FG000|Overall Study|Physician Decision|1|||
164466963|NCT03733925|594082092|FG000|Overall Study|Lost to Follow-up|1|||
164466964|NCT03733925|594082092|FG000|Overall Study|Withdrawal by Subject|2|||
164466965|NCT03733925|594082092|FG000|Overall Study|Adverse Event|2|||
164466966|NCT03733925|594082092|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164466967|NCT03213873|594082093|FG000|Overall Study|Withdrawal by Subject|8|||
164466968|NCT03213873|594082094|FG001|Overall Study|Withdrawal by Subject|9|||
164466969|NCT03213873|594082093|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
164466970|NCT03213873|594082094|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
164466971|NCT03213873|594082093|FG000|Overall Study|Lost to Follow-up|0|||
164466972|NCT03213873|594082094|FG001|Overall Study|Lost to Follow-up|2|||
164466973|NCT02631746|594082100|FG000|Overall Study|Lack of Efficacy|3|||
164466974|NCT02361216|594082101|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
164466975|NCT02361216|594082102|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
164466976|NCT02361216|594082101|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
164466977|NCT02361216|594082102|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
164466978|NCT02361216|594082101|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
164466979|NCT02361216|594082102|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
164466980|NCT02361216|594082101|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
164466981|NCT02361216|594082102|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
164466982|NCT02361216|594082101|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
164466983|NCT02361216|594082102|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
164466984|NCT02361216|594082101|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
164466985|NCT02361216|594082102|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
164466986|NCT04709419|594082103|FG000|Overall Study|Physician Decision|1|||
164466987|NCT04709419|594082104|FG001|Overall Study|Physician Decision|0|||
164466988|NCT05683340|594082105|FG000|Overall Study|Adverse Event|1|||
164466989|NCT05683340|594082106|FG001|Overall Study|Adverse Event|1|||
164466990|NCT05683340|594082105|FG000|Overall Study|Protocol Violation|1|||
164466991|NCT05683340|594082106|FG001|Overall Study|Protocol Violation|0|||
164466992|NCT05683340|594082105|FG000|Overall Study|Withdrawal by Subject|0|||
164466993|NCT05683340|594082106|FG001|Overall Study|Withdrawal by Subject|2|||
164466994|NCT02224144|594082110|FG000|Overall Study|Lost to Follow-up|3|||
164466995|NCT02224144|594082111|FG001|Overall Study|Lost to Follow-up|1|||
164466996|NCT02224144|594082110|FG000|Overall Study|Death|2|||
164466997|NCT02224144|594082111|FG001|Overall Study|Death|0|||
164466998|NCT02224144|594082110|FG000|Overall Study|Withdrawal by Subject|0|||
164466999|NCT02224144|594082111|FG001|Overall Study|Withdrawal by Subject|1|||
164711252|NCT00229723|594966306|FG000|Maintenance Phase|Clinical progression|4|||
164711253|NCT00229723|594966307|FG001|Maintenance Phase|Clinical progression|1|||
164711254|NCT00229723|594966308|FG002|Maintenance Phase|Clinical progression|2|||
164711255|NCT00229723|594966309|FG003|Maintenance Phase|Clinical progression|2|||
164711256|NCT00229723|594966310|FG004|Maintenance Phase|Clinical progression|1|||
164711257|NCT00229723|594966311|FG005|Maintenance Phase|Clinical progression|1|||
164144825|NCT01524978|592891784|FG010|Overall Study|Death|17|||
164415917|NCT01108510|593893454|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
164415918|NCT01108510|593893455|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
164415919|NCT01108510|593893454|FG000|Overall Study|Adverse Event|26|||
164415920|NCT01108510|593893455|FG001|Overall Study|Adverse Event|19|||
164415921|NCT01108510|593893454|FG000|Overall Study|Lost to Follow-up|20|||
164415922|NCT01108510|593893455|FG001|Overall Study|Lost to Follow-up|17|||
164415923|NCT01108510|593893454|FG000|Overall Study|Withdrew Consent|21|||
164415924|NCT01108510|593893455|FG001|Overall Study|Withdrew Consent|15|||
164415925|NCT01108510|593893454|FG000|Overall Study|Investigator's Discretion|12|||
164415926|NCT01108510|593893455|FG001|Overall Study|Investigator's Discretion|10|||
164415927|NCT01108510|593893454|FG000|Overall Study|Participant Noncompliance|5|||
164415928|NCT01108510|593893455|FG001|Overall Study|Participant Noncompliance|7|||
164415929|NCT01108510|593893454|FG000|Overall Study|Lack of Efficacy|3|||
164415930|NCT01108510|593893455|FG001|Overall Study|Lack of Efficacy|0|||
164467000|NCT03505008|594082112|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
164415931|NCT01108510|593893454|FG000|Overall Study|Pregnancy|0|||
164415932|NCT01108510|593893455|FG001|Overall Study|Pregnancy|3|||
164415933|NCT01108510|593893454|FG000|Overall Study|Death|1|||
164415934|NCT01108510|593893455|FG001|Overall Study|Death|1|||
164467001|NCT03505008|594082113|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
164467002|NCT03505008|594082114|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
164467003|NCT03505008|594082115|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
164467004|NCT03505008|594082112|FG000|Before Week 24 Randomization|Adverse Event|10|||
164467005|NCT03505008|594082113|FG001|Before Week 24 Randomization|Adverse Event|0|||
164467006|NCT03505008|594082114|FG002|Before Week 24 Randomization|Adverse Event|0|||
164467007|NCT03505008|594082115|FG003|Before Week 24 Randomization|Adverse Event|0|||
164467008|NCT03505008|594082112|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
164467009|NCT03505008|594082113|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
164467010|NCT03505008|594082114|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
164467011|NCT03505008|594082115|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
164467012|NCT03505008|594082112|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
164467013|NCT03505008|594082113|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
164467014|NCT03505008|594082114|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
164467015|NCT03505008|594082115|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
164467016|NCT03505008|594082112|FG000|Before Week 24 Randomization|Physician Decision|2|||
164467017|NCT03505008|594082113|FG001|Before Week 24 Randomization|Physician Decision|0|||
164467018|NCT03505008|594082114|FG002|Before Week 24 Randomization|Physician Decision|0|||
164467019|NCT03505008|594082115|FG003|Before Week 24 Randomization|Physician Decision|0|||
164467020|NCT03505008|594082112|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
164467021|NCT03505008|594082113|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
164467022|NCT03505008|594082114|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
164467023|NCT03505008|594082115|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
164467024|NCT03505008|594082112|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
164467025|NCT03505008|594082113|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
164467026|NCT03505008|594082114|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
164467027|NCT03505008|594082115|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
164467028|NCT03505008|594082112|FG000|Before Week 24 Randomization|Complication|1|||
164467029|NCT03505008|594082113|FG001|Before Week 24 Randomization|Complication|0|||
164467030|NCT03505008|594082114|FG002|Before Week 24 Randomization|Complication|0|||
164467031|NCT03505008|594082115|FG003|Before Week 24 Randomization|Complication|0|||
164467032|NCT03505008|594082112|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
164467033|NCT03505008|594082113|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
164467034|NCT03505008|594082114|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
164467035|NCT03505008|594082115|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
164467036|NCT03505008|594082112|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
164467037|NCT03505008|594082113|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
164467038|NCT03505008|594082114|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
164467039|NCT03505008|594082115|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
164467040|NCT03505008|594082112|FG000|After Week 24 Randomization|Adverse Event|0|||
164467041|NCT03505008|594082113|FG001|After Week 24 Randomization|Adverse Event|1|||
164467042|NCT03505008|594082114|FG002|After Week 24 Randomization|Adverse Event|2|||
164467043|NCT03505008|594082115|FG003|After Week 24 Randomization|Adverse Event|2|||
164467044|NCT03505008|594082112|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
164467045|NCT03505008|594082113|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
164467046|NCT03505008|594082114|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
164467047|NCT03505008|594082115|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
164467048|NCT03505008|594082112|FG000|After Week 24 Randomization|Protocol Violation|0|||
164467049|NCT03505008|594082113|FG001|After Week 24 Randomization|Protocol Violation|0|||
164467050|NCT03505008|594082114|FG002|After Week 24 Randomization|Protocol Violation|1|||
164467051|NCT03505008|594082115|FG003|After Week 24 Randomization|Protocol Violation|0|||
164467052|NCT02437136|594082116|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
164467053|NCT02437136|594082117|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
164467054|NCT02437136|594082118|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
164467055|NCT02437136|594082119|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
164467056|NCT02437136|594082120|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
164467057|NCT02437136|594082121|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
164467058|NCT02437136|594082122|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
164467059|NCT02437136|594082116|FG000|Expansion (Phase 2)|Death|0|||
164467060|NCT02437136|594082117|FG001|Expansion (Phase 2)|Death|0|||
164467061|NCT02437136|594082118|FG002|Expansion (Phase 2)|Death|0|||
164467062|NCT02437136|594082119|FG003|Expansion (Phase 2)|Death|6|||
164467063|NCT02437136|594082120|FG004|Expansion (Phase 2)|Death|37|||
164467064|NCT02437136|594082121|FG005|Expansion (Phase 2)|Death|29|||
164467065|NCT02437136|594082122|FG006|Expansion (Phase 2)|Death|24|||
164467066|NCT02437136|594082116|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
164467067|NCT02437136|594082117|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
164711258|NCT00229723|594966312|FG006|Maintenance Phase|Clinical progression|1|||
164711259|NCT00229723|594966306|FG000|Maintenance Phase|Lost to Follow-up|0|||
164467068|NCT02437136|594082118|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
164467069|NCT02437136|594082119|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
164467070|NCT02437136|594082120|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
164467071|NCT02437136|594082121|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
164467072|NCT02437136|594082122|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
164467073|NCT02437136|594082116|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
164467074|NCT02437136|594082117|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
164467075|NCT02437136|594082118|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
164467076|NCT02437136|594082119|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
164467077|NCT02437136|594082120|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
164467078|NCT02437136|594082121|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
164467079|NCT02437136|594082122|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
164467080|NCT02056834|594082125|FG000|Overall Study|Lost to Follow-up|7|||
164467081|NCT02780700|594082127|FG000|Overall Study|Progressive disease|1|||
164467082|NCT04580914|594082137|FG000|Overall Study|Withdrawal by Subject|6|||
164467083|NCT04580914|594082137|FG000|Overall Study|Lost to Follow-up|2|||
164467084|NCT02828358|594082141|FG000|Overall Study|Physician Decision|7|||
164467085|NCT02828358|594082142|FG001|Overall Study|Physician Decision|1|||
164467086|NCT02828358|594082141|FG000|Overall Study|Treatment Failure|6|||
164467087|NCT02828358|594082142|FG001|Overall Study|Treatment Failure|0|||
164467088|NCT02828358|594082141|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
164467089|NCT02828358|594082142|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
164467090|NCT02828358|594082141|FG000|Overall Study|Refusal of further protocol therapy|2|||
164467091|NCT02828358|594082142|FG001|Overall Study|Refusal of further protocol therapy|0|||
164467092|NCT02828358|594082141|FG000|Overall Study|Relapse|25|||
164467093|NCT02828358|594082142|FG001|Overall Study|Relapse|0|||
164467094|NCT02828358|594082141|FG000|Overall Study|Still on therapy|5|||
164467095|NCT02828358|594082142|FG001|Overall Study|Still on therapy|0|||
164467096|NCT05285137|594082157|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
164467097|NCT05285137|594082158|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
164467098|NCT05285137|594082159|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
164467099|NCT05285137|594082160|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
164415935|NCT00779584|593893458|FG000|Overall Study|Protocol Violation|0|||
164415936|NCT00779584|593893459|FG001|Overall Study|Protocol Violation|0|||
164415937|NCT00779584|593893460|FG002|Overall Study|Protocol Violation|0|||
164415938|NCT00779584|593893461|FG003|Overall Study|Protocol Violation|0|||
164415939|NCT00779584|593893462|FG004|Overall Study|Protocol Violation|0|||
164415940|NCT00779584|593893463|FG005|Overall Study|Protocol Violation|1|||
164415941|NCT00779584|593893464|FG006|Overall Study|Protocol Violation|0|||
164415942|NCT00779584|593893465|FG007|Overall Study|Protocol Violation|0|||
164415943|NCT00779584|593893466|FG008|Overall Study|Protocol Violation|0|||
164415944|NCT00779584|593893458|FG000|Overall Study|Withdrawal by Subject|1|||
164415945|NCT00779584|593893459|FG001|Overall Study|Withdrawal by Subject|1|||
164415946|NCT00779584|593893460|FG002|Overall Study|Withdrawal by Subject|2|||
164415947|NCT00779584|593893461|FG003|Overall Study|Withdrawal by Subject|0|||
164415948|NCT00779584|593893462|FG004|Overall Study|Withdrawal by Subject|0|||
164415949|NCT00779584|593893463|FG005|Overall Study|Withdrawal by Subject|2|||
164415950|NCT00779584|593893464|FG006|Overall Study|Withdrawal by Subject|1|||
164415951|NCT00779584|593893465|FG007|Overall Study|Withdrawal by Subject|0|||
164415952|NCT00779584|593893466|FG008|Overall Study|Withdrawal by Subject|0|||
164415953|NCT00779584|593893458|FG000|Overall Study|Lost to Follow-up|0|||
164415954|NCT00779584|593893459|FG001|Overall Study|Lost to Follow-up|0|||
164415955|NCT00779584|593893460|FG002|Overall Study|Lost to Follow-up|0|||
164415956|NCT00779584|593893461|FG003|Overall Study|Lost to Follow-up|0|||
164415957|NCT00779584|593893462|FG004|Overall Study|Lost to Follow-up|1|||
164415958|NCT00779584|593893463|FG005|Overall Study|Lost to Follow-up|0|||
164415959|NCT00779584|593893464|FG006|Overall Study|Lost to Follow-up|0|||
164415960|NCT00779584|593893465|FG007|Overall Study|Lost to Follow-up|0|||
164415961|NCT00779584|593893466|FG008|Overall Study|Lost to Follow-up|0|||
164415962|NCT00779584|593893458|FG000|Overall Study|Progression of Disease|0|||
164415963|NCT00779584|593893459|FG001|Overall Study|Progression of Disease|1|||
164415964|NCT00779584|593893460|FG002|Overall Study|Progression of Disease|2|||
164415965|NCT00779584|593893461|FG003|Overall Study|Progression of Disease|6|||
164415966|NCT00779584|593893462|FG004|Overall Study|Progression of Disease|5|||
164415967|NCT00779584|593893463|FG005|Overall Study|Progression of Disease|1|||
164415968|NCT00779584|593893464|FG006|Overall Study|Progression of Disease|4|||
164415969|NCT00779584|593893465|FG007|Overall Study|Progression of Disease|2|||
164467100|NCT05285137|594082161|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
164467101|NCT05285137|594082162|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
164415970|NCT00779584|593893466|FG008|Overall Study|Progression of Disease|1|||
164415971|NCT00779584|593893458|FG000|Overall Study|Adverse Event|1|||
164415972|NCT00779584|593893459|FG001|Overall Study|Adverse Event|0|||
164415973|NCT00779584|593893460|FG002|Overall Study|Adverse Event|2|||
164415974|NCT00779584|593893461|FG003|Overall Study|Adverse Event|0|||
164415975|NCT00779584|593893462|FG004|Overall Study|Adverse Event|0|||
164415976|NCT00779584|593893463|FG005|Overall Study|Adverse Event|0|||
164415977|NCT00779584|593893464|FG006|Overall Study|Adverse Event|2|||
164415978|NCT00779584|593893465|FG007|Overall Study|Adverse Event|1|||
164415979|NCT00779584|593893466|FG008|Overall Study|Adverse Event|1|||
164711260|NCT00229723|594966307|FG001|Maintenance Phase|Lost to Follow-up|1|||
164711261|NCT00229723|594966308|FG002|Maintenance Phase|Lost to Follow-up|2|||
164711262|NCT00229723|594966309|FG003|Maintenance Phase|Lost to Follow-up|2|||
164711263|NCT00229723|594966310|FG004|Maintenance Phase|Lost to Follow-up|0|||
164711264|NCT00229723|594966311|FG005|Maintenance Phase|Lost to Follow-up|0|||
164711265|NCT00229723|594966312|FG006|Maintenance Phase|Lost to Follow-up|1|||
164711266|NCT00229723|594966306|FG000|Maintenance Phase|Informed consent withdrawn|1|||
164711267|NCT00229723|594966307|FG001|Maintenance Phase|Informed consent withdrawn|0|||
164711268|NCT00229723|594966308|FG002|Maintenance Phase|Informed consent withdrawn|0|||
164711269|NCT00229723|594966309|FG003|Maintenance Phase|Informed consent withdrawn|1|||
164711270|NCT00229723|594966310|FG004|Maintenance Phase|Informed consent withdrawn|1|||
164711271|NCT00229723|594966311|FG005|Maintenance Phase|Informed consent withdrawn|1|||
164467102|NCT05285137|594082163|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
164711272|NCT00229723|594966312|FG006|Maintenance Phase|Informed consent withdrawn|0|||
164711273|NCT00229723|594966306|FG000|Maintenance Phase|Severe non-compliance|3|||
164467103|NCT05285137|594082164|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
164467104|NCT05285137|594082165|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
164467105|NCT05285137|594082157|FG000|Overall Study|Lost to Follow-up|0|||
164467106|NCT05285137|594082158|FG001|Overall Study|Lost to Follow-up|0|||
164467107|NCT05285137|594082159|FG002|Overall Study|Lost to Follow-up|1|||
164467108|NCT05285137|594082160|FG003|Overall Study|Lost to Follow-up|3|||
164467109|NCT05285137|594082161|FG004|Overall Study|Lost to Follow-up|0|||
164467110|NCT05285137|594082162|FG005|Overall Study|Lost to Follow-up|0|||
164467111|NCT05285137|594082163|FG006|Overall Study|Lost to Follow-up|1|||
164467112|NCT05285137|594082164|FG007|Overall Study|Lost to Follow-up|0|||
164467113|NCT05285137|594082165|FG008|Overall Study|Lost to Follow-up|0|||
164467114|NCT05285137|594082157|FG000|Overall Study|Physician Decision|0|||
164467115|NCT05285137|594082158|FG001|Overall Study|Physician Decision|1|||
164467116|NCT05285137|594082159|FG002|Overall Study|Physician Decision|0|||
164467117|NCT05285137|594082160|FG003|Overall Study|Physician Decision|0|||
164467118|NCT05285137|594082161|FG004|Overall Study|Physician Decision|0|||
164467119|NCT05285137|594082162|FG005|Overall Study|Physician Decision|0|||
164467120|NCT05285137|594082163|FG006|Overall Study|Physician Decision|0|||
164467121|NCT05285137|594082164|FG007|Overall Study|Physician Decision|0|||
164467122|NCT05285137|594082165|FG008|Overall Study|Physician Decision|0|||
164467123|NCT05285137|594082157|FG000|Overall Study|Pregnancy|0|||
164467124|NCT05285137|594082158|FG001|Overall Study|Pregnancy|0|||
164467125|NCT05285137|594082159|FG002|Overall Study|Pregnancy|0|||
164467126|NCT05285137|594082160|FG003|Overall Study|Pregnancy|0|||
164467127|NCT05285137|594082161|FG004|Overall Study|Pregnancy|0|||
164467128|NCT05285137|594082162|FG005|Overall Study|Pregnancy|0|||
164467129|NCT05285137|594082163|FG006|Overall Study|Pregnancy|1|||
164467130|NCT05285137|594082164|FG007|Overall Study|Pregnancy|0|||
164467131|NCT05285137|594082165|FG008|Overall Study|Pregnancy|0|||
164467132|NCT05285137|594082157|FG000|Overall Study|Withdrawal by Subject|0|||
164467133|NCT05285137|594082158|FG001|Overall Study|Withdrawal by Subject|1|||
164467134|NCT05285137|594082159|FG002|Overall Study|Withdrawal by Subject|2|||
164467135|NCT05285137|594082160|FG003|Overall Study|Withdrawal by Subject|1|||
164467136|NCT05285137|594082161|FG004|Overall Study|Withdrawal by Subject|0|||
164467137|NCT05285137|594082162|FG005|Overall Study|Withdrawal by Subject|0|||
164467138|NCT05285137|594082163|FG006|Overall Study|Withdrawal by Subject|0|||
164467139|NCT05285137|594082164|FG007|Overall Study|Withdrawal by Subject|0|||
164467140|NCT05285137|594082165|FG008|Overall Study|Withdrawal by Subject|1|||
164467141|NCT05309291|594082166|FG000|Overall Study|Adverse Event|0|||
164467142|NCT05309291|594082167|FG001|Overall Study|Adverse Event|1|||
164467143|NCT03221426|594082169|FG000|Overall Study|Ongoing in study|212|||
164467144|NCT03221426|594082170|FG001|Overall Study|Ongoing in study|193|||
164467145|NCT03221426|594082171|FG002|Overall Study|Ongoing in study|61|||
164467146|NCT03221426|594082172|FG003|Overall Study|Ongoing in study|55|||
164467147|NCT03221426|594082169|FG000|Overall Study|Withdrawal by Subject|12|||
164467148|NCT03221426|594082170|FG001|Overall Study|Withdrawal by Subject|4|||
164467149|NCT03221426|594082171|FG002|Overall Study|Withdrawal by Subject|2|||
164467150|NCT03221426|594082172|FG003|Overall Study|Withdrawal by Subject|3|||
164467151|NCT03221426|594082169|FG000|Overall Study|Lost to Follow-up|4|||
164467152|NCT03221426|594082170|FG001|Overall Study|Lost to Follow-up|1|||
164467153|NCT03221426|594082171|FG002|Overall Study|Lost to Follow-up|1|||
164467154|NCT03221426|594082172|FG003|Overall Study|Lost to Follow-up|0|||
164467155|NCT03221426|594082169|FG000|Overall Study|Death|174|||
164467156|NCT03221426|594082170|FG001|Overall Study|Death|204|||
164467157|NCT03221426|594082171|FG002|Overall Study|Death|36|||
164467158|NCT03221426|594082172|FG003|Overall Study|Death|45|||
164467159|NCT06262477|594083609|FG000|Overall Study|Withdrawal by Subject|1|||
164467160|NCT06262477|594083610|FG001|Overall Study|Withdrawal by Subject|0|||
164467161|NCT06262477|594083609|FG000|Overall Study|Adverse Event|0|||
164467162|NCT06262477|594083610|FG001|Overall Study|Adverse Event|1|||
164467163|NCT06262477|594083609|FG000|Overall Study|Lost to Follow-up|0|||
164467164|NCT06262477|594083610|FG001|Overall Study|Lost to Follow-up|1|||
164467165|NCT04797858|594083611|FG000|Overall Study|Withdrawal by Subject|0|||
164467166|NCT04797858|594083612|FG001|Overall Study|Withdrawal by Subject|1|||
164467167|NCT04797858|594083611|FG000|Overall Study|Excluded due to administrative error|7|||
164467168|NCT04797858|594083612|FG001|Overall Study|Excluded due to administrative error|8|||
164467169|NCT01880515|594083617|FG000|Overall Study|Lost to Follow-up|3|||
164467170|NCT01880515|594083618|FG001|Overall Study|Lost to Follow-up|2|||
164467171|NCT01880515|594083617|FG000|Overall Study|Disease Progression|5|||
164467172|NCT01880515|594083618|FG001|Overall Study|Disease Progression|7|||
164467173|NCT03220035|594083622|FG000|Overall Study|Adverse Event|1|||
164467174|NCT03220035|594083622|FG000|Overall Study|Protocol Violation|1|||
164467175|NCT03220035|594083622|FG000|Overall Study|Progressive Disease|2|||
164467176|NCT02593773|594083623|FG000|Overall Study|Voluntary Withdrawal|3|||
164467177|NCT02593773|594083623|FG000|Overall Study|Study Terminated by Sponsor|31|||
164467178|NCT02593773|594083623|FG000|Overall Study|Death|1|||
164467179|NCT04304144|594083624|FG000|DLT Observation Period|Physician Decision|0|||
164467180|NCT04304144|594083625|FG001|DLT Observation Period|Physician Decision|1|||
164467181|NCT04304144|594083626|FG002|DLT Observation Period|Physician Decision|0|||
164711274|NCT00229723|594966307|FG001|Maintenance Phase|Severe non-compliance|1|||
164711275|NCT00229723|594966308|FG002|Maintenance Phase|Severe non-compliance|0|||
164711276|NCT00229723|594966309|FG003|Maintenance Phase|Severe non-compliance|0|||
164711277|NCT00229723|594966310|FG004|Maintenance Phase|Severe non-compliance|1|||
164711278|NCT00229723|594966311|FG005|Maintenance Phase|Severe non-compliance|0|||
164711279|NCT00229723|594966312|FG006|Maintenance Phase|Severe non-compliance|0|||
164711280|NCT00229723|594966306|FG000|Maintenance Phase|Other|5|||
164711281|NCT00229723|594966307|FG001|Maintenance Phase|Other|4|||
164711282|NCT00229723|594966308|FG002|Maintenance Phase|Other|1|||
164711283|NCT00229723|594966309|FG003|Maintenance Phase|Other|2|||
164711284|NCT00229723|594966310|FG004|Maintenance Phase|Other|3|||
164711285|NCT00229723|594966311|FG005|Maintenance Phase|Other|3|||
164711286|NCT00229723|594966312|FG006|Maintenance Phase|Other|1|||
164711287|NCT01338870|594966316|FG000|Overall Study|Lost to Follow-up|0|||
164711288|NCT01338870|594966317|FG001|Overall Study|Lost to Follow-up|0|||
164711289|NCT01338870|594966318|FG002|Overall Study|Lost to Follow-up|1|||
164711290|NCT01338870|594966319|FG003|Overall Study|Lost to Follow-up|0|||
164711291|NCT01338870|594966320|FG004|Overall Study|Lost to Follow-up|1|||
164711292|NCT01338870|594966321|FG005|Overall Study|Lost to Follow-up|0|||
164711293|NCT01338870|594966316|FG000|Overall Study|Withdrawal by Subject|2|||
164711294|NCT01338870|594966317|FG001|Overall Study|Withdrawal by Subject|3|||
164711295|NCT01338870|594966318|FG002|Overall Study|Withdrawal by Subject|4|||
164711296|NCT01338870|594966319|FG003|Overall Study|Withdrawal by Subject|0|||
164711297|NCT01338870|594966320|FG004|Overall Study|Withdrawal by Subject|0|||
164711298|NCT01338870|594966321|FG005|Overall Study|Withdrawal by Subject|2|||
164711299|NCT01338870|594966316|FG000|Overall Study|Other|3|||
164711300|NCT01338870|594966317|FG001|Overall Study|Other|3|||
164711301|NCT01338870|594966318|FG002|Overall Study|Other|3|||
164711302|NCT01338870|594966319|FG003|Overall Study|Other|2|||
164711303|NCT01338870|594966320|FG004|Overall Study|Other|0|||
164711304|NCT01338870|594966321|FG005|Overall Study|Other|2|||
164711305|NCT01338870|594966316|FG000|Overall Study|Protocol Violation|0|||
164711306|NCT01338870|594966317|FG001|Overall Study|Protocol Violation|2|||
164711307|NCT01338870|594966318|FG002|Overall Study|Protocol Violation|2|||
164711308|NCT01338870|594966319|FG003|Overall Study|Protocol Violation|2|||
164711309|NCT01338870|594966320|FG004|Overall Study|Protocol Violation|1|||
164711310|NCT01338870|594966321|FG005|Overall Study|Protocol Violation|1|||
164711311|NCT01338870|594966316|FG000|Overall Study|Adverse Event|4|||
164711312|NCT01338870|594966317|FG001|Overall Study|Adverse Event|4|||
164711313|NCT01338870|594966318|FG002|Overall Study|Adverse Event|1|||
164711314|NCT01338870|594966319|FG003|Overall Study|Adverse Event|5|||
164711315|NCT01338870|594966320|FG004|Overall Study|Adverse Event|4|||
164711316|NCT01338870|594966321|FG005|Overall Study|Adverse Event|1|||
164711317|NCT03201445|594966323|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
164711318|NCT03201445|594966324|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
164711319|NCT03201445|594966323|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
164711320|NCT03201445|594966324|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
164711321|NCT03201445|594966323|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
164711322|NCT03201445|594966324|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
164711323|NCT03201445|594966323|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
164711324|NCT03201445|594966324|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
164711325|NCT03201445|594966323|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
164711326|NCT03201445|594966324|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
164711327|NCT03201445|594966323|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
164711328|NCT03201445|594966324|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
164711329|NCT03201445|594966323|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
164711330|NCT03201445|594966324|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
164711331|NCT03201445|594966323|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
164711332|NCT03201445|594966324|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
164467182|NCT04304144|594083627|FG003|DLT Observation Period|Physician Decision|0|||
164467183|NCT04304144|594083624|FG000|Continued Treatment Period|Adverse Event|0|||
164467184|NCT04304144|594083625|FG001|Continued Treatment Period|Adverse Event|1|||
164467185|NCT04304144|594083626|FG002|Continued Treatment Period|Adverse Event|0|||
164467186|NCT04304144|594083627|FG003|Continued Treatment Period|Adverse Event|0|||
164711333|NCT03201445|594966323|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
164711334|NCT03201445|594966324|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
164711335|NCT03201445|594966323|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
164711336|NCT03201445|594966324|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
164711337|NCT03201445|594966323|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
164711338|NCT03201445|594966324|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
164711339|NCT03201445|594966323|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
164711340|NCT03201445|594966324|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
164711341|NCT03201445|594966323|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
164711342|NCT03201445|594966324|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
164711343|NCT03201445|594966323|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
164711344|NCT03201445|594966324|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
164711345|NCT03201445|594966323|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
164711346|NCT03201445|594966324|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
164711347|NCT03201445|594966323|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
164711348|NCT03201445|594966324|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
164711349|NCT03201445|594966323|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
164711350|NCT03201445|594966324|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
164711351|NCT03201445|594966323|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
164711352|NCT03201445|594966324|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
164711353|NCT03201445|594966323|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
164711354|NCT03201445|594966324|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
164711355|NCT03201445|594966323|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
164711356|NCT03201445|594966324|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
164711357|NCT03201445|594966323|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
164711358|NCT03201445|594966324|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
164711359|NCT01228019|594966325|FG000|Overall Study|Dose Violation|70|||
164711360|NCT01228019|594966325|FG000|Overall Study|Duplicate enrollment|1|||
164711361|NCT01228019|594966325|FG000|Overall Study|Missing pre-treatment data|72|||
164711362|NCT01228019|594966325|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
164711363|NCT01228019|594966325|FG000|Overall Study|Violation of Entry Criterion|9|||
164711364|NCT01268501|594966326|FG000|Overall Study|Lost to Follow-up|1|||
164711365|NCT01268501|594966326|FG000|Overall Study|Withdrawal by Subject|3|||
164711366|NCT01268501|594966326|FG000|Overall Study|Unacceptable Subjective Vision|3|||
164711367|NCT01268501|594966326|FG000|Overall Study|Handling Difficulties|2|||
164711368|NCT00474266|594966329|FG000|Overall Study|Withdrawal by Subject|7|||
164711369|NCT00474266|594966330|FG001|Overall Study|Withdrawal by Subject|20|||
164711370|NCT00474266|594966331|FG002|Overall Study|Withdrawal by Subject|4|||
164711371|NCT00474266|594966332|FG003|Overall Study|Withdrawal by Subject|7|||
164711372|NCT02774642|594966333|FG000|Overall Study|Lost to Follow-up|9|||
164711373|NCT02774642|594966334|FG001|Overall Study|Lost to Follow-up|7|||
164711374|NCT02329847|594966335|FG000|Overall Study|Death|4|||
164711375|NCT02329847|594966336|FG001|Overall Study|Death|4|||
164711376|NCT02329847|594966337|FG002|Overall Study|Death|22|||
164711377|NCT02329847|594966338|FG003|Overall Study|Death|12|||
164711378|NCT02329847|594966339|FG004|Overall Study|Death|20|||
164711379|NCT02329847|594966340|FG005|Overall Study|Death|13|||
164711380|NCT02329847|594966335|FG000|Overall Study|Lost to Follow-up|0|||
164711381|NCT02329847|594966336|FG001|Overall Study|Lost to Follow-up|0|||
164711382|NCT02329847|594966337|FG002|Overall Study|Lost to Follow-up|2|||
164711383|NCT02329847|594966338|FG003|Overall Study|Lost to Follow-up|3|||
164711384|NCT02329847|594966339|FG004|Overall Study|Lost to Follow-up|0|||
164711385|NCT02329847|594966340|FG005|Overall Study|Lost to Follow-up|1|||
164711386|NCT02329847|594966335|FG000|Overall Study|Physician Decision|0|||
164467187|NCT04304144|594083624|FG000|Continued Treatment Period|Death|0|||
164467188|NCT04304144|594083625|FG001|Continued Treatment Period|Death|0|||
164467189|NCT04304144|594083626|FG002|Continued Treatment Period|Death|1|||
164467190|NCT04304144|594083627|FG003|Continued Treatment Period|Death|2|||
164467191|NCT04304144|594083624|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
164467192|NCT04304144|594083625|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
164467193|NCT04304144|594083626|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
164467194|NCT04304144|594083627|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
164467195|NCT04304144|594083624|FG000|Continued Treatment Period|Other than specified|2|||
164467196|NCT04304144|594083625|FG001|Continued Treatment Period|Other than specified|0|||
164467197|NCT04304144|594083626|FG002|Continued Treatment Period|Other than specified|1|||
164467198|NCT04304144|594083627|FG003|Continued Treatment Period|Other than specified|1|||
164467199|NCT04101357|594083628|FG000|Overall Study|Death|1|||
164467200|NCT04101357|594083629|FG001|Overall Study|Death|1|||
164467201|NCT04101357|594083630|FG002|Overall Study|Death|1|||
164467202|NCT04101357|594083631|FG003|Overall Study|Death|2|||
164467203|NCT04101357|594083632|FG004|Overall Study|Death|4|||
164711387|NCT02329847|594966336|FG001|Overall Study|Physician Decision|0|||
164711388|NCT02329847|594966337|FG002|Overall Study|Physician Decision|0|||
164711389|NCT02329847|594966338|FG003|Overall Study|Physician Decision|0|||
164711390|NCT02329847|594966339|FG004|Overall Study|Physician Decision|1|||
164711391|NCT02329847|594966340|FG005|Overall Study|Physician Decision|0|||
164711392|NCT02329847|594966335|FG000|Overall Study|Withdrawal by Subject|2|||
164711393|NCT02329847|594966336|FG001|Overall Study|Withdrawal by Subject|1|||
164711394|NCT02329847|594966337|FG002|Overall Study|Withdrawal by Subject|5|||
164467204|NCT04101357|594083633|FG005|Overall Study|Death|11|||
164467205|NCT04101357|594083634|FG006|Overall Study|Death|4|||
164467206|NCT04101357|594083635|FG007|Overall Study|Death|4|||
164467207|NCT04101357|594083636|FG008|Overall Study|Death|5|||
164467208|NCT04101357|594083637|FG009|Overall Study|Death|2|||
164467209|NCT04101357|594083638|FG010|Overall Study|Death|3|||
164467210|NCT04101357|594083628|FG000|Overall Study|Trial closure|0|||
164711395|NCT02329847|594966338|FG003|Overall Study|Withdrawal by Subject|7|||
164711396|NCT02329847|594966339|FG004|Overall Study|Withdrawal by Subject|8|||
164711397|NCT02329847|594966340|FG005|Overall Study|Withdrawal by Subject|3|||
164711398|NCT02329847|594966335|FG000|Overall Study|Other|1|||
164711399|NCT02329847|594966336|FG001|Overall Study|Other|2|||
164711400|NCT02329847|594966337|FG002|Overall Study|Other|6|||
164711401|NCT02329847|594966338|FG003|Overall Study|Other|13|||
164711402|NCT02329847|594966339|FG004|Overall Study|Other|10|||
164711403|NCT02329847|594966340|FG005|Overall Study|Other|3|||
164711404|NCT05330468|594966341|FG000|Overall Study|Death|6|||
164711405|NCT05330468|594966341|FG000|Overall Study|Withdrawal by Subject|4|||
164711406|NCT05330468|594966341|FG000|Overall Study|Lost to Follow-up|4|||
164711407|NCT02828241|594966344|FG000|Overall Study|Adverse Event|7|||
164711408|NCT02828241|594966345|FG001|Overall Study|Adverse Event|2|||
164711409|NCT02828241|594966344|FG000|Overall Study|Protocol Violation|1|||
164711410|NCT02828241|594966345|FG001|Overall Study|Protocol Violation|0|||
164711411|NCT04572893|594966346|FG000|Part A|Adverse Event|1|||
164711412|NCT04572893|594966347|FG001|Part A|Adverse Event|0|||
164711413|NCT04572893|594966348|FG002|Part A|Adverse Event|0|||
164711414|NCT04572893|594966349|FG003|Part A|Adverse Event|0|||
164711415|NCT04572893|594966350|FG004|Part A|Adverse Event|0|||
164711416|NCT04572893|594966351|FG005|Part A|Adverse Event|0|||
164711417|NCT04572893|594966352|FG006|Part A|Adverse Event|0|||
164711418|NCT04572893|594966346|FG000|Part B|Withdrawal by Subject|0|||
164711419|NCT04572893|594966347|FG001|Part B|Withdrawal by Subject|0|||
164711420|NCT04572893|594966348|FG002|Part B|Withdrawal by Subject|0|||
164711421|NCT04572893|594966349|FG003|Part B|Withdrawal by Subject|0|||
164711422|NCT04572893|594966350|FG004|Part B|Withdrawal by Subject|0|||
164711423|NCT04572893|594966351|FG005|Part B|Withdrawal by Subject|1|||
164711424|NCT04572893|594966352|FG006|Part B|Withdrawal by Subject|0|||
164711425|NCT04572893|594966346|FG000|Part B|Study terminated by sponsor|0|||
164711426|NCT04572893|594966347|FG001|Part B|Study terminated by sponsor|0|||
164711427|NCT04572893|594966348|FG002|Part B|Study terminated by sponsor|0|||
164711428|NCT04572893|594966349|FG003|Part B|Study terminated by sponsor|0|||
164711429|NCT04572893|594966350|FG004|Part B|Study terminated by sponsor|7|||
164711430|NCT04572893|594966351|FG005|Part B|Study terminated by sponsor|5|||
164711431|NCT04572893|594966352|FG006|Part B|Study terminated by sponsor|3|||
164711432|NCT04572893|594966346|FG000|Part B|Lost to Follow-up|0|||
164711433|NCT04572893|594966347|FG001|Part B|Lost to Follow-up|0|||
164711434|NCT04572893|594966348|FG002|Part B|Lost to Follow-up|0|||
164711435|NCT04572893|594966349|FG003|Part B|Lost to Follow-up|0|||
164711436|NCT04572893|594966350|FG004|Part B|Lost to Follow-up|0|||
164711437|NCT04572893|594966351|FG005|Part B|Lost to Follow-up|0|||
164711438|NCT04572893|594966352|FG006|Part B|Lost to Follow-up|1|||
164711439|NCT04572893|594966346|FG000|Part B|Adverse Event|0|||
164711440|NCT04572893|594966347|FG001|Part B|Adverse Event|0|||
164711441|NCT04572893|594966348|FG002|Part B|Adverse Event|0|||
164711442|NCT04572893|594966349|FG003|Part B|Adverse Event|0|||
164711443|NCT04572893|594966350|FG004|Part B|Adverse Event|1|||
164711444|NCT04572893|594966351|FG005|Part B|Adverse Event|1|||
164467211|NCT04101357|594083629|FG001|Overall Study|Trial closure|0|||
164467212|NCT04101357|594083630|FG002|Overall Study|Trial closure|0|||
164467213|NCT04101357|594083631|FG003|Overall Study|Trial closure|0|||
164467214|NCT04101357|594083632|FG004|Overall Study|Trial closure|0|||
164467215|NCT04101357|594083633|FG005|Overall Study|Trial closure|2|||
164467216|NCT04101357|594083634|FG006|Overall Study|Trial closure|2|||
164467217|NCT04101357|594083635|FG007|Overall Study|Trial closure|0|||
164467218|NCT04101357|594083636|FG008|Overall Study|Trial closure|0|||
164711445|NCT04572893|594966352|FG006|Part B|Adverse Event|0|||
164711446|NCT00477295|594966360|FG000|Overall Study|Adverse Event|31|||
164711447|NCT00477295|594966361|FG001|Overall Study|Adverse Event|35|||
164711448|NCT00477295|594966360|FG000|Overall Study|Withdrawal by Subject|35|||
164711449|NCT00477295|594966361|FG001|Overall Study|Withdrawal by Subject|24|||
164711450|NCT00477295|594966360|FG000|Overall Study|Lack of Efficacy|23|||
164711451|NCT00477295|594966361|FG001|Overall Study|Lack of Efficacy|23|||
164711452|NCT00477295|594966360|FG000|Overall Study|Protocol Violation|3|||
164711453|NCT00477295|594966361|FG001|Overall Study|Protocol Violation|8|||
164711454|NCT00477295|594966360|FG000|Overall Study|Physician Decision|4|||
164711455|NCT00477295|594966361|FG001|Overall Study|Physician Decision|5|||
164711456|NCT00477295|594966360|FG000|Overall Study|Lost to Follow-up|21|||
164711457|NCT00477295|594966361|FG001|Overall Study|Lost to Follow-up|11|||
164711458|NCT00477295|594966360|FG000|Overall Study|Other|4|||
164711459|NCT00477295|594966361|FG001|Overall Study|Other|3|||
164467219|NCT04101357|594083637|FG009|Overall Study|Trial closure|0|||
164711460|NCT03276780|594966364|FG000|Overall Study|Withdrawal by Subject|5|||
164467220|NCT04101357|594083638|FG010|Overall Study|Trial closure|1|||
164711461|NCT03276780|594966365|FG001|Overall Study|Withdrawal by Subject|3|||
164711462|NCT03276780|594966364|FG000|Overall Study|Lost to Follow-up|3|||
164711463|NCT03276780|594966365|FG001|Overall Study|Lost to Follow-up|5|||
164711464|NCT03276780|594966364|FG000|Overall Study|Moved out of state|1|||
164711465|NCT03276780|594966365|FG001|Overall Study|Moved out of state|1|||
164711466|NCT03276780|594966364|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
164467221|NCT04101357|594083628|FG000|Overall Study|Lost to Follow-up|0|||
164467222|NCT04101357|594083629|FG001|Overall Study|Lost to Follow-up|0|||
164467223|NCT04101357|594083630|FG002|Overall Study|Lost to Follow-up|0|||
164467224|NCT04101357|594083631|FG003|Overall Study|Lost to Follow-up|1|||
164467225|NCT04101357|594083632|FG004|Overall Study|Lost to Follow-up|0|||
164467226|NCT04101357|594083633|FG005|Overall Study|Lost to Follow-up|0|||
164467227|NCT04101357|594083634|FG006|Overall Study|Lost to Follow-up|0|||
164467228|NCT04101357|594083635|FG007|Overall Study|Lost to Follow-up|1|||
164467229|NCT04101357|594083636|FG008|Overall Study|Lost to Follow-up|0|||
164467230|NCT04101357|594083637|FG009|Overall Study|Lost to Follow-up|0|||
164467231|NCT04101357|594083638|FG010|Overall Study|Lost to Follow-up|0|||
164467232|NCT04101357|594083628|FG000|Overall Study|Withdrawal by Subject|1|||
164467233|NCT04101357|594083629|FG001|Overall Study|Withdrawal by Subject|0|||
164467234|NCT04101357|594083630|FG002|Overall Study|Withdrawal by Subject|0|||
164467235|NCT04101357|594083631|FG003|Overall Study|Withdrawal by Subject|0|||
164467236|NCT04101357|594083632|FG004|Overall Study|Withdrawal by Subject|0|||
164467237|NCT04101357|594083633|FG005|Overall Study|Withdrawal by Subject|0|||
164467238|NCT04101357|594083634|FG006|Overall Study|Withdrawal by Subject|0|||
164467239|NCT04101357|594083635|FG007|Overall Study|Withdrawal by Subject|0|||
164467240|NCT04101357|594083636|FG008|Overall Study|Withdrawal by Subject|1|||
164467241|NCT04101357|594083637|FG009|Overall Study|Withdrawal by Subject|1|||
164467242|NCT04101357|594083638|FG010|Overall Study|Withdrawal by Subject|0|||
164467243|NCT04101357|594083628|FG000|Overall Study|Other|0|||
164467244|NCT04101357|594083629|FG001|Overall Study|Other|0|||
164467245|NCT04101357|594083630|FG002|Overall Study|Other|0|||
164467246|NCT04101357|594083631|FG003|Overall Study|Other|0|||
164467247|NCT04101357|594083632|FG004|Overall Study|Other|0|||
164467248|NCT04101357|594083633|FG005|Overall Study|Other|1|||
164467249|NCT04101357|594083634|FG006|Overall Study|Other|2|||
164467250|NCT04101357|594083635|FG007|Overall Study|Other|1|||
164467251|NCT04101357|594083636|FG008|Overall Study|Other|0|||
164467252|NCT04101357|594083637|FG009|Overall Study|Other|0|||
164467253|NCT04101357|594083638|FG010|Overall Study|Other|0|||
164467254|NCT04101357|594083628|FG000|Overall Study|Enrolled but not treated|0|||
164467255|NCT04101357|594083629|FG001|Overall Study|Enrolled but not treated|0|||
164467256|NCT04101357|594083630|FG002|Overall Study|Enrolled but not treated|0|||
164467257|NCT04101357|594083631|FG003|Overall Study|Enrolled but not treated|0|||
164467258|NCT04101357|594083632|FG004|Overall Study|Enrolled but not treated|0|||
164467259|NCT04101357|594083633|FG005|Overall Study|Enrolled but not treated|1|||
164467260|NCT04101357|594083634|FG006|Overall Study|Enrolled but not treated|1|||
164467261|NCT04101357|594083635|FG007|Overall Study|Enrolled but not treated|0|||
164467262|NCT04101357|594083636|FG008|Overall Study|Enrolled but not treated|0|||
164467263|NCT04101357|594083637|FG009|Overall Study|Enrolled but not treated|0|||
164467264|NCT04101357|594083638|FG010|Overall Study|Enrolled but not treated|0|||
164467265|NCT05167864|594083639|FG000|Overall Study|Lost to Follow-up|7|||
164467266|NCT05167864|594083640|FG001|Overall Study|Lost to Follow-up|6|||
164467267|NCT05167864|594083641|FG002|Overall Study|Lost to Follow-up|7|||
164467268|NCT05167864|594083642|FG003|Overall Study|Lost to Follow-up|9|||
164467269|NCT01828112|594083646|FG000|Treatment Phase|Adverse Event|7|||
164467270|NCT01828112|594083647|FG001|Treatment Phase|Adverse Event|8|||
164467271|NCT01828112|594083648|FG002|Treatment Phase|Adverse Event|0|||
164467272|NCT01828112|594083646|FG000|Treatment Phase|Death|9|||
164467273|NCT01828112|594083647|FG001|Treatment Phase|Death|5|||
164467274|NCT01828112|594083648|FG002|Treatment Phase|Death|0|||
164467275|NCT01828112|594083646|FG000|Treatment Phase|No longer required treatment|0|||
164467276|NCT01828112|594083647|FG001|Treatment Phase|No longer required treatment|1|||
164467277|NCT01828112|594083648|FG002|Treatment Phase|No longer required treatment|0|||
164467278|NCT01828112|594083646|FG000|Treatment Phase|Physician Decision|6|||
164467279|NCT01828112|594083647|FG001|Treatment Phase|Physician Decision|7|||
164467280|NCT01828112|594083648|FG002|Treatment Phase|Physician Decision|0|||
164467281|NCT01828112|594083646|FG000|Treatment Phase|Pregnancy|1|||
164467282|NCT01828112|594083647|FG001|Treatment Phase|Pregnancy|0|||
164467283|NCT01828112|594083648|FG002|Treatment Phase|Pregnancy|0|||
164467284|NCT01828112|594083646|FG000|Treatment Phase|Progressive disease|79|||
164467285|NCT01828112|594083647|FG001|Treatment Phase|Progressive disease|87|||
164467286|NCT01828112|594083648|FG002|Treatment Phase|Progressive disease|0|||
164467287|NCT01828112|594083646|FG000|Treatment Phase|Study terminated by sponsor|1|||
164467288|NCT01828112|594083647|FG001|Treatment Phase|Study terminated by sponsor|0|||
164467289|NCT01828112|594083648|FG002|Treatment Phase|Study terminated by sponsor|0|||
164467290|NCT01828112|594083646|FG000|Treatment Phase|Subject/guardian decision|12|||
164467291|NCT01828112|594083647|FG001|Treatment Phase|Subject/guardian decision|8|||
164467292|NCT01828112|594083648|FG002|Treatment Phase|Subject/guardian decision|0|||
164467293|NCT01828112|594083646|FG000|Extension Treatment Phase|Adverse Event|0|||
164467294|NCT01828112|594083647|FG001|Extension Treatment Phase|Adverse Event|0|||
164467295|NCT01828112|594083648|FG002|Extension Treatment Phase|Adverse Event|6|||
164467296|NCT01828112|594083646|FG000|Extension Treatment Phase|Death|0|||
164467297|NCT01828112|594083647|FG001|Extension Treatment Phase|Death|0|||
164467298|NCT01828112|594083648|FG002|Extension Treatment Phase|Death|17|||
164467299|NCT01828112|594083646|FG000|Extension Treatment Phase|Physician Decision|0|||
164711467|NCT03276780|594966365|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
164711468|NCT03276780|594966364|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
164711469|NCT03276780|594966365|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
164711470|NCT00510289|594966366|FG000|Overall Study|Withdrawal by Subject|7|||
164711471|NCT00510289|594966366|FG000|Overall Study|Refused bone marrow biopsy|2|||
164711472|NCT00510289|594966366|FG000|Overall Study|Lost to Follow-up|1|||
164711473|NCT00510289|594966366|FG000|Overall Study|Progressed prior to starting drug|2|||
164711474|NCT03835221|594966367|FG000|Methafilcon A|Withdrawal by Subject|1|||
164711475|NCT00861198|594966368|FG000|Overall Study|SpyGlass Failed|5|||
164711476|NCT02288182|594966369|FG000|Overall Study|Adverse Event|0|||
164711477|NCT02288182|594966370|FG001|Overall Study|Adverse Event|1|||
164711478|NCT02288182|594966369|FG000|Overall Study|Lost to Follow-up|0|||
164711479|NCT02288182|594966370|FG001|Overall Study|Lost to Follow-up|1|||
164711480|NCT04619992|594966375|FG000|Overall Study|Withdrawal by Subject|1|||
164711481|NCT04619992|594966376|FG001|Overall Study|Withdrawal by Subject|0|||
164711482|NCT01197755|594966377|FG000|Overall Study|Adverse Event|8|||
164711483|NCT01197755|594966378|FG001|Overall Study|Adverse Event|10|||
164711484|NCT01197755|594966379|FG002|Overall Study|Adverse Event|10|||
164711485|NCT01197755|594966377|FG000|Overall Study|Study-specific discontinuation criteria|2|||
164711486|NCT01197755|594966378|FG001|Overall Study|Study-specific discontinuation criteria|1|||
164711487|NCT01197755|594966379|FG002|Overall Study|Study-specific discontinuation criteria|0|||
164711488|NCT01197755|594966377|FG000|Overall Study|Entered the long-term extension study|18|||
164711489|NCT01197755|594966378|FG001|Overall Study|Entered the long-term extension study|21|||
164711490|NCT01197755|594966379|FG002|Overall Study|Entered the long-term extension study|35|||
164711491|NCT01197755|594966377|FG000|Overall Study|Lack of therapeutic response|0|||
164711492|NCT01197755|594966378|FG001|Overall Study|Lack of therapeutic response|7|||
164711493|NCT01197755|594966379|FG002|Overall Study|Lack of therapeutic response|4|||
164711494|NCT01197755|594966377|FG000|Overall Study|Severe non-compliance to the protocol|2|||
164711495|NCT01197755|594966378|FG001|Overall Study|Severe non-compliance to the protocol|1|||
164711496|NCT01197755|594966379|FG002|Overall Study|Severe non-compliance to the protocol|2|||
164711497|NCT01197755|594966377|FG000|Overall Study|Withdrawal by Subject|1|||
164711498|NCT01197755|594966378|FG001|Overall Study|Withdrawal by Subject|0|||
164711499|NCT01197755|594966379|FG002|Overall Study|Withdrawal by Subject|0|||
164711500|NCT01197755|594966377|FG000|Overall Study|Lost to Follow-up|0|||
164711501|NCT01197755|594966378|FG001|Overall Study|Lost to Follow-up|0|||
164711502|NCT01197755|594966379|FG002|Overall Study|Lost to Follow-up|1|||
164711503|NCT01197755|594966377|FG000|Overall Study|eg, change in circumstances|7|||
164711504|NCT01197755|594966378|FG001|Overall Study|eg, change in circumstances|3|||
164711505|NCT01197755|594966379|FG002|Overall Study|eg, change in circumstances|2|||
164711506|NCT03365011|594966380|FG000|Overall Study|Withdrawal by Subject|1|||
164711507|NCT03365011|594966381|FG001|Overall Study|Withdrawal by Subject|2|||
164711508|NCT00499174|594966382|FG000|Overall Study|Physician Decision|78|||
164711509|NCT00499174|594966383|FG001|Overall Study|Physician Decision|9|||
164711510|NCT03582826|594966384|FG000|Overall Study|Lost to Follow-up|39|||
164711511|NCT03582826|594966385|FG001|Overall Study|Lost to Follow-up|0|||
164711512|NCT03582826|594966384|FG000|Overall Study|Withdrawal by Subject|2|||
164711513|NCT03582826|594966385|FG001|Overall Study|Withdrawal by Subject|0|||
164711514|NCT01214915|594966389|FG000|Overall Study|Adverse Event|8|||
164711515|NCT01214915|594966389|FG000|Overall Study|Lack of Efficacy|3|||
164711516|NCT00574912|594966390|FG000|Overall Study|Could not place IV lines.|3|||
164711517|NCT00574912|594966390|FG000|Overall Study|scheduling conflicts|3|||
164711518|NCT00574912|594966390|FG000|Overall Study|Physician Decision|2|||
164711519|NCT00638027|594966398|FG000|Overall Study|Adverse Event|0|||
164711520|NCT00638027|594966399|FG001|Overall Study|Adverse Event|2|||
164711521|NCT02342639|594966406|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
164711522|NCT02342639|594966407|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
164415980|NCT00779584|593893458|FG000|Overall Study|Symptomatic Deterioration|1|||
164711523|NCT02342639|594966406|FG000|Overall Study|Protocol Violation|0|||
164711524|NCT02342639|594966407|FG001|Overall Study|Protocol Violation|2|||
164711525|NCT01200069|594968158|FG000|Overall Study|Withdrawal by Subject|0|||
164711526|NCT01200069|594968159|FG001|Overall Study|Withdrawal by Subject|1|||
164711527|NCT00761657|594968160|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
164711528|NCT00761657|594968161|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
164711529|NCT00761657|594968162|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
164711530|NCT00761657|594968163|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
164711531|NCT00761657|594968164|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
164415981|NCT00779584|593893459|FG001|Overall Study|Symptomatic Deterioration|1|||
164415982|NCT00779584|593893460|FG002|Overall Study|Symptomatic Deterioration|1|||
164415983|NCT00779584|593893461|FG003|Overall Study|Symptomatic Deterioration|0|||
164415984|NCT00779584|593893462|FG004|Overall Study|Symptomatic Deterioration|0|||
164415985|NCT00779584|593893463|FG005|Overall Study|Symptomatic Deterioration|1|||
164415986|NCT00779584|593893464|FG006|Overall Study|Symptomatic Deterioration|1|||
164467300|NCT01828112|594083647|FG001|Extension Treatment Phase|Physician Decision|0|||
164415987|NCT00779584|593893465|FG007|Overall Study|Symptomatic Deterioration|0|||
164711532|NCT00761657|594968165|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
164711533|NCT00761657|594968166|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
164711534|NCT00761657|594968167|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
164711535|NCT00761657|594968168|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
164711536|NCT00761657|594968160|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
164711537|NCT00761657|594968161|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
164711538|NCT00761657|594968162|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
164711539|NCT00761657|594968163|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
164711540|NCT00761657|594968164|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
164711541|NCT00761657|594968165|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
164711542|NCT00761657|594968166|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
164711543|NCT00761657|594968167|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
164711544|NCT00761657|594968168|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
164711545|NCT00761657|594968160|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
164711546|NCT00761657|594968161|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
164711547|NCT00761657|594968162|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
164711548|NCT00761657|594968163|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
164711549|NCT00761657|594968164|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
164711550|NCT00761657|594968165|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
164711551|NCT00761657|594968166|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
164467301|NCT01828112|594083648|FG002|Extension Treatment Phase|Physician Decision|5|||
164467302|NCT01828112|594083646|FG000|Extension Treatment Phase|Progressive disease|0|||
164467303|NCT01828112|594083647|FG001|Extension Treatment Phase|Progressive disease|0|||
164467304|NCT01828112|594083648|FG002|Extension Treatment Phase|Progressive disease|46|||
164467305|NCT01828112|594083646|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
164467306|NCT01828112|594083647|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
164467307|NCT01828112|594083648|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
164467308|NCT01828112|594083646|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
164467309|NCT01828112|594083647|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
164467310|NCT01828112|594083648|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
164467311|NCT05565820|594083659|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
164467312|NCT05565820|594083660|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
164467313|NCT05565820|594083659|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
164467314|NCT05565820|594083660|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
164467315|NCT04871529|594083664|FG000|Overall Study|Withdrawal by Subject|0|||
164467316|NCT04871529|594083665|FG001|Overall Study|Withdrawal by Subject|1|||
164467317|NCT04871529|594083664|FG000|Overall Study|Death|0|||
164467318|NCT04871529|594083665|FG001|Overall Study|Death|1|||
164467319|NCT04871529|594083664|FG000|Overall Study|Not protocol specified|0|||
164467320|NCT04871529|594083665|FG001|Overall Study|Not protocol specified|1|||
164467321|NCT05184452|594083666|FG000|Overall Study|Lost to Follow-up|0|||
164467322|NCT05184452|594083667|FG001|Overall Study|Lost to Follow-up|0|||
164467323|NCT05184452|594083668|FG002|Overall Study|Lost to Follow-up|0|||
164467324|NCT05184452|594083669|FG003|Overall Study|Lost to Follow-up|0|||
164467325|NCT05184452|594083670|FG004|Overall Study|Lost to Follow-up|0|||
164467326|NCT05184452|594083671|FG005|Overall Study|Lost to Follow-up|2|||
164467327|NCT05184452|594083672|FG006|Overall Study|Lost to Follow-up|0|||
164467328|NCT05184452|594083673|FG007|Overall Study|Lost to Follow-up|0|||
164467329|NCT05184452|594083674|FG008|Overall Study|Lost to Follow-up|0|||
164467330|NCT05184452|594083675|FG009|Overall Study|Lost to Follow-up|1|||
164467331|NCT05184452|594083666|FG000|Overall Study|Withdrawal by Subject|0|||
164467332|NCT05184452|594083667|FG001|Overall Study|Withdrawal by Subject|0|||
164467333|NCT05184452|594083668|FG002|Overall Study|Withdrawal by Subject|0|||
164467334|NCT05184452|594083669|FG003|Overall Study|Withdrawal by Subject|0|||
164467335|NCT05184452|594083670|FG004|Overall Study|Withdrawal by Subject|0|||
164711552|NCT00761657|594968167|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
164711553|NCT00761657|594968168|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
164711554|NCT00761657|594968160|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
164711555|NCT00761657|594968161|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
164711556|NCT00761657|594968162|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
164711557|NCT00761657|594968163|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
164711558|NCT00761657|594968164|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
164711559|NCT00761657|594968165|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
164711560|NCT00761657|594968166|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
164467336|NCT05184452|594083671|FG005|Overall Study|Withdrawal by Subject|1|||
164467337|NCT05184452|594083672|FG006|Overall Study|Withdrawal by Subject|0|||
164467338|NCT05184452|594083673|FG007|Overall Study|Withdrawal by Subject|0|||
164467339|NCT05184452|594083674|FG008|Overall Study|Withdrawal by Subject|0|||
164467340|NCT05184452|594083675|FG009|Overall Study|Withdrawal by Subject|1|||
164467341|NCT05586490|594083676|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
164467342|NCT05586490|594083677|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
164467343|NCT05586490|594083678|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
164467344|NCT05586490|594083679|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
164467345|NCT05586490|594083680|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
164467346|NCT05586490|594083676|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
164467347|NCT05586490|594083677|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
164467348|NCT05586490|594083678|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
164467349|NCT05586490|594083679|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
164467350|NCT05586490|594083680|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
164467351|NCT05586490|594083676|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
164467352|NCT05586490|594083677|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
164467353|NCT05586490|594083678|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
164467354|NCT05586490|594083679|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
164467355|NCT05586490|594083680|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
164467356|NCT04136912|594083681|FG000|Overall Study|Operational reasons|0|||
164467357|NCT04136912|594083682|FG001|Overall Study|Operational reasons|0|||
164467358|NCT04136912|594083683|FG002|Overall Study|Operational reasons|2|||
164467359|NCT03606408|594083684|FG000|Overall Study|Adverse Event|13|||
164467360|NCT03606408|594083684|FG000|Overall Study|Withdrawal by Subject|7|||
164467361|NCT03606408|594083684|FG000|Overall Study|Physician Decision|4|||
164467362|NCT03606408|594083684|FG000|Overall Study|Lack of Efficacy|2|||
164467363|NCT03606408|594083684|FG000|Overall Study|Death|1|||
164467364|NCT03606408|594083684|FG000|Overall Study|new therapy for study indication|1|||
164467365|NCT03556293|594083685|FG000|Overall Study|Ineligible for analysis|1904|||
164467366|NCT03556293|594083686|FG001|Overall Study|Ineligible for analysis|1471|||
164467367|NCT03556293|594083687|FG002|Overall Study|Ineligible for analysis|1091|||
164467368|NCT03556293|594083688|FG003|Overall Study|Ineligible for analysis|1269|||
164467369|NCT03292484|594083694|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
164467370|NCT03292484|594083694|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
164467371|NCT03292484|594083694|FG000|Overall Study|Protocol Violation|2|||
164467372|NCT03292484|594083694|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
164467373|NCT03292484|594083694|FG000|Overall Study|Sponsor decision|349|||
164467374|NCT03292484|594083694|FG000|Overall Study|Lost to Follow-up|7|||
164467375|NCT03292484|594083694|FG000|Overall Study|Coronavirus Disease 2019|1|||
164467376|NCT03292484|594083694|FG000|Overall Study|Other|20|||
164467377|NCT05290493|594083695|FG000|Overall Study|Withdrawal by Subject|2|||
164467378|NCT05290493|594083696|FG001|Overall Study|Withdrawal by Subject|2|||
164467379|NCT05290493|594083695|FG000|Overall Study|Adverse Event|1|||
164467380|NCT05290493|594083696|FG001|Overall Study|Adverse Event|0|||
164467381|NCT03673501|594083700|FG000|Overall Study|Participants ongoing.|36|||
164467382|NCT03673501|594083701|FG001|Overall Study|Participants ongoing.|24|||
164467383|NCT05838027|594083702|FG000|Overall Study|Lost to Follow-up|5|||
164467384|NCT05838027|594083703|FG001|Overall Study|Lost to Follow-up|1|||
164467385|NCT05838027|594083702|FG000|Overall Study|Withdrawal by Subject|1|||
164467386|NCT05838027|594083703|FG001|Overall Study|Withdrawal by Subject|0|||
164467387|NCT04526886|594083706|FG000|Overall Study|Physician Decision|4|||
164467388|NCT03824366|594083710|FG000|Overall Study|Death|1|||
164467389|NCT03824366|594083710|FG000|Overall Study|Previously unidentified metal artifact|1|||
164467390|NCT03824366|594083710|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
164467391|NCT03824366|594083710|FG000|Overall Study|Withdrawal by Subject|1|||
164467392|NCT04068831|594083711|FG000|Overall Study|Disease Progression|10|||
164467393|NCT04068831|594083712|FG001|Overall Study|Disease Progression|8|||
164467394|NCT00323856|594083713|FG000|Overall Study|Withdrawal by Subject|1|||
164467395|NCT00323856|594083713|FG000|Overall Study|Was uncooperative and noncompliant|1|||
164467396|NCT00323856|594083713|FG000|Overall Study|Reason not specified|1|||
164467397|NCT00323856|594083713|FG000|Overall Study|Missing|2|||
164467398|NCT04086121|594083715|FG000|Overall Study|Other than listed|8|||
164467399|NCT04086121|594083715|FG000|Overall Study|Withdrawal by Subject|3|||
164467400|NCT04086121|594083715|FG000|Overall Study|Lost to Follow-up|2|||
164467401|NCT04086121|594083715|FG000|Overall Study|Adverse Event|1|||
164467402|NCT02834390|594083720|FG000|Induction Phase|Progressive disease|0|||
164467403|NCT02834390|594083721|FG001|Induction Phase|Progressive disease|1|||
164599532|NCT01274338|594556273|FG001|Overall Study|Did not start treatment|116|||
164599533|NCT01274338|594556274|FG002|Overall Study|Did not start treatment|7|||
164599534|NCT01274338|594556275|FG003|Overall Study|Did not start treatment|0|||
164599535|NCT01274338|594556276|FG004|Overall Study|Did not start treatment|0|||
164467404|NCT02834390|594083720|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
164467405|NCT02834390|594083721|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
164467406|NCT02834390|594083720|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
164467407|NCT02834390|594083721|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
164467408|NCT02834390|594083720|FG000|Consolidation Phase|Physician Decision|1|||
164467409|NCT02834390|594083721|FG001|Consolidation Phase|Physician Decision|1|||
164467410|NCT03118518|594083722|FG000|Overall Study|Early Exit after treatment|2|||
164467411|NCT03118518|594083723|FG001|Overall Study|Early Exit after treatment|8|||
164599536|NCT01274338|594556277|FG005|Overall Study|Did not start treatment|0|||
164467412|NCT03118518|594083722|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
164467413|NCT03118518|594083723|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
164467414|NCT05533190|594083733|FG000|Overall Study|Lost to Follow-up|19|||
164467415|NCT05533190|594083734|FG001|Overall Study|Lost to Follow-up|7|||
164467416|NCT05533190|594083733|FG000|Overall Study|Failed to download app|1|||
164467417|NCT05533190|594083734|FG001|Overall Study|Failed to download app|0|||
164467418|NCT05533190|594083733|FG000|Overall Study|Thought app was a scam|1|||
164467419|NCT05533190|594083734|FG001|Overall Study|Thought app was a scam|0|||
164467420|NCT05533190|594083733|FG000|Overall Study|Withdrawal by Subject|2|||
164467421|NCT05533190|594083734|FG001|Overall Study|Withdrawal by Subject|0|||
164467422|NCT05552508|594083735|FG000|Overall Study|Adverse Event|3|||
164467423|NCT04451772|594083738|FG000|Overall Study|Adverse Event|1|||
164467424|NCT04451772|594083739|FG001|Overall Study|Adverse Event|0|||
164467425|NCT04451772|594083740|FG002|Overall Study|Adverse Event|1|||
164467426|NCT04451772|594083741|FG003|Overall Study|Adverse Event|1|||
164467427|NCT04451772|594083742|FG004|Overall Study|Adverse Event|0|||
164467428|NCT04451772|594083743|FG005|Overall Study|Adverse Event|3|||
164467429|NCT04451772|594083738|FG000|Overall Study|Withdrawal by Subject|2|||
164467430|NCT04451772|594083739|FG001|Overall Study|Withdrawal by Subject|7|||
164467431|NCT04451772|594083740|FG002|Overall Study|Withdrawal by Subject|2|||
164467432|NCT04451772|594083741|FG003|Overall Study|Withdrawal by Subject|1|||
164467433|NCT04451772|594083742|FG004|Overall Study|Withdrawal by Subject|1|||
164467434|NCT04451772|594083743|FG005|Overall Study|Withdrawal by Subject|0|||
164467435|NCT04451772|594083738|FG000|Overall Study|Other, not specified|1|||
164467436|NCT04451772|594083739|FG001|Overall Study|Other, not specified|2|||
164467437|NCT04451772|594083740|FG002|Overall Study|Other, not specified|1|||
164467438|NCT04451772|594083741|FG003|Overall Study|Other, not specified|0|||
164467439|NCT04451772|594083742|FG004|Overall Study|Other, not specified|0|||
164467440|NCT04451772|594083743|FG005|Overall Study|Other, not specified|1|||
164467441|NCT04451772|594083738|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
164467442|NCT04451772|594083739|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
164467443|NCT04451772|594083740|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
164467444|NCT04451772|594083741|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
164467445|NCT04451772|594083742|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
164467446|NCT04451772|594083743|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
164467447|NCT04311632|594083744|FG000|Overall Study|Withdrawal by Subject|0|||
164467448|NCT04311632|594083745|FG001|Overall Study|Withdrawal by Subject|0|||
164467449|NCT04311632|594083746|FG002|Overall Study|Withdrawal by Subject|1|||
164467450|NCT05856435|594083747|FG000|Overall Study|Lost to Follow-up|6|||
164467451|NCT04632225|594083748|FG000|Overall Study|Withdrawal by Subject|2|||
164467452|NCT04632225|594083749|FG001|Overall Study|Withdrawal by Subject|2|||
164467453|NCT05660434|594083754|FG000|Overall Study|Never obtained study materials|2|||
164467454|NCT05660434|594083755|FG001|Overall Study|Never obtained study materials|1|||
164467455|NCT01199133|594083759|FG000|Year 1|Adverse Event|16|||
164467456|NCT01199133|594083760|FG001|Year 1|Adverse Event|4|||
164467457|NCT01199133|594083759|FG000|Year 1|Withdrawal by Subject|8|||
164467458|NCT01199133|594083760|FG001|Year 1|Withdrawal by Subject|4|||
164467459|NCT01199133|594083759|FG000|Year 1|Any other reason not above-mentioned|6|||
164467460|NCT01199133|594083760|FG001|Year 1|Any other reason not above-mentioned|7|||
164467461|NCT01199133|594083759|FG000|Year 2|Adverse Event|1|||
164467462|NCT01199133|594083760|FG001|Year 2|Adverse Event|0|||
164467463|NCT01199133|594083759|FG000|Year 2|Withdrawal by Subject|1|||
164467464|NCT01199133|594083760|FG001|Year 2|Withdrawal by Subject|1|||
164467465|NCT01199133|594083759|FG000|Year 2|Any other reason not above-mentioned|1|||
164467466|NCT01199133|594083760|FG001|Year 2|Any other reason not above-mentioned|2|||
164467467|NCT02575950|594083761|FG000|Overall Study|Withdrawal by Subject|0|||
164467468|NCT02575950|594083762|FG001|Overall Study|Withdrawal by Subject|0|||
164467469|NCT02575950|594083763|FG002|Overall Study|Withdrawal by Subject|0|||
164467470|NCT02575950|594083764|FG003|Overall Study|Withdrawal by Subject|2|||
164467471|NCT02575950|594083761|FG000|Overall Study|Lost to Follow-up|0|||
164467472|NCT02575950|594083762|FG001|Overall Study|Lost to Follow-up|1|||
164467473|NCT02575950|594083763|FG002|Overall Study|Lost to Follow-up|0|||
164467474|NCT02575950|594083764|FG003|Overall Study|Lost to Follow-up|3|||
164467475|NCT03106740|594085257|FG000|Overall Study|Lost to Follow-up|2|||
164467476|NCT03106740|594085258|FG001|Overall Study|Lost to Follow-up|2|||
164467477|NCT03106740|594085257|FG000|Overall Study|Withdrawal by Subject|2|||
164467478|NCT03106740|594085258|FG001|Overall Study|Withdrawal by Subject|4|||
164467479|NCT03106740|594085257|FG000|Overall Study|Physician Decision|0|||
164467480|NCT03106740|594085258|FG001|Overall Study|Physician Decision|1|||
164467481|NCT03106740|594085257|FG000|Overall Study|Partial data|1|||
164467482|NCT03106740|594085258|FG001|Overall Study|Partial data|0|||
164467483|NCT01064440|594085259|FG000|Overall Study|Lost to Follow-up|1|||
164467484|NCT01064440|594085260|FG001|Overall Study|Lost to Follow-up|1|||
164467485|NCT01064440|594085261|FG002|Overall Study|Lost to Follow-up|1|||
164467486|NCT01064440|594085259|FG000|Overall Study|Non-compliance|0|||
164711561|NCT00761657|594968167|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
164711562|NCT00761657|594968168|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
164711563|NCT00478244|594968171|FG000|Overall Study|Did not receive transplant|1|||
164711564|NCT02152605|594968176|FG000|Overall Study|Adverse Event|6|||
164711565|NCT02152605|594968177|FG001|Overall Study|Adverse Event|8|||
164711566|NCT02152605|594968176|FG000|Overall Study|Lack of Efficacy|7|||
164711567|NCT02152605|594968177|FG001|Overall Study|Lack of Efficacy|4|||
164711568|NCT02152605|594968176|FG000|Overall Study|Protocol deviation|1|||
164711569|NCT02152605|594968177|FG001|Overall Study|Protocol deviation|4|||
164711570|NCT02152605|594968176|FG000|Overall Study|Lost to Follow-up|1|||
164711571|NCT02152605|594968177|FG001|Overall Study|Lost to Follow-up|0|||
164711572|NCT02152605|594968176|FG000|Overall Study|Withdrew consent|4|||
164711573|NCT02152605|594968177|FG001|Overall Study|Withdrew consent|2|||
164711574|NCT01564537|594968178|FG000|Overall Study|Site Terminated by Sponsor|1|||
164711575|NCT01564537|594968179|FG001|Overall Study|Site Terminated by Sponsor|0|||
164711576|NCT01564537|594968178|FG000|Overall Study|Withdrawal by Subject|12|||
164711577|NCT01564537|594968179|FG001|Overall Study|Withdrawal by Subject|14|||
164711578|NCT01564537|594968178|FG000|Overall Study|Lost to Follow-up|7|||
164711579|NCT01564537|594968179|FG001|Overall Study|Lost to Follow-up|3|||
164711580|NCT01564537|594968178|FG000|Overall Study|Reason not specified|81|||
164711581|NCT01564537|594968179|FG001|Overall Study|Reason not specified|82|||
164711582|NCT02932306|594968187|FG000|Overall Study|Withdrawal by Subject|16|||
164711583|NCT02932306|594968188|FG001|Overall Study|Withdrawal by Subject|25|||
164711584|NCT02932306|594968187|FG000|Overall Study|Adverse Event|3|||
164711585|NCT02932306|594968188|FG001|Overall Study|Adverse Event|0|||
164711586|NCT02932306|594968187|FG000|Overall Study|Pregnancy|2|||
164711587|NCT02932306|594968188|FG001|Overall Study|Pregnancy|0|||
164711588|NCT02932306|594968187|FG000|Overall Study|Protocol Violation|1|||
164711589|NCT02932306|594968188|FG001|Overall Study|Protocol Violation|1|||
164711590|NCT02932306|594968187|FG000|Overall Study|Noncompliance with Study Drug|1|||
164711591|NCT02932306|594968188|FG001|Overall Study|Noncompliance with Study Drug|1|||
164711592|NCT02932306|594968187|FG000|Overall Study|Lost to Follow-up|36|||
164711593|NCT02932306|594968188|FG001|Overall Study|Lost to Follow-up|40|||
164711594|NCT02932306|594968187|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
164711595|NCT02932306|594968188|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
164467487|NCT01064440|594085260|FG001|Overall Study|Non-compliance|1|||
164467488|NCT01064440|594085261|FG002|Overall Study|Non-compliance|0|||
164467489|NCT01064440|594085259|FG000|Overall Study|Death|1|||
164467490|NCT01064440|594085260|FG001|Overall Study|Death|0|||
164467491|NCT01064440|594085261|FG002|Overall Study|Death|1|||
164467492|NCT01064440|594085259|FG000|Overall Study|Withdrawal by Subject|0|||
164467493|NCT01064440|594085260|FG001|Overall Study|Withdrawal by Subject|1|||
164467494|NCT01064440|594085261|FG002|Overall Study|Withdrawal by Subject|1|||
164467495|NCT01064440|594085259|FG000|Overall Study|Other: amputation|1|||
164467496|NCT01064440|594085260|FG001|Overall Study|Other: amputation|0|||
164467497|NCT01064440|594085261|FG002|Overall Study|Other: amputation|0|||
164467498|NCT03505710|594085262|FG000|Overall Study|Progressive Disease|24|||
164467499|NCT03505710|594085263|FG001|Overall Study|Progressive Disease|17|||
164467500|NCT03505710|594085264|FG002|Overall Study|Progressive Disease|43|||
164467501|NCT03505710|594085262|FG000|Overall Study|Clinical Progression|6|||
164467502|NCT03505710|594085263|FG001|Overall Study|Clinical Progression|8|||
164467503|NCT03505710|594085264|FG002|Overall Study|Clinical Progression|3|||
164467504|NCT03505710|594085262|FG000|Overall Study|Adverse Event|12|||
164467505|NCT03505710|594085263|FG001|Overall Study|Adverse Event|6|||
164467506|NCT03505710|594085264|FG002|Overall Study|Adverse Event|28|||
164467507|NCT03505710|594085262|FG000|Overall Study|Withdrawal by Subject|1|||
164467508|NCT03505710|594085263|FG001|Overall Study|Withdrawal by Subject|3|||
164467509|NCT03505710|594085264|FG002|Overall Study|Withdrawal by Subject|7|||
164467510|NCT03505710|594085262|FG000|Overall Study|Physician Decision|1|||
164467511|NCT03505710|594085263|FG001|Overall Study|Physician Decision|1|||
164467512|NCT03505710|594085264|FG002|Overall Study|Physician Decision|2|||
164467513|NCT03505710|594085262|FG000|Overall Study|Death|4|||
164467514|NCT03505710|594085263|FG001|Overall Study|Death|5|||
164711596|NCT02932306|594968187|FG000|Overall Study|Lack of Efficacy|0|||
164711597|NCT02932306|594968188|FG001|Overall Study|Lack of Efficacy|2|||
164711598|NCT02932306|594968187|FG000|Overall Study|Worsening condition|2|||
164711599|NCT02932306|594968188|FG001|Overall Study|Worsening condition|0|||
164711600|NCT02932306|594968187|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
164711601|NCT02932306|594968188|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
164711602|NCT02448706|594968199|FG000|Overall Study|Withdrawal by Subject|4|||
164467515|NCT03505710|594085264|FG002|Overall Study|Death|6|||
164467516|NCT03505710|594085262|FG000|Overall Study|Other Reasons|1|||
164711603|NCT02448706|594968200|FG001|Overall Study|Withdrawal by Subject|3|||
164711604|NCT02448706|594968199|FG000|Overall Study|Protocol Violation|1|||
164711605|NCT02448706|594968200|FG001|Overall Study|Protocol Violation|1|||
164711606|NCT02065700|594968201|FG000|Overall Study|Adverse Event|165|||
164711607|NCT02065700|594968202|FG001|Overall Study|Adverse Event|101|||
164467517|NCT03505710|594085263|FG001|Overall Study|Other Reasons|1|||
164711608|NCT02065700|594968201|FG000|Overall Study|Withdrawal by Subject|90|||
164467518|NCT03505710|594085264|FG002|Overall Study|Other Reasons|1|||
164467519|NCT03505710|594085262|FG000|Overall Study|Study Terminated by Sponsor|0|||
164467520|NCT03505710|594085263|FG001|Overall Study|Study Terminated by Sponsor|0|||
164467521|NCT03505710|594085264|FG002|Overall Study|Study Terminated by Sponsor|1|||
164467522|NCT04414722|594085265|FG000|Overall Study|Lost to Follow-up|3|||
164467523|NCT04414722|594085266|FG001|Overall Study|Lost to Follow-up|4|||
164467524|NCT04414722|594085267|FG002|Overall Study|Lost to Follow-up|3|||
164467525|NCT04414722|594085268|FG003|Overall Study|Lost to Follow-up|2|||
164467526|NCT04414722|594085269|FG004|Overall Study|Lost to Follow-up|3|||
164467527|NCT04414722|594085265|FG000|Overall Study|Withdrawal by Subject|6|||
164467528|NCT04414722|594085266|FG001|Overall Study|Withdrawal by Subject|3|||
164467529|NCT04414722|594085267|FG002|Overall Study|Withdrawal by Subject|1|||
164467530|NCT04414722|594085268|FG003|Overall Study|Withdrawal by Subject|5|||
164467531|NCT04414722|594085269|FG004|Overall Study|Withdrawal by Subject|1|||
164467532|NCT04414722|594085265|FG000|Overall Study|Physician Decision|0|||
164467533|NCT04414722|594085266|FG001|Overall Study|Physician Decision|1|||
164467534|NCT04414722|594085267|FG002|Overall Study|Physician Decision|2|||
164467535|NCT04414722|594085268|FG003|Overall Study|Physician Decision|0|||
164467536|NCT04414722|594085269|FG004|Overall Study|Physician Decision|0|||
164467537|NCT04414722|594085265|FG000|Overall Study|Non-participatory|0|||
164467538|NCT04414722|594085266|FG001|Overall Study|Non-participatory|1|||
164467539|NCT04414722|594085267|FG002|Overall Study|Non-participatory|1|||
164467540|NCT04414722|594085268|FG003|Overall Study|Non-participatory|0|||
164467541|NCT04414722|594085269|FG004|Overall Study|Non-participatory|0|||
164467542|NCT04766892|594085270|FG000|Overall Study|Withdrawal by Subject|1|||
164467543|NCT04766892|594085270|FG000|Overall Study|Lost to Follow-up|1|||
164467544|NCT04766892|594085270|FG000|Overall Study|Adverse Event|3|||
164467545|NCT04766892|594085270|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
164467546|NCT04359654|594085271|FG000|Overall Study|Withdrawal by Subject|1|||
164467547|NCT04359654|594085272|FG001|Overall Study|Withdrawal by Subject|0|||
164467548|NCT04359654|594085271|FG000|Overall Study|Adverse Event|0|||
164467549|NCT04359654|594085272|FG001|Overall Study|Adverse Event|1|||
164467550|NCT03711474|594085275|FG000|Overall Study|Physician Decision|2|||
164467551|NCT03711474|594085276|FG001|Overall Study|Physician Decision|0|||
164467552|NCT04003246|594085280|FG000|Overall Study|Death|9|||
164467553|NCT05363163|594085286|FG000|Overall Study|Withdrawal by Subject|13|||
164467554|NCT05237284|594085290|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
164467555|NCT05237284|594085291|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
164467556|NCT05237284|594085292|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
164467557|NCT05237284|594085293|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
164467558|NCT05237284|594085290|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
164467559|NCT05237284|594085291|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
164467560|NCT05237284|594085292|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
164467561|NCT05237284|594085293|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
164467562|NCT05237284|594085290|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
164467563|NCT05237284|594085291|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
164467564|NCT05237284|594085292|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
164467565|NCT05237284|594085293|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
164467566|NCT05237284|594085290|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
164467567|NCT05237284|594085291|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
164467568|NCT05237284|594085292|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
164467569|NCT05237284|594085293|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
164467570|NCT05237284|594085290|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
164467571|NCT05237284|594085291|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
164467572|NCT05237284|594085292|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
164467573|NCT05237284|594085293|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
164467574|NCT05237284|594085290|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
164467575|NCT05237284|594085291|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
164467576|NCT05237284|594085292|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
164467577|NCT05237284|594085293|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
164467578|NCT05237284|594085290|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
164467579|NCT05237284|594085291|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
164467580|NCT05237284|594085292|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
164467581|NCT05237284|594085293|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
164467582|NCT05237284|594085290|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
164467583|NCT05237284|594085291|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
164467584|NCT05237284|594085292|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
164467585|NCT05237284|594085293|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
164599537|NCT01274338|594556272|FG000|Overall Study|Alternative therapy|0|||
164599538|NCT01274338|594556273|FG001|Overall Study|Alternative therapy|1|||
164599539|NCT01274338|594556274|FG002|Overall Study|Alternative therapy|0|||
164415988|NCT00779584|593893466|FG008|Overall Study|Symptomatic Deterioration|0|||
164415989|NCT00779584|593893458|FG000|Overall Study|Ongoing in Study|0|||
164415990|NCT00779584|593893459|FG001|Overall Study|Ongoing in Study|0|||
164467586|NCT05237284|594085290|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
164467587|NCT05237284|594085291|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
164467588|NCT05237284|594085292|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
164467589|NCT05237284|594085293|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
164467590|NCT04599634|594085294|FG000|Overall Study|Dose limiting toxicity|0|||
164467591|NCT04599634|594085295|FG001|Overall Study|Dose limiting toxicity|0|||
164467592|NCT04599634|594085296|FG002|Overall Study|Dose limiting toxicity|2|||
164467593|NCT04599634|594085297|FG003|Overall Study|Dose limiting toxicity|0|||
164467594|NCT03276676|594085300|FG000|Overall Study|Withdrawal by Subject|2|||
164467595|NCT03276676|594085301|FG001|Overall Study|Withdrawal by Subject|1|||
164467596|NCT02962076|594085304|FG000|Overall Study|MHED tracer not available|5|||
164467597|NCT02962076|594085304|FG000|Overall Study|Protocol Violation|1|||
164467598|NCT02962076|594085304|FG000|Overall Study|Physician Decision|1|||
164467599|NCT03583333|594085311|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
164467600|NCT03583333|594085312|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
164467601|NCT03583333|594085311|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
164467602|NCT03583333|594085312|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
164467603|NCT03583333|594085311|FG000|Overall Study|Withdrawal by Subject|9|||
164415991|NCT00779584|593893460|FG002|Overall Study|Ongoing in Study|0|||
164415992|NCT00779584|593893461|FG003|Overall Study|Ongoing in Study|0|||
164415993|NCT00779584|593893462|FG004|Overall Study|Ongoing in Study|1|||
164415994|NCT00779584|593893463|FG005|Overall Study|Ongoing in Study|1|||
164415995|NCT00779584|593893464|FG006|Overall Study|Ongoing in Study|0|||
164415996|NCT00779584|593893465|FG007|Overall Study|Ongoing in Study|0|||
164415997|NCT00779584|593893466|FG008|Overall Study|Ongoing in Study|0|||
164415998|NCT01775930|593893467|FG000|Overall Study|Futility stopping boundary met|1|||
164415999|NCT01208415|593893468|FG000|Overall Study|Death|1|||
164416000|NCT01208415|593893468|FG000|Overall Study|Lost to Follow-up|2|||
164416001|NCT01208415|593893468|FG000|Overall Study|Withdrawal by Subject|3|||
164416002|NCT01208415|593893468|FG000|Overall Study|Device not placed|1|||
164416003|NCT01208415|593893468|FG000|Overall Study|Still be eligible for follow-up|33|||
164416004|NCT01115491|593893469|FG000|Overall Study|Death|22|||
164416005|NCT01115491|593893469|FG000|Overall Study|Adverse Event|3|||
164416006|NCT01115491|593893469|FG000|Overall Study|Lost to Follow-up|3|||
164416007|NCT01115491|593893469|FG000|Overall Study|Withdrawal by Subject|1|||
164416008|NCT01115491|593893469|FG000|Overall Study|Physician Decision|1|||
164416009|NCT01586338|593893471|FG000|Overall Study|Adverse Event|3|||
164416010|NCT01586338|593893471|FG000|Overall Study|Lost to Follow-up|1|||
164416011|NCT01586338|593893471|FG000|Overall Study|Withdrawal by participant|3|||
164416012|NCT01586338|593893471|FG000|Overall Study|Other|1|||
164416013|NCT01868074|593893476|FG000|Overall Study|Lost to Follow-up|3|||
164416014|NCT01868074|593893477|FG001|Overall Study|Lost to Follow-up|2|||
164416015|NCT01868074|593893476|FG000|Overall Study|Withdrawal by Subject|4|||
164416016|NCT01868074|593893477|FG001|Overall Study|Withdrawal by Subject|2|||
164416017|NCT03306043|593893478|FG000|Overall Study|Adverse Event|1|||
164416018|NCT03306043|593893478|FG000|Overall Study|Lost to Follow-up|1|||
164416019|NCT03306043|593893478|FG000|Overall Study|Withdrawal by Subject|2|||
164416020|NCT01544491|593893479|FG000|Overall Study|Withdrawal by Subject|3|||
164416021|NCT01544491|593893480|FG001|Overall Study|Withdrawal by Subject|2|||
164416022|NCT01544491|593893479|FG000|Overall Study|Lost to Follow-up|0|||
164416023|NCT01544491|593893480|FG001|Overall Study|Lost to Follow-up|1|||
164416024|NCT01544491|593893479|FG000|Overall Study|administrative problems|2|||
164416025|NCT01544491|593893480|FG001|Overall Study|administrative problems|0|||
164416026|NCT02494206|593893494|FG000|Overall Study|Adverse Event|1|||
164416027|NCT02494206|593893494|FG000|Overall Study|Disease Progression|1|||
164416028|NCT01013792|593893495|FG000|Overall Study|Study suspended|2|||
164416029|NCT01013792|593893496|FG001|Overall Study|Study suspended|1|||
164416030|NCT01013792|593893495|FG000|Overall Study|Adverse Event|0|||
164416031|NCT01013792|593893496|FG001|Overall Study|Adverse Event|3|||
164416032|NCT01013792|593893495|FG000|Overall Study|Lost to Follow-up|0|||
164416033|NCT01013792|593893496|FG001|Overall Study|Lost to Follow-up|1|||
164416034|NCT01234649|593893497|FG000|Overall Study|Withdrawal by Subject|32|||
164416035|NCT01234649|593893498|FG001|Overall Study|Withdrawal by Subject|26|||
164416036|NCT01234649|593893497|FG000|Overall Study|Pregnancy|6|||
164416037|NCT01234649|593893498|FG001|Overall Study|Pregnancy|6|||
164416038|NCT01234649|593893497|FG000|Overall Study|intolerant to side effects|4|||
164416039|NCT01234649|593893498|FG001|Overall Study|intolerant to side effects|3|||
164416040|NCT01234649|593893497|FG000|Overall Study|Allergic reaction|1|||
164416041|NCT01234649|593893498|FG001|Overall Study|Allergic reaction|0|||
164416042|NCT01234649|593893497|FG000|Overall Study|Lack of Efficacy|0|||
164416043|NCT01234649|593893498|FG001|Overall Study|Lack of Efficacy|3|||
164416044|NCT03688711|593893503|FG000|Overall Study|Withdrawal by Subject|0|||
164416045|NCT03688711|593893504|FG001|Overall Study|Withdrawal by Subject|1|||
164416046|NCT05064735|593893505|FG000|Overall Study|Withdrawal by Subject|7|||
164416047|NCT05064735|593893506|FG001|Overall Study|Withdrawal by Subject|8|||
164416048|NCT05064735|593893505|FG000|Overall Study|Lost to Follow-up|7|||
164416049|NCT05064735|593893506|FG001|Overall Study|Lost to Follow-up|2|||
164416050|NCT05064735|593893505|FG000|Overall Study|Physician Decision|2|||
164416051|NCT05064735|593893506|FG001|Overall Study|Physician Decision|1|||
164416052|NCT05064735|593893505|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
164416053|NCT05064735|593893506|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
164416054|NCT05064735|593893505|FG000|Overall Study|Site Closure|7|||
164416055|NCT05064735|593893506|FG001|Overall Study|Site Closure|2|||
164416056|NCT03691948|593893507|FG000|Overall Study|Lost to Follow-up|1|||
164416057|NCT03691948|593893508|FG001|Overall Study|Lost to Follow-up|3|||
164416058|NCT02301156|593893509|FG000|Overall Study|Adverse Event|13|||
164416059|NCT02301156|593893510|FG001|Overall Study|Adverse Event|14|||
164416060|NCT02301156|593893509|FG000|Overall Study|Death|1|||
164416061|NCT02301156|593893510|FG001|Overall Study|Death|5|||
164417594|NCT01474512|593899500|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
164417595|NCT01474512|593899501|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
164417596|NCT01474512|593899502|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
164417597|NCT01474512|593899503|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
164417598|NCT01474512|593899504|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
164417599|NCT01474512|593899505|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
164417600|NCT01474512|593899506|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
164417601|NCT01474512|593899489|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
164417602|NCT01474512|593899490|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
164417603|NCT01474512|593899491|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
164417604|NCT01474512|593899492|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
164417605|NCT01474512|593899493|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
164417606|NCT01474512|593899494|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
164417607|NCT01474512|593899495|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
164417608|NCT01474512|593899496|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
164417609|NCT01474512|593899497|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
164417610|NCT01474512|593899498|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
164417611|NCT01474512|593899499|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
164417612|NCT01474512|593899500|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
164417613|NCT01474512|593899501|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
164417614|NCT01474512|593899502|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
164417615|NCT01474512|593899503|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
164417616|NCT01474512|593899504|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
164417617|NCT01474512|593899505|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
164417618|NCT01474512|593899506|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
164417619|NCT01474512|593899489|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
164417620|NCT01474512|593899490|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
164417621|NCT01474512|593899491|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
164417622|NCT01474512|593899492|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
164417623|NCT01474512|593899493|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
164417624|NCT01474512|593899494|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
164417625|NCT01474512|593899495|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
164417626|NCT01474512|593899496|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
164417627|NCT01474512|593899497|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
164417628|NCT01474512|593899498|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
164417629|NCT01474512|593899499|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
164417630|NCT01474512|593899500|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
164417631|NCT01474512|593899501|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
164417632|NCT01474512|593899502|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
164417633|NCT01474512|593899503|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
164417634|NCT01474512|593899504|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
164417635|NCT01474512|593899505|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
164417636|NCT01474512|593899506|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
164417637|NCT01474512|593899489|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
164417638|NCT01474512|593899490|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
164417639|NCT01474512|593899491|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
164417640|NCT01474512|593899492|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
164417641|NCT01474512|593899493|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
164417642|NCT01474512|593899494|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
164417643|NCT01474512|593899495|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
164417644|NCT01474512|593899496|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
164417645|NCT01474512|593899497|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
164417646|NCT01474512|593899498|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
164417647|NCT01474512|593899499|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
164417648|NCT01474512|593899500|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
164417649|NCT01474512|593899501|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
164417650|NCT01474512|593899502|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
164417651|NCT01474512|593899503|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
164416062|NCT02301156|593893509|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
164416063|NCT02301156|593893510|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
164416064|NCT02301156|593893509|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
164416065|NCT02301156|593893510|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
164416066|NCT02301156|593893509|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
164416067|NCT02301156|593893510|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
164416068|NCT02301156|593893509|FG000|Overall Study|Reason not Specified|6|||
164416069|NCT02301156|593893510|FG001|Overall Study|Reason not Specified|3|||
164416070|NCT03734991|593893513|FG000|Overall Study|Adverse Event|4|||
164416071|NCT03734991|593893514|FG001|Overall Study|Adverse Event|0|||
164416072|NCT03734991|593893513|FG000|Overall Study|Lost to Follow-up|4|||
164416073|NCT03734991|593893514|FG001|Overall Study|Lost to Follow-up|0|||
164416074|NCT03734991|593893513|FG000|Overall Study|Physician Decision|0|||
164416075|NCT03734991|593893514|FG001|Overall Study|Physician Decision|1|||
164416076|NCT03734991|593893513|FG000|Overall Study|Pregnancy|1|||
164416077|NCT03734991|593893514|FG001|Overall Study|Pregnancy|0|||
164416078|NCT03734991|593893513|FG000|Overall Study|Withdrawal by Subject|6|||
164416079|NCT03734991|593893514|FG001|Overall Study|Withdrawal by Subject|3|||
164416080|NCT03734991|593893513|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
164416081|NCT03734991|593893514|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
164416082|NCT03734991|593893513|FG000|Overall Study|Other|2|||
164416083|NCT03734991|593893514|FG001|Overall Study|Other|2|||
164416084|NCT03797326|593893515|FG000|Overall Study|Lost to Follow-up|1|||
164416085|NCT03797326|593893516|FG001|Overall Study|Lost to Follow-up|0|||
164416086|NCT03797326|593893517|FG002|Overall Study|Lost to Follow-up|0|||
164416087|NCT03797326|593893518|FG003|Overall Study|Lost to Follow-up|1|||
164416088|NCT03797326|593893519|FG004|Overall Study|Lost to Follow-up|0|||
164416089|NCT03797326|593893520|FG005|Overall Study|Lost to Follow-up|0|||
164416090|NCT03797326|593893521|FG006|Overall Study|Lost to Follow-up|0|||
164416091|NCT03797326|593893522|FG007|Overall Study|Lost to Follow-up|0|||
164416092|NCT03797326|593893515|FG000|Overall Study|Withdrawal by Subject|0|||
164416093|NCT03797326|593893516|FG001|Overall Study|Withdrawal by Subject|0|||
164416094|NCT03797326|593893517|FG002|Overall Study|Withdrawal by Subject|1|||
164599540|NCT01274338|594556275|FG003|Overall Study|Alternative therapy|0|||
164416095|NCT03797326|593893518|FG003|Overall Study|Withdrawal by Subject|3|||
164416096|NCT03797326|593893519|FG004|Overall Study|Withdrawal by Subject|0|||
164416097|NCT03797326|593893520|FG005|Overall Study|Withdrawal by Subject|2|||
164416098|NCT03797326|593893521|FG006|Overall Study|Withdrawal by Subject|2|||
164416099|NCT03797326|593893522|FG007|Overall Study|Withdrawal by Subject|3|||
164599541|NCT01274338|594556276|FG004|Overall Study|Alternative therapy|0|||
164599542|NCT01274338|594556277|FG005|Overall Study|Alternative therapy|0|||
164599543|NCT01274338|594556272|FG000|Overall Study|Other complicating diseases|0|||
164599544|NCT01274338|594556273|FG001|Overall Study|Other complicating diseases|3|||
164599545|NCT01274338|594556274|FG002|Overall Study|Other complicating diseases|1|||
164599546|NCT01274338|594556275|FG003|Overall Study|Other complicating diseases|0|||
164599547|NCT01274338|594556276|FG004|Overall Study|Other complicating diseases|0|||
164599548|NCT01274338|594556277|FG005|Overall Study|Other complicating diseases|0|||
164599549|NCT01274338|594556272|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
164599550|NCT01274338|594556273|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
164599551|NCT01274338|594556274|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
164599552|NCT01274338|594556275|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
164599553|NCT01274338|594556276|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
164599554|NCT01274338|594556277|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
164599555|NCT01274338|594556272|FG000|Overall Study|Pregnancy|0|||
164599556|NCT01274338|594556273|FG001|Overall Study|Pregnancy|0|||
164599557|NCT01274338|594556274|FG002|Overall Study|Pregnancy|1|||
164599558|NCT01274338|594556275|FG003|Overall Study|Pregnancy|0|||
164599559|NCT01274338|594556276|FG004|Overall Study|Pregnancy|0|||
164599560|NCT01274338|594556277|FG005|Overall Study|Pregnancy|0|||
164599561|NCT01274338|594556272|FG000|Overall Study|Reason not reported|12|||
164599562|NCT01274338|594556273|FG001|Overall Study|Reason not reported|21|||
164599563|NCT01274338|594556274|FG002|Overall Study|Reason not reported|3|||
164599564|NCT01274338|594556275|FG003|Overall Study|Reason not reported|0|||
164599565|NCT01274338|594556276|FG004|Overall Study|Reason not reported|1|||
164599566|NCT01274338|594556277|FG005|Overall Study|Reason not reported|0|||
164599567|NCT00485589|594556285|FG000|Overall Study|Death|2|||
164599568|NCT00485589|594556286|FG001|Overall Study|Death|2|||
164599569|NCT00485589|594556287|FG002|Overall Study|Death|0|||
164599570|NCT00485589|594556285|FG000|Overall Study|Failure to return|6|||
164599571|NCT00485589|594556286|FG001|Overall Study|Failure to return|5|||
164599572|NCT00485589|594556287|FG002|Overall Study|Failure to return|1|||
164599573|NCT00485589|594556285|FG000|Overall Study|Protocol Violation|1|||
164599574|NCT00485589|594556286|FG001|Overall Study|Protocol Violation|0|||
164599575|NCT00485589|594556287|FG002|Overall Study|Protocol Violation|0|||
164599576|NCT00485589|594556285|FG000|Overall Study|Violation of selection criteria at entry|0|||
164599577|NCT00485589|594556286|FG001|Overall Study|Violation of selection criteria at entry|3|||
164467604|NCT03583333|594085312|FG001|Overall Study|Withdrawal by Subject|5|||
164467605|NCT03583333|594085311|FG000|Overall Study|Physician Decision|3|||
164467606|NCT03583333|594085312|FG001|Overall Study|Physician Decision|2|||
164416100|NCT03797326|593893515|FG000|Overall Study|Sponsor Decision|3|||
164416101|NCT03797326|593893516|FG001|Overall Study|Sponsor Decision|3|||
164416102|NCT03797326|593893517|FG002|Overall Study|Sponsor Decision|3|||
164416103|NCT03797326|593893518|FG003|Overall Study|Sponsor Decision|6|||
164416104|NCT03797326|593893519|FG004|Overall Study|Sponsor Decision|0|||
164416105|NCT03797326|593893520|FG005|Overall Study|Sponsor Decision|3|||
164416106|NCT03797326|593893521|FG006|Overall Study|Sponsor Decision|3|||
164416107|NCT03797326|593893522|FG007|Overall Study|Sponsor Decision|2|||
164416108|NCT03797326|593893515|FG000|Overall Study|Death|27|||
164416109|NCT03797326|593893516|FG001|Overall Study|Death|28|||
164416110|NCT03797326|593893517|FG002|Overall Study|Death|95|||
164416111|NCT03797326|593893518|FG003|Overall Study|Death|95|||
164416112|NCT03797326|593893519|FG004|Overall Study|Death|30|||
164416113|NCT03797326|593893520|FG005|Overall Study|Death|96|||
164467607|NCT03583333|594085311|FG000|Overall Study|Death|12|||
164467608|NCT03583333|594085312|FG001|Overall Study|Death|7|||
164467609|NCT03926130|594085313|FG000|Overall Study|Adverse Event|9|||
164467610|NCT03926130|594085314|FG001|Overall Study|Adverse Event|11|||
164467611|NCT03926130|594085315|FG002|Overall Study|Adverse Event|2|||
164467612|NCT03926130|594085316|FG003|Overall Study|Adverse Event|0|||
164467613|NCT03926130|594085313|FG000|Overall Study|Death|2|||
164467614|NCT03926130|594085314|FG001|Overall Study|Death|0|||
164467615|NCT03926130|594085315|FG002|Overall Study|Death|1|||
164467616|NCT03926130|594085316|FG003|Overall Study|Death|0|||
164467617|NCT03926130|594085313|FG000|Overall Study|Lack of Efficacy|14|||
164467618|NCT03926130|594085314|FG001|Overall Study|Lack of Efficacy|11|||
164467619|NCT03926130|594085315|FG002|Overall Study|Lack of Efficacy|7|||
164467620|NCT03926130|594085316|FG003|Overall Study|Lack of Efficacy|1|||
164467621|NCT03926130|594085313|FG000|Overall Study|Lost to Follow-up|0|||
164467622|NCT03926130|594085314|FG001|Overall Study|Lost to Follow-up|7|||
164467623|NCT03926130|594085315|FG002|Overall Study|Lost to Follow-up|1|||
164467624|NCT03926130|594085316|FG003|Overall Study|Lost to Follow-up|0|||
164467625|NCT03926130|594085313|FG000|Overall Study|As Reported by Investigator|2|||
164467626|NCT03926130|594085314|FG001|Overall Study|As Reported by Investigator|6|||
164467627|NCT03926130|594085315|FG002|Overall Study|As Reported by Investigator|6|||
164467628|NCT03926130|594085316|FG003|Overall Study|As Reported by Investigator|0|||
164467629|NCT03926130|594085313|FG000|Overall Study|Physician Decision|3|||
164467630|NCT03926130|594085314|FG001|Overall Study|Physician Decision|2|||
164467631|NCT03926130|594085315|FG002|Overall Study|Physician Decision|1|||
164467632|NCT03926130|594085316|FG003|Overall Study|Physician Decision|0|||
164467633|NCT03926130|594085313|FG000|Overall Study|Pregnancy|2|||
164467634|NCT03926130|594085314|FG001|Overall Study|Pregnancy|2|||
164467635|NCT03926130|594085315|FG002|Overall Study|Pregnancy|1|||
164467636|NCT03926130|594085316|FG003|Overall Study|Pregnancy|0|||
164467637|NCT03926130|594085313|FG000|Overall Study|Withdrawal by Subject|20|||
164467638|NCT03926130|594085314|FG001|Overall Study|Withdrawal by Subject|28|||
164467639|NCT03926130|594085315|FG002|Overall Study|Withdrawal by Subject|18|||
164467640|NCT03926130|594085316|FG003|Overall Study|Withdrawal by Subject|1|||
164467641|NCT03926130|594085313|FG000|Overall Study|Non-Compliance|1|||
164467642|NCT03926130|594085314|FG001|Overall Study|Non-Compliance|1|||
164467643|NCT03926130|594085315|FG002|Overall Study|Non-Compliance|0|||
164467644|NCT03926130|594085316|FG003|Overall Study|Non-Compliance|0|||
164467645|NCT03926130|594085313|FG000|Overall Study|Disposition Not Captured|0|||
164467646|NCT03926130|594085314|FG001|Overall Study|Disposition Not Captured|2|||
164467647|NCT03926130|594085315|FG002|Overall Study|Disposition Not Captured|1|||
164467648|NCT03926130|594085316|FG003|Overall Study|Disposition Not Captured|0|||
164467649|NCT05069896|594085323|FG000|Overall Study|Adverse Event|0|||
164467650|NCT05069896|594085324|FG001|Overall Study|Adverse Event|1|||
164467651|NCT05069896|594085325|FG002|Overall Study|Adverse Event|1|||
164467652|NCT05069896|594085326|FG003|Overall Study|Adverse Event|0|||
164467653|NCT05069896|594085327|FG004|Overall Study|Adverse Event|0|||
164467654|NCT05069896|594085328|FG005|Overall Study|Adverse Event|0|||
164467655|NCT05069896|594085323|FG000|Overall Study|Lost to Follow-up|0|||
164467656|NCT05069896|594085324|FG001|Overall Study|Lost to Follow-up|0|||
164467657|NCT05069896|594085325|FG002|Overall Study|Lost to Follow-up|1|||
164467658|NCT05069896|594085326|FG003|Overall Study|Lost to Follow-up|0|||
164467659|NCT05069896|594085327|FG004|Overall Study|Lost to Follow-up|1|||
164416114|NCT03797326|593893521|FG006|Overall Study|Death|97|||
164467660|NCT05069896|594085328|FG005|Overall Study|Lost to Follow-up|2|||
164467661|NCT03580356|594085332|FG000|Treatment Period|Withdrawal by Subject|13|||
164416115|NCT03797326|593893522|FG007|Overall Study|Death|98|||
164416116|NCT03797326|593893515|FG000|Overall Study|Enrolled in error|0|||
164467662|NCT03580356|594085333|FG001|Treatment Period|Withdrawal by Subject|0|||
164416117|NCT03797326|593893516|FG001|Overall Study|Enrolled in error|0|||
164467663|NCT03580356|594085334|FG002|Treatment Period|Withdrawal by Subject|13|||
164467664|NCT03580356|594085335|FG003|Treatment Period|Withdrawal by Subject|1|||
164467665|NCT03580356|594085336|FG004|Treatment Period|Withdrawal by Subject|17|||
164467666|NCT03580356|594085337|FG005|Treatment Period|Withdrawal by Subject|0|||
164467667|NCT03580356|594085338|FG006|Treatment Period|Withdrawal by Subject|5|||
164416118|NCT03797326|593893517|FG002|Overall Study|Enrolled in error|3|||
164467668|NCT03580356|594085339|FG007|Treatment Period|Withdrawal by Subject|0|||
164467669|NCT03580356|594085332|FG000|Treatment Period|Adverse Event|10|||
164467670|NCT03580356|594085333|FG001|Treatment Period|Adverse Event|0|||
164467671|NCT03580356|594085334|FG002|Treatment Period|Adverse Event|13|||
164599578|NCT00485589|594556287|FG002|Overall Study|Violation of selection criteria at entry|1|||
164416119|NCT03797326|593893518|FG003|Overall Study|Enrolled in error|2|||
164416120|NCT03797326|593893519|FG004|Overall Study|Enrolled in error|2|||
164416121|NCT03797326|593893520|FG005|Overall Study|Enrolled in error|1|||
164416122|NCT03797326|593893521|FG006|Overall Study|Enrolled in error|1|||
164416123|NCT03797326|593893522|FG007|Overall Study|Enrolled in error|0|||
164416124|NCT03012061|593893523|FG000|Overall Study|Withdrawal by Subject|1|||
164416125|NCT03012061|593893524|FG001|Overall Study|Withdrawal by Subject|5|||
164416126|NCT03012061|593893525|FG002|Overall Study|Withdrawal by Subject|4|||
164416127|NCT03012061|593893523|FG000|Overall Study|Investigator Site Closed|1|||
164416128|NCT03012061|593893524|FG001|Overall Study|Investigator Site Closed|2|||
164416129|NCT03012061|593893525|FG002|Overall Study|Investigator Site Closed|0|||
164416130|NCT03012061|593893523|FG000|Overall Study|Lost to Follow-up|2|||
164416131|NCT03012061|593893524|FG001|Overall Study|Lost to Follow-up|1|||
164416132|NCT03012061|593893525|FG002|Overall Study|Lost to Follow-up|0|||
164416133|NCT03012061|593893523|FG000|Overall Study|Study closed/ Terminated|0|||
164416134|NCT03012061|593893524|FG001|Overall Study|Study closed/ Terminated|0|||
164416135|NCT03012061|593893525|FG002|Overall Study|Study closed/ Terminated|1|||
164416136|NCT03012061|593893523|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
164416137|NCT03012061|593893524|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
164416138|NCT03012061|593893525|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
164416139|NCT03012061|593893523|FG000|Overall Study|Protocol Violation|0|||
164416140|NCT03012061|593893524|FG001|Overall Study|Protocol Violation|0|||
164416141|NCT03012061|593893525|FG002|Overall Study|Protocol Violation|2|||
164416142|NCT03012061|593893523|FG000|Overall Study|Lack of Efficacy|0|||
164416143|NCT03012061|593893524|FG001|Overall Study|Lack of Efficacy|1|||
164416144|NCT03012061|593893525|FG002|Overall Study|Lack of Efficacy|0|||
164416145|NCT03012061|593893523|FG000|Overall Study|Adverse Event|2|||
164416146|NCT03012061|593893524|FG001|Overall Study|Adverse Event|0|||
164416147|NCT03012061|593893525|FG002|Overall Study|Adverse Event|0|||
164416148|NCT04152343|593893526|FG000|Overall Study|Transplanted|5|||
164416149|NCT04152343|593893526|FG000|Overall Study|Death|20|||
164416150|NCT04152343|593893526|FG000|Overall Study|Lost to Follow-up|3|||
164416151|NCT01164228|593893527|FG000|Overall Study|Progression|24|||
164416152|NCT01164228|593893528|FG001|Overall Study|Progression|25|||
164416153|NCT01164228|593893527|FG000|Overall Study|Adverse Event|13|||
164416154|NCT01164228|593893528|FG001|Overall Study|Adverse Event|7|||
164416155|NCT01164228|593893527|FG000|Overall Study|Death|1|||
164416156|NCT01164228|593893528|FG001|Overall Study|Death|1|||
164416157|NCT01164228|593893527|FG000|Overall Study|Withdrawal by Subject|2|||
164416158|NCT01164228|593893528|FG001|Overall Study|Withdrawal by Subject|0|||
164416159|NCT01164228|593893527|FG000|Overall Study|Physician Decision|1|||
164416160|NCT01164228|593893528|FG001|Overall Study|Physician Decision|2|||
164416161|NCT01164228|593893527|FG000|Overall Study|Symptomatic deterioration|1|||
164416162|NCT01164228|593893528|FG001|Overall Study|Symptomatic deterioration|0|||
164416163|NCT01164228|593893527|FG000|Overall Study|Never started treatment|1|||
164416164|NCT01164228|593893528|FG001|Overall Study|Never started treatment|3|||
164416165|NCT01164228|593893527|FG000|Overall Study|Ineligible|1|||
164416166|NCT01164228|593893528|FG001|Overall Study|Ineligible|0|||
164467672|NCT03580356|594085335|FG003|Treatment Period|Adverse Event|0|||
164599579|NCT00485589|594556285|FG000|Overall Study|Administrative/Other|1|||
164599580|NCT00485589|594556286|FG001|Overall Study|Administrative/Other|2|||
164599581|NCT00485589|594556287|FG002|Overall Study|Administrative/Other|1|||
164599582|NCT00485589|594556285|FG000|Overall Study|Insufficient therapeutic response|10|||
164599583|NCT00485589|594556286|FG001|Overall Study|Insufficient therapeutic response|3|||
164599584|NCT00485589|594556287|FG002|Overall Study|Insufficient therapeutic response|1|||
164599585|NCT00485589|594556285|FG000|Overall Study|Refused treatment/did not cooperate|1|||
164599586|NCT00485589|594556286|FG001|Overall Study|Refused treatment/did not cooperate|0|||
164599587|NCT00485589|594556287|FG002|Overall Study|Refused treatment/did not cooperate|2|||
164599588|NCT00485589|594556285|FG000|Overall Study|Withdrawal by Subject|3|||
164599589|NCT00485589|594556286|FG001|Overall Study|Withdrawal by Subject|2|||
164599590|NCT00485589|594556287|FG002|Overall Study|Withdrawal by Subject|2|||
164599591|NCT00485589|594556285|FG000|Overall Study|Adverse Event|3|||
164599592|NCT00485589|594556286|FG001|Overall Study|Adverse Event|3|||
164599593|NCT00485589|594556287|FG002|Overall Study|Adverse Event|10|||
164599594|NCT02411201|594556288|FG000|Overall Study|Adverse Event|2|||
164599595|NCT02411201|594556288|FG000|Overall Study|Withdrawal by Subject|2|||
164599596|NCT02411201|594556288|FG000|Overall Study|Age group completed|2|||
164599597|NCT01260467|594556289|FG000|Overall Study|Withdrawal by Subject|2|||
164599598|NCT00798694|594556290|FG000|Overall Study|Lost to Follow-up|1|||
164599599|NCT00798694|594556291|FG001|Overall Study|Lost to Follow-up|1|||
164599600|NCT00798694|594556290|FG000|Overall Study|Physician Decision|1|||
164711609|NCT02065700|594968202|FG001|Overall Study|Withdrawal by Subject|29|||
164711610|NCT02065700|594968201|FG000|Overall Study|Lost to Follow-up|12|||
164711611|NCT02065700|594968202|FG001|Overall Study|Lost to Follow-up|9|||
164711612|NCT02065700|594968201|FG000|Overall Study|Physician Decision|2|||
164711613|NCT02065700|594968202|FG001|Overall Study|Physician Decision|0|||
164711614|NCT02065700|594968201|FG000|Overall Study|Sponsor Request|38|||
164711615|NCT02065700|594968202|FG001|Overall Study|Sponsor Request|15|||
164711616|NCT02065700|594968201|FG000|Overall Study|Treatment Failure|3|||
164711617|NCT02065700|594968202|FG001|Overall Study|Treatment Failure|2|||
164711618|NCT02065700|594968201|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
164711619|NCT02065700|594968202|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
164711620|NCT02065700|594968201|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
164711621|NCT02065700|594968202|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
164711622|NCT02065700|594968201|FG000|Overall Study|Non-compliance with Study Procedures|2|||
164711623|NCT02065700|594968202|FG001|Overall Study|Non-compliance with Study Procedures|0|||
164711624|NCT02065700|594968201|FG000|Overall Study|Not Defined|21|||
164711625|NCT02065700|594968202|FG001|Overall Study|Not Defined|3|||
164711626|NCT02315196|594968205|FG000|Overall Study|Withdrew consent|9|||
164711627|NCT03559400|594968206|FG000|Overall Study|Lost to Follow-up|9|||
164711628|NCT03559400|594968207|FG001|Overall Study|Lost to Follow-up|7|||
164711629|NCT03559400|594968206|FG000|Overall Study|Death|0|||
164711630|NCT03559400|594968207|FG001|Overall Study|Death|2|||
164711631|NCT04933968|594968212|FG000|Overall Study|Adverse Event|0|||
164711632|NCT04933968|594968213|FG001|Overall Study|Adverse Event|0|||
164711633|NCT04933968|594968214|FG002|Overall Study|Adverse Event|1|||
164711634|NCT04933968|594968215|FG003|Overall Study|Adverse Event|1|||
164711635|NCT04933968|594968216|FG004|Overall Study|Adverse Event|0|||
164711636|NCT04933968|594968217|FG005|Overall Study|Adverse Event|0|||
164711637|NCT04933968|594968212|FG000|Overall Study|Lost to Follow-up|1|||
164711638|NCT04933968|594968213|FG001|Overall Study|Lost to Follow-up|0|||
164711639|NCT04933968|594968214|FG002|Overall Study|Lost to Follow-up|1|||
164711640|NCT04933968|594968215|FG003|Overall Study|Lost to Follow-up|0|||
164711641|NCT04933968|594968216|FG004|Overall Study|Lost to Follow-up|0|||
164711642|NCT04933968|594968217|FG005|Overall Study|Lost to Follow-up|0|||
164711643|NCT04933968|594968212|FG000|Overall Study|Randomized not treated|1|||
164711644|NCT04933968|594968213|FG001|Overall Study|Randomized not treated|0|||
164711645|NCT04933968|594968214|FG002|Overall Study|Randomized not treated|0|||
164711646|NCT04933968|594968215|FG003|Overall Study|Randomized not treated|0|||
164711647|NCT04933968|594968216|FG004|Overall Study|Randomized not treated|0|||
164711648|NCT04933968|594968217|FG005|Overall Study|Randomized not treated|0|||
164711649|NCT04933968|594968212|FG000|Overall Study|Sponsor terminated study|0|||
164711650|NCT04933968|594968213|FG001|Overall Study|Sponsor terminated study|0|||
164711651|NCT04933968|594968214|FG002|Overall Study|Sponsor terminated study|0|||
164711652|NCT04933968|594968215|FG003|Overall Study|Sponsor terminated study|1|||
164467673|NCT03580356|594085336|FG004|Treatment Period|Adverse Event|5|||
164467674|NCT03580356|594085337|FG005|Treatment Period|Adverse Event|0|||
164467675|NCT03580356|594085338|FG006|Treatment Period|Adverse Event|8|||
164467676|NCT03580356|594085339|FG007|Treatment Period|Adverse Event|0|||
164467677|NCT03580356|594085332|FG000|Treatment Period|Protocol Violation|5|||
164467678|NCT03580356|594085333|FG001|Treatment Period|Protocol Violation|0|||
164467679|NCT03580356|594085334|FG002|Treatment Period|Protocol Violation|6|||
164467680|NCT03580356|594085335|FG003|Treatment Period|Protocol Violation|1|||
164467681|NCT03580356|594085336|FG004|Treatment Period|Protocol Violation|9|||
164467682|NCT03580356|594085337|FG005|Treatment Period|Protocol Violation|1|||
164467683|NCT03580356|594085338|FG006|Treatment Period|Protocol Violation|1|||
164467684|NCT03580356|594085339|FG007|Treatment Period|Protocol Violation|0|||
164467685|NCT03580356|594085332|FG000|Treatment Period|Lack of Efficacy|6|||
164467686|NCT03580356|594085333|FG001|Treatment Period|Lack of Efficacy|0|||
164467687|NCT03580356|594085334|FG002|Treatment Period|Lack of Efficacy|2|||
164467688|NCT03580356|594085335|FG003|Treatment Period|Lack of Efficacy|0|||
164467689|NCT03580356|594085336|FG004|Treatment Period|Lack of Efficacy|3|||
164467690|NCT03580356|594085337|FG005|Treatment Period|Lack of Efficacy|0|||
164467691|NCT03580356|594085338|FG006|Treatment Period|Lack of Efficacy|3|||
164711653|NCT04933968|594968216|FG004|Overall Study|Sponsor terminated study|2|||
164711654|NCT04933968|594968217|FG005|Overall Study|Sponsor terminated study|0|||
164711655|NCT04933968|594968212|FG000|Overall Study|Other|0|||
164711656|NCT04933968|594968213|FG001|Overall Study|Other|0|||
164711657|NCT04933968|594968214|FG002|Overall Study|Other|0|||
164711658|NCT04933968|594968215|FG003|Overall Study|Other|1|||
164711659|NCT04933968|594968216|FG004|Overall Study|Other|0|||
164711660|NCT04933968|594968217|FG005|Overall Study|Other|0|||
164467692|NCT03580356|594085339|FG007|Treatment Period|Lack of Efficacy|0|||
164467693|NCT03580356|594085332|FG000|Treatment Period|Pregnancy|1|||
164467694|NCT03580356|594085333|FG001|Treatment Period|Pregnancy|0|||
164711661|NCT04933968|594968212|FG000|Overall Study|Missing|1|||
164711662|NCT04933968|594968213|FG001|Overall Study|Missing|3|||
164711663|NCT04933968|594968214|FG002|Overall Study|Missing|2|||
164711664|NCT04933968|594968215|FG003|Overall Study|Missing|1|||
164711665|NCT04933968|594968216|FG004|Overall Study|Missing|1|||
164711666|NCT04933968|594968217|FG005|Overall Study|Missing|0|||
164467695|NCT03580356|594085334|FG002|Treatment Period|Pregnancy|7|||
164467696|NCT03580356|594085335|FG003|Treatment Period|Pregnancy|0|||
164467697|NCT03580356|594085336|FG004|Treatment Period|Pregnancy|2|||
164467698|NCT03580356|594085337|FG005|Treatment Period|Pregnancy|0|||
164467699|NCT03580356|594085338|FG006|Treatment Period|Pregnancy|1|||
164467700|NCT03580356|594085339|FG007|Treatment Period|Pregnancy|0|||
164467701|NCT03580356|594085332|FG000|Treatment Period|Physician Decision|2|||
164467702|NCT03580356|594085333|FG001|Treatment Period|Physician Decision|0|||
164467703|NCT03580356|594085334|FG002|Treatment Period|Physician Decision|1|||
164467704|NCT03580356|594085335|FG003|Treatment Period|Physician Decision|0|||
164467705|NCT03580356|594085336|FG004|Treatment Period|Physician Decision|4|||
164467706|NCT03580356|594085337|FG005|Treatment Period|Physician Decision|0|||
164467707|NCT03580356|594085338|FG006|Treatment Period|Physician Decision|2|||
164467708|NCT03580356|594085339|FG007|Treatment Period|Physician Decision|0|||
164467709|NCT03580356|594085332|FG000|Treatment Period|Lost to Follow-up|1|||
164467710|NCT03580356|594085333|FG001|Treatment Period|Lost to Follow-up|1|||
164467711|NCT03580356|594085334|FG002|Treatment Period|Lost to Follow-up|1|||
164467712|NCT03580356|594085335|FG003|Treatment Period|Lost to Follow-up|0|||
164467713|NCT03580356|594085336|FG004|Treatment Period|Lost to Follow-up|3|||
164467714|NCT03580356|594085337|FG005|Treatment Period|Lost to Follow-up|0|||
164467715|NCT03580356|594085338|FG006|Treatment Period|Lost to Follow-up|1|||
164467716|NCT03580356|594085339|FG007|Treatment Period|Lost to Follow-up|0|||
164467717|NCT03580356|594085332|FG000|Treatment Period|Death|0|||
164467718|NCT03580356|594085333|FG001|Treatment Period|Death|0|||
164467719|NCT03580356|594085334|FG002|Treatment Period|Death|1|||
164467720|NCT03580356|594085335|FG003|Treatment Period|Death|0|||
164467721|NCT03580356|594085336|FG004|Treatment Period|Death|0|||
164467722|NCT03580356|594085337|FG005|Treatment Period|Death|0|||
164467723|NCT03580356|594085338|FG006|Treatment Period|Death|0|||
164467724|NCT03580356|594085339|FG007|Treatment Period|Death|0|||
164467725|NCT03580356|594085332|FG000|Treatment Period|Technical problems|0|||
164467726|NCT03580356|594085333|FG001|Treatment Period|Technical problems|0|||
164467727|NCT03580356|594085334|FG002|Treatment Period|Technical problems|0|||
164467728|NCT03580356|594085335|FG003|Treatment Period|Technical problems|0|||
164467729|NCT03580356|594085336|FG004|Treatment Period|Technical problems|1|||
164467730|NCT03580356|594085337|FG005|Treatment Period|Technical problems|0|||
164467731|NCT03580356|594085338|FG006|Treatment Period|Technical problems|0|||
164467732|NCT03580356|594085339|FG007|Treatment Period|Technical problems|0|||
164467733|NCT03580356|594085332|FG000|Treatment Period|Misrandomized, no treatment|0|||
164467734|NCT03580356|594085333|FG001|Treatment Period|Misrandomized, no treatment|0|||
164467735|NCT03580356|594085334|FG002|Treatment Period|Misrandomized, no treatment|1|||
164467736|NCT03580356|594085335|FG003|Treatment Period|Misrandomized, no treatment|0|||
164467737|NCT03580356|594085336|FG004|Treatment Period|Misrandomized, no treatment|2|||
164467738|NCT03580356|594085337|FG005|Treatment Period|Misrandomized, no treatment|0|||
164467739|NCT03580356|594085338|FG006|Treatment Period|Misrandomized, no treatment|0|||
164467740|NCT03580356|594085339|FG007|Treatment Period|Misrandomized, no treatment|0|||
164467741|NCT03580356|594085332|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
164467742|NCT03580356|594085333|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
164467743|NCT03580356|594085334|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
164467744|NCT03580356|594085335|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
164467745|NCT03580356|594085336|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
164467746|NCT03580356|594085337|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
164467747|NCT03580356|594085338|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
164467748|NCT03580356|594085339|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
164467749|NCT03580356|594085332|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
164467750|NCT03580356|594085333|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
164467751|NCT03580356|594085334|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
164467752|NCT03580356|594085335|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
164467753|NCT03580356|594085336|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
164467754|NCT03580356|594085337|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
164467755|NCT03580356|594085338|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
164467756|NCT03580356|594085339|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
164467757|NCT03580356|594085332|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
164599601|NCT00798694|594556291|FG001|Overall Study|Physician Decision|0|||
164467758|NCT03580356|594085333|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
164467759|NCT03580356|594085334|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
164467760|NCT03580356|594085335|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
164467761|NCT03580356|594085336|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
164467762|NCT03580356|594085337|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
164467763|NCT03580356|594085338|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
164467764|NCT03580356|594085339|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
164467765|NCT03580356|594085332|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
164467766|NCT03580356|594085333|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
164467767|NCT03580356|594085334|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
164467768|NCT03580356|594085335|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
164467769|NCT03580356|594085336|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
164467770|NCT03580356|594085337|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
164467771|NCT03580356|594085338|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
164467772|NCT03580356|594085339|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
164467773|NCT03580356|594085332|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
164467774|NCT03580356|594085333|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
164467775|NCT03580356|594085334|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
164467776|NCT03580356|594085335|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
164467777|NCT03580356|594085336|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
164467778|NCT03580356|594085337|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
164467779|NCT03580356|594085338|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
164467780|NCT03580356|594085339|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
164467781|NCT03580356|594085332|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
164467782|NCT03580356|594085333|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
164467783|NCT03580356|594085334|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
164467784|NCT03580356|594085335|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
164467785|NCT03580356|594085336|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
164467786|NCT03580356|594085337|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
164467787|NCT03580356|594085338|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
164467788|NCT03580356|594085339|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
164467789|NCT03580356|594085332|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
164467790|NCT03580356|594085333|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
164467791|NCT03580356|594085334|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
164467792|NCT03580356|594085335|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
164467793|NCT03580356|594085336|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
164467794|NCT03580356|594085337|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
164467795|NCT03580356|594085338|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
164467796|NCT03580356|594085339|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
164467797|NCT05715528|594085340|FG000|Overall Study|Randomized but never treated|11|||
164467798|NCT05715528|594085341|FG001|Overall Study|Randomized but never treated|13|||
164467799|NCT05715528|594085340|FG000|Overall Study|Withdrew consent|7|||
164467800|NCT05715528|594085341|FG001|Overall Study|Withdrew consent|15|||
164467801|NCT05715528|594085340|FG000|Overall Study|Lost to Follow-up|5|||
164467802|NCT05715528|594085341|FG001|Overall Study|Lost to Follow-up|13|||
164467803|NCT05715528|594085340|FG000|Overall Study|Investigator's discretion|3|||
164467804|NCT05715528|594085341|FG001|Overall Study|Investigator's discretion|1|||
164467805|NCT05715528|594085340|FG000|Overall Study|Protocol Violation|2|||
164467806|NCT05715528|594085341|FG001|Overall Study|Protocol Violation|0|||
164467807|NCT05715528|594085340|FG000|Overall Study|Non-compliance with study drug|0|||
164467808|NCT05715528|594085341|FG001|Overall Study|Non-compliance with study drug|1|||
164467809|NCT03485729|594085344|FG000|Overall Study|Withdrawal by Subject|0|||
164467810|NCT03485729|594085345|FG001|Overall Study|Withdrawal by Subject|0|||
164467811|NCT03485729|594085346|FG002|Overall Study|Withdrawal by Subject|1|||
164467812|NCT03485729|594085344|FG000|Overall Study|Disease progression|8|||
164467813|NCT03485729|594085345|FG001|Overall Study|Disease progression|13|||
164467814|NCT03485729|594085346|FG002|Overall Study|Disease progression|1|||
164467815|NCT03485729|594085344|FG000|Overall Study|Hospice care|1|||
164467816|NCT03485729|594085345|FG001|Overall Study|Hospice care|0|||
164467817|NCT03485729|594085346|FG002|Overall Study|Hospice care|0|||
164467818|NCT03485729|594085344|FG000|Overall Study|Poor performance status|1|||
164467819|NCT03485729|594085345|FG001|Overall Study|Poor performance status|0|||
164467820|NCT03485729|594085346|FG002|Overall Study|Poor performance status|0|||
164467821|NCT03485729|594085344|FG000|Overall Study|Illness|0|||
164599602|NCT03364608|594556295|FG000|Overall Study|Withdrawal by Subject|4|||
164599603|NCT03364608|594556295|FG000|Overall Study|Protocol Violation|2|||
164599604|NCT03364608|594556295|FG000|Overall Study|Lost to Follow-up|2|||
164599605|NCT01163253|594556298|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
164599606|NCT01163253|594556299|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
164599607|NCT01163253|594556298|FG000|Overall Study|Study Terminated by Sponsor|978|||
164599608|NCT01163253|594556299|FG001|Overall Study|Study Terminated by Sponsor|349|||
164599609|NCT01163253|594556298|FG000|Overall Study|Protocol Violation|43|||
164599610|NCT01163253|594556299|FG001|Overall Study|Protocol Violation|12|||
164599611|NCT01163253|594556298|FG000|Overall Study|Withdrawal by Subject|199|||
164599612|NCT01163253|594556299|FG001|Overall Study|Withdrawal by Subject|50|||
164599613|NCT01163253|594556298|FG000|Overall Study|Medication Error|1|||
164599614|NCT01163253|594556299|FG001|Overall Study|Medication Error|0|||
164599615|NCT01163253|594556298|FG000|Overall Study|Lost to Follow-up|125|||
164599616|NCT01163253|594556299|FG001|Overall Study|Lost to Follow-up|23|||
164599617|NCT01163253|594556298|FG000|Overall Study|Insufficient Clinical Response|423|||
164599618|NCT01163253|594556299|FG001|Overall Study|Insufficient Clinical Response|29|||
164599619|NCT01163253|594556298|FG000|Overall Study|Adverse Event|300|||
164467822|NCT03485729|594085345|FG001|Overall Study|Illness|1|||
164467823|NCT03485729|594085346|FG002|Overall Study|Illness|0|||
164467824|NCT05035654|594085347|FG000|Overall Study|Physician Decision|0|||
164467825|NCT05035654|594085348|FG001|Overall Study|Physician Decision|1|||
164467826|NCT05035654|594085349|FG002|Overall Study|Physician Decision|0|||
164467827|NCT05035654|594085347|FG000|Overall Study|Adverse Event|0|||
164467828|NCT05035654|594085348|FG001|Overall Study|Adverse Event|1|||
164467829|NCT05035654|594085349|FG002|Overall Study|Adverse Event|0|||
164467830|NCT05035654|594085347|FG000|Overall Study|Withdrawal by Subject|0|||
164467831|NCT05035654|594085348|FG001|Overall Study|Withdrawal by Subject|0|||
164467832|NCT05035654|594085349|FG002|Overall Study|Withdrawal by Subject|4|||
164467833|NCT05035654|594085347|FG000|Overall Study|Bilateral Dislodgement|1|||
164467834|NCT05035654|594085348|FG001|Overall Study|Bilateral Dislodgement|0|||
164467835|NCT05035654|594085349|FG002|Overall Study|Bilateral Dislodgement|0|||
164467836|NCT04605159|594085363|FG000|Overall Study|Adverse Event|6|||
164467837|NCT04605159|594085364|FG001|Overall Study|Adverse Event|3|||
164467838|NCT04605159|594085365|FG002|Overall Study|Adverse Event|21|||
164467839|NCT04605159|594085366|FG003|Overall Study|Adverse Event|4|||
164467840|NCT04605159|594085363|FG000|Overall Study|Lost to Follow-up|74|||
164467841|NCT04605159|594085364|FG001|Overall Study|Lost to Follow-up|45|||
164467842|NCT04605159|594085365|FG002|Overall Study|Lost to Follow-up|119|||
164467843|NCT04605159|594085366|FG003|Overall Study|Lost to Follow-up|80|||
164467844|NCT04605159|594085363|FG000|Overall Study|Protocol Violation|4|||
164467845|NCT04605159|594085364|FG001|Overall Study|Protocol Violation|5|||
164467846|NCT04605159|594085365|FG002|Overall Study|Protocol Violation|2|||
164467847|NCT04605159|594085366|FG003|Overall Study|Protocol Violation|0|||
164467848|NCT04605159|594085363|FG000|Overall Study|Withdrawal by Subject|66|||
164467849|NCT04605159|594085364|FG001|Overall Study|Withdrawal by Subject|37|||
164467850|NCT04605159|594085365|FG002|Overall Study|Withdrawal by Subject|68|||
164467851|NCT04605159|594085366|FG003|Overall Study|Withdrawal by Subject|50|||
164467852|NCT04605159|594085363|FG000|Overall Study|Migrated / moved from the study area|32|||
164467853|NCT04605159|594085364|FG001|Overall Study|Migrated / moved from the study area|22|||
164467854|NCT04605159|594085365|FG002|Overall Study|Migrated / moved from the study area|41|||
164467855|NCT04605159|594085366|FG003|Overall Study|Migrated / moved from the study area|21|||
164467856|NCT04605159|594085363|FG000|Overall Study|Other|1|||
164467857|NCT04605159|594085364|FG001|Overall Study|Other|2|||
164467858|NCT04605159|594085365|FG002|Overall Study|Other|7|||
164467859|NCT04605159|594085366|FG003|Overall Study|Other|3|||
164467860|NCT04934072|594085368|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
164467861|NCT04934072|594085369|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
164467862|NCT04934072|594085370|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
164467863|NCT04934072|594085371|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
164467864|NCT04934072|594085372|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
164467865|NCT04934072|594085368|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
164467866|NCT04934072|594085369|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
164467867|NCT04934072|594085370|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
164467868|NCT04934072|594085371|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
164467869|NCT04934072|594085372|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
164467870|NCT04934072|594085368|FG000|Day 0 to Week 52|Other|3|||
164467871|NCT04934072|594085369|FG001|Day 0 to Week 52|Other|1|||
164467872|NCT04934072|594085370|FG002|Day 0 to Week 52|Other|0|||
164467873|NCT04934072|594085371|FG003|Day 0 to Week 52|Other|0|||
164467874|NCT04934072|594085372|FG004|Day 0 to Week 52|Other|0|||
164467875|NCT04934072|594085368|FG000|Day 0 to Week 52|Adverse Event|1|||
164467876|NCT04934072|594085369|FG001|Day 0 to Week 52|Adverse Event|3|||
164467877|NCT04934072|594085370|FG002|Day 0 to Week 52|Adverse Event|0|||
164416167|NCT01965938|593893529|FG000|Overall Study|Withdrawal by Subject|1|||
164416168|NCT01965938|593893530|FG001|Overall Study|Withdrawal by Subject|0|||
164416169|NCT02736968|593893535|FG000|Overall Study|Lost to Follow-up|0|||
164416170|NCT02736968|593893536|FG001|Overall Study|Lost to Follow-up|0|||
164416171|NCT02736968|593893537|FG002|Overall Study|Lost to Follow-up|0|||
164416172|NCT02736968|593893538|FG003|Overall Study|Lost to Follow-up|0|||
164416173|NCT02736968|593893539|FG004|Overall Study|Lost to Follow-up|0|||
164467878|NCT04934072|594085371|FG003|Day 0 to Week 52|Adverse Event|0|||
164467879|NCT04934072|594085372|FG004|Day 0 to Week 52|Adverse Event|0|||
164467880|NCT04934072|594085368|FG000|Week 52 to Week 78|Adverse Event|0|||
164467881|NCT04934072|594085369|FG001|Week 52 to Week 78|Adverse Event|0|||
164467882|NCT04934072|594085370|FG002|Week 52 to Week 78|Adverse Event|0|||
164467883|NCT04934072|594085371|FG003|Week 52 to Week 78|Adverse Event|1|||
164467884|NCT04934072|594085372|FG004|Week 52 to Week 78|Adverse Event|1|||
164467885|NCT04934072|594085368|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
164467886|NCT04934072|594085369|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
164467887|NCT04934072|594085370|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
164467888|NCT04934072|594085371|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
164416174|NCT02736968|593893540|FG005|Overall Study|Lost to Follow-up|0|||
164467889|NCT04934072|594085372|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
164467890|NCT04934072|594085368|FG000|Week 52 to Week 78|Other|0|||
164467891|NCT04934072|594085369|FG001|Week 52 to Week 78|Other|0|||
164467892|NCT04934072|594085370|FG002|Week 52 to Week 78|Other|1|||
164467893|NCT04934072|594085371|FG003|Week 52 to Week 78|Other|0|||
164467894|NCT04934072|594085372|FG004|Week 52 to Week 78|Other|0|||
164467895|NCT05424380|594085375|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
164467896|NCT05424380|594085376|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
164467897|NCT05424380|594085377|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
164467898|NCT05424380|594085378|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
164467899|NCT05424380|594085379|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
164467900|NCT05424380|594085380|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
164467901|NCT05424380|594085375|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
164467902|NCT05424380|594085376|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
164467903|NCT05424380|594085377|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
164467904|NCT05424380|594085378|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
164467905|NCT05424380|594085379|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
164467906|NCT05424380|594085380|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
164467907|NCT05424380|594085375|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
164467908|NCT05424380|594085376|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
164467909|NCT05424380|594085377|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
164467910|NCT05424380|594085378|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
164467911|NCT05424380|594085379|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
164467912|NCT05424380|594085380|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
164467913|NCT05424380|594085375|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
164467914|NCT05424380|594085376|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
164467915|NCT05424380|594085377|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
164467916|NCT05424380|594085378|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
164467917|NCT05424380|594085379|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
164467918|NCT05424380|594085380|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
164467919|NCT05424380|594085375|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
164467920|NCT05424380|594085376|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
164467921|NCT05424380|594085377|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
164467922|NCT05424380|594085378|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
164467923|NCT05424380|594085379|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
164467924|NCT05424380|594085380|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
164467925|NCT05424380|594085375|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
164467926|NCT05424380|594085376|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
164467927|NCT05424380|594085377|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
164467928|NCT05424380|594085378|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
164467929|NCT05424380|594085379|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
164467930|NCT05424380|594085380|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
164467931|NCT05424380|594085375|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
164467932|NCT05424380|594085376|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
164467933|NCT05424380|594085377|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
164467934|NCT05424380|594085378|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
164467935|NCT05424380|594085379|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
164467936|NCT05424380|594085380|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
164467937|NCT05424380|594085375|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
164467938|NCT05424380|594085376|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
164467939|NCT05424380|594085377|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
164467940|NCT05424380|594085378|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
164599620|NCT01163253|594556299|FG001|Overall Study|Adverse Event|78|||
164599621|NCT01163253|594556298|FG000|Overall Study|Death|17|||
164599622|NCT01163253|594556299|FG001|Overall Study|Death|5|||
164599623|NCT01163253|594556298|FG000|Overall Study|Ongoing|13|||
164599624|NCT01163253|594556299|FG001|Overall Study|Ongoing|4|||
164599625|NCT01163253|594556298|FG000|Overall Study|Other Unspecified|170|||
164599626|NCT01163253|594556299|FG001|Overall Study|Other Unspecified|34|||
164599627|NCT03888391|594556302|FG000|Overall Study|Lost to Follow-up|15|||
164599628|NCT03025217|594556308|FG000|Overall Study|Pregnancy|1|||
164599629|NCT03025217|594556308|FG000|Overall Study|Lost to Follow-up|1|||
164599630|NCT03025217|594556308|FG000|Overall Study|Not eligible, poor English|2|||
164599631|NCT02130427|594556314|FG000|Overall Study|Imaging results not interpretable|30|||
164599632|NCT04032171|594556316|FG000|Overall Study|Study Termination|1|||
164599633|NCT04032171|594556317|FG001|Overall Study|Study Termination|0|||
164599634|NCT00992784|594556318|FG000|Overall Study|Adverse Event|2|||
164599635|NCT00992784|594556319|FG001|Overall Study|Adverse Event|1|||
164599636|NCT00992784|594556320|FG002|Overall Study|Adverse Event|0|||
164599637|NCT00992784|594556318|FG000|Overall Study|Withdrawal by Subject|1|||
164599638|NCT00992784|594556319|FG001|Overall Study|Withdrawal by Subject|1|||
164599639|NCT00992784|594556320|FG002|Overall Study|Withdrawal by Subject|1|||
164599640|NCT00781599|594556321|FG000|Overall Study|Lost to Follow-up|7|||
164599641|NCT00781599|594556322|FG001|Overall Study|Lost to Follow-up|4|||
164599642|NCT01088438|594556323|FG000|Overall Study|Withdrawal by Subject|11|||
164599643|NCT01088438|594556324|FG001|Overall Study|Withdrawal by Subject|6|||
164416175|NCT02736968|593893541|FG006|Overall Study|Lost to Follow-up|5|||
164416176|NCT02736968|593893542|FG007|Overall Study|Lost to Follow-up|2|||
164416177|NCT02736968|593893535|FG000|Overall Study|COVID-19 Pandemic|0|||
164416178|NCT02736968|593893536|FG001|Overall Study|COVID-19 Pandemic|0|||
164416179|NCT02736968|593893537|FG002|Overall Study|COVID-19 Pandemic|0|||
164416180|NCT02736968|593893538|FG003|Overall Study|COVID-19 Pandemic|0|||
164416181|NCT02736968|593893539|FG004|Overall Study|COVID-19 Pandemic|0|||
164416182|NCT02736968|593893540|FG005|Overall Study|COVID-19 Pandemic|0|||
164416183|NCT02736968|593893541|FG006|Overall Study|COVID-19 Pandemic|2|||
164416184|NCT02736968|593893542|FG007|Overall Study|COVID-19 Pandemic|0|||
164416185|NCT02736968|593893535|FG000|Overall Study|Withdrawal by Subject|0|||
164416186|NCT02736968|593893536|FG001|Overall Study|Withdrawal by Subject|0|||
164416187|NCT02736968|593893537|FG002|Overall Study|Withdrawal by Subject|0|||
164416188|NCT02736968|593893538|FG003|Overall Study|Withdrawal by Subject|0|||
164416189|NCT02736968|593893539|FG004|Overall Study|Withdrawal by Subject|0|||
164416190|NCT02736968|593893540|FG005|Overall Study|Withdrawal by Subject|0|||
164416191|NCT02736968|593893541|FG006|Overall Study|Withdrawal by Subject|1|||
164416192|NCT02736968|593893542|FG007|Overall Study|Withdrawal by Subject|0|||
164416193|NCT03342053|593893543|FG000|Overall Study|Adverse Event|2|||
164416194|NCT03342053|593893544|FG001|Overall Study|Adverse Event|0|||
164416195|NCT03342053|593893543|FG000|Overall Study|Withdrawal by Subject|0|||
164416196|NCT03342053|593893544|FG001|Overall Study|Withdrawal by Subject|1|||
164416197|NCT00171873|593893547|FG000|Overall Study|Withdrawal by Subject|4|||
164416198|NCT00171873|593893548|FG001|Overall Study|Withdrawal by Subject|2|||
164416199|NCT00171873|593893547|FG000|Overall Study|Adverse Event|5|||
164416200|NCT00171873|593893548|FG001|Overall Study|Adverse Event|0|||
164416201|NCT00171873|593893547|FG000|Overall Study|Switched to Octreotide|0|||
164416202|NCT00171873|593893548|FG001|Overall Study|Switched to Octreotide|1|||
164416203|NCT02041923|593893549|FG000|Overall Study|Lost to Follow-up|26|||
164416204|NCT02041923|593893550|FG001|Overall Study|Lost to Follow-up|30|||
164416205|NCT00309608|593893551|FG000|Overall Study|Adverse Event|1|||
164416206|NCT00309608|593893552|FG001|Overall Study|Adverse Event|5|||
164416207|NCT00309608|593893553|FG002|Overall Study|Adverse Event|3|||
164416208|NCT00309608|593893554|FG003|Overall Study|Adverse Event|2|||
164416209|NCT00309608|593893555|FG004|Overall Study|Adverse Event|3|||
164416210|NCT00309608|593893551|FG000|Overall Study|Protocol Violation|2|||
164416211|NCT00309608|593893552|FG001|Overall Study|Protocol Violation|0|||
164416212|NCT00309608|593893553|FG002|Overall Study|Protocol Violation|0|||
164467941|NCT05424380|594085379|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
164467942|NCT05424380|594085380|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
164467943|NCT05424380|594085375|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
164467944|NCT05424380|594085376|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
164467945|NCT05424380|594085377|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
164467946|NCT05424380|594085378|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
164467947|NCT05424380|594085379|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
164467948|NCT05424380|594085380|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
164467949|NCT05424380|594085375|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
164467950|NCT05424380|594085376|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
164467951|NCT05424380|594085377|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
164467952|NCT05424380|594085378|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
164467953|NCT05424380|594085379|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
164467954|NCT05424380|594085380|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
164467955|NCT05424380|594085375|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
164467956|NCT05424380|594085376|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
164467957|NCT05424380|594085377|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
164467958|NCT05424380|594085378|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
164467959|NCT05424380|594085379|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
164467960|NCT05424380|594085380|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
164467961|NCT05424380|594085375|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
164467962|NCT05424380|594085376|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
164467963|NCT05424380|594085377|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
164416213|NCT00309608|593893554|FG003|Overall Study|Protocol Violation|0|||
164416214|NCT00309608|593893555|FG004|Overall Study|Protocol Violation|0|||
164416215|NCT00309608|593893551|FG000|Overall Study|Lost to Follow-up|0|||
164416216|NCT00309608|593893552|FG001|Overall Study|Lost to Follow-up|0|||
164416217|NCT00309608|593893553|FG002|Overall Study|Lost to Follow-up|2|||
164416218|NCT00309608|593893554|FG003|Overall Study|Lost to Follow-up|0|||
164416219|NCT00309608|593893555|FG004|Overall Study|Lost to Follow-up|1|||
164416220|NCT00309608|593893551|FG000|Overall Study|Withdrawal by Subject|1|||
164416221|NCT00309608|593893552|FG001|Overall Study|Withdrawal by Subject|4|||
164416222|NCT00309608|593893553|FG002|Overall Study|Withdrawal by Subject|2|||
164416223|NCT00309608|593893554|FG003|Overall Study|Withdrawal by Subject|0|||
164416224|NCT00309608|593893555|FG004|Overall Study|Withdrawal by Subject|0|||
164416225|NCT00309608|593893551|FG000|Overall Study|Other incl. Lack of efficacy|10|||
164467964|NCT05424380|594085378|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
164467965|NCT05424380|594085379|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
164467966|NCT05424380|594085380|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
164467967|NCT05424380|594085375|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
164467968|NCT05424380|594085376|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
164467969|NCT05424380|594085377|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
164467970|NCT05424380|594085378|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
164467971|NCT05424380|594085379|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
164467972|NCT05424380|594085380|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
164467973|NCT05424380|594085375|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
164467974|NCT05424380|594085376|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
164467975|NCT05424380|594085377|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
164467976|NCT05424380|594085378|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
164467977|NCT05424380|594085379|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
164467978|NCT05424380|594085380|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
164467979|NCT03213678|594085386|FG000|Overall Study|Death|1|||
164467980|NCT03213678|594085386|FG000|Overall Study|Physician Decision|1|||
164467981|NCT03213678|594085386|FG000|Overall Study|Progressive disease|16|||
164467982|NCT04218851|594085387|FG000|Overall Study|Death|1|||
164467983|NCT04218851|594085388|FG001|Overall Study|Death|3|||
164467984|NCT03717935|594085389|FG000|Overall Study|Withdrawal by Subject|0|||
164467985|NCT03717935|594085390|FG001|Overall Study|Withdrawal by Subject|2|||
164467986|NCT04456296|594085391|FG000|Overall Study|Withdrawal by Subject|14|||
164467987|NCT04456296|594085392|FG001|Overall Study|Withdrawal by Subject|21|||
164467988|NCT04456296|594085393|FG002|Overall Study|Withdrawal by Subject|21|||
164467989|NCT04456296|594085391|FG000|Overall Study|Adverse Event|2|||
164467990|NCT04456296|594085392|FG001|Overall Study|Adverse Event|2|||
164467991|NCT04456296|594085393|FG002|Overall Study|Adverse Event|2|||
164467992|NCT04456296|594085391|FG000|Overall Study|Death|1|||
164467993|NCT04456296|594085392|FG001|Overall Study|Death|0|||
164467994|NCT04456296|594085393|FG002|Overall Study|Death|0|||
164467995|NCT04456296|594085391|FG000|Overall Study|Lost to Follow-up|3|||
164467996|NCT04456296|594085392|FG001|Overall Study|Lost to Follow-up|5|||
164467997|NCT04456296|594085393|FG002|Overall Study|Lost to Follow-up|6|||
164467998|NCT04456296|594085391|FG000|Overall Study|Other than specified|0|||
164467999|NCT04456296|594085392|FG001|Overall Study|Other than specified|1|||
164468000|NCT04456296|594085393|FG002|Overall Study|Other than specified|4|||
164468001|NCT04456296|594085391|FG000|Overall Study|Randomized, not treated|2|||
164468002|NCT04456296|594085392|FG001|Overall Study|Randomized, not treated|1|||
164468003|NCT04456296|594085393|FG002|Overall Study|Randomized, not treated|0|||
164468004|NCT05736458|594085394|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
164468005|NCT05736458|594085395|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
164468006|NCT05736458|594085396|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
164468007|NCT05736458|594085394|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
164468008|NCT05736458|594085395|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
164468009|NCT05736458|594085396|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
164468010|NCT05736458|594085394|FG000|TMS/fMRI #1|Physician Decision|0|||
164468011|NCT05736458|594085395|FG001|TMS/fMRI #1|Physician Decision|0|||
164468012|NCT05736458|594085396|FG002|TMS/fMRI #1|Physician Decision|2|||
164468013|NCT05736458|594085394|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
164468014|NCT05736458|594085395|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
164468015|NCT05736458|594085396|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
164468016|NCT02990338|594085397|FG000|Overall Study|Randomized and not treated|4|||
164468017|NCT02990338|594085398|FG001|Overall Study|Randomized and not treated|2|||
164468018|NCT02990338|594085397|FG000|Overall Study|Adverse Event|23|||
164468019|NCT02990338|594085398|FG001|Overall Study|Adverse Event|22|||
164468020|NCT02990338|594085397|FG000|Overall Study|Progressive disease|118|||
164468021|NCT02990338|594085398|FG001|Overall Study|Progressive disease|107|||
164468022|NCT02990338|594085397|FG000|Overall Study|Poor compliance to protocol|0|||
164711667|NCT01664130|594968220|FG000|Overall Study|competing secondary disease|2|||
164711668|NCT02679235|594968223|FG000|Overall Study|Withdrawal by Subject|3|||
164711669|NCT02679235|594968223|FG000|Overall Study|Adverse Event|1|||
164711670|NCT00923273|594968224|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
164711671|NCT00923273|594968225|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
164711672|NCT00923273|594968226|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
164711673|NCT00923273|594968227|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
164711674|NCT00923273|594968228|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
164711675|NCT00923273|594968224|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
164711676|NCT00923273|594968225|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
164711677|NCT00923273|594968226|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
164711678|NCT00923273|594968227|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
164144826|NCT05445492|592891790|FG000|Overall Study|Physician Decision|1|||
164468023|NCT02990338|594085398|FG001|Overall Study|Poor compliance to protocol|1|||
164468024|NCT02990338|594085397|FG000|Overall Study|Withdrawal by Subject|6|||
164468025|NCT02990338|594085398|FG001|Overall Study|Withdrawal by Subject|8|||
164468026|NCT02990338|594085397|FG000|Overall Study|Physician's decision|2|||
164468027|NCT02990338|594085398|FG001|Overall Study|Physician's decision|6|||
164468028|NCT02990338|594085397|FG000|Overall Study|Treatment extension study|0|||
164468029|NCT02990338|594085398|FG001|Overall Study|Treatment extension study|6|||
164468030|NCT02990338|594085397|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
164468031|NCT02990338|594085398|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
164468032|NCT02990338|594085397|FG000|Overall Study|Continue with therapy available commercially|0|||
164468033|NCT02990338|594085398|FG001|Overall Study|Continue with therapy available commercially|1|||
164468034|NCT03993392|594085400|FG000|Overall Study|Withdrawal by Subject|3|||
164468035|NCT03993392|594085400|FG000|Overall Study|Lost to Follow-up|2|||
164468036|NCT03993392|594085400|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
164468037|NCT05292391|594085403|FG000|Overall Study|Lost to Follow-up|0|||
164468038|NCT05292391|594085404|FG001|Overall Study|Lost to Follow-up|0|||
164468039|NCT05292391|594085405|FG002|Overall Study|Lost to Follow-up|0|||
164468040|NCT05292391|594085406|FG003|Overall Study|Lost to Follow-up|1|||
164468041|NCT05292391|594085407|FG004|Overall Study|Lost to Follow-up|0|||
164468042|NCT04857723|594085410|FG000|Overall Study|Withdrawal by Subject|2|||
164468043|NCT04565990|594086490|FG000|Overall Study|Death|5|||
164468044|NCT04565990|594086490|FG000|Overall Study|Lost to Follow-up|1|||
164468045|NCT04565990|594086490|FG000|Overall Study|Withdrawal by Subject|1|||
164468046|NCT05507333|594086491|FG000|Overall Study|Protocol Violation|1|||
164468047|NCT01960452|594086494|FG000|Overall Study|Withdrawal by Subject|2|||
164468048|NCT01960452|594086495|FG001|Overall Study|Withdrawal by Subject|1|||
164468049|NCT01960452|594086494|FG000|Overall Study|Sleep apnea in Night 1|1|||
164468050|NCT01960452|594086495|FG001|Overall Study|Sleep apnea in Night 1|0|||
164468051|NCT01960452|594086494|FG000|Overall Study|Poor Sleep in Night 1|0|||
164468052|NCT01960452|594086495|FG001|Overall Study|Poor Sleep in Night 1|2|||
164468053|NCT01960452|594086494|FG000|Overall Study|No Sex/Age Match Night 1|1|||
164468054|NCT01960452|594086495|FG001|Overall Study|No Sex/Age Match Night 1|0|||
164468055|NCT01960452|594086494|FG000|Overall Study|No Sex/Age Match Night 2|0|||
164468056|NCT01960452|594086495|FG001|Overall Study|No Sex/Age Match Night 2|2|||
164468057|NCT01960452|594086494|FG000|Overall Study|Technical Difficulties Night 2|2|||
164468058|NCT01960452|594086495|FG001|Overall Study|Technical Difficulties Night 2|0|||
164468059|NCT03981926|594086496|FG000|Overall Study|Lost to Follow-up|5|||
164468060|NCT03981926|594086497|FG001|Overall Study|Lost to Follow-up|9|||
164468061|NCT02446236|594086498|FG000|Overall Study|Screen Failure|1|||
164468062|NCT02446236|594086499|FG001|Overall Study|Screen Failure|0|||
164468063|NCT02446236|594086500|FG002|Overall Study|Screen Failure|1|||
164468064|NCT02446236|594086498|FG000|Overall Study|Actively Receiving Therapy|0|||
164468065|NCT02446236|594086499|FG001|Overall Study|Actively Receiving Therapy|0|||
164468066|NCT02446236|594086500|FG002|Overall Study|Actively Receiving Therapy|1|||
164468067|NCT03677141|594086501|FG000|Overall Study|Death|2|||
164468068|NCT03677141|594086502|FG001|Overall Study|Death|1|||
164468069|NCT03677141|594086503|FG002|Overall Study|Death|6|||
164468070|NCT03677141|594086504|FG003|Overall Study|Death|9|||
164468071|NCT03677141|594086505|FG004|Overall Study|Death|5|||
164468072|NCT03677141|594086506|FG005|Overall Study|Death|3|||
164468073|NCT03677141|594086501|FG000|Overall Study|Lost to Follow-up|0|||
164468074|NCT03677141|594086502|FG001|Overall Study|Lost to Follow-up|0|||
164468075|NCT03677141|594086503|FG002|Overall Study|Lost to Follow-up|0|||
164468076|NCT03677141|594086504|FG003|Overall Study|Lost to Follow-up|2|||
164468077|NCT03677141|594086505|FG004|Overall Study|Lost to Follow-up|0|||
164468078|NCT03677141|594086506|FG005|Overall Study|Lost to Follow-up|0|||
164468079|NCT03677141|594086501|FG000|Overall Study|Screen failure or enrolled in error|0|||
164468080|NCT03677141|594086502|FG001|Overall Study|Screen failure or enrolled in error|0|||
164468081|NCT03677141|594086503|FG002|Overall Study|Screen failure or enrolled in error|0|||
164468082|NCT03677141|594086504|FG003|Overall Study|Screen failure or enrolled in error|0|||
164468083|NCT03677141|594086505|FG004|Overall Study|Screen failure or enrolled in error|2|||
164468084|NCT03677141|594086506|FG005|Overall Study|Screen failure or enrolled in error|0|||
164468085|NCT03677141|594086501|FG000|Overall Study|Physician Decision|0|||
164468086|NCT03677141|594086502|FG001|Overall Study|Physician Decision|0|||
164468087|NCT03677141|594086503|FG002|Overall Study|Physician Decision|0|||
164468088|NCT03677141|594086504|FG003|Overall Study|Physician Decision|0|||
164468089|NCT03677141|594086505|FG004|Overall Study|Physician Decision|1|||
164468090|NCT03677141|594086506|FG005|Overall Study|Physician Decision|0|||
164468091|NCT03677141|594086501|FG000|Overall Study|Withdrawal by Subject|0|||
164468092|NCT03677141|594086502|FG001|Overall Study|Withdrawal by Subject|0|||
164468093|NCT03677141|594086503|FG002|Overall Study|Withdrawal by Subject|1|||
164468094|NCT03677141|594086504|FG003|Overall Study|Withdrawal by Subject|1|||
164468095|NCT03677141|594086505|FG004|Overall Study|Withdrawal by Subject|1|||
164468096|NCT03677141|594086506|FG005|Overall Study|Withdrawal by Subject|0|||
164468097|NCT00844415|594086516|FG000|Overall Study|Withdrawal by Subject|1|||
164468098|NCT03174275|594086517|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
164468099|NCT03174275|594086517|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
164468100|NCT03174275|594086517|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
164468101|NCT03174275|594086517|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
164468102|NCT03174275|594086517|FG000|Adjuvant Chemotherapy|Progression|1|||
164468103|NCT03174275|594086517|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
164468104|NCT03174275|594086517|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
164468105|NCT03174275|594086517|FG000|Adjuvant Durvalumab|Progression|1|||
164468106|NCT03174275|594086517|FG000|Adjuvant Durvalumab|Adverse Event|3|||
164468107|NCT03174275|594086517|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
164468108|NCT03174275|594086517|FG000|Adjuvant Radiotherapy|Progression|1|||
164468109|NCT03174275|594086517|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
164468110|NCT02413489|594086518|FG000|Overall Study|Death|11|||
164468111|NCT02413489|594086519|FG001|Overall Study|Death|3|||
164468112|NCT02413489|594086520|FG002|Overall Study|Death|4|||
164468113|NCT02413489|594086518|FG000|Overall Study|Withdrawal by Subject|2|||
164468114|NCT02413489|594086519|FG001|Overall Study|Withdrawal by Subject|0|||
164468115|NCT02413489|594086520|FG002|Overall Study|Withdrawal by Subject|0|||
164468116|NCT02413489|594086518|FG000|Overall Study|Study Terminated By Sponsor|2|||
164468117|NCT02413489|594086519|FG001|Overall Study|Study Terminated By Sponsor|13|||
164468118|NCT02413489|594086520|FG002|Overall Study|Study Terminated By Sponsor|1|||
164468119|NCT05970861|594086521|FG000|Overall Study|Physician Decision|4|||
164468120|NCT05970861|594086522|FG001|Overall Study|Physician Decision|4|||
164468121|NCT05970861|594086521|FG000|Overall Study|Lost to Follow-up|4|||
164468122|NCT05970861|594086522|FG001|Overall Study|Lost to Follow-up|3|||
164468123|NCT04186819|594086523|FG000|Overall Study|Adverse Event|1|||
164468124|NCT04186819|594086523|FG000|Overall Study|Lost to Follow-up|1|||
164468125|NCT04186819|594086523|FG000|Overall Study|Opted for EBRT|1|||
164468126|NCT04186819|594086523|FG000|Overall Study|Opted SBRT|1|||
164468127|NCT04186819|594086523|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
164468128|NCT04186819|594086523|FG000|Overall Study|Physician Decision|1|||
164468129|NCT04186819|594086523|FG000|Overall Study|RP Delayed|1|||
164468130|NCT04186819|594086523|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
164468131|NCT04186819|594086523|FG000|Overall Study|Subject declined for financial reasons|1|||
164468132|NCT04186819|594086523|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
164468133|NCT04186819|594086523|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
164468134|NCT04186819|594086523|FG000|Overall Study|The subject opted for other treatment option|2|||
164468135|NCT04186819|594086523|FG000|Overall Study|The subject opted for other treatment options|1|||
164468136|NCT04186819|594086523|FG000|Overall Study|Withdrawal by Subject|3|||
164468137|NCT04186819|594086523|FG000|Overall Study|Reason not specified|1|||
164468138|NCT05100628|594086529|FG000|Overall Study|Progressive Disease|1|||
164468139|NCT05100628|594086530|FG001|Overall Study|Progressive Disease|0|||
164468140|NCT05100628|594086531|FG002|Overall Study|Progressive Disease|0|||
164468141|NCT05100628|594086532|FG003|Overall Study|Progressive Disease|0|||
164468142|NCT05100628|594086529|FG000|Overall Study|Study Terminated by Sponsor|0|||
164468143|NCT05100628|594086530|FG001|Overall Study|Study Terminated by Sponsor|0|||
164468144|NCT05100628|594086531|FG002|Overall Study|Study Terminated by Sponsor|3|||
164468145|NCT05100628|594086532|FG003|Overall Study|Study Terminated by Sponsor|0|||
164468146|NCT05100628|594086529|FG000|Overall Study|unkown|0|||
164468147|NCT05100628|594086530|FG001|Overall Study|unkown|1|||
164468148|NCT05100628|594086531|FG002|Overall Study|unkown|0|||
164468149|NCT05100628|594086532|FG003|Overall Study|unkown|0|||
164468150|NCT03914469|594086535|FG000|Overall Study|Lost to Follow-up|1|||
164468151|NCT03914469|594086536|FG001|Overall Study|Lost to Follow-up|4|||
164468152|NCT03334695|594086545|FG000|Overall Study|Lost to Follow-up|3|||
164468153|NCT03334695|594086546|FG001|Overall Study|Lost to Follow-up|3|||
164468154|NCT03334695|594086545|FG000|Overall Study|Physician Decision|1|||
164468155|NCT03334695|594086546|FG001|Overall Study|Physician Decision|2|||
164468156|NCT03334695|594086545|FG000|Overall Study|Protocol Violation|0|||
164468157|NCT03334695|594086546|FG001|Overall Study|Protocol Violation|1|||
164468158|NCT02938923|594086547|FG000|Overall Study|Death|1|||
164468159|NCT02938923|594086548|FG001|Overall Study|Death|0|||
164468160|NCT02938923|594086549|FG002|Overall Study|Death|0|||
164468161|NCT02938923|594086547|FG000|Overall Study|Physician Decision|0|||
164468162|NCT02938923|594086548|FG001|Overall Study|Physician Decision|2|||
164468163|NCT02938923|594086549|FG002|Overall Study|Physician Decision|0|||
164468164|NCT02938923|594086547|FG000|Overall Study|Withdrawal by Subject|0|||
164468165|NCT02938923|594086548|FG001|Overall Study|Withdrawal by Subject|1|||
164468166|NCT02938923|594086549|FG002|Overall Study|Withdrawal by Subject|1|||
164468167|NCT00721149|594086550|FG000|Overall Study|Physician Decision|1|||
164468168|NCT04614948|594086552|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
164599644|NCT01088438|594556323|FG000|Overall Study|Lost to Follow-up|18|||
164468169|NCT04614948|594086553|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
164468170|NCT04614948|594086554|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
164468171|NCT04614948|594086552|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
164599645|NCT01088438|594556324|FG001|Overall Study|Lost to Follow-up|30|||
164599646|NCT00089479|594556325|FG000|Overall Study|Death|108|||
164599647|NCT00089479|594556326|FG001|Overall Study|Death|75|||
164468172|NCT04614948|594086553|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
164468173|NCT04614948|594086554|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
164468174|NCT04614948|594086552|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
164468175|NCT04614948|594086553|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
164468176|NCT04614948|594086554|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
164468177|NCT04614948|594086552|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
164468178|NCT04614948|594086553|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
164468179|NCT04614948|594086554|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
164468180|NCT04614948|594086552|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
164468181|NCT04614948|594086553|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
164468182|NCT04614948|594086554|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
164468183|NCT04614948|594086552|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
164468184|NCT04614948|594086553|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
164468185|NCT04614948|594086554|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
164468186|NCT04614948|594086552|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
164468187|NCT04614948|594086553|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
164468188|NCT04614948|594086554|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
164468189|NCT04614948|594086552|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
164468190|NCT04614948|594086553|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
164468191|NCT04614948|594086554|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
164468192|NCT04614948|594086552|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
164468193|NCT04614948|594086553|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
164468194|NCT04614948|594086554|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
164468195|NCT04614948|594086552|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
164468196|NCT04614948|594086553|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
164468197|NCT04614948|594086554|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
164468198|NCT04614948|594086552|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
164468199|NCT04614948|594086553|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
164468200|NCT04614948|594086554|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
164468201|NCT04614948|594086552|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
164468202|NCT04614948|594086553|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
164468203|NCT04614948|594086554|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
164468204|NCT04614948|594086552|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
164468205|NCT04614948|594086553|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
164468206|NCT04614948|594086554|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
164468207|NCT04614948|594086552|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
164468208|NCT04614948|594086553|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
164468209|NCT04614948|594086554|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
164468210|NCT04614948|594086552|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
164468211|NCT04614948|594086553|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
164468212|NCT04614948|594086554|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
164468213|NCT04614948|594086552|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
164468214|NCT04614948|594086553|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
164468215|NCT04614948|594086554|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
164468216|NCT04614948|594086552|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
164468217|NCT04614948|594086553|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
164468218|NCT04614948|594086554|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
164468219|NCT04614948|594086552|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
164468220|NCT04614948|594086553|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
164468221|NCT04614948|594086554|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
164468222|NCT04614948|594086552|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
164468223|NCT04614948|594086553|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
164468224|NCT04614948|594086554|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
164468225|NCT04614948|594086552|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
164468226|NCT04614948|594086553|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
164468227|NCT04614948|594086554|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
164468228|NCT04614948|594086552|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
164468229|NCT04614948|594086553|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
164468230|NCT04614948|594086554|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
164468231|NCT04614948|594086552|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
164468232|NCT04614948|594086553|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
164468233|NCT04614948|594086554|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
164468234|NCT04614948|594086552|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
164468235|NCT04614948|594086553|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
164468236|NCT04614948|594086554|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
164468237|NCT04271046|594086555|FG000|Overall Study|Death|0|||
164468238|NCT04271046|594086556|FG001|Overall Study|Death|2|||
164468239|NCT04271046|594086557|FG002|Overall Study|Death|0|||
164468240|NCT04271046|594086558|FG003|Overall Study|Death|2|||
164468241|NCT04271046|594086555|FG000|Overall Study|Lost to Follow-up|12|||
164468242|NCT04271046|594086556|FG001|Overall Study|Lost to Follow-up|12|||
164468243|NCT04271046|594086557|FG002|Overall Study|Lost to Follow-up|11|||
164468244|NCT04271046|594086558|FG003|Overall Study|Lost to Follow-up|11|||
164468245|NCT04271046|594086555|FG000|Overall Study|Patient with Dementia Died|2|||
164468246|NCT04271046|594086556|FG001|Overall Study|Patient with Dementia Died|0|||
164468247|NCT04271046|594086557|FG002|Overall Study|Patient with Dementia Died|2|||
164468248|NCT04271046|594086558|FG003|Overall Study|Patient with Dementia Died|0|||
164468249|NCT04271046|594086555|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
164468250|NCT04271046|594086556|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
164468251|NCT04271046|594086557|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
164468252|NCT04271046|594086558|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
164468253|NCT01570361|594086559|FG000|Overall Study|Subject discontinued|1|||
164468254|NCT01570361|594086560|FG001|Overall Study|Subject discontinued|2|||
164468255|NCT01570361|594086559|FG000|Overall Study|Sponsor closing the study|51|||
164468256|NCT01570361|594086560|FG001|Overall Study|Sponsor closing the study|50|||
164468257|NCT01570361|594086559|FG000|Overall Study|Subject excluded|5|||
164468258|NCT01570361|594086560|FG001|Overall Study|Subject excluded|3|||
164468259|NCT01570361|594086559|FG000|Overall Study|Subject withdrew consent|14|||
164468260|NCT01570361|594086560|FG001|Overall Study|Subject withdrew consent|9|||
164468261|NCT01570361|594086559|FG000|Overall Study|Adverse Event|2|||
164468262|NCT01570361|594086560|FG001|Overall Study|Adverse Event|1|||
164468263|NCT01570361|594086559|FG000|Overall Study|Lost to Follow-up|4|||
164468264|NCT01570361|594086560|FG001|Overall Study|Lost to Follow-up|4|||
164468265|NCT01570361|594086559|FG000|Overall Study|Death|5|||
164468266|NCT01570361|594086560|FG001|Overall Study|Death|4|||
164468267|NCT01570361|594086559|FG000|Overall Study|Other|0|||
164468268|NCT01570361|594086560|FG001|Overall Study|Other|2|||
164468269|NCT05158504|594086561|FG000|Overall Study|Lost to Follow-up|2|||
164468270|NCT05158504|594086562|FG001|Overall Study|Lost to Follow-up|3|||
164468271|NCT03606512|594086565|FG000|Overall Study|Lost to Follow-up|0|||
164468272|NCT03606512|594086566|FG001|Overall Study|Lost to Follow-up|1|||
164468273|NCT03606512|594086565|FG000|Overall Study|'moved from study area|0|||
164468274|NCT03606512|594086566|FG001|Overall Study|'moved from study area|1|||
164468275|NCT05513937|594086567|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
164468276|NCT05513937|594086568|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
164468277|NCT05513937|594086569|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
164468278|NCT05513937|594086570|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
164468279|NCT05513937|594086567|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
164468280|NCT05513937|594086568|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
164468281|NCT05513937|594086569|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
164468282|NCT05513937|594086570|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
164468283|NCT05513937|594086567|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
164468284|NCT05513937|594086568|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
164468285|NCT05513937|594086569|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
164468286|NCT05513937|594086570|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
164468287|NCT05513937|594086567|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
164468288|NCT05513937|594086568|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
164468289|NCT05513937|594086569|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
164468290|NCT05513937|594086570|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
164468291|NCT05513937|594086567|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
164468292|NCT05513937|594086568|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
164711679|NCT00923273|594968228|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
164711680|NCT03146962|594968233|FG000|Overall Study|Lost to Follow-up|1|||
164711681|NCT03146962|594968234|FG001|Overall Study|Lost to Follow-up|1|||
164711682|NCT03146962|594968235|FG002|Overall Study|Lost to Follow-up|0|||
164711683|NCT03146962|594968236|FG003|Overall Study|Lost to Follow-up|0|||
164711684|NCT03146962|594968237|FG004|Overall Study|Lost to Follow-up|0|||
164711685|NCT03146962|594968238|FG005|Overall Study|Lost to Follow-up|0|||
164711686|NCT03146962|594968239|FG006|Overall Study|Lost to Follow-up|0|||
164711687|NCT03146962|594968240|FG007|Overall Study|Lost to Follow-up|0|||
164711688|NCT03146962|594968241|FG008|Overall Study|Lost to Follow-up|0|||
164711689|NCT03146962|594968242|FG009|Overall Study|Lost to Follow-up|0|||
164711690|NCT03146962|594968233|FG000|Overall Study|Adverse Event|0|||
164468293|NCT05513937|594086569|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
164468294|NCT05513937|594086570|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
164468295|NCT05513937|594086567|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
164468296|NCT05513937|594086568|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
164468297|NCT05513937|594086569|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
164468298|NCT05513937|594086570|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
164468299|NCT02846545|594086571|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
164468300|NCT02846545|594086572|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
164468301|NCT02846545|594086571|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
164468302|NCT02846545|594086572|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
164468303|NCT02846545|594086571|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
164468304|NCT02846545|594086572|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
164468305|NCT02846545|594086571|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
164468306|NCT02846545|594086572|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
164468307|NCT02846545|594086571|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
164468308|NCT02846545|594086572|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
164468309|NCT02326974|594086575|FG000|Overall Study|Withdrawal by Subject|2|||
164468310|NCT02326974|594086575|FG000|Overall Study|failed heterogenity evaluation|5|||
164468311|NCT04924400|594086577|FG000|Overall Study|Lost to Follow-up|3|||
164468312|NCT04924400|594086578|FG001|Overall Study|Lost to Follow-up|0|||
164468313|NCT04633538|594086579|FG000|Overall Study|Death|1|||
164468314|NCT04633538|594086579|FG000|Overall Study|Lost to Follow-up|3|||
164468315|NCT04633538|594086579|FG000|Overall Study|Withdrawal by Subject|1|||
164468316|NCT03372057|594086590|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
164468317|NCT03372057|594086591|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
164468318|NCT03372057|594086592|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
164468319|NCT03372057|594086590|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
164468320|NCT03372057|594086591|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
164468321|NCT03372057|594086592|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
164468322|NCT03372057|594086590|FG000|Dose Optimization Phase|Death|16|||
164416226|NCT00309608|593893552|FG001|Overall Study|Other incl. Lack of efficacy|4|||
164416227|NCT00309608|593893553|FG002|Overall Study|Other incl. Lack of efficacy|3|||
164416228|NCT00309608|593893554|FG003|Overall Study|Other incl. Lack of efficacy|4|||
164416229|NCT00309608|593893555|FG004|Overall Study|Other incl. Lack of efficacy|0|||
164416230|NCT05200936|593893556|FG000|Overall Study|Withdrawal by Subject|2|||
164416231|NCT05200936|593893557|FG001|Overall Study|Withdrawal by Subject|2|||
164416232|NCT05200936|593893556|FG000|Overall Study|Lost to Follow-up|2|||
164416233|NCT05200936|593893557|FG001|Overall Study|Lost to Follow-up|0|||
164416234|NCT05200936|593893556|FG000|Overall Study|Pregnancy|0|||
164711691|NCT03146962|594968234|FG001|Overall Study|Adverse Event|3|||
164468323|NCT03372057|594086591|FG001|Dose Optimization Phase|Death|11|||
164468324|NCT03372057|594086592|FG002|Dose Optimization Phase|Death|0|||
164468325|NCT03372057|594086590|FG000|Expansion Phase|Withdrawal by Subject|0|||
164468326|NCT03372057|594086591|FG001|Expansion Phase|Withdrawal by Subject|0|||
164468327|NCT03372057|594086592|FG002|Expansion Phase|Withdrawal by Subject|4|||
164468328|NCT03372057|594086590|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
164468329|NCT03372057|594086591|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
164468330|NCT03372057|594086592|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
164468331|NCT03372057|594086590|FG000|Expansion Phase|Death|0|||
164468332|NCT03372057|594086591|FG001|Expansion Phase|Death|0|||
164468333|NCT03372057|594086592|FG002|Expansion Phase|Death|78|||
164468334|NCT03372057|594086590|FG000|Expansion Phase|Progressive Disease|0|||
164468335|NCT03372057|594086591|FG001|Expansion Phase|Progressive Disease|0|||
164468336|NCT03372057|594086592|FG002|Expansion Phase|Progressive Disease|1|||
164468337|NCT03372057|594086590|FG000|Expansion Phase|Adverse Event|0|||
164468338|NCT03372057|594086591|FG001|Expansion Phase|Adverse Event|0|||
164468339|NCT03372057|594086592|FG002|Expansion Phase|Adverse Event|1|||
164468340|NCT02518048|594086593|FG000|Overall Study|Withdrawal by Subject|1|||
164468341|NCT04505410|594086594|FG000|Overall Study|Adverse Event|2|||
164468342|NCT04505410|594086595|FG001|Overall Study|Adverse Event|0|||
164468343|NCT04505410|594086594|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
164468344|NCT04505410|594086595|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
164468345|NCT04505410|594086594|FG000|Overall Study|did not want to follow diet|1|||
164468346|NCT04505410|594086595|FG001|Overall Study|did not want to follow diet|0|||
164468347|NCT04505410|594086594|FG000|Overall Study|flare up of ulcerative colitis|0|||
164711692|NCT03146962|594968235|FG002|Overall Study|Adverse Event|0|||
164416235|NCT05200936|593893557|FG001|Overall Study|Pregnancy|1|||
164416236|NCT00127413|593893558|FG000|Overall Study|Lost to Follow-up|6|||
164416237|NCT00127413|593893559|FG001|Overall Study|Lost to Follow-up|4|||
164468348|NCT04505410|594086595|FG001|Overall Study|flare up of ulcerative colitis|1|||
164711693|NCT03146962|594968236|FG003|Overall Study|Adverse Event|0|||
164711694|NCT03146962|594968237|FG004|Overall Study|Adverse Event|0|||
164416238|NCT00127413|593893560|FG002|Overall Study|Lost to Follow-up|8|||
164468349|NCT04505410|594086594|FG000|Overall Study|Lost to Follow-up|0|||
164468350|NCT04505410|594086595|FG001|Overall Study|Lost to Follow-up|2|||
164468351|NCT04505410|594086594|FG000|Overall Study|Lost to Follow-up|1|||
164468352|NCT04505410|594086595|FG001|Overall Study|Lost to Follow-up|0|||
164468353|NCT04505410|594086594|FG000|Overall Study|initiated another diet on their own|0|||
164468354|NCT04505410|594086595|FG001|Overall Study|initiated another diet on their own|2|||
164468355|NCT05123027|594086596|FG000|Overall Study|Lost to Follow-up|17|||
164468356|NCT05123027|594086597|FG001|Overall Study|Lost to Follow-up|22|||
164468357|NCT05123027|594086596|FG000|Overall Study|Incarceration|3|||
164468358|NCT05123027|594086597|FG001|Overall Study|Incarceration|4|||
164468359|NCT05123027|594086596|FG000|Overall Study|Death|2|||
164468360|NCT05123027|594086597|FG001|Overall Study|Death|2|||
164468361|NCT05123027|594086596|FG000|Overall Study|Other|2|||
164468362|NCT05123027|594086597|FG001|Overall Study|Other|0|||
164468363|NCT05654662|594086598|FG000|Overall Study|Withdrawal by Subject|1|||
164468364|NCT05654662|594086599|FG001|Overall Study|Withdrawal by Subject|0|||
164468365|NCT05654662|594086598|FG000|Overall Study|A death in the family|1|||
164468366|NCT05654662|594086599|FG001|Overall Study|A death in the family|0|||
164468367|NCT04330040|594086600|FG000|Overall Study|Other: Adverse event|5|||
164468368|NCT04330040|594086601|FG001|Overall Study|Other: Adverse event|0|||
164468369|NCT04330040|594086602|FG002|Overall Study|Other: Adverse event|0|||
164468370|NCT04330040|594086600|FG000|Overall Study|Disease progression|38|||
164468371|NCT04330040|594086601|FG001|Overall Study|Disease progression|10|||
164468372|NCT04330040|594086602|FG002|Overall Study|Disease progression|0|||
164468373|NCT04330040|594086600|FG000|Overall Study|Physician Decision|5|||
164468374|NCT04330040|594086601|FG001|Overall Study|Physician Decision|3|||
164468375|NCT04330040|594086602|FG002|Overall Study|Physician Decision|0|||
164468376|NCT04330040|594086600|FG000|Overall Study|Lost to Follow-up|1|||
164468377|NCT04330040|594086601|FG001|Overall Study|Lost to Follow-up|1|||
164468378|NCT04330040|594086602|FG002|Overall Study|Lost to Follow-up|0|||
164468379|NCT04330040|594086600|FG000|Overall Study|Death|2|||
164468380|NCT04330040|594086601|FG001|Overall Study|Death|1|||
164468381|NCT04330040|594086602|FG002|Overall Study|Death|0|||
164468382|NCT04330040|594086600|FG000|Overall Study|Withdrawal by Subject|3|||
164468383|NCT04330040|594086601|FG001|Overall Study|Withdrawal by Subject|3|||
164468384|NCT04330040|594086602|FG002|Overall Study|Withdrawal by Subject|0|||
164468385|NCT04330040|594086600|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
164468386|NCT04330040|594086601|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
164468387|NCT04330040|594086602|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
164468388|NCT04330040|594086600|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
164468389|NCT04330040|594086601|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
164468390|NCT04330040|594086602|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
164468391|NCT04330040|594086600|FG000|Overall Study|Other: Disease progression|1|||
164468392|NCT04330040|594086601|FG001|Overall Study|Other: Disease progression|0|||
164468393|NCT04330040|594086602|FG002|Overall Study|Other: Disease progression|0|||
164468394|NCT04330040|594086600|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
164468395|NCT04330040|594086601|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
164468396|NCT04330040|594086602|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
164468397|NCT04330040|594086600|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
164468398|NCT04330040|594086601|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
164468399|NCT04330040|594086602|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
164468400|NCT04330040|594086600|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
164468401|NCT04330040|594086601|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
164468402|NCT04330040|594086602|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
164468403|NCT04230681|594086603|FG000|Overall Study|Physician Decision|2|||
164468404|NCT04230681|594086604|FG001|Overall Study|Physician Decision|3|||
164468405|NCT04230681|594086603|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
164468406|NCT04230681|594086604|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
164468407|NCT04230681|594086603|FG000|Overall Study|IV inadvertently removed|0|||
164468408|NCT04230681|594086604|FG001|Overall Study|IV inadvertently removed|1|||
164468409|NCT05962814|594086605|FG000|Overall Study|failed eligibility|1|||
164468410|NCT04427007|594088394|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
164468411|NCT04427007|594088395|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
164468412|NCT05311176|594088398|FG000|Overall Study|Death|6|||
164468413|NCT05311176|594088398|FG000|Overall Study|Sponsor discontinued the study|1|||
164468414|NCT05247034|594088399|FG000|Overall Study|Lost to Follow-up|3|||
164468415|NCT05247034|594088400|FG001|Overall Study|Lost to Follow-up|2|||
164468416|NCT05247034|594088399|FG000|Overall Study|Organizational problems when attending appointments|1|||
164468417|NCT05247034|594088400|FG001|Overall Study|Organizational problems when attending appointments|0|||
164468418|NCT05464069|594088406|FG000|Overall Study|Protocol Violation|3|||
164468419|NCT05464069|594088407|FG001|Overall Study|Protocol Violation|2|||
164468420|NCT04615273|594088415|FG000|Overall Study|Withdrawal by Subject|3|||
164468421|NCT04615273|594088416|FG001|Overall Study|Withdrawal by Subject|1|||
164468422|NCT04615273|594088417|FG002|Overall Study|Withdrawal by Subject|2|||
164468423|NCT04615273|594088415|FG000|Overall Study|Adverse Event|1|||
164468424|NCT04615273|594088416|FG001|Overall Study|Adverse Event|0|||
164468425|NCT04615273|594088417|FG002|Overall Study|Adverse Event|1|||
164468426|NCT04615273|594088415|FG000|Overall Study|Lost to Follow-up|0|||
164468427|NCT04615273|594088416|FG001|Overall Study|Lost to Follow-up|1|||
164468428|NCT04615273|594088417|FG002|Overall Study|Lost to Follow-up|0|||
164468429|NCT04615273|594088415|FG000|Overall Study|Physician Decision|0|||
164468430|NCT04615273|594088416|FG001|Overall Study|Physician Decision|0|||
164468431|NCT04615273|594088417|FG002|Overall Study|Physician Decision|1|||
164468432|NCT04615273|594088415|FG000|Overall Study|Other|0|||
164468433|NCT04615273|594088416|FG001|Overall Study|Other|1|||
164468434|NCT04615273|594088417|FG002|Overall Study|Other|0|||
164468435|NCT04615273|594088415|FG000|Overall Study|Randomized but not treated|1|||
164468436|NCT04615273|594088416|FG001|Overall Study|Randomized but not treated|3|||
164468437|NCT04615273|594088417|FG002|Overall Study|Randomized but not treated|1|||
164468438|NCT04820322|594088422|FG000|Overall Study|Adverse Event|1|||
164468439|NCT04820322|594088423|FG001|Overall Study|Adverse Event|0|||
164468440|NCT03156465|594088429|FG000|Overall Study|Withdrawal by Subject|2|||
164468441|NCT05524116|594088430|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
164468442|NCT05524116|594088431|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
164468443|NCT05524116|594088430|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
164468444|NCT05524116|594088431|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
164468445|NCT05524116|594088430|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
164468446|NCT05524116|594088431|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
164468447|NCT05524116|594088430|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
164468448|NCT05524116|594088431|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
164468449|NCT05524116|594088430|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
164468450|NCT05524116|594088431|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
164468451|NCT03181516|594088440|FG000|Overall Study|Withdrawal by Subject|14|||
164468452|NCT03181516|594088441|FG001|Overall Study|Withdrawal by Subject|7|||
164468453|NCT03181516|594088440|FG000|Overall Study|Lost to Follow-up|2|||
164468454|NCT03181516|594088441|FG001|Overall Study|Lost to Follow-up|2|||
164468455|NCT04544007|594088447|FG000|Overall Study|Withdrawal by Subject|1|||
164468456|NCT04544007|594088447|FG000|Overall Study|Confirmed Progressive Disease|1|||
164468457|NCT05405985|594088455|FG000|Overall Study|Withdrawal by Subject|1|||
164468458|NCT05405985|594088456|FG001|Overall Study|Withdrawal by Subject|0|||
164468459|NCT02839265|594088457|FG000|Overall Study|Screen Failure|2|||
164468460|NCT02839265|594088457|FG000|Overall Study|Death|1|||
164468461|NCT02839265|594088457|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
164468462|NCT02323880|594088462|FG000|Overall Study|Adverse Event|2|||
164468463|NCT02323880|594088463|FG001|Overall Study|Adverse Event|0|||
164468464|NCT02323880|594088464|FG002|Overall Study|Adverse Event|1|||
164468465|NCT02323880|594088465|FG003|Overall Study|Adverse Event|1|||
164468466|NCT02323880|594088466|FG004|Overall Study|Adverse Event|1|||
164468467|NCT02323880|594088467|FG005|Overall Study|Adverse Event|0|||
164468468|NCT02323880|594088468|FG006|Overall Study|Adverse Event|1|||
164711695|NCT03146962|594968238|FG005|Overall Study|Adverse Event|0|||
164711696|NCT03146962|594968239|FG006|Overall Study|Adverse Event|0|||
164468469|NCT02323880|594088469|FG007|Overall Study|Adverse Event|0|||
164468470|NCT02323880|594088462|FG000|Overall Study|Death|0|||
164468471|NCT02323880|594088463|FG001|Overall Study|Death|0|||
164468472|NCT02323880|594088464|FG002|Overall Study|Death|0|||
164468473|NCT02323880|594088465|FG003|Overall Study|Death|0|||
164468474|NCT02323880|594088466|FG004|Overall Study|Death|0|||
164468475|NCT02323880|594088467|FG005|Overall Study|Death|1|||
164468476|NCT02323880|594088468|FG006|Overall Study|Death|0|||
164468477|NCT02323880|594088469|FG007|Overall Study|Death|0|||
164468478|NCT02323880|594088462|FG000|Overall Study|Lack of Efficacy|4|||
164468479|NCT02323880|594088463|FG001|Overall Study|Lack of Efficacy|11|||
164468480|NCT02323880|594088464|FG002|Overall Study|Lack of Efficacy|5|||
164468481|NCT02323880|594088465|FG003|Overall Study|Lack of Efficacy|5|||
164468482|NCT02323880|594088466|FG004|Overall Study|Lack of Efficacy|4|||
164468483|NCT02323880|594088467|FG005|Overall Study|Lack of Efficacy|8|||
164468484|NCT02323880|594088468|FG006|Overall Study|Lack of Efficacy|4|||
164468485|NCT02323880|594088469|FG007|Overall Study|Lack of Efficacy|6|||
164468486|NCT02323880|594088462|FG000|Overall Study|Physician Decision|0|||
164468487|NCT02323880|594088463|FG001|Overall Study|Physician Decision|0|||
164468488|NCT02323880|594088464|FG002|Overall Study|Physician Decision|0|||
164468489|NCT02323880|594088465|FG003|Overall Study|Physician Decision|0|||
164468490|NCT02323880|594088466|FG004|Overall Study|Physician Decision|1|||
164468491|NCT02323880|594088467|FG005|Overall Study|Physician Decision|1|||
164468492|NCT02323880|594088468|FG006|Overall Study|Physician Decision|1|||
164468493|NCT02323880|594088469|FG007|Overall Study|Physician Decision|0|||
164468494|NCT02323880|594088462|FG000|Overall Study|Withdrawal by Subject|0|||
164468495|NCT02323880|594088463|FG001|Overall Study|Withdrawal by Subject|2|||
164468496|NCT02323880|594088464|FG002|Overall Study|Withdrawal by Subject|0|||
164468497|NCT02323880|594088465|FG003|Overall Study|Withdrawal by Subject|0|||
164468498|NCT02323880|594088466|FG004|Overall Study|Withdrawal by Subject|0|||
164468499|NCT02323880|594088467|FG005|Overall Study|Withdrawal by Subject|0|||
164468500|NCT02323880|594088468|FG006|Overall Study|Withdrawal by Subject|0|||
164468501|NCT02323880|594088469|FG007|Overall Study|Withdrawal by Subject|0|||
164468502|NCT03015532|594088480|FG000|Overall Study|Adverse Event|0|||
164468503|NCT03015532|594088481|FG001|Overall Study|Adverse Event|0|||
164468504|NCT03015532|594088482|FG002|Overall Study|Adverse Event|0|||
164468505|NCT03015532|594088483|FG003|Overall Study|Adverse Event|0|||
164468506|NCT03015532|594088484|FG004|Overall Study|Adverse Event|0|||
164468507|NCT03015532|594088485|FG005|Overall Study|Adverse Event|2|||
164468508|NCT03015532|594088486|FG006|Overall Study|Adverse Event|1|||
164468509|NCT03015532|594088487|FG007|Overall Study|Adverse Event|0|||
164468510|NCT03015532|594088480|FG000|Overall Study|Withdrawal by Subject|0|||
164468511|NCT03015532|594088481|FG001|Overall Study|Withdrawal by Subject|0|||
164468512|NCT03015532|594088482|FG002|Overall Study|Withdrawal by Subject|0|||
164468513|NCT03015532|594088483|FG003|Overall Study|Withdrawal by Subject|0|||
164468514|NCT03015532|594088484|FG004|Overall Study|Withdrawal by Subject|0|||
164468515|NCT03015532|594088485|FG005|Overall Study|Withdrawal by Subject|0|||
164468516|NCT03015532|594088486|FG006|Overall Study|Withdrawal by Subject|1|||
164468517|NCT03015532|594088487|FG007|Overall Study|Withdrawal by Subject|0|||
164468518|NCT03484819|594088488|FG000|Overall Study|Death|2|||
164468519|NCT03484819|594088488|FG000|Overall Study|Adverse Event|2|||
164468520|NCT03484819|594088488|FG000|Overall Study|Physician Decision|1|||
164468521|NCT03484819|594088488|FG000|Overall Study|Withdrawal by Subject|2|||
164468522|NCT03484819|594088488|FG000|Overall Study|Disease Progression|4|||
164468523|NCT03484819|594088488|FG000|Overall Study|Complicating Condition|1|||
164468524|NCT03252288|594088494|FG000|Overall Study|Death|1|||
164468525|NCT03252288|594088495|FG001|Overall Study|Death|0|||
164468526|NCT03252288|594088496|FG002|Overall Study|Death|0|||
164468527|NCT03252288|594088494|FG000|Overall Study|Death|11|||
164468528|NCT03252288|594088495|FG001|Overall Study|Death|0|||
164468529|NCT03252288|594088496|FG002|Overall Study|Death|0|||
164468530|NCT03252288|594088494|FG000|Overall Study|Withdrawal by Subject|2|||
164468531|NCT03252288|594088495|FG001|Overall Study|Withdrawal by Subject|0|||
164468532|NCT03252288|594088496|FG002|Overall Study|Withdrawal by Subject|0|||
164468533|NCT03252288|594088494|FG000|Overall Study|Lost to Follow-up|79|||
164468534|NCT03252288|594088495|FG001|Overall Study|Lost to Follow-up|0|||
164468535|NCT03252288|594088496|FG002|Overall Study|Lost to Follow-up|0|||
164468536|NCT03252288|594088494|FG000|Overall Study|Loss of baseline data on tablets|6|||
164468537|NCT03252288|594088495|FG001|Overall Study|Loss of baseline data on tablets|0|||
164468538|NCT03252288|594088496|FG002|Overall Study|Loss of baseline data on tablets|0|||
164468539|NCT05900154|594088497|FG000|Follow-Up Period|Lost to Follow-up|1|||
164468540|NCT05900154|594088498|FG001|Follow-Up Period|Lost to Follow-up|2|||
164468541|NCT05900154|594088499|FG002|Follow-Up Period|Lost to Follow-up|1|||
164468542|NCT05900154|594088500|FG003|Follow-Up Period|Lost to Follow-up|0|||
164468543|NCT05900154|594088501|FG004|Follow-Up Period|Lost to Follow-up|1|||
164468544|NCT05900154|594088502|FG005|Follow-Up Period|Lost to Follow-up|1|||
164468545|NCT04102111|594088504|FG000|Overall Study|Withdrawal by Subject|2|||
164468546|NCT04102111|594088505|FG001|Overall Study|Withdrawal by Subject|3|||
164468547|NCT04102111|594088504|FG000|Overall Study|Adverse Event|1|||
164468548|NCT04102111|594088505|FG001|Overall Study|Adverse Event|1|||
164468549|NCT04102111|594088504|FG000|Overall Study|Study terminated by sponsor|1|||
164468550|NCT04102111|594088505|FG001|Overall Study|Study terminated by sponsor|3|||
164468551|NCT02542631|594088506|FG000|Overall Study|Adverse Event|1|||
164468552|NCT02542631|594088507|FG001|Overall Study|Adverse Event|1|||
164599648|NCT00089479|594556325|FG000|Overall Study|Withdrawal by Subject|86|||
164599649|NCT00089479|594556326|FG001|Overall Study|Withdrawal by Subject|107|||
164416239|NCT00127413|593893561|FG003|Overall Study|Lost to Follow-up|2|||
164416240|NCT03713021|593893563|FG000|Overall Study|Did not have CT sim scan available|6|||
164416241|NCT03713021|593893563|FG000|Overall Study|Not eligible|4|||
164416242|NCT03713021|593893563|FG000|Overall Study|Issues with TraceIT markers|5|||
164416243|NCT01338012|593893566|FG000|Overall Study|Death|4|||
164416244|NCT01338012|593893566|FG000|Overall Study|Study terminated|4|||
164468553|NCT02542631|594088506|FG000|Overall Study|Sponsor Termination|1|||
164468554|NCT02542631|594088507|FG001|Overall Study|Sponsor Termination|0|||
164468555|NCT02542631|594088506|FG000|Overall Study|Withdrawal by Subject|11|||
164468556|NCT02542631|594088507|FG001|Overall Study|Withdrawal by Subject|16|||
164468557|NCT02542631|594088506|FG000|Overall Study|Protocol Violation|1|||
164468558|NCT02542631|594088507|FG001|Overall Study|Protocol Violation|1|||
164468559|NCT02542631|594088506|FG000|Overall Study|Physician Decision|6|||
164468560|NCT02542631|594088507|FG001|Overall Study|Physician Decision|4|||
164468561|NCT02542631|594088506|FG000|Overall Study|Lost to Follow-up|6|||
164468562|NCT02542631|594088507|FG001|Overall Study|Lost to Follow-up|5|||
164468563|NCT02542631|594088506|FG000|Overall Study|Death|1|||
164468564|NCT02542631|594088507|FG001|Overall Study|Death|2|||
164468565|NCT02542631|594088506|FG000|Overall Study|Other|2|||
164468566|NCT02542631|594088507|FG001|Overall Study|Other|1|||
164468567|NCT02542631|594088506|FG000|Overall Study|Used Prohibited Medication|2|||
164468568|NCT02542631|594088507|FG001|Overall Study|Used Prohibited Medication|1|||
164468569|NCT02641730|594088508|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
164468570|NCT02641730|594088509|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
164468571|NCT02641730|594088510|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
164599650|NCT00089479|594556325|FG000|Overall Study|Lost to Follow-up|137|||
164599651|NCT00089479|594556326|FG001|Overall Study|Lost to Follow-up|107|||
164599652|NCT03337152|594556328|FG000|Overall Study|Physician Decision|1|||
164599653|NCT03337152|594556329|FG001|Overall Study|Physician Decision|0|||
164416245|NCT00154063|593895686|FG000|Overall Study|Adverse Event|4|||
164416246|NCT00154063|593895687|FG001|Overall Study|Adverse Event|8|||
164416247|NCT00154063|593895686|FG000|Overall Study|Protocol Violation|1|||
164416248|NCT00154063|593895687|FG001|Overall Study|Protocol Violation|1|||
164416249|NCT00154063|593895686|FG000|Overall Study|Investigator or Sponsor Request|0|||
164416250|NCT00154063|593895687|FG001|Overall Study|Investigator or Sponsor Request|1|||
164416251|NCT00154063|593895686|FG000|Overall Study|Withdrawal by Subject|4|||
164416252|NCT00154063|593895687|FG001|Overall Study|Withdrawal by Subject|9|||
164416253|NCT00154063|593895686|FG000|Overall Study|Other|3|||
164416254|NCT00154063|593895687|FG001|Overall Study|Other|3|||
164416255|NCT00603265|593895695|FG000|Overall Study|Adverse Event|2|||
164416256|NCT00603265|593895696|FG001|Overall Study|Adverse Event|11|||
164416257|NCT00603265|593895697|FG002|Overall Study|Adverse Event|1|||
164416258|NCT00603265|593895695|FG000|Overall Study|Withdrawal by Subject|1|||
164416259|NCT00603265|593895696|FG001|Overall Study|Withdrawal by Subject|2|||
164416260|NCT00603265|593895697|FG002|Overall Study|Withdrawal by Subject|1|||
164416261|NCT00603265|593895695|FG000|Overall Study|Lack of Efficacy|3|||
164416262|NCT00603265|593895696|FG001|Overall Study|Lack of Efficacy|0|||
164416263|NCT00603265|593895697|FG002|Overall Study|Lack of Efficacy|3|||
164416264|NCT00603265|593895695|FG000|Overall Study|Lost to Follow-up|0|||
164416265|NCT00603265|593895696|FG001|Overall Study|Lost to Follow-up|1|||
164416266|NCT00603265|593895697|FG002|Overall Study|Lost to Follow-up|0|||
164416267|NCT00603265|593895695|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
164416268|NCT00603265|593895696|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
164416269|NCT00603265|593895697|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
164416270|NCT00603265|593895695|FG000|Overall Study|Participant Left Country, No Responses|0|||
164468572|NCT02641730|594088511|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
164468573|NCT02641730|594088512|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
164599654|NCT03337152|594556328|FG000|Overall Study|Lost to Follow-up|1|||
164599655|NCT03337152|594556329|FG001|Overall Study|Lost to Follow-up|3|||
164599656|NCT03337152|594556328|FG000|Overall Study|Adverse Event|3|||
164599657|NCT03337152|594556329|FG001|Overall Study|Adverse Event|1|||
164599658|NCT03337152|594556328|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
164599659|NCT03337152|594556329|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
164599660|NCT00421343|594556330|FG000|Overall Study|Death|1|||
164599661|NCT00421343|594556330|FG000|Overall Study|Withdrawal by Subject|2|||
164599662|NCT00421343|594556330|FG000|Overall Study|Lost to Follow-up|3|||
164599663|NCT00678587|594556331|FG000|Overall Study|Adverse Event|3|||
164711697|NCT03146962|594968240|FG007|Overall Study|Adverse Event|1|||
164711698|NCT03146962|594968241|FG008|Overall Study|Adverse Event|0|||
164711699|NCT03146962|594968242|FG009|Overall Study|Adverse Event|0|||
164711700|NCT03146962|594968233|FG000|Overall Study|Withdrawal by Subject|0|||
164711701|NCT03146962|594968234|FG001|Overall Study|Withdrawal by Subject|0|||
164711702|NCT03146962|594968235|FG002|Overall Study|Withdrawal by Subject|0|||
164711703|NCT03146962|594968236|FG003|Overall Study|Withdrawal by Subject|0|||
164711704|NCT03146962|594968237|FG004|Overall Study|Withdrawal by Subject|1|||
164711705|NCT03146962|594968238|FG005|Overall Study|Withdrawal by Subject|0|||
164711706|NCT03146962|594968239|FG006|Overall Study|Withdrawal by Subject|0|||
164416271|NCT00603265|593895696|FG001|Overall Study|Participant Left Country, No Responses|1|||
164416272|NCT00603265|593895697|FG002|Overall Study|Participant Left Country, No Responses|0|||
164416273|NCT00603265|593895695|FG000|Overall Study|Protocol Violation|1|||
164416274|NCT00603265|593895696|FG001|Overall Study|Protocol Violation|0|||
164416275|NCT00603265|593895697|FG002|Overall Study|Protocol Violation|0|||
164416276|NCT01912781|593895702|FG000|Overall Study|Withdrawal by Subject|2|||
164416277|NCT01912781|593895703|FG001|Overall Study|Withdrawal by Subject|0|||
164416278|NCT03377790|593895706|FG000|Overall Study|Withdrawal by Subject|1|||
164416279|NCT03377790|593895707|FG001|Overall Study|Withdrawal by Subject|0|||
164416280|NCT03377790|593895706|FG000|Overall Study|Adverse Event|1|||
164416281|NCT03377790|593895707|FG001|Overall Study|Adverse Event|0|||
164416282|NCT03377790|593895706|FG000|Overall Study|Lost to Follow-up|0|||
164416283|NCT03377790|593895707|FG001|Overall Study|Lost to Follow-up|2|||
164416284|NCT03377790|593895706|FG000|Overall Study|Randomized but not treated|1|||
164416285|NCT03377790|593895707|FG001|Overall Study|Randomized but not treated|0|||
164416286|NCT03377790|593895706|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
164416287|NCT03377790|593895707|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
164416288|NCT02564055|593895708|FG000|Overall Study|Adverse Event|1|||
164416289|NCT02564055|593895709|FG001|Overall Study|Adverse Event|0|||
164416290|NCT02564055|593895710|FG002|Overall Study|Adverse Event|4|||
164416291|NCT02564055|593895711|FG003|Overall Study|Adverse Event|1|||
164416292|NCT02564055|593895712|FG004|Overall Study|Adverse Event|4|||
164416293|NCT02564055|593895713|FG005|Overall Study|Adverse Event|1|||
164416294|NCT02564055|593895708|FG000|Overall Study|Protocol Violation|1|||
164416295|NCT02564055|593895709|FG001|Overall Study|Protocol Violation|0|||
164416296|NCT02564055|593895710|FG002|Overall Study|Protocol Violation|0|||
164416297|NCT02564055|593895711|FG003|Overall Study|Protocol Violation|0|||
164416298|NCT02564055|593895712|FG004|Overall Study|Protocol Violation|0|||
164416299|NCT02564055|593895713|FG005|Overall Study|Protocol Violation|0|||
164416300|NCT02564055|593895708|FG000|Overall Study|Reached stopping criteria|0|||
164416301|NCT02564055|593895709|FG001|Overall Study|Reached stopping criteria|0|||
164468574|NCT02641730|594088508|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
164468575|NCT02641730|594088509|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
164468576|NCT02641730|594088510|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
164468577|NCT02641730|594088511|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
164468578|NCT02641730|594088512|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
164468579|NCT02641730|594088508|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
164468580|NCT02641730|594088509|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
164468581|NCT02641730|594088510|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
164468582|NCT02641730|594088511|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
164468583|NCT02641730|594088512|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
164468584|NCT02641730|594088508|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
164468585|NCT02641730|594088509|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
164468586|NCT02641730|594088510|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
164468587|NCT02641730|594088511|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
164468588|NCT02641730|594088512|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
164468589|NCT02641730|594088508|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
164468590|NCT02641730|594088509|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
164468591|NCT02641730|594088510|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
164468592|NCT02641730|594088511|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
164468593|NCT02641730|594088512|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
164468594|NCT02641730|594088508|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
164468595|NCT02641730|594088509|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
164599664|NCT00678587|594556332|FG001|Overall Study|Adverse Event|3|||
164416302|NCT02564055|593895710|FG002|Overall Study|Reached stopping criteria|0|||
164416303|NCT02564055|593895711|FG003|Overall Study|Reached stopping criteria|0|||
164416304|NCT02564055|593895712|FG004|Overall Study|Reached stopping criteria|0|||
164416305|NCT02564055|593895713|FG005|Overall Study|Reached stopping criteria|1|||
164416306|NCT02564055|593895708|FG000|Overall Study|Lost to Follow-up|0|||
164416307|NCT02564055|593895709|FG001|Overall Study|Lost to Follow-up|1|||
164416308|NCT02564055|593895710|FG002|Overall Study|Lost to Follow-up|4|||
164416309|NCT02564055|593895711|FG003|Overall Study|Lost to Follow-up|2|||
164416310|NCT02564055|593895712|FG004|Overall Study|Lost to Follow-up|1|||
164416311|NCT02564055|593895713|FG005|Overall Study|Lost to Follow-up|0|||
164599665|NCT00678587|594556331|FG000|Overall Study|Lack of Efficacy|1|||
164416312|NCT02564055|593895708|FG000|Overall Study|Physician Decision|0|||
164416313|NCT02564055|593895709|FG001|Overall Study|Physician Decision|0|||
164416314|NCT02564055|593895710|FG002|Overall Study|Physician Decision|1|||
164416315|NCT02564055|593895711|FG003|Overall Study|Physician Decision|0|||
164416316|NCT02564055|593895712|FG004|Overall Study|Physician Decision|0|||
164416317|NCT02564055|593895713|FG005|Overall Study|Physician Decision|0|||
164416318|NCT02564055|593895708|FG000|Overall Study|Withdrawal by Subject|4|||
164416319|NCT02564055|593895709|FG001|Overall Study|Withdrawal by Subject|4|||
164416320|NCT02564055|593895710|FG002|Overall Study|Withdrawal by Subject|3|||
164468596|NCT02641730|594088510|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
164468597|NCT02641730|594088511|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
164468598|NCT02641730|594088512|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
164468599|NCT05460871|594088513|FG000|Overall Study|Withdrawal by Subject|1|||
164468600|NCT05460871|594088514|FG001|Overall Study|Withdrawal by Subject|2|||
164468601|NCT04129554|594088516|FG000|Overall Study|Withdrawal by Subject|4|||
164468602|NCT04129554|594088517|FG001|Overall Study|Withdrawal by Subject|3|||
164468603|NCT04129554|594088516|FG000|Overall Study|Other|0|||
164468604|NCT04129554|594088517|FG001|Overall Study|Other|2|||
164468605|NCT03663205|594088518|FG000|Overall Study|Death|144|||
164468606|NCT03663205|594088519|FG001|Overall Study|Death|69|||
164468607|NCT03663205|594088518|FG000|Overall Study|Sponsor decision|53|||
164468608|NCT03663205|594088519|FG001|Overall Study|Sponsor decision|19|||
164468609|NCT03663205|594088518|FG000|Overall Study|Withdrawal by Subject|8|||
164468610|NCT03663205|594088519|FG001|Overall Study|Withdrawal by Subject|11|||
164468611|NCT03663205|594088518|FG000|Overall Study|Lost to Follow-up|7|||
164468612|NCT03663205|594088519|FG001|Overall Study|Lost to Follow-up|9|||
164468613|NCT03663205|594088518|FG000|Overall Study|Transferred to long term extension study|11|||
164468614|NCT03663205|594088519|FG001|Overall Study|Transferred to long term extension study|3|||
164468615|NCT03245840|594088524|FG000|Overall Study|Adverse Event|6|||
164468616|NCT03245840|594088525|FG001|Overall Study|Adverse Event|0|||
164468617|NCT03245840|594088524|FG000|Overall Study|Death|2|||
164468618|NCT03245840|594088525|FG001|Overall Study|Death|0|||
164468619|NCT03245840|594088524|FG000|Overall Study|Withdrawal by Subject|31|||
164468620|NCT03245840|594088525|FG001|Overall Study|Withdrawal by Subject|1|||
164468621|NCT03245840|594088524|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
164468622|NCT03245840|594088525|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164468623|NCT03245840|594088524|FG000|Overall Study|Physician Decision|4|||
164468624|NCT03245840|594088525|FG001|Overall Study|Physician Decision|1|||
164468625|NCT03245840|594088524|FG000|Overall Study|Study Terminated by Sponsor|56|||
164468626|NCT03245840|594088525|FG001|Overall Study|Study Terminated by Sponsor|6|||
164468627|NCT03245840|594088524|FG000|Overall Study|Site Terminated by Sponsor|4|||
164468628|NCT03245840|594088525|FG001|Overall Study|Site Terminated by Sponsor|0|||
164468629|NCT03245840|594088524|FG000|Overall Study|Lost to Follow-up|12|||
164468630|NCT03245840|594088525|FG001|Overall Study|Lost to Follow-up|2|||
164468631|NCT03245840|594088524|FG000|Overall Study|Pregnancy|2|||
164468632|NCT03245840|594088525|FG001|Overall Study|Pregnancy|0|||
164468633|NCT03245840|594088524|FG000|Overall Study|Non-Compliance with Study Drug|2|||
164468634|NCT03245840|594088525|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164468635|NCT03245840|594088524|FG000|Overall Study|Not treated|1|||
164468636|NCT03245840|594088525|FG001|Overall Study|Not treated|1|||
164468637|NCT03582033|594088526|FG000|Part A|Other|0|||
164468638|NCT03582033|594088527|FG001|Part A|Other|0|||
164468639|NCT03582033|594088528|FG002|Part A|Other|0|||
164468640|NCT03582033|594088529|FG003|Part A|Other|0|||
164468641|NCT03582033|594088530|FG004|Part A|Other|2|||
164468642|NCT03582033|594088531|FG005|Part A|Other|0|||
164468643|NCT03582033|594088532|FG006|Part A|Other|0|||
164468644|NCT03582033|594088533|FG007|Part A|Other|0|||
164468645|NCT03582033|594088534|FG008|Part A|Other|0|||
164468646|NCT03582033|594088535|FG009|Part A|Other|0|||
164468647|NCT03582033|594088526|FG000|Part A|Death|1|||
164468648|NCT03582033|594088527|FG001|Part A|Death|1|||
164468649|NCT03582033|594088528|FG002|Part A|Death|2|||
164468650|NCT03582033|594088529|FG003|Part A|Death|4|||
164468651|NCT03582033|594088530|FG004|Part A|Death|11|||
164468652|NCT03582033|594088531|FG005|Part A|Death|0|||
164468653|NCT03582033|594088532|FG006|Part A|Death|0|||
164468654|NCT03582033|594088533|FG007|Part A|Death|0|||
164468655|NCT03582033|594088534|FG008|Part A|Death|0|||
164468656|NCT03582033|594088535|FG009|Part A|Death|0|||
164468657|NCT03582033|594088526|FG000|Part A|Lost to Follow-up|0|||
164468658|NCT03582033|594088527|FG001|Part A|Lost to Follow-up|0|||
164468659|NCT03582033|594088528|FG002|Part A|Lost to Follow-up|0|||
164468660|NCT03582033|594088529|FG003|Part A|Lost to Follow-up|0|||
164468661|NCT03582033|594088530|FG004|Part A|Lost to Follow-up|1|||
164468662|NCT03582033|594088531|FG005|Part A|Lost to Follow-up|0|||
164468663|NCT03582033|594088532|FG006|Part A|Lost to Follow-up|0|||
164468664|NCT03582033|594088533|FG007|Part A|Lost to Follow-up|0|||
164468665|NCT03582033|594088534|FG008|Part A|Lost to Follow-up|0|||
164468666|NCT03582033|594088535|FG009|Part A|Lost to Follow-up|0|||
164468667|NCT03582033|594088526|FG000|Part A|Study terminated by sponsor|0|||
164468668|NCT03582033|594088527|FG001|Part A|Study terminated by sponsor|0|||
164468669|NCT03582033|594088528|FG002|Part A|Study terminated by sponsor|0|||
164468670|NCT03582033|594088529|FG003|Part A|Study terminated by sponsor|2|||
164468671|NCT03582033|594088530|FG004|Part A|Study terminated by sponsor|1|||
164468672|NCT03582033|594088531|FG005|Part A|Study terminated by sponsor|0|||
164468673|NCT03582033|594088532|FG006|Part A|Study terminated by sponsor|0|||
164468674|NCT03582033|594088533|FG007|Part A|Study terminated by sponsor|0|||
164468675|NCT03582033|594088534|FG008|Part A|Study terminated by sponsor|0|||
164468676|NCT03582033|594088535|FG009|Part A|Study terminated by sponsor|0|||
164468677|NCT03582033|594088526|FG000|Part A|Withdrawal by Subject|1|||
164468678|NCT03582033|594088527|FG001|Part A|Withdrawal by Subject|1|||
164468679|NCT03582033|594088528|FG002|Part A|Withdrawal by Subject|0|||
164468680|NCT03582033|594088529|FG003|Part A|Withdrawal by Subject|1|||
164468681|NCT03582033|594088530|FG004|Part A|Withdrawal by Subject|7|||
164468682|NCT03582033|594088531|FG005|Part A|Withdrawal by Subject|0|||
164468683|NCT03582033|594088532|FG006|Part A|Withdrawal by Subject|0|||
164468684|NCT03582033|594088533|FG007|Part A|Withdrawal by Subject|0|||
164468685|NCT03582033|594088534|FG008|Part A|Withdrawal by Subject|0|||
164468686|NCT03582033|594088535|FG009|Part A|Withdrawal by Subject|0|||
164468687|NCT03582033|594088526|FG000|Part B|Death|0|||
164468688|NCT03582033|594088527|FG001|Part B|Death|0|||
164468689|NCT03582033|594088528|FG002|Part B|Death|0|||
164468690|NCT03582033|594088529|FG003|Part B|Death|0|||
164468691|NCT03582033|594088530|FG004|Part B|Death|0|||
164468692|NCT03582033|594088531|FG005|Part B|Death|2|||
164468693|NCT03582033|594088532|FG006|Part B|Death|0|||
164468694|NCT03582033|594088533|FG007|Part B|Death|0|||
164468695|NCT03582033|594088534|FG008|Part B|Death|0|||
164468696|NCT03582033|594088535|FG009|Part B|Death|0|||
164468697|NCT03582033|594088526|FG000|Part B|Study terminated by sponsor|0|||
164468698|NCT03582033|594088527|FG001|Part B|Study terminated by sponsor|0|||
164468699|NCT03582033|594088528|FG002|Part B|Study terminated by sponsor|0|||
164468700|NCT03582033|594088529|FG003|Part B|Study terminated by sponsor|0|||
164468701|NCT03582033|594088530|FG004|Part B|Study terminated by sponsor|0|||
164468702|NCT03582033|594088531|FG005|Part B|Study terminated by sponsor|12|||
164468703|NCT03582033|594088532|FG006|Part B|Study terminated by sponsor|0|||
164468704|NCT03582033|594088533|FG007|Part B|Study terminated by sponsor|0|||
164468705|NCT03582033|594088534|FG008|Part B|Study terminated by sponsor|0|||
164468706|NCT03582033|594088535|FG009|Part B|Study terminated by sponsor|0|||
164468707|NCT03582033|594088526|FG000|Part B|Withdrawal by Subject|0|||
164468708|NCT03582033|594088527|FG001|Part B|Withdrawal by Subject|0|||
164468709|NCT03582033|594088528|FG002|Part B|Withdrawal by Subject|0|||
164468710|NCT03582033|594088529|FG003|Part B|Withdrawal by Subject|0|||
164468711|NCT03582033|594088530|FG004|Part B|Withdrawal by Subject|0|||
164468712|NCT03582033|594088531|FG005|Part B|Withdrawal by Subject|6|||
164468713|NCT03582033|594088532|FG006|Part B|Withdrawal by Subject|0|||
164468714|NCT03582033|594088533|FG007|Part B|Withdrawal by Subject|0|||
164468715|NCT03582033|594088534|FG008|Part B|Withdrawal by Subject|0|||
164468716|NCT03582033|594088535|FG009|Part B|Withdrawal by Subject|0|||
164468717|NCT03582033|594088526|FG000|Part C|Other|0|||
164468718|NCT03582033|594088527|FG001|Part C|Other|0|||
164468719|NCT03582033|594088528|FG002|Part C|Other|0|||
164468720|NCT03582033|594088529|FG003|Part C|Other|0|||
164468721|NCT03582033|594088530|FG004|Part C|Other|0|||
164468722|NCT03582033|594088531|FG005|Part C|Other|0|||
164468723|NCT03582033|594088532|FG006|Part C|Other|2|||
164468724|NCT03582033|594088533|FG007|Part C|Other|0|||
164468725|NCT03582033|594088534|FG008|Part C|Other|0|||
164468726|NCT03582033|594088535|FG009|Part C|Other|0|||
164468727|NCT03582033|594088526|FG000|Part C|Death|0|||
164468728|NCT03582033|594088527|FG001|Part C|Death|0|||
164468729|NCT03582033|594088528|FG002|Part C|Death|0|||
164468730|NCT03582033|594088529|FG003|Part C|Death|0|||
164468731|NCT03582033|594088530|FG004|Part C|Death|0|||
164468732|NCT03582033|594088531|FG005|Part C|Death|0|||
164468733|NCT03582033|594088532|FG006|Part C|Death|6|||
164468734|NCT03582033|594088533|FG007|Part C|Death|1|||
164468735|NCT03582033|594088534|FG008|Part C|Death|2|||
164468736|NCT03582033|594088535|FG009|Part C|Death|0|||
164468737|NCT03582033|594088526|FG000|Part C|Study terminated by sponsor|0|||
164468738|NCT03582033|594088527|FG001|Part C|Study terminated by sponsor|0|||
164468739|NCT03582033|594088528|FG002|Part C|Study terminated by sponsor|0|||
164468740|NCT03582033|594088529|FG003|Part C|Study terminated by sponsor|0|||
164468741|NCT03582033|594088530|FG004|Part C|Study terminated by sponsor|0|||
164468742|NCT03582033|594088531|FG005|Part C|Study terminated by sponsor|0|||
164468743|NCT03582033|594088532|FG006|Part C|Study terminated by sponsor|3|||
164468744|NCT03582033|594088533|FG007|Part C|Study terminated by sponsor|3|||
164468745|NCT03582033|594088534|FG008|Part C|Study terminated by sponsor|2|||
164468746|NCT03582033|594088535|FG009|Part C|Study terminated by sponsor|0|||
164468747|NCT03582033|594088526|FG000|Part C|Withdrawal by Subject|0|||
164468748|NCT03582033|594088527|FG001|Part C|Withdrawal by Subject|0|||
164468749|NCT03582033|594088528|FG002|Part C|Withdrawal by Subject|0|||
164468750|NCT03582033|594088529|FG003|Part C|Withdrawal by Subject|0|||
164468751|NCT03582033|594088530|FG004|Part C|Withdrawal by Subject|0|||
164468752|NCT03582033|594088531|FG005|Part C|Withdrawal by Subject|0|||
164468753|NCT03582033|594088532|FG006|Part C|Withdrawal by Subject|1|||
164468754|NCT03582033|594088533|FG007|Part C|Withdrawal by Subject|2|||
164468755|NCT03582033|594088534|FG008|Part C|Withdrawal by Subject|1|||
164468756|NCT03582033|594088535|FG009|Part C|Withdrawal by Subject|0|||
164468757|NCT03582033|594088526|FG000|Part D|Death|0|||
164468758|NCT03582033|594088527|FG001|Part D|Death|0|||
164468759|NCT03582033|594088528|FG002|Part D|Death|0|||
164468760|NCT03582033|594088529|FG003|Part D|Death|0|||
164468761|NCT03582033|594088530|FG004|Part D|Death|0|||
164468762|NCT03582033|594088531|FG005|Part D|Death|0|||
164468763|NCT03582033|594088532|FG006|Part D|Death|0|||
164468764|NCT03582033|594088533|FG007|Part D|Death|0|||
164468765|NCT03582033|594088534|FG008|Part D|Death|0|||
164468766|NCT03582033|594088535|FG009|Part D|Death|1|||
164468767|NCT03582033|594088526|FG000|Part D|Study terminated by sponsor|0|||
164468768|NCT03582033|594088527|FG001|Part D|Study terminated by sponsor|0|||
164468769|NCT03582033|594088528|FG002|Part D|Study terminated by sponsor|0|||
164468770|NCT03582033|594088529|FG003|Part D|Study terminated by sponsor|0|||
164468771|NCT03582033|594088530|FG004|Part D|Study terminated by sponsor|0|||
164468772|NCT03582033|594088531|FG005|Part D|Study terminated by sponsor|0|||
164468773|NCT03582033|594088532|FG006|Part D|Study terminated by sponsor|0|||
164468774|NCT03582033|594088533|FG007|Part D|Study terminated by sponsor|0|||
164468775|NCT03582033|594088534|FG008|Part D|Study terminated by sponsor|0|||
164468776|NCT03582033|594088535|FG009|Part D|Study terminated by sponsor|4|||
164468777|NCT06010836|594088536|FG000|Overall Study|Lost to Follow-up|2|||
164468778|NCT06010836|594088537|FG001|Overall Study|Lost to Follow-up|2|||
164468779|NCT06010836|594088536|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
164468780|NCT06010836|594088537|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
164468781|NCT06010836|594088536|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
164468782|NCT06010836|594088537|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
164468783|NCT06010836|594088536|FG000|Overall Study|Did not receive intervention discussion|0|||
164468784|NCT06010836|594088537|FG001|Overall Study|Did not receive intervention discussion|4|||
164468785|NCT03812614|594088538|FG000|Intervention|Withdrawal by Subject|7|||
164468786|NCT03812614|594088539|FG001|Intervention|Withdrawal by Subject|2|||
164468787|NCT03812614|594088540|FG002|Intervention|Withdrawal by Subject|7|||
164468788|NCT03812614|594088541|FG003|Intervention|Withdrawal by Subject|2|||
164468789|NCT03812614|594088538|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
164468790|NCT03812614|594088539|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
164468791|NCT03812614|594088540|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
164468792|NCT03812614|594088541|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
164468793|NCT03812614|594088538|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
164468794|NCT03812614|594088539|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
164468795|NCT03812614|594088540|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
164468796|NCT03812614|594088541|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
164468797|NCT03812614|594088538|FG000|6-month Follow-up|Lost to Follow-up|0|||
164468798|NCT03812614|594088539|FG001|6-month Follow-up|Lost to Follow-up|0|||
164468799|NCT03812614|594088540|FG002|6-month Follow-up|Lost to Follow-up|12|||
164468800|NCT03812614|594088541|FG003|6-month Follow-up|Lost to Follow-up|8|||
164468801|NCT03812614|594088538|FG000|12-month Follow-up|Lost to Follow-up|18|||
164468802|NCT03812614|594088539|FG001|12-month Follow-up|Lost to Follow-up|17|||
164468803|NCT03812614|594088540|FG002|12-month Follow-up|Lost to Follow-up|5|||
164468804|NCT03812614|594088541|FG003|12-month Follow-up|Lost to Follow-up|2|||
164468805|NCT04206787|594088545|FG000|Overall Study|Other than listed|2|||
164468806|NCT04206787|594088545|FG000|Overall Study|Investigator decision|1|||
164468807|NCT04206787|594088545|FG000|Overall Study|Death|25|||
164468808|NCT04206787|594088545|FG000|Overall Study|Lost to Follow-up|9|||
164468809|NCT04206787|594088545|FG000|Overall Study|Withdrawal of consent|9|||
164468810|NCT05008055|594088546|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
164468811|NCT05008055|594088547|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
164468812|NCT05008055|594088548|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
164468813|NCT03011034|594088557|FG000|Overall Study|Adverse Event|1|||
164468814|NCT03011034|594088558|FG001|Overall Study|Adverse Event|0|||
164468815|NCT03735979|594088566|FG000|Overall Study|Lost to Follow-up|1|||
164468816|NCT03735979|594088567|FG001|Overall Study|Lost to Follow-up|12|||
164468817|NCT03735979|594088568|FG002|Overall Study|Lost to Follow-up|14|||
164468818|NCT03735979|594088566|FG000|Overall Study|Withdrawal by Subject|1|||
164468819|NCT03735979|594088567|FG001|Overall Study|Withdrawal by Subject|5|||
164468820|NCT03735979|594088568|FG002|Overall Study|Withdrawal by Subject|2|||
164468821|NCT03735979|594088566|FG000|Overall Study|Not due to the above reasons|1|||
164468822|NCT03735979|594088567|FG001|Overall Study|Not due to the above reasons|0|||
164468823|NCT03735979|594088568|FG002|Overall Study|Not due to the above reasons|0|||
164468824|NCT03057054|594088569|FG000|Overall Study|Death|4|||
164468825|NCT03057054|594088570|FG001|Overall Study|Death|4|||
164468826|NCT03057054|594088569|FG000|Overall Study|Withdrawal by Subject|6|||
164468827|NCT03057054|594088570|FG001|Overall Study|Withdrawal by Subject|3|||
164468828|NCT03057054|594088569|FG000|Overall Study|Ineligible|1|||
164468829|NCT03057054|594088570|FG001|Overall Study|Ineligible|1|||
164468830|NCT06106022|594089480|FG000|Overall Study|Lost to Follow-up|1|||
164468831|NCT06106022|594089481|FG001|Overall Study|Lost to Follow-up|0|||
164468832|NCT06106022|594089480|FG000|Overall Study|Voluntary Withdrawal|0|||
164468833|NCT06106022|594089481|FG001|Overall Study|Voluntary Withdrawal|2|||
164468834|NCT03640286|594089482|FG000|Overall Study|Adverse Event|6|||
164416321|NCT02564055|593895711|FG003|Overall Study|Withdrawal by Subject|3|||
164416322|NCT02564055|593895712|FG004|Overall Study|Withdrawal by Subject|10|||
164416323|NCT02564055|593895713|FG005|Overall Study|Withdrawal by Subject|10|||
164416324|NCT00919893|593895715|FG000|Overall Study|Protocol Violation|19|||
164416325|NCT00919893|593895716|FG001|Overall Study|Protocol Violation|9|||
164416326|NCT00365378|593895724|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
164416327|NCT00365378|593895725|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
164416328|NCT00365378|593895726|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
164416329|NCT00365378|593895724|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
164416330|NCT00365378|593895725|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
164416331|NCT00365378|593895726|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
164416332|NCT00365378|593895724|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
164416333|NCT00365378|593895725|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
164416334|NCT00365378|593895726|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
164416335|NCT00365378|593895724|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
164416336|NCT00365378|593895725|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
164416337|NCT00365378|593895726|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
164416338|NCT00365378|593895724|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
164416339|NCT00365378|593895725|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
164416340|NCT00365378|593895726|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
164416341|NCT00365378|593895724|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
164416342|NCT00365378|593895725|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
164416343|NCT00365378|593895726|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
164416344|NCT00365378|593895724|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
164416345|NCT00365378|593895725|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
164416346|NCT00365378|593895726|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
164416347|NCT00365378|593895724|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
164416348|NCT00365378|593895725|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
164416349|NCT00365378|593895726|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
164416350|NCT00365378|593895724|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
164416351|NCT00365378|593895725|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
164416352|NCT00365378|593895726|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
164416353|NCT00365378|593895724|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
164416354|NCT00365378|593895725|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
164416355|NCT00365378|593895726|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
164416356|NCT00365378|593895724|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
164416357|NCT00365378|593895725|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
164416358|NCT00365378|593895726|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
164416359|NCT00365378|593895724|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
164416360|NCT00365378|593895725|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
164416361|NCT00365378|593895726|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
164416362|NCT00365378|593895724|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
164416363|NCT00365378|593895725|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
164416364|NCT00365378|593895726|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
164416365|NCT00365378|593895724|FG000|Extension|Adverse Event|0|||
164416366|NCT00365378|593895725|FG001|Extension|Adverse Event|0|||
164416367|NCT00365378|593895726|FG002|Extension|Adverse Event|1|||
164416368|NCT00365378|593895724|FG000|Extension|Moved|0|||
164416369|NCT00365378|593895725|FG001|Extension|Moved|0|||
164416370|NCT00365378|593895726|FG002|Extension|Moved|8|||
164416371|NCT00365378|593895724|FG000|Extension|Lost to Follow-up|0|||
164416372|NCT00365378|593895725|FG001|Extension|Lost to Follow-up|0|||
164416373|NCT00365378|593895726|FG002|Extension|Lost to Follow-up|57|||
164416374|NCT00365378|593895724|FG000|Extension|Protocol Violation|0|||
164416375|NCT00365378|593895725|FG001|Extension|Protocol Violation|0|||
164416376|NCT00365378|593895726|FG002|Extension|Protocol Violation|2|||
164711707|NCT03146962|594968240|FG007|Overall Study|Withdrawal by Subject|0|||
164711708|NCT03146962|594968241|FG008|Overall Study|Withdrawal by Subject|0|||
164711709|NCT03146962|594968242|FG009|Overall Study|Withdrawal by Subject|0|||
164711710|NCT03146962|594968233|FG000|Overall Study|Death|0|||
164711711|NCT03146962|594968234|FG001|Overall Study|Death|1|||
164711712|NCT03146962|594968235|FG002|Overall Study|Death|0|||
164416377|NCT00365378|593895724|FG000|Extension|Withdrawal by Subject|0|||
164416378|NCT00365378|593895725|FG001|Extension|Withdrawal by Subject|0|||
164416379|NCT00365378|593895726|FG002|Extension|Withdrawal by Subject|98|||
164416380|NCT00365378|593895724|FG000|Extension|Other|0|||
164416381|NCT00365378|593895725|FG001|Extension|Other|0|||
164416382|NCT00365378|593895726|FG002|Extension|Other|31|||
164416383|NCT04741802|593895727|FG000|Overall Study|Death|1|||
164416384|NCT04741802|593895727|FG000|Overall Study|Lost to Follow-up|11|||
164416385|NCT04161807|593895733|FG000|Overall Study|Withdrawal by Subject|2|||
164416386|NCT04161807|593895733|FG000|Overall Study|Performed only 1 treatment|2|||
164416387|NCT00708305|593895736|FG000|Period 1|Protocol Violation|1|||
164711713|NCT03146962|594968236|FG003|Overall Study|Death|0|||
164711714|NCT03146962|594968237|FG004|Overall Study|Death|0|||
164711715|NCT03146962|594968238|FG005|Overall Study|Death|0|||
164468835|NCT03640286|594089483|FG001|Overall Study|Adverse Event|6|||
164468836|NCT03640286|594089482|FG000|Overall Study|Lost to Follow-up|3|||
164468837|NCT03640286|594089483|FG001|Overall Study|Lost to Follow-up|6|||
164468838|NCT03640286|594089482|FG000|Overall Study|Pregnancy|1|||
164468839|NCT03640286|594089483|FG001|Overall Study|Pregnancy|0|||
164468840|NCT03640286|594089482|FG000|Overall Study|Withdrawal by Subject|10|||
164468841|NCT03640286|594089483|FG001|Overall Study|Withdrawal by Subject|10|||
164468842|NCT03640286|594089482|FG000|Overall Study|Non-compliance|4|||
164468843|NCT03640286|594089483|FG001|Overall Study|Non-compliance|10|||
164468844|NCT03640286|594089482|FG000|Overall Study|Medication change|1|||
164468845|NCT03640286|594089483|FG001|Overall Study|Medication change|0|||
164468846|NCT03640286|594089482|FG000|Overall Study|Other|1|||
164468847|NCT03640286|594089483|FG001|Overall Study|Other|2|||
164468848|NCT03640286|594089482|FG000|Overall Study|Joined another lifestyle program|0|||
164468849|NCT03640286|594089483|FG001|Overall Study|Joined another lifestyle program|1|||
164468850|NCT04389957|594089484|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
164468851|NCT04389957|594089485|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
164468852|NCT04389957|594089486|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
164468853|NCT04389957|594089487|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
164468854|NCT04389957|594089488|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
164468855|NCT01820611|594089490|FG000|Overall Study|Death|8|||
164468856|NCT01820611|594089490|FG000|Overall Study|Adverse Event|1|||
164468857|NCT01820611|594089490|FG000|Overall Study|Withdrawal by Subject|9|||
164468858|NCT05013385|594089492|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
164416388|NCT00708305|593895737|FG001|Period 1|Protocol Violation|0|||
164416389|NCT00708305|593895738|FG002|Period 1|Protocol Violation|1|||
164416390|NCT00708305|593895739|FG003|Period 1|Protocol Violation|0|||
164416391|NCT00708305|593895736|FG000|Period 1|Other Reason|0|||
164416392|NCT00708305|593895737|FG001|Period 1|Other Reason|0|||
164416393|NCT00708305|593895738|FG002|Period 1|Other Reason|0|||
164416394|NCT00708305|593895739|FG003|Period 1|Other Reason|2|||
164416395|NCT00708305|593895736|FG000|Period 2|Lost to Follow-up|0|||
164416396|NCT00708305|593895737|FG001|Period 2|Lost to Follow-up|1|||
164416397|NCT00708305|593895738|FG002|Period 2|Lost to Follow-up|0|||
164416398|NCT00708305|593895739|FG003|Period 2|Lost to Follow-up|0|||
164416399|NCT00708305|593895736|FG000|Period 2|Protocol Violation|0|||
164416400|NCT00708305|593895737|FG001|Period 2|Protocol Violation|1|||
164416401|NCT00708305|593895738|FG002|Period 2|Protocol Violation|0|||
164416402|NCT00708305|593895739|FG003|Period 2|Protocol Violation|0|||
164416403|NCT00708305|593895736|FG000|Period 2|Other Reason|1|||
164416404|NCT00708305|593895737|FG001|Period 2|Other Reason|0|||
164416405|NCT00708305|593895738|FG002|Period 2|Other Reason|0|||
164416406|NCT00708305|593895739|FG003|Period 2|Other Reason|1|||
164416407|NCT00708305|593895736|FG000|Period 3|Protocol Violation|0|||
164416408|NCT00708305|593895737|FG001|Period 3|Protocol Violation|2|||
164416409|NCT00708305|593895738|FG002|Period 3|Protocol Violation|0|||
164416410|NCT00708305|593895739|FG003|Period 3|Protocol Violation|0|||
164416411|NCT00708305|593895736|FG000|Period 3|Other Reason|1|||
164416412|NCT00708305|593895737|FG001|Period 3|Other Reason|0|||
164416413|NCT00708305|593895738|FG002|Period 3|Other Reason|0|||
164468859|NCT01447719|594089493|FG000|Overall Study|Image acquisition failure|2|||
164468860|NCT01447719|594089493|FG000|Overall Study|Invalid image or not imaged|3|||
164416414|NCT00708305|593895739|FG003|Period 3|Other Reason|0|||
164416415|NCT00192023|593895744|FG000|Period III - Double-Blind|Adverse Event|3|||
164416416|NCT00192023|593895745|FG001|Period III - Double-Blind|Adverse Event|0|||
164416417|NCT00192023|593895744|FG000|Period III - Double-Blind|Physician Decision|2|||
164416418|NCT00192023|593895745|FG001|Period III - Double-Blind|Physician Decision|0|||
164416419|NCT00192023|593895744|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
164416420|NCT00192023|593895745|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
164416421|NCT00192023|593895744|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
164416422|NCT00192023|593895745|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
164416423|NCT00192023|593895744|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
164416424|NCT00192023|593895745|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
164416425|NCT00192023|593895744|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
164416426|NCT00192023|593895745|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
164416427|NCT00192023|593895744|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
164416428|NCT00192023|593895745|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
164416429|NCT00192023|593895744|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
164416430|NCT00192023|593895745|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
164416431|NCT00192023|593895744|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
164416432|NCT00192023|593895745|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
164416433|NCT00192023|593895744|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
164416434|NCT00192023|593895745|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
164416435|NCT04789577|593895749|FG000|Overall Study|Withdrawal by Subject|1|||
164416436|NCT04789577|593895750|FG001|Overall Study|Withdrawal by Subject|1|||
164416437|NCT04789577|593895751|FG002|Overall Study|Withdrawal by Subject|1|||
164416438|NCT04789577|593895752|FG003|Overall Study|Withdrawal by Subject|3|||
164416439|NCT04789577|593895753|FG004|Overall Study|Withdrawal by Subject|1|||
164416440|NCT04789577|593895754|FG005|Overall Study|Withdrawal by Subject|7|||
164416441|NCT04789577|593895755|FG006|Overall Study|Withdrawal by Subject|1|||
164416442|NCT04789577|593895749|FG000|Overall Study|Lost to Follow-up|7|||
164416443|NCT04789577|593895750|FG001|Overall Study|Lost to Follow-up|12|||
164416444|NCT04789577|593895751|FG002|Overall Study|Lost to Follow-up|7|||
164416445|NCT04789577|593895752|FG003|Overall Study|Lost to Follow-up|10|||
164416446|NCT04789577|593895753|FG004|Overall Study|Lost to Follow-up|8|||
164416447|NCT04789577|593895754|FG005|Overall Study|Lost to Follow-up|6|||
164416448|NCT04789577|593895755|FG006|Overall Study|Lost to Follow-up|10|||
164416449|NCT04789577|593895749|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
164416450|NCT04789577|593895750|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
164416451|NCT04789577|593895751|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
164416452|NCT04789577|593895752|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
164416453|NCT04789577|593895753|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
164416454|NCT04789577|593895754|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
164416455|NCT04789577|593895755|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
164416456|NCT04789577|593895749|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
164416457|NCT04789577|593895750|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
164416458|NCT04789577|593895751|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
164416459|NCT04789577|593895752|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
164416460|NCT04789577|593895753|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
164416461|NCT04789577|593895754|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
164416462|NCT04789577|593895755|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
164416463|NCT02572817|593895780|FG000|Overall Study|Death|6|||
164416464|NCT02572817|593895781|FG001|Overall Study|Death|3|||
164416465|NCT02572817|593895780|FG000|Overall Study|Lost to Follow-up|3|||
164416466|NCT02572817|593895781|FG001|Overall Study|Lost to Follow-up|3|||
164416467|NCT02441946|593895783|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
164416468|NCT02441946|593895784|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
164416469|NCT02441946|593895785|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
164416470|NCT02441946|593895783|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
164416471|NCT02441946|593895784|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
164416472|NCT02441946|593895785|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
164416473|NCT02441946|593895783|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
164416474|NCT02441946|593895784|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
164416475|NCT02441946|593895785|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
164416476|NCT02441946|593895783|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
164416477|NCT02441946|593895784|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
164416478|NCT02441946|593895785|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
164416479|NCT02441946|593895783|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
164416480|NCT02441946|593895784|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
164416481|NCT02441946|593895785|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
164416482|NCT02441946|593895783|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
164416483|NCT02441946|593895784|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
164599666|NCT00678587|594556332|FG001|Overall Study|Lack of Efficacy|0|||
164468861|NCT01447719|594089493|FG000|Overall Study|Subject still living at end of study|79|||
164468862|NCT01447719|594089493|FG000|Overall Study|Withdrawal by Subject|2|||
164468863|NCT01447719|594089493|FG000|Overall Study|Family withdrew autopsy consent|7|||
164468864|NCT00677365|594089499|FG000|Overall Study|Adverse Event|2|||
164468865|NCT00677365|594089500|FG001|Overall Study|Adverse Event|1|||
164468866|NCT00677365|594089501|FG002|Overall Study|Adverse Event|1|||
164468867|NCT00677365|594089502|FG003|Overall Study|Adverse Event|2|||
164468868|NCT00677365|594089499|FG000|Overall Study|Withdrawal by Subject|0|||
164599667|NCT00678587|594556331|FG000|Overall Study|Protocol Violation|2|||
164599668|NCT00678587|594556332|FG001|Overall Study|Protocol Violation|1|||
164599669|NCT00678587|594556331|FG000|Overall Study|Study Closed/Terminated|1|||
164599670|NCT00678587|594556332|FG001|Overall Study|Study Closed/Terminated|0|||
164599671|NCT00678587|594556331|FG000|Overall Study|Lost to Follow-up|3|||
164599672|NCT00678587|594556332|FG001|Overall Study|Lost to Follow-up|5|||
164599673|NCT00678587|594556331|FG000|Overall Study|Investigator Discretion|2|||
164599674|NCT00678587|594556332|FG001|Overall Study|Investigator Discretion|6|||
164599675|NCT00678587|594556331|FG000|Overall Study|Withdrew Consent|8|||
164599676|NCT00678587|594556332|FG001|Overall Study|Withdrew Consent|3|||
164599677|NCT00976950|594556333|FG000|Overall Study|Adverse Event|3|||
164599678|NCT00976950|594556333|FG000|Overall Study|Events with no relationship to Aptivus|3|||
164599679|NCT01019486|594556334|FG000|Overall Study|Withdrawal by Subject|1|||
164599680|NCT01019486|594556335|FG001|Overall Study|Withdrawal by Subject|1|||
164599681|NCT01019486|594556336|FG002|Overall Study|Withdrawal by Subject|1|||
164599682|NCT02932332|594556337|FG000|Overall Study|Withdrawal by Subject|1|||
164599683|NCT02932332|594556338|FG001|Overall Study|Withdrawal by Subject|1|||
164599684|NCT02932332|594556339|FG002|Overall Study|Withdrawal by Subject|0|||
164599685|NCT02932332|594556340|FG003|Overall Study|Withdrawal by Subject|1|||
164599686|NCT02932332|594556337|FG000|Overall Study|Chest pain|0|||
164599687|NCT02932332|594556338|FG001|Overall Study|Chest pain|0|||
164599688|NCT02932332|594556339|FG002|Overall Study|Chest pain|0|||
164599689|NCT02932332|594556340|FG003|Overall Study|Chest pain|1|||
164599690|NCT02932332|594556337|FG000|Overall Study|Not Dyspneic cough|1|||
164599691|NCT02932332|594556338|FG001|Overall Study|Not Dyspneic cough|2|||
164599692|NCT02932332|594556339|FG002|Overall Study|Not Dyspneic cough|1|||
164599693|NCT02932332|594556340|FG003|Overall Study|Not Dyspneic cough|0|||
164599694|NCT01069523|594556342|FG000|Overall Study|Withdrawal by Subject|4|||
164599695|NCT01069523|594556343|FG001|Overall Study|Withdrawal by Subject|7|||
164599696|NCT01875367|594556344|FG000|Overall Study|Not complete at least 2 questionaries|4|||
164599697|NCT01875367|594556345|FG001|Overall Study|Not complete at least 2 questionaries|2|||
164599698|NCT01875367|594556344|FG000|Overall Study|Not receive study treatment|1|||
164599699|NCT01875367|594556345|FG001|Overall Study|Not receive study treatment|0|||
164599700|NCT02045212|594556351|FG000|Overall Study|Adverse Event|0|||
164599701|NCT02045212|594556352|FG001|Overall Study|Adverse Event|1|||
164599702|NCT02045212|594556351|FG000|Overall Study|Withdrawal by Subject|1|||
164599703|NCT02045212|594556352|FG001|Overall Study|Withdrawal by Subject|0|||
164599704|NCT02045212|594556351|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
164416484|NCT02441946|593895785|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
164416485|NCT02441946|593895783|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
164416486|NCT02441946|593895784|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
164416487|NCT02441946|593895785|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
164416488|NCT02441946|593895783|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
164416489|NCT02441946|593895784|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
164416490|NCT02441946|593895785|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
164416491|NCT02441946|593895783|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
164416492|NCT02441946|593895784|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
164416493|NCT02441946|593895785|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
164416494|NCT02441946|593895783|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
164416495|NCT02441946|593895784|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
164416496|NCT02441946|593895785|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
164416497|NCT02441946|593895783|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
164416498|NCT02441946|593895784|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
164416499|NCT02441946|593895785|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
164416500|NCT00579982|593895792|FG000|Overall Study|Adverse Event|4|||
164416501|NCT00579982|593895792|FG000|Overall Study|Protocol Violation|4|||
164416502|NCT01258660|593895794|FG000|Overall Study|Adverse Event|2|||
164416503|NCT01258660|593895795|FG001|Overall Study|Adverse Event|4|||
164416504|NCT01258660|593895794|FG000|Overall Study|Withdrawal by Subject|3|||
164416505|NCT01258660|593895795|FG001|Overall Study|Withdrawal by Subject|0|||
164416506|NCT01258660|593895794|FG000|Overall Study|due to relocation|2|||
164416507|NCT01258660|593895795|FG001|Overall Study|due to relocation|0|||
164416508|NCT01258660|593895794|FG000|Overall Study|Protocol Violation|0|||
164416509|NCT01258660|593895795|FG001|Overall Study|Protocol Violation|1|||
164416510|NCT01258660|593895794|FG000|Overall Study|Invalid for primary analysis data set|4|||
164416511|NCT01258660|593895795|FG001|Overall Study|Invalid for primary analysis data set|6|||
164416512|NCT00988351|593895796|FG000|Overall Study|Withdrawal by Subject|8|||
164416513|NCT00988351|593895797|FG001|Overall Study|Withdrawal by Subject|0|||
164416514|NCT00988351|593895796|FG000|Overall Study|Lost to Follow-up|6|||
164416515|NCT00988351|593895797|FG001|Overall Study|Lost to Follow-up|9|||
164416516|NCT00988351|593895796|FG000|Overall Study|not using CPAP|5|||
164416517|NCT00988351|593895797|FG001|Overall Study|not using CPAP|3|||
164416518|NCT02038764|593895798|FG000|Overall Study|Adverse Event|0|||
164416519|NCT02038764|593895799|FG001|Overall Study|Adverse Event|0|||
164416520|NCT02038764|593895800|FG002|Overall Study|Adverse Event|1|||
164416521|NCT02038764|593895801|FG003|Overall Study|Adverse Event|0|||
164416522|NCT02038764|593895802|FG004|Overall Study|Adverse Event|0|||
164416523|NCT02038764|593895798|FG000|Overall Study|Lost to Follow-up|0|||
164416524|NCT02038764|593895799|FG001|Overall Study|Lost to Follow-up|1|||
164416525|NCT02038764|593895800|FG002|Overall Study|Lost to Follow-up|0|||
164416526|NCT02038764|593895801|FG003|Overall Study|Lost to Follow-up|0|||
164416527|NCT02038764|593895802|FG004|Overall Study|Lost to Follow-up|0|||
164416528|NCT02038764|593895798|FG000|Overall Study|Withdrawal by Subject|0|||
164416529|NCT02038764|593895799|FG001|Overall Study|Withdrawal by Subject|0|||
164416530|NCT02038764|593895800|FG002|Overall Study|Withdrawal by Subject|0|||
164416531|NCT02038764|593895801|FG003|Overall Study|Withdrawal by Subject|0|||
164416532|NCT02038764|593895802|FG004|Overall Study|Withdrawal by Subject|1|||
164416533|NCT02038764|593895798|FG000|Overall Study|Other|1|||
164416534|NCT02038764|593895799|FG001|Overall Study|Other|0|||
164416535|NCT02038764|593895800|FG002|Overall Study|Other|1|||
164416536|NCT02038764|593895801|FG003|Overall Study|Other|0|||
164416537|NCT02038764|593895802|FG004|Overall Study|Other|0|||
164416538|NCT04192630|593895803|FG000|Overall Study|Discontinued before surgery|2|||
164416539|NCT04192630|593895804|FG001|Overall Study|Discontinued before surgery|0|||
164416540|NCT04192630|593895803|FG000|Overall Study|Discontinued after surgery|5|||
164416541|NCT04192630|593895804|FG001|Overall Study|Discontinued after surgery|3|||
164416542|NCT01193582|593895805|FG000|Vaccination Series|Withdrawal by Subject|11|||
164416543|NCT01193582|593895806|FG001|Vaccination Series|Withdrawal by Subject|13|||
164416544|NCT01193582|593895807|FG002|Vaccination Series|Withdrawal by Subject|8|||
164416545|NCT01193582|593895808|FG003|Vaccination Series|Withdrawal by Subject|3|||
164416546|NCT01193582|593895805|FG000|12 Month Follow-up|Death|0|||
164416547|NCT01193582|593895806|FG001|12 Month Follow-up|Death|0|||
164416548|NCT01193582|593895807|FG002|12 Month Follow-up|Death|1|||
164416549|NCT01193582|593895808|FG003|12 Month Follow-up|Death|0|||
164416550|NCT01193582|593895805|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
164416551|NCT01193582|593895806|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
164416552|NCT01193582|593895807|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
164416553|NCT01193582|593895808|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
164468869|NCT00677365|594089500|FG001|Overall Study|Withdrawal by Subject|0|||
164468870|NCT00677365|594089501|FG002|Overall Study|Withdrawal by Subject|1|||
164468871|NCT00677365|594089502|FG003|Overall Study|Withdrawal by Subject|0|||
164468872|NCT00677365|594089499|FG000|Overall Study|Other reason|0|||
164468873|NCT00677365|594089500|FG001|Overall Study|Other reason|0|||
164468874|NCT00677365|594089501|FG002|Overall Study|Other reason|0|||
164468875|NCT00677365|594089502|FG003|Overall Study|Other reason|1|||
164468876|NCT02944968|594089503|FG000|Overall Study|Subject excluded before study procedure|1|||
164468877|NCT02944968|594089503|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
164468878|NCT04424316|594089509|FG000|Overall Study|Adverse Event|0|||
164468879|NCT04424316|594089510|FG001|Overall Study|Adverse Event|1|||
164468880|NCT04424316|594089511|FG002|Overall Study|Adverse Event|0|||
164468881|NCT04424316|594089512|FG003|Overall Study|Adverse Event|0|||
164468882|NCT04424316|594089509|FG000|Overall Study|Death|1|||
164468883|NCT04424316|594089510|FG001|Overall Study|Death|0|||
164468884|NCT04424316|594089511|FG002|Overall Study|Death|8|||
164468885|NCT04424316|594089512|FG003|Overall Study|Death|14|||
164468886|NCT04424316|594089509|FG000|Overall Study|Lost to Follow-up|93|||
164468887|NCT04424316|594089510|FG001|Overall Study|Lost to Follow-up|88|||
164468888|NCT04424316|594089511|FG002|Overall Study|Lost to Follow-up|224|||
164468889|NCT04424316|594089512|FG003|Overall Study|Lost to Follow-up|211|||
164468890|NCT04424316|594089509|FG000|Overall Study|No longer met eligibility criteria|1|||
164468891|NCT04424316|594089510|FG001|Overall Study|No longer met eligibility criteria|0|||
164468892|NCT04424316|594089511|FG002|Overall Study|No longer met eligibility criteria|0|||
164468893|NCT04424316|594089512|FG003|Overall Study|No longer met eligibility criteria|0|||
164468894|NCT04424316|594089509|FG000|Overall Study|Other|15|||
164468895|NCT04424316|594089510|FG001|Overall Study|Other|11|||
164468896|NCT04424316|594089511|FG002|Overall Study|Other|34|||
164468897|NCT04424316|594089512|FG003|Overall Study|Other|45|||
164468898|NCT04424316|594089509|FG000|Overall Study|Physician Decision|1|||
164468899|NCT04424316|594089510|FG001|Overall Study|Physician Decision|0|||
164468900|NCT04424316|594089511|FG002|Overall Study|Physician Decision|1|||
164468901|NCT04424316|594089512|FG003|Overall Study|Physician Decision|1|||
164468902|NCT04424316|594089509|FG000|Overall Study|Protocol Violation|0|||
164468903|NCT04424316|594089510|FG001|Overall Study|Protocol Violation|1|||
164468904|NCT04424316|594089511|FG002|Overall Study|Protocol Violation|0|||
164468905|NCT04424316|594089512|FG003|Overall Study|Protocol Violation|0|||
164468906|NCT04424316|594089509|FG000|Overall Study|Withdrawal by Subject|71|||
164468907|NCT04424316|594089510|FG001|Overall Study|Withdrawal by Subject|77|||
164468908|NCT04424316|594089511|FG002|Overall Study|Withdrawal by Subject|0|||
164468909|NCT04424316|594089512|FG003|Overall Study|Withdrawal by Subject|0|||
164468910|NCT04424316|594089509|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164468911|NCT04424316|594089510|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164468912|NCT04424316|594089511|FG002|Overall Study|Withdrawal by parent/guardian|74|||
164468913|NCT04424316|594089512|FG003|Overall Study|Withdrawal by parent/guardian|81|||
164468914|NCT04424316|594089509|FG000|Overall Study|Randomized but not vaccinated|13|||
164468915|NCT04424316|594089510|FG001|Overall Study|Randomized but not vaccinated|21|||
164468916|NCT04424316|594089511|FG002|Overall Study|Randomized but not vaccinated|0|||
164468917|NCT04424316|594089512|FG003|Overall Study|Randomized but not vaccinated|0|||
164468918|NCT04424316|594089509|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
164468919|NCT04424316|594089510|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
164468920|NCT04424316|594089511|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
164468921|NCT04424316|594089512|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
164468922|NCT05070741|594089517|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
164468923|NCT05652010|594089523|FG000|First Intervention|Withdrawal by Subject|0|||
164468924|NCT05652010|594089524|FG001|First Intervention|Withdrawal by Subject|1|||
164468925|NCT05652010|594089523|FG000|Second Intervention|Withdrawal by Subject|1|||
164468926|NCT05652010|594089524|FG001|Second Intervention|Withdrawal by Subject|0|||
164468927|NCT05451693|594089526|FG000|Overall Study|Withdrawal by Subject|1|||
164468928|NCT05451693|594089527|FG001|Overall Study|Withdrawal by Subject|1|||
164468929|NCT05890105|594089532|FG000|Overall Study|Adverse Event|1|||
164468930|NCT05890105|594089533|FG001|Overall Study|Adverse Event|0|||
164468931|NCT05890105|594089534|FG002|Overall Study|Adverse Event|0|||
164468932|NCT05890105|594089532|FG000|Overall Study|Other|1|||
164468933|NCT05890105|594089533|FG001|Overall Study|Other|2|||
164711716|NCT03146962|594968239|FG006|Overall Study|Death|0|||
164468934|NCT05890105|594089534|FG002|Overall Study|Other|0|||
164468935|NCT04761198|594089537|FG000|Overall Study|Progressive Disease|1|||
164468936|NCT04761198|594089538|FG001|Overall Study|Progressive Disease|0|||
164468937|NCT04761198|594089539|FG002|Overall Study|Progressive Disease|0|||
164468938|NCT04761198|594089540|FG003|Overall Study|Progressive Disease|1|||
164468939|NCT04761198|594089541|FG004|Overall Study|Progressive Disease|4|||
164468940|NCT04761198|594089542|FG005|Overall Study|Progressive Disease|1|||
164468941|NCT04761198|594089543|FG006|Overall Study|Progressive Disease|2|||
164468942|NCT04761198|594089537|FG000|Overall Study|Protocol Violation|0|||
164468943|NCT04761198|594089538|FG001|Overall Study|Protocol Violation|0|||
164711717|NCT03146962|594968240|FG007|Overall Study|Death|0|||
164711718|NCT03146962|594968241|FG008|Overall Study|Death|0|||
164711719|NCT03146962|594968242|FG009|Overall Study|Death|0|||
164711720|NCT03146962|594968233|FG000|Overall Study|COVID Precautions|1|||
164711721|NCT03146962|594968234|FG001|Overall Study|COVID Precautions|0|||
164416554|NCT02340520|593895820|FG000|Overall Study|Lost to Follow-up|1|||
164416555|NCT02340520|593895820|FG000|Overall Study|Patient did not take drug as specified|1|||
164416556|NCT02340520|593895820|FG000|Overall Study|Withdrawal by Subject|1|||
164416557|NCT01464255|593895823|FG000|Overall Study|unresolve corneal staining|0|||
164416558|NCT01464255|593895824|FG001|Overall Study|unresolve corneal staining|1|||
164416559|NCT00896454|593895826|FG000|Overall Study|Death|10|||
164416560|NCT00896454|593895826|FG000|Overall Study|Adverse Event|8|||
164416561|NCT00896454|593895826|FG000|Overall Study|Disease Progression|5|||
164416562|NCT00896454|593895826|FG000|Overall Study|Other|4|||
164416563|NCT00896454|593895826|FG000|Overall Study|Requirement for alternative therapy|3|||
164416564|NCT00896454|593895826|FG000|Overall Study|Ongoing in study|2|||
164711722|NCT03146962|594968235|FG002|Overall Study|COVID Precautions|0|||
164711723|NCT03146962|594968236|FG003|Overall Study|COVID Precautions|0|||
164468944|NCT04761198|594089539|FG002|Overall Study|Protocol Violation|0|||
164468945|NCT04761198|594089540|FG003|Overall Study|Protocol Violation|0|||
164468946|NCT04761198|594089541|FG004|Overall Study|Protocol Violation|1|||
164468947|NCT04761198|594089542|FG005|Overall Study|Protocol Violation|0|||
164468948|NCT04761198|594089543|FG006|Overall Study|Protocol Violation|0|||
164468949|NCT04761198|594089537|FG000|Overall Study|Death|2|||
164468950|NCT04761198|594089538|FG001|Overall Study|Death|1|||
164468951|NCT04761198|594089539|FG002|Overall Study|Death|2|||
164468952|NCT04761198|594089540|FG003|Overall Study|Death|5|||
164468953|NCT04761198|594089541|FG004|Overall Study|Death|14|||
164468954|NCT04761198|594089542|FG005|Overall Study|Death|2|||
164468955|NCT04761198|594089543|FG006|Overall Study|Death|5|||
164468956|NCT04761198|594089537|FG000|Overall Study|Lost to Follow-up|0|||
164468957|NCT04761198|594089538|FG001|Overall Study|Lost to Follow-up|0|||
164468958|NCT04761198|594089539|FG002|Overall Study|Lost to Follow-up|0|||
164468959|NCT04761198|594089540|FG003|Overall Study|Lost to Follow-up|0|||
164468960|NCT04761198|594089541|FG004|Overall Study|Lost to Follow-up|1|||
164468961|NCT04761198|594089542|FG005|Overall Study|Lost to Follow-up|0|||
164468962|NCT04761198|594089543|FG006|Overall Study|Lost to Follow-up|0|||
164468963|NCT04761198|594089537|FG000|Overall Study|Withdrawal by Subject|2|||
164468964|NCT04761198|594089538|FG001|Overall Study|Withdrawal by Subject|0|||
164468965|NCT04761198|594089539|FG002|Overall Study|Withdrawal by Subject|1|||
164468966|NCT04761198|594089540|FG003|Overall Study|Withdrawal by Subject|0|||
164468967|NCT04761198|594089541|FG004|Overall Study|Withdrawal by Subject|2|||
164468968|NCT04761198|594089542|FG005|Overall Study|Withdrawal by Subject|0|||
164468969|NCT04761198|594089543|FG006|Overall Study|Withdrawal by Subject|1|||
164468970|NCT04761198|594089537|FG000|Overall Study|Study Terminated by Sponsor|6|||
164468971|NCT04761198|594089538|FG001|Overall Study|Study Terminated by Sponsor|0|||
164468972|NCT04761198|594089539|FG002|Overall Study|Study Terminated by Sponsor|5|||
164468973|NCT04761198|594089540|FG003|Overall Study|Study Terminated by Sponsor|3|||
164468974|NCT04761198|594089541|FG004|Overall Study|Study Terminated by Sponsor|10|||
164711724|NCT03146962|594968237|FG004|Overall Study|COVID Precautions|0|||
164711725|NCT03146962|594968238|FG005|Overall Study|COVID Precautions|0|||
164711726|NCT03146962|594968239|FG006|Overall Study|COVID Precautions|0|||
164711727|NCT03146962|594968240|FG007|Overall Study|COVID Precautions|0|||
164711728|NCT03146962|594968241|FG008|Overall Study|COVID Precautions|0|||
164711729|NCT03146962|594968242|FG009|Overall Study|COVID Precautions|0|||
164711730|NCT03146962|594968233|FG000|Overall Study|Physician Decision|0|||
164711731|NCT03146962|594968234|FG001|Overall Study|Physician Decision|0|||
164711732|NCT03146962|594968235|FG002|Overall Study|Physician Decision|0|||
164711733|NCT03146962|594968236|FG003|Overall Study|Physician Decision|0|||
164711734|NCT03146962|594968237|FG004|Overall Study|Physician Decision|0|||
164711735|NCT03146962|594968238|FG005|Overall Study|Physician Decision|0|||
164711736|NCT03146962|594968239|FG006|Overall Study|Physician Decision|0|||
164711737|NCT03146962|594968240|FG007|Overall Study|Physician Decision|0|||
164416565|NCT00896454|593895826|FG000|Overall Study|Withdrawal by Subject|1|||
164468975|NCT04761198|594089542|FG005|Overall Study|Study Terminated by Sponsor|1|||
164468976|NCT04761198|594089543|FG006|Overall Study|Study Terminated by Sponsor|2|||
164468977|NCT02994927|594089544|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164468978|NCT02994927|594089545|FG001|Overall Study|Withdrawal by parent/guardian|1|||
164416566|NCT00856661|593895836|FG000|Overall Study|Death|15|||
164468979|NCT02994927|594089544|FG000|Overall Study|Did not meet eligibility criteria|0|||
164468980|NCT02994927|594089545|FG001|Overall Study|Did not meet eligibility criteria|1|||
164468981|NCT02994927|594089544|FG000|Overall Study|Physician Decision|4|||
164711738|NCT03146962|594968241|FG008|Overall Study|Physician Decision|0|||
164416567|NCT00856661|593895837|FG001|Overall Study|Death|18|||
164468982|NCT02994927|594089545|FG001|Overall Study|Physician Decision|3|||
164468983|NCT02994927|594089544|FG000|Overall Study|Death|4|||
164711739|NCT03146962|594968242|FG009|Overall Study|Physician Decision|1|||
164711740|NCT03146962|594968233|FG000|Overall Study|Started New Treatment|0|||
164711741|NCT03146962|594968234|FG001|Overall Study|Started New Treatment|1|||
164711742|NCT03146962|594968235|FG002|Overall Study|Started New Treatment|0|||
164468984|NCT02994927|594089545|FG001|Overall Study|Death|2|||
164468985|NCT02994927|594089544|FG000|Overall Study|Adverse Event|2|||
164468986|NCT02994927|594089545|FG001|Overall Study|Adverse Event|1|||
164468987|NCT02994927|594089544|FG000|Overall Study|Withdrawal by Subject|3|||
164468988|NCT02994927|594089545|FG001|Overall Study|Withdrawal by Subject|6|||
164468989|NCT02994927|594089544|FG000|Overall Study|Lost to Follow-up|2|||
164468990|NCT02994927|594089545|FG001|Overall Study|Lost to Follow-up|1|||
164468991|NCT03417284|594090986|FG000|Overall Study|Inadequate supply on study drug|1|||
164468992|NCT03417284|594090987|FG001|Overall Study|Inadequate supply on study drug|0|||
164468993|NCT03417284|594090988|FG002|Overall Study|Inadequate supply on study drug|0|||
164468994|NCT03417284|594090989|FG003|Overall Study|Inadequate supply on study drug|0|||
164468995|NCT03417284|594090986|FG000|Overall Study|Disease Progression|0|||
164468996|NCT03417284|594090987|FG001|Overall Study|Disease Progression|0|||
164468997|NCT03417284|594090988|FG002|Overall Study|Disease Progression|1|||
164468998|NCT03417284|594090989|FG003|Overall Study|Disease Progression|0|||
164468999|NCT03972150|594090990|FG000|Overall Study|Adverse Event|0|||
164469000|NCT03972150|594090991|FG001|Overall Study|Adverse Event|1|||
164469001|NCT03972150|594090992|FG002|Overall Study|Adverse Event|1|||
164469002|NCT03972150|594090993|FG003|Overall Study|Adverse Event|0|||
164469003|NCT03972150|594090994|FG004|Overall Study|Adverse Event|0|||
164469004|NCT03972150|594090990|FG000|Overall Study|Progressive disease|3|||
164469005|NCT03972150|594090991|FG001|Overall Study|Progressive disease|5|||
164469006|NCT03972150|594090992|FG002|Overall Study|Progressive disease|2|||
164469007|NCT03972150|594090993|FG003|Overall Study|Progressive disease|2|||
164469008|NCT03972150|594090994|FG004|Overall Study|Progressive disease|3|||
164469009|NCT02668692|594090995|FG000|Overall Study|Adverse Event|1|||
164469010|NCT02668692|594090996|FG001|Overall Study|Adverse Event|0|||
164469011|NCT03442309|594090997|FG000|Overall Study|Lost to Follow-up|1676|||
164469012|NCT03442309|594090998|FG001|Overall Study|Lost to Follow-up|1642|||
164469013|NCT01314105|594091004|FG000|Overall Study|Progressive Disease|6|||
164469014|NCT01314105|594091005|FG001|Overall Study|Progressive Disease|10|||
164469015|NCT01314105|594091004|FG000|Overall Study|Refused to continue taking medication|0|||
164469016|NCT01314105|594091005|FG001|Overall Study|Refused to continue taking medication|1|||
164469017|NCT01314105|594091004|FG000|Overall Study|Other Adverse Event|1|||
164469018|NCT01314105|594091005|FG001|Overall Study|Other Adverse Event|1|||
164469019|NCT04089865|594091006|FG000|Overall Study|Withdrawal by Subject|2|||
164469020|NCT04089865|594091007|FG001|Overall Study|Withdrawal by Subject|2|||
164469021|NCT04089865|594091008|FG002|Overall Study|Withdrawal by Subject|7|||
164469022|NCT04089865|594091009|FG003|Overall Study|Withdrawal by Subject|2|||
164469023|NCT01917084|594091010|FG000|Overall Study|Withdrawal by Subject|1|||
164469024|NCT03571386|594091011|FG000|Overall Study|scheduling conflict|4|||
164469025|NCT03571386|594091012|FG001|Overall Study|scheduling conflict|0|||
164469026|NCT03571386|594091011|FG000|Overall Study|Withdrawal by Subject|15|||
164469027|NCT03571386|594091012|FG001|Overall Study|Withdrawal by Subject|5|||
164469028|NCT06037668|594091019|FG000|Overall Study|Lost to Follow-up|1|||
164711743|NCT03146962|594968236|FG003|Overall Study|Started New Treatment|0|||
164711744|NCT03146962|594968237|FG004|Overall Study|Started New Treatment|0|||
164711745|NCT03146962|594968238|FG005|Overall Study|Started New Treatment|0|||
164711746|NCT03146962|594968239|FG006|Overall Study|Started New Treatment|0|||
164711747|NCT03146962|594968240|FG007|Overall Study|Started New Treatment|0|||
164711748|NCT03146962|594968241|FG008|Overall Study|Started New Treatment|0|||
164711749|NCT03146962|594968242|FG009|Overall Study|Started New Treatment|0|||
164711750|NCT02383810|594968243|FG000|Overall Study|Physician Decision|1|||
164711751|NCT02383810|594968244|FG001|Overall Study|Physician Decision|1|||
164711752|NCT02383810|594968245|FG002|Overall Study|Physician Decision|0|||
164711753|NCT02383810|594968246|FG003|Overall Study|Physician Decision|0|||
164711754|NCT02383810|594968247|FG004|Overall Study|Physician Decision|0|||
164711755|NCT02383810|594968248|FG005|Overall Study|Physician Decision|0|||
164711756|NCT02383810|594968249|FG006|Overall Study|Physician Decision|0|||
164711757|NCT02383810|594968250|FG007|Overall Study|Physician Decision|0|||
164711758|NCT02383810|594968243|FG000|Overall Study|Withdrawal by Subject|2|||
164711759|NCT02383810|594968244|FG001|Overall Study|Withdrawal by Subject|3|||
164711760|NCT02383810|594968245|FG002|Overall Study|Withdrawal by Subject|3|||
164711761|NCT02383810|594968246|FG003|Overall Study|Withdrawal by Subject|3|||
164711762|NCT02383810|594968247|FG004|Overall Study|Withdrawal by Subject|0|||
164469029|NCT06037668|594091020|FG001|Overall Study|Lost to Follow-up|1|||
164469030|NCT06037668|594091019|FG000|Overall Study|Protocol Violation|1|||
164469031|NCT06037668|594091020|FG001|Overall Study|Protocol Violation|0|||
164469032|NCT06037668|594091019|FG000|Overall Study|Withdrawal by Subject|1|||
164469033|NCT06037668|594091020|FG001|Overall Study|Withdrawal by Subject|0|||
164711763|NCT02383810|594968248|FG005|Overall Study|Withdrawal by Subject|0|||
164469034|NCT06037668|594091019|FG000|Overall Study|Other Study Discontinuation Reason|1|||
164469035|NCT06037668|594091020|FG001|Overall Study|Other Study Discontinuation Reason|0|||
164469036|NCT02473445|594091021|FG000|Overall Study|Withdrawal by Subject|2|||
164469037|NCT02473445|594091021|FG000|Overall Study|Sponsor Decision|20|||
164469038|NCT04881461|594091022|FG000|Overall Study|Adverse Event|2|||
164469039|NCT04881461|594091023|FG001|Overall Study|Adverse Event|4|||
164711764|NCT02383810|594968249|FG006|Overall Study|Withdrawal by Subject|0|||
164711765|NCT02383810|594968250|FG007|Overall Study|Withdrawal by Subject|0|||
164711766|NCT02383810|594968243|FG000|Overall Study|Adverse Event|0|||
164711767|NCT02383810|594968244|FG001|Overall Study|Adverse Event|2|||
164711768|NCT02383810|594968245|FG002|Overall Study|Adverse Event|4|||
164711769|NCT02383810|594968246|FG003|Overall Study|Adverse Event|5|||
164711770|NCT02383810|594968247|FG004|Overall Study|Adverse Event|0|||
164711771|NCT02383810|594968248|FG005|Overall Study|Adverse Event|1|||
164711772|NCT02383810|594968249|FG006|Overall Study|Adverse Event|1|||
164711773|NCT02383810|594968250|FG007|Overall Study|Adverse Event|0|||
164711774|NCT02383810|594968243|FG000|Overall Study|Lost to Follow-up|0|||
164711775|NCT02383810|594968244|FG001|Overall Study|Lost to Follow-up|1|||
164711776|NCT02383810|594968245|FG002|Overall Study|Lost to Follow-up|0|||
164711777|NCT02383810|594968246|FG003|Overall Study|Lost to Follow-up|1|||
164711778|NCT02383810|594968247|FG004|Overall Study|Lost to Follow-up|0|||
164711779|NCT02383810|594968248|FG005|Overall Study|Lost to Follow-up|0|||
164711780|NCT02383810|594968249|FG006|Overall Study|Lost to Follow-up|0|||
164711781|NCT02383810|594968250|FG007|Overall Study|Lost to Follow-up|0|||
164711782|NCT02383810|594968243|FG000|Overall Study|other|0|||
164711783|NCT02383810|594968244|FG001|Overall Study|other|0|||
164711784|NCT02383810|594968245|FG002|Overall Study|other|0|||
164711785|NCT02383810|594968246|FG003|Overall Study|other|2|||
164711786|NCT02383810|594968247|FG004|Overall Study|other|0|||
164711787|NCT02383810|594968248|FG005|Overall Study|other|0|||
164711788|NCT02383810|594968249|FG006|Overall Study|other|0|||
164711789|NCT02383810|594968250|FG007|Overall Study|other|0|||
164711790|NCT02383810|594968243|FG000|Overall Study|subject did not receive study treatment|0|||
164711791|NCT02383810|594968244|FG001|Overall Study|subject did not receive study treatment|1|||
164711792|NCT02383810|594968245|FG002|Overall Study|subject did not receive study treatment|0|||
164711793|NCT02383810|594968246|FG003|Overall Study|subject did not receive study treatment|0|||
164711794|NCT02383810|594968247|FG004|Overall Study|subject did not receive study treatment|0|||
164711795|NCT02383810|594968248|FG005|Overall Study|subject did not receive study treatment|0|||
164711796|NCT02383810|594968249|FG006|Overall Study|subject did not receive study treatment|0|||
164711797|NCT02383810|594968250|FG007|Overall Study|subject did not receive study treatment|0|||
164711798|NCT02549027|594968253|FG000|Washout After Period 4|Withdrawal by Subject|0|||
164711799|NCT02549027|594968254|FG001|Washout After Period 4|Withdrawal by Subject|1|||
164711800|NCT02549027|594968255|FG002|Washout After Period 4|Withdrawal by Subject|1|||
164711801|NCT02549027|594968256|FG003|Washout After Period 4|Withdrawal by Subject|1|||
164711802|NCT02549027|594968257|FG004|Washout After Period 4|Withdrawal by Subject|0|||
164711803|NCT02549027|594968258|FG005|Washout After Period 4|Withdrawal by Subject|0|||
164711804|NCT02549027|594968253|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
164711805|NCT02549027|594968254|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
164711806|NCT02549027|594968255|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
164711807|NCT02549027|594968256|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
164711808|NCT02549027|594968257|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
164711809|NCT02549027|594968258|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
164711810|NCT02278055|594968259|FG000|Overall Study|Adverse Event|1|||
164711811|NCT02278055|594968259|FG000|Overall Study|Lost to Follow-up|1|||
164711812|NCT02278055|594968259|FG000|Overall Study|Withdrawal by Subject|2|||
164711813|NCT02278055|594968259|FG000|Overall Study|Progressive Disease|4|||
164711814|NCT01934335|594968260|FG000|Overall Study|Withdrawal by Subject|1|||
164711815|NCT01934335|594968261|FG001|Overall Study|Withdrawal by Subject|1|||
164711816|NCT03016975|594968272|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
164711817|NCT03016975|594968273|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
164711818|NCT03016975|594968274|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
164711819|NCT03016975|594968272|FG000|At 6 Months Follow-up|Death|2|||
164711820|NCT03016975|594968273|FG001|At 6 Months Follow-up|Death|0|||
164711821|NCT03016975|594968274|FG002|At 6 Months Follow-up|Death|0|||
164711822|NCT03016975|594968272|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
164711823|NCT03016975|594968273|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
164711824|NCT03016975|594968274|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
164711825|NCT03016975|594968272|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
164711826|NCT03016975|594968273|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
164711827|NCT03016975|594968274|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
164711828|NCT03016975|594968272|FG000|At 6 Months Follow-up|Aborted implant|1|||
164711829|NCT03016975|594968273|FG001|At 6 Months Follow-up|Aborted implant|0|||
164711830|NCT03016975|594968274|FG002|At 6 Months Follow-up|Aborted implant|0|||
164711831|NCT03016975|594968272|FG000|At 2 Year Follow-up|Death|1|||
164711832|NCT03016975|594968273|FG001|At 2 Year Follow-up|Death|0|||
164711833|NCT03016975|594968274|FG002|At 2 Year Follow-up|Death|0|||
164711834|NCT03016975|594968272|FG000|At 3 Year Follow-up|Death|1|||
164711835|NCT03016975|594968273|FG001|At 3 Year Follow-up|Death|0|||
164711836|NCT03016975|594968274|FG002|At 3 Year Follow-up|Death|0|||
164711837|NCT03016975|594968272|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
164711838|NCT03016975|594968273|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
164711839|NCT03016975|594968274|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
164711840|NCT03016975|594968272|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
164469040|NCT04881461|594091022|FG000|Overall Study|Withdrawal by Subject|19|||
164469041|NCT04881461|594091023|FG001|Overall Study|Withdrawal by Subject|19|||
164469042|NCT04881461|594091022|FG000|Overall Study|Lost to Follow-up|4|||
164469043|NCT04881461|594091023|FG001|Overall Study|Lost to Follow-up|4|||
164469044|NCT04881461|594091022|FG000|Overall Study|Lack of Efficacy|1|||
164469045|NCT04881461|594091023|FG001|Overall Study|Lack of Efficacy|0|||
164469046|NCT04881461|594091022|FG000|Overall Study|"Reason stated as other in CRF"|1|||
164469047|NCT04881461|594091023|FG001|Overall Study|"Reason stated as other in CRF"|2|||
164469048|NCT03988621|594091024|FG000|Overall Study|Lost to Follow-up|16|||
164469049|NCT03988621|594091025|FG001|Overall Study|Lost to Follow-up|17|||
164469050|NCT03988621|594091024|FG000|Overall Study|Withdrawal by Subject|14|||
164469051|NCT03988621|594091025|FG001|Overall Study|Withdrawal by Subject|7|||
164711841|NCT03016975|594968273|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
164711842|NCT03016975|594968274|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
164711843|NCT00811928|594968275|FG000|Overall Study|AEs and SAEs Including Death|7|||
164711844|NCT00811928|594968276|FG001|Overall Study|AEs and SAEs Including Death|11|||
164711845|NCT00811928|594968275|FG000|Overall Study|Withdrawal by Subject|18|||
164711846|NCT00811928|594968276|FG001|Overall Study|Withdrawal by Subject|12|||
164711847|NCT00811928|594968275|FG000|Overall Study|Did Not Take Study Drug|3|||
164711848|NCT00811928|594968276|FG001|Overall Study|Did Not Take Study Drug|0|||
164711849|NCT00811928|594968275|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
164711850|NCT00811928|594968276|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
164469052|NCT03988621|594091024|FG000|Overall Study|Patient Lost to Follow Up|15|||
164469053|NCT03988621|594091025|FG001|Overall Study|Patient Lost to Follow Up|15|||
164469054|NCT03988621|594091024|FG000|Overall Study|Patient death|1|||
164469055|NCT03988621|594091025|FG001|Overall Study|Patient death|5|||
164711851|NCT00811928|594968275|FG000|Overall Study|Investigator Decision|2|||
164711852|NCT00811928|594968276|FG001|Overall Study|Investigator Decision|1|||
164711853|NCT00811928|594968275|FG000|Overall Study|Poor Compliance|2|||
164711854|NCT00811928|594968276|FG001|Overall Study|Poor Compliance|5|||
164711855|NCT02910011|594968277|FG000|Overall Study|Physician Decision|2|||
164711856|NCT02348723|594968278|FG000|Overall Study|No ablation|21|||
164469056|NCT02905331|594091026|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
164469057|NCT02905331|594091027|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
164711857|NCT02348723|594968279|FG001|Overall Study|No ablation|20|||
164711858|NCT02348723|594968278|FG000|Overall Study|Non-compliant with Protocol|1|||
164711859|NCT02348723|594968279|FG001|Overall Study|Non-compliant with Protocol|0|||
164711860|NCT02348723|594968278|FG000|Overall Study|Lost to Follow-up|1|||
164711861|NCT02348723|594968279|FG001|Overall Study|Lost to Follow-up|1|||
164469058|NCT02905331|594091028|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
164469059|NCT02905331|594091026|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
164469060|NCT02905331|594091027|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
164469061|NCT02905331|594091028|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
164469062|NCT02905331|594091026|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
164469063|NCT02905331|594091027|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
164469064|NCT02905331|594091028|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
164469065|NCT02905331|594091026|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
164711862|NCT02348723|594968278|FG000|Overall Study|Consent withdrawn|1|||
164711863|NCT02348723|594968279|FG001|Overall Study|Consent withdrawn|3|||
164711864|NCT02348723|594968278|FG000|Overall Study|Reason other than specified|1|||
164711865|NCT02348723|594968279|FG001|Overall Study|Reason other than specified|1|||
164469066|NCT02905331|594091027|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
164469067|NCT02905331|594091028|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
164469068|NCT02905331|594091026|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
164469069|NCT02905331|594091027|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
164469070|NCT02905331|594091028|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
164469071|NCT02095691|594091029|FG000|Overall Study|Physician Decision|1|||
164469072|NCT05007080|594091031|FG000|Overall Study|Lost to Follow-up|0|||
164469073|NCT05007080|594091032|FG001|Overall Study|Lost to Follow-up|1|||
164469074|NCT05007080|594091033|FG002|Overall Study|Lost to Follow-up|0|||
164469075|NCT05007080|594091034|FG003|Overall Study|Lost to Follow-up|1|||
164469076|NCT05007080|594091035|FG004|Overall Study|Lost to Follow-up|1|||
164469077|NCT05007080|594091036|FG005|Overall Study|Lost to Follow-up|1|||
164711866|NCT02348723|594968278|FG000|Overall Study|Adverse Event|3|||
164711867|NCT02348723|594968279|FG001|Overall Study|Adverse Event|1|||
164711868|NCT00678886|594968280|FG000|Overall Study|Withdrawal by Subject|0|||
164711869|NCT00678886|594968281|FG001|Overall Study|Withdrawal by Subject|0|||
164711870|NCT00678886|594968282|FG002|Overall Study|Withdrawal by Subject|4|||
164711871|NCT00678886|594968283|FG003|Overall Study|Withdrawal by Subject|6|||
164469078|NCT05007080|594091031|FG000|Overall Study|Death|0|||
164469079|NCT05007080|594091032|FG001|Overall Study|Death|1|||
164469080|NCT05007080|594091033|FG002|Overall Study|Death|0|||
164469081|NCT05007080|594091034|FG003|Overall Study|Death|0|||
164469082|NCT05007080|594091035|FG004|Overall Study|Death|0|||
164711872|NCT00678886|594968280|FG000|Overall Study|Physician Decision|0|||
164711873|NCT00678886|594968281|FG001|Overall Study|Physician Decision|0|||
164711874|NCT00678886|594968282|FG002|Overall Study|Physician Decision|1|||
164711875|NCT00678886|594968283|FG003|Overall Study|Physician Decision|1|||
164711876|NCT00678886|594968280|FG000|Overall Study|Lost to Follow-up|0|||
164711877|NCT00678886|594968281|FG001|Overall Study|Lost to Follow-up|0|||
164711878|NCT00678886|594968282|FG002|Overall Study|Lost to Follow-up|3|||
164711879|NCT00678886|594968283|FG003|Overall Study|Lost to Follow-up|2|||
164711880|NCT00678886|594968280|FG000|Overall Study|Other|0|||
164711881|NCT00678886|594968281|FG001|Overall Study|Other|0|||
164711882|NCT00678886|594968282|FG002|Overall Study|Other|1|||
164711883|NCT00678886|594968283|FG003|Overall Study|Other|0|||
164711884|NCT01147107|594968284|FG000|Overall Study|Lack of Efficacy|5|||
164711885|NCT01147107|594968285|FG001|Overall Study|Lack of Efficacy|0|||
164711886|NCT01147107|594968284|FG000|Overall Study|Withdrawal by Subject|1|||
164711887|NCT01147107|594968285|FG001|Overall Study|Withdrawal by Subject|1|||
164711888|NCT04435184|594968286|FG000|Overall Study|follow-up blood draws missing|3|||
164711889|NCT04435184|594968287|FG001|Overall Study|follow-up blood draws missing|5|||
164711890|NCT04693416|594968288|FG000|Overall Study|Lost to Follow-up|13|||
164711891|NCT04693416|594968289|FG001|Overall Study|Lost to Follow-up|0|||
164711892|NCT02290223|594968290|FG000|6 Months|Lost to Follow-up|9|||
164711893|NCT02290223|594968291|FG001|6 Months|Lost to Follow-up|6|||
164711894|NCT02290223|594968290|FG000|6 Months|Withdrawal by Subject|5|||
164711895|NCT02290223|594968291|FG001|6 Months|Withdrawal by Subject|0|||
164711896|NCT02290223|594968290|FG000|6 Months|deceased (not related to study)|2|||
164711897|NCT02290223|594968291|FG001|6 Months|deceased (not related to study)|0|||
164711898|NCT02290223|594968290|FG000|12 Months|Lost to Follow-up|16|||
164711899|NCT02290223|594968291|FG001|12 Months|Lost to Follow-up|10|||
164711900|NCT02290223|594968290|FG000|12 Months|Refusal|0|||
164711901|NCT02290223|594968291|FG001|12 Months|Refusal|1|||
164711902|NCT05293639|594968292|FG000|Overall Study|Withdrawal by Subject|1|||
164711903|NCT05293639|594968293|FG001|Overall Study|Withdrawal by Subject|1|||
164711904|NCT05293639|594968294|FG002|Overall Study|Withdrawal by Subject|2|||
164711905|NCT05293639|594968292|FG000|Overall Study|Death|0|||
164711906|NCT05293639|594968293|FG001|Overall Study|Death|1|||
164711907|NCT05293639|594968294|FG002|Overall Study|Death|0|||
164711908|NCT05293639|594968292|FG000|Overall Study|Lost to Follow-up|0|||
164711909|NCT05293639|594968293|FG001|Overall Study|Lost to Follow-up|0|||
164711910|NCT05293639|594968294|FG002|Overall Study|Lost to Follow-up|5|||
164711911|NCT05293639|594968292|FG000|Overall Study|Other|0|||
164711912|NCT05293639|594968293|FG001|Overall Study|Other|0|||
164711913|NCT05293639|594968294|FG002|Overall Study|Other|1|||
164711914|NCT01860677|594968301|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
164711915|NCT01860677|594968302|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
164711916|NCT01671332|594968308|FG000|Overall Study|Withdrawal by Subject|1|||
164711917|NCT01671332|594968309|FG001|Overall Study|Withdrawal by Subject|1|||
164711918|NCT00371397|594968310|FG000|Session 1|Withdrawal by Subject|1|||
164711919|NCT00371397|594968311|FG001|Session 1|Withdrawal by Subject|0|||
164711920|NCT00371397|594968312|FG002|Session 1|Withdrawal by Subject|0|||
164711921|NCT00371397|594968313|FG003|Session 1|Withdrawal by Subject|0|||
164711922|NCT00371397|594968314|FG004|Session 1|Withdrawal by Subject|0|||
164711923|NCT00371397|594968315|FG005|Session 1|Withdrawal by Subject|0|||
164711924|NCT00371397|594968316|FG006|Session 1|Withdrawal by Subject|0|||
164711925|NCT00371397|594968317|FG007|Session 1|Withdrawal by Subject|1|||
164711926|NCT00371397|594968318|FG008|Session 1|Withdrawal by Subject|0|||
164711927|NCT00371397|594968319|FG009|Session 1|Withdrawal by Subject|0|||
164711928|NCT00371397|594968320|FG010|Session 1|Withdrawal by Subject|0|||
164711929|NCT00371397|594968321|FG011|Session 1|Withdrawal by Subject|0|||
164711930|NCT03753763|594968322|FG000|Overall Study|Adverse Event|2|||
164711931|NCT03753763|594968323|FG001|Overall Study|Adverse Event|0|||
164711932|NCT03753763|594968322|FG000|Overall Study|Withdrawal by Subject|3|||
164711933|NCT03753763|594968323|FG001|Overall Study|Withdrawal by Subject|1|||
164711934|NCT03753763|594968322|FG000|Overall Study|clinical deterioration|1|||
164711935|NCT03753763|594968323|FG001|Overall Study|clinical deterioration|0|||
164711936|NCT01104779|594968324|FG000|Overall Study|Protocol Violation|1|||
164711937|NCT01104779|594968325|FG001|Overall Study|Protocol Violation|2|||
164711938|NCT01104779|594968326|FG002|Overall Study|Protocol Violation|2|||
164711939|NCT01104779|594968324|FG000|Overall Study|Lack of Efficacy|26|||
164711940|NCT01104779|594968325|FG001|Overall Study|Lack of Efficacy|12|||
164711941|NCT01104779|594968326|FG002|Overall Study|Lack of Efficacy|13|||
164711942|NCT01104779|594968324|FG000|Overall Study|Adverse Event|13|||
164711943|NCT01104779|594968325|FG001|Overall Study|Adverse Event|14|||
164711944|NCT01104779|594968326|FG002|Overall Study|Adverse Event|13|||
164711945|NCT01104779|594968324|FG000|Overall Study|Did not meet inc/exc criteria|1|||
164711946|NCT01104779|594968325|FG001|Overall Study|Did not meet inc/exc criteria|1|||
164711947|NCT01104779|594968326|FG002|Overall Study|Did not meet inc/exc criteria|1|||
164711948|NCT01104779|594968324|FG000|Overall Study|Other reasons|0|||
164711949|NCT01104779|594968325|FG001|Overall Study|Other reasons|1|||
164711950|NCT01104779|594968326|FG002|Overall Study|Other reasons|0|||
164711951|NCT01104779|594968324|FG000|Overall Study|Lost to Follow-up|2|||
164711952|NCT01104779|594968325|FG001|Overall Study|Lost to Follow-up|0|||
164711953|NCT01104779|594968326|FG002|Overall Study|Lost to Follow-up|1|||
164711954|NCT01104779|594968324|FG000|Overall Study|Withdrawal by Subject|16|||
164711955|NCT01104779|594968325|FG001|Overall Study|Withdrawal by Subject|25|||
164711956|NCT01104779|594968326|FG002|Overall Study|Withdrawal by Subject|32|||
164711957|NCT01372774|594968327|FG000|Overall Study|Withdrawal prior to treatment|4|||
164711958|NCT01372774|594968328|FG001|Overall Study|Withdrawal prior to treatment|5|||
164711959|NCT00871741|594968329|FG000|Overall Study|Premature study termination|9|||
164711960|NCT00871741|594968330|FG001|Overall Study|Premature study termination|7|||
164469083|NCT05007080|594091036|FG005|Overall Study|Death|0|||
164711961|NCT01565850|594968331|FG000|Overall Study|Adverse Event|0|||
164711962|NCT01565850|594968332|FG001|Overall Study|Adverse Event|1|||
164711963|NCT01565850|594968331|FG000|Overall Study|Lost to Follow-up|12|||
164711964|NCT01565850|594968332|FG001|Overall Study|Lost to Follow-up|4|||
164469084|NCT05007080|594091031|FG000|Overall Study|Withdrawal by Subject|1|||
164711965|NCT01565850|594968331|FG000|Overall Study|Investigator's Discretion|2|||
164711966|NCT01565850|594968332|FG001|Overall Study|Investigator's Discretion|1|||
164469085|NCT05007080|594091032|FG001|Overall Study|Withdrawal by Subject|2|||
164469086|NCT05007080|594091033|FG002|Overall Study|Withdrawal by Subject|0|||
164469087|NCT05007080|594091034|FG003|Overall Study|Withdrawal by Subject|2|||
164469088|NCT05007080|594091035|FG004|Overall Study|Withdrawal by Subject|1|||
164469089|NCT05007080|594091036|FG005|Overall Study|Withdrawal by Subject|1|||
164469090|NCT05007080|594091031|FG000|Overall Study|Other|1|||
164469091|NCT05007080|594091032|FG001|Overall Study|Other|0|||
164469092|NCT05007080|594091033|FG002|Overall Study|Other|1|||
164469093|NCT05007080|594091034|FG003|Overall Study|Other|1|||
164469094|NCT05007080|594091035|FG004|Overall Study|Other|0|||
164469095|NCT05007080|594091036|FG005|Overall Study|Other|2|||
164469096|NCT05007080|594091031|FG000|Overall Study|Randomized not vaccinated|0|||
164469097|NCT05007080|594091032|FG001|Overall Study|Randomized not vaccinated|0|||
164469098|NCT05007080|594091033|FG002|Overall Study|Randomized not vaccinated|0|||
164469099|NCT05007080|594091034|FG003|Overall Study|Randomized not vaccinated|0|||
164469100|NCT05007080|594091035|FG004|Overall Study|Randomized not vaccinated|0|||
164469101|NCT05007080|594091036|FG005|Overall Study|Randomized not vaccinated|1|||
164469102|NCT02874742|594091038|FG000|Overall Study|Death|0|||
164469103|NCT02874742|594091039|FG001|Overall Study|Death|1|||
164469104|NCT02874742|594091040|FG002|Overall Study|Death|0|||
164469105|NCT02874742|594091038|FG000|Overall Study|Lost to Follow-up|5|||
164469106|NCT02874742|594091039|FG001|Overall Study|Lost to Follow-up|4|||
164469107|NCT02874742|594091040|FG002|Overall Study|Lost to Follow-up|1|||
164469108|NCT02874742|594091038|FG000|Overall Study|Withdrawal by Subject|17|||
164469109|NCT02874742|594091039|FG001|Overall Study|Withdrawal by Subject|8|||
164469110|NCT02874742|594091040|FG002|Overall Study|Withdrawal by Subject|0|||
164469111|NCT02874742|594091038|FG000|Overall Study|Other|4|||
164469112|NCT02874742|594091039|FG001|Overall Study|Other|1|||
164469113|NCT02874742|594091040|FG002|Overall Study|Other|0|||
164469114|NCT02874742|594091038|FG000|Overall Study|Progressive Disease|1|||
164469115|NCT02874742|594091039|FG001|Overall Study|Progressive Disease|0|||
164469116|NCT02874742|594091040|FG002|Overall Study|Progressive Disease|0|||
164469117|NCT02874742|594091038|FG000|Overall Study|Screen Failure|0|||
164469118|NCT02874742|594091039|FG001|Overall Study|Screen Failure|2|||
164469119|NCT02874742|594091040|FG002|Overall Study|Screen Failure|0|||
164469120|NCT04583280|594091044|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
164469121|NCT04583280|594091045|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
164469122|NCT00964392|594091048|FG000|Overall Study|Withdrawal by Subject|4|||
164469123|NCT00964392|594091049|FG001|Overall Study|Withdrawal by Subject|6|||
164469124|NCT00964392|594091048|FG000|Overall Study|Lost to Follow-up|4|||
164469125|NCT00964392|594091049|FG001|Overall Study|Lost to Follow-up|10|||
164469126|NCT00964392|594091048|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
164469127|NCT00964392|594091049|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
164469128|NCT00964392|594091048|FG000|Overall Study|Not completed|44|||
164469129|NCT00964392|594091049|FG001|Overall Study|Not completed|168|||
164469130|NCT00631475|594091050|FG000|Overall Study|Death|18|||
164469131|NCT00631475|594091050|FG000|Overall Study|Adverse Event|14|||
164469132|NCT00631475|594091050|FG000|Overall Study|Withdrew consent|5|||
164469133|NCT00631475|594091050|FG000|Overall Study|Preparation for lung transplant|8|||
164469134|NCT03691298|594091053|FG000|Overall Study|Lost to Follow-up|8|||
164469135|NCT03691298|594091053|FG000|Overall Study|Sponsor terminated study|2|||
164469136|NCT02577354|594091057|FG000|Overall Study|Lack of Efficacy|4|||
164469137|NCT02577354|594091058|FG001|Overall Study|Lack of Efficacy|4|||
164469138|NCT02577354|594091057|FG000|Overall Study|Lost to Follow-up|3|||
164469139|NCT02577354|594091058|FG001|Overall Study|Lost to Follow-up|1|||
164469140|NCT02577354|594091057|FG000|Overall Study|Missed Visit|4|||
164469141|NCT02577354|594091058|FG001|Overall Study|Missed Visit|3|||
164469142|NCT02577354|594091057|FG000|Overall Study|Adverse Event|4|||
164469143|NCT02577354|594091058|FG001|Overall Study|Adverse Event|5|||
164469144|NCT04173247|594091061|FG000|Overall Study|Withdrawal by Subject|0|||
164469145|NCT04173247|594091062|FG001|Overall Study|Withdrawal by Subject|2|||
164469146|NCT04173247|594091061|FG000|Overall Study|Death|1|||
164469147|NCT04173247|594091062|FG001|Overall Study|Death|0|||
164469148|NCT04173247|594091061|FG000|Overall Study|Physician Decision|1|||
164469149|NCT04173247|594091062|FG001|Overall Study|Physician Decision|0|||
164469150|NCT04214834|594091067|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
164469151|NCT04214834|594091068|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
164469152|NCT04109066|594091074|FG000|Pre-treatment|Participant withdrew consent|2|||
164469153|NCT04109066|594091075|FG001|Pre-treatment|Participant withdrew consent|0|||
164469154|NCT04109066|594091074|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
164469155|NCT04109066|594091075|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
164469156|NCT04109066|594091074|FG000|Treatment|Lack of Efficacy|2|||
164469157|NCT04109066|594091075|FG001|Treatment|Lack of Efficacy|4|||
164469158|NCT04109066|594091074|FG000|Treatment|Adverse Event|23|||
164469159|NCT04109066|594091075|FG001|Treatment|Adverse Event|7|||
164469160|NCT04109066|594091074|FG000|Treatment|Participant request to discontinue Study treatment|15|||
164469161|NCT04109066|594091075|FG001|Treatment|Participant request to discontinue Study treatment|14|||
164469162|NCT04109066|594091074|FG000|Treatment|Withdrawal by Subject|8|||
164469163|NCT04109066|594091075|FG001|Treatment|Withdrawal by Subject|8|||
164469164|NCT04109066|594091074|FG000|Treatment|Death|3|||
164469165|NCT04109066|594091075|FG001|Treatment|Death|0|||
164469166|NCT04109066|594091074|FG000|Treatment|Participant no longer meets study criteria|2|||
164469167|NCT04109066|594091075|FG001|Treatment|Participant no longer meets study criteria|2|||
164469168|NCT04109066|594091074|FG000|Treatment|Administrative reasons by sponsor|2|||
164469169|NCT04109066|594091075|FG001|Treatment|Administrative reasons by sponsor|3|||
164469170|NCT04109066|594091074|FG000|Treatment|Other reasons|17|||
164469171|NCT04109066|594091075|FG001|Treatment|Other reasons|23|||
164469172|NCT04109066|594091074|FG000|Treatment|Disease Progression|4|||
164469173|NCT04109066|594091075|FG001|Treatment|Disease Progression|7|||
164469174|NCT04109066|594091074|FG000|Treatment|Study drug toxicity|12|||
164469175|NCT04109066|594091075|FG001|Treatment|Study drug toxicity|5|||
164469176|NCT04109066|594091074|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
164469177|NCT04109066|594091075|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
164469178|NCT04109066|594091074|FG000|Treatment|Disease Recurrence|0|||
164469179|NCT04109066|594091075|FG001|Treatment|Disease Recurrence|2|||
164469180|NCT04109066|594091074|FG000|Treatment|Not reported|4|||
164469181|NCT04109066|594091075|FG001|Treatment|Not reported|8|||
164469182|NCT04967599|594091076|FG000|Overall Study|Lost to Follow-up|35|||
164469183|NCT04967599|594091077|FG001|Overall Study|Lost to Follow-up|19|||
164469184|NCT04967599|594091078|FG002|Overall Study|Lost to Follow-up|23|||
164469185|NCT04369911|594091080|FG000|Overall Study|Lost to Follow-up|3|||
164469186|NCT04369911|594091081|FG001|Overall Study|Lost to Follow-up|3|||
164469187|NCT04369911|594091080|FG000|Overall Study|Withdrawal by Subject|1|||
164469188|NCT04369911|594091081|FG001|Overall Study|Withdrawal by Subject|2|||
164469189|NCT05741294|594091082|FG000|Overall Study|Lost to Follow-up|3|||
164469190|NCT05741294|594091082|FG000|Overall Study|Protocol deviation|3|||
164469191|NCT05741294|594091082|FG000|Overall Study|Withdrawal by Subject|1|||
164469192|NCT00450216|594091083|FG000|Overall Study|Adverse Event|38|||
164469193|NCT00450216|594091084|FG001|Overall Study|Adverse Event|23|||
164469194|NCT00450216|594091083|FG000|Overall Study|Withdrawal by Subject|48|||
164469195|NCT00450216|594091084|FG001|Overall Study|Withdrawal by Subject|26|||
164469196|NCT00450216|594091083|FG000|Overall Study|Lost to Follow-up|16|||
164469197|NCT00450216|594091084|FG001|Overall Study|Lost to Follow-up|9|||
164469198|NCT00450216|594091083|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
164469199|NCT00450216|594091084|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
164469200|NCT00450216|594091083|FG000|Overall Study|misc|21|||
164469201|NCT00450216|594091084|FG001|Overall Study|misc|20|||
164469202|NCT00319111|594091087|FG000|Overall Study|Adverse Event|20|||
164469203|NCT00319111|594091087|FG000|Overall Study|Withdrawal of consent|11|||
164469204|NCT00319111|594091087|FG000|Overall Study|Death|9|||
164469205|NCT00319111|594091087|FG000|Overall Study|Lack of clinical improvement|4|||
164469206|NCT00319111|594091087|FG000|Overall Study|Administrative|2|||
164469207|NCT00319111|594091087|FG000|Overall Study|Treatment failure|1|||
164469208|NCT03418740|594091088|FG000|Overall Study|Lost to Follow-up|13|||
164469209|NCT03418740|594091088|FG000|Overall Study|Scheduling Issues|7|||
164469210|NCT03418740|594091088|FG000|Overall Study|Withdrawal by Subject|2|||
164469211|NCT03418740|594091088|FG000|Overall Study|Unable to Continue Consent|1|||
164469212|NCT01475786|594091089|FG000|Overall Study|Adverse Event|0|||
164469213|NCT01475786|594091090|FG001|Overall Study|Adverse Event|1|||
164469214|NCT01475786|594091091|FG002|Overall Study|Adverse Event|0|||
164469215|NCT01475786|594091089|FG000|Overall Study|Lost to Follow-up|1|||
164469216|NCT01475786|594091090|FG001|Overall Study|Lost to Follow-up|2|||
164469217|NCT01475786|594091091|FG002|Overall Study|Lost to Follow-up|1|||
164469218|NCT01475786|594091089|FG000|Overall Study|Withdrawal by Subject|0|||
164711967|NCT01565850|594968331|FG000|Overall Study|Participant noncompliance|2|||
164711968|NCT01565850|594968332|FG001|Overall Study|Participant noncompliance|0|||
164711969|NCT01565850|594968331|FG000|Overall Study|Withdrew Consent|4|||
164711970|NCT01565850|594968332|FG001|Overall Study|Withdrew Consent|2|||
164711971|NCT04324073|594970216|FG000|Overall Study|withdrew consent|0|||
164711972|NCT04324073|594970217|FG001|Overall Study|withdrew consent|4|||
164711973|NCT04324073|594970218|FG002|Overall Study|withdrew consent|2|||
164469219|NCT01475786|594091090|FG001|Overall Study|Withdrawal by Subject|1|||
164469220|NCT01475786|594091091|FG002|Overall Study|Withdrawal by Subject|1|||
164469221|NCT01475786|594091089|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
164711974|NCT04324073|594970219|FG003|Overall Study|withdrew consent|8|||
164469222|NCT01475786|594091090|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
164469223|NCT01475786|594091091|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
164469224|NCT03165955|594091093|FG000|Treatment|Withdrawal by Subject|3|||
164469225|NCT03165955|594091093|FG000|Treatment|Death|1|||
164469226|NCT03165955|594091093|FG000|Treatment|Adverse Event|1|||
164469227|NCT03165955|594091093|FG000|Treatment|Progressive disease|3|||
164469228|NCT03533257|594091103|FG000|Overall Study|Adverse Event|4|||
164469229|NCT03533257|594091104|FG001|Overall Study|Adverse Event|2|||
164469230|NCT03533257|594091103|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
164711975|NCT03665441|594970220|FG000|Overall Study|survival follow up ongoing|23|||
164711976|NCT03665441|594970221|FG001|Overall Study|survival follow up ongoing|0|||
164711977|NCT03665441|594970220|FG000|Overall Study|Patients ongoing on treatment|9|||
164711978|NCT03665441|594970221|FG001|Overall Study|Patients ongoing on treatment|6|||
164711979|NCT03665441|594970220|FG000|Overall Study|Randomized but not treated|7|||
164711980|NCT03665441|594970221|FG001|Overall Study|Randomized but not treated|11|||
164711981|NCT03610516|594970222|FG000|Treatment Epoch|Adverse Event|3|||
164711982|NCT03610516|594970223|FG001|Treatment Epoch|Adverse Event|1|||
164711983|NCT03610516|594970222|FG000|Treatment Epoch|Death|1|||
164711984|NCT03610516|594970223|FG001|Treatment Epoch|Death|0|||
164711985|NCT03610516|594970222|FG000|Treatment Epoch|Lack of Efficacy|0|||
164711986|NCT03610516|594970223|FG001|Treatment Epoch|Lack of Efficacy|1|||
164711987|NCT03610516|594970222|FG000|Treatment Epoch|No longer requires treatment|1|||
164711988|NCT03610516|594970223|FG001|Treatment Epoch|No longer requires treatment|0|||
164711989|NCT03610516|594970222|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
164711990|NCT03610516|594970223|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
164711991|NCT03610516|594970222|FG000|Treatment Epoch|Physician Decision|8|||
164711992|NCT03610516|594970223|FG001|Treatment Epoch|Physician Decision|5|||
164711993|NCT03610516|594970222|FG000|Treatment Epoch|Protocol Deviation|1|||
164711994|NCT03610516|594970223|FG001|Treatment Epoch|Protocol Deviation|0|||
164711995|NCT03610516|594970222|FG000|Treatment Epoch|Withdrawal by Subject|3|||
164711996|NCT03610516|594970223|FG001|Treatment Epoch|Withdrawal by Subject|1|||
164711997|NCT03610516|594970222|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
164711998|NCT03610516|594970223|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
164711999|NCT03610516|594970222|FG000|Post-Treatment Follow-up|Death|1|||
164712000|NCT03610516|594970223|FG001|Post-Treatment Follow-up|Death|0|||
164712001|NCT02886624|594970227|FG000|12-week Post Treatment Follow-up|Death|1|||
164712002|NCT02886624|594970227|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
164712003|NCT00359801|594970232|FG000|Overall Study|Lost to Follow-up|72|||
164712004|NCT00359801|594970233|FG001|Overall Study|Lost to Follow-up|58|||
164712005|NCT00359801|594970232|FG000|Overall Study|Withdrawal by Subject|143|||
164712006|NCT00359801|594970233|FG001|Overall Study|Withdrawal by Subject|96|||
164712007|NCT00359801|594970232|FG000|Overall Study|Other|66|||
164712008|NCT00359801|594970233|FG001|Overall Study|Other|46|||
164712009|NCT00359801|594970232|FG000|Overall Study|Final Status Unknown: missing data|7|||
164712010|NCT00359801|594970233|FG001|Overall Study|Final Status Unknown: missing data|4|||
164712011|NCT00359801|594970232|FG000|Overall Study|Sponsor Decision|17|||
164712012|NCT00359801|594970233|FG001|Overall Study|Sponsor Decision|16|||
164712013|NCT02929056|594970240|FG000|Overall Study|Lost to Follow-up|0|||
164712014|NCT02929056|594970241|FG001|Overall Study|Lost to Follow-up|1|||
164712015|NCT02245412|594970247|FG000|Treatment Period|Death|1|||
164712016|NCT02245412|594970248|FG001|Treatment Period|Death|1|||
164712017|NCT02245412|594970249|FG002|Treatment Period|Death|0|||
164712018|NCT02245412|594970247|FG000|Treatment Period|Physician Decision|1|||
164712019|NCT02245412|594970248|FG001|Treatment Period|Physician Decision|1|||
164469231|NCT03533257|594091104|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
164469232|NCT05525104|594091106|FG000|Overall Study|Failed caudal analgesia|1|||
164469233|NCT05525104|594091107|FG001|Overall Study|Failed caudal analgesia|3|||
164469234|NCT05525104|594091106|FG000|Overall Study|Premedication needed|0|||
164469235|NCT05525104|594091107|FG001|Overall Study|Premedication needed|1|||
164469236|NCT05525104|594091106|FG000|Overall Study|Protocol Violation|10|||
164469237|NCT05525104|594091107|FG001|Overall Study|Protocol Violation|0|||
164469238|NCT05525104|594091106|FG000|Overall Study|Cancelled operation|1|||
164469239|NCT05525104|594091107|FG001|Overall Study|Cancelled operation|0|||
164469240|NCT02039401|594091108|FG000|Overall Study|Adverse Event|0|||
164469241|NCT02039401|594091109|FG001|Overall Study|Adverse Event|1|||
164469242|NCT02865538|594091110|FG000|Overall Study|Withdrawal by Subject|0|||
164469243|NCT02865538|594091111|FG001|Overall Study|Withdrawal by Subject|0|||
164469244|NCT02865538|594091112|FG002|Overall Study|Withdrawal by Subject|1|||
164712020|NCT02245412|594970249|FG002|Treatment Period|Physician Decision|0|||
164469245|NCT02865538|594091113|FG003|Overall Study|Withdrawal by Subject|0|||
164712021|NCT02245412|594970247|FG000|Treatment Period|Withdrawal by Subject|2|||
164712022|NCT02245412|594970248|FG001|Treatment Period|Withdrawal by Subject|1|||
164712023|NCT02245412|594970249|FG002|Treatment Period|Withdrawal by Subject|0|||
164712024|NCT02245412|594970247|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
164712025|NCT02245412|594970248|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
164712026|NCT02245412|594970249|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
164712027|NCT02245412|594970247|FG000|Follow-Up Period|Death|4|||
164712028|NCT02245412|594970248|FG001|Follow-Up Period|Death|2|||
164469246|NCT02865538|594091114|FG004|Overall Study|Withdrawal by Subject|0|||
164469247|NCT02865538|594091110|FG000|Overall Study|Lost to Follow-up|1|||
164712029|NCT02245412|594970249|FG002|Follow-Up Period|Death|1|||
164712030|NCT02245412|594970247|FG000|Follow-Up Period|Physician Decision|1|||
164469248|NCT02865538|594091111|FG001|Overall Study|Lost to Follow-up|0|||
164712031|NCT02245412|594970248|FG001|Follow-Up Period|Physician Decision|0|||
164712032|NCT02245412|594970249|FG002|Follow-Up Period|Physician Decision|0|||
164712033|NCT02245412|594970247|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
164416568|NCT00856661|593895836|FG000|Overall Study|Protocol Violation|2|||
164416569|NCT00856661|593895837|FG001|Overall Study|Protocol Violation|1|||
164416570|NCT00856661|593895836|FG000|Overall Study|Withdrawal by Subject|1|||
164416571|NCT00856661|593895837|FG001|Overall Study|Withdrawal by Subject|2|||
164416572|NCT00856661|593895836|FG000|Overall Study|Lost to Follow-up|1|||
164416573|NCT00856661|593895837|FG001|Overall Study|Lost to Follow-up|3|||
164416574|NCT00856661|593895836|FG000|Overall Study|Physician Judgement|8|||
164469249|NCT02865538|594091112|FG002|Overall Study|Lost to Follow-up|0|||
164712034|NCT02245412|594970248|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
164712035|NCT02245412|594970249|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
164712036|NCT01056289|594970250|FG000|Open-label Phase|Adverse Event|29|||
164712037|NCT01056289|594970251|FG001|Open-label Phase|Adverse Event|0|||
164712038|NCT01056289|594970252|FG002|Open-label Phase|Adverse Event|0|||
164712039|NCT01056289|594970253|FG003|Open-label Phase|Adverse Event|0|||
164712040|NCT01056289|594970250|FG000|Open-label Phase|Lost to Follow-up|30|||
164712041|NCT01056289|594970251|FG001|Open-label Phase|Lost to Follow-up|0|||
164712042|NCT01056289|594970252|FG002|Open-label Phase|Lost to Follow-up|0|||
164712043|NCT01056289|594970253|FG003|Open-label Phase|Lost to Follow-up|0|||
164712044|NCT01056289|594970250|FG000|Open-label Phase|Other|9|||
164712045|NCT01056289|594970251|FG001|Open-label Phase|Other|0|||
164712046|NCT01056289|594970252|FG002|Open-label Phase|Other|0|||
164712047|NCT01056289|594970253|FG003|Open-label Phase|Other|0|||
164712048|NCT01056289|594970250|FG000|Open-label Phase|Protocol Violation|6|||
164712049|NCT01056289|594970251|FG001|Open-label Phase|Protocol Violation|0|||
164712050|NCT01056289|594970252|FG002|Open-label Phase|Protocol Violation|0|||
164712051|NCT01056289|594970253|FG003|Open-label Phase|Protocol Violation|0|||
164712052|NCT01056289|594970250|FG000|Open-label Phase|Withdrawal by Subject|26|||
164712053|NCT01056289|594970251|FG001|Open-label Phase|Withdrawal by Subject|0|||
164712054|NCT01056289|594970252|FG002|Open-label Phase|Withdrawal by Subject|0|||
164712055|NCT01056289|594970253|FG003|Open-label Phase|Withdrawal by Subject|0|||
164712056|NCT01056289|594970250|FG000|Open-label Phase|Lack of Efficacy|18|||
164712057|NCT01056289|594970251|FG001|Open-label Phase|Lack of Efficacy|0|||
164712058|NCT01056289|594970252|FG002|Open-label Phase|Lack of Efficacy|0|||
164712059|NCT01056289|594970253|FG003|Open-label Phase|Lack of Efficacy|0|||
164416575|NCT00856661|593895837|FG001|Overall Study|Physician Judgement|5|||
164469250|NCT02865538|594091113|FG003|Overall Study|Lost to Follow-up|0|||
164469251|NCT02865538|594091114|FG004|Overall Study|Lost to Follow-up|0|||
164469252|NCT04244175|594092322|FG000|Overall Study|Adverse Event|3|||
164469253|NCT04244175|594092323|FG001|Overall Study|Adverse Event|2|||
164712060|NCT01056289|594970250|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
164712061|NCT01056289|594970251|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
164712062|NCT01056289|594970252|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
164712063|NCT01056289|594970253|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
164712064|NCT01056289|594970250|FG000|Double-blind Phase|Adverse Event|0|||
164712065|NCT01056289|594970251|FG001|Double-blind Phase|Adverse Event|1|||
164712066|NCT01056289|594970252|FG002|Double-blind Phase|Adverse Event|2|||
164712067|NCT01056289|594970253|FG003|Double-blind Phase|Adverse Event|1|||
164712068|NCT01056289|594970250|FG000|Double-blind Phase|Lost to Follow-up|0|||
164712069|NCT01056289|594970251|FG001|Double-blind Phase|Lost to Follow-up|2|||
164712070|NCT01056289|594970252|FG002|Double-blind Phase|Lost to Follow-up|2|||
164712071|NCT01056289|594970253|FG003|Double-blind Phase|Lost to Follow-up|2|||
164712072|NCT01056289|594970250|FG000|Double-blind Phase|Other|0|||
164712073|NCT01056289|594970251|FG001|Double-blind Phase|Other|0|||
164712074|NCT01056289|594970252|FG002|Double-blind Phase|Other|1|||
164712075|NCT01056289|594970253|FG003|Double-blind Phase|Other|2|||
164712076|NCT01056289|594970250|FG000|Double-blind Phase|Protocol Violation|0|||
164416576|NCT02294474|593895843|FG000|Overall Study|Adverse Event|7|||
164416577|NCT02294474|593895844|FG001|Overall Study|Adverse Event|7|||
164416578|NCT02294474|593895843|FG000|Overall Study|Lack of Efficacy|2|||
164416579|NCT02294474|593895844|FG001|Overall Study|Lack of Efficacy|1|||
164416580|NCT02294474|593895843|FG000|Overall Study|Protocol Violation|4|||
164416581|NCT02294474|593895844|FG001|Overall Study|Protocol Violation|2|||
164416582|NCT02294474|593895843|FG000|Overall Study|Other than specified above|12|||
164416583|NCT02294474|593895844|FG001|Overall Study|Other than specified above|12|||
164416584|NCT02961374|593895845|FG000|Overall Study|Adverse Event|4|||
164416585|NCT02023879|593895849|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
164416586|NCT02023879|593895850|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
164416587|NCT02023879|593895851|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
164416588|NCT02023879|593895849|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
164469254|NCT04244175|594092324|FG002|Overall Study|Adverse Event|5|||
164469255|NCT04244175|594092322|FG000|Overall Study|Lack of Efficacy|1|||
164712077|NCT01056289|594970251|FG001|Double-blind Phase|Protocol Violation|0|||
164712078|NCT01056289|594970252|FG002|Double-blind Phase|Protocol Violation|1|||
164712079|NCT01056289|594970253|FG003|Double-blind Phase|Protocol Violation|1|||
164712080|NCT01056289|594970250|FG000|Double-blind Phase|Withdrawal by Subject|0|||
164416589|NCT02023879|593895850|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
164416590|NCT02023879|593895851|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
164416591|NCT02023879|593895849|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
164416592|NCT02023879|593895850|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
164416593|NCT02023879|593895851|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
164416594|NCT02023879|593895849|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
164416595|NCT02023879|593895850|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
164416596|NCT02023879|593895851|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
164416597|NCT02023879|593895849|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
164416598|NCT02023879|593895850|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
164416599|NCT02023879|593895851|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
164416600|NCT02023879|593895849|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
164416601|NCT02023879|593895850|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
164416602|NCT02023879|593895851|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
164416603|NCT02023879|593895849|FG000|Extension Open Label Treatment|Adverse Event|1|||
164416604|NCT02023879|593895850|FG001|Extension Open Label Treatment|Adverse Event|7|||
164416605|NCT02023879|593895851|FG002|Extension Open Label Treatment|Adverse Event|3|||
164416606|NCT02023879|593895849|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
164416607|NCT02023879|593895850|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
164416608|NCT02023879|593895851|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
164416609|NCT02023879|593895849|FG000|Extension Open Label Treatment|Participant moved|1|||
164416610|NCT02023879|593895850|FG001|Extension Open Label Treatment|Participant moved|2|||
164416611|NCT02023879|593895851|FG002|Extension Open Label Treatment|Participant moved|0|||
164416612|NCT02023879|593895849|FG000|Extension Open Label Treatment|Other than specified above|2|||
164416613|NCT02023879|593895850|FG001|Extension Open Label Treatment|Other than specified above|7|||
164416614|NCT02023879|593895851|FG002|Extension Open Label Treatment|Other than specified above|2|||
164416615|NCT00874432|593895852|FG000|Overall Study|Withdrawal by Subject|1|||
164416616|NCT00874432|593895853|FG001|Overall Study|Withdrawal by Subject|0|||
164416617|NCT00874432|593895854|FG002|Overall Study|Withdrawal by Subject|0|||
164469256|NCT04244175|594092323|FG001|Overall Study|Lack of Efficacy|0|||
164469257|NCT04244175|594092324|FG002|Overall Study|Lack of Efficacy|1|||
164469258|NCT04244175|594092322|FG000|Overall Study|Lost to Follow-up|1|||
164469259|NCT04244175|594092323|FG001|Overall Study|Lost to Follow-up|0|||
164469260|NCT04244175|594092324|FG002|Overall Study|Lost to Follow-up|0|||
164469261|NCT04244175|594092322|FG000|Overall Study|Non-compliance with study drug|1|||
164469262|NCT04244175|594092323|FG001|Overall Study|Non-compliance with study drug|0|||
164469263|NCT04244175|594092324|FG002|Overall Study|Non-compliance with study drug|1|||
164469264|NCT04244175|594092322|FG000|Overall Study|Protocol deviation|0|||
164712081|NCT01056289|594970251|FG001|Double-blind Phase|Withdrawal by Subject|0|||
164712082|NCT01056289|594970252|FG002|Double-blind Phase|Withdrawal by Subject|4|||
164712083|NCT01056289|594970253|FG003|Double-blind Phase|Withdrawal by Subject|2|||
164712084|NCT01056289|594970250|FG000|Double-blind Phase|Discontinuation symptom|0|||
164712085|NCT01056289|594970251|FG001|Double-blind Phase|Discontinuation symptom|1|||
164712086|NCT01056289|594970252|FG002|Double-blind Phase|Discontinuation symptom|2|||
164712087|NCT01056289|594970253|FG003|Double-blind Phase|Discontinuation symptom|2|||
164712088|NCT01056289|594970250|FG000|Double-blind Phase|Physician Decision|0|||
164712089|NCT01056289|594970251|FG001|Double-blind Phase|Physician Decision|0|||
164712090|NCT01056289|594970252|FG002|Double-blind Phase|Physician Decision|1|||
164712091|NCT01056289|594970253|FG003|Double-blind Phase|Physician Decision|0|||
164712092|NCT00459043|594970260|FG000|Overall Study|Withdrawal by Subject|1|||
164712093|NCT00459043|594970261|FG001|Overall Study|Withdrawal by Subject|0|||
164712094|NCT00270855|594970264|FG000|Overall Study|Withdrawal by Subject|8|||
164712095|NCT00270855|594970265|FG001|Overall Study|Withdrawal by Subject|8|||
164712096|NCT02500043|594970268|FG000|Overall Study|Randomized, but not Treated|2|||
164712097|NCT02500043|594970269|FG001|Overall Study|Randomized, but not Treated|2|||
164712098|NCT02500043|594970268|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
164712099|NCT02500043|594970269|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
164469265|NCT04244175|594092323|FG001|Overall Study|Protocol deviation|1|||
164469266|NCT04244175|594092324|FG002|Overall Study|Protocol deviation|0|||
164469267|NCT04244175|594092322|FG000|Overall Study|Withdrawal by Subject|1|||
164469268|NCT04244175|594092323|FG001|Overall Study|Withdrawal by Subject|3|||
164469269|NCT04244175|594092324|FG002|Overall Study|Withdrawal by Subject|1|||
164469270|NCT04244175|594092322|FG000|Overall Study|Other, not specified|0|||
164469271|NCT04244175|594092323|FG001|Overall Study|Other, not specified|1|||
164469272|NCT04244175|594092324|FG002|Overall Study|Other, not specified|2|||
164469273|NCT02585323|594092327|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
164469274|NCT02585323|594092328|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
164469275|NCT02585323|594092327|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
164469276|NCT02585323|594092328|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
164469277|NCT02585323|594092327|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
164469278|NCT02585323|594092328|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
164469279|NCT02585323|594092327|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
164469280|NCT02585323|594092328|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
164469281|NCT01130883|594092329|FG000|Overall Study|Patient Noncompliance|6|||
164469282|NCT01130883|594092329|FG000|Overall Study|Reason Unknown|1|||
164469283|NCT01130883|594092329|FG000|Overall Study|Adverse Event|3|||
164469284|NCT04282980|594092339|FG000|Overall Study|Remained on treatment|6|||
164469285|NCT04282980|594092339|FG000|Overall Study|Survival follow-up|11|||
164469286|NCT04282980|594092339|FG000|Overall Study|Withdrawal of informed consent|1|||
164469287|NCT04282980|594092339|FG000|Overall Study|Lost to Follow-up|1|||
164469288|NCT04247802|594092341|FG000|Overall Study|Withdrawal by Subject|1|||
164469289|NCT04247802|594092342|FG001|Overall Study|Withdrawal by Subject|3|||
164469290|NCT04247802|594092341|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
164469291|NCT04247802|594092342|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
164469292|NCT04629339|594092348|FG000|Overall Study|Death|1|||
164469293|NCT04629339|594092349|FG001|Overall Study|Death|0|||
164469294|NCT04629339|594092350|FG002|Overall Study|Death|2|||
164469295|NCT04629339|594092351|FG003|Overall Study|Death|2|||
164469296|NCT04629339|594092352|FG004|Overall Study|Death|0|||
164712100|NCT02500043|594970268|FG000|Overall Study|Adverse Event|33|||
164712101|NCT02500043|594970269|FG001|Overall Study|Adverse Event|11|||
164712102|NCT02500043|594970268|FG000|Overall Study|Clinical Progression|54|||
164712103|NCT02500043|594970269|FG001|Overall Study|Clinical Progression|35|||
164712104|NCT02500043|594970268|FG000|Overall Study|Radiological Progression|192|||
164469297|NCT04629339|594092348|FG000|Overall Study|Disease Progression|0|||
164469298|NCT04629339|594092349|FG001|Overall Study|Disease Progression|0|||
164469299|NCT04629339|594092350|FG002|Overall Study|Disease Progression|1|||
164469300|NCT04629339|594092351|FG003|Overall Study|Disease Progression|1|||
164469301|NCT04629339|594092352|FG004|Overall Study|Disease Progression|0|||
164469302|NCT04629339|594092348|FG000|Overall Study|Lost to Follow-up|0|||
164469303|NCT04629339|594092349|FG001|Overall Study|Lost to Follow-up|0|||
164469304|NCT04629339|594092350|FG002|Overall Study|Lost to Follow-up|0|||
164712105|NCT02500043|594970269|FG001|Overall Study|Radiological Progression|110|||
164712106|NCT02500043|594970268|FG000|Overall Study|Physician's Decision|11|||
164712107|NCT02500043|594970269|FG001|Overall Study|Physician's Decision|3|||
164469305|NCT04629339|594092351|FG003|Overall Study|Lost to Follow-up|1|||
164469306|NCT04629339|594092352|FG004|Overall Study|Lost to Follow-up|0|||
164469307|NCT04629339|594092348|FG000|Overall Study|Physician Decision|0|||
164469308|NCT04629339|594092349|FG001|Overall Study|Physician Decision|1|||
164469309|NCT04629339|594092350|FG002|Overall Study|Physician Decision|0|||
164469310|NCT04629339|594092351|FG003|Overall Study|Physician Decision|0|||
164469311|NCT04629339|594092352|FG004|Overall Study|Physician Decision|0|||
164469312|NCT04629339|594092348|FG000|Overall Study|Study Terminated by Sponsor|0|||
164469313|NCT04629339|594092349|FG001|Overall Study|Study Terminated by Sponsor|0|||
164469314|NCT04629339|594092350|FG002|Overall Study|Study Terminated by Sponsor|0|||
164469315|NCT04629339|594092351|FG003|Overall Study|Study Terminated by Sponsor|1|||
164469316|NCT04629339|594092352|FG004|Overall Study|Study Terminated by Sponsor|0|||
164469317|NCT04629339|594092348|FG000|Overall Study|Withdrawal by Subject|0|||
164469318|NCT04629339|594092349|FG001|Overall Study|Withdrawal by Subject|0|||
164469319|NCT04629339|594092350|FG002|Overall Study|Withdrawal by Subject|2|||
164469320|NCT04629339|594092351|FG003|Overall Study|Withdrawal by Subject|2|||
164469321|NCT04629339|594092352|FG004|Overall Study|Withdrawal by Subject|0|||
164469322|NCT04778410|594092359|FG000|Safety Run-in Period|Death|5|||
164469323|NCT04778410|594092360|FG001|Safety Run-in Period|Death|6|||
164469324|NCT04778410|594092361|FG002|Safety Run-in Period|Death|0|||
164469325|NCT04778410|594092362|FG003|Safety Run-in Period|Death|0|||
164469326|NCT04778410|594092363|FG004|Safety Run-in Period|Death|0|||
164469327|NCT04778410|594092364|FG005|Safety Run-in Period|Death|0|||
164469328|NCT04778410|594092359|FG000|Phase 2 Period|Death|0|||
164469329|NCT04778410|594092360|FG001|Phase 2 Period|Death|0|||
164469330|NCT04778410|594092361|FG002|Phase 2 Period|Death|0|||
164469331|NCT04778410|594092362|FG003|Phase 2 Period|Death|5|||
164469332|NCT04778410|594092363|FG004|Phase 2 Period|Death|18|||
164469333|NCT04778410|594092364|FG005|Phase 2 Period|Death|0|||
164469334|NCT04778410|594092359|FG000|Phase 2 Period|Lost to Follow-up|0|||
164469335|NCT04778410|594092360|FG001|Phase 2 Period|Lost to Follow-up|0|||
164469336|NCT04778410|594092361|FG002|Phase 2 Period|Lost to Follow-up|0|||
164469337|NCT04778410|594092362|FG003|Phase 2 Period|Lost to Follow-up|1|||
164469338|NCT04778410|594092363|FG004|Phase 2 Period|Lost to Follow-up|1|||
164469339|NCT04778410|594092364|FG005|Phase 2 Period|Lost to Follow-up|0|||
164469340|NCT04778410|594092359|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
164469341|NCT04778410|594092360|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
164469342|NCT04778410|594092361|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
164599705|NCT02045212|594556352|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
164599706|NCT00515008|594556353|FG000|Overall Study|Lost to Follow-up|1|||
164599707|NCT00515008|594556354|FG001|Overall Study|Lost to Follow-up|0|||
164599708|NCT00515008|594556353|FG000|Overall Study|Declined|0|||
164599709|NCT00515008|594556354|FG001|Overall Study|Declined|3|||
164599710|NCT00515008|594556353|FG000|Overall Study|Left the Boston Area|1|||
164599711|NCT00515008|594556354|FG001|Overall Study|Left the Boston Area|1|||
164599712|NCT00515008|594556353|FG000|Overall Study|Scheduling conflict|1|||
164599713|NCT00515008|594556354|FG001|Overall Study|Scheduling conflict|0|||
164599714|NCT02951988|594556355|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
164599715|NCT02951988|594556356|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
164599716|NCT02951988|594556357|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
164599717|NCT02951988|594556358|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
164712108|NCT02500043|594970268|FG000|Overall Study|Withdrawal by Subject|14|||
164712109|NCT02500043|594970269|FG001|Overall Study|Withdrawal by Subject|4|||
164712110|NCT02500043|594970268|FG000|Overall Study|Death|11|||
164712111|NCT02500043|594970269|FG001|Overall Study|Death|2|||
164712112|NCT02500043|594970268|FG000|Overall Study|Protocol Deviation|1|||
164712113|NCT02500043|594970269|FG001|Overall Study|Protocol Deviation|0|||
164712114|NCT00580788|594970270|FG000|Overall Study|Adverse Event|0|||
164712115|NCT00580788|594970271|FG001|Overall Study|Adverse Event|0|||
164712116|NCT00580788|594970272|FG002|Overall Study|Adverse Event|0|||
164712117|NCT00580788|594970273|FG003|Overall Study|Adverse Event|1|||
164712118|NCT01403051|594970274|FG000|Overall Study|Protocol Violation|2|||
164712119|NCT01403051|594970275|FG001|Overall Study|Protocol Violation|0|||
164712120|NCT01403051|594970274|FG000|Overall Study|Death|1|||
164712121|NCT01403051|594970275|FG001|Overall Study|Death|0|||
164712122|NCT01403051|594970274|FG000|Overall Study|Withdrawal by Subject|2|||
164712123|NCT01403051|594970275|FG001|Overall Study|Withdrawal by Subject|1|||
164712124|NCT01403051|594970274|FG000|Overall Study|Lost to Follow-up|5|||
164469343|NCT04778410|594092362|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
164469344|NCT04778410|594092363|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
164599718|NCT02951988|594556355|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
164469345|NCT04778410|594092364|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
164469346|NCT04778410|594092359|FG000|Phase 2 Period|Withdrew Consent|0|||
164469347|NCT04778410|594092360|FG001|Phase 2 Period|Withdrew Consent|0|||
164599719|NCT02951988|594556356|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
164712125|NCT01403051|594970275|FG001|Overall Study|Lost to Follow-up|5|||
164712126|NCT05776862|594970282|FG000|Overall Study|Adverse Event|0|||
164712127|NCT05776862|594970283|FG001|Overall Study|Adverse Event|1|||
164712128|NCT05776862|594970282|FG000|Overall Study|non-compliance|1|||
164416618|NCT00874432|593895855|FG003|Overall Study|Withdrawal by Subject|0|||
164416619|NCT00874432|593895852|FG000|Overall Study|Physician Decision|1|||
164416620|NCT00874432|593895853|FG001|Overall Study|Physician Decision|0|||
164416621|NCT00874432|593895854|FG002|Overall Study|Physician Decision|0|||
164416622|NCT00874432|593895855|FG003|Overall Study|Physician Decision|0|||
164416623|NCT00874432|593895852|FG000|Overall Study|Other|1|||
164416624|NCT00874432|593895853|FG001|Overall Study|Other|2|||
164416625|NCT00874432|593895854|FG002|Overall Study|Other|8|||
164416626|NCT00874432|593895855|FG003|Overall Study|Other|3|||
164416627|NCT05256381|593895856|FG000|Overall Study|Withdrawal by Subject|4|||
164416628|NCT05256381|593895857|FG001|Overall Study|Withdrawal by Subject|0|||
164416629|NCT05256381|593895858|FG002|Overall Study|Withdrawal by Subject|2|||
164416630|NCT05256381|593895859|FG003|Overall Study|Withdrawal by Subject|2|||
164416631|NCT05256381|593895860|FG004|Overall Study|Withdrawal by Subject|8|||
164416632|NCT05256381|593895861|FG005|Overall Study|Withdrawal by Subject|6|||
164416633|NCT05256381|593895856|FG000|Overall Study|Physician Decision|0|||
164416634|NCT05256381|593895857|FG001|Overall Study|Physician Decision|0|||
164416635|NCT05256381|593895858|FG002|Overall Study|Physician Decision|1|||
164416636|NCT05256381|593895859|FG003|Overall Study|Physician Decision|0|||
164416637|NCT05256381|593895860|FG004|Overall Study|Physician Decision|2|||
164416638|NCT05256381|593895861|FG005|Overall Study|Physician Decision|0|||
164416639|NCT05256381|593895856|FG000|Overall Study|Death|17|||
164416640|NCT05256381|593895857|FG001|Overall Study|Death|3|||
164416641|NCT05256381|593895858|FG002|Overall Study|Death|4|||
164416642|NCT05256381|593895859|FG003|Overall Study|Death|5|||
164416643|NCT05256381|593895860|FG004|Overall Study|Death|24|||
164416644|NCT05256381|593895861|FG005|Overall Study|Death|21|||
164416645|NCT05256381|593895856|FG000|Overall Study|Other, not specified|0|||
164416646|NCT05256381|593895857|FG001|Overall Study|Other, not specified|0|||
164416647|NCT05256381|593895858|FG002|Overall Study|Other, not specified|0|||
164416648|NCT05256381|593895859|FG003|Overall Study|Other, not specified|0|||
164416649|NCT05256381|593895860|FG004|Overall Study|Other, not specified|2|||
164416650|NCT05256381|593895861|FG005|Overall Study|Other, not specified|1|||
164416651|NCT05256381|593895856|FG000|Overall Study|Study terminated by sponsor|18|||
164416652|NCT05256381|593895857|FG001|Overall Study|Study terminated by sponsor|5|||
164416653|NCT05256381|593895858|FG002|Overall Study|Study terminated by sponsor|5|||
164416654|NCT05256381|593895859|FG003|Overall Study|Study terminated by sponsor|5|||
164416655|NCT05256381|593895860|FG004|Overall Study|Study terminated by sponsor|18|||
164416656|NCT05256381|593895861|FG005|Overall Study|Study terminated by sponsor|11|||
164416657|NCT05256381|593895856|FG000|Overall Study|Lost to Follow-up|1|||
164416658|NCT05256381|593895857|FG001|Overall Study|Lost to Follow-up|0|||
164416659|NCT05256381|593895858|FG002|Overall Study|Lost to Follow-up|0|||
164416660|NCT05256381|593895859|FG003|Overall Study|Lost to Follow-up|0|||
164416661|NCT05256381|593895860|FG004|Overall Study|Lost to Follow-up|1|||
164416662|NCT05256381|593895861|FG005|Overall Study|Lost to Follow-up|0|||
164416663|NCT00802737|593897746|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
164416664|NCT00802737|593897747|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
164416665|NCT00802737|593897748|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
164416666|NCT00802737|593897746|FG000|Overall Study|Death|6|||
164416667|NCT00802737|593897747|FG001|Overall Study|Death|5|||
164416668|NCT00802737|593897748|FG002|Overall Study|Death|1|||
164416669|NCT00802737|593897746|FG000|Overall Study|Adverse Event|1|||
164416670|NCT00802737|593897747|FG001|Overall Study|Adverse Event|0|||
164416671|NCT00802737|593897748|FG002|Overall Study|Adverse Event|0|||
164416672|NCT00802737|593897746|FG000|Overall Study|Received Prohibited Therapy|1|||
164416673|NCT00802737|593897747|FG001|Overall Study|Received Prohibited Therapy|0|||
164416674|NCT00802737|593897748|FG002|Overall Study|Received Prohibited Therapy|0|||
164416675|NCT00802737|593897746|FG000|Overall Study|Ongoing CLL-Treatment|0|||
164416676|NCT00802737|593897747|FG001|Overall Study|Ongoing CLL-Treatment|1|||
164416677|NCT00802737|593897748|FG002|Overall Study|Ongoing CLL-Treatment|0|||
164416678|NCT00802737|593897746|FG000|Overall Study|Participant too Unwell|0|||
164416679|NCT00802737|593897747|FG001|Overall Study|Participant too Unwell|2|||
164416680|NCT00802737|593897748|FG002|Overall Study|Participant too Unwell|0|||
164416681|NCT03864926|593897749|FG000|Overall Study|Death|0|||
164416682|NCT03864926|593897750|FG001|Overall Study|Death|2|||
164416683|NCT00445601|593897751|FG000|Overall Study|Withdrawal by Subject|11|||
164416684|NCT00445601|593897752|FG001|Overall Study|Withdrawal by Subject|11|||
164416685|NCT00445601|593897751|FG000|Overall Study|TURBT Complication|12|||
164416686|NCT00445601|593897752|FG001|Overall Study|TURBT Complication|8|||
164416687|NCT00445601|593897751|FG000|Overall Study|Incorrect Disease Status|6|||
164416688|NCT00445601|593897752|FG001|Overall Study|Incorrect Disease Status|6|||
164416689|NCT00445601|593897751|FG000|Overall Study|Drug Delivery Issue|2|||
164416690|NCT00445601|593897752|FG001|Overall Study|Drug Delivery Issue|2|||
164416691|NCT00445601|593897751|FG000|Overall Study|Adverse Event|2|||
164416692|NCT00445601|593897752|FG001|Overall Study|Adverse Event|0|||
164416693|NCT00445601|593897751|FG000|Overall Study|Death prior to TURBT|0|||
164416694|NCT00445601|593897752|FG001|Overall Study|Death prior to TURBT|1|||
164416695|NCT01340482|593897753|FG000|Overall Study|Adverse Event|2|||
164416696|NCT01340482|593897754|FG001|Overall Study|Adverse Event|0|||
164469348|NCT04778410|594092361|FG002|Phase 2 Period|Withdrew Consent|0|||
164469349|NCT04778410|594092362|FG003|Phase 2 Period|Withdrew Consent|0|||
164469350|NCT04778410|594092363|FG004|Phase 2 Period|Withdrew Consent|2|||
164469351|NCT04778410|594092364|FG005|Phase 2 Period|Withdrew Consent|0|||
164469352|NCT05422885|594092371|FG000|Overall Study|Lost to Follow-up|1|||
164469353|NCT05422885|594092371|FG000|Overall Study|Withdrawal by Subject|2|||
164469354|NCT04084574|594092372|FG000|Overall Study|Lost to Follow-up|1|||
164469355|NCT04084574|594092373|FG001|Overall Study|Lost to Follow-up|0|||
164469356|NCT04084574|594092372|FG000|Overall Study|Physician Decision|1|||
164469357|NCT04084574|594092373|FG001|Overall Study|Physician Decision|0|||
164469358|NCT04084574|594092372|FG000|Overall Study|Relocated out of state|1|||
164469359|NCT04084574|594092373|FG001|Overall Study|Relocated out of state|0|||
164469360|NCT01121588|594092374|FG000|Overall Study|Death|5|||
164469361|NCT01121588|594092375|FG001|Overall Study|Death|3|||
164469362|NCT01121588|594092376|FG002|Overall Study|Death|13|||
164469363|NCT01121588|594092374|FG000|Overall Study|Study Terminated by Sponsor|1|||
164469364|NCT01121588|594092375|FG001|Overall Study|Study Terminated by Sponsor|1|||
164469365|NCT01121588|594092376|FG002|Overall Study|Study Terminated by Sponsor|0|||
164469366|NCT01121588|594092374|FG000|Overall Study|Participant Refused Further Followup|2|||
164469367|NCT01121588|594092375|FG001|Overall Study|Participant Refused Further Followup|0|||
164469368|NCT01121588|594092376|FG002|Overall Study|Participant Refused Further Followup|2|||
164469369|NCT01121588|594092374|FG000|Overall Study|Lost to Follow-up|0|||
164469370|NCT01121588|594092375|FG001|Overall Study|Lost to Follow-up|1|||
164469371|NCT01121588|594092376|FG002|Overall Study|Lost to Follow-up|1|||
164469372|NCT01121588|594092374|FG000|Overall Study|Non-Specified Reasons|9|||
164469373|NCT01121588|594092375|FG001|Overall Study|Non-Specified Reasons|4|||
164469374|NCT01121588|594092376|FG002|Overall Study|Non-Specified Reasons|2|||
164469375|NCT00942877|594092377|FG000|Overall Study|Refused further treatment|1|||
164469376|NCT00942877|594092378|FG001|Overall Study|Refused further treatment|1|||
164469377|NCT00942877|594092377|FG000|Overall Study|Patient was not treated|1|||
164469378|NCT00942877|594092378|FG001|Overall Study|Patient was not treated|0|||
164469379|NCT00942877|594092377|FG000|Overall Study|Adverse Event|1|||
164469380|NCT00942877|594092378|FG001|Overall Study|Adverse Event|0|||
164469381|NCT00942877|594092377|FG000|Overall Study|Progressive disease|42|||
164469382|NCT00942877|594092378|FG001|Overall Study|Progressive disease|3|||
164469383|NCT01385202|594092379|FG000|Overall Study|Lost to Follow-up|6|||
164469384|NCT01385202|594092379|FG000|Overall Study|Not Eligible|11|||
164469385|NCT01385202|594092379|FG000|Overall Study|Withdrawn|1|||
164469386|NCT03681262|594092380|FG000|Overall Study|Continuing on study|3|||
164469387|NCT03681262|594092381|FG001|Overall Study|Continuing on study|3|||
164469388|NCT03681262|594092380|FG000|Overall Study|Lost to Follow-up|1|||
164469389|NCT03681262|594092381|FG001|Overall Study|Lost to Follow-up|0|||
164469390|NCT00887198|594092382|FG000|Randomized Period|Ongoing|42|||
164469391|NCT00887198|594092383|FG001|Randomized Period|Ongoing|0|||
164469392|NCT00887198|594092384|FG002|Randomized Period|Ongoing|0|||
164469393|NCT00887198|594092382|FG000|Randomized Period|Adverse Event|50|||
164469394|NCT00887198|594092383|FG001|Randomized Period|Adverse Event|33|||
164416697|NCT01340482|593897755|FG002|Overall Study|Adverse Event|0|||
164416698|NCT00619476|593897756|FG000|Overall Study|Adverse Event|12|||
164416699|NCT00619476|593897757|FG001|Overall Study|Adverse Event|6|||
164416700|NCT00619476|593897758|FG002|Overall Study|Adverse Event|12|||
164416701|NCT00619476|593897759|FG003|Overall Study|Adverse Event|16|||
164416702|NCT00619476|593897756|FG000|Overall Study|Lack of Efficacy|6|||
164416703|NCT00619476|593897757|FG001|Overall Study|Lack of Efficacy|1|||
164416704|NCT00619476|593897758|FG002|Overall Study|Lack of Efficacy|1|||
164416705|NCT00619476|593897759|FG003|Overall Study|Lack of Efficacy|4|||
164416706|NCT00619476|593897756|FG000|Overall Study|Protocol Violation|5|||
164416707|NCT00619476|593897757|FG001|Overall Study|Protocol Violation|4|||
164416708|NCT00619476|593897758|FG002|Overall Study|Protocol Violation|4|||
164469395|NCT00887198|594092384|FG002|Randomized Period|Adverse Event|0|||
164469396|NCT00887198|594092382|FG000|Randomized Period|Lost to Follow-up|1|||
164416709|NCT00619476|593897759|FG003|Overall Study|Protocol Violation|9|||
164469397|NCT00887198|594092383|FG001|Randomized Period|Lost to Follow-up|0|||
164469398|NCT00887198|594092384|FG002|Randomized Period|Lost to Follow-up|0|||
164469399|NCT00887198|594092382|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
164469400|NCT00887198|594092383|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
164469401|NCT00887198|594092384|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
164416710|NCT00619476|593897756|FG000|Overall Study|Lost to Follow-up|1|||
164416711|NCT00619476|593897757|FG001|Overall Study|Lost to Follow-up|2|||
164416712|NCT00619476|593897758|FG002|Overall Study|Lost to Follow-up|0|||
164416713|NCT00619476|593897759|FG003|Overall Study|Lost to Follow-up|1|||
164469402|NCT00887198|594092382|FG000|Randomized Period|Withdrawal by Subject|41|||
164469403|NCT00887198|594092383|FG001|Randomized Period|Withdrawal by Subject|56|||
164469404|NCT00887198|594092384|FG002|Randomized Period|Withdrawal by Subject|0|||
164469405|NCT00887198|594092382|FG000|Randomized Period|Progressive disease|366|||
164469406|NCT00887198|594092383|FG001|Randomized Period|Progressive disease|370|||
164469407|NCT00887198|594092384|FG002|Randomized Period|Progressive disease|0|||
164416714|NCT00619476|593897756|FG000|Overall Study|Investigator Discretion|2|||
164416715|NCT00619476|593897757|FG001|Overall Study|Investigator Discretion|2|||
164416716|NCT00619476|593897758|FG002|Overall Study|Investigator Discretion|2|||
164416717|NCT00619476|593897759|FG003|Overall Study|Investigator Discretion|0|||
164416718|NCT00619476|593897756|FG000|Overall Study|Withdrawal by Subject|5|||
164416719|NCT00619476|593897757|FG001|Overall Study|Withdrawal by Subject|7|||
164416720|NCT00619476|593897758|FG002|Overall Study|Withdrawal by Subject|5|||
164416721|NCT00619476|593897759|FG003|Overall Study|Withdrawal by Subject|4|||
164416722|NCT01091428|593897760|FG000|Phase 1|Progressive Disease|24|||
164416723|NCT01091428|593897761|FG001|Phase 1|Progressive Disease|8|||
164416724|NCT01091428|593897762|FG002|Phase 1|Progressive Disease|0|||
164416725|NCT01091428|593897763|FG003|Phase 1|Progressive Disease|0|||
164416726|NCT01091428|593897760|FG000|Phase 1|Symptomatic Deterioration|3|||
164416727|NCT01091428|593897761|FG001|Phase 1|Symptomatic Deterioration|2|||
164416728|NCT01091428|593897762|FG002|Phase 1|Symptomatic Deterioration|0|||
164416729|NCT01091428|593897763|FG003|Phase 1|Symptomatic Deterioration|0|||
164416730|NCT01091428|593897760|FG000|Phase 1|Adverse Event|2|||
164416731|NCT01091428|593897761|FG001|Phase 1|Adverse Event|0|||
164416732|NCT01091428|593897762|FG002|Phase 1|Adverse Event|0|||
164416733|NCT01091428|593897763|FG003|Phase 1|Adverse Event|0|||
164416734|NCT01091428|593897760|FG000|Phase 1|Withdrawal by Subject|7|||
164416735|NCT01091428|593897761|FG001|Phase 1|Withdrawal by Subject|0|||
164416736|NCT01091428|593897762|FG002|Phase 1|Withdrawal by Subject|0|||
164416737|NCT01091428|593897763|FG003|Phase 1|Withdrawal by Subject|0|||
164416738|NCT01091428|593897760|FG000|Phase 1|Reason not specified|0|||
164416739|NCT01091428|593897761|FG001|Phase 1|Reason not specified|1|||
164416740|NCT01091428|593897762|FG002|Phase 1|Reason not specified|0|||
164416741|NCT01091428|593897763|FG003|Phase 1|Reason not specified|0|||
164416742|NCT01091428|593897760|FG000|Phase 1|Single-Patient IND|2|||
164416743|NCT01091428|593897761|FG001|Phase 1|Single-Patient IND|0|||
164416744|NCT01091428|593897762|FG002|Phase 1|Single-Patient IND|0|||
164416745|NCT01091428|593897763|FG003|Phase 1|Single-Patient IND|0|||
164416746|NCT01091428|593897760|FG000|Phase 2|Progressive Disease|0|||
164416747|NCT01091428|593897761|FG001|Phase 2|Progressive Disease|0|||
164416748|NCT01091428|593897762|FG002|Phase 2|Progressive Disease|44|||
164416749|NCT01091428|593897763|FG003|Phase 2|Progressive Disease|46|||
164416750|NCT01091428|593897760|FG000|Phase 2|Symptomatic Deterioration|0|||
164416751|NCT01091428|593897761|FG001|Phase 2|Symptomatic Deterioration|0|||
164416752|NCT01091428|593897762|FG002|Phase 2|Symptomatic Deterioration|1|||
164416753|NCT01091428|593897763|FG003|Phase 2|Symptomatic Deterioration|6|||
164416754|NCT01091428|593897760|FG000|Phase 2|Adverse Event|0|||
164416755|NCT01091428|593897761|FG001|Phase 2|Adverse Event|0|||
164416756|NCT01091428|593897762|FG002|Phase 2|Adverse Event|12|||
164416757|NCT01091428|593897763|FG003|Phase 2|Adverse Event|5|||
164416758|NCT01091428|593897760|FG000|Phase 2|Withdrawal by Subject|0|||
164416759|NCT01091428|593897761|FG001|Phase 2|Withdrawal by Subject|0|||
164416760|NCT01091428|593897762|FG002|Phase 2|Withdrawal by Subject|9|||
164416761|NCT01091428|593897763|FG003|Phase 2|Withdrawal by Subject|8|||
164416762|NCT01091428|593897760|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
164416763|NCT01091428|593897761|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
164416764|NCT01091428|593897762|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
164416765|NCT01091428|593897763|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
164416766|NCT01091428|593897760|FG000|Phase 2|Reason not specified|0|||
164416767|NCT01091428|593897761|FG001|Phase 2|Reason not specified|0|||
164416768|NCT01091428|593897762|FG002|Phase 2|Reason not specified|4|||
164416769|NCT01091428|593897763|FG003|Phase 2|Reason not specified|3|||
164416770|NCT01091428|593897760|FG000|Phase 2|Physician Decision|0|||
164416771|NCT01091428|593897761|FG001|Phase 2|Physician Decision|0|||
164416772|NCT01091428|593897762|FG002|Phase 2|Physician Decision|2|||
164416773|NCT01091428|593897763|FG003|Phase 2|Physician Decision|0|||
164416774|NCT01282476|593897768|FG000|Overall Study|Death|11|||
164416775|NCT01625910|593897771|FG000|Overall Study|Lost to Follow-up|3|||
164416776|NCT01625910|593897772|FG001|Overall Study|Lost to Follow-up|4|||
164416777|NCT03918239|593897778|FG000|Overall Study|Lost to Follow-up|3|||
164416778|NCT03918239|593897779|FG001|Overall Study|Lost to Follow-up|1|||
164416779|NCT03918239|593897778|FG000|Overall Study|Pregnancy|0|||
164416780|NCT03918239|593897779|FG001|Overall Study|Pregnancy|2|||
164416781|NCT03918239|593897778|FG000|Overall Study|Withdrawal by Subject|3|||
164416782|NCT03918239|593897779|FG001|Overall Study|Withdrawal by Subject|3|||
164416783|NCT03918239|593897778|FG000|Overall Study|positive urine drug screening results|4|||
164416784|NCT03918239|593897779|FG001|Overall Study|positive urine drug screening results|1|||
164416785|NCT01681368|593897786|FG000|Overall Study|Refused further treatment|1|||
164416786|NCT01681368|593897786|FG000|Overall Study|Refused further follow up|1|||
164416787|NCT01984424|593897787|FG000|Overall Study|Withdrawal by Subject|3|||
164416788|NCT01984424|593897788|FG001|Overall Study|Withdrawal by Subject|5|||
164416789|NCT01984424|593897787|FG000|Overall Study|Sponsor Decision|0|||
164416790|NCT01984424|593897788|FG001|Overall Study|Sponsor Decision|1|||
164416791|NCT01984424|593897787|FG000|Overall Study|Lost to Follow-up|0|||
164469408|NCT00887198|594092382|FG000|Randomized Period|Other|42|||
164416792|NCT01984424|593897788|FG001|Overall Study|Lost to Follow-up|1|||
164469409|NCT00887198|594092383|FG001|Randomized Period|Other|30|||
164469410|NCT00887198|594092384|FG002|Randomized Period|Other|0|||
164469411|NCT00887198|594092382|FG000|Randomized Period|Randomized, Not treated|4|||
164469412|NCT00887198|594092383|FG001|Randomized Period|Randomized, Not treated|2|||
164469413|NCT00887198|594092384|FG002|Randomized Period|Randomized, Not treated|0|||
164469414|NCT00887198|594092382|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
164469415|NCT00887198|594092383|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
164469416|NCT00887198|594092384|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
164469417|NCT00887198|594092382|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
164469418|NCT00887198|594092383|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
164469419|NCT00887198|594092384|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
164469420|NCT00887198|594092382|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
164469421|NCT00887198|594092383|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
164469422|NCT00887198|594092384|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
164469423|NCT00887198|594092382|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
164469424|NCT00887198|594092383|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
164469425|NCT00887198|594092384|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
164469426|NCT00887198|594092382|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
164469427|NCT00887198|594092383|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
164469428|NCT00887198|594092384|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
164469429|NCT00887198|594092382|FG000|Cross Over (Placebo to AA)|Other|0|||
164469430|NCT00887198|594092383|FG001|Cross Over (Placebo to AA)|Other|0|||
164469431|NCT00887198|594092384|FG002|Cross Over (Placebo to AA)|Other|19|||
164469432|NCT02782676|594092385|FG000|Overall Study|Lost to Follow-up|0|||
164469433|NCT02782676|594092386|FG001|Overall Study|Lost to Follow-up|1|||
164469434|NCT05830799|594092387|FG000|Overall Study|Withdrawal by Subject|1|||
164469435|NCT04631016|594092391|FG000|Overall Study|Adverse Event|3|||
164469436|NCT04631016|594092392|FG001|Overall Study|Adverse Event|0|||
164469437|NCT04631016|594092391|FG000|Overall Study|Withdrawal by Subject|5|||
164469438|NCT04631016|594092392|FG001|Overall Study|Withdrawal by Subject|4|||
164469439|NCT04631016|594092391|FG000|Overall Study|Reason unspecified|1|||
164469440|NCT04631016|594092392|FG001|Overall Study|Reason unspecified|0|||
164469441|NCT04631016|594092391|FG000|Overall Study|Failure to meet randomization criteria|2|||
164469442|NCT04631016|594092392|FG001|Overall Study|Failure to meet randomization criteria|1|||
164469443|NCT05205161|594092393|FG000|Overall Study|Study terminated by sponsor|3|||
164469444|NCT05205161|594092394|FG001|Overall Study|Study terminated by sponsor|3|||
164469445|NCT05205161|594092395|FG002|Overall Study|Study terminated by sponsor|1|||
164469446|NCT04707768|594092400|FG000|Overall Study|Adverse Event|9|||
164469447|NCT04707768|594092401|FG001|Overall Study|Adverse Event|18|||
164469448|NCT04707768|594092402|FG002|Overall Study|Adverse Event|3|||
164469449|NCT04707768|594092400|FG000|Overall Study|Investigator's Discretion|8|||
164469450|NCT04707768|594092401|FG001|Overall Study|Investigator's Discretion|4|||
164469451|NCT04707768|594092402|FG002|Overall Study|Investigator's Discretion|3|||
164469452|NCT04707768|594092400|FG000|Overall Study|Withdrawal by Subject|6|||
164469453|NCT04707768|594092401|FG001|Overall Study|Withdrawal by Subject|8|||
164469454|NCT04707768|594092402|FG002|Overall Study|Withdrawal by Subject|2|||
164469455|NCT04707768|594092400|FG000|Overall Study|Lack of Efficacy|1|||
164469456|NCT04707768|594092401|FG001|Overall Study|Lack of Efficacy|3|||
164469457|NCT04707768|594092402|FG002|Overall Study|Lack of Efficacy|0|||
164469458|NCT04707768|594092400|FG000|Overall Study|Lost to Follow-up|0|||
164469459|NCT04707768|594092401|FG001|Overall Study|Lost to Follow-up|0|||
164469460|NCT04707768|594092402|FG002|Overall Study|Lost to Follow-up|3|||
164469461|NCT04707768|594092400|FG000|Overall Study|Death|13|||
164469462|NCT04707768|594092401|FG001|Overall Study|Death|11|||
164469463|NCT04707768|594092402|FG002|Overall Study|Death|13|||
164469464|NCT04707768|594092400|FG000|Overall Study|Protocol Violation|2|||
164469465|NCT04707768|594092401|FG001|Overall Study|Protocol Violation|1|||
164469466|NCT04707768|594092402|FG002|Overall Study|Protocol Violation|0|||
164469467|NCT04707768|594092400|FG000|Overall Study|Non Compliance with Study Drug|1|||
164469468|NCT04707768|594092401|FG001|Overall Study|Non Compliance with Study Drug|0|||
164469469|NCT04707768|594092402|FG002|Overall Study|Non Compliance with Study Drug|0|||
164469470|NCT04707768|594092400|FG000|Overall Study|Transplant|4|||
164469471|NCT04707768|594092401|FG001|Overall Study|Transplant|4|||
164469472|NCT04707768|594092402|FG002|Overall Study|Transplant|8|||
164469473|NCT04707768|594092400|FG000|Overall Study|Other|9|||
164469474|NCT04707768|594092401|FG001|Overall Study|Other|5|||
164469475|NCT04707768|594092402|FG002|Overall Study|Other|2|||
164469476|NCT04490109|594092403|FG000|Overall Study|Lost to Follow-up|3|||
164469477|NCT04490109|594092404|FG001|Overall Study|Lost to Follow-up|10|||
164469478|NCT04490109|594092405|FG002|Overall Study|Lost to Follow-up|4|||
164469479|NCT04490109|594092403|FG000|Overall Study|Withdrawal by Subject|8|||
164469480|NCT04490109|594092404|FG001|Overall Study|Withdrawal by Subject|6|||
164469481|NCT04490109|594092405|FG002|Overall Study|Withdrawal by Subject|9|||
164469482|NCT04490109|594092403|FG000|Overall Study|Physician Decision|0|||
164469483|NCT04490109|594092404|FG001|Overall Study|Physician Decision|2|||
164469484|NCT04490109|594092405|FG002|Overall Study|Physician Decision|3|||
164469485|NCT04490109|594092403|FG000|Overall Study|Adverse Event|2|||
164469486|NCT04490109|594092404|FG001|Overall Study|Adverse Event|1|||
164469487|NCT04490109|594092405|FG002|Overall Study|Adverse Event|0|||
164469488|NCT04490109|594092403|FG000|Overall Study|Significant Non-Compliance|2|||
164469489|NCT04490109|594092404|FG001|Overall Study|Significant Non-Compliance|4|||
164469490|NCT04490109|594092405|FG002|Overall Study|Significant Non-Compliance|4|||
164469491|NCT04490109|594092403|FG000|Overall Study|Significant Clinical Event|0|||
164469492|NCT04490109|594092404|FG001|Overall Study|Significant Clinical Event|1|||
164469493|NCT04490109|594092405|FG002|Overall Study|Significant Clinical Event|0|||
164469494|NCT04490109|594092403|FG000|Overall Study|Other Reason|4|||
164469495|NCT04490109|594092404|FG001|Overall Study|Other Reason|1|||
164712129|NCT05776862|594970283|FG001|Overall Study|non-compliance|0|||
164712130|NCT01635218|594970284|FG000|Overall Study|Lost to Follow-up|3|||
164712131|NCT01635218|594970285|FG001|Overall Study|Lost to Follow-up|7|||
164712132|NCT01635218|594970286|FG002|Overall Study|Lost to Follow-up|6|||
164712133|NCT03262038|594970287|FG000|Overall Study|Withdrawal by Subject|0|||
164712134|NCT03262038|594970288|FG001|Overall Study|Withdrawal by Subject|1|||
164712135|NCT03323437|594970289|FG000|Overall Study|Withdrawal by Subject|0|||
164712136|NCT03323437|594970290|FG001|Overall Study|Withdrawal by Subject|4|||
164712137|NCT00282919|594970291|FG000|Overall Study|Lack of Efficacy|4|||
164712138|NCT00282919|594970291|FG000|Overall Study|Withdrawal by Subject|1|||
164712139|NCT00282919|594970291|FG000|Overall Study|Asymptomatic Parasitemia|2|||
164712140|NCT00168818|594970296|FG000|Overall Study|Adverse Event|23|||
164712141|NCT00168818|594970297|FG001|Overall Study|Adverse Event|29|||
164712142|NCT00168818|594970298|FG002|Overall Study|Adverse Event|31|||
164712143|NCT00168818|594970296|FG000|Overall Study|Protocol Violation|16|||
164712144|NCT00168818|594970297|FG001|Overall Study|Protocol Violation|11|||
164712145|NCT00168818|594970298|FG002|Overall Study|Protocol Violation|11|||
164712146|NCT00168818|594970296|FG000|Overall Study|Lost to Follow-up|13|||
164712147|NCT00168818|594970297|FG001|Overall Study|Lost to Follow-up|4|||
164712148|NCT00168818|594970298|FG002|Overall Study|Lost to Follow-up|15|||
164712149|NCT00168818|594970296|FG000|Overall Study|Withdrawal by Subject|43|||
164712150|NCT00168818|594970297|FG001|Overall Study|Withdrawal by Subject|41|||
164712151|NCT00168818|594970298|FG002|Overall Study|Withdrawal by Subject|37|||
164712152|NCT00168818|594970296|FG000|Overall Study|Other|22|||
164712153|NCT00168818|594970297|FG001|Overall Study|Other|24|||
164712154|NCT00168818|594970298|FG002|Overall Study|Other|30|||
164712155|NCT00168818|594970296|FG000|Treatment|Adverse Event|77|||
164712156|NCT00168818|594970297|FG001|Treatment|Adverse Event|89|||
164712157|NCT00168818|594970298|FG002|Treatment|Adverse Event|68|||
164712158|NCT00168818|594970296|FG000|Treatment|Protocol Violation|8|||
164712159|NCT00168818|594970297|FG001|Treatment|Protocol Violation|11|||
164712160|NCT00168818|594970298|FG002|Treatment|Protocol Violation|11|||
164712161|NCT00168818|594970296|FG000|Treatment|Lost to Follow-up|0|||
164712162|NCT00168818|594970297|FG001|Treatment|Lost to Follow-up|2|||
164712163|NCT00168818|594970298|FG002|Treatment|Lost to Follow-up|1|||
164712164|NCT00168818|594970296|FG000|Treatment|Withdrawal by Subject|25|||
164712165|NCT00168818|594970297|FG001|Treatment|Withdrawal by Subject|20|||
164712166|NCT00168818|594970298|FG002|Treatment|Withdrawal by Subject|22|||
164712167|NCT00168818|594970296|FG000|Treatment|Other|23|||
164712168|NCT00168818|594970297|FG001|Treatment|Other|29|||
164712169|NCT00168818|594970298|FG002|Treatment|Other|31|||
164712170|NCT01994291|594970299|FG000|Overall Study|Adverse Event|4|||
164712171|NCT01994291|594970300|FG001|Overall Study|Adverse Event|1|||
164712172|NCT01994291|594970301|FG002|Overall Study|Adverse Event|3|||
164712173|NCT01994291|594970299|FG000|Overall Study|Lost to Follow-up|1|||
164712174|NCT01994291|594970300|FG001|Overall Study|Lost to Follow-up|1|||
164712175|NCT01994291|594970301|FG002|Overall Study|Lost to Follow-up|0|||
164712176|NCT01994291|594970299|FG000|Overall Study|Does not meet entrance criteria|1|||
164712177|NCT01994291|594970300|FG001|Overall Study|Does not meet entrance criteria|0|||
164712178|NCT01994291|594970301|FG002|Overall Study|Does not meet entrance criteria|0|||
164469496|NCT04490109|594092405|FG002|Overall Study|Other Reason|1|||
164712179|NCT01994291|594970299|FG000|Overall Study|Medication error without associated AE|1|||
164469497|NCT03817983|594092406|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
164469498|NCT03817983|594092407|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
164712180|NCT01994291|594970300|FG001|Overall Study|Medication error without associated AE|0|||
164712181|NCT01994291|594970301|FG002|Overall Study|Medication error without associated AE|1|||
164712182|NCT01994291|594970299|FG000|Overall Study|Protocol Violation|1|||
164469499|NCT03817983|594092408|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
164469500|NCT03744676|594092409|FG000|Pre-Treatment Phase|Disease related complications|2|||
164712183|NCT01994291|594970300|FG001|Overall Study|Protocol Violation|0|||
164712184|NCT01994291|594970301|FG002|Overall Study|Protocol Violation|0|||
164712185|NCT01994291|594970299|FG000|Overall Study|Withdrawal by Subject|6|||
164712186|NCT01994291|594970300|FG001|Overall Study|Withdrawal by Subject|3|||
164712187|NCT01994291|594970301|FG002|Overall Study|Withdrawal by Subject|5|||
164712188|NCT01994291|594970299|FG000|Overall Study|Other|1|||
164416793|NCT00592319|593897789|FG000|Overall Study|Lost to Follow-up|0|||
164416794|NCT00592319|593897790|FG001|Overall Study|Lost to Follow-up|3|||
164416795|NCT01807221|593897793|FG000|Overall Study|Progressive disease|1|||
164416796|NCT01807221|593897794|FG001|Overall Study|Progressive disease|0|||
164416797|NCT01807221|593897795|FG002|Overall Study|Progressive disease|1|||
164416798|NCT01807221|593897796|FG003|Overall Study|Progressive disease|0|||
164416799|NCT01807221|593897797|FG004|Overall Study|Progressive disease|0|||
164416800|NCT01807221|593897798|FG005|Overall Study|Progressive disease|0|||
164416801|NCT01807221|593897793|FG000|Overall Study|Death|7|||
164416802|NCT01807221|593897794|FG001|Overall Study|Death|9|||
164416803|NCT01807221|593897795|FG002|Overall Study|Death|4|||
164416804|NCT01807221|593897796|FG003|Overall Study|Death|2|||
164416805|NCT01807221|593897797|FG004|Overall Study|Death|1|||
164416806|NCT01807221|593897798|FG005|Overall Study|Death|6|||
164416807|NCT01807221|593897793|FG000|Overall Study|Physician Decision|2|||
164416808|NCT01807221|593897794|FG001|Overall Study|Physician Decision|1|||
164416809|NCT01807221|593897795|FG002|Overall Study|Physician Decision|0|||
164416810|NCT01807221|593897796|FG003|Overall Study|Physician Decision|0|||
164416811|NCT01807221|593897797|FG004|Overall Study|Physician Decision|0|||
164416812|NCT01807221|593897798|FG005|Overall Study|Physician Decision|0|||
164416813|NCT01807221|593897793|FG000|Overall Study|Adverse Event|33|||
164416814|NCT01807221|593897794|FG001|Overall Study|Adverse Event|22|||
164416815|NCT01807221|593897795|FG002|Overall Study|Adverse Event|26|||
164416816|NCT01807221|593897796|FG003|Overall Study|Adverse Event|25|||
164416817|NCT01807221|593897797|FG004|Overall Study|Adverse Event|18|||
164416818|NCT01807221|593897798|FG005|Overall Study|Adverse Event|21|||
164416819|NCT01807221|593897793|FG000|Overall Study|Protocol Violation|0|||
164416820|NCT01807221|593897794|FG001|Overall Study|Protocol Violation|2|||
164416821|NCT01807221|593897795|FG002|Overall Study|Protocol Violation|1|||
164416822|NCT01807221|593897796|FG003|Overall Study|Protocol Violation|2|||
164416823|NCT01807221|593897797|FG004|Overall Study|Protocol Violation|0|||
164416824|NCT01807221|593897798|FG005|Overall Study|Protocol Violation|1|||
164416825|NCT01807221|593897793|FG000|Overall Study|Non-compliance|1|||
164416826|NCT01807221|593897794|FG001|Overall Study|Non-compliance|2|||
164416827|NCT01807221|593897795|FG002|Overall Study|Non-compliance|0|||
164416828|NCT01807221|593897796|FG003|Overall Study|Non-compliance|1|||
164416829|NCT01807221|593897797|FG004|Overall Study|Non-compliance|0|||
164416830|NCT01807221|593897798|FG005|Overall Study|Non-compliance|0|||
164416831|NCT01807221|593897793|FG000|Overall Study|Logistical difficulties|0|||
164416832|NCT01807221|593897794|FG001|Overall Study|Logistical difficulties|1|||
164416833|NCT01807221|593897795|FG002|Overall Study|Logistical difficulties|0|||
164416834|NCT01807221|593897796|FG003|Overall Study|Logistical difficulties|0|||
164416835|NCT01807221|593897797|FG004|Overall Study|Logistical difficulties|1|||
164416836|NCT01807221|593897798|FG005|Overall Study|Logistical difficulties|0|||
164416837|NCT01807221|593897793|FG000|Overall Study|Withdrawal by Subject|33|||
164416838|NCT01807221|593897794|FG001|Overall Study|Withdrawal by Subject|15|||
164416839|NCT01807221|593897795|FG002|Overall Study|Withdrawal by Subject|8|||
164416840|NCT01807221|593897796|FG003|Overall Study|Withdrawal by Subject|14|||
164416841|NCT01807221|593897797|FG004|Overall Study|Withdrawal by Subject|16|||
164416842|NCT01807221|593897798|FG005|Overall Study|Withdrawal by Subject|13|||
164416843|NCT01807221|593897793|FG000|Overall Study|Sponsor decision|2|||
164416844|NCT01807221|593897794|FG001|Overall Study|Sponsor decision|0|||
164416845|NCT01807221|593897795|FG002|Overall Study|Sponsor decision|1|||
164416846|NCT01807221|593897796|FG003|Overall Study|Sponsor decision|1|||
164416847|NCT01807221|593897797|FG004|Overall Study|Sponsor decision|0|||
164416848|NCT01807221|593897798|FG005|Overall Study|Sponsor decision|0|||
164416849|NCT01807221|593897793|FG000|Overall Study|Lost to Follow-up|1|||
164416850|NCT01807221|593897794|FG001|Overall Study|Lost to Follow-up|0|||
164416851|NCT01807221|593897795|FG002|Overall Study|Lost to Follow-up|2|||
164416852|NCT01807221|593897796|FG003|Overall Study|Lost to Follow-up|1|||
164416853|NCT01807221|593897797|FG004|Overall Study|Lost to Follow-up|0|||
164416854|NCT01807221|593897798|FG005|Overall Study|Lost to Follow-up|0|||
164416855|NCT03884231|593897799|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
164416856|NCT03884231|593897799|FG000|Overall Study|Subject Withdrew Consent|1|||
164416857|NCT03884231|593897799|FG000|Overall Study|MRI Scan Not Performed|1|||
164416858|NCT00900627|593897800|FG000|Overall Study|Condition under investigation worsened|4|||
164416859|NCT00900627|593897801|FG001|Overall Study|Condition under investigation worsened|0|||
164416860|NCT00900627|593897802|FG002|Overall Study|Condition under investigation worsened|5|||
164416861|NCT00900627|593897803|FG003|Overall Study|Condition under investigation worsened|3|||
164469501|NCT03744676|594092409|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
164416862|NCT00900627|593897804|FG004|Overall Study|Condition under investigation worsened|0|||
164416863|NCT00900627|593897805|FG005|Overall Study|Condition under investigation worsened|0|||
164416864|NCT00900627|593897800|FG000|Overall Study|Withdrawal by Subject|1|||
164416865|NCT00900627|593897801|FG001|Overall Study|Withdrawal by Subject|0|||
164416866|NCT00900627|593897802|FG002|Overall Study|Withdrawal by Subject|1|||
164416867|NCT00900627|593897803|FG003|Overall Study|Withdrawal by Subject|0|||
164416868|NCT00900627|593897804|FG004|Overall Study|Withdrawal by Subject|1|||
164416869|NCT00900627|593897805|FG005|Overall Study|Withdrawal by Subject|2|||
164712189|NCT01994291|594970300|FG001|Overall Study|Other|2|||
164712190|NCT01994291|594970301|FG002|Overall Study|Other|0|||
164712191|NCT01775189|594970302|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164712192|NCT01775189|594970303|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
164712193|NCT01775189|594970304|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164712194|NCT01775189|594970305|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164712195|NCT01775189|594970306|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164712196|NCT01775189|594970307|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164712197|NCT01775189|594970308|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164712198|NCT01775189|594970302|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164712199|NCT01775189|594970303|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
164712200|NCT01775189|594970304|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164712201|NCT01775189|594970305|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164712202|NCT01775189|594970306|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164712203|NCT01775189|594970307|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164712204|NCT01775189|594970308|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164712205|NCT01775189|594970302|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
164712206|NCT01775189|594970303|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
164712207|NCT01775189|594970304|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
164712208|NCT01775189|594970305|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
164712209|NCT01775189|594970306|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
164712210|NCT01775189|594970307|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
164712211|NCT01775189|594970308|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
164712212|NCT01775189|594970302|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
164712213|NCT01775189|594970303|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
164712214|NCT01775189|594970304|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
164712215|NCT01775189|594970305|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
164712216|NCT01775189|594970306|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
164712217|NCT01775189|594970307|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
164712218|NCT01775189|594970308|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
164712219|NCT01775189|594970302|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
164712220|NCT01775189|594970303|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
164712221|NCT01775189|594970304|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
164712222|NCT01775189|594970305|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
164712223|NCT01775189|594970306|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
164712224|NCT01775189|594970307|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
164712225|NCT01775189|594970308|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
164712226|NCT01775189|594970302|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
164712227|NCT01775189|594970303|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
164712228|NCT01775189|594970304|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
164712229|NCT01775189|594970305|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
164712230|NCT01775189|594970306|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
164712231|NCT01775189|594970307|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
164712232|NCT01775189|594970308|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
164712233|NCT02227446|594970309|FG000|Overall Study|not eligible post randomization|18|||
164712234|NCT02227446|594970310|FG001|Overall Study|not eligible post randomization|29|||
164712235|NCT02227446|594970309|FG000|Overall Study|Withdrawal by Subject|4|||
164712236|NCT02227446|594970310|FG001|Overall Study|Withdrawal by Subject|5|||
164712237|NCT02368314|594970317|FG000|Overall Study|Withdrawal by Subject|2|||
164469502|NCT03744676|594092409|FG000|Pre-Treatment Phase|Death|7|||
164712238|NCT02368314|594970318|FG001|Overall Study|Withdrawal by Subject|1|||
164712239|NCT02368314|594970317|FG000|Overall Study|Adverse Event|1|||
164712240|NCT02368314|594970318|FG001|Overall Study|Adverse Event|2|||
164712241|NCT01085357|594970319|FG000|Overall Study|Adverse Event|1|||
164712242|NCT01085357|594970320|FG001|Overall Study|Adverse Event|1|||
164712243|NCT01085357|594970319|FG000|Overall Study|Subject Decision|4|||
164712244|NCT01085357|594970320|FG001|Overall Study|Subject Decision|3|||
164712245|NCT01085357|594970319|FG000|Overall Study|Investigator Decision|1|||
164712246|NCT01085357|594970320|FG001|Overall Study|Investigator Decision|1|||
164712247|NCT01085357|594970319|FG000|Overall Study|Death|11|||
164712248|NCT01085357|594970320|FG001|Overall Study|Death|1|||
164712249|NCT01085357|594970319|FG000|Overall Study|Lost to Follow-up|2|||
164712250|NCT01085357|594970320|FG001|Overall Study|Lost to Follow-up|0|||
164712251|NCT00838435|594970321|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
164712252|NCT00838435|594970321|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
164712253|NCT00838435|594970321|FG000|Part 2 (7 Years)|Adverse Event|2|||
164712254|NCT00838435|594970321|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
164712255|NCT00838435|594970321|FG000|Part 2 (7 Years)|Physician Decision|1|||
164712256|NCT00838435|594970321|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
164712257|NCT00838435|594970321|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
164416870|NCT00900627|593897800|FG000|Overall Study|Adverse Event|1|||
164416871|NCT00900627|593897801|FG001|Overall Study|Adverse Event|2|||
164416872|NCT00900627|593897802|FG002|Overall Study|Adverse Event|0|||
164416873|NCT00900627|593897803|FG003|Overall Study|Adverse Event|3|||
164416874|NCT00900627|593897804|FG004|Overall Study|Adverse Event|0|||
164416875|NCT00900627|593897805|FG005|Overall Study|Adverse Event|0|||
164416876|NCT00900627|593897800|FG000|Overall Study|Death|0|||
164416877|NCT00900627|593897801|FG001|Overall Study|Death|0|||
164416878|NCT00900627|593897802|FG002|Overall Study|Death|0|||
164416879|NCT00900627|593897803|FG003|Overall Study|Death|0|||
164416880|NCT00900627|593897804|FG004|Overall Study|Death|28|||
164469503|NCT03744676|594092409|FG000|Pre-Treatment Phase|Other Reasons|7|||
164469504|NCT03744676|594092409|FG000|Treatment Phase|Participant withdrew consent|8|||
164469505|NCT03744676|594092409|FG000|Treatment Phase|Death|33|||
164469506|NCT03744676|594092409|FG000|Treatment Phase|other reasons|6|||
164469507|NCT02510235|594092410|FG000|Overall Study|Withdrawal by Subject|1|||
164469508|NCT02510235|594092411|FG001|Overall Study|Withdrawal by Subject|0|||
164469509|NCT04108130|594093591|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
164469510|NCT04108130|594093592|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
164469511|NCT04108130|594093591|FG000|Overall Study|Consent Withdrawn|9|||
164469512|NCT04108130|594093592|FG001|Overall Study|Consent Withdrawn|6|||
164469513|NCT04108130|594093591|FG000|Overall Study|Surgery Cancelled|4|||
164469514|NCT04108130|594093592|FG001|Overall Study|Surgery Cancelled|4|||
164469515|NCT04108130|594093591|FG000|Overall Study|Found Ineligible for Study|4|||
164469516|NCT04108130|594093592|FG001|Overall Study|Found Ineligible for Study|3|||
164469517|NCT04108130|594093591|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
164469518|NCT04108130|594093592|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
164469519|NCT04108130|594093591|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
164469520|NCT04108130|594093592|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
164469521|NCT05132400|594093593|FG000|Overall Study|Withdrawal by Subject|14|||
164469522|NCT05132400|594093594|FG001|Overall Study|Withdrawal by Subject|8|||
164469523|NCT05132400|594093593|FG000|Overall Study|Lost to Follow-up|132|||
164469524|NCT05132400|594093594|FG001|Overall Study|Lost to Follow-up|121|||
164469525|NCT03636490|594093597|FG000|Overall Study|Dropped out or incomplete data|141|||
164469526|NCT00739908|594093598|FG000|Overall Study|Adverse Event|5|||
164469527|NCT00739908|594093599|FG001|Overall Study|Adverse Event|6|||
164469528|NCT00739908|594093598|FG000|Overall Study|Withdrawal by Subject|4|||
164469529|NCT00739908|594093599|FG001|Overall Study|Withdrawal by Subject|2|||
164469530|NCT00739908|594093598|FG000|Overall Study|Lost to Follow-up|14|||
164469531|NCT00739908|594093599|FG001|Overall Study|Lost to Follow-up|9|||
164469532|NCT00739908|594093598|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
164469533|NCT00739908|594093599|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
164469534|NCT00739908|594093598|FG000|Overall Study|Non-Compliance With Study Medication|0|||
164469535|NCT00739908|594093599|FG001|Overall Study|Non-Compliance With Study Medication|3|||
164469536|NCT00739908|594093598|FG000|Overall Study|Lack of Efficacy|0|||
164469537|NCT00739908|594093599|FG001|Overall Study|Lack of Efficacy|1|||
164469538|NCT00739908|594093598|FG000|Overall Study|Relocation|0|||
164469539|NCT00739908|594093599|FG001|Overall Study|Relocation|1|||
164469540|NCT02076009|594093609|FG000|Overall Study|Death|172|||
164469541|NCT02076009|594093610|FG001|Overall Study|Death|153|||
164469542|NCT02076009|594093609|FG000|Overall Study|Withdrawal by Subject|16|||
164469543|NCT02076009|594093610|FG001|Overall Study|Withdrawal by Subject|12|||
164469544|NCT02076009|594093609|FG000|Overall Study|Lost to Follow-up|4|||
164469545|NCT02076009|594093610|FG001|Overall Study|Lost to Follow-up|2|||
164469546|NCT02076009|594093609|FG000|Overall Study|Progressive Disease|1|||
164469547|NCT02076009|594093610|FG001|Overall Study|Progressive Disease|0|||
164469548|NCT02076009|594093609|FG000|Overall Study|Physician Decision|0|||
164469549|NCT02076009|594093610|FG001|Overall Study|Physician Decision|1|||
164469550|NCT02076009|594093609|FG000|Overall Study|End of data collection|90|||
164469551|NCT02076009|594093610|FG001|Overall Study|End of data collection|118|||
164469552|NCT04165213|594093611|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
164469553|NCT04165213|594093612|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
164469554|NCT04165213|594093611|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
164469555|NCT04165213|594093612|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
164469556|NCT04165213|594093611|FG000|Clinician Enrollment|Termination from site|0|||
164469557|NCT04165213|594093612|FG001|Clinician Enrollment|Termination from site|1|||
164469558|NCT04165213|594093611|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
164469559|NCT04165213|594093612|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
164469560|NCT04165213|594093611|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
164469561|NCT04165213|594093612|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
164469562|NCT04165213|594093611|FG000|Caregiver Enrollment|Physician Decision|1|||
164469563|NCT04165213|594093612|FG001|Caregiver Enrollment|Physician Decision|0|||
164469564|NCT04165213|594093611|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
164712258|NCT00369317|594970322|FG000|Overall Study|Adverse Event|3|||
164416881|NCT00900627|593897805|FG005|Overall Study|Death|24|||
164416882|NCT00373295|593897806|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
164712259|NCT00369317|594970322|FG000|Overall Study|Death|1|||
164712260|NCT00369317|594970322|FG000|Overall Study|Lack of Efficacy|5|||
164712261|NCT00369317|594970322|FG000|Overall Study|Physician Decision|2|||
164712262|NCT00369317|594970322|FG000|Overall Study|Withdrawal by Subject|8|||
164712263|NCT00369317|594970322|FG000|Overall Study|Ineligible|1|||
164712264|NCT02722148|594970328|FG000|Overall Study|Lost to Follow-up|2|||
164712265|NCT02722148|594970328|FG000|Overall Study|Non compliant with treatment regimen|3|||
164416883|NCT00373295|593897807|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
164416884|NCT00373295|593897808|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
164416885|NCT00373295|593897809|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
164416886|NCT00373295|593897810|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
164416887|NCT00373295|593897811|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
164416888|NCT00830947|593897812|FG000|Overall Study|Lost to Follow-up|4|||
164416889|NCT00830947|593897813|FG001|Overall Study|Lost to Follow-up|4|||
164416890|NCT01087723|593897822|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
164416891|NCT01087723|593897823|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
164416892|NCT01087723|593897822|FG000|Overall Study|Withdrawal by Subject|10|||
164416893|NCT01087723|593897823|FG001|Overall Study|Withdrawal by Subject|13|||
164416894|NCT01087723|593897822|FG000|Overall Study|Physician Decision|2|||
164416895|NCT01087723|593897823|FG001|Overall Study|Physician Decision|0|||
164416896|NCT01087723|593897822|FG000|Overall Study|Lost to Follow-up|1|||
164416897|NCT01087723|593897823|FG001|Overall Study|Lost to Follow-up|4|||
164416898|NCT01087723|593897822|FG000|Overall Study|Reason Not Specified|1|||
164416899|NCT01087723|593897823|FG001|Overall Study|Reason Not Specified|2|||
164416900|NCT01868035|593897824|FG000|Overall Study|Lost to Follow-up|3|||
164416901|NCT01868035|593897824|FG000|Overall Study|Withdrawal by Subject|1|||
164416902|NCT01868035|593897824|FG000|Overall Study|Progressive Disease|2|||
164416903|NCT01868035|593897824|FG000|Overall Study|Non-compliance|1|||
164416904|NCT01912222|593897827|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
164416905|NCT01912222|593897828|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
164416906|NCT01912222|593897829|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
164416907|NCT01912222|593897827|FG000|Part B: Treatment Period|Progressive disease|10|||
164416908|NCT01912222|593897828|FG001|Part B: Treatment Period|Progressive disease|12|||
164416909|NCT01912222|593897829|FG002|Part B: Treatment Period|Progressive disease|15|||
164416910|NCT01912222|593897827|FG000|Part B: Treatment Period|Adverse Event|1|||
164416911|NCT01912222|593897828|FG001|Part B: Treatment Period|Adverse Event|2|||
164416912|NCT01912222|593897829|FG002|Part B: Treatment Period|Adverse Event|3|||
164416913|NCT01912222|593897827|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
164416914|NCT01912222|593897828|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
164416915|NCT01912222|593897829|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
164416916|NCT01804673|593897830|FG000|Overall Study|Adverse Event|4|||
164416917|NCT01804673|593897830|FG000|Overall Study|Withdrawal by Subject|1|||
164416918|NCT01804673|593897830|FG000|Overall Study|Lack of Efficacy|9|||
164416919|NCT01804673|593897830|FG000|Overall Study|Change to Oral Therapy|37|||
164416920|NCT01804673|593897830|FG000|Overall Study|No Further Therapy Required|84|||
164416921|NCT01804673|593897830|FG000|Overall Study|Use of Prohibited Medication|1|||
164416922|NCT01804673|593897830|FG000|Overall Study|Other|4|||
164416923|NCT01857934|593897831|FG000|Overall Study|Relapse or progression|2|||
164416924|NCT01857934|593897831|FG000|Overall Study|Unacceptable toxicity|3|||
164416925|NCT01857934|593897831|FG000|Overall Study|Unwillingness or inability to comply|2|||
164416926|NCT01857934|593897831|FG000|Overall Study|Physician Decision|3|||
164416927|NCT04012814|593897835|FG000|Overall Study|Lost to Follow-up|4|||
164416928|NCT04012814|593897835|FG000|Overall Study|Withdrawal by Subject|2|||
164416929|NCT04012814|593897835|FG000|Overall Study|Protocol Violation|1|||
164416930|NCT04012814|593897835|FG000|Overall Study|Adverse Event|1|||
164416931|NCT04175912|593897841|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
164416932|NCT04175912|593897842|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
164416933|NCT04175912|593897841|FG000|Overall Study|Adverse Event|0|||
164416934|NCT04175912|593897842|FG001|Overall Study|Adverse Event|3|||
164416935|NCT04175912|593897841|FG000|Overall Study|Never started treatment|3|||
164416936|NCT04175912|593897842|FG001|Overall Study|Never started treatment|3|||
164416937|NCT04175912|593897841|FG000|Overall Study|Death|0|||
164416938|NCT04175912|593897842|FG001|Overall Study|Death|1|||
164416939|NCT04654468|593897843|FG000|Overall Study|Death|1|||
164416940|NCT04654468|593897843|FG000|Overall Study|Ongoing in the Study|50|||
164416941|NCT01155661|593897844|FG000|Overall Study|Adverse Event|101|||
164416942|NCT01155661|593897844|FG000|Overall Study|Death|1|||
164416943|NCT01155661|593897844|FG000|Overall Study|Lack of Efficacy|32|||
164416944|NCT01155661|593897844|FG000|Overall Study|Lost to Follow-up|22|||
164416945|NCT01155661|593897844|FG000|Overall Study|Physician Decision|3|||
164416946|NCT01155661|593897844|FG000|Overall Study|Protocol Violation|35|||
164416947|NCT01155661|593897844|FG000|Overall Study|Withdrawal by Subject|73|||
164712266|NCT01458106|594970329|FG000|Overall Study|Withdrawal by Subject|2|||
164712267|NCT01458106|594970330|FG001|Overall Study|Withdrawal by Subject|0|||
164712268|NCT01458106|594970329|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
164712269|NCT01458106|594970330|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
164712270|NCT01458106|594970329|FG000|Overall Study|Withdrawn Per Protocol|0|||
164712271|NCT01458106|594970330|FG001|Overall Study|Withdrawn Per Protocol|1|||
164712272|NCT00073021|594970331|FG000|Overall Study|Protocol Violation|2|||
164712273|NCT00073021|594970332|FG001|Overall Study|Protocol Violation|1|||
164712274|NCT00073021|594970331|FG000|Overall Study|Adverse Event|4|||
164712275|NCT00073021|594970332|FG001|Overall Study|Adverse Event|4|||
164712276|NCT00073021|594970331|FG000|Overall Study|Withdrawal by Subject|6|||
164712277|NCT00073021|594970332|FG001|Overall Study|Withdrawal by Subject|5|||
164712278|NCT00073021|594970331|FG000|Overall Study|Physician Decision|3|||
164712279|NCT00073021|594970332|FG001|Overall Study|Physician Decision|1|||
164712280|NCT00073021|594970331|FG000|Overall Study|Lack of Efficacy|11|||
164712281|NCT00073021|594970332|FG001|Overall Study|Lack of Efficacy|5|||
164712282|NCT04428333|594970336|FG000|Overall Study|Physician Decision|5|||
164712283|NCT04428333|594970337|FG001|Overall Study|Physician Decision|6|||
164712284|NCT04428333|594970336|FG000|Overall Study|Withdrawal by Subject|1|||
164712285|NCT04428333|594970337|FG001|Overall Study|Withdrawal by Subject|3|||
164712286|NCT04428333|594970336|FG000|Overall Study|Study Terminated By Sponsor|14|||
164712287|NCT04428333|594970337|FG001|Overall Study|Study Terminated By Sponsor|16|||
164712288|NCT03155945|594970342|FG000|Overall Study|Lost to Follow-up|0|||
164712289|NCT03155945|594970343|FG001|Overall Study|Lost to Follow-up|1|||
164712290|NCT03155945|594970342|FG000|Overall Study|Withdrawal by Subject|0|||
164712291|NCT03155945|594970343|FG001|Overall Study|Withdrawal by Subject|1|||
164712292|NCT03155945|594970342|FG000|Overall Study|Other Reason|0|||
164712293|NCT03155945|594970343|FG001|Overall Study|Other Reason|1|||
164712294|NCT02013674|594970347|FG000|Overall Study|Death|0|||
164712295|NCT02013674|594970348|FG001|Overall Study|Death|1|||
164712296|NCT02013674|594970347|FG000|Overall Study|Lost to Follow-up|1|||
164712297|NCT02013674|594970348|FG001|Overall Study|Lost to Follow-up|0|||
164712298|NCT00416884|594970349|FG000|Overall Study|Study terminated due to low accrual|1|||
164712299|NCT03982199|594970350|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
164712300|NCT03982199|594970351|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
164712301|NCT03982199|594970352|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
164712302|NCT03982199|594970353|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
164712303|NCT03982199|594970354|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
164712304|NCT03982199|594970355|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
164712305|NCT03982199|594970356|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
164712306|NCT03982199|594970357|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
164712307|NCT03982199|594970358|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
164712308|NCT03982199|594970359|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
164712309|NCT03982199|594970360|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
164712310|NCT03982199|594970361|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
164712311|NCT03982199|594970362|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
164712312|NCT03982199|594970363|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
164712313|NCT03982199|594970350|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
164712314|NCT03982199|594970351|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
164712315|NCT03982199|594970352|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
164712316|NCT03982199|594970353|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
164712317|NCT03982199|594970354|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
164712318|NCT03982199|594970355|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
164712319|NCT03982199|594970356|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
164712320|NCT03982199|594970357|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
164712321|NCT03982199|594970358|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
164416948|NCT01155661|593897844|FG000|Overall Study|Sponsor Decision|13|||
164416949|NCT05407311|593897854|FG000|Overall Study|Withdrawal by Subject|5|||
164416950|NCT05407311|593897854|FG000|Overall Study|Protocol Violation|3|||
164416951|NCT05407311|593897854|FG000|Overall Study|Physician Decision|1|||
164416952|NCT05407311|593897854|FG000|Overall Study|Non-compliance|1|||
164416953|NCT01265823|593897855|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
164416954|NCT01265823|593897855|FG000|Overall Study|Failure to Return|4|||
164416955|NCT01265823|593897855|FG000|Overall Study|Protocol Violation|1|||
164416956|NCT01265823|593897855|FG000|Overall Study|Participant Request|1|||
164416957|NCT01263106|593897856|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
164416958|NCT01263106|593897857|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
164416959|NCT04844970|593897867|FG000|Overall Study|Adverse Event|0|||
164416960|NCT04844970|593897868|FG001|Overall Study|Adverse Event|1|||
164416961|NCT04844970|593897867|FG000|Overall Study|Withdrawal by Subject|2|||
164416962|NCT04844970|593897868|FG001|Overall Study|Withdrawal by Subject|0|||
164416963|NCT05027074|593897869|FG000|Overall Study|Death|47|||
164416964|NCT05027074|593897870|FG001|Overall Study|Death|42|||
164416965|NCT05027074|593897871|FG002|Overall Study|Death|39|||
164416966|NCT05027074|593897869|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
164416967|NCT05027074|593897870|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164712322|NCT03982199|594970359|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
164712323|NCT03982199|594970360|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
164712324|NCT03982199|594970361|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
164416968|NCT05027074|593897871|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
164416969|NCT05027074|593897869|FG000|Overall Study|Site Terminated By Sponsor|3|||
164416970|NCT05027074|593897870|FG001|Overall Study|Site Terminated By Sponsor|0|||
164416971|NCT05027074|593897871|FG002|Overall Study|Site Terminated By Sponsor|2|||
164416972|NCT05027074|593897869|FG000|Overall Study|Withdrawal by Subject|13|||
164416973|NCT05027074|593897870|FG001|Overall Study|Withdrawal by Subject|8|||
164416974|NCT05027074|593897871|FG002|Overall Study|Withdrawal by Subject|10|||
164416975|NCT05027074|593897869|FG000|Overall Study|Lost to Follow-up|2|||
164416976|NCT05027074|593897870|FG001|Overall Study|Lost to Follow-up|4|||
164416977|NCT05027074|593897871|FG002|Overall Study|Lost to Follow-up|3|||
164416978|NCT05027074|593897869|FG000|Overall Study|Status Not Recorded|0|||
164416979|NCT05027074|593897870|FG001|Overall Study|Status Not Recorded|0|||
164416980|NCT05027074|593897871|FG002|Overall Study|Status Not Recorded|1|||
164416981|NCT03169881|593897872|FG000|Overall Study|Incomplete Follow-up|10|||
164416982|NCT03169881|593897873|FG001|Overall Study|Incomplete Follow-up|15|||
164416983|NCT03169881|593897872|FG000|Overall Study|Lost to Follow-up|18|||
164416984|NCT03169881|593897873|FG001|Overall Study|Lost to Follow-up|20|||
164416985|NCT03169881|593897872|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
164416986|NCT03169881|593897873|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
164416987|NCT00447954|593897876|FG000|Overall Study|Adverse Event|0|||
164416988|NCT00447954|593897877|FG001|Overall Study|Adverse Event|2|||
164416989|NCT00447954|593897878|FG002|Overall Study|Adverse Event|0|||
164416990|NCT00447954|593897876|FG000|Overall Study|Withdrawal by Subject|0|||
164416991|NCT00447954|593897877|FG001|Overall Study|Withdrawal by Subject|1|||
164416992|NCT00447954|593897878|FG002|Overall Study|Withdrawal by Subject|1|||
164416993|NCT00447954|593897876|FG000|Overall Study|Lost to Follow-up|0|||
164416994|NCT00447954|593897877|FG001|Overall Study|Lost to Follow-up|1|||
164416995|NCT00447954|593897878|FG002|Overall Study|Lost to Follow-up|0|||
164416996|NCT00447954|593897876|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
164416997|NCT00447954|593897877|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
164416998|NCT00447954|593897878|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
164416999|NCT02180438|593897882|FG000|Overall Study|Lost to Follow-up|1|||
164417000|NCT00785707|593897883|FG000|Overall Study|Lost to Follow-up|7|||
164417001|NCT02090634|593897884|FG000|Overall Study|Lost to Follow-up|0|||
164417002|NCT02090634|593897885|FG001|Overall Study|Lost to Follow-up|1|||
164417003|NCT02090634|593897884|FG000|Overall Study|Death|0|||
164417004|NCT02090634|593897885|FG001|Overall Study|Death|1|||
164417005|NCT02090634|593897884|FG000|Overall Study|Protocol Violation|3|||
164417006|NCT02090634|593897885|FG001|Overall Study|Protocol Violation|1|||
164417007|NCT02090634|593897884|FG000|Overall Study|Adverse Event|2|||
164417008|NCT02090634|593897885|FG001|Overall Study|Adverse Event|0|||
164417009|NCT03757234|593897886|FG000|Overall Study|Adverse Event|0|||
164417010|NCT03757234|593897887|FG001|Overall Study|Adverse Event|0|||
164417011|NCT03757234|593897888|FG002|Overall Study|Adverse Event|0|||
164417012|NCT03757234|593897889|FG003|Overall Study|Adverse Event|0|||
164417013|NCT03757234|593897890|FG004|Overall Study|Adverse Event|1|||
164417014|NCT03757234|593897886|FG000|Overall Study|Lost to Follow-up|1|||
164417015|NCT03757234|593897887|FG001|Overall Study|Lost to Follow-up|0|||
164417016|NCT03757234|593897888|FG002|Overall Study|Lost to Follow-up|0|||
164417017|NCT03757234|593897889|FG003|Overall Study|Lost to Follow-up|0|||
164417018|NCT03757234|593897890|FG004|Overall Study|Lost to Follow-up|1|||
164417019|NCT03757234|593897886|FG000|Overall Study|Withdrawal by Subject|1|||
164417020|NCT03757234|593897887|FG001|Overall Study|Withdrawal by Subject|1|||
164417021|NCT03757234|593897888|FG002|Overall Study|Withdrawal by Subject|0|||
164417022|NCT03757234|593897889|FG003|Overall Study|Withdrawal by Subject|1|||
164417023|NCT03757234|593897890|FG004|Overall Study|Withdrawal by Subject|2|||
164417024|NCT03757234|593897886|FG000|Overall Study|Other|1|||
164417025|NCT03757234|593897887|FG001|Overall Study|Other|1|||
164417026|NCT03757234|593897888|FG002|Overall Study|Other|0|||
164417027|NCT03757234|593897889|FG003|Overall Study|Other|0|||
164417028|NCT03757234|593897890|FG004|Overall Study|Other|0|||
164417029|NCT04908449|593897894|FG000|Overall Study|Patient with major surgical bleeding unerlated to block|0|||
164417030|NCT04908449|593897895|FG001|Overall Study|Patient with major surgical bleeding unerlated to block|1|||
164417031|NCT04908449|593897894|FG000|Overall Study|Patient required postop RVAD, unrelated to block|0|||
164417032|NCT04908449|593897895|FG001|Overall Study|Patient required postop RVAD, unrelated to block|1|||
164417033|NCT02401308|593897898|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
164417034|NCT02401308|593897899|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
164417035|NCT01518946|593897900|FG000|Open-label Phase|Other|4|||
164417036|NCT01518946|593897901|FG001|Open-label Phase|Other|0|||
164417037|NCT01518946|593897902|FG002|Open-label Phase|Other|0|||
164417038|NCT01518946|593897900|FG000|Randomized Phase (First Intervention)|Other|0|||
164417039|NCT01518946|593897901|FG001|Randomized Phase (First Intervention)|Other|1|||
164417040|NCT01518946|593897902|FG002|Randomized Phase (First Intervention)|Other|0|||
164469565|NCT04165213|594093612|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
164469566|NCT04165213|594093611|FG000|Caregiver Enrollment|PLWD death|2|||
164469567|NCT04165213|594093612|FG001|Caregiver Enrollment|PLWD death|0|||
164712325|NCT03982199|594970362|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
164712326|NCT03982199|594970363|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
164712327|NCT03982199|594970350|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
164712328|NCT03982199|594970351|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
164712329|NCT03982199|594970352|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
164712330|NCT03982199|594970353|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
164712331|NCT03982199|594970354|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
164712332|NCT03982199|594970355|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
164712333|NCT03982199|594970356|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
164712334|NCT03982199|594970357|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
164712335|NCT03982199|594970358|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
164712336|NCT03982199|594970359|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
164712337|NCT03982199|594970360|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
164712338|NCT03982199|594970361|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
164712339|NCT03982199|594970362|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
164712340|NCT03982199|594970363|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
164712341|NCT03982199|594970350|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
164712342|NCT03982199|594970351|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
164712343|NCT03982199|594970352|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
164712344|NCT03982199|594970353|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
164712345|NCT03982199|594970354|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
164712346|NCT03982199|594970355|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
164712347|NCT03982199|594970356|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
164712348|NCT03982199|594970357|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
164712349|NCT03982199|594970358|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
164712350|NCT03982199|594970359|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
164712351|NCT03982199|594970360|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
164712352|NCT03982199|594970361|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
164712353|NCT03982199|594970362|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
164712354|NCT03982199|594970363|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
164712355|NCT03982199|594970350|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
164712356|NCT03982199|594970351|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
164712357|NCT03982199|594970352|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
164712358|NCT03982199|594970353|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
164712359|NCT03982199|594970354|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
164712360|NCT03982199|594970355|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
164712361|NCT03982199|594970356|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
164712362|NCT03982199|594970357|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
164712363|NCT03982199|594970358|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
164712364|NCT03982199|594970359|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
164712365|NCT03982199|594970360|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
164712366|NCT03982199|594970361|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
164712367|NCT03982199|594970362|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
164712368|NCT03982199|594970363|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
164712369|NCT03982199|594970350|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
164712370|NCT03982199|594970351|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
164712371|NCT03982199|594970352|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
164712372|NCT03982199|594970353|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
164712373|NCT03982199|594970354|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
164712374|NCT03982199|594970355|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
164712375|NCT03982199|594970356|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
164712376|NCT03982199|594970357|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
164712377|NCT03982199|594970358|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
164712378|NCT03982199|594970359|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
164712379|NCT03982199|594970360|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
164712380|NCT03982199|594970361|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
164712381|NCT03982199|594970362|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
164712382|NCT03982199|594970363|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
164469568|NCT04165213|594093611|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
164469569|NCT04165213|594093612|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
164469570|NCT04165213|594093611|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
164712383|NCT03982199|594970350|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
164712384|NCT03982199|594970351|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
164712385|NCT03982199|594970352|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
164417041|NCT00381641|593897903|FG000|Overall Study|Withdrawal by Subject|0|||
164469571|NCT04165213|594093612|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
164469572|NCT04165213|594093611|FG000|PLWD Enrollment|Lost to Follow-up|1|||
164469573|NCT04165213|594093612|FG001|PLWD Enrollment|Lost to Follow-up|1|||
164469574|NCT04165213|594093611|FG000|PLWD Enrollment|Physician Decision|1|||
164469575|NCT04165213|594093612|FG001|PLWD Enrollment|Physician Decision|0|||
164469576|NCT04165213|594093611|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
164469577|NCT04165213|594093612|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
164469578|NCT04165213|594093611|FG000|PLWD Enrollment|Death|2|||
164469579|NCT04165213|594093612|FG001|PLWD Enrollment|Death|0|||
164469580|NCT04165213|594093611|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
164469581|NCT04165213|594093612|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
164469582|NCT04464564|594093613|FG000|Period A (Placebo lead-in)|Other|5|||
164712386|NCT03982199|594970353|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
164712387|NCT03982199|594970354|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
164712388|NCT03982199|594970355|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
164712389|NCT03982199|594970356|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
164712390|NCT03982199|594970357|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
164712391|NCT03982199|594970358|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
164712392|NCT03982199|594970359|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
164712393|NCT03982199|594970360|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
164712394|NCT03982199|594970361|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
164712395|NCT03982199|594970362|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
164712396|NCT03982199|594970363|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
164712397|NCT03982199|594970350|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
164712398|NCT03982199|594970351|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
164712399|NCT03982199|594970352|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
164712400|NCT03982199|594970353|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
164712401|NCT03982199|594970354|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
164417042|NCT00381641|593897904|FG001|Overall Study|Withdrawal by Subject|2|||
164417043|NCT01474512|593899489|FG000|Induction Period|Adverse Event|6|||
164417044|NCT01474512|593899490|FG001|Induction Period|Adverse Event|10|||
164417045|NCT01474512|593899491|FG002|Induction Period|Adverse Event|10|||
164712402|NCT03982199|594970355|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
164712403|NCT03982199|594970356|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
164712404|NCT03982199|594970357|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
164712405|NCT03982199|594970358|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
164712406|NCT03982199|594970359|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
164712407|NCT03982199|594970360|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
164712408|NCT03982199|594970361|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
164712409|NCT03982199|594970362|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
164712410|NCT03982199|594970363|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
164712411|NCT03982199|594970350|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
164712412|NCT03982199|594970351|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
164712413|NCT03982199|594970352|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
164712414|NCT03982199|594970353|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
164712415|NCT03982199|594970354|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
164712416|NCT03982199|594970355|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
164417046|NCT01474512|593899492|FG003|Induction Period|Adverse Event|0|||
164417047|NCT01474512|593899493|FG004|Induction Period|Adverse Event|0|||
164417048|NCT01474512|593899494|FG005|Induction Period|Adverse Event|0|||
164417049|NCT01474512|593899495|FG006|Induction Period|Adverse Event|0|||
164417050|NCT01474512|593899496|FG007|Induction Period|Adverse Event|0|||
164417051|NCT01474512|593899497|FG008|Induction Period|Adverse Event|0|||
164417052|NCT01474512|593899498|FG009|Induction Period|Adverse Event|0|||
164417053|NCT01474512|593899499|FG010|Induction Period|Adverse Event|0|||
164417054|NCT01474512|593899500|FG011|Induction Period|Adverse Event|0|||
164417055|NCT01474512|593899501|FG012|Induction Period|Adverse Event|0|||
164417056|NCT01474512|593899502|FG013|Induction Period|Adverse Event|0|||
164417057|NCT01474512|593899503|FG014|Induction Period|Adverse Event|0|||
164417058|NCT01474512|593899504|FG015|Induction Period|Adverse Event|0|||
164417059|NCT01474512|593899505|FG016|Induction Period|Adverse Event|0|||
164417060|NCT01474512|593899506|FG017|Induction Period|Adverse Event|0|||
164417061|NCT01474512|593899489|FG000|Induction Period|Lack of Efficacy|7|||
164417062|NCT01474512|593899490|FG001|Induction Period|Lack of Efficacy|1|||
164417063|NCT01474512|593899491|FG002|Induction Period|Lack of Efficacy|0|||
164417064|NCT01474512|593899492|FG003|Induction Period|Lack of Efficacy|0|||
164417065|NCT01474512|593899493|FG004|Induction Period|Lack of Efficacy|0|||
164417066|NCT01474512|593899494|FG005|Induction Period|Lack of Efficacy|0|||
164417067|NCT01474512|593899495|FG006|Induction Period|Lack of Efficacy|0|||
164417068|NCT01474512|593899496|FG007|Induction Period|Lack of Efficacy|0|||
164469583|NCT04464564|594093614|FG001|Period A (Placebo lead-in)|Other|0|||
164469584|NCT04464564|594093615|FG002|Period A (Placebo lead-in)|Other|0|||
164469585|NCT04464564|594093616|FG003|Period A (Placebo lead-in)|Other|0|||
164469586|NCT04464564|594093613|FG000|Period B (Randomization Period)|Adverse Event|0|||
164469587|NCT04464564|594093614|FG001|Period B (Randomization Period)|Adverse Event|1|||
164469588|NCT04464564|594093615|FG002|Period B (Randomization Period)|Adverse Event|2|||
164469589|NCT04464564|594093616|FG003|Period B (Randomization Period)|Adverse Event|8|||
164469590|NCT04464564|594093613|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
164469591|NCT04464564|594093614|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
164469592|NCT04464564|594093615|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
164469593|NCT04464564|594093616|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
164469594|NCT04464564|594093613|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
164469595|NCT04464564|594093614|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
164469596|NCT04464564|594093615|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
164469597|NCT04464564|594093616|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
164469598|NCT04464564|594093613|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
164469599|NCT04464564|594093614|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
164469600|NCT04464564|594093615|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
164469601|NCT04464564|594093616|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
164469602|NCT04464564|594093613|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
164469603|NCT04464564|594093614|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
164469604|NCT04464564|594093615|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
164469605|NCT04464564|594093616|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
164469606|NCT04464564|594093613|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
164469607|NCT04464564|594093614|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
164469608|NCT04464564|594093615|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
164469609|NCT04464564|594093616|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
164469610|NCT04464564|594093613|FG000|Period B (Randomization Period)|Reason not Specified|0|||
164469611|NCT04464564|594093614|FG001|Period B (Randomization Period)|Reason not Specified|3|||
164469612|NCT04464564|594093615|FG002|Period B (Randomization Period)|Reason not Specified|3|||
164469613|NCT04464564|594093616|FG003|Period B (Randomization Period)|Reason not Specified|3|||
164469614|NCT03786926|594093619|FG000|Overall Study|Adverse Event|0|||
164469615|NCT03786926|594093620|FG001|Overall Study|Adverse Event|0|||
164469616|NCT03786926|594093621|FG002|Overall Study|Adverse Event|0|||
164469617|NCT03786926|594093622|FG003|Overall Study|Adverse Event|0|||
164469618|NCT03786926|594093623|FG004|Overall Study|Adverse Event|0|||
164469619|NCT03786926|594093624|FG005|Overall Study|Adverse Event|0|||
164469620|NCT03786926|594093625|FG006|Overall Study|Adverse Event|0|||
164469621|NCT03786926|594093626|FG007|Overall Study|Adverse Event|1|||
164469622|NCT03786926|594093627|FG008|Overall Study|Adverse Event|1|||
164469623|NCT03786926|594093628|FG009|Overall Study|Adverse Event|0|||
164469624|NCT03786926|594093629|FG010|Overall Study|Adverse Event|1|||
164469625|NCT03786926|594093619|FG000|Overall Study|Progressive disease|3|||
164469626|NCT03786926|594093620|FG001|Overall Study|Progressive disease|0|||
164712417|NCT03982199|594970356|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
164712418|NCT03982199|594970357|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
164712419|NCT03982199|594970358|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
164712420|NCT03982199|594970359|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
164712421|NCT03982199|594970360|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
164712422|NCT03982199|594970361|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
164712423|NCT03982199|594970362|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
164712424|NCT03982199|594970363|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
164712425|NCT03982199|594970350|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
164712426|NCT03982199|594970351|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
164712427|NCT03982199|594970352|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
164712428|NCT03982199|594970353|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
164712429|NCT03982199|594970354|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
164712430|NCT03982199|594970355|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
164712431|NCT03982199|594970356|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
164712432|NCT03982199|594970357|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
164469627|NCT03786926|594093621|FG002|Overall Study|Progressive disease|3|||
164469628|NCT03786926|594093622|FG003|Overall Study|Progressive disease|1|||
164712433|NCT03982199|594970358|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
164712434|NCT03982199|594970359|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
164469629|NCT03786926|594093623|FG004|Overall Study|Progressive disease|2|||
164469630|NCT03786926|594093624|FG005|Overall Study|Progressive disease|2|||
164469631|NCT03786926|594093625|FG006|Overall Study|Progressive disease|1|||
164469632|NCT03786926|594093626|FG007|Overall Study|Progressive disease|6|||
164469633|NCT03786926|594093627|FG008|Overall Study|Progressive disease|1|||
164469634|NCT03786926|594093628|FG009|Overall Study|Progressive disease|1|||
164469635|NCT03786926|594093629|FG010|Overall Study|Progressive disease|1|||
164469636|NCT03786926|594093619|FG000|Overall Study|Death|0|||
164469637|NCT03786926|594093620|FG001|Overall Study|Death|1|||
164469638|NCT03786926|594093621|FG002|Overall Study|Death|1|||
164469639|NCT03786926|594093622|FG003|Overall Study|Death|0|||
164469640|NCT03786926|594093623|FG004|Overall Study|Death|0|||
164469641|NCT03786926|594093624|FG005|Overall Study|Death|0|||
164469642|NCT03786926|594093625|FG006|Overall Study|Death|0|||
164469643|NCT03786926|594093626|FG007|Overall Study|Death|0|||
164469644|NCT03786926|594093627|FG008|Overall Study|Death|0|||
164469645|NCT03786926|594093628|FG009|Overall Study|Death|1|||
164469646|NCT03786926|594093629|FG010|Overall Study|Death|2|||
164469647|NCT03786926|594093619|FG000|Overall Study|Physician Decision|0|||
164469648|NCT03786926|594093620|FG001|Overall Study|Physician Decision|1|||
164469649|NCT03786926|594093621|FG002|Overall Study|Physician Decision|0|||
164469650|NCT03786926|594093622|FG003|Overall Study|Physician Decision|1|||
164469651|NCT03786926|594093623|FG004|Overall Study|Physician Decision|2|||
164469652|NCT03786926|594093624|FG005|Overall Study|Physician Decision|0|||
164469653|NCT03786926|594093625|FG006|Overall Study|Physician Decision|0|||
164469654|NCT03786926|594093626|FG007|Overall Study|Physician Decision|2|||
164469655|NCT03786926|594093627|FG008|Overall Study|Physician Decision|1|||
164469656|NCT03786926|594093628|FG009|Overall Study|Physician Decision|1|||
164469657|NCT03786926|594093629|FG010|Overall Study|Physician Decision|0|||
164469658|NCT03786926|594093619|FG000|Overall Study|Withdrawal by Subject|0|||
164469659|NCT03786926|594093620|FG001|Overall Study|Withdrawal by Subject|1|||
164469660|NCT03786926|594093621|FG002|Overall Study|Withdrawal by Subject|1|||
164469661|NCT03786926|594093622|FG003|Overall Study|Withdrawal by Subject|0|||
164469662|NCT03786926|594093623|FG004|Overall Study|Withdrawal by Subject|0|||
164469663|NCT03786926|594093624|FG005|Overall Study|Withdrawal by Subject|0|||
164469664|NCT03786926|594093625|FG006|Overall Study|Withdrawal by Subject|1|||
164469665|NCT03786926|594093626|FG007|Overall Study|Withdrawal by Subject|0|||
164469666|NCT03786926|594093627|FG008|Overall Study|Withdrawal by Subject|1|||
164469667|NCT03786926|594093628|FG009|Overall Study|Withdrawal by Subject|0|||
164469668|NCT03786926|594093629|FG010|Overall Study|Withdrawal by Subject|1|||
164469669|NCT03786926|594093619|FG000|Overall Study|Study terminated by Sponsor|0|||
164469670|NCT03786926|594093620|FG001|Overall Study|Study terminated by Sponsor|0|||
164469671|NCT03786926|594093621|FG002|Overall Study|Study terminated by Sponsor|0|||
164469672|NCT03786926|594093622|FG003|Overall Study|Study terminated by Sponsor|0|||
164469673|NCT03786926|594093623|FG004|Overall Study|Study terminated by Sponsor|1|||
164469674|NCT03786926|594093624|FG005|Overall Study|Study terminated by Sponsor|0|||
164469675|NCT03786926|594093625|FG006|Overall Study|Study terminated by Sponsor|0|||
164469676|NCT03786926|594093626|FG007|Overall Study|Study terminated by Sponsor|4|||
164469677|NCT03786926|594093627|FG008|Overall Study|Study terminated by Sponsor|0|||
164469678|NCT03786926|594093628|FG009|Overall Study|Study terminated by Sponsor|0|||
164469679|NCT03786926|594093629|FG010|Overall Study|Study terminated by Sponsor|0|||
164469680|NCT03786926|594093619|FG000|Overall Study|Anti-neoplasm treatment|0|||
164469681|NCT03786926|594093620|FG001|Overall Study|Anti-neoplasm treatment|0|||
164469682|NCT03786926|594093621|FG002|Overall Study|Anti-neoplasm treatment|0|||
164469683|NCT03786926|594093622|FG003|Overall Study|Anti-neoplasm treatment|0|||
164469684|NCT03786926|594093623|FG004|Overall Study|Anti-neoplasm treatment|1|||
164469685|NCT03786926|594093624|FG005|Overall Study|Anti-neoplasm treatment|0|||
164469686|NCT03786926|594093625|FG006|Overall Study|Anti-neoplasm treatment|1|||
164469687|NCT03786926|594093626|FG007|Overall Study|Anti-neoplasm treatment|0|||
164469688|NCT03786926|594093627|FG008|Overall Study|Anti-neoplasm treatment|0|||
164469689|NCT03786926|594093628|FG009|Overall Study|Anti-neoplasm treatment|0|||
164469690|NCT03786926|594093629|FG010|Overall Study|Anti-neoplasm treatment|0|||
164469691|NCT03786926|594093619|FG000|Overall Study|Other|0|||
164469692|NCT03786926|594093620|FG001|Overall Study|Other|0|||
164469693|NCT03786926|594093621|FG002|Overall Study|Other|0|||
164469694|NCT03786926|594093622|FG003|Overall Study|Other|1|||
164469695|NCT03786926|594093623|FG004|Overall Study|Other|0|||
164469696|NCT03786926|594093624|FG005|Overall Study|Other|1|||
164469697|NCT03786926|594093625|FG006|Overall Study|Other|0|||
164469698|NCT03786926|594093626|FG007|Overall Study|Other|0|||
164469699|NCT03786926|594093627|FG008|Overall Study|Other|2|||
164469700|NCT03786926|594093628|FG009|Overall Study|Other|0|||
164469701|NCT03786926|594093629|FG010|Overall Study|Other|0|||
164469702|NCT02278211|594093633|FG000|Overall Study|Unable to analyse PET scan|2|||
164469703|NCT02909686|594093635|FG000|Overall Study|Physician Decision|3|||
164469704|NCT02909686|594093635|FG000|Overall Study|Withdrawal by Subject|2|||
164469705|NCT03858517|594093636|FG000|Overall Study|Adverse Event|1|||
164469706|NCT03858517|594093636|FG000|Overall Study|Lost to Follow-up|1|||
164469707|NCT03858517|594093636|FG000|Overall Study|removed for being incarcerated|1|||
164469708|NCT03858517|594093636|FG000|Overall Study|Sponsor Closure|48|||
164712435|NCT03982199|594970360|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
164712436|NCT03982199|594970361|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
164712437|NCT03982199|594970362|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
164712438|NCT03982199|594970363|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
164712439|NCT03982199|594970350|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
164712440|NCT03982199|594970351|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
164712441|NCT03982199|594970352|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
164712442|NCT03982199|594970353|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
164712443|NCT03982199|594970354|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
164712444|NCT03982199|594970355|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
164712445|NCT03982199|594970356|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
164712446|NCT03982199|594970357|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
164712447|NCT03982199|594970358|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
164712448|NCT03982199|594970359|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
164712449|NCT03982199|594970360|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
164712450|NCT03982199|594970361|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
164712451|NCT03982199|594970362|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
164712452|NCT03982199|594970363|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
164712453|NCT03982199|594970350|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
164712454|NCT03982199|594970351|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
164712455|NCT03982199|594970352|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
164712456|NCT03982199|594970353|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
164712457|NCT03982199|594970354|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
164712458|NCT03982199|594970355|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
164712459|NCT03982199|594970356|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
164712460|NCT03982199|594970357|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
164712461|NCT03982199|594970358|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
164712462|NCT03982199|594970359|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
164712463|NCT03982199|594970360|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
164712464|NCT03982199|594970361|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
164712465|NCT03982199|594970362|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
164417069|NCT01474512|593899497|FG008|Induction Period|Lack of Efficacy|0|||
164417070|NCT01474512|593899498|FG009|Induction Period|Lack of Efficacy|0|||
164417071|NCT01474512|593899499|FG010|Induction Period|Lack of Efficacy|0|||
164417072|NCT01474512|593899500|FG011|Induction Period|Lack of Efficacy|0|||
164417073|NCT01474512|593899501|FG012|Induction Period|Lack of Efficacy|0|||
164417074|NCT01474512|593899502|FG013|Induction Period|Lack of Efficacy|0|||
164417075|NCT01474512|593899503|FG014|Induction Period|Lack of Efficacy|0|||
164417076|NCT01474512|593899504|FG015|Induction Period|Lack of Efficacy|0|||
164417077|NCT01474512|593899505|FG016|Induction Period|Lack of Efficacy|0|||
164417078|NCT01474512|593899506|FG017|Induction Period|Lack of Efficacy|0|||
164417079|NCT01474512|593899489|FG000|Induction Period|Withdrawal by Subject|6|||
164417080|NCT01474512|593899490|FG001|Induction Period|Withdrawal by Subject|6|||
164417081|NCT01474512|593899491|FG002|Induction Period|Withdrawal by Subject|5|||
164417082|NCT01474512|593899492|FG003|Induction Period|Withdrawal by Subject|0|||
164417083|NCT01474512|593899493|FG004|Induction Period|Withdrawal by Subject|0|||
164417084|NCT01474512|593899494|FG005|Induction Period|Withdrawal by Subject|0|||
164417085|NCT01474512|593899495|FG006|Induction Period|Withdrawal by Subject|0|||
164417086|NCT01474512|593899496|FG007|Induction Period|Withdrawal by Subject|0|||
164417087|NCT01474512|593899497|FG008|Induction Period|Withdrawal by Subject|0|||
164417088|NCT01474512|593899498|FG009|Induction Period|Withdrawal by Subject|0|||
164417089|NCT01474512|593899499|FG010|Induction Period|Withdrawal by Subject|0|||
164417090|NCT01474512|593899500|FG011|Induction Period|Withdrawal by Subject|0|||
164417091|NCT01474512|593899501|FG012|Induction Period|Withdrawal by Subject|0|||
164417092|NCT01474512|593899502|FG013|Induction Period|Withdrawal by Subject|0|||
164417093|NCT01474512|593899503|FG014|Induction Period|Withdrawal by Subject|0|||
164417094|NCT01474512|593899504|FG015|Induction Period|Withdrawal by Subject|0|||
164417095|NCT01474512|593899505|FG016|Induction Period|Withdrawal by Subject|0|||
164417096|NCT01474512|593899506|FG017|Induction Period|Withdrawal by Subject|0|||
164417097|NCT01474512|593899489|FG000|Induction Period|Protocol Violation|3|||
164417098|NCT01474512|593899490|FG001|Induction Period|Protocol Violation|6|||
164417099|NCT01474512|593899491|FG002|Induction Period|Protocol Violation|0|||
164417100|NCT01474512|593899492|FG003|Induction Period|Protocol Violation|0|||
164417101|NCT01474512|593899493|FG004|Induction Period|Protocol Violation|0|||
164417102|NCT01474512|593899494|FG005|Induction Period|Protocol Violation|0|||
164417103|NCT01474512|593899495|FG006|Induction Period|Protocol Violation|0|||
164417104|NCT01474512|593899496|FG007|Induction Period|Protocol Violation|0|||
164417105|NCT01474512|593899497|FG008|Induction Period|Protocol Violation|0|||
164712466|NCT03982199|594970363|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
164712467|NCT03982199|594970350|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164712468|NCT03982199|594970351|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164712469|NCT03982199|594970352|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164712470|NCT03982199|594970353|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
164712471|NCT03982199|594970354|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164712472|NCT03982199|594970355|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164712473|NCT03982199|594970356|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164712474|NCT03982199|594970357|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164712475|NCT03982199|594970358|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164712476|NCT03982199|594970359|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164712477|NCT03982199|594970360|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164712478|NCT03982199|594970361|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164712479|NCT03982199|594970362|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164712480|NCT03982199|594970363|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164712481|NCT03982199|594970350|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164712482|NCT03982199|594970351|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164712483|NCT03982199|594970352|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
164712484|NCT03982199|594970353|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164712485|NCT03982199|594970354|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164712486|NCT03982199|594970355|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164712487|NCT03982199|594970356|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164712488|NCT03982199|594970357|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164712489|NCT03982199|594970358|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164712490|NCT03982199|594970359|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164712491|NCT03982199|594970360|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164712492|NCT03982199|594970361|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164712493|NCT03982199|594970362|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164712494|NCT03982199|594970363|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164712495|NCT03982199|594970350|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164712496|NCT03982199|594970351|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164712497|NCT03982199|594970352|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
164712498|NCT03982199|594970353|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164712499|NCT03982199|594970354|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164712500|NCT03982199|594970355|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164712501|NCT03982199|594970356|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164712502|NCT03982199|594970357|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164712503|NCT03982199|594970358|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164712504|NCT03982199|594970359|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164712505|NCT03982199|594970360|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164712506|NCT03982199|594970361|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164712507|NCT03982199|594970362|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164712508|NCT03982199|594970363|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164712509|NCT03982199|594970350|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
164712510|NCT03982199|594970351|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
164712511|NCT03982199|594970352|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
164712512|NCT03982199|594970353|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
164712513|NCT03982199|594970354|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
164712514|NCT03982199|594970355|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
164712515|NCT03982199|594970356|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
164712516|NCT03982199|594970357|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
164712517|NCT03982199|594970358|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
164712518|NCT03982199|594970359|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
164712519|NCT03982199|594970360|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
164712520|NCT03982199|594970361|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
164712521|NCT03982199|594970362|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
164712522|NCT03982199|594970363|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
164712523|NCT03982199|594970350|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164417106|NCT01474512|593899498|FG009|Induction Period|Protocol Violation|0|||
164417107|NCT01474512|593899499|FG010|Induction Period|Protocol Violation|0|||
164417108|NCT01474512|593899500|FG011|Induction Period|Protocol Violation|0|||
164469709|NCT04804540|594093639|FG000|Overall Study|Adverse Event|26|||
164469710|NCT04804540|594093640|FG001|Overall Study|Adverse Event|13|||
164469711|NCT05172232|594093641|FG000|Overall Study|Lost to Follow-up|3|||
164469712|NCT01828021|594093642|FG000|Overall Study|Adverse Event|5|||
164469713|NCT01828021|594093642|FG000|Overall Study|Lack of Efficacy|17|||
164469714|NCT01828021|594093642|FG000|Overall Study|Withdrawal by Subject|2|||
164469715|NCT01828021|594093642|FG000|Overall Study|Ileal obstruction, unrelated|1|||
164469716|NCT00303459|594093653|FG000|Overall Study|Death|33|||
164469717|NCT00303459|594093654|FG001|Overall Study|Death|44|||
164469718|NCT00303459|594093653|FG000|Overall Study|Withdrawal of consent|32|||
164469719|NCT00303459|594093654|FG001|Overall Study|Withdrawal of consent|26|||
164712524|NCT03982199|594970351|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164712525|NCT03982199|594970352|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164712526|NCT03982199|594970353|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
164712527|NCT03982199|594970354|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164712528|NCT03982199|594970355|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164712529|NCT03982199|594970356|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164712530|NCT03982199|594970357|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164712531|NCT03982199|594970358|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164712532|NCT03982199|594970359|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164712533|NCT03982199|594970360|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164712534|NCT03982199|594970361|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164712535|NCT03982199|594970362|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164712536|NCT03982199|594970363|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164712537|NCT03982199|594970350|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
164712538|NCT03982199|594970351|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
164712539|NCT03982199|594970352|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
164712540|NCT03982199|594970353|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
164712541|NCT03982199|594970354|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
164712542|NCT03982199|594970355|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
164712543|NCT03982199|594970356|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
164712544|NCT03982199|594970357|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
164712545|NCT03982199|594970358|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
164712546|NCT03982199|594970359|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
164712547|NCT03982199|594970360|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
164712548|NCT03982199|594970361|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
164712549|NCT03982199|594970362|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
164712550|NCT03982199|594970363|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
164469720|NCT00303459|594093653|FG000|Overall Study|Lost to Follow-up|5|||
164469721|NCT00303459|594093654|FG001|Overall Study|Lost to Follow-up|4|||
164469722|NCT00303459|594093653|FG000|Overall Study|Administrative reason|7|||
164712551|NCT03982199|594970350|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164712552|NCT03982199|594970351|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164712553|NCT03982199|594970352|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164712554|NCT03982199|594970353|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164712555|NCT03982199|594970354|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164712556|NCT03982199|594970355|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164712557|NCT03982199|594970356|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164469723|NCT00303459|594093654|FG001|Overall Study|Administrative reason|7|||
164469724|NCT00303459|594093653|FG000|Overall Study|Decision by the investigator|5|||
164469725|NCT00303459|594093654|FG001|Overall Study|Decision by the investigator|7|||
164469726|NCT00303459|594093653|FG000|Overall Study|Lung transplantation|1|||
164469727|NCT00303459|594093654|FG001|Overall Study|Lung transplantation|1|||
164469728|NCT04163991|594093657|FG000|Overall Study|Adverse Event|0|||
164469729|NCT04163991|594093658|FG001|Overall Study|Adverse Event|0|||
164469730|NCT04163991|594093659|FG002|Overall Study|Adverse Event|0|||
164469731|NCT04163991|594093660|FG003|Overall Study|Adverse Event|1|||
164712558|NCT03982199|594970357|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164712559|NCT03982199|594970358|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
164469732|NCT04163991|594093661|FG004|Overall Study|Adverse Event|0|||
164469733|NCT04163991|594093657|FG000|Overall Study|Death|0|||
164469734|NCT04163991|594093658|FG001|Overall Study|Death|0|||
164469735|NCT04163991|594093659|FG002|Overall Study|Death|1|||
164469736|NCT04163991|594093660|FG003|Overall Study|Death|0|||
164469737|NCT04163991|594093661|FG004|Overall Study|Death|0|||
164469738|NCT04163991|594093657|FG000|Overall Study|Lost to Follow-up|0|||
164469739|NCT04163991|594093658|FG001|Overall Study|Lost to Follow-up|1|||
164469740|NCT04163991|594093659|FG002|Overall Study|Lost to Follow-up|0|||
164469741|NCT04163991|594093660|FG003|Overall Study|Lost to Follow-up|0|||
164469742|NCT04163991|594093661|FG004|Overall Study|Lost to Follow-up|0|||
164712560|NCT03982199|594970359|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164712561|NCT03982199|594970360|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164712562|NCT03982199|594970361|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164712563|NCT03982199|594970362|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164712564|NCT03982199|594970363|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164712565|NCT03982199|594970350|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164712566|NCT03982199|594970351|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164417109|NCT01474512|593899501|FG012|Induction Period|Protocol Violation|0|||
164417110|NCT01474512|593899502|FG013|Induction Period|Protocol Violation|0|||
164417111|NCT01474512|593899503|FG014|Induction Period|Protocol Violation|0|||
164417112|NCT01474512|593899504|FG015|Induction Period|Protocol Violation|0|||
164417113|NCT01474512|593899505|FG016|Induction Period|Protocol Violation|0|||
164417114|NCT01474512|593899506|FG017|Induction Period|Protocol Violation|0|||
164417115|NCT01474512|593899489|FG000|Induction Period|Sponsor Decision|1|||
164417116|NCT01474512|593899490|FG001|Induction Period|Sponsor Decision|1|||
164417117|NCT01474512|593899491|FG002|Induction Period|Sponsor Decision|1|||
164417118|NCT01474512|593899492|FG003|Induction Period|Sponsor Decision|0|||
164417119|NCT01474512|593899493|FG004|Induction Period|Sponsor Decision|0|||
164417120|NCT01474512|593899494|FG005|Induction Period|Sponsor Decision|0|||
164417121|NCT01474512|593899495|FG006|Induction Period|Sponsor Decision|0|||
164417122|NCT01474512|593899496|FG007|Induction Period|Sponsor Decision|0|||
164417123|NCT01474512|593899497|FG008|Induction Period|Sponsor Decision|0|||
164417124|NCT01474512|593899498|FG009|Induction Period|Sponsor Decision|0|||
164417125|NCT01474512|593899499|FG010|Induction Period|Sponsor Decision|0|||
164417126|NCT01474512|593899500|FG011|Induction Period|Sponsor Decision|0|||
164417127|NCT01474512|593899501|FG012|Induction Period|Sponsor Decision|0|||
164417128|NCT01474512|593899502|FG013|Induction Period|Sponsor Decision|0|||
164417129|NCT01474512|593899503|FG014|Induction Period|Sponsor Decision|0|||
164417130|NCT01474512|593899504|FG015|Induction Period|Sponsor Decision|0|||
164417131|NCT01474512|593899505|FG016|Induction Period|Sponsor Decision|0|||
164417132|NCT01474512|593899506|FG017|Induction Period|Sponsor Decision|0|||
164417133|NCT01474512|593899489|FG000|Induction Period|Lost to Follow-up|1|||
164417134|NCT01474512|593899490|FG001|Induction Period|Lost to Follow-up|0|||
164417135|NCT01474512|593899491|FG002|Induction Period|Lost to Follow-up|2|||
164417136|NCT01474512|593899492|FG003|Induction Period|Lost to Follow-up|0|||
164417137|NCT01474512|593899493|FG004|Induction Period|Lost to Follow-up|0|||
164417138|NCT01474512|593899494|FG005|Induction Period|Lost to Follow-up|0|||
164417139|NCT01474512|593899495|FG006|Induction Period|Lost to Follow-up|0|||
164417140|NCT01474512|593899496|FG007|Induction Period|Lost to Follow-up|0|||
164417141|NCT01474512|593899497|FG008|Induction Period|Lost to Follow-up|0|||
164417142|NCT01474512|593899498|FG009|Induction Period|Lost to Follow-up|0|||
164417143|NCT01474512|593899499|FG010|Induction Period|Lost to Follow-up|0|||
164417144|NCT01474512|593899500|FG011|Induction Period|Lost to Follow-up|0|||
164417145|NCT01474512|593899501|FG012|Induction Period|Lost to Follow-up|0|||
164417146|NCT01474512|593899502|FG013|Induction Period|Lost to Follow-up|0|||
164417147|NCT01474512|593899503|FG014|Induction Period|Lost to Follow-up|0|||
164417148|NCT01474512|593899504|FG015|Induction Period|Lost to Follow-up|0|||
164417149|NCT01474512|593899505|FG016|Induction Period|Lost to Follow-up|0|||
164417150|NCT01474512|593899506|FG017|Induction Period|Lost to Follow-up|0|||
164417151|NCT01474512|593899489|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
164417152|NCT01474512|593899490|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
164417153|NCT01474512|593899491|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
164417154|NCT01474512|593899492|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
164417155|NCT01474512|593899493|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
164417156|NCT01474512|593899494|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
164417157|NCT01474512|593899495|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
164417158|NCT01474512|593899496|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
164417159|NCT01474512|593899497|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
164417160|NCT01474512|593899498|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
164417161|NCT01474512|593899499|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
164417162|NCT01474512|593899500|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
164417163|NCT01474512|593899501|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
164417164|NCT01474512|593899502|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
164417165|NCT01474512|593899503|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
164417166|NCT01474512|593899504|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
164417167|NCT01474512|593899505|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
164417168|NCT01474512|593899506|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
164417169|NCT01474512|593899489|FG000|Maintenance Period|Adverse Event|0|||
164417170|NCT01474512|593899490|FG001|Maintenance Period|Adverse Event|0|||
164417171|NCT01474512|593899491|FG002|Maintenance Period|Adverse Event|0|||
164417172|NCT01474512|593899492|FG003|Maintenance Period|Adverse Event|4|||
164417173|NCT01474512|593899493|FG004|Maintenance Period|Adverse Event|2|||
164417174|NCT01474512|593899494|FG005|Maintenance Period|Adverse Event|7|||
164417175|NCT01474512|593899495|FG006|Maintenance Period|Adverse Event|0|||
164417176|NCT01474512|593899496|FG007|Maintenance Period|Adverse Event|19|||
164417177|NCT01474512|593899497|FG008|Maintenance Period|Adverse Event|1|||
164469743|NCT04163991|594093657|FG000|Overall Study|Withdrawal by Subject|1|||
164469744|NCT04163991|594093658|FG001|Overall Study|Withdrawal by Subject|1|||
164469745|NCT04163991|594093659|FG002|Overall Study|Withdrawal by Subject|3|||
164469746|NCT04163991|594093660|FG003|Overall Study|Withdrawal by Subject|1|||
164469747|NCT04163991|594093661|FG004|Overall Study|Withdrawal by Subject|1|||
164469748|NCT04163991|594093657|FG000|Overall Study|Other, Not Specified|0|||
164469749|NCT04163991|594093658|FG001|Overall Study|Other, Not Specified|1|||
164469750|NCT04163991|594093659|FG002|Overall Study|Other, Not Specified|1|||
164469751|NCT04163991|594093660|FG003|Overall Study|Other, Not Specified|1|||
164469752|NCT04163991|594093661|FG004|Overall Study|Other, Not Specified|0|||
164469753|NCT05953740|594093662|FG000|Period 1|Physician Decision|0|||
164469754|NCT05953740|594093663|FG001|Period 1|Physician Decision|1|||
164469755|NCT05953740|594093664|FG002|Period 1|Physician Decision|0|||
164469756|NCT05953740|594093665|FG003|Period 1|Physician Decision|0|||
164469757|NCT05953740|594093666|FG004|Period 1|Physician Decision|0|||
164469758|NCT05953740|594093667|FG005|Period 1|Physician Decision|0|||
164469759|NCT05953740|594093668|FG006|Period 1|Physician Decision|0|||
164469760|NCT05953740|594093669|FG007|Period 1|Physician Decision|0|||
164469761|NCT05953740|594093662|FG000|Period 2|Withdrawal by Subject|0|||
164469762|NCT05953740|594093663|FG001|Period 2|Withdrawal by Subject|1|||
164469763|NCT05953740|594093664|FG002|Period 2|Withdrawal by Subject|1|||
164469764|NCT05953740|594093665|FG003|Period 2|Withdrawal by Subject|0|||
164469765|NCT05953740|594093666|FG004|Period 2|Withdrawal by Subject|0|||
164469766|NCT05953740|594093667|FG005|Period 2|Withdrawal by Subject|0|||
164469767|NCT05953740|594093668|FG006|Period 2|Withdrawal by Subject|0|||
164469768|NCT05953740|594093669|FG007|Period 2|Withdrawal by Subject|0|||
164469769|NCT05112900|594093670|FG000|Overall Study|Withdrawal by Subject|960|||
164469770|NCT05112900|594093671|FG001|Overall Study|Withdrawal by Subject|921|||
164469771|NCT05112900|594093672|FG002|Overall Study|Withdrawal by Subject|968|||
164469772|NCT05541484|594093675|FG000|Overall Study|Withdrawal by Subject|1|||
164469773|NCT05541484|594093676|FG001|Overall Study|Withdrawal by Subject|0|||
164469774|NCT01438853|594093682|FG000|Overall Study|Death|0|||
164469775|NCT01438853|594093683|FG001|Overall Study|Death|0|||
164469776|NCT01438853|594093684|FG002|Overall Study|Death|0|||
164469777|NCT01438853|594093685|FG003|Overall Study|Death|1|||
164469778|NCT01438853|594093682|FG000|Overall Study|Withdrawal by Subject|0|||
164469779|NCT01438853|594093683|FG001|Overall Study|Withdrawal by Subject|0|||
164469780|NCT01438853|594093684|FG002|Overall Study|Withdrawal by Subject|1|||
164469781|NCT01438853|594093685|FG003|Overall Study|Withdrawal by Subject|0|||
164469782|NCT04743973|594093687|FG000|Overall Study|Withdrawal by Subject|5|||
164469783|NCT00626795|594093688|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
164469784|NCT00626795|594093689|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
164469785|NCT00626795|594093690|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
164469786|NCT00626795|594093688|FG000|Blinded Treatment|Lack of Efficacy|2|||
164469787|NCT00626795|594093689|FG001|Blinded Treatment|Lack of Efficacy|0|||
164469788|NCT00626795|594093690|FG002|Blinded Treatment|Lack of Efficacy|0|||
164469789|NCT00626795|594093688|FG000|Blinded Treatment|Unacceptable adverse event|0|||
164469790|NCT00626795|594093689|FG001|Blinded Treatment|Unacceptable adverse event|0|||
164469791|NCT00626795|594093690|FG002|Blinded Treatment|Unacceptable adverse event|1|||
164469792|NCT00626795|594093688|FG000|Blinded Treatment|Protocol Violation|0|||
164469793|NCT00626795|594093689|FG001|Blinded Treatment|Protocol Violation|1|||
164469794|NCT00626795|594093690|FG002|Blinded Treatment|Protocol Violation|1|||
164469795|NCT00626795|594093688|FG000|Blinded Treatment|Withdrawal by Subject|1|||
164469796|NCT00626795|594093689|FG001|Blinded Treatment|Withdrawal by Subject|1|||
164469797|NCT00626795|594093690|FG002|Blinded Treatment|Withdrawal by Subject|0|||
164469798|NCT00626795|594093688|FG000|Blinded Treatment|Other reasons|2|||
164469799|NCT00626795|594093689|FG001|Blinded Treatment|Other reasons|0|||
164417178|NCT01474512|593899498|FG009|Maintenance Period|Adverse Event|3|||
164417179|NCT01474512|593899499|FG010|Maintenance Period|Adverse Event|0|||
164417180|NCT01474512|593899500|FG011|Maintenance Period|Adverse Event|0|||
164417181|NCT01474512|593899501|FG012|Maintenance Period|Adverse Event|0|||
164417182|NCT01474512|593899502|FG013|Maintenance Period|Adverse Event|0|||
164417183|NCT01474512|593899503|FG014|Maintenance Period|Adverse Event|0|||
164417184|NCT01474512|593899504|FG015|Maintenance Period|Adverse Event|0|||
164469800|NCT00626795|594093690|FG002|Blinded Treatment|Other reasons|2|||
164469801|NCT00626795|594093688|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
164469802|NCT00626795|594093689|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
164469803|NCT00626795|594093690|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
164469804|NCT04499521|594093694|FG000|Overall Study|Disease Progression|1|||
164469805|NCT04499521|594093695|FG001|Overall Study|Disease Progression|0|||
164469806|NCT05988398|594094468|FG000|Overall Study|Lack of time|21|||
164417185|NCT01474512|593899505|FG016|Maintenance Period|Adverse Event|0|||
164469807|NCT05988398|594094469|FG001|Overall Study|Lack of time|0|||
164469808|NCT05988398|594094468|FG000|Overall Study|Absent from school|0|||
164469809|NCT05988398|594094469|FG001|Overall Study|Absent from school|38|||
164469810|NCT05988398|594094468|FG000|Overall Study|Chose not to participate|0|||
164417186|NCT01474512|593899506|FG017|Maintenance Period|Adverse Event|0|||
164712567|NCT03982199|594970352|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164712568|NCT03982199|594970353|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164712569|NCT03982199|594970354|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164712570|NCT03982199|594970355|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164712571|NCT03982199|594970356|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164712572|NCT03982199|594970357|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164712573|NCT03982199|594970358|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
164712574|NCT03982199|594970359|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164712575|NCT03982199|594970360|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164712576|NCT03982199|594970361|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164712577|NCT03982199|594970362|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164712578|NCT03982199|594970363|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164712579|NCT03982199|594970350|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164712580|NCT03982199|594970351|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164712581|NCT03982199|594970352|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164712582|NCT03982199|594970353|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164712583|NCT03982199|594970354|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164712584|NCT03982199|594970355|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164712585|NCT03982199|594970356|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164712586|NCT03982199|594970357|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164712587|NCT03982199|594970358|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
164712588|NCT03982199|594970359|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164712589|NCT03982199|594970360|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164712590|NCT03982199|594970361|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164712591|NCT03982199|594970362|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164712592|NCT03982199|594970363|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164712593|NCT03982199|594970350|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164712594|NCT03982199|594970351|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164712595|NCT03982199|594970352|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164712596|NCT03982199|594970353|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164712597|NCT03982199|594970354|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164712598|NCT03982199|594970355|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164712599|NCT03982199|594970356|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164712600|NCT03982199|594970357|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164712601|NCT03982199|594970358|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
164712602|NCT03982199|594970359|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164712603|NCT03982199|594970360|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164712604|NCT03982199|594970361|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164712605|NCT03982199|594970362|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164712606|NCT03982199|594970363|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164712607|NCT03982199|594970350|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164712608|NCT03982199|594970351|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164712609|NCT03982199|594970352|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164712610|NCT03982199|594970353|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164712611|NCT03982199|594970354|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164712612|NCT03982199|594970355|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164712613|NCT03982199|594970356|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164469811|NCT05988398|594094469|FG001|Overall Study|Chose not to participate|42|||
164469812|NCT05988398|594094468|FG000|Overall Study|Other commitments (e.g., sports)|0|||
164469813|NCT05988398|594094469|FG001|Overall Study|Other commitments (e.g., sports)|25|||
164469814|NCT03733626|594094471|FG000|Overall Study|Physician Decision|4|||
164469815|NCT03733626|594094472|FG001|Overall Study|Physician Decision|4|||
164469816|NCT02997202|594094473|FG000|Overall Study|Miscellaneous|2|||
164469817|NCT02997202|594094474|FG001|Overall Study|Miscellaneous|2|||
164469818|NCT02997202|594094473|FG000|Overall Study|Withdrawal by Subject|8|||
164469819|NCT02997202|594094474|FG001|Overall Study|Withdrawal by Subject|12|||
164469820|NCT02997202|594094473|FG000|Overall Study|Lost to Follow-up|5|||
164469821|NCT02997202|594094474|FG001|Overall Study|Lost to Follow-up|3|||
164469822|NCT02997202|594094473|FG000|Overall Study|Death|41|||
164469823|NCT02997202|594094474|FG001|Overall Study|Death|45|||
164712614|NCT03982199|594970357|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164712615|NCT03982199|594970358|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
164712616|NCT03982199|594970359|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164469824|NCT05147584|594094475|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
164469825|NCT04055012|594094482|FG000|Overall Study|Withdrawal by Subject|1|||
164469826|NCT04055012|594094483|FG001|Overall Study|Withdrawal by Subject|3|||
164469827|NCT04055012|594094484|FG002|Overall Study|Withdrawal by Subject|1|||
164469828|NCT04055012|594094485|FG003|Overall Study|Withdrawal by Subject|0|||
164469829|NCT04055012|594094482|FG000|Overall Study|Metformin Recall|1|||
164469830|NCT04055012|594094483|FG001|Overall Study|Metformin Recall|1|||
164469831|NCT04055012|594094484|FG002|Overall Study|Metformin Recall|1|||
164469832|NCT04055012|594094485|FG003|Overall Study|Metformin Recall|0|||
164469833|NCT02492711|594094489|FG000|Overall Study|Adverse Event|9|||
164469834|NCT02492711|594094490|FG001|Overall Study|Adverse Event|9|||
164469835|NCT02492711|594094491|FG002|Overall Study|Adverse Event|2|||
164469836|NCT02492711|594094489|FG000|Overall Study|Death|3|||
164469837|NCT02492711|594094490|FG001|Overall Study|Death|3|||
164469838|NCT02492711|594094491|FG002|Overall Study|Death|0|||
164469839|NCT02492711|594094489|FG000|Overall Study|Withdrawal by Subject|10|||
164469840|NCT02492711|594094490|FG001|Overall Study|Withdrawal by Subject|16|||
164469841|NCT02492711|594094491|FG002|Overall Study|Withdrawal by Subject|5|||
164469842|NCT02492711|594094489|FG000|Overall Study|Physician Decision|10|||
164469843|NCT02492711|594094490|FG001|Overall Study|Physician Decision|6|||
164469844|NCT02492711|594094491|FG002|Overall Study|Physician Decision|4|||
164469845|NCT02492711|594094489|FG000|Overall Study|Lost to Follow-up|0|||
164469846|NCT02492711|594094490|FG001|Overall Study|Lost to Follow-up|0|||
164469847|NCT02492711|594094491|FG002|Overall Study|Lost to Follow-up|1|||
164469848|NCT02492711|594094489|FG000|Overall Study|study treatment delay|2|||
164469849|NCT02492711|594094490|FG001|Overall Study|study treatment delay|1|||
164469850|NCT02492711|594094491|FG002|Overall Study|study treatment delay|0|||
164469851|NCT02492711|594094489|FG000|Overall Study|change in chemotherapy|0|||
164469852|NCT02492711|594094490|FG001|Overall Study|change in chemotherapy|1|||
164469853|NCT02492711|594094491|FG002|Overall Study|change in chemotherapy|0|||
164469854|NCT02492711|594094489|FG000|Overall Study|never treated|2|||
164469855|NCT02492711|594094490|FG001|Overall Study|never treated|4|||
164469856|NCT02492711|594094491|FG002|Overall Study|never treated|0|||
164469857|NCT02492711|594094489|FG000|Overall Study|Other|0|||
164469858|NCT02492711|594094490|FG001|Overall Study|Other|0|||
164469859|NCT02492711|594094491|FG002|Overall Study|Other|1|||
164469860|NCT03652272|594094495|FG000|3 Month|Withdrawal by Subject|1|||
164469861|NCT03652272|594094496|FG001|3 Month|Withdrawal by Subject|1|||
164469862|NCT03652272|594094495|FG000|3 Month|Lost to Follow-up|16|||
164469863|NCT03652272|594094496|FG001|3 Month|Lost to Follow-up|14|||
164469864|NCT02163694|594094497|FG000|Overall Study|Adverse event- related to progression|4|||
164469865|NCT02163694|594094498|FG001|Overall Study|Adverse event- related to progression|10|||
164469866|NCT02163694|594094497|FG000|Overall Study|Adverse event- not related to progression|7|||
164469867|NCT02163694|594094498|FG001|Overall Study|Adverse event- not related to progression|22|||
164469868|NCT02163694|594094497|FG000|Overall Study|Withdrew consent|13|||
164469869|NCT02163694|594094498|FG001|Overall Study|Withdrew consent|28|||
164469870|NCT02163694|594094497|FG000|Overall Study|Lost to Follow-up|2|||
164469871|NCT02163694|594094498|FG001|Overall Study|Lost to Follow-up|2|||
164469872|NCT02163694|594094497|FG000|Overall Study|Sponsor discontinued study|3|||
164469873|NCT02163694|594094498|FG001|Overall Study|Sponsor discontinued study|29|||
164469874|NCT02163694|594094497|FG000|Overall Study|Progressive disease per protocol|125|||
164712617|NCT03982199|594970360|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164712618|NCT03982199|594970361|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164712619|NCT03982199|594970362|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164712620|NCT03982199|594970363|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164469875|NCT02163694|594094498|FG001|Overall Study|Progressive disease per protocol|224|||
164469876|NCT02163694|594094497|FG000|Overall Study|Other, not specified|17|||
164469877|NCT02163694|594094498|FG001|Overall Study|Other, not specified|22|||
164469878|NCT02163694|594094497|FG000|Overall Study|Randomized but Not Treated|1|||
164469879|NCT02163694|594094498|FG001|Overall Study|Randomized but Not Treated|0|||
164469880|NCT02163694|594094497|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
164469881|NCT02163694|594094498|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
164469882|NCT03884101|594094499|FG000|Overall Study|Participant Ongoing in Study|202|||
164469883|NCT03884101|594094500|FG001|Overall Study|Participant Ongoing in Study|186|||
164469884|NCT03884101|594094499|FG000|Overall Study|Death|212|||
164712621|NCT03982199|594970350|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
164712622|NCT03982199|594970351|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
164469885|NCT03884101|594094500|FG001|Overall Study|Death|224|||
164469886|NCT03884101|594094499|FG000|Overall Study|Lost to Follow-up|0|||
164469887|NCT03884101|594094500|FG001|Overall Study|Lost to Follow-up|1|||
164469888|NCT03884101|594094499|FG000|Overall Study|Withdrawal by Subject|6|||
164469889|NCT03884101|594094500|FG001|Overall Study|Withdrawal by Subject|11|||
164469890|NCT03370913|594094501|FG000|Overall Study|Death|1|||
164469891|NCT03370913|594094501|FG000|Overall Study|Lost to Follow-up|1|||
164469892|NCT04560179|594094504|FG000|Overall Study|Physician Decision|1|||
164469893|NCT04560179|594094505|FG001|Overall Study|Physician Decision|0|||
164469894|NCT04560179|594094506|FG002|Overall Study|Physician Decision|0|||
164469895|NCT04560179|594094507|FG003|Overall Study|Physician Decision|0|||
164469896|NCT04560179|594094508|FG004|Overall Study|Physician Decision|0|||
164469897|NCT04560179|594094504|FG000|Overall Study|Adverse Event|0|||
164469898|NCT04560179|594094505|FG001|Overall Study|Adverse Event|0|||
164469899|NCT04560179|594094506|FG002|Overall Study|Adverse Event|0|||
164469900|NCT04560179|594094507|FG003|Overall Study|Adverse Event|1|||
164469901|NCT04560179|594094508|FG004|Overall Study|Adverse Event|0|||
164469902|NCT03880955|594094511|FG000|Overall Study|Adverse Event|1|||
164469903|NCT03880955|594094511|FG000|Overall Study|Death|1|||
164469904|NCT03880955|594094511|FG000|Overall Study|Lost to Follow-up|12|||
164469905|NCT03880955|594094511|FG000|Overall Study|Withdrawal by Subject|4|||
164599720|NCT02951988|594556357|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
164469906|NCT03880955|594094511|FG000|Overall Study|Missing- Study Site Closed|27|||
164469907|NCT04078152|594094512|FG000|Overall Study|Other|83|||
164599721|NCT02951988|594556358|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
164599722|NCT02951988|594556355|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
164599723|NCT02951988|594556356|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
164599724|NCT02951988|594556357|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
164599725|NCT02951988|594556358|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
164599726|NCT02951988|594556355|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
164599727|NCT02951988|594556356|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
164599728|NCT02951988|594556357|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
164599729|NCT02951988|594556358|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
164599730|NCT02951988|594556355|FG000|Open-Label Treatment Period|Protocol Violation|22|||
164599731|NCT02951988|594556356|FG001|Open-Label Treatment Period|Protocol Violation|0|||
164599732|NCT02951988|594556357|FG002|Open-Label Treatment Period|Protocol Violation|0|||
164599733|NCT02951988|594556358|FG003|Open-Label Treatment Period|Protocol Violation|0|||
164599734|NCT02951988|594556355|FG000|Open-Label Treatment Period|Pregnancy|2|||
164599735|NCT02951988|594556356|FG001|Open-Label Treatment Period|Pregnancy|0|||
164599736|NCT02951988|594556357|FG002|Open-Label Treatment Period|Pregnancy|0|||
164599737|NCT02951988|594556358|FG003|Open-Label Treatment Period|Pregnancy|0|||
164599738|NCT02951988|594556355|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
164599739|NCT02951988|594556356|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
164599740|NCT02951988|594556357|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
164599741|NCT02951988|594556358|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
164599742|NCT02951988|594556355|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
164599743|NCT02951988|594556356|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
164599744|NCT02951988|594556357|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
164599745|NCT02951988|594556358|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
164599746|NCT02951988|594556355|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
164599747|NCT02951988|594556356|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
164599748|NCT02951988|594556357|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
164599749|NCT02951988|594556358|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
164599750|NCT02951988|594556355|FG000|Open-Label Treatment Period|Adverse Event|45|||
164599751|NCT02951988|594556356|FG001|Open-Label Treatment Period|Adverse Event|0|||
164599752|NCT02951988|594556357|FG002|Open-Label Treatment Period|Adverse Event|0|||
164599753|NCT02951988|594556358|FG003|Open-Label Treatment Period|Adverse Event|0|||
164599754|NCT02951988|594556355|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
164599755|NCT02951988|594556356|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
164599756|NCT02951988|594556357|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
164599757|NCT02951988|594556358|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
164599758|NCT02951988|594556355|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
164599759|NCT02951988|594556356|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
164599760|NCT02951988|594556357|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
164599761|NCT02951988|594556358|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
164599762|NCT02951988|594556355|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
164599763|NCT02951988|594556356|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
164599764|NCT02951988|594556357|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
164599765|NCT02951988|594556358|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
164599766|NCT02951988|594556355|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
164599767|NCT02951988|594556356|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
164599768|NCT02951988|594556357|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
164599769|NCT02951988|594556358|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
164599770|NCT02951988|594556355|FG000|Double-Blind Treatment Period|Pregnancy|0|||
164599771|NCT02951988|594556356|FG001|Double-Blind Treatment Period|Pregnancy|1|||
164599772|NCT02951988|594556357|FG002|Double-Blind Treatment Period|Pregnancy|1|||
164599773|NCT02951988|594556358|FG003|Double-Blind Treatment Period|Pregnancy|0|||
164599774|NCT02951988|594556355|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
164599775|NCT02951988|594556356|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
164712623|NCT03982199|594970352|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
164712624|NCT03982199|594970353|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
164469908|NCT04078152|594094513|FG001|Overall Study|Other|22|||
164469909|NCT04078152|594094514|FG002|Overall Study|Other|25|||
164469910|NCT04078152|594094512|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
164469911|NCT04078152|594094513|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
164469912|NCT04078152|594094514|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
164469913|NCT04078152|594094512|FG000|Overall Study|Withdrawal by Subject|5|||
164469914|NCT04078152|594094513|FG001|Overall Study|Withdrawal by Subject|0|||
164469915|NCT04078152|594094514|FG002|Overall Study|Withdrawal by Subject|1|||
164469916|NCT04078152|594094512|FG000|Overall Study|Death|10|||
164469917|NCT04078152|594094513|FG001|Overall Study|Death|2|||
164469918|NCT04078152|594094514|FG002|Overall Study|Death|12|||
164469919|NCT04078152|594094512|FG000|Overall Study|Adverse Event|1|||
164469920|NCT04078152|594094513|FG001|Overall Study|Adverse Event|0|||
164469921|NCT04078152|594094514|FG002|Overall Study|Adverse Event|0|||
164469922|NCT04795245|594094518|FG000|Overall Study|Unkown reason|7|||
164469923|NCT04795245|594094518|FG000|Overall Study|Death|17|||
164469924|NCT04795245|594094518|FG000|Overall Study|Other than listed|19|||
164469925|NCT04795245|594094518|FG000|Overall Study|Adverse Event|143|||
164469926|NCT04795245|594094518|FG000|Overall Study|Progressive disease|512|||
164469927|NCT04795245|594094518|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
164469928|NCT02919917|594094519|FG000|Overall Study|Withdrawal by Subject|4|||
164469929|NCT02919917|594094520|FG001|Overall Study|Withdrawal by Subject|8|||
164469930|NCT03279978|594094525|FG000|Overall Study|Withdrawal by Subject|0|||
164469931|NCT03279978|594094526|FG001|Overall Study|Withdrawal by Subject|1|||
164469932|NCT03279978|594094527|FG002|Overall Study|Withdrawal by Subject|0|||
164469933|NCT03279978|594094528|FG003|Overall Study|Withdrawal by Subject|0|||
164469934|NCT03279978|594094529|FG004|Overall Study|Withdrawal by Subject|0|||
164469935|NCT03279978|594094530|FG005|Overall Study|Withdrawal by Subject|0|||
164469936|NCT03279978|594094531|FG006|Overall Study|Withdrawal by Subject|0|||
164469937|NCT03279978|594094532|FG007|Overall Study|Withdrawal by Subject|0|||
164469938|NCT03279978|594094533|FG008|Overall Study|Withdrawal by Subject|0|||
164469939|NCT03279978|594094534|FG009|Overall Study|Withdrawal by Subject|1|||
164469940|NCT03279978|594094525|FG000|Overall Study|Lost to Follow-up|1|||
164469941|NCT03279978|594094526|FG001|Overall Study|Lost to Follow-up|0|||
164469942|NCT03279978|594094527|FG002|Overall Study|Lost to Follow-up|1|||
164469943|NCT03279978|594094528|FG003|Overall Study|Lost to Follow-up|0|||
164469944|NCT03279978|594094529|FG004|Overall Study|Lost to Follow-up|0|||
164469945|NCT03279978|594094530|FG005|Overall Study|Lost to Follow-up|0|||
164469946|NCT03279978|594094531|FG006|Overall Study|Lost to Follow-up|0|||
164469947|NCT03279978|594094532|FG007|Overall Study|Lost to Follow-up|0|||
164469948|NCT03279978|594094533|FG008|Overall Study|Lost to Follow-up|0|||
164469949|NCT03279978|594094534|FG009|Overall Study|Lost to Follow-up|0|||
164469950|NCT03279978|594094525|FG000|Overall Study|Other than stated above|0|||
164469951|NCT03279978|594094526|FG001|Overall Study|Other than stated above|0|||
164469952|NCT03279978|594094527|FG002|Overall Study|Other than stated above|0|||
164469953|NCT03279978|594094528|FG003|Overall Study|Other than stated above|0|||
164469954|NCT03279978|594094529|FG004|Overall Study|Other than stated above|0|||
164469955|NCT03279978|594094530|FG005|Overall Study|Other than stated above|0|||
164469956|NCT03279978|594094531|FG006|Overall Study|Other than stated above|1|||
164469957|NCT03279978|594094532|FG007|Overall Study|Other than stated above|0|||
164469958|NCT03279978|594094533|FG008|Overall Study|Other than stated above|0|||
164469959|NCT03279978|594094534|FG009|Overall Study|Other than stated above|0|||
164469960|NCT02461134|594094536|FG000|Overall Study|Adverse Event|1|||
164712625|NCT03982199|594970354|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
164712626|NCT03982199|594970355|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
164712627|NCT03982199|594970356|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
164712628|NCT03982199|594970357|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
164712629|NCT03982199|594970358|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
164712630|NCT03982199|594970359|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
164712631|NCT03982199|594970360|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
164469961|NCT04159519|594094537|FG000|Overall Study|Adverse Event|1|||
164469962|NCT04159519|594094538|FG001|Overall Study|Adverse Event|1|||
164469963|NCT04159519|594094537|FG000|Overall Study|Lack of Efficacy|1|||
164469964|NCT04159519|594094538|FG001|Overall Study|Lack of Efficacy|0|||
164469965|NCT04159519|594094537|FG000|Overall Study|Discontinued from study|1|||
164469966|NCT04159519|594094538|FG001|Overall Study|Discontinued from study|0|||
164469967|NCT04159519|594094537|FG000|Overall Study|Protocol Violation|1|||
164469968|NCT04159519|594094538|FG001|Overall Study|Protocol Violation|1|||
164469969|NCT04159519|594094537|FG000|Overall Study|Withdrawal by Subject|4|||
164469970|NCT04159519|594094538|FG001|Overall Study|Withdrawal by Subject|4|||
164469971|NCT03493542|594094541|FG000|Base Study|Withdrawal by Subject|0|||
164469972|NCT03493542|594094542|FG001|Base Study|Withdrawal by Subject|4|||
164469973|NCT03493542|594094543|FG002|Base Study|Withdrawal by Subject|0|||
164712632|NCT03982199|594970361|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
164712633|NCT03982199|594970362|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
164417187|NCT01474512|593899489|FG000|Maintenance Period|Withdrawal by Subject|0|||
164417188|NCT01474512|593899490|FG001|Maintenance Period|Withdrawal by Subject|0|||
164417189|NCT01474512|593899491|FG002|Maintenance Period|Withdrawal by Subject|0|||
164417190|NCT01474512|593899492|FG003|Maintenance Period|Withdrawal by Subject|6|||
164417191|NCT01474512|593899493|FG004|Maintenance Period|Withdrawal by Subject|2|||
164417192|NCT01474512|593899494|FG005|Maintenance Period|Withdrawal by Subject|3|||
164417193|NCT01474512|593899495|FG006|Maintenance Period|Withdrawal by Subject|1|||
164417194|NCT01474512|593899496|FG007|Maintenance Period|Withdrawal by Subject|6|||
164417195|NCT01474512|593899497|FG008|Maintenance Period|Withdrawal by Subject|3|||
164417196|NCT01474512|593899498|FG009|Maintenance Period|Withdrawal by Subject|1|||
164417197|NCT01474512|593899499|FG010|Maintenance Period|Withdrawal by Subject|0|||
164417198|NCT01474512|593899500|FG011|Maintenance Period|Withdrawal by Subject|0|||
164417199|NCT01474512|593899501|FG012|Maintenance Period|Withdrawal by Subject|0|||
164417200|NCT01474512|593899502|FG013|Maintenance Period|Withdrawal by Subject|0|||
164417201|NCT01474512|593899503|FG014|Maintenance Period|Withdrawal by Subject|0|||
164417202|NCT01474512|593899504|FG015|Maintenance Period|Withdrawal by Subject|0|||
164417203|NCT01474512|593899505|FG016|Maintenance Period|Withdrawal by Subject|0|||
164417204|NCT01474512|593899506|FG017|Maintenance Period|Withdrawal by Subject|0|||
164417205|NCT01474512|593899489|FG000|Maintenance Period|Lost to Follow-up|0|||
164417206|NCT01474512|593899490|FG001|Maintenance Period|Lost to Follow-up|0|||
164417207|NCT01474512|593899491|FG002|Maintenance Period|Lost to Follow-up|0|||
164417208|NCT01474512|593899492|FG003|Maintenance Period|Lost to Follow-up|3|||
164417209|NCT01474512|593899493|FG004|Maintenance Period|Lost to Follow-up|3|||
164417210|NCT01474512|593899494|FG005|Maintenance Period|Lost to Follow-up|0|||
164417211|NCT01474512|593899495|FG006|Maintenance Period|Lost to Follow-up|0|||
164417212|NCT01474512|593899496|FG007|Maintenance Period|Lost to Follow-up|2|||
164417213|NCT01474512|593899497|FG008|Maintenance Period|Lost to Follow-up|1|||
164417214|NCT01474512|593899498|FG009|Maintenance Period|Lost to Follow-up|1|||
164417215|NCT01474512|593899499|FG010|Maintenance Period|Lost to Follow-up|0|||
164417216|NCT01474512|593899500|FG011|Maintenance Period|Lost to Follow-up|0|||
164417217|NCT01474512|593899501|FG012|Maintenance Period|Lost to Follow-up|0|||
164417218|NCT01474512|593899502|FG013|Maintenance Period|Lost to Follow-up|0|||
164417219|NCT01474512|593899503|FG014|Maintenance Period|Lost to Follow-up|0|||
164417220|NCT01474512|593899504|FG015|Maintenance Period|Lost to Follow-up|0|||
164417221|NCT01474512|593899505|FG016|Maintenance Period|Lost to Follow-up|0|||
164417222|NCT01474512|593899506|FG017|Maintenance Period|Lost to Follow-up|0|||
164417223|NCT01474512|593899489|FG000|Maintenance Period|Death|0|||
164417224|NCT01474512|593899490|FG001|Maintenance Period|Death|0|||
164417225|NCT01474512|593899491|FG002|Maintenance Period|Death|0|||
164417226|NCT01474512|593899492|FG003|Maintenance Period|Death|0|||
164417227|NCT01474512|593899493|FG004|Maintenance Period|Death|0|||
164417228|NCT01474512|593899494|FG005|Maintenance Period|Death|2|||
164417229|NCT01474512|593899495|FG006|Maintenance Period|Death|0|||
164417230|NCT01474512|593899496|FG007|Maintenance Period|Death|0|||
164417231|NCT01474512|593899497|FG008|Maintenance Period|Death|0|||
164417232|NCT01474512|593899498|FG009|Maintenance Period|Death|0|||
164417233|NCT01474512|593899499|FG010|Maintenance Period|Death|0|||
164417234|NCT01474512|593899500|FG011|Maintenance Period|Death|0|||
164417235|NCT01474512|593899501|FG012|Maintenance Period|Death|0|||
164417236|NCT01474512|593899502|FG013|Maintenance Period|Death|0|||
164417237|NCT01474512|593899503|FG014|Maintenance Period|Death|0|||
164417238|NCT01474512|593899504|FG015|Maintenance Period|Death|0|||
164417239|NCT01474512|593899505|FG016|Maintenance Period|Death|0|||
164417240|NCT01474512|593899506|FG017|Maintenance Period|Death|0|||
164417241|NCT01474512|593899489|FG000|Maintenance Period|Physician Decision|0|||
164417242|NCT01474512|593899490|FG001|Maintenance Period|Physician Decision|0|||
164417243|NCT01474512|593899491|FG002|Maintenance Period|Physician Decision|0|||
164417244|NCT01474512|593899492|FG003|Maintenance Period|Physician Decision|0|||
164469974|NCT03493542|594094541|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
164469975|NCT03493542|594094542|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
164469976|NCT03493542|594094543|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
164469977|NCT03493542|594094541|FG000|Extension Study|Withdrawal by Subject|0|||
164417245|NCT01474512|593899493|FG004|Maintenance Period|Physician Decision|0|||
164417246|NCT01474512|593899494|FG005|Maintenance Period|Physician Decision|1|||
164417247|NCT01474512|593899495|FG006|Maintenance Period|Physician Decision|0|||
164417248|NCT01474512|593899496|FG007|Maintenance Period|Physician Decision|2|||
164417249|NCT01474512|593899497|FG008|Maintenance Period|Physician Decision|0|||
164417250|NCT01474512|593899498|FG009|Maintenance Period|Physician Decision|0|||
164417251|NCT01474512|593899499|FG010|Maintenance Period|Physician Decision|0|||
164417252|NCT01474512|593899500|FG011|Maintenance Period|Physician Decision|0|||
164417253|NCT01474512|593899501|FG012|Maintenance Period|Physician Decision|0|||
164417254|NCT01474512|593899502|FG013|Maintenance Period|Physician Decision|0|||
164417255|NCT01474512|593899503|FG014|Maintenance Period|Physician Decision|0|||
164417256|NCT01474512|593899504|FG015|Maintenance Period|Physician Decision|0|||
164417257|NCT01474512|593899505|FG016|Maintenance Period|Physician Decision|0|||
164469978|NCT03493542|594094542|FG001|Extension Study|Withdrawal by Subject|0|||
164469979|NCT03493542|594094543|FG002|Extension Study|Withdrawal by Subject|25|||
164469980|NCT04595331|594095057|FG000|Overall Study|Withdrawal by Subject|0|||
164469981|NCT04595331|594095058|FG001|Overall Study|Withdrawal by Subject|1|||
164469982|NCT04595331|594095057|FG000|Overall Study|Lost to Follow-up|0|||
164469983|NCT04595331|594095058|FG001|Overall Study|Lost to Follow-up|5|||
164469984|NCT04595331|594095057|FG000|Overall Study|Medical reason|0|||
164469985|NCT04595331|594095058|FG001|Overall Study|Medical reason|1|||
164469986|NCT05412004|594095062|FG000|Overall Study|Adverse Event|0|||
164469987|NCT05412004|594095063|FG001|Overall Study|Adverse Event|2|||
164469988|NCT05412004|594095064|FG002|Overall Study|Adverse Event|1|||
164469989|NCT05412004|594095065|FG003|Overall Study|Adverse Event|5|||
164469990|NCT05412004|594095062|FG000|Overall Study|Assigned Treatment by Mistake|5|||
164469991|NCT05412004|594095063|FG001|Overall Study|Assigned Treatment by Mistake|10|||
164469992|NCT05412004|594095064|FG002|Overall Study|Assigned Treatment by Mistake|2|||
164469993|NCT05412004|594095065|FG003|Overall Study|Assigned Treatment by Mistake|5|||
164469994|NCT05412004|594095062|FG000|Overall Study|Lost to Follow-up|3|||
164469995|NCT05412004|594095063|FG001|Overall Study|Lost to Follow-up|0|||
164469996|NCT05412004|594095064|FG002|Overall Study|Lost to Follow-up|0|||
164469997|NCT05412004|594095065|FG003|Overall Study|Lost to Follow-up|0|||
164469998|NCT05412004|594095062|FG000|Overall Study|Patient could not travel to site|0|||
164469999|NCT05412004|594095063|FG001|Overall Study|Patient could not travel to site|1|||
164470000|NCT05412004|594095064|FG002|Overall Study|Patient could not travel to site|0|||
164470001|NCT05412004|594095065|FG003|Overall Study|Patient could not travel to site|0|||
164470002|NCT05412004|594095062|FG000|Overall Study|Physician Decision|0|||
164470003|NCT05412004|594095063|FG001|Overall Study|Physician Decision|1|||
164470004|NCT05412004|594095064|FG002|Overall Study|Physician Decision|0|||
164470005|NCT05412004|594095065|FG003|Overall Study|Physician Decision|0|||
164470006|NCT05412004|594095062|FG000|Overall Study|Pregnancy|0|||
164470007|NCT05412004|594095063|FG001|Overall Study|Pregnancy|1|||
164470008|NCT05412004|594095064|FG002|Overall Study|Pregnancy|0|||
164470009|NCT05412004|594095065|FG003|Overall Study|Pregnancy|0|||
164470010|NCT05412004|594095062|FG000|Overall Study|Protocol Violation|1|||
164470011|NCT05412004|594095063|FG001|Overall Study|Protocol Violation|0|||
164470012|NCT05412004|594095064|FG002|Overall Study|Protocol Violation|0|||
164470013|NCT05412004|594095065|FG003|Overall Study|Protocol Violation|0|||
164470014|NCT05412004|594095062|FG000|Overall Study|Withdrawal by Subject|4|||
164470015|NCT05412004|594095063|FG001|Overall Study|Withdrawal by Subject|19|||
164470016|NCT05412004|594095064|FG002|Overall Study|Withdrawal by Subject|4|||
164470017|NCT05412004|594095065|FG003|Overall Study|Withdrawal by Subject|14|||
164470018|NCT05412004|594095062|FG000|Overall Study|Screen Failure|0|||
164470019|NCT05412004|594095063|FG001|Overall Study|Screen Failure|0|||
164470020|NCT05412004|594095064|FG002|Overall Study|Screen Failure|0|||
164470021|NCT05412004|594095065|FG003|Overall Study|Screen Failure|1|||
164470022|NCT05412004|594095062|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
164470023|NCT05412004|594095063|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
164470024|NCT05412004|594095064|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
164470025|NCT05412004|594095065|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
164470026|NCT03781089|594095066|FG000|Overall Study|Constipation|1|||
164470027|NCT03781089|594095067|FG001|Overall Study|Constipation|0|||
164470028|NCT03781089|594095066|FG000|Overall Study|Positive pregnancy test|0|||
164470029|NCT03781089|594095067|FG001|Overall Study|Positive pregnancy test|1|||
164470030|NCT04644029|594095068|FG000|Overall Study|Death|1|||
164470031|NCT04644029|594095069|FG001|Overall Study|Death|0|||
164470032|NCT04644029|594095068|FG000|Overall Study|Physician Decision|1|||
164470033|NCT04644029|594095069|FG001|Overall Study|Physician Decision|2|||
164470034|NCT04644029|594095068|FG000|Overall Study|Withdrawal by Subject|21|||
164470035|NCT04644029|594095069|FG001|Overall Study|Withdrawal by Subject|19|||
164470036|NCT04644029|594095068|FG000|Overall Study|Lost to Follow-up|31|||
164470037|NCT04644029|594095069|FG001|Overall Study|Lost to Follow-up|34|||
164470038|NCT04644029|594095068|FG000|Overall Study|Study Terminated by Sponsor|308|||
164470039|NCT04644029|594095069|FG001|Overall Study|Study Terminated by Sponsor|309|||
164470040|NCT04644029|594095068|FG000|Overall Study|Randomized in Error|2|||
164470041|NCT04644029|594095069|FG001|Overall Study|Randomized in Error|1|||
164470042|NCT04644029|594095068|FG000|Overall Study|Other|0|||
164470043|NCT04644029|594095069|FG001|Overall Study|Other|1|||
164470044|NCT02246127|594095070|FG000|First Course Treatment|Adverse Event|9|||
164470045|NCT02246127|594095071|FG001|First Course Treatment|Adverse Event|7|||
164470046|NCT02246127|594095070|FG000|First Course Treatment|Withdrawal by Subject|6|||
164470047|NCT02246127|594095071|FG001|First Course Treatment|Withdrawal by Subject|7|||
164470048|NCT02246127|594095070|FG000|First Course Treatment|Physician Decision|9|||
164470049|NCT02246127|594095071|FG001|First Course Treatment|Physician Decision|9|||
164470050|NCT02246127|594095070|FG000|First Course Treatment|Death|3|||
164470051|NCT02246127|594095071|FG001|First Course Treatment|Death|3|||
164470052|NCT02246127|594095070|FG000|First Course Treatment|Not reported reasons|6|||
164712634|NCT03982199|594970363|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
164712635|NCT03982199|594970350|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164712636|NCT03982199|594970351|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164712637|NCT03982199|594970352|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164712638|NCT03982199|594970353|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164712639|NCT03982199|594970354|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164712640|NCT03982199|594970355|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164712641|NCT03982199|594970356|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164712642|NCT03982199|594970357|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164712643|NCT03982199|594970358|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
164712644|NCT03982199|594970359|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164712645|NCT03982199|594970360|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164712646|NCT03982199|594970361|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164470053|NCT02246127|594095071|FG001|First Course Treatment|Not reported reasons|7|||
164470054|NCT02246127|594095070|FG000|First Course Treatment|Not treated|3|||
164470055|NCT02246127|594095071|FG001|First Course Treatment|Not treated|3|||
164470056|NCT04679389|594095075|FG000|Overall Study|Adverse Event|1|||
164470057|NCT04679389|594095076|FG001|Overall Study|Adverse Event|0|||
164470058|NCT04679389|594095075|FG000|Overall Study|Protocol Violation|2|||
164470059|NCT04679389|594095076|FG001|Overall Study|Protocol Violation|0|||
164470060|NCT04679389|594095075|FG000|Overall Study|Physician Decision|3|||
164470061|NCT04679389|594095076|FG001|Overall Study|Physician Decision|5|||
164470062|NCT04679389|594095075|FG000|Overall Study|Withdrawal by Subject|5|||
164470063|NCT04679389|594095076|FG001|Overall Study|Withdrawal by Subject|7|||
164470064|NCT05454514|594095079|FG000|Overall Study|Withdrawal by Subject|4|||
164470065|NCT03904576|594095086|FG000|Washout Period|Protocol Violation|1|||
164470066|NCT03904576|594095087|FG001|Washout Period|Protocol Violation|1|||
164470067|NCT05215054|594095090|FG000|Overall Study|Lost to Follow-up|1|||
164470068|NCT05215054|594095091|FG001|Overall Study|Lost to Follow-up|1|||
164470069|NCT05215054|594095090|FG000|Overall Study|Protocol Violation|1|||
164470070|NCT05215054|594095091|FG001|Overall Study|Protocol Violation|1|||
164470071|NCT05215054|594095090|FG000|Overall Study|Withdrawal by Subject|4|||
164470072|NCT05215054|594095091|FG001|Overall Study|Withdrawal by Subject|4|||
164470073|NCT01897441|594095092|FG000|Overall Study|Lost to Follow-up|0|||
164470074|NCT01897441|594095093|FG001|Overall Study|Lost to Follow-up|0|||
164470075|NCT01897441|594095094|FG002|Overall Study|Lost to Follow-up|1|||
164470076|NCT01897441|594095095|FG003|Overall Study|Lost to Follow-up|0|||
164470077|NCT01897441|594095096|FG004|Overall Study|Lost to Follow-up|0|||
164470078|NCT01897441|594095097|FG005|Overall Study|Lost to Follow-up|0|||
164470079|NCT01897441|594095092|FG000|Overall Study|Withdrawal by Subject|0|||
164470080|NCT01897441|594095093|FG001|Overall Study|Withdrawal by Subject|0|||
164470081|NCT01897441|594095094|FG002|Overall Study|Withdrawal by Subject|0|||
164470082|NCT01897441|594095095|FG003|Overall Study|Withdrawal by Subject|0|||
164470083|NCT01897441|594095096|FG004|Overall Study|Withdrawal by Subject|1|||
164470084|NCT01897441|594095097|FG005|Overall Study|Withdrawal by Subject|0|||
164470085|NCT01897441|594095092|FG000|Overall Study|Withdrawn by Provider|0|||
164470086|NCT01897441|594095093|FG001|Overall Study|Withdrawn by Provider|2|||
164470087|NCT01897441|594095094|FG002|Overall Study|Withdrawn by Provider|0|||
164470088|NCT01897441|594095095|FG003|Overall Study|Withdrawn by Provider|0|||
164470089|NCT01897441|594095096|FG004|Overall Study|Withdrawn by Provider|0|||
164470090|NCT01897441|594095097|FG005|Overall Study|Withdrawn by Provider|0|||
164470091|NCT01756300|594095098|FG000|Overall Study|Death|1|||
164470092|NCT01756300|594095098|FG000|Overall Study|Withdrawal by Subject|1|||
164712647|NCT03982199|594970362|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164712648|NCT03982199|594970363|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164470093|NCT04780581|594095099|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
164470094|NCT04780581|594095100|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
164470095|NCT04780581|594095099|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
164470096|NCT04780581|594095100|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
164470097|NCT01651000|594095101|FG000|Overall Study|Adverse Event|2|||
164470098|NCT01651000|594095102|FG001|Overall Study|Adverse Event|8|||
164470099|NCT01651000|594095101|FG000|Overall Study|Lost to Follow-up|3|||
164712649|NCT03982199|594970350|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
164712650|NCT03982199|594970351|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
164470100|NCT01651000|594095102|FG001|Overall Study|Lost to Follow-up|2|||
164470101|NCT01651000|594095101|FG000|Overall Study|Protocol Violation|0|||
164470102|NCT01651000|594095102|FG001|Overall Study|Protocol Violation|3|||
164470103|NCT01651000|594095101|FG000|Overall Study|Withdrawal by Subject|2|||
164470104|NCT01651000|594095102|FG001|Overall Study|Withdrawal by Subject|10|||
164470105|NCT01651000|594095101|FG000|Overall Study|Subject noncompliance|0|||
164470106|NCT01651000|594095102|FG001|Overall Study|Subject noncompliance|3|||
164470107|NCT01651000|594095101|FG000|Overall Study|Lack of Efficacy|1|||
164712651|NCT03982199|594970352|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
164712652|NCT03982199|594970353|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
164712653|NCT03982199|594970354|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
164712654|NCT03982199|594970355|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
164712655|NCT03982199|594970356|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
164712656|NCT03982199|594970357|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
164712657|NCT03982199|594970358|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
164712658|NCT03982199|594970359|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
164712659|NCT03982199|594970360|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
164712660|NCT03982199|594970361|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
164712661|NCT03982199|594970362|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
164712662|NCT03982199|594970363|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
164712663|NCT03982199|594970350|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
164712664|NCT03982199|594970351|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
164712665|NCT03982199|594970352|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
164712666|NCT03982199|594970353|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
164712667|NCT03982199|594970354|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
164712668|NCT03982199|594970355|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
164712669|NCT03982199|594970356|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
164712670|NCT03982199|594970357|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
164712671|NCT03982199|594970358|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
164712672|NCT03982199|594970359|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
164712673|NCT03982199|594970360|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
164712674|NCT03982199|594970361|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
164712675|NCT03982199|594970362|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
164712676|NCT03982199|594970363|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
164712677|NCT03982199|594970350|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164712678|NCT03982199|594970351|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164712679|NCT03982199|594970352|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164712680|NCT03982199|594970353|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164712681|NCT03982199|594970354|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164712682|NCT03982199|594970355|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164712683|NCT03982199|594970356|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164712684|NCT03982199|594970357|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164712685|NCT03982199|594970358|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164712686|NCT03982199|594970359|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
164712687|NCT03982199|594970360|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164712688|NCT03982199|594970361|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164712689|NCT03982199|594970362|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164470108|NCT01651000|594095102|FG001|Overall Study|Lack of Efficacy|1|||
164470109|NCT01651000|594095101|FG000|Overall Study|Physician Decision|1|||
164470110|NCT01651000|594095102|FG001|Overall Study|Physician Decision|0|||
164470111|NCT01651000|594095101|FG000|Overall Study|Administrative reason|1|||
164470112|NCT01651000|594095102|FG001|Overall Study|Administrative reason|0|||
164470113|NCT01651000|594095101|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
164470114|NCT01651000|594095102|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
164470115|NCT02765412|594095103|FG000|Overall Study|Death|482|||
164470116|NCT02765412|594095104|FG001|Overall Study|Death|855|||
164470117|NCT05020353|594096204|FG000|Overall Study|Protocol Violation|7|||
164470118|NCT05020353|594096204|FG000|Overall Study|Withdrawal by Subject|33|||
164470119|NCT04633278|594096205|FG000|Overall Study|Adverse Event|1|||
164470120|NCT04633278|594096206|FG001|Overall Study|Adverse Event|0|||
164470121|NCT04633278|594096205|FG000|Overall Study|Withdrawal by Subject|1|||
164470122|NCT04633278|594096206|FG001|Overall Study|Withdrawal by Subject|0|||
164470123|NCT04633278|594096205|FG000|Overall Study|Death|11|||
164470124|NCT04633278|594096206|FG001|Overall Study|Death|7|||
164470125|NCT04633278|594096205|FG000|Overall Study|Sponsor Decision|3|||
164470126|NCT04633278|594096206|FG001|Overall Study|Sponsor Decision|0|||
164470127|NCT04633278|594096205|FG000|Overall Study|Not Listed|1|||
164470128|NCT04633278|594096206|FG001|Overall Study|Not Listed|0|||
164470129|NCT02611687|594096207|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
164470130|NCT02611687|594096208|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
164470131|NCT03705793|594096209|FG000|Overall Study|Lost to Follow-up|3|||
164470132|NCT03705793|594096210|FG001|Overall Study|Lost to Follow-up|4|||
164470133|NCT03705793|594096209|FG000|Overall Study|Withdrawal by Subject|2|||
164470134|NCT03705793|594096210|FG001|Overall Study|Withdrawal by Subject|1|||
164470135|NCT03934931|594096211|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
164470136|NCT03934931|594096212|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
164470137|NCT03934931|594096213|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
164470138|NCT00447980|594096216|FG000|Overall Study|Withdrawal by Subject|1|||
164470139|NCT00447980|594096217|FG001|Overall Study|Withdrawal by Subject|1|||
164470140|NCT00447980|594096218|FG002|Overall Study|Withdrawal by Subject|4|||
164470141|NCT00447980|594096219|FG003|Overall Study|Withdrawal by Subject|4|||
164470142|NCT00447980|594096216|FG000|Overall Study|Lost to Follow-up|1|||
164470143|NCT00447980|594096217|FG001|Overall Study|Lost to Follow-up|1|||
164470144|NCT00447980|594096218|FG002|Overall Study|Lost to Follow-up|0|||
164470145|NCT00447980|594096219|FG003|Overall Study|Lost to Follow-up|0|||
164470146|NCT00447980|594096216|FG000|Overall Study|Did not proceed with surgery|3|||
164470147|NCT00447980|594096217|FG001|Overall Study|Did not proceed with surgery|3|||
164470148|NCT00447980|594096218|FG002|Overall Study|Did not proceed with surgery|2|||
164470149|NCT00447980|594096219|FG003|Overall Study|Did not proceed with surgery|2|||
164470150|NCT02720068|594096220|FG000|Overall Study|Adverse Event|0|||
164470151|NCT02720068|594096221|FG001|Overall Study|Adverse Event|0|||
164470152|NCT02720068|594096222|FG002|Overall Study|Adverse Event|0|||
164470153|NCT02720068|594096223|FG003|Overall Study|Adverse Event|0|||
164470154|NCT02720068|594096224|FG004|Overall Study|Adverse Event|0|||
164470155|NCT02720068|594096225|FG005|Overall Study|Adverse Event|0|||
164470156|NCT02720068|594096226|FG006|Overall Study|Adverse Event|0|||
164470157|NCT02720068|594096227|FG007|Overall Study|Adverse Event|0|||
164470158|NCT02720068|594096228|FG008|Overall Study|Adverse Event|0|||
164470159|NCT02720068|594096229|FG009|Overall Study|Adverse Event|0|||
164470160|NCT02720068|594096230|FG010|Overall Study|Adverse Event|0|||
164470161|NCT02720068|594096231|FG011|Overall Study|Adverse Event|1|||
164470162|NCT02720068|594096232|FG012|Overall Study|Adverse Event|0|||
164470163|NCT02720068|594096233|FG013|Overall Study|Adverse Event|0|||
164470164|NCT02720068|594096234|FG014|Overall Study|Adverse Event|0|||
164470165|NCT02720068|594096235|FG015|Overall Study|Adverse Event|0|||
164470166|NCT02720068|594096236|FG016|Overall Study|Adverse Event|0|||
164470167|NCT02720068|594096237|FG017|Overall Study|Adverse Event|0|||
164470168|NCT02720068|594096220|FG000|Overall Study|Death|1|||
164470169|NCT02720068|594096221|FG001|Overall Study|Death|3|||
164470170|NCT02720068|594096222|FG002|Overall Study|Death|2|||
164470171|NCT02720068|594096223|FG003|Overall Study|Death|1|||
164470172|NCT02720068|594096224|FG004|Overall Study|Death|2|||
164470173|NCT02720068|594096225|FG005|Overall Study|Death|1|||
164470174|NCT02720068|594096226|FG006|Overall Study|Death|2|||
164470175|NCT02720068|594096227|FG007|Overall Study|Death|2|||
164470176|NCT02720068|594096228|FG008|Overall Study|Death|3|||
164470177|NCT02720068|594096229|FG009|Overall Study|Death|1|||
164470178|NCT02720068|594096230|FG010|Overall Study|Death|20|||
164470179|NCT02720068|594096231|FG011|Overall Study|Death|166|||
164470180|NCT02720068|594096232|FG012|Overall Study|Death|34|||
164470181|NCT02720068|594096233|FG013|Overall Study|Death|30|||
164470182|NCT02720068|594096234|FG014|Overall Study|Death|45|||
164470183|NCT02720068|594096235|FG015|Overall Study|Death|16|||
164470184|NCT02720068|594096236|FG016|Overall Study|Death|20|||
164470185|NCT02720068|594096237|FG017|Overall Study|Death|28|||
164470186|NCT02720068|594096220|FG000|Overall Study|Lost to Follow-up|0|||
164470187|NCT02720068|594096221|FG001|Overall Study|Lost to Follow-up|0|||
164470188|NCT02720068|594096222|FG002|Overall Study|Lost to Follow-up|0|||
164470189|NCT02720068|594096223|FG003|Overall Study|Lost to Follow-up|0|||
164470190|NCT02720068|594096224|FG004|Overall Study|Lost to Follow-up|0|||
164470191|NCT02720068|594096225|FG005|Overall Study|Lost to Follow-up|0|||
164470192|NCT02720068|594096226|FG006|Overall Study|Lost to Follow-up|0|||
164470193|NCT02720068|594096227|FG007|Overall Study|Lost to Follow-up|0|||
164470194|NCT02720068|594096228|FG008|Overall Study|Lost to Follow-up|0|||
164470195|NCT02720068|594096229|FG009|Overall Study|Lost to Follow-up|0|||
164470196|NCT02720068|594096230|FG010|Overall Study|Lost to Follow-up|0|||
164470197|NCT02720068|594096231|FG011|Overall Study|Lost to Follow-up|1|||
164470198|NCT02720068|594096232|FG012|Overall Study|Lost to Follow-up|0|||
164470199|NCT02720068|594096233|FG013|Overall Study|Lost to Follow-up|1|||
164470200|NCT02720068|594096234|FG014|Overall Study|Lost to Follow-up|2|||
164470201|NCT02720068|594096235|FG015|Overall Study|Lost to Follow-up|0|||
164470202|NCT02720068|594096236|FG016|Overall Study|Lost to Follow-up|0|||
164470203|NCT02720068|594096237|FG017|Overall Study|Lost to Follow-up|1|||
164470204|NCT02720068|594096220|FG000|Overall Study|Physician Decision|0|||
164470205|NCT02720068|594096221|FG001|Overall Study|Physician Decision|0|||
164470206|NCT02720068|594096222|FG002|Overall Study|Physician Decision|0|||
164470207|NCT02720068|594096223|FG003|Overall Study|Physician Decision|1|||
164470208|NCT02720068|594096224|FG004|Overall Study|Physician Decision|0|||
164470209|NCT02720068|594096225|FG005|Overall Study|Physician Decision|0|||
164470210|NCT02720068|594096226|FG006|Overall Study|Physician Decision|0|||
164470211|NCT02720068|594096227|FG007|Overall Study|Physician Decision|0|||
164470212|NCT02720068|594096228|FG008|Overall Study|Physician Decision|0|||
164470213|NCT02720068|594096229|FG009|Overall Study|Physician Decision|0|||
164470214|NCT02720068|594096230|FG010|Overall Study|Physician Decision|0|||
164470215|NCT02720068|594096231|FG011|Overall Study|Physician Decision|1|||
164470216|NCT02720068|594096232|FG012|Overall Study|Physician Decision|0|||
164470217|NCT02720068|594096233|FG013|Overall Study|Physician Decision|0|||
164470218|NCT02720068|594096234|FG014|Overall Study|Physician Decision|0|||
164470219|NCT02720068|594096235|FG015|Overall Study|Physician Decision|0|||
164470220|NCT02720068|594096236|FG016|Overall Study|Physician Decision|0|||
164470221|NCT02720068|594096237|FG017|Overall Study|Physician Decision|1|||
164470222|NCT02720068|594096220|FG000|Overall Study|Progressive Disease|2|||
164470223|NCT02720068|594096221|FG001|Overall Study|Progressive Disease|3|||
164470224|NCT02720068|594096222|FG002|Overall Study|Progressive Disease|1|||
164470225|NCT02720068|594096223|FG003|Overall Study|Progressive Disease|1|||
164470226|NCT02720068|594096224|FG004|Overall Study|Progressive Disease|1|||
164470227|NCT02720068|594096225|FG005|Overall Study|Progressive Disease|2|||
164470228|NCT02720068|594096226|FG006|Overall Study|Progressive Disease|1|||
164470229|NCT02720068|594096227|FG007|Overall Study|Progressive Disease|1|||
164470230|NCT02720068|594096228|FG008|Overall Study|Progressive Disease|0|||
164470231|NCT02720068|594096229|FG009|Overall Study|Progressive Disease|1|||
164470232|NCT02720068|594096230|FG010|Overall Study|Progressive Disease|0|||
164470233|NCT02720068|594096231|FG011|Overall Study|Progressive Disease|4|||
164470234|NCT02720068|594096232|FG012|Overall Study|Progressive Disease|1|||
164470235|NCT02720068|594096233|FG013|Overall Study|Progressive Disease|0|||
164470236|NCT02720068|594096234|FG014|Overall Study|Progressive Disease|0|||
164470237|NCT02720068|594096235|FG015|Overall Study|Progressive Disease|0|||
164470238|NCT02720068|594096236|FG016|Overall Study|Progressive Disease|0|||
164470239|NCT02720068|594096237|FG017|Overall Study|Progressive Disease|0|||
164470240|NCT02720068|594096220|FG000|Overall Study|Sponsor Decision|0|||
164470241|NCT02720068|594096221|FG001|Overall Study|Sponsor Decision|0|||
164470242|NCT02720068|594096222|FG002|Overall Study|Sponsor Decision|0|||
164470243|NCT02720068|594096223|FG003|Overall Study|Sponsor Decision|0|||
164470244|NCT02720068|594096224|FG004|Overall Study|Sponsor Decision|0|||
164470245|NCT02720068|594096225|FG005|Overall Study|Sponsor Decision|0|||
164470246|NCT02720068|594096226|FG006|Overall Study|Sponsor Decision|0|||
164470247|NCT02720068|594096227|FG007|Overall Study|Sponsor Decision|0|||
164470248|NCT02720068|594096228|FG008|Overall Study|Sponsor Decision|0|||
164470249|NCT02720068|594096229|FG009|Overall Study|Sponsor Decision|0|||
164470250|NCT02720068|594096230|FG010|Overall Study|Sponsor Decision|0|||
164470251|NCT02720068|594096231|FG011|Overall Study|Sponsor Decision|6|||
164470252|NCT02720068|594096232|FG012|Overall Study|Sponsor Decision|3|||
164470253|NCT02720068|594096233|FG013|Overall Study|Sponsor Decision|2|||
164470254|NCT02720068|594096234|FG014|Overall Study|Sponsor Decision|4|||
164470255|NCT02720068|594096235|FG015|Overall Study|Sponsor Decision|4|||
164470256|NCT02720068|594096236|FG016|Overall Study|Sponsor Decision|0|||
164470257|NCT02720068|594096237|FG017|Overall Study|Sponsor Decision|8|||
164470258|NCT02720068|594096220|FG000|Overall Study|Withdrawal by Subject|0|||
164470259|NCT02720068|594096221|FG001|Overall Study|Withdrawal by Subject|0|||
164470260|NCT02720068|594096222|FG002|Overall Study|Withdrawal by Subject|0|||
164470261|NCT02720068|594096223|FG003|Overall Study|Withdrawal by Subject|0|||
164470262|NCT02720068|594096224|FG004|Overall Study|Withdrawal by Subject|0|||
164470263|NCT02720068|594096225|FG005|Overall Study|Withdrawal by Subject|0|||
164470264|NCT02720068|594096226|FG006|Overall Study|Withdrawal by Subject|0|||
164470265|NCT02720068|594096227|FG007|Overall Study|Withdrawal by Subject|0|||
164470266|NCT02720068|594096228|FG008|Overall Study|Withdrawal by Subject|0|||
164470267|NCT02720068|594096229|FG009|Overall Study|Withdrawal by Subject|1|||
164470268|NCT02720068|594096230|FG010|Overall Study|Withdrawal by Subject|0|||
164470269|NCT02720068|594096231|FG011|Overall Study|Withdrawal by Subject|27|||
164470270|NCT02720068|594096232|FG012|Overall Study|Withdrawal by Subject|2|||
164470271|NCT02720068|594096233|FG013|Overall Study|Withdrawal by Subject|8|||
164470272|NCT02720068|594096234|FG014|Overall Study|Withdrawal by Subject|7|||
164470273|NCT02720068|594096235|FG015|Overall Study|Withdrawal by Subject|0|||
164470274|NCT02720068|594096236|FG016|Overall Study|Withdrawal by Subject|0|||
164470275|NCT02720068|594096237|FG017|Overall Study|Withdrawal by Subject|2|||
164470276|NCT02720068|594096220|FG000|Overall Study|Protocol Violation|0|||
164470277|NCT02720068|594096221|FG001|Overall Study|Protocol Violation|0|||
164470278|NCT02720068|594096222|FG002|Overall Study|Protocol Violation|0|||
164470279|NCT02720068|594096223|FG003|Overall Study|Protocol Violation|0|||
164470280|NCT02720068|594096224|FG004|Overall Study|Protocol Violation|0|||
164470281|NCT02720068|594096225|FG005|Overall Study|Protocol Violation|0|||
164470282|NCT02720068|594096226|FG006|Overall Study|Protocol Violation|0|||
164470283|NCT02720068|594096227|FG007|Overall Study|Protocol Violation|0|||
164470284|NCT02720068|594096228|FG008|Overall Study|Protocol Violation|0|||
164470285|NCT02720068|594096229|FG009|Overall Study|Protocol Violation|0|||
164470286|NCT02720068|594096230|FG010|Overall Study|Protocol Violation|1|||
164470287|NCT02720068|594096231|FG011|Overall Study|Protocol Violation|0|||
164470288|NCT02720068|594096232|FG012|Overall Study|Protocol Violation|0|||
164470289|NCT02720068|594096233|FG013|Overall Study|Protocol Violation|0|||
164470290|NCT02720068|594096234|FG014|Overall Study|Protocol Violation|1|||
164470291|NCT02720068|594096235|FG015|Overall Study|Protocol Violation|0|||
164470292|NCT02720068|594096236|FG016|Overall Study|Protocol Violation|1|||
164470293|NCT02720068|594096237|FG017|Overall Study|Protocol Violation|0|||
164470294|NCT03635567|594096243|FG000|Overall Study|Lost to Follow-up|4|||
164470295|NCT03635567|594096244|FG001|Overall Study|Lost to Follow-up|1|||
164470296|NCT03635567|594096243|FG000|Overall Study|Withdrawal by Subject|11|||
164470297|NCT03635567|594096244|FG001|Overall Study|Withdrawal by Subject|16|||
164470298|NCT03635567|594096243|FG000|Overall Study|Sponsor Decision|99|||
164470299|NCT03635567|594096244|FG001|Overall Study|Sponsor Decision|57|||
164470300|NCT03635567|594096243|FG000|Overall Study|Death|194|||
164470301|NCT03635567|594096244|FG001|Overall Study|Death|235|||
164470302|NCT05157841|594096245|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
164470303|NCT05157841|594096246|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
164470304|NCT05157841|594096247|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
164470305|NCT05157841|594096245|FG000|Part A (14 Days)|Adverse Event|1|||
164470306|NCT05157841|594096246|FG001|Part A (14 Days)|Adverse Event|0|||
164470307|NCT05157841|594096247|FG002|Part A (14 Days)|Adverse Event|0|||
164470308|NCT05157841|594096245|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
164470309|NCT05157841|594096246|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
164470310|NCT05157841|594096247|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
164470311|NCT02075554|594096250|FG000|Overall Study|Lost to Follow-up|7|||
164470312|NCT02075554|594096250|FG000|Overall Study|Withdrawal by Subject|5|||
164470313|NCT02075554|594096250|FG000|Overall Study|Physician Decision|3|||
164470314|NCT01773993|594096256|FG000|Overall Study|No Visit After Treatment|35|||
164470315|NCT04664881|594096257|FG000|Overall Study|Withdrawal by Subject|1|||
164470316|NCT04664881|594096258|FG001|Overall Study|Withdrawal by Subject|8|||
164470317|NCT04664881|594096257|FG000|Overall Study|Physician Decision|0|||
164470318|NCT04664881|594096258|FG001|Overall Study|Physician Decision|5|||
164470319|NCT04664881|594096257|FG000|Overall Study|Lost to Follow-up|1|||
164470320|NCT04664881|594096258|FG001|Overall Study|Lost to Follow-up|0|||
164470321|NCT04757753|594096272|FG000|Overall Study|Lost to Follow-up|7|||
164470322|NCT04757753|594096273|FG001|Overall Study|Lost to Follow-up|7|||
164470323|NCT04757753|594096272|FG000|Overall Study|Withdrawal by Subject|0|||
164470324|NCT04757753|594096273|FG001|Overall Study|Withdrawal by Subject|3|||
164470325|NCT04757753|594096272|FG000|Overall Study|Endodontic treatment failure|1|||
164470326|NCT04757753|594096273|FG001|Overall Study|Endodontic treatment failure|2|||
164470327|NCT04757753|594096272|FG000|Overall Study|Tooth fracture/extraction|3|||
164470328|NCT04757753|594096273|FG001|Overall Study|Tooth fracture/extraction|0|||
164470329|NCT00942734|594096284|FG000|Overall Study|Adverse Event|2|||
164470330|NCT00942734|594096284|FG000|Overall Study|Protocol Violation|3|||
164470331|NCT00942734|594096284|FG000|Overall Study|Disease Progression|2|||
164470332|NCT00942734|594096284|FG000|Overall Study|Physician Decision|1|||
164470333|NCT00319046|594096290|FG000|Overall Study|withdrawal of subject's consent|7|||
164470334|NCT00319046|594096290|FG000|Overall Study|administrative reason|1|||
164470335|NCT03816397|594096297|FG000|Overall Study|Censored at interim analysis date.|13|||
164470336|NCT03816397|594096298|FG001|Overall Study|Censored at interim analysis date.|6|||
164470337|NCT03816397|594096297|FG000|Overall Study|Withdrawal by Subject|1|||
164470338|NCT03816397|594096298|FG001|Overall Study|Withdrawal by Subject|1|||
164470339|NCT04496752|594096301|FG000|Second Assessment|Lost to Follow-up|3|||
164470340|NCT04496752|594096302|FG001|Second Assessment|Lost to Follow-up|3|||
164470341|NCT04496752|594096301|FG000|Second Assessment|Adverse Event|2|||
164470342|NCT04496752|594096302|FG001|Second Assessment|Adverse Event|0|||
164470343|NCT04214418|594096303|FG000|Overall Study|Withdrawal by Subject|1|||
164470344|NCT04214418|594096304|FG001|Overall Study|Withdrawal by Subject|0|||
164470345|NCT04214418|594096305|FG002|Overall Study|Withdrawal by Subject|0|||
164470346|NCT04214418|594096306|FG003|Overall Study|Withdrawal by Subject|0|||
164470347|NCT04214418|594096307|FG004|Overall Study|Withdrawal by Subject|0|||
164470348|NCT04214418|594096308|FG005|Overall Study|Withdrawal by Subject|0|||
164470349|NCT04214418|594096303|FG000|Overall Study|Adverse Event|0|||
164470350|NCT04214418|594096304|FG001|Overall Study|Adverse Event|2|||
164470351|NCT04214418|594096305|FG002|Overall Study|Adverse Event|0|||
164470352|NCT04214418|594096306|FG003|Overall Study|Adverse Event|0|||
164470353|NCT04214418|594096307|FG004|Overall Study|Adverse Event|0|||
164470354|NCT04214418|594096308|FG005|Overall Study|Adverse Event|0|||
164470355|NCT04214418|594096303|FG000|Overall Study|Death|1|||
164470356|NCT04214418|594096304|FG001|Overall Study|Death|0|||
164470357|NCT04214418|594096305|FG002|Overall Study|Death|0|||
164470358|NCT04214418|594096306|FG003|Overall Study|Death|0|||
164470359|NCT04214418|594096307|FG004|Overall Study|Death|0|||
164470360|NCT04214418|594096308|FG005|Overall Study|Death|0|||
164470361|NCT04908930|594096313|FG000|Overall Study|Lost to Follow-up|1|||
164470362|NCT04908930|594096314|FG001|Overall Study|Lost to Follow-up|1|||
164470363|NCT04908930|594096315|FG002|Overall Study|Lost to Follow-up|0|||
164470364|NCT04908930|594096316|FG003|Overall Study|Lost to Follow-up|0|||
164470365|NCT04908930|594096317|FG004|Overall Study|Lost to Follow-up|0|||
164470366|NCT04908930|594096313|FG000|Overall Study|hardware in mouth|1|||
164470367|NCT04908930|594096314|FG001|Overall Study|hardware in mouth|1|||
164470368|NCT04908930|594096315|FG002|Overall Study|hardware in mouth|0|||
164712690|NCT03982199|594970363|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164712691|NCT03982199|594970350|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164712692|NCT03982199|594970351|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164712693|NCT03982199|594970352|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164712694|NCT03982199|594970353|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164417258|NCT01474512|593899506|FG017|Maintenance Period|Physician Decision|0|||
164417259|NCT01474512|593899489|FG000|Maintenance Period|Clinical Relapse|0|||
164417260|NCT01474512|593899490|FG001|Maintenance Period|Clinical Relapse|0|||
164417261|NCT01474512|593899491|FG002|Maintenance Period|Clinical Relapse|0|||
164417262|NCT01474512|593899492|FG003|Maintenance Period|Clinical Relapse|1|||
164417263|NCT01474512|593899493|FG004|Maintenance Period|Clinical Relapse|0|||
164417264|NCT01474512|593899494|FG005|Maintenance Period|Clinical Relapse|0|||
164417265|NCT01474512|593899495|FG006|Maintenance Period|Clinical Relapse|0|||
164417266|NCT01474512|593899496|FG007|Maintenance Period|Clinical Relapse|0|||
164417267|NCT01474512|593899497|FG008|Maintenance Period|Clinical Relapse|0|||
164417268|NCT01474512|593899498|FG009|Maintenance Period|Clinical Relapse|0|||
164417269|NCT01474512|593899499|FG010|Maintenance Period|Clinical Relapse|0|||
164417270|NCT01474512|593899500|FG011|Maintenance Period|Clinical Relapse|0|||
164417271|NCT01474512|593899501|FG012|Maintenance Period|Clinical Relapse|0|||
164417272|NCT01474512|593899502|FG013|Maintenance Period|Clinical Relapse|0|||
164417273|NCT01474512|593899503|FG014|Maintenance Period|Clinical Relapse|0|||
164417274|NCT01474512|593899504|FG015|Maintenance Period|Clinical Relapse|0|||
164417275|NCT01474512|593899505|FG016|Maintenance Period|Clinical Relapse|0|||
164417276|NCT01474512|593899506|FG017|Maintenance Period|Clinical Relapse|0|||
164417277|NCT01474512|593899489|FG000|Maintenance Period|Lack of Efficacy|0|||
164417278|NCT01474512|593899490|FG001|Maintenance Period|Lack of Efficacy|0|||
164417279|NCT01474512|593899491|FG002|Maintenance Period|Lack of Efficacy|0|||
164417280|NCT01474512|593899492|FG003|Maintenance Period|Lack of Efficacy|1|||
164417281|NCT01474512|593899493|FG004|Maintenance Period|Lack of Efficacy|0|||
164417282|NCT01474512|593899494|FG005|Maintenance Period|Lack of Efficacy|0|||
164417283|NCT01474512|593899495|FG006|Maintenance Period|Lack of Efficacy|0|||
164417284|NCT01474512|593899496|FG007|Maintenance Period|Lack of Efficacy|11|||
164417285|NCT01474512|593899497|FG008|Maintenance Period|Lack of Efficacy|11|||
164417286|NCT01474512|593899498|FG009|Maintenance Period|Lack of Efficacy|12|||
164417287|NCT01474512|593899499|FG010|Maintenance Period|Lack of Efficacy|0|||
164417288|NCT01474512|593899500|FG011|Maintenance Period|Lack of Efficacy|0|||
164417289|NCT01474512|593899501|FG012|Maintenance Period|Lack of Efficacy|0|||
164417290|NCT01474512|593899502|FG013|Maintenance Period|Lack of Efficacy|0|||
164417291|NCT01474512|593899503|FG014|Maintenance Period|Lack of Efficacy|0|||
164417292|NCT01474512|593899504|FG015|Maintenance Period|Lack of Efficacy|0|||
164417293|NCT01474512|593899505|FG016|Maintenance Period|Lack of Efficacy|0|||
164417294|NCT01474512|593899506|FG017|Maintenance Period|Lack of Efficacy|0|||
164417295|NCT01474512|593899489|FG000|Maintenance Period|Protocol Violation|0|||
164417296|NCT01474512|593899490|FG001|Maintenance Period|Protocol Violation|0|||
164417297|NCT01474512|593899491|FG002|Maintenance Period|Protocol Violation|0|||
164417298|NCT01474512|593899492|FG003|Maintenance Period|Protocol Violation|1|||
164417299|NCT01474512|593899493|FG004|Maintenance Period|Protocol Violation|0|||
164417300|NCT01474512|593899494|FG005|Maintenance Period|Protocol Violation|0|||
164417301|NCT01474512|593899495|FG006|Maintenance Period|Protocol Violation|0|||
164417302|NCT01474512|593899496|FG007|Maintenance Period|Protocol Violation|1|||
164417303|NCT01474512|593899497|FG008|Maintenance Period|Protocol Violation|0|||
164417304|NCT01474512|593899498|FG009|Maintenance Period|Protocol Violation|1|||
164417305|NCT01474512|593899499|FG010|Maintenance Period|Protocol Violation|0|||
164417306|NCT01474512|593899500|FG011|Maintenance Period|Protocol Violation|0|||
164417307|NCT01474512|593899501|FG012|Maintenance Period|Protocol Violation|0|||
164417308|NCT01474512|593899502|FG013|Maintenance Period|Protocol Violation|0|||
164417309|NCT01474512|593899503|FG014|Maintenance Period|Protocol Violation|0|||
164417310|NCT01474512|593899504|FG015|Maintenance Period|Protocol Violation|0|||
164417311|NCT01474512|593899505|FG016|Maintenance Period|Protocol Violation|0|||
164417312|NCT01474512|593899506|FG017|Maintenance Period|Protocol Violation|0|||
164417313|NCT01474512|593899489|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
164417314|NCT01474512|593899490|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
164417315|NCT01474512|593899491|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
164417316|NCT01474512|593899492|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
164417317|NCT01474512|593899493|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
164417318|NCT01474512|593899494|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
164417319|NCT01474512|593899495|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
164417320|NCT01474512|593899496|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
164417321|NCT01474512|593899497|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
164417322|NCT01474512|593899498|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
164417323|NCT01474512|593899499|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
164417324|NCT01474512|593899500|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
164417325|NCT01474512|593899501|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
164470369|NCT04908930|594096316|FG003|Overall Study|hardware in mouth|0|||
164470370|NCT04908930|594096317|FG004|Overall Study|hardware in mouth|0|||
164470371|NCT04908930|594096313|FG000|Overall Study|wrong team|1|||
164470372|NCT04908930|594096314|FG001|Overall Study|wrong team|0|||
164470373|NCT04908930|594096315|FG002|Overall Study|wrong team|0|||
164470374|NCT04908930|594096316|FG003|Overall Study|wrong team|0|||
164470375|NCT04908930|594096317|FG004|Overall Study|wrong team|0|||
164470376|NCT04908930|594096313|FG000|Overall Study|quit team|2|||
164470377|NCT04908930|594096314|FG001|Overall Study|quit team|4|||
164470378|NCT04908930|594096315|FG002|Overall Study|quit team|0|||
164470379|NCT04908930|594096316|FG003|Overall Study|quit team|0|||
164470380|NCT04908930|594096317|FG004|Overall Study|quit team|0|||
164470381|NCT04908930|594096313|FG000|Overall Study|Withdrawal by Subject|1|||
164470382|NCT04908930|594096314|FG001|Overall Study|Withdrawal by Subject|2|||
164470383|NCT04908930|594096315|FG002|Overall Study|Withdrawal by Subject|0|||
164470384|NCT04908930|594096316|FG003|Overall Study|Withdrawal by Subject|0|||
164470385|NCT04908930|594096317|FG004|Overall Study|Withdrawal by Subject|0|||
164470386|NCT04908930|594096313|FG000|Overall Study|parent not liking program|0|||
164470387|NCT04908930|594096314|FG001|Overall Study|parent not liking program|1|||
164470388|NCT04908930|594096315|FG002|Overall Study|parent not liking program|0|||
164470389|NCT04908930|594096316|FG003|Overall Study|parent not liking program|0|||
164470390|NCT04908930|594096317|FG004|Overall Study|parent not liking program|0|||
164470391|NCT02777593|594096318|FG000|Overall Study|Still in study|1|||
164470392|NCT02777593|594096319|FG001|Overall Study|Still in study|32|||
164470393|NCT02777593|594096320|FG002|Overall Study|Still in study|3|||
164470394|NCT02777593|594096321|FG003|Overall Study|Still in study|6|||
164470395|NCT02777593|594096322|FG004|Overall Study|Still in study|5|||
164470396|NCT02777593|594096318|FG000|Overall Study|Death|21|||
164470397|NCT02777593|594096319|FG001|Overall Study|Death|28|||
164470398|NCT02777593|594096320|FG002|Overall Study|Death|0|||
164470399|NCT02777593|594096321|FG003|Overall Study|Death|5|||
164470400|NCT02777593|594096322|FG004|Overall Study|Death|0|||
164470401|NCT02777593|594096318|FG000|Overall Study|Withdrawal by Subject|8|||
164470402|NCT02777593|594096319|FG001|Overall Study|Withdrawal by Subject|4|||
164470403|NCT02777593|594096320|FG002|Overall Study|Withdrawal by Subject|1|||
164470404|NCT02777593|594096321|FG003|Overall Study|Withdrawal by Subject|1|||
164470405|NCT02777593|594096322|FG004|Overall Study|Withdrawal by Subject|0|||
164470406|NCT02777593|594096318|FG000|Overall Study|Lost to Follow-up|8|||
164470407|NCT02777593|594096319|FG001|Overall Study|Lost to Follow-up|16|||
164470408|NCT02777593|594096320|FG002|Overall Study|Lost to Follow-up|5|||
164470409|NCT02777593|594096321|FG003|Overall Study|Lost to Follow-up|0|||
164470410|NCT02777593|594096322|FG004|Overall Study|Lost to Follow-up|1|||
164470411|NCT02777593|594096318|FG000|Overall Study|Physician Decision|2|||
164470412|NCT02777593|594096319|FG001|Overall Study|Physician Decision|2|||
164470413|NCT02777593|594096320|FG002|Overall Study|Physician Decision|0|||
164470414|NCT02777593|594096321|FG003|Overall Study|Physician Decision|0|||
164470415|NCT02777593|594096322|FG004|Overall Study|Physician Decision|0|||
164470416|NCT02777593|594096318|FG000|Overall Study|Discontinued due to Other|1|||
164470417|NCT02777593|594096319|FG001|Overall Study|Discontinued due to Other|0|||
164470418|NCT02777593|594096320|FG002|Overall Study|Discontinued due to Other|0|||
164470419|NCT02777593|594096321|FG003|Overall Study|Discontinued due to Other|0|||
164470420|NCT02777593|594096322|FG004|Overall Study|Discontinued due to Other|0|||
164470421|NCT02933489|594096325|FG000|Overall Study|Ineligible|3|||
164470422|NCT02933489|594096326|FG001|Overall Study|Ineligible|3|||
164470423|NCT02933489|594096325|FG000|Overall Study|Withdrawal by Subject|27|||
164470424|NCT02933489|594096326|FG001|Overall Study|Withdrawal by Subject|18|||
164470425|NCT02933489|594096325|FG000|Overall Study|Unable to complete exams (other)|14|||
164470426|NCT02933489|594096326|FG001|Overall Study|Unable to complete exams (other)|7|||
164470427|NCT04678856|594096327|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
164470428|NCT04678856|594096328|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
164470429|NCT04678856|594096327|FG000|Overall Study|Withdrawal by Subject|5|||
164470430|NCT04678856|594096328|FG001|Overall Study|Withdrawal by Subject|1|||
164470431|NCT03734029|594096329|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
164470432|NCT03734029|594096330|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
164470433|NCT03734029|594096329|FG000|Overall Study|Adverse Event|60|||
164470434|NCT03734029|594096330|FG001|Overall Study|Adverse Event|14|||
164470435|NCT03734029|594096329|FG000|Overall Study|Withdrawal by Subject|12|||
164470436|NCT03734029|594096330|FG001|Overall Study|Withdrawal by Subject|11|||
164470437|NCT03734029|594096329|FG000|Overall Study|Clinical progression by investigator|10|||
164470438|NCT03734029|594096330|FG001|Overall Study|Clinical progression by investigator|8|||
164470439|NCT03734029|594096329|FG000|Overall Study|Death|5|||
164470440|NCT03734029|594096330|FG001|Overall Study|Death|2|||
164470441|NCT03734029|594096329|FG000|Overall Study|Physician Decision|4|||
164470442|NCT03734029|594096330|FG001|Overall Study|Physician Decision|3|||
164470443|NCT03734029|594096329|FG000|Overall Study|Other|2|||
164470444|NCT03734029|594096330|FG001|Overall Study|Other|0|||
164470445|NCT03734029|594096329|FG000|Overall Study|Lost to Follow-up|0|||
164470446|NCT03734029|594096330|FG001|Overall Study|Lost to Follow-up|1|||
164470447|NCT03734029|594096329|FG000|Overall Study|Randomized, but not treated|2|||
164470448|NCT03734029|594096330|FG001|Overall Study|Randomized, but not treated|12|||
164470449|NCT04408755|594097236|FG000|Period A (Placebo lead-in)|Other|11|||
164470450|NCT04408755|594097237|FG001|Period A (Placebo lead-in)|Other|0|||
164470451|NCT04408755|594097238|FG002|Period A (Placebo lead-in)|Other|0|||
164470452|NCT04408755|594097239|FG003|Period A (Placebo lead-in)|Other|0|||
164470453|NCT04408755|594097236|FG000|Period B (Randomization Period)|Adverse Event|0|||
164470454|NCT04408755|594097237|FG001|Period B (Randomization Period)|Adverse Event|3|||
164470455|NCT04408755|594097238|FG002|Period B (Randomization Period)|Adverse Event|0|||
164470456|NCT04408755|594097239|FG003|Period B (Randomization Period)|Adverse Event|1|||
164470457|NCT04408755|594097236|FG000|Period B (Randomization Period)|Death|0|||
164470458|NCT04408755|594097237|FG001|Period B (Randomization Period)|Death|0|||
164470459|NCT04408755|594097238|FG002|Period B (Randomization Period)|Death|1|||
164470460|NCT04408755|594097239|FG003|Period B (Randomization Period)|Death|0|||
164470461|NCT04408755|594097236|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
164470462|NCT04408755|594097237|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
164470463|NCT04408755|594097238|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
164470464|NCT04408755|594097239|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
164470465|NCT04408755|594097236|FG000|Period B (Randomization Period)|Physician Decision|0|||
164470466|NCT04408755|594097237|FG001|Period B (Randomization Period)|Physician Decision|0|||
164470467|NCT04408755|594097238|FG002|Period B (Randomization Period)|Physician Decision|1|||
164470468|NCT04408755|594097239|FG003|Period B (Randomization Period)|Physician Decision|0|||
164470469|NCT04408755|594097236|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
164470470|NCT04408755|594097237|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
164470471|NCT04408755|594097238|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
164470472|NCT04408755|594097239|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
164470473|NCT04408755|594097236|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
164470474|NCT04408755|594097237|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
164470475|NCT04408755|594097238|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
164470476|NCT04408755|594097239|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
164470477|NCT04408755|594097236|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
164470478|NCT04408755|594097237|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
164470479|NCT04408755|594097238|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
164470480|NCT04408755|594097239|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
164470481|NCT04408755|594097236|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
164470482|NCT04408755|594097237|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
164470483|NCT04408755|594097238|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
164470484|NCT04408755|594097239|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
164470485|NCT04408755|594097236|FG000|Period B (Randomization Period)|Reason not Specified|0|||
164470486|NCT04408755|594097237|FG001|Period B (Randomization Period)|Reason not Specified|1|||
164470487|NCT04408755|594097238|FG002|Period B (Randomization Period)|Reason not Specified|0|||
164470488|NCT04408755|594097239|FG003|Period B (Randomization Period)|Reason not Specified|2|||
164470489|NCT00308997|594097240|FG000|Overall Study|Subject feigned clinical data|0|||
164470490|NCT00308997|594097241|FG001|Overall Study|Subject feigned clinical data|1|||
164470491|NCT00308997|594097240|FG000|Overall Study|Unable to tolerate intervention|1|||
164470492|NCT00308997|594097241|FG001|Overall Study|Unable to tolerate intervention|0|||
164470493|NCT06655818|594097242|FG000|Overall Study|Withdrawal by Subject|1|||
164470494|NCT03662022|594097243|FG000|Year 1 2019|prevalent case|83|||
164470495|NCT03662022|594097244|FG001|Year 1 2019|prevalent case|116|||
164470496|NCT03662022|594097245|FG002|Year 1 2019|prevalent case|158|||
164470497|NCT03662022|594097246|FG003|Year 1 2019|prevalent case|99|||
164470498|NCT03662022|594097243|FG000|Year 2 2020|incident case|18|||
164470499|NCT03662022|594097244|FG001|Year 2 2020|incident case|18|||
164470500|NCT03662022|594097245|FG002|Year 2 2020|incident case|16|||
164470501|NCT03662022|594097246|FG003|Year 2 2020|incident case|26|||
164712695|NCT03982199|594970354|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164712696|NCT03982199|594970355|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164470502|NCT03662022|594097243|FG000|Year 2 2020|other case|18|||
164470503|NCT03662022|594097244|FG001|Year 2 2020|other case|16|||
164470504|NCT03662022|594097245|FG002|Year 2 2020|other case|16|||
164470505|NCT03662022|594097246|FG003|Year 2 2020|other case|24|||
164470506|NCT03662022|594097243|FG000|Year 2 2020|Lost to Follow-up|1633|||
164470507|NCT03662022|594097244|FG001|Year 2 2020|Lost to Follow-up|1183|||
164470508|NCT03662022|594097245|FG002|Year 2 2020|Lost to Follow-up|1381|||
164470509|NCT03662022|594097246|FG003|Year 2 2020|Lost to Follow-up|2858|||
164470510|NCT03662022|594097243|FG000|Year 3 2021|incident case|24|||
164470511|NCT03662022|594097244|FG001|Year 3 2021|incident case|27|||
164470512|NCT03662022|594097245|FG002|Year 3 2021|incident case|24|||
164470513|NCT03662022|594097246|FG003|Year 3 2021|incident case|11|||
164470514|NCT03662022|594097243|FG000|Year 3 2021|other case|4|||
164470515|NCT03662022|594097244|FG001|Year 3 2021|other case|15|||
164470516|NCT03662022|594097245|FG002|Year 3 2021|other case|10|||
164470517|NCT03662022|594097246|FG003|Year 3 2021|other case|14|||
164470518|NCT03662022|594097243|FG000|Year 3 2021|Lost to Follow-up|179|||
164470519|NCT03662022|594097244|FG001|Year 3 2021|Lost to Follow-up|244|||
164470520|NCT03662022|594097245|FG002|Year 3 2021|Lost to Follow-up|480|||
164470521|NCT03662022|594097246|FG003|Year 3 2021|Lost to Follow-up|477|||
164470522|NCT03662022|594097243|FG000|Year 4 2022|incident case|25|||
164470523|NCT03662022|594097244|FG001|Year 4 2022|incident case|41|||
164470524|NCT03662022|594097245|FG002|Year 4 2022|incident case|28|||
164470525|NCT03662022|594097246|FG003|Year 4 2022|incident case|7|||
164470526|NCT03662022|594097243|FG000|Year 4 2022|other case|8|||
164470527|NCT03662022|594097244|FG001|Year 4 2022|other case|19|||
164470528|NCT03662022|594097245|FG002|Year 4 2022|other case|13|||
164470529|NCT03662022|594097246|FG003|Year 4 2022|other case|7|||
164470530|NCT03662022|594097243|FG000|Year 4 2022|Lost to Follow-up|986|||
164470531|NCT03662022|594097244|FG001|Year 4 2022|Lost to Follow-up|1079|||
164470532|NCT03662022|594097245|FG002|Year 4 2022|Lost to Follow-up|1236|||
164470533|NCT03662022|594097246|FG003|Year 4 2022|Lost to Follow-up|1826|||
164470534|NCT05836012|594097249|FG000|Overall Study|Lost to Follow-up|1|||
164470535|NCT05836012|594097250|FG001|Overall Study|Lost to Follow-up|0|||
164470536|NCT05836012|594097249|FG000|Overall Study|Withdrawal by Subject|1|||
164470537|NCT05836012|594097250|FG001|Overall Study|Withdrawal by Subject|3|||
164470538|NCT05836012|594097249|FG000|Overall Study|Reason not included in pre-specified categories|2|||
164470539|NCT05836012|594097250|FG001|Overall Study|Reason not included in pre-specified categories|1|||
164470540|NCT03248479|594097251|FG000|Overall Study|Death|12|||
164470541|NCT03248479|594097252|FG001|Overall Study|Death|44|||
164470542|NCT03248479|594097253|FG002|Overall Study|Death|1|||
164470543|NCT03248479|594097254|FG003|Overall Study|Death|72|||
164470544|NCT03248479|594097255|FG004|Overall Study|Death|17|||
164470545|NCT03248479|594097256|FG005|Overall Study|Death|6|||
164470546|NCT03248479|594097257|FG006|Overall Study|Death|1|||
164470547|NCT03248479|594097258|FG007|Overall Study|Death|14|||
164470548|NCT03248479|594097259|FG008|Overall Study|Death|3|||
164470549|NCT03248479|594097260|FG009|Overall Study|Death|7|||
164470550|NCT03248479|594097261|FG010|Overall Study|Death|3|||
164470551|NCT03248479|594097262|FG011|Overall Study|Death|1|||
164470552|NCT03248479|594097263|FG012|Overall Study|Death|1|||
164470553|NCT03248479|594097251|FG000|Overall Study|Study terminated by sponsor|12|||
164470554|NCT03248479|594097252|FG001|Overall Study|Study terminated by sponsor|15|||
164470555|NCT03248479|594097253|FG002|Overall Study|Study terminated by sponsor|0|||
164470556|NCT03248479|594097254|FG003|Overall Study|Study terminated by sponsor|5|||
164470557|NCT03248479|594097255|FG004|Overall Study|Study terminated by sponsor|0|||
164470558|NCT03248479|594097256|FG005|Overall Study|Study terminated by sponsor|0|||
164470559|NCT03248479|594097257|FG006|Overall Study|Study terminated by sponsor|0|||
164470560|NCT03248479|594097258|FG007|Overall Study|Study terminated by sponsor|1|||
164470561|NCT03248479|594097259|FG008|Overall Study|Study terminated by sponsor|1|||
164470562|NCT03248479|594097260|FG009|Overall Study|Study terminated by sponsor|0|||
164470563|NCT03248479|594097261|FG010|Overall Study|Study terminated by sponsor|5|||
164470564|NCT03248479|594097262|FG011|Overall Study|Study terminated by sponsor|4|||
164470565|NCT03248479|594097263|FG012|Overall Study|Study terminated by sponsor|0|||
164470566|NCT03248479|594097251|FG000|Overall Study|Consent withdrawn|6|||
164470567|NCT03248479|594097252|FG001|Overall Study|Consent withdrawn|3|||
164470568|NCT03248479|594097253|FG002|Overall Study|Consent withdrawn|0|||
164470569|NCT03248479|594097254|FG003|Overall Study|Consent withdrawn|9|||
164470570|NCT03248479|594097255|FG004|Overall Study|Consent withdrawn|1|||
164470571|NCT03248479|594097256|FG005|Overall Study|Consent withdrawn|0|||
164470572|NCT03248479|594097257|FG006|Overall Study|Consent withdrawn|0|||
164470573|NCT03248479|594097258|FG007|Overall Study|Consent withdrawn|1|||
164470574|NCT03248479|594097259|FG008|Overall Study|Consent withdrawn|0|||
164470575|NCT03248479|594097260|FG009|Overall Study|Consent withdrawn|3|||
164470576|NCT03248479|594097261|FG010|Overall Study|Consent withdrawn|1|||
164470577|NCT03248479|594097262|FG011|Overall Study|Consent withdrawn|0|||
164470578|NCT03248479|594097263|FG012|Overall Study|Consent withdrawn|1|||
164470579|NCT03248479|594097251|FG000|Overall Study|Lost to Follow-up|2|||
164470580|NCT03248479|594097252|FG001|Overall Study|Lost to Follow-up|1|||
164470581|NCT03248479|594097253|FG002|Overall Study|Lost to Follow-up|0|||
164470582|NCT03248479|594097254|FG003|Overall Study|Lost to Follow-up|0|||
164470583|NCT03248479|594097255|FG004|Overall Study|Lost to Follow-up|0|||
164470584|NCT03248479|594097256|FG005|Overall Study|Lost to Follow-up|0|||
164470585|NCT03248479|594097257|FG006|Overall Study|Lost to Follow-up|0|||
164470586|NCT03248479|594097258|FG007|Overall Study|Lost to Follow-up|0|||
164470587|NCT03248479|594097259|FG008|Overall Study|Lost to Follow-up|0|||
164599776|NCT02951988|594556357|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
164470588|NCT03248479|594097260|FG009|Overall Study|Lost to Follow-up|0|||
164470589|NCT03248479|594097261|FG010|Overall Study|Lost to Follow-up|0|||
164470590|NCT03248479|594097262|FG011|Overall Study|Lost to Follow-up|0|||
164470591|NCT03248479|594097263|FG012|Overall Study|Lost to Follow-up|1|||
164470592|NCT03248479|594097251|FG000|Overall Study|Not reported|0|||
164470593|NCT03248479|594097252|FG001|Overall Study|Not reported|0|||
164470594|NCT03248479|594097253|FG002|Overall Study|Not reported|0|||
164470595|NCT03248479|594097254|FG003|Overall Study|Not reported|1|||
164470596|NCT03248479|594097255|FG004|Overall Study|Not reported|1|||
164470597|NCT03248479|594097256|FG005|Overall Study|Not reported|0|||
164470598|NCT03248479|594097257|FG006|Overall Study|Not reported|0|||
164470599|NCT03248479|594097258|FG007|Overall Study|Not reported|1|||
164470600|NCT03248479|594097259|FG008|Overall Study|Not reported|1|||
164470601|NCT03248479|594097260|FG009|Overall Study|Not reported|0|||
164470602|NCT03248479|594097261|FG010|Overall Study|Not reported|0|||
164470603|NCT03248479|594097262|FG011|Overall Study|Not reported|0|||
164470604|NCT03248479|594097263|FG012|Overall Study|Not reported|0|||
164470605|NCT05785130|594097269|FG000|Overall Study|Withdrawal by Subject|1|||
164470606|NCT05785130|594097270|FG001|Overall Study|Withdrawal by Subject|0|||
164470607|NCT05785130|594097269|FG000|Overall Study|Lack of Efficacy|0|||
164470608|NCT05785130|594097270|FG001|Overall Study|Lack of Efficacy|1|||
164470609|NCT02624050|594097275|FG000|Overall Study|Physician Decision|4|||
164470610|NCT02624050|594097276|FG001|Overall Study|Physician Decision|0|||
164470611|NCT02624050|594097275|FG000|Overall Study|Protocol Violation|2|||
164470612|NCT02624050|594097276|FG001|Overall Study|Protocol Violation|0|||
164470613|NCT03547271|594097277|FG000|Overall Study|Adverse Event|1|||
164712697|NCT03982199|594970356|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164712698|NCT03982199|594970357|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164712699|NCT03982199|594970358|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164712700|NCT03982199|594970359|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164712701|NCT03982199|594970360|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164712702|NCT03982199|594970361|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164712703|NCT03982199|594970362|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164712704|NCT03982199|594970363|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
164712705|NCT03982199|594970350|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
164712706|NCT03982199|594970351|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
164712707|NCT03982199|594970352|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
164712708|NCT03982199|594970353|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
164712709|NCT03982199|594970354|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
164712710|NCT03982199|594970355|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
164712711|NCT03982199|594970356|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
164712712|NCT03982199|594970357|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
164712713|NCT03982199|594970358|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
164712714|NCT03982199|594970359|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
164470614|NCT03547271|594097278|FG001|Overall Study|Adverse Event|1|||
164470615|NCT03547271|594097279|FG002|Overall Study|Adverse Event|0|||
164470616|NCT03547271|594097280|FG003|Overall Study|Adverse Event|0|||
164470617|NCT03547271|594097277|FG000|Overall Study|Protocol deviation|5|||
164470618|NCT03547271|594097278|FG001|Overall Study|Protocol deviation|7|||
164470619|NCT03547271|594097279|FG002|Overall Study|Protocol deviation|3|||
164470620|NCT03547271|594097280|FG003|Overall Study|Protocol deviation|0|||
164470621|NCT03547271|594097277|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
164470622|NCT03547271|594097278|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
164470623|NCT03547271|594097279|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
164470624|NCT03547271|594097280|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
164470625|NCT03547271|594097277|FG000|Overall Study|Lost to Follow-up|3|||
164470626|NCT03547271|594097278|FG001|Overall Study|Lost to Follow-up|3|||
164470627|NCT03547271|594097279|FG002|Overall Study|Lost to Follow-up|1|||
164470628|NCT03547271|594097280|FG003|Overall Study|Lost to Follow-up|0|||
164470629|NCT06065735|594097285|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
164470630|NCT06065735|594097286|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
164470631|NCT06065735|594097287|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
164470632|NCT06065735|594097285|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
164470633|NCT06065735|594097286|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
164470634|NCT06065735|594097287|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
164470635|NCT06065735|594097285|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
164470636|NCT06065735|594097286|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
164470637|NCT06065735|594097287|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
164470638|NCT06065735|594097285|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
164470639|NCT06065735|594097286|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
164470640|NCT06065735|594097287|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
164470641|NCT06065735|594097285|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
164470642|NCT06065735|594097286|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
164470643|NCT06065735|594097287|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
164712715|NCT03982199|594970360|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
164712716|NCT03982199|594970361|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
164712717|NCT03982199|594970362|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
164712718|NCT03982199|594970363|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
164712719|NCT03982199|594970350|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164470644|NCT03522298|594097288|FG000|Overall Study|Adverse Event|1|||
164470645|NCT03522298|594097289|FG001|Overall Study|Adverse Event|0|||
164470646|NCT03522298|594097290|FG002|Overall Study|Adverse Event|0|||
164470647|NCT03522298|594097291|FG003|Overall Study|Adverse Event|1|||
164470648|NCT03522298|594097288|FG000|Overall Study|Death|2|||
164470649|NCT03522298|594097289|FG001|Overall Study|Death|4|||
164470650|NCT03522298|594097290|FG002|Overall Study|Death|8|||
164470651|NCT03522298|594097291|FG003|Overall Study|Death|8|||
164470652|NCT03522298|594097288|FG000|Overall Study|Patient decision|0|||
164470653|NCT03522298|594097289|FG001|Overall Study|Patient decision|2|||
164470654|NCT03522298|594097290|FG002|Overall Study|Patient decision|2|||
164470655|NCT03522298|594097291|FG003|Overall Study|Patient decision|2|||
164470656|NCT05718687|594097296|FG000|Overall Study|Withdrawal by Subject|3|||
164470657|NCT05485935|594097299|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
164470658|NCT05485935|594097300|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
164470659|NCT05485935|594097299|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
164470660|NCT05485935|594097300|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
164470661|NCT05485935|594097299|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
164470662|NCT05485935|594097300|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
164470663|NCT05485935|594097299|FG000|Period 2 (T2 and V3)|loss of contact|0|||
164470664|NCT05485935|594097300|FG001|Period 2 (T2 and V3)|loss of contact|1|||
164470665|NCT04093869|594097301|FG000|Overall Study|Death|0|||
164470666|NCT04093869|594097302|FG001|Overall Study|Death|1|||
164470667|NCT04093869|594097301|FG000|Overall Study|Withdrawal by Subject|1|||
164470668|NCT04093869|594097302|FG001|Overall Study|Withdrawal by Subject|0|||
164712720|NCT03982199|594970351|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164712721|NCT03982199|594970352|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164712722|NCT03982199|594970353|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164712723|NCT03982199|594970354|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164712724|NCT03982199|594970355|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164712725|NCT03982199|594970356|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164712726|NCT03982199|594970357|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164470669|NCT05129501|594097305|FG000|Overall Study|Lost to Follow-up|54|||
164470670|NCT05129501|594097306|FG001|Overall Study|Lost to Follow-up|41|||
164470671|NCT02325154|594097307|FG000|Overall Study|Physician Decision|1|||
164470672|NCT03990883|594097308|FG000|Blinded Treatment Phase|Adverse Event|1|||
164470673|NCT03990883|594097309|FG001|Blinded Treatment Phase|Adverse Event|1|||
164470674|NCT03990883|594097310|FG002|Blinded Treatment Phase|Adverse Event|0|||
164470675|NCT03990883|594097308|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
164470676|NCT03990883|594097309|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
164470677|NCT03990883|594097310|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
164470678|NCT03990883|594097308|FG000|Blinded Treatment Phase|Physician Decision|1|||
164470679|NCT03990883|594097309|FG001|Blinded Treatment Phase|Physician Decision|0|||
164470680|NCT03990883|594097310|FG002|Blinded Treatment Phase|Physician Decision|0|||
164470681|NCT03990883|594097308|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
164470682|NCT03990883|594097309|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
164470683|NCT03990883|594097310|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
164470684|NCT03990883|594097308|FG000|Blinded Treatment Phase|COVID-19|3|||
164470685|NCT03990883|594097309|FG001|Blinded Treatment Phase|COVID-19|2|||
164470686|NCT03990883|594097310|FG002|Blinded Treatment Phase|COVID-19|0|||
164470687|NCT03990883|594097308|FG000|Blinded Treatment Phase|Personal Reasons|6|||
164470688|NCT03990883|594097309|FG001|Blinded Treatment Phase|Personal Reasons|3|||
164470689|NCT03990883|594097310|FG002|Blinded Treatment Phase|Personal Reasons|0|||
164470690|NCT03990883|594097308|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
164470691|NCT03990883|594097309|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
164470692|NCT03990883|594097310|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
164470693|NCT03990883|594097308|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
164470694|NCT03990883|594097309|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
164470695|NCT03990883|594097310|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
164470696|NCT03990883|594097308|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
164470697|NCT03990883|594097309|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
164470698|NCT03990883|594097310|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
164470699|NCT04675034|594097716|FG000|Overall Study|Lost to Follow-up|1|||
164470700|NCT04675034|594097717|FG001|Overall Study|Lost to Follow-up|1|||
164470701|NCT04675034|594097718|FG002|Overall Study|Lost to Follow-up|0|||
164470702|NCT04675034|594097719|FG003|Overall Study|Lost to Follow-up|2|||
164470703|NCT04675034|594097720|FG004|Overall Study|Lost to Follow-up|0|||
164470704|NCT04675034|594097716|FG000|Overall Study|Protocol Violation|1|||
164470705|NCT04675034|594097717|FG001|Overall Study|Protocol Violation|0|||
164470706|NCT04675034|594097718|FG002|Overall Study|Protocol Violation|0|||
164470707|NCT04675034|594097719|FG003|Overall Study|Protocol Violation|1|||
164470708|NCT04675034|594097720|FG004|Overall Study|Protocol Violation|3|||
164712727|NCT03982199|594970358|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164470709|NCT04675034|594097716|FG000|Overall Study|Withdrawal by Subject|9|||
164470710|NCT04675034|594097717|FG001|Overall Study|Withdrawal by Subject|3|||
164470711|NCT04675034|594097718|FG002|Overall Study|Withdrawal by Subject|4|||
164470712|NCT04675034|594097719|FG003|Overall Study|Withdrawal by Subject|8|||
164470713|NCT04675034|594097720|FG004|Overall Study|Withdrawal by Subject|6|||
164470714|NCT03201939|594097721|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
164470715|NCT03201939|594097722|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
164470716|NCT02806726|594097731|FG000|Overall Study|Lost to Follow-up|1|||
164470717|NCT01499368|594097732|FG000|Overall Study|Did not meet I/E criteria|8|||
164470718|NCT01499368|594097733|FG001|Overall Study|Did not meet I/E criteria|4|||
164470719|NCT01499368|594097734|FG002|Overall Study|Did not meet I/E criteria|4|||
164470720|NCT01499368|594097732|FG000|Overall Study|Prohibited Concomitant medication|1|||
164470721|NCT01499368|594097733|FG001|Overall Study|Prohibited Concomitant medication|1|||
164470722|NCT01499368|594097734|FG002|Overall Study|Prohibited Concomitant medication|0|||
164470723|NCT01499368|594097732|FG000|Overall Study|Withdrawal by Subject|11|||
164470724|NCT01499368|594097733|FG001|Overall Study|Withdrawal by Subject|10|||
164470725|NCT01499368|594097734|FG002|Overall Study|Withdrawal by Subject|8|||
164470726|NCT01499368|594097732|FG000|Overall Study|Lost to Follow-up|3|||
164470727|NCT01499368|594097733|FG001|Overall Study|Lost to Follow-up|2|||
164470728|NCT01499368|594097734|FG002|Overall Study|Lost to Follow-up|5|||
164599777|NCT02951988|594556358|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
164599778|NCT02951988|594556355|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164599779|NCT02951988|594556356|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
164599780|NCT02951988|594556357|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
164599781|NCT02951988|594556358|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
164599782|NCT02951988|594556355|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164599783|NCT02951988|594556356|FG001|Double-Blind Treatment Period|Adverse Event|8|||
164599784|NCT02951988|594556357|FG002|Double-Blind Treatment Period|Adverse Event|3|||
164599785|NCT02951988|594556358|FG003|Double-Blind Treatment Period|Adverse Event|6|||
164599786|NCT02951988|594556355|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
164599787|NCT02951988|594556356|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
164599788|NCT02951988|594556357|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
164599789|NCT02951988|594556358|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
164599790|NCT00516269|594556364|FG000|Overall Study|Adverse Event|2|||
164599791|NCT00516269|594556365|FG001|Overall Study|Adverse Event|1|||
164599792|NCT00516269|594556364|FG000|Overall Study|Lost to Follow-up|0|||
164599793|NCT00516269|594556365|FG001|Overall Study|Lost to Follow-up|1|||
164599794|NCT00516269|594556364|FG000|Overall Study|Protocol Violation|0|||
164599795|NCT00516269|594556365|FG001|Overall Study|Protocol Violation|1|||
164599796|NCT04570657|594556370|FG000|Overall Study|Adverse Event|0|||
164599797|NCT04570657|594556371|FG001|Overall Study|Adverse Event|0|||
164599798|NCT04570657|594556372|FG002|Overall Study|Adverse Event|1|||
164599799|NCT04570657|594556370|FG000|Overall Study|Lost to Follow-up|0|||
164599800|NCT04570657|594556371|FG001|Overall Study|Lost to Follow-up|0|||
164599801|NCT04570657|594556372|FG002|Overall Study|Lost to Follow-up|1|||
164599802|NCT04570657|594556370|FG000|Overall Study|Physician Decision|0|||
164599803|NCT04570657|594556371|FG001|Overall Study|Physician Decision|1|||
164599804|NCT04570657|594556372|FG002|Overall Study|Physician Decision|0|||
164599805|NCT04570657|594556370|FG000|Overall Study|Withdrawal by Subject|1|||
164599806|NCT04570657|594556371|FG001|Overall Study|Withdrawal by Subject|2|||
164599807|NCT04570657|594556372|FG002|Overall Study|Withdrawal by Subject|2|||
164599808|NCT01079962|594556373|FG000|Overall Study|Adverse Event|2|||
164599809|NCT01079962|594556374|FG001|Overall Study|Adverse Event|2|||
164599810|NCT01079962|594556373|FG000|Overall Study|Withdrawal by Subject|5|||
164599811|NCT01079962|594556374|FG001|Overall Study|Withdrawal by Subject|7|||
164599812|NCT01079962|594556373|FG000|Overall Study|Protocol Violation|2|||
164599813|NCT01079962|594556374|FG001|Overall Study|Protocol Violation|2|||
164599814|NCT01079962|594556373|FG000|Overall Study|No blood pressure (BP) control|3|||
164599815|NCT01079962|594556374|FG001|Overall Study|No blood pressure (BP) control|0|||
164599816|NCT01079962|594556373|FG000|Overall Study|Inclusion/exclusion criteria|1|||
164599817|NCT01079962|594556374|FG001|Overall Study|Inclusion/exclusion criteria|3|||
164599818|NCT01079962|594556373|FG000|Overall Study|Participant not returning for next visit|1|||
164599819|NCT01079962|594556374|FG001|Overall Study|Participant not returning for next visit|0|||
164599820|NCT01079962|594556373|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
164599821|NCT01079962|594556374|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
164599822|NCT01072539|594556375|FG000|Overall Study|Treated prior to the Site Initiation|1|||
164599823|NCT01072539|594556375|FG000|Overall Study|Protocol Violation|2|||
164599824|NCT00946530|594556376|FG000|Overall Study|Withdrawal by Subject|0|||
164599825|NCT00946530|594556377|FG001|Overall Study|Withdrawal by Subject|3|||
164599826|NCT00946530|594556378|FG002|Overall Study|Withdrawal by Subject|0|||
164599827|NCT00946530|594556379|FG003|Overall Study|Withdrawal by Subject|3|||
164599828|NCT00946530|594556376|FG000|Overall Study|Physician Decision|1|||
164599829|NCT00946530|594556377|FG001|Overall Study|Physician Decision|1|||
164599830|NCT00946530|594556378|FG002|Overall Study|Physician Decision|1|||
164599831|NCT00946530|594556379|FG003|Overall Study|Physician Decision|1|||
164599832|NCT04167306|594556380|FG000|Overall Study|Lost to Follow-up|2|||
164599833|NCT04167306|594556381|FG001|Overall Study|Lost to Follow-up|2|||
164599834|NCT04167306|594556382|FG002|Overall Study|Lost to Follow-up|5|||
164712728|NCT03982199|594970359|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164712729|NCT03982199|594970360|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164712730|NCT03982199|594970361|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164712731|NCT03982199|594970362|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164712732|NCT03982199|594970363|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
164712733|NCT03982199|594970350|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
164712734|NCT03982199|594970351|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
164712735|NCT03982199|594970352|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
164712736|NCT03982199|594970353|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
164712737|NCT03982199|594970354|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
164712738|NCT03982199|594970355|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
164712739|NCT03982199|594970356|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
164712740|NCT03982199|594970357|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
164712741|NCT03982199|594970358|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
164712742|NCT03982199|594970359|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
164712743|NCT03982199|594970360|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
164712744|NCT03982199|594970361|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
164712745|NCT03982199|594970362|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
164712746|NCT03982199|594970363|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
164712747|NCT03982199|594970350|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164712748|NCT03982199|594970351|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164712749|NCT03982199|594970352|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164712750|NCT03982199|594970353|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164712751|NCT03982199|594970354|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164712752|NCT03982199|594970355|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164712753|NCT03982199|594970356|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164712754|NCT03982199|594970357|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164712755|NCT03982199|594970358|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164712756|NCT03982199|594970359|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164712757|NCT03982199|594970360|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164712758|NCT03982199|594970361|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164712759|NCT03982199|594970362|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
164712760|NCT03982199|594970363|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164417326|NCT01474512|593899502|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
164417327|NCT01474512|593899503|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
164417328|NCT01474512|593899504|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
164417329|NCT01474512|593899505|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
164417330|NCT01474512|593899506|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
164417331|NCT01474512|593899489|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
164417332|NCT01474512|593899490|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
164417333|NCT01474512|593899491|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
164417334|NCT01474512|593899492|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
164417335|NCT01474512|593899493|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
164417336|NCT01474512|593899494|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
164417337|NCT01474512|593899495|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
164417338|NCT01474512|593899496|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
164417339|NCT01474512|593899497|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
164417340|NCT01474512|593899498|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
164417341|NCT01474512|593899499|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
164417342|NCT01474512|593899500|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
164417343|NCT01474512|593899501|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
164417344|NCT01474512|593899502|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
164417345|NCT01474512|593899503|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
164599835|NCT04167306|594556383|FG003|Overall Study|Lost to Follow-up|5|||
164599836|NCT04167306|594556380|FG000|Overall Study|Adverse Event|13|||
164599837|NCT04167306|594556381|FG001|Overall Study|Adverse Event|14|||
164599838|NCT04167306|594556382|FG002|Overall Study|Adverse Event|5|||
164599839|NCT04167306|594556383|FG003|Overall Study|Adverse Event|4|||
164599840|NCT04167306|594556380|FG000|Overall Study|Withdrawal by Subject|4|||
164599841|NCT04167306|594556381|FG001|Overall Study|Withdrawal by Subject|6|||
164599842|NCT04167306|594556382|FG002|Overall Study|Withdrawal by Subject|8|||
164599843|NCT04167306|594556383|FG003|Overall Study|Withdrawal by Subject|3|||
164599844|NCT04167306|594556380|FG000|Overall Study|covid|1|||
164712761|NCT03433755|594970364|FG000|Overall Study|Lost to Follow-up|1|||
164470729|NCT01499368|594097732|FG000|Overall Study|Adverse Event|4|||
164470730|NCT01499368|594097733|FG001|Overall Study|Adverse Event|0|||
164470731|NCT01499368|594097734|FG002|Overall Study|Adverse Event|2|||
164470732|NCT01499368|594097732|FG000|Overall Study|Physician Decision|0|||
164470733|NCT01499368|594097733|FG001|Overall Study|Physician Decision|1|||
164470734|NCT01499368|594097734|FG002|Overall Study|Physician Decision|0|||
164470735|NCT01499368|594097732|FG000|Overall Study|Deviation from visit window|0|||
164470736|NCT01499368|594097733|FG001|Overall Study|Deviation from visit window|0|||
164470737|NCT01499368|594097734|FG002|Overall Study|Deviation from visit window|1|||
164470738|NCT01499368|594097732|FG000|Overall Study|Error of Prescriptions|0|||
164470739|NCT01499368|594097733|FG001|Overall Study|Error of Prescriptions|0|||
164470740|NCT01499368|594097734|FG002|Overall Study|Error of Prescriptions|1|||
164470741|NCT03092674|594097735|FG000|Overall Study|Adverse Event or Side Effects|1|||
164470742|NCT03092674|594097736|FG001|Overall Study|Adverse Event or Side Effects|4|||
164470743|NCT03092674|594097737|FG002|Overall Study|Adverse Event or Side Effects|4|||
164470744|NCT03092674|594097735|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
164470745|NCT03092674|594097736|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
164470746|NCT03092674|594097737|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
164470747|NCT03092674|594097735|FG000|Overall Study|Progression/Relapse|5|||
164470748|NCT03092674|594097736|FG001|Overall Study|Progression/Relapse|4|||
164470749|NCT03092674|594097737|FG002|Overall Study|Progression/Relapse|8|||
164470750|NCT03092674|594097735|FG000|Overall Study|Death|4|||
164470751|NCT03092674|594097736|FG001|Overall Study|Death|8|||
164470752|NCT03092674|594097737|FG002|Overall Study|Death|2|||
164470753|NCT03092674|594097735|FG000|Overall Study|Other - Not Protocol Specified|11|||
164470754|NCT03092674|594097736|FG001|Overall Study|Other - Not Protocol Specified|8|||
164470755|NCT03092674|594097737|FG002|Overall Study|Other - Not Protocol Specified|8|||
164470756|NCT01527188|594097738|FG000|Overall Study|Adverse Event|5|||
164470757|NCT01527188|594097739|FG001|Overall Study|Adverse Event|5|||
164470758|NCT01527188|594097740|FG002|Overall Study|Adverse Event|11|||
164470759|NCT01527188|594097741|FG003|Overall Study|Adverse Event|0|||
164470760|NCT01527188|594097738|FG000|Overall Study|Withdrawal by Subject|3|||
164470761|NCT01527188|594097739|FG001|Overall Study|Withdrawal by Subject|6|||
164470762|NCT01527188|594097740|FG002|Overall Study|Withdrawal by Subject|4|||
164470763|NCT01527188|594097741|FG003|Overall Study|Withdrawal by Subject|4|||
164470764|NCT01527188|594097738|FG000|Overall Study|Any other reason not above-mentioned|6|||
164470765|NCT01527188|594097739|FG001|Overall Study|Any other reason not above-mentioned|7|||
164470766|NCT01527188|594097740|FG002|Overall Study|Any other reason not above-mentioned|8|||
164470767|NCT01527188|594097741|FG003|Overall Study|Any other reason not above-mentioned|8|||
164470768|NCT04626427|594097742|FG000|Overall Study|Death|1|||
164470769|NCT04626427|594097742|FG000|Overall Study|Withdrawal by Subject|1|||
164470770|NCT04626427|594097742|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
164470771|NCT04626427|594097742|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
164470772|NCT01553149|594097743|FG000|Overall Study|Adverse Event|0|||
164470773|NCT01553149|594097744|FG001|Overall Study|Adverse Event|9|||
164470774|NCT01553149|594097743|FG000|Overall Study|Physician Decision|5|||
164470775|NCT01553149|594097744|FG001|Overall Study|Physician Decision|10|||
164470776|NCT01553149|594097743|FG000|Overall Study|Ineligible|0|||
164470777|NCT01553149|594097744|FG001|Overall Study|Ineligible|1|||
164470778|NCT01265537|594097745|FG000|Overall Study|Adverse Event|2|||
164470779|NCT01265537|594097746|FG001|Overall Study|Adverse Event|1|||
164470780|NCT01265537|594097745|FG000|Overall Study|Physician Decision|0|||
164470781|NCT01265537|594097746|FG001|Overall Study|Physician Decision|1|||
164470782|NCT04518943|594098684|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
164470783|NCT04518943|594098685|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
164470784|NCT04518943|594098686|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
164712762|NCT03433755|594970365|FG001|Overall Study|Lost to Follow-up|0|||
164712763|NCT03433755|594970366|FG002|Overall Study|Lost to Follow-up|0|||
164712764|NCT03433755|594970367|FG003|Overall Study|Lost to Follow-up|0|||
164712765|NCT03433755|594970364|FG000|Overall Study|Decision by Sponsor|1|||
164712766|NCT03433755|594970365|FG001|Overall Study|Decision by Sponsor|0|||
164712767|NCT03433755|594970366|FG002|Overall Study|Decision by Sponsor|0|||
164712768|NCT03433755|594970367|FG003|Overall Study|Decision by Sponsor|0|||
164470785|NCT04518943|594098687|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
164712769|NCT05065567|594970369|FG000|Overall Study|Lost to Follow-up|10|||
164712770|NCT05065567|594970370|FG001|Overall Study|Lost to Follow-up|9|||
164470786|NCT04518943|594098688|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
164470787|NCT04518943|594098689|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
164470788|NCT04518943|594098690|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
164470789|NCT04518943|594098691|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
164470790|NCT04518943|594098692|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
164470791|NCT04518943|594098693|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
164712771|NCT05065567|594970371|FG002|Overall Study|Lost to Follow-up|6|||
164712772|NCT05323123|594970372|FG000|Overall Study|Withdrawal by Subject|2|||
164470792|NCT04518943|594098694|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
164470793|NCT04518943|594098695|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
164470794|NCT04518943|594098696|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
164470795|NCT04518943|594098697|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
164470796|NCT04518943|594098698|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
164470797|NCT04518943|594098699|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
164470798|NCT06408870|594098703|FG000|Washout period|Withdrawal by Subject|1|||
164470799|NCT06408870|594098704|FG001|Washout period|Withdrawal by Subject|0|||
164470800|NCT06408870|594098703|FG000|Washout period|Adverse Event|2|||
164470801|NCT06408870|594098704|FG001|Washout period|Adverse Event|0|||
164470802|NCT04993677|594098708|FG000|Overall Study|Lost to Follow-up|1|||
164470803|NCT04993677|594098709|FG001|Overall Study|Lost to Follow-up|0|||
164470804|NCT04993677|594098710|FG002|Overall Study|Lost to Follow-up|0|||
164470805|NCT04993677|594098711|FG003|Overall Study|Lost to Follow-up|0|||
164470806|NCT04993677|594098708|FG000|Overall Study|Death|11|||
164470807|NCT04993677|594098709|FG001|Overall Study|Death|8|||
164470808|NCT04993677|594098710|FG002|Overall Study|Death|3|||
164470809|NCT04993677|594098711|FG003|Overall Study|Death|1|||
164470810|NCT04993677|594098708|FG000|Overall Study|Subject withdrawal of consent|4|||
164470811|NCT04993677|594098709|FG001|Overall Study|Subject withdrawal of consent|3|||
164470812|NCT04993677|594098710|FG002|Overall Study|Subject withdrawal of consent|0|||
164470813|NCT04993677|594098711|FG003|Overall Study|Subject withdrawal of consent|2|||
164470814|NCT04993677|594098708|FG000|Overall Study|Study termination by sponsor|3|||
164470815|NCT04993677|594098709|FG001|Overall Study|Study termination by sponsor|25|||
164470816|NCT04993677|594098710|FG002|Overall Study|Study termination by sponsor|3|||
164470817|NCT04993677|594098711|FG003|Overall Study|Study termination by sponsor|3|||
164470818|NCT04993677|594098708|FG000|Overall Study|Other|2|||
164470819|NCT04993677|594098709|FG001|Overall Study|Other|3|||
164470820|NCT04993677|594098710|FG002|Overall Study|Other|3|||
164470821|NCT04993677|594098711|FG003|Overall Study|Other|2|||
164470822|NCT04174170|594098712|FG000|Placebo Run-in Period|Not Randomized|38|||
164470823|NCT04174170|594098713|FG001|Placebo Run-in Period|Not Randomized|0|||
164470824|NCT04174170|594098714|FG002|Placebo Run-in Period|Not Randomized|0|||
164470825|NCT04174170|594098715|FG003|Placebo Run-in Period|Not Randomized|0|||
164470826|NCT04174170|594098712|FG000|Double Blind Treatment Period|Adverse Event|0|||
164470827|NCT04174170|594098713|FG001|Double Blind Treatment Period|Adverse Event|9|||
164470828|NCT04174170|594098714|FG002|Double Blind Treatment Period|Adverse Event|9|||
164470829|NCT04174170|594098715|FG003|Double Blind Treatment Period|Adverse Event|8|||
164470830|NCT04174170|594098712|FG000|Double Blind Treatment Period|Death|0|||
164470831|NCT04174170|594098713|FG001|Double Blind Treatment Period|Death|1|||
164470832|NCT04174170|594098714|FG002|Double Blind Treatment Period|Death|0|||
164470833|NCT04174170|594098715|FG003|Double Blind Treatment Period|Death|0|||
164470834|NCT04174170|594098712|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
164470835|NCT04174170|594098713|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
164470836|NCT04174170|594098714|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
164470837|NCT04174170|594098715|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
164470838|NCT04174170|594098712|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
164470839|NCT04174170|594098713|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
164470840|NCT04174170|594098714|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
164470841|NCT04174170|594098715|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
164470842|NCT04174170|594098712|FG000|Double Blind Treatment Period|Physician Decision|0|||
164470843|NCT04174170|594098713|FG001|Double Blind Treatment Period|Physician Decision|1|||
164470844|NCT04174170|594098714|FG002|Double Blind Treatment Period|Physician Decision|0|||
164470845|NCT04174170|594098715|FG003|Double Blind Treatment Period|Physician Decision|1|||
164470846|NCT04174170|594098712|FG000|Double Blind Treatment Period|Pregnancy|0|||
164470847|NCT04174170|594098713|FG001|Double Blind Treatment Period|Pregnancy|1|||
164470848|NCT04174170|594098714|FG002|Double Blind Treatment Period|Pregnancy|0|||
164470849|NCT04174170|594098715|FG003|Double Blind Treatment Period|Pregnancy|1|||
164470850|NCT04174170|594098712|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
164470851|NCT04174170|594098713|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
164470852|NCT04174170|594098714|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
164470853|NCT04174170|594098715|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
164470854|NCT04174170|594098712|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
164470855|NCT04174170|594098713|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
164470856|NCT04174170|594098714|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
164470857|NCT04174170|594098715|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
164470858|NCT04174170|594098712|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
164599845|NCT04167306|594556381|FG001|Overall Study|covid|1|||
164470859|NCT04174170|594098713|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
164470860|NCT04174170|594098714|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
164470861|NCT04174170|594098715|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
164599846|NCT04167306|594556382|FG002|Overall Study|covid|2|||
164470862|NCT04772534|594098717|FG000|Overall Study|Physician Decision|1|||
164470863|NCT04772534|594098718|FG001|Overall Study|Physician Decision|0|||
164470864|NCT04772534|594098719|FG002|Overall Study|Physician Decision|0|||
164470865|NCT04772534|594098717|FG000|Overall Study|Withdrawal by Subject|3|||
164470866|NCT04772534|594098718|FG001|Overall Study|Withdrawal by Subject|0|||
164470867|NCT04772534|594098719|FG002|Overall Study|Withdrawal by Subject|1|||
164470868|NCT04194450|594098720|FG000|Overall Study|not eligible|1|||
164470869|NCT04194450|594098721|FG001|Overall Study|not eligible|0|||
164470870|NCT05875701|594098730|FG000|Overall Study|Lost to Follow-up|2|||
164470871|NCT05875701|594098731|FG001|Overall Study|Lost to Follow-up|0|||
164470872|NCT05875701|594098730|FG000|Overall Study|Withdrawal by Subject|1|||
164470873|NCT05875701|594098731|FG001|Overall Study|Withdrawal by Subject|1|||
164470874|NCT04490356|594098737|FG000|Overall Study|Lost to Follow-up|1|||
164470875|NCT00412607|594098740|FG000|Overall Study|Withdrawal by Subject|9|||
164470876|NCT00412607|594098740|FG000|Overall Study|Lost to Follow-up|19|||
164470877|NCT00412607|594098740|FG000|Overall Study|Death|61|||
164470878|NCT00412607|594098740|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
164470879|NCT03250676|594098745|FG000|Overall Study|Adverse Event|0|||
164470880|NCT03250676|594098746|FG001|Overall Study|Adverse Event|0|||
164470881|NCT03250676|594098747|FG002|Overall Study|Adverse Event|0|||
164470882|NCT03250676|594098748|FG003|Overall Study|Adverse Event|1|||
164470883|NCT03250676|594098749|FG004|Overall Study|Adverse Event|2|||
164470884|NCT03250676|594098750|FG005|Overall Study|Adverse Event|9|||
164470885|NCT03250676|594098745|FG000|Overall Study|Withdrawal by Subject|1|||
164470886|NCT03250676|594098746|FG001|Overall Study|Withdrawal by Subject|0|||
164470887|NCT03250676|594098747|FG002|Overall Study|Withdrawal by Subject|0|||
164470888|NCT03250676|594098748|FG003|Overall Study|Withdrawal by Subject|1|||
164470889|NCT03250676|594098749|FG004|Overall Study|Withdrawal by Subject|1|||
164470890|NCT03250676|594098750|FG005|Overall Study|Withdrawal by Subject|2|||
164470891|NCT03250676|594098745|FG000|Overall Study|Physician Decision|0|||
164470892|NCT03250676|594098746|FG001|Overall Study|Physician Decision|0|||
164470893|NCT03250676|594098747|FG002|Overall Study|Physician Decision|0|||
164470894|NCT03250676|594098748|FG003|Overall Study|Physician Decision|2|||
164470895|NCT03250676|594098749|FG004|Overall Study|Physician Decision|0|||
164470896|NCT03250676|594098750|FG005|Overall Study|Physician Decision|3|||
164470897|NCT03250676|594098745|FG000|Overall Study|Withdrawal of consent|0|||
164470898|NCT03250676|594098746|FG001|Overall Study|Withdrawal of consent|0|||
164470899|NCT03250676|594098747|FG002|Overall Study|Withdrawal of consent|2|||
164470900|NCT03250676|594098748|FG003|Overall Study|Withdrawal of consent|0|||
164470901|NCT03250676|594098749|FG004|Overall Study|Withdrawal of consent|0|||
164470902|NCT03250676|594098750|FG005|Overall Study|Withdrawal of consent|2|||
164470903|NCT03250676|594098745|FG000|Overall Study|Other|1|||
164470904|NCT03250676|594098746|FG001|Overall Study|Other|0|||
164470905|NCT03250676|594098747|FG002|Overall Study|Other|0|||
164470906|NCT03250676|594098748|FG003|Overall Study|Other|0|||
164470907|NCT03250676|594098749|FG004|Overall Study|Other|0|||
164470908|NCT03250676|594098750|FG005|Overall Study|Other|0|||
164470909|NCT03250676|594098745|FG000|Overall Study|Disease progression|4|||
164470910|NCT03250676|594098746|FG001|Overall Study|Disease progression|12|||
164470911|NCT03250676|594098747|FG002|Overall Study|Disease progression|9|||
164470912|NCT03250676|594098748|FG003|Overall Study|Disease progression|7|||
164470913|NCT03250676|594098749|FG004|Overall Study|Disease progression|4|||
164470914|NCT03250676|594098750|FG005|Overall Study|Disease progression|88|||
164470915|NCT04281498|594098751|FG000|Overall Study|Progression of disease|1|||
164470916|NCT04281498|594098751|FG000|Overall Study|Planned SCT|1|||
164470917|NCT04281498|594098751|FG000|Overall Study|Alternative Treatment|1|||
164470918|NCT03142009|594098754|FG000|Overall Study|Lost to Follow-up|45|||
164470919|NCT03142009|594098755|FG001|Overall Study|Lost to Follow-up|30|||
164470920|NCT03587805|594098757|FG000|Overall Study|Adverse Event|72|||
164470921|NCT03587805|594098757|FG000|Overall Study|Death|1|||
164470922|NCT03587805|594098757|FG000|Overall Study|Lost to Follow-up|78|||
164470923|NCT03587805|594098757|FG000|Overall Study|Withdrawal by Subject|105|||
164470924|NCT03587805|594098757|FG000|Overall Study|Lack of Efficacy|119|||
164470925|NCT03587805|594098757|FG000|Overall Study|Reason unknown|26|||
164470926|NCT03587805|594098757|FG000|Overall Study|COVID_19 pandemic|4|||
164470927|NCT03587805|594098757|FG000|Overall Study|Various reasons|121|||
164470928|NCT03587805|594098757|FG000|Overall Study|Withdrawal by parent/guardian|3|||
164470929|NCT03982186|594098758|FG000|Overall Study|Lost to Follow-up|0|||
164470930|NCT03982186|594098759|FG001|Overall Study|Lost to Follow-up|1|||
164470931|NCT03982186|594098760|FG002|Overall Study|Lost to Follow-up|2|||
164470932|NCT03982186|594098761|FG003|Overall Study|Lost to Follow-up|1|||
164470933|NCT03982186|594098762|FG004|Overall Study|Lost to Follow-up|1|||
164470934|NCT03982186|594098763|FG005|Overall Study|Lost to Follow-up|0|||
164470935|NCT03982186|594098758|FG000|Overall Study|Physician Decision|0|||
164470936|NCT03982186|594098759|FG001|Overall Study|Physician Decision|1|||
164470937|NCT03982186|594098760|FG002|Overall Study|Physician Decision|0|||
164470938|NCT03982186|594098761|FG003|Overall Study|Physician Decision|0|||
164470939|NCT03982186|594098762|FG004|Overall Study|Physician Decision|0|||
164470940|NCT03982186|594098763|FG005|Overall Study|Physician Decision|0|||
164712773|NCT05323123|594970373|FG001|Overall Study|Withdrawal by Subject|1|||
164712774|NCT05323123|594970372|FG000|Overall Study|Lost to Follow-up|4|||
164712775|NCT05323123|594970373|FG001|Overall Study|Lost to Follow-up|2|||
164712776|NCT05323123|594970372|FG000|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|1|||
164712777|NCT05323123|594970373|FG001|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|0|||
164712778|NCT05529472|594970374|FG000|Overall Study|Withdrawal by Subject|1|||
164712779|NCT05529472|594970375|FG001|Overall Study|Withdrawal by Subject|1|||
164712780|NCT03408639|594972133|FG000|Overall Study|Death|5|||
164712781|NCT03408639|594972134|FG001|Overall Study|Death|5|||
164712782|NCT03408639|594972133|FG000|Overall Study|Lost to Follow-up|1|||
164712783|NCT03408639|594972134|FG001|Overall Study|Lost to Follow-up|4|||
164712784|NCT03408639|594972133|FG000|Overall Study|Withdrawal by Subject|2|||
164712785|NCT03408639|594972134|FG001|Overall Study|Withdrawal by Subject|7|||
164712786|NCT03408639|594972133|FG000|Overall Study|Physician Decision|3|||
164712787|NCT03408639|594972134|FG001|Overall Study|Physician Decision|6|||
164712788|NCT00213135|594972137|FG000|Overall Study|Adverse Event|9|||
164712789|NCT00213135|594972138|FG001|Overall Study|Adverse Event|5|||
164712790|NCT00213135|594972139|FG002|Overall Study|Adverse Event|5|||
164712791|NCT00213135|594972137|FG000|Overall Study|Lost to Follow-up|11|||
164712792|NCT00213135|594972138|FG001|Overall Study|Lost to Follow-up|8|||
164417346|NCT01474512|593899504|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
164417347|NCT01474512|593899505|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
164417348|NCT01474512|593899506|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
164417349|NCT01474512|593899489|FG000|Long-Term Extension Period|Adverse Event|0|||
164417350|NCT01474512|593899490|FG001|Long-Term Extension Period|Adverse Event|0|||
164417351|NCT01474512|593899491|FG002|Long-Term Extension Period|Adverse Event|0|||
164417352|NCT01474512|593899492|FG003|Long-Term Extension Period|Adverse Event|0|||
164417353|NCT01474512|593899493|FG004|Long-Term Extension Period|Adverse Event|0|||
164417354|NCT01474512|593899494|FG005|Long-Term Extension Period|Adverse Event|0|||
164417355|NCT01474512|593899495|FG006|Long-Term Extension Period|Adverse Event|0|||
164417356|NCT01474512|593899496|FG007|Long-Term Extension Period|Adverse Event|0|||
164417357|NCT01474512|593899497|FG008|Long-Term Extension Period|Adverse Event|0|||
164417358|NCT01474512|593899498|FG009|Long-Term Extension Period|Adverse Event|0|||
164417359|NCT01474512|593899499|FG010|Long-Term Extension Period|Adverse Event|0|||
164417360|NCT01474512|593899500|FG011|Long-Term Extension Period|Adverse Event|1|||
164417361|NCT01474512|593899501|FG012|Long-Term Extension Period|Adverse Event|57|||
164417362|NCT01474512|593899502|FG013|Long-Term Extension Period|Adverse Event|58|||
164417363|NCT01474512|593899503|FG014|Long-Term Extension Period|Adverse Event|0|||
164417364|NCT01474512|593899504|FG015|Long-Term Extension Period|Adverse Event|0|||
164417365|NCT01474512|593899505|FG016|Long-Term Extension Period|Adverse Event|0|||
164417366|NCT01474512|593899506|FG017|Long-Term Extension Period|Adverse Event|0|||
164417367|NCT01474512|593899489|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
164417368|NCT01474512|593899490|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
164417369|NCT01474512|593899491|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
164417370|NCT01474512|593899492|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
164417371|NCT01474512|593899493|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
164417372|NCT01474512|593899494|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
164417373|NCT01474512|593899495|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
164417374|NCT01474512|593899496|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
164417375|NCT01474512|593899497|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
164417376|NCT01474512|593899498|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
164417377|NCT01474512|593899499|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
164417378|NCT01474512|593899500|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
164417379|NCT01474512|593899501|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
164417380|NCT01474512|593899502|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
164417381|NCT01474512|593899503|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
164417382|NCT01474512|593899504|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
164417383|NCT01474512|593899505|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
164417384|NCT01474512|593899506|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
164417385|NCT01474512|593899489|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
164417386|NCT01474512|593899490|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
164417387|NCT01474512|593899491|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
164417388|NCT01474512|593899492|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
164417389|NCT01474512|593899493|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
164417390|NCT01474512|593899494|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
164417391|NCT01474512|593899495|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
164417392|NCT01474512|593899496|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
164417393|NCT01474512|593899497|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
164417394|NCT01474512|593899498|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
164417395|NCT01474512|593899499|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
164417396|NCT01474512|593899500|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
164417397|NCT01474512|593899501|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
164417398|NCT01474512|593899502|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
164470941|NCT03982186|594098758|FG000|Overall Study|Withdrawal by Subject|3|||
164470942|NCT03982186|594098759|FG001|Overall Study|Withdrawal by Subject|4|||
164470943|NCT03982186|594098760|FG002|Overall Study|Withdrawal by Subject|1|||
164470944|NCT03982186|594098761|FG003|Overall Study|Withdrawal by Subject|7|||
164470945|NCT03982186|594098762|FG004|Overall Study|Withdrawal by Subject|2|||
164470946|NCT03982186|594098763|FG005|Overall Study|Withdrawal by Subject|0|||
164470947|NCT03982186|594098758|FG000|Overall Study|Randomized and not treated|0|||
164470948|NCT03982186|594098759|FG001|Overall Study|Randomized and not treated|0|||
164470949|NCT03982186|594098760|FG002|Overall Study|Randomized and not treated|0|||
164470950|NCT03982186|594098761|FG003|Overall Study|Randomized and not treated|1|||
164470951|NCT03982186|594098762|FG004|Overall Study|Randomized and not treated|0|||
164470952|NCT03982186|594098763|FG005|Overall Study|Randomized and not treated|0|||
164470953|NCT03008382|594098764|FG000|Overall Study|Withdrawal by Subject|2|||
164470954|NCT03008382|594098765|FG001|Overall Study|Withdrawal by Subject|5|||
164470955|NCT03008382|594098766|FG002|Overall Study|Withdrawal by Subject|2|||
164470956|NCT03008382|594098767|FG003|Overall Study|Withdrawal by Subject|0|||
164470957|NCT03008382|594098764|FG000|Overall Study|Protocol Violation|1|||
164470958|NCT03008382|594098765|FG001|Overall Study|Protocol Violation|0|||
164470959|NCT03008382|594098766|FG002|Overall Study|Protocol Violation|0|||
164470960|NCT03008382|594098767|FG003|Overall Study|Protocol Violation|0|||
164470961|NCT03008382|594098764|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
164470962|NCT03008382|594098765|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
164470963|NCT03008382|594098766|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
164470964|NCT03008382|594098767|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
164470965|NCT03008382|594098764|FG000|Overall Study|Lost to Follow-up|0|||
164470966|NCT03008382|594098765|FG001|Overall Study|Lost to Follow-up|0|||
164470967|NCT03008382|594098766|FG002|Overall Study|Lost to Follow-up|1|||
164470968|NCT03008382|594098767|FG003|Overall Study|Lost to Follow-up|0|||
164470969|NCT03008382|594098764|FG000|Overall Study|Screenfail|0|||
164470970|NCT03008382|594098765|FG001|Overall Study|Screenfail|0|||
164470971|NCT03008382|594098766|FG002|Overall Study|Screenfail|2|||
164470972|NCT03008382|594098767|FG003|Overall Study|Screenfail|0|||
164470973|NCT04039113|594098770|FG000|Overall Study|Withdrawal by Subject|8|||
164470974|NCT04039113|594098771|FG001|Overall Study|Withdrawal by Subject|11|||
164470975|NCT04039113|594098770|FG000|Overall Study|Lost to Follow-up|1|||
164470976|NCT04039113|594098771|FG001|Overall Study|Lost to Follow-up|1|||
164470977|NCT04039113|594098770|FG000|Overall Study|Adverse Event|2|||
164470978|NCT04039113|594098771|FG001|Overall Study|Adverse Event|2|||
164470979|NCT04039113|594098770|FG000|Overall Study|Death|2|||
164470980|NCT04039113|594098771|FG001|Overall Study|Death|4|||
164470981|NCT04039113|594098770|FG000|Overall Study|Site Closure|6|||
164470982|NCT04039113|594098771|FG001|Overall Study|Site Closure|0|||
164470983|NCT04039113|594098770|FG000|Overall Study|Failure to meet randomisation criteria|4|||
164470984|NCT04039113|594098771|FG001|Overall Study|Failure to meet randomisation criteria|0|||
164470985|NCT03512301|594099597|FG000|Overall Study|Protocol Violation|2|||
164470986|NCT03512301|594099597|FG000|Overall Study|Did Not Qualify|3|||
164470987|NCT03512301|594099597|FG000|Overall Study|Age-ineligible|1|||
164470988|NCT03512301|594099597|FG000|Overall Study|Inadequate fluency with the English language|3|||
164470989|NCT02719574|594099600|FG000|Phase 1 (Dose Escalation)|Other|0|||
164470990|NCT02719574|594099601|FG001|Phase 1 (Dose Escalation)|Other|2|||
164470991|NCT02719574|594099602|FG002|Phase 1 (Dose Escalation)|Other|1|||
164470992|NCT02719574|594099603|FG003|Phase 1 (Dose Escalation)|Other|2|||
164470993|NCT02719574|594099604|FG004|Phase 1 (Dose Escalation)|Other|2|||
164470994|NCT02719574|594099605|FG005|Phase 1 (Dose Escalation)|Other|0|||
164470995|NCT02719574|594099606|FG006|Phase 1 (Dose Escalation)|Other|0|||
164470996|NCT02719574|594099607|FG007|Phase 1 (Dose Escalation)|Other|0|||
164470997|NCT02719574|594099608|FG008|Phase 1 (Dose Escalation)|Other|0|||
164470998|NCT02719574|594099609|FG009|Phase 1 (Dose Escalation)|Other|0|||
164470999|NCT02719574|594099610|FG010|Phase 1 (Dose Escalation)|Other|0|||
164471000|NCT02719574|594099611|FG011|Phase 1 (Dose Escalation)|Other|0|||
164471001|NCT02719574|594099612|FG012|Phase 1 (Dose Escalation)|Other|0|||
164471002|NCT02719574|594099613|FG013|Phase 1 (Dose Escalation)|Other|0|||
164471003|NCT02719574|594099614|FG014|Phase 1 (Dose Escalation)|Other|0|||
164471004|NCT02719574|594099615|FG015|Phase 1 (Dose Escalation)|Other|0|||
164471005|NCT02719574|594099616|FG016|Phase 1 (Dose Escalation)|Other|0|||
164471006|NCT02719574|594099600|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
164471007|NCT02719574|594099601|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
164471008|NCT02719574|594099602|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
164471009|NCT02719574|594099603|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
164471010|NCT02719574|594099604|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
164471011|NCT02719574|594099605|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
164471012|NCT02719574|594099606|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
164471013|NCT02719574|594099607|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
164471014|NCT02719574|594099608|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
164599847|NCT04167306|594556383|FG003|Overall Study|covid|1|||
164599848|NCT04167306|594556380|FG000|Overall Study|concomitant medication|0|||
164599849|NCT04167306|594556381|FG001|Overall Study|concomitant medication|0|||
164471015|NCT02719574|594099609|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
164471016|NCT02719574|594099610|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
164471017|NCT02719574|594099611|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
164471018|NCT02719574|594099612|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
164471019|NCT02719574|594099613|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
164471020|NCT02719574|594099614|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
164471021|NCT02719574|594099615|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
164471022|NCT02719574|594099616|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
164471023|NCT02719574|594099600|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
164471024|NCT02719574|594099601|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
164471025|NCT02719574|594099602|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
164471026|NCT02719574|594099603|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
164471027|NCT02719574|594099604|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
164471028|NCT02719574|594099605|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
164471029|NCT02719574|594099606|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
164471030|NCT02719574|594099607|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
164471031|NCT02719574|594099608|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
164471032|NCT02719574|594099609|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
164471033|NCT02719574|594099610|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
164471034|NCT02719574|594099611|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
164471035|NCT02719574|594099612|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
164471036|NCT02719574|594099613|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
164471037|NCT02719574|594099614|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
164471038|NCT02719574|594099615|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
164471039|NCT02719574|594099616|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
164471040|NCT02719574|594099600|FG000|Phase 1 (Dose Escalation)|Death|2|||
164471041|NCT02719574|594099601|FG001|Phase 1 (Dose Escalation)|Death|1|||
164471042|NCT02719574|594099602|FG002|Phase 1 (Dose Escalation)|Death|1|||
164471043|NCT02719574|594099603|FG003|Phase 1 (Dose Escalation)|Death|0|||
164471044|NCT02719574|594099604|FG004|Phase 1 (Dose Escalation)|Death|0|||
164471045|NCT02719574|594099605|FG005|Phase 1 (Dose Escalation)|Death|0|||
164471046|NCT02719574|594099606|FG006|Phase 1 (Dose Escalation)|Death|0|||
164471047|NCT02719574|594099607|FG007|Phase 1 (Dose Escalation)|Death|0|||
164471048|NCT02719574|594099608|FG008|Phase 1 (Dose Escalation)|Death|0|||
164471049|NCT02719574|594099609|FG009|Phase 1 (Dose Escalation)|Death|0|||
164471050|NCT02719574|594099610|FG010|Phase 1 (Dose Escalation)|Death|0|||
164471051|NCT02719574|594099611|FG011|Phase 1 (Dose Escalation)|Death|0|||
164471052|NCT02719574|594099612|FG012|Phase 1 (Dose Escalation)|Death|0|||
164471053|NCT02719574|594099613|FG013|Phase 1 (Dose Escalation)|Death|0|||
164471054|NCT02719574|594099614|FG014|Phase 1 (Dose Escalation)|Death|0|||
164471055|NCT02719574|594099615|FG015|Phase 1 (Dose Escalation)|Death|0|||
164471056|NCT02719574|594099616|FG016|Phase 1 (Dose Escalation)|Death|0|||
164471057|NCT02719574|594099600|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
164471058|NCT02719574|594099601|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
164471059|NCT02719574|594099602|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
164471060|NCT02719574|594099603|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
164471061|NCT02719574|594099604|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
164471062|NCT02719574|594099605|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
164471063|NCT02719574|594099606|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
164471064|NCT02719574|594099607|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
164471065|NCT02719574|594099608|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
164471066|NCT02719574|594099609|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
164471067|NCT02719574|594099610|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
164471068|NCT02719574|594099611|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
164471069|NCT02719574|594099612|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
164471070|NCT02719574|594099613|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
164471071|NCT02719574|594099614|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
164471072|NCT02719574|594099615|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
164471073|NCT02719574|594099616|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
164471074|NCT02719574|594099600|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
164471075|NCT02719574|594099601|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
164471076|NCT02719574|594099602|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
164471077|NCT02719574|594099603|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
164471078|NCT02719574|594099604|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
164471079|NCT02719574|594099605|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
164471080|NCT02719574|594099606|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
164471081|NCT02719574|594099607|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
164471082|NCT02719574|594099608|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
164471083|NCT02719574|594099609|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
164471084|NCT02719574|594099610|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
164471085|NCT02719574|594099611|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
164471086|NCT02719574|594099612|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
164471087|NCT02719574|594099613|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
164471088|NCT02719574|594099614|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
164471089|NCT02719574|594099615|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
164471090|NCT02719574|594099616|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
164471091|NCT02719574|594099600|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
164471092|NCT02719574|594099601|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
164471093|NCT02719574|594099602|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
164471094|NCT02719574|594099603|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
164471095|NCT02719574|594099604|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
164471096|NCT02719574|594099605|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
164712793|NCT00213135|594972139|FG002|Overall Study|Lost to Follow-up|4|||
164712794|NCT00213135|594972137|FG000|Overall Study|Protocol Violation|4|||
164712795|NCT00213135|594972138|FG001|Overall Study|Protocol Violation|4|||
164712796|NCT00213135|594972139|FG002|Overall Study|Protocol Violation|10|||
164471097|NCT02719574|594099606|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
164471098|NCT02719574|594099607|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
164471099|NCT02719574|594099608|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
164471100|NCT02719574|594099609|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
164471101|NCT02719574|594099610|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
164471102|NCT02719574|594099611|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
164471103|NCT02719574|594099612|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
164471104|NCT02719574|594099613|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
164471105|NCT02719574|594099614|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
164471106|NCT02719574|594099615|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
164471107|NCT02719574|594099616|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
164471108|NCT02719574|594099600|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
164471109|NCT02719574|594099601|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
164471110|NCT02719574|594099602|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
164471111|NCT02719574|594099603|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
164471112|NCT02719574|594099604|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
164471113|NCT02719574|594099605|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
164471114|NCT02719574|594099606|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
164471115|NCT02719574|594099607|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
164471116|NCT02719574|594099608|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
164471117|NCT02719574|594099609|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
164471118|NCT02719574|594099610|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
164471119|NCT02719574|594099611|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
164471120|NCT02719574|594099612|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
164471121|NCT02719574|594099613|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
164471122|NCT02719574|594099614|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
164471123|NCT02719574|594099615|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
164471124|NCT02719574|594099616|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
164471125|NCT02719574|594099600|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
164471126|NCT02719574|594099601|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
164471127|NCT02719574|594099602|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
164471128|NCT02719574|594099603|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
164471129|NCT02719574|594099604|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
164471130|NCT02719574|594099605|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
164471131|NCT02719574|594099606|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
164471132|NCT02719574|594099607|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
164471133|NCT02719574|594099608|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
164471134|NCT02719574|594099609|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
164712797|NCT00213135|594972137|FG000|Overall Study|Death|1|||
164712798|NCT00213135|594972138|FG001|Overall Study|Death|1|||
164712799|NCT00213135|594972139|FG002|Overall Study|Death|2|||
164712800|NCT00213135|594972137|FG000|Overall Study|Disease progression|4|||
164712801|NCT00213135|594972138|FG001|Overall Study|Disease progression|5|||
164712802|NCT00213135|594972139|FG002|Overall Study|Disease progression|21|||
164712803|NCT00213135|594972137|FG000|Overall Study|Other|21|||
164471135|NCT02719574|594099610|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
164712804|NCT00213135|594972138|FG001|Overall Study|Other|12|||
164712805|NCT00213135|594972139|FG002|Overall Study|Other|15|||
164712806|NCT01924754|594972144|FG000|Overall Study|Lost to Follow-up|1|||
164712807|NCT01924754|594972145|FG001|Overall Study|Lost to Follow-up|2|||
164471136|NCT02719574|594099611|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
164471137|NCT02719574|594099612|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
164471138|NCT02719574|594099613|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
164471139|NCT02719574|594099614|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
164712808|NCT01924754|594972146|FG002|Overall Study|Lost to Follow-up|1|||
164471140|NCT02719574|594099615|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
164471141|NCT02719574|594099616|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
164471142|NCT02719574|594099600|FG000|Phase 1 (Dose Expansion)|Death|0|||
164471143|NCT02719574|594099601|FG001|Phase 1 (Dose Expansion)|Death|0|||
164712809|NCT01924754|594972144|FG000|Overall Study|Pregnancy|0|||
164712810|NCT01924754|594972145|FG001|Overall Study|Pregnancy|1|||
164712811|NCT01924754|594972146|FG002|Overall Study|Pregnancy|2|||
164712812|NCT03132155|594972147|FG000|Overall Study|Lack of Efficacy|6|||
164712813|NCT03132155|594972147|FG000|Overall Study|Lost to Follow-up|1|||
164471144|NCT02719574|594099602|FG002|Phase 1 (Dose Expansion)|Death|0|||
164471145|NCT02719574|594099603|FG003|Phase 1 (Dose Expansion)|Death|0|||
164471146|NCT02719574|594099604|FG004|Phase 1 (Dose Expansion)|Death|0|||
164471147|NCT02719574|594099605|FG005|Phase 1 (Dose Expansion)|Death|0|||
164471148|NCT02719574|594099606|FG006|Phase 1 (Dose Expansion)|Death|1|||
164471149|NCT02719574|594099607|FG007|Phase 1 (Dose Expansion)|Death|6|||
164471150|NCT02719574|594099608|FG008|Phase 1 (Dose Expansion)|Death|0|||
164471151|NCT02719574|594099609|FG009|Phase 1 (Dose Expansion)|Death|0|||
164471152|NCT02719574|594099610|FG010|Phase 1 (Dose Expansion)|Death|0|||
164471153|NCT02719574|594099611|FG011|Phase 1 (Dose Expansion)|Death|0|||
164471154|NCT02719574|594099612|FG012|Phase 1 (Dose Expansion)|Death|0|||
164471155|NCT02719574|594099613|FG013|Phase 1 (Dose Expansion)|Death|0|||
164471156|NCT02719574|594099614|FG014|Phase 1 (Dose Expansion)|Death|0|||
164471157|NCT02719574|594099615|FG015|Phase 1 (Dose Expansion)|Death|0|||
164471158|NCT02719574|594099616|FG016|Phase 1 (Dose Expansion)|Death|0|||
164471159|NCT02719574|594099600|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
164471160|NCT02719574|594099601|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
164471161|NCT02719574|594099602|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
164471162|NCT02719574|594099603|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
164471163|NCT02719574|594099604|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
164471164|NCT02719574|594099605|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
164471165|NCT02719574|594099606|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
164471166|NCT02719574|594099607|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
164471167|NCT02719574|594099608|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
164471168|NCT02719574|594099609|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
164471169|NCT02719574|594099610|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
164471170|NCT02719574|594099611|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
164471171|NCT02719574|594099612|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
164471172|NCT02719574|594099613|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
164471173|NCT02719574|594099614|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
164471174|NCT02719574|594099615|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
164471175|NCT02719574|594099616|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
164471176|NCT02719574|594099600|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
164471177|NCT02719574|594099601|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
164471178|NCT02719574|594099602|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
164471179|NCT02719574|594099603|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
164471180|NCT02719574|594099604|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
164471181|NCT02719574|594099605|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
164471182|NCT02719574|594099606|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
164471183|NCT02719574|594099607|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
164471184|NCT02719574|594099608|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
164471185|NCT02719574|594099609|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
164471186|NCT02719574|594099610|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
164471187|NCT02719574|594099611|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
164471188|NCT02719574|594099612|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
164471189|NCT02719574|594099613|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
164471190|NCT02719574|594099614|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
164471191|NCT02719574|594099615|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
164471192|NCT02719574|594099616|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
164471193|NCT02719574|594099600|FG000|Phase 1 (Dose Expansion)|Other|0|||
164471194|NCT02719574|594099601|FG001|Phase 1 (Dose Expansion)|Other|0|||
164471195|NCT02719574|594099602|FG002|Phase 1 (Dose Expansion)|Other|0|||
164471196|NCT02719574|594099603|FG003|Phase 1 (Dose Expansion)|Other|0|||
164471197|NCT02719574|594099604|FG004|Phase 1 (Dose Expansion)|Other|0|||
164471198|NCT02719574|594099605|FG005|Phase 1 (Dose Expansion)|Other|0|||
164471199|NCT02719574|594099606|FG006|Phase 1 (Dose Expansion)|Other|1|||
164471200|NCT02719574|594099607|FG007|Phase 1 (Dose Expansion)|Other|7|||
164471201|NCT02719574|594099608|FG008|Phase 1 (Dose Expansion)|Other|0|||
164471202|NCT02719574|594099609|FG009|Phase 1 (Dose Expansion)|Other|0|||
164471203|NCT02719574|594099610|FG010|Phase 1 (Dose Expansion)|Other|0|||
164471204|NCT02719574|594099611|FG011|Phase 1 (Dose Expansion)|Other|0|||
164471205|NCT02719574|594099612|FG012|Phase 1 (Dose Expansion)|Other|0|||
164471206|NCT02719574|594099613|FG013|Phase 1 (Dose Expansion)|Other|0|||
164471207|NCT02719574|594099614|FG014|Phase 1 (Dose Expansion)|Other|0|||
164471208|NCT02719574|594099615|FG015|Phase 1 (Dose Expansion)|Other|0|||
164471209|NCT02719574|594099616|FG016|Phase 1 (Dose Expansion)|Other|0|||
164471210|NCT02719574|594099600|FG000|Phase 2|Protocol Defined Disease Progression|0|||
164712814|NCT03132155|594972147|FG000|Overall Study|Withdrawal by Subject|1|||
164712815|NCT02925403|594972153|FG000|Overall Study|Lost to Follow-up|0|||
164712816|NCT02925403|594972154|FG001|Overall Study|Lost to Follow-up|1|||
164471211|NCT02719574|594099601|FG001|Phase 2|Protocol Defined Disease Progression|0|||
164471212|NCT02719574|594099602|FG002|Phase 2|Protocol Defined Disease Progression|0|||
164471213|NCT02719574|594099603|FG003|Phase 2|Protocol Defined Disease Progression|0|||
164471214|NCT02719574|594099604|FG004|Phase 2|Protocol Defined Disease Progression|0|||
164471215|NCT02719574|594099605|FG005|Phase 2|Protocol Defined Disease Progression|0|||
164471216|NCT02719574|594099606|FG006|Phase 2|Protocol Defined Disease Progression|0|||
164471217|NCT02719574|594099607|FG007|Phase 2|Protocol Defined Disease Progression|0|||
164471218|NCT02719574|594099608|FG008|Phase 2|Protocol Defined Disease Progression|0|||
164471219|NCT02719574|594099609|FG009|Phase 2|Protocol Defined Disease Progression|65|||
164471220|NCT02719574|594099610|FG010|Phase 2|Protocol Defined Disease Progression|8|||
164471221|NCT02719574|594099611|FG011|Phase 2|Protocol Defined Disease Progression|2|||
164471222|NCT02719574|594099612|FG012|Phase 2|Protocol Defined Disease Progression|4|||
164471223|NCT02719574|594099613|FG013|Phase 2|Protocol Defined Disease Progression|9|||
164471224|NCT02719574|594099614|FG014|Phase 2|Protocol Defined Disease Progression|11|||
164471225|NCT02719574|594099615|FG015|Phase 2|Protocol Defined Disease Progression|3|||
164471226|NCT02719574|594099616|FG016|Phase 2|Protocol Defined Disease Progression|4|||
164471227|NCT02719574|594099600|FG000|Phase 2|Adverse Event|0|||
164471228|NCT02719574|594099601|FG001|Phase 2|Adverse Event|0|||
164471229|NCT02719574|594099602|FG002|Phase 2|Adverse Event|0|||
164471230|NCT02719574|594099603|FG003|Phase 2|Adverse Event|0|||
164471231|NCT02719574|594099604|FG004|Phase 2|Adverse Event|0|||
164471232|NCT02719574|594099605|FG005|Phase 2|Adverse Event|0|||
164471233|NCT02719574|594099606|FG006|Phase 2|Adverse Event|0|||
164471234|NCT02719574|594099607|FG007|Phase 2|Adverse Event|0|||
164471235|NCT02719574|594099608|FG008|Phase 2|Adverse Event|0|||
164471236|NCT02719574|594099609|FG009|Phase 2|Adverse Event|27|||
164471237|NCT02719574|594099610|FG010|Phase 2|Adverse Event|0|||
164471238|NCT02719574|594099611|FG011|Phase 2|Adverse Event|1|||
164471239|NCT02719574|594099612|FG012|Phase 2|Adverse Event|1|||
164471240|NCT02719574|594099613|FG013|Phase 2|Adverse Event|1|||
164471241|NCT02719574|594099614|FG014|Phase 2|Adverse Event|2|||
164471242|NCT02719574|594099615|FG015|Phase 2|Adverse Event|2|||
164471243|NCT02719574|594099616|FG016|Phase 2|Adverse Event|3|||
164471244|NCT02719574|594099600|FG000|Phase 2|Other|0|||
164471245|NCT02719574|594099601|FG001|Phase 2|Other|0|||
164471246|NCT02719574|594099602|FG002|Phase 2|Other|0|||
164471247|NCT02719574|594099603|FG003|Phase 2|Other|0|||
164471248|NCT02719574|594099604|FG004|Phase 2|Other|0|||
164471249|NCT02719574|594099605|FG005|Phase 2|Other|0|||
164471250|NCT02719574|594099606|FG006|Phase 2|Other|0|||
164471251|NCT02719574|594099607|FG007|Phase 2|Other|0|||
164471252|NCT02719574|594099608|FG008|Phase 2|Other|0|||
164471253|NCT02719574|594099609|FG009|Phase 2|Other|20|||
164471254|NCT02719574|594099610|FG010|Phase 2|Other|7|||
164471255|NCT02719574|594099611|FG011|Phase 2|Other|0|||
164471256|NCT02719574|594099612|FG012|Phase 2|Other|5|||
164471257|NCT02719574|594099613|FG013|Phase 2|Other|7|||
164471258|NCT02719574|594099614|FG014|Phase 2|Other|0|||
164471259|NCT02719574|594099615|FG015|Phase 2|Other|1|||
164471260|NCT02719574|594099616|FG016|Phase 2|Other|4|||
164471261|NCT02719574|594099600|FG000|Phase 2|Transplant|0|||
164471262|NCT02719574|594099601|FG001|Phase 2|Transplant|0|||
164471263|NCT02719574|594099602|FG002|Phase 2|Transplant|0|||
164471264|NCT02719574|594099603|FG003|Phase 2|Transplant|0|||
164471265|NCT02719574|594099604|FG004|Phase 2|Transplant|0|||
164471266|NCT02719574|594099605|FG005|Phase 2|Transplant|0|||
164471267|NCT02719574|594099606|FG006|Phase 2|Transplant|0|||
164471268|NCT02719574|594099607|FG007|Phase 2|Transplant|0|||
164471269|NCT02719574|594099608|FG008|Phase 2|Transplant|0|||
164471270|NCT02719574|594099609|FG009|Phase 2|Transplant|15|||
164471271|NCT02719574|594099610|FG010|Phase 2|Transplant|2|||
164471272|NCT02719574|594099611|FG011|Phase 2|Transplant|0|||
164471273|NCT02719574|594099612|FG012|Phase 2|Transplant|6|||
164471274|NCT02719574|594099613|FG013|Phase 2|Transplant|1|||
164471275|NCT02719574|594099614|FG014|Phase 2|Transplant|1|||
164471276|NCT02719574|594099615|FG015|Phase 2|Transplant|0|||
164471277|NCT02719574|594099616|FG016|Phase 2|Transplant|0|||
164471278|NCT02719574|594099600|FG000|Phase 2|Death|0|||
164471279|NCT02719574|594099601|FG001|Phase 2|Death|0|||
164471280|NCT02719574|594099602|FG002|Phase 2|Death|0|||
164471281|NCT02719574|594099603|FG003|Phase 2|Death|0|||
164471282|NCT02719574|594099604|FG004|Phase 2|Death|0|||
164471283|NCT02719574|594099605|FG005|Phase 2|Death|0|||
164471284|NCT02719574|594099606|FG006|Phase 2|Death|0|||
164471285|NCT02719574|594099607|FG007|Phase 2|Death|0|||
164471286|NCT02719574|594099608|FG008|Phase 2|Death|0|||
164471287|NCT02719574|594099609|FG009|Phase 2|Death|14|||
164471288|NCT02719574|594099610|FG010|Phase 2|Death|0|||
164471289|NCT02719574|594099611|FG011|Phase 2|Death|0|||
164471290|NCT02719574|594099612|FG012|Phase 2|Death|1|||
164471291|NCT02719574|594099613|FG013|Phase 2|Death|1|||
164471292|NCT02719574|594099614|FG014|Phase 2|Death|2|||
164471293|NCT02719574|594099615|FG015|Phase 2|Death|0|||
164471294|NCT02719574|594099616|FG016|Phase 2|Death|0|||
164471295|NCT02719574|594099600|FG000|Phase 2|Investigator Decision|0|||
164471296|NCT02719574|594099601|FG001|Phase 2|Investigator Decision|0|||
164471297|NCT02719574|594099602|FG002|Phase 2|Investigator Decision|0|||
164471298|NCT02719574|594099603|FG003|Phase 2|Investigator Decision|0|||
164471299|NCT02719574|594099604|FG004|Phase 2|Investigator Decision|0|||
164471300|NCT02719574|594099605|FG005|Phase 2|Investigator Decision|0|||
164471301|NCT02719574|594099606|FG006|Phase 2|Investigator Decision|0|||
164471302|NCT02719574|594099607|FG007|Phase 2|Investigator Decision|0|||
164471303|NCT02719574|594099608|FG008|Phase 2|Investigator Decision|0|||
164712817|NCT00402116|594972155|FG000|Overall Study|Jaw infection after surgery-other|1|||
164712818|NCT00402116|594972156|FG001|Overall Study|Jaw infection after surgery-other|0|||
164712819|NCT00402116|594972157|FG002|Overall Study|Jaw infection after surgery-other|0|||
164712820|NCT00402116|594972155|FG000|Overall Study|Withdrawal by Subject|1|||
164712821|NCT00402116|594972156|FG001|Overall Study|Withdrawal by Subject|0|||
164712822|NCT00402116|594972157|FG002|Overall Study|Withdrawal by Subject|5|||
164712823|NCT00402116|594972155|FG000|Overall Study|Treatment completed per protocol|1|||
164712824|NCT00402116|594972156|FG001|Overall Study|Treatment completed per protocol|1|||
164712825|NCT00402116|594972157|FG002|Overall Study|Treatment completed per protocol|2|||
164712826|NCT00402116|594972155|FG000|Overall Study|other complicating disease|0|||
164712827|NCT00402116|594972156|FG001|Overall Study|other complicating disease|0|||
164712828|NCT00402116|594972157|FG002|Overall Study|other complicating disease|2|||
164712829|NCT00402116|594972155|FG000|Overall Study|Disease Progression|0|||
164712830|NCT00402116|594972156|FG001|Overall Study|Disease Progression|4|||
164712831|NCT00402116|594972157|FG002|Overall Study|Disease Progression|38|||
164712832|NCT00402116|594972155|FG000|Overall Study|mistaken thrombocytopenia|0|||
164712833|NCT00402116|594972156|FG001|Overall Study|mistaken thrombocytopenia|0|||
164712834|NCT00402116|594972157|FG002|Overall Study|mistaken thrombocytopenia|1|||
164712835|NCT00402116|594972155|FG000|Overall Study|decline related hyponatremia/tumor|0|||
164712836|NCT00402116|594972156|FG001|Overall Study|decline related hyponatremia/tumor|0|||
164712837|NCT00402116|594972157|FG002|Overall Study|decline related hyponatremia/tumor|1|||
164712838|NCT00402116|594972155|FG000|Overall Study|Adverse Event|0|||
164712839|NCT00402116|594972156|FG001|Overall Study|Adverse Event|1|||
164712840|NCT00402116|594972157|FG002|Overall Study|Adverse Event|6|||
164712841|NCT02899195|594972162|FG000|Concurrent Durvalumab|Adverse Event|4|||
164712842|NCT02899195|594972162|FG000|Concurrent Durvalumab|Physician Decision|1|||
164712843|NCT02899195|594972162|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
164712844|NCT02899195|594972162|FG000|Concurrent Durvalumab|Progressive Disease|5|||
164712845|NCT02899195|594972162|FG000|Maintenance Durvalumab|Adverse Event|1|||
164712846|NCT02899195|594972162|FG000|Maintenance Durvalumab|Physician Decision|1|||
164712847|NCT02899195|594972162|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
164471304|NCT02719574|594099609|FG009|Phase 2|Investigator Decision|6|||
164471305|NCT02719574|594099610|FG010|Phase 2|Investigator Decision|1|||
164471306|NCT02719574|594099611|FG011|Phase 2|Investigator Decision|2|||
164471307|NCT02719574|594099612|FG012|Phase 2|Investigator Decision|3|||
164471308|NCT02719574|594099613|FG013|Phase 2|Investigator Decision|1|||
164471309|NCT02719574|594099614|FG014|Phase 2|Investigator Decision|3|||
164712848|NCT02899195|594972162|FG000|Maintenance Durvalumab|Progressive Disease|31|||
164712849|NCT03156504|594972164|FG000|Overall Study|Withdrawal by Subject|1|||
164712850|NCT00450801|594972165|FG000|Overall Study|Death|1|||
164712851|NCT05048329|594972166|FG000|Overall Study|Withdrawal by Subject|1|||
164712852|NCT05048329|594972166|FG000|Overall Study|Screenfail|1|||
164712853|NCT00324649|594972167|FG000|Overall Study|Adverse Event|1|||
164712854|NCT00324649|594972168|FG001|Overall Study|Adverse Event|4|||
164712855|NCT00324649|594972167|FG000|Overall Study|Withdrawal by Subject|0|||
164712856|NCT00324649|594972168|FG001|Overall Study|Withdrawal by Subject|1|||
164712857|NCT00324649|594972167|FG000|Overall Study|Noncompliance|1|||
164712858|NCT00324649|594972168|FG001|Overall Study|Noncompliance|0|||
164712859|NCT01396512|594972169|FG000|Overall Study|Withdrawal by Subject|0|||
164712860|NCT01396512|594972170|FG001|Overall Study|Withdrawal by Subject|1|||
164712861|NCT02618759|594972171|FG000|Overall Study|Lost to Follow-up|0|||
164712862|NCT02618759|594972172|FG001|Overall Study|Lost to Follow-up|1|||
164712863|NCT02618759|594972171|FG000|Overall Study|Withdrawal by Subject|1|||
164712864|NCT02618759|594972172|FG001|Overall Study|Withdrawal by Subject|0|||
164712865|NCT02618759|594972171|FG000|Overall Study|Other Reasons|1|||
164712866|NCT02618759|594972172|FG001|Overall Study|Other Reasons|4|||
164712867|NCT03301649|594972177|FG000|Overall Study|Need alternate therapy due to live lice|17|||
164471310|NCT02719574|594099615|FG015|Phase 2|Investigator Decision|2|||
164471311|NCT02719574|594099616|FG016|Phase 2|Investigator Decision|0|||
164471312|NCT02719574|594099600|FG000|Phase 2|Withdrawal by Subject|0|||
164471313|NCT02719574|594099601|FG001|Phase 2|Withdrawal by Subject|0|||
164471314|NCT02719574|594099602|FG002|Phase 2|Withdrawal by Subject|0|||
164712868|NCT03301649|594972178|FG001|Overall Study|Need alternate therapy due to live lice|25|||
164712869|NCT03301649|594972179|FG002|Overall Study|Need alternate therapy due to live lice|81|||
164712870|NCT03301649|594972177|FG000|Overall Study|Lost to Follow-up|11|||
164712871|NCT03301649|594972178|FG001|Overall Study|Lost to Follow-up|11|||
164712872|NCT03301649|594972179|FG002|Overall Study|Lost to Follow-up|3|||
164712873|NCT03301649|594972177|FG000|Overall Study|Protocol Violation|0|||
164712874|NCT03301649|594972178|FG001|Overall Study|Protocol Violation|1|||
164712875|NCT03301649|594972179|FG002|Overall Study|Protocol Violation|1|||
164712876|NCT03301649|594972177|FG000|Overall Study|Withdrawal by Subject|10|||
164712877|NCT03301649|594972178|FG001|Overall Study|Withdrawal by Subject|4|||
164712878|NCT03301649|594972179|FG002|Overall Study|Withdrawal by Subject|0|||
164471315|NCT02719574|594099603|FG003|Phase 2|Withdrawal by Subject|0|||
164471316|NCT02719574|594099604|FG004|Phase 2|Withdrawal by Subject|0|||
164471317|NCT02719574|594099605|FG005|Phase 2|Withdrawal by Subject|0|||
164712879|NCT03301649|594972177|FG000|Overall Study|Other than specified|5|||
164712880|NCT03301649|594972178|FG001|Overall Study|Other than specified|3|||
164712881|NCT03301649|594972179|FG002|Overall Study|Other than specified|0|||
164712882|NCT03257865|594972181|FG000|Overall Study|Adverse Event|4|||
164712883|NCT03257865|594972182|FG001|Overall Study|Adverse Event|8|||
164712884|NCT03257865|594972181|FG000|Overall Study|Lack of Efficacy|1|||
164712885|NCT03257865|594972182|FG001|Overall Study|Lack of Efficacy|2|||
164712886|NCT03257865|594972181|FG000|Overall Study|Non-compliance with Study Drug|0|||
164712887|NCT03257865|594972182|FG001|Overall Study|Non-compliance with Study Drug|2|||
164712888|NCT03257865|594972181|FG000|Overall Study|Withdrawal by Subject|23|||
164712889|NCT03257865|594972182|FG001|Overall Study|Withdrawal by Subject|17|||
164712890|NCT03257865|594972181|FG000|Overall Study|Physician Decision|3|||
164712891|NCT03257865|594972182|FG001|Overall Study|Physician Decision|1|||
164712892|NCT03257865|594972181|FG000|Overall Study|Other|0|||
164712893|NCT03257865|594972182|FG001|Overall Study|Other|1|||
164712894|NCT03257865|594972181|FG000|Overall Study|Lost to Follow-up|4|||
164712895|NCT03257865|594972182|FG001|Overall Study|Lost to Follow-up|4|||
164712896|NCT01111825|594972183|FG000|Overall Study|Withdrawal by Subject|0|||
164712897|NCT01111825|594972184|FG001|Overall Study|Withdrawal by Subject|0|||
164712898|NCT01111825|594972185|FG002|Overall Study|Withdrawal by Subject|1|||
164712899|NCT01111825|594972186|FG003|Overall Study|Withdrawal by Subject|0|||
164712900|NCT01111825|594972183|FG000|Overall Study|Lost to Follow-up|0|||
164712901|NCT01111825|594972184|FG001|Overall Study|Lost to Follow-up|0|||
164712902|NCT01111825|594972185|FG002|Overall Study|Lost to Follow-up|3|||
164712903|NCT01111825|594972186|FG003|Overall Study|Lost to Follow-up|1|||
164712904|NCT01111825|594972183|FG000|Overall Study|Adverse Event|2|||
164712905|NCT01111825|594972184|FG001|Overall Study|Adverse Event|1|||
164712906|NCT01111825|594972185|FG002|Overall Study|Adverse Event|4|||
164712907|NCT01111825|594972186|FG003|Overall Study|Adverse Event|0|||
164712908|NCT01111825|594972183|FG000|Overall Study|Disease Progression|1|||
164712909|NCT01111825|594972184|FG001|Overall Study|Disease Progression|0|||
164471318|NCT02719574|594099606|FG006|Phase 2|Withdrawal by Subject|0|||
164471319|NCT02719574|594099607|FG007|Phase 2|Withdrawal by Subject|0|||
164471320|NCT02719574|594099608|FG008|Phase 2|Withdrawal by Subject|0|||
164471321|NCT02719574|594099609|FG009|Phase 2|Withdrawal by Subject|5|||
164471322|NCT02719574|594099610|FG010|Phase 2|Withdrawal by Subject|0|||
164471323|NCT02719574|594099611|FG011|Phase 2|Withdrawal by Subject|0|||
164471324|NCT02719574|594099612|FG012|Phase 2|Withdrawal by Subject|0|||
164471325|NCT02719574|594099613|FG013|Phase 2|Withdrawal by Subject|1|||
164471326|NCT02719574|594099614|FG014|Phase 2|Withdrawal by Subject|1|||
164471327|NCT02719574|594099615|FG015|Phase 2|Withdrawal by Subject|2|||
164471328|NCT02719574|594099616|FG016|Phase 2|Withdrawal by Subject|0|||
164471329|NCT02719574|594099600|FG000|Phase 2|Protocol Violation|0|||
164471330|NCT02719574|594099601|FG001|Phase 2|Protocol Violation|0|||
164471331|NCT02719574|594099602|FG002|Phase 2|Protocol Violation|0|||
164471332|NCT02719574|594099603|FG003|Phase 2|Protocol Violation|0|||
164471333|NCT02719574|594099604|FG004|Phase 2|Protocol Violation|0|||
164471334|NCT02719574|594099605|FG005|Phase 2|Protocol Violation|0|||
164471335|NCT02719574|594099606|FG006|Phase 2|Protocol Violation|0|||
164471336|NCT02719574|594099607|FG007|Phase 2|Protocol Violation|0|||
164471337|NCT02719574|594099608|FG008|Phase 2|Protocol Violation|0|||
164471338|NCT02719574|594099609|FG009|Phase 2|Protocol Violation|1|||
164471339|NCT02719574|594099610|FG010|Phase 2|Protocol Violation|0|||
164471340|NCT02719574|594099611|FG011|Phase 2|Protocol Violation|0|||
164471341|NCT02719574|594099612|FG012|Phase 2|Protocol Violation|0|||
164471342|NCT02719574|594099613|FG013|Phase 2|Protocol Violation|0|||
164471343|NCT02719574|594099614|FG014|Phase 2|Protocol Violation|0|||
164471344|NCT02719574|594099615|FG015|Phase 2|Protocol Violation|0|||
164471345|NCT02719574|594099616|FG016|Phase 2|Protocol Violation|0|||
164471346|NCT00113360|594099617|FG000|Overall Study|Adverse Event|3|||
164471347|NCT00113360|594099617|FG000|Overall Study|Subject required surgery|1|||
164471348|NCT00113360|594099617|FG000|Overall Study|Did not meet eligibility criteria|3|||
164471349|NCT02467270|594099628|FG000|Overall Study|Participants Never Treated|0|||
164471350|NCT02467270|594099629|FG001|Overall Study|Participants Never Treated|1|||
164471351|NCT02467270|594099630|FG002|Overall Study|Participants Never Treated|0|||
164471352|NCT02467270|594099628|FG000|Overall Study|Ongoing|50|||
164471353|NCT02467270|594099629|FG001|Overall Study|Ongoing|41|||
164471354|NCT02467270|594099630|FG002|Overall Study|Ongoing|43|||
164471355|NCT02467270|594099628|FG000|Overall Study|Adverse Event|16|||
164471356|NCT02467270|594099629|FG001|Overall Study|Adverse Event|15|||
164471357|NCT02467270|594099630|FG002|Overall Study|Adverse Event|14|||
164471358|NCT02467270|594099628|FG000|Overall Study|Progressive Disease|7|||
164471359|NCT02467270|594099629|FG001|Overall Study|Progressive Disease|7|||
164471360|NCT02467270|594099630|FG002|Overall Study|Progressive Disease|4|||
164471361|NCT02467270|594099628|FG000|Overall Study|Death|2|||
164471362|NCT02467270|594099629|FG001|Overall Study|Death|0|||
164471363|NCT02467270|594099630|FG002|Overall Study|Death|2|||
164471364|NCT02467270|594099628|FG000|Overall Study|Lack of Efficacy|12|||
164712910|NCT01111825|594972185|FG002|Overall Study|Disease Progression|0|||
164712911|NCT01111825|594972186|FG003|Overall Study|Disease Progression|0|||
164471365|NCT02467270|594099629|FG001|Overall Study|Lack of Efficacy|18|||
164471366|NCT02467270|594099630|FG002|Overall Study|Lack of Efficacy|23|||
164471367|NCT02467270|594099628|FG000|Overall Study|Non-compliance With Study Drug|0|||
164471368|NCT02467270|594099629|FG001|Overall Study|Non-compliance With Study Drug|2|||
164471369|NCT02467270|594099630|FG002|Overall Study|Non-compliance With Study Drug|1|||
164471370|NCT02467270|594099628|FG000|Overall Study|Lost to Follow-up|2|||
164471371|NCT02467270|594099629|FG001|Overall Study|Lost to Follow-up|1|||
164471372|NCT02467270|594099630|FG002|Overall Study|Lost to Follow-up|0|||
164471373|NCT02467270|594099628|FG000|Overall Study|Pregnancy|0|||
164471374|NCT02467270|594099629|FG001|Overall Study|Pregnancy|1|||
164471375|NCT02467270|594099630|FG002|Overall Study|Pregnancy|0|||
164471376|NCT02467270|594099628|FG000|Overall Study|Physician Decision|0|||
164471377|NCT02467270|594099629|FG001|Overall Study|Physician Decision|4|||
164471378|NCT02467270|594099630|FG002|Overall Study|Physician Decision|1|||
164471379|NCT02467270|594099628|FG000|Overall Study|Withdrawal by Subject|4|||
164471380|NCT02467270|594099629|FG001|Overall Study|Withdrawal by Subject|3|||
164471381|NCT02467270|594099630|FG002|Overall Study|Withdrawal by Subject|5|||
164471382|NCT02467270|594099628|FG000|Overall Study|Reason not Specified|1|||
164471383|NCT02467270|594099629|FG001|Overall Study|Reason not Specified|2|||
164471384|NCT02467270|594099630|FG002|Overall Study|Reason not Specified|1|||
164712912|NCT01111825|594972183|FG000|Overall Study|Discontinuation by Sponsor|0|||
164712913|NCT01111825|594972184|FG001|Overall Study|Discontinuation by Sponsor|0|||
164712914|NCT01111825|594972185|FG002|Overall Study|Discontinuation by Sponsor|0|||
164712915|NCT01111825|594972186|FG003|Overall Study|Discontinuation by Sponsor|20|||
164712916|NCT01377987|594972187|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
164712917|NCT01377987|594972188|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
164712918|NCT00469144|594972189|FG000|Overall Study|Death|0|||
164712919|NCT00469144|594972190|FG001|Overall Study|Death|1|||
164712920|NCT00469144|594972189|FG000|Overall Study|No Response|5|||
164712921|NCT00469144|594972190|FG001|Overall Study|No Response|5|||
164712922|NCT00469144|594972189|FG000|Overall Study|Progressive Disease|1|||
164712923|NCT00469144|594972190|FG001|Overall Study|Progressive Disease|0|||
164712924|NCT02901548|594972193|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
164712925|NCT01266031|594972194|FG000|Overall Study|Not treated|0|||
164712926|NCT01266031|594972195|FG001|Overall Study|Not treated|3|||
164712927|NCT01266031|594972196|FG002|Overall Study|Not treated|2|||
164712928|NCT04893018|594972197|FG000|Overall Study|Lost to Follow-up|1|||
164712929|NCT04893018|594972198|FG001|Overall Study|Lost to Follow-up|0|||
164712930|NCT04893018|594972197|FG000|Overall Study|Withdrawal by Subject|2|||
164712931|NCT04893018|594972198|FG001|Overall Study|Withdrawal by Subject|0|||
164712932|NCT04893018|594972197|FG000|Overall Study|Study Terminated|1|||
164712933|NCT04893018|594972198|FG001|Overall Study|Study Terminated|2|||
164712934|NCT03336528|594972201|FG000|Overall Study|Protocol Violation|1|||
164712935|NCT03336528|594972202|FG001|Overall Study|Protocol Violation|1|||
164712936|NCT03336528|594972201|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
164712937|NCT03336528|594972202|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
164712938|NCT03336528|594972201|FG000|Overall Study|Did not receive study medication|1|||
164417399|NCT01474512|593899503|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
164471385|NCT02231749|594099644|FG000|Overall Study|Disease progression|229|||
164471386|NCT02231749|594099645|FG001|Overall Study|Disease progression|297|||
164471387|NCT02231749|594099644|FG000|Overall Study|Study Drug Toxicity|134|||
164471388|NCT02231749|594099645|FG001|Overall Study|Study Drug Toxicity|63|||
164471389|NCT02231749|594099644|FG000|Overall Study|Death|1|||
164471390|NCT02231749|594099645|FG001|Overall Study|Death|1|||
164471391|NCT02231749|594099644|FG000|Overall Study|AE unrelated to Study drug|32|||
164471392|NCT02231749|594099645|FG001|Overall Study|AE unrelated to Study drug|31|||
164471393|NCT02231749|594099644|FG000|Overall Study|Participant's request to discontinue|10|||
164471394|NCT02231749|594099645|FG001|Overall Study|Participant's request to discontinue|21|||
164712939|NCT03336528|594972202|FG001|Overall Study|Did not receive study medication|2|||
164712940|NCT01333397|594972204|FG000|Overall Study|Lost to Follow-up|1|||
164712941|NCT01333397|594972205|FG001|Overall Study|Lost to Follow-up|0|||
164417400|NCT01474512|593899504|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
164417401|NCT01474512|593899505|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
164417402|NCT01474512|593899506|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
164417403|NCT01474512|593899489|FG000|Long-Term Extension Period|Physician Decision|0|||
164417404|NCT01474512|593899490|FG001|Long-Term Extension Period|Physician Decision|0|||
164417405|NCT01474512|593899491|FG002|Long-Term Extension Period|Physician Decision|0|||
164471395|NCT02231749|594099644|FG000|Overall Study|Participant withdrew Consent|8|||
164471396|NCT02231749|594099645|FG001|Overall Study|Participant withdrew Consent|15|||
164471397|NCT02231749|594099644|FG000|Overall Study|Lost to Follow-up|1|||
164471398|NCT02231749|594099645|FG001|Overall Study|Lost to Follow-up|2|||
164471399|NCT02231749|594099644|FG000|Overall Study|Maximum Clinical Benefit|5|||
164471400|NCT02231749|594099645|FG001|Overall Study|Maximum Clinical Benefit|8|||
164471401|NCT02231749|594099644|FG000|Overall Study|Poor/Non-Compliance|0|||
164471402|NCT02231749|594099645|FG001|Overall Study|Poor/Non-Compliance|3|||
164471403|NCT02231749|594099644|FG000|Overall Study|Pregnancy|1|||
164471404|NCT02231749|594099645|FG001|Overall Study|Pregnancy|0|||
164471405|NCT02231749|594099644|FG000|Overall Study|other|0|||
164471406|NCT02231749|594099645|FG001|Overall Study|other|8|||
164471407|NCT02231749|594099644|FG000|Overall Study|No longer meets Study Criteria|1|||
164471408|NCT02231749|594099645|FG001|Overall Study|No longer meets Study Criteria|0|||
164471409|NCT03884439|594099660|FG000|Overall Study|No informed consent for publication of study results|38|||
164471410|NCT03884439|594099660|FG000|Overall Study|Contract violation/deficiency|7|||
164471411|NCT06059443|594099662|FG000|Overall Study|Withdrawal by Subject|2|||
164471412|NCT06059443|594099663|FG001|Overall Study|Withdrawal by Subject|0|||
164471413|NCT06059443|594099662|FG000|Overall Study|Lost to Follow-up|2|||
164471414|NCT06059443|594099663|FG001|Overall Study|Lost to Follow-up|2|||
164471415|NCT00709956|594099667|FG000|Overall Study|Withdrawal by Subject|1|||
164471416|NCT00709956|594099668|FG001|Overall Study|Withdrawal by Subject|1|||
164471417|NCT00709956|594099667|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
164471418|NCT00709956|594099668|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
164471419|NCT04940624|594099671|FG000|Overall Study|Adverse Event|4|||
164471420|NCT04940624|594099672|FG001|Overall Study|Adverse Event|11|||
164471421|NCT04940624|594099671|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
164471422|NCT04940624|594099672|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
164471423|NCT04940624|594099671|FG000|Overall Study|Physician Decision|1|||
164471424|NCT04940624|594099672|FG001|Overall Study|Physician Decision|0|||
164471425|NCT04940624|594099671|FG000|Overall Study|Lost to Follow-up|1|||
164471426|NCT04940624|594099672|FG001|Overall Study|Lost to Follow-up|0|||
164471427|NCT04940624|594099671|FG000|Overall Study|Reason Not Specified|1|||
164471428|NCT04940624|594099672|FG001|Overall Study|Reason Not Specified|0|||
164471429|NCT00353496|594099673|FG000|Overall Study|Adverse Event|1|||
164471430|NCT00353496|594099674|FG001|Overall Study|Adverse Event|0|||
164471431|NCT00353496|594099673|FG000|Overall Study|Protocol Violation|2|||
164471432|NCT00353496|594099674|FG001|Overall Study|Protocol Violation|2|||
164471433|NCT00353496|594099673|FG000|Overall Study|Withdrawal by Subject|3|||
164471434|NCT00353496|594099674|FG001|Overall Study|Withdrawal by Subject|4|||
164471435|NCT00353496|594099673|FG000|Overall Study|Physician Decision|6|||
164471436|NCT00353496|594099674|FG001|Overall Study|Physician Decision|9|||
164471437|NCT00353496|594099673|FG000|Overall Study|Not otherwise specified|4|||
164471438|NCT00353496|594099674|FG001|Overall Study|Not otherwise specified|2|||
164471439|NCT02180867|594099675|FG000|Overall Study|Adverse Event|3|||
164471440|NCT02180867|594099676|FG001|Overall Study|Adverse Event|4|||
164471441|NCT02180867|594099677|FG002|Overall Study|Adverse Event|1|||
164471442|NCT02180867|594099678|FG003|Overall Study|Adverse Event|5|||
164471443|NCT02180867|594099679|FG004|Overall Study|Adverse Event|0|||
164471444|NCT02180867|594099680|FG005|Overall Study|Adverse Event|0|||
164471445|NCT02180867|594099681|FG006|Overall Study|Adverse Event|0|||
164471446|NCT02180867|594099675|FG000|Overall Study|Death|0|||
164471447|NCT02180867|594099676|FG001|Overall Study|Death|0|||
164471448|NCT02180867|594099677|FG002|Overall Study|Death|0|||
164471449|NCT02180867|594099678|FG003|Overall Study|Death|0|||
164471450|NCT02180867|594099679|FG004|Overall Study|Death|1|||
164471451|NCT02180867|594099680|FG005|Overall Study|Death|0|||
164471452|NCT02180867|594099681|FG006|Overall Study|Death|0|||
164471453|NCT02180867|594099675|FG000|Overall Study|Lack of Efficacy|0|||
164471454|NCT02180867|594099676|FG001|Overall Study|Lack of Efficacy|2|||
164471455|NCT02180867|594099677|FG002|Overall Study|Lack of Efficacy|0|||
164471456|NCT02180867|594099678|FG003|Overall Study|Lack of Efficacy|1|||
164471457|NCT02180867|594099679|FG004|Overall Study|Lack of Efficacy|6|||
164471458|NCT02180867|594099680|FG005|Overall Study|Lack of Efficacy|0|||
164471459|NCT02180867|594099681|FG006|Overall Study|Lack of Efficacy|1|||
164471460|NCT02180867|594099675|FG000|Overall Study|Physician Decision|1|||
164471461|NCT02180867|594099676|FG001|Overall Study|Physician Decision|3|||
164471462|NCT02180867|594099677|FG002|Overall Study|Physician Decision|1|||
164471463|NCT02180867|594099678|FG003|Overall Study|Physician Decision|10|||
164471464|NCT02180867|594099679|FG004|Overall Study|Physician Decision|9|||
164471465|NCT02180867|594099680|FG005|Overall Study|Physician Decision|3|||
164471466|NCT02180867|594099681|FG006|Overall Study|Physician Decision|4|||
164471467|NCT02180867|594099675|FG000|Overall Study|Withdrawal by Subject|0|||
164471468|NCT02180867|594099676|FG001|Overall Study|Withdrawal by Subject|0|||
164471469|NCT02180867|594099677|FG002|Overall Study|Withdrawal by Subject|0|||
164471470|NCT02180867|594099678|FG003|Overall Study|Withdrawal by Subject|1|||
164471471|NCT02180867|594099679|FG004|Overall Study|Withdrawal by Subject|1|||
164471472|NCT02180867|594099680|FG005|Overall Study|Withdrawal by Subject|0|||
164471473|NCT02180867|594099681|FG006|Overall Study|Withdrawal by Subject|0|||
164471474|NCT02180867|594099675|FG000|Overall Study|Ineligible|1|||
164471475|NCT02180867|594099676|FG001|Overall Study|Ineligible|2|||
164471476|NCT02180867|594099677|FG002|Overall Study|Ineligible|0|||
164471477|NCT02180867|594099678|FG003|Overall Study|Ineligible|3|||
164471478|NCT02180867|594099679|FG004|Overall Study|Ineligible|5|||
164471479|NCT02180867|594099680|FG005|Overall Study|Ineligible|0|||
164471480|NCT02180867|594099681|FG006|Overall Study|Ineligible|0|||
164471481|NCT02180867|594099675|FG000|Overall Study|Repeat Eligibility Studies|0|||
164471482|NCT02180867|594099676|FG001|Overall Study|Repeat Eligibility Studies|0|||
164471483|NCT02180867|594099677|FG002|Overall Study|Repeat Eligibility Studies|0|||
164471484|NCT02180867|594099678|FG003|Overall Study|Repeat Eligibility Studies|0|||
164471485|NCT02180867|594099679|FG004|Overall Study|Repeat Eligibility Studies|1|||
164471486|NCT02180867|594099680|FG005|Overall Study|Repeat Eligibility Studies|0|||
164471487|NCT02180867|594099681|FG006|Overall Study|Repeat Eligibility Studies|0|||
164471488|NCT02180867|594099675|FG000|Overall Study|Refusal of further protocol therapy|1|||
164471489|NCT02180867|594099676|FG001|Overall Study|Refusal of further protocol therapy|0|||
164471490|NCT02180867|594099677|FG002|Overall Study|Refusal of further protocol therapy|2|||
164471491|NCT02180867|594099678|FG003|Overall Study|Refusal of further protocol therapy|6|||
164471492|NCT02180867|594099679|FG004|Overall Study|Refusal of further protocol therapy|4|||
164471493|NCT02180867|594099680|FG005|Overall Study|Refusal of further protocol therapy|0|||
164471494|NCT02180867|594099681|FG006|Overall Study|Refusal of further protocol therapy|0|||
164471495|NCT05267639|594100537|FG000|Overall Study|Withdrawal by Subject|1|||
164471496|NCT05267639|594100538|FG001|Overall Study|Withdrawal by Subject|0|||
164471497|NCT04732871|594100539|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
164471498|NCT04732871|594100540|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
164471499|NCT04732871|594100541|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
164471500|NCT04732871|594100539|FG000|Overall Study|Lost to Follow-up|7|||
164471501|NCT04732871|594100540|FG001|Overall Study|Lost to Follow-up|4|||
164471502|NCT04732871|594100541|FG002|Overall Study|Lost to Follow-up|3|||
164471503|NCT04732871|594100539|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
164471504|NCT04732871|594100540|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
164471505|NCT04732871|594100541|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
164471506|NCT04732871|594100539|FG000|Overall Study|Migrated / moved from the study area|5|||
164471507|NCT04732871|594100540|FG001|Overall Study|Migrated / moved from the study area|0|||
164471508|NCT04732871|594100541|FG002|Overall Study|Migrated / moved from the study area|0|||
164471509|NCT04732871|594100539|FG000|Overall Study|Other|1|||
164471510|NCT04732871|594100540|FG001|Overall Study|Other|0|||
164471511|NCT04732871|594100541|FG002|Overall Study|Other|1|||
164471512|NCT04732871|594100539|FG000|Overall Study|Ongoing|6|||
164471513|NCT04732871|594100540|FG001|Overall Study|Ongoing|0|||
164471514|NCT04732871|594100541|FG002|Overall Study|Ongoing|1|||
164471515|NCT04732871|594100539|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
164471516|NCT04732871|594100540|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
164471517|NCT04732871|594100541|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
164471518|NCT05180539|594100547|FG000|Overall Study|Lost to Follow-up|27|||
164471519|NCT05180539|594100548|FG001|Overall Study|Lost to Follow-up|30|||
164471520|NCT00968149|594100549|FG000|Overall Study|Adverse Event|5|||
164471521|NCT00968149|594100550|FG001|Overall Study|Adverse Event|1|||
164471522|NCT00968149|594100549|FG000|Overall Study|Lack of Efficacy|0|||
164471523|NCT00968149|594100550|FG001|Overall Study|Lack of Efficacy|4|||
164471524|NCT00968149|594100549|FG000|Overall Study|Lost to Follow-up|0|||
164471525|NCT00968149|594100550|FG001|Overall Study|Lost to Follow-up|1|||
164471526|NCT00968149|594100549|FG000|Overall Study|Protocol Violation|4|||
164471527|NCT00968149|594100550|FG001|Overall Study|Protocol Violation|0|||
164471528|NCT00968149|594100549|FG000|Overall Study|Withdrawal by Subject|2|||
164471529|NCT00968149|594100550|FG001|Overall Study|Withdrawal by Subject|0|||
164471530|NCT02502266|594100551|FG000|Overall Study|Adverse Event|0|||
164471531|NCT02502266|594100552|FG001|Overall Study|Adverse Event|0|||
164471532|NCT02502266|594100553|FG002|Overall Study|Adverse Event|0|||
164471533|NCT02502266|594100554|FG003|Overall Study|Adverse Event|0|||
164471534|NCT02502266|594100555|FG004|Overall Study|Adverse Event|1|||
164471535|NCT02502266|594100556|FG005|Overall Study|Adverse Event|1|||
164471536|NCT02502266|594100557|FG006|Overall Study|Adverse Event|1|||
164471537|NCT02502266|594100551|FG000|Overall Study|Withdrawal by Subject|30|||
164471538|NCT02502266|594100552|FG001|Overall Study|Withdrawal by Subject|15|||
164471539|NCT02502266|594100553|FG002|Overall Study|Withdrawal by Subject|16|||
164471540|NCT02502266|594100554|FG003|Overall Study|Withdrawal by Subject|0|||
164471541|NCT02502266|594100555|FG004|Overall Study|Withdrawal by Subject|0|||
164471542|NCT02502266|594100556|FG005|Overall Study|Withdrawal by Subject|0|||
164471543|NCT02502266|594100557|FG006|Overall Study|Withdrawal by Subject|0|||
164471544|NCT02502266|594100551|FG000|Overall Study|Still on Treatment|0|||
164471545|NCT02502266|594100552|FG001|Overall Study|Still on Treatment|0|||
164471546|NCT02502266|594100553|FG002|Overall Study|Still on Treatment|1|||
164471547|NCT02502266|594100554|FG003|Overall Study|Still on Treatment|0|||
164471548|NCT02502266|594100555|FG004|Overall Study|Still on Treatment|0|||
164712942|NCT01333397|594972206|FG002|Overall Study|Lost to Follow-up|0|||
164712943|NCT01333397|594972207|FG003|Overall Study|Lost to Follow-up|1|||
164471549|NCT02502266|594100556|FG005|Overall Study|Still on Treatment|0|||
164471550|NCT02502266|594100557|FG006|Overall Study|Still on Treatment|0|||
164712944|NCT01333397|594972208|FG004|Overall Study|Lost to Follow-up|0|||
164471551|NCT02502266|594100551|FG000|Overall Study|Other Reasons|19|||
164712945|NCT00314951|594972211|FG000|Treatment|Didn't meet criteria for mITT population|16|||
164471552|NCT02502266|594100552|FG001|Overall Study|Other Reasons|6|||
164471553|NCT02502266|594100553|FG002|Overall Study|Other Reasons|14|||
164471554|NCT02502266|594100554|FG003|Overall Study|Other Reasons|0|||
164712946|NCT00314951|594972212|FG001|Treatment|Didn't meet criteria for mITT population|11|||
164712947|NCT00314951|594972211|FG000|Follow-up|mITT failure|44|||
164712948|NCT00314951|594972212|FG001|Follow-up|mITT failure|34|||
164712949|NCT00920790|594972213|FG000|Overall Study|aggravation of general condition|14|||
164471555|NCT02502266|594100555|FG004|Overall Study|Other Reasons|1|||
164471556|NCT02502266|594100556|FG005|Overall Study|Other Reasons|1|||
164471557|NCT02502266|594100557|FG006|Overall Study|Other Reasons|0|||
164471558|NCT02502266|594100551|FG000|Overall Study|Arm 4 Discontinued|0|||
164471559|NCT02502266|594100552|FG001|Overall Study|Arm 4 Discontinued|0|||
164471560|NCT02502266|594100553|FG002|Overall Study|Arm 4 Discontinued|0|||
164471561|NCT02502266|594100554|FG003|Overall Study|Arm 4 Discontinued|52|||
164471562|NCT02502266|594100555|FG004|Overall Study|Arm 4 Discontinued|0|||
164471563|NCT02502266|594100556|FG005|Overall Study|Arm 4 Discontinued|0|||
164471564|NCT02502266|594100557|FG006|Overall Study|Arm 4 Discontinued|0|||
164471565|NCT02502266|594100551|FG000|Overall Study|Never treated|0|||
164471566|NCT02502266|594100552|FG001|Overall Study|Never treated|0|||
164471567|NCT02502266|594100553|FG002|Overall Study|Never treated|0|||
164471568|NCT02502266|594100554|FG003|Overall Study|Never treated|0|||
164471569|NCT02502266|594100555|FG004|Overall Study|Never treated|0|||
164471570|NCT02502266|594100556|FG005|Overall Study|Never treated|1|||
164471571|NCT02502266|594100557|FG006|Overall Study|Never treated|0|||
164471572|NCT01976936|594100560|FG000|Overall Study|Did not receive at least 9 doses|9|||
164471573|NCT01976936|594100561|FG001|Overall Study|Did not receive at least 9 doses|4|||
164471574|NCT00495677|594100562|FG000|Stage 1 (25 Days)|Adverse Event|0|||
164471575|NCT00495677|594100563|FG001|Stage 1 (25 Days)|Adverse Event|0|||
164471576|NCT00495677|594100564|FG002|Stage 1 (25 Days)|Adverse Event|1|||
164471577|NCT00495677|594100565|FG003|Stage 1 (25 Days)|Adverse Event|0|||
164471578|NCT00495677|594100566|FG004|Stage 1 (25 Days)|Adverse Event|0|||
164471579|NCT00495677|594100567|FG005|Stage 1 (25 Days)|Adverse Event|0|||
164471580|NCT00495677|594100568|FG006|Stage 1 (25 Days)|Adverse Event|0|||
164471581|NCT02306161|594100574|FG000|Overall Study|Death|1|||
164471582|NCT02306161|594100575|FG001|Overall Study|Death|3|||
164471583|NCT02306161|594100574|FG000|Overall Study|Lack of Efficacy|20|||
164471584|NCT02306161|594100575|FG001|Overall Study|Lack of Efficacy|43|||
164471585|NCT02306161|594100574|FG000|Overall Study|Physician Decision|30|||
164471586|NCT02306161|594100575|FG001|Overall Study|Physician Decision|18|||
164471587|NCT02306161|594100574|FG000|Overall Study|Withdrawal by Subject|4|||
164471588|NCT02306161|594100575|FG001|Overall Study|Withdrawal by Subject|0|||
164471589|NCT02306161|594100574|FG000|Overall Study|Ineligible|9|||
164471590|NCT02306161|594100575|FG001|Overall Study|Ineligible|5|||
164471591|NCT05162586|594100576|FG000|Overall Study|Other|0|||
164471592|NCT05162586|594100577|FG001|Overall Study|Other|0|||
164471593|NCT05162586|594100578|FG002|Overall Study|Other|0|||
164471594|NCT05162586|594100579|FG003|Overall Study|Other|0|||
164471595|NCT05162586|594100580|FG004|Overall Study|Other|1|||
164471596|NCT05162586|594100581|FG005|Overall Study|Other|0|||
164471597|NCT05162586|594100582|FG006|Overall Study|Other|2|||
164471598|NCT05162586|594100583|FG007|Overall Study|Other|2|||
164471599|NCT05162586|594100576|FG000|Overall Study|Lack of Efficacy|0|||
164471600|NCT05162586|594100577|FG001|Overall Study|Lack of Efficacy|0|||
164471601|NCT05162586|594100578|FG002|Overall Study|Lack of Efficacy|0|||
164471602|NCT05162586|594100579|FG003|Overall Study|Lack of Efficacy|0|||
164471603|NCT05162586|594100580|FG004|Overall Study|Lack of Efficacy|1|||
164471604|NCT05162586|594100581|FG005|Overall Study|Lack of Efficacy|0|||
164471605|NCT05162586|594100582|FG006|Overall Study|Lack of Efficacy|0|||
164471606|NCT05162586|594100583|FG007|Overall Study|Lack of Efficacy|1|||
164471607|NCT05162586|594100576|FG000|Overall Study|Lost to Follow-up|0|||
164471608|NCT05162586|594100577|FG001|Overall Study|Lost to Follow-up|0|||
164471609|NCT05162586|594100578|FG002|Overall Study|Lost to Follow-up|0|||
164471610|NCT05162586|594100579|FG003|Overall Study|Lost to Follow-up|0|||
164471611|NCT05162586|594100580|FG004|Overall Study|Lost to Follow-up|2|||
164471612|NCT05162586|594100581|FG005|Overall Study|Lost to Follow-up|0|||
164712950|NCT04411914|594972214|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
164471613|NCT05162586|594100582|FG006|Overall Study|Lost to Follow-up|0|||
164471614|NCT05162586|594100583|FG007|Overall Study|Lost to Follow-up|2|||
164471615|NCT05162586|594100576|FG000|Overall Study|Non-Compliance|0|||
164471616|NCT05162586|594100577|FG001|Overall Study|Non-Compliance|1|||
164471617|NCT05162586|594100578|FG002|Overall Study|Non-Compliance|0|||
164712951|NCT04411914|594972215|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
164471618|NCT05162586|594100579|FG003|Overall Study|Non-Compliance|0|||
164471619|NCT05162586|594100580|FG004|Overall Study|Non-Compliance|1|||
164471620|NCT05162586|594100581|FG005|Overall Study|Non-Compliance|0|||
164471621|NCT05162586|594100582|FG006|Overall Study|Non-Compliance|0|||
164471622|NCT05162586|594100583|FG007|Overall Study|Non-Compliance|1|||
164471623|NCT05162586|594100576|FG000|Overall Study|Withdrawal by Subject|2|||
164471624|NCT05162586|594100577|FG001|Overall Study|Withdrawal by Subject|0|||
164471625|NCT05162586|594100578|FG002|Overall Study|Withdrawal by Subject|0|||
164471626|NCT05162586|594100579|FG003|Overall Study|Withdrawal by Subject|0|||
164471627|NCT05162586|594100580|FG004|Overall Study|Withdrawal by Subject|7|||
164471628|NCT05162586|594100581|FG005|Overall Study|Withdrawal by Subject|6|||
164471629|NCT05162586|594100582|FG006|Overall Study|Withdrawal by Subject|2|||
164712952|NCT02639052|594972221|FG000|Overall Study|Lost to Follow-up|1|||
164712953|NCT02655666|594972223|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
164712954|NCT00895414|594972224|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
164712955|NCT00895414|594972225|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
164712956|NCT00895414|594972224|FG000|First Intervention (14 Days)|Physician Decision|0|||
164712957|NCT00895414|594972225|FG001|First Intervention (14 Days)|Physician Decision|1|||
164712958|NCT00789737|594972230|FG000|Overall Study|Withdrawal by Subject|13|||
164712959|NCT00789737|594972231|FG001|Overall Study|Withdrawal by Subject|22|||
164712960|NCT00789737|594972230|FG000|Overall Study|Lost to Follow-up|10|||
164712961|NCT00789737|594972231|FG001|Overall Study|Lost to Follow-up|14|||
164712962|NCT00789737|594972230|FG000|Overall Study|Adverse Event|8|||
164712963|NCT00789737|594972231|FG001|Overall Study|Adverse Event|8|||
164712964|NCT00789737|594972230|FG000|Overall Study|Protocol Violation|3|||
164712965|NCT00789737|594972231|FG001|Overall Study|Protocol Violation|0|||
164712966|NCT00789737|594972230|FG000|Overall Study|Lack of Efficacy|3|||
164712967|NCT00789737|594972231|FG001|Overall Study|Lack of Efficacy|0|||
164471630|NCT05162586|594100583|FG007|Overall Study|Withdrawal by Subject|2|||
164471631|NCT05162586|594100576|FG000|Overall Study|Adverse Event|2|||
164471632|NCT05162586|594100577|FG001|Overall Study|Adverse Event|0|||
164471633|NCT05162586|594100578|FG002|Overall Study|Adverse Event|1|||
164471634|NCT05162586|594100579|FG003|Overall Study|Adverse Event|2|||
164471635|NCT05162586|594100580|FG004|Overall Study|Adverse Event|4|||
164471636|NCT05162586|594100581|FG005|Overall Study|Adverse Event|1|||
164471637|NCT05162586|594100582|FG006|Overall Study|Adverse Event|5|||
164471638|NCT05162586|594100583|FG007|Overall Study|Adverse Event|2|||
164471639|NCT00982644|594100586|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
164471640|NCT00982644|594100587|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
164471641|NCT00982644|594100586|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
164471642|NCT00982644|594100587|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
164471643|NCT00982644|594100586|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
164471644|NCT00982644|594100587|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
164471645|NCT00982644|594100586|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
164471646|NCT00982644|594100587|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
164471647|NCT00982644|594100586|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
164471648|NCT00982644|594100587|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
164471649|NCT00982644|594100586|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
164471650|NCT00982644|594100587|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
164471651|NCT00982644|594100586|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
164471652|NCT00982644|594100587|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
164471653|NCT00982644|594100586|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
164471654|NCT00982644|594100587|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
164471655|NCT00982644|594100586|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
164471656|NCT00982644|594100587|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
164471657|NCT00982644|594100586|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
164471658|NCT00982644|594100587|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
164471659|NCT05030584|594100588|FG000|Overall Study|Adverse Event|17|||
164471660|NCT05030584|594100589|FG001|Overall Study|Adverse Event|2|||
164471661|NCT05030584|594100588|FG000|Overall Study|Lack of Efficacy|0|||
164471662|NCT05030584|594100589|FG001|Overall Study|Lack of Efficacy|6|||
164471663|NCT05030584|594100588|FG000|Overall Study|Lost to Follow-up|5|||
164471664|NCT05030584|594100589|FG001|Overall Study|Lost to Follow-up|2|||
164471665|NCT05030584|594100588|FG000|Overall Study|Non-Compliance with Study Drug|2|||
164471666|NCT05030584|594100589|FG001|Overall Study|Non-Compliance with Study Drug|3|||
164471667|NCT05030584|594100588|FG000|Overall Study|Other reason|4|||
164471668|NCT05030584|594100589|FG001|Overall Study|Other reason|3|||
164471669|NCT05030584|594100588|FG000|Overall Study|Physician Decision|1|||
164471670|NCT05030584|594100589|FG001|Overall Study|Physician Decision|4|||
164471671|NCT05030584|594100588|FG000|Overall Study|Protocol Violation|0|||
164471672|NCT05030584|594100589|FG001|Overall Study|Protocol Violation|2|||
164712968|NCT00789737|594972230|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
164712969|NCT00789737|594972231|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
164712970|NCT00789737|594972230|FG000|Overall Study|Other|11|||
164712971|NCT00789737|594972231|FG001|Overall Study|Other|7|||
164712972|NCT02458287|594972232|FG000|Overall Study|Adverse Event|0|||
164712973|NCT02458287|594972233|FG001|Overall Study|Adverse Event|0|||
164712974|NCT02458287|594972234|FG002|Overall Study|Adverse Event|0|||
164471673|NCT05030584|594100588|FG000|Overall Study|Randomized by Mistake|0|||
164471674|NCT05030584|594100589|FG001|Overall Study|Randomized by Mistake|2|||
164144827|NCT04289363|592891792|FG000|Overall Study|Lost to Follow-up|14|||
164471675|NCT05030584|594100588|FG000|Overall Study|Withdrawal by Subject|21|||
164471676|NCT05030584|594100589|FG001|Overall Study|Withdrawal by Subject|28|||
164712975|NCT02458287|594972235|FG003|Overall Study|Adverse Event|1|||
164712976|NCT02458287|594972232|FG000|Overall Study|Lost to Follow-up|0|||
164712977|NCT02458287|594972233|FG001|Overall Study|Lost to Follow-up|1|||
164712978|NCT02458287|594972234|FG002|Overall Study|Lost to Follow-up|1|||
164712979|NCT02458287|594972235|FG003|Overall Study|Lost to Follow-up|0|||
164712980|NCT02458287|594972232|FG000|Overall Study|Protocol Violation|0|||
164471677|NCT05030584|594100588|FG000|Overall Study|Technical Problems|0|||
164471678|NCT05030584|594100589|FG001|Overall Study|Technical Problems|1|||
164471679|NCT05030584|594100588|FG000|Overall Study|Completed post-treatment/FU visits|41|||
164471680|NCT05030584|594100589|FG001|Overall Study|Completed post-treatment/FU visits|31|||
164471681|NCT02989662|594100590|FG000|Overall Study|Lost to Follow-up|0|||
164471682|NCT02989662|594100591|FG001|Overall Study|Lost to Follow-up|0|||
164471683|NCT02989662|594100592|FG002|Overall Study|Lost to Follow-up|0|||
164471684|NCT02989662|594100593|FG003|Overall Study|Lost to Follow-up|2|||
164471685|NCT02989662|594100590|FG000|Overall Study|Physician Decision|3|||
164471686|NCT02989662|594100591|FG001|Overall Study|Physician Decision|0|||
164471687|NCT02989662|594100592|FG002|Overall Study|Physician Decision|0|||
164471688|NCT02989662|594100593|FG003|Overall Study|Physician Decision|0|||
164471689|NCT02989662|594100590|FG000|Overall Study|Withdrawal by Subject|1|||
164471690|NCT02989662|594100591|FG001|Overall Study|Withdrawal by Subject|0|||
164471691|NCT02989662|594100592|FG002|Overall Study|Withdrawal by Subject|0|||
164471692|NCT02989662|594100593|FG003|Overall Study|Withdrawal by Subject|0|||
164471693|NCT06393127|594100594|FG000|Washout period|Withdrawal by Subject|1|||
164471694|NCT06393127|594100595|FG001|Washout period|Withdrawal by Subject|0|||
164471695|NCT06393127|594100594|FG000|Washout period|Non-compliance from subject with trial procedures|1|||
164471696|NCT06393127|594100595|FG001|Washout period|Non-compliance from subject with trial procedures|0|||
164471697|NCT02446600|594100596|FG000|Overall Study|Never treated|20|||
164471698|NCT02446600|594100597|FG001|Overall Study|Never treated|2|||
164471699|NCT02446600|594100598|FG002|Overall Study|Never treated|6|||
164471700|NCT02446600|594100599|FG003|Overall Study|Never treated|0|||
164471701|NCT02446600|594100596|FG000|Overall Study|Withdrawal by Subject|19|||
164471702|NCT02446600|594100597|FG001|Overall Study|Withdrawal by Subject|5|||
164471703|NCT02446600|594100598|FG002|Overall Study|Withdrawal by Subject|17|||
164471704|NCT02446600|594100599|FG003|Overall Study|Withdrawal by Subject|0|||
164471705|NCT02446600|594100596|FG000|Overall Study|Ineligible|1|||
164471706|NCT02446600|594100597|FG001|Overall Study|Ineligible|4|||
164471707|NCT02446600|594100598|FG002|Overall Study|Ineligible|4|||
164471708|NCT02446600|594100599|FG003|Overall Study|Ineligible|1|||
164471709|NCT02446600|594100596|FG000|Overall Study|Duplicate Enrollment|0|||
164471710|NCT02446600|594100597|FG001|Overall Study|Duplicate Enrollment|1|||
164471711|NCT02446600|594100598|FG002|Overall Study|Duplicate Enrollment|0|||
164471712|NCT02446600|594100599|FG003|Overall Study|Duplicate Enrollment|0|||
164471713|NCT00328783|594100600|FG000|Overall Study|Could not tolerate ABC|21|||
164471714|NCT00328783|594100600|FG000|Overall Study|No heart in RT field|4|||
164471715|NCT00328783|594100600|FG000|Overall Study|Withdrawal by Subject|1|||
164471716|NCT00357682|594100601|FG000|Overall Study|Did not receive allocated Treatment|10|||
164471717|NCT00357682|594100602|FG001|Overall Study|Did not receive allocated Treatment|9|||
164471718|NCT00357682|594100603|FG002|Overall Study|Did not receive allocated Treatment|9|||
164471719|NCT00357682|594100604|FG003|Overall Study|Did not receive allocated Treatment|10|||
164471720|NCT00357682|594100601|FG000|Overall Study|Withdrew consent|6|||
164471721|NCT00357682|594100602|FG001|Overall Study|Withdrew consent|6|||
164471722|NCT00357682|594100603|FG002|Overall Study|Withdrew consent|5|||
164471723|NCT00357682|594100604|FG003|Overall Study|Withdrew consent|5|||
164471724|NCT00357682|594100601|FG000|Overall Study|Lost to Follow-up|39|||
164471725|NCT00357682|594100602|FG001|Overall Study|Lost to Follow-up|33|||
164471726|NCT00357682|594100603|FG002|Overall Study|Lost to Follow-up|26|||
164471727|NCT00357682|594100604|FG003|Overall Study|Lost to Follow-up|35|||
164471728|NCT00357682|594100601|FG000|Overall Study|Adverse Event|24|||
164471729|NCT00357682|594100602|FG001|Overall Study|Adverse Event|32|||
164471730|NCT00357682|594100603|FG002|Overall Study|Adverse Event|22|||
164471731|NCT00357682|594100604|FG003|Overall Study|Adverse Event|27|||
164471732|NCT00357682|594100601|FG000|Overall Study|Physician Decision|32|||
164471733|NCT00357682|594100602|FG001|Overall Study|Physician Decision|20|||
164471734|NCT00357682|594100603|FG002|Overall Study|Physician Decision|24|||
164712981|NCT02458287|594972233|FG001|Overall Study|Protocol Violation|1|||
164712982|NCT02458287|594972234|FG002|Overall Study|Protocol Violation|0|||
164712983|NCT02458287|594972235|FG003|Overall Study|Protocol Violation|0|||
164471735|NCT00357682|594100604|FG003|Overall Study|Physician Decision|30|||
164471736|NCT00357682|594100601|FG000|Overall Study|Patient decision|73|||
164471737|NCT00357682|594100602|FG001|Overall Study|Patient decision|80|||
164471738|NCT00357682|594100603|FG002|Overall Study|Patient decision|51|||
164471739|NCT00357682|594100604|FG003|Overall Study|Patient decision|59|||
164471740|NCT00357682|594100601|FG000|Overall Study|Other reason|157|||
164471741|NCT00357682|594100602|FG001|Overall Study|Other reason|130|||
164712984|NCT02458287|594972232|FG000|Overall Study|Withdrawal by Subject|0|||
164712985|NCT02458287|594972233|FG001|Overall Study|Withdrawal by Subject|2|||
164712986|NCT02458287|594972234|FG002|Overall Study|Withdrawal by Subject|2|||
164471742|NCT00357682|594100603|FG002|Overall Study|Other reason|114|||
164471743|NCT00357682|594100604|FG003|Overall Study|Other reason|99|||
164471744|NCT03660930|594100605|FG000|Overall Study|Adverse Event|0|||
164471745|NCT03660930|594100606|FG001|Overall Study|Adverse Event|0|||
164712987|NCT02458287|594972235|FG003|Overall Study|Withdrawal by Subject|1|||
164712988|NCT02458287|594972232|FG000|Overall Study|Relocated Out of State|0|||
164712989|NCT02458287|594972233|FG001|Overall Study|Relocated Out of State|0|||
164712990|NCT02458287|594972234|FG002|Overall Study|Relocated Out of State|0|||
164712991|NCT02458287|594972235|FG003|Overall Study|Relocated Out of State|1|||
164712992|NCT00813800|594972238|FG000|Overall Study|Screen Failure after Consent|2|||
164712993|NCT00813800|594972238|FG000|Overall Study|Adverse Event|1|||
164712994|NCT00813800|594972238|FG000|Overall Study|Worsening of depression|2|||
164712995|NCT00813800|594972238|FG000|Overall Study|Physician Decision|1|||
164712996|NCT02365558|594972239|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
164712997|NCT02365558|594972240|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
164712998|NCT02365558|594972239|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
164712999|NCT02365558|594972240|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
164713000|NCT00642278|594972241|FG000|Overall Study|Adverse Event|2|||
164713001|NCT00642278|594972242|FG001|Overall Study|Adverse Event|1|||
164713002|NCT00642278|594972243|FG002|Overall Study|Adverse Event|3|||
164713003|NCT00642278|594972244|FG003|Overall Study|Adverse Event|1|||
164713004|NCT00642278|594972245|FG004|Overall Study|Adverse Event|2|||
164713005|NCT00642278|594972246|FG005|Overall Study|Adverse Event|2|||
164713006|NCT00642278|594972247|FG006|Overall Study|Adverse Event|0|||
164713007|NCT00642278|594972241|FG000|Overall Study|Lack of Efficacy|0|||
164713008|NCT00642278|594972242|FG001|Overall Study|Lack of Efficacy|1|||
164713009|NCT00642278|594972243|FG002|Overall Study|Lack of Efficacy|0|||
164713010|NCT00642278|594972244|FG003|Overall Study|Lack of Efficacy|0|||
164713011|NCT00642278|594972245|FG004|Overall Study|Lack of Efficacy|0|||
164713012|NCT00642278|594972246|FG005|Overall Study|Lack of Efficacy|0|||
164713013|NCT00642278|594972247|FG006|Overall Study|Lack of Efficacy|0|||
164713014|NCT00642278|594972241|FG000|Overall Study|Lost to Follow-up|5|||
164713015|NCT00642278|594972242|FG001|Overall Study|Lost to Follow-up|1|||
164713016|NCT00642278|594972243|FG002|Overall Study|Lost to Follow-up|0|||
164713017|NCT00642278|594972244|FG003|Overall Study|Lost to Follow-up|1|||
164713018|NCT00642278|594972245|FG004|Overall Study|Lost to Follow-up|0|||
164713019|NCT00642278|594972246|FG005|Overall Study|Lost to Follow-up|1|||
164713020|NCT00642278|594972247|FG006|Overall Study|Lost to Follow-up|1|||
164713021|NCT00642278|594972241|FG000|Overall Study|Physician Decision|0|||
164713022|NCT00642278|594972242|FG001|Overall Study|Physician Decision|0|||
164713023|NCT00642278|594972243|FG002|Overall Study|Physician Decision|0|||
164713024|NCT00642278|594972244|FG003|Overall Study|Physician Decision|1|||
164471746|NCT03660930|594100607|FG002|Overall Study|Adverse Event|0|||
164471747|NCT03660930|594100608|FG003|Overall Study|Adverse Event|2|||
164471748|NCT03660930|594100609|FG004|Overall Study|Adverse Event|0|||
164471749|NCT03660930|594100610|FG005|Overall Study|Adverse Event|1|||
164471750|NCT03660930|594100611|FG006|Overall Study|Adverse Event|0|||
164471751|NCT03660930|594100612|FG007|Overall Study|Adverse Event|0|||
164471752|NCT03660930|594100605|FG000|Overall Study|Withdrawal by Subject|0|||
164471753|NCT03660930|594100606|FG001|Overall Study|Withdrawal by Subject|0|||
164471754|NCT03660930|594100607|FG002|Overall Study|Withdrawal by Subject|0|||
164471755|NCT03660930|594100608|FG003|Overall Study|Withdrawal by Subject|0|||
164471756|NCT03660930|594100609|FG004|Overall Study|Withdrawal by Subject|0|||
164471757|NCT03660930|594100610|FG005|Overall Study|Withdrawal by Subject|1|||
164471758|NCT03660930|594100611|FG006|Overall Study|Withdrawal by Subject|0|||
164471759|NCT03660930|594100612|FG007|Overall Study|Withdrawal by Subject|0|||
164471760|NCT03242915|594100613|FG000|Overall Study|Adverse Event|5|||
164471761|NCT03242915|594100614|FG001|Overall Study|Adverse Event|1|||
164471762|NCT03242915|594100613|FG000|Overall Study|Withdrawal by Subject|0|||
164471763|NCT03242915|594100614|FG001|Overall Study|Withdrawal by Subject|2|||
164471764|NCT03242915|594100613|FG000|Overall Study|Physician Decision|4|||
164471765|NCT03242915|594100614|FG001|Overall Study|Physician Decision|1|||
164471766|NCT02532621|594100617|FG000|Overall Study|Death|3|||
164471767|NCT02532621|594100617|FG000|Overall Study|Lost to Follow-up|3|||
164471768|NCT02532621|594100617|FG000|Overall Study|Withdrawal by Subject|6|||
164471769|NCT02532621|594100617|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
164471770|NCT02532621|594100617|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
164471771|NCT05424718|594100618|FG000|Overall Study|Lost to Follow-up|5|||
164471772|NCT05424718|594100619|FG001|Overall Study|Lost to Follow-up|4|||
164713025|NCT00642278|594972245|FG004|Overall Study|Physician Decision|0|||
164713026|NCT00642278|594972246|FG005|Overall Study|Physician Decision|0|||
164713027|NCT00642278|594972247|FG006|Overall Study|Physician Decision|0|||
164713028|NCT00642278|594972241|FG000|Overall Study|Protocol Violation|0|||
164713029|NCT00642278|594972242|FG001|Overall Study|Protocol Violation|0|||
164713030|NCT00642278|594972243|FG002|Overall Study|Protocol Violation|1|||
164713031|NCT00642278|594972244|FG003|Overall Study|Protocol Violation|1|||
164471773|NCT04046549|594100620|FG000|Overall Study|Adverse Event|1|||
164471774|NCT04046549|594100620|FG000|Overall Study|Physician Decision|1|||
164471775|NCT04046549|594100620|FG000|Overall Study|Withdrawal by Subject|3|||
164471776|NCT04046549|594100620|FG000|Overall Study|Other, Not Specified|5|||
164713032|NCT00642278|594972245|FG004|Overall Study|Protocol Violation|0|||
164713033|NCT00642278|594972246|FG005|Overall Study|Protocol Violation|1|||
164471777|NCT05771467|594100622|FG000|Overall Study|Lost to Follow-up|6|||
164471778|NCT05771467|594100623|FG001|Overall Study|Lost to Follow-up|3|||
164471779|NCT01220531|594100626|FG000|Overall Study|Death|7|||
164471780|NCT01220531|594100626|FG000|Overall Study|Lost to Follow-up|1|||
164471781|NCT05866926|594100629|FG000|Overall Study|Death|16|||
164471782|NCT05866926|594100630|FG001|Overall Study|Death|9|||
164471783|NCT05866926|594100629|FG000|Overall Study|Lost to Follow-up|0|||
164471784|NCT05866926|594100630|FG001|Overall Study|Lost to Follow-up|1|||
164471785|NCT05866926|594100629|FG000|Overall Study|Adverse Event|1|||
164471786|NCT05866926|594100630|FG001|Overall Study|Adverse Event|0|||
164471787|NCT05866926|594100629|FG000|Overall Study|Withdrawal by Subject|5|||
164471788|NCT05866926|594100630|FG001|Overall Study|Withdrawal by Subject|1|||
164471789|NCT05866926|594100629|FG000|Overall Study|Disease progression|1|||
164471790|NCT05866926|594100630|FG001|Overall Study|Disease progression|0|||
164471791|NCT05866926|594100629|FG000|Overall Study|other causes|2|||
164471792|NCT05866926|594100630|FG001|Overall Study|other causes|1|||
164471793|NCT01105091|594100631|FG000|Overall Study|Death|2|||
164471794|NCT01105091|594100632|FG001|Overall Study|Death|0|||
164471795|NCT04479787|594100633|FG000|Through 6 Months|Withdrawal by Subject|16|||
164471796|NCT04479787|594100634|FG001|Through 6 Months|Withdrawal by Subject|14|||
164471797|NCT04479787|594100633|FG000|Through 6 Months|Unsuccessful Trial|17|||
164471798|NCT04479787|594100634|FG001|Through 6 Months|Unsuccessful Trial|0|||
164471799|NCT04479787|594100633|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
164471800|NCT04479787|594100634|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
164471801|NCT04479787|594100633|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
164471802|NCT04479787|594100634|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
164471803|NCT04479787|594100633|FG000|Through 6 Months|Lost to Follow-up|3|||
164471804|NCT04479787|594100634|FG001|Through 6 Months|Lost to Follow-up|2|||
164471805|NCT04479787|594100633|FG000|Through 6 Months|Death|3|||
164471806|NCT04479787|594100634|FG001|Through 6 Months|Death|0|||
164471807|NCT04479787|594100633|FG000|Through 6 Months|Inclusion/Exclusion|2|||
164471808|NCT04479787|594100634|FG001|Through 6 Months|Inclusion/Exclusion|1|||
164471809|NCT04479787|594100633|FG000|Through 6 Months|Subject Became Pregnant|1|||
164471810|NCT04479787|594100634|FG001|Through 6 Months|Subject Became Pregnant|1|||
164471811|NCT04479787|594100633|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
164471812|NCT04479787|594100634|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
164471813|NCT04479787|594100633|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
164471814|NCT04479787|594100634|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
164471815|NCT04479787|594100633|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
164471816|NCT04479787|594100634|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
164471817|NCT04479787|594100633|FG000|After 6 Months|Withdrawal by Subject|3|||
164471818|NCT04479787|594100634|FG001|After 6 Months|Withdrawal by Subject|13|||
164471819|NCT04479787|594100633|FG000|After 6 Months|Unsuccessful Trial|0|||
164471820|NCT04479787|594100634|FG001|After 6 Months|Unsuccessful Trial|7|||
164471821|NCT04479787|594100633|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
164471822|NCT04479787|594100634|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
164471823|NCT04479787|594100633|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
164471824|NCT04479787|594100634|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
164471825|NCT04479787|594100633|FG000|After 6 Months|Death|2|||
164471826|NCT04479787|594100634|FG001|After 6 Months|Death|0|||
164471827|NCT04479787|594100633|FG000|After 6 Months|Lost to Follow-up|1|||
164471828|NCT04479787|594100634|FG001|After 6 Months|Lost to Follow-up|1|||
164471829|NCT04479787|594100633|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
164471830|NCT04479787|594100634|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
164471831|NCT04479787|594100633|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
164471832|NCT04479787|594100634|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
164471833|NCT04479787|594100633|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
164471834|NCT04479787|594100634|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
164471835|NCT04479787|594100633|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
164471836|NCT04479787|594100634|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
164471837|NCT03699163|594101174|FG000|Overall Study|Physician Decision|12|||
164471838|NCT03699163|594101175|FG001|Overall Study|Physician Decision|0|||
164471839|NCT03699163|594101174|FG000|Overall Study|failed QC measures|205|||
164471840|NCT03699163|594101175|FG001|Overall Study|failed QC measures|206|||
164471841|NCT00557492|594101178|FG000|Overall Study|Change in health insurance|1|||
164471842|NCT02567435|594101194|FG000|Overall Study|Death|1|||
164471843|NCT02567435|594101195|FG001|Overall Study|Death|1|||
164471844|NCT02567435|594101196|FG002|Overall Study|Death|0|||
164471845|NCT02567435|594101197|FG003|Overall Study|Death|0|||
164471846|NCT02567435|594101194|FG000|Overall Study|Ineligible|1|||
164471847|NCT02567435|594101195|FG001|Overall Study|Ineligible|3|||
164471848|NCT02567435|594101196|FG002|Overall Study|Ineligible|0|||
164471849|NCT02567435|594101197|FG003|Overall Study|Ineligible|0|||
164471850|NCT02567435|594101194|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
164713034|NCT00642278|594972247|FG006|Overall Study|Protocol Violation|2|||
164713035|NCT00642278|594972241|FG000|Overall Study|Withdrawal by Subject|1|||
164713036|NCT00642278|594972242|FG001|Overall Study|Withdrawal by Subject|1|||
164713037|NCT00642278|594972243|FG002|Overall Study|Withdrawal by Subject|1|||
164713038|NCT00642278|594972244|FG003|Overall Study|Withdrawal by Subject|3|||
164713039|NCT00642278|594972245|FG004|Overall Study|Withdrawal by Subject|6|||
164713040|NCT00642278|594972246|FG005|Overall Study|Withdrawal by Subject|2|||
164713041|NCT00642278|594972247|FG006|Overall Study|Withdrawal by Subject|2|||
164713042|NCT00642278|594972241|FG000|Overall Study|Noncompliance with study drug regimen|0|||
164713043|NCT00642278|594972242|FG001|Overall Study|Noncompliance with study drug regimen|0|||
164713044|NCT00642278|594972243|FG002|Overall Study|Noncompliance with study drug regimen|0|||
164713045|NCT00642278|594972244|FG003|Overall Study|Noncompliance with study drug regimen|1|||
164713046|NCT00642278|594972245|FG004|Overall Study|Noncompliance with study drug regimen|0|||
164713047|NCT00642278|594972246|FG005|Overall Study|Noncompliance with study drug regimen|0|||
164713048|NCT00642278|594972247|FG006|Overall Study|Noncompliance with study drug regimen|0|||
164713049|NCT00642278|594972241|FG000|Overall Study|Other|2|||
164713050|NCT00642278|594972242|FG001|Overall Study|Other|1|||
164713051|NCT00642278|594972243|FG002|Overall Study|Other|0|||
164713052|NCT00642278|594972244|FG003|Overall Study|Other|1|||
164713053|NCT00642278|594972245|FG004|Overall Study|Other|0|||
164713054|NCT00642278|594972246|FG005|Overall Study|Other|1|||
164713055|NCT00642278|594972247|FG006|Overall Study|Other|0|||
164713056|NCT03713619|594972248|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
164713057|NCT03713619|594972249|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
164713058|NCT03713619|594972250|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
164713059|NCT03713619|594972251|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
164471851|NCT02567435|594101195|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
164471852|NCT02567435|594101196|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
164471853|NCT02567435|594101197|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
164471854|NCT02166463|594101198|FG000|Overall Study|Lost to Follow-up|0|||
164471855|NCT02166463|594101199|FG001|Overall Study|Lost to Follow-up|1|||
164471856|NCT02166463|594101198|FG000|Overall Study|Physician Decision|10|||
164471857|NCT02166463|594101199|FG001|Overall Study|Physician Decision|10|||
164471858|NCT02166463|594101198|FG000|Overall Study|Ineligible|11|||
164471859|NCT02166463|594101199|FG001|Overall Study|Ineligible|2|||
164471860|NCT02166463|594101198|FG000|Overall Study|Progressive Disease|9|||
164471861|NCT02166463|594101199|FG001|Overall Study|Progressive Disease|6|||
164471862|NCT02166463|594101198|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
164471863|NCT02166463|594101199|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
164471864|NCT02166463|594101198|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
164471865|NCT02166463|594101199|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
164471866|NCT02166463|594101198|FG000|Overall Study|Refusal of further protocol therapy|5|||
164471867|NCT02166463|594101199|FG001|Overall Study|Refusal of further protocol therapy|6|||
164471868|NCT03333915|594101210|FG000|Overall Study|Lost to Follow-up|0|||
164471869|NCT03333915|594101211|FG001|Overall Study|Lost to Follow-up|0|||
164471870|NCT03333915|594101212|FG002|Overall Study|Lost to Follow-up|1|||
164471871|NCT03333915|594101213|FG003|Overall Study|Lost to Follow-up|0|||
164471872|NCT03333915|594101214|FG004|Overall Study|Lost to Follow-up|0|||
164471873|NCT03333915|594101210|FG000|Overall Study|Disease Progression|0|||
164471874|NCT03333915|594101211|FG001|Overall Study|Disease Progression|1|||
164471875|NCT03333915|594101212|FG002|Overall Study|Disease Progression|0|||
164471876|NCT03333915|594101213|FG003|Overall Study|Disease Progression|0|||
164471877|NCT03333915|594101214|FG004|Overall Study|Disease Progression|0|||
164471878|NCT03333915|594101210|FG000|Overall Study|Death|0|||
164471879|NCT03333915|594101211|FG001|Overall Study|Death|0|||
164471880|NCT03333915|594101212|FG002|Overall Study|Death|0|||
164471881|NCT03333915|594101213|FG003|Overall Study|Death|37|||
164471882|NCT03333915|594101214|FG004|Overall Study|Death|18|||
164713060|NCT03713619|594972252|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
164713061|NCT03713619|594972248|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
164713062|NCT03713619|594972249|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
164713063|NCT03713619|594972250|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
164713064|NCT03713619|594972251|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
164471883|NCT03333915|594101210|FG000|Overall Study|Sponsor's Decision|0|||
164471884|NCT03333915|594101211|FG001|Overall Study|Sponsor's Decision|0|||
164471885|NCT03333915|594101212|FG002|Overall Study|Sponsor's Decision|0|||
164471886|NCT03333915|594101213|FG003|Overall Study|Sponsor's Decision|48|||
164471887|NCT03333915|594101214|FG004|Overall Study|Sponsor's Decision|4|||
164713065|NCT03713619|594972252|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
164713066|NCT03713619|594972248|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
164713067|NCT03713619|594972249|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
164713068|NCT03713619|594972250|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
164471888|NCT03333915|594101210|FG000|Overall Study|Withdrawal by Subject|0|||
164471889|NCT03333915|594101211|FG001|Overall Study|Withdrawal by Subject|0|||
164471890|NCT03333915|594101212|FG002|Overall Study|Withdrawal by Subject|0|||
164471891|NCT03333915|594101213|FG003|Overall Study|Withdrawal by Subject|5|||
164471892|NCT03333915|594101214|FG004|Overall Study|Withdrawal by Subject|1|||
164471893|NCT00945724|594101232|FG000|Overall Study|Withdrawal by Subject|2|||
164471894|NCT00945724|594101232|FG000|Overall Study|Physician Decision|1|||
164471895|NCT00945724|594101232|FG000|Overall Study|Adverse Event|5|||
164471896|NCT00945724|594101232|FG000|Overall Study|Second malignancy|1|||
164471897|NCT01964300|594101841|FG000|Overall Study|Ineligible after enrollment|0|||
164471898|NCT01964300|594101842|FG001|Overall Study|Ineligible after enrollment|1|||
164471899|NCT01964300|594101841|FG000|Overall Study|Adverse Event|1|||
164471900|NCT01964300|594101842|FG001|Overall Study|Adverse Event|1|||
164471901|NCT01964300|594101841|FG000|Overall Study|Lack of Efficacy|3|||
164471902|NCT01964300|594101842|FG001|Overall Study|Lack of Efficacy|5|||
164471903|NCT01964300|594101841|FG000|Overall Study|Withdrawal by Subject|0|||
164471904|NCT01964300|594101842|FG001|Overall Study|Withdrawal by Subject|1|||
164471905|NCT01964300|594101841|FG000|Overall Study|To receive alternative therapy|1|||
164471906|NCT01964300|594101842|FG001|Overall Study|To receive alternative therapy|2|||
164471907|NCT01964300|594101841|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
164471908|NCT01964300|594101842|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
164471909|NCT01964300|594101841|FG000|Overall Study|Weight criteria not met|0|||
164471910|NCT01964300|594101842|FG001|Overall Study|Weight criteria not met|1|||
164471911|NCT03653364|594101844|FG000|Overall Study|Withdrawal by Subject|1|||
164471912|NCT03653364|594101844|FG000|Overall Study|Enrolled in Error|1|||
164471913|NCT03653364|594101844|FG000|Overall Study|Death|1|||
164471914|NCT03286114|594101847|FG000|Overall Study|Adverse Event|6|||
164471915|NCT03286114|594101847|FG000|Overall Study|Death|3|||
164471916|NCT03983382|594101850|FG000|Overall Study|Death|1|||
164471917|NCT03983382|594101850|FG000|Overall Study|Lost to Follow-up|3|||
164471918|NCT03983382|594101850|FG000|Overall Study|Physician Decision|2|||
164471919|NCT03983382|594101850|FG000|Overall Study|Withdrawal by Subject|10|||
164471920|NCT03983382|594101850|FG000|Overall Study|Change in cancer treatment|2|||
164471921|NCT03767335|594101852|FG000|Overall Study|Physician Decision|1|||
164471922|NCT03767335|594101853|FG001|Overall Study|Physician Decision|1|||
164471923|NCT03767335|594101854|FG002|Overall Study|Physician Decision|0|||
164471924|NCT03767335|594101852|FG000|Overall Study|Withdrawal by Subject|0|||
164471925|NCT03767335|594101853|FG001|Overall Study|Withdrawal by Subject|0|||
164471926|NCT03767335|594101854|FG002|Overall Study|Withdrawal by Subject|6|||
164471927|NCT03767335|594101852|FG000|Overall Study|Participant excluded from efficacy population|0|||
164471928|NCT03767335|594101853|FG001|Overall Study|Participant excluded from efficacy population|0|||
164471929|NCT03767335|594101854|FG002|Overall Study|Participant excluded from efficacy population|1|||
164471930|NCT03767335|594101852|FG000|Overall Study|Death|0|||
164471931|NCT03767335|594101853|FG001|Overall Study|Death|0|||
164471932|NCT03767335|594101854|FG002|Overall Study|Death|2|||
164471933|NCT03767335|594101852|FG000|Overall Study|Progressive Disease|2|||
164471934|NCT03767335|594101853|FG001|Overall Study|Progressive Disease|2|||
164471935|NCT03767335|594101854|FG002|Overall Study|Progressive Disease|2|||
164471936|NCT03767335|594101852|FG000|Overall Study|Disease progression needing additional medication|0|||
164471937|NCT03767335|594101853|FG001|Overall Study|Disease progression needing additional medication|0|||
164471938|NCT03767335|594101854|FG002|Overall Study|Disease progression needing additional medication|17|||
164471939|NCT03767335|594101852|FG000|Overall Study|Sponsor decision|0|||
164471940|NCT03767335|594101853|FG001|Overall Study|Sponsor decision|0|||
164471941|NCT03767335|594101854|FG002|Overall Study|Sponsor decision|2|||
164471942|NCT03767335|594101852|FG000|Overall Study|Other Medical Reasons|0|||
164471943|NCT03767335|594101853|FG001|Overall Study|Other Medical Reasons|0|||
164471944|NCT03767335|594101854|FG002|Overall Study|Other Medical Reasons|3|||
164471945|NCT03705390|594101855|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
164471946|NCT03705390|594101855|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
164471947|NCT03047213|594101856|FG000|Overall Study|Withdrawal by Subject|2|||
164471948|NCT03047213|594101857|FG001|Overall Study|Withdrawal by Subject|0|||
164471949|NCT03047213|594101856|FG000|Overall Study|Adverse Event|2|||
164471950|NCT03047213|594101857|FG001|Overall Study|Adverse Event|0|||
164713069|NCT03713619|594972251|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
164713070|NCT03713619|594972252|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
164471951|NCT03725332|594101863|FG000|Overall Study|Adverse Event|5|||
164471952|NCT03725332|594101864|FG001|Overall Study|Adverse Event|10|||
164471953|NCT03725332|594101863|FG000|Overall Study|Death|1|||
164471954|NCT03725332|594101864|FG001|Overall Study|Death|3|||
164713071|NCT03713619|594972248|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
164471955|NCT03725332|594101863|FG000|Overall Study|Lost to Follow-up|43|||
164471956|NCT03725332|594101864|FG001|Overall Study|Lost to Follow-up|122|||
164471957|NCT03725332|594101863|FG000|Overall Study|Withdrawal by Subject|0|||
164471958|NCT03725332|594101864|FG001|Overall Study|Withdrawal by Subject|1|||
164471959|NCT03725332|594101863|FG000|Overall Study|Duplicate enrollment|0|||
164471960|NCT03725332|594101864|FG001|Overall Study|Duplicate enrollment|1|||
164471961|NCT03725332|594101863|FG000|Overall Study|Did not consent|0|||
164471962|NCT03725332|594101864|FG001|Overall Study|Did not consent|1|||
164471963|NCT02726386|594101871|FG000|Overall Study|Adverse Event|17|||
164471964|NCT02726386|594101872|FG001|Overall Study|Adverse Event|20|||
164471965|NCT02726386|594101871|FG000|Overall Study|Withdrawal by Subject|14|||
164471966|NCT02726386|594101872|FG001|Overall Study|Withdrawal by Subject|28|||
164471967|NCT02726386|594101871|FG000|Overall Study|Other reasons|7|||
164471968|NCT02726386|594101872|FG001|Overall Study|Other reasons|8|||
164471969|NCT02754596|594101873|FG000|Overall Study|Withdrawal by Subject|3|||
164471970|NCT02754596|594101874|FG001|Overall Study|Withdrawal by Subject|4|||
164471971|NCT02754596|594101875|FG002|Overall Study|Withdrawal by Subject|0|||
164471972|NCT02754596|594101873|FG000|Overall Study|Physician Decision|1|||
164471973|NCT02754596|594101874|FG001|Overall Study|Physician Decision|1|||
164471974|NCT02754596|594101875|FG002|Overall Study|Physician Decision|1|||
164471975|NCT02754596|594101873|FG000|Overall Study|Lost to Follow-up|1|||
164471976|NCT02754596|594101874|FG001|Overall Study|Lost to Follow-up|1|||
164471977|NCT02754596|594101875|FG002|Overall Study|Lost to Follow-up|2|||
164471978|NCT02754596|594101873|FG000|Overall Study|Death|0|||
164471979|NCT02754596|594101874|FG001|Overall Study|Death|2|||
164471980|NCT02754596|594101875|FG002|Overall Study|Death|0|||
164471981|NCT02754596|594101873|FG000|Overall Study|Adverse Event|1|||
164471982|NCT02754596|594101874|FG001|Overall Study|Adverse Event|0|||
164471983|NCT02754596|594101875|FG002|Overall Study|Adverse Event|1|||
164471984|NCT02754596|594101873|FG000|Overall Study|Other|1|||
164471985|NCT02754596|594101874|FG001|Overall Study|Other|0|||
164471986|NCT02754596|594101875|FG002|Overall Study|Other|0|||
164471987|NCT02101853|594101880|FG000|Block 1 Induction|Adverse Event|11|||
164471988|NCT02101853|594101881|FG001|Block 1 Induction|Adverse Event|0|||
164471989|NCT02101853|594101882|FG002|Block 1 Induction|Adverse Event|0|||
164471990|NCT02101853|594101883|FG003|Block 1 Induction|Adverse Event|0|||
164471991|NCT02101853|594101884|FG004|Block 1 Induction|Adverse Event|0|||
164471992|NCT02101853|594101885|FG005|Block 1 Induction|Adverse Event|0|||
164471993|NCT02101853|594101880|FG000|Block 1 Induction|Death|20|||
164471994|NCT02101853|594101881|FG001|Block 1 Induction|Death|0|||
164471995|NCT02101853|594101882|FG002|Block 1 Induction|Death|0|||
164471996|NCT02101853|594101883|FG003|Block 1 Induction|Death|0|||
164471997|NCT02101853|594101884|FG004|Block 1 Induction|Death|0|||
164471998|NCT02101853|594101885|FG005|Block 1 Induction|Death|0|||
164471999|NCT02101853|594101880|FG000|Block 1 Induction|Lack of Efficacy|6|||
164472000|NCT02101853|594101881|FG001|Block 1 Induction|Lack of Efficacy|0|||
164472001|NCT02101853|594101882|FG002|Block 1 Induction|Lack of Efficacy|0|||
164472002|NCT02101853|594101883|FG003|Block 1 Induction|Lack of Efficacy|0|||
164472003|NCT02101853|594101884|FG004|Block 1 Induction|Lack of Efficacy|0|||
164472004|NCT02101853|594101885|FG005|Block 1 Induction|Lack of Efficacy|0|||
164472005|NCT02101853|594101880|FG000|Block 1 Induction|Physician Decision|61|||
164472006|NCT02101853|594101881|FG001|Block 1 Induction|Physician Decision|0|||
164472007|NCT02101853|594101882|FG002|Block 1 Induction|Physician Decision|0|||
164472008|NCT02101853|594101883|FG003|Block 1 Induction|Physician Decision|0|||
164472009|NCT02101853|594101884|FG004|Block 1 Induction|Physician Decision|0|||
164472010|NCT02101853|594101885|FG005|Block 1 Induction|Physician Decision|0|||
164472011|NCT02101853|594101880|FG000|Block 1 Induction|Protocol Violation|2|||
164472012|NCT02101853|594101881|FG001|Block 1 Induction|Protocol Violation|0|||
164472013|NCT02101853|594101882|FG002|Block 1 Induction|Protocol Violation|0|||
164472014|NCT02101853|594101883|FG003|Block 1 Induction|Protocol Violation|0|||
164472015|NCT02101853|594101884|FG004|Block 1 Induction|Protocol Violation|0|||
164472016|NCT02101853|594101885|FG005|Block 1 Induction|Protocol Violation|0|||
164472017|NCT02101853|594101880|FG000|Block 1 Induction|Withdrawal by Subject|65|||
164472018|NCT02101853|594101881|FG001|Block 1 Induction|Withdrawal by Subject|0|||
164472019|NCT02101853|594101882|FG002|Block 1 Induction|Withdrawal by Subject|0|||
164472020|NCT02101853|594101883|FG003|Block 1 Induction|Withdrawal by Subject|0|||
164472021|NCT02101853|594101884|FG004|Block 1 Induction|Withdrawal by Subject|0|||
164472022|NCT02101853|594101885|FG005|Block 1 Induction|Withdrawal by Subject|0|||
164472023|NCT02101853|594101880|FG000|Block 1 Induction|Ineligible|8|||
164472024|NCT02101853|594101881|FG001|Block 1 Induction|Ineligible|0|||
164472025|NCT02101853|594101882|FG002|Block 1 Induction|Ineligible|0|||
164472026|NCT02101853|594101883|FG003|Block 1 Induction|Ineligible|0|||
164472027|NCT02101853|594101884|FG004|Block 1 Induction|Ineligible|0|||
164472028|NCT02101853|594101885|FG005|Block 1 Induction|Ineligible|0|||
164472029|NCT02101853|594101880|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
164472030|NCT02101853|594101881|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
164472031|NCT02101853|594101882|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
164472032|NCT02101853|594101883|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
164472033|NCT02101853|594101884|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
164472034|NCT02101853|594101885|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
164472035|NCT02101853|594101880|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
164713072|NCT03713619|594972249|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
164713073|NCT03713619|594972250|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
164713074|NCT03713619|594972251|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
164713075|NCT03713619|594972252|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
164713076|NCT03713619|594972248|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
164713077|NCT03713619|594972249|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
164713078|NCT03713619|594972250|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
164713079|NCT03713619|594972251|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
164713080|NCT03713619|594972252|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
164713081|NCT03713619|594972248|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
164713082|NCT03713619|594972249|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
164713083|NCT03713619|594972250|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
164713084|NCT03713619|594972251|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
164713085|NCT03713619|594972252|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
164713086|NCT03713619|594972248|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
164713087|NCT03713619|594972249|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
164713088|NCT03713619|594972250|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
164713089|NCT03713619|594972251|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
164713090|NCT03713619|594972252|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
164713091|NCT03713619|594972248|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
164713092|NCT03713619|594972249|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
164472036|NCT02101853|594101881|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
164472037|NCT02101853|594101882|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
164472038|NCT02101853|594101883|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
164472039|NCT02101853|594101884|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
164472040|NCT02101853|594101885|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
164472041|NCT02101853|594101880|FG000|Post Induction Randomization|Adverse Event|0|||
164472042|NCT02101853|594101881|FG001|Post Induction Randomization|Adverse Event|3|||
164472043|NCT02101853|594101882|FG002|Post Induction Randomization|Adverse Event|8|||
164472044|NCT02101853|594101883|FG003|Post Induction Randomization|Adverse Event|4|||
164472045|NCT02101853|594101884|FG004|Post Induction Randomization|Adverse Event|4|||
164472046|NCT02101853|594101885|FG005|Post Induction Randomization|Adverse Event|0|||
164472047|NCT02101853|594101880|FG000|Post Induction Randomization|Death|0|||
164472048|NCT02101853|594101881|FG001|Post Induction Randomization|Death|9|||
164472049|NCT02101853|594101882|FG002|Post Induction Randomization|Death|2|||
164472050|NCT02101853|594101883|FG003|Post Induction Randomization|Death|2|||
164472051|NCT02101853|594101884|FG004|Post Induction Randomization|Death|0|||
164472052|NCT02101853|594101885|FG005|Post Induction Randomization|Death|0|||
164472053|NCT02101853|594101880|FG000|Post Induction Randomization|Lack of Efficacy|0|||
164472054|NCT02101853|594101881|FG001|Post Induction Randomization|Lack of Efficacy|14|||
164472055|NCT02101853|594101882|FG002|Post Induction Randomization|Lack of Efficacy|23|||
164472056|NCT02101853|594101883|FG003|Post Induction Randomization|Lack of Efficacy|18|||
164472057|NCT02101853|594101884|FG004|Post Induction Randomization|Lack of Efficacy|21|||
164472058|NCT02101853|594101885|FG005|Post Induction Randomization|Lack of Efficacy|0|||
164472059|NCT02101853|594101880|FG000|Post Induction Randomization|Physician Decision|0|||
164472060|NCT02101853|594101881|FG001|Post Induction Randomization|Physician Decision|43|||
164472061|NCT02101853|594101882|FG002|Post Induction Randomization|Physician Decision|23|||
164472062|NCT02101853|594101883|FG003|Post Induction Randomization|Physician Decision|14|||
164472063|NCT02101853|594101884|FG004|Post Induction Randomization|Physician Decision|14|||
164472064|NCT02101853|594101885|FG005|Post Induction Randomization|Physician Decision|0|||
164472065|NCT02101853|594101880|FG000|Post Induction Randomization|Protocol Violation|0|||
164472066|NCT02101853|594101881|FG001|Post Induction Randomization|Protocol Violation|3|||
164472067|NCT02101853|594101882|FG002|Post Induction Randomization|Protocol Violation|0|||
164472068|NCT02101853|594101883|FG003|Post Induction Randomization|Protocol Violation|0|||
164472069|NCT02101853|594101884|FG004|Post Induction Randomization|Protocol Violation|0|||
164472070|NCT02101853|594101885|FG005|Post Induction Randomization|Protocol Violation|0|||
164472071|NCT02101853|594101880|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
164472072|NCT02101853|594101881|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
164472073|NCT02101853|594101882|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
164472074|NCT02101853|594101883|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
164472075|NCT02101853|594101884|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
164472076|NCT02101853|594101885|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
164472077|NCT02101853|594101880|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
164472078|NCT02101853|594101881|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
164472079|NCT02101853|594101882|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
164472080|NCT02101853|594101883|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
164472081|NCT02101853|594101884|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
164472082|NCT02101853|594101885|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
164472083|NCT02101853|594101880|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
164472084|NCT02101853|594101881|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
164472085|NCT02101853|594101882|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
164472086|NCT02101853|594101883|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
164472087|NCT02101853|594101884|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
164472088|NCT02101853|594101885|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
164472089|NCT02101853|594101880|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
164472090|NCT02101853|594101881|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
164472091|NCT02101853|594101882|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
164472092|NCT02101853|594101883|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
164472093|NCT02101853|594101884|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
164472094|NCT02101853|594101885|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
164472095|NCT02101853|594101880|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
164472096|NCT02101853|594101881|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
164472097|NCT02101853|594101882|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
164472098|NCT02101853|594101883|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
164472099|NCT02101853|594101884|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
164472100|NCT02101853|594101885|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
164472101|NCT02101853|594101880|FG000|Blinatumomab Salvage Therapy|Death|0|||
164472102|NCT02101853|594101881|FG001|Blinatumomab Salvage Therapy|Death|0|||
164472103|NCT02101853|594101882|FG002|Blinatumomab Salvage Therapy|Death|0|||
164472104|NCT02101853|594101883|FG003|Blinatumomab Salvage Therapy|Death|0|||
164472105|NCT02101853|594101884|FG004|Blinatumomab Salvage Therapy|Death|0|||
164472106|NCT02101853|594101885|FG005|Blinatumomab Salvage Therapy|Death|2|||
164472107|NCT02101853|594101880|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
164472108|NCT02101853|594101881|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
164472109|NCT02101853|594101882|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
164472110|NCT02101853|594101883|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
164472111|NCT02101853|594101884|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
164472112|NCT02101853|594101885|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
164472113|NCT02101853|594101880|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
164472114|NCT02101853|594101881|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
164472115|NCT02101853|594101882|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
164472116|NCT02101853|594101883|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
164472117|NCT02101853|594101884|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
164472118|NCT02101853|594101885|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
164472119|NCT02101853|594101880|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
164472120|NCT02101853|594101881|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
164472121|NCT02101853|594101882|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
164472122|NCT02101853|594101883|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
164472123|NCT02101853|594101884|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
164472124|NCT02101853|594101885|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
164472125|NCT02112916|594101886|FG000|Overall Study|Adverse Event|6|||
164472126|NCT02112916|594101887|FG001|Overall Study|Adverse Event|9|||
164472127|NCT02112916|594101888|FG002|Overall Study|Adverse Event|3|||
164472128|NCT02112916|594101889|FG003|Overall Study|Adverse Event|2|||
164472129|NCT02112916|594101886|FG000|Overall Study|Death|9|||
164472130|NCT02112916|594101887|FG001|Overall Study|Death|9|||
164472131|NCT02112916|594101888|FG002|Overall Study|Death|3|||
164472132|NCT02112916|594101889|FG003|Overall Study|Death|4|||
164472133|NCT02112916|594101886|FG000|Overall Study|Lost to Follow-up|1|||
164472134|NCT02112916|594101887|FG001|Overall Study|Lost to Follow-up|0|||
164472135|NCT02112916|594101888|FG002|Overall Study|Lost to Follow-up|0|||
164472136|NCT02112916|594101889|FG003|Overall Study|Lost to Follow-up|0|||
164472137|NCT02112916|594101886|FG000|Overall Study|Physician Decision|94|||
164472138|NCT02112916|594101887|FG001|Overall Study|Physician Decision|72|||
164472139|NCT02112916|594101888|FG002|Overall Study|Physician Decision|24|||
164472140|NCT02112916|594101889|FG003|Overall Study|Physician Decision|15|||
164472141|NCT02112916|594101886|FG000|Overall Study|Withdrawal by Subject|5|||
164472142|NCT02112916|594101887|FG001|Overall Study|Withdrawal by Subject|3|||
164472143|NCT02112916|594101888|FG002|Overall Study|Withdrawal by Subject|1|||
164472144|NCT02112916|594101889|FG003|Overall Study|Withdrawal by Subject|1|||
164713093|NCT03713619|594972250|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
164472145|NCT02112916|594101886|FG000|Overall Study|Ineligible|4|||
164472146|NCT02112916|594101887|FG001|Overall Study|Ineligible|8|||
164713094|NCT03713619|594972251|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
164713095|NCT03713619|594972252|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
164713096|NCT03713619|594972248|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
164713097|NCT03713619|594972249|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
164713098|NCT03713619|594972250|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
164713099|NCT03713619|594972251|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
164713100|NCT03713619|594972252|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
164713101|NCT03713619|594972248|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
164713102|NCT03713619|594972249|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
164713103|NCT03713619|594972250|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
164713104|NCT03713619|594972251|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
164713105|NCT03713619|594972252|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
164713106|NCT03713619|594972248|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
164713107|NCT03713619|594972249|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
164713108|NCT03713619|594972250|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
164713109|NCT03713619|594972251|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
164713110|NCT03713619|594972252|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
164713111|NCT03713619|594972248|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
164713112|NCT03713619|594972249|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
164713113|NCT03713619|594972250|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
164713114|NCT03713619|594972251|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
164713115|NCT03713619|594972252|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
164713116|NCT03713619|594972248|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
164713117|NCT03713619|594972249|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
164713118|NCT03713619|594972250|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
164713119|NCT03713619|594972251|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
164713120|NCT03713619|594972252|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
164713121|NCT03553576|594972253|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
164713122|NCT03553576|594972254|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
164713123|NCT03553576|594972253|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
164713124|NCT03553576|594972254|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
164713125|NCT03553576|594972253|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
164713126|NCT03553576|594972254|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
164713127|NCT03553576|594972253|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
164713128|NCT03553576|594972254|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
164472147|NCT02112916|594101888|FG002|Overall Study|Ineligible|3|||
164472148|NCT02112916|594101889|FG003|Overall Study|Ineligible|8|||
164472149|NCT02112916|594101886|FG000|Overall Study|Inevaluable|6|||
164472150|NCT02112916|594101887|FG001|Overall Study|Inevaluable|4|||
164472151|NCT02112916|594101888|FG002|Overall Study|Inevaluable|5|||
164472152|NCT02112916|594101889|FG003|Overall Study|Inevaluable|5|||
164472153|NCT02112916|594101886|FG000|Overall Study|Refusal of further protocol therapy|19|||
164472154|NCT02112916|594101887|FG001|Overall Study|Refusal of further protocol therapy|16|||
164472155|NCT02112916|594101888|FG002|Overall Study|Refusal of further protocol therapy|1|||
164472156|NCT02112916|594101889|FG003|Overall Study|Refusal of further protocol therapy|7|||
164472157|NCT02112916|594101886|FG000|Overall Study|Development of SMN|1|||
164472158|NCT02112916|594101887|FG001|Overall Study|Development of SMN|0|||
164472159|NCT02112916|594101888|FG002|Overall Study|Development of SMN|0|||
164472160|NCT02112916|594101889|FG003|Overall Study|Development of SMN|1|||
164472161|NCT02112916|594101886|FG000|Overall Study|Relapse/Progression|10|||
164472162|NCT02112916|594101887|FG001|Overall Study|Relapse/Progression|18|||
164472163|NCT02112916|594101888|FG002|Overall Study|Relapse/Progression|15|||
164472164|NCT02112916|594101889|FG003|Overall Study|Relapse/Progression|2|||
164472165|NCT02112916|594101886|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
164472166|NCT02112916|594101887|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
164472167|NCT02112916|594101888|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
164472168|NCT02112916|594101889|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
164472169|NCT02112916|594101886|FG000|Overall Study|Still on Therapy|44|||
164472170|NCT02112916|594101887|FG001|Overall Study|Still on Therapy|47|||
164472171|NCT02112916|594101888|FG002|Overall Study|Still on Therapy|3|||
164472172|NCT02112916|594101889|FG003|Overall Study|Still on Therapy|2|||
164472173|NCT02112916|594101886|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
164472174|NCT02112916|594101887|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
164472175|NCT02112916|594101888|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
164472176|NCT02112916|594101889|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
164472177|NCT02112916|594101886|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
164472178|NCT02112916|594101887|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
164472179|NCT02112916|594101888|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
164472180|NCT02112916|594101889|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
164472181|NCT04018495|594101894|FG000|Overall Study|Physician Decision|1|||
164472182|NCT03782116|594101895|FG000|Completed Intervetion|Lost to Follow-up|11|||
164472183|NCT03782116|594101896|FG001|Completed Intervetion|Lost to Follow-up|7|||
164472184|NCT03782116|594101895|FG000|Completed Intervetion|Withdrawal by Subject|6|||
164472185|NCT03782116|594101896|FG001|Completed Intervetion|Withdrawal by Subject|5|||
164472186|NCT03782116|594101895|FG000|Included in Analysis|Protocol Violation|5|||
164472187|NCT03782116|594101896|FG001|Included in Analysis|Protocol Violation|5|||
164472188|NCT04908514|594101899|FG000|Overall Study|Lost to Follow-up|2|||
164472189|NCT04908514|594101899|FG000|Overall Study|Withdrawal by Subject|1|||
164472190|NCT02890355|594101906|FG000|Overall Study|Adverse Event|5|||
164472191|NCT02890355|594101907|FG001|Overall Study|Adverse Event|5|||
164472192|NCT02890355|594101906|FG000|Overall Study|Refusal unrelated to adverse event|5|||
164472193|NCT02890355|594101907|FG001|Overall Study|Refusal unrelated to adverse event|10|||
164472194|NCT02890355|594101906|FG000|Overall Study|Progression/relapse|46|||
164472195|NCT02890355|594101907|FG001|Overall Study|Progression/relapse|39|||
164472196|NCT02890355|594101906|FG000|Overall Study|Not protocol specified|3|||
164472197|NCT02890355|594101907|FG001|Overall Study|Not protocol specified|4|||
164472198|NCT02206828|594101908|FG000|Overall Study|Lost to Follow-up|7|||
164472199|NCT05039021|594102841|FG000|Overall Study|Death|1|||
164713129|NCT03553576|594972253|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
164713130|NCT03553576|594972254|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
164713131|NCT03553576|594972253|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
164472200|NCT05039021|594102841|FG000|Overall Study|Lost to Follow-up|3|||
164472201|NCT00994643|594102842|FG000|Overall Study|Withdrawal by Subject|1|||
164472202|NCT02566889|594102843|FG000|Overall Study|Withdrawal by Subject|3|||
164472203|NCT02566889|594102844|FG001|Overall Study|Withdrawal by Subject|1|||
164472204|NCT02566889|594102843|FG000|Overall Study|Adverse Event|4|||
164472205|NCT02566889|594102844|FG001|Overall Study|Adverse Event|2|||
164472206|NCT02566889|594102843|FG000|Overall Study|Other|6|||
164472207|NCT02566889|594102844|FG001|Overall Study|Other|2|||
164472208|NCT03391466|594102846|FG000|Overall Study|Death|84|||
164472209|NCT03391466|594102847|FG001|Overall Study|Death|91|||
164472210|NCT03391466|594102846|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|80|||
164472211|NCT03391466|594102847|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|0|||
164472212|NCT03391466|594102846|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
164472213|NCT03391466|594102847|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|13|||
164472214|NCT03391466|594102846|FG000|Overall Study|Lost to Follow-up|9|||
164472215|NCT03391466|594102847|FG001|Overall Study|Lost to Follow-up|5|||
164472216|NCT03391466|594102846|FG000|Overall Study|Reason Not Specified|2|||
164472217|NCT03391466|594102847|FG001|Overall Study|Reason Not Specified|2|||
164472218|NCT03391466|594102846|FG000|Overall Study|Investigator Decision|0|||
164472219|NCT03391466|594102847|FG001|Overall Study|Investigator Decision|1|||
164472220|NCT03140670|594102848|FG000|Overall Study|Withdrawal by Subject|2|||
164472221|NCT03140670|594102848|FG000|Overall Study|Lost to Follow-up|1|||
164472222|NCT03140670|594102848|FG000|Overall Study|Physician Decision|1|||
164472223|NCT00220805|594102849|FG000|Overall Study|Adverse Event|1|||
164472224|NCT00220805|594102850|FG001|Overall Study|Adverse Event|3|||
164472225|NCT00220805|594102849|FG000|Overall Study|Withdrawal by Subject|3|||
164472226|NCT00220805|594102850|FG001|Overall Study|Withdrawal by Subject|0|||
164472227|NCT00220805|594102849|FG000|Overall Study|Lack of Efficacy|1|||
164472228|NCT00220805|594102850|FG001|Overall Study|Lack of Efficacy|0|||
164472229|NCT00220805|594102849|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
164472230|NCT00220805|594102850|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
164472231|NCT02325466|594102851|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
164472232|NCT02325466|594102852|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
164472233|NCT02325466|594102853|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
164472234|NCT02325466|594102851|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
164472235|NCT02325466|594102852|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
164472236|NCT02325466|594102853|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
164472237|NCT02325466|594102851|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
164472238|NCT02325466|594102852|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
164472239|NCT02325466|594102853|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
164472240|NCT02325466|594102851|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
164472241|NCT02325466|594102852|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
164472242|NCT02325466|594102853|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
164472243|NCT02325466|594102851|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
164472244|NCT02325466|594102852|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
164472245|NCT02325466|594102853|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
164472246|NCT02325466|594102851|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
164472247|NCT02325466|594102852|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
164472248|NCT02325466|594102853|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
164472249|NCT02325466|594102851|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
164472250|NCT02325466|594102852|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
164472251|NCT02325466|594102853|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
164472252|NCT02325466|594102851|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
164472253|NCT02325466|594102852|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
164472254|NCT02325466|594102853|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
164472255|NCT02325466|594102851|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
164472256|NCT02325466|594102852|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
164472257|NCT02325466|594102853|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
164472258|NCT00692913|594102865|FG000|Overall Study|Adverse Event|8|||
164472259|NCT00692913|594102866|FG001|Overall Study|Adverse Event|4|||
164472260|NCT00692913|594102865|FG000|Overall Study|Lost to Follow-up|3|||
164472261|NCT00692913|594102866|FG001|Overall Study|Lost to Follow-up|5|||
164472262|NCT00692913|594102865|FG000|Overall Study|Physician Decision|2|||
164472263|NCT00692913|594102866|FG001|Overall Study|Physician Decision|0|||
164472264|NCT00692913|594102865|FG000|Overall Study|Protocol Violation|1|||
164472265|NCT00692913|594102866|FG001|Overall Study|Protocol Violation|1|||
164472266|NCT00692913|594102865|FG000|Overall Study|Withdrawal by Subject|15|||
164472267|NCT00692913|594102866|FG001|Overall Study|Withdrawal by Subject|20|||
164713132|NCT03553576|594972254|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
164472268|NCT01637402|594102867|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
164472269|NCT01637402|594102868|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
164472270|NCT01637402|594102867|FG000|Standard Dose Regimen|Adverse Event|1|||
164472271|NCT01637402|594102868|FG001|Standard Dose Regimen|Adverse Event|0|||
164472272|NCT01637402|594102867|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
164472273|NCT01637402|594102868|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
164472274|NCT01637402|594102867|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
164472275|NCT01637402|594102868|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
164472276|NCT01637402|594102867|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
164472277|NCT01637402|594102868|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
164472278|NCT01637402|594102867|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
164472279|NCT01637402|594102868|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
164472280|NCT02285270|594102871|FG000|Overall Study|Lost to Follow-up|1|||
164472281|NCT02285270|594102871|FG000|Overall Study|Physician Decision|3|||
164472282|NCT02285270|594102871|FG000|Overall Study|Determined to be ineligible|1|||
164472283|NCT02111096|594102872|FG000|Overall Study|Adverse Event|4|||
164713133|NCT03553576|594972253|FG000|Overall Study|Physician Decision|2|||
164713134|NCT03553576|594972254|FG001|Overall Study|Physician Decision|5|||
164713135|NCT02552212|594972255|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
164713136|NCT02552212|594972256|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
164713137|NCT02552212|594972257|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
164713138|NCT02552212|594972255|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
164713139|NCT02552212|594972256|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
164713140|NCT02552212|594972257|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
164713141|NCT02552212|594972255|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
164713142|NCT02552212|594972256|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
164713143|NCT02552212|594972257|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
164713144|NCT02552212|594972255|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
164713145|NCT02552212|594972256|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
164713146|NCT02552212|594972257|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
164713147|NCT02552212|594972255|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
164713148|NCT02552212|594972256|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
164713149|NCT02552212|594972257|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
164713150|NCT02552212|594972255|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
164713151|NCT02552212|594972256|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
164713152|NCT02552212|594972257|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
164713153|NCT02552212|594972255|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
164713154|NCT02552212|594972256|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
164713155|NCT02552212|594972257|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
164472284|NCT02111096|594102873|FG001|Overall Study|Adverse Event|1|||
164472285|NCT02111096|594102874|FG002|Overall Study|Adverse Event|2|||
164472286|NCT02111096|594102872|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164472287|NCT02111096|594102873|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164472288|NCT02111096|594102874|FG002|Overall Study|Non-Compliance with Study Drug|0|||
164472289|NCT02111096|594102872|FG000|Overall Study|Lost to Follow Up|1|||
164472290|NCT02111096|594102873|FG001|Overall Study|Lost to Follow Up|1|||
164472291|NCT02111096|594102874|FG002|Overall Study|Lost to Follow Up|1|||
164472292|NCT02111096|594102872|FG000|Overall Study|Physician Decision|0|||
164472293|NCT02111096|594102873|FG001|Overall Study|Physician Decision|1|||
164472294|NCT02111096|594102874|FG002|Overall Study|Physician Decision|0|||
164472295|NCT02111096|594102872|FG000|Overall Study|Protocol Violation|1|||
164472296|NCT02111096|594102873|FG001|Overall Study|Protocol Violation|0|||
164472297|NCT02111096|594102874|FG002|Overall Study|Protocol Violation|1|||
164472298|NCT02111096|594102872|FG000|Overall Study|Terminated by Sponsor|53|||
164472299|NCT02111096|594102873|FG001|Overall Study|Terminated by Sponsor|35|||
164472300|NCT02111096|594102874|FG002|Overall Study|Terminated by Sponsor|54|||
164472301|NCT02111096|594102872|FG000|Overall Study|Withdrawal by Subject|4|||
164472302|NCT02111096|594102873|FG001|Overall Study|Withdrawal by Subject|2|||
164472303|NCT02111096|594102874|FG002|Overall Study|Withdrawal by Subject|8|||
164472304|NCT00439270|594102877|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
164472305|NCT00439270|594102878|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
164472306|NCT00439270|594102879|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
164472307|NCT00439270|594102880|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
164472308|NCT00439270|594102881|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
164472309|NCT00439270|594102877|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
164472310|NCT00439270|594102878|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
164472311|NCT00439270|594102879|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
164472312|NCT00439270|594102880|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
164472313|NCT00439270|594102881|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
164472314|NCT00439270|594102877|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
164472315|NCT00439270|594102878|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
164472316|NCT00439270|594102879|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
164472317|NCT00439270|594102880|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
164472318|NCT00439270|594102881|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
164472319|NCT00439270|594102877|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
164472320|NCT00439270|594102878|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
164472321|NCT00439270|594102879|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
164472322|NCT00439270|594102880|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
164472323|NCT00439270|594102881|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
164472324|NCT00439270|594102877|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
164472325|NCT00439270|594102878|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
164472326|NCT00439270|594102879|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
164472327|NCT00439270|594102880|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
164472328|NCT00439270|594102881|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
164472329|NCT00439270|594102877|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
164472330|NCT00439270|594102878|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
164472331|NCT00439270|594102879|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
164472332|NCT00439270|594102880|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
164472333|NCT00439270|594102881|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
164472334|NCT00439270|594102877|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
164472335|NCT00439270|594102878|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
164472336|NCT00439270|594102879|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
164472337|NCT00439270|594102880|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
164472338|NCT00439270|594102881|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
164472339|NCT00439270|594102877|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
164472340|NCT00439270|594102878|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
164472341|NCT00439270|594102879|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
164472342|NCT00439270|594102880|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
164472343|NCT00439270|594102881|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
164472344|NCT00439270|594102877|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
164472345|NCT00439270|594102878|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
164472346|NCT00439270|594102879|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
164472347|NCT00439270|594102880|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
164472348|NCT00439270|594102881|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
164472349|NCT00439270|594102877|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
164472350|NCT00439270|594102878|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
164472351|NCT00439270|594102879|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
164472352|NCT00439270|594102880|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
164472353|NCT00439270|594102881|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
164472354|NCT01268306|594102882|FG000|Overall Study|Lost to Follow-up|1|||
164472355|NCT04121546|594102883|FG000|Overall Study|Lost to Follow-up|1|||
164472356|NCT04121546|594102884|FG001|Overall Study|Lost to Follow-up|3|||
164472357|NCT04129164|594102885|FG000|Overall Study|Non-compliance with procedures|0|||
164472358|NCT04129164|594102886|FG001|Overall Study|Non-compliance with procedures|0|||
164472359|NCT04129164|594102887|FG002|Overall Study|Non-compliance with procedures|2|||
164472360|NCT04129164|594102888|FG003|Overall Study|Non-compliance with procedures|0|||
164472361|NCT04129164|594102885|FG000|Overall Study|Adverse Event|0|||
164472362|NCT04129164|594102886|FG001|Overall Study|Adverse Event|0|||
164472363|NCT04129164|594102887|FG002|Overall Study|Adverse Event|2|||
164472364|NCT04129164|594102888|FG003|Overall Study|Adverse Event|0|||
164472365|NCT04129164|594102885|FG000|Overall Study|Pregnancy|0|||
164472366|NCT04129164|594102886|FG001|Overall Study|Pregnancy|0|||
164472367|NCT04129164|594102887|FG002|Overall Study|Pregnancy|0|||
164472368|NCT04129164|594102888|FG003|Overall Study|Pregnancy|1|||
164472369|NCT04129164|594102885|FG000|Overall Study|Withdrawal by Subject|3|||
164472370|NCT04129164|594102886|FG001|Overall Study|Withdrawal by Subject|2|||
164472371|NCT04129164|594102887|FG002|Overall Study|Withdrawal by Subject|4|||
164472372|NCT04129164|594102888|FG003|Overall Study|Withdrawal by Subject|6|||
164472373|NCT04129164|594102885|FG000|Overall Study|Death|0|||
164472374|NCT04129164|594102886|FG001|Overall Study|Death|1|||
164472375|NCT04129164|594102887|FG002|Overall Study|Death|0|||
164472376|NCT04129164|594102888|FG003|Overall Study|Death|0|||
164472377|NCT04129164|594102885|FG000|Overall Study|Lost to Follow-up|0|||
164472378|NCT04129164|594102886|FG001|Overall Study|Lost to Follow-up|1|||
164472379|NCT04129164|594102887|FG002|Overall Study|Lost to Follow-up|0|||
164472380|NCT04129164|594102888|FG003|Overall Study|Lost to Follow-up|0|||
164472381|NCT01260896|594102894|FG000|First Intervention|Withdrawn Due to Emesis|2|||
164472382|NCT01260896|594102895|FG001|First Intervention|Withdrawn Due to Emesis|0|||
164472383|NCT00943917|594102904|FG000|Stage I|Adverse Event|1|||
164472384|NCT00943917|594102905|FG001|Stage I|Adverse Event|2|||
164472385|NCT00943917|594102906|FG002|Stage I|Adverse Event|2|||
164472386|NCT00943917|594102907|FG003|Stage I|Adverse Event|0|||
164472387|NCT00943917|594102908|FG004|Stage I|Adverse Event|0|||
164472388|NCT00943917|594102909|FG005|Stage I|Adverse Event|0|||
164472389|NCT00943917|594102910|FG006|Stage I|Adverse Event|0|||
164472390|NCT00943917|594102911|FG007|Stage I|Adverse Event|0|||
164472391|NCT00943917|594102912|FG008|Stage I|Adverse Event|0|||
164472392|NCT00943917|594102913|FG009|Stage I|Adverse Event|0|||
164472393|NCT00943917|594102914|FG010|Stage I|Adverse Event|0|||
164472394|NCT00943917|594102915|FG011|Stage I|Adverse Event|0|||
164472395|NCT00943917|594102916|FG012|Stage I|Adverse Event|0|||
164472396|NCT00943917|594102917|FG013|Stage I|Adverse Event|0|||
164472397|NCT00943917|594102918|FG014|Stage I|Adverse Event|0|||
164472398|NCT00943917|594102904|FG000|Stage I|Lost to Follow-up|0|||
164472399|NCT00943917|594102905|FG001|Stage I|Lost to Follow-up|0|||
164472400|NCT00943917|594102906|FG002|Stage I|Lost to Follow-up|1|||
164472401|NCT00943917|594102907|FG003|Stage I|Lost to Follow-up|0|||
164472402|NCT00943917|594102908|FG004|Stage I|Lost to Follow-up|0|||
164472403|NCT00943917|594102909|FG005|Stage I|Lost to Follow-up|0|||
164472404|NCT00943917|594102910|FG006|Stage I|Lost to Follow-up|0|||
164472405|NCT00943917|594102911|FG007|Stage I|Lost to Follow-up|0|||
164472406|NCT00943917|594102912|FG008|Stage I|Lost to Follow-up|0|||
164472407|NCT00943917|594102913|FG009|Stage I|Lost to Follow-up|0|||
164472408|NCT00943917|594102914|FG010|Stage I|Lost to Follow-up|0|||
164472409|NCT00943917|594102915|FG011|Stage I|Lost to Follow-up|0|||
164472410|NCT00943917|594102916|FG012|Stage I|Lost to Follow-up|0|||
164472411|NCT00943917|594102917|FG013|Stage I|Lost to Follow-up|0|||
164472412|NCT00943917|594102918|FG014|Stage I|Lost to Follow-up|0|||
164472413|NCT00943917|594102904|FG000|Stage I|hyperglycemia|0|||
164472414|NCT00943917|594102905|FG001|Stage I|hyperglycemia|0|||
164472415|NCT00943917|594102906|FG002|Stage I|hyperglycemia|1|||
164472416|NCT00943917|594102907|FG003|Stage I|hyperglycemia|0|||
164472417|NCT00943917|594102908|FG004|Stage I|hyperglycemia|0|||
164472418|NCT00943917|594102909|FG005|Stage I|hyperglycemia|0|||
164472419|NCT00943917|594102910|FG006|Stage I|hyperglycemia|0|||
164472420|NCT00943917|594102911|FG007|Stage I|hyperglycemia|0|||
164472421|NCT00943917|594102912|FG008|Stage I|hyperglycemia|0|||
164472422|NCT00943917|594102913|FG009|Stage I|hyperglycemia|0|||
164472423|NCT00943917|594102914|FG010|Stage I|hyperglycemia|0|||
164472424|NCT00943917|594102915|FG011|Stage I|hyperglycemia|0|||
164472425|NCT00943917|594102916|FG012|Stage I|hyperglycemia|0|||
164472426|NCT00943917|594102917|FG013|Stage I|hyperglycemia|0|||
164472427|NCT00943917|594102918|FG014|Stage I|hyperglycemia|0|||
164472428|NCT00943917|594102904|FG000|Stage I|A1C elevation|1|||
164472429|NCT00943917|594102905|FG001|Stage I|A1C elevation|0|||
164472430|NCT00943917|594102906|FG002|Stage I|A1C elevation|0|||
164472431|NCT00943917|594102907|FG003|Stage I|A1C elevation|0|||
164472432|NCT00943917|594102908|FG004|Stage I|A1C elevation|0|||
164472433|NCT00943917|594102909|FG005|Stage I|A1C elevation|0|||
164472434|NCT00943917|594102910|FG006|Stage I|A1C elevation|0|||
164472435|NCT00943917|594102911|FG007|Stage I|A1C elevation|0|||
164472436|NCT00943917|594102912|FG008|Stage I|A1C elevation|0|||
164472437|NCT00943917|594102913|FG009|Stage I|A1C elevation|0|||
164472438|NCT00943917|594102914|FG010|Stage I|A1C elevation|0|||
164472439|NCT00943917|594102915|FG011|Stage I|A1C elevation|0|||
164472440|NCT00943917|594102916|FG012|Stage I|A1C elevation|0|||
164472441|NCT00943917|594102917|FG013|Stage I|A1C elevation|0|||
164472442|NCT00943917|594102918|FG014|Stage I|A1C elevation|0|||
164472443|NCT00943917|594102904|FG000|Stage I|Withdrawal by Subject|2|||
164472444|NCT00943917|594102905|FG001|Stage I|Withdrawal by Subject|1|||
164472445|NCT00943917|594102906|FG002|Stage I|Withdrawal by Subject|2|||
164472446|NCT00943917|594102907|FG003|Stage I|Withdrawal by Subject|0|||
164472447|NCT00943917|594102908|FG004|Stage I|Withdrawal by Subject|0|||
164713156|NCT02552212|594972255|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
164713157|NCT02552212|594972256|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
164713158|NCT02552212|594972257|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
164713159|NCT02552212|594972255|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
164713160|NCT02552212|594972256|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
164713161|NCT02552212|594972257|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
164713162|NCT02552212|594972255|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
164713163|NCT02552212|594972256|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
164713164|NCT02552212|594972257|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
164713165|NCT02552212|594972255|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
164713166|NCT02552212|594972256|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
164713167|NCT02552212|594972257|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
164713168|NCT02552212|594972255|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
164713169|NCT02552212|594972256|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
164713170|NCT02552212|594972257|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
164713171|NCT02552212|594972255|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
164713172|NCT02552212|594972256|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
164713173|NCT02552212|594972257|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
164713174|NCT02552212|594972255|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
164713175|NCT02552212|594972256|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
164713176|NCT02552212|594972257|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
164713177|NCT02552212|594972255|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
164713178|NCT02552212|594972256|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
164713179|NCT02552212|594972257|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
164713180|NCT02552212|594972255|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
164713181|NCT02552212|594972256|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
164713182|NCT02552212|594972257|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
164713183|NCT02552212|594972255|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
164713184|NCT02552212|594972256|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
164713185|NCT02552212|594972257|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
164713186|NCT02552212|594972255|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
164713187|NCT02552212|594972256|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
164713188|NCT02552212|594972257|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
164713189|NCT02552212|594972255|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
164713190|NCT02552212|594972256|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
164713191|NCT02552212|594972257|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
164713192|NCT02552212|594972255|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
164713193|NCT02552212|594972256|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
164713194|NCT02552212|594972257|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
164713195|NCT02552212|594972255|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
164713196|NCT02552212|594972256|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
164713197|NCT02552212|594972257|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
164713198|NCT01425723|594972259|FG000|Overall Study|Lack of Efficacy|0|||
164713199|NCT01425723|594972260|FG001|Overall Study|Lack of Efficacy|1|||
164472448|NCT00943917|594102909|FG005|Stage I|Withdrawal by Subject|0|||
164472449|NCT00943917|594102910|FG006|Stage I|Withdrawal by Subject|0|||
164472450|NCT00943917|594102911|FG007|Stage I|Withdrawal by Subject|0|||
164472451|NCT00943917|594102912|FG008|Stage I|Withdrawal by Subject|0|||
164472452|NCT00943917|594102913|FG009|Stage I|Withdrawal by Subject|0|||
164472453|NCT00943917|594102914|FG010|Stage I|Withdrawal by Subject|0|||
164472454|NCT00943917|594102915|FG011|Stage I|Withdrawal by Subject|0|||
164472455|NCT00943917|594102916|FG012|Stage I|Withdrawal by Subject|0|||
164472456|NCT00943917|594102917|FG013|Stage I|Withdrawal by Subject|0|||
164472457|NCT00943917|594102918|FG014|Stage I|Withdrawal by Subject|0|||
164472458|NCT00943917|594102904|FG000|Stage II|Adverse Event|0|||
164713200|NCT01425723|594972259|FG000|Overall Study|Withdrawal by Subject|1|||
164713201|NCT01425723|594972260|FG001|Overall Study|Withdrawal by Subject|4|||
164713202|NCT01425723|594972259|FG000|Overall Study|Lost to Follow-up|0|||
164713203|NCT01425723|594972260|FG001|Overall Study|Lost to Follow-up|3|||
164713204|NCT01425723|594972259|FG000|Overall Study|Physician Decision|2|||
164713205|NCT01425723|594972260|FG001|Overall Study|Physician Decision|0|||
164713206|NCT01425723|594972259|FG000|Overall Study|Other|1|||
164472459|NCT00943917|594102905|FG001|Stage II|Adverse Event|0|||
164472460|NCT00943917|594102906|FG002|Stage II|Adverse Event|0|||
164472461|NCT00943917|594102907|FG003|Stage II|Adverse Event|0|||
164472462|NCT00943917|594102908|FG004|Stage II|Adverse Event|0|||
164472463|NCT00943917|594102909|FG005|Stage II|Adverse Event|1|||
164472464|NCT00943917|594102910|FG006|Stage II|Adverse Event|3|||
164472465|NCT00943917|594102911|FG007|Stage II|Adverse Event|0|||
164472466|NCT00943917|594102912|FG008|Stage II|Adverse Event|1|||
164472467|NCT00943917|594102913|FG009|Stage II|Adverse Event|0|||
164472468|NCT00943917|594102914|FG010|Stage II|Adverse Event|0|||
164472469|NCT00943917|594102915|FG011|Stage II|Adverse Event|0|||
164472470|NCT00943917|594102916|FG012|Stage II|Adverse Event|0|||
164472471|NCT00943917|594102917|FG013|Stage II|Adverse Event|0|||
164472472|NCT00943917|594102918|FG014|Stage II|Adverse Event|0|||
164472473|NCT00943917|594102904|FG000|Stage II|Withdrawal by Subject|0|||
164472474|NCT00943917|594102905|FG001|Stage II|Withdrawal by Subject|0|||
164472475|NCT00943917|594102906|FG002|Stage II|Withdrawal by Subject|0|||
164472476|NCT00943917|594102907|FG003|Stage II|Withdrawal by Subject|0|||
164472477|NCT00943917|594102908|FG004|Stage II|Withdrawal by Subject|0|||
164472478|NCT00943917|594102909|FG005|Stage II|Withdrawal by Subject|1|||
164472479|NCT00943917|594102910|FG006|Stage II|Withdrawal by Subject|0|||
164472480|NCT00943917|594102911|FG007|Stage II|Withdrawal by Subject|0|||
164472481|NCT00943917|594102912|FG008|Stage II|Withdrawal by Subject|0|||
164472482|NCT00943917|594102913|FG009|Stage II|Withdrawal by Subject|0|||
164472483|NCT00943917|594102914|FG010|Stage II|Withdrawal by Subject|0|||
164472484|NCT00943917|594102915|FG011|Stage II|Withdrawal by Subject|0|||
164472485|NCT00943917|594102916|FG012|Stage II|Withdrawal by Subject|0|||
164472486|NCT00943917|594102917|FG013|Stage II|Withdrawal by Subject|0|||
164472487|NCT00943917|594102918|FG014|Stage II|Withdrawal by Subject|0|||
164472488|NCT00943917|594102904|FG000|Stage II|Pregnancy|0|||
164472489|NCT00943917|594102905|FG001|Stage II|Pregnancy|0|||
164472490|NCT00943917|594102906|FG002|Stage II|Pregnancy|0|||
164472491|NCT00943917|594102907|FG003|Stage II|Pregnancy|0|||
164472492|NCT00943917|594102908|FG004|Stage II|Pregnancy|0|||
164472493|NCT00943917|594102909|FG005|Stage II|Pregnancy|1|||
164472494|NCT00943917|594102910|FG006|Stage II|Pregnancy|0|||
164472495|NCT00943917|594102911|FG007|Stage II|Pregnancy|0|||
164472496|NCT00943917|594102912|FG008|Stage II|Pregnancy|0|||
164472497|NCT00943917|594102913|FG009|Stage II|Pregnancy|0|||
164472498|NCT00943917|594102914|FG010|Stage II|Pregnancy|0|||
164472499|NCT00943917|594102915|FG011|Stage II|Pregnancy|0|||
164472500|NCT00943917|594102916|FG012|Stage II|Pregnancy|0|||
164472501|NCT00943917|594102917|FG013|Stage II|Pregnancy|0|||
164713207|NCT01425723|594972260|FG001|Overall Study|Other|10|||
164713208|NCT00418821|594972261|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
164713209|NCT04853992|594972262|FG000|Treatment Period A|Adverse Event|0|||
164713210|NCT04853992|594972263|FG001|Treatment Period A|Adverse Event|1|||
164713211|NCT04853992|594972262|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
164713212|NCT04853992|594972263|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
164472502|NCT00943917|594102918|FG014|Stage II|Pregnancy|0|||
164472503|NCT00943917|594102904|FG000|Stage II Continuation|Adverse Event|0|||
164472504|NCT00943917|594102905|FG001|Stage II Continuation|Adverse Event|0|||
164472505|NCT00943917|594102906|FG002|Stage II Continuation|Adverse Event|0|||
164472506|NCT00943917|594102907|FG003|Stage II Continuation|Adverse Event|0|||
164472507|NCT00943917|594102908|FG004|Stage II Continuation|Adverse Event|0|||
164472508|NCT00943917|594102909|FG005|Stage II Continuation|Adverse Event|0|||
164472509|NCT00943917|594102910|FG006|Stage II Continuation|Adverse Event|0|||
164472510|NCT00943917|594102911|FG007|Stage II Continuation|Adverse Event|0|||
164472511|NCT00943917|594102912|FG008|Stage II Continuation|Adverse Event|0|||
164472512|NCT00943917|594102913|FG009|Stage II Continuation|Adverse Event|0|||
164472513|NCT00943917|594102914|FG010|Stage II Continuation|Adverse Event|0|||
164472514|NCT00943917|594102915|FG011|Stage II Continuation|Adverse Event|1|||
164472515|NCT00943917|594102916|FG012|Stage II Continuation|Adverse Event|2|||
164472516|NCT00943917|594102917|FG013|Stage II Continuation|Adverse Event|1|||
164472517|NCT00943917|594102918|FG014|Stage II Continuation|Adverse Event|1|||
164472518|NCT00943917|594102904|FG000|Stage II Continuation|Withdrawal by Subject|0|||
164472519|NCT00943917|594102905|FG001|Stage II Continuation|Withdrawal by Subject|0|||
164472520|NCT00943917|594102906|FG002|Stage II Continuation|Withdrawal by Subject|0|||
164472521|NCT00943917|594102907|FG003|Stage II Continuation|Withdrawal by Subject|0|||
164472522|NCT00943917|594102908|FG004|Stage II Continuation|Withdrawal by Subject|0|||
164472523|NCT00943917|594102909|FG005|Stage II Continuation|Withdrawal by Subject|0|||
164472524|NCT00943917|594102910|FG006|Stage II Continuation|Withdrawal by Subject|0|||
164472525|NCT00943917|594102911|FG007|Stage II Continuation|Withdrawal by Subject|0|||
164472526|NCT00943917|594102912|FG008|Stage II Continuation|Withdrawal by Subject|0|||
164472527|NCT00943917|594102913|FG009|Stage II Continuation|Withdrawal by Subject|0|||
164472528|NCT00943917|594102914|FG010|Stage II Continuation|Withdrawal by Subject|0|||
164472529|NCT00943917|594102915|FG011|Stage II Continuation|Withdrawal by Subject|0|||
164472530|NCT00943917|594102916|FG012|Stage II Continuation|Withdrawal by Subject|0|||
164472531|NCT00943917|594102917|FG013|Stage II Continuation|Withdrawal by Subject|1|||
164472532|NCT00943917|594102918|FG014|Stage II Continuation|Withdrawal by Subject|3|||
164472533|NCT00943917|594102904|FG000|Stage II Continuation|Protocol Violation|0|||
164472534|NCT00943917|594102905|FG001|Stage II Continuation|Protocol Violation|0|||
164472535|NCT00943917|594102906|FG002|Stage II Continuation|Protocol Violation|0|||
164472536|NCT00943917|594102907|FG003|Stage II Continuation|Protocol Violation|0|||
164472537|NCT00943917|594102908|FG004|Stage II Continuation|Protocol Violation|0|||
164472538|NCT00943917|594102909|FG005|Stage II Continuation|Protocol Violation|0|||
164713213|NCT02269163|594972264|FG000|Overall Study|Lost to Follow-up|1|||
164713214|NCT02269163|594972265|FG001|Overall Study|Lost to Follow-up|0|||
164713215|NCT02269163|594972264|FG000|Overall Study|Major protocol violation|0|||
164713216|NCT02269163|594972265|FG001|Overall Study|Major protocol violation|1|||
164713217|NCT02269163|594972264|FG000|Overall Study|Other|2|||
164713218|NCT02269163|594972265|FG001|Overall Study|Other|2|||
164713219|NCT02269163|594972264|FG000|Overall Study|Withdrawal by Subject|0|||
164713220|NCT02269163|594972265|FG001|Overall Study|Withdrawal by Subject|3|||
164713221|NCT02269163|594972264|FG000|Overall Study|Physician Decision|0|||
164713222|NCT02269163|594972265|FG001|Overall Study|Physician Decision|1|||
164713223|NCT02351960|594972266|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
164713224|NCT02351960|594972267|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
164713225|NCT02351960|594972266|FG000|Overall Study|Voluntary Withdrawal|5|||
164713226|NCT02351960|594972267|FG001|Overall Study|Voluntary Withdrawal|4|||
164713227|NCT02351960|594972266|FG000|Overall Study|Significant Protocol Deviation|0|||
164713228|NCT02351960|594972267|FG001|Overall Study|Significant Protocol Deviation|5|||
164713229|NCT03866902|594972268|FG000|Overall Study|Lost to Follow-up|98|||
164713230|NCT03866902|594972269|FG001|Overall Study|Lost to Follow-up|82|||
164713231|NCT03866902|594972268|FG000|Overall Study|Pregnancy|18|||
164713232|NCT03866902|594972269|FG001|Overall Study|Pregnancy|24|||
164713233|NCT02092467|594972271|FG000|Overall Study|Death|49|||
164713234|NCT02092467|594972272|FG001|Overall Study|Death|66|||
164713235|NCT02092467|594972273|FG002|Overall Study|Death|38|||
164713236|NCT02092467|594972271|FG000|Overall Study|Lost to Follow-up|38|||
164713237|NCT02092467|594972272|FG001|Overall Study|Lost to Follow-up|35|||
164713238|NCT02092467|594972273|FG002|Overall Study|Lost to Follow-up|40|||
164713239|NCT02092467|594972271|FG000|Overall Study|Global Deterioration of Health Status|1|||
164713240|NCT02092467|594972272|FG001|Overall Study|Global Deterioration of Health Status|0|||
164713241|NCT02092467|594972273|FG002|Overall Study|Global Deterioration of Health Status|0|||
164713242|NCT02092467|594972271|FG000|Overall Study|Other|32|||
164713243|NCT02092467|594972272|FG001|Overall Study|Other|30|||
164713244|NCT02092467|594972273|FG002|Overall Study|Other|24|||
164713245|NCT02092467|594972271|FG000|Overall Study|Withdrawal by Subject|282|||
164713246|NCT02092467|594972272|FG001|Overall Study|Withdrawal by Subject|327|||
164713247|NCT02092467|594972273|FG002|Overall Study|Withdrawal by Subject|289|||
164713248|NCT02092467|594972271|FG000|Overall Study|Randomized but not treated|2|||
164713249|NCT02092467|594972272|FG001|Overall Study|Randomized but not treated|1|||
164713250|NCT02092467|594972273|FG002|Overall Study|Randomized but not treated|7|||
164713251|NCT01284621|594972274|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
164713252|NCT01284621|594972275|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
164713253|NCT01284621|594972276|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
164713254|NCT01284621|594972277|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
164713255|NCT01284621|594972278|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
164713256|NCT01284621|594972279|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
164713257|NCT02377427|594972282|FG000|Part A (Up to Week 20)|Physician Decision|1|||
164713258|NCT02377427|594972283|FG001|Part A (Up to Week 20)|Physician Decision|0|||
164713259|NCT02377427|594972284|FG002|Part A (Up to Week 20)|Physician Decision|0|||
164713260|NCT02377427|594972285|FG003|Part A (Up to Week 20)|Physician Decision|0|||
164713261|NCT02377427|594972286|FG004|Part A (Up to Week 20)|Physician Decision|0|||
164713262|NCT02377427|594972282|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
164713263|NCT02377427|594972283|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
164713264|NCT02377427|594972284|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
164713265|NCT02377427|594972285|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
164713266|NCT02377427|594972286|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
164713267|NCT02377427|594972282|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
164713268|NCT02377427|594972283|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
164713269|NCT02377427|594972284|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
164472539|NCT00943917|594102910|FG006|Stage II Continuation|Protocol Violation|0|||
164472540|NCT00943917|594102911|FG007|Stage II Continuation|Protocol Violation|0|||
164472541|NCT00943917|594102912|FG008|Stage II Continuation|Protocol Violation|0|||
164713270|NCT02377427|594972285|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
164713271|NCT02377427|594972286|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
164713272|NCT02377427|594972282|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
164713273|NCT02377427|594972283|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
164713274|NCT02377427|594972284|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
164713275|NCT02377427|594972285|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
164713276|NCT02377427|594972286|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
164713277|NCT02293863|594972287|FG000|Overall Study|Death|4|||
164713278|NCT02293863|594972288|FG001|Overall Study|Death|6|||
164713279|NCT02293863|594972289|FG002|Overall Study|Death|4|||
164472542|NCT00943917|594102913|FG009|Stage II Continuation|Protocol Violation|1|||
164472543|NCT00943917|594102914|FG010|Stage II Continuation|Protocol Violation|0|||
164472544|NCT00943917|594102915|FG011|Stage II Continuation|Protocol Violation|1|||
164713280|NCT02293863|594972287|FG000|Overall Study|Lost to Follow-up|2|||
164713281|NCT02293863|594972288|FG001|Overall Study|Lost to Follow-up|2|||
164713282|NCT02293863|594972289|FG002|Overall Study|Lost to Follow-up|2|||
164472545|NCT00943917|594102916|FG012|Stage II Continuation|Protocol Violation|0|||
164472546|NCT00943917|594102917|FG013|Stage II Continuation|Protocol Violation|0|||
164472547|NCT00943917|594102918|FG014|Stage II Continuation|Protocol Violation|0|||
164472548|NCT00943917|594102904|FG000|Stage II Continuation|hypoglycemia|0|||
164472549|NCT00943917|594102905|FG001|Stage II Continuation|hypoglycemia|0|||
164472550|NCT00943917|594102906|FG002|Stage II Continuation|hypoglycemia|0|||
164472551|NCT00943917|594102907|FG003|Stage II Continuation|hypoglycemia|0|||
164472552|NCT00943917|594102908|FG004|Stage II Continuation|hypoglycemia|0|||
164472553|NCT00943917|594102909|FG005|Stage II Continuation|hypoglycemia|0|||
164472554|NCT00943917|594102910|FG006|Stage II Continuation|hypoglycemia|0|||
164472555|NCT00943917|594102911|FG007|Stage II Continuation|hypoglycemia|0|||
164472556|NCT00943917|594102912|FG008|Stage II Continuation|hypoglycemia|0|||
164472557|NCT00943917|594102913|FG009|Stage II Continuation|hypoglycemia|0|||
164472558|NCT00943917|594102914|FG010|Stage II Continuation|hypoglycemia|0|||
164472559|NCT00943917|594102915|FG011|Stage II Continuation|hypoglycemia|0|||
164472560|NCT00943917|594102916|FG012|Stage II Continuation|hypoglycemia|1|||
164472561|NCT00943917|594102917|FG013|Stage II Continuation|hypoglycemia|0|||
164472562|NCT00943917|594102918|FG014|Stage II Continuation|hypoglycemia|0|||
164472563|NCT00943917|594102904|FG000|Stage II Continuation|A1C elevation|0|||
164472564|NCT00943917|594102905|FG001|Stage II Continuation|A1C elevation|0|||
164472565|NCT00943917|594102906|FG002|Stage II Continuation|A1C elevation|0|||
164472566|NCT00943917|594102907|FG003|Stage II Continuation|A1C elevation|0|||
164472567|NCT00943917|594102908|FG004|Stage II Continuation|A1C elevation|0|||
164472568|NCT00943917|594102909|FG005|Stage II Continuation|A1C elevation|0|||
164472569|NCT00943917|594102910|FG006|Stage II Continuation|A1C elevation|0|||
164472570|NCT00943917|594102911|FG007|Stage II Continuation|A1C elevation|0|||
164472571|NCT00943917|594102912|FG008|Stage II Continuation|A1C elevation|0|||
164472572|NCT00943917|594102913|FG009|Stage II Continuation|A1C elevation|0|||
164472573|NCT00943917|594102914|FG010|Stage II Continuation|A1C elevation|0|||
164472574|NCT00943917|594102915|FG011|Stage II Continuation|A1C elevation|0|||
164472575|NCT00943917|594102916|FG012|Stage II Continuation|A1C elevation|0|||
164472576|NCT00943917|594102917|FG013|Stage II Continuation|A1C elevation|1|||
164472577|NCT00943917|594102918|FG014|Stage II Continuation|A1C elevation|0|||
164472578|NCT01171976|594102919|FG000|Overall Study|Protocol Violation|0|||
164472579|NCT01171976|594102920|FG001|Overall Study|Protocol Violation|0|||
164472580|NCT01171976|594102921|FG002|Overall Study|Protocol Violation|1|||
164472581|NCT01171976|594102919|FG000|Overall Study|Death|2|||
164472582|NCT01171976|594102920|FG001|Overall Study|Death|4|||
164472583|NCT01171976|594102921|FG002|Overall Study|Death|1|||
164472584|NCT01171976|594102919|FG000|Overall Study|Lost to Follow-up|4|||
164472585|NCT01171976|594102920|FG001|Overall Study|Lost to Follow-up|0|||
164472586|NCT01171976|594102921|FG002|Overall Study|Lost to Follow-up|2|||
164472587|NCT01171976|594102919|FG000|Overall Study|Withdrawal by Subject|1|||
164472588|NCT01171976|594102920|FG001|Overall Study|Withdrawal by Subject|5|||
164472589|NCT01171976|594102921|FG002|Overall Study|Withdrawal by Subject|6|||
164472590|NCT01171976|594102919|FG000|Overall Study|Abnormal test result|1|||
164472591|NCT01171976|594102920|FG001|Overall Study|Abnormal test result|0|||
164472592|NCT01171976|594102921|FG002|Overall Study|Abnormal test result|0|||
164472593|NCT01171976|594102919|FG000|Overall Study|Adverse Event|6|||
164472594|NCT01171976|594102920|FG001|Overall Study|Adverse Event|2|||
164472595|NCT01171976|594102921|FG002|Overall Study|Adverse Event|5|||
164472596|NCT00003222|594102922|FG000|Overall Study|Physician Decision|0|||
164472597|NCT00003222|594102923|FG001|Overall Study|Physician Decision|1|||
164472598|NCT01313559|594102925|FG000|Overall Study|Withdrawal by Subject|1|||
164472599|NCT01313559|594102926|FG001|Overall Study|Withdrawal by Subject|2|||
164472600|NCT01313559|594102925|FG000|Overall Study|Disease progression|1|||
164472601|NCT01313559|594102926|FG001|Overall Study|Disease progression|0|||
164472602|NCT01313559|594102925|FG000|Overall Study|Rising PSA|2|||
164472603|NCT01313559|594102926|FG001|Overall Study|Rising PSA|0|||
164472604|NCT02466971|594102927|FG000|Overall Study|eligible and never treated|14|||
164472605|NCT02466971|594102928|FG001|Overall Study|eligible and never treated|20|||
164472606|NCT02466971|594102927|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
164472607|NCT02466971|594102928|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
164472608|NCT02466971|594102927|FG000|Overall Study|ineligible and treated|1|||
164472609|NCT02466971|594102928|FG001|Overall Study|ineligible and treated|0|||
164472610|NCT02466971|594102927|FG000|Overall Study|ineligible and never treated|0|||
164472611|NCT02466971|594102928|FG001|Overall Study|ineligible and never treated|1|||
164472612|NCT05707351|594102942|FG000|Overall Study|Withdrawal by Subject|2|||
164472613|NCT05707351|594102942|FG000|Overall Study|Reason Not Specified|1|||
164472614|NCT04174560|594102946|FG000|Overall Study|Lost to Follow-up|1|||
164472615|NCT04174560|594102947|FG001|Overall Study|Lost to Follow-up|0|||
164472616|NCT04174560|594102948|FG002|Overall Study|Lost to Follow-up|0|||
164472617|NCT04174560|594102949|FG003|Overall Study|Lost to Follow-up|0|||
164472618|NCT04174560|594102946|FG000|Overall Study|Withdrawal by Subject|0|||
164472619|NCT04174560|594102947|FG001|Overall Study|Withdrawal by Subject|0|||
164472620|NCT04174560|594102948|FG002|Overall Study|Withdrawal by Subject|2|||
164472621|NCT04174560|594102949|FG003|Overall Study|Withdrawal by Subject|0|||
164472622|NCT03872466|594102950|FG000|Overall Study|Withdrawal by Subject|1|||
164472623|NCT03872466|594102951|FG001|Overall Study|Withdrawal by Subject|0|||
164472624|NCT03872466|594102950|FG000|Overall Study|Physician Decision|2|||
164472625|NCT03872466|594102951|FG001|Overall Study|Physician Decision|0|||
164472626|NCT01778686|594102952|FG000|Overall Study|Adverse Event|0|||
164472627|NCT01778686|594102953|FG001|Overall Study|Adverse Event|0|||
164472628|NCT01778686|594102954|FG002|Overall Study|Adverse Event|1|||
164472629|NCT05934292|594102955|FG000|Overall Study|Lost to Follow-up|0|||
164472630|NCT05934292|594102956|FG001|Overall Study|Lost to Follow-up|0|||
164472631|NCT05934292|594102957|FG002|Overall Study|Lost to Follow-up|1|||
164472632|NCT05934292|594102958|FG003|Overall Study|Lost to Follow-up|0|||
164472633|NCT05864209|594103921|FG000|Overall Study|Lost to Follow-up|2|||
164472634|NCT05864209|594103922|FG001|Overall Study|Lost to Follow-up|3|||
164472635|NCT04530487|594103923|FG000|Overall Study|Death|1|||
164472636|NCT04977583|594103924|FG000|Overall Study|Lost to Follow-up|8|||
164472637|NCT04977583|594103925|FG001|Overall Study|Lost to Follow-up|4|||
164472638|NCT04977583|594103926|FG002|Overall Study|Lost to Follow-up|13|||
164472639|NCT04977583|594103924|FG000|Overall Study|Withdrawal by Subject|3|||
164472640|NCT04977583|594103925|FG001|Overall Study|Withdrawal by Subject|2|||
164472641|NCT04977583|594103926|FG002|Overall Study|Withdrawal by Subject|1|||
164472642|NCT04974047|594103931|FG000|Overall Study|Sponsor Ended Study|20|||
164472643|NCT04974047|594103932|FG001|Overall Study|Sponsor Ended Study|22|||
164472644|NCT04974047|594103931|FG000|Overall Study|Death|8|||
164472645|NCT04974047|594103932|FG001|Overall Study|Death|17|||
164472646|NCT04974047|594103931|FG000|Overall Study|Lost to Follow-up|2|||
164472647|NCT04974047|594103932|FG001|Overall Study|Lost to Follow-up|0|||
164472648|NCT04974047|594103931|FG000|Overall Study|Withdrawal by Subject|0|||
164472649|NCT04974047|594103932|FG001|Overall Study|Withdrawal by Subject|1|||
164472650|NCT00655499|594103933|FG000|Overall Study|not eligible|4|||
164472651|NCT00146172|594103935|FG000|Overall Study|Adverse Event|0|||
164472652|NCT00146172|594103936|FG001|Overall Study|Adverse Event|0|||
164472653|NCT00146172|594103937|FG002|Overall Study|Adverse Event|1|||
164472654|NCT00146172|594103938|FG003|Overall Study|Adverse Event|1|||
164472655|NCT00146172|594103939|FG004|Overall Study|Adverse Event|0|||
164472656|NCT00146172|594103940|FG005|Overall Study|Adverse Event|2|||
164472657|NCT00146172|594103941|FG006|Overall Study|Adverse Event|3|||
164472658|NCT00146172|594103942|FG007|Overall Study|Adverse Event|10|||
164472659|NCT00146172|594103935|FG000|Overall Study|Lost to Follow-up|0|||
164472660|NCT00146172|594103936|FG001|Overall Study|Lost to Follow-up|0|||
164472661|NCT00146172|594103937|FG002|Overall Study|Lost to Follow-up|0|||
164472662|NCT00146172|594103938|FG003|Overall Study|Lost to Follow-up|0|||
164472663|NCT00146172|594103939|FG004|Overall Study|Lost to Follow-up|0|||
164472664|NCT00146172|594103940|FG005|Overall Study|Lost to Follow-up|0|||
164472665|NCT00146172|594103941|FG006|Overall Study|Lost to Follow-up|0|||
164472666|NCT00146172|594103942|FG007|Overall Study|Lost to Follow-up|1|||
164472667|NCT00146172|594103935|FG000|Overall Study|Disease Progression|2|||
164472668|NCT00146172|594103936|FG001|Overall Study|Disease Progression|4|||
164472669|NCT00146172|594103937|FG002|Overall Study|Disease Progression|2|||
164472670|NCT00146172|594103938|FG003|Overall Study|Disease Progression|5|||
164472671|NCT00146172|594103939|FG004|Overall Study|Disease Progression|2|||
164472672|NCT00146172|594103940|FG005|Overall Study|Disease Progression|2|||
164472673|NCT00146172|594103941|FG006|Overall Study|Disease Progression|1|||
164472674|NCT00146172|594103942|FG007|Overall Study|Disease Progression|22|||
164472675|NCT00146172|594103935|FG000|Overall Study|Death|0|||
164472676|NCT00146172|594103936|FG001|Overall Study|Death|0|||
164472677|NCT00146172|594103937|FG002|Overall Study|Death|0|||
164472678|NCT00146172|594103938|FG003|Overall Study|Death|0|||
164472679|NCT00146172|594103939|FG004|Overall Study|Death|0|||
164472680|NCT00146172|594103940|FG005|Overall Study|Death|0|||
164472681|NCT00146172|594103941|FG006|Overall Study|Death|1|||
164472682|NCT00146172|594103942|FG007|Overall Study|Death|0|||
164472683|NCT00146172|594103935|FG000|Overall Study|Physician Decision|0|||
164472684|NCT00146172|594103936|FG001|Overall Study|Physician Decision|0|||
164472685|NCT00146172|594103937|FG002|Overall Study|Physician Decision|0|||
164472686|NCT00146172|594103938|FG003|Overall Study|Physician Decision|0|||
164472687|NCT00146172|594103939|FG004|Overall Study|Physician Decision|0|||
164472688|NCT00146172|594103940|FG005|Overall Study|Physician Decision|0|||
164472689|NCT00146172|594103941|FG006|Overall Study|Physician Decision|0|||
164472690|NCT00146172|594103942|FG007|Overall Study|Physician Decision|1|||
164472691|NCT00146172|594103935|FG000|Overall Study|Withdrawal by Subject|0|||
164472692|NCT00146172|594103936|FG001|Overall Study|Withdrawal by Subject|0|||
164472693|NCT00146172|594103937|FG002|Overall Study|Withdrawal by Subject|0|||
164472694|NCT00146172|594103938|FG003|Overall Study|Withdrawal by Subject|0|||
164472695|NCT00146172|594103939|FG004|Overall Study|Withdrawal by Subject|0|||
164472696|NCT00146172|594103940|FG005|Overall Study|Withdrawal by Subject|1|||
164472697|NCT00146172|594103941|FG006|Overall Study|Withdrawal by Subject|1|||
164472698|NCT00146172|594103942|FG007|Overall Study|Withdrawal by Subject|4|||
164472699|NCT00146172|594103935|FG000|Overall Study|Symptomatic Deterioration|1|||
164472700|NCT00146172|594103936|FG001|Overall Study|Symptomatic Deterioration|0|||
164472701|NCT00146172|594103937|FG002|Overall Study|Symptomatic Deterioration|1|||
164472702|NCT00146172|594103938|FG003|Overall Study|Symptomatic Deterioration|0|||
164713283|NCT02293863|594972287|FG000|Overall Study|Withdrawal by Subject|3|||
164713284|NCT02293863|594972288|FG001|Overall Study|Withdrawal by Subject|3|||
164713285|NCT02293863|594972289|FG002|Overall Study|Withdrawal by Subject|1|||
164713286|NCT02293863|594972287|FG000|Overall Study|Reason Not Specified|0|||
164713287|NCT02293863|594972288|FG001|Overall Study|Reason Not Specified|2|||
164713288|NCT02293863|594972289|FG002|Overall Study|Reason Not Specified|2|||
164713289|NCT04778904|594974783|FG000|Overall Study|Protocol Violation|1|||
164713290|NCT04778904|594974784|FG001|Overall Study|Protocol Violation|0|||
164713291|NCT04778904|594974785|FG002|Overall Study|Protocol Violation|0|||
164713292|NCT04778904|594974786|FG003|Overall Study|Protocol Violation|0|||
164713293|NCT04778904|594974783|FG000|Overall Study|Withdrawal by Subject|0|||
164713294|NCT04778904|594974784|FG001|Overall Study|Withdrawal by Subject|0|||
164713295|NCT04778904|594974785|FG002|Overall Study|Withdrawal by Subject|1|||
164713296|NCT04778904|594974786|FG003|Overall Study|Withdrawal by Subject|0|||
164713297|NCT03452137|594974787|FG000|Overall Study|Death|67|||
164713298|NCT03452137|594974788|FG001|Overall Study|Death|70|||
164713299|NCT03452137|594974787|FG000|Overall Study|Lost to Follow-up|4|||
164472703|NCT00146172|594103939|FG004|Overall Study|Symptomatic Deterioration|1|||
164472704|NCT00146172|594103940|FG005|Overall Study|Symptomatic Deterioration|2|||
164472705|NCT00146172|594103941|FG006|Overall Study|Symptomatic Deterioration|0|||
164472706|NCT00146172|594103942|FG007|Overall Study|Symptomatic Deterioration|2|||
164472707|NCT00210106|594103943|FG000|Overall Study|Death|1|||
164472708|NCT00210106|594103943|FG000|Overall Study|Protocol Violation|13|||
164472709|NCT00786864|594103944|FG000|Overall Study|Lost to Follow-up|0|||
164472710|NCT00786864|594103945|FG001|Overall Study|Lost to Follow-up|1|||
164472711|NCT00786864|594103944|FG000|Overall Study|Sustained serious back injury|1|||
164472712|NCT00786864|594103945|FG001|Overall Study|Sustained serious back injury|0|||
164472713|NCT02422615|594103946|FG000|Treatment Period|Progressive disease|314|||
164472714|NCT02422615|594103947|FG001|Treatment Period|Progressive disease|200|||
164472715|NCT02422615|594103946|FG000|Treatment Period|Adverse Event|51|||
164472716|NCT02422615|594103947|FG001|Treatment Period|Adverse Event|9|||
164472717|NCT02422615|594103946|FG000|Treatment Period|Physician Decision|32|||
164472718|NCT02422615|594103947|FG001|Treatment Period|Physician Decision|8|||
164472719|NCT02422615|594103946|FG000|Treatment Period|Subject/guardian decision|38|||
164472720|NCT02422615|594103947|FG001|Treatment Period|Subject/guardian decision|8|||
164472721|NCT02422615|594103946|FG000|Treatment Period|Death|2|||
164472722|NCT02422615|594103947|FG001|Treatment Period|Death|1|||
164472723|NCT02422615|594103946|FG000|Treatment Period|Technical problems|0|||
164472724|NCT02422615|594103947|FG001|Treatment Period|Technical problems|1|||
164472725|NCT02422615|594103946|FG000|Treatment Period|Protocol deviation|1|||
164472726|NCT02422615|594103947|FG001|Treatment Period|Protocol deviation|1|||
164472727|NCT02422615|594103946|FG000|Treatment Period|Study terminated as per protocol|46|||
164472728|NCT02422615|594103947|FG001|Treatment Period|Study terminated as per protocol|14|||
164472729|NCT02422615|594103946|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
164472730|NCT02422615|594103947|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
164472731|NCT02422615|594103946|FG000|Post-treatment Efficacy Follow-up|Death|2|||
164472732|NCT02422615|594103947|FG001|Post-treatment Efficacy Follow-up|Death|1|||
164472733|NCT02422615|594103946|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
164472734|NCT02422615|594103947|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
164472735|NCT02422615|594103946|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
164472736|NCT02422615|594103947|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
164472737|NCT02422615|594103946|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
164472738|NCT02422615|594103947|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
164472739|NCT02422615|594103946|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
164472740|NCT02422615|594103947|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
164472741|NCT01288443|594103948|FG000|Overall Study|Adverse Event|0|||
164472742|NCT01288443|594103949|FG001|Overall Study|Adverse Event|0|||
164472743|NCT01288443|594103950|FG002|Overall Study|Adverse Event|1|||
164472744|NCT01288443|594103951|FG003|Overall Study|Adverse Event|1|||
164472745|NCT01288443|594103952|FG004|Overall Study|Adverse Event|3|||
164472746|NCT01288443|594103953|FG005|Overall Study|Adverse Event|1|||
164472747|NCT01288443|594103948|FG000|Overall Study|Poor compliance to protocol|0|||
164472748|NCT01288443|594103949|FG001|Overall Study|Poor compliance to protocol|0|||
164472749|NCT01288443|594103950|FG002|Overall Study|Poor compliance to protocol|0|||
164472750|NCT01288443|594103951|FG003|Overall Study|Poor compliance to protocol|0|||
164472751|NCT01288443|594103952|FG004|Overall Study|Poor compliance to protocol|0|||
164472752|NCT01288443|594103953|FG005|Overall Study|Poor compliance to protocol|1|||
164472753|NCT01288443|594103948|FG000|Overall Study|Participant Moved|0|||
164472754|NCT01288443|594103949|FG001|Overall Study|Participant Moved|0|||
164472755|NCT01288443|594103950|FG002|Overall Study|Participant Moved|0|||
164472756|NCT01288443|594103951|FG003|Overall Study|Participant Moved|1|||
164713300|NCT03452137|594974788|FG001|Overall Study|Lost to Follow-up|2|||
164472757|NCT01288443|594103952|FG004|Overall Study|Participant Moved|2|||
164472758|NCT01288443|594103953|FG005|Overall Study|Participant Moved|1|||
164713301|NCT03452137|594974787|FG000|Overall Study|Physician Decision|0|||
164713302|NCT03452137|594974788|FG001|Overall Study|Physician Decision|1|||
164713303|NCT03452137|594974787|FG000|Overall Study|Study Terminated by Sponsor|120|||
164713304|NCT03452137|594974788|FG001|Overall Study|Study Terminated by Sponsor|121|||
164713305|NCT03452137|594974787|FG000|Overall Study|Withdrawal by Subject|12|||
164713306|NCT03452137|594974788|FG001|Overall Study|Withdrawal by Subject|9|||
164713307|NCT04138043|594974789|FG000|Overall Study|Withdrawal by Subject|0|||
164713308|NCT04138043|594974790|FG001|Overall Study|Withdrawal by Subject|1|||
164713309|NCT03772717|594974791|FG000|Overall Study|Withdrawal by Subject|2|||
164713310|NCT02856802|594974792|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
164713311|NCT02856802|594974793|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
164713312|NCT02856802|594974792|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
164713313|NCT02856802|594974793|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
164713314|NCT02856802|594974792|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
164713315|NCT02856802|594974793|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
164713316|NCT02856802|594974792|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
164713317|NCT02856802|594974793|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
164713318|NCT02856802|594974792|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
164713319|NCT02856802|594974793|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
164713320|NCT02856802|594974792|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
164713321|NCT02856802|594974793|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
164713322|NCT00587860|594974794|FG000|Overall Study|Lost to Follow-up|2|||
164713323|NCT00587860|594974795|FG001|Overall Study|Lost to Follow-up|2|||
164713324|NCT00587860|594974794|FG000|Overall Study|Withdrawal by Subject|3|||
164713325|NCT00587860|594974795|FG001|Overall Study|Withdrawal by Subject|3|||
164713326|NCT01659125|594974796|FG000|Overall Study|Withdrawal by Subject|2|||
164713327|NCT01659125|594974796|FG000|Overall Study|Lost to Follow-up|7|||
164713328|NCT01659125|594974796|FG000|Overall Study|Technical Problem|1|||
164713329|NCT01659125|594974796|FG000|Overall Study|Time Constraints|2|||
164713330|NCT01659125|594974796|FG000|Overall Study|Failed to Start Treatment|2|||
164713331|NCT00261443|594974797|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
164713332|NCT00261443|594974798|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
164713333|NCT00261443|594974799|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
164713334|NCT00261443|594974797|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
164713335|NCT00261443|594974798|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
164713336|NCT00261443|594974799|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
164713337|NCT00261443|594974797|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
164713338|NCT00261443|594974798|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
164713339|NCT00261443|594974799|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
164713340|NCT00261443|594974797|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
164713341|NCT00261443|594974798|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
164472759|NCT01288443|594103948|FG000|Overall Study|Consent withdrawn by Participant|0|||
164472760|NCT01288443|594103949|FG001|Overall Study|Consent withdrawn by Participant|0|||
164472761|NCT01288443|594103950|FG002|Overall Study|Consent withdrawn by Participant|0|||
164472762|NCT01288443|594103951|FG003|Overall Study|Consent withdrawn by Participant|0|||
164472763|NCT01288443|594103952|FG004|Overall Study|Consent withdrawn by Participant|0|||
164472764|NCT01288443|594103953|FG005|Overall Study|Consent withdrawn by Participant|1|||
164472765|NCT01288443|594103948|FG000|Overall Study|Lost to Follow-up|0|||
164472766|NCT01288443|594103949|FG001|Overall Study|Lost to Follow-up|1|||
164472767|NCT01288443|594103950|FG002|Overall Study|Lost to Follow-up|0|||
164472768|NCT01288443|594103951|FG003|Overall Study|Lost to Follow-up|0|||
164713342|NCT00261443|594974799|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
164713343|NCT00261443|594974797|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
164713344|NCT00261443|594974798|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
164713345|NCT00261443|594974799|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
164713346|NCT00261443|594974797|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
164713347|NCT00261443|594974798|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
164713348|NCT00261443|594974799|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
164713349|NCT00261443|594974797|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
164713350|NCT00261443|594974798|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
164713351|NCT00261443|594974799|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
164472769|NCT01288443|594103952|FG004|Overall Study|Lost to Follow-up|0|||
164472770|NCT01288443|594103953|FG005|Overall Study|Lost to Follow-up|0|||
164472771|NCT01288443|594103948|FG000|Overall Study|Study drug auto-injector administration|0|||
164472772|NCT01288443|594103949|FG001|Overall Study|Study drug auto-injector administration|0|||
164472773|NCT01288443|594103950|FG002|Overall Study|Study drug auto-injector administration|0|||
164472774|NCT01288443|594103951|FG003|Overall Study|Study drug auto-injector administration|0|||
164713352|NCT00261443|594974797|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
164713353|NCT00261443|594974798|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
164713354|NCT00261443|594974799|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
164713355|NCT00261443|594974797|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
164713356|NCT00261443|594974798|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
164713357|NCT00261443|594974799|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
164713358|NCT00261443|594974797|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
164713359|NCT00261443|594974798|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
164713360|NCT00261443|594974799|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
164713361|NCT00261443|594974797|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
164713362|NCT00261443|594974798|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
164713363|NCT00261443|594974799|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
164713364|NCT00261443|594974797|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
164713365|NCT00261443|594974798|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
164713366|NCT00261443|594974799|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
164713367|NCT00261443|594974797|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
164713368|NCT00261443|594974798|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
164713369|NCT00261443|594974799|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
164713370|NCT00261443|594974797|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
164713371|NCT00261443|594974798|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
164713372|NCT00261443|594974799|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
164713373|NCT00261443|594974797|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
164713374|NCT00261443|594974798|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
164713375|NCT00261443|594974799|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
164713376|NCT00261443|594974797|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
164713377|NCT00261443|594974798|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
164713378|NCT00261443|594974799|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
164713379|NCT00261443|594974797|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
164713380|NCT00261443|594974798|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
164713381|NCT00261443|594974799|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
164713382|NCT00261443|594974797|FG000|3: Assessment of Relapse|Adverse Event|0|||
164713383|NCT00261443|594974798|FG001|3: Assessment of Relapse|Adverse Event|15|||
164713384|NCT00261443|594974799|FG002|3: Assessment of Relapse|Adverse Event|19|||
164713385|NCT00261443|594974797|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
164713386|NCT00261443|594974798|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
164713387|NCT00261443|594974799|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
164713388|NCT00261443|594974797|FG000|3: Assessment of Relapse|Death|0|||
164472775|NCT01288443|594103952|FG004|Overall Study|Study drug auto-injector administration|1|||
164472776|NCT01288443|594103953|FG005|Overall Study|Study drug auto-injector administration|1|||
164472777|NCT01288443|594103948|FG000|Overall Study|Other than above|0|||
164472778|NCT01288443|594103949|FG001|Overall Study|Other than above|0|||
164472779|NCT01288443|594103950|FG002|Overall Study|Other than above|0|||
164472780|NCT01288443|594103951|FG003|Overall Study|Other than above|2|||
164472781|NCT01288443|594103952|FG004|Overall Study|Other than above|1|||
164472782|NCT01288443|594103953|FG005|Overall Study|Other than above|0|||
164472783|NCT01596972|594103954|FG000|Overall Study|Physician Decision|1|||
164472784|NCT01596972|594103955|FG001|Overall Study|Physician Decision|9|||
164472785|NCT01596972|594103954|FG000|Overall Study|Lost to Follow-up|0|||
164472786|NCT01596972|594103955|FG001|Overall Study|Lost to Follow-up|4|||
164472787|NCT01596972|594103954|FG000|Overall Study|Withdrawal by Subject|0|||
164472788|NCT01596972|594103955|FG001|Overall Study|Withdrawal by Subject|1|||
164472789|NCT01639131|594103957|FG000|Overall Study|Disease Progression|6|||
164472790|NCT00945321|594103961|FG000|Period 1|Adverse Event|0|||
164472791|NCT00945321|594103962|FG001|Period 1|Adverse Event|0|||
164472792|NCT00945321|594103963|FG002|Period 1|Adverse Event|0|||
164713389|NCT00261443|594974798|FG001|3: Assessment of Relapse|Death|0|||
164713390|NCT00261443|594974799|FG002|3: Assessment of Relapse|Death|1|||
164713391|NCT00261443|594974797|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
164713392|NCT00261443|594974798|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
164713393|NCT00261443|594974799|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
164713394|NCT00261443|594974797|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
164713395|NCT00261443|594974798|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
164713396|NCT00261443|594974799|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
164472793|NCT00945321|594103964|FG003|Period 1|Adverse Event|0|||
164472794|NCT00945321|594103965|FG004|Period 1|Adverse Event|1|||
164472795|NCT00945321|594103966|FG005|Period 1|Adverse Event|0|||
164472796|NCT00945321|594103961|FG000|Period 4|Lost to Follow-up|0|||
164472797|NCT00945321|594103962|FG001|Period 4|Lost to Follow-up|0|||
164472798|NCT00945321|594103963|FG002|Period 4|Lost to Follow-up|0|||
164472799|NCT00945321|594103964|FG003|Period 4|Lost to Follow-up|0|||
164472800|NCT00945321|594103965|FG004|Period 4|Lost to Follow-up|0|||
164472801|NCT00945321|594103966|FG005|Period 4|Lost to Follow-up|1|||
164472802|NCT02438137|594103967|FG000|Overall Study|Lost to Follow-up|3|||
164472803|NCT02438137|594103968|FG001|Overall Study|Lost to Follow-up|2|||
164472804|NCT02438137|594103967|FG000|Overall Study|Adverse Event|1|||
164472805|NCT02438137|594103968|FG001|Overall Study|Adverse Event|0|||
164713397|NCT00261443|594974797|FG000|3: Assessment of Relapse|Pregnancy|0|||
164713398|NCT00261443|594974798|FG001|3: Assessment of Relapse|Pregnancy|2|||
164713399|NCT00261443|594974799|FG002|3: Assessment of Relapse|Pregnancy|1|||
164713400|NCT00261443|594974797|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
164713401|NCT00261443|594974798|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
164713402|NCT00261443|594974799|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
164713403|NCT00261443|594974797|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
164713404|NCT00261443|594974798|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
164713405|NCT00261443|594974799|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
164713406|NCT00261443|594974797|FG000|3: Assessment of Relapse|Other Reasons|0|||
164713407|NCT00261443|594974798|FG001|3: Assessment of Relapse|Other Reasons|4|||
164713408|NCT00261443|594974799|FG002|3: Assessment of Relapse|Other Reasons|3|||
164713409|NCT00261443|594974797|FG000|4: Extension Phase|Adverse Event|0|||
164713410|NCT00261443|594974798|FG001|4: Extension Phase|Adverse Event|1|||
164713411|NCT00261443|594974799|FG002|4: Extension Phase|Adverse Event|0|||
164713412|NCT00261443|594974797|FG000|4: Extension Phase|Withdrawal by Subject|0|||
164713413|NCT00261443|594974798|FG001|4: Extension Phase|Withdrawal by Subject|1|||
164713414|NCT00261443|594974799|FG002|4: Extension Phase|Withdrawal by Subject|2|||
164713415|NCT00261443|594974797|FG000|4: Extension Phase|Lost to Follow-up|0|||
164713416|NCT00261443|594974798|FG001|4: Extension Phase|Lost to Follow-up|1|||
164713417|NCT00261443|594974799|FG002|4: Extension Phase|Lost to Follow-up|0|||
164713418|NCT02755649|594974800|FG000|Overall Study|Transitioned into OLE study|99|||
164713419|NCT02755649|594974801|FG001|Overall Study|Transitioned into OLE study|98|||
164713420|NCT02755649|594974802|FG002|Overall Study|Transitioned into OLE study|100|||
164713421|NCT02755649|594974800|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
164713422|NCT02755649|594974801|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
164713423|NCT02755649|594974802|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
164713424|NCT02755649|594974800|FG000|Overall Study|Physician Decision|0|||
164713425|NCT02755649|594974801|FG001|Overall Study|Physician Decision|0|||
164713426|NCT02755649|594974802|FG002|Overall Study|Physician Decision|2|||
164713427|NCT02755649|594974800|FG000|Overall Study|Withdrawal by Subject|0|||
164713428|NCT02755649|594974801|FG001|Overall Study|Withdrawal by Subject|1|||
164713429|NCT02755649|594974802|FG002|Overall Study|Withdrawal by Subject|0|||
164713430|NCT02755649|594974800|FG000|Overall Study|Undecided|1|||
164713431|NCT02755649|594974801|FG001|Overall Study|Undecided|0|||
164713432|NCT02755649|594974802|FG002|Overall Study|Undecided|0|||
164713433|NCT01286753|594974803|FG000|Overall Study|Adverse Event|7|||
164713434|NCT01286753|594974804|FG001|Overall Study|Adverse Event|6|||
164713435|NCT01286753|594974803|FG000|Overall Study|Progression|11|||
164713436|NCT01286753|594974804|FG001|Overall Study|Progression|13|||
164713437|NCT01286753|594974803|FG000|Overall Study|Refused Treatment|1|||
164713438|NCT01286753|594974804|FG001|Overall Study|Refused Treatment|0|||
164713439|NCT01286753|594974803|FG000|Overall Study|Withdrawal of Consent|0|||
164713440|NCT01286753|594974804|FG001|Overall Study|Withdrawal of Consent|2|||
164713441|NCT01286753|594974803|FG000|Overall Study|Discontinued to Join Extension Study|6|||
164713442|NCT01286753|594974804|FG001|Overall Study|Discontinued to Join Extension Study|4|||
164713443|NCT01286753|594974803|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
164713444|NCT01286753|594974804|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
164472806|NCT02438137|594103967|FG000|Overall Study|Withdrawal by Subject|4|||
164472807|NCT02438137|594103968|FG001|Overall Study|Withdrawal by Subject|3|||
164472808|NCT02438137|594103967|FG000|Overall Study|Physician Decision|0|||
164472809|NCT02438137|594103968|FG001|Overall Study|Physician Decision|1|||
164472810|NCT03248492|594103979|FG000|Overall Study|Progressive Disease|24|||
164472811|NCT03248492|594103980|FG001|Overall Study|Progressive Disease|23|||
164472812|NCT03248492|594103981|FG002|Overall Study|Progressive Disease|11|||
164472813|NCT03248492|594103982|FG003|Overall Study|Progressive Disease|66|||
164472814|NCT03248492|594103983|FG004|Overall Study|Progressive Disease|1|||
164472815|NCT03248492|594103979|FG000|Overall Study|Adverse Event|14|||
164472816|NCT03248492|594103980|FG001|Overall Study|Adverse Event|13|||
164472817|NCT03248492|594103981|FG002|Overall Study|Adverse Event|9|||
164472818|NCT03248492|594103982|FG003|Overall Study|Adverse Event|22|||
164472819|NCT03248492|594103983|FG004|Overall Study|Adverse Event|2|||
164472820|NCT03248492|594103979|FG000|Overall Study|Withdrawal by Subject|5|||
164472821|NCT03248492|594103980|FG001|Overall Study|Withdrawal by Subject|4|||
164472822|NCT03248492|594103981|FG002|Overall Study|Withdrawal by Subject|0|||
164472823|NCT03248492|594103982|FG003|Overall Study|Withdrawal by Subject|8|||
164472824|NCT03248492|594103983|FG004|Overall Study|Withdrawal by Subject|1|||
164472825|NCT03248492|594103979|FG000|Overall Study|Physician Decision|1|||
164472826|NCT03248492|594103980|FG001|Overall Study|Physician Decision|1|||
164472827|NCT03248492|594103981|FG002|Overall Study|Physician Decision|1|||
164472828|NCT03248492|594103982|FG003|Overall Study|Physician Decision|7|||
164472829|NCT03248492|594103983|FG004|Overall Study|Physician Decision|0|||
164472830|NCT03248492|594103979|FG000|Overall Study|Death|1|||
164472831|NCT03248492|594103980|FG001|Overall Study|Death|1|||
164713445|NCT02126826|594974808|FG000|Overall Study|Withdrawal by Subject|0|||
164472832|NCT03248492|594103981|FG002|Overall Study|Death|0|||
164713446|NCT02126826|594974809|FG001|Overall Study|Withdrawal by Subject|0|||
164713447|NCT02126826|594974810|FG002|Overall Study|Withdrawal by Subject|0|||
164713448|NCT02126826|594974811|FG003|Overall Study|Withdrawal by Subject|1|||
164713449|NCT02126826|594974812|FG004|Overall Study|Withdrawal by Subject|0|||
164713450|NCT02126826|594974813|FG005|Overall Study|Withdrawal by Subject|0|||
164713451|NCT02126826|594974814|FG006|Overall Study|Withdrawal by Subject|0|||
164713452|NCT01371747|594974815|FG000|Overall Study|Adverse Event|4|||
164472833|NCT03248492|594103982|FG003|Overall Study|Death|6|||
164472834|NCT03248492|594103983|FG004|Overall Study|Death|0|||
164472835|NCT03248492|594103979|FG000|Overall Study|Study Terminated by Sponsor|3|||
164472836|NCT03248492|594103980|FG001|Overall Study|Study Terminated by Sponsor|1|||
164472837|NCT03248492|594103981|FG002|Overall Study|Study Terminated by Sponsor|0|||
164472838|NCT03248492|594103982|FG003|Overall Study|Study Terminated by Sponsor|7|||
164472839|NCT03248492|594103983|FG004|Overall Study|Study Terminated by Sponsor|0|||
164472840|NCT03248492|594103979|FG000|Overall Study|Other|2|||
164472841|NCT03248492|594103980|FG001|Overall Study|Other|5|||
164472842|NCT03248492|594103981|FG002|Overall Study|Other|0|||
164472843|NCT03248492|594103982|FG003|Overall Study|Other|14|||
164472844|NCT03248492|594103983|FG004|Overall Study|Other|0|||
164472845|NCT04495621|594103984|FG000|Overall Study|Withdrawal by Subject|0|||
164472846|NCT04495621|594103985|FG001|Overall Study|Withdrawal by Subject|3|||
164472847|NCT04495621|594103984|FG000|Overall Study|Death|7|||
164472848|NCT04495621|594103985|FG001|Overall Study|Death|11|||
164472849|NCT04495621|594103984|FG000|Overall Study|Investigator Decision|0|||
164472850|NCT04495621|594103985|FG001|Overall Study|Investigator Decision|7|||
164472851|NCT04495621|594103984|FG000|Overall Study|Lost to Follow-up|0|||
164472852|NCT04495621|594103985|FG001|Overall Study|Lost to Follow-up|1|||
164472853|NCT04012567|594103988|FG000|Overall Study|Lost to Follow-up|0|||
164472854|NCT04012567|594103989|FG001|Overall Study|Lost to Follow-up|1|||
164472855|NCT04012567|594103988|FG000|Overall Study|Withdrawal by Subject|1|||
164472856|NCT04012567|594103989|FG001|Overall Study|Withdrawal by Subject|0|||
164472857|NCT05714059|594103994|FG000|Overall Study|Withdrawal by Subject|2|||
164472858|NCT05714059|594103995|FG001|Overall Study|Withdrawal by Subject|2|||
164472859|NCT05714059|594103994|FG000|Overall Study|Adverse Event|0|||
164472860|NCT05714059|594103995|FG001|Overall Study|Adverse Event|1|||
164472861|NCT05714059|594103994|FG000|Overall Study|Lost to Follow-up|0|||
164472862|NCT05714059|594103995|FG001|Overall Study|Lost to Follow-up|1|||
164472863|NCT05714059|594103994|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
164472864|NCT05714059|594103995|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
164472865|NCT05714059|594103994|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
164472866|NCT05714059|594103995|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
164472867|NCT04899674|594103996|FG000|Test|Adverse Event|1|||
164472868|NCT04121741|594103999|FG000|Overall Study|Protocol Violation|1|||
164472869|NCT04121741|594104000|FG001|Overall Study|Protocol Violation|0|||
164472870|NCT04121741|594104001|FG002|Overall Study|Protocol Violation|0|||
164472871|NCT04121741|594104002|FG003|Overall Study|Protocol Violation|0|||
164472872|NCT04121741|594104003|FG004|Overall Study|Protocol Violation|0|||
164472873|NCT04121741|594104004|FG005|Overall Study|Protocol Violation|0|||
164472874|NCT01084863|594104005|FG000|Main Study Treatment Period|Disease progression|11|||
164472875|NCT01084863|594104006|FG001|Main Study Treatment Period|Disease progression|7|||
164472876|NCT01084863|594104005|FG000|Main Study Treatment Period|Adverse Event|5|||
164472877|NCT01084863|594104006|FG001|Main Study Treatment Period|Adverse Event|3|||
164472878|NCT01084863|594104005|FG000|Main Study Treatment Period|Other Reason|0|||
164472879|NCT01084863|594104006|FG001|Main Study Treatment Period|Other Reason|1|||
164472880|NCT01084863|594104005|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
164472881|NCT01084863|594104006|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
164472882|NCT01084863|594104005|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
164472883|NCT01084863|594104006|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
164472884|NCT01084863|594104005|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
164472885|NCT01084863|594104006|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
164472886|NCT01084863|594104005|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
164472887|NCT01084863|594104006|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
164472888|NCT01084863|594104005|FG000|Treatment Period Beyond Cycle 8|Other|0|||
164472889|NCT01084863|594104006|FG001|Treatment Period Beyond Cycle 8|Other|1|||
164472890|NCT01084863|594104005|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
164472891|NCT01084863|594104006|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
164472892|NCT04505722|594104008|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
164472893|NCT04505722|594104009|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
164472894|NCT04505722|594104010|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
164472895|NCT04505722|594104008|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
164472896|NCT04505722|594104009|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
164713453|NCT01371747|594974816|FG001|Overall Study|Adverse Event|2|||
164472897|NCT04505722|594104010|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
164472898|NCT04505722|594104008|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
164472899|NCT04505722|594104009|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
164472900|NCT04505722|594104010|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
164472901|NCT04505722|594104008|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
164472902|NCT04505722|594104009|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
164472903|NCT04505722|594104010|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
164472904|NCT04505722|594104008|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
164472905|NCT04505722|594104009|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
164472906|NCT04505722|594104010|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
164472907|NCT04505722|594104008|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
164472908|NCT04505722|594104009|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
164472909|NCT04505722|594104010|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
164472910|NCT04505722|594104008|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
164472911|NCT04505722|594104009|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
164472912|NCT04505722|594104010|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
164472913|NCT04505722|594104008|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
164472914|NCT04505722|594104009|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
164472915|NCT04505722|594104010|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
164472916|NCT04505722|594104008|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
164472917|NCT04505722|594104009|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
164472918|NCT04505722|594104010|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
164472919|NCT04505722|594104008|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
164472920|NCT04505722|594104009|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
164472921|NCT04505722|594104010|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
164472922|NCT04505722|594104008|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
164472923|NCT04505722|594104009|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
164472924|NCT04505722|594104010|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
164472925|NCT04505722|594104008|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
164472926|NCT04505722|594104009|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
164472927|NCT04505722|594104010|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
164472928|NCT04505722|594104008|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
164472929|NCT04505722|594104009|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
164472930|NCT04505722|594104010|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
164472931|NCT04505722|594104008|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
164472932|NCT04505722|594104009|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
164472933|NCT04505722|594104010|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
164472934|NCT04505722|594104008|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
164472935|NCT04505722|594104009|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
164472936|NCT04505722|594104010|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
164472937|NCT03473223|594104011|FG000|Overall Study|Lost to Follow-up|1|||
164472938|NCT03473223|594104012|FG001|Overall Study|Lost to Follow-up|1|||
164472939|NCT03473223|594104011|FG000|Overall Study|Withdrawal by Subject|47|||
164472940|NCT03473223|594104012|FG001|Overall Study|Withdrawal by Subject|42|||
164472941|NCT03473223|594104011|FG000|Overall Study|Indirect contact|32|||
164472942|NCT03473223|594104012|FG001|Overall Study|Indirect contact|29|||
164472943|NCT03473223|594104011|FG000|Overall Study|Other (Not specified)|32|||
164472944|NCT03473223|594104012|FG001|Overall Study|Other (Not specified)|20|||
164472945|NCT04755595|594104013|FG000|Overall Study|Lost to Follow-up|1|||
164472946|NCT04305327|594104016|FG000|Overall Study|Study early termination|2|||
164472947|NCT04305327|594104017|FG001|Overall Study|Study early termination|5|||
164472948|NCT04305327|594104018|FG002|Overall Study|Study early termination|2|||
164472949|NCT04305327|594104019|FG003|Overall Study|Study early termination|2|||
164472950|NCT04305327|594104016|FG000|Overall Study|Withdrawal by Subject|0|||
164472951|NCT04305327|594104017|FG001|Overall Study|Withdrawal by Subject|1|||
164472952|NCT04305327|594104018|FG002|Overall Study|Withdrawal by Subject|0|||
164472953|NCT04305327|594104019|FG003|Overall Study|Withdrawal by Subject|0|||
164472954|NCT02291913|594104775|FG000|Overall Study|Progressive Disease|32|||
164472955|NCT02291913|594104775|FG000|Overall Study|Adverse Event|11|||
164472956|NCT02291913|594104775|FG000|Overall Study|Death|2|||
164472957|NCT02291913|594104775|FG000|Overall Study|Physician Decision|1|||
164472958|NCT02291913|594104775|FG000|Overall Study|Withdrawal by Subject|1|||
164472959|NCT02291913|594104775|FG000|Overall Study|Protocol Violation|1|||
164472960|NCT04876417|594104776|FG000|Overall Study|Lost to Follow-up|5|||
164472961|NCT04876417|594104777|FG001|Overall Study|Lost to Follow-up|8|||
164472962|NCT04876417|594104778|FG002|Overall Study|Lost to Follow-up|0|||
164472963|NCT04876417|594104779|FG003|Overall Study|Lost to Follow-up|0|||
164472964|NCT04334317|594104780|FG000|Overall Study|Adverse Event|1|||
164472965|NCT04334317|594104781|FG001|Overall Study|Adverse Event|2|||
164472966|NCT04334317|594104782|FG002|Overall Study|Adverse Event|0|||
164472967|NCT04334317|594104783|FG003|Overall Study|Adverse Event|0|||
164472968|NCT04334317|594104780|FG000|Overall Study|Protocol Deviation|0|||
164472969|NCT04334317|594104781|FG001|Overall Study|Protocol Deviation|1|||
164472970|NCT04334317|594104782|FG002|Overall Study|Protocol Deviation|0|||
164472971|NCT04334317|594104783|FG003|Overall Study|Protocol Deviation|0|||
164472972|NCT04334317|594104780|FG000|Overall Study|Withdrawal by Subject|2|||
164472973|NCT04334317|594104781|FG001|Overall Study|Withdrawal by Subject|2|||
164472974|NCT04334317|594104782|FG002|Overall Study|Withdrawal by Subject|0|||
164472975|NCT04334317|594104783|FG003|Overall Study|Withdrawal by Subject|0|||
164472976|NCT03621735|594104784|FG000|Overall Study|Withdrawal by Subject|13|||
164472977|NCT03621735|594104785|FG001|Overall Study|Withdrawal by Subject|13|||
164472978|NCT00605306|594104788|FG000|Overall Study|Adverse Event|0|||
164472979|NCT00605306|594104789|FG001|Overall Study|Adverse Event|1|||
164472980|NCT03875313|594104792|FG000|Overall Study|Withdrawal by Subject|1|||
164472981|NCT03875313|594104793|FG001|Overall Study|Withdrawal by Subject|3|||
164472982|NCT03875313|594104794|FG002|Overall Study|Withdrawal by Subject|0|||
164472983|NCT03875313|594104795|FG003|Overall Study|Withdrawal by Subject|0|||
164472984|NCT03875313|594104796|FG004|Overall Study|Withdrawal by Subject|0|||
164472985|NCT03875313|594104792|FG000|Overall Study|Death|0|||
164472986|NCT03875313|594104793|FG001|Overall Study|Death|0|||
164472987|NCT03875313|594104794|FG002|Overall Study|Death|0|||
164472988|NCT03875313|594104795|FG003|Overall Study|Death|0|||
164472989|NCT03875313|594104796|FG004|Overall Study|Death|1|||
164472990|NCT03875313|594104792|FG000|Overall Study|Lost to Follow-up|0|||
164472991|NCT03875313|594104793|FG001|Overall Study|Lost to Follow-up|0|||
164472992|NCT03875313|594104794|FG002|Overall Study|Lost to Follow-up|0|||
164472993|NCT03875313|594104795|FG003|Overall Study|Lost to Follow-up|0|||
164472994|NCT03875313|594104796|FG004|Overall Study|Lost to Follow-up|1|||
164472995|NCT03875313|594104792|FG000|Overall Study|Study Termination by Sponsor|0|||
164472996|NCT03875313|594104793|FG001|Overall Study|Study Termination by Sponsor|1|||
164472997|NCT03875313|594104794|FG002|Overall Study|Study Termination by Sponsor|1|||
164472998|NCT03875313|594104795|FG003|Overall Study|Study Termination by Sponsor|0|||
164472999|NCT03875313|594104796|FG004|Overall Study|Study Termination by Sponsor|1|||
164473000|NCT03875313|594104792|FG000|Overall Study|New Anticancer Treatment|0|||
164473001|NCT03875313|594104793|FG001|Overall Study|New Anticancer Treatment|1|||
164473002|NCT03875313|594104794|FG002|Overall Study|New Anticancer Treatment|2|||
164473003|NCT03875313|594104795|FG003|Overall Study|New Anticancer Treatment|1|||
164473004|NCT03875313|594104796|FG004|Overall Study|New Anticancer Treatment|0|||
164473005|NCT03875313|594104792|FG000|Overall Study|Other, Not Specified|2|||
164473006|NCT03875313|594104793|FG001|Overall Study|Other, Not Specified|11|||
164473007|NCT03875313|594104794|FG002|Overall Study|Other, Not Specified|3|||
164473008|NCT03875313|594104795|FG003|Overall Study|Other, Not Specified|3|||
164473009|NCT03875313|594104796|FG004|Overall Study|Other, Not Specified|1|||
164473010|NCT01092416|594104797|FG000|Enrollment|Atherectomy device not inserted|3|||
164473011|NCT01092416|594104797|FG000|30-Day Follow-up|Death|2|||
164473012|NCT01092416|594104797|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
164473013|NCT01092416|594104797|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
164473014|NCT01092416|594104797|FG000|12-Month Follow-up|Death|16|||
164473015|NCT01092416|594104797|FG000|12-Month Follow-up|Lost to Follow-up|4|||
164473016|NCT01092416|594104797|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
164473017|NCT01092416|594104797|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
164473018|NCT01092416|594104797|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
164473019|NCT03709706|594104798|FG000|Overall Study|Adverse Event|0|||
164473020|NCT03709706|594104799|FG001|Overall Study|Adverse Event|1|||
164473021|NCT03709706|594104798|FG000|Overall Study|Physician Decision|14|||
164473022|NCT03709706|594104799|FG001|Overall Study|Physician Decision|8|||
164473023|NCT03709706|594104798|FG000|Overall Study|Withdrawal by Subject|2|||
164473024|NCT03709706|594104799|FG001|Overall Study|Withdrawal by Subject|1|||
164473025|NCT03709706|594104798|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
164473026|NCT03709706|594104799|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
164473027|NCT01105975|594104800|FG000|Overall Study|Adverse Event|2|||
164473028|NCT01105975|594104801|FG001|Overall Study|Adverse Event|1|||
164473029|NCT01105975|594104802|FG002|Overall Study|Adverse Event|5|||
164473030|NCT01105975|594104803|FG003|Overall Study|Adverse Event|1|||
164473031|NCT01105975|594104804|FG004|Overall Study|Adverse Event|0|||
164473032|NCT01105975|594104805|FG005|Overall Study|Adverse Event|1|||
164473033|NCT01105975|594104806|FG006|Overall Study|Adverse Event|2|||
164713454|NCT01371747|594974817|FG002|Overall Study|Adverse Event|7|||
164713455|NCT01371747|594974818|FG003|Overall Study|Adverse Event|2|||
164473034|NCT01105975|594104807|FG007|Overall Study|Adverse Event|4|||
164473035|NCT01105975|594104808|FG008|Overall Study|Adverse Event|1|||
164473036|NCT01105975|594104809|FG009|Overall Study|Adverse Event|4|||
164473037|NCT01105975|594104800|FG000|Overall Study|Withdrawal by Subject|2|||
164473038|NCT01105975|594104801|FG001|Overall Study|Withdrawal by Subject|2|||
164473039|NCT01105975|594104802|FG002|Overall Study|Withdrawal by Subject|2|||
164473040|NCT01105975|594104803|FG003|Overall Study|Withdrawal by Subject|0|||
164473041|NCT01105975|594104804|FG004|Overall Study|Withdrawal by Subject|4|||
164473042|NCT01105975|594104805|FG005|Overall Study|Withdrawal by Subject|1|||
164473043|NCT01105975|594104806|FG006|Overall Study|Withdrawal by Subject|2|||
164713456|NCT01371747|594974819|FG004|Overall Study|Adverse Event|2|||
164144828|NCT04289363|592891793|FG001|Overall Study|Lost to Follow-up|0|||
164713457|NCT01371747|594974820|FG005|Overall Study|Adverse Event|2|||
164473044|NCT01105975|594104807|FG007|Overall Study|Withdrawal by Subject|1|||
164473045|NCT01105975|594104808|FG008|Overall Study|Withdrawal by Subject|0|||
164473046|NCT01105975|594104809|FG009|Overall Study|Withdrawal by Subject|3|||
164473047|NCT01105975|594104800|FG000|Overall Study|Lost to Follow-up|1|||
164473048|NCT01105975|594104801|FG001|Overall Study|Lost to Follow-up|0|||
164473049|NCT01105975|594104802|FG002|Overall Study|Lost to Follow-up|0|||
164473050|NCT01105975|594104803|FG003|Overall Study|Lost to Follow-up|1|||
164473051|NCT01105975|594104804|FG004|Overall Study|Lost to Follow-up|1|||
164473052|NCT01105975|594104805|FG005|Overall Study|Lost to Follow-up|0|||
164473053|NCT01105975|594104806|FG006|Overall Study|Lost to Follow-up|0|||
164473054|NCT01105975|594104807|FG007|Overall Study|Lost to Follow-up|0|||
164473055|NCT01105975|594104808|FG008|Overall Study|Lost to Follow-up|1|||
164473056|NCT01105975|594104809|FG009|Overall Study|Lost to Follow-up|0|||
164473057|NCT01105975|594104800|FG000|Overall Study|Physician Decision|0|||
164473058|NCT01105975|594104801|FG001|Overall Study|Physician Decision|0|||
164473059|NCT01105975|594104802|FG002|Overall Study|Physician Decision|0|||
164473060|NCT01105975|594104803|FG003|Overall Study|Physician Decision|0|||
164473061|NCT01105975|594104804|FG004|Overall Study|Physician Decision|0|||
164473062|NCT01105975|594104805|FG005|Overall Study|Physician Decision|0|||
164473063|NCT01105975|594104806|FG006|Overall Study|Physician Decision|2|||
164473064|NCT01105975|594104807|FG007|Overall Study|Physician Decision|0|||
164473065|NCT01105975|594104808|FG008|Overall Study|Physician Decision|0|||
164473066|NCT01105975|594104809|FG009|Overall Study|Physician Decision|0|||
164473067|NCT01105975|594104800|FG000|Overall Study|Protocol Violation|0|||
164473068|NCT01105975|594104801|FG001|Overall Study|Protocol Violation|2|||
164473069|NCT01105975|594104802|FG002|Overall Study|Protocol Violation|2|||
164473070|NCT01105975|594104803|FG003|Overall Study|Protocol Violation|0|||
164473071|NCT01105975|594104804|FG004|Overall Study|Protocol Violation|1|||
164473072|NCT01105975|594104805|FG005|Overall Study|Protocol Violation|1|||
164473073|NCT01105975|594104806|FG006|Overall Study|Protocol Violation|1|||
164473074|NCT01105975|594104807|FG007|Overall Study|Protocol Violation|1|||
164473075|NCT01105975|594104808|FG008|Overall Study|Protocol Violation|2|||
164473076|NCT01105975|594104809|FG009|Overall Study|Protocol Violation|2|||
164473077|NCT01105975|594104800|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
164473078|NCT01105975|594104801|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
164473079|NCT01105975|594104802|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
164473080|NCT01105975|594104803|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
164473081|NCT01105975|594104804|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
164473082|NCT01105975|594104805|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
164473083|NCT01105975|594104806|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
164473084|NCT01105975|594104807|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
164473085|NCT01105975|594104808|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
164473086|NCT01105975|594104809|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
164473087|NCT04868617|594104810|FG000|Overall Study|Death|1|||
164473088|NCT04868617|594104811|FG001|Overall Study|Death|0|||
164473089|NCT04868617|594104810|FG000|Overall Study|Adverse Event|1|||
164473090|NCT04868617|594104811|FG001|Overall Study|Adverse Event|0|||
164473091|NCT04868617|594104810|FG000|Overall Study|Withdrawal by Subject|1|||
164473092|NCT04868617|594104811|FG001|Overall Study|Withdrawal by Subject|0|||
164473093|NCT04868617|594104810|FG000|Overall Study|Device deficiency|1|||
164473094|NCT04868617|594104811|FG001|Overall Study|Device deficiency|0|||
164473095|NCT00686595|594104814|FG000|Overall Study|Adverse Event|3|||
164473096|NCT00686595|594104814|FG000|Overall Study|Protocol Violation|1|||
164473097|NCT00686595|594104814|FG000|Overall Study|Lost to Follow-up|1|||
164473098|NCT00686595|594104814|FG000|Overall Study|Lack of Efficacy|1|||
164713458|NCT01371747|594974815|FG000|Overall Study|Death|1|||
164473099|NCT00686595|594104814|FG000|Overall Study|Poor Compliance|1|||
164473100|NCT01315132|594104817|FG000|Overall Study|not treated due to disease progression|1|||
164473101|NCT03774472|594104825|FG000|Overall Study|Physician Decision|1|||
164473102|NCT03774472|594104826|FG001|Overall Study|Physician Decision|0|||
164473103|NCT03774472|594104827|FG002|Overall Study|Physician Decision|0|||
164473104|NCT03774472|594104825|FG000|Overall Study|Progression prior to 4 weeks|0|||
164473105|NCT03774472|594104826|FG001|Overall Study|Progression prior to 4 weeks|1|||
164473106|NCT03774472|594104827|FG002|Overall Study|Progression prior to 4 weeks|0|||
164473107|NCT03774472|594104825|FG000|Overall Study|Withdrawal by Subject|0|||
164473108|NCT03774472|594104826|FG001|Overall Study|Withdrawal by Subject|1|||
164473109|NCT03774472|594104827|FG002|Overall Study|Withdrawal by Subject|0|||
164713459|NCT01371747|594974816|FG001|Overall Study|Death|0|||
164713460|NCT01371747|594974817|FG002|Overall Study|Death|4|||
164713461|NCT01371747|594974818|FG003|Overall Study|Death|1|||
164473110|NCT04059406|594104832|FG000|Overall Study|Early Treatment Termination|5|||
164473111|NCT04059406|594104833|FG001|Overall Study|Early Treatment Termination|5|||
164473112|NCT04059406|594104834|FG002|Overall Study|Early Treatment Termination|15|||
164473113|NCT05155306|594104835|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
164473114|NCT05155306|594104836|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
164713462|NCT01371747|594974819|FG004|Overall Study|Death|2|||
164713463|NCT01371747|594974820|FG005|Overall Study|Death|0|||
164473115|NCT05155306|594104837|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
164473116|NCT05155306|594104838|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
164473117|NCT05155306|594104835|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
164473118|NCT05155306|594104836|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
164473119|NCT05155306|594104837|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
164473120|NCT05155306|594104838|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
164473121|NCT00319696|594104842|FG000|Overall Study|Adverse Event|36|||
164473122|NCT00319696|594104842|FG000|Overall Study|withdrawal of consent|14|||
164473123|NCT00319696|594104842|FG000|Overall Study|administrative|7|||
164473124|NCT00319696|594104842|FG000|Overall Study|Lost to Follow-up|3|||
164473125|NCT03777657|594104844|FG000|Overall Study|Death|397|||
164473126|NCT03777657|594104845|FG001|Overall Study|Death|431|||
164473127|NCT03777657|594104844|FG000|Overall Study|Study Closed by Sponsor|77|||
164473128|NCT03777657|594104845|FG001|Overall Study|Study Closed by Sponsor|38|||
164473129|NCT03777657|594104844|FG000|Overall Study|Withdrawal by Subject|20|||
164473130|NCT03777657|594104845|FG001|Overall Study|Withdrawal by Subject|17|||
164473131|NCT03777657|594104844|FG000|Overall Study|Lost to Follow-up|6|||
164473132|NCT03777657|594104845|FG001|Overall Study|Lost to Follow-up|10|||
164473133|NCT02549352|594104848|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
164473134|NCT02549352|594104849|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
164473135|NCT02549352|594104848|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
164473136|NCT02549352|594104849|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
164473137|NCT02549352|594104848|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
164473138|NCT02549352|594104849|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
164473139|NCT02549352|594104848|FG000|12-month Follow-up|Withdrawal by Subject|4|||
164473140|NCT02549352|594104849|FG001|12-month Follow-up|Withdrawal by Subject|5|||
164473141|NCT02549352|594104848|FG000|12-month Follow-up|Lost to Follow-up|3|||
164473142|NCT02549352|594104849|FG001|12-month Follow-up|Lost to Follow-up|2|||
164473143|NCT02549352|594104848|FG000|12-month Follow-up|Death|0|||
164473144|NCT02549352|594104849|FG001|12-month Follow-up|Death|1|||
164473145|NCT02549352|594104848|FG000|12-month Follow-up|Protocol Violation|0|||
164473146|NCT02549352|594104849|FG001|12-month Follow-up|Protocol Violation|1|||
164473147|NCT02549352|594104848|FG000|12-month Follow-up|Other|1|||
164473148|NCT02549352|594104849|FG001|12-month Follow-up|Other|3|||
164473149|NCT04129450|594104851|FG000|Overall Study|Lost to Follow-up|20|||
164473150|NCT04129450|594104852|FG001|Overall Study|Lost to Follow-up|10|||
164473151|NCT04129450|594104851|FG000|Overall Study|Withdrawal by Subject|9|||
164473152|NCT04129450|594104852|FG001|Overall Study|Withdrawal by Subject|5|||
164473153|NCT04129450|594104851|FG000|Overall Study|Work Family Obligations|2|||
164473154|NCT04129450|594104852|FG001|Overall Study|Work Family Obligations|0|||
164473155|NCT04129450|594104851|FG000|Overall Study|Other|3|||
164473156|NCT04129450|594104852|FG001|Overall Study|Other|0|||
164473157|NCT01574716|594105500|FG000|Part 1|Death|3|||
164473158|NCT01574716|594105501|FG001|Part 1|Death|1|||
164473159|NCT01574716|594105502|FG002|Part 1|Death|8|||
164473160|NCT01574716|594105503|FG003|Part 1|Death|0|||
164473161|NCT01574716|594105504|FG004|Part 1|Death|0|||
164473162|NCT01574716|594105500|FG000|Part 1|Discontinuation of study by sponsor|0|||
164473163|NCT01574716|594105501|FG001|Part 1|Discontinuation of study by sponsor|0|||
164473164|NCT01574716|594105502|FG002|Part 1|Discontinuation of study by sponsor|1|||
164473165|NCT01574716|594105503|FG003|Part 1|Discontinuation of study by sponsor|0|||
164473166|NCT01574716|594105504|FG004|Part 1|Discontinuation of study by sponsor|0|||
164473167|NCT01574716|594105500|FG000|Part 1|Withdrawal by Subject|0|||
164473168|NCT01574716|594105501|FG001|Part 1|Withdrawal by Subject|2|||
164473169|NCT01574716|594105502|FG002|Part 1|Withdrawal by Subject|0|||
164473170|NCT01574716|594105503|FG003|Part 1|Withdrawal by Subject|0|||
164473171|NCT01574716|594105504|FG004|Part 1|Withdrawal by Subject|0|||
164473172|NCT01574716|594105500|FG000|Part 1|Lost to Follow-up|0|||
164473173|NCT01574716|594105501|FG001|Part 1|Lost to Follow-up|1|||
164473174|NCT01574716|594105502|FG002|Part 1|Lost to Follow-up|0|||
164473175|NCT01574716|594105503|FG003|Part 1|Lost to Follow-up|0|||
164473176|NCT01574716|594105504|FG004|Part 1|Lost to Follow-up|0|||
164473177|NCT01574716|594105500|FG000|Part 2|Progressive disease|0|||
164473178|NCT01574716|594105501|FG001|Part 2|Progressive disease|0|||
164473179|NCT01574716|594105502|FG002|Part 2|Progressive disease|0|||
164473180|NCT01574716|594105503|FG003|Part 2|Progressive disease|1|||
164473181|NCT01574716|594105504|FG004|Part 2|Progressive disease|0|||
164473182|NCT01574716|594105500|FG000|Part 2|Death|0|||
164473183|NCT01574716|594105501|FG001|Part 2|Death|0|||
164473184|NCT01574716|594105502|FG002|Part 2|Death|0|||
164473185|NCT01574716|594105503|FG003|Part 2|Death|76|||
164473186|NCT01574716|594105504|FG004|Part 2|Death|35|||
164473187|NCT01574716|594105500|FG000|Part 2|Discontinuation of study by sponsor|0|||
164473188|NCT01574716|594105501|FG001|Part 2|Discontinuation of study by sponsor|0|||
164473189|NCT01574716|594105502|FG002|Part 2|Discontinuation of study by sponsor|0|||
164473190|NCT01574716|594105503|FG003|Part 2|Discontinuation of study by sponsor|51|||
164473191|NCT01574716|594105504|FG004|Part 2|Discontinuation of study by sponsor|31|||
164473192|NCT01574716|594105500|FG000|Part 2|Withdrawal by Subject|0|||
164473193|NCT01574716|594105501|FG001|Part 2|Withdrawal by Subject|0|||
164473194|NCT01574716|594105502|FG002|Part 2|Withdrawal by Subject|0|||
164473195|NCT01574716|594105503|FG003|Part 2|Withdrawal by Subject|5|||
164473196|NCT01574716|594105504|FG004|Part 2|Withdrawal by Subject|4|||
164473197|NCT01574716|594105500|FG000|Part 2|Brain metastases|0|||
164473198|NCT01574716|594105501|FG001|Part 2|Brain metastases|0|||
164473199|NCT01574716|594105502|FG002|Part 2|Brain metastases|0|||
164473200|NCT01574716|594105503|FG003|Part 2|Brain metastases|1|||
164713464|NCT01371747|594974815|FG000|Overall Study|Abnormal Renal Function|0|||
164713465|NCT01371747|594974816|FG001|Overall Study|Abnormal Renal Function|2|||
164713466|NCT01371747|594974817|FG002|Overall Study|Abnormal Renal Function|0|||
164713467|NCT01371747|594974818|FG003|Overall Study|Abnormal Renal Function|1|||
164713468|NCT01371747|594974819|FG004|Overall Study|Abnormal Renal Function|0|||
164713469|NCT01371747|594974820|FG005|Overall Study|Abnormal Renal Function|1|||
164713470|NCT01371747|594974815|FG000|Overall Study|High Serum Potassium Results|1|||
164713471|NCT01371747|594974816|FG001|Overall Study|High Serum Potassium Results|1|||
164713472|NCT01371747|594974817|FG002|Overall Study|High Serum Potassium Results|1|||
164713473|NCT01371747|594974818|FG003|Overall Study|High Serum Potassium Results|2|||
164713474|NCT01371747|594974819|FG004|Overall Study|High Serum Potassium Results|0|||
164713475|NCT01371747|594974820|FG005|Overall Study|High Serum Potassium Results|2|||
164713476|NCT01371747|594974815|FG000|Overall Study|Low Serum Potassium Results|1|||
164713477|NCT01371747|594974816|FG001|Overall Study|Low Serum Potassium Results|1|||
164713478|NCT01371747|594974817|FG002|Overall Study|Low Serum Potassium Results|1|||
164713479|NCT01371747|594974818|FG003|Overall Study|Low Serum Potassium Results|1|||
164473201|NCT01574716|594105504|FG004|Part 2|Brain metastases|0|||
164473202|NCT01574716|594105500|FG000|Part 2|Lost to Follow-up|0|||
164473203|NCT01574716|594105501|FG001|Part 2|Lost to Follow-up|0|||
164473204|NCT01574716|594105502|FG002|Part 2|Lost to Follow-up|0|||
164473205|NCT01574716|594105503|FG003|Part 2|Lost to Follow-up|3|||
164473206|NCT01574716|594105504|FG004|Part 2|Lost to Follow-up|0|||
164473207|NCT03183050|594105505|FG000|Overall Study|Lost to Follow-up|23|||
164473208|NCT02797132|594105506|FG000|Part A (15 Days)|Adverse Event|1|||
164473209|NCT02797132|594105506|FG000|Part B (24 Weeks)|Adverse Event|3|||
164473210|NCT01074294|594105507|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
164473211|NCT01074294|594105508|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
164473212|NCT01074294|594105509|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
164473213|NCT01074294|594105510|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
164473214|NCT01074294|594105507|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
164473215|NCT01074294|594105508|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
164473216|NCT01074294|594105509|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
164473217|NCT01074294|594105510|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
164473218|NCT01074294|594105507|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
164473219|NCT01074294|594105508|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
164473220|NCT01074294|594105509|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
164473221|NCT01074294|594105510|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
164473222|NCT01074294|594105507|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
164473223|NCT01074294|594105508|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
164473224|NCT01074294|594105509|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
164473225|NCT01074294|594105510|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
164473226|NCT01074294|594105507|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
164473227|NCT01074294|594105508|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
164473228|NCT01074294|594105509|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
164473229|NCT01074294|594105510|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
164473230|NCT01074294|594105507|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
164473231|NCT01074294|594105508|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
164473232|NCT01074294|594105509|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
164473233|NCT01074294|594105510|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
164473234|NCT01074294|594105507|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
164713480|NCT01371747|594974819|FG004|Overall Study|Low Serum Potassium Results|0|||
164473235|NCT01074294|594105508|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
164473236|NCT01074294|594105509|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
164473237|NCT01074294|594105510|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
164473238|NCT01074294|594105507|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
164473239|NCT01074294|594105508|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
164473240|NCT01074294|594105509|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
164473241|NCT01074294|594105510|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
164713481|NCT01371747|594974820|FG005|Overall Study|Low Serum Potassium Results|3|||
164713482|NCT01371747|594974815|FG000|Overall Study|Protocol Violation|0|||
164473242|NCT01074294|594105507|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
164473243|NCT01074294|594105508|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
164713483|NCT01371747|594974816|FG001|Overall Study|Protocol Violation|0|||
164713484|NCT01371747|594974817|FG002|Overall Study|Protocol Violation|1|||
164473244|NCT01074294|594105509|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
164473245|NCT01074294|594105510|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
164473246|NCT01074294|594105507|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
164473247|NCT01074294|594105508|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
164473248|NCT01074294|594105509|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
164473249|NCT01074294|594105510|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
164473250|NCT01074294|594105507|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
164473251|NCT01074294|594105508|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
164473252|NCT01074294|594105509|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
164473253|NCT01074294|594105510|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
164473254|NCT01074294|594105507|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
164473255|NCT01074294|594105508|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
164473256|NCT01074294|594105509|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
164473257|NCT01074294|594105510|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
164473258|NCT01074294|594105507|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
164473259|NCT01074294|594105508|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
164473260|NCT01074294|594105509|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
164473261|NCT01074294|594105510|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
164473262|NCT00112359|594105511|FG000|Overall Study|Unrelated adverse event|16|||
164473263|NCT00112359|594105512|FG001|Overall Study|Unrelated adverse event|8|||
164473264|NCT00112359|594105511|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
164473265|NCT00112359|594105512|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
164473266|NCT00112359|594105511|FG000|Overall Study|Related adverse event|5|||
164473267|NCT00112359|594105512|FG001|Overall Study|Related adverse event|3|||
164473268|NCT00112359|594105511|FG000|Overall Study|Lost to Follow-up|0|||
164473269|NCT00112359|594105512|FG001|Overall Study|Lost to Follow-up|1|||
164473270|NCT00112359|594105511|FG000|Overall Study|Personal/administrative|1|||
164473271|NCT00112359|594105512|FG001|Overall Study|Personal/administrative|1|||
164473272|NCT00112359|594105511|FG000|Overall Study|Other|3|||
164473273|NCT00112359|594105512|FG001|Overall Study|Other|0|||
164473274|NCT01500200|594105513|FG000|Stage 1|Adverse Event|1|||
164473275|NCT01500200|594105514|FG001|Stage 1|Adverse Event|4|||
164473276|NCT01500200|594105515|FG002|Stage 1|Adverse Event|5|||
164473277|NCT01500200|594105516|FG003|Stage 1|Adverse Event|0|||
164473278|NCT01500200|594105517|FG004|Stage 1|Adverse Event|0|||
164473279|NCT01500200|594105518|FG005|Stage 1|Adverse Event|0|||
164473280|NCT01500200|594105513|FG000|Stage 1|Lost to Follow-up|2|||
164473281|NCT01500200|594105514|FG001|Stage 1|Lost to Follow-up|2|||
164473282|NCT01500200|594105515|FG002|Stage 1|Lost to Follow-up|1|||
164473283|NCT01500200|594105516|FG003|Stage 1|Lost to Follow-up|0|||
164473284|NCT01500200|594105517|FG004|Stage 1|Lost to Follow-up|0|||
164473285|NCT01500200|594105518|FG005|Stage 1|Lost to Follow-up|0|||
164473286|NCT01500200|594105513|FG000|Stage 1|Withdrawal by Subject|3|||
164473287|NCT01500200|594105514|FG001|Stage 1|Withdrawal by Subject|0|||
164473288|NCT01500200|594105515|FG002|Stage 1|Withdrawal by Subject|0|||
164473289|NCT01500200|594105516|FG003|Stage 1|Withdrawal by Subject|0|||
164473290|NCT01500200|594105517|FG004|Stage 1|Withdrawal by Subject|0|||
164473291|NCT01500200|594105518|FG005|Stage 1|Withdrawal by Subject|0|||
164473292|NCT01500200|594105513|FG000|Stage 1|Noncompliance with Study Drug|1|||
164473293|NCT01500200|594105514|FG001|Stage 1|Noncompliance with Study Drug|0|||
164473294|NCT01500200|594105515|FG002|Stage 1|Noncompliance with Study Drug|0|||
164473295|NCT01500200|594105516|FG003|Stage 1|Noncompliance with Study Drug|0|||
164473296|NCT01500200|594105517|FG004|Stage 1|Noncompliance with Study Drug|0|||
164473297|NCT01500200|594105518|FG005|Stage 1|Noncompliance with Study Drug|0|||
164473298|NCT01500200|594105513|FG000|Stage 1|Physician Decision|1|||
164473299|NCT01500200|594105514|FG001|Stage 1|Physician Decision|0|||
164473300|NCT01500200|594105515|FG002|Stage 1|Physician Decision|0|||
164473301|NCT01500200|594105516|FG003|Stage 1|Physician Decision|0|||
164473302|NCT01500200|594105517|FG004|Stage 1|Physician Decision|0|||
164473303|NCT01500200|594105518|FG005|Stage 1|Physician Decision|0|||
164473304|NCT01500200|594105513|FG000|Stage 2|Adverse Event|0|||
164473305|NCT01500200|594105514|FG001|Stage 2|Adverse Event|0|||
164473306|NCT01500200|594105515|FG002|Stage 2|Adverse Event|0|||
164473307|NCT01500200|594105516|FG003|Stage 2|Adverse Event|0|||
164473308|NCT01500200|594105517|FG004|Stage 2|Adverse Event|5|||
164473309|NCT01500200|594105518|FG005|Stage 2|Adverse Event|4|||
164473310|NCT00312208|594105519|FG000|Overall Study|Adverse Event|97|||
164473311|NCT00312208|594105520|FG001|Overall Study|Adverse Event|61|||
164473312|NCT00312208|594105519|FG000|Overall Study|Protocol Violation|5|||
164473313|NCT00312208|594105520|FG001|Overall Study|Protocol Violation|3|||
164473314|NCT00312208|594105519|FG000|Overall Study|Death|2|||
164473315|NCT00312208|594105520|FG001|Overall Study|Death|1|||
164473316|NCT00312208|594105519|FG000|Overall Study|Lack of Efficacy|7|||
164473317|NCT00312208|594105520|FG001|Overall Study|Lack of Efficacy|4|||
164473318|NCT00312208|594105519|FG000|Overall Study|Lost to Follow-up|3|||
164473319|NCT00312208|594105520|FG001|Overall Study|Lost to Follow-up|5|||
164713485|NCT01371747|594974818|FG003|Overall Study|Protocol Violation|0|||
164713486|NCT01371747|594974819|FG004|Overall Study|Protocol Violation|0|||
164713487|NCT01371747|594974820|FG005|Overall Study|Protocol Violation|0|||
164713488|NCT01371747|594974815|FG000|Overall Study|Non-Compliance|3|||
164713489|NCT01371747|594974816|FG001|Overall Study|Non-Compliance|4|||
164713490|NCT01371747|594974817|FG002|Overall Study|Non-Compliance|3|||
164713491|NCT01371747|594974818|FG003|Overall Study|Non-Compliance|0|||
164713492|NCT01371747|594974819|FG004|Overall Study|Non-Compliance|0|||
164713493|NCT01371747|594974820|FG005|Overall Study|Non-Compliance|1|||
164713494|NCT01371747|594974815|FG000|Overall Study|Physician Decision|0|||
164713495|NCT01371747|594974816|FG001|Overall Study|Physician Decision|0|||
164713496|NCT01371747|594974817|FG002|Overall Study|Physician Decision|0|||
164713497|NCT01371747|594974818|FG003|Overall Study|Physician Decision|0|||
164713498|NCT01371747|594974819|FG004|Overall Study|Physician Decision|1|||
164713499|NCT01371747|594974820|FG005|Overall Study|Physician Decision|0|||
164713500|NCT01371747|594974815|FG000|Overall Study|Withdrawal by Subject|6|||
164713501|NCT01371747|594974816|FG001|Overall Study|Withdrawal by Subject|12|||
164713502|NCT01371747|594974817|FG002|Overall Study|Withdrawal by Subject|5|||
164713503|NCT01371747|594974818|FG003|Overall Study|Withdrawal by Subject|2|||
164713504|NCT01371747|594974819|FG004|Overall Study|Withdrawal by Subject|2|||
164713505|NCT01371747|594974820|FG005|Overall Study|Withdrawal by Subject|4|||
164713506|NCT01371747|594974815|FG000|Overall Study|Other Reasons|2|||
164713507|NCT01371747|594974816|FG001|Overall Study|Other Reasons|1|||
164713508|NCT01371747|594974817|FG002|Overall Study|Other Reasons|2|||
164713509|NCT01371747|594974818|FG003|Overall Study|Other Reasons|0|||
164713510|NCT01371747|594974819|FG004|Overall Study|Other Reasons|0|||
164713511|NCT01371747|594974820|FG005|Overall Study|Other Reasons|1|||
164713512|NCT03092219|594974821|FG000|Overall Study|Protocol Violation|7|||
164713513|NCT03092219|594974822|FG001|Overall Study|Protocol Violation|4|||
164713514|NCT05013008|594974829|FG000|Overall Study|Exclusion from mBFAS|5|||
164713515|NCT05013008|594974830|FG001|Overall Study|Exclusion from mBFAS|25|||
164713516|NCT02094417|594974831|FG000|Overall Study|Adverse Event|0|||
164713517|NCT02094417|594974832|FG001|Overall Study|Adverse Event|0|||
164713518|NCT02094417|594974833|FG002|Overall Study|Adverse Event|0|||
164713519|NCT02094417|594974834|FG003|Overall Study|Adverse Event|1|||
164713520|NCT02094417|594974831|FG000|Overall Study|Eligibility criteria|0|||
164713521|NCT02094417|594974832|FG001|Overall Study|Eligibility criteria|1|||
164713522|NCT02094417|594974833|FG002|Overall Study|Eligibility criteria|0|||
164713523|NCT02094417|594974834|FG003|Overall Study|Eligibility criteria|0|||
164713524|NCT02094417|594974831|FG000|Overall Study|No responder|4|||
164713525|NCT02094417|594974832|FG001|Overall Study|No responder|4|||
164713526|NCT02094417|594974833|FG002|Overall Study|No responder|4|||
164473320|NCT00312208|594105519|FG000|Overall Study|Withdrawal by Subject|53|||
164473321|NCT00312208|594105520|FG001|Overall Study|Withdrawal by Subject|42|||
164473322|NCT00312208|594105519|FG000|Overall Study|Other|5|||
164473323|NCT00312208|594105520|FG001|Overall Study|Other|7|||
164473324|NCT01218659|594105522|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
164473325|NCT01218659|594105523|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
164473326|NCT01218659|594105524|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
164473327|NCT01218659|594105522|FG000|18-Month Randomized Period|Did not receive study drug|0|||
164473328|NCT01218659|594105523|FG001|18-Month Randomized Period|Did not receive study drug|3|||
164473329|NCT01218659|594105524|FG002|18-Month Randomized Period|Did not receive study drug|0|||
164473330|NCT01218659|594105522|FG000|12-Month OLE|Withdrawal by Subject|0|||
164473331|NCT01218659|594105523|FG001|12-Month OLE|Withdrawal by Subject|0|||
164473332|NCT01218659|594105524|FG002|12-Month OLE|Withdrawal by Subject|2|||
164473333|NCT01218659|594105522|FG000|12-Month OLE|Physician Decision|0|||
164473334|NCT01218659|594105523|FG001|12-Month OLE|Physician Decision|0|||
164473335|NCT01218659|594105524|FG002|12-Month OLE|Physician Decision|1|||
164473336|NCT01218659|594105522|FG000|12-Month OLE|Lost to Follow-up|0|||
164713527|NCT02094417|594974834|FG003|Overall Study|No responder|3|||
164713528|NCT02094417|594974831|FG000|Overall Study|Unable to conduct observations or assess|0|||
164713529|NCT02094417|594974832|FG001|Overall Study|Unable to conduct observations or assess|1|||
164713530|NCT02094417|594974833|FG002|Overall Study|Unable to conduct observations or assess|0|||
164713531|NCT02094417|594974834|FG003|Overall Study|Unable to conduct observations or assess|0|||
164713532|NCT02094417|594974831|FG000|Overall Study|Withdrawal by Subject|1|||
164713533|NCT02094417|594974832|FG001|Overall Study|Withdrawal by Subject|2|||
164713534|NCT02094417|594974833|FG002|Overall Study|Withdrawal by Subject|1|||
164713535|NCT02094417|594974834|FG003|Overall Study|Withdrawal by Subject|3|||
164473337|NCT01218659|594105523|FG001|12-Month OLE|Lost to Follow-up|0|||
164473338|NCT01218659|594105524|FG002|12-Month OLE|Lost to Follow-up|1|||
164473339|NCT01218659|594105522|FG000|12-Month OLE|Pregnancy|0|||
164713536|NCT01443728|594974835|FG000|Overall Study|Lost to Follow-up|2|||
164713537|NCT01443728|594974836|FG001|Overall Study|Lost to Follow-up|0|||
164713538|NCT01443728|594974835|FG000|Overall Study|Withdrawal by Subject|1|||
164713539|NCT01443728|594974836|FG001|Overall Study|Withdrawal by Subject|1|||
164713540|NCT01443728|594974835|FG000|Overall Study|Adverse Event|0|||
164713541|NCT01443728|594974836|FG001|Overall Study|Adverse Event|2|||
164473340|NCT01218659|594105523|FG001|12-Month OLE|Pregnancy|0|||
164473341|NCT01218659|594105524|FG002|12-Month OLE|Pregnancy|1|||
164473342|NCT01218659|594105522|FG000|12-Month OLE|Lack of Efficacy|0|||
164473343|NCT01218659|594105523|FG001|12-Month OLE|Lack of Efficacy|0|||
164473344|NCT01218659|594105524|FG002|12-Month OLE|Lack of Efficacy|1|||
164473345|NCT01218659|594105522|FG000|12-Month OLE|Declined to participate in the OLE|0|||
164473346|NCT01218659|594105523|FG001|12-Month OLE|Declined to participate in the OLE|0|||
164473347|NCT01218659|594105524|FG002|12-Month OLE|Declined to participate in the OLE|4|||
164473348|NCT03066609|594105527|FG000|INDUCTION|Pregnancy|0|||
164473349|NCT03066609|594105528|FG001|INDUCTION|Pregnancy|0|||
164473350|NCT03066609|594105529|FG002|INDUCTION|Pregnancy|1|||
164473351|NCT03066609|594105530|FG003|INDUCTION|Pregnancy|0|||
164473352|NCT03066609|594105527|FG000|INDUCTION|Lack of Efficacy|0|||
164473353|NCT03066609|594105528|FG001|INDUCTION|Lack of Efficacy|0|||
164473354|NCT03066609|594105529|FG002|INDUCTION|Lack of Efficacy|1|||
164473355|NCT03066609|594105530|FG003|INDUCTION|Lack of Efficacy|0|||
164473356|NCT03066609|594105527|FG000|INDUCTION|Adverse Event|2|||
164473357|NCT03066609|594105528|FG001|INDUCTION|Adverse Event|2|||
164473358|NCT03066609|594105529|FG002|INDUCTION|Adverse Event|0|||
164473359|NCT03066609|594105530|FG003|INDUCTION|Adverse Event|0|||
164473360|NCT03066609|594105527|FG000|MAINTENANCE|Adverse Event|0|||
164473361|NCT03066609|594105528|FG001|MAINTENANCE|Adverse Event|0|||
164473362|NCT03066609|594105529|FG002|MAINTENANCE|Adverse Event|0|||
164473363|NCT03066609|594105530|FG003|MAINTENANCE|Adverse Event|1|||
164473364|NCT03066609|594105527|FG000|MAINTENANCE|Withdrawal by Subject|4|||
164473365|NCT03066609|594105528|FG001|MAINTENANCE|Withdrawal by Subject|2|||
164473366|NCT03066609|594105529|FG002|MAINTENANCE|Withdrawal by Subject|1|||
164473367|NCT03066609|594105530|FG003|MAINTENANCE|Withdrawal by Subject|1|||
164473368|NCT03066609|594105527|FG000|MAINTENANCE|Lost to Follow-up|0|||
164473369|NCT03066609|594105528|FG001|MAINTENANCE|Lost to Follow-up|1|||
164473370|NCT03066609|594105529|FG002|MAINTENANCE|Lost to Follow-up|1|||
164473371|NCT03066609|594105530|FG003|MAINTENANCE|Lost to Follow-up|0|||
164473372|NCT03066609|594105527|FG000|MAINTENANCE|Pregnancy|1|||
164473373|NCT03066609|594105528|FG001|MAINTENANCE|Pregnancy|0|||
164473374|NCT03066609|594105529|FG002|MAINTENANCE|Pregnancy|0|||
164473375|NCT03066609|594105530|FG003|MAINTENANCE|Pregnancy|0|||
164473376|NCT03066609|594105527|FG000|MAINTENANCE|Lack of Efficacy|2|||
164473377|NCT03066609|594105528|FG001|MAINTENANCE|Lack of Efficacy|1|||
164473378|NCT03066609|594105529|FG002|MAINTENANCE|Lack of Efficacy|0|||
164473379|NCT03066609|594105530|FG003|MAINTENANCE|Lack of Efficacy|1|||
164473380|NCT03066609|594105527|FG000|OVERALL STUDY|Adverse Event|2|||
164473381|NCT03066609|594105528|FG001|OVERALL STUDY|Adverse Event|2|||
164473382|NCT03066609|594105529|FG002|OVERALL STUDY|Adverse Event|0|||
164473383|NCT03066609|594105530|FG003|OVERALL STUDY|Adverse Event|1|||
164473384|NCT03066609|594105527|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
164473385|NCT03066609|594105528|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
164473386|NCT03066609|594105529|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
164473387|NCT03066609|594105530|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
164473388|NCT03066609|594105527|FG000|OVERALL STUDY|Lost to Follow-up|1|||
164473389|NCT03066609|594105528|FG001|OVERALL STUDY|Lost to Follow-up|1|||
164473390|NCT03066609|594105529|FG002|OVERALL STUDY|Lost to Follow-up|1|||
164473391|NCT03066609|594105530|FG003|OVERALL STUDY|Lost to Follow-up|1|||
164473392|NCT03066609|594105527|FG000|OVERALL STUDY|Pregnancy|1|||
164473393|NCT03066609|594105528|FG001|OVERALL STUDY|Pregnancy|0|||
164473394|NCT03066609|594105529|FG002|OVERALL STUDY|Pregnancy|1|||
164473395|NCT03066609|594105530|FG003|OVERALL STUDY|Pregnancy|0|||
164473396|NCT03066609|594105527|FG000|OVERALL STUDY|Lack of Efficacy|2|||
164473397|NCT03066609|594105528|FG001|OVERALL STUDY|Lack of Efficacy|1|||
164473398|NCT03066609|594105529|FG002|OVERALL STUDY|Lack of Efficacy|1|||
164473399|NCT03066609|594105530|FG003|OVERALL STUDY|Lack of Efficacy|1|||
164473400|NCT03066609|594105527|FG000|OVERALL STUDY|discontinued follow up|0|||
164473401|NCT03066609|594105528|FG001|OVERALL STUDY|discontinued follow up|2|||
164473402|NCT03066609|594105529|FG002|OVERALL STUDY|discontinued follow up|0|||
164473403|NCT03066609|594105530|FG003|OVERALL STUDY|discontinued follow up|0|||
164473404|NCT02284113|594105531|FG000|Overall Study|Adverse Event|1|||
164473405|NCT02284113|594105532|FG001|Overall Study|Adverse Event|0|||
164473406|NCT02284113|594105531|FG000|Overall Study|non-compliance|0|||
164473407|NCT02284113|594105532|FG001|Overall Study|non-compliance|1|||
164473408|NCT02284113|594105531|FG000|Overall Study|Withdrawal by Subject|0|||
164473409|NCT02284113|594105532|FG001|Overall Study|Withdrawal by Subject|1|||
164473410|NCT02284113|594105531|FG000|Overall Study|not provided|0|||
164473411|NCT02284113|594105532|FG001|Overall Study|not provided|1|||
164473412|NCT02284113|594105531|FG000|Overall Study|surgery cancelled|2|||
164473413|NCT02284113|594105532|FG001|Overall Study|surgery cancelled|0|||
164473414|NCT01324310|594105535|FG000|Overall Study|Adverse Event|1|||
164473415|NCT01324310|594105535|FG000|Overall Study|Disease Progression|1|||
164473416|NCT03170882|594105536|FG000|Overall Study|Death|17|||
164473417|NCT03170882|594105537|FG001|Overall Study|Death|29|||
164473418|NCT03170882|594105536|FG000|Overall Study|Lost to Follow-up|0|||
164473419|NCT03170882|594105537|FG001|Overall Study|Lost to Follow-up|1|||
164473420|NCT03170882|594105536|FG000|Overall Study|Withdrawal by Subject|4|||
164473421|NCT03170882|594105537|FG001|Overall Study|Withdrawal by Subject|7|||
164473422|NCT03170882|594105536|FG000|Overall Study|Reason not Specified|28|||
164473423|NCT03170882|594105537|FG001|Overall Study|Reason not Specified|36|||
164473424|NCT03213457|594105538|FG000|Screening Period|Withdrawal by Subject|0|||
164473425|NCT03213457|594105539|FG001|Screening Period|Withdrawal by Subject|1|||
164473426|NCT03213457|594105540|FG002|Screening Period|Withdrawal by Subject|0|||
164473427|NCT03213457|594105538|FG000|Screening Period|Other|1|||
164473428|NCT03213457|594105539|FG001|Screening Period|Other|0|||
164473429|NCT03213457|594105540|FG002|Screening Period|Other|0|||
164473430|NCT03213457|594105538|FG000|Double-Blind Period|Adverse Event|3|||
164473431|NCT03213457|594105539|FG001|Double-Blind Period|Adverse Event|2|||
164473432|NCT03213457|594105540|FG002|Double-Blind Period|Adverse Event|7|||
164473433|NCT03213457|594105538|FG000|Double-Blind Period|Withdrawal by Subject|14|||
164473434|NCT03213457|594105539|FG001|Double-Blind Period|Withdrawal by Subject|2|||
164473435|NCT03213457|594105540|FG002|Double-Blind Period|Withdrawal by Subject|14|||
164473436|NCT03213457|594105538|FG000|Double-Blind Period|Lost to Follow-up|2|||
164473437|NCT03213457|594105539|FG001|Double-Blind Period|Lost to Follow-up|3|||
164473438|NCT03213457|594105540|FG002|Double-Blind Period|Lost to Follow-up|9|||
164473439|NCT03213457|594105538|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
164473440|NCT03213457|594105539|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
164473441|NCT03213457|594105540|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
164473442|NCT03213457|594105538|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
164473443|NCT03213457|594105539|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
164473444|NCT03213457|594105540|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
164473445|NCT03213457|594105538|FG000|Double-Blind Period|Pregnancy|5|||
164473446|NCT03213457|594105539|FG001|Double-Blind Period|Pregnancy|0|||
164473447|NCT03213457|594105540|FG002|Double-Blind Period|Pregnancy|0|||
164473448|NCT03213457|594105538|FG000|Double-Blind Period|Other|10|||
164473449|NCT03213457|594105539|FG001|Double-Blind Period|Other|3|||
164473450|NCT03213457|594105540|FG002|Double-Blind Period|Other|17|||
164473451|NCT03213457|594105538|FG000|Open-Label Period|Adverse Event|1|||
164473452|NCT03213457|594105539|FG001|Open-Label Period|Adverse Event|2|||
164473453|NCT03213457|594105540|FG002|Open-Label Period|Adverse Event|2|||
164473454|NCT03213457|594105538|FG000|Open-Label Period|Withdrawal by Subject|12|||
164473455|NCT03213457|594105539|FG001|Open-Label Period|Withdrawal by Subject|5|||
164473456|NCT03213457|594105540|FG002|Open-Label Period|Withdrawal by Subject|24|||
164473457|NCT03213457|594105538|FG000|Open-Label Period|Lost to Follow-up|1|||
164473458|NCT03213457|594105539|FG001|Open-Label Period|Lost to Follow-up|2|||
164473459|NCT03213457|594105540|FG002|Open-Label Period|Lost to Follow-up|8|||
164473460|NCT03213457|594105538|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
164473461|NCT03213457|594105539|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
164473462|NCT03213457|594105540|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
164473463|NCT03213457|594105538|FG000|Open-Label Period|Non-compliance with study procedures|1|||
164473464|NCT03213457|594105539|FG001|Open-Label Period|Non-compliance with study procedures|1|||
164473465|NCT03213457|594105540|FG002|Open-Label Period|Non-compliance with study procedures|2|||
164473466|NCT03213457|594105538|FG000|Open-Label Period|Exclusionary medications|0|||
164473467|NCT03213457|594105539|FG001|Open-Label Period|Exclusionary medications|0|||
164473468|NCT03213457|594105540|FG002|Open-Label Period|Exclusionary medications|1|||
164473469|NCT03213457|594105538|FG000|Open-Label Period|Other|1|||
164473470|NCT03213457|594105539|FG001|Open-Label Period|Other|1|||
164473471|NCT03213457|594105540|FG002|Open-Label Period|Other|6|||
164473472|NCT03213457|594105538|FG000|Follow-Up Period|Adverse Event|16|||
164473473|NCT03213457|594105539|FG001|Follow-Up Period|Adverse Event|8|||
164473474|NCT03213457|594105540|FG002|Follow-Up Period|Adverse Event|37|||
164473475|NCT03213457|594105538|FG000|Follow-Up Period|Withdrawal by Subject|18|||
164473476|NCT03213457|594105539|FG001|Follow-Up Period|Withdrawal by Subject|11|||
164473477|NCT03213457|594105540|FG002|Follow-Up Period|Withdrawal by Subject|55|||
164473478|NCT03213457|594105538|FG000|Follow-Up Period|Lost to Follow-up|28|||
164473479|NCT03213457|594105539|FG001|Follow-Up Period|Lost to Follow-up|15|||
164713542|NCT00887289|594974839|FG000|Overall Study|Lack of Efficacy|14|||
164473480|NCT03213457|594105540|FG002|Follow-Up Period|Lost to Follow-up|50|||
164473481|NCT03213457|594105538|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
164473482|NCT03213457|594105539|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
164473483|NCT03213457|594105540|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
164473484|NCT03213457|594105538|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
164473485|NCT03213457|594105539|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
164473486|NCT03213457|594105540|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
164713543|NCT00887289|594974839|FG000|Overall Study|Adverse Event|27|||
164473487|NCT03213457|594105538|FG000|Follow-Up Period|Pregnancy|7|||
164473488|NCT03213457|594105539|FG001|Follow-Up Period|Pregnancy|0|||
164599850|NCT04167306|594556382|FG002|Overall Study|concomitant medication|0|||
164713544|NCT00887289|594974839|FG000|Overall Study|Withdrawal by Subject|26|||
164713545|NCT00887289|594974839|FG000|Overall Study|Lost to Follow-up|8|||
164473489|NCT03213457|594105540|FG002|Follow-Up Period|Pregnancy|18|||
164473490|NCT03213457|594105538|FG000|Follow-Up Period|Exclusionary medications|1|||
164473491|NCT03213457|594105539|FG001|Follow-Up Period|Exclusionary medications|1|||
164473492|NCT03213457|594105540|FG002|Follow-Up Period|Exclusionary medications|5|||
164473493|NCT03213457|594105538|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
164473494|NCT03213457|594105539|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
164473495|NCT03213457|594105540|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
164473496|NCT03213457|594105538|FG000|Follow-Up Period|Other|14|||
164473497|NCT03213457|594105539|FG001|Follow-Up Period|Other|10|||
164473498|NCT03213457|594105540|FG002|Follow-Up Period|Other|31|||
164473499|NCT05116774|594105541|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
164473500|NCT05116774|594105542|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
164473501|NCT05116774|594105541|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
164473502|NCT05116774|594105542|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
164713546|NCT00887289|594974839|FG000|Overall Study|Other|20|||
164713547|NCT00591773|594974842|FG000|Overall Study|Adverse Event|9|||
164713548|NCT00591773|594974843|FG001|Overall Study|Adverse Event|9|||
164713549|NCT00591773|594974844|FG002|Overall Study|Adverse Event|6|||
164713550|NCT00591773|594974842|FG000|Overall Study|Protocol Violation|2|||
164713551|NCT00591773|594974843|FG001|Overall Study|Protocol Violation|3|||
164713552|NCT00591773|594974844|FG002|Overall Study|Protocol Violation|0|||
164713553|NCT00591773|594974842|FG000|Overall Study|Lost to Follow-up|1|||
164713554|NCT00591773|594974843|FG001|Overall Study|Lost to Follow-up|4|||
164713555|NCT00591773|594974844|FG002|Overall Study|Lost to Follow-up|1|||
164713556|NCT00591773|594974842|FG000|Overall Study|Withdrawal by Subject|2|||
164713557|NCT00591773|594974843|FG001|Overall Study|Withdrawal by Subject|5|||
164713558|NCT00591773|594974844|FG002|Overall Study|Withdrawal by Subject|3|||
164713559|NCT00591773|594974842|FG000|Overall Study|Lack of Efficacy|1|||
164713560|NCT00591773|594974843|FG001|Overall Study|Lack of Efficacy|2|||
164713561|NCT00591773|594974844|FG002|Overall Study|Lack of Efficacy|2|||
164713562|NCT00591773|594974842|FG000|Overall Study|Other|1|||
164713563|NCT00591773|594974843|FG001|Overall Study|Other|1|||
164713564|NCT00591773|594974844|FG002|Overall Study|Other|4|||
164713565|NCT02135614|594974845|FG000|Overall Study|Randomized but Not Treated|2|||
164473503|NCT05116774|594105541|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
164473504|NCT05116774|594105542|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
164473505|NCT05116774|594105541|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
164713566|NCT02135614|594974846|FG001|Overall Study|Randomized but Not Treated|1|||
164713567|NCT02135614|594974845|FG000|Overall Study|Adverse Event|0|||
164713568|NCT02135614|594974846|FG001|Overall Study|Adverse Event|1|||
164713569|NCT02135614|594974845|FG000|Overall Study|Death|1|||
164713570|NCT02135614|594974846|FG001|Overall Study|Death|0|||
164713571|NCT02135614|594974845|FG000|Overall Study|Investigator's Discretion|0|||
164713572|NCT02135614|594974846|FG001|Overall Study|Investigator's Discretion|1|||
164713573|NCT02135614|594974845|FG000|Overall Study|Withdrew Consent|2|||
164713574|NCT02135614|594974846|FG001|Overall Study|Withdrew Consent|2|||
164713575|NCT02135614|594974845|FG000|Overall Study|Lost to Follow-up|3|||
164713576|NCT02135614|594974846|FG001|Overall Study|Lost to Follow-up|0|||
164713577|NCT03022084|594974847|FG000|Overall Study|Lost to Follow-up|2|||
164713578|NCT03022084|594974848|FG001|Overall Study|Lost to Follow-up|3|||
164713579|NCT02640482|594974849|FG000|Overall Study|Lost to Follow-up|3|||
164713580|NCT02640482|594974850|FG001|Overall Study|Lost to Follow-up|0|||
164713581|NCT00554606|594974851|FG000|Overall Study|Adverse Event|3|||
164713582|NCT00554606|594974851|FG000|Overall Study|Abnormal laboratory values|1|||
164713583|NCT00554606|594974851|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
164713584|NCT00554606|594974851|FG000|Overall Study|Subject withdrew consent|2|||
164713585|NCT00554606|594974851|FG000|Overall Study|Lost to Follow-up|2|||
164713586|NCT00554606|594974851|FG000|Overall Study|Administrative problems|60|||
164713587|NCT00554606|594974851|FG000|Overall Study|Death|1|||
164473506|NCT05116774|594105542|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
164473507|NCT03150862|594105543|FG000|Overall Study|Death|2|||
164713588|NCT00554606|594974851|FG000|Overall Study|Protocol deviation|2|||
164713589|NCT00605540|594974853|FG000|Overall Study|Death|15|||
164713590|NCT00605540|594974853|FG000|Overall Study|Lost to Follow-up|23|||
164473508|NCT03150862|594105544|FG001|Overall Study|Death|7|||
164713591|NCT00509366|594974854|FG000|Overall Study|Not Treated (Screen Failure)|1|||
164713592|NCT00509366|594974855|FG001|Overall Study|Not Treated (Screen Failure)|1|||
164713593|NCT00509366|594974856|FG002|Overall Study|Not Treated (Screen Failure)|1|||
164713594|NCT00509366|594974857|FG003|Overall Study|Not Treated (Screen Failure)|0|||
164713595|NCT00509366|594974858|FG004|Overall Study|Not Treated (Screen Failure)|0|||
164713596|NCT02119819|594974861|FG000|Overall Study|Adverse Event|3|||
164713597|NCT02119819|594974862|FG001|Overall Study|Adverse Event|1|||
164713598|NCT02119819|594974863|FG002|Overall Study|Adverse Event|2|||
164713599|NCT02119819|594974864|FG003|Overall Study|Adverse Event|3|||
164473509|NCT03150862|594105545|FG002|Overall Study|Death|8|||
164713600|NCT02119819|594974865|FG004|Overall Study|Adverse Event|0|||
164473510|NCT03150862|594105546|FG003|Overall Study|Death|27|||
164473511|NCT03150862|594105547|FG004|Overall Study|Death|4|||
164713601|NCT02119819|594974866|FG005|Overall Study|Adverse Event|1|||
164473512|NCT03150862|594105548|FG005|Overall Study|Death|8|||
164473513|NCT03150862|594105549|FG006|Overall Study|Death|6|||
164473514|NCT03150862|594105550|FG007|Overall Study|Death|21|||
164473515|NCT03150862|594105543|FG000|Overall Study|Withdrawal by Subject|1|||
164473516|NCT03150862|594105544|FG001|Overall Study|Withdrawal by Subject|1|||
164473517|NCT03150862|594105545|FG002|Overall Study|Withdrawal by Subject|0|||
164473518|NCT03150862|594105546|FG003|Overall Study|Withdrawal by Subject|3|||
164473519|NCT03150862|594105547|FG004|Overall Study|Withdrawal by Subject|1|||
164473520|NCT03150862|594105548|FG005|Overall Study|Withdrawal by Subject|1|||
164473521|NCT03150862|594105549|FG006|Overall Study|Withdrawal by Subject|1|||
164473522|NCT03150862|594105550|FG007|Overall Study|Withdrawal by Subject|3|||
164473523|NCT03150862|594105543|FG000|Overall Study|Lost to Follow-up|0|||
164473524|NCT03150862|594105544|FG001|Overall Study|Lost to Follow-up|0|||
164473525|NCT03150862|594105545|FG002|Overall Study|Lost to Follow-up|1|||
164473526|NCT03150862|594105546|FG003|Overall Study|Lost to Follow-up|0|||
164473527|NCT03150862|594105547|FG004|Overall Study|Lost to Follow-up|0|||
164473528|NCT03150862|594105548|FG005|Overall Study|Lost to Follow-up|0|||
164473529|NCT03150862|594105549|FG006|Overall Study|Lost to Follow-up|0|||
164473530|NCT03150862|594105550|FG007|Overall Study|Lost to Follow-up|2|||
164473531|NCT03150862|594105543|FG000|Overall Study|Sponsor's decision|0|||
164473532|NCT03150862|594105544|FG001|Overall Study|Sponsor's decision|0|||
164473533|NCT03150862|594105545|FG002|Overall Study|Sponsor's decision|0|||
164473534|NCT03150862|594105546|FG003|Overall Study|Sponsor's decision|10|||
164473535|NCT03150862|594105547|FG004|Overall Study|Sponsor's decision|3|||
164473536|NCT03150862|594105548|FG005|Overall Study|Sponsor's decision|0|||
164473537|NCT03150862|594105549|FG006|Overall Study|Sponsor's decision|1|||
164473538|NCT03150862|594105550|FG007|Overall Study|Sponsor's decision|1|||
164473539|NCT03150862|594105543|FG000|Overall Study|Change in Methylation status|0|||
164473540|NCT03150862|594105544|FG001|Overall Study|Change in Methylation status|0|||
164473541|NCT03150862|594105545|FG002|Overall Study|Change in Methylation status|0|||
164473542|NCT03150862|594105546|FG003|Overall Study|Change in Methylation status|0|||
164473543|NCT03150862|594105547|FG004|Overall Study|Change in Methylation status|1|||
164473544|NCT03150862|594105548|FG005|Overall Study|Change in Methylation status|0|||
164473545|NCT03150862|594105549|FG006|Overall Study|Change in Methylation status|0|||
164473546|NCT03150862|594105550|FG007|Overall Study|Change in Methylation status|0|||
164473547|NCT03150862|594105543|FG000|Overall Study|Roll over in to Long Term Extension|0|||
164473548|NCT03150862|594105544|FG001|Overall Study|Roll over in to Long Term Extension|0|||
164473549|NCT03150862|594105545|FG002|Overall Study|Roll over in to Long Term Extension|0|||
164473550|NCT03150862|594105546|FG003|Overall Study|Roll over in to Long Term Extension|0|||
164473551|NCT03150862|594105547|FG004|Overall Study|Roll over in to Long Term Extension|0|||
164473552|NCT03150862|594105548|FG005|Overall Study|Roll over in to Long Term Extension|0|||
164473553|NCT03150862|594105549|FG006|Overall Study|Roll over in to Long Term Extension|0|||
164473554|NCT03150862|594105550|FG007|Overall Study|Roll over in to Long Term Extension|1|||
164473555|NCT03150862|594105543|FG000|Overall Study|Progressive Disease|0|||
164473556|NCT03150862|594105544|FG001|Overall Study|Progressive Disease|0|||
164713602|NCT02119819|594974861|FG000|Overall Study|Lack of Efficacy|0|||
164713603|NCT02119819|594974862|FG001|Overall Study|Lack of Efficacy|0|||
164713604|NCT02119819|594974863|FG002|Overall Study|Lack of Efficacy|0|||
164713605|NCT02119819|594974864|FG003|Overall Study|Lack of Efficacy|0|||
164713606|NCT02119819|594974865|FG004|Overall Study|Lack of Efficacy|0|||
164713607|NCT02119819|594974866|FG005|Overall Study|Lack of Efficacy|1|||
164713608|NCT02119819|594974861|FG000|Overall Study|Lost to Follow-up|0|||
164713609|NCT02119819|594974862|FG001|Overall Study|Lost to Follow-up|0|||
164713610|NCT02119819|594974863|FG002|Overall Study|Lost to Follow-up|1|||
164713611|NCT02119819|594974864|FG003|Overall Study|Lost to Follow-up|2|||
164713612|NCT02119819|594974865|FG004|Overall Study|Lost to Follow-up|1|||
164713613|NCT02119819|594974866|FG005|Overall Study|Lost to Follow-up|2|||
164713614|NCT02119819|594974861|FG000|Overall Study|Physician Decision|1|||
164713615|NCT02119819|594974862|FG001|Overall Study|Physician Decision|1|||
164713616|NCT02119819|594974863|FG002|Overall Study|Physician Decision|0|||
164713617|NCT02119819|594974864|FG003|Overall Study|Physician Decision|0|||
164473557|NCT03150862|594105545|FG002|Overall Study|Progressive Disease|0|||
164473558|NCT03150862|594105546|FG003|Overall Study|Progressive Disease|0|||
164713618|NCT02119819|594974865|FG004|Overall Study|Physician Decision|0|||
164713619|NCT02119819|594974866|FG005|Overall Study|Physician Decision|1|||
164713620|NCT02119819|594974861|FG000|Overall Study|Withdrawal by Subject|5|||
164713621|NCT02119819|594974862|FG001|Overall Study|Withdrawal by Subject|3|||
164713622|NCT02119819|594974863|FG002|Overall Study|Withdrawal by Subject|0|||
164473559|NCT03150862|594105547|FG004|Overall Study|Progressive Disease|0|||
164473560|NCT03150862|594105548|FG005|Overall Study|Progressive Disease|0|||
164473561|NCT03150862|594105549|FG006|Overall Study|Progressive Disease|0|||
164473562|NCT03150862|594105550|FG007|Overall Study|Progressive Disease|2|||
164713623|NCT02119819|594974864|FG003|Overall Study|Withdrawal by Subject|0|||
164473563|NCT04158141|594105551|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
164713624|NCT02119819|594974865|FG004|Overall Study|Withdrawal by Subject|6|||
164473564|NCT04158141|594105552|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
164713625|NCT02119819|594974866|FG005|Overall Study|Withdrawal by Subject|10|||
164473565|NCT04158141|594105553|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
164473566|NCT04158141|594105551|FG000|Step 1: Registration|Adverse Event|1|||
164473567|NCT04158141|594105552|FG001|Step 1: Registration|Adverse Event|0|||
164473568|NCT04158141|594105553|FG002|Step 1: Registration|Adverse Event|0|||
164473569|NCT04158141|594105551|FG000|Step 1: Registration|Withdrawal by Subject|1|||
164473570|NCT04158141|594105552|FG001|Step 1: Registration|Withdrawal by Subject|0|||
164473571|NCT04158141|594105553|FG002|Step 1: Registration|Withdrawal by Subject|0|||
164473572|NCT04158141|594105551|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
164473573|NCT04158141|594105552|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
164473574|NCT04158141|594105553|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
164473575|NCT05521516|594105554|FG000|Overall Study|Withdrawal by Subject|1|||
164473576|NCT05521516|594105555|FG001|Overall Study|Withdrawal by Subject|1|||
164473577|NCT00747565|594105556|FG000|Overall Study|Withdrawal by Subject|10|||
164473578|NCT00747565|594105557|FG001|Overall Study|Withdrawal by Subject|6|||
164473579|NCT00747565|594105556|FG000|Overall Study|Lost to Follow-up|4|||
164473580|NCT00747565|594105557|FG001|Overall Study|Lost to Follow-up|1|||
164473581|NCT04559698|594105978|FG000|Overall Study|Lost to Follow-up|14|||
164473582|NCT04559698|594105979|FG001|Overall Study|Lost to Follow-up|15|||
164473583|NCT04559698|594105978|FG000|Overall Study|Withdrawal by Subject|0|||
164473584|NCT04559698|594105979|FG001|Overall Study|Withdrawal by Subject|1|||
164473585|NCT01982682|594105980|FG000|Overall Study|Physician Decision|1|||
164473586|NCT02760654|594105981|FG000|Overall Study|Lost to Follow-up|3|||
164473587|NCT02760654|594105982|FG001|Overall Study|Lost to Follow-up|3|||
164473588|NCT02760654|594105981|FG000|Overall Study|Withdrawal by Subject|4|||
164473589|NCT02760654|594105982|FG001|Overall Study|Withdrawal by Subject|3|||
164473590|NCT01128595|594105986|FG000|Treatment Period 3|Withdrawal by Subject|0|||
164473591|NCT01128595|594105987|FG001|Treatment Period 3|Withdrawal by Subject|1|||
164473592|NCT01128595|594105988|FG002|Treatment Period 3|Withdrawal by Subject|0|||
164473593|NCT01128595|594105989|FG003|Treatment Period 3|Withdrawal by Subject|0|||
164473594|NCT02502526|594105991|FG000|Overall Study|Lost to Follow-up|2|||
164473595|NCT02502526|594105992|FG001|Overall Study|Lost to Follow-up|2|||
164473596|NCT02502526|594105993|FG002|Overall Study|Lost to Follow-up|3|||
164473597|NCT02502526|594105991|FG000|Overall Study|Withdrawal by Subject|0|||
164473598|NCT02502526|594105992|FG001|Overall Study|Withdrawal by Subject|1|||
164473599|NCT02502526|594105993|FG002|Overall Study|Withdrawal by Subject|1|||
164473600|NCT02502526|594105991|FG000|Overall Study|Disqualified due to cataract grading|0|||
164473601|NCT02502526|594105992|FG001|Overall Study|Disqualified due to cataract grading|0|||
164473602|NCT02502526|594105993|FG002|Overall Study|Disqualified due to cataract grading|1|||
164473603|NCT02502526|594105991|FG000|Overall Study|Enrollment suspension|4|||
164473604|NCT02502526|594105992|FG001|Overall Study|Enrollment suspension|1|||
164473605|NCT02502526|594105993|FG002|Overall Study|Enrollment suspension|1|||
164473606|NCT02964741|594105995|FG000|Overall Study|Protocol Violation|1|||
164473607|NCT02964741|594105996|FG001|Overall Study|Protocol Violation|0|||
164473608|NCT02964741|594105997|FG002|Overall Study|Protocol Violation|0|||
164473609|NCT02964741|594105995|FG000|Overall Study|Withdrawal by Subject|0|||
164473610|NCT02964741|594105996|FG001|Overall Study|Withdrawal by Subject|1|||
164473611|NCT02964741|594105997|FG002|Overall Study|Withdrawal by Subject|0|||
164473612|NCT02964741|594105995|FG000|Overall Study|claustrophobia|1|||
164473613|NCT02964741|594105996|FG001|Overall Study|claustrophobia|0|||
164473614|NCT02964741|594105997|FG002|Overall Study|claustrophobia|0|||
164473615|NCT00640159|594106001|FG000|Overall Study|Lost to Follow-up|2|||
164473616|NCT03355573|594106002|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
164473617|NCT03355573|594106002|FG000|Overall Study|Sponsor's decision|1|||
164473618|NCT03355573|594106002|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
164473619|NCT03355573|594106002|FG000|Overall Study|PI's decision|2|||
164713626|NCT02119819|594974861|FG000|Overall Study|Jury Duty|0|||
164713627|NCT02119819|594974862|FG001|Overall Study|Jury Duty|0|||
164713628|NCT02119819|594974863|FG002|Overall Study|Jury Duty|1|||
164713629|NCT02119819|594974864|FG003|Overall Study|Jury Duty|0|||
164713630|NCT02119819|594974865|FG004|Overall Study|Jury Duty|0|||
164713631|NCT02119819|594974866|FG005|Overall Study|Jury Duty|0|||
164473620|NCT03355573|594106002|FG000|Overall Study|Withdrawal by Subject|23|||
164473621|NCT03355573|594106002|FG000|Overall Study|Lost to Follow-up|4|||
164473622|NCT03355573|594106002|FG000|Overall Study|Lack of Efficacy|2|||
164473623|NCT03355573|594106002|FG000|Overall Study|Adverse Event, non-fatal|17|||
164473624|NCT03355573|594106002|FG000|Overall Study|Adverse Event, serious fatal|2|||
164473625|NCT04191824|594106003|FG000|Overall Study|Death|13|||
164473626|NCT04191824|594106004|FG001|Overall Study|Death|12|||
164473627|NCT04191824|594106003|FG000|Overall Study|Lost to Follow-up|456|||
164473628|NCT04191824|594106004|FG001|Overall Study|Lost to Follow-up|435|||
164473629|NCT04191824|594106003|FG000|Overall Study|Physician Decision|2|||
164473630|NCT04191824|594106004|FG001|Overall Study|Physician Decision|1|||
164473631|NCT04191824|594106003|FG000|Overall Study|Protocol Violation|0|||
164473632|NCT04191824|594106004|FG001|Overall Study|Protocol Violation|2|||
164713632|NCT02119819|594974861|FG000|Overall Study|Protocol Violation|0|||
164713633|NCT02119819|594974862|FG001|Overall Study|Protocol Violation|0|||
164473633|NCT04191824|594106003|FG000|Overall Study|Withdrawal by Subject|16|||
164473634|NCT04191824|594106004|FG001|Overall Study|Withdrawal by Subject|18|||
164473635|NCT04191824|594106003|FG000|Overall Study|Early site closure|24|||
164473636|NCT04191824|594106004|FG001|Overall Study|Early site closure|22|||
164473637|NCT01218009|594106005|FG000|Overall Study|Protocol Violation|2|||
164473638|NCT01218009|594106006|FG001|Overall Study|Protocol Violation|1|||
164473639|NCT01218009|594106005|FG000|Overall Study|Withdrawal by Subject|3|||
164473640|NCT01218009|594106006|FG001|Overall Study|Withdrawal by Subject|1|||
164473641|NCT01218009|594106005|FG000|Overall Study|Sponsor terminated study|161|||
164473642|NCT01218009|594106006|FG001|Overall Study|Sponsor terminated study|163|||
164473643|NCT01371994|594106010|FG000|Overall Study|Adverse Event|3|||
164473644|NCT01371994|594106011|FG001|Overall Study|Adverse Event|6|||
164473645|NCT01371994|594106010|FG000|Overall Study|Lack of Efficacy|3|||
164473646|NCT01371994|594106011|FG001|Overall Study|Lack of Efficacy|0|||
164473647|NCT01371994|594106010|FG000|Overall Study|Withdrawal by Subject|13|||
164473648|NCT01371994|594106011|FG001|Overall Study|Withdrawal by Subject|7|||
164473649|NCT01371994|594106010|FG000|Overall Study|Lost to Follow-up|1|||
164473650|NCT01371994|594106011|FG001|Overall Study|Lost to Follow-up|1|||
164473651|NCT01371994|594106010|FG000|Overall Study|Protocol Violation|24|||
164713634|NCT02119819|594974863|FG002|Overall Study|Protocol Violation|0|||
164473652|NCT01371994|594106011|FG001|Overall Study|Protocol Violation|17|||
164473653|NCT01371994|594106010|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
164473654|NCT01371994|594106011|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
164473655|NCT01371994|594106010|FG000|Overall Study|Physician Decision|1|||
164473656|NCT01371994|594106011|FG001|Overall Study|Physician Decision|1|||
164713635|NCT02119819|594974864|FG003|Overall Study|Protocol Violation|1|||
164713636|NCT02119819|594974865|FG004|Overall Study|Protocol Violation|0|||
164713637|NCT02119819|594974866|FG005|Overall Study|Protocol Violation|0|||
164713638|NCT02119819|594974861|FG000|Overall Study|Left the city to get a job|0|||
164713639|NCT02119819|594974862|FG001|Overall Study|Left the city to get a job|0|||
164713640|NCT02119819|594974863|FG002|Overall Study|Left the city to get a job|0|||
164713641|NCT02119819|594974864|FG003|Overall Study|Left the city to get a job|1|||
164473657|NCT01371994|594106010|FG000|Overall Study|Miscellaneous Reasons|6|||
164473658|NCT01371994|594106011|FG001|Overall Study|Miscellaneous Reasons|4|||
164473659|NCT00087685|594106012|FG000|Overall Study|Adverse Event|5|||
164473660|NCT00087685|594106012|FG000|Overall Study|Non-Compliance|1|||
164473661|NCT00087685|594106012|FG000|Overall Study|Progressive Disease|5|||
164473662|NCT00087685|594106012|FG000|Overall Study|Withdrawal by Subject|3|||
164473663|NCT01830595|594106013|FG000|First Period|Withdrawal by Subject|1|||
164473664|NCT01830595|594106014|FG001|First Period|Withdrawal by Subject|3|||
164473665|NCT01830595|594106013|FG000|Washout|Withdrawal by Subject|2|||
164473666|NCT01830595|594106014|FG001|Washout|Withdrawal by Subject|2|||
164473667|NCT03280030|594106016|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
164473668|NCT03280030|594106017|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
164473669|NCT03280030|594106018|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
164473670|NCT03280030|594106016|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
164473671|NCT03280030|594106017|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
164473672|NCT03280030|594106018|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
164473673|NCT03280030|594106016|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
164473674|NCT03280030|594106017|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
164473675|NCT03280030|594106018|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
164473676|NCT03280030|594106016|FG000|Part 2 - Efficacy|Adverse Event|0|||
164473677|NCT03280030|594106017|FG001|Part 2 - Efficacy|Adverse Event|4|||
164473678|NCT03280030|594106018|FG002|Part 2 - Efficacy|Adverse Event|6|||
164473679|NCT03280030|594106016|FG000|Part 2 - Efficacy|Death|0|||
164473680|NCT03280030|594106017|FG001|Part 2 - Efficacy|Death|3|||
164473681|NCT03280030|594106018|FG002|Part 2 - Efficacy|Death|0|||
164473682|NCT03280030|594106016|FG000|Part 2 - Efficacy|Physician Decision|0|||
164473683|NCT03280030|594106017|FG001|Part 2 - Efficacy|Physician Decision|10|||
164473684|NCT03280030|594106018|FG002|Part 2 - Efficacy|Physician Decision|16|||
164473685|NCT03280030|594106016|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
164473686|NCT03280030|594106017|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
164473687|NCT03280030|594106018|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
164473688|NCT03280030|594106016|FG000|Part 2 - Efficacy|Progressive disease|0|||
164473689|NCT03280030|594106017|FG001|Part 2 - Efficacy|Progressive disease|7|||
164713642|NCT02119819|594974865|FG004|Overall Study|Left the city to get a job|0|||
164713643|NCT02119819|594974866|FG005|Overall Study|Left the city to get a job|0|||
164713644|NCT04497948|594974869|FG000|Overall Study|Death|2|||
164473690|NCT03280030|594106018|FG002|Part 2 - Efficacy|Progressive disease|5|||
164473691|NCT05139992|594106019|FG000|Overall Study|Withdrawal by Subject|12|||
164473692|NCT05139992|594106019|FG000|Overall Study|Lost to Follow-up|6|||
164473693|NCT03437733|594106914|FG000|Overall Study|Eligibility criteria not met|0|||
164473694|NCT03437733|594106915|FG001|Overall Study|Eligibility criteria not met|3|||
164473695|NCT01084694|594106916|FG000|Overall Study|Withdrawal by Subject|2|||
164473696|NCT01084694|594106917|FG001|Overall Study|Withdrawal by Subject|1|||
164599851|NCT04167306|594556383|FG003|Overall Study|concomitant medication|1|||
164713645|NCT01421511|594974875|FG000|Overall Study|Lost to Follow-up|11|||
164713646|NCT01421511|594974876|FG001|Overall Study|Lost to Follow-up|14|||
164713647|NCT01421511|594974875|FG000|Overall Study|Randomized but didn't receive study drug|1|||
164473697|NCT01084694|594106916|FG000|Overall Study|Death|2|||
164473698|NCT01084694|594106917|FG001|Overall Study|Death|12|||
164473699|NCT01084694|594106916|FG000|Overall Study|eligibility not maintained|2|||
164473700|NCT01084694|594106917|FG001|Overall Study|eligibility not maintained|7|||
164473701|NCT04017611|594106922|FG000|Overall Study|Withdrawn prior to completion|1|||
164473702|NCT02185794|594106935|FG000|Overall Study|Enrolled but Never Dosed|1|||
164713648|NCT01421511|594974876|FG001|Overall Study|Randomized but didn't receive study drug|7|||
164713649|NCT01421511|594974875|FG000|Overall Study|Physician Decision|0|||
164713650|NCT01421511|594974876|FG001|Overall Study|Physician Decision|1|||
164713651|NCT01421511|594974875|FG000|Overall Study|Withdrawal by Subject|6|||
164713652|NCT01421511|594974876|FG001|Overall Study|Withdrawal by Subject|5|||
164713653|NCT01421511|594974875|FG000|Overall Study|Death|1|||
164713654|NCT01421511|594974876|FG001|Overall Study|Death|1|||
164713655|NCT02242045|594974877|FG000|Overall Study|Investigator's Discretion|1|||
164713656|NCT02242045|594974877|FG000|Overall Study|Progressive Disease|2|||
164713657|NCT02242045|594974877|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
164713658|NCT02242045|594974877|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
164713659|NCT00749892|594974878|FG000|Overall Study|Withdrawal by Subject|3|||
164713660|NCT00106964|594974880|FG000|Overall Study|Lost to Follow-up|8|||
164713661|NCT00106964|594974881|FG001|Overall Study|Lost to Follow-up|6|||
164713662|NCT00106964|594974882|FG002|Overall Study|Lost to Follow-up|2|||
164713663|NCT00106964|594974880|FG000|Overall Study|Pregnancy|2|||
164713664|NCT00106964|594974881|FG001|Overall Study|Pregnancy|3|||
164713665|NCT00106964|594974882|FG002|Overall Study|Pregnancy|2|||
164713666|NCT00106964|594974880|FG000|Overall Study|Death|1|||
164713667|NCT00106964|594974881|FG001|Overall Study|Death|1|||
164713668|NCT00106964|594974882|FG002|Overall Study|Death|0|||
164713669|NCT00106964|594974880|FG000|Overall Study|Incarceration|0|||
164713670|NCT00106964|594974881|FG001|Overall Study|Incarceration|1|||
164713671|NCT00106964|594974882|FG002|Overall Study|Incarceration|0|||
164713672|NCT00106964|594974880|FG000|Overall Study|Site Funding Terminated|0|||
164713673|NCT00106964|594974881|FG001|Overall Study|Site Funding Terminated|1|||
164713674|NCT00106964|594974882|FG002|Overall Study|Site Funding Terminated|1|||
164713675|NCT00106964|594974880|FG000|Overall Study|Failure to adhere|2|||
164713676|NCT00106964|594974881|FG001|Overall Study|Failure to adhere|0|||
164713677|NCT00106964|594974882|FG002|Overall Study|Failure to adhere|0|||
164713678|NCT00106964|594974880|FG000|Overall Study|Did not meet eligibility criteria|0|||
164713679|NCT00106964|594974881|FG001|Overall Study|Did not meet eligibility criteria|2|||
164713680|NCT00106964|594974882|FG002|Overall Study|Did not meet eligibility criteria|2|||
164713681|NCT00106964|594974880|FG000|Overall Study|Required disallowed medication|0|||
164713682|NCT00106964|594974881|FG001|Overall Study|Required disallowed medication|1|||
164713683|NCT00106964|594974882|FG002|Overall Study|Required disallowed medication|0|||
164713684|NCT04040192|594974883|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
164713685|NCT04040192|594974884|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
164713686|NCT04040192|594974885|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
164713687|NCT04040192|594974883|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
164713688|NCT04040192|594974884|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
164713689|NCT04040192|594974885|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
164713690|NCT04040192|594974883|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
164713691|NCT04040192|594974884|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
164713692|NCT04040192|594974885|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
164473703|NCT02185794|594106936|FG001|Overall Study|Enrolled but Never Dosed|6|||
164473704|NCT02185794|594106937|FG002|Overall Study|Enrolled but Never Dosed|3|||
164473705|NCT02185794|594106938|FG003|Overall Study|Enrolled but Never Dosed|1|||
164473706|NCT02185794|594106939|FG004|Overall Study|Enrolled but Never Dosed|1|||
164473707|NCT02185794|594106940|FG005|Overall Study|Enrolled but Never Dosed|0|||
164473708|NCT02185794|594106935|FG000|Overall Study|Investigator's Discretion|1|||
164713693|NCT04040192|594974883|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
164713694|NCT04040192|594974884|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
164713695|NCT04040192|594974885|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
164713696|NCT04040192|594974883|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
164713697|NCT04040192|594974884|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
164713698|NCT04040192|594974885|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
164713699|NCT04040192|594974883|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
164713700|NCT04040192|594974884|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
164713701|NCT04040192|594974885|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
164713702|NCT04040192|594974883|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
164473709|NCT02185794|594106936|FG001|Overall Study|Investigator's Discretion|0|||
164473710|NCT02185794|594106937|FG002|Overall Study|Investigator's Discretion|1|||
164713703|NCT04040192|594974884|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
164713704|NCT04040192|594974885|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
164473711|NCT02185794|594106938|FG003|Overall Study|Investigator's Discretion|2|||
164473712|NCT02185794|594106939|FG004|Overall Study|Investigator's Discretion|2|||
164473713|NCT02185794|594106940|FG005|Overall Study|Investigator's Discretion|15|||
164473714|NCT02185794|594106935|FG000|Overall Study|Withdrew Consent|2|||
164473715|NCT02185794|594106936|FG001|Overall Study|Withdrew Consent|5|||
164473716|NCT02185794|594106937|FG002|Overall Study|Withdrew Consent|10|||
164473717|NCT02185794|594106938|FG003|Overall Study|Withdrew Consent|2|||
164473718|NCT02185794|594106939|FG004|Overall Study|Withdrew Consent|0|||
164473719|NCT02185794|594106940|FG005|Overall Study|Withdrew Consent|0|||
164473720|NCT02185794|594106935|FG000|Overall Study|Lost to Follow-up|1|||
164473721|NCT02185794|594106936|FG001|Overall Study|Lost to Follow-up|2|||
164473722|NCT02185794|594106937|FG002|Overall Study|Lost to Follow-up|2|||
164473723|NCT02185794|594106938|FG003|Overall Study|Lost to Follow-up|3|||
164473724|NCT02185794|594106939|FG004|Overall Study|Lost to Follow-up|0|||
164473725|NCT02185794|594106940|FG005|Overall Study|Lost to Follow-up|1|||
164473726|NCT00336505|594106941|FG000|Overall Study|Adverse Event|10|||
164473727|NCT00336505|594106942|FG001|Overall Study|Adverse Event|9|||
164473728|NCT00336505|594106941|FG000|Overall Study|Lack of Efficacy|8|||
164473729|NCT00336505|594106942|FG001|Overall Study|Lack of Efficacy|4|||
164473730|NCT00336505|594106941|FG000|Overall Study|Lost to Follow-up|7|||
164473731|NCT00336505|594106942|FG001|Overall Study|Lost to Follow-up|4|||
164473732|NCT00336505|594106941|FG000|Overall Study|Withdrawal by Subject|5|||
164473733|NCT00336505|594106942|FG001|Overall Study|Withdrawal by Subject|3|||
164473734|NCT00336505|594106941|FG000|Overall Study|Other|7|||
164473735|NCT00336505|594106942|FG001|Overall Study|Other|7|||
164473736|NCT00366249|594106943|FG000|Overall Study|Adverse Event|53|||
164473737|NCT00366249|594106944|FG001|Overall Study|Adverse Event|28|||
164473738|NCT00366249|594106943|FG000|Overall Study|Death|0|||
164473739|NCT00366249|594106944|FG001|Overall Study|Death|1|||
164473740|NCT00366249|594106943|FG000|Overall Study|Physician Decision|5|||
164473741|NCT00366249|594106944|FG001|Overall Study|Physician Decision|2|||
164473742|NCT00366249|594106943|FG000|Overall Study|Lost to Follow-up|2|||
164473743|NCT00366249|594106944|FG001|Overall Study|Lost to Follow-up|0|||
164473744|NCT00366249|594106943|FG000|Overall Study|Protocol Violation|1|||
164473745|NCT00366249|594106944|FG001|Overall Study|Protocol Violation|2|||
164473746|NCT00366249|594106943|FG000|Overall Study|Withdrawal by Subject|18|||
164473747|NCT00366249|594106944|FG001|Overall Study|Withdrawal by Subject|4|||
164473748|NCT00366249|594106943|FG000|Overall Study|Lack of Efficacy|21|||
164473749|NCT00366249|594106944|FG001|Overall Study|Lack of Efficacy|21|||
164473750|NCT00366249|594106943|FG000|Overall Study|Most due to osteomylitis status|31|||
164473751|NCT00366249|594106944|FG001|Overall Study|Most due to osteomylitis status|20|||
164473752|NCT00246805|594106945|FG000|Phase 1|Lost to Follow-up|1|||
164473753|NCT00246805|594106946|FG001|Phase 1|Lost to Follow-up|0|||
164473754|NCT00609869|594106947|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
164473755|NCT00609869|594106947|FG000|Overall Study|Severe hematologic toxicity|1|||
164473756|NCT00609869|594106947|FG000|Overall Study|Withdrawal by Subject|1|||
164473757|NCT00609869|594106947|FG000|Overall Study|Seizures|1|||
164473758|NCT00609869|594106947|FG000|Overall Study|Severe tumor flare reaction|1|||
164473759|NCT00609869|594106947|FG000|Overall Study|Hepatitis B infection|1|||
164473760|NCT00609869|594106947|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
164473761|NCT00609869|594106947|FG000|Overall Study|Mantle cell: not evaluable|4|||
164473762|NCT03478969|594106948|FG000|Overall Study|Withdrawal by Subject|4|||
164473763|NCT03478969|594106949|FG001|Overall Study|Withdrawal by Subject|7|||
164473764|NCT03478969|594106950|FG002|Overall Study|Withdrawal by Subject|6|||
164473765|NCT03478969|594106948|FG000|Overall Study|Adverse Event|2|||
164473766|NCT03478969|594106949|FG001|Overall Study|Adverse Event|0|||
164473767|NCT03478969|594106950|FG002|Overall Study|Adverse Event|1|||
164473768|NCT03478969|594106948|FG000|Overall Study|Pregnancy|1|||
164473769|NCT03478969|594106949|FG001|Overall Study|Pregnancy|0|||
164473770|NCT03478969|594106950|FG002|Overall Study|Pregnancy|0|||
164473771|NCT03478969|594106948|FG000|Overall Study|Personal Reasons|1|||
164473772|NCT03478969|594106949|FG001|Overall Study|Personal Reasons|0|||
164473773|NCT03478969|594106950|FG002|Overall Study|Personal Reasons|1|||
164473774|NCT03478969|594106948|FG000|Overall Study|Covid-19|1|||
164713705|NCT04040192|594974883|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
164713706|NCT04040192|594974884|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
164473775|NCT03478969|594106949|FG001|Overall Study|Covid-19|4|||
164473776|NCT03478969|594106950|FG002|Overall Study|Covid-19|3|||
164473777|NCT03478969|594106948|FG000|Overall Study|Multiple Reasons|0|||
164473778|NCT03478969|594106949|FG001|Overall Study|Multiple Reasons|1|||
164473779|NCT03478969|594106950|FG002|Overall Study|Multiple Reasons|1|||
164473780|NCT03478969|594106948|FG000|Overall Study|Eligibility Criteria|0|||
164473781|NCT03478969|594106949|FG001|Overall Study|Eligibility Criteria|0|||
164473782|NCT03478969|594106950|FG002|Overall Study|Eligibility Criteria|5|||
164473783|NCT03478969|594106948|FG000|Overall Study|Lost to Follow-up|0|||
164473784|NCT03478969|594106949|FG001|Overall Study|Lost to Follow-up|0|||
164473785|NCT03478969|594106950|FG002|Overall Study|Lost to Follow-up|1|||
164713707|NCT04040192|594974885|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
164713708|NCT04040192|594974883|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
164713709|NCT04040192|594974884|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
164713710|NCT04040192|594974885|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
164713711|NCT04040192|594974883|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
164713712|NCT04040192|594974884|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
164713713|NCT04040192|594974885|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
164713714|NCT04040192|594974883|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
164713715|NCT04040192|594974884|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
164713716|NCT04040192|594974885|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
164713717|NCT04040192|594974883|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
164713718|NCT04040192|594974884|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
164713719|NCT04040192|594974885|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
164713720|NCT04040192|594974883|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
164713721|NCT04040192|594974884|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
164473786|NCT01185600|594106951|FG000|Overall Study|Adverse Event|1|||
164713722|NCT04040192|594974885|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
164713723|NCT04040192|594974883|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
164713724|NCT04040192|594974884|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
164713725|NCT04040192|594974885|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
164713726|NCT04040192|594974883|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
164713727|NCT04040192|594974884|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
164713728|NCT04040192|594974885|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
164713729|NCT04040192|594974883|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
164473787|NCT01185600|594106952|FG001|Overall Study|Adverse Event|1|||
164473788|NCT01185600|594106951|FG000|Overall Study|Death|0|||
164473789|NCT01185600|594106952|FG001|Overall Study|Death|1|||
164713730|NCT04040192|594974884|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
164713731|NCT04040192|594974885|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
164713732|NCT04040192|594974883|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
164713733|NCT04040192|594974884|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
164713734|NCT04040192|594974885|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
164713735|NCT03207243|594974886|FG000|Overall Study|Adverse Event|2|||
164713736|NCT03207243|594974887|FG001|Overall Study|Adverse Event|2|||
164713737|NCT03207243|594974886|FG000|Overall Study|Loss of Asthma Control|47|||
164713738|NCT03207243|594974887|FG001|Overall Study|Loss of Asthma Control|31|||
164713739|NCT03207243|594974886|FG000|Overall Study|Withdrawal by Subject|2|||
164713740|NCT03207243|594974887|FG001|Overall Study|Withdrawal by Subject|4|||
164713741|NCT03207243|594974886|FG000|Overall Study|Physician Decision|1|||
164713742|NCT03207243|594974887|FG001|Overall Study|Physician Decision|1|||
164713743|NCT03207243|594974886|FG000|Overall Study|Lost to Follow-up|0|||
164713744|NCT03207243|594974887|FG001|Overall Study|Lost to Follow-up|1|||
164713745|NCT03207243|594974886|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
164713746|NCT03207243|594974887|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
164713747|NCT03207243|594974886|FG000|Overall Study|Protocol Violation|0|||
164713748|NCT03207243|594974887|FG001|Overall Study|Protocol Violation|3|||
164473790|NCT01185600|594106951|FG000|Overall Study|Lost to Follow-up|0|||
164473791|NCT01185600|594106952|FG001|Overall Study|Lost to Follow-up|5|||
164473792|NCT01185600|594106951|FG000|Overall Study|Physician Decision|29|||
164473793|NCT01185600|594106952|FG001|Overall Study|Physician Decision|35|||
164473794|NCT01185600|594106951|FG000|Overall Study|Withdrawal by Subject|1|||
164473795|NCT01185600|594106952|FG001|Overall Study|Withdrawal by Subject|1|||
164473796|NCT01185600|594106951|FG000|Overall Study|Hold by DSMB|1|||
164473797|NCT01185600|594106952|FG001|Overall Study|Hold by DSMB|2|||
164473798|NCT05405244|594106953|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
164473799|NCT05405244|594106954|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
164473800|NCT05405244|594106953|FG000|Washout (2 Weeks)|Adverse Event|2|||
164473801|NCT05405244|594106954|FG001|Washout (2 Weeks)|Adverse Event|0|||
164473802|NCT05405244|594106953|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
164473803|NCT05405244|594106954|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
164473804|NCT00739934|594106955|FG000|Voriconazole IV|Adverse Event|6|||
164473805|NCT00739934|594106955|FG000|Voriconazole Oral|Other|3|||
164473806|NCT04353492|594106958|FG000|Overall Study|Subject decision|24|||
164473807|NCT04353492|594106958|FG000|Overall Study|Physician Decision|5|||
164473808|NCT04353492|594106958|FG000|Overall Study|Adverse Event|3|||
164713749|NCT00603837|594974896|FG000|Overall Study|Physician Decision|3|||
164473809|NCT04353492|594106958|FG000|Overall Study|Pregnancy|3|||
164473810|NCT04353492|594106958|FG000|Overall Study|Lost to Follow-up|2|||
164473811|NCT04353492|594106958|FG000|Overall Study|Protocol deviation|1|||
164473812|NCT04353492|594106958|FG000|Overall Study|Technical problems|1|||
164473813|NCT01342367|594106959|FG000|Overall Study|Death|1|||
164473814|NCT01342367|594106960|FG001|Overall Study|Death|0|||
164473815|NCT01342367|594106959|FG000|Overall Study|Withdrawal by Subject|1|||
164473816|NCT01342367|594106960|FG001|Overall Study|Withdrawal by Subject|2|||
164473817|NCT01952366|594106961|FG000|Overall Study|Death|22|||
164473818|NCT01952366|594106961|FG000|Overall Study|Withdrawal by Subject|9|||
164473819|NCT00623194|594106962|FG000|Overall Study|Lack of Efficacy|1|||
164473820|NCT00623194|594106962|FG000|Overall Study|Protocol Violation|3|||
164473821|NCT00623194|594106962|FG000|Overall Study|Unclassified|1|||
164473822|NCT00857766|594106963|FG000|Overall Study|Adverse Event|13|||
164473823|NCT00857766|594106964|FG001|Overall Study|Adverse Event|12|||
164473824|NCT00857766|594106963|FG000|Overall Study|Protocol Violation|11|||
164473825|NCT00857766|594106964|FG001|Overall Study|Protocol Violation|11|||
164473826|NCT00857766|594106963|FG000|Overall Study|Lost to Follow-up|1|||
164473827|NCT00857766|594106964|FG001|Overall Study|Lost to Follow-up|0|||
164473828|NCT00857766|594106963|FG000|Overall Study|Investigator Discretion|2|||
164473829|NCT00857766|594106964|FG001|Overall Study|Investigator Discretion|3|||
164473830|NCT00857766|594106963|FG000|Overall Study|Participant Withdrew Consent|4|||
164473831|NCT00857766|594106964|FG001|Overall Study|Participant Withdrew Consent|4|||
164473832|NCT01961609|594106965|FG000|Initiation|Missing|3|||
164473833|NCT01961609|594106966|FG001|Initiation|Missing|2|||
164473834|NCT01961609|594106967|FG002|Initiation|Missing|0|||
164473835|NCT01961609|594106968|FG003|Initiation|Missing|0|||
164473836|NCT01961609|594106965|FG000|Initiation|Protocol deviation|1|||
164473837|NCT01961609|594106966|FG001|Initiation|Protocol deviation|0|||
164473838|NCT01961609|594106967|FG002|Initiation|Protocol deviation|0|||
164473839|NCT01961609|594106968|FG003|Initiation|Protocol deviation|0|||
164473840|NCT01961609|594106965|FG000|Initiation|Death|0|||
164473841|NCT01961609|594106966|FG001|Initiation|Death|1|||
164473842|NCT01961609|594106967|FG002|Initiation|Death|0|||
164473843|NCT01961609|594106968|FG003|Initiation|Death|0|||
164473844|NCT01961609|594106965|FG000|Initiation|Administrative problems|1|||
164473845|NCT01961609|594106966|FG001|Initiation|Administrative problems|0|||
164473846|NCT01961609|594106967|FG002|Initiation|Administrative problems|0|||
164473847|NCT01961609|594106968|FG003|Initiation|Administrative problems|0|||
164473848|NCT01961609|594106965|FG000|Initiation|Withdrawal by Subject|1|||
164473849|NCT01961609|594106966|FG001|Initiation|Withdrawal by Subject|2|||
164473850|NCT01961609|594106967|FG002|Initiation|Withdrawal by Subject|0|||
164473851|NCT01961609|594106968|FG003|Initiation|Withdrawal by Subject|0|||
164473852|NCT01961609|594106965|FG000|Initiation|Lack of Efficacy|2|||
164473853|NCT01961609|594106966|FG001|Initiation|Lack of Efficacy|1|||
164473854|NCT01961609|594106967|FG002|Initiation|Lack of Efficacy|0|||
164473855|NCT01961609|594106968|FG003|Initiation|Lack of Efficacy|0|||
164473856|NCT01961609|594106965|FG000|Initiation|Abnormal lab values|0|||
164473857|NCT01961609|594106966|FG001|Initiation|Abnormal lab values|1|||
164473858|NCT01961609|594106967|FG002|Initiation|Abnormal lab values|0|||
164473859|NCT01961609|594106968|FG003|Initiation|Abnormal lab values|0|||
164473860|NCT01961609|594106965|FG000|Initiation|Adverse Event|3|||
164473861|NCT01961609|594106966|FG001|Initiation|Adverse Event|5|||
164473862|NCT01961609|594106967|FG002|Initiation|Adverse Event|0|||
164473863|NCT01961609|594106968|FG003|Initiation|Adverse Event|0|||
164713750|NCT00603837|594974897|FG001|Overall Study|Physician Decision|0|||
164713751|NCT04611529|594974898|FG000|2-day Follow up|Lost to Follow-up|5|||
164713752|NCT04611529|594974899|FG001|2-day Follow up|Lost to Follow-up|6|||
164713753|NCT04611529|594974900|FG002|2-day Follow up|Lost to Follow-up|3|||
164713754|NCT02121392|594974901|FG000|Prior to Intervention|Protocol Violation|40|||
164713755|NCT02121392|594974902|FG001|Prior to Intervention|Protocol Violation|35|||
164713756|NCT02121392|594974901|FG000|Prior to Intervention|Withdrawal by Subject|8|||
164713757|NCT02121392|594974902|FG001|Prior to Intervention|Withdrawal by Subject|6|||
164713758|NCT02121392|594974901|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
164713759|NCT02121392|594974902|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
164713760|NCT02121392|594974901|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
164713761|NCT02121392|594974902|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
164713762|NCT01352416|594974903|FG000|Overall Study|Physician Decision|1|||
164473864|NCT01961609|594106965|FG000|Initiation|Randomized but not treated|1|||
164473865|NCT01961609|594106966|FG001|Initiation|Randomized but not treated|1|||
164473866|NCT01961609|594106967|FG002|Initiation|Randomized but not treated|0|||
164473867|NCT01961609|594106968|FG003|Initiation|Randomized but not treated|0|||
164473868|NCT01961609|594106965|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
164473869|NCT01961609|594106966|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
164473870|NCT01961609|594106967|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
164473871|NCT01961609|594106968|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
164473872|NCT01961609|594106965|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
164473873|NCT01961609|594106966|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
164473874|NCT01961609|594106967|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
164473875|NCT01961609|594106968|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
164473876|NCT01961609|594106965|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
164473877|NCT01961609|594106966|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
164473878|NCT01961609|594106967|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
164713763|NCT01352416|594974904|FG001|Overall Study|Physician Decision|2|||
164473879|NCT01961609|594106968|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
164473880|NCT01961609|594106965|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
164473881|NCT01961609|594106966|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
164473882|NCT01961609|594106967|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
164473883|NCT01961609|594106968|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
164473884|NCT01961609|594106965|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
164473885|NCT01961609|594106966|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
164473886|NCT01961609|594106967|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
164473887|NCT01961609|594106968|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
164713764|NCT01352416|594974905|FG002|Overall Study|Physician Decision|2|||
164713765|NCT01352416|594974906|FG003|Overall Study|Physician Decision|1|||
164713766|NCT00253448|594974907|FG000|Overall Study|Withdrawal by Subject|1|||
164713767|NCT02564887|594974908|FG000|Overall Study|Lost to Follow-up|6|||
164713768|NCT02564887|594974909|FG001|Overall Study|Lost to Follow-up|0|||
164713769|NCT01851330|594974910|FG000|Overall Study|Lack of Efficacy|10|||
164713770|NCT01851330|594974911|FG001|Overall Study|Lack of Efficacy|9|||
164713771|NCT01851330|594974912|FG002|Overall Study|Lack of Efficacy|2|||
164713772|NCT01851330|594974910|FG000|Overall Study|Lost to Follow-up|1|||
164713773|NCT01851330|594974911|FG001|Overall Study|Lost to Follow-up|6|||
164713774|NCT01851330|594974912|FG002|Overall Study|Lost to Follow-up|9|||
164713775|NCT01851330|594974910|FG000|Overall Study|Withdrew Consent|2|||
164713776|NCT01851330|594974911|FG001|Overall Study|Withdrew Consent|1|||
164713777|NCT01851330|594974912|FG002|Overall Study|Withdrew Consent|0|||
164713778|NCT01851330|594974910|FG000|Overall Study|Investigator's Discretion|0|||
164713779|NCT01851330|594974911|FG001|Overall Study|Investigator's Discretion|0|||
164713780|NCT01851330|594974912|FG002|Overall Study|Investigator's Discretion|1|||
164713781|NCT01199016|594974913|FG000|Overall Study|No longer meets eligibility criteria|4|||
164713782|NCT01199016|594974913|FG000|Overall Study|Entrance criteria|5|||
164713783|NCT01199016|594974913|FG000|Overall Study|Protocol Violation|9|||
164713784|NCT01199016|594974913|FG000|Overall Study|Other|13|||
164713785|NCT01199016|594974913|FG000|Overall Study|Withdrawal by Subject|21|||
164713786|NCT01199016|594974913|FG000|Overall Study|Lost to Follow-up|25|||
164713787|NCT02960490|594974922|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
164713788|NCT02960490|594974923|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
164713789|NCT02960490|594974924|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
164713790|NCT02960490|594974925|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
164713791|NCT02960490|594974926|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
164713792|NCT02960490|594974927|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
164713793|NCT02960490|594974928|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
164713794|NCT02960490|594974929|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
164713795|NCT02960490|594974930|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
164713796|NCT02960490|594974931|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
164713797|NCT02960490|594974922|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
164713798|NCT02960490|594974923|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
164713799|NCT02960490|594974924|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
164473888|NCT01961609|594106965|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
164473889|NCT01961609|594106966|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
164473890|NCT01961609|594106967|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
164473891|NCT01961609|594106968|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
164473892|NCT01961609|594106965|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
164473893|NCT01961609|594106966|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
164473894|NCT01961609|594106967|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
164473895|NCT01961609|594106968|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
164473896|NCT01961609|594106965|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
164473897|NCT01961609|594106966|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
164473898|NCT01961609|594106967|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
164473899|NCT01961609|594106968|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
164473900|NCT01961609|594106965|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
164473901|NCT01961609|594106966|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
164473902|NCT01961609|594106967|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
164473903|NCT01961609|594106968|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
164473904|NCT01961609|594106965|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
164473905|NCT01961609|594106966|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
164473906|NCT01961609|594106967|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
164473907|NCT01961609|594106968|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
164713800|NCT02960490|594974925|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
164713801|NCT02960490|594974926|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
164713802|NCT02960490|594974927|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
164713803|NCT02960490|594974928|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
164713804|NCT02960490|594974929|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
164473908|NCT01961609|594106965|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
164473909|NCT01961609|594106966|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
164473910|NCT01961609|594106967|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
164473911|NCT01961609|594106968|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
164473912|NCT01961609|594106965|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
164473913|NCT01961609|594106966|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
164473914|NCT01961609|594106967|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
164473915|NCT01961609|594106968|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
164473916|NCT01988402|594106969|FG000|Overall Study|Adverse Event|1|||
164473917|NCT01988402|594106970|FG001|Overall Study|Adverse Event|2|||
164473918|NCT01988402|594106969|FG000|Overall Study|Withdrawal by Subject|1|||
164473919|NCT01988402|594106970|FG001|Overall Study|Withdrawal by Subject|0|||
164473920|NCT01212744|594106973|FG000|Overall Study|Withdrawal by Subject|1|||
164473921|NCT02167451|594106974|FG000|Overall Study|Withdrawal by Subject|1|||
164473922|NCT00571649|594106975|FG000|Treatment Period|Adverse Event|438|||
164473923|NCT00571649|594106976|FG001|Treatment Period|Adverse Event|385|||
164473924|NCT00571649|594106975|FG000|Treatment Period|Clinical endpoint reached|50|||
164473925|NCT00571649|594106976|FG001|Treatment Period|Clinical endpoint reached|56|||
164473926|NCT00571649|594106975|FG000|Treatment Period|Withdrawal by Subject|285|||
164473927|NCT00571649|594106976|FG001|Treatment Period|Withdrawal by Subject|255|||
164473928|NCT00571649|594106975|FG000|Treatment Period|Death|76|||
164473929|NCT00571649|594106976|FG001|Treatment Period|Death|59|||
164473930|NCT00571649|594106975|FG000|Treatment Period|Physician Decision|8|||
164473931|NCT00571649|594106976|FG001|Treatment Period|Physician Decision|9|||
164473932|NCT00571649|594106975|FG000|Treatment Period|Lost to Follow-up|43|||
164473933|NCT00571649|594106976|FG001|Treatment Period|Lost to Follow-up|41|||
164473934|NCT00571649|594106975|FG000|Treatment Period|Non-compliant with study medication|88|||
164473935|NCT00571649|594106976|FG001|Treatment Period|Non-compliant with study medication|89|||
164473936|NCT00571649|594106975|FG000|Treatment Period|Patient convenience|11|||
164473937|NCT00571649|594106976|FG001|Treatment Period|Patient convenience|13|||
164473938|NCT00571649|594106975|FG000|Treatment Period|Protocol Violation|90|||
164473939|NCT00571649|594106976|FG001|Treatment Period|Protocol Violation|92|||
164473940|NCT00571649|594106975|FG000|Treatment Period|Technical problems|3|||
164473941|NCT00571649|594106976|FG001|Treatment Period|Technical problems|5|||
164473942|NCT00571649|594106975|FG000|Follow-up Period|Adverse Event|46|||
164473943|NCT00571649|594106976|FG001|Follow-up Period|Adverse Event|40|||
164473944|NCT00571649|594106975|FG000|Follow-up Period|Clinical endpoint reached|5|||
164473945|NCT00571649|594106976|FG001|Follow-up Period|Clinical endpoint reached|2|||
164473946|NCT00571649|594106975|FG000|Follow-up Period|Withdrawal by Subject|119|||
164473947|NCT00571649|594106976|FG001|Follow-up Period|Withdrawal by Subject|115|||
164473948|NCT00571649|594106975|FG000|Follow-up Period|Death|132|||
164473949|NCT00571649|594106976|FG001|Follow-up Period|Death|133|||
164473950|NCT00571649|594106975|FG000|Follow-up Period|Physician Decision|7|||
164473951|NCT00571649|594106976|FG001|Follow-up Period|Physician Decision|13|||
164473952|NCT00571649|594106975|FG000|Follow-up Period|Lost to Follow-up|95|||
164473953|NCT00571649|594106976|FG001|Follow-up Period|Lost to Follow-up|92|||
164473954|NCT00571649|594106975|FG000|Follow-up Period|Patient convenience|136|||
164473955|NCT00571649|594106976|FG001|Follow-up Period|Patient convenience|121|||
164473956|NCT00571649|594106975|FG000|Follow-up Period|Protocol Violation|5|||
164473957|NCT00571649|594106976|FG001|Follow-up Period|Protocol Violation|12|||
164473958|NCT01566890|594106981|FG000|Overall Study|Adverse Event|1|||
164473959|NCT01566890|594106982|FG001|Overall Study|Adverse Event|0|||
164473960|NCT01566890|594106983|FG002|Overall Study|Adverse Event|0|||
164473961|NCT01566890|594106984|FG003|Overall Study|Adverse Event|0|||
164473962|NCT01566890|594106985|FG004|Overall Study|Adverse Event|0|||
164473963|NCT01566890|594106981|FG000|Overall Study|Withdrawal by Subject|3|||
164473964|NCT01566890|594106982|FG001|Overall Study|Withdrawal by Subject|1|||
164473965|NCT01566890|594106983|FG002|Overall Study|Withdrawal by Subject|1|||
164473966|NCT01566890|594106984|FG003|Overall Study|Withdrawal by Subject|1|||
164713805|NCT02960490|594974930|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
164713806|NCT02960490|594974931|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
164713807|NCT02960490|594974922|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
164713808|NCT02960490|594974923|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
164713809|NCT02960490|594974924|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
164713810|NCT02960490|594974925|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
164713811|NCT02960490|594974926|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
164473967|NCT01566890|594106985|FG004|Overall Study|Withdrawal by Subject|0|||
164473968|NCT01566890|594106981|FG000|Overall Study|Screen failure|6|||
164473969|NCT01566890|594106982|FG001|Overall Study|Screen failure|0|||
164473970|NCT01566890|594106983|FG002|Overall Study|Screen failure|1|||
164473971|NCT01566890|594106984|FG003|Overall Study|Screen failure|1|||
164473972|NCT01566890|594106985|FG004|Overall Study|Screen failure|0|||
164473973|NCT01566890|594106981|FG000|Overall Study|Incomplete CEU data|1|||
164473974|NCT01566890|594106982|FG001|Overall Study|Incomplete CEU data|3|||
164473975|NCT01566890|594106983|FG002|Overall Study|Incomplete CEU data|5|||
164473976|NCT01566890|594106984|FG003|Overall Study|Incomplete CEU data|8|||
164473977|NCT01566890|594106985|FG004|Overall Study|Incomplete CEU data|0|||
164473978|NCT01566890|594106981|FG000|Overall Study|Lost to Follow-up|0|||
164473979|NCT01566890|594106982|FG001|Overall Study|Lost to Follow-up|0|||
164473980|NCT01566890|594106983|FG002|Overall Study|Lost to Follow-up|4|||
164473981|NCT01566890|594106984|FG003|Overall Study|Lost to Follow-up|4|||
164473982|NCT01566890|594106985|FG004|Overall Study|Lost to Follow-up|0|||
164473983|NCT01566890|594106981|FG000|Overall Study|Other|0|||
164473984|NCT01566890|594106982|FG001|Overall Study|Other|0|||
164473985|NCT01566890|594106983|FG002|Overall Study|Other|0|||
164473986|NCT01566890|594106984|FG003|Overall Study|Other|0|||
164473987|NCT01566890|594106985|FG004|Overall Study|Other|7|||
164473988|NCT02397096|594106988|FG000|Day 1 to Week 24|Adverse Event|7|||
164473989|NCT02397096|594106989|FG001|Day 1 to Week 24|Adverse Event|1|||
164473990|NCT02397096|594106988|FG000|Day 1 to Week 24|Death|1|||
164473991|NCT02397096|594106989|FG001|Day 1 to Week 24|Death|0|||
164473992|NCT02397096|594106988|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
164473993|NCT02397096|594106989|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
164473994|NCT02397096|594106988|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
164473995|NCT02397096|594106989|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
164473996|NCT02397096|594106988|FG000|Day 1 to Week 24|Physician Decision|2|||
164473997|NCT02397096|594106989|FG001|Day 1 to Week 24|Physician Decision|3|||
164473998|NCT02397096|594106988|FG000|Day 1 to Week 24|Protocol Violation|1|||
164473999|NCT02397096|594106989|FG001|Day 1 to Week 24|Protocol Violation|4|||
164474000|NCT02397096|594106988|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
164474001|NCT02397096|594106989|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
164474002|NCT02397096|594106988|FG000|Day 1 to Week 24|Randomized, not treated|3|||
164474003|NCT02397096|594106989|FG001|Day 1 to Week 24|Randomized, not treated|0|||
164474004|NCT02397096|594106988|FG000|Week 24 to Week 48|Adverse Event|6|||
164474005|NCT02397096|594106989|FG001|Week 24 to Week 48|Adverse Event|2|||
164474006|NCT02397096|594106988|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
164474007|NCT02397096|594106989|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
164474008|NCT02397096|594106988|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
164474009|NCT02397096|594106989|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
164474010|NCT02397096|594106988|FG000|Week 24 to Week 48|Physician Decision|2|||
164474011|NCT02397096|594106989|FG001|Week 24 to Week 48|Physician Decision|1|||
164474012|NCT02397096|594106988|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
164474013|NCT02397096|594106989|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
164474014|NCT02397096|594106988|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
164474015|NCT02397096|594106989|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
164474016|NCT02397096|594106988|FG000|Study Extension 1|Adverse Event|7|||
164474017|NCT02397096|594106989|FG001|Study Extension 1|Adverse Event|5|||
164474018|NCT02397096|594106988|FG000|Study Extension 1|Death|1|||
164474019|NCT02397096|594106989|FG001|Study Extension 1|Death|0|||
164474020|NCT02397096|594106988|FG000|Study Extension 1|Lack of Efficacy|2|||
164474021|NCT02397096|594106989|FG001|Study Extension 1|Lack of Efficacy|5|||
164474022|NCT02397096|594106988|FG000|Study Extension 1|Lost to Follow-up|2|||
164474023|NCT02397096|594106989|FG001|Study Extension 1|Lost to Follow-up|3|||
164474024|NCT02397096|594106988|FG000|Study Extension 1|Non-compliance with study drug|3|||
164474025|NCT02397096|594106989|FG001|Study Extension 1|Non-compliance with study drug|0|||
164474026|NCT02397096|594106988|FG000|Study Extension 1|Physician Decision|4|||
164474027|NCT02397096|594106989|FG001|Study Extension 1|Physician Decision|2|||
164474028|NCT02397096|594106988|FG000|Study Extension 1|Pregnancy|1|||
164474029|NCT02397096|594106989|FG001|Study Extension 1|Pregnancy|0|||
164474030|NCT02397096|594106988|FG000|Study Extension 1|Protocol Violation|0|||
164474031|NCT02397096|594106989|FG001|Study Extension 1|Protocol Violation|1|||
164474032|NCT02397096|594106988|FG000|Study Extension 1|Withdrawal by Subject|21|||
164474033|NCT02397096|594106989|FG001|Study Extension 1|Withdrawal by Subject|7|||
164474034|NCT02397096|594106988|FG000|Study Extension 2|Adverse Event|3|||
164474035|NCT02397096|594106989|FG001|Study Extension 2|Adverse Event|3|||
164474036|NCT02397096|594106988|FG000|Study Extension 2|Availability of study medication locally|152|||
164474037|NCT02397096|594106989|FG001|Study Extension 2|Availability of study medication locally|64|||
164474038|NCT02397096|594106988|FG000|Study Extension 2|Death|2|||
164474039|NCT02397096|594106989|FG001|Study Extension 2|Death|0|||
164474040|NCT02397096|594106988|FG000|Study Extension 2|Lack of Efficacy|1|||
164474041|NCT02397096|594106989|FG001|Study Extension 2|Lack of Efficacy|0|||
164474042|NCT02397096|594106988|FG000|Study Extension 2|Lost to Follow-up|2|||
164474043|NCT02397096|594106989|FG001|Study Extension 2|Lost to Follow-up|1|||
164474044|NCT02397096|594106988|FG000|Study Extension 2|Non-compliance with study drug|1|||
164474045|NCT02397096|594106989|FG001|Study Extension 2|Non-compliance with study drug|0|||
164474046|NCT02397096|594106988|FG000|Study Extension 2|Physician Decision|2|||
164474047|NCT02397096|594106989|FG001|Study Extension 2|Physician Decision|5|||
164474048|NCT02397096|594106988|FG000|Study Extension 2|Pregnancy|1|||
164474049|NCT02397096|594106989|FG001|Study Extension 2|Pregnancy|0|||
164474050|NCT02397096|594106988|FG000|Study Extension 2|Withdrawal by Subject|10|||
164474051|NCT02397096|594106989|FG001|Study Extension 2|Withdrawal by Subject|3|||
164474052|NCT02397096|594106988|FG000|Study Extension 3|Adverse Event|1|||
164474053|NCT02397096|594106989|FG001|Study Extension 3|Adverse Event|0|||
164474054|NCT02397096|594106988|FG000|Study Extension 3|Availability of study medication locally|11|||
164474055|NCT02397096|594106989|FG001|Study Extension 3|Availability of study medication locally|3|||
164474056|NCT02397096|594106988|FG000|Study Extension 3|Lost to Follow-up|1|||
164474057|NCT02397096|594106989|FG001|Study Extension 3|Lost to Follow-up|0|||
164474058|NCT02397096|594106988|FG000|Study Extension 3|Withdrawal by Subject|2|||
164474059|NCT02397096|594106989|FG001|Study Extension 3|Withdrawal by Subject|1|||
164474060|NCT01983683|594107000|FG000|Overall Study|Withdrawal by Subject|14|||
164474061|NCT01983683|594107001|FG001|Overall Study|Withdrawal by Subject|18|||
164474062|NCT01983683|594107000|FG000|Overall Study|Death|11|||
164474063|NCT01983683|594107001|FG001|Overall Study|Death|15|||
164474064|NCT01983683|594107000|FG000|Overall Study|Physician Decision|8|||
164474065|NCT01983683|594107001|FG001|Overall Study|Physician Decision|9|||
164474066|NCT01983683|594107000|FG000|Overall Study|Lost to Follow-up|4|||
164474067|NCT01983683|594107001|FG001|Overall Study|Lost to Follow-up|8|||
164474068|NCT01983683|594107000|FG000|Overall Study|Sponsor Decision|1|||
164474069|NCT01983683|594107001|FG001|Overall Study|Sponsor Decision|1|||
164474070|NCT04882917|594107004|FG000|Overall Study|Adverse Event|0|||
164474071|NCT04882917|594107005|FG001|Overall Study|Adverse Event|1|||
164474072|NCT04882917|594107006|FG002|Overall Study|Adverse Event|2|||
164474073|NCT04882917|594107007|FG003|Overall Study|Adverse Event|2|||
164474074|NCT04882917|594107004|FG000|Overall Study|Withdrawal by Subject|1|||
164474075|NCT04882917|594107005|FG001|Overall Study|Withdrawal by Subject|0|||
164474076|NCT04882917|594107006|FG002|Overall Study|Withdrawal by Subject|2|||
164474077|NCT04882917|594107007|FG003|Overall Study|Withdrawal by Subject|1|||
164474078|NCT04882917|594107004|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
164474079|NCT04882917|594107005|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
164474080|NCT04882917|594107006|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
164474081|NCT04882917|594107007|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
164474082|NCT00319020|594107008|FG000|Overall Study|Death|2|||
164474083|NCT00319020|594107009|FG001|Overall Study|Death|2|||
164474084|NCT00319020|594107008|FG000|Overall Study|Withdrawal by Subject|4|||
164599852|NCT04167306|594556380|FG000|Overall Study|Alcohol treatment|0|||
164599853|NCT04167306|594556381|FG001|Overall Study|Alcohol treatment|4|||
164599854|NCT04167306|594556382|FG002|Overall Study|Alcohol treatment|3|||
164599855|NCT04167306|594556383|FG003|Overall Study|Alcohol treatment|2|||
164599856|NCT04167306|594556380|FG000|Overall Study|non-compliance|0|||
164599857|NCT04167306|594556381|FG001|Overall Study|non-compliance|0|||
164599858|NCT04167306|594556382|FG002|Overall Study|non-compliance|1|||
164599859|NCT04167306|594556383|FG003|Overall Study|non-compliance|0|||
164599860|NCT04167306|594556380|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
164599861|NCT04167306|594556381|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
164599862|NCT04167306|594556382|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
164599863|NCT04167306|594556383|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
164599864|NCT00621855|594556384|FG000|Overall Study|Adverse Event|32|||
164599865|NCT00621855|594556385|FG001|Overall Study|Adverse Event|31|||
164599866|NCT00621855|594556386|FG002|Overall Study|Adverse Event|48|||
164599867|NCT00621855|594556387|FG003|Overall Study|Adverse Event|34|||
164599868|NCT00621855|594556388|FG004|Overall Study|Adverse Event|31|||
164599869|NCT00621855|594556384|FG000|Overall Study|Lost to Follow-up|0|||
164599870|NCT00621855|594556385|FG001|Overall Study|Lost to Follow-up|1|||
164599871|NCT00621855|594556386|FG002|Overall Study|Lost to Follow-up|3|||
164599872|NCT00621855|594556387|FG003|Overall Study|Lost to Follow-up|4|||
164599873|NCT00621855|594556388|FG004|Overall Study|Lost to Follow-up|1|||
164599874|NCT00621855|594556384|FG000|Overall Study|Protocol Violation|16|||
164599875|NCT00621855|594556385|FG001|Overall Study|Protocol Violation|8|||
164599876|NCT00621855|594556386|FG002|Overall Study|Protocol Violation|6|||
164599877|NCT00621855|594556387|FG003|Overall Study|Protocol Violation|7|||
164713812|NCT02960490|594974927|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
164599878|NCT00621855|594556388|FG004|Overall Study|Protocol Violation|8|||
164599879|NCT00621855|594556384|FG000|Overall Study|Withdrawal by Subject|16|||
164599880|NCT00621855|594556385|FG001|Overall Study|Withdrawal by Subject|11|||
164599881|NCT00621855|594556386|FG002|Overall Study|Withdrawal by Subject|13|||
164599882|NCT00621855|594556387|FG003|Overall Study|Withdrawal by Subject|13|||
164599883|NCT00621855|594556388|FG004|Overall Study|Withdrawal by Subject|9|||
164713813|NCT02960490|594974928|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
164474085|NCT00319020|594107009|FG001|Overall Study|Withdrawal by Subject|1|||
164474086|NCT00319020|594107008|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
164599884|NCT00621855|594556384|FG000|Overall Study|Other|9|||
164599885|NCT00621855|594556385|FG001|Overall Study|Other|7|||
164599886|NCT00621855|594556386|FG002|Overall Study|Other|6|||
164599887|NCT00621855|594556387|FG003|Overall Study|Other|5|||
164599888|NCT00621855|594556388|FG004|Overall Study|Other|4|||
164599889|NCT00621855|594556384|FG000|Overall Study|Patients did not receive study drug|3|||
164599890|NCT00621855|594556385|FG001|Overall Study|Patients did not receive study drug|3|||
164474087|NCT00319020|594107009|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
164474088|NCT00319020|594107008|FG000|Overall Study|Administrative reason|0|||
164474089|NCT00319020|594107009|FG001|Overall Study|Administrative reason|5|||
164474090|NCT00319020|594107008|FG000|Overall Study|Disease progression|0|||
164474091|NCT00319020|594107009|FG001|Overall Study|Disease progression|2|||
164474092|NCT00319020|594107008|FG000|Overall Study|Transplant|0|||
164474093|NCT00319020|594107009|FG001|Overall Study|Transplant|1|||
164474094|NCT00319020|594107008|FG000|Overall Study|Treatment failure|0|||
164474095|NCT00319020|594107009|FG001|Overall Study|Treatment failure|1|||
164474096|NCT00319020|594107008|FG000|Overall Study|Adverse Event|0|||
164474097|NCT00319020|594107009|FG001|Overall Study|Adverse Event|1|||
164474098|NCT04926740|594107010|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
164474099|NCT04926740|594107011|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
164474100|NCT04926740|594107010|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
164474101|NCT04926740|594107011|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
164474102|NCT04980300|594107012|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
164474103|NCT04980300|594107013|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
164474104|NCT04980300|594107012|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
164474105|NCT04980300|594107013|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
164474106|NCT04980300|594107012|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
164474107|NCT04980300|594107013|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
164474108|NCT04980300|594107012|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
164474109|NCT04980300|594107013|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
164474110|NCT06056310|594108324|FG000|Overall Study|Other Reasons|2|||
164474111|NCT06056310|594108324|FG000|Overall Study|Sponsor Request|16|||
164474112|NCT05802173|594108331|FG000|Overall Study|Withdrawal by Subject|2|||
164474113|NCT05802173|594108332|FG001|Overall Study|Withdrawal by Subject|0|||
164474114|NCT05802173|594108333|FG002|Overall Study|Withdrawal by Subject|0|||
164474115|NCT05802173|594108331|FG000|Overall Study|Protocol Violation|1|||
164474116|NCT05802173|594108332|FG001|Overall Study|Protocol Violation|0|||
164474117|NCT05802173|594108333|FG002|Overall Study|Protocol Violation|0|||
164474118|NCT05802173|594108331|FG000|Overall Study|Lost to Follow-up|0|||
164474119|NCT05802173|594108332|FG001|Overall Study|Lost to Follow-up|6|||
164474120|NCT05802173|594108333|FG002|Overall Study|Lost to Follow-up|4|||
164474121|NCT05802173|594108331|FG000|Overall Study|non-compliance|0|||
164474122|NCT05802173|594108332|FG001|Overall Study|non-compliance|1|||
164474123|NCT05802173|594108333|FG002|Overall Study|non-compliance|0|||
164474124|NCT04503681|594108339|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
164474125|NCT04503681|594108340|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
164474126|NCT03352713|594108343|FG000|Overall Study|Lost to Follow-up|8|||
164474127|NCT03352713|594108343|FG000|Overall Study|Withdrawn by investigator|5|||
164474128|NCT03352713|594108343|FG000|Overall Study|Completed 0 EMAs|8|||
164474129|NCT03352713|594108343|FG000|Overall Study|Device incompatible/stolen|5|||
164474130|NCT01812759|594108344|FG000|Overall Study|Physician Decision|0|||
164474131|NCT01812759|594108345|FG001|Overall Study|Physician Decision|0|||
164713814|NCT02960490|594974929|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
164713815|NCT02960490|594974930|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
164474132|NCT01812759|594108346|FG002|Overall Study|Physician Decision|1|||
164474133|NCT00536120|594108347|FG000|Overall Study|Lost to Follow-up|1|||
164474134|NCT00536120|594108348|FG001|Overall Study|Lost to Follow-up|0|||
164474135|NCT00536120|594108347|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
164474136|NCT00536120|594108348|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
164474137|NCT00536120|594108347|FG000|Overall Study|Non-compliance|1|||
164474138|NCT00536120|594108348|FG001|Overall Study|Non-compliance|0|||
164474139|NCT00536120|594108347|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
164474140|NCT00536120|594108348|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
164474141|NCT00536120|594108347|FG000|Overall Study|Steroid Use|0|||
164474142|NCT00536120|594108348|FG001|Overall Study|Steroid Use|2|||
164474143|NCT00536120|594108347|FG000|Overall Study|Missed Study Visit|0|||
164474144|NCT00536120|594108348|FG001|Overall Study|Missed Study Visit|1|||
164474145|NCT02722434|594108349|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
164474146|NCT02722434|594108350|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
164474147|NCT02722434|594108349|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
164474148|NCT02722434|594108350|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
164474149|NCT00360269|594108351|FG000|Overall Study|Lost to Follow-up|7|||
164474150|NCT00360269|594108352|FG001|Overall Study|Lost to Follow-up|9|||
164474151|NCT00360269|594108351|FG000|Overall Study|Physician Decision|1|||
164474152|NCT00360269|594108352|FG001|Overall Study|Physician Decision|2|||
164474153|NCT00360269|594108351|FG000|Overall Study|Adverse Event|1|||
164474154|NCT00360269|594108352|FG001|Overall Study|Adverse Event|0|||
164474155|NCT00360269|594108351|FG000|Overall Study|Withdrawal by Subject|1|||
164713816|NCT02960490|594974931|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
164713817|NCT02960490|594974922|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
164474156|NCT00360269|594108352|FG001|Overall Study|Withdrawal by Subject|1|||
164474157|NCT04989816|594108355|FG000|Overall Study|Death|77|||
164474158|NCT04989816|594108355|FG000|Overall Study|Lost to Follow-up|3|||
164474159|NCT03758638|594108356|FG000|Overall Study|Pregnancy|17|||
164474160|NCT03758638|594108357|FG001|Overall Study|Pregnancy|25|||
164474161|NCT03758638|594108356|FG000|Overall Study|Lost to Follow-up|60|||
164474162|NCT03758638|594108357|FG001|Overall Study|Lost to Follow-up|54|||
164474163|NCT03758638|594108356|FG000|Overall Study|Protocol Violation|2|||
164474164|NCT03758638|594108357|FG001|Overall Study|Protocol Violation|0|||
164474165|NCT03758638|594108356|FG000|Overall Study|Withdrawal by Subject|8|||
164474166|NCT03758638|594108357|FG001|Overall Study|Withdrawal by Subject|2|||
164474167|NCT03758638|594108356|FG000|Overall Study|Providers not included in the primary outcome.|183|||
164474168|NCT03758638|594108357|FG001|Overall Study|Providers not included in the primary outcome.|128|||
164474169|NCT03876457|594108364|FG000|Overall Study|Lost to Follow-up|1|||
164474170|NCT03876457|594108365|FG001|Overall Study|Lost to Follow-up|3|||
164474171|NCT01184326|594108366|FG000|Overall Study|Adverse Event|1|||
164474172|NCT01184326|594108367|FG001|Overall Study|Adverse Event|2|||
164474173|NCT01184326|594108368|FG002|Overall Study|Adverse Event|0|||
164474174|NCT01184326|594108366|FG000|Overall Study|Death|0|||
164474175|NCT01184326|594108367|FG001|Overall Study|Death|0|||
164474176|NCT01184326|594108368|FG002|Overall Study|Death|1|||
164474177|NCT01184326|594108366|FG000|Overall Study|Withdrawal by Subject|0|||
164474178|NCT01184326|594108367|FG001|Overall Study|Withdrawal by Subject|0|||
164474179|NCT01184326|594108368|FG002|Overall Study|Withdrawal by Subject|1|||
164474180|NCT01184326|594108366|FG000|Overall Study|Physician Decision|1|||
164474181|NCT01184326|594108367|FG001|Overall Study|Physician Decision|1|||
164474182|NCT01184326|594108368|FG002|Overall Study|Physician Decision|0|||
164474183|NCT01184326|594108366|FG000|Overall Study|Disease Progression|1|||
164474184|NCT01184326|594108367|FG001|Overall Study|Disease Progression|3|||
164474185|NCT01184326|594108368|FG002|Overall Study|Disease Progression|12|||
164474186|NCT01036724|594108369|FG000|Overall Study|Adverse Event|1|||
164474187|NCT01036724|594108370|FG001|Overall Study|Adverse Event|2|||
164474188|NCT01036724|594108369|FG000|Overall Study|Lack of Efficacy|1|||
164474189|NCT01036724|594108370|FG001|Overall Study|Lack of Efficacy|1|||
164474190|NCT01036724|594108369|FG000|Overall Study|Protocol Violation|4|||
164474191|NCT01036724|594108370|FG001|Overall Study|Protocol Violation|5|||
164474192|NCT03442777|594108373|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
164474193|NCT03442777|594108374|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
164474194|NCT03442777|594108375|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
164474195|NCT02866942|594108376|FG000|Overall Study|Invalid consent|1|||
164474196|NCT00372775|594108377|FG000|Overall Study|Adverse Event|8|||
164474197|NCT00372775|594108377|FG000|Overall Study|Death|15|||
164474198|NCT00372775|594108377|FG000|Overall Study|Objective progression or relapse|30|||
164474199|NCT00372775|594108377|FG000|Overall Study|Global deterioration of health status|6|||
164474200|NCT00372775|594108377|FG000|Overall Study|Withdrawal by Subject|1|||
164474201|NCT00372775|594108377|FG000|Overall Study|Other|1|||
164474202|NCT00372775|594108377|FG000|Overall Study|Not Treated|2|||
164474203|NCT01750684|594108378|FG000|Overall Study|Death|1|||
164474204|NCT01750684|594108379|FG001|Overall Study|Death|0|||
164474205|NCT01750684|594108378|FG000|Overall Study|Non-compliance with Study Drug|0|||
164474206|NCT01750684|594108379|FG001|Overall Study|Non-compliance with Study Drug|1|||
164474207|NCT01750684|594108378|FG000|Overall Study|Withdrawn by Sponsor|0|||
164474208|NCT01750684|594108379|FG001|Overall Study|Withdrawn by Sponsor|1|||
164474209|NCT01750684|594108378|FG000|Overall Study|Protocol Violation|1|||
164474210|NCT01750684|594108379|FG001|Overall Study|Protocol Violation|0|||
164474211|NCT01561300|594108380|FG000|Run in on Placebo|Adverse Event|1|||
164474212|NCT01561300|594108381|FG001|Run in on Placebo|Adverse Event|0|||
164474213|NCT00777049|594108382|FG000|Overall Study|Withdrawal by Subject|1|||
164474214|NCT00777049|594108383|FG001|Overall Study|Withdrawal by Subject|0|||
164474215|NCT00777049|594108382|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
164474216|NCT00777049|594108383|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
164474217|NCT00790569|594108384|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
164474218|NCT00790569|594108385|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
164474219|NCT00790569|594108386|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
164474220|NCT00790569|594108384|FG000|End of Treatment (6 Month Interview)|Death|0|||
164474221|NCT00790569|594108385|FG001|End of Treatment (6 Month Interview)|Death|2|||
164474222|NCT00790569|594108386|FG002|End of Treatment (6 Month Interview)|Death|1|||
164474223|NCT00790569|594108384|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
164474224|NCT00790569|594108385|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
164474225|NCT00790569|594108386|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
164474226|NCT00790569|594108384|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
164474227|NCT00790569|594108385|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
164474228|NCT00790569|594108386|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
164474229|NCT00790569|594108384|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
164474230|NCT00790569|594108385|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
164474231|NCT00790569|594108386|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
164474232|NCT00790569|594108384|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
164474233|NCT00790569|594108385|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
164474234|NCT00790569|594108386|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
164474235|NCT01627561|594108387|FG000|Overall Study|Lost to Follow-up|1|||
164474236|NCT01627561|594108388|FG001|Overall Study|Lost to Follow-up|0|||
164474237|NCT01627561|594108387|FG000|Overall Study|Withdrawal by Subject|0|||
164474238|NCT01627561|594108388|FG001|Overall Study|Withdrawal by Subject|1|||
164474239|NCT01627561|594108387|FG000|Overall Study|Migrated/moved from study area|0|||
164474240|NCT01627561|594108388|FG001|Overall Study|Migrated/moved from study area|2|||
164474241|NCT00724126|594108389|FG000|Overall Study|Adverse Event|2|||
164474242|NCT00724126|594108390|FG001|Overall Study|Adverse Event|0|||
164474243|NCT00724126|594108389|FG000|Overall Study|Withdrawal by Subject|8|||
164474244|NCT00724126|594108390|FG001|Overall Study|Withdrawal by Subject|6|||
164474245|NCT00724126|594108389|FG000|Overall Study|Lost to Follow-up|6|||
164474246|NCT00724126|594108390|FG001|Overall Study|Lost to Follow-up|6|||
164474247|NCT00724126|594108389|FG000|Overall Study|Noncompliance|2|||
164474248|NCT00724126|594108390|FG001|Overall Study|Noncompliance|1|||
164474249|NCT00724126|594108389|FG000|Overall Study|Subject randomized although ineligible|1|||
164474250|NCT00724126|594108390|FG001|Overall Study|Subject randomized although ineligible|1|||
164474251|NCT00724126|594108389|FG000|Overall Study|Subject had to leave vicinity of site|0|||
164474252|NCT00724126|594108390|FG001|Overall Study|Subject had to leave vicinity of site|1|||
164474253|NCT01436175|594108391|FG000|Overall Study|Adverse Event|111|||
164474254|NCT01436175|594108391|FG000|Overall Study|Protocol Violation|49|||
164474255|NCT01436175|594108391|FG000|Overall Study|Withdrawal by Subject|108|||
164474256|NCT01436175|594108391|FG000|Overall Study|Lost to Follow-up|89|||
164474257|NCT01436175|594108391|FG000|Overall Study|Lack of Efficacy|24|||
164474258|NCT01436175|594108391|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
164474259|NCT01436175|594108391|FG000|Overall Study|Other|826|||
164474260|NCT03577106|594108395|FG000|Overall Study|Withdrawal by Subject|3|||
164474261|NCT01579318|594108396|FG000|Overall Study|Disease Progression|1|||
164474262|NCT03601715|594108399|FG000|Second Intervention|Lost to Follow-up|1|||
164474263|NCT03601715|594108400|FG001|Second Intervention|Lost to Follow-up|1|||
164474264|NCT03601715|594108401|FG002|Second Intervention|Lost to Follow-up|0|||
164474265|NCT01478594|594108403|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
164474266|NCT01478594|594108404|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
164474267|NCT01478594|594108403|FG000|Overall Study|Death|45|||
164474268|NCT01478594|594108404|FG001|Overall Study|Death|18|||
164474269|NCT01478594|594108403|FG000|Overall Study|Lost to Follow-up|3|||
164474270|NCT01478594|594108404|FG001|Overall Study|Lost to Follow-up|1|||
164474271|NCT01478594|594108403|FG000|Overall Study|Withdrawal by Subject|9|||
164474272|NCT01478594|594108404|FG001|Overall Study|Withdrawal by Subject|3|||
164474273|NCT01478594|594108403|FG000|Overall Study|Study Closed by Sponsor|8|||
164474274|NCT01478594|594108404|FG001|Overall Study|Study Closed by Sponsor|5|||
164474275|NCT01313884|594108406|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
164474276|NCT01970007|594108407|FG000|Overall Study|Death|5|||
164474277|NCT01970007|594108407|FG000|Overall Study|Withdrawal by Subject|23|||
164474278|NCT01970007|594108407|FG000|Overall Study|Lost to Follow-up|24|||
164474279|NCT01970007|594108407|FG000|Overall Study|"Other endpoint"|3|||
164474280|NCT00754065|594108411|FG000|Overall Study|Never received treatment|12|||
164474281|NCT00754065|594108412|FG001|Overall Study|Never received treatment|2|||
164474282|NCT00754065|594108411|FG000|Overall Study|Adverse Event|19|||
164474283|NCT00754065|594108412|FG001|Overall Study|Adverse Event|25|||
164474284|NCT00754065|594108411|FG000|Overall Study|Lost to Follow-up|7|||
164474285|NCT00754065|594108412|FG001|Overall Study|Lost to Follow-up|11|||
164474286|NCT00754065|594108411|FG000|Overall Study|Protocol Violation|12|||
164474287|NCT00754065|594108412|FG001|Overall Study|Protocol Violation|10|||
164474288|NCT00754065|594108411|FG000|Overall Study|Withdrawal by Subject|4|||
164474289|NCT00754065|594108412|FG001|Overall Study|Withdrawal by Subject|5|||
164474290|NCT00754065|594108411|FG000|Overall Study|Pregnancy|6|||
164474291|NCT00754065|594108412|FG001|Overall Study|Pregnancy|0|||
164474292|NCT00754065|594108411|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
164474293|NCT00754065|594108412|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
164474294|NCT04250194|594108415|FG000|Overall Study|Declined to schedule biopsy|6|||
164474295|NCT04250194|594108416|FG001|Overall Study|Declined to schedule biopsy|10|||
164474296|NCT04250194|594108415|FG000|Overall Study|Medically Unfit for Biopsy|2|||
164474297|NCT04250194|594108416|FG001|Overall Study|Medically Unfit for Biopsy|1|||
164474298|NCT04250194|594108415|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
164474299|NCT04250194|594108416|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
164474300|NCT04250194|594108415|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
164474301|NCT04250194|594108416|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
164474302|NCT04250194|594108415|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
164532254|NCT00615836|594320505|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
164474303|NCT04250194|594108416|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
164474304|NCT00274261|594108419|FG000|Overall Study|Adverse Event|19|||
164474305|NCT00274261|594108420|FG001|Overall Study|Adverse Event|11|||
164474306|NCT00274261|594108419|FG000|Overall Study|Pregnancy|114|||
164474307|NCT00274261|594108420|FG001|Overall Study|Pregnancy|83|||
164474308|NCT00274261|594108419|FG000|Overall Study|Withdrawal by Subject|179|||
164474309|NCT00274261|594108420|FG001|Overall Study|Withdrawal by Subject|126|||
164474310|NCT00274261|594108419|FG000|Overall Study|Protocol Violation|71|||
164474311|NCT00274261|594108420|FG001|Overall Study|Protocol Violation|42|||
164474312|NCT00274261|594108419|FG000|Overall Study|Lost to Follow-up|106|||
164474313|NCT00274261|594108420|FG001|Overall Study|Lost to Follow-up|75|||
164474314|NCT03500549|594108421|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
164474315|NCT03500549|594108422|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
164474316|NCT03500549|594108421|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
164474317|NCT03500549|594108422|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
164474318|NCT02016872|594108425|FG000|Overall Study|Withdrawal by Subject|10|||
164474319|NCT02016872|594108425|FG000|Overall Study|Death Progression|2|||
164474320|NCT02016872|594108425|FG000|Overall Study|No FMISO scan|1|||
164474321|NCT02016872|594108425|FG000|Overall Study|Ineligible|2|||
164474322|NCT03275285|594108426|FG000|Overall Study|Ongoing|45|||
164474323|NCT03275285|594108427|FG001|Overall Study|Ongoing|69|||
164474324|NCT00115934|594108428|FG000|Overall Study|Lost to Follow-up|1|||
164474325|NCT00115934|594108429|FG001|Overall Study|Lost to Follow-up|0|||
164474326|NCT00115934|594108428|FG000|Overall Study|Did not receive intervention|3|||
164474327|NCT00115934|594108429|FG001|Overall Study|Did not receive intervention|2|||
164474328|NCT03789110|594108430|FG000|Overall Study|Adverse Event|2|||
164474329|NCT03789110|594108430|FG000|Overall Study|Physician Decision|1|||
164474330|NCT03789110|594108430|FG000|Overall Study|Withdrawal by Subject|2|||
164474331|NCT03789110|594108430|FG000|Overall Study|Lack of Efficacy|22|||
164474332|NCT03789110|594108430|FG000|Overall Study|still on treatment|3|||
164474333|NCT03959423|594108434|FG000|Overall Study|Withdrawal by Subject|2|||
164474334|NCT03959423|594108435|FG001|Overall Study|Withdrawal by Subject|3|||
164474335|NCT03959423|594108434|FG000|Overall Study|Physician Decision|0|||
164474336|NCT03959423|594108435|FG001|Overall Study|Physician Decision|1|||
164474337|NCT03959423|594108434|FG000|Overall Study|Lost to Follow-up|1|||
164474338|NCT03959423|594108435|FG001|Overall Study|Lost to Follow-up|0|||
164474339|NCT03959423|594108434|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
164474340|NCT03959423|594108435|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164474341|NCT00593840|594108438|FG000|Overall Study|Withdrawal by Subject|1|||
164474342|NCT03752684|594109598|FG000|Overall Study|Lost to Follow-up|4|||
164474343|NCT00048932|594109601|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
164474344|NCT00048932|594109602|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
164474345|NCT00048932|594109603|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
164474346|NCT00048932|594109601|FG000|Double Blind Period (DB)|Adverse Event|51|||
164474347|NCT00048932|594109602|FG001|Double Blind Period (DB)|Adverse Event|19|||
164474348|NCT00048932|594109603|FG002|Double Blind Period (DB)|Adverse Event|0|||
164474349|NCT00048932|594109601|FG000|Double Blind Period (DB)|Death|5|||
164474350|NCT00048932|594109602|FG001|Double Blind Period (DB)|Death|3|||
164474351|NCT00048932|594109603|FG002|Double Blind Period (DB)|Death|0|||
164474352|NCT00048932|594109601|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
164474353|NCT00048932|594109602|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
164474354|NCT00048932|594109603|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
164474355|NCT00048932|594109601|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
164474356|NCT00048932|594109602|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
164474357|NCT00048932|594109603|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
164474358|NCT00048932|594109601|FG000|Double Blind Period (DB)|Relocation|1|||
164474359|NCT00048932|594109602|FG001|Double Blind Period (DB)|Relocation|0|||
164474360|NCT00048932|594109603|FG002|Double Blind Period (DB)|Relocation|0|||
164474361|NCT00048932|594109601|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
164474362|NCT00048932|594109602|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
164474363|NCT00048932|594109603|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
164474364|NCT00048932|594109601|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
164474365|NCT00048932|594109602|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
164474366|NCT00048932|594109603|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
164474367|NCT00048932|594109601|FG000|Double Blind Period (DB)|Pregnancy|1|||
164474368|NCT00048932|594109602|FG001|Double Blind Period (DB)|Pregnancy|0|||
164474369|NCT00048932|594109603|FG002|Double Blind Period (DB)|Pregnancy|0|||
164474370|NCT00048932|594109601|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
164474371|NCT00048932|594109602|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
164474372|NCT00048932|594109603|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
164474373|NCT00048932|594109601|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
164474374|NCT00048932|594109602|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
164474375|NCT00048932|594109603|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
164474376|NCT00048932|594109601|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
164474377|NCT00048932|594109602|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
164474378|NCT00048932|594109603|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
164474379|NCT00048932|594109601|FG000|Open Label Period (OL)|Death|0|||
164474380|NCT00048932|594109602|FG001|Open Label Period (OL)|Death|0|||
164474381|NCT00048932|594109603|FG002|Open Label Period (OL)|Death|25|||
164474382|NCT00048932|594109601|FG000|Open Label Period (OL)|Adverse Event|0|||
164474383|NCT00048932|594109602|FG001|Open Label Period (OL)|Adverse Event|0|||
164474384|NCT00048932|594109603|FG002|Open Label Period (OL)|Adverse Event|103|||
164474385|NCT00048932|594109601|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
164474386|NCT00048932|594109602|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
164474387|NCT00048932|594109603|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
164474388|NCT00048932|594109601|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
164474389|NCT00048932|594109602|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
164474390|NCT00048932|594109603|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
164474391|NCT00048932|594109601|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
164474392|NCT00048932|594109602|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
164474393|NCT00048932|594109603|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
164474394|NCT00048932|594109601|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
164474395|NCT00048932|594109602|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
164474396|NCT00048932|594109603|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
164474397|NCT00048932|594109601|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
164474398|NCT00048932|594109602|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
164474399|NCT00048932|594109603|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
164474400|NCT00048932|594109601|FG000|Open Label Period (OL)|Pregnancy|0|||
164474401|NCT00048932|594109602|FG001|Open Label Period (OL)|Pregnancy|0|||
164474402|NCT00048932|594109603|FG002|Open Label Period (OL)|Pregnancy|6|||
164474403|NCT00048932|594109601|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
164474404|NCT00048932|594109602|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
164474405|NCT00048932|594109603|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
164474406|NCT00048932|594109601|FG000|Open Label Period (OL)|Investigator Retiring|0|||
164474407|NCT00048932|594109602|FG001|Open Label Period (OL)|Investigator Retiring|0|||
164474408|NCT00048932|594109603|FG002|Open Label Period (OL)|Investigator Retiring|2|||
164474409|NCT00048932|594109601|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
164474410|NCT00048932|594109602|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
164474411|NCT00048932|594109603|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
164474412|NCT00048932|594109601|FG000|Open Label Period (OL)|Participant Relocated|0|||
164474413|NCT00048932|594109602|FG001|Open Label Period (OL)|Participant Relocated|0|||
164474414|NCT00048932|594109603|FG002|Open Label Period (OL)|Participant Relocated|6|||
164474415|NCT00048932|594109601|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
164474416|NCT00048932|594109602|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
164474417|NCT00048932|594109603|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
164713818|NCT02960490|594974923|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
164713819|NCT02960490|594974924|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
164713820|NCT02960490|594974925|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
164713821|NCT02960490|594974926|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
164713822|NCT02960490|594974927|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
164713823|NCT02960490|594974928|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
164713824|NCT02960490|594974929|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
164713825|NCT02960490|594974930|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
164713826|NCT02960490|594974931|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
164713827|NCT02960490|594974922|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
164713828|NCT02960490|594974923|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
164713829|NCT02960490|594974924|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
164713830|NCT02960490|594974925|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
164713831|NCT02960490|594974926|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
164713832|NCT02960490|594974927|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
164713833|NCT02960490|594974928|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
164474418|NCT00048932|594109601|FG000|Open Label Period (OL)|Site Closure|0|||
164474419|NCT00048932|594109602|FG001|Open Label Period (OL)|Site Closure|0|||
164474420|NCT00048932|594109603|FG002|Open Label Period (OL)|Site Closure|3|||
164474421|NCT00048932|594109601|FG000|Open Label Period (OL)|Trial Terminated|0|||
164713834|NCT02960490|594974929|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
164474422|NCT00048932|594109602|FG001|Open Label Period (OL)|Trial Terminated|0|||
164474423|NCT00048932|594109603|FG002|Open Label Period (OL)|Trial Terminated|1|||
164474424|NCT00048932|594109601|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
164713835|NCT02960490|594974930|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
164474425|NCT00048932|594109602|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
164474426|NCT00048932|594109603|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
164474427|NCT00048932|594109601|FG000|Open Label Period (OL)|Patient Decision|0|||
164474428|NCT00048932|594109602|FG001|Open Label Period (OL)|Patient Decision|0|||
164474429|NCT00048932|594109603|FG002|Open Label Period (OL)|Patient Decision|4|||
164474430|NCT00048932|594109601|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
164474431|NCT00048932|594109602|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
164474432|NCT00048932|594109603|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
164474433|NCT00048932|594109601|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
164474434|NCT00048932|594109602|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
164474435|NCT00048932|594109603|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
164474436|NCT00048932|594109601|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
164474437|NCT00048932|594109602|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
164474438|NCT00048932|594109603|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
164474439|NCT00048932|594109601|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
164474440|NCT00048932|594109602|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
164474441|NCT00048932|594109603|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
164474442|NCT00048932|594109601|FG000|Open Label Period (OL)|Investigator Decision|0|||
164474443|NCT00048932|594109602|FG001|Open Label Period (OL)|Investigator Decision|0|||
164474444|NCT00048932|594109603|FG002|Open Label Period (OL)|Investigator Decision|4|||
164474445|NCT00048932|594109601|FG000|Open Label Period (OL)|Site Staff Issues|0|||
164474446|NCT00048932|594109602|FG001|Open Label Period (OL)|Site Staff Issues|0|||
164474447|NCT00048932|594109603|FG002|Open Label Period (OL)|Site Staff Issues|2|||
164474448|NCT00048932|594109601|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
164474449|NCT00048932|594109602|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
164474450|NCT00048932|594109603|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
164474451|NCT00048932|594109601|FG000|Open Label Period (OL)|Participant Surgery|0|||
164474452|NCT00048932|594109602|FG001|Open Label Period (OL)|Participant Surgery|0|||
164474453|NCT00048932|594109603|FG002|Open Label Period (OL)|Participant Surgery|1|||
164474454|NCT04213807|594109606|FG000|Overall Study|Physician Decision|0|||
164474455|NCT04213807|594109607|FG001|Overall Study|Physician Decision|0|||
164474456|NCT04213807|594109608|FG002|Overall Study|Physician Decision|1|||
164474457|NCT03418922|594109609|FG000|Overall Study|Withdrawal by Subject|0|||
164474458|NCT03418922|594109610|FG001|Overall Study|Withdrawal by Subject|2|||
164474459|NCT03418922|594109609|FG000|Overall Study|Adverse Event|2|||
164474460|NCT03418922|594109610|FG001|Overall Study|Adverse Event|2|||
164474461|NCT03418922|594109609|FG000|Overall Study|Death|0|||
164474462|NCT03418922|594109610|FG001|Overall Study|Death|1|||
164474463|NCT03418922|594109609|FG000|Overall Study|Physician Decision|0|||
164474464|NCT03418922|594109610|FG001|Overall Study|Physician Decision|1|||
164474465|NCT03451422|594109611|FG000|Overall Study|Lost to Follow-up|0|||
164474466|NCT03451422|594109612|FG001|Overall Study|Lost to Follow-up|0|||
164474467|NCT03451422|594109613|FG002|Overall Study|Lost to Follow-up|0|||
164474468|NCT03451422|594109614|FG003|Overall Study|Lost to Follow-up|0|||
164474469|NCT03451422|594109615|FG004|Overall Study|Lost to Follow-up|0|||
164474470|NCT03451422|594109616|FG005|Overall Study|Lost to Follow-up|1|||
164474471|NCT03451422|594109611|FG000|Overall Study|Decision by sponsor|1|||
164474472|NCT03451422|594109612|FG001|Overall Study|Decision by sponsor|0|||
164474473|NCT03451422|594109613|FG002|Overall Study|Decision by sponsor|1|||
164474474|NCT03451422|594109614|FG003|Overall Study|Decision by sponsor|0|||
164474475|NCT03451422|594109615|FG004|Overall Study|Decision by sponsor|0|||
164474476|NCT03451422|594109616|FG005|Overall Study|Decision by sponsor|0|||
164474477|NCT03451422|594109611|FG000|Overall Study|Withdrawal by Subject|0|||
164474478|NCT03451422|594109612|FG001|Overall Study|Withdrawal by Subject|0|||
164474479|NCT03451422|594109613|FG002|Overall Study|Withdrawal by Subject|2|||
164474480|NCT03451422|594109614|FG003|Overall Study|Withdrawal by Subject|3|||
164474481|NCT03451422|594109615|FG004|Overall Study|Withdrawal by Subject|2|||
164474482|NCT03451422|594109616|FG005|Overall Study|Withdrawal by Subject|1|||
164474483|NCT02347332|594109617|FG000|Overall Study|Not treated|5|||
164474484|NCT02347332|594109618|FG001|Overall Study|Not treated|2|||
164474485|NCT02347332|594109617|FG000|Overall Study|Progressive disease|141|||
164474486|NCT02347332|594109618|FG001|Overall Study|Progressive disease|159|||
164474487|NCT02347332|594109617|FG000|Overall Study|Adverse Event|50|||
164474488|NCT02347332|594109618|FG001|Overall Study|Adverse Event|41|||
164474489|NCT02347332|594109617|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
164474490|NCT02347332|594109618|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
164474491|NCT02347332|594109617|FG000|Overall Study|Protocol Violation|1|||
164474492|NCT02347332|594109618|FG001|Overall Study|Protocol Violation|1|||
164474493|NCT02347332|594109617|FG000|Overall Study|Lost to Follow-up|2|||
164474494|NCT02347332|594109618|FG001|Overall Study|Lost to Follow-up|1|||
164474495|NCT02347332|594109617|FG000|Overall Study|Physician Decision|4|||
164474496|NCT02347332|594109618|FG001|Overall Study|Physician Decision|3|||
164474497|NCT02347332|594109617|FG000|Overall Study|Withdrawal by Subject|20|||
164474498|NCT02347332|594109618|FG001|Overall Study|Withdrawal by Subject|14|||
164474499|NCT02347332|594109617|FG000|Overall Study|Protocol requirement|1|||
164474500|NCT02347332|594109618|FG001|Overall Study|Protocol requirement|1|||
164474501|NCT02347332|594109617|FG000|Overall Study|Switch Post-Trial program|0|||
164474502|NCT02347332|594109618|FG001|Overall Study|Switch Post-Trial program|1|||
164474503|NCT04384172|594109620|FG000|Overall Study|Lost to Follow-up|0|||
164474504|NCT04384172|594109621|FG001|Overall Study|Lost to Follow-up|2|||
164474505|NCT04384172|594109620|FG000|Overall Study|Pregnancy|1|||
164474506|NCT04384172|594109621|FG001|Overall Study|Pregnancy|0|||
164474507|NCT04384172|594109620|FG000|Overall Study|Withdrawal by Subject|0|||
164474508|NCT04384172|594109621|FG001|Overall Study|Withdrawal by Subject|1|||
164474509|NCT04860505|594109622|FG000|Overall Study|Lost to Follow-up|2|||
164474510|NCT01640951|594109623|FG000|Overall Study|Adverse Event|8|||
164474511|NCT01640951|594109624|FG001|Overall Study|Adverse Event|3|||
164474512|NCT01640951|594109625|FG002|Overall Study|Adverse Event|10|||
164474513|NCT01640951|594109626|FG003|Overall Study|Adverse Event|6|||
164474514|NCT01640951|594109627|FG004|Overall Study|Adverse Event|1|||
164474515|NCT01640951|594109628|FG005|Overall Study|Adverse Event|11|||
164474516|NCT01640951|594109629|FG006|Overall Study|Adverse Event|1|||
164474517|NCT01640951|594109630|FG007|Overall Study|Adverse Event|3|||
164474518|NCT01640951|594109623|FG000|Overall Study|Lack of Efficacy|20|||
164474519|NCT01640951|594109624|FG001|Overall Study|Lack of Efficacy|1|||
164474520|NCT01640951|594109625|FG002|Overall Study|Lack of Efficacy|7|||
164474521|NCT01640951|594109626|FG003|Overall Study|Lack of Efficacy|14|||
164474522|NCT01640951|594109627|FG004|Overall Study|Lack of Efficacy|0|||
164474523|NCT01640951|594109628|FG005|Overall Study|Lack of Efficacy|6|||
164474524|NCT01640951|594109629|FG006|Overall Study|Lack of Efficacy|5|||
164474525|NCT01640951|594109630|FG007|Overall Study|Lack of Efficacy|6|||
164474526|NCT01640951|594109623|FG000|Overall Study|Lost to Follow-up|1|||
164474527|NCT01640951|594109624|FG001|Overall Study|Lost to Follow-up|0|||
164474528|NCT01640951|594109625|FG002|Overall Study|Lost to Follow-up|6|||
164474529|NCT01640951|594109626|FG003|Overall Study|Lost to Follow-up|2|||
164474530|NCT01640951|594109627|FG004|Overall Study|Lost to Follow-up|2|||
164474531|NCT01640951|594109628|FG005|Overall Study|Lost to Follow-up|3|||
164474532|NCT01640951|594109629|FG006|Overall Study|Lost to Follow-up|1|||
164474533|NCT01640951|594109630|FG007|Overall Study|Lost to Follow-up|1|||
164474534|NCT01640951|594109623|FG000|Overall Study|Non-compliance with study treatment|0|||
164474535|NCT01640951|594109624|FG001|Overall Study|Non-compliance with study treatment|0|||
164474536|NCT01640951|594109625|FG002|Overall Study|Non-compliance with study treatment|1|||
164474537|NCT01640951|594109626|FG003|Overall Study|Non-compliance with study treatment|1|||
164474538|NCT01640951|594109627|FG004|Overall Study|Non-compliance with study treatment|1|||
164474539|NCT01640951|594109628|FG005|Overall Study|Non-compliance with study treatment|4|||
164474540|NCT01640951|594109629|FG006|Overall Study|Non-compliance with study treatment|1|||
164474541|NCT01640951|594109630|FG007|Overall Study|Non-compliance with study treatment|0|||
164474542|NCT01640951|594109623|FG000|Overall Study|Physician Decision|2|||
164474543|NCT01640951|594109624|FG001|Overall Study|Physician Decision|5|||
164474544|NCT01640951|594109625|FG002|Overall Study|Physician Decision|2|||
164474545|NCT01640951|594109626|FG003|Overall Study|Physician Decision|2|||
164474546|NCT01640951|594109627|FG004|Overall Study|Physician Decision|2|||
164474547|NCT01640951|594109628|FG005|Overall Study|Physician Decision|3|||
164474548|NCT01640951|594109629|FG006|Overall Study|Physician Decision|3|||
164474549|NCT01640951|594109630|FG007|Overall Study|Physician Decision|0|||
164474550|NCT01640951|594109623|FG000|Overall Study|Pregnancy|3|||
164474551|NCT01640951|594109624|FG001|Overall Study|Pregnancy|0|||
164474552|NCT01640951|594109625|FG002|Overall Study|Pregnancy|0|||
164474553|NCT01640951|594109626|FG003|Overall Study|Pregnancy|4|||
164474554|NCT01640951|594109627|FG004|Overall Study|Pregnancy|0|||
164713836|NCT02960490|594974931|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
164713837|NCT02960490|594974922|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
164713838|NCT02960490|594974923|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
164713839|NCT02960490|594974924|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
164713840|NCT02960490|594974925|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
164713841|NCT02960490|594974926|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
164713842|NCT02960490|594974927|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
164713843|NCT02960490|594974928|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
164713844|NCT02960490|594974929|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
164474555|NCT01640951|594109628|FG005|Overall Study|Pregnancy|0|||
164474556|NCT01640951|594109629|FG006|Overall Study|Pregnancy|2|||
164474557|NCT01640951|594109630|FG007|Overall Study|Pregnancy|0|||
164474558|NCT01640951|594109623|FG000|Overall Study|Protocol Deviation|0|||
164474559|NCT01640951|594109624|FG001|Overall Study|Protocol Deviation|1|||
164713845|NCT02960490|594974930|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
164713846|NCT02960490|594974931|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
164713847|NCT02960490|594974922|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
164474560|NCT01640951|594109625|FG002|Overall Study|Protocol Deviation|2|||
164474561|NCT01640951|594109626|FG003|Overall Study|Protocol Deviation|1|||
164474562|NCT01640951|594109627|FG004|Overall Study|Protocol Deviation|0|||
164474563|NCT01640951|594109628|FG005|Overall Study|Protocol Deviation|1|||
164474564|NCT01640951|594109629|FG006|Overall Study|Protocol Deviation|0|||
164474565|NCT01640951|594109630|FG007|Overall Study|Protocol Deviation|0|||
164474566|NCT01640951|594109623|FG000|Overall Study|Subject/Guardian decision|12|||
164474567|NCT01640951|594109624|FG001|Overall Study|Subject/Guardian decision|4|||
164474568|NCT01640951|594109625|FG002|Overall Study|Subject/Guardian decision|13|||
164474569|NCT01640951|594109626|FG003|Overall Study|Subject/Guardian decision|15|||
164474570|NCT01640951|594109627|FG004|Overall Study|Subject/Guardian decision|7|||
164474571|NCT01640951|594109628|FG005|Overall Study|Subject/Guardian decision|19|||
164474572|NCT01640951|594109629|FG006|Overall Study|Subject/Guardian decision|5|||
164474573|NCT01640951|594109630|FG007|Overall Study|Subject/Guardian decision|4|||
164474574|NCT01640951|594109623|FG000|Overall Study|Death|0|||
164474575|NCT01640951|594109624|FG001|Overall Study|Death|1|||
164474576|NCT01640951|594109625|FG002|Overall Study|Death|1|||
164474577|NCT01640951|594109626|FG003|Overall Study|Death|0|||
164474578|NCT01640951|594109627|FG004|Overall Study|Death|0|||
164474579|NCT01640951|594109628|FG005|Overall Study|Death|0|||
164474580|NCT01640951|594109629|FG006|Overall Study|Death|0|||
164474581|NCT01640951|594109630|FG007|Overall Study|Death|2|||
164474582|NCT00582972|594109631|FG000|Overall Study|Protocol Violation|2|||
164474583|NCT00293397|594109634|FG000|Overall Study|Death|2|||
164474584|NCT00523419|594109636|FG000|Overall Study|Adverse Event|1|||
164474585|NCT00523419|594109636|FG000|Overall Study|Withdrawal by Subject|1|||
164474586|NCT00523419|594109636|FG000|Overall Study|Physician Decision|2|||
164474587|NCT00523419|594109636|FG000|Overall Study|Progressive Disease|22|||
164474588|NCT00523419|594109636|FG000|Overall Study|Death due to Study Disease|4|||
164474589|NCT00523419|594109636|FG000|Overall Study|Death due to Adverse Event|2|||
164474590|NCT00822120|594109637|FG000|Initial Registration|Adverse Event|1|||
164474591|NCT00822120|594109638|FG001|Initial Registration|Adverse Event|0|||
164474592|NCT00822120|594109639|FG002|Initial Registration|Adverse Event|0|||
164474593|NCT00822120|594109640|FG003|Initial Registration|Adverse Event|0|||
164474594|NCT00822120|594109641|FG004|Initial Registration|Adverse Event|0|||
164474595|NCT00822120|594109642|FG005|Initial Registration|Adverse Event|0|||
164474596|NCT00822120|594109637|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
164474597|NCT00822120|594109638|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
164474598|NCT00822120|594109639|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
164474599|NCT00822120|594109640|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
164474600|NCT00822120|594109641|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
164474601|NCT00822120|594109642|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
164474602|NCT00822120|594109637|FG000|Initial Registration|Reasons not Protocol Specified|2|||
164474603|NCT00822120|594109638|FG001|Initial Registration|Reasons not Protocol Specified|0|||
164474604|NCT00822120|594109639|FG002|Initial Registration|Reasons not Protocol Specified|0|||
164474605|NCT00822120|594109640|FG003|Initial Registration|Reasons not Protocol Specified|0|||
164474606|NCT00822120|594109641|FG004|Initial Registration|Reasons not Protocol Specified|0|||
164474607|NCT00822120|594109642|FG005|Initial Registration|Reasons not Protocol Specified|0|||
164474608|NCT00822120|594109637|FG000|Initial Registration|Ineligible|22|||
164474609|NCT00822120|594109638|FG001|Initial Registration|Ineligible|1|||
164474610|NCT00822120|594109639|FG002|Initial Registration|Ineligible|0|||
164474611|NCT00822120|594109640|FG003|Initial Registration|Ineligible|0|||
164474612|NCT00822120|594109641|FG004|Initial Registration|Ineligible|0|||
164474613|NCT00822120|594109642|FG005|Initial Registration|Ineligible|0|||
164474614|NCT00822120|594109637|FG000|PET-directed Therapy|Adverse Event|0|||
164474615|NCT00822120|594109638|FG001|PET-directed Therapy|Adverse Event|0|||
164474616|NCT00822120|594109639|FG002|PET-directed Therapy|Adverse Event|0|||
164474617|NCT00822120|594109640|FG003|PET-directed Therapy|Adverse Event|1|||
164474618|NCT00822120|594109641|FG004|PET-directed Therapy|Adverse Event|0|||
164474619|NCT00822120|594109642|FG005|PET-directed Therapy|Adverse Event|0|||
164474620|NCT00822120|594109637|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
164474621|NCT00822120|594109638|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
164474622|NCT00822120|594109639|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
164474623|NCT00822120|594109640|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
164474624|NCT00822120|594109641|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
164474625|NCT00822120|594109642|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
164474626|NCT00822120|594109637|FG000|PET-directed Therapy|Death|0|||
164713848|NCT02960490|594974923|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
164713849|NCT02960490|594974924|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
164474627|NCT00822120|594109638|FG001|PET-directed Therapy|Death|0|||
164474628|NCT00822120|594109639|FG002|PET-directed Therapy|Death|0|||
164474629|NCT00822120|594109640|FG003|PET-directed Therapy|Death|2|||
164713850|NCT02960490|594974925|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
164474630|NCT00822120|594109641|FG004|PET-directed Therapy|Death|0|||
164474631|NCT00822120|594109642|FG005|PET-directed Therapy|Death|0|||
164474632|NCT00822120|594109637|FG000|PET-directed Therapy|Protocol Violation|0|||
164474633|NCT00822120|594109638|FG001|PET-directed Therapy|Protocol Violation|0|||
164474634|NCT00822120|594109639|FG002|PET-directed Therapy|Protocol Violation|0|||
164474635|NCT00822120|594109640|FG003|PET-directed Therapy|Protocol Violation|6|||
164474636|NCT00822120|594109641|FG004|PET-directed Therapy|Protocol Violation|0|||
164474637|NCT00822120|594109642|FG005|PET-directed Therapy|Protocol Violation|0|||
164474638|NCT01759862|594109643|FG000|Overall Study|Physician Decision|3|||
164474639|NCT01759862|594109644|FG001|Overall Study|Physician Decision|1|||
164474640|NCT01759862|594109643|FG000|Overall Study|Adverse Event|0|||
164474641|NCT01759862|594109644|FG001|Overall Study|Adverse Event|1|||
164474642|NCT04060212|594109646|FG000|Overall Study|Withdrawal by Subject|7|||
164474643|NCT01499849|594109647|FG000|Overall Study|Adverse Event|28|||
164474644|NCT01499849|594109648|FG001|Overall Study|Adverse Event|32|||
164474645|NCT01499849|594109647|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
164474646|NCT01499849|594109648|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
164474647|NCT01499849|594109647|FG000|Overall Study|Withdrawal by Subject|43|||
164474648|NCT01499849|594109648|FG001|Overall Study|Withdrawal by Subject|43|||
164474649|NCT01499849|594109647|FG000|Overall Study|Death|5|||
164474650|NCT01499849|594109648|FG001|Overall Study|Death|7|||
164474651|NCT01499849|594109647|FG000|Overall Study|Disease Progression|11|||
164474652|NCT01499849|594109648|FG001|Overall Study|Disease Progression|10|||
164474653|NCT01499849|594109647|FG000|Overall Study|Protocol Violation|11|||
164474654|NCT01499849|594109648|FG001|Overall Study|Protocol Violation|11|||
164474655|NCT01499849|594109647|FG000|Overall Study|Physician Decision|20|||
164474656|NCT01499849|594109648|FG001|Overall Study|Physician Decision|19|||
164474657|NCT01499849|594109647|FG000|Overall Study|Lack of Efficacy|3|||
164474658|NCT01499849|594109648|FG001|Overall Study|Lack of Efficacy|4|||
164474659|NCT01499849|594109647|FG000|Overall Study|Lost to Follow-up|6|||
164474660|NCT01499849|594109648|FG001|Overall Study|Lost to Follow-up|3|||
164474661|NCT01499849|594109647|FG000|Overall Study|Other Reasons|27|||
164474662|NCT01499849|594109648|FG001|Overall Study|Other Reasons|30|||
164474663|NCT02646618|594109649|FG000|Overall Study|Lost to Follow-up|10|||
164474664|NCT02646618|594109650|FG001|Overall Study|Lost to Follow-up|14|||
164474665|NCT03885232|594109651|FG000|Overall Study|Lost to Follow-up|74|||
164474666|NCT03885232|594109652|FG001|Overall Study|Lost to Follow-up|32|||
164474667|NCT03885232|594109651|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
164474668|NCT03885232|594109652|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
164474669|NCT00918203|594109654|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
164474670|NCT00918203|594109655|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
164474671|NCT00918203|594109656|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
164474672|NCT00918203|594109654|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
164474673|NCT00918203|594109655|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
164474674|NCT00918203|594109656|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
164474675|NCT00918203|594109654|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
164474676|NCT00918203|594109655|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
164474677|NCT00918203|594109656|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
164474678|NCT00918203|594109654|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
164599891|NCT00621855|594556386|FG002|Overall Study|Patients did not receive study drug|5|||
164599892|NCT00621855|594556387|FG003|Overall Study|Patients did not receive study drug|4|||
164599893|NCT00621855|594556388|FG004|Overall Study|Patients did not receive study drug|2|||
164599894|NCT03731364|594556389|FG000|Overall Study|Adverse Event|0|||
164599895|NCT03731364|594556390|FG001|Overall Study|Adverse Event|0|||
164599896|NCT03731364|594556391|FG002|Overall Study|Adverse Event|1|||
164599897|NCT03731364|594556392|FG003|Overall Study|Adverse Event|2|||
164599898|NCT03731364|594556393|FG004|Overall Study|Adverse Event|1|||
164599899|NCT02112994|594556394|FG000|Overall Study|Progressive Disease|0|||
164599900|NCT02112994|594556395|FG001|Overall Study|Progressive Disease|0|||
164599901|NCT02112994|594556396|FG002|Overall Study|Progressive Disease|1|||
164599902|NCT02112994|594556394|FG000|Overall Study|Pregnancy|0|||
164599903|NCT02112994|594556395|FG001|Overall Study|Pregnancy|1|||
164599904|NCT02112994|594556396|FG002|Overall Study|Pregnancy|1|||
164599905|NCT02112994|594556394|FG000|Overall Study|Liver Transplant|0|||
164599906|NCT02112994|594556395|FG001|Overall Study|Liver Transplant|1|||
164599907|NCT02112994|594556396|FG002|Overall Study|Liver Transplant|0|||
164599908|NCT02112994|594556394|FG000|Overall Study|Withdrawal by Subject|0|||
164599909|NCT02112994|594556395|FG001|Overall Study|Withdrawal by Subject|0|||
164599910|NCT02112994|594556396|FG002|Overall Study|Withdrawal by Subject|1|||
164599911|NCT04387136|594556397|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
164599912|NCT04387136|594556398|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
164599913|NCT00417976|594556399|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
164713851|NCT02960490|594974926|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
164599914|NCT00417976|594556399|FG000|Overall Study|Treatment -related toxicity|2|||
164599915|NCT02358369|594556400|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
164599916|NCT02358369|594556401|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
164599917|NCT02358369|594556402|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
164599918|NCT02358369|594556403|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
164713852|NCT02960490|594974927|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
164474679|NCT00918203|594109655|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
164474680|NCT00918203|594109656|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
164474681|NCT04066075|594109657|FG000|Overall Study|Lost to Follow-up|3|||
164474682|NCT04066075|594109658|FG001|Overall Study|Lost to Follow-up|3|||
164474683|NCT04066075|594109657|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
164474684|NCT04066075|594109658|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
164474685|NCT04066075|594109657|FG000|Overall Study|Withdrawal by Subject|2|||
164474686|NCT04066075|594109658|FG001|Overall Study|Withdrawal by Subject|2|||
164474687|NCT00309166|594109659|FG000|Overall Study|Adverse event, non-fatal|1|||
164474688|NCT00309166|594109660|FG001|Overall Study|Adverse event, non-fatal|0|||
164474689|NCT00309166|594109659|FG000|Overall Study|Withdrawal by Subject|4|||
164474690|NCT00309166|594109660|FG001|Overall Study|Withdrawal by Subject|3|||
164474691|NCT00701701|594109663|FG000|Overall Study|Withdrawal by Subject|0|||
164474692|NCT00701701|594109664|FG001|Overall Study|Withdrawal by Subject|1|||
164474693|NCT00701701|594109663|FG000|Overall Study|Adverse Event|0|||
164474694|NCT00701701|594109664|FG001|Overall Study|Adverse Event|1|||
164474695|NCT05018143|594109665|FG000|Overall Study|Lost to Follow-up|5|||
164474696|NCT05018143|594109666|FG001|Overall Study|Lost to Follow-up|4|||
164474697|NCT05018143|594109665|FG000|Overall Study|Withdrawal by Subject|0|||
164474698|NCT05018143|594109666|FG001|Overall Study|Withdrawal by Subject|1|||
164474699|NCT06688357|594109667|FG000|Overall Study|Adverse Event|0|||
164474700|NCT06688357|594109668|FG001|Overall Study|Adverse Event|1|||
164474701|NCT00545545|594109669|FG000|Overall Study|Progressive Neoplastic Disease|1|||
164474702|NCT00545545|594109670|FG001|Overall Study|Progressive Neoplastic Disease|5|||
164474703|NCT00545545|594109671|FG002|Overall Study|Progressive Neoplastic Disease|0|||
164474704|NCT00545545|594109672|FG003|Overall Study|Progressive Neoplastic Disease|4|||
164474705|NCT00545545|594109673|FG004|Overall Study|Progressive Neoplastic Disease|8|||
164474706|NCT00545545|594109674|FG005|Overall Study|Progressive Neoplastic Disease|7|||
164474707|NCT00545545|594109669|FG000|Overall Study|Withdrawal by Subject|0|||
164474708|NCT00545545|594109670|FG001|Overall Study|Withdrawal by Subject|1|||
164474709|NCT00545545|594109671|FG002|Overall Study|Withdrawal by Subject|0|||
164474710|NCT00545545|594109672|FG003|Overall Study|Withdrawal by Subject|0|||
164474711|NCT00545545|594109673|FG004|Overall Study|Withdrawal by Subject|0|||
164474712|NCT00545545|594109674|FG005|Overall Study|Withdrawal by Subject|0|||
164474713|NCT00545545|594109669|FG000|Overall Study|Physician Decision|1|||
164474714|NCT00545545|594109670|FG001|Overall Study|Physician Decision|0|||
164474715|NCT00545545|594109671|FG002|Overall Study|Physician Decision|0|||
164474716|NCT00545545|594109672|FG003|Overall Study|Physician Decision|0|||
164474717|NCT00545545|594109673|FG004|Overall Study|Physician Decision|0|||
164474718|NCT00545545|594109674|FG005|Overall Study|Physician Decision|1|||
164474719|NCT00545545|594109669|FG000|Overall Study|Irinotecan intolerance|1|||
164474720|NCT00545545|594109670|FG001|Overall Study|Irinotecan intolerance|1|||
164474721|NCT00545545|594109671|FG002|Overall Study|Irinotecan intolerance|0|||
164474722|NCT00545545|594109672|FG003|Overall Study|Irinotecan intolerance|0|||
164474723|NCT00545545|594109673|FG004|Overall Study|Irinotecan intolerance|0|||
164474724|NCT00545545|594109674|FG005|Overall Study|Irinotecan intolerance|0|||
164474725|NCT00545545|594109669|FG000|Overall Study|No target lesions to track post surgery|0|||
164474726|NCT00545545|594109670|FG001|Overall Study|No target lesions to track post surgery|0|||
164474727|NCT00545545|594109671|FG002|Overall Study|No target lesions to track post surgery|0|||
164474728|NCT00545545|594109672|FG003|Overall Study|No target lesions to track post surgery|0|||
164474729|NCT00545545|594109673|FG004|Overall Study|No target lesions to track post surgery|1|||
164474730|NCT00545545|594109674|FG005|Overall Study|No target lesions to track post surgery|1|||
164474731|NCT00227266|594109678|FG000|Overall Study|Withdrawal by Subject|0|||
164474732|NCT00227266|594109679|FG001|Overall Study|Withdrawal by Subject|0|||
164474733|NCT00227266|594109680|FG002|Overall Study|Withdrawal by Subject|1|||
164474734|NCT00227266|594109678|FG000|Overall Study|Protocol Violation|1|||
164474735|NCT00227266|594109679|FG001|Overall Study|Protocol Violation|0|||
164474736|NCT00227266|594109680|FG002|Overall Study|Protocol Violation|1|||
164474737|NCT00227266|594109678|FG000|Overall Study|Excessive weight gain|0|||
164474738|NCT00227266|594109679|FG001|Overall Study|Excessive weight gain|0|||
164474739|NCT00227266|594109680|FG002|Overall Study|Excessive weight gain|2|||
164474740|NCT02761187|594109684|FG000|Overall Study|Too ill to Participate|13|||
164713853|NCT02960490|594974928|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
164713854|NCT02960490|594974929|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
164713855|NCT02960490|594974930|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
164713856|NCT02960490|594974931|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
164474741|NCT02761187|594109685|FG001|Overall Study|Too ill to Participate|8|||
164474742|NCT02761187|594109684|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
164474743|NCT02761187|594109685|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
164474744|NCT02761187|594109684|FG000|Overall Study|Patient withdrew consent|64|||
164474745|NCT02761187|594109685|FG001|Overall Study|Patient withdrew consent|58|||
164474746|NCT02761187|594109684|FG000|Overall Study|Physician discretion|4|||
164474747|NCT02761187|594109685|FG001|Overall Study|Physician discretion|8|||
164474748|NCT02761187|594109684|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
164474749|NCT02761187|594109685|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
164474750|NCT02761187|594109684|FG000|Overall Study|On Hospice|20|||
164474751|NCT02761187|594109685|FG001|Overall Study|On Hospice|26|||
164474752|NCT02761187|594109684|FG000|Overall Study|Deceased|474|||
164474753|NCT02761187|594109685|FG001|Overall Study|Deceased|642|||
164474754|NCT02761187|594109684|FG000|Overall Study|Lost to Follow-up|73|||
164474755|NCT02761187|594109685|FG001|Overall Study|Lost to Follow-up|63|||
164474756|NCT02761187|594109684|FG000|Overall Study|Due to study discontinued at site|100|||
164474757|NCT02761187|594109685|FG001|Overall Study|Due to study discontinued at site|85|||
164474758|NCT02761187|594109684|FG000|Overall Study|Reason not Specified|1484|||
164474759|NCT02761187|594109685|FG001|Overall Study|Reason not Specified|937|||
164474760|NCT05786612|594109688|FG000|Overall Study|Adverse Event|1|||
164474761|NCT05786612|594109689|FG001|Overall Study|Adverse Event|2|||
164474762|NCT05786612|594109688|FG000|Overall Study|one screening failure|0|||
164474763|NCT05786612|594109689|FG001|Overall Study|one screening failure|2|||
164474764|NCT05704725|594109694|FG000|Overall Study|Lost to Follow-up|0|||
164474765|NCT05704725|594109695|FG001|Overall Study|Lost to Follow-up|1|||
164474766|NCT05704725|594109694|FG000|Overall Study|Withdrawal by Subject|1|||
164474767|NCT05704725|594109695|FG001|Overall Study|Withdrawal by Subject|0|||
164474768|NCT01470144|594109696|FG000|Overall Study|Adverse Event|2|||
164474769|NCT01470144|594109696|FG000|Overall Study|Death|1|||
164474770|NCT01470144|594109696|FG000|Overall Study|Lung transplant|6|||
164474771|NCT01470144|594109696|FG000|Overall Study|Patient's and investigator's decision|1|||
164474772|NCT03459196|594111069|FG000|Overall Study|Subject didn't receive study catheter|2|||
164474773|NCT03367156|594111070|FG000|Overall Study|Lack of interest|3|||
164474774|NCT03367156|594111071|FG001|Overall Study|Lack of interest|1|||
164474775|NCT03367156|594111070|FG000|Overall Study|Death|2|||
164474776|NCT03367156|594111071|FG001|Overall Study|Death|0|||
164474777|NCT03367156|594111070|FG000|Overall Study|Lost to Follow-up|2|||
164474778|NCT03367156|594111071|FG001|Overall Study|Lost to Follow-up|1|||
164474779|NCT03367156|594111070|FG000|Overall Study|Became ineligible|1|||
164474780|NCT03367156|594111071|FG001|Overall Study|Became ineligible|2|||
164474781|NCT03367156|594111070|FG000|Overall Study|Hospitalization|1|||
164474782|NCT03367156|594111071|FG001|Overall Study|Hospitalization|0|||
164474783|NCT03367156|594111070|FG000|Overall Study|Concerned about Treatment|11|||
164474784|NCT03367156|594111071|FG001|Overall Study|Concerned about Treatment|3|||
164474785|NCT03367156|594111070|FG000|Overall Study|Started new treatment|4|||
164474786|NCT03367156|594111071|FG001|Overall Study|Started new treatment|1|||
164474787|NCT03762850|594111072|FG000|Overall Study|Death|0|||
164474788|NCT03762850|594111073|FG001|Overall Study|Death|1|||
164474789|NCT03762850|594111072|FG000|Overall Study|Lost to Follow-up|0|||
164474790|NCT03762850|594111073|FG001|Overall Study|Lost to Follow-up|1|||
164474791|NCT03762850|594111072|FG000|Overall Study|Physician Decision|0|||
164474792|NCT03762850|594111073|FG001|Overall Study|Physician Decision|1|||
164474793|NCT03762850|594111072|FG000|Overall Study|Withdrawal by Subject|4|||
164474794|NCT03762850|594111073|FG001|Overall Study|Withdrawal by Subject|9|||
164474795|NCT00092534|594111076|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
164474796|NCT00092534|594111077|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
164713857|NCT02960490|594974922|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
164474797|NCT00092534|594111078|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
164474798|NCT00092534|594111079|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
164474799|NCT00092534|594111080|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
164474800|NCT00092534|594111076|FG000|Base Study Vaccination Period|Adverse Event|3|||
164474801|NCT00092534|594111077|FG001|Base Study Vaccination Period|Adverse Event|1|||
164474802|NCT00092534|594111078|FG002|Base Study Vaccination Period|Adverse Event|0|||
164474803|NCT00092534|594111079|FG003|Base Study Vaccination Period|Adverse Event|0|||
164474804|NCT00092534|594111080|FG004|Base Study Vaccination Period|Adverse Event|0|||
164474805|NCT00092534|594111076|FG000|Base Study Vaccination Period|Death|5|||
164474806|NCT00092534|594111077|FG001|Base Study Vaccination Period|Death|4|||
164474807|NCT00092534|594111078|FG002|Base Study Vaccination Period|Death|0|||
164474808|NCT00092534|594111079|FG003|Base Study Vaccination Period|Death|0|||
164474809|NCT00092534|594111080|FG004|Base Study Vaccination Period|Death|0|||
164474810|NCT00092534|594111076|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
164474811|NCT00092534|594111077|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
164474812|NCT00092534|594111078|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
164474813|NCT00092534|594111079|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
164474814|NCT00092534|594111080|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
164474815|NCT00092534|594111076|FG000|Base Study Vaccination Period|Physician Decision|1|||
164474816|NCT00092534|594111077|FG001|Base Study Vaccination Period|Physician Decision|0|||
164474817|NCT00092534|594111078|FG002|Base Study Vaccination Period|Physician Decision|0|||
164474818|NCT00092534|594111079|FG003|Base Study Vaccination Period|Physician Decision|0|||
164474819|NCT00092534|594111080|FG004|Base Study Vaccination Period|Physician Decision|0|||
164474820|NCT00092534|594111076|FG000|Base Study Vaccination Period|Pregnancy|9|||
164474821|NCT00092534|594111077|FG001|Base Study Vaccination Period|Pregnancy|7|||
164474822|NCT00092534|594111078|FG002|Base Study Vaccination Period|Pregnancy|0|||
164474823|NCT00092534|594111079|FG003|Base Study Vaccination Period|Pregnancy|0|||
164474824|NCT00092534|594111080|FG004|Base Study Vaccination Period|Pregnancy|0|||
164474825|NCT00092534|594111076|FG000|Base Study Vaccination Period|Protocol Violation|2|||
164474826|NCT00092534|594111077|FG001|Base Study Vaccination Period|Protocol Violation|1|||
164474827|NCT00092534|594111078|FG002|Base Study Vaccination Period|Protocol Violation|0|||
164474828|NCT00092534|594111079|FG003|Base Study Vaccination Period|Protocol Violation|0|||
164474829|NCT00092534|594111080|FG004|Base Study Vaccination Period|Protocol Violation|0|||
164474830|NCT00092534|594111076|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
164474831|NCT00092534|594111077|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
164474832|NCT00092534|594111078|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
164474833|NCT00092534|594111079|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
164474834|NCT00092534|594111080|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
164474835|NCT00092534|594111076|FG000|Base Study Vaccination Period|Moved|14|||
164474836|NCT00092534|594111077|FG001|Base Study Vaccination Period|Moved|12|||
164474837|NCT00092534|594111078|FG002|Base Study Vaccination Period|Moved|0|||
164474838|NCT00092534|594111079|FG003|Base Study Vaccination Period|Moved|0|||
164474839|NCT00092534|594111080|FG004|Base Study Vaccination Period|Moved|0|||
164474840|NCT00092534|594111076|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
164474841|NCT00092534|594111077|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
164474842|NCT00092534|594111078|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
164474843|NCT00092534|594111079|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
164474844|NCT00092534|594111080|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
164474845|NCT00092534|594111076|FG000|Base Study Vaccination Period|Travel|1|||
164474846|NCT00092534|594111077|FG001|Base Study Vaccination Period|Travel|0|||
164474847|NCT00092534|594111078|FG002|Base Study Vaccination Period|Travel|0|||
164474848|NCT00092534|594111079|FG003|Base Study Vaccination Period|Travel|0|||
164474849|NCT00092534|594111080|FG004|Base Study Vaccination Period|Travel|0|||
164474850|NCT00092534|594111076|FG000|Base Study Vaccination Period|Site Closed|0|||
164474851|NCT00092534|594111077|FG001|Base Study Vaccination Period|Site Closed|1|||
164474852|NCT00092534|594111078|FG002|Base Study Vaccination Period|Site Closed|0|||
164474853|NCT00092534|594111079|FG003|Base Study Vaccination Period|Site Closed|0|||
164474854|NCT00092534|594111080|FG004|Base Study Vaccination Period|Site Closed|0|||
164474855|NCT00092534|594111076|FG000|Base Study Follow-Up Period|Adverse Event|2|||
164474856|NCT00092534|594111077|FG001|Base Study Follow-Up Period|Adverse Event|4|||
164474857|NCT00092534|594111078|FG002|Base Study Follow-Up Period|Adverse Event|0|||
164474858|NCT00092534|594111079|FG003|Base Study Follow-Up Period|Adverse Event|0|||
164474859|NCT00092534|594111080|FG004|Base Study Follow-Up Period|Adverse Event|0|||
164474860|NCT00092534|594111076|FG000|Base Study Follow-Up Period|Death|2|||
164474861|NCT00092534|594111077|FG001|Base Study Follow-Up Period|Death|1|||
164474862|NCT00092534|594111078|FG002|Base Study Follow-Up Period|Death|0|||
164474863|NCT00092534|594111079|FG003|Base Study Follow-Up Period|Death|0|||
164474864|NCT00092534|594111080|FG004|Base Study Follow-Up Period|Death|0|||
164474865|NCT00092534|594111076|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
164713858|NCT02960490|594974923|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
164713859|NCT02960490|594974924|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
164713860|NCT02960490|594974925|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
164713861|NCT02960490|594974926|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
164713862|NCT02960490|594974927|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
164713863|NCT02960490|594974928|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
164713864|NCT02960490|594974929|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
164713865|NCT02960490|594974930|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
164713866|NCT02960490|594974931|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
164474866|NCT00092534|594111077|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
164474867|NCT00092534|594111078|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
164474868|NCT00092534|594111079|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
164474869|NCT00092534|594111080|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
164474870|NCT00092534|594111076|FG000|Base Study Follow-Up Period|Pregnancy|6|||
164474871|NCT00092534|594111077|FG001|Base Study Follow-Up Period|Pregnancy|10|||
164474872|NCT00092534|594111078|FG002|Base Study Follow-Up Period|Pregnancy|0|||
164474873|NCT00092534|594111079|FG003|Base Study Follow-Up Period|Pregnancy|0|||
164474874|NCT00092534|594111080|FG004|Base Study Follow-Up Period|Pregnancy|0|||
164474875|NCT00092534|594111076|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
164474876|NCT00092534|594111077|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
164474877|NCT00092534|594111078|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
164474878|NCT00092534|594111079|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
164474879|NCT00092534|594111080|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
164474880|NCT00092534|594111076|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
164474881|NCT00092534|594111077|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
164474882|NCT00092534|594111078|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
164474883|NCT00092534|594111079|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
164474884|NCT00092534|594111080|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
164474885|NCT00092534|594111076|FG000|Base Study Follow-Up Period|Moved|62|||
164474886|NCT00092534|594111077|FG001|Base Study Follow-Up Period|Moved|58|||
164474887|NCT00092534|594111078|FG002|Base Study Follow-Up Period|Moved|0|||
164474888|NCT00092534|594111079|FG003|Base Study Follow-Up Period|Moved|0|||
164474889|NCT00092534|594111080|FG004|Base Study Follow-Up Period|Moved|0|||
164474890|NCT00092534|594111076|FG000|Base Study Follow-Up Period|Travel|10|||
164474891|NCT00092534|594111077|FG001|Base Study Follow-Up Period|Travel|7|||
164474892|NCT00092534|594111078|FG002|Base Study Follow-Up Period|Travel|0|||
164474893|NCT00092534|594111079|FG003|Base Study Follow-Up Period|Travel|0|||
164474894|NCT00092534|594111080|FG004|Base Study Follow-Up Period|Travel|0|||
164474895|NCT00092534|594111076|FG000|Base Study Follow-Up Period|Site Closed|0|||
164474896|NCT00092534|594111077|FG001|Base Study Follow-Up Period|Site Closed|2|||
164474897|NCT00092534|594111078|FG002|Base Study Follow-Up Period|Site Closed|0|||
164474898|NCT00092534|594111079|FG003|Base Study Follow-Up Period|Site Closed|0|||
164474899|NCT00092534|594111080|FG004|Base Study Follow-Up Period|Site Closed|0|||
164474900|NCT00092534|594111076|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
164474901|NCT00092534|594111077|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
164474902|NCT00092534|594111078|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
164474903|NCT00092534|594111079|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
164474904|NCT00092534|594111080|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
164474905|NCT00092534|594111076|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
164474906|NCT00092534|594111077|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
164474907|NCT00092534|594111078|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
164474908|NCT00092534|594111079|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
164474909|NCT00092534|594111080|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
164474910|NCT00092534|594111076|FG000|Base Study EXT|Lost to Follow-up|0|||
164474911|NCT00092534|594111077|FG001|Base Study EXT|Lost to Follow-up|0|||
164474912|NCT00092534|594111078|FG002|Base Study EXT|Lost to Follow-up|41|||
164474913|NCT00092534|594111079|FG003|Base Study EXT|Lost to Follow-up|0|||
164474914|NCT00092534|594111080|FG004|Base Study EXT|Lost to Follow-up|0|||
164474915|NCT00092534|594111076|FG000|Base Study EXT|Physician Decision|0|||
164474916|NCT00092534|594111077|FG001|Base Study EXT|Physician Decision|0|||
164474917|NCT00092534|594111078|FG002|Base Study EXT|Physician Decision|1|||
164474918|NCT00092534|594111079|FG003|Base Study EXT|Physician Decision|0|||
164474919|NCT00092534|594111080|FG004|Base Study EXT|Physician Decision|0|||
164474920|NCT00092534|594111076|FG000|Base Study EXT|Pregnancy|0|||
164474921|NCT00092534|594111077|FG001|Base Study EXT|Pregnancy|0|||
164474922|NCT00092534|594111078|FG002|Base Study EXT|Pregnancy|12|||
164474923|NCT00092534|594111079|FG003|Base Study EXT|Pregnancy|0|||
164474924|NCT00092534|594111080|FG004|Base Study EXT|Pregnancy|0|||
164474925|NCT00092534|594111076|FG000|Base Study EXT|Withdrawal by Subject|0|||
164474926|NCT00092534|594111077|FG001|Base Study EXT|Withdrawal by Subject|0|||
164474927|NCT00092534|594111078|FG002|Base Study EXT|Withdrawal by Subject|18|||
164474928|NCT00092534|594111079|FG003|Base Study EXT|Withdrawal by Subject|0|||
164474929|NCT00092534|594111080|FG004|Base Study EXT|Withdrawal by Subject|0|||
164474930|NCT00092534|594111076|FG000|Base Study EXT|Participant moved|0|||
164474931|NCT00092534|594111077|FG001|Base Study EXT|Participant moved|0|||
164474932|NCT00092534|594111078|FG002|Base Study EXT|Participant moved|6|||
164474933|NCT00092534|594111079|FG003|Base Study EXT|Participant moved|0|||
164474934|NCT00092534|594111080|FG004|Base Study EXT|Participant moved|0|||
164474935|NCT00092534|594111076|FG000|Base Study EXT|Travel|0|||
164474936|NCT00092534|594111077|FG001|Base Study EXT|Travel|0|||
164474937|NCT00092534|594111078|FG002|Base Study EXT|Travel|2|||
164474938|NCT00092534|594111079|FG003|Base Study EXT|Travel|0|||
164474939|NCT00092534|594111080|FG004|Base Study EXT|Travel|0|||
164474940|NCT00092534|594111076|FG000|Base Study EXT|Site closed|0|||
164474941|NCT00092534|594111077|FG001|Base Study EXT|Site closed|0|||
164474942|NCT00092534|594111078|FG002|Base Study EXT|Site closed|21|||
164474943|NCT00092534|594111079|FG003|Base Study EXT|Site closed|0|||
164474944|NCT00092534|594111080|FG004|Base Study EXT|Site closed|0|||
164474945|NCT00092534|594111076|FG000|Base Study EXT|Study ended|0|||
164474946|NCT00092534|594111077|FG001|Base Study EXT|Study ended|0|||
164474947|NCT00092534|594111078|FG002|Base Study EXT|Study ended|29|||
164474948|NCT00092534|594111079|FG003|Base Study EXT|Study ended|0|||
164474949|NCT00092534|594111080|FG004|Base Study EXT|Study ended|0|||
164474950|NCT00092534|594111076|FG000|Base Study EXT|Protocol Violation|0|||
164474951|NCT00092534|594111077|FG001|Base Study EXT|Protocol Violation|0|||
164474952|NCT00092534|594111078|FG002|Base Study EXT|Protocol Violation|15|||
164474953|NCT00092534|594111079|FG003|Base Study EXT|Protocol Violation|0|||
164474954|NCT00092534|594111080|FG004|Base Study EXT|Protocol Violation|0|||
164474955|NCT00092534|594111076|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
164474956|NCT00092534|594111077|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
164474957|NCT00092534|594111078|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
164474958|NCT00092534|594111079|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
164474959|NCT00092534|594111080|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
164474960|NCT03083366|594111081|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
164474961|NCT03083366|594111082|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
164474962|NCT03083366|594111081|FG000|Enrollment Period|Lack of Efficacy|1|||
164474963|NCT03083366|594111082|FG001|Enrollment Period|Lack of Efficacy|0|||
164474964|NCT05250115|594111083|FG000|Overall Study|Premature study end|40|||
164474965|NCT05250115|594111083|FG000|Overall Study|Adverse Event|8|||
164474966|NCT05250115|594111083|FG000|Overall Study|Lost to Follow-up|7|||
164474967|NCT05250115|594111083|FG000|Overall Study|Withdrawal by Subject|6|||
164474968|NCT05250115|594111083|FG000|Overall Study|Withdrawal of informed consent|1|||
164474969|NCT05250115|594111083|FG000|Overall Study|Other|7|||
164474970|NCT00622700|594111087|FG000|Core Treatment Period|Randomized but Not Treated|0|||
164474971|NCT00622700|594111088|FG001|Core Treatment Period|Randomized but Not Treated|2|||
164474972|NCT00622700|594111089|FG002|Core Treatment Period|Randomized but Not Treated|2|||
164474973|NCT00622700|594111090|FG003|Core Treatment Period|Randomized but Not Treated|0|||
164474974|NCT00622700|594111091|FG004|Core Treatment Period|Randomized but Not Treated|0|||
164474975|NCT00622700|594111092|FG005|Core Treatment Period|Randomized but Not Treated|0|||
164474976|NCT00622700|594111093|FG006|Core Treatment Period|Randomized but Not Treated|0|||
164474977|NCT00622700|594111087|FG000|Core Treatment Period|Adverse Event|18|||
164474978|NCT00622700|594111088|FG001|Core Treatment Period|Adverse Event|25|||
164474979|NCT00622700|594111089|FG002|Core Treatment Period|Adverse Event|18|||
164474980|NCT00622700|594111090|FG003|Core Treatment Period|Adverse Event|0|||
164474981|NCT00622700|594111091|FG004|Core Treatment Period|Adverse Event|0|||
164474982|NCT00622700|594111092|FG005|Core Treatment Period|Adverse Event|0|||
164474983|NCT00622700|594111093|FG006|Core Treatment Period|Adverse Event|0|||
164474984|NCT00622700|594111087|FG000|Core Treatment Period|Lack of Efficacy|19|||
164474985|NCT00622700|594111088|FG001|Core Treatment Period|Lack of Efficacy|6|||
164474986|NCT00622700|594111089|FG002|Core Treatment Period|Lack of Efficacy|12|||
164474987|NCT00622700|594111090|FG003|Core Treatment Period|Lack of Efficacy|0|||
164474988|NCT00622700|594111091|FG004|Core Treatment Period|Lack of Efficacy|0|||
164474989|NCT00622700|594111092|FG005|Core Treatment Period|Lack of Efficacy|0|||
164474990|NCT00622700|594111093|FG006|Core Treatment Period|Lack of Efficacy|0|||
164474991|NCT00622700|594111087|FG000|Core Treatment Period|Lost to Follow-up|1|||
164474992|NCT00622700|594111088|FG001|Core Treatment Period|Lost to Follow-up|1|||
164474993|NCT00622700|594111089|FG002|Core Treatment Period|Lost to Follow-up|1|||
164474994|NCT00622700|594111090|FG003|Core Treatment Period|Lost to Follow-up|0|||
164474995|NCT00622700|594111091|FG004|Core Treatment Period|Lost to Follow-up|0|||
164474996|NCT00622700|594111092|FG005|Core Treatment Period|Lost to Follow-up|0|||
164474997|NCT00622700|594111093|FG006|Core Treatment Period|Lost to Follow-up|0|||
164474998|NCT00622700|594111087|FG000|Core Treatment Period|Death|1|||
164474999|NCT00622700|594111088|FG001|Core Treatment Period|Death|0|||
164475000|NCT00622700|594111089|FG002|Core Treatment Period|Death|0|||
164475001|NCT00622700|594111090|FG003|Core Treatment Period|Death|0|||
164475002|NCT00622700|594111091|FG004|Core Treatment Period|Death|0|||
164475003|NCT00622700|594111092|FG005|Core Treatment Period|Death|0|||
164475004|NCT00622700|594111093|FG006|Core Treatment Period|Death|0|||
164475005|NCT00622700|594111087|FG000|Core Treatment Period|Progressive Disease|3|||
164475006|NCT00622700|594111088|FG001|Core Treatment Period|Progressive Disease|1|||
164475007|NCT00622700|594111089|FG002|Core Treatment Period|Progressive Disease|0|||
164475008|NCT00622700|594111090|FG003|Core Treatment Period|Progressive Disease|0|||
164475009|NCT00622700|594111091|FG004|Core Treatment Period|Progressive Disease|0|||
164475010|NCT00622700|594111092|FG005|Core Treatment Period|Progressive Disease|0|||
164475011|NCT00622700|594111093|FG006|Core Treatment Period|Progressive Disease|0|||
164475012|NCT00622700|594111087|FG000|Core Treatment Period|Withdrawal by Subject|12|||
164475013|NCT00622700|594111088|FG001|Core Treatment Period|Withdrawal by Subject|18|||
164475014|NCT00622700|594111089|FG002|Core Treatment Period|Withdrawal by Subject|15|||
164475015|NCT00622700|594111090|FG003|Core Treatment Period|Withdrawal by Subject|0|||
164475016|NCT00622700|594111091|FG004|Core Treatment Period|Withdrawal by Subject|0|||
164475017|NCT00622700|594111092|FG005|Core Treatment Period|Withdrawal by Subject|0|||
164475018|NCT00622700|594111093|FG006|Core Treatment Period|Withdrawal by Subject|0|||
164475019|NCT00622700|594111087|FG000|Core Treatment Period|Other than specified above|2|||
164475020|NCT00622700|594111088|FG001|Core Treatment Period|Other than specified above|2|||
164475021|NCT00622700|594111089|FG002|Core Treatment Period|Other than specified above|5|||
164475022|NCT00622700|594111090|FG003|Core Treatment Period|Other than specified above|0|||
164475023|NCT00622700|594111091|FG004|Core Treatment Period|Other than specified above|0|||
164475024|NCT00622700|594111092|FG005|Core Treatment Period|Other than specified above|0|||
164475025|NCT00622700|594111093|FG006|Core Treatment Period|Other than specified above|0|||
164475026|NCT00622700|594111087|FG000|Extension Treatment Period|Adverse Event|0|||
164475027|NCT00622700|594111088|FG001|Extension Treatment Period|Adverse Event|0|||
164475028|NCT00622700|594111089|FG002|Extension Treatment Period|Adverse Event|0|||
164475029|NCT00622700|594111090|FG003|Extension Treatment Period|Adverse Event|5|||
164475030|NCT00622700|594111091|FG004|Extension Treatment Period|Adverse Event|9|||
164475031|NCT00622700|594111092|FG005|Extension Treatment Period|Adverse Event|6|||
164475032|NCT00622700|594111093|FG006|Extension Treatment Period|Adverse Event|8|||
164475033|NCT00622700|594111087|FG000|Extension Treatment Period|Lack of Efficacy|0|||
164475034|NCT00622700|594111088|FG001|Extension Treatment Period|Lack of Efficacy|0|||
164475035|NCT00622700|594111089|FG002|Extension Treatment Period|Lack of Efficacy|0|||
164475036|NCT00622700|594111090|FG003|Extension Treatment Period|Lack of Efficacy|2|||
164475037|NCT00622700|594111091|FG004|Extension Treatment Period|Lack of Efficacy|8|||
164475038|NCT00622700|594111092|FG005|Extension Treatment Period|Lack of Efficacy|1|||
164475039|NCT00622700|594111093|FG006|Extension Treatment Period|Lack of Efficacy|9|||
164475040|NCT00622700|594111087|FG000|Extension Treatment Period|Protocol Violation|0|||
164475041|NCT00622700|594111088|FG001|Extension Treatment Period|Protocol Violation|0|||
164475042|NCT00622700|594111089|FG002|Extension Treatment Period|Protocol Violation|0|||
164475043|NCT00622700|594111090|FG003|Extension Treatment Period|Protocol Violation|0|||
164475044|NCT00622700|594111091|FG004|Extension Treatment Period|Protocol Violation|0|||
164475045|NCT00622700|594111092|FG005|Extension Treatment Period|Protocol Violation|2|||
164475046|NCT00622700|594111093|FG006|Extension Treatment Period|Protocol Violation|0|||
164475047|NCT00622700|594111087|FG000|Extension Treatment Period|Lost to Follow-up|0|||
164475048|NCT00622700|594111088|FG001|Extension Treatment Period|Lost to Follow-up|0|||
164475049|NCT00622700|594111089|FG002|Extension Treatment Period|Lost to Follow-up|0|||
164475050|NCT00622700|594111090|FG003|Extension Treatment Period|Lost to Follow-up|0|||
164475051|NCT00622700|594111091|FG004|Extension Treatment Period|Lost to Follow-up|1|||
164475052|NCT00622700|594111092|FG005|Extension Treatment Period|Lost to Follow-up|0|||
164475053|NCT00622700|594111093|FG006|Extension Treatment Period|Lost to Follow-up|0|||
164475054|NCT00622700|594111087|FG000|Extension Treatment Period|Progressive Disease|0|||
164475055|NCT00622700|594111088|FG001|Extension Treatment Period|Progressive Disease|0|||
164475056|NCT00622700|594111089|FG002|Extension Treatment Period|Progressive Disease|0|||
164475057|NCT00622700|594111090|FG003|Extension Treatment Period|Progressive Disease|1|||
164475058|NCT00622700|594111091|FG004|Extension Treatment Period|Progressive Disease|2|||
164475059|NCT00622700|594111092|FG005|Extension Treatment Period|Progressive Disease|0|||
164475060|NCT00622700|594111093|FG006|Extension Treatment Period|Progressive Disease|2|||
164475061|NCT00622700|594111087|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
164475062|NCT00622700|594111088|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
164475063|NCT00622700|594111089|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
164475064|NCT00622700|594111090|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
164475065|NCT00622700|594111091|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
164475066|NCT00622700|594111092|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
164475067|NCT00622700|594111093|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
164475068|NCT00622700|594111087|FG000|Extension Treatment Period|Missing|0|||
164475069|NCT00622700|594111088|FG001|Extension Treatment Period|Missing|0|||
164475070|NCT00622700|594111089|FG002|Extension Treatment Period|Missing|0|||
164475071|NCT00622700|594111090|FG003|Extension Treatment Period|Missing|2|||
164475072|NCT00622700|594111091|FG004|Extension Treatment Period|Missing|3|||
164475073|NCT00622700|594111092|FG005|Extension Treatment Period|Missing|1|||
164475074|NCT00622700|594111093|FG006|Extension Treatment Period|Missing|0|||
164475075|NCT00622700|594111087|FG000|Extension Treatment Period|Other than specified above|0|||
164475076|NCT00622700|594111088|FG001|Extension Treatment Period|Other than specified above|0|||
164475077|NCT00622700|594111089|FG002|Extension Treatment Period|Other than specified above|0|||
164475078|NCT00622700|594111090|FG003|Extension Treatment Period|Other than specified above|0|||
164475079|NCT00622700|594111091|FG004|Extension Treatment Period|Other than specified above|0|||
164475080|NCT00622700|594111092|FG005|Extension Treatment Period|Other than specified above|1|||
164475081|NCT00622700|594111093|FG006|Extension Treatment Period|Other than specified above|1|||
164475082|NCT02844439|594111111|FG000|Overall Study|Withdrawal by Subject|1|||
164475083|NCT02844439|594111111|FG000|Overall Study|Lost to Follow-up|2|||
164475084|NCT02844439|594111111|FG000|Overall Study|Termination by Sponsor|4|||
164475085|NCT02844439|594111111|FG000|Overall Study|Death|28|||
164475086|NCT02844439|594111111|FG000|Overall Study|Other|5|||
164475087|NCT04035447|594111112|FG000|Treatment Period|Lost to Follow-up|6|||
164475088|NCT04035447|594111113|FG001|Treatment Period|Lost to Follow-up|5|||
164475089|NCT04035447|594111112|FG000|Treatment Period|Physician Decision|0|||
164475090|NCT04035447|594111113|FG001|Treatment Period|Physician Decision|2|||
164475091|NCT04622332|594111114|FG000|Overall Study|Withdrawal by Subject|4|||
164475092|NCT04622332|594111115|FG001|Overall Study|Withdrawal by Subject|2|||
164475093|NCT04622332|594111114|FG000|Overall Study|Physician Decision|1|||
164475094|NCT04622332|594111115|FG001|Overall Study|Physician Decision|1|||
164475095|NCT04622332|594111114|FG000|Overall Study|Adverse Event|0|||
164475096|NCT04622332|594111115|FG001|Overall Study|Adverse Event|2|||
164475097|NCT04622332|594111114|FG000|Overall Study|Protocol Violation|0|||
164713867|NCT02960490|594974922|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
164475098|NCT04622332|594111115|FG001|Overall Study|Protocol Violation|1|||
164475099|NCT05966155|594111116|FG000|Overall Study|Death|1|||
164475100|NCT05966155|594111117|FG001|Overall Study|Death|2|||
164475101|NCT05966155|594111116|FG000|Overall Study|Lost to Follow-up|63|||
164475102|NCT05966155|594111117|FG001|Overall Study|Lost to Follow-up|67|||
164475103|NCT05966155|594111116|FG000|Overall Study|Protocol Violation|1|||
164475104|NCT05966155|594111117|FG001|Overall Study|Protocol Violation|0|||
164475105|NCT05966155|594111116|FG000|Overall Study|Withdrawal by Subject|8|||
164475106|NCT05966155|594111117|FG001|Overall Study|Withdrawal by Subject|9|||
164475107|NCT05966155|594111116|FG000|Overall Study|Enrolled Erroneously|0|||
164475108|NCT05966155|594111117|FG001|Overall Study|Enrolled Erroneously|1|||
164475109|NCT05966155|594111116|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
164475110|NCT05966155|594111117|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
164475111|NCT03304587|594111121|FG000|Overall Study|Headache after intervention|0|||
164475112|NCT03304587|594111122|FG001|Overall Study|Headache after intervention|1|||
164475113|NCT03304587|594111121|FG000|Overall Study|Withdrawal by Subject|1|||
164475114|NCT03304587|594111122|FG001|Overall Study|Withdrawal by Subject|0|||
164475115|NCT05036278|594111125|FG000|Overall Study|Withdrawal by Subject|1|||
164475116|NCT05036278|594111125|FG000|Overall Study|Adverse Event|1|||
164475117|NCT01458366|594111127|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
164475118|NCT01458366|594111128|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
164475119|NCT01458366|594111129|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
164475120|NCT01458366|594111130|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
164475121|NCT01458366|594111131|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
164475122|NCT01458366|594111127|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
164475123|NCT01458366|594111128|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
164475124|NCT01458366|594111129|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
164475125|NCT01458366|594111130|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
164475126|NCT01458366|594111131|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
164475127|NCT04647487|594111132|FG000|Overall Study|Protocol Deviation|0|||
164475128|NCT04647487|594111133|FG001|Overall Study|Protocol Deviation|0|||
164475129|NCT04647487|594111134|FG002|Overall Study|Protocol Deviation|1|||
164475130|NCT04647487|594111132|FG000|Overall Study|Withdrawal by Subject|1|||
164475131|NCT04647487|594111133|FG001|Overall Study|Withdrawal by Subject|0|||
164475132|NCT04647487|594111134|FG002|Overall Study|Withdrawal by Subject|2|||
164475133|NCT02787005|594111135|FG000|Overall Study|Adverse Event|24|||
164475134|NCT02787005|594111136|FG001|Overall Study|Adverse Event|9|||
164475135|NCT02787005|594111137|FG002|Overall Study|Adverse Event|9|||
164475136|NCT02787005|594111138|FG003|Overall Study|Adverse Event|7|||
164475137|NCT02787005|594111139|FG004|Overall Study|Adverse Event|2|||
164475138|NCT02787005|594111135|FG000|Overall Study|Death|100|||
164475139|NCT02787005|594111136|FG001|Overall Study|Death|53|||
164475140|NCT02787005|594111137|FG002|Overall Study|Death|48|||
164475141|NCT02787005|594111138|FG003|Overall Study|Death|69|||
164475142|NCT02787005|594111139|FG004|Overall Study|Death|38|||
164475143|NCT02787005|594111135|FG000|Overall Study|Sponsor Decision|7|||
164475144|NCT02787005|594111136|FG001|Overall Study|Sponsor Decision|4|||
164475145|NCT02787005|594111137|FG002|Overall Study|Sponsor Decision|0|||
164475146|NCT02787005|594111138|FG003|Overall Study|Sponsor Decision|4|||
164475147|NCT02787005|594111139|FG004|Overall Study|Sponsor Decision|5|||
164475148|NCT02787005|594111135|FG000|Overall Study|Withdrawal by Subject|2|||
164475149|NCT02787005|594111136|FG001|Overall Study|Withdrawal by Subject|1|||
164475150|NCT02787005|594111137|FG002|Overall Study|Withdrawal by Subject|1|||
164475151|NCT02787005|594111138|FG003|Overall Study|Withdrawal by Subject|0|||
164475152|NCT02787005|594111139|FG004|Overall Study|Withdrawal by Subject|1|||
164475153|NCT02787005|594111135|FG000|Overall Study|Screen Failure|0|||
164475154|NCT02787005|594111136|FG001|Overall Study|Screen Failure|2|||
164475155|NCT02787005|594111137|FG002|Overall Study|Screen Failure|0|||
164475156|NCT02787005|594111138|FG003|Overall Study|Screen Failure|0|||
164475157|NCT02787005|594111139|FG004|Overall Study|Screen Failure|1|||
164475158|NCT02787005|594111135|FG000|Overall Study|Lost to Follow-up|0|||
164475159|NCT02787005|594111136|FG001|Overall Study|Lost to Follow-up|0|||
164475160|NCT02787005|594111137|FG002|Overall Study|Lost to Follow-up|0|||
164475161|NCT02787005|594111138|FG003|Overall Study|Lost to Follow-up|1|||
164475162|NCT02787005|594111139|FG004|Overall Study|Lost to Follow-up|0|||
164475163|NCT01753999|594111145|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
164475164|NCT01753999|594111146|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
164713868|NCT02960490|594974923|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
164475165|NCT01753999|594111145|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
164475166|NCT01753999|594111146|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
164713869|NCT02960490|594974924|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
164475167|NCT01753999|594111145|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
164475168|NCT01753999|594111146|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
164475169|NCT01753999|594111145|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
164475170|NCT01753999|594111146|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
164475171|NCT01753999|594111145|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
164475172|NCT01753999|594111146|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
164475173|NCT01753999|594111145|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
164475174|NCT01753999|594111146|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
164475175|NCT03890289|594111147|FG000|Overall Study|Adverse Event|1|||
164475176|NCT03890289|594111147|FG000|Overall Study|Physician Decision|1|||
164475177|NCT03890289|594111147|FG000|Overall Study|Lack of Efficacy|2|||
164475178|NCT02744066|594111154|FG000|Overall Study|Withdrawal by parent|0|||
164475179|NCT02744066|594111155|FG001|Overall Study|Withdrawal by parent|1|||
164475180|NCT02744066|594111154|FG000|Overall Study|Discharged from NICU prior to completion|0|||
164475181|NCT02744066|594111155|FG001|Overall Study|Discharged from NICU prior to completion|4|||
164475182|NCT05509816|594111156|FG000|Overall Study|Lost to Follow-up|1|||
164475183|NCT02107261|594111161|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
164475184|NCT02107261|594111162|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
164475185|NCT02107261|594111161|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
164475186|NCT02107261|594111162|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
164475187|NCT01738438|594111164|FG000|Overall Study|Disease Progression|32|||
164475188|NCT01738438|594111164|FG000|Overall Study|Adverse Event|3|||
164475189|NCT02130557|594111165|FG000|Overall Study|Withdrawal by Subject|12|||
164475190|NCT02130557|594111166|FG001|Overall Study|Withdrawal by Subject|12|||
164475191|NCT02130557|594111165|FG000|Overall Study|Investigator Request|0|||
164475192|NCT02130557|594111166|FG001|Overall Study|Investigator Request|2|||
164475193|NCT02130557|594111165|FG000|Overall Study|Deceased|14|||
164475194|NCT02130557|594111166|FG001|Overall Study|Deceased|14|||
164475195|NCT02130557|594111165|FG000|Overall Study|Lost to Follow-up|6|||
164475196|NCT02130557|594111166|FG001|Overall Study|Lost to Follow-up|7|||
164475197|NCT02130557|594111165|FG000|Overall Study|Other|2|||
164475198|NCT02130557|594111166|FG001|Overall Study|Other|1|||
164475199|NCT02130557|594111165|FG000|Overall Study|Missing|2|||
164475200|NCT02130557|594111166|FG001|Overall Study|Missing|1|||
164475201|NCT01532999|594111167|FG000|Overall Study|Lost to Follow-up|14|||
164475202|NCT01532999|594111168|FG001|Overall Study|Lost to Follow-up|8|||
164475203|NCT01532999|594111167|FG000|Overall Study|Physician Decision|1|||
164475204|NCT01532999|594111168|FG001|Overall Study|Physician Decision|2|||
164475205|NCT01532999|594111167|FG000|Overall Study|Withdrawal by Subject|5|||
164475206|NCT01532999|594111168|FG001|Overall Study|Withdrawal by Subject|0|||
164475207|NCT01532999|594111167|FG000|Overall Study|Relocated|2|||
164475208|NCT01532999|594111168|FG001|Overall Study|Relocated|0|||
164475209|NCT01532999|594111167|FG000|Overall Study|should not have been randomized|1|||
164475210|NCT01532999|594111168|FG001|Overall Study|should not have been randomized|0|||
164475211|NCT01532999|594111167|FG000|Overall Study|substantial noncompliance|2|||
164475212|NCT01532999|594111168|FG001|Overall Study|substantial noncompliance|0|||
164475213|NCT01532999|594111167|FG000|Overall Study|no show for week 9 assessments|6|||
164475214|NCT01532999|594111168|FG001|Overall Study|no show for week 9 assessments|4|||
164475215|NCT01532999|594111167|FG000|Overall Study|Adverse Event|0|||
164475216|NCT01532999|594111168|FG001|Overall Study|Adverse Event|1|||
164475217|NCT01532999|594111167|FG000|Overall Study|incarcerated|0|||
164475218|NCT01532999|594111168|FG001|Overall Study|incarcerated|1|||
164475219|NCT01532999|594111167|FG000|Overall Study|New job|0|||
164475220|NCT01532999|594111168|FG001|Overall Study|New job|2|||
164475221|NCT03333109|594111169|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
164475222|NCT03333109|594111170|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
164475223|NCT03333109|594111171|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
164475224|NCT03333109|594111169|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
164475225|NCT03333109|594111170|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
164475226|NCT03333109|594111171|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
164475227|NCT03333109|594111169|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
164475228|NCT03333109|594111170|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
164475229|NCT03333109|594111171|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
164475230|NCT03333109|594111169|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
164475231|NCT03333109|594111170|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
164475232|NCT03333109|594111171|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
164475233|NCT03333109|594111169|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
164475234|NCT03333109|594111170|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
164475235|NCT03333109|594111171|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
164475236|NCT03333109|594111169|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
164475237|NCT03333109|594111170|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
164475238|NCT03333109|594111171|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
164475239|NCT03333109|594111169|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
164475240|NCT03333109|594111170|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
164475241|NCT03333109|594111171|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
164475242|NCT03333109|594111169|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
164475243|NCT03333109|594111170|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
164475244|NCT03333109|594111171|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
164475245|NCT00589875|594111172|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
164475246|NCT00589875|594111172|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
164475247|NCT05601882|594111173|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
164475248|NCT05601882|594111174|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
164475249|NCT05601882|594111175|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
164475250|NCT05601882|594111176|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
164475251|NCT05601882|594111173|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
164475252|NCT05601882|594111174|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
164475253|NCT05601882|594111175|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
164475254|NCT05601882|594111176|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
164475255|NCT05601882|594111173|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
164475256|NCT05601882|594111174|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
164475257|NCT05601882|594111175|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
164475258|NCT05601882|594111176|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
164475259|NCT05601882|594111173|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
164475260|NCT05601882|594111174|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
164475261|NCT05601882|594111175|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
164475262|NCT05601882|594111176|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
164475263|NCT05601882|594111173|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
164475264|NCT05601882|594111174|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
164475265|NCT05601882|594111175|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
164475266|NCT05601882|594111176|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
164475267|NCT05601882|594111173|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
164475268|NCT05601882|594111174|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
164475269|NCT05601882|594111175|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
164475270|NCT05601882|594111176|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
164475271|NCT03834740|594111177|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
164475272|NCT03834740|594111178|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
164475273|NCT03834740|594111179|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
164475274|NCT01208974|594111180|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
164475275|NCT01208974|594111181|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
164475276|NCT01208974|594111182|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
164475277|NCT01208974|594111183|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
164475278|NCT01208974|594111180|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
164475279|NCT01208974|594111181|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
164475280|NCT01208974|594111182|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
164475281|NCT01208974|594111183|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
164475282|NCT01208974|594111180|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
164475283|NCT01208974|594111181|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
164475284|NCT01208974|594111182|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
164475285|NCT01208974|594111183|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
164475286|NCT03593226|594111184|FG000|Overall Study|Disease progression|6|||
164475287|NCT03593226|594111185|FG001|Overall Study|Disease progression|13|||
164475288|NCT03593226|594111186|FG002|Overall Study|Disease progression|5|||
164475289|NCT03593226|594111187|FG003|Overall Study|Disease progression|6|||
164475290|NCT03593226|594111184|FG000|Overall Study|Adverse Event|0|||
164475291|NCT03593226|594111185|FG001|Overall Study|Adverse Event|1|||
164475292|NCT03593226|594111186|FG002|Overall Study|Adverse Event|0|||
164475293|NCT03593226|594111187|FG003|Overall Study|Adverse Event|0|||
164475294|NCT03593226|594111184|FG000|Overall Study|Withdrawal by Subject|0|||
164475295|NCT03593226|594111185|FG001|Overall Study|Withdrawal by Subject|4|||
164475296|NCT03593226|594111186|FG002|Overall Study|Withdrawal by Subject|1|||
164475297|NCT03593226|594111187|FG003|Overall Study|Withdrawal by Subject|0|||
164475298|NCT03593226|594111184|FG000|Overall Study|Physician Decision|0|||
164475299|NCT03593226|594111185|FG001|Overall Study|Physician Decision|1|||
164475300|NCT03593226|594111186|FG002|Overall Study|Physician Decision|0|||
164475301|NCT03593226|594111187|FG003|Overall Study|Physician Decision|0|||
164475302|NCT03593226|594111184|FG000|Overall Study|Clinical disease progression|0|||
164475303|NCT03593226|594111185|FG001|Overall Study|Clinical disease progression|0|||
164475304|NCT03593226|594111186|FG002|Overall Study|Clinical disease progression|1|||
164475305|NCT03593226|594111187|FG003|Overall Study|Clinical disease progression|0|||
164475306|NCT02500576|594111188|FG000|Overall Study|Adverse Event|0|||
164475307|NCT02500576|594111189|FG001|Overall Study|Adverse Event|1|||
164475308|NCT02500576|594111188|FG000|Overall Study|Death|2|||
164475309|NCT02500576|594111189|FG001|Overall Study|Death|1|||
164475310|NCT02500576|594111188|FG000|Overall Study|Lack of Efficacy|5|||
164475311|NCT02500576|594111189|FG001|Overall Study|Lack of Efficacy|5|||
164475312|NCT02500576|594111188|FG000|Overall Study|Withdrawal by Subject|1|||
164475313|NCT02500576|594111189|FG001|Overall Study|Withdrawal by Subject|1|||
164475314|NCT03691493|594111190|FG000|Overall Study|Withdrawal by Subject|1|||
164475315|NCT02678689|594111203|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
164475316|NCT02678689|594111204|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
164475317|NCT05071430|594111205|FG000|Overall Study|Adverse Event|1|||
164475318|NCT05071430|594111206|FG001|Overall Study|Adverse Event|2|||
164475319|NCT05071430|594111205|FG000|Overall Study|Lost to Follow-up|4|||
164475320|NCT05071430|594111206|FG001|Overall Study|Lost to Follow-up|4|||
164475321|NCT05071430|594111205|FG000|Overall Study|Protocol Violation|1|||
164475322|NCT05071430|594111206|FG001|Overall Study|Protocol Violation|0|||
164713870|NCT02960490|594974925|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
164475323|NCT05071430|594111205|FG000|Overall Study|Withdrawal by Subject|3|||
164475324|NCT05071430|594111206|FG001|Overall Study|Withdrawal by Subject|2|||
164475325|NCT05071430|594111205|FG000|Overall Study|Other|1|||
164475326|NCT05071430|594111206|FG001|Overall Study|Other|1|||
164475327|NCT01958021|594111207|FG000|Treatment|Progressive disease|206|||
164475328|NCT01958021|594111208|FG001|Treatment|Progressive disease|265|||
164475329|NCT01958021|594111207|FG000|Treatment|Adverse Event|38|||
164475330|NCT01958021|594111208|FG001|Treatment|Adverse Event|10|||
164475331|NCT01958021|594111207|FG000|Treatment|Subject/guardian decision|29|||
164475332|NCT01958021|594111208|FG001|Treatment|Subject/guardian decision|25|||
164475333|NCT01958021|594111207|FG000|Treatment|Physician Decision|28|||
164475334|NCT01958021|594111208|FG001|Treatment|Physician Decision|21|||
164475335|NCT01958021|594111207|FG000|Treatment|Death|6|||
164475336|NCT01958021|594111208|FG001|Treatment|Death|1|||
164475337|NCT01958021|594111207|FG000|Treatment|Protocol deviation|3|||
164475338|NCT01958021|594111208|FG001|Treatment|Protocol deviation|1|||
164475339|NCT01958021|594111207|FG000|Treatment|Sponsor decision|24|||
164475340|NCT01958021|594111208|FG001|Treatment|Sponsor decision|11|||
164475341|NCT01958021|594111207|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
164475342|NCT01958021|594111208|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
164475343|NCT01958021|594111207|FG000|Post-treatment Efficacy Follow-up|Death|1|||
164475344|NCT01958021|594111208|FG001|Post-treatment Efficacy Follow-up|Death|0|||
164475345|NCT01958021|594111207|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
164475346|NCT01958021|594111208|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
164475347|NCT01958021|594111207|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
164475348|NCT01958021|594111208|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
164475349|NCT01958021|594111207|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
164475350|NCT01958021|594111208|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
164475351|NCT01958021|594111207|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
164475352|NCT01958021|594111208|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
164475353|NCT01958021|594111207|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
164475354|NCT01958021|594111208|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
164475355|NCT00490139|594111209|FG000|Overall Study|Lost to Follow-up|249|||
164475356|NCT00490139|594111210|FG001|Overall Study|Lost to Follow-up|216|||
164475357|NCT00490139|594111211|FG002|Overall Study|Lost to Follow-up|205|||
164475358|NCT00490139|594111212|FG003|Overall Study|Lost to Follow-up|229|||
164475359|NCT00490139|594111209|FG000|Overall Study|Withdrawal by Subject|333|||
164475360|NCT00490139|594111210|FG001|Overall Study|Withdrawal by Subject|322|||
164475361|NCT00490139|594111211|FG002|Overall Study|Withdrawal by Subject|396|||
164475362|NCT00490139|594111212|FG003|Overall Study|Withdrawal by Subject|295|||
164475363|NCT00490139|594111209|FG000|Overall Study|Patient did not sign ICF 12|169|||
164475364|NCT00490139|594111210|FG001|Overall Study|Patient did not sign ICF 12|176|||
164475365|NCT00490139|594111211|FG002|Overall Study|Patient did not sign ICF 12|139|||
164475366|NCT00490139|594111212|FG003|Overall Study|Patient did not sign ICF 12|167|||
164475367|NCT00490139|594111209|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
164475368|NCT00490139|594111210|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
164475369|NCT00490139|594111211|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
164475370|NCT00490139|594111212|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
164475371|NCT00490139|594111209|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
164475372|NCT00490139|594111210|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
164475373|NCT00490139|594111211|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
164475374|NCT00490139|594111212|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
164475375|NCT00490139|594111209|FG000|Overall Study|Other reasons as defined per protocol|98|||
164475376|NCT00490139|594111210|FG001|Overall Study|Other reasons as defined per protocol|84|||
164475377|NCT00490139|594111211|FG002|Overall Study|Other reasons as defined per protocol|82|||
164475378|NCT00490139|594111212|FG003|Overall Study|Other reasons as defined per protocol|105|||
164475379|NCT02798471|594111216|FG000|Overall Study|Adverse Event|7|||
164475380|NCT02798471|594111217|FG001|Overall Study|Adverse Event|2|||
164475381|NCT02798471|594111216|FG000|Overall Study|Physician Decision|3|||
164475382|NCT02798471|594111217|FG001|Overall Study|Physician Decision|7|||
164475383|NCT02798471|594111216|FG000|Overall Study|Death|2|||
164475384|NCT02798471|594111217|FG001|Overall Study|Death|3|||
164475385|NCT02798471|594111216|FG000|Overall Study|Lost to Follow-up|0|||
164475386|NCT02798471|594111217|FG001|Overall Study|Lost to Follow-up|1|||
164475387|NCT02798471|594111216|FG000|Overall Study|Other|5|||
164475388|NCT02798471|594111217|FG001|Overall Study|Other|3|||
164475389|NCT02798471|594111216|FG000|Overall Study|Subject withdrew consent|0|||
164475390|NCT02798471|594111217|FG001|Overall Study|Subject withdrew consent|6|||
164475391|NCT02798471|594111216|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
164475392|NCT02798471|594111217|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
164475393|NCT02798471|594111216|FG000|Overall Study|Randomized, but not treated|0|||
164475394|NCT02798471|594111217|FG001|Overall Study|Randomized, but not treated|2|||
164713871|NCT02960490|594974926|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
164475395|NCT00754325|594112593|FG000|Initial Treatment|Continuing Active Treatment|4|||
164475396|NCT00754325|594112594|FG001|Initial Treatment|Continuing Active Treatment|5|||
164475397|NCT00754325|594112593|FG000|Initial Treatment|Adverse Event|7|||
164475398|NCT00754325|594112594|FG001|Initial Treatment|Adverse Event|6|||
164475399|NCT00754325|594112593|FG000|Initial Treatment|Withdrawal by Subject|2|||
164475400|NCT00754325|594112594|FG001|Initial Treatment|Withdrawal by Subject|2|||
164475401|NCT00754325|594112593|FG000|Initial Treatment|Physician Decision|2|||
164475402|NCT00754325|594112594|FG001|Initial Treatment|Physician Decision|0|||
164475403|NCT00754325|594112593|FG000|Initial Treatment|Sponsor Request|0|||
164475404|NCT00754325|594112594|FG001|Initial Treatment|Sponsor Request|1|||
164475405|NCT00754325|594112593|FG000|Initial Treatment|Disease Progression|35|||
164475406|NCT00754325|594112594|FG001|Initial Treatment|Disease Progression|35|||
164475407|NCT03738228|594112595|FG000|Overall Study|Never received study treatment|2|||
164475408|NCT03738228|594112596|FG001|Overall Study|Never received study treatment|2|||
164475409|NCT03801148|594112597|FG000|Period 1 (2 Days)|Adverse Event|1|||
164475410|NCT03801148|594112598|FG001|Period 1 (2 Days)|Adverse Event|1|||
164475411|NCT03801148|594112599|FG002|Period 1 (2 Days)|Adverse Event|0|||
164475412|NCT03801148|594112600|FG003|Period 1 (2 Days)|Adverse Event|0|||
164475413|NCT03801148|594112597|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
164475414|NCT03801148|594112598|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
164475415|NCT03801148|594112599|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
164475416|NCT03801148|594112600|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
164475417|NCT03801148|594112597|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
164475418|NCT03801148|594112598|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
164475419|NCT03801148|594112599|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
164475420|NCT03801148|594112600|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
164475421|NCT03801148|594112597|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
164475422|NCT03801148|594112598|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
164475423|NCT03801148|594112599|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
164475424|NCT03801148|594112600|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
164475425|NCT06212752|594112601|FG000|Overall Study|Death|5|||
164475426|NCT06212752|594112602|FG001|Overall Study|Death|3|||
164475427|NCT06212752|594112601|FG000|Overall Study|Participants ongoing|23|||
164475428|NCT06212752|594112602|FG001|Overall Study|Participants ongoing|8|||
164475429|NCT04162210|594112603|FG000|Overall Study|Lost to Follow-up|4|||
164475430|NCT04162210|594112604|FG001|Overall Study|Lost to Follow-up|1|||
164475431|NCT04162210|594112603|FG000|Overall Study|Withdrawal by Subject|17|||
164475432|NCT04162210|594112604|FG001|Overall Study|Withdrawal by Subject|9|||
164475433|NCT04162210|594112603|FG000|Overall Study|Ongoing|113|||
164475434|NCT04162210|594112604|FG001|Overall Study|Ongoing|59|||
164475435|NCT03244800|594112605|FG000|Overall Study|Adverse Event|0|||
164475436|NCT03244800|594112606|FG001|Overall Study|Adverse Event|1|||
164475437|NCT03244800|594112607|FG002|Overall Study|Adverse Event|0|||
164475438|NCT03244800|594112608|FG003|Overall Study|Adverse Event|1|||
164475439|NCT03244800|594112605|FG000|Overall Study|Withdrew treatment|0|||
164475440|NCT03244800|594112606|FG001|Overall Study|Withdrew treatment|0|||
164475441|NCT03244800|594112607|FG002|Overall Study|Withdrew treatment|0|||
164475442|NCT03244800|594112608|FG003|Overall Study|Withdrew treatment|1|||
164475443|NCT00890591|594112617|FG000|Overall Study|Lack of Efficacy|20|||
164475444|NCT02941549|594112618|FG000|Overall Study|Adverse Event|1|||
164475445|NCT02941549|594112619|FG001|Overall Study|Adverse Event|0|||
164475446|NCT02941549|594112620|FG002|Overall Study|Adverse Event|0|||
164475447|NCT02941549|594112618|FG000|Overall Study|Withdrawal by Subject|2|||
164475448|NCT02941549|594112619|FG001|Overall Study|Withdrawal by Subject|1|||
164475449|NCT02941549|594112620|FG002|Overall Study|Withdrawal by Subject|2|||
164475450|NCT00776009|594112623|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
164475451|NCT00776009|594112624|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
164475452|NCT00776009|594112625|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
164475453|NCT00776009|594112626|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
164475454|NCT00776009|594112627|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
164475455|NCT00776009|594112628|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
164475456|NCT00776009|594112623|FG000|Period 1: First Intervention|Protocol Violation|0|||
164475457|NCT00776009|594112624|FG001|Period 1: First Intervention|Protocol Violation|1|||
164475458|NCT00776009|594112625|FG002|Period 1: First Intervention|Protocol Violation|0|||
164475459|NCT00776009|594112626|FG003|Period 1: First Intervention|Protocol Violation|0|||
164475460|NCT00776009|594112627|FG004|Period 1: First Intervention|Protocol Violation|1|||
164475461|NCT00776009|594112628|FG005|Period 1: First Intervention|Protocol Violation|0|||
164475462|NCT00776009|594112623|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
164475463|NCT00776009|594112624|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
164713872|NCT02960490|594974927|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
164475464|NCT00776009|594112625|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
164475465|NCT00776009|594112626|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
164475466|NCT00776009|594112627|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
164713873|NCT02960490|594974928|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
164713874|NCT02960490|594974929|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
164713875|NCT02960490|594974930|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
164713876|NCT02960490|594974931|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
164713877|NCT02960490|594974922|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
164713878|NCT02960490|594974923|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
164713879|NCT02960490|594974924|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
164713880|NCT02960490|594974925|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
164713881|NCT02960490|594974926|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
164713882|NCT02960490|594974927|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
164713883|NCT02960490|594974928|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
164713884|NCT02960490|594974929|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
164713885|NCT02960490|594974930|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
164713886|NCT02960490|594974931|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
164713887|NCT02960490|594974922|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
164713888|NCT02960490|594974923|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
164713889|NCT02960490|594974924|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
164713890|NCT02960490|594974925|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
164713891|NCT02960490|594974926|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
164713892|NCT02960490|594974927|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
164713893|NCT02960490|594974928|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
164713894|NCT02960490|594974929|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
164713895|NCT02960490|594974930|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
164713896|NCT02960490|594974931|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
164713897|NCT02960490|594974922|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
164713898|NCT02960490|594974923|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
164713899|NCT02960490|594974924|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
164713900|NCT02960490|594974925|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
164713901|NCT02960490|594974926|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
164713902|NCT02960490|594974927|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
164713903|NCT02960490|594974928|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
164713904|NCT02960490|594974929|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
164713905|NCT02960490|594974930|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
164713906|NCT02960490|594974931|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
164713907|NCT02842073|594974934|FG000|Overall Study|Withdrawal by Subject|1|||
164713908|NCT00195338|594974935|FG000|Overall Study|Lost to Follow-up|2|||
164713909|NCT00195338|594974935|FG000|Overall Study|Adverse Event|5|||
164713910|NCT00195338|594974935|FG000|Overall Study|Lack of Efficacy|1|||
164713911|NCT00195338|594974935|FG000|Overall Study|Early closure of the site|4|||
164713912|NCT02047734|594974938|FG000|Overall Study|Adverse Event|18|||
164713913|NCT02047734|594974939|FG001|Overall Study|Adverse Event|13|||
164713914|NCT02047734|594974940|FG002|Overall Study|Adverse Event|13|||
164713915|NCT02047734|594974938|FG000|Overall Study|Lack of Efficacy|4|||
164713916|NCT02047734|594974939|FG001|Overall Study|Lack of Efficacy|5|||
164713917|NCT02047734|594974940|FG002|Overall Study|Lack of Efficacy|1|||
164713918|NCT02047734|594974938|FG000|Overall Study|Protocol Violation|3|||
164713919|NCT02047734|594974939|FG001|Overall Study|Protocol Violation|1|||
164713920|NCT02047734|594974940|FG002|Overall Study|Protocol Violation|1|||
164713921|NCT02047734|594974938|FG000|Overall Study|Lost to Follow-up|1|||
164713922|NCT02047734|594974939|FG001|Overall Study|Lost to Follow-up|4|||
164713923|NCT02047734|594974940|FG002|Overall Study|Lost to Follow-up|0|||
164713924|NCT02047734|594974938|FG000|Overall Study|Death|0|||
164713925|NCT02047734|594974939|FG001|Overall Study|Death|1|||
164713926|NCT02047734|594974940|FG002|Overall Study|Death|0|||
164713927|NCT02047734|594974938|FG000|Overall Study|Withdrawal by Subject|30|||
164713928|NCT02047734|594974939|FG001|Overall Study|Withdrawal by Subject|31|||
164713929|NCT02047734|594974940|FG002|Overall Study|Withdrawal by Subject|19|||
164713930|NCT02047734|594974938|FG000|Overall Study|Physician Decision|7|||
164713931|NCT02047734|594974939|FG001|Overall Study|Physician Decision|6|||
164713932|NCT02047734|594974940|FG002|Overall Study|Physician Decision|5|||
164713933|NCT02047734|594974938|FG000|Overall Study|Miscellaneous|2|||
164713934|NCT02047734|594974939|FG001|Overall Study|Miscellaneous|4|||
164713935|NCT02047734|594974940|FG002|Overall Study|Miscellaneous|6|||
164713936|NCT02047734|594974938|FG000|Overall Study|Did Not Receive Study Drug|2|||
164713937|NCT02047734|594974939|FG001|Overall Study|Did Not Receive Study Drug|4|||
164713938|NCT02047734|594974940|FG002|Overall Study|Did Not Receive Study Drug|1|||
164713939|NCT04106661|594974941|FG000|Overall Study|Protocol Violation|3|||
164713940|NCT04106661|594974942|FG001|Overall Study|Protocol Violation|0|||
164713941|NCT04106661|594974941|FG000|Overall Study|Scheduling difficulties|1|||
164713942|NCT04106661|594974942|FG001|Overall Study|Scheduling difficulties|1|||
164713943|NCT00233402|594974943|FG000|Overall Study|No pathology data|12|||
164713944|NCT00233402|594974944|FG001|Overall Study|No pathology data|9|||
164713945|NCT00233402|594974943|FG000|Overall Study|No Ta/T1|89|||
164713946|NCT00233402|594974944|FG001|Overall Study|No Ta/T1|94|||
164713947|NCT00233402|594974943|FG000|Overall Study|Lost to follow up etc|3|||
164713948|NCT00233402|594974944|FG001|Overall Study|Lost to follow up etc|21|||
164713949|NCT03280381|594974945|FG000|Overall Study|Physician Decision|0|||
164713950|NCT03280381|594974946|FG001|Overall Study|Physician Decision|2|||
164713951|NCT03503864|594974947|FG000|Overall Study|Protocol Violation|6|||
164713952|NCT03503864|594974947|FG000|Overall Study|Withdrawal by Subject|7|||
164713953|NCT00423319|594974948|FG000|Overall Study|Death|2|||
164713954|NCT00423319|594974949|FG001|Overall Study|Death|0|||
164713955|NCT00423319|594974948|FG000|Overall Study|Adverse Event|93|||
164713956|NCT00423319|594974949|FG001|Overall Study|Adverse Event|112|||
164713957|NCT00423319|594974948|FG000|Overall Study|Withdrawal by Subject|86|||
164713958|NCT00423319|594974949|FG001|Overall Study|Withdrawal by Subject|99|||
164713959|NCT00423319|594974948|FG000|Overall Study|Lost to Follow-up|4|||
164713960|NCT00423319|594974949|FG001|Overall Study|Lost to Follow-up|3|||
164713961|NCT00423319|594974948|FG000|Overall Study|Poor compliance or noncompliance|1|||
164713962|NCT00423319|594974949|FG001|Overall Study|Poor compliance or noncompliance|1|||
164713963|NCT00423319|594974948|FG000|Overall Study|No longer meets study criteria|15|||
164713964|NCT00423319|594974949|FG001|Overall Study|No longer meets study criteria|15|||
164713965|NCT00423319|594974948|FG000|Overall Study|Other|23|||
164713966|NCT00423319|594974949|FG001|Overall Study|Other|22|||
164713967|NCT02087189|594974951|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
164713968|NCT00478426|594974952|FG000|Overall Study|Withdrawal by Subject|1|||
164475467|NCT00776009|594112628|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
164475468|NCT00776009|594112623|FG000|Period 2: Second Intervention|Protocol Violation|1|||
164475469|NCT00776009|594112624|FG001|Period 2: Second Intervention|Protocol Violation|0|||
164475470|NCT00776009|594112625|FG002|Period 2: Second Intervention|Protocol Violation|1|||
164475471|NCT00776009|594112626|FG003|Period 2: Second Intervention|Protocol Violation|0|||
164475472|NCT00776009|594112627|FG004|Period 2: Second Intervention|Protocol Violation|0|||
164475473|NCT00776009|594112628|FG005|Period 2: Second Intervention|Protocol Violation|0|||
164475474|NCT00776009|594112623|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
164475475|NCT00776009|594112624|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
164475476|NCT00776009|594112625|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
164475477|NCT00776009|594112626|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
164475478|NCT00776009|594112627|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
164475479|NCT00776009|594112628|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
164475480|NCT01536093|594112634|FG000|Overall Study|Death|1|||
164475481|NCT01536093|594112635|FG001|Overall Study|Death|2|||
164475482|NCT01536093|594112634|FG000|Overall Study|absence of maternal colostrum|2|||
164475483|NCT01536093|594112635|FG001|Overall Study|absence of maternal colostrum|0|||
164475484|NCT01536093|594112634|FG000|Overall Study|Withdrawal by Subject|0|||
164475485|NCT01536093|594112635|FG001|Overall Study|Withdrawal by Subject|1|||
164475486|NCT02275611|594112638|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
164475487|NCT02275611|594112639|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
164475488|NCT02275611|594112640|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
164475489|NCT02275611|594112641|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
164475490|NCT03631407|594112647|FG000|Overall Study|Withdrawal by Subject|3|||
164475491|NCT03631407|594112648|FG001|Overall Study|Withdrawal by Subject|2|||
164475492|NCT03631407|594112647|FG000|Overall Study|Sponsor Decision|0|||
164475493|NCT03631407|594112648|FG001|Overall Study|Sponsor Decision|2|||
164475494|NCT03631407|594112647|FG000|Overall Study|Death|16|||
164475495|NCT03631407|594112648|FG001|Overall Study|Death|16|||
164475496|NCT03631407|594112647|FG000|Overall Study|Randomized by mistake without study treatment|1|||
164475497|NCT03631407|594112648|FG001|Overall Study|Randomized by mistake without study treatment|0|||
164475498|NCT01437319|594112650|FG000|Phase I|Lost to Follow-up|2|||
164475499|NCT01437319|594112651|FG001|Phase I|Lost to Follow-up|0|||
164475500|NCT01437319|594112652|FG002|Phase I|Lost to Follow-up|0|||
164713969|NCT01189487|594974953|FG000|Overall Study|Lack of Efficacy|2|||
164713970|NCT01189487|594974953|FG000|Overall Study|Adverse Event|1|||
164713971|NCT04630158|594974954|FG000|Overall Study|Adverse Event|1|||
164713972|NCT04630158|594974955|FG001|Overall Study|Adverse Event|1|||
164713973|NCT04630158|594974956|FG002|Overall Study|Adverse Event|1|||
164713974|NCT04630158|594974954|FG000|Overall Study|Physician Decision|0|||
164713975|NCT04630158|594974955|FG001|Overall Study|Physician Decision|2|||
164713976|NCT04630158|594974956|FG002|Overall Study|Physician Decision|0|||
164713977|NCT04630158|594974954|FG000|Overall Study|Protocol Violation|1|||
164144829|NCT03790657|592891794|FG000|Overall Study|Adverse Event|1|||
164713978|NCT04630158|594974955|FG001|Overall Study|Protocol Violation|0|||
164713979|NCT04630158|594974956|FG002|Overall Study|Protocol Violation|1|||
164713980|NCT04630158|594974954|FG000|Overall Study|Withdrawal by Subject|2|||
164713981|NCT04630158|594974955|FG001|Overall Study|Withdrawal by Subject|1|||
164713982|NCT04630158|594974956|FG002|Overall Study|Withdrawal by Subject|2|||
164713983|NCT03136965|594974959|FG000|Overall Study|Lost to Follow-up|0|||
164713984|NCT03136965|594974960|FG001|Overall Study|Lost to Follow-up|1|||
164713985|NCT03136965|594974961|FG002|Overall Study|Lost to Follow-up|0|||
164475501|NCT01437319|594112650|FG000|Phase I|Protocol Violation|1|||
164475502|NCT01437319|594112651|FG001|Phase I|Protocol Violation|0|||
164475503|NCT01437319|594112652|FG002|Phase I|Protocol Violation|0|||
164475504|NCT01437319|594112650|FG000|Phase I|Study related symptoms/complaints|27|||
164475505|NCT01437319|594112651|FG001|Phase I|Study related symptoms/complaints|0|||
164475506|NCT01437319|594112652|FG002|Phase I|Study related symptoms/complaints|0|||
164475507|NCT01437319|594112650|FG000|Phase I|Withdrawal by Subject|25|||
164475508|NCT01437319|594112651|FG001|Phase I|Withdrawal by Subject|0|||
164475509|NCT01437319|594112652|FG002|Phase I|Withdrawal by Subject|0|||
164475510|NCT01437319|594112650|FG000|Phase II|Withdrawal by Subject|0|||
164475511|NCT01437319|594112651|FG001|Phase II|Withdrawal by Subject|8|||
164475512|NCT01437319|594112652|FG002|Phase II|Withdrawal by Subject|16|||
164475513|NCT01437319|594112650|FG000|Phase II|Lost to Follow-up|0|||
164475514|NCT01437319|594112651|FG001|Phase II|Lost to Follow-up|7|||
164475515|NCT01437319|594112652|FG002|Phase II|Lost to Follow-up|2|||
164475516|NCT01437319|594112650|FG000|Phase II|Study related symptoms/complaints|0|||
164475517|NCT01437319|594112651|FG001|Phase II|Study related symptoms/complaints|28|||
164475518|NCT01437319|594112652|FG002|Phase II|Study related symptoms/complaints|19|||
164475519|NCT01437319|594112650|FG000|Phase II|Protocol Violation|0|||
164475520|NCT01437319|594112651|FG001|Phase II|Protocol Violation|1|||
164475521|NCT01437319|594112652|FG002|Phase II|Protocol Violation|0|||
164475522|NCT00811941|594112653|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
164475523|NCT00811941|594112654|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
164475524|NCT00811941|594112653|FG000|All Treated Patients|Adverse Event|2|||
164475525|NCT00811941|594112654|FG001|All Treated Patients|Adverse Event|43|||
164475526|NCT00811941|594112653|FG000|All Treated Patients|Lack of Efficacy|2|||
164475527|NCT00811941|594112654|FG001|All Treated Patients|Lack of Efficacy|3|||
164475528|NCT00811941|594112653|FG000|All Treated Patients|Non-compliance|1|||
164475529|NCT00811941|594112654|FG001|All Treated Patients|Non-compliance|8|||
164475530|NCT00811941|594112653|FG000|All Treated Patients|Protocol Violation|5|||
164475531|NCT00811941|594112654|FG001|All Treated Patients|Protocol Violation|17|||
164475532|NCT00811941|594112653|FG000|All Treated Patients|Withdrawal by Subject|35|||
164475533|NCT00811941|594112654|FG001|All Treated Patients|Withdrawal by Subject|94|||
164475534|NCT00811941|594112653|FG000|All Treated Patients|Lost to Follow-up|3|||
164475535|NCT00811941|594112654|FG001|All Treated Patients|Lost to Follow-up|12|||
164475536|NCT00811941|594112653|FG000|All Treated Patients|Other Reason|4|||
164475537|NCT00811941|594112654|FG001|All Treated Patients|Other Reason|14|||
164475538|NCT03802994|594112657|FG000|Overall Study|Lost to Follow-up|0|||
164475539|NCT03802994|594112658|FG001|Overall Study|Lost to Follow-up|2|||
164475540|NCT03802994|594112659|FG002|Overall Study|Lost to Follow-up|3|||
164475541|NCT03802994|594112660|FG003|Overall Study|Lost to Follow-up|2|||
164475542|NCT03802994|594112661|FG004|Overall Study|Lost to Follow-up|2|||
164475543|NCT00983294|594112667|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
164475544|NCT00983294|594112667|FG000|Colchicine With Azithromycin|Adverse Event|1|||
164475545|NCT00942266|594112668|FG000|Overall Study|Withdrawal by Subject|1|||
164475546|NCT00942266|594112669|FG001|Overall Study|Withdrawal by Subject|0|||
164475547|NCT00942266|594112668|FG000|Overall Study|Adverse Event|2|||
164475548|NCT00942266|594112669|FG001|Overall Study|Adverse Event|1|||
164475549|NCT00942266|594112668|FG000|Overall Study|Disease Progression|38|||
164475550|NCT00942266|594112669|FG001|Overall Study|Disease Progression|11|||
164713986|NCT02752087|594974962|FG000|Washout|Physician Decision|1|||
164713987|NCT02752087|594974963|FG001|Washout|Physician Decision|0|||
164713988|NCT02823652|594974966|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
164475551|NCT00942266|594112668|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
164475552|NCT00942266|594112669|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
164475553|NCT00942266|594112668|FG000|Overall Study|Intercurrent illness|0|||
164475554|NCT00942266|594112669|FG001|Overall Study|Intercurrent illness|1|||
164475555|NCT00942266|594112668|FG000|Overall Study|Physician Decision|2|||
164475556|NCT00942266|594112669|FG001|Overall Study|Physician Decision|0|||
164713989|NCT02823652|594974967|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
164713990|NCT02823652|594974968|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
164475557|NCT00942266|594112668|FG000|Overall Study|medical deterioration (pneumonia)|0|||
164475558|NCT00942266|594112669|FG001|Overall Study|medical deterioration (pneumonia)|1|||
164475559|NCT03611556|594112670|FG000|Overall Study|Death|7|||
164475560|NCT03611556|594112671|FG001|Overall Study|Death|7|||
164475561|NCT03611556|594112672|FG002|Overall Study|Death|3|||
164475562|NCT03611556|594112673|FG003|Overall Study|Death|8|||
164475563|NCT03611556|594112674|FG004|Overall Study|Death|47|||
164475564|NCT03611556|594112675|FG005|Overall Study|Death|32|||
164475565|NCT03611556|594112676|FG006|Overall Study|Death|53|||
164475566|NCT03611556|594112670|FG000|Overall Study|Withdrawal by Subject|0|||
164475567|NCT03611556|594112671|FG001|Overall Study|Withdrawal by Subject|0|||
164475568|NCT03611556|594112672|FG002|Overall Study|Withdrawal by Subject|0|||
164475569|NCT03611556|594112673|FG003|Overall Study|Withdrawal by Subject|0|||
164475570|NCT03611556|594112674|FG004|Overall Study|Withdrawal by Subject|4|||
164475571|NCT03611556|594112675|FG005|Overall Study|Withdrawal by Subject|2|||
164713991|NCT02823652|594974966|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
164475572|NCT03611556|594112676|FG006|Overall Study|Withdrawal by Subject|4|||
164475573|NCT03611556|594112670|FG000|Overall Study|Sponsor decision|0|||
164475574|NCT03611556|594112671|FG001|Overall Study|Sponsor decision|0|||
164475575|NCT03611556|594112672|FG002|Overall Study|Sponsor decision|0|||
164475576|NCT03611556|594112673|FG003|Overall Study|Sponsor decision|0|||
164475577|NCT03611556|594112674|FG004|Overall Study|Sponsor decision|9|||
164475578|NCT03611556|594112675|FG005|Overall Study|Sponsor decision|4|||
164475579|NCT03611556|594112676|FG006|Overall Study|Sponsor decision|12|||
164475580|NCT03611556|594112670|FG000|Overall Study|Reasons|0|||
164475581|NCT03611556|594112671|FG001|Overall Study|Reasons|0|||
164475582|NCT03611556|594112672|FG002|Overall Study|Reasons|0|||
164475583|NCT03611556|594112673|FG003|Overall Study|Reasons|0|||
164475584|NCT03611556|594112674|FG004|Overall Study|Reasons|2|||
164475585|NCT03611556|594112675|FG005|Overall Study|Reasons|0|||
164475586|NCT03611556|594112676|FG006|Overall Study|Reasons|1|||
164475587|NCT00390884|594112685|FG000|Overall Study|Withdrawal by Subject|2|||
164475588|NCT00390884|594112686|FG001|Overall Study|Withdrawal by Subject|2|||
164475589|NCT00756574|594112687|FG000|Overall Study|Withdrawal by Subject|9|||
164475590|NCT00756574|594112688|FG001|Overall Study|Withdrawal by Subject|7|||
164475591|NCT00756574|594112687|FG000|Overall Study|Lost to Follow-up|4|||
164475592|NCT00756574|594112688|FG001|Overall Study|Lost to Follow-up|4|||
164475593|NCT04795167|594112693|FG000|Overall Study|Death|1|||
164475594|NCT04795167|594112694|FG001|Overall Study|Death|18|||
164475595|NCT04795167|594112695|FG002|Overall Study|Death|1|||
164475596|NCT04795167|594112693|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
164475597|NCT04795167|594112694|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
164475598|NCT04795167|594112695|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
164475599|NCT02029235|594112697|FG000|Overall Study|Non-compliance with study meds or diary|4|||
164475600|NCT02029235|594112698|FG001|Overall Study|Non-compliance with study meds or diary|1|||
164475601|NCT00174252|594112699|FG000|Overall Study|Protocol Violation|2|||
164475602|NCT01400958|594112702|FG000|Overall Study|Physician Decision|0|||
164475603|NCT01400958|594112703|FG001|Overall Study|Physician Decision|1|||
164475604|NCT01400958|594112702|FG000|Overall Study|Withdrawal by Subject|0|||
164475605|NCT01400958|594112703|FG001|Overall Study|Withdrawal by Subject|1|||
164475606|NCT01400958|594112702|FG000|Overall Study|Adverse Event|1|||
164475607|NCT01400958|594112703|FG001|Overall Study|Adverse Event|0|||
164475608|NCT04337931|594112705|FG000|Overall Study|Death|4|||
164475609|NCT04337931|594112706|FG001|Overall Study|Death|1|||
164475610|NCT04337931|594112707|FG002|Overall Study|Death|7|||
164475611|NCT04337931|594112705|FG000|Overall Study|Withdrawal by Subject|0|||
164475612|NCT04337931|594112706|FG001|Overall Study|Withdrawal by Subject|1|||
164475613|NCT04337931|594112707|FG002|Overall Study|Withdrawal by Subject|0|||
164475614|NCT04337931|594112705|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
164475615|NCT04337931|594112706|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
164475616|NCT04337931|594112707|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
164475617|NCT04337931|594112705|FG000|Overall Study|Study terminated by sponsor|3|||
164475618|NCT04337931|594112706|FG001|Overall Study|Study terminated by sponsor|6|||
164475619|NCT04337931|594112707|FG002|Overall Study|Study terminated by sponsor|2|||
164475620|NCT04337931|594112705|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
164475621|NCT04337931|594112706|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
164475622|NCT04337931|594112707|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
164475623|NCT04337931|594112705|FG000|Overall Study|Colorectal cancer treatment|1|||
164475624|NCT04337931|594112706|FG001|Overall Study|Colorectal cancer treatment|0|||
164475625|NCT04337931|594112707|FG002|Overall Study|Colorectal cancer treatment|0|||
164475626|NCT04337931|594112705|FG000|Overall Study|Participant decision|0|||
164475627|NCT04337931|594112706|FG001|Overall Study|Participant decision|1|||
164475628|NCT04337931|594112707|FG002|Overall Study|Participant decision|0|||
164475629|NCT04436289|594112708|FG000|Overall Study|Death prior to hospital discharge|8|||
164475630|NCT04436289|594112709|FG001|Overall Study|Death prior to hospital discharge|5|||
164475631|NCT04436289|594112710|FG002|Overall Study|Death prior to hospital discharge|0|||
164475632|NCT04436289|594112711|FG003|Overall Study|Death prior to hospital discharge|1|||
164475633|NCT04436289|594112708|FG000|Overall Study|Withdrawal by Subject|0|||
164475634|NCT04436289|594112709|FG001|Overall Study|Withdrawal by Subject|1|||
164475635|NCT04436289|594112710|FG002|Overall Study|Withdrawal by Subject|4|||
164713992|NCT02823652|594974967|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
164713993|NCT02823652|594974968|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
164475636|NCT04436289|594112711|FG003|Overall Study|Withdrawal by Subject|0|||
164475637|NCT04436289|594112708|FG000|Overall Study|Extended hospital stay|0|||
164713994|NCT02823652|594974966|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
164475638|NCT04436289|594112709|FG001|Overall Study|Extended hospital stay|1|||
164475639|NCT04436289|594112710|FG002|Overall Study|Extended hospital stay|0|||
164475640|NCT04436289|594112711|FG003|Overall Study|Extended hospital stay|0|||
164475641|NCT04436289|594112708|FG000|Overall Study|Lost to Follow-up|0|||
164300202|NCT05966142|593475159|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
164300203|NCT05966142|593475160|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
164713995|NCT02823652|594974967|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
164300204|NCT04849364|593475161|FG000|Overall Study|Eligibility criteria not meet|0|||
164300205|NCT04849364|593475162|FG001|Overall Study|Eligibility criteria not meet|1|||
164300206|NCT04849364|593475163|FG002|Overall Study|Eligibility criteria not meet|0|||
164300207|NCT00894803|593475164|FG000|Overall Study|Death|20|||
164300208|NCT00894803|593475165|FG001|Overall Study|Death|4|||
164300209|NCT00894803|593475164|FG000|Overall Study|Lost to Follow-up|0|||
164300210|NCT00894803|593475165|FG001|Overall Study|Lost to Follow-up|1|||
164300211|NCT00449696|593475172|FG000|Overall Study|Other Treatment Required|6|||
164300212|NCT00449696|593475173|FG001|Overall Study|Other Treatment Required|1|||
164300213|NCT00449696|593475172|FG000|Overall Study|Withdrawal by Subject|5|||
164300214|NCT00449696|593475173|FG001|Overall Study|Withdrawal by Subject|5|||
164300215|NCT00449696|593475172|FG000|Overall Study|Lost to Follow-up|2|||
164300216|NCT00449696|593475173|FG001|Overall Study|Lost to Follow-up|3|||
164300217|NCT00449696|593475172|FG000|Overall Study|Others|7|||
164300218|NCT00449696|593475173|FG001|Overall Study|Others|0|||
164300219|NCT00307801|593475178|FG000|Overall Study|Adverse Event|12|||
164300220|NCT00307801|593475179|FG001|Overall Study|Adverse Event|4|||
164300221|NCT00307801|593475178|FG000|Overall Study|Withdrawal by Subject|9|||
164300222|NCT00307801|593475179|FG001|Overall Study|Withdrawal by Subject|4|||
164300223|NCT00307801|593475178|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
164300224|NCT00307801|593475179|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
164300225|NCT00307801|593475178|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
164300226|NCT00307801|593475179|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
164300227|NCT00307801|593475178|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
164300228|NCT00307801|593475179|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
164300229|NCT00307801|593475178|FG000|Overall Study|Wrong Randomization|1|||
164300230|NCT00307801|593475179|FG001|Overall Study|Wrong Randomization|0|||
164300231|NCT00307801|593475178|FG000|Overall Study|Lack of Efficacy|0|||
164300232|NCT00307801|593475179|FG001|Overall Study|Lack of Efficacy|2|||
164300233|NCT00307801|593475178|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
164300234|NCT00307801|593475179|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
164300235|NCT00307801|593475178|FG000|Overall Study|Frustration with e-diary|1|||
164300236|NCT00307801|593475179|FG001|Overall Study|Frustration with e-diary|0|||
164300237|NCT00307801|593475178|FG000|Overall Study|Protocol Violation|3|||
164300238|NCT00307801|593475179|FG001|Overall Study|Protocol Violation|2|||
164300239|NCT00307801|593475178|FG000|Overall Study|No reason specified|2|||
164300240|NCT00307801|593475179|FG001|Overall Study|No reason specified|0|||
164300241|NCT00307801|593475178|FG000|Overall Study|Pregnancy|0|||
164300242|NCT00307801|593475179|FG001|Overall Study|Pregnancy|1|||
164300243|NCT00577889|593475182|FG000|Overall Study|Withdrawal by Subject|1|||
164300244|NCT00577889|593475183|FG001|Overall Study|Withdrawal by Subject|0|||
164300245|NCT00577889|593475184|FG002|Overall Study|Withdrawal by Subject|0|||
164300246|NCT01523756|593475186|FG000|Baseline Period|Adverse Event|0|||
164300247|NCT01523756|593475187|FG001|Baseline Period|Adverse Event|1|||
164300248|NCT01523756|593475186|FG000|Test Period 1|Adverse Event|1|||
164300249|NCT01523756|593475187|FG001|Test Period 1|Adverse Event|0|||
164300250|NCT01523756|593475186|FG000|Test Period 2|Withdrawal by Subject|0|||
164300251|NCT01523756|593475187|FG001|Test Period 2|Withdrawal by Subject|1|||
164300252|NCT03224819|593475188|FG000|Overall Study|Withdrawal by Subject|0|||
164300253|NCT03224819|593475189|FG001|Overall Study|Withdrawal by Subject|0|||
164300254|NCT03224819|593475190|FG002|Overall Study|Withdrawal by Subject|0|||
164300255|NCT03224819|593475191|FG003|Overall Study|Withdrawal by Subject|0|||
164713996|NCT02823652|594974968|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
164713997|NCT02823652|594974966|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
164713998|NCT02823652|594974967|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
164713999|NCT02823652|594974968|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
164714000|NCT01094886|594974969|FG000|Overall Study|Adverse Event|2|||
164714001|NCT01094886|594974969|FG000|Overall Study|Withdrawal by Subject|5|||
164714002|NCT05819203|594974972|FG000|Overall Study|Protocol Violation|1|||
164714003|NCT05819203|594974973|FG001|Overall Study|Protocol Violation|2|||
164300256|NCT03224819|593475192|FG004|Overall Study|Withdrawal by Subject|0|||
164300257|NCT03224819|593475193|FG005|Overall Study|Withdrawal by Subject|0|||
164300258|NCT03224819|593475194|FG006|Overall Study|Withdrawal by Subject|0|||
164300259|NCT03224819|593475195|FG007|Overall Study|Withdrawal by Subject|0|||
164300260|NCT03224819|593475196|FG008|Overall Study|Withdrawal by Subject|0|||
164300261|NCT03224819|593475197|FG009|Overall Study|Withdrawal by Subject|0|||
164300262|NCT03224819|593475198|FG010|Overall Study|Withdrawal by Subject|0|||
164599919|NCT02358369|594556404|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
164300263|NCT03224819|593475199|FG011|Overall Study|Withdrawal by Subject|0|||
164300264|NCT03224819|593475200|FG012|Overall Study|Withdrawal by Subject|1|||
164300265|NCT03224819|593475201|FG013|Overall Study|Withdrawal by Subject|0|||
164300266|NCT03224819|593475188|FG000|Overall Study|Sponsor Decision|0|||
164300267|NCT03224819|593475189|FG001|Overall Study|Sponsor Decision|0|||
164300268|NCT03224819|593475190|FG002|Overall Study|Sponsor Decision|0|||
164714004|NCT05819203|594974972|FG000|Overall Study|Withdrawal by Subject|1|||
164300269|NCT03224819|593475191|FG003|Overall Study|Sponsor Decision|1|||
164714005|NCT05819203|594974973|FG001|Overall Study|Withdrawal by Subject|0|||
164714006|NCT02952898|594974974|FG000|Overall Study|Withdrawal by Subject|10|||
164714007|NCT02952898|594974975|FG001|Overall Study|Withdrawal by Subject|8|||
164714008|NCT02952898|594974976|FG002|Overall Study|Withdrawal by Subject|8|||
164714009|NCT02952898|594974974|FG000|Overall Study|Adverse Event|8|||
164714010|NCT02952898|594974975|FG001|Overall Study|Adverse Event|8|||
164714011|NCT02952898|594974976|FG002|Overall Study|Adverse Event|3|||
164300270|NCT03224819|593475192|FG004|Overall Study|Sponsor Decision|1|||
164300271|NCT03224819|593475193|FG005|Overall Study|Sponsor Decision|2|||
164300272|NCT03224819|593475194|FG006|Overall Study|Sponsor Decision|1|||
164300273|NCT03224819|593475195|FG007|Overall Study|Sponsor Decision|1|||
164714012|NCT02952898|594974974|FG000|Overall Study|Lost to Follow-up|3|||
164714013|NCT02952898|594974975|FG001|Overall Study|Lost to Follow-up|2|||
164714014|NCT02952898|594974976|FG002|Overall Study|Lost to Follow-up|2|||
164714015|NCT02952898|594974974|FG000|Overall Study|Non-compliance with study drug|1|||
164714016|NCT02952898|594974975|FG001|Overall Study|Non-compliance with study drug|1|||
164714017|NCT02952898|594974976|FG002|Overall Study|Non-compliance with study drug|2|||
164714018|NCT04844762|594974977|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164714019|NCT04844762|594974978|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164714020|NCT04844762|594974979|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
164714021|NCT04844762|594974980|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164714022|NCT04844762|594974981|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164714023|NCT04844762|594974982|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164714024|NCT04844762|594974977|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
164714025|NCT04844762|594974978|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
164714026|NCT04844762|594974979|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
164714027|NCT04844762|594974980|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
164714028|NCT04844762|594974981|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
164300274|NCT03224819|593475196|FG008|Overall Study|Sponsor Decision|1|||
164300275|NCT03224819|593475197|FG009|Overall Study|Sponsor Decision|2|||
164300276|NCT03224819|593475198|FG010|Overall Study|Sponsor Decision|1|||
164300277|NCT03224819|593475199|FG011|Overall Study|Sponsor Decision|1|||
164300278|NCT03224819|593475200|FG012|Overall Study|Sponsor Decision|1|||
164300279|NCT03224819|593475201|FG013|Overall Study|Sponsor Decision|0|||
164300280|NCT03224819|593475188|FG000|Overall Study|Lost to Follow-up|0|||
164300281|NCT03224819|593475189|FG001|Overall Study|Lost to Follow-up|0|||
164300282|NCT03224819|593475190|FG002|Overall Study|Lost to Follow-up|0|||
164300283|NCT03224819|593475191|FG003|Overall Study|Lost to Follow-up|0|||
164300284|NCT03224819|593475192|FG004|Overall Study|Lost to Follow-up|0|||
164300285|NCT03224819|593475193|FG005|Overall Study|Lost to Follow-up|0|||
164300286|NCT03224819|593475194|FG006|Overall Study|Lost to Follow-up|0|||
164300287|NCT03224819|593475195|FG007|Overall Study|Lost to Follow-up|0|||
164300288|NCT03224819|593475196|FG008|Overall Study|Lost to Follow-up|1|||
164300289|NCT03224819|593475197|FG009|Overall Study|Lost to Follow-up|0|||
164300290|NCT03224819|593475198|FG010|Overall Study|Lost to Follow-up|0|||
164300291|NCT03224819|593475199|FG011|Overall Study|Lost to Follow-up|0|||
164300292|NCT03224819|593475200|FG012|Overall Study|Lost to Follow-up|0|||
164300293|NCT03224819|593475201|FG013|Overall Study|Lost to Follow-up|0|||
164300294|NCT03224819|593475188|FG000|Overall Study|Death|0|||
164300295|NCT03224819|593475189|FG001|Overall Study|Death|1|||
164300296|NCT03224819|593475190|FG002|Overall Study|Death|0|||
164300297|NCT03224819|593475191|FG003|Overall Study|Death|0|||
164300298|NCT03224819|593475192|FG004|Overall Study|Death|0|||
164300299|NCT03224819|593475193|FG005|Overall Study|Death|0|||
164300300|NCT03224819|593475194|FG006|Overall Study|Death|0|||
164300301|NCT03224819|593475195|FG007|Overall Study|Death|1|||
164300302|NCT03224819|593475196|FG008|Overall Study|Death|0|||
164300303|NCT03224819|593475197|FG009|Overall Study|Death|0|||
164300304|NCT03224819|593475198|FG010|Overall Study|Death|0|||
164300305|NCT03224819|593475199|FG011|Overall Study|Death|1|||
164714029|NCT04844762|594974982|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
164714030|NCT04844762|594974977|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
164714031|NCT04844762|594974978|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
164714032|NCT04844762|594974979|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
164714033|NCT04844762|594974980|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
164714034|NCT04844762|594974981|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
164714035|NCT04844762|594974982|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
164300306|NCT03224819|593475200|FG012|Overall Study|Death|0|||
164300307|NCT03224819|593475201|FG013|Overall Study|Death|0|||
164300308|NCT00795535|593475202|FG000|Overall Study|incomplete data and technical problems|20|||
164300309|NCT03955146|593475203|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
164300310|NCT03955146|593475204|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
164300311|NCT03955146|593475205|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
164300312|NCT03955146|593475206|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
164300313|NCT03955146|593475203|FG000|DB Period (48 Weeks)|Adverse Event|2|||
164714036|NCT04844762|594974977|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164714037|NCT04844762|594974978|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164714038|NCT04844762|594974979|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
164714039|NCT04844762|594974980|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
164714040|NCT04844762|594974981|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
164714041|NCT04844762|594974982|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164714042|NCT04844762|594974977|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
164714043|NCT04844762|594974978|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
164714044|NCT04844762|594974979|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
164714045|NCT04844762|594974980|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
164714046|NCT04844762|594974981|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
164714047|NCT04844762|594974982|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
164714048|NCT04844762|594974977|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
164714049|NCT04844762|594974978|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
164714050|NCT04844762|594974979|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
164714051|NCT04844762|594974980|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
164714052|NCT04844762|594974981|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
164714053|NCT04844762|594974982|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
164714054|NCT04844762|594974977|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164714055|NCT04844762|594974978|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164714056|NCT04844762|594974979|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164714057|NCT04844762|594974980|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164714058|NCT04844762|594974981|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
164714059|NCT04844762|594974982|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164714060|NCT04844762|594974977|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
164714061|NCT04844762|594974978|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
164714062|NCT04844762|594974979|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
164714063|NCT04844762|594974980|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
164714064|NCT04844762|594974981|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
164714065|NCT04844762|594974982|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
164714066|NCT04844762|594974977|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
164714067|NCT04844762|594974978|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
164714068|NCT04844762|594974979|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
164714069|NCT04844762|594974980|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
164714070|NCT04844762|594974981|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
164714071|NCT04844762|594974982|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
164714072|NCT04844762|594974977|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
164714073|NCT04844762|594974978|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
164714074|NCT04844762|594974979|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
164714075|NCT04844762|594974980|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
164714076|NCT04844762|594974981|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
164714077|NCT04844762|594974982|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
164714078|NCT04844762|594974977|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
164714079|NCT04844762|594974978|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
164714080|NCT04844762|594974979|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
164714081|NCT04844762|594974980|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
164300314|NCT03955146|593475204|FG001|DB Period (48 Weeks)|Adverse Event|5|||
164300315|NCT03955146|593475205|FG002|DB Period (48 Weeks)|Adverse Event|1|||
164300316|NCT03955146|593475206|FG003|DB Period (48 Weeks)|Adverse Event|2|||
164300317|NCT03955146|593475203|FG000|DB Period (48 Weeks)|Death|13|||
164300318|NCT03955146|593475204|FG001|DB Period (48 Weeks)|Death|17|||
164714082|NCT04844762|594974981|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
164714083|NCT04844762|594974982|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
164714084|NCT02802631|594974985|FG000|Overall Study|Withdrawal by Subject|1|||
164714085|NCT02802631|594974986|FG001|Overall Study|Withdrawal by Subject|0|||
164714086|NCT02802631|594974987|FG002|Overall Study|Withdrawal by Subject|0|||
164714087|NCT02802631|594974988|FG003|Overall Study|Withdrawal by Subject|0|||
164714088|NCT02802631|594974989|FG004|Overall Study|Withdrawal by Subject|0|||
164300319|NCT03955146|593475205|FG002|DB Period (48 Weeks)|Death|1|||
164300320|NCT03955146|593475206|FG003|DB Period (48 Weeks)|Death|0|||
164300321|NCT03955146|593475203|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
164714089|NCT02802631|594974990|FG005|Overall Study|Withdrawal by Subject|0|||
164714090|NCT02802631|594974991|FG006|Overall Study|Withdrawal by Subject|0|||
164714091|NCT02802631|594974992|FG007|Overall Study|Withdrawal by Subject|0|||
164714092|NCT02802631|594974985|FG000|Overall Study|Physician Decision|1|||
164714093|NCT02802631|594974986|FG001|Overall Study|Physician Decision|0|||
164300322|NCT03955146|593475204|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
164300323|NCT03955146|593475205|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
164300324|NCT03955146|593475206|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
164300325|NCT03955146|593475203|FG000|DB Period (48 Weeks)|Disease Progression|2|||
164300326|NCT03955146|593475204|FG001|DB Period (48 Weeks)|Disease Progression|0|||
164300327|NCT03955146|593475205|FG002|DB Period (48 Weeks)|Disease Progression|0|||
164300328|NCT03955146|593475206|FG003|DB Period (48 Weeks)|Disease Progression|0|||
164300329|NCT03955146|593475203|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
164300330|NCT03955146|593475204|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
164300331|NCT03955146|593475205|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
164300332|NCT03955146|593475206|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
164300333|NCT03955146|593475203|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
164300334|NCT03955146|593475204|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
164300335|NCT03955146|593475205|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
164300336|NCT03955146|593475206|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
164300337|NCT03955146|593475203|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
164300338|NCT03955146|593475204|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
164300339|NCT03955146|593475205|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
164300340|NCT03955146|593475206|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
164300341|NCT03955146|593475203|FG000|DB Period (48 Weeks)|Participant Decision|9|||
164300342|NCT03955146|593475204|FG001|DB Period (48 Weeks)|Participant Decision|12|||
164300343|NCT03955146|593475205|FG002|DB Period (48 Weeks)|Participant Decision|1|||
164300344|NCT03955146|593475206|FG003|DB Period (48 Weeks)|Participant Decision|1|||
164300345|NCT03955146|593475203|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
164300346|NCT03955146|593475204|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
164300347|NCT03955146|593475205|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
164300348|NCT03955146|593475206|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
164300349|NCT03955146|593475203|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
164300350|NCT03955146|593475204|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
164300351|NCT03955146|593475205|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
164300352|NCT03955146|593475206|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
164300353|NCT03955146|593475203|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
164300354|NCT03955146|593475204|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
164300355|NCT03955146|593475205|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
164300356|NCT03955146|593475206|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
164300357|NCT03955146|593475203|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
164300358|NCT03955146|593475204|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
164300359|NCT03955146|593475205|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
164300360|NCT03955146|593475206|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
164300361|NCT03955146|593475203|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
164300362|NCT03955146|593475204|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
164300363|NCT03955146|593475205|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
164300364|NCT03955146|593475206|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
164300365|NCT03955146|593475203|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
164300366|NCT03955146|593475204|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
164300367|NCT03955146|593475205|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
164300368|NCT03955146|593475206|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
164300369|NCT03955146|593475203|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
164300370|NCT03955146|593475204|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
164300371|NCT03955146|593475205|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
164300372|NCT03955146|593475206|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
164300373|NCT03955146|593475203|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
164300374|NCT03955146|593475204|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
164300375|NCT03955146|593475205|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
164300376|NCT03955146|593475206|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
164300377|NCT03955146|593475203|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
164300378|NCT03955146|593475204|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
164300379|NCT03955146|593475205|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
164300380|NCT03955146|593475206|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
164300381|NCT03955146|593475203|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
164300382|NCT03955146|593475204|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
164300383|NCT03955146|593475205|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
164300384|NCT03955146|593475206|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
164300385|NCT03955146|593475203|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
164300386|NCT03955146|593475204|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
164300387|NCT03955146|593475205|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
164300388|NCT03955146|593475206|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
164300389|NCT04363320|593475207|FG000|Overall Study|Lost to Follow-up|43|||
164300390|NCT04363320|593475208|FG001|Overall Study|Lost to Follow-up|42|||
164714094|NCT02802631|594974987|FG002|Overall Study|Physician Decision|0|||
164714095|NCT02802631|594974988|FG003|Overall Study|Physician Decision|0|||
164714096|NCT02802631|594974989|FG004|Overall Study|Physician Decision|0|||
164714097|NCT02802631|594974990|FG005|Overall Study|Physician Decision|0|||
164714098|NCT02802631|594974991|FG006|Overall Study|Physician Decision|1|||
164714099|NCT02802631|594974992|FG007|Overall Study|Physician Decision|0|||
164714100|NCT02802631|594974985|FG000|Overall Study|Adverse Event|0|||
164714101|NCT02802631|594974986|FG001|Overall Study|Adverse Event|2|||
164714102|NCT02802631|594974987|FG002|Overall Study|Adverse Event|0|||
164714103|NCT02802631|594974988|FG003|Overall Study|Adverse Event|1|||
164714104|NCT02802631|594974989|FG004|Overall Study|Adverse Event|6|||
164714105|NCT02802631|594974990|FG005|Overall Study|Adverse Event|1|||
164714106|NCT02802631|594974991|FG006|Overall Study|Adverse Event|4|||
164714107|NCT02802631|594974992|FG007|Overall Study|Adverse Event|0|||
164714108|NCT02802631|594974985|FG000|Overall Study|Sponsor Decision|0|||
164714109|NCT02802631|594974986|FG001|Overall Study|Sponsor Decision|0|||
164714110|NCT02802631|594974987|FG002|Overall Study|Sponsor Decision|6|||
164714111|NCT02802631|594974988|FG003|Overall Study|Sponsor Decision|0|||
164714112|NCT02802631|594974989|FG004|Overall Study|Sponsor Decision|2|||
164300391|NCT04363320|593475209|FG002|Overall Study|Lost to Follow-up|24|||
164300392|NCT04363320|593475210|FG003|Overall Study|Lost to Follow-up|29|||
164300393|NCT04363320|593475207|FG000|Overall Study|Death|0|||
164300394|NCT04363320|593475208|FG001|Overall Study|Death|0|||
164300395|NCT04363320|593475209|FG002|Overall Study|Death|1|||
164300396|NCT04363320|593475210|FG003|Overall Study|Death|0|||
164300397|NCT00604565|593475211|FG000|Overall Study|Study terminated|0|||
164300398|NCT00604565|593475212|FG001|Overall Study|Study terminated|3|||
164300399|NCT03605667|593475213|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
164300400|NCT03605667|593475214|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
164300401|NCT03605667|593475213|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
164300402|NCT03605667|593475214|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
164300403|NCT03605667|593475213|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
164300404|NCT03605667|593475214|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
164300405|NCT03605667|593475213|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
164300406|NCT03605667|593475214|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
164300407|NCT03605667|593475213|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
164300408|NCT03605667|593475214|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
164300409|NCT03605667|593475213|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
164300410|NCT03605667|593475214|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
164300411|NCT03605667|593475213|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
164300412|NCT03605667|593475214|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
164300413|NCT03605667|593475213|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
164300414|NCT03605667|593475214|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
164300415|NCT03605667|593475213|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
164300416|NCT03605667|593475214|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
164300417|NCT03605667|593475213|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
164300418|NCT03605667|593475214|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
164714113|NCT02802631|594974990|FG005|Overall Study|Sponsor Decision|0|||
164714114|NCT02802631|594974991|FG006|Overall Study|Sponsor Decision|0|||
164714115|NCT02802631|594974992|FG007|Overall Study|Sponsor Decision|4|||
164714116|NCT00477633|594974993|FG000|Overall Study|Did not receive treatment|23|||
164300419|NCT03605667|593475213|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
164300420|NCT03605667|593475214|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
164300421|NCT03605667|593475213|FG000|OLE Phase (48 Weeks)|Other|6|||
164300422|NCT03605667|593475214|FG001|OLE Phase (48 Weeks)|Other|8|||
164300423|NCT03605667|593475213|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
164300424|NCT03605667|593475214|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
164300425|NCT03605667|593475213|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
164300426|NCT03605667|593475214|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
164300427|NCT03605667|593475213|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
164300428|NCT03605667|593475214|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
164300429|NCT03605667|593475213|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
164300430|NCT03605667|593475214|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
164300431|NCT03605667|593475213|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
164300432|NCT03605667|593475214|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
164300433|NCT03605667|593475213|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
164300434|NCT03605667|593475214|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
164300435|NCT03605667|593475213|FG000|OLE Phase (48 Weeks)|Death|0|||
164300436|NCT03605667|593475214|FG001|OLE Phase (48 Weeks)|Death|2|||
164714117|NCT00477633|594974993|FG000|Overall Study|Adverse Event|143|||
164714118|NCT00477633|594974993|FG000|Overall Study|Pregnancy|23|||
164714119|NCT00477633|594974993|FG000|Overall Study|Lost to Follow-up|271|||
164714120|NCT00477633|594974993|FG000|Overall Study|Withdrawal by Subject|149|||
164714121|NCT00477633|594974993|FG000|Overall Study|Protocol Violation|25|||
164300437|NCT03605667|593475213|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
164300438|NCT03605667|593475214|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
164300439|NCT05632211|593475215|FG000|Overall Study|Withdrawal by Subject|2|||
164300440|NCT05632211|593475216|FG001|Overall Study|Withdrawal by Subject|0|||
164300441|NCT05632211|593475217|FG002|Overall Study|Withdrawal by Subject|2|||
164300442|NCT05632211|593475215|FG000|Overall Study|Other reasons|1|||
164300443|NCT05632211|593475216|FG001|Overall Study|Other reasons|1|||
164300444|NCT05632211|593475217|FG002|Overall Study|Other reasons|1|||
164300445|NCT00541658|593475218|FG000|Overall Study|Adverse Event|28|||
164300446|NCT00541658|593475219|FG001|Overall Study|Adverse Event|37|||
164300447|NCT00541658|593475220|FG002|Overall Study|Adverse Event|25|||
164300448|NCT00541658|593475218|FG000|Overall Study|Physician Decision|0|||
164300449|NCT00541658|593475219|FG001|Overall Study|Physician Decision|0|||
164300450|NCT00541658|593475220|FG002|Overall Study|Physician Decision|4|||
164300451|NCT00541658|593475218|FG000|Overall Study|Lost to Follow-up|3|||
164300452|NCT00541658|593475219|FG001|Overall Study|Lost to Follow-up|3|||
164300453|NCT00541658|593475220|FG002|Overall Study|Lost to Follow-up|6|||
164300454|NCT00541658|593475218|FG000|Overall Study|Protocol Violation|0|||
164300455|NCT00541658|593475219|FG001|Overall Study|Protocol Violation|1|||
164300456|NCT00541658|593475220|FG002|Overall Study|Protocol Violation|1|||
164300457|NCT00541658|593475218|FG000|Overall Study|Withdrawal by Subject|28|||
164300458|NCT00541658|593475219|FG001|Overall Study|Withdrawal by Subject|32|||
164300459|NCT00541658|593475220|FG002|Overall Study|Withdrawal by Subject|32|||
164300460|NCT00541658|593475218|FG000|Overall Study|Took No Study Drug|1|||
164300461|NCT00541658|593475219|FG001|Overall Study|Took No Study Drug|0|||
164300462|NCT00541658|593475220|FG002|Overall Study|Took No Study Drug|0|||
164300463|NCT05194124|593475234|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
164300464|NCT05194124|593475235|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
164300465|NCT05194124|593475236|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
164300466|NCT05194124|593475237|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
164300467|NCT05194124|593475238|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
164300468|NCT05194124|593475239|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
164300469|NCT05194124|593475240|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
164300470|NCT05194124|593475241|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
164300471|NCT05194124|593475242|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
164300472|NCT05194124|593475243|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
164300473|NCT05194124|593475234|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
164300474|NCT05194124|593475235|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
164300475|NCT05194124|593475236|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
164300476|NCT05194124|593475237|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
164300477|NCT05194124|593475238|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
164300478|NCT05194124|593475239|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
164300479|NCT05194124|593475240|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
164300480|NCT05194124|593475241|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
164300481|NCT05194124|593475242|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
164300482|NCT05194124|593475243|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
164300483|NCT05408429|593475248|FG000|Overall Study|Lost to Follow-up|1|||
164300484|NCT05408429|593475249|FG001|Overall Study|Lost to Follow-up|1|||
164300485|NCT05408429|593475250|FG002|Overall Study|Lost to Follow-up|0|||
164300486|NCT05408429|593475248|FG000|Overall Study|Withdrawal by Subject|5|||
164300487|NCT05408429|593475249|FG001|Overall Study|Withdrawal by Subject|0|||
164300488|NCT05408429|593475250|FG002|Overall Study|Withdrawal by Subject|1|||
164300489|NCT03642873|593475251|FG000|Third Intervention (1 Day)|Screen failure|0|||
164300490|NCT03642873|593475252|FG001|Third Intervention (1 Day)|Screen failure|0|||
164300491|NCT03642873|593475253|FG002|Third Intervention (1 Day)|Screen failure|0|||
164300492|NCT03642873|593475254|FG003|Third Intervention (1 Day)|Screen failure|0|||
164300493|NCT03642873|593475255|FG004|Third Intervention (1 Day)|Screen failure|1|||
164300494|NCT03642873|593475256|FG005|Third Intervention (1 Day)|Screen failure|0|||
164300495|NCT01253291|593475258|FG000|Overall Study|Withdrawal by Subject|1|||
164300496|NCT01253291|593475259|FG001|Overall Study|Withdrawal by Subject|1|||
164300497|NCT01253291|593475260|FG002|Overall Study|Withdrawal by Subject|0|||
164300498|NCT01253291|593475261|FG003|Overall Study|Withdrawal by Subject|0|||
164300499|NCT01253291|593475262|FG004|Overall Study|Withdrawal by Subject|0|||
164300500|NCT01253291|593475258|FG000|Overall Study|Adverse Event|0|||
164300501|NCT01253291|593475259|FG001|Overall Study|Adverse Event|1|||
164300502|NCT01253291|593475260|FG002|Overall Study|Adverse Event|0|||
164300503|NCT01253291|593475261|FG003|Overall Study|Adverse Event|0|||
164300504|NCT01253291|593475262|FG004|Overall Study|Adverse Event|0|||
164300505|NCT01253291|593475258|FG000|Overall Study|Lack of Efficacy|1|||
164300506|NCT01253291|593475259|FG001|Overall Study|Lack of Efficacy|0|||
164300507|NCT01253291|593475260|FG002|Overall Study|Lack of Efficacy|0|||
164300508|NCT01253291|593475261|FG003|Overall Study|Lack of Efficacy|0|||
164300509|NCT01253291|593475262|FG004|Overall Study|Lack of Efficacy|0|||
164300510|NCT01253291|593475258|FG000|Overall Study|Physician Decision|2|||
164300511|NCT01253291|593475259|FG001|Overall Study|Physician Decision|0|||
164300512|NCT01253291|593475260|FG002|Overall Study|Physician Decision|0|||
164300513|NCT01253291|593475261|FG003|Overall Study|Physician Decision|0|||
164300514|NCT01253291|593475262|FG004|Overall Study|Physician Decision|2|||
164300515|NCT03312231|593475266|FG000|Overall Study|Lost to Follow-up|2|||
164300516|NCT03312231|593475267|FG001|Overall Study|Lost to Follow-up|6|||
164300517|NCT03312231|593475268|FG002|Overall Study|Lost to Follow-up|1|||
164300518|NCT03312231|593475269|FG003|Overall Study|Lost to Follow-up|3|||
164300519|NCT03312231|593475270|FG004|Overall Study|Lost to Follow-up|1|||
164300520|NCT03312231|593475266|FG000|Overall Study|Withdrawal by Subject|0|||
164300521|NCT03312231|593475267|FG001|Overall Study|Withdrawal by Subject|3|||
164300522|NCT03312231|593475268|FG002|Overall Study|Withdrawal by Subject|1|||
164300523|NCT03312231|593475269|FG003|Overall Study|Withdrawal by Subject|0|||
164300524|NCT03312231|593475270|FG004|Overall Study|Withdrawal by Subject|0|||
164300525|NCT03312231|593475266|FG000|Overall Study|Death|0|||
164300526|NCT03312231|593475267|FG001|Overall Study|Death|1|||
164300527|NCT03312231|593475268|FG002|Overall Study|Death|1|||
164300528|NCT03312231|593475269|FG003|Overall Study|Death|0|||
164300529|NCT03312231|593475270|FG004|Overall Study|Death|0|||
164300530|NCT03312231|593475266|FG000|Overall Study|Study Vaccination not Received|1|||
164300531|NCT03312231|593475267|FG001|Overall Study|Study Vaccination not Received|1|||
164300532|NCT03312231|593475268|FG002|Overall Study|Study Vaccination not Received|1|||
164300533|NCT03312231|593475269|FG003|Overall Study|Study Vaccination not Received|0|||
164300534|NCT03312231|593475270|FG004|Overall Study|Study Vaccination not Received|0|||
164300535|NCT03157830|593475274|FG000|Overall Study|Lost to Follow-up|1|||
164300536|NCT03157830|593475274|FG000|Overall Study|Withdrawal by Subject|1|||
164300537|NCT02195518|593475275|FG000|Overall Study|Adverse Event|1|||
164300538|NCT02195518|593475275|FG000|Overall Study|Protocol Violation|4|||
164300539|NCT02195518|593475275|FG000|Overall Study|Pregnancy|2|||
164300540|NCT02195518|593475275|FG000|Overall Study|Withdrawal by Subject|1|||
164300541|NCT02195518|593475275|FG000|Overall Study|Lost to Follow-up|1|||
164300542|NCT03694353|593475276|FG000|Overall Study|Withdrawal by Subject|1|||
164300543|NCT03694353|593475276|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
164300544|NCT03804528|593475281|FG000|Overall Study|Time Commitment|18|||
164300545|NCT03804528|593475281|FG000|Overall Study|Health Reasons|5|||
164300546|NCT00651742|593475283|FG000|Overall Study|Objective Disease Progression|22|||
164300547|NCT00651742|593475283|FG000|Overall Study|Toxicity|3|||
164300548|NCT00651742|593475283|FG000|Overall Study|Investigator Judgment|1|||
164300549|NCT00651742|593475283|FG000|Overall Study|Withdrawal of Consent|1|||
164300550|NCT00651742|593475283|FG000|Overall Study|Enrolled but not treated|1|||
164300551|NCT01074970|593475284|FG000|Overall Study|Never Treated|0|||
164300552|NCT01074970|593475285|FG001|Overall Study|Never Treated|0|||
164300553|NCT01074970|593475286|FG002|Overall Study|Never Treated|8|||
164300554|NCT01074970|593475287|FG003|Overall Study|Never Treated|1|||
164300555|NCT01074970|593475284|FG000|Overall Study|Adverse Event|1|||
164300556|NCT01074970|593475285|FG001|Overall Study|Adverse Event|0|||
164300557|NCT01074970|593475286|FG002|Overall Study|Adverse Event|4|||
164300558|NCT01074970|593475287|FG003|Overall Study|Adverse Event|3|||
164300559|NCT01074970|593475284|FG000|Overall Study|Disease progression during treatment|3|||
164300560|NCT01074970|593475285|FG001|Overall Study|Disease progression during treatment|1|||
164300561|NCT01074970|593475286|FG002|Overall Study|Disease progression during treatment|2|||
164300562|NCT01074970|593475287|FG003|Overall Study|Disease progression during treatment|9|||
164300563|NCT01074970|593475284|FG000|Overall Study|Lost to Follow-up|0|||
164300564|NCT01074970|593475285|FG001|Overall Study|Lost to Follow-up|0|||
164300565|NCT01074970|593475286|FG002|Overall Study|Lost to Follow-up|1|||
164300566|NCT01074970|593475287|FG003|Overall Study|Lost to Follow-up|0|||
164300567|NCT01074970|593475284|FG000|Overall Study|Withdrawal by Subject|0|||
164300568|NCT01074970|593475285|FG001|Overall Study|Withdrawal by Subject|0|||
164300569|NCT01074970|593475286|FG002|Overall Study|Withdrawal by Subject|6|||
164300570|NCT01074970|593475287|FG003|Overall Study|Withdrawal by Subject|4|||
164300571|NCT00734149|593475289|FG000|Overall Study|Withdrawal by Subject|1|||
164300572|NCT04314284|593475290|FG000|Overall Study|Withdrawal by Subject|4|||
164300573|NCT04314284|593475291|FG001|Overall Study|Withdrawal by Subject|7|||
164300574|NCT04314284|593475290|FG000|Overall Study|Consented but did not complete survey|0|||
164300575|NCT04314284|593475291|FG001|Overall Study|Consented but did not complete survey|6|||
164300576|NCT03312634|593476496|FG000|Overall Study|Adverse Event|11|||
164300577|NCT03312634|593476497|FG001|Overall Study|Adverse Event|0|||
164300578|NCT03312634|593476496|FG000|Overall Study|Sponsor request|2|||
164300579|NCT03312634|593476497|FG001|Overall Study|Sponsor request|0|||
164300580|NCT03312634|593476496|FG000|Overall Study|Withdrawal by Subject|31|||
164300581|NCT03312634|593476497|FG001|Overall Study|Withdrawal by Subject|9|||
164300582|NCT03312634|593476496|FG000|Overall Study|Enrolled in an interventional study|0|||
164300583|NCT03312634|593476497|FG001|Overall Study|Enrolled in an interventional study|52|||
164300584|NCT03312634|593476496|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
164300585|NCT03312634|593476497|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
164300586|NCT03312634|593476496|FG000|Overall Study|Death|0|||
164300587|NCT03312634|593476497|FG001|Overall Study|Death|1|||
164300588|NCT03312634|593476496|FG000|Overall Study|Non-compliance|0|||
164300589|NCT03312634|593476497|FG001|Overall Study|Non-compliance|2|||
164300590|NCT03312634|593476496|FG000|Overall Study|Lost to Follow-up|0|||
164300591|NCT03312634|593476497|FG001|Overall Study|Lost to Follow-up|1|||
164300592|NCT03312634|593476496|FG000|Overall Study|Enrolled into non-interventional study|0|||
164300593|NCT03312634|593476497|FG001|Overall Study|Enrolled into non-interventional study|5|||
164300594|NCT03312634|593476496|FG000|Overall Study|Worsening clinical condition|0|||
164300595|NCT03312634|593476497|FG001|Overall Study|Worsening clinical condition|1|||
164300596|NCT03312634|593476496|FG000|Overall Study|Participant did not want to travel|0|||
164300597|NCT03312634|593476497|FG001|Overall Study|Participant did not want to travel|1|||
164300598|NCT03312634|593476496|FG000|Overall Study|Physician Decision|1|||
164300599|NCT03312634|593476497|FG001|Overall Study|Physician Decision|0|||
164300600|NCT03312634|593476496|FG000|Overall Study|Other|13|||
164300601|NCT03312634|593476497|FG001|Overall Study|Other|0|||
164300602|NCT04610281|593476498|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
164300603|NCT04610281|593476499|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
164300604|NCT01942837|593476500|FG000|Overall Study|Death|1|||
164300605|NCT01942837|593476500|FG000|Overall Study|Symptomatic or radiographic progression|49|||
164300606|NCT01942837|593476500|FG000|Overall Study|Adverse Event|6|||
164300607|NCT01942837|593476500|FG000|Overall Study|Physician Decision|3|||
164300608|NCT01942837|593476500|FG000|Overall Study|Withdrawal by Subject|2|||
164300609|NCT01942837|593476500|FG000|Overall Study|Intercurrent Illness|1|||
164300610|NCT01942837|593476500|FG000|Overall Study|On treatment|3|||
164300611|NCT01942837|593476500|FG000|Overall Study|Never initiate the treatment|2|||
164300612|NCT01298648|593476501|FG000|Overall Study|Withdrawal by Subject|2|||
164300613|NCT01298648|593476501|FG000|Overall Study|Lost to Follow-up|21|||
164300614|NCT01458392|593476506|FG000|Overall Study|Death|2|||
164300615|NCT01458392|593476507|FG001|Overall Study|Death|11|||
164300616|NCT01458392|593476508|FG002|Overall Study|Death|22|||
164300617|NCT01458392|593476506|FG000|Overall Study|At the discretion of the sponsor|0|||
164300618|NCT01458392|593476507|FG001|Overall Study|At the discretion of the sponsor|2|||
164300619|NCT01458392|593476508|FG002|Overall Study|At the discretion of the sponsor|7|||
164300620|NCT01458392|593476506|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
164300621|NCT01458392|593476507|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
164300622|NCT01458392|593476508|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
164300623|NCT02038933|593476509|FG000|Overall Study|Disease progression|104|||
164300624|NCT02038933|593476509|FG000|Overall Study|Study drug toxicity|6|||
164300625|NCT02038933|593476509|FG000|Overall Study|Adverse event unrelated to study drug|6|||
164300626|NCT02038933|593476509|FG000|Overall Study|Participant request to discontinue treatment|2|||
164300627|NCT02038933|593476509|FG000|Overall Study|Lost to Follow-up|1|||
164300628|NCT02038933|593476509|FG000|Overall Study|Other reasons|2|||
164300629|NCT03250273|593476542|FG000|Overall Study|Disease Progression|2|||
164300630|NCT03250273|593476543|FG001|Overall Study|Disease Progression|11|||
164300631|NCT03250273|593476542|FG000|Overall Study|Death|0|||
164300632|NCT03250273|593476543|FG001|Overall Study|Death|1|||
164300633|NCT04154904|593476544|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
164300634|NCT04154904|593476545|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
164300635|NCT04154904|593476546|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
164300636|NCT00936715|593476547|FG000|Overall Study|Investigators Discretion|1|||
164300637|NCT00936715|593476547|FG000|Overall Study|Protocol Violation|1|||
164714122|NCT00477633|594974993|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
164714123|NCT03888066|594976820|FG000|Run-in Phase|Randomization Criterion #1|24|||
164714124|NCT03888066|594976821|FG001|Run-in Phase|Randomization Criterion #1|0|||
164714125|NCT03888066|594976820|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
164714126|NCT03888066|594976821|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
164714127|NCT03888066|594976820|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
164714128|NCT03888066|594976821|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
164714129|NCT03888066|594976820|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
164714130|NCT03888066|594976821|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
164714131|NCT03888066|594976820|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
164714132|NCT03888066|594976821|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
164714133|NCT03888066|594976820|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
164714134|NCT03888066|594976821|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
164300638|NCT00936715|593476547|FG000|Overall Study|Safety or Tolerability Reasons|4|||
164300639|NCT03040336|593476549|FG000|Overall Study|Death|1|||
164300640|NCT03040336|593476550|FG001|Overall Study|Death|0|||
164300641|NCT03040336|593476549|FG000|Overall Study|Withdrawal by Subject|2|||
164300642|NCT03040336|593476550|FG001|Overall Study|Withdrawal by Subject|3|||
164300643|NCT02000440|593476551|FG000|Overall Study|Adverse Event|3|||
164300644|NCT02000440|593476551|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
164714135|NCT03888066|594976820|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
164714136|NCT03888066|594976821|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
164714137|NCT03888066|594976820|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
164714138|NCT03888066|594976821|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
164714139|NCT03888066|594976820|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
164300645|NCT02383576|593476553|FG000|Overall Study|Death|53|||
164300646|NCT02383576|593476554|FG001|Overall Study|Death|33|||
164300647|NCT02383576|593476553|FG000|Overall Study|Lost to Follow-up|7|||
164300648|NCT02383576|593476554|FG001|Overall Study|Lost to Follow-up|1|||
164300649|NCT02383576|593476553|FG000|Overall Study|Withdrew Consent|1|||
164300650|NCT02383576|593476554|FG001|Overall Study|Withdrew Consent|6|||
164300651|NCT02383576|593476553|FG000|Overall Study|Investigator's Decision|0|||
164300652|NCT02383576|593476554|FG001|Overall Study|Investigator's Decision|1|||
164300653|NCT02383576|593476553|FG000|Overall Study|Administrative/Other|2|||
164300654|NCT02383576|593476554|FG001|Overall Study|Administrative/Other|4|||
164300655|NCT00871975|593476555|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
164300656|NCT00871975|593476555|FG000|Overall Study|Catheters could not be inserted|1|||
164300657|NCT00871975|593476555|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
164300658|NCT00871975|593476555|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
164300659|NCT01436149|593476556|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
164300660|NCT01436149|593476557|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
164300661|NCT01436149|593476558|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
164300662|NCT01436149|593476556|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
164300663|NCT01436149|593476557|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
164300664|NCT01436149|593476558|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
164300665|NCT01436149|593476556|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
164300666|NCT01436149|593476557|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
164300667|NCT01436149|593476558|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
164300668|NCT01436149|593476556|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
164300669|NCT01436149|593476557|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
164300670|NCT01436149|593476558|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
164300671|NCT01436149|593476556|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
164300672|NCT01436149|593476557|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
164300673|NCT01436149|593476558|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
164300674|NCT01436149|593476556|FG000|Antidepressant Lead-in Phase|Other|119|||
164300675|NCT01436149|593476557|FG001|Antidepressant Lead-in Phase|Other|0|||
164300676|NCT01436149|593476558|FG002|Antidepressant Lead-in Phase|Other|0|||
164300677|NCT01436149|593476556|FG000|Randomized Phase|Adverse Event|9|||
164300678|NCT01436149|593476557|FG001|Randomized Phase|Adverse Event|10|||
164300679|NCT01436149|593476558|FG002|Randomized Phase|Adverse Event|11|||
164300680|NCT01436149|593476556|FG000|Randomized Phase|Protocol Violation|4|||
164300681|NCT01436149|593476557|FG001|Randomized Phase|Protocol Violation|5|||
164300682|NCT01436149|593476558|FG002|Randomized Phase|Protocol Violation|0|||
164300683|NCT01436149|593476556|FG000|Randomized Phase|Withdrawal by Subject|16|||
164300684|NCT01436149|593476557|FG001|Randomized Phase|Withdrawal by Subject|10|||
164300685|NCT01436149|593476558|FG002|Randomized Phase|Withdrawal by Subject|10|||
164300686|NCT01436149|593476556|FG000|Randomized Phase|Lost to Follow-up|34|||
164300687|NCT01436149|593476557|FG001|Randomized Phase|Lost to Follow-up|5|||
164300688|NCT01436149|593476558|FG002|Randomized Phase|Lost to Follow-up|6|||
164300689|NCT01436149|593476556|FG000|Randomized Phase|Lack of Efficacy|0|||
164300690|NCT01436149|593476557|FG001|Randomized Phase|Lack of Efficacy|0|||
164300691|NCT01436149|593476558|FG002|Randomized Phase|Lack of Efficacy|1|||
164300692|NCT01436149|593476556|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
164300693|NCT01436149|593476557|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
164300694|NCT01436149|593476558|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
164300695|NCT01436149|593476556|FG000|Randomized Phase|Other|12|||
164300696|NCT01436149|593476557|FG001|Randomized Phase|Other|5|||
164300697|NCT01436149|593476558|FG002|Randomized Phase|Other|11|||
164300698|NCT01690143|593476559|FG000|Overall Study|Withdrawal by Subject|1|||
164300699|NCT01643668|593476560|FG000|Overall Study|Death|1|||
164300700|NCT01409707|593476561|FG000|Overall Study|Withdrawal by Subject|5|||
164300701|NCT01409707|593476562|FG001|Overall Study|Withdrawal by Subject|17|||
164300702|NCT01409707|593476563|FG002|Overall Study|Withdrawal by Subject|16|||
164300703|NCT00632229|593476564|FG000|Overall Study|Adverse Event|6|||
164300704|NCT00632229|593476565|FG001|Overall Study|Adverse Event|0|||
164300705|NCT00632229|593476564|FG000|Overall Study|Lost to Follow-up|0|||
164300706|NCT00632229|593476565|FG001|Overall Study|Lost to Follow-up|3|||
164300707|NCT00632229|593476564|FG000|Overall Study|Lack of Efficacy|0|||
164300708|NCT00632229|593476565|FG001|Overall Study|Lack of Efficacy|2|||
164300709|NCT00632229|593476564|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
164300710|NCT00632229|593476565|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
164300711|NCT01716234|593476566|FG000|Overall Study|Protocol Violation|0|||
164300712|NCT01716234|593476567|FG001|Overall Study|Protocol Violation|0|||
164300713|NCT01716234|593476568|FG002|Overall Study|Protocol Violation|0|||
164300714|NCT01716234|593476569|FG003|Overall Study|Protocol Violation|1|||
164300715|NCT01716234|593476570|FG004|Overall Study|Protocol Violation|1|||
164714140|NCT03888066|594976821|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
164714141|NCT03888066|594976820|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
164714142|NCT03888066|594976821|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
164300716|NCT01716234|593476571|FG005|Overall Study|Protocol Violation|1|||
164300717|NCT01716234|593476572|FG006|Overall Study|Protocol Violation|0|||
164300718|NCT01716234|593476566|FG000|Overall Study|Lack of Efficacy|0|||
164300719|NCT01716234|593476567|FG001|Overall Study|Lack of Efficacy|0|||
164300720|NCT01716234|593476568|FG002|Overall Study|Lack of Efficacy|0|||
164300721|NCT01716234|593476569|FG003|Overall Study|Lack of Efficacy|1|||
164300722|NCT01716234|593476570|FG004|Overall Study|Lack of Efficacy|0|||
164300723|NCT01716234|593476571|FG005|Overall Study|Lack of Efficacy|0|||
164300724|NCT01716234|593476572|FG006|Overall Study|Lack of Efficacy|0|||
164300725|NCT01716234|593476566|FG000|Overall Study|Did not meet protocol eligibility|0|||
164300726|NCT01716234|593476567|FG001|Overall Study|Did not meet protocol eligibility|0|||
164300727|NCT01716234|593476568|FG002|Overall Study|Did not meet protocol eligibility|1|||
164300728|NCT01716234|593476569|FG003|Overall Study|Did not meet protocol eligibility|0|||
164300729|NCT01716234|593476570|FG004|Overall Study|Did not meet protocol eligibility|0|||
164300730|NCT01716234|593476571|FG005|Overall Study|Did not meet protocol eligibility|4|||
164300731|NCT01716234|593476572|FG006|Overall Study|Did not meet protocol eligibility|0|||
164300732|NCT01716234|593476566|FG000|Overall Study|Adverse Event|7|||
164300733|NCT01716234|593476567|FG001|Overall Study|Adverse Event|10|||
164300734|NCT01716234|593476568|FG002|Overall Study|Adverse Event|2|||
164300735|NCT01716234|593476569|FG003|Overall Study|Adverse Event|8|||
164300736|NCT01716234|593476570|FG004|Overall Study|Adverse Event|3|||
164300737|NCT01716234|593476571|FG005|Overall Study|Adverse Event|6|||
164300738|NCT01716234|593476572|FG006|Overall Study|Adverse Event|0|||
164300739|NCT01716234|593476566|FG000|Overall Study|Withdrawal by Subject|3|||
164300740|NCT01716234|593476567|FG001|Overall Study|Withdrawal by Subject|0|||
164300741|NCT01716234|593476568|FG002|Overall Study|Withdrawal by Subject|2|||
164300742|NCT01716234|593476569|FG003|Overall Study|Withdrawal by Subject|2|||
164300743|NCT01716234|593476570|FG004|Overall Study|Withdrawal by Subject|1|||
164300744|NCT01716234|593476571|FG005|Overall Study|Withdrawal by Subject|3|||
164300745|NCT01716234|593476572|FG006|Overall Study|Withdrawal by Subject|0|||
164300746|NCT01467960|593476573|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
164300747|NCT01467960|593476574|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
164300748|NCT01467960|593476575|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
164300749|NCT01467960|593476576|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
164300750|NCT01467960|593476577|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
164300751|NCT01467960|593476578|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
164300752|NCT00474812|593476579|FG000|Overall Study|Withdrawal by Subject|5|||
164300753|NCT00474812|593476579|FG000|Overall Study|No Initiation of treatment|2|||
164300754|NCT00737672|593476588|FG000|Overall Study|Graft Abandonment|48|||
164300755|NCT00737672|593476589|FG001|Overall Study|Graft Abandonment|56|||
164300756|NCT00737672|593476588|FG000|Overall Study|Death|23|||
164300757|NCT00737672|593476589|FG001|Overall Study|Death|22|||
164300758|NCT00737672|593476588|FG000|Overall Study|Withdrawal by Subject|1|||
164300759|NCT00737672|593476589|FG001|Overall Study|Withdrawal by Subject|2|||
164300760|NCT00737672|593476588|FG000|Overall Study|Lost to Follow-up|1|||
164300761|NCT00737672|593476589|FG001|Overall Study|Lost to Follow-up|0|||
164300762|NCT00737672|593476588|FG000|Overall Study|Miscellaneous|7|||
164300763|NCT00737672|593476589|FG001|Overall Study|Miscellaneous|1|||
164300764|NCT00737672|593476588|FG000|Overall Study|Physician Decision|0|||
164300765|NCT00737672|593476589|FG001|Overall Study|Physician Decision|2|||
164300766|NCT02002598|593476594|FG000|Dose Level 1|Withdrawal by Subject|1|||
164300767|NCT02002598|593476595|FG001|Dose Level 1|Withdrawal by Subject|0|||
164300768|NCT02002598|593476596|FG002|Dose Level 1|Withdrawal by Subject|0|||
164300769|NCT02002598|593476597|FG003|Dose Level 1|Withdrawal by Subject|0|||
164300770|NCT02002598|593476598|FG004|Dose Level 1|Withdrawal by Subject|0|||
164300771|NCT02018562|593476600|FG000|Overall Study|Withdrawal by Subject|2|||
164300772|NCT02018562|593476601|FG001|Overall Study|Withdrawal by Subject|0|||
164300773|NCT02018562|593476600|FG000|Overall Study|Discharged prior to study completion|1|||
164300774|NCT02018562|593476601|FG001|Overall Study|Discharged prior to study completion|0|||
164714143|NCT03888066|594976820|FG000|Run-in Phase|Randomization Criterion #2|5|||
164300775|NCT01838395|593476602|FG000|Overall Study|Withdrawal by Subject|0|||
164300776|NCT01838395|593476603|FG001|Overall Study|Withdrawal by Subject|0|||
164300777|NCT01838395|593476604|FG002|Overall Study|Withdrawal by Subject|0|||
164300778|NCT01838395|593476605|FG003|Overall Study|Withdrawal by Subject|0|||
164300779|NCT01838395|593476606|FG004|Overall Study|Withdrawal by Subject|1|||
164300780|NCT01838395|593476607|FG005|Overall Study|Withdrawal by Subject|0|||
164300781|NCT01838395|593476602|FG000|Overall Study|Death|0|||
164300782|NCT01838395|593476603|FG001|Overall Study|Death|0|||
164300783|NCT01838395|593476604|FG002|Overall Study|Death|1|||
164300784|NCT01838395|593476605|FG003|Overall Study|Death|0|||
164300785|NCT01838395|593476606|FG004|Overall Study|Death|0|||
164300786|NCT01838395|593476607|FG005|Overall Study|Death|0|||
164300787|NCT01838395|593476602|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
164300788|NCT01838395|593476603|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
164300789|NCT01838395|593476604|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
164300790|NCT01838395|593476605|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
164300791|NCT01838395|593476606|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
164300792|NCT01838395|593476607|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
164300793|NCT05720897|593476613|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
164300794|NCT05720897|593476614|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
164300795|NCT00400179|593476615|FG000|Overall Study|Adverse Event|2|||
164300796|NCT00400179|593476616|FG001|Overall Study|Adverse Event|2|||
164300797|NCT00400179|593476615|FG000|Overall Study|Death|1|||
164300798|NCT00400179|593476616|FG001|Overall Study|Death|2|||
164300799|NCT00400179|593476615|FG000|Overall Study|Withdrew Consent|1|||
164300800|NCT00400179|593476616|FG001|Overall Study|Withdrew Consent|5|||
164300801|NCT00400179|593476615|FG000|Overall Study|Disease progression|1|||
164300802|NCT00400179|593476616|FG001|Overall Study|Disease progression|1|||
164300803|NCT00400179|593476615|FG000|Overall Study|Intercurrent illness|0|||
164300804|NCT00400179|593476616|FG001|Overall Study|Intercurrent illness|1|||
164300805|NCT00400179|593476615|FG000|Overall Study|Investigator judgment|0|||
164300806|NCT00400179|593476616|FG001|Overall Study|Investigator judgment|1|||
164300807|NCT00400179|593476615|FG000|Overall Study|Randomization error/patient ineligible|1|||
164300808|NCT00400179|593476616|FG001|Overall Study|Randomization error/patient ineligible|6|||
164300809|NCT04780061|593476617|FG000|Overall Study|Withdrawal by Subject|5|||
164300810|NCT04780061|593476618|FG001|Overall Study|Withdrawal by Subject|8|||
164300811|NCT04780061|593476617|FG000|Overall Study|Adverse Event|2|||
164300812|NCT04780061|593476618|FG001|Overall Study|Adverse Event|2|||
164300813|NCT04780061|593476617|FG000|Overall Study|Lost to Follow-up|1|||
164300814|NCT04780061|593476618|FG001|Overall Study|Lost to Follow-up|5|||
164300815|NCT04050553|593476620|FG000|Period 1|Physician Decision|2|||
164300816|NCT04050553|593476621|FG001|Period 1|Physician Decision|2|||
164300817|NCT04050553|593476620|FG000|Period 1|Adverse Event|1|||
164300818|NCT04050553|593476621|FG001|Period 1|Adverse Event|1|||
164300819|NCT04050553|593476620|FG000|Period 1|Withdrawal by Subject|0|||
164300820|NCT04050553|593476621|FG001|Period 1|Withdrawal by Subject|1|||
164300821|NCT04050553|593476620|FG000|Wash-out|Adverse Event|0|||
164300822|NCT04050553|593476621|FG001|Wash-out|Adverse Event|1|||
164300823|NCT04050553|593476620|FG000|Wash-out|Withdrawal by Subject|0|||
164300824|NCT04050553|593476621|FG001|Wash-out|Withdrawal by Subject|1|||
164300825|NCT01535040|593476622|FG000|Overall Study|Physician Decision|0|||
164300826|NCT01535040|593476623|FG001|Overall Study|Physician Decision|1|||
164300827|NCT01535040|593476622|FG000|Overall Study|Withdrawal by Subject|13|||
164300828|NCT01535040|593476623|FG001|Overall Study|Withdrawal by Subject|10|||
164300829|NCT01535040|593476622|FG000|Overall Study|Never Started|9|||
164300830|NCT01535040|593476623|FG001|Overall Study|Never Started|4|||
164300831|NCT01535040|593476622|FG000|Overall Study|Toxicity|7|||
164300832|NCT01535040|593476623|FG001|Overall Study|Toxicity|5|||
164300833|NCT01535040|593476622|FG000|Overall Study|Multiple Reasons|1|||
164300834|NCT01535040|593476623|FG001|Overall Study|Multiple Reasons|1|||
164300835|NCT02023086|593476629|FG000|Overall Study|Withdrawal by Subject|2|||
164300836|NCT02023086|593476630|FG001|Overall Study|Withdrawal by Subject|0|||
164300837|NCT04607005|593476631|FG000|Overall Study|Adverse Event|0|||
164300838|NCT04607005|593476632|FG001|Overall Study|Adverse Event|1|||
164300839|NCT04607005|593476631|FG000|Overall Study|Lack of Efficacy|1|||
164300840|NCT04607005|593476632|FG001|Overall Study|Lack of Efficacy|6|||
164300841|NCT04607005|593476631|FG000|Overall Study|Withdrawal by Subject|4|||
164300842|NCT04607005|593476632|FG001|Overall Study|Withdrawal by Subject|9|||
164300843|NCT04607005|593476631|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
164300844|NCT04607005|593476632|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
164300845|NCT03589859|593476635|FG000|Overall Study|Withdrawal by Subject|0|||
164300846|NCT03589859|593476636|FG001|Overall Study|Withdrawal by Subject|6|||
164300847|NCT03043794|593476639|FG000|Overall Study|Lost to Follow-up|1|||
164300848|NCT00626106|593476641|FG000|Overall Study|Withdrawal by Subject|2|||
164300849|NCT00626106|593476642|FG001|Overall Study|Withdrawal by Subject|1|||
164300850|NCT00626106|593476641|FG000|Overall Study|Lost to Follow-up|1|||
164300851|NCT00626106|593476642|FG001|Overall Study|Lost to Follow-up|4|||
164300852|NCT00626106|593476641|FG000|Overall Study|Death|64|||
164300853|NCT00626106|593476642|FG001|Overall Study|Death|19|||
164300854|NCT03472885|593476643|FG000|24-Week Treatment Period|Adverse Event|1|||
164300855|NCT05417438|593476644|FG000|Overall Study|Withdrawal by Subject|3|||
164300856|NCT02201953|593476649|FG000|Overall Study|Randomized but Never Treated|1|||
164300857|NCT02201953|593476650|FG001|Overall Study|Randomized but Never Treated|5|||
164300858|NCT02201953|593476649|FG000|Overall Study|Lack of Efficacy|9|||
164300859|NCT02201953|593476650|FG001|Overall Study|Lack of Efficacy|30|||
164300860|NCT02201953|593476649|FG000|Overall Study|Lost to Follow-up|8|||
164300861|NCT02201953|593476650|FG001|Overall Study|Lost to Follow-up|8|||
164300862|NCT02201953|593476649|FG000|Overall Study|Withdrew Consent|2|||
164300863|NCT02201953|593476650|FG001|Overall Study|Withdrew Consent|5|||
164300864|NCT02201953|593476649|FG000|Overall Study|Adverse Event|0|||
164300865|NCT02201953|593476650|FG001|Overall Study|Adverse Event|5|||
164300866|NCT02201953|593476649|FG000|Overall Study|Death|0|||
164300867|NCT02201953|593476650|FG001|Overall Study|Death|3|||
164300868|NCT02079246|593478348|FG000|OLEX|Withdrawal before treatment|1|||
164300869|NCT02079246|593478349|FG001|OLEX|Withdrawal before treatment|0|||
164300870|NCT02079246|593478348|FG000|OLEX|Death|11|||
164300871|NCT02079246|593478349|FG001|OLEX|Death|0|||
164300872|NCT02079246|593478348|FG000|OLEX|Adverse Event|66|||
164300873|NCT02079246|593478349|FG001|OLEX|Adverse Event|0|||
164300874|NCT02079246|593478348|FG000|OLEX|Withdrawal by Subject|60|||
164300875|NCT02079246|593478349|FG001|OLEX|Withdrawal by Subject|0|||
164300876|NCT02079246|593478348|FG000|OLEX|Lost to Follow-up|6|||
164300877|NCT02079246|593478349|FG001|OLEX|Lost to Follow-up|0|||
164300878|NCT02079246|593478348|FG000|OLEX|Protocol Violation|6|||
164300879|NCT02079246|593478349|FG001|OLEX|Protocol Violation|0|||
164300880|NCT02079246|593478348|FG000|OLEX|Lack of Efficacy|3|||
164300881|NCT02079246|593478349|FG001|OLEX|Lack of Efficacy|0|||
164300882|NCT02079246|593478348|FG000|OLEX|Results of the lead-in studies|58|||
164300883|NCT02079246|593478349|FG001|OLEX|Results of the lead-in studies|0|||
164300884|NCT02079246|593478348|FG000|OLEX|Other: Disallowed medication|8|||
164300885|NCT02079246|593478349|FG001|OLEX|Other: Disallowed medication|0|||
164300886|NCT02079246|593478348|FG000|OLEX|Other: Insufficient compliance|2|||
164300887|NCT02079246|593478349|FG001|OLEX|Other: Insufficient compliance|0|||
164300888|NCT02079246|593478348|FG000|OLEX|Other: Caregiver unavailable|3|||
164300889|NCT02079246|593478349|FG001|OLEX|Other: Caregiver unavailable|0|||
164300890|NCT02079246|593478348|FG000|OLEX|Other: Coordinator decision|1|||
164300891|NCT02079246|593478349|FG001|OLEX|Other: Coordinator decision|0|||
164300892|NCT02079246|593478348|FG000|OLEX|Other: Worsening of condition|1|||
164300893|NCT02079246|593478349|FG001|OLEX|Other: Worsening of condition|0|||
164300894|NCT02079246|593478348|FG000|OLEX|Other: Moved to nursing home|1|||
164300895|NCT02079246|593478349|FG001|OLEX|Other: Moved to nursing home|0|||
164300896|NCT02079246|593478348|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
164300897|NCT02079246|593478349|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
164300898|NCT02079246|593478348|FG000|OLEX-MEM|Adverse Event|0|||
164300899|NCT02079246|593478349|FG001|OLEX-MEM|Adverse Event|6|||
164300900|NCT02079246|593478348|FG000|OLEX-MEM|Withdrawal by Subject|0|||
164300901|NCT02079246|593478349|FG001|OLEX-MEM|Withdrawal by Subject|7|||
164300902|NCT02079246|593478348|FG000|OLEX-MEM|Protocol Violation|0|||
164300903|NCT02079246|593478349|FG001|OLEX-MEM|Protocol Violation|2|||
164300904|NCT02079246|593478348|FG000|OLEX-MEM|Lost to Follow-up|0|||
164300905|NCT02079246|593478349|FG001|OLEX-MEM|Lost to Follow-up|1|||
164300906|NCT02079246|593478348|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
164300907|NCT02079246|593478349|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
164300908|NCT01712399|593478358|FG000|Overall Study|Lost to Follow-up|1|||
164300909|NCT01712399|593478358|FG000|Overall Study|Withdrawal by Subject|39|||
164300910|NCT01712399|593478358|FG000|Overall Study|Death|1|||
164300911|NCT01712399|593478358|FG000|Overall Study|Adverse Event|11|||
164300912|NCT01712399|593478358|FG000|Overall Study|Study closure|345|||
164300913|NCT01803607|593478360|FG000|Overall Study|Adverse Event|5|||
164300914|NCT01803607|593478361|FG001|Overall Study|Adverse Event|3|||
164300915|NCT01803607|593478360|FG000|Overall Study|Lack of Efficacy|0|||
164300916|NCT01803607|593478361|FG001|Overall Study|Lack of Efficacy|1|||
164300917|NCT01803607|593478360|FG000|Overall Study|Protocol Violation|3|||
164300918|NCT01803607|593478361|FG001|Overall Study|Protocol Violation|2|||
164300919|NCT01803607|593478360|FG000|Overall Study|Study terminated by sponsor|54|||
164300920|NCT01803607|593478361|FG001|Overall Study|Study terminated by sponsor|56|||
164300921|NCT01803607|593478360|FG000|Overall Study|Withdrawal by Subject|6|||
164300922|NCT01803607|593478361|FG001|Overall Study|Withdrawal by Subject|5|||
164300923|NCT03077412|593478362|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
164300924|NCT03077412|593478363|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
164300925|NCT03077412|593478364|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
164300926|NCT03077412|593478362|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
164300927|NCT03077412|593478363|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
164599920|NCT02358369|594556400|FG000|Treatment Period A/B|Adverse Event|0|||
164599921|NCT02358369|594556401|FG001|Treatment Period A/B|Adverse Event|0|||
164599922|NCT02358369|594556402|FG002|Treatment Period A/B|Adverse Event|1|||
164599923|NCT02358369|594556403|FG003|Treatment Period A/B|Adverse Event|2|||
164300928|NCT03077412|593478364|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
164300929|NCT03077412|593478362|FG000|Overall Study|Adverse Event|1|||
164300930|NCT03077412|593478363|FG001|Overall Study|Adverse Event|2|||
164300931|NCT03077412|593478364|FG002|Overall Study|Adverse Event|2|||
164300932|NCT03077412|593478362|FG000|Overall Study|Investigator's Discretion|0|||
164300933|NCT03077412|593478363|FG001|Overall Study|Investigator's Discretion|1|||
164300934|NCT03077412|593478364|FG002|Overall Study|Investigator's Discretion|1|||
164300935|NCT03077412|593478362|FG000|Overall Study|Withdrew Consent|0|||
164300936|NCT03077412|593478363|FG001|Overall Study|Withdrew Consent|2|||
164300937|NCT03077412|593478364|FG002|Overall Study|Withdrew Consent|0|||
164300938|NCT03038100|593478378|FG000|Overall Study|Death|289|||
164300939|NCT03038100|593478379|FG001|Overall Study|Death|272|||
164300940|NCT03038100|593478378|FG000|Overall Study|Lost to Follow-up|9|||
164300941|NCT03038100|593478379|FG001|Overall Study|Lost to Follow-up|10|||
164300942|NCT03038100|593478378|FG000|Overall Study|Protocol Deviation|1|||
164300943|NCT03038100|593478379|FG001|Overall Study|Protocol Deviation|4|||
164300944|NCT03038100|593478378|FG000|Overall Study|Withdrawal by Subject|45|||
164300945|NCT03038100|593478379|FG001|Overall Study|Withdrawal by Subject|51|||
164300946|NCT03038100|593478378|FG000|Overall Study|Study Terminated By Sponsor|305|||
164300947|NCT03038100|593478379|FG001|Overall Study|Study Terminated By Sponsor|311|||
164300948|NCT03038100|593478378|FG000|Overall Study|Physician Decision|1|||
164300949|NCT03038100|593478379|FG001|Overall Study|Physician Decision|3|||
164300950|NCT00918255|593478380|FG000|Overall Study|Adverse Event|1|||
164300951|NCT00918255|593478381|FG001|Overall Study|Adverse Event|0|||
164300952|NCT00918255|593478382|FG002|Overall Study|Adverse Event|0|||
164300953|NCT00918255|593478380|FG000|Overall Study|Withdrawal by Subject|1|||
164300954|NCT00918255|593478381|FG001|Overall Study|Withdrawal by Subject|0|||
164300955|NCT00918255|593478382|FG002|Overall Study|Withdrawal by Subject|2|||
164300956|NCT00918255|593478380|FG000|Overall Study|Lack of Efficacy|1|||
164300957|NCT00918255|593478381|FG001|Overall Study|Lack of Efficacy|0|||
164300958|NCT00918255|593478382|FG002|Overall Study|Lack of Efficacy|0|||
164300959|NCT00918255|593478380|FG000|Overall Study|Lost to Follow-up|1|||
164300960|NCT00918255|593478381|FG001|Overall Study|Lost to Follow-up|0|||
164300961|NCT00918255|593478382|FG002|Overall Study|Lost to Follow-up|2|||
164300962|NCT00918255|593478380|FG000|Overall Study|Exceeded allowed number of interventions|0|||
164300963|NCT00918255|593478381|FG001|Overall Study|Exceeded allowed number of interventions|0|||
164300964|NCT00918255|593478382|FG002|Overall Study|Exceeded allowed number of interventions|1|||
164300965|NCT00918255|593478380|FG000|Overall Study|Non-compliance|1|||
164300966|NCT00918255|593478381|FG001|Overall Study|Non-compliance|0|||
164300967|NCT00918255|593478382|FG002|Overall Study|Non-compliance|0|||
164300968|NCT00918255|593478380|FG000|Overall Study|Investigator discretion|1|||
164300969|NCT00918255|593478381|FG001|Overall Study|Investigator discretion|0|||
164300970|NCT00918255|593478382|FG002|Overall Study|Investigator discretion|0|||
164300971|NCT02392624|593478383|FG000|Overall Study|Withdrawal by Subject|15|||
164300972|NCT02392624|593478384|FG001|Overall Study|Withdrawal by Subject|12|||
164300973|NCT02392624|593478385|FG002|Overall Study|Withdrawal by Subject|9|||
164300974|NCT02392624|593478383|FG000|Overall Study|Adverse Event|4|||
164300975|NCT02392624|593478384|FG001|Overall Study|Adverse Event|1|||
164300976|NCT02392624|593478385|FG002|Overall Study|Adverse Event|2|||
164300977|NCT02392624|593478383|FG000|Overall Study|Pregnancy|1|||
164475642|NCT04436289|594112709|FG001|Overall Study|Lost to Follow-up|4|||
164475643|NCT04436289|594112710|FG002|Overall Study|Lost to Follow-up|1|||
164475644|NCT04436289|594112711|FG003|Overall Study|Lost to Follow-up|3|||
164475645|NCT02928172|594112713|FG000|Overall Study|Device did not record data|1|||
164475646|NCT02408887|594112714|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
164475647|NCT02408887|594112715|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
164475648|NCT02408887|594112714|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
164475649|NCT02408887|594112715|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
164475650|NCT03357952|594112722|FG000|Overall Study|Withdrawal by Subject|0|||
164475651|NCT03357952|594112723|FG001|Overall Study|Withdrawal by Subject|1|||
164475652|NCT03357952|594112722|FG000|Overall Study|Sponsor Decision|9|||
164475653|NCT03357952|594112723|FG001|Overall Study|Sponsor Decision|0|||
164475654|NCT03598907|594112724|FG000|Overall Study|Physician Decision|14|||
164475655|NCT03598907|594112725|FG001|Overall Study|Physician Decision|19|||
164475656|NCT01675492|594112728|FG000|Overall Study|study completed early - product approval|42|||
164475657|NCT04517435|594112745|FG000|Overall Study|Withdrawal by Subject|0|||
164475658|NCT04517435|594112746|FG001|Overall Study|Withdrawal by Subject|0|||
164475659|NCT04517435|594112747|FG002|Overall Study|Withdrawal by Subject|1|||
164475660|NCT04517435|594112745|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
164475661|NCT04517435|594112746|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
164475662|NCT04517435|594112747|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
164475663|NCT03656718|594112748|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
164475664|NCT03656718|594112749|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
164475665|NCT03656718|594112750|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
164599924|NCT02358369|594556404|FG004|Treatment Period A/B|Adverse Event|0|||
164714144|NCT03888066|594976821|FG001|Run-in Phase|Randomization Criterion #2|0|||
164475666|NCT03656718|594112751|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
164475667|NCT03656718|594112752|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
164475668|NCT03656718|594112753|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
164475669|NCT03656718|594112754|FG006|Treatment Period Parts A, B, D, and E|Disease progression|21|||
164475670|NCT03656718|594112748|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
164475671|NCT03656718|594112749|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
164475672|NCT03656718|594112750|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
164475673|NCT03656718|594112751|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
164475674|NCT03656718|594112752|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
164475675|NCT03656718|594112753|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
164475676|NCT03656718|594112754|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
164475677|NCT03656718|594112748|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
164475678|NCT03656718|594112749|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
164475679|NCT03656718|594112750|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
164475680|NCT03656718|594112751|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
164475681|NCT03656718|594112752|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
164475682|NCT03656718|594112753|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
164475683|NCT03656718|594112754|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
164475684|NCT03656718|594112748|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
164475685|NCT03656718|594112749|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
164475686|NCT03656718|594112750|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
164475687|NCT03656718|594112751|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
164475688|NCT03656718|594112752|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
164475689|NCT03656718|594112753|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
164475690|NCT03656718|594112754|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|1|||
164475691|NCT03656718|594112748|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
164475692|NCT03656718|594112749|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
164475693|NCT03656718|594112750|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
164475694|NCT03656718|594112751|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
164475695|NCT03656718|594112752|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
164475696|NCT03656718|594112753|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
164475697|NCT03656718|594112754|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|2|||
164475698|NCT03656718|594112748|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
164475699|NCT03656718|594112749|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
164475700|NCT03656718|594112750|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
164475701|NCT03656718|594112751|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
164475702|NCT03656718|594112752|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
164475703|NCT03656718|594112753|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
164475704|NCT03656718|594112754|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
164475705|NCT03656718|594112748|FG000|Treatment Period Part C|Disease progression|0|||
164475706|NCT03656718|594112749|FG001|Treatment Period Part C|Disease progression|0|||
164475707|NCT03656718|594112750|FG002|Treatment Period Part C|Disease progression|0|||
164475708|NCT03656718|594112751|FG003|Treatment Period Part C|Disease progression|0|||
164475709|NCT03656718|594112752|FG004|Treatment Period Part C|Disease progression|12|||
164475710|NCT03656718|594112753|FG005|Treatment Period Part C|Disease progression|0|||
164475711|NCT03656718|594112754|FG006|Treatment Period Part C|Disease progression|0|||
164475712|NCT03656718|594112748|FG000|Treatment Period Part C|Death|0|||
164475713|NCT03656718|594112749|FG001|Treatment Period Part C|Death|0|||
164475714|NCT03656718|594112750|FG002|Treatment Period Part C|Death|0|||
164475715|NCT03656718|594112751|FG003|Treatment Period Part C|Death|0|||
164475716|NCT03656718|594112752|FG004|Treatment Period Part C|Death|1|||
164475717|NCT03656718|594112753|FG005|Treatment Period Part C|Death|0|||
164475718|NCT03656718|594112754|FG006|Treatment Period Part C|Death|0|||
164475719|NCT03656718|594112748|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
164475720|NCT03656718|594112749|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
164475721|NCT03656718|594112750|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
164475722|NCT03656718|594112751|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
164475723|NCT03656718|594112752|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
164475724|NCT03656718|594112753|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
164475725|NCT03656718|594112754|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
164475726|NCT03656718|594112748|FG000|Treatment Period Part C|Other reasons|0|||
164475727|NCT03656718|594112749|FG001|Treatment Period Part C|Other reasons|0|||
164475728|NCT03656718|594112750|FG002|Treatment Period Part C|Other reasons|0|||
164475729|NCT03656718|594112751|FG003|Treatment Period Part C|Other reasons|0|||
164475730|NCT03656718|594112752|FG004|Treatment Period Part C|Other reasons|1|||
164475731|NCT03656718|594112753|FG005|Treatment Period Part C|Other reasons|0|||
164475732|NCT03656718|594112754|FG006|Treatment Period Part C|Other reasons|0|||
164475733|NCT03656718|594112748|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
164475734|NCT03656718|594112749|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
164475735|NCT03656718|594112750|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
164475736|NCT03656718|594112751|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
164475737|NCT03656718|594112752|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
164475738|NCT03656718|594112753|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
164475739|NCT03656718|594112754|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
164475740|NCT06191679|594112755|FG000|Baseline|Lost to Follow-up|1|||
164475741|NCT06191679|594112756|FG001|Baseline|Lost to Follow-up|0|||
164475742|NCT06191679|594112757|FG002|Baseline|Lost to Follow-up|1|||
164475743|NCT06191679|594112758|FG003|Baseline|Lost to Follow-up|0|||
164475744|NCT06191679|594112755|FG000|Allocation to Group|Withdrawal by Subject|0|||
164475745|NCT06191679|594112756|FG001|Allocation to Group|Withdrawal by Subject|1|||
164475746|NCT06191679|594112757|FG002|Allocation to Group|Withdrawal by Subject|2|||
164475747|NCT06191679|594112758|FG003|Allocation to Group|Withdrawal by Subject|0|||
164475748|NCT06191679|594112755|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
164475749|NCT06191679|594112756|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
164475750|NCT06191679|594112757|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
164475751|NCT06191679|594112758|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
164475752|NCT06191679|594112755|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
164475753|NCT06191679|594112756|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
164475754|NCT06191679|594112757|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
164475755|NCT06191679|594112758|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
164475756|NCT06191679|594112755|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
164475757|NCT06191679|594112756|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
164475758|NCT06191679|594112757|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
164475759|NCT06191679|594112758|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
164532255|NCT01630434|594320506|FG000|Overall Study|Donor lungs turned down|1|||
164532256|NCT01630434|594320507|FG001|Overall Study|Donor lungs turned down|0|||
164532257|NCT01630434|594320506|FG000|Overall Study|Protocol Violation|9|||
164532258|NCT01630434|594320507|FG001|Overall Study|Protocol Violation|4|||
164532259|NCT01630434|594320506|FG000|Overall Study|Death|20|||
164532260|NCT01630434|594320507|FG001|Overall Study|Death|26|||
164532261|NCT00687973|594320508|FG000|Overall Study|Adverse Event|18|||
164532262|NCT00687973|594320509|FG001|Overall Study|Adverse Event|28|||
164532263|NCT00687973|594320508|FG000|Overall Study|Lack of Efficacy|2|||
164532264|NCT00687973|594320509|FG001|Overall Study|Lack of Efficacy|3|||
164532265|NCT00687973|594320508|FG000|Overall Study|Protocol Violation|1|||
164532266|NCT00687973|594320509|FG001|Overall Study|Protocol Violation|2|||
164532267|NCT00687973|594320508|FG000|Overall Study|Administrative Reasons|0|||
164532268|NCT00687973|594320509|FG001|Overall Study|Administrative Reasons|2|||
164532269|NCT00687973|594320508|FG000|Overall Study|Withdrawal by Subject|3|||
164532270|NCT00687973|594320509|FG001|Overall Study|Withdrawal by Subject|3|||
164532271|NCT00511472|594320515|FG000|Overall Study|Clinical Adverse Event|1|||
164532272|NCT00511472|594320516|FG001|Overall Study|Clinical Adverse Event|2|||
164532273|NCT00511472|594320515|FG000|Overall Study|Laboratory Adverse Event|0|||
164532274|NCT00511472|594320516|FG001|Overall Study|Laboratory Adverse Event|2|||
164532275|NCT00511472|594320515|FG000|Overall Study|Not reported|2|||
164532276|NCT00511472|594320516|FG001|Overall Study|Not reported|2|||
164532277|NCT01079741|594320517|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
164532278|NCT01079741|594320518|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
164532279|NCT01079741|594320519|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
164532280|NCT01079741|594320520|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
164532281|NCT01079741|594320521|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
164532282|NCT01079741|594320517|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
164532283|NCT01079741|594320518|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
164714145|NCT03888066|594976820|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
164714146|NCT03888066|594976821|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
164714147|NCT03888066|594976820|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
164714148|NCT03888066|594976821|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
164714149|NCT03888066|594976820|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
164532284|NCT01079741|594320519|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
164532285|NCT01079741|594320520|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
164532286|NCT01079741|594320521|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
164532287|NCT02075541|594320522|FG000|Overall Study|Serious Adverse Event|1|||
164532288|NCT02075541|594320523|FG001|Overall Study|Serious Adverse Event|4|||
164532289|NCT02075541|594320522|FG000|Overall Study|Protocol Violation|1|||
164532290|NCT02075541|594320523|FG001|Overall Study|Protocol Violation|0|||
164475760|NCT03116464|594114590|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
164475761|NCT00065182|594114599|FG000|Overall Study|Adverse Event|24|||
164475762|NCT00065182|594114600|FG001|Overall Study|Adverse Event|17|||
164475763|NCT00065182|594114599|FG000|Overall Study|Lost to Follow-up|0|||
164475764|NCT00065182|594114600|FG001|Overall Study|Lost to Follow-up|4|||
164475765|NCT00065182|594114599|FG000|Overall Study|Protocol Violation|3|||
164475766|NCT00065182|594114600|FG001|Overall Study|Protocol Violation|4|||
164475767|NCT00065182|594114599|FG000|Overall Study|Serious adverse events (SAE)|1|||
164475768|NCT00065182|594114600|FG001|Overall Study|Serious adverse events (SAE)|0|||
164475769|NCT00065182|594114599|FG000|Overall Study|Sponsor Decision|11|||
164475770|NCT00065182|594114600|FG001|Overall Study|Sponsor Decision|7|||
164475771|NCT00065182|594114599|FG000|Overall Study|Withdrawal by Subject|8|||
164475772|NCT00065182|594114600|FG001|Overall Study|Withdrawal by Subject|3|||
164475773|NCT00065182|594114599|FG000|Overall Study|No clinical benefit|1|||
164475774|NCT00065182|594114600|FG001|Overall Study|No clinical benefit|0|||
164475775|NCT00065182|594114599|FG000|Overall Study|Death|0|||
164475776|NCT00065182|594114600|FG001|Overall Study|Death|1|||
164475777|NCT00065182|594114599|FG000|Overall Study|Decline in Status|0|||
164475778|NCT00065182|594114600|FG001|Overall Study|Decline in Status|1|||
164475779|NCT02633215|594114601|FG000|Overall Study|Lost to Follow-up|2|||
164475780|NCT02633215|594114602|FG001|Overall Study|Lost to Follow-up|3|||
164475781|NCT02568215|594114603|FG000|Overall Study|Death|1|||
164475782|NCT02568215|594114604|FG001|Overall Study|Death|2|||
164475783|NCT02568215|594114605|FG002|Overall Study|Death|0|||
164475784|NCT02568215|594114603|FG000|Overall Study|Physician Decision|2|||
164475785|NCT02568215|594114604|FG001|Overall Study|Physician Decision|2|||
164475786|NCT02568215|594114605|FG002|Overall Study|Physician Decision|2|||
164475787|NCT02568215|594114603|FG000|Overall Study|Lost to Follow-up|29|||
164475788|NCT02568215|594114604|FG001|Overall Study|Lost to Follow-up|32|||
164475789|NCT02568215|594114605|FG002|Overall Study|Lost to Follow-up|41|||
164475790|NCT02568215|594114603|FG000|Overall Study|Withdrawal by Subject|21|||
164475791|NCT02568215|594114604|FG001|Overall Study|Withdrawal by Subject|19|||
164475792|NCT02568215|594114605|FG002|Overall Study|Withdrawal by Subject|22|||
164475793|NCT02568215|594114603|FG000|Overall Study|Protocol Violation|1|||
164475794|NCT02568215|594114604|FG001|Overall Study|Protocol Violation|1|||
164475795|NCT02568215|594114605|FG002|Overall Study|Protocol Violation|0|||
164475796|NCT02568215|594114603|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
164475797|NCT02568215|594114604|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
164475798|NCT02568215|594114605|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
164475799|NCT02568215|594114603|FG000|Overall Study|Other|0|||
164475800|NCT02568215|594114604|FG001|Overall Study|Other|1|||
164475801|NCT02568215|594114605|FG002|Overall Study|Other|4|||
164475802|NCT01641900|594114606|FG000|Overall Study|Withdrawal by Subject|2|||
164475803|NCT01641900|594114607|FG001|Overall Study|Withdrawal by Subject|2|||
164475804|NCT00263757|594114608|FG000|Overall Study|Withdrawal by Subject|5|||
164475805|NCT00263757|594114609|FG001|Overall Study|Withdrawal by Subject|4|||
164475806|NCT00263757|594114608|FG000|Overall Study|Screen failure|0|||
164475807|NCT00263757|594114609|FG001|Overall Study|Screen failure|1|||
164475808|NCT00263757|594114608|FG000|Overall Study|Adverse Event|3|||
164475809|NCT00263757|594114609|FG001|Overall Study|Adverse Event|3|||
164475810|NCT00713596|594114610|FG000|Overall Study|Study was terminated|2|||
164714150|NCT03888066|594976821|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
164714151|NCT03888066|594976820|FG000|Run-in Phase|Randomization Criterion #3|11|||
164475811|NCT00713596|594114611|FG001|Overall Study|Study was terminated|3|||
164475812|NCT00713596|594114612|FG002|Overall Study|Study was terminated|2|||
164475813|NCT03712371|594114613|FG000|Overall Study|Lack of Efficacy|0|||
164475814|NCT03712371|594114614|FG001|Overall Study|Lack of Efficacy|0|||
164475815|NCT03712371|594114615|FG002|Overall Study|Lack of Efficacy|0|||
164475816|NCT03712371|594114616|FG003|Overall Study|Lack of Efficacy|1|||
164475817|NCT01211184|594114621|FG000|Overall Study|Withdrawal by Subject|0|||
164475818|NCT01211184|594114622|FG001|Overall Study|Withdrawal by Subject|2|||
164475819|NCT01211184|594114623|FG002|Overall Study|Withdrawal by Subject|1|||
164475820|NCT01421667|594114624|FG000|Overall Study|Withdrawal by Subject|0|||
164475821|NCT01421667|594114625|FG001|Overall Study|Withdrawal by Subject|1|||
164475822|NCT01421667|594114626|FG002|Overall Study|Withdrawal by Subject|2|||
164475823|NCT01421667|594114627|FG003|Overall Study|Withdrawal by Subject|1|||
164475824|NCT01421667|594114624|FG000|Overall Study|Lost to Follow-up|0|||
164475825|NCT01421667|594114625|FG001|Overall Study|Lost to Follow-up|1|||
164475826|NCT01421667|594114626|FG002|Overall Study|Lost to Follow-up|0|||
164475827|NCT01421667|594114627|FG003|Overall Study|Lost to Follow-up|0|||
164475828|NCT00503906|594114628|FG000|Overall Study|Withdrawal by Subject|1|||
164475829|NCT05580003|594114629|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475830|NCT05580003|594114630|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475831|NCT05580003|594114631|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475832|NCT05580003|594114632|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475833|NCT05580003|594114633|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164714152|NCT03888066|594976821|FG001|Run-in Phase|Randomization Criterion #3|0|||
164475834|NCT05580003|594114634|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475835|NCT05580003|594114635|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
164475836|NCT05580003|594114636|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475837|NCT05580003|594114637|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475838|NCT05580003|594114638|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475839|NCT05580003|594114639|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475840|NCT05580003|594114640|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475841|NCT05580003|594114641|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475842|NCT05580003|594114642|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475843|NCT05580003|594114643|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475844|NCT05580003|594114644|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475845|NCT05580003|594114645|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475846|NCT05580003|594114646|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475847|NCT05580003|594114647|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475848|NCT05580003|594114648|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475849|NCT05580003|594114649|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475850|NCT05580003|594114650|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475851|NCT05580003|594114651|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475852|NCT05580003|594114652|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475853|NCT05580003|594114653|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475854|NCT05580003|594114654|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475855|NCT05580003|594114655|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475856|NCT05580003|594114656|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164475857|NCT05580003|594114629|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475858|NCT05580003|594114630|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475859|NCT05580003|594114631|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475860|NCT05580003|594114632|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475861|NCT05580003|594114633|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475862|NCT05580003|594114634|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
164475863|NCT05580003|594114635|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475864|NCT05580003|594114636|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475865|NCT05580003|594114637|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475866|NCT05580003|594114638|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475867|NCT05580003|594114639|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475868|NCT05580003|594114640|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475869|NCT05580003|594114641|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475870|NCT05580003|594114642|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475871|NCT05580003|594114643|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475872|NCT05580003|594114644|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475873|NCT05580003|594114645|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475874|NCT05580003|594114646|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475875|NCT05580003|594114647|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475876|NCT05580003|594114648|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475877|NCT05580003|594114649|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475878|NCT05580003|594114650|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475879|NCT05580003|594114651|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475880|NCT05580003|594114652|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475881|NCT05580003|594114653|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475882|NCT05580003|594114654|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475883|NCT05580003|594114655|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475884|NCT05580003|594114656|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164475885|NCT05580003|594114629|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475886|NCT05580003|594114630|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475887|NCT05580003|594114631|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475888|NCT05580003|594114632|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
164475889|NCT05580003|594114633|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475890|NCT05580003|594114634|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475891|NCT05580003|594114635|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475892|NCT05580003|594114636|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475893|NCT05580003|594114637|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475894|NCT05580003|594114638|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475895|NCT05580003|594114639|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475896|NCT05580003|594114640|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475897|NCT05580003|594114641|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164714153|NCT03888066|594976820|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
164714154|NCT03888066|594976821|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
164714155|NCT03888066|594976820|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
164714156|NCT03888066|594976821|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
164475898|NCT05580003|594114642|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475899|NCT05580003|594114643|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475900|NCT05580003|594114644|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475901|NCT05580003|594114645|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475902|NCT05580003|594114646|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475903|NCT05580003|594114647|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475904|NCT05580003|594114648|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475905|NCT05580003|594114649|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475906|NCT05580003|594114650|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475907|NCT05580003|594114651|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475908|NCT05580003|594114652|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475909|NCT05580003|594114653|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475910|NCT05580003|594114654|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475911|NCT05580003|594114655|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475912|NCT05580003|594114656|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
164475913|NCT05580003|594114629|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475914|NCT05580003|594114630|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
164475915|NCT05580003|594114631|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475916|NCT05580003|594114632|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475917|NCT05580003|594114633|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475918|NCT05580003|594114634|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475919|NCT05580003|594114635|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475920|NCT05580003|594114636|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475921|NCT05580003|594114637|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475922|NCT05580003|594114638|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475923|NCT05580003|594114639|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475924|NCT05580003|594114640|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475925|NCT05580003|594114641|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475926|NCT05580003|594114642|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475927|NCT05580003|594114643|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475928|NCT05580003|594114644|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475929|NCT05580003|594114645|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475930|NCT05580003|594114646|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475931|NCT05580003|594114647|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164714157|NCT03888066|594976820|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
164714158|NCT03888066|594976821|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
164714159|NCT03888066|594976820|FG000|Run-in Phase|Randomization Criterion #4|3|||
164714160|NCT03888066|594976821|FG001|Run-in Phase|Randomization Criterion #4|0|||
164714161|NCT03888066|594976820|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
164714162|NCT03888066|594976821|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
164714163|NCT03888066|594976820|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
164714164|NCT03888066|594976821|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
164714165|NCT03888066|594976820|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
164714166|NCT03888066|594976821|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
164714167|NCT03888066|594976820|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
164714168|NCT03888066|594976821|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
164475932|NCT05580003|594114648|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475933|NCT05580003|594114649|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475934|NCT05580003|594114650|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475935|NCT05580003|594114651|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475936|NCT05580003|594114652|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475937|NCT05580003|594114653|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475938|NCT05580003|594114654|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475939|NCT05580003|594114655|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164475940|NCT05580003|594114656|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164714169|NCT03888066|594976820|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
164475941|NCT05580003|594114629|FG000|Part 2 (up to 10 Days)|Other|0|||
164475942|NCT05580003|594114630|FG001|Part 2 (up to 10 Days)|Other|0|||
164475943|NCT05580003|594114631|FG002|Part 2 (up to 10 Days)|Other|0|||
164475944|NCT05580003|594114632|FG003|Part 2 (up to 10 Days)|Other|0|||
164475945|NCT05580003|594114633|FG004|Part 2 (up to 10 Days)|Other|0|||
164475946|NCT05580003|594114634|FG005|Part 2 (up to 10 Days)|Other|0|||
164475947|NCT05580003|594114635|FG006|Part 2 (up to 10 Days)|Other|0|||
164475948|NCT05580003|594114636|FG007|Part 2 (up to 10 Days)|Other|0|||
164475949|NCT05580003|594114637|FG008|Part 2 (up to 10 Days)|Other|0|||
164475950|NCT05580003|594114638|FG009|Part 2 (up to 10 Days)|Other|1|||
164475951|NCT05580003|594114639|FG010|Part 2 (up to 10 Days)|Other|0|||
164475952|NCT05580003|594114640|FG011|Part 2 (up to 10 Days)|Other|0|||
164475953|NCT05580003|594114641|FG012|Part 2 (up to 10 Days)|Other|0|||
164475954|NCT05580003|594114642|FG013|Part 2 (up to 10 Days)|Other|0|||
164475955|NCT05580003|594114643|FG014|Part 2 (up to 10 Days)|Other|0|||
164475956|NCT05580003|594114644|FG015|Part 2 (up to 10 Days)|Other|0|||
164475957|NCT05580003|594114645|FG016|Part 2 (up to 10 Days)|Other|0|||
164475958|NCT05580003|594114646|FG017|Part 2 (up to 10 Days)|Other|0|||
164475959|NCT05580003|594114647|FG018|Part 2 (up to 10 Days)|Other|0|||
164475960|NCT05580003|594114648|FG019|Part 2 (up to 10 Days)|Other|0|||
164475961|NCT05580003|594114649|FG020|Part 2 (up to 10 Days)|Other|0|||
164475962|NCT05580003|594114650|FG021|Part 2 (up to 10 Days)|Other|0|||
164475963|NCT05580003|594114651|FG022|Part 2 (up to 10 Days)|Other|0|||
164475964|NCT05580003|594114652|FG023|Part 2 (up to 10 Days)|Other|0|||
164475965|NCT05580003|594114653|FG024|Part 2 (up to 10 Days)|Other|0|||
164475966|NCT05580003|594114654|FG025|Part 2 (up to 10 Days)|Other|0|||
164475967|NCT05580003|594114655|FG026|Part 2 (up to 10 Days)|Other|0|||
164475968|NCT05580003|594114656|FG027|Part 2 (up to 10 Days)|Other|0|||
164475969|NCT05580003|594114629|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475970|NCT05580003|594114630|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475971|NCT05580003|594114631|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475972|NCT05580003|594114632|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475973|NCT05580003|594114633|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475974|NCT05580003|594114634|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475975|NCT05580003|594114635|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475976|NCT05580003|594114636|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475977|NCT05580003|594114637|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475978|NCT05580003|594114638|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475979|NCT05580003|594114639|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475980|NCT05580003|594114640|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475981|NCT05580003|594114641|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475982|NCT05580003|594114642|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475983|NCT05580003|594114643|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475984|NCT05580003|594114644|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475985|NCT05580003|594114645|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475986|NCT05580003|594114646|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475987|NCT05580003|594114647|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475988|NCT05580003|594114648|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
164475989|NCT05580003|594114649|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475990|NCT05580003|594114650|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475991|NCT05580003|594114651|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475992|NCT05580003|594114652|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475993|NCT05580003|594114653|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475994|NCT05580003|594114654|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475995|NCT05580003|594114655|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475996|NCT05580003|594114656|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164475997|NCT05580003|594114629|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164475998|NCT05580003|594114630|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164475999|NCT05580003|594114631|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164476000|NCT05580003|594114632|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164476001|NCT05580003|594114633|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164476002|NCT05580003|594114634|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164476003|NCT05580003|594114635|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164476004|NCT05580003|594114636|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164476005|NCT05580003|594114637|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164476006|NCT05580003|594114638|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164476007|NCT05580003|594114639|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164476008|NCT05580003|594114640|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164476009|NCT05580003|594114641|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164476010|NCT05580003|594114642|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164476011|NCT05580003|594114643|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164476012|NCT05580003|594114644|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164476013|NCT05580003|594114645|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164476014|NCT05580003|594114646|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164476015|NCT05580003|594114647|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164476016|NCT05580003|594114648|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164476017|NCT05580003|594114649|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
164476018|NCT05580003|594114650|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164599925|NCT02358369|594556400|FG000|Treatment Period A/B|Death|0|||
164476019|NCT05580003|594114651|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164476020|NCT05580003|594114652|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164476021|NCT05580003|594114653|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164476022|NCT05580003|594114654|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164476023|NCT05580003|594114655|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164476024|NCT05580003|594114656|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164476025|NCT05580003|594114629|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476026|NCT05580003|594114630|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476027|NCT05580003|594114631|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476028|NCT05580003|594114632|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476029|NCT05580003|594114633|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476030|NCT05580003|594114634|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476031|NCT05580003|594114635|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476032|NCT05580003|594114636|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476033|NCT05580003|594114637|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476034|NCT05580003|594114638|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476035|NCT05580003|594114639|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476036|NCT05580003|594114640|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476037|NCT05580003|594114641|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476038|NCT05580003|594114642|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476039|NCT05580003|594114643|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476040|NCT05580003|594114644|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476041|NCT05580003|594114645|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476042|NCT05580003|594114646|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476043|NCT05580003|594114647|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476044|NCT05580003|594114648|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476045|NCT05580003|594114649|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476046|NCT05580003|594114650|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
164476047|NCT05580003|594114651|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476048|NCT05580003|594114652|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476049|NCT05580003|594114653|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476050|NCT05580003|594114654|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476051|NCT05580003|594114655|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476052|NCT05580003|594114656|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164476053|NCT05580003|594114629|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476054|NCT05580003|594114630|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476055|NCT05580003|594114631|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476056|NCT05580003|594114632|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476057|NCT05580003|594114633|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476058|NCT05580003|594114634|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476059|NCT05580003|594114635|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476060|NCT05580003|594114636|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476061|NCT05580003|594114637|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476062|NCT05580003|594114638|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476063|NCT05580003|594114639|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476064|NCT05580003|594114640|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476065|NCT05580003|594114641|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476066|NCT05580003|594114642|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476067|NCT05580003|594114643|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476068|NCT05580003|594114644|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476069|NCT05580003|594114645|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476070|NCT05580003|594114646|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476071|NCT05580003|594114647|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476072|NCT05580003|594114648|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476073|NCT05580003|594114649|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476074|NCT05580003|594114650|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476075|NCT05580003|594114651|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476076|NCT05580003|594114652|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476077|NCT05580003|594114653|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476078|NCT05580003|594114654|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476079|NCT05580003|594114655|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164476080|NCT05580003|594114656|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
164476081|NCT05580003|594114629|FG000|Part 6 Period 2 (Day 1)|Other|0|||
164476082|NCT05580003|594114630|FG001|Part 6 Period 2 (Day 1)|Other|0|||
164476083|NCT05580003|594114631|FG002|Part 6 Period 2 (Day 1)|Other|0|||
164714170|NCT03888066|594976821|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
164714171|NCT03888066|594976820|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
164714172|NCT03888066|594976821|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
164714173|NCT03888066|594976820|FG000|Run-in Phase|AE (Adverse Event)|17|||
164476084|NCT05580003|594114632|FG003|Part 6 Period 2 (Day 1)|Other|0|||
164476085|NCT05580003|594114633|FG004|Part 6 Period 2 (Day 1)|Other|0|||
164476086|NCT05580003|594114634|FG005|Part 6 Period 2 (Day 1)|Other|0|||
164476087|NCT05580003|594114635|FG006|Part 6 Period 2 (Day 1)|Other|0|||
164476088|NCT05580003|594114636|FG007|Part 6 Period 2 (Day 1)|Other|0|||
164476089|NCT05580003|594114637|FG008|Part 6 Period 2 (Day 1)|Other|0|||
164476090|NCT05580003|594114638|FG009|Part 6 Period 2 (Day 1)|Other|0|||
164476091|NCT05580003|594114639|FG010|Part 6 Period 2 (Day 1)|Other|0|||
164476092|NCT05580003|594114640|FG011|Part 6 Period 2 (Day 1)|Other|0|||
164476093|NCT05580003|594114641|FG012|Part 6 Period 2 (Day 1)|Other|0|||
164476094|NCT05580003|594114642|FG013|Part 6 Period 2 (Day 1)|Other|0|||
164476095|NCT05580003|594114643|FG014|Part 6 Period 2 (Day 1)|Other|0|||
164476096|NCT05580003|594114644|FG015|Part 6 Period 2 (Day 1)|Other|0|||
164476097|NCT05580003|594114645|FG016|Part 6 Period 2 (Day 1)|Other|0|||
164476098|NCT05580003|594114646|FG017|Part 6 Period 2 (Day 1)|Other|0|||
164476099|NCT05580003|594114647|FG018|Part 6 Period 2 (Day 1)|Other|0|||
164476100|NCT05580003|594114648|FG019|Part 6 Period 2 (Day 1)|Other|0|||
164476101|NCT05580003|594114649|FG020|Part 6 Period 2 (Day 1)|Other|0|||
164476102|NCT05580003|594114650|FG021|Part 6 Period 2 (Day 1)|Other|0|||
164476103|NCT05580003|594114651|FG022|Part 6 Period 2 (Day 1)|Other|0|||
164476104|NCT05580003|594114652|FG023|Part 6 Period 2 (Day 1)|Other|0|||
164476105|NCT05580003|594114653|FG024|Part 6 Period 2 (Day 1)|Other|1|||
164476106|NCT05580003|594114654|FG025|Part 6 Period 2 (Day 1)|Other|0|||
164476107|NCT05580003|594114655|FG026|Part 6 Period 2 (Day 1)|Other|0|||
164476108|NCT05580003|594114656|FG027|Part 6 Period 2 (Day 1)|Other|0|||
164476109|NCT03516812|594114657|FG000|Overall Study|Adverse Event|4|||
164476110|NCT03516812|594114657|FG000|Overall Study|Lack of Efficacy|2|||
164476111|NCT03840902|594114658|FG000|Overall Study|Randomized but not treated|1|||
164476112|NCT03840902|594114659|FG001|Overall Study|Randomized but not treated|1|||
164476113|NCT02392234|594114660|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
164476114|NCT02392234|594114661|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
164476115|NCT02392234|594114662|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
164476116|NCT02392234|594114663|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
164476117|NCT02392234|594114664|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
164476118|NCT02392234|594114665|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
164476119|NCT02392234|594114660|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
164476120|NCT02392234|594114661|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
164476121|NCT02392234|594114662|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
164476122|NCT02392234|594114663|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
164476123|NCT02392234|594114664|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
164476124|NCT02392234|594114665|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
164476125|NCT02392234|594114660|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
164476126|NCT02392234|594114661|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
164476127|NCT02392234|594114662|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
164476128|NCT02392234|594114663|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
164476129|NCT02392234|594114664|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
164476130|NCT02392234|594114665|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
164476131|NCT02392234|594114660|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
164476132|NCT02392234|594114661|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
164476133|NCT02392234|594114662|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
164476134|NCT02392234|594114663|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
164476135|NCT02392234|594114664|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
164476136|NCT02392234|594114665|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
164476137|NCT02392234|594114660|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
164476138|NCT02392234|594114661|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
164476139|NCT02392234|594114662|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
164476140|NCT02392234|594114663|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
164476141|NCT02392234|594114664|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
164476142|NCT02392234|594114665|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
164476143|NCT02392234|594114660|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
164476144|NCT02392234|594114661|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
164476145|NCT02392234|594114662|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
164476146|NCT02392234|594114663|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
164476147|NCT02392234|594114664|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
164476148|NCT02392234|594114665|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
164476149|NCT02392234|594114660|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
164476150|NCT02392234|594114661|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
164476151|NCT02392234|594114662|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
164476152|NCT02392234|594114663|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
164476153|NCT02392234|594114664|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
164476154|NCT02392234|594114665|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
164476155|NCT02392234|594114660|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
164476156|NCT02392234|594114661|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
164476157|NCT02392234|594114662|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
164476158|NCT02392234|594114663|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
164476159|NCT02392234|594114664|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
164476160|NCT02392234|594114665|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
164476161|NCT02816398|594114670|FG000|Overall Study|Death|5|||
164476162|NCT02816398|594114670|FG000|Overall Study|Lack of Efficacy|8|||
164476163|NCT02816398|594114670|FG000|Overall Study|Lost to Follow-up|1|||
164476164|NCT01387516|594114671|FG000|Overall Study|Lost to Follow-up|4|||
164476165|NCT01387516|594114672|FG001|Overall Study|Lost to Follow-up|4|||
164476166|NCT01387516|594114673|FG002|Overall Study|Lost to Follow-up|2|||
164476167|NCT01387516|594114674|FG003|Overall Study|Lost to Follow-up|3|||
164476168|NCT01387516|594114671|FG000|Overall Study|Withdrawal by Subject|1|||
164476169|NCT01387516|594114672|FG001|Overall Study|Withdrawal by Subject|1|||
164476170|NCT01387516|594114673|FG002|Overall Study|Withdrawal by Subject|2|||
164476171|NCT01387516|594114674|FG003|Overall Study|Withdrawal by Subject|0|||
164476172|NCT01387516|594114671|FG000|Overall Study|Death|0|||
164476173|NCT01387516|594114672|FG001|Overall Study|Death|0|||
164476174|NCT01387516|594114673|FG002|Overall Study|Death|0|||
164476175|NCT01387516|594114674|FG003|Overall Study|Death|1|||
164476176|NCT03582475|594114675|FG000|Treatment Period|Withdrawal by Subject|0|||
164476177|NCT03582475|594114676|FG001|Treatment Period|Withdrawal by Subject|1|||
164476178|NCT03582475|594114675|FG000|Follow-up Period|Withdrawal by Subject|0|||
164476179|NCT03582475|594114676|FG001|Follow-up Period|Withdrawal by Subject|1|||
164476180|NCT03509909|594114682|FG000|Overall Study|Withdrawal by Subject|16|||
164476181|NCT03509909|594114683|FG001|Overall Study|Withdrawal by Subject|9|||
164476182|NCT03509909|594114682|FG000|Overall Study|Lost to Follow-up|3|||
164476183|NCT03509909|594114683|FG001|Overall Study|Lost to Follow-up|4|||
164476184|NCT03509909|594114682|FG000|Overall Study|Adverse Event|2|||
164476185|NCT03509909|594114683|FG001|Overall Study|Adverse Event|0|||
164476186|NCT03683576|594114685|FG000|Overall Study|Withdrawal by Subject|2|||
164476187|NCT03683576|594114686|FG001|Overall Study|Withdrawal by Subject|0|||
164476188|NCT03683576|594114687|FG002|Overall Study|Withdrawal by Subject|8|||
164476189|NCT03683576|594114688|FG003|Overall Study|Withdrawal by Subject|3|||
164476190|NCT03683576|594114685|FG000|Overall Study|Adverse Event|3|||
164476191|NCT03683576|594114686|FG001|Overall Study|Adverse Event|0|||
164476192|NCT03683576|594114687|FG002|Overall Study|Adverse Event|0|||
164476193|NCT03683576|594114688|FG003|Overall Study|Adverse Event|4|||
164476194|NCT03683576|594114685|FG000|Overall Study|Lack of Efficacy|1|||
164476195|NCT03683576|594114686|FG001|Overall Study|Lack of Efficacy|0|||
164476196|NCT03683576|594114687|FG002|Overall Study|Lack of Efficacy|1|||
164476197|NCT03683576|594114688|FG003|Overall Study|Lack of Efficacy|1|||
164476198|NCT03683576|594114685|FG000|Overall Study|Lost to Follow-up|0|||
164476199|NCT03683576|594114686|FG001|Overall Study|Lost to Follow-up|1|||
164476200|NCT03683576|594114687|FG002|Overall Study|Lost to Follow-up|2|||
164476201|NCT03683576|594114688|FG003|Overall Study|Lost to Follow-up|0|||
164476202|NCT03683576|594114685|FG000|Overall Study|Other, Not Specified|0|||
164476203|NCT03683576|594114686|FG001|Overall Study|Other, Not Specified|2|||
164476204|NCT03683576|594114687|FG002|Overall Study|Other, Not Specified|0|||
164476205|NCT03683576|594114688|FG003|Overall Study|Other, Not Specified|0|||
164476206|NCT03683576|594114685|FG000|Overall Study|Protocol Violation|0|||
164476207|NCT03683576|594114686|FG001|Overall Study|Protocol Violation|1|||
164476208|NCT03683576|594114687|FG002|Overall Study|Protocol Violation|1|||
164476209|NCT03683576|594114688|FG003|Overall Study|Protocol Violation|0|||
164476210|NCT01588951|594114689|FG000|Overall Study|Ineligible in retrospect|0|||
164476211|NCT01588951|594114690|FG001|Overall Study|Ineligible in retrospect|0|||
164476212|NCT01588951|594114691|FG002|Overall Study|Ineligible in retrospect|1|||
164476213|NCT03211247|594114692|FG000|Overall Study|Adverse Event|8|||
164476214|NCT03211247|594114693|FG001|Overall Study|Adverse Event|0|||
164476215|NCT03211247|594114694|FG002|Overall Study|Adverse Event|1|||
164476216|NCT03211247|594114695|FG003|Overall Study|Adverse Event|0|||
164476217|NCT03211247|594114696|FG004|Overall Study|Adverse Event|0|||
164476218|NCT03211247|594114692|FG000|Overall Study|Lost to Follow-up|2|||
164476219|NCT03211247|594114693|FG001|Overall Study|Lost to Follow-up|1|||
164476220|NCT03211247|594114694|FG002|Overall Study|Lost to Follow-up|0|||
164476221|NCT03211247|594114695|FG003|Overall Study|Lost to Follow-up|0|||
164476222|NCT03211247|594114696|FG004|Overall Study|Lost to Follow-up|0|||
164476223|NCT03211247|594114692|FG000|Overall Study|Physician Decision|1|||
164476224|NCT03211247|594114693|FG001|Overall Study|Physician Decision|2|||
164476225|NCT03211247|594114694|FG002|Overall Study|Physician Decision|0|||
164476226|NCT03211247|594114695|FG003|Overall Study|Physician Decision|0|||
164476227|NCT03211247|594114696|FG004|Overall Study|Physician Decision|0|||
164476228|NCT03211247|594114692|FG000|Overall Study|Non-compliance with study drug|2|||
164476229|NCT03211247|594114693|FG001|Overall Study|Non-compliance with study drug|0|||
164476230|NCT03211247|594114694|FG002|Overall Study|Non-compliance with study drug|0|||
164476231|NCT03211247|594114695|FG003|Overall Study|Non-compliance with study drug|0|||
164144830|NCT03790657|592891795|FG001|Overall Study|Adverse Event|1|||
164476232|NCT03211247|594114696|FG004|Overall Study|Non-compliance with study drug|0|||
164476233|NCT03211247|594114692|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
164476234|NCT03211247|594114693|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
164476235|NCT03211247|594114694|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
164476236|NCT03211247|594114695|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
164476237|NCT03211247|594114696|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
164476238|NCT03211247|594114692|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
164476239|NCT03211247|594114693|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
164476240|NCT03211247|594114694|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
164476241|NCT03211247|594114695|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
164476242|NCT03211247|594114696|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
164476243|NCT03211247|594114692|FG000|Overall Study|Protocol Violation|0|||
164476244|NCT03211247|594114693|FG001|Overall Study|Protocol Violation|1|||
164476245|NCT03211247|594114694|FG002|Overall Study|Protocol Violation|0|||
164476246|NCT03211247|594114695|FG003|Overall Study|Protocol Violation|0|||
164476247|NCT03211247|594114696|FG004|Overall Study|Protocol Violation|0|||
164476248|NCT02415127|594114697|FG000|Overall Study|Adverse Event|1|||
164476249|NCT02415127|594114698|FG001|Overall Study|Adverse Event|0|||
164476250|NCT05827068|594114699|FG000|Overall Study|Lost to Follow-up|1|||
164476251|NCT05827068|594114700|FG001|Overall Study|Lost to Follow-up|4|||
164476252|NCT05827068|594114701|FG002|Overall Study|Lost to Follow-up|1|||
164476253|NCT05827068|594114702|FG003|Overall Study|Lost to Follow-up|1|||
164476254|NCT05827068|594114703|FG004|Overall Study|Lost to Follow-up|2|||
164476255|NCT05827068|594114704|FG005|Overall Study|Lost to Follow-up|4|||
164476256|NCT05827068|594114705|FG006|Overall Study|Lost to Follow-up|1|||
164476257|NCT05827068|594114699|FG000|Overall Study|Withdrawal by Subject|4|||
164476258|NCT05827068|594114700|FG001|Overall Study|Withdrawal by Subject|0|||
164476259|NCT05827068|594114701|FG002|Overall Study|Withdrawal by Subject|1|||
164476260|NCT05827068|594114702|FG003|Overall Study|Withdrawal by Subject|2|||
164476261|NCT05827068|594114703|FG004|Overall Study|Withdrawal by Subject|3|||
164476262|NCT05827068|594114704|FG005|Overall Study|Withdrawal by Subject|0|||
164476263|NCT05827068|594114705|FG006|Overall Study|Withdrawal by Subject|1|||
164476264|NCT05827068|594114699|FG000|Overall Study|Physician Decision|0|||
164476265|NCT05827068|594114700|FG001|Overall Study|Physician Decision|0|||
164476266|NCT05827068|594114701|FG002|Overall Study|Physician Decision|0|||
164476267|NCT05827068|594114702|FG003|Overall Study|Physician Decision|0|||
164476268|NCT05827068|594114703|FG004|Overall Study|Physician Decision|1|||
164476269|NCT05827068|594114704|FG005|Overall Study|Physician Decision|0|||
164476270|NCT05827068|594114705|FG006|Overall Study|Physician Decision|1|||
164476271|NCT05827068|594114699|FG000|Overall Study|Other Than Specified|0|||
164476272|NCT05827068|594114700|FG001|Overall Study|Other Than Specified|1|||
164476273|NCT05827068|594114701|FG002|Overall Study|Other Than Specified|0|||
164476274|NCT05827068|594114702|FG003|Overall Study|Other Than Specified|0|||
164476275|NCT05827068|594114703|FG004|Overall Study|Other Than Specified|0|||
164476276|NCT05827068|594114704|FG005|Overall Study|Other Than Specified|0|||
164476277|NCT05827068|594114705|FG006|Overall Study|Other Than Specified|0|||
164476278|NCT05464732|594114708|FG000|Overall Study|Lost to Follow-up|0|||
164476279|NCT05464732|594114709|FG001|Overall Study|Lost to Follow-up|1|||
164476280|NCT05464732|594114708|FG000|Overall Study|Adverse Event|1|||
164476281|NCT05464732|594114709|FG001|Overall Study|Adverse Event|0|||
164476282|NCT04153890|594114710|FG000|Overall Study|Lost to Follow-up|9|||
164476283|NCT04153890|594114711|FG001|Overall Study|Lost to Follow-up|0|||
164476284|NCT04153890|594114712|FG002|Overall Study|Lost to Follow-up|9|||
164476285|NCT04153890|594114713|FG003|Overall Study|Lost to Follow-up|0|||
164476286|NCT04153890|594114710|FG000|Overall Study|Death|0|||
164476287|NCT04153890|594114711|FG001|Overall Study|Death|2|||
164476288|NCT04153890|594114712|FG002|Overall Study|Death|0|||
164476289|NCT04153890|594114713|FG003|Overall Study|Death|0|||
164476290|NCT04153890|594114710|FG000|Overall Study|Withdrawal by Subject|0|||
164476291|NCT04153890|594114711|FG001|Overall Study|Withdrawal by Subject|0|||
164476292|NCT04153890|594114712|FG002|Overall Study|Withdrawal by Subject|0|||
164476293|NCT04153890|594114713|FG003|Overall Study|Withdrawal by Subject|2|||
164476294|NCT03610581|594114714|FG000|Overall Study|Study terminated by sponsor|2|||
164476295|NCT03610581|594114715|FG001|Overall Study|Study terminated by sponsor|0|||
164476296|NCT03610581|594114714|FG000|Overall Study|Other|0|||
164476297|NCT03610581|594114715|FG001|Overall Study|Other|1|||
164476298|NCT03610581|594114714|FG000|Overall Study|Withdrawal by Subject|1|||
164476299|NCT03610581|594114715|FG001|Overall Study|Withdrawal by Subject|0|||
164476300|NCT03997474|594114721|FG000|Overall Study|Death|6|||
164476301|NCT03997474|594114722|FG001|Overall Study|Death|2|||
164476302|NCT03997474|594114723|FG002|Overall Study|Death|1|||
164476303|NCT03997474|594114721|FG000|Overall Study|Physician Decision|2|||
164476304|NCT03997474|594114722|FG001|Overall Study|Physician Decision|0|||
164476305|NCT03997474|594114723|FG002|Overall Study|Physician Decision|0|||
164476306|NCT03997474|594114721|FG000|Overall Study|study terminated by sponsor|1|||
164476307|NCT03997474|594114722|FG001|Overall Study|study terminated by sponsor|0|||
164476308|NCT03997474|594114723|FG002|Overall Study|study terminated by sponsor|1|||
164476309|NCT05630833|594114724|FG000|Overall Study|Adverse Event|3|||
164476310|NCT05630833|594114725|FG001|Overall Study|Adverse Event|0|||
164476311|NCT05630833|594114724|FG000|Overall Study|Lack of Efficacy|0|||
164476312|NCT05630833|594114725|FG001|Overall Study|Lack of Efficacy|1|||
164476313|NCT05630833|594114724|FG000|Overall Study|Lost to Follow-up|1|||
164476314|NCT05630833|594114725|FG001|Overall Study|Lost to Follow-up|0|||
164476315|NCT05630833|594114724|FG000|Overall Study|Withdrawal by Subject|3|||
164476316|NCT05630833|594114725|FG001|Overall Study|Withdrawal by Subject|1|||
164476317|NCT03277989|594114727|FG000|Overall Study|Lost to Follow-up|6|||
164476318|NCT03277989|594114727|FG000|Overall Study|Adverse Event|6|||
164476319|NCT03277989|594114727|FG000|Overall Study|Withdrawal by Subject|3|||
164476320|NCT03277989|594114727|FG000|Overall Study|Didn't Receive Study Device|7|||
164476321|NCT03277989|594114727|FG000|Overall Study|Site Closure|26|||
164476322|NCT03277989|594114727|FG000|Overall Study|Sponsor Closure|107|||
164476323|NCT04306367|594114728|FG000|Overall Study|Progression of Disease|9|||
164476324|NCT04306367|594114728|FG000|Overall Study|Adverse Event|3|||
164476325|NCT04306367|594114728|FG000|Overall Study|Withdrawal by Subject|1|||
164476326|NCT02751528|594114735|FG000|Overall Study|Withdrawal by Subject|1|||
164476327|NCT02751528|594114735|FG000|Overall Study|Adverse Event|1|||
164476328|NCT05485805|594114736|FG000|Overall Study|Withdrawal by Subject|1|||
164476329|NCT05485805|594114737|FG001|Overall Study|Withdrawal by Subject|2|||
164476330|NCT05485805|594114738|FG002|Overall Study|Withdrawal by Subject|2|||
164476331|NCT05485805|594114739|FG003|Overall Study|Withdrawal by Subject|0|||
164476332|NCT05485805|594114740|FG004|Overall Study|Withdrawal by Subject|2|||
164476333|NCT05485805|594114736|FG000|Overall Study|Adverse Event|0|||
164476334|NCT05485805|594114737|FG001|Overall Study|Adverse Event|1|||
164476335|NCT05485805|594114738|FG002|Overall Study|Adverse Event|0|||
164476336|NCT05485805|594114739|FG003|Overall Study|Adverse Event|0|||
164476337|NCT05485805|594114740|FG004|Overall Study|Adverse Event|0|||
164476338|NCT05485805|594114736|FG000|Overall Study|Lost to Follow-up|1|||
164476339|NCT05485805|594114737|FG001|Overall Study|Lost to Follow-up|1|||
164476340|NCT05485805|594114738|FG002|Overall Study|Lost to Follow-up|3|||
164476341|NCT05485805|594114739|FG003|Overall Study|Lost to Follow-up|1|||
164476342|NCT05485805|594114740|FG004|Overall Study|Lost to Follow-up|0|||
164476343|NCT04218357|594114741|FG000|1st Allocation|Withdrawal by Subject|1|||
164476344|NCT04218357|594114742|FG001|1st Allocation|Withdrawal by Subject|0|||
164476345|NCT05349838|594114743|FG000|Overall Study|Virological Failure|1|||
164476346|NCT05349838|594114744|FG001|Overall Study|Virological Failure|2|||
164476347|NCT05349838|594114743|FG000|Overall Study|Withdrawal by Subject|2|||
164476348|NCT05349838|594114744|FG001|Overall Study|Withdrawal by Subject|3|||
164476349|NCT05349838|594114743|FG000|Overall Study|Adverse Event|3|||
164476350|NCT05349838|594114744|FG001|Overall Study|Adverse Event|1|||
164476351|NCT05349838|594114743|FG000|Overall Study|Lost to Follow-up|1|||
164476352|NCT05349838|594114744|FG001|Overall Study|Lost to Follow-up|2|||
164476353|NCT05349838|594114743|FG000|Overall Study|Other reasons|5|||
164476354|NCT05349838|594114744|FG001|Overall Study|Other reasons|1|||
164476355|NCT05037513|594114749|FG000|Intervention Period|Lost to Follow-up|1|||
164476356|NCT05037513|594114750|FG001|Intervention Period|Lost to Follow-up|2|||
164476357|NCT05037513|594114749|FG000|Follow Up Period|Lost to Follow-up|16|||
164476358|NCT05037513|594114750|FG001|Follow Up Period|Lost to Follow-up|21|||
164476359|NCT05037513|594114749|FG000|Follow Up Period|Death|0|||
164476360|NCT05037513|594114750|FG001|Follow Up Period|Death|1|||
164476361|NCT05037513|594114749|FG000|Follow Up Period|Incarcerated|4|||
164476362|NCT05037513|594114750|FG001|Follow Up Period|Incarcerated|2|||
164476363|NCT03664804|594114752|FG000|Overall Study|Withdrawal by Subject|7|||
164476364|NCT05529992|594114753|FG000|Overall Study|Withdrawal by Subject|1|||
164476365|NCT06140290|594114754|FG000|Period 1|Adverse Event|1|||
164476366|NCT06140290|594114755|FG001|Period 1|Adverse Event|0|||
164476367|NCT06140290|594114754|FG000|Period 2|Assigned but not treated|0|||
164476368|NCT06140290|594114755|FG001|Period 2|Assigned but not treated|1|||
164476369|NCT06140290|594114754|FG000|Period 2|Withdrawal by Subject|0|||
164476370|NCT06140290|594114755|FG001|Period 2|Withdrawal by Subject|1|||
164476371|NCT02036970|594116265|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
164476372|NCT02036970|594116266|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
164476373|NCT02036970|594116267|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
164476374|NCT02036970|594116268|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
164476375|NCT02036970|594116269|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
164476376|NCT02036970|594116270|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
164476377|NCT02036970|594116271|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
164714174|NCT03888066|594976821|FG001|Run-in Phase|AE (Adverse Event)|0|||
164476378|NCT02036970|594116272|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
164476379|NCT02036970|594116273|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
164476380|NCT02036970|594116274|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
164476381|NCT02036970|594116265|FG000|Part 1: Day 1 Through Week 16|Death|0|||
164476382|NCT02036970|594116266|FG001|Part 1: Day 1 Through Week 16|Death|0|||
164476383|NCT02036970|594116267|FG002|Part 1: Day 1 Through Week 16|Death|0|||
164476384|NCT02036970|594116268|FG003|Part 1: Day 1 Through Week 16|Death|0|||
164476385|NCT02036970|594116269|FG004|Part 1: Day 1 Through Week 16|Death|0|||
164476386|NCT02036970|594116270|FG005|Part 1: Day 1 Through Week 16|Death|0|||
164476387|NCT02036970|594116271|FG006|Part 1: Day 1 Through Week 16|Death|0|||
164476388|NCT02036970|594116272|FG007|Part 1: Day 1 Through Week 16|Death|0|||
164476389|NCT02036970|594116273|FG008|Part 1: Day 1 Through Week 16|Death|1|||
164476390|NCT02036970|594116274|FG009|Part 1: Day 1 Through Week 16|Death|0|||
164476391|NCT02036970|594116265|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
164476392|NCT02036970|594116266|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
164476393|NCT02036970|594116267|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
164476394|NCT02036970|594116268|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
164476395|NCT02036970|594116269|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
164476396|NCT02036970|594116270|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
164476397|NCT02036970|594116271|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
164476398|NCT02036970|594116272|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
164476399|NCT02036970|594116273|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
164476400|NCT02036970|594116274|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
164476401|NCT02036970|594116265|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
164476402|NCT02036970|594116266|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
164476403|NCT02036970|594116267|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
164476404|NCT02036970|594116268|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
164476405|NCT02036970|594116269|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
164476406|NCT02036970|594116270|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
164476407|NCT02036970|594116271|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
164476408|NCT02036970|594116272|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
164476409|NCT02036970|594116273|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
164476410|NCT02036970|594116274|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
164476411|NCT02036970|594116265|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
164476412|NCT02036970|594116266|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
164476413|NCT02036970|594116267|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
164476414|NCT02036970|594116268|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
164476415|NCT02036970|594116269|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
164476416|NCT02036970|594116270|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
164476417|NCT02036970|594116271|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
164476418|NCT02036970|594116272|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
164476419|NCT02036970|594116273|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
164476420|NCT02036970|594116274|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
164476421|NCT02036970|594116265|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
164476422|NCT02036970|594116266|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
164476423|NCT02036970|594116267|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
164476424|NCT02036970|594116268|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
164476425|NCT02036970|594116269|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
164476426|NCT02036970|594116270|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
164476427|NCT02036970|594116271|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
164476428|NCT02036970|594116272|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
164476429|NCT02036970|594116273|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
164476430|NCT02036970|594116274|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
164476431|NCT02036970|594116265|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
164476432|NCT02036970|594116266|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
164476433|NCT02036970|594116267|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
164476434|NCT02036970|594116268|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
164476435|NCT02036970|594116269|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
164476436|NCT02036970|594116270|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
164476437|NCT02036970|594116271|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
164476438|NCT02036970|594116272|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
164476439|NCT02036970|594116273|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
164476440|NCT02036970|594116274|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
164476441|NCT02036970|594116265|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
164476442|NCT02036970|594116266|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
164476443|NCT02036970|594116267|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
164476444|NCT02036970|594116268|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
164476445|NCT02036970|594116269|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
164476446|NCT02036970|594116270|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
164476447|NCT02036970|594116271|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
164476448|NCT02036970|594116272|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
164476449|NCT02036970|594116273|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
164476450|NCT02036970|594116274|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
164476451|NCT02036970|594116265|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
164476452|NCT02036970|594116266|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
164476453|NCT02036970|594116267|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
164599926|NCT02358369|594556401|FG001|Treatment Period A/B|Death|0|||
164476454|NCT02036970|594116268|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
164476455|NCT02036970|594116269|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
164476456|NCT02036970|594116270|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
164476457|NCT02036970|594116271|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
164476458|NCT02036970|594116272|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
164476459|NCT02036970|594116273|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
164476460|NCT02036970|594116274|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
164476461|NCT02386098|594116277|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
164476462|NCT02386098|594116278|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
164476463|NCT02386098|594116279|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
164476464|NCT02386098|594116280|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
164476465|NCT02386098|594116281|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
164476466|NCT02386098|594116277|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
164476467|NCT02386098|594116278|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
164476468|NCT02386098|594116279|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
164476469|NCT02386098|594116280|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
164476470|NCT02386098|594116281|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
164476471|NCT02386098|594116277|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
164476472|NCT02386098|594116278|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
164476473|NCT02386098|594116279|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
164476474|NCT02386098|594116280|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
164476475|NCT02386098|594116281|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
164476476|NCT02386098|594116277|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
164476477|NCT02386098|594116278|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
164476478|NCT02386098|594116279|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
164476479|NCT02386098|594116280|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
164476480|NCT02386098|594116281|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
164476481|NCT02386098|594116277|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
164476482|NCT02386098|594116278|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
164476483|NCT02386098|594116279|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
164476484|NCT02386098|594116280|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
164476485|NCT02386098|594116281|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
164476486|NCT02386098|594116277|FG000|Stage 1 (96 Weeks)|Other|1|||
164476487|NCT02386098|594116278|FG001|Stage 1 (96 Weeks)|Other|0|||
164476488|NCT02386098|594116279|FG002|Stage 1 (96 Weeks)|Other|0|||
164476489|NCT02386098|594116280|FG003|Stage 1 (96 Weeks)|Other|0|||
164476490|NCT02386098|594116281|FG004|Stage 1 (96 Weeks)|Other|0|||
164476491|NCT02386098|594116277|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
164476492|NCT02386098|594116278|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
164476493|NCT02386098|594116279|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
164476494|NCT02386098|594116280|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
164476495|NCT02386098|594116281|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
164476496|NCT02702843|594116282|FG000|Overall Study|Insufficient data to analyze|15|||
164476497|NCT02702843|594116283|FG001|Overall Study|Insufficient data to analyze|23|||
164476498|NCT05029284|594116286|FG000|Overall Study|Lost to Follow-up|1|||
164476499|NCT03002194|594116288|FG000|Overall Study|Lost to Follow-up|6|||
164476500|NCT03002194|594116288|FG000|Overall Study|Adverse Event|1|||
164476501|NCT03002194|594116288|FG000|Overall Study|Lack of Efficacy|1|||
164476502|NCT03002194|594116288|FG000|Overall Study|Withdrawal by Subject|2|||
164476503|NCT02232737|594116289|FG000|Overall Study|Lost to Follow-up|18|||
164476504|NCT02232737|594116290|FG001|Overall Study|Lost to Follow-up|28|||
164476505|NCT02232737|594116291|FG002|Overall Study|Lost to Follow-up|33|||
164476506|NCT02232737|594116289|FG000|Overall Study|Personal reasons|7|||
164476507|NCT02232737|594116290|FG001|Overall Study|Personal reasons|8|||
164476508|NCT02232737|594116291|FG002|Overall Study|Personal reasons|14|||
164476509|NCT02232737|594116289|FG000|Overall Study|Adverse Event|6|||
164476510|NCT02232737|594116290|FG001|Overall Study|Adverse Event|3|||
164476511|NCT02232737|594116291|FG002|Overall Study|Adverse Event|8|||
164476512|NCT02232737|594116289|FG000|Overall Study|Incarcerated|2|||
164476513|NCT02232737|594116290|FG001|Overall Study|Incarcerated|1|||
164476514|NCT02232737|594116291|FG002|Overall Study|Incarcerated|2|||
164476515|NCT02232737|594116289|FG000|Overall Study|Withdrawal by Subject|0|||
164476516|NCT02232737|594116290|FG001|Overall Study|Withdrawal by Subject|1|||
164476517|NCT02232737|594116291|FG002|Overall Study|Withdrawal by Subject|2|||
164476518|NCT02232737|594116289|FG000|Overall Study|Death|0|||
164714175|NCT03888066|594976820|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
164476519|NCT02232737|594116290|FG001|Overall Study|Death|1|||
164476520|NCT02232737|594116291|FG002|Overall Study|Death|1|||
164476521|NCT02232737|594116289|FG000|Overall Study|Physician Decision|1|||
164476522|NCT02232737|594116290|FG001|Overall Study|Physician Decision|3|||
164476523|NCT02232737|594116291|FG002|Overall Study|Physician Decision|1|||
164476524|NCT02232737|594116289|FG000|Overall Study|Protocol Violation|1|||
164476525|NCT02232737|594116290|FG001|Overall Study|Protocol Violation|0|||
164476526|NCT02232737|594116291|FG002|Overall Study|Protocol Violation|1|||
164476527|NCT02232737|594116289|FG000|Overall Study|Reason unknown|1|||
164476528|NCT02232737|594116290|FG001|Overall Study|Reason unknown|0|||
164476529|NCT02232737|594116291|FG002|Overall Study|Reason unknown|0|||
164476530|NCT02200705|594116294|FG000|Overall Study|Excluded|12|||
164476531|NCT02200705|594116294|FG000|Overall Study|Death|21|||
164476532|NCT02200705|594116294|FG000|Overall Study|Withdrawal by Subject|22|||
164476533|NCT02200705|594116294|FG000|Overall Study|Lost to Follow-up|13|||
164476534|NCT02200705|594116294|FG000|Overall Study|Physician Decision|5|||
164476535|NCT02200705|594116294|FG000|Overall Study|Adverse Event|2|||
164476536|NCT00371345|594116295|FG000|Overall Study|Disease Progression|21|||
164476537|NCT00371345|594116296|FG001|Overall Study|Disease Progression|35|||
164476538|NCT00371345|594116295|FG000|Overall Study|Study Drug Toxicity|1|||
164476539|NCT00371345|594116296|FG001|Overall Study|Study Drug Toxicity|7|||
164476540|NCT00371345|594116295|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
164476541|NCT00371345|594116296|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
164476542|NCT00371345|594116295|FG000|Overall Study|Participant Request|1|||
164476543|NCT00371345|594116296|FG001|Overall Study|Participant Request|1|||
164476544|NCT00371345|594116295|FG000|Overall Study|Participant Withdrew Consent|0|||
164476545|NCT00371345|594116296|FG001|Overall Study|Participant Withdrew Consent|1|||
164476546|NCT00705406|594116297|FG000|Overall Study|Lost to Follow-up|3|||
164476547|NCT00705406|594116298|FG001|Overall Study|Lost to Follow-up|3|||
164476548|NCT00705406|594116297|FG000|Overall Study|Did not receive study drug|1|||
164476549|NCT00705406|594116298|FG001|Overall Study|Did not receive study drug|2|||
164476550|NCT00442104|594116299|FG000|Overall Study|Adverse Event|5|||
164476551|NCT00442104|594116299|FG000|Overall Study|Death|2|||
164476552|NCT00442104|594116299|FG000|Overall Study|Lost to Follow-up|3|||
164476553|NCT00442104|594116299|FG000|Overall Study|Withdrawal by Subject|5|||
164476554|NCT00442104|594116299|FG000|Overall Study|Insufficient Clinical Response|10|||
164476555|NCT00442104|594116299|FG000|Overall Study|Other|21|||
164476556|NCT00442104|594116299|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
164476557|NCT04545619|594116300|FG000|Overall Study|due to equipment challenges|1|||
164476558|NCT00975585|594116301|FG000|Overall Study|Adverse Event|0|||
164476559|NCT00975585|594116302|FG001|Overall Study|Adverse Event|4|||
164476560|NCT00975585|594116301|FG000|Overall Study|Lost to Follow-up|3|||
164476561|NCT00975585|594116302|FG001|Overall Study|Lost to Follow-up|5|||
164476562|NCT00975585|594116301|FG000|Overall Study|Withdrawal by Subject|2|||
164476563|NCT00975585|594116302|FG001|Overall Study|Withdrawal by Subject|1|||
164476564|NCT00975585|594116301|FG000|Overall Study|Lens issue|2|||
164476565|NCT00975585|594116302|FG001|Overall Study|Lens issue|2|||
164476566|NCT00683800|594116304|FG000|Overall Study|Adverse Event|195|||
164476567|NCT00683800|594116305|FG001|Overall Study|Adverse Event|102|||
164476568|NCT00683800|594116304|FG000|Overall Study|Death|0|||
164476569|NCT00683800|594116305|FG001|Overall Study|Death|1|||
164476570|NCT00683800|594116304|FG000|Overall Study|Lost to Follow-up|57|||
164476571|NCT00683800|594116305|FG001|Overall Study|Lost to Follow-up|44|||
164476572|NCT00683800|594116304|FG000|Overall Study|Other|5|||
164476573|NCT00683800|594116305|FG001|Overall Study|Other|2|||
164476574|NCT00683800|594116304|FG000|Overall Study|Protocol Violation|13|||
164476575|NCT00683800|594116305|FG001|Overall Study|Protocol Violation|16|||
164476576|NCT00683800|594116304|FG000|Overall Study|Withdrawal by Subject|66|||
164476577|NCT00683800|594116305|FG001|Overall Study|Withdrawal by Subject|64|||
164476578|NCT00683800|594116304|FG000|Overall Study|Lack of Efficacy|61|||
164476579|NCT00683800|594116305|FG001|Overall Study|Lack of Efficacy|104|||
164476580|NCT00683800|594116304|FG000|Overall Study|Randomized, not treated|35|||
164476581|NCT00683800|594116305|FG001|Overall Study|Randomized, not treated|33|||
164476582|NCT00205179|594116308|FG000|Overall Study|Death|0|||
164476583|NCT00205179|594116309|FG001|Overall Study|Death|2|||
164476584|NCT00205179|594116308|FG000|Overall Study|Physician Decision|1|||
164476585|NCT00205179|594116309|FG001|Overall Study|Physician Decision|1|||
164476586|NCT00205179|594116308|FG000|Overall Study|Adverse Event|1|||
164476587|NCT00205179|594116309|FG001|Overall Study|Adverse Event|1|||
164476588|NCT01619059|594116316|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
164476589|NCT01619059|594116317|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
164476590|NCT01619059|594116316|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
164476591|NCT01619059|594116317|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
164476592|NCT01619059|594116316|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
164476593|NCT01619059|594116317|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
164476594|NCT01619059|594116316|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
164476595|NCT01619059|594116317|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
164476596|NCT01619059|594116316|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
164476597|NCT01619059|594116317|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
164476598|NCT01619059|594116316|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
164476599|NCT01619059|594116317|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
164476600|NCT01619059|594116316|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
164476601|NCT01619059|594116317|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
164476602|NCT01619059|594116316|FG000|Long-Term (LT) Treatment Period|Death|1|||
164476603|NCT01619059|594116317|FG001|Long-Term (LT) Treatment Period|Death|0|||
164476604|NCT01619059|594116316|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
164476605|NCT01619059|594116317|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
164476606|NCT01619059|594116316|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
164476607|NCT01619059|594116317|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
164476608|NCT04949542|594116320|FG000|Overall Study|Lost to Follow-up|4|||
164476609|NCT04949542|594116321|FG001|Overall Study|Lost to Follow-up|1|||
164476610|NCT03021993|594116323|FG000|Overall Study|Withdrawal by Subject|4|||
164476611|NCT03021993|594116323|FG000|Overall Study|Physician Decision|1|||
164476612|NCT03021993|594116323|FG000|Overall Study|enrolled but were not treated|1|||
164476613|NCT03021993|594116323|FG000|Overall Study|Death|3|||
164476614|NCT02101775|594116325|FG000|Overall Study|Adverse Event|4|||
164476615|NCT02101775|594116326|FG001|Overall Study|Adverse Event|0|||
164476616|NCT02101775|594116327|FG002|Overall Study|Adverse Event|0|||
164476617|NCT02101775|594116325|FG000|Overall Study|Admission to Hospital|0|||
164476618|NCT02101775|594116326|FG001|Overall Study|Admission to Hospital|1|||
164476619|NCT02101775|594116327|FG002|Overall Study|Admission to Hospital|0|||
164476620|NCT03170648|594116335|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
164476621|NCT03170648|594116335|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
164476622|NCT02454959|594116339|FG000|Overall Study|Protocol-Specified Criteria|3|||
164476623|NCT02454959|594116339|FG000|Overall Study|Physician Decision|1|||
164476624|NCT02454959|594116339|FG000|Overall Study|Withdrawal by Subject|3|||
164476625|NCT02454959|594116339|FG000|Overall Study|Adverse Event|2|||
164476626|NCT02350634|594116340|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
164476627|NCT02499328|594116349|FG000|Overall Study|Withdrawal by Subject|1|||
164476628|NCT02499328|594116350|FG001|Overall Study|Withdrawal by Subject|1|||
164476629|NCT02499328|594116351|FG002|Overall Study|Withdrawal by Subject|5|||
164476630|NCT02499328|594116352|FG003|Overall Study|Withdrawal by Subject|3|||
164476631|NCT02499328|594116353|FG004|Overall Study|Withdrawal by Subject|5|||
164476632|NCT02499328|594116354|FG005|Overall Study|Withdrawal by Subject|0|||
164476633|NCT02499328|594116355|FG006|Overall Study|Withdrawal by Subject|0|||
164476634|NCT02499328|594116356|FG007|Overall Study|Withdrawal by Subject|0|||
164476635|NCT02499328|594116357|FG008|Overall Study|Withdrawal by Subject|2|||
164476636|NCT02499328|594116358|FG009|Overall Study|Withdrawal by Subject|2|||
164476637|NCT02499328|594116359|FG010|Overall Study|Withdrawal by Subject|0|||
164476638|NCT02499328|594116360|FG011|Overall Study|Withdrawal by Subject|3|||
164476639|NCT02499328|594116361|FG012|Overall Study|Withdrawal by Subject|7|||
164476640|NCT02499328|594116362|FG013|Overall Study|Withdrawal by Subject|3|||
164476641|NCT02499328|594116363|FG014|Overall Study|Withdrawal by Subject|1|||
164476642|NCT02499328|594116364|FG015|Overall Study|Withdrawal by Subject|0|||
164476643|NCT02499328|594116365|FG016|Overall Study|Withdrawal by Subject|0|||
164476644|NCT02499328|594116366|FG017|Overall Study|Withdrawal by Subject|3|||
164476645|NCT02499328|594116367|FG018|Overall Study|Withdrawal by Subject|0|||
164476646|NCT02499328|594116349|FG000|Overall Study|Lost to Follow-up|0|||
164476647|NCT02499328|594116350|FG001|Overall Study|Lost to Follow-up|1|||
164476648|NCT02499328|594116351|FG002|Overall Study|Lost to Follow-up|1|||
164476649|NCT02499328|594116352|FG003|Overall Study|Lost to Follow-up|2|||
164476650|NCT02499328|594116353|FG004|Overall Study|Lost to Follow-up|0|||
164476651|NCT02499328|594116354|FG005|Overall Study|Lost to Follow-up|0|||
164476652|NCT02499328|594116355|FG006|Overall Study|Lost to Follow-up|0|||
164476653|NCT02499328|594116356|FG007|Overall Study|Lost to Follow-up|2|||
164476654|NCT02499328|594116357|FG008|Overall Study|Lost to Follow-up|3|||
164476655|NCT02499328|594116358|FG009|Overall Study|Lost to Follow-up|0|||
164476656|NCT02499328|594116359|FG010|Overall Study|Lost to Follow-up|0|||
164476657|NCT02499328|594116360|FG011|Overall Study|Lost to Follow-up|0|||
164476658|NCT02499328|594116361|FG012|Overall Study|Lost to Follow-up|0|||
164476659|NCT02499328|594116362|FG013|Overall Study|Lost to Follow-up|0|||
164476660|NCT02499328|594116363|FG014|Overall Study|Lost to Follow-up|0|||
164476661|NCT02499328|594116364|FG015|Overall Study|Lost to Follow-up|0|||
164476662|NCT02499328|594116365|FG016|Overall Study|Lost to Follow-up|0|||
164476663|NCT02499328|594116366|FG017|Overall Study|Lost to Follow-up|0|||
164714176|NCT03888066|594976821|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
164476664|NCT02499328|594116367|FG018|Overall Study|Lost to Follow-up|1|||
164476665|NCT02499328|594116349|FG000|Overall Study|Death|0|||
164476666|NCT02499328|594116350|FG001|Overall Study|Death|3|||
164476667|NCT02499328|594116351|FG002|Overall Study|Death|3|||
164476668|NCT02499328|594116352|FG003|Overall Study|Death|2|||
164476669|NCT02499328|594116353|FG004|Overall Study|Death|4|||
164476670|NCT02499328|594116354|FG005|Overall Study|Death|7|||
164476671|NCT02499328|594116355|FG006|Overall Study|Death|3|||
164476672|NCT02499328|594116356|FG007|Overall Study|Death|0|||
164476673|NCT02499328|594116357|FG008|Overall Study|Death|2|||
164476674|NCT02499328|594116358|FG009|Overall Study|Death|6|||
164476675|NCT02499328|594116359|FG010|Overall Study|Death|6|||
164476676|NCT02499328|594116360|FG011|Overall Study|Death|20|||
164476677|NCT02499328|594116361|FG012|Overall Study|Death|9|||
164476678|NCT02499328|594116362|FG013|Overall Study|Death|7|||
164476679|NCT02499328|594116363|FG014|Overall Study|Death|3|||
164476680|NCT02499328|594116364|FG015|Overall Study|Death|1|||
164714177|NCT03888066|594976820|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
164714178|NCT03888066|594976821|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
164714179|NCT03888066|594976820|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
164476681|NCT02499328|594116365|FG016|Overall Study|Death|1|||
164476682|NCT02499328|594116366|FG017|Overall Study|Death|16|||
164476683|NCT02499328|594116367|FG018|Overall Study|Death|5|||
164476684|NCT02499328|594116349|FG000|Overall Study|"Other"|2|||
164476685|NCT02499328|594116350|FG001|Overall Study|"Other"|2|||
164476686|NCT02499328|594116351|FG002|Overall Study|"Other"|1|||
164476687|NCT02499328|594116352|FG003|Overall Study|"Other"|3|||
164476688|NCT02499328|594116353|FG004|Overall Study|"Other"|6|||
164476689|NCT02499328|594116354|FG005|Overall Study|"Other"|2|||
164476690|NCT02499328|594116355|FG006|Overall Study|"Other"|3|||
164476691|NCT02499328|594116356|FG007|Overall Study|"Other"|4|||
164476692|NCT02499328|594116357|FG008|Overall Study|"Other"|6|||
164476693|NCT02499328|594116358|FG009|Overall Study|"Other"|16|||
164476694|NCT02499328|594116359|FG010|Overall Study|"Other"|13|||
164476695|NCT02499328|594116360|FG011|Overall Study|"Other"|31|||
164476696|NCT02499328|594116361|FG012|Overall Study|"Other"|8|||
164476697|NCT02499328|594116362|FG013|Overall Study|"Other"|7|||
164476698|NCT02499328|594116363|FG014|Overall Study|"Other"|6|||
164476699|NCT02499328|594116364|FG015|Overall Study|"Other"|0|||
164476700|NCT02499328|594116365|FG016|Overall Study|"Other"|0|||
164476701|NCT02499328|594116366|FG017|Overall Study|"Other"|34|||
164476702|NCT02499328|594116367|FG018|Overall Study|"Other"|43|||
164476703|NCT02499328|594116349|FG000|Overall Study|Disease Progression|0|||
164476704|NCT02499328|594116350|FG001|Overall Study|Disease Progression|0|||
164476705|NCT02499328|594116351|FG002|Overall Study|Disease Progression|0|||
164476706|NCT02499328|594116352|FG003|Overall Study|Disease Progression|0|||
164476707|NCT02499328|594116353|FG004|Overall Study|Disease Progression|0|||
164476708|NCT02499328|594116354|FG005|Overall Study|Disease Progression|0|||
164476709|NCT02499328|594116355|FG006|Overall Study|Disease Progression|1|||
164476710|NCT02499328|594116356|FG007|Overall Study|Disease Progression|0|||
164476711|NCT02499328|594116357|FG008|Overall Study|Disease Progression|1|||
164476712|NCT02499328|594116358|FG009|Overall Study|Disease Progression|0|||
164476713|NCT02499328|594116359|FG010|Overall Study|Disease Progression|1|||
164476714|NCT02499328|594116360|FG011|Overall Study|Disease Progression|0|||
164476715|NCT02499328|594116361|FG012|Overall Study|Disease Progression|0|||
164476716|NCT02499328|594116362|FG013|Overall Study|Disease Progression|0|||
164476717|NCT02499328|594116363|FG014|Overall Study|Disease Progression|0|||
164476718|NCT02499328|594116364|FG015|Overall Study|Disease Progression|0|||
164476719|NCT02499328|594116365|FG016|Overall Study|Disease Progression|0|||
164476720|NCT02499328|594116366|FG017|Overall Study|Disease Progression|2|||
164476721|NCT02499328|594116367|FG018|Overall Study|Disease Progression|0|||
164476722|NCT02499328|594116349|FG000|Overall Study|Adverse Event|1|||
164476723|NCT02499328|594116350|FG001|Overall Study|Adverse Event|0|||
164476724|NCT02499328|594116351|FG002|Overall Study|Adverse Event|0|||
164476725|NCT02499328|594116352|FG003|Overall Study|Adverse Event|1|||
164476726|NCT02499328|594116353|FG004|Overall Study|Adverse Event|0|||
164476727|NCT02499328|594116354|FG005|Overall Study|Adverse Event|0|||
164476728|NCT02499328|594116355|FG006|Overall Study|Adverse Event|0|||
164476729|NCT02499328|594116356|FG007|Overall Study|Adverse Event|0|||
164476730|NCT02499328|594116357|FG008|Overall Study|Adverse Event|0|||
164476731|NCT02499328|594116358|FG009|Overall Study|Adverse Event|0|||
164476732|NCT02499328|594116359|FG010|Overall Study|Adverse Event|0|||
164476733|NCT02499328|594116360|FG011|Overall Study|Adverse Event|0|||
164476734|NCT02499328|594116361|FG012|Overall Study|Adverse Event|1|||
164476735|NCT02499328|594116362|FG013|Overall Study|Adverse Event|0|||
164476736|NCT02499328|594116363|FG014|Overall Study|Adverse Event|0|||
164476737|NCT02499328|594116364|FG015|Overall Study|Adverse Event|0|||
164476738|NCT02499328|594116365|FG016|Overall Study|Adverse Event|0|||
164476739|NCT02499328|594116366|FG017|Overall Study|Adverse Event|0|||
164476740|NCT02499328|594116367|FG018|Overall Study|Adverse Event|0|||
164476741|NCT03611075|594116368|FG000|Overall Study|Physician Decision|0|||
164476742|NCT03611075|594116369|FG001|Overall Study|Physician Decision|1|||
164476743|NCT03611075|594116370|FG002|Overall Study|Physician Decision|1|||
164476744|NCT03611075|594116371|FG003|Overall Study|Physician Decision|0|||
164476745|NCT03611075|594116372|FG004|Overall Study|Physician Decision|0|||
164476746|NCT03611075|594116373|FG005|Overall Study|Physician Decision|0|||
164476747|NCT03611075|594116374|FG006|Overall Study|Physician Decision|0|||
164476748|NCT03611075|594116375|FG007|Overall Study|Physician Decision|0|||
164476749|NCT03611075|594116376|FG008|Overall Study|Physician Decision|0|||
164476750|NCT03611075|594116368|FG000|Overall Study|Lost to Follow-up|1|||
164476751|NCT03611075|594116369|FG001|Overall Study|Lost to Follow-up|0|||
164476752|NCT03611075|594116370|FG002|Overall Study|Lost to Follow-up|0|||
164476753|NCT03611075|594116371|FG003|Overall Study|Lost to Follow-up|2|||
164476754|NCT03611075|594116372|FG004|Overall Study|Lost to Follow-up|0|||
164476755|NCT03611075|594116373|FG005|Overall Study|Lost to Follow-up|0|||
164476756|NCT03611075|594116374|FG006|Overall Study|Lost to Follow-up|0|||
164476757|NCT03611075|594116375|FG007|Overall Study|Lost to Follow-up|0|||
164476758|NCT03611075|594116376|FG008|Overall Study|Lost to Follow-up|0|||
164476759|NCT03611075|594116368|FG000|Overall Study|Withdrawal by Subject|0|||
164476760|NCT03611075|594116369|FG001|Overall Study|Withdrawal by Subject|1|||
164476761|NCT03611075|594116370|FG002|Overall Study|Withdrawal by Subject|1|||
164476762|NCT03611075|594116371|FG003|Overall Study|Withdrawal by Subject|1|||
164476763|NCT03611075|594116372|FG004|Overall Study|Withdrawal by Subject|0|||
164476764|NCT03611075|594116373|FG005|Overall Study|Withdrawal by Subject|0|||
164476765|NCT03611075|594116374|FG006|Overall Study|Withdrawal by Subject|1|||
164476766|NCT03611075|594116375|FG007|Overall Study|Withdrawal by Subject|0|||
164476767|NCT03611075|594116376|FG008|Overall Study|Withdrawal by Subject|0|||
164476768|NCT03611075|594116368|FG000|Overall Study|Reason unknown|0|||
164476769|NCT03611075|594116369|FG001|Overall Study|Reason unknown|0|||
164476770|NCT03611075|594116370|FG002|Overall Study|Reason unknown|0|||
164476771|NCT03611075|594116371|FG003|Overall Study|Reason unknown|1|||
164476772|NCT03611075|594116372|FG004|Overall Study|Reason unknown|0|||
164476773|NCT03611075|594116373|FG005|Overall Study|Reason unknown|0|||
164476774|NCT03611075|594116374|FG006|Overall Study|Reason unknown|1|||
164476775|NCT03611075|594116375|FG007|Overall Study|Reason unknown|0|||
164476776|NCT03611075|594116376|FG008|Overall Study|Reason unknown|0|||
164476777|NCT02972359|594116377|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
164476778|NCT02972359|594116377|FG000|Overall Study|Lack of Efficacy|1|||
164476779|NCT02972359|594116377|FG000|Overall Study|Adverse Event|4|||
164476780|NCT02972359|594116377|FG000|Overall Study|Death|1|||
164476781|NCT02972359|594116377|FG000|Overall Study|Withdrawal by Subject|30|||
164476782|NCT02972359|594116377|FG000|Overall Study|Protocol Violation|1|||
164476783|NCT02972359|594116377|FG000|Overall Study|Lost to Follow-up|26|||
164476784|NCT02972359|594116377|FG000|Overall Study|Other reasons|5|||
164476785|NCT02972359|594116377|FG000|Overall Study|Missing|1|||
164476786|NCT03488719|594116378|FG000|Overall Study|Adverse Event|0|||
164476787|NCT03488719|594116379|FG001|Overall Study|Adverse Event|4|||
164476788|NCT03488719|594116380|FG002|Overall Study|Adverse Event|2|||
164476789|NCT03488719|594116378|FG000|Overall Study|Other|0|||
164476790|NCT03488719|594116379|FG001|Overall Study|Other|0|||
164476791|NCT03488719|594116380|FG002|Overall Study|Other|5|||
164476792|NCT02307682|594116395|FG000|Overall Study|Adverse Event|9|||
164476793|NCT02307682|594116396|FG001|Overall Study|Adverse Event|8|||
164476794|NCT02307682|594116397|FG002|Overall Study|Adverse Event|12|||
164476795|NCT02307682|594116395|FG000|Overall Study|Lack of Efficacy|1|||
164476796|NCT02307682|594116396|FG001|Overall Study|Lack of Efficacy|0|||
164476797|NCT02307682|594116397|FG002|Overall Study|Lack of Efficacy|1|||
164476798|NCT02307682|594116395|FG000|Overall Study|Physician Decision|2|||
164476799|NCT02307682|594116396|FG001|Overall Study|Physician Decision|2|||
164476800|NCT02307682|594116397|FG002|Overall Study|Physician Decision|8|||
164476801|NCT02307682|594116395|FG000|Overall Study|Progressive Disease|1|||
164476802|NCT02307682|594116396|FG001|Overall Study|Progressive Disease|0|||
164476803|NCT02307682|594116397|FG002|Overall Study|Progressive Disease|0|||
164476804|NCT02307682|594116395|FG000|Overall Study|Withdrawal by Subject|26|||
164476805|NCT02307682|594116396|FG001|Overall Study|Withdrawal by Subject|34|||
164476806|NCT02307682|594116397|FG002|Overall Study|Withdrawal by Subject|23|||
164476807|NCT02307682|594116395|FG000|Overall Study|Death|9|||
164476808|NCT02307682|594116396|FG001|Overall Study|Death|7|||
164476809|NCT02307682|594116397|FG002|Overall Study|Death|12|||
164476810|NCT02307682|594116395|FG000|Overall Study|Lost to Follow-up|1|||
164476811|NCT02307682|594116396|FG001|Overall Study|Lost to Follow-up|5|||
164476812|NCT02307682|594116397|FG002|Overall Study|Lost to Follow-up|6|||
164476813|NCT02307682|594116395|FG000|Overall Study|Protocol Deviation|0|||
164476814|NCT02307682|594116396|FG001|Overall Study|Protocol Deviation|0|||
164476815|NCT02307682|594116397|FG002|Overall Study|Protocol Deviation|2|||
164476816|NCT02307682|594116395|FG000|Overall Study|Other|1|||
164476817|NCT02307682|594116396|FG001|Overall Study|Other|1|||
164476818|NCT02307682|594116397|FG002|Overall Study|Other|0|||
164476819|NCT02157116|594117618|FG000|Overall Study|Withdrawal by Subject|4|||
164476820|NCT02157116|594117618|FG000|Overall Study|Physician Decision|3|||
164476821|NCT02157116|594117618|FG000|Overall Study|Failed Screening|2|||
164476822|NCT02463448|594117619|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
164476823|NCT02463448|594117619|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
164476824|NCT02463448|594117619|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
164476825|NCT02463448|594117619|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
164476826|NCT01728324|594117620|FG000|Termination of DBV|Adverse Event|14|||
164476827|NCT01728324|594117621|FG001|Termination of DBV|Adverse Event|13|||
164476828|NCT01728324|594117622|FG002|Termination of DBV|Adverse Event|4|||
164476829|NCT01728324|594117620|FG000|Termination of DBV|Lack of Efficacy|14|||
164476830|NCT01728324|594117621|FG001|Termination of DBV|Lack of Efficacy|12|||
164476831|NCT01728324|594117622|FG002|Termination of DBV|Lack of Efficacy|8|||
164476832|NCT01728324|594117620|FG000|Termination of DBV|Withdrawal by Subject|9|||
164476833|NCT01728324|594117621|FG001|Termination of DBV|Withdrawal by Subject|6|||
164476834|NCT01728324|594117622|FG002|Termination of DBV|Withdrawal by Subject|2|||
164476835|NCT01728324|594117620|FG000|Termination of DBV|Other than stated|1|||
164476836|NCT01728324|594117621|FG001|Termination of DBV|Other than stated|3|||
164476837|NCT01728324|594117622|FG002|Termination of DBV|Other than stated|0|||
164714180|NCT03888066|594976821|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
164476838|NCT01728324|594117620|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
164476839|NCT01728324|594117621|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
164476840|NCT01728324|594117622|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
164476841|NCT01728324|594117620|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
164476842|NCT01728324|594117621|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
164476843|NCT01728324|594117622|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
164476844|NCT01728324|594117620|FG000|Termination of FDV|Adverse Event|14|||
164476845|NCT01728324|594117621|FG001|Termination of FDV|Adverse Event|13|||
164476846|NCT01728324|594117622|FG002|Termination of FDV|Adverse Event|4|||
164476847|NCT01728324|594117620|FG000|Termination of FDV|Lack of Efficacy|14|||
164476848|NCT01728324|594117621|FG001|Termination of FDV|Lack of Efficacy|12|||
164476849|NCT01728324|594117622|FG002|Termination of FDV|Lack of Efficacy|8|||
164476850|NCT01728324|594117620|FG000|Termination of FDV|Withdrawal by Subject|9|||
164476851|NCT01728324|594117621|FG001|Termination of FDV|Withdrawal by Subject|6|||
164476852|NCT01728324|594117622|FG002|Termination of FDV|Withdrawal by Subject|2|||
164476853|NCT01728324|594117620|FG000|Termination of FDV|Other than stated|1|||
164476854|NCT01728324|594117621|FG001|Termination of FDV|Other than stated|3|||
164476855|NCT01728324|594117622|FG002|Termination of FDV|Other than stated|0|||
164476856|NCT01728324|594117620|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
164476857|NCT01728324|594117621|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
164476858|NCT01728324|594117622|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
164476859|NCT01728324|594117620|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
164476860|NCT01728324|594117621|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
164476861|NCT01728324|594117622|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
164476862|NCT01728324|594117620|FG000|Termination of RBV|Adverse Event|15|||
164476863|NCT01728324|594117621|FG001|Termination of RBV|Adverse Event|16|||
164476864|NCT01728324|594117622|FG002|Termination of RBV|Adverse Event|5|||
164476865|NCT01728324|594117620|FG000|Termination of RBV|Lack of Efficacy|14|||
164476866|NCT01728324|594117621|FG001|Termination of RBV|Lack of Efficacy|11|||
164476867|NCT01728324|594117622|FG002|Termination of RBV|Lack of Efficacy|7|||
164476868|NCT01728324|594117620|FG000|Termination of RBV|Withdrawal by Subject|9|||
164476869|NCT01728324|594117621|FG001|Termination of RBV|Withdrawal by Subject|5|||
164476870|NCT01728324|594117622|FG002|Termination of RBV|Withdrawal by Subject|2|||
164476871|NCT01728324|594117620|FG000|Termination of RBV|Other than stated|1|||
164476872|NCT01728324|594117621|FG001|Termination of RBV|Other than stated|3|||
164476873|NCT01728324|594117622|FG002|Termination of RBV|Other than stated|1|||
164476874|NCT01728324|594117620|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
164476875|NCT01728324|594117621|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
164476876|NCT01728324|594117622|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
164476877|NCT01728324|594117620|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
164476878|NCT01728324|594117621|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
164476879|NCT01728324|594117622|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
164476880|NCT01787032|594117625|FG000|Overall Study|Protocol Violation|0|||
164476881|NCT01787032|594117626|FG001|Overall Study|Protocol Violation|0|||
164476882|NCT01787032|594117627|FG002|Overall Study|Protocol Violation|0|||
164476883|NCT01787032|594117628|FG003|Overall Study|Protocol Violation|0|||
164476884|NCT01787032|594117629|FG004|Overall Study|Protocol Violation|1|||
164476885|NCT01787032|594117630|FG005|Overall Study|Protocol Violation|1|||
164476886|NCT00388726|594117631|FG000|Overall Study|Adverse Event|50|||
164476887|NCT00388726|594117632|FG001|Overall Study|Adverse Event|24|||
164476888|NCT00388726|594117631|FG000|Overall Study|Progressive Disease|336|||
164476889|NCT00388726|594117632|FG001|Overall Study|Progressive Disease|153|||
164476890|NCT00388726|594117631|FG000|Overall Study|Clinical Progression|61|||
164476891|NCT00388726|594117632|FG001|Overall Study|Clinical Progression|36|||
164476892|NCT00388726|594117631|FG000|Overall Study|Withdrawal by Subject|10|||
164476893|NCT00388726|594117632|FG001|Overall Study|Withdrawal by Subject|7|||
164476894|NCT00388726|594117631|FG000|Overall Study|Administrative|6|||
164476895|NCT00388726|594117632|FG001|Overall Study|Administrative|9|||
164476896|NCT00388726|594117631|FG000|Overall Study|Physician Decision|18|||
164476897|NCT00388726|594117632|FG001|Overall Study|Physician Decision|13|||
164476898|NCT00388726|594117631|FG000|Overall Study|Death|3|||
164476899|NCT00388726|594117632|FG001|Overall Study|Death|2|||
164476900|NCT02406092|594117633|FG000|Overall Study|Screen failure|10|||
164476901|NCT02406092|594117634|FG001|Overall Study|Screen failure|7|||
164476902|NCT02406092|594117633|FG000|Overall Study|Death|22|||
164476903|NCT02406092|594117634|FG001|Overall Study|Death|5|||
164476904|NCT02406092|594117633|FG000|Overall Study|Lost to Follow-up|4|||
164476905|NCT02406092|594117634|FG001|Overall Study|Lost to Follow-up|1|||
164476906|NCT02406092|594117633|FG000|Overall Study|Adverse Event|1|||
164476907|NCT02406092|594117634|FG001|Overall Study|Adverse Event|0|||
164476908|NCT02406092|594117633|FG000|Overall Study|Withdrawal by Subject|1|||
164476909|NCT02406092|594117634|FG001|Overall Study|Withdrawal by Subject|0|||
164476910|NCT03041233|594117635|FG000|Overall Study|Death|5|||
164476911|NCT03041233|594117635|FG000|Overall Study|Physician Decision|1|||
164476912|NCT03041233|594117635|FG000|Overall Study|Lost to Follow-up|16|||
164476913|NCT03041233|594117635|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
164476914|NCT03041233|594117635|FG000|Overall Study|Sponsor Request|1|||
164476915|NCT03041233|594117635|FG000|Overall Study|Duplicate subject|1|||
164476916|NCT03041233|594117635|FG000|Overall Study|Re-ablation|1|||
164476917|NCT00853593|594117639|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
164476918|NCT00853593|594117639|FG000|Overall Study|Model 4396 lead not attempted|29|||
164476919|NCT00853593|594117639|FG000|Overall Study|Implant not attempted|4|||
164476920|NCT00641537|594117642|FG000|96-week Period|Adverse Event|0|||
164476921|NCT00641537|594117643|FG001|96-week Period|Adverse Event|1|||
164476922|NCT00641537|594117644|FG002|96-week Period|Adverse Event|3|||
164476923|NCT00641537|594117645|FG003|96-week Period|Adverse Event|0|||
164476924|NCT00641537|594117646|FG004|96-week Period|Adverse Event|2|||
164476925|NCT00641537|594117647|FG005|96-week Period|Adverse Event|0|||
164476926|NCT00641537|594117648|FG006|96-week Period|Adverse Event|0|||
164476927|NCT00641537|594117649|FG007|96-week Period|Adverse Event|0|||
164476928|NCT00641537|594117642|FG000|96-week Period|Lost to Follow-up|3|||
164476929|NCT00641537|594117643|FG001|96-week Period|Lost to Follow-up|1|||
164476930|NCT00641537|594117644|FG002|96-week Period|Lost to Follow-up|2|||
164476931|NCT00641537|594117645|FG003|96-week Period|Lost to Follow-up|2|||
164476932|NCT00641537|594117646|FG004|96-week Period|Lost to Follow-up|4|||
164476933|NCT00641537|594117647|FG005|96-week Period|Lost to Follow-up|0|||
164476934|NCT00641537|594117648|FG006|96-week Period|Lost to Follow-up|1|||
164476935|NCT00641537|594117649|FG007|96-week Period|Lost to Follow-up|0|||
164476936|NCT00641537|594117642|FG000|96-week Period|Protocol Violation|0|||
164476937|NCT00641537|594117643|FG001|96-week Period|Protocol Violation|1|||
164476938|NCT00641537|594117644|FG002|96-week Period|Protocol Violation|0|||
164476939|NCT00641537|594117645|FG003|96-week Period|Protocol Violation|1|||
164476940|NCT00641537|594117646|FG004|96-week Period|Protocol Violation|0|||
164476941|NCT00641537|594117647|FG005|96-week Period|Protocol Violation|1|||
164476942|NCT00641537|594117648|FG006|96-week Period|Protocol Violation|0|||
164476943|NCT00641537|594117649|FG007|96-week Period|Protocol Violation|0|||
164476944|NCT00641537|594117642|FG000|96-week Period|Death|2|||
164476945|NCT00641537|594117643|FG001|96-week Period|Death|0|||
164476946|NCT00641537|594117644|FG002|96-week Period|Death|1|||
164476947|NCT00641537|594117645|FG003|96-week Period|Death|0|||
164476948|NCT00641537|594117646|FG004|96-week Period|Death|0|||
164476949|NCT00641537|594117647|FG005|96-week Period|Death|0|||
164476950|NCT00641537|594117648|FG006|96-week Period|Death|0|||
164476951|NCT00641537|594117649|FG007|96-week Period|Death|0|||
164476952|NCT00641537|594117642|FG000|96-week Period|Other|4|||
164476953|NCT00641537|594117643|FG001|96-week Period|Other|7|||
164476954|NCT00641537|594117644|FG002|96-week Period|Other|14|||
164476955|NCT00641537|594117645|FG003|96-week Period|Other|9|||
164476956|NCT00641537|594117646|FG004|96-week Period|Other|11|||
164476957|NCT00641537|594117647|FG005|96-week Period|Other|6|||
164476958|NCT00641537|594117648|FG006|96-week Period|Other|4|||
164476959|NCT00641537|594117649|FG007|96-week Period|Other|6|||
164476960|NCT00641537|594117642|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
164476961|NCT00641537|594117643|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
164476962|NCT00641537|594117644|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
164476963|NCT00641537|594117645|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
164476964|NCT00641537|594117646|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
164476965|NCT00641537|594117647|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
164476966|NCT00641537|594117648|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
164476967|NCT00641537|594117649|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
164476968|NCT00641537|594117642|FG000|24-Week Supplemental Follow-up Period|Other|0|||
164476969|NCT00641537|594117643|FG001|24-Week Supplemental Follow-up Period|Other|2|||
164476970|NCT00641537|594117644|FG002|24-Week Supplemental Follow-up Period|Other|2|||
164476971|NCT00641537|594117645|FG003|24-Week Supplemental Follow-up Period|Other|1|||
164476972|NCT00641537|594117646|FG004|24-Week Supplemental Follow-up Period|Other|3|||
164476973|NCT00641537|594117647|FG005|24-Week Supplemental Follow-up Period|Other|0|||
164476974|NCT00641537|594117648|FG006|24-Week Supplemental Follow-up Period|Other|1|||
164476975|NCT00641537|594117649|FG007|24-Week Supplemental Follow-up Period|Other|1|||
164476976|NCT03229408|594117650|FG000|Overall Study|Withdrawal by Subject|4|||
164476977|NCT03229408|594117651|FG001|Overall Study|Withdrawal by Subject|1|||
164476978|NCT03229408|594117650|FG000|Overall Study|Adverse Event|2|||
164476979|NCT03229408|594117651|FG001|Overall Study|Adverse Event|0|||
164476980|NCT03229408|594117650|FG000|Overall Study|Pregnancy|0|||
164476981|NCT03229408|594117651|FG001|Overall Study|Pregnancy|1|||
164476982|NCT03229408|594117650|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
164476983|NCT03229408|594117651|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
164476984|NCT03745313|594117654|FG000|At 30 Days Follow-up|Death|2|||
164476985|NCT03745313|594117654|FG000|At 6 Months Follow-up|Death|1|||
164476986|NCT03745313|594117654|FG000|At 6 Months Follow-up|Missed Visit|1|||
164476987|NCT03745313|594117654|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
164476988|NCT03745313|594117654|FG000|At 1 Year Follow-up|Death|2|||
164476989|NCT03745313|594117654|FG000|At 1 Year Follow-up|Missed Visit|2|||
164476990|NCT03745313|594117654|FG000|At 2 Year Follow-up|Missed Visit|1|||
164476991|NCT02052440|594117658|FG000|Overall Study|Withdrawal by Subject|0|||
164476992|NCT02052440|594117659|FG001|Overall Study|Withdrawal by Subject|1|||
164476993|NCT01367236|594117660|FG000|Overall Study|Withdrawal by Subject|3|||
164476994|NCT01367236|594117661|FG001|Overall Study|Withdrawal by Subject|1|||
164476995|NCT02235298|594117662|FG000|Overall Study|Lost to Follow-up|6|||
164476996|NCT02235298|594117663|FG001|Overall Study|Lost to Follow-up|5|||
164476997|NCT02235298|594117662|FG000|Overall Study|Adverse Event|2|||
164476998|NCT02235298|594117663|FG001|Overall Study|Adverse Event|2|||
164476999|NCT02235298|594117662|FG000|Overall Study|Withdrawal by Subject|0|||
164477000|NCT02235298|594117663|FG001|Overall Study|Withdrawal by Subject|1|||
164477001|NCT03414684|594117666|FG000|First-course Treatment|Complete response|0|||
164477002|NCT03414684|594117667|FG001|First-course Treatment|Complete response|1|||
164477003|NCT03414684|594117666|FG000|First-course Treatment|Intercurrent illness|1|||
164477004|NCT03414684|594117667|FG001|First-course Treatment|Intercurrent illness|0|||
164477005|NCT03414684|594117666|FG000|First-course Treatment|Progressive Disease|31|||
164477006|NCT03414684|594117667|FG001|First-course Treatment|Progressive Disease|32|||
164477007|NCT03414684|594117666|FG000|First-course Treatment|Adverse Event|1|||
164477008|NCT03414684|594117667|FG001|First-course Treatment|Adverse Event|2|||
164477009|NCT03414684|594117666|FG000|First-course Treatment|Physician Decision|0|||
164477010|NCT03414684|594117667|FG001|First-course Treatment|Physician Decision|1|||
164477011|NCT03414684|594117666|FG000|First-course Treatment|Withdrawal by Subject|0|||
164477012|NCT03414684|594117667|FG001|First-course Treatment|Withdrawal by Subject|1|||
164477013|NCT03414684|594117666|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
164477014|NCT03414684|594117667|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
164477015|NCT03414684|594117666|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
164477016|NCT03414684|594117667|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
164477017|NCT03414684|594117666|FG000|First-course Treatment|Still on treatment|3|||
164477018|NCT03414684|594117667|FG001|First-course Treatment|Still on treatment|0|||
164477019|NCT03414684|594117666|FG000|First-course Treatment|Never started protocol therapy|2|||
164477020|NCT03414684|594117667|FG001|First-course Treatment|Never started protocol therapy|1|||
164477021|NCT03414684|594117666|FG000|Crossover Treatment|Progressive disease|0|||
164477022|NCT03414684|594117667|FG001|Crossover Treatment|Progressive disease|12|||
164477023|NCT03414684|594117666|FG000|Crossover Treatment|Adverse Event|0|||
164477024|NCT03414684|594117667|FG001|Crossover Treatment|Adverse Event|3|||
164477025|NCT03414684|594117666|FG000|Crossover Treatment|Physician Decision|0|||
164477026|NCT03414684|594117667|FG001|Crossover Treatment|Physician Decision|1|||
164477027|NCT03414684|594117666|FG000|Crossover Treatment|Still on treatment|0|||
164477028|NCT03414684|594117667|FG001|Crossover Treatment|Still on treatment|2|||
164477029|NCT04038580|594117668|FG000|Washout 1|Death|0|||
164477030|NCT04038580|594117669|FG001|Washout 1|Death|0|||
164477031|NCT04038580|594117670|FG002|Washout 1|Death|0|||
164477032|NCT04038580|594117671|FG003|Washout 1|Death|1|||
164477033|NCT04038580|594117672|FG004|Washout 1|Death|0|||
164477034|NCT04038580|594117673|FG005|Washout 1|Death|0|||
164477035|NCT04038580|594117668|FG000|Washout 1|Withdrawal by Subject|0|||
164477036|NCT04038580|594117669|FG001|Washout 1|Withdrawal by Subject|0|||
164477037|NCT04038580|594117670|FG002|Washout 1|Withdrawal by Subject|0|||
164477038|NCT04038580|594117671|FG003|Washout 1|Withdrawal by Subject|0|||
164714181|NCT03888066|594976820|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
164714182|NCT03888066|594976821|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
164714183|NCT03888066|594976820|FG000|Run-in Phase|Withdrawal by Subject|43|||
164714184|NCT03888066|594976821|FG001|Run-in Phase|Withdrawal by Subject|0|||
164714185|NCT03888066|594976820|FG000|Run-in Phase|AE; Physician Decision|1|||
164714186|NCT03888066|594976821|FG001|Run-in Phase|AE; Physician Decision|0|||
164714187|NCT03888066|594976820|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
164714188|NCT03888066|594976821|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
164714189|NCT03888066|594976820|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
164714190|NCT03888066|594976821|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
164714191|NCT03888066|594976820|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
164714192|NCT03888066|594976821|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
164714193|NCT03888066|594976820|FG000|Run-in Phase|Death|1|||
164714194|NCT03888066|594976821|FG001|Run-in Phase|Death|0|||
164714195|NCT03888066|594976820|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
164714196|NCT03888066|594976821|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
164714197|NCT03888066|594976820|FG000|Run-in Phase|Physician Decision|1|||
164477039|NCT04038580|594117672|FG004|Washout 1|Withdrawal by Subject|1|||
164477040|NCT04038580|594117673|FG005|Washout 1|Withdrawal by Subject|0|||
164477041|NCT04038580|594117668|FG000|Wash-out 2|Withdrawal by Subject|1|||
164477042|NCT04038580|594117669|FG001|Wash-out 2|Withdrawal by Subject|0|||
164477043|NCT04038580|594117670|FG002|Wash-out 2|Withdrawal by Subject|0|||
164477044|NCT04038580|594117671|FG003|Wash-out 2|Withdrawal by Subject|2|||
164477045|NCT04038580|594117672|FG004|Wash-out 2|Withdrawal by Subject|0|||
164477046|NCT04038580|594117673|FG005|Wash-out 2|Withdrawal by Subject|1|||
164477047|NCT04038580|594117668|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
164477048|NCT04038580|594117669|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
164477049|NCT04038580|594117670|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
164477050|NCT04038580|594117671|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
164477051|NCT04038580|594117672|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
164477052|NCT04038580|594117673|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
164477053|NCT04038580|594117668|FG000|Wash-out 3|Withdrawal by Subject|1|||
164477054|NCT04038580|594117669|FG001|Wash-out 3|Withdrawal by Subject|0|||
164477055|NCT04038580|594117670|FG002|Wash-out 3|Withdrawal by Subject|2|||
164477056|NCT04038580|594117671|FG003|Wash-out 3|Withdrawal by Subject|0|||
164477057|NCT04038580|594117672|FG004|Wash-out 3|Withdrawal by Subject|0|||
164477058|NCT04038580|594117673|FG005|Wash-out 3|Withdrawal by Subject|0|||
164477059|NCT03477175|594117674|FG000|Overall Study|Unable to travel due to COVID-19|0|||
164477060|NCT03477175|594117675|FG001|Overall Study|Unable to travel due to COVID-19|1|||
164477061|NCT03477175|594117674|FG000|Overall Study|Physician Decision|1|||
164477062|NCT03477175|594117675|FG001|Overall Study|Physician Decision|0|||
164477063|NCT03477175|594117674|FG000|Overall Study|Transitioned to commercial drug|6|||
164477064|NCT03477175|594117675|FG001|Overall Study|Transitioned to commercial drug|6|||
164477065|NCT03477175|594117674|FG000|Overall Study|Lost to Follow-up|1|||
164477066|NCT03477175|594117675|FG001|Overall Study|Lost to Follow-up|1|||
164477067|NCT03477175|594117674|FG000|Overall Study|Withdrawal by Subject|3|||
164477068|NCT03477175|594117675|FG001|Overall Study|Withdrawal by Subject|1|||
164477069|NCT03477175|594117674|FG000|Overall Study|Adverse Event|1|||
164477070|NCT03477175|594117675|FG001|Overall Study|Adverse Event|5|||
164477071|NCT03477175|594117674|FG000|Overall Study|Disease Progression|7|||
164477072|NCT03477175|594117675|FG001|Overall Study|Disease Progression|7|||
164477073|NCT02078648|594117676|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
164477074|NCT02078648|594117677|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
164477075|NCT02078648|594117676|FG000|Overall Study|Adverse Event|0|||
164477076|NCT02078648|594117677|FG001|Overall Study|Adverse Event|1|||
164477077|NCT02078648|594117676|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
164477078|NCT02078648|594117677|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
164477079|NCT02078648|594117676|FG000|Overall Study|Withdrawal by Subject|3|||
164477080|NCT02078648|594117677|FG001|Overall Study|Withdrawal by Subject|1|||
164477081|NCT02078648|594117676|FG000|Overall Study|Investigator Decision|5|||
164477082|NCT02078648|594117677|FG001|Overall Study|Investigator Decision|7|||
164477083|NCT02078648|594117676|FG000|Overall Study|Death|1|||
164477084|NCT02078648|594117677|FG001|Overall Study|Death|1|||
164477085|NCT02078648|594117676|FG000|Overall Study|Undefined|0|||
164477086|NCT02078648|594117677|FG001|Overall Study|Undefined|1|||
164477087|NCT04088227|594117678|FG000|Overall Study|Withdrawal by Subject|1|||
164477088|NCT04088227|594117679|FG001|Overall Study|Withdrawal by Subject|0|||
164477089|NCT04088227|594117678|FG000|Overall Study|Surgery postponed >5weeks|1|||
164477090|NCT04088227|594117679|FG001|Overall Study|Surgery postponed >5weeks|0|||
164477091|NCT04021862|594117680|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
164477092|NCT04021862|594117681|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
164477093|NCT04021862|594117682|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
164477094|NCT04021862|594117683|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
164477095|NCT04021862|594117684|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
164477096|NCT04021862|594117685|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
164477097|NCT04021862|594117680|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
164477098|NCT04021862|594117681|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
164477099|NCT04021862|594117682|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
164477100|NCT04021862|594117683|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
164477101|NCT04021862|594117684|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
164477102|NCT04021862|594117685|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
164477103|NCT04021862|594117680|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
164477104|NCT04021862|594117681|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
164477105|NCT04021862|594117682|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
164477106|NCT04021862|594117683|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
164477107|NCT04021862|594117684|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
164477108|NCT04021862|594117685|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
164477109|NCT04021862|594117680|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
164477110|NCT04021862|594117681|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
164477111|NCT04021862|594117682|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
164477112|NCT04021862|594117683|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
164477113|NCT04021862|594117684|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
164599927|NCT02358369|594556402|FG002|Treatment Period A/B|Death|1|||
164714198|NCT03888066|594976821|FG001|Run-in Phase|Physician Decision|0|||
164714199|NCT03888066|594976820|FG000|Run-in Phase|Protocol Violation|13|||
164714200|NCT03888066|594976821|FG001|Run-in Phase|Protocol Violation|0|||
164477114|NCT04021862|594117685|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
164477115|NCT04021862|594117680|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
164477116|NCT04021862|594117681|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
164477117|NCT04021862|594117682|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
164477118|NCT04021862|594117683|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
164477119|NCT04021862|594117684|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
164477120|NCT04021862|594117685|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
164477121|NCT01855750|594117686|FG000|Overall Study|Death|78|||
164477122|NCT01855750|594117687|FG001|Overall Study|Death|78|||
164477123|NCT01855750|594117686|FG000|Overall Study|Lost to Follow-up|9|||
164477124|NCT01855750|594117687|FG001|Overall Study|Lost to Follow-up|23|||
164477125|NCT01855750|594117686|FG000|Overall Study|Withdrawal by Subject|35|||
164477126|NCT01855750|594117687|FG001|Overall Study|Withdrawal by Subject|28|||
164477127|NCT01855750|594117686|FG000|Overall Study|Sponsor ends the study|297|||
164477128|NCT01855750|594117687|FG001|Overall Study|Sponsor ends the study|290|||
164477129|NCT05379270|594117688|FG000|Overall Study|Withdrawal by Subject|1|||
164477130|NCT05379270|594117689|FG001|Overall Study|Withdrawal by Subject|1|||
164477131|NCT05525572|594117690|FG000|Overall Study|Lost to Follow-up|2|||
164477132|NCT05025384|594117697|FG000|Overall Study|Physician Decision|5|||
164477133|NCT05025384|594117698|FG001|Overall Study|Physician Decision|6|||
164477134|NCT03160885|594117699|FG000|Initial Treatment Period|Not dosed|2|||
164477135|NCT03160885|594117700|FG001|Initial Treatment Period|Not dosed|0|||
164477136|NCT03160885|594117701|FG002|Initial Treatment Period|Not dosed|0|||
164477137|NCT03160885|594117702|FG003|Initial Treatment Period|Not dosed|0|||
164477138|NCT03160885|594117703|FG004|Initial Treatment Period|Not dosed|0|||
164477139|NCT03160885|594117704|FG005|Initial Treatment Period|Not dosed|0|||
164477140|NCT03160885|594117705|FG006|Initial Treatment Period|Not dosed|0|||
164477141|NCT03160885|594117699|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
164477142|NCT03160885|594117700|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
164477143|NCT03160885|594117701|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
164477144|NCT03160885|594117702|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
164477145|NCT03160885|594117703|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
164477146|NCT03160885|594117704|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
164477147|NCT03160885|594117705|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
164477148|NCT03160885|594117699|FG000|Open-label Treatment|Not dosed|0|||
164477149|NCT03160885|594117700|FG001|Open-label Treatment|Not dosed|0|||
164477150|NCT03160885|594117701|FG002|Open-label Treatment|Not dosed|0|||
164477151|NCT03160885|594117702|FG003|Open-label Treatment|Not dosed|0|||
164477152|NCT03160885|594117703|FG004|Open-label Treatment|Not dosed|0|||
164477153|NCT03160885|594117704|FG005|Open-label Treatment|Not dosed|0|||
164477154|NCT03160885|594117705|FG006|Open-label Treatment|Not dosed|2|||
164477155|NCT03160885|594117699|FG000|Open-label Treatment|Discontinued IMP|0|||
164477156|NCT03160885|594117700|FG001|Open-label Treatment|Discontinued IMP|0|||
164477157|NCT03160885|594117701|FG002|Open-label Treatment|Discontinued IMP|0|||
164477158|NCT03160885|594117702|FG003|Open-label Treatment|Discontinued IMP|0|||
164477159|NCT03160885|594117703|FG004|Open-label Treatment|Discontinued IMP|0|||
164477160|NCT03160885|594117704|FG005|Open-label Treatment|Discontinued IMP|0|||
164477161|NCT03160885|594117705|FG006|Open-label Treatment|Discontinued IMP|131|||
164477162|NCT03160885|594117699|FG000|Open-label Treatment|Completed Week 50|0|||
164477163|NCT03160885|594117700|FG001|Open-label Treatment|Completed Week 50|0|||
164477164|NCT03160885|594117701|FG002|Open-label Treatment|Completed Week 50|0|||
164477165|NCT03160885|594117702|FG003|Open-label Treatment|Completed Week 50|0|||
164477166|NCT03160885|594117703|FG004|Open-label Treatment|Completed Week 50|0|||
164477167|NCT03160885|594117704|FG005|Open-label Treatment|Completed Week 50|0|||
164477168|NCT03160885|594117705|FG006|Open-label Treatment|Completed Week 50|4|||
164477169|NCT03160885|594117699|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
164477170|NCT03160885|594117700|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
164477171|NCT03160885|594117701|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
164477172|NCT03160885|594117702|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
164477173|NCT03160885|594117703|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
164477174|NCT03160885|594117704|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
164477175|NCT03160885|594117705|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
164477176|NCT03160885|594117699|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
164477177|NCT03160885|594117700|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
164477178|NCT03160885|594117701|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
164477179|NCT03160885|594117702|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
164477180|NCT03160885|594117703|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
164477181|NCT03160885|594117704|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
164477182|NCT03160885|594117705|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
164477183|NCT03160885|594117699|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
164599928|NCT02358369|594556403|FG003|Treatment Period A/B|Death|0|||
164144907|NCT05199090|592891822|FG000|Overall Study|Physician Decision|0|||
164477184|NCT03160885|594117700|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
164477185|NCT03160885|594117701|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
164477186|NCT03160885|594117702|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
164477187|NCT03160885|594117703|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
164477188|NCT03160885|594117704|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
164477189|NCT03160885|594117705|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
164477190|NCT03160885|594117699|FG000|Maintenance Treatment Period|Completed Week 50|0|||
164477191|NCT03160885|594117700|FG001|Maintenance Treatment Period|Completed Week 50|0|||
164477192|NCT03160885|594117701|FG002|Maintenance Treatment Period|Completed Week 50|1|||
164477193|NCT03160885|594117702|FG003|Maintenance Treatment Period|Completed Week 50|0|||
164477194|NCT03160885|594117703|FG004|Maintenance Treatment Period|Completed Week 50|0|||
164477195|NCT03160885|594117704|FG005|Maintenance Treatment Period|Completed Week 50|0|||
164477196|NCT03160885|594117705|FG006|Maintenance Treatment Period|Completed Week 50|0|||
164477197|NCT03425682|594117706|FG000|Overall Study|Lost to Follow-up|2|||
164477198|NCT03425682|594117707|FG001|Overall Study|Lost to Follow-up|4|||
164477199|NCT03425682|594117706|FG000|Overall Study|Withdrawal by Subject|0|||
164477200|NCT03425682|594117707|FG001|Overall Study|Withdrawal by Subject|3|||
164477201|NCT03425682|594117706|FG000|Overall Study|Subject did not meet I/E|4|||
164477202|NCT03425682|594117707|FG001|Overall Study|Subject did not meet I/E|10|||
164477203|NCT00489307|594117708|FG000|Overall Study|Death|1|||
164477204|NCT00489307|594117709|FG001|Overall Study|Death|1|||
164477205|NCT00489307|594117708|FG000|Overall Study|Lost to Follow-up|2|||
164477206|NCT00489307|594117709|FG001|Overall Study|Lost to Follow-up|2|||
164477207|NCT00489307|594117708|FG000|Overall Study|Physician Decision|1|||
164477208|NCT00489307|594117709|FG001|Overall Study|Physician Decision|0|||
164477209|NCT00489307|594117708|FG000|Overall Study|Withdrawal by Subject|2|||
164477210|NCT00489307|594117709|FG001|Overall Study|Withdrawal by Subject|4|||
164477211|NCT00489307|594117708|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
164477212|NCT00489307|594117709|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
164477213|NCT00489307|594117708|FG000|Overall Study|Surgery after assignment|1|||
164477214|NCT00489307|594117709|FG001|Overall Study|Surgery after assignment|0|||
164477215|NCT00489307|594117708|FG000|Overall Study|Did not fill up the forms|2|||
164477216|NCT00489307|594117709|FG001|Overall Study|Did not fill up the forms|1|||
164477217|NCT00489307|594117708|FG000|Overall Study|Patient or family refusal|5|||
164477218|NCT00489307|594117709|FG001|Overall Study|Patient or family refusal|9|||
164477219|NCT03835754|594117710|FG000|Overall Study|Death|4|||
164477220|NCT03227861|594117713|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
164477221|NCT03227861|594117713|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
164477222|NCT03227861|594117713|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
164477223|NCT03227861|594117713|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
164477224|NCT03227861|594117713|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
164477225|NCT03227861|594117713|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
164477226|NCT03227861|594117713|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
164477227|NCT03227861|594117713|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
164477228|NCT03227861|594117713|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
164477229|NCT03227861|594117713|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
164477230|NCT05613907|594117714|FG000|Overall Study|Lost to Follow-up|5|||
164477231|NCT05613907|594117714|FG000|Overall Study|Death|3|||
164477232|NCT05613907|594117714|FG000|Overall Study|Withdrawal by Subject|2|||
164477233|NCT03789656|594117724|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
164477234|NCT03789656|594117725|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
164477235|NCT03789656|594117726|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
164477236|NCT03789656|594117727|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
164477237|NCT03789656|594117728|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
164477238|NCT03789656|594117724|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
164477239|NCT03789656|594117725|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
164477240|NCT03789656|594117726|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
164477241|NCT03789656|594117727|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
164477242|NCT03789656|594117728|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
164477243|NCT03789656|594117724|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
164714201|NCT03888066|594976820|FG000|Run-in Phase|Sponsor Request|34|||
164477244|NCT03789656|594117725|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
164477245|NCT03789656|594117726|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
164477246|NCT03789656|594117727|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
164477247|NCT03789656|594117728|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
164477248|NCT03789656|594117724|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
164477249|NCT03789656|594117725|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
164477250|NCT03789656|594117726|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
164714202|NCT03888066|594976821|FG001|Run-in Phase|Sponsor Request|0|||
164714203|NCT03888066|594976820|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
164477251|NCT03789656|594117727|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
164477252|NCT03789656|594117728|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
164477253|NCT05810285|594117735|FG000|Overall Study|Death|4|||
164477254|NCT05810285|594117736|FG001|Overall Study|Death|21|||
164477255|NCT05810285|594117735|FG000|Overall Study|Adverse Event|18|||
164477256|NCT05810285|594117736|FG001|Overall Study|Adverse Event|16|||
164477257|NCT04484623|594117737|FG000|Overall Study|Lost to Follow-up|0|||
164477258|NCT04484623|594117738|FG001|Overall Study|Lost to Follow-up|1|||
164477259|NCT04484623|594117737|FG000|Overall Study|Protocol Deviation|1|||
164477260|NCT04484623|594117738|FG001|Overall Study|Protocol Deviation|0|||
164477261|NCT04484623|594117737|FG000|Overall Study|Physician Decision|1|||
164477262|NCT04484623|594117738|FG001|Overall Study|Physician Decision|0|||
164477263|NCT04484623|594117737|FG000|Overall Study|Withdrawal by Subject|11|||
164477264|NCT04484623|594117738|FG001|Overall Study|Withdrawal by Subject|8|||
164477265|NCT04484623|594117737|FG000|Overall Study|Ongoing|94|||
164477266|NCT04484623|594117738|FG001|Overall Study|Ongoing|84|||
164477267|NCT05886777|594117739|FG000|Overall Study|Lost to Follow-up|1|||
164477268|NCT05886777|594117740|FG001|Overall Study|Lost to Follow-up|0|||
164477269|NCT05886777|594117741|FG002|Overall Study|Lost to Follow-up|2|||
164477270|NCT05886777|594117742|FG003|Overall Study|Lost to Follow-up|1|||
164477271|NCT05886777|594117743|FG004|Overall Study|Lost to Follow-up|0|||
164477272|NCT05886777|594117744|FG005|Overall Study|Lost to Follow-up|2|||
164477273|NCT05886777|594117745|FG006|Overall Study|Lost to Follow-up|0|||
164477274|NCT05886777|594117739|FG000|Overall Study|Other|0|||
164477275|NCT05886777|594117740|FG001|Overall Study|Other|2|||
164477276|NCT05886777|594117741|FG002|Overall Study|Other|1|||
164477277|NCT05886777|594117742|FG003|Overall Study|Other|0|||
164477278|NCT05886777|594117743|FG004|Overall Study|Other|0|||
164477279|NCT05886777|594117744|FG005|Overall Study|Other|0|||
164477280|NCT05886777|594117745|FG006|Overall Study|Other|0|||
164477281|NCT05886777|594117739|FG000|Overall Study|Withdrawal by Subject|1|||
164477282|NCT05886777|594117740|FG001|Overall Study|Withdrawal by Subject|0|||
164477283|NCT05886777|594117741|FG002|Overall Study|Withdrawal by Subject|1|||
164477284|NCT05886777|594117742|FG003|Overall Study|Withdrawal by Subject|4|||
164477285|NCT05886777|594117743|FG004|Overall Study|Withdrawal by Subject|3|||
164477286|NCT05886777|594117744|FG005|Overall Study|Withdrawal by Subject|1|||
164477287|NCT05886777|594117745|FG006|Overall Study|Withdrawal by Subject|1|||
164477288|NCT05886777|594117739|FG000|Overall Study|Protocol Violation|0|||
164477289|NCT05886777|594117740|FG001|Overall Study|Protocol Violation|0|||
164477290|NCT05886777|594117741|FG002|Overall Study|Protocol Violation|1|||
164477291|NCT05886777|594117742|FG003|Overall Study|Protocol Violation|0|||
164477292|NCT05886777|594117743|FG004|Overall Study|Protocol Violation|0|||
164477293|NCT05886777|594117744|FG005|Overall Study|Protocol Violation|0|||
164477294|NCT05886777|594117745|FG006|Overall Study|Protocol Violation|0|||
164477295|NCT05886777|594117739|FG000|Overall Study|No longer met eligibility criteria|0|||
164477296|NCT05886777|594117740|FG001|Overall Study|No longer met eligibility criteria|1|||
164477297|NCT05886777|594117741|FG002|Overall Study|No longer met eligibility criteria|0|||
164477298|NCT05886777|594117742|FG003|Overall Study|No longer met eligibility criteria|0|||
164477299|NCT05886777|594117743|FG004|Overall Study|No longer met eligibility criteria|0|||
164477300|NCT05886777|594117744|FG005|Overall Study|No longer met eligibility criteria|0|||
164477301|NCT05886777|594117745|FG006|Overall Study|No longer met eligibility criteria|0|||
164477302|NCT04172675|594118753|FG000|Overall Study|Withdrawal by Subject|7|||
164477303|NCT04172675|594118754|FG001|Overall Study|Withdrawal by Subject|5|||
164477304|NCT04172675|594118755|FG002|Overall Study|Withdrawal by Subject|1|||
164477305|NCT04172675|594118756|FG003|Overall Study|Withdrawal by Subject|4|||
164477306|NCT00378898|594118757|FG000|Overall Study|Withdrawal by Subject|10|||
164477307|NCT00378898|594118758|FG001|Overall Study|Withdrawal by Subject|5|||
164477308|NCT00378898|594118757|FG000|Overall Study|Protocol Violation|1|||
164477309|NCT00378898|594118758|FG001|Overall Study|Protocol Violation|1|||
164477310|NCT00551421|594118759|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
164477311|NCT00345046|594118765|FG000|Overall Study|Protocol Violation|1|||
164477312|NCT00345046|594118766|FG001|Overall Study|Protocol Violation|1|||
164477313|NCT00345046|594118767|FG002|Overall Study|Protocol Violation|2|||
164477314|NCT02000752|594118770|FG000|Overall Study|Dystocic delivery|19|||
164477315|NCT02000752|594118771|FG001|Overall Study|Dystocic delivery|8|||
164477316|NCT02000752|594118770|FG000|Overall Study|Shift Changes|12|||
164477317|NCT02000752|594118771|FG001|Overall Study|Shift Changes|5|||
164477318|NCT02357966|594118772|FG000|Overall Study|Death|0|||
164477319|NCT02357966|594118773|FG001|Overall Study|Death|0|||
164477320|NCT02357966|594118774|FG002|Overall Study|Death|1|||
164477321|NCT02357966|594118775|FG003|Overall Study|Death|0|||
164477322|NCT02357966|594118776|FG004|Overall Study|Death|2|||
164477323|NCT02357966|594118777|FG005|Overall Study|Death|0|||
164477324|NCT02357966|594118772|FG000|Overall Study|Physician Decision|1|||
164477325|NCT02357966|594118773|FG001|Overall Study|Physician Decision|0|||
164477326|NCT02357966|594118774|FG002|Overall Study|Physician Decision|0|||
164477327|NCT02357966|594118775|FG003|Overall Study|Physician Decision|0|||
164477328|NCT02357966|594118776|FG004|Overall Study|Physician Decision|1|||
164477329|NCT02357966|594118777|FG005|Overall Study|Physician Decision|0|||
164477330|NCT01779700|594118778|FG000|Overall Study|Adverse Event|4|||
164477331|NCT01779700|594118779|FG001|Overall Study|Adverse Event|3|||
164477332|NCT01779700|594118778|FG000|Overall Study|Withdrawal by Subject|0|||
164477333|NCT01779700|594118779|FG001|Overall Study|Withdrawal by Subject|2|||
164477334|NCT00019604|594118780|FG000|Overall Study|Death|1|||
164477335|NCT00019604|594118780|FG000|Overall Study|Progressive disease|23|||
164477336|NCT00019604|594118780|FG000|Overall Study|Refused treatment|1|||
164477337|NCT00019604|594118780|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
164477338|NCT00019604|594118780|FG000|Overall Study|Going to have liver transplant|1|||
164477339|NCT00019604|594118780|FG000|Overall Study|Move to a different study|1|||
164477340|NCT00019604|594118780|FG000|Overall Study|Non compliant on systemic CH|1|||
164477341|NCT00019604|594118780|FG000|Overall Study|Non compliant|1|||
164477342|NCT00019604|594118780|FG000|Overall Study|Resectable disease|1|||
164477343|NCT00019604|594118780|FG000|Overall Study|Started new chemo regimen|1|||
164477344|NCT00019604|594118780|FG000|Overall Study|Pt going to immunotherapy study|1|||
164477345|NCT00019604|594118780|FG000|Overall Study|Too much disease|1|||
164477346|NCT00019604|594118780|FG000|Overall Study|Unable to evaluate|1|||
164477347|NCT00019604|594118780|FG000|Overall Study|Details for other not available|4|||
164477348|NCT00918333|594118785|FG000|Overall Study|Drug not taken per protocol|1|||
164477349|NCT00918333|594118786|FG001|Overall Study|Drug not taken per protocol|0|||
164477350|NCT00918333|594118785|FG000|Overall Study|Inadequate amount of drugs provided|1|||
164477351|NCT00918333|594118786|FG001|Overall Study|Inadequate amount of drugs provided|4|||
164477352|NCT00918333|594118785|FG000|Overall Study|Ineligible|1|||
164477353|NCT00918333|594118786|FG001|Overall Study|Ineligible|0|||
164477354|NCT00918333|594118785|FG000|Overall Study|Withdrawal by Subject|0|||
164477355|NCT00918333|594118786|FG001|Overall Study|Withdrawal by Subject|1|||
164477356|NCT03392194|594118787|FG000|Overall Study|Withdrawal by Subject|1|||
164477357|NCT03392194|594118788|FG001|Overall Study|Withdrawal by Subject|2|||
164477358|NCT03392194|594118787|FG000|Overall Study|Conflicts with personal schedule|1|||
164477359|NCT03392194|594118788|FG001|Overall Study|Conflicts with personal schedule|0|||
164477360|NCT04497415|594118794|FG000|Overall Study|Lost to Follow-up|43|||
164477361|NCT04497415|594118795|FG001|Overall Study|Lost to Follow-up|27|||
164477362|NCT00620854|594118796|FG000|Washout 1|Withdrawal by Subject|0|||
164477363|NCT00620854|594118797|FG001|Washout 1|Withdrawal by Subject|0|||
164477364|NCT00620854|594118798|FG002|Washout 1|Withdrawal by Subject|1|||
164477365|NCT00620854|594118799|FG003|Washout 1|Withdrawal by Subject|1|||
164477366|NCT00620854|594118800|FG004|Washout 1|Withdrawal by Subject|0|||
164477367|NCT00620854|594118801|FG005|Washout 1|Withdrawal by Subject|0|||
164477368|NCT00463229|594118808|FG000|Overall Study|Lost to Follow-up|5|||
164477369|NCT00463229|594118809|FG001|Overall Study|Lost to Follow-up|7|||
164477370|NCT00463229|594118808|FG000|Overall Study|Death|4|||
164477371|NCT00463229|594118809|FG001|Overall Study|Death|3|||
164477372|NCT01359150|594118816|FG000|Overall Study|Lack of Efficacy|1|||
164477373|NCT01359150|594118817|FG001|Overall Study|Lack of Efficacy|1|||
164477374|NCT01359150|594118816|FG000|Overall Study|Withdrawal by Subject|1|||
164477375|NCT01359150|594118817|FG001|Overall Study|Withdrawal by Subject|1|||
164477376|NCT01359150|594118816|FG000|Overall Study|Adverse Event|4|||
164477377|NCT01359150|594118817|FG001|Overall Study|Adverse Event|3|||
164477378|NCT01359150|594118816|FG000|Overall Study|Other|1|||
164477379|NCT01359150|594118817|FG001|Overall Study|Other|0|||
164477380|NCT03113409|594118818|FG000|Overall Study|Withdrawal by Subject|5|||
164477381|NCT03113409|594118819|FG001|Overall Study|Withdrawal by Subject|0|||
164477382|NCT03113409|594118820|FG002|Overall Study|Withdrawal by Subject|0|||
164477383|NCT02040870|594118821|FG000|Overall Study|Completed treatment phase|6|||
164477384|NCT02040870|594118821|FG000|Overall Study|Adverse Event|7|||
164477385|NCT02040870|594118821|FG000|Overall Study|Progressive disease|58|||
164477386|NCT02040870|594118821|FG000|Overall Study|Physician Decision|6|||
164477387|NCT02040870|594118821|FG000|Overall Study|Subject/guardian decision|10|||
164714204|NCT03888066|594976821|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
164714205|NCT03888066|594976820|FG000|Run-in Phase|Withdrawal Of Consent|1|||
164714206|NCT03888066|594976821|FG001|Run-in Phase|Withdrawal Of Consent|0|||
164477388|NCT02040870|594118821|FG000|Overall Study|Lost to Follow-up|3|||
164477389|NCT02040870|594118821|FG000|Overall Study|Death|13|||
164477390|NCT01706159|594118831|FG000|Overall Study|Withdrawal Criteria|2|||
164477391|NCT01706159|594118832|FG001|Overall Study|Withdrawal Criteria|1|||
164477392|NCT01706159|594118831|FG000|Overall Study|Unclassified|6|||
164477393|NCT01706159|594118832|FG001|Overall Study|Unclassified|1|||
164477394|NCT02628626|594118835|FG000|Overall Study|Withdrawal by Subject|2|||
164477395|NCT02628626|594118836|FG001|Overall Study|Withdrawal by Subject|2|||
164477396|NCT01593020|594118837|FG000|Overall Study|Adverse Event|1|||
164477397|NCT01593020|594118838|FG001|Overall Study|Adverse Event|1|||
164477398|NCT01593020|594118837|FG000|Overall Study|Death|0|||
164477399|NCT01593020|594118838|FG001|Overall Study|Death|1|||
164477400|NCT01593020|594118837|FG000|Overall Study|Ineligible|1|||
164477401|NCT01593020|594118838|FG001|Overall Study|Ineligible|0|||
164477402|NCT04801420|594118844|FG000|Overall Study|Other|1|||
164477403|NCT04801420|594118845|FG001|Overall Study|Other|2|||
164477404|NCT04801420|594118846|FG002|Overall Study|Other|1|||
164477405|NCT04801420|594118844|FG000|Overall Study|Lost to Follow-up|7|||
164477406|NCT04801420|594118845|FG001|Overall Study|Lost to Follow-up|9|||
164477407|NCT04801420|594118846|FG002|Overall Study|Lost to Follow-up|10|||
164477408|NCT04801420|594118844|FG000|Overall Study|Moved from study area|0|||
164477409|NCT04801420|594118845|FG001|Overall Study|Moved from study area|1|||
164477410|NCT04801420|594118846|FG002|Overall Study|Moved from study area|1|||
164477411|NCT04801420|594118844|FG000|Overall Study|Withdrawal by Subject|5|||
164477412|NCT04801420|594118845|FG001|Overall Study|Withdrawal by Subject|1|||
164477413|NCT04801420|594118846|FG002|Overall Study|Withdrawal by Subject|4|||
164477414|NCT04801420|594118844|FG000|Overall Study|Individual stopping criteria reached|0|||
164477415|NCT04801420|594118845|FG001|Overall Study|Individual stopping criteria reached|1|||
164477416|NCT04801420|594118846|FG002|Overall Study|Individual stopping criteria reached|0|||
164477417|NCT04801420|594118844|FG000|Overall Study|Ongoing in the study|195|||
164477418|NCT04801420|594118845|FG001|Overall Study|Ongoing in the study|195|||
164477419|NCT04801420|594118846|FG002|Overall Study|Ongoing in the study|192|||
164477420|NCT03371017|594118847|FG000|Overall Study|Physician Decision|0|||
164477421|NCT03371017|594118848|FG001|Overall Study|Physician Decision|1|||
164477422|NCT03371017|594118847|FG000|Overall Study|Reason not Specified|0|||
164477423|NCT03371017|594118848|FG001|Overall Study|Reason not Specified|1|||
164477424|NCT03371017|594118847|FG000|Overall Study|Lost to Follow-up|13|||
164477425|NCT03371017|594118848|FG001|Overall Study|Lost to Follow-up|16|||
164477426|NCT03371017|594118847|FG000|Overall Study|Death|228|||
164477427|NCT03371017|594118848|FG001|Overall Study|Death|215|||
164477428|NCT03371017|594118847|FG000|Overall Study|Withdrawal by Subject|20|||
164477429|NCT03371017|594118848|FG001|Overall Study|Withdrawal by Subject|25|||
164477430|NCT03371017|594118847|FG000|Overall Study|Study Ended by Sponsor|37|||
164477431|NCT03371017|594118848|FG001|Overall Study|Study Ended by Sponsor|38|||
164477432|NCT03371017|594118847|FG000|Overall Study|Protocol Deviation|0|||
164477433|NCT03371017|594118848|FG001|Overall Study|Protocol Deviation|1|||
164477434|NCT04057131|594118849|FG000|Overall Study|Protocol Violation|24|||
164477435|NCT02830204|594118850|FG000|Overall Study|Death|9|||
164477436|NCT02830204|594118850|FG000|Overall Study|Withdrawal by Subject|1|||
164477437|NCT02517268|594118853|FG000|Overall Study|Withdrawal by Subject|1|||
164477438|NCT02517268|594118854|FG001|Overall Study|Withdrawal by Subject|0|||
164477439|NCT04686266|594118857|FG000|Overall Study|Withdrawal by Subject|0|||
164477440|NCT04686266|594118858|FG001|Overall Study|Withdrawal by Subject|1|||
164477441|NCT02401815|594118863|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
164477442|NCT02401815|594118864|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
164477443|NCT02401815|594118865|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
164477444|NCT02401815|594118866|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
164477445|NCT02401815|594118867|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
164477446|NCT02401815|594118868|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
164477447|NCT02401815|594118869|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
164477448|NCT02401815|594118870|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
164477449|NCT02401815|594118871|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
164477450|NCT02401815|594118872|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
164477451|NCT02401815|594118863|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
164477452|NCT02401815|594118864|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
164477453|NCT02401815|594118865|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
164477454|NCT02401815|594118866|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
164477455|NCT02401815|594118867|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
164477456|NCT02401815|594118868|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
164477457|NCT02401815|594118869|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
164477458|NCT02401815|594118870|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
164477459|NCT02401815|594118871|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
164477460|NCT02401815|594118872|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
164477461|NCT02401815|594118863|FG000|Dose Escalation (up to 670 Days)|Death|1|||
164477462|NCT02401815|594118864|FG001|Dose Escalation (up to 670 Days)|Death|2|||
164477463|NCT02401815|594118865|FG002|Dose Escalation (up to 670 Days)|Death|3|||
164477464|NCT02401815|594118866|FG003|Dose Escalation (up to 670 Days)|Death|5|||
164477465|NCT02401815|594118867|FG004|Dose Escalation (up to 670 Days)|Death|4|||
164477466|NCT02401815|594118868|FG005|Dose Escalation (up to 670 Days)|Death|0|||
164477467|NCT02401815|594118869|FG006|Dose Escalation (up to 670 Days)|Death|0|||
164477468|NCT02401815|594118870|FG007|Dose Escalation (up to 670 Days)|Death|0|||
164477469|NCT02401815|594118871|FG008|Dose Escalation (up to 670 Days)|Death|0|||
164477470|NCT02401815|594118872|FG009|Dose Escalation (up to 670 Days)|Death|0|||
164477471|NCT02401815|594118863|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
164477472|NCT02401815|594118864|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
164477473|NCT02401815|594118865|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
164477474|NCT02401815|594118866|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
164477475|NCT02401815|594118867|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
164477476|NCT02401815|594118868|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
164477477|NCT02401815|594118869|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
164477478|NCT02401815|594118870|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
164477479|NCT02401815|594118871|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
164477480|NCT02401815|594118872|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
164477481|NCT02401815|594118863|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
164477482|NCT02401815|594118864|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
164477483|NCT02401815|594118865|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
164477484|NCT02401815|594118866|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
164477485|NCT02401815|594118867|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
164477486|NCT02401815|594118868|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
164477487|NCT02401815|594118869|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
164477488|NCT02401815|594118870|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
164477489|NCT02401815|594118871|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
164477490|NCT02401815|594118872|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
164477491|NCT02401815|594118863|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
164477492|NCT02401815|594118864|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
164477493|NCT02401815|594118865|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
164477494|NCT02401815|594118866|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
164477495|NCT02401815|594118867|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
164477496|NCT02401815|594118868|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
164477497|NCT02401815|594118869|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
164477498|NCT02401815|594118870|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
164477499|NCT02401815|594118871|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
164477500|NCT02401815|594118872|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
164477501|NCT02401815|594118863|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
164477502|NCT02401815|594118864|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
164477503|NCT02401815|594118865|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
164477504|NCT02401815|594118866|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
164477505|NCT02401815|594118867|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
164477506|NCT02401815|594118868|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
164477507|NCT02401815|594118869|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
164477508|NCT02401815|594118870|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
164477509|NCT02401815|594118871|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
164477510|NCT02401815|594118872|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
164477511|NCT02401815|594118863|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
164477512|NCT02401815|594118864|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
164477513|NCT02401815|594118865|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
164477514|NCT02401815|594118866|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
164477515|NCT02401815|594118867|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
164477516|NCT02401815|594118868|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
164477517|NCT02401815|594118869|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
164477518|NCT02401815|594118870|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
164477519|NCT02401815|594118871|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
164477520|NCT02401815|594118872|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
164477521|NCT02401815|594118863|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
164477522|NCT02401815|594118864|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
164477523|NCT02401815|594118865|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
164477524|NCT02401815|594118866|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
164477525|NCT02401815|594118867|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
164477526|NCT02401815|594118868|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
164477527|NCT02401815|594118869|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
164477528|NCT02401815|594118870|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
164477529|NCT02401815|594118871|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
164477530|NCT02401815|594118872|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
164477531|NCT02401815|594118863|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
164477532|NCT02401815|594118864|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
164477533|NCT02401815|594118865|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
164477534|NCT02401815|594118866|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
164477535|NCT02401815|594118867|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
164477536|NCT02401815|594118868|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
164477537|NCT02401815|594118869|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
164477538|NCT02401815|594118870|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
164477539|NCT02401815|594118871|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
164477540|NCT02401815|594118872|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
164144908|NCT05199090|592891823|FG001|Overall Study|Physician Decision|0|||
164477541|NCT02401815|594118863|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
164477542|NCT02401815|594118864|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
164477543|NCT02401815|594118865|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
164477544|NCT02401815|594118866|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
164477545|NCT02401815|594118867|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
164477546|NCT02401815|594118868|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
164477547|NCT02401815|594118869|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
164477548|NCT02401815|594118870|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
164477549|NCT02401815|594118871|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
164477550|NCT02401815|594118872|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
164477551|NCT02401815|594118863|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
164477552|NCT02401815|594118864|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
164477553|NCT02401815|594118865|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
164477554|NCT02401815|594118866|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
164477555|NCT02401815|594118867|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
164477556|NCT02401815|594118868|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
164477557|NCT02401815|594118869|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
164477558|NCT02401815|594118870|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
164477559|NCT02401815|594118871|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
164477560|NCT02401815|594118872|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
164477561|NCT02401815|594118863|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
164477562|NCT02401815|594118864|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
164477563|NCT02401815|594118865|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
164477564|NCT02401815|594118866|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
164477565|NCT02401815|594118867|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
164477566|NCT02401815|594118868|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
164477567|NCT02401815|594118869|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
164477568|NCT02401815|594118870|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
164477569|NCT02401815|594118871|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
164477570|NCT02401815|594118872|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
164477571|NCT02401815|594118863|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
164477572|NCT02401815|594118864|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
164477573|NCT02401815|594118865|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
164477574|NCT02401815|594118866|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
164477575|NCT02401815|594118867|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
164477576|NCT02401815|594118868|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
164477577|NCT02401815|594118869|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
164477578|NCT02401815|594118870|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
164477579|NCT02401815|594118871|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
164477580|NCT02401815|594118872|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
164477581|NCT03773107|594118873|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
164477582|NCT03773107|594118874|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
164477583|NCT03773107|594118875|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
164477584|NCT03773107|594118876|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
164477585|NCT07204444|594118878|FG000|Overall Study|Medical/Hospitalization|6|||
164477586|NCT07204444|594118879|FG001|Overall Study|Medical/Hospitalization|9|||
164477587|NCT07204444|594118880|FG002|Overall Study|Medical/Hospitalization|6|||
164477588|NCT07204444|594118878|FG000|Overall Study|Treatment Provider Issue|1|||
164477589|NCT07204444|594118879|FG001|Overall Study|Treatment Provider Issue|3|||
164477590|NCT07204444|594118880|FG002|Overall Study|Treatment Provider Issue|0|||
164477591|NCT07204444|594118878|FG000|Overall Study|Withdrawal by Subject|11|||
164477592|NCT07204444|594118879|FG001|Overall Study|Withdrawal by Subject|5|||
164477593|NCT07204444|594118880|FG002|Overall Study|Withdrawal by Subject|5|||
164477594|NCT07204444|594118878|FG000|Overall Study|Death|3|||
164477595|NCT07204444|594118879|FG001|Overall Study|Death|6|||
164477596|NCT07204444|594118880|FG002|Overall Study|Death|1|||
164477597|NCT07204444|594118878|FG000|Overall Study|Unable To Reach|29|||
164477598|NCT07204444|594118879|FG001|Overall Study|Unable To Reach|26|||
164477599|NCT07204444|594118880|FG002|Overall Study|Unable To Reach|17|||
164477600|NCT07204444|594118878|FG000|Overall Study|Protocol Deviation|3|||
164477601|NCT07204444|594118879|FG001|Overall Study|Protocol Deviation|2|||
164477602|NCT07204444|594118880|FG002|Overall Study|Protocol Deviation|0|||
164714207|NCT03888066|594976820|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
164714208|NCT03888066|594976821|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
164714209|NCT03888066|594976820|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
164477603|NCT03220724|594120080|FG000|Overall Study|Lost to Follow-up|2|||
164477604|NCT03220724|594120081|FG001|Overall Study|Lost to Follow-up|2|||
164477605|NCT03220724|594120082|FG002|Overall Study|Lost to Follow-up|0|||
164477606|NCT03220724|594120083|FG003|Overall Study|Lost to Follow-up|3|||
164477607|NCT03220724|594120084|FG004|Overall Study|Lost to Follow-up|1|||
164477608|NCT03220724|594120085|FG005|Overall Study|Lost to Follow-up|0|||
164477609|NCT03220724|594120086|FG006|Overall Study|Lost to Follow-up|2|||
164477610|NCT03220724|594120087|FG007|Overall Study|Lost to Follow-up|1|||
164477611|NCT03220724|594120088|FG008|Overall Study|Lost to Follow-up|0|||
164477612|NCT03220724|594120080|FG000|Overall Study|Withdrawal by Subject|1|||
164477613|NCT03220724|594120081|FG001|Overall Study|Withdrawal by Subject|0|||
164477614|NCT03220724|594120082|FG002|Overall Study|Withdrawal by Subject|1|||
164477615|NCT03220724|594120083|FG003|Overall Study|Withdrawal by Subject|0|||
164477616|NCT03220724|594120084|FG004|Overall Study|Withdrawal by Subject|0|||
164477617|NCT03220724|594120085|FG005|Overall Study|Withdrawal by Subject|0|||
164477618|NCT03220724|594120086|FG006|Overall Study|Withdrawal by Subject|0|||
164477619|NCT03220724|594120087|FG007|Overall Study|Withdrawal by Subject|0|||
164477620|NCT03220724|594120088|FG008|Overall Study|Withdrawal by Subject|0|||
164477621|NCT01613417|594120089|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
164477622|NCT01613417|594120090|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
164477623|NCT00512252|594120092|FG000|Overall Study|Lost to Follow-up|0|||
164477624|NCT00512252|594120093|FG001|Overall Study|Lost to Follow-up|0|||
164477625|NCT00512252|594120094|FG002|Overall Study|Lost to Follow-up|1|||
164477626|NCT00512252|594120092|FG000|Overall Study|Protocol Violation|0|||
164477627|NCT00512252|594120093|FG001|Overall Study|Protocol Violation|0|||
164477628|NCT00512252|594120094|FG002|Overall Study|Protocol Violation|1|||
164477629|NCT00512252|594120092|FG000|Overall Study|Death|0|||
164477630|NCT00512252|594120093|FG001|Overall Study|Death|0|||
164477631|NCT00512252|594120094|FG002|Overall Study|Death|1|||
164477632|NCT04608409|594120098|FG000|Overall Study|Physician Decision|1|||
164477633|NCT04608409|594120099|FG001|Overall Study|Physician Decision|1|||
164477634|NCT04608409|594120100|FG002|Overall Study|Physician Decision|2|||
164477635|NCT00047385|594120101|FG000|Overall Study|Death before any screening|2|||
164477636|NCT00047385|594120102|FG001|Overall Study|Death before any screening|5|||
164477637|NCT00047385|594120101|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
164477638|NCT00047385|594120102|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
164477639|NCT00047385|594120101|FG000|Overall Study|Eligible for screening but had no screen|260|||
164477640|NCT00047385|594120102|FG001|Overall Study|Eligible for screening but had no screen|492|||
164477641|NCT03865732|594120103|FG000|Overall Study|Adverse Event|0|||
164477642|NCT03865732|594120104|FG001|Overall Study|Adverse Event|1|||
164477643|NCT00454194|594120105|FG000|Overall Study|Adverse Event|7|||
164477644|NCT00454194|594120106|FG001|Overall Study|Adverse Event|2|||
164477645|NCT00454194|594120105|FG000|Overall Study|Withdrawal by Subject|12|||
164477646|NCT00454194|594120106|FG001|Overall Study|Withdrawal by Subject|8|||
164477647|NCT00454194|594120105|FG000|Overall Study|Other Medical Problems|1|||
164477648|NCT00454194|594120106|FG001|Overall Study|Other Medical Problems|2|||
164477649|NCT00454194|594120105|FG000|Overall Study|Other Unspecified Reason|2|||
164477650|NCT00454194|594120106|FG001|Overall Study|Other Unspecified Reason|2|||
164477651|NCT02095145|594120109|FG000|Overall Study|Withdrawal by Subject|1|||
164477652|NCT02095145|594120110|FG001|Overall Study|Withdrawal by Subject|0|||
164477653|NCT01170208|594120119|FG000|Overall Study|Withdrawal by Subject|5|||
164477654|NCT01170208|594120120|FG001|Overall Study|Withdrawal by Subject|0|||
164477655|NCT01170208|594120121|FG002|Overall Study|Withdrawal by Subject|1|||
164477656|NCT01170208|594120119|FG000|Overall Study|Protocol Violation|1|||
164477657|NCT01170208|594120120|FG001|Overall Study|Protocol Violation|0|||
164477658|NCT01170208|594120121|FG002|Overall Study|Protocol Violation|1|||
164477659|NCT03335488|594120122|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
164477660|NCT03335488|594120123|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
164477661|NCT03335488|594120122|FG000|Safety Extension Period|Adverse Event|1|||
164477662|NCT03335488|594120123|FG001|Safety Extension Period|Adverse Event|0|||
164477663|NCT03335488|594120122|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
164477664|NCT03335488|594120123|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
164477665|NCT04971733|594120124|FG000|Overall Study|Adverse Event|1|||
164477666|NCT04971733|594120125|FG001|Overall Study|Adverse Event|1|||
164477667|NCT04971733|594120124|FG000|Overall Study|Subject choice|2|||
164477668|NCT04971733|594120125|FG001|Overall Study|Subject choice|0|||
164477669|NCT04971733|594120124|FG000|Overall Study|Withdrawal by Subject|1|||
164477670|NCT04971733|594120125|FG001|Overall Study|Withdrawal by Subject|0|||
164477671|NCT04971733|594120124|FG000|Overall Study|Other|1|||
164477672|NCT04971733|594120125|FG001|Overall Study|Other|0|||
164477673|NCT01160354|594120126|FG000|Overall Study|Death|0|||
164477674|NCT01160354|594120127|FG001|Overall Study|Death|1|||
164477675|NCT01160354|594120128|FG002|Overall Study|Death|1|||
164477676|NCT00600353|594120132|FG000|Overall Study|history of malignancy within 5 years|1|||
164477677|NCT00600353|594120133|FG001|Overall Study|history of malignancy within 5 years|0|||
164477678|NCT00600353|594120132|FG000|Overall Study|History of prepartive regimen|0|||
164477679|NCT00600353|594120133|FG001|Overall Study|History of prepartive regimen|1|||
164477680|NCT04941482|594120134|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
164477681|NCT04941482|594120135|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
164477682|NCT04200664|594120136|FG000|Overall Study|Withdrawal by Subject|1|||
164477683|NCT04200664|594120137|FG001|Overall Study|Withdrawal by Subject|0|||
164477684|NCT04200664|594120138|FG002|Overall Study|Withdrawal by Subject|0|||
164477685|NCT03362190|594120141|FG000|Overall Study|Adverse Event|0|||
164477686|NCT03362190|594120142|FG001|Overall Study|Adverse Event|0|||
164477687|NCT03362190|594120143|FG002|Overall Study|Adverse Event|0|||
164477688|NCT03362190|594120144|FG003|Overall Study|Adverse Event|1|||
164477689|NCT03362190|594120141|FG000|Overall Study|Withdrawal by Subject|0|||
164477690|NCT03362190|594120142|FG001|Overall Study|Withdrawal by Subject|0|||
164477691|NCT03362190|594120143|FG002|Overall Study|Withdrawal by Subject|0|||
164477692|NCT03362190|594120144|FG003|Overall Study|Withdrawal by Subject|1|||
164477693|NCT00687219|594120145|FG000|Overall Study|Adverse Event|8|||
164477694|NCT00687219|594120145|FG000|Overall Study|Discontinuance criteria met|7|||
164477695|NCT00687219|594120145|FG000|Overall Study|HCV-RNA positive conversion|34|||
164477696|NCT00687219|594120145|FG000|Overall Study|Withdrawal by Subject|1|||
164477697|NCT00687219|594120145|FG000|Overall Study|Lack of Efficacy|1|||
164477698|NCT03102034|594120152|FG000|Overall Study|Withdrawal by Subject|1|||
164477699|NCT03102034|594120153|FG001|Overall Study|Withdrawal by Subject|0|||
164477700|NCT00676091|594120155|FG000|Infant Series|Parent or legal guardian request|10|||
164477701|NCT00676091|594120156|FG001|Infant Series|Parent or legal guardian request|8|||
164477702|NCT00676091|594120155|FG000|Infant Series|Protocol Violation|6|||
164477703|NCT00676091|594120156|FG001|Infant Series|Protocol Violation|3|||
164477704|NCT00676091|594120155|FG000|Infant Series|Adverse Event|2|||
164477705|NCT00676091|594120156|FG001|Infant Series|Adverse Event|3|||
164477706|NCT00676091|594120155|FG000|Infant Series|Failed to return|1|||
164477707|NCT00676091|594120156|FG001|Infant Series|Failed to return|3|||
164477708|NCT00676091|594120155|FG000|Infant Series|Lost to Follow-up|1|||
164477709|NCT00676091|594120156|FG001|Infant Series|Lost to Follow-up|0|||
164477710|NCT00676091|594120155|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
164477711|NCT00676091|594120156|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
164477712|NCT00676091|594120155|FG000|After Infant Series|Adverse Event|0|||
164477713|NCT00676091|594120156|FG001|After Infant Series|Adverse Event|1|||
164477714|NCT00676091|594120155|FG000|After Infant Series|Protocol Violation|0|||
164477715|NCT00676091|594120156|FG001|After Infant Series|Protocol Violation|1|||
164477716|NCT00676091|594120155|FG000|After Infant Series|Failed to return|1|||
164477717|NCT00676091|594120156|FG001|After Infant Series|Failed to return|1|||
164477718|NCT00676091|594120155|FG000|Toddler Dose|Failed to return|2|||
164477719|NCT00676091|594120156|FG001|Toddler Dose|Failed to return|0|||
164477720|NCT00676091|594120155|FG000|Toddler Dose|Parent or legal guardian request|1|||
164477721|NCT00676091|594120156|FG001|Toddler Dose|Parent or legal guardian request|0|||
164477722|NCT00989196|594120162|FG000|Treatment Period|Lost to Follow-up|1|||
164477723|NCT00989196|594120163|FG001|Treatment Period|Lost to Follow-up|0|||
164477724|NCT04300023|594120166|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
164477725|NCT04300023|594120167|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
164477726|NCT05251363|594120168|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
164477727|NCT05251363|594120168|FG000|Overall Study After Implant Period|Death|9|||
164477728|NCT05251363|594120168|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
164477729|NCT05251363|594120168|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
164477730|NCT05251363|594120168|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
164477731|NCT05251363|594120168|FG000|Overall Study After Implant Period|Physician Decision|1|||
164477732|NCT05251363|594120168|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
164477733|NCT00748709|594120169|FG000|Overall Study|Progressive disease|15|||
164477734|NCT00748709|594120169|FG000|Overall Study|Drug reducing Toxity|2|||
164477735|NCT00748709|594120169|FG000|Overall Study|Other Adverse Event|1|||
164477736|NCT00748709|594120169|FG000|Overall Study|Withdrawal by Subject|1|||
164477737|NCT00748709|594120169|FG000|Overall Study|Other Reasons|1|||
164477738|NCT05470114|594120171|FG000|Overall Study|Withdrawal by Subject|1|||
164477739|NCT05470114|594120172|FG001|Overall Study|Withdrawal by Subject|0|||
164477740|NCT05470114|594120171|FG000|Overall Study|Lost to Follow-up|1|||
164477741|NCT05470114|594120172|FG001|Overall Study|Lost to Follow-up|0|||
164477742|NCT05325294|594120177|FG000|Overall Study|Adverse Event|3|||
164714210|NCT03888066|594976821|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
164714211|NCT03888066|594976820|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
164477743|NCT05325294|594120178|FG001|Overall Study|Adverse Event|3|||
164477744|NCT05325294|594120177|FG000|Overall Study|Physician Decision|0|||
164714212|NCT03888066|594976821|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
164714213|NCT03888066|594976820|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
164477745|NCT05325294|594120178|FG001|Overall Study|Physician Decision|1|||
164477746|NCT05325294|594120177|FG000|Overall Study|Withdrawal by Subject|0|||
164477747|NCT05325294|594120178|FG001|Overall Study|Withdrawal by Subject|3|||
164477748|NCT05325294|594120177|FG000|Overall Study|Lost to Follow-up|1|||
164714214|NCT03888066|594976821|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
164714215|NCT03888066|594976820|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
164714216|NCT03888066|594976821|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
164714217|NCT03888066|594976820|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
164714218|NCT03888066|594976821|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
164477749|NCT05325294|594120178|FG001|Overall Study|Lost to Follow-up|0|||
164477750|NCT05325294|594120177|FG000|Overall Study|Sponsor Request|0|||
164477751|NCT05325294|594120178|FG001|Overall Study|Sponsor Request|2|||
164477752|NCT04649047|594120179|FG000|Overall Study|Withdrawal by Subject|3|||
164477753|NCT02488408|594120180|FG000|Part A|Adverse Event|2|||
164477754|NCT02488408|594120181|FG001|Part A|Adverse Event|0|||
164477755|NCT02488408|594120182|FG002|Part A|Adverse Event|0|||
164477756|NCT02488408|594120183|FG003|Part A|Adverse Event|0|||
164477757|NCT02488408|594120184|FG004|Part A|Adverse Event|0|||
164477758|NCT02488408|594120185|FG005|Part A|Adverse Event|0|||
164477759|NCT02488408|594120186|FG006|Part A|Adverse Event|0|||
164477760|NCT02488408|594120187|FG007|Part A|Adverse Event|0|||
164477761|NCT02488408|594120188|FG008|Part A|Adverse Event|0|||
164477762|NCT02488408|594120189|FG009|Part A|Adverse Event|0|||
164714219|NCT03888066|594976820|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
164714220|NCT03888066|594976821|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
164714221|NCT03888066|594976820|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
164714222|NCT03888066|594976821|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
164714223|NCT03888066|594976820|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
164714224|NCT03888066|594976821|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
164714225|NCT03888066|594976820|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
164714226|NCT03888066|594976821|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
164477763|NCT02488408|594120180|FG000|Part A|Death|1|||
164477764|NCT02488408|594120181|FG001|Part A|Death|5|||
164477765|NCT02488408|594120182|FG002|Part A|Death|0|||
164477766|NCT02488408|594120183|FG003|Part A|Death|0|||
164477767|NCT02488408|594120184|FG004|Part A|Death|3|||
164477768|NCT02488408|594120185|FG005|Part A|Death|0|||
164477769|NCT02488408|594120186|FG006|Part A|Death|0|||
164477770|NCT02488408|594120187|FG007|Part A|Death|0|||
164477771|NCT02488408|594120188|FG008|Part A|Death|0|||
164477772|NCT02488408|594120189|FG009|Part A|Death|0|||
164477773|NCT02488408|594120180|FG000|Part A|Disease Progression|2|||
164477774|NCT02488408|594120181|FG001|Part A|Disease Progression|8|||
164477775|NCT02488408|594120182|FG002|Part A|Disease Progression|2|||
164477776|NCT02488408|594120183|FG003|Part A|Disease Progression|3|||
164477777|NCT02488408|594120184|FG004|Part A|Disease Progression|4|||
164477778|NCT02488408|594120185|FG005|Part A|Disease Progression|0|||
164477779|NCT02488408|594120186|FG006|Part A|Disease Progression|0|||
164477780|NCT02488408|594120187|FG007|Part A|Disease Progression|0|||
164477781|NCT02488408|594120188|FG008|Part A|Disease Progression|0|||
164477782|NCT02488408|594120189|FG009|Part A|Disease Progression|0|||
164477783|NCT02488408|594120180|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
164477784|NCT02488408|594120181|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
164477785|NCT02488408|594120182|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
164477786|NCT02488408|594120183|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
164477787|NCT02488408|594120184|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
164477788|NCT02488408|594120185|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
164477789|NCT02488408|594120186|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
164477790|NCT02488408|594120187|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
164477791|NCT02488408|594120188|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
164477792|NCT02488408|594120189|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
164477793|NCT02488408|594120180|FG000|Part A|Investigator Decision|0|||
164477794|NCT02488408|594120181|FG001|Part A|Investigator Decision|1|||
164477795|NCT02488408|594120182|FG002|Part A|Investigator Decision|1|||
164477796|NCT02488408|594120183|FG003|Part A|Investigator Decision|0|||
164477797|NCT02488408|594120184|FG004|Part A|Investigator Decision|0|||
164477798|NCT02488408|594120185|FG005|Part A|Investigator Decision|0|||
164477799|NCT02488408|594120186|FG006|Part A|Investigator Decision|0|||
164477800|NCT02488408|594120187|FG007|Part A|Investigator Decision|0|||
164477801|NCT02488408|594120188|FG008|Part A|Investigator Decision|0|||
164477802|NCT02488408|594120189|FG009|Part A|Investigator Decision|0|||
164477803|NCT02488408|594120180|FG000|Part A|Withdrawal by Subject|0|||
164477804|NCT02488408|594120181|FG001|Part A|Withdrawal by Subject|0|||
164477805|NCT02488408|594120182|FG002|Part A|Withdrawal by Subject|2|||
164477806|NCT02488408|594120183|FG003|Part A|Withdrawal by Subject|0|||
164477807|NCT02488408|594120184|FG004|Part A|Withdrawal by Subject|0|||
164477808|NCT02488408|594120185|FG005|Part A|Withdrawal by Subject|0|||
164477809|NCT02488408|594120186|FG006|Part A|Withdrawal by Subject|0|||
164477810|NCT02488408|594120187|FG007|Part A|Withdrawal by Subject|0|||
164477811|NCT02488408|594120188|FG008|Part A|Withdrawal by Subject|0|||
164477812|NCT02488408|594120189|FG009|Part A|Withdrawal by Subject|0|||
164477813|NCT02488408|594120180|FG000|Part A|Other|1|||
164477814|NCT02488408|594120181|FG001|Part A|Other|0|||
164477815|NCT02488408|594120182|FG002|Part A|Other|0|||
164477816|NCT02488408|594120183|FG003|Part A|Other|0|||
164477817|NCT02488408|594120184|FG004|Part A|Other|0|||
164477818|NCT02488408|594120185|FG005|Part A|Other|0|||
164477819|NCT02488408|594120186|FG006|Part A|Other|0|||
164477820|NCT02488408|594120187|FG007|Part A|Other|0|||
164477821|NCT02488408|594120188|FG008|Part A|Other|0|||
164477822|NCT02488408|594120189|FG009|Part A|Other|0|||
164477823|NCT02488408|594120180|FG000|Part B|Adverse Event|0|||
164477824|NCT02488408|594120181|FG001|Part B|Adverse Event|0|||
164477825|NCT02488408|594120182|FG002|Part B|Adverse Event|0|||
164477826|NCT02488408|594120183|FG003|Part B|Adverse Event|0|||
164477827|NCT02488408|594120184|FG004|Part B|Adverse Event|0|||
164477828|NCT02488408|594120185|FG005|Part B|Adverse Event|2|||
164477829|NCT02488408|594120186|FG006|Part B|Adverse Event|2|||
164477830|NCT02488408|594120187|FG007|Part B|Adverse Event|7|||
164477831|NCT02488408|594120188|FG008|Part B|Adverse Event|2|||
164477832|NCT02488408|594120189|FG009|Part B|Adverse Event|2|||
164477833|NCT02488408|594120180|FG000|Part B|Death|0|||
164477834|NCT02488408|594120181|FG001|Part B|Death|0|||
164477835|NCT02488408|594120182|FG002|Part B|Death|0|||
164477836|NCT02488408|594120183|FG003|Part B|Death|0|||
164477837|NCT02488408|594120184|FG004|Part B|Death|0|||
164477838|NCT02488408|594120185|FG005|Part B|Death|3|||
164477839|NCT02488408|594120186|FG006|Part B|Death|1|||
164477840|NCT02488408|594120187|FG007|Part B|Death|2|||
164477841|NCT02488408|594120188|FG008|Part B|Death|2|||
164477842|NCT02488408|594120189|FG009|Part B|Death|2|||
164477843|NCT02488408|594120180|FG000|Part B|Death due to Disease Progression|0|||
164477844|NCT02488408|594120181|FG001|Part B|Death due to Disease Progression|0|||
164477845|NCT02488408|594120182|FG002|Part B|Death due to Disease Progression|0|||
164477846|NCT02488408|594120183|FG003|Part B|Death due to Disease Progression|0|||
164477847|NCT02488408|594120184|FG004|Part B|Death due to Disease Progression|0|||
164477848|NCT02488408|594120185|FG005|Part B|Death due to Disease Progression|2|||
164477849|NCT02488408|594120186|FG006|Part B|Death due to Disease Progression|2|||
164477850|NCT02488408|594120187|FG007|Part B|Death due to Disease Progression|1|||
164477851|NCT02488408|594120188|FG008|Part B|Death due to Disease Progression|1|||
164477852|NCT02488408|594120189|FG009|Part B|Death due to Disease Progression|1|||
164477853|NCT02488408|594120180|FG000|Part B|Disease Progression|0|||
164477854|NCT02488408|594120181|FG001|Part B|Disease Progression|0|||
164477855|NCT02488408|594120182|FG002|Part B|Disease Progression|0|||
164477856|NCT02488408|594120183|FG003|Part B|Disease Progression|0|||
164477857|NCT02488408|594120184|FG004|Part B|Disease Progression|0|||
164477858|NCT02488408|594120185|FG005|Part B|Disease Progression|6|||
164477859|NCT02488408|594120186|FG006|Part B|Disease Progression|9|||
164477860|NCT02488408|594120187|FG007|Part B|Disease Progression|7|||
164477861|NCT02488408|594120188|FG008|Part B|Disease Progression|9|||
164477862|NCT02488408|594120189|FG009|Part B|Disease Progression|11|||
164477863|NCT02488408|594120180|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
164477864|NCT02488408|594120181|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
164477865|NCT02488408|594120182|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
164477866|NCT02488408|594120183|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
164477867|NCT02488408|594120184|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
164477868|NCT02488408|594120185|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
164477869|NCT02488408|594120186|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
164477870|NCT02488408|594120187|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
164477871|NCT02488408|594120188|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
164477872|NCT02488408|594120189|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
164477873|NCT02488408|594120180|FG000|Part B|Investigator Decision|0|||
164477874|NCT02488408|594120181|FG001|Part B|Investigator Decision|0|||
164477875|NCT02488408|594120182|FG002|Part B|Investigator Decision|0|||
164477876|NCT02488408|594120183|FG003|Part B|Investigator Decision|0|||
164477877|NCT02488408|594120184|FG004|Part B|Investigator Decision|0|||
164477878|NCT02488408|594120185|FG005|Part B|Investigator Decision|0|||
164477879|NCT02488408|594120186|FG006|Part B|Investigator Decision|1|||
164477880|NCT02488408|594120187|FG007|Part B|Investigator Decision|0|||
164477881|NCT02488408|594120188|FG008|Part B|Investigator Decision|2|||
164477882|NCT02488408|594120189|FG009|Part B|Investigator Decision|1|||
164477883|NCT00719888|594120190|FG000|Overall Study|Death|24|||
164477884|NCT00719888|594120191|FG001|Overall Study|Death|9|||
164599929|NCT02358369|594556404|FG004|Treatment Period A/B|Death|0|||
164477885|NCT00719888|594120190|FG000|Overall Study|Relapse|8|||
164477886|NCT00719888|594120191|FG001|Overall Study|Relapse|3|||
164477887|NCT00719888|594120190|FG000|Overall Study|Physician Decision|1|||
164477888|NCT00719888|594120191|FG001|Overall Study|Physician Decision|0|||
164477889|NCT00719888|594120190|FG000|Overall Study|Withdrawal by Subject|1|||
164477890|NCT00719888|594120191|FG001|Overall Study|Withdrawal by Subject|0|||
164477891|NCT00491894|594120192|FG000|Overall Study|Adverse Event|14|||
164477892|NCT00491894|594120192|FG000|Overall Study|Withdrawal by Subject|5|||
164477893|NCT00491894|594120192|FG000|Overall Study|Death|3|||
164477894|NCT00491894|594120192|FG000|Overall Study|Lost to Follow-up|3|||
164477895|NCT00491894|594120192|FG000|Overall Study|Lack of Efficacy|2|||
164477896|NCT00491894|594120192|FG000|Overall Study|Other-Failed to meet any criteria|2|||
164477897|NCT00491894|594120192|FG000|Overall Study|Physician Decision|2|||
164477898|NCT00491894|594120192|FG000|Overall Study|Protocol Violation|2|||
164477899|NCT00491894|594120192|FG000|Overall Study|Other-Intake of prohibited medication|1|||
164477900|NCT05422339|594121414|FG000|Overall Study|Withdrawal by Subject|17|||
164477901|NCT05422339|594121415|FG001|Overall Study|Withdrawal by Subject|15|||
164477902|NCT03136159|594121422|FG000|Overall Study|chorioamnionitis|2|||
164477903|NCT03136159|594121423|FG001|Overall Study|chorioamnionitis|0|||
164477904|NCT03136159|594121422|FG000|Overall Study|vertical skin incision|1|||
164477905|NCT03136159|594121423|FG001|Overall Study|vertical skin incision|0|||
164477906|NCT03136159|594121422|FG000|Overall Study|additional dressing|1|||
164477907|NCT03136159|594121423|FG001|Overall Study|additional dressing|0|||
164477908|NCT03136159|594121422|FG000|Overall Study|never got dressing placed|1|||
164477909|NCT03136159|594121423|FG001|Overall Study|never got dressing placed|0|||
164477910|NCT01278030|594121424|FG000|Overall Study|Withdrawal by Subject|8|||
164477911|NCT01278030|594121425|FG001|Overall Study|Withdrawal by Subject|4|||
164477912|NCT00731692|594121426|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
164477913|NCT00731692|594121427|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
164477914|NCT00731692|594121428|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
164477915|NCT00731692|594121426|FG000|Core Study (36 Months)|Physician Decision|1|||
164477916|NCT00731692|594121427|FG001|Core Study (36 Months)|Physician Decision|0|||
164477917|NCT00731692|594121428|FG002|Core Study (36 Months)|Physician Decision|2|||
164477918|NCT00731692|594121426|FG000|Core Study (36 Months)|Death|2|||
164477919|NCT00731692|594121427|FG001|Core Study (36 Months)|Death|1|||
164477920|NCT00731692|594121428|FG002|Core Study (36 Months)|Death|2|||
164477921|NCT00731692|594121426|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
164477922|NCT00731692|594121427|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
164477923|NCT00731692|594121428|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
164477924|NCT00731692|594121426|FG000|Core Study (36 Months)|Administrative|2|||
164477925|NCT00731692|594121427|FG001|Core Study (36 Months)|Administrative|2|||
164477926|NCT00731692|594121428|FG002|Core Study (36 Months)|Administrative|6|||
164477927|NCT00731692|594121426|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
164477928|NCT00731692|594121427|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
164477929|NCT00731692|594121428|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
164477930|NCT00731692|594121426|FG000|Core Study (36 Months)|Protocol Violation|4|||
164477931|NCT00731692|594121427|FG001|Core Study (36 Months)|Protocol Violation|5|||
164477932|NCT00731692|594121428|FG002|Core Study (36 Months)|Protocol Violation|8|||
164477933|NCT00731692|594121426|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
164477934|NCT00731692|594121427|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
164477935|NCT00731692|594121428|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
164477936|NCT00731692|594121426|FG000|Core Study (36 Months)|Adverse Event|25|||
164477937|NCT00731692|594121427|FG001|Core Study (36 Months)|Adverse Event|28|||
164477938|NCT00731692|594121428|FG002|Core Study (36 Months)|Adverse Event|29|||
164477939|NCT00731692|594121426|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
164477940|NCT00731692|594121427|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
164477941|NCT00731692|594121428|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
164477942|NCT00731692|594121426|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
164477943|NCT00731692|594121427|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
164477944|NCT00731692|594121428|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
164477945|NCT00731692|594121426|FG000|Extension Phase|Abnormal test procedure|0|||
164477946|NCT00731692|594121427|FG001|Extension Phase|Abnormal test procedure|0|||
164477947|NCT00731692|594121428|FG002|Extension Phase|Abnormal test procedure|1|||
164477948|NCT00731692|594121426|FG000|Extension Phase|Abnormal lab values|0|||
164477949|NCT00731692|594121427|FG001|Extension Phase|Abnormal lab values|0|||
164477950|NCT00731692|594121428|FG002|Extension Phase|Abnormal lab values|1|||
164477951|NCT00731692|594121426|FG000|Extension Phase|Lost to Follow-up|0|||
164477952|NCT00731692|594121427|FG001|Extension Phase|Lost to Follow-up|1|||
164477953|NCT00731692|594121428|FG002|Extension Phase|Lost to Follow-up|4|||
164477954|NCT00731692|594121426|FG000|Extension Phase|Withdrawal by Subject|4|||
164477955|NCT00731692|594121427|FG001|Extension Phase|Withdrawal by Subject|5|||
164477956|NCT00731692|594121428|FG002|Extension Phase|Withdrawal by Subject|3|||
164477957|NCT00731692|594121426|FG000|Extension Phase|Adverse Event|1|||
164477958|NCT00731692|594121427|FG001|Extension Phase|Adverse Event|1|||
164477959|NCT00731692|594121428|FG002|Extension Phase|Adverse Event|15|||
164477960|NCT00458783|594121429|FG000|Overall Study|Protocol Violation|1228|||
164477961|NCT00458783|594121430|FG001|Overall Study|Protocol Violation|1220|||
164477962|NCT01737398|594121431|FG000|Overall Study|Adverse event or SAE|16|||
164477963|NCT01737398|594121432|FG001|Overall Study|Adverse event or SAE|1|||
164477964|NCT01737398|594121431|FG000|Overall Study|Stopping rule met|2|||
164477965|NCT01737398|594121432|FG001|Overall Study|Stopping rule met|1|||
164477966|NCT01737398|594121431|FG000|Overall Study|Voluntary withdrawal|2|||
164477967|NCT01737398|594121432|FG001|Overall Study|Voluntary withdrawal|3|||
164477968|NCT01737398|594121431|FG000|Overall Study|Ineligibility|1|||
164477969|NCT01737398|594121432|FG001|Overall Study|Ineligibility|0|||
164477970|NCT01737398|594121431|FG000|Overall Study|Liver transplant|1|||
164477971|NCT01737398|594121432|FG001|Overall Study|Liver transplant|0|||
164477972|NCT01737398|594121431|FG000|Overall Study|Disease progression|2|||
164477973|NCT01737398|594121432|FG001|Overall Study|Disease progression|3|||
164477974|NCT01737398|594121431|FG000|Overall Study|Sponsor's decision|2|||
164477975|NCT01737398|594121432|FG001|Overall Study|Sponsor's decision|0|||
164477976|NCT02372799|594121436|FG000|Treatment Period|Adverse Event|3|||
164477977|NCT02372799|594121437|FG001|Treatment Period|Adverse Event|10|||
164477978|NCT02372799|594121438|FG002|Treatment Period|Adverse Event|6|||
164477979|NCT02372799|594121436|FG000|Treatment Period|Insufficient therapeutic response|2|||
164477980|NCT02372799|594121437|FG001|Treatment Period|Insufficient therapeutic response|2|||
164477981|NCT02372799|594121438|FG002|Treatment Period|Insufficient therapeutic response|0|||
164477982|NCT02372799|594121436|FG000|Treatment Period|Withdrawal by Subject|10|||
164477983|NCT02372799|594121437|FG001|Treatment Period|Withdrawal by Subject|10|||
164477984|NCT02372799|594121438|FG002|Treatment Period|Withdrawal by Subject|2|||
164477985|NCT02372799|594121436|FG000|Treatment Period|Lost to Follow-up|11|||
164477986|NCT02372799|594121437|FG001|Treatment Period|Lost to Follow-up|5|||
164477987|NCT02372799|594121438|FG002|Treatment Period|Lost to Follow-up|3|||
164477988|NCT02372799|594121436|FG000|Treatment Period|Protocol Violation|3|||
164477989|NCT02372799|594121437|FG001|Treatment Period|Protocol Violation|0|||
164477990|NCT02372799|594121438|FG002|Treatment Period|Protocol Violation|0|||
164477991|NCT02372799|594121436|FG000|Treatment Period|Non-compliance with study drug|4|||
164477992|NCT02372799|594121437|FG001|Treatment Period|Non-compliance with study drug|4|||
164477993|NCT02372799|594121438|FG002|Treatment Period|Non-compliance with study drug|4|||
164477994|NCT02372799|594121436|FG000|Treatment Period|Miscellaneous Reasons|1|||
164477995|NCT02372799|594121437|FG001|Treatment Period|Miscellaneous Reasons|1|||
164477996|NCT02372799|594121438|FG002|Treatment Period|Miscellaneous Reasons|0|||
164477997|NCT02372799|594121436|FG000|Down-taper Period|Lost to Follow-up|1|||
164477998|NCT02372799|594121437|FG001|Down-taper Period|Lost to Follow-up|2|||
164477999|NCT02372799|594121438|FG002|Down-taper Period|Lost to Follow-up|2|||
164478000|NCT00089609|594121439|FG000|Overall Study|Withdrawal by Subject|3|||
164478001|NCT00089609|594121440|FG001|Overall Study|Withdrawal by Subject|1|||
164478002|NCT05815342|594121442|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
164478003|NCT05815342|594121442|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
164478004|NCT05815342|594121442|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
164478005|NCT05815342|594121442|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
164478006|NCT05815342|594121442|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
164478007|NCT01833455|594121443|FG000|Overall Study|Withdrawal by Subject|1|||
164478008|NCT01833455|594121444|FG001|Overall Study|Withdrawal by Subject|0|||
164478009|NCT03689946|594121447|FG000|Overall Study|Withdrawal by Subject|3|||
164478010|NCT03689946|594121447|FG000|Overall Study|Lost to Follow-up|3|||
164478011|NCT03689946|594121447|FG000|Overall Study|Data corruption|2|||
164478012|NCT01555138|594121448|FG000|Overall Study|Death|0|||
164478013|NCT01555138|594121449|FG001|Overall Study|Death|1|||
164478014|NCT01555138|594121448|FG000|Overall Study|Lost to Follow-up|1|||
164478015|NCT01555138|594121449|FG001|Overall Study|Lost to Follow-up|0|||
164478016|NCT01555138|594121448|FG000|Overall Study|Abnormal Lab reults|1|||
164478017|NCT01555138|594121449|FG001|Overall Study|Abnormal Lab reults|3|||
164478018|NCT01555138|594121448|FG000|Overall Study|Lack of Efficacy|2|||
164478019|NCT01555138|594121449|FG001|Overall Study|Lack of Efficacy|2|||
164478020|NCT01555138|594121448|FG000|Overall Study|Protocol Violation|5|||
164478021|NCT01555138|594121449|FG001|Overall Study|Protocol Violation|3|||
164478022|NCT01555138|594121448|FG000|Overall Study|Administrative problems|8|||
164478023|NCT01555138|594121449|FG001|Overall Study|Administrative problems|0|||
164599930|NCT02358369|594556400|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
164599931|NCT02358369|594556401|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
164599932|NCT02358369|594556402|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
164599933|NCT02358369|594556403|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
164599934|NCT02358369|594556404|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
164599935|NCT02358369|594556400|FG000|Treatment Period C|Adverse Event|0|||
164599936|NCT02358369|594556401|FG001|Treatment Period C|Adverse Event|0|||
164599937|NCT02358369|594556402|FG002|Treatment Period C|Adverse Event|0|||
164599938|NCT02358369|594556403|FG003|Treatment Period C|Adverse Event|0|||
164599939|NCT02358369|594556404|FG004|Treatment Period C|Adverse Event|7|||
164599940|NCT03655717|594556405|FG000|Overall Study|Withdrawal by Subject|4|||
164599941|NCT03655717|594556406|FG001|Overall Study|Withdrawal by Subject|8|||
164478024|NCT01555138|594121448|FG000|Overall Study|Withdrawal by Subject|16|||
164478025|NCT01555138|594121449|FG001|Overall Study|Withdrawal by Subject|15|||
164478026|NCT01555138|594121448|FG000|Overall Study|Adverse Event|14|||
164478027|NCT01555138|594121449|FG001|Overall Study|Adverse Event|14|||
164478028|NCT02085941|594121451|FG000|Overall Study|Lack of Efficacy|1|||
164599942|NCT03655717|594556407|FG002|Overall Study|Withdrawal by Subject|1|||
164599943|NCT03655717|594556408|FG003|Overall Study|Withdrawal by Subject|0|||
164599944|NCT03655717|594556409|FG004|Overall Study|Withdrawal by Subject|0|||
164478029|NCT02085941|594121452|FG001|Overall Study|Lack of Efficacy|0|||
164478030|NCT02085941|594121451|FG000|Overall Study|Death|6|||
164478031|NCT02085941|594121452|FG001|Overall Study|Death|1|||
164478032|NCT02085941|594121451|FG000|Overall Study|Lost to Follow-up|1|||
164478033|NCT02085941|594121452|FG001|Overall Study|Lost to Follow-up|0|||
164478034|NCT02085941|594121451|FG000|Overall Study|Physician Decision|0|||
164478035|NCT02085941|594121452|FG001|Overall Study|Physician Decision|2|||
164478036|NCT00229658|594121461|FG000|Overall Study|Administrative|2|||
164478037|NCT00229658|594121462|FG001|Overall Study|Administrative|1|||
164478038|NCT00229658|594121461|FG000|Overall Study|Investigator decision|13|||
164478039|NCT00229658|594121462|FG001|Overall Study|Investigator decision|10|||
164478040|NCT00229658|594121461|FG000|Overall Study|Other|80|||
164478041|NCT00229658|594121462|FG001|Overall Study|Other|60|||
164478042|NCT00229658|594121461|FG000|Overall Study|Lost to Follow-up|82|||
164478043|NCT00229658|594121462|FG001|Overall Study|Lost to Follow-up|55|||
164478044|NCT00229658|594121461|FG000|Overall Study|Serious Adverse Event|2|||
164478045|NCT00229658|594121462|FG001|Overall Study|Serious Adverse Event|2|||
164478046|NCT00229658|594121461|FG000|Overall Study|Withdrawal of consent|46|||
164478047|NCT00229658|594121462|FG001|Overall Study|Withdrawal of consent|39|||
164478048|NCT00093496|594121463|FG000|Overall Study|Protocol Violation|1|||
164478049|NCT00093496|594121464|FG001|Overall Study|Protocol Violation|3|||
164478050|NCT01953224|594121465|FG000|Overall Study|Lost to Follow-up|1|||
164478051|NCT01953224|594121466|FG001|Overall Study|Lost to Follow-up|1|||
164478052|NCT01953224|594121465|FG000|Overall Study|Withdrawal by Subject|1|||
164478053|NCT01953224|594121466|FG001|Overall Study|Withdrawal by Subject|2|||
164478054|NCT00586313|594121467|FG000|Overall Study|Lack of Efficacy|2|||
164478055|NCT03205566|594121472|FG000|Phase 1|Protocol Violation|1|||
164478056|NCT03205566|594121473|FG001|Phase 1|Protocol Violation|1|||
164478057|NCT03184987|594121474|FG000|Overall Study|Withdrawal by Subject|0|||
164478058|NCT03184987|594121475|FG001|Overall Study|Withdrawal by Subject|1|||
164478059|NCT03184987|594121476|FG002|Overall Study|Withdrawal by Subject|2|||
164478060|NCT03184987|594121474|FG000|Overall Study|Physician Decision|0|||
164478061|NCT03184987|594121475|FG001|Overall Study|Physician Decision|0|||
164478062|NCT03184987|594121476|FG002|Overall Study|Physician Decision|1|||
164478063|NCT03184987|594121474|FG000|Overall Study|Adverse Event|1|||
164478064|NCT03184987|594121475|FG001|Overall Study|Adverse Event|0|||
164478065|NCT03184987|594121476|FG002|Overall Study|Adverse Event|1|||
164478066|NCT01767467|594121477|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
164478067|NCT01767467|594121478|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
164478068|NCT01767467|594121477|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
164478069|NCT01767467|594121478|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
164478070|NCT01767467|594121477|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
164478071|NCT01767467|594121478|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
164478072|NCT01767467|594121477|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
164478073|NCT01767467|594121478|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
164478074|NCT01767467|594121477|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
164478075|NCT01767467|594121478|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
164478076|NCT01767467|594121477|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
164478077|NCT01767467|594121478|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
164478078|NCT01767467|594121477|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
164478079|NCT01767467|594121478|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
164478080|NCT01767467|594121477|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
164478081|NCT01767467|594121478|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
164478082|NCT01767467|594121477|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
164478083|NCT01767467|594121478|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
164478084|NCT01767467|594121477|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
164478085|NCT01767467|594121478|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
164478086|NCT01767467|594121477|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
164478087|NCT01767467|594121478|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
164478088|NCT01767467|594121477|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
164478089|NCT01767467|594121478|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
164478090|NCT01767467|594121477|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
164478091|NCT01767467|594121478|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
164478092|NCT01767467|594121477|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
164478093|NCT01767467|594121478|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
164478094|NCT00853580|594121479|FG000|Overall Study|Lost to Follow-up|3|||
164478095|NCT00853580|594121480|FG001|Overall Study|Lost to Follow-up|5|||
164478096|NCT00853580|594121479|FG000|Overall Study|Protocol Violation|2|||
164478097|NCT00853580|594121480|FG001|Overall Study|Protocol Violation|1|||
164478098|NCT00853580|594121479|FG000|Overall Study|Withdrawal by Subject|2|||
164478099|NCT00853580|594121480|FG001|Overall Study|Withdrawal by Subject|8|||
164478100|NCT00853580|594121479|FG000|Overall Study|Commenced contraindicated therapy|0|||
164478101|NCT00853580|594121480|FG001|Overall Study|Commenced contraindicated therapy|2|||
164478102|NCT01700205|594121481|FG000|Overall Study|Withdrawal by Subject|13|||
164478103|NCT01700205|594121482|FG001|Overall Study|Withdrawal by Subject|13|||
164478104|NCT01700205|594121481|FG000|Overall Study|Protocol Violation|2|||
164478105|NCT01700205|594121482|FG001|Overall Study|Protocol Violation|2|||
164478106|NCT02203799|594121489|FG000|Overall Study|Withdrawal by Subject|3|||
164478107|NCT02384382|594121492|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
164478108|NCT02384382|594121492|FG000|Overall Study|Death|1|||
164478109|NCT02384382|594121492|FG000|Overall Study|Adverse Event|1|||
164478110|NCT02384382|594121492|FG000|Overall Study|Disease progression|16|||
164478111|NCT01953692|594121493|FG000|Overall Study|Adverse Event|5|||
164478112|NCT01953692|594121494|FG001|Overall Study|Adverse Event|2|||
164478113|NCT01953692|594121495|FG002|Overall Study|Adverse Event|4|||
164478114|NCT01953692|594121496|FG003|Overall Study|Adverse Event|2|||
164478115|NCT01953692|594121497|FG004|Overall Study|Adverse Event|1|||
164478116|NCT01953692|594121498|FG005|Overall Study|Adverse Event|2|||
164478117|NCT01953692|594121499|FG006|Overall Study|Adverse Event|0|||
164478118|NCT01953692|594121500|FG007|Overall Study|Adverse Event|0|||
164478119|NCT01953692|594121501|FG008|Overall Study|Adverse Event|0|||
164478120|NCT01953692|594121493|FG000|Overall Study|Clinical Progression|0|||
164478121|NCT01953692|594121494|FG001|Overall Study|Clinical Progression|15|||
164478122|NCT01953692|594121495|FG002|Overall Study|Clinical Progression|7|||
164478123|NCT01953692|594121496|FG003|Overall Study|Clinical Progression|5|||
164478124|NCT01953692|594121497|FG004|Overall Study|Clinical Progression|0|||
164478125|NCT01953692|594121498|FG005|Overall Study|Clinical Progression|7|||
164478126|NCT01953692|594121499|FG006|Overall Study|Clinical Progression|20|||
164478127|NCT01953692|594121500|FG007|Overall Study|Clinical Progression|3|||
164478128|NCT01953692|594121501|FG008|Overall Study|Clinical Progression|3|||
164478129|NCT01953692|594121493|FG000|Overall Study|Death|5|||
164478130|NCT01953692|594121494|FG001|Overall Study|Death|0|||
164478131|NCT01953692|594121495|FG002|Overall Study|Death|2|||
164478132|NCT01953692|594121496|FG003|Overall Study|Death|2|||
164478133|NCT01953692|594121497|FG004|Overall Study|Death|1|||
164478134|NCT01953692|594121498|FG005|Overall Study|Death|3|||
164478135|NCT01953692|594121499|FG006|Overall Study|Death|6|||
164478136|NCT01953692|594121500|FG007|Overall Study|Death|2|||
164478137|NCT01953692|594121501|FG008|Overall Study|Death|1|||
164478138|NCT01953692|594121493|FG000|Overall Study|Excluded Medication|1|||
164478139|NCT01953692|594121494|FG001|Overall Study|Excluded Medication|0|||
164478140|NCT01953692|594121495|FG002|Overall Study|Excluded Medication|0|||
164478141|NCT01953692|594121496|FG003|Overall Study|Excluded Medication|0|||
164478142|NCT01953692|594121497|FG004|Overall Study|Excluded Medication|0|||
164478143|NCT01953692|594121498|FG005|Overall Study|Excluded Medication|0|||
164478144|NCT01953692|594121499|FG006|Overall Study|Excluded Medication|0|||
164478145|NCT01953692|594121500|FG007|Overall Study|Excluded Medication|0|||
164478146|NCT01953692|594121501|FG008|Overall Study|Excluded Medication|0|||
164478147|NCT01953692|594121493|FG000|Overall Study|Lost to Follow-up|1|||
164478148|NCT01953692|594121494|FG001|Overall Study|Lost to Follow-up|0|||
164478149|NCT01953692|594121495|FG002|Overall Study|Lost to Follow-up|3|||
164478150|NCT01953692|594121496|FG003|Overall Study|Lost to Follow-up|1|||
164478151|NCT01953692|594121497|FG004|Overall Study|Lost to Follow-up|0|||
164478152|NCT01953692|594121498|FG005|Overall Study|Lost to Follow-up|1|||
164478153|NCT01953692|594121499|FG006|Overall Study|Lost to Follow-up|0|||
164478154|NCT01953692|594121500|FG007|Overall Study|Lost to Follow-up|0|||
164478155|NCT01953692|594121501|FG008|Overall Study|Lost to Follow-up|0|||
164478156|NCT01953692|594121493|FG000|Overall Study|Physician Decision|11|||
164478157|NCT01953692|594121494|FG001|Overall Study|Physician Decision|4|||
164478158|NCT01953692|594121495|FG002|Overall Study|Physician Decision|2|||
164478159|NCT01953692|594121496|FG003|Overall Study|Physician Decision|2|||
164478160|NCT01953692|594121497|FG004|Overall Study|Physician Decision|1|||
164478161|NCT01953692|594121498|FG005|Overall Study|Physician Decision|2|||
164478162|NCT01953692|594121499|FG006|Overall Study|Physician Decision|4|||
164478163|NCT01953692|594121500|FG007|Overall Study|Physician Decision|1|||
164478164|NCT01953692|594121501|FG008|Overall Study|Physician Decision|0|||
164478165|NCT01953692|594121493|FG000|Overall Study|Protocol Violation|0|||
164478166|NCT01953692|594121494|FG001|Overall Study|Protocol Violation|2|||
164478167|NCT01953692|594121495|FG002|Overall Study|Protocol Violation|1|||
164478168|NCT01953692|594121496|FG003|Overall Study|Protocol Violation|0|||
164478169|NCT01953692|594121497|FG004|Overall Study|Protocol Violation|0|||
164478170|NCT01953692|594121498|FG005|Overall Study|Protocol Violation|0|||
164478171|NCT01953692|594121499|FG006|Overall Study|Protocol Violation|0|||
164478172|NCT01953692|594121500|FG007|Overall Study|Protocol Violation|1|||
164478173|NCT01953692|594121501|FG008|Overall Study|Protocol Violation|0|||
164478174|NCT01953692|594121493|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
164478175|NCT01953692|594121494|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
164478176|NCT01953692|594121495|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
164478177|NCT01953692|594121496|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
164478178|NCT01953692|594121497|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
164478179|NCT01953692|594121498|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
164478180|NCT01953692|594121499|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
164478181|NCT01953692|594121500|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
164478182|NCT01953692|594121501|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
164478183|NCT01953692|594121493|FG000|Overall Study|Withdrawal by Subject|4|||
164714227|NCT03888066|594976820|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
164714228|NCT03888066|594976821|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
164714229|NCT03888066|594976820|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
164478184|NCT01953692|594121494|FG001|Overall Study|Withdrawal by Subject|2|||
164478185|NCT01953692|594121495|FG002|Overall Study|Withdrawal by Subject|1|||
164478186|NCT01953692|594121496|FG003|Overall Study|Withdrawal by Subject|2|||
164478187|NCT01953692|594121497|FG004|Overall Study|Withdrawal by Subject|0|||
164478188|NCT01953692|594121498|FG005|Overall Study|Withdrawal by Subject|3|||
164478189|NCT01953692|594121499|FG006|Overall Study|Withdrawal by Subject|2|||
164478190|NCT01953692|594121500|FG007|Overall Study|Withdrawal by Subject|1|||
164478191|NCT01953692|594121501|FG008|Overall Study|Withdrawal by Subject|1|||
164478192|NCT01822756|594121508|FG000|Overall Study|Adverse Event|0|||
164478193|NCT01822756|594121509|FG001|Overall Study|Adverse Event|0|||
164478194|NCT01822756|594121510|FG002|Overall Study|Adverse Event|0|||
164478195|NCT01822756|594121511|FG003|Overall Study|Adverse Event|2|||
164478196|NCT01822756|594121512|FG004|Overall Study|Adverse Event|0|||
164478197|NCT01822756|594121508|FG000|Overall Study|Disease progression|11|||
164478198|NCT01822756|594121509|FG001|Overall Study|Disease progression|1|||
164478199|NCT01822756|594121510|FG002|Overall Study|Disease progression|7|||
164478200|NCT01822756|594121511|FG003|Overall Study|Disease progression|2|||
164478201|NCT01822756|594121512|FG004|Overall Study|Disease progression|6|||
164478202|NCT01822756|594121508|FG000|Overall Study|Death|2|||
164478203|NCT01822756|594121509|FG001|Overall Study|Death|2|||
164478204|NCT01822756|594121510|FG002|Overall Study|Death|1|||
164478205|NCT01822756|594121511|FG003|Overall Study|Death|0|||
164478206|NCT01822756|594121512|FG004|Overall Study|Death|0|||
164478207|NCT01822756|594121508|FG000|Overall Study|Lost to Follow-up|1|||
164478208|NCT01822756|594121509|FG001|Overall Study|Lost to Follow-up|0|||
164478209|NCT01822756|594121510|FG002|Overall Study|Lost to Follow-up|1|||
164478210|NCT01822756|594121511|FG003|Overall Study|Lost to Follow-up|0|||
164478211|NCT01822756|594121512|FG004|Overall Study|Lost to Follow-up|1|||
164478212|NCT01822756|594121508|FG000|Overall Study|Physician Decision|0|||
164478213|NCT01822756|594121509|FG001|Overall Study|Physician Decision|1|||
164478214|NCT01822756|594121510|FG002|Overall Study|Physician Decision|0|||
164478215|NCT01822756|594121511|FG003|Overall Study|Physician Decision|0|||
164478216|NCT01822756|594121512|FG004|Overall Study|Physician Decision|0|||
164478217|NCT01822756|594121508|FG000|Overall Study|disease progression & patient preference|2|||
164478218|NCT01822756|594121509|FG001|Overall Study|disease progression & patient preference|0|||
164478219|NCT01822756|594121510|FG002|Overall Study|disease progression & patient preference|1|||
164478220|NCT01822756|594121511|FG003|Overall Study|disease progression & patient preference|0|||
164478221|NCT01822756|594121512|FG004|Overall Study|disease progression & patient preference|0|||
164478222|NCT01065779|594121513|FG000|Overall Study|Duplicate Investigation|1|||
164478223|NCT01065779|594121513|FG000|Overall Study|Investigation Before Contract Date|37|||
164478224|NCT01065779|594121513|FG000|Overall Study|Non-enrollment Period Administration|10|||
164478225|NCT01065779|594121513|FG000|Overall Study|Not Administered With Study Drug|17|||
164478226|NCT01065779|594121513|FG000|Overall Study|Failed to Follow-up|10|||
164478227|NCT01065779|594121513|FG000|Overall Study|Inclusion Criteria Violation|7|||
164478228|NCT02157948|594121514|FG000|Overall Study|Withdrawal by Subject|4|||
164478229|NCT02157948|594121515|FG001|Overall Study|Withdrawal by Subject|5|||
164478230|NCT02157948|594121514|FG000|Overall Study|Lost to Follow-up|3|||
164478231|NCT02157948|594121515|FG001|Overall Study|Lost to Follow-up|2|||
164478232|NCT02157948|594121514|FG000|Overall Study|Protocol Specified Criteria|2|||
164478233|NCT02157948|594121515|FG001|Overall Study|Protocol Specified Criteria|1|||
164478234|NCT02157948|594121514|FG000|Overall Study|Decision by Sponsor|0|||
164478235|NCT02157948|594121515|FG001|Overall Study|Decision by Sponsor|1|||
164478236|NCT02743819|594121516|FG000|Overall Study|Lack of Efficacy|5|||
164478237|NCT02743819|594121516|FG000|Overall Study|Death|2|||
164478238|NCT02743819|594121516|FG000|Overall Study|Adverse Event|1|||
164478239|NCT04762277|594121521|FG000|Overall Study|Withdrawal by Subject|0|||
164478240|NCT04762277|594121522|FG001|Overall Study|Withdrawal by Subject|2|||
164478241|NCT04762277|594121521|FG000|Overall Study|Protocol Violation|0|||
164714230|NCT03888066|594976821|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
164478242|NCT04762277|594121522|FG001|Overall Study|Protocol Violation|1|||
164478243|NCT04762277|594121521|FG000|Overall Study|Adverse Event|1|||
164714231|NCT03278626|594976822|FG000|Overall Study|Death|2|||
164714232|NCT03278626|594976822|FG000|Overall Study|Toxicity|1|||
164478244|NCT04762277|594121522|FG001|Overall Study|Adverse Event|0|||
164478245|NCT02556918|594123377|FG000|Overall Study|Protocol Violation|5|||
164478246|NCT02556918|594123378|FG001|Overall Study|Protocol Violation|6|||
164478247|NCT02556918|594123377|FG000|Overall Study|Withdrawal by Subject|4|||
164478248|NCT02556918|594123378|FG001|Overall Study|Withdrawal by Subject|4|||
164478249|NCT04511702|594123388|FG000|Overall Study|Lost to Follow-up|3|||
164478250|NCT04511702|594123389|FG001|Overall Study|Lost to Follow-up|0|||
164478251|NCT04511702|594123390|FG002|Overall Study|Lost to Follow-up|4|||
164478252|NCT04511702|594123388|FG000|Overall Study|Withdrawal by Subject|17|||
164478253|NCT04511702|594123389|FG001|Overall Study|Withdrawal by Subject|1|||
164478254|NCT04511702|594123390|FG002|Overall Study|Withdrawal by Subject|8|||
164478255|NCT05349721|594123391|FG000|Part A (24 Weeks)|Adverse Event|9|||
164478256|NCT05349721|594123392|FG001|Part A (24 Weeks)|Adverse Event|2|||
164478257|NCT05349721|594123391|FG000|Part A (24 Weeks)|Death|8|||
164478258|NCT05349721|594123392|FG001|Part A (24 Weeks)|Death|3|||
164478259|NCT05349721|594123391|FG000|Part A (24 Weeks)|Disease Progression|1|||
164478260|NCT05349721|594123392|FG001|Part A (24 Weeks)|Disease Progression|1|||
164478261|NCT05349721|594123391|FG000|Part A (24 Weeks)|Screen Failure|2|||
164478262|NCT05349721|594123392|FG001|Part A (24 Weeks)|Screen Failure|0|||
164478263|NCT05349721|594123391|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
164478264|NCT05349721|594123392|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
164478265|NCT05349721|594123391|FG000|Part A (24 Weeks)|Other Than Specified|5|||
164478266|NCT05349721|594123392|FG001|Part A (24 Weeks)|Other Than Specified|1|||
164478267|NCT05349721|594123391|FG000|Part B (28 Weeks)|Adverse Event|3|||
164478268|NCT05349721|594123392|FG001|Part B (28 Weeks)|Adverse Event|0|||
164478269|NCT05349721|594123391|FG000|Part B (28 Weeks)|Death|21|||
164478270|NCT05349721|594123392|FG001|Part B (28 Weeks)|Death|11|||
164478271|NCT05349721|594123391|FG000|Part B (28 Weeks)|Disease Progression|2|||
164478272|NCT05349721|594123392|FG001|Part B (28 Weeks)|Disease Progression|1|||
164478273|NCT05349721|594123391|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
164478274|NCT05349721|594123392|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
164478275|NCT05349721|594123391|FG000|Part B (28 Weeks)|Physician Decision|1|||
164478276|NCT05349721|594123392|FG001|Part B (28 Weeks)|Physician Decision|0|||
164478277|NCT05349721|594123391|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
164478278|NCT05349721|594123392|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
164478279|NCT05349721|594123391|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
164478280|NCT05349721|594123392|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
164478281|NCT05349721|594123391|FG000|Part B (28 Weeks)|Other Than Specified|4|||
164478282|NCT05349721|594123392|FG001|Part B (28 Weeks)|Other Than Specified|2|||
164478283|NCT05349721|594123391|FG000|Part C (108 Weeks)|Death|0|||
164478284|NCT05349721|594123392|FG001|Part C (108 Weeks)|Death|1|||
164478285|NCT05349721|594123391|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
164478286|NCT05349721|594123392|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
164478287|NCT05349721|594123391|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
164478288|NCT05349721|594123392|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
164478289|NCT05349721|594123391|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
164478290|NCT05349721|594123392|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
164478291|NCT03070392|594123393|FG000|Overall Study|Not Treated|7|||
164478292|NCT03070392|594123394|FG001|Overall Study|Not Treated|0|||
164478293|NCT03070392|594123395|FG002|Overall Study|Not Treated|3|||
164478294|NCT03070392|594123396|FG003|Overall Study|Not Treated|12|||
164478295|NCT03070392|594123393|FG000|Overall Study|Death|3|||
164478296|NCT03070392|594123394|FG001|Overall Study|Death|0|||
164478297|NCT03070392|594123395|FG002|Overall Study|Death|0|||
164478298|NCT03070392|594123396|FG003|Overall Study|Death|1|||
164478299|NCT03070392|594123393|FG000|Overall Study|Withdrawal by Subject|7|||
164478300|NCT03070392|594123394|FG001|Overall Study|Withdrawal by Subject|0|||
164478301|NCT03070392|594123395|FG002|Overall Study|Withdrawal by Subject|0|||
164478302|NCT03070392|594123396|FG003|Overall Study|Withdrawal by Subject|3|||
164478303|NCT03070392|594123393|FG000|Overall Study|Physician Decision|1|||
164478304|NCT03070392|594123394|FG001|Overall Study|Physician Decision|0|||
164478305|NCT03070392|594123395|FG002|Overall Study|Physician Decision|0|||
164478306|NCT03070392|594123396|FG003|Overall Study|Physician Decision|2|||
164478307|NCT03070392|594123393|FG000|Overall Study|Progressive Disease|154|||
164478308|NCT03070392|594123394|FG001|Overall Study|Progressive Disease|6|||
164478309|NCT03070392|594123395|FG002|Overall Study|Progressive Disease|2|||
164478310|NCT03070392|594123396|FG003|Overall Study|Progressive Disease|70|||
164478311|NCT03070392|594123393|FG000|Overall Study|Adverse Event|6|||
164478312|NCT03070392|594123394|FG001|Overall Study|Adverse Event|1|||
164478313|NCT03070392|594123395|FG002|Overall Study|Adverse Event|1|||
164478314|NCT03070392|594123396|FG003|Overall Study|Adverse Event|3|||
164478315|NCT03070392|594123393|FG000|Overall Study|Alternate anticancer treatment|1|||
164478316|NCT03070392|594123394|FG001|Overall Study|Alternate anticancer treatment|0|||
164714233|NCT03278626|594976822|FG000|Overall Study|Disease Progression|2|||
164478317|NCT03070392|594123395|FG002|Overall Study|Alternate anticancer treatment|0|||
164478318|NCT03070392|594123396|FG003|Overall Study|Alternate anticancer treatment|1|||
164478319|NCT03070392|594123393|FG000|Overall Study|Ongoing|73|||
164478320|NCT03070392|594123394|FG001|Overall Study|Ongoing|0|||
164478321|NCT03070392|594123395|FG002|Overall Study|Ongoing|0|||
164478322|NCT03070392|594123396|FG003|Overall Study|Ongoing|11|||
164478323|NCT02972034|594123398|FG000|Overall Study|Death|11|||
164478324|NCT02972034|594123399|FG001|Overall Study|Death|1|||
164478325|NCT02972034|594123400|FG002|Overall Study|Death|3|||
164478326|NCT02972034|594123401|FG003|Overall Study|Death|3|||
164478327|NCT02972034|594123402|FG004|Overall Study|Death|2|||
164478328|NCT02972034|594123403|FG005|Overall Study|Death|2|||
164478329|NCT02972034|594123404|FG006|Overall Study|Death|3|||
164478330|NCT02972034|594123405|FG007|Overall Study|Death|4|||
164478331|NCT02972034|594123406|FG008|Overall Study|Death|8|||
164478332|NCT02972034|594123407|FG009|Overall Study|Death|11|||
164478333|NCT02972034|594123408|FG010|Overall Study|Death|3|||
164714234|NCT02856555|594976823|FG000|Overall Study|Adverse Event|1|||
164714235|NCT02856555|594976824|FG001|Overall Study|Adverse Event|0|||
164478334|NCT02972034|594123409|FG011|Overall Study|Death|2|||
164478335|NCT02972034|594123410|FG012|Overall Study|Death|11|||
164478336|NCT02972034|594123411|FG013|Overall Study|Death|10|||
164478337|NCT02972034|594123412|FG014|Overall Study|Death|9|||
164478338|NCT02972034|594123398|FG000|Overall Study|Lost to Follow-up|0|||
164478339|NCT02972034|594123399|FG001|Overall Study|Lost to Follow-up|0|||
164478340|NCT02972034|594123400|FG002|Overall Study|Lost to Follow-up|0|||
164478341|NCT02972034|594123401|FG003|Overall Study|Lost to Follow-up|0|||
164478342|NCT02972034|594123402|FG004|Overall Study|Lost to Follow-up|1|||
164478343|NCT02972034|594123403|FG005|Overall Study|Lost to Follow-up|0|||
164478344|NCT02972034|594123404|FG006|Overall Study|Lost to Follow-up|0|||
164478345|NCT02972034|594123405|FG007|Overall Study|Lost to Follow-up|1|||
164478346|NCT02972034|594123406|FG008|Overall Study|Lost to Follow-up|0|||
164478347|NCT02972034|594123407|FG009|Overall Study|Lost to Follow-up|0|||
164478348|NCT02972034|594123408|FG010|Overall Study|Lost to Follow-up|0|||
164478349|NCT02972034|594123409|FG011|Overall Study|Lost to Follow-up|0|||
164478350|NCT02972034|594123410|FG012|Overall Study|Lost to Follow-up|0|||
164478351|NCT02972034|594123411|FG013|Overall Study|Lost to Follow-up|0|||
164478352|NCT02972034|594123412|FG014|Overall Study|Lost to Follow-up|1|||
164478353|NCT02972034|594123398|FG000|Overall Study|Physician Decision|0|||
164478354|NCT02972034|594123399|FG001|Overall Study|Physician Decision|0|||
164478355|NCT02972034|594123400|FG002|Overall Study|Physician Decision|0|||
164478356|NCT02972034|594123401|FG003|Overall Study|Physician Decision|0|||
164478357|NCT02972034|594123402|FG004|Overall Study|Physician Decision|0|||
164478358|NCT02972034|594123403|FG005|Overall Study|Physician Decision|0|||
164478359|NCT02972034|594123404|FG006|Overall Study|Physician Decision|0|||
164478360|NCT02972034|594123405|FG007|Overall Study|Physician Decision|1|||
164478361|NCT02972034|594123406|FG008|Overall Study|Physician Decision|0|||
164478362|NCT02972034|594123407|FG009|Overall Study|Physician Decision|0|||
164478363|NCT02972034|594123408|FG010|Overall Study|Physician Decision|1|||
164478364|NCT02972034|594123409|FG011|Overall Study|Physician Decision|0|||
164478365|NCT02972034|594123410|FG012|Overall Study|Physician Decision|0|||
164478366|NCT02972034|594123411|FG013|Overall Study|Physician Decision|0|||
164478367|NCT02972034|594123412|FG014|Overall Study|Physician Decision|0|||
164478368|NCT02972034|594123398|FG000|Overall Study|Sponsor Decision|0|||
164478369|NCT02972034|594123399|FG001|Overall Study|Sponsor Decision|0|||
164478370|NCT02972034|594123400|FG002|Overall Study|Sponsor Decision|0|||
164478371|NCT02972034|594123401|FG003|Overall Study|Sponsor Decision|1|||
164478372|NCT02972034|594123402|FG004|Overall Study|Sponsor Decision|0|||
164478373|NCT02972034|594123403|FG005|Overall Study|Sponsor Decision|0|||
164478374|NCT02972034|594123404|FG006|Overall Study|Sponsor Decision|1|||
164478375|NCT02972034|594123405|FG007|Overall Study|Sponsor Decision|1|||
164478376|NCT02972034|594123406|FG008|Overall Study|Sponsor Decision|1|||
164478377|NCT02972034|594123407|FG009|Overall Study|Sponsor Decision|2|||
164478378|NCT02972034|594123408|FG010|Overall Study|Sponsor Decision|2|||
164478379|NCT02972034|594123409|FG011|Overall Study|Sponsor Decision|0|||
164478380|NCT02972034|594123410|FG012|Overall Study|Sponsor Decision|1|||
164478381|NCT02972034|594123411|FG013|Overall Study|Sponsor Decision|0|||
164478382|NCT02972034|594123412|FG014|Overall Study|Sponsor Decision|1|||
164478383|NCT02972034|594123398|FG000|Overall Study|Withdrawal by Subject|3|||
164478384|NCT02972034|594123399|FG001|Overall Study|Withdrawal by Subject|0|||
164478385|NCT02972034|594123400|FG002|Overall Study|Withdrawal by Subject|0|||
164478386|NCT02972034|594123401|FG003|Overall Study|Withdrawal by Subject|0|||
164478387|NCT02972034|594123402|FG004|Overall Study|Withdrawal by Subject|1|||
164478388|NCT02972034|594123403|FG005|Overall Study|Withdrawal by Subject|1|||
164478389|NCT02972034|594123404|FG006|Overall Study|Withdrawal by Subject|0|||
164478390|NCT02972034|594123405|FG007|Overall Study|Withdrawal by Subject|0|||
164478391|NCT02972034|594123406|FG008|Overall Study|Withdrawal by Subject|1|||
164478392|NCT02972034|594123407|FG009|Overall Study|Withdrawal by Subject|1|||
164478393|NCT02972034|594123408|FG010|Overall Study|Withdrawal by Subject|2|||
164714236|NCT02856555|594976825|FG002|Overall Study|Adverse Event|0|||
164478394|NCT02972034|594123409|FG011|Overall Study|Withdrawal by Subject|1|||
164714237|NCT02856555|594976823|FG000|Overall Study|Lost to Follow-up|1|||
164714238|NCT02856555|594976824|FG001|Overall Study|Lost to Follow-up|3|||
164478395|NCT02972034|594123410|FG012|Overall Study|Withdrawal by Subject|1|||
164478396|NCT02972034|594123411|FG013|Overall Study|Withdrawal by Subject|1|||
164478397|NCT02972034|594123412|FG014|Overall Study|Withdrawal by Subject|0|||
164478398|NCT02972034|594123398|FG000|Overall Study|Screen Failure|0|||
164478399|NCT02972034|594123399|FG001|Overall Study|Screen Failure|0|||
164478400|NCT02972034|594123400|FG002|Overall Study|Screen Failure|0|||
164478401|NCT02972034|594123401|FG003|Overall Study|Screen Failure|0|||
164478402|NCT02972034|594123402|FG004|Overall Study|Screen Failure|0|||
164478403|NCT02972034|594123403|FG005|Overall Study|Screen Failure|0|||
164478404|NCT02972034|594123404|FG006|Overall Study|Screen Failure|0|||
164714239|NCT02856555|594976825|FG002|Overall Study|Lost to Follow-up|0|||
164478405|NCT02972034|594123405|FG007|Overall Study|Screen Failure|0|||
164478406|NCT02972034|594123406|FG008|Overall Study|Screen Failure|0|||
164478407|NCT02972034|594123407|FG009|Overall Study|Screen Failure|0|||
164478408|NCT02972034|594123408|FG010|Overall Study|Screen Failure|0|||
164478409|NCT02972034|594123409|FG011|Overall Study|Screen Failure|0|||
164478410|NCT02972034|594123410|FG012|Overall Study|Screen Failure|1|||
164478411|NCT02972034|594123411|FG013|Overall Study|Screen Failure|0|||
164478412|NCT02972034|594123412|FG014|Overall Study|Screen Failure|0|||
164478413|NCT03861052|594123413|FG000|Overall Study|Adverse Event|1|||
164478414|NCT03861052|594123414|FG001|Overall Study|Adverse Event|1|||
164478415|NCT03861052|594123415|FG002|Overall Study|Adverse Event|2|||
164478416|NCT03861052|594123416|FG003|Overall Study|Adverse Event|4|||
164478417|NCT03861052|594123413|FG000|Overall Study|Lost to Follow-up|0|||
164478418|NCT03861052|594123414|FG001|Overall Study|Lost to Follow-up|0|||
164478419|NCT03861052|594123415|FG002|Overall Study|Lost to Follow-up|0|||
164478420|NCT03861052|594123416|FG003|Overall Study|Lost to Follow-up|1|||
164478421|NCT03861052|594123413|FG000|Overall Study|Physician Decision|0|||
164478422|NCT03861052|594123414|FG001|Overall Study|Physician Decision|1|||
164478423|NCT03861052|594123415|FG002|Overall Study|Physician Decision|0|||
164478424|NCT03861052|594123416|FG003|Overall Study|Physician Decision|0|||
164478425|NCT03861052|594123413|FG000|Overall Study|Withdrawal by Subject|2|||
164478426|NCT03861052|594123414|FG001|Overall Study|Withdrawal by Subject|5|||
164478427|NCT03861052|594123415|FG002|Overall Study|Withdrawal by Subject|3|||
164478428|NCT03861052|594123416|FG003|Overall Study|Withdrawal by Subject|0|||
164478429|NCT03861052|594123413|FG000|Overall Study|Relocation to other city|1|||
164478430|NCT03861052|594123414|FG001|Overall Study|Relocation to other city|0|||
164478431|NCT03861052|594123415|FG002|Overall Study|Relocation to other city|0|||
164478432|NCT03861052|594123416|FG003|Overall Study|Relocation to other city|0|||
164478433|NCT03009344|594123417|FG000|Overall Study|Lack of Efficacy|5|||
164478434|NCT03009344|594123417|FG000|Overall Study|Withdrawal by Subject|1|||
164478435|NCT03009344|594123417|FG000|Overall Study|Adverse Event|1|||
164478436|NCT03678688|594123418|FG000|Overall Study|Reason not Specified|0|||
164478437|NCT03678688|594123419|FG001|Overall Study|Reason not Specified|0|||
164478438|NCT03678688|594123420|FG002|Overall Study|Reason not Specified|3|||
164478439|NCT03678688|594123421|FG003|Overall Study|Reason not Specified|0|||
164478440|NCT03678688|594123422|FG004|Overall Study|Reason not Specified|1|||
164478441|NCT03678688|594123423|FG005|Overall Study|Reason not Specified|0|||
164478442|NCT03678688|594123424|FG006|Overall Study|Reason not Specified|0|||
164478443|NCT03678688|594123425|FG007|Overall Study|Reason not Specified|0|||
164478444|NCT03678688|594123426|FG008|Overall Study|Reason not Specified|0|||
164478445|NCT03678688|594123418|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
164478446|NCT03678688|594123419|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
164478447|NCT03678688|594123420|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
164478448|NCT03678688|594123421|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
164478449|NCT03678688|594123422|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
164478450|NCT03678688|594123423|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
164478451|NCT03678688|594123424|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
164478452|NCT03678688|594123425|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
164478453|NCT03678688|594123426|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
164478454|NCT03678688|594123418|FG000|Overall Study|Covid Related Adverse Event|0|||
164478455|NCT03678688|594123419|FG001|Overall Study|Covid Related Adverse Event|0|||
164478456|NCT03678688|594123420|FG002|Overall Study|Covid Related Adverse Event|0|||
164478457|NCT03678688|594123421|FG003|Overall Study|Covid Related Adverse Event|0|||
164478458|NCT03678688|594123422|FG004|Overall Study|Covid Related Adverse Event|0|||
164478459|NCT03678688|594123423|FG005|Overall Study|Covid Related Adverse Event|3|||
164478460|NCT03678688|594123424|FG006|Overall Study|Covid Related Adverse Event|1|||
164478461|NCT03678688|594123425|FG007|Overall Study|Covid Related Adverse Event|1|||
164478462|NCT03678688|594123426|FG008|Overall Study|Covid Related Adverse Event|0|||
164478463|NCT03678688|594123418|FG000|Overall Study|Physician Decision|0|||
164478464|NCT03678688|594123419|FG001|Overall Study|Physician Decision|0|||
164478465|NCT03678688|594123420|FG002|Overall Study|Physician Decision|0|||
164478466|NCT03678688|594123421|FG003|Overall Study|Physician Decision|0|||
164478467|NCT03678688|594123422|FG004|Overall Study|Physician Decision|0|||
164478468|NCT03678688|594123423|FG005|Overall Study|Physician Decision|1|||
164478469|NCT03678688|594123424|FG006|Overall Study|Physician Decision|0|||
164478470|NCT03678688|594123425|FG007|Overall Study|Physician Decision|0|||
164478471|NCT03678688|594123426|FG008|Overall Study|Physician Decision|0|||
164478472|NCT03678688|594123418|FG000|Overall Study|Withdrawal by Subject|0|||
164478473|NCT03678688|594123419|FG001|Overall Study|Withdrawal by Subject|0|||
164478474|NCT03678688|594123420|FG002|Overall Study|Withdrawal by Subject|0|||
164478475|NCT03678688|594123421|FG003|Overall Study|Withdrawal by Subject|0|||
164478476|NCT03678688|594123422|FG004|Overall Study|Withdrawal by Subject|0|||
164478477|NCT03678688|594123423|FG005|Overall Study|Withdrawal by Subject|0|||
164478478|NCT03678688|594123424|FG006|Overall Study|Withdrawal by Subject|2|||
164478479|NCT03678688|594123425|FG007|Overall Study|Withdrawal by Subject|1|||
164478480|NCT03678688|594123426|FG008|Overall Study|Withdrawal by Subject|0|||
164478481|NCT02534233|594123432|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
164478482|NCT03823703|594123434|FG000|Overall Study|Sponsor request|0|||
164478483|NCT03823703|594123435|FG001|Overall Study|Sponsor request|3|||
164599945|NCT03655717|594556410|FG005|Overall Study|Withdrawal by Subject|1|||
164599946|NCT03655717|594556411|FG006|Overall Study|Withdrawal by Subject|3|||
164599947|NCT03655717|594556412|FG007|Overall Study|Withdrawal by Subject|1|||
164599948|NCT03655717|594556413|FG008|Overall Study|Withdrawal by Subject|2|||
164599949|NCT03655717|594556414|FG009|Overall Study|Withdrawal by Subject|0|||
164599950|NCT03655717|594556415|FG010|Overall Study|Withdrawal by Subject|0|||
164599951|NCT03655717|594556416|FG011|Overall Study|Withdrawal by Subject|1|||
164599952|NCT03655717|594556417|FG012|Overall Study|Withdrawal by Subject|0|||
164599953|NCT03655717|594556418|FG013|Overall Study|Withdrawal by Subject|3|||
164599954|NCT03655717|594556419|FG014|Overall Study|Withdrawal by Subject|0|||
164599955|NCT03655717|594556420|FG015|Overall Study|Withdrawal by Subject|1|||
164599956|NCT03655717|594556421|FG016|Overall Study|Withdrawal by Subject|0|||
164599957|NCT03655717|594556422|FG017|Overall Study|Withdrawal by Subject|0|||
164599958|NCT03655717|594556423|FG018|Overall Study|Withdrawal by Subject|1|||
164599959|NCT03655717|594556424|FG019|Overall Study|Withdrawal by Subject|0|||
164599960|NCT03655717|594556425|FG020|Overall Study|Withdrawal by Subject|0|||
164599961|NCT03655717|594556426|FG021|Overall Study|Withdrawal by Subject|1|||
164599962|NCT03655717|594556427|FG022|Overall Study|Withdrawal by Subject|2|||
164599963|NCT03655717|594556428|FG023|Overall Study|Withdrawal by Subject|1|||
164599964|NCT03655717|594556429|FG024|Overall Study|Withdrawal by Subject|1|||
164599965|NCT03655717|594556430|FG025|Overall Study|Withdrawal by Subject|0|||
164599966|NCT03655717|594556405|FG000|Overall Study|Physician Decision|3|||
164599967|NCT03655717|594556406|FG001|Overall Study|Physician Decision|3|||
164599968|NCT03655717|594556407|FG002|Overall Study|Physician Decision|0|||
164599969|NCT03655717|594556408|FG003|Overall Study|Physician Decision|0|||
164599970|NCT03655717|594556409|FG004|Overall Study|Physician Decision|0|||
164599971|NCT03655717|594556410|FG005|Overall Study|Physician Decision|0|||
164599972|NCT03655717|594556411|FG006|Overall Study|Physician Decision|0|||
164599973|NCT03655717|594556412|FG007|Overall Study|Physician Decision|0|||
164599974|NCT03655717|594556413|FG008|Overall Study|Physician Decision|0|||
164599975|NCT03655717|594556414|FG009|Overall Study|Physician Decision|1|||
164599976|NCT03655717|594556415|FG010|Overall Study|Physician Decision|0|||
164599977|NCT03655717|594556416|FG011|Overall Study|Physician Decision|0|||
164599978|NCT03655717|594556417|FG012|Overall Study|Physician Decision|0|||
164599979|NCT03655717|594556418|FG013|Overall Study|Physician Decision|0|||
164599980|NCT03655717|594556419|FG014|Overall Study|Physician Decision|0|||
164599981|NCT03655717|594556420|FG015|Overall Study|Physician Decision|0|||
164599982|NCT03655717|594556421|FG016|Overall Study|Physician Decision|0|||
164599983|NCT03655717|594556422|FG017|Overall Study|Physician Decision|0|||
164599984|NCT03655717|594556423|FG018|Overall Study|Physician Decision|0|||
164599985|NCT03655717|594556424|FG019|Overall Study|Physician Decision|1|||
164599986|NCT03655717|594556425|FG020|Overall Study|Physician Decision|0|||
164599987|NCT03655717|594556426|FG021|Overall Study|Physician Decision|0|||
164599988|NCT03655717|594556427|FG022|Overall Study|Physician Decision|0|||
164599989|NCT03655717|594556428|FG023|Overall Study|Physician Decision|1|||
164599990|NCT03655717|594556429|FG024|Overall Study|Physician Decision|0|||
164599991|NCT03655717|594556430|FG025|Overall Study|Physician Decision|0|||
164599992|NCT03655717|594556405|FG000|Overall Study|Lost to Follow-up|3|||
164599993|NCT03655717|594556406|FG001|Overall Study|Lost to Follow-up|1|||
164599994|NCT03655717|594556407|FG002|Overall Study|Lost to Follow-up|0|||
164599995|NCT03655717|594556408|FG003|Overall Study|Lost to Follow-up|1|||
164599996|NCT03655717|594556409|FG004|Overall Study|Lost to Follow-up|0|||
164599997|NCT03655717|594556410|FG005|Overall Study|Lost to Follow-up|1|||
164599998|NCT03655717|594556411|FG006|Overall Study|Lost to Follow-up|0|||
164599999|NCT03655717|594556412|FG007|Overall Study|Lost to Follow-up|0|||
164600000|NCT03655717|594556413|FG008|Overall Study|Lost to Follow-up|0|||
164600001|NCT03655717|594556414|FG009|Overall Study|Lost to Follow-up|0|||
164600002|NCT03655717|594556415|FG010|Overall Study|Lost to Follow-up|0|||
164600003|NCT03655717|594556416|FG011|Overall Study|Lost to Follow-up|1|||
164600004|NCT03655717|594556417|FG012|Overall Study|Lost to Follow-up|0|||
164600005|NCT03655717|594556418|FG013|Overall Study|Lost to Follow-up|0|||
164600006|NCT03655717|594556419|FG014|Overall Study|Lost to Follow-up|0|||
164600007|NCT03655717|594556420|FG015|Overall Study|Lost to Follow-up|0|||
164600008|NCT03655717|594556421|FG016|Overall Study|Lost to Follow-up|0|||
164600009|NCT03655717|594556422|FG017|Overall Study|Lost to Follow-up|0|||
164600010|NCT03655717|594556423|FG018|Overall Study|Lost to Follow-up|0|||
164600011|NCT03655717|594556424|FG019|Overall Study|Lost to Follow-up|0|||
164600012|NCT03655717|594556425|FG020|Overall Study|Lost to Follow-up|0|||
164600013|NCT03655717|594556426|FG021|Overall Study|Lost to Follow-up|0|||
164600014|NCT03655717|594556427|FG022|Overall Study|Lost to Follow-up|0|||
164600015|NCT03655717|594556428|FG023|Overall Study|Lost to Follow-up|0|||
164600016|NCT03655717|594556429|FG024|Overall Study|Lost to Follow-up|0|||
164600017|NCT03655717|594556430|FG025|Overall Study|Lost to Follow-up|0|||
164600018|NCT01185249|594556431|FG000|Overall Study|Patients discharged or change in status|42|||
164600019|NCT01973452|594556432|FG000|Overall Study|Lack of Efficacy|0|||
164600020|NCT01973452|594556433|FG001|Overall Study|Lack of Efficacy|1|||
164600021|NCT01973452|594556432|FG000|Overall Study|Lost to Follow-up|1|||
164600022|NCT01973452|594556433|FG001|Overall Study|Lost to Follow-up|0|||
164600023|NCT01973452|594556432|FG000|Overall Study|Withdrawal by Subject|10|||
164600024|NCT01973452|594556433|FG001|Overall Study|Withdrawal by Subject|9|||
164600025|NCT01973452|594556432|FG000|Overall Study|Ineligible|1|||
164600026|NCT01973452|594556433|FG001|Overall Study|Ineligible|1|||
164600027|NCT01973452|594556432|FG000|Overall Study|Surgery canceled by participant|5|||
164600028|NCT01973452|594556433|FG001|Overall Study|Surgery canceled by participant|3|||
164600029|NCT00064350|594556435|FG000|Induction Treatment|Disease Progression|5|||
164600030|NCT00064350|594556436|FG001|Induction Treatment|Disease Progression|1|||
164600031|NCT00064350|594556437|FG002|Induction Treatment|Disease Progression|110|||
164600032|NCT00064350|594556435|FG000|Induction Treatment|Adverse Event|0|||
164600033|NCT00064350|594556436|FG001|Induction Treatment|Adverse Event|2|||
164600034|NCT00064350|594556437|FG002|Induction Treatment|Adverse Event|49|||
164600035|NCT00064350|594556435|FG000|Induction Treatment|Death|0|||
164600036|NCT00064350|594556436|FG001|Induction Treatment|Death|0|||
164600037|NCT00064350|594556437|FG002|Induction Treatment|Death|9|||
164600038|NCT00064350|594556435|FG000|Induction Treatment|Withdrawal by Subject|0|||
164600039|NCT00064350|594556436|FG001|Induction Treatment|Withdrawal by Subject|0|||
164600040|NCT00064350|594556437|FG002|Induction Treatment|Withdrawal by Subject|21|||
164600041|NCT00064350|594556435|FG000|Induction Treatment|Ineligible or never started treatment|3|||
164600042|NCT00064350|594556436|FG001|Induction Treatment|Ineligible or never started treatment|6|||
164600043|NCT00064350|594556437|FG002|Induction Treatment|Ineligible or never started treatment|34|||
164600044|NCT00064350|594556435|FG000|Induction Treatment|Other|0|||
164600045|NCT00064350|594556436|FG001|Induction Treatment|Other|0|||
164600046|NCT00064350|594556437|FG002|Induction Treatment|Other|13|||
164600047|NCT00064350|594556435|FG000|Randomization|Adverse Event|8|||
164600048|NCT00064350|594556436|FG001|Randomization|Adverse Event|3|||
164600049|NCT00064350|594556437|FG002|Randomization|Adverse Event|0|||
164600050|NCT00064350|594556435|FG000|Randomization|Death|3|||
164600051|NCT00064350|594556436|FG001|Randomization|Death|0|||
164600052|NCT00064350|594556437|FG002|Randomization|Death|0|||
164600053|NCT00064350|594556435|FG000|Randomization|Withdrawal by Subject|1|||
164600054|NCT00064350|594556436|FG001|Randomization|Withdrawal by Subject|0|||
164600055|NCT00064350|594556437|FG002|Randomization|Withdrawal by Subject|0|||
164600056|NCT00064350|594556435|FG000|Randomization|Ineligible or never started treatment|9|||
164600057|NCT00064350|594556436|FG001|Randomization|Ineligible or never started treatment|15|||
164600058|NCT00064350|594556437|FG002|Randomization|Ineligible or never started treatment|0|||
164600059|NCT00064350|594556435|FG000|Randomization|Other|5|||
164600060|NCT00064350|594556436|FG001|Randomization|Other|0|||
164600061|NCT00064350|594556437|FG002|Randomization|Other|0|||
164600062|NCT00064350|594556435|FG000|Cross-Over|Adverse Event|0|||
164600063|NCT00064350|594556436|FG001|Cross-Over|Adverse Event|1|||
164600064|NCT00064350|594556437|FG002|Cross-Over|Adverse Event|0|||
164600065|NCT00064350|594556435|FG000|Cross-Over|Death|1|||
164600066|NCT00064350|594556436|FG001|Cross-Over|Death|3|||
164600067|NCT00064350|594556437|FG002|Cross-Over|Death|0|||
164600068|NCT00064350|594556435|FG000|Cross-Over|Withdrawal by Subject|2|||
164600069|NCT00064350|594556436|FG001|Cross-Over|Withdrawal by Subject|2|||
164600070|NCT00064350|594556437|FG002|Cross-Over|Withdrawal by Subject|0|||
164600071|NCT00064350|594556435|FG000|Cross-Over|Ineligible or never started treatment|3|||
164600072|NCT00064350|594556436|FG001|Cross-Over|Ineligible or never started treatment|6|||
164600073|NCT00064350|594556437|FG002|Cross-Over|Ineligible or never started treatment|0|||
164600074|NCT00064350|594556435|FG000|Cross-Over|Other|0|||
164600075|NCT00064350|594556436|FG001|Cross-Over|Other|2|||
164600076|NCT00064350|594556437|FG002|Cross-Over|Other|0|||
164714240|NCT02856555|594976823|FG000|Overall Study|Withdrawal by Subject|3|||
164714241|NCT02856555|594976824|FG001|Overall Study|Withdrawal by Subject|0|||
164714242|NCT02856555|594976825|FG002|Overall Study|Withdrawal by Subject|0|||
164714243|NCT02856555|594976823|FG000|Overall Study|Randomized but Never Treated|0|||
164714244|NCT02856555|594976824|FG001|Overall Study|Randomized but Never Treated|1|||
164714245|NCT02856555|594976825|FG002|Overall Study|Randomized but Never Treated|0|||
164600077|NCT00115765|594556438|FG000|Overall Study|Withdrawal by Subject|22|||
164600078|NCT00115765|594556439|FG001|Overall Study|Withdrawal by Subject|53|||
164600079|NCT00115765|594556440|FG002|Overall Study|Withdrawal by Subject|76|||
164600080|NCT00115765|594556441|FG003|Overall Study|Withdrawal by Subject|15|||
164600081|NCT00115765|594556438|FG000|Overall Study|Physician Decision|4|||
164714246|NCT03333941|594976826|FG000|Overall Study|Lost to Follow-up|10|||
164714247|NCT03333941|594976826|FG000|Overall Study|Death|2|||
164600082|NCT00115765|594556439|FG001|Overall Study|Physician Decision|15|||
164600083|NCT00115765|594556440|FG002|Overall Study|Physician Decision|18|||
164600084|NCT00115765|594556441|FG003|Overall Study|Physician Decision|13|||
164600085|NCT00115765|594556438|FG000|Overall Study|Lost to Follow-up|3|||
164600086|NCT00115765|594556439|FG001|Overall Study|Lost to Follow-up|20|||
164600087|NCT00115765|594556440|FG002|Overall Study|Lost to Follow-up|18|||
164600088|NCT00115765|594556441|FG003|Overall Study|Lost to Follow-up|1|||
164478484|NCT03823703|594123436|FG002|Overall Study|Sponsor request|4|||
164478485|NCT03823703|594123434|FG000|Overall Study|Adverse Event|3|||
164478486|NCT03823703|594123435|FG001|Overall Study|Adverse Event|1|||
164478487|NCT03823703|594123436|FG002|Overall Study|Adverse Event|0|||
164478488|NCT03823703|594123434|FG000|Overall Study|Withdrawal by Subject|0|||
164478489|NCT03823703|594123435|FG001|Overall Study|Withdrawal by Subject|1|||
164478490|NCT03823703|594123436|FG002|Overall Study|Withdrawal by Subject|0|||
164478491|NCT00799409|594123437|FG000|Overall Study|Withdrawal by Subject|1|||
164478492|NCT00799409|594123438|FG001|Overall Study|Withdrawal by Subject|0|||
164478493|NCT00799409|594123439|FG002|Overall Study|Withdrawal by Subject|0|||
164478494|NCT00799409|594123437|FG000|Overall Study|Lost to Follow-up|1|||
164478495|NCT00799409|594123438|FG001|Overall Study|Lost to Follow-up|0|||
164478496|NCT00799409|594123439|FG002|Overall Study|Lost to Follow-up|0|||
164478497|NCT00799409|594123437|FG000|Overall Study|Optimal Dose Not Achieved|2|||
164478498|NCT00799409|594123438|FG001|Overall Study|Optimal Dose Not Achieved|0|||
164478499|NCT00799409|594123439|FG002|Overall Study|Optimal Dose Not Achieved|0|||
164478500|NCT00799409|594123437|FG000|Overall Study|Failure to follow study protocol)|1|||
164478501|NCT00799409|594123438|FG001|Overall Study|Failure to follow study protocol)|0|||
164478502|NCT00799409|594123439|FG002|Overall Study|Failure to follow study protocol)|0|||
164478503|NCT00799409|594123437|FG000|Overall Study|Did not attend lab school day 1|1|||
164478504|NCT00799409|594123438|FG001|Overall Study|Did not attend lab school day 1|0|||
164478505|NCT00799409|594123439|FG002|Overall Study|Did not attend lab school day 1|0|||
164478506|NCT00799409|594123437|FG000|Overall Study|medication compliance|1|||
164478507|NCT00799409|594123438|FG001|Overall Study|medication compliance|0|||
164478508|NCT00799409|594123439|FG002|Overall Study|medication compliance|0|||
164478509|NCT04323800|594123440|FG000|Overall Study|Withdrawal by Subject|4|||
164478510|NCT04323800|594123441|FG001|Overall Study|Withdrawal by Subject|4|||
164478511|NCT04323800|594123440|FG000|Overall Study|Incomplete transfusion|1|||
164478512|NCT04323800|594123441|FG001|Overall Study|Incomplete transfusion|0|||
164478513|NCT04323800|594123440|FG000|Overall Study|Other|0|||
164478514|NCT04323800|594123441|FG001|Overall Study|Other|1|||
164478515|NCT04323800|594123440|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
164478516|NCT04323800|594123441|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
164478517|NCT00489554|594123442|FG000|Overall Study|Adverse Event|2|||
164478518|NCT00489554|594123442|FG000|Overall Study|Withdrawal by Subject|1|||
164478519|NCT00489554|594123442|FG000|Overall Study|Lost to Follow-up|1|||
164478520|NCT01732757|594123443|FG000|Overall Study|Lost to Follow-up|1|||
164478521|NCT01732757|594123444|FG001|Overall Study|Lost to Follow-up|0|||
164478522|NCT01732757|594123445|FG002|Overall Study|Lost to Follow-up|0|||
164478523|NCT00925548|594123446|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
164478524|NCT00925548|594123447|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
164478525|NCT00108355|594123449|FG000|Overall Study|Peritonitis at index paracentesis|1|||
164478526|NCT00108355|594123450|FG001|Overall Study|Peritonitis at index paracentesis|1|||
164478527|NCT00108355|594123449|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
164478528|NCT00108355|594123450|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
164478529|NCT00747006|594123451|FG000|Overall Study|Adverse Event|1|||
164478530|NCT00747006|594123452|FG001|Overall Study|Adverse Event|0|||
164478531|NCT00747006|594123453|FG002|Overall Study|Adverse Event|0|||
164478532|NCT00747006|594123451|FG000|Overall Study|Lost to Follow-up|0|||
164478533|NCT00747006|594123452|FG001|Overall Study|Lost to Follow-up|1|||
164478534|NCT00747006|594123453|FG002|Overall Study|Lost to Follow-up|0|||
164478535|NCT00747006|594123451|FG000|Overall Study|Physician Decision|2|||
164478536|NCT00747006|594123452|FG001|Overall Study|Physician Decision|0|||
164478537|NCT00747006|594123453|FG002|Overall Study|Physician Decision|1|||
164478538|NCT00357994|594123456|FG000|Overall Study|Adverse Event|1|||
164478539|NCT00357994|594123457|FG001|Overall Study|Adverse Event|2|||
164600089|NCT00115765|594556438|FG000|Overall Study|Other|6|||
164478540|NCT00357994|594123456|FG000|Overall Study|Lack of Efficacy|0|||
164478541|NCT00357994|594123457|FG001|Overall Study|Lack of Efficacy|1|||
164478542|NCT00357994|594123456|FG000|Overall Study|Protocol Violation|1|||
164478543|NCT00357994|594123457|FG001|Overall Study|Protocol Violation|0|||
164478544|NCT02132949|594123460|FG000|Overall Study|Death|7|||
164478545|NCT02132949|594123461|FG001|Overall Study|Death|13|||
164478546|NCT02132949|594123460|FG000|Overall Study|Lost to Follow-up|14|||
164478547|NCT02132949|594123461|FG001|Overall Study|Lost to Follow-up|4|||
164478548|NCT02132949|594123460|FG000|Overall Study|Withdrawal by Subject|6|||
164478549|NCT02132949|594123461|FG001|Overall Study|Withdrawal by Subject|5|||
164478550|NCT02132949|594123460|FG000|Overall Study|Noncompliance|5|||
164478551|NCT02132949|594123461|FG001|Overall Study|Noncompliance|1|||
164478552|NCT02132949|594123460|FG000|Overall Study|Physician Decision|3|||
164478553|NCT02132949|594123461|FG001|Overall Study|Physician Decision|1|||
164478554|NCT02132949|594123460|FG000|Overall Study|Disease Progression|3|||
164478555|NCT02132949|594123461|FG001|Overall Study|Disease Progression|0|||
164478556|NCT02132949|594123460|FG000|Overall Study|Adverse Event|2|||
164478557|NCT02132949|594123461|FG001|Overall Study|Adverse Event|1|||
164478558|NCT02132949|594123460|FG000|Overall Study|Withdrew Prior to Treatment|1|||
164478559|NCT02132949|594123461|FG001|Overall Study|Withdrew Prior to Treatment|2|||
164478560|NCT02132949|594123460|FG000|Overall Study|Reason Unspecified|0|||
164478561|NCT02132949|594123461|FG001|Overall Study|Reason Unspecified|1|||
164478562|NCT00745875|594123468|FG000|Overall Study|Continuing study treatment|4|||
164478563|NCT00745875|594123469|FG001|Overall Study|Continuing study treatment|4|||
164478564|NCT01583166|594123470|FG000|Overall Study|Withdrawal by Subject|4|||
164478565|NCT01583166|594123471|FG001|Overall Study|Withdrawal by Subject|6|||
164478566|NCT04652869|594123476|FG000|Overall Study|Withdrawal by Subject|0|||
164478567|NCT04652869|594123477|FG001|Overall Study|Withdrawal by Subject|2|||
164478568|NCT04652869|594123478|FG002|Overall Study|Withdrawal by Subject|0|||
164478569|NCT01372085|594123479|FG000|Washout Period 2|Physician Decision|0|||
164478570|NCT01372085|594123480|FG001|Washout Period 2|Physician Decision|0|||
164478571|NCT01372085|594123481|FG002|Washout Period 2|Physician Decision|0|||
164478572|NCT01372085|594123482|FG003|Washout Period 2|Physician Decision|0|||
164478573|NCT01372085|594123483|FG004|Washout Period 2|Physician Decision|1|||
164478574|NCT01372085|594123484|FG005|Washout Period 2|Physician Decision|0|||
164478575|NCT01372085|594123485|FG006|Washout Period 2|Physician Decision|0|||
164478576|NCT01372085|594123486|FG007|Washout Period 2|Physician Decision|0|||
164478577|NCT01372085|594123487|FG008|Washout Period 2|Physician Decision|0|||
164478578|NCT01372085|594123488|FG009|Washout Period 2|Physician Decision|0|||
164478579|NCT01372085|594123479|FG000|Washout Period 3|Withdrawal by Subject|0|||
164478580|NCT01372085|594123480|FG001|Washout Period 3|Withdrawal by Subject|0|||
164478581|NCT01372085|594123481|FG002|Washout Period 3|Withdrawal by Subject|0|||
164478582|NCT01372085|594123482|FG003|Washout Period 3|Withdrawal by Subject|0|||
164478583|NCT01372085|594123483|FG004|Washout Period 3|Withdrawal by Subject|0|||
164478584|NCT01372085|594123484|FG005|Washout Period 3|Withdrawal by Subject|2|||
164478585|NCT01372085|594123485|FG006|Washout Period 3|Withdrawal by Subject|0|||
164478586|NCT01372085|594123486|FG007|Washout Period 3|Withdrawal by Subject|0|||
164478587|NCT01372085|594123487|FG008|Washout Period 3|Withdrawal by Subject|0|||
164478588|NCT01372085|594123488|FG009|Washout Period 3|Withdrawal by Subject|0|||
164478589|NCT00562094|594123489|FG000|Overall Study|Lost to Follow-up|62|||
164478590|NCT03960645|594123490|FG000|Overall Study|Protocol Violation|1|||
164478591|NCT03960645|594123491|FG001|Overall Study|Protocol Violation|0|||
164478592|NCT01801007|594123496|FG000|Overall Study|Adverse Event|2|||
164478593|NCT01801007|594123496|FG000|Overall Study|Lost to Follow-up|4|||
164478594|NCT01801007|594123496|FG000|Overall Study|Withdrawal by Subject|5|||
164478595|NCT01683409|594123497|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
164478596|NCT01683409|594123498|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
164478597|NCT01683409|594123499|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
164478598|NCT01683409|594123500|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
164478599|NCT01683409|594123501|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
164478600|NCT01683409|594123497|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
164478601|NCT01683409|594123498|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
164478602|NCT01683409|594123499|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
164478603|NCT01683409|594123500|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
164478604|NCT01683409|594123501|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
164478605|NCT01683409|594123497|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
164478606|NCT01683409|594123498|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
164478607|NCT01683409|594123499|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
164478608|NCT01683409|594123500|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
164478609|NCT01683409|594123501|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
164478610|NCT01683409|594123497|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
164478611|NCT01683409|594123498|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
164478612|NCT01683409|594123499|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
164478613|NCT01683409|594123500|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
164478614|NCT01683409|594123501|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
164478615|NCT01683409|594123497|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
164478616|NCT01683409|594123498|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
164600090|NCT00115765|594556439|FG001|Overall Study|Other|12|||
164478617|NCT01683409|594123499|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
164478618|NCT01683409|594123500|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
164478619|NCT01683409|594123501|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
164478620|NCT01683409|594123497|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
164478621|NCT01683409|594123498|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
164478622|NCT01683409|594123499|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
164600091|NCT00115765|594556440|FG002|Overall Study|Other|9|||
164478623|NCT01683409|594123500|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
164478624|NCT01683409|594123501|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
164478625|NCT01683409|594123497|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
164478626|NCT01683409|594123498|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
164478627|NCT01683409|594123499|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
164478628|NCT01683409|594123500|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
164478629|NCT01683409|594123501|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
164478630|NCT01683409|594123497|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
164478631|NCT01683409|594123498|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
164478632|NCT01683409|594123499|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
164478633|NCT01683409|594123500|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
164478634|NCT01683409|594123501|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
164478635|NCT01683409|594123497|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
164478636|NCT01683409|594123498|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
164478637|NCT01683409|594123499|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
164478638|NCT01683409|594123500|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
164478639|NCT01683409|594123501|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
164478640|NCT01683409|594123497|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
164478641|NCT01683409|594123498|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
164478642|NCT01683409|594123499|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
164478643|NCT01683409|594123500|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
164478644|NCT01683409|594123501|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
164478645|NCT01683409|594123497|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
164478646|NCT01683409|594123498|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
164478647|NCT01683409|594123499|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
164478648|NCT01683409|594123500|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
164478649|NCT01683409|594123501|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
164478650|NCT00553332|594123503|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
164478651|NCT00145470|594123511|FG000|Overall Study|Adverse Event|19|||
164478652|NCT00145470|594123512|FG001|Overall Study|Adverse Event|25|||
164478653|NCT00145470|594123511|FG000|Overall Study|Lack of Efficacy|27|||
164478654|NCT00145470|594123512|FG001|Overall Study|Lack of Efficacy|13|||
164478655|NCT00145470|594123511|FG000|Overall Study|Withdrawal by Subject|36|||
164478656|NCT00145470|594123512|FG001|Overall Study|Withdrawal by Subject|34|||
164478657|NCT00145470|594123511|FG000|Overall Study|Lost to Follow-up|21|||
164478658|NCT00145470|594123512|FG001|Overall Study|Lost to Follow-up|17|||
164478659|NCT00145470|594123511|FG000|Overall Study|Reason Not Reported|9|||
164478660|NCT00145470|594123512|FG001|Overall Study|Reason Not Reported|9|||
164478661|NCT02063659|594123513|FG000|Double-Blind Treatment Period|Adverse Event|1|||
164478662|NCT02063659|594123514|FG001|Double-Blind Treatment Period|Adverse Event|2|||
164478663|NCT02063659|594123515|FG002|Double-Blind Treatment Period|Adverse Event|0|||
164478664|NCT02063659|594123516|FG003|Double-Blind Treatment Period|Adverse Event|0|||
164478665|NCT02063659|594123513|FG000|Double-Blind Treatment Period|Physician Decision|1|||
164478666|NCT02063659|594123514|FG001|Double-Blind Treatment Period|Physician Decision|0|||
164478667|NCT02063659|594123515|FG002|Double-Blind Treatment Period|Physician Decision|0|||
164478668|NCT02063659|594123516|FG003|Double-Blind Treatment Period|Physician Decision|0|||
164478669|NCT02063659|594123513|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
164478670|NCT02063659|594123514|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
164478671|NCT02063659|594123515|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
164478672|NCT02063659|594123516|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
164478673|NCT02063659|594123513|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
164478674|NCT02063659|594123514|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
164478675|NCT02063659|594123515|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
164478676|NCT02063659|594123516|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
164478677|NCT02063659|594123513|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
164478678|NCT02063659|594123514|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
164478679|NCT02063659|594123515|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
164478680|NCT02063659|594123516|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
164478681|NCT02063659|594123513|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
164478682|NCT02063659|594123514|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
164478683|NCT02063659|594123515|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
164478684|NCT02063659|594123516|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
164478685|NCT02063659|594123513|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
164478686|NCT02063659|594123514|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
164478687|NCT02063659|594123515|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
164714248|NCT03333941|594976826|FG000|Overall Study|Adverse Event|1|||
164478688|NCT02063659|594123516|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
164478689|NCT02063659|594123513|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
164478690|NCT02063659|594123514|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
164144909|NCT05199090|592891824|FG002|Overall Study|Physician Decision|0|||
164600092|NCT00115765|594556441|FG003|Overall Study|Other|2|||
164600093|NCT01683071|594556444|FG000|Part 1|Lack of Efficacy|1|||
164478691|NCT02063659|594123515|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
164478692|NCT02063659|594123516|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
164478693|NCT04827732|594123517|FG000|Overall Study|Did not start treatment|0|||
164478694|NCT04827732|594123518|FG001|Overall Study|Did not start treatment|1|||
164478695|NCT04827732|594123519|FG002|Overall Study|Did not start treatment|0|||
164478696|NCT04827732|594123520|FG003|Overall Study|Did not start treatment|1|||
164478697|NCT05366751|594123521|FG000|Overall Study|Adverse Event|25|||
164478698|NCT05366751|594123521|FG000|Overall Study|Physician Decision|3|||
164478699|NCT05366751|594123521|FG000|Overall Study|Lost to Follow-up|2|||
164478700|NCT05366751|594123521|FG000|Overall Study|Withdrawal by Subject|14|||
164478701|NCT05366751|594123521|FG000|Overall Study|Study Terminated by Sponsor|50|||
164478702|NCT05366751|594123521|FG000|Overall Study|Site Terminated by Sponsor|3|||
164478703|NCT01690624|594123526|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
164478704|NCT01690624|594123527|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
164478705|NCT01690624|594123528|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
164478706|NCT01690624|594123529|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
164478707|NCT01690624|594123526|FG000|Overall Study|Adverse event (other than DLT)|3|||
164478708|NCT01690624|594123527|FG001|Overall Study|Adverse event (other than DLT)|1|||
164478709|NCT01690624|594123528|FG002|Overall Study|Adverse event (other than DLT)|1|||
164478710|NCT01690624|594123529|FG003|Overall Study|Adverse event (other than DLT)|1|||
164478711|NCT01690624|594123526|FG000|Overall Study|Withdrawal by Subject|0|||
164478712|NCT01690624|594123527|FG001|Overall Study|Withdrawal by Subject|0|||
164478713|NCT01690624|594123528|FG002|Overall Study|Withdrawal by Subject|1|||
164478714|NCT01690624|594123529|FG003|Overall Study|Withdrawal by Subject|0|||
164478715|NCT01690624|594123526|FG000|Overall Study|Sponsor is ending trial|0|||
164478716|NCT01690624|594123527|FG001|Overall Study|Sponsor is ending trial|0|||
164478717|NCT01690624|594123528|FG002|Overall Study|Sponsor is ending trial|0|||
164478718|NCT01690624|594123529|FG003|Overall Study|Sponsor is ending trial|1|||
164478719|NCT01690624|594123526|FG000|Overall Study|Physician Decision|0|||
164478720|NCT01690624|594123527|FG001|Overall Study|Physician Decision|0|||
164478721|NCT01690624|594123528|FG002|Overall Study|Physician Decision|0|||
164478722|NCT01690624|594123529|FG003|Overall Study|Physician Decision|1|||
164478723|NCT01690624|594123526|FG000|Overall Study|Withdrawal by Subject|0|||
164478724|NCT01690624|594123527|FG001|Overall Study|Withdrawal by Subject|1|||
164478725|NCT01690624|594123528|FG002|Overall Study|Withdrawal by Subject|0|||
164478726|NCT01690624|594123529|FG003|Overall Study|Withdrawal by Subject|0|||
164478727|NCT01690624|594123526|FG000|Overall Study|Lack of Efficacy|1|||
164478728|NCT01690624|594123527|FG001|Overall Study|Lack of Efficacy|1|||
164478729|NCT01690624|594123528|FG002|Overall Study|Lack of Efficacy|3|||
164478730|NCT01690624|594123529|FG003|Overall Study|Lack of Efficacy|0|||
164478731|NCT05293717|594123534|FG000|Overall Study|Physician Decision|1|||
164478732|NCT03732807|594125272|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
164478733|NCT03732807|594125273|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
164600094|NCT01683071|594556445|FG001|Part 1|Lack of Efficacy|0|||
164600095|NCT01683071|594556446|FG002|Part 1|Lack of Efficacy|0|||
164600096|NCT01683071|594556447|FG003|Part 1|Lack of Efficacy|3|||
164600097|NCT01683071|594556448|FG004|Part 1|Lack of Efficacy|0|||
164600098|NCT01683071|594556449|FG005|Part 1|Lack of Efficacy|0|||
164600099|NCT01683071|594556444|FG000|Part 1|Withdrawal by Subject|1|||
164600100|NCT01683071|594556445|FG001|Part 1|Withdrawal by Subject|2|||
164600101|NCT01683071|594556446|FG002|Part 1|Withdrawal by Subject|2|||
164600102|NCT01683071|594556447|FG003|Part 1|Withdrawal by Subject|1|||
164600103|NCT01683071|594556448|FG004|Part 1|Withdrawal by Subject|0|||
164600104|NCT01683071|594556449|FG005|Part 1|Withdrawal by Subject|0|||
164714249|NCT04981717|594976832|FG000|Overall Study|Protocol Violation|0|||
164714250|NCT04981717|594976833|FG001|Overall Study|Protocol Violation|3|||
164714251|NCT04981717|594976832|FG000|Overall Study|Adverse Event|1|||
164478734|NCT03732807|594125274|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
164478735|NCT03732807|594125275|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
164600105|NCT01683071|594556444|FG000|Part 1|Surgery Cancelled|1|||
164600106|NCT01683071|594556445|FG001|Part 1|Surgery Cancelled|0|||
164714252|NCT04981717|594976833|FG001|Overall Study|Adverse Event|3|||
164714253|NCT04981717|594976832|FG000|Overall Study|Pregnancy|1|||
164714254|NCT04981717|594976833|FG001|Overall Study|Pregnancy|0|||
164478736|NCT03732807|594125276|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
164478737|NCT03732807|594125277|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
164478738|NCT03732807|594125278|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
164478739|NCT03732807|594125272|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
164478740|NCT03732807|594125273|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
164478741|NCT03732807|594125274|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
164600107|NCT01683071|594556446|FG002|Part 1|Surgery Cancelled|0|||
164600108|NCT01683071|594556447|FG003|Part 1|Surgery Cancelled|0|||
164600109|NCT01683071|594556448|FG004|Part 1|Surgery Cancelled|0|||
164714255|NCT04981717|594976832|FG000|Overall Study|Physician Decision|1|||
164714256|NCT04981717|594976833|FG001|Overall Study|Physician Decision|0|||
164478742|NCT03732807|594125275|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
164478743|NCT03732807|594125276|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
164478744|NCT03732807|594125277|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
164478745|NCT03732807|594125278|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
164478746|NCT03732807|594125272|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
164478747|NCT03732807|594125273|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
164478748|NCT03732807|594125274|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
164478749|NCT03732807|594125275|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
164478750|NCT03732807|594125276|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
164478751|NCT03732807|594125277|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
164478752|NCT03732807|594125278|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
164478753|NCT03732807|594125272|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
164478754|NCT03732807|594125273|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
164478755|NCT03732807|594125274|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
164478756|NCT03732807|594125275|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
164478757|NCT03732807|594125276|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
164478758|NCT03732807|594125277|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
164478759|NCT03732807|594125278|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
164478760|NCT03732807|594125272|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
164478761|NCT03732807|594125273|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
164478762|NCT03732807|594125274|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
164478763|NCT03732807|594125275|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
164478764|NCT03732807|594125276|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
164478765|NCT03732807|594125277|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
164478766|NCT03732807|594125278|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
164600110|NCT01683071|594556449|FG005|Part 1|Surgery Cancelled|0|||
164600111|NCT01683071|594556444|FG000|Part 1|Did not receive study drug|1|||
164600112|NCT01683071|594556445|FG001|Part 1|Did not receive study drug|0|||
164600113|NCT01683071|594556446|FG002|Part 1|Did not receive study drug|0|||
164600114|NCT01683071|594556447|FG003|Part 1|Did not receive study drug|1|||
164600115|NCT01683071|594556448|FG004|Part 1|Did not receive study drug|0|||
164600116|NCT01683071|594556449|FG005|Part 1|Did not receive study drug|0|||
164600117|NCT01683071|594556444|FG000|Part 1|Early termination; met exclusion criteria|0|||
164600118|NCT01683071|594556445|FG001|Part 1|Early termination; met exclusion criteria|2|||
164600119|NCT01683071|594556446|FG002|Part 1|Early termination; met exclusion criteria|1|||
164600120|NCT01683071|594556447|FG003|Part 1|Early termination; met exclusion criteria|0|||
164600121|NCT01683071|594556448|FG004|Part 1|Early termination; met exclusion criteria|0|||
164600122|NCT01683071|594556449|FG005|Part 1|Early termination; met exclusion criteria|0|||
164600123|NCT01683071|594556444|FG000|Part 2|Lack of Efficacy|0|||
164600124|NCT01683071|594556445|FG001|Part 2|Lack of Efficacy|0|||
164600125|NCT01683071|594556446|FG002|Part 2|Lack of Efficacy|0|||
164600126|NCT01683071|594556447|FG003|Part 2|Lack of Efficacy|0|||
164600127|NCT01683071|594556448|FG004|Part 2|Lack of Efficacy|3|||
164600128|NCT01683071|594556449|FG005|Part 2|Lack of Efficacy|4|||
164600129|NCT01683071|594556444|FG000|Part 2|Lost to Follow-up|0|||
164600130|NCT01683071|594556445|FG001|Part 2|Lost to Follow-up|0|||
164600131|NCT01683071|594556446|FG002|Part 2|Lost to Follow-up|0|||
164600132|NCT01683071|594556447|FG003|Part 2|Lost to Follow-up|0|||
164600133|NCT01683071|594556448|FG004|Part 2|Lost to Follow-up|2|||
164600134|NCT01683071|594556449|FG005|Part 2|Lost to Follow-up|0|||
164600135|NCT01683071|594556444|FG000|Part 2|Withdrawal by Subject|0|||
164600136|NCT01683071|594556445|FG001|Part 2|Withdrawal by Subject|0|||
164600137|NCT01683071|594556446|FG002|Part 2|Withdrawal by Subject|0|||
164600138|NCT01683071|594556447|FG003|Part 2|Withdrawal by Subject|0|||
164714257|NCT04981717|594976832|FG000|Overall Study|Sponsor Request|157|||
164714258|NCT04981717|594976833|FG001|Overall Study|Sponsor Request|172|||
164714259|NCT04981717|594976832|FG000|Overall Study|Lost to Follow-up|4|||
164478767|NCT03732807|594125272|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
164478768|NCT03732807|594125273|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
164478769|NCT03732807|594125274|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
164478770|NCT03732807|594125275|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
164478771|NCT03732807|594125276|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
164478772|NCT03732807|594125277|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
164478773|NCT03732807|594125278|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
164478774|NCT03732807|594125272|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
164600139|NCT01683071|594556448|FG004|Part 2|Withdrawal by Subject|3|||
164600140|NCT01683071|594556449|FG005|Part 2|Withdrawal by Subject|3|||
164714260|NCT04981717|594976833|FG001|Overall Study|Lost to Follow-up|5|||
164714261|NCT04981717|594976832|FG000|Overall Study|Withdrawal by Subject|50|||
164714262|NCT04981717|594976833|FG001|Overall Study|Withdrawal by Subject|37|||
164600141|NCT01683071|594556444|FG000|Part 2|Surgery cancelled|0|||
164600142|NCT01683071|594556445|FG001|Part 2|Surgery cancelled|0|||
164600143|NCT01683071|594556446|FG002|Part 2|Surgery cancelled|0|||
164714263|NCT00974922|594976834|FG000|Overall Study|study terminated|24|||
164714264|NCT01762800|594976835|FG000|Overall Study|Adverse Event|8|||
164714265|NCT01762800|594976836|FG001|Overall Study|Adverse Event|13|||
164714266|NCT01762800|594976835|FG000|Overall Study|Lack of Efficacy|3|||
164714267|NCT01762800|594976836|FG001|Overall Study|Lack of Efficacy|2|||
164714268|NCT01762800|594976835|FG000|Overall Study|Study Closed/Terminated|0|||
164478775|NCT03732807|594125273|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
164478776|NCT03732807|594125274|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
164478777|NCT03732807|594125275|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
164478778|NCT03732807|594125276|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
164478779|NCT03732807|594125277|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
164478780|NCT03732807|594125278|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
164478781|NCT03732807|594125272|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
164478782|NCT03732807|594125273|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
164478783|NCT03732807|594125274|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
164478784|NCT03732807|594125275|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
164478785|NCT03732807|594125276|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
164478786|NCT03732807|594125277|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
164478787|NCT03732807|594125278|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
164478788|NCT03732807|594125272|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
164478789|NCT03732807|594125273|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
164478790|NCT03732807|594125274|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
164478791|NCT03732807|594125275|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
164478792|NCT03732807|594125276|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
164478793|NCT03732807|594125277|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
164478794|NCT03732807|594125278|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
164478795|NCT03732807|594125272|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
164478796|NCT03732807|594125273|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
164478797|NCT03732807|594125274|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
164478798|NCT03732807|594125275|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
164478799|NCT03732807|594125276|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
164478800|NCT03732807|594125277|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
164478801|NCT03732807|594125278|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
164478802|NCT03732807|594125272|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
164478803|NCT03732807|594125273|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
164478804|NCT03732807|594125274|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
164478805|NCT03732807|594125275|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
164478806|NCT03732807|594125276|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
164478807|NCT03732807|594125277|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
164478808|NCT03732807|594125278|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
164478809|NCT03732807|594125272|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
164478810|NCT03732807|594125273|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
164478811|NCT03732807|594125274|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
164478812|NCT03732807|594125275|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
164478813|NCT03732807|594125276|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
164478814|NCT03732807|594125277|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
164478815|NCT03732807|594125278|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
164478816|NCT03732807|594125272|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
164478817|NCT03732807|594125273|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
164478818|NCT03732807|594125274|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
164478819|NCT03732807|594125275|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
164478820|NCT03732807|594125276|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
164478821|NCT03732807|594125277|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
164478822|NCT03732807|594125278|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
164478823|NCT03732807|594125272|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
164478824|NCT03732807|594125273|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
164478825|NCT03732807|594125274|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
164478826|NCT03732807|594125275|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
164478827|NCT03732807|594125276|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
164478828|NCT03732807|594125277|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
164478829|NCT03732807|594125278|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
164478830|NCT03345979|594125279|FG000|Overall Study|Withdrawal by Subject|20|||
164478831|NCT03345979|594125280|FG001|Overall Study|Withdrawal by Subject|31|||
164478832|NCT03345979|594125279|FG000|Overall Study|Adverse Event|10|||
164478833|NCT03345979|594125280|FG001|Overall Study|Adverse Event|11|||
164478834|NCT03345979|594125279|FG000|Overall Study|Lost to Follow-up|8|||
164714269|NCT01762800|594976836|FG001|Overall Study|Study Closed/Terminated|1|||
164714270|NCT01762800|594976835|FG000|Overall Study|Physician Decision|1|||
164600144|NCT01683071|594556447|FG003|Part 2|Surgery cancelled|0|||
164600145|NCT01683071|594556448|FG004|Part 2|Surgery cancelled|4|||
164600146|NCT01683071|594556449|FG005|Part 2|Surgery cancelled|2|||
164600147|NCT01683071|594556444|FG000|Part 2|Did not receive study drug|0|||
164600148|NCT01683071|594556445|FG001|Part 2|Did not receive study drug|0|||
164600149|NCT01683071|594556446|FG002|Part 2|Did not receive study drug|0|||
164600150|NCT01683071|594556447|FG003|Part 2|Did not receive study drug|0|||
164600151|NCT01683071|594556448|FG004|Part 2|Did not receive study drug|2|||
164600152|NCT01683071|594556449|FG005|Part 2|Did not receive study drug|1|||
164600153|NCT01683071|594556444|FG000|Part 2|Met exclusion criterion|0|||
164600154|NCT01683071|594556445|FG001|Part 2|Met exclusion criterion|0|||
164600155|NCT01683071|594556446|FG002|Part 2|Met exclusion criterion|0|||
164600156|NCT01683071|594556447|FG003|Part 2|Met exclusion criterion|0|||
164600157|NCT01683071|594556448|FG004|Part 2|Met exclusion criterion|1|||
164600158|NCT01683071|594556449|FG005|Part 2|Met exclusion criterion|1|||
164600159|NCT01683071|594556444|FG000|Part 2|Protocol deviation|0|||
164600160|NCT01683071|594556445|FG001|Part 2|Protocol deviation|0|||
164600161|NCT01683071|594556446|FG002|Part 2|Protocol deviation|0|||
164600162|NCT01683071|594556447|FG003|Part 2|Protocol deviation|0|||
164600163|NCT01683071|594556448|FG004|Part 2|Protocol deviation|1|||
164600164|NCT01683071|594556449|FG005|Part 2|Protocol deviation|2|||
164600165|NCT01683071|594556444|FG000|Part 2|Withdrawal by investigator decision|0|||
164600166|NCT01683071|594556445|FG001|Part 2|Withdrawal by investigator decision|0|||
164600167|NCT01683071|594556446|FG002|Part 2|Withdrawal by investigator decision|0|||
164600168|NCT01683071|594556447|FG003|Part 2|Withdrawal by investigator decision|0|||
164600169|NCT01683071|594556448|FG004|Part 2|Withdrawal by investigator decision|1|||
164600170|NCT01683071|594556449|FG005|Part 2|Withdrawal by investigator decision|2|||
164600171|NCT03707158|594556450|FG000|Midtreatment|Lost to Follow-up|16|||
164600172|NCT03707158|594556451|FG001|Midtreatment|Lost to Follow-up|7|||
164600173|NCT03707158|594556450|FG000|Midtreatment|Withdrawal by Subject|28|||
164600174|NCT03707158|594556451|FG001|Midtreatment|Withdrawal by Subject|19|||
164600175|NCT03707158|594556450|FG000|Posttreatment|Lost to Follow-up|0|||
164714271|NCT01762800|594976836|FG001|Overall Study|Physician Decision|1|||
164714272|NCT01762800|594976835|FG000|Overall Study|Withdrawal by Subject|7|||
164478835|NCT03345979|594125280|FG001|Overall Study|Lost to Follow-up|9|||
164478836|NCT03345979|594125279|FG000|Overall Study|Lack of Efficacy|4|||
164478837|NCT03345979|594125280|FG001|Overall Study|Lack of Efficacy|2|||
164478838|NCT03345979|594125279|FG000|Overall Study|Protocol Violation|1|||
164478839|NCT03345979|594125280|FG001|Overall Study|Protocol Violation|3|||
164478840|NCT03345979|594125279|FG000|Overall Study|Physician Decision|0|||
164478841|NCT03345979|594125280|FG001|Overall Study|Physician Decision|2|||
164478842|NCT00734578|594125282|FG000|Overall Study|Adverse Event|4|||
164478843|NCT00734578|594125283|FG001|Overall Study|Adverse Event|6|||
164478844|NCT00734578|594125284|FG002|Overall Study|Adverse Event|1|||
164478845|NCT00734578|594125282|FG000|Overall Study|Protocol Violation|8|||
164478846|NCT00734578|594125283|FG001|Overall Study|Protocol Violation|6|||
164478847|NCT00734578|594125284|FG002|Overall Study|Protocol Violation|3|||
164478848|NCT00734578|594125282|FG000|Overall Study|Withdrawal by Subject|7|||
164478849|NCT00734578|594125283|FG001|Overall Study|Withdrawal by Subject|8|||
164478850|NCT00734578|594125284|FG002|Overall Study|Withdrawal by Subject|11|||
164478851|NCT00734578|594125282|FG000|Overall Study|Lost to Follow-up|9|||
164478852|NCT00734578|594125283|FG001|Overall Study|Lost to Follow-up|3|||
164478853|NCT00734578|594125284|FG002|Overall Study|Lost to Follow-up|5|||
164478854|NCT00734578|594125282|FG000|Overall Study|Lack of Efficacy|3|||
164478855|NCT00734578|594125283|FG001|Overall Study|Lack of Efficacy|2|||
164478856|NCT00734578|594125284|FG002|Overall Study|Lack of Efficacy|5|||
164478857|NCT00734578|594125282|FG000|Overall Study|Randomized in error|1|||
164600176|NCT03707158|594556451|FG001|Posttreatment|Lost to Follow-up|5|||
164600177|NCT03707158|594556450|FG000|Follow-up|Lost to Follow-up|19|||
164600178|NCT03707158|594556451|FG001|Follow-up|Lost to Follow-up|18|||
164600179|NCT03707158|594556450|FG000|Follow-up|Withdrawal by Subject|13|||
164600180|NCT03707158|594556451|FG001|Follow-up|Withdrawal by Subject|6|||
164600181|NCT00831441|594558143|FG000|Randomized|Death|82|||
164600182|NCT00831441|594558144|FG001|Randomized|Death|81|||
164714273|NCT01762800|594976836|FG001|Overall Study|Withdrawal by Subject|4|||
164478858|NCT00734578|594125283|FG001|Overall Study|Randomized in error|0|||
164478859|NCT00734578|594125284|FG002|Overall Study|Randomized in error|0|||
164478860|NCT00734578|594125282|FG000|Overall Study|Exclusion criteria|1|||
164600183|NCT00831441|594558143|FG000|Randomized|Adverse Event|248|||
164600184|NCT00831441|594558144|FG001|Randomized|Adverse Event|321|||
164600185|NCT00831441|594558143|FG000|Randomized|Emergency procedure|2|||
164478861|NCT00734578|594125283|FG001|Overall Study|Exclusion criteria|0|||
164600186|NCT00831441|594558144|FG001|Randomized|Emergency procedure|2|||
164600187|NCT00831441|594558143|FG000|Randomized|Elective procedure|26|||
164600188|NCT00831441|594558144|FG001|Randomized|Elective procedure|25|||
164478862|NCT00734578|594125284|FG002|Overall Study|Exclusion criteria|0|||
164478863|NCT00999596|594125285|FG000|Overall Study|Statistical population not required|101|||
164478864|NCT04693637|594125287|FG000|Overall Study|Death|4|||
164600189|NCT00831441|594558143|FG000|Randomized|Physician Decision|26|||
164600190|NCT00831441|594558144|FG001|Randomized|Physician Decision|35|||
164600191|NCT00831441|594558143|FG000|Randomized|No longer met criteria|13|||
164478865|NCT04693637|594125287|FG000|Overall Study|Withdrawal by Subject|3|||
164478866|NCT04693637|594125287|FG000|Overall Study|Physician Decision|2|||
164478867|NCT04693637|594125287|FG000|Overall Study|Lost to Follow-up|1|||
164478868|NCT04885998|594125290|FG000|Overall Study|Withdrawal by Subject|0|||
164478869|NCT04885998|594125291|FG001|Overall Study|Withdrawal by Subject|2|||
164478870|NCT04885998|594125292|FG002|Overall Study|Withdrawal by Subject|0|||
164478871|NCT04885998|594125293|FG003|Overall Study|Withdrawal by Subject|3|||
164478872|NCT04885998|594125290|FG000|Overall Study|Lost to Follow-up|1|||
164478873|NCT04885998|594125291|FG001|Overall Study|Lost to Follow-up|1|||
164478874|NCT04885998|594125292|FG002|Overall Study|Lost to Follow-up|0|||
164478875|NCT04885998|594125293|FG003|Overall Study|Lost to Follow-up|0|||
164478876|NCT04885998|594125290|FG000|Overall Study|Death|2|||
164478877|NCT04885998|594125291|FG001|Overall Study|Death|1|||
164478878|NCT04885998|594125292|FG002|Overall Study|Death|2|||
164478879|NCT04885998|594125293|FG003|Overall Study|Death|2|||
164478880|NCT04885998|594125290|FG000|Overall Study|Decision by sponsor|1|||
164478881|NCT04885998|594125291|FG001|Overall Study|Decision by sponsor|1|||
164478882|NCT04885998|594125292|FG002|Overall Study|Decision by sponsor|0|||
164478883|NCT04885998|594125293|FG003|Overall Study|Decision by sponsor|0|||
164478884|NCT05260437|594125297|FG000|Overall Study|Lost to Follow-up|5|||
164478885|NCT05260437|594125298|FG001|Overall Study|Lost to Follow-up|2|||
164478886|NCT05260437|594125299|FG002|Overall Study|Lost to Follow-up|1|||
164478887|NCT05260437|594125300|FG003|Overall Study|Lost to Follow-up|2|||
164478888|NCT05260437|594125301|FG004|Overall Study|Lost to Follow-up|2|||
164478889|NCT05260437|594125297|FG000|Overall Study|Withdrawal by Subject|3|||
164478890|NCT05260437|594125298|FG001|Overall Study|Withdrawal by Subject|0|||
164478891|NCT05260437|594125299|FG002|Overall Study|Withdrawal by Subject|4|||
164478892|NCT05260437|594125300|FG003|Overall Study|Withdrawal by Subject|5|||
164478893|NCT05260437|594125301|FG004|Overall Study|Withdrawal by Subject|0|||
164478894|NCT05260437|594125297|FG000|Overall Study|Vaccine Not Administered|0|||
164478895|NCT05260437|594125298|FG001|Overall Study|Vaccine Not Administered|1|||
164478896|NCT05260437|594125299|FG002|Overall Study|Vaccine Not Administered|0|||
164478897|NCT05260437|594125300|FG003|Overall Study|Vaccine Not Administered|0|||
164478898|NCT05260437|594125301|FG004|Overall Study|Vaccine Not Administered|0|||
164478899|NCT00910962|594125302|FG000|Overall Study|Adverse Event|5|||
164478900|NCT00910962|594125303|FG001|Overall Study|Adverse Event|20|||
164478901|NCT00910962|594125304|FG002|Overall Study|Adverse Event|17|||
164478902|NCT00910962|594125302|FG000|Overall Study|Protocol Violation|1|||
164478903|NCT00910962|594125303|FG001|Overall Study|Protocol Violation|3|||
164478904|NCT00910962|594125304|FG002|Overall Study|Protocol Violation|3|||
164478905|NCT00910962|594125302|FG000|Overall Study|Lost to Follow-up|0|||
164478906|NCT00910962|594125303|FG001|Overall Study|Lost to Follow-up|3|||
164478907|NCT00910962|594125304|FG002|Overall Study|Lost to Follow-up|1|||
164478908|NCT00910962|594125302|FG000|Overall Study|Physician Decision|0|||
164478909|NCT00910962|594125303|FG001|Overall Study|Physician Decision|6|||
164478910|NCT00910962|594125304|FG002|Overall Study|Physician Decision|6|||
164478911|NCT00910962|594125302|FG000|Overall Study|Withdrawal by Subject|25|||
164478912|NCT00910962|594125303|FG001|Overall Study|Withdrawal by Subject|32|||
164478913|NCT00910962|594125304|FG002|Overall Study|Withdrawal by Subject|32|||
164478914|NCT00910962|594125302|FG000|Overall Study|Reached defined stopping criteria|12|||
164478915|NCT00910962|594125303|FG001|Overall Study|Reached defined stopping criteria|14|||
164478916|NCT00910962|594125304|FG002|Overall Study|Reached defined stopping criteria|17|||
164478917|NCT00195819|594125305|FG000|Double-Blind|Withdrawal by Subject|1|||
164478918|NCT00195819|594125306|FG001|Double-Blind|Withdrawal by Subject|0|||
164478919|NCT00195819|594125305|FG000|Double-Blind|Moved|1|||
164478920|NCT00195819|594125306|FG001|Double-Blind|Moved|0|||
164478921|NCT00195819|594125305|FG000|Open-label|Adverse Event|0|||
164478922|NCT00195819|594125306|FG001|Open-label|Adverse Event|9|||
164478923|NCT00195819|594125305|FG000|Open-label|Lack of Efficacy|0|||
164478924|NCT00195819|594125306|FG001|Open-label|Lack of Efficacy|2|||
164478925|NCT00195819|594125305|FG000|Open-label|Pregnancy|0|||
164478926|NCT00195819|594125306|FG001|Open-label|Pregnancy|1|||
164478927|NCT00195819|594125305|FG000|Open-label|Protocol Violation|0|||
164478928|NCT00195819|594125306|FG001|Open-label|Protocol Violation|2|||
164478929|NCT00195819|594125305|FG000|Open-label|Moved|0|||
164478930|NCT00195819|594125306|FG001|Open-label|Moved|1|||
164478931|NCT00195819|594125305|FG000|Open-label|Withdrawal by Subject|0|||
164478932|NCT00195819|594125306|FG001|Open-label|Withdrawal by Subject|5|||
164478933|NCT00787176|594125307|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
164478934|NCT00787176|594125308|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
164478935|NCT00787176|594125309|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
164478936|NCT00787176|594125310|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
164478937|NCT01124045|594125311|FG000|Overall Study|Lost to Follow-up|0|||
164478938|NCT01124045|594125312|FG001|Overall Study|Lost to Follow-up|1|||
164478939|NCT01124045|594125311|FG000|Overall Study|Physician Decision|0|||
164478940|NCT01124045|594125312|FG001|Overall Study|Physician Decision|2|||
164478941|NCT03298087|594125318|FG000|Overall Study|Withdrawal by Subject|4|||
164478942|NCT02060487|594125344|FG000|Overall Study|Other|1|||
164478943|NCT02060487|594125345|FG001|Overall Study|Other|2|||
164714274|NCT00517881|594976837|FG000|Overall Study|Protocol Violation|2|||
164714275|NCT00517881|594976837|FG000|Overall Study|Adverse Event|1|||
164478944|NCT02060487|594125346|FG002|Overall Study|Other|1|||
164478945|NCT02060487|594125344|FG000|Overall Study|Lack of Efficacy|0|||
164478946|NCT02060487|594125345|FG001|Overall Study|Lack of Efficacy|1|||
164478947|NCT02060487|594125346|FG002|Overall Study|Lack of Efficacy|0|||
164478948|NCT02060487|594125344|FG000|Overall Study|Withdrawal by Subject|3|||
164478949|NCT02060487|594125345|FG001|Overall Study|Withdrawal by Subject|10|||
164478950|NCT02060487|594125346|FG002|Overall Study|Withdrawal by Subject|4|||
164478951|NCT02060487|594125344|FG000|Overall Study|Study Terminated By Sponsor|87|||
164478952|NCT02060487|594125345|FG001|Overall Study|Study Terminated By Sponsor|89|||
164478953|NCT02060487|594125346|FG002|Overall Study|Study Terminated By Sponsor|100|||
164478954|NCT02060487|594125344|FG000|Overall Study|Randomized in error|1|||
164478955|NCT02060487|594125345|FG001|Overall Study|Randomized in error|0|||
164478956|NCT02060487|594125346|FG002|Overall Study|Randomized in error|0|||
164478957|NCT02060487|594125344|FG000|Overall Study|Protocol Violation|0|||
164478958|NCT02060487|594125345|FG001|Overall Study|Protocol Violation|1|||
164478959|NCT02060487|594125346|FG002|Overall Study|Protocol Violation|1|||
164478960|NCT02060487|594125344|FG000|Overall Study|Lost to Follow-up|3|||
164478961|NCT02060487|594125345|FG001|Overall Study|Lost to Follow-up|0|||
164478962|NCT02060487|594125346|FG002|Overall Study|Lost to Follow-up|2|||
164478963|NCT02060487|594125344|FG000|Overall Study|Death|34|||
164478964|NCT02060487|594125345|FG001|Overall Study|Death|25|||
164478965|NCT02060487|594125346|FG002|Overall Study|Death|19|||
164478966|NCT02060487|594125344|FG000|Overall Study|Adverse Event|0|||
164478967|NCT02060487|594125345|FG001|Overall Study|Adverse Event|0|||
164478968|NCT02060487|594125346|FG002|Overall Study|Adverse Event|1|||
164478969|NCT03389802|594125347|FG000|Overall Study|Lack of Efficacy|3|||
164478970|NCT03389802|594125348|FG001|Overall Study|Lack of Efficacy|3|||
164478971|NCT03389802|594125349|FG002|Overall Study|Lack of Efficacy|13|||
164478972|NCT03389802|594125350|FG003|Overall Study|Lack of Efficacy|6|||
164478973|NCT03389802|594125351|FG004|Overall Study|Lack of Efficacy|1|||
164478974|NCT03389802|594125347|FG000|Overall Study|Adverse Event|0|||
164478975|NCT03389802|594125348|FG001|Overall Study|Adverse Event|0|||
164478976|NCT03389802|594125349|FG002|Overall Study|Adverse Event|1|||
164478977|NCT03389802|594125350|FG003|Overall Study|Adverse Event|0|||
164478978|NCT03389802|594125351|FG004|Overall Study|Adverse Event|4|||
164478979|NCT03389802|594125347|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
164478980|NCT03389802|594125348|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
164478981|NCT03389802|594125349|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
164478982|NCT03389802|594125350|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
164478983|NCT03389802|594125351|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
164478984|NCT02426138|594125352|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
164478985|NCT02426138|594125353|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
164478986|NCT04677738|594125358|FG000|Overall Study|Withdrawal by Subject|4|||
164478987|NCT04677738|594125359|FG001|Overall Study|Withdrawal by Subject|2|||
164478988|NCT03697603|594125363|FG000|Overall Study|Adverse Event|3|||
164478989|NCT03697603|594125364|FG001|Overall Study|Adverse Event|18|||
164478990|NCT03697603|594125365|FG002|Overall Study|Adverse Event|3|||
164478991|NCT03697603|594125363|FG000|Overall Study|Physician Decision|1|||
164478992|NCT03697603|594125364|FG001|Overall Study|Physician Decision|0|||
164478993|NCT03697603|594125365|FG002|Overall Study|Physician Decision|2|||
164478994|NCT03697603|594125363|FG000|Overall Study|Protocol Violation|3|||
164478995|NCT03697603|594125364|FG001|Overall Study|Protocol Violation|8|||
164478996|NCT03697603|594125365|FG002|Overall Study|Protocol Violation|5|||
164478997|NCT03697603|594125363|FG000|Overall Study|Withdrawal by Subject|5|||
164478998|NCT03697603|594125364|FG001|Overall Study|Withdrawal by Subject|1|||
164478999|NCT03697603|594125365|FG002|Overall Study|Withdrawal by Subject|1|||
164479000|NCT03697603|594125363|FG000|Overall Study|Protocol Violation|0|||
164479001|NCT03697603|594125364|FG001|Overall Study|Protocol Violation|0|||
164479002|NCT03697603|594125365|FG002|Overall Study|Protocol Violation|1|||
164714276|NCT00517881|594976837|FG000|Overall Study|Renal transplantation|2|||
164714277|NCT01207583|594976838|FG000|Overall Study|Withdrawal by Subject|0|||
164714278|NCT01207583|594976839|FG001|Overall Study|Withdrawal by Subject|3|||
164714279|NCT01207583|594976840|FG002|Overall Study|Withdrawal by Subject|1|||
164714280|NCT01207583|594976838|FG000|Overall Study|Participant failed to return|1|||
164479003|NCT04218864|594125368|FG000|Overall Study|Lost to Follow-up|8|||
164714281|NCT01207583|594976839|FG001|Overall Study|Participant failed to return|0|||
164714282|NCT01207583|594976840|FG002|Overall Study|Participant failed to return|0|||
164714283|NCT01207583|594976838|FG000|Overall Study|Lost to Follow-up|0|||
164479004|NCT04218864|594125369|FG001|Overall Study|Lost to Follow-up|4|||
164479005|NCT04218864|594125368|FG000|Overall Study|Withdrawal by Subject|1|||
164479006|NCT04218864|594125369|FG001|Overall Study|Withdrawal by Subject|3|||
164479007|NCT00467272|594125370|FG000|Overall Study|Pneumonia|2|||
164600192|NCT00831441|594558144|FG001|Randomized|No longer met criteria|19|||
164479008|NCT00467272|594125370|FG000|Overall Study|Thrombophlebitis|1|||
164714284|NCT01207583|594976839|FG001|Overall Study|Lost to Follow-up|2|||
164714285|NCT01207583|594976840|FG002|Overall Study|Lost to Follow-up|0|||
164479009|NCT03683030|594125371|FG000|Overall Study|Enrolled but screen failures|12|||
164479010|NCT03683030|594125372|FG001|Overall Study|Enrolled but screen failures|7|||
164479011|NCT03683030|594125371|FG000|Overall Study|Enrolled but no catheter inserted|11|||
164479012|NCT03683030|594125372|FG001|Overall Study|Enrolled but no catheter inserted|13|||
164479013|NCT03683030|594125371|FG000|Overall Study|Withdrawal by Subject|0|||
164479014|NCT03683030|594125372|FG001|Overall Study|Withdrawal by Subject|2|||
164479015|NCT03683030|594125371|FG000|Overall Study|Early termination by subject|1|||
164479016|NCT03683030|594125372|FG001|Overall Study|Early termination by subject|0|||
164479017|NCT03683030|594125371|FG000|Overall Study|Lost to Follow-up|0|||
164479018|NCT03683030|594125372|FG001|Overall Study|Lost to Follow-up|6|||
164479019|NCT03683030|594125371|FG000|Overall Study|Death|0|||
164479020|NCT03683030|594125372|FG001|Overall Study|Death|2|||
164479021|NCT03683030|594125371|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
164479022|NCT03683030|594125372|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
164479023|NCT02222493|594125375|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
164479024|NCT02222493|594125376|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
164479025|NCT02222493|594125375|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
164479026|NCT02222493|594125376|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
164479027|NCT02222493|594125375|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
164479028|NCT02222493|594125376|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
164479029|NCT02222493|594125375|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
164479030|NCT02222493|594125376|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
164479031|NCT02222493|594125375|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
164479032|NCT02222493|594125376|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
164479033|NCT02222493|594125375|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
164479034|NCT02222493|594125376|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
164479035|NCT02222493|594125375|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
164479036|NCT02222493|594125376|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
164479037|NCT02222493|594125375|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
164479038|NCT02222493|594125376|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
164479039|NCT02222493|594125375|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
164479040|NCT02222493|594125376|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
164479041|NCT02222493|594125375|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
164479042|NCT02222493|594125376|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
164479043|NCT02222493|594125375|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
164479044|NCT02222493|594125376|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
164479045|NCT02222493|594125375|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
164479046|NCT02222493|594125376|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
164479047|NCT02222493|594125375|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
164479048|NCT02222493|594125376|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
164479049|NCT02222493|594125375|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
164479050|NCT02222493|594125376|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
164479051|NCT02222493|594125375|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
164479052|NCT02222493|594125376|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
164479053|NCT02222493|594125375|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
164479054|NCT02222493|594125376|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
164479055|NCT02222493|594125375|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
164479056|NCT02222493|594125376|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
164479057|NCT02222493|594125375|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
164479058|NCT02222493|594125376|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
164479059|NCT02222493|594125375|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
164479060|NCT02222493|594125376|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
164479061|NCT02222493|594125375|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
164479062|NCT02222493|594125376|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
164479063|NCT02222493|594125375|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
164479064|NCT02222493|594125376|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
164479065|NCT02222493|594125375|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
164479066|NCT02222493|594125376|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
164479067|NCT00914966|594125379|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
164479068|NCT00914966|594125379|FG000|Step 1: 1500 Units|Physician Decision|1|||
164479069|NCT00914966|594125379|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
164479070|NCT01701401|594125380|FG000|Overall Study|Randomized But Not Treated|3|||
164479071|NCT01701401|594125381|FG001|Overall Study|Randomized But Not Treated|1|||
164479072|NCT01701401|594125382|FG002|Overall Study|Randomized But Not Treated|0|||
164479073|NCT01701401|594125383|FG003|Overall Study|Randomized But Not Treated|1|||
164479074|NCT01701401|594125380|FG000|Overall Study|Lost to Follow-up|5|||
164600193|NCT00831441|594558143|FG000|Randomized|Withdrawal by Subject|178|||
164600194|NCT00831441|594558144|FG001|Randomized|Withdrawal by Subject|212|||
164600195|NCT00831441|594558143|FG000|Randomized|Lost to Follow-up|26|||
164600196|NCT00831441|594558144|FG001|Randomized|Lost to Follow-up|35|||
164600197|NCT00831441|594558143|FG000|Randomized|Administrative reason by sponsor|2780|||
164600198|NCT00831441|594558144|FG001|Randomized|Administrative reason by sponsor|2671|||
164600199|NCT00831441|594558143|FG000|Randomized|poor/non-compliance|30|||
164600200|NCT00831441|594558144|FG001|Randomized|poor/non-compliance|38|||
164600201|NCT00831441|594558143|FG000|Randomized|non-specified|276|||
164600202|NCT00831441|594558144|FG001|Randomized|non-specified|266|||
164600203|NCT00831441|594558143|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
164600204|NCT00831441|594558144|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
164600205|NCT00831441|594558143|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
164600206|NCT00831441|594558144|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
164600207|NCT00831441|594558143|FG000|Follow Up (30 Days)|Death|63|||
164600208|NCT00831441|594558144|FG001|Follow Up (30 Days)|Death|86|||
164600209|NCT00831441|594558143|FG000|Follow Up (30 Days)|non-specified|16|||
164600210|NCT00831441|594558144|FG001|Follow Up (30 Days)|non-specified|26|||
164600211|NCT00831441|594558143|FG000|Follow Up (30 Days)|missing end of study status|0|||
164600212|NCT00831441|594558144|FG001|Follow Up (30 Days)|missing end of study status|1|||
164600213|NCT02924688|594558148|FG000|Overall Study|Adverse Event|9|||
164600214|NCT02924688|594558149|FG001|Overall Study|Adverse Event|3|||
164600215|NCT02924688|594558150|FG002|Overall Study|Adverse Event|2|||
164600216|NCT02924688|594558151|FG003|Overall Study|Adverse Event|2|||
164600217|NCT02924688|594558152|FG004|Overall Study|Adverse Event|3|||
164600218|NCT02924688|594558153|FG005|Overall Study|Adverse Event|2|||
164600219|NCT02924688|594558148|FG000|Overall Study|Lack of Efficacy|2|||
164600220|NCT02924688|594558149|FG001|Overall Study|Lack of Efficacy|3|||
164600221|NCT02924688|594558150|FG002|Overall Study|Lack of Efficacy|4|||
164600222|NCT02924688|594558151|FG003|Overall Study|Lack of Efficacy|2|||
164600223|NCT02924688|594558152|FG004|Overall Study|Lack of Efficacy|1|||
164600224|NCT02924688|594558153|FG005|Overall Study|Lack of Efficacy|1|||
164600225|NCT02924688|594558148|FG000|Overall Study|Protocol Violation|3|||
164600226|NCT02924688|594558149|FG001|Overall Study|Protocol Violation|7|||
164600227|NCT02924688|594558150|FG002|Overall Study|Protocol Violation|5|||
164600228|NCT02924688|594558151|FG003|Overall Study|Protocol Violation|6|||
164600229|NCT02924688|594558152|FG004|Overall Study|Protocol Violation|2|||
164600230|NCT02924688|594558153|FG005|Overall Study|Protocol Violation|2|||
164600231|NCT02924688|594558148|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
164600232|NCT02924688|594558149|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
164600233|NCT02924688|594558150|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
164600234|NCT02924688|594558151|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
164600235|NCT02924688|594558152|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
164600236|NCT02924688|594558153|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
164600237|NCT02924688|594558148|FG000|Overall Study|Lost to Follow-up|2|||
164600238|NCT02924688|594558149|FG001|Overall Study|Lost to Follow-up|4|||
164600239|NCT02924688|594558150|FG002|Overall Study|Lost to Follow-up|2|||
164600240|NCT02924688|594558151|FG003|Overall Study|Lost to Follow-up|4|||
164600241|NCT02924688|594558152|FG004|Overall Study|Lost to Follow-up|2|||
164600242|NCT02924688|594558153|FG005|Overall Study|Lost to Follow-up|4|||
164600243|NCT02924688|594558148|FG000|Overall Study|Physician Decision|2|||
164600244|NCT02924688|594558149|FG001|Overall Study|Physician Decision|1|||
164600245|NCT02924688|594558150|FG002|Overall Study|Physician Decision|0|||
164600246|NCT02924688|594558151|FG003|Overall Study|Physician Decision|1|||
164600247|NCT02924688|594558152|FG004|Overall Study|Physician Decision|1|||
164600248|NCT02924688|594558153|FG005|Overall Study|Physician Decision|1|||
164600249|NCT02924688|594558148|FG000|Overall Study|Withdrawal by Subject|14|||
164600250|NCT02924688|594558149|FG001|Overall Study|Withdrawal by Subject|13|||
164600251|NCT02924688|594558150|FG002|Overall Study|Withdrawal by Subject|9|||
164600252|NCT02924688|594558151|FG003|Overall Study|Withdrawal by Subject|12|||
164600253|NCT02924688|594558152|FG004|Overall Study|Withdrawal by Subject|13|||
164600254|NCT02924688|594558153|FG005|Overall Study|Withdrawal by Subject|14|||
164600255|NCT03072719|594558154|FG000|Overall Study|Adverse Event|1|||
164600256|NCT03072719|594558155|FG001|Overall Study|Adverse Event|1|||
164600257|NCT02586233|594558156|FG000|Overall Study|Randomized but did not receive treatment|0|||
164600258|NCT02586233|594558157|FG001|Overall Study|Randomized but did not receive treatment|1|||
164600259|NCT02586233|594558158|FG002|Overall Study|Randomized but did not receive treatment|0|||
164600260|NCT02586233|594558159|FG003|Overall Study|Randomized but did not receive treatment|0|||
164600261|NCT02586233|594558160|FG004|Overall Study|Randomized but did not receive treatment|0|||
164600262|NCT02586233|594558161|FG005|Overall Study|Randomized but did not receive treatment|2|||
164600263|NCT02586233|594558162|FG006|Overall Study|Randomized but did not receive treatment|2|||
164600264|NCT02586233|594558156|FG000|Overall Study|Death|0|||
164600265|NCT02586233|594558157|FG001|Overall Study|Death|1|||
164600266|NCT02586233|594558158|FG002|Overall Study|Death|0|||
164600267|NCT02586233|594558159|FG003|Overall Study|Death|0|||
164600268|NCT02586233|594558160|FG004|Overall Study|Death|2|||
164600269|NCT02586233|594558161|FG005|Overall Study|Death|0|||
164600270|NCT02586233|594558162|FG006|Overall Study|Death|0|||
164600271|NCT01708941|594558165|FG000|Overall Study|Adverse Event|4|||
164600272|NCT01708941|594558166|FG001|Overall Study|Adverse Event|6|||
164600273|NCT01708941|594558167|FG002|Overall Study|Adverse Event|1|||
164600274|NCT01708941|594558168|FG003|Overall Study|Adverse Event|0|||
164600275|NCT01708941|594558165|FG000|Overall Study|Death|1|||
164600276|NCT01708941|594558166|FG001|Overall Study|Death|1|||
164600277|NCT01708941|594558167|FG002|Overall Study|Death|2|||
164600278|NCT01708941|594558168|FG003|Overall Study|Death|14|||
164600279|NCT01708941|594558165|FG000|Overall Study|Withdrawal by Subject|1|||
164600280|NCT01708941|594558166|FG001|Overall Study|Withdrawal by Subject|0|||
164600281|NCT01708941|594558167|FG002|Overall Study|Withdrawal by Subject|3|||
164600282|NCT01708941|594558168|FG003|Overall Study|Withdrawal by Subject|4|||
164600283|NCT01708941|594558165|FG000|Overall Study|Disease progression|9|||
164600284|NCT01708941|594558166|FG001|Overall Study|Disease progression|10|||
164600285|NCT01708941|594558167|FG002|Overall Study|Disease progression|8|||
164600286|NCT01708941|594558168|FG003|Overall Study|Disease progression|0|||
164600287|NCT01708941|594558165|FG000|Overall Study|Alternative therapy|0|||
164600288|NCT01708941|594558166|FG001|Overall Study|Alternative therapy|0|||
164600289|NCT01708941|594558167|FG002|Overall Study|Alternative therapy|2|||
164600290|NCT01708941|594558168|FG003|Overall Study|Alternative therapy|0|||
164600291|NCT01708941|594558165|FG000|Overall Study|Ineligible and never started treatment|1|||
164600292|NCT01708941|594558166|FG001|Overall Study|Ineligible and never started treatment|0|||
164600293|NCT01708941|594558167|FG002|Overall Study|Ineligible and never started treatment|1|||
164600294|NCT01708941|594558168|FG003|Overall Study|Ineligible and never started treatment|0|||
164600295|NCT01708941|594558165|FG000|Overall Study|Never started treatment|2|||
164600296|NCT01708941|594558166|FG001|Overall Study|Never started treatment|1|||
164479075|NCT01701401|594125381|FG001|Overall Study|Lost to Follow-up|5|||
164479076|NCT01701401|594125382|FG002|Overall Study|Lost to Follow-up|1|||
164479077|NCT01701401|594125383|FG003|Overall Study|Lost to Follow-up|3|||
164479078|NCT01701401|594125380|FG000|Overall Study|Withdrew Consent|0|||
164479079|NCT01701401|594125381|FG001|Overall Study|Withdrew Consent|3|||
164479080|NCT01701401|594125382|FG002|Overall Study|Withdrew Consent|1|||
164479081|NCT01701401|594125383|FG003|Overall Study|Withdrew Consent|2|||
164479082|NCT01701401|594125380|FG000|Overall Study|Lack of Efficacy|1|||
164479083|NCT01701401|594125381|FG001|Overall Study|Lack of Efficacy|0|||
164479084|NCT01701401|594125382|FG002|Overall Study|Lack of Efficacy|2|||
164479085|NCT01701401|594125383|FG003|Overall Study|Lack of Efficacy|0|||
164479086|NCT01701401|594125380|FG000|Overall Study|Adverse Event|1|||
164479087|NCT01701401|594125381|FG001|Overall Study|Adverse Event|0|||
164479088|NCT01701401|594125382|FG002|Overall Study|Adverse Event|0|||
164479089|NCT01701401|594125383|FG003|Overall Study|Adverse Event|0|||
164479090|NCT01701401|594125380|FG000|Overall Study|Protocol Violation|0|||
164479091|NCT01701401|594125381|FG001|Overall Study|Protocol Violation|0|||
164479092|NCT01701401|594125382|FG002|Overall Study|Protocol Violation|1|||
164479093|NCT01701401|594125383|FG003|Overall Study|Protocol Violation|0|||
164479094|NCT00933270|594125384|FG000|Overall Study|Withdrawal by Subject|26|||
164479095|NCT00933270|594125384|FG000|Overall Study|Insufficient Follow-up|10|||
164479096|NCT00933270|594125384|FG000|Overall Study|Lost to Follow-up|14|||
164479097|NCT00933270|594125384|FG000|Overall Study|Adverse Event|1|||
164479098|NCT00933270|594125384|FG000|Overall Study|Missed Visit|2|||
164479099|NCT00933270|594125384|FG000|Overall Study|Death|24|||
164600297|NCT01708941|594558167|FG002|Overall Study|Never started treatment|0|||
164600298|NCT01708941|594558168|FG003|Overall Study|Never started treatment|0|||
164600299|NCT01708941|594558165|FG000|Overall Study|Ineligible|0|||
164600300|NCT01708941|594558166|FG001|Overall Study|Ineligible|0|||
164600301|NCT01708941|594558167|FG002|Overall Study|Ineligible|2|||
164600302|NCT01708941|594558168|FG003|Overall Study|Ineligible|0|||
164600303|NCT00229203|594558169|FG000|Overall Study|Progressive disease|18|||
164600304|NCT00229203|594558170|FG001|Overall Study|Progressive disease|9|||
164600305|NCT00229203|594558169|FG000|Overall Study|Toxicity|6|||
164600306|NCT00229203|594558170|FG001|Overall Study|Toxicity|1|||
164600307|NCT00229203|594558169|FG000|Overall Study|Death|4|||
164600308|NCT00229203|594558170|FG001|Overall Study|Death|2|||
164600309|NCT00229203|594558169|FG000|Overall Study|Other|3|||
164479100|NCT00933270|594125384|FG000|Overall Study|Moved or would not return|10|||
164479101|NCT02542943|594125388|FG000|Overall Study|Lost to Follow-up|1|||
164479102|NCT02542943|594125389|FG001|Overall Study|Lost to Follow-up|0|||
164479103|NCT02542943|594125390|FG002|Overall Study|Lost to Follow-up|0|||
164479104|NCT02542943|594125388|FG000|Overall Study|Withdrawal by Subject|0|||
164479105|NCT02542943|594125389|FG001|Overall Study|Withdrawal by Subject|1|||
164479106|NCT02542943|594125390|FG002|Overall Study|Withdrawal by Subject|0|||
164479107|NCT02409680|594125391|FG000|Overall Study|Lost to Follow-up|15|||
164479108|NCT02409680|594125392|FG001|Overall Study|Lost to Follow-up|30|||
164600310|NCT00229203|594558170|FG001|Overall Study|Other|3|||
164600311|NCT00229203|594558169|FG000|Overall Study|Withdrawal by Subject|1|||
164600312|NCT00229203|594558170|FG001|Overall Study|Withdrawal by Subject|4|||
164479109|NCT01563185|594125393|FG000|Overall Study|Withdrawal by Subject|1|||
164479110|NCT01563185|594125393|FG000|Overall Study|Non-Compliance with study drug|1|||
164479111|NCT04577651|594125394|FG000|Overall Study|Screen Failure|7|||
164479112|NCT04577651|594125394|FG000|Overall Study|Adverse Event|1|||
164479113|NCT04577651|594125394|FG000|Overall Study|Death|1|||
164479114|NCT04577651|594125394|FG000|Overall Study|Physician Decision|1|||
164479115|NCT04577651|594125394|FG000|Overall Study|Withdrawal by Subject|3|||
164479116|NCT00647387|594125397|FG000|Overall Study|Lost to Follow-up|6|||
164479117|NCT00647387|594125397|FG000|Overall Study|Unsuccessful implant|5|||
164479118|NCT00647387|594125397|FG000|Overall Study|Device explanted|3|||
164479119|NCT00647387|594125397|FG000|Overall Study|Other Reason|3|||
164479120|NCT00647387|594125397|FG000|Overall Study|Death|2|||
164479121|NCT03147287|594125398|FG000|Overall Study|Randomized Not Treated|2|||
164479122|NCT03147287|594125399|FG001|Overall Study|Randomized Not Treated|1|||
164479123|NCT03147287|594125400|FG002|Overall Study|Randomized Not Treated|1|||
164479124|NCT03147287|594125398|FG000|Overall Study|Progressive Disease RECIST|31|||
164479125|NCT03147287|594125399|FG001|Overall Study|Progressive Disease RECIST|72|||
164479126|NCT03147287|594125400|FG002|Overall Study|Progressive Disease RECIST|32|||
164479127|NCT03147287|594125398|FG000|Overall Study|Progressive Disease not RECIST|13|||
164479128|NCT03147287|594125399|FG001|Overall Study|Progressive Disease not RECIST|21|||
164479129|NCT03147287|594125400|FG002|Overall Study|Progressive Disease not RECIST|13|||
164479130|NCT03147287|594125398|FG000|Overall Study|Physician Decision|1|||
164479131|NCT03147287|594125399|FG001|Overall Study|Physician Decision|2|||
164479132|NCT03147287|594125400|FG002|Overall Study|Physician Decision|1|||
164479133|NCT03147287|594125398|FG000|Overall Study|Intercurrent illness|0|||
164479134|NCT03147287|594125399|FG001|Overall Study|Intercurrent illness|1|||
164479135|NCT03147287|594125400|FG002|Overall Study|Intercurrent illness|0|||
164479136|NCT03147287|594125398|FG000|Overall Study|Withdrawal by Subject|2|||
164479137|NCT03147287|594125399|FG001|Overall Study|Withdrawal by Subject|3|||
164479138|NCT03147287|594125400|FG002|Overall Study|Withdrawal by Subject|2|||
164479139|NCT03147287|594125398|FG000|Overall Study|Patient Non-Compliance|0|||
164479140|NCT03147287|594125399|FG001|Overall Study|Patient Non-Compliance|2|||
164479141|NCT03147287|594125400|FG002|Overall Study|Patient Non-Compliance|0|||
164479142|NCT03147287|594125398|FG000|Overall Study|Patient moved|0|||
164479143|NCT03147287|594125399|FG001|Overall Study|Patient moved|1|||
164479144|NCT03147287|594125400|FG002|Overall Study|Patient moved|0|||
164479145|NCT03147287|594125398|FG000|Overall Study|Arm A crossover without PD|1|||
164479146|NCT03147287|594125399|FG001|Overall Study|Arm A crossover without PD|0|||
164479147|NCT03147287|594125400|FG002|Overall Study|Arm A crossover without PD|0|||
164479148|NCT03147287|594125398|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
164479149|NCT03147287|594125399|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
164479150|NCT03147287|594125400|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
164479151|NCT00302211|594125401|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
164479152|NCT00302211|594125402|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
164479153|NCT00302211|594125403|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
164479154|NCT00302211|594125404|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
164479155|NCT00302211|594125405|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
164479156|NCT00302211|594125401|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
164479157|NCT00302211|594125402|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
164479158|NCT00302211|594125403|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
164479159|NCT00302211|594125404|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
164479160|NCT00302211|594125405|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
164479161|NCT00302211|594125401|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
164479162|NCT00302211|594125402|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
164479163|NCT00302211|594125403|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
164479164|NCT00302211|594125404|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
164479165|NCT00302211|594125405|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
164479166|NCT00302211|594125401|FG000|Double Blind Period (New Patients)|Disease progression|0|||
164479167|NCT00302211|594125402|FG001|Double Blind Period (New Patients)|Disease progression|1|||
164479168|NCT00302211|594125403|FG002|Double Blind Period (New Patients)|Disease progression|1|||
164479169|NCT00302211|594125404|FG003|Double Blind Period (New Patients)|Disease progression|0|||
164479170|NCT00302211|594125405|FG004|Double Blind Period (New Patients)|Disease progression|0|||
164479171|NCT00302211|594125401|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
164479172|NCT00302211|594125402|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
164479173|NCT00302211|594125403|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
164479174|NCT00302211|594125404|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
164479175|NCT00302211|594125405|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
164479176|NCT00302211|594125401|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
164479177|NCT00302211|594125402|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
164479178|NCT00302211|594125403|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
164479179|NCT00302211|594125404|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
164479180|NCT00302211|594125405|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
164479181|NCT00302211|594125401|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
164479182|NCT00302211|594125402|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
164479183|NCT00302211|594125403|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
164479184|NCT00302211|594125404|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
164479185|NCT00302211|594125405|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
164479186|NCT00302211|594125401|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
164479187|NCT00302211|594125402|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
164479188|NCT00302211|594125403|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
164479189|NCT00302211|594125404|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
164479190|NCT00302211|594125405|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
164479191|NCT00302211|594125401|FG000|Open Label-Patients From Double-Blind|Death|0|||
164479192|NCT00302211|594125402|FG001|Open Label-Patients From Double-Blind|Death|0|||
164479193|NCT00302211|594125403|FG002|Open Label-Patients From Double-Blind|Death|0|||
164479194|NCT00302211|594125404|FG003|Open Label-Patients From Double-Blind|Death|1|||
164479195|NCT00302211|594125405|FG004|Open Label-Patients From Double-Blind|Death|1|||
164479196|NCT00302211|594125401|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
164479197|NCT00302211|594125402|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
164479198|NCT00302211|594125403|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
164479199|NCT00302211|594125404|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
164714286|NCT01433549|594976842|FG000|Phase 2: Second Study Product|Adverse Event|0|||
164714287|NCT01433549|594976843|FG001|Phase 2: Second Study Product|Adverse Event|1|||
164714288|NCT05384171|594976844|FG000|Overall Study|Lost to Follow-up|9|||
164714289|NCT05384171|594976845|FG001|Overall Study|Lost to Follow-up|9|||
164714290|NCT05384171|594976844|FG000|Overall Study|Withdrawal by Subject|3|||
164714291|NCT05384171|594976845|FG001|Overall Study|Withdrawal by Subject|0|||
164714292|NCT02052011|594976852|FG000|Overall Study|Lost to Follow-up|3|||
164714293|NCT02052011|594976853|FG001|Overall Study|Lost to Follow-up|0|||
164714294|NCT02052011|594976852|FG000|Overall Study|Withdrawal by Subject|1|||
164714295|NCT02052011|594976853|FG001|Overall Study|Withdrawal by Subject|2|||
164714296|NCT00000620|594976854|FG000|Overall Study|Death|86|||
164714297|NCT00000620|594976855|FG001|Overall Study|Death|67|||
164714298|NCT00000620|594976856|FG002|Overall Study|Death|112|||
164714299|NCT00000620|594976857|FG003|Overall Study|Death|126|||
164714300|NCT00000620|594976858|FG004|Overall Study|Death|64|||
164479200|NCT00302211|594125405|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
164479201|NCT00302211|594125401|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
164479202|NCT00302211|594125402|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
164479203|NCT00302211|594125403|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
164479204|NCT00302211|594125404|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
164479205|NCT00302211|594125405|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
164479206|NCT00302211|594125401|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
164479207|NCT00302211|594125402|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
164479208|NCT00302211|594125403|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
164479209|NCT00302211|594125404|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
164479210|NCT00302211|594125405|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
164479211|NCT03137459|594126857|FG000|2-month Assessment|Withdrawal by Subject|13|||
164479212|NCT03137459|594126858|FG001|2-month Assessment|Withdrawal by Subject|3|||
164479213|NCT03137459|594126857|FG000|2-month Assessment|Unable to reach|42|||
164479214|NCT03137459|594126858|FG001|2-month Assessment|Unable to reach|32|||
164479215|NCT03137459|594126857|FG000|2-month Assessment|Refused assessment|7|||
164479216|NCT03137459|594126858|FG001|2-month Assessment|Refused assessment|5|||
164479217|NCT03137459|594126857|FG000|2-month Assessment|Acutely ill|6|||
164479218|NCT03137459|594126858|FG001|2-month Assessment|Acutely ill|2|||
164479219|NCT03137459|594126857|FG000|4-month Assessment|Death|4|||
164479220|NCT03137459|594126858|FG001|4-month Assessment|Death|2|||
164479221|NCT03137459|594126857|FG000|4-month Assessment|Withdrawal by Subject|4|||
164479222|NCT03137459|594126858|FG001|4-month Assessment|Withdrawal by Subject|2|||
164479223|NCT03137459|594126857|FG000|4-month Assessment|Unable to reach|44|||
164479224|NCT03137459|594126858|FG001|4-month Assessment|Unable to reach|29|||
164714301|NCT00000620|594976859|FG005|Overall Study|Death|77|||
164479225|NCT03137459|594126857|FG000|4-month Assessment|Refused assessment|24|||
164479226|NCT03137459|594126858|FG001|4-month Assessment|Refused assessment|10|||
164479227|NCT03137459|594126857|FG000|4-month Assessment|Acutely ill|2|||
164714302|NCT00000620|594976860|FG006|Overall Study|Death|91|||
164714303|NCT00000620|594976861|FG007|Overall Study|Death|95|||
164714304|NCT00000620|594976854|FG000|Overall Study|Lost to Follow-up|14|||
164479228|NCT03137459|594126858|FG001|4-month Assessment|Acutely ill|3|||
164479229|NCT03137459|594126857|FG000|6-months|Lost to Follow-up|14|||
164479230|NCT03137459|594126858|FG001|6-months|Lost to Follow-up|11|||
164479231|NCT03137459|594126857|FG000|6-months|Death|0|||
164479232|NCT03137459|594126858|FG001|6-months|Death|2|||
164479233|NCT03137459|594126857|FG000|6-months|Refused assessment|6|||
164479234|NCT03137459|594126858|FG001|6-months|Refused assessment|3|||
164479235|NCT03137459|594126857|FG000|6-months|Acutely ill|1|||
164479236|NCT03137459|594126858|FG001|6-months|Acutely ill|1|||
164479237|NCT06571695|594126859|FG000|Overall Study|Lost to Follow-up|1|||
164479238|NCT06571695|594126860|FG001|Overall Study|Lost to Follow-up|6|||
164479239|NCT04921358|594126861|FG000|Overall Study|Withdrawal by Subject|6|||
164479240|NCT04921358|594126862|FG001|Overall Study|Withdrawal by Subject|13|||
164479241|NCT04921358|594126861|FG000|Overall Study|Lost to Follow-up|3|||
164479242|NCT04921358|594126862|FG001|Overall Study|Lost to Follow-up|6|||
164479243|NCT04921358|594126861|FG000|Overall Study|Study Terminated by Sponsor|86|||
164479244|NCT04921358|594126862|FG001|Overall Study|Study Terminated by Sponsor|89|||
164479245|NCT04921358|594126861|FG000|Overall Study|Death|92|||
164479246|NCT04921358|594126862|FG001|Overall Study|Death|82|||
164479247|NCT02278796|594126863|FG000|Overall Study|Death|2|||
164479248|NCT02278796|594126864|FG001|Overall Study|Death|3|||
164479249|NCT04926857|594126865|FG000|Overall Study|Withdrawal by Subject|40|||
164479250|NCT04926857|594126865|FG000|Overall Study|Death|9|||
164479251|NCT04926857|594126865|FG000|Overall Study|Study product no longer in use|44|||
164479252|NCT04926857|594126865|FG000|Overall Study|Inadequate data to address primary objective|16|||
164479253|NCT00670449|594126869|FG000|Overall Study|Adverse Event|6|||
164479254|NCT00670449|594126870|FG001|Overall Study|Adverse Event|2|||
164479255|NCT00670449|594126871|FG002|Overall Study|Adverse Event|8|||
164479256|NCT00670449|594126872|FG003|Overall Study|Adverse Event|5|||
164479257|NCT00670449|594126869|FG000|Overall Study|Protocol Deviation|1|||
164479258|NCT00670449|594126870|FG001|Overall Study|Protocol Deviation|2|||
164479259|NCT00670449|594126871|FG002|Overall Study|Protocol Deviation|0|||
164479260|NCT00670449|594126872|FG003|Overall Study|Protocol Deviation|1|||
164479261|NCT00670449|594126869|FG000|Overall Study|Administrative Problems|0|||
164479262|NCT00670449|594126870|FG001|Overall Study|Administrative Problems|2|||
164479263|NCT00670449|594126871|FG002|Overall Study|Administrative Problems|0|||
164479264|NCT00670449|594126872|FG003|Overall Study|Administrative Problems|1|||
164479265|NCT00670449|594126869|FG000|Overall Study|Subject Withdrew Consent|0|||
164479266|NCT00670449|594126870|FG001|Overall Study|Subject Withdrew Consent|2|||
164479267|NCT00670449|594126871|FG002|Overall Study|Subject Withdrew Consent|0|||
164479268|NCT00670449|594126872|FG003|Overall Study|Subject Withdrew Consent|1|||
164479269|NCT00670449|594126869|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
164479270|NCT00670449|594126870|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
164479271|NCT00670449|594126871|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
164479272|NCT00670449|594126872|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
164479273|NCT00670449|594126869|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
164479274|NCT00670449|594126870|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
164479275|NCT00670449|594126871|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
164479276|NCT00670449|594126872|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
164479277|NCT00597376|594126873|FG000|Overall Study|Withdrawal by Subject|4|||
164479278|NCT00597376|594126874|FG001|Overall Study|Withdrawal by Subject|3|||
164479279|NCT00597376|594126873|FG000|Overall Study|Adverse Event|4|||
164479280|NCT00597376|594126874|FG001|Overall Study|Adverse Event|1|||
164479281|NCT01380145|594126875|FG000|Overall Study|Progressive disease|4|||
164479282|NCT02634307|594126876|FG000|Overall Study|Adverse Event|50|||
164479283|NCT02634307|594126877|FG001|Overall Study|Adverse Event|24|||
164479284|NCT02634307|594126878|FG002|Overall Study|Adverse Event|14|||
164479285|NCT02634307|594126876|FG000|Overall Study|Lost to Follow-up|21|||
164479286|NCT02634307|594126877|FG001|Overall Study|Lost to Follow-up|5|||
164479287|NCT02634307|594126878|FG002|Overall Study|Lost to Follow-up|6|||
164479288|NCT02634307|594126876|FG000|Overall Study|Pregnancy|5|||
164479289|NCT02634307|594126877|FG001|Overall Study|Pregnancy|1|||
164479290|NCT02634307|594126878|FG002|Overall Study|Pregnancy|3|||
164479291|NCT02634307|594126876|FG000|Overall Study|Withdrawal by Subject|38|||
164479292|NCT02634307|594126877|FG001|Overall Study|Withdrawal by Subject|24|||
164479293|NCT02634307|594126878|FG002|Overall Study|Withdrawal by Subject|18|||
164479294|NCT02634307|594126876|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164479295|NCT02634307|594126877|FG001|Overall Study|Non-Compliance with Study Drug|2|||
164479296|NCT02634307|594126878|FG002|Overall Study|Non-Compliance with Study Drug|2|||
164714305|NCT00000620|594976855|FG001|Overall Study|Lost to Follow-up|14|||
164479297|NCT02634307|594126876|FG000|Overall Study|Lack of Efficacy|1|||
164479298|NCT02634307|594126877|FG001|Overall Study|Lack of Efficacy|5|||
164479299|NCT02634307|594126878|FG002|Overall Study|Lack of Efficacy|3|||
164479300|NCT02634307|594126876|FG000|Overall Study|Physician Decision|7|||
164479301|NCT02634307|594126877|FG001|Overall Study|Physician Decision|5|||
164479302|NCT02634307|594126878|FG002|Overall Study|Physician Decision|5|||
164479303|NCT02634307|594126876|FG000|Overall Study|Reason not Specified|3|||
164479304|NCT02634307|594126877|FG001|Overall Study|Reason not Specified|5|||
164479305|NCT02634307|594126878|FG002|Overall Study|Reason not Specified|10|||
164479306|NCT01256359|594126880|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
164479307|NCT01256359|594126881|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
164479308|NCT01256359|594126880|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
164479309|NCT01256359|594126881|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
164479310|NCT03737110|594126886|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
164479311|NCT03737110|594126887|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
164479312|NCT03737110|594126888|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
164479313|NCT03737110|594126889|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
164479314|NCT03737110|594126890|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
164479315|NCT03737110|594126891|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
164479316|NCT03737110|594126886|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
164479317|NCT03737110|594126887|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
164479318|NCT03737110|594126888|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
164479319|NCT03737110|594126889|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
164479320|NCT03737110|594126890|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
164479321|NCT03737110|594126891|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
164479322|NCT03737110|594126886|FG000|Run-in (RI) Period|Adverse Event|4|||
164479323|NCT03737110|594126887|FG001|Run-in (RI) Period|Adverse Event|0|||
164479324|NCT03737110|594126888|FG002|Run-in (RI) Period|Adverse Event|0|||
164479325|NCT03737110|594126889|FG003|Run-in (RI) Period|Adverse Event|0|||
164479326|NCT03737110|594126890|FG004|Run-in (RI) Period|Adverse Event|0|||
164479327|NCT03737110|594126891|FG005|Run-in (RI) Period|Adverse Event|0|||
164479328|NCT03737110|594126886|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
164479329|NCT03737110|594126887|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
164479330|NCT03737110|594126888|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
164479331|NCT03737110|594126889|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
164479332|NCT03737110|594126890|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
164479333|NCT03737110|594126891|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
164479334|NCT03737110|594126886|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
164479335|NCT03737110|594126887|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
164479336|NCT03737110|594126888|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
164479337|NCT03737110|594126889|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
164479338|NCT03737110|594126890|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
164479339|NCT03737110|594126891|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
164479340|NCT03737110|594126886|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
164479341|NCT03737110|594126887|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
164479342|NCT03737110|594126888|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
164479343|NCT03737110|594126889|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
164479344|NCT03737110|594126890|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
164479345|NCT03737110|594126891|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
164479346|NCT03737110|594126886|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
164479347|NCT03737110|594126887|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
164479348|NCT03737110|594126888|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
164479349|NCT03737110|594126889|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
164479350|NCT03737110|594126890|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
164479351|NCT03737110|594126891|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
164479352|NCT03737110|594126886|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
164479353|NCT03737110|594126887|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
164479354|NCT03737110|594126888|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
164479355|NCT03737110|594126889|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
164479356|NCT03737110|594126890|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
164479357|NCT03737110|594126891|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
164479358|NCT00599196|594126896|FG000|Overall Study|Lack of Efficacy|22|||
164479359|NCT00599196|594126896|FG000|Overall Study|Adverse Event|93|||
164479360|NCT00599196|594126896|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
164479361|NCT00599196|594126896|FG000|Overall Study|Subject withdrew consent|43|||
164479362|NCT00599196|594126896|FG000|Overall Study|Study ended per sponsor|197|||
164479363|NCT00599196|594126896|FG000|Overall Study|Lost to Follow-up|17|||
164479364|NCT00599196|594126896|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
164479365|NCT00599196|594126896|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
164479366|NCT00599196|594126896|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
164479367|NCT00599196|594126896|FG000|Overall Study|Other: Pt Moved To Australia|1|||
164479368|NCT00599196|594126896|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
164479369|NCT00599196|594126896|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
164479370|NCT01009645|594126901|FG000|Overall Study|Lost to Follow-up|2|||
164479371|NCT01009645|594126902|FG001|Overall Study|Lost to Follow-up|8|||
164479372|NCT01009645|594126903|FG002|Overall Study|Lost to Follow-up|4|||
164479373|NCT01009645|594126904|FG003|Overall Study|Lost to Follow-up|5|||
164479374|NCT04237792|594126907|FG000|Treatment (Day 1)|Adverse Event|1|||
164479375|NCT04237792|594126908|FG001|Treatment (Day 1)|Adverse Event|0|||
164479376|NCT04237792|594126909|FG002|Treatment (Day 1)|Adverse Event|0|||
164479377|NCT04237792|594126910|FG003|Treatment (Day 1)|Adverse Event|0|||
164479378|NCT04237792|594126911|FG004|Treatment (Day 1)|Adverse Event|1|||
164479379|NCT04237792|594126912|FG005|Treatment (Day 1)|Adverse Event|1|||
164479380|NCT04237792|594126907|FG000|Treatment (Day 1)|Other|0|||
164479381|NCT04237792|594126908|FG001|Treatment (Day 1)|Other|0|||
164479382|NCT04237792|594126909|FG002|Treatment (Day 1)|Other|1|||
164479383|NCT04237792|594126910|FG003|Treatment (Day 1)|Other|0|||
164479384|NCT04237792|594126911|FG004|Treatment (Day 1)|Other|0|||
164479385|NCT04237792|594126912|FG005|Treatment (Day 1)|Other|1|||
164479386|NCT04237792|594126907|FG000|Treatment (Day 1)|Not treated|1|||
164479387|NCT04237792|594126908|FG001|Treatment (Day 1)|Not treated|1|||
164479388|NCT04237792|594126909|FG002|Treatment (Day 1)|Not treated|2|||
164479389|NCT04237792|594126910|FG003|Treatment (Day 1)|Not treated|1|||
164479390|NCT04237792|594126911|FG004|Treatment (Day 1)|Not treated|0|||
164479391|NCT04237792|594126912|FG005|Treatment (Day 1)|Not treated|1|||
164479392|NCT03052517|594126914|FG000|Overall Study|Study Terminated By Sponsor|928|||
164479393|NCT03052517|594126915|FG001|Overall Study|Study Terminated By Sponsor|938|||
164479394|NCT03052517|594126916|FG002|Overall Study|Study Terminated By Sponsor|296|||
164479395|NCT03052517|594126914|FG000|Overall Study|Subject/Guardian Decision|50|||
164479396|NCT03052517|594126915|FG001|Overall Study|Subject/Guardian Decision|45|||
164479397|NCT03052517|594126916|FG002|Overall Study|Subject/Guardian Decision|22|||
164479398|NCT03052517|594126914|FG000|Overall Study|Lack of Efficacy|23|||
164479399|NCT03052517|594126915|FG001|Overall Study|Lack of Efficacy|14|||
164479400|NCT03052517|594126916|FG002|Overall Study|Lack of Efficacy|7|||
164479401|NCT03052517|594126914|FG000|Overall Study|Adverse Event|6|||
164479402|NCT03052517|594126915|FG001|Overall Study|Adverse Event|5|||
164479403|NCT03052517|594126916|FG002|Overall Study|Adverse Event|0|||
164479404|NCT03052517|594126914|FG000|Overall Study|Physician Decision|4|||
164479405|NCT03052517|594126915|FG001|Overall Study|Physician Decision|5|||
164479406|NCT03052517|594126916|FG002|Overall Study|Physician Decision|1|||
164479407|NCT03052517|594126914|FG000|Overall Study|Death|3|||
164479408|NCT03052517|594126915|FG001|Overall Study|Death|0|||
164479409|NCT03052517|594126916|FG002|Overall Study|Death|1|||
164479410|NCT03052517|594126914|FG000|Overall Study|Lost to Follow-up|2|||
164479411|NCT03052517|594126915|FG001|Overall Study|Lost to Follow-up|4|||
164479412|NCT03052517|594126916|FG002|Overall Study|Lost to Follow-up|0|||
164479413|NCT03052517|594126914|FG000|Overall Study|Pregnancy|1|||
164479414|NCT03052517|594126915|FG001|Overall Study|Pregnancy|0|||
164479415|NCT03052517|594126916|FG002|Overall Study|Pregnancy|1|||
164479416|NCT03052517|594126914|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
164479417|NCT03052517|594126915|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
164479418|NCT03052517|594126916|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
164479419|NCT03052517|594126914|FG000|Overall Study|Technical Problems|0|||
164479420|NCT03052517|594126915|FG001|Overall Study|Technical Problems|1|||
164479421|NCT03052517|594126916|FG002|Overall Study|Technical Problems|0|||
164479422|NCT01079806|594126917|FG000|Day 1 to Week 96|Adverse Event|0|||
164479423|NCT01079806|594126918|FG001|Day 1 to Week 96|Adverse Event|3|||
164479424|NCT01079806|594126917|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
164479425|NCT01079806|594126918|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
164479426|NCT01079806|594126917|FG000|Day 1 to Week 96|Pregnancy|0|||
164479427|NCT01079806|594126918|FG001|Day 1 to Week 96|Pregnancy|1|||
164479428|NCT01079806|594126917|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
164479429|NCT01079806|594126918|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
164479430|NCT01079806|594126917|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
164479431|NCT01079806|594126918|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
164479432|NCT01079806|594126917|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
164479433|NCT01079806|594126918|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
164479434|NCT01079806|594126917|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
164479435|NCT01079806|594126918|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
164479436|NCT01079806|594126917|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
164479437|NCT01079806|594126918|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
164479438|NCT01079806|594126917|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
164479439|NCT01079806|594126918|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
164479440|NCT01079806|594126917|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
164479441|NCT01079806|594126918|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
164479442|NCT02788981|594126923|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
164479443|NCT02788981|594126924|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
164479444|NCT05553366|594126925|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
164479445|NCT05553366|594126926|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
164714306|NCT00000620|594976856|FG002|Overall Study|Lost to Follow-up|14|||
164479446|NCT05553366|594126927|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
164479447|NCT05553366|594126925|FG000|Overall Study|Lost to Follow-up|3|||
164479448|NCT05553366|594126926|FG001|Overall Study|Lost to Follow-up|3|||
164479449|NCT05553366|594126927|FG002|Overall Study|Lost to Follow-up|3|||
164479450|NCT05553366|594126925|FG000|Overall Study|Other non-compliance|1|||
164479451|NCT05553366|594126926|FG001|Overall Study|Other non-compliance|1|||
164479452|NCT05553366|594126927|FG002|Overall Study|Other non-compliance|0|||
164479453|NCT05553366|594126925|FG000|Overall Study|Randomized but not dosed|0|||
164479454|NCT05553366|594126926|FG001|Overall Study|Randomized but not dosed|0|||
164479455|NCT05553366|594126927|FG002|Overall Study|Randomized but not dosed|2|||
164479456|NCT00249769|594126928|FG000|Overall Study|Withdrawal by Subject|1|||
164479457|NCT00249769|594126929|FG001|Overall Study|Withdrawal by Subject|10|||
164479458|NCT00249769|594126930|FG002|Overall Study|Withdrawal by Subject|6|||
164479459|NCT00249769|594126928|FG000|Overall Study|Migration from Study Area|1|||
164479460|NCT00249769|594126929|FG001|Overall Study|Migration from Study Area|3|||
164479461|NCT00249769|594126930|FG002|Overall Study|Migration from Study Area|14|||
164479462|NCT00249769|594126928|FG000|Overall Study|Miscellaneous|0|||
164479463|NCT00249769|594126929|FG001|Overall Study|Miscellaneous|2|||
164479464|NCT00249769|594126930|FG002|Overall Study|Miscellaneous|2|||
164479465|NCT00249769|594126928|FG000|Overall Study|Adverse Event|0|||
164479466|NCT00249769|594126929|FG001|Overall Study|Adverse Event|0|||
164479467|NCT00249769|594126930|FG002|Overall Study|Adverse Event|1|||
164479468|NCT00249769|594126928|FG000|Overall Study|Physician Decision|0|||
164479469|NCT00249769|594126929|FG001|Overall Study|Physician Decision|0|||
164479470|NCT00249769|594126930|FG002|Overall Study|Physician Decision|2|||
164479471|NCT00249769|594126928|FG000|Overall Study|Lost to Follow-up|0|||
164479472|NCT00249769|594126929|FG001|Overall Study|Lost to Follow-up|0|||
164479473|NCT00249769|594126930|FG002|Overall Study|Lost to Follow-up|3|||
164479474|NCT02022657|594126935|FG000|Overall Study|Withdrawal by Subject|2|||
164479475|NCT02022657|594126936|FG001|Overall Study|Withdrawal by Subject|0|||
164479476|NCT02022657|594126937|FG002|Overall Study|Withdrawal by Subject|1|||
164479477|NCT02022657|594126938|FG003|Overall Study|Withdrawal by Subject|0|||
164479478|NCT02022657|594126939|FG004|Overall Study|Withdrawal by Subject|0|||
164479479|NCT02022657|594126940|FG005|Overall Study|Withdrawal by Subject|0|||
164479480|NCT02022657|594126935|FG000|Overall Study|Physician Decision|0|||
164479481|NCT02022657|594126936|FG001|Overall Study|Physician Decision|0|||
164479482|NCT02022657|594126937|FG002|Overall Study|Physician Decision|0|||
164479483|NCT02022657|594126938|FG003|Overall Study|Physician Decision|0|||
164479484|NCT02022657|594126939|FG004|Overall Study|Physician Decision|0|||
164479485|NCT02022657|594126940|FG005|Overall Study|Physician Decision|1|||
164479486|NCT03739866|594126942|FG000|Overall Study|Lost to Follow-up|0|||
164479487|NCT03739866|594126943|FG001|Overall Study|Lost to Follow-up|0|||
164479488|NCT03739866|594126944|FG002|Overall Study|Lost to Follow-up|0|||
164479489|NCT03739866|594126945|FG003|Overall Study|Lost to Follow-up|1|||
164479490|NCT03739866|594126946|FG004|Overall Study|Lost to Follow-up|0|||
164479491|NCT03739866|594126947|FG005|Overall Study|Lost to Follow-up|0|||
164479492|NCT03739866|594126948|FG006|Overall Study|Lost to Follow-up|0|||
164479493|NCT03739866|594126949|FG007|Overall Study|Lost to Follow-up|0|||
164479494|NCT03739866|594126942|FG000|Overall Study|Enrolled but not treated|0|||
164479495|NCT03739866|594126943|FG001|Overall Study|Enrolled but not treated|0|||
164479496|NCT03739866|594126944|FG002|Overall Study|Enrolled but not treated|1|||
164479497|NCT03739866|594126945|FG003|Overall Study|Enrolled but not treated|0|||
164479498|NCT03739866|594126946|FG004|Overall Study|Enrolled but not treated|1|||
164479499|NCT03739866|594126947|FG005|Overall Study|Enrolled but not treated|0|||
164479500|NCT03739866|594126948|FG006|Overall Study|Enrolled but not treated|0|||
164479501|NCT03739866|594126949|FG007|Overall Study|Enrolled but not treated|0|||
164479502|NCT00836498|594126950|FG000|Overall Study|Adverse Event|1|||
164479503|NCT00836498|594126951|FG001|Overall Study|Adverse Event|0|||
164479504|NCT00836498|594126950|FG000|Overall Study|Lost to Follow-up|1|||
164479505|NCT00836498|594126951|FG001|Overall Study|Lost to Follow-up|0|||
164479506|NCT00836498|594126950|FG000|Overall Study|Withdrawal by Subject|2|||
164479507|NCT00836498|594126951|FG001|Overall Study|Withdrawal by Subject|1|||
164479508|NCT01034306|594126952|FG000|Overall Study|Adverse Event|1|||
164479509|NCT01034306|594126953|FG001|Overall Study|Adverse Event|0|||
164479510|NCT01034306|594126952|FG000|Overall Study|Lost to Follow-up|0|||
164479511|NCT01034306|594126953|FG001|Overall Study|Lost to Follow-up|1|||
164479512|NCT01034306|594126952|FG000|Overall Study|Withdrawal by Subject|2|||
164479513|NCT01034306|594126953|FG001|Overall Study|Withdrawal by Subject|2|||
164479514|NCT01034306|594126952|FG000|Overall Study|hospitalized and decided to stop|1|||
164479515|NCT01034306|594126953|FG001|Overall Study|hospitalized and decided to stop|0|||
164479516|NCT01034306|594126952|FG000|Overall Study|Noncomplience|1|||
164479517|NCT01034306|594126953|FG001|Overall Study|Noncomplience|0|||
164479518|NCT03057600|594126954|FG000|Overall Study|Adverse Event|0|||
164479519|NCT03057600|594126955|FG001|Overall Study|Adverse Event|0|||
164479520|NCT03057600|594126956|FG002|Overall Study|Adverse Event|4|||
164479521|NCT03057600|594126957|FG003|Overall Study|Adverse Event|0|||
164479522|NCT03057600|594126954|FG000|Overall Study|Radiologic Disease Progression|8|||
164479523|NCT03057600|594126955|FG001|Overall Study|Radiologic Disease Progression|7|||
164479524|NCT03057600|594126956|FG002|Overall Study|Radiologic Disease Progression|13|||
164479525|NCT03057600|594126957|FG003|Overall Study|Radiologic Disease Progression|10|||
164479526|NCT03057600|594126954|FG000|Overall Study|Symptomatic Deterioration|0|||
164479527|NCT03057600|594126955|FG001|Overall Study|Symptomatic Deterioration|1|||
164479528|NCT03057600|594126956|FG002|Overall Study|Symptomatic Deterioration|1|||
164479529|NCT03057600|594126957|FG003|Overall Study|Symptomatic Deterioration|0|||
164479530|NCT03057600|594126954|FG000|Overall Study|Investigator Decision|0|||
164479531|NCT03057600|594126955|FG001|Overall Study|Investigator Decision|0|||
164479532|NCT03057600|594126956|FG002|Overall Study|Investigator Decision|1|||
164479533|NCT03057600|594126957|FG003|Overall Study|Investigator Decision|0|||
164479534|NCT03057600|594126954|FG000|Overall Study|Study Termination by Sponsor|0|||
164479535|NCT03057600|594126955|FG001|Overall Study|Study Termination by Sponsor|0|||
164479536|NCT03057600|594126956|FG002|Overall Study|Study Termination by Sponsor|0|||
164479537|NCT03057600|594126957|FG003|Overall Study|Study Termination by Sponsor|2|||
164479538|NCT03057600|594126954|FG000|Overall Study|Withdrawal by Subject|0|||
164479539|NCT03057600|594126955|FG001|Overall Study|Withdrawal by Subject|1|||
164479540|NCT03057600|594126956|FG002|Overall Study|Withdrawal by Subject|0|||
164479541|NCT03057600|594126957|FG003|Overall Study|Withdrawal by Subject|0|||
164479542|NCT03057600|594126954|FG000|Overall Study|Other, Not Specified|1|||
164479543|NCT03057600|594126955|FG001|Overall Study|Other, Not Specified|1|||
164479544|NCT03057600|594126956|FG002|Overall Study|Other, Not Specified|1|||
164479545|NCT03057600|594126957|FG003|Overall Study|Other, Not Specified|1|||
164479546|NCT02022670|594126960|FG000|Overall Study|Adverse Event|1|||
164479547|NCT02022670|594126961|FG001|Overall Study|Adverse Event|0|||
164479548|NCT02022670|594126962|FG002|Overall Study|Adverse Event|1|||
164479549|NCT02113449|594126963|FG000|Overall Study|Adverse Event|4|||
164479550|NCT00109031|594126964|FG000|Overall Study|Adverse Event|0|||
164479551|NCT00109031|594126965|FG001|Overall Study|Adverse Event|0|||
164479552|NCT00109031|594126966|FG002|Overall Study|Adverse Event|1|||
164479553|NCT00109031|594126967|FG003|Overall Study|Adverse Event|0|||
164479554|NCT00109031|594126964|FG000|Overall Study|Withdrawal by Subject|0|||
164479555|NCT00109031|594126965|FG001|Overall Study|Withdrawal by Subject|1|||
164479556|NCT00109031|594126966|FG002|Overall Study|Withdrawal by Subject|0|||
164479557|NCT00109031|594126967|FG003|Overall Study|Withdrawal by Subject|0|||
164479558|NCT00109031|594126964|FG000|Overall Study|Physician Decision|0|||
164479559|NCT00109031|594126965|FG001|Overall Study|Physician Decision|1|||
164479560|NCT00109031|594126966|FG002|Overall Study|Physician Decision|0|||
164479561|NCT00109031|594126967|FG003|Overall Study|Physician Decision|0|||
164479562|NCT00109031|594126964|FG000|Overall Study|Protocol Violation|0|||
164479563|NCT00109031|594126965|FG001|Overall Study|Protocol Violation|0|||
164479564|NCT00109031|594126966|FG002|Overall Study|Protocol Violation|1|||
164479565|NCT00109031|594126967|FG003|Overall Study|Protocol Violation|0|||
164479566|NCT02091752|594126968|FG000|Overall Study|Study terminated by Sponsor|2|||
164479567|NCT02091752|594126968|FG000|Overall Study|Adverse Event|1|||
164479568|NCT02208843|594126975|FG000|Overall Study|Clinical symptoms of progression|2|||
164479569|NCT02208843|594126975|FG000|Overall Study|Progression disease according to RECIST|24|||
164479570|NCT02208843|594126975|FG000|Overall Study|Adverse Event|12|||
164479571|NCT02208843|594126975|FG000|Overall Study|Protocol Violation|1|||
164479572|NCT02208843|594126975|FG000|Overall Study|Withdrawal by Subject|1|||
164479573|NCT02208843|594126975|FG000|Overall Study|Switched to commercial afatinib|20|||
164479574|NCT01604824|594126977|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
164479575|NCT01604824|594126978|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
164479576|NCT01604824|594126979|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
164479577|NCT01604824|594126980|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
164479578|NCT01604824|594126981|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
164479579|NCT01604824|594126982|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
164479580|NCT01604824|594126977|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
164479581|NCT01604824|594126978|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
164479582|NCT01604824|594126979|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
164479583|NCT01604824|594126980|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
164479584|NCT01604824|594126981|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
164479585|NCT01604824|594126982|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
164479586|NCT02630966|594126983|FG000|Overall Study|Adverse Event|1|||
164479587|NCT02630966|594126984|FG001|Overall Study|Adverse Event|3|||
164714307|NCT00000620|594976857|FG003|Overall Study|Lost to Follow-up|14|||
164479588|NCT02630966|594126983|FG000|Overall Study|Significant Protocol Deviation|0|||
164479589|NCT02630966|594126984|FG001|Overall Study|Significant Protocol Deviation|2|||
164479590|NCT02630966|594126983|FG000|Overall Study|Voluntary Withdrawal|1|||
164479591|NCT02630966|594126984|FG001|Overall Study|Voluntary Withdrawal|1|||
164479592|NCT02630966|594126983|FG000|Overall Study|Lack of Efficacy|0|||
164479593|NCT02630966|594126984|FG001|Overall Study|Lack of Efficacy|2|||
164714308|NCT00000620|594976858|FG004|Overall Study|Lost to Follow-up|15|||
164714309|NCT00000620|594976859|FG005|Overall Study|Lost to Follow-up|15|||
164714310|NCT00000620|594976860|FG006|Overall Study|Lost to Follow-up|13|||
164600313|NCT03457103|594558171|FG000|Overall Study|illness/hospitalization|4|||
164479594|NCT00665392|594126985|FG000|Overall Study|not treated|1|||
164479595|NCT00243867|594126991|FG000|Overall Study|Adverse Event|24|||
164479596|NCT00243867|594126992|FG001|Overall Study|Adverse Event|34|||
164479597|NCT00243867|594126991|FG000|Overall Study|Lack of Efficacy|115|||
164479598|NCT00243867|594126992|FG001|Overall Study|Lack of Efficacy|78|||
164479599|NCT00243867|594126991|FG000|Overall Study|Withdrawal by Subject|11|||
164479600|NCT00243867|594126992|FG001|Overall Study|Withdrawal by Subject|23|||
164479601|NCT00243867|594126991|FG000|Overall Study|Lost to Follow-up|2|||
164479602|NCT00243867|594126992|FG001|Overall Study|Lost to Follow-up|1|||
164479603|NCT00243867|594126991|FG000|Overall Study|Physician Decision|2|||
164479604|NCT00243867|594126992|FG001|Overall Study|Physician Decision|7|||
164479605|NCT00243867|594126991|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
164479606|NCT00243867|594126992|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
164479607|NCT04399837|594126993|FG000|Overall Study|Other than listed|0|||
164479608|NCT04399837|594126994|FG001|Overall Study|Other than listed|2|||
164479609|NCT04399837|594126995|FG002|Overall Study|Other than listed|2|||
164479610|NCT04399837|594126996|FG003|Overall Study|Other than listed|3|||
164479611|NCT04399837|594126993|FG000|Overall Study|Withdrawal by Subject|1|||
164479612|NCT04399837|594126994|FG001|Overall Study|Withdrawal by Subject|2|||
164479613|NCT04399837|594126995|FG002|Overall Study|Withdrawal by Subject|1|||
164479614|NCT04399837|594126996|FG003|Overall Study|Withdrawal by Subject|1|||
164479615|NCT05824559|594126999|FG000|Overall Study|Adverse Event|2|||
164479616|NCT05824559|594126999|FG000|Overall Study|Physician Decision|2|||
164479617|NCT05824559|594126999|FG000|Overall Study|Progressive Disease|16|||
164479618|NCT05824559|594126999|FG000|Overall Study|Study Terminated by Sponsor|1|||
164479619|NCT05824559|594126999|FG000|Overall Study|Withdrawal by Subject|2|||
164479620|NCT04701203|594127004|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
164479621|NCT04701203|594127005|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
164479622|NCT04701203|594127006|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
164479623|NCT04701203|594127004|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
164479624|NCT04701203|594127005|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
164479625|NCT04701203|594127006|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
164479626|NCT04701203|594127004|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
164479627|NCT04701203|594127005|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
164479628|NCT04701203|594127006|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
164479629|NCT04701203|594127004|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
164479630|NCT04701203|594127005|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
164479631|NCT04701203|594127006|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
164479632|NCT00949117|594129473|FG000|Overall Study|Lack of Efficacy|2|||
164479633|NCT00949117|594129474|FG001|Overall Study|Lack of Efficacy|3|||
164479634|NCT00949117|594129473|FG000|Overall Study|Protocol Violation|1|||
164479635|NCT00949117|594129474|FG001|Overall Study|Protocol Violation|1|||
164479636|NCT00949117|594129473|FG000|Overall Study|Adverse Event|0|||
164479637|NCT00949117|594129474|FG001|Overall Study|Adverse Event|1|||
164479638|NCT00985088|594129475|FG000|Overall Study|Serious Adverse Event|1|||
164479639|NCT00985088|594129476|FG001|Overall Study|Serious Adverse Event|1|||
164479640|NCT00985088|594129477|FG002|Overall Study|Serious Adverse Event|0|||
164479641|NCT00985088|594129478|FG003|Overall Study|Serious Adverse Event|0|||
164479642|NCT00985088|594129479|FG004|Overall Study|Serious Adverse Event|0|||
164479643|NCT00985088|594129480|FG005|Overall Study|Serious Adverse Event|0|||
164479644|NCT00985088|594129481|FG006|Overall Study|Serious Adverse Event|0|||
164479645|NCT00985088|594129482|FG007|Overall Study|Serious Adverse Event|1|||
164479646|NCT00985088|594129475|FG000|Overall Study|Adverse Event|0|||
164479647|NCT00985088|594129476|FG001|Overall Study|Adverse Event|0|||
164479648|NCT00985088|594129477|FG002|Overall Study|Adverse Event|1|||
164479649|NCT00985088|594129478|FG003|Overall Study|Adverse Event|0|||
164600314|NCT03457103|594558172|FG001|Overall Study|illness/hospitalization|2|||
164600315|NCT03457103|594558171|FG000|Overall Study|Lost to Follow-up|2|||
164600316|NCT03457103|594558172|FG001|Overall Study|Lost to Follow-up|1|||
164479650|NCT00985088|594129479|FG004|Overall Study|Adverse Event|0|||
164479651|NCT00985088|594129480|FG005|Overall Study|Adverse Event|0|||
164479652|NCT00985088|594129481|FG006|Overall Study|Adverse Event|0|||
164600317|NCT03457103|594558171|FG000|Overall Study|Withdrawal by Subject|1|||
164600318|NCT03457103|594558172|FG001|Overall Study|Withdrawal by Subject|2|||
164600319|NCT03457103|594558171|FG000|Overall Study|financial/ insurance issues|1|||
164479653|NCT00985088|594129482|FG007|Overall Study|Adverse Event|0|||
164479654|NCT00985088|594129475|FG000|Overall Study|Withdrawal by Subject|4|||
164479655|NCT00985088|594129476|FG001|Overall Study|Withdrawal by Subject|0|||
164479656|NCT00985088|594129477|FG002|Overall Study|Withdrawal by Subject|0|||
164479657|NCT00985088|594129478|FG003|Overall Study|Withdrawal by Subject|1|||
164479658|NCT00985088|594129479|FG004|Overall Study|Withdrawal by Subject|3|||
164479659|NCT00985088|594129480|FG005|Overall Study|Withdrawal by Subject|2|||
164600320|NCT03457103|594558172|FG001|Overall Study|financial/ insurance issues|1|||
164479660|NCT00985088|594129481|FG006|Overall Study|Withdrawal by Subject|1|||
164600321|NCT03004469|594558173|FG000|Overall Study|Adverse Event|6|||
164479661|NCT00985088|594129482|FG007|Overall Study|Withdrawal by Subject|2|||
164479662|NCT00985088|594129475|FG000|Overall Study|Migrated/moved from study area|0|||
164479663|NCT00985088|594129476|FG001|Overall Study|Migrated/moved from study area|0|||
164479664|NCT00985088|594129477|FG002|Overall Study|Migrated/moved from study area|1|||
164479665|NCT00985088|594129478|FG003|Overall Study|Migrated/moved from study area|0|||
164479666|NCT00985088|594129479|FG004|Overall Study|Migrated/moved from study area|0|||
164479667|NCT00985088|594129480|FG005|Overall Study|Migrated/moved from study area|0|||
164479668|NCT00985088|594129481|FG006|Overall Study|Migrated/moved from study area|0|||
164479669|NCT00985088|594129482|FG007|Overall Study|Migrated/moved from study area|1|||
164479670|NCT00985088|594129475|FG000|Overall Study|Lost to Follow-up|6|||
164479671|NCT00985088|594129476|FG001|Overall Study|Lost to Follow-up|1|||
164479672|NCT00985088|594129477|FG002|Overall Study|Lost to Follow-up|2|||
164479673|NCT00985088|594129478|FG003|Overall Study|Lost to Follow-up|6|||
164479674|NCT00985088|594129479|FG004|Overall Study|Lost to Follow-up|6|||
164479675|NCT00985088|594129480|FG005|Overall Study|Lost to Follow-up|5|||
164479676|NCT00985088|594129481|FG006|Overall Study|Lost to Follow-up|3|||
164479677|NCT00985088|594129482|FG007|Overall Study|Lost to Follow-up|2|||
164479678|NCT03964974|594129483|FG000|Overall Study|Lost to Follow-up|3|||
164479679|NCT03964974|594129484|FG001|Overall Study|Lost to Follow-up|2|||
164479680|NCT03964974|594129483|FG000|Overall Study|Withdrawal by Subject|0|||
164479681|NCT03964974|594129484|FG001|Overall Study|Withdrawal by Subject|3|||
164479682|NCT01970878|594129486|FG000|Overall Study|Withdrawal by Subject|11|||
164479683|NCT01970878|594129487|FG001|Overall Study|Withdrawal by Subject|10|||
164479684|NCT01970878|594129488|FG002|Overall Study|Withdrawal by Subject|14|||
164479685|NCT01970878|594129489|FG003|Overall Study|Withdrawal by Subject|7|||
164479686|NCT01970878|594129486|FG000|Overall Study|Lost to Follow-up|1|||
164479687|NCT01970878|594129487|FG001|Overall Study|Lost to Follow-up|3|||
164479688|NCT01970878|594129488|FG002|Overall Study|Lost to Follow-up|2|||
164479689|NCT01970878|594129489|FG003|Overall Study|Lost to Follow-up|4|||
164479690|NCT01970878|594129486|FG000|Overall Study|Administrative Reasons|1|||
164479691|NCT01970878|594129487|FG001|Overall Study|Administrative Reasons|0|||
164479692|NCT01970878|594129488|FG002|Overall Study|Administrative Reasons|0|||
164479693|NCT01970878|594129489|FG003|Overall Study|Administrative Reasons|4|||
164479694|NCT01970878|594129486|FG000|Overall Study|Lack of Efficacy|2|||
164479695|NCT01970878|594129487|FG001|Overall Study|Lack of Efficacy|1|||
164479696|NCT01970878|594129488|FG002|Overall Study|Lack of Efficacy|2|||
164479697|NCT01970878|594129489|FG003|Overall Study|Lack of Efficacy|0|||
164479698|NCT01970878|594129486|FG000|Overall Study|Adverse Event|12|||
164479699|NCT01970878|594129487|FG001|Overall Study|Adverse Event|7|||
164479700|NCT01970878|594129488|FG002|Overall Study|Adverse Event|4|||
164479701|NCT01970878|594129489|FG003|Overall Study|Adverse Event|3|||
164479702|NCT01970878|594129486|FG000|Overall Study|Protocol Specified Criteria|10|||
164479703|NCT01970878|594129487|FG001|Overall Study|Protocol Specified Criteria|4|||
164479704|NCT01970878|594129488|FG002|Overall Study|Protocol Specified Criteria|3|||
164479705|NCT01970878|594129489|FG003|Overall Study|Protocol Specified Criteria|6|||
164479706|NCT01970878|594129486|FG000|Overall Study|Physician Decision|0|||
164479707|NCT01970878|594129487|FG001|Overall Study|Physician Decision|1|||
164479708|NCT01970878|594129488|FG002|Overall Study|Physician Decision|1|||
164479709|NCT01970878|594129489|FG003|Overall Study|Physician Decision|0|||
164479710|NCT01970878|594129486|FG000|Overall Study|No Completion Status|0|||
164479711|NCT01970878|594129487|FG001|Overall Study|No Completion Status|1|||
164479712|NCT01970878|594129488|FG002|Overall Study|No Completion Status|0|||
164479713|NCT01970878|594129489|FG003|Overall Study|No Completion Status|0|||
164479714|NCT02014402|594129493|FG000|Overall Study|Adverse Event|1|||
164479715|NCT02014402|594129494|FG001|Overall Study|Adverse Event|0|||
164479716|NCT02014402|594129495|FG002|Overall Study|Adverse Event|0|||
164479717|NCT02014402|594129496|FG003|Overall Study|Adverse Event|0|||
164479718|NCT02014402|594129493|FG000|Overall Study|Withdrawal by Subject|1|||
164479719|NCT02014402|594129494|FG001|Overall Study|Withdrawal by Subject|2|||
164479720|NCT02014402|594129495|FG002|Overall Study|Withdrawal by Subject|2|||
164479721|NCT02014402|594129496|FG003|Overall Study|Withdrawal by Subject|1|||
164479722|NCT02014402|594129493|FG000|Overall Study|Subject did not have transportation|0|||
164479723|NCT02014402|594129494|FG001|Overall Study|Subject did not have transportation|1|||
164479724|NCT02014402|594129495|FG002|Overall Study|Subject did not have transportation|0|||
164479725|NCT02014402|594129496|FG003|Overall Study|Subject did not have transportation|0|||
164479726|NCT02014402|594129493|FG000|Overall Study|Lost to Follow-up|0|||
164479727|NCT02014402|594129494|FG001|Overall Study|Lost to Follow-up|0|||
164479728|NCT02014402|594129495|FG002|Overall Study|Lost to Follow-up|1|||
164479729|NCT02014402|594129496|FG003|Overall Study|Lost to Follow-up|2|||
164714311|NCT00000620|594976861|FG007|Overall Study|Lost to Follow-up|14|||
164714312|NCT00000620|594976854|FG000|Overall Study|Withdrawal by Subject|40|||
164714313|NCT00000620|594976855|FG001|Overall Study|Withdrawal by Subject|27|||
164714314|NCT00000620|594976856|FG002|Overall Study|Withdrawal by Subject|28|||
164714315|NCT00000620|594976857|FG003|Overall Study|Withdrawal by Subject|27|||
164714316|NCT00000620|594976858|FG004|Overall Study|Withdrawal by Subject|30|||
164714317|NCT00000620|594976859|FG005|Overall Study|Withdrawal by Subject|32|||
164479730|NCT04992273|594129500|FG000|Overall Study|Lost to Follow-up|0|||
164479731|NCT04992273|594129501|FG001|Overall Study|Lost to Follow-up|1|||
164479732|NCT03214081|594129502|FG000|Overall Study|Case Report Forms Uncollected|9|||
164479733|NCT03214081|594129502|FG000|Overall Study|Protocol Deviation|54|||
164479734|NCT02637063|594129503|FG000|Overall Study|Lost to Follow-up|3|||
164479735|NCT02637063|594129504|FG001|Overall Study|Lost to Follow-up|2|||
164479736|NCT02637063|594129505|FG002|Overall Study|Lost to Follow-up|3|||
164479737|NCT02637063|594129503|FG000|Overall Study|Withdrawal by Subject|2|||
164479738|NCT02637063|594129504|FG001|Overall Study|Withdrawal by Subject|2|||
164479739|NCT02637063|594129505|FG002|Overall Study|Withdrawal by Subject|3|||
164479740|NCT00491400|594129506|FG000|Overall Study|Withdrawal by Subject|5|||
164479741|NCT00491400|594129507|FG001|Overall Study|Withdrawal by Subject|4|||
164479742|NCT00413283|594129508|FG000|Overall Study|Withdrawal by Subject|1|||
164479743|NCT00413283|594129509|FG001|Overall Study|Withdrawal by Subject|0|||
164479744|NCT00413283|594129510|FG002|Overall Study|Withdrawal by Subject|0|||
164479745|NCT00413283|594129511|FG003|Overall Study|Withdrawal by Subject|1|||
164479746|NCT00413283|594129508|FG000|Overall Study|Death|0|||
164479747|NCT00413283|594129509|FG001|Overall Study|Death|0|||
164479748|NCT00413283|594129510|FG002|Overall Study|Death|1|||
164479749|NCT00413283|594129511|FG003|Overall Study|Death|1|||
164479750|NCT00413283|594129508|FG000|Overall Study|Adverse Event|0|||
164479751|NCT00413283|594129509|FG001|Overall Study|Adverse Event|0|||
164479752|NCT00413283|594129510|FG002|Overall Study|Adverse Event|0|||
164479753|NCT00413283|594129511|FG003|Overall Study|Adverse Event|1|||
164479754|NCT00413283|594129508|FG000|Overall Study|Ineligibility determined|0|||
164479755|NCT00413283|594129509|FG001|Overall Study|Ineligibility determined|0|||
164479756|NCT00413283|594129510|FG002|Overall Study|Ineligibility determined|0|||
164479757|NCT00413283|594129511|FG003|Overall Study|Ineligibility determined|1|||
164479758|NCT00413283|594129508|FG000|Overall Study|Protocol deviation|0|||
164479759|NCT00413283|594129509|FG001|Overall Study|Protocol deviation|1|||
164479760|NCT00413283|594129510|FG002|Overall Study|Protocol deviation|0|||
164479761|NCT00413283|594129511|FG003|Overall Study|Protocol deviation|0|||
164479762|NCT00413283|594129508|FG000|Overall Study|Requirement for alternative therapy|0|||
164479763|NCT00413283|594129509|FG001|Overall Study|Requirement for alternative therapy|2|||
164479764|NCT00413283|594129510|FG002|Overall Study|Requirement for alternative therapy|0|||
164479765|NCT00413283|594129511|FG003|Overall Study|Requirement for alternative therapy|0|||
164479766|NCT00413283|594129508|FG000|Overall Study|Other|0|||
164479767|NCT00413283|594129509|FG001|Overall Study|Other|0|||
164479768|NCT00413283|594129510|FG002|Overall Study|Other|1|||
164479769|NCT00413283|594129511|FG003|Overall Study|Other|0|||
164479770|NCT01823224|594129512|FG000|Overall Study|Lost to Follow-up|5|||
164479771|NCT01823224|594129513|FG001|Overall Study|Lost to Follow-up|6|||
164479772|NCT01823224|594129512|FG000|Overall Study|didn't qualify|1|||
164479773|NCT01823224|594129513|FG001|Overall Study|didn't qualify|2|||
164479774|NCT01823224|594129512|FG000|Overall Study|pharmacy error|0|||
164479775|NCT01823224|594129513|FG001|Overall Study|pharmacy error|1|||
164479776|NCT01823224|594129512|FG000|Overall Study|missed med dose|0|||
164479777|NCT01823224|594129513|FG001|Overall Study|missed med dose|1|||
164479778|NCT01823224|594129512|FG000|Overall Study|Withdrawal by Subject|0|||
164479779|NCT01823224|594129513|FG001|Overall Study|Withdrawal by Subject|1|||
164479780|NCT02148705|594129516|FG000|Overall Study|Death|2|||
164479781|NCT02148705|594129517|FG001|Overall Study|Death|0|||
164479782|NCT02148705|594129518|FG002|Overall Study|Death|0|||
164479783|NCT02148705|594129516|FG000|Overall Study|Lost to Follow-up|13|||
164479784|NCT02148705|594129517|FG001|Overall Study|Lost to Follow-up|4|||
164479785|NCT02148705|594129518|FG002|Overall Study|Lost to Follow-up|10|||
164479786|NCT02148705|594129516|FG000|Overall Study|Withdrawal by Subject|3|||
164714318|NCT00000620|594976860|FG006|Overall Study|Withdrawal by Subject|32|||
164479787|NCT02148705|594129517|FG001|Overall Study|Withdrawal by Subject|0|||
164479788|NCT02148705|594129518|FG002|Overall Study|Withdrawal by Subject|2|||
164479789|NCT02148705|594129516|FG000|Overall Study|Not Treated|0|||
164479790|NCT02148705|594129517|FG001|Overall Study|Not Treated|1|||
164479791|NCT02148705|594129518|FG002|Overall Study|Not Treated|5|||
164479792|NCT01737021|594129521|FG000|Overall Study|Lost to Follow-up|5|||
164479793|NCT01737021|594129522|FG001|Overall Study|Lost to Follow-up|3|||
164479794|NCT01673594|594129523|FG000|Overall Study|Adverse Event|3|||
164479795|NCT01673594|594129524|FG001|Overall Study|Adverse Event|1|||
164479796|NCT01673594|594129523|FG000|Overall Study|Lost to Follow-up|1|||
164479797|NCT01673594|594129524|FG001|Overall Study|Lost to Follow-up|0|||
164479798|NCT01673594|594129523|FG000|Overall Study|Physician Decision|2|||
164479799|NCT01673594|594129524|FG001|Overall Study|Physician Decision|4|||
164479800|NCT01673594|594129523|FG000|Overall Study|Withdrawal by Subject|0|||
164479801|NCT01673594|594129524|FG001|Overall Study|Withdrawal by Subject|1|||
164479802|NCT02824198|594129525|FG000|Overall Study|Non-compliance with the protocol|5|||
164479803|NCT02824198|594129526|FG001|Overall Study|Non-compliance with the protocol|1|||
164479804|NCT02824198|594129525|FG000|Overall Study|Lost to Follow-up|5|||
164479805|NCT02824198|594129526|FG001|Overall Study|Lost to Follow-up|2|||
164479806|NCT02824198|594129525|FG000|Overall Study|Withdrawal by Subject|5|||
164479807|NCT02824198|594129526|FG001|Overall Study|Withdrawal by Subject|0|||
164479808|NCT03883828|594129527|FG000|Overall Study|Did not start radiotherapy|1|||
164479809|NCT03883828|594129528|FG001|Overall Study|Did not start radiotherapy|2|||
164479810|NCT02575365|594129533|FG000|Overall Study|Lost to Follow-up|4|||
164479811|NCT02736188|594129544|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
164479812|NCT02736188|594129544|FG000|Overall Study|Adverse Event|1|||
164479813|NCT02736188|594129544|FG000|Overall Study|Withdrawal by Subject|1|||
164479814|NCT02736188|594129544|FG000|Overall Study|Other|6|||
164479815|NCT01698918|594129545|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
164479816|NCT01698918|594129545|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
164479817|NCT01698918|594129545|FG000|First Line Treatment (Core+Extension)|Death|2|||
164479818|NCT01698918|594129545|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
164479819|NCT01698918|594129545|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
164479820|NCT01698918|594129545|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
164479821|NCT01698918|594129545|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
164479822|NCT01698918|594129545|FG000|Second Line Treatment (Core+Extension)|Death|1|||
164479823|NCT01698918|594129545|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
164479824|NCT01698918|594129545|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
164479825|NCT03176407|594129546|FG000|Overall Study|Protocol Violation|1|||
164479826|NCT03176407|594129546|FG000|Overall Study|human failure|1|||
164479827|NCT03176407|594129546|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
164479828|NCT01428583|594129548|FG000|Overall Study|Adverse Event|75|||
164479829|NCT01428583|594129548|FG000|Overall Study|Withdrawal by Subject|51|||
164479830|NCT01428583|594129548|FG000|Overall Study|Lack of Efficacy|37|||
164479831|NCT01428583|594129548|FG000|Overall Study|Lost to Follow-up|17|||
164479832|NCT01428583|594129548|FG000|Overall Study|Death|1|||
164479833|NCT01428583|594129548|FG000|Overall Study|Pregnancy|1|||
164479834|NCT01428583|594129548|FG000|Overall Study|Protocol Violation|1|||
164479835|NCT01428583|594129548|FG000|Overall Study|Physician Decision|12|||
164479836|NCT01428583|594129548|FG000|Overall Study|Non-compliant|25|||
164479837|NCT01428583|594129548|FG000|Overall Study|Confirmed positive urine drug test|8|||
164479838|NCT01428583|594129548|FG000|Overall Study|Sponsor's request|3|||
164479839|NCT01428583|594129548|FG000|Overall Study|Other|6|||
164479840|NCT00768755|594129552|FG000|Phase 1|Death|6|||
164479841|NCT00768755|594129553|FG001|Phase 1|Death|0|||
164479842|NCT00768755|594129554|FG002|Phase 1|Death|0|||
164479843|NCT00768755|594129555|FG003|Phase 1|Death|0|||
164479844|NCT00768755|594129552|FG000|Phase 1|Other|4|||
164479845|NCT00768755|594129553|FG001|Phase 1|Other|0|||
164479846|NCT00768755|594129554|FG002|Phase 1|Other|0|||
164479847|NCT00768755|594129555|FG003|Phase 1|Other|0|||
164479848|NCT00768755|594129552|FG000|Phase 2|Death|0|||
164479849|NCT00768755|594129553|FG001|Phase 2|Death|37|||
164479850|NCT00768755|594129554|FG002|Phase 2|Death|48|||
164479851|NCT00768755|594129555|FG003|Phase 2|Death|31|||
164479852|NCT00768755|594129552|FG000|Phase 2|Protocol Violation|0|||
164479853|NCT00768755|594129553|FG001|Phase 2|Protocol Violation|2|||
164479854|NCT00768755|594129554|FG002|Phase 2|Protocol Violation|0|||
164479855|NCT00768755|594129555|FG003|Phase 2|Protocol Violation|1|||
164479856|NCT00768755|594129552|FG000|Phase 2|Lost to Follow-up|0|||
164479857|NCT00768755|594129553|FG001|Phase 2|Lost to Follow-up|1|||
164479858|NCT00768755|594129554|FG002|Phase 2|Lost to Follow-up|1|||
164479859|NCT00768755|594129555|FG003|Phase 2|Lost to Follow-up|4|||
164479860|NCT00768755|594129552|FG000|Phase 2|Withdrawal by Subject|0|||
164479861|NCT00768755|594129553|FG001|Phase 2|Withdrawal by Subject|1|||
164479862|NCT00768755|594129554|FG002|Phase 2|Withdrawal by Subject|0|||
164479863|NCT00768755|594129555|FG003|Phase 2|Withdrawal by Subject|1|||
164479864|NCT00768755|594129552|FG000|Phase 2|Other|0|||
164479865|NCT00768755|594129553|FG001|Phase 2|Other|1|||
164600322|NCT03004469|594558174|FG001|Overall Study|Adverse Event|4|||
164600323|NCT03004469|594558175|FG002|Overall Study|Adverse Event|6|||
164714319|NCT00000620|594976861|FG007|Overall Study|Withdrawal by Subject|21|||
164714320|NCT00000620|594976854|FG000|Overall Study|missed closeout visit|22|||
164479866|NCT00768755|594129554|FG002|Phase 2|Other|2|||
164479867|NCT00768755|594129555|FG003|Phase 2|Other|4|||
164479868|NCT00768755|594129552|FG000|Phase 2|Study Terminated by Sponsor|0|||
164479869|NCT00768755|594129553|FG001|Phase 2|Study Terminated by Sponsor|13|||
164479870|NCT00768755|594129554|FG002|Phase 2|Study Terminated by Sponsor|7|||
164479871|NCT00768755|594129555|FG003|Phase 2|Study Terminated by Sponsor|14|||
164479872|NCT00768755|594129552|FG000|Phase 2|Randomized but not treated|0|||
164479873|NCT00768755|594129553|FG001|Phase 2|Randomized but not treated|0|||
164479874|NCT00768755|594129554|FG002|Phase 2|Randomized but not treated|0|||
164479875|NCT00768755|594129555|FG003|Phase 2|Randomized but not treated|2|||
164479876|NCT00670488|594129556|FG000|Overall Study|Adverse Event|0|||
164479877|NCT00670488|594129557|FG001|Overall Study|Adverse Event|7|||
164479878|NCT00670488|594129558|FG002|Overall Study|Adverse Event|0|||
164479879|NCT00670488|594129559|FG003|Overall Study|Adverse Event|3|||
164479880|NCT00670488|594129560|FG004|Overall Study|Adverse Event|1|||
164479881|NCT00670488|594129561|FG005|Overall Study|Adverse Event|1|||
164479882|NCT00670488|594129562|FG006|Overall Study|Adverse Event|5|||
164479883|NCT00670488|594129563|FG007|Overall Study|Adverse Event|1|||
164479884|NCT00670488|594129564|FG008|Overall Study|Adverse Event|0|||
164479885|NCT00670488|594129565|FG009|Overall Study|Adverse Event|1|||
164479886|NCT00670488|594129556|FG000|Overall Study|Physician Decision|1|||
164479887|NCT00670488|594129557|FG001|Overall Study|Physician Decision|9|||
164479888|NCT00670488|594129558|FG002|Overall Study|Physician Decision|0|||
164479889|NCT00670488|594129559|FG003|Overall Study|Physician Decision|1|||
164479890|NCT00670488|594129560|FG004|Overall Study|Physician Decision|0|||
164479891|NCT00670488|594129561|FG005|Overall Study|Physician Decision|0|||
164479892|NCT00670488|594129562|FG006|Overall Study|Physician Decision|0|||
164479893|NCT00670488|594129563|FG007|Overall Study|Physician Decision|0|||
164479894|NCT00670488|594129564|FG008|Overall Study|Physician Decision|0|||
164479895|NCT00670488|594129565|FG009|Overall Study|Physician Decision|0|||
164479896|NCT00670488|594129556|FG000|Overall Study|Progressive Disease|2|||
164479897|NCT00670488|594129557|FG001|Overall Study|Progressive Disease|41|||
164479898|NCT00670488|594129558|FG002|Overall Study|Progressive Disease|3|||
164479899|NCT00670488|594129559|FG003|Overall Study|Progressive Disease|2|||
164479900|NCT00670488|594129560|FG004|Overall Study|Progressive Disease|2|||
164479901|NCT00670488|594129561|FG005|Overall Study|Progressive Disease|4|||
164479902|NCT00670488|594129562|FG006|Overall Study|Progressive Disease|11|||
164479903|NCT00670488|594129563|FG007|Overall Study|Progressive Disease|2|||
164479904|NCT00670488|594129564|FG008|Overall Study|Progressive Disease|2|||
164479905|NCT00670488|594129565|FG009|Overall Study|Progressive Disease|1|||
164479906|NCT00670488|594129556|FG000|Overall Study|Withdrawal by Subject|0|||
164479907|NCT00670488|594129557|FG001|Overall Study|Withdrawal by Subject|1|||
164479908|NCT00670488|594129558|FG002|Overall Study|Withdrawal by Subject|0|||
164479909|NCT00670488|594129559|FG003|Overall Study|Withdrawal by Subject|1|||
164479910|NCT00670488|594129560|FG004|Overall Study|Withdrawal by Subject|0|||
164479911|NCT00670488|594129561|FG005|Overall Study|Withdrawal by Subject|0|||
164479912|NCT00670488|594129562|FG006|Overall Study|Withdrawal by Subject|1|||
164479913|NCT00670488|594129563|FG007|Overall Study|Withdrawal by Subject|0|||
164479914|NCT00670488|594129564|FG008|Overall Study|Withdrawal by Subject|1|||
164479915|NCT00670488|594129565|FG009|Overall Study|Withdrawal by Subject|0|||
164479916|NCT00878189|594129566|FG000|Overall Study|Death|0|||
164479917|NCT00878189|594129567|FG001|Overall Study|Death|1|||
164479918|NCT00878189|594129568|FG002|Overall Study|Death|0|||
164479919|NCT00878189|594129569|FG003|Overall Study|Death|1|||
164479920|NCT00878189|594129570|FG004|Overall Study|Death|0|||
164479921|NCT00878189|594129571|FG005|Overall Study|Death|0|||
164714321|NCT00000620|594976855|FG001|Overall Study|missed closeout visit|28|||
164714322|NCT00000620|594976856|FG002|Overall Study|missed closeout visit|16|||
164714323|NCT00000620|594976857|FG003|Overall Study|missed closeout visit|11|||
164714324|NCT00000620|594976858|FG004|Overall Study|missed closeout visit|26|||
164714325|NCT00000620|594976859|FG005|Overall Study|missed closeout visit|28|||
164714326|NCT00000620|594976860|FG006|Overall Study|missed closeout visit|13|||
164714327|NCT00000620|594976861|FG007|Overall Study|missed closeout visit|16|||
164714328|NCT02648932|594976862|FG000|Overall Study|No transplant|3|||
164479922|NCT00878189|594129572|FG006|Overall Study|Death|0|||
164479923|NCT00878189|594129573|FG007|Overall Study|Death|0|||
164479924|NCT00878189|594129574|FG008|Overall Study|Death|1|||
164479925|NCT00878189|594129566|FG000|Overall Study|Participant Refused to Follow-up|0|||
164479926|NCT00878189|594129567|FG001|Overall Study|Participant Refused to Follow-up|0|||
164479927|NCT00878189|594129568|FG002|Overall Study|Participant Refused to Follow-up|0|||
164479928|NCT00878189|594129569|FG003|Overall Study|Participant Refused to Follow-up|0|||
164714329|NCT02648932|594976863|FG001|Overall Study|No transplant|1|||
164479929|NCT00878189|594129570|FG004|Overall Study|Participant Refused to Follow-up|0|||
164479930|NCT00878189|594129571|FG005|Overall Study|Participant Refused to Follow-up|4|||
164479931|NCT00878189|594129572|FG006|Overall Study|Participant Refused to Follow-up|0|||
164479932|NCT00878189|594129573|FG007|Overall Study|Participant Refused to Follow-up|0|||
164479933|NCT00878189|594129574|FG008|Overall Study|Participant Refused to Follow-up|0|||
164479934|NCT00878189|594129566|FG000|Overall Study|Other|3|||
164479935|NCT00878189|594129567|FG001|Overall Study|Other|2|||
164479936|NCT00878189|594129568|FG002|Overall Study|Other|4|||
164479937|NCT00878189|594129569|FG003|Overall Study|Other|7|||
164600324|NCT03004469|594558173|FG000|Overall Study|Lack of Efficacy|1|||
164600325|NCT03004469|594558174|FG001|Overall Study|Lack of Efficacy|0|||
164479938|NCT00878189|594129570|FG004|Overall Study|Other|4|||
164479939|NCT00878189|594129571|FG005|Overall Study|Other|18|||
164479940|NCT00878189|594129572|FG006|Overall Study|Other|15|||
164479941|NCT00878189|594129573|FG007|Overall Study|Other|3|||
164479942|NCT00878189|594129574|FG008|Overall Study|Other|4|||
164479943|NCT00878189|594129566|FG000|Overall Study|Lost to Follow-up|0|||
164479944|NCT00878189|594129567|FG001|Overall Study|Lost to Follow-up|0|||
164479945|NCT00878189|594129568|FG002|Overall Study|Lost to Follow-up|0|||
164479946|NCT00878189|594129569|FG003|Overall Study|Lost to Follow-up|0|||
164479947|NCT00878189|594129570|FG004|Overall Study|Lost to Follow-up|0|||
164479948|NCT00878189|594129571|FG005|Overall Study|Lost to Follow-up|1|||
164479949|NCT00878189|594129572|FG006|Overall Study|Lost to Follow-up|1|||
164479950|NCT00878189|594129573|FG007|Overall Study|Lost to Follow-up|0|||
164479951|NCT00878189|594129574|FG008|Overall Study|Lost to Follow-up|0|||
164479952|NCT00878189|594129566|FG000|Overall Study|Objection Progression or Relapse|0|||
164479953|NCT00878189|594129567|FG001|Overall Study|Objection Progression or Relapse|0|||
164479954|NCT00878189|594129568|FG002|Overall Study|Objection Progression or Relapse|0|||
164479955|NCT00878189|594129569|FG003|Overall Study|Objection Progression or Relapse|0|||
164479956|NCT00878189|594129570|FG004|Overall Study|Objection Progression or Relapse|0|||
164479957|NCT00878189|594129571|FG005|Overall Study|Objection Progression or Relapse|0|||
164479958|NCT00878189|594129572|FG006|Overall Study|Objection Progression or Relapse|0|||
164479959|NCT00878189|594129573|FG007|Overall Study|Objection Progression or Relapse|0|||
164479960|NCT00878189|594129574|FG008|Overall Study|Objection Progression or Relapse|3|||
164479961|NCT02708498|594129575|FG000|Overall Study|Death|20|||
164479962|NCT02708498|594129576|FG001|Overall Study|Death|19|||
164479963|NCT02708498|594129577|FG002|Overall Study|Death|0|||
164479964|NCT02708498|594129578|FG003|Overall Study|Death|0|||
164479965|NCT02708498|594129579|FG004|Overall Study|Death|1|||
164479966|NCT02708498|594129580|FG005|Overall Study|Death|0|||
164479967|NCT02708498|594129581|FG006|Overall Study|Death|0|||
164479968|NCT02708498|594129582|FG007|Overall Study|Death|0|||
164479969|NCT02708498|594129575|FG000|Overall Study|Unknown reason, missing data|0|||
164479970|NCT02708498|594129576|FG001|Overall Study|Unknown reason, missing data|0|||
164479971|NCT02708498|594129577|FG002|Overall Study|Unknown reason, missing data|62|||
164479972|NCT02708498|594129578|FG003|Overall Study|Unknown reason, missing data|51|||
164479973|NCT02708498|594129579|FG004|Overall Study|Unknown reason, missing data|195|||
164479974|NCT02708498|594129580|FG005|Overall Study|Unknown reason, missing data|132|||
164479975|NCT02708498|594129581|FG006|Overall Study|Unknown reason, missing data|0|||
164479976|NCT02708498|594129582|FG007|Overall Study|Unknown reason, missing data|0|||
164479977|NCT01829711|594129583|FG000|Overall Study|Lost to Follow-up|2|||
164479978|NCT01829711|594129583|FG000|Overall Study|Withdrawal by Subject|3|||
164479979|NCT01829711|594129583|FG000|Overall Study|Death|4|||
164479980|NCT01829711|594129583|FG000|Overall Study|Started new therapies|17|||
164479981|NCT01829711|594129583|FG000|Overall Study|Adverse Event|3|||
164479982|NCT01829711|594129583|FG000|Overall Study|Due to progression of disease|13|||
164479983|NCT01829711|594129583|FG000|Overall Study|Due to lack of response|1|||
164479984|NCT01480258|594129584|FG000|Infant Series|Protocol Violation|2|||
164479985|NCT01480258|594129585|FG001|Infant Series|Protocol Violation|0|||
164479986|NCT01480258|594129584|FG000|Infant Series|Physician Decision|0|||
164479987|NCT01480258|594129585|FG001|Infant Series|Physician Decision|1|||
164479988|NCT01480258|594129584|FG000|Infant Series|Not Vaccinated|3|||
164479989|NCT01480258|594129585|FG001|Infant Series|Not Vaccinated|0|||
164479990|NCT01480258|594129584|FG000|Infant Series|Adverse Event|1|||
164479991|NCT01480258|594129585|FG001|Infant Series|Adverse Event|1|||
164479992|NCT01480258|594129584|FG000|Infant Series|Withdrawal by Subject|1|||
164479993|NCT01480258|594129585|FG001|Infant Series|Withdrawal by Subject|6|||
164479994|NCT01480258|594129584|FG000|Interim Period|Lost to Follow-up|0|||
164479995|NCT01480258|594129585|FG001|Interim Period|Lost to Follow-up|2|||
164479996|NCT01480258|594129584|FG000|Interim Period|Physician Decision|1|||
164479997|NCT01480258|594129585|FG001|Interim Period|Physician Decision|0|||
164479998|NCT01480258|594129584|FG000|Interim Period|Protocol Violation|0|||
164479999|NCT01480258|594129585|FG001|Interim Period|Protocol Violation|1|||
164480000|NCT01480258|594129584|FG000|Interim Period|Withdrawal by Subject|9|||
164480001|NCT01480258|594129585|FG001|Interim Period|Withdrawal by Subject|6|||
164480002|NCT03274076|594129586|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
164480003|NCT03274076|594129587|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
164480004|NCT03274076|594129588|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
164480005|NCT03274076|594129589|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
164480006|NCT03274076|594129586|FG000|24 Weeks Open Label|Adverse Event|0|||
164480007|NCT03274076|594129587|FG001|24 Weeks Open Label|Adverse Event|0|||
164480008|NCT03274076|594129588|FG002|24 Weeks Open Label|Adverse Event|2|||
164480009|NCT03274076|594129589|FG003|24 Weeks Open Label|Adverse Event|0|||
164480010|NCT03274076|594129586|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
164480011|NCT03274076|594129587|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
164480012|NCT03274076|594129588|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
164480013|NCT03274076|594129589|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
164600326|NCT03004469|594558175|FG002|Overall Study|Lack of Efficacy|1|||
164480014|NCT00795184|594129591|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
164480015|NCT00795184|594129592|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
164480016|NCT03781375|594129593|FG000|Double-blind Phase|Adverse Event|0|||
164480017|NCT03781375|594129594|FG001|Double-blind Phase|Adverse Event|1|||
164480018|NCT03781375|594129593|FG000|Double-blind Phase|Lack of Response|6|||
164480019|NCT03781375|594129594|FG001|Double-blind Phase|Lack of Response|2|||
164480020|NCT03781375|594129593|FG000|Double-blind Phase|Other|1|||
164480021|NCT03781375|594129594|FG001|Double-blind Phase|Other|3|||
164480022|NCT03781375|594129593|FG000|Open-label Phase|Protocol Issues|0|||
164480023|NCT03781375|594129594|FG001|Open-label Phase|Protocol Issues|1|||
164480024|NCT03781375|594129593|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
164480025|NCT03781375|594129594|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
164480026|NCT03781375|594129593|FG000|Open-label Phase|Other|2|||
164480027|NCT03781375|594129594|FG001|Open-label Phase|Other|2|||
164480028|NCT01629589|594129595|FG000|Overall Study|Protocol Violation|4|||
164480029|NCT01629589|594129596|FG001|Overall Study|Protocol Violation|2|||
164480030|NCT01629589|594129595|FG000|Overall Study|Lost to Follow-up|2|||
164480031|NCT01629589|594129596|FG001|Overall Study|Lost to Follow-up|1|||
164480032|NCT01629589|594129595|FG000|Overall Study|Withdrawal by Subject|2|||
164480033|NCT01629589|594129596|FG001|Overall Study|Withdrawal by Subject|3|||
164480034|NCT01629589|594129595|FG000|Overall Study|Did not receive study vaccine|0|||
164480035|NCT01629589|594129596|FG001|Overall Study|Did not receive study vaccine|1|||
164480036|NCT01530334|594129597|FG000|Overall Study|Adverse Event|3|||
164480037|NCT01530334|594129597|FG000|Overall Study|unknown reason|1|||
164480038|NCT01530334|594129597|FG000|Overall Study|Progressive disease|47|||
164480039|NCT01303510|594129599|FG000|Overall Study|Lost to Follow-up|1|||
164480040|NCT01303510|594129600|FG001|Overall Study|Lost to Follow-up|0|||
164480041|NCT02079649|594129601|FG000|Overall Study|Lost to Follow-up|0|||
164480042|NCT02079649|594129602|FG001|Overall Study|Lost to Follow-up|0|||
164480043|NCT02079649|594129603|FG002|Overall Study|Lost to Follow-up|0|||
164480044|NCT02079649|594129604|FG003|Overall Study|Lost to Follow-up|1|||
164480045|NCT02079649|594129601|FG000|Overall Study|Withdrawal by Subject|0|||
164480046|NCT02079649|594129602|FG001|Overall Study|Withdrawal by Subject|0|||
164480047|NCT02079649|594129603|FG002|Overall Study|Withdrawal by Subject|0|||
164480048|NCT02079649|594129604|FG003|Overall Study|Withdrawal by Subject|1|||
164480049|NCT02079649|594129601|FG000|Overall Study|Randomization error (prior to treatment)|1|||
164480050|NCT02079649|594129602|FG001|Overall Study|Randomization error (prior to treatment)|0|||
164480051|NCT02079649|594129603|FG002|Overall Study|Randomization error (prior to treatment)|1|||
164480052|NCT02079649|594129604|FG003|Overall Study|Randomization error (prior to treatment)|0|||
164480053|NCT01932970|594129629|FG000|Overall Study|Withdrawal by Subject|5|||
164480054|NCT01932970|594129629|FG000|Overall Study|Death|1|||
164480055|NCT01932970|594129629|FG000|Overall Study|Lost to Follow-up|2|||
164480056|NCT01932970|594129629|FG000|Overall Study|Protocol Specified Criteria|10|||
164480057|NCT00822900|594129630|FG000|Overall Study|Withdrawal by Subject|14|||
164480058|NCT00822900|594129631|FG001|Overall Study|Withdrawal by Subject|14|||
164480059|NCT00822900|594129630|FG000|Overall Study|Lost to Follow-up|9|||
164480060|NCT00822900|594129631|FG001|Overall Study|Lost to Follow-up|9|||
164480061|NCT00822900|594129630|FG000|Overall Study|Death|83|||
164480062|NCT00822900|594129631|FG001|Overall Study|Death|69|||
164480063|NCT00822900|594129630|FG000|Overall Study|Became a ward of the state|2|||
164480064|NCT00822900|594129631|FG001|Overall Study|Became a ward of the state|1|||
164480065|NCT01968967|594129632|FG000|Treatment Period|Other|22|||
164480066|NCT01968967|594129633|FG001|Treatment Period|Other|22|||
164480067|NCT01968967|594129634|FG002|Treatment Period|Other|0|||
164480068|NCT01968967|594129635|FG003|Treatment Period|Other|0|||
164480069|NCT01968967|594129636|FG004|Treatment Period|Other|0|||
164480070|NCT01968967|594129632|FG000|Treatment Period|Withdrawal by Subject|71|||
164480071|NCT01968967|594129633|FG001|Treatment Period|Withdrawal by Subject|61|||
164480072|NCT01968967|594129634|FG002|Treatment Period|Withdrawal by Subject|0|||
164480073|NCT01968967|594129635|FG003|Treatment Period|Withdrawal by Subject|0|||
164480074|NCT01968967|594129636|FG004|Treatment Period|Withdrawal by Subject|0|||
164480075|NCT01968967|594129632|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
164600327|NCT03004469|594558173|FG000|Overall Study|Lost to Follow-up|23|||
164600328|NCT03004469|594558174|FG001|Overall Study|Lost to Follow-up|14|||
164480076|NCT01968967|594129633|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
164480077|NCT01968967|594129634|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
164480078|NCT01968967|594129635|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
164600329|NCT03004469|594558175|FG002|Overall Study|Lost to Follow-up|6|||
164480079|NCT01968967|594129636|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
164480080|NCT01968967|594129632|FG000|Treatment Period|Lost to Follow-up|26|||
164600330|NCT03004469|594558173|FG000|Overall Study|Non-Compliance with Study Drug|2|||
164600331|NCT03004469|594558174|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164480081|NCT01968967|594129633|FG001|Treatment Period|Lost to Follow-up|31|||
164480082|NCT01968967|594129634|FG002|Treatment Period|Lost to Follow-up|0|||
164480083|NCT01968967|594129635|FG003|Treatment Period|Lost to Follow-up|0|||
164480084|NCT01968967|594129636|FG004|Treatment Period|Lost to Follow-up|0|||
164480085|NCT01968967|594129632|FG000|Treatment Period|Protocol Violation|1|||
164480086|NCT01968967|594129633|FG001|Treatment Period|Protocol Violation|2|||
164480087|NCT01968967|594129634|FG002|Treatment Period|Protocol Violation|0|||
164480088|NCT01968967|594129635|FG003|Treatment Period|Protocol Violation|0|||
164480089|NCT01968967|594129636|FG004|Treatment Period|Protocol Violation|0|||
164480090|NCT01968967|594129632|FG000|Treatment Period|Adverse Event|9|||
164480091|NCT01968967|594129633|FG001|Treatment Period|Adverse Event|8|||
164480092|NCT01968967|594129634|FG002|Treatment Period|Adverse Event|0|||
164480093|NCT01968967|594129635|FG003|Treatment Period|Adverse Event|0|||
164480094|NCT01968967|594129636|FG004|Treatment Period|Adverse Event|0|||
164480095|NCT01968967|594129632|FG000|Treatment Period|Death|9|||
164480096|NCT01968967|594129633|FG001|Treatment Period|Death|2|||
164480097|NCT01968967|594129634|FG002|Treatment Period|Death|0|||
164480098|NCT01968967|594129635|FG003|Treatment Period|Death|0|||
164480099|NCT01968967|594129636|FG004|Treatment Period|Death|0|||
164480100|NCT01968967|594129632|FG000|Treatment Period|Randomized Not Treated|6|||
164480101|NCT01968967|594129633|FG001|Treatment Period|Randomized Not Treated|5|||
164480102|NCT01968967|594129634|FG002|Treatment Period|Randomized Not Treated|0|||
164480103|NCT01968967|594129635|FG003|Treatment Period|Randomized Not Treated|0|||
164480104|NCT01968967|594129636|FG004|Treatment Period|Randomized Not Treated|0|||
164480105|NCT01968967|594129632|FG000|Extension Period|Withdrew Consent|0|||
164480106|NCT01968967|594129633|FG001|Extension Period|Withdrew Consent|0|||
164480107|NCT01968967|594129634|FG002|Extension Period|Withdrew Consent|2|||
164480108|NCT01968967|594129635|FG003|Extension Period|Withdrew Consent|0|||
164480109|NCT01968967|594129636|FG004|Extension Period|Withdrew Consent|5|||
164480110|NCT03489369|594129637|FG000|Overall Study|Documented Progressive Disease|3|||
164480111|NCT03489369|594129638|FG001|Overall Study|Documented Progressive Disease|2|||
164480112|NCT03489369|594129639|FG002|Overall Study|Documented Progressive Disease|3|||
164480113|NCT03489369|594129640|FG003|Overall Study|Documented Progressive Disease|6|||
164480114|NCT03489369|594129637|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
164480115|NCT03489369|594129638|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
164480116|NCT03489369|594129639|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
164480117|NCT03489369|594129640|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
164480118|NCT00701415|594129649|FG000|Overall Study|Adverse Event|0|||
164480119|NCT00701415|594129650|FG001|Overall Study|Adverse Event|1|||
164480120|NCT00701415|594129649|FG000|Overall Study|Social/family issues and needle phobia|1|||
164480121|NCT00701415|594129650|FG001|Overall Study|Social/family issues and needle phobia|0|||
164480122|NCT02106884|594129659|FG000|Overall Study|Change of diagnosis/exclusion|0|||
164480123|NCT02106884|594129660|FG001|Overall Study|Change of diagnosis/exclusion|1|||
164480124|NCT00659373|594129662|FG000|Overall Study|Withdrawal by Subject|3|||
164480125|NCT00659373|594129663|FG001|Overall Study|Withdrawal by Subject|5|||
164480126|NCT00659373|594129662|FG000|Overall Study|Assessment Missed|2|||
164480127|NCT00659373|594129663|FG001|Overall Study|Assessment Missed|2|||
164480128|NCT04224272|594129670|FG000|Part 1 - Dose Finding|Death|4|||
164480129|NCT04224272|594129670|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
164480130|NCT04224272|594129670|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
164480131|NCT04224272|594129670|FG000|Part 2 - Dose Expansion|Death|10|||
164480132|NCT04224272|594129670|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
164480133|NCT02609048|594129671|FG000|Overall Study|Adverse Event|3|||
164480134|NCT02609048|594129672|FG001|Overall Study|Adverse Event|0|||
164480135|NCT02609048|594129673|FG002|Overall Study|Adverse Event|0|||
164480136|NCT02609048|594129671|FG000|Overall Study|Randomized but never treated|1|||
164480137|NCT02609048|594129672|FG001|Overall Study|Randomized but never treated|1|||
164480138|NCT02609048|594129673|FG002|Overall Study|Randomized but never treated|1|||
164480139|NCT02609048|594129671|FG000|Overall Study|Withdrawal of informed consent|1|||
164480140|NCT02609048|594129672|FG001|Overall Study|Withdrawal of informed consent|0|||
164480141|NCT02609048|594129673|FG002|Overall Study|Withdrawal of informed consent|0|||
164480142|NCT02609048|594129671|FG000|Overall Study|Reason not specified|6|||
164480143|NCT02609048|594129672|FG001|Overall Study|Reason not specified|9|||
164480144|NCT02609048|594129673|FG002|Overall Study|Reason not specified|9|||
164480145|NCT04445831|594129674|FG000|Overall Study|Withdrawal by Subject|2|||
164480146|NCT04445831|594129675|FG001|Overall Study|Withdrawal by Subject|1|||
164480147|NCT04445831|594129676|FG002|Overall Study|Withdrawal by Subject|1|||
164480148|NCT04445831|594129677|FG003|Overall Study|Withdrawal by Subject|0|||
164480149|NCT04445831|594129678|FG004|Overall Study|Withdrawal by Subject|0|||
164480150|NCT04445831|594129679|FG005|Overall Study|Withdrawal by Subject|0|||
164480151|NCT04445831|594129680|FG006|Overall Study|Withdrawal by Subject|0|||
164480152|NCT04445831|594129674|FG000|Overall Study|Subject withdrawal by caregiver|0|||
164480153|NCT04445831|594129675|FG001|Overall Study|Subject withdrawal by caregiver|1|||
164480154|NCT04445831|594129676|FG002|Overall Study|Subject withdrawal by caregiver|0|||
164480155|NCT04445831|594129677|FG003|Overall Study|Subject withdrawal by caregiver|0|||
164480156|NCT04445831|594129678|FG004|Overall Study|Subject withdrawal by caregiver|0|||
164480157|NCT04445831|594129679|FG005|Overall Study|Subject withdrawal by caregiver|0|||
164480158|NCT04445831|594129680|FG006|Overall Study|Subject withdrawal by caregiver|0|||
164480159|NCT04912856|594129684|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
164480160|NCT04912856|594129685|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
164480161|NCT04912856|594129684|FG000|Overall Study|Not reported in synoptic CSR.|0|||
164480162|NCT04912856|594129685|FG001|Overall Study|Not reported in synoptic CSR.|1|||
164480163|NCT02434328|594129686|FG000|Overall Study|Adverse Event|9|||
164480164|NCT02434328|594129687|FG001|Overall Study|Adverse Event|4|||
164480165|NCT02434328|594129686|FG000|Overall Study|Lack of Efficacy|0|||
164480166|NCT02434328|594129687|FG001|Overall Study|Lack of Efficacy|2|||
164480167|NCT02434328|594129686|FG000|Overall Study|Physician Decision|0|||
164480168|NCT02434328|594129687|FG001|Overall Study|Physician Decision|1|||
164480169|NCT02434328|594129686|FG000|Overall Study|Withdrawal by Subject|12|||
164480170|NCT02434328|594129687|FG001|Overall Study|Withdrawal by Subject|21|||
164480171|NCT02434328|594129686|FG000|Overall Study|Death|4|||
164480172|NCT02434328|594129687|FG001|Overall Study|Death|7|||
164480173|NCT02434328|594129686|FG000|Overall Study|Lost to Follow-up|1|||
164480174|NCT02434328|594129687|FG001|Overall Study|Lost to Follow-up|6|||
164480175|NCT02434328|594129686|FG000|Overall Study|Other|4|||
164480176|NCT02434328|594129687|FG001|Overall Study|Other|1|||
164480177|NCT01276509|594130951|FG000|Overall Study|Adverse Event|9|||
164480178|NCT01276509|594130952|FG001|Overall Study|Adverse Event|8|||
164480179|NCT01276509|594130953|FG002|Overall Study|Adverse Event|4|||
164480180|NCT01276509|594130954|FG003|Overall Study|Adverse Event|3|||
164480181|NCT01276509|594130951|FG000|Overall Study|Lack of Efficacy|2|||
164480182|NCT01276509|594130952|FG001|Overall Study|Lack of Efficacy|1|||
164480183|NCT01276509|594130953|FG002|Overall Study|Lack of Efficacy|1|||
164480184|NCT01276509|594130954|FG003|Overall Study|Lack of Efficacy|2|||
164480185|NCT01276509|594130951|FG000|Overall Study|Pregnancy|1|||
164480186|NCT01276509|594130952|FG001|Overall Study|Pregnancy|0|||
164480187|NCT01276509|594130953|FG002|Overall Study|Pregnancy|0|||
164480188|NCT01276509|594130954|FG003|Overall Study|Pregnancy|0|||
164480189|NCT01276509|594130951|FG000|Overall Study|Withdrawal by Subject|1|||
164480190|NCT01276509|594130952|FG001|Overall Study|Withdrawal by Subject|2|||
164480191|NCT01276509|594130953|FG002|Overall Study|Withdrawal by Subject|0|||
164480192|NCT01276509|594130954|FG003|Overall Study|Withdrawal by Subject|0|||
164480193|NCT01276509|594130951|FG000|Overall Study|Other|0|||
164480194|NCT01276509|594130952|FG001|Overall Study|Other|1|||
164480195|NCT01276509|594130953|FG002|Overall Study|Other|0|||
164480196|NCT01276509|594130954|FG003|Overall Study|Other|0|||
164480197|NCT01364597|594130955|FG000|Overall Study|Adverse Event|4|||
164480198|NCT01364597|594130956|FG001|Overall Study|Adverse Event|5|||
164480199|NCT01364597|594130957|FG002|Overall Study|Adverse Event|16|||
164480200|NCT01364597|594130958|FG003|Overall Study|Adverse Event|7|||
164480201|NCT01364597|594130955|FG000|Overall Study|Lack of Efficacy|4|||
164480202|NCT01364597|594130956|FG001|Overall Study|Lack of Efficacy|4|||
164480203|NCT01364597|594130957|FG002|Overall Study|Lack of Efficacy|23|||
164480204|NCT01364597|594130958|FG003|Overall Study|Lack of Efficacy|8|||
164480205|NCT01364597|594130955|FG000|Overall Study|Protocol Violation|0|||
164480206|NCT01364597|594130956|FG001|Overall Study|Protocol Violation|0|||
164480207|NCT01364597|594130957|FG002|Overall Study|Protocol Violation|2|||
164480208|NCT01364597|594130958|FG003|Overall Study|Protocol Violation|0|||
164480209|NCT01364597|594130955|FG000|Overall Study|Lost to Follow-up|0|||
164480210|NCT01364597|594130956|FG001|Overall Study|Lost to Follow-up|0|||
164480211|NCT01364597|594130957|FG002|Overall Study|Lost to Follow-up|5|||
164480212|NCT01364597|594130958|FG003|Overall Study|Lost to Follow-up|3|||
164480213|NCT01364597|594130955|FG000|Overall Study|Withdrawal by Subject|4|||
164480214|NCT01364597|594130956|FG001|Overall Study|Withdrawal by Subject|1|||
164480215|NCT01364597|594130957|FG002|Overall Study|Withdrawal by Subject|18|||
164480216|NCT01364597|594130958|FG003|Overall Study|Withdrawal by Subject|6|||
164480217|NCT01364597|594130955|FG000|Overall Study|Non compliance|1|||
164480218|NCT01364597|594130956|FG001|Overall Study|Non compliance|0|||
164480219|NCT01364597|594130957|FG002|Overall Study|Non compliance|1|||
164480220|NCT01364597|594130958|FG003|Overall Study|Non compliance|0|||
164480221|NCT01364597|594130955|FG000|Overall Study|Lack of compliance|1|||
164600332|NCT03004469|594558175|FG002|Overall Study|Non-Compliance with Study Drug|0|||
164480222|NCT01364597|594130956|FG001|Overall Study|Lack of compliance|0|||
164480223|NCT01364597|594130957|FG002|Overall Study|Lack of compliance|0|||
164480224|NCT01364597|594130958|FG003|Overall Study|Lack of compliance|0|||
164480225|NCT01364597|594130955|FG000|Overall Study|End of treatment epilepsy|1|||
164480226|NCT01364597|594130956|FG001|Overall Study|End of treatment epilepsy|0|||
164480227|NCT01364597|594130957|FG002|Overall Study|End of treatment epilepsy|0|||
164480228|NCT01364597|594130958|FG003|Overall Study|End of treatment epilepsy|0|||
164480229|NCT01364597|594130955|FG000|Overall Study|No Seizures|1|||
164480230|NCT01364597|594130956|FG001|Overall Study|No Seizures|0|||
164480231|NCT01364597|594130957|FG002|Overall Study|No Seizures|0|||
164480232|NCT01364597|594130958|FG003|Overall Study|No Seizures|0|||
164480233|NCT01364597|594130955|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
164480234|NCT01364597|594130956|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
164480235|NCT01364597|594130957|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
164480236|NCT01364597|594130958|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
164480237|NCT01364597|594130955|FG000|Overall Study|Cure|1|||
164480238|NCT01364597|594130956|FG001|Overall Study|Cure|0|||
164480239|NCT01364597|594130957|FG002|Overall Study|Cure|0|||
164600333|NCT03004469|594558173|FG000|Overall Study|Protocol Violation|0|||
164600334|NCT03004469|594558174|FG001|Overall Study|Protocol Violation|0|||
164600335|NCT03004469|594558175|FG002|Overall Study|Protocol Violation|1|||
164600336|NCT03004469|594558173|FG000|Overall Study|Withdrawal by Subject|29|||
164600337|NCT03004469|594558174|FG001|Overall Study|Withdrawal by Subject|27|||
164600338|NCT03004469|594558175|FG002|Overall Study|Withdrawal by Subject|10|||
164600339|NCT03004469|594558173|FG000|Overall Study|Other unspecified reason|0|||
164600340|NCT03004469|594558174|FG001|Overall Study|Other unspecified reason|4|||
164480240|NCT01364597|594130958|FG003|Overall Study|Cure|0|||
164480241|NCT01364597|594130955|FG000|Overall Study|Patient was moving|0|||
164480242|NCT01364597|594130956|FG001|Overall Study|Patient was moving|1|||
164480243|NCT01364597|594130957|FG002|Overall Study|Patient was moving|0|||
164480244|NCT01364597|594130958|FG003|Overall Study|Patient was moving|0|||
164480245|NCT01364597|594130955|FG000|Overall Study|Seizures resolved|0|||
164480246|NCT01364597|594130956|FG001|Overall Study|Seizures resolved|0|||
164480247|NCT01364597|594130957|FG002|Overall Study|Seizures resolved|1|||
164480248|NCT01364597|594130958|FG003|Overall Study|Seizures resolved|0|||
164480249|NCT01364597|594130955|FG000|Overall Study|Patient became seizure-free after surgery|0|||
164480250|NCT01364597|594130956|FG001|Overall Study|Patient became seizure-free after surgery|0|||
164480251|NCT01364597|594130957|FG002|Overall Study|Patient became seizure-free after surgery|1|||
164480252|NCT01364597|594130958|FG003|Overall Study|Patient became seizure-free after surgery|0|||
164480253|NCT01364597|594130955|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
164480254|NCT01364597|594130956|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
164480255|NCT01364597|594130957|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
164480256|NCT01364597|594130958|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
164480257|NCT01364597|594130955|FG000|Overall Study|Patient cured from Epilepsy|0|||
164480258|NCT01364597|594130956|FG001|Overall Study|Patient cured from Epilepsy|0|||
164480259|NCT01364597|594130957|FG002|Overall Study|Patient cured from Epilepsy|1|||
164480260|NCT01364597|594130958|FG003|Overall Study|Patient cured from Epilepsy|0|||
164480261|NCT01364597|594130955|FG000|Overall Study|Investigator decision|0|||
164480262|NCT01364597|594130956|FG001|Overall Study|Investigator decision|0|||
164480263|NCT01364597|594130957|FG002|Overall Study|Investigator decision|1|||
164480264|NCT01364597|594130958|FG003|Overall Study|Investigator decision|0|||
164480265|NCT01364597|594130955|FG000|Overall Study|Sponsor recommended discontinuation|0|||
164480266|NCT01364597|594130956|FG001|Overall Study|Sponsor recommended discontinuation|0|||
164480267|NCT01364597|594130957|FG002|Overall Study|Sponsor recommended discontinuation|0|||
164480268|NCT01364597|594130958|FG003|Overall Study|Sponsor recommended discontinuation|1|||
164480269|NCT01364597|594130955|FG000|Overall Study|Parents went abroad with the patient|0|||
164480270|NCT01364597|594130956|FG001|Overall Study|Parents went abroad with the patient|0|||
164480271|NCT01364597|594130957|FG002|Overall Study|Parents went abroad with the patient|1|||
164480272|NCT01364597|594130958|FG003|Overall Study|Parents went abroad with the patient|0|||
164480273|NCT01364597|594130955|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
164480274|NCT01364597|594130956|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
164480275|NCT01364597|594130957|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
164480276|NCT01364597|594130958|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
164480277|NCT01364597|594130955|FG000|Overall Study|BRV administration dropout|0|||
164480278|NCT01364597|594130956|FG001|Overall Study|BRV administration dropout|0|||
164480279|NCT01364597|594130957|FG002|Overall Study|BRV administration dropout|1|||
164480280|NCT01364597|594130958|FG003|Overall Study|BRV administration dropout|0|||
164480281|NCT01364597|594130955|FG000|Overall Study|Dropout|0|||
164480282|NCT01364597|594130956|FG001|Overall Study|Dropout|0|||
164480283|NCT01364597|594130957|FG002|Overall Study|Dropout|3|||
164480284|NCT01364597|594130958|FG003|Overall Study|Dropout|1|||
164480285|NCT01364597|594130955|FG000|Overall Study|Unreliable subject|0|||
164480286|NCT01364597|594130956|FG001|Overall Study|Unreliable subject|0|||
164480287|NCT01364597|594130957|FG002|Overall Study|Unreliable subject|0|||
164480288|NCT01364597|594130958|FG003|Overall Study|Unreliable subject|1|||
164480289|NCT01364597|594130955|FG000|Overall Study|Other|0|||
164480290|NCT01364597|594130956|FG001|Overall Study|Other|0|||
164480291|NCT01364597|594130957|FG002|Overall Study|Other|0|||
164480292|NCT01364597|594130958|FG003|Overall Study|Other|1|||
164480293|NCT02962284|594130959|FG000|Overall Study|Death|2|||
164480294|NCT02962284|594130960|FG001|Overall Study|Death|0|||
164480295|NCT02962284|594130959|FG000|Overall Study|Progressive disease|2|||
164714330|NCT01590797|594976864|FG000|Overall Study|Adverse Event|4|||
164480296|NCT02962284|594130960|FG001|Overall Study|Progressive disease|3|||
164714331|NCT01590797|594976865|FG001|Overall Study|Adverse Event|3|||
164714332|NCT01590797|594976864|FG000|Overall Study|Lack of Efficacy|0|||
164714333|NCT01590797|594976865|FG001|Overall Study|Lack of Efficacy|2|||
164480297|NCT02962284|594130959|FG000|Overall Study|Withdrawal by Subject|1|||
164480298|NCT02962284|594130960|FG001|Overall Study|Withdrawal by Subject|0|||
164480299|NCT03493282|594130961|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
164480300|NCT03493282|594130962|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
164600341|NCT03004469|594558175|FG002|Overall Study|Other unspecified reason|1|||
164714334|NCT01590797|594976864|FG000|Overall Study|Lost to Follow-up|0|||
164714335|NCT01590797|594976865|FG001|Overall Study|Lost to Follow-up|1|||
164480301|NCT03493282|594130963|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
164480302|NCT03493282|594130961|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
164480303|NCT03493282|594130962|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
164480304|NCT03493282|594130963|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
164480305|NCT00667017|594130968|FG000|Overall Study|Withdrawal by Subject|1|||
164480306|NCT01532648|594130975|FG000|Overall Study|Lost to Follow-up|3|||
164480307|NCT01532648|594130976|FG001|Overall Study|Lost to Follow-up|4|||
164480308|NCT01532648|594130975|FG000|Overall Study|Lack of Efficacy|4|||
164480309|NCT01532648|594130976|FG001|Overall Study|Lack of Efficacy|1|||
164480310|NCT01532648|594130975|FG000|Overall Study|Protocol Violation|1|||
164480311|NCT01532648|594130976|FG001|Overall Study|Protocol Violation|1|||
164480312|NCT01532648|594130975|FG000|Overall Study|Adverse Event|12|||
164480313|NCT01532648|594130976|FG001|Overall Study|Adverse Event|9|||
164480314|NCT01532648|594130975|FG000|Overall Study|Withdrawal by Subject|16|||
164480315|NCT01532648|594130976|FG001|Overall Study|Withdrawal by Subject|2|||
164480316|NCT02310581|594130977|FG000|Overall Study|Adverse Event|1|||
164480317|NCT02310581|594130978|FG001|Overall Study|Adverse Event|1|||
164480318|NCT02310581|594130979|FG002|Overall Study|Adverse Event|1|||
164480319|NCT02310581|594130980|FG003|Overall Study|Adverse Event|0|||
164480320|NCT02310581|594130977|FG000|Overall Study|Withdrawal by Subject|2|||
164480321|NCT02310581|594130978|FG001|Overall Study|Withdrawal by Subject|1|||
164480322|NCT02310581|594130979|FG002|Overall Study|Withdrawal by Subject|0|||
164480323|NCT02310581|594130980|FG003|Overall Study|Withdrawal by Subject|1|||
164480324|NCT00887224|594130981|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
164480325|NCT00887224|594130982|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
164480326|NCT00887224|594130983|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
164480327|NCT00887224|594130981|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
164480328|NCT00887224|594130982|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
164480329|NCT00887224|594130983|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
164480330|NCT00887224|594130981|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
164480331|NCT00887224|594130982|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
164480332|NCT00887224|594130983|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
164480333|NCT00887224|594130981|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
164480334|NCT00887224|594130982|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
164480335|NCT00887224|594130983|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
164480336|NCT00887224|594130981|FG000|Open-label Response (OLR) Phase|Other|1|||
164480337|NCT00887224|594130982|FG001|Open-label Response (OLR) Phase|Other|0|||
164480338|NCT00887224|594130983|FG002|Open-label Response (OLR) Phase|Other|0|||
164480339|NCT00887224|594130981|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
164480340|NCT00887224|594130982|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
164480341|NCT00887224|594130983|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
164480342|NCT00887224|594130981|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
164480343|NCT00887224|594130982|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
164480344|NCT00887224|594130983|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
164480345|NCT00887224|594130981|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
164480346|NCT00887224|594130982|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
164480347|NCT00887224|594130983|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
164480348|NCT00887224|594130981|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
164480349|NCT00887224|594130982|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
164480350|NCT00887224|594130983|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
164480351|NCT00887224|594130981|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
164480352|NCT00887224|594130982|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
164480353|NCT00887224|594130983|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
164480354|NCT00887224|594130981|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
164480355|NCT00887224|594130982|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
164480356|NCT00887224|594130983|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
164480357|NCT00887224|594130981|FG000|Open-label Stability (OLS) Phase|Other|1|||
164480358|NCT00887224|594130982|FG001|Open-label Stability (OLS) Phase|Other|0|||
164480359|NCT00887224|594130983|FG002|Open-label Stability (OLS) Phase|Other|0|||
164480360|NCT00887224|594130981|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
164480361|NCT00887224|594130982|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
164480362|NCT00887224|594130983|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
164480363|NCT00887224|594130981|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
164480364|NCT00887224|594130982|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
164480365|NCT00887224|594130983|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
164480366|NCT00887224|594130981|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
164480367|NCT00887224|594130982|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
164714336|NCT01590797|594976864|FG000|Overall Study|Protocol Violation|4|||
164714337|NCT01590797|594976865|FG001|Overall Study|Protocol Violation|1|||
164714338|NCT01590797|594976864|FG000|Overall Study|Withdrawal by Subject|7|||
164714339|NCT01590797|594976865|FG001|Overall Study|Withdrawal by Subject|5|||
164480368|NCT00887224|594130983|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
164480369|NCT00887224|594130981|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
164480370|NCT00887224|594130982|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
164480371|NCT00887224|594130983|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
164480372|NCT00887224|594130981|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
164480373|NCT00887224|594130982|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
164480374|NCT00887224|594130983|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
164480375|NCT00887224|594130981|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
164480376|NCT00887224|594130982|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
164480377|NCT00887224|594130983|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
164480378|NCT00887224|594130981|FG000|OL Taper Phase / OL Follow Up|Other|30|||
164480379|NCT00887224|594130982|FG001|OL Taper Phase / OL Follow Up|Other|0|||
164480380|NCT00887224|594130983|FG002|OL Taper Phase / OL Follow Up|Other|0|||
164480381|NCT00887224|594130981|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
164480382|NCT00887224|594130982|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
164480383|NCT00887224|594130983|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
164480384|NCT00887224|594130981|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
164480385|NCT00887224|594130982|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
164480386|NCT00887224|594130983|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
164480387|NCT00887224|594130981|FG000|Double-blind (DB) Phase|Adverse Event|0|||
164480388|NCT00887224|594130982|FG001|Double-blind (DB) Phase|Adverse Event|7|||
164480389|NCT00887224|594130983|FG002|Double-blind (DB) Phase|Adverse Event|2|||
164480390|NCT00887224|594130981|FG000|Double-blind (DB) Phase|Failed to return|0|||
164480391|NCT00887224|594130982|FG001|Double-blind (DB) Phase|Failed to return|2|||
164480392|NCT00887224|594130983|FG002|Double-blind (DB) Phase|Failed to return|2|||
164480393|NCT00887224|594130981|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
164480394|NCT00887224|594130982|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
164480395|NCT00887224|594130983|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
164480396|NCT00887224|594130981|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
164480397|NCT00887224|594130982|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
164480398|NCT00887224|594130983|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
164480399|NCT00887224|594130981|FG000|Double-blind (DB) Phase|Other|0|||
164480400|NCT00887224|594130982|FG001|Double-blind (DB) Phase|Other|2|||
164480401|NCT00887224|594130983|FG002|Double-blind (DB) Phase|Other|0|||
164480402|NCT00887224|594130981|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
164480403|NCT00887224|594130982|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
164480404|NCT00887224|594130983|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
164480405|NCT00887224|594130981|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
164480406|NCT00887224|594130982|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
164480407|NCT00887224|594130983|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
164480408|NCT00887224|594130981|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
164480409|NCT00887224|594130982|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
164480410|NCT00887224|594130983|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
164480411|NCT00887224|594130981|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
164480412|NCT00887224|594130982|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
164480413|NCT00887224|594130983|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
164480414|NCT00887224|594130981|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
164480415|NCT00887224|594130982|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
164480416|NCT00887224|594130983|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
164480417|NCT00887224|594130981|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
164480418|NCT00887224|594130982|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
164480419|NCT00887224|594130983|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
164480420|NCT00887224|594130981|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
164480421|NCT00887224|594130982|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
164480422|NCT00887224|594130983|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
164480423|NCT00887224|594130981|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
164480424|NCT00887224|594130982|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
164480425|NCT00887224|594130983|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
164480426|NCT00887224|594130981|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
164480427|NCT00887224|594130982|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
164480428|NCT00887224|594130983|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
164480429|NCT01353274|594130984|FG000|Overall Study|No case report form (CRF) collected|28|||
164480430|NCT00022672|594130986|FG000|Main Phase: 24 Months|Adverse Event|6|||
164480431|NCT00022672|594130987|FG001|Main Phase: 24 Months|Adverse Event|0|||
164480432|NCT00022672|594130986|FG000|Main Phase: 24 Months|Death|0|||
164480433|NCT00022672|594130987|FG001|Main Phase: 24 Months|Death|3|||
164480434|NCT00022672|594130986|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
164480435|NCT00022672|594130987|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
164480436|NCT00022672|594130986|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
164480437|NCT00022672|594130987|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
164600342|NCT00423735|594558176|FG000|Overall Study|Ineligible / No protocol treatment|8|||
164600343|NCT00423735|594558177|FG001|Overall Study|Ineligible / No protocol treatment|6|||
164600344|NCT00423735|594558178|FG002|Overall Study|Ineligible / No protocol treatment|0|||
164600345|NCT00579501|594558179|FG000|Overall Study|Death|1|||
164600346|NCT00579501|594558179|FG000|Overall Study|End of neoadjuvant therapy|25|||
164600347|NCT00579501|594558179|FG000|Overall Study|toxicity|1|||
164600348|NCT00579501|594558179|FG000|Overall Study|Secondary lesion|1|||
164600349|NCT00579501|594558179|FG000|Overall Study|Radiation therapy before surgery|1|||
164600350|NCT00190983|594558180|FG000|Overall Study|Inevaluable (never treated)|2|||
164600351|NCT02287402|594558181|FG000|Treatment Period|Adverse Event|17|||
164600352|NCT02287402|594558181|FG000|Treatment Period|Voluntary Withdrawal|10|||
164600353|NCT02287402|594558181|FG000|Follow-up|Lost to Follow-up|1|||
164600354|NCT02287402|594558181|FG000|Follow-up|Voluntary Withdrawal|2|||
164600355|NCT02394808|594558182|FG000|Period 1|Unsatisfactory lens fitting|0|||
164600356|NCT02394808|594558183|FG001|Period 1|Unsatisfactory lens fitting|1|||
164600357|NCT02394808|594558182|FG000|Period 2|Lost to Follow-up|1|||
164600358|NCT02394808|594558183|FG001|Period 2|Lost to Follow-up|0|||
164600359|NCT03150095|594558187|FG000|Overall Study|Death|0|||
164600360|NCT03150095|594558188|FG001|Overall Study|Death|1|||
164600361|NCT03150095|594558187|FG000|Overall Study|Lost to Follow-up|1|||
164600362|NCT03150095|594558188|FG001|Overall Study|Lost to Follow-up|1|||
164600363|NCT03150095|594558187|FG000|Overall Study|Withdrawal by Subject|4|||
164600364|NCT03150095|594558188|FG001|Overall Study|Withdrawal by Subject|0|||
164600365|NCT03150095|594558187|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
164600366|NCT03150095|594558188|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
164600367|NCT03943953|594558197|FG000|Trial of ITG 1|Lost to Follow-up|19|||
164600368|NCT03943953|594558198|FG001|Trial of ITG 1|Lost to Follow-up|1|||
164600369|NCT03943953|594558197|FG000|Trial of ITG 2|Lost to Follow-up|8|||
164600370|NCT03943953|594558198|FG001|Trial of ITG 2|Lost to Follow-up|0|||
164600371|NCT03943953|594558197|FG000|Trial of ITG 3|Lost to Follow-up|2|||
164600372|NCT03943953|594558198|FG001|Trial of ITG 3|Lost to Follow-up|0|||
164600373|NCT03943953|594558197|FG000|Trial of ITG 4|Lost to Follow-up|2|||
164600374|NCT03943953|594558198|FG001|Trial of ITG 4|Lost to Follow-up|0|||
164600375|NCT00289185|594558201|FG000|Overall Study|Withdrawal by Subject|4|||
164600376|NCT00289185|594558202|FG001|Overall Study|Withdrawal by Subject|8|||
164480438|NCT00022672|594130986|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
164480439|NCT00022672|594130987|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
164480440|NCT00022672|594130986|FG000|Main Phase: 24 Months|Refused Treatment|3|||
164480441|NCT00022672|594130987|FG001|Main Phase: 24 Months|Refused Treatment|4|||
164480442|NCT00022672|594130986|FG000|Main Phase: 24 Months|Failure to Return|1|||
164480443|NCT00022672|594130987|FG001|Main Phase: 24 Months|Failure to Return|1|||
164480444|NCT00022672|594130986|FG000|Main Phase: 24 Months|Other|1|||
164480445|NCT00022672|594130987|FG001|Main Phase: 24 Months|Other|0|||
164480446|NCT00022672|594130986|FG000|Extension Phase|Adverse Event|1|||
164480447|NCT00022672|594130987|FG001|Extension Phase|Adverse Event|3|||
164480448|NCT00022672|594130986|FG000|Extension Phase|Death|0|||
164480449|NCT00022672|594130987|FG001|Extension Phase|Death|1|||
164480450|NCT00022672|594130986|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
164480451|NCT00022672|594130987|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
164480452|NCT00022672|594130986|FG000|Extension Phase|Refused Treatment|0|||
164480453|NCT00022672|594130987|FG001|Extension Phase|Refused Treatment|2|||
164480454|NCT00022672|594130986|FG000|Extension Phase|Other|1|||
164480455|NCT00022672|594130987|FG001|Extension Phase|Other|1|||
164600377|NCT00289185|594558201|FG000|Overall Study|Lost to Follow-up|23|||
164600378|NCT00289185|594558202|FG001|Overall Study|Lost to Follow-up|17|||
164600379|NCT00289185|594558201|FG000|Overall Study|Death|1|||
164600380|NCT00289185|594558202|FG001|Overall Study|Death|1|||
164600381|NCT01742078|594558203|FG000|Overall Study|Withdrawal by Subject|0|||
164480456|NCT00403494|594130988|FG000|Overall Study|Adverse Event|10|||
164480457|NCT00403494|594130989|FG001|Overall Study|Adverse Event|8|||
164600382|NCT01742078|594558204|FG001|Overall Study|Withdrawal by Subject|0|||
164600383|NCT01742078|594558205|FG002|Overall Study|Withdrawal by Subject|0|||
164600384|NCT01742078|594558206|FG003|Overall Study|Withdrawal by Subject|1|||
164600385|NCT01742078|594558207|FG004|Overall Study|Withdrawal by Subject|0|||
164480458|NCT00403494|594130988|FG000|Overall Study|Withdrew Consent|3|||
164600386|NCT01742078|594558208|FG005|Overall Study|Withdrawal by Subject|0|||
164600387|NCT01742078|594558209|FG006|Overall Study|Withdrawal by Subject|0|||
164600388|NCT01742078|594558210|FG007|Overall Study|Withdrawal by Subject|0|||
164600389|NCT01742078|594558211|FG008|Overall Study|Withdrawal by Subject|0|||
164600390|NCT03471767|594558214|FG000|Overall Study|Withdrawal by Subject|3|||
164600391|NCT03471767|594558215|FG001|Overall Study|Withdrawal by Subject|1|||
164600392|NCT03471767|594558214|FG000|Overall Study|Adverse Event|1|||
164480459|NCT00403494|594130989|FG001|Overall Study|Withdrew Consent|2|||
164480460|NCT00403494|594130988|FG000|Overall Study|Inappropriately enrolled|0|||
164480461|NCT00403494|594130989|FG001|Overall Study|Inappropriately enrolled|1|||
164480462|NCT00403494|594130988|FG000|Overall Study|Lost to Follow-up|0|||
164480463|NCT00403494|594130989|FG001|Overall Study|Lost to Follow-up|2|||
164600393|NCT03471767|594558215|FG001|Overall Study|Adverse Event|0|||
164480464|NCT00403494|594130988|FG000|Overall Study|Protocol noncompliance|0|||
164480465|NCT00403494|594130989|FG001|Overall Study|Protocol noncompliance|1|||
164480466|NCT00403494|594130988|FG000|Overall Study|Death|1|||
164480467|NCT00403494|594130989|FG001|Overall Study|Death|0|||
164480468|NCT00403494|594130988|FG000|Overall Study|Sponsor Request|1|||
164480469|NCT00403494|594130989|FG001|Overall Study|Sponsor Request|0|||
164480470|NCT05005247|594130990|FG000|Overall Study|Withdrawal by Subject|0|||
164480471|NCT05005247|594130991|FG001|Overall Study|Withdrawal by Subject|1|||
164480472|NCT05005247|594130992|FG002|Overall Study|Withdrawal by Subject|0|||
164480473|NCT03648541|594130993|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
164480474|NCT03648541|594130994|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
164480475|NCT03648541|594130993|FG000|Re-induction Period Only|Lack of Efficacy|7|||
164480476|NCT03648541|594130994|FG001|Re-induction Period Only|Lack of Efficacy|0|||
164480477|NCT03648541|594130993|FG000|Maintenance Period Only|Missing|0|||
164480478|NCT03648541|594130994|FG001|Maintenance Period Only|Missing|1|||
164480479|NCT03648541|594130993|FG000|Maintenance Period Only|Other not listed below|0|||
164480480|NCT03648541|594130994|FG001|Maintenance Period Only|Other not listed below|4|||
164480481|NCT03648541|594130993|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
164480482|NCT03648541|594130994|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
164480483|NCT03648541|594130993|FG000|Maintenance Period Only|Protocol Violation|0|||
164480484|NCT03648541|594130994|FG001|Maintenance Period Only|Protocol Violation|1|||
164480485|NCT03648541|594130993|FG000|Maintenance Period Only|Lack of Efficacy|0|||
164480486|NCT03648541|594130994|FG001|Maintenance Period Only|Lack of Efficacy|18|||
164480487|NCT03648541|594130993|FG000|Maintenance Period Only|Adverse Event|0|||
164480488|NCT03648541|594130994|FG001|Maintenance Period Only|Adverse Event|4|||
164480489|NCT03648541|594130993|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
164480490|NCT03648541|594130994|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
164480491|NCT03042767|594130999|FG000|Overall Study|Lost to Follow-up|1|||
164480492|NCT03042767|594131000|FG001|Overall Study|Lost to Follow-up|2|||
164480493|NCT01543204|594131002|FG000|Overall Study|Non-compliance|1|||
164480494|NCT01543204|594131002|FG000|Overall Study|Adverse Event|1|||
164480495|NCT01543204|594131002|FG000|Overall Study|Withdrawal by Subject|4|||
164480496|NCT01543204|594131002|FG000|Overall Study|Requirement for Alternative Therapy|1|||
164480497|NCT01543204|594131002|FG000|Overall Study|Lost to Follow-up|1|||
164480498|NCT04638816|594131003|FG000|Overall Study|Withdrawal by Subject|0|||
164480499|NCT04638816|594131004|FG001|Overall Study|Withdrawal by Subject|1|||
164480500|NCT04638816|594131003|FG000|Overall Study|Lost to Follow-up|0|||
164480501|NCT04638816|594131004|FG001|Overall Study|Lost to Follow-up|1|||
164480502|NCT01074242|594131007|FG000|Overall Study|Case report before date of contract|40|||
164480503|NCT01074242|594131007|FG000|Overall Study|Lost to Follow-up|1|||
164480504|NCT01074242|594131007|FG000|Overall Study|Case report unclear|6|||
164480505|NCT01074242|594131007|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
164480506|NCT01074242|594131007|FG000|Overall Study|Duplicate Case Report Form|5|||
164480507|NCT01328496|594131008|FG000|Overall Study|Significant Change in Health Status|1|||
164480508|NCT01328496|594131009|FG001|Overall Study|Significant Change in Health Status|0|||
164480509|NCT01668719|594131016|FG000|Phase I|On treatment|1|||
164480510|NCT01668719|594131017|FG001|Phase I|On treatment|0|||
164480511|NCT01668719|594131018|FG002|Phase I|On treatment|0|||
164480512|NCT01668719|594131016|FG000|Phase I|Adverse Event|2|||
164480513|NCT01668719|594131017|FG001|Phase I|Adverse Event|0|||
164480514|NCT01668719|594131018|FG002|Phase I|Adverse Event|0|||
164480515|NCT01668719|594131016|FG000|Phase I|Progression/relapse|1|||
164480516|NCT01668719|594131017|FG001|Phase I|Progression/relapse|0|||
164480517|NCT01668719|594131018|FG002|Phase I|Progression/relapse|0|||
164480518|NCT01668719|594131016|FG000|Phase I|not protocol specified|2|||
164480519|NCT01668719|594131017|FG001|Phase I|not protocol specified|0|||
164480520|NCT01668719|594131018|FG002|Phase I|not protocol specified|0|||
164480521|NCT01668719|594131016|FG000|Phase II|On treatment|0|||
164480522|NCT01668719|594131017|FG001|Phase II|On treatment|4|||
164480523|NCT01668719|594131018|FG002|Phase II|On treatment|3|||
164480524|NCT01668719|594131016|FG000|Phase II|Adverse Event|0|||
164480525|NCT01668719|594131017|FG001|Phase II|Adverse Event|18|||
164480526|NCT01668719|594131018|FG002|Phase II|Adverse Event|18|||
164480527|NCT01668719|594131016|FG000|Phase II|Refusal unrelated to adverse event|0|||
164480528|NCT01668719|594131017|FG001|Phase II|Refusal unrelated to adverse event|4|||
164480529|NCT01668719|594131018|FG002|Phase II|Refusal unrelated to adverse event|1|||
164480530|NCT01668719|594131016|FG000|Phase II|Progression/relapse|0|||
164480531|NCT01668719|594131017|FG001|Phase II|Progression/relapse|13|||
164480532|NCT01668719|594131018|FG002|Phase II|Progression/relapse|17|||
164480533|NCT01668719|594131016|FG000|Phase II|Death|0|||
164480534|NCT01668719|594131017|FG001|Phase II|Death|0|||
164480535|NCT01668719|594131018|FG002|Phase II|Death|2|||
164480536|NCT01668719|594131016|FG000|Phase II|not protocol specified|0|||
164480537|NCT01668719|594131017|FG001|Phase II|not protocol specified|13|||
164480538|NCT01668719|594131018|FG002|Phase II|not protocol specified|7|||
164480539|NCT01321073|594131020|FG000|Overall Study|Did not attempt implant|4|||
164480540|NCT01321073|594131020|FG000|Overall Study|Death|3|||
164480541|NCT01638000|594131021|FG000|Overall Study|Randomized but Never Received Drug|7|||
164480542|NCT01638000|594131022|FG001|Overall Study|Randomized but Never Received Drug|10|||
164480543|NCT01638000|594131021|FG000|Overall Study|Adverse Event|14|||
164480544|NCT01638000|594131022|FG001|Overall Study|Adverse Event|16|||
164480545|NCT01638000|594131021|FG000|Overall Study|Lack of Efficacy|5|||
164480546|NCT01638000|594131022|FG001|Overall Study|Lack of Efficacy|6|||
164480547|NCT01638000|594131021|FG000|Overall Study|Protocol Violation|11|||
164480548|NCT01638000|594131022|FG001|Overall Study|Protocol Violation|13|||
164480549|NCT01638000|594131021|FG000|Overall Study|Withdrawal by Subject|21|||
164480550|NCT01638000|594131022|FG001|Overall Study|Withdrawal by Subject|24|||
164480551|NCT01638000|594131021|FG000|Overall Study|Miscellaneous|2|||
164480552|NCT01638000|594131022|FG001|Overall Study|Miscellaneous|2|||
164480553|NCT04248803|594131023|FG000|Overall Study|Lost to Follow-up|7|||
164480554|NCT04248803|594131024|FG001|Overall Study|Lost to Follow-up|7|||
164480555|NCT04248803|594131025|FG002|Overall Study|Lost to Follow-up|7|||
164480556|NCT04248803|594131026|FG003|Overall Study|Lost to Follow-up|7|||
164480557|NCT04248803|594131027|FG004|Overall Study|Lost to Follow-up|7|||
164480558|NCT04248803|594131028|FG005|Overall Study|Lost to Follow-up|7|||
164480559|NCT02686658|594131029|FG000|Overall Study|Adverse Event|0|||
164480560|NCT02686658|594131030|FG001|Overall Study|Adverse Event|0|||
164480561|NCT02686658|594131031|FG002|Overall Study|Adverse Event|1|||
164480562|NCT02686658|594131032|FG003|Overall Study|Adverse Event|1|||
164480563|NCT02686658|594131033|FG004|Overall Study|Adverse Event|2|||
164480564|NCT02686658|594131034|FG005|Overall Study|Adverse Event|1|||
164480565|NCT02686658|594131029|FG000|Overall Study|Investigator decision|0|||
164480566|NCT02686658|594131030|FG001|Overall Study|Investigator decision|0|||
164480567|NCT02686658|594131031|FG002|Overall Study|Investigator decision|0|||
164480568|NCT02686658|594131032|FG003|Overall Study|Investigator decision|1|||
164480569|NCT02686658|594131033|FG004|Overall Study|Investigator decision|2|||
164480570|NCT02686658|594131034|FG005|Overall Study|Investigator decision|1|||
164480571|NCT02686658|594131029|FG000|Overall Study|Sponsor decision|1|||
164480572|NCT02686658|594131030|FG001|Overall Study|Sponsor decision|2|||
164480573|NCT02686658|594131031|FG002|Overall Study|Sponsor decision|1|||
164480574|NCT02686658|594131032|FG003|Overall Study|Sponsor decision|5|||
164480575|NCT02686658|594131033|FG004|Overall Study|Sponsor decision|13|||
164480576|NCT02686658|594131034|FG005|Overall Study|Sponsor decision|2|||
164480577|NCT02686658|594131029|FG000|Overall Study|Lost to Follow-up|0|||
164480578|NCT02686658|594131030|FG001|Overall Study|Lost to Follow-up|0|||
164480579|NCT02686658|594131031|FG002|Overall Study|Lost to Follow-up|2|||
164480580|NCT02686658|594131032|FG003|Overall Study|Lost to Follow-up|0|||
164480581|NCT02686658|594131033|FG004|Overall Study|Lost to Follow-up|0|||
164480582|NCT02686658|594131034|FG005|Overall Study|Lost to Follow-up|1|||
164480583|NCT02686658|594131029|FG000|Overall Study|Death|1|||
164480584|NCT02686658|594131030|FG001|Overall Study|Death|0|||
164480585|NCT02686658|594131031|FG002|Overall Study|Death|0|||
164480586|NCT02686658|594131032|FG003|Overall Study|Death|1|||
164480587|NCT02686658|594131033|FG004|Overall Study|Death|1|||
164480588|NCT02686658|594131034|FG005|Overall Study|Death|1|||
164480589|NCT02686658|594131029|FG000|Overall Study|Withdrawal by Subject|2|||
164480590|NCT02686658|594131030|FG001|Overall Study|Withdrawal by Subject|5|||
164480591|NCT02686658|594131031|FG002|Overall Study|Withdrawal by Subject|4|||
164480592|NCT02686658|594131032|FG003|Overall Study|Withdrawal by Subject|4|||
164480593|NCT02686658|594131033|FG004|Overall Study|Withdrawal by Subject|17|||
164480594|NCT02686658|594131034|FG005|Overall Study|Withdrawal by Subject|8|||
164480595|NCT02686658|594131029|FG000|Overall Study|Placed in hospice care|0|||
164480596|NCT02686658|594131030|FG001|Overall Study|Placed in hospice care|0|||
164480597|NCT02686658|594131031|FG002|Overall Study|Placed in hospice care|1|||
164480598|NCT02686658|594131032|FG003|Overall Study|Placed in hospice care|0|||
164480599|NCT02686658|594131033|FG004|Overall Study|Placed in hospice care|0|||
164480600|NCT02686658|594131034|FG005|Overall Study|Placed in hospice care|0|||
164480601|NCT02686658|594131029|FG000|Overall Study|Participant non-compliance|0|||
164480602|NCT02686658|594131030|FG001|Overall Study|Participant non-compliance|0|||
164480603|NCT02686658|594131031|FG002|Overall Study|Participant non-compliance|0|||
164480604|NCT02686658|594131032|FG003|Overall Study|Participant non-compliance|0|||
164480605|NCT02686658|594131033|FG004|Overall Study|Participant non-compliance|0|||
164480606|NCT02686658|594131034|FG005|Overall Study|Participant non-compliance|1|||
164480607|NCT02686658|594131029|FG000|Overall Study|Concern over coronavirus disease care|0|||
164480608|NCT02686658|594131030|FG001|Overall Study|Concern over coronavirus disease care|0|||
164480609|NCT02686658|594131031|FG002|Overall Study|Concern over coronavirus disease care|0|||
164480610|NCT02686658|594131032|FG003|Overall Study|Concern over coronavirus disease care|0|||
164480611|NCT02686658|594131033|FG004|Overall Study|Concern over coronavirus disease care|2|||
164480612|NCT02686658|594131034|FG005|Overall Study|Concern over coronavirus disease care|1|||
164480613|NCT02309294|594131037|FG000|Overall Study|Withdrawal by Subject|2|||
164480614|NCT01227421|594131038|FG000|Overall Study|Lost to Follow-up|6|||
164480615|NCT01227421|594131039|FG001|Overall Study|Lost to Follow-up|7|||
164480616|NCT01227421|594131040|FG002|Overall Study|Lost to Follow-up|5|||
164600394|NCT03471767|594558214|FG000|Overall Study|Lost to Follow-up|1|||
164480617|NCT01227421|594131038|FG000|Overall Study|Adverse Event|2|||
164480618|NCT01227421|594131039|FG001|Overall Study|Adverse Event|7|||
164480619|NCT01227421|594131040|FG002|Overall Study|Adverse Event|2|||
164480620|NCT01227421|594131038|FG000|Overall Study|Withdrawal by Subject|1|||
164480621|NCT01227421|594131039|FG001|Overall Study|Withdrawal by Subject|2|||
164480622|NCT01227421|594131040|FG002|Overall Study|Withdrawal by Subject|1|||
164480623|NCT01227421|594131038|FG000|Overall Study|Protocol Violation|1|||
164480624|NCT01227421|594131039|FG001|Overall Study|Protocol Violation|1|||
164480625|NCT01227421|594131040|FG002|Overall Study|Protocol Violation|2|||
164480626|NCT01227421|594131038|FG000|Overall Study|Randomized in error|1|||
164480627|NCT01227421|594131039|FG001|Overall Study|Randomized in error|1|||
164480628|NCT01227421|594131040|FG002|Overall Study|Randomized in error|0|||
164480629|NCT01000805|594131046|FG000|Overall Study|Adverse Event|21|||
164480630|NCT01000805|594131047|FG001|Overall Study|Adverse Event|9|||
164480631|NCT01000805|594131046|FG000|Overall Study|Lack of Efficacy|5|||
164480632|NCT01000805|594131047|FG001|Overall Study|Lack of Efficacy|16|||
164480633|NCT01000805|594131046|FG000|Overall Study|Lost to Follow-up|16|||
164480634|NCT01000805|594131047|FG001|Overall Study|Lost to Follow-up|21|||
164480635|NCT01000805|594131046|FG000|Overall Study|Physician Decision|0|||
164480636|NCT01000805|594131047|FG001|Overall Study|Physician Decision|1|||
164480637|NCT01000805|594131046|FG000|Overall Study|Protocol Violation|12|||
164480638|NCT01000805|594131047|FG001|Overall Study|Protocol Violation|8|||
164480639|NCT01000805|594131046|FG000|Overall Study|Withdrawal by Subject|16|||
164480640|NCT01000805|594131047|FG001|Overall Study|Withdrawal by Subject|6|||
164480641|NCT01000805|594131046|FG000|Overall Study|Sponsor Decision|0|||
164480642|NCT01000805|594131047|FG001|Overall Study|Sponsor Decision|1|||
164480643|NCT03476798|594131049|FG000|Overall Study|Death|1|||
164480644|NCT03476798|594131049|FG000|Overall Study|Withdrawal by Subject|2|||
164480645|NCT03476798|594131049|FG000|Overall Study|Protocol Violation|2|||
164480646|NCT06269003|594131050|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
164480647|NCT06269003|594131051|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
164480648|NCT06269003|594131052|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
164480649|NCT06269003|594131053|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
164480650|NCT03343704|594131059|FG000|Overall Study|Refused to complete follow up|0|||
164480651|NCT03343704|594131060|FG001|Overall Study|Refused to complete follow up|1|||
164480652|NCT03343704|594131059|FG000|Overall Study|Death|0|||
164480653|NCT03343704|594131060|FG001|Overall Study|Death|1|||
164480654|NCT03343704|594131059|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
164480655|NCT03343704|594131060|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
164480656|NCT02969356|594131062|FG000|Overall Study|Adverse Event|7|||
164480657|NCT02969356|594131062|FG000|Overall Study|Consent withdrawn|2|||
164480658|NCT02969356|594131062|FG000|Overall Study|Lost to Follow-up|3|||
164480659|NCT02969356|594131062|FG000|Overall Study|Did not need to be reinjected|6|||
164480660|NCT02969356|594131062|FG000|Overall Study|Personal reasons|5|||
164480661|NCT05432986|594131073|FG000|Overall Study|Withdrawal by Subject|2|||
164480662|NCT05432986|594131073|FG000|Overall Study|incomplete measurement|7|||
164480663|NCT02830893|594132490|FG000|Overall Study|Relocation to out of the country|1|||
164480664|NCT02830893|594132491|FG001|Overall Study|Relocation to out of the country|0|||
164480665|NCT02830893|594132490|FG000|Overall Study|Lost to Follow-up|0|||
164480666|NCT02830893|594132491|FG001|Overall Study|Lost to Follow-up|2|||
164480667|NCT02830893|594132490|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
164480668|NCT02830893|594132491|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
164480669|NCT01277302|594132492|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
164480670|NCT01277302|594132493|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
164480671|NCT01277302|594132494|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
164480672|NCT01277302|594132492|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
164480673|NCT01277302|594132493|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
164480674|NCT01277302|594132494|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
164480675|NCT01277302|594132492|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
164480676|NCT01277302|594132493|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
164480677|NCT01277302|594132494|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
164480678|NCT01277302|594132492|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
164480679|NCT01277302|594132493|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
164480680|NCT01277302|594132494|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
164480681|NCT01277302|594132492|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
164480682|NCT01277302|594132493|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
164480683|NCT01277302|594132494|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
164480684|NCT01277302|594132492|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
164480685|NCT01277302|594132493|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
164480686|NCT01277302|594132494|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
164480687|NCT01277302|594132492|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
164480688|NCT01277302|594132493|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
164480689|NCT01277302|594132494|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
164480690|NCT01277302|594132492|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
164480691|NCT01277302|594132493|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
164480692|NCT01277302|594132494|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
164480693|NCT01277302|594132492|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
164480694|NCT01277302|594132493|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
164480695|NCT01277302|594132494|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
164480696|NCT02710669|594132495|FG000|Overall Study|Physician Decision|2|||
164480697|NCT02710669|594132496|FG001|Overall Study|Physician Decision|1|||
164480698|NCT02710669|594132497|FG002|Overall Study|Physician Decision|0|||
164480699|NCT02710669|594132495|FG000|Overall Study|Institutional delays (including COVID)|2|||
164480700|NCT02710669|594132496|FG001|Overall Study|Institutional delays (including COVID)|2|||
164480701|NCT02710669|594132497|FG002|Overall Study|Institutional delays (including COVID)|0|||
164480702|NCT02710669|594132495|FG000|Overall Study|arrived in afib/aflutter|10|||
164480703|NCT02710669|594132496|FG001|Overall Study|arrived in afib/aflutter|8|||
164480704|NCT02710669|594132497|FG002|Overall Study|arrived in afib/aflutter|2|||
164480705|NCT01567852|594132498|FG000|Overall Study|Withdrawal by Subject|3|||
164480706|NCT01567852|594132499|FG001|Overall Study|Withdrawal by Subject|6|||
164480707|NCT01567852|594132498|FG000|Overall Study|ECT discontinued|1|||
164480708|NCT01567852|594132499|FG001|Overall Study|ECT discontinued|1|||
164480709|NCT02698475|594132501|FG000|Main Study Period|Lack of Efficacy|1|||
164480710|NCT02698475|594132501|FG000|Main Study Period|Protocol Violation|2|||
164480711|NCT02698475|594132501|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
164480712|NCT02698475|594132501|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
164480713|NCT02698475|594132501|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
164480714|NCT02698475|594132501|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
164480715|NCT02698475|594132501|FG000|Long-Term Extension Period|Other|1|||
164480716|NCT02038049|594132502|FG000|Overall Study|Lost to Follow-up|1|||
164480717|NCT02038049|594132503|FG001|Overall Study|Lost to Follow-up|0|||
164480718|NCT02660086|594132505|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
164480719|NCT02660086|594132506|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
164480720|NCT02660086|594132505|FG000|Overall Study- 12-month|Left full-time employment|12|||
164480721|NCT02660086|594132506|FG001|Overall Study- 12-month|Left full-time employment|20|||
164480722|NCT02660086|594132505|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
164480723|NCT02660086|594132506|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
164480724|NCT02660086|594132505|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
164480725|NCT02660086|594132506|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
164480726|NCT02660086|594132505|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
164480727|NCT02660086|594132506|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
164480728|NCT02660086|594132505|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
164480729|NCT02660086|594132506|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
164480730|NCT01377844|594132507|FG000|Overall Study|Withdrawal by Subject|25|||
164480731|NCT01377844|594132508|FG001|Overall Study|Withdrawal by Subject|28|||
164480732|NCT01377844|594132507|FG000|Overall Study|Protocol Violation|2|||
164480733|NCT01377844|594132508|FG001|Overall Study|Protocol Violation|3|||
164480734|NCT01377844|594132507|FG000|Overall Study|Adverse Event|3|||
164480735|NCT01377844|594132508|FG001|Overall Study|Adverse Event|0|||
164480736|NCT01377844|594132507|FG000|Overall Study|Physician Decision|6|||
164480737|NCT01377844|594132508|FG001|Overall Study|Physician Decision|3|||
164480738|NCT01377844|594132507|FG000|Overall Study|Study terminated by Sponsor|0|||
164480739|NCT01377844|594132508|FG001|Overall Study|Study terminated by Sponsor|1|||
164480740|NCT01214200|594132512|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
164480741|NCT01214200|594132512|FG000|Overall Study|Withdrawal by Subject|2|||
164480742|NCT01719172|594132513|FG000|Overall Study|Lost to Follow-up|1|||
164480743|NCT01719172|594132513|FG000|Overall Study|Death|1|||
164480744|NCT00587171|594132514|FG000|Overall Study|Lost to Follow-up|1|||
164480745|NCT00587171|594132515|FG001|Overall Study|Lost to Follow-up|1|||
164480746|NCT03469258|594132516|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
164480747|NCT04250636|594132519|FG000|Overall Study|Lost to Follow-up|2|||
164480748|NCT01128959|594132520|FG000|Lead in Period|Adverse Event|3|||
164480749|NCT01128959|594132520|FG000|Treatment Period|Adverse Event|3|||
164480750|NCT01128959|594132520|FG000|Treatment Period|Withdrawal by Subject|1|||
164600395|NCT03471767|594558215|FG001|Overall Study|Lost to Follow-up|0|||
164600396|NCT03471767|594558214|FG000|Overall Study|PI Withdrawal|1|||
164600397|NCT03471767|594558215|FG001|Overall Study|PI Withdrawal|3|||
164600398|NCT01081873|594558216|FG000|Overall Study|Death|86|||
164600399|NCT01081873|594558216|FG000|Overall Study|Withdrawal by Subject|10|||
164600400|NCT01081873|594558216|FG000|Overall Study|Lost to Follow-up|142|||
164600401|NCT01081873|594558216|FG000|Overall Study|Progression of prostate cancer|13|||
164600402|NCT01081873|594558216|FG000|Overall Study|Other|47|||
164600403|NCT02491073|594558217|FG000|Overall Study|screen failure|1|||
164600404|NCT02491073|594558218|FG001|Overall Study|screen failure|0|||
164600405|NCT02768194|594558223|FG000|Period 1|Adverse Event|0|||
164600406|NCT02768194|594558224|FG001|Period 1|Adverse Event|0|||
164600407|NCT02768194|594558225|FG002|Period 1|Adverse Event|0|||
164600408|NCT02768194|594558226|FG003|Period 1|Adverse Event|1|||
164600409|NCT02768194|594558227|FG004|Period 1|Adverse Event|0|||
164600410|NCT02768194|594558228|FG005|Period 1|Adverse Event|0|||
164600411|NCT02768194|594558223|FG000|Period 2|Other (Reason not specified)|1|||
164600412|NCT02768194|594558224|FG001|Period 2|Other (Reason not specified)|0|||
164600413|NCT02768194|594558225|FG002|Period 2|Other (Reason not specified)|0|||
164600414|NCT02768194|594558226|FG003|Period 2|Other (Reason not specified)|0|||
164600415|NCT02768194|594558227|FG004|Period 2|Other (Reason not specified)|0|||
164600416|NCT02768194|594558228|FG005|Period 2|Other (Reason not specified)|0|||
164600417|NCT02768194|594558223|FG000|Period 3|Other (Reason not specified)|0|||
164600418|NCT02768194|594558224|FG001|Period 3|Other (Reason not specified)|1|||
164600419|NCT02768194|594558225|FG002|Period 3|Other (Reason not specified)|0|||
164600420|NCT02768194|594558226|FG003|Period 3|Other (Reason not specified)|0|||
164600421|NCT02768194|594558227|FG004|Period 3|Other (Reason not specified)|0|||
164600422|NCT02768194|594558228|FG005|Period 3|Other (Reason not specified)|0|||
164600423|NCT01982773|594558230|FG000|Overall Study|Withdrawal by Subject|1|||
164600424|NCT01982773|594558231|FG001|Overall Study|Withdrawal by Subject|3|||
164600425|NCT01982773|594558230|FG000|Overall Study|Lost to Follow-up|7|||
164600426|NCT01982773|594558231|FG001|Overall Study|Lost to Follow-up|1|||
164600427|NCT01029886|594558234|FG000|Overall Study|Adverse Event|12|||
164600428|NCT01029886|594558235|FG001|Overall Study|Adverse Event|25|||
164600429|NCT01029886|594558234|FG000|Overall Study|Lost to Follow-up|1|||
164600430|NCT01029886|594558235|FG001|Overall Study|Lost to Follow-up|0|||
164600431|NCT01029886|594558234|FG000|Overall Study|Physician Decision|2|||
164600432|NCT01029886|594558235|FG001|Overall Study|Physician Decision|6|||
164600433|NCT01029886|594558234|FG000|Overall Study|Protocol Violation|17|||
164480751|NCT01409837|594132521|FG000|Overall Study|Withdrawal by Subject|2|||
164480752|NCT01409837|594132522|FG001|Overall Study|Withdrawal by Subject|1|||
164480753|NCT01409837|594132521|FG000|Overall Study|Lost to Follow-up|1|||
164480754|NCT01409837|594132522|FG001|Overall Study|Lost to Follow-up|0|||
164480755|NCT01409837|594132521|FG000|Overall Study|Physician Decision|0|||
164480756|NCT01409837|594132522|FG001|Overall Study|Physician Decision|1|||
164480757|NCT03490032|594132524|FG000|Overall Study|family issue (child custody)|1|||
164480758|NCT03490032|594132525|FG001|Overall Study|family issue (child custody)|0|||
164480759|NCT03490032|594132526|FG002|Overall Study|family issue (child custody)|0|||
164480760|NCT01852045|594132531|FG000|Overall Study|Adverse Event|1|||
164480761|NCT01852045|594132532|FG001|Overall Study|Adverse Event|0|||
164480762|NCT01852045|594132533|FG002|Overall Study|Adverse Event|0|||
164480763|NCT01852045|594132531|FG000|Overall Study|Lack of Efficacy|3|||
164480764|NCT01852045|594132532|FG001|Overall Study|Lack of Efficacy|0|||
164480765|NCT01852045|594132533|FG002|Overall Study|Lack of Efficacy|0|||
164480766|NCT01852045|594132531|FG000|Overall Study|Lost to Follow-up|0|||
164480767|NCT01852045|594132532|FG001|Overall Study|Lost to Follow-up|1|||
164480768|NCT01852045|594132533|FG002|Overall Study|Lost to Follow-up|1|||
164480769|NCT01852045|594132531|FG000|Overall Study|Withdrawal by Subject|1|||
164480770|NCT01852045|594132532|FG001|Overall Study|Withdrawal by Subject|0|||
164480771|NCT01852045|594132533|FG002|Overall Study|Withdrawal by Subject|1|||
164480772|NCT01852045|594132531|FG000|Overall Study|Other Miscellaneous Reasons|1|||
164600434|NCT01029886|594558235|FG001|Overall Study|Protocol Violation|5|||
164600435|NCT01029886|594558234|FG000|Overall Study|Withdrawal by Subject|8|||
164600436|NCT01029886|594558235|FG001|Overall Study|Withdrawal by Subject|18|||
164600437|NCT01029886|594558234|FG000|Overall Study|Entry Criteria Not Met|13|||
164600438|NCT01029886|594558235|FG001|Overall Study|Entry Criteria Not Met|5|||
164480773|NCT01852045|594132532|FG001|Overall Study|Other Miscellaneous Reasons|3|||
164600439|NCT01029886|594558234|FG000|Overall Study|Sponsor Decision|1|||
164600440|NCT01029886|594558235|FG001|Overall Study|Sponsor Decision|0|||
164600441|NCT01029886|594558234|FG000|Overall Study|Loss Glucose Control|7|||
164600442|NCT01029886|594558235|FG001|Overall Study|Loss Glucose Control|1|||
164600443|NCT03294681|594558236|FG000|Overall Study|Withdrawal by Subject|1|||
164480774|NCT01852045|594132533|FG002|Overall Study|Other Miscellaneous Reasons|2|||
164480775|NCT01951703|594132534|FG000|First Intervention|Withdrawal by Subject|1|||
164480776|NCT01951703|594132535|FG001|First Intervention|Withdrawal by Subject|0|||
164480777|NCT01951703|594132534|FG000|First Intervention|Subject was not compliant|1|||
164600444|NCT01553916|594558237|FG000|Overall Study|Withdrawal by Subject|2|||
164600445|NCT01553916|594558237|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
164600446|NCT03089216|594558238|FG000|Overall Study|Adverse Event|0|||
164600447|NCT03089216|594558239|FG001|Overall Study|Adverse Event|0|||
164600448|NCT03089216|594558240|FG002|Overall Study|Adverse Event|0|||
164600449|NCT03089216|594558241|FG003|Overall Study|Adverse Event|1|||
164600450|NCT02720016|594558244|FG000|Overall Study|Separation of couple|6|||
164600451|NCT02720016|594558245|FG001|Overall Study|Separation of couple|8|||
164600452|NCT02720016|594558246|FG002|Overall Study|Separation of couple|2|||
164600453|NCT02720016|594558244|FG000|Overall Study|Withdrawal by Subject|6|||
164600454|NCT02720016|594558245|FG001|Overall Study|Withdrawal by Subject|6|||
164600455|NCT02720016|594558246|FG002|Overall Study|Withdrawal by Subject|4|||
164600456|NCT02720016|594558244|FG000|Overall Study|Scheduling issues|2|||
164600457|NCT02720016|594558245|FG001|Overall Study|Scheduling issues|4|||
164600458|NCT02720016|594558246|FG002|Overall Study|Scheduling issues|7|||
164600459|NCT02720016|594558244|FG000|Overall Study|Childcare|2|||
164600460|NCT02720016|594558245|FG001|Overall Study|Childcare|0|||
164600461|NCT02720016|594558246|FG002|Overall Study|Childcare|2|||
164600462|NCT02720016|594558244|FG000|Overall Study|Withdrawal by PI|2|||
164600463|NCT02720016|594558245|FG001|Overall Study|Withdrawal by PI|2|||
164600464|NCT02720016|594558246|FG002|Overall Study|Withdrawal by PI|0|||
164600465|NCT02720016|594558244|FG000|Overall Study|Moved away|2|||
164600466|NCT02720016|594558245|FG001|Overall Study|Moved away|0|||
164600467|NCT02720016|594558246|FG002|Overall Study|Moved away|0|||
164600468|NCT02720016|594558244|FG000|Overall Study|Not Primary Health Concern|0|||
164600469|NCT02720016|594558245|FG001|Overall Study|Not Primary Health Concern|0|||
164600470|NCT02720016|594558246|FG002|Overall Study|Not Primary Health Concern|2|||
164600471|NCT02720016|594558244|FG000|Overall Study|Transportation issues|0|||
164600472|NCT02720016|594558245|FG001|Overall Study|Transportation issues|0|||
164600473|NCT02720016|594558246|FG002|Overall Study|Transportation issues|1|||
164600474|NCT02720016|594558244|FG000|Overall Study|Other|0|||
164600475|NCT02720016|594558245|FG001|Overall Study|Other|0|||
164600476|NCT02720016|594558246|FG002|Overall Study|Other|2|||
164600477|NCT04501679|594558247|FG000|Overall Study|Pregnancy|0|||
164600478|NCT04501679|594558248|FG001|Overall Study|Pregnancy|1|||
164600479|NCT04501679|594558247|FG000|Overall Study|Adverse Event|4|||
164600480|NCT04501679|594558248|FG001|Overall Study|Adverse Event|2|||
164600481|NCT04501679|594558247|FG000|Overall Study|Withdrawal by Subject|2|||
164600482|NCT04501679|594558248|FG001|Overall Study|Withdrawal by Subject|0|||
164600483|NCT04501679|594558247|FG000|Overall Study|Physician Decision|1|||
164600484|NCT04501679|594558248|FG001|Overall Study|Physician Decision|0|||
164600485|NCT04501679|594558247|FG000|Overall Study|Lost to Follow-up|2|||
164600486|NCT04501679|594558248|FG001|Overall Study|Lost to Follow-up|0|||
164600487|NCT02121756|594558252|FG000|Overall Study|Adverse Event|3|||
164600488|NCT02121756|594558253|FG001|Overall Study|Adverse Event|0|||
164480778|NCT01951703|594132535|FG001|First Intervention|Subject was not compliant|1|||
164480779|NCT01951703|594132534|FG000|First Intervention|Physician Decision|1|||
164480780|NCT01951703|594132535|FG001|First Intervention|Physician Decision|0|||
164480781|NCT01951703|594132534|FG000|Second Intervention|Protocol Violation|0|||
164480782|NCT01951703|594132535|FG001|Second Intervention|Protocol Violation|1|||
164480783|NCT01951703|594132534|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
164480784|NCT01951703|594132535|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
164480785|NCT00487240|594132536|FG000|Overall Study|Withdrawal by Subject|12|||
164480786|NCT00487240|594132537|FG001|Overall Study|Withdrawal by Subject|6|||
164480787|NCT00487240|594132536|FG000|Overall Study|Lost to Follow-up|7|||
164480788|NCT00487240|594132537|FG001|Overall Study|Lost to Follow-up|6|||
164480789|NCT00487240|594132536|FG000|Overall Study|Adverse Event|0|||
164480790|NCT00487240|594132537|FG001|Overall Study|Adverse Event|4|||
164480791|NCT00487240|594132536|FG000|Overall Study|Protocol Violation|5|||
164480792|NCT00487240|594132537|FG001|Overall Study|Protocol Violation|5|||
164480793|NCT00487240|594132536|FG000|Overall Study|Entry Criteria Not Met|3|||
164480794|NCT00487240|594132537|FG001|Overall Study|Entry Criteria Not Met|4|||
164600489|NCT02121756|594558252|FG000|Overall Study|Protocol Violation|1|||
164600490|NCT02121756|594558253|FG001|Overall Study|Protocol Violation|1|||
164600491|NCT02121756|594558252|FG000|Overall Study|Physician Decision|2|||
164600492|NCT02121756|594558253|FG001|Overall Study|Physician Decision|1|||
164600493|NCT05319080|594558254|FG000|Overall Study|Withdrawal by Subject|2|||
164600494|NCT05319080|594558254|FG000|Overall Study|Physician Decision|4|||
164600495|NCT00448916|594558257|FG000|Overall Study|Adverse Event|2|||
164480795|NCT00487240|594132536|FG000|Overall Study|Sponsor Decision|2|||
164600496|NCT00448916|594558258|FG001|Overall Study|Adverse Event|2|||
164600497|NCT00448916|594558259|FG002|Overall Study|Adverse Event|3|||
164600498|NCT00448916|594558260|FG003|Overall Study|Adverse Event|2|||
164480796|NCT00487240|594132537|FG001|Overall Study|Sponsor Decision|1|||
164480797|NCT00487240|594132536|FG000|Overall Study|Physician Decision|2|||
164480798|NCT00487240|594132537|FG001|Overall Study|Physician Decision|0|||
164480799|NCT00240994|594132538|FG000|Overall Study|Lost to Follow-up|1|||
164600499|NCT00448916|594558257|FG000|Overall Study|Lack of Efficacy|1|||
164600500|NCT00448916|594558258|FG001|Overall Study|Lack of Efficacy|0|||
164600501|NCT00448916|594558259|FG002|Overall Study|Lack of Efficacy|2|||
164600502|NCT00448916|594558260|FG003|Overall Study|Lack of Efficacy|1|||
164600503|NCT00448916|594558257|FG000|Overall Study|Withdrawal by Subject|3|||
164480800|NCT00240994|594132538|FG000|Overall Study|Protocol Violation|1|||
164480801|NCT00240994|594132538|FG000|Overall Study|Graft failure|1|||
164480802|NCT02630186|594132540|FG000|Overall Study|Withdrawal by Subject|1|||
164480803|NCT00439218|594132541|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
164480804|NCT03142932|594132542|FG000|Overall Study|Lost to Follow-up|2|||
164480805|NCT03142932|594132543|FG001|Overall Study|Lost to Follow-up|11|||
164480806|NCT02128269|594132544|FG000|Treatment Period|Adverse Event|1|||
164480807|NCT02128269|594132544|FG000|Treatment Period|Physician Decision|1|||
164480808|NCT01858688|594132549|FG000|Overall Study|Withdrawal by Subject|8|||
164480809|NCT01858688|594132549|FG000|Overall Study|Participant began another therapy|3|||
164480810|NCT01858688|594132549|FG000|Overall Study|Physician Decision|2|||
164480811|NCT01858688|594132549|FG000|Overall Study|Progressive Disease|2|||
164480812|NCT01858688|594132549|FG000|Overall Study|Reason not reproted|5|||
164480813|NCT01485887|594132550|FG000|Overall Study|Withdrawal by Subject|2|||
164480814|NCT01485887|594132550|FG000|Overall Study|Adverse Event|8|||
164480815|NCT01485887|594132550|FG000|Overall Study|Deterioration of primary disease|1|||
164480816|NCT01485887|594132550|FG000|Overall Study|Primary disease markedly improved|1|||
164480817|NCT02234141|594132551|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
164480818|NCT02234141|594132552|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
164480819|NCT02234141|594132553|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
164480820|NCT02234141|594132554|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
164480821|NCT02234141|594132555|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
164480822|NCT02234141|594132556|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
164480823|NCT02234141|594132557|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
164480824|NCT02234141|594132551|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
164480825|NCT02234141|594132552|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
164480826|NCT02234141|594132553|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
164480827|NCT02234141|594132554|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
164480828|NCT02234141|594132555|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
164480829|NCT02234141|594132556|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
164480830|NCT02234141|594132557|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
164480831|NCT02234141|594132551|FG000|Treatment Period (24 Weeks)|Death|1|||
164480832|NCT02234141|594132552|FG001|Treatment Period (24 Weeks)|Death|2|||
164480833|NCT02234141|594132553|FG002|Treatment Period (24 Weeks)|Death|0|||
164480834|NCT02234141|594132554|FG003|Treatment Period (24 Weeks)|Death|1|||
164480835|NCT02234141|594132555|FG004|Treatment Period (24 Weeks)|Death|0|||
164480836|NCT02234141|594132556|FG005|Treatment Period (24 Weeks)|Death|0|||
164480837|NCT02234141|594132557|FG006|Treatment Period (24 Weeks)|Death|0|||
164480838|NCT02234141|594132551|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
164480839|NCT02234141|594132552|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
164480840|NCT02234141|594132553|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
164480841|NCT02234141|594132554|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
164480842|NCT02234141|594132555|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
164480843|NCT02234141|594132556|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
164480844|NCT02234141|594132557|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
164480845|NCT02234141|594132551|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
164480846|NCT02234141|594132552|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
164480847|NCT02234141|594132553|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
164480848|NCT02234141|594132554|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
164480849|NCT02234141|594132555|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
164480850|NCT02234141|594132556|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
164480851|NCT02234141|594132557|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
164480852|NCT02234141|594132551|FG000|Long-Term Treatment Period|Death|0|||
164480853|NCT02234141|594132552|FG001|Long-Term Treatment Period|Death|0|||
164480854|NCT02234141|594132553|FG002|Long-Term Treatment Period|Death|0|||
164480855|NCT02234141|594132554|FG003|Long-Term Treatment Period|Death|0|||
164480856|NCT02234141|594132555|FG004|Long-Term Treatment Period|Death|0|||
164480857|NCT02234141|594132556|FG005|Long-Term Treatment Period|Death|1|||
164480858|NCT02234141|594132557|FG006|Long-Term Treatment Period|Death|0|||
164480859|NCT02234141|594132551|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
164480860|NCT02234141|594132552|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
164480861|NCT02234141|594132553|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
164480862|NCT02234141|594132554|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
164480863|NCT02234141|594132555|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
164480864|NCT02234141|594132556|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
164480865|NCT02234141|594132557|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
164480866|NCT02234141|594132551|FG000|Long-Term Treatment Period|Adverse Event|4|||
164480867|NCT02234141|594132552|FG001|Long-Term Treatment Period|Adverse Event|0|||
164480868|NCT02234141|594132553|FG002|Long-Term Treatment Period|Adverse Event|5|||
164480869|NCT02234141|594132554|FG003|Long-Term Treatment Period|Adverse Event|0|||
164480870|NCT02234141|594132555|FG004|Long-Term Treatment Period|Adverse Event|1|||
164480871|NCT02234141|594132556|FG005|Long-Term Treatment Period|Adverse Event|1|||
164480872|NCT02234141|594132557|FG006|Long-Term Treatment Period|Adverse Event|1|||
164480873|NCT02234141|594132551|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
164480874|NCT02234141|594132552|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
164480875|NCT02234141|594132553|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
164480876|NCT02234141|594132554|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
164480877|NCT02234141|594132555|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
164480878|NCT02234141|594132556|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
164480879|NCT02234141|594132557|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
164480880|NCT02234141|594132551|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
164480881|NCT02234141|594132552|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
164480882|NCT02234141|594132553|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
164480883|NCT02234141|594132554|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
164480884|NCT02234141|594132555|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
164480885|NCT02234141|594132556|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
164480886|NCT02234141|594132557|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
164480887|NCT00895245|594132558|FG000|Overall Study|Lack of Efficacy|6|||
164480888|NCT04248868|594132559|FG000|Overall Study|Death|1|||
164480889|NCT04248868|594132559|FG000|Overall Study|Lost to Follow-up|3|||
164480890|NCT04248868|594132559|FG000|Overall Study|Protocol Violation|2|||
164480891|NCT01972776|594132560|FG000|Part 1|Withdrawal by Subject|0|||
164480892|NCT01972776|594132561|FG001|Part 1|Withdrawal by Subject|0|||
164480893|NCT01972776|594132562|FG002|Part 1|Withdrawal by Subject|1|||
164480894|NCT01972776|594132563|FG003|Part 1|Withdrawal by Subject|0|||
164480895|NCT01972776|594132564|FG004|Part 1|Withdrawal by Subject|0|||
164480896|NCT01972776|594132565|FG005|Part 1|Withdrawal by Subject|0|||
164480897|NCT01972776|594132560|FG000|Part 1|Adverse Event|0|||
164480898|NCT01972776|594132561|FG001|Part 1|Adverse Event|0|||
164480899|NCT01972776|594132562|FG002|Part 1|Adverse Event|1|||
164480900|NCT01972776|594132563|FG003|Part 1|Adverse Event|1|||
164480901|NCT01972776|594132564|FG004|Part 1|Adverse Event|0|||
164480902|NCT01972776|594132565|FG005|Part 1|Adverse Event|0|||
164480903|NCT01972776|594132560|FG000|Part 2|Adverse Event|0|||
164480904|NCT01972776|594132561|FG001|Part 2|Adverse Event|0|||
164480905|NCT01972776|594132562|FG002|Part 2|Adverse Event|0|||
164480906|NCT01972776|594132563|FG003|Part 2|Adverse Event|0|||
164480907|NCT01972776|594132564|FG004|Part 2|Adverse Event|3|||
164480908|NCT01972776|594132565|FG005|Part 2|Adverse Event|0|||
164480909|NCT01972776|594132560|FG000|Part 2|Administrative problems|0|||
164480910|NCT01972776|594132561|FG001|Part 2|Administrative problems|0|||
164480911|NCT01972776|594132562|FG002|Part 2|Administrative problems|0|||
164480912|NCT01972776|594132563|FG003|Part 2|Administrative problems|0|||
164480913|NCT01972776|594132564|FG004|Part 2|Administrative problems|10|||
164480914|NCT01972776|594132565|FG005|Part 2|Administrative problems|7|||
164480915|NCT01228734|594132566|FG000|Overall Study|Randomized, but not treated|0|||
164480916|NCT01228734|594132567|FG001|Overall Study|Randomized, but not treated|4|||
164480917|NCT02382640|594132573|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
164480918|NCT02382640|594132574|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
164480919|NCT02382640|594132575|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
164480920|NCT02382640|594132576|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
164480921|NCT01220999|594132577|FG000|Overall Study|Progressive disease|0|||
164480922|NCT01220999|594132578|FG001|Overall Study|Progressive disease|0|||
164480923|NCT01220999|594132579|FG002|Overall Study|Progressive disease|1|||
164480924|NCT01220999|594132580|FG003|Overall Study|Progressive disease|0|||
164480925|NCT01220999|594132581|FG004|Overall Study|Progressive disease|0|||
164480926|NCT01560429|594132583|FG000|Overall Study|Protocol Violation|3|||
164480927|NCT01560429|594132584|FG001|Overall Study|Protocol Violation|6|||
164480928|NCT02449902|594132585|FG000|Overall Study|Adverse Event|0|||
164480929|NCT02449902|594132586|FG001|Overall Study|Adverse Event|1|||
164600504|NCT00448916|594558258|FG001|Overall Study|Withdrawal by Subject|3|||
164600505|NCT00448916|594558259|FG002|Overall Study|Withdrawal by Subject|1|||
164480930|NCT02449902|594132585|FG000|Overall Study|Withdrawal by Subject|0|||
164480931|NCT02449902|594132586|FG001|Overall Study|Withdrawal by Subject|1|||
164480932|NCT01365546|594132587|FG000|Overall Study|Withdrawal by Subject|1|||
164480933|NCT01365546|594132587|FG000|Overall Study|Screen failure|9|||
164480934|NCT01365546|594132587|FG000|Overall Study|Study termination|1|||
164480935|NCT03326856|594132588|FG000|Overall Study|Lost to Follow-up|1|||
164480936|NCT03326856|594132589|FG001|Overall Study|Lost to Follow-up|1|||
164480937|NCT03326856|594132590|FG002|Overall Study|Lost to Follow-up|0|||
164480938|NCT03326856|594132591|FG003|Overall Study|Lost to Follow-up|0|||
164480939|NCT03326856|594132592|FG004|Overall Study|Lost to Follow-up|0|||
164480940|NCT03162614|594132595|FG000|Overall Study|Lost to Follow-up|2|||
164480941|NCT03162614|594132596|FG001|Overall Study|Lost to Follow-up|1|||
164600506|NCT00448916|594558260|FG003|Overall Study|Withdrawal by Subject|1|||
164480942|NCT03162614|594132597|FG002|Overall Study|Lost to Follow-up|1|||
164480943|NCT03162614|594132598|FG003|Overall Study|Lost to Follow-up|1|||
164480944|NCT03162614|594132599|FG004|Overall Study|Lost to Follow-up|2|||
164600507|NCT00448916|594558257|FG000|Overall Study|Other|1|||
164480945|NCT03162614|594132600|FG005|Overall Study|Lost to Follow-up|0|||
164480946|NCT03162614|594132595|FG000|Overall Study|Protocol Violation|0|||
164480947|NCT03162614|594132596|FG001|Overall Study|Protocol Violation|1|||
164480948|NCT03162614|594132597|FG002|Overall Study|Protocol Violation|0|||
164480949|NCT03162614|594132598|FG003|Overall Study|Protocol Violation|1|||
164480950|NCT03162614|594132599|FG004|Overall Study|Protocol Violation|0|||
164480951|NCT03162614|594132600|FG005|Overall Study|Protocol Violation|0|||
164480952|NCT03162614|594132595|FG000|Overall Study|Withdrawal by Subject|2|||
164480953|NCT03162614|594132596|FG001|Overall Study|Withdrawal by Subject|1|||
164480954|NCT03162614|594132597|FG002|Overall Study|Withdrawal by Subject|1|||
164480955|NCT03162614|594132598|FG003|Overall Study|Withdrawal by Subject|1|||
164480956|NCT03162614|594132599|FG004|Overall Study|Withdrawal by Subject|0|||
164480957|NCT03162614|594132600|FG005|Overall Study|Withdrawal by Subject|0|||
164480958|NCT03162614|594132595|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
164480959|NCT03162614|594132596|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
164480960|NCT03162614|594132597|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
164480961|NCT03162614|594132598|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
164480962|NCT03162614|594132599|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
164480963|NCT03162614|594132600|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
164480964|NCT03861234|594132601|FG000|Overall Study|Not treated|0|||
164480965|NCT03861234|594132602|FG001|Overall Study|Not treated|0|||
164480966|NCT03861234|594132603|FG002|Overall Study|Not treated|0|||
164480967|NCT03861234|594132604|FG003|Overall Study|Not treated|0|||
164480968|NCT03861234|594132605|FG004|Overall Study|Not treated|0|||
164480969|NCT03861234|594132606|FG005|Overall Study|Not treated|1|||
164480970|NCT03861234|594132607|FG006|Overall Study|Not treated|0|||
164480971|NCT03861234|594132608|FG007|Overall Study|Not treated|0|||
164480972|NCT03861234|594132601|FG000|Overall Study|Adverse Event|0|||
164480973|NCT03861234|594132602|FG001|Overall Study|Adverse Event|0|||
164480974|NCT03861234|594132603|FG002|Overall Study|Adverse Event|0|||
164480975|NCT03861234|594132604|FG003|Overall Study|Adverse Event|0|||
164480976|NCT03861234|594132605|FG004|Overall Study|Adverse Event|0|||
164480977|NCT03861234|594132606|FG005|Overall Study|Adverse Event|1|||
164480978|NCT03861234|594132607|FG006|Overall Study|Adverse Event|0|||
164480979|NCT03861234|594132608|FG007|Overall Study|Adverse Event|0|||
164480980|NCT03861234|594132601|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
164480981|NCT03861234|594132602|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
164480982|NCT03861234|594132603|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
164480983|NCT03861234|594132604|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
164480984|NCT03861234|594132605|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
164480985|NCT03861234|594132606|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
164480986|NCT03861234|594132607|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
164480987|NCT03861234|594132608|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
164480988|NCT03861234|594132601|FG000|Overall Study|As per sponsor decision|0|||
164480989|NCT03861234|594132602|FG001|Overall Study|As per sponsor decision|0|||
164480990|NCT03861234|594132603|FG002|Overall Study|As per sponsor decision|0|||
164480991|NCT03861234|594132604|FG003|Overall Study|As per sponsor decision|0|||
164480992|NCT03861234|594132605|FG004|Overall Study|As per sponsor decision|0|||
164480993|NCT03861234|594132606|FG005|Overall Study|As per sponsor decision|0|||
164480994|NCT03861234|594132607|FG006|Overall Study|As per sponsor decision|1|||
164480995|NCT03861234|594132608|FG007|Overall Study|As per sponsor decision|0|||
164480996|NCT03861234|594132601|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
164480997|NCT03861234|594132602|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
164480998|NCT03861234|594132603|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
164480999|NCT03861234|594132604|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
164481000|NCT03861234|594132605|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
164481001|NCT03861234|594132606|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
164481002|NCT03861234|594132607|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
164481003|NCT03861234|594132608|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
164481004|NCT00621842|594132609|FG000|Overall Study|Adverse Event|6|||
164481005|NCT00621842|594132609|FG000|Overall Study|Withdrawal by Subject|7|||
164481006|NCT00621842|594132609|FG000|Overall Study|Protocol Violation|4|||
164481007|NCT00621842|594132609|FG000|Overall Study|Lack of Efficacy|2|||
164481008|NCT01957163|594132612|FG000|Overall Study|Adverse Event|5|||
164481009|NCT01957163|594132613|FG001|Overall Study|Adverse Event|2|||
164481010|NCT01957163|594132614|FG002|Overall Study|Adverse Event|4|||
164600508|NCT00448916|594558258|FG001|Overall Study|Other|0|||
164600509|NCT00448916|594558259|FG002|Overall Study|Other|0|||
164481011|NCT01957163|594132612|FG000|Overall Study|Lack of Efficacy|5|||
164481012|NCT01957163|594132613|FG001|Overall Study|Lack of Efficacy|4|||
164481013|NCT01957163|594132614|FG002|Overall Study|Lack of Efficacy|9|||
164481014|NCT01957163|594132612|FG000|Overall Study|Protocol Violation|1|||
164481015|NCT01957163|594132613|FG001|Overall Study|Protocol Violation|2|||
164481016|NCT01957163|594132614|FG002|Overall Study|Protocol Violation|0|||
164714340|NCT01590797|594976864|FG000|Overall Study|Other Protocol Specified Criteria|2|||
164481017|NCT01957163|594132612|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
164481018|NCT01957163|594132613|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
164481019|NCT01957163|594132614|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
164481020|NCT01957163|594132612|FG000|Overall Study|Lost to Follow-up|0|||
164481021|NCT01957163|594132613|FG001|Overall Study|Lost to Follow-up|1|||
164481022|NCT01957163|594132614|FG002|Overall Study|Lost to Follow-up|0|||
164481023|NCT01957163|594132612|FG000|Overall Study|Withdrawal by Subject|4|||
164481024|NCT01957163|594132613|FG001|Overall Study|Withdrawal by Subject|2|||
164481025|NCT01957163|594132614|FG002|Overall Study|Withdrawal by Subject|4|||
164481026|NCT03822832|594132617|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
164481027|NCT03822832|594132618|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
164481028|NCT03822832|594132617|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
164481029|NCT03822832|594132618|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
164481030|NCT03822832|594132617|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
164481031|NCT03822832|594132618|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
164481032|NCT03822832|594132617|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
164481033|NCT03822832|594132618|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
164481034|NCT03822832|594132617|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
164481035|NCT03822832|594132618|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
164481036|NCT03822832|594132617|FG000|Re-allocation|Not re-allocated to open label period|2|||
164481037|NCT03822832|594132618|FG001|Re-allocation|Not re-allocated to open label period|6|||
164481038|NCT03822832|594132617|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
164481039|NCT03822832|594132618|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
164481040|NCT03822832|594132617|FG000|Period 2 - Open Label Period|Adverse Event|0|||
164481041|NCT03822832|594132618|FG001|Period 2 - Open Label Period|Adverse Event|3|||
164481042|NCT05169684|594132619|FG000|Overall Study|Adverse Event|1|||
164481043|NCT05169684|594132620|FG001|Overall Study|Adverse Event|3|||
164481044|NCT05169684|594132619|FG000|Overall Study|Physician Decision|0|||
164481045|NCT05169684|594132620|FG001|Overall Study|Physician Decision|1|||
164481046|NCT05169684|594132619|FG000|Overall Study|Progressive Disease|1|||
164481047|NCT05169684|594132620|FG001|Overall Study|Progressive Disease|1|||
164481048|NCT05169684|594132619|FG000|Overall Study|Participant request to discontinue treatment|0|||
164481049|NCT05169684|594132620|FG001|Overall Study|Participant request to discontinue treatment|1|||
164481050|NCT05169684|594132619|FG000|Overall Study|Other Reason|0|||
164481051|NCT05169684|594132620|FG001|Overall Study|Other Reason|1|||
164481052|NCT03539055|594132621|FG000|Overall Study|Death|4|||
164481053|NCT03539055|594132621|FG000|Overall Study|Lost to Follow-up|1|||
164481054|NCT03539055|594132621|FG000|Overall Study|Withdrawal by Subject|2|||
164481055|NCT03539055|594132621|FG000|Overall Study|Screen Fail|7|||
164481056|NCT03539055|594132621|FG000|Overall Study|Drug Intolerance|2|||
164481057|NCT05352230|594132622|FG000|First Intervention (3 Months)|study terminated|2|||
164481058|NCT05352230|594132623|FG001|First Intervention (3 Months)|study terminated|2|||
164481059|NCT00786188|594132630|FG000|Overall Study|Adverse Event|3|||
164481060|NCT00786188|594132631|FG001|Overall Study|Adverse Event|1|||
164481061|NCT00786188|594132630|FG000|Overall Study|Withdrawal by Subject|2|||
164481062|NCT00786188|594132631|FG001|Overall Study|Withdrawal by Subject|0|||
164481063|NCT00326183|594132632|FG000|Overall Study|Lost to Follow-up|104|||
164481064|NCT00326183|594132633|FG001|Overall Study|Lost to Follow-up|56|||
164481065|NCT00326183|594132632|FG000|Overall Study|Protocol Violation|6|||
164481066|NCT00326183|594132633|FG001|Overall Study|Protocol Violation|3|||
164481067|NCT00326183|594132632|FG000|Overall Study|Withdrawal by Subject|35|||
164481068|NCT00326183|594132633|FG001|Overall Study|Withdrawal by Subject|7|||
164481069|NCT00326183|594132632|FG000|Overall Study|Subject Moved|7|||
164481070|NCT00326183|594132633|FG001|Overall Study|Subject Moved|4|||
164481071|NCT00326183|594132632|FG000|Overall Study|Other|47|||
164481072|NCT00326183|594132633|FG001|Overall Study|Other|13|||
164481073|NCT00326183|594132632|FG000|Overall Study|Adverse Event|1|||
164481074|NCT00326183|594132633|FG001|Overall Study|Adverse Event|0|||
164600510|NCT00448916|594558260|FG003|Overall Study|Other|0|||
164600511|NCT00448916|594558257|FG000|Overall Study|Lost to Follow-up|0|||
164714341|NCT01590797|594976865|FG001|Overall Study|Other Protocol Specified Criteria|4|||
164714342|NCT03106987|594976866|FG000|Overall Study|Death|37|||
164714343|NCT03106987|594976867|FG001|Overall Study|Death|22|||
164481075|NCT01827839|594132636|FG000|Overall Study|Adverse Event|1|||
164481076|NCT01827839|594132636|FG000|Overall Study|Consent Withdrawal|2|||
164481077|NCT04493424|594133979|FG000|Overall Study|Termination of the trial by the sponsor|89|||
164481078|NCT04493424|594133979|FG000|Overall Study|Withdrawal by Subject|9|||
164481079|NCT04493424|594133979|FG000|Overall Study|Lost to Follow-up|2|||
164481080|NCT04493424|594133979|FG000|Overall Study|Lack of Efficacy|3|||
164481081|NCT04493424|594133979|FG000|Overall Study|Adverse Event|5|||
164481082|NCT03769090|594133981|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
164481083|NCT03769090|594133982|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
164481084|NCT03769090|594133983|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
164600512|NCT00448916|594558258|FG001|Overall Study|Lost to Follow-up|1|||
164481085|NCT03769090|594133981|FG000|Overall Study|Withdrawal by Subject|52|||
164481086|NCT03769090|594133982|FG001|Overall Study|Withdrawal by Subject|62|||
164481087|NCT03769090|594133983|FG002|Overall Study|Withdrawal by Subject|74|||
164481088|NCT03769090|594133981|FG000|Overall Study|Death|4|||
164481089|NCT03769090|594133982|FG001|Overall Study|Death|2|||
164481090|NCT03769090|594133983|FG002|Overall Study|Death|2|||
164481091|NCT03769090|594133981|FG000|Overall Study|Adverse Event|7|||
164481092|NCT03769090|594133982|FG001|Overall Study|Adverse Event|7|||
164481093|NCT03769090|594133983|FG002|Overall Study|Adverse Event|8|||
164481094|NCT03769090|594133981|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
164481095|NCT03769090|594133982|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
164481096|NCT03769090|594133983|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
164481097|NCT03769090|594133981|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
164481098|NCT03769090|594133982|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
164481099|NCT03769090|594133983|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
164481100|NCT03769090|594133981|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
164481101|NCT03769090|594133982|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
164481102|NCT03769090|594133983|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
164481103|NCT03769090|594133981|FG000|Overall Study|Protocol Violation|5|||
164481104|NCT03769090|594133982|FG001|Overall Study|Protocol Violation|6|||
164481105|NCT03769090|594133983|FG002|Overall Study|Protocol Violation|8|||
164481106|NCT03769090|594133981|FG000|Overall Study|Pregnancy|1|||
164481107|NCT03769090|594133982|FG001|Overall Study|Pregnancy|0|||
164481108|NCT03769090|594133983|FG002|Overall Study|Pregnancy|3|||
164481109|NCT03769090|594133981|FG000|Overall Study|Lost to Follow-up|19|||
164481110|NCT03769090|594133982|FG001|Overall Study|Lost to Follow-up|25|||
164481111|NCT03769090|594133983|FG002|Overall Study|Lost to Follow-up|21|||
164481112|NCT03769090|594133981|FG000|Overall Study|Condition under investigation worsened|2|||
164481113|NCT03769090|594133982|FG001|Overall Study|Condition under investigation worsened|0|||
164481114|NCT03769090|594133983|FG002|Overall Study|Condition under investigation worsened|1|||
164481115|NCT03769090|594133981|FG000|Overall Study|Lack of Efficacy|1|||
164481116|NCT03769090|594133982|FG001|Overall Study|Lack of Efficacy|2|||
164481117|NCT03769090|594133983|FG002|Overall Study|Lack of Efficacy|2|||
164481118|NCT03769090|594133981|FG000|Overall Study|Other reasons|8|||
164481119|NCT03769090|594133982|FG001|Overall Study|Other reasons|12|||
164481120|NCT03769090|594133983|FG002|Overall Study|Other reasons|15|||
164481121|NCT03332589|594133991|FG000|Overall Study|Lack of Efficacy|2|||
164481122|NCT03332589|594133992|FG001|Overall Study|Lack of Efficacy|0|||
164481123|NCT03332589|594133993|FG002|Overall Study|Lack of Efficacy|0|||
164481124|NCT03332589|594133991|FG000|Overall Study|Adverse Event|1|||
164481125|NCT03332589|594133992|FG001|Overall Study|Adverse Event|0|||
164481126|NCT03332589|594133993|FG002|Overall Study|Adverse Event|0|||
164481127|NCT03332589|594133991|FG000|Overall Study|Death|1|||
164481128|NCT03332589|594133992|FG001|Overall Study|Death|0|||
164481129|NCT03332589|594133993|FG002|Overall Study|Death|0|||
164481130|NCT01190124|594133994|FG000|Overall Study|Death|3|||
164481131|NCT01190124|594133995|FG001|Overall Study|Death|0|||
164481132|NCT01190124|594133996|FG002|Overall Study|Death|0|||
164481133|NCT01190124|594133994|FG000|Overall Study|Therapeutic Failure|12|||
164481134|NCT01190124|594133995|FG001|Overall Study|Therapeutic Failure|0|||
164481135|NCT01190124|594133996|FG002|Overall Study|Therapeutic Failure|1|||
164481136|NCT01190124|594133994|FG000|Overall Study|Lost to Follow-up|2|||
164481137|NCT01190124|594133995|FG001|Overall Study|Lost to Follow-up|0|||
164481138|NCT01190124|594133996|FG002|Overall Study|Lost to Follow-up|0|||
164481139|NCT02771366|594133997|FG000|Period 1|Withdrawal by Subject|0|||
164481140|NCT02771366|594133998|FG001|Period 1|Withdrawal by Subject|2|||
164481141|NCT02771366|594133997|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
164481142|NCT02771366|594133998|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
164481143|NCT02092285|594134000|FG000|Induction Phase|Adverse Event|7|||
164481144|NCT02092285|594134000|FG000|Induction Phase|Physician Decision|4|||
164481145|NCT02092285|594134000|FG000|Induction Phase|Pregnancy|1|||
164481146|NCT02092285|594134000|FG000|Induction Phase|Relapse/Recurrence|7|||
164481147|NCT02092285|594134000|FG000|Induction Phase|Withdrawal by Subject|2|||
164481148|NCT02092285|594134000|FG000|Induction Phase|Lack of Efficacy|14|||
164481149|NCT02092285|594134000|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
164714344|NCT03106987|594976868|FG002|Overall Study|Death|12|||
164714345|NCT03106987|594976869|FG003|Overall Study|Death|8|||
164481150|NCT02092285|594134000|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
164481151|NCT02092285|594134000|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
164600513|NCT00448916|594558259|FG002|Overall Study|Lost to Follow-up|0|||
164714346|NCT03106987|594976866|FG000|Overall Study|Lost to Follow-up|2|||
164481152|NCT02092285|594134000|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
164714347|NCT03106987|594976867|FG001|Overall Study|Lost to Follow-up|0|||
164481153|NCT02092285|594134000|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
164481154|NCT02092285|594134000|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
164481155|NCT02092285|594134000|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
164600514|NCT00448916|594558260|FG003|Overall Study|Lost to Follow-up|1|||
164600515|NCT00448916|594558257|FG000|Overall Study|Protocol Violation|0|||
164600516|NCT00448916|594558258|FG001|Overall Study|Protocol Violation|0|||
164600517|NCT00448916|594558259|FG002|Overall Study|Protocol Violation|0|||
164600518|NCT00448916|594558260|FG003|Overall Study|Protocol Violation|1|||
164600519|NCT03521193|594558261|FG000|Overall Study|Withdrawal by Subject|8|||
164600520|NCT03521193|594558262|FG001|Overall Study|Withdrawal by Subject|0|||
164600521|NCT03521193|594558261|FG000|Overall Study|non compliant to ASA treatment|8|||
164600522|NCT03521193|594558262|FG001|Overall Study|non compliant to ASA treatment|0|||
164600523|NCT00838916|594558263|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
164600524|NCT00838916|594558264|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
164600525|NCT00838916|594558263|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
164600526|NCT00838916|594558264|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
164600527|NCT00838916|594558263|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
164600528|NCT00838916|594558264|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
164600529|NCT00838916|594558263|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
164600530|NCT00838916|594558264|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
164600531|NCT00838916|594558263|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
164600532|NCT00838916|594558264|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
164600533|NCT00838916|594558263|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
164600534|NCT00838916|594558264|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
164600535|NCT00838916|594558263|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
164600536|NCT00838916|594558264|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
164600537|NCT00838916|594558263|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
164600538|NCT00838916|594558264|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
164600539|NCT00838916|594558263|FG000|Treatment Period (156 Weeks)|Missing|3|||
164600540|NCT00838916|594558264|FG001|Treatment Period (156 Weeks)|Missing|1|||
164600541|NCT00838916|594558263|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
164600542|NCT00838916|594558264|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
164600543|NCT00838916|594558263|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
164600544|NCT00838916|594558264|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
164600545|NCT00838916|594558263|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
164600546|NCT00838916|594558264|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
164600547|NCT00838916|594558263|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
164600548|NCT00838916|594558264|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
164600549|NCT00838916|594558263|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
164600550|NCT00838916|594558264|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
164600551|NCT00838916|594558263|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
164600552|NCT00838916|594558264|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
164600553|NCT00838916|594558263|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
164600554|NCT00838916|594558264|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
164600555|NCT00838916|594558263|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
164600556|NCT00838916|594558264|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
164600557|NCT00838916|594558263|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
164600558|NCT00838916|594558264|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
164600559|NCT00838916|594558263|FG000|Follow-up Period (8 Weeks)|Missing|3|||
164600560|NCT00838916|594558264|FG001|Follow-up Period (8 Weeks)|Missing|0|||
164600561|NCT01454401|594558266|FG000|Overall Study|Death|1|||
164600562|NCT01454401|594558266|FG000|Overall Study|hospitalised|1|||
164600563|NCT01454401|594558266|FG000|Overall Study|osteomyelitis|2|||
164600564|NCT01454401|594558266|FG000|Overall Study|non-adherence|1|||
164600565|NCT01968187|594558274|FG000|Overall Study|Adverse Event|0|||
164600566|NCT01968187|594558275|FG001|Overall Study|Adverse Event|1|||
164600567|NCT01968187|594558274|FG000|Overall Study|Randomized but not treated|1|||
164600568|NCT01968187|594558275|FG001|Overall Study|Randomized but not treated|0|||
164600569|NCT00430521|594558276|FG000|Overall Study|Adverse Event|0|||
164600570|NCT00430521|594558277|FG001|Overall Study|Adverse Event|0|||
164600571|NCT00430521|594558278|FG002|Overall Study|Adverse Event|0|||
164600572|NCT00430521|594558279|FG003|Overall Study|Adverse Event|0|||
164600573|NCT00430521|594558280|FG004|Overall Study|Adverse Event|0|||
164600574|NCT00430521|594558281|FG005|Overall Study|Adverse Event|2|||
164600575|NCT00430521|594558282|FG006|Overall Study|Adverse Event|1|||
164600576|NCT00430521|594558283|FG007|Overall Study|Adverse Event|0|||
164600577|NCT00430521|594558276|FG000|Overall Study|Lost to Follow-up|7|||
164600578|NCT00430521|594558277|FG001|Overall Study|Lost to Follow-up|8|||
164600579|NCT00430521|594558278|FG002|Overall Study|Lost to Follow-up|3|||
164714348|NCT03106987|594976868|FG002|Overall Study|Lost to Follow-up|2|||
164600580|NCT00430521|594558279|FG003|Overall Study|Lost to Follow-up|5|||
164600581|NCT00430521|594558280|FG004|Overall Study|Lost to Follow-up|5|||
164600582|NCT00430521|594558281|FG005|Overall Study|Lost to Follow-up|2|||
164600583|NCT00430521|594558282|FG006|Overall Study|Lost to Follow-up|8|||
164600584|NCT00430521|594558283|FG007|Overall Study|Lost to Follow-up|10|||
164600585|NCT00430521|594558276|FG000|Overall Study|Pregnancy|0|||
164600586|NCT00430521|594558277|FG001|Overall Study|Pregnancy|0|||
164600587|NCT00430521|594558278|FG002|Overall Study|Pregnancy|0|||
164481156|NCT02092285|594134000|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
164481157|NCT02092285|594134000|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
164481158|NCT01185340|594134003|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
164481159|NCT01185340|594134004|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
164481160|NCT01185340|594134005|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
164481161|NCT01185340|594134006|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
164481162|NCT01185340|594134003|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
164481163|NCT01185340|594134004|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
164481164|NCT01185340|594134005|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
164481165|NCT01185340|594134006|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
164481166|NCT01185340|594134003|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
164481167|NCT01185340|594134004|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
164481168|NCT01185340|594134005|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
164481169|NCT01185340|594134006|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
164481170|NCT01185340|594134003|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
164481171|NCT01185340|594134004|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
164481172|NCT01185340|594134005|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
164481173|NCT01185340|594134006|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
164481174|NCT01185340|594134003|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
164481175|NCT01185340|594134004|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
164481176|NCT01185340|594134005|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
164481177|NCT01185340|594134006|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
164481178|NCT01185340|594134003|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
164481179|NCT01185340|594134004|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
164481180|NCT01185340|594134005|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
164481181|NCT01185340|594134006|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
164481182|NCT01185340|594134003|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
164481183|NCT01185340|594134004|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
164481184|NCT01185340|594134005|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
164481185|NCT01185340|594134006|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
164481186|NCT01185340|594134003|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
164481187|NCT01185340|594134004|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
164481188|NCT01185340|594134005|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
164481189|NCT01185340|594134006|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
164481190|NCT01185340|594134003|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
164481191|NCT01185340|594134004|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
164481192|NCT01185340|594134005|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
164481193|NCT01185340|594134006|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
164481194|NCT01185340|594134003|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
164481195|NCT01185340|594134004|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
164481196|NCT01185340|594134005|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
164481197|NCT01185340|594134006|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
164481198|NCT01185340|594134003|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
164481199|NCT01185340|594134004|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
164481200|NCT01185340|594134005|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
164481201|NCT01185340|594134006|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
164481202|NCT01185340|594134003|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
164481203|NCT01185340|594134004|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
164481204|NCT01185340|594134005|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
164481205|NCT01185340|594134006|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
164481206|NCT01185340|594134003|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
164481207|NCT01185340|594134004|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
164481208|NCT01185340|594134005|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
164481209|NCT01185340|594134006|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
164481210|NCT01185340|594134003|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
164481211|NCT01185340|594134004|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
164481212|NCT01185340|594134005|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
164481213|NCT01185340|594134006|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
164481214|NCT00087516|594134007|FG000|Overall Study|Adverse Event|10|||
164481215|NCT00087516|594134008|FG001|Overall Study|Adverse Event|10|||
164481216|NCT00087516|594134009|FG002|Overall Study|Adverse Event|3|||
164481217|NCT00087516|594134010|FG003|Overall Study|Adverse Event|6|||
164481218|NCT00087516|594134007|FG000|Overall Study|Lack of Efficacy|82|||
164481219|NCT00087516|594134008|FG001|Overall Study|Lack of Efficacy|80|||
164714349|NCT03106987|594976869|FG003|Overall Study|Lost to Follow-up|2|||
164714350|NCT03106987|594976866|FG000|Overall Study|Withdrawal by Subject|5|||
164714351|NCT03106987|594976867|FG001|Overall Study|Withdrawal by Subject|1|||
164481220|NCT00087516|594134009|FG002|Overall Study|Lack of Efficacy|39|||
164481221|NCT00087516|594134010|FG003|Overall Study|Lack of Efficacy|29|||
164481222|NCT00087516|594134007|FG000|Overall Study|Lost to Follow-up|8|||
164481223|NCT00087516|594134008|FG001|Overall Study|Lost to Follow-up|6|||
164481224|NCT00087516|594134009|FG002|Overall Study|Lost to Follow-up|5|||
164481225|NCT00087516|594134010|FG003|Overall Study|Lost to Follow-up|5|||
164481226|NCT00087516|594134007|FG000|Overall Study|Protocol Violation|4|||
164481227|NCT00087516|594134008|FG001|Overall Study|Protocol Violation|8|||
164481228|NCT00087516|594134009|FG002|Overall Study|Protocol Violation|3|||
164481229|NCT00087516|594134010|FG003|Overall Study|Protocol Violation|6|||
164481230|NCT00087516|594134007|FG000|Overall Study|Withdrawal by Subject|16|||
164481231|NCT00087516|594134008|FG001|Overall Study|Withdrawal by Subject|27|||
164481232|NCT00087516|594134009|FG002|Overall Study|Withdrawal by Subject|11|||
164481233|NCT00087516|594134010|FG003|Overall Study|Withdrawal by Subject|12|||
164481234|NCT00087516|594134007|FG000|Overall Study|Site terminated|0|||
164481235|NCT00087516|594134008|FG001|Overall Study|Site terminated|2|||
164481236|NCT00087516|594134009|FG002|Overall Study|Site terminated|1|||
164481237|NCT00087516|594134010|FG003|Overall Study|Site terminated|0|||
164481238|NCT00087516|594134007|FG000|Overall Study|Protocol specified discontinuation|35|||
164481239|NCT00087516|594134008|FG001|Overall Study|Protocol specified discontinuation|33|||
164481240|NCT00087516|594134009|FG002|Overall Study|Protocol specified discontinuation|33|||
164481241|NCT00087516|594134010|FG003|Overall Study|Protocol specified discontinuation|26|||
164481242|NCT00087516|594134007|FG000|Overall Study|Patient moved|3|||
164481243|NCT00087516|594134008|FG001|Overall Study|Patient moved|2|||
164481244|NCT00087516|594134009|FG002|Overall Study|Patient moved|1|||
164481245|NCT00087516|594134010|FG003|Overall Study|Patient moved|0|||
164481246|NCT00087516|594134007|FG000|Overall Study|Patient was non-compliant|3|||
164481247|NCT00087516|594134008|FG001|Overall Study|Patient was non-compliant|1|||
164481248|NCT00087516|594134009|FG002|Overall Study|Patient was non-compliant|0|||
164481249|NCT00087516|594134010|FG003|Overall Study|Patient was non-compliant|0|||
164481250|NCT00087516|594134007|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
164481251|NCT00087516|594134008|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
164481252|NCT00087516|594134009|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
164481253|NCT00087516|594134010|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
164481254|NCT00087516|594134007|FG000|Overall Study|Other|0|||
164481255|NCT00087516|594134008|FG001|Overall Study|Other|0|||
164481256|NCT00087516|594134009|FG002|Overall Study|Other|1|||
164481257|NCT00087516|594134010|FG003|Overall Study|Other|0|||
164481258|NCT00246129|594134013|FG000|Overall Study|Lost to Follow-up|1|||
164481259|NCT00246129|594134014|FG001|Overall Study|Lost to Follow-up|0|||
164481260|NCT00246129|594134013|FG000|Overall Study|Death|2|||
164481261|NCT00246129|594134014|FG001|Overall Study|Death|1|||
164481262|NCT00246129|594134013|FG000|Overall Study|suffered primary non-function|1|||
164481263|NCT00246129|594134014|FG001|Overall Study|suffered primary non-function|0|||
164481264|NCT00246129|594134013|FG000|Overall Study|grafts failed|3|||
164481265|NCT00246129|594134014|FG001|Overall Study|grafts failed|1|||
164481266|NCT02605174|594134019|FG000|Overall Study|Adverse Event|0|||
164481267|NCT02605174|594134020|FG001|Overall Study|Adverse Event|0|||
164481268|NCT02605174|594134021|FG002|Overall Study|Adverse Event|1|||
164481269|NCT02605174|594134022|FG003|Overall Study|Adverse Event|0|||
164481270|NCT02605174|594134023|FG004|Overall Study|Adverse Event|4|||
164481271|NCT02605174|594134024|FG005|Overall Study|Adverse Event|0|||
164481272|NCT02605174|594134025|FG006|Overall Study|Adverse Event|0|||
164481273|NCT02605174|594134019|FG000|Overall Study|Lost to Follow-up|20|||
164481274|NCT02605174|594134020|FG001|Overall Study|Lost to Follow-up|7|||
164481275|NCT02605174|594134021|FG002|Overall Study|Lost to Follow-up|27|||
164481276|NCT02605174|594134022|FG003|Overall Study|Lost to Follow-up|10|||
164481277|NCT02605174|594134023|FG004|Overall Study|Lost to Follow-up|20|||
164481278|NCT02605174|594134024|FG005|Overall Study|Lost to Follow-up|10|||
164600588|NCT00430521|594558279|FG003|Overall Study|Pregnancy|0|||
164600589|NCT00430521|594558280|FG004|Overall Study|Pregnancy|0|||
164600590|NCT00430521|594558281|FG005|Overall Study|Pregnancy|0|||
164600591|NCT00430521|594558282|FG006|Overall Study|Pregnancy|1|||
164481279|NCT02605174|594134025|FG006|Overall Study|Lost to Follow-up|29|||
164481280|NCT02605174|594134019|FG000|Overall Study|Protocol Violation|10|||
164481281|NCT02605174|594134020|FG001|Overall Study|Protocol Violation|4|||
164481282|NCT02605174|594134021|FG002|Overall Study|Protocol Violation|14|||
164481283|NCT02605174|594134022|FG003|Overall Study|Protocol Violation|6|||
164481284|NCT02605174|594134023|FG004|Overall Study|Protocol Violation|7|||
164481285|NCT02605174|594134024|FG005|Overall Study|Protocol Violation|7|||
164481286|NCT02605174|594134025|FG006|Overall Study|Protocol Violation|12|||
164481287|NCT02605174|594134019|FG000|Overall Study|Pregnancy|1|||
164481288|NCT02605174|594134020|FG001|Overall Study|Pregnancy|0|||
164481289|NCT02605174|594134021|FG002|Overall Study|Pregnancy|0|||
164481290|NCT02605174|594134022|FG003|Overall Study|Pregnancy|2|||
164481291|NCT02605174|594134023|FG004|Overall Study|Pregnancy|0|||
164481292|NCT02605174|594134024|FG005|Overall Study|Pregnancy|0|||
164481293|NCT02605174|594134025|FG006|Overall Study|Pregnancy|0|||
164481294|NCT02605174|594134019|FG000|Overall Study|Withdrawal by Subject|9|||
164600592|NCT00430521|594558283|FG007|Overall Study|Pregnancy|0|||
164600593|NCT00430521|594558276|FG000|Overall Study|Vaccine Expired|0|||
164600594|NCT00430521|594558277|FG001|Overall Study|Vaccine Expired|0|||
164600595|NCT00430521|594558278|FG002|Overall Study|Vaccine Expired|0|||
164600596|NCT00430521|594558279|FG003|Overall Study|Vaccine Expired|0|||
164600597|NCT00430521|594558280|FG004|Overall Study|Vaccine Expired|0|||
164600598|NCT00430521|594558281|FG005|Overall Study|Vaccine Expired|1|||
164600599|NCT00430521|594558282|FG006|Overall Study|Vaccine Expired|0|||
164600600|NCT00430521|594558283|FG007|Overall Study|Vaccine Expired|0|||
164600601|NCT00430521|594558276|FG000|Overall Study|Protocol Violation|1|||
164600602|NCT00430521|594558277|FG001|Overall Study|Protocol Violation|0|||
164600603|NCT00430521|594558278|FG002|Overall Study|Protocol Violation|0|||
164600604|NCT00430521|594558279|FG003|Overall Study|Protocol Violation|0|||
164600605|NCT00430521|594558280|FG004|Overall Study|Protocol Violation|0|||
164600606|NCT00430521|594558281|FG005|Overall Study|Protocol Violation|0|||
164600607|NCT00430521|594558282|FG006|Overall Study|Protocol Violation|0|||
164600608|NCT00430521|594558283|FG007|Overall Study|Protocol Violation|0|||
164600609|NCT00430521|594558276|FG000|Overall Study|Withdrawal by Subject|3|||
164600610|NCT00430521|594558277|FG001|Overall Study|Withdrawal by Subject|1|||
164600611|NCT00430521|594558278|FG002|Overall Study|Withdrawal by Subject|0|||
164600612|NCT00430521|594558279|FG003|Overall Study|Withdrawal by Subject|3|||
164600613|NCT00430521|594558280|FG004|Overall Study|Withdrawal by Subject|0|||
164600614|NCT00430521|594558281|FG005|Overall Study|Withdrawal by Subject|0|||
164600615|NCT00430521|594558282|FG006|Overall Study|Withdrawal by Subject|0|||
164600616|NCT00430521|594558283|FG007|Overall Study|Withdrawal by Subject|2|||
164600617|NCT03675737|594558284|FG000|Overall Study|Death|593|||
164600618|NCT03675737|594558285|FG001|Overall Study|Death|660|||
164481295|NCT02605174|594134020|FG001|Overall Study|Withdrawal by Subject|6|||
164481296|NCT02605174|594134021|FG002|Overall Study|Withdrawal by Subject|14|||
164481297|NCT02605174|594134022|FG003|Overall Study|Withdrawal by Subject|11|||
164481298|NCT02605174|594134023|FG004|Overall Study|Withdrawal by Subject|6|||
164481299|NCT02605174|594134024|FG005|Overall Study|Withdrawal by Subject|4|||
164481300|NCT02605174|594134025|FG006|Overall Study|Withdrawal by Subject|15|||
164481301|NCT02605174|594134019|FG000|Overall Study|Physician Decision|2|||
164481302|NCT02605174|594134020|FG001|Overall Study|Physician Decision|0|||
164481303|NCT02605174|594134021|FG002|Overall Study|Physician Decision|0|||
164481304|NCT02605174|594134022|FG003|Overall Study|Physician Decision|0|||
164481305|NCT02605174|594134023|FG004|Overall Study|Physician Decision|0|||
164481306|NCT02605174|594134024|FG005|Overall Study|Physician Decision|0|||
164600619|NCT03675737|594558284|FG000|Overall Study|Lost to Follow-up|1|||
164600620|NCT03675737|594558285|FG001|Overall Study|Lost to Follow-up|5|||
164600621|NCT03675737|594558284|FG000|Overall Study|Physician Decision|1|||
164600622|NCT03675737|594558285|FG001|Overall Study|Physician Decision|0|||
164600623|NCT03675737|594558284|FG000|Overall Study|Withdrawal by Subject|14|||
164600624|NCT03675737|594558285|FG001|Overall Study|Withdrawal by Subject|12|||
164600625|NCT03675737|594558284|FG000|Overall Study|Ongoing in Study|181|||
164600626|NCT03675737|594558285|FG001|Overall Study|Ongoing in Study|112|||
164600627|NCT03422133|594558290|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
164600628|NCT03422133|594558291|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
164600629|NCT02180724|594559799|FG000|Overall Study|Death|26|||
164600630|NCT02180724|594559800|FG001|Overall Study|Death|1|||
164600631|NCT02180724|594559799|FG000|Overall Study|Lost to Follow-up|3|||
164600632|NCT02180724|594559800|FG001|Overall Study|Lost to Follow-up|1|||
164600633|NCT02180724|594559799|FG000|Overall Study|Withdrawal by Subject|4|||
164600634|NCT02180724|594559800|FG001|Overall Study|Withdrawal by Subject|2|||
164600635|NCT02180724|594559799|FG000|Overall Study|PI Decision|5|||
164600636|NCT02180724|594559800|FG001|Overall Study|PI Decision|2|||
164600637|NCT02180724|594559799|FG000|Overall Study|Study terminated by sponsor|54|||
164600638|NCT02180724|594559800|FG001|Overall Study|Study terminated by sponsor|8|||
164714352|NCT03106987|594976868|FG002|Overall Study|Withdrawal by Subject|4|||
164481307|NCT02605174|594134025|FG006|Overall Study|Physician Decision|3|||
164481308|NCT02605174|594134019|FG000|Overall Study|Randomization Failure|22|||
164481309|NCT02605174|594134020|FG001|Overall Study|Randomization Failure|6|||
164481310|NCT02605174|594134021|FG002|Overall Study|Randomization Failure|20|||
164714353|NCT03106987|594976869|FG003|Overall Study|Withdrawal by Subject|1|||
164481311|NCT02605174|594134022|FG003|Overall Study|Randomization Failure|7|||
164481312|NCT02605174|594134023|FG004|Overall Study|Randomization Failure|16|||
164481313|NCT02605174|594134024|FG005|Overall Study|Randomization Failure|11|||
164481314|NCT02605174|594134025|FG006|Overall Study|Randomization Failure|30|||
164600639|NCT05168813|594559801|FG000|Part A (Open-label)|Lost to Follow-up|21|||
164600640|NCT05168813|594559802|FG001|Part A (Open-label)|Lost to Follow-up|39|||
164600641|NCT05168813|594559803|FG002|Part A (Open-label)|Lost to Follow-up|8|||
164600642|NCT05168813|594559804|FG003|Part A (Open-label)|Lost to Follow-up|26|||
164600643|NCT05168813|594559805|FG004|Part A (Open-label)|Lost to Follow-up|0|||
164600644|NCT05168813|594559806|FG005|Part A (Open-label)|Lost to Follow-up|0|||
164600645|NCT05168813|594559801|FG000|Part A (Open-label)|Withdrawal by Subject|35|||
164600646|NCT05168813|594559802|FG001|Part A (Open-label)|Withdrawal by Subject|30|||
164714354|NCT02114385|594976876|FG000|Overall Study|Withdrawal by Subject|3|||
164481315|NCT01779050|594134028|FG000|Overall Study|Withdrawal by Subject|1|||
164481316|NCT01779050|594134029|FG001|Overall Study|Withdrawal by Subject|0|||
164481317|NCT03403036|594134030|FG000|Overall Study|Lack of Efficacy|5|||
164481318|NCT04938453|594134033|FG000|Washout Period 1|Adverse Event|1|||
164481319|NCT04938453|594134034|FG001|Washout Period 1|Adverse Event|0|||
164481320|NCT04938453|594134033|FG000|Washout Period 1|Physician Decision|0|||
164481321|NCT04938453|594134034|FG001|Washout Period 1|Physician Decision|1|||
164481322|NCT03292406|594134035|FG000|Overall Study|Progressive Disease|6|||
164481323|NCT03292406|594134036|FG001|Overall Study|Progressive Disease|3|||
164481324|NCT03292406|594134037|FG002|Overall Study|Progressive Disease|4|||
164481325|NCT03292406|594134035|FG000|Overall Study|Adverse Event|7|||
164481326|NCT03292406|594134036|FG001|Overall Study|Adverse Event|1|||
164481327|NCT03292406|594134037|FG002|Overall Study|Adverse Event|4|||
164481328|NCT03292406|594134035|FG000|Overall Study|Withdrawal by Subject|0|||
164481329|NCT03292406|594134036|FG001|Overall Study|Withdrawal by Subject|7|||
164481330|NCT03292406|594134037|FG002|Overall Study|Withdrawal by Subject|2|||
164481331|NCT03292406|594134035|FG000|Overall Study|Protocol Violation|0|||
164481332|NCT03292406|594134036|FG001|Overall Study|Protocol Violation|1|||
164481333|NCT03292406|594134037|FG002|Overall Study|Protocol Violation|1|||
164481334|NCT03292406|594134035|FG000|Overall Study|Other|0|||
164481335|NCT03292406|594134036|FG001|Overall Study|Other|1|||
164481336|NCT03292406|594134037|FG002|Overall Study|Other|2|||
164481337|NCT00308308|594134039|FG000|Overall Study|Adverse Event|17|||
164481338|NCT00308308|594134040|FG001|Overall Study|Adverse Event|2|||
164481339|NCT00308308|594134039|FG000|Overall Study|Lost to Follow-up|5|||
164481340|NCT00308308|594134040|FG001|Overall Study|Lost to Follow-up|5|||
164481341|NCT00308308|594134039|FG000|Overall Study|Physician Decision|15|||
164481342|NCT00308308|594134040|FG001|Overall Study|Physician Decision|7|||
164481343|NCT00308308|594134039|FG000|Overall Study|Protocol Violation|3|||
164481344|NCT00308308|594134040|FG001|Overall Study|Protocol Violation|14|||
164481345|NCT00308308|594134039|FG000|Overall Study|Withdrawal by Subject|47|||
164481346|NCT00308308|594134040|FG001|Overall Study|Withdrawal by Subject|19|||
164481347|NCT00308308|594134039|FG000|Overall Study|Various|7|||
164481348|NCT00308308|594134040|FG001|Overall Study|Various|5|||
164481349|NCT00308308|594134039|FG000|Overall Study|Randomized but not dosed|8|||
164481350|NCT00308308|594134040|FG001|Overall Study|Randomized but not dosed|16|||
164481351|NCT00308308|594134039|FG000|Overall Study|Other|1|||
164481352|NCT00308308|594134040|FG001|Overall Study|Other|0|||
164481353|NCT02392507|594134047|FG000|Induction Regimen|Death|3|||
164481354|NCT02392507|594134047|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
164481355|NCT02392507|594134047|FG000|Induction Regimen|Physician Decision|1|||
164481356|NCT02392507|594134047|FG000|Induction Regimen|Withdrawal by Subject|2|||
164481357|NCT02392507|594134047|FG000|Maintenance Regimen|Death|1|||
164481358|NCT02392507|594134047|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
164481359|NCT00273052|594134048|FG000|Overall Study|Withdrawal by Subject|16|||
164481360|NCT00273052|594134049|FG001|Overall Study|Withdrawal by Subject|19|||
164481361|NCT00273052|594134048|FG000|Overall Study|Adverse Event|21|||
164481362|NCT00273052|594134049|FG001|Overall Study|Adverse Event|19|||
164481363|NCT00273052|594134048|FG000|Overall Study|Protocol Violation|14|||
164481364|NCT00273052|594134049|FG001|Overall Study|Protocol Violation|18|||
164481365|NCT00273052|594134048|FG000|Overall Study|Lost to Follow-up|7|||
164481366|NCT00273052|594134049|FG001|Overall Study|Lost to Follow-up|25|||
164481367|NCT00273052|594134048|FG000|Overall Study|Lack of Efficacy|6|||
164481368|NCT00273052|594134049|FG001|Overall Study|Lack of Efficacy|4|||
164481369|NCT00273052|594134048|FG000|Overall Study|Non-Compliance|3|||
164481370|NCT00273052|594134049|FG001|Overall Study|Non-Compliance|1|||
164481371|NCT00273052|594134048|FG000|Overall Study|Other|2|||
164481372|NCT00273052|594134049|FG001|Overall Study|Other|0|||
164481373|NCT00273052|594134048|FG000|Overall Study|Worsening serum lipid levels|0|||
164481374|NCT00273052|594134049|FG001|Overall Study|Worsening serum lipid levels|2|||
164481375|NCT00704340|594134050|FG000|Overall Study|Lost to Follow-up|2|||
164481376|NCT00704340|594134051|FG001|Overall Study|Lost to Follow-up|1|||
164481377|NCT00704340|594134050|FG000|Overall Study|Death|0|||
164481378|NCT00704340|594134051|FG001|Overall Study|Death|1|||
164481379|NCT02827201|594134052|FG000|Overall Study|Death|1|||
164481380|NCT02827201|594134053|FG001|Overall Study|Death|2|||
164481381|NCT02827201|594134052|FG000|Overall Study|Patients not treated|1|||
164481382|NCT02827201|594134053|FG001|Overall Study|Patients not treated|1|||
164481383|NCT01021748|594134059|FG000|Overall Study|Adverse Event|2|||
164481384|NCT01021748|594134060|FG001|Overall Study|Adverse Event|1|||
164481385|NCT01021748|594134061|FG002|Overall Study|Adverse Event|2|||
164481386|NCT01021748|594134062|FG003|Overall Study|Adverse Event|0|||
164481387|NCT01021748|594134063|FG004|Overall Study|Adverse Event|2|||
164481388|NCT01021748|594134064|FG005|Overall Study|Adverse Event|0|||
164481389|NCT01021748|594134065|FG006|Overall Study|Adverse Event|1|||
164481390|NCT01021748|594134066|FG007|Overall Study|Adverse Event|0|||
164481391|NCT01021748|594134067|FG008|Overall Study|Adverse Event|7|||
164481392|NCT01021748|594134059|FG000|Overall Study|Physician Decision|1|||
164481393|NCT01021748|594134060|FG001|Overall Study|Physician Decision|0|||
164481394|NCT01021748|594134061|FG002|Overall Study|Physician Decision|1|||
164481395|NCT01021748|594134062|FG003|Overall Study|Physician Decision|1|||
164481396|NCT01021748|594134063|FG004|Overall Study|Physician Decision|0|||
164481397|NCT01021748|594134064|FG005|Overall Study|Physician Decision|0|||
164481398|NCT01021748|594134065|FG006|Overall Study|Physician Decision|1|||
164481399|NCT01021748|594134066|FG007|Overall Study|Physician Decision|1|||
164481400|NCT01021748|594134067|FG008|Overall Study|Physician Decision|2|||
164481401|NCT01021748|594134059|FG000|Overall Study|Progressive Disease|3|||
164481402|NCT01021748|594134060|FG001|Overall Study|Progressive Disease|3|||
164481403|NCT01021748|594134061|FG002|Overall Study|Progressive Disease|4|||
164481404|NCT01021748|594134062|FG003|Overall Study|Progressive Disease|6|||
164481405|NCT01021748|594134063|FG004|Overall Study|Progressive Disease|7|||
164481406|NCT01021748|594134064|FG005|Overall Study|Progressive Disease|3|||
164481407|NCT01021748|594134065|FG006|Overall Study|Progressive Disease|0|||
164481408|NCT01021748|594134066|FG007|Overall Study|Progressive Disease|5|||
164481409|NCT01021748|594134067|FG008|Overall Study|Progressive Disease|6|||
164481410|NCT01021748|594134059|FG000|Overall Study|Withdrawal by Subject|0|||
164481411|NCT01021748|594134060|FG001|Overall Study|Withdrawal by Subject|0|||
164481412|NCT01021748|594134061|FG002|Overall Study|Withdrawal by Subject|0|||
164481413|NCT01021748|594134062|FG003|Overall Study|Withdrawal by Subject|0|||
164481414|NCT01021748|594134063|FG004|Overall Study|Withdrawal by Subject|0|||
164481415|NCT01021748|594134064|FG005|Overall Study|Withdrawal by Subject|0|||
164481416|NCT01021748|594134065|FG006|Overall Study|Withdrawal by Subject|1|||
164481417|NCT01021748|594134066|FG007|Overall Study|Withdrawal by Subject|0|||
164481418|NCT01021748|594134067|FG008|Overall Study|Withdrawal by Subject|1|||
164481419|NCT01021748|594134059|FG000|Overall Study|Not Treated|0|||
164481420|NCT01021748|594134060|FG001|Overall Study|Not Treated|1|||
164481421|NCT01021748|594134061|FG002|Overall Study|Not Treated|0|||
164481422|NCT01021748|594134062|FG003|Overall Study|Not Treated|0|||
164481423|NCT01021748|594134063|FG004|Overall Study|Not Treated|0|||
164481424|NCT01021748|594134064|FG005|Overall Study|Not Treated|0|||
164481425|NCT01021748|594134065|FG006|Overall Study|Not Treated|0|||
164481426|NCT01021748|594134066|FG007|Overall Study|Not Treated|0|||
164481427|NCT01021748|594134067|FG008|Overall Study|Not Treated|0|||
164481428|NCT00403845|594134071|FG000|Treatment Period 1|Subject withdrew consent|1|||
164481429|NCT00403845|594134072|FG001|Treatment Period 1|Subject withdrew consent|0|||
164481430|NCT00403845|594134073|FG002|Treatment Period 1|Subject withdrew consent|0|||
164481431|NCT00403845|594134074|FG003|Treatment Period 1|Subject withdrew consent|0|||
164481432|NCT00403845|594134071|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
164481433|NCT00403845|594134072|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
164481434|NCT00403845|594134073|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
164481435|NCT00403845|594134074|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
164481436|NCT00403845|594134071|FG000|Treatment Period 2|Subject withdrew consent|1|||
164481437|NCT00403845|594134072|FG001|Treatment Period 2|Subject withdrew consent|0|||
164481438|NCT00403845|594134073|FG002|Treatment Period 2|Subject withdrew consent|0|||
164481439|NCT00403845|594134074|FG003|Treatment Period 2|Subject withdrew consent|0|||
164481440|NCT00403845|594134071|FG000|Treatment Period 3|Subject withdrew consent|0|||
164481441|NCT00403845|594134072|FG001|Treatment Period 3|Subject withdrew consent|0|||
164481442|NCT00403845|594134073|FG002|Treatment Period 3|Subject withdrew consent|0|||
164481443|NCT00403845|594134074|FG003|Treatment Period 3|Subject withdrew consent|1|||
164481444|NCT00403845|594134071|FG000|Treatment Period 3|Adverse Event|0|||
164481445|NCT00403845|594134072|FG001|Treatment Period 3|Adverse Event|0|||
164481446|NCT00403845|594134073|FG002|Treatment Period 3|Adverse Event|0|||
164481447|NCT00403845|594134074|FG003|Treatment Period 3|Adverse Event|1|||
164481448|NCT03316170|594134075|FG000|Overall Study|Death|1|||
164481449|NCT03316170|594134076|FG001|Overall Study|Death|0|||
164481450|NCT03316170|594134075|FG000|Overall Study|Lost to Follow-up|6|||
164481451|NCT03316170|594134076|FG001|Overall Study|Lost to Follow-up|7|||
164481452|NCT01640288|594134077|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
164481453|NCT01640288|594134078|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
164481454|NCT01640288|594134077|FG000|Overall Study|Screen Failure|20|||
164481455|NCT01640288|594134078|FG001|Overall Study|Screen Failure|18|||
164481456|NCT01640288|594134077|FG000|Overall Study|Withdrawn by PI|5|||
164481457|NCT01640288|594134078|FG001|Overall Study|Withdrawn by PI|0|||
164481458|NCT01640288|594134077|FG000|Overall Study|Withdrawal by Subject|1|||
164481459|NCT01640288|594134078|FG001|Overall Study|Withdrawal by Subject|0|||
164481460|NCT02095678|594134079|FG000|Overall Study|Withdrawal by Subject|0|||
164481461|NCT02095678|594134080|FG001|Overall Study|Withdrawal by Subject|1|||
164481462|NCT02095678|594134079|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
164481463|NCT02095678|594134080|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
164481464|NCT02095678|594134079|FG000|Overall Study|lesion impacted by previous treatment|1|||
164481465|NCT02095678|594134080|FG001|Overall Study|lesion impacted by previous treatment|1|||
164481466|NCT02095678|594134079|FG000|Overall Study|No Confirmed Diagnosis|0|||
164481467|NCT02095678|594134080|FG001|Overall Study|No Confirmed Diagnosis|3|||
164481468|NCT02095678|594134079|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
164600647|NCT05168813|594559803|FG002|Part A (Open-label)|Withdrawal by Subject|14|||
164600648|NCT05168813|594559804|FG003|Part A (Open-label)|Withdrawal by Subject|17|||
164600649|NCT05168813|594559805|FG004|Part A (Open-label)|Withdrawal by Subject|0|||
164600650|NCT05168813|594559806|FG005|Part A (Open-label)|Withdrawal by Subject|0|||
164600651|NCT05168813|594559801|FG000|Part A (Open-label)|Death|23|||
164600652|NCT05168813|594559802|FG001|Part A (Open-label)|Death|28|||
164600653|NCT05168813|594559803|FG002|Part A (Open-label)|Death|1|||
164600654|NCT05168813|594559804|FG003|Part A (Open-label)|Death|9|||
164600655|NCT05168813|594559805|FG004|Part A (Open-label)|Death|0|||
164600656|NCT05168813|594559806|FG005|Part A (Open-label)|Death|0|||
164600657|NCT05168813|594559801|FG000|Part A (Open-label)|Physician Decision|0|||
164600658|NCT05168813|594559802|FG001|Part A (Open-label)|Physician Decision|1|||
164600659|NCT05168813|594559803|FG002|Part A (Open-label)|Physician Decision|0|||
164600660|NCT05168813|594559804|FG003|Part A (Open-label)|Physician Decision|2|||
164600661|NCT05168813|594559805|FG004|Part A (Open-label)|Physician Decision|0|||
164600662|NCT05168813|594559806|FG005|Part A (Open-label)|Physician Decision|0|||
164600663|NCT05168813|594559801|FG000|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|10|||
164600664|NCT05168813|594559802|FG001|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|18|||
164600665|NCT05168813|594559803|FG002|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
164600666|NCT05168813|594559804|FG003|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|7|||
164600667|NCT05168813|594559805|FG004|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
164600668|NCT05168813|594559806|FG005|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
164600669|NCT05168813|594559801|FG000|Part A (Open-label)|Protocol Violation|0|||
164600670|NCT05168813|594559802|FG001|Part A (Open-label)|Protocol Violation|1|||
164600671|NCT05168813|594559803|FG002|Part A (Open-label)|Protocol Violation|0|||
164600672|NCT05168813|594559804|FG003|Part A (Open-label)|Protocol Violation|0|||
164600673|NCT05168813|594559805|FG004|Part A (Open-label)|Protocol Violation|0|||
164600674|NCT05168813|594559806|FG005|Part A (Open-label)|Protocol Violation|0|||
164600675|NCT05168813|594559801|FG000|Part A (Open-label)|Study Terminated by Sponsor|3|||
164600676|NCT05168813|594559802|FG001|Part A (Open-label)|Study Terminated by Sponsor|4|||
164600677|NCT05168813|594559803|FG002|Part A (Open-label)|Study Terminated by Sponsor|1|||
164600678|NCT05168813|594559804|FG003|Part A (Open-label)|Study Terminated by Sponsor|5|||
164600679|NCT05168813|594559805|FG004|Part A (Open-label)|Study Terminated by Sponsor|0|||
164600680|NCT05168813|594559806|FG005|Part A (Open-label)|Study Terminated by Sponsor|0|||
164600681|NCT05168813|594559801|FG000|Part A (Open-label)|Other|0|||
164600682|NCT05168813|594559802|FG001|Part A (Open-label)|Other|1|||
164600683|NCT05168813|594559803|FG002|Part A (Open-label)|Other|0|||
164714355|NCT02114385|594976877|FG001|Overall Study|Withdrawal by Subject|2|||
164714356|NCT02114385|594976876|FG000|Overall Study|Lost to Follow-up|0|||
164714357|NCT02114385|594976877|FG001|Overall Study|Lost to Follow-up|6|||
164714358|NCT05320887|594976881|FG000|Overall Study|Lost to Follow-up|0|||
164714359|NCT05320887|594976882|FG001|Overall Study|Lost to Follow-up|3|||
164714360|NCT05320887|594976883|FG002|Overall Study|Lost to Follow-up|0|||
164714361|NCT05320887|594976884|FG003|Overall Study|Lost to Follow-up|0|||
164714362|NCT02460679|594976887|FG000|Overall Study|Investigator Decision|1|||
164714363|NCT02460679|594976887|FG000|Overall Study|Withdrawal by Subject|4|||
164714364|NCT03066258|594976900|FG000|Overall Study|Death|1|||
164714365|NCT03066258|594976901|FG001|Overall Study|Death|0|||
164714366|NCT03066258|594976902|FG002|Overall Study|Death|0|||
164714367|NCT03066258|594976903|FG003|Overall Study|Death|0|||
164714368|NCT03066258|594976904|FG004|Overall Study|Death|1|||
164714369|NCT02784795|594976905|FG000|Overall Study|Progressive Disease|2|||
164714370|NCT02784795|594976906|FG001|Overall Study|Progressive Disease|1|||
164714371|NCT02784795|594976907|FG002|Overall Study|Progressive Disease|1|||
164714372|NCT02784795|594976908|FG003|Overall Study|Progressive Disease|0|||
164714373|NCT02784795|594976909|FG004|Overall Study|Progressive Disease|2|||
164714374|NCT02784795|594976910|FG005|Overall Study|Progressive Disease|0|||
164714375|NCT02784795|594976911|FG006|Overall Study|Progressive Disease|2|||
164714376|NCT02784795|594976912|FG007|Overall Study|Progressive Disease|0|||
164714377|NCT02784795|594976913|FG008|Overall Study|Progressive Disease|0|||
164481469|NCT02095678|594134080|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
164481470|NCT02095678|594134079|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
164481471|NCT02095678|594134080|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
164481472|NCT03418545|594134081|FG000|Overall Study|Withdrawal by Participant|2|||
164481473|NCT03418545|594134082|FG001|Overall Study|Withdrawal by Participant|4|||
164481474|NCT03418545|594134081|FG000|Overall Study|Lost to Follow-up|3|||
164481475|NCT03418545|594134082|FG001|Overall Study|Lost to Follow-up|5|||
164481476|NCT03418545|594134081|FG000|Overall Study|Reason Not Specified|0|||
164481477|NCT03418545|594134082|FG001|Overall Study|Reason Not Specified|1|||
164481478|NCT03418545|594134081|FG000|Overall Study|Missing Completion Status|0|||
164481479|NCT03418545|594134082|FG001|Overall Study|Missing Completion Status|1|||
164600684|NCT05168813|594559804|FG003|Part A (Open-label)|Other|0|||
164600685|NCT05168813|594559805|FG004|Part A (Open-label)|Other|0|||
164714378|NCT02784795|594976914|FG009|Overall Study|Progressive Disease|0|||
164600686|NCT05168813|594559806|FG005|Part A (Open-label)|Other|0|||
164600687|NCT05168813|594559801|FG000|Part B (Blinded)|Lost to Follow-up|0|||
164481480|NCT05484661|594134088|FG000|Overall Study|Withdrawal by Subject|1|||
164481481|NCT05484661|594134089|FG001|Overall Study|Withdrawal by Subject|0|||
164481482|NCT00875706|594134090|FG000|Overall Study|Withdrawal by Subject|1|||
164481483|NCT00875706|594134091|FG001|Overall Study|Withdrawal by Subject|0|||
164481484|NCT00875706|594134092|FG002|Overall Study|Withdrawal by Subject|0|||
164481485|NCT03775213|594134093|FG000|Overall Study|Withdrawal by Subject|51|||
164481486|NCT03775213|594134094|FG001|Overall Study|Withdrawal by Subject|53|||
164481487|NCT03775213|594134093|FG000|Overall Study|Incomplete Survey|7|||
164481488|NCT03775213|594134094|FG001|Overall Study|Incomplete Survey|7|||
164481489|NCT00570505|594134096|FG000|Overall Study|Adverse Event|7|||
164481490|NCT00570505|594134096|FG000|Overall Study|Withdrawal by Subject|7|||
164481491|NCT00570505|594134096|FG000|Overall Study|Lost to Follow-up|23|||
164481492|NCT00570505|594134096|FG000|Overall Study|Other loss to follow-up|4|||
164481493|NCT00614614|594134097|FG000|Primary Vaccination Phase|Adverse Event|6|||
164481494|NCT00614614|594134098|FG001|Primary Vaccination Phase|Adverse Event|0|||
164481495|NCT00614614|594134099|FG002|Primary Vaccination Phase|Adverse Event|0|||
164481496|NCT00614614|594134100|FG003|Primary Vaccination Phase|Adverse Event|0|||
164481497|NCT00614614|594134101|FG004|Primary Vaccination Phase|Adverse Event|0|||
164481498|NCT00614614|594134097|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
164481499|NCT00614614|594134098|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
164481500|NCT00614614|594134099|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
164481501|NCT00614614|594134100|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
164481502|NCT00614614|594134101|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
164481503|NCT00614614|594134097|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
164481504|NCT00614614|594134098|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
164481505|NCT00614614|594134099|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
164481506|NCT00614614|594134100|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
164481507|NCT00614614|594134101|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
164481508|NCT00614614|594134097|FG000|Primary Vaccination Phase|Protocol Violation|9|||
164481509|NCT00614614|594134098|FG001|Primary Vaccination Phase|Protocol Violation|3|||
164481510|NCT00614614|594134099|FG002|Primary Vaccination Phase|Protocol Violation|0|||
164600688|NCT05168813|594559802|FG001|Part B (Blinded)|Lost to Follow-up|0|||
164600689|NCT05168813|594559803|FG002|Part B (Blinded)|Lost to Follow-up|0|||
164600690|NCT05168813|594559804|FG003|Part B (Blinded)|Lost to Follow-up|0|||
164600691|NCT05168813|594559805|FG004|Part B (Blinded)|Lost to Follow-up|219|||
164600692|NCT05168813|594559806|FG005|Part B (Blinded)|Lost to Follow-up|88|||
164600693|NCT05168813|594559801|FG000|Part B (Blinded)|Withdrawal by Subject|0|||
164600694|NCT05168813|594559802|FG001|Part B (Blinded)|Withdrawal by Subject|0|||
164600695|NCT05168813|594559803|FG002|Part B (Blinded)|Withdrawal by Subject|0|||
164600696|NCT05168813|594559804|FG003|Part B (Blinded)|Withdrawal by Subject|0|||
164600697|NCT05168813|594559805|FG004|Part B (Blinded)|Withdrawal by Subject|91|||
164714379|NCT02784795|594976915|FG010|Overall Study|Progressive Disease|1|||
164714380|NCT02784795|594976916|FG011|Overall Study|Progressive Disease|0|||
164714381|NCT02784795|594976905|FG000|Overall Study|Adverse Event|1|||
164714382|NCT02784795|594976906|FG001|Overall Study|Adverse Event|0|||
164714383|NCT02784795|594976907|FG002|Overall Study|Adverse Event|0|||
164714384|NCT02784795|594976908|FG003|Overall Study|Adverse Event|1|||
164714385|NCT02784795|594976909|FG004|Overall Study|Adverse Event|0|||
164714386|NCT02784795|594976910|FG005|Overall Study|Adverse Event|0|||
164714387|NCT02784795|594976911|FG006|Overall Study|Adverse Event|1|||
164714388|NCT02784795|594976912|FG007|Overall Study|Adverse Event|0|||
164714389|NCT02784795|594976913|FG008|Overall Study|Adverse Event|0|||
164714390|NCT02784795|594976914|FG009|Overall Study|Adverse Event|0|||
164714391|NCT02784795|594976915|FG010|Overall Study|Adverse Event|0|||
164714392|NCT02784795|594976916|FG011|Overall Study|Adverse Event|2|||
164714393|NCT02784795|594976905|FG000|Overall Study|Withdrawal by Subject|1|||
164714394|NCT02784795|594976906|FG001|Overall Study|Withdrawal by Subject|0|||
164714395|NCT02784795|594976907|FG002|Overall Study|Withdrawal by Subject|2|||
164714396|NCT02784795|594976908|FG003|Overall Study|Withdrawal by Subject|1|||
164714397|NCT02784795|594976909|FG004|Overall Study|Withdrawal by Subject|3|||
164714398|NCT02784795|594976910|FG005|Overall Study|Withdrawal by Subject|0|||
164714399|NCT02784795|594976911|FG006|Overall Study|Withdrawal by Subject|0|||
164714400|NCT02784795|594976912|FG007|Overall Study|Withdrawal by Subject|1|||
164714401|NCT02784795|594976913|FG008|Overall Study|Withdrawal by Subject|0|||
164714402|NCT02784795|594976914|FG009|Overall Study|Withdrawal by Subject|0|||
164714403|NCT02784795|594976915|FG010|Overall Study|Withdrawal by Subject|0|||
164481511|NCT00614614|594134100|FG003|Primary Vaccination Phase|Protocol Violation|0|||
164481512|NCT00614614|594134101|FG004|Primary Vaccination Phase|Protocol Violation|0|||
164481513|NCT00614614|594134097|FG000|Primary Vaccination Phase|Other|4|||
164481514|NCT00614614|594134098|FG001|Primary Vaccination Phase|Other|0|||
164481515|NCT00614614|594134099|FG002|Primary Vaccination Phase|Other|0|||
164481516|NCT00614614|594134100|FG003|Primary Vaccination Phase|Other|0|||
164600698|NCT05168813|594559806|FG005|Part B (Blinded)|Withdrawal by Subject|55|||
164714404|NCT02784795|594976916|FG011|Overall Study|Withdrawal by Subject|2|||
164714405|NCT02784795|594976905|FG000|Overall Study|Death|0|||
164714406|NCT02784795|594976906|FG001|Overall Study|Death|0|||
164600699|NCT05168813|594559801|FG000|Part B (Blinded)|Death|0|||
164600700|NCT05168813|594559802|FG001|Part B (Blinded)|Death|0|||
164600701|NCT05168813|594559803|FG002|Part B (Blinded)|Death|0|||
164600702|NCT05168813|594559804|FG003|Part B (Blinded)|Death|0|||
164600703|NCT05168813|594559805|FG004|Part B (Blinded)|Death|63|||
164600704|NCT05168813|594559806|FG005|Part B (Blinded)|Death|19|||
164600705|NCT05168813|594559801|FG000|Part B (Blinded)|Physician Decision|0|||
164600706|NCT05168813|594559802|FG001|Part B (Blinded)|Physician Decision|0|||
164600707|NCT05168813|594559803|FG002|Part B (Blinded)|Physician Decision|0|||
164600708|NCT05168813|594559804|FG003|Part B (Blinded)|Physician Decision|0|||
164600709|NCT05168813|594559805|FG004|Part B (Blinded)|Physician Decision|6|||
164600710|NCT05168813|594559806|FG005|Part B (Blinded)|Physician Decision|1|||
164600711|NCT05168813|594559801|FG000|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
164600712|NCT05168813|594559802|FG001|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
164600713|NCT05168813|594559803|FG002|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
164600714|NCT05168813|594559804|FG003|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
164600715|NCT05168813|594559805|FG004|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|54|||
164600716|NCT05168813|594559806|FG005|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|21|||
164600717|NCT05168813|594559801|FG000|Part B (Blinded)|Pregnancy|0|||
164600718|NCT05168813|594559802|FG001|Part B (Blinded)|Pregnancy|0|||
164600719|NCT05168813|594559803|FG002|Part B (Blinded)|Pregnancy|0|||
164600720|NCT05168813|594559804|FG003|Part B (Blinded)|Pregnancy|0|||
164600721|NCT05168813|594559805|FG004|Part B (Blinded)|Pregnancy|1|||
164600722|NCT05168813|594559806|FG005|Part B (Blinded)|Pregnancy|0|||
164600723|NCT05168813|594559801|FG000|Part B (Blinded)|Study Terminated by Sponsor|0|||
164600724|NCT05168813|594559802|FG001|Part B (Blinded)|Study Terminated by Sponsor|0|||
164600725|NCT05168813|594559803|FG002|Part B (Blinded)|Study Terminated by Sponsor|0|||
164600726|NCT05168813|594559804|FG003|Part B (Blinded)|Study Terminated by Sponsor|0|||
164600727|NCT05168813|594559805|FG004|Part B (Blinded)|Study Terminated by Sponsor|8682|||
164600728|NCT05168813|594559806|FG005|Part B (Blinded)|Study Terminated by Sponsor|125|||
164600729|NCT05168813|594559801|FG000|Part B (Blinded)|Other|0|||
164600730|NCT05168813|594559802|FG001|Part B (Blinded)|Other|0|||
164600731|NCT05168813|594559803|FG002|Part B (Blinded)|Other|0|||
164600732|NCT05168813|594559804|FG003|Part B (Blinded)|Other|0|||
164600733|NCT05168813|594559805|FG004|Part B (Blinded)|Other|41|||
164600734|NCT05168813|594559806|FG005|Part B (Blinded)|Other|27|||
164600735|NCT01397552|594559808|FG000|Overall Study|Adverse Event|1|||
164600736|NCT01397552|594559809|FG001|Overall Study|Adverse Event|0|||
164600737|NCT01397552|594559808|FG000|Overall Study|Withdrawal by Subject|2|||
164600738|NCT01397552|594559809|FG001|Overall Study|Withdrawal by Subject|1|||
164600739|NCT01089582|594559810|FG000|Overall Study|Death|2|||
164600740|NCT01089582|594559810|FG000|Overall Study|Adverse Event|15|||
164600741|NCT01089582|594559810|FG000|Overall Study|Lost to Follow-up|8|||
164600742|NCT01089582|594559810|FG000|Overall Study|Other|4|||
164600743|NCT01089582|594559810|FG000|Overall Study|Withdrawal by Subject|1|||
164600744|NCT04247815|594559811|FG000|Overall Study|Adverse Event|1|||
164600745|NCT04247815|594559812|FG001|Overall Study|Adverse Event|0|||
164600746|NCT04247815|594559811|FG000|Overall Study|Withdrawal by Subject|1|||
164600747|NCT04247815|594559812|FG001|Overall Study|Withdrawal by Subject|0|||
164600748|NCT04247815|594559811|FG000|Overall Study|Protocol Violation|0|||
164600749|NCT04247815|594559812|FG001|Overall Study|Protocol Violation|1|||
164600750|NCT02108600|594559815|FG000|Overall Study|Withdrawal by Subject|2|||
164600751|NCT02108600|594559816|FG001|Overall Study|Withdrawal by Subject|0|||
164600752|NCT02108600|594559815|FG000|Overall Study|Lost to Follow-up|1|||
164600753|NCT02108600|594559816|FG001|Overall Study|Lost to Follow-up|1|||
164600754|NCT01295580|594559819|FG000|Overall Study|Protocol Violation|4|||
164600755|NCT01295580|594559820|FG001|Overall Study|Protocol Violation|2|||
164600756|NCT01295580|594559819|FG000|Overall Study|Withdrawal by Subject|1|||
164600757|NCT01295580|594559820|FG001|Overall Study|Withdrawal by Subject|4|||
164600758|NCT01295580|594559819|FG000|Overall Study|Adverse Event|2|||
164600759|NCT01295580|594559820|FG001|Overall Study|Adverse Event|1|||
164600760|NCT01295580|594559819|FG000|Overall Study|Lost to Follow-up|1|||
164714407|NCT02784795|594976907|FG002|Overall Study|Death|0|||
164600761|NCT01295580|594559820|FG001|Overall Study|Lost to Follow-up|0|||
164600762|NCT01295580|594559819|FG000|Overall Study|Lack of Efficacy|1|||
164600763|NCT01295580|594559820|FG001|Overall Study|Lack of Efficacy|0|||
164600764|NCT01295580|594559819|FG000|Overall Study|Other: inconvenience|1|||
164600765|NCT01295580|594559820|FG001|Overall Study|Other: inconvenience|0|||
164600766|NCT01295580|594559819|FG000|Overall Study|Other: family objection|0|||
164600767|NCT01295580|594559820|FG001|Overall Study|Other: family objection|1|||
164600768|NCT01124448|594559822|FG000|Overall Study|Lost to Follow-up|0|||
164600769|NCT01124448|594559823|FG001|Overall Study|Lost to Follow-up|3|||
164600770|NCT01124448|594559822|FG000|Overall Study|Protocol Violation|2|||
164600771|NCT01124448|594559823|FG001|Overall Study|Protocol Violation|0|||
164600772|NCT05025787|594559826|FG000|Overall Study|Lack of Efficacy|0|||
164600773|NCT05025787|594559827|FG001|Overall Study|Lack of Efficacy|1|||
164600774|NCT05025787|594559826|FG000|Overall Study|Adverse Event|2|||
164600775|NCT05025787|594559827|FG001|Overall Study|Adverse Event|4|||
164481517|NCT00614614|594134101|FG004|Primary Vaccination Phase|Other|0|||
164481518|NCT00614614|594134097|FG000|Booster Vaccination Phase|Adverse Event|0|||
164481519|NCT00614614|594134098|FG001|Booster Vaccination Phase|Adverse Event|0|||
164481520|NCT00614614|594134099|FG002|Booster Vaccination Phase|Adverse Event|1|||
164481521|NCT00614614|594134100|FG003|Booster Vaccination Phase|Adverse Event|1|||
164481522|NCT00614614|594134101|FG004|Booster Vaccination Phase|Adverse Event|0|||
164481523|NCT00614614|594134097|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
164481524|NCT00614614|594134098|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
164481525|NCT00614614|594134099|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
164481526|NCT00614614|594134100|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
164481527|NCT00614614|594134101|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
164481528|NCT00614614|594134097|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
164481529|NCT00614614|594134098|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
164481530|NCT00614614|594134099|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
164481531|NCT00614614|594134100|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
164481532|NCT00614614|594134101|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
164481533|NCT00614614|594134097|FG000|Booster Vaccination Phase|Protocol Violation|0|||
164481534|NCT00614614|594134098|FG001|Booster Vaccination Phase|Protocol Violation|0|||
164481535|NCT00614614|594134099|FG002|Booster Vaccination Phase|Protocol Violation|2|||
164481536|NCT00614614|594134100|FG003|Booster Vaccination Phase|Protocol Violation|3|||
164481537|NCT00614614|594134101|FG004|Booster Vaccination Phase|Protocol Violation|0|||
164481538|NCT00614614|594134097|FG000|Booster Vaccination Phase|Other|0|||
164481539|NCT00614614|594134098|FG001|Booster Vaccination Phase|Other|1|||
164481540|NCT00614614|594134099|FG002|Booster Vaccination Phase|Other|3|||
164481541|NCT00614614|594134100|FG003|Booster Vaccination Phase|Other|2|||
164481542|NCT00614614|594134101|FG004|Booster Vaccination Phase|Other|1|||
164481543|NCT05426109|594134102|FG000|Overall Study|Withdrawal by Subject|0|||
164481544|NCT05426109|594134103|FG001|Overall Study|Withdrawal by Subject|1|||
164481545|NCT05212285|594134104|FG000|Overall Study|Lack of Efficacy|12|||
164481546|NCT05212285|594134105|FG001|Overall Study|Lack of Efficacy|8|||
164481547|NCT05212285|594134104|FG000|Overall Study|Withdrawal by Subject|8|||
164481548|NCT05212285|594134105|FG001|Overall Study|Withdrawal by Subject|1|||
164481549|NCT05212285|594134104|FG000|Overall Study|Lost to Follow-up|13|||
164481550|NCT05212285|594134105|FG001|Overall Study|Lost to Follow-up|1|||
164481551|NCT05212285|594134104|FG000|Overall Study|miss data|21|||
164481552|NCT05212285|594134105|FG001|Overall Study|miss data|2|||
164481553|NCT02334215|594134108|FG000|Overall Study|Death|1|||
164481554|NCT02334215|594134109|FG001|Overall Study|Death|1|||
164481555|NCT02334215|594134110|FG002|Overall Study|Death|0|||
164481556|NCT02334215|594134108|FG000|Overall Study|Lost to Follow-up|1|||
164481557|NCT02334215|594134109|FG001|Overall Study|Lost to Follow-up|0|||
164481558|NCT02334215|594134110|FG002|Overall Study|Lost to Follow-up|4|||
164481559|NCT02334215|594134108|FG000|Overall Study|Withdrawal by Subject|2|||
164481560|NCT02334215|594134109|FG001|Overall Study|Withdrawal by Subject|2|||
164481561|NCT02334215|594134110|FG002|Overall Study|Withdrawal by Subject|1|||
164481562|NCT02334215|594134108|FG000|Overall Study|Not released from incarceration on time|3|||
164481563|NCT02334215|594134109|FG001|Overall Study|Not released from incarceration on time|3|||
164481564|NCT02334215|594134110|FG002|Overall Study|Not released from incarceration on time|3|||
164481565|NCT02334215|594134108|FG000|Overall Study|Incarcerated|0|||
164481566|NCT02334215|594134109|FG001|Overall Study|Incarcerated|0|||
164481567|NCT02334215|594134110|FG002|Overall Study|Incarcerated|7|||
164481568|NCT05995977|594134111|FG000|Overall Study|Withdrawal by Subject|1|||
164481569|NCT05995977|594134112|FG001|Overall Study|Withdrawal by Subject|4|||
164481570|NCT05995977|594134111|FG000|Overall Study|Lost to Follow-up|2|||
164481571|NCT05995977|594134112|FG001|Overall Study|Lost to Follow-up|0|||
164481572|NCT04181788|594134113|FG000|TREATMENT|Adverse Event|0|||
164481573|NCT04181788|594134114|FG001|TREATMENT|Adverse Event|2|||
164481574|NCT04181788|594134115|FG002|TREATMENT|Adverse Event|1|||
164481575|NCT04181788|594134116|FG003|TREATMENT|Adverse Event|0|||
164481576|NCT04181788|594134117|FG004|TREATMENT|Adverse Event|1|||
164481577|NCT04181788|594134118|FG005|TREATMENT|Adverse Event|3|||
164481578|NCT04181788|594134113|FG000|TREATMENT|Death|0|||
164481579|NCT04181788|594134114|FG001|TREATMENT|Death|0|||
164481580|NCT04181788|594134115|FG002|TREATMENT|Death|0|||
164481581|NCT04181788|594134116|FG003|TREATMENT|Death|0|||
164481582|NCT04181788|594134117|FG004|TREATMENT|Death|8|||
164481583|NCT04181788|594134118|FG005|TREATMENT|Death|8|||
164481584|NCT04181788|594134113|FG000|TREATMENT|Physician Decision|0|||
164481585|NCT04181788|594134114|FG001|TREATMENT|Physician Decision|0|||
164481586|NCT04181788|594134115|FG002|TREATMENT|Physician Decision|0|||
164481587|NCT04181788|594134116|FG003|TREATMENT|Physician Decision|0|||
164481588|NCT04181788|594134117|FG004|TREATMENT|Physician Decision|0|||
164481589|NCT04181788|594134118|FG005|TREATMENT|Physician Decision|1|||
164481590|NCT04181788|594134113|FG000|TREATMENT|Progressive disease|3|||
164481591|NCT04181788|594134114|FG001|TREATMENT|Progressive disease|3|||
164481592|NCT04181788|594134115|FG002|TREATMENT|Progressive disease|5|||
164481593|NCT04181788|594134116|FG003|TREATMENT|Progressive disease|7|||
164481594|NCT04181788|594134117|FG004|TREATMENT|Progressive disease|20|||
164481595|NCT04181788|594134118|FG005|TREATMENT|Progressive disease|38|||
164600776|NCT05025787|594559826|FG000|Overall Study|Non compliance|0|||
164600777|NCT05025787|594559827|FG001|Overall Study|Non compliance|1|||
164600778|NCT05025787|594559826|FG000|Overall Study|Protocol Violation|3|||
164600779|NCT05025787|594559827|FG001|Overall Study|Protocol Violation|1|||
164600780|NCT05025787|594559826|FG000|Overall Study|Stopping criteria met|1|||
164600781|NCT05025787|594559827|FG001|Overall Study|Stopping criteria met|1|||
164600782|NCT05025787|594559826|FG000|Overall Study|Withdrawal by Subject|3|||
164600783|NCT05025787|594559827|FG001|Overall Study|Withdrawal by Subject|1|||
164600784|NCT05600309|594559828|FG000|Overall Study|Death|41|||
164600785|NCT05600309|594559829|FG001|Overall Study|Death|38|||
164600786|NCT05600309|594559828|FG000|Overall Study|Sponsor Decision|9|||
164481596|NCT04181788|594134113|FG000|TREATMENT|Global deterioration of health status|0|||
164481597|NCT04181788|594134114|FG001|TREATMENT|Global deterioration of health status|2|||
164481598|NCT04181788|594134115|FG002|TREATMENT|Global deterioration of health status|0|||
164481599|NCT04181788|594134116|FG003|TREATMENT|Global deterioration of health status|0|||
164481600|NCT04181788|594134117|FG004|TREATMENT|Global deterioration of health status|2|||
164481601|NCT04181788|594134118|FG005|TREATMENT|Global deterioration of health status|8|||
164481602|NCT04181788|594134113|FG000|TREATMENT|Withdrawal by Subject|1|||
164481603|NCT04181788|594134114|FG001|TREATMENT|Withdrawal by Subject|2|||
164481604|NCT04181788|594134115|FG002|TREATMENT|Withdrawal by Subject|0|||
164481605|NCT04181788|594134116|FG003|TREATMENT|Withdrawal by Subject|0|||
164481606|NCT04181788|594134117|FG004|TREATMENT|Withdrawal by Subject|3|||
164481607|NCT04181788|594134118|FG005|TREATMENT|Withdrawal by Subject|5|||
164481608|NCT04181788|594134113|FG000|TREATMENT|Other unspecified|0|||
164481609|NCT04181788|594134114|FG001|TREATMENT|Other unspecified|0|||
164481610|NCT04181788|594134115|FG002|TREATMENT|Other unspecified|0|||
164481611|NCT04181788|594134116|FG003|TREATMENT|Other unspecified|0|||
164481612|NCT04181788|594134117|FG004|TREATMENT|Other unspecified|0|||
164481613|NCT04181788|594134118|FG005|TREATMENT|Other unspecified|2|||
164481614|NCT04181788|594134113|FG000|TREATMENT|Ongoing|0|||
164481615|NCT04181788|594134114|FG001|TREATMENT|Ongoing|3|||
164481616|NCT04181788|594134115|FG002|TREATMENT|Ongoing|0|||
164481617|NCT04181788|594134116|FG003|TREATMENT|Ongoing|5|||
164481618|NCT04181788|594134117|FG004|TREATMENT|Ongoing|7|||
164481619|NCT04181788|594134118|FG005|TREATMENT|Ongoing|15|||
164481620|NCT04181788|594134113|FG000|FOLLOW-UP|Death|0|||
164481621|NCT04181788|594134114|FG001|FOLLOW-UP|Death|0|||
164481622|NCT04181788|594134115|FG002|FOLLOW-UP|Death|1|||
164481623|NCT04181788|594134116|FG003|FOLLOW-UP|Death|2|||
164481624|NCT04181788|594134117|FG004|FOLLOW-UP|Death|8|||
164481625|NCT04181788|594134118|FG005|FOLLOW-UP|Death|20|||
164481626|NCT04181788|594134113|FG000|FOLLOW-UP|Lost to Follow-up|0|||
164481627|NCT04181788|594134114|FG001|FOLLOW-UP|Lost to Follow-up|0|||
164481628|NCT04181788|594134115|FG002|FOLLOW-UP|Lost to Follow-up|0|||
164481629|NCT04181788|594134116|FG003|FOLLOW-UP|Lost to Follow-up|0|||
164481630|NCT04181788|594134117|FG004|FOLLOW-UP|Lost to Follow-up|0|||
164481631|NCT04181788|594134118|FG005|FOLLOW-UP|Lost to Follow-up|2|||
164481632|NCT04181788|594134113|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
164481633|NCT04181788|594134114|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
164481634|NCT04181788|594134115|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
164481635|NCT04181788|594134116|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
164481636|NCT04181788|594134117|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
164481637|NCT04181788|594134118|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
164481638|NCT04181788|594134113|FG000|FOLLOW-UP|Other unspecified|0|||
164481639|NCT04181788|594134114|FG001|FOLLOW-UP|Other unspecified|1|||
164600787|NCT05600309|594559829|FG001|Overall Study|Sponsor Decision|6|||
164600788|NCT03977727|594559832|FG000|Second Treatment|Lost to Follow-up|0|||
164600789|NCT03977727|594559833|FG001|Second Treatment|Lost to Follow-up|3|||
164600790|NCT03352414|594559837|FG000|Overall Study|Ineligible by operative criteria|12|||
164600791|NCT03352414|594559838|FG001|Overall Study|Ineligible by operative criteria|10|||
164600792|NCT00115804|594559845|FG000|Overall Study|Adverse Event|2|||
164600793|NCT00403559|594559846|FG000|Overall Study|Adverse Event|0|||
164481640|NCT04181788|594134115|FG002|FOLLOW-UP|Other unspecified|0|||
164481641|NCT04181788|594134116|FG003|FOLLOW-UP|Other unspecified|0|||
164481642|NCT04181788|594134117|FG004|FOLLOW-UP|Other unspecified|0|||
164481643|NCT04181788|594134118|FG005|FOLLOW-UP|Other unspecified|3|||
164481644|NCT04181788|594134113|FG000|FOLLOW-UP|Ongoing|0|||
164481645|NCT04181788|594134114|FG001|FOLLOW-UP|Ongoing|0|||
164481646|NCT04181788|594134115|FG002|FOLLOW-UP|Ongoing|1|||
164481647|NCT04181788|594134116|FG003|FOLLOW-UP|Ongoing|3|||
164600794|NCT00403559|594559847|FG001|Overall Study|Adverse Event|1|||
164600795|NCT00403559|594559846|FG000|Overall Study|Lost to Follow-up|3|||
164600796|NCT00403559|594559847|FG001|Overall Study|Lost to Follow-up|3|||
164481648|NCT04181788|594134117|FG004|FOLLOW-UP|Ongoing|2|||
164481649|NCT04181788|594134118|FG005|FOLLOW-UP|Ongoing|2|||
164600797|NCT00403559|594559846|FG000|Overall Study|Withdrawal by Subject|1|||
164481650|NCT04535414|594134119|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
164481651|NCT04535414|594134120|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
164481652|NCT04535414|594134119|FG000|Overall Study|Cancelled appointment|1|||
164481653|NCT04535414|594134120|FG001|Overall Study|Cancelled appointment|0|||
164481654|NCT04535414|594134119|FG000|Overall Study|cancelled - food in stomach|2|||
164481655|NCT04535414|594134120|FG001|Overall Study|cancelled - food in stomach|0|||
164481656|NCT04535414|594134119|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
164481657|NCT04535414|594134120|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
164481658|NCT04535414|594134119|FG000|Overall Study|Withdrawal by Subject|0|||
164481659|NCT04535414|594134120|FG001|Overall Study|Withdrawal by Subject|1|||
164481660|NCT03662659|594134121|FG000|Pre-treatment|Participant no longer met study criteria|1|||
164481661|NCT03662659|594134122|FG001|Pre-treatment|Participant no longer met study criteria|1|||
164481662|NCT03662659|594134121|FG000|Pre-treatment|Other reasons|1|||
164481663|NCT03662659|594134122|FG001|Pre-treatment|Other reasons|0|||
164481664|NCT03662659|594134121|FG000|Treatment|Completed Treatment|0|||
164481665|NCT03662659|594134122|FG001|Treatment|Completed Treatment|2|||
164481666|NCT03662659|594134121|FG000|Treatment|Disease Progression|85|||
164481667|NCT03662659|594134122|FG001|Treatment|Disease Progression|97|||
164481668|NCT03662659|594134121|FG000|Treatment|Study Drug Toxicity|19|||
164481669|NCT03662659|594134122|FG001|Treatment|Study Drug Toxicity|9|||
164481670|NCT03662659|594134121|FG000|Treatment|Death|11|||
164481671|NCT03662659|594134122|FG001|Treatment|Death|9|||
164481672|NCT03662659|594134121|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
164481673|NCT03662659|594134122|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
164481674|NCT03662659|594134121|FG000|Treatment|Withdrawal by Subject|1|||
164481675|NCT03662659|594134122|FG001|Treatment|Withdrawal by Subject|1|||
164481676|NCT03662659|594134121|FG000|Treatment|Poor/Non-compliance|1|||
164481677|NCT03662659|594134122|FG001|Treatment|Poor/Non-compliance|0|||
164481678|NCT03662659|594134121|FG000|Treatment|Participant no longer meets study criteria|1|||
164481679|NCT03662659|594134122|FG001|Treatment|Participant no longer meets study criteria|0|||
164481680|NCT03662659|594134121|FG000|Treatment|Other reasons|10|||
164481681|NCT03662659|594134122|FG001|Treatment|Other reasons|8|||
164481682|NCT03662659|594134121|FG000|Treatment|Administrative reasons by sponsor|1|||
164481683|NCT03662659|594134122|FG001|Treatment|Administrative reasons by sponsor|0|||
164481684|NCT03662659|594134121|FG000|Treatment|maximum clinical benefit|0|||
164481685|NCT03662659|594134122|FG001|Treatment|maximum clinical benefit|2|||
164481686|NCT04118894|594134127|FG000|Overall Study|Lost to Follow-up|21|||
164481687|NCT04118894|594134127|FG000|Overall Study|Withdrawal by Subject|10|||
164481688|NCT04118894|594134127|FG000|Overall Study|Adverse Event|4|||
164481689|NCT04369664|594135234|FG000|Overall Study|Physician Decision|1|||
164481690|NCT04369664|594135235|FG001|Overall Study|Physician Decision|0|||
164481691|NCT02713594|594135236|FG000|Overall Study|Withdrawal by Subject|32|||
164481692|NCT02713594|594135237|FG001|Overall Study|Withdrawal by Subject|22|||
164481693|NCT02713594|594135236|FG000|Overall Study|Lost to Follow-up|358|||
164481694|NCT02713594|594135237|FG001|Overall Study|Lost to Follow-up|374|||
164481695|NCT03690219|594135238|FG000|Overall Study|no injuries|9|||
164481696|NCT03690219|594135239|FG001|Overall Study|no injuries|20|||
164481697|NCT03690219|594135238|FG000|Overall Study|missing information|7|||
164481698|NCT03690219|594135239|FG001|Overall Study|missing information|7|||
164481699|NCT01523392|594135240|FG000|Treatment Period 1|Withdrawal by Subject|2|||
164481700|NCT01523392|594135241|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164481701|NCT01523392|594135240|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
164481702|NCT01523392|594135241|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
164481703|NCT01523392|594135240|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
164481704|NCT01523392|594135241|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
164481705|NCT00671853|594135242|FG000|Overall Study|Lack of Efficacy|3|||
164481706|NCT00671853|594135243|FG001|Overall Study|Lack of Efficacy|7|||
164481707|NCT00671853|594135242|FG000|Overall Study|Adverse Event|7|||
164481708|NCT00671853|594135243|FG001|Overall Study|Adverse Event|1|||
164481709|NCT00671853|594135242|FG000|Overall Study|Withdrawal by Subject|1|||
164481710|NCT00671853|594135243|FG001|Overall Study|Withdrawal by Subject|5|||
164481711|NCT00671853|594135242|FG000|Overall Study|Lost to Follow-up|8|||
164481712|NCT00671853|594135243|FG001|Overall Study|Lost to Follow-up|8|||
164481713|NCT00671853|594135242|FG000|Overall Study|Physician Decision|0|||
164481714|NCT00671853|594135243|FG001|Overall Study|Physician Decision|2|||
164481715|NCT00671853|594135242|FG000|Overall Study|Non-adherence with study procedures|1|||
164481716|NCT00671853|594135243|FG001|Overall Study|Non-adherence with study procedures|4|||
164714408|NCT02784795|594976908|FG003|Overall Study|Death|0|||
164714409|NCT02784795|594976909|FG004|Overall Study|Death|1|||
164714410|NCT02784795|594976910|FG005|Overall Study|Death|0|||
164714411|NCT02784795|594976911|FG006|Overall Study|Death|0|||
164481717|NCT02354417|594135244|FG000|Overall Study|Physician Decision|1|||
164481718|NCT01848483|594135245|FG000|Overall Study|Death|2|||
164481719|NCT01848483|594135246|FG001|Overall Study|Death|1|||
164481720|NCT01848483|594135245|FG000|Overall Study|Lost to Follow-up|6|||
164481721|NCT01848483|594135246|FG001|Overall Study|Lost to Follow-up|8|||
164481722|NCT01848483|594135245|FG000|Overall Study|Withdrawal by Subject|1|||
164481723|NCT01848483|594135246|FG001|Overall Study|Withdrawal by Subject|0|||
164481724|NCT01848483|594135245|FG000|Overall Study|Incarceration|2|||
164481725|NCT01848483|594135246|FG001|Overall Study|Incarceration|2|||
164481726|NCT01450007|594135250|FG000|Overall Study|Late exclusion before treatment|2|||
164714412|NCT02784795|594976912|FG007|Overall Study|Death|0|||
164600798|NCT00403559|594559847|FG001|Overall Study|Withdrawal by Subject|0|||
164600799|NCT00547378|594559848|FG000|Randomized Cohort|Withdrawal by Subject|7|||
164600800|NCT00547378|594559849|FG001|Randomized Cohort|Withdrawal by Subject|5|||
164600801|NCT00547378|594559850|FG002|Randomized Cohort|Withdrawal by Subject|0|||
164600802|NCT00547378|594559848|FG000|Randomized Cohort|Death|0|||
164600803|NCT00547378|594559849|FG001|Randomized Cohort|Death|1|||
164600804|NCT00547378|594559850|FG002|Randomized Cohort|Death|0|||
164600805|NCT00547378|594559848|FG000|Randomized Cohort|Lost to Follow-up|1|||
164600806|NCT00547378|594559849|FG001|Randomized Cohort|Lost to Follow-up|0|||
164600807|NCT00547378|594559850|FG002|Randomized Cohort|Lost to Follow-up|0|||
164600808|NCT00547378|594559848|FG000|Randomized Cohort|Adverse Event|1|||
164600809|NCT00547378|594559849|FG001|Randomized Cohort|Adverse Event|0|||
164600810|NCT00547378|594559850|FG002|Randomized Cohort|Adverse Event|0|||
164600811|NCT00547378|594559848|FG000|Randomized Cohort|Other reasons|2|||
164600812|NCT00547378|594559849|FG001|Randomized Cohort|Other reasons|0|||
164600813|NCT00547378|594559850|FG002|Randomized Cohort|Other reasons|0|||
164600814|NCT00547378|594559848|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
164600815|NCT00547378|594559849|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
164600816|NCT00547378|594559850|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
164600817|NCT00547378|594559848|FG000|All Implanted Cohort|Adverse Event|4|||
164600818|NCT00547378|594559849|FG001|All Implanted Cohort|Adverse Event|10|||
164600819|NCT00547378|594559850|FG002|All Implanted Cohort|Adverse Event|17|||
164600820|NCT00547378|594559848|FG000|All Implanted Cohort|Lost to Follow-up|0|||
164600821|NCT00547378|594559849|FG001|All Implanted Cohort|Lost to Follow-up|1|||
164600822|NCT00547378|594559850|FG002|All Implanted Cohort|Lost to Follow-up|14|||
164600823|NCT00547378|594559848|FG000|All Implanted Cohort|Death|3|||
164600824|NCT00547378|594559849|FG001|All Implanted Cohort|Death|1|||
164600825|NCT00547378|594559850|FG002|All Implanted Cohort|Death|4|||
164600826|NCT00547378|594559848|FG000|All Implanted Cohort|Physician Decision|0|||
164600827|NCT00547378|594559849|FG001|All Implanted Cohort|Physician Decision|2|||
164600828|NCT00547378|594559850|FG002|All Implanted Cohort|Physician Decision|6|||
164600829|NCT00547378|594559848|FG000|All Implanted Cohort|Site closure|2|||
164600830|NCT00547378|594559849|FG001|All Implanted Cohort|Site closure|0|||
164600831|NCT00547378|594559850|FG002|All Implanted Cohort|Site closure|1|||
164600832|NCT00547378|594559848|FG000|All Implanted Cohort|Other reasons|1|||
164600833|NCT00547378|594559849|FG001|All Implanted Cohort|Other reasons|0|||
164600834|NCT00547378|594559850|FG002|All Implanted Cohort|Other reasons|1|||
164600835|NCT01449682|594559851|FG000|Overall Study|Death|0|||
164600836|NCT01449682|594559852|FG001|Overall Study|Death|1|||
164600837|NCT01449682|594559851|FG000|Overall Study|Adverse Event|1|||
164600838|NCT01449682|594559852|FG001|Overall Study|Adverse Event|0|||
164600839|NCT04633473|594559857|FG000|Overall Study|Withdrawal by Subject|6|||
164600840|NCT01822691|594559858|FG000|Overall Study|Withdrawal by Subject|2|||
164600841|NCT00751114|594559859|FG000|Overall Study|Adverse Event|2|||
164600842|NCT00751114|594559860|FG001|Overall Study|Adverse Event|4|||
164600843|NCT00751114|594559859|FG000|Overall Study|Protocol Violation|8|||
164600844|NCT00751114|594559860|FG001|Overall Study|Protocol Violation|9|||
164600845|NCT00751114|594559859|FG000|Overall Study|Withdrawal by Subject|9|||
164600846|NCT00751114|594559860|FG001|Overall Study|Withdrawal by Subject|4|||
164600847|NCT00751114|594559859|FG000|Overall Study|Lost to Follow-up|4|||
164600848|NCT00751114|594559860|FG001|Overall Study|Lost to Follow-up|7|||
164600849|NCT00751114|594559859|FG000|Overall Study|Lack of Efficacy|0|||
164600850|NCT00751114|594559860|FG001|Overall Study|Lack of Efficacy|7|||
164600851|NCT00751114|594559859|FG000|Overall Study|Not Treated|13|||
164600852|NCT00751114|594559860|FG001|Overall Study|Not Treated|1|||
164600853|NCT00751114|594559859|FG000|Overall Study|Out of country for 2 months|1|||
164600854|NCT00751114|594559860|FG001|Overall Study|Out of country for 2 months|0|||
164600855|NCT00751114|594559859|FG000|Overall Study|Move to another city|1|||
164600856|NCT00751114|594559860|FG001|Overall Study|Move to another city|0|||
164600857|NCT03095521|594559861|FG000|Overall Study|Withdrawal by Subject|0|||
164600858|NCT03095521|594559862|FG001|Overall Study|Withdrawal by Subject|1|||
164481727|NCT01450007|594135251|FG001|Overall Study|Late exclusion before treatment|3|||
164481728|NCT01450007|594135252|FG002|Overall Study|Late exclusion before treatment|2|||
164481729|NCT01450007|594135250|FG000|Overall Study|Protocol Violation|0|||
164481730|NCT01450007|594135251|FG001|Overall Study|Protocol Violation|1|||
164481731|NCT01450007|594135252|FG002|Overall Study|Protocol Violation|1|||
164481732|NCT01450007|594135250|FG000|Overall Study|Adverse Event|0|||
164481733|NCT01450007|594135251|FG001|Overall Study|Adverse Event|1|||
164481734|NCT01450007|594135252|FG002|Overall Study|Adverse Event|0|||
164481735|NCT03851094|594135253|FG000|Overall Study|Withdrawal by Subject|0|||
164481736|NCT03851094|594135254|FG001|Overall Study|Withdrawal by Subject|1|||
164481737|NCT03851094|594135253|FG000|Overall Study|Participant lost device|0|||
164481738|NCT03851094|594135254|FG001|Overall Study|Participant lost device|1|||
164481739|NCT03851094|594135253|FG000|Overall Study|Participant returned device|0|||
164481740|NCT03851094|594135254|FG001|Overall Study|Participant returned device|2|||
164481741|NCT02958553|594135255|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
164481742|NCT02958553|594135255|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
164481743|NCT04311983|594135257|FG000|Overall Study|Lost to Follow-up|421|||
164481744|NCT04311983|594135258|FG001|Overall Study|Lost to Follow-up|456|||
164481745|NCT04311983|594135257|FG000|Overall Study|Incomplete survey|7|||
164481746|NCT04311983|594135258|FG001|Overall Study|Incomplete survey|9|||
164481747|NCT04311983|594135257|FG000|Overall Study|Death|1|||
164481748|NCT04311983|594135258|FG001|Overall Study|Death|0|||
164481749|NCT02007070|594135259|FG000|Overall Study|Adverse Event|4|||
164481750|NCT02007070|594135259|FG000|Overall Study|Clinical Progression|4|||
164481751|NCT02007070|594135259|FG000|Overall Study|Death|1|||
164481752|NCT02007070|594135259|FG000|Overall Study|Protocol Violation|2|||
164481753|NCT02007070|594135259|FG000|Overall Study|Physician Decision|1|||
164481754|NCT02007070|594135259|FG000|Overall Study|Progressive Disease|21|||
164481755|NCT00703092|594135260|FG000|Overall Study|Withdrawal by Subject|2|||
164481756|NCT02935673|594135261|FG000|Overall Study|Adverse Event|0|||
164481757|NCT02935673|594135262|FG001|Overall Study|Adverse Event|1|||
164481758|NCT02935673|594135263|FG002|Overall Study|Adverse Event|0|||
164481759|NCT02935673|594135261|FG000|Overall Study|Withdrawal by Subject|1|||
164481760|NCT02935673|594135262|FG001|Overall Study|Withdrawal by Subject|2|||
164481761|NCT02935673|594135263|FG002|Overall Study|Withdrawal by Subject|0|||
164481762|NCT01836523|594135264|FG000|Overall Study|Adverse Event|15|||
164481763|NCT01836523|594135265|FG001|Overall Study|Adverse Event|41|||
164481764|NCT01836523|594135266|FG002|Overall Study|Adverse Event|49|||
164481765|NCT01836523|594135267|FG003|Overall Study|Adverse Event|14|||
164481766|NCT01836523|594135264|FG000|Overall Study|Protocol Violation|6|||
164481767|NCT01836523|594135265|FG001|Overall Study|Protocol Violation|3|||
164481768|NCT01836523|594135266|FG002|Overall Study|Protocol Violation|2|||
164481769|NCT01836523|594135267|FG003|Overall Study|Protocol Violation|4|||
164481770|NCT01836523|594135264|FG000|Overall Study|Met Withdrawal Criteria|13|||
164481771|NCT01836523|594135265|FG001|Overall Study|Met Withdrawal Criteria|13|||
164481772|NCT01836523|594135266|FG002|Overall Study|Met Withdrawal Criteria|21|||
164481773|NCT01836523|594135267|FG003|Overall Study|Met Withdrawal Criteria|27|||
164481774|NCT01836523|594135264|FG000|Overall Study|Unclassified|17|||
164481775|NCT01836523|594135265|FG001|Overall Study|Unclassified|28|||
164481776|NCT01836523|594135266|FG002|Overall Study|Unclassified|19|||
164481777|NCT01836523|594135267|FG003|Overall Study|Unclassified|29|||
164481778|NCT04070105|594135268|FG000|Overall Study|Lost to Follow-up|0|||
164481779|NCT04070105|594135269|FG001|Overall Study|Lost to Follow-up|0|||
164481780|NCT04070105|594135270|FG002|Overall Study|Lost to Follow-up|0|||
164481781|NCT04070105|594135271|FG003|Overall Study|Lost to Follow-up|0|||
164481782|NCT04070105|594135272|FG004|Overall Study|Lost to Follow-up|0|||
164481783|NCT04070105|594135273|FG005|Overall Study|Lost to Follow-up|1|||
164481784|NCT00749944|594135274|FG000|Overall Study|Lost to Follow-up|2|||
164481785|NCT00749944|594135275|FG001|Overall Study|Lost to Follow-up|1|||
164481786|NCT00749944|594135274|FG000|Overall Study|Other|1|||
164714413|NCT02784795|594976913|FG008|Overall Study|Death|0|||
164714414|NCT02784795|594976914|FG009|Overall Study|Death|0|||
164714415|NCT02784795|594976915|FG010|Overall Study|Death|0|||
164481787|NCT00749944|594135275|FG001|Overall Study|Other|0|||
164714416|NCT02784795|594976916|FG011|Overall Study|Death|0|||
164481788|NCT00749944|594135274|FG000|Overall Study|Withdrawal by Subject|2|||
164481789|NCT00749944|594135275|FG001|Overall Study|Withdrawal by Subject|0|||
164481790|NCT00624377|594135276|FG000|Overall Study|Lost to Follow-up|355|||
164714417|NCT02784795|594976905|FG000|Overall Study|Physician Decision|0|||
164481791|NCT00624377|594135276|FG000|Overall Study|Withdrawal by Subject|100|||
164481792|NCT00624377|594135276|FG000|Overall Study|Adverse Event|14|||
164481793|NCT00624377|594135276|FG000|Overall Study|Other|91|||
164481794|NCT00624377|594135276|FG000|Overall Study|Non-evaluable population|84|||
164481795|NCT04660799|594135282|FG000|Overall Study|Progressive Disease|1|||
164481796|NCT04660799|594135283|FG001|Overall Study|Progressive Disease|1|||
164714418|NCT02784795|594976906|FG001|Overall Study|Physician Decision|0|||
164481797|NCT04660799|594135282|FG000|Overall Study|Death|2|||
164481798|NCT04660799|594135283|FG001|Overall Study|Death|1|||
164481799|NCT04660799|594135282|FG000|Overall Study|Adverse Event|2|||
164714419|NCT02784795|594976907|FG002|Overall Study|Physician Decision|0|||
164600859|NCT03095521|594559861|FG000|Overall Study|Lost to Follow-up|0|||
164600860|NCT03095521|594559862|FG001|Overall Study|Lost to Follow-up|1|||
164600861|NCT03259490|594559863|FG000|Period 1|Withdrawal by Subject|0|||
164600862|NCT03259490|594559864|FG001|Period 1|Withdrawal by Subject|1|||
164600863|NCT03259490|594559863|FG000|Period 2|Protocol Violation|1|||
164600864|NCT03259490|594559864|FG001|Period 2|Protocol Violation|0|||
164600865|NCT01536119|594559867|FG000|Overall Study|Lost to Follow-up|17|||
164600866|NCT01536119|594559868|FG001|Overall Study|Lost to Follow-up|14|||
164600867|NCT02365584|594559869|FG000|Overall Study|Adverse Event|2|||
164600868|NCT02365584|594559870|FG001|Overall Study|Adverse Event|2|||
164600869|NCT02365584|594559869|FG000|Overall Study|Withdrawal by Subject|1|||
164600870|NCT02365584|594559870|FG001|Overall Study|Withdrawal by Subject|0|||
164600871|NCT02365584|594559869|FG000|Overall Study|Disease Progression|9|||
164600872|NCT02365584|594559870|FG001|Overall Study|Disease Progression|12|||
164600873|NCT00819585|594559871|FG000|Core Study|Adverse Event|2|||
164600874|NCT00819585|594559872|FG001|Core Study|Adverse Event|1|||
164600875|NCT00819585|594559873|FG002|Core Study|Adverse Event|1|||
164600876|NCT00819585|594559874|FG003|Core Study|Adverse Event|4|||
164600877|NCT00819585|594559875|FG004|Core Study|Adverse Event|1|||
164600878|NCT00819585|594559876|FG005|Core Study|Adverse Event|0|||
164600879|NCT00819585|594559877|FG006|Core Study|Adverse Event|2|||
164600880|NCT00819585|594559878|FG007|Core Study|Adverse Event|0|||
164600881|NCT00819585|594559879|FG008|Core Study|Adverse Event|0|||
164600882|NCT00819585|594559880|FG009|Core Study|Adverse Event|0|||
164600883|NCT00819585|594559881|FG010|Core Study|Adverse Event|0|||
164600884|NCT00819585|594559871|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
164600885|NCT00819585|594559872|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
164600886|NCT00819585|594559873|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
164600887|NCT00819585|594559874|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
164600888|NCT00819585|594559875|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
164600889|NCT00819585|594559876|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
164600890|NCT00819585|594559877|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
164600891|NCT00819585|594559878|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
164600892|NCT00819585|594559879|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
164600893|NCT00819585|594559880|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
164600894|NCT00819585|594559881|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
164600895|NCT00819585|594559871|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
164600896|NCT00819585|594559872|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
164600897|NCT00819585|594559873|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
164600898|NCT00819585|594559874|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
164600899|NCT00819585|594559875|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
164481800|NCT04660799|594135283|FG001|Overall Study|Adverse Event|1|||
164481801|NCT04660799|594135282|FG000|Overall Study|Withdrawal by Subject|2|||
164481802|NCT04660799|594135283|FG001|Overall Study|Withdrawal by Subject|5|||
164481803|NCT02706483|594135284|FG000|Overall Study|Adverse Event|97|||
164481804|NCT02706483|594135284|FG000|Overall Study|Death|1|||
164481805|NCT02706483|594135284|FG000|Overall Study|Lack of Efficacy|39|||
164481806|NCT02706483|594135284|FG000|Overall Study|Lost to Follow-up|101|||
164481807|NCT02706483|594135284|FG000|Overall Study|Non-compliance with study drug|15|||
164481808|NCT02706483|594135284|FG000|Overall Study|Physician Decision|6|||
164481809|NCT02706483|594135284|FG000|Overall Study|Pregnancy|6|||
164481810|NCT02706483|594135284|FG000|Overall Study|Protocol Violation|18|||
164481811|NCT02706483|594135284|FG000|Overall Study|Withdrawal by Subject|136|||
164481812|NCT02706483|594135284|FG000|Overall Study|Non-compliance with visits|6|||
164481813|NCT02706483|594135284|FG000|Overall Study|Site closure|4|||
164481814|NCT02706483|594135284|FG000|Overall Study|Subject moved|1|||
164481815|NCT03131713|594135285|FG000|Overall Study|Lost to Follow-up|5|||
164481816|NCT03131713|594135286|FG001|Overall Study|Lost to Follow-up|0|||
164481817|NCT00089791|594135293|FG000|Overall Study|Physician Decision|6|||
164481818|NCT00089791|594135294|FG001|Overall Study|Physician Decision|3|||
164481819|NCT00089791|594135293|FG000|Overall Study|Adverse Event|81|||
164481820|NCT00089791|594135294|FG001|Overall Study|Adverse Event|93|||
164481821|NCT00089791|594135293|FG000|Overall Study|Withdrawal by Subject|403|||
164481822|NCT00089791|594135294|FG001|Overall Study|Withdrawal by Subject|344|||
164481823|NCT00089791|594135293|FG000|Overall Study|Death|78|||
164481824|NCT00089791|594135294|FG001|Overall Study|Death|62|||
164481825|NCT00089791|594135293|FG000|Overall Study|Disease progression|7|||
164600900|NCT00819585|594559876|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
164600901|NCT00819585|594559877|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
164600902|NCT00819585|594559878|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
164600903|NCT00819585|594559879|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
164600904|NCT00819585|594559880|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
164600905|NCT00819585|594559881|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
164600906|NCT00819585|594559871|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
164481826|NCT00089791|594135294|FG001|Overall Study|Disease progression|3|||
164481827|NCT00089791|594135293|FG000|Overall Study|Ineligibility determined|12|||
164481828|NCT00089791|594135294|FG001|Overall Study|Ineligibility determined|9|||
164714420|NCT02784795|594976908|FG003|Overall Study|Physician Decision|0|||
164714421|NCT02784795|594976909|FG004|Overall Study|Physician Decision|0|||
164481829|NCT00089791|594135293|FG000|Overall Study|Lost to Follow-up|57|||
164481830|NCT00089791|594135294|FG001|Overall Study|Lost to Follow-up|57|||
164481831|NCT00089791|594135293|FG000|Overall Study|Noncompliance|17|||
164481832|NCT00089791|594135294|FG001|Overall Study|Noncompliance|13|||
164481833|NCT00089791|594135293|FG000|Overall Study|Other|20|||
164481834|NCT00089791|594135294|FG001|Overall Study|Other|32|||
164481835|NCT00089791|594135293|FG000|Overall Study|Protocol deviation|12|||
164481836|NCT00089791|594135294|FG001|Overall Study|Protocol deviation|10|||
164481837|NCT00089791|594135293|FG000|Overall Study|Requirement for alternative therapy|7|||
164481838|NCT00089791|594135294|FG001|Overall Study|Requirement for alternative therapy|4|||
164481839|NCT02161458|594135295|FG000|Overall Study|Withdrawal by Subject|0|||
164481840|NCT02161458|594135296|FG001|Overall Study|Withdrawal by Subject|4|||
164481841|NCT02161458|594135297|FG002|Overall Study|Withdrawal by Subject|4|||
164481842|NCT02161458|594135298|FG003|Overall Study|Withdrawal by Subject|0|||
164481843|NCT02161458|594135295|FG000|Overall Study|Lost to Follow-up|0|||
164481844|NCT02161458|594135296|FG001|Overall Study|Lost to Follow-up|2|||
164481845|NCT02161458|594135297|FG002|Overall Study|Lost to Follow-up|1|||
164481846|NCT02161458|594135298|FG003|Overall Study|Lost to Follow-up|0|||
164481847|NCT02037568|594135299|FG000|Overall Study|Withdrawal by Subject|17|||
164481848|NCT02037568|594135300|FG001|Overall Study|Withdrawal by Subject|24|||
164481849|NCT02037568|594135299|FG000|Overall Study|Lost to Follow-up|16|||
164481850|NCT02037568|594135300|FG001|Overall Study|Lost to Follow-up|13|||
164481851|NCT02037568|594135299|FG000|Overall Study|Screen Failure|3|||
164481852|NCT02037568|594135300|FG001|Overall Study|Screen Failure|1|||
164481853|NCT02037568|594135299|FG000|Overall Study|Patient did not receive transplant|0|||
164481854|NCT02037568|594135300|FG001|Overall Study|Patient did not receive transplant|1|||
164481855|NCT05074433|594135305|FG000|Overall Study|Adverse Event|0|||
164481856|NCT05074433|594135306|FG001|Overall Study|Adverse Event|2|||
164481857|NCT05074433|594135307|FG002|Overall Study|Adverse Event|0|||
164481858|NCT05074433|594135308|FG003|Overall Study|Adverse Event|1|||
164481859|NCT05074433|594135305|FG000|Overall Study|Sponsor Request|0|||
164481860|NCT05074433|594135306|FG001|Overall Study|Sponsor Request|1|||
164481861|NCT05074433|594135307|FG002|Overall Study|Sponsor Request|1|||
164481862|NCT05074433|594135308|FG003|Overall Study|Sponsor Request|0|||
164481863|NCT05074433|594135305|FG000|Overall Study|Death|1|||
164481864|NCT05074433|594135306|FG001|Overall Study|Death|0|||
164481865|NCT05074433|594135307|FG002|Overall Study|Death|0|||
164481866|NCT05074433|594135308|FG003|Overall Study|Death|0|||
164481867|NCT05074433|594135305|FG000|Overall Study|Lost to Follow-up|0|||
164481868|NCT05074433|594135306|FG001|Overall Study|Lost to Follow-up|0|||
164481869|NCT05074433|594135307|FG002|Overall Study|Lost to Follow-up|2|||
164481870|NCT05074433|594135308|FG003|Overall Study|Lost to Follow-up|0|||
164481871|NCT05074433|594135305|FG000|Overall Study|Subject Decision|8|||
164481872|NCT05074433|594135306|FG001|Overall Study|Subject Decision|6|||
164481873|NCT05074433|594135307|FG002|Overall Study|Subject Decision|4|||
164481874|NCT05074433|594135308|FG003|Overall Study|Subject Decision|5|||
164481875|NCT04397263|594135309|FG000|Overall Study|Withdrawal by Subject|2|||
164481876|NCT03567616|594135310|FG000|Overall Study|Disease progression|4|||
164481877|NCT03567616|594135310|FG000|Overall Study|Withdrawal by Subject|1|||
164481878|NCT03567616|594135310|FG000|Overall Study|Physician Decision|1|||
164481879|NCT03567616|594135310|FG000|Overall Study|Death|1|||
164481880|NCT03567616|594135310|FG000|Overall Study|Adverse Event|1|||
164481881|NCT00380250|594135312|FG000|Overall Study|Withdrawal by Subject|39|||
164481882|NCT00380250|594135313|FG001|Overall Study|Withdrawal by Subject|28|||
164481883|NCT00380250|594135312|FG000|Overall Study|Adverse Event|20|||
164481884|NCT00380250|594135313|FG001|Overall Study|Adverse Event|9|||
164481885|NCT00380250|594135312|FG000|Overall Study|Lack of Efficacy|10|||
164481886|NCT00380250|594135313|FG001|Overall Study|Lack of Efficacy|8|||
164481887|NCT00380250|594135312|FG000|Overall Study|Protocol Violation|15|||
164481888|NCT00380250|594135313|FG001|Overall Study|Protocol Violation|5|||
164481889|NCT00380250|594135312|FG000|Overall Study|Lost to Follow-up|14|||
164481890|NCT00380250|594135313|FG001|Overall Study|Lost to Follow-up|5|||
164481891|NCT00380250|594135312|FG000|Overall Study|Physician Decision|1|||
164481892|NCT00380250|594135313|FG001|Overall Study|Physician Decision|0|||
164481893|NCT01989104|594135314|FG000|Overall Study|Withdrawal by Subject|3|||
164481894|NCT01989104|594135315|FG001|Overall Study|Withdrawal by Subject|0|||
164481895|NCT01989104|594135316|FG002|Overall Study|Withdrawal by Subject|0|||
164481896|NCT01989104|594135317|FG003|Overall Study|Withdrawal by Subject|0|||
164481897|NCT01989104|594135318|FG004|Overall Study|Withdrawal by Subject|0|||
164481898|NCT05613088|594135321|FG000|Treatment|Ongoing Study Treatment|9|||
164481899|NCT05613088|594135322|FG001|Treatment|Ongoing Study Treatment|2|||
164481900|NCT05613088|594135321|FG000|Treatment|Adverse Event|3|||
164481901|NCT05613088|594135322|FG001|Treatment|Adverse Event|1|||
164481902|NCT05613088|594135321|FG000|Treatment|Other Reasons|0|||
164481903|NCT05613088|594135322|FG001|Treatment|Other Reasons|1|||
164481904|NCT05613088|594135321|FG000|Treatment|Progressive Disease|58|||
164481905|NCT05613088|594135322|FG001|Treatment|Progressive Disease|26|||
164481906|NCT05613088|594135321|FG000|Treatment|Withdrawal by Subject|0|||
164481907|NCT05613088|594135322|FG001|Treatment|Withdrawal by Subject|4|||
164481908|NCT04748341|594135326|FG000|Overall Study|Lost to Follow-up|1|||
164481909|NCT04748341|594135327|FG001|Overall Study|Lost to Follow-up|1|||
164481910|NCT05865392|594135330|FG000|Overall Study|Withdrawal by Subject|4|||
164481911|NCT05865392|594135331|FG001|Overall Study|Withdrawal by Subject|0|||
164481912|NCT05865392|594135330|FG000|Overall Study|Didn't meet inclusion criteria|4|||
164481913|NCT05865392|594135331|FG001|Overall Study|Didn't meet inclusion criteria|0|||
164481914|NCT02159989|594135332|FG000|Overall Study|Adverse Event|1|||
164481915|NCT02159989|594135333|FG001|Overall Study|Adverse Event|0|||
164481916|NCT02159989|594135334|FG002|Overall Study|Adverse Event|0|||
164481917|NCT02159989|594135335|FG003|Overall Study|Adverse Event|0|||
164481918|NCT02159989|594135336|FG004|Overall Study|Adverse Event|1|||
164481919|NCT02159989|594135337|FG005|Overall Study|Adverse Event|0|||
164481920|NCT02159989|594135338|FG006|Overall Study|Adverse Event|1|||
164481921|NCT02159989|594135339|FG007|Overall Study|Adverse Event|2|||
164481922|NCT02159989|594135340|FG008|Overall Study|Adverse Event|0|||
164481923|NCT02159989|594135341|FG009|Overall Study|Adverse Event|2|||
164481924|NCT02159989|594135342|FG010|Overall Study|Adverse Event|1|||
164481925|NCT02159989|594135332|FG000|Overall Study|Death|0|||
164481926|NCT02159989|594135333|FG001|Overall Study|Death|0|||
164481927|NCT02159989|594135334|FG002|Overall Study|Death|0|||
164481928|NCT02159989|594135335|FG003|Overall Study|Death|0|||
164481929|NCT02159989|594135336|FG004|Overall Study|Death|0|||
164481930|NCT02159989|594135337|FG005|Overall Study|Death|0|||
164481931|NCT02159989|594135338|FG006|Overall Study|Death|0|||
164481932|NCT02159989|594135339|FG007|Overall Study|Death|0|||
164481933|NCT02159989|594135340|FG008|Overall Study|Death|0|||
164481934|NCT02159989|594135341|FG009|Overall Study|Death|0|||
164481935|NCT02159989|594135342|FG010|Overall Study|Death|1|||
164481936|NCT02159989|594135332|FG000|Overall Study|Lack of Efficacy|2|||
164481937|NCT02159989|594135333|FG001|Overall Study|Lack of Efficacy|3|||
164481938|NCT02159989|594135334|FG002|Overall Study|Lack of Efficacy|3|||
164481939|NCT02159989|594135335|FG003|Overall Study|Lack of Efficacy|0|||
164481940|NCT02159989|594135336|FG004|Overall Study|Lack of Efficacy|2|||
164481941|NCT02159989|594135337|FG005|Overall Study|Lack of Efficacy|3|||
164481942|NCT02159989|594135338|FG006|Overall Study|Lack of Efficacy|3|||
164481943|NCT02159989|594135339|FG007|Overall Study|Lack of Efficacy|1|||
164481944|NCT02159989|594135340|FG008|Overall Study|Lack of Efficacy|3|||
164481945|NCT02159989|594135341|FG009|Overall Study|Lack of Efficacy|6|||
164481946|NCT02159989|594135342|FG010|Overall Study|Lack of Efficacy|7|||
164481947|NCT02159989|594135332|FG000|Overall Study|Lost to Follow-up|0|||
164481948|NCT02159989|594135333|FG001|Overall Study|Lost to Follow-up|0|||
164481949|NCT02159989|594135334|FG002|Overall Study|Lost to Follow-up|0|||
164481950|NCT02159989|594135335|FG003|Overall Study|Lost to Follow-up|1|||
164481951|NCT02159989|594135336|FG004|Overall Study|Lost to Follow-up|0|||
164481952|NCT02159989|594135337|FG005|Overall Study|Lost to Follow-up|0|||
164481953|NCT02159989|594135338|FG006|Overall Study|Lost to Follow-up|0|||
164481954|NCT02159989|594135339|FG007|Overall Study|Lost to Follow-up|0|||
164481955|NCT02159989|594135340|FG008|Overall Study|Lost to Follow-up|0|||
164481956|NCT02159989|594135341|FG009|Overall Study|Lost to Follow-up|0|||
164481957|NCT02159989|594135342|FG010|Overall Study|Lost to Follow-up|1|||
164481958|NCT02159989|594135332|FG000|Overall Study|Withdrawal by Subject|2|||
164481959|NCT02159989|594135333|FG001|Overall Study|Withdrawal by Subject|0|||
164481960|NCT02159989|594135334|FG002|Overall Study|Withdrawal by Subject|0|||
164481961|NCT02159989|594135335|FG003|Overall Study|Withdrawal by Subject|2|||
164481962|NCT02159989|594135336|FG004|Overall Study|Withdrawal by Subject|1|||
164481963|NCT02159989|594135337|FG005|Overall Study|Withdrawal by Subject|0|||
164481964|NCT02159989|594135338|FG006|Overall Study|Withdrawal by Subject|3|||
164481965|NCT02159989|594135339|FG007|Overall Study|Withdrawal by Subject|1|||
164481966|NCT02159989|594135340|FG008|Overall Study|Withdrawal by Subject|0|||
164481967|NCT02159989|594135341|FG009|Overall Study|Withdrawal by Subject|0|||
164481968|NCT02159989|594135342|FG010|Overall Study|Withdrawal by Subject|0|||
164481969|NCT02159989|594135332|FG000|Overall Study|New treatment|0|||
164481970|NCT02159989|594135333|FG001|Overall Study|New treatment|1|||
164481971|NCT02159989|594135334|FG002|Overall Study|New treatment|0|||
164481972|NCT02159989|594135335|FG003|Overall Study|New treatment|0|||
164481973|NCT02159989|594135336|FG004|Overall Study|New treatment|0|||
164481974|NCT02159989|594135337|FG005|Overall Study|New treatment|0|||
164481975|NCT02159989|594135338|FG006|Overall Study|New treatment|0|||
164481976|NCT02159989|594135339|FG007|Overall Study|New treatment|0|||
164481977|NCT02159989|594135340|FG008|Overall Study|New treatment|0|||
164481978|NCT02159989|594135341|FG009|Overall Study|New treatment|0|||
164481979|NCT02159989|594135342|FG010|Overall Study|New treatment|0|||
164481980|NCT02159989|594135332|FG000|Overall Study|Insurance Issues|0|||
164481981|NCT02159989|594135333|FG001|Overall Study|Insurance Issues|0|||
164481982|NCT02159989|594135334|FG002|Overall Study|Insurance Issues|0|||
164481983|NCT02159989|594135335|FG003|Overall Study|Insurance Issues|0|||
164481984|NCT02159989|594135336|FG004|Overall Study|Insurance Issues|0|||
164481985|NCT02159989|594135337|FG005|Overall Study|Insurance Issues|0|||
164481986|NCT02159989|594135338|FG006|Overall Study|Insurance Issues|0|||
164481987|NCT02159989|594135339|FG007|Overall Study|Insurance Issues|0|||
164481988|NCT02159989|594135340|FG008|Overall Study|Insurance Issues|0|||
164481989|NCT02159989|594135341|FG009|Overall Study|Insurance Issues|1|||
164481990|NCT02159989|594135342|FG010|Overall Study|Insurance Issues|0|||
164481991|NCT02485925|594135344|FG000|Overall Study|Withdrawal by Subject|3|||
164481992|NCT02485925|594135344|FG000|Overall Study|Death|1|||
164481993|NCT02485925|594135344|FG000|Overall Study|Lost to Follow-up|11|||
164481994|NCT04937504|594135345|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
164481995|NCT04937504|594135346|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
164481996|NCT04937504|594135345|FG000|9 Months Assessment|Lost to Follow-up|3|||
164481997|NCT04937504|594135346|FG001|9 Months Assessment|Lost to Follow-up|2|||
164481998|NCT03840200|594138025|FG000|Overall Study|Death|6|||
164481999|NCT03840200|594138026|FG001|Overall Study|Death|3|||
164482000|NCT03840200|594138027|FG002|Overall Study|Death|6|||
164482001|NCT03840200|594138028|FG003|Overall Study|Death|10|||
164482002|NCT03840200|594138025|FG000|Overall Study|Reason Not Specified|2|||
164482003|NCT03840200|594138026|FG001|Overall Study|Reason Not Specified|2|||
164482004|NCT03840200|594138027|FG002|Overall Study|Reason Not Specified|1|||
164482005|NCT03840200|594138028|FG003|Overall Study|Reason Not Specified|15|||
164482006|NCT03840200|594138025|FG000|Overall Study|Physician Decision|0|||
164482007|NCT03840200|594138026|FG001|Overall Study|Physician Decision|0|||
164482008|NCT03840200|594138027|FG002|Overall Study|Physician Decision|0|||
164482009|NCT03840200|594138028|FG003|Overall Study|Physician Decision|2|||
164482010|NCT03840200|594138025|FG000|Overall Study|Progressive Disease|0|||
164482011|NCT03840200|594138026|FG001|Overall Study|Progressive Disease|0|||
164482012|NCT03840200|594138027|FG002|Overall Study|Progressive Disease|0|||
164482013|NCT03840200|594138028|FG003|Overall Study|Progressive Disease|1|||
164482014|NCT03840200|594138025|FG000|Overall Study|Withdrawal by Subject|0|||
164482015|NCT03840200|594138026|FG001|Overall Study|Withdrawal by Subject|1|||
164482016|NCT03840200|594138027|FG002|Overall Study|Withdrawal by Subject|0|||
164482017|NCT03840200|594138028|FG003|Overall Study|Withdrawal by Subject|2|||
164482018|NCT02196259|594138033|FG000|Overall Study|Researcher choice|0|||
164482019|NCT02196259|594138034|FG001|Overall Study|Researcher choice|0|||
164482020|NCT02196259|594138035|FG002|Overall Study|Researcher choice|1|||
164482021|NCT02196259|594138033|FG000|Overall Study|Partial data analysis|0|||
164482022|NCT02196259|594138034|FG001|Overall Study|Partial data analysis|3|||
164482023|NCT02196259|594138035|FG002|Overall Study|Partial data analysis|0|||
164482024|NCT00264576|594138036|FG000|Overall Study|Lost to Follow-up|1|||
164482025|NCT00264576|594138037|FG001|Overall Study|Lost to Follow-up|1|||
164482026|NCT01668355|594138039|FG000|Overall Study|Death|3|||
164482027|NCT01668355|594138040|FG001|Overall Study|Death|1|||
164482028|NCT01668355|594138039|FG000|Overall Study|Withdrawal by Subject|6|||
164482029|NCT01668355|594138040|FG001|Overall Study|Withdrawal by Subject|1|||
164482030|NCT02202317|594138041|FG000|Overall Study|Lost to Follow-up|1|||
164482031|NCT02701296|594138042|FG000|Overall Study|Incomplete Data|0|||
164482032|NCT02701296|594138043|FG001|Overall Study|Incomplete Data|2|||
164482033|NCT00484198|594138044|FG000|Overall Study|Participant Withdrew Consent|12|||
164482034|NCT00484198|594138045|FG001|Overall Study|Participant Withdrew Consent|21|||
164482035|NCT00484198|594138046|FG002|Overall Study|Participant Withdrew Consent|47|||
164482036|NCT00484198|594138047|FG003|Overall Study|Participant Withdrew Consent|59|||
164482037|NCT00484198|594138044|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
164482038|NCT00484198|594138045|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
164482039|NCT00484198|594138046|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
164482040|NCT00484198|594138047|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
164482041|NCT00484198|594138044|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
164482042|NCT00484198|594138045|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
164482043|NCT00484198|594138046|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
164482044|NCT00484198|594138047|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
164482045|NCT00484198|594138044|FG000|Overall Study|Adverse Event|3|||
164482046|NCT00484198|594138045|FG001|Overall Study|Adverse Event|11|||
164482047|NCT00484198|594138046|FG002|Overall Study|Adverse Event|32|||
164714422|NCT02784795|594976910|FG005|Overall Study|Physician Decision|0|||
164714423|NCT02784795|594976911|FG006|Overall Study|Physician Decision|1|||
164714424|NCT02784795|594976912|FG007|Overall Study|Physician Decision|0|||
164482048|NCT00484198|594138047|FG003|Overall Study|Adverse Event|31|||
164482049|NCT00484198|594138044|FG000|Overall Study|Protocol Violation|0|||
164482050|NCT00484198|594138045|FG001|Overall Study|Protocol Violation|5|||
164482051|NCT00484198|594138046|FG002|Overall Study|Protocol Violation|6|||
164482052|NCT00484198|594138047|FG003|Overall Study|Protocol Violation|8|||
164482053|NCT00484198|594138044|FG000|Overall Study|Other|7|||
164482054|NCT00484198|594138045|FG001|Overall Study|Other|10|||
164482055|NCT00484198|594138046|FG002|Overall Study|Other|31|||
164482056|NCT00484198|594138047|FG003|Overall Study|Other|28|||
164482057|NCT01332266|594138048|FG000|Phase 1b|Death|3|||
164482058|NCT01332266|594138049|FG001|Phase 1b|Death|3|||
164482059|NCT01332266|594138050|FG002|Phase 1b|Death|2|||
164482060|NCT01332266|594138051|FG003|Phase 1b|Death|0|||
164482061|NCT01332266|594138052|FG004|Phase 1b|Death|0|||
164482062|NCT01332266|594138048|FG000|Phase 1b|Lost to Follow-up|0|||
164482063|NCT01332266|594138049|FG001|Phase 1b|Lost to Follow-up|1|||
164482064|NCT01332266|594138050|FG002|Phase 1b|Lost to Follow-up|0|||
164714425|NCT02784795|594976913|FG008|Overall Study|Physician Decision|0|||
164482065|NCT01332266|594138051|FG003|Phase 1b|Lost to Follow-up|0|||
164482066|NCT01332266|594138052|FG004|Phase 1b|Lost to Follow-up|0|||
164482067|NCT01332266|594138048|FG000|Phase 1b|Withdrawal by Subject|1|||
164482068|NCT01332266|594138049|FG001|Phase 1b|Withdrawal by Subject|1|||
164482069|NCT01332266|594138050|FG002|Phase 1b|Withdrawal by Subject|1|||
164482070|NCT01332266|594138051|FG003|Phase 1b|Withdrawal by Subject|0|||
164482071|NCT01332266|594138052|FG004|Phase 1b|Withdrawal by Subject|0|||
164482072|NCT01332266|594138048|FG000|Phase 2|Death|0|||
164482073|NCT01332266|594138049|FG001|Phase 2|Death|0|||
164482074|NCT01332266|594138050|FG002|Phase 2|Death|0|||
164482075|NCT01332266|594138051|FG003|Phase 2|Death|33|||
164482076|NCT01332266|594138052|FG004|Phase 2|Death|36|||
164482077|NCT01332266|594138048|FG000|Phase 2|Lost to Follow-up|0|||
164482078|NCT01332266|594138049|FG001|Phase 2|Lost to Follow-up|0|||
164482079|NCT01332266|594138050|FG002|Phase 2|Lost to Follow-up|0|||
164482080|NCT01332266|594138051|FG003|Phase 2|Lost to Follow-up|2|||
164482081|NCT01332266|594138052|FG004|Phase 2|Lost to Follow-up|0|||
164482082|NCT01332266|594138048|FG000|Phase 2|Physician Decision|0|||
164482083|NCT01332266|594138049|FG001|Phase 2|Physician Decision|0|||
164482084|NCT01332266|594138050|FG002|Phase 2|Physician Decision|0|||
164482085|NCT01332266|594138051|FG003|Phase 2|Physician Decision|3|||
164482086|NCT01332266|594138052|FG004|Phase 2|Physician Decision|1|||
164482087|NCT01332266|594138048|FG000|Phase 2|Symptomatic deterioration|0|||
164482088|NCT01332266|594138049|FG001|Phase 2|Symptomatic deterioration|0|||
164482089|NCT01332266|594138050|FG002|Phase 2|Symptomatic deterioration|0|||
164482090|NCT01332266|594138051|FG003|Phase 2|Symptomatic deterioration|0|||
164482091|NCT01332266|594138052|FG004|Phase 2|Symptomatic deterioration|1|||
164482092|NCT01332266|594138048|FG000|Phase 2|Progression Disease|0|||
164482093|NCT01332266|594138049|FG001|Phase 2|Progression Disease|0|||
164482094|NCT01332266|594138050|FG002|Phase 2|Progression Disease|0|||
164482095|NCT01332266|594138051|FG003|Phase 2|Progression Disease|2|||
164482096|NCT01332266|594138052|FG004|Phase 2|Progression Disease|1|||
164482097|NCT01332266|594138048|FG000|Phase 2|Withdrawal by Subject|0|||
164482098|NCT01332266|594138049|FG001|Phase 2|Withdrawal by Subject|0|||
164482099|NCT01332266|594138050|FG002|Phase 2|Withdrawal by Subject|0|||
164482100|NCT01332266|594138051|FG003|Phase 2|Withdrawal by Subject|2|||
164482101|NCT01332266|594138052|FG004|Phase 2|Withdrawal by Subject|2|||
164482102|NCT01536704|594138055|FG000|Washout Period 1|Withdrawal by Subject|1|||
164482103|NCT01536704|594138056|FG001|Washout Period 1|Withdrawal by Subject|2|||
164482104|NCT01536704|594138057|FG002|Washout Period 1|Withdrawal by Subject|0|||
164482105|NCT01536704|594138058|FG003|Washout Period 1|Withdrawal by Subject|0|||
164482106|NCT01536704|594138055|FG000|Washout Period 2|Adverse Event|1|||
164482107|NCT01536704|594138056|FG001|Washout Period 2|Adverse Event|0|||
164482108|NCT01536704|594138057|FG002|Washout Period 2|Adverse Event|0|||
164482109|NCT01536704|594138058|FG003|Washout Period 2|Adverse Event|0|||
164482110|NCT01536704|594138055|FG000|Washout Period 2|Withdrawal by Subject|0|||
164482111|NCT01536704|594138056|FG001|Washout Period 2|Withdrawal by Subject|0|||
164482112|NCT01536704|594138057|FG002|Washout Period 2|Withdrawal by Subject|0|||
164482113|NCT01536704|594138058|FG003|Washout Period 2|Withdrawal by Subject|1|||
164482114|NCT01536704|594138055|FG000|Period 3|Adverse Event|0|||
164482115|NCT01536704|594138056|FG001|Period 3|Adverse Event|0|||
164482116|NCT01536704|594138057|FG002|Period 3|Adverse Event|0|||
164482117|NCT01536704|594138058|FG003|Period 3|Adverse Event|1|||
164482118|NCT01536704|594138055|FG000|Washout Period 3|Adverse Event|0|||
164482119|NCT01536704|594138056|FG001|Washout Period 3|Adverse Event|0|||
164482120|NCT01536704|594138057|FG002|Washout Period 3|Adverse Event|1|||
164482121|NCT01536704|594138058|FG003|Washout Period 3|Adverse Event|0|||
164482122|NCT04658784|594138059|FG000|6-month Follow-up|Lost to Follow-up|2|||
164482123|NCT04658784|594138060|FG001|6-month Follow-up|Lost to Follow-up|5|||
164482124|NCT01205126|594138061|FG000|Titration Phase|Adverse Event|5|||
164482125|NCT01205126|594138062|FG001|Titration Phase|Adverse Event|3|||
164482126|NCT01205126|594138061|FG000|Titration Phase|Withdrawal by Subject|5|||
164482127|NCT01205126|594138062|FG001|Titration Phase|Withdrawal by Subject|5|||
164482128|NCT01205126|594138061|FG000|Titration Phase|Lost to Follow-up|2|||
164482129|NCT01205126|594138062|FG001|Titration Phase|Lost to Follow-up|2|||
164482130|NCT01205126|594138061|FG000|Titration Phase|No stable titration dose|1|||
164482131|NCT01205126|594138062|FG001|Titration Phase|No stable titration dose|0|||
164482132|NCT01205126|594138061|FG000|Titration Phase|More than maximum dosage required|2|||
164482133|NCT01205126|594138062|FG001|Titration Phase|More than maximum dosage required|3|||
164482134|NCT01205126|594138061|FG000|Titration Phase|Other|8|||
164482135|NCT01205126|594138062|FG001|Titration Phase|Other|6|||
164482136|NCT01205126|594138061|FG000|Between Titration & Maintenance Phase|Other|0|||
164482137|NCT01205126|594138062|FG001|Between Titration & Maintenance Phase|Other|4|||
164482138|NCT01205126|594138061|FG000|Maintenance Phase|Adverse Event|3|||
164482139|NCT01205126|594138062|FG001|Maintenance Phase|Adverse Event|7|||
164482140|NCT01205126|594138061|FG000|Maintenance Phase|Death|4|||
164482141|NCT01205126|594138062|FG001|Maintenance Phase|Death|4|||
164482142|NCT01205126|594138061|FG000|Maintenance Phase|More than the maximum dosage required|5|||
164482143|NCT01205126|594138062|FG001|Maintenance Phase|More than the maximum dosage required|5|||
164482144|NCT01205126|594138061|FG000|Maintenance Phase|Prohibited drugs used|1|||
164482145|NCT01205126|594138062|FG001|Maintenance Phase|Prohibited drugs used|0|||
164482146|NCT01205126|594138061|FG000|Maintenance Phase|Other|11|||
164482147|NCT01205126|594138062|FG001|Maintenance Phase|Other|8|||
164482148|NCT01205126|594138061|FG000|Maintenance Phase|Lost to Follow-up|5|||
164482149|NCT01205126|594138062|FG001|Maintenance Phase|Lost to Follow-up|5|||
164482150|NCT01205126|594138061|FG000|Maintenance Phase|Withdrawal by Subject|8|||
164482151|NCT01205126|594138062|FG001|Maintenance Phase|Withdrawal by Subject|11|||
164482152|NCT00923078|594138068|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
164482153|NCT00923078|594138069|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
164482154|NCT00923078|594138070|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
164482155|NCT00923078|594138068|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
164482156|NCT00923078|594138069|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
164482157|NCT00923078|594138070|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
164482158|NCT01072149|594138074|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164482159|NCT01072149|594138075|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164482160|NCT01072149|594138076|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
164482161|NCT01072149|594138077|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164482162|NCT01072149|594138078|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164482163|NCT01072149|594138079|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164482164|NCT01072149|594138080|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164482165|NCT01072149|594138081|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164482166|NCT01072149|594138082|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164482167|NCT01072149|594138083|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164482168|NCT01072149|594138084|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164482169|NCT01072149|594138085|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164482170|NCT01072149|594138086|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164482171|NCT01072149|594138087|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164482172|NCT01072149|594138088|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164482173|NCT01072149|594138089|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164482174|NCT01072149|594138090|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164482175|NCT01072149|594138091|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164482176|NCT01072149|594138074|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
164482177|NCT01072149|594138075|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
164482178|NCT01072149|594138076|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
164482179|NCT01072149|594138077|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
164482180|NCT01072149|594138078|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
164482181|NCT01072149|594138079|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
164482182|NCT01072149|594138080|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
164482183|NCT01072149|594138081|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
164482184|NCT01072149|594138082|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
164482185|NCT01072149|594138083|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
164482186|NCT01072149|594138084|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
164482187|NCT01072149|594138085|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
164482188|NCT01072149|594138086|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
164482189|NCT01072149|594138087|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
164482190|NCT01072149|594138088|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
164482191|NCT01072149|594138089|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
164482192|NCT01072149|594138090|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
164482193|NCT01072149|594138091|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
164482194|NCT01072149|594138074|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164482195|NCT01072149|594138075|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164482196|NCT01072149|594138076|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164482197|NCT01072149|594138077|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164482198|NCT01072149|594138078|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164482199|NCT01072149|594138079|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164482200|NCT01072149|594138080|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164482201|NCT01072149|594138081|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164482202|NCT01072149|594138082|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164482203|NCT01072149|594138083|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164482204|NCT01072149|594138084|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
164482205|NCT01072149|594138085|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164482206|NCT01072149|594138086|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164482207|NCT01072149|594138087|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164482208|NCT01072149|594138088|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164482209|NCT01072149|594138089|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164482210|NCT01072149|594138090|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164482211|NCT01072149|594138091|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164482212|NCT01072149|594138074|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164482213|NCT01072149|594138075|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
164600907|NCT00819585|594559872|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
164600908|NCT00819585|594559873|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
164482214|NCT01072149|594138076|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164482215|NCT01072149|594138077|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164482216|NCT01072149|594138078|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164482217|NCT01072149|594138079|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164482218|NCT01072149|594138080|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164482219|NCT01072149|594138081|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164482220|NCT01072149|594138082|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164482221|NCT01072149|594138083|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164482222|NCT01072149|594138084|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164482223|NCT01072149|594138085|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164482224|NCT01072149|594138086|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164482225|NCT01072149|594138087|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164482226|NCT01072149|594138088|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164482227|NCT01072149|594138089|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164482228|NCT01072149|594138090|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164482229|NCT01072149|594138091|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164482230|NCT01072149|594138074|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
164482231|NCT01072149|594138075|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
164482232|NCT01072149|594138076|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
164482233|NCT01072149|594138077|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
164482234|NCT01072149|594138078|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
164482235|NCT01072149|594138079|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
164482236|NCT01072149|594138080|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
164482237|NCT01072149|594138081|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
164482238|NCT01072149|594138082|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
164482239|NCT01072149|594138083|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
164482240|NCT01072149|594138084|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
164482241|NCT01072149|594138085|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
164482242|NCT01072149|594138086|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
164482243|NCT01072149|594138087|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
164482244|NCT01072149|594138088|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
164482245|NCT01072149|594138089|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
164482246|NCT01072149|594138090|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
164482247|NCT01072149|594138091|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
164482248|NCT01072149|594138074|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
164482249|NCT01072149|594138075|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
164482250|NCT01072149|594138076|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
164482251|NCT01072149|594138077|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
164482252|NCT01072149|594138078|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
164482253|NCT01072149|594138079|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
164482254|NCT01072149|594138080|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
164482255|NCT01072149|594138081|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
164482256|NCT01072149|594138082|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
164482257|NCT01072149|594138083|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
164482258|NCT01072149|594138084|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
164482259|NCT01072149|594138085|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
164482260|NCT01072149|594138086|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
164482261|NCT01072149|594138087|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
164482262|NCT01072149|594138088|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
164482263|NCT01072149|594138089|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
164482264|NCT01072149|594138090|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
164482265|NCT01072149|594138091|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
164482266|NCT01072149|594138074|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
164482267|NCT01072149|594138075|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
164482268|NCT01072149|594138076|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
164482269|NCT01072149|594138077|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
164482270|NCT01072149|594138078|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
164482271|NCT01072149|594138079|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
164482272|NCT01072149|594138080|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
164482273|NCT01072149|594138081|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
164482274|NCT01072149|594138082|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
164482275|NCT01072149|594138083|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
164482276|NCT01072149|594138084|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
164482277|NCT01072149|594138085|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
164482278|NCT01072149|594138086|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
164482279|NCT01072149|594138087|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
164482280|NCT01072149|594138088|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
164482281|NCT01072149|594138089|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
164482282|NCT01072149|594138090|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
164482283|NCT01072149|594138091|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
164482284|NCT01072149|594138074|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
164482285|NCT01072149|594138075|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
164482286|NCT01072149|594138076|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
164482287|NCT01072149|594138077|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
164482288|NCT01072149|594138078|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
164482289|NCT01072149|594138079|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
164482290|NCT01072149|594138080|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
164482291|NCT01072149|594138081|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
164482292|NCT01072149|594138082|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
164482293|NCT01072149|594138083|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
164482294|NCT01072149|594138084|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
164482295|NCT01072149|594138085|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
164482296|NCT01072149|594138086|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
164482297|NCT01072149|594138087|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
164482298|NCT01072149|594138088|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
164482299|NCT01072149|594138089|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
164482300|NCT01072149|594138090|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
164482301|NCT01072149|594138091|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
164482302|NCT01072149|594138074|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
164482303|NCT01072149|594138075|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
164482304|NCT01072149|594138076|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
164482305|NCT01072149|594138077|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
164482306|NCT01072149|594138078|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
164482307|NCT01072149|594138079|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
164482308|NCT01072149|594138080|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
164482309|NCT01072149|594138081|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
164482310|NCT01072149|594138082|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
164482311|NCT01072149|594138083|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
164482312|NCT01072149|594138084|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
164482313|NCT01072149|594138085|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
164482314|NCT01072149|594138086|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
164482315|NCT01072149|594138087|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
164482316|NCT01072149|594138088|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
164482317|NCT01072149|594138089|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
164482318|NCT01072149|594138090|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
164482319|NCT01072149|594138091|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
164482320|NCT01072149|594138074|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
164482321|NCT01072149|594138075|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
164482322|NCT01072149|594138076|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
164482323|NCT01072149|594138077|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
164482324|NCT01072149|594138078|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
164482325|NCT01072149|594138079|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
164482326|NCT01072149|594138080|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
164482327|NCT01072149|594138081|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
164482328|NCT01072149|594138082|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
164482329|NCT01072149|594138083|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
164482330|NCT01072149|594138084|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
164482331|NCT01072149|594138085|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
164482332|NCT01072149|594138086|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
164482333|NCT01072149|594138087|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
164482334|NCT01072149|594138088|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
164482335|NCT01072149|594138089|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
164482336|NCT01072149|594138090|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
164482337|NCT01072149|594138091|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
164482338|NCT01072149|594138074|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
164482339|NCT01072149|594138075|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
164482340|NCT01072149|594138076|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
164482341|NCT01072149|594138077|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
164482342|NCT01072149|594138078|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
164482343|NCT01072149|594138079|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
164482344|NCT01072149|594138080|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
164482345|NCT01072149|594138081|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
164482346|NCT01072149|594138082|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
164482347|NCT01072149|594138083|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
164482348|NCT01072149|594138084|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
164482349|NCT01072149|594138085|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
164482350|NCT01072149|594138086|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
164482351|NCT01072149|594138087|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
164600909|NCT00819585|594559874|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
164600910|NCT00819585|594559875|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
164600911|NCT00819585|594559876|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
164600912|NCT00819585|594559877|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
164600913|NCT00819585|594559878|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
164600914|NCT00819585|594559879|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
164600915|NCT00819585|594559880|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
164600916|NCT00819585|594559881|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
164600917|NCT00819585|594559871|FG000|Core Study|Subject Withdrew Consent|0|||
164600918|NCT00819585|594559872|FG001|Core Study|Subject Withdrew Consent|3|||
164600919|NCT00819585|594559873|FG002|Core Study|Subject Withdrew Consent|2|||
164600920|NCT00819585|594559874|FG003|Core Study|Subject Withdrew Consent|1|||
164600921|NCT00819585|594559875|FG004|Core Study|Subject Withdrew Consent|0|||
164600922|NCT00819585|594559876|FG005|Core Study|Subject Withdrew Consent|0|||
164600923|NCT00819585|594559877|FG006|Core Study|Subject Withdrew Consent|3|||
164600924|NCT00819585|594559878|FG007|Core Study|Subject Withdrew Consent|0|||
164600925|NCT00819585|594559879|FG008|Core Study|Subject Withdrew Consent|0|||
164600926|NCT00819585|594559880|FG009|Core Study|Subject Withdrew Consent|0|||
164600927|NCT00819585|594559881|FG010|Core Study|Subject Withdrew Consent|0|||
164600928|NCT00819585|594559871|FG000|Core Study|Lost to Follow-up|2|||
164600929|NCT00819585|594559872|FG001|Core Study|Lost to Follow-up|1|||
164600930|NCT00819585|594559873|FG002|Core Study|Lost to Follow-up|2|||
164600931|NCT00819585|594559874|FG003|Core Study|Lost to Follow-up|0|||
164600932|NCT00819585|594559875|FG004|Core Study|Lost to Follow-up|1|||
164600933|NCT00819585|594559876|FG005|Core Study|Lost to Follow-up|1|||
164600934|NCT00819585|594559877|FG006|Core Study|Lost to Follow-up|1|||
164600935|NCT00819585|594559878|FG007|Core Study|Lost to Follow-up|0|||
164600936|NCT00819585|594559879|FG008|Core Study|Lost to Follow-up|0|||
164600937|NCT00819585|594559880|FG009|Core Study|Lost to Follow-up|0|||
164600938|NCT00819585|594559881|FG010|Core Study|Lost to Follow-up|0|||
164600939|NCT00819585|594559871|FG000|Core Study|Administrative Problems|0|||
164600940|NCT00819585|594559872|FG001|Core Study|Administrative Problems|0|||
164600941|NCT00819585|594559873|FG002|Core Study|Administrative Problems|0|||
164600942|NCT00819585|594559874|FG003|Core Study|Administrative Problems|0|||
164600943|NCT00819585|594559875|FG004|Core Study|Administrative Problems|0|||
164600944|NCT00819585|594559876|FG005|Core Study|Administrative Problems|0|||
164600945|NCT00819585|594559877|FG006|Core Study|Administrative Problems|2|||
164600946|NCT00819585|594559878|FG007|Core Study|Administrative Problems|0|||
164600947|NCT00819585|594559879|FG008|Core Study|Administrative Problems|0|||
164600948|NCT00819585|594559880|FG009|Core Study|Administrative Problems|0|||
164600949|NCT00819585|594559881|FG010|Core Study|Administrative Problems|0|||
164600950|NCT00819585|594559871|FG000|Core Study|Death|0|||
164600951|NCT00819585|594559872|FG001|Core Study|Death|0|||
164600952|NCT00819585|594559873|FG002|Core Study|Death|0|||
164600953|NCT00819585|594559874|FG003|Core Study|Death|0|||
164600954|NCT00819585|594559875|FG004|Core Study|Death|0|||
164600955|NCT00819585|594559876|FG005|Core Study|Death|0|||
164600956|NCT00819585|594559877|FG006|Core Study|Death|1|||
164600957|NCT00819585|594559878|FG007|Core Study|Death|0|||
164600958|NCT00819585|594559879|FG008|Core Study|Death|0|||
164600959|NCT00819585|594559880|FG009|Core Study|Death|0|||
164600960|NCT00819585|594559881|FG010|Core Study|Death|0|||
164600961|NCT00819585|594559871|FG000|Core Study|Protocol Violation|0|||
164600962|NCT00819585|594559872|FG001|Core Study|Protocol Violation|0|||
164600963|NCT00819585|594559873|FG002|Core Study|Protocol Violation|1|||
164600964|NCT00819585|594559874|FG003|Core Study|Protocol Violation|0|||
164600965|NCT00819585|594559875|FG004|Core Study|Protocol Violation|0|||
164600966|NCT00819585|594559876|FG005|Core Study|Protocol Violation|1|||
164482352|NCT01072149|594138088|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
164482353|NCT01072149|594138089|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
164482354|NCT01072149|594138090|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
164482355|NCT01072149|594138091|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
164482356|NCT00871494|594138096|FG000|Overall Study|Protocol Violation|5|||
164482357|NCT00871494|594138096|FG000|Overall Study|Lack of Efficacy|4|||
164482358|NCT00871494|594138096|FG000|Overall Study|Adverse Event|4|||
164600967|NCT00819585|594559877|FG006|Core Study|Protocol Violation|3|||
164600968|NCT00819585|594559878|FG007|Core Study|Protocol Violation|0|||
164600969|NCT00819585|594559879|FG008|Core Study|Protocol Violation|0|||
164600970|NCT00819585|594559880|FG009|Core Study|Protocol Violation|0|||
164600971|NCT00819585|594559881|FG010|Core Study|Protocol Violation|0|||
164600972|NCT00819585|594559871|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
164600973|NCT00819585|594559872|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
164600974|NCT00819585|594559873|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
164600975|NCT00819585|594559874|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
164600976|NCT00819585|594559875|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
164600977|NCT00819585|594559876|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
164482359|NCT00871494|594138096|FG000|Overall Study|Lost to Follow-up|1|||
164714426|NCT02784795|594976914|FG009|Overall Study|Physician Decision|0|||
164600978|NCT00819585|594559877|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
164600979|NCT00819585|594559878|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
164600980|NCT00819585|594559879|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
164600981|NCT00819585|594559880|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
164600982|NCT00819585|594559881|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
164600983|NCT00819585|594559871|FG000|Extension Study|Subject Withdrew Consent|0|||
164600984|NCT00819585|594559872|FG001|Extension Study|Subject Withdrew Consent|0|||
164600985|NCT00819585|594559873|FG002|Extension Study|Subject Withdrew Consent|0|||
164600986|NCT00819585|594559874|FG003|Extension Study|Subject Withdrew Consent|0|||
164600987|NCT00819585|594559875|FG004|Extension Study|Subject Withdrew Consent|0|||
164600988|NCT00819585|594559876|FG005|Extension Study|Subject Withdrew Consent|0|||
164600989|NCT00819585|594559877|FG006|Extension Study|Subject Withdrew Consent|0|||
164600990|NCT00819585|594559878|FG007|Extension Study|Subject Withdrew Consent|0|||
164600991|NCT00819585|594559879|FG008|Extension Study|Subject Withdrew Consent|3|||
164600992|NCT00819585|594559880|FG009|Extension Study|Subject Withdrew Consent|0|||
164600993|NCT00819585|594559881|FG010|Extension Study|Subject Withdrew Consent|1|||
164600994|NCT00819585|594559871|FG000|Extension Study|Lost to Follow-up|0|||
164600995|NCT00819585|594559872|FG001|Extension Study|Lost to Follow-up|0|||
164600996|NCT00819585|594559873|FG002|Extension Study|Lost to Follow-up|0|||
164600997|NCT00819585|594559874|FG003|Extension Study|Lost to Follow-up|0|||
164600998|NCT00819585|594559875|FG004|Extension Study|Lost to Follow-up|0|||
164600999|NCT00819585|594559876|FG005|Extension Study|Lost to Follow-up|0|||
164601000|NCT00819585|594559877|FG006|Extension Study|Lost to Follow-up|0|||
164601001|NCT00819585|594559878|FG007|Extension Study|Lost to Follow-up|0|||
164601002|NCT00819585|594559879|FG008|Extension Study|Lost to Follow-up|2|||
164601003|NCT00819585|594559880|FG009|Extension Study|Lost to Follow-up|1|||
164601004|NCT00819585|594559881|FG010|Extension Study|Lost to Follow-up|1|||
164601005|NCT00819585|594559871|FG000|Extension Study|Death|0|||
164601006|NCT00819585|594559872|FG001|Extension Study|Death|0|||
164601007|NCT00819585|594559873|FG002|Extension Study|Death|0|||
164601008|NCT00819585|594559874|FG003|Extension Study|Death|0|||
164601009|NCT00819585|594559875|FG004|Extension Study|Death|0|||
164601010|NCT00819585|594559876|FG005|Extension Study|Death|0|||
164601011|NCT00819585|594559877|FG006|Extension Study|Death|0|||
164601012|NCT00819585|594559878|FG007|Extension Study|Death|0|||
164601013|NCT00819585|594559879|FG008|Extension Study|Death|2|||
164601014|NCT00819585|594559880|FG009|Extension Study|Death|0|||
164601015|NCT00819585|594559881|FG010|Extension Study|Death|0|||
164601016|NCT01927419|594559882|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
164601017|NCT01927419|594559883|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
164601018|NCT01927419|594559882|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
164601019|NCT01927419|594559883|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
164601020|NCT01927419|594559882|FG000|Treatment Period|Disease progression|17|||
164601021|NCT01927419|594559883|FG001|Treatment Period|Disease progression|20|||
164601022|NCT01927419|594559882|FG000|Treatment Period|Study drug toxicity|48|||
164601023|NCT01927419|594559883|FG001|Treatment Period|Study drug toxicity|10|||
164601024|NCT01927419|594559882|FG000|Treatment Period|Death|0|||
164601025|NCT01927419|594559883|FG001|Treatment Period|Death|1|||
164601026|NCT01927419|594559882|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
164601027|NCT01927419|594559883|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
164601028|NCT01927419|594559882|FG000|Treatment Period|Participant request to discontinue|12|||
164601029|NCT01927419|594559883|FG001|Treatment Period|Participant request to discontinue|4|||
164601030|NCT01927419|594559882|FG000|Treatment Period|Withdrawal by Subject|1|||
164601031|NCT01927419|594559883|FG001|Treatment Period|Withdrawal by Subject|1|||
164601032|NCT01927419|594559882|FG000|Treatment Period|Maximum Clinical Benefit|6|||
164601033|NCT01927419|594559883|FG001|Treatment Period|Maximum Clinical Benefit|2|||
164601034|NCT01927419|594559882|FG000|Treatment Period|Other reasons|3|||
164601035|NCT01927419|594559883|FG001|Treatment Period|Other reasons|4|||
164601036|NCT01927419|594559882|FG000|Treatment Period|Not Reported|1|||
164601037|NCT01927419|594559883|FG001|Treatment Period|Not Reported|1|||
164714427|NCT02784795|594976915|FG010|Overall Study|Physician Decision|0|||
164714428|NCT02784795|594976916|FG011|Overall Study|Physician Decision|0|||
164714429|NCT01994850|594976917|FG000|Overall Study|Physician Decision|1|||
164714430|NCT01994850|594976917|FG000|Overall Study|Withdrawal by Subject|1|||
164714431|NCT00339144|594976952|FG000|Overall Study|Disease progression|5|||
164714432|NCT00339144|594976953|FG001|Overall Study|Disease progression|2|||
164601038|NCT01935336|594559886|FG000|Overall Study|Adverse Event|1|||
164601039|NCT01935336|594559887|FG001|Overall Study|Adverse Event|0|||
164601040|NCT01935336|594559888|FG002|Overall Study|Adverse Event|0|||
164601041|NCT01935336|594559889|FG003|Overall Study|Adverse Event|0|||
164601042|NCT01935336|594559886|FG000|Overall Study|Progressive disease|5|||
164601043|NCT01935336|594559887|FG001|Overall Study|Progressive disease|3|||
164714433|NCT00339144|594976954|FG002|Overall Study|Disease progression|2|||
164601044|NCT01935336|594559888|FG002|Overall Study|Progressive disease|47|||
164601045|NCT01935336|594559889|FG003|Overall Study|Progressive disease|66|||
164601046|NCT02773238|594559890|FG000|Overall Study|Lack of Efficacy|4|||
164601047|NCT03260205|594559891|FG000|Overall Study|Adverse Event|2|||
164482360|NCT03265132|594138105|FG000|Overall Study|Adverse Event|0|||
164482361|NCT03265132|594138106|FG001|Overall Study|Adverse Event|1|||
164482362|NCT03265132|594138105|FG000|Overall Study|Lack of Efficacy|0|||
164482363|NCT03265132|594138106|FG001|Overall Study|Lack of Efficacy|2|||
164482364|NCT03265132|594138105|FG000|Overall Study|Progressive disease|0|||
164482365|NCT03265132|594138106|FG001|Overall Study|Progressive disease|2|||
164482366|NCT03265132|594138105|FG000|Overall Study|Withdrawal by Subject|0|||
164482367|NCT03265132|594138106|FG001|Overall Study|Withdrawal by Subject|1|||
164482368|NCT00681109|594138107|FG000|Overall Study|Lost to Follow-up|2|||
164482369|NCT00681109|594138108|FG001|Overall Study|Lost to Follow-up|6|||
164482370|NCT00681109|594138109|FG002|Overall Study|Lost to Follow-up|0|||
164482371|NCT03259568|594138110|FG000|Overall Study|Participant performance was low|3|||
164482372|NCT03128099|594138113|FG000|Overall Study|High dose task was too long|0|||
164482373|NCT03128099|594138114|FG001|Overall Study|High dose task was too long|4|||
164482374|NCT03128099|594138115|FG002|Overall Study|High dose task was too long|0|||
164482375|NCT03128099|594138113|FG000|Overall Study|Participant got a full time job.|1|||
164482376|NCT03128099|594138114|FG001|Overall Study|Participant got a full time job.|0|||
164482377|NCT03128099|594138115|FG002|Overall Study|Participant got a full time job.|0|||
164482378|NCT03128099|594138113|FG000|Overall Study|Became homeless and lost contact|1|||
164482379|NCT03128099|594138114|FG001|Overall Study|Became homeless and lost contact|0|||
164482380|NCT03128099|594138115|FG002|Overall Study|Became homeless and lost contact|0|||
164482381|NCT03128099|594138113|FG000|Overall Study|Did not complete all the assessments|0|||
164482382|NCT03128099|594138114|FG001|Overall Study|Did not complete all the assessments|0|||
164482383|NCT03128099|594138115|FG002|Overall Study|Did not complete all the assessments|1|||
164482384|NCT00148122|594138116|FG000|Overall Study|Withdrawal by Subject|2|||
164482385|NCT02362789|594138124|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
164482386|NCT02362789|594138125|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
164482387|NCT02362789|594138126|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
164482388|NCT02362789|594138124|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
164482389|NCT02362789|594138125|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
164482390|NCT02362789|594138126|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
164482391|NCT02362789|594138124|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
164482392|NCT02362789|594138125|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
164482393|NCT02362789|594138126|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
164482394|NCT02362789|594138124|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
164482395|NCT02362789|594138125|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
164482396|NCT02362789|594138126|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
164482397|NCT02362789|594138124|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
164482398|NCT02362789|594138125|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
164482399|NCT02362789|594138126|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
164482400|NCT00721734|594138127|FG000|Overall Study|Progressive Disease|3|||
164482401|NCT00721734|594138128|FG001|Overall Study|Progressive Disease|10|||
164482402|NCT00721734|594138129|FG002|Overall Study|Progressive Disease|4|||
164482403|NCT00721734|594138130|FG003|Overall Study|Progressive Disease|5|||
164482404|NCT00721734|594138131|FG004|Overall Study|Progressive Disease|2|||
164482405|NCT00721734|594138127|FG000|Overall Study|Adverse Event|3|||
164482406|NCT00721734|594138128|FG001|Overall Study|Adverse Event|1|||
164482407|NCT00721734|594138129|FG002|Overall Study|Adverse Event|4|||
164482408|NCT00721734|594138130|FG003|Overall Study|Adverse Event|0|||
164482409|NCT00721734|594138131|FG004|Overall Study|Adverse Event|3|||
164482410|NCT00721734|594138127|FG000|Overall Study|Withdrawal by Subject|2|||
164482411|NCT00721734|594138128|FG001|Overall Study|Withdrawal by Subject|1|||
164482412|NCT00721734|594138129|FG002|Overall Study|Withdrawal by Subject|0|||
164482413|NCT00721734|594138130|FG003|Overall Study|Withdrawal by Subject|0|||
164482414|NCT00721734|594138131|FG004|Overall Study|Withdrawal by Subject|1|||
164482415|NCT00721734|594138127|FG000|Overall Study|Other|0|||
164482416|NCT00721734|594138128|FG001|Overall Study|Other|0|||
164482417|NCT00721734|594138129|FG002|Overall Study|Other|0|||
164482418|NCT00721734|594138130|FG003|Overall Study|Other|1|||
164482419|NCT00721734|594138131|FG004|Overall Study|Other|0|||
164482420|NCT02251652|594138132|FG000|Overall Study|Withdrawal by Subject|1|||
164482421|NCT01989689|594138133|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
164482422|NCT01989689|594138134|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
164482423|NCT01989689|594138133|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
164482424|NCT01989689|594138134|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
164482425|NCT04492475|594138135|FG000|Overall Study|Enrolled but not treated|8|||
164482426|NCT04492475|594138136|FG001|Overall Study|Enrolled but not treated|8|||
164482427|NCT04492475|594138135|FG000|Overall Study|Withdrawal by Subject|4|||
164482428|NCT04492475|594138136|FG001|Overall Study|Withdrawal by Subject|0|||
164482429|NCT04492475|594138135|FG000|Overall Study|Became ineligible after enrollment|2|||
164482430|NCT04492475|594138136|FG001|Overall Study|Became ineligible after enrollment|0|||
164482431|NCT02066636|594138137|FG000|Overall Study|Disease progression|51|||
164482432|NCT02066636|594138138|FG001|Overall Study|Disease progression|60|||
164482433|NCT02066636|594138139|FG002|Overall Study|Disease progression|700|||
164482434|NCT02066636|594138137|FG000|Overall Study|Study drug toxicity|13|||
164482435|NCT02066636|594138138|FG001|Overall Study|Study drug toxicity|2|||
164482436|NCT02066636|594138139|FG002|Overall Study|Study drug toxicity|58|||
164482437|NCT02066636|594138137|FG000|Overall Study|Death|4|||
164482438|NCT02066636|594138138|FG001|Overall Study|Death|2|||
164482439|NCT02066636|594138139|FG002|Overall Study|Death|158|||
164482440|NCT02066636|594138137|FG000|Overall Study|Adverse event unrelated to study drug|6|||
164482441|NCT02066636|594138138|FG001|Overall Study|Adverse event unrelated to study drug|4|||
164482442|NCT02066636|594138139|FG002|Overall Study|Adverse event unrelated to study drug|45|||
164482443|NCT02066636|594138137|FG000|Overall Study|Participant request to discontinue treatment|12|||
164482444|NCT02066636|594138138|FG001|Overall Study|Participant request to discontinue treatment|12|||
164482445|NCT02066636|594138139|FG002|Overall Study|Participant request to discontinue treatment|70|||
164601048|NCT03260205|594559892|FG001|Overall Study|Adverse Event|0|||
164601049|NCT03260205|594559893|FG002|Overall Study|Adverse Event|2|||
164601050|NCT03260205|594559894|FG003|Overall Study|Adverse Event|2|||
164601051|NCT03260205|594559895|FG004|Overall Study|Adverse Event|4|||
164601052|NCT03260205|594559891|FG000|Overall Study|Lost to Follow-up|2|||
164601053|NCT03260205|594559892|FG001|Overall Study|Lost to Follow-up|2|||
164601054|NCT03260205|594559893|FG002|Overall Study|Lost to Follow-up|1|||
164601055|NCT03260205|594559894|FG003|Overall Study|Lost to Follow-up|1|||
164601056|NCT03260205|594559895|FG004|Overall Study|Lost to Follow-up|5|||
164601057|NCT03260205|594559891|FG000|Overall Study|Protocol Violation|0|||
164601058|NCT03260205|594559892|FG001|Overall Study|Protocol Violation|0|||
164601059|NCT03260205|594559893|FG002|Overall Study|Protocol Violation|2|||
164601060|NCT03260205|594559894|FG003|Overall Study|Protocol Violation|0|||
164601061|NCT03260205|594559895|FG004|Overall Study|Protocol Violation|1|||
164601062|NCT03260205|594559891|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
164601063|NCT03260205|594559892|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
164601064|NCT03260205|594559893|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
164601065|NCT03260205|594559894|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
164601066|NCT03260205|594559895|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
164601067|NCT03260205|594559891|FG000|Overall Study|Other: Unspecified|0|||
164601068|NCT03260205|594559892|FG001|Overall Study|Other: Unspecified|0|||
164601069|NCT03260205|594559893|FG002|Overall Study|Other: Unspecified|3|||
164601070|NCT03260205|594559894|FG003|Overall Study|Other: Unspecified|1|||
164601071|NCT03260205|594559895|FG004|Overall Study|Other: Unspecified|1|||
164601072|NCT03260205|594559891|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
164601073|NCT03260205|594559892|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
164601074|NCT03260205|594559893|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
164601075|NCT03260205|594559894|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
164601076|NCT03260205|594559895|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
164601077|NCT01877382|594559896|FG000|Dose Escalation|Progressive disease|2|||
164601078|NCT01877382|594559897|FG001|Dose Escalation|Progressive disease|0|||
164601079|NCT01877382|594559898|FG002|Dose Escalation|Progressive disease|1|||
164601080|NCT01877382|594559899|FG003|Dose Escalation|Progressive disease|6|||
164601081|NCT01877382|594559900|FG004|Dose Escalation|Progressive disease|1|||
164601082|NCT01877382|594559901|FG005|Dose Escalation|Progressive disease|0|||
164601083|NCT01877382|594559902|FG006|Dose Escalation|Progressive disease|3|||
164601084|NCT01877382|594559903|FG007|Dose Escalation|Progressive disease|10|||
164601085|NCT01877382|594559904|FG008|Dose Escalation|Progressive disease|4|||
164601086|NCT01877382|594559905|FG009|Dose Escalation|Progressive disease|2|||
164601087|NCT01877382|594559906|FG010|Dose Escalation|Progressive disease|3|||
164601088|NCT01877382|594559907|FG011|Dose Escalation|Progressive disease|3|||
164601089|NCT01877382|594559908|FG012|Dose Escalation|Progressive disease|13|||
164601090|NCT01877382|594559909|FG013|Dose Escalation|Progressive disease|1|||
164601091|NCT01877382|594559910|FG014|Dose Escalation|Progressive disease|0|||
164601092|NCT01877382|594559896|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
164482446|NCT02066636|594138137|FG000|Overall Study|Participant withdrew consent|10|||
164482447|NCT02066636|594138138|FG001|Overall Study|Participant withdrew consent|18|||
164601093|NCT01877382|594559897|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164601094|NCT01877382|594559898|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164601095|NCT01877382|594559899|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
164601096|NCT01877382|594559900|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164601097|NCT01877382|594559901|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164601098|NCT01877382|594559902|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
164482448|NCT02066636|594138139|FG002|Overall Study|Participant withdrew consent|61|||
164601099|NCT01877382|594559903|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164601100|NCT01877382|594559904|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164601101|NCT01877382|594559905|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164601102|NCT01877382|594559906|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164601103|NCT01877382|594559907|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164601104|NCT01877382|594559908|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164601105|NCT01877382|594559909|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164601106|NCT01877382|594559910|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164601107|NCT01877382|594559896|FG000|Dose Escalation|Clinical progression|0|||
164601108|NCT01877382|594559897|FG001|Dose Escalation|Clinical progression|1|||
164601109|NCT01877382|594559898|FG002|Dose Escalation|Clinical progression|0|||
164601110|NCT01877382|594559899|FG003|Dose Escalation|Clinical progression|2|||
164601111|NCT01877382|594559900|FG004|Dose Escalation|Clinical progression|0|||
164601112|NCT01877382|594559901|FG005|Dose Escalation|Clinical progression|0|||
164601113|NCT01877382|594559902|FG006|Dose Escalation|Clinical progression|1|||
164601114|NCT01877382|594559903|FG007|Dose Escalation|Clinical progression|0|||
164601115|NCT01877382|594559904|FG008|Dose Escalation|Clinical progression|0|||
164601116|NCT01877382|594559905|FG009|Dose Escalation|Clinical progression|1|||
164601117|NCT01877382|594559906|FG010|Dose Escalation|Clinical progression|0|||
164601118|NCT01877382|594559907|FG011|Dose Escalation|Clinical progression|0|||
164601119|NCT01877382|594559908|FG012|Dose Escalation|Clinical progression|2|||
164601120|NCT01877382|594559909|FG013|Dose Escalation|Clinical progression|1|||
164601121|NCT01877382|594559910|FG014|Dose Escalation|Clinical progression|0|||
164601122|NCT01877382|594559896|FG000|Dose Escalation|Adverse Event|0|||
164601123|NCT01877382|594559897|FG001|Dose Escalation|Adverse Event|0|||
164601124|NCT01877382|594559898|FG002|Dose Escalation|Adverse Event|0|||
164601125|NCT01877382|594559899|FG003|Dose Escalation|Adverse Event|4|||
164601126|NCT01877382|594559900|FG004|Dose Escalation|Adverse Event|1|||
164601127|NCT01877382|594559901|FG005|Dose Escalation|Adverse Event|2|||
164601128|NCT01877382|594559902|FG006|Dose Escalation|Adverse Event|1|||
164601129|NCT01877382|594559903|FG007|Dose Escalation|Adverse Event|2|||
164601130|NCT01877382|594559904|FG008|Dose Escalation|Adverse Event|0|||
164601131|NCT01877382|594559905|FG009|Dose Escalation|Adverse Event|0|||
164601132|NCT01877382|594559906|FG010|Dose Escalation|Adverse Event|0|||
164601133|NCT01877382|594559907|FG011|Dose Escalation|Adverse Event|0|||
164601134|NCT01877382|594559908|FG012|Dose Escalation|Adverse Event|1|||
164601135|NCT01877382|594559909|FG013|Dose Escalation|Adverse Event|0|||
164601136|NCT01877382|594559910|FG014|Dose Escalation|Adverse Event|0|||
164601137|NCT01877382|594559896|FG000|Dose Escalation|Withdrawal by Subject|0|||
164601138|NCT01877382|594559897|FG001|Dose Escalation|Withdrawal by Subject|0|||
164601139|NCT01877382|594559898|FG002|Dose Escalation|Withdrawal by Subject|0|||
164601140|NCT01877382|594559899|FG003|Dose Escalation|Withdrawal by Subject|0|||
164601141|NCT01877382|594559900|FG004|Dose Escalation|Withdrawal by Subject|0|||
164601142|NCT01877382|594559901|FG005|Dose Escalation|Withdrawal by Subject|3|||
164601143|NCT01877382|594559902|FG006|Dose Escalation|Withdrawal by Subject|2|||
164601144|NCT01877382|594559903|FG007|Dose Escalation|Withdrawal by Subject|1|||
164601145|NCT01877382|594559904|FG008|Dose Escalation|Withdrawal by Subject|1|||
164714434|NCT00339144|594976952|FG000|Overall Study|Study drug toxicity|3|||
164714435|NCT00339144|594976953|FG001|Overall Study|Study drug toxicity|1|||
164714436|NCT00339144|594976954|FG002|Overall Study|Study drug toxicity|1|||
164714437|NCT00339144|594976952|FG000|Overall Study|Participant's request to discontinuation|1|||
164714438|NCT00339144|594976953|FG001|Overall Study|Participant's request to discontinuation|0|||
164714439|NCT00339144|594976954|FG002|Overall Study|Participant's request to discontinuation|1|||
164714440|NCT01292226|594976955|FG000|Overall Study|Adverse Event|5|||
164714441|NCT01292226|594976955|FG000|Overall Study|Death|1|||
164714442|NCT01292226|594976955|FG000|Overall Study|Graft loss|1|||
164714443|NCT01292226|594976955|FG000|Overall Study|Protocol Violation|3|||
164714444|NCT01292226|594976955|FG000|Overall Study|Withdrawal by Subject|1|||
164714445|NCT01292226|594976955|FG000|Overall Study|Other|2|||
164714446|NCT00468650|594976961|FG000|Overall Study|Lost to Follow-up|4|||
164714447|NCT00468650|594976961|FG000|Overall Study|Withdrawal by Subject|2|||
164714448|NCT00468650|594976961|FG000|Overall Study|Protocol Violation|1|||
164714449|NCT01267994|594976962|FG000|Overall Study|Adverse Event|2|||
164714450|NCT01210612|594976967|FG000|Overall Study|Withdrawal by Subject|0|||
164601146|NCT01877382|594559905|FG009|Dose Escalation|Withdrawal by Subject|0|||
164714451|NCT01210612|594976968|FG001|Overall Study|Withdrawal by Subject|2|||
164601147|NCT01877382|594559906|FG010|Dose Escalation|Withdrawal by Subject|0|||
164601148|NCT01877382|594559907|FG011|Dose Escalation|Withdrawal by Subject|0|||
164601149|NCT01877382|594559908|FG012|Dose Escalation|Withdrawal by Subject|0|||
164601150|NCT01877382|594559909|FG013|Dose Escalation|Withdrawal by Subject|0|||
164601151|NCT01877382|594559910|FG014|Dose Escalation|Withdrawal by Subject|0|||
164714452|NCT00843635|594976969|FG000|Overall Study|Adverse Event|2|||
164714453|NCT00843635|594976970|FG001|Overall Study|Adverse Event|2|||
164714454|NCT00843635|594976971|FG002|Overall Study|Adverse Event|0|||
164482449|NCT02066636|594138137|FG000|Overall Study|Lost to Follow-up|0|||
164482450|NCT02066636|594138138|FG001|Overall Study|Lost to Follow-up|2|||
164482451|NCT02066636|594138139|FG002|Overall Study|Lost to Follow-up|2|||
164482452|NCT02066636|594138137|FG000|Overall Study|Maximum clinical benefit|2|||
164482453|NCT02066636|594138138|FG001|Overall Study|Maximum clinical benefit|2|||
164482454|NCT02066636|594138139|FG002|Overall Study|Maximum clinical benefit|3|||
164482455|NCT02066636|594138137|FG000|Overall Study|Poor/non-compliance|2|||
164482456|NCT02066636|594138138|FG001|Overall Study|Poor/non-compliance|1|||
164482457|NCT02066636|594138139|FG002|Overall Study|Poor/non-compliance|1|||
164482458|NCT02066636|594138137|FG000|Overall Study|Participant no loner meets study criteria|3|||
164482459|NCT02066636|594138138|FG001|Overall Study|Participant no loner meets study criteria|2|||
164482460|NCT02066636|594138139|FG002|Overall Study|Participant no loner meets study criteria|28|||
164482461|NCT02066636|594138137|FG000|Overall Study|Administrative reasons by sponsor|8|||
164482462|NCT02066636|594138138|FG001|Overall Study|Administrative reasons by sponsor|5|||
164482463|NCT02066636|594138139|FG002|Overall Study|Administrative reasons by sponsor|0|||
164482464|NCT02066636|594138137|FG000|Overall Study|Other reasons|16|||
164482465|NCT02066636|594138138|FG001|Overall Study|Other reasons|15|||
164482466|NCT02066636|594138139|FG002|Overall Study|Other reasons|50|||
164482467|NCT00391170|594138146|FG000|Overall Study|Withdrawal by Subject|1|||
164482468|NCT00391170|594138147|FG001|Overall Study|Withdrawal by Subject|0|||
164482469|NCT00391170|594138146|FG000|Overall Study|Adverse Event|3|||
164482470|NCT00391170|594138147|FG001|Overall Study|Adverse Event|2|||
164482471|NCT00391170|594138146|FG000|Overall Study|Physician Decision|2|||
164482472|NCT00391170|594138147|FG001|Overall Study|Physician Decision|2|||
164482473|NCT02833948|594138152|FG000|Overall Study|Death|2|||
164482474|NCT02833948|594138153|FG001|Overall Study|Death|3|||
164482475|NCT02833948|594138152|FG000|Overall Study|were not scanned|8|||
164482476|NCT02833948|594138153|FG001|Overall Study|were not scanned|13|||
164482477|NCT02833948|594138152|FG000|Overall Study|scans could not be evaluated|5|||
164482478|NCT02833948|594138153|FG001|Overall Study|scans could not be evaluated|2|||
164482479|NCT00680771|594138154|FG000|Overall Study|Withdrawal by Subject|1|||
164482480|NCT00680771|594138155|FG001|Overall Study|Withdrawal by Subject|0|||
164482481|NCT00680771|594138154|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
164482482|NCT00680771|594138155|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
164482483|NCT00680771|594138154|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
164482484|NCT00680771|594138155|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
164482485|NCT02691702|594138156|FG000|Overall Study|Adverse Event|1|||
164482486|NCT02691702|594138157|FG001|Overall Study|Adverse Event|0|||
164482487|NCT02691702|594138158|FG002|Overall Study|Adverse Event|0|||
164482488|NCT02691702|594138159|FG003|Overall Study|Adverse Event|0|||
164482489|NCT02691702|594138160|FG004|Overall Study|Adverse Event|0|||
164482490|NCT02691702|594138161|FG005|Overall Study|Adverse Event|0|||
164482491|NCT02691702|594138162|FG006|Overall Study|Adverse Event|0|||
164482492|NCT02691702|594138163|FG007|Overall Study|Adverse Event|0|||
164482493|NCT02691702|594138164|FG008|Overall Study|Adverse Event|1|||
164482494|NCT02691702|594138165|FG009|Overall Study|Adverse Event|0|||
164482495|NCT02691702|594138166|FG010|Overall Study|Adverse Event|1|||
164482496|NCT02691702|594138156|FG000|Overall Study|Lost to Follow-up|0|||
164482497|NCT02691702|594138157|FG001|Overall Study|Lost to Follow-up|0|||
164482498|NCT02691702|594138158|FG002|Overall Study|Lost to Follow-up|1|||
164482499|NCT02691702|594138159|FG003|Overall Study|Lost to Follow-up|0|||
164482500|NCT02691702|594138160|FG004|Overall Study|Lost to Follow-up|0|||
164482501|NCT02691702|594138161|FG005|Overall Study|Lost to Follow-up|2|||
164482502|NCT02691702|594138162|FG006|Overall Study|Lost to Follow-up|0|||
164482503|NCT02691702|594138163|FG007|Overall Study|Lost to Follow-up|0|||
164482504|NCT02691702|594138164|FG008|Overall Study|Lost to Follow-up|0|||
164482505|NCT02691702|594138165|FG009|Overall Study|Lost to Follow-up|0|||
164482506|NCT02691702|594138166|FG010|Overall Study|Lost to Follow-up|1|||
164482507|NCT02691702|594138156|FG000|Overall Study|Withdrawal by Subject|1|||
164482508|NCT02691702|594138157|FG001|Overall Study|Withdrawal by Subject|1|||
164482509|NCT02691702|594138158|FG002|Overall Study|Withdrawal by Subject|0|||
164482510|NCT02691702|594138159|FG003|Overall Study|Withdrawal by Subject|0|||
164482511|NCT02691702|594138160|FG004|Overall Study|Withdrawal by Subject|0|||
164482512|NCT02691702|594138161|FG005|Overall Study|Withdrawal by Subject|1|||
164482513|NCT02691702|594138162|FG006|Overall Study|Withdrawal by Subject|2|||
164482514|NCT02691702|594138163|FG007|Overall Study|Withdrawal by Subject|0|||
164482515|NCT02691702|594138164|FG008|Overall Study|Withdrawal by Subject|0|||
164482516|NCT02691702|594138165|FG009|Overall Study|Withdrawal by Subject|0|||
164482517|NCT02691702|594138166|FG010|Overall Study|Withdrawal by Subject|0|||
164482518|NCT02691702|594138156|FG000|Overall Study|Other|0|||
164482519|NCT02691702|594138157|FG001|Overall Study|Other|0|||
164482520|NCT02691702|594138158|FG002|Overall Study|Other|0|||
164601152|NCT01877382|594559896|FG000|Dose Escalation|Protocol Violation|0|||
164482521|NCT02691702|594138159|FG003|Overall Study|Other|0|||
164482522|NCT02691702|594138160|FG004|Overall Study|Other|0|||
164482523|NCT02691702|594138161|FG005|Overall Study|Other|0|||
164482524|NCT02691702|594138162|FG006|Overall Study|Other|1|||
164482525|NCT02691702|594138163|FG007|Overall Study|Other|0|||
164482526|NCT02691702|594138164|FG008|Overall Study|Other|1|||
164482527|NCT02691702|594138165|FG009|Overall Study|Other|0|||
164482528|NCT02691702|594138166|FG010|Overall Study|Other|0|||
164482529|NCT02691702|594138156|FG000|Overall Study|Protocol Violation|0|||
164482530|NCT02691702|594138157|FG001|Overall Study|Protocol Violation|0|||
164482531|NCT02691702|594138158|FG002|Overall Study|Protocol Violation|0|||
164482532|NCT02691702|594138159|FG003|Overall Study|Protocol Violation|0|||
164482533|NCT02691702|594138160|FG004|Overall Study|Protocol Violation|0|||
164482534|NCT02691702|594138161|FG005|Overall Study|Protocol Violation|0|||
164482535|NCT02691702|594138162|FG006|Overall Study|Protocol Violation|0|||
164482536|NCT02691702|594138163|FG007|Overall Study|Protocol Violation|0|||
164482537|NCT02691702|594138164|FG008|Overall Study|Protocol Violation|0|||
164482538|NCT02691702|594138165|FG009|Overall Study|Protocol Violation|2|||
164482539|NCT02691702|594138166|FG010|Overall Study|Protocol Violation|0|||
164482540|NCT03652610|594138172|FG000|Overall Study|Lost to Follow-up|1|||
164482541|NCT03652610|594138173|FG001|Overall Study|Lost to Follow-up|0|||
164482542|NCT03652610|594138172|FG000|Overall Study|Withdrawal by Subject|3|||
164482543|NCT03652610|594138173|FG001|Overall Study|Withdrawal by Subject|5|||
164482544|NCT01263496|594138177|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
164482545|NCT01263496|594138178|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
164482546|NCT01263496|594138179|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
164482547|NCT01263496|594138180|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
164482548|NCT01263496|594138181|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
164482549|NCT01263496|594138182|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
164482550|NCT01263496|594138183|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
164482551|NCT01263496|594138184|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
164482552|NCT01263496|594138185|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
164482553|NCT01263496|594138177|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
164482554|NCT01263496|594138178|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
164482555|NCT01263496|594138179|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
164482556|NCT01263496|594138180|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
164482557|NCT01263496|594138181|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
164482558|NCT01263496|594138182|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
164482559|NCT01263496|594138183|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
164482560|NCT01263496|594138184|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
164482561|NCT01263496|594138185|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
164482562|NCT01263496|594138177|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
164482563|NCT01263496|594138178|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
164482564|NCT01263496|594138179|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
164482565|NCT01263496|594138180|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
164482566|NCT01263496|594138181|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
164482567|NCT01263496|594138182|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
164482568|NCT01263496|594138183|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
164482569|NCT01263496|594138184|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
164482570|NCT01263496|594138185|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
164482571|NCT01263496|594138177|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
164482572|NCT01263496|594138178|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
164482573|NCT01263496|594138179|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
164482574|NCT01263496|594138180|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
164482575|NCT01263496|594138181|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
164482576|NCT01263496|594138182|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
164482577|NCT01263496|594138183|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
164482578|NCT01263496|594138184|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
164482579|NCT01263496|594138185|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
164482580|NCT01263496|594138177|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
164482581|NCT01263496|594138178|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
164482582|NCT01263496|594138179|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
164482583|NCT01263496|594138180|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
164482584|NCT01263496|594138181|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
164482585|NCT01263496|594138182|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
164482586|NCT01263496|594138183|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
164482587|NCT01263496|594138184|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
164482588|NCT01263496|594138185|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
164482589|NCT01263496|594138177|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
164482590|NCT01263496|594138178|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
164482591|NCT01263496|594138179|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
164482592|NCT01263496|594138180|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
164482593|NCT01263496|594138181|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
164482594|NCT01263496|594138182|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
164482595|NCT01263496|594138183|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
164482596|NCT01263496|594138184|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
164482597|NCT01263496|594138185|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
164482598|NCT01263496|594138177|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
164482599|NCT01263496|594138178|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
164482600|NCT01263496|594138179|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
164482601|NCT01263496|594138180|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
164482602|NCT01263496|594138181|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
164482603|NCT01263496|594138182|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
164482604|NCT01263496|594138183|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
164482605|NCT01263496|594138184|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
164482606|NCT01263496|594138185|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
164482607|NCT01218594|594138186|FG000|Overall Study|Death|1|||
164482608|NCT01218594|594138186|FG000|Overall Study|Withdrawal by Subject|3|||
164482609|NCT01218594|594138186|FG000|Overall Study|Adverse Event|2|||
164482610|NCT01218594|594138186|FG000|Overall Study|Physician Decision|6|||
164482611|NCT02203032|594138187|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
164482612|NCT02203032|594138188|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
164482613|NCT02203032|594138189|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
164482614|NCT02203032|594138190|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
164482615|NCT02203032|594138187|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
164482616|NCT02203032|594138188|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
164482617|NCT02203032|594138189|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
164482618|NCT02203032|594138190|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
164482619|NCT02203032|594138187|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
164482620|NCT02203032|594138188|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
164482621|NCT02203032|594138189|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
164482622|NCT02203032|594138190|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
164482623|NCT02203032|594138187|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
164482624|NCT02203032|594138188|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
164482625|NCT02203032|594138189|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
164482626|NCT02203032|594138190|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
164482627|NCT02203032|594138187|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
164482628|NCT02203032|594138188|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
164482629|NCT02203032|594138189|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
164482630|NCT02203032|594138190|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
164482631|NCT02203032|594138187|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
164482632|NCT02203032|594138188|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
164482633|NCT02203032|594138189|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
164482634|NCT02203032|594138190|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
164482635|NCT02203032|594138187|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
164482636|NCT02203032|594138188|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
164482637|NCT02203032|594138189|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
164482638|NCT02203032|594138190|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
164482639|NCT02203032|594138187|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
164482640|NCT02203032|594138188|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
164482641|NCT02203032|594138189|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
164482642|NCT02203032|594138190|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
164482643|NCT02203032|594138187|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
164482644|NCT02203032|594138188|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
164482645|NCT02203032|594138189|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
164482646|NCT02203032|594138190|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
164482647|NCT02203032|594138187|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
164482648|NCT02203032|594138188|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
164482649|NCT02203032|594138189|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
164482650|NCT02203032|594138190|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
164482651|NCT02203032|594138187|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
164482652|NCT02203032|594138188|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
164482653|NCT02203032|594138189|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
164482654|NCT02203032|594138190|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
164482655|NCT02203032|594138187|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
164482656|NCT02203032|594138188|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
164482657|NCT02203032|594138189|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
164482658|NCT02203032|594138190|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
164482659|NCT02241785|594138193|FG000|Overall Study|Sponsor Termination|43|||
164482660|NCT02241785|594138193|FG000|Overall Study|Withdrawal by Subject|1|||
164601153|NCT01877382|594559897|FG001|Dose Escalation|Protocol Violation|0|||
164601154|NCT01877382|594559898|FG002|Dose Escalation|Protocol Violation|0|||
164601155|NCT01877382|594559899|FG003|Dose Escalation|Protocol Violation|0|||
164601156|NCT01877382|594559900|FG004|Dose Escalation|Protocol Violation|0|||
164601157|NCT01877382|594559901|FG005|Dose Escalation|Protocol Violation|0|||
164601158|NCT01877382|594559902|FG006|Dose Escalation|Protocol Violation|1|||
164601159|NCT01877382|594559903|FG007|Dose Escalation|Protocol Violation|0|||
164601160|NCT01877382|594559904|FG008|Dose Escalation|Protocol Violation|0|||
164601161|NCT01877382|594559905|FG009|Dose Escalation|Protocol Violation|0|||
164601162|NCT01877382|594559906|FG010|Dose Escalation|Protocol Violation|0|||
164601163|NCT01877382|594559907|FG011|Dose Escalation|Protocol Violation|0|||
164601164|NCT01877382|594559908|FG012|Dose Escalation|Protocol Violation|0|||
164601165|NCT01877382|594559909|FG013|Dose Escalation|Protocol Violation|0|||
164601166|NCT01877382|594559910|FG014|Dose Escalation|Protocol Violation|0|||
164601167|NCT01877382|594559896|FG000|Dose Escalation|Study terminated by sponsor|0|||
164601168|NCT01877382|594559897|FG001|Dose Escalation|Study terminated by sponsor|0|||
164601169|NCT01877382|594559898|FG002|Dose Escalation|Study terminated by sponsor|0|||
164601170|NCT01877382|594559899|FG003|Dose Escalation|Study terminated by sponsor|0|||
164601171|NCT01877382|594559900|FG004|Dose Escalation|Study terminated by sponsor|0|||
164601172|NCT01877382|594559901|FG005|Dose Escalation|Study terminated by sponsor|0|||
164601173|NCT01877382|594559902|FG006|Dose Escalation|Study terminated by sponsor|0|||
164601174|NCT01877382|594559903|FG007|Dose Escalation|Study terminated by sponsor|1|||
164601175|NCT01877382|594559904|FG008|Dose Escalation|Study terminated by sponsor|1|||
164601176|NCT01877382|594559905|FG009|Dose Escalation|Study terminated by sponsor|0|||
164601177|NCT01877382|594559906|FG010|Dose Escalation|Study terminated by sponsor|0|||
164601178|NCT01877382|594559907|FG011|Dose Escalation|Study terminated by sponsor|0|||
164601179|NCT01877382|594559908|FG012|Dose Escalation|Study terminated by sponsor|3|||
164601180|NCT01877382|594559909|FG013|Dose Escalation|Study terminated by sponsor|0|||
164601181|NCT01877382|594559910|FG014|Dose Escalation|Study terminated by sponsor|0|||
164601182|NCT01877382|594559896|FG000|Dose Escalation|Death|0|||
164601183|NCT01877382|594559897|FG001|Dose Escalation|Death|0|||
164601184|NCT01877382|594559898|FG002|Dose Escalation|Death|0|||
164601185|NCT01877382|594559899|FG003|Dose Escalation|Death|0|||
164601186|NCT01877382|594559900|FG004|Dose Escalation|Death|0|||
164601187|NCT01877382|594559901|FG005|Dose Escalation|Death|0|||
164601188|NCT01877382|594559902|FG006|Dose Escalation|Death|0|||
164601189|NCT01877382|594559903|FG007|Dose Escalation|Death|1|||
164601190|NCT01877382|594559904|FG008|Dose Escalation|Death|0|||
164601191|NCT01877382|594559905|FG009|Dose Escalation|Death|0|||
164601192|NCT01877382|594559906|FG010|Dose Escalation|Death|0|||
164601193|NCT01877382|594559907|FG011|Dose Escalation|Death|0|||
164601194|NCT01877382|594559908|FG012|Dose Escalation|Death|1|||
164601195|NCT01877382|594559909|FG013|Dose Escalation|Death|1|||
164601196|NCT01877382|594559910|FG014|Dose Escalation|Death|0|||
164601197|NCT01877382|594559896|FG000|Dose Expansion|Progressive disease|0|||
164601198|NCT01877382|594559897|FG001|Dose Expansion|Progressive disease|0|||
164601199|NCT01877382|594559898|FG002|Dose Expansion|Progressive disease|0|||
164601200|NCT01877382|594559899|FG003|Dose Expansion|Progressive disease|0|||
164601201|NCT01877382|594559900|FG004|Dose Expansion|Progressive disease|0|||
164601202|NCT01877382|594559901|FG005|Dose Expansion|Progressive disease|0|||
164601203|NCT01877382|594559902|FG006|Dose Expansion|Progressive disease|0|||
164601204|NCT01877382|594559903|FG007|Dose Expansion|Progressive disease|0|||
164601205|NCT01877382|594559904|FG008|Dose Expansion|Progressive disease|0|||
164601206|NCT01877382|594559905|FG009|Dose Expansion|Progressive disease|0|||
164601207|NCT01877382|594559906|FG010|Dose Expansion|Progressive disease|0|||
164601208|NCT01877382|594559907|FG011|Dose Expansion|Progressive disease|0|||
164601209|NCT01877382|594559908|FG012|Dose Expansion|Progressive disease|0|||
164601210|NCT01877382|594559909|FG013|Dose Expansion|Progressive disease|0|||
164601211|NCT01877382|594559910|FG014|Dose Expansion|Progressive disease|11|||
164601212|NCT01877382|594559896|FG000|Dose Expansion|Clinical progression|0|||
164601213|NCT01877382|594559897|FG001|Dose Expansion|Clinical progression|0|||
164601214|NCT01877382|594559898|FG002|Dose Expansion|Clinical progression|0|||
164714455|NCT01144715|594976972|FG000|Overall Study|Lost to Follow-up|2|||
164714456|NCT01144715|594976973|FG001|Overall Study|Lost to Follow-up|1|||
164714457|NCT01144715|594976972|FG000|Overall Study|Withdrawal by Subject|2|||
164714458|NCT01144715|594976973|FG001|Overall Study|Withdrawal by Subject|1|||
164601215|NCT01877382|594559899|FG003|Dose Expansion|Clinical progression|0|||
164601216|NCT01877382|594559900|FG004|Dose Expansion|Clinical progression|0|||
164601217|NCT01877382|594559901|FG005|Dose Expansion|Clinical progression|0|||
164714459|NCT01144715|594976972|FG000|Overall Study|Adverse Event|0|||
164601218|NCT01877382|594559902|FG006|Dose Expansion|Clinical progression|0|||
164601219|NCT01877382|594559903|FG007|Dose Expansion|Clinical progression|0|||
164601220|NCT01877382|594559904|FG008|Dose Expansion|Clinical progression|0|||
164601221|NCT01877382|594559905|FG009|Dose Expansion|Clinical progression|0|||
164601222|NCT01877382|594559906|FG010|Dose Expansion|Clinical progression|0|||
164601223|NCT01877382|594559907|FG011|Dose Expansion|Clinical progression|0|||
164601224|NCT01877382|594559908|FG012|Dose Expansion|Clinical progression|0|||
164601225|NCT01877382|594559909|FG013|Dose Expansion|Clinical progression|0|||
164714460|NCT01144715|594976973|FG001|Overall Study|Adverse Event|1|||
164482661|NCT02241785|594138193|FG000|Overall Study|Lost to Follow-up|2|||
164482662|NCT02241785|594138193|FG000|Overall Study|Adverse Event|1|||
164482663|NCT05615363|594138194|FG000|Overall Study|Adverse Event|0|||
164482664|NCT05615363|594138195|FG001|Overall Study|Adverse Event|4|||
164482665|NCT05615363|594138196|FG002|Overall Study|Adverse Event|4|||
164482666|NCT05615363|594138197|FG003|Overall Study|Adverse Event|3|||
164482667|NCT05615363|594138198|FG004|Overall Study|Adverse Event|1|||
164482668|NCT05615363|594138194|FG000|Overall Study|Physician Decision|2|||
164482669|NCT05615363|594138195|FG001|Overall Study|Physician Decision|0|||
164482670|NCT05615363|594138196|FG002|Overall Study|Physician Decision|4|||
164482671|NCT05615363|594138197|FG003|Overall Study|Physician Decision|1|||
164482672|NCT05615363|594138198|FG004|Overall Study|Physician Decision|3|||
164482673|NCT05615363|594138194|FG000|Overall Study|Protocol Violation|2|||
164482674|NCT05615363|594138195|FG001|Overall Study|Protocol Violation|0|||
164482675|NCT05615363|594138196|FG002|Overall Study|Protocol Violation|0|||
164482676|NCT05615363|594138197|FG003|Overall Study|Protocol Violation|0|||
164482677|NCT05615363|594138198|FG004|Overall Study|Protocol Violation|1|||
164482678|NCT05615363|594138194|FG000|Overall Study|Withdrawal by Subject|0|||
164482679|NCT05615363|594138195|FG001|Overall Study|Withdrawal by Subject|0|||
164482680|NCT05615363|594138196|FG002|Overall Study|Withdrawal by Subject|1|||
164482681|NCT05615363|594138197|FG003|Overall Study|Withdrawal by Subject|0|||
164482682|NCT05615363|594138198|FG004|Overall Study|Withdrawal by Subject|0|||
164482683|NCT03905642|594138199|FG000|Overall Study|Withdrawal by Subject|3|||
164482684|NCT03905642|594138199|FG000|Overall Study|Pregnancy|1|||
164482685|NCT03905642|594138199|FG000|Overall Study|Adverse Event|1|||
164482686|NCT03905642|594138199|FG000|Overall Study|Lack of Efficacy|1|||
164482687|NCT03905642|594138199|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
164482688|NCT05289037|594138200|FG000|Overall Study|Withdrawal by Subject|7|||
164482689|NCT05289037|594138201|FG001|Overall Study|Withdrawal by Subject|0|||
164482690|NCT05289037|594138202|FG002|Overall Study|Withdrawal by Subject|3|||
164482691|NCT05289037|594138203|FG003|Overall Study|Withdrawal by Subject|3|||
164482692|NCT05289037|594138204|FG004|Overall Study|Withdrawal by Subject|1|||
164482693|NCT05289037|594138205|FG005|Overall Study|Withdrawal by Subject|5|||
164482694|NCT05289037|594138206|FG006|Overall Study|Withdrawal by Subject|2|||
164482695|NCT05289037|594138207|FG007|Overall Study|Withdrawal by Subject|1|||
164482696|NCT05289037|594138208|FG008|Overall Study|Withdrawal by Subject|2|||
164482697|NCT05289037|594138209|FG009|Overall Study|Withdrawal by Subject|2|||
164482698|NCT05289037|594138210|FG010|Overall Study|Withdrawal by Subject|1|||
164482699|NCT05289037|594138211|FG011|Overall Study|Withdrawal by Subject|0|||
164482700|NCT05289037|594138212|FG012|Overall Study|Withdrawal by Subject|1|||
164482701|NCT05289037|594138213|FG013|Overall Study|Withdrawal by Subject|2|||
164482702|NCT05289037|594138214|FG014|Overall Study|Withdrawal by Subject|0|||
164482703|NCT05289037|594138215|FG015|Overall Study|Withdrawal by Subject|3|||
164482704|NCT05289037|594138216|FG016|Overall Study|Withdrawal by Subject|3|||
164482705|NCT05289037|594138200|FG000|Overall Study|Lost to Follow-up|1|||
164482706|NCT05289037|594138201|FG001|Overall Study|Lost to Follow-up|4|||
164482707|NCT05289037|594138202|FG002|Overall Study|Lost to Follow-up|3|||
164482708|NCT05289037|594138203|FG003|Overall Study|Lost to Follow-up|3|||
164482709|NCT05289037|594138204|FG004|Overall Study|Lost to Follow-up|3|||
164482710|NCT05289037|594138205|FG005|Overall Study|Lost to Follow-up|2|||
164482711|NCT05289037|594138206|FG006|Overall Study|Lost to Follow-up|3|||
164482712|NCT05289037|594138207|FG007|Overall Study|Lost to Follow-up|2|||
164482713|NCT05289037|594138208|FG008|Overall Study|Lost to Follow-up|2|||
164482714|NCT05289037|594138209|FG009|Overall Study|Lost to Follow-up|1|||
164482715|NCT05289037|594138210|FG010|Overall Study|Lost to Follow-up|3|||
164482716|NCT05289037|594138211|FG011|Overall Study|Lost to Follow-up|4|||
164482717|NCT05289037|594138212|FG012|Overall Study|Lost to Follow-up|2|||
164482718|NCT05289037|594138213|FG013|Overall Study|Lost to Follow-up|7|||
164482719|NCT05289037|594138214|FG014|Overall Study|Lost to Follow-up|4|||
164482720|NCT05289037|594138215|FG015|Overall Study|Lost to Follow-up|6|||
164482721|NCT05289037|594138216|FG016|Overall Study|Lost to Follow-up|4|||
164601226|NCT01877382|594559910|FG014|Dose Expansion|Clinical progression|6|||
164601227|NCT01877382|594559896|FG000|Dose Expansion|Adverse Event|0|||
164482722|NCT05289037|594138200|FG000|Overall Study|Death|0|||
164482723|NCT05289037|594138201|FG001|Overall Study|Death|0|||
164482724|NCT05289037|594138202|FG002|Overall Study|Death|0|||
164601228|NCT01877382|594559897|FG001|Dose Expansion|Adverse Event|0|||
164482725|NCT05289037|594138203|FG003|Overall Study|Death|0|||
164482726|NCT05289037|594138204|FG004|Overall Study|Death|0|||
164482727|NCT05289037|594138205|FG005|Overall Study|Death|1|||
164482728|NCT05289037|594138206|FG006|Overall Study|Death|0|||
164601229|NCT01877382|594559898|FG002|Dose Expansion|Adverse Event|0|||
164482729|NCT05289037|594138207|FG007|Overall Study|Death|0|||
164482730|NCT05289037|594138208|FG008|Overall Study|Death|0|||
164482731|NCT05289037|594138209|FG009|Overall Study|Death|0|||
164482732|NCT05289037|594138210|FG010|Overall Study|Death|0|||
164482733|NCT05289037|594138211|FG011|Overall Study|Death|0|||
164482734|NCT05289037|594138212|FG012|Overall Study|Death|0|||
164482735|NCT05289037|594138213|FG013|Overall Study|Death|0|||
164482736|NCT05289037|594138214|FG014|Overall Study|Death|1|||
164482737|NCT05289037|594138215|FG015|Overall Study|Death|0|||
164482738|NCT05289037|594138216|FG016|Overall Study|Death|0|||
164482739|NCT05289037|594138200|FG000|Overall Study|Did not receive vaccine|0|||
164482740|NCT05289037|594138201|FG001|Overall Study|Did not receive vaccine|3|||
164482741|NCT05289037|594138202|FG002|Overall Study|Did not receive vaccine|0|||
164482742|NCT05289037|594138203|FG003|Overall Study|Did not receive vaccine|0|||
164482743|NCT05289037|594138204|FG004|Overall Study|Did not receive vaccine|1|||
164482744|NCT05289037|594138205|FG005|Overall Study|Did not receive vaccine|1|||
164482745|NCT05289037|594138206|FG006|Overall Study|Did not receive vaccine|1|||
164482746|NCT05289037|594138207|FG007|Overall Study|Did not receive vaccine|0|||
164482747|NCT05289037|594138208|FG008|Overall Study|Did not receive vaccine|0|||
164482748|NCT05289037|594138209|FG009|Overall Study|Did not receive vaccine|0|||
164482749|NCT05289037|594138210|FG010|Overall Study|Did not receive vaccine|0|||
164482750|NCT05289037|594138211|FG011|Overall Study|Did not receive vaccine|0|||
164482751|NCT05289037|594138212|FG012|Overall Study|Did not receive vaccine|0|||
164482752|NCT05289037|594138213|FG013|Overall Study|Did not receive vaccine|0|||
164482753|NCT05289037|594138214|FG014|Overall Study|Did not receive vaccine|1|||
164482754|NCT05289037|594138215|FG015|Overall Study|Did not receive vaccine|0|||
164482755|NCT05289037|594138216|FG016|Overall Study|Did not receive vaccine|0|||
164482756|NCT05289037|594138200|FG000|Overall Study|Unable to make last visit|0|||
164482757|NCT05289037|594138201|FG001|Overall Study|Unable to make last visit|0|||
164482758|NCT05289037|594138202|FG002|Overall Study|Unable to make last visit|1|||
164482759|NCT05289037|594138203|FG003|Overall Study|Unable to make last visit|0|||
164482760|NCT05289037|594138204|FG004|Overall Study|Unable to make last visit|0|||
164482761|NCT05289037|594138205|FG005|Overall Study|Unable to make last visit|0|||
164482762|NCT05289037|594138206|FG006|Overall Study|Unable to make last visit|0|||
164482763|NCT05289037|594138207|FG007|Overall Study|Unable to make last visit|0|||
164482764|NCT05289037|594138208|FG008|Overall Study|Unable to make last visit|0|||
164482765|NCT05289037|594138209|FG009|Overall Study|Unable to make last visit|0|||
164482766|NCT05289037|594138210|FG010|Overall Study|Unable to make last visit|0|||
164482767|NCT05289037|594138211|FG011|Overall Study|Unable to make last visit|0|||
164482768|NCT05289037|594138212|FG012|Overall Study|Unable to make last visit|0|||
164482769|NCT05289037|594138213|FG013|Overall Study|Unable to make last visit|0|||
164482770|NCT05289037|594138214|FG014|Overall Study|Unable to make last visit|0|||
164482771|NCT05289037|594138215|FG015|Overall Study|Unable to make last visit|0|||
164482772|NCT05289037|594138216|FG016|Overall Study|Unable to make last visit|0|||
164482773|NCT05289037|594138200|FG000|Overall Study|Protocol deviation|0|||
164482774|NCT05289037|594138201|FG001|Overall Study|Protocol deviation|0|||
164482775|NCT05289037|594138202|FG002|Overall Study|Protocol deviation|0|||
164482776|NCT05289037|594138203|FG003|Overall Study|Protocol deviation|0|||
164482777|NCT05289037|594138204|FG004|Overall Study|Protocol deviation|0|||
164482778|NCT05289037|594138205|FG005|Overall Study|Protocol deviation|0|||
164482779|NCT05289037|594138206|FG006|Overall Study|Protocol deviation|0|||
164482780|NCT05289037|594138207|FG007|Overall Study|Protocol deviation|0|||
164482781|NCT05289037|594138208|FG008|Overall Study|Protocol deviation|0|||
164482782|NCT05289037|594138209|FG009|Overall Study|Protocol deviation|0|||
164482783|NCT05289037|594138210|FG010|Overall Study|Protocol deviation|0|||
164482784|NCT05289037|594138211|FG011|Overall Study|Protocol deviation|0|||
164482785|NCT05289037|594138212|FG012|Overall Study|Protocol deviation|0|||
164482786|NCT05289037|594138213|FG013|Overall Study|Protocol deviation|0|||
164482787|NCT05289037|594138214|FG014|Overall Study|Protocol deviation|0|||
164482788|NCT05289037|594138215|FG015|Overall Study|Protocol deviation|1|||
164482789|NCT05289037|594138216|FG016|Overall Study|Protocol deviation|0|||
164482790|NCT04447027|594138221|FG000|Dose Escalation|Withdrawal by Subject|1|||
164482791|NCT04447027|594138222|FG001|Dose Escalation|Withdrawal by Subject|4|||
164482792|NCT04447027|594138223|FG002|Dose Escalation|Withdrawal by Subject|3|||
164482793|NCT04447027|594138224|FG003|Dose Escalation|Withdrawal by Subject|3|||
164482794|NCT04447027|594138225|FG004|Dose Escalation|Withdrawal by Subject|1|||
164482795|NCT04447027|594138226|FG005|Dose Escalation|Withdrawal by Subject|0|||
164482796|NCT04447027|594138227|FG006|Dose Escalation|Withdrawal by Subject|0|||
164482797|NCT04447027|594138228|FG007|Dose Escalation|Withdrawal by Subject|0|||
164482798|NCT04447027|594138229|FG008|Dose Escalation|Withdrawal by Subject|0|||
164482799|NCT04447027|594138221|FG000|Dose Escalation|Refused further treatment|0|||
164482800|NCT04447027|594138222|FG001|Dose Escalation|Refused further treatment|1|||
164482801|NCT04447027|594138223|FG002|Dose Escalation|Refused further treatment|1|||
164482802|NCT04447027|594138224|FG003|Dose Escalation|Refused further treatment|0|||
164482803|NCT04447027|594138225|FG004|Dose Escalation|Refused further treatment|0|||
164482804|NCT04447027|594138226|FG005|Dose Escalation|Refused further treatment|0|||
164482805|NCT04447027|594138227|FG006|Dose Escalation|Refused further treatment|0|||
164482806|NCT04447027|594138228|FG007|Dose Escalation|Refused further treatment|0|||
164482807|NCT04447027|594138229|FG008|Dose Escalation|Refused further treatment|0|||
164601230|NCT01877382|594559899|FG003|Dose Expansion|Adverse Event|0|||
164714461|NCT00857584|594976981|FG000|Overall Study|Lack of Efficacy|1|||
164482808|NCT04447027|594138221|FG000|Dose Expansion|Withdrawal by Subject|0|||
164482809|NCT04447027|594138222|FG001|Dose Expansion|Withdrawal by Subject|0|||
164482810|NCT04447027|594138223|FG002|Dose Expansion|Withdrawal by Subject|0|||
164482811|NCT04447027|594138224|FG003|Dose Expansion|Withdrawal by Subject|0|||
164482812|NCT04447027|594138225|FG004|Dose Expansion|Withdrawal by Subject|0|||
164714462|NCT00857584|594976982|FG001|Overall Study|Lack of Efficacy|2|||
164714463|NCT00857584|594976981|FG000|Overall Study|Adverse Event|2|||
164482813|NCT04447027|594138226|FG005|Dose Expansion|Withdrawal by Subject|2|||
164482814|NCT04447027|594138227|FG006|Dose Expansion|Withdrawal by Subject|0|||
164482815|NCT04447027|594138228|FG007|Dose Expansion|Withdrawal by Subject|2|||
164482816|NCT04447027|594138229|FG008|Dose Expansion|Withdrawal by Subject|0|||
164482817|NCT02659059|594140054|FG000|Overall Study|Other reasons|6|||
164482818|NCT02659059|594140055|FG001|Overall Study|Other reasons|1|||
164482819|NCT02659059|594140054|FG000|Overall Study|Disease Progression|143|||
164482820|NCT02659059|594140055|FG001|Overall Study|Disease Progression|16|||
164482821|NCT02659059|594140054|FG000|Overall Study|Study Drug toxicity|56|||
164482822|NCT02659059|594140055|FG001|Overall Study|Study Drug toxicity|9|||
164482823|NCT02659059|594140054|FG000|Overall Study|Death|3|||
164482824|NCT02659059|594140055|FG001|Overall Study|Death|1|||
164482825|NCT02659059|594140054|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
164482826|NCT02659059|594140055|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
164482827|NCT02659059|594140054|FG000|Overall Study|Participant request to discontinue study treatment|5|||
164482828|NCT02659059|594140055|FG001|Overall Study|Participant request to discontinue study treatment|0|||
164482829|NCT02659059|594140054|FG000|Overall Study|Participant withdrew consent|6|||
164482830|NCT02659059|594140055|FG001|Overall Study|Participant withdrew consent|1|||
164482831|NCT00535626|594140056|FG000|Overall Study|Death|15|||
164482832|NCT00535626|594140056|FG000|Overall Study|Lost to Follow-up|29|||
164482833|NCT00535626|594140056|FG000|Overall Study|Withdrawal by Subject|20|||
164482834|NCT00535626|594140056|FG000|Overall Study|Removal/revision of study component|8|||
164482835|NCT00535626|594140056|FG000|Overall Study|Subject terminated|31|||
164482836|NCT00535626|594140056|FG000|Overall Study|Unable to return|2|||
164482837|NCT04633200|594140057|FG000|Overall Study|Lost to Follow-up|3|||
164482838|NCT04633200|594140058|FG001|Overall Study|Lost to Follow-up|5|||
164482839|NCT04809623|594140059|FG000|Overall Study|Study Terminated by Sponsor|1|||
164482840|NCT04809623|594140060|FG001|Overall Study|Study Terminated by Sponsor|0|||
164482841|NCT01808534|594140061|FG000|Overall Study|Disease progression|3|||
164482842|NCT01808534|594140061|FG000|Overall Study|Physician Decision|1|||
164482843|NCT02236611|594140062|FG000|Overall Study|Adverse Event|10|||
164482844|NCT02236611|594140063|FG001|Overall Study|Adverse Event|16|||
164482845|NCT02236611|594140062|FG000|Overall Study|Lack of Efficacy|4|||
164482846|NCT02236611|594140063|FG001|Overall Study|Lack of Efficacy|7|||
164482847|NCT02236611|594140062|FG000|Overall Study|Lost to Follow-up|0|||
164482848|NCT02236611|594140063|FG001|Overall Study|Lost to Follow-up|2|||
164482849|NCT02236611|594140062|FG000|Overall Study|Protocol deviation|3|||
164482850|NCT02236611|594140063|FG001|Overall Study|Protocol deviation|5|||
164482851|NCT02236611|594140062|FG000|Overall Study|Withdrew consent|9|||
164482852|NCT02236611|594140063|FG001|Overall Study|Withdrew consent|4|||
164482853|NCT03041090|594140064|FG000|Overall Study|technical error|0|||
164482854|NCT03041090|594140065|FG001|Overall Study|technical error|3|||
164482855|NCT02338999|594140066|FG000|First Intervention|Withdrawal by Subject|3|||
164482856|NCT02338999|594140067|FG001|First Intervention|Withdrawal by Subject|1|||
164482857|NCT02338999|594140066|FG000|Washout Period|Withdrawal by Subject|0|||
164482858|NCT02338999|594140067|FG001|Washout Period|Withdrawal by Subject|2|||
164482859|NCT02338999|594140066|FG000|Second Intervention|Withdrawal by Subject|0|||
164482860|NCT02338999|594140067|FG001|Second Intervention|Withdrawal by Subject|2|||
164482861|NCT01686152|594140068|FG000|Overall Study|Withdrawal by Subject|11|||
164482862|NCT01686152|594140069|FG001|Overall Study|Withdrawal by Subject|11|||
164482863|NCT01686152|594140070|FG002|Overall Study|Withdrawal by Subject|3|||
164482864|NCT01686152|594140068|FG000|Overall Study|Drug Code Unblinded|0|||
164482865|NCT01686152|594140069|FG001|Overall Study|Drug Code Unblinded|1|||
164482866|NCT01686152|594140070|FG002|Overall Study|Drug Code Unblinded|0|||
164482867|NCT01686152|594140068|FG000|Overall Study|Protocol Violation|6|||
164482868|NCT01686152|594140069|FG001|Overall Study|Protocol Violation|1|||
164482869|NCT01686152|594140070|FG002|Overall Study|Protocol Violation|0|||
164482870|NCT01686152|594140068|FG000|Overall Study|Adverse Event|12|||
164482871|NCT01686152|594140069|FG001|Overall Study|Adverse Event|11|||
164482872|NCT01686152|594140070|FG002|Overall Study|Adverse Event|0|||
164482873|NCT01686152|594140068|FG000|Overall Study|Lack of Efficacy|0|||
164482874|NCT01686152|594140069|FG001|Overall Study|Lack of Efficacy|0|||
164482875|NCT01686152|594140070|FG002|Overall Study|Lack of Efficacy|1|||
164482876|NCT01686152|594140068|FG000|Overall Study|IP Non-compliance|5|||
164601231|NCT01877382|594559900|FG004|Dose Expansion|Adverse Event|0|||
164714464|NCT00857584|594976982|FG001|Overall Study|Adverse Event|2|||
164482877|NCT01686152|594140069|FG001|Overall Study|IP Non-compliance|5|||
164714465|NCT00857584|594976981|FG000|Overall Study|Physician Decision|1|||
164714466|NCT00857584|594976982|FG001|Overall Study|Physician Decision|1|||
164482878|NCT01686152|594140070|FG002|Overall Study|IP Non-compliance|0|||
164482879|NCT01686152|594140068|FG000|Overall Study|Lost to Follow-up|7|||
164482880|NCT01686152|594140069|FG001|Overall Study|Lost to Follow-up|6|||
164482881|NCT01686152|594140070|FG002|Overall Study|Lost to Follow-up|5|||
164482882|NCT01802333|594140071|FG000|Overall Study|Ineligible|2|||
164601232|NCT01877382|594559901|FG005|Dose Expansion|Adverse Event|0|||
164482883|NCT01802333|594140072|FG001|Overall Study|Ineligible|6|||
164482884|NCT01802333|594140073|FG002|Overall Study|Ineligible|8|||
164482885|NCT01802333|594140071|FG000|Overall Study|Adverse Event|1|||
164482886|NCT01802333|594140072|FG001|Overall Study|Adverse Event|8|||
164482887|NCT01802333|594140073|FG002|Overall Study|Adverse Event|8|||
164482888|NCT01802333|594140071|FG000|Overall Study|Withdrawal by Subject|6|||
164482889|NCT01802333|594140072|FG001|Overall Study|Withdrawal by Subject|6|||
164482890|NCT01802333|594140073|FG002|Overall Study|Withdrawal by Subject|5|||
164482891|NCT01802333|594140071|FG000|Overall Study|Progression/relapse|1|||
164482892|NCT01802333|594140072|FG001|Overall Study|Progression/relapse|3|||
164482893|NCT01802333|594140073|FG002|Overall Study|Progression/relapse|0|||
164482894|NCT01802333|594140071|FG000|Overall Study|Death|7|||
164482895|NCT01802333|594140072|FG001|Overall Study|Death|14|||
164482896|NCT01802333|594140073|FG002|Overall Study|Death|13|||
164482897|NCT01802333|594140071|FG000|Overall Study|Other - not protocol specified|32|||
164482898|NCT01802333|594140072|FG001|Overall Study|Other - not protocol specified|22|||
164482899|NCT01802333|594140073|FG002|Overall Study|Other - not protocol specified|24|||
164482900|NCT01802333|594140071|FG000|Overall Study|Did not start treatment|0|||
164482901|NCT01802333|594140072|FG001|Overall Study|Did not start treatment|2|||
164482902|NCT01802333|594140073|FG002|Overall Study|Did not start treatment|5|||
164482903|NCT01947491|594140077|FG000|Overall Study|Lost to Follow-up|5|||
164482904|NCT01947491|594140078|FG001|Overall Study|Lost to Follow-up|3|||
164482905|NCT01947491|594140079|FG002|Overall Study|Lost to Follow-up|1|||
164482906|NCT01947491|594140080|FG003|Overall Study|Lost to Follow-up|2|||
164482907|NCT01947491|594140077|FG000|Overall Study|Lack of Efficacy|1|||
164482908|NCT01947491|594140078|FG001|Overall Study|Lack of Efficacy|0|||
164482909|NCT01947491|594140079|FG002|Overall Study|Lack of Efficacy|0|||
164482910|NCT01947491|594140080|FG003|Overall Study|Lack of Efficacy|1|||
164482911|NCT01947491|594140077|FG000|Overall Study|Protocol Violation|1|||
164482912|NCT01947491|594140078|FG001|Overall Study|Protocol Violation|0|||
164482913|NCT01947491|594140079|FG002|Overall Study|Protocol Violation|0|||
164482914|NCT01947491|594140080|FG003|Overall Study|Protocol Violation|0|||
164482915|NCT01947491|594140077|FG000|Overall Study|Withdrawal by Subject|1|||
164482916|NCT01947491|594140078|FG001|Overall Study|Withdrawal by Subject|1|||
164482917|NCT01947491|594140079|FG002|Overall Study|Withdrawal by Subject|1|||
164482918|NCT01947491|594140080|FG003|Overall Study|Withdrawal by Subject|0|||
164482919|NCT01947491|594140077|FG000|Overall Study|Worsening of condition|0|||
164482920|NCT01947491|594140078|FG001|Overall Study|Worsening of condition|1|||
164482921|NCT01947491|594140079|FG002|Overall Study|Worsening of condition|0|||
164482922|NCT01947491|594140080|FG003|Overall Study|Worsening of condition|0|||
164482923|NCT01947491|594140077|FG000|Overall Study|Adverse Event|0|||
164482924|NCT01947491|594140078|FG001|Overall Study|Adverse Event|1|||
164482925|NCT01947491|594140079|FG002|Overall Study|Adverse Event|0|||
164482926|NCT01947491|594140080|FG003|Overall Study|Adverse Event|2|||
164482927|NCT02224755|594140081|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
164482928|NCT02224755|594140082|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
164482929|NCT02224755|594140081|FG000|Two Year Follow up Post-implant|Death|103|||
164482930|NCT02224755|594140082|FG001|Two Year Follow up Post-implant|Death|98|||
164482931|NCT02224755|594140081|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
164482932|NCT02224755|594140082|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
164482933|NCT02224755|594140081|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
164482934|NCT02224755|594140082|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
164482935|NCT02224755|594140081|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
164482936|NCT02224755|594140082|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
164482937|NCT02067663|594140083|FG000|Overall Study|Lost to Follow-up|13|||
164482938|NCT02067663|594140084|FG001|Overall Study|Lost to Follow-up|14|||
164482939|NCT03236779|594140087|FG000|Overall Study|Lost to Follow-up|13|||
164482940|NCT03236779|594140088|FG001|Overall Study|Lost to Follow-up|21|||
164482941|NCT00929526|594140090|FG000|Overall Study|Withdrawal by Subject|1|||
164482942|NCT00929526|594140091|FG001|Overall Study|Withdrawal by Subject|11|||
164482943|NCT00929526|594140090|FG000|Overall Study|Lost to Follow-up|8|||
164482944|NCT00929526|594140091|FG001|Overall Study|Lost to Follow-up|12|||
164482945|NCT00929526|594140090|FG000|Overall Study|Other|8|||
164482946|NCT00929526|594140091|FG001|Overall Study|Other|6|||
164482947|NCT00578344|594140092|FG000|Overall Study|Insurance problems|1|||
164482948|NCT00578344|594140092|FG000|Overall Study|Graft failure|1|||
164482949|NCT03374254|594140095|FG000|Overall Study|Death|5|||
164482950|NCT03374254|594140096|FG001|Overall Study|Death|16|||
164482951|NCT03374254|594140097|FG002|Overall Study|Death|13|||
164482952|NCT03374254|594140098|FG003|Overall Study|Death|11|||
164482953|NCT03374254|594140099|FG004|Overall Study|Death|9|||
164482954|NCT03374254|594140100|FG005|Overall Study|Death|12|||
164482955|NCT03374254|594140101|FG006|Overall Study|Death|11|||
164482956|NCT03374254|594140102|FG007|Overall Study|Death|6|||
164482957|NCT03374254|594140103|FG008|Overall Study|Death|7|||
164482958|NCT03374254|594140095|FG000|Overall Study|Lost to Follow-up|0|||
164482959|NCT03374254|594140096|FG001|Overall Study|Lost to Follow-up|0|||
164482960|NCT03374254|594140097|FG002|Overall Study|Lost to Follow-up|0|||
164482961|NCT03374254|594140098|FG003|Overall Study|Lost to Follow-up|0|||
164482962|NCT03374254|594140099|FG004|Overall Study|Lost to Follow-up|0|||
164482963|NCT03374254|594140100|FG005|Overall Study|Lost to Follow-up|0|||
164482964|NCT03374254|594140101|FG006|Overall Study|Lost to Follow-up|2|||
164482965|NCT03374254|594140102|FG007|Overall Study|Lost to Follow-up|0|||
164482966|NCT03374254|594140103|FG008|Overall Study|Lost to Follow-up|0|||
164482967|NCT03374254|594140095|FG000|Overall Study|Sponsor Decision|1|||
164482968|NCT03374254|594140096|FG001|Overall Study|Sponsor Decision|0|||
164482969|NCT03374254|594140097|FG002|Overall Study|Sponsor Decision|2|||
164482970|NCT03374254|594140098|FG003|Overall Study|Sponsor Decision|3|||
164482971|NCT03374254|594140099|FG004|Overall Study|Sponsor Decision|2|||
164482972|NCT03374254|594140100|FG005|Overall Study|Sponsor Decision|3|||
164482973|NCT03374254|594140101|FG006|Overall Study|Sponsor Decision|3|||
164482974|NCT03374254|594140102|FG007|Overall Study|Sponsor Decision|3|||
164482975|NCT03374254|594140103|FG008|Overall Study|Sponsor Decision|4|||
164482976|NCT03374254|594140095|FG000|Overall Study|Withdrawal by Subject|0|||
164482977|NCT03374254|594140096|FG001|Overall Study|Withdrawal by Subject|0|||
164482978|NCT03374254|594140097|FG002|Overall Study|Withdrawal by Subject|0|||
164482979|NCT03374254|594140098|FG003|Overall Study|Withdrawal by Subject|2|||
164482980|NCT03374254|594140099|FG004|Overall Study|Withdrawal by Subject|0|||
164482981|NCT03374254|594140100|FG005|Overall Study|Withdrawal by Subject|1|||
164482982|NCT03374254|594140101|FG006|Overall Study|Withdrawal by Subject|0|||
164482983|NCT03374254|594140102|FG007|Overall Study|Withdrawal by Subject|0|||
164482984|NCT03374254|594140103|FG008|Overall Study|Withdrawal by Subject|0|||
164482985|NCT02309515|594140105|FG000|Overall Study|Withdrawal by Subject|0|||
164482986|NCT02309515|594140106|FG001|Overall Study|Withdrawal by Subject|1|||
164482987|NCT02547974|594140109|FG000|Overall Study|Withdrawal by Subject|1|||
164482988|NCT02547974|594140110|FG001|Overall Study|Withdrawal by Subject|0|||
164482989|NCT02547974|594140111|FG002|Overall Study|Withdrawal by Subject|0|||
164482990|NCT02547974|594140112|FG003|Overall Study|Withdrawal by Subject|0|||
164482991|NCT02245620|594140114|FG000|Overall Study|Physician Decision|1|||
164482992|NCT02245620|594140115|FG001|Overall Study|Physician Decision|1|||
164482993|NCT01768572|594140116|FG000|Overall Study|Adverse Event|7|||
164482994|NCT01768572|594140117|FG001|Overall Study|Adverse Event|8|||
164482995|NCT01768572|594140118|FG002|Overall Study|Adverse Event|4|||
164482996|NCT01768572|594140116|FG000|Overall Study|Lack of Efficacy|1|||
164482997|NCT01768572|594140117|FG001|Overall Study|Lack of Efficacy|3|||
164482998|NCT01768572|594140118|FG002|Overall Study|Lack of Efficacy|1|||
164482999|NCT01768572|594140116|FG000|Overall Study|Other, Not due to an adverse event|1|||
164483000|NCT01768572|594140117|FG001|Overall Study|Other, Not due to an adverse event|1|||
164483001|NCT01768572|594140118|FG002|Overall Study|Other, Not due to an adverse event|1|||
164483002|NCT04766996|594140119|FG000|Overall Study|Withdrawal by Subject|1|||
164483003|NCT04766996|594140120|FG001|Overall Study|Withdrawal by Subject|0|||
164483004|NCT04766996|594140121|FG002|Overall Study|Withdrawal by Subject|13|||
164483005|NCT01322386|594140122|FG000|Overall Study|Protocol Violation|0|||
164483006|NCT01322386|594140123|FG001|Overall Study|Protocol Violation|1|||
164483007|NCT01322386|594140122|FG000|Overall Study|Physician Decision|0|||
164483008|NCT01322386|594140123|FG001|Overall Study|Physician Decision|1|||
164483009|NCT01102426|594140124|FG000|Overall Study|Randomized but not treated|4|||
164483010|NCT01102426|594140125|FG001|Overall Study|Randomized but not treated|1|||
164483011|NCT01102426|594140124|FG000|Overall Study|Adverse Events (treatment-related)|15|||
164483012|NCT01102426|594140125|FG001|Overall Study|Adverse Events (treatment-related)|8|||
164483013|NCT01102426|594140124|FG000|Overall Study|Physician Decision|9|||
164483014|NCT01102426|594140125|FG001|Overall Study|Physician Decision|6|||
164483015|NCT01102426|594140124|FG000|Overall Study|Progressive Disease|85|||
164483016|NCT01102426|594140125|FG001|Overall Study|Progressive Disease|44|||
164483017|NCT01102426|594140124|FG000|Overall Study|Adverse Events (unrelated to|9|||
164483018|NCT01102426|594140125|FG001|Overall Study|Adverse Events (unrelated to|1|||
164483019|NCT01102426|594140124|FG000|Overall Study|Patient Refusal|24|||
164483020|NCT01102426|594140125|FG001|Overall Study|Patient Refusal|12|||
164483021|NCT01102426|594140124|FG000|Overall Study|Death (due to adverse events|0|||
164483022|NCT01102426|594140125|FG001|Overall Study|Death (due to adverse events|1|||
164483023|NCT01102426|594140124|FG000|Overall Study|Death (non-related to the study|19|||
164483024|NCT01102426|594140125|FG001|Overall Study|Death (non-related to the study|8|||
164483025|NCT00088166|594140129|FG000|Overall Study|Adverse Event|11|||
164483026|NCT00088166|594140130|FG001|Overall Study|Adverse Event|9|||
164483027|NCT00088166|594140129|FG000|Overall Study|Death|3|||
164483028|NCT00088166|594140130|FG001|Overall Study|Death|1|||
164483029|NCT00088166|594140129|FG000|Overall Study|Lost to Follow-up|0|||
164483030|NCT00088166|594140130|FG001|Overall Study|Lost to Follow-up|1|||
164483031|NCT00088166|594140129|FG000|Overall Study|Physician Decision|4|||
164483032|NCT00088166|594140130|FG001|Overall Study|Physician Decision|1|||
164483033|NCT00088166|594140129|FG000|Overall Study|Protocol Violation|1|||
164483034|NCT00088166|594140130|FG001|Overall Study|Protocol Violation|5|||
164483035|NCT00088166|594140129|FG000|Overall Study|Patient deterioration|29|||
164483036|NCT00088166|594140130|FG001|Overall Study|Patient deterioration|39|||
164483037|NCT00088166|594140129|FG000|Overall Study|Withdrawal by Subject|5|||
164483038|NCT00088166|594140130|FG001|Overall Study|Withdrawal by Subject|5|||
164601233|NCT01877382|594559902|FG006|Dose Expansion|Adverse Event|0|||
164601234|NCT01877382|594559903|FG007|Dose Expansion|Adverse Event|0|||
164601235|NCT01877382|594559904|FG008|Dose Expansion|Adverse Event|0|||
164483039|NCT02671266|594140131|FG000|Overall Study|Withdrawal by Subject|1|||
164483040|NCT02671266|594140132|FG001|Overall Study|Withdrawal by Subject|1|||
164601236|NCT01877382|594559905|FG009|Dose Expansion|Adverse Event|0|||
164601237|NCT01877382|594559906|FG010|Dose Expansion|Adverse Event|0|||
164601238|NCT01877382|594559907|FG011|Dose Expansion|Adverse Event|0|||
164601239|NCT01877382|594559908|FG012|Dose Expansion|Adverse Event|0|||
164601240|NCT01877382|594559909|FG013|Dose Expansion|Adverse Event|0|||
164601241|NCT01877382|594559910|FG014|Dose Expansion|Adverse Event|1|||
164601242|NCT01877382|594559896|FG000|Dose Expansion|Death|0|||
164601243|NCT01877382|594559897|FG001|Dose Expansion|Death|0|||
164601244|NCT01877382|594559898|FG002|Dose Expansion|Death|0|||
164601245|NCT01877382|594559899|FG003|Dose Expansion|Death|0|||
164601246|NCT01877382|594559900|FG004|Dose Expansion|Death|0|||
164601247|NCT01877382|594559901|FG005|Dose Expansion|Death|0|||
164601248|NCT01877382|594559902|FG006|Dose Expansion|Death|0|||
164601249|NCT01877382|594559903|FG007|Dose Expansion|Death|0|||
164601250|NCT01877382|594559904|FG008|Dose Expansion|Death|0|||
164601251|NCT01877382|594559905|FG009|Dose Expansion|Death|0|||
164601252|NCT01877382|594559906|FG010|Dose Expansion|Death|0|||
164601253|NCT01877382|594559907|FG011|Dose Expansion|Death|0|||
164601254|NCT01877382|594559908|FG012|Dose Expansion|Death|0|||
164601255|NCT01877382|594559909|FG013|Dose Expansion|Death|0|||
164601256|NCT01877382|594559910|FG014|Dose Expansion|Death|1|||
164601257|NCT01877382|594559896|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164601258|NCT01877382|594559897|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164601259|NCT01877382|594559898|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164601260|NCT01877382|594559899|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164483041|NCT00666705|594140133|FG000|Overall Study|Withdrawal by Subject|1|||
164483042|NCT01976507|594140136|FG000|Overall Study|Adverse Event|6|||
164483043|NCT01976507|594140136|FG000|Overall Study|ablation not done, drug not given|1|||
164483044|NCT01029704|594140138|FG000|Overall Study|Adverse Event|0|||
164483045|NCT01029704|594140139|FG001|Overall Study|Adverse Event|0|||
164483046|NCT01029704|594140140|FG002|Overall Study|Adverse Event|0|||
164483047|NCT01029704|594140141|FG003|Overall Study|Adverse Event|0|||
164483048|NCT01029704|594140142|FG004|Overall Study|Adverse Event|0|||
164483049|NCT01029704|594140143|FG005|Overall Study|Adverse Event|0|||
164483050|NCT01029704|594140144|FG006|Overall Study|Adverse Event|1|||
164483051|NCT01029704|594140145|FG007|Overall Study|Adverse Event|1|||
164483052|NCT01029704|594140146|FG008|Overall Study|Adverse Event|0|||
164483053|NCT01029704|594140138|FG000|Overall Study|Withdrawal by Subject|0|||
164483054|NCT01029704|594140139|FG001|Overall Study|Withdrawal by Subject|0|||
164483055|NCT01029704|594140140|FG002|Overall Study|Withdrawal by Subject|0|||
164483056|NCT01029704|594140141|FG003|Overall Study|Withdrawal by Subject|0|||
164483057|NCT01029704|594140142|FG004|Overall Study|Withdrawal by Subject|2|||
164483058|NCT01029704|594140143|FG005|Overall Study|Withdrawal by Subject|1|||
164483059|NCT01029704|594140144|FG006|Overall Study|Withdrawal by Subject|1|||
164483060|NCT01029704|594140145|FG007|Overall Study|Withdrawal by Subject|1|||
164601261|NCT01877382|594559900|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164601262|NCT01877382|594559901|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164601263|NCT01877382|594559902|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164601264|NCT01877382|594559903|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164601265|NCT01877382|594559904|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164601266|NCT01877382|594559905|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164483061|NCT01029704|594140146|FG008|Overall Study|Withdrawal by Subject|0|||
164483062|NCT01029704|594140138|FG000|Overall Study|Lost to Follow-up|0|||
164483063|NCT01029704|594140139|FG001|Overall Study|Lost to Follow-up|0|||
164601267|NCT01877382|594559906|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164601268|NCT01877382|594559907|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164601269|NCT01877382|594559908|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164601270|NCT01877382|594559909|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164601271|NCT01877382|594559910|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
164601272|NCT03423979|594559911|FG000|Overall Study|Death|5|||
164601273|NCT03423979|594559911|FG000|Overall Study|Adverse Event|4|||
164601274|NCT03423979|594559911|FG000|Overall Study|Withdrawal by Subject|3|||
164601275|NCT03423979|594559911|FG000|Overall Study|Lost to Follow-up|16|||
164601276|NCT00808249|594559914|FG000|Overall Study|Adverse Event|4|||
164601277|NCT00808249|594559915|FG001|Overall Study|Adverse Event|7|||
164601278|NCT00808249|594559916|FG002|Overall Study|Adverse Event|10|||
164601279|NCT00808249|594559917|FG003|Overall Study|Adverse Event|6|||
164601280|NCT00808249|594559914|FG000|Overall Study|Lost to Follow-up|2|||
164601281|NCT00808249|594559915|FG001|Overall Study|Lost to Follow-up|3|||
164601282|NCT00808249|594559916|FG002|Overall Study|Lost to Follow-up|3|||
164601283|NCT00808249|594559917|FG003|Overall Study|Lost to Follow-up|5|||
164601284|NCT00808249|594559914|FG000|Overall Study|Withdrawal by Subject|4|||
164601285|NCT00808249|594559915|FG001|Overall Study|Withdrawal by Subject|0|||
164601286|NCT00808249|594559916|FG002|Overall Study|Withdrawal by Subject|2|||
164601287|NCT00808249|594559917|FG003|Overall Study|Withdrawal by Subject|4|||
164601288|NCT00808249|594559914|FG000|Overall Study|Protocol Violation|3|||
164601289|NCT00808249|594559915|FG001|Overall Study|Protocol Violation|3|||
164601290|NCT00808249|594559916|FG002|Overall Study|Protocol Violation|3|||
164601291|NCT00808249|594559917|FG003|Overall Study|Protocol Violation|0|||
164601292|NCT00808249|594559914|FG000|Overall Study|Lack of Efficacy|1|||
164601293|NCT00808249|594559915|FG001|Overall Study|Lack of Efficacy|1|||
164601294|NCT00808249|594559916|FG002|Overall Study|Lack of Efficacy|0|||
164601295|NCT00808249|594559917|FG003|Overall Study|Lack of Efficacy|0|||
164601296|NCT00808249|594559914|FG000|Overall Study|study specific discontinuation criteria|1|||
164601297|NCT00808249|594559915|FG001|Overall Study|study specific discontinuation criteria|0|||
164601298|NCT00808249|594559916|FG002|Overall Study|study specific discontinuation criteria|1|||
164601299|NCT00808249|594559917|FG003|Overall Study|study specific discontinuation criteria|0|||
164601300|NCT00808249|594559914|FG000|Overall Study|All other reasons|2|||
164601301|NCT00808249|594559915|FG001|Overall Study|All other reasons|1|||
164601302|NCT00808249|594559916|FG002|Overall Study|All other reasons|3|||
164601303|NCT00808249|594559917|FG003|Overall Study|All other reasons|1|||
164601304|NCT05108805|594559921|FG000|Overall Study|T-cell expansion was not successful.|5|||
164601305|NCT04095286|594559922|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
164601306|NCT04095286|594559923|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
164601307|NCT04095286|594559924|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
164601308|NCT04095286|594559925|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
164601309|NCT04095286|594559926|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
164601310|NCT04095286|594559927|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
164601311|NCT04095286|594559922|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
164601312|NCT04095286|594559923|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
164601313|NCT04095286|594559924|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
164601314|NCT04095286|594559925|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
164601315|NCT04095286|594559926|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
164601316|NCT04095286|594559927|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
164601317|NCT04095286|594559922|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
164601318|NCT04095286|594559923|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
164601319|NCT04095286|594559924|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
164601320|NCT04095286|594559925|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
164483064|NCT01029704|594140140|FG002|Overall Study|Lost to Follow-up|0|||
164483065|NCT01029704|594140141|FG003|Overall Study|Lost to Follow-up|0|||
164483066|NCT01029704|594140142|FG004|Overall Study|Lost to Follow-up|0|||
164483067|NCT01029704|594140143|FG005|Overall Study|Lost to Follow-up|0|||
164483068|NCT01029704|594140144|FG006|Overall Study|Lost to Follow-up|1|||
164483069|NCT01029704|594140145|FG007|Overall Study|Lost to Follow-up|1|||
164483070|NCT01029704|594140146|FG008|Overall Study|Lost to Follow-up|1|||
164483071|NCT01029704|594140138|FG000|Overall Study|Lack of Efficacy|0|||
164483072|NCT01029704|594140139|FG001|Overall Study|Lack of Efficacy|0|||
164483073|NCT01029704|594140140|FG002|Overall Study|Lack of Efficacy|0|||
164483074|NCT01029704|594140141|FG003|Overall Study|Lack of Efficacy|0|||
164483075|NCT01029704|594140142|FG004|Overall Study|Lack of Efficacy|2|||
164483076|NCT01029704|594140143|FG005|Overall Study|Lack of Efficacy|3|||
164483077|NCT01029704|594140144|FG006|Overall Study|Lack of Efficacy|1|||
164483078|NCT01029704|594140145|FG007|Overall Study|Lack of Efficacy|2|||
164483079|NCT01029704|594140146|FG008|Overall Study|Lack of Efficacy|0|||
164483080|NCT01029704|594140138|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
164483081|NCT01029704|594140139|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
164483082|NCT01029704|594140140|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
164483083|NCT01029704|594140141|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
164483084|NCT01029704|594140142|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
164483085|NCT01029704|594140143|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
164483086|NCT01029704|594140144|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
164483087|NCT01029704|594140145|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
164483088|NCT01029704|594140146|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
164483089|NCT03845517|594140147|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
164483090|NCT03845517|594140148|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
164483091|NCT03845517|594140149|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
164483092|NCT03845517|594140150|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
164483093|NCT03845517|594140147|FG000|Treatment Period (52 Weeks)|Death|0|||
164483094|NCT03845517|594140148|FG001|Treatment Period (52 Weeks)|Death|0|||
164483095|NCT03845517|594140149|FG002|Treatment Period (52 Weeks)|Death|1|||
164483096|NCT03845517|594140150|FG003|Treatment Period (52 Weeks)|Death|0|||
164483097|NCT03845517|594140147|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
164483098|NCT03845517|594140148|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
164483099|NCT03845517|594140149|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
164483100|NCT03845517|594140150|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
164483101|NCT03845517|594140147|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
164483102|NCT03845517|594140148|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
164483103|NCT03845517|594140149|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
164483104|NCT03845517|594140150|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
164483105|NCT03845517|594140147|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
164483106|NCT03845517|594140148|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
164483107|NCT03845517|594140149|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
164483108|NCT03845517|594140150|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
164483109|NCT03845517|594140147|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
164483110|NCT03845517|594140148|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
164483111|NCT03845517|594140149|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
164483112|NCT03845517|594140150|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
164483113|NCT03845517|594140147|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
164483114|NCT03845517|594140148|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
164483115|NCT03845517|594140149|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
164483116|NCT03845517|594140150|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
164483117|NCT03845517|594140147|FG000|Treatment Period (52 Weeks)|Other|2|||
164483118|NCT03845517|594140148|FG001|Treatment Period (52 Weeks)|Other|0|||
164483119|NCT03845517|594140149|FG002|Treatment Period (52 Weeks)|Other|0|||
164483120|NCT03845517|594140150|FG003|Treatment Period (52 Weeks)|Other|0|||
164483121|NCT03845517|594140147|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
164483122|NCT03845517|594140148|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
164483123|NCT03845517|594140149|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
164483124|NCT03845517|594140150|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
164483125|NCT03845517|594140147|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
164483126|NCT03845517|594140148|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
164483127|NCT03845517|594140149|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
164483128|NCT03845517|594140150|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
164483129|NCT03845517|594140147|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
164483130|NCT03845517|594140148|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
164483131|NCT03845517|594140149|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
164483132|NCT03845517|594140150|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
164483133|NCT03845517|594140147|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
164483134|NCT03845517|594140148|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
164483135|NCT03845517|594140149|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
164483136|NCT03845517|594140150|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
164601321|NCT04095286|594559926|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
164601322|NCT04095286|594559927|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
164601323|NCT04095286|594559922|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
164601324|NCT04095286|594559923|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
164601325|NCT04095286|594559924|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
164601326|NCT04095286|594559925|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
164601327|NCT04095286|594559926|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
164601328|NCT04095286|594559927|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
164601329|NCT04095286|594559922|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
164601330|NCT04095286|594559923|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
164601331|NCT04095286|594559924|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
164601332|NCT04095286|594559925|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
164601333|NCT04095286|594559926|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
164601334|NCT04095286|594559927|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
164601335|NCT00479557|594559928|FG000|Overall Study|Death|0|||
164601336|NCT00479557|594559929|FG001|Overall Study|Death|0|||
164483137|NCT03845517|594140147|FG000|Follow-up Period (4 Weeks)|Death|0|||
164483138|NCT03845517|594140148|FG001|Follow-up Period (4 Weeks)|Death|0|||
164483139|NCT03845517|594140149|FG002|Follow-up Period (4 Weeks)|Death|1|||
164483140|NCT03845517|594140150|FG003|Follow-up Period (4 Weeks)|Death|1|||
164483141|NCT03845517|594140147|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
164483142|NCT03845517|594140148|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
164483143|NCT03845517|594140149|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
164483144|NCT03845517|594140150|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
164483145|NCT03845517|594140147|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
164483146|NCT03845517|594140148|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
164483147|NCT03845517|594140149|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
164483148|NCT03845517|594140150|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
164483149|NCT03845517|594140147|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
164483150|NCT03845517|594140148|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
164483151|NCT03845517|594140149|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
164483152|NCT03845517|594140150|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
164483153|NCT03845517|594140147|FG000|Follow-up Period (4 Weeks)|Other|1|||
164483154|NCT03845517|594140148|FG001|Follow-up Period (4 Weeks)|Other|0|||
164483155|NCT03845517|594140149|FG002|Follow-up Period (4 Weeks)|Other|1|||
164483156|NCT03845517|594140150|FG003|Follow-up Period (4 Weeks)|Other|0|||
164483157|NCT03845517|594140147|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
164483158|NCT03845517|594140148|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
164483159|NCT03845517|594140149|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
164483160|NCT03845517|594140150|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
164483161|NCT03845517|594140147|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
164483162|NCT03845517|594140148|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
164483163|NCT03845517|594140149|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
164483164|NCT03845517|594140150|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
164483165|NCT03845517|594140147|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
164483166|NCT03845517|594140148|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
164483167|NCT03845517|594140149|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
164483168|NCT03845517|594140150|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
164483169|NCT01109979|594140151|FG000|Overall Study|Physician Decision|2|||
164483170|NCT01109979|594140152|FG001|Overall Study|Physician Decision|0|||
164483171|NCT01109979|594140151|FG000|Overall Study|Withdrawal by Subject|0|||
164483172|NCT01109979|594140152|FG001|Overall Study|Withdrawal by Subject|1|||
164483173|NCT03136861|594140155|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
164483174|NCT03136861|594140156|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
164483175|NCT03136861|594140157|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
164483176|NCT03136861|594140158|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
164483177|NCT03136861|594140159|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
164483178|NCT03136861|594140160|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
164483179|NCT03136861|594140161|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
164483180|NCT03136861|594140155|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
164601337|NCT00479557|594559930|FG002|Overall Study|Death|0|||
164483181|NCT03136861|594140156|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
164601338|NCT00479557|594559931|FG003|Overall Study|Death|0|||
164144910|NCT05199090|592891825|FG003|Overall Study|Physician Decision|0|||
164483182|NCT03136861|594140157|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
164483183|NCT03136861|594140158|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
164483184|NCT03136861|594140159|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
164714467|NCT00673387|594976983|FG000|Overall Study|Withdrawal by Subject|15|||
164483185|NCT03136861|594140160|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
164483186|NCT03136861|594140161|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
164483187|NCT03136861|594140155|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
164483188|NCT03136861|594140156|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
164483189|NCT03136861|594140157|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
164483190|NCT03136861|594140158|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
164483191|NCT03136861|594140159|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
164483192|NCT03136861|594140160|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
164483193|NCT03136861|594140161|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
164483194|NCT03136861|594140155|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
164483195|NCT03136861|594140156|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
164483196|NCT03136861|594140157|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
164483197|NCT03136861|594140158|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
164483198|NCT03136861|594140159|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
164483199|NCT03136861|594140160|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
164483200|NCT03136861|594140161|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
164483201|NCT03136861|594140155|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
164483202|NCT03136861|594140156|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
164483203|NCT03136861|594140157|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
164483204|NCT03136861|594140158|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
164483205|NCT03136861|594140159|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
164483206|NCT03136861|594140160|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
164483207|NCT03136861|594140161|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
164483208|NCT03136861|594140155|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
164483209|NCT03136861|594140156|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
164483210|NCT03136861|594140157|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
164483211|NCT03136861|594140158|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
164483212|NCT03136861|594140159|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
164483213|NCT03136861|594140160|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
164483214|NCT03136861|594140161|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
164483215|NCT03136861|594140155|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
164483216|NCT03136861|594140156|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
164483217|NCT03136861|594140157|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
164483218|NCT03136861|594140158|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
164483219|NCT03136861|594140159|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
164483220|NCT03136861|594140160|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
164483221|NCT03136861|594140161|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
164483222|NCT03136861|594140155|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
164483223|NCT03136861|594140156|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
164483224|NCT03136861|594140157|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
164483225|NCT03136861|594140158|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
164483226|NCT03136861|594140159|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
164483227|NCT03136861|594140160|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
164483228|NCT03136861|594140161|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
164483229|NCT03390166|594140162|FG000|Overall Study|Death|0|||
164483230|NCT03390166|594140163|FG001|Overall Study|Death|1|||
164483231|NCT03390166|594140162|FG000|Overall Study|Lost to Follow-up|6|||
164483232|NCT03390166|594140163|FG001|Overall Study|Lost to Follow-up|4|||
164483233|NCT03390166|594140162|FG000|Overall Study|Physician Decision|2|||
164483234|NCT03390166|594140163|FG001|Overall Study|Physician Decision|1|||
164483235|NCT03390166|594140162|FG000|Overall Study|Move from study area|3|||
164483236|NCT03390166|594140163|FG001|Overall Study|Move from study area|2|||
164483237|NCT03390166|594140162|FG000|Overall Study|To militarycamp for conscript|1|||
164483238|NCT03390166|594140163|FG001|Overall Study|To militarycamp for conscript|0|||
164483239|NCT03390166|594140162|FG000|Overall Study|To drug therapy course|0|||
164483240|NCT03390166|594140163|FG001|Overall Study|To drug therapy course|1|||
164483241|NCT03390166|594140162|FG000|Overall Study|Move to work oversea|0|||
164483242|NCT03390166|594140163|FG001|Overall Study|Move to work oversea|1|||
164483243|NCT01328756|594140169|FG000|Overall Study|Protocol Violation|4|||
164483244|NCT01328756|594140169|FG000|Overall Study|Adverse Event|39|||
164483245|NCT01328756|594140169|FG000|Overall Study|Lack of Efficacy|5|||
164483246|NCT01328756|594140169|FG000|Overall Study|Withdrawal by Subject|41|||
164483247|NCT01328756|594140169|FG000|Overall Study|Lost to Follow-up|5|||
164483248|NCT01328756|594140169|FG000|Overall Study|Other|29|||
164714468|NCT00673387|594976984|FG001|Overall Study|Withdrawal by Subject|16|||
164483249|NCT00526994|594140170|FG000|Overall Study|Lost to Follow-up|98|||
164483250|NCT00526994|594140171|FG001|Overall Study|Lost to Follow-up|108|||
164483251|NCT00526994|594140172|FG002|Overall Study|Lost to Follow-up|96|||
164483252|NCT00526994|594140170|FG000|Overall Study|Death|4|||
164483253|NCT00526994|594140171|FG001|Overall Study|Death|3|||
164483254|NCT00526994|594140172|FG002|Overall Study|Death|3|||
164483255|NCT00526994|594140170|FG000|Overall Study|Withdrawal by Subject|2|||
164483256|NCT00526994|594140171|FG001|Overall Study|Withdrawal by Subject|7|||
164483257|NCT00526994|594140172|FG002|Overall Study|Withdrawal by Subject|5|||
164483258|NCT00526994|594140170|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
164483259|NCT00526994|594140171|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
164483260|NCT00526994|594140172|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
164483261|NCT03035942|594140173|FG000|Overall Study|Adverse Event|8|||
164483262|NCT03035942|594140174|FG001|Overall Study|Adverse Event|4|||
164483263|NCT03035942|594140175|FG002|Overall Study|Adverse Event|5|||
164483264|NCT05270460|594140176|FG000|Overall Study|Adverse Event|0|||
164483265|NCT05270460|594140177|FG001|Overall Study|Adverse Event|1|||
164483266|NCT05270460|594140178|FG002|Overall Study|Adverse Event|0|||
164483267|NCT05270460|594140176|FG000|Overall Study|Early Termination|0|||
164483268|NCT05270460|594140177|FG001|Overall Study|Early Termination|1|||
164483269|NCT05270460|594140178|FG002|Overall Study|Early Termination|0|||
164483270|NCT03205488|594140179|FG000|Overall Study|Adverse Event|1|||
164483271|NCT03205488|594140180|FG001|Overall Study|Adverse Event|2|||
164483272|NCT03205488|594140181|FG002|Overall Study|Adverse Event|4|||
164483273|NCT03205488|594140179|FG000|Overall Study|Protocol Violation|0|||
164483274|NCT03205488|594140180|FG001|Overall Study|Protocol Violation|0|||
164483275|NCT03205488|594140181|FG002|Overall Study|Protocol Violation|1|||
164483276|NCT05163353|594140184|FG000|Overall Study|Adverse Event|1|||
164483277|NCT05163353|594140185|FG001|Overall Study|Adverse Event|0|||
164483278|NCT05163353|594140184|FG000|Overall Study|Withdrawal by Subject|21|||
164483279|NCT05163353|594140185|FG001|Overall Study|Withdrawal by Subject|6|||
164483280|NCT05163353|594140184|FG000|Overall Study|Protocol Violation|0|||
164483281|NCT05163353|594140185|FG001|Overall Study|Protocol Violation|1|||
164483282|NCT05163353|594140184|FG000|Overall Study|Lost to Follow-up|13|||
164483283|NCT05163353|594140185|FG001|Overall Study|Lost to Follow-up|2|||
164483284|NCT06086028|594140187|FG000|Overall Study|Withdrawal by Subject|1|||
164483285|NCT06086028|594140188|FG001|Overall Study|Withdrawal by Subject|1|||
164483286|NCT06086028|594140187|FG000|Overall Study|Lost to Follow-up|2|||
164483287|NCT06086028|594140188|FG001|Overall Study|Lost to Follow-up|3|||
164483288|NCT00824408|594140189|FG000|Run-in Phase|Progressive disease|4|||
164483289|NCT00824408|594140190|FG001|Run-in Phase|Progressive disease|4|||
164483290|NCT00824408|594140191|FG002|Run-in Phase|Progressive disease|0|||
164483291|NCT00824408|594140192|FG003|Run-in Phase|Progressive disease|0|||
164483292|NCT00824408|594140193|FG004|Run-in Phase|Progressive disease|0|||
164483293|NCT00824408|594140189|FG000|Run-in Phase|Adverse Event|1|||
164483294|NCT00824408|594140190|FG001|Run-in Phase|Adverse Event|1|||
164483295|NCT00824408|594140191|FG002|Run-in Phase|Adverse Event|0|||
164483296|NCT00824408|594140192|FG003|Run-in Phase|Adverse Event|0|||
164483297|NCT00824408|594140193|FG004|Run-in Phase|Adverse Event|0|||
164483298|NCT00824408|594140189|FG000|Run-in Phase|Refused to continue medication|1|||
164483299|NCT00824408|594140190|FG001|Run-in Phase|Refused to continue medication|0|||
164483300|NCT00824408|594140191|FG002|Run-in Phase|Refused to continue medication|0|||
164483301|NCT00824408|594140192|FG003|Run-in Phase|Refused to continue medication|0|||
164483302|NCT00824408|594140193|FG004|Run-in Phase|Refused to continue medication|0|||
164483303|NCT00824408|594140189|FG000|Run-in Phase|Other reason not defined above|0|||
164483304|NCT00824408|594140190|FG001|Run-in Phase|Other reason not defined above|1|||
164483305|NCT00824408|594140191|FG002|Run-in Phase|Other reason not defined above|0|||
164483306|NCT00824408|594140192|FG003|Run-in Phase|Other reason not defined above|0|||
164483307|NCT00824408|594140193|FG004|Run-in Phase|Other reason not defined above|0|||
164483308|NCT00824408|594140189|FG000|Randomized Phase|Not treated|0|||
164714469|NCT00673387|594976985|FG002|Overall Study|Withdrawal by Subject|20|||
164483309|NCT00824408|594140190|FG001|Randomized Phase|Not treated|0|||
164483310|NCT00824408|594140191|FG002|Randomized Phase|Not treated|1|||
164601339|NCT00479557|594559932|FG004|Overall Study|Death|0|||
164601340|NCT00479557|594559933|FG005|Overall Study|Death|1|||
164714470|NCT00673387|594976986|FG003|Overall Study|Withdrawal by Subject|16|||
164714471|NCT00673387|594976987|FG004|Overall Study|Withdrawal by Subject|18|||
164601341|NCT00479557|594559934|FG006|Overall Study|Death|0|||
164714472|NCT00673387|594976988|FG005|Overall Study|Withdrawal by Subject|21|||
164483311|NCT00824408|594140192|FG003|Randomized Phase|Not treated|1|||
164483312|NCT00824408|594140193|FG004|Randomized Phase|Not treated|1|||
164483313|NCT00824408|594140189|FG000|Randomized Phase|Progressive disease|0|||
164483314|NCT00824408|594140190|FG001|Randomized Phase|Progressive disease|0|||
164483315|NCT00824408|594140191|FG002|Randomized Phase|Progressive disease|25|||
164483316|NCT00824408|594140192|FG003|Randomized Phase|Progressive disease|36|||
164483317|NCT00824408|594140193|FG004|Randomized Phase|Progressive disease|34|||
164483318|NCT00824408|594140189|FG000|Randomized Phase|Adverse Event|0|||
164483319|NCT00824408|594140190|FG001|Randomized Phase|Adverse Event|0|||
164714473|NCT00673387|594976989|FG006|Overall Study|Withdrawal by Subject|15|||
164714474|NCT00673387|594976990|FG007|Overall Study|Withdrawal by Subject|21|||
164714475|NCT00673387|594976983|FG000|Overall Study|Adverse Event|3|||
164714476|NCT00673387|594976984|FG001|Overall Study|Adverse Event|1|||
164483320|NCT00824408|594140191|FG002|Randomized Phase|Adverse Event|4|||
164483321|NCT00824408|594140192|FG003|Randomized Phase|Adverse Event|5|||
164483322|NCT00824408|594140193|FG004|Randomized Phase|Adverse Event|5|||
164483323|NCT00824408|594140189|FG000|Randomized Phase|Refused to continue medication|0|||
164483324|NCT00824408|594140190|FG001|Randomized Phase|Refused to continue medication|0|||
164483325|NCT00824408|594140191|FG002|Randomized Phase|Refused to continue medication|2|||
164483326|NCT00824408|594140192|FG003|Randomized Phase|Refused to continue medication|2|||
164483327|NCT00824408|594140193|FG004|Randomized Phase|Refused to continue medication|2|||
164483328|NCT00824408|594140189|FG000|Randomized Phase|Other reason not defined above|0|||
164483329|NCT00824408|594140190|FG001|Randomized Phase|Other reason not defined above|0|||
164483330|NCT00824408|594140191|FG002|Randomized Phase|Other reason not defined above|4|||
164483331|NCT00824408|594140192|FG003|Randomized Phase|Other reason not defined above|2|||
164483332|NCT00824408|594140193|FG004|Randomized Phase|Other reason not defined above|4|||
164483333|NCT01915914|594140201|FG000|Acute Phase|Withdrawal by Subject|4|||
164483334|NCT01915914|594140202|FG001|Acute Phase|Withdrawal by Subject|0|||
164483335|NCT01915914|594140203|FG002|Acute Phase|Withdrawal by Subject|0|||
164483336|NCT01915914|594140204|FG003|Acute Phase|Withdrawal by Subject|0|||
164483337|NCT01915914|594140201|FG000|Acute Phase|Lost to Follow-up|4|||
164483338|NCT01915914|594140202|FG001|Acute Phase|Lost to Follow-up|0|||
164483339|NCT01915914|594140203|FG002|Acute Phase|Lost to Follow-up|0|||
164483340|NCT01915914|594140204|FG003|Acute Phase|Lost to Follow-up|0|||
164483341|NCT01915914|594140201|FG000|Acute Phase|Physician Decision|1|||
164483342|NCT01915914|594140202|FG001|Acute Phase|Physician Decision|0|||
164483343|NCT01915914|594140203|FG002|Acute Phase|Physician Decision|0|||
164483344|NCT01915914|594140204|FG003|Acute Phase|Physician Decision|0|||
164483345|NCT01915914|594140201|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
164483346|NCT01915914|594140202|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
164483347|NCT01915914|594140203|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
164483348|NCT01915914|594140204|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
164483349|NCT01915914|594140201|FG000|Acute Phase|"Not Achieved treatment success"|1|||
164483350|NCT01915914|594140202|FG001|Acute Phase|"Not Achieved treatment success"|0|||
164483351|NCT01915914|594140203|FG002|Acute Phase|"Not Achieved treatment success"|0|||
164483352|NCT01915914|594140204|FG003|Acute Phase|"Not Achieved treatment success"|0|||
164483353|NCT01915914|594140201|FG000|Acute Phase|Missing|1|||
164483354|NCT01915914|594140202|FG001|Acute Phase|Missing|0|||
164483355|NCT01915914|594140203|FG002|Acute Phase|Missing|0|||
164483356|NCT01915914|594140204|FG003|Acute Phase|Missing|0|||
164483357|NCT01915914|594140201|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164483358|NCT01915914|594140202|FG001|Maintenance Phase|Withdrawal by Subject|1|||
164483359|NCT01915914|594140203|FG002|Maintenance Phase|Withdrawal by Subject|1|||
164483360|NCT01915914|594140204|FG003|Maintenance Phase|Withdrawal by Subject|0|||
164483361|NCT01915914|594140201|FG000|Maintenance Phase|Lost to Follow-up|0|||
164483362|NCT01915914|594140202|FG001|Maintenance Phase|Lost to Follow-up|4|||
164483363|NCT01915914|594140203|FG002|Maintenance Phase|Lost to Follow-up|1|||
164483364|NCT01915914|594140204|FG003|Maintenance Phase|Lost to Follow-up|0|||
164483365|NCT01915914|594140201|FG000|Maintenance Phase|Missing|0|||
164483366|NCT01915914|594140202|FG001|Maintenance Phase|Missing|1|||
164483367|NCT01915914|594140203|FG002|Maintenance Phase|Missing|0|||
164483368|NCT01915914|594140204|FG003|Maintenance Phase|Missing|0|||
164483369|NCT01915914|594140201|FG000|Follow-up Phase|Withdrawal by Subject|0|||
164483370|NCT01915914|594140202|FG001|Follow-up Phase|Withdrawal by Subject|0|||
164483371|NCT01915914|594140203|FG002|Follow-up Phase|Withdrawal by Subject|0|||
164483372|NCT01915914|594140204|FG003|Follow-up Phase|Withdrawal by Subject|1|||
164483373|NCT01915914|594140201|FG000|Follow-up Phase|Physician Decision|0|||
164483374|NCT01915914|594140202|FG001|Follow-up Phase|Physician Decision|0|||
164483375|NCT01915914|594140203|FG002|Follow-up Phase|Physician Decision|0|||
164483376|NCT01915914|594140204|FG003|Follow-up Phase|Physician Decision|1|||
164483377|NCT00667732|594140205|FG000|Run -In (8 Weeks)|Adverse Event|4|||
164483378|NCT00667732|594140206|FG001|Run -In (8 Weeks)|Adverse Event|0|||
164483379|NCT00667732|594140207|FG002|Run -In (8 Weeks)|Adverse Event|0|||
164483380|NCT00667732|594140205|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
164483381|NCT00667732|594140206|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
164483382|NCT00667732|594140207|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
164483383|NCT00667732|594140205|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
164483384|NCT00667732|594140206|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
164483385|NCT00667732|594140207|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
164483386|NCT04186247|594140212|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
164483387|NCT04186247|594140213|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
164714477|NCT00673387|594976985|FG002|Overall Study|Adverse Event|5|||
164483388|NCT04186247|594140214|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
164483389|NCT04186247|594140215|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
164483390|NCT04186247|594140216|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
164483391|NCT04852978|594140217|FG000|Overall Study|Physician Decision|0|||
164483392|NCT04852978|594140218|FG001|Overall Study|Physician Decision|1|||
164483393|NCT04852978|594140219|FG002|Overall Study|Physician Decision|0|||
164483394|NCT04852978|594140220|FG003|Overall Study|Physician Decision|0|||
164483395|NCT04852978|594140221|FG004|Overall Study|Physician Decision|0|||
164483396|NCT04852978|594140222|FG005|Overall Study|Physician Decision|0|||
164483397|NCT04852978|594140223|FG006|Overall Study|Physician Decision|0|||
164483398|NCT04852978|594140224|FG007|Overall Study|Physician Decision|2|||
164483399|NCT04852978|594140225|FG008|Overall Study|Physician Decision|0|||
164483400|NCT04852978|594140217|FG000|Overall Study|Sponsor request|0|||
164483401|NCT04852978|594140218|FG001|Overall Study|Sponsor request|0|||
164483402|NCT04852978|594140219|FG002|Overall Study|Sponsor request|1|||
164483403|NCT04852978|594140220|FG003|Overall Study|Sponsor request|0|||
164483404|NCT04852978|594140221|FG004|Overall Study|Sponsor request|0|||
164483405|NCT04852978|594140222|FG005|Overall Study|Sponsor request|0|||
164483406|NCT04852978|594140223|FG006|Overall Study|Sponsor request|0|||
164483407|NCT04852978|594140224|FG007|Overall Study|Sponsor request|0|||
164483408|NCT04852978|594140225|FG008|Overall Study|Sponsor request|0|||
164483409|NCT04852978|594140217|FG000|Overall Study|Death|0|||
164483410|NCT04852978|594140218|FG001|Overall Study|Death|0|||
164483411|NCT04852978|594140219|FG002|Overall Study|Death|0|||
164483412|NCT04852978|594140220|FG003|Overall Study|Death|0|||
164483413|NCT04852978|594140221|FG004|Overall Study|Death|0|||
164483414|NCT04852978|594140222|FG005|Overall Study|Death|0|||
164483415|NCT04852978|594140223|FG006|Overall Study|Death|1|||
164483416|NCT04852978|594140224|FG007|Overall Study|Death|0|||
164483417|NCT04852978|594140225|FG008|Overall Study|Death|0|||
164483418|NCT04852978|594140217|FG000|Overall Study|Lost to Follow-up|3|||
164483419|NCT04852978|594140218|FG001|Overall Study|Lost to Follow-up|2|||
164483420|NCT04852978|594140219|FG002|Overall Study|Lost to Follow-up|2|||
164483421|NCT04852978|594140220|FG003|Overall Study|Lost to Follow-up|0|||
164483422|NCT04852978|594140221|FG004|Overall Study|Lost to Follow-up|2|||
164483423|NCT04852978|594140222|FG005|Overall Study|Lost to Follow-up|4|||
164483424|NCT04852978|594140223|FG006|Overall Study|Lost to Follow-up|1|||
164483425|NCT04852978|594140224|FG007|Overall Study|Lost to Follow-up|2|||
164483426|NCT04852978|594140225|FG008|Overall Study|Lost to Follow-up|2|||
164483427|NCT04852978|594140217|FG000|Overall Study|Withdrawal by Subject|4|||
164483428|NCT04852978|594140218|FG001|Overall Study|Withdrawal by Subject|2|||
164483429|NCT04852978|594140219|FG002|Overall Study|Withdrawal by Subject|2|||
164483430|NCT04852978|594140220|FG003|Overall Study|Withdrawal by Subject|1|||
164483431|NCT04852978|594140221|FG004|Overall Study|Withdrawal by Subject|5|||
164483432|NCT04852978|594140222|FG005|Overall Study|Withdrawal by Subject|3|||
164483433|NCT04852978|594140223|FG006|Overall Study|Withdrawal by Subject|2|||
164483434|NCT04852978|594140224|FG007|Overall Study|Withdrawal by Subject|2|||
164483435|NCT04852978|594140225|FG008|Overall Study|Withdrawal by Subject|1|||
164483436|NCT03786471|594140226|FG000|Overall Study|Death|254|||
164483437|NCT03786471|594140227|FG001|Overall Study|Death|223|||
164483438|NCT03786471|594140228|FG002|Overall Study|Death|37|||
164483439|NCT03786471|594140226|FG000|Overall Study|Lost to Follow-up|63|||
164483440|NCT03786471|594140227|FG001|Overall Study|Lost to Follow-up|50|||
164483441|NCT03786471|594140228|FG002|Overall Study|Lost to Follow-up|15|||
164483442|NCT03786471|594140226|FG000|Overall Study|Withdrawal by Subject|99|||
164483443|NCT03786471|594140227|FG001|Overall Study|Withdrawal by Subject|81|||
164483444|NCT03786471|594140228|FG002|Overall Study|Withdrawal by Subject|11|||
164483445|NCT05006703|594141811|FG000|Overall Study|Withdrawal by Subject|1|||
164483446|NCT05006703|594141812|FG001|Overall Study|Withdrawal by Subject|0|||
164483447|NCT05006703|594141811|FG000|Overall Study|Lost to Follow-up|13|||
164483448|NCT05006703|594141812|FG001|Overall Study|Lost to Follow-up|5|||
164483449|NCT01148017|594141815|FG000|Overall Study|Withdrawal by Subject|31|||
164483450|NCT01148017|594141816|FG001|Overall Study|Withdrawal by Subject|14|||
164483451|NCT01148017|594141817|FG002|Overall Study|Withdrawal by Subject|0|||
164483452|NCT01148017|594141818|FG003|Overall Study|Withdrawal by Subject|0|||
164483453|NCT01148017|594141815|FG000|Overall Study|Lost to Follow-up|23|||
164483454|NCT01148017|594141816|FG001|Overall Study|Lost to Follow-up|10|||
164483455|NCT01148017|594141817|FG002|Overall Study|Lost to Follow-up|0|||
164483456|NCT01148017|594141818|FG003|Overall Study|Lost to Follow-up|0|||
164483457|NCT01148017|594141815|FG000|Overall Study|Inappropriate enrollment|1|||
164483458|NCT01148017|594141816|FG001|Overall Study|Inappropriate enrollment|0|||
164483459|NCT01148017|594141817|FG002|Overall Study|Inappropriate enrollment|0|||
164483460|NCT01148017|594141818|FG003|Overall Study|Inappropriate enrollment|0|||
164483461|NCT01148017|594141815|FG000|Overall Study|Administrative reason|22|||
164483462|NCT01148017|594141816|FG001|Overall Study|Administrative reason|9|||
164483463|NCT01148017|594141817|FG002|Overall Study|Administrative reason|0|||
164483464|NCT01148017|594141818|FG003|Overall Study|Administrative reason|0|||
164483465|NCT01148017|594141815|FG000|Overall Study|Unable to classify|3|||
164483466|NCT01148017|594141816|FG001|Overall Study|Unable to classify|1|||
164483467|NCT01148017|594141817|FG002|Overall Study|Unable to classify|0|||
164483468|NCT01148017|594141818|FG003|Overall Study|Unable to classify|0|||
164483469|NCT01019135|594141820|FG000|Overall Study|Did not receive allocated intervention|12|||
164483470|NCT01019135|594141821|FG001|Overall Study|Did not receive allocated intervention|6|||
164483471|NCT01019135|594141822|FG002|Overall Study|Did not receive allocated intervention|25|||
164483472|NCT01019135|594141820|FG000|Overall Study|Did not attend CR|8|||
164483473|NCT01019135|594141821|FG001|Overall Study|Did not attend CR|13|||
164483474|NCT01019135|594141822|FG002|Overall Study|Did not attend CR|6|||
164483475|NCT00486954|594141823|FG000|Pilot Part|Adverse Event|4|||
164483476|NCT00486954|594141824|FG001|Pilot Part|Adverse Event|0|||
164483477|NCT00486954|594141825|FG002|Pilot Part|Adverse Event|5|||
164483478|NCT00486954|594141826|FG003|Pilot Part|Adverse Event|0|||
164483479|NCT00486954|594141827|FG004|Pilot Part|Adverse Event|0|||
164483480|NCT00486954|594141823|FG000|Pilot Part|Disease Progression|2|||
164483481|NCT00486954|594141824|FG001|Pilot Part|Disease Progression|0|||
164483482|NCT00486954|594141825|FG002|Pilot Part|Disease Progression|1|||
164483483|NCT00486954|594141826|FG003|Pilot Part|Disease Progression|0|||
164483484|NCT00486954|594141827|FG004|Pilot Part|Disease Progression|0|||
164483485|NCT00486954|594141823|FG000|Randomized Part|Lost to Follow-up|0|||
164483486|NCT00486954|594141824|FG001|Randomized Part|Lost to Follow-up|0|||
164483487|NCT00486954|594141825|FG002|Randomized Part|Lost to Follow-up|0|||
164483488|NCT00486954|594141826|FG003|Randomized Part|Lost to Follow-up|0|||
164483489|NCT00486954|594141827|FG004|Randomized Part|Lost to Follow-up|1|||
164483490|NCT00486954|594141823|FG000|Randomized Part|Withdrawal by Subject|0|||
164483491|NCT00486954|594141824|FG001|Randomized Part|Withdrawal by Subject|0|||
164483492|NCT00486954|594141825|FG002|Randomized Part|Withdrawal by Subject|0|||
164483493|NCT00486954|594141826|FG003|Randomized Part|Withdrawal by Subject|1|||
164483494|NCT00486954|594141827|FG004|Randomized Part|Withdrawal by Subject|0|||
164483495|NCT00486954|594141823|FG000|Randomized Part|Sponsor Terminated Study|0|||
164483496|NCT00486954|594141824|FG001|Randomized Part|Sponsor Terminated Study|0|||
164483497|NCT00486954|594141825|FG002|Randomized Part|Sponsor Terminated Study|0|||
164483498|NCT00486954|594141826|FG003|Randomized Part|Sponsor Terminated Study|19|||
164483499|NCT00486954|594141827|FG004|Randomized Part|Sponsor Terminated Study|13|||
164483500|NCT05124210|594141828|FG000|Overall Study|Lost to Follow-up|1|||
164483501|NCT05124210|594141829|FG001|Overall Study|Lost to Follow-up|0|||
164483502|NCT05124210|594141828|FG000|Overall Study|Withdrawal by Subject|1|||
164483503|NCT05124210|594141829|FG001|Overall Study|Withdrawal by Subject|0|||
164483504|NCT00638456|594141830|FG000|Overall Study|Withdrawal by Subject|6|||
164483505|NCT00638456|594141831|FG001|Overall Study|Withdrawal by Subject|2|||
164483506|NCT02169414|594141832|FG000|Overall Study|Withdrawal by Subject|1|||
164483507|NCT02169414|594141833|FG001|Overall Study|Withdrawal by Subject|0|||
164483508|NCT02169414|594141834|FG002|Overall Study|Withdrawal by Subject|0|||
164483509|NCT02169414|594141835|FG003|Overall Study|Withdrawal by Subject|0|||
164483510|NCT02169414|594141832|FG000|Overall Study|Adverse Event|0|||
164483511|NCT02169414|594141833|FG001|Overall Study|Adverse Event|1|||
164483512|NCT02169414|594141834|FG002|Overall Study|Adverse Event|0|||
164483513|NCT02169414|594141835|FG003|Overall Study|Adverse Event|0|||
164483514|NCT02753075|594141836|FG000|Overall Study|Adverse Event|2|||
164483515|NCT02753075|594141837|FG001|Overall Study|Adverse Event|1|||
164483516|NCT02753075|594141838|FG002|Overall Study|Adverse Event|0|||
164483517|NCT02753075|594141836|FG000|Overall Study|Lost to Follow-up|2|||
164483518|NCT02753075|594141837|FG001|Overall Study|Lost to Follow-up|0|||
164483519|NCT02753075|594141838|FG002|Overall Study|Lost to Follow-up|0|||
164483520|NCT02753075|594141836|FG000|Overall Study|Withdrawal of Consent|1|||
164483521|NCT02753075|594141837|FG001|Overall Study|Withdrawal of Consent|1|||
164483522|NCT02753075|594141838|FG002|Overall Study|Withdrawal of Consent|3|||
164483523|NCT02753075|594141836|FG000|Overall Study|Physician Decision|3|||
164483524|NCT02753075|594141837|FG001|Overall Study|Physician Decision|1|||
164483525|NCT02753075|594141838|FG002|Overall Study|Physician Decision|0|||
164483526|NCT02784834|594141839|FG000|Overall Study|Lack of Efficacy|1|||
164483527|NCT02143713|594141840|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
164483528|NCT02143713|594141841|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
164483529|NCT02143713|594141842|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
164483530|NCT02143713|594141843|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
164483531|NCT02143713|594141840|FG000|Treatment Period (6 Months)|Adverse Event|7|||
164483532|NCT02143713|594141841|FG001|Treatment Period (6 Months)|Adverse Event|8|||
164483533|NCT02143713|594141842|FG002|Treatment Period (6 Months)|Adverse Event|8|||
164483534|NCT02143713|594141843|FG003|Treatment Period (6 Months)|Adverse Event|9|||
164483535|NCT02143713|594141840|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
164483536|NCT02143713|594141841|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
164483537|NCT02143713|594141842|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
164483538|NCT02143713|594141843|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
164483539|NCT02143713|594141840|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
164483540|NCT02143713|594141841|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
164483541|NCT02143713|594141842|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
164483542|NCT02143713|594141843|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
164483543|NCT02143713|594141840|FG000|Treatment Period (6 Months)|Pregnancy|0|||
164483544|NCT02143713|594141841|FG001|Treatment Period (6 Months)|Pregnancy|2|||
164483545|NCT02143713|594141842|FG002|Treatment Period (6 Months)|Pregnancy|2|||
164483546|NCT02143713|594141843|FG003|Treatment Period (6 Months)|Pregnancy|0|||
164483547|NCT02143713|594141840|FG000|Treatment Period (6 Months)|Non-compliance|1|||
164483548|NCT02143713|594141841|FG001|Treatment Period (6 Months)|Non-compliance|0|||
164483549|NCT02143713|594141842|FG002|Treatment Period (6 Months)|Non-compliance|0|||
164483550|NCT02143713|594141843|FG003|Treatment Period (6 Months)|Non-compliance|3|||
164483551|NCT02143713|594141840|FG000|Treatment Period (6 Months)|Other|3|||
164483552|NCT02143713|594141841|FG001|Treatment Period (6 Months)|Other|0|||
164483553|NCT02143713|594141842|FG002|Treatment Period (6 Months)|Other|3|||
164483554|NCT02143713|594141843|FG003|Treatment Period (6 Months)|Other|2|||
164483555|NCT02143713|594141840|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
164483556|NCT02143713|594141841|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
164483557|NCT02143713|594141842|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
164483558|NCT02143713|594141843|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
164483559|NCT02143713|594141840|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
164483560|NCT02143713|594141841|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
164483561|NCT02143713|594141842|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
164483562|NCT02143713|594141843|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
164483563|NCT02143713|594141840|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
164483564|NCT02143713|594141841|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
164483565|NCT02143713|594141842|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
164483566|NCT02143713|594141843|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
164483567|NCT02143713|594141840|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
164483568|NCT02143713|594141841|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
164483569|NCT02143713|594141842|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
164483570|NCT02143713|594141843|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
164483571|NCT02143713|594141840|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
164483572|NCT02143713|594141841|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
164483573|NCT02143713|594141842|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
164483574|NCT02143713|594141843|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
164483575|NCT02143713|594141840|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
164483576|NCT02143713|594141841|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
164483577|NCT02143713|594141842|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
164483578|NCT02143713|594141843|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
164483579|NCT02143713|594141840|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
164483580|NCT02143713|594141841|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
164483581|NCT02143713|594141842|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
164483582|NCT02143713|594141843|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
164483583|NCT02143713|594141840|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
164483584|NCT02143713|594141841|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
164483585|NCT02143713|594141842|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
164483586|NCT02143713|594141843|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
164483587|NCT02143713|594141840|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
164483588|NCT02143713|594141841|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
164601342|NCT00479557|594559928|FG000|Overall Study|Lack of Efficacy|1|||
164601343|NCT00479557|594559929|FG001|Overall Study|Lack of Efficacy|0|||
164483589|NCT02143713|594141842|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
164483590|NCT02143713|594141843|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
164483591|NCT01999335|594141844|FG000|Overall Study|Discontinued before receiving treatment|0|||
164483592|NCT01999335|594141845|FG001|Overall Study|Discontinued before receiving treatment|0|||
164483593|NCT01999335|594141846|FG002|Overall Study|Discontinued before receiving treatment|0|||
164483594|NCT01999335|594141847|FG003|Overall Study|Discontinued before receiving treatment|0|||
164483595|NCT01999335|594141848|FG004|Overall Study|Discontinued before receiving treatment|2|||
164483596|NCT01215253|594141849|FG000|Overall Study|Withdrawal by Subject|57|||
164483597|NCT01215253|594141850|FG001|Overall Study|Withdrawal by Subject|35|||
164483598|NCT01215253|594141849|FG000|Overall Study|Physician Decision|9|||
164483599|NCT01215253|594141850|FG001|Overall Study|Physician Decision|12|||
164483600|NCT01215253|594141849|FG000|Overall Study|Lost to Follow-up|6|||
164483601|NCT01215253|594141850|FG001|Overall Study|Lost to Follow-up|4|||
164483602|NCT01215253|594141849|FG000|Overall Study|Other|14|||
164483603|NCT01215253|594141850|FG001|Overall Study|Other|12|||
164483604|NCT00080119|594141851|FG000|Overall Study|Discontinued because of study closure|0|||
164483605|NCT00080119|594141852|FG001|Overall Study|Discontinued because of study closure|0|||
164483606|NCT00080119|594141853|FG002|Overall Study|Discontinued because of study closure|130|||
164483607|NCT00080119|594141854|FG003|Overall Study|Discontinued because of study closure|141|||
164483608|NCT00080119|594141851|FG000|Overall Study|Unable to get to clinic|24|||
164483609|NCT00080119|594141852|FG001|Overall Study|Unable to get to clinic|24|||
164483610|NCT00080119|594141853|FG002|Overall Study|Unable to get to clinic|7|||
164483611|NCT00080119|594141854|FG003|Overall Study|Unable to get to clinic|1|||
164483612|NCT00080119|594141851|FG000|Overall Study|Consent withdrawn|13|||
164483613|NCT00080119|594141852|FG001|Overall Study|Consent withdrawn|17|||
164483614|NCT00080119|594141853|FG002|Overall Study|Consent withdrawn|4|||
164483615|NCT00080119|594141854|FG003|Overall Study|Consent withdrawn|6|||
164483616|NCT00080119|594141851|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
164483617|NCT00080119|594141852|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
164483618|NCT00080119|594141853|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
164483619|NCT00080119|594141854|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
164483620|NCT00080119|594141851|FG000|Overall Study|Lost to Follow-up|16|||
164483621|NCT00080119|594141852|FG001|Overall Study|Lost to Follow-up|19|||
164483622|NCT00080119|594141853|FG002|Overall Study|Lost to Follow-up|19|||
164483623|NCT00080119|594141854|FG003|Overall Study|Lost to Follow-up|14|||
164483624|NCT02988713|594141866|FG000|Overall Study|Withdrawal by Subject|1|||
164483625|NCT02988713|594141866|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
164483626|NCT02404441|594141867|FG000|Phase 1 Part|Adverse Event|1|||
164483627|NCT02404441|594141868|FG001|Phase 1 Part|Adverse Event|0|||
164483628|NCT02404441|594141869|FG002|Phase 1 Part|Adverse Event|0|||
164483629|NCT02404441|594141870|FG003|Phase 1 Part|Adverse Event|0|||
164483630|NCT02404441|594141871|FG004|Phase 1 Part|Adverse Event|0|||
164483631|NCT02404441|594141872|FG005|Phase 1 Part|Adverse Event|0|||
164483632|NCT02404441|594141873|FG006|Phase 1 Part|Adverse Event|0|||
164483633|NCT02404441|594141874|FG007|Phase 1 Part|Adverse Event|0|||
164483634|NCT02404441|594141875|FG008|Phase 1 Part|Adverse Event|0|||
164483635|NCT02404441|594141876|FG009|Phase 1 Part|Adverse Event|0|||
164483636|NCT02404441|594141867|FG000|Phase 1 Part|Physician Decision|0|||
164483637|NCT02404441|594141868|FG001|Phase 1 Part|Physician Decision|1|||
164483638|NCT02404441|594141869|FG002|Phase 1 Part|Physician Decision|0|||
164483639|NCT02404441|594141870|FG003|Phase 1 Part|Physician Decision|0|||
164483640|NCT02404441|594141871|FG004|Phase 1 Part|Physician Decision|0|||
164483641|NCT02404441|594141872|FG005|Phase 1 Part|Physician Decision|0|||
164483642|NCT02404441|594141873|FG006|Phase 1 Part|Physician Decision|0|||
164483643|NCT02404441|594141874|FG007|Phase 1 Part|Physician Decision|0|||
164483644|NCT02404441|594141875|FG008|Phase 1 Part|Physician Decision|0|||
164483645|NCT02404441|594141876|FG009|Phase 1 Part|Physician Decision|0|||
164483646|NCT02404441|594141867|FG000|Phase 1 Part|Progressive Disease|14|||
164483647|NCT02404441|594141868|FG001|Phase 1 Part|Progressive Disease|11|||
164483648|NCT02404441|594141869|FG002|Phase 1 Part|Progressive Disease|7|||
164483649|NCT02404441|594141870|FG003|Phase 1 Part|Progressive Disease|6|||
164483650|NCT02404441|594141871|FG004|Phase 1 Part|Progressive Disease|9|||
164483651|NCT02404441|594141872|FG005|Phase 1 Part|Progressive Disease|0|||
164483652|NCT02404441|594141873|FG006|Phase 1 Part|Progressive Disease|0|||
164483653|NCT02404441|594141874|FG007|Phase 1 Part|Progressive Disease|0|||
164483654|NCT02404441|594141875|FG008|Phase 1 Part|Progressive Disease|0|||
164483655|NCT02404441|594141876|FG009|Phase 1 Part|Progressive Disease|0|||
164483656|NCT02404441|594141867|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
164483657|NCT02404441|594141868|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
164483658|NCT02404441|594141869|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
164483659|NCT02404441|594141870|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
164483660|NCT02404441|594141871|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
164483661|NCT02404441|594141872|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
164483662|NCT02404441|594141873|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
164483663|NCT02404441|594141874|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
164483664|NCT02404441|594141875|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
164483665|NCT02404441|594141876|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
164483666|NCT02404441|594141867|FG000|Phase 1 Part|Death|1|||
164483667|NCT02404441|594141868|FG001|Phase 1 Part|Death|1|||
164483668|NCT02404441|594141869|FG002|Phase 1 Part|Death|1|||
164483669|NCT02404441|594141870|FG003|Phase 1 Part|Death|0|||
164483670|NCT02404441|594141871|FG004|Phase 1 Part|Death|1|||
164483671|NCT02404441|594141872|FG005|Phase 1 Part|Death|0|||
164483672|NCT02404441|594141873|FG006|Phase 1 Part|Death|0|||
164483673|NCT02404441|594141874|FG007|Phase 1 Part|Death|0|||
164483674|NCT02404441|594141875|FG008|Phase 1 Part|Death|0|||
164483675|NCT02404441|594141876|FG009|Phase 1 Part|Death|0|||
164483676|NCT02404441|594141867|FG000|Phase 2 Part|Adverse Event|0|||
164483677|NCT02404441|594141868|FG001|Phase 2 Part|Adverse Event|0|||
164483678|NCT02404441|594141869|FG002|Phase 2 Part|Adverse Event|0|||
164483679|NCT02404441|594141870|FG003|Phase 2 Part|Adverse Event|0|||
164483680|NCT02404441|594141871|FG004|Phase 2 Part|Adverse Event|0|||
164483681|NCT02404441|594141872|FG005|Phase 2 Part|Adverse Event|2|||
164483682|NCT02404441|594141873|FG006|Phase 2 Part|Adverse Event|3|||
164483683|NCT02404441|594141874|FG007|Phase 2 Part|Adverse Event|3|||
164483684|NCT02404441|594141875|FG008|Phase 2 Part|Adverse Event|6|||
164483685|NCT02404441|594141876|FG009|Phase 2 Part|Adverse Event|1|||
164483686|NCT02404441|594141867|FG000|Phase 2 Part|Physician Decision|0|||
164483687|NCT02404441|594141868|FG001|Phase 2 Part|Physician Decision|0|||
164483688|NCT02404441|594141869|FG002|Phase 2 Part|Physician Decision|0|||
164483689|NCT02404441|594141870|FG003|Phase 2 Part|Physician Decision|0|||
164483690|NCT02404441|594141871|FG004|Phase 2 Part|Physician Decision|0|||
164483691|NCT02404441|594141872|FG005|Phase 2 Part|Physician Decision|7|||
164483692|NCT02404441|594141873|FG006|Phase 2 Part|Physician Decision|9|||
164483693|NCT02404441|594141874|FG007|Phase 2 Part|Physician Decision|2|||
164483694|NCT02404441|594141875|FG008|Phase 2 Part|Physician Decision|1|||
164483695|NCT02404441|594141876|FG009|Phase 2 Part|Physician Decision|3|||
164483696|NCT02404441|594141867|FG000|Phase 2 Part|Progressive disease|0|||
164483697|NCT02404441|594141868|FG001|Phase 2 Part|Progressive disease|0|||
164483698|NCT02404441|594141869|FG002|Phase 2 Part|Progressive disease|0|||
164483699|NCT02404441|594141870|FG003|Phase 2 Part|Progressive disease|0|||
164483700|NCT02404441|594141871|FG004|Phase 2 Part|Progressive disease|0|||
164483701|NCT02404441|594141872|FG005|Phase 2 Part|Progressive disease|43|||
164483702|NCT02404441|594141873|FG006|Phase 2 Part|Progressive disease|32|||
164483703|NCT02404441|594141874|FG007|Phase 2 Part|Progressive disease|31|||
164483704|NCT02404441|594141875|FG008|Phase 2 Part|Progressive disease|39|||
164483705|NCT02404441|594141876|FG009|Phase 2 Part|Progressive disease|27|||
164483706|NCT02404441|594141867|FG000|Phase 2 Part|Subject/guardian decision|0|||
164483707|NCT02404441|594141868|FG001|Phase 2 Part|Subject/guardian decision|0|||
164483708|NCT02404441|594141869|FG002|Phase 2 Part|Subject/guardian decision|0|||
164483709|NCT02404441|594141870|FG003|Phase 2 Part|Subject/guardian decision|0|||
164483710|NCT02404441|594141871|FG004|Phase 2 Part|Subject/guardian decision|0|||
164483711|NCT02404441|594141872|FG005|Phase 2 Part|Subject/guardian decision|3|||
164483712|NCT02404441|594141873|FG006|Phase 2 Part|Subject/guardian decision|9|||
164483713|NCT02404441|594141874|FG007|Phase 2 Part|Subject/guardian decision|0|||
164483714|NCT02404441|594141875|FG008|Phase 2 Part|Subject/guardian decision|3|||
164483715|NCT02404441|594141876|FG009|Phase 2 Part|Subject/guardian decision|2|||
164483716|NCT02404441|594141867|FG000|Phase 2 Part|Death|0|||
164483717|NCT02404441|594141868|FG001|Phase 2 Part|Death|0|||
164483718|NCT02404441|594141869|FG002|Phase 2 Part|Death|0|||
164483719|NCT02404441|594141870|FG003|Phase 2 Part|Death|0|||
164483720|NCT02404441|594141871|FG004|Phase 2 Part|Death|0|||
164483721|NCT02404441|594141872|FG005|Phase 2 Part|Death|4|||
164483722|NCT02404441|594141873|FG006|Phase 2 Part|Death|8|||
164483723|NCT02404441|594141874|FG007|Phase 2 Part|Death|4|||
164483724|NCT02404441|594141875|FG008|Phase 2 Part|Death|10|||
164483725|NCT02404441|594141876|FG009|Phase 2 Part|Death|9|||
164483726|NCT03200574|594141892|FG000|Overall Study|Death|4|||
164483727|NCT03200574|594141892|FG000|Overall Study|Withdrawal by Subject|8|||
164483728|NCT03200574|594141892|FG000|Overall Study|Long-Term need for anticoagulation|1|||
164483729|NCT03200574|594141892|FG000|Overall Study|Relocation|2|||
164483730|NCT03200574|594141892|FG000|Overall Study|Lost to Follow-up|2|||
164483731|NCT00705159|594141896|FG000|Overall Study|Withdrawal by Subject|0|||
164483732|NCT00705159|594141897|FG001|Overall Study|Withdrawal by Subject|1|||
164483733|NCT00705159|594141898|FG002|Overall Study|Withdrawal by Subject|1|||
164483734|NCT00705159|594141899|FG003|Overall Study|Withdrawal by Subject|1|||
164483735|NCT00705159|594141896|FG000|Overall Study|Protocol Violation|0|||
164483736|NCT00705159|594141897|FG001|Overall Study|Protocol Violation|1|||
164483737|NCT00705159|594141898|FG002|Overall Study|Protocol Violation|0|||
164483738|NCT00705159|594141899|FG003|Overall Study|Protocol Violation|0|||
164483739|NCT00705159|594141896|FG000|Overall Study|Adverse Event|0|||
164483740|NCT00705159|594141897|FG001|Overall Study|Adverse Event|0|||
164483741|NCT00705159|594141898|FG002|Overall Study|Adverse Event|1|||
164483742|NCT00705159|594141899|FG003|Overall Study|Adverse Event|0|||
164483743|NCT00705159|594141896|FG000|Overall Study|Lost to Follow-up|0|||
164483744|NCT00705159|594141897|FG001|Overall Study|Lost to Follow-up|0|||
164483745|NCT00705159|594141898|FG002|Overall Study|Lost to Follow-up|3|||
164483746|NCT00705159|594141899|FG003|Overall Study|Lost to Follow-up|2|||
164483747|NCT00705159|594141896|FG000|Overall Study|Screen Failure|0|||
164483748|NCT00705159|594141897|FG001|Overall Study|Screen Failure|0|||
164483749|NCT00705159|594141898|FG002|Overall Study|Screen Failure|0|||
164483750|NCT00705159|594141899|FG003|Overall Study|Screen Failure|1|||
164483751|NCT03026166|594141900|FG000|Overall Study|Death|22|||
164483752|NCT03026166|594141901|FG001|Overall Study|Death|7|||
164483753|NCT03026166|594141900|FG000|Overall Study|Physician Decision|2|||
164483754|NCT03026166|594141901|FG001|Overall Study|Physician Decision|0|||
164483755|NCT03026166|594141900|FG000|Overall Study|Withdrawal by Subject|1|||
164483756|NCT03026166|594141901|FG001|Overall Study|Withdrawal by Subject|2|||
164483757|NCT03026166|594141900|FG000|Overall Study|Lost to Follow-up|1|||
164483758|NCT03026166|594141901|FG001|Overall Study|Lost to Follow-up|0|||
164483759|NCT03026166|594141900|FG000|Overall Study|Study Terminated by Sponsor|3|||
164483760|NCT03026166|594141901|FG001|Overall Study|Study Terminated by Sponsor|3|||
164483761|NCT03026166|594141900|FG000|Overall Study|Other|1|||
164483762|NCT03026166|594141901|FG001|Overall Study|Other|0|||
164483763|NCT02102724|594141906|FG000|Overall Study|Lost to Follow-up|1|||
164483764|NCT02102724|594141907|FG001|Overall Study|Lost to Follow-up|0|||
164483765|NCT02102724|594141906|FG000|Overall Study|surgery for brain aneurysm|1|||
164483766|NCT02102724|594141907|FG001|Overall Study|surgery for brain aneurysm|1|||
164483767|NCT04821271|594141908|FG000|Period 1|Withdrawal by Subject|2|||
164483768|NCT04821271|594141909|FG001|Period 1|Withdrawal by Subject|0|||
164483769|NCT02521493|594141912|FG000|Overall Study|Death|3|||
164483770|NCT02521493|594141913|FG001|Overall Study|Death|4|||
164483771|NCT02521493|594141914|FG002|Overall Study|Death|1|||
164483772|NCT02521493|594141912|FG000|Overall Study|Physician Decision|19|||
164483773|NCT02521493|594141913|FG001|Overall Study|Physician Decision|1|||
164483774|NCT02521493|594141914|FG002|Overall Study|Physician Decision|2|||
164483775|NCT02521493|594141912|FG000|Overall Study|Withdrawal by Subject|3|||
164483776|NCT02521493|594141913|FG001|Overall Study|Withdrawal by Subject|0|||
164483777|NCT02521493|594141914|FG002|Overall Study|Withdrawal by Subject|0|||
164483778|NCT02521493|594141912|FG000|Overall Study|Ineligible|0|||
164483779|NCT02521493|594141913|FG001|Overall Study|Ineligible|1|||
164483780|NCT02521493|594141914|FG002|Overall Study|Ineligible|0|||
164483781|NCT02521493|594141912|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
164483782|NCT02521493|594141913|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
164483783|NCT02521493|594141914|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
164483784|NCT02521493|594141912|FG000|Overall Study|No MRD result|0|||
164483785|NCT02521493|594141913|FG001|Overall Study|No MRD result|0|||
164483786|NCT02521493|594141914|FG002|Overall Study|No MRD result|4|||
164483787|NCT02008916|594141915|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
164483788|NCT02008916|594141916|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
164483789|NCT02008916|594141917|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
164483790|NCT02008916|594141915|FG000|Week 16 - 156|Adverse Event|4|||
164483791|NCT02008916|594141916|FG001|Week 16 - 156|Adverse Event|2|||
164483792|NCT02008916|594141917|FG002|Week 16 - 156|Adverse Event|3|||
164483793|NCT02008916|594141915|FG000|Week 16 - 156|Withdrawal by Subject|7|||
164483794|NCT02008916|594141916|FG001|Week 16 - 156|Withdrawal by Subject|3|||
164483795|NCT02008916|594141917|FG002|Week 16 - 156|Withdrawal by Subject|5|||
164483796|NCT02008916|594141915|FG000|Week 16 - 156|No longer requires treatment|0|||
164483797|NCT02008916|594141916|FG001|Week 16 - 156|No longer requires treatment|1|||
164483798|NCT02008916|594141917|FG002|Week 16 - 156|No longer requires treatment|0|||
164483799|NCT02008916|594141915|FG000|Week 16 - 156|Lost to Follow-up|5|||
164601344|NCT00479557|594559930|FG002|Overall Study|Lack of Efficacy|0|||
164601345|NCT00479557|594559931|FG003|Overall Study|Lack of Efficacy|0|||
164601346|NCT00479557|594559932|FG004|Overall Study|Lack of Efficacy|0|||
164601347|NCT00479557|594559933|FG005|Overall Study|Lack of Efficacy|0|||
164601348|NCT00479557|594559934|FG006|Overall Study|Lack of Efficacy|0|||
164601349|NCT00479557|594559928|FG000|Overall Study|Lost to Follow-up|0|||
164483800|NCT02008916|594141916|FG001|Week 16 - 156|Lost to Follow-up|0|||
164483801|NCT02008916|594141917|FG002|Week 16 - 156|Lost to Follow-up|0|||
164483802|NCT02008916|594141915|FG000|Week 16 - 156|Lack of Efficacy|3|||
164483803|NCT02008916|594141916|FG001|Week 16 - 156|Lack of Efficacy|5|||
164483804|NCT02008916|594141917|FG002|Week 16 - 156|Lack of Efficacy|2|||
164483805|NCT02008916|594141915|FG000|Week 16 - 156|Pregnancy|0|||
164483806|NCT02008916|594141916|FG001|Week 16 - 156|Pregnancy|1|||
164483807|NCT02008916|594141917|FG002|Week 16 - 156|Pregnancy|0|||
164483808|NCT02008916|594141915|FG000|Week 16 - 156|Physician Decision|0|||
164483809|NCT02008916|594141916|FG001|Week 16 - 156|Physician Decision|1|||
164483810|NCT02008916|594141917|FG002|Week 16 - 156|Physician Decision|0|||
164483811|NCT01880736|594141918|FG000|Overall Study|Adverse Event|0|||
164483812|NCT01880736|594141919|FG001|Overall Study|Adverse Event|0|||
164483813|NCT01880736|594141920|FG002|Overall Study|Adverse Event|0|||
164483814|NCT01880736|594141921|FG003|Overall Study|Adverse Event|1|||
164601350|NCT00479557|594559929|FG001|Overall Study|Lost to Follow-up|2|||
164483815|NCT01880736|594141918|FG000|Overall Study|Withdrawal Criteria|1|||
164483816|NCT01880736|594141919|FG001|Overall Study|Withdrawal Criteria|2|||
164483817|NCT01880736|594141920|FG002|Overall Study|Withdrawal Criteria|1|||
164483818|NCT01880736|594141921|FG003|Overall Study|Withdrawal Criteria|5|||
164483819|NCT00266656|594141922|FG000|Overall Study|Death|1|||
164483820|NCT00266656|594141923|FG001|Overall Study|Death|0|||
164483821|NCT00266656|594141922|FG000|Overall Study|Lost to Follow-up|4|||
164483822|NCT00266656|594141923|FG001|Overall Study|Lost to Follow-up|1|||
164483823|NCT00266656|594141922|FG000|Overall Study|Withdrawal by Subject|4|||
164483824|NCT00266656|594141923|FG001|Overall Study|Withdrawal by Subject|2|||
164483825|NCT00266656|594141922|FG000|Overall Study|Did Not Reach Final Height|4|||
164483826|NCT00266656|594141923|FG001|Overall Study|Did Not Reach Final Height|8|||
164483827|NCT00266656|594141922|FG000|Overall Study|Parent/Caregiver Decision|1|||
164483828|NCT00266656|594141923|FG001|Overall Study|Parent/Caregiver Decision|2|||
164483829|NCT00428714|594141928|FG000|Overall Study|Progressive Disease|28|||
164483830|NCT00428714|594141929|FG001|Overall Study|Progressive Disease|36|||
164483831|NCT00428714|594141928|FG000|Overall Study|Withdrawal by Subject|0|||
164483832|NCT00428714|594141929|FG001|Overall Study|Withdrawal by Subject|3|||
164483833|NCT00428714|594141928|FG000|Overall Study|Adverse Event|0|||
164483834|NCT00428714|594141929|FG001|Overall Study|Adverse Event|2|||
164483835|NCT00428714|594141928|FG000|Overall Study|Physician Decision|1|||
164483836|NCT00428714|594141929|FG001|Overall Study|Physician Decision|1|||
164483837|NCT00428714|594141928|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
164483838|NCT00428714|594141929|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
164483839|NCT00428714|594141928|FG000|Overall Study|Death due to other then PD|1|||
164483840|NCT00428714|594141929|FG001|Overall Study|Death due to other then PD|0|||
164483841|NCT00513071|594141931|FG000|Overall Study|Adverse Event|1|||
164483842|NCT00513071|594141931|FG000|Overall Study|Withdrawal by Subject|1|||
164483843|NCT00513071|594141931|FG000|Overall Study|Physician Decision|3|||
164483844|NCT02106325|594141935|FG000|Phase 1|Lost to Follow-up|2|||
164483845|NCT02106325|594141936|FG001|Phase 1|Lost to Follow-up|2|||
164714478|NCT00673387|594976986|FG003|Overall Study|Adverse Event|2|||
164714479|NCT00673387|594976987|FG004|Overall Study|Adverse Event|6|||
164714480|NCT00673387|594976988|FG005|Overall Study|Adverse Event|2|||
164714481|NCT00673387|594976989|FG006|Overall Study|Adverse Event|5|||
164714482|NCT00673387|594976990|FG007|Overall Study|Adverse Event|5|||
164483846|NCT02106325|594141935|FG000|Phase 2|Lost to Follow-up|2|||
164483847|NCT02106325|594141936|FG001|Phase 2|Lost to Follow-up|3|||
164483848|NCT02106325|594141935|FG000|Phase 3|Lost to Follow-up|2|||
164483849|NCT02106325|594141936|FG001|Phase 3|Lost to Follow-up|1|||
164483850|NCT00452114|594141938|FG000|Overall Study|Physician Decision|3|||
164483851|NCT00452114|594141939|FG001|Overall Study|Physician Decision|3|||
164483852|NCT03242863|594141940|FG000|Study Week 1|Withdrawal by Subject|0|||
164483853|NCT03242863|594141941|FG001|Study Week 1|Withdrawal by Subject|1|||
164483854|NCT03242863|594141942|FG002|Study Week 1|Withdrawal by Subject|0|||
164483855|NCT03242863|594141943|FG003|Study Week 1|Withdrawal by Subject|0|||
164483856|NCT03242863|594141944|FG004|Study Week 1|Withdrawal by Subject|3|||
164483857|NCT03242863|594141945|FG005|Study Week 1|Withdrawal by Subject|0|||
164483858|NCT04602728|594141950|FG000|Overall Study|Lost to Follow-up|4|||
164483859|NCT04602728|594141951|FG001|Overall Study|Lost to Follow-up|4|||
164483860|NCT05338476|594141957|FG000|Period 2|Adverse Event|0|||
164714483|NCT00673387|594976983|FG000|Overall Study|Physician Decision|0|||
164714484|NCT00673387|594976984|FG001|Overall Study|Physician Decision|0|||
164714485|NCT00673387|594976985|FG002|Overall Study|Physician Decision|0|||
164714486|NCT00673387|594976986|FG003|Overall Study|Physician Decision|0|||
164714487|NCT00673387|594976987|FG004|Overall Study|Physician Decision|0|||
164714488|NCT00673387|594976988|FG005|Overall Study|Physician Decision|5|||
164714489|NCT00673387|594976989|FG006|Overall Study|Physician Decision|1|||
164714490|NCT00673387|594976990|FG007|Overall Study|Physician Decision|1|||
164714491|NCT00673387|594976983|FG000|Overall Study|Protocol Violation|3|||
164714492|NCT00673387|594976984|FG001|Overall Study|Protocol Violation|0|||
164714493|NCT00673387|594976985|FG002|Overall Study|Protocol Violation|1|||
164714494|NCT00673387|594976986|FG003|Overall Study|Protocol Violation|2|||
164714495|NCT00673387|594976987|FG004|Overall Study|Protocol Violation|0|||
164714496|NCT00673387|594976988|FG005|Overall Study|Protocol Violation|1|||
164714497|NCT00673387|594976989|FG006|Overall Study|Protocol Violation|1|||
164714498|NCT00673387|594976990|FG007|Overall Study|Protocol Violation|3|||
164714499|NCT00673387|594976983|FG000|Overall Study|Lost to Follow-up|8|||
164714500|NCT00673387|594976984|FG001|Overall Study|Lost to Follow-up|6|||
164483861|NCT05338476|594141958|FG001|Period 2|Adverse Event|1|||
164483862|NCT00747149|594143125|FG000|Overall Study|Adverse Event|0|||
164483863|NCT00747149|594143126|FG001|Overall Study|Adverse Event|15|||
164483864|NCT00747149|594143125|FG000|Overall Study|Lost to Follow-up|0|||
164483865|NCT00747149|594143126|FG001|Overall Study|Lost to Follow-up|10|||
164483866|NCT00747149|594143125|FG000|Overall Study|Withdrawal by Subject|0|||
164483867|NCT00747149|594143126|FG001|Overall Study|Withdrawal by Subject|6|||
164483868|NCT00747149|594143125|FG000|Overall Study|Did not receive treatment|0|||
164483869|NCT00747149|594143126|FG001|Overall Study|Did not receive treatment|1|||
164483870|NCT00747149|594143125|FG000|Overall Study|Incorrect enrollment|0|||
164483871|NCT00747149|594143126|FG001|Overall Study|Incorrect enrollment|6|||
164601351|NCT00479557|594559930|FG002|Overall Study|Lost to Follow-up|0|||
164714501|NCT00673387|594976985|FG002|Overall Study|Lost to Follow-up|5|||
164714502|NCT00673387|594976986|FG003|Overall Study|Lost to Follow-up|6|||
164714503|NCT00673387|594976987|FG004|Overall Study|Lost to Follow-up|6|||
164714504|NCT00673387|594976988|FG005|Overall Study|Lost to Follow-up|5|||
164483872|NCT00747149|594143125|FG000|Overall Study|Severe non-compliance to protocol|0|||
164483873|NCT00747149|594143126|FG001|Overall Study|Severe non-compliance to protocol|1|||
164483874|NCT00747149|594143125|FG000|Overall Study|Not reported|1|||
164483875|NCT00747149|594143126|FG001|Overall Study|Not reported|4|||
164483876|NCT03141177|594143129|FG000|Overall Study|Death|62|||
164483877|NCT03141177|594143130|FG001|Overall Study|Death|13|||
164483878|NCT03141177|594143131|FG002|Overall Study|Death|84|||
164483879|NCT03141177|594143129|FG000|Overall Study|Participant withdrew consent|9|||
164483880|NCT03141177|594143130|FG001|Overall Study|Participant withdrew consent|2|||
164483881|NCT03141177|594143131|FG002|Overall Study|Participant withdrew consent|13|||
164483882|NCT03141177|594143129|FG000|Overall Study|Not reported|1|||
164483883|NCT03141177|594143130|FG001|Overall Study|Not reported|0|||
164483884|NCT03141177|594143131|FG002|Overall Study|Not reported|1|||
164483885|NCT03141177|594143129|FG000|Overall Study|Lost to Follow-up|2|||
164483886|NCT03141177|594143130|FG001|Overall Study|Lost to Follow-up|1|||
164483887|NCT03141177|594143131|FG002|Overall Study|Lost to Follow-up|1|||
164483888|NCT03141177|594143129|FG000|Overall Study|Other reasons|4|||
164483889|NCT03141177|594143130|FG001|Overall Study|Other reasons|0|||
164483890|NCT03141177|594143131|FG002|Overall Study|Other reasons|11|||
164483891|NCT03141177|594143129|FG000|Overall Study|Participants did not start treatment period|3|||
164483892|NCT03141177|594143130|FG001|Overall Study|Participants did not start treatment period|0|||
164483893|NCT03141177|594143131|FG002|Overall Study|Participants did not start treatment period|8|||
164483894|NCT03924193|594143132|FG000|Overall Study|Adverse Event|10|||
164483895|NCT03924193|594143133|FG001|Overall Study|Adverse Event|0|||
164483896|NCT03924193|594143134|FG002|Overall Study|Adverse Event|10|||
164483897|NCT03924193|594143132|FG000|Overall Study|Withdrawal by Subject|5|||
164483898|NCT03924193|594143133|FG001|Overall Study|Withdrawal by Subject|10|||
164483899|NCT03924193|594143134|FG002|Overall Study|Withdrawal by Subject|2|||
164483900|NCT02489799|594143135|FG000|Overall Study|Lost to Follow-up|4|||
164483901|NCT02489799|594143136|FG001|Overall Study|Lost to Follow-up|1|||
164483902|NCT02489799|594143135|FG000|Overall Study|Failure to Maintain Eligibility|4|||
164483903|NCT02489799|594143136|FG001|Overall Study|Failure to Maintain Eligibility|6|||
164483904|NCT02489799|594143135|FG000|Overall Study|Withdrawal by Subject|1|||
164483905|NCT02489799|594143136|FG001|Overall Study|Withdrawal by Subject|1|||
164483906|NCT02489799|594143135|FG000|Overall Study|Death|0|||
164483907|NCT02489799|594143136|FG001|Overall Study|Death|1|||
164483908|NCT00515112|594143137|FG000|Overall Study|Death|0|||
164483909|NCT00515112|594143138|FG001|Overall Study|Death|1|||
164483910|NCT00515112|594143137|FG000|Overall Study|The study was terminated|3|||
164483911|NCT00515112|594143138|FG001|Overall Study|The study was terminated|2|||
164483912|NCT02002689|594143143|FG000|Overall Study|Disease Progression|7|||
164483913|NCT02002689|594143143|FG000|Overall Study|Adverse Event|3|||
164483914|NCT00278395|594143146|FG000|Overall Study|Adverse Event|2|||
164483915|NCT00278395|594143146|FG000|Overall Study|Nonevaluable|1|||
164483916|NCT04025762|594143148|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
164483917|NCT04025762|594143149|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
164483918|NCT00569166|594143151|FG000|Overall Study|Withdrawal by Subject|7|||
164483919|NCT00569166|594143152|FG001|Overall Study|Withdrawal by Subject|5|||
164483920|NCT00569166|594143153|FG002|Overall Study|Withdrawal by Subject|3|||
164483921|NCT00569166|594143151|FG000|Overall Study|Lost to Follow-up|2|||
164483922|NCT00569166|594143152|FG001|Overall Study|Lost to Follow-up|1|||
164483923|NCT00569166|594143153|FG002|Overall Study|Lost to Follow-up|1|||
164483924|NCT01853384|594143154|FG000|Randomized|Adverse Event|5|||
164483925|NCT01853384|594143155|FG001|Randomized|Adverse Event|3|||
164483926|NCT01853384|594143154|FG000|Randomized|Death|1|||
164483927|NCT01853384|594143155|FG001|Randomized|Death|2|||
164483928|NCT01853384|594143154|FG000|Randomized|Lost to Follow-up|1|||
164483929|NCT01853384|594143155|FG001|Randomized|Lost to Follow-up|1|||
164483930|NCT01853384|594143154|FG000|Randomized|Withdrawal by Subject|5|||
164483931|NCT01853384|594143155|FG001|Randomized|Withdrawal by Subject|3|||
164483932|NCT01853384|594143154|FG000|Randomized|Sponsor Decision|47|||
164483933|NCT01853384|594143155|FG001|Randomized|Sponsor Decision|34|||
164483934|NCT01853384|594143154|FG000|Randomized|Other|3|||
164483935|NCT01853384|594143155|FG001|Randomized|Other|3|||
164483936|NCT01853384|594143154|FG000|Completed Follow up Visit 1|Early Termination|13|||
164483937|NCT01853384|594143155|FG001|Completed Follow up Visit 1|Early Termination|9|||
164483938|NCT01853384|594143154|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
164483939|NCT01853384|594143155|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
164483940|NCT01853384|594143154|FG000|Completed Follow up Visit 2|Adverse Event|1|||
164483941|NCT01853384|594143155|FG001|Completed Follow up Visit 2|Adverse Event|0|||
164483942|NCT01853384|594143154|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
164483943|NCT01853384|594143155|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
164483944|NCT01853384|594143154|FG000|Completed Follow up Visit 2|Death|1|||
164483945|NCT01853384|594143155|FG001|Completed Follow up Visit 2|Death|0|||
164714505|NCT00673387|594976989|FG006|Overall Study|Lost to Follow-up|8|||
164483946|NCT01853384|594143154|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
164483947|NCT01853384|594143155|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
164483948|NCT03137784|594143156|FG000|Overall Study|Adverse Event|1|||
164483949|NCT03137784|594143157|FG001|Overall Study|Adverse Event|1|||
164483950|NCT03137784|594143158|FG002|Overall Study|Adverse Event|0|||
164483951|NCT03137784|594143159|FG003|Overall Study|Adverse Event|0|||
164483952|NCT03137784|594143160|FG004|Overall Study|Adverse Event|0|||
164483953|NCT03137784|594143161|FG005|Overall Study|Adverse Event|0|||
164483954|NCT03137784|594143156|FG000|Overall Study|Subject/guardian decision|1|||
164483955|NCT03137784|594143157|FG001|Overall Study|Subject/guardian decision|0|||
164483956|NCT03137784|594143158|FG002|Overall Study|Subject/guardian decision|0|||
164483957|NCT03137784|594143159|FG003|Overall Study|Subject/guardian decision|0|||
164483958|NCT03137784|594143160|FG004|Overall Study|Subject/guardian decision|0|||
164483959|NCT03137784|594143161|FG005|Overall Study|Subject/guardian decision|0|||
164483960|NCT03137784|594143156|FG000|Overall Study|Non-compliance with study treatment|0|||
164483961|NCT03137784|594143157|FG001|Overall Study|Non-compliance with study treatment|0|||
164483962|NCT03137784|594143158|FG002|Overall Study|Non-compliance with study treatment|0|||
164483963|NCT03137784|594143159|FG003|Overall Study|Non-compliance with study treatment|0|||
164483964|NCT03137784|594143160|FG004|Overall Study|Non-compliance with study treatment|1|||
164483965|NCT03137784|594143161|FG005|Overall Study|Non-compliance with study treatment|0|||
164483966|NCT04803734|594143167|FG000|Overall Study|Withdrawal by Subject|0|||
164483967|NCT04803734|594143168|FG001|Overall Study|Withdrawal by Subject|1|||
164483968|NCT04803734|594143167|FG000|Overall Study|Protocol Violation|0|||
164483969|NCT04803734|594143168|FG001|Overall Study|Protocol Violation|1|||
164483970|NCT00889863|594143182|FG000|Part I: Open Label|Death|1|||
164483971|NCT00889863|594143183|FG001|Part I: Open Label|Death|0|||
164483972|NCT00889863|594143182|FG000|Part I: Open Label|Adverse Event|4|||
164483973|NCT00889863|594143183|FG001|Part I: Open Label|Adverse Event|0|||
164483974|NCT00889863|594143182|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
164483975|NCT00889863|594143183|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
164483976|NCT00889863|594143182|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
164483977|NCT00889863|594143183|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
164483978|NCT00889863|594143182|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
164483979|NCT00889863|594143183|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
164483980|NCT00889863|594143182|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
164483981|NCT00889863|594143183|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
164483982|NCT00889863|594143182|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
164483983|NCT00889863|594143183|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
164483984|NCT01090739|594143184|FG000|Enrollment|Withdrawal by Subject|24|||
164483985|NCT01090739|594143184|FG000|Enrollment|Protocol Violation|14|||
164483986|NCT01090739|594143184|FG000|Enrollment|Lost to Follow-up|5|||
164483987|NCT01090739|594143184|FG000|Enrollment|Physician Decision|5|||
164483988|NCT01090739|594143184|FG000|Enrollment|Sponsor termination of site|4|||
164483989|NCT01090739|594143184|FG000|Enrollment|Study implant limit reached|2|||
164483990|NCT01090739|594143184|FG000|Enrollment|Adverse Event|1|||
164483991|NCT01090739|594143184|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
164483992|NCT01090739|594143184|FG000|12 Month Follow-up|Lost to Follow-up|1|||
164483993|NCT01090739|594143184|FG000|12 Month Follow-up|Physician Decision|1|||
164483994|NCT01090739|594143184|FG000|12 Month Follow-up|Death|1|||
164483995|NCT01090739|594143184|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
164483996|NCT01090739|594143184|FG000|24 Month Follow-up|Lost to Follow-up|1|||
164483997|NCT01090739|594143184|FG000|24 Month Follow-up|Death|1|||
164483998|NCT01090739|594143184|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
164483999|NCT01090739|594143184|FG000|36 Month Follow-up|Visit still pending|17|||
164484000|NCT00441168|594143185|FG000|Treatment Period|Death|3|||
164484001|NCT00441168|594143186|FG001|Treatment Period|Death|0|||
164484002|NCT00441168|594143185|FG000|Treatment Period|Adverse Event|1|||
164484003|NCT00441168|594143186|FG001|Treatment Period|Adverse Event|2|||
164484004|NCT00441168|594143185|FG000|Treatment Period|Progressive Disease|0|||
164714506|NCT00673387|594976990|FG007|Overall Study|Lost to Follow-up|5|||
164484005|NCT00441168|594143186|FG001|Treatment Period|Progressive Disease|2|||
164484006|NCT00441168|594143185|FG000|Treatment Period|Protocol Violation|0|||
164484007|NCT00441168|594143186|FG001|Treatment Period|Protocol Violation|1|||
164484008|NCT00441168|594143185|FG000|Treatment Period|Lost to Follow-up|0|||
164484009|NCT00441168|594143186|FG001|Treatment Period|Lost to Follow-up|1|||
164484010|NCT00441168|594143185|FG000|Treatment Period|Withdrawal by Subject|3|||
164484011|NCT00441168|594143186|FG001|Treatment Period|Withdrawal by Subject|0|||
164484012|NCT00441168|594143185|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
164484013|NCT00441168|594143186|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
164484014|NCT00441168|594143185|FG000|Treatment Period|refractory disease|1|||
164484015|NCT00441168|594143186|FG001|Treatment Period|refractory disease|0|||
164484016|NCT00441168|594143185|FG000|Follow-up Period|Death|3|||
164484017|NCT00441168|594143186|FG001|Follow-up Period|Death|0|||
164484018|NCT00441168|594143185|FG000|Follow-up Period|Lost to Follow-up|5|||
164484019|NCT00441168|594143186|FG001|Follow-up Period|Lost to Follow-up|6|||
164714507|NCT02533375|594976991|FG000|Overall Study|Lack of Efficacy|3|||
164484020|NCT00441168|594143185|FG000|Follow-up Period|Withdrawal by Subject|3|||
164484021|NCT00441168|594143186|FG001|Follow-up Period|Withdrawal by Subject|0|||
164484022|NCT00441168|594143185|FG000|Follow-up Period|Other|1|||
164484023|NCT00441168|594143186|FG001|Follow-up Period|Other|3|||
164484024|NCT04410445|594143188|FG000|Overall Study|Lost to Follow-up|3|||
164484025|NCT04410445|594143189|FG001|Overall Study|Lost to Follow-up|9|||
164484026|NCT04410445|594143188|FG000|Overall Study|Withdrawal by Subject|27|||
164484027|NCT04410445|594143189|FG001|Overall Study|Withdrawal by Subject|15|||
164484028|NCT02291861|594143190|FG000|Overall Study|Adverse Event|2|||
164484029|NCT02291861|594143191|FG001|Overall Study|Adverse Event|4|||
164484030|NCT02291861|594143192|FG002|Overall Study|Adverse Event|1|||
164484031|NCT02291861|594143193|FG003|Overall Study|Adverse Event|2|||
164484032|NCT02291861|594143190|FG000|Overall Study|Death|0|||
164484033|NCT02291861|594143191|FG001|Overall Study|Death|0|||
164484034|NCT02291861|594143192|FG002|Overall Study|Death|1|||
164484035|NCT02291861|594143193|FG003|Overall Study|Death|1|||
164484036|NCT02291861|594143190|FG000|Overall Study|Protocol Violation|1|||
164484037|NCT02291861|594143191|FG001|Overall Study|Protocol Violation|0|||
164484038|NCT02291861|594143192|FG002|Overall Study|Protocol Violation|0|||
164484039|NCT02291861|594143193|FG003|Overall Study|Protocol Violation|1|||
164484040|NCT02291861|594143190|FG000|Overall Study|Withdrawal by Subject|1|||
164484041|NCT02291861|594143191|FG001|Overall Study|Withdrawal by Subject|2|||
164484042|NCT02291861|594143192|FG002|Overall Study|Withdrawal by Subject|1|||
164484043|NCT02291861|594143193|FG003|Overall Study|Withdrawal by Subject|4|||
164484044|NCT02291861|594143190|FG000|Overall Study|Noncompliance|1|||
164484045|NCT02291861|594143191|FG001|Overall Study|Noncompliance|1|||
164484046|NCT02291861|594143192|FG002|Overall Study|Noncompliance|2|||
164484047|NCT02291861|594143193|FG003|Overall Study|Noncompliance|1|||
164484048|NCT02291861|594143190|FG000|Overall Study|Lost to Follow-up|2|||
164484049|NCT02291861|594143191|FG001|Overall Study|Lost to Follow-up|1|||
164484050|NCT02291861|594143192|FG002|Overall Study|Lost to Follow-up|4|||
164484051|NCT02291861|594143193|FG003|Overall Study|Lost to Follow-up|0|||
164484052|NCT02291861|594143190|FG000|Overall Study|Other|0|||
164484053|NCT02291861|594143191|FG001|Overall Study|Other|0|||
164484054|NCT02291861|594143192|FG002|Overall Study|Other|0|||
164484055|NCT02291861|594143193|FG003|Overall Study|Other|1|||
164484056|NCT02005484|594143196|FG000|Overall Study|Death|1|||
164484057|NCT02005484|594143196|FG000|Overall Study|Disease progression|1|||
164484058|NCT02005484|594143196|FG000|Overall Study|Changed to a Different Study|1|||
164484059|NCT02005484|594143196|FG000|Overall Study|Sponsor decision|1|||
164484060|NCT03547154|594143200|FG000|Overall Study|Disease Progression/Recurrence|6|||
164484061|NCT03547154|594143201|FG001|Overall Study|Disease Progression/Recurrence|14|||
164484062|NCT03547154|594143200|FG000|Overall Study|Adverse Event|26|||
164484063|NCT03547154|594143201|FG001|Overall Study|Adverse Event|31|||
164484064|NCT03547154|594143200|FG000|Overall Study|Protocol Violation|6|||
164484065|NCT03547154|594143201|FG001|Overall Study|Protocol Violation|1|||
164484066|NCT03547154|594143200|FG000|Overall Study|Physician Decision|4|||
164484067|NCT03547154|594143201|FG001|Overall Study|Physician Decision|3|||
164484068|NCT03547154|594143200|FG000|Overall Study|Insufficient Therapeutic Response|13|||
164484069|NCT03547154|594143201|FG001|Overall Study|Insufficient Therapeutic Response|10|||
164484070|NCT03547154|594143200|FG000|Overall Study|Withdrawal by Subject|10|||
164484071|NCT03547154|594143201|FG001|Overall Study|Withdrawal by Subject|6|||
164484072|NCT03547154|594143200|FG000|Overall Study|Not Selected|0|||
164484073|NCT03547154|594143201|FG001|Overall Study|Not Selected|1|||
164484074|NCT03547154|594143200|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
164484075|NCT03547154|594143201|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
164484076|NCT03909100|594143202|FG000|Overall Study|Protocol Deviation|2|||
164484077|NCT03909100|594143202|FG000|Overall Study|Technical Problems|4|||
164484078|NCT03909100|594143202|FG000|Overall Study|Withdrawal by Subject|4|||
164714508|NCT02533375|594976991|FG000|Overall Study|Adverse Event|2|||
164714509|NCT00960115|594976992|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
164714510|NCT00960115|594976993|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
164714511|NCT01104792|594976994|FG000|Overall Study|Adverse Event|77|||
164714512|NCT01104792|594976994|FG000|Overall Study|Insufficient Therapeutic Response|22|||
164484079|NCT03909100|594143202|FG000|Overall Study|Lost to Follow-up|1|||
164484080|NCT03909100|594143202|FG000|Overall Study|Reason not Specified|4|||
164484081|NCT01794299|594143204|FG000|Overall Study|ATIR manufacturing not possible|1|||
164484082|NCT01794299|594143204|FG000|Overall Study|Death|14|||
164484083|NCT01794299|594143204|FG000|Overall Study|Graft failure|1|||
164484084|NCT01794299|594143204|FG000|Overall Study|ATIR batch rejected|2|||
164484085|NCT01794299|594143204|FG000|Overall Study|Relapse|2|||
164484086|NCT01794299|594143204|FG000|Overall Study|Discontinued from active follow-up|1|||
164484087|NCT01794299|594143204|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
164484088|NCT03006393|594143205|FG000|Overall Study|Withdrawal by Subject|1|||
164484089|NCT03006393|594143206|FG001|Overall Study|Withdrawal by Subject|1|||
164484090|NCT03006393|594143205|FG000|Overall Study|Pregnancy|0|||
164484091|NCT03006393|594143206|FG001|Overall Study|Pregnancy|1|||
164484092|NCT03006393|594143205|FG000|Overall Study|Lost to Follow-up|0|||
164714513|NCT01104792|594976994|FG000|Overall Study|Protocol Violation|45|||
164484093|NCT03006393|594143206|FG001|Overall Study|Lost to Follow-up|1|||
164484094|NCT00807599|594143209|FG000|Overall Study|Not treated on protocol study|0|||
164484095|NCT00807599|594143210|FG001|Overall Study|Not treated on protocol study|0|||
164484096|NCT00807599|594143211|FG002|Overall Study|Not treated on protocol study|2|||
164484097|NCT00807599|594143209|FG000|Overall Study|Adverse Event|0|||
164484098|NCT00807599|594143210|FG001|Overall Study|Adverse Event|0|||
164484099|NCT00807599|594143211|FG002|Overall Study|Adverse Event|5|||
164484100|NCT00807599|594143209|FG000|Overall Study|Inadequate response to induction|0|||
164484101|NCT00807599|594143210|FG001|Overall Study|Inadequate response to induction|0|||
164484102|NCT00807599|594143211|FG002|Overall Study|Inadequate response to induction|9|||
164484103|NCT00807599|594143209|FG000|Overall Study|Withdrawal by Subject|0|||
164484104|NCT00807599|594143210|FG001|Overall Study|Withdrawal by Subject|0|||
164484105|NCT00807599|594143211|FG002|Overall Study|Withdrawal by Subject|1|||
164484106|NCT01262456|594143212|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
164484107|NCT01262456|594143213|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
164484108|NCT01262456|594143214|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
164484109|NCT01262456|594143212|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
164484110|NCT01262456|594143213|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
164484111|NCT01262456|594143214|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
164484112|NCT01262456|594143212|FG000|3-Month Double-Blind Period|Adverse Event|6|||
164484113|NCT01262456|594143213|FG001|3-Month Double-Blind Period|Adverse Event|4|||
164484114|NCT01262456|594143214|FG002|3-Month Double-Blind Period|Adverse Event|8|||
164484115|NCT01262456|594143212|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
164484116|NCT01262456|594143213|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
164484117|NCT01262456|594143214|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
164484118|NCT01262456|594143212|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
164484119|NCT01262456|594143213|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
164484120|NCT01262456|594143214|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
164484121|NCT01262456|594143212|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
164484122|NCT01262456|594143213|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
164484123|NCT01262456|594143214|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
164484124|NCT01262456|594143212|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
164484125|NCT01262456|594143213|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
164484126|NCT01262456|594143214|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
164484127|NCT01262456|594143212|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
164484128|NCT01262456|594143213|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
164484129|NCT01262456|594143214|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
164484130|NCT01262456|594143212|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
164484131|NCT01262456|594143213|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
164484132|NCT01262456|594143214|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
164484133|NCT03938272|594143215|FG000|Overall Study|Withdrawal by Subject|1|||
164484134|NCT03938272|594143216|FG001|Overall Study|Withdrawal by Subject|0|||
164484135|NCT03938272|594143215|FG000|Overall Study|Physician Decision|0|||
164484136|NCT03938272|594143216|FG001|Overall Study|Physician Decision|2|||
164484137|NCT03938272|594143215|FG000|Overall Study|Study termination by sponsor|10|||
164484138|NCT03938272|594143216|FG001|Overall Study|Study termination by sponsor|8|||
164484139|NCT02538094|594143217|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
164484140|NCT02538094|594143218|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
164484141|NCT02538094|594143217|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
164484142|NCT02538094|594143218|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
164484143|NCT03288506|594143219|FG000|Overall Study|Withdrawal by Subject|52|||
164484144|NCT03692871|594143220|FG000|Overall Study|Death|1|||
164484145|NCT03692871|594143221|FG001|Overall Study|Death|1|||
164484146|NCT03692871|594143220|FG000|Overall Study|Lost to Follow-up|24|||
164484147|NCT03692871|594143221|FG001|Overall Study|Lost to Follow-up|9|||
164484148|NCT03692871|594143220|FG000|Overall Study|Physician Decision|22|||
164484149|NCT03692871|594143221|FG001|Overall Study|Physician Decision|7|||
164484150|NCT03692871|594143220|FG000|Overall Study|Protocol Deviation|1|||
164484151|NCT03692871|594143221|FG001|Overall Study|Protocol Deviation|0|||
164484152|NCT03692871|594143220|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
164484153|NCT03692871|594143221|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
164484154|NCT01316913|594143222|FG000|Overall Study|Adverse Event|17|||
164484155|NCT01316913|594143223|FG001|Overall Study|Adverse Event|20|||
164484156|NCT01316913|594143224|FG002|Overall Study|Adverse Event|15|||
164484157|NCT01316913|594143225|FG003|Overall Study|Adverse Event|11|||
164484158|NCT01316913|594143222|FG000|Overall Study|Lack of Efficacy|22|||
164484159|NCT01316913|594143223|FG001|Overall Study|Lack of Efficacy|12|||
164484160|NCT01316913|594143224|FG002|Overall Study|Lack of Efficacy|9|||
164484161|NCT01316913|594143225|FG003|Overall Study|Lack of Efficacy|13|||
164484162|NCT01316913|594143222|FG000|Overall Study|Protocol Violation|1|||
164484163|NCT01316913|594143223|FG001|Overall Study|Protocol Violation|4|||
164484164|NCT01316913|594143224|FG002|Overall Study|Protocol Violation|4|||
164484165|NCT01316913|594143225|FG003|Overall Study|Protocol Violation|1|||
164484166|NCT01316913|594143222|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
164484167|NCT01316913|594143223|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
164484168|NCT01316913|594143224|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
164484169|NCT01316913|594143225|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
164484170|NCT01316913|594143222|FG000|Overall Study|Lost to Follow-up|0|||
164484171|NCT01316913|594143223|FG001|Overall Study|Lost to Follow-up|1|||
164484172|NCT01316913|594143224|FG002|Overall Study|Lost to Follow-up|0|||
164484173|NCT01316913|594143225|FG003|Overall Study|Lost to Follow-up|2|||
164484174|NCT01316913|594143222|FG000|Overall Study|Withdrawal by Subject|10|||
164484175|NCT01316913|594143223|FG001|Overall Study|Withdrawal by Subject|9|||
164484176|NCT01316913|594143224|FG002|Overall Study|Withdrawal by Subject|10|||
164484177|NCT01316913|594143225|FG003|Overall Study|Withdrawal by Subject|6|||
164484178|NCT02114515|594143227|FG000|Overall Study|Lost to Follow-up|52|||
164484179|NCT02114515|594143228|FG001|Overall Study|Lost to Follow-up|55|||
164484180|NCT02114515|594143227|FG000|Overall Study|Death|12|||
164484181|NCT02114515|594143228|FG001|Overall Study|Death|12|||
164484182|NCT02114515|594143227|FG000|Overall Study|Withdrawal by Subject|4|||
164484183|NCT02114515|594143228|FG001|Overall Study|Withdrawal by Subject|22|||
164484184|NCT02114515|594143227|FG000|Overall Study|Other|65|||
164484185|NCT02114515|594143228|FG001|Overall Study|Other|61|||
164484186|NCT02144285|594143229|FG000|Overall Study|Withdrawal by Subject|0|||
164484187|NCT02144285|594143230|FG001|Overall Study|Withdrawal by Subject|0|||
164484188|NCT02144285|594143231|FG002|Overall Study|Withdrawal by Subject|0|||
164484189|NCT02144285|594143232|FG003|Overall Study|Withdrawal by Subject|0|||
164484190|NCT02144285|594143233|FG004|Overall Study|Withdrawal by Subject|1|||
164484191|NCT02144285|594143234|FG005|Overall Study|Withdrawal by Subject|0|||
164484192|NCT02144285|594143235|FG006|Overall Study|Withdrawal by Subject|0|||
164484193|NCT02144285|594143236|FG007|Overall Study|Withdrawal by Subject|0|||
164484194|NCT02144285|594143237|FG008|Overall Study|Withdrawal by Subject|0|||
164484195|NCT02144285|594143238|FG009|Overall Study|Withdrawal by Subject|0|||
164484196|NCT02831049|594143240|FG000|Overall Study|Lost to Follow-up|0|||
164484197|NCT02831049|594143241|FG001|Overall Study|Lost to Follow-up|0|||
164484198|NCT02831049|594143242|FG002|Overall Study|Lost to Follow-up|1|||
164484199|NCT02831049|594143240|FG000|Overall Study|Withdrawal by Subject|0|||
164484200|NCT02831049|594143241|FG001|Overall Study|Withdrawal by Subject|1|||
164484201|NCT02831049|594143242|FG002|Overall Study|Withdrawal by Subject|1|||
164484202|NCT02831049|594143240|FG000|Overall Study|Pandemic shutdown|1|||
164484203|NCT02831049|594143241|FG001|Overall Study|Pandemic shutdown|0|||
164484204|NCT02831049|594143242|FG002|Overall Study|Pandemic shutdown|0|||
164484205|NCT00711555|594144652|FG000|Overall Study|Adverse Event|3|||
164484206|NCT05522777|594144657|FG000|Overall Study|Lack of Efficacy|1|||
164484207|NCT05522777|594144657|FG000|Overall Study|Withdrawal by Subject|1|||
164484208|NCT05487300|594144660|FG000|Overall Study|Withdrawal by Subject|1|||
164484209|NCT05487300|594144661|FG001|Overall Study|Withdrawal by Subject|0|||
164484210|NCT00092456|594144664|FG000|Overall Study|Adverse Event|0|||
164484211|NCT00092456|594144665|FG001|Overall Study|Adverse Event|0|||
164484212|NCT00092456|594144666|FG002|Overall Study|Adverse Event|1|||
164484213|NCT00092456|594144667|FG003|Overall Study|Adverse Event|1|||
164484214|NCT00092456|594144664|FG000|Overall Study|Lost to Follow-up|2|||
164484215|NCT00092456|594144665|FG001|Overall Study|Lost to Follow-up|2|||
164484216|NCT00092456|594144666|FG002|Overall Study|Lost to Follow-up|1|||
164484217|NCT00092456|594144667|FG003|Overall Study|Lost to Follow-up|2|||
164484218|NCT00092456|594144664|FG000|Overall Study|Protocol Violation|5|||
164484219|NCT00092456|594144665|FG001|Overall Study|Protocol Violation|7|||
164484220|NCT00092456|594144666|FG002|Overall Study|Protocol Violation|8|||
164484221|NCT00092456|594144667|FG003|Overall Study|Protocol Violation|6|||
164484222|NCT00092456|594144664|FG000|Overall Study|Withdrawal by Subject|13|||
164484223|NCT00092456|594144665|FG001|Overall Study|Withdrawal by Subject|5|||
164484224|NCT00092456|594144666|FG002|Overall Study|Withdrawal by Subject|16|||
164484225|NCT00092456|594144667|FG003|Overall Study|Withdrawal by Subject|6|||
164484226|NCT00092456|594144664|FG000|Overall Study|Moved|1|||
164484227|NCT00092456|594144665|FG001|Overall Study|Moved|1|||
164484228|NCT00092456|594144666|FG002|Overall Study|Moved|0|||
164484229|NCT00092456|594144667|FG003|Overall Study|Moved|1|||
164484230|NCT00092456|594144664|FG000|Overall Study|Other|4|||
164484231|NCT00092456|594144665|FG001|Overall Study|Other|2|||
164484232|NCT00092456|594144666|FG002|Overall Study|Other|3|||
164484233|NCT00092456|594144667|FG003|Overall Study|Other|0|||
164484234|NCT00215943|594144668|FG000|Overall Study|Disease Progression|3|||
164484235|NCT00215943|594144669|FG001|Overall Study|Disease Progression|5|||
164484236|NCT00215943|594144668|FG000|Overall Study|Alternate therapy|0|||
164484237|NCT00215943|594144669|FG001|Overall Study|Alternate therapy|1|||
164484238|NCT00215943|594144668|FG000|Overall Study|Adverse Event|3|||
164484239|NCT00215943|594144669|FG001|Overall Study|Adverse Event|6|||
164484240|NCT00215943|594144668|FG000|Overall Study|Other disease|0|||
164484241|NCT00215943|594144669|FG001|Overall Study|Other disease|1|||
164484242|NCT00215943|594144668|FG000|Overall Study|Other complications|3|||
164601352|NCT00479557|594559931|FG003|Overall Study|Lost to Follow-up|2|||
164484243|NCT00215943|594144669|FG001|Overall Study|Other complications|1|||
164484244|NCT00443820|594144670|FG000|Overall Study|Adverse Event|1|||
164714514|NCT01104792|594976994|FG000|Overall Study|Withdrawal of Consent|179|||
164714515|NCT01104792|594976994|FG000|Overall Study|Lost to Follow-up|43|||
164714516|NCT01104792|594976994|FG000|Overall Study|Reasons Not Specified|27|||
164714517|NCT01104792|594976994|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
164714518|NCT01102374|594976995|FG000|Overall Study|Death|9|||
164484245|NCT00443820|594144671|FG001|Overall Study|Adverse Event|1|||
164484246|NCT00443820|594144672|FG002|Overall Study|Adverse Event|0|||
164484247|NCT00443820|594144673|FG003|Overall Study|Adverse Event|0|||
164484248|NCT00443820|594144670|FG000|Overall Study|Lack of Efficacy|3|||
164484249|NCT00443820|594144671|FG001|Overall Study|Lack of Efficacy|2|||
164484250|NCT00443820|594144672|FG002|Overall Study|Lack of Efficacy|1|||
164484251|NCT00443820|594144673|FG003|Overall Study|Lack of Efficacy|1|||
164484252|NCT00443820|594144670|FG000|Overall Study|Protocol Violation|2|||
164484253|NCT00443820|594144671|FG001|Overall Study|Protocol Violation|1|||
164484254|NCT00443820|594144672|FG002|Overall Study|Protocol Violation|2|||
164484255|NCT00443820|594144673|FG003|Overall Study|Protocol Violation|1|||
164484256|NCT00443820|594144670|FG000|Overall Study|Withdrawal by Subject|6|||
164484257|NCT00443820|594144671|FG001|Overall Study|Withdrawal by Subject|7|||
164484258|NCT00443820|594144672|FG002|Overall Study|Withdrawal by Subject|8|||
164484259|NCT00443820|594144673|FG003|Overall Study|Withdrawal by Subject|9|||
164484260|NCT00443820|594144670|FG000|Overall Study|Lost to Follow-up|9|||
164484261|NCT00443820|594144671|FG001|Overall Study|Lost to Follow-up|8|||
164484262|NCT00443820|594144672|FG002|Overall Study|Lost to Follow-up|6|||
164484263|NCT00443820|594144673|FG003|Overall Study|Lost to Follow-up|5|||
164484264|NCT00443820|594144670|FG000|Overall Study|Administrative problems|0|||
164484265|NCT00443820|594144671|FG001|Overall Study|Administrative problems|0|||
164484266|NCT00443820|594144672|FG002|Overall Study|Administrative problems|0|||
164484267|NCT00443820|594144673|FG003|Overall Study|Administrative problems|1|||
164484268|NCT00443820|594144670|FG000|Overall Study|Death|0|||
164484269|NCT00443820|594144671|FG001|Overall Study|Death|0|||
164484270|NCT00443820|594144672|FG002|Overall Study|Death|1|||
164484271|NCT00443820|594144673|FG003|Overall Study|Death|0|||
164484272|NCT02121808|594144674|FG000|Overall Study|Technical problem|3|||
164484273|NCT01304940|594144676|FG000|Overall Study|not meet symptom severity requirement|3|||
164484274|NCT01304940|594144677|FG001|Overall Study|not meet symptom severity requirement|0|||
164484275|NCT00304278|594144678|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
164484276|NCT00304278|594144678|FG000|Overall Study|PT had medical condition preventing TX|1|||
164484277|NCT02065895|594144681|FG000|Overall Study|Protocol Violation|1|||
164484278|NCT02065895|594144682|FG001|Overall Study|Protocol Violation|0|||
164484279|NCT02065895|594144683|FG002|Overall Study|Protocol Violation|0|||
164484280|NCT02065895|594144684|FG003|Overall Study|Protocol Violation|1|||
164484281|NCT02065895|594144685|FG004|Overall Study|Protocol Violation|0|||
164484282|NCT02065895|594144686|FG005|Overall Study|Protocol Violation|0|||
164484283|NCT02065895|594144681|FG000|Overall Study|Scheduling conflicts|0|||
164484284|NCT02065895|594144682|FG001|Overall Study|Scheduling conflicts|1|||
164484285|NCT02065895|594144683|FG002|Overall Study|Scheduling conflicts|0|||
164484286|NCT02065895|594144684|FG003|Overall Study|Scheduling conflicts|0|||
164484287|NCT02065895|594144685|FG004|Overall Study|Scheduling conflicts|0|||
164484288|NCT02065895|594144686|FG005|Overall Study|Scheduling conflicts|0|||
164484289|NCT03740737|594144687|FG000|Overall Study|Protocol deviation|13|||
164484290|NCT03740737|594144688|FG001|Overall Study|Protocol deviation|0|||
164484291|NCT03740737|594144687|FG000|Overall Study|Adverse Event|2|||
164484292|NCT03740737|594144688|FG001|Overall Study|Adverse Event|0|||
164484293|NCT03740737|594144687|FG000|Overall Study|Lost to Follow-up|1|||
164484294|NCT03740737|594144688|FG001|Overall Study|Lost to Follow-up|0|||
164484295|NCT03740737|594144687|FG000|Overall Study|Randomization failure|1|||
164484296|NCT03740737|594144688|FG001|Overall Study|Randomization failure|0|||
164484297|NCT03740737|594144687|FG000|Overall Study|Participant withdrew consent|1|||
164601353|NCT00479557|594559932|FG004|Overall Study|Lost to Follow-up|0|||
164714519|NCT01102374|594976996|FG001|Overall Study|Death|13|||
164714520|NCT01102374|594976995|FG000|Overall Study|Lost to Follow-up|7|||
164484298|NCT03740737|594144688|FG001|Overall Study|Participant withdrew consent|0|||
164484299|NCT03740737|594144687|FG000|Overall Study|Participant withdrew from trial|2|||
164484300|NCT03740737|594144688|FG001|Overall Study|Participant withdrew from trial|1|||
164484301|NCT00507429|594144689|FG000|Treatment Phase|Disease Progression|12|||
164484302|NCT00507429|594144690|FG001|Treatment Phase|Disease Progression|5|||
164484303|NCT00507429|594144689|FG000|Treatment Phase|Adverse Event|12|||
164484304|NCT00507429|594144690|FG001|Treatment Phase|Adverse Event|5|||
164484305|NCT00507429|594144689|FG000|Treatment Phase|Withdrawal by Subject|3|||
164484306|NCT00507429|594144690|FG001|Treatment Phase|Withdrawal by Subject|3|||
164484307|NCT00507429|594144689|FG000|Treatment Phase|Physician Decision|4|||
164601354|NCT00479557|594559933|FG005|Overall Study|Lost to Follow-up|0|||
164714521|NCT01102374|594976996|FG001|Overall Study|Lost to Follow-up|6|||
164714522|NCT02071849|594976998|FG000|6-month Primary Endpoint|Did not receive device|4|||
164484308|NCT00507429|594144690|FG001|Treatment Phase|Physician Decision|2|||
164484309|NCT00507429|594144689|FG000|Treatment Phase|Other|6|||
164484310|NCT00507429|594144690|FG001|Treatment Phase|Other|3|||
164484311|NCT00507429|594144689|FG000|Maintenance Phase|Progressive Disease|14|||
164484312|NCT00507429|594144690|FG001|Maintenance Phase|Progressive Disease|0|||
164484313|NCT02152384|594144693|FG000|Period 1|Withdrawal by Subject|0|||
164484314|NCT02152384|594144694|FG001|Period 1|Withdrawal by Subject|1|||
164484315|NCT02152384|594144693|FG000|Period 1|Adverse Event|1|||
164484316|NCT02152384|594144694|FG001|Period 1|Adverse Event|1|||
164484317|NCT02446015|594144695|FG000|Overall Study|Adverse Event|0|||
164484318|NCT02446015|594144696|FG001|Overall Study|Adverse Event|1|||
164484319|NCT02446015|594144695|FG000|Overall Study|Withdrawal by Subject|1|||
164484320|NCT02446015|594144696|FG001|Overall Study|Withdrawal by Subject|0|||
164484321|NCT01393600|594144697|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
164484322|NCT01393600|594144698|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
164484323|NCT01393600|594144699|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
164484324|NCT01393600|594144700|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
164484325|NCT01393600|594144697|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
164484326|NCT01393600|594144698|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
164484327|NCT01393600|594144699|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
164484328|NCT01393600|594144700|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
164484329|NCT01393600|594144697|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
164484330|NCT01393600|594144698|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
164484331|NCT01393600|594144699|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
164484332|NCT01393600|594144700|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
164484333|NCT01393600|594144697|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
164484334|NCT01393600|594144698|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
164484335|NCT01393600|594144699|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
164484336|NCT01393600|594144700|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
164484337|NCT01393600|594144697|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
164484338|NCT01393600|594144698|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
164484339|NCT01393600|594144699|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
164484340|NCT01393600|594144700|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
164484341|NCT01393600|594144697|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
164484342|NCT01393600|594144698|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
164484343|NCT01393600|594144699|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
164484344|NCT01393600|594144700|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
164484345|NCT01393600|594144697|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
164484346|NCT01393600|594144698|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
164484347|NCT01393600|594144699|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
164484348|NCT01393600|594144700|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
164484349|NCT00603798|594144701|FG000|Overall Study|Adverse Event|4|||
164484350|NCT00603798|594144702|FG001|Overall Study|Adverse Event|2|||
164484351|NCT00603798|594144703|FG002|Overall Study|Adverse Event|1|||
164484352|NCT00603798|594144701|FG000|Overall Study|Withdrawal by Subject|4|||
164484353|NCT00603798|594144702|FG001|Overall Study|Withdrawal by Subject|3|||
164484354|NCT00603798|594144703|FG002|Overall Study|Withdrawal by Subject|4|||
164484355|NCT00603798|594144701|FG000|Overall Study|Lost to Follow-up|1|||
164484356|NCT00603798|594144702|FG001|Overall Study|Lost to Follow-up|0|||
164484357|NCT00603798|594144703|FG002|Overall Study|Lost to Follow-up|1|||
164484358|NCT00603798|594144701|FG000|Overall Study|Non-compliance with study procedures|0|||
164484359|NCT00603798|594144702|FG001|Overall Study|Non-compliance with study procedures|1|||
164484360|NCT00603798|594144703|FG002|Overall Study|Non-compliance with study procedures|0|||
164484361|NCT00603798|594144701|FG000|Overall Study|Not due to AE|1|||
164484362|NCT00603798|594144702|FG001|Overall Study|Not due to AE|1|||
164484363|NCT00603798|594144703|FG002|Overall Study|Not due to AE|4|||
164484364|NCT00988429|594144707|FG000|Overall Study|Adverse Event|9|||
164484365|NCT00988429|594144708|FG001|Overall Study|Adverse Event|21|||
164484366|NCT00988429|594144709|FG002|Overall Study|Adverse Event|45|||
164484367|NCT00988429|594144707|FG000|Overall Study|Lack of Efficacy|0|||
164601355|NCT00479557|594559934|FG006|Overall Study|Lost to Follow-up|0|||
164601356|NCT00479557|594559928|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
164601357|NCT00479557|594559929|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
164484368|NCT00988429|594144708|FG001|Overall Study|Lack of Efficacy|0|||
164484369|NCT00988429|594144709|FG002|Overall Study|Lack of Efficacy|1|||
164484370|NCT00988429|594144707|FG000|Overall Study|Non-Compliance with Study Drug|5|||
164484371|NCT00988429|594144708|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164484372|NCT00988429|594144709|FG002|Overall Study|Non-Compliance with Study Drug|3|||
164484373|NCT00988429|594144707|FG000|Overall Study|Physician Decision|1|||
164484374|NCT00988429|594144708|FG001|Overall Study|Physician Decision|0|||
164484375|NCT00988429|594144709|FG002|Overall Study|Physician Decision|3|||
164484376|NCT00988429|594144707|FG000|Overall Study|Pregnancy|2|||
164484377|NCT00988429|594144708|FG001|Overall Study|Pregnancy|1|||
164484378|NCT00988429|594144709|FG002|Overall Study|Pregnancy|0|||
164484379|NCT00988429|594144707|FG000|Overall Study|Protocol Violation|4|||
164484380|NCT00988429|594144708|FG001|Overall Study|Protocol Violation|3|||
164484381|NCT00988429|594144709|FG002|Overall Study|Protocol Violation|3|||
164484382|NCT00988429|594144707|FG000|Overall Study|Withdrawal by Subject|7|||
164484383|NCT00988429|594144708|FG001|Overall Study|Withdrawal by Subject|7|||
164484384|NCT00988429|594144709|FG002|Overall Study|Withdrawal by Subject|12|||
164484385|NCT00988429|594144707|FG000|Overall Study|Administrative Reasons|1|||
164484386|NCT00988429|594144708|FG001|Overall Study|Administrative Reasons|2|||
164484387|NCT00988429|594144709|FG002|Overall Study|Administrative Reasons|1|||
164484388|NCT00988429|594144707|FG000|Overall Study|other reasons|8|||
164484389|NCT00988429|594144708|FG001|Overall Study|other reasons|8|||
164484390|NCT00988429|594144709|FG002|Overall Study|other reasons|1|||
164484391|NCT02964234|594144710|FG000|Overall Study|Lost to Follow-up|22|||
164484392|NCT02964234|594144711|FG001|Overall Study|Lost to Follow-up|13|||
164484393|NCT01799993|594144712|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
164484394|NCT01799993|594144713|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
164484395|NCT01799993|594144712|FG000|Overall Study|Death|61|||
164484396|NCT01799993|594144713|FG001|Overall Study|Death|45|||
164484397|NCT01799993|594144712|FG000|Overall Study|Withdrawal by Subject|23|||
164484398|NCT01799993|594144713|FG001|Overall Study|Withdrawal by Subject|24|||
164484399|NCT01799993|594144712|FG000|Overall Study|Lost to Follow-up|5|||
164484400|NCT01799993|594144713|FG001|Overall Study|Lost to Follow-up|8|||
164484401|NCT01799993|594144712|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
164484402|NCT01799993|594144713|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
164484403|NCT01799993|594144712|FG000|Overall Study|Protocol driven decision point|0|||
164484404|NCT01799993|594144713|FG001|Overall Study|Protocol driven decision point|3|||
164484405|NCT01799993|594144712|FG000|Overall Study|Protocol Violation|1|||
164484406|NCT01799993|594144713|FG001|Overall Study|Protocol Violation|1|||
164484407|NCT01799993|594144712|FG000|Overall Study|Deterioration of general conditions|2|||
164484408|NCT01799993|594144713|FG001|Overall Study|Deterioration of general conditions|0|||
164484409|NCT01799993|594144712|FG000|Overall Study|Screen failure|0|||
164484410|NCT01799993|594144713|FG001|Overall Study|Screen failure|1|||
164484411|NCT01799993|594144712|FG000|Overall Study|Adverse Event|1|||
164484412|NCT01799993|594144713|FG001|Overall Study|Adverse Event|0|||
164484413|NCT01799993|594144712|FG000|Overall Study|Lack of Efficacy|1|||
164484414|NCT01799993|594144713|FG001|Overall Study|Lack of Efficacy|0|||
164484415|NCT01799993|594144712|FG000|Overall Study|Recovery|0|||
164484416|NCT01799993|594144713|FG001|Overall Study|Recovery|1|||
164484417|NCT01799993|594144712|FG000|Overall Study|Logistical difficulties|1|||
164484418|NCT01799993|594144713|FG001|Overall Study|Logistical difficulties|0|||
164484419|NCT01799993|594144712|FG000|Overall Study|Protocol deviation|1|||
164484420|NCT01799993|594144713|FG001|Overall Study|Protocol deviation|0|||
164484421|NCT01799993|594144712|FG000|Overall Study|Non-compliance with medical device|1|||
164484422|NCT01799993|594144713|FG001|Overall Study|Non-compliance with medical device|0|||
164484423|NCT01799993|594144712|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164484424|NCT01799993|594144713|FG001|Overall Study|Withdrawal by parent/guardian|1|||
164484425|NCT01799993|594144712|FG000|Overall Study|Other|1|||
164484426|NCT01799993|594144713|FG001|Overall Study|Other|0|||
164484427|NCT01799993|594144712|FG000|Overall Study|Subject didn't return for follow-up|0|||
164484428|NCT01799993|594144713|FG001|Overall Study|Subject didn't return for follow-up|1|||
164484429|NCT01320683|594144714|FG000|Overall Study|Positive antibody response|1|||
164484430|NCT01123356|594144715|FG000|Overall Study|Adverse Event|2|||
164484431|NCT01123356|594144715|FG000|Overall Study|Lack of Efficacy|4|||
164484432|NCT01123356|594144715|FG000|Overall Study|Withdrawal by Subject|1|||
164484433|NCT04361617|594144718|FG000|Overall Study|Withdrawal by Subject|0|||
164484434|NCT04361617|594144719|FG001|Overall Study|Withdrawal by Subject|1|||
164484435|NCT01263223|594144720|FG000|Period 2|Withdrawal by Subject|0|||
164484436|NCT01263223|594144721|FG001|Period 2|Withdrawal by Subject|1|||
164484437|NCT01263223|594144720|FG000|7-day Follow-up|Withdrawal by Subject|0|||
164484438|NCT01263223|594144721|FG001|7-day Follow-up|Withdrawal by Subject|1|||
164484439|NCT01263223|594144720|FG000|7-day Follow-up|Lost to Follow-up|1|||
164484440|NCT01263223|594144721|FG001|7-day Follow-up|Lost to Follow-up|0|||
164484441|NCT02246647|594144723|FG000|Overall Study|Withdrawal by Subject|1|||
164484442|NCT02246647|594144724|FG001|Overall Study|Withdrawal by Subject|1|||
164484443|NCT01113541|594144729|FG000|Overall Study|Withdrawal by Subject|1|||
164484444|NCT01113541|594144729|FG000|Overall Study|Protocol Violation|1|||
164484445|NCT01113541|594144729|FG000|Overall Study|Study Terminated by Sponsor|7|||
164484446|NCT01113541|594144729|FG000|Overall Study|Adverse Event|4|||
164484447|NCT00687297|594144737|FG000|Randomization|Withdrawal by Subject|2|||
164484448|NCT00687297|594144738|FG001|Randomization|Withdrawal by Subject|0|||
164484449|NCT00687297|594144737|FG000|Randomization|Withdrew before treatment, ineligible|1|||
164484450|NCT00687297|594144738|FG001|Randomization|Withdrew before treatment, ineligible|1|||
164601358|NCT00479557|594559930|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
164601359|NCT00479557|594559931|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
164601360|NCT00479557|594559932|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
164601361|NCT00479557|594559933|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
164601362|NCT00479557|594559934|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
164601363|NCT00479557|594559928|FG000|Overall Study|AE not related to Study Drug|1|||
164601364|NCT00479557|594559929|FG001|Overall Study|AE not related to Study Drug|3|||
164601365|NCT00479557|594559930|FG002|Overall Study|AE not related to Study Drug|0|||
164601366|NCT00479557|594559931|FG003|Overall Study|AE not related to Study Drug|0|||
164601367|NCT00479557|594559932|FG004|Overall Study|AE not related to Study Drug|2|||
164601368|NCT00479557|594559933|FG005|Overall Study|AE not related to Study Drug|2|||
164601369|NCT00479557|594559934|FG006|Overall Study|AE not related to Study Drug|1|||
164601370|NCT00479557|594559928|FG000|Overall Study|Caregiver Request|2|||
164601371|NCT00479557|594559929|FG001|Overall Study|Caregiver Request|2|||
164601372|NCT00479557|594559930|FG002|Overall Study|Caregiver Request|2|||
164601373|NCT00479557|594559931|FG003|Overall Study|Caregiver Request|0|||
164601374|NCT00479557|594559932|FG004|Overall Study|Caregiver Request|1|||
164601375|NCT00479557|594559933|FG005|Overall Study|Caregiver Request|2|||
164601376|NCT00479557|594559934|FG006|Overall Study|Caregiver Request|0|||
164601377|NCT00479557|594559928|FG000|Overall Study|Investigator Request|0|||
164601378|NCT00479557|594559929|FG001|Overall Study|Investigator Request|0|||
164601379|NCT00479557|594559930|FG002|Overall Study|Investigator Request|1|||
164601380|NCT00479557|594559931|FG003|Overall Study|Investigator Request|0|||
164601381|NCT00479557|594559932|FG004|Overall Study|Investigator Request|0|||
164601382|NCT00479557|594559933|FG005|Overall Study|Investigator Request|0|||
164601383|NCT00479557|594559934|FG006|Overall Study|Investigator Request|0|||
164601384|NCT00479557|594559928|FG000|Overall Study|Subject Request|3|||
164601385|NCT00479557|594559929|FG001|Overall Study|Subject Request|0|||
164484451|NCT00687297|594144737|FG000|Induction|Withdrawal by Subject|4|||
164484452|NCT00687297|594144738|FG001|Induction|Withdrawal by Subject|4|||
164484453|NCT00687297|594144737|FG000|Induction|Adverse Event|16|||
164484454|NCT00687297|594144738|FG001|Induction|Adverse Event|15|||
164484455|NCT00687297|594144737|FG000|Induction|Death|7|||
164484456|NCT00687297|594144738|FG001|Induction|Death|11|||
164484457|NCT00687297|594144737|FG000|Induction|Lack of Efficacy|17|||
164484458|NCT00687297|594144738|FG001|Induction|Lack of Efficacy|21|||
164484459|NCT00687297|594144737|FG000|Induction|Ineligible|0|||
164484460|NCT00687297|594144738|FG001|Induction|Ineligible|1|||
164484461|NCT00687297|594144737|FG000|Induction|Patient Noncompliance|1|||
164484462|NCT00687297|594144738|FG001|Induction|Patient Noncompliance|0|||
164484463|NCT00687297|594144737|FG000|Induction|Physician Decision|0|||
164484464|NCT00687297|594144738|FG001|Induction|Physician Decision|2|||
164484465|NCT00687297|594144737|FG000|Induction|Other|0|||
164484466|NCT00687297|594144738|FG001|Induction|Other|1|||
164484467|NCT03695185|594144739|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
164484468|NCT03695185|594144739|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
164484469|NCT03695185|594144739|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
164484470|NCT03695185|594144739|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
164601386|NCT00479557|594559930|FG002|Overall Study|Subject Request|1|||
164601387|NCT00479557|594559931|FG003|Overall Study|Subject Request|1|||
164601388|NCT00479557|594559932|FG004|Overall Study|Subject Request|1|||
164601389|NCT00479557|594559933|FG005|Overall Study|Subject Request|4|||
164601390|NCT00479557|594559934|FG006|Overall Study|Subject Request|1|||
164601391|NCT00479557|594559928|FG000|Overall Study|Other|2|||
164601392|NCT00479557|594559929|FG001|Overall Study|Other|3|||
164714523|NCT02071849|594976998|FG000|6-month Primary Endpoint|Adverse Event|1|||
164714524|NCT02071849|594976998|FG000|2-year Extended Follow-up|Adverse Event|1|||
164714525|NCT02056392|594977001|FG000|Overall Study|Lost to Follow-up|0|||
164714526|NCT02056392|594977002|FG001|Overall Study|Lost to Follow-up|1|||
164714527|NCT02056392|594977003|FG002|Overall Study|Lost to Follow-up|2|||
164714528|NCT02056392|594977004|FG003|Overall Study|Lost to Follow-up|0|||
164714529|NCT02056392|594977005|FG004|Overall Study|Lost to Follow-up|0|||
164714530|NCT02056392|594977006|FG005|Overall Study|Lost to Follow-up|0|||
164714531|NCT02056392|594977001|FG000|Overall Study|Protocol Violation|1|||
164714532|NCT02056392|594977002|FG001|Overall Study|Protocol Violation|0|||
164484471|NCT03695185|594144739|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
164484472|NCT03695185|594144739|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
164484473|NCT01182285|594144742|FG000|First Intervention Week 1-10|Disease progression|1|||
164484474|NCT01182285|594144743|FG001|First Intervention Week 1-10|Disease progression|0|||
164484475|NCT01182285|594144744|FG002|First Intervention Week 1-10|Disease progression|0|||
164601393|NCT00479557|594559930|FG002|Overall Study|Other|1|||
164601394|NCT00479557|594559931|FG003|Overall Study|Other|0|||
164601395|NCT00479557|594559932|FG004|Overall Study|Other|0|||
164714533|NCT02056392|594977003|FG002|Overall Study|Protocol Violation|1|||
164714534|NCT02056392|594977004|FG003|Overall Study|Protocol Violation|0|||
164714535|NCT02056392|594977005|FG004|Overall Study|Protocol Violation|0|||
164484476|NCT01182285|594144742|FG000|First Intervention Week 1-10|Adverse Event|1|||
164484477|NCT01182285|594144743|FG001|First Intervention Week 1-10|Adverse Event|0|||
164484478|NCT01182285|594144744|FG002|First Intervention Week 1-10|Adverse Event|0|||
164484479|NCT01182285|594144742|FG000|First Intervention Week 1-10|Non-compliance|1|||
164484480|NCT01182285|594144743|FG001|First Intervention Week 1-10|Non-compliance|0|||
164484481|NCT01182285|594144744|FG002|First Intervention Week 1-10|Non-compliance|0|||
164484482|NCT01182285|594144742|FG000|Third Intervention Week 11-52|Disease Progression|0|||
164484483|NCT01182285|594144743|FG001|Third Intervention Week 11-52|Disease Progression|0|||
164484484|NCT01182285|594144744|FG002|Third Intervention Week 11-52|Disease Progression|6|||
164484485|NCT01182285|594144742|FG000|Third Intervention Week 11-52|Other|0|||
164484486|NCT01182285|594144743|FG001|Third Intervention Week 11-52|Other|0|||
164484487|NCT01182285|594144744|FG002|Third Intervention Week 11-52|Other|2|||
164484488|NCT00274287|594144745|FG000|Overall Study|Withdrawal by Subject|1|||
164484489|NCT00274287|594144745|FG000|Overall Study|subject non-compliance|1|||
164484490|NCT04617847|594144746|FG000|Overall Study|Withdrawal by Subject|1|||
164484491|NCT04617847|594144747|FG001|Overall Study|Withdrawal by Subject|0|||
164484492|NCT04617847|594144746|FG000|Overall Study|Adverse Event|0|||
164484493|NCT04617847|594144747|FG001|Overall Study|Adverse Event|2|||
164484494|NCT04617847|594144746|FG000|Overall Study|Death|0|||
164484495|NCT04617847|594144747|FG001|Overall Study|Death|1|||
164484496|NCT04617847|594144746|FG000|Overall Study|Termination of Study by Sponsor|2|||
164484497|NCT04617847|594144747|FG001|Overall Study|Termination of Study by Sponsor|21|||
164484498|NCT01525875|594144748|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
164484499|NCT01525875|594144749|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
164484500|NCT01525875|594144748|FG000|Open-label Period|Lost to Follow-up|0|||
164484501|NCT01525875|594144749|FG001|Open-label Period|Lost to Follow-up|2|||
164484502|NCT04183491|594144754|FG000|Overall Study|Withdrawal by Subject|0|||
164484503|NCT04183491|594144755|FG001|Overall Study|Withdrawal by Subject|0|||
164484504|NCT04183491|594144756|FG002|Overall Study|Withdrawal by Subject|1|||
164484505|NCT04183491|594144757|FG003|Overall Study|Withdrawal by Subject|0|||
164484506|NCT04183491|594144758|FG004|Overall Study|Withdrawal by Subject|0|||
164484507|NCT04183491|594144759|FG005|Overall Study|Withdrawal by Subject|1|||
164484508|NCT04183491|594144760|FG006|Overall Study|Withdrawal by Subject|0|||
164484509|NCT03031782|594144763|FG000|Treatment Period 1|Lack of Efficacy|3|||
164484510|NCT03031782|594144764|FG001|Treatment Period 1|Lack of Efficacy|0|||
164484511|NCT03031782|594144765|FG002|Treatment Period 1|Lack of Efficacy|0|||
164484512|NCT03031782|594144766|FG003|Treatment Period 1|Lack of Efficacy|0|||
164484513|NCT03031782|594144767|FG004|Treatment Period 1|Lack of Efficacy|0|||
164484514|NCT03031782|594144763|FG000|Treatment Period 2|Physician Decision|0|||
164484515|NCT03031782|594144764|FG001|Treatment Period 2|Physician Decision|1|||
164484516|NCT03031782|594144765|FG002|Treatment Period 2|Physician Decision|0|||
164484517|NCT03031782|594144766|FG003|Treatment Period 2|Physician Decision|0|||
164484518|NCT03031782|594144767|FG004|Treatment Period 2|Physician Decision|3|||
164484519|NCT03031782|594144763|FG000|Treatment Period 2|Lack of Efficacy|0|||
164484520|NCT03031782|594144764|FG001|Treatment Period 2|Lack of Efficacy|1|||
164484521|NCT03031782|594144765|FG002|Treatment Period 2|Lack of Efficacy|0|||
164484522|NCT03031782|594144766|FG003|Treatment Period 2|Lack of Efficacy|0|||
164484523|NCT03031782|594144767|FG004|Treatment Period 2|Lack of Efficacy|1|||
164484524|NCT03031782|594144763|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164484525|NCT03031782|594144764|FG001|Treatment Period 2|Withdrawal by Subject|3|||
164484526|NCT03031782|594144765|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164484527|NCT03031782|594144766|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164484528|NCT03031782|594144767|FG004|Treatment Period 2|Withdrawal by Subject|1|||
164484529|NCT03031782|594144763|FG000|Treatment Period 2|Adverse Event|0|||
164484530|NCT03031782|594144764|FG001|Treatment Period 2|Adverse Event|1|||
164484531|NCT03031782|594144765|FG002|Treatment Period 2|Adverse Event|2|||
164484532|NCT03031782|594144766|FG003|Treatment Period 2|Adverse Event|0|||
164484533|NCT03031782|594144767|FG004|Treatment Period 2|Adverse Event|0|||
164484534|NCT03031782|594144763|FG000|Treatment Period 3|Withdrawal by Subject|0|||
164484535|NCT03031782|594144764|FG001|Treatment Period 3|Withdrawal by Subject|0|||
164484536|NCT03031782|594144765|FG002|Treatment Period 3|Withdrawal by Subject|0|||
164484537|NCT03031782|594144766|FG003|Treatment Period 3|Withdrawal by Subject|1|||
164484538|NCT03031782|594144767|FG004|Treatment Period 3|Withdrawal by Subject|0|||
164484539|NCT02852824|594144772|FG000|Overall Study|Withdrawal by Subject|1|||
164484540|NCT02852824|594144773|FG001|Overall Study|Withdrawal by Subject|0|||
164484541|NCT02852824|594144774|FG002|Overall Study|Withdrawal by Subject|0|||
164484542|NCT02852824|594144775|FG003|Overall Study|Withdrawal by Subject|0|||
164484543|NCT02852824|594144776|FG004|Overall Study|Withdrawal by Subject|0|||
164484544|NCT02852824|594144777|FG005|Overall Study|Withdrawal by Subject|0|||
164484545|NCT02852824|594144778|FG006|Overall Study|Withdrawal by Subject|0|||
164484546|NCT02852824|594144772|FG000|Overall Study|Adverse Event|0|||
164484547|NCT02852824|594144773|FG001|Overall Study|Adverse Event|0|||
164484548|NCT02852824|594144774|FG002|Overall Study|Adverse Event|0|||
164484549|NCT02852824|594144775|FG003|Overall Study|Adverse Event|0|||
164484550|NCT02852824|594144776|FG004|Overall Study|Adverse Event|2|||
164484551|NCT02852824|594144777|FG005|Overall Study|Adverse Event|0|||
164484552|NCT02852824|594144778|FG006|Overall Study|Adverse Event|0|||
164484553|NCT01860079|594144779|FG000|Overall Study|Physician Decision|14|||
164484554|NCT01860079|594144780|FG001|Overall Study|Physician Decision|22|||
164484555|NCT04867382|594144781|FG000|Overall Study|Did not complete the survey|2|||
164484556|NCT04867382|594144782|FG001|Overall Study|Did not complete the survey|1|||
164484557|NCT05445557|594144783|FG000|Double Blind Part|Lost to Follow-up|1|||
164484558|NCT03803475|594144784|FG000|Overall Study|Physician Decision|1|||
164484559|NCT01323790|594144785|FG000|Overall Study|Other|3|||
164484560|NCT01323790|594144786|FG001|Overall Study|Other|2|||
164484561|NCT01323790|594144787|FG002|Overall Study|Other|1|||
164484562|NCT01323790|594144785|FG000|Overall Study|Lost to Follow-up|11|||
164484563|NCT01323790|594144786|FG001|Overall Study|Lost to Follow-up|9|||
164484564|NCT01323790|594144787|FG002|Overall Study|Lost to Follow-up|9|||
164484565|NCT01323790|594144785|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
164484566|NCT01323790|594144786|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
164484567|NCT01323790|594144787|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
164484568|NCT01323790|594144785|FG000|Overall Study|Lack of Efficacy|3|||
164484569|NCT01323790|594144786|FG001|Overall Study|Lack of Efficacy|0|||
164484570|NCT01323790|594144787|FG002|Overall Study|Lack of Efficacy|3|||
164484571|NCT01323790|594144785|FG000|Overall Study|Adverse Event|11|||
164484572|NCT01323790|594144786|FG001|Overall Study|Adverse Event|24|||
164484573|NCT01323790|594144787|FG002|Overall Study|Adverse Event|12|||
164484574|NCT01323790|594144785|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
164484575|NCT01323790|594144786|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
164484576|NCT01323790|594144787|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
164484577|NCT01323790|594144785|FG000|Overall Study|Withdrawal by Subject|23|||
164484578|NCT01323790|594144786|FG001|Overall Study|Withdrawal by Subject|20|||
164484579|NCT01323790|594144787|FG002|Overall Study|Withdrawal by Subject|13|||
164484580|NCT01323790|594144785|FG000|Overall Study|Did Not Receive Treatment|2|||
164484581|NCT01323790|594144786|FG001|Overall Study|Did Not Receive Treatment|0|||
164484582|NCT01323790|594144787|FG002|Overall Study|Did Not Receive Treatment|1|||
164484583|NCT01323790|594144785|FG000|Overall Study|Severe non-compliance with protocol|2|||
164484584|NCT01323790|594144786|FG001|Overall Study|Severe non-compliance with protocol|2|||
164484585|NCT01323790|594144787|FG002|Overall Study|Severe non-compliance with protocol|2|||
164484586|NCT02915783|594144794|FG000|Overall Study|Death|21|||
164484587|NCT02915783|594144794|FG000|Overall Study|Lost to Follow-up|1|||
164484588|NCT02915783|594144794|FG000|Overall Study|Withdrawal by Subject|2|||
164484589|NCT02950961|594144795|FG000|Overall Study|Study had to stop due to COVID.|7|||
164484590|NCT02432274|594144796|FG000|Overall Study|Death|2|||
164484591|NCT02432274|594144797|FG001|Overall Study|Death|6|||
164484592|NCT02432274|594144798|FG002|Overall Study|Death|7|||
164484593|NCT02432274|594144799|FG003|Overall Study|Death|0|||
164484594|NCT02432274|594144800|FG004|Overall Study|Death|27|||
164484595|NCT02432274|594144801|FG005|Overall Study|Death|7|||
164484596|NCT02432274|594144802|FG006|Overall Study|Death|9|||
164484597|NCT02432274|594144803|FG007|Overall Study|Death|14|||
164484598|NCT02432274|594144796|FG000|Overall Study|Withdrawal of Consent|0|||
164484599|NCT02432274|594144797|FG001|Overall Study|Withdrawal of Consent|0|||
164484600|NCT02432274|594144798|FG002|Overall Study|Withdrawal of Consent|0|||
164484601|NCT02432274|594144799|FG003|Overall Study|Withdrawal of Consent|0|||
164484602|NCT02432274|594144800|FG004|Overall Study|Withdrawal of Consent|2|||
164484603|NCT02432274|594144801|FG005|Overall Study|Withdrawal of Consent|0|||
164484604|NCT02432274|594144802|FG006|Overall Study|Withdrawal of Consent|1|||
164484605|NCT02432274|594144803|FG007|Overall Study|Withdrawal of Consent|2|||
164484606|NCT01736475|594144806|FG000|Overall Study|Adverse Event|4|||
164484607|NCT01736475|594144807|FG001|Overall Study|Adverse Event|0|||
164484608|NCT01736475|594144806|FG000|Overall Study|Withdrawal by Subject|2|||
164484609|NCT01736475|594144807|FG001|Overall Study|Withdrawal by Subject|0|||
164484610|NCT01736475|594144806|FG000|Overall Study|Protocol Violation|4|||
164484611|NCT01736475|594144807|FG001|Overall Study|Protocol Violation|0|||
164484612|NCT01736475|594144806|FG000|Overall Study|Other - Screen failure|1|||
164484613|NCT01736475|594144807|FG001|Overall Study|Other - Screen failure|0|||
164601396|NCT00479557|594559933|FG005|Overall Study|Other|3|||
164601397|NCT00479557|594559934|FG006|Overall Study|Other|0|||
164601398|NCT02509494|594559937|FG000|Overall Study|Lost to Follow-up|8|||
164484614|NCT01736475|594144806|FG000|Overall Study|Other - Surgical procedure|1|||
164484615|NCT01736475|594144807|FG001|Overall Study|Other - Surgical procedure|0|||
164484616|NCT02807857|594144808|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
164484617|NCT02807857|594144808|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
164484618|NCT02807857|594144808|FG000|Follow-Up Set|Withdrawal by Subject|8|||
164484619|NCT02807857|594144808|FG000|Follow-Up Set|Lost to Follow-up|7|||
164484620|NCT02807857|594144808|FG000|Follow-Up Set|Physician Decision|6|||
164484621|NCT02807857|594144808|FG000|Follow-Up Set|Adverse Event|3|||
164484622|NCT02807857|594144808|FG000|Follow-Up Set|Death|27|||
164484623|NCT02807857|594144808|FG000|Follow-Up Set|Relocation|2|||
164714536|NCT02056392|594977006|FG005|Overall Study|Protocol Violation|0|||
164484624|NCT04197713|594144809|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
164484625|NCT04197713|594144810|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
164484626|NCT01079949|594144811|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
164484627|NCT01079949|594144812|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
164484628|NCT01079949|594144811|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
164484629|NCT01079949|594144812|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
164484630|NCT01079949|594144811|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
164484631|NCT01079949|594144812|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
164484632|NCT01079949|594144811|FG000|Overall Study|Randomized but not treated|1|||
164484633|NCT01079949|594144812|FG001|Overall Study|Randomized but not treated|0|||
164484634|NCT01529632|594144813|FG000|Overall Study|Administrative problem|2|||
164484635|NCT01529632|594144814|FG001|Overall Study|Administrative problem|1|||
164484636|NCT01529632|594144813|FG000|Overall Study|Protocol Violation|0|||
164484637|NCT01529632|594144814|FG001|Overall Study|Protocol Violation|1|||
164484638|NCT01529632|594144813|FG000|Overall Study|Adverse Event|1|||
164484639|NCT01529632|594144814|FG001|Overall Study|Adverse Event|1|||
164484640|NCT05184062|594144815|FG000|Overall Study|Lost to Follow-up|5|||
164484641|NCT05184062|594144816|FG001|Overall Study|Lost to Follow-up|1|||
164484642|NCT05184062|594144815|FG000|Overall Study|Withdrawal by Subject|1|||
164484643|NCT05184062|594144816|FG001|Overall Study|Withdrawal by Subject|0|||
164484644|NCT04914897|594146459|FG000|Overall Study|Withdrawal by Subject|3|||
164484645|NCT04914897|594146460|FG001|Overall Study|Withdrawal by Subject|1|||
164484646|NCT04914897|594146461|FG002|Overall Study|Withdrawal by Subject|1|||
164484647|NCT04914897|594146462|FG003|Overall Study|Withdrawal by Subject|1|||
164484648|NCT04914897|594146459|FG000|Overall Study|Poor compliance to protocol|0|||
164484649|NCT04914897|594146460|FG001|Overall Study|Poor compliance to protocol|0|||
164484650|NCT04914897|594146461|FG002|Overall Study|Poor compliance to protocol|1|||
164484651|NCT04914897|594146462|FG003|Overall Study|Poor compliance to protocol|0|||
164484652|NCT04914897|594146459|FG000|Overall Study|Progressive disease|5|||
164484653|NCT04914897|594146460|FG001|Overall Study|Progressive disease|14|||
164484654|NCT04914897|594146461|FG002|Overall Study|Progressive disease|30|||
164484655|NCT04914897|594146462|FG003|Overall Study|Progressive disease|21|||
164484656|NCT04914897|594146459|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
164484657|NCT04914897|594146460|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
164484658|NCT04914897|594146461|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
164484659|NCT04914897|594146462|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
164484660|NCT04914897|594146459|FG000|Overall Study|Other|1|||
164484661|NCT04914897|594146460|FG001|Overall Study|Other|0|||
164484662|NCT04914897|594146461|FG002|Overall Study|Other|0|||
164484663|NCT04914897|594146462|FG003|Overall Study|Other|1|||
164484664|NCT04783389|594146472|FG000|Overall Study|Withdrawal by Subject|2|||
164484665|NCT04783389|594146473|FG001|Overall Study|Withdrawal by Subject|0|||
164484666|NCT04783389|594146474|FG002|Overall Study|Withdrawal by Subject|0|||
164484667|NCT04783389|594146472|FG000|Overall Study|Termination of Study by Sponsor|10|||
164484668|NCT04783389|594146473|FG001|Overall Study|Termination of Study by Sponsor|12|||
164484669|NCT04783389|594146474|FG002|Overall Study|Termination of Study by Sponsor|14|||
164484670|NCT02164578|594146476|FG000|Treatment Period|Withdrawal by Subject|3|||
164484671|NCT02164578|594146477|FG001|Treatment Period|Withdrawal by Subject|3|||
164484672|NCT02164578|594146476|FG000|Treatment Period|Adverse Event|13|||
164484673|NCT02164578|594146477|FG001|Treatment Period|Adverse Event|6|||
164484674|NCT02164578|594146476|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
164484675|NCT02164578|594146477|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
164484676|NCT02164578|594146476|FG000|Treatment Period|Protocol Violation|0|||
164484677|NCT02164578|594146477|FG001|Treatment Period|Protocol Violation|2|||
164484678|NCT02164578|594146476|FG000|Extension Period|Withdrawal by Subject|2|||
164484679|NCT02164578|594146477|FG001|Extension Period|Withdrawal by Subject|0|||
164484680|NCT02164578|594146476|FG000|Extension Period|Adverse Event|4|||
164484681|NCT02164578|594146477|FG001|Extension Period|Adverse Event|0|||
164484682|NCT02164578|594146476|FG000|Extension Period|Expiry of study medication|1|||
164484683|NCT02164578|594146477|FG001|Extension Period|Expiry of study medication|0|||
164484684|NCT02164578|594146476|FG000|Extension Period|Protocol Violation|0|||
164484685|NCT02164578|594146477|FG001|Extension Period|Protocol Violation|1|||
164484686|NCT02507297|594146483|FG000|Overall Study|Withdrawal by Subject|1|||
164484687|NCT02507297|594146484|FG001|Overall Study|Withdrawal by Subject|0|||
164714537|NCT02056392|594977001|FG000|Overall Study|Withdrawal by Subject|1|||
164714538|NCT02056392|594977002|FG001|Overall Study|Withdrawal by Subject|0|||
164714539|NCT02056392|594977003|FG002|Overall Study|Withdrawal by Subject|0|||
164714540|NCT02056392|594977004|FG003|Overall Study|Withdrawal by Subject|0|||
164714541|NCT02056392|594977005|FG004|Overall Study|Withdrawal by Subject|1|||
164714542|NCT02056392|594977006|FG005|Overall Study|Withdrawal by Subject|0|||
164484688|NCT02507297|594146483|FG000|Overall Study|Lost to Follow-up|0|||
164484689|NCT02507297|594146484|FG001|Overall Study|Lost to Follow-up|1|||
164484690|NCT01562275|594146485|FG000|Stage 1|Adverse Event|0|||
164484691|NCT01562275|594146486|FG001|Stage 1|Adverse Event|0|||
164714543|NCT00103610|594977007|FG000|Overall Study|Entered Rescue Procedure|10|||
164484692|NCT01562275|594146487|FG002|Stage 1|Adverse Event|0|||
164601399|NCT02509494|594559938|FG001|Overall Study|Lost to Follow-up|47|||
164601400|NCT02509494|594559939|FG002|Overall Study|Lost to Follow-up|19|||
164601401|NCT02509494|594559940|FG003|Overall Study|Lost to Follow-up|6|||
164601402|NCT02509494|594559941|FG004|Overall Study|Lost to Follow-up|3|||
164601403|NCT02509494|594559942|FG005|Overall Study|Lost to Follow-up|3|||
164484693|NCT01562275|594146488|FG003|Stage 1|Adverse Event|1|||
164484694|NCT01562275|594146489|FG004|Stage 1|Adverse Event|1|||
164484695|NCT01562275|594146490|FG005|Stage 1|Adverse Event|0|||
164601404|NCT02509494|594559943|FG006|Overall Study|Lost to Follow-up|1|||
164601405|NCT02509494|594559944|FG007|Overall Study|Lost to Follow-up|3|||
164601406|NCT02509494|594559945|FG008|Overall Study|Lost to Follow-up|1|||
164601407|NCT02509494|594559937|FG000|Overall Study|Physician Decision|2|||
164601408|NCT02509494|594559938|FG001|Overall Study|Physician Decision|1|||
164601409|NCT02509494|594559939|FG002|Overall Study|Physician Decision|0|||
164601410|NCT02509494|594559940|FG003|Overall Study|Physician Decision|0|||
164601411|NCT02509494|594559941|FG004|Overall Study|Physician Decision|0|||
164601412|NCT02509494|594559942|FG005|Overall Study|Physician Decision|0|||
164601413|NCT02509494|594559943|FG006|Overall Study|Physician Decision|0|||
164601414|NCT02509494|594559944|FG007|Overall Study|Physician Decision|0|||
164601415|NCT02509494|594559945|FG008|Overall Study|Physician Decision|0|||
164601416|NCT02509494|594559937|FG000|Overall Study|Withdrawal by Subject|4|||
164601417|NCT02509494|594559938|FG001|Overall Study|Withdrawal by Subject|17|||
164601418|NCT02509494|594559939|FG002|Overall Study|Withdrawal by Subject|7|||
164601419|NCT02509494|594559940|FG003|Overall Study|Withdrawal by Subject|5|||
164601420|NCT02509494|594559941|FG004|Overall Study|Withdrawal by Subject|0|||
164601421|NCT02509494|594559942|FG005|Overall Study|Withdrawal by Subject|6|||
164601422|NCT02509494|594559943|FG006|Overall Study|Withdrawal by Subject|1|||
164601423|NCT02509494|594559944|FG007|Overall Study|Withdrawal by Subject|2|||
164601424|NCT02509494|594559945|FG008|Overall Study|Withdrawal by Subject|1|||
164601425|NCT02509494|594559937|FG000|Overall Study|Death|0|||
164601426|NCT02509494|594559938|FG001|Overall Study|Death|1|||
164601427|NCT02509494|594559939|FG002|Overall Study|Death|0|||
164601428|NCT02509494|594559940|FG003|Overall Study|Death|0|||
164601429|NCT02509494|594559941|FG004|Overall Study|Death|1|||
164601430|NCT02509494|594559942|FG005|Overall Study|Death|0|||
164601431|NCT02509494|594559943|FG006|Overall Study|Death|0|||
164601432|NCT02509494|594559944|FG007|Overall Study|Death|1|||
164601433|NCT02509494|594559945|FG008|Overall Study|Death|0|||
164601434|NCT02509494|594559937|FG000|Overall Study|Other|0|||
164601435|NCT02509494|594559938|FG001|Overall Study|Other|4|||
164601436|NCT02509494|594559939|FG002|Overall Study|Other|5|||
164484696|NCT01562275|594146491|FG006|Stage 1|Adverse Event|0|||
164484697|NCT01562275|594146492|FG007|Stage 1|Adverse Event|0|||
164484698|NCT01562275|594146493|FG008|Stage 1|Adverse Event|0|||
164484699|NCT01562275|594146494|FG009|Stage 1|Adverse Event|1|||
164484700|NCT01562275|594146495|FG010|Stage 1|Adverse Event|0|||
164484701|NCT01562275|594146496|FG011|Stage 1|Adverse Event|0|||
164484702|NCT01562275|594146497|FG012|Stage 1|Adverse Event|0|||
164484703|NCT01562275|594146485|FG000|Stage 1|Death|1|||
164601437|NCT02509494|594559940|FG003|Overall Study|Other|0|||
164601438|NCT02509494|594559941|FG004|Overall Study|Other|0|||
164601439|NCT02509494|594559942|FG005|Overall Study|Other|0|||
164601440|NCT02509494|594559943|FG006|Overall Study|Other|0|||
164601441|NCT02509494|594559944|FG007|Overall Study|Other|0|||
164601442|NCT02509494|594559945|FG008|Overall Study|Other|0|||
164601443|NCT02509494|594559937|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164601444|NCT02509494|594559938|FG001|Overall Study|Non-Compliance With Study Drug|11|||
164714544|NCT00103610|594977008|FG001|Overall Study|Entered Rescue Procedure|52|||
164714545|NCT00103610|594977007|FG000|Overall Study|Death|16|||
164714546|NCT00103610|594977008|FG001|Overall Study|Death|12|||
164484704|NCT01562275|594146486|FG001|Stage 1|Death|0|||
164601445|NCT02509494|594559939|FG002|Overall Study|Non-Compliance With Study Drug|7|||
164601446|NCT02509494|594559940|FG003|Overall Study|Non-Compliance With Study Drug|0|||
164601447|NCT02509494|594559941|FG004|Overall Study|Non-Compliance With Study Drug|1|||
164601448|NCT02509494|594559942|FG005|Overall Study|Non-Compliance With Study Drug|2|||
164601449|NCT02509494|594559943|FG006|Overall Study|Non-Compliance With Study Drug|1|||
164601450|NCT02509494|594559944|FG007|Overall Study|Non-Compliance With Study Drug|1|||
164601451|NCT02509494|594559945|FG008|Overall Study|Non-Compliance With Study Drug|0|||
164601452|NCT01511107|594559946|FG000|Overall Study|Ineligible|3|||
164601453|NCT01511107|594559947|FG001|Overall Study|Ineligible|2|||
164601454|NCT01511107|594559946|FG000|Overall Study|Lost to Follow-up|10|||
164601455|NCT01511107|594559947|FG001|Overall Study|Lost to Follow-up|19|||
164601456|NCT01511107|594559946|FG000|Overall Study|Withdrawal by Subject|9|||
164601457|NCT01511107|594559947|FG001|Overall Study|Withdrawal by Subject|20|||
164601458|NCT05371912|594559948|FG000|Overall Study|Lost to Follow-up|3|||
164714547|NCT00103610|594977007|FG000|Overall Study|Elective Withdrawal|4|||
164484705|NCT01562275|594146487|FG002|Stage 1|Death|0|||
164484706|NCT01562275|594146488|FG003|Stage 1|Death|0|||
164484707|NCT01562275|594146489|FG004|Stage 1|Death|0|||
164601459|NCT05371912|594559949|FG001|Overall Study|Lost to Follow-up|2|||
164601460|NCT04752189|594559950|FG000|Overall Study|Withdrawal by Subject|0|||
164601461|NCT04752189|594559951|FG001|Overall Study|Withdrawal by Subject|150|||
164484708|NCT01562275|594146490|FG005|Stage 1|Death|0|||
164484709|NCT01562275|594146491|FG006|Stage 1|Death|0|||
164484710|NCT01562275|594146492|FG007|Stage 1|Death|0|||
164484711|NCT01562275|594146493|FG008|Stage 1|Death|0|||
164484712|NCT01562275|594146494|FG009|Stage 1|Death|0|||
164484713|NCT01562275|594146495|FG010|Stage 1|Death|0|||
164484714|NCT01562275|594146496|FG011|Stage 1|Death|0|||
164484715|NCT01562275|594146497|FG012|Stage 1|Death|0|||
164484716|NCT01562275|594146485|FG000|Stage 1|Non Compliance|0|||
164484717|NCT01562275|594146486|FG001|Stage 1|Non Compliance|0|||
164484718|NCT01562275|594146487|FG002|Stage 1|Non Compliance|1|||
164484719|NCT01562275|594146488|FG003|Stage 1|Non Compliance|0|||
164484720|NCT01562275|594146489|FG004|Stage 1|Non Compliance|0|||
164484721|NCT01562275|594146490|FG005|Stage 1|Non Compliance|0|||
164484722|NCT01562275|594146491|FG006|Stage 1|Non Compliance|0|||
164484723|NCT01562275|594146492|FG007|Stage 1|Non Compliance|0|||
164484724|NCT01562275|594146493|FG008|Stage 1|Non Compliance|0|||
164484725|NCT01562275|594146494|FG009|Stage 1|Non Compliance|0|||
164484726|NCT01562275|594146495|FG010|Stage 1|Non Compliance|0|||
164484727|NCT01562275|594146496|FG011|Stage 1|Non Compliance|0|||
164484728|NCT01562275|594146497|FG012|Stage 1|Non Compliance|0|||
164484729|NCT01562275|594146485|FG000|Stage 1|Physician Decision|0|||
164484730|NCT01562275|594146486|FG001|Stage 1|Physician Decision|0|||
164484731|NCT01562275|594146487|FG002|Stage 1|Physician Decision|0|||
164484732|NCT01562275|594146488|FG003|Stage 1|Physician Decision|0|||
164484733|NCT01562275|594146489|FG004|Stage 1|Physician Decision|1|||
164484734|NCT01562275|594146490|FG005|Stage 1|Physician Decision|0|||
164484735|NCT01562275|594146491|FG006|Stage 1|Physician Decision|1|||
164484736|NCT01562275|594146492|FG007|Stage 1|Physician Decision|0|||
164484737|NCT01562275|594146493|FG008|Stage 1|Physician Decision|1|||
164484738|NCT01562275|594146494|FG009|Stage 1|Physician Decision|0|||
164484739|NCT01562275|594146495|FG010|Stage 1|Physician Decision|0|||
164484740|NCT01562275|594146496|FG011|Stage 1|Physician Decision|0|||
164484741|NCT01562275|594146497|FG012|Stage 1|Physician Decision|0|||
164484742|NCT01562275|594146485|FG000|Stage 1|Progression of Disease|2|||
164484743|NCT01562275|594146486|FG001|Stage 1|Progression of Disease|6|||
164484744|NCT01562275|594146487|FG002|Stage 1|Progression of Disease|2|||
164484745|NCT01562275|594146488|FG003|Stage 1|Progression of Disease|1|||
164484746|NCT01562275|594146489|FG004|Stage 1|Progression of Disease|2|||
164484747|NCT01562275|594146490|FG005|Stage 1|Progression of Disease|4|||
164484748|NCT01562275|594146491|FG006|Stage 1|Progression of Disease|1|||
164484749|NCT01562275|594146492|FG007|Stage 1|Progression of Disease|7|||
164484750|NCT01562275|594146493|FG008|Stage 1|Progression of Disease|2|||
164484751|NCT01562275|594146494|FG009|Stage 1|Progression of Disease|5|||
164484752|NCT01562275|594146495|FG010|Stage 1|Progression of Disease|3|||
164484753|NCT01562275|594146496|FG011|Stage 1|Progression of Disease|0|||
164484754|NCT01562275|594146497|FG012|Stage 1|Progression of Disease|0|||
164484755|NCT01562275|594146485|FG000|Stage 1|Withdrawal by Subject|0|||
164484756|NCT01562275|594146486|FG001|Stage 1|Withdrawal by Subject|1|||
164484757|NCT01562275|594146487|FG002|Stage 1|Withdrawal by Subject|0|||
164484758|NCT01562275|594146488|FG003|Stage 1|Withdrawal by Subject|2|||
164484759|NCT01562275|594146489|FG004|Stage 1|Withdrawal by Subject|0|||
164484760|NCT01562275|594146490|FG005|Stage 1|Withdrawal by Subject|0|||
164484761|NCT01562275|594146491|FG006|Stage 1|Withdrawal by Subject|1|||
164484762|NCT01562275|594146492|FG007|Stage 1|Withdrawal by Subject|0|||
164484763|NCT01562275|594146493|FG008|Stage 1|Withdrawal by Subject|0|||
164484764|NCT01562275|594146494|FG009|Stage 1|Withdrawal by Subject|1|||
164484765|NCT01562275|594146495|FG010|Stage 1|Withdrawal by Subject|0|||
164484766|NCT01562275|594146496|FG011|Stage 1|Withdrawal by Subject|0|||
164484767|NCT01562275|594146497|FG012|Stage 1|Withdrawal by Subject|0|||
164484768|NCT01562275|594146485|FG000|Stage 2|Death|0|||
164484769|NCT01562275|594146486|FG001|Stage 2|Death|0|||
164484770|NCT01562275|594146487|FG002|Stage 2|Death|0|||
164484771|NCT01562275|594146488|FG003|Stage 2|Death|0|||
164484772|NCT01562275|594146489|FG004|Stage 2|Death|0|||
164484773|NCT01562275|594146490|FG005|Stage 2|Death|0|||
164484774|NCT01562275|594146491|FG006|Stage 2|Death|0|||
164484775|NCT01562275|594146492|FG007|Stage 2|Death|0|||
164484776|NCT01562275|594146493|FG008|Stage 2|Death|0|||
164484777|NCT01562275|594146494|FG009|Stage 2|Death|0|||
164484778|NCT01562275|594146495|FG010|Stage 2|Death|0|||
164484779|NCT01562275|594146496|FG011|Stage 2|Death|2|||
164484780|NCT01562275|594146497|FG012|Stage 2|Death|1|||
164484781|NCT01562275|594146485|FG000|Stage 2|Progression of Disease|0|||
164484782|NCT01562275|594146486|FG001|Stage 2|Progression of Disease|0|||
164484783|NCT01562275|594146487|FG002|Stage 2|Progression of Disease|0|||
164484784|NCT01562275|594146488|FG003|Stage 2|Progression of Disease|0|||
164484785|NCT01562275|594146489|FG004|Stage 2|Progression of Disease|0|||
164484786|NCT01562275|594146490|FG005|Stage 2|Progression of Disease|0|||
164484787|NCT01562275|594146491|FG006|Stage 2|Progression of Disease|0|||
164484788|NCT01562275|594146492|FG007|Stage 2|Progression of Disease|0|||
164484789|NCT01562275|594146493|FG008|Stage 2|Progression of Disease|0|||
164484790|NCT01562275|594146494|FG009|Stage 2|Progression of Disease|0|||
164484791|NCT01562275|594146495|FG010|Stage 2|Progression of Disease|0|||
164484792|NCT01562275|594146496|FG011|Stage 2|Progression of Disease|12|||
164484793|NCT01562275|594146497|FG012|Stage 2|Progression of Disease|4|||
164484794|NCT01863368|594146498|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
164484795|NCT01863368|594146499|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
164484796|NCT01863368|594146498|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
164484797|NCT01863368|594146499|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
164484798|NCT01863368|594146498|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
164484799|NCT01863368|594146499|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
164484800|NCT01863368|594146498|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
164484801|NCT01863368|594146499|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
164484802|NCT01863368|594146498|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
164484803|NCT01863368|594146499|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
164484804|NCT01863368|594146498|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
164484805|NCT01863368|594146499|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
164484806|NCT00070707|594146500|FG000|Overall Study|Adverse Event|1|||
164484807|NCT00070707|594146501|FG001|Overall Study|Adverse Event|2|||
164484808|NCT00070707|594146500|FG000|Overall Study|Lack of Efficacy|4|||
164484809|NCT00070707|594146501|FG001|Overall Study|Lack of Efficacy|1|||
164484810|NCT00070707|594146500|FG000|Overall Study|Protocol Violation|8|||
164484811|NCT00070707|594146501|FG001|Overall Study|Protocol Violation|4|||
164484812|NCT00070707|594146500|FG000|Overall Study|Unrelated to Study Medication|1|||
164484813|NCT00070707|594146501|FG001|Overall Study|Unrelated to Study Medication|0|||
164484814|NCT00647699|594146502|FG000|Overall Study|Lost to Follow-up|5|||
164484815|NCT00647699|594146503|FG001|Overall Study|Lost to Follow-up|4|||
164484816|NCT00647699|594146502|FG000|Overall Study|Withdrawal by Subject|3|||
164484817|NCT00647699|594146503|FG001|Overall Study|Withdrawal by Subject|8|||
164484818|NCT04909593|594146504|FG000|Overall Study|Withdrawal by Subject|1|||
164484819|NCT01018992|594146505|FG000|Overall Study|Adverse Event|8|||
164484820|NCT01018992|594146506|FG001|Overall Study|Adverse Event|3|||
164484821|NCT01018992|594146505|FG000|Overall Study|Withdrawal by Subject|3|||
164484822|NCT01018992|594146506|FG001|Overall Study|Withdrawal by Subject|8|||
164484823|NCT01018992|594146505|FG000|Overall Study|Protocol Violation|0|||
164484824|NCT01018992|594146506|FG001|Overall Study|Protocol Violation|4|||
164484825|NCT01018992|594146505|FG000|Overall Study|Lost to Follow-up|5|||
164484826|NCT01018992|594146506|FG001|Overall Study|Lost to Follow-up|1|||
164484827|NCT03029585|594146509|FG000|Overall Study|Death|1|||
164484828|NCT03029585|594146510|FG001|Overall Study|Death|1|||
164484829|NCT03029585|594146509|FG000|Overall Study|Withdrawal by Subject|1|||
164484830|NCT03029585|594146510|FG001|Overall Study|Withdrawal by Subject|0|||
164484831|NCT01241448|594146515|FG000|Overall Study|Adverse Event|1|||
164484832|NCT01241448|594146516|FG001|Overall Study|Adverse Event|0|||
164484833|NCT01241448|594146517|FG002|Overall Study|Adverse Event|2|||
164484834|NCT01241448|594146518|FG003|Overall Study|Adverse Event|2|||
164484835|NCT01241448|594146515|FG000|Overall Study|Lost to Follow-up|2|||
164484836|NCT01241448|594146516|FG001|Overall Study|Lost to Follow-up|1|||
164484837|NCT01241448|594146517|FG002|Overall Study|Lost to Follow-up|1|||
164484838|NCT01241448|594146518|FG003|Overall Study|Lost to Follow-up|1|||
164484839|NCT01241448|594146515|FG000|Overall Study|Physician Decision|0|||
164484840|NCT01241448|594146516|FG001|Overall Study|Physician Decision|2|||
164484841|NCT01241448|594146517|FG002|Overall Study|Physician Decision|0|||
164484842|NCT01241448|594146518|FG003|Overall Study|Physician Decision|0|||
164484843|NCT01241448|594146515|FG000|Overall Study|Protocol Violation|10|||
164484844|NCT01241448|594146516|FG001|Overall Study|Protocol Violation|5|||
164484845|NCT01241448|594146517|FG002|Overall Study|Protocol Violation|3|||
164484846|NCT01241448|594146518|FG003|Overall Study|Protocol Violation|6|||
164484847|NCT01241448|594146515|FG000|Overall Study|Sponsor Decision|17|||
164484848|NCT01241448|594146516|FG001|Overall Study|Sponsor Decision|14|||
164484849|NCT01241448|594146517|FG002|Overall Study|Sponsor Decision|12|||
164484850|NCT01241448|594146518|FG003|Overall Study|Sponsor Decision|6|||
164484851|NCT01241448|594146515|FG000|Overall Study|Withdrawal by Subject|4|||
164484852|NCT01241448|594146516|FG001|Overall Study|Withdrawal by Subject|5|||
164484853|NCT01241448|594146517|FG002|Overall Study|Withdrawal by Subject|3|||
164484854|NCT01241448|594146518|FG003|Overall Study|Withdrawal by Subject|6|||
164484855|NCT01241448|594146515|FG000|Overall Study|Excluded due to data integrity issues|3|||
164484856|NCT01241448|594146516|FG001|Overall Study|Excluded due to data integrity issues|2|||
164484857|NCT01241448|594146517|FG002|Overall Study|Excluded due to data integrity issues|2|||
164484858|NCT01241448|594146518|FG003|Overall Study|Excluded due to data integrity issues|2|||
164484859|NCT02400749|594146519|FG000|Week 0 -16|Withdrawal by Subject|5|||
164484860|NCT02400749|594146520|FG001|Week 0 -16|Withdrawal by Subject|5|||
164484861|NCT02400749|594146519|FG000|Week 0 -16|Adverse Event|3|||
164484862|NCT02400749|594146520|FG001|Week 0 -16|Adverse Event|1|||
164484863|NCT02400749|594146519|FG000|Week 0 -16|Lost to Follow-up|2|||
164484864|NCT02400749|594146520|FG001|Week 0 -16|Lost to Follow-up|0|||
164484865|NCT02400749|594146519|FG000|Week 0 -16|Protocol Violation|1|||
164484866|NCT02400749|594146520|FG001|Week 0 -16|Protocol Violation|0|||
164484867|NCT02400749|594146519|FG000|Week 17 - 32|Withdrawal by Subject|3|||
164601462|NCT04752189|594559950|FG000|Overall Study|Lost to Follow-up|261|||
164484868|NCT02400749|594146520|FG001|Week 17 - 32|Withdrawal by Subject|2|||
164484869|NCT02400749|594146519|FG000|Week 17 - 32|Adverse Event|2|||
164484870|NCT02400749|594146520|FG001|Week 17 - 32|Adverse Event|1|||
164484871|NCT01825785|594146521|FG000|Overall Study|Adverse Event|0|||
164484872|NCT01825785|594146522|FG001|Overall Study|Adverse Event|0|||
164484873|NCT01825785|594146523|FG002|Overall Study|Adverse Event|0|||
164484874|NCT01825785|594146524|FG003|Overall Study|Adverse Event|0|||
164484875|NCT01825785|594146525|FG004|Overall Study|Adverse Event|1|||
164484876|NCT01825785|594146526|FG005|Overall Study|Adverse Event|0|||
164484877|NCT01825785|594146527|FG006|Overall Study|Adverse Event|0|||
164484878|NCT01825785|594146521|FG000|Overall Study|Withdrawal by Subject|0|||
164484879|NCT01825785|594146522|FG001|Overall Study|Withdrawal by Subject|0|||
164484880|NCT01825785|594146523|FG002|Overall Study|Withdrawal by Subject|0|||
164484881|NCT01825785|594146524|FG003|Overall Study|Withdrawal by Subject|0|||
164484882|NCT01825785|594146525|FG004|Overall Study|Withdrawal by Subject|1|||
164484883|NCT01825785|594146526|FG005|Overall Study|Withdrawal by Subject|1|||
164484884|NCT01825785|594146527|FG006|Overall Study|Withdrawal by Subject|0|||
164484885|NCT03340961|594146532|FG000|Overall Study|Adverse Event|1|||
164484886|NCT03340961|594146533|FG001|Overall Study|Adverse Event|3|||
164484887|NCT03340961|594146534|FG002|Overall Study|Adverse Event|2|||
164484888|NCT03340961|594146535|FG003|Overall Study|Adverse Event|4|||
164484889|NCT03340961|594146532|FG000|Overall Study|Lost to Follow-up|0|||
164484890|NCT03340961|594146533|FG001|Overall Study|Lost to Follow-up|1|||
164484891|NCT03340961|594146534|FG002|Overall Study|Lost to Follow-up|0|||
164484892|NCT03340961|594146535|FG003|Overall Study|Lost to Follow-up|1|||
164484893|NCT03340961|594146532|FG000|Overall Study|Withdrawal by Subject|3|||
164484894|NCT03340961|594146533|FG001|Overall Study|Withdrawal by Subject|2|||
164484895|NCT03340961|594146534|FG002|Overall Study|Withdrawal by Subject|4|||
164484896|NCT03340961|594146535|FG003|Overall Study|Withdrawal by Subject|7|||
164484897|NCT03340961|594146532|FG000|Overall Study|Use of prohibited treatment|0|||
164484898|NCT03340961|594146533|FG001|Overall Study|Use of prohibited treatment|3|||
164484899|NCT03340961|594146534|FG002|Overall Study|Use of prohibited treatment|2|||
164484900|NCT03340961|594146535|FG003|Overall Study|Use of prohibited treatment|4|||
164484901|NCT03340961|594146532|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
164484902|NCT03340961|594146533|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
164484903|NCT03340961|594146534|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
164484904|NCT03340961|594146535|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
164484905|NCT03340961|594146532|FG000|Overall Study|Subject developed an exclusion criterion|0|||
164484906|NCT03340961|594146533|FG001|Overall Study|Subject developed an exclusion criterion|1|||
164484907|NCT03340961|594146534|FG002|Overall Study|Subject developed an exclusion criterion|0|||
164484908|NCT03340961|594146535|FG003|Overall Study|Subject developed an exclusion criterion|0|||
164484909|NCT03340961|594146532|FG000|Overall Study|Protocol Violation|1|||
164484910|NCT03340961|594146533|FG001|Overall Study|Protocol Violation|0|||
164484911|NCT03340961|594146534|FG002|Overall Study|Protocol Violation|1|||
164484912|NCT03340961|594146535|FG003|Overall Study|Protocol Violation|0|||
164484913|NCT03340961|594146532|FG000|Overall Study|Adverse Event|1|||
164484914|NCT03340961|594146533|FG001|Overall Study|Adverse Event|1|||
164484915|NCT03340961|594146534|FG002|Overall Study|Adverse Event|0|||
164484916|NCT03340961|594146535|FG003|Overall Study|Adverse Event|0|||
164484917|NCT03340961|594146532|FG000|Overall Study|Lack of Efficacy|0|||
164484918|NCT03340961|594146533|FG001|Overall Study|Lack of Efficacy|0|||
164484919|NCT03340961|594146534|FG002|Overall Study|Lack of Efficacy|0|||
164484920|NCT03340961|594146535|FG003|Overall Study|Lack of Efficacy|1|||
164484921|NCT01286311|594146536|FG000|Overall Study|Physician did not want outreach sent|14|||
164484922|NCT01286311|594146537|FG001|Overall Study|Physician did not want outreach sent|0|||
164484923|NCT01437540|594146540|FG000|Overall Study|Not listed below|7|||
164484924|NCT01437540|594146541|FG001|Overall Study|Not listed below|6|||
164484925|NCT01437540|594146540|FG000|Overall Study|COPD exacerbation|13|||
164484926|NCT01437540|594146541|FG001|Overall Study|COPD exacerbation|3|||
164484927|NCT01437540|594146540|FG000|Overall Study|Lost to Follow-up|3|||
164484928|NCT01437540|594146541|FG001|Overall Study|Lost to Follow-up|5|||
164484929|NCT01437540|594146540|FG000|Overall Study|Lack of Efficacy|23|||
164484930|NCT01437540|594146541|FG001|Overall Study|Lack of Efficacy|11|||
164484931|NCT01437540|594146540|FG000|Overall Study|Protocol Violation|24|||
164484932|NCT01437540|594146541|FG001|Overall Study|Protocol Violation|12|||
164484933|NCT01437540|594146540|FG000|Overall Study|Adverse Event|26|||
164714548|NCT00103610|594977008|FG001|Overall Study|Elective Withdrawal|0|||
164484934|NCT01437540|594146541|FG001|Overall Study|Adverse Event|13|||
164484935|NCT01437540|594146540|FG000|Overall Study|Withdrawal by Subject|31|||
164484936|NCT01437540|594146541|FG001|Overall Study|Withdrawal by Subject|15|||
164484937|NCT01381549|594146544|FG000|Overall Study|Ineligible: No organisms isolated|0|||
164484938|NCT01381549|594146545|FG001|Overall Study|Ineligible: No organisms isolated|0|||
164484939|NCT01381549|594146546|FG002|Overall Study|Ineligible: No organisms isolated|1|||
164484940|NCT04328467|594146551|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
164484941|NCT04328467|594146552|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
164484942|NCT04328467|594146553|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
164484943|NCT00990184|594146554|FG000|Overall Study|Physician Decision|1|||
164714549|NCT00103610|594977007|FG000|Overall Study|Lost to Follow-up|3|||
164484944|NCT01975701|594146555|FG000|Overall Study|Lost to Follow-up|1|||
164484945|NCT01975701|594146555|FG000|Overall Study|Death|23|||
164484946|NCT01975701|594146555|FG000|Overall Study|Physician Decision|1|||
164484947|NCT01877720|594146556|FG000|Overall Study|Adverse Event|1|||
164484948|NCT01877720|594146557|FG001|Overall Study|Adverse Event|0|||
164484949|NCT00267956|594146560|FG000|Controlled Period|Adverse Event|4|||
164484950|NCT00267956|594146561|FG001|Controlled Period|Adverse Event|1|||
164484951|NCT00267956|594146562|FG002|Controlled Period|Adverse Event|0|||
164484952|NCT00267956|594146563|FG003|Controlled Period|Adverse Event|0|||
164484953|NCT00267956|594146560|FG000|Controlled Period|Lack of Efficacy|4|||
164484954|NCT00267956|594146561|FG001|Controlled Period|Lack of Efficacy|2|||
164484955|NCT00267956|594146562|FG002|Controlled Period|Lack of Efficacy|0|||
164484956|NCT00267956|594146563|FG003|Controlled Period|Lack of Efficacy|0|||
164484957|NCT00267956|594146560|FG000|Controlled Period|Lost to Follow-up|2|||
164484958|NCT00267956|594146561|FG001|Controlled Period|Lost to Follow-up|0|||
164484959|NCT00267956|594146562|FG002|Controlled Period|Lost to Follow-up|0|||
164484960|NCT00267956|594146563|FG003|Controlled Period|Lost to Follow-up|0|||
164484961|NCT00267956|594146560|FG000|Controlled Period|Withdrew consent|3|||
164484962|NCT00267956|594146561|FG001|Controlled Period|Withdrew consent|1|||
164484963|NCT00267956|594146562|FG002|Controlled Period|Withdrew consent|0|||
164484964|NCT00267956|594146563|FG003|Controlled Period|Withdrew consent|0|||
164484965|NCT00267956|594146560|FG000|After Controlled Period|Adverse Event|0|||
164484966|NCT00267956|594146561|FG001|After Controlled Period|Adverse Event|0|||
164484967|NCT00267956|594146562|FG002|After Controlled Period|Adverse Event|2|||
164484968|NCT00267956|594146563|FG003|After Controlled Period|Adverse Event|1|||
164484969|NCT00267956|594146560|FG000|After Controlled Period|Lack of Efficacy|0|||
164484970|NCT00267956|594146561|FG001|After Controlled Period|Lack of Efficacy|0|||
164484971|NCT00267956|594146562|FG002|After Controlled Period|Lack of Efficacy|1|||
164484972|NCT00267956|594146563|FG003|After Controlled Period|Lack of Efficacy|1|||
164484973|NCT00267956|594146560|FG000|After Controlled Period|Lost to Follow-up|0|||
164484974|NCT00267956|594146561|FG001|After Controlled Period|Lost to Follow-up|0|||
164484975|NCT00267956|594146562|FG002|After Controlled Period|Lost to Follow-up|1|||
164484976|NCT00267956|594146563|FG003|After Controlled Period|Lost to Follow-up|0|||
164484977|NCT00267956|594146560|FG000|After Controlled Period|Withdrew consent|0|||
164484978|NCT00267956|594146561|FG001|After Controlled Period|Withdrew consent|0|||
164484979|NCT00267956|594146562|FG002|After Controlled Period|Withdrew consent|1|||
164484980|NCT00267956|594146563|FG003|After Controlled Period|Withdrew consent|0|||
164484981|NCT01918033|594146564|FG000|Overall Study|Adverse Event|1|||
164484982|NCT01918033|594146565|FG001|Overall Study|Adverse Event|0|||
164484983|NCT01918033|594146566|FG002|Overall Study|Adverse Event|2|||
164484984|NCT01918033|594146564|FG000|Overall Study|Lost to Follow-up|0|||
164484985|NCT01918033|594146565|FG001|Overall Study|Lost to Follow-up|1|||
164484986|NCT01918033|594146566|FG002|Overall Study|Lost to Follow-up|0|||
164484987|NCT01918033|594146564|FG000|Overall Study|Protocol Violation|2|||
164484988|NCT01918033|594146565|FG001|Overall Study|Protocol Violation|0|||
164484989|NCT01918033|594146566|FG002|Overall Study|Protocol Violation|1|||
164714550|NCT00103610|594977008|FG001|Overall Study|Lost to Follow-up|1|||
164714551|NCT00103610|594977007|FG000|Overall Study|Adverse Event|2|||
164714552|NCT00103610|594977008|FG001|Overall Study|Adverse Event|2|||
164714553|NCT00103610|594977007|FG000|Overall Study|Other|2|||
164714554|NCT00103610|594977008|FG001|Overall Study|Other|7|||
164714555|NCT00103610|594977007|FG000|Overall Study|Failed mobilization|1|||
164714556|NCT00103610|594977008|FG001|Overall Study|Failed mobilization|5|||
164484990|NCT01918033|594146564|FG000|Overall Study|Withdrawal by Subject|2|||
164484991|NCT01918033|594146565|FG001|Overall Study|Withdrawal by Subject|1|||
164484992|NCT01918033|594146566|FG002|Overall Study|Withdrawal by Subject|0|||
164484993|NCT04679675|594146567|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
164484994|NCT04679675|594146568|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
164484995|NCT04679675|594146569|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
164484996|NCT04679675|594146570|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
164484997|NCT04679675|594146567|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
164601463|NCT04752189|594559951|FG001|Overall Study|Lost to Follow-up|126|||
164601464|NCT00975195|594559952|FG000|Overall Study|Adverse Event|108|||
164601465|NCT00975195|594559953|FG001|Overall Study|Adverse Event|101|||
164601466|NCT00975195|594559952|FG000|Overall Study|Lack of Efficacy|6|||
164601467|NCT00975195|594559953|FG001|Overall Study|Lack of Efficacy|6|||
164601468|NCT00975195|594559952|FG000|Overall Study|Protocol Violation|27|||
164601469|NCT00975195|594559953|FG001|Overall Study|Protocol Violation|23|||
164601470|NCT00975195|594559952|FG000|Overall Study|Lost to Follow-up|9|||
164601471|NCT00975195|594559953|FG001|Overall Study|Lost to Follow-up|7|||
164601472|NCT00975195|594559952|FG000|Overall Study|Withdrawal by Subject|48|||
164601473|NCT00975195|594559953|FG001|Overall Study|Withdrawal by Subject|61|||
164601474|NCT00975195|594559952|FG000|Overall Study|Other reason not defined above|29|||
164714557|NCT00103610|594977007|FG000|Overall Study|Noncompliance|0|||
164714558|NCT00103610|594977008|FG001|Overall Study|Noncompliance|1|||
164484998|NCT04679675|594146568|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
164484999|NCT04679675|594146569|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
164485000|NCT04679675|594146570|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
164485001|NCT01494467|594146578|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
164485002|NCT01494467|594146579|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
164485003|NCT01494467|594146578|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
164485004|NCT01494467|594146579|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
164485005|NCT01494467|594146578|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
164485006|NCT01494467|594146579|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
164485007|NCT01494467|594146578|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
164485008|NCT01494467|594146579|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
164485009|NCT01494467|594146578|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
164485010|NCT01494467|594146579|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
164485011|NCT01494467|594146578|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
164485012|NCT01494467|594146579|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
164485013|NCT01494467|594146578|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
164485014|NCT01494467|594146579|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
164485015|NCT01494467|594146578|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
164485016|NCT01494467|594146579|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
164485017|NCT01494467|594146578|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
164485018|NCT01494467|594146579|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
164485019|NCT01494467|594146578|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
164485020|NCT01494467|594146579|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
164485021|NCT01494467|594146578|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
164485022|NCT01494467|594146579|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
164485023|NCT01494467|594146578|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
164485024|NCT01494467|594146579|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
164485025|NCT01494467|594146578|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
164485026|NCT01494467|594146579|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
164485027|NCT01494467|594146578|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
164485028|NCT01494467|594146579|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
164485029|NCT01722097|594146584|FG000|Overall Study|Patient sheets not returned|6|||
164485030|NCT01722097|594146585|FG001|Overall Study|Patient sheets not returned|5|||
164485031|NCT01535261|594146586|FG000|Overall Study|Physician Decision|8|||
164485032|NCT01535261|594146586|FG000|Overall Study|Protocol Violation|3|||
164485033|NCT01535261|594146586|FG000|Overall Study|Death|5|||
164485034|NCT01535261|594146586|FG000|Overall Study|Lost to Follow-up|8|||
164485035|NCT01535261|594146586|FG000|Overall Study|Withdrawal by Subject|14|||
164485036|NCT01535261|594146586|FG000|Overall Study|Adverse Event|12|||
164485037|NCT01137682|594146587|FG000|Overall Study|Adverse Event-CORE|2|||
164485038|NCT01137682|594146588|FG001|Overall Study|Adverse Event-CORE|4|||
164485039|NCT01137682|594146589|FG002|Overall Study|Adverse Event-CORE|0|||
164485040|NCT01137682|594146587|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
164485041|NCT01137682|594146588|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
164485042|NCT01137682|594146589|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
164485043|NCT01137682|594146587|FG000|Overall Study|Administrative problems-CORE|2|||
164485044|NCT01137682|594146588|FG001|Overall Study|Administrative problems-CORE|1|||
164485045|NCT01137682|594146589|FG002|Overall Study|Administrative problems-CORE|0|||
164485046|NCT01137682|594146587|FG000|Overall Study|Protocol Violation-CORE|0|||
164485047|NCT01137682|594146588|FG001|Overall Study|Protocol Violation-CORE|1|||
164485048|NCT01137682|594146589|FG002|Overall Study|Protocol Violation-CORE|1|||
164485049|NCT01137682|594146587|FG000|Overall Study|Adverse Event-Extension|4|||
164485050|NCT01137682|594146588|FG001|Overall Study|Adverse Event-Extension|8|||
164485051|NCT01137682|594146589|FG002|Overall Study|Adverse Event-Extension|7|||
164601475|NCT00975195|594559953|FG001|Overall Study|Other reason not defined above|33|||
164601476|NCT00975195|594559952|FG000|Overall Study|Not treated|1|||
164601477|NCT00975195|594559953|FG001|Overall Study|Not treated|2|||
164485052|NCT01137682|594146587|FG000|Overall Study|Lack of Efficacy-Extension|15|||
164601478|NCT03003403|594559954|FG000|Overall Study|Ineligible|8|||
164601479|NCT03003403|594559955|FG001|Overall Study|Ineligible|7|||
164601480|NCT03003403|594559954|FG000|Overall Study|Withdrawal by Subject|3|||
164601481|NCT03003403|594559955|FG001|Overall Study|Withdrawal by Subject|1|||
164601482|NCT01255306|594562571|FG000|Overall Study|Physician Decision|1|||
164714559|NCT00658021|594977009|FG000|28-Week Treatment Period|Adverse Event|3|||
164714560|NCT00658021|594977010|FG001|28-Week Treatment Period|Adverse Event|1|||
164714561|NCT00658021|594977011|FG002|28-Week Treatment Period|Adverse Event|0|||
164714562|NCT00658021|594977009|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
164144911|NCT05199090|592891826|FG004|Overall Study|Physician Decision|0|||
164601483|NCT01255306|594562572|FG001|Overall Study|Physician Decision|1|||
164601484|NCT05195359|594562573|FG000|Overall Study|Lost to Follow-up|124|||
164601485|NCT05195359|594562574|FG001|Overall Study|Lost to Follow-up|34|||
164485053|NCT01137682|594146588|FG001|Overall Study|Lack of Efficacy-Extension|9|||
164485054|NCT01137682|594146589|FG002|Overall Study|Lack of Efficacy-Extension|13|||
164485055|NCT01137682|594146587|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
164485056|NCT01137682|594146588|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
164485057|NCT01137682|594146589|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
164485058|NCT01137682|594146587|FG000|Overall Study|Lost to Follow Up-Extension|0|||
164485059|NCT01137682|594146588|FG001|Overall Study|Lost to Follow Up-Extension|1|||
164485060|NCT01137682|594146589|FG002|Overall Study|Lost to Follow Up-Extension|0|||
164485061|NCT01137682|594146587|FG000|Overall Study|Administrative problems-Extension|0|||
164485062|NCT01137682|594146588|FG001|Overall Study|Administrative problems-Extension|2|||
164485063|NCT01137682|594146589|FG002|Overall Study|Administrative problems-Extension|0|||
164485064|NCT01137682|594146587|FG000|Overall Study|Death-Extension|2|||
164485065|NCT01137682|594146588|FG001|Overall Study|Death-Extension|0|||
164485066|NCT01137682|594146589|FG002|Overall Study|Death-Extension|0|||
164485067|NCT01137682|594146587|FG000|Overall Study|Protocol Violation-Extension|2|||
164485068|NCT01137682|594146588|FG001|Overall Study|Protocol Violation-Extension|1|||
164485069|NCT01137682|594146589|FG002|Overall Study|Protocol Violation-Extension|0|||
164485070|NCT01137682|594146587|FG000|Overall Study|Did not enter extension|2|||
164485071|NCT01137682|594146588|FG001|Overall Study|Did not enter extension|3|||
164485072|NCT01137682|594146589|FG002|Overall Study|Did not enter extension|2|||
164485073|NCT01137682|594146587|FG000|Overall Study|Did not receive treatment in extension|0|||
164485074|NCT01137682|594146588|FG001|Overall Study|Did not receive treatment in extension|0|||
164485075|NCT01137682|594146589|FG002|Overall Study|Did not receive treatment in extension|1|||
164485076|NCT02009332|594146590|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
164485077|NCT02009332|594146591|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
164485078|NCT02009332|594146592|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
164485079|NCT02009332|594146593|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
164485080|NCT02009332|594146594|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
164485081|NCT02009332|594146595|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
164485082|NCT02009332|594146590|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
164485083|NCT02009332|594146591|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
164485084|NCT02009332|594146592|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
164485085|NCT02009332|594146593|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
164485086|NCT02009332|594146594|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
164485087|NCT02009332|594146595|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
164485088|NCT02009332|594146590|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
164485089|NCT02009332|594146591|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
164485090|NCT02009332|594146592|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
164485091|NCT02009332|594146593|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
164485092|NCT02009332|594146594|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
164485093|NCT02009332|594146595|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
164485094|NCT01912599|594146596|FG000|Overall Study|Withdrawal by Subject|0|||
164485095|NCT01912599|594146597|FG001|Overall Study|Withdrawal by Subject|1|||
164485096|NCT01757288|594146599|FG000|Overall Study|Consent withdrawal|0|||
164485097|NCT01757288|594146600|FG001|Overall Study|Consent withdrawal|4|||
164485098|NCT01757288|594146601|FG002|Overall Study|Consent withdrawal|4|||
164485099|NCT01757288|594146599|FG000|Overall Study|Patient off study, IRB hold.|0|||
164485100|NCT01757288|594146600|FG001|Overall Study|Patient off study, IRB hold.|0|||
164485101|NCT01757288|594146601|FG002|Overall Study|Patient off study, IRB hold.|1|||
164485102|NCT01757288|594146599|FG000|Overall Study|Patient death prior to starting treatment|0|||
164485103|NCT01757288|594146600|FG001|Overall Study|Patient death prior to starting treatment|0|||
164485104|NCT01757288|594146601|FG002|Overall Study|Patient death prior to starting treatment|1|||
164485105|NCT01757288|594146599|FG000|Overall Study|Wrong medication administered|0|||
164485106|NCT01757288|594146600|FG001|Overall Study|Wrong medication administered|1|||
164485107|NCT01757288|594146601|FG002|Overall Study|Wrong medication administered|0|||
164485108|NCT01757288|594146599|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
164485109|NCT01757288|594146600|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
164485110|NCT01757288|594146601|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
164485111|NCT01757288|594146599|FG000|Overall Study|Not meeting protocol constraints|0|||
164601486|NCT01146951|594562579|FG000|Overall Study|Adverse Event|4|||
164601487|NCT01146951|594562580|FG001|Overall Study|Adverse Event|1|||
164601488|NCT01677624|594562585|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
164601489|NCT01747811|594562586|FG000|Overall Study|Lack of Efficacy|2|||
164601490|NCT01747811|594562587|FG001|Overall Study|Lack of Efficacy|4|||
164601491|NCT01617655|594562591|FG000|Overall Study|Adverse Event|2|||
164485112|NCT01757288|594146600|FG001|Overall Study|Not meeting protocol constraints|1|||
164485113|NCT01757288|594146601|FG002|Overall Study|Not meeting protocol constraints|1|||
164485114|NCT01757288|594146599|FG000|Overall Study|Multiple missed appointments|0|||
164485115|NCT01757288|594146600|FG001|Overall Study|Multiple missed appointments|1|||
164485116|NCT01757288|594146601|FG002|Overall Study|Multiple missed appointments|0|||
164601492|NCT01617655|594562592|FG001|Overall Study|Adverse Event|3|||
164485117|NCT01757288|594146599|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
164485118|NCT01757288|594146600|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
164485119|NCT01757288|594146601|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
164485120|NCT01757288|594146599|FG000|Overall Study|>2 weeks treatment break|0|||
164485121|NCT01757288|594146600|FG001|Overall Study|>2 weeks treatment break|0|||
164485122|NCT01757288|594146601|FG002|Overall Study|>2 weeks treatment break|1|||
164485123|NCT02825550|594146602|FG000|Overall Study|Physician Decision|1|||
164485124|NCT03386344|594146603|FG000|Overall Study|Adverse Event|6|||
164485125|NCT03386344|594146604|FG001|Overall Study|Adverse Event|3|||
164485126|NCT03386344|594146605|FG002|Overall Study|Adverse Event|1|||
164485127|NCT03386344|594146603|FG000|Overall Study|Poor Compliance to Protocol|0|||
164485128|NCT03386344|594146604|FG001|Overall Study|Poor Compliance to Protocol|1|||
164485129|NCT03386344|594146605|FG002|Overall Study|Poor Compliance to Protocol|0|||
164485130|NCT03386344|594146603|FG000|Overall Study|Study Terminated by Sponsor|101|||
164485131|NCT03386344|594146604|FG001|Overall Study|Study Terminated by Sponsor|102|||
164485132|NCT03386344|594146605|FG002|Overall Study|Study Terminated by Sponsor|106|||
164485133|NCT03386344|594146603|FG000|Overall Study|Lost to Follow-up|3|||
164485134|NCT03386344|594146604|FG001|Overall Study|Lost to Follow-up|2|||
164485135|NCT03386344|594146605|FG002|Overall Study|Lost to Follow-up|1|||
164485136|NCT03386344|594146603|FG000|Overall Study|At the Participant's own Request|7|||
164485137|NCT03386344|594146604|FG001|Overall Study|At the Participant's own Request|7|||
164485138|NCT03386344|594146605|FG002|Overall Study|At the Participant's own Request|8|||
164485139|NCT03386344|594146603|FG000|Overall Study|Reason not Specified|0|||
164485140|NCT03386344|594146604|FG001|Overall Study|Reason not Specified|1|||
164485141|NCT03386344|594146605|FG002|Overall Study|Reason not Specified|0|||
164485142|NCT01077284|594146606|FG000|Overall Study|Adverse Event|2|||
164485143|NCT01077284|594146607|FG001|Overall Study|Adverse Event|0|||
164485144|NCT01077284|594146608|FG002|Overall Study|Adverse Event|1|||
164485145|NCT01077284|594146606|FG000|Overall Study|Lost to Follow-up|1|||
164485146|NCT01077284|594146607|FG001|Overall Study|Lost to Follow-up|2|||
164485147|NCT01077284|594146608|FG002|Overall Study|Lost to Follow-up|0|||
164485148|NCT01077284|594146606|FG000|Overall Study|Withdrawal by Subject|2|||
164485149|NCT01077284|594146607|FG001|Overall Study|Withdrawal by Subject|3|||
164485150|NCT01077284|594146608|FG002|Overall Study|Withdrawal by Subject|1|||
164485151|NCT01077284|594146606|FG000|Overall Study|Other|0|||
164485152|NCT01077284|594146607|FG001|Overall Study|Other|0|||
164485153|NCT01077284|594146608|FG002|Overall Study|Other|1|||
164485154|NCT00042939|594146613|FG000|Overall Study|Adverse Event|6|||
164485155|NCT00042939|594146614|FG001|Overall Study|Adverse Event|7|||
164485156|NCT00042939|594146613|FG000|Overall Study|Death|3|||
164485157|NCT00042939|594146614|FG001|Overall Study|Death|2|||
164485158|NCT00042939|594146613|FG000|Overall Study|Withdrawal by Subject|3|||
164485159|NCT00042939|594146614|FG001|Overall Study|Withdrawal by Subject|4|||
164485160|NCT00042939|594146613|FG000|Overall Study|Other disease|1|||
164485161|NCT00042939|594146614|FG001|Overall Study|Other disease|0|||
164485162|NCT00042939|594146613|FG000|Overall Study|Ineligible|2|||
164485163|NCT00042939|594146614|FG001|Overall Study|Ineligible|2|||
164485164|NCT00042939|594146613|FG000|Overall Study|Deterioration of health|3|||
164485165|NCT00042939|594146614|FG001|Overall Study|Deterioration of health|4|||
164485166|NCT00042939|594146613|FG000|Overall Study|QOL diminished|1|||
164485167|NCT00042939|594146614|FG001|Overall Study|QOL diminished|0|||
164485168|NCT00042939|594146613|FG000|Overall Study|Rising ca 19-9|1|||
164485169|NCT00042939|594146614|FG001|Overall Study|Rising ca 19-9|0|||
164485170|NCT00042939|594146613|FG000|Overall Study|Patient non-compliance|1|||
164485171|NCT00042939|594146614|FG001|Overall Study|Patient non-compliance|0|||
164485172|NCT00042939|594146613|FG000|Overall Study|Still on treatment|1|||
164485173|NCT00042939|594146614|FG001|Overall Study|Still on treatment|0|||
164485174|NCT00042939|594146613|FG000|Overall Study|Treatment break > 4 weeks|0|||
164485175|NCT00042939|594146614|FG001|Overall Study|Treatment break > 4 weeks|1|||
164485176|NCT00042939|594146613|FG000|Overall Study|Did not start treatment|2|||
164485177|NCT00042939|594146614|FG001|Overall Study|Did not start treatment|1|||
164485178|NCT03349476|594146615|FG000|Overall Study|Physician Decision|3|||
164485179|NCT02525744|594146616|FG000|Period 1|Physician Decision|0|||
164485180|NCT02525744|594146617|FG001|Period 1|Physician Decision|0|||
164485181|NCT02525744|594146618|FG002|Period 1|Physician Decision|1|||
164485182|NCT02525744|594146619|FG003|Period 1|Physician Decision|0|||
164485183|NCT02525744|594146616|FG000|Period 3|Adverse Event|0|||
164485184|NCT02525744|594146617|FG001|Period 3|Adverse Event|1|||
164485185|NCT02525744|594146618|FG002|Period 3|Adverse Event|0|||
164485186|NCT02525744|594146619|FG003|Period 3|Adverse Event|0|||
164485187|NCT02525744|594146616|FG000|Period 4|Withdrawal by Subject|1|||
164485188|NCT02525744|594146617|FG001|Period 4|Withdrawal by Subject|0|||
164485189|NCT02525744|594146618|FG002|Period 4|Withdrawal by Subject|0|||
164485190|NCT02525744|594146619|FG003|Period 4|Withdrawal by Subject|0|||
164485191|NCT02525744|594146616|FG000|Period 5|Physician Decision|1|||
164485192|NCT02525744|594146617|FG001|Period 5|Physician Decision|0|||
164485193|NCT02525744|594146618|FG002|Period 5|Physician Decision|0|||
164485194|NCT02525744|594146619|FG003|Period 5|Physician Decision|0|||
164485195|NCT00472082|594146620|FG000|Overall Study|Study prematurely terminated|5|||
164485196|NCT02069379|594146623|FG000|Baseline Measurements|Lost to Follow-up|1|||
164485197|NCT02069379|594146624|FG001|Baseline Measurements|Lost to Follow-up|0|||
164485198|NCT02069379|594146625|FG002|Baseline Measurements|Lost to Follow-up|0|||
164485199|NCT02069379|594146626|FG003|Baseline Measurements|Lost to Follow-up|0|||
164714563|NCT00658021|594977010|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
164714564|NCT00658021|594977011|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
164485200|NCT02069379|594146623|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
164485201|NCT02069379|594146624|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
164485202|NCT02069379|594146625|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
164485203|NCT02069379|594146626|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
164485204|NCT02069379|594146623|FG000|First Treatment Arm|Lost to Follow-up|0|||
164485205|NCT02069379|594146624|FG001|First Treatment Arm|Lost to Follow-up|1|||
164485206|NCT02069379|594146625|FG002|First Treatment Arm|Lost to Follow-up|1|||
164485207|NCT02069379|594146626|FG003|First Treatment Arm|Lost to Follow-up|0|||
164485208|NCT02069379|594146623|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
164485209|NCT02069379|594146624|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
164485210|NCT02069379|594146625|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
164485211|NCT02069379|594146626|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
164485212|NCT02069379|594146623|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
164485213|NCT02069379|594146624|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
164485214|NCT02069379|594146625|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
164485215|NCT02069379|594146626|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
164485216|NCT02069379|594146623|FG000|Second Treatment Arm|Lost to Follow-up|0|||
164485217|NCT02069379|594146624|FG001|Second Treatment Arm|Lost to Follow-up|0|||
164485218|NCT02069379|594146625|FG002|Second Treatment Arm|Lost to Follow-up|1|||
164485219|NCT02069379|594146626|FG003|Second Treatment Arm|Lost to Follow-up|0|||
164485220|NCT01762345|594146629|FG000|Overall Study|Adverse Event|5|||
164714565|NCT00658021|594977009|FG000|28-Week Treatment Period|Protocol Violation|0|||
164485221|NCT01762345|594146629|FG000|Overall Study|Protocol Violation|2|||
164485222|NCT00700999|594146630|FG000|Overall Study|Lost to Follow-up|7|||
164485223|NCT00700999|594146631|FG001|Overall Study|Lost to Follow-up|7|||
164485224|NCT00700999|594146630|FG000|Overall Study|Excluded - did not meet study criteria|0|||
164485225|NCT00700999|594146631|FG001|Overall Study|Excluded - did not meet study criteria|1|||
164485226|NCT00700999|594146630|FG000|Overall Study|Withdrawal by Subject|8|||
164485227|NCT00700999|594146631|FG001|Overall Study|Withdrawal by Subject|1|||
164485228|NCT02379078|594146632|FG000|Overall Study|Lost to Follow-up|33|||
164485229|NCT02379078|594146633|FG001|Overall Study|Lost to Follow-up|30|||
164485230|NCT02379078|594146632|FG000|Overall Study|Withdrawal by Subject|6|||
164485231|NCT02379078|594146633|FG001|Overall Study|Withdrawal by Subject|5|||
164485232|NCT00346398|594146636|FG000|Overall Study|Lost to Follow-up|3|||
164485233|NCT00346398|594146637|FG001|Overall Study|Lost to Follow-up|0|||
164485234|NCT00346398|594146636|FG000|Overall Study|Withdrawal by Subject|0|||
164485235|NCT00346398|594146637|FG001|Overall Study|Withdrawal by Subject|2|||
164485236|NCT00960206|594146642|FG000|Overall Study|Death|7|||
164485237|NCT00960206|594146643|FG001|Overall Study|Death|4|||
164485238|NCT00960206|594146644|FG002|Overall Study|Death|1|||
164485239|NCT00960206|594146642|FG000|Overall Study|Unwilling/Unable to return|1|||
164485240|NCT00960206|594146643|FG001|Overall Study|Unwilling/Unable to return|2|||
164714566|NCT00658021|594977010|FG001|28-Week Treatment Period|Protocol Violation|2|||
164714567|NCT00658021|594977011|FG002|28-Week Treatment Period|Protocol Violation|1|||
164714568|NCT00658021|594977009|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
164714569|NCT00658021|594977010|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
164485241|NCT00960206|594146644|FG002|Overall Study|Unwilling/Unable to return|0|||
164485242|NCT00960206|594146642|FG000|Overall Study|Lost to Follow-up|8|||
164714570|NCT00658021|594977011|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
164714571|NCT00658021|594977009|FG000|28-Week Treatment Period|Physician Decision|1|||
164485243|NCT00960206|594146643|FG001|Overall Study|Lost to Follow-up|14|||
164485244|NCT00960206|594146644|FG002|Overall Study|Lost to Follow-up|8|||
164485245|NCT00960206|594146642|FG000|Overall Study|Withdrawal by Subject|2|||
164485246|NCT00960206|594146643|FG001|Overall Study|Withdrawal by Subject|4|||
164485247|NCT00960206|594146644|FG002|Overall Study|Withdrawal by Subject|0|||
164485248|NCT00960206|594146642|FG000|Overall Study|Revision of study component|2|||
164485249|NCT00960206|594146643|FG001|Overall Study|Revision of study component|2|||
164485250|NCT00960206|594146644|FG002|Overall Study|Revision of study component|2|||
164601493|NCT01617655|594562591|FG000|Overall Study|Poor compliance to protocol|1|||
164714572|NCT00658021|594977010|FG001|28-Week Treatment Period|Physician Decision|2|||
164485251|NCT00960206|594146642|FG000|Overall Study|Missing 10 year data|20|||
164485252|NCT00960206|594146643|FG001|Overall Study|Missing 10 year data|1|||
164485253|NCT00960206|594146644|FG002|Overall Study|Missing 10 year data|1|||
164485254|NCT01240590|594146645|FG000|Phase I|Refused further treatment|0|||
164485255|NCT01240590|594146646|FG001|Phase I|Refused further treatment|0|||
164485256|NCT01240590|594146647|FG002|Phase I|Refused further treatment|3|||
164485257|NCT01240590|594146648|FG003|Phase I|Refused further treatment|0|||
164485258|NCT01240590|594146649|FG004|Phase I|Refused further treatment|0|||
164485259|NCT01240590|594146645|FG000|Phase II|Refused further treatment|0|||
164485260|NCT01240590|594146646|FG001|Phase II|Refused further treatment|0|||
164485261|NCT01240590|594146647|FG002|Phase II|Refused further treatment|0|||
164485262|NCT01240590|594146648|FG003|Phase II|Refused further treatment|2|||
164485263|NCT01240590|594146649|FG004|Phase II|Refused further treatment|1|||
164485264|NCT05066230|594148573|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
164485265|NCT05066230|594148574|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
164485266|NCT05066230|594148573|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
164485267|NCT05066230|594148574|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
164485268|NCT05066230|594148573|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
164485269|NCT05066230|594148574|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
164485270|NCT05066230|594148573|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
164485271|NCT05066230|594148574|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
164485272|NCT05066230|594148573|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
164485273|NCT05066230|594148574|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
164485274|NCT05066230|594148573|FG000|After Week 48|Adverse Event|1|||
164485275|NCT05066230|594148574|FG001|After Week 48|Adverse Event|0|||
164485276|NCT05066230|594148573|FG000|After Week 48|Non-compliance with study schedule|1|||
164485277|NCT05066230|594148574|FG001|After Week 48|Non-compliance with study schedule|0|||
164485278|NCT05066230|594148573|FG000|After Week 48|Withdrawal by Subject|0|||
164485279|NCT05066230|594148574|FG001|After Week 48|Withdrawal by Subject|1|||
164485280|NCT05066230|594148573|FG000|After Week 48|Lost to Follow-up|3|||
164485281|NCT05066230|594148574|FG001|After Week 48|Lost to Follow-up|3|||
164485282|NCT05066230|594148573|FG000|After Week 48|Sponsor Request|115|||
164485283|NCT05066230|594148574|FG001|After Week 48|Sponsor Request|111|||
164485284|NCT04425252|594148575|FG000|Overall Study|Withdrawal by Subject|2|||
164485285|NCT04425252|594148576|FG001|Overall Study|Withdrawal by Subject|1|||
164485286|NCT04425252|594148575|FG000|Overall Study|Lost to Follow-up|1|||
164485287|NCT04425252|594148576|FG001|Overall Study|Lost to Follow-up|0|||
164485288|NCT04425252|594148575|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
164485289|NCT04425252|594148576|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
164485290|NCT00307489|594148577|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
164485291|NCT00307489|594148578|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
164485292|NCT00307489|594148577|FG000|Baseline Through Week 48|Physician Decision|1|||
164485293|NCT00307489|594148578|FG001|Baseline Through Week 48|Physician Decision|0|||
164485294|NCT00307489|594148577|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
164485295|NCT00307489|594148578|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
164485296|NCT00307489|594148577|FG000|Week 48 Through Week 168|Adverse Event|1|||
164485297|NCT00307489|594148578|FG001|Week 48 Through Week 168|Adverse Event|0|||
164485298|NCT00307489|594148577|FG000|Week 48 Through Week 168|Physician Decision|1|||
164485299|NCT00307489|594148578|FG001|Week 48 Through Week 168|Physician Decision|0|||
164485300|NCT00307489|594148577|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
164485301|NCT00307489|594148578|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
164485302|NCT00307489|594148577|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
164485303|NCT00307489|594148578|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
164485304|NCT00307489|594148577|FG000|Week 48 Through Week 168|Death|0|||
164485305|NCT00307489|594148578|FG001|Week 48 Through Week 168|Death|1|||
164485306|NCT00307489|594148577|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
164485307|NCT00307489|594148578|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
164485308|NCT00307489|594148577|FG000|Week 48 Through Week 168|Seroconversion|1|||
164485309|NCT00307489|594148578|FG001|Week 48 Through Week 168|Seroconversion|0|||
164485310|NCT02981953|594148579|FG000|Overall Study|Death|9|||
164485311|NCT02981953|594148579|FG000|Overall Study|Withdrawal by Subject|1|||
164485312|NCT02981953|594148579|FG000|Overall Study|Withdrawal to non-compliance|1|||
164485313|NCT02165202|594148584|FG000|Oral Phase|Refused further participation|5|||
164485314|NCT02165202|594148585|FG001|Oral Phase|Refused further participation|1|||
164485315|NCT02165202|594148584|FG000|Oral Phase|Study product Related Toxicity|1|||
164485316|NCT02165202|594148585|FG001|Oral Phase|Study product Related Toxicity|0|||
164485317|NCT02165202|594148584|FG000|Oral Phase|Unable to contact Participant|1|||
164485318|NCT02165202|594148585|FG001|Oral Phase|Unable to contact Participant|1|||
164485319|NCT02165202|594148584|FG000|Oral Phase|Clinical reasons|1|||
164485320|NCT02165202|594148585|FG001|Oral Phase|Clinical reasons|0|||
164485321|NCT02165202|594148584|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
164485322|NCT02165202|594148585|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
164485323|NCT02165202|594148584|FG000|Oral Phase|CMC advised termination|1|||
164601494|NCT01617655|594562592|FG001|Overall Study|Poor compliance to protocol|4|||
164601495|NCT01617655|594562591|FG000|Overall Study|Participants moved|0|||
164601496|NCT01617655|594562592|FG001|Overall Study|Participants moved|4|||
164601497|NCT01617655|594562591|FG000|Overall Study|Consent withdrawn by participant|1|||
164601498|NCT01617655|594562592|FG001|Overall Study|Consent withdrawn by participant|1|||
164601499|NCT01617655|594562591|FG000|Overall Study|Last visit outside protocol visit window|1|||
164601500|NCT01617655|594562592|FG001|Overall Study|Last visit outside protocol visit window|10|||
164601501|NCT01617655|594562591|FG000|Overall Study|Site closure|3|||
164601502|NCT01617655|594562592|FG001|Overall Study|Site closure|5|||
164601503|NCT01617655|594562591|FG000|Overall Study|Other than specified above|1|||
164601504|NCT01617655|594562592|FG001|Overall Study|Other than specified above|2|||
164601505|NCT01175213|594562595|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
164601506|NCT01175213|594562596|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
164601507|NCT01175213|594562595|FG000|IGSC, 10%/rHuPH20|Death|1|||
164601508|NCT01175213|594562596|FG001|IGSC, 10%/rHuPH20|Death|0|||
164601509|NCT01175213|594562595|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
164601510|NCT01175213|594562596|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
164601511|NCT01175213|594562595|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
164601512|NCT01175213|594562596|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
164601513|NCT01175213|594562595|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
164601514|NCT01175213|594562596|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
164601515|NCT01175213|594562595|FG000|Safety Follow-up|Adverse Event|1|||
164601516|NCT01175213|594562596|FG001|Safety Follow-up|Adverse Event|0|||
164601517|NCT01517412|594562600|FG000|Overall Study|Adverse Event|10|||
164601518|NCT01517412|594562601|FG001|Overall Study|Adverse Event|11|||
164601519|NCT01517412|594562600|FG000|Overall Study|Lack of Efficacy|10|||
164601520|NCT01517412|594562601|FG001|Overall Study|Lack of Efficacy|5|||
164601521|NCT01517412|594562600|FG000|Overall Study|Poor compliance to protocol|8|||
164601522|NCT01517412|594562601|FG001|Overall Study|Poor compliance to protocol|3|||
164601523|NCT01517412|594562600|FG000|Overall Study|Other than specified above|8|||
164601524|NCT01517412|594562601|FG001|Overall Study|Other than specified above|5|||
164601525|NCT01253187|594562602|FG000|Period 2|Withdrawal by Subject|0|||
164601526|NCT01253187|594562603|FG001|Period 2|Withdrawal by Subject|0|||
164601527|NCT01253187|594562604|FG002|Period 2|Withdrawal by Subject|0|||
164601528|NCT01253187|594562605|FG003|Period 2|Withdrawal by Subject|0|||
164601529|NCT01253187|594562606|FG004|Period 2|Withdrawal by Subject|1|||
164601530|NCT01253187|594562607|FG005|Period 2|Withdrawal by Subject|0|||
164601531|NCT01253187|594562602|FG000|Period 3|Pregnancy|1|||
164601532|NCT01253187|594562603|FG001|Period 3|Pregnancy|0|||
164601533|NCT01253187|594562604|FG002|Period 3|Pregnancy|0|||
164601534|NCT01253187|594562605|FG003|Period 3|Pregnancy|0|||
164601535|NCT01253187|594562606|FG004|Period 3|Pregnancy|0|||
164601536|NCT01253187|594562607|FG005|Period 3|Pregnancy|0|||
164601537|NCT01253187|594562602|FG000|Period 3|difficulty with blood sampling|0|||
164601538|NCT01253187|594562603|FG001|Period 3|difficulty with blood sampling|1|||
164601539|NCT01253187|594562604|FG002|Period 3|difficulty with blood sampling|0|||
164601540|NCT01253187|594562605|FG003|Period 3|difficulty with blood sampling|0|||
164601541|NCT01253187|594562606|FG004|Period 3|difficulty with blood sampling|0|||
164601542|NCT01253187|594562607|FG005|Period 3|difficulty with blood sampling|0|||
164601543|NCT01253187|594562602|FG000|Period 3|non-compliance|0|||
164601544|NCT01253187|594562603|FG001|Period 3|non-compliance|0|||
164601545|NCT01253187|594562604|FG002|Period 3|non-compliance|0|||
164601546|NCT01253187|594562605|FG003|Period 3|non-compliance|0|||
164601547|NCT01253187|594562606|FG004|Period 3|non-compliance|1|||
164601548|NCT01253187|594562607|FG005|Period 3|non-compliance|0|||
164601549|NCT03569449|594562608|FG000|Overall Study|Lost to Follow-up|0|||
164601550|NCT03569449|594562609|FG001|Overall Study|Lost to Follow-up|1|||
164601551|NCT03569449|594562610|FG002|Overall Study|Lost to Follow-up|0|||
164601552|NCT03569449|594562611|FG003|Overall Study|Lost to Follow-up|2|||
164601553|NCT03569449|594562612|FG004|Overall Study|Lost to Follow-up|0|||
164601554|NCT03569449|594562613|FG005|Overall Study|Lost to Follow-up|0|||
164601555|NCT03569449|594562614|FG006|Overall Study|Lost to Follow-up|0|||
164601556|NCT03569449|594562615|FG007|Overall Study|Lost to Follow-up|0|||
164601557|NCT03569449|594562616|FG008|Overall Study|Lost to Follow-up|0|||
164601558|NCT03569449|594562617|FG009|Overall Study|Lost to Follow-up|0|||
164601559|NCT03569449|594562618|FG010|Overall Study|Lost to Follow-up|0|||
164601560|NCT03569449|594562619|FG011|Overall Study|Lost to Follow-up|0|||
164601561|NCT03569449|594562620|FG012|Overall Study|Lost to Follow-up|0|||
164601562|NCT03569449|594562621|FG013|Overall Study|Lost to Follow-up|0|||
164601563|NCT03569449|594562622|FG014|Overall Study|Lost to Follow-up|1|||
164601564|NCT03569449|594562623|FG015|Overall Study|Lost to Follow-up|0|||
164601565|NCT03569449|594562608|FG000|Overall Study|Withdrawal by Subject|0|||
164601566|NCT03569449|594562609|FG001|Overall Study|Withdrawal by Subject|1|||
164601567|NCT03569449|594562610|FG002|Overall Study|Withdrawal by Subject|0|||
164601568|NCT03569449|594562611|FG003|Overall Study|Withdrawal by Subject|0|||
164601569|NCT03569449|594562612|FG004|Overall Study|Withdrawal by Subject|1|||
164601570|NCT03569449|594562613|FG005|Overall Study|Withdrawal by Subject|0|||
164601571|NCT03569449|594562614|FG006|Overall Study|Withdrawal by Subject|0|||
164601572|NCT03569449|594562615|FG007|Overall Study|Withdrawal by Subject|0|||
164601573|NCT03569449|594562616|FG008|Overall Study|Withdrawal by Subject|0|||
164601574|NCT03569449|594562617|FG009|Overall Study|Withdrawal by Subject|0|||
164601575|NCT03569449|594562618|FG010|Overall Study|Withdrawal by Subject|0|||
164601576|NCT03569449|594562619|FG011|Overall Study|Withdrawal by Subject|0|||
164601577|NCT03569449|594562620|FG012|Overall Study|Withdrawal by Subject|0|||
164601578|NCT03569449|594562621|FG013|Overall Study|Withdrawal by Subject|0|||
164601579|NCT03569449|594562622|FG014|Overall Study|Withdrawal by Subject|0|||
164601580|NCT03569449|594562623|FG015|Overall Study|Withdrawal by Subject|0|||
164601581|NCT04124692|594562624|FG000|Overall Study|Medical reason|0|||
164601582|NCT04124692|594562625|FG001|Overall Study|Medical reason|1|||
164601583|NCT04124692|594562624|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
164601584|NCT04124692|594562625|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
164601585|NCT04124692|594562624|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
164601586|NCT04124692|594562625|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
164601587|NCT04124692|594562624|FG000|Overall Study|Lost to Follow-up|2|||
164601588|NCT04124692|594562625|FG001|Overall Study|Lost to Follow-up|4|||
164601589|NCT04124692|594562624|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
164601590|NCT04124692|594562625|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
164601591|NCT05279898|594562637|FG000|Overall Study|Withdrawal by Subject|1|||
164601592|NCT05279898|594562638|FG001|Overall Study|Withdrawal by Subject|0|||
164601593|NCT05279898|594562637|FG000|Overall Study|Physician Decision|1|||
164601594|NCT05279898|594562638|FG001|Overall Study|Physician Decision|1|||
164601595|NCT05136170|594562639|FG000|Overall Study|Withdrawal by Subject|2|||
164601596|NCT05136170|594562640|FG001|Overall Study|Withdrawal by Subject|2|||
164601597|NCT05136170|594562639|FG000|Overall Study|Can no longer make office visits|1|||
164601598|NCT05136170|594562640|FG001|Overall Study|Can no longer make office visits|0|||
164601599|NCT04393038|594562641|FG000|Overall Study|Adverse Event|11|||
164601600|NCT04393038|594562642|FG001|Overall Study|Adverse Event|2|||
164601601|NCT04393038|594562641|FG000|Overall Study|Protocol Violation|1|||
164601602|NCT04393038|594562642|FG001|Overall Study|Protocol Violation|0|||
164601603|NCT04393038|594562641|FG000|Overall Study|Death|6|||
164601604|NCT04393038|594562642|FG001|Overall Study|Death|4|||
164601605|NCT04393038|594562641|FG000|Overall Study|Withdrawal by Subject|24|||
164601606|NCT04393038|594562642|FG001|Overall Study|Withdrawal by Subject|8|||
164601607|NCT04393038|594562641|FG000|Overall Study|Lost to Follow-up|5|||
164601608|NCT04393038|594562642|FG001|Overall Study|Lost to Follow-up|4|||
164601609|NCT04393038|594562641|FG000|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|94|||
164601610|NCT04393038|594562642|FG001|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|49|||
164601611|NCT04393038|594562641|FG000|Overall Study|End of Study date not collected in the eCRF|10|||
164601612|NCT04393038|594562642|FG001|Overall Study|End of Study date not collected in the eCRF|4|||
164601613|NCT02492997|594562643|FG000|Overall Study|Withdrawal by Subject|1|||
164601614|NCT02492997|594562644|FG001|Overall Study|Withdrawal by Subject|0|||
164601615|NCT02492997|594562643|FG000|Overall Study|Gained Weight|1|||
164601616|NCT02492997|594562644|FG001|Overall Study|Gained Weight|0|||
164601617|NCT02492997|594562643|FG000|Overall Study|Lost to Follow-up|0|||
164601618|NCT02492997|594562644|FG001|Overall Study|Lost to Follow-up|1|||
164601619|NCT04069156|594562645|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
164601620|NCT04069156|594562646|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
164601621|NCT04069156|594562645|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
164601622|NCT04069156|594562646|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
164601623|NCT04069156|594562645|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
164601624|NCT04069156|594562646|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
164601625|NCT04069156|594562645|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
164601626|NCT04069156|594562646|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
164601627|NCT04580394|594562651|FG000|First Intervention|Incorrectly Randomized|1|||
164601628|NCT04580394|594562651|FG000|First Intervention|Physician Decision|1|||
164601629|NCT04580394|594562651|FG000|First Intervention|Lost to Follow-up|1|||
164601630|NCT04580394|594562651|FG000|Washout (One Week)|Withdrawal by Subject|1|||
164601631|NCT04580394|594562651|FG000|Washout (One Week)|Adverse Event|1|||
164601632|NCT04580394|594562651|FG000|Washout (One Week)|Withdrawal by Subject|2|||
164601633|NCT04580394|594562651|FG000|Third Intervention|Adverse Event|1|||
164714573|NCT00658021|594977011|FG002|28-Week Treatment Period|Physician Decision|1|||
164601634|NCT04580394|594562651|FG000|Third Intervention|Withdrawal by Subject|1|||
164601635|NCT04580394|594562651|FG000|Washout (One Week)|Withdrawal by Subject|2|||
164601636|NCT03806179|594562655|FG000|Overall Study|Progressive disease|0|||
164601637|NCT03806179|594562656|FG001|Overall Study|Progressive disease|2|||
164601638|NCT05822830|594562657|FG000|Overall Study|Adverse Event|6|||
164601639|NCT05822830|594562658|FG001|Overall Study|Adverse Event|6|||
164601640|NCT05822830|594562657|FG000|Overall Study|Assigned Treatment by Mistake|5|||
164601641|NCT05822830|594562658|FG001|Overall Study|Assigned Treatment by Mistake|3|||
164601642|NCT05822830|594562657|FG000|Overall Study|Lost to Follow-up|16|||
164714574|NCT00658021|594977009|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
164485324|NCT02165202|594148585|FG001|Oral Phase|CMC advised termination|0|||
164485325|NCT02165202|594148584|FG000|Oral Phase|Relocated, no follow-up planned|1|||
164485326|NCT02165202|594148585|FG001|Oral Phase|Relocated, no follow-up planned|0|||
164485327|NCT02165202|594148584|FG000|Oral Phase|Abnormal EKG|0|||
164485328|NCT02165202|594148585|FG001|Oral Phase|Abnormal EKG|1|||
164485329|NCT02165202|594148584|FG000|Injection Phase|Abnormal Lab Value|5|||
164485330|NCT02165202|594148585|FG001|Injection Phase|Abnormal Lab Value|1|||
164485331|NCT02165202|594148584|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
164485332|NCT02165202|594148585|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
164485333|NCT02165202|594148584|FG000|Injection Phase|Unable to attend within Visit Window|1|||
164485334|NCT02165202|594148585|FG001|Injection Phase|Unable to attend within Visit Window|0|||
164485335|NCT02165202|594148584|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
164485336|NCT02165202|594148585|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
164485337|NCT02165202|594148584|FG000|Injection Phase|End of Study|2|||
164485338|NCT02165202|594148585|FG001|Injection Phase|End of Study|1|||
164485339|NCT02165202|594148584|FG000|Injection Phase|Study Product related Toxicity|1|||
164485340|NCT02165202|594148585|FG001|Injection Phase|Study Product related Toxicity|0|||
164485341|NCT02165202|594148584|FG000|Injection Phase|No longer interested|0|||
164485342|NCT02165202|594148585|FG001|Injection Phase|No longer interested|1|||
164485343|NCT02165202|594148584|FG000|Injection Phase|Participant unwilling to comply|1|||
164485344|NCT02165202|594148585|FG001|Injection Phase|Participant unwilling to comply|0|||
164485345|NCT00376259|594148591|FG000|Overall Study|Sponsor request - study termination|21|||
164485346|NCT00376259|594148592|FG001|Overall Study|Sponsor request - study termination|21|||
164485347|NCT00376259|594148591|FG000|Overall Study|Patient request|1|||
164485348|NCT00376259|594148592|FG001|Overall Study|Patient request|0|||
164485349|NCT01393964|594148594|FG000|Overall Study|Disease Progression|4|||
164485350|NCT01393964|594148595|FG001|Overall Study|Disease Progression|3|||
164485351|NCT01393964|594148596|FG002|Overall Study|Disease Progression|5|||
164485352|NCT01393964|594148594|FG000|Overall Study|Study drug toxicity|1|||
164485353|NCT01393964|594148595|FG001|Overall Study|Study drug toxicity|0|||
164485354|NCT01393964|594148596|FG002|Overall Study|Study drug toxicity|0|||
164485355|NCT01393964|594148594|FG000|Overall Study|Withdrawal by Subject|0|||
164485356|NCT01393964|594148595|FG001|Overall Study|Withdrawal by Subject|0|||
164485357|NCT01393964|594148596|FG002|Overall Study|Withdrawal by Subject|1|||
164485358|NCT01393964|594148594|FG000|Overall Study|Adverse event unrelated to study drug|0|||
164485359|NCT01393964|594148595|FG001|Overall Study|Adverse event unrelated to study drug|3|||
164485360|NCT01393964|594148596|FG002|Overall Study|Adverse event unrelated to study drug|0|||
164485361|NCT01393964|594148594|FG000|Overall Study|Subject request stop study treatment|0|||
164485362|NCT01393964|594148595|FG001|Overall Study|Subject request stop study treatment|1|||
164485363|NCT01393964|594148596|FG002|Overall Study|Subject request stop study treatment|0|||
164485364|NCT01393964|594148594|FG000|Overall Study|Subject decided to move to transplant|1|||
164485365|NCT01393964|594148595|FG001|Overall Study|Subject decided to move to transplant|0|||
164485366|NCT01393964|594148596|FG002|Overall Study|Subject decided to move to transplant|0|||
164485367|NCT01393964|594148594|FG000|Overall Study|Subject switched to commercial supply|1|||
164485368|NCT01393964|594148595|FG001|Overall Study|Subject switched to commercial supply|0|||
164485369|NCT01393964|594148596|FG002|Overall Study|Subject switched to commercial supply|2|||
164485370|NCT01393964|594148594|FG000|Overall Study|Subject plateaued in terms of effect|1|||
164485371|NCT01393964|594148595|FG001|Overall Study|Subject plateaued in terms of effect|0|||
164485372|NCT01393964|594148596|FG002|Overall Study|Subject plateaued in terms of effect|0|||
164485373|NCT01393964|594148594|FG000|Overall Study|Investigator removed subject from study|0|||
164485374|NCT01393964|594148595|FG001|Overall Study|Investigator removed subject from study|1|||
164485375|NCT01393964|594148596|FG002|Overall Study|Investigator removed subject from study|0|||
164485376|NCT01393964|594148594|FG000|Overall Study|Subject converted to roll-over study|0|||
164485377|NCT01393964|594148595|FG001|Overall Study|Subject converted to roll-over study|1|||
164485378|NCT01393964|594148596|FG002|Overall Study|Subject converted to roll-over study|0|||
164485379|NCT01393964|594148594|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
164601643|NCT05822830|594562658|FG001|Overall Study|Lost to Follow-up|18|||
164601644|NCT05822830|594562657|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164714575|NCT00658021|594977010|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
164714576|NCT00658021|594977011|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
164714577|NCT00658021|594977009|FG000|28-Week Treatment Period|Loss of glucose control|1|||
164714578|NCT00658021|594977010|FG001|28-Week Treatment Period|Loss of glucose control|1|||
164714579|NCT00658021|594977011|FG002|28-Week Treatment Period|Loss of glucose control|10|||
164714580|NCT00658021|594977009|FG000|28-Week Treatment Period|Other|2|||
164485380|NCT01393964|594148595|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
164485381|NCT01393964|594148596|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
164485382|NCT02721147|594148599|FG000|Overall Study|Lost to Follow-up|2|||
164485383|NCT02721147|594148600|FG001|Overall Study|Lost to Follow-up|0|||
164714581|NCT00658021|594977010|FG001|28-Week Treatment Period|Other|3|||
164714582|NCT00658021|594977011|FG002|28-Week Treatment Period|Other|1|||
164714583|NCT00658021|594977009|FG000|28-Week Treatment Period|Did not receive treatment|2|||
164485384|NCT02721147|594148601|FG002|Overall Study|Lost to Follow-up|0|||
164485385|NCT01280721|594148602|FG000|Overall Study|Adverse Event|4|||
164485386|NCT01280721|594148602|FG000|Overall Study|Physician Decision|3|||
164485387|NCT01280721|594148602|FG000|Overall Study|Withdrawal by Subject|6|||
164485388|NCT01280721|594148602|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
164485389|NCT01280721|594148602|FG000|Overall Study|No tolerability for the lowest dose|2|||
164485390|NCT01180400|594148603|FG000|Overall Study|Withdrawal by Subject|5|||
164485391|NCT01180400|594148604|FG001|Overall Study|Withdrawal by Subject|6|||
164485392|NCT01180400|594148603|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164485393|NCT01180400|594148604|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
164485394|NCT01180400|594148603|FG000|Overall Study|Adverse Event|12|||
164485395|NCT01180400|594148604|FG001|Overall Study|Adverse Event|10|||
164485396|NCT01180400|594148603|FG000|Overall Study|Severe non-compliance to protocol|1|||
164485397|NCT01180400|594148604|FG001|Overall Study|Severe non-compliance to protocol|2|||
164485398|NCT01180400|594148603|FG000|Overall Study|Condition under investigation worsened|2|||
164485399|NCT01180400|594148604|FG001|Overall Study|Condition under investigation worsened|1|||
164485400|NCT01180400|594148603|FG000|Overall Study|Lack of Efficacy|2|||
164485401|NCT01180400|594148604|FG001|Overall Study|Lack of Efficacy|0|||
164485402|NCT01180400|594148603|FG000|Overall Study|Study-specific withdrawal criteria|1|||
164485403|NCT01180400|594148604|FG001|Overall Study|Study-specific withdrawal criteria|2|||
164485404|NCT01180400|594148603|FG000|Overall Study|Lost to Follow-up|2|||
164485405|NCT01180400|594148604|FG001|Overall Study|Lost to Follow-up|3|||
164485406|NCT01180400|594148603|FG000|Overall Study|Other|0|||
164485407|NCT01180400|594148604|FG001|Overall Study|Other|1|||
164485408|NCT00795639|594148605|FG000|Overall Study|Death|1|||
164485409|NCT00795639|594148606|FG001|Overall Study|Death|6|||
164485410|NCT00795639|594148605|FG000|Overall Study|Withdrawal by Subject|1|||
164485411|NCT00795639|594148606|FG001|Overall Study|Withdrawal by Subject|3|||
164485412|NCT00795639|594148605|FG000|Overall Study|Pregnancy|1|||
164485413|NCT00795639|594148606|FG001|Overall Study|Pregnancy|0|||
164485414|NCT00795639|594148605|FG000|Overall Study|Adverse Event|5|||
164485415|NCT00795639|594148606|FG001|Overall Study|Adverse Event|2|||
164485416|NCT00795639|594148605|FG000|Overall Study|Other|0|||
164485417|NCT00795639|594148606|FG001|Overall Study|Other|2|||
164485418|NCT00795639|594148605|FG000|Overall Study|Terminated by sponsor|13|||
164485419|NCT00795639|594148606|FG001|Overall Study|Terminated by sponsor|12|||
164485420|NCT00795639|594148605|FG000|Overall Study|Randomized and not treated|0|||
164485421|NCT00795639|594148606|FG001|Overall Study|Randomized and not treated|1|||
164485422|NCT04626128|594148607|FG000|Overall Study|Withdrawal by Subject|0|||
164485423|NCT04626128|594148608|FG001|Overall Study|Withdrawal by Subject|1|||
164485424|NCT04626128|594148609|FG002|Overall Study|Withdrawal by Subject|0|||
164485425|NCT04626128|594148610|FG003|Overall Study|Withdrawal by Subject|0|||
164485426|NCT00248794|594148611|FG000|Overall Study|Lost to Follow-up|6|||
164485427|NCT00248794|594148612|FG001|Overall Study|Lost to Follow-up|8|||
164485428|NCT00248794|594148613|FG002|Overall Study|Lost to Follow-up|3|||
164485429|NCT01358175|594148614|FG000|Overall Study|Death|1|||
164485430|NCT01358175|594148615|FG001|Overall Study|Death|0|||
164485431|NCT01358175|594148616|FG002|Overall Study|Death|1|||
164485432|NCT01358175|594148614|FG000|Overall Study|Withdrawal by Subject|9|||
164485433|NCT01358175|594148615|FG001|Overall Study|Withdrawal by Subject|5|||
164485434|NCT01358175|594148616|FG002|Overall Study|Withdrawal by Subject|10|||
164601645|NCT05822830|594562658|FG001|Overall Study|Non-Compliance With Study Drug|1|||
164601646|NCT05822830|594562657|FG000|Overall Study|Participant was Out of the Country|0|||
164485435|NCT01358175|594148614|FG000|Overall Study|Technical issues|0|||
164485436|NCT01358175|594148615|FG001|Overall Study|Technical issues|1|||
164485437|NCT01358175|594148616|FG002|Overall Study|Technical issues|0|||
164485438|NCT01358175|594148614|FG000|Overall Study|Pregnancy|0|||
164485439|NCT01358175|594148615|FG001|Overall Study|Pregnancy|1|||
164485440|NCT01358175|594148616|FG002|Overall Study|Pregnancy|0|||
164485441|NCT01358175|594148614|FG000|Overall Study|Physician Decision|1|||
164485442|NCT01358175|594148615|FG001|Overall Study|Physician Decision|0|||
164485443|NCT01358175|594148616|FG002|Overall Study|Physician Decision|0|||
164485444|NCT01358175|594148614|FG000|Overall Study|Non Compliance with Study Treatment|0|||
164485445|NCT01358175|594148615|FG001|Overall Study|Non Compliance with Study Treatment|1|||
164601647|NCT05822830|594562658|FG001|Overall Study|Participant was Out of the Country|1|||
164485446|NCT01358175|594148616|FG002|Overall Study|Non Compliance with Study Treatment|1|||
164485447|NCT01358175|594148614|FG000|Overall Study|Lost to Follow-up|1|||
164485448|NCT01358175|594148615|FG001|Overall Study|Lost to Follow-up|1|||
164485449|NCT01358175|594148616|FG002|Overall Study|Lost to Follow-up|3|||
164485450|NCT01358175|594148614|FG000|Overall Study|Lack of Efficacy|3|||
164485451|NCT01358175|594148615|FG001|Overall Study|Lack of Efficacy|8|||
164485452|NCT01358175|594148616|FG002|Overall Study|Lack of Efficacy|6|||
164485453|NCT01358175|594148614|FG000|Overall Study|Adverse Event|6|||
164485454|NCT01358175|594148615|FG001|Overall Study|Adverse Event|11|||
164485455|NCT01358175|594148616|FG002|Overall Study|Adverse Event|11|||
164485456|NCT03481725|594148617|FG000|Overall Study|Withdrawal by Subject|1|||
164485457|NCT03481725|594148618|FG001|Overall Study|Withdrawal by Subject|0|||
164485458|NCT00244751|594148619|FG000|Overall Study|Adverse Event|7|||
164485459|NCT00244751|594148620|FG001|Overall Study|Adverse Event|7|||
164485460|NCT00244751|594148621|FG002|Overall Study|Adverse Event|5|||
164485461|NCT00244751|594148619|FG000|Overall Study|Lost to Follow-up|0|||
164485462|NCT00244751|594148620|FG001|Overall Study|Lost to Follow-up|1|||
164485463|NCT00244751|594148621|FG002|Overall Study|Lost to Follow-up|0|||
164485464|NCT00244751|594148619|FG000|Overall Study|Protocol Violation|1|||
164485465|NCT00244751|594148620|FG001|Overall Study|Protocol Violation|0|||
164485466|NCT00244751|594148621|FG002|Overall Study|Protocol Violation|1|||
164485467|NCT00244751|594148619|FG000|Overall Study|Withdrawal by Subject|7|||
164485468|NCT00244751|594148620|FG001|Overall Study|Withdrawal by Subject|5|||
164485469|NCT00244751|594148621|FG002|Overall Study|Withdrawal by Subject|3|||
164485470|NCT00244751|594148619|FG000|Overall Study|Elevated liver enzymes|1|||
164485471|NCT00244751|594148620|FG001|Overall Study|Elevated liver enzymes|0|||
164485472|NCT00244751|594148621|FG002|Overall Study|Elevated liver enzymes|0|||
164485473|NCT00244751|594148619|FG000|Overall Study|Lack of compliance with protocol|0|||
164485474|NCT00244751|594148620|FG001|Overall Study|Lack of compliance with protocol|1|||
164485475|NCT00244751|594148621|FG002|Overall Study|Lack of compliance with protocol|0|||
164485476|NCT00244751|594148619|FG000|Overall Study|Safety reasons|0|||
164485477|NCT00244751|594148620|FG001|Overall Study|Safety reasons|1|||
164485478|NCT00244751|594148621|FG002|Overall Study|Safety reasons|0|||
164485479|NCT00244751|594148619|FG000|Overall Study|Participant randomized by mistake|0|||
164485480|NCT00244751|594148620|FG001|Overall Study|Participant randomized by mistake|0|||
164485481|NCT00244751|594148621|FG002|Overall Study|Participant randomized by mistake|1|||
164485482|NCT04908488|594148622|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
164485483|NCT04908488|594148623|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
164485484|NCT04908488|594148622|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
164485485|NCT04908488|594148623|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
164485486|NCT03444155|594148628|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
164485487|NCT03444155|594148629|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
164485488|NCT02877680|594148630|FG000|Overall Study|Lost to Follow-up|1|||
164485489|NCT02877680|594148631|FG001|Overall Study|Lost to Follow-up|1|||
164485490|NCT01133678|594148632|FG000|Overall Study|Death|1|||
164485491|NCT01133678|594148633|FG001|Overall Study|Death|1|||
164485492|NCT02206607|594148634|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
164485493|NCT02206607|594148635|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
164485494|NCT02206607|594148636|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
164485495|NCT02206607|594148637|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
164485496|NCT02206607|594148638|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
164485497|NCT02206607|594148634|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
164485498|NCT02206607|594148635|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
164485499|NCT02206607|594148636|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
164485500|NCT02206607|594148637|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
164485501|NCT02206607|594148638|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
164485502|NCT00761267|594148645|FG000|Overall Study|Death|1|||
164485503|NCT00761267|594148646|FG001|Overall Study|Death|2|||
164485504|NCT00761267|594148647|FG002|Overall Study|Death|5|||
164485505|NCT00761267|594148645|FG000|Overall Study|Lost to Follow-up|0|||
164485506|NCT00761267|594148646|FG001|Overall Study|Lost to Follow-up|0|||
164485507|NCT00761267|594148647|FG002|Overall Study|Lost to Follow-up|1|||
164485508|NCT00761267|594148645|FG000|Overall Study|Randomized but not treated|1|||
164485509|NCT00761267|594148646|FG001|Overall Study|Randomized but not treated|1|||
164485510|NCT00761267|594148647|FG002|Overall Study|Randomized but not treated|0|||
164485511|NCT00761267|594148645|FG000|Overall Study|Withdrawal by Subject|0|||
164485512|NCT00761267|594148646|FG001|Overall Study|Withdrawal by Subject|1|||
164485513|NCT00761267|594148647|FG002|Overall Study|Withdrawal by Subject|0|||
164485514|NCT01864200|594148648|FG000|Overall Study|Lost to Follow-up|1|||
164485515|NCT01864200|594148649|FG001|Overall Study|Lost to Follow-up|3|||
164485516|NCT01864200|594148648|FG000|Overall Study|Protocol Violation|1|||
164485517|NCT01864200|594148649|FG001|Overall Study|Protocol Violation|0|||
164485518|NCT02077374|594148656|FG000|Overall Study|Withdrawal by Subject|0|||
164601648|NCT05822830|594562657|FG000|Overall Study|Pregnancy|1|||
164601649|NCT05822830|594562658|FG001|Overall Study|Pregnancy|2|||
164485519|NCT02077374|594148657|FG001|Overall Study|Withdrawal by Subject|1|||
164485520|NCT02077374|594148656|FG000|Overall Study|Protocol Violation|0|||
164485521|NCT02077374|594148657|FG001|Overall Study|Protocol Violation|1|||
164485522|NCT01777932|594148658|FG000|Overall Study|Disease progression|136|||
164485523|NCT01777932|594148658|FG000|Overall Study|Death|3|||
164485524|NCT01777932|594148658|FG000|Overall Study|Adverse Event|34|||
164485525|NCT01777932|594148658|FG000|Overall Study|Lost to Follow-up|3|||
164485526|NCT01777932|594148658|FG000|Overall Study|Investigator decision|10|||
164485527|NCT01777932|594148658|FG000|Overall Study|Reimbursement limit|9|||
164485528|NCT01777932|594148658|FG000|Overall Study|Patient refused further treatment|10|||
164485529|NCT00963924|594148664|FG000|Overall Study|Adverse Event|1|||
164485530|NCT00963924|594148665|FG001|Overall Study|Adverse Event|0|||
164485531|NCT00963924|594148664|FG000|Overall Study|Withdrawal by Subject|0|||
164485532|NCT00963924|594148665|FG001|Overall Study|Withdrawal by Subject|1|||
164485533|NCT00963924|594148664|FG000|Overall Study|Changed antipsychotic|0|||
164485534|NCT00963924|594148665|FG001|Overall Study|Changed antipsychotic|1|||
164485535|NCT00963924|594148664|FG000|Overall Study|Lost to Follow-up|0|||
164485536|NCT00963924|594148665|FG001|Overall Study|Lost to Follow-up|1|||
164485537|NCT00068107|594148666|FG000|Overall Study|end-stage renal disease|6|||
164485538|NCT00068107|594148666|FG000|Overall Study|Death|2|||
164485539|NCT00068107|594148666|FG000|Overall Study|Withdrawal by Subject|1|||
164485540|NCT00446095|594148667|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
164485541|NCT00446095|594148668|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
164485542|NCT00446095|594148669|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
164485543|NCT00446095|594148670|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
164485544|NCT00446095|594148671|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
164485545|NCT00446095|594148667|FG000|Phase II (8 Weeks)|Adverse Event|0|||
164485546|NCT00446095|594148668|FG001|Phase II (8 Weeks)|Adverse Event|1|||
164485547|NCT00446095|594148669|FG002|Phase II (8 Weeks)|Adverse Event|1|||
164485548|NCT00446095|594148670|FG003|Phase II (8 Weeks)|Adverse Event|0|||
164485549|NCT00446095|594148671|FG004|Phase II (8 Weeks)|Adverse Event|0|||
164485550|NCT00446095|594148667|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
164485551|NCT00446095|594148668|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
164485552|NCT00446095|594148669|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
164485553|NCT00446095|594148670|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
164485554|NCT00446095|594148671|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
164485555|NCT00446095|594148667|FG000|Phase II (8 Weeks)|Physician Decision|1|||
164485556|NCT00446095|594148668|FG001|Phase II (8 Weeks)|Physician Decision|0|||
164485557|NCT00446095|594148669|FG002|Phase II (8 Weeks)|Physician Decision|0|||
164485558|NCT00446095|594148670|FG003|Phase II (8 Weeks)|Physician Decision|0|||
164485559|NCT00446095|594148671|FG004|Phase II (8 Weeks)|Physician Decision|0|||
164485560|NCT00446095|594148667|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
164485561|NCT00446095|594148668|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
164485562|NCT00446095|594148669|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
164485563|NCT00446095|594148670|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
164485564|NCT00446095|594148671|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
164485565|NCT00446095|594148667|FG000|Phase II (8 Weeks)|Ongoing|0|||
164485566|NCT00446095|594148668|FG001|Phase II (8 Weeks)|Ongoing|0|||
164485567|NCT00446095|594148669|FG002|Phase II (8 Weeks)|Ongoing|1|||
164485568|NCT00446095|594148670|FG003|Phase II (8 Weeks)|Ongoing|0|||
164485569|NCT00446095|594148671|FG004|Phase II (8 Weeks)|Ongoing|0|||
164485570|NCT00446095|594148667|FG000|Phase I (28 Days)|Adverse Event|0|||
164485571|NCT00446095|594148668|FG001|Phase I (28 Days)|Adverse Event|0|||
164485572|NCT00446095|594148669|FG002|Phase I (28 Days)|Adverse Event|0|||
164485573|NCT00446095|594148670|FG003|Phase I (28 Days)|Adverse Event|1|||
164485574|NCT00446095|594148671|FG004|Phase I (28 Days)|Adverse Event|0|||
164485575|NCT00446095|594148667|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
164485576|NCT00446095|594148668|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
164485577|NCT00446095|594148669|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
164485578|NCT00446095|594148670|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
164485579|NCT00446095|594148671|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
164485580|NCT01419184|594148673|FG000|Overall Study|Site data not available|3|||
164485581|NCT01419184|594148674|FG001|Overall Study|Site data not available|2|||
164485582|NCT01419184|594148673|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
164485583|NCT01419184|594148674|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
164485584|NCT01419184|594148673|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
164485585|NCT01419184|594148674|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
164485586|NCT01419184|594148673|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
164485587|NCT01419184|594148674|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
164485588|NCT01419184|594148673|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
164485589|NCT01419184|594148674|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
164485590|NCT01419184|594148673|FG000|Overall Study|Participant randomized, not treated|1|||
164485591|NCT01419184|594148674|FG001|Overall Study|Participant randomized, not treated|0|||
164485592|NCT03989232|594148679|FG000|Overall Study|Lost to Follow-up|3|||
164485593|NCT03989232|594148680|FG001|Overall Study|Lost to Follow-up|10|||
164485594|NCT03989232|594148679|FG000|Overall Study|Withdrawal by Subject|6|||
164485595|NCT03989232|594148680|FG001|Overall Study|Withdrawal by Subject|6|||
164485596|NCT03989232|594148679|FG000|Overall Study|Death|1|||
164485597|NCT03989232|594148680|FG001|Overall Study|Death|2|||
164485598|NCT01930188|594148681|FG000|Overall Study|unclassified|4|||
164485599|NCT01930188|594148682|FG001|Overall Study|unclassified|5|||
164485600|NCT01930188|594148683|FG002|Overall Study|unclassified|3|||
164485601|NCT01930188|594148681|FG000|Overall Study|Missing follow-up information|2|||
164485602|NCT01930188|594148682|FG001|Overall Study|Missing follow-up information|2|||
164485603|NCT01930188|594148683|FG002|Overall Study|Missing follow-up information|3|||
164485604|NCT01930188|594148681|FG000|Overall Study|Lost to Follow-up|5|||
164601650|NCT05822830|594562657|FG000|Overall Study|Withdrawal by Subject|27|||
164601651|NCT05822830|594562658|FG001|Overall Study|Withdrawal by Subject|26|||
164601652|NCT03201965|594562667|FG000|Overall Study|Death|5|||
164601653|NCT03201965|594562668|FG001|Overall Study|Death|65|||
164601654|NCT03201965|594562669|FG002|Overall Study|Death|47|||
164601655|NCT03201965|594562667|FG000|Overall Study|Lost to Follow-up|0|||
164601656|NCT03201965|594562668|FG001|Overall Study|Lost to Follow-up|6|||
164601657|NCT03201965|594562669|FG002|Overall Study|Lost to Follow-up|0|||
164601658|NCT03201965|594562667|FG000|Overall Study|Withdrawal by Subject|3|||
164601659|NCT03201965|594562668|FG001|Overall Study|Withdrawal by Subject|23|||
164601660|NCT03201965|594562669|FG002|Overall Study|Withdrawal by Subject|8|||
164601661|NCT03201965|594562667|FG000|Overall Study|Sponsor's Decision|20|||
164601662|NCT03201965|594562668|FG001|Overall Study|Sponsor's Decision|99|||
164601663|NCT03201965|594562669|FG002|Overall Study|Sponsor's Decision|140|||
164601664|NCT03368664|594562670|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
164601665|NCT03368664|594562670|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
164601666|NCT03368664|594562670|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
164601667|NCT03368664|594562670|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
164601668|NCT05441592|594562671|FG000|Overall Study|Lost to Follow-up|1|||
164601669|NCT05441592|594562672|FG001|Overall Study|Lost to Follow-up|5|||
164601670|NCT01021852|594562673|FG000|Treatment Period 1|Adverse Event|3|||
164601671|NCT01021852|594562674|FG001|Treatment Period 1|Adverse Event|1|||
164601672|NCT01021852|594562675|FG002|Treatment Period 1|Adverse Event|1|||
164601673|NCT01021852|594562676|FG003|Treatment Period 1|Adverse Event|0|||
164601674|NCT01021852|594562677|FG004|Treatment Period 1|Adverse Event|2|||
164601675|NCT01021852|594562678|FG005|Treatment Period 1|Adverse Event|2|||
164601676|NCT01021852|594562679|FG006|Treatment Period 1|Adverse Event|0|||
164601677|NCT01021852|594562680|FG007|Treatment Period 1|Adverse Event|0|||
164601678|NCT01021852|594562673|FG000|Treatment Period 1|Pregnancy|0|||
164601679|NCT01021852|594562674|FG001|Treatment Period 1|Pregnancy|0|||
164601680|NCT01021852|594562675|FG002|Treatment Period 1|Pregnancy|1|||
164601681|NCT01021852|594562676|FG003|Treatment Period 1|Pregnancy|0|||
164601682|NCT01021852|594562677|FG004|Treatment Period 1|Pregnancy|0|||
164601683|NCT01021852|594562678|FG005|Treatment Period 1|Pregnancy|0|||
164485605|NCT01930188|594148682|FG001|Overall Study|Lost to Follow-up|2|||
164485606|NCT01930188|594148683|FG002|Overall Study|Lost to Follow-up|2|||
164485607|NCT01930188|594148681|FG000|Overall Study|Death|2|||
164485608|NCT01930188|594148682|FG001|Overall Study|Death|1|||
164485609|NCT01930188|594148683|FG002|Overall Study|Death|3|||
164485610|NCT01930188|594148681|FG000|Overall Study|Withdrawal by Subject|9|||
164485611|NCT01930188|594148682|FG001|Overall Study|Withdrawal by Subject|11|||
164485612|NCT01930188|594148683|FG002|Overall Study|Withdrawal by Subject|8|||
164485613|NCT02170207|594148684|FG000|Overall Study|Case report forms unavailable|5|||
164485614|NCT00657709|594148685|FG000|Overall Study|AE or Death|7|||
164485615|NCT00657709|594148686|FG001|Overall Study|AE or Death|7|||
164485616|NCT00657709|594148687|FG002|Overall Study|AE or Death|6|||
164485617|NCT00657709|594148688|FG003|Overall Study|AE or Death|7|||
164485618|NCT00657709|594148689|FG004|Overall Study|AE or Death|1|||
164485619|NCT00657709|594148685|FG000|Overall Study|Withdrawal by Subject|7|||
164485620|NCT00657709|594148686|FG001|Overall Study|Withdrawal by Subject|15|||
164485621|NCT00657709|594148687|FG002|Overall Study|Withdrawal by Subject|15|||
164485622|NCT00657709|594148688|FG003|Overall Study|Withdrawal by Subject|5|||
164485623|NCT00657709|594148689|FG004|Overall Study|Withdrawal by Subject|9|||
164485624|NCT00657709|594148685|FG000|Overall Study|Lost to Follow-up|9|||
164485625|NCT00657709|594148686|FG001|Overall Study|Lost to Follow-up|9|||
164485626|NCT00657709|594148687|FG002|Overall Study|Lost to Follow-up|7|||
164485627|NCT00657709|594148688|FG003|Overall Study|Lost to Follow-up|1|||
164601684|NCT01021852|594562679|FG006|Treatment Period 1|Pregnancy|0|||
164601685|NCT01021852|594562680|FG007|Treatment Period 1|Pregnancy|0|||
164601686|NCT01021852|594562673|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164601687|NCT01021852|594562674|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164601688|NCT01021852|594562675|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164714584|NCT00658021|594977010|FG001|28-Week Treatment Period|Did not receive treatment|0|||
164485628|NCT00657709|594148689|FG004|Overall Study|Lost to Follow-up|21|||
164485629|NCT00657709|594148685|FG000|Overall Study|Protocol Violation|0|||
164485630|NCT00657709|594148686|FG001|Overall Study|Protocol Violation|2|||
164601689|NCT01021852|594562676|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164601690|NCT01021852|594562677|FG004|Treatment Period 1|Withdrawal by Subject|1|||
164601691|NCT01021852|594562678|FG005|Treatment Period 1|Withdrawal by Subject|0|||
164601692|NCT01021852|594562679|FG006|Treatment Period 1|Withdrawal by Subject|0|||
164485631|NCT00657709|594148687|FG002|Overall Study|Protocol Violation|0|||
164485632|NCT00657709|594148688|FG003|Overall Study|Protocol Violation|1|||
164485633|NCT00657709|594148689|FG004|Overall Study|Protocol Violation|2|||
164485634|NCT03122860|594148690|FG000|Overall Study|Discontinued Before Treatment|1|||
164485635|NCT03122860|594148691|FG001|Overall Study|Discontinued Before Treatment|1|||
164485636|NCT03122860|594148692|FG002|Overall Study|Discontinued Before Treatment|2|||
164485637|NCT03122860|594148693|FG003|Overall Study|Discontinued Before Treatment|0|||
164485638|NCT03122860|594148694|FG004|Overall Study|Discontinued Before Treatment|1|||
164485639|NCT03122860|594148695|FG005|Overall Study|Discontinued Before Treatment|0|||
164485640|NCT03122860|594148690|FG000|Overall Study|Adverse Event|1|||
164485641|NCT03122860|594148691|FG001|Overall Study|Adverse Event|0|||
164485642|NCT03122860|594148692|FG002|Overall Study|Adverse Event|1|||
164485643|NCT03122860|594148693|FG003|Overall Study|Adverse Event|1|||
164485644|NCT03122860|594148694|FG004|Overall Study|Adverse Event|0|||
164485645|NCT03122860|594148695|FG005|Overall Study|Adverse Event|0|||
164485646|NCT03122860|594148690|FG000|Overall Study|Lost to Follow-up|5|||
164485647|NCT03122860|594148691|FG001|Overall Study|Lost to Follow-up|2|||
164485648|NCT03122860|594148692|FG002|Overall Study|Lost to Follow-up|3|||
164485649|NCT03122860|594148693|FG003|Overall Study|Lost to Follow-up|3|||
164485650|NCT03122860|594148694|FG004|Overall Study|Lost to Follow-up|5|||
164485651|NCT03122860|594148695|FG005|Overall Study|Lost to Follow-up|4|||
164485652|NCT03122860|594148690|FG000|Overall Study|Subject Non-Compliance|0|||
164485653|NCT03122860|594148691|FG001|Overall Study|Subject Non-Compliance|0|||
164485654|NCT03122860|594148692|FG002|Overall Study|Subject Non-Compliance|1|||
164485655|NCT03122860|594148693|FG003|Overall Study|Subject Non-Compliance|0|||
164485656|NCT03122860|594148694|FG004|Overall Study|Subject Non-Compliance|0|||
164485657|NCT03122860|594148695|FG005|Overall Study|Subject Non-Compliance|0|||
164485658|NCT03122860|594148690|FG000|Overall Study|Withdrawal by Subject|3|||
164485659|NCT03122860|594148691|FG001|Overall Study|Withdrawal by Subject|2|||
164485660|NCT03122860|594148692|FG002|Overall Study|Withdrawal by Subject|5|||
164485661|NCT03122860|594148693|FG003|Overall Study|Withdrawal by Subject|7|||
164485662|NCT03122860|594148694|FG004|Overall Study|Withdrawal by Subject|9|||
164485663|NCT03122860|594148695|FG005|Overall Study|Withdrawal by Subject|8|||
164485664|NCT01138657|594148696|FG000|Overall Study|Adverse Event|3|||
164485665|NCT01138657|594148697|FG001|Overall Study|Adverse Event|10|||
164485666|NCT01138657|594148696|FG000|Overall Study|Lack of Efficacy|2|||
164485667|NCT01138657|594148697|FG001|Overall Study|Lack of Efficacy|1|||
164485668|NCT01138657|594148696|FG000|Overall Study|Lost to Follow-up|0|||
164485669|NCT01138657|594148697|FG001|Overall Study|Lost to Follow-up|3|||
164485670|NCT01138657|594148696|FG000|Overall Study|Miscellaneous Reasons|3|||
164485671|NCT01138657|594148697|FG001|Overall Study|Miscellaneous Reasons|4|||
164485672|NCT02574286|594148698|FG000|Overall Study|Adverse Event|3|||
164485673|NCT02574286|594148698|FG000|Overall Study|Withdrawal by Subject|2|||
164485674|NCT02399449|594148699|FG000|Overall Study|Withdrawal by Subject|3|||
164485675|NCT02399449|594148700|FG001|Overall Study|Withdrawal by Subject|9|||
164485676|NCT02399449|594148699|FG000|Overall Study|Physician Decision|0|||
164485677|NCT02399449|594148700|FG001|Overall Study|Physician Decision|1|||
164485678|NCT00529529|594148701|FG000|Overall Study|Adverse Event|12|||
164485679|NCT00529529|594148702|FG001|Overall Study|Adverse Event|17|||
164485680|NCT00529529|594148703|FG002|Overall Study|Adverse Event|8|||
164485681|NCT00529529|594148701|FG000|Overall Study|Subject withdrew consent|12|||
164485682|NCT00529529|594148702|FG001|Overall Study|Subject withdrew consent|9|||
164485683|NCT00529529|594148703|FG002|Overall Study|Subject withdrew consent|12|||
164485684|NCT00529529|594148701|FG000|Overall Study|Protocol deviation|8|||
164485685|NCT00529529|594148702|FG001|Overall Study|Protocol deviation|12|||
164485686|NCT00529529|594148703|FG002|Overall Study|Protocol deviation|5|||
164485687|NCT00529529|594148701|FG000|Overall Study|Lost to Follow-up|5|||
164485688|NCT00529529|594148702|FG001|Overall Study|Lost to Follow-up|3|||
164485689|NCT00529529|594148703|FG002|Overall Study|Lost to Follow-up|1|||
164485690|NCT00529529|594148701|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164485691|NCT00529529|594148702|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164485692|NCT00529529|594148703|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
164485693|NCT00529529|594148701|FG000|Overall Study|Death|2|||
164485694|NCT00529529|594148702|FG001|Overall Study|Death|0|||
164485695|NCT00529529|594148703|FG002|Overall Study|Death|0|||
164485696|NCT00529529|594148701|FG000|Overall Study|Abnormal test procedure result(s)|1|||
164485697|NCT00529529|594148702|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164485698|NCT00529529|594148703|FG002|Overall Study|Abnormal test procedure result(s)|0|||
164485699|NCT00529529|594148701|FG000|Overall Study|Administrative problems|1|||
164485700|NCT00529529|594148702|FG001|Overall Study|Administrative problems|0|||
164485701|NCT00529529|594148703|FG002|Overall Study|Administrative problems|3|||
164485702|NCT01020435|594148704|FG000|Overall Study|Lost to Follow-up|0|||
164485703|NCT01020435|594148705|FG001|Overall Study|Lost to Follow-up|1|||
164485704|NCT00337610|594148706|FG000|Overall Study|Adverse Event|2|||
164485705|NCT00337610|594148707|FG001|Overall Study|Adverse Event|2|||
164485706|NCT00337610|594148706|FG000|Overall Study|Death|0|||
164485707|NCT00337610|594148707|FG001|Overall Study|Death|1|||
164485708|NCT00337610|594148706|FG000|Overall Study|Lack of Efficacy|6|||
164485709|NCT00337610|594148707|FG001|Overall Study|Lack of Efficacy|3|||
164485710|NCT00337610|594148706|FG000|Overall Study|Lost to Follow-up|3|||
164485711|NCT00337610|594148707|FG001|Overall Study|Lost to Follow-up|3|||
164485712|NCT00337610|594148706|FG000|Overall Study|Withdrawal by Subject|6|||
164485713|NCT00337610|594148707|FG001|Overall Study|Withdrawal by Subject|5|||
164485714|NCT03979040|594148708|FG000|Overall Study|Withdrawal by Subject|24|||
164485715|NCT03979040|594148709|FG001|Overall Study|Withdrawal by Subject|32|||
164485716|NCT03979040|594148708|FG000|Overall Study|randomized but never started treatment|32|||
164485717|NCT03979040|594148709|FG001|Overall Study|randomized but never started treatment|39|||
164485718|NCT03979040|594148708|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
164485719|NCT03979040|594148709|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
164485720|NCT02607956|594148710|FG000|Double-Blinded Phase|Withdrew Consent|17|||
164485721|NCT02607956|594148711|FG001|Double-Blinded Phase|Withdrew Consent|19|||
164485722|NCT02607956|594148712|FG002|Double-Blinded Phase|Withdrew Consent|0|||
164485723|NCT02607956|594148713|FG003|Double-Blinded Phase|Withdrew Consent|0|||
164485724|NCT02607956|594148710|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
164485725|NCT02607956|594148711|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
164485726|NCT02607956|594148712|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
164485727|NCT02607956|594148713|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
164485728|NCT02607956|594148710|FG000|Double-Blinded Phase|Randomized but never treated|7|||
164485729|NCT02607956|594148711|FG001|Double-Blinded Phase|Randomized but never treated|5|||
164485730|NCT02607956|594148712|FG002|Double-Blinded Phase|Randomized but never treated|0|||
164485731|NCT02607956|594148713|FG003|Double-Blinded Phase|Randomized but never treated|0|||
164485732|NCT02607956|594148710|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
164485733|NCT02607956|594148711|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
164485734|NCT02607956|594148712|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
164485735|NCT02607956|594148713|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
164485736|NCT02607956|594148710|FG000|Double-Blinded Phase|Death|4|||
164485737|NCT02607956|594148711|FG001|Double-Blinded Phase|Death|4|||
164485738|NCT02607956|594148712|FG002|Double-Blinded Phase|Death|0|||
164485739|NCT02607956|594148713|FG003|Double-Blinded Phase|Death|0|||
164485740|NCT02607956|594148710|FG000|Double-Blinded Phase|Adverse Event|4|||
164485741|NCT02607956|594148711|FG001|Double-Blinded Phase|Adverse Event|3|||
164485742|NCT02607956|594148712|FG002|Double-Blinded Phase|Adverse Event|0|||
164485743|NCT02607956|594148713|FG003|Double-Blinded Phase|Adverse Event|0|||
164485744|NCT02607956|594148710|FG000|Double-Blinded Phase|Protocol Violation|3|||
164485745|NCT02607956|594148711|FG001|Double-Blinded Phase|Protocol Violation|1|||
164485746|NCT02607956|594148712|FG002|Double-Blinded Phase|Protocol Violation|0|||
164485747|NCT02607956|594148713|FG003|Double-Blinded Phase|Protocol Violation|0|||
164485748|NCT02607956|594148710|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
164485749|NCT02607956|594148711|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
164485750|NCT02607956|594148712|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
164485751|NCT02607956|594148713|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
164485752|NCT02607956|594148710|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
164485753|NCT02607956|594148711|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
164485754|NCT02607956|594148712|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
164485755|NCT02607956|594148713|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
164485756|NCT02607956|594148710|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
164485757|NCT02607956|594148711|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
164485758|NCT02607956|594148712|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
164485759|NCT02607956|594148713|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
164485760|NCT02607956|594148710|FG000|Open-Label Extension Phase|Death|0|||
164485761|NCT02607956|594148711|FG001|Open-Label Extension Phase|Death|0|||
164485762|NCT02607956|594148712|FG002|Open-Label Extension Phase|Death|1|||
164485763|NCT02607956|594148713|FG003|Open-Label Extension Phase|Death|3|||
164485764|NCT02607956|594148710|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
164485765|NCT02607956|594148711|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
164485766|NCT02607956|594148712|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
164485767|NCT02607956|594148713|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
164485768|NCT02607956|594148710|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
164485769|NCT02607956|594148711|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
164485770|NCT02607956|594148712|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
164485771|NCT02607956|594148713|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
164485772|NCT02607956|594148710|FG000|Open-Label Extension Phase|Protocol Violation|0|||
164485773|NCT02607956|594148711|FG001|Open-Label Extension Phase|Protocol Violation|0|||
164714585|NCT00658021|594977011|FG002|28-Week Treatment Period|Did not receive treatment|0|||
164714586|NCT00658021|594977009|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
164714587|NCT00658021|594977010|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
164485774|NCT02607956|594148712|FG002|Open-Label Extension Phase|Protocol Violation|0|||
164485775|NCT02607956|594148713|FG003|Open-Label Extension Phase|Protocol Violation|2|||
164485776|NCT02607956|594148710|FG000|Open-Label Extension Phase|Pregnancy|0|||
164485777|NCT02607956|594148711|FG001|Open-Label Extension Phase|Pregnancy|0|||
164485778|NCT02607956|594148712|FG002|Open-Label Extension Phase|Pregnancy|0|||
164485779|NCT02607956|594148713|FG003|Open-Label Extension Phase|Pregnancy|1|||
164485780|NCT02279732|594148722|FG000|Overall Study|Death|23|||
164485781|NCT02279732|594148723|FG001|Overall Study|Death|20|||
164485782|NCT02279732|594148722|FG000|Overall Study|Disease Progression|13|||
164485783|NCT02279732|594148723|FG001|Overall Study|Disease Progression|3|||
164485784|NCT02279732|594148722|FG000|Overall Study|Withdrawal by Subject|2|||
164485785|NCT02279732|594148723|FG001|Overall Study|Withdrawal by Subject|7|||
164485786|NCT02279732|594148722|FG000|Overall Study|Adverse Event|1|||
164485787|NCT02279732|594148723|FG001|Overall Study|Adverse Event|2|||
164485788|NCT02279732|594148722|FG000|Overall Study|Administrative Reason By Sponsor|0|||
164485789|NCT02279732|594148723|FG001|Overall Study|Administrative Reason By Sponsor|2|||
164485790|NCT02279732|594148722|FG000|Overall Study|Study Drug Toxicity|2|||
164485791|NCT02279732|594148723|FG001|Overall Study|Study Drug Toxicity|0|||
164485792|NCT02279732|594148722|FG000|Overall Study|Lost to Follow-up|0|||
164485793|NCT02279732|594148723|FG001|Overall Study|Lost to Follow-up|1|||
164485794|NCT02279732|594148722|FG000|Overall Study|Maximum Clinical Benefit|1|||
164485795|NCT02279732|594148723|FG001|Overall Study|Maximum Clinical Benefit|0|||
164485796|NCT02279732|594148722|FG000|Overall Study|Subject Requested to Discontinue|0|||
164485797|NCT02279732|594148723|FG001|Overall Study|Subject Requested to Discontinue|1|||
164485798|NCT02279732|594148722|FG000|Overall Study|Other|53|||
164485799|NCT02279732|594148723|FG001|Overall Study|Other|67|||
164485800|NCT02279732|594148722|FG000|Overall Study|Other|3|||
164485801|NCT02279732|594148723|FG001|Overall Study|Other|3|||
164485802|NCT00090519|594148724|FG000|Overall Study|Adverse Event|5|||
164485803|NCT00090519|594148725|FG001|Overall Study|Adverse Event|4|||
164485804|NCT00090519|594148724|FG000|Overall Study|Death|9|||
164485805|NCT00090519|594148725|FG001|Overall Study|Death|9|||
164485806|NCT00090519|594148724|FG000|Overall Study|Lost to Follow-up|26|||
164485807|NCT00090519|594148725|FG001|Overall Study|Lost to Follow-up|29|||
164485808|NCT00090519|594148724|FG000|Overall Study|Withdrawal by Subject|28|||
164485809|NCT00090519|594148725|FG001|Overall Study|Withdrawal by Subject|29|||
164485810|NCT00090519|594148724|FG000|Overall Study|Physician Decision|2|||
164485811|NCT00090519|594148725|FG001|Overall Study|Physician Decision|3|||
164485812|NCT00090519|594148724|FG000|Overall Study|Sponsor Decision|3|||
164485813|NCT00090519|594148725|FG001|Overall Study|Sponsor Decision|1|||
164485814|NCT02548585|594148728|FG000|Overall Study|Withdrawal by Subject|0|||
164485815|NCT02548585|594148729|FG001|Overall Study|Withdrawal by Subject|0|||
164485816|NCT02548585|594148730|FG002|Overall Study|Withdrawal by Subject|0|||
164485817|NCT02548585|594148731|FG003|Overall Study|Withdrawal by Subject|0|||
164485818|NCT02548585|594148732|FG004|Overall Study|Withdrawal by Subject|0|||
164485819|NCT02548585|594148733|FG005|Overall Study|Withdrawal by Subject|1|||
164485820|NCT02548585|594148734|FG006|Overall Study|Withdrawal by Subject|0|||
164485821|NCT02548585|594148728|FG000|Overall Study|Lost to Follow-up|1|||
164485822|NCT02548585|594148729|FG001|Overall Study|Lost to Follow-up|0|||
164485823|NCT02548585|594148730|FG002|Overall Study|Lost to Follow-up|0|||
164485824|NCT02548585|594148731|FG003|Overall Study|Lost to Follow-up|0|||
164485825|NCT02548585|594148732|FG004|Overall Study|Lost to Follow-up|0|||
164485826|NCT02548585|594148733|FG005|Overall Study|Lost to Follow-up|0|||
164485827|NCT02548585|594148734|FG006|Overall Study|Lost to Follow-up|0|||
164485828|NCT02548585|594148728|FG000|Overall Study|Other|1|||
164485829|NCT02548585|594148729|FG001|Overall Study|Other|0|||
164485830|NCT02548585|594148730|FG002|Overall Study|Other|0|||
164485831|NCT02548585|594148731|FG003|Overall Study|Other|2|||
164485832|NCT02548585|594148732|FG004|Overall Study|Other|3|||
164485833|NCT02548585|594148733|FG005|Overall Study|Other|0|||
164485834|NCT02548585|594148734|FG006|Overall Study|Other|1|||
164485835|NCT02548585|594148728|FG000|Overall Study|Randomized but not treated|0|||
164485836|NCT02548585|594148729|FG001|Overall Study|Randomized but not treated|0|||
164485837|NCT02548585|594148730|FG002|Overall Study|Randomized but not treated|0|||
164485838|NCT02548585|594148731|FG003|Overall Study|Randomized but not treated|0|||
164485839|NCT02548585|594148732|FG004|Overall Study|Randomized but not treated|0|||
164485840|NCT02548585|594148733|FG005|Overall Study|Randomized but not treated|1|||
164485841|NCT02548585|594148734|FG006|Overall Study|Randomized but not treated|0|||
164485842|NCT01075152|594148735|FG000|Overall Study|Withdrawal by Subject|1|||
164714588|NCT00658021|594977011|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
164714589|NCT00658021|594977009|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
164714590|NCT00658021|594977010|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
164714591|NCT00658021|594977011|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
164714592|NCT02968849|594977014|FG000|Overall Study|Death|8|||
164485843|NCT01075152|594148736|FG001|Overall Study|Withdrawal by Subject|0|||
164485844|NCT03659136|594148743|FG000|Overall Study|Not treated|2|||
164485845|NCT03659136|594148744|FG001|Overall Study|Not treated|0|||
164714593|NCT02968849|594977015|FG001|Overall Study|Death|10|||
164485846|NCT03659136|594148743|FG000|Overall Study|Covid-19 related|1|||
164485847|NCT03659136|594148744|FG001|Overall Study|Covid-19 related|1|||
164485848|NCT03659136|594148743|FG000|Overall Study|Withdrawal by Subject|1|||
164485849|NCT03659136|594148744|FG001|Overall Study|Withdrawal by Subject|6|||
164485850|NCT03659136|594148743|FG000|Overall Study|Adverse Event|4|||
164485851|NCT03659136|594148744|FG001|Overall Study|Adverse Event|6|||
164485852|NCT03659136|594148743|FG000|Overall Study|Progressive disease|37|||
164485853|NCT03659136|594148744|FG001|Overall Study|Progressive disease|31|||
164485854|NCT03659136|594148743|FG000|Overall Study|Study closure|2|||
164485855|NCT03659136|594148744|FG001|Overall Study|Study closure|2|||
164485856|NCT03659136|594148743|FG000|Overall Study|Sponsor decision/recommendation|3|||
164601693|NCT01021852|594562680|FG007|Treatment Period 1|Withdrawal by Subject|1|||
164601694|NCT01021852|594562673|FG000|Treatment Period 1|Not Treated|0|||
164485857|NCT03659136|594148744|FG001|Overall Study|Sponsor decision/recommendation|2|||
164485858|NCT03659136|594148743|FG000|Overall Study|Switched to other drug/therapy|2|||
164485859|NCT03659136|594148744|FG001|Overall Study|Switched to other drug/therapy|2|||
164485860|NCT03659136|594148743|FG000|Overall Study|Lack of clinical benefit|0|||
164485861|NCT03659136|594148744|FG001|Overall Study|Lack of clinical benefit|1|||
164485862|NCT00813709|594150692|FG000|Double Blind Period|Adverse Event|4|||
164601695|NCT01021852|594562674|FG001|Treatment Period 1|Not Treated|0|||
164601696|NCT01021852|594562675|FG002|Treatment Period 1|Not Treated|0|||
164601697|NCT01021852|594562676|FG003|Treatment Period 1|Not Treated|2|||
164601698|NCT01021852|594562677|FG004|Treatment Period 1|Not Treated|0|||
164601699|NCT01021852|594562678|FG005|Treatment Period 1|Not Treated|0|||
164601700|NCT01021852|594562679|FG006|Treatment Period 1|Not Treated|0|||
164601701|NCT01021852|594562680|FG007|Treatment Period 1|Not Treated|0|||
164601702|NCT01021852|594562673|FG000|Washout Period-Placebo|Adverse Event|0|||
164601703|NCT01021852|594562674|FG001|Washout Period-Placebo|Adverse Event|0|||
164601704|NCT01021852|594562675|FG002|Washout Period-Placebo|Adverse Event|0|||
164601705|NCT01021852|594562676|FG003|Washout Period-Placebo|Adverse Event|1|||
164601706|NCT01021852|594562677|FG004|Washout Period-Placebo|Adverse Event|0|||
164601707|NCT01021852|594562678|FG005|Washout Period-Placebo|Adverse Event|1|||
164601708|NCT01021852|594562679|FG006|Washout Period-Placebo|Adverse Event|0|||
164601709|NCT01021852|594562680|FG007|Washout Period-Placebo|Adverse Event|0|||
164601710|NCT01021852|594562673|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
164601711|NCT01021852|594562674|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
164601712|NCT01021852|594562675|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
164601713|NCT01021852|594562676|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
164601714|NCT01021852|594562677|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
164601715|NCT01021852|594562678|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
164601716|NCT01021852|594562679|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
164601717|NCT01021852|594562680|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
164601718|NCT01021852|594562673|FG000|Washout Period-Placebo|Protocol Violation|0|||
164601719|NCT01021852|594562674|FG001|Washout Period-Placebo|Protocol Violation|0|||
164601720|NCT01021852|594562675|FG002|Washout Period-Placebo|Protocol Violation|0|||
164601721|NCT01021852|594562676|FG003|Washout Period-Placebo|Protocol Violation|0|||
164601722|NCT01021852|594562677|FG004|Washout Period-Placebo|Protocol Violation|0|||
164601723|NCT01021852|594562678|FG005|Washout Period-Placebo|Protocol Violation|0|||
164601724|NCT01021852|594562679|FG006|Washout Period-Placebo|Protocol Violation|1|||
164601725|NCT01021852|594562680|FG007|Washout Period-Placebo|Protocol Violation|0|||
164601726|NCT01021852|594562673|FG000|Washout Period-No Drug|Adverse Event|1|||
164601727|NCT01021852|594562674|FG001|Washout Period-No Drug|Adverse Event|0|||
164601728|NCT01021852|594562675|FG002|Washout Period-No Drug|Adverse Event|0|||
164601729|NCT01021852|594562676|FG003|Washout Period-No Drug|Adverse Event|0|||
164601730|NCT01021852|594562677|FG004|Washout Period-No Drug|Adverse Event|0|||
164601731|NCT01021852|594562678|FG005|Washout Period-No Drug|Adverse Event|1|||
164601732|NCT01021852|594562679|FG006|Washout Period-No Drug|Adverse Event|0|||
164601733|NCT01021852|594562680|FG007|Washout Period-No Drug|Adverse Event|0|||
164601734|NCT01021852|594562673|FG000|Treatment Period 2|Adverse Event|0|||
164601735|NCT01021852|594562674|FG001|Treatment Period 2|Adverse Event|1|||
164601736|NCT01021852|594562675|FG002|Treatment Period 2|Adverse Event|0|||
164601737|NCT01021852|594562676|FG003|Treatment Period 2|Adverse Event|0|||
164601738|NCT01021852|594562677|FG004|Treatment Period 2|Adverse Event|1|||
164714594|NCT02968849|594977014|FG000|Overall Study|Lost to Follow-up|31|||
164714595|NCT02968849|594977015|FG001|Overall Study|Lost to Follow-up|29|||
164485863|NCT00813709|594150693|FG001|Double Blind Period|Adverse Event|1|||
164485864|NCT00813709|594150694|FG002|Double Blind Period|Adverse Event|4|||
164714596|NCT02968849|594977014|FG000|Overall Study|Withdrawal by Subject|73|||
164714597|NCT02968849|594977015|FG001|Overall Study|Withdrawal by Subject|64|||
164714598|NCT02968849|594977014|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
164485865|NCT00813709|594150695|FG003|Double Blind Period|Adverse Event|0|||
164485866|NCT00813709|594150696|FG004|Double Blind Period|Adverse Event|0|||
164601739|NCT01021852|594562678|FG005|Treatment Period 2|Adverse Event|0|||
164601740|NCT01021852|594562679|FG006|Treatment Period 2|Adverse Event|1|||
164601741|NCT01021852|594562680|FG007|Treatment Period 2|Adverse Event|0|||
164601742|NCT01021852|594562673|FG000|Treatment Period 2|Lack of Efficacy|0|||
164714599|NCT02968849|594977015|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
164485867|NCT00813709|594150697|FG005|Double Blind Period|Adverse Event|0|||
164601743|NCT01021852|594562674|FG001|Treatment Period 2|Lack of Efficacy|0|||
164601744|NCT01021852|594562675|FG002|Treatment Period 2|Lack of Efficacy|0|||
164601745|NCT01021852|594562676|FG003|Treatment Period 2|Lack of Efficacy|0|||
164601746|NCT01021852|594562677|FG004|Treatment Period 2|Lack of Efficacy|0|||
164601747|NCT01021852|594562678|FG005|Treatment Period 2|Lack of Efficacy|1|||
164601748|NCT01021852|594562679|FG006|Treatment Period 2|Lack of Efficacy|0|||
164601749|NCT01021852|594562680|FG007|Treatment Period 2|Lack of Efficacy|0|||
164601750|NCT01021852|594562673|FG000|Treatment Period 2|Physician Decision|0|||
164485868|NCT00813709|594150692|FG000|Double Blind Period|Lost to Follow-up|3|||
164601751|NCT01021852|594562674|FG001|Treatment Period 2|Physician Decision|0|||
164601752|NCT01021852|594562675|FG002|Treatment Period 2|Physician Decision|1|||
164601753|NCT01021852|594562676|FG003|Treatment Period 2|Physician Decision|0|||
164601754|NCT01021852|594562677|FG004|Treatment Period 2|Physician Decision|0|||
164601755|NCT01021852|594562678|FG005|Treatment Period 2|Physician Decision|0|||
164601756|NCT01021852|594562679|FG006|Treatment Period 2|Physician Decision|0|||
164601757|NCT01021852|594562680|FG007|Treatment Period 2|Physician Decision|0|||
164601758|NCT01021852|594562673|FG000|Treatment Period 2|Protocol Violation|0|||
164601759|NCT01021852|594562674|FG001|Treatment Period 2|Protocol Violation|0|||
164601760|NCT01021852|594562675|FG002|Treatment Period 2|Protocol Violation|0|||
164601761|NCT01021852|594562676|FG003|Treatment Period 2|Protocol Violation|0|||
164601762|NCT01021852|594562677|FG004|Treatment Period 2|Protocol Violation|1|||
164601763|NCT01021852|594562678|FG005|Treatment Period 2|Protocol Violation|0|||
164601764|NCT01021852|594562679|FG006|Treatment Period 2|Protocol Violation|1|||
164601765|NCT01021852|594562680|FG007|Treatment Period 2|Protocol Violation|0|||
164601766|NCT01021852|594562673|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164601767|NCT01021852|594562674|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164601768|NCT01021852|594562675|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164601769|NCT01021852|594562676|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164601770|NCT01021852|594562677|FG004|Treatment Period 2|Withdrawal by Subject|0|||
164601771|NCT01021852|594562678|FG005|Treatment Period 2|Withdrawal by Subject|0|||
164601772|NCT01021852|594562679|FG006|Treatment Period 2|Withdrawal by Subject|1|||
164601773|NCT01021852|594562680|FG007|Treatment Period 2|Withdrawal by Subject|2|||
164601774|NCT01025817|594562682|FG000|Completed Study Medication|Adverse Event|66|||
164601775|NCT01025817|594562683|FG001|Completed Study Medication|Adverse Event|39|||
164601776|NCT01025817|594562682|FG000|Completed Study Medication|Protocol Deviation|9|||
164601777|NCT01025817|594562683|FG001|Completed Study Medication|Protocol Deviation|8|||
164601778|NCT01025817|594562682|FG000|Completed Study Medication|Withdrawal by Subject|8|||
164601779|NCT01025817|594562683|FG001|Completed Study Medication|Withdrawal by Subject|9|||
164601780|NCT01025817|594562682|FG000|Completed Study Medication|Administrative problems|7|||
164601781|NCT01025817|594562683|FG001|Completed Study Medication|Administrative problems|5|||
164601782|NCT01025817|594562682|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
164601783|NCT01025817|594562683|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
164601784|NCT01025817|594562682|FG000|Completed Study Medication|Abnormal test procedure|4|||
164601785|NCT01025817|594562683|FG001|Completed Study Medication|Abnormal test procedure|0|||
164601786|NCT01025817|594562682|FG000|Completed Study Medication|Graft loss|2|||
164601787|NCT01025817|594562683|FG001|Completed Study Medication|Graft loss|5|||
164601788|NCT01025817|594562682|FG000|Completed Study Medication|Death|2|||
164601789|NCT01025817|594562683|FG001|Completed Study Medication|Death|2|||
164601790|NCT01025817|594562682|FG000|Completed Study Medication|Abnormal lab values|0|||
164601791|NCT01025817|594562683|FG001|Completed Study Medication|Abnormal lab values|2|||
164601792|NCT01025817|594562682|FG000|Completed Study Medication|Subject no longer required study drug|0|||
164601793|NCT01025817|594562683|FG001|Completed Study Medication|Subject no longer required study drug|1|||
164601794|NCT01025817|594562682|FG000|Completed Study Medication|Lost to Follow-up|0|||
164601795|NCT01025817|594562683|FG001|Completed Study Medication|Lost to Follow-up|1|||
164601796|NCT01025817|594562682|FG000|Completed Study|Withdrawal by Subject|8|||
164601797|NCT01025817|594562683|FG001|Completed Study|Withdrawal by Subject|16|||
164601798|NCT01025817|594562682|FG000|Completed Study|Death|6|||
164601799|NCT01025817|594562683|FG001|Completed Study|Death|5|||
164601800|NCT01025817|594562682|FG000|Completed Study|Missing|2|||
164485869|NCT00813709|594150693|FG001|Double Blind Period|Lost to Follow-up|2|||
164485870|NCT00813709|594150694|FG002|Double Blind Period|Lost to Follow-up|2|||
164485871|NCT00813709|594150695|FG003|Double Blind Period|Lost to Follow-up|0|||
164485872|NCT00813709|594150696|FG004|Double Blind Period|Lost to Follow-up|0|||
164485873|NCT00813709|594150697|FG005|Double Blind Period|Lost to Follow-up|0|||
164485874|NCT00813709|594150692|FG000|Double Blind Period|Switched to open label phase|9|||
164485875|NCT00813709|594150693|FG001|Double Blind Period|Switched to open label phase|26|||
164485876|NCT00813709|594150694|FG002|Double Blind Period|Switched to open label phase|18|||
164485877|NCT00813709|594150695|FG003|Double Blind Period|Switched to open label phase|0|||
164485878|NCT00813709|594150696|FG004|Double Blind Period|Switched to open label phase|0|||
164485879|NCT00813709|594150697|FG005|Double Blind Period|Switched to open label phase|0|||
164485880|NCT00813709|594150692|FG000|Double Blind Period|Randomized but not treated|1|||
164485881|NCT00813709|594150693|FG001|Double Blind Period|Randomized but not treated|3|||
164485882|NCT00813709|594150694|FG002|Double Blind Period|Randomized but not treated|1|||
164485883|NCT00813709|594150695|FG003|Double Blind Period|Randomized but not treated|0|||
164485884|NCT00813709|594150696|FG004|Double Blind Period|Randomized but not treated|0|||
164485885|NCT00813709|594150697|FG005|Double Blind Period|Randomized but not treated|0|||
164601801|NCT01025817|594562683|FG001|Completed Study|Missing|0|||
164601802|NCT01025817|594562682|FG000|Completed Study|Lost to Follow-up|0|||
164601803|NCT01025817|594562683|FG001|Completed Study|Lost to Follow-up|1|||
164601804|NCT00807846|594562684|FG000|Overall Study|Adverse Event|5|||
164601805|NCT00807846|594562685|FG001|Overall Study|Adverse Event|0|||
164601806|NCT00807846|594562684|FG000|Overall Study|Lack of Efficacy|2|||
164485886|NCT00813709|594150692|FG000|Double Blind Period|Other|14|||
164485887|NCT00813709|594150693|FG001|Double Blind Period|Other|9|||
164485888|NCT00813709|594150694|FG002|Double Blind Period|Other|6|||
164485889|NCT00813709|594150695|FG003|Double Blind Period|Other|0|||
164485890|NCT00813709|594150696|FG004|Double Blind Period|Other|0|||
164485891|NCT00813709|594150697|FG005|Double Blind Period|Other|0|||
164485892|NCT00813709|594150692|FG000|Open Label Period|Adverse Event|0|||
164485893|NCT00813709|594150693|FG001|Open Label Period|Adverse Event|0|||
164485894|NCT00813709|594150694|FG002|Open Label Period|Adverse Event|0|||
164485895|NCT00813709|594150695|FG003|Open Label Period|Adverse Event|5|||
164485896|NCT00813709|594150696|FG004|Open Label Period|Adverse Event|4|||
164485897|NCT00813709|594150697|FG005|Open Label Period|Adverse Event|3|||
164485898|NCT00813709|594150692|FG000|Open Label Period|Lack of Efficacy|0|||
164485899|NCT00813709|594150693|FG001|Open Label Period|Lack of Efficacy|0|||
164485900|NCT00813709|594150694|FG002|Open Label Period|Lack of Efficacy|0|||
164485901|NCT00813709|594150695|FG003|Open Label Period|Lack of Efficacy|3|||
164485902|NCT00813709|594150696|FG004|Open Label Period|Lack of Efficacy|1|||
164485903|NCT00813709|594150697|FG005|Open Label Period|Lack of Efficacy|1|||
164485904|NCT00813709|594150692|FG000|Open Label Period|Randomized but not treated|0|||
164485905|NCT00813709|594150693|FG001|Open Label Period|Randomized but not treated|0|||
164485906|NCT00813709|594150694|FG002|Open Label Period|Randomized but not treated|0|||
164485907|NCT00813709|594150695|FG003|Open Label Period|Randomized but not treated|1|||
164485908|NCT00813709|594150696|FG004|Open Label Period|Randomized but not treated|0|||
164485909|NCT00813709|594150697|FG005|Open Label Period|Randomized but not treated|1|||
164485910|NCT00813709|594150692|FG000|Open Label Period|Other|0|||
164485911|NCT00813709|594150693|FG001|Open Label Period|Other|0|||
164485912|NCT00813709|594150694|FG002|Open Label Period|Other|0|||
164485913|NCT00813709|594150695|FG003|Open Label Period|Other|11|||
164485914|NCT00813709|594150696|FG004|Open Label Period|Other|5|||
164485915|NCT00813709|594150697|FG005|Open Label Period|Other|6|||
164485916|NCT01655498|594150698|FG000|Overall Study|Unrelated health issue|2|||
164485917|NCT01655498|594150698|FG000|Overall Study|Protocol Violation|2|||
164485918|NCT01655498|594150698|FG000|Overall Study|Withdrawal by Subject|1|||
164485919|NCT00857311|594150701|FG000|Overall Study|Lost to Follow-up|1|||
164485920|NCT00857311|594150702|FG001|Overall Study|Lost to Follow-up|0|||
164485921|NCT00857311|594150703|FG002|Overall Study|Lost to Follow-up|0|||
164485922|NCT00857311|594150704|FG003|Overall Study|Lost to Follow-up|0|||
164485923|NCT01587703|594150705|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
164485924|NCT01587703|594150706|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
164485925|NCT01587703|594150707|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
164485926|NCT01587703|594150708|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
164485927|NCT01587703|594150709|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
164485928|NCT01587703|594150710|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
164485929|NCT01587703|594150711|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
164485930|NCT01587703|594150712|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
164485931|NCT01587703|594150713|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
164485932|NCT01587703|594150714|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
164485933|NCT01587703|594150715|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
164485934|NCT01587703|594150716|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
164485935|NCT01587703|594150717|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
164485936|NCT01587703|594150718|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
164485937|NCT01587703|594150719|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
164485938|NCT01587703|594150720|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
164485939|NCT01587703|594150721|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
164485940|NCT01587703|594150722|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
164485941|NCT01587703|594150723|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
164485942|NCT01587703|594150705|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
164485943|NCT01587703|594150706|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
164485944|NCT01587703|594150707|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
164485945|NCT01587703|594150708|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
164485946|NCT01587703|594150709|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
164485947|NCT01587703|594150710|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
164485948|NCT01587703|594150711|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
164485949|NCT01587703|594150712|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
164485950|NCT01587703|594150713|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
164485951|NCT01587703|594150714|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
164485952|NCT01587703|594150715|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
164485953|NCT01587703|594150716|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
164485954|NCT01587703|594150717|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
164485955|NCT01587703|594150718|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
164485956|NCT01587703|594150719|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
164714600|NCT02968849|594977014|FG000|Overall Study|Physician Decision|6|||
164714601|NCT02968849|594977015|FG001|Overall Study|Physician Decision|9|||
164714602|NCT02968849|594977014|FG000|Overall Study|Other|16|||
164714603|NCT02968849|594977015|FG001|Overall Study|Other|10|||
164714604|NCT05292183|594978659|FG000|Overall Study|Adverse Event|1|||
164714605|NCT02017015|594978664|FG000|Overall Study|Adverse Event|9|||
164714606|NCT02017015|594978664|FG000|Overall Study|Withdrawal by Subject|21|||
164714607|NCT02017015|594978664|FG000|Overall Study|Death|4|||
164714608|NCT02017015|594978664|FG000|Overall Study|Progressive Disease|31|||
164485957|NCT01587703|594150720|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
164485958|NCT01587703|594150721|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
164485959|NCT01587703|594150722|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
164485960|NCT01587703|594150723|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
164485961|NCT01587703|594150705|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
164485962|NCT01587703|594150706|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
164485963|NCT01587703|594150707|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
164485964|NCT01587703|594150708|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
164485965|NCT01587703|594150709|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
164485966|NCT01587703|594150710|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
164485967|NCT01587703|594150711|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
164485968|NCT01587703|594150712|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
164485969|NCT01587703|594150713|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
164485970|NCT01587703|594150714|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
164485971|NCT01587703|594150715|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
164485972|NCT01587703|594150716|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
164485973|NCT01587703|594150717|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
164485974|NCT01587703|594150718|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
164485975|NCT01587703|594150719|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
164485976|NCT01587703|594150720|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
164485977|NCT01587703|594150721|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
164485978|NCT01587703|594150722|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
164485979|NCT01587703|594150723|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
164485980|NCT01587703|594150705|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
164485981|NCT01587703|594150706|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
164485982|NCT01587703|594150707|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
164485983|NCT01587703|594150708|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
164485984|NCT01587703|594150709|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
164485985|NCT01587703|594150710|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
164485986|NCT01587703|594150711|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
164485987|NCT01587703|594150712|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
164485988|NCT01587703|594150713|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
164485989|NCT01587703|594150714|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
164485990|NCT01587703|594150715|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
164485991|NCT01587703|594150716|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
164485992|NCT01587703|594150717|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
164485993|NCT01587703|594150718|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
164485994|NCT01587703|594150719|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
164485995|NCT01587703|594150720|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
164485996|NCT01587703|594150721|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
164485997|NCT01587703|594150722|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
164485998|NCT01587703|594150723|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
164485999|NCT01587703|594150705|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
164486000|NCT01587703|594150706|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
164714609|NCT02017015|594978664|FG000|Overall Study|Non-compliance with study drug|2|||
164714610|NCT02017015|594978664|FG000|Overall Study|Physician Decision|2|||
164714611|NCT01277601|594978667|FG000|Overall Study|Adverse Event|5|||
164486001|NCT01587703|594150707|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
164486002|NCT01587703|594150708|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
164486003|NCT01587703|594150709|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
164486004|NCT01587703|594150710|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
164486005|NCT01587703|594150711|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
164486006|NCT01587703|594150712|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
164486007|NCT01587703|594150713|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
164714612|NCT01277601|594978668|FG001|Overall Study|Adverse Event|3|||
164714613|NCT01277601|594978669|FG002|Overall Study|Adverse Event|0|||
164714614|NCT01277601|594978670|FG003|Overall Study|Adverse Event|7|||
164714615|NCT01277601|594978667|FG000|Overall Study|Withdrawal by Subject|18|||
164486008|NCT01587703|594150714|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
164486009|NCT01587703|594150715|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
164714616|NCT01277601|594978668|FG001|Overall Study|Withdrawal by Subject|21|||
164486010|NCT01587703|594150716|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
164486011|NCT01587703|594150717|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
164486012|NCT01587703|594150718|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
164486013|NCT01587703|594150719|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
164486014|NCT01587703|594150720|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
164486015|NCT01587703|594150721|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
164486016|NCT01587703|594150722|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
164486017|NCT01587703|594150723|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
164486018|NCT01587703|594150705|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
164486019|NCT01587703|594150706|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
164486020|NCT01587703|594150707|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
164486021|NCT01587703|594150708|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
164486022|NCT01587703|594150709|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
164486023|NCT01587703|594150710|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
164486024|NCT01587703|594150711|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
164486025|NCT01587703|594150712|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
164486026|NCT01587703|594150713|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
164486027|NCT01587703|594150714|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
164486028|NCT01587703|594150715|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
164486029|NCT01587703|594150716|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
164486030|NCT01587703|594150717|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
164486031|NCT01587703|594150718|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
164486032|NCT01587703|594150719|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
164486033|NCT01587703|594150720|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
164486034|NCT01587703|594150721|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
164486035|NCT01587703|594150722|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
164486036|NCT01587703|594150723|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
164486037|NCT01587703|594150705|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
164486038|NCT01587703|594150706|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
164486039|NCT01587703|594150707|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
164486040|NCT01587703|594150708|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
164486041|NCT01587703|594150709|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
164486042|NCT01587703|594150710|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
164486043|NCT01587703|594150711|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
164486044|NCT01587703|594150712|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
164486045|NCT01587703|594150713|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
164486046|NCT01587703|594150714|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
164486047|NCT01587703|594150715|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
164486048|NCT01587703|594150716|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
164486049|NCT01587703|594150717|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
164486050|NCT01587703|594150718|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
164486051|NCT01587703|594150719|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
164486052|NCT01587703|594150720|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
164486053|NCT01587703|594150721|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
164486054|NCT01587703|594150722|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
164486055|NCT01587703|594150723|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
164486056|NCT01587703|594150705|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
164486057|NCT01587703|594150706|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
164486058|NCT01587703|594150707|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
164486059|NCT01587703|594150708|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
164486060|NCT01587703|594150709|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
164714617|NCT01277601|594978669|FG002|Overall Study|Withdrawal by Subject|8|||
164714618|NCT01277601|594978670|FG003|Overall Study|Withdrawal by Subject|17|||
164714619|NCT01277601|594978667|FG000|Overall Study|Lost to Follow-up|7|||
164714620|NCT01277601|594978668|FG001|Overall Study|Lost to Follow-up|9|||
164714621|NCT01277601|594978669|FG002|Overall Study|Lost to Follow-up|4|||
164714622|NCT01277601|594978670|FG003|Overall Study|Lost to Follow-up|2|||
164714623|NCT01277601|594978667|FG000|Overall Study|Physician Decision|3|||
164486061|NCT01587703|594150710|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
164486062|NCT01587703|594150711|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
164486063|NCT01587703|594150712|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
164486064|NCT01587703|594150713|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
164486065|NCT01587703|594150714|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
164714624|NCT01277601|594978668|FG001|Overall Study|Physician Decision|5|||
164714625|NCT01277601|594978669|FG002|Overall Study|Physician Decision|1|||
164714626|NCT01277601|594978670|FG003|Overall Study|Physician Decision|6|||
164601807|NCT00807846|594562685|FG001|Overall Study|Lack of Efficacy|0|||
164601808|NCT00807846|594562684|FG000|Overall Study|Protocol Violation|2|||
164486066|NCT01587703|594150715|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
164486067|NCT01587703|594150716|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
164486068|NCT01587703|594150717|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
164486069|NCT01587703|594150718|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
164486070|NCT01587703|594150719|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
164486071|NCT01587703|594150720|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
164486072|NCT01587703|594150721|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
164486073|NCT01587703|594150722|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
164486074|NCT01587703|594150723|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
164486075|NCT01587703|594150705|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
164486076|NCT01587703|594150706|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
164486077|NCT01587703|594150707|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
164486078|NCT01587703|594150708|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
164486079|NCT01587703|594150709|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
164486080|NCT01587703|594150710|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
164486081|NCT01587703|594150711|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
164486082|NCT01587703|594150712|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
164486083|NCT01587703|594150713|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
164486084|NCT01587703|594150714|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
164486085|NCT01587703|594150715|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
164486086|NCT01587703|594150716|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
164486087|NCT01587703|594150717|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
164486088|NCT01587703|594150718|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
164486089|NCT01587703|594150719|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
164486090|NCT01587703|594150720|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
164486091|NCT01587703|594150721|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
164486092|NCT01587703|594150722|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
164601809|NCT00807846|594562685|FG001|Overall Study|Protocol Violation|1|||
164486093|NCT01587703|594150723|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
164486094|NCT01587703|594150705|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
164486095|NCT01587703|594150706|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
164601810|NCT00807846|594562684|FG000|Overall Study|Withdrawal by Subject|2|||
164486096|NCT01587703|594150707|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
164486097|NCT01587703|594150708|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
164486098|NCT01587703|594150709|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
164486099|NCT01587703|594150710|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
164486100|NCT01587703|594150711|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
164486101|NCT01587703|594150712|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
164486102|NCT01587703|594150713|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
164486103|NCT01587703|594150714|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
164486104|NCT01587703|594150715|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
164486105|NCT01587703|594150716|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
164486106|NCT01587703|594150717|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
164486107|NCT01587703|594150718|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
164486108|NCT01587703|594150719|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
164486109|NCT01587703|594150720|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
164486110|NCT01587703|594150721|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
164486111|NCT01587703|594150722|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
164486112|NCT01587703|594150723|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
164486113|NCT01587703|594150705|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
164486114|NCT01587703|594150706|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
164486115|NCT01587703|594150707|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
164486116|NCT01587703|594150708|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
164486117|NCT01587703|594150709|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
164486118|NCT01587703|594150710|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
164486119|NCT01587703|594150711|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
164486120|NCT01587703|594150712|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
164486121|NCT01587703|594150713|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
164486122|NCT01587703|594150714|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
164486123|NCT01587703|594150715|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
164486124|NCT01587703|594150716|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
164486125|NCT01587703|594150717|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
164486126|NCT01587703|594150718|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
164486127|NCT01587703|594150719|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
164486128|NCT01587703|594150720|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
164486129|NCT01587703|594150721|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
164486130|NCT01587703|594150722|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
164486131|NCT01587703|594150723|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
164486132|NCT01587703|594150705|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
164486133|NCT01587703|594150706|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
164486134|NCT01587703|594150707|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
164486135|NCT01587703|594150708|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
164486136|NCT01587703|594150709|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
164486137|NCT01587703|594150710|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
164486138|NCT01587703|594150711|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
164486139|NCT01587703|594150712|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
164486140|NCT01587703|594150713|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
164486141|NCT01587703|594150714|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
164486142|NCT01587703|594150715|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
164486143|NCT01587703|594150716|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
164486144|NCT01587703|594150717|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
164486145|NCT01587703|594150718|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
164486146|NCT01587703|594150719|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
164486147|NCT01587703|594150720|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
164486148|NCT01587703|594150721|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
164486149|NCT01587703|594150722|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
164486150|NCT01587703|594150723|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
164486151|NCT01587703|594150705|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
164486152|NCT01587703|594150706|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
164486153|NCT01587703|594150707|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
164486154|NCT01587703|594150708|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
164601811|NCT00807846|594562685|FG001|Overall Study|Withdrawal by Subject|1|||
164486155|NCT01587703|594150709|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
164486156|NCT01587703|594150710|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
164486157|NCT01587703|594150711|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
164486158|NCT01587703|594150712|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
164486159|NCT01587703|594150713|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
164486160|NCT01587703|594150714|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
164486161|NCT01587703|594150715|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
164486162|NCT01587703|594150716|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
164486163|NCT01587703|594150717|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
164486164|NCT01587703|594150718|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
164486165|NCT01587703|594150719|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
164486166|NCT01587703|594150720|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
164486167|NCT01587703|594150721|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
164486168|NCT01587703|594150722|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
164486169|NCT01587703|594150723|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
164486170|NCT01587703|594150705|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
164486171|NCT01587703|594150706|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
164486172|NCT01587703|594150707|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
164486173|NCT01587703|594150708|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
164486174|NCT01587703|594150709|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
164486175|NCT01587703|594150710|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
164486176|NCT01587703|594150711|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
164486177|NCT01587703|594150712|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
164486178|NCT01587703|594150713|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
164486179|NCT01587703|594150714|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
164486180|NCT01587703|594150715|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
164486181|NCT01587703|594150716|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
164486182|NCT01587703|594150717|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
164486183|NCT01587703|594150718|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
164486184|NCT01587703|594150719|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
164486185|NCT01587703|594150720|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
164486186|NCT01587703|594150721|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
164486187|NCT01587703|594150722|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
164486188|NCT01587703|594150723|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
164486189|NCT01587703|594150705|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
164486190|NCT01587703|594150706|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
164486191|NCT01587703|594150707|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
164486192|NCT01587703|594150708|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
164486193|NCT01587703|594150709|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
164486194|NCT01587703|594150710|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
164486195|NCT01587703|594150711|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
164486196|NCT01587703|594150712|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
164486197|NCT01587703|594150713|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
164486198|NCT01587703|594150714|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
164486199|NCT01587703|594150715|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
164486200|NCT01587703|594150716|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
164486201|NCT01587703|594150717|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
164486202|NCT01587703|594150718|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
164486203|NCT01587703|594150719|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
164486204|NCT01587703|594150720|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
164486205|NCT01587703|594150721|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
164486206|NCT01587703|594150722|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
164486207|NCT01587703|594150723|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
164486208|NCT01714947|594150724|FG000|Part B|Progressive Disease|3|||
164486209|NCT01345253|594150728|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
164486210|NCT01345253|594150729|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
164486211|NCT01345253|594150728|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
164486212|NCT01345253|594150729|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
164486213|NCT01345253|594150728|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
164486214|NCT01345253|594150729|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
164486215|NCT01345253|594150728|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
164486216|NCT01345253|594150729|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
164486217|NCT01345253|594150728|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
164486218|NCT01345253|594150729|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
164486219|NCT01345253|594150728|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
164486220|NCT01345253|594150729|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
164486221|NCT01345253|594150728|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
164486222|NCT01345253|594150729|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
164486223|NCT01345253|594150728|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
164486224|NCT01345253|594150729|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
164486225|NCT01345253|594150728|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
164486226|NCT01345253|594150729|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
164601812|NCT00807846|594562684|FG000|Overall Study|Other|1|||
164486227|NCT01345253|594150728|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
164486228|NCT01345253|594150729|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
164486229|NCT01345253|594150728|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
164486230|NCT01345253|594150729|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
164486231|NCT01345253|594150728|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
164486232|NCT01345253|594150729|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
164486233|NCT01345253|594150728|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
164486234|NCT01345253|594150729|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
164486235|NCT01345253|594150728|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
164486236|NCT01345253|594150729|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
164486237|NCT01345253|594150728|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
164486238|NCT01345253|594150729|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
164486239|NCT00759681|594150730|FG000|Overall Study|Death|2|||
164486240|NCT00759681|594150731|FG001|Overall Study|Death|5|||
164486241|NCT00759681|594150730|FG000|Overall Study|Lost to Follow-up|8|||
164486242|NCT00759681|594150731|FG001|Overall Study|Lost to Follow-up|5|||
164486243|NCT00930644|594150732|FG000|Overall Study|Withdrawal by Subject|4|||
164486244|NCT00930644|594150732|FG000|Overall Study|Physician Decision|2|||
164486245|NCT00930644|594150732|FG000|Overall Study|Death|1|||
164486246|NCT00930644|594150732|FG000|Overall Study|Adverse Event|16|||
164486247|NCT01012999|594150733|FG000|Overall Study|Protocol Violation|1|||
164486248|NCT02410278|594150734|FG000|Run-in Period|Adverse Event|5|||
164486249|NCT02410278|594150735|FG001|Run-in Period|Adverse Event|0|||
164486250|NCT02410278|594150736|FG002|Run-in Period|Adverse Event|0|||
164486251|NCT02410278|594150734|FG000|Run-in Period|GSRS Threshold Not Met|30|||
164486252|NCT02410278|594150735|FG001|Run-in Period|GSRS Threshold Not Met|0|||
164486253|NCT02410278|594150736|FG002|Run-in Period|GSRS Threshold Not Met|0|||
164486254|NCT02410278|594150734|FG000|Run-in Period|Lost to Follow-up|1|||
164486255|NCT02410278|594150735|FG001|Run-in Period|Lost to Follow-up|0|||
164486256|NCT02410278|594150736|FG002|Run-in Period|Lost to Follow-up|0|||
164486257|NCT02410278|594150734|FG000|Run-in Period|Withdrawal by Subject|1|||
164486258|NCT02410278|594150735|FG001|Run-in Period|Withdrawal by Subject|0|||
164486259|NCT02410278|594150736|FG002|Run-in Period|Withdrawal by Subject|0|||
164601813|NCT00807846|594562685|FG001|Overall Study|Other|2|||
164601814|NCT01165021|594562687|FG000|Overall Study|Death|1|||
164601815|NCT01419665|594562688|FG000|Combination Treatment|Adverse Event|7|||
164714627|NCT01277601|594978667|FG000|Overall Study|Pregnancy|2|||
164714628|NCT01277601|594978668|FG001|Overall Study|Pregnancy|2|||
164714629|NCT01277601|594978669|FG002|Overall Study|Pregnancy|4|||
164714630|NCT01277601|594978670|FG003|Overall Study|Pregnancy|1|||
164714631|NCT01277601|594978667|FG000|Overall Study|Noncompliance with Study Drug|1|||
164714632|NCT01277601|594978668|FG001|Overall Study|Noncompliance with Study Drug|3|||
164714633|NCT01277601|594978669|FG002|Overall Study|Noncompliance with Study Drug|2|||
164714634|NCT01277601|594978670|FG003|Overall Study|Noncompliance with Study Drug|0|||
164714635|NCT01277601|594978667|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
164714636|NCT01277601|594978668|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
164714637|NCT01277601|594978669|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
164714638|NCT01277601|594978670|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
164714639|NCT01277601|594978667|FG000|Overall Study|Protocol Violation|0|||
164714640|NCT01277601|594978668|FG001|Overall Study|Protocol Violation|2|||
164714641|NCT01277601|594978669|FG002|Overall Study|Protocol Violation|5|||
164714642|NCT01277601|594978670|FG003|Overall Study|Protocol Violation|0|||
164714643|NCT01277601|594978667|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
164714644|NCT01277601|594978668|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
164714645|NCT01277601|594978669|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
164714646|NCT01277601|594978670|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
164714647|NCT02260570|594978672|FG000|Overall Study|Withdrawal by Subject|2|||
164601816|NCT01419665|594562689|FG001|Combination Treatment|Adverse Event|10|||
164601817|NCT01419665|594562688|FG000|Combination Treatment|Physician Decision|5|||
164601818|NCT01419665|594562689|FG001|Combination Treatment|Physician Decision|8|||
164601819|NCT01419665|594562688|FG000|Combination Treatment|Protocol Violation|6|||
164601820|NCT01419665|594562689|FG001|Combination Treatment|Protocol Violation|2|||
164601821|NCT01419665|594562688|FG000|Combination Treatment|disease progression|10|||
164601822|NCT01419665|594562689|FG001|Combination Treatment|disease progression|9|||
164601823|NCT01419665|594562688|FG000|Combination Treatment|Death|5|||
164601824|NCT01419665|594562689|FG001|Combination Treatment|Death|7|||
164601825|NCT01419665|594562688|FG000|Combination Treatment|administrative problems|0|||
164601826|NCT01419665|594562689|FG001|Combination Treatment|administrative problems|1|||
164601827|NCT01419665|594562688|FG000|Combination Treatment|Withdrawal by Subject|5|||
164601828|NCT01419665|594562689|FG001|Combination Treatment|Withdrawal by Subject|4|||
164601829|NCT01419665|594562688|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
164601830|NCT01419665|594562689|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
164601831|NCT01419665|594562688|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
164486260|NCT02410278|594150734|FG000|Run-in Period|Pregnancy|1|||
164486261|NCT02410278|594150735|FG001|Run-in Period|Pregnancy|0|||
164486262|NCT02410278|594150736|FG002|Run-in Period|Pregnancy|0|||
164486263|NCT02410278|594150734|FG000|Study Treatment Period|Adverse Event|0|||
164486264|NCT02410278|594150735|FG001|Study Treatment Period|Adverse Event|6|||
164486265|NCT02410278|594150736|FG002|Study Treatment Period|Adverse Event|3|||
164486266|NCT02410278|594150734|FG000|Study Treatment Period|Physician Decision|0|||
164486267|NCT02410278|594150735|FG001|Study Treatment Period|Physician Decision|0|||
164486268|NCT02410278|594150736|FG002|Study Treatment Period|Physician Decision|1|||
164486269|NCT02410278|594150734|FG000|Study Treatment Period|Withdrawal by Subject|0|||
164486270|NCT02410278|594150735|FG001|Study Treatment Period|Withdrawal by Subject|1|||
164486271|NCT02410278|594150736|FG002|Study Treatment Period|Withdrawal by Subject|0|||
164486272|NCT02410278|594150734|FG000|Study Treatment Period|Other|0|||
164486273|NCT02410278|594150735|FG001|Study Treatment Period|Other|3|||
164486274|NCT02410278|594150736|FG002|Study Treatment Period|Other|0|||
164486275|NCT02410278|594150734|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
164486276|NCT02410278|594150735|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
164486277|NCT02410278|594150736|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
164486278|NCT02584257|594150737|FG000|Period 1|Withdrawal by Subject|0|||
164486279|NCT02584257|594150738|FG001|Period 1|Withdrawal by Subject|0|||
164486280|NCT02584257|594150739|FG002|Period 1|Withdrawal by Subject|0|||
164486281|NCT02584257|594150740|FG003|Period 1|Withdrawal by Subject|0|||
164486282|NCT02584257|594150741|FG004|Period 1|Withdrawal by Subject|0|||
164486283|NCT02584257|594150742|FG005|Period 1|Withdrawal by Subject|0|||
164486284|NCT02584257|594150743|FG006|Period 1|Withdrawal by Subject|1|||
164486285|NCT02584257|594150744|FG007|Period 1|Withdrawal by Subject|0|||
164486286|NCT02584257|594150745|FG008|Period 1|Withdrawal by Subject|0|||
164486287|NCT02584257|594150737|FG000|Period 2|Physician Decision|1|||
164486288|NCT02584257|594150738|FG001|Period 2|Physician Decision|0|||
164486289|NCT02584257|594150739|FG002|Period 2|Physician Decision|0|||
164486290|NCT02584257|594150740|FG003|Period 2|Physician Decision|0|||
164486291|NCT02584257|594150741|FG004|Period 2|Physician Decision|0|||
164486292|NCT02584257|594150742|FG005|Period 2|Physician Decision|0|||
164486293|NCT02584257|594150743|FG006|Period 2|Physician Decision|0|||
164486294|NCT02584257|594150744|FG007|Period 2|Physician Decision|0|||
164486295|NCT02584257|594150745|FG008|Period 2|Physician Decision|0|||
164486296|NCT02584257|594150737|FG000|Period 2|Adverse Event|0|||
164486297|NCT02584257|594150738|FG001|Period 2|Adverse Event|1|||
164486298|NCT02584257|594150739|FG002|Period 2|Adverse Event|0|||
164486299|NCT02584257|594150740|FG003|Period 2|Adverse Event|0|||
164486300|NCT02584257|594150741|FG004|Period 2|Adverse Event|0|||
164486301|NCT02584257|594150742|FG005|Period 2|Adverse Event|0|||
164486302|NCT02584257|594150743|FG006|Period 2|Adverse Event|0|||
164486303|NCT02584257|594150744|FG007|Period 2|Adverse Event|0|||
164486304|NCT02584257|594150745|FG008|Period 2|Adverse Event|0|||
164486305|NCT01670877|594150746|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
164486306|NCT01670877|594150747|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
164486307|NCT01670877|594150748|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
164486308|NCT01670877|594150749|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
164486309|NCT01670877|594150750|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
164486310|NCT01670877|594150751|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
164486311|NCT01670877|594150746|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
164486312|NCT01670877|594150747|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
164486313|NCT01670877|594150748|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
164601832|NCT01419665|594562689|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
164601833|NCT01419665|594562688|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
164486314|NCT01670877|594150749|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
164486315|NCT01670877|594150750|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
164601834|NCT01419665|594562689|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
164601835|NCT01419665|594562688|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
164601836|NCT01419665|594562689|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
164486316|NCT01670877|594150751|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
164486317|NCT01670877|594150746|FG000|Part I and Part 2|Grade 2 vomiting|0|||
164486318|NCT01670877|594150747|FG001|Part I and Part 2|Grade 2 vomiting|0|||
164486319|NCT01670877|594150748|FG002|Part I and Part 2|Grade 2 vomiting|0|||
164486320|NCT01670877|594150749|FG003|Part I and Part 2|Grade 2 vomiting|1|||
164486321|NCT01670877|594150750|FG004|Part I and Part 2|Grade 2 vomiting|0|||
164486322|NCT01670877|594150751|FG005|Part I and Part 2|Grade 2 vomiting|0|||
164601837|NCT01419665|594562688|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
164486323|NCT01670877|594150746|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
164486324|NCT01670877|594150747|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
164486325|NCT01670877|594150748|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
164486326|NCT01670877|594150749|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
164601838|NCT01419665|594562689|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
164486327|NCT01670877|594150750|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
164486328|NCT01670877|594150751|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
164486329|NCT01670877|594150746|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
164486330|NCT01670877|594150747|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
164486331|NCT01670877|594150748|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
164486332|NCT01670877|594150749|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
164486333|NCT01670877|594150750|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
164486334|NCT01670877|594150751|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
164486335|NCT00417885|594150752|FG000|Overall Study|Adverse Event|1|||
164486336|NCT00417885|594150752|FG000|Overall Study|Objective Progression or Relapse|3|||
164486337|NCT00417885|594150752|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
164486338|NCT02309892|594150753|FG000|Overall Study|Physician Decision|1|||
164486339|NCT02309892|594150754|FG001|Overall Study|Physician Decision|0|||
164486340|NCT02309892|594150755|FG002|Overall Study|Physician Decision|0|||
164486341|NCT02309892|594150756|FG003|Overall Study|Physician Decision|0|||
164486342|NCT02309892|594150757|FG004|Overall Study|Physician Decision|0|||
164486343|NCT02309892|594150758|FG005|Overall Study|Physician Decision|0|||
164486344|NCT02309892|594150759|FG006|Overall Study|Physician Decision|0|||
164486345|NCT02309892|594150753|FG000|Overall Study|Adverse Event|1|||
164486346|NCT02309892|594150754|FG001|Overall Study|Adverse Event|0|||
164486347|NCT02309892|594150755|FG002|Overall Study|Adverse Event|1|||
164486348|NCT02309892|594150756|FG003|Overall Study|Adverse Event|0|||
164486349|NCT02309892|594150757|FG004|Overall Study|Adverse Event|0|||
164486350|NCT02309892|594150758|FG005|Overall Study|Adverse Event|0|||
164486351|NCT02309892|594150759|FG006|Overall Study|Adverse Event|0|||
164486352|NCT02309892|594150753|FG000|Overall Study|Progressive Disease|0|||
164486353|NCT02309892|594150754|FG001|Overall Study|Progressive Disease|1|||
164486354|NCT02309892|594150755|FG002|Overall Study|Progressive Disease|0|||
164486355|NCT02309892|594150756|FG003|Overall Study|Progressive Disease|0|||
164486356|NCT02309892|594150757|FG004|Overall Study|Progressive Disease|1|||
164486357|NCT02309892|594150758|FG005|Overall Study|Progressive Disease|0|||
164486358|NCT02309892|594150759|FG006|Overall Study|Progressive Disease|0|||
164486359|NCT02309892|594150753|FG000|Overall Study|Death|0|||
164486360|NCT02309892|594150754|FG001|Overall Study|Death|0|||
164486361|NCT02309892|594150755|FG002|Overall Study|Death|0|||
164486362|NCT02309892|594150756|FG003|Overall Study|Death|0|||
164486363|NCT02309892|594150757|FG004|Overall Study|Death|0|||
164486364|NCT02309892|594150758|FG005|Overall Study|Death|1|||
164486365|NCT02309892|594150759|FG006|Overall Study|Death|0|||
164486366|NCT05376397|594150762|FG000|Overall Study|Lost to Follow-up|1|||
164486367|NCT00648895|594150768|FG000|Overall Study|Lack of Efficacy|0|||
164486368|NCT00648895|594150769|FG001|Overall Study|Lack of Efficacy|1|||
164486369|NCT03449979|594150773|FG000|Overall Study|Technical difficulty|0|||
164486370|NCT03449979|594150774|FG001|Overall Study|Technical difficulty|0|||
164486371|NCT03449979|594150775|FG002|Overall Study|Technical difficulty|0|||
164486372|NCT03449979|594150776|FG003|Overall Study|Technical difficulty|1|||
164486373|NCT03209492|594150777|FG000|Overall Study|Case Report Forms Uncollected|5|||
164486374|NCT01894620|594150782|FG000|Overall Study|Withdrawal by Subject|0|||
164486375|NCT01894620|594150783|FG001|Overall Study|Withdrawal by Subject|1|||
164486376|NCT01124916|594150784|FG000|Overall Study|Lost to Follow-up|3|||
164486377|NCT01124916|594150785|FG001|Overall Study|Lost to Follow-up|2|||
164486378|NCT00879710|594150786|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
164486379|NCT00879710|594150787|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
164486380|NCT00879710|594150788|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
164486381|NCT00879710|594150789|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
164486382|NCT00879710|594150786|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
164486383|NCT00879710|594150787|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
164486384|NCT00879710|594150788|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
164486385|NCT00879710|594150789|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
164486386|NCT02644122|594150792|FG000|Overall Study|Withdrawal by Subject|1|||
164486387|NCT00424476|594150795|FG000|Overall Study|Withdrawal by Subject|7|||
164486388|NCT00424476|594150796|FG001|Overall Study|Withdrawal by Subject|6|||
164486389|NCT00424476|594150797|FG002|Overall Study|Withdrawal by Subject|3|||
164486390|NCT00424476|594150795|FG000|Overall Study|Adverse Event|19|||
164486391|NCT00424476|594150796|FG001|Overall Study|Adverse Event|16|||
164486392|NCT00424476|594150797|FG002|Overall Study|Adverse Event|15|||
164486393|NCT00424476|594150795|FG000|Overall Study|Lack of Efficacy|16|||
164486394|NCT00424476|594150796|FG001|Overall Study|Lack of Efficacy|12|||
164486395|NCT00424476|594150797|FG002|Overall Study|Lack of Efficacy|12|||
164486396|NCT00424476|594150795|FG000|Overall Study|Lack of Compliance|1|||
164486397|NCT00424476|594150796|FG001|Overall Study|Lack of Compliance|1|||
164486398|NCT00424476|594150797|FG002|Overall Study|Lack of Compliance|1|||
164486399|NCT00424476|594150795|FG000|Overall Study|Lost to Follow-up|4|||
164486400|NCT00424476|594150796|FG001|Overall Study|Lost to Follow-up|6|||
164486401|NCT00424476|594150797|FG002|Overall Study|Lost to Follow-up|3|||
164486402|NCT00424476|594150795|FG000|Overall Study|Protocol Violation|7|||
164486403|NCT00424476|594150796|FG001|Overall Study|Protocol Violation|2|||
164486404|NCT00424476|594150797|FG002|Overall Study|Protocol Violation|3|||
164486405|NCT00424476|594150795|FG000|Overall Study|Physician Decision|3|||
164486406|NCT00424476|594150796|FG001|Overall Study|Physician Decision|2|||
164486407|NCT00424476|594150797|FG002|Overall Study|Physician Decision|3|||
164486408|NCT00424476|594150795|FG000|Overall Study|Other|4|||
164486409|NCT00424476|594150796|FG001|Overall Study|Other|3|||
164486410|NCT00424476|594150797|FG002|Overall Study|Other|9|||
164486411|NCT02514824|594150798|FG000|Overall Study|Withdrawal by Subject|1|||
164486412|NCT02514824|594150799|FG001|Overall Study|Withdrawal by Subject|0|||
164486413|NCT02514824|594150800|FG002|Overall Study|Withdrawal by Subject|0|||
164486414|NCT02514824|594150801|FG003|Overall Study|Withdrawal by Subject|0|||
164486415|NCT02514824|594150798|FG000|Overall Study|Dose-Limiting Toxicity|0|||
164486416|NCT02514824|594150799|FG001|Overall Study|Dose-Limiting Toxicity|1|||
164486417|NCT02514824|594150800|FG002|Overall Study|Dose-Limiting Toxicity|0|||
164486418|NCT02514824|594150801|FG003|Overall Study|Dose-Limiting Toxicity|0|||
164486419|NCT00753896|594150804|FG000|Overall Study|Adverse Event|4|||
164486420|NCT00753896|594150804|FG000|Overall Study|Death|1|||
164486421|NCT00753896|594150804|FG000|Overall Study|Lost to Follow-up|2|||
164486422|NCT00753896|594150804|FG000|Overall Study|Protocol Violation|1|||
164486423|NCT00753896|594150804|FG000|Overall Study|Withdrawal by Subject|4|||
164486424|NCT00753896|594150804|FG000|Overall Study|Entry Criteria Not Met|4|||
164486425|NCT00952523|594150805|FG000|Overall Study|Withdrawal by Subject|7|||
164486426|NCT02159352|594150806|FG000|Overall Study|Adverse Event|3|||
164486427|NCT02159352|594150807|FG001|Overall Study|Adverse Event|1|||
164486428|NCT02159352|594150806|FG000|Overall Study|Withdrawal by Subject|0|||
164486429|NCT02159352|594150807|FG001|Overall Study|Withdrawal by Subject|1|||
164486430|NCT02707952|594150808|FG000|Overall Study|Adverse Event|1|||
164486431|NCT02707952|594150809|FG001|Overall Study|Adverse Event|0|||
164486432|NCT02707952|594150810|FG002|Overall Study|Adverse Event|0|||
164486433|NCT02707952|594150811|FG003|Overall Study|Adverse Event|0|||
164486434|NCT02707952|594150808|FG000|Overall Study|Lost to Follow-up|1|||
164486435|NCT02707952|594150809|FG001|Overall Study|Lost to Follow-up|0|||
164486436|NCT02707952|594150810|FG002|Overall Study|Lost to Follow-up|0|||
164486437|NCT02707952|594150811|FG003|Overall Study|Lost to Follow-up|0|||
164486438|NCT02707952|594150808|FG000|Overall Study|Withdrawal by Subject|0|||
164486439|NCT02707952|594150809|FG001|Overall Study|Withdrawal by Subject|1|||
164486440|NCT02707952|594150810|FG002|Overall Study|Withdrawal by Subject|2|||
164486441|NCT02707952|594150811|FG003|Overall Study|Withdrawal by Subject|0|||
164486442|NCT03072862|594150816|FG000|Overall Study|Withdrawal by Subject|4|||
164486443|NCT03072862|594150816|FG000|Overall Study|Lost to Follow-up|6|||
164486444|NCT03072862|594150816|FG000|Overall Study|Protocol Violation|4|||
164601839|NCT01419665|594562688|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
164601840|NCT01419665|594562689|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
164601841|NCT01419665|594562688|FG000|Maintenance Treatment and/or Follow up|Death|1|||
164601842|NCT01419665|594562689|FG001|Maintenance Treatment and/or Follow up|Death|2|||
164601843|NCT01419665|594562688|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
164601844|NCT01419665|594562689|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
164601845|NCT01419665|594562688|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
164601846|NCT01419665|594562689|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
164601847|NCT01419665|594562688|FG000|Open Label Phase|Death|1|||
164601848|NCT01419665|594562689|FG001|Open Label Phase|Death|0|||
164601849|NCT01419665|594562688|FG000|Open Label Phase|disease progression|0|||
164601850|NCT01419665|594562689|FG001|Open Label Phase|disease progression|1|||
164601851|NCT01655823|594562691|FG000|Overall Study|Lost to Follow-up|0|||
164601852|NCT01655823|594562692|FG001|Overall Study|Lost to Follow-up|1|||
164601853|NCT01655823|594562693|FG002|Overall Study|Lost to Follow-up|0|||
164601854|NCT01655823|594562694|FG003|Overall Study|Lost to Follow-up|0|||
164601855|NCT01655823|594562695|FG004|Overall Study|Lost to Follow-up|1|||
164601856|NCT01655823|594562691|FG000|Overall Study|Withdrawal by Subject|0|||
164601857|NCT01655823|594562692|FG001|Overall Study|Withdrawal by Subject|1|||
164486445|NCT03072862|594150816|FG000|Overall Study|Physician Decision|2|||
164486446|NCT03072862|594150816|FG000|Overall Study|Death|1|||
164486447|NCT03072862|594150816|FG000|Overall Study|Adverse Event|1|||
164486448|NCT02203513|594150817|FG000|Overall Study|Refused further treatment|2|||
164486449|NCT02203513|594150818|FG001|Overall Study|Refused further treatment|0|||
164601858|NCT01655823|594562693|FG002|Overall Study|Withdrawal by Subject|0|||
164486450|NCT02203513|594150819|FG002|Overall Study|Refused further treatment|1|||
164486451|NCT02203513|594150820|FG003|Overall Study|Refused further treatment|0|||
164486452|NCT02203513|594150821|FG004|Overall Study|Refused further treatment|0|||
164601859|NCT01655823|594562694|FG003|Overall Study|Withdrawal by Subject|1|||
164486453|NCT02203513|594150817|FG000|Overall Study|Switched to alternative treatment|3|||
164486454|NCT02203513|594150818|FG001|Overall Study|Switched to alternative treatment|4|||
164486455|NCT02203513|594150819|FG002|Overall Study|Switched to alternative treatment|0|||
164486456|NCT02203513|594150820|FG003|Overall Study|Switched to alternative treatment|0|||
164486457|NCT02203513|594150821|FG004|Overall Study|Switched to alternative treatment|4|||
164486458|NCT02203513|594150817|FG000|Overall Study|Did not receive investigational product (IP)|0|||
164601860|NCT01655823|594562695|FG004|Overall Study|Withdrawal by Subject|0|||
164486459|NCT02203513|594150818|FG001|Overall Study|Did not receive investigational product (IP)|1|||
164486460|NCT02203513|594150819|FG002|Overall Study|Did not receive investigational product (IP)|0|||
164486461|NCT02203513|594150820|FG003|Overall Study|Did not receive investigational product (IP)|0|||
164486462|NCT02203513|594150821|FG004|Overall Study|Did not receive investigational product (IP)|0|||
164486463|NCT02203513|594150817|FG000|Overall Study|Death (unrelated to study therapy)|1|||
164486464|NCT02203513|594150818|FG001|Overall Study|Death (unrelated to study therapy)|3|||
164486465|NCT02203513|594150819|FG002|Overall Study|Death (unrelated to study therapy)|1|||
164486466|NCT02203513|594150820|FG003|Overall Study|Death (unrelated to study therapy)|0|||
164486467|NCT02203513|594150821|FG004|Overall Study|Death (unrelated to study therapy)|2|||
164486468|NCT02203513|594150817|FG000|Overall Study|Lost to Follow-up|0|||
164486469|NCT02203513|594150818|FG001|Overall Study|Lost to Follow-up|0|||
164486470|NCT02203513|594150819|FG002|Overall Study|Lost to Follow-up|1|||
164486471|NCT02203513|594150820|FG003|Overall Study|Lost to Follow-up|1|||
164486472|NCT02203513|594150821|FG004|Overall Study|Lost to Follow-up|0|||
164486473|NCT01441596|594150822|FG000|Overall Study|Other reason not defined below|0|||
164486474|NCT01441596|594150823|FG001|Overall Study|Other reason not defined below|2|||
164486475|NCT01441596|594150824|FG002|Overall Study|Other reason not defined below|1|||
164486476|NCT01441596|594150822|FG000|Overall Study|Withdrawal by Subject|4|||
164486477|NCT01441596|594150823|FG001|Overall Study|Withdrawal by Subject|0|||
164486478|NCT01441596|594150824|FG002|Overall Study|Withdrawal by Subject|2|||
164486479|NCT01441596|594150822|FG000|Overall Study|Not treated|0|||
164486480|NCT01441596|594150823|FG001|Overall Study|Not treated|1|||
164486481|NCT01441596|594150824|FG002|Overall Study|Not treated|1|||
164486482|NCT03015220|594150827|FG000|Overall Study|Withdrawal by Subject|3|||
164486483|NCT03015220|594150828|FG001|Overall Study|Withdrawal by Subject|2|||
164486484|NCT03015220|594150829|FG002|Overall Study|Withdrawal by Subject|2|||
164486485|NCT03015220|594150830|FG003|Overall Study|Withdrawal by Subject|2|||
164486486|NCT03015220|594150827|FG000|Overall Study|Lost to Follow-up|0|||
164486487|NCT03015220|594150828|FG001|Overall Study|Lost to Follow-up|0|||
164486488|NCT03015220|594150829|FG002|Overall Study|Lost to Follow-up|1|||
164486489|NCT03015220|594150830|FG003|Overall Study|Lost to Follow-up|0|||
164486490|NCT01670526|594150831|FG000|Overall Study|Withdrawal by Subject|3|||
164486491|NCT01670526|594150832|FG001|Overall Study|Withdrawal by Subject|1|||
164486492|NCT01670526|594150831|FG000|Overall Study|Lost to Follow-up|9|||
164486493|NCT01670526|594150832|FG001|Overall Study|Lost to Follow-up|5|||
164486494|NCT03055988|594150833|FG000|Period 1|Adverse Event|0|||
164486495|NCT03055988|594150834|FG001|Period 1|Adverse Event|1|||
164486496|NCT03055988|594150833|FG000|Period 1|Lost to Follow-up|1|||
164486497|NCT03055988|594150834|FG001|Period 1|Lost to Follow-up|0|||
164486498|NCT03055988|594150833|FG000|Period 1|Withdrawal by Subject|0|||
164486499|NCT03055988|594150834|FG001|Period 1|Withdrawal by Subject|4|||
164486500|NCT03055988|594150833|FG000|Period 2|Adverse Event|0|||
164486501|NCT03055988|594150834|FG001|Period 2|Adverse Event|1|||
164486502|NCT03055988|594150833|FG000|Period 2|Other than listed|1|||
164486503|NCT03055988|594150834|FG001|Period 2|Other than listed|1|||
164486504|NCT00392197|594150835|FG000|Overall Study|Adverse Event|4|||
164486505|NCT00392197|594150836|FG001|Overall Study|Adverse Event|12|||
164486506|NCT00392197|594150835|FG000|Overall Study|Lack of Efficacy|3|||
164486507|NCT00392197|594150836|FG001|Overall Study|Lack of Efficacy|4|||
164486508|NCT00392197|594150835|FG000|Overall Study|Lost to Follow-up|0|||
164486509|NCT00392197|594150836|FG001|Overall Study|Lost to Follow-up|1|||
164486510|NCT00392197|594150835|FG000|Overall Study|Physician Decision|3|||
164486511|NCT00392197|594150836|FG001|Overall Study|Physician Decision|2|||
164486512|NCT00392197|594150835|FG000|Overall Study|Protocol Violation|7|||
164486513|NCT00392197|594150836|FG001|Overall Study|Protocol Violation|5|||
164486514|NCT00392197|594150835|FG000|Overall Study|Withdrawal by Subject|4|||
164486515|NCT00392197|594150836|FG001|Overall Study|Withdrawal by Subject|6|||
164486516|NCT00800176|594150840|FG000|Overall Study|Adverse Event|2|||
164486517|NCT00800176|594150841|FG001|Overall Study|Adverse Event|1|||
164486518|NCT00800176|594150842|FG002|Overall Study|Adverse Event|0|||
164601861|NCT04799405|594562696|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
164486519|NCT00800176|594150843|FG003|Overall Study|Adverse Event|2|||
164486520|NCT00800176|594150844|FG004|Overall Study|Adverse Event|1|||
164486521|NCT00800176|594150845|FG005|Overall Study|Adverse Event|1|||
164486522|NCT00800176|594150840|FG000|Overall Study|Refused treatment|3|||
164486523|NCT00800176|594150841|FG001|Overall Study|Refused treatment|2|||
164601862|NCT00603980|594562697|FG000|Study Qualification|Protocol Violation|3|||
164486524|NCT00800176|594150842|FG002|Overall Study|Refused treatment|0|||
164486525|NCT00800176|594150843|FG003|Overall Study|Refused treatment|0|||
164486526|NCT00800176|594150844|FG004|Overall Study|Refused treatment|1|||
164486527|NCT00800176|594150845|FG005|Overall Study|Refused treatment|4|||
164486528|NCT00800176|594150840|FG000|Overall Study|Failure to return|3|||
164486529|NCT00800176|594150841|FG001|Overall Study|Failure to return|3|||
164486530|NCT00800176|594150842|FG002|Overall Study|Failure to return|0|||
164486531|NCT00800176|594150843|FG003|Overall Study|Failure to return|2|||
164486532|NCT00800176|594150844|FG004|Overall Study|Failure to return|0|||
164601863|NCT00603980|594562697|FG000|Study Qualification|Inconsistent data reporting|13|||
164601864|NCT00603980|594562697|FG000|Main Study|14th subject completed trial|1|||
164486533|NCT00800176|594150845|FG005|Overall Study|Failure to return|0|||
164486534|NCT00800176|594150840|FG000|Overall Study|Other|1|||
164486535|NCT00800176|594150841|FG001|Overall Study|Other|0|||
164486536|NCT00800176|594150842|FG002|Overall Study|Other|0|||
164486537|NCT00800176|594150843|FG003|Overall Study|Other|0|||
164486538|NCT00800176|594150844|FG004|Overall Study|Other|2|||
164486539|NCT00800176|594150845|FG005|Overall Study|Other|0|||
164486540|NCT02326220|594150848|FG000|Double-blind Treatment Period|Adverse Event|1|||
164486541|NCT02326220|594150849|FG001|Double-blind Treatment Period|Adverse Event|2|||
164486542|NCT02326220|594150850|FG002|Double-blind Treatment Period|Adverse Event|0|||
164486543|NCT02326220|594150848|FG000|Double-blind Treatment Period|Protocol Violation|0|||
164486544|NCT02326220|594150849|FG001|Double-blind Treatment Period|Protocol Violation|1|||
164486545|NCT02326220|594150850|FG002|Double-blind Treatment Period|Protocol Violation|0|||
164486546|NCT02326220|594150848|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
164486547|NCT02326220|594150849|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
164486548|NCT02326220|594150850|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
164486549|NCT02326220|594150848|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
164486550|NCT02326220|594150849|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
164486551|NCT02326220|594150850|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
164486552|NCT02326220|594150848|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
164486553|NCT02326220|594150849|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
164486554|NCT02326220|594150850|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
164486555|NCT02699099|594150851|FG000|Overall Study|Adverse Event|1|||
164486556|NCT02699099|594150852|FG001|Overall Study|Adverse Event|0|||
164486557|NCT02699099|594150853|FG002|Overall Study|Adverse Event|2|||
164486558|NCT02699099|594150851|FG000|Overall Study|Lost to Follow-up|0|||
164714648|NCT02260570|594978673|FG001|Overall Study|Withdrawal by Subject|1|||
164714649|NCT02260570|594978672|FG000|Overall Study|Physician Decision|1|||
164714650|NCT02260570|594978673|FG001|Overall Study|Physician Decision|1|||
164714651|NCT04034927|594978674|FG000|Overall Study|Adverse Event|4|||
164714652|NCT04034927|594978675|FG001|Overall Study|Adverse Event|9|||
164714653|NCT04034927|594978674|FG000|Overall Study|Death|0|||
164714654|NCT04034927|594978675|FG001|Overall Study|Death|1|||
164714655|NCT04034927|594978674|FG000|Overall Study|Withdrawal by Subject|0|||
164714656|NCT04034927|594978675|FG001|Overall Study|Withdrawal by Subject|3|||
164714657|NCT04034927|594978674|FG000|Overall Study|Still on Treatment|2|||
164714658|NCT04034927|594978675|FG001|Overall Study|Still on Treatment|1|||
164714659|NCT04034927|594978674|FG000|Overall Study|Other|1|||
164714660|NCT04034927|594978675|FG001|Overall Study|Other|1|||
164714661|NCT03996447|594978678|FG000|First MRI Examination|Adverse Event|2|||
164714662|NCT03996447|594978679|FG001|First MRI Examination|Adverse Event|0|||
164714663|NCT03996447|594978678|FG000|First MRI Examination|Withdrawal by Subject|1|||
164714664|NCT03996447|594978679|FG001|First MRI Examination|Withdrawal by Subject|2|||
164714665|NCT03996447|594978678|FG000|First MRI Examination|Protocol Violation|0|||
164714666|NCT03996447|594978679|FG001|First MRI Examination|Protocol Violation|1|||
164714667|NCT03996447|594978678|FG000|Washout|Adverse Event|2|||
164714668|NCT03996447|594978679|FG001|Washout|Adverse Event|0|||
164714669|NCT03996447|594978678|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
164714670|NCT03996447|594978679|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
164714671|NCT03996447|594978678|FG000|Washout|Withdrawal by Subject|0|||
164714672|NCT03996447|594978679|FG001|Washout|Withdrawal by Subject|1|||
164714673|NCT03996447|594978678|FG000|Washout|Other reason|1|||
164714674|NCT03996447|594978679|FG001|Washout|Other reason|1|||
164714675|NCT00369486|594978681|FG000|4-Week Visit|Missed visit|2|||
164714676|NCT00369486|594978682|FG001|4-Week Visit|Missed visit|2|||
164714677|NCT00369486|594978683|FG002|4-Week Visit|Missed visit|0|||
164714678|NCT00369486|594978684|FG003|4-Week Visit|Missed visit|2|||
164486559|NCT02699099|594150852|FG001|Overall Study|Lost to Follow-up|1|||
164486560|NCT02699099|594150853|FG002|Overall Study|Lost to Follow-up|0|||
164486561|NCT02699099|594150851|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
164486562|NCT02699099|594150852|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
164486563|NCT02699099|594150853|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
164486564|NCT02659540|594150856|FG000|Overall Study|Adverse Event|3|||
164486565|NCT02659540|594150857|FG001|Overall Study|Adverse Event|2|||
164714679|NCT00369486|594978685|FG004|4-Week Visit|Missed visit|1|||
164714680|NCT00369486|594978681|FG000|4-Week Visit|Dropped|0|||
164714681|NCT00369486|594978682|FG001|4-Week Visit|Dropped|0|||
164714682|NCT00369486|594978683|FG002|4-Week Visit|Dropped|1|||
164486566|NCT02659540|594150856|FG000|Overall Study|Death|1|||
164486567|NCT02659540|594150857|FG001|Overall Study|Death|0|||
164486568|NCT02659540|594150856|FG000|Overall Study|Progressive disease|2|||
164486569|NCT02659540|594150857|FG001|Overall Study|Progressive disease|6|||
164714683|NCT00369486|594978684|FG003|4-Week Visit|Dropped|0|||
164714684|NCT00369486|594978685|FG004|4-Week Visit|Dropped|0|||
164714685|NCT00369486|594978681|FG000|8-Week Visit|Missed visit|0|||
164714686|NCT00369486|594978682|FG001|8-Week Visit|Missed visit|1|||
164714687|NCT00369486|594978683|FG002|8-Week Visit|Missed visit|0|||
164714688|NCT00369486|594978684|FG003|8-Week Visit|Missed visit|0|||
164714689|NCT00369486|594978685|FG004|8-Week Visit|Missed visit|1|||
164714690|NCT00369486|594978681|FG000|8-Week Visit|Dropped|0|||
164486570|NCT00824850|594150858|FG000|Overall Study|Withdrawal by Subject|0|||
164486571|NCT00824850|594150859|FG001|Overall Study|Withdrawal by Subject|1|||
164486572|NCT00882050|594150860|FG000|Overall Study|Physician Decision|1|||
164486573|NCT00882050|594150861|FG001|Overall Study|Physician Decision|0|||
164486574|NCT00882050|594150862|FG002|Overall Study|Physician Decision|0|||
164486575|NCT04820491|594150867|FG000|Overall Study|Withdrawal by Subject|1|||
164486576|NCT04820491|594150868|FG001|Overall Study|Withdrawal by Subject|0|||
164486577|NCT00452452|594150869|FG000|Overall Study|Protocol Violation|0|||
164486578|NCT00452452|594150870|FG001|Overall Study|Protocol Violation|0|||
164486579|NCT00452452|594150871|FG002|Overall Study|Protocol Violation|1|||
164486580|NCT00452452|594150869|FG000|Overall Study|Withdrawal by Subject|1|||
164486581|NCT00452452|594150870|FG001|Overall Study|Withdrawal by Subject|0|||
164486582|NCT00452452|594150871|FG002|Overall Study|Withdrawal by Subject|0|||
164486583|NCT00452452|594150869|FG000|Overall Study|Lost to Follow-up|1|||
164486584|NCT00452452|594150870|FG001|Overall Study|Lost to Follow-up|0|||
164486585|NCT00452452|594150871|FG002|Overall Study|Lost to Follow-up|0|||
164486586|NCT03020914|594152337|FG000|Overall Study|Surgery Cancelled|1|||
164486587|NCT03020914|594152338|FG001|Overall Study|Surgery Cancelled|0|||
164486588|NCT04620733|594152339|FG000|Overall Study|Adverse Event|4|||
164486589|NCT04620733|594152340|FG001|Overall Study|Adverse Event|3|||
164486590|NCT04620733|594152339|FG000|Overall Study|Withdrawal by Subject|2|||
164486591|NCT04620733|594152340|FG001|Overall Study|Withdrawal by Subject|5|||
164486592|NCT04620733|594152339|FG000|Overall Study|Lost to Follow-up|1|||
164486593|NCT04620733|594152340|FG001|Overall Study|Lost to Follow-up|1|||
164486594|NCT04620733|594152339|FG000|Overall Study|Protocol Deviation|1|||
164486595|NCT04620733|594152340|FG001|Overall Study|Protocol Deviation|1|||
164486596|NCT04620733|594152339|FG000|Overall Study|Reason Not Specified|0|||
164486597|NCT04620733|594152340|FG001|Overall Study|Reason Not Specified|1|||
164486598|NCT03976102|594152344|FG000|Overall Study|Withdrawal by Subject|4|||
164486599|NCT03976102|594152345|FG001|Overall Study|Withdrawal by Subject|4|||
164486600|NCT03976102|594152344|FG000|Overall Study|Adverse Event|2|||
164486601|NCT03976102|594152345|FG001|Overall Study|Adverse Event|4|||
164486602|NCT03976102|594152344|FG000|Overall Study|Not related to Covid-19|9|||
164486603|NCT03976102|594152345|FG001|Overall Study|Not related to Covid-19|13|||
164486604|NCT03976102|594152344|FG000|Overall Study|Lost to Follow-up|0|||
164486605|NCT03976102|594152345|FG001|Overall Study|Lost to Follow-up|2|||
164486606|NCT03976102|594152344|FG000|Overall Study|Death|3|||
164486607|NCT03976102|594152345|FG001|Overall Study|Death|2|||
164486608|NCT03976102|594152344|FG000|Overall Study|Physician Decision|1|||
164486609|NCT03976102|594152345|FG001|Overall Study|Physician Decision|1|||
164486610|NCT00451906|594152347|FG000|Overall Study|Adverse Event|515|||
164486611|NCT00451906|594152347|FG000|Overall Study|Lost to Follow-up|31|||
164486612|NCT00451906|594152347|FG000|Overall Study|Withdrawal by Subject|111|||
164486613|NCT00451906|594152347|FG000|Overall Study|Protocol Violation|21|||
164486614|NCT00451906|594152347|FG000|Overall Study|Progressive disease|1328|||
164486615|NCT00451906|594152347|FG000|Overall Study|Termination of the study|108|||
164486616|NCT00451906|594152347|FG000|Overall Study|Other Reasons|121|||
164486617|NCT00451906|594152347|FG000|Overall Study|Did not complete final visit|4|||
164486618|NCT02889900|594152355|FG000|Overall Study|Adverse Event|11|||
164486619|NCT02889900|594152355|FG000|Overall Study|Condition under investigation worsened|32|||
164486620|NCT02889900|594152355|FG000|Overall Study|Other|5|||
164486621|NCT02889900|594152355|FG000|Overall Study|Withdrawal by Subject|7|||
164714691|NCT00369486|594978682|FG001|8-Week Visit|Dropped|0|||
164714692|NCT00369486|594978683|FG002|8-Week Visit|Dropped|0|||
164486622|NCT02889900|594152355|FG000|Overall Study|Not treated|2|||
164486623|NCT00805792|594152356|FG000|Overall Study|Death|3|||
164486624|NCT00805792|594152356|FG000|Overall Study|Lost to Follow-up|2|||
164486625|NCT01416285|594152359|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
164486626|NCT01416285|594152360|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
164486627|NCT01248715|594152367|FG000|Overall Study|Not influenza positive|501|||
164486628|NCT01248715|594152368|FG001|Overall Study|Not influenza positive|510|||
164486629|NCT01807234|594152369|FG000|Overall Study|Lost to Follow-up|2|||
164486630|NCT01807234|594152370|FG001|Overall Study|Lost to Follow-up|5|||
164486631|NCT01807234|594152371|FG002|Overall Study|Lost to Follow-up|1|||
164486632|NCT01807234|594152372|FG003|Overall Study|Lost to Follow-up|1|||
164486633|NCT01807234|594152373|FG004|Overall Study|Lost to Follow-up|1|||
164486634|NCT01807234|594152374|FG005|Overall Study|Lost to Follow-up|2|||
164486635|NCT01807234|594152369|FG000|Overall Study|Withdrawal by Subject|3|||
164486636|NCT01807234|594152370|FG001|Overall Study|Withdrawal by Subject|1|||
164486637|NCT01807234|594152371|FG002|Overall Study|Withdrawal by Subject|1|||
164714693|NCT00369486|594978684|FG003|8-Week Visit|Dropped|1|||
164486638|NCT01807234|594152372|FG003|Overall Study|Withdrawal by Subject|1|||
164486639|NCT01807234|594152373|FG004|Overall Study|Withdrawal by Subject|2|||
164486640|NCT01807234|594152374|FG005|Overall Study|Withdrawal by Subject|1|||
164486641|NCT01807234|594152369|FG000|Overall Study|Lack of Efficacy|0|||
164486642|NCT01807234|594152370|FG001|Overall Study|Lack of Efficacy|0|||
164486643|NCT01807234|594152371|FG002|Overall Study|Lack of Efficacy|0|||
164714694|NCT00369486|594978685|FG004|8-Week Visit|Dropped|0|||
164486644|NCT01807234|594152372|FG003|Overall Study|Lack of Efficacy|0|||
164486645|NCT01807234|594152373|FG004|Overall Study|Lack of Efficacy|1|||
164486646|NCT01807234|594152374|FG005|Overall Study|Lack of Efficacy|1|||
164486647|NCT01540474|594152375|FG000|Vaccination Period|Lost to Follow-up|0|||
164486648|NCT01540474|594152376|FG001|Vaccination Period|Lost to Follow-up|1|||
164486649|NCT01540474|594152377|FG002|Vaccination Period|Lost to Follow-up|0|||
164486650|NCT01540474|594152378|FG003|Vaccination Period|Lost to Follow-up|0|||
164486651|NCT00828139|594152379|FG000|Overall Study|Adverse Event|8|||
164486652|NCT00828139|594152380|FG001|Overall Study|Adverse Event|1|||
164486653|NCT00828139|594152381|FG002|Overall Study|Adverse Event|10|||
164486654|NCT00828139|594152382|FG003|Overall Study|Adverse Event|5|||
164486655|NCT00828139|594152379|FG000|Overall Study|Death|2|||
164486656|NCT00828139|594152380|FG001|Overall Study|Death|1|||
164486657|NCT00828139|594152381|FG002|Overall Study|Death|0|||
164486658|NCT00828139|594152382|FG003|Overall Study|Death|2|||
164486659|NCT00828139|594152379|FG000|Overall Study|Refusal unrelated to toxicity|3|||
164486660|NCT00828139|594152380|FG001|Overall Study|Refusal unrelated to toxicity|4|||
164486661|NCT00828139|594152381|FG002|Overall Study|Refusal unrelated to toxicity|5|||
164486662|NCT00828139|594152382|FG003|Overall Study|Refusal unrelated to toxicity|3|||
164486663|NCT00828139|594152379|FG000|Overall Study|Disease Progression|24|||
164486664|NCT00828139|594152380|FG001|Overall Study|Disease Progression|33|||
164486665|NCT00828139|594152381|FG002|Overall Study|Disease Progression|35|||
164486666|NCT00828139|594152382|FG003|Overall Study|Disease Progression|39|||
164486667|NCT00828139|594152379|FG000|Overall Study|Other|4|||
164486668|NCT00828139|594152380|FG001|Overall Study|Other|2|||
164486669|NCT00828139|594152381|FG002|Overall Study|Other|5|||
164486670|NCT00828139|594152382|FG003|Overall Study|Other|2|||
164486671|NCT04271254|594152383|FG000|Overall Study|Withdrawal by Subject|3|||
164486672|NCT04751929|594152384|FG000|Overall Study|Withdrawal by Subject|2|||
164486673|NCT04751929|594152385|FG001|Overall Study|Withdrawal by Subject|0|||
164486674|NCT04751929|594152386|FG002|Overall Study|Withdrawal by Subject|0|||
164486675|NCT04751929|594152387|FG003|Overall Study|Withdrawal by Subject|0|||
164486676|NCT04751929|594152384|FG000|Overall Study|Rising PSA|0|||
164486677|NCT04751929|594152385|FG001|Overall Study|Rising PSA|1|||
164486678|NCT04751929|594152386|FG002|Overall Study|Rising PSA|0|||
164486679|NCT04751929|594152387|FG003|Overall Study|Rising PSA|0|||
164486680|NCT04751929|594152384|FG000|Overall Study|Adverse Event|1|||
164486681|NCT04751929|594152385|FG001|Overall Study|Adverse Event|2|||
164486682|NCT04751929|594152386|FG002|Overall Study|Adverse Event|0|||
164486683|NCT04751929|594152387|FG003|Overall Study|Adverse Event|0|||
164486684|NCT04751929|594152384|FG000|Overall Study|Progressive Disease|3|||
164486685|NCT04751929|594152385|FG001|Overall Study|Progressive Disease|4|||
164486686|NCT04751929|594152386|FG002|Overall Study|Progressive Disease|4|||
164486687|NCT04751929|594152387|FG003|Overall Study|Progressive Disease|0|||
164486688|NCT04751929|594152384|FG000|Overall Study|Death|1|||
164486689|NCT04751929|594152385|FG001|Overall Study|Death|1|||
164486690|NCT04751929|594152386|FG002|Overall Study|Death|0|||
164486691|NCT04751929|594152387|FG003|Overall Study|Death|0|||
164486692|NCT00473512|594152392|FG000|Period 1 (Phase 1)|Adverse Event|0|||
164486693|NCT00473512|594152393|FG001|Period 1 (Phase 1)|Adverse Event|0|||
164486694|NCT00473512|594152394|FG002|Period 1 (Phase 1)|Adverse Event|0|||
164486695|NCT00473512|594152395|FG003|Period 1 (Phase 1)|Adverse Event|5|||
164486696|NCT00473512|594152396|FG004|Period 1 (Phase 1)|Adverse Event|0|||
164486697|NCT00473512|594152392|FG000|Period 1 (Phase 1)|Death|0|||
164486698|NCT00473512|594152393|FG001|Period 1 (Phase 1)|Death|0|||
164486699|NCT00473512|594152394|FG002|Period 1 (Phase 1)|Death|0|||
164486700|NCT00473512|594152395|FG003|Period 1 (Phase 1)|Death|1|||
164486701|NCT00473512|594152396|FG004|Period 1 (Phase 1)|Death|0|||
164486702|NCT00473512|594152392|FG000|Period 1 (Phase 1)|Disease Progression|1|||
164486703|NCT00473512|594152393|FG001|Period 1 (Phase 1)|Disease Progression|1|||
164486704|NCT00473512|594152394|FG002|Period 1 (Phase 1)|Disease Progression|0|||
164486705|NCT00473512|594152395|FG003|Period 1 (Phase 1)|Disease Progression|10|||
164601865|NCT01029002|594562698|FG000|Overall Study|Lost to Follow-up|2|||
164601866|NCT01029002|594562699|FG001|Overall Study|Lost to Follow-up|4|||
164601867|NCT02683525|594562700|FG000|Overall Study|Lost to Follow-up|1|||
164601868|NCT02683525|594562700|FG000|Overall Study|Physician Decision|1|||
164601869|NCT02683525|594562700|FG000|Overall Study|Disease Progression|6|||
164601870|NCT01577160|594562701|FG000|Overall Study|Adverse Event|9|||
164601871|NCT01577160|594562701|FG000|Overall Study|Lack of Efficacy|15|||
164601872|NCT01577160|594562701|FG000|Overall Study|Lost to Follow-up|40|||
164601873|NCT01577160|594562701|FG000|Overall Study|Withdrawal by Subject|18|||
164601874|NCT01577160|594562701|FG000|Overall Study|Subject Uncooperative|7|||
164601875|NCT01577160|594562701|FG000|Overall Study|Other|9|||
164601876|NCT02632110|594562702|FG000|Overall Study|Withdrawal by Subject|1|||
164601877|NCT02632110|594562703|FG001|Overall Study|Withdrawal by Subject|1|||
164601878|NCT02632110|594562704|FG002|Overall Study|Withdrawal by Subject|0|||
164601879|NCT02632110|594562705|FG003|Overall Study|Withdrawal by Subject|0|||
164601880|NCT02632110|594562706|FG004|Overall Study|Withdrawal by Subject|1|||
164601881|NCT02632110|594562707|FG005|Overall Study|Withdrawal by Subject|1|||
164601882|NCT02632110|594562708|FG006|Overall Study|Withdrawal by Subject|3|||
164601883|NCT02632110|594562709|FG007|Overall Study|Withdrawal by Subject|3|||
164601884|NCT02632110|594562710|FG008|Overall Study|Withdrawal by Subject|1|||
164601885|NCT02632110|594562711|FG009|Overall Study|Withdrawal by Subject|1|||
164601886|NCT01341652|594562712|FG000|Overall Study|Incorrect Random Assignment|0|||
164601887|NCT01341652|594562713|FG001|Overall Study|Incorrect Random Assignment|1|||
164601888|NCT01341652|594562712|FG000|Overall Study|ineligible; presence metastatic disease|0|||
164601889|NCT01341652|594562713|FG001|Overall Study|ineligible; presence metastatic disease|1|||
164601890|NCT02618928|594562714|FG000|Overall Study|Failure to Return|28|||
164601891|NCT02618928|594562714|FG000|Overall Study|Insufficient Virological Response|1|||
164601892|NCT02618928|594562714|FG000|Overall Study|Withdrawal by Subject|2|||
164601893|NCT02618928|594562714|FG000|Overall Study|Death|3|||
164601894|NCT02618928|594562714|FG000|Overall Study|Other|11|||
164601895|NCT02618928|594562714|FG000|Overall Study|Missing|6|||
164601896|NCT02618928|594562714|FG000|Overall Study|Treatment Never Started|7|||
164601897|NCT01096849|594562719|FG000|Overall Study|Consent Withdrawn|1|||
164601898|NCT01096849|594562720|FG001|Overall Study|Consent Withdrawn|4|||
164601899|NCT01096849|594562721|FG002|Overall Study|Consent Withdrawn|2|||
164601900|NCT01096849|594562719|FG000|Overall Study|Lack of Efficacy|0|||
164601901|NCT01096849|594562720|FG001|Overall Study|Lack of Efficacy|2|||
164601902|NCT01096849|594562721|FG002|Overall Study|Lack of Efficacy|0|||
164601903|NCT01096849|594562719|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
164601904|NCT01096849|594562720|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
164601905|NCT01096849|594562721|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
164601906|NCT01096849|594562719|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
164601907|NCT01096849|594562720|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
164601908|NCT01096849|594562721|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
164601909|NCT01096849|594562719|FG000|Overall Study|Administrative Reasons|0|||
164714695|NCT00369486|594978681|FG000|17-Week Visit|Missed visit|0|||
164714696|NCT00369486|594978682|FG001|17-Week Visit|Missed visit|0|||
164714697|NCT00369486|594978683|FG002|17-Week Visit|Missed visit|1|||
164714698|NCT00369486|594978684|FG003|17-Week Visit|Missed visit|1|||
164714699|NCT00369486|594978685|FG004|17-Week Visit|Missed visit|1|||
164714700|NCT00369486|594978681|FG000|34-Week Visit|Dropped|0|||
164714701|NCT00369486|594978682|FG001|34-Week Visit|Dropped|1|||
164714702|NCT00369486|594978683|FG002|34-Week Visit|Dropped|1|||
164714703|NCT00369486|594978684|FG003|34-Week Visit|Dropped|3|||
164714704|NCT00369486|594978685|FG004|34-Week Visit|Dropped|3|||
164714705|NCT04971187|594978692|FG000|Overall Study|Screen failures|2|||
164714706|NCT02207634|594978693|FG000|Overall Study|Withdrawal by Subject|21|||
164714707|NCT02207634|594978694|FG001|Overall Study|Withdrawal by Subject|31|||
164601910|NCT01096849|594562720|FG001|Overall Study|Administrative Reasons|1|||
164714708|NCT02207634|594978693|FG000|Overall Study|Lost to Follow-up|1|||
164714709|NCT02207634|594978694|FG001|Overall Study|Lost to Follow-up|0|||
164714710|NCT02077140|594978695|FG000|Overall Study|Lost to Follow-up|4|||
164714711|NCT02077140|594978696|FG001|Overall Study|Lost to Follow-up|1|||
164601911|NCT01096849|594562721|FG002|Overall Study|Administrative Reasons|2|||
164601912|NCT01096849|594562719|FG000|Overall Study|Lost to Follow-up|1|||
164601913|NCT01096849|594562720|FG001|Overall Study|Lost to Follow-up|3|||
164601914|NCT01096849|594562721|FG002|Overall Study|Lost to Follow-up|1|||
164601915|NCT00118482|594562722|FG000|Overall Study|Lost to Follow-up|7|||
164601916|NCT00118482|594562723|FG001|Overall Study|Lost to Follow-up|7|||
164601917|NCT00118482|594562722|FG000|Overall Study|Withdrawal by Subject|23|||
164601918|NCT00118482|594562723|FG001|Overall Study|Withdrawal by Subject|22|||
164714712|NCT02077140|594978697|FG002|Overall Study|Lost to Follow-up|2|||
164714713|NCT02077140|594978698|FG003|Overall Study|Lost to Follow-up|2|||
164714714|NCT02077140|594978699|FG004|Overall Study|Lost to Follow-up|3|||
164601919|NCT01008995|594562724|FG000|Controlled Period|Adverse Event|1|||
164601920|NCT01008995|594562725|FG001|Controlled Period|Adverse Event|2|||
164601921|NCT01008995|594562726|FG002|Controlled Period|Adverse Event|0|||
164601922|NCT01008995|594562727|FG003|Controlled Period|Adverse Event|0|||
164601923|NCT01008995|594562724|FG000|Controlled Period|Other|2|||
164601924|NCT01008995|594562725|FG001|Controlled Period|Other|1|||
164601925|NCT01008995|594562726|FG002|Controlled Period|Other|0|||
164601926|NCT01008995|594562727|FG003|Controlled Period|Other|0|||
164601927|NCT01008995|594562724|FG000|After Controlled Period|Adverse Event|0|||
164601928|NCT01008995|594562725|FG001|After Controlled Period|Adverse Event|0|||
164601929|NCT01008995|594562726|FG002|After Controlled Period|Adverse Event|1|||
164601930|NCT01008995|594562727|FG003|After Controlled Period|Adverse Event|1|||
164601931|NCT01008995|594562724|FG000|After Controlled Period|Other|0|||
164601932|NCT01008995|594562725|FG001|After Controlled Period|Other|0|||
164601933|NCT01008995|594562726|FG002|After Controlled Period|Other|1|||
164601934|NCT01008995|594562727|FG003|After Controlled Period|Other|0|||
164601935|NCT04146467|594562732|FG000|Overall Study|Adverse Event|0|||
164601936|NCT04146467|594562733|FG001|Overall Study|Adverse Event|1|||
164601937|NCT04146467|594562732|FG000|Overall Study|Lost to Follow-up|0|||
164601938|NCT04146467|594562733|FG001|Overall Study|Lost to Follow-up|2|||
164486706|NCT00473512|594152396|FG004|Period 1 (Phase 1)|Disease Progression|1|||
164486707|NCT00473512|594152392|FG000|Period 1 (Phase 1)|Other|0|||
164486708|NCT00473512|594152393|FG001|Period 1 (Phase 1)|Other|0|||
164486709|NCT00473512|594152394|FG002|Period 1 (Phase 1)|Other|0|||
164601939|NCT02128763|594562736|FG000|Overall Study|Death|1|||
164601940|NCT02128763|594562737|FG001|Overall Study|Death|0|||
164601941|NCT02128763|594562736|FG000|Overall Study|Lost to Follow-up|19|||
164486710|NCT00473512|594152395|FG003|Period 1 (Phase 1)|Other|1|||
164486711|NCT00473512|594152396|FG004|Period 1 (Phase 1)|Other|0|||
164486712|NCT00473512|594152392|FG000|Period 2 (Phase 2)|Adverse Event|0|||
164486713|NCT00473512|594152393|FG001|Period 2 (Phase 2)|Adverse Event|0|||
164486714|NCT00473512|594152394|FG002|Period 2 (Phase 2)|Adverse Event|0|||
164486715|NCT00473512|594152395|FG003|Period 2 (Phase 2)|Adverse Event|1|||
164486716|NCT00473512|594152396|FG004|Period 2 (Phase 2)|Adverse Event|0|||
164486717|NCT00473512|594152392|FG000|Period 2 (Phase 2)|Death|0|||
164486718|NCT00473512|594152393|FG001|Period 2 (Phase 2)|Death|0|||
164486719|NCT00473512|594152394|FG002|Period 2 (Phase 2)|Death|0|||
164486720|NCT00473512|594152395|FG003|Period 2 (Phase 2)|Death|1|||
164486721|NCT00473512|594152396|FG004|Period 2 (Phase 2)|Death|1|||
164486722|NCT00473512|594152392|FG000|Period 2 (Phase 2)|Disease Progression|0|||
164486723|NCT00473512|594152393|FG001|Period 2 (Phase 2)|Disease Progression|2|||
164486724|NCT00473512|594152394|FG002|Period 2 (Phase 2)|Disease Progression|2|||
164486725|NCT00473512|594152395|FG003|Period 2 (Phase 2)|Disease Progression|17|||
164486726|NCT00473512|594152396|FG004|Period 2 (Phase 2)|Disease Progression|1|||
164486727|NCT00473512|594152392|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
164486728|NCT00473512|594152393|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
164486729|NCT00473512|594152394|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
164486730|NCT00473512|594152395|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
164486731|NCT00473512|594152396|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
164486732|NCT00473512|594152392|FG000|Period 2 (Phase 2)|Other|1|||
164486733|NCT00473512|594152393|FG001|Period 2 (Phase 2)|Other|0|||
164486734|NCT00473512|594152394|FG002|Period 2 (Phase 2)|Other|0|||
164601942|NCT02128763|594562737|FG001|Overall Study|Lost to Follow-up|16|||
164601943|NCT02953782|594562738|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
164601944|NCT02953782|594562739|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
164601945|NCT02953782|594562740|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
164601946|NCT02953782|594562741|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
164714715|NCT02077140|594978695|FG000|Overall Study|Withdrawal by Subject|0|||
164714716|NCT02077140|594978696|FG001|Overall Study|Withdrawal by Subject|1|||
164714717|NCT02077140|594978697|FG002|Overall Study|Withdrawal by Subject|0|||
164714718|NCT02077140|594978698|FG003|Overall Study|Withdrawal by Subject|2|||
164714719|NCT02077140|594978699|FG004|Overall Study|Withdrawal by Subject|2|||
164714720|NCT00113763|594978701|FG000|Overall Study|Adverse Event|5|||
164714721|NCT00113763|594978702|FG001|Overall Study|Adverse Event|2|||
164714722|NCT00113763|594978701|FG000|Overall Study|Disease Progression|28|||
164486735|NCT00473512|594152395|FG003|Period 2 (Phase 2)|Other|3|||
164486736|NCT00473512|594152396|FG004|Period 2 (Phase 2)|Other|0|||
164486737|NCT01129011|594152399|FG000|Overall Study|Adverse Event|20|||
164486738|NCT01129011|594152400|FG001|Overall Study|Adverse Event|30|||
164486739|NCT01129011|594152399|FG000|Overall Study|Withdrawal by Subject|24|||
164486740|NCT01129011|594152400|FG001|Overall Study|Withdrawal by Subject|8|||
164486741|NCT01129011|594152399|FG000|Overall Study|Lost to Follow-up|6|||
164601947|NCT02953782|594562742|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
164601948|NCT02953782|594562743|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
164601949|NCT02953782|594562744|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
164601950|NCT02953782|594562745|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
164601951|NCT02953782|594562738|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
164601952|NCT02953782|594562739|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
164714723|NCT00113763|594978702|FG001|Overall Study|Disease Progression|14|||
164486742|NCT01129011|594152400|FG001|Overall Study|Lost to Follow-up|7|||
164486743|NCT01129011|594152399|FG000|Overall Study|Duodenal Ulcer|2|||
164486744|NCT01129011|594152400|FG001|Overall Study|Duodenal Ulcer|8|||
164486745|NCT01129011|594152399|FG000|Overall Study|misc|7|||
164486746|NCT01129011|594152400|FG001|Overall Study|misc|4|||
164486747|NCT03557307|594152403|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
164486748|NCT03557307|594152403|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
164486749|NCT03557307|594152403|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
164486750|NCT03557307|594152403|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
164486751|NCT03557307|594152403|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
164486752|NCT03557307|594152403|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
164486753|NCT03557307|594152403|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
164486754|NCT03557307|594152403|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
164486755|NCT03557307|594152403|FG000|Period 2: Maintenance Phase|Death|3|||
164486756|NCT03557307|594152403|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
164486757|NCT03557307|594152403|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
164486758|NCT03557307|594152403|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
164486759|NCT03557307|594152403|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
164486760|NCT03557307|594152403|FG000|Period 2: Maintenance Phase|other|3|||
164486761|NCT03745651|594152404|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
164486762|NCT03745651|594152405|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
164486763|NCT03745651|594152406|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
164486764|NCT03745651|594152407|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
164486765|NCT03745651|594152408|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
164486766|NCT03745651|594152409|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
164486767|NCT03745651|594152410|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
164486768|NCT03745651|594152404|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
164486769|NCT03745651|594152405|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
164486770|NCT03745651|594152406|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
164486771|NCT03745651|594152407|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164486772|NCT03745651|594152408|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164486773|NCT03745651|594152409|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164486774|NCT03745651|594152410|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164486775|NCT03745651|594152404|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
164486776|NCT03745651|594152405|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
164486777|NCT03745651|594152406|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
164486778|NCT03745651|594152407|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
164486779|NCT03745651|594152408|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
164486780|NCT03745651|594152409|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
164486781|NCT03745651|594152410|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
164486782|NCT03745651|594152404|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
164486783|NCT03745651|594152405|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
164486784|NCT03745651|594152406|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
164486785|NCT03745651|594152407|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
164486786|NCT03745651|594152408|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
164486787|NCT03745651|594152409|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
164486788|NCT03745651|594152410|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
164486789|NCT03745651|594152404|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
164486790|NCT03745651|594152405|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
164486791|NCT03745651|594152406|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
164486792|NCT03745651|594152407|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164486793|NCT03745651|594152408|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164486794|NCT03745651|594152409|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164486795|NCT03745651|594152410|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164486796|NCT03745651|594152404|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
164486797|NCT03745651|594152405|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
164486798|NCT03745651|594152406|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
164486799|NCT03745651|594152407|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
164486800|NCT03745651|594152408|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
164486801|NCT03745651|594152409|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
164486802|NCT03745651|594152410|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
164486803|NCT03745651|594152404|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
164601953|NCT02953782|594562740|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
164601954|NCT02953782|594562741|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
164601955|NCT02953782|594562742|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
164601956|NCT02953782|594562743|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
164601957|NCT02953782|594562744|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
164601958|NCT02953782|594562745|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
164601959|NCT02953782|594562738|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
164601960|NCT02953782|594562739|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
164601961|NCT02953782|594562740|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
164601962|NCT02953782|594562741|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
164601963|NCT02953782|594562742|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
164601964|NCT02953782|594562743|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
164601965|NCT02953782|594562744|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
164601966|NCT02953782|594562745|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
164601967|NCT02953782|594562738|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
164601968|NCT02953782|594562739|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
164601969|NCT02953782|594562740|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
164601970|NCT02953782|594562741|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
164601971|NCT02953782|594562742|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
164601972|NCT02953782|594562743|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
164601973|NCT02953782|594562744|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
164486804|NCT03745651|594152405|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
164486805|NCT03745651|594152406|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
164486806|NCT03745651|594152407|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
164486807|NCT03745651|594152408|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
164486808|NCT03745651|594152409|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
164486809|NCT03745651|594152410|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
164486810|NCT03745651|594152404|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
164486811|NCT03745651|594152405|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
164486812|NCT03745651|594152406|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
164486813|NCT03745651|594152407|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
164486814|NCT03745651|594152408|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
164486815|NCT03745651|594152409|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
164486816|NCT03745651|594152410|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
164486817|NCT03745651|594152404|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
164486818|NCT03745651|594152405|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
164486819|NCT03745651|594152406|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
164486820|NCT03745651|594152407|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
164486821|NCT03745651|594152408|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
164486822|NCT03745651|594152409|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
164486823|NCT03745651|594152410|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
164486824|NCT03745651|594152404|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
164486825|NCT03745651|594152405|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
164486826|NCT03745651|594152406|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
164486827|NCT03745651|594152407|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
164486828|NCT03745651|594152408|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
164486829|NCT03745651|594152409|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
164486830|NCT03745651|594152410|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
164486831|NCT03745651|594152404|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
164486832|NCT03745651|594152405|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
164486833|NCT03745651|594152406|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
164486834|NCT03745651|594152407|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
164486835|NCT03745651|594152408|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
164486836|NCT03745651|594152409|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
164486837|NCT03745651|594152410|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
164486838|NCT03745651|594152404|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
164486839|NCT03745651|594152405|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
164486840|NCT03745651|594152406|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
164601974|NCT02953782|594562745|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
164601975|NCT02953782|594562738|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
164601976|NCT02953782|594562739|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
164601977|NCT02953782|594562740|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
164486841|NCT03745651|594152407|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
164486842|NCT03745651|594152408|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
164486843|NCT03745651|594152409|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
164486844|NCT03745651|594152410|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
164486845|NCT03745651|594152404|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
164486846|NCT03745651|594152405|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
164486847|NCT03745651|594152406|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
164486848|NCT03745651|594152407|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
164486849|NCT03745651|594152408|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
164486850|NCT03745651|594152409|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
164486851|NCT03745651|594152410|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
164486852|NCT03745651|594152404|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
164486853|NCT03745651|594152405|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
164486854|NCT03745651|594152406|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
164486855|NCT03745651|594152407|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
164486856|NCT03745651|594152408|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
164486857|NCT03745651|594152409|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
164486858|NCT03745651|594152410|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
164486859|NCT04175834|594152411|FG000|Overall Study|Withdrawal by Subject|1|||
164486860|NCT04175834|594152412|FG001|Overall Study|Withdrawal by Subject|0|||
164486861|NCT03693989|594152415|FG000|Overall Study|Protocol Violation|3|||
164486862|NCT03693989|594152416|FG001|Overall Study|Protocol Violation|4|||
164486863|NCT01190436|594152417|FG000|Overall Study|Lost to Follow-up|35|||
164486864|NCT01190436|594152417|FG000|Overall Study|Other|4|||
164486865|NCT00841321|594152426|FG000|Overall Study|Lost to Follow-up|1|||
164486866|NCT00841321|594152427|FG001|Overall Study|Lost to Follow-up|1|||
164486867|NCT00841321|594152426|FG000|Overall Study|Adverse Event|0|||
164486868|NCT00841321|594152427|FG001|Overall Study|Adverse Event|2|||
164486869|NCT02632747|594152430|FG000|Wash-out Period|Adverse Event|1|||
164486870|NCT02632747|594152431|FG001|Wash-out Period|Adverse Event|0|||
164486871|NCT03651271|594152432|FG000|Overall Study|Death|4|||
164486872|NCT03651271|594152433|FG001|Overall Study|Death|37|||
164486873|NCT03651271|594152434|FG002|Overall Study|Death|0|||
164486874|NCT03651271|594152435|FG003|Overall Study|Death|2|||
164486875|NCT03651271|594152436|FG004|Overall Study|Death|6|||
164486876|NCT03651271|594152432|FG000|Overall Study|Lost to Follow-up|1|||
164486877|NCT03651271|594152433|FG001|Overall Study|Lost to Follow-up|5|||
164486878|NCT03651271|594152434|FG002|Overall Study|Lost to Follow-up|0|||
164486879|NCT03651271|594152435|FG003|Overall Study|Lost to Follow-up|1|||
164486880|NCT03651271|594152436|FG004|Overall Study|Lost to Follow-up|0|||
164486881|NCT03651271|594152432|FG000|Overall Study|Physician Decision|0|||
164486882|NCT03651271|594152433|FG001|Overall Study|Physician Decision|2|||
164486883|NCT03651271|594152434|FG002|Overall Study|Physician Decision|0|||
164486884|NCT03651271|594152435|FG003|Overall Study|Physician Decision|0|||
164486885|NCT03651271|594152436|FG004|Overall Study|Physician Decision|0|||
164486886|NCT03651271|594152432|FG000|Overall Study|Withdrawal by Subject|1|||
164486887|NCT03651271|594152433|FG001|Overall Study|Withdrawal by Subject|15|||
164486888|NCT03651271|594152434|FG002|Overall Study|Withdrawal by Subject|0|||
164486889|NCT03651271|594152435|FG003|Overall Study|Withdrawal by Subject|0|||
164486890|NCT03651271|594152436|FG004|Overall Study|Withdrawal by Subject|1|||
164486891|NCT03651271|594152432|FG000|Overall Study|Patient medically unable to continue|0|||
164486892|NCT03651271|594152433|FG001|Overall Study|Patient medically unable to continue|0|||
164486893|NCT03651271|594152434|FG002|Overall Study|Patient medically unable to continue|0|||
164486894|NCT03651271|594152435|FG003|Overall Study|Patient medically unable to continue|1|||
164486895|NCT03651271|594152436|FG004|Overall Study|Patient medically unable to continue|0|||
164486896|NCT00595959|594152437|FG000|Overall Study|Withdrawal by Subject|1|||
164486897|NCT00595959|594152437|FG000|Overall Study|Lost to Follow-up|1|||
164486898|NCT00886834|594152438|FG000|Overall Study|Protocol Violation|0|||
164486899|NCT00886834|594152439|FG001|Overall Study|Protocol Violation|3|||
164486900|NCT03875729|594152440|FG000|Overall Study|Adverse Event|0|||
164486901|NCT03875729|594152441|FG001|Overall Study|Adverse Event|5|||
164486902|NCT03875729|594152440|FG000|Overall Study|Withdrawal by Subject|8|||
164486903|NCT03875729|594152441|FG001|Overall Study|Withdrawal by Subject|11|||
164486904|NCT03875729|594152440|FG000|Overall Study|Pregnancy|0|||
164486905|NCT03875729|594152441|FG001|Overall Study|Pregnancy|1|||
164486906|NCT03875729|594152440|FG000|Overall Study|Lost to Follow-up|0|||
164486907|NCT03875729|594152441|FG001|Overall Study|Lost to Follow-up|5|||
164486908|NCT03875729|594152440|FG000|Overall Study|Personal reasons|2|||
164486909|NCT03875729|594152441|FG001|Overall Study|Personal reasons|0|||
164486910|NCT01280656|594152442|FG000|Overall Study|Adverse Event|1|||
164486911|NCT01280656|594152443|FG001|Overall Study|Adverse Event|14|||
164486912|NCT01280656|594152444|FG002|Overall Study|Adverse Event|13|||
164486913|NCT01280656|594152442|FG000|Overall Study|Lack of Efficacy|1|||
164486914|NCT01280656|594152443|FG001|Overall Study|Lack of Efficacy|22|||
164486915|NCT01280656|594152444|FG002|Overall Study|Lack of Efficacy|38|||
164486916|NCT01280656|594152442|FG000|Overall Study|Treatment shortening (RGT)|0|||
164486917|NCT01280656|594152443|FG001|Overall Study|Treatment shortening (RGT)|4|||
164486918|NCT01280656|594152444|FG002|Overall Study|Treatment shortening (RGT)|5|||
164486919|NCT01280656|594152442|FG000|Overall Study|Other|1|||
164486920|NCT01280656|594152443|FG001|Overall Study|Other|7|||
164486921|NCT01280656|594152444|FG002|Overall Study|Other|7|||
164486922|NCT04085614|594152445|FG000|Overall Study|Protocol Violation|9|||
164486923|NCT04085614|594152446|FG001|Overall Study|Protocol Violation|6|||
164486924|NCT01029925|594152447|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
164486925|NCT01029925|594152447|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
164486926|NCT01029925|594152447|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
164486927|NCT05265247|594152448|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
164486928|NCT05265247|594152449|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
164486929|NCT05265247|594152448|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
164486930|NCT05265247|594152449|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
164486931|NCT05265247|594152448|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
164486932|NCT05265247|594152449|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
164486933|NCT00476957|594152450|FG000|Overall Study|Lost to Follow-up|176|||
164486934|NCT00476957|594152451|FG001|Overall Study|Lost to Follow-up|193|||
164486935|NCT02516202|594152452|FG000|Overall Study|Withdrawal by Subject|1|||
164486936|NCT02516202|594152453|FG001|Overall Study|Withdrawal by Subject|0|||
164486937|NCT02516202|594152454|FG002|Overall Study|Withdrawal by Subject|1|||
164486938|NCT02516202|594152452|FG000|Overall Study|Lost to Follow-up|1|||
164486939|NCT02516202|594152453|FG001|Overall Study|Lost to Follow-up|1|||
164486940|NCT02516202|594152454|FG002|Overall Study|Lost to Follow-up|1|||
164486941|NCT02516202|594152452|FG000|Overall Study|Stopped Follow-up|0|||
164486942|NCT02516202|594152453|FG001|Overall Study|Stopped Follow-up|0|||
164486943|NCT02516202|594152454|FG002|Overall Study|Stopped Follow-up|1|||
164486944|NCT01000649|594152457|FG000|Overall Study|Adverse Event|5|||
164486945|NCT01000649|594152458|FG001|Overall Study|Adverse Event|1|||
164486946|NCT01000649|594152459|FG002|Overall Study|Adverse Event|2|||
164486947|NCT01000649|594152460|FG003|Overall Study|Adverse Event|4|||
164486948|NCT01000649|594152457|FG000|Overall Study|Lost to Follow-up|0|||
164486949|NCT01000649|594152458|FG001|Overall Study|Lost to Follow-up|2|||
164486950|NCT01000649|594152459|FG002|Overall Study|Lost to Follow-up|0|||
164486951|NCT01000649|594152460|FG003|Overall Study|Lost to Follow-up|2|||
164486952|NCT01916109|594152461|FG000|Overall Study|Withdrawal by Subject|1|||
164486953|NCT00103857|594152462|FG000|54-Week Base Study|Adverse Event|12|||
164486954|NCT00103857|594152463|FG001|54-Week Base Study|Adverse Event|9|||
164486955|NCT00103857|594152464|FG002|54-Week Base Study|Adverse Event|11|||
164486956|NCT00103857|594152465|FG003|54-Week Base Study|Adverse Event|6|||
164486957|NCT00103857|594152466|FG004|54-Week Base Study|Adverse Event|5|||
164486958|NCT00103857|594152467|FG005|54-Week Base Study|Adverse Event|11|||
164486959|NCT00103857|594152468|FG006|54-Week Base Study|Adverse Event|3|||
164486960|NCT00103857|594152462|FG000|54-Week Base Study|Death|0|||
164486961|NCT00103857|594152463|FG001|54-Week Base Study|Death|0|||
164486962|NCT00103857|594152464|FG002|54-Week Base Study|Death|0|||
164486963|NCT00103857|594152465|FG003|54-Week Base Study|Death|0|||
164486964|NCT00103857|594152466|FG004|54-Week Base Study|Death|1|||
164486965|NCT00103857|594152467|FG005|54-Week Base Study|Death|1|||
164486966|NCT00103857|594152468|FG006|54-Week Base Study|Death|0|||
164486967|NCT00103857|594152462|FG000|54-Week Base Study|Lack of Efficacy|11|||
164486968|NCT00103857|594152463|FG001|54-Week Base Study|Lack of Efficacy|14|||
164486969|NCT00103857|594152464|FG002|54-Week Base Study|Lack of Efficacy|8|||
164486970|NCT00103857|594152465|FG003|54-Week Base Study|Lack of Efficacy|4|||
164486971|NCT00103857|594152466|FG004|54-Week Base Study|Lack of Efficacy|3|||
164486972|NCT00103857|594152467|FG005|54-Week Base Study|Lack of Efficacy|14|||
164486973|NCT00103857|594152468|FG006|54-Week Base Study|Lack of Efficacy|19|||
164486974|NCT00103857|594152462|FG000|54-Week Base Study|Lost to Follow-up|5|||
164486975|NCT00103857|594152463|FG001|54-Week Base Study|Lost to Follow-up|4|||
164486976|NCT00103857|594152464|FG002|54-Week Base Study|Lost to Follow-up|7|||
164486977|NCT00103857|594152465|FG003|54-Week Base Study|Lost to Follow-up|5|||
164486978|NCT00103857|594152466|FG004|54-Week Base Study|Lost to Follow-up|10|||
164486979|NCT00103857|594152467|FG005|54-Week Base Study|Lost to Follow-up|9|||
164486980|NCT00103857|594152468|FG006|54-Week Base Study|Lost to Follow-up|3|||
164486981|NCT00103857|594152462|FG000|54-Week Base Study|Physician Decision|1|||
164486982|NCT00103857|594152463|FG001|54-Week Base Study|Physician Decision|1|||
164486983|NCT00103857|594152464|FG002|54-Week Base Study|Physician Decision|0|||
164486984|NCT00103857|594152465|FG003|54-Week Base Study|Physician Decision|0|||
164486985|NCT00103857|594152466|FG004|54-Week Base Study|Physician Decision|1|||
164486986|NCT00103857|594152467|FG005|54-Week Base Study|Physician Decision|0|||
164486987|NCT00103857|594152468|FG006|54-Week Base Study|Physician Decision|0|||
164486988|NCT00103857|594152462|FG000|54-Week Base Study|Pregnancy|1|||
164486989|NCT00103857|594152463|FG001|54-Week Base Study|Pregnancy|0|||
164486990|NCT00103857|594152464|FG002|54-Week Base Study|Pregnancy|0|||
164486991|NCT00103857|594152465|FG003|54-Week Base Study|Pregnancy|0|||
164486992|NCT00103857|594152466|FG004|54-Week Base Study|Pregnancy|1|||
164486993|NCT00103857|594152467|FG005|54-Week Base Study|Pregnancy|0|||
164486994|NCT00103857|594152468|FG006|54-Week Base Study|Pregnancy|1|||
164486995|NCT00103857|594152462|FG000|54-Week Base Study|Protocol Violation|6|||
164486996|NCT00103857|594152463|FG001|54-Week Base Study|Protocol Violation|4|||
164486997|NCT00103857|594152464|FG002|54-Week Base Study|Protocol Violation|2|||
164486998|NCT00103857|594152465|FG003|54-Week Base Study|Protocol Violation|4|||
164486999|NCT00103857|594152466|FG004|54-Week Base Study|Protocol Violation|0|||
164487000|NCT00103857|594152467|FG005|54-Week Base Study|Protocol Violation|3|||
164487001|NCT00103857|594152468|FG006|54-Week Base Study|Protocol Violation|3|||
164487002|NCT00103857|594152462|FG000|54-Week Base Study|Withdrawal by Subject|17|||
164487003|NCT00103857|594152463|FG001|54-Week Base Study|Withdrawal by Subject|16|||
164487004|NCT00103857|594152464|FG002|54-Week Base Study|Withdrawal by Subject|16|||
164487005|NCT00103857|594152465|FG003|54-Week Base Study|Withdrawal by Subject|15|||
164487006|NCT00103857|594152466|FG004|54-Week Base Study|Withdrawal by Subject|10|||
164487007|NCT00103857|594152467|FG005|54-Week Base Study|Withdrawal by Subject|15|||
164487008|NCT00103857|594152468|FG006|54-Week Base Study|Withdrawal by Subject|4|||
164487009|NCT00103857|594152462|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
164487010|NCT00103857|594152463|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
164487011|NCT00103857|594152464|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
164487012|NCT00103857|594152465|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
164487013|NCT00103857|594152466|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
164487014|NCT00103857|594152467|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
164487015|NCT00103857|594152468|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
164487016|NCT00103857|594152462|FG000|54-Week Base Study|patient moved|0|||
164487017|NCT00103857|594152463|FG001|54-Week Base Study|patient moved|1|||
164487018|NCT00103857|594152464|FG002|54-Week Base Study|patient moved|1|||
164487019|NCT00103857|594152465|FG003|54-Week Base Study|patient moved|2|||
164487020|NCT00103857|594152466|FG004|54-Week Base Study|patient moved|3|||
164487021|NCT00103857|594152467|FG005|54-Week Base Study|patient moved|1|||
164487022|NCT00103857|594152468|FG006|54-Week Base Study|patient moved|0|||
164487023|NCT00103857|594152462|FG000|54-Week Base Study|non-compliance with study procedures|1|||
164487024|NCT00103857|594152463|FG001|54-Week Base Study|non-compliance with study procedures|2|||
164487025|NCT00103857|594152464|FG002|54-Week Base Study|non-compliance with study procedures|0|||
164487026|NCT00103857|594152465|FG003|54-Week Base Study|non-compliance with study procedures|0|||
164487027|NCT00103857|594152466|FG004|54-Week Base Study|non-compliance with study procedures|0|||
164487028|NCT00103857|594152467|FG005|54-Week Base Study|non-compliance with study procedures|2|||
164487029|NCT00103857|594152468|FG006|54-Week Base Study|non-compliance with study procedures|0|||
164487030|NCT00103857|594152462|FG000|54-Week Base Study|patient incarcerated|0|||
164487031|NCT00103857|594152463|FG001|54-Week Base Study|patient incarcerated|0|||
164487032|NCT00103857|594152464|FG002|54-Week Base Study|patient incarcerated|0|||
164487033|NCT00103857|594152465|FG003|54-Week Base Study|patient incarcerated|0|||
164487034|NCT00103857|594152466|FG004|54-Week Base Study|patient incarcerated|1|||
164487035|NCT00103857|594152467|FG005|54-Week Base Study|patient incarcerated|1|||
164487036|NCT00103857|594152468|FG006|54-Week Base Study|patient incarcerated|0|||
164487037|NCT00103857|594152462|FG000|54-Week Base Study|laboratory reporting error|0|||
164487038|NCT00103857|594152463|FG001|54-Week Base Study|laboratory reporting error|0|||
164487039|NCT00103857|594152464|FG002|54-Week Base Study|laboratory reporting error|0|||
164487040|NCT00103857|594152465|FG003|54-Week Base Study|laboratory reporting error|0|||
164487041|NCT00103857|594152466|FG004|54-Week Base Study|laboratory reporting error|1|||
164487042|NCT00103857|594152467|FG005|54-Week Base Study|laboratory reporting error|0|||
164487043|NCT00103857|594152468|FG006|54-Week Base Study|laboratory reporting error|0|||
164487044|NCT00103857|594152462|FG000|54-Week Base Study|site error|0|||
164487045|NCT00103857|594152463|FG001|54-Week Base Study|site error|0|||
164487046|NCT00103857|594152464|FG002|54-Week Base Study|site error|0|||
164487047|NCT00103857|594152465|FG003|54-Week Base Study|site error|0|||
164487048|NCT00103857|594152466|FG004|54-Week Base Study|site error|0|||
164487049|NCT00103857|594152467|FG005|54-Week Base Study|site error|1|||
164487050|NCT00103857|594152468|FG006|54-Week Base Study|site error|0|||
164487051|NCT00103857|594152462|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
164487052|NCT00103857|594152463|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
164487053|NCT00103857|594152464|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
164487054|NCT00103857|594152465|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
164487055|NCT00103857|594152466|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
164487056|NCT00103857|594152467|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
164487057|NCT00103857|594152468|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
164487058|NCT00103857|594152462|FG000|50-Week Extension Study|Adverse Event|2|||
164487059|NCT00103857|594152463|FG001|50-Week Extension Study|Adverse Event|3|||
164487060|NCT00103857|594152464|FG002|50-Week Extension Study|Adverse Event|2|||
164487061|NCT00103857|594152465|FG003|50-Week Extension Study|Adverse Event|0|||
164601978|NCT02953782|594562741|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
164601979|NCT02953782|594562742|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
164601980|NCT02953782|594562743|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
164601981|NCT02953782|594562744|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
164601982|NCT02953782|594562745|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
164487062|NCT00103857|594152466|FG004|50-Week Extension Study|Adverse Event|1|||
164487063|NCT00103857|594152467|FG005|50-Week Extension Study|Adverse Event|1|||
164487064|NCT00103857|594152468|FG006|50-Week Extension Study|Adverse Event|0|||
164487065|NCT00103857|594152462|FG000|50-Week Extension Study|Death|0|||
164487066|NCT00103857|594152463|FG001|50-Week Extension Study|Death|0|||
164487067|NCT00103857|594152464|FG002|50-Week Extension Study|Death|0|||
164487068|NCT00103857|594152465|FG003|50-Week Extension Study|Death|1|||
164487069|NCT00103857|594152466|FG004|50-Week Extension Study|Death|0|||
164487070|NCT00103857|594152467|FG005|50-Week Extension Study|Death|1|||
164487071|NCT00103857|594152468|FG006|50-Week Extension Study|Death|0|||
164487072|NCT00103857|594152462|FG000|50-Week Extension Study|Lack of Efficacy|26|||
164487073|NCT00103857|594152463|FG001|50-Week Extension Study|Lack of Efficacy|15|||
164487074|NCT00103857|594152464|FG002|50-Week Extension Study|Lack of Efficacy|13|||
164487075|NCT00103857|594152465|FG003|50-Week Extension Study|Lack of Efficacy|16|||
164487076|NCT00103857|594152466|FG004|50-Week Extension Study|Lack of Efficacy|8|||
164487077|NCT00103857|594152467|FG005|50-Week Extension Study|Lack of Efficacy|8|||
164487078|NCT00103857|594152468|FG006|50-Week Extension Study|Lack of Efficacy|0|||
164487079|NCT00103857|594152462|FG000|50-Week Extension Study|Lost to Follow-up|4|||
164487080|NCT00103857|594152463|FG001|50-Week Extension Study|Lost to Follow-up|0|||
164487081|NCT00103857|594152464|FG002|50-Week Extension Study|Lost to Follow-up|1|||
164487082|NCT00103857|594152465|FG003|50-Week Extension Study|Lost to Follow-up|4|||
164487083|NCT00103857|594152466|FG004|50-Week Extension Study|Lost to Follow-up|3|||
164487084|NCT00103857|594152467|FG005|50-Week Extension Study|Lost to Follow-up|3|||
164487085|NCT00103857|594152468|FG006|50-Week Extension Study|Lost to Follow-up|0|||
164487086|NCT00103857|594152462|FG000|50-Week Extension Study|Physician Decision|0|||
164487087|NCT00103857|594152463|FG001|50-Week Extension Study|Physician Decision|1|||
164487088|NCT00103857|594152464|FG002|50-Week Extension Study|Physician Decision|1|||
164487089|NCT00103857|594152465|FG003|50-Week Extension Study|Physician Decision|0|||
164487090|NCT00103857|594152466|FG004|50-Week Extension Study|Physician Decision|0|||
164487091|NCT00103857|594152467|FG005|50-Week Extension Study|Physician Decision|0|||
164487092|NCT00103857|594152468|FG006|50-Week Extension Study|Physician Decision|0|||
164487093|NCT00103857|594152462|FG000|50-Week Extension Study|Pregnancy|0|||
164487094|NCT00103857|594152463|FG001|50-Week Extension Study|Pregnancy|0|||
164487095|NCT00103857|594152464|FG002|50-Week Extension Study|Pregnancy|1|||
164487096|NCT00103857|594152465|FG003|50-Week Extension Study|Pregnancy|0|||
164487097|NCT00103857|594152466|FG004|50-Week Extension Study|Pregnancy|1|||
164487098|NCT00103857|594152467|FG005|50-Week Extension Study|Pregnancy|0|||
164487099|NCT00103857|594152468|FG006|50-Week Extension Study|Pregnancy|0|||
164487100|NCT00103857|594152462|FG000|50-Week Extension Study|Protocol Violation|1|||
164487101|NCT00103857|594152463|FG001|50-Week Extension Study|Protocol Violation|1|||
164487102|NCT00103857|594152464|FG002|50-Week Extension Study|Protocol Violation|1|||
164487103|NCT00103857|594152465|FG003|50-Week Extension Study|Protocol Violation|2|||
164487104|NCT00103857|594152466|FG004|50-Week Extension Study|Protocol Violation|0|||
164487105|NCT00103857|594152467|FG005|50-Week Extension Study|Protocol Violation|1|||
164487106|NCT00103857|594152468|FG006|50-Week Extension Study|Protocol Violation|0|||
164487107|NCT00103857|594152462|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
164487108|NCT00103857|594152463|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
164487109|NCT00103857|594152464|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
164487110|NCT00103857|594152465|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
164487111|NCT00103857|594152466|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
164487112|NCT00103857|594152467|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
164487113|NCT00103857|594152468|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
164487114|NCT00103857|594152462|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
164487115|NCT00103857|594152463|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
164487116|NCT00103857|594152464|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
164487117|NCT00103857|594152465|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
164487118|NCT00103857|594152466|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
164487119|NCT00103857|594152467|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
164487120|NCT00103857|594152468|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
164601983|NCT02953782|594562738|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
164714724|NCT00113763|594978701|FG000|Overall Study|Lost to Follow-up|10|||
164487121|NCT00103857|594152462|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
164487122|NCT00103857|594152463|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
164487123|NCT00103857|594152464|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
164487124|NCT00103857|594152465|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
164487125|NCT00103857|594152466|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
164487126|NCT00103857|594152467|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
164487127|NCT00103857|594152468|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
164487128|NCT00103857|594152462|FG000|50-Week Extension Study|patient moved|0|||
164487129|NCT00103857|594152463|FG001|50-Week Extension Study|patient moved|0|||
164487130|NCT00103857|594152464|FG002|50-Week Extension Study|patient moved|1|||
164714725|NCT00113763|594978702|FG001|Overall Study|Lost to Follow-up|0|||
164487131|NCT00103857|594152465|FG003|50-Week Extension Study|patient moved|2|||
164487132|NCT00103857|594152466|FG004|50-Week Extension Study|patient moved|0|||
164487133|NCT00103857|594152467|FG005|50-Week Extension Study|patient moved|0|||
164487134|NCT00103857|594152468|FG006|50-Week Extension Study|patient moved|0|||
164487135|NCT00103857|594152462|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
164487136|NCT00103857|594152463|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
164487137|NCT00103857|594152464|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
164487138|NCT00103857|594152465|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
164487139|NCT00103857|594152466|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
164487140|NCT00103857|594152467|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
164487141|NCT00103857|594152468|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
164487142|NCT00103857|594152462|FG000|50-Week Extension Study|reason unspecified|0|||
164487143|NCT00103857|594152463|FG001|50-Week Extension Study|reason unspecified|0|||
164487144|NCT00103857|594152464|FG002|50-Week Extension Study|reason unspecified|0|||
164487145|NCT00103857|594152465|FG003|50-Week Extension Study|reason unspecified|0|||
164487146|NCT00103857|594152466|FG004|50-Week Extension Study|reason unspecified|1|||
164487147|NCT00103857|594152467|FG005|50-Week Extension Study|reason unspecified|0|||
164487148|NCT00103857|594152468|FG006|50-Week Extension Study|reason unspecified|0|||
164487149|NCT01287832|594152471|FG000|Overall Study|Adverse Event|1|||
164487150|NCT01287832|594152472|FG001|Overall Study|Adverse Event|0|||
164487151|NCT01287832|594152471|FG000|Overall Study|Death|0|||
164487152|NCT01287832|594152472|FG001|Overall Study|Death|1|||
164487153|NCT03065400|594152475|FG000|Overall Study|Adverse Event|1|||
164487154|NCT03065400|594152475|FG000|Overall Study|Physician Decision|3|||
164487155|NCT03065400|594152475|FG000|Overall Study|Withdrawal by Subject|1|||
164487156|NCT03065400|594152475|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
164487157|NCT00632736|594152476|FG000|Overall Study|Adverse Event|104|||
164487158|NCT00632736|594152476|FG000|Overall Study|Lost to Follow-up|15|||
164487159|NCT00632736|594152476|FG000|Overall Study|Protocol Violation|14|||
164487160|NCT00632736|594152476|FG000|Overall Study|Withdrawal by Subject|99|||
164487161|NCT00632736|594152476|FG000|Overall Study|Lack of Efficacy|5|||
164487162|NCT00632736|594152476|FG000|Overall Study|Sponsor terminated study|5|||
164487163|NCT00632736|594152476|FG000|Overall Study|Non-compliance|10|||
164487164|NCT00632736|594152476|FG000|Overall Study|Other|16|||
164487165|NCT03347396|594152477|FG000|Part A (26 Weeks)|Adverse Event|1|||
164487166|NCT03347396|594152478|FG001|Part A (26 Weeks)|Adverse Event|0|||
164487167|NCT03347396|594152477|FG000|Part A (26 Weeks)|Death|0|||
164487168|NCT03347396|594152478|FG001|Part A (26 Weeks)|Death|1|||
164487169|NCT03347396|594152477|FG000|Part B (149 Weeks)|Adverse Event|1|||
164487170|NCT03347396|594152478|FG001|Part B (149 Weeks)|Adverse Event|1|||
164487171|NCT03347396|594152477|FG000|Part B (149 Weeks)|Death|1|||
164487172|NCT03347396|594152478|FG001|Part B (149 Weeks)|Death|0|||
164487173|NCT02312258|594152479|FG000|Overall Study|Lost to Follow-up|8|||
164487174|NCT02312258|594152480|FG001|Overall Study|Lost to Follow-up|8|||
164487175|NCT02312258|594152479|FG000|Overall Study|Withdrawal by Patient|49|||
164487176|NCT02312258|594152480|FG001|Overall Study|Withdrawal by Patient|76|||
164487177|NCT02312258|594152479|FG000|Overall Study|Reason not Specified|107|||
164487178|NCT02312258|594152480|FG001|Overall Study|Reason not Specified|159|||
164487179|NCT02312258|594152479|FG000|Overall Study|Missing|2|||
164487180|NCT02312258|594152480|FG001|Overall Study|Missing|1|||
164487181|NCT02312258|594152479|FG000|Overall Study|Death|115|||
164487182|NCT02312258|594152480|FG001|Overall Study|Death|181|||
164487183|NCT01528605|594152481|FG000|Overall Study|Lost to Follow-up|1|||
164487184|NCT01528605|594152482|FG001|Overall Study|Lost to Follow-up|0|||
164487185|NCT01528605|594152483|FG002|Overall Study|Lost to Follow-up|1|||
164487186|NCT01528605|594152484|FG003|Overall Study|Lost to Follow-up|1|||
164487187|NCT01528605|594152485|FG004|Overall Study|Lost to Follow-up|0|||
164487188|NCT01528605|594152486|FG005|Overall Study|Lost to Follow-up|0|||
164487189|NCT01528605|594152481|FG000|Overall Study|Death|1|||
164487190|NCT01528605|594152482|FG001|Overall Study|Death|0|||
164487191|NCT01528605|594152483|FG002|Overall Study|Death|0|||
164487192|NCT01528605|594152484|FG003|Overall Study|Death|0|||
164487193|NCT01528605|594152485|FG004|Overall Study|Death|0|||
164487194|NCT01528605|594152486|FG005|Overall Study|Death|0|||
164487195|NCT01681511|594152488|FG000|Overall Study|No Treatment Received|1|||
164487196|NCT01681511|594152489|FG001|Overall Study|No Treatment Received|3|||
164487197|NCT01681511|594152488|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
164487198|NCT01681511|594152489|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
164487199|NCT01681511|594152488|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
164487200|NCT01681511|594152489|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
164487201|NCT01681511|594152488|FG000|Overall Study|No Daily Urine Sample Collected|0|||
164487202|NCT01681511|594152489|FG001|Overall Study|No Daily Urine Sample Collected|1|||
164487203|NCT01681511|594152488|FG000|Overall Study|No post-catheter sample collected|11|||
164487204|NCT01681511|594152489|FG001|Overall Study|No post-catheter sample collected|4|||
164601984|NCT02953782|594562739|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
164487205|NCT01156675|594152490|FG000|Overall Study|Death|5|||
164601985|NCT02953782|594562740|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
164601986|NCT02953782|594562741|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
164601987|NCT02953782|594562742|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
164601988|NCT02953782|594562743|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
164601989|NCT02953782|594562744|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
164601990|NCT02953782|594562745|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
164601991|NCT02953782|594562738|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
164601992|NCT02953782|594562739|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
164601993|NCT02953782|594562740|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
164601994|NCT02953782|594562741|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
164601995|NCT02953782|594562742|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
164601996|NCT02953782|594562743|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
164601997|NCT02953782|594562744|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
164601998|NCT02953782|594562745|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
164601999|NCT02953782|594562738|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
164602000|NCT02953782|594562739|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
164602001|NCT02953782|594562740|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
164602002|NCT02953782|594562741|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
164602003|NCT02953782|594562742|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
164602004|NCT02953782|594562743|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
164602005|NCT02953782|594562744|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
164602006|NCT02953782|594562745|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
164602007|NCT01934192|594562748|FG000|Overall Study|Protocol Violation|0|||
164602008|NCT01934192|594562749|FG001|Overall Study|Protocol Violation|0|||
164602009|NCT01934192|594562750|FG002|Overall Study|Protocol Violation|0|||
164602010|NCT01934192|594562751|FG003|Overall Study|Protocol Violation|1|||
164602011|NCT01934192|594562748|FG000|Overall Study|Other: reached stopping criteria|6|||
164602012|NCT01934192|594562749|FG001|Overall Study|Other: reached stopping criteria|5|||
164602013|NCT01934192|594562750|FG002|Overall Study|Other: reached stopping criteria|1|||
164602014|NCT01934192|594562751|FG003|Overall Study|Other: reached stopping criteria|0|||
164602015|NCT01934192|594562748|FG000|Overall Study|Physician Decision|3|||
164602016|NCT01934192|594562749|FG001|Overall Study|Physician Decision|2|||
164602017|NCT01934192|594562750|FG002|Overall Study|Physician Decision|0|||
164602018|NCT01934192|594562751|FG003|Overall Study|Physician Decision|0|||
164602019|NCT01737840|594562752|FG000|Overall Study|Diagnosed with an other pathology|2|||
164602020|NCT01737840|594562753|FG001|Overall Study|Diagnosed with an other pathology|2|||
164602021|NCT01189435|594562754|FG000|Overall Study|Withdrawal by Subject|1|||
164602022|NCT01189435|594562754|FG000|Overall Study|Physician Decision|1|||
164602023|NCT02357849|594562757|FG000|Overall Study|Withdrawal by Subject|2|||
164602024|NCT02357849|594562758|FG001|Overall Study|Withdrawal by Subject|3|||
164602025|NCT03105700|594562761|FG000|Overall Study|screen fail|3|||
164602026|NCT03105700|594562761|FG000|Overall Study|Lost to Follow-up|4|||
164602027|NCT01253421|594562762|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
164602028|NCT01253421|594562763|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
164602029|NCT01253421|594562764|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
164602030|NCT01253421|594562765|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
164602031|NCT01253421|594562766|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
164602032|NCT01253421|594562762|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
164714726|NCT00113763|594978701|FG000|Overall Study|Withdrawal by Subject|1|||
164714727|NCT00113763|594978702|FG001|Overall Study|Withdrawal by Subject|4|||
164714728|NCT00113763|594978701|FG000|Overall Study|Other|27|||
164714729|NCT00113763|594978702|FG001|Overall Study|Other|6|||
164714730|NCT00113763|594978701|FG000|Overall Study|Non-compliance|1|||
164714731|NCT00113763|594978702|FG001|Overall Study|Non-compliance|0|||
164714732|NCT00113763|594978701|FG000|Overall Study|Ongoing|1|||
164714733|NCT00113763|594978702|FG001|Overall Study|Ongoing|0|||
164714734|NCT00094861|594978703|FG000|Overall Study|Adverse Event|5|||
164714735|NCT00094861|594978704|FG001|Overall Study|Adverse Event|2|||
164714736|NCT00094861|594978703|FG000|Overall Study|Withdrawal by Subject|5|||
164602033|NCT01253421|594562763|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
164714737|NCT00094861|594978704|FG001|Overall Study|Withdrawal by Subject|3|||
164602034|NCT01253421|594562764|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
164602035|NCT01253421|594562765|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
164602036|NCT01253421|594562766|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
164714738|NCT00094861|594978703|FG000|Overall Study|Physician Decision|1|||
164714739|NCT00094861|594978704|FG001|Overall Study|Physician Decision|1|||
164714740|NCT00094861|594978703|FG000|Overall Study|Lost to Follow-up|0|||
164714741|NCT00094861|594978704|FG001|Overall Study|Lost to Follow-up|1|||
164602037|NCT01253421|594562762|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
164602038|NCT01253421|594562763|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
164602039|NCT01253421|594562764|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
164714742|NCT00094861|594978703|FG000|Overall Study|Death|4|||
164487206|NCT01156675|594152491|FG001|Overall Study|Death|3|||
164487207|NCT01156675|594152492|FG002|Overall Study|Death|0|||
164487208|NCT01156675|594152490|FG000|Overall Study|No data|29|||
164487209|NCT01156675|594152491|FG001|Overall Study|No data|22|||
164487210|NCT01156675|594152492|FG002|Overall Study|No data|2|||
164487211|NCT01970527|594152493|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
164487212|NCT01970527|594152494|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
164487213|NCT01970527|594152493|FG000|Treatment|Disease progression|0|||
164487214|NCT01970527|594152494|FG001|Treatment|Disease progression|1|||
164487215|NCT01970527|594152493|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
164487216|NCT01970527|594152494|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
164487217|NCT01970527|594152493|FG000|Treatment|Death|0|||
164487218|NCT01970527|594152494|FG001|Treatment|Death|1|||
164487219|NCT01970527|594152493|FG000|Follow-up Clinic Visit|Disease progression|1|||
164487220|NCT01970527|594152494|FG001|Follow-up Clinic Visit|Disease progression|1|||
164487221|NCT01970527|594152493|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
164487222|NCT01970527|594152494|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
164487223|NCT01970527|594152493|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
164487224|NCT01970527|594152494|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
164487225|NCT00116649|594152510|FG000|Overall Study|Adverse Event|20|||
164487226|NCT00116649|594152510|FG000|Overall Study|Lack of Efficacy|1|||
164487227|NCT00116649|594152510|FG000|Overall Study|Lost to Follow-up|32|||
164487228|NCT00116649|594152510|FG000|Overall Study|Withdrawal by Subject|68|||
164487229|NCT00116649|594152510|FG000|Overall Study|Local Skin Reaction|9|||
164487230|NCT00116649|594152510|FG000|Overall Study|Various Reasons|18|||
164487231|NCT00116649|594152510|FG000|Overall Study|Protocol Specified|7|||
164487232|NCT02161146|594152511|FG000|Overall Study|Adverse Event|1|||
164487233|NCT02161146|594152512|FG001|Overall Study|Adverse Event|1|||
164487234|NCT02161146|594152513|FG002|Overall Study|Adverse Event|0|||
164487235|NCT02161146|594152514|FG003|Overall Study|Adverse Event|1|||
164487236|NCT02161146|594152515|FG004|Overall Study|Adverse Event|0|||
164487237|NCT02161146|594152511|FG000|Overall Study|Lost to Follow-up|0|||
164487238|NCT02161146|594152512|FG001|Overall Study|Lost to Follow-up|1|||
164487239|NCT02161146|594152513|FG002|Overall Study|Lost to Follow-up|0|||
164487240|NCT02161146|594152514|FG003|Overall Study|Lost to Follow-up|0|||
164487241|NCT02161146|594152515|FG004|Overall Study|Lost to Follow-up|0|||
164487242|NCT02161146|594152511|FG000|Overall Study|Personal Reasons|0|||
164487243|NCT02161146|594152512|FG001|Overall Study|Personal Reasons|1|||
164487244|NCT02161146|594152513|FG002|Overall Study|Personal Reasons|0|||
164487245|NCT02161146|594152514|FG003|Overall Study|Personal Reasons|2|||
164487246|NCT02161146|594152515|FG004|Overall Study|Personal Reasons|1|||
164487247|NCT02161146|594152511|FG000|Overall Study|Other Miscellaneous Reasons|0|||
164487248|NCT02161146|594152512|FG001|Overall Study|Other Miscellaneous Reasons|1|||
164487249|NCT02161146|594152513|FG002|Overall Study|Other Miscellaneous Reasons|0|||
164487250|NCT02161146|594152514|FG003|Overall Study|Other Miscellaneous Reasons|0|||
164487251|NCT02161146|594152515|FG004|Overall Study|Other Miscellaneous Reasons|0|||
164487252|NCT00845520|594152516|FG000|Overall Study|Death|1|||
164487253|NCT00845520|594152517|FG001|Overall Study|Death|2|||
164487254|NCT00845520|594152518|FG002|Overall Study|Death|0|||
164487255|NCT00845520|594152516|FG000|Overall Study|Lost to Follow-up|1|||
164487256|NCT00845520|594152517|FG001|Overall Study|Lost to Follow-up|0|||
164487257|NCT00845520|594152518|FG002|Overall Study|Lost to Follow-up|0|||
164487258|NCT00845520|594152516|FG000|Overall Study|Adverse Event|0|||
164487259|NCT00845520|594152517|FG001|Overall Study|Adverse Event|0|||
164487260|NCT00845520|594152518|FG002|Overall Study|Adverse Event|1|||
164487261|NCT02613403|594152519|FG000|Overall Study|Lost to Follow-up|0|||
164487262|NCT02613403|594152520|FG001|Overall Study|Lost to Follow-up|1|||
164487263|NCT02613403|594152521|FG002|Overall Study|Lost to Follow-up|0|||
164487264|NCT02613403|594152522|FG003|Overall Study|Lost to Follow-up|0|||
164487265|NCT02613403|594152523|FG004|Overall Study|Lost to Follow-up|0|||
164487266|NCT02613403|594152519|FG000|Overall Study|Withdrawal by Subject|2|||
164487267|NCT02613403|594152520|FG001|Overall Study|Withdrawal by Subject|0|||
164487268|NCT02613403|594152521|FG002|Overall Study|Withdrawal by Subject|0|||
164487269|NCT02613403|594152522|FG003|Overall Study|Withdrawal by Subject|0|||
164487270|NCT02613403|594152523|FG004|Overall Study|Withdrawal by Subject|0|||
164487271|NCT03072238|594154358|FG000|Overall Study|Withdrawal by Subject|44|||
164487272|NCT03072238|594154359|FG001|Overall Study|Withdrawal by Subject|64|||
164487273|NCT03072238|594154358|FG000|Overall Study|Lost to Follow-up|14|||
164487274|NCT03072238|594154359|FG001|Overall Study|Lost to Follow-up|5|||
164487275|NCT03072238|594154358|FG000|Overall Study|Physician Decision|4|||
164487276|NCT03072238|594154359|FG001|Overall Study|Physician Decision|6|||
164487277|NCT03072238|594154358|FG000|Overall Study|Death|351|||
164487278|NCT03072238|594154359|FG001|Overall Study|Death|318|||
164487279|NCT03072238|594154358|FG000|Overall Study|Progressive Disease|3|||
164487280|NCT03072238|594154359|FG001|Overall Study|Progressive Disease|4|||
164487281|NCT03072238|594154358|FG000|Overall Study|Reason Not Specified|138|||
164487282|NCT03072238|594154359|FG001|Overall Study|Reason Not Specified|150|||
164487283|NCT01945593|594154360|FG000|Overall Study|Adverse Event|0|||
164487284|NCT01945593|594154361|FG001|Overall Study|Adverse Event|0|||
164487285|NCT01945593|594154362|FG002|Overall Study|Adverse Event|0|||
164487286|NCT01945593|594154363|FG003|Overall Study|Adverse Event|5|||
164487287|NCT01945593|594154360|FG000|Overall Study|Physician Decision|0|||
164487288|NCT01945593|594154361|FG001|Overall Study|Physician Decision|0|||
164487289|NCT01945593|594154362|FG002|Overall Study|Physician Decision|1|||
164487290|NCT01945593|594154363|FG003|Overall Study|Physician Decision|1|||
164487291|NCT01945593|594154360|FG000|Overall Study|Withdrawal by Subject|0|||
164487292|NCT01945593|594154361|FG001|Overall Study|Withdrawal by Subject|2|||
164487293|NCT01945593|594154362|FG002|Overall Study|Withdrawal by Subject|0|||
164487294|NCT01945593|594154363|FG003|Overall Study|Withdrawal by Subject|4|||
164487295|NCT01945593|594154360|FG000|Overall Study|Protocol Violation|0|||
164487296|NCT01945593|594154361|FG001|Overall Study|Protocol Violation|2|||
164487297|NCT01945593|594154362|FG002|Overall Study|Protocol Violation|1|||
164487298|NCT01945593|594154363|FG003|Overall Study|Protocol Violation|3|||
164487299|NCT01945593|594154360|FG000|Overall Study|Death|0|||
164487300|NCT01945593|594154361|FG001|Overall Study|Death|0|||
164487301|NCT01945593|594154362|FG002|Overall Study|Death|1|||
164487302|NCT01945593|594154363|FG003|Overall Study|Death|0|||
164487303|NCT01945593|594154360|FG000|Overall Study|Other: Terminated|0|||
164487304|NCT01945593|594154361|FG001|Overall Study|Other: Terminated|0|||
164487305|NCT01945593|594154362|FG002|Overall Study|Other: Terminated|0|||
164487306|NCT01945593|594154363|FG003|Overall Study|Other: Terminated|1|||
164487307|NCT01945593|594154360|FG000|Overall Study|Other: Surgical Procedure|0|||
164487308|NCT01945593|594154361|FG001|Overall Study|Other: Surgical Procedure|2|||
164487309|NCT01945593|594154362|FG002|Overall Study|Other: Surgical Procedure|0|||
164487310|NCT01945593|594154363|FG003|Overall Study|Other: Surgical Procedure|6|||
164487311|NCT01945593|594154360|FG000|Overall Study|Other: Screen Failure|0|||
164487312|NCT01945593|594154361|FG001|Overall Study|Other: Screen Failure|2|||
164487313|NCT01945593|594154362|FG002|Overall Study|Other: Screen Failure|0|||
164487314|NCT01945593|594154363|FG003|Overall Study|Other: Screen Failure|0|||
164487315|NCT00608959|594154366|FG000|Part 1|Did not meet eligibility criteria|1|||
164487316|NCT01005602|594154367|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
164487317|NCT01005602|594154368|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
164487318|NCT01919489|594154374|FG000|Overall Study|Rejected the need of injections|4|||
164487319|NCT01919489|594154375|FG001|Overall Study|Rejected the need of injections|7|||
164487320|NCT01919489|594154374|FG000|Overall Study|Adverse Event|10|||
164487321|NCT01919489|594154375|FG001|Overall Study|Adverse Event|0|||
164714743|NCT00094861|594978704|FG001|Overall Study|Death|2|||
164714744|NCT00094861|594978703|FG000|Overall Study|Other|3|||
164714745|NCT00094861|594978704|FG001|Overall Study|Other|0|||
164714746|NCT00451204|594978706|FG000|Overall Study|Adverse Event|4|||
164714747|NCT00451204|594978707|FG001|Overall Study|Adverse Event|6|||
164714748|NCT00451204|594978706|FG000|Overall Study|Lack of Efficacy|4|||
164487322|NCT01919489|594154374|FG000|Overall Study|Hospital readmission|2|||
164487323|NCT01919489|594154375|FG001|Overall Study|Hospital readmission|9|||
164487324|NCT01919489|594154374|FG000|Overall Study|Death|2|||
164487325|NCT01919489|594154375|FG001|Overall Study|Death|1|||
164487326|NCT01919489|594154374|FG000|Overall Study|Lost to Follow-up|38|||
164487327|NCT01919489|594154375|FG001|Overall Study|Lost to Follow-up|27|||
164487328|NCT01131325|594154376|FG000|Overall Study|Adverse Event|1|||
164487329|NCT01131325|594154376|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
164487330|NCT03884478|594154377|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
164487331|NCT03884478|594154378|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
164487332|NCT03884478|594154379|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
164487333|NCT03884478|594154377|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
164487334|NCT03884478|594154378|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
164487335|NCT03884478|594154379|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
164487336|NCT03884478|594154377|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
164487337|NCT03884478|594154378|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
164487338|NCT03884478|594154379|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
164487339|NCT03884478|594154377|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
164487340|NCT03884478|594154378|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
164487341|NCT03884478|594154379|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
164487342|NCT02163499|594154380|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
164487343|NCT02163499|594154380|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
164487344|NCT02163499|594154380|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
164487345|NCT02163499|594154380|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
164714749|NCT00451204|594978707|FG001|Overall Study|Lack of Efficacy|4|||
164487346|NCT02163499|594154380|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
164487347|NCT02163499|594154380|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
164487348|NCT02163499|594154380|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
164487349|NCT02163499|594154380|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
164487350|NCT02163499|594154380|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
164714750|NCT00451204|594978706|FG000|Overall Study|Lost to Follow-up|4|||
164487351|NCT02163499|594154380|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
164487352|NCT02163499|594154380|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
164487353|NCT02163499|594154380|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
164487354|NCT02163499|594154380|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
164487355|NCT02163499|594154380|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
164487356|NCT02163499|594154380|FG000|Extended Dosing Phase: ZS|Death|8|||
164487357|NCT02163499|594154380|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
164487358|NCT02163499|594154380|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
164487359|NCT02163499|594154380|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
164487360|NCT04454125|594154381|FG000|Overall Study|Lost to Follow-up|0|||
164487361|NCT04454125|594154382|FG001|Overall Study|Lost to Follow-up|1|||
164487362|NCT00476151|594154383|FG000|Overall Study|Adverse Event|0|||
164487363|NCT00476151|594154384|FG001|Overall Study|Adverse Event|2|||
164487364|NCT00476151|594154383|FG000|Overall Study|Protocol Violation|1|||
164487365|NCT00476151|594154384|FG001|Overall Study|Protocol Violation|3|||
164487366|NCT00476151|594154383|FG000|Overall Study|Withdrawal by Subject|2|||
164487367|NCT00476151|594154384|FG001|Overall Study|Withdrawal by Subject|0|||
164487368|NCT00476151|594154383|FG000|Overall Study|Physician Decision|0|||
164487369|NCT00476151|594154384|FG001|Overall Study|Physician Decision|2|||
164487370|NCT02068352|594154386|FG000|Overall Study|Lost to Follow-up|0|||
164487371|NCT02068352|594154387|FG001|Overall Study|Lost to Follow-up|2|||
164487372|NCT02068352|594154388|FG002|Overall Study|Lost to Follow-up|0|||
164487373|NCT02068352|594154386|FG000|Overall Study|Adverse Event|4|||
164487374|NCT02068352|594154387|FG001|Overall Study|Adverse Event|2|||
164487375|NCT02068352|594154388|FG002|Overall Study|Adverse Event|7|||
164487376|NCT02068352|594154386|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
164487377|NCT02068352|594154387|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
164487378|NCT02068352|594154388|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
164487379|NCT02068352|594154386|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
164487380|NCT02068352|594154387|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
164487381|NCT02068352|594154388|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
164487382|NCT02068352|594154386|FG000|Overall Study|Protocol Deviation|0|||
164487383|NCT02068352|594154387|FG001|Overall Study|Protocol Deviation|0|||
164487384|NCT02068352|594154388|FG002|Overall Study|Protocol Deviation|1|||
164487385|NCT01767376|594154392|FG000|Overall Study|Lost to Follow-up|3|||
164487386|NCT01767376|594154393|FG001|Overall Study|Lost to Follow-up|2|||
164487387|NCT01767376|594154394|FG002|Overall Study|Lost to Follow-up|0|||
164487388|NCT01767376|594154392|FG000|Overall Study|Withdrawal by Subject|1|||
164487389|NCT01767376|594154393|FG001|Overall Study|Withdrawal by Subject|1|||
164487390|NCT01767376|594154394|FG002|Overall Study|Withdrawal by Subject|0|||
164487391|NCT00946088|594154395|FG000|Overall Study|Withdrawal by Subject|0|||
164487392|NCT00946088|594154396|FG001|Overall Study|Withdrawal by Subject|1|||
164487393|NCT01322347|594154400|FG000|Overall Study|Adverse Event|7|||
164487394|NCT01322347|594154401|FG001|Overall Study|Adverse Event|2|||
164487395|NCT01322347|594154400|FG000|Overall Study|Death|5|||
164487396|NCT01322347|594154401|FG001|Overall Study|Death|3|||
164487397|NCT01322347|594154400|FG000|Overall Study|Physician Decision|2|||
164487398|NCT01322347|594154401|FG001|Overall Study|Physician Decision|1|||
164487399|NCT01322347|594154400|FG000|Overall Study|Protocol Violation|5|||
164487400|NCT01322347|594154401|FG001|Overall Study|Protocol Violation|2|||
164487401|NCT01322347|594154400|FG000|Overall Study|Withdrawal by Subject|1|||
164487402|NCT01322347|594154401|FG001|Overall Study|Withdrawal by Subject|4|||
164487403|NCT01322347|594154400|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
164487404|NCT01322347|594154401|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
164487405|NCT01322347|594154400|FG000|Overall Study|blood transfusion|5|||
164487406|NCT01322347|594154401|FG001|Overall Study|blood transfusion|5|||
164487407|NCT01322347|594154400|FG000|Overall Study|sponsor decision|1|||
164487408|NCT01322347|594154401|FG001|Overall Study|sponsor decision|3|||
164487409|NCT01322347|594154400|FG000|Overall Study|ineligible|6|||
164487410|NCT01322347|594154401|FG001|Overall Study|ineligible|3|||
164487411|NCT01322347|594154400|FG000|Overall Study|kidney transplant|3|||
164487412|NCT01322347|594154401|FG001|Overall Study|kidney transplant|1|||
164714751|NCT00451204|594978707|FG001|Overall Study|Lost to Follow-up|4|||
164714752|NCT00451204|594978706|FG000|Overall Study|Protocol Violation|1|||
164714753|NCT00451204|594978707|FG001|Overall Study|Protocol Violation|0|||
164487413|NCT01322347|594154400|FG000|Overall Study|study drug withheld > 12 wks|0|||
164487414|NCT01322347|594154401|FG001|Overall Study|study drug withheld > 12 wks|1|||
164487415|NCT01322347|594154400|FG000|Overall Study|moved/changed dialysis|2|||
164487416|NCT01322347|594154401|FG001|Overall Study|moved/changed dialysis|4|||
164487417|NCT01193283|594154402|FG000|Overall Study|Death|1|||
164487418|NCT04883541|594154403|FG000|Overall Study|Not attending regular yoga class|16|||
164487419|NCT04883541|594154404|FG001|Overall Study|Not attending regular yoga class|0|||
164487420|NCT04883541|594154403|FG000|Overall Study|Not attending the pregnancy school|0|||
164487421|NCT04883541|594154404|FG001|Overall Study|Not attending the pregnancy school|9|||
164487422|NCT01369147|594154405|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
164714754|NCT00451204|594978706|FG000|Overall Study|Patient refusal|8|||
164487423|NCT01369147|594154406|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
164487424|NCT01369147|594154407|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
164487425|NCT04239911|594154408|FG000|Overall Study|Lost to Follow-up|2|||
164487426|NCT04239911|594154409|FG001|Overall Study|Lost to Follow-up|1|||
164487427|NCT03456856|594154410|FG000|Overall Study|Lost to Follow-up|2|||
164487428|NCT03456856|594154410|FG000|Overall Study|Withdrawal by Subject|1|||
164487429|NCT02542696|594154412|FG000|Overall Study|Adverse Event|167|||
164487430|NCT02542696|594154412|FG000|Overall Study|Lack of Efficacy|26|||
164487431|NCT02542696|594154412|FG000|Overall Study|Lost to Follow-up|6|||
164487432|NCT02542696|594154412|FG000|Overall Study|Withdrawal by Subject|104|||
164487433|NCT02542696|594154412|FG000|Overall Study|Protocol Violation|5|||
164487434|NCT02542696|594154412|FG000|Overall Study|Death|8|||
164487435|NCT02542696|594154412|FG000|Overall Study|DECREASED OFF TIME|1|||
164487436|NCT02542696|594154412|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
164487437|NCT02542696|594154412|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
164487438|NCT02542696|594154412|FG000|Overall Study|MEDICAL HISTORY|1|||
164487439|NCT02542696|594154412|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
164487440|NCT02542696|594154412|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
164487441|NCT02542696|594154412|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
164487442|NCT02542696|594154412|FG000|Overall Study|SPONSOR DECISION|3|||
164487443|NCT02542696|594154412|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
164487444|NCT02542696|594154412|FG000|Overall Study|SUBJECT DECISION|2|||
164487445|NCT02137785|594154413|FG000|Overall Study|Lost to Follow-up|1|||
164487446|NCT02137785|594154414|FG001|Overall Study|Lost to Follow-up|0|||
164487447|NCT02137785|594154413|FG000|Overall Study|Withdrawal by Subject|1|||
164487448|NCT02137785|594154414|FG001|Overall Study|Withdrawal by Subject|4|||
164487449|NCT02137785|594154413|FG000|Overall Study|subject moved out of state|1|||
164487450|NCT02137785|594154414|FG001|Overall Study|subject moved out of state|0|||
164487451|NCT03345407|594154416|FG000|Overall Study|Withdrawal by Subject|11|||
164487452|NCT03345407|594154417|FG001|Overall Study|Withdrawal by Subject|1|||
164487453|NCT03345407|594154418|FG002|Overall Study|Withdrawal by Subject|5|||
164487454|NCT03345407|594154419|FG003|Overall Study|Withdrawal by Subject|6|||
164487455|NCT03345407|594154420|FG004|Overall Study|Withdrawal by Subject|3|||
164487456|NCT03345407|594154421|FG005|Overall Study|Withdrawal by Subject|6|||
164487457|NCT03345407|594154422|FG006|Overall Study|Withdrawal by Subject|16|||
164487458|NCT03345407|594154416|FG000|Overall Study|Physician Decision|3|||
164487459|NCT03345407|594154417|FG001|Overall Study|Physician Decision|1|||
164487460|NCT03345407|594154418|FG002|Overall Study|Physician Decision|0|||
164487461|NCT03345407|594154419|FG003|Overall Study|Physician Decision|0|||
164487462|NCT03345407|594154420|FG004|Overall Study|Physician Decision|1|||
164487463|NCT03345407|594154421|FG005|Overall Study|Physician Decision|2|||
164487464|NCT03345407|594154422|FG006|Overall Study|Physician Decision|3|||
164487465|NCT03345407|594154416|FG000|Overall Study|Lost to Follow-up|2|||
164487466|NCT03345407|594154417|FG001|Overall Study|Lost to Follow-up|0|||
164487467|NCT03345407|594154418|FG002|Overall Study|Lost to Follow-up|1|||
164487468|NCT03345407|594154419|FG003|Overall Study|Lost to Follow-up|0|||
164487469|NCT03345407|594154420|FG004|Overall Study|Lost to Follow-up|1|||
164487470|NCT03345407|594154421|FG005|Overall Study|Lost to Follow-up|2|||
164487471|NCT03345407|594154422|FG006|Overall Study|Lost to Follow-up|3|||
164487472|NCT03345407|594154416|FG000|Overall Study|Protocol-defined stopping criteria|9|||
164487473|NCT03345407|594154417|FG001|Overall Study|Protocol-defined stopping criteria|0|||
164487474|NCT03345407|594154418|FG002|Overall Study|Protocol-defined stopping criteria|0|||
164602040|NCT01253421|594562765|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
164487475|NCT03345407|594154419|FG003|Overall Study|Protocol-defined stopping criteria|0|||
164487476|NCT03345407|594154420|FG004|Overall Study|Protocol-defined stopping criteria|2|||
164487477|NCT03345407|594154421|FG005|Overall Study|Protocol-defined stopping criteria|1|||
164487478|NCT03345407|594154422|FG006|Overall Study|Protocol-defined stopping criteria|1|||
164487479|NCT03345407|594154416|FG000|Overall Study|Protocol Violation|2|||
164487480|NCT03345407|594154417|FG001|Overall Study|Protocol Violation|0|||
164487481|NCT03345407|594154418|FG002|Overall Study|Protocol Violation|0|||
164487482|NCT03345407|594154419|FG003|Overall Study|Protocol Violation|0|||
164487483|NCT03345407|594154420|FG004|Overall Study|Protocol Violation|1|||
164602041|NCT01253421|594562766|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
164602042|NCT01253421|594562762|FG000|Assessment and Scheduling|Physician Decision|1|||
164487484|NCT03345407|594154421|FG005|Overall Study|Protocol Violation|0|||
164487485|NCT03345407|594154422|FG006|Overall Study|Protocol Violation|3|||
164487486|NCT03345407|594154416|FG000|Overall Study|Lack of Efficacy|1|||
164602043|NCT01253421|594562763|FG001|Assessment and Scheduling|Physician Decision|0|||
164487487|NCT03345407|594154417|FG001|Overall Study|Lack of Efficacy|1|||
164487488|NCT03345407|594154418|FG002|Overall Study|Lack of Efficacy|1|||
164487489|NCT03345407|594154419|FG003|Overall Study|Lack of Efficacy|1|||
164487490|NCT03345407|594154420|FG004|Overall Study|Lack of Efficacy|1|||
164487491|NCT03345407|594154421|FG005|Overall Study|Lack of Efficacy|0|||
164487492|NCT03345407|594154422|FG006|Overall Study|Lack of Efficacy|3|||
164487493|NCT03345407|594154416|FG000|Overall Study|Adverse Event|4|||
164487494|NCT03345407|594154417|FG001|Overall Study|Adverse Event|0|||
164487495|NCT03345407|594154418|FG002|Overall Study|Adverse Event|5|||
164487496|NCT03345407|594154419|FG003|Overall Study|Adverse Event|4|||
164487497|NCT03345407|594154420|FG004|Overall Study|Adverse Event|6|||
164487498|NCT03345407|594154421|FG005|Overall Study|Adverse Event|5|||
164487499|NCT03345407|594154422|FG006|Overall Study|Adverse Event|16|||
164487500|NCT01584648|594154423|FG000|Overall Study|Death|136|||
164487501|NCT01584648|594154424|FG001|Overall Study|Death|146|||
164487502|NCT01584648|594154423|FG000|Overall Study|Lost to Follow-up|9|||
164487503|NCT01584648|594154424|FG001|Overall Study|Lost to Follow-up|9|||
164487504|NCT01584648|594154423|FG000|Overall Study|Investigator discretion|3|||
164487505|NCT01584648|594154424|FG001|Overall Study|Investigator discretion|2|||
164487506|NCT01584648|594154423|FG000|Overall Study|Withdrew consent|13|||
164487507|NCT01584648|594154424|FG001|Overall Study|Withdrew consent|4|||
164487508|NCT01584648|594154423|FG000|Overall Study|Study closed/terminated|50|||
164487509|NCT01584648|594154424|FG001|Overall Study|Study closed/terminated|23|||
164487510|NCT01584648|594154423|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
164487511|NCT01584648|594154424|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
164487512|NCT03262389|594154425|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
164487513|NCT03262389|594154425|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
164487514|NCT03262389|594154425|FG000|Overall Study|opted out of PET/MR|1|||
164487515|NCT03146845|594154427|FG000|Overall Study|Reference ulcer healed|1|||
164487516|NCT03146845|594154428|FG001|Overall Study|Reference ulcer healed|0|||
164487517|NCT03146845|594154427|FG000|Overall Study|Physician Decision|1|||
164487518|NCT03146845|594154428|FG001|Overall Study|Physician Decision|0|||
164487519|NCT03146845|594154427|FG000|Overall Study|Adverse Event|1|||
164487520|NCT03146845|594154428|FG001|Overall Study|Adverse Event|0|||
164487521|NCT03146845|594154427|FG000|Overall Study|Withdrawal by Subject|2|||
164487522|NCT03146845|594154428|FG001|Overall Study|Withdrawal by Subject|0|||
164487523|NCT03146845|594154427|FG000|Overall Study|Noncompliance|0|||
164487524|NCT03146845|594154428|FG001|Overall Study|Noncompliance|1|||
164487525|NCT03146845|594154427|FG000|Overall Study|Protocol Violation|0|||
164487526|NCT03146845|594154428|FG001|Overall Study|Protocol Violation|2|||
164487527|NCT03146845|594154427|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
164487528|NCT03146845|594154428|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
164487529|NCT01052272|594154429|FG000|Overall Study|Death|0|||
164487530|NCT01052272|594154430|FG001|Overall Study|Death|0|||
164487531|NCT01052272|594154431|FG002|Overall Study|Death|1|||
164487532|NCT01052272|594154432|FG003|Overall Study|Death|1|||
164487533|NCT01052272|594154429|FG000|Overall Study|Physician Decision|0|||
164487534|NCT01052272|594154430|FG001|Overall Study|Physician Decision|1|||
164487535|NCT01052272|594154431|FG002|Overall Study|Physician Decision|0|||
164487536|NCT01052272|594154432|FG003|Overall Study|Physician Decision|0|||
164487537|NCT01052272|594154429|FG000|Overall Study|patient refuses follow-up|5|||
164487538|NCT01052272|594154430|FG001|Overall Study|patient refuses follow-up|4|||
164487539|NCT01052272|594154431|FG002|Overall Study|patient refuses follow-up|2|||
164487540|NCT01052272|594154432|FG003|Overall Study|patient refuses follow-up|4|||
164487541|NCT01052272|594154429|FG000|Overall Study|Withdrawal by Subject|0|||
164487542|NCT01052272|594154430|FG001|Overall Study|Withdrawal by Subject|2|||
164487543|NCT01052272|594154431|FG002|Overall Study|Withdrawal by Subject|3|||
164487544|NCT01052272|594154432|FG003|Overall Study|Withdrawal by Subject|2|||
164487545|NCT01052272|594154429|FG000|Overall Study|placed in long-term care|0|||
164602044|NCT01253421|594562764|FG002|Assessment and Scheduling|Physician Decision|0|||
164487546|NCT01052272|594154430|FG001|Overall Study|placed in long-term care|0|||
164487547|NCT01052272|594154431|FG002|Overall Study|placed in long-term care|1|||
164487548|NCT01052272|594154432|FG003|Overall Study|placed in long-term care|0|||
164487549|NCT01052272|594154429|FG000|Overall Study|decline in health|0|||
164487550|NCT01052272|594154430|FG001|Overall Study|decline in health|0|||
164487551|NCT01052272|594154431|FG002|Overall Study|decline in health|1|||
164487552|NCT01052272|594154432|FG003|Overall Study|decline in health|0|||
164487553|NCT02256553|594154434|FG000|Period I|Adverse Event|5|||
164487554|NCT02256553|594154434|FG000|Period I|Protocol Violation|1|||
164487555|NCT02256553|594154434|FG000|Period II|Adverse Event|1|||
164487556|NCT02256553|594154434|FG000|Period II|Subject Moved|1|||
164487557|NCT02256553|594154434|FG000|Period III|Adverse Event|3|||
164602045|NCT01253421|594562765|FG003|Assessment and Scheduling|Physician Decision|0|||
164602046|NCT01253421|594562766|FG004|Assessment and Scheduling|Physician Decision|0|||
164602047|NCT01253421|594562762|FG000|Drug+Scanning Visit|Physician Decision|0|||
164602048|NCT01253421|594562763|FG001|Drug+Scanning Visit|Physician Decision|0|||
164602049|NCT01253421|594562764|FG002|Drug+Scanning Visit|Physician Decision|0|||
164602050|NCT01253421|594562765|FG003|Drug+Scanning Visit|Physician Decision|0|||
164602051|NCT01253421|594562766|FG004|Drug+Scanning Visit|Physician Decision|1|||
164602052|NCT04105244|594562768|FG000|Overall Study|Withdrawal by Subject|10|||
164602053|NCT04105244|594562769|FG001|Overall Study|Withdrawal by Subject|12|||
164602054|NCT04105244|594562768|FG000|Overall Study|Lost to Follow-up|20|||
164602055|NCT04105244|594562769|FG001|Overall Study|Lost to Follow-up|15|||
164602056|NCT04105244|594562768|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
164487558|NCT00113529|594154435|FG000|Overall Study|Adverse Event|4|||
164487559|NCT00113529|594154435|FG000|Overall Study|Lack of Efficacy|20|||
164487560|NCT00113529|594154435|FG000|Overall Study|Decision of sponsor|6|||
164487561|NCT00113529|594154435|FG000|Overall Study|Withdrawal by Subject|4|||
164487562|NCT04421456|594154438|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
164487563|NCT04421456|594154439|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
164487564|NCT04421456|594154440|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
164487565|NCT04421456|594154438|FG000|Randomized Treatment Period|Adverse Event|0|||
164487566|NCT04421456|594154439|FG001|Randomized Treatment Period|Adverse Event|1|||
164487567|NCT04421456|594154440|FG002|Randomized Treatment Period|Adverse Event|0|||
164487568|NCT04421456|594154438|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
164487569|NCT04421456|594154439|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
164487570|NCT04421456|594154440|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
164487571|NCT04421456|594154438|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
164487572|NCT04421456|594154439|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
164487573|NCT04421456|594154440|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
164487574|NCT04421456|594154438|FG000|Randomized Treatment Period|Participant non-compliance|1|||
164487575|NCT04421456|594154439|FG001|Randomized Treatment Period|Participant non-compliance|1|||
164487576|NCT04421456|594154440|FG002|Randomized Treatment Period|Participant non-compliance|2|||
164487577|NCT04421456|594154438|FG000|Randomized Treatment Period|Other|0|||
164487578|NCT04421456|594154439|FG001|Randomized Treatment Period|Other|1|||
164487579|NCT04421456|594154440|FG002|Randomized Treatment Period|Other|3|||
164487580|NCT00379210|594154441|FG000|Overall Study|Withdrawal by Subject|10|||
164487581|NCT00379210|594154442|FG001|Overall Study|Withdrawal by Subject|7|||
164487582|NCT00821093|594154443|FG000|Overall Study|Adverse Event|20|||
164487583|NCT00821093|594154444|FG001|Overall Study|Adverse Event|12|||
164487584|NCT00821093|594154443|FG000|Overall Study|Withdrawal by Subject|9|||
164487585|NCT00821093|594154444|FG001|Overall Study|Withdrawal by Subject|13|||
164487586|NCT00821093|594154443|FG000|Overall Study|Lost to Follow-up|9|||
164487587|NCT00821093|594154444|FG001|Overall Study|Lost to Follow-up|3|||
164487588|NCT00821093|594154443|FG000|Overall Study|Protocol deviation|3|||
164487589|NCT00821093|594154444|FG001|Overall Study|Protocol deviation|6|||
164487590|NCT00821093|594154443|FG000|Overall Study|Abnormal laboratory value(s)|2|||
164487591|NCT00821093|594154444|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164487592|NCT00821093|594154443|FG000|Overall Study|Lack of Efficacy|2|||
164487593|NCT00821093|594154444|FG001|Overall Study|Lack of Efficacy|2|||
164487594|NCT00821093|594154443|FG000|Overall Study|Death|2|||
164487595|NCT00821093|594154444|FG001|Overall Study|Death|1|||
164487596|NCT00821093|594154443|FG000|Overall Study|Abnormal test procedure result(s)|1|||
164602057|NCT04105244|594562769|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
164602058|NCT04105244|594562768|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
164602059|NCT04105244|594562769|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
164602060|NCT04863014|594562770|FG000|Overall Study|Lost to Follow-up|3|||
164602061|NCT04863014|594562771|FG001|Overall Study|Lost to Follow-up|2|||
164602062|NCT04863014|594562770|FG000|Overall Study|Subject Decision|0|||
164602063|NCT04863014|594562771|FG001|Overall Study|Subject Decision|4|||
164602064|NCT01608724|594562772|FG000|Overall Study|Withdrawal by Subject|131|||
164602065|NCT01608724|594562772|FG000|Overall Study|Lost to Follow-up|41|||
164602066|NCT01608724|594562772|FG000|Overall Study|Study-specific discontinuation criteria|32|||
164602067|NCT01608724|594562772|FG000|Overall Study|Adverse Event|29|||
164602068|NCT01608724|594562772|FG000|Overall Study|Protocol Violation|6|||
164602069|NCT01608724|594562772|FG000|Overall Study|bood sugar too high, etc.|3|||
164602070|NCT01608724|594562772|FG000|Overall Study|Safety reasons|1|||
164602071|NCT00099359|594562773|FG000|Overall Study|Death|11|||
164602072|NCT00099359|594562774|FG001|Overall Study|Death|15|||
164602073|NCT00099359|594562775|FG002|Overall Study|Death|17|||
164602074|NCT00099359|594562773|FG000|Overall Study|Withdrawal by Subject|19|||
164602075|NCT00099359|594562774|FG001|Overall Study|Withdrawal by Subject|19|||
164487597|NCT00821093|594154444|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164487598|NCT00821093|594154443|FG000|Overall Study|Administrative problems|1|||
164602076|NCT00099359|594562775|FG002|Overall Study|Withdrawal by Subject|23|||
164602077|NCT00099359|594562773|FG000|Overall Study|Lost to Follow-up|15|||
164602078|NCT00099359|594562774|FG001|Overall Study|Lost to Follow-up|24|||
164602079|NCT00099359|594562775|FG002|Overall Study|Lost to Follow-up|24|||
164602080|NCT00099359|594562773|FG000|Overall Study|moved out of area|9|||
164602081|NCT00099359|594562774|FG001|Overall Study|moved out of area|7|||
164714755|NCT00451204|594978707|FG001|Overall Study|Patient refusal|4|||
164714756|NCT00451204|594978706|FG000|Overall Study|Other|1|||
164714757|NCT00451204|594978707|FG001|Overall Study|Other|2|||
164714758|NCT01696058|594978708|FG000|Overall Study|Adverse Event|21|||
164487599|NCT00821093|594154444|FG001|Overall Study|Administrative problems|2|||
164487600|NCT01107912|594154445|FG000|Period 1|Adverse Event|0|||
164487601|NCT01107912|594154446|FG001|Period 1|Adverse Event|0|||
164602082|NCT00099359|594562775|FG002|Overall Study|moved out of area|4|||
164602083|NCT00717366|594562776|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
164487602|NCT01107912|594154447|FG002|Period 1|Adverse Event|0|||
164487603|NCT01107912|594154448|FG003|Period 1|Adverse Event|0|||
164487604|NCT01107912|594154449|FG004|Period 1|Adverse Event|2|||
164487605|NCT01107912|594154450|FG005|Period 1|Adverse Event|0|||
164487606|NCT01107912|594154445|FG000|Period 1|Physician Decision|0|||
164487607|NCT01107912|594154446|FG001|Period 1|Physician Decision|0|||
164487608|NCT01107912|594154447|FG002|Period 1|Physician Decision|0|||
164487609|NCT01107912|594154448|FG003|Period 1|Physician Decision|0|||
164487610|NCT01107912|594154449|FG004|Period 1|Physician Decision|1|||
164487611|NCT01107912|594154450|FG005|Period 1|Physician Decision|0|||
164487612|NCT01107912|594154445|FG000|Period 1|Withdrawal by Subject|1|||
164487613|NCT01107912|594154446|FG001|Period 1|Withdrawal by Subject|0|||
164487614|NCT01107912|594154447|FG002|Period 1|Withdrawal by Subject|0|||
164487615|NCT01107912|594154448|FG003|Period 1|Withdrawal by Subject|0|||
164487616|NCT01107912|594154449|FG004|Period 1|Withdrawal by Subject|0|||
164487617|NCT01107912|594154450|FG005|Period 1|Withdrawal by Subject|0|||
164487618|NCT01107912|594154445|FG000|Period 2|Physician Decision|0|||
164487619|NCT01107912|594154446|FG001|Period 2|Physician Decision|0|||
164487620|NCT01107912|594154447|FG002|Period 2|Physician Decision|1|||
164487621|NCT01107912|594154448|FG003|Period 2|Physician Decision|0|||
164487622|NCT01107912|594154449|FG004|Period 2|Physician Decision|0|||
164487623|NCT01107912|594154450|FG005|Period 2|Physician Decision|0|||
164487624|NCT01107912|594154445|FG000|Period 3|Adverse Event|0|||
164487625|NCT01107912|594154446|FG001|Period 3|Adverse Event|1|||
164487626|NCT01107912|594154447|FG002|Period 3|Adverse Event|1|||
164487627|NCT01107912|594154448|FG003|Period 3|Adverse Event|0|||
164487628|NCT01107912|594154449|FG004|Period 3|Adverse Event|0|||
164487629|NCT01107912|594154450|FG005|Period 3|Adverse Event|0|||
164487630|NCT01107912|594154445|FG000|Period 3|Withdrawal by Subject|0|||
164487631|NCT01107912|594154446|FG001|Period 3|Withdrawal by Subject|0|||
164487632|NCT01107912|594154447|FG002|Period 3|Withdrawal by Subject|0|||
164487633|NCT01107912|594154448|FG003|Period 3|Withdrawal by Subject|1|||
164487634|NCT01107912|594154449|FG004|Period 3|Withdrawal by Subject|0|||
164487635|NCT01107912|594154450|FG005|Period 3|Withdrawal by Subject|0|||
164487636|NCT03529942|594154452|FG000|Overall Study|Withdrawal by Subject|13|||
164487637|NCT03529942|594154452|FG000|Overall Study|Physician Decision|1|||
164487638|NCT03529942|594154452|FG000|Overall Study|Lost to Follow-up|7|||
164487639|NCT03529942|594154452|FG000|Overall Study|Needle inserted but no drug administered|1|||
164487640|NCT03529942|594154452|FG000|Overall Study|Personal reasons|1|||
164487641|NCT00409747|594154463|FG000|Overall Study|Withdrawal by Subject|1|||
164487642|NCT01989156|594154466|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
164487643|NCT01989156|594154467|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
164487644|NCT01989156|594154468|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
164487645|NCT01989156|594154466|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
164487646|NCT01989156|594154467|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
164487647|NCT01989156|594154468|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
164487648|NCT01989156|594154466|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
164487649|NCT01989156|594154467|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
164487650|NCT01989156|594154468|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
164487651|NCT01989156|594154466|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
164487652|NCT01989156|594154467|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
164487653|NCT01989156|594154468|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
164487654|NCT01989156|594154466|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
164487655|NCT01989156|594154467|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
164487656|NCT01989156|594154468|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
164487657|NCT01989156|594154466|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
164487658|NCT01989156|594154467|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
164487659|NCT01989156|594154468|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
164487660|NCT01989156|594154466|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
164487661|NCT01989156|594154467|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
164487662|NCT01989156|594154468|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
164487663|NCT01989156|594154466|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
164487664|NCT01989156|594154467|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
164487665|NCT01989156|594154468|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
164487666|NCT03839355|594154469|FG000|Overall Study|Withdrawal by Subject|1|||
164487667|NCT03839355|594154470|FG001|Overall Study|Withdrawal by Subject|0|||
164487668|NCT01794689|594154473|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
164487669|NCT01794689|594154474|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
164487670|NCT01794689|594154475|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
164487671|NCT01794689|594154476|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
164487672|NCT01794689|594154473|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
164487673|NCT01794689|594154474|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
164487674|NCT01794689|594154475|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
164487675|NCT01794689|594154476|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
164487676|NCT01794689|594154473|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
164487677|NCT01794689|594154474|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
164487678|NCT01794689|594154475|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
164487679|NCT01794689|594154476|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
164487680|NCT01794689|594154473|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
164487681|NCT01794689|594154474|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
164487682|NCT01794689|594154475|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
164487683|NCT01794689|594154476|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
164487684|NCT01697956|594154477|FG000|Overall Study|Protocol Violation|1|||
164487685|NCT01697956|594154478|FG001|Overall Study|Protocol Violation|1|||
164487686|NCT03060525|594154479|FG000|Overall Study|moved out of state|1|||
164487687|NCT03060525|594154480|FG001|Overall Study|moved out of state|1|||
164487688|NCT03060525|594154481|FG002|Overall Study|moved out of state|1|||
164487689|NCT03060525|594154482|FG003|Overall Study|moved out of state|1|||
164487690|NCT03060525|594154479|FG000|Overall Study|unable to meet time commitment required of study|2|||
164487691|NCT03060525|594154480|FG001|Overall Study|unable to meet time commitment required of study|3|||
164487692|NCT03060525|594154481|FG002|Overall Study|unable to meet time commitment required of study|3|||
164487693|NCT03060525|594154482|FG003|Overall Study|unable to meet time commitment required of study|1|||
164487694|NCT03060525|594154479|FG000|Overall Study|no longer interested in doing intervention|0|||
164487695|NCT03060525|594154480|FG001|Overall Study|no longer interested in doing intervention|0|||
164487696|NCT03060525|594154481|FG002|Overall Study|no longer interested in doing intervention|0|||
164487697|NCT03060525|594154482|FG003|Overall Study|no longer interested in doing intervention|1|||
164487698|NCT01964547|594154483|FG000|Overall Study|Adverse Event|8|||
164487699|NCT01964547|594154484|FG001|Overall Study|Adverse Event|2|||
164487700|NCT01964547|594154483|FG000|Overall Study|Withdrawal by Subject|4|||
164487701|NCT01964547|594154484|FG001|Overall Study|Withdrawal by Subject|7|||
164487702|NCT01964547|594154483|FG000|Overall Study|Lost to Follow-up|0|||
164487703|NCT01964547|594154484|FG001|Overall Study|Lost to Follow-up|1|||
164487704|NCT01964547|594154483|FG000|Overall Study|Withdrawal by Investigator|0|||
164487705|NCT01964547|594154484|FG001|Overall Study|Withdrawal by Investigator|1|||
164487706|NCT01115309|594154485|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
164487707|NCT01115309|594154485|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
164487708|NCT01115309|594154485|FG000|Long-term Follow-up|Lost to Follow-up|6|||
164487709|NCT04447287|594154486|FG000|Period 1: Run-in Period|Adverse Event|3|||
164487710|NCT04447287|594154487|FG001|Period 1: Run-in Period|Adverse Event|0|||
164487711|NCT04447287|594154488|FG002|Period 1: Run-in Period|Adverse Event|0|||
164487712|NCT04447287|594154486|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
164487713|NCT04447287|594154487|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
164487714|NCT04447287|594154488|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
164487715|NCT04447287|594154486|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
164487716|NCT04447287|594154487|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
164487717|NCT04447287|594154488|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
164487718|NCT05700851|594154489|FG000|Overall Study|Received a kidney transplant|1|||
164487719|NCT05700851|594154489|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
164487720|NCT05700851|594154489|FG000|Overall Study|Withdrawal by Subject|1|||
164487721|NCT02147093|594154490|FG000|Period 1|Lost to Follow-up|0|||
164487722|NCT02147093|594154491|FG001|Period 1|Lost to Follow-up|1|||
164487723|NCT02147093|594154490|FG000|Period 2|Protocol Violation|2|||
164487724|NCT02147093|594154491|FG001|Period 2|Protocol Violation|0|||
164487725|NCT03246724|594154492|FG000|Overall Study|Withdrawal by Subject|5|||
164487726|NCT03246724|594154493|FG001|Overall Study|Withdrawal by Subject|2|||
164487727|NCT03246724|594154494|FG002|Overall Study|Withdrawal by Subject|4|||
164487728|NCT03246724|594154495|FG003|Overall Study|Withdrawal by Subject|2|||
164487729|NCT03246724|594154492|FG000|Overall Study|Ineligible on day of surgery|7|||
164487730|NCT03246724|594154493|FG001|Overall Study|Ineligible on day of surgery|2|||
164487731|NCT03246724|594154494|FG002|Overall Study|Ineligible on day of surgery|0|||
164487732|NCT03246724|594154495|FG003|Overall Study|Ineligible on day of surgery|3|||
164487733|NCT03246724|594154492|FG000|Overall Study|Study completed before surgical date|2|||
164487734|NCT03246724|594154493|FG001|Overall Study|Study completed before surgical date|1|||
164487735|NCT03246724|594154494|FG002|Overall Study|Study completed before surgical date|8|||
164487736|NCT03246724|594154495|FG003|Overall Study|Study completed before surgical date|1|||
164487737|NCT03246724|594154492|FG000|Overall Study|Transferred to other arm|0|||
164487738|NCT03246724|594154493|FG001|Overall Study|Transferred to other arm|0|||
164487739|NCT03246724|594154494|FG002|Overall Study|Transferred to other arm|1|||
164487740|NCT03246724|594154495|FG003|Overall Study|Transferred to other arm|0|||
164487741|NCT03246724|594154492|FG000|Overall Study|Unable to obtain medication timely|0|||
164487742|NCT03246724|594154493|FG001|Overall Study|Unable to obtain medication timely|2|||
164487743|NCT03246724|594154494|FG002|Overall Study|Unable to obtain medication timely|2|||
164487744|NCT03246724|594154495|FG003|Overall Study|Unable to obtain medication timely|1|||
164487745|NCT03246724|594154492|FG000|Overall Study|Re-consented to participate|0|||
164487746|NCT03246724|594154493|FG001|Overall Study|Re-consented to participate|0|||
164487747|NCT03246724|594154494|FG002|Overall Study|Re-consented to participate|0|||
164487748|NCT03246724|594154495|FG003|Overall Study|Re-consented to participate|1|||
164487749|NCT00655824|594154496|FG000|Overall Study|Adverse Event|3|||
164487750|NCT00655824|594154496|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
164487751|NCT00655824|594154496|FG000|Overall Study|Protocol Violation|1|||
164487752|NCT00655824|594154496|FG000|Overall Study|Withdrawal by Subject|4|||
164487753|NCT00655824|594154496|FG000|Overall Study|Deterioration of Trial Disease|2|||
164487754|NCT02978716|594154497|FG000|Overall Study|Death|25|||
164487755|NCT02978716|594154498|FG001|Overall Study|Death|13|||
164487756|NCT02978716|594154499|FG002|Overall Study|Death|20|||
164487757|NCT02978716|594154497|FG000|Overall Study|Lost to Follow-up|0|||
164487758|NCT02978716|594154498|FG001|Overall Study|Lost to Follow-up|0|||
164487759|NCT02978716|594154499|FG002|Overall Study|Lost to Follow-up|1|||
164487760|NCT02978716|594154497|FG000|Overall Study|Withdrawal by Subject|6|||
164487761|NCT02978716|594154498|FG001|Overall Study|Withdrawal by Subject|4|||
164487762|NCT02978716|594154499|FG002|Overall Study|Withdrawal by Subject|5|||
164487763|NCT02978716|594154497|FG000|Overall Study|Sponsor terminated|2|||
164487764|NCT02978716|594154498|FG001|Overall Study|Sponsor terminated|13|||
164487765|NCT02978716|594154499|FG002|Overall Study|Sponsor terminated|9|||
164487766|NCT02978716|594154497|FG000|Overall Study|Other|1|||
164487767|NCT02978716|594154498|FG001|Overall Study|Other|3|||
164487768|NCT02978716|594154499|FG002|Overall Study|Other|0|||
164487769|NCT00589628|594154500|FG000|Overall Study|Lost to Follow-up|0|||
164487770|NCT00589628|594154501|FG001|Overall Study|Lost to Follow-up|1|||
164487771|NCT00946998|594156515|FG000|Overall Study|Exited prior to first outcome assessment|5|||
164487772|NCT00946998|594156516|FG001|Overall Study|Exited prior to first outcome assessment|3|||
164487773|NCT00228813|594156517|FG000|Overall Study|Death|4|||
164487774|NCT03761849|594156522|FG000|Overall Study|transferred to OpenLabelExtension|35|||
164487775|NCT03761849|594156523|FG001|Overall Study|transferred to OpenLabelExtension|34|||
164487776|NCT03761849|594156524|FG002|Overall Study|transferred to OpenLabelExtension|36|||
164487777|NCT03761849|594156525|FG003|Overall Study|transferred to OpenLabelExtension|0|||
164487778|NCT03761849|594156526|FG004|Overall Study|transferred to OpenLabelExtension|0|||
164487779|NCT03761849|594156527|FG005|Overall Study|transferred to OpenLabelExtension|0|||
164487780|NCT03761849|594156522|FG000|Overall Study|Adverse Event|1|||
164487781|NCT03761849|594156523|FG001|Overall Study|Adverse Event|0|||
164487782|NCT03761849|594156524|FG002|Overall Study|Adverse Event|0|||
164487783|NCT03761849|594156525|FG003|Overall Study|Adverse Event|0|||
164487784|NCT03761849|594156526|FG004|Overall Study|Adverse Event|2|||
164487785|NCT03761849|594156527|FG005|Overall Study|Adverse Event|3|||
164487786|NCT03761849|594156522|FG000|Overall Study|Withdrawal by Subject|0|||
164487787|NCT03761849|594156523|FG001|Overall Study|Withdrawal by Subject|0|||
164487788|NCT03761849|594156524|FG002|Overall Study|Withdrawal by Subject|0|||
164487789|NCT03761849|594156525|FG003|Overall Study|Withdrawal by Subject|41|||
164487790|NCT03761849|594156526|FG004|Overall Study|Withdrawal by Subject|43|||
164487791|NCT03761849|594156527|FG005|Overall Study|Withdrawal by Subject|35|||
164487792|NCT03761849|594156522|FG000|Overall Study|Lost to Follow-up|0|||
164487793|NCT03761849|594156523|FG001|Overall Study|Lost to Follow-up|1|||
164487794|NCT03761849|594156524|FG002|Overall Study|Lost to Follow-up|0|||
164487795|NCT03761849|594156525|FG003|Overall Study|Lost to Follow-up|2|||
164487796|NCT03761849|594156526|FG004|Overall Study|Lost to Follow-up|4|||
164487797|NCT03761849|594156527|FG005|Overall Study|Lost to Follow-up|5|||
164487798|NCT03761849|594156522|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
164487799|NCT03761849|594156523|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
164487800|NCT03761849|594156524|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
164487801|NCT03761849|594156525|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
164487802|NCT03761849|594156526|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
164487803|NCT03761849|594156527|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
164487804|NCT03761849|594156522|FG000|Overall Study|Physician Decision|0|||
164487805|NCT03761849|594156523|FG001|Overall Study|Physician Decision|0|||
164487806|NCT03761849|594156524|FG002|Overall Study|Physician Decision|0|||
164714759|NCT01696058|594978709|FG001|Overall Study|Adverse Event|11|||
164714760|NCT01696058|594978708|FG000|Overall Study|Lack of Efficacy|2|||
164714761|NCT01696058|594978709|FG001|Overall Study|Lack of Efficacy|3|||
164714762|NCT01696058|594978708|FG000|Overall Study|Protocol Violation|9|||
164487807|NCT03761849|594156525|FG003|Overall Study|Physician Decision|1|||
164487808|NCT03761849|594156526|FG004|Overall Study|Physician Decision|4|||
164487809|NCT03761849|594156527|FG005|Overall Study|Physician Decision|4|||
164487810|NCT03761849|594156522|FG000|Overall Study|Death|0|||
164487811|NCT03761849|594156523|FG001|Overall Study|Death|0|||
164487812|NCT03761849|594156524|FG002|Overall Study|Death|0|||
164487813|NCT03761849|594156525|FG003|Overall Study|Death|1|||
164487814|NCT03761849|594156526|FG004|Overall Study|Death|1|||
164487815|NCT03761849|594156527|FG005|Overall Study|Death|3|||
164487816|NCT03761849|594156522|FG000|Overall Study|Protocol Violation|0|||
164487817|NCT03761849|594156523|FG001|Overall Study|Protocol Violation|0|||
164487818|NCT03761849|594156524|FG002|Overall Study|Protocol Violation|0|||
164714763|NCT01696058|594978709|FG001|Overall Study|Protocol Violation|3|||
164487819|NCT03761849|594156525|FG003|Overall Study|Protocol Violation|2|||
164487820|NCT03761849|594156526|FG004|Overall Study|Protocol Violation|2|||
164487821|NCT03761849|594156527|FG005|Overall Study|Protocol Violation|1|||
164487822|NCT03761849|594156522|FG000|Overall Study|Participant could not come to site|0|||
164487823|NCT03761849|594156523|FG001|Overall Study|Participant could not come to site|0|||
164487824|NCT03761849|594156524|FG002|Overall Study|Participant could not come to site|0|||
164487825|NCT03761849|594156525|FG003|Overall Study|Participant could not come to site|0|||
164487826|NCT03761849|594156526|FG004|Overall Study|Participant could not come to site|1|||
164487827|NCT03761849|594156527|FG005|Overall Study|Participant could not come to site|0|||
164487828|NCT03761849|594156522|FG000|Overall Study|SF- safety Finding|0|||
164487829|NCT03761849|594156523|FG001|Overall Study|SF- safety Finding|0|||
164487830|NCT03761849|594156524|FG002|Overall Study|SF- safety Finding|0|||
164487831|NCT03761849|594156525|FG003|Overall Study|SF- safety Finding|0|||
164487832|NCT03761849|594156526|FG004|Overall Study|SF- safety Finding|0|||
164487833|NCT03761849|594156527|FG005|Overall Study|SF- safety Finding|1|||
164487834|NCT03761849|594156522|FG000|Overall Study|Patient did not attend visit|0|||
164487835|NCT03761849|594156523|FG001|Overall Study|Patient did not attend visit|0|||
164487836|NCT03761849|594156524|FG002|Overall Study|Patient did not attend visit|0|||
164487837|NCT03761849|594156525|FG003|Overall Study|Patient did not attend visit|0|||
164487838|NCT03761849|594156526|FG004|Overall Study|Patient did not attend visit|0|||
164487839|NCT03761849|594156527|FG005|Overall Study|Patient did not attend visit|1|||
164487840|NCT02213094|594156530|FG000|Overall Study|Adverse Event|1|||
164487841|NCT02213094|594156531|FG001|Overall Study|Adverse Event|0|||
164487842|NCT00538629|594156532|FG000|Overall Study|At subject's request|1|||
164487843|NCT00538629|594156532|FG000|Overall Study|Adverse Event|2|||
164487844|NCT00538629|594156532|FG000|Overall Study|Lack of Efficacy|12|||
164487845|NCT00538629|594156532|FG000|Overall Study|Lost to Follow-up|6|||
164487846|NCT00538629|594156532|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
164487847|NCT00555620|594156538|FG000|Overall Study|Death|0|||
164487848|NCT00555620|594156539|FG001|Overall Study|Death|1|||
164487849|NCT00555620|594156540|FG002|Overall Study|Death|0|||
164487850|NCT00555620|594156541|FG003|Overall Study|Death|0|||
164487851|NCT00555620|594156542|FG004|Overall Study|Death|0|||
164487852|NCT00555620|594156543|FG005|Overall Study|Death|1|||
164487853|NCT00555620|594156538|FG000|Overall Study|Study terminated by sponsor|0|||
164487854|NCT00555620|594156539|FG001|Overall Study|Study terminated by sponsor|0|||
164487855|NCT00555620|594156540|FG002|Overall Study|Study terminated by sponsor|1|||
164487856|NCT00555620|594156541|FG003|Overall Study|Study terminated by sponsor|0|||
164487857|NCT00555620|594156542|FG004|Overall Study|Study terminated by sponsor|0|||
164487858|NCT00555620|594156543|FG005|Overall Study|Study terminated by sponsor|0|||
164487859|NCT00555620|594156538|FG000|Overall Study|Adverse Event|0|||
164487860|NCT00555620|594156539|FG001|Overall Study|Adverse Event|0|||
164487861|NCT00555620|594156540|FG002|Overall Study|Adverse Event|1|||
164487862|NCT00555620|594156541|FG003|Overall Study|Adverse Event|5|||
164487863|NCT00555620|594156542|FG004|Overall Study|Adverse Event|0|||
164487864|NCT00555620|594156543|FG005|Overall Study|Adverse Event|1|||
164487865|NCT00555620|594156538|FG000|Overall Study|Objective progression or relapse|6|||
164487866|NCT00555620|594156539|FG001|Overall Study|Objective progression or relapse|5|||
164602084|NCT00717366|594562777|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
164602085|NCT00717366|594562776|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
164602086|NCT00717366|594562777|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
164487867|NCT00555620|594156540|FG002|Overall Study|Objective progression or relapse|12|||
164487868|NCT00555620|594156541|FG003|Overall Study|Objective progression or relapse|17|||
164487869|NCT00555620|594156542|FG004|Overall Study|Objective progression or relapse|3|||
164487870|NCT00555620|594156543|FG005|Overall Study|Objective progression or relapse|16|||
164487871|NCT00555620|594156538|FG000|Overall Study|Participant refused treatment|0|||
164487872|NCT00555620|594156539|FG001|Overall Study|Participant refused treatment|1|||
164487873|NCT00555620|594156540|FG002|Overall Study|Participant refused treatment|1|||
164487874|NCT00555620|594156541|FG003|Overall Study|Participant refused treatment|0|||
164487875|NCT00555620|594156542|FG004|Overall Study|Participant refused treatment|0|||
164487876|NCT00555620|594156543|FG005|Overall Study|Participant refused treatment|1|||
164487877|NCT00555620|594156538|FG000|Overall Study|Other|0|||
164487878|NCT00555620|594156539|FG001|Overall Study|Other|0|||
164487879|NCT00555620|594156540|FG002|Overall Study|Other|0|||
164487880|NCT00555620|594156541|FG003|Overall Study|Other|1|||
164487881|NCT00555620|594156542|FG004|Overall Study|Other|0|||
164602087|NCT00717366|594562776|FG000|Core Study Period (20 Weeks)|Death|0|||
164602088|NCT00717366|594562777|FG001|Core Study Period (20 Weeks)|Death|1|||
164602089|NCT00717366|594562776|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
164487882|NCT00555620|594156543|FG005|Overall Study|Other|3|||
164487883|NCT01922102|594156544|FG000|Overall Study|Withdrawal by Subject|7|||
164487884|NCT01922102|594156545|FG001|Overall Study|Withdrawal by Subject|3|||
164487885|NCT01922102|594156546|FG002|Overall Study|Withdrawal by Subject|7|||
164487886|NCT01922102|594156544|FG000|Overall Study|Physician Decision|0|||
164487887|NCT01922102|594156545|FG001|Overall Study|Physician Decision|2|||
164487888|NCT01922102|594156546|FG002|Overall Study|Physician Decision|1|||
164487889|NCT01922102|594156544|FG000|Overall Study|Adverse Event|1|||
164487890|NCT01922102|594156545|FG001|Overall Study|Adverse Event|2|||
164487891|NCT01922102|594156546|FG002|Overall Study|Adverse Event|0|||
164487892|NCT01922102|594156544|FG000|Overall Study|Lost to Follow-up|1|||
164487893|NCT01922102|594156545|FG001|Overall Study|Lost to Follow-up|0|||
164487894|NCT01922102|594156546|FG002|Overall Study|Lost to Follow-up|0|||
164487895|NCT01922102|594156544|FG000|Overall Study|Administrative problems|0|||
164487896|NCT01922102|594156545|FG001|Overall Study|Administrative problems|2|||
164487897|NCT01922102|594156546|FG002|Overall Study|Administrative problems|0|||
164487898|NCT05203822|594156547|FG000|Overall Study|Adverse Event|1|||
164487899|NCT05203822|594156547|FG000|Overall Study|Withdrawal by Subject|1|||
164487900|NCT01816165|594156554|FG000|Overall Study|Adverse Event|1|||
164487901|NCT01816165|594156555|FG001|Overall Study|Adverse Event|0|||
164487902|NCT01816165|594156556|FG002|Overall Study|Adverse Event|0|||
164487903|NCT01816165|594156557|FG003|Overall Study|Adverse Event|0|||
164487904|NCT00447499|594156558|FG000|Overall Study|Adverse Event|1|||
164487905|NCT00447499|594156558|FG000|Overall Study|Patient Decision|4|||
164487906|NCT00447499|594156558|FG000|Overall Study|Sponsor Decision|1|||
164487907|NCT00447499|594156558|FG000|Overall Study|Physician Decision|1|||
164487908|NCT02092909|594156560|FG000|Overall Study|Adverse Event|0|||
164487909|NCT02092909|594156561|FG001|Overall Study|Adverse Event|0|||
164487910|NCT02092909|594156562|FG002|Overall Study|Adverse Event|4|||
164487911|NCT02092909|594156563|FG003|Overall Study|Adverse Event|2|||
164487912|NCT02092909|594156560|FG000|Overall Study|Lack of Efficacy|0|||
164487913|NCT02092909|594156561|FG001|Overall Study|Lack of Efficacy|2|||
164487914|NCT02092909|594156562|FG002|Overall Study|Lack of Efficacy|1|||
164487915|NCT02092909|594156563|FG003|Overall Study|Lack of Efficacy|0|||
164487916|NCT02092909|594156560|FG000|Overall Study|Withdrawal by Subject|0|||
164487917|NCT02092909|594156561|FG001|Overall Study|Withdrawal by Subject|0|||
164487918|NCT02092909|594156562|FG002|Overall Study|Withdrawal by Subject|2|||
164487919|NCT02092909|594156563|FG003|Overall Study|Withdrawal by Subject|1|||
164487920|NCT02092909|594156560|FG000|Overall Study|Study terminated by Sponsor|0|||
164487921|NCT02092909|594156561|FG001|Overall Study|Study terminated by Sponsor|0|||
164487922|NCT02092909|594156562|FG002|Overall Study|Study terminated by Sponsor|0|||
164487923|NCT02092909|594156563|FG003|Overall Study|Study terminated by Sponsor|2|||
164487924|NCT02092909|594156560|FG000|Overall Study|Miscellaneous|1|||
164487925|NCT02092909|594156561|FG001|Overall Study|Miscellaneous|1|||
164487926|NCT02092909|594156562|FG002|Overall Study|Miscellaneous|2|||
164487927|NCT02092909|594156563|FG003|Overall Study|Miscellaneous|1|||
164487928|NCT02865083|594156564|FG000|Overall Study|Early Termination|3|||
164487929|NCT02865083|594156565|FG001|Overall Study|Early Termination|1|||
164487930|NCT00096278|594156566|FG000|Overall Study|No follow-up data|15|||
164487931|NCT00096278|594156567|FG001|Overall Study|No follow-up data|18|||
164487932|NCT00096278|594156566|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
164487933|NCT00096278|594156567|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
164487934|NCT02105688|594156568|FG000|Part A: Double-Blind|Adverse Event|1|||
164487935|NCT02105688|594156569|FG001|Part A: Double-Blind|Adverse Event|0|||
164487936|NCT02105688|594156568|FG000|Part A: Double-Blind|Death|0|||
164487937|NCT02105688|594156569|FG001|Part A: Double-Blind|Death|1|||
164487938|NCT02105688|594156568|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
164487939|NCT02105688|594156569|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
164487940|NCT02105688|594156568|FG000|Part A: Double-Blind|Physician Decision|0|||
164487941|NCT02105688|594156569|FG001|Part A: Double-Blind|Physician Decision|1|||
164602090|NCT00717366|594562777|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
164487942|NCT02105688|594156568|FG000|Part A: Double-Blind|Status Unknown|0|||
164487943|NCT02105688|594156569|FG001|Part A: Double-Blind|Status Unknown|2|||
164487944|NCT02105688|594156568|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
164487945|NCT02105688|594156569|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
164487946|NCT02105688|594156568|FG000|Part B: Observational Follow-up|Death|2|||
164487947|NCT02105688|594156569|FG001|Part B: Observational Follow-up|Death|1|||
164487948|NCT02105688|594156568|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
164487949|NCT02105688|594156569|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
164487950|NCT02105688|594156568|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
164487951|NCT02105688|594156569|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
164487952|NCT02105688|594156568|FG000|Part B: Observational Follow-up|Physician Decision|3|||
164487953|NCT02105688|594156569|FG001|Part B: Observational Follow-up|Physician Decision|1|||
164602091|NCT00717366|594562776|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
164487954|NCT05104242|594156575|FG000|Overall Study|Withdrawal by Subject|1|||
164487955|NCT05104242|594156576|FG001|Overall Study|Withdrawal by Subject|5|||
164487956|NCT05104242|594156575|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
164487957|NCT05104242|594156576|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
164487958|NCT02469155|594156581|FG000|Overall Study|Adverse Event|6|||
164487959|NCT02469155|594156582|FG001|Overall Study|Adverse Event|0|||
164602092|NCT00717366|594562777|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
164602093|NCT00717366|594562776|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
164602094|NCT00717366|594562777|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
164602095|NCT00717366|594562776|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
164602096|NCT00717366|594562777|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
164602097|NCT02104804|594562780|FG000|Overall Study|Did not take study medication|0|||
164602098|NCT02104804|594562781|FG001|Overall Study|Did not take study medication|1|||
164602099|NCT02104804|594562780|FG000|Overall Study|Study specific discontinuation criteria|6|||
164602100|NCT02104804|594562781|FG001|Overall Study|Study specific discontinuation criteria|1|||
164602101|NCT02104804|594562780|FG000|Overall Study|Other listed|2|||
164602102|NCT02104804|594562781|FG001|Overall Study|Other listed|1|||
164602103|NCT02104804|594562780|FG000|Overall Study|Protocol Violation|0|||
164602104|NCT02104804|594562781|FG001|Overall Study|Protocol Violation|1|||
164602105|NCT02104804|594562780|FG000|Overall Study|Adverse Event|4|||
164602106|NCT02104804|594562781|FG001|Overall Study|Adverse Event|3|||
164487960|NCT02469155|594156583|FG002|Overall Study|Adverse Event|1|||
164487961|NCT02469155|594156584|FG003|Overall Study|Adverse Event|10|||
164487962|NCT02469155|594156581|FG000|Overall Study|Lack of Efficacy|13|||
164487963|NCT02469155|594156582|FG001|Overall Study|Lack of Efficacy|10|||
164487964|NCT02469155|594156583|FG002|Overall Study|Lack of Efficacy|10|||
164487965|NCT02469155|594156584|FG003|Overall Study|Lack of Efficacy|8|||
164487966|NCT02469155|594156581|FG000|Overall Study|Death|0|||
164487967|NCT02469155|594156582|FG001|Overall Study|Death|0|||
164487968|NCT02469155|594156583|FG002|Overall Study|Death|0|||
164487969|NCT02469155|594156584|FG003|Overall Study|Death|1|||
164487970|NCT02469155|594156581|FG000|Overall Study|Lost to Follow-up|5|||
164487971|NCT02469155|594156582|FG001|Overall Study|Lost to Follow-up|2|||
164487972|NCT02469155|594156583|FG002|Overall Study|Lost to Follow-up|7|||
164487973|NCT02469155|594156584|FG003|Overall Study|Lost to Follow-up|2|||
164487974|NCT02469155|594156581|FG000|Overall Study|Physician Decision|0|||
164487975|NCT02469155|594156582|FG001|Overall Study|Physician Decision|0|||
164487976|NCT02469155|594156583|FG002|Overall Study|Physician Decision|1|||
164487977|NCT02469155|594156584|FG003|Overall Study|Physician Decision|0|||
164487978|NCT02469155|594156581|FG000|Overall Study|Withdrawal by Subject|34|||
164487979|NCT02469155|594156582|FG001|Overall Study|Withdrawal by Subject|30|||
164487980|NCT02469155|594156583|FG002|Overall Study|Withdrawal by Subject|20|||
164487981|NCT02469155|594156584|FG003|Overall Study|Withdrawal by Subject|37|||
164487982|NCT02469155|594156581|FG000|Overall Study|Other|3|||
164487983|NCT02469155|594156582|FG001|Overall Study|Other|3|||
164487984|NCT02469155|594156583|FG002|Overall Study|Other|2|||
164487985|NCT02469155|594156584|FG003|Overall Study|Other|10|||
164487986|NCT02469155|594156581|FG000|Overall Study|Protocol Violation|0|||
164487987|NCT02469155|594156582|FG001|Overall Study|Protocol Violation|1|||
164487988|NCT02469155|594156583|FG002|Overall Study|Protocol Violation|0|||
164487989|NCT02469155|594156584|FG003|Overall Study|Protocol Violation|1|||
164487990|NCT02991118|594156585|FG000|Overall Study|Death|3|||
164487991|NCT02991118|594156586|FG001|Overall Study|Death|8|||
164487992|NCT02991118|594156585|FG000|Overall Study|Protocol Violation|0|||
164487993|NCT02991118|594156586|FG001|Overall Study|Protocol Violation|3|||
164487994|NCT02991118|594156585|FG000|Overall Study|Physician Decision|0|||
164487995|NCT02991118|594156586|FG001|Overall Study|Physician Decision|1|||
164487996|NCT02991118|594156585|FG000|Overall Study|Moved out of the country|0|||
164487997|NCT02991118|594156586|FG001|Overall Study|Moved out of the country|1|||
164487998|NCT02991118|594156585|FG000|Overall Study|Adverse Event|2|||
164487999|NCT02991118|594156586|FG001|Overall Study|Adverse Event|2|||
164488000|NCT02991118|594156585|FG000|Overall Study|Withdrawal by Subject|1|||
164488001|NCT02991118|594156586|FG001|Overall Study|Withdrawal by Subject|7|||
164602107|NCT02104804|594562780|FG000|Overall Study|Withdrawal by Subject|4|||
164714764|NCT01696058|594978708|FG000|Overall Study|Lost to Follow-up|2|||
164602108|NCT02104804|594562781|FG001|Overall Study|Withdrawal by Subject|12|||
164602109|NCT05084053|594564753|FG000|Epoch 1: Up to 6 months|Withdrawal by Subject|1|||
164602110|NCT05084053|594564754|FG001|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
164602111|NCT05084053|594564755|FG002|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
164602112|NCT05084053|594564756|FG003|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
164488002|NCT02991118|594156585|FG000|Overall Study|Could not attend study visits|0|||
164488003|NCT02991118|594156586|FG001|Overall Study|Could not attend study visits|1|||
164488004|NCT02991118|594156585|FG000|Overall Study|Lost to Follow-up|1|||
164488005|NCT02991118|594156586|FG001|Overall Study|Lost to Follow-up|9|||
164602113|NCT05084053|594564753|FG000|Epoch 1: Up to 6 months|Physician Decision|1|||
164488006|NCT02764320|594156593|FG000|Overall Study|Withdrawal by Subject|35|||
164488007|NCT02764320|594156594|FG001|Overall Study|Withdrawal by Subject|38|||
164488008|NCT02764320|594156593|FG000|Overall Study|Protocol Violation|11|||
164488009|NCT02764320|594156594|FG001|Overall Study|Protocol Violation|6|||
164488010|NCT02764320|594156593|FG000|Overall Study|Adverse Event|2|||
164488011|NCT02764320|594156594|FG001|Overall Study|Adverse Event|0|||
164602114|NCT05084053|594564754|FG001|Epoch 1: Up to 6 months|Physician Decision|0|||
164602115|NCT05084053|594564755|FG002|Epoch 1: Up to 6 months|Physician Decision|0|||
164602116|NCT05084053|594564756|FG003|Epoch 1: Up to 6 months|Physician Decision|0|||
164602117|NCT05084053|594564753|FG000|Epoch 2: Up to 6 months|Physician Decision|0|||
164602118|NCT05084053|594564754|FG001|Epoch 2: Up to 6 months|Physician Decision|0|||
164602119|NCT05084053|594564755|FG002|Epoch 2: Up to 6 months|Physician Decision|1|||
164602120|NCT05084053|594564756|FG003|Epoch 2: Up to 6 months|Physician Decision|0|||
164602121|NCT01179347|594564760|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
164602122|NCT01179347|594564761|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
164602123|NCT01179347|594564760|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
164602124|NCT01179347|594564761|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
164602125|NCT01179347|594564760|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
164602126|NCT01179347|594564761|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
164602127|NCT01179347|594564760|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
164602128|NCT01179347|594564761|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
164602129|NCT01179347|594564760|FG000|Double-blind Period (12 Weeks)|Other|2|||
164602130|NCT01179347|594564761|FG001|Double-blind Period (12 Weeks)|Other|4|||
164602131|NCT01179347|594564760|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
164602132|NCT01179347|594564761|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
164602133|NCT01179347|594564760|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
164602134|NCT01179347|594564761|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
164602135|NCT01179347|594564760|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
164602136|NCT01179347|594564761|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
164602137|NCT01179347|594564760|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
164602138|NCT01179347|594564761|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
164602139|NCT01179347|594564760|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
164602140|NCT01179347|594564761|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
164602141|NCT01179347|594564760|FG000|Open-label Period (12 Weeks)|Other|7|||
164602142|NCT01179347|594564761|FG001|Open-label Period (12 Weeks)|Other|4|||
164602143|NCT04092816|594564762|FG000|Overall Study|Lost to Follow-up|1|||
164602144|NCT04092816|594564763|FG001|Overall Study|Lost to Follow-up|2|||
164602145|NCT03833817|594564764|FG000|Overall Study|Withdrawal by Subject|3|||
164602146|NCT03833817|594564765|FG001|Overall Study|Withdrawal by Subject|3|||
164602147|NCT03833817|594564764|FG000|Overall Study|Lost to Follow-up|3|||
164602148|NCT03833817|594564765|FG001|Overall Study|Lost to Follow-up|3|||
164602149|NCT03363919|594564772|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
164602150|NCT03363919|594564773|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
164602151|NCT03363919|594564772|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
164602152|NCT03363919|594564773|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
164602153|NCT01975246|594564774|FG000|Overall Study|Adverse Event|2|||
164602154|NCT01975246|594564775|FG001|Overall Study|Adverse Event|1|||
164602155|NCT01975246|594564774|FG000|Overall Study|Lack of Efficacy|1|||
164602156|NCT01975246|594564775|FG001|Overall Study|Lack of Efficacy|0|||
164602157|NCT01975246|594564774|FG000|Overall Study|Protocol Violation|1|||
164602158|NCT01975246|594564775|FG001|Overall Study|Protocol Violation|0|||
164602159|NCT01975246|594564774|FG000|Overall Study|Other than stated|0|||
164602160|NCT01975246|594564775|FG001|Overall Study|Other than stated|1|||
164602161|NCT00574119|594564776|FG000|Overall Study|Adverse Event|1|||
164488012|NCT02764320|594156593|FG000|Overall Study|Health Issues unable to continue|2|||
164488013|NCT02764320|594156594|FG001|Overall Study|Health Issues unable to continue|0|||
164488014|NCT02764320|594156593|FG000|Overall Study|Did not meet inclusion criteria|1|||
164488015|NCT02764320|594156594|FG001|Overall Study|Did not meet inclusion criteria|0|||
164488016|NCT02764320|594156593|FG000|Overall Study|Subject moved|0|||
164488017|NCT02764320|594156594|FG001|Overall Study|Subject moved|2|||
164488018|NCT02764320|594156593|FG000|Overall Study|Overused medication unavailable|0|||
164488019|NCT02764320|594156594|FG001|Overall Study|Overused medication unavailable|1|||
164488020|NCT02764320|594156593|FG000|Overall Study|Seeking care outside site|0|||
164488021|NCT02764320|594156594|FG001|Overall Study|Seeking care outside site|1|||
164488022|NCT02764320|594156593|FG000|Overall Study|Technology barriers|0|||
164488023|NCT02764320|594156594|FG001|Overall Study|Technology barriers|1|||
164488024|NCT04765046|594156595|FG000|Overall Study|Screen Failure|2|||
164602162|NCT00574119|594564776|FG000|Overall Study|Protocol Violation|1|||
164602163|NCT00574119|594564776|FG000|Overall Study|Withdrawal by Subject|1|||
164602164|NCT00574119|594564776|FG000|Overall Study|Physician Decision|1|||
164602165|NCT03287245|594564777|FG000|Overall Study|Study terminated by sponsor|3|||
164488025|NCT04765046|594156595|FG000|Overall Study|Withdrawal by Subject|4|||
164488026|NCT04765046|594156595|FG000|Overall Study|Physician Decision|4|||
164602166|NCT03287245|594564778|FG001|Overall Study|Study terminated by sponsor|0|||
164602167|NCT03287245|594564779|FG002|Overall Study|Study terminated by sponsor|3|||
164602168|NCT03287245|594564780|FG003|Overall Study|Study terminated by sponsor|1|||
164602169|NCT03287245|594564777|FG000|Overall Study|Adverse Event|1|||
164602170|NCT03287245|594564778|FG001|Overall Study|Adverse Event|0|||
164602171|NCT03287245|594564779|FG002|Overall Study|Adverse Event|0|||
164602172|NCT03287245|594564780|FG003|Overall Study|Adverse Event|0|||
164714765|NCT01696058|594978709|FG001|Overall Study|Lost to Follow-up|5|||
164714766|NCT01696058|594978708|FG000|Overall Study|Withdrawal by Subject|4|||
164714767|NCT01696058|594978709|FG001|Overall Study|Withdrawal by Subject|6|||
164488027|NCT04765046|594156595|FG000|Overall Study|Surgery Cancelled|8|||
164488028|NCT02959866|594156600|FG000|Overall Study|Withdrawal by Subject|1|||
164488029|NCT03150589|594156601|FG000|Overall Study|Withdrawal by Subject|16|||
164488030|NCT03150589|594156602|FG001|Overall Study|Withdrawal by Subject|9|||
164488031|NCT03150589|594156601|FG000|Overall Study|Adverse Event|7|||
164488032|NCT03150589|594156602|FG001|Overall Study|Adverse Event|6|||
164488033|NCT03150589|594156601|FG000|Overall Study|Protocol Violation|4|||
164488034|NCT03150589|594156602|FG001|Overall Study|Protocol Violation|3|||
164488035|NCT03150589|594156601|FG000|Overall Study|Lost to Follow-up|3|||
164488036|NCT03150589|594156602|FG001|Overall Study|Lost to Follow-up|3|||
164488037|NCT03150589|594156601|FG000|Overall Study|Death|2|||
164488038|NCT03150589|594156602|FG001|Overall Study|Death|3|||
164488039|NCT03150589|594156601|FG000|Overall Study|IP non-compliance and other reasons|12|||
164488040|NCT03150589|594156602|FG001|Overall Study|IP non-compliance and other reasons|3|||
164488041|NCT01405508|594156603|FG000|Overall Study|AE, non-serious non-fatal|1|||
164488042|NCT01405508|594156604|FG001|Overall Study|AE, non-serious non-fatal|1|||
164488043|NCT01405508|594156605|FG002|Overall Study|AE, non-serious non-fatal|0|||
164488044|NCT01405508|594156606|FG003|Overall Study|AE, non-serious non-fatal|0|||
164488045|NCT03541369|594156610|FG000|Overall Study|Death|0|||
164488046|NCT03541369|594156611|FG001|Overall Study|Death|0|||
164488047|NCT03541369|594156612|FG002|Overall Study|Death|0|||
164488048|NCT03541369|594156613|FG003|Overall Study|Death|0|||
164488049|NCT03541369|594156614|FG004|Overall Study|Death|1|||
164488050|NCT03541369|594156615|FG005|Overall Study|Death|1|||
164488051|NCT03541369|594156616|FG006|Overall Study|Death|0|||
164488052|NCT03541369|594156617|FG007|Overall Study|Death|2|||
164488053|NCT03541369|594156618|FG008|Overall Study|Death|1|||
164488054|NCT03541369|594156619|FG009|Overall Study|Death|2|||
164488055|NCT03541369|594156620|FG010|Overall Study|Death|1|||
164488056|NCT03541369|594156621|FG011|Overall Study|Death|0|||
164488057|NCT03541369|594156622|FG012|Overall Study|Death|2|||
164488058|NCT03541369|594156623|FG013|Overall Study|Death|1|||
164488059|NCT03541369|594156624|FG014|Overall Study|Death|1|||
164488060|NCT03541369|594156625|FG015|Overall Study|Death|1|||
164488061|NCT03541369|594156626|FG016|Overall Study|Death|0|||
164488062|NCT03541369|594156627|FG017|Overall Study|Death|1|||
164488063|NCT03541369|594156610|FG000|Overall Study|Decision by sponsor|0|||
164488064|NCT03541369|594156611|FG001|Overall Study|Decision by sponsor|0|||
164488065|NCT03541369|594156612|FG002|Overall Study|Decision by sponsor|0|||
164488066|NCT03541369|594156613|FG003|Overall Study|Decision by sponsor|1|||
164488067|NCT03541369|594156614|FG004|Overall Study|Decision by sponsor|0|||
164488068|NCT03541369|594156615|FG005|Overall Study|Decision by sponsor|2|||
164488069|NCT03541369|594156616|FG006|Overall Study|Decision by sponsor|0|||
164488070|NCT03541369|594156617|FG007|Overall Study|Decision by sponsor|1|||
164488071|NCT03541369|594156618|FG008|Overall Study|Decision by sponsor|2|||
164488072|NCT03541369|594156619|FG009|Overall Study|Decision by sponsor|0|||
164488073|NCT03541369|594156620|FG010|Overall Study|Decision by sponsor|0|||
164488074|NCT03541369|594156621|FG011|Overall Study|Decision by sponsor|0|||
164488075|NCT03541369|594156622|FG012|Overall Study|Decision by sponsor|2|||
164488076|NCT03541369|594156623|FG013|Overall Study|Decision by sponsor|2|||
164488077|NCT03541369|594156624|FG014|Overall Study|Decision by sponsor|0|||
164488078|NCT03541369|594156625|FG015|Overall Study|Decision by sponsor|1|||
164488079|NCT03541369|594156626|FG016|Overall Study|Decision by sponsor|1|||
164488080|NCT03541369|594156627|FG017|Overall Study|Decision by sponsor|1|||
164488081|NCT03541369|594156610|FG000|Overall Study|Withdrawal by Subject|0|||
164488082|NCT03541369|594156611|FG001|Overall Study|Withdrawal by Subject|0|||
164488083|NCT03541369|594156612|FG002|Overall Study|Withdrawal by Subject|0|||
164602173|NCT03287245|594564777|FG000|Overall Study|Withdrawal by Subject|8|||
164602174|NCT03287245|594564778|FG001|Overall Study|Withdrawal by Subject|3|||
164602175|NCT03287245|594564779|FG002|Overall Study|Withdrawal by Subject|3|||
164602176|NCT03287245|594564780|FG003|Overall Study|Withdrawal by Subject|0|||
164602177|NCT03287245|594564777|FG000|Overall Study|Physician Decision|3|||
164602178|NCT03287245|594564778|FG001|Overall Study|Physician Decision|2|||
164602179|NCT03287245|594564779|FG002|Overall Study|Physician Decision|0|||
164488084|NCT03541369|594156613|FG003|Overall Study|Withdrawal by Subject|0|||
164488085|NCT03541369|594156614|FG004|Overall Study|Withdrawal by Subject|0|||
164488086|NCT03541369|594156615|FG005|Overall Study|Withdrawal by Subject|0|||
164488087|NCT03541369|594156616|FG006|Overall Study|Withdrawal by Subject|1|||
164488088|NCT03541369|594156617|FG007|Overall Study|Withdrawal by Subject|0|||
164488089|NCT03541369|594156618|FG008|Overall Study|Withdrawal by Subject|0|||
164488090|NCT03541369|594156619|FG009|Overall Study|Withdrawal by Subject|0|||
164488091|NCT03541369|594156620|FG010|Overall Study|Withdrawal by Subject|0|||
164488092|NCT03541369|594156621|FG011|Overall Study|Withdrawal by Subject|1|||
164488093|NCT03541369|594156622|FG012|Overall Study|Withdrawal by Subject|0|||
164488094|NCT03541369|594156623|FG013|Overall Study|Withdrawal by Subject|0|||
164488095|NCT03541369|594156624|FG014|Overall Study|Withdrawal by Subject|3|||
164488096|NCT03541369|594156625|FG015|Overall Study|Withdrawal by Subject|0|||
164488097|NCT03541369|594156626|FG016|Overall Study|Withdrawal by Subject|4|||
164488098|NCT03541369|594156627|FG017|Overall Study|Withdrawal by Subject|2|||
164488099|NCT03541369|594156610|FG000|Overall Study|Lost to Follow-up|0|||
164602180|NCT03287245|594564780|FG003|Overall Study|Physician Decision|0|||
164488100|NCT03541369|594156611|FG001|Overall Study|Lost to Follow-up|0|||
164488101|NCT03541369|594156612|FG002|Overall Study|Lost to Follow-up|0|||
164488102|NCT03541369|594156613|FG003|Overall Study|Lost to Follow-up|0|||
164488103|NCT03541369|594156614|FG004|Overall Study|Lost to Follow-up|1|||
164488104|NCT03541369|594156615|FG005|Overall Study|Lost to Follow-up|0|||
164488105|NCT03541369|594156616|FG006|Overall Study|Lost to Follow-up|0|||
164488106|NCT03541369|594156617|FG007|Overall Study|Lost to Follow-up|0|||
164488107|NCT03541369|594156618|FG008|Overall Study|Lost to Follow-up|1|||
164488108|NCT03541369|594156619|FG009|Overall Study|Lost to Follow-up|0|||
164488109|NCT03541369|594156620|FG010|Overall Study|Lost to Follow-up|0|||
164488110|NCT03541369|594156621|FG011|Overall Study|Lost to Follow-up|0|||
164488111|NCT03541369|594156622|FG012|Overall Study|Lost to Follow-up|1|||
164488112|NCT03541369|594156623|FG013|Overall Study|Lost to Follow-up|0|||
164488113|NCT03541369|594156624|FG014|Overall Study|Lost to Follow-up|0|||
164488114|NCT03541369|594156625|FG015|Overall Study|Lost to Follow-up|0|||
164488115|NCT03541369|594156626|FG016|Overall Study|Lost to Follow-up|0|||
164488116|NCT03541369|594156627|FG017|Overall Study|Lost to Follow-up|0|||
164488117|NCT02189759|594156636|FG000|Overall Study|Lost to Follow-up|0|||
164488118|NCT02189759|594156637|FG001|Overall Study|Lost to Follow-up|0|||
164488119|NCT02189759|594156638|FG002|Overall Study|Lost to Follow-up|2|||
164488120|NCT02189759|594156639|FG003|Overall Study|Lost to Follow-up|5|||
164488121|NCT03032198|594156640|FG000|Overall Study|Screen Fail|1|||
164488122|NCT02470806|594156641|FG000|Overall Study|Lost to Follow-up|1|||
164488123|NCT02470806|594156642|FG001|Overall Study|Lost to Follow-up|1|||
164488124|NCT02470806|594156641|FG000|Overall Study|Adverse Event|5|||
164488125|NCT02470806|594156642|FG001|Overall Study|Adverse Event|2|||
164488126|NCT02470806|594156641|FG000|Overall Study|Protocol Violation|4|||
164488127|NCT02470806|594156642|FG001|Overall Study|Protocol Violation|11|||
164488128|NCT02470806|594156641|FG000|Overall Study|Physician Decision|0|||
164488129|NCT02470806|594156642|FG001|Overall Study|Physician Decision|3|||
164488130|NCT02470806|594156641|FG000|Overall Study|Withdrawal by Subject|3|||
164488131|NCT02470806|594156642|FG001|Overall Study|Withdrawal by Subject|10|||
164488132|NCT02470806|594156641|FG000|Overall Study|Lack of Efficacy|5|||
164488133|NCT02470806|594156642|FG001|Overall Study|Lack of Efficacy|15|||
164488134|NCT01147471|594156643|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
164488135|NCT01147471|594156644|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
164488136|NCT01147471|594156643|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
164488137|NCT01147471|594156644|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
164488138|NCT01147471|594156643|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
164488139|NCT01147471|594156644|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
164488140|NCT01147471|594156643|FG000|3 Month Follow Up|Lost to Follow-up|1|||
164488141|NCT01147471|594156644|FG001|3 Month Follow Up|Lost to Follow-up|1|||
164488142|NCT01147471|594156643|FG000|3 Month Follow Up|Physician Decision|0|||
164488143|NCT01147471|594156644|FG001|3 Month Follow Up|Physician Decision|1|||
164488144|NCT01147471|594156643|FG000|6 Month Follow Up|Lost to Follow-up|4|||
164488145|NCT01147471|594156644|FG001|6 Month Follow Up|Lost to Follow-up|2|||
164488146|NCT00866619|594156645|FG000|Overall Study|Adverse Event|112|||
164488147|NCT00866619|594156646|FG001|Overall Study|Adverse Event|106|||
164488148|NCT00866619|594156647|FG002|Overall Study|Adverse Event|47|||
164488149|NCT00866619|594156648|FG003|Overall Study|Adverse Event|44|||
164488150|NCT00866619|594156645|FG000|Overall Study|Protocol Violation|2|||
164488151|NCT00866619|594156646|FG001|Overall Study|Protocol Violation|39|||
164488152|NCT00866619|594156647|FG002|Overall Study|Protocol Violation|2|||
164488153|NCT00866619|594156648|FG003|Overall Study|Protocol Violation|17|||
164488154|NCT00866619|594156645|FG000|Overall Study|Withdrawal by Subject|587|||
164488155|NCT00866619|594156646|FG001|Overall Study|Withdrawal by Subject|295|||
164488156|NCT00866619|594156647|FG002|Overall Study|Withdrawal by Subject|272|||
164488157|NCT00866619|594156648|FG003|Overall Study|Withdrawal by Subject|144|||
164488158|NCT00866619|594156645|FG000|Overall Study|Lost to Follow-up|1145|||
164488159|NCT00866619|594156646|FG001|Overall Study|Lost to Follow-up|830|||
164488160|NCT00866619|594156647|FG002|Overall Study|Lost to Follow-up|568|||
164488161|NCT00866619|594156648|FG003|Overall Study|Lost to Follow-up|425|||
164488162|NCT01307800|594156655|FG000|Overall Study|Adverse Event|9|||
164488163|NCT01307800|594156656|FG001|Overall Study|Adverse Event|8|||
164488164|NCT01307800|594156657|FG002|Overall Study|Adverse Event|10|||
164488165|NCT01307800|594156658|FG003|Overall Study|Adverse Event|14|||
164488166|NCT01307800|594156655|FG000|Overall Study|Entry Criteria Not Met|0|||
164488167|NCT01307800|594156656|FG001|Overall Study|Entry Criteria Not Met|0|||
164488168|NCT01307800|594156657|FG002|Overall Study|Entry Criteria Not Met|0|||
164488169|NCT01307800|594156658|FG003|Overall Study|Entry Criteria Not Met|2|||
164488170|NCT01307800|594156655|FG000|Overall Study|Lost to Follow-up|5|||
164488171|NCT01307800|594156656|FG001|Overall Study|Lost to Follow-up|6|||
164488172|NCT01307800|594156657|FG002|Overall Study|Lost to Follow-up|2|||
164488173|NCT01307800|594156658|FG003|Overall Study|Lost to Follow-up|8|||
164488174|NCT01307800|594156655|FG000|Overall Study|Perceived Lack of Efficacy|24|||
164488175|NCT01307800|594156656|FG001|Overall Study|Perceived Lack of Efficacy|23|||
164488176|NCT01307800|594156657|FG002|Overall Study|Perceived Lack of Efficacy|20|||
164488177|NCT01307800|594156658|FG003|Overall Study|Perceived Lack of Efficacy|33|||
164602181|NCT02862548|594564781|FG000|Randomized Phase (Up to Week 48)|Death|0|||
164602182|NCT02862548|594564782|FG001|Randomized Phase (Up to Week 48)|Death|1|||
164602183|NCT02862548|594564781|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
164602184|NCT02862548|594564782|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
164602185|NCT02862548|594564781|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
164602186|NCT02862548|594564782|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
164602187|NCT02862548|594564781|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
164602188|NCT02862548|594564782|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
164602189|NCT00880763|594564783|FG000|Extension Period (Part 2)|Adverse Event|0|||
164602190|NCT00880763|594564784|FG001|Extension Period (Part 2)|Adverse Event|0|||
164602191|NCT00880763|594564785|FG002|Extension Period (Part 2)|Adverse Event|1|||
164602192|NCT00880763|594564786|FG003|Extension Period (Part 2)|Adverse Event|1|||
164602193|NCT00880763|594564783|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
164602194|NCT00880763|594564784|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
164602195|NCT00880763|594564785|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
164602196|NCT00880763|594564786|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
164602197|NCT00880763|594564783|FG000|Extension Period (Part 2)|Physician Decision|0|||
164602198|NCT00880763|594564784|FG001|Extension Period (Part 2)|Physician Decision|1|||
164602199|NCT00880763|594564785|FG002|Extension Period (Part 2)|Physician Decision|1|||
164602200|NCT00880763|594564786|FG003|Extension Period (Part 2)|Physician Decision|0|||
164602201|NCT00880763|594564783|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
164602202|NCT00880763|594564784|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
164602203|NCT00880763|594564785|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
164602204|NCT00880763|594564786|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
164602205|NCT00600028|594564791|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
164602206|NCT00600028|594564792|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
164602207|NCT00600028|594564791|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
164602208|NCT00600028|594564792|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
164602209|NCT00600028|594564791|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
164602210|NCT00600028|594564792|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
164602211|NCT01830816|594564793|FG000|Overall Study|Progressive Disease|12|||
164602212|NCT01830816|594564794|FG001|Overall Study|Progressive Disease|7|||
164602213|NCT01830816|594564795|FG002|Overall Study|Progressive Disease|7|||
164602214|NCT01830816|594564793|FG000|Overall Study|Adverse Event|3|||
164602215|NCT01830816|594564794|FG001|Overall Study|Adverse Event|4|||
164602216|NCT01830816|594564795|FG002|Overall Study|Adverse Event|0|||
164602217|NCT01830816|594564793|FG000|Overall Study|Study Terminated by Sponsor|1|||
164602218|NCT01830816|594564794|FG001|Overall Study|Study Terminated by Sponsor|1|||
164602219|NCT01830816|594564795|FG002|Overall Study|Study Terminated by Sponsor|0|||
164602220|NCT01830816|594564793|FG000|Overall Study|Withdrawal by Subject|1|||
164602221|NCT01830816|594564794|FG001|Overall Study|Withdrawal by Subject|1|||
164602222|NCT01830816|594564795|FG002|Overall Study|Withdrawal by Subject|0|||
164602223|NCT01830816|594564793|FG000|Overall Study|Lost to Follow-up|0|||
164602224|NCT01830816|594564794|FG001|Overall Study|Lost to Follow-up|1|||
164602225|NCT01830816|594564795|FG002|Overall Study|Lost to Follow-up|0|||
164602226|NCT01830816|594564793|FG000|Overall Study|Symptomatic Deterioration|1|||
164602227|NCT01830816|594564794|FG001|Overall Study|Symptomatic Deterioration|0|||
164602228|NCT01830816|594564795|FG002|Overall Study|Symptomatic Deterioration|0|||
164602229|NCT01830816|594564793|FG000|Overall Study|Reason not Specified|2|||
164602230|NCT01830816|594564794|FG001|Overall Study|Reason not Specified|0|||
164602231|NCT01830816|594564795|FG002|Overall Study|Reason not Specified|0|||
164602232|NCT01754922|594564801|FG000|Overall Study|Adverse Event|0|||
164602233|NCT01754922|594564802|FG001|Overall Study|Adverse Event|1|||
164602234|NCT01885078|594564805|FG000|Treatment Period|Adverse Event|52|||
164602235|NCT01885078|594564806|FG001|Treatment Period|Adverse Event|136|||
164602236|NCT01885078|594564807|FG002|Treatment Period|Adverse Event|30|||
164602237|NCT01885078|594564808|FG003|Treatment Period|Adverse Event|73|||
164602238|NCT01885078|594564809|FG004|Treatment Period|Adverse Event|17|||
164602239|NCT01885078|594564810|FG005|Treatment Period|Adverse Event|72|||
164602240|NCT01885078|594564811|FG006|Treatment Period|Adverse Event|24|||
164602241|NCT01885078|594564812|FG007|Treatment Period|Adverse Event|5|||
164602242|NCT01885078|594564813|FG008|Treatment Period|Adverse Event|0|||
164602243|NCT01885078|594564814|FG009|Treatment Period|Adverse Event|0|||
164602244|NCT01885078|594564805|FG000|Treatment Period|Death|13|||
164602245|NCT01885078|594564806|FG001|Treatment Period|Death|33|||
164602246|NCT01885078|594564807|FG002|Treatment Period|Death|5|||
164602247|NCT01885078|594564808|FG003|Treatment Period|Death|9|||
164602248|NCT01885078|594564809|FG004|Treatment Period|Death|2|||
164602249|NCT01885078|594564810|FG005|Treatment Period|Death|10|||
164602250|NCT01885078|594564811|FG006|Treatment Period|Death|3|||
164602251|NCT01885078|594564812|FG007|Treatment Period|Death|2|||
164602252|NCT01885078|594564813|FG008|Treatment Period|Death|0|||
164602253|NCT01885078|594564814|FG009|Treatment Period|Death|0|||
164602254|NCT01885078|594564805|FG000|Treatment Period|Lack of Efficacy|12|||
164602255|NCT01885078|594564806|FG001|Treatment Period|Lack of Efficacy|33|||
164602256|NCT01885078|594564807|FG002|Treatment Period|Lack of Efficacy|10|||
164602257|NCT01885078|594564808|FG003|Treatment Period|Lack of Efficacy|23|||
164714768|NCT01696058|594978708|FG000|Overall Study|Other reason prematurely discontinued|5|||
164488178|NCT01307800|594156655|FG000|Overall Study|Protocol Violation|0|||
164488179|NCT01307800|594156656|FG001|Overall Study|Protocol Violation|3|||
164488180|NCT01307800|594156657|FG002|Overall Study|Protocol Violation|4|||
164488181|NCT01307800|594156658|FG003|Overall Study|Protocol Violation|5|||
164488182|NCT01307800|594156655|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
164488183|NCT01307800|594156656|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
164488184|NCT01307800|594156657|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
164488185|NCT01307800|594156658|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
164488186|NCT01307800|594156655|FG000|Overall Study|Sponsor Decision|6|||
164488187|NCT01307800|594156656|FG001|Overall Study|Sponsor Decision|9|||
164488188|NCT01307800|594156657|FG002|Overall Study|Sponsor Decision|12|||
164488189|NCT01307800|594156658|FG003|Overall Study|Sponsor Decision|28|||
164488190|NCT01307800|594156655|FG000|Overall Study|Withdrawal by Subject|10|||
164488191|NCT01307800|594156656|FG001|Overall Study|Withdrawal by Subject|11|||
164488192|NCT01307800|594156657|FG002|Overall Study|Withdrawal by Subject|8|||
164488193|NCT01307800|594156658|FG003|Overall Study|Withdrawal by Subject|15|||
164488194|NCT01307800|594156655|FG000|Overall Study|Participant Moved|0|||
164488195|NCT01307800|594156656|FG001|Overall Study|Participant Moved|2|||
164488196|NCT01307800|594156657|FG002|Overall Study|Participant Moved|1|||
164488197|NCT01307800|594156658|FG003|Overall Study|Participant Moved|3|||
164488198|NCT02892019|594156659|FG000|Overall Study|randomized but not treated|0|||
164488199|NCT02892019|594156660|FG001|Overall Study|randomized but not treated|1|||
164488200|NCT02892019|594156659|FG000|Overall Study|Withdrawal by Subject|0|||
164488201|NCT02892019|594156660|FG001|Overall Study|Withdrawal by Subject|1|||
164488202|NCT02892019|594156659|FG000|Overall Study|Adverse Event|1|||
164488203|NCT02892019|594156660|FG001|Overall Study|Adverse Event|1|||
164488204|NCT00689351|594156661|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
164488205|NCT00689351|594156662|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
164488206|NCT00689351|594156661|FG000|Infant Series of Dosing|Adverse Event|1|||
164488207|NCT00689351|594156662|FG001|Infant Series of Dosing|Adverse Event|0|||
164488208|NCT00689351|594156661|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
164488209|NCT00689351|594156662|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
164488210|NCT00689351|594156661|FG000|After Infant Series|Parent/legal guardian request|1|||
164488211|NCT00689351|594156662|FG001|After Infant Series|Parent/legal guardian request|0|||
164488212|NCT01766206|594156663|FG000|Overall Study|Withdrawal by Subject|22|||
164488213|NCT01766206|594156663|FG000|Overall Study|Lost to Follow-up|10|||
164488214|NCT01766206|594156663|FG000|Overall Study|Inappropriate enrollment|18|||
164488215|NCT01766206|594156663|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
164488216|NCT01662505|594156664|FG000|Overall Study|Progressive disease|6|||
164488217|NCT01662505|594156665|FG001|Overall Study|Progressive disease|1|||
164488218|NCT01662505|594156666|FG002|Overall Study|Progressive disease|5|||
164488219|NCT01662505|594156664|FG000|Overall Study|Refused cont. medication|0|||
164488220|NCT01662505|594156665|FG001|Overall Study|Refused cont. medication|0|||
164488221|NCT01662505|594156666|FG002|Overall Study|Refused cont. medication|1|||
164488222|NCT01662505|594156664|FG000|Overall Study|Not specified above|1|||
164488223|NCT01662505|594156665|FG001|Overall Study|Not specified above|3|||
164488224|NCT01662505|594156666|FG002|Overall Study|Not specified above|2|||
164488225|NCT01313663|594156667|FG000|Overall Study|Study Closed/Terminated|2|||
164488226|NCT01313663|594156668|FG001|Overall Study|Study Closed/Terminated|4|||
164488227|NCT01313663|594156667|FG000|Overall Study|Lost to Follow-up|0|||
164488228|NCT01313663|594156668|FG001|Overall Study|Lost to Follow-up|1|||
164488229|NCT01313663|594156667|FG000|Overall Study|Physician Decision|0|||
164488230|NCT01313663|594156668|FG001|Overall Study|Physician Decision|2|||
164488231|NCT01313663|594156667|FG000|Overall Study|Withdrawal by Subject|2|||
164488232|NCT01313663|594156668|FG001|Overall Study|Withdrawal by Subject|1|||
164488233|NCT01229176|594156669|FG000|Overall Study|Withdrawal by Subject|0|||
164488234|NCT01229176|594156670|FG001|Overall Study|Withdrawal by Subject|0|||
164488235|NCT01229176|594156671|FG002|Overall Study|Withdrawal by Subject|0|||
164488236|NCT01229176|594156672|FG003|Overall Study|Withdrawal by Subject|1|||
164488237|NCT01229176|594156673|FG004|Overall Study|Withdrawal by Subject|1|||
164488238|NCT01229176|594156674|FG005|Overall Study|Withdrawal by Subject|1|||
164488239|NCT01229176|594156675|FG006|Overall Study|Withdrawal by Subject|0|||
164488240|NCT01229176|594156676|FG007|Overall Study|Withdrawal by Subject|1|||
164488241|NCT01229176|594156669|FG000|Overall Study|Lost to Follow-up|0|||
164488242|NCT01229176|594156670|FG001|Overall Study|Lost to Follow-up|3|||
164488243|NCT01229176|594156671|FG002|Overall Study|Lost to Follow-up|0|||
164488244|NCT01229176|594156672|FG003|Overall Study|Lost to Follow-up|0|||
164488245|NCT01229176|594156673|FG004|Overall Study|Lost to Follow-up|1|||
164488246|NCT01229176|594156674|FG005|Overall Study|Lost to Follow-up|1|||
164488247|NCT01229176|594156675|FG006|Overall Study|Lost to Follow-up|0|||
164488248|NCT01229176|594156676|FG007|Overall Study|Lost to Follow-up|2|||
164488249|NCT03890484|594156680|FG000|Overall Study|Lost to Follow-up|1|||
164488250|NCT03890484|594156681|FG001|Overall Study|Lost to Follow-up|1|||
164488251|NCT00518206|594156684|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
164488252|NCT00518206|594156685|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
164488253|NCT00518206|594156684|FG000|Overall Study|Withdrawal by Subject|2|||
164488254|NCT00518206|594156685|FG001|Overall Study|Withdrawal by Subject|0|||
164488255|NCT00518206|594156684|FG000|Overall Study|Drug Supply Issue|1|||
164488256|NCT00518206|594156685|FG001|Overall Study|Drug Supply Issue|0|||
164488257|NCT00518206|594156684|FG000|Overall Study|Reason Unknown|1|||
164488258|NCT00518206|594156685|FG001|Overall Study|Reason Unknown|0|||
164488259|NCT00518206|594156684|FG000|Overall Study|Completion Status Unknown|1|||
164488260|NCT00518206|594156685|FG001|Overall Study|Completion Status Unknown|0|||
164488261|NCT03075878|594156686|FG000|Overall Study|Physician Decision|1|||
164488262|NCT02188459|594156687|FG000|Overall Study|Lost to Follow-up|3|||
164488263|NCT02188459|594156688|FG001|Overall Study|Lost to Follow-up|4|||
164488264|NCT02188459|594156687|FG000|Overall Study|Early Termination|0|||
164488265|NCT02188459|594156688|FG001|Overall Study|Early Termination|3|||
164488266|NCT02367794|594156693|FG000|Overall Study|Death|252|||
164488267|NCT02367794|594156694|FG001|Overall Study|Death|245|||
164488268|NCT02367794|594156695|FG002|Overall Study|Death|243|||
164488269|NCT02367794|594156693|FG000|Overall Study|Lost to Follow-up|1|||
164488270|NCT02367794|594156694|FG001|Overall Study|Lost to Follow-up|2|||
164488271|NCT02367794|594156695|FG002|Overall Study|Lost to Follow-up|2|||
164488272|NCT02367794|594156693|FG000|Overall Study|Physician Decision|0|||
164488273|NCT02367794|594156694|FG001|Overall Study|Physician Decision|5|||
164488274|NCT02367794|594156695|FG002|Overall Study|Physician Decision|3|||
164488275|NCT02367794|594156693|FG000|Overall Study|Protocol Violation|1|||
164488276|NCT02367794|594156694|FG001|Overall Study|Protocol Violation|0|||
164488277|NCT02367794|594156695|FG002|Overall Study|Protocol Violation|1|||
164488278|NCT02367794|594156693|FG000|Overall Study|Withdrawal by Subject|25|||
164488279|NCT02367794|594156694|FG001|Overall Study|Withdrawal by Subject|12|||
164488280|NCT02367794|594156695|FG002|Overall Study|Withdrawal by Subject|20|||
164488281|NCT02367794|594156693|FG000|Overall Study|Brain metastasis|1|||
164488282|NCT02367794|594156694|FG001|Overall Study|Brain metastasis|0|||
164488283|NCT02367794|594156695|FG002|Overall Study|Brain metastasis|0|||
164488284|NCT02367794|594156693|FG000|Overall Study|Randomized in error|0|||
164488285|NCT02367794|594156694|FG001|Overall Study|Randomized in error|0|||
164488286|NCT02367794|594156695|FG002|Overall Study|Randomized in error|1|||
164488287|NCT02367794|594156693|FG000|Overall Study|Patient unable to receive carboplatin|0|||
164488288|NCT02367794|594156694|FG001|Overall Study|Patient unable to receive carboplatin|0|||
164488289|NCT02367794|594156695|FG002|Overall Study|Patient unable to receive carboplatin|1|||
164488290|NCT02367794|594156693|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
164488291|NCT02367794|594156694|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
164488292|NCT02367794|594156695|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
164488293|NCT02367794|594156693|FG000|Overall Study|Adverse Event|0|||
164488294|NCT02367794|594156694|FG001|Overall Study|Adverse Event|0|||
164488295|NCT02367794|594156695|FG002|Overall Study|Adverse Event|2|||
164488296|NCT02367794|594156693|FG000|Overall Study|Study Terminated By Sponsor|0|||
164488297|NCT02367794|594156694|FG001|Overall Study|Study Terminated By Sponsor|1|||
164488298|NCT02367794|594156695|FG002|Overall Study|Study Terminated By Sponsor|1|||
164602258|NCT01885078|594564809|FG004|Treatment Period|Lack of Efficacy|24|||
164602259|NCT01885078|594564810|FG005|Treatment Period|Lack of Efficacy|58|||
164602260|NCT01885078|594564811|FG006|Treatment Period|Lack of Efficacy|9|||
164602261|NCT01885078|594564812|FG007|Treatment Period|Lack of Efficacy|5|||
164602262|NCT01885078|594564813|FG008|Treatment Period|Lack of Efficacy|0|||
164602263|NCT01885078|594564814|FG009|Treatment Period|Lack of Efficacy|0|||
164602264|NCT01885078|594564805|FG000|Treatment Period|Lost to Follow-up|16|||
164602265|NCT01885078|594564806|FG001|Treatment Period|Lost to Follow-up|19|||
164602266|NCT01885078|594564807|FG002|Treatment Period|Lost to Follow-up|7|||
164602267|NCT01885078|594564808|FG003|Treatment Period|Lost to Follow-up|9|||
164602268|NCT01885078|594564809|FG004|Treatment Period|Lost to Follow-up|2|||
164602269|NCT01885078|594564810|FG005|Treatment Period|Lost to Follow-up|8|||
164602270|NCT01885078|594564811|FG006|Treatment Period|Lost to Follow-up|2|||
164602271|NCT01885078|594564812|FG007|Treatment Period|Lost to Follow-up|0|||
164488299|NCT02367794|594156693|FG000|Overall Study|Moved to Roll-Over Study|0|||
164488300|NCT02367794|594156694|FG001|Overall Study|Moved to Roll-Over Study|15|||
164488301|NCT02367794|594156695|FG002|Overall Study|Moved to Roll-Over Study|13|||
164488302|NCT02367794|594156693|FG000|Overall Study|Sponsor Request|60|||
164488303|NCT02367794|594156694|FG001|Overall Study|Sponsor Request|57|||
164488304|NCT02367794|594156695|FG002|Overall Study|Sponsor Request|45|||
164488305|NCT02367794|594156693|FG000|Overall Study|Moved into PTAP Study|0|||
164488306|NCT02367794|594156694|FG001|Overall Study|Moved into PTAP Study|2|||
164488307|NCT02367794|594156695|FG002|Overall Study|Moved into PTAP Study|3|||
164488308|NCT02367794|594156693|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
164488309|NCT02367794|594156694|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
164488310|NCT02367794|594156695|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
164488311|NCT02367794|594156693|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
164488312|NCT02367794|594156694|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
164488313|NCT02367794|594156695|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
164488314|NCT02367794|594156693|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
164488315|NCT02367794|594156694|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
164488316|NCT02367794|594156695|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
164488317|NCT02367794|594156693|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
164488318|NCT02367794|594156694|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
164488319|NCT02367794|594156695|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
164488320|NCT05379400|594157906|FG000|Overall Study|Lost to Follow-up|1|||
164488321|NCT05379400|594157907|FG001|Overall Study|Lost to Follow-up|1|||
164488322|NCT05356130|594157908|FG000|Overall Study|Withdrawal by Subject|0|||
164488323|NCT05356130|594157909|FG001|Overall Study|Withdrawal by Subject|0|||
164488324|NCT05356130|594157910|FG002|Overall Study|Withdrawal by Subject|3|||
164488325|NCT04851587|594157911|FG000|Overall Study|Lost to Follow-up|18|||
164488326|NCT02109172|594157920|FG000|Overall Study|Withdrawal by Subject|1|||
164488327|NCT02109172|594157921|FG001|Overall Study|Withdrawal by Subject|0|||
164488328|NCT02109172|594157922|FG002|Overall Study|Withdrawal by Subject|0|||
164488329|NCT02109172|594157923|FG003|Overall Study|Withdrawal by Subject|1|||
164488330|NCT02109172|594157924|FG004|Overall Study|Withdrawal by Subject|0|||
164488331|NCT02109172|594157925|FG005|Overall Study|Withdrawal by Subject|0|||
164488332|NCT02109172|594157920|FG000|Overall Study|Adverse Event|0|||
164488333|NCT02109172|594157921|FG001|Overall Study|Adverse Event|0|||
164488334|NCT02109172|594157922|FG002|Overall Study|Adverse Event|1|||
164488335|NCT02109172|594157923|FG003|Overall Study|Adverse Event|0|||
164488336|NCT02109172|594157924|FG004|Overall Study|Adverse Event|0|||
164488337|NCT02109172|594157925|FG005|Overall Study|Adverse Event|1|||
164488338|NCT02109172|594157920|FG000|Overall Study|Death|0|||
164488339|NCT02109172|594157921|FG001|Overall Study|Death|0|||
164488340|NCT02109172|594157922|FG002|Overall Study|Death|0|||
164488341|NCT02109172|594157923|FG003|Overall Study|Death|0|||
164488342|NCT02109172|594157924|FG004|Overall Study|Death|1|||
164488343|NCT02109172|594157925|FG005|Overall Study|Death|0|||
164488344|NCT01279447|594157926|FG000|Overall Study|Lost to Follow-up|3|||
164488345|NCT01279447|594157927|FG001|Overall Study|Lost to Follow-up|1|||
164488346|NCT03360071|594157928|FG000|Overall Study|Lost to Follow-up|1|||
164488347|NCT03360071|594157929|FG001|Overall Study|Lost to Follow-up|0|||
164488348|NCT00850993|594157938|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
164488349|NCT00850993|594157939|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
164488350|NCT00850993|594157940|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
164488351|NCT00850993|594157941|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
164488352|NCT00636168|594157947|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
164488353|NCT00636168|594157948|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
164488354|NCT00636168|594157947|FG000|Randomized to Study Drug|Adverse Event|1|||
164488355|NCT00636168|594157948|FG001|Randomized to Study Drug|Adverse Event|0|||
164488356|NCT00636168|594157947|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
164488357|NCT00636168|594157948|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
164488358|NCT00636168|594157947|FG000|Treated With Study Drug|Recurrence of disease|135|||
164488359|NCT00636168|594157948|FG001|Treated With Study Drug|Recurrence of disease|282|||
164488360|NCT00636168|594157947|FG000|Treated With Study Drug|Adverse Event|250|||
164488361|NCT00636168|594157948|FG001|Treated With Study Drug|Adverse Event|22|||
164488362|NCT00636168|594157947|FG000|Treated With Study Drug|Participant withdrew consent|16|||
164488363|NCT00636168|594157948|FG001|Treated With Study Drug|Participant withdrew consent|21|||
164488364|NCT00636168|594157947|FG000|Treated With Study Drug|Poor/non-compliance|1|||
164488365|NCT00636168|594157948|FG001|Treated With Study Drug|Poor/non-compliance|3|||
164488366|NCT00636168|594157947|FG000|Treated With Study Drug|Death|3|||
164488367|NCT00636168|594157948|FG001|Treated With Study Drug|Death|0|||
164488368|NCT00636168|594157947|FG000|Treated With Study Drug|Pregnancy|1|||
164488369|NCT00636168|594157948|FG001|Treated With Study Drug|Pregnancy|0|||
164488370|NCT00636168|594157947|FG000|Treated With Study Drug|No longer meets study criteria|1|||
164488371|NCT00636168|594157948|FG001|Treated With Study Drug|No longer meets study criteria|0|||
164488372|NCT00636168|594157947|FG000|Treated With Study Drug|Other reason|1|||
164488373|NCT00636168|594157948|FG001|Treated With Study Drug|Other reason|3|||
164488374|NCT00636168|594157947|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
164488375|NCT00636168|594157948|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
164488376|NCT00636168|594157947|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
164488377|NCT00636168|594157948|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
164488378|NCT00636168|594157947|FG000|Long Term Follow-Up|Death|8|||
164488379|NCT00636168|594157948|FG001|Long Term Follow-Up|Death|9|||
164488380|NCT04501614|594157952|FG000|Overall Study|Study Terminated by Sponsor|6|||
164602272|NCT01885078|594564813|FG008|Treatment Period|Lost to Follow-up|0|||
164488381|NCT04501614|594157953|FG001|Overall Study|Study Terminated by Sponsor|3|||
164488382|NCT04501614|594157952|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
164488383|NCT04501614|594157953|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
164488384|NCT02555397|594157957|FG000|Overall Study|Withdrawal by Subject|1|||
164488385|NCT02555397|594157958|FG001|Overall Study|Withdrawal by Subject|0|||
164488386|NCT02555397|594157959|FG002|Overall Study|Withdrawal by Subject|0|||
164488387|NCT02555397|594157960|FG003|Overall Study|Withdrawal by Subject|0|||
164488388|NCT02555397|594157961|FG004|Overall Study|Withdrawal by Subject|0|||
164488389|NCT04529941|594157964|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
164488390|NCT04529941|594157965|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
164488391|NCT02971683|594157967|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
164488392|NCT02971683|594157968|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
164488393|NCT02971683|594157967|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
164488394|NCT02971683|594157968|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
164488395|NCT02971683|594157967|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
164488396|NCT02971683|594157968|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
164488397|NCT02971683|594157967|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
164488398|NCT02971683|594157968|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
164488399|NCT02971683|594157967|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
164488400|NCT02971683|594157968|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
164488401|NCT02971683|594157967|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
164488402|NCT02971683|594157968|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
164488403|NCT02971683|594157967|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
164488404|NCT02971683|594157968|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
164488405|NCT02971683|594157967|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
164488406|NCT02971683|594157968|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
164488407|NCT02971683|594157967|FG000|Open-Label|Lost to Follow-up|1|||
164488408|NCT02971683|594157968|FG001|Open-Label|Lost to Follow-up|0|||
164488409|NCT02971683|594157967|FG000|Open-Label|Participants withdrew consent|0|||
164488410|NCT02971683|594157968|FG001|Open-Label|Participants withdrew consent|2|||
164488411|NCT02971683|594157967|FG000|Open-Label|Participant request to discontinue study treatment|1|||
164488412|NCT02971683|594157968|FG001|Open-Label|Participant request to discontinue study treatment|0|||
164488413|NCT02971683|594157967|FG000|Open-Label|Lack of Efficacy|2|||
164488414|NCT02971683|594157968|FG001|Open-Label|Lack of Efficacy|0|||
164488415|NCT02971683|594157967|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
164488416|NCT02971683|594157968|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
164488417|NCT02971683|594157967|FG000|Long-Term Open Label|Participant withdrew consent|1|||
164488418|NCT02971683|594157968|FG001|Long-Term Open Label|Participant withdrew consent|0|||
164488419|NCT02971683|594157967|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
164488420|NCT02971683|594157968|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
164488421|NCT02971683|594157967|FG000|Long-Term Open Label|Adverse Event|1|||
164488422|NCT02971683|594157968|FG001|Long-Term Open Label|Adverse Event|2|||
164488423|NCT02971683|594157967|FG000|Long-Term Open Label|Lack of Efficacy|1|||
164488424|NCT02971683|594157968|FG001|Long-Term Open Label|Lack of Efficacy|1|||
164488425|NCT01856569|594157969|FG000|Overall Study|Other|1|||
164488426|NCT01856569|594157969|FG000|Overall Study|Changed Site/Structure|1|||
164488427|NCT01856569|594157969|FG000|Overall Study|Lost to Follow-up|3|||
164488428|NCT01856569|594157969|FG000|Overall Study|Did not met inclusion criteria|8|||
164488429|NCT01005914|594157970|FG000|Overall Study|Adverse Event|4|||
164488430|NCT01005914|594157970|FG000|Overall Study|Death|4|||
164488431|NCT01005914|594157970|FG000|Overall Study|Lack of Efficacy|1|||
164488432|NCT01005914|594157970|FG000|Overall Study|Withdrawal by Subject|1|||
164488433|NCT01240785|594157973|FG000|Overall Study|Lost to Follow-up|1|||
164488434|NCT01240785|594157974|FG001|Overall Study|Lost to Follow-up|0|||
164488435|NCT01240785|594157973|FG000|Overall Study|Protocol Violation|0|||
164488436|NCT01240785|594157974|FG001|Overall Study|Protocol Violation|3|||
164488437|NCT00696241|594157975|FG000|Overall Study|Adverse Event|11|||
164488438|NCT00696241|594157976|FG001|Overall Study|Adverse Event|3|||
164488439|NCT00696241|594157977|FG002|Overall Study|Adverse Event|6|||
164488440|NCT00696241|594157978|FG003|Overall Study|Adverse Event|4|||
164488441|NCT00696241|594157979|FG004|Overall Study|Adverse Event|5|||
164488442|NCT00696241|594157975|FG000|Overall Study|Protocol Violation|1|||
164488443|NCT00696241|594157976|FG001|Overall Study|Protocol Violation|1|||
164488444|NCT00696241|594157977|FG002|Overall Study|Protocol Violation|2|||
164488445|NCT00696241|594157978|FG003|Overall Study|Protocol Violation|0|||
164714769|NCT01696058|594978709|FG001|Overall Study|Other reason prematurely discontinued|3|||
164714770|NCT02186834|594978711|FG000|Dose Escalation|Death|0|||
164714771|NCT02186834|594978712|FG001|Dose Escalation|Death|0|||
164714772|NCT02186834|594978713|FG002|Dose Escalation|Death|0|||
164714773|NCT02186834|594978714|FG003|Dose Escalation|Death|1|||
164488446|NCT00696241|594157979|FG004|Overall Study|Protocol Violation|3|||
164488447|NCT00696241|594157975|FG000|Overall Study|Lost to Follow-up|1|||
164488448|NCT00696241|594157976|FG001|Overall Study|Lost to Follow-up|4|||
164488449|NCT00696241|594157977|FG002|Overall Study|Lost to Follow-up|1|||
164714774|NCT02186834|594978715|FG004|Dose Escalation|Death|0|||
164488450|NCT00696241|594157978|FG003|Overall Study|Lost to Follow-up|2|||
164488451|NCT00696241|594157979|FG004|Overall Study|Lost to Follow-up|0|||
164488452|NCT00696241|594157975|FG000|Overall Study|Withdrawal by Subject|4|||
164488453|NCT00696241|594157976|FG001|Overall Study|Withdrawal by Subject|8|||
164488454|NCT00696241|594157977|FG002|Overall Study|Withdrawal by Subject|6|||
164488455|NCT00696241|594157978|FG003|Overall Study|Withdrawal by Subject|1|||
164488456|NCT00696241|594157979|FG004|Overall Study|Withdrawal by Subject|0|||
164488457|NCT00696241|594157975|FG000|Overall Study|Lack of Efficacy|1|||
164488458|NCT00696241|594157976|FG001|Overall Study|Lack of Efficacy|5|||
164488459|NCT00696241|594157977|FG002|Overall Study|Lack of Efficacy|4|||
164488460|NCT00696241|594157978|FG003|Overall Study|Lack of Efficacy|5|||
164488461|NCT00696241|594157979|FG004|Overall Study|Lack of Efficacy|3|||
164488462|NCT00696241|594157975|FG000|Overall Study|Other|6|||
164488463|NCT00696241|594157976|FG001|Overall Study|Other|1|||
164488464|NCT00696241|594157977|FG002|Overall Study|Other|5|||
164488465|NCT00696241|594157978|FG003|Overall Study|Other|2|||
164488466|NCT00696241|594157979|FG004|Overall Study|Other|1|||
164488467|NCT01613599|594157980|FG000|Overall Study|Death|9|||
164488468|NCT01613599|594157980|FG000|Overall Study|Lost to Follow-up|5|||
164488469|NCT01613599|594157980|FG000|Overall Study|Withdrawal by Subject|8|||
164488470|NCT01613599|594157980|FG000|Overall Study|Reason not specified|3|||
164488471|NCT02066389|594157982|FG000|Overall Study|Adverse Event|1|||
164488472|NCT02066389|594157983|FG001|Overall Study|Adverse Event|1|||
164488473|NCT02066389|594157984|FG002|Overall Study|Adverse Event|1|||
164488474|NCT02066389|594157985|FG003|Overall Study|Adverse Event|1|||
164488475|NCT02066389|594157986|FG004|Overall Study|Adverse Event|5|||
164488476|NCT02066389|594157987|FG005|Overall Study|Adverse Event|1|||
164488477|NCT02066389|594157982|FG000|Overall Study|Withdrawal by Subject|4|||
164488478|NCT02066389|594157983|FG001|Overall Study|Withdrawal by Subject|0|||
164488479|NCT02066389|594157984|FG002|Overall Study|Withdrawal by Subject|5|||
164488480|NCT02066389|594157985|FG003|Overall Study|Withdrawal by Subject|1|||
164488481|NCT02066389|594157986|FG004|Overall Study|Withdrawal by Subject|1|||
164488482|NCT02066389|594157987|FG005|Overall Study|Withdrawal by Subject|2|||
164488483|NCT02066389|594157982|FG000|Overall Study|Lost to Follow-up|0|||
164488484|NCT02066389|594157983|FG001|Overall Study|Lost to Follow-up|0|||
164488485|NCT02066389|594157984|FG002|Overall Study|Lost to Follow-up|0|||
164488486|NCT02066389|594157985|FG003|Overall Study|Lost to Follow-up|1|||
164488487|NCT02066389|594157986|FG004|Overall Study|Lost to Follow-up|1|||
164488488|NCT02066389|594157987|FG005|Overall Study|Lost to Follow-up|1|||
164488489|NCT02066389|594157982|FG000|Overall Study|Randomized in Error|0|||
164488490|NCT02066389|594157983|FG001|Overall Study|Randomized in Error|0|||
164488491|NCT02066389|594157984|FG002|Overall Study|Randomized in Error|0|||
164488492|NCT02066389|594157985|FG003|Overall Study|Randomized in Error|0|||
164488493|NCT02066389|594157986|FG004|Overall Study|Randomized in Error|0|||
164488494|NCT02066389|594157987|FG005|Overall Study|Randomized in Error|1|||
164488495|NCT04749797|594157991|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
164488496|NCT04749797|594157992|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
164488497|NCT04749797|594157993|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
164488498|NCT02513667|594157994|FG000|Overall Study|Withdrawal by Subject|0|||
164488499|NCT02513667|594157995|FG001|Overall Study|Withdrawal by Subject|1|||
164488500|NCT00871715|594158004|FG000|Overall Study|Withdrawal by Subject|6|||
164488501|NCT00871715|594158005|FG001|Overall Study|Withdrawal by Subject|10|||
164488502|NCT00871715|594158006|FG002|Overall Study|Withdrawal by Subject|15|||
164488503|NCT00871715|594158004|FG000|Overall Study|Physician Decision|6|||
164488504|NCT00871715|594158005|FG001|Overall Study|Physician Decision|0|||
164488505|NCT00871715|594158006|FG002|Overall Study|Physician Decision|2|||
164488506|NCT00871715|594158004|FG000|Overall Study|Lost to Follow-up|3|||
164488507|NCT00871715|594158005|FG001|Overall Study|Lost to Follow-up|6|||
164488508|NCT00871715|594158006|FG002|Overall Study|Lost to Follow-up|9|||
164488509|NCT02291549|594158009|FG000|Overall Study|Lost to Follow-up|1|||
164488510|NCT02291549|594158010|FG001|Overall Study|Lost to Follow-up|0|||
164488511|NCT02291549|594158009|FG000|Overall Study|Withdrawal by Subject|0|||
164488512|NCT02291549|594158010|FG001|Overall Study|Withdrawal by Subject|1|||
164488513|NCT00537914|594158011|FG000|Overall Study|Death|1|||
164488514|NCT00537914|594158011|FG000|Overall Study|Adverse Event|7|||
164488515|NCT00537914|594158011|FG000|Overall Study|Treatment failure|10|||
164488516|NCT00537914|594158011|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
164488517|NCT00537914|594158011|FG000|Overall Study|Lost to Follow-up|19|||
164602273|NCT01885078|594564814|FG009|Treatment Period|Lost to Follow-up|0|||
164488518|NCT00537914|594158011|FG000|Overall Study|Withdrawal of informed consent|59|||
164488519|NCT01986348|594158019|FG000|Overall Study|Death|8|||
164144912|NCT05199090|592891827|FG005|Overall Study|Physician Decision|1|||
164488520|NCT01986348|594158020|FG001|Overall Study|Death|22|||
164488521|NCT01986348|594158021|FG002|Overall Study|Death|10|||
164488522|NCT01986348|594158022|FG003|Overall Study|Death|21|||
164488523|NCT01986348|594158019|FG000|Overall Study|Lost to Follow-up|0|||
164488524|NCT01986348|594158020|FG001|Overall Study|Lost to Follow-up|0|||
164488525|NCT01986348|594158021|FG002|Overall Study|Lost to Follow-up|0|||
164488526|NCT01986348|594158022|FG003|Overall Study|Lost to Follow-up|2|||
164488527|NCT01986348|594158019|FG000|Overall Study|Physician Decision|0|||
164488528|NCT01986348|594158020|FG001|Overall Study|Physician Decision|0|||
164488529|NCT01986348|594158021|FG002|Overall Study|Physician Decision|0|||
164488530|NCT01986348|594158022|FG003|Overall Study|Physician Decision|1|||
164488531|NCT01986348|594158019|FG000|Overall Study|Progressive Disease|0|||
164488532|NCT01986348|594158020|FG001|Overall Study|Progressive Disease|0|||
164488533|NCT01986348|594158021|FG002|Overall Study|Progressive Disease|2|||
164488534|NCT01986348|594158022|FG003|Overall Study|Progressive Disease|0|||
164488535|NCT01986348|594158019|FG000|Overall Study|Withdrawal by Participant|0|||
164488536|NCT01986348|594158020|FG001|Overall Study|Withdrawal by Participant|1|||
164488537|NCT01986348|594158021|FG002|Overall Study|Withdrawal by Participant|2|||
164488538|NCT01986348|594158022|FG003|Overall Study|Withdrawal by Participant|1|||
164488539|NCT01986348|594158019|FG000|Overall Study|Study Terminated by Sponsor|0|||
164488540|NCT01986348|594158020|FG001|Overall Study|Study Terminated by Sponsor|0|||
164488541|NCT01986348|594158021|FG002|Overall Study|Study Terminated by Sponsor|0|||
164488542|NCT01986348|594158022|FG003|Overall Study|Study Terminated by Sponsor|3|||
164488543|NCT01986348|594158019|FG000|Overall Study|Other-unspecified|0|||
164488544|NCT01986348|594158020|FG001|Overall Study|Other-unspecified|1|||
164488545|NCT01986348|594158021|FG002|Overall Study|Other-unspecified|0|||
164488546|NCT01986348|594158022|FG003|Overall Study|Other-unspecified|2|||
164488547|NCT02612285|594158023|FG000|Overall Study|Withdrawal by Subject|1|||
164488548|NCT02010684|594158024|FG000|Overall Study|Lost to Follow-up|8|||
164488549|NCT02010684|594158025|FG001|Overall Study|Lost to Follow-up|18|||
164488550|NCT02010684|594158024|FG000|Overall Study|Withdrawal by Subject|4|||
164488551|NCT02010684|594158025|FG001|Overall Study|Withdrawal by Subject|5|||
164488552|NCT00805441|594158026|FG000|Overall Study|Adverse Event|5|||
164488553|NCT00805441|594158027|FG001|Overall Study|Adverse Event|2|||
164488554|NCT00805441|594158026|FG000|Overall Study|Lack of Efficacy|0|||
164488555|NCT00805441|594158027|FG001|Overall Study|Lack of Efficacy|2|||
164488556|NCT00805441|594158026|FG000|Overall Study|Protocol Violation|4|||
164488557|NCT00805441|594158027|FG001|Overall Study|Protocol Violation|8|||
164488558|NCT00805441|594158026|FG000|Overall Study|Lost to Follow-up|10|||
164488559|NCT00805441|594158027|FG001|Overall Study|Lost to Follow-up|13|||
164488560|NCT00805441|594158026|FG000|Overall Study|Withdrawal by Subject|15|||
164488561|NCT00805441|594158027|FG001|Overall Study|Withdrawal by Subject|9|||
164488562|NCT00805441|594158026|FG000|Overall Study|Physician Decision|0|||
164488563|NCT00805441|594158027|FG001|Overall Study|Physician Decision|1|||
164488564|NCT00805441|594158026|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
164488565|NCT00805441|594158027|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
164488566|NCT02935894|594158036|FG000|Overall Study|Subject dismissed|1|||
164488567|NCT00853957|594158039|FG000|Overall Study|Adverse Event|9|||
164488568|NCT00853957|594158040|FG001|Overall Study|Adverse Event|3|||
164488569|NCT00853957|594158039|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164488570|NCT00853957|594158040|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164488571|NCT00853957|594158039|FG000|Overall Study|Subject withdrew consent|4|||
164488572|NCT00853957|594158040|FG001|Overall Study|Subject withdrew consent|5|||
164488573|NCT00853957|594158039|FG000|Overall Study|Lost to Follow-up|1|||
164488574|NCT00853957|594158040|FG001|Overall Study|Lost to Follow-up|6|||
164488575|NCT00853957|594158039|FG000|Overall Study|Protocol deviation|0|||
164488576|NCT00853957|594158040|FG001|Overall Study|Protocol deviation|3|||
164488577|NCT01884571|594158041|FG000|Overall Study|Adverse Event|1|||
164488578|NCT01884571|594158041|FG000|Overall Study|Death|2|||
164488579|NCT01884571|594158041|FG000|Overall Study|Withdrawal by Subject|2|||
164488580|NCT01884571|594158041|FG000|Overall Study|Disease progression|3|||
164488581|NCT01186809|594158044|FG000|Overall Study|Death|30|||
164488582|NCT04895085|594158045|FG000|Overall Study|Death|1|||
164488583|NCT04895085|594158045|FG000|Overall Study|Withdrawal by Subject|1|||
164488584|NCT04895085|594158045|FG000|Overall Study|No longer eligible: Moved from area|1|||
164488585|NCT01159600|594158051|FG000|Overall Study|Not treated|0|||
164488586|NCT01159600|594158052|FG001|Overall Study|Not treated|0|||
164488587|NCT01159600|594158053|FG002|Overall Study|Not treated|1|||
164488588|NCT01159600|594158054|FG003|Overall Study|Not treated|0|||
164488589|NCT01159600|594158055|FG004|Overall Study|Not treated|0|||
164488590|NCT01159600|594158056|FG005|Overall Study|Not treated|1|||
164488591|NCT01159600|594158057|FG006|Overall Study|Not treated|2|||
164488592|NCT01159600|594158058|FG007|Overall Study|Not treated|2|||
164488593|NCT01159600|594158051|FG000|Overall Study|Adverse Event|7|||
164488594|NCT01159600|594158052|FG001|Overall Study|Adverse Event|2|||
164488595|NCT01159600|594158053|FG002|Overall Study|Adverse Event|5|||
164488596|NCT01159600|594158054|FG003|Overall Study|Adverse Event|1|||
164488597|NCT01159600|594158055|FG004|Overall Study|Adverse Event|8|||
164488598|NCT01159600|594158056|FG005|Overall Study|Adverse Event|6|||
164488599|NCT01159600|594158057|FG006|Overall Study|Adverse Event|7|||
164488600|NCT01159600|594158058|FG007|Overall Study|Adverse Event|5|||
164488601|NCT01159600|594158051|FG000|Overall Study|Lack of Efficacy|0|||
164488602|NCT01159600|594158052|FG001|Overall Study|Lack of Efficacy|0|||
164488603|NCT01159600|594158053|FG002|Overall Study|Lack of Efficacy|0|||
164488604|NCT01159600|594158054|FG003|Overall Study|Lack of Efficacy|0|||
164488605|NCT01159600|594158055|FG004|Overall Study|Lack of Efficacy|2|||
164488606|NCT01159600|594158056|FG005|Overall Study|Lack of Efficacy|0|||
164488607|NCT01159600|594158057|FG006|Overall Study|Lack of Efficacy|0|||
164488608|NCT01159600|594158058|FG007|Overall Study|Lack of Efficacy|1|||
164488609|NCT01159600|594158051|FG000|Overall Study|Non compliant with protocol|2|||
164488610|NCT01159600|594158052|FG001|Overall Study|Non compliant with protocol|1|||
164488611|NCT01159600|594158053|FG002|Overall Study|Non compliant with protocol|0|||
164488612|NCT01159600|594158054|FG003|Overall Study|Non compliant with protocol|0|||
164488613|NCT01159600|594158055|FG004|Overall Study|Non compliant with protocol|2|||
164488614|NCT01159600|594158056|FG005|Overall Study|Non compliant with protocol|0|||
164488615|NCT01159600|594158057|FG006|Overall Study|Non compliant with protocol|2|||
164488616|NCT01159600|594158058|FG007|Overall Study|Non compliant with protocol|0|||
164488617|NCT01159600|594158051|FG000|Overall Study|Lost to Follow-up|2|||
164488618|NCT01159600|594158052|FG001|Overall Study|Lost to Follow-up|3|||
164488619|NCT01159600|594158053|FG002|Overall Study|Lost to Follow-up|4|||
164488620|NCT01159600|594158054|FG003|Overall Study|Lost to Follow-up|3|||
164488621|NCT01159600|594158055|FG004|Overall Study|Lost to Follow-up|3|||
164488622|NCT01159600|594158056|FG005|Overall Study|Lost to Follow-up|0|||
164488623|NCT01159600|594158057|FG006|Overall Study|Lost to Follow-up|3|||
164488624|NCT01159600|594158058|FG007|Overall Study|Lost to Follow-up|2|||
164488625|NCT01159600|594158051|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
164488626|NCT01159600|594158052|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
164488627|NCT01159600|594158053|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
164488628|NCT01159600|594158054|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
164488629|NCT01159600|594158055|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
164488630|NCT01159600|594158056|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
164488631|NCT01159600|594158057|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
164488632|NCT01159600|594158058|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
164488633|NCT01159600|594158051|FG000|Overall Study|Other reason not defined above|3|||
164488634|NCT01159600|594158052|FG001|Overall Study|Other reason not defined above|0|||
164488635|NCT01159600|594158053|FG002|Overall Study|Other reason not defined above|4|||
164488636|NCT01159600|594158054|FG003|Overall Study|Other reason not defined above|2|||
164488637|NCT01159600|594158055|FG004|Overall Study|Other reason not defined above|5|||
164488638|NCT01159600|594158056|FG005|Overall Study|Other reason not defined above|7|||
164488639|NCT01159600|594158057|FG006|Overall Study|Other reason not defined above|3|||
164488640|NCT01159600|594158058|FG007|Overall Study|Other reason not defined above|3|||
164488641|NCT04820023|594159308|FG000|Overall Study|Death|0|||
164488642|NCT04820023|594159309|FG001|Overall Study|Death|0|||
164488643|NCT04820023|594159310|FG002|Overall Study|Death|0|||
164488644|NCT04820023|594159311|FG003|Overall Study|Death|0|||
164488645|NCT04820023|594159312|FG004|Overall Study|Death|0|||
164488646|NCT04820023|594159313|FG005|Overall Study|Death|0|||
164488647|NCT04820023|594159314|FG006|Overall Study|Death|1|||
164488648|NCT04820023|594159315|FG007|Overall Study|Death|0|||
164488649|NCT04820023|594159316|FG008|Overall Study|Death|1|||
164488650|NCT04820023|594159308|FG000|Overall Study|Withdrawal by Subject|1|||
164488651|NCT04820023|594159309|FG001|Overall Study|Withdrawal by Subject|2|||
164488652|NCT04820023|594159310|FG002|Overall Study|Withdrawal by Subject|2|||
164488653|NCT04820023|594159311|FG003|Overall Study|Withdrawal by Subject|1|||
164488654|NCT04820023|594159312|FG004|Overall Study|Withdrawal by Subject|4|||
164488655|NCT04820023|594159313|FG005|Overall Study|Withdrawal by Subject|3|||
164488656|NCT04820023|594159314|FG006|Overall Study|Withdrawal by Subject|3|||
164488657|NCT04820023|594159315|FG007|Overall Study|Withdrawal by Subject|6|||
164488658|NCT04820023|594159316|FG008|Overall Study|Withdrawal by Subject|5|||
164488659|NCT04820023|594159308|FG000|Overall Study|Progressive Disease|3|||
164488660|NCT04820023|594159309|FG001|Overall Study|Progressive Disease|0|||
164488661|NCT04820023|594159310|FG002|Overall Study|Progressive Disease|2|||
164488662|NCT04820023|594159311|FG003|Overall Study|Progressive Disease|2|||
164488663|NCT04820023|594159312|FG004|Overall Study|Progressive Disease|2|||
164488664|NCT04820023|594159313|FG005|Overall Study|Progressive Disease|0|||
164488665|NCT04820023|594159314|FG006|Overall Study|Progressive Disease|1|||
164488666|NCT04820023|594159315|FG007|Overall Study|Progressive Disease|1|||
164488667|NCT04820023|594159316|FG008|Overall Study|Progressive Disease|0|||
164488668|NCT04820023|594159308|FG000|Overall Study|New anti-cancer therapy|0|||
164488669|NCT04820023|594159309|FG001|Overall Study|New anti-cancer therapy|0|||
164488670|NCT04820023|594159310|FG002|Overall Study|New anti-cancer therapy|0|||
164488671|NCT04820023|594159311|FG003|Overall Study|New anti-cancer therapy|0|||
164488672|NCT04820023|594159312|FG004|Overall Study|New anti-cancer therapy|2|||
164488673|NCT04820023|594159313|FG005|Overall Study|New anti-cancer therapy|0|||
164488674|NCT04820023|594159314|FG006|Overall Study|New anti-cancer therapy|0|||
164488675|NCT04820023|594159315|FG007|Overall Study|New anti-cancer therapy|0|||
164488676|NCT04820023|594159316|FG008|Overall Study|New anti-cancer therapy|0|||
164488677|NCT04820023|594159308|FG000|Overall Study|Other|0|||
164488678|NCT04820023|594159309|FG001|Overall Study|Other|1|||
164488679|NCT04820023|594159310|FG002|Overall Study|Other|0|||
164488680|NCT04820023|594159311|FG003|Overall Study|Other|0|||
164488681|NCT04820023|594159312|FG004|Overall Study|Other|0|||
164488682|NCT04820023|594159313|FG005|Overall Study|Other|0|||
164145217|NCT02125877|592894246|FG001|Overall Study|Death|1|||
164488683|NCT04820023|594159314|FG006|Overall Study|Other|0|||
164488684|NCT04820023|594159315|FG007|Overall Study|Other|2|||
164488685|NCT04820023|594159316|FG008|Overall Study|Other|0|||
164488686|NCT01020487|594159317|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
164488687|NCT01020487|594159318|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
164488688|NCT01020487|594159319|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
164488689|NCT01020487|594159317|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
164488690|NCT01020487|594159318|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
164488691|NCT01020487|594159319|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
164488692|NCT01020487|594159317|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
164488693|NCT01020487|594159318|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
164488694|NCT01020487|594159319|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
164488695|NCT01020487|594159317|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
164488696|NCT01020487|594159318|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
164488697|NCT01020487|594159319|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
164488698|NCT01020487|594159317|FG000|Part 2 Open-label Period|Adverse Event|0|||
164488699|NCT01020487|594159318|FG001|Part 2 Open-label Period|Adverse Event|4|||
164488700|NCT01020487|594159319|FG002|Part 2 Open-label Period|Adverse Event|1|||
164488701|NCT03184519|594159327|FG000|Overall Study|Lost to Follow-up|6|||
164488702|NCT03184519|594159327|FG000|Overall Study|Physician Decision|21|||
164488703|NCT02823574|594159331|FG000|Randomization|Disease Progression|0|||
164488704|NCT02823574|594159332|FG001|Randomization|Disease Progression|0|||
164488705|NCT02823574|594159333|FG002|Randomization|Disease Progression|1|||
164488706|NCT02823574|594159334|FG003|Randomization|Disease Progression|0|||
164488707|NCT02823574|594159331|FG000|Randomization|AE unrelated to Study Drug|1|||
164488708|NCT02823574|594159332|FG001|Randomization|AE unrelated to Study Drug|0|||
164488709|NCT02823574|594159333|FG002|Randomization|AE unrelated to Study Drug|0|||
164488710|NCT02823574|594159334|FG003|Randomization|AE unrelated to Study Drug|0|||
164488711|NCT02823574|594159331|FG000|Treatment Period|Poor/Non Compliance|1|||
164488712|NCT02823574|594159332|FG001|Treatment Period|Poor/Non Compliance|0|||
164488713|NCT02823574|594159333|FG002|Treatment Period|Poor/Non Compliance|0|||
164488714|NCT02823574|594159334|FG003|Treatment Period|Poor/Non Compliance|1|||
164488715|NCT02823574|594159331|FG000|Treatment Period|Maximum Clinical Benefit|8|||
164488716|NCT02823574|594159332|FG001|Treatment Period|Maximum Clinical Benefit|4|||
164488717|NCT02823574|594159333|FG002|Treatment Period|Maximum Clinical Benefit|7|||
164488718|NCT02823574|594159334|FG003|Treatment Period|Maximum Clinical Benefit|1|||
164488719|NCT02823574|594159331|FG000|Treatment Period|Lost to Follow-up|1|||
164488720|NCT02823574|594159332|FG001|Treatment Period|Lost to Follow-up|1|||
164488721|NCT02823574|594159333|FG002|Treatment Period|Lost to Follow-up|0|||
164488722|NCT02823574|594159334|FG003|Treatment Period|Lost to Follow-up|0|||
164488723|NCT02823574|594159331|FG000|Treatment Period|Participant withdrew consent|4|||
164488724|NCT02823574|594159332|FG001|Treatment Period|Participant withdrew consent|0|||
164488725|NCT02823574|594159333|FG002|Treatment Period|Participant withdrew consent|0|||
164488726|NCT02823574|594159334|FG003|Treatment Period|Participant withdrew consent|1|||
164488727|NCT02823574|594159331|FG000|Treatment Period|Participant request to discontinue|5|||
164488728|NCT02823574|594159332|FG001|Treatment Period|Participant request to discontinue|0|||
164488729|NCT02823574|594159333|FG002|Treatment Period|Participant request to discontinue|3|||
164488730|NCT02823574|594159334|FG003|Treatment Period|Participant request to discontinue|2|||
164488731|NCT02823574|594159331|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
164488732|NCT02823574|594159332|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
164488733|NCT02823574|594159333|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
164488734|NCT02823574|594159334|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
164488735|NCT02823574|594159331|FG000|Treatment Period|Study Drug Toxicity|11|||
164488736|NCT02823574|594159332|FG001|Treatment Period|Study Drug Toxicity|2|||
164488737|NCT02823574|594159333|FG002|Treatment Period|Study Drug Toxicity|14|||
164488738|NCT02823574|594159334|FG003|Treatment Period|Study Drug Toxicity|4|||
164488739|NCT02823574|594159331|FG000|Treatment Period|Disease Progression|113|||
164488740|NCT02823574|594159332|FG001|Treatment Period|Disease Progression|64|||
164488741|NCT02823574|594159333|FG002|Treatment Period|Disease Progression|82|||
164488742|NCT02823574|594159334|FG003|Treatment Period|Disease Progression|43|||
164488743|NCT02823574|594159331|FG000|Treatment Period|Other reasons|5|||
164488744|NCT02823574|594159332|FG001|Treatment Period|Other reasons|9|||
164488745|NCT02823574|594159333|FG002|Treatment Period|Other reasons|3|||
164488746|NCT02823574|594159334|FG003|Treatment Period|Other reasons|6|||
164488747|NCT02823574|594159331|FG000|Treatment Period|Participant no longer meets study criteria|0|||
164488748|NCT02823574|594159332|FG001|Treatment Period|Participant no longer meets study criteria|0|||
164488749|NCT02823574|594159333|FG002|Treatment Period|Participant no longer meets study criteria|1|||
164488750|NCT02823574|594159334|FG003|Treatment Period|Participant no longer meets study criteria|0|||
164488751|NCT02823574|594159331|FG000|Treatment Period|Death|0|||
164488752|NCT02823574|594159332|FG001|Treatment Period|Death|0|||
164714775|NCT02186834|594978716|FG005|Dose Escalation|Death|0|||
164714776|NCT02186834|594978711|FG000|Treatment at RP2D|Died prior to treatment|0|||
164714777|NCT02186834|594978712|FG001|Treatment at RP2D|Died prior to treatment|0|||
164714778|NCT02186834|594978713|FG002|Treatment at RP2D|Died prior to treatment|0|||
164488753|NCT02823574|594159333|FG002|Treatment Period|Death|3|||
164488754|NCT02823574|594159334|FG003|Treatment Period|Death|1|||
164488755|NCT00590759|594159335|FG000|Overall Study|Death|52|||
164488756|NCT00590759|594159335|FG000|Overall Study|Lost to Follow-up|28|||
164488757|NCT01951105|594159342|FG000|Overall Study|Adverse Event|0|||
164488758|NCT01951105|594159343|FG001|Overall Study|Adverse Event|5|||
164488759|NCT01951105|594159344|FG002|Overall Study|Adverse Event|0|||
164488760|NCT01951105|594159342|FG000|Overall Study|Lost to Follow-up|0|||
164488761|NCT01951105|594159343|FG001|Overall Study|Lost to Follow-up|1|||
164488762|NCT01951105|594159344|FG002|Overall Study|Lost to Follow-up|0|||
164488763|NCT01951105|594159342|FG000|Overall Study|Protocol Violation|1|||
164488764|NCT01951105|594159343|FG001|Overall Study|Protocol Violation|1|||
164488765|NCT01951105|594159344|FG002|Overall Study|Protocol Violation|1|||
164488766|NCT01951105|594159342|FG000|Overall Study|Withdrawal by Subject|0|||
164488767|NCT01951105|594159343|FG001|Overall Study|Withdrawal by Subject|3|||
164488768|NCT01951105|594159344|FG002|Overall Study|Withdrawal by Subject|1|||
164488769|NCT02727998|594159345|FG000|Overall Study|Lost to Follow-up|3|||
164488770|NCT02727998|594159346|FG001|Overall Study|Lost to Follow-up|3|||
164488771|NCT02727998|594159345|FG000|Overall Study|Withdrawal by Subject|0|||
164488772|NCT02727998|594159346|FG001|Overall Study|Withdrawal by Subject|1|||
164488773|NCT05072795|594159349|FG000|Overall Study|Lost to Follow-up|5|||
164488774|NCT00901459|594159352|FG000|Overall Study|Withdrawal by Subject|6|||
164488775|NCT00422162|594159353|FG000|Overall Study|Adverse Event|11|||
164488776|NCT00422162|594159354|FG001|Overall Study|Adverse Event|9|||
164488777|NCT00422162|594159353|FG000|Overall Study|Lack of Efficacy|4|||
164488778|NCT00422162|594159354|FG001|Overall Study|Lack of Efficacy|10|||
164488779|NCT00422162|594159353|FG000|Overall Study|Withdrawal by Subject|7|||
164488780|NCT00422162|594159354|FG001|Overall Study|Withdrawal by Subject|6|||
164488781|NCT00422162|594159353|FG000|Overall Study|Lost to Follow-up|1|||
164488782|NCT00422162|594159354|FG001|Overall Study|Lost to Follow-up|2|||
164488783|NCT00422162|594159353|FG000|Overall Study|Non-Compliant with Protocol|1|||
164488784|NCT00422162|594159354|FG001|Overall Study|Non-Compliant with Protocol|1|||
164488785|NCT00422162|594159353|FG000|Overall Study|Other|0|||
164488786|NCT00422162|594159354|FG001|Overall Study|Other|1|||
164488787|NCT00422162|594159353|FG000|Overall Study|Didn't Receive Treatment|0|||
164488788|NCT00422162|594159354|FG001|Overall Study|Didn't Receive Treatment|1|||
164488789|NCT05274906|594159355|FG000|Overall Study|Withdrawal by Subject|2|||
164488790|NCT05274906|594159356|FG001|Overall Study|Withdrawal by Subject|1|||
164488791|NCT00910871|594159363|FG000|Overall Study|Adverse Event|5|||
164488792|NCT00910871|594159363|FG000|Overall Study|Death|12|||
164488793|NCT00910871|594159363|FG000|Overall Study|Lost to Follow-up|8|||
164488794|NCT00910871|594159363|FG000|Overall Study|Protocol Violation|11|||
164488795|NCT00910871|594159363|FG000|Overall Study|Withdrawal by Subject|12|||
164488796|NCT00910871|594159363|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
164488797|NCT00910871|594159363|FG000|Overall Study|Undefined|1|||
164714779|NCT02186834|594978714|FG003|Treatment at RP2D|Died prior to treatment|0|||
164714780|NCT02186834|594978715|FG004|Treatment at RP2D|Died prior to treatment|0|||
164714781|NCT02186834|594978716|FG005|Treatment at RP2D|Died prior to treatment|1|||
164714782|NCT04581369|594978717|FG000|Overall Study|Death|7|||
164714783|NCT04581369|594978718|FG001|Overall Study|Death|6|||
164488798|NCT01622088|594159364|FG000|Overall Study|Adverse Event|20|||
164488799|NCT01622088|594159364|FG000|Overall Study|Lost to Follow-up|1|||
164488800|NCT01622088|594159364|FG000|Overall Study|Withdrawal by Subject|20|||
164488801|NCT01622088|594159364|FG000|Overall Study|Investigator Decision|1|||
164488802|NCT01622088|594159364|FG000|Overall Study|Death|53|||
164488803|NCT01622088|594159364|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
164488804|NCT00237809|594159365|FG000|Overall Study|Lost to Follow-up|11|||
164488805|NCT00237809|594159366|FG001|Overall Study|Lost to Follow-up|10|||
164488806|NCT00237809|594159367|FG002|Overall Study|Lost to Follow-up|9|||
164488807|NCT00237809|594159368|FG003|Overall Study|Lost to Follow-up|9|||
164488808|NCT00321555|594159369|FG000|Overall Study|Developed antibodies|1|||
164488809|NCT00321555|594159369|FG000|Overall Study|Switched to alternative treatment|3|||
164488810|NCT00321555|594159369|FG000|Overall Study|Physician Decision|1|||
164488811|NCT00321555|594159369|FG000|Overall Study|Disease progression on study|1|||
164488812|NCT01468597|594159372|FG000|Overall Study|Found ineligible|17|||
164488813|NCT01468597|594159372|FG000|Overall Study|concomitant valves|12|||
164488814|NCT01468597|594159372|FG000|Overall Study|off-pump CABG|1|||
164488815|NCT01468597|594159372|FG000|Overall Study|no platelet function data|5|||
164488816|NCT02561195|594159373|FG000|Vaccination 1 to 3|Adverse Event|4|||
164488817|NCT02561195|594159374|FG001|Vaccination 1 to 3|Adverse Event|5|||
164488818|NCT02561195|594159375|FG002|Vaccination 1 to 3|Adverse Event|0|||
164488819|NCT02561195|594159376|FG003|Vaccination 1 to 3|Adverse Event|3|||
164488820|NCT02561195|594159377|FG004|Vaccination 1 to 3|Adverse Event|4|||
164714784|NCT04581369|594978719|FG002|Overall Study|Death|0|||
164488821|NCT02561195|594159378|FG005|Vaccination 1 to 3|Adverse Event|0|||
164488822|NCT02561195|594159379|FG006|Vaccination 1 to 3|Adverse Event|0|||
164488823|NCT02561195|594159380|FG007|Vaccination 1 to 3|Adverse Event|0|||
164488824|NCT02561195|594159381|FG008|Vaccination 1 to 3|Adverse Event|0|||
164488825|NCT02561195|594159382|FG009|Vaccination 1 to 3|Adverse Event|0|||
164488826|NCT02561195|594159383|FG010|Vaccination 1 to 3|Adverse Event|0|||
164488827|NCT02561195|594159384|FG011|Vaccination 1 to 3|Adverse Event|0|||
164488828|NCT02561195|594159385|FG012|Vaccination 1 to 3|Adverse Event|0|||
164488829|NCT02561195|594159386|FG013|Vaccination 1 to 3|Adverse Event|0|||
164488830|NCT02561195|594159373|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
164488831|NCT02561195|594159374|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
164488832|NCT02561195|594159375|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
164488833|NCT02561195|594159376|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
164488834|NCT02561195|594159377|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
164488835|NCT02561195|594159378|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
164488836|NCT02561195|594159379|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
164488837|NCT02561195|594159380|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
164488838|NCT02561195|594159381|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
164488839|NCT02561195|594159382|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
164488840|NCT02561195|594159383|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
164488841|NCT02561195|594159384|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
164488842|NCT02561195|594159385|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
164488843|NCT02561195|594159386|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
164488844|NCT02561195|594159373|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
164488845|NCT02561195|594159374|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
164488846|NCT02561195|594159375|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
164488847|NCT02561195|594159376|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
164488848|NCT02561195|594159377|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
164488849|NCT02561195|594159378|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
164488850|NCT02561195|594159379|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
164488851|NCT02561195|594159380|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
164488852|NCT02561195|594159381|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
164488853|NCT02561195|594159382|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
164488854|NCT02561195|594159383|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
164488855|NCT02561195|594159384|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
164488856|NCT02561195|594159385|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
164488857|NCT02561195|594159386|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
164488858|NCT02561195|594159373|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
164488859|NCT02561195|594159374|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
164488860|NCT02561195|594159375|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
164488861|NCT02561195|594159376|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
164488862|NCT02561195|594159377|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
164488863|NCT02561195|594159378|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
164488864|NCT02561195|594159379|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
164488865|NCT02561195|594159380|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
164488866|NCT02561195|594159381|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
164488867|NCT02561195|594159382|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
164488868|NCT02561195|594159383|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
164488869|NCT02561195|594159384|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
164488870|NCT02561195|594159385|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
164488871|NCT02561195|594159386|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
164488872|NCT02561195|594159373|FG000|Vaccination 1 to 3|Other|7|||
164488873|NCT02561195|594159374|FG001|Vaccination 1 to 3|Other|3|||
164488874|NCT02561195|594159375|FG002|Vaccination 1 to 3|Other|1|||
164488875|NCT02561195|594159376|FG003|Vaccination 1 to 3|Other|7|||
164488876|NCT02561195|594159377|FG004|Vaccination 1 to 3|Other|5|||
164488877|NCT02561195|594159378|FG005|Vaccination 1 to 3|Other|1|||
164488878|NCT02561195|594159379|FG006|Vaccination 1 to 3|Other|0|||
164488879|NCT02561195|594159380|FG007|Vaccination 1 to 3|Other|0|||
164488880|NCT02561195|594159381|FG008|Vaccination 1 to 3|Other|0|||
164488881|NCT02561195|594159382|FG009|Vaccination 1 to 3|Other|0|||
164488882|NCT02561195|594159383|FG010|Vaccination 1 to 3|Other|0|||
164488883|NCT02561195|594159384|FG011|Vaccination 1 to 3|Other|0|||
164714785|NCT04581369|594978717|FG000|Overall Study|Lost to Follow-up|7|||
164488884|NCT02561195|594159385|FG012|Vaccination 1 to 3|Other|0|||
164488885|NCT02561195|594159386|FG013|Vaccination 1 to 3|Other|0|||
164488886|NCT02561195|594159373|FG000|Vaccination 1 to 3|Protocol Violation|1|||
164488887|NCT02561195|594159374|FG001|Vaccination 1 to 3|Protocol Violation|0|||
164488888|NCT02561195|594159375|FG002|Vaccination 1 to 3|Protocol Violation|1|||
164488889|NCT02561195|594159376|FG003|Vaccination 1 to 3|Protocol Violation|2|||
164488890|NCT02561195|594159377|FG004|Vaccination 1 to 3|Protocol Violation|5|||
164488891|NCT02561195|594159378|FG005|Vaccination 1 to 3|Protocol Violation|2|||
164488892|NCT02561195|594159379|FG006|Vaccination 1 to 3|Protocol Violation|0|||
164488893|NCT02561195|594159380|FG007|Vaccination 1 to 3|Protocol Violation|0|||
164488894|NCT02561195|594159381|FG008|Vaccination 1 to 3|Protocol Violation|0|||
164488895|NCT02561195|594159382|FG009|Vaccination 1 to 3|Protocol Violation|0|||
164488896|NCT02561195|594159383|FG010|Vaccination 1 to 3|Protocol Violation|0|||
164488897|NCT02561195|594159384|FG011|Vaccination 1 to 3|Protocol Violation|0|||
164488898|NCT02561195|594159385|FG012|Vaccination 1 to 3|Protocol Violation|0|||
164488899|NCT02561195|594159386|FG013|Vaccination 1 to 3|Protocol Violation|0|||
164488900|NCT02561195|594159373|FG000|Vaccination 1 to 3|Death|2|||
164488901|NCT02561195|594159374|FG001|Vaccination 1 to 3|Death|1|||
164488902|NCT02561195|594159375|FG002|Vaccination 1 to 3|Death|0|||
164488903|NCT02561195|594159376|FG003|Vaccination 1 to 3|Death|2|||
164488904|NCT02561195|594159377|FG004|Vaccination 1 to 3|Death|0|||
164488905|NCT02561195|594159378|FG005|Vaccination 1 to 3|Death|0|||
164488906|NCT02561195|594159379|FG006|Vaccination 1 to 3|Death|0|||
164488907|NCT02561195|594159380|FG007|Vaccination 1 to 3|Death|0|||
164488908|NCT02561195|594159381|FG008|Vaccination 1 to 3|Death|0|||
164488909|NCT02561195|594159382|FG009|Vaccination 1 to 3|Death|0|||
164488910|NCT02561195|594159383|FG010|Vaccination 1 to 3|Death|0|||
164488911|NCT02561195|594159384|FG011|Vaccination 1 to 3|Death|0|||
164488912|NCT02561195|594159385|FG012|Vaccination 1 to 3|Death|0|||
164488913|NCT02561195|594159386|FG013|Vaccination 1 to 3|Death|0|||
164488914|NCT02561195|594159373|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
164488915|NCT02561195|594159374|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
164488916|NCT02561195|594159375|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
164488917|NCT02561195|594159376|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
164488918|NCT02561195|594159377|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
164488919|NCT02561195|594159378|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
164488920|NCT02561195|594159379|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
164488921|NCT02561195|594159380|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
164488922|NCT02561195|594159381|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
164488923|NCT02561195|594159382|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
164488924|NCT02561195|594159383|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
164488925|NCT02561195|594159384|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
164488926|NCT02561195|594159385|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
164488927|NCT02561195|594159386|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
164488928|NCT02561195|594159373|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
164488929|NCT02561195|594159374|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
164488930|NCT02561195|594159375|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
164488931|NCT02561195|594159376|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
164488932|NCT02561195|594159377|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
164488933|NCT02561195|594159378|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
164488934|NCT02561195|594159379|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
164488935|NCT02561195|594159380|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
164488936|NCT02561195|594159381|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
164488937|NCT02561195|594159382|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
164488938|NCT02561195|594159383|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
164488939|NCT02561195|594159384|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
164488940|NCT02561195|594159385|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
164488941|NCT02561195|594159386|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
164488942|NCT02561195|594159373|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
164488943|NCT02561195|594159374|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
164488944|NCT02561195|594159375|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
164488945|NCT02561195|594159376|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
164488946|NCT02561195|594159377|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
164488947|NCT02561195|594159378|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
164602274|NCT01885078|594564805|FG000|Treatment Period|Physician Decision|19|||
164488948|NCT02561195|594159379|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
164488949|NCT02561195|594159380|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
164488950|NCT02561195|594159381|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
164488951|NCT02561195|594159382|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
164488952|NCT02561195|594159383|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
164488953|NCT02561195|594159384|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
164488954|NCT02561195|594159385|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
164488955|NCT02561195|594159386|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
164488956|NCT02561195|594159373|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
164488957|NCT02561195|594159374|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
164488958|NCT02561195|594159375|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
164488959|NCT02561195|594159376|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
164488960|NCT02561195|594159377|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
164488961|NCT02561195|594159378|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
164488962|NCT02561195|594159379|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
164488963|NCT02561195|594159380|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
164488964|NCT02561195|594159381|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
164488965|NCT02561195|594159382|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
164602275|NCT01885078|594564806|FG001|Treatment Period|Physician Decision|21|||
164488966|NCT02561195|594159383|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
164488967|NCT02561195|594159384|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
164488968|NCT02561195|594159385|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
164488969|NCT02561195|594159386|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
164488970|NCT02561195|594159373|FG000|Extension Stage (Vaccination 4)|Death|0|||
164488971|NCT02561195|594159374|FG001|Extension Stage (Vaccination 4)|Death|0|||
164488972|NCT02561195|594159375|FG002|Extension Stage (Vaccination 4)|Death|0|||
164488973|NCT02561195|594159376|FG003|Extension Stage (Vaccination 4)|Death|0|||
164488974|NCT02561195|594159377|FG004|Extension Stage (Vaccination 4)|Death|0|||
164488975|NCT02561195|594159378|FG005|Extension Stage (Vaccination 4)|Death|0|||
164488976|NCT02561195|594159379|FG006|Extension Stage (Vaccination 4)|Death|0|||
164488977|NCT02561195|594159380|FG007|Extension Stage (Vaccination 4)|Death|0|||
164488978|NCT02561195|594159381|FG008|Extension Stage (Vaccination 4)|Death|0|||
164488979|NCT02561195|594159382|FG009|Extension Stage (Vaccination 4)|Death|1|||
164488980|NCT02561195|594159383|FG010|Extension Stage (Vaccination 4)|Death|0|||
164488981|NCT02561195|594159384|FG011|Extension Stage (Vaccination 4)|Death|0|||
164488982|NCT02561195|594159385|FG012|Extension Stage (Vaccination 4)|Death|0|||
164488983|NCT02561195|594159386|FG013|Extension Stage (Vaccination 4)|Death|0|||
164488984|NCT02561195|594159373|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
164488985|NCT02561195|594159374|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
164488986|NCT02561195|594159375|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
164488987|NCT02561195|594159376|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
164488988|NCT02561195|594159377|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
164488989|NCT02561195|594159378|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
164488990|NCT02561195|594159379|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
164488991|NCT02561195|594159380|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
164488992|NCT02561195|594159381|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
164488993|NCT02561195|594159382|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
164488994|NCT02561195|594159383|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
164488995|NCT02561195|594159384|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
164488996|NCT02561195|594159385|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
164488997|NCT02561195|594159386|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
164488998|NCT02561195|594159373|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
164488999|NCT02561195|594159374|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
164489000|NCT02561195|594159375|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
164489001|NCT02561195|594159376|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
164489002|NCT02561195|594159377|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
164489003|NCT02561195|594159378|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
164489004|NCT02561195|594159379|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
164489005|NCT02561195|594159380|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
164489006|NCT02561195|594159381|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
164489007|NCT02561195|594159382|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
164489008|NCT02561195|594159383|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
164489009|NCT02561195|594159384|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
164489010|NCT02561195|594159385|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
164489011|NCT02561195|594159386|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
164489012|NCT02561195|594159373|FG000|Extension Stage (Vaccination 4)|Other|0|||
164489013|NCT02561195|594159374|FG001|Extension Stage (Vaccination 4)|Other|0|||
164489014|NCT02561195|594159375|FG002|Extension Stage (Vaccination 4)|Other|0|||
164489015|NCT02561195|594159376|FG003|Extension Stage (Vaccination 4)|Other|0|||
164489016|NCT02561195|594159377|FG004|Extension Stage (Vaccination 4)|Other|0|||
164489017|NCT02561195|594159378|FG005|Extension Stage (Vaccination 4)|Other|0|||
164489018|NCT02561195|594159379|FG006|Extension Stage (Vaccination 4)|Other|0|||
164489019|NCT02561195|594159380|FG007|Extension Stage (Vaccination 4)|Other|0|||
164602276|NCT01885078|594564807|FG002|Treatment Period|Physician Decision|5|||
164602277|NCT01885078|594564808|FG003|Treatment Period|Physician Decision|12|||
164602278|NCT01885078|594564809|FG004|Treatment Period|Physician Decision|9|||
164145296|NCT00025259|592894263|FG000|Overall Study|Protocol Violation|3|||
164489020|NCT02561195|594159381|FG008|Extension Stage (Vaccination 4)|Other|0|||
164489021|NCT02561195|594159382|FG009|Extension Stage (Vaccination 4)|Other|0|||
164489022|NCT02561195|594159383|FG010|Extension Stage (Vaccination 4)|Other|2|||
164602279|NCT01885078|594564810|FG005|Treatment Period|Physician Decision|24|||
164602280|NCT01885078|594564811|FG006|Treatment Period|Physician Decision|4|||
164489023|NCT02561195|594159384|FG011|Extension Stage (Vaccination 4)|Other|2|||
164489024|NCT02561195|594159385|FG012|Extension Stage (Vaccination 4)|Other|1|||
164489025|NCT02561195|594159386|FG013|Extension Stage (Vaccination 4)|Other|0|||
164489026|NCT02561195|594159373|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
164489027|NCT02561195|594159374|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
164489028|NCT02561195|594159375|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
164489029|NCT02561195|594159376|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
164489030|NCT02561195|594159377|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
164489031|NCT02561195|594159378|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
164489032|NCT02561195|594159379|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
164489033|NCT02561195|594159380|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
164489034|NCT02561195|594159381|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
164489035|NCT02561195|594159382|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
164489036|NCT02561195|594159383|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
164489037|NCT02561195|594159384|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
164489038|NCT02561195|594159385|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
164489039|NCT02561195|594159386|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
164489040|NCT00736502|594159387|FG000|Overall Study|Adverse Event|22|||
164489041|NCT00736502|594159387|FG000|Overall Study|Lack of Efficacy|16|||
164489042|NCT00736502|594159387|FG000|Overall Study|Lost to Follow-up|27|||
164489043|NCT00070317|594159388|FG000|Overall Study|Inevaluable (Never Treated)|1|||
164489044|NCT00070317|594159388|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
164489045|NCT00070317|594159388|FG000|Overall Study|Ineligible required test not done|1|||
164489046|NCT00070317|594159388|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
164489047|NCT00070317|594159388|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
164489048|NCT00508144|594159389|FG000|Overall Study|Not eligible|6|||
164489049|NCT00508144|594159389|FG000|Overall Study|Death|5|||
164489050|NCT01661972|594159390|FG000|Overall Study|Adverse Event|1|||
164489051|NCT01661972|594159391|FG001|Overall Study|Adverse Event|2|||
164489052|NCT01661972|594159390|FG000|Overall Study|Death during Treatment period|1|||
164489053|NCT01661972|594159391|FG001|Overall Study|Death during Treatment period|1|||
164489054|NCT01661972|594159390|FG000|Overall Study|Withdrawal by Subject|0|||
164489055|NCT01661972|594159391|FG001|Overall Study|Withdrawal by Subject|1|||
164489056|NCT01084772|594159392|FG000|Baseline|Withdrawal by Subject|7|||
164489057|NCT01084772|594159393|FG001|Baseline|Withdrawal by Subject|6|||
164489058|NCT01084772|594159392|FG000|3 Months|Death|1|||
164489059|NCT01084772|594159393|FG001|3 Months|Death|0|||
164489060|NCT01084772|594159392|FG000|3 Months|Study Termination|2|||
164489061|NCT01084772|594159393|FG001|3 Months|Study Termination|2|||
164489062|NCT01084772|594159392|FG000|1 Year|Withdrawal by Subject|0|||
164489063|NCT01084772|594159393|FG001|1 Year|Withdrawal by Subject|1|||
164489064|NCT01084772|594159392|FG000|1 Year|Lost to Follow-up|3|||
164489065|NCT01084772|594159393|FG001|1 Year|Lost to Follow-up|0|||
164489066|NCT01084772|594159392|FG000|1 Year|Study Termination|0|||
164489067|NCT01084772|594159393|FG001|1 Year|Study Termination|7|||
164489068|NCT01084772|594159392|FG000|2 Years|Withdrawal by Subject|1|||
164489069|NCT01084772|594159393|FG001|2 Years|Withdrawal by Subject|0|||
164489070|NCT01084772|594159392|FG000|2 Years|Lost to Follow-up|5|||
164489071|NCT01084772|594159393|FG001|2 Years|Lost to Follow-up|2|||
164489072|NCT01084772|594159392|FG000|2 Years|Study Termination|3|||
164489073|NCT01084772|594159393|FG001|2 Years|Study Termination|2|||
164489074|NCT01294644|594159394|FG000|Overall Study|Adverse Event|2|||
164489075|NCT01294644|594159395|FG001|Overall Study|Adverse Event|0|||
164489076|NCT01294644|594159396|FG002|Overall Study|Adverse Event|1|||
164489077|NCT01294644|594159394|FG000|Overall Study|Withdrawal by Subject|3|||
164489078|NCT01294644|594159395|FG001|Overall Study|Withdrawal by Subject|7|||
164489079|NCT01294644|594159396|FG002|Overall Study|Withdrawal by Subject|4|||
164489080|NCT01294644|594159394|FG000|Overall Study|Lost to Follow-up|3|||
164489081|NCT01294644|594159395|FG001|Overall Study|Lost to Follow-up|2|||
164714786|NCT04581369|594978718|FG001|Overall Study|Lost to Follow-up|3|||
164714787|NCT04581369|594978719|FG002|Overall Study|Lost to Follow-up|0|||
164714788|NCT04581369|594978717|FG000|Overall Study|liver transplant|2|||
164714789|NCT04581369|594978718|FG001|Overall Study|liver transplant|2|||
164489082|NCT01294644|594159396|FG002|Overall Study|Lost to Follow-up|5|||
164489083|NCT01294644|594159394|FG000|Overall Study|Miscellaneous Reason|2|||
164489084|NCT01294644|594159395|FG001|Overall Study|Miscellaneous Reason|1|||
164489085|NCT01294644|594159396|FG002|Overall Study|Miscellaneous Reason|4|||
164489086|NCT01517282|594159397|FG000|Overall Study|Consent withdrawn|0|||
164489087|NCT01517282|594159398|FG001|Overall Study|Consent withdrawn|1|||
164489088|NCT01517282|594159399|FG002|Overall Study|Consent withdrawn|1|||
164489089|NCT01517282|594159400|FG003|Overall Study|Consent withdrawn|1|||
164489090|NCT01517282|594159397|FG000|Overall Study|Physician Decision|1|||
164489091|NCT01517282|594159398|FG001|Overall Study|Physician Decision|0|||
164489092|NCT01517282|594159399|FG002|Overall Study|Physician Decision|0|||
164489093|NCT01517282|594159400|FG003|Overall Study|Physician Decision|0|||
164489094|NCT02942771|594159403|FG000|Overall Study|Adverse Event|1|||
164489095|NCT02942771|594159404|FG001|Overall Study|Adverse Event|0|||
164489096|NCT02942771|594159405|FG002|Overall Study|Adverse Event|0|||
164489097|NCT02942771|594159406|FG003|Overall Study|Adverse Event|0|||
164489098|NCT02942771|594159407|FG004|Overall Study|Adverse Event|2|||
164489099|NCT02942771|594159403|FG000|Overall Study|Lost to Follow-up|1|||
164489100|NCT02942771|594159404|FG001|Overall Study|Lost to Follow-up|0|||
164489101|NCT02942771|594159405|FG002|Overall Study|Lost to Follow-up|0|||
164489102|NCT02942771|594159406|FG003|Overall Study|Lost to Follow-up|0|||
164489103|NCT02942771|594159407|FG004|Overall Study|Lost to Follow-up|0|||
164489104|NCT02942771|594159403|FG000|Overall Study|Withdrawal by Subject|1|||
164489105|NCT02942771|594159404|FG001|Overall Study|Withdrawal by Subject|0|||
164489106|NCT02942771|594159405|FG002|Overall Study|Withdrawal by Subject|0|||
164489107|NCT02942771|594159406|FG003|Overall Study|Withdrawal by Subject|0|||
164489108|NCT02942771|594159407|FG004|Overall Study|Withdrawal by Subject|2|||
164489109|NCT02158806|594159408|FG000|Overall Study|Death|2|||
164489110|NCT02158806|594159409|FG001|Overall Study|Death|0|||
164489111|NCT02158806|594159408|FG000|Overall Study|Withdrawal by Subject|2|||
164489112|NCT02158806|594159409|FG001|Overall Study|Withdrawal by Subject|0|||
164489113|NCT02158806|594159408|FG000|Overall Study|Lost to Follow-up|0|||
164489114|NCT02158806|594159409|FG001|Overall Study|Lost to Follow-up|3|||
164489115|NCT02158806|594159408|FG000|Overall Study|Moved out of area|0|||
164489116|NCT02158806|594159409|FG001|Overall Study|Moved out of area|1|||
164489117|NCT02158806|594159408|FG000|Overall Study|Transferred to palliative care|0|||
164489118|NCT02158806|594159409|FG001|Overall Study|Transferred to palliative care|1|||
164489119|NCT01898299|594159410|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
164489120|NCT01898299|594159411|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
164489121|NCT02340806|594159415|FG000|Overall Study|Protocol Violation|2|||
164489122|NCT02340806|594159416|FG001|Overall Study|Protocol Violation|0|||
164489123|NCT02340806|594159415|FG000|Overall Study|epidural catheter replaced|2|||
164489124|NCT02340806|594159416|FG001|Overall Study|epidural catheter replaced|1|||
164489125|NCT02340806|594159415|FG000|Overall Study|history of chronic pain medication|1|||
164489126|NCT02340806|594159416|FG001|Overall Study|history of chronic pain medication|0|||
164489127|NCT02340806|594159415|FG000|Overall Study|re-dose < 90 min of CSE|1|||
164489128|NCT02340806|594159416|FG001|Overall Study|re-dose < 90 min of CSE|3|||
164489129|NCT04919499|594159417|FG000|Overall Study|Adverse Event|0|||
164489130|NCT04919499|594159418|FG001|Overall Study|Adverse Event|0|||
164489131|NCT04919499|594159419|FG002|Overall Study|Adverse Event|0|||
164489132|NCT04919499|594159420|FG003|Overall Study|Adverse Event|0|||
164489133|NCT04919499|594159421|FG004|Overall Study|Adverse Event|2|||
164489134|NCT04919499|594159417|FG000|Overall Study|Not treated|0|||
164489135|NCT04919499|594159418|FG001|Overall Study|Not treated|0|||
164489136|NCT04919499|594159419|FG002|Overall Study|Not treated|0|||
164489137|NCT04919499|594159420|FG003|Overall Study|Not treated|1|||
164489138|NCT04919499|594159421|FG004|Overall Study|Not treated|0|||
164489139|NCT04520256|594159422|FG000|Overall Study|Lost to Follow-up|6|||
164489140|NCT04520256|594159423|FG001|Overall Study|Lost to Follow-up|4|||
164489141|NCT04520256|594159424|FG002|Overall Study|Lost to Follow-up|2|||
164489142|NCT04520256|594159425|FG003|Overall Study|Lost to Follow-up|3|||
164489143|NCT04520256|594159426|FG004|Overall Study|Lost to Follow-up|6|||
164489144|NCT04520256|594159427|FG005|Overall Study|Lost to Follow-up|6|||
164489145|NCT04520256|594159428|FG006|Overall Study|Lost to Follow-up|4|||
164489146|NCT04520256|594159429|FG007|Overall Study|Lost to Follow-up|6|||
164489147|NCT04520256|594159430|FG008|Overall Study|Lost to Follow-up|1|||
164489148|NCT04520256|594159431|FG009|Overall Study|Lost to Follow-up|3|||
164489149|NCT04520256|594159432|FG010|Overall Study|Lost to Follow-up|3|||
164489150|NCT04520256|594159433|FG011|Overall Study|Lost to Follow-up|2|||
164489151|NCT04520256|594159434|FG012|Overall Study|Lost to Follow-up|5|||
164489152|NCT04520256|594159435|FG013|Overall Study|Lost to Follow-up|3|||
164489153|NCT04520256|594159436|FG014|Overall Study|Lost to Follow-up|3|||
164489154|NCT04520256|594159437|FG015|Overall Study|Lost to Follow-up|6|||
164489155|NCT04520256|594159438|FG016|Overall Study|Lost to Follow-up|6|||
164489156|NCT04520256|594159439|FG017|Overall Study|Lost to Follow-up|4|||
164489157|NCT04520256|594159440|FG018|Overall Study|Lost to Follow-up|3|||
164489158|NCT04520256|594159441|FG019|Overall Study|Lost to Follow-up|3|||
164489159|NCT04520256|594159442|FG020|Overall Study|Lost to Follow-up|7|||
164489160|NCT04520256|594159443|FG021|Overall Study|Lost to Follow-up|3|||
164714790|NCT04581369|594978719|FG002|Overall Study|liver transplant|0|||
164489161|NCT04520256|594159444|FG022|Overall Study|Lost to Follow-up|3|||
164489162|NCT04520256|594159445|FG023|Overall Study|Lost to Follow-up|8|||
164489163|NCT04520256|594159446|FG024|Overall Study|Lost to Follow-up|5|||
164489164|NCT04520256|594159447|FG025|Overall Study|Lost to Follow-up|4|||
164489165|NCT04520256|594159448|FG026|Overall Study|Lost to Follow-up|3|||
164489166|NCT04520256|594159449|FG027|Overall Study|Lost to Follow-up|4|||
164489167|NCT04520256|594159450|FG028|Overall Study|Lost to Follow-up|3|||
164489168|NCT04520256|594159451|FG029|Overall Study|Lost to Follow-up|4|||
164489169|NCT04520256|594159452|FG030|Overall Study|Lost to Follow-up|4|||
164489170|NCT04520256|594159453|FG031|Overall Study|Lost to Follow-up|4|||
164489171|NCT00760877|594160616|FG000|Overall Study|Protocol Violation|1|||
164489172|NCT00760877|594160617|FG001|Overall Study|Protocol Violation|0|||
164489173|NCT00760877|594160616|FG000|Overall Study|Non-compliance with protocol treatment|2|||
164489174|NCT00760877|594160617|FG001|Overall Study|Non-compliance with protocol treatment|1|||
164489175|NCT00760877|594160616|FG000|Overall Study|Pregnancy|1|||
164489176|NCT00760877|594160617|FG001|Overall Study|Pregnancy|4|||
164489177|NCT00760877|594160616|FG000|Overall Study|Death|2|||
164489178|NCT00760877|594160617|FG001|Overall Study|Death|1|||
164489179|NCT00760877|594160616|FG000|Overall Study|Withdrawal by Subject|7|||
164489180|NCT00760877|594160617|FG001|Overall Study|Withdrawal by Subject|3|||
164489181|NCT00760877|594160616|FG000|Overall Study|Adverse Event|19|||
164489182|NCT00760877|594160617|FG001|Overall Study|Adverse Event|12|||
164489183|NCT00760877|594160616|FG000|Overall Study|Participant diagnosed with AML|0|||
164489184|NCT00760877|594160617|FG001|Overall Study|Participant diagnosed with AML|1|||
164489185|NCT00760877|594160616|FG000|Overall Study|Participant not eligible to cross-over|0|||
164489186|NCT00760877|594160617|FG001|Overall Study|Participant not eligible to cross-over|1|||
164489187|NCT00760877|594160616|FG000|Overall Study|Physician Decision|1|||
164489188|NCT00760877|594160617|FG001|Overall Study|Physician Decision|2|||
164489189|NCT00760877|594160616|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
164489190|NCT00760877|594160617|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
164489191|NCT00760877|594160616|FG000|Overall Study|Treatment failure|1|||
164489192|NCT00760877|594160617|FG001|Overall Study|Treatment failure|0|||
164489193|NCT04413149|594160620|FG000|Overall Study|Death|10|||
164489194|NCT04413149|594160621|FG001|Overall Study|Death|5|||
164489195|NCT04413149|594160620|FG000|Overall Study|Lung transplantation|1|||
164489196|NCT04413149|594160621|FG001|Overall Study|Lung transplantation|0|||
164489197|NCT00676195|594160622|FG000|Overall Study|Lost to Follow-up|1|||
164489198|NCT00676195|594160622|FG000|Overall Study|Adverse Event|1|||
164489199|NCT00676195|594160622|FG000|Overall Study|Physician Decision|1|||
164489200|NCT02878590|594160623|FG000|Overall Study|Withdrawal by Subject|2|||
164489201|NCT03978130|594160631|FG000|Overall Study|Lost to Follow-up|13|||
164489202|NCT03978130|594160632|FG001|Overall Study|Lost to Follow-up|14|||
164489203|NCT03978130|594160631|FG000|Overall Study|Withdrawal by Subject|12|||
164489204|NCT03978130|594160632|FG001|Overall Study|Withdrawal by Subject|2|||
164489205|NCT03978130|594160631|FG000|Overall Study|Adverse Event|2|||
164489206|NCT03978130|594160632|FG001|Overall Study|Adverse Event|1|||
164489207|NCT05878990|594160637|FG000|Overall Study|Lost to Follow-up|7|||
164489208|NCT05878990|594160637|FG000|Overall Study|Withdrawal by Subject|1|||
164489209|NCT00668746|594160638|FG000|Overall Study|Lost to Follow-up|2|||
164489210|NCT00668746|594160639|FG001|Overall Study|Lost to Follow-up|1|||
164489211|NCT03409276|594160640|FG000|Overall Study|Withdrawal by Subject|0|||
164489212|NCT03409276|594160641|FG001|Overall Study|Withdrawal by Subject|0|||
164489213|NCT03409276|594160642|FG002|Overall Study|Withdrawal by Subject|0|||
164489214|NCT03409276|594160643|FG003|Overall Study|Withdrawal by Subject|0|||
164489215|NCT03409276|594160644|FG004|Overall Study|Withdrawal by Subject|1|||
164489216|NCT03409276|594160640|FG000|Overall Study|Lost to Follow-up|0|||
164489217|NCT03409276|594160641|FG001|Overall Study|Lost to Follow-up|0|||
164489218|NCT03409276|594160642|FG002|Overall Study|Lost to Follow-up|0|||
164489219|NCT03409276|594160643|FG003|Overall Study|Lost to Follow-up|2|||
164489220|NCT03409276|594160644|FG004|Overall Study|Lost to Follow-up|2|||
164489221|NCT03605745|594160645|FG000|Overall Study|Study was terminated for business reasons|47|||
164489222|NCT01074229|594160646|FG000|Overall Study|Lost to Follow-up|1|||
164489223|NCT01074229|594160647|FG001|Overall Study|Lost to Follow-up|0|||
164489224|NCT01074229|594160648|FG002|Overall Study|Lost to Follow-up|0|||
164489225|NCT01074229|594160646|FG000|Overall Study|Change to open surgical procedure|1|||
164489226|NCT01074229|594160647|FG001|Overall Study|Change to open surgical procedure|3|||
164489227|NCT01074229|594160648|FG002|Overall Study|Change to open surgical procedure|4|||
164489228|NCT05361304|594160658|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
164489229|NCT05361304|594160659|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
164489230|NCT05361304|594160658|FG000|Overall Study|COVID-19 Related|1|||
164489231|NCT05361304|594160659|FG001|Overall Study|COVID-19 Related|2|||
164489232|NCT05361304|594160658|FG000|Overall Study|Withdrawal by Subject|1|||
164489233|NCT05361304|594160659|FG001|Overall Study|Withdrawal by Subject|0|||
164489234|NCT03320941|594160660|FG000|Overall Study|subject/guardian decision|0|||
164489235|NCT03320941|594160661|FG001|Overall Study|subject/guardian decision|0|||
164489236|NCT03320941|594160662|FG002|Overall Study|subject/guardian decision|0|||
164489237|NCT03320941|594160663|FG003|Overall Study|subject/guardian decision|1|||
164602281|NCT01885078|594564812|FG007|Treatment Period|Physician Decision|3|||
164602282|NCT01885078|594564813|FG008|Treatment Period|Physician Decision|0|||
164602283|NCT01885078|594564814|FG009|Treatment Period|Physician Decision|0|||
164489238|NCT03320941|594160664|FG004|Overall Study|subject/guardian decision|0|||
164489239|NCT02368691|594160666|FG000|Overall Study|Death|13|||
164489240|NCT02368691|594160666|FG000|Overall Study|Lack of Efficacy|15|||
164489241|NCT02368691|594160666|FG000|Overall Study|Physician Decision|4|||
164489242|NCT02069366|594160667|FG000|Overall Study|Lost to Follow-up|0|||
164489243|NCT02069366|594160668|FG001|Overall Study|Lost to Follow-up|0|||
164489244|NCT02069366|594160669|FG002|Overall Study|Lost to Follow-up|1|||
164489245|NCT02069366|594160670|FG003|Overall Study|Lost to Follow-up|0|||
164489246|NCT02069366|594160671|FG004|Overall Study|Lost to Follow-up|0|||
164489247|NCT02069366|594160672|FG005|Overall Study|Lost to Follow-up|2|||
164489248|NCT02069366|594160667|FG000|Overall Study|Protocol Violation|0|||
164489249|NCT02069366|594160668|FG001|Overall Study|Protocol Violation|0|||
164489250|NCT02069366|594160669|FG002|Overall Study|Protocol Violation|1|||
164489251|NCT02069366|594160670|FG003|Overall Study|Protocol Violation|0|||
164489252|NCT02069366|594160671|FG004|Overall Study|Protocol Violation|0|||
164489253|NCT02069366|594160672|FG005|Overall Study|Protocol Violation|0|||
164489254|NCT02069366|594160667|FG000|Overall Study|Withdrawal by Subject|1|||
164489255|NCT02069366|594160668|FG001|Overall Study|Withdrawal by Subject|0|||
164489256|NCT02069366|594160669|FG002|Overall Study|Withdrawal by Subject|1|||
164489257|NCT02069366|594160670|FG003|Overall Study|Withdrawal by Subject|2|||
164489258|NCT02069366|594160671|FG004|Overall Study|Withdrawal by Subject|0|||
164489259|NCT02069366|594160672|FG005|Overall Study|Withdrawal by Subject|0|||
164489260|NCT03314233|594160673|FG000|Overall Study|No longer eligible at time of delivery|1|||
164489261|NCT01797705|594160674|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
164489262|NCT01797705|594160674|FG000|Overall Study|Withdrawal by Subject|1|||
164489263|NCT01838447|594160675|FG000|Overall Study|Change in surgical plan|1|||
164489264|NCT01838447|594160676|FG001|Overall Study|Change in surgical plan|2|||
164489265|NCT01838447|594160675|FG000|Overall Study|Withdrawal by Subject|1|||
164489266|NCT01838447|594160676|FG001|Overall Study|Withdrawal by Subject|1|||
164489267|NCT02030847|594160678|FG000|Overall Study|Death|10|||
164489268|NCT02030847|594160678|FG000|Overall Study|Disease Progression|15|||
164489269|NCT02030847|594160678|FG000|Overall Study|New Cancer Therapy|8|||
164489270|NCT02030847|594160678|FG000|Overall Study|Physician Decision|3|||
164489271|NCT02030847|594160678|FG000|Overall Study|Withdrawal by Subject|1|||
164489272|NCT00584909|594160679|FG000|Overall Study|Adverse Event|4|||
164489273|NCT03436797|594160680|FG000|Main Study|Withdrawal by Subject|2|||
164489274|NCT03436797|594160680|FG000|Main Study|Adverse Event|4|||
164489275|NCT03436797|594160680|FG000|Main Study|Lost to Follow-up|1|||
164489276|NCT03436797|594160680|FG000|Main Study|Death|1|||
164489277|NCT03436797|594160680|FG000|Main Study|Non-Specific|2|||
164489278|NCT03436797|594160680|FG000|Extended Dosing|Patient decision|1|||
164489279|NCT00561678|594160681|FG000|Overall Study|Withdrawal by Subject|4|||
164489280|NCT00561678|594160682|FG001|Overall Study|Withdrawal by Subject|3|||
164489281|NCT00561678|594160681|FG000|Overall Study|surgery cancelled|1|||
164489282|NCT00561678|594160682|FG001|Overall Study|surgery cancelled|1|||
164489283|NCT00561678|594160681|FG000|Overall Study|surgery rescheduled to different site|2|||
164489284|NCT00561678|594160682|FG001|Overall Study|surgery rescheduled to different site|2|||
164489285|NCT00561678|594160681|FG000|Overall Study|anesthesia provider refusal|1|||
164489286|NCT00561678|594160682|FG001|Overall Study|anesthesia provider refusal|0|||
164489287|NCT01601821|594160688|FG000|Overall Study|Death|2|||
164489288|NCT01601821|594160689|FG001|Overall Study|Death|5|||
164489289|NCT01601821|594160688|FG000|Overall Study|Protocol Violation|2|||
164489290|NCT01601821|594160689|FG001|Overall Study|Protocol Violation|2|||
164489291|NCT01601821|594160688|FG000|Overall Study|Lost to Follow-up|6|||
164489292|NCT01601821|594160689|FG001|Overall Study|Lost to Follow-up|14|||
164489293|NCT01601821|594160688|FG000|Overall Study|Withdrawal by Subject|1|||
164489294|NCT01601821|594160689|FG001|Overall Study|Withdrawal by Subject|0|||
164489295|NCT01601821|594160688|FG000|Overall Study|Graft Loss|6|||
164489296|NCT01601821|594160689|FG001|Overall Study|Graft Loss|6|||
164489297|NCT01601821|594160688|FG000|Overall Study|Study Events|7|||
164489298|NCT01601821|594160689|FG001|Overall Study|Study Events|1|||
164489299|NCT01601821|594160688|FG000|Overall Study|Other|5|||
164489300|NCT01601821|594160689|FG001|Overall Study|Other|1|||
164489301|NCT01901302|594160693|FG000|Overall Study|Adverse Event|2|||
164489302|NCT01901302|594160694|FG001|Overall Study|Adverse Event|1|||
164489303|NCT01901302|594160693|FG000|Overall Study|Lack of Efficacy|0|||
164489304|NCT01901302|594160694|FG001|Overall Study|Lack of Efficacy|2|||
164489305|NCT01901302|594160693|FG000|Overall Study|Study Terminated by Sponsor|23|||
164489306|NCT01901302|594160694|FG001|Overall Study|Study Terminated by Sponsor|20|||
164489307|NCT01901302|594160693|FG000|Overall Study|Withdrawal by Subject|2|||
164489308|NCT01901302|594160694|FG001|Overall Study|Withdrawal by Subject|0|||
164489309|NCT00848198|594160696|FG000|Overall Study|Incomplete Case Report Forms|15|||
164489310|NCT03708744|594160697|FG000|Overall Study|Withdrawal by Subject|0|||
164489311|NCT03708744|594160698|FG001|Overall Study|Withdrawal by Subject|0|||
164602284|NCT01885078|594564805|FG000|Treatment Period|Protocol Violation|3|||
164602285|NCT01885078|594564806|FG001|Treatment Period|Protocol Violation|5|||
164602286|NCT01885078|594564807|FG002|Treatment Period|Protocol Violation|0|||
164602287|NCT01885078|594564808|FG003|Treatment Period|Protocol Violation|3|||
164602288|NCT01885078|594564809|FG004|Treatment Period|Protocol Violation|1|||
164489312|NCT03708744|594160699|FG002|Overall Study|Withdrawal by Subject|1|||
164602289|NCT01885078|594564810|FG005|Treatment Period|Protocol Violation|6|||
164602290|NCT01885078|594564811|FG006|Treatment Period|Protocol Violation|0|||
164489313|NCT03708744|594160700|FG003|Overall Study|Withdrawal by Subject|0|||
164489314|NCT02062827|594160701|FG000|Overall Study|Death|1|||
164489315|NCT02062827|594160702|FG001|Overall Study|Death|0|||
164489316|NCT02062827|594160703|FG002|Overall Study|Death|0|||
164489317|NCT02062827|594160704|FG003|Overall Study|Death|0|||
164489318|NCT02062827|594160705|FG004|Overall Study|Death|0|||
164489319|NCT02062827|594160706|FG005|Overall Study|Death|0|||
164489320|NCT02062827|594160707|FG006|Overall Study|Death|0|||
164489321|NCT02062827|594160708|FG007|Overall Study|Death|0|||
164489322|NCT02062827|594160701|FG000|Overall Study|Withdrawal by Subject|3|||
164489323|NCT02062827|594160702|FG001|Overall Study|Withdrawal by Subject|1|||
164602291|NCT01885078|594564812|FG007|Treatment Period|Protocol Violation|0|||
164489324|NCT02062827|594160703|FG002|Overall Study|Withdrawal by Subject|1|||
164489325|NCT02062827|594160704|FG003|Overall Study|Withdrawal by Subject|2|||
164489326|NCT02062827|594160705|FG004|Overall Study|Withdrawal by Subject|6|||
164489327|NCT02062827|594160706|FG005|Overall Study|Withdrawal by Subject|0|||
164489328|NCT02062827|594160707|FG006|Overall Study|Withdrawal by Subject|5|||
164489329|NCT02062827|594160708|FG007|Overall Study|Withdrawal by Subject|0|||
164489330|NCT02062827|594160701|FG000|Overall Study|Screen Fail|0|||
164489331|NCT02062827|594160702|FG001|Overall Study|Screen Fail|0|||
164489332|NCT02062827|594160703|FG002|Overall Study|Screen Fail|0|||
164489333|NCT02062827|594160704|FG003|Overall Study|Screen Fail|0|||
164489334|NCT02062827|594160705|FG004|Overall Study|Screen Fail|0|||
164489335|NCT02062827|594160706|FG005|Overall Study|Screen Fail|0|||
164489336|NCT02062827|594160707|FG006|Overall Study|Screen Fail|0|||
164489337|NCT02062827|594160708|FG007|Overall Study|Screen Fail|8|||
164489338|NCT02812706|594160710|FG000|Phase 1|Adverse Event|0|||
164489339|NCT02812706|594160711|FG001|Phase 1|Adverse Event|2|||
164489340|NCT02812706|594160712|FG002|Phase 1|Adverse Event|0|||
164489341|NCT02812706|594160710|FG000|Phase 1|Progressive disease|3|||
164489342|NCT02812706|594160711|FG001|Phase 1|Progressive disease|3|||
164489343|NCT02812706|594160712|FG002|Phase 1|Progressive disease|0|||
164489344|NCT02812706|594160710|FG000|Phase 2|Adverse Event|0|||
164489345|NCT02812706|594160711|FG001|Phase 2|Adverse Event|0|||
164489346|NCT02812706|594160712|FG002|Phase 2|Adverse Event|2|||
164489347|NCT02812706|594160710|FG000|Phase 2|Progressive disease|0|||
164489348|NCT02812706|594160711|FG001|Phase 2|Progressive disease|0|||
164489349|NCT02812706|594160712|FG002|Phase 2|Progressive disease|22|||
164489350|NCT02812706|594160710|FG000|Phase 2|Other-Unspecified|0|||
164489351|NCT02812706|594160711|FG001|Phase 2|Other-Unspecified|0|||
164489352|NCT02812706|594160712|FG002|Phase 2|Other-Unspecified|4|||
164489353|NCT02006641|594160713|FG000|Overall Study|Withdrawal before treatment|2|||
164489354|NCT02006641|594160714|FG001|Overall Study|Withdrawal before treatment|5|||
164489355|NCT02006641|594160715|FG002|Overall Study|Withdrawal before treatment|3|||
164489356|NCT02006641|594160713|FG000|Overall Study|Adverse Event|15|||
164489357|NCT02006641|594160714|FG001|Overall Study|Adverse Event|11|||
164489358|NCT02006641|594160715|FG002|Overall Study|Adverse Event|15|||
164489359|NCT02006641|594160713|FG000|Overall Study|Protocol Violation|0|||
164489360|NCT02006641|594160714|FG001|Overall Study|Protocol Violation|2|||
164489361|NCT02006641|594160715|FG002|Overall Study|Protocol Violation|2|||
164489362|NCT02006641|594160713|FG000|Overall Study|Lost to Follow-up|0|||
164489363|NCT02006641|594160714|FG001|Overall Study|Lost to Follow-up|1|||
164489364|NCT02006641|594160715|FG002|Overall Study|Lost to Follow-up|0|||
164489365|NCT02006641|594160713|FG000|Overall Study|Withdrawal by Subject|7|||
164489366|NCT02006641|594160714|FG001|Overall Study|Withdrawal by Subject|12|||
164489367|NCT02006641|594160715|FG002|Overall Study|Withdrawal by Subject|11|||
164489368|NCT02006641|594160713|FG000|Overall Study|Other reason: patient didn't show up|1|||
164489369|NCT02006641|594160714|FG001|Overall Study|Other reason: patient didn't show up|0|||
164489370|NCT02006641|594160715|FG002|Overall Study|Other reason: patient didn't show up|0|||
164489371|NCT02006641|594160713|FG000|Overall Study|Other reason:patient didn't want to come|0|||
164489372|NCT02006641|594160714|FG001|Overall Study|Other reason:patient didn't want to come|0|||
164489373|NCT02006641|594160715|FG002|Overall Study|Other reason:patient didn't want to come|1|||
164489374|NCT02006641|594160713|FG000|Overall Study|Other reason: patient has moved|1|||
164489375|NCT02006641|594160714|FG001|Overall Study|Other reason: patient has moved|0|||
164489376|NCT02006641|594160715|FG002|Overall Study|Other reason: patient has moved|1|||
164489377|NCT02006641|594160713|FG000|Overall Study|Other reason: caregiver in hospital|0|||
164489378|NCT02006641|594160714|FG001|Overall Study|Other reason: caregiver in hospital|1|||
164489379|NCT02006641|594160715|FG002|Overall Study|Other reason: caregiver in hospital|0|||
164489380|NCT02006641|594160713|FG000|Overall Study|Other reason: patient's wife has died|0|||
164489381|NCT02006641|594160714|FG001|Overall Study|Other reason: patient's wife has died|0|||
164489382|NCT02006641|594160715|FG002|Overall Study|Other reason: patient's wife has died|1|||
164489383|NCT02006641|594160713|FG000|Overall Study|Other reason: hospitalisation|0|||
164489384|NCT02006641|594160714|FG001|Overall Study|Other reason: hospitalisation|1|||
164602292|NCT01885078|594564813|FG008|Treatment Period|Protocol Violation|0|||
164602293|NCT01885078|594564814|FG009|Treatment Period|Protocol Violation|0|||
164602294|NCT01885078|594564805|FG000|Treatment Period|Sponsor Decision|245|||
164489385|NCT02006641|594160715|FG002|Overall Study|Other reason: hospitalisation|0|||
164489386|NCT02006641|594160713|FG000|Overall Study|Other reason: caregiver impossibility|0|||
164489387|NCT02006641|594160714|FG001|Overall Study|Other reason: caregiver impossibility|0|||
164489388|NCT02006641|594160715|FG002|Overall Study|Other reason: caregiver impossibility|1|||
164489389|NCT02006641|594160713|FG000|Overall Study|Other reason: protocol non-compliance|0|||
164489390|NCT02006641|594160714|FG001|Overall Study|Other reason: protocol non-compliance|0|||
164489391|NCT02006641|594160715|FG002|Overall Study|Other reason: protocol non-compliance|1|||
164489392|NCT02132195|594160721|FG000|Initial Assignment|Relapsed|14|||
164489393|NCT02132195|594160722|FG001|Initial Assignment|Relapsed|0|||
164489394|NCT02132195|594160723|FG002|Initial Assignment|Relapsed|0|||
164489395|NCT02132195|594160721|FG000|Rescue Therapy|Relapsed|0|||
164489396|NCT02132195|594160722|FG001|Rescue Therapy|Relapsed|0|||
164489397|NCT02132195|594160723|FG002|Rescue Therapy|Relapsed|7|||
164489398|NCT02132195|594160721|FG000|Rescue Therapy|Physician Decision|0|||
164489399|NCT02132195|594160722|FG001|Rescue Therapy|Physician Decision|0|||
164489400|NCT02132195|594160723|FG002|Rescue Therapy|Physician Decision|1|||
164489401|NCT02132195|594160721|FG000|Rescue Therapy|Withdrawal by Subject|0|||
164489402|NCT02132195|594160722|FG001|Rescue Therapy|Withdrawal by Subject|0|||
164489403|NCT02132195|594160723|FG002|Rescue Therapy|Withdrawal by Subject|1|||
164489404|NCT02132195|594160721|FG000|Rescue Therapy|Adverse Event|0|||
164489405|NCT02132195|594160722|FG001|Rescue Therapy|Adverse Event|0|||
164489406|NCT02132195|594160723|FG002|Rescue Therapy|Adverse Event|2|||
164489407|NCT01699178|594160724|FG000|Overall Study|Adverse Event|1|||
164489408|NCT01699178|594160725|FG001|Overall Study|Adverse Event|5|||
164489409|NCT01699178|594160724|FG000|Overall Study|Lost to Follow-up|1|||
164489410|NCT01699178|594160725|FG001|Overall Study|Lost to Follow-up|6|||
164489411|NCT01699178|594160724|FG000|Overall Study|Non-compliance with Study Drug|3|||
164489412|NCT01699178|594160725|FG001|Overall Study|Non-compliance with Study Drug|1|||
164489413|NCT01699178|594160724|FG000|Overall Study|Physician Decision|1|||
164489414|NCT01699178|594160725|FG001|Overall Study|Physician Decision|0|||
164489415|NCT01699178|594160724|FG000|Overall Study|Withdrawal by Subject|4|||
164489416|NCT01699178|594160725|FG001|Overall Study|Withdrawal by Subject|12|||
164489417|NCT01699178|594160724|FG000|Overall Study|Hematocrit >54%|1|||
164489418|NCT01699178|594160725|FG001|Overall Study|Hematocrit >54%|1|||
164489419|NCT01699178|594160724|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
164489420|NCT01699178|594160725|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
164489421|NCT01699178|594160724|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
164489422|NCT01699178|594160725|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
164489423|NCT00912964|594160726|FG000|Overall Study|Eligibility criterion not met|1|||
164489424|NCT00912964|594160727|FG001|Overall Study|Eligibility criterion not met|1|||
164489425|NCT00912964|594160728|FG002|Overall Study|Eligibility criterion not met|0|||
164489426|NCT00912964|594160726|FG000|Overall Study|Adverse Event|15|||
164489427|NCT00912964|594160727|FG001|Overall Study|Adverse Event|18|||
164489428|NCT00912964|594160728|FG002|Overall Study|Adverse Event|12|||
164489429|NCT00912964|594160726|FG000|Overall Study|Lack of Efficacy|11|||
164489430|NCT00912964|594160727|FG001|Overall Study|Lack of Efficacy|4|||
164489431|NCT00912964|594160728|FG002|Overall Study|Lack of Efficacy|3|||
164489432|NCT00912964|594160726|FG000|Overall Study|Withdrawal by Subject|20|||
164489433|NCT00912964|594160727|FG001|Overall Study|Withdrawal by Subject|12|||
164489434|NCT00912964|594160728|FG002|Overall Study|Withdrawal by Subject|18|||
164489435|NCT00912964|594160726|FG000|Overall Study|Lost to Follow-up|4|||
164489436|NCT00912964|594160727|FG001|Overall Study|Lost to Follow-up|3|||
164489437|NCT00912964|594160728|FG002|Overall Study|Lost to Follow-up|3|||
164489438|NCT00912964|594160726|FG000|Overall Study|Protocol Violation|5|||
164489439|NCT00912964|594160727|FG001|Overall Study|Protocol Violation|3|||
164489440|NCT00912964|594160728|FG002|Overall Study|Protocol Violation|8|||
164489441|NCT00912964|594160726|FG000|Overall Study|Taking exclusionary medications|7|||
164489442|NCT00912964|594160727|FG001|Overall Study|Taking exclusionary medications|4|||
164489443|NCT00912964|594160728|FG002|Overall Study|Taking exclusionary medications|8|||
164489444|NCT00912964|594160726|FG000|Overall Study|Medical History|1|||
164489445|NCT00912964|594160727|FG001|Overall Study|Medical History|0|||
164489446|NCT00912964|594160728|FG002|Overall Study|Medical History|0|||
164489447|NCT00912964|594160726|FG000|Overall Study|Non-compliance with study procedures|2|||
164489448|NCT00912964|594160727|FG001|Overall Study|Non-compliance with study procedures|0|||
164489449|NCT00912964|594160728|FG002|Overall Study|Non-compliance with study procedures|0|||
164489450|NCT00912964|594160726|FG000|Overall Study|Violation of exclusion criterion|0|||
164489451|NCT00912964|594160727|FG001|Overall Study|Violation of exclusion criterion|0|||
164489452|NCT00912964|594160728|FG002|Overall Study|Violation of exclusion criterion|2|||
164489453|NCT00912964|594160726|FG000|Overall Study|Randomized but never received study drug|0|||
164489454|NCT00912964|594160727|FG001|Overall Study|Randomized but never received study drug|1|||
164489455|NCT00912964|594160728|FG002|Overall Study|Randomized but never received study drug|0|||
164489456|NCT03905512|594160730|FG000|Overall Study|Withdrawal by Subject|9|||
164489457|NCT03905512|594160731|FG001|Overall Study|Withdrawal by Subject|8|||
164489458|NCT03905512|594160730|FG000|Overall Study|Adverse Event|1|||
164489459|NCT03905512|594160731|FG001|Overall Study|Adverse Event|2|||
164489460|NCT03905512|594160730|FG000|Overall Study|Lost to Follow-up|4|||
164489461|NCT03905512|594160731|FG001|Overall Study|Lost to Follow-up|3|||
164489462|NCT03905512|594160730|FG000|Overall Study|Other than Specified|7|||
164489463|NCT03905512|594160731|FG001|Overall Study|Other than Specified|4|||
164489464|NCT03987074|594160739|FG000|Overall Study|Withdrew Consent|1|||
164489465|NCT03987074|594160740|FG001|Overall Study|Withdrew Consent|1|||
164489466|NCT03987074|594160741|FG002|Overall Study|Withdrew Consent|0|||
164489467|NCT03987074|594160742|FG003|Overall Study|Withdrew Consent|2|||
164489468|NCT03987074|594160743|FG004|Overall Study|Withdrew Consent|1|||
164489469|NCT03987074|594160739|FG000|Overall Study|Adverse Event|2|||
164489470|NCT03987074|594160740|FG001|Overall Study|Adverse Event|1|||
164489471|NCT03987074|594160741|FG002|Overall Study|Adverse Event|0|||
164489472|NCT03987074|594160742|FG003|Overall Study|Adverse Event|0|||
164489473|NCT03987074|594160743|FG004|Overall Study|Adverse Event|1|||
164714791|NCT04581369|594978717|FG000|Overall Study|transitioned to hospice care|0|||
164714792|NCT04581369|594978718|FG001|Overall Study|transitioned to hospice care|5|||
164714793|NCT04581369|594978719|FG002|Overall Study|transitioned to hospice care|0|||
164714794|NCT04746794|594978722|FG000|Overall Study|Did not complete any study assessment|50303|||
164714795|NCT04746794|594978723|FG001|Overall Study|Did not complete any study assessment|44997|||
164714796|NCT01422187|594978726|FG000|Overall Study|Personal reason|1|||
164489474|NCT03987074|594160739|FG000|Overall Study|Lost to Follow-up|0|||
164489475|NCT03987074|594160740|FG001|Overall Study|Lost to Follow-up|0|||
164489476|NCT03987074|594160741|FG002|Overall Study|Lost to Follow-up|1|||
164489477|NCT03987074|594160742|FG003|Overall Study|Lost to Follow-up|1|||
164489478|NCT03987074|594160743|FG004|Overall Study|Lost to Follow-up|0|||
164489479|NCT03987074|594160739|FG000|Overall Study|Investigator's Discretion|0|||
164489480|NCT03987074|594160740|FG001|Overall Study|Investigator's Discretion|0|||
164489481|NCT03987074|594160741|FG002|Overall Study|Investigator's Discretion|0|||
164489482|NCT03987074|594160742|FG003|Overall Study|Investigator's Discretion|1|||
164489483|NCT03987074|594160743|FG004|Overall Study|Investigator's Discretion|0|||
164489484|NCT02138838|594160744|FG000|Overall Study|Study Closure|7|||
164489485|NCT02138838|594160745|FG001|Overall Study|Study Closure|6|||
164489486|NCT02138838|594160744|FG000|Overall Study|Withdrawal by Subject|1|||
164489487|NCT02138838|594160745|FG001|Overall Study|Withdrawal by Subject|5|||
164489488|NCT04433091|594160749|FG000|Overall Study|Lost to Follow-up|1|||
164489489|NCT04433091|594160750|FG001|Overall Study|Lost to Follow-up|0|||
164489490|NCT04433091|594160749|FG000|Overall Study|Withdrawn .|2|||
164489491|NCT04433091|594160750|FG001|Overall Study|Withdrawn .|4|||
164489492|NCT01730118|594162263|FG000|Dose Escalation|Death on study|5|||
164489493|NCT01730118|594162264|FG001|Dose Escalation|Death on study|7|||
164489494|NCT01730118|594162265|FG002|Dose Escalation|Death on study|2|||
164489495|NCT01730118|594162266|FG003|Dose Escalation|Death on study|6|||
164489496|NCT01730118|594162267|FG004|Dose Escalation|Death on study|0|||
164489497|NCT01730118|594162268|FG005|Dose Escalation|Death on study|0|||
164489498|NCT01730118|594162269|FG006|Dose Escalation|Death on study|0|||
164489499|NCT01730118|594162263|FG000|Dose Escalation|Died before treatment|0|||
164489500|NCT01730118|594162264|FG001|Dose Escalation|Died before treatment|0|||
164489501|NCT01730118|594162265|FG002|Dose Escalation|Died before treatment|0|||
164489502|NCT01730118|594162266|FG003|Dose Escalation|Died before treatment|0|||
164489503|NCT01730118|594162267|FG004|Dose Escalation|Died before treatment|0|||
164489504|NCT01730118|594162268|FG005|Dose Escalation|Died before treatment|0|||
164489505|NCT01730118|594162269|FG006|Dose Escalation|Died before treatment|1|||
164489506|NCT01730118|594162263|FG000|Dose Escalation|Chose to start a different treatment|1|||
164489507|NCT01730118|594162264|FG001|Dose Escalation|Chose to start a different treatment|0|||
164489508|NCT01730118|594162265|FG002|Dose Escalation|Chose to start a different treatment|0|||
164489509|NCT01730118|594162266|FG003|Dose Escalation|Chose to start a different treatment|0|||
164489510|NCT01730118|594162267|FG004|Dose Escalation|Chose to start a different treatment|0|||
164489511|NCT01730118|594162268|FG005|Dose Escalation|Chose to start a different treatment|0|||
164489512|NCT01730118|594162269|FG006|Dose Escalation|Chose to start a different treatment|0|||
164489513|NCT01730118|594162263|FG000|Dose Escalation|Withdrawal by Subject|0|||
164489514|NCT01730118|594162264|FG001|Dose Escalation|Withdrawal by Subject|0|||
164489515|NCT01730118|594162265|FG002|Dose Escalation|Withdrawal by Subject|1|||
164489516|NCT01730118|594162266|FG003|Dose Escalation|Withdrawal by Subject|0|||
164489517|NCT01730118|594162267|FG004|Dose Escalation|Withdrawal by Subject|0|||
164489518|NCT01730118|594162268|FG005|Dose Escalation|Withdrawal by Subject|0|||
164489519|NCT01730118|594162269|FG006|Dose Escalation|Withdrawal by Subject|0|||
164489520|NCT01730118|594162263|FG000|Dose Escalation|Disease progression prior to treatment|0|||
164489521|NCT01730118|594162264|FG001|Dose Escalation|Disease progression prior to treatment|0|||
164489522|NCT01730118|594162265|FG002|Dose Escalation|Disease progression prior to treatment|0|||
164489523|NCT01730118|594162266|FG003|Dose Escalation|Disease progression prior to treatment|0|||
164489524|NCT01730118|594162267|FG004|Dose Escalation|Disease progression prior to treatment|0|||
164489525|NCT01730118|594162268|FG005|Dose Escalation|Disease progression prior to treatment|0|||
164489526|NCT01730118|594162269|FG006|Dose Escalation|Disease progression prior to treatment|1|||
164714797|NCT01422187|594978727|FG001|Overall Study|Personal reason|0|||
164714798|NCT01422187|594978728|FG002|Overall Study|Personal reason|0|||
164489527|NCT01730118|594162263|FG000|Dose Expansion|Death|0|||
164489528|NCT01730118|594162264|FG001|Dose Expansion|Death|0|||
164489529|NCT01730118|594162265|FG002|Dose Expansion|Death|0|||
164489530|NCT01730118|594162266|FG003|Dose Expansion|Death|0|||
164489531|NCT01730118|594162267|FG004|Dose Expansion|Death|1|||
164489532|NCT01730118|594162268|FG005|Dose Expansion|Death|0|||
164489533|NCT01730118|594162269|FG006|Dose Expansion|Death|0|||
164489534|NCT01730118|594162263|FG000|Dose Expansion|Other medical condition|0|||
164489535|NCT01730118|594162264|FG001|Dose Expansion|Other medical condition|0|||
164489536|NCT01730118|594162265|FG002|Dose Expansion|Other medical condition|0|||
164489537|NCT01730118|594162266|FG003|Dose Expansion|Other medical condition|0|||
164714799|NCT01422187|594978726|FG000|Overall Study|Lost to Follow-up|0|||
164714800|NCT01422187|594978727|FG001|Overall Study|Lost to Follow-up|1|||
164714801|NCT01422187|594978728|FG002|Overall Study|Lost to Follow-up|0|||
164714802|NCT00856375|594978789|FG000|Overall Study|Other|0|||
164489538|NCT01730118|594162267|FG004|Dose Expansion|Other medical condition|1|||
164489539|NCT01730118|594162268|FG005|Dose Expansion|Other medical condition|0|||
164489540|NCT01730118|594162269|FG006|Dose Expansion|Other medical condition|0|||
164489541|NCT01730118|594162263|FG000|Dose Expansion|Withdrawal by Subject|0|||
164489542|NCT01730118|594162264|FG001|Dose Expansion|Withdrawal by Subject|0|||
164489543|NCT01730118|594162265|FG002|Dose Expansion|Withdrawal by Subject|0|||
164489544|NCT01730118|594162266|FG003|Dose Expansion|Withdrawal by Subject|0|||
164489545|NCT01730118|594162267|FG004|Dose Expansion|Withdrawal by Subject|1|||
164489546|NCT01730118|594162268|FG005|Dose Expansion|Withdrawal by Subject|0|||
164489547|NCT01730118|594162269|FG006|Dose Expansion|Withdrawal by Subject|0|||
164489548|NCT01730118|594162263|FG000|Dose Expansion|Disease progression|0|||
164489549|NCT01730118|594162264|FG001|Dose Expansion|Disease progression|0|||
164489550|NCT01730118|594162265|FG002|Dose Expansion|Disease progression|0|||
164489551|NCT01730118|594162266|FG003|Dose Expansion|Disease progression|0|||
164489552|NCT01730118|594162267|FG004|Dose Expansion|Disease progression|0|||
164489553|NCT01730118|594162268|FG005|Dose Expansion|Disease progression|1|||
164489554|NCT01730118|594162269|FG006|Dose Expansion|Disease progression|0|||
164489555|NCT01730118|594162263|FG000|Dose Expansion|Inability to return|0|||
164489556|NCT01730118|594162264|FG001|Dose Expansion|Inability to return|0|||
164489557|NCT01730118|594162265|FG002|Dose Expansion|Inability to return|0|||
164489558|NCT01730118|594162266|FG003|Dose Expansion|Inability to return|0|||
164489559|NCT01730118|594162267|FG004|Dose Expansion|Inability to return|0|||
164489560|NCT01730118|594162268|FG005|Dose Expansion|Inability to return|1|||
164489561|NCT01730118|594162269|FG006|Dose Expansion|Inability to return|0|||
164489562|NCT01730118|594162263|FG000|Dose Expansion|Physician Decision|0|||
164489563|NCT01730118|594162264|FG001|Dose Expansion|Physician Decision|0|||
164489564|NCT01730118|594162265|FG002|Dose Expansion|Physician Decision|0|||
164489565|NCT01730118|594162266|FG003|Dose Expansion|Physician Decision|0|||
164489566|NCT01730118|594162267|FG004|Dose Expansion|Physician Decision|0|||
164489567|NCT01730118|594162268|FG005|Dose Expansion|Physician Decision|1|||
164489568|NCT01730118|594162269|FG006|Dose Expansion|Physician Decision|0|||
164489569|NCT02880293|594162272|FG000|Overall Study|Inevaluable|5|||
164489570|NCT02101554|594162273|FG000|Overall Study|Protocol Violation|0|||
164489571|NCT02101554|594162274|FG001|Overall Study|Protocol Violation|1|||
164489572|NCT02101554|594162275|FG002|Overall Study|Protocol Violation|0|||
164489573|NCT02101554|594162273|FG000|Overall Study|Insufficient Clinical Response|0|||
164489574|NCT02101554|594162274|FG001|Overall Study|Insufficient Clinical Response|2|||
164489575|NCT02101554|594162275|FG002|Overall Study|Insufficient Clinical Response|0|||
164489576|NCT02101554|594162273|FG000|Overall Study|Adverse Event|2|||
164489577|NCT02101554|594162274|FG001|Overall Study|Adverse Event|1|||
164489578|NCT02101554|594162275|FG002|Overall Study|Adverse Event|1|||
164489579|NCT02101554|594162273|FG000|Overall Study|Lost to Follow-up|0|||
164489580|NCT02101554|594162274|FG001|Overall Study|Lost to Follow-up|1|||
164489581|NCT02101554|594162275|FG002|Overall Study|Lost to Follow-up|0|||
164489582|NCT02101554|594162273|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
164489583|NCT02101554|594162274|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
164489584|NCT02101554|594162275|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
164489585|NCT04049578|594162277|FG000|Overall Study|Physician Decision|1|||
164489586|NCT04385849|594162278|FG000|Overall Study|Lost to Follow-up|1|||
164489587|NCT04385849|594162279|FG001|Overall Study|Lost to Follow-up|0|||
164489588|NCT02011568|594162280|FG000|Overall Study|Withdrawal by Subject|8|||
164489589|NCT02011568|594162281|FG001|Overall Study|Withdrawal by Subject|10|||
164489590|NCT02011568|594162280|FG000|Overall Study|Physician Decision|1|||
164489591|NCT02011568|594162281|FG001|Overall Study|Physician Decision|3|||
164489592|NCT00168805|594162283|FG000|Overall Study|Adverse Event|7|||
164489593|NCT00168805|594162284|FG001|Overall Study|Adverse Event|11|||
164489594|NCT00168805|594162285|FG002|Overall Study|Adverse Event|16|||
164489595|NCT00168805|594162283|FG000|Overall Study|Protocol Violation|12|||
164489596|NCT00168805|594162284|FG001|Overall Study|Protocol Violation|11|||
164489597|NCT00168805|594162285|FG002|Overall Study|Protocol Violation|8|||
164489598|NCT00168805|594162283|FG000|Overall Study|Lost to Follow-up|12|||
164489599|NCT00168805|594162284|FG001|Overall Study|Lost to Follow-up|17|||
164489600|NCT00168805|594162285|FG002|Overall Study|Lost to Follow-up|11|||
164489601|NCT00168805|594162283|FG000|Overall Study|Withdrawal by Subject|16|||
164489602|NCT00168805|594162284|FG001|Overall Study|Withdrawal by Subject|18|||
164489603|NCT00168805|594162285|FG002|Overall Study|Withdrawal by Subject|21|||
164489604|NCT00168805|594162283|FG000|Overall Study|Other|24|||
164489605|NCT00168805|594162284|FG001|Overall Study|Other|21|||
164489606|NCT00168805|594162285|FG002|Overall Study|Other|22|||
164489607|NCT00168805|594162283|FG000|Treatment|Adverse Event|25|||
164489608|NCT00168805|594162284|FG001|Treatment|Adverse Event|26|||
164489609|NCT00168805|594162285|FG002|Treatment|Adverse Event|32|||
164489610|NCT00168805|594162283|FG000|Treatment|Protocol Violation|3|||
164489611|NCT00168805|594162284|FG001|Treatment|Protocol Violation|5|||
164489612|NCT00168805|594162285|FG002|Treatment|Protocol Violation|5|||
164489613|NCT00168805|594162283|FG000|Treatment|Withdrawal by Subject|3|||
164489614|NCT00168805|594162284|FG001|Treatment|Withdrawal by Subject|7|||
164489615|NCT00168805|594162285|FG002|Treatment|Withdrawal by Subject|8|||
164489616|NCT00168805|594162283|FG000|Treatment|Other|18|||
164489617|NCT00168805|594162284|FG001|Treatment|Other|18|||
164489618|NCT00168805|594162285|FG002|Treatment|Other|17|||
164489619|NCT01114217|594162286|FG000|Overall Study|Adverse Event|5|||
164489620|NCT01114217|594162287|FG001|Overall Study|Adverse Event|3|||
164489621|NCT01114217|594162286|FG000|Overall Study|Lost to Follow-up|17|||
164489622|NCT01114217|594162287|FG001|Overall Study|Lost to Follow-up|33|||
164489623|NCT01114217|594162286|FG000|Overall Study|Withdrawal by Subject|21|||
164489624|NCT01114217|594162287|FG001|Overall Study|Withdrawal by Subject|28|||
164489625|NCT01114217|594162286|FG000|Overall Study|Other-Clerical Error|3|||
164489626|NCT01114217|594162287|FG001|Overall Study|Other-Clerical Error|0|||
164489627|NCT01114217|594162286|FG000|Overall Study|Other-Early termination|6|||
164489628|NCT01114217|594162287|FG001|Overall Study|Other-Early termination|10|||
164489629|NCT01114217|594162286|FG000|Overall Study|Other-Procedure|1|||
164489630|NCT01114217|594162287|FG001|Overall Study|Other-Procedure|1|||
164489631|NCT01114217|594162286|FG000|Overall Study|Other-Pregnancy|2|||
164489632|NCT01114217|594162287|FG001|Overall Study|Other-Pregnancy|4|||
164489633|NCT01114217|594162286|FG000|Overall Study|Other-Protocol Violation|1|||
164489634|NCT01114217|594162287|FG001|Overall Study|Other-Protocol Violation|3|||
164489635|NCT01114217|594162286|FG000|Overall Study|Other-Lack of Efficacy|1|||
164489636|NCT01114217|594162287|FG001|Overall Study|Other-Lack of Efficacy|0|||
164489637|NCT01114217|594162286|FG000|Overall Study|Other-Non Compliance|2|||
164489638|NCT01114217|594162287|FG001|Overall Study|Other-Non Compliance|0|||
164489639|NCT01114217|594162286|FG000|Overall Study|Other-Physician Decision|1|||
164489640|NCT01114217|594162287|FG001|Overall Study|Other-Physician Decision|1|||
164489641|NCT01114217|594162286|FG000|Overall Study|Other-Sponsor Decision|10|||
164489642|NCT01114217|594162287|FG001|Overall Study|Other-Sponsor Decision|12|||
164489643|NCT01114217|594162286|FG000|Overall Study|Other-Study Termination|0|||
164489644|NCT01114217|594162287|FG001|Overall Study|Other-Study Termination|1|||
164489645|NCT01114217|594162286|FG000|Overall Study|Other-Study Withdrawn|1|||
164489646|NCT01114217|594162287|FG001|Overall Study|Other-Study Withdrawn|1|||
164489647|NCT01114217|594162286|FG000|Overall Study|Other-Site Stopped Communicating|2|||
164489648|NCT01114217|594162287|FG001|Overall Study|Other-Site Stopped Communicating|0|||
164489649|NCT01114217|594162286|FG000|Overall Study|Other-Lost to Follow-up|1|||
164489650|NCT01114217|594162287|FG001|Overall Study|Other-Lost to Follow-up|0|||
164489651|NCT01114217|594162286|FG000|Overall Study|Other-Withdrawal by Subject|1|||
164489652|NCT01114217|594162287|FG001|Overall Study|Other-Withdrawal by Subject|1|||
164489653|NCT01837719|594162288|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
164489654|NCT01837719|594162288|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
164489655|NCT01703988|594162289|FG000|Overall Study|Investigator Judgment|0|||
164489656|NCT01703988|594162290|FG001|Overall Study|Investigator Judgment|0|||
164489657|NCT01703988|594162291|FG002|Overall Study|Investigator Judgment|0|||
164489658|NCT01703988|594162292|FG003|Overall Study|Investigator Judgment|1|||
164489659|NCT06247488|594162293|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
164489660|NCT06247488|594162294|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
164489661|NCT06247488|594162295|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
164489662|NCT06247488|594162296|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
164489663|NCT06247488|594162297|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
164489664|NCT06247488|594162298|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
164489665|NCT06247488|594162293|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
164489666|NCT06247488|594162294|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
164489667|NCT06247488|594162295|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
164489668|NCT06247488|594162296|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
164489669|NCT06247488|594162297|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
164489670|NCT06247488|594162298|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
164489671|NCT06247488|594162293|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
164489672|NCT06247488|594162294|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
164489673|NCT06247488|594162295|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
164489674|NCT06247488|594162296|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
164489675|NCT06247488|594162297|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
164489676|NCT06247488|594162298|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
164489677|NCT06247488|594162293|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
164489678|NCT06247488|594162294|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
164489679|NCT06247488|594162295|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
164489680|NCT06247488|594162296|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
164489681|NCT06247488|594162297|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
164489682|NCT06247488|594162298|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
164489683|NCT06247488|594162293|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
164489684|NCT06247488|594162294|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
164489685|NCT06247488|594162295|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
164489686|NCT06247488|594162296|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
164489687|NCT06247488|594162297|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
164489688|NCT06247488|594162298|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
164602295|NCT01885078|594564806|FG001|Treatment Period|Sponsor Decision|648|||
164489689|NCT06247488|594162293|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
164489690|NCT06247488|594162294|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
164489691|NCT06247488|594162295|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
164489692|NCT06247488|594162296|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
164489693|NCT06247488|594162297|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
164489694|NCT06247488|594162298|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
164489695|NCT06247488|594162293|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
164489696|NCT06247488|594162294|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
164489697|NCT06247488|594162295|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
164489698|NCT06247488|594162296|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
164489699|NCT06247488|594162297|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
164489700|NCT06247488|594162298|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
164489701|NCT02995733|594162299|FG000|Overall Study|Study site closed|9|||
164489702|NCT02995733|594162300|FG001|Overall Study|Study site closed|10|||
164489703|NCT02995733|594162299|FG000|Overall Study|Death|3|||
164489704|NCT02995733|594162300|FG001|Overall Study|Death|4|||
164489705|NCT02995733|594162299|FG000|Overall Study|Withdrawal by Subject|6|||
164489706|NCT02995733|594162300|FG001|Overall Study|Withdrawal by Subject|2|||
164489707|NCT02995733|594162299|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
164489708|NCT02995733|594162300|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
164489709|NCT02995733|594162299|FG000|Overall Study|Lost to Follow-up|48|||
164489710|NCT02995733|594162300|FG001|Overall Study|Lost to Follow-up|37|||
164489711|NCT02995733|594162299|FG000|Overall Study|Other|0|||
164489712|NCT02995733|594162300|FG001|Overall Study|Other|1|||
164489713|NCT01183013|594162303|FG000|Overall Study|Adverse Event|6|||
164489714|NCT01183013|594162304|FG001|Overall Study|Adverse Event|8|||
164489715|NCT01183013|594162305|FG002|Overall Study|Adverse Event|5|||
164489716|NCT01183013|594162306|FG003|Overall Study|Adverse Event|5|||
164489717|NCT01183013|594162307|FG004|Overall Study|Adverse Event|10|||
164489718|NCT01183013|594162308|FG005|Overall Study|Adverse Event|10|||
164489719|NCT01183013|594162309|FG006|Overall Study|Adverse Event|6|||
164489720|NCT01183013|594162303|FG000|Overall Study|Lack of Efficacy|3|||
164489721|NCT01183013|594162304|FG001|Overall Study|Lack of Efficacy|2|||
164489722|NCT01183013|594162305|FG002|Overall Study|Lack of Efficacy|1|||
164489723|NCT01183013|594162306|FG003|Overall Study|Lack of Efficacy|2|||
164489724|NCT01183013|594162307|FG004|Overall Study|Lack of Efficacy|1|||
164489725|NCT01183013|594162308|FG005|Overall Study|Lack of Efficacy|2|||
164489726|NCT01183013|594162309|FG006|Overall Study|Lack of Efficacy|0|||
164489727|NCT01183013|594162303|FG000|Overall Study|Protocol Violation|5|||
164489728|NCT01183013|594162304|FG001|Overall Study|Protocol Violation|2|||
164489729|NCT01183013|594162305|FG002|Overall Study|Protocol Violation|4|||
164489730|NCT01183013|594162306|FG003|Overall Study|Protocol Violation|0|||
164489731|NCT01183013|594162307|FG004|Overall Study|Protocol Violation|4|||
164489732|NCT01183013|594162308|FG005|Overall Study|Protocol Violation|3|||
164489733|NCT01183013|594162309|FG006|Overall Study|Protocol Violation|3|||
164489734|NCT01183013|594162303|FG000|Overall Study|Lost to Follow-up|7|||
164489735|NCT01183013|594162304|FG001|Overall Study|Lost to Follow-up|3|||
164489736|NCT01183013|594162305|FG002|Overall Study|Lost to Follow-up|4|||
164489737|NCT01183013|594162306|FG003|Overall Study|Lost to Follow-up|3|||
164489738|NCT01183013|594162307|FG004|Overall Study|Lost to Follow-up|2|||
164489739|NCT01183013|594162308|FG005|Overall Study|Lost to Follow-up|6|||
164489740|NCT01183013|594162309|FG006|Overall Study|Lost to Follow-up|5|||
164489741|NCT01183013|594162303|FG000|Overall Study|Withdrawal by Subject|9|||
164489742|NCT01183013|594162304|FG001|Overall Study|Withdrawal by Subject|13|||
164489743|NCT01183013|594162305|FG002|Overall Study|Withdrawal by Subject|10|||
164489744|NCT01183013|594162306|FG003|Overall Study|Withdrawal by Subject|8|||
164489745|NCT01183013|594162307|FG004|Overall Study|Withdrawal by Subject|7|||
164489746|NCT01183013|594162308|FG005|Overall Study|Withdrawal by Subject|9|||
164489747|NCT01183013|594162309|FG006|Overall Study|Withdrawal by Subject|10|||
164489748|NCT01183013|594162303|FG000|Overall Study|Reasons other than stated above|15|||
164489749|NCT01183013|594162304|FG001|Overall Study|Reasons other than stated above|11|||
164489750|NCT01183013|594162305|FG002|Overall Study|Reasons other than stated above|17|||
164489751|NCT01183013|594162306|FG003|Overall Study|Reasons other than stated above|12|||
164489752|NCT01183013|594162307|FG004|Overall Study|Reasons other than stated above|12|||
164489753|NCT01183013|594162308|FG005|Overall Study|Reasons other than stated above|15|||
164489754|NCT01183013|594162309|FG006|Overall Study|Reasons other than stated above|13|||
164489755|NCT04468633|594162313|FG000|Overall Study|Withdrawal by Subject|4|||
164489756|NCT04468633|594162314|FG001|Overall Study|Withdrawal by Subject|0|||
164489757|NCT00460434|594162317|FG000|Overall Study|Lost to Follow-up|3|||
164489758|NCT00460434|594162318|FG001|Overall Study|Lost to Follow-up|7|||
164489759|NCT01498445|594162319|FG000|Overall Study|Lack of Efficacy|0|||
164489760|NCT01498445|594162320|FG001|Overall Study|Lack of Efficacy|0|||
164489761|NCT01498445|594162321|FG002|Overall Study|Lack of Efficacy|1|||
164489762|NCT01498445|594162322|FG003|Overall Study|Lack of Efficacy|2|||
164489763|NCT01498445|594162323|FG004|Overall Study|Lack of Efficacy|0|||
164489764|NCT01498445|594162324|FG005|Overall Study|Lack of Efficacy|0|||
164489765|NCT01498445|594162319|FG000|Overall Study|Screen Failure|0|||
164489766|NCT01498445|594162320|FG001|Overall Study|Screen Failure|0|||
164489767|NCT01498445|594162321|FG002|Overall Study|Screen Failure|0|||
164489768|NCT01498445|594162322|FG003|Overall Study|Screen Failure|0|||
164489769|NCT01498445|594162323|FG004|Overall Study|Screen Failure|1|||
164489770|NCT01498445|594162324|FG005|Overall Study|Screen Failure|1|||
164489771|NCT04739306|594162325|FG000|Main Study Period|Adverse Event|6|||
164489772|NCT04739306|594162326|FG001|Main Study Period|Adverse Event|7|||
164489773|NCT04739306|594162325|FG000|Main Study Period|Lost to Follow-up|4|||
164489774|NCT04739306|594162326|FG001|Main Study Period|Lost to Follow-up|6|||
164489775|NCT04739306|594162325|FG000|Main Study Period|Physician Decision|1|||
164489776|NCT04739306|594162326|FG001|Main Study Period|Physician Decision|1|||
164489777|NCT04739306|594162325|FG000|Main Study Period|Withdrawal by Subject|8|||
164489778|NCT04739306|594162326|FG001|Main Study Period|Withdrawal by Subject|6|||
164489779|NCT04739306|594162325|FG000|Main Study Period|Protocol Violation|0|||
164489780|NCT04739306|594162326|FG001|Main Study Period|Protocol Violation|1|||
164489781|NCT04739306|594162325|FG000|Main Study Period|War in Ukraine|1|||
164489782|NCT04739306|594162326|FG001|Main Study Period|War in Ukraine|1|||
164489783|NCT02722278|594162329|FG000|Overall Study|Withdrawal by Subject|5|||
164489784|NCT02722278|594162330|FG001|Overall Study|Withdrawal by Subject|3|||
164489785|NCT02722278|594162329|FG000|Overall Study|Adverse Event|4|||
164489786|NCT02722278|594162330|FG001|Overall Study|Adverse Event|1|||
164489787|NCT02722278|594162329|FG000|Overall Study|Lost to Follow-up|2|||
164489788|NCT02722278|594162330|FG001|Overall Study|Lost to Follow-up|0|||
164489789|NCT02722278|594162329|FG000|Overall Study|Protocol Violation|1|||
164489790|NCT02722278|594162330|FG001|Overall Study|Protocol Violation|0|||
164489791|NCT02722278|594162329|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
164489792|NCT02722278|594162330|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
164489793|NCT02722278|594162329|FG000|Overall Study|Subject declined after tx assignment|0|||
164489794|NCT02722278|594162330|FG001|Overall Study|Subject declined after tx assignment|1|||
164489795|NCT02722278|594162329|FG000|Overall Study|Site closure not study related|0|||
164489796|NCT02722278|594162330|FG001|Overall Study|Site closure not study related|1|||
164489797|NCT02465866|594162331|FG000|Period 3|Withdrawal by Subject|0|||
164489798|NCT02465866|594162332|FG001|Period 3|Withdrawal by Subject|1|||
164489799|NCT02465866|594162333|FG002|Period 3|Withdrawal by Subject|0|||
164489800|NCT02465866|594162334|FG003|Period 3|Withdrawal by Subject|0|||
164489801|NCT02023099|594162335|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
164489802|NCT02023099|594162336|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
164489803|NCT02023099|594162337|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
164489804|NCT02023099|594162335|FG000|Overall Study|Withdrawn Consent|3|||
164489805|NCT02023099|594162336|FG001|Overall Study|Withdrawn Consent|0|||
164489806|NCT02023099|594162337|FG002|Overall Study|Withdrawn Consent|1|||
164489807|NCT02023099|594162335|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
164489808|NCT02023099|594162336|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
164489809|NCT02023099|594162337|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
164489810|NCT00203502|594162338|FG000|Overall Study|Death|1|||
164489811|NCT04175392|594162339|FG000|Overall Study|Withdrawal by Subject|3|||
164489812|NCT04175392|594162340|FG001|Overall Study|Withdrawal by Subject|2|||
164489813|NCT01469819|594162341|FG000|Overall Study|Withdrawal by Subject|1|||
164489814|NCT01469819|594162341|FG000|Overall Study|Did not meet inclusionary criteria|2|||
164489815|NCT01469819|594162341|FG000|Overall Study|Could not swallow SmartPill|2|||
164489816|NCT01469819|594162341|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
164489817|NCT01103141|594162342|FG000|Overall Study|Death|0|||
164489818|NCT01103141|594162343|FG001|Overall Study|Death|1|||
164489819|NCT01103141|594162342|FG000|Overall Study|Lost to Follow-up|2|||
164489820|NCT01103141|594162343|FG001|Overall Study|Lost to Follow-up|1|||
164489821|NCT01403805|594162344|FG000|Overall Study|Withdrawal by Subject|0|||
164489822|NCT01403805|594162345|FG001|Overall Study|Withdrawal by Subject|4|||
164489823|NCT01403805|594162344|FG000|Overall Study|Lost to Follow-up|0|||
164489824|NCT01403805|594162345|FG001|Overall Study|Lost to Follow-up|2|||
164602296|NCT01885078|594564807|FG002|Treatment Period|Sponsor Decision|49|||
164489825|NCT01403805|594162344|FG000|Overall Study|Death|0|||
164489826|NCT01403805|594162345|FG001|Overall Study|Death|1|||
164489827|NCT01695993|594162346|FG000|Overall Study|Lost to Follow-up|2|||
164602297|NCT01885078|594564808|FG003|Treatment Period|Sponsor Decision|90|||
164602298|NCT01885078|594564809|FG004|Treatment Period|Sponsor Decision|20|||
164602299|NCT01885078|594564810|FG005|Treatment Period|Sponsor Decision|38|||
164602300|NCT01885078|594564811|FG006|Treatment Period|Sponsor Decision|162|||
164489828|NCT01695993|594162347|FG001|Overall Study|Lost to Follow-up|1|||
164489829|NCT01695993|594162348|FG002|Overall Study|Lost to Follow-up|3|||
164489830|NCT01695993|594162346|FG000|Overall Study|Withdrawal by Subject|2|||
164489831|NCT01695993|594162347|FG001|Overall Study|Withdrawal by Subject|2|||
164489832|NCT01695993|594162348|FG002|Overall Study|Withdrawal by Subject|2|||
164602301|NCT01885078|594564812|FG007|Treatment Period|Sponsor Decision|3|||
164489833|NCT01695993|594162346|FG000|Overall Study|To ill to continue|1|||
164489834|NCT01695993|594162347|FG001|Overall Study|To ill to continue|2|||
164602302|NCT01885078|594564813|FG008|Treatment Period|Sponsor Decision|0|||
164602303|NCT01885078|594564814|FG009|Treatment Period|Sponsor Decision|0|||
164489835|NCT01695993|594162348|FG002|Overall Study|To ill to continue|0|||
164489836|NCT01695993|594162346|FG000|Overall Study|Changed Medical Facility|0|||
164489837|NCT01695993|594162347|FG001|Overall Study|Changed Medical Facility|0|||
164489838|NCT01695993|594162348|FG002|Overall Study|Changed Medical Facility|1|||
164489839|NCT00472199|594162349|FG000|Overall Study|Adverse Event|19|||
164489840|NCT00472199|594162350|FG001|Overall Study|Adverse Event|23|||
164489841|NCT00472199|594162349|FG000|Overall Study|Lack of Efficacy|4|||
164489842|NCT00472199|594162350|FG001|Overall Study|Lack of Efficacy|25|||
164489843|NCT00472199|594162349|FG000|Overall Study|Lost to Follow-up|2|||
164489844|NCT00472199|594162350|FG001|Overall Study|Lost to Follow-up|4|||
164489845|NCT00472199|594162349|FG000|Overall Study|Protocol Violation|3|||
164489846|NCT00472199|594162350|FG001|Overall Study|Protocol Violation|2|||
164489847|NCT00472199|594162349|FG000|Overall Study|Withdrawal by Subject|6|||
164489848|NCT00472199|594162350|FG001|Overall Study|Withdrawal by Subject|5|||
164489849|NCT00472199|594162349|FG000|Overall Study|personal reason|0|||
164489850|NCT00472199|594162350|FG001|Overall Study|personal reason|1|||
164489851|NCT00472199|594162349|FG000|Overall Study|patient was asymptomatic|1|||
164489852|NCT00472199|594162350|FG001|Overall Study|patient was asymptomatic|0|||
164489853|NCT04930263|594162351|FG000|Overall Study|Withdrawal by Subject|3|||
164489854|NCT04930263|594162352|FG001|Overall Study|Withdrawal by Subject|5|||
164489855|NCT02213458|594162355|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
164489856|NCT02213458|594162356|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
164489857|NCT02213458|594162355|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
164489858|NCT02213458|594162356|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
164489859|NCT02213458|594162355|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
164489860|NCT02213458|594162356|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
164489861|NCT02213458|594162355|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
164489862|NCT02213458|594162356|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
164489863|NCT02213458|594162355|FG000|Overall Study|Refused re-consent|6|||
164489864|NCT02213458|594162356|FG001|Overall Study|Refused re-consent|0|||
164489865|NCT02213458|594162355|FG000|Overall Study|Lost to Follow-up|2|||
164489866|NCT02213458|594162356|FG001|Overall Study|Lost to Follow-up|2|||
164489867|NCT02213458|594162355|FG000|Overall Study|Withdrawal by Subject|26|||
164489868|NCT02213458|594162356|FG001|Overall Study|Withdrawal by Subject|8|||
164489869|NCT04362176|594162359|FG000|Overall Study|Lost to Follow-up|5|||
164489870|NCT04362176|594162360|FG001|Overall Study|Lost to Follow-up|8|||
164489871|NCT04362176|594162359|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
164489872|NCT04362176|594162360|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
164489873|NCT06312566|594162361|FG000|Overall Study|Protocol Violation|0|||
164489874|NCT06312566|594162362|FG001|Overall Study|Protocol Violation|1|||
164489875|NCT02632045|594162363|FG000|Overall Study|Withdrawal by Subject|1|||
164489876|NCT02632045|594162364|FG001|Overall Study|Withdrawal by Subject|2|||
164489877|NCT03503188|594162365|FG000|Overall Study|Non eligible in the sub study|0|||
164489878|NCT03503188|594162366|FG001|Overall Study|Non eligible in the sub study|1|||
164489879|NCT03547167|594162372|FG000|Overall Study|Withdrawal by Subject|34|||
164489880|NCT03547167|594162373|FG001|Overall Study|Withdrawal by Subject|12|||
164489881|NCT03547167|594162372|FG000|Overall Study|Screen Failure|0|||
164489882|NCT03547167|594162373|FG001|Overall Study|Screen Failure|1|||
164489883|NCT03547167|594162372|FG000|Overall Study|Lost to Follow-up|59|||
164489884|NCT03547167|594162373|FG001|Overall Study|Lost to Follow-up|15|||
164489885|NCT03547167|594162372|FG000|Overall Study|Death|4|||
164489886|NCT03547167|594162373|FG001|Overall Study|Death|2|||
164489887|NCT00645411|594162374|FG000|Overall Study|Adverse Event|0|||
164489888|NCT00645411|594162375|FG001|Overall Study|Adverse Event|0|||
164489889|NCT00645411|594162376|FG002|Overall Study|Adverse Event|0|||
164489890|NCT00645411|594162377|FG003|Overall Study|Adverse Event|2|||
164489891|NCT00645411|594162374|FG000|Overall Study|Withdrawal by Subject|2|||
164489892|NCT00645411|594162375|FG001|Overall Study|Withdrawal by Subject|1|||
164489893|NCT00645411|594162376|FG002|Overall Study|Withdrawal by Subject|19|||
164714803|NCT00856375|594978790|FG001|Overall Study|Other|1|||
164714804|NCT00856375|594978789|FG000|Overall Study|Death|32|||
164714805|NCT00856375|594978790|FG001|Overall Study|Death|30|||
164714806|NCT00856375|594978789|FG000|Overall Study|Sponsor Terminated Study|7|||
164489894|NCT00645411|594162377|FG003|Overall Study|Withdrawal by Subject|21|||
164489895|NCT00645411|594162374|FG000|Overall Study|Lost to Follow-up|10|||
164714807|NCT00856375|594978790|FG001|Overall Study|Sponsor Terminated Study|7|||
164489896|NCT00645411|594162375|FG001|Overall Study|Lost to Follow-up|5|||
164489897|NCT00645411|594162376|FG002|Overall Study|Lost to Follow-up|124|||
164489898|NCT00645411|594162377|FG003|Overall Study|Lost to Follow-up|75|||
164489899|NCT00645411|594162374|FG000|Overall Study|Protocol Violation|1|||
164489900|NCT00645411|594162375|FG001|Overall Study|Protocol Violation|0|||
164489901|NCT00645411|594162376|FG002|Overall Study|Protocol Violation|1|||
164489902|NCT00645411|594162377|FG003|Overall Study|Protocol Violation|0|||
164489903|NCT00645411|594162374|FG000|Overall Study|Inappropriate enrollment|0|||
164489904|NCT00645411|594162375|FG001|Overall Study|Inappropriate enrollment|0|||
164714808|NCT00856375|594978789|FG000|Overall Study|Withdrawal by Subject|2|||
164489905|NCT00645411|594162376|FG002|Overall Study|Inappropriate enrollment|4|||
164489906|NCT00645411|594162377|FG003|Overall Study|Inappropriate enrollment|1|||
164489907|NCT00645411|594162374|FG000|Overall Study|Unable to classify|0|||
164489908|NCT00645411|594162375|FG001|Overall Study|Unable to classify|0|||
164489909|NCT00645411|594162376|FG002|Overall Study|Unable to classify|3|||
164489910|NCT00645411|594162377|FG003|Overall Study|Unable to classify|4|||
164489911|NCT03100370|594162381|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
164489912|NCT03100370|594162382|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
164489913|NCT03100370|594162383|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
164489914|NCT03100370|594162384|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
164489915|NCT03100370|594162385|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
164489916|NCT03100370|594162386|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
164489917|NCT02674399|594162387|FG000|Overall Study|Lost to Follow-up|2|||
164489918|NCT02674399|594162388|FG001|Overall Study|Lost to Follow-up|0|||
164489919|NCT01867307|594162391|FG000|Overall Study|Protocol Violation|2|||
164489920|NCT01867307|594162392|FG001|Overall Study|Protocol Violation|0|||
164489921|NCT01867307|594162391|FG000|Overall Study|Other Adverse Event|1|||
164489922|NCT01867307|594162392|FG001|Overall Study|Other Adverse Event|3|||
164489923|NCT00091572|594162404|FG000|Overall Study|Lost to Follow-up|1|||
164489924|NCT00091572|594162405|FG001|Overall Study|Lost to Follow-up|1|||
164489925|NCT00091572|594162404|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
164489926|NCT00091572|594162405|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
164489927|NCT00091572|594162404|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
164489928|NCT00091572|594162405|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
164489929|NCT00091572|594162404|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
164489930|NCT00091572|594162405|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
164489931|NCT00091572|594162404|FG000|Overall Study|Other Reason|6|||
164489932|NCT00091572|594162405|FG001|Overall Study|Other Reason|13|||
164489933|NCT00091572|594162404|FG000|Overall Study|Ongoing (still on treatment)|8|||
164489934|NCT00091572|594162405|FG001|Overall Study|Ongoing (still on treatment)|12|||
164489935|NCT00091572|594162404|FG000|Overall Study|Major Protocol Violation|2|||
164489936|NCT00091572|594162405|FG001|Overall Study|Major Protocol Violation|0|||
164489937|NCT00091572|594162404|FG000|Overall Study|Toxicity (Related AE)|53|||
164489938|NCT00091572|594162405|FG001|Overall Study|Toxicity (Related AE)|9|||
164489939|NCT03122548|594162410|FG000|Overall Study|Death|2|||
164489940|NCT03122548|594162410|FG000|Overall Study|Progression - subject went into hospice|1|||
164489941|NCT03122548|594162410|FG000|Overall Study|Study Terminated by Sponsor|2|||
164489942|NCT01199302|594162416|FG000|Overall Study|Adverse Event|1|||
164489943|NCT01199302|594162417|FG001|Overall Study|Adverse Event|1|||
164489944|NCT01199302|594162418|FG002|Overall Study|Adverse Event|2|||
164489945|NCT01199302|594162419|FG003|Overall Study|Adverse Event|0|||
164489946|NCT01199302|594162416|FG000|Overall Study|Withdrawal by Subject|2|||
164489947|NCT01199302|594162417|FG001|Overall Study|Withdrawal by Subject|2|||
164489948|NCT01199302|594162418|FG002|Overall Study|Withdrawal by Subject|3|||
164489949|NCT01199302|594162419|FG003|Overall Study|Withdrawal by Subject|0|||
164489950|NCT01199302|594162416|FG000|Overall Study|Disease Progression|3|||
164489951|NCT01199302|594162417|FG001|Overall Study|Disease Progression|4|||
164489952|NCT01199302|594162418|FG002|Overall Study|Disease Progression|4|||
164489953|NCT01199302|594162419|FG003|Overall Study|Disease Progression|2|||
164489954|NCT01199302|594162416|FG000|Overall Study|Study Termination|13|||
164489955|NCT01199302|594162417|FG001|Overall Study|Study Termination|8|||
164489956|NCT01199302|594162418|FG002|Overall Study|Study Termination|11|||
164489957|NCT01199302|594162419|FG003|Overall Study|Study Termination|9|||
164489958|NCT01199302|594162416|FG000|Overall Study|Lost to Follow-up|0|||
164489959|NCT01199302|594162417|FG001|Overall Study|Lost to Follow-up|1|||
164489960|NCT01199302|594162418|FG002|Overall Study|Lost to Follow-up|0|||
164489961|NCT01199302|594162419|FG003|Overall Study|Lost to Follow-up|0|||
164489962|NCT01199302|594162416|FG000|Overall Study|Other|1|||
164489963|NCT01199302|594162417|FG001|Overall Study|Other|0|||
164489964|NCT01199302|594162418|FG002|Overall Study|Other|0|||
164489965|NCT01199302|594162419|FG003|Overall Study|Other|0|||
164489966|NCT01634165|594162421|FG000|Period 2|Adverse Event|0|||
164489967|NCT01634165|594162422|FG001|Period 2|Adverse Event|1|||
164489968|NCT01634165|594162423|FG002|Period 2|Adverse Event|0|||
164489969|NCT01634165|594162424|FG003|Period 2|Adverse Event|0|||
164489970|NCT04097535|594162427|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
164489971|NCT03322514|594163894|FG000|Overall Study|Withdrawal by Subject|1|||
164489972|NCT03322514|594163895|FG001|Overall Study|Withdrawal by Subject|1|||
164714809|NCT00856375|594978790|FG001|Overall Study|Withdrawal by Subject|1|||
164714810|NCT00856375|594978789|FG000|Overall Study|Lost to Follow-up|1|||
164489973|NCT00088452|594163896|FG000|Overall Study|Did not receive intervention|1|||
164489974|NCT00088452|594163897|FG001|Overall Study|Did not receive intervention|0|||
164489975|NCT00088452|594163898|FG002|Overall Study|Did not receive intervention|1|||
164489976|NCT02081196|594163900|FG000|Overall Study|Lost to Follow-up|1|||
164489977|NCT00961298|594163901|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
164489978|NCT00961298|594163901|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
164489979|NCT00961298|594163901|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
164489980|NCT04044352|594163904|FG000|Overall Study|Lost to Follow-up|9|||
164489981|NCT04044352|594163904|FG000|Overall Study|Withdrawal by Subject|2|||
164489982|NCT00814632|594163908|FG000|Overall Study|Lack of Efficacy|2|||
164489983|NCT02514577|594163917|FG000|Overall Study|Lost to Follow-up|6|||
164489984|NCT02514577|594163918|FG001|Overall Study|Lost to Follow-up|6|||
164489985|NCT02514577|594163917|FG000|Overall Study|Protocol Violation|1|||
164489986|NCT02514577|594163918|FG001|Overall Study|Protocol Violation|0|||
164489987|NCT02514577|594163917|FG000|Overall Study|Withdrawal by Subject|6|||
164489988|NCT02514577|594163918|FG001|Overall Study|Withdrawal by Subject|6|||
164489989|NCT02514577|594163917|FG000|Overall Study|Adverse Event|1|||
164489990|NCT02514577|594163918|FG001|Overall Study|Adverse Event|1|||
164489991|NCT02136797|594163919|FG000|Overall Study|Not Treated|8|||
164489992|NCT04523571|594163920|FG000|Received 2 Doses|Withdrawal by Subject|0|||
164489993|NCT04523571|594163921|FG001|Received 2 Doses|Withdrawal by Subject|0|||
164489994|NCT04523571|594163922|FG002|Received 2 Doses|Withdrawal by Subject|0|||
164489995|NCT04523571|594163923|FG003|Received 2 Doses|Withdrawal by Subject|1|||
164489996|NCT04523571|594163924|FG004|Received 2 Doses|Withdrawal by Subject|1|||
164489997|NCT04523571|594163925|FG005|Received 2 Doses|Withdrawal by Subject|0|||
164489998|NCT04523571|594163920|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
164489999|NCT04523571|594163921|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
164490000|NCT04523571|594163922|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
164490001|NCT04523571|594163923|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
164490002|NCT04523571|594163924|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
164490003|NCT04523571|594163925|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
164490004|NCT04523571|594163920|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
164490005|NCT04523571|594163921|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
164490006|NCT04523571|594163922|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
164490007|NCT04523571|594163923|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
164490008|NCT04523571|594163924|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
164490009|NCT04523571|594163925|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
164490010|NCT04523571|594163920|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
164490011|NCT04523571|594163921|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
164490012|NCT04523571|594163922|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
164490013|NCT04523571|594163923|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
164490014|NCT04523571|594163924|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
164490015|NCT04523571|594163925|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
164490016|NCT01038128|594163928|FG000|Overall Study|Lack of Efficacy|1|||
164490017|NCT01038128|594163928|FG000|Overall Study|Lost to Follow-up|1|||
164490018|NCT01038128|594163928|FG000|Overall Study|Withdrawal by Subject|2|||
164490019|NCT03344458|594163933|FG000|Overall Study|Physician Decision|1|||
164490020|NCT03344458|594163933|FG000|Overall Study|Withdrawal by Subject|16|||
164490021|NCT03344458|594163933|FG000|Overall Study|Other reasons|10|||
164490022|NCT03344458|594163933|FG000|Overall Study|Lost to Follow-up|9|||
164490023|NCT03344458|594163933|FG000|Overall Study|Protocol Violation|3|||
164490024|NCT00396409|594163938|FG000|Period 1 - 2007|Adverse Event|0|||
164490025|NCT00396409|594163939|FG001|Period 1 - 2007|Adverse Event|1|||
164490026|NCT00396409|594163938|FG000|Period 1 - 2007|Lack of Efficacy|0|||
164490027|NCT00396409|594163939|FG001|Period 1 - 2007|Lack of Efficacy|1|||
164490028|NCT00396409|594163938|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
164490029|NCT00396409|594163939|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
164490030|NCT00396409|594163938|FG000|Period 1 - 2007|Lost to Follow-up|2|||
164490031|NCT00396409|594163939|FG001|Period 1 - 2007|Lost to Follow-up|3|||
164490032|NCT00396409|594163938|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
164490033|NCT00396409|594163939|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
164490034|NCT00396409|594163938|FG000|Period 2 - 2008|Protocol Violation|1|||
164490035|NCT00396409|594163939|FG001|Period 2 - 2008|Protocol Violation|0|||
164490036|NCT00396409|594163938|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
164490037|NCT00396409|594163939|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
164490038|NCT00396409|594163938|FG000|Period 2 - 2008|Lost to Follow-up|3|||
164490039|NCT00396409|594163939|FG001|Period 2 - 2008|Lost to Follow-up|1|||
164490040|NCT00331799|594163940|FG000|Overall Study|Withdrawal by Subject|2|||
164490041|NCT00331799|594163940|FG000|Overall Study|Sedation|1|||
164490042|NCT02889809|594163941|FG000|Overall Study|Withdrawal by Subject|30|||
164490043|NCT02889809|594163942|FG001|Overall Study|Withdrawal by Subject|21|||
164490044|NCT02889809|594163941|FG000|Overall Study|Lost to Follow-up|1|||
164490045|NCT02889809|594163942|FG001|Overall Study|Lost to Follow-up|1|||
164490046|NCT02889809|594163941|FG000|Overall Study|Site Closed|12|||
164490047|NCT02889809|594163942|FG001|Overall Study|Site Closed|11|||
164490048|NCT03960437|594163945|FG000|Overall Study|Removed by PI|4|||
164490049|NCT03960437|594163945|FG000|Overall Study|Lost to Follow-up|2|||
164490050|NCT03960437|594163945|FG000|Overall Study|Withdrawal by Subject|1|||
164490051|NCT03960437|594163945|FG000|Overall Study|Death|2|||
164490052|NCT01136733|594163951|FG000|Phase 1b|Adverse Event|0|||
164490053|NCT01136733|594163952|FG001|Phase 1b|Adverse Event|3|||
164490054|NCT01136733|594163953|FG002|Phase 1b|Adverse Event|1|||
164490055|NCT01136733|594163954|FG003|Phase 1b|Adverse Event|0|||
164490056|NCT01136733|594163955|FG004|Phase 1b|Adverse Event|0|||
164490057|NCT01136733|594163956|FG005|Phase 1b|Adverse Event|0|||
164490058|NCT01136733|594163957|FG006|Phase 1b|Adverse Event|0|||
164490059|NCT01136733|594163951|FG000|Phase 1b|Participant Choice|0|||
164490060|NCT01136733|594163952|FG001|Phase 1b|Participant Choice|0|||
164490061|NCT01136733|594163953|FG002|Phase 1b|Participant Choice|1|||
164490062|NCT01136733|594163954|FG003|Phase 1b|Participant Choice|0|||
164490063|NCT01136733|594163955|FG004|Phase 1b|Participant Choice|0|||
164490064|NCT01136733|594163956|FG005|Phase 1b|Participant Choice|0|||
164490065|NCT01136733|594163957|FG006|Phase 1b|Participant Choice|0|||
164490066|NCT01136733|594163951|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
164490067|NCT01136733|594163952|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
164490068|NCT01136733|594163953|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
164490069|NCT01136733|594163954|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
164490070|NCT01136733|594163955|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
164490071|NCT01136733|594163956|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
164490072|NCT01136733|594163957|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
164490073|NCT01136733|594163951|FG000|Phase 1b|Clinical Progression|1|||
164490074|NCT01136733|594163952|FG001|Phase 1b|Clinical Progression|1|||
164490075|NCT01136733|594163953|FG002|Phase 1b|Clinical Progression|0|||
164490076|NCT01136733|594163954|FG003|Phase 1b|Clinical Progression|0|||
164490077|NCT01136733|594163955|FG004|Phase 1b|Clinical Progression|0|||
164490078|NCT01136733|594163956|FG005|Phase 1b|Clinical Progression|0|||
164490079|NCT01136733|594163957|FG006|Phase 1b|Clinical Progression|0|||
164490080|NCT01136733|594163951|FG000|Phase 2|Disease Progression|0|||
164490081|NCT01136733|594163952|FG001|Phase 2|Disease Progression|0|||
164490082|NCT01136733|594163953|FG002|Phase 2|Disease Progression|0|||
164490083|NCT01136733|594163954|FG003|Phase 2|Disease Progression|0|||
164490084|NCT01136733|594163955|FG004|Phase 2|Disease Progression|30|||
164490085|NCT01136733|594163956|FG005|Phase 2|Disease Progression|32|||
164490086|NCT01136733|594163957|FG006|Phase 2|Disease Progression|38|||
164490087|NCT01136733|594163951|FG000|Phase 2|Adverse Event|0|||
164490088|NCT01136733|594163952|FG001|Phase 2|Adverse Event|0|||
164490089|NCT01136733|594163953|FG002|Phase 2|Adverse Event|0|||
164490090|NCT01136733|594163954|FG003|Phase 2|Adverse Event|0|||
164490091|NCT01136733|594163955|FG004|Phase 2|Adverse Event|11|||
164490092|NCT01136733|594163956|FG005|Phase 2|Adverse Event|13|||
164490093|NCT01136733|594163957|FG006|Phase 2|Adverse Event|5|||
164490094|NCT01136733|594163951|FG000|Phase 2|Participant Choice|0|||
164490095|NCT01136733|594163952|FG001|Phase 2|Participant Choice|0|||
164490096|NCT01136733|594163953|FG002|Phase 2|Participant Choice|0|||
164490097|NCT01136733|594163954|FG003|Phase 2|Participant Choice|0|||
164490098|NCT01136733|594163955|FG004|Phase 2|Participant Choice|3|||
164490099|NCT01136733|594163956|FG005|Phase 2|Participant Choice|0|||
164490100|NCT01136733|594163957|FG006|Phase 2|Participant Choice|1|||
164490101|NCT01136733|594163951|FG000|Phase 2|Administrative-Withdrew Consent|0|||
164490102|NCT01136733|594163952|FG001|Phase 2|Administrative-Withdrew Consent|0|||
164490103|NCT01136733|594163953|FG002|Phase 2|Administrative-Withdrew Consent|0|||
164490104|NCT01136733|594163954|FG003|Phase 2|Administrative-Withdrew Consent|0|||
164490105|NCT01136733|594163955|FG004|Phase 2|Administrative-Withdrew Consent|1|||
164490106|NCT01136733|594163956|FG005|Phase 2|Administrative-Withdrew Consent|0|||
164490107|NCT01136733|594163957|FG006|Phase 2|Administrative-Withdrew Consent|0|||
164490108|NCT01136733|594163951|FG000|Phase 2|Other|0|||
164490109|NCT01136733|594163952|FG001|Phase 2|Other|0|||
164490110|NCT01136733|594163953|FG002|Phase 2|Other|0|||
164490111|NCT01136733|594163954|FG003|Phase 2|Other|0|||
164490112|NCT01136733|594163955|FG004|Phase 2|Other|6|||
164490113|NCT01136733|594163956|FG005|Phase 2|Other|7|||
164490114|NCT01136733|594163957|FG006|Phase 2|Other|6|||
164490115|NCT01533181|594163959|FG000|Overall Study|Disease progression pre-active treatment|0|||
164490116|NCT01533181|594163960|FG001|Overall Study|Disease progression pre-active treatment|1|||
164490117|NCT01533181|594163959|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
164490118|NCT01533181|594163960|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
164490119|NCT03785210|594163961|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
164490120|NCT03785210|594163962|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
164490121|NCT00460577|594163975|FG000|Overall Study|Protocol Violation|2|||
164490122|NCT00460577|594163976|FG001|Overall Study|Protocol Violation|6|||
164490123|NCT04043806|594163979|FG000|Overall Study|Commercial drug is available for participants|13|||
164490124|NCT04043806|594163979|FG000|Overall Study|Physician Decision|2|||
164490125|NCT04043806|594163979|FG000|Overall Study|Other|12|||
164490126|NCT04043806|594163979|FG000|Overall Study|Adverse Event|2|||
164490127|NCT04043806|594163979|FG000|Overall Study|Lost to Follow-up|6|||
164490128|NCT04043806|594163979|FG000|Overall Study|Other non-compliance|2|||
164490129|NCT04043806|594163979|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
164490130|NCT04043806|594163979|FG000|Overall Study|Never Dosed|1|||
164490131|NCT01721109|594163987|FG000|Overall Study|Lack of Efficacy|1|||
164490132|NCT01721109|594163987|FG000|Overall Study|Non- Compliance with Study Drug|3|||
164490133|NCT01721109|594163987|FG000|Overall Study|Withdrew Consent|1|||
164490134|NCT01721109|594163987|FG000|Overall Study|Lost to Follow-up|2|||
164490135|NCT00134056|594163988|FG000|Randomization|Not eligible for assigned treatment|22|||
164490136|NCT00134056|594163989|FG001|Randomization|Not eligible for assigned treatment|20|||
164490137|NCT00134056|594163988|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
164490138|NCT00134056|594163989|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
164490139|NCT00134056|594163988|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
164490140|NCT00134056|594163989|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
164490141|NCT00134056|594163988|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
164490142|NCT00134056|594163989|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
164490143|NCT00134056|594163988|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
164490144|NCT00134056|594163989|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
164490145|NCT03166215|594163990|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
164490146|NCT03166215|594163991|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
164490147|NCT03166215|594163992|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
164490148|NCT03166215|594163990|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
164490149|NCT03166215|594163991|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
164490150|NCT03166215|594163992|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
164490151|NCT00742560|594163994|FG000|Overall Study|Adverse Event|0|||
164490152|NCT00742560|594163995|FG001|Overall Study|Adverse Event|0|||
164490153|NCT00742560|594163996|FG002|Overall Study|Adverse Event|1|||
164490154|NCT00742560|594163997|FG003|Overall Study|Adverse Event|1|||
164490155|NCT00742560|594163998|FG004|Overall Study|Adverse Event|1|||
164490156|NCT00742560|594163994|FG000|Overall Study|Death|0|||
164490157|NCT00742560|594163995|FG001|Overall Study|Death|2|||
164490158|NCT00742560|594163996|FG002|Overall Study|Death|0|||
164490159|NCT00742560|594163997|FG003|Overall Study|Death|2|||
164490160|NCT00742560|594163998|FG004|Overall Study|Death|3|||
164490161|NCT00742560|594163994|FG000|Overall Study|Subject's Decision|1|||
164490162|NCT00742560|594163995|FG001|Overall Study|Subject's Decision|0|||
164490163|NCT00742560|594163996|FG002|Overall Study|Subject's Decision|2|||
164490164|NCT00742560|594163997|FG003|Overall Study|Subject's Decision|3|||
164490165|NCT00742560|594163998|FG004|Overall Study|Subject's Decision|3|||
164490166|NCT00742560|594163994|FG000|Overall Study|Investigator's Decision|0|||
164490167|NCT00742560|594163995|FG001|Overall Study|Investigator's Decision|0|||
164490168|NCT00742560|594163996|FG002|Overall Study|Investigator's Decision|4|||
164490169|NCT00742560|594163997|FG003|Overall Study|Investigator's Decision|1|||
164490170|NCT00742560|594163998|FG004|Overall Study|Investigator's Decision|0|||
164490171|NCT00742560|594163994|FG000|Overall Study|Disease Progression|1|||
164490172|NCT00742560|594163995|FG001|Overall Study|Disease Progression|0|||
164490173|NCT00742560|594163996|FG002|Overall Study|Disease Progression|5|||
164490174|NCT00742560|594163997|FG003|Overall Study|Disease Progression|17|||
164490175|NCT00742560|594163998|FG004|Overall Study|Disease Progression|16|||
164490176|NCT00742560|594163994|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
164490177|NCT00742560|594163995|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
164490178|NCT00742560|594163996|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
164490179|NCT00742560|594163997|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
164490180|NCT00742560|594163998|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
164490181|NCT00742560|594163994|FG000|Overall Study|Other|0|||
164490182|NCT00742560|594163995|FG001|Overall Study|Other|1|||
164490183|NCT00742560|594163996|FG002|Overall Study|Other|8|||
164490184|NCT00742560|594163997|FG003|Overall Study|Other|9|||
164490185|NCT00742560|594163998|FG004|Overall Study|Other|9|||
164490186|NCT00742560|594163994|FG000|Overall Study|MIssing|0|||
164490187|NCT00742560|594163995|FG001|Overall Study|MIssing|0|||
164490188|NCT00742560|594163996|FG002|Overall Study|MIssing|0|||
164490189|NCT00742560|594163997|FG003|Overall Study|MIssing|0|||
164490190|NCT00742560|594163998|FG004|Overall Study|MIssing|1|||
164490191|NCT01536795|594164000|FG000|Overall Study|Lost to Follow-up|0|||
164490192|NCT01536795|594164001|FG001|Overall Study|Lost to Follow-up|2|||
164602304|NCT01885078|594564805|FG000|Treatment Period|Withdrawal by Subject|72|||
164602305|NCT01885078|594564806|FG001|Treatment Period|Withdrawal by Subject|132|||
164602306|NCT01885078|594564807|FG002|Treatment Period|Withdrawal by Subject|25|||
164490193|NCT01536795|594164000|FG000|Overall Study|Lack of Efficacy|1|||
164490194|NCT01536795|594164001|FG001|Overall Study|Lack of Efficacy|0|||
164602307|NCT01885078|594564808|FG003|Treatment Period|Withdrawal by Subject|63|||
164490195|NCT02267746|594164002|FG000|Overall Study|Adverse Event|0|||
164602308|NCT01885078|594564809|FG004|Treatment Period|Withdrawal by Subject|15|||
164602309|NCT01885078|594564810|FG005|Treatment Period|Withdrawal by Subject|34|||
164602310|NCT01885078|594564811|FG006|Treatment Period|Withdrawal by Subject|17|||
164602311|NCT01885078|594564812|FG007|Treatment Period|Withdrawal by Subject|10|||
164602312|NCT01885078|594564813|FG008|Treatment Period|Withdrawal by Subject|0|||
164490196|NCT02267746|594164003|FG001|Overall Study|Adverse Event|2|||
164490197|NCT02267746|594164004|FG002|Overall Study|Adverse Event|1|||
164490198|NCT02267746|594164002|FG000|Overall Study|Protocol Violation|8|||
164490199|NCT02267746|594164003|FG001|Overall Study|Protocol Violation|7|||
164490200|NCT02267746|594164004|FG002|Overall Study|Protocol Violation|3|||
164490201|NCT02267746|594164002|FG000|Overall Study|Lack of Efficacy|11|||
164490202|NCT02267746|594164003|FG001|Overall Study|Lack of Efficacy|11|||
164490203|NCT02267746|594164004|FG002|Overall Study|Lack of Efficacy|15|||
164490204|NCT02267746|594164002|FG000|Overall Study|Protocol Violation|1|||
164490205|NCT02267746|594164003|FG001|Overall Study|Protocol Violation|2|||
164490206|NCT02267746|594164004|FG002|Overall Study|Protocol Violation|1|||
164490207|NCT02267746|594164002|FG000|Overall Study|Miscellaneous|1|||
164490208|NCT02267746|594164003|FG001|Overall Study|Miscellaneous|0|||
164490209|NCT02267746|594164004|FG002|Overall Study|Miscellaneous|1|||
164490210|NCT05008224|594164005|FG000|Overall Study|Death|3|||
164490211|NCT05008224|594164005|FG000|Overall Study|Lost to Follow-up|2|||
164490212|NCT05008224|594164005|FG000|Overall Study|Did Not Continue on Extension Study|39|||
164490213|NCT05008224|594164005|FG000|Overall Study|Transferred to Extension Study|100|||
164490214|NCT05008224|594164005|FG000|Overall Study|Withdrawal by Subject|2|||
164490215|NCT04985604|594164006|FG000|Overall Study|Death|4|||
164490216|NCT04985604|594164007|FG001|Overall Study|Death|6|||
164490217|NCT04985604|594164006|FG000|Overall Study|Withdrawal by Subject|0|||
164490218|NCT04985604|594164007|FG001|Overall Study|Withdrawal by Subject|1|||
164490219|NCT04598776|594164008|FG000|Overall Study|Protocol Violation|5|||
164490220|NCT04598776|594164008|FG000|Overall Study|Physician Decision|4|||
164490221|NCT00348283|594164009|FG000|Induction|Adverse Event|0|||
164490222|NCT00348283|594164010|FG001|Induction|Adverse Event|2|||
164490223|NCT00348283|594164009|FG000|Induction|Protocol Violation|0|||
164490224|NCT00348283|594164010|FG001|Induction|Protocol Violation|4|||
164490225|NCT00348283|594164009|FG000|Double Blind|Adverse Event|2|||
164490226|NCT00348283|594164010|FG001|Double Blind|Adverse Event|5|||
164490227|NCT00348283|594164009|FG000|Double Blind|Withdrawal by Subject|1|||
164490228|NCT00348283|594164010|FG001|Double Blind|Withdrawal by Subject|1|||
164490229|NCT00348283|594164009|FG000|Double Blind|Protocol Violation|0|||
164490230|NCT00348283|594164010|FG001|Double Blind|Protocol Violation|1|||
164490231|NCT00348283|594164009|FG000|Double Blind|Lack of Efficacy|2|||
164490232|NCT00348283|594164010|FG001|Double Blind|Lack of Efficacy|2|||
164490233|NCT00348283|594164009|FG000|Double Blind|Pregnancy|0|||
164490234|NCT00348283|594164010|FG001|Double Blind|Pregnancy|1|||
164490235|NCT00348283|594164009|FG000|Open Label|Adverse Event|0|||
164490236|NCT00348283|594164010|FG001|Open Label|Adverse Event|8|||
164490237|NCT00348283|594164009|FG000|Open Label|Withdrawal by Subject|0|||
164490238|NCT00348283|594164010|FG001|Open Label|Withdrawal by Subject|4|||
164490239|NCT00348283|594164009|FG000|Open Label|Lost to Follow-up|0|||
164490240|NCT00348283|594164010|FG001|Open Label|Lost to Follow-up|1|||
164490241|NCT00348283|594164009|FG000|Open Label|Lack of Efficacy|0|||
164490242|NCT00348283|594164010|FG001|Open Label|Lack of Efficacy|13|||
164490243|NCT00348283|594164009|FG000|Open Label|Administrative reasons|0|||
164490244|NCT00348283|594164010|FG001|Open Label|Administrative reasons|5|||
164490245|NCT00348283|594164009|FG000|Open Label|Subject moved to the United States|0|||
164490246|NCT00348283|594164010|FG001|Open Label|Subject moved to the United States|1|||
164490247|NCT00348283|594164009|FG000|Open Label|Pregnancy|0|||
164490248|NCT00348283|594164010|FG001|Open Label|Pregnancy|1|||
164490249|NCT00348283|594164009|FG000|Open Label|Sponsor decision|0|||
164490250|NCT00348283|594164010|FG001|Open Label|Sponsor decision|1|||
164490251|NCT02282761|594164011|FG000|Overall Study|Death|0|||
164490252|NCT02282761|594164012|FG001|Overall Study|Death|0|||
164490253|NCT02282761|594164013|FG002|Overall Study|Death|1|||
164490254|NCT02282761|594164011|FG000|Overall Study|Adverse Event|6|||
164490255|NCT02282761|594164012|FG001|Overall Study|Adverse Event|2|||
164490256|NCT02282761|594164013|FG002|Overall Study|Adverse Event|0|||
164490257|NCT02282761|594164011|FG000|Overall Study|Lack of Efficacy|11|||
164490258|NCT02282761|594164012|FG001|Overall Study|Lack of Efficacy|6|||
164490259|NCT02282761|594164013|FG002|Overall Study|Lack of Efficacy|17|||
164490260|NCT02282761|594164011|FG000|Overall Study|Lost to Follow-up|2|||
164490261|NCT02282761|594164012|FG001|Overall Study|Lost to Follow-up|2|||
164490262|NCT02282761|594164013|FG002|Overall Study|Lost to Follow-up|1|||
164490263|NCT02282761|594164011|FG000|Overall Study|Physician Decision|0|||
164490264|NCT02282761|594164012|FG001|Overall Study|Physician Decision|0|||
164490265|NCT02282761|594164013|FG002|Overall Study|Physician Decision|2|||
164490266|NCT02282761|594164011|FG000|Overall Study|Withdrawal by Subject|8|||
164602313|NCT01885078|594564814|FG009|Treatment Period|Withdrawal by Subject|0|||
164490267|NCT02282761|594164012|FG001|Overall Study|Withdrawal by Subject|10|||
164490268|NCT02282761|594164013|FG002|Overall Study|Withdrawal by Subject|16|||
164490269|NCT02282761|594164011|FG000|Overall Study|Other|3|||
164490270|NCT02282761|594164012|FG001|Overall Study|Other|2|||
164490271|NCT02282761|594164013|FG002|Overall Study|Other|1|||
164490272|NCT00658632|594164016|FG000|Overall Study|Adverse Event|13|||
164490273|NCT00658632|594164017|FG001|Overall Study|Adverse Event|11|||
164490274|NCT00658632|594164016|FG000|Overall Study|Lost to Follow-up|25|||
164490275|NCT00658632|594164017|FG001|Overall Study|Lost to Follow-up|23|||
164490276|NCT00658632|594164016|FG000|Overall Study|Withdrawal by Subject|10|||
164490277|NCT00658632|594164017|FG001|Overall Study|Withdrawal by Subject|7|||
164490278|NCT00658632|594164016|FG000|Overall Study|Lack of Efficacy|0|||
164490279|NCT00658632|594164017|FG001|Overall Study|Lack of Efficacy|1|||
164490280|NCT00658632|594164016|FG000|Overall Study|Withdrawal of consent|8|||
164490281|NCT00658632|594164017|FG001|Overall Study|Withdrawal of consent|14|||
164490282|NCT00658632|594164016|FG000|Overall Study|Pregnancy|1|||
164490283|NCT00658632|594164017|FG001|Overall Study|Pregnancy|1|||
164490284|NCT00658632|594164016|FG000|Overall Study|Other|7|||
164490285|NCT00658632|594164017|FG001|Overall Study|Other|8|||
164490286|NCT04551053|594164018|FG000|Overall Study|Death|10|||
164490287|NCT04551053|594164019|FG001|Overall Study|Death|9|||
164490288|NCT04551053|594164018|FG000|Overall Study|Lost to Follow-up|0|||
164490289|NCT04551053|594164019|FG001|Overall Study|Lost to Follow-up|2|||
164490290|NCT04551053|594164018|FG000|Overall Study|Study Terminated by Sponsor|57|||
164490291|NCT04551053|594164019|FG001|Overall Study|Study Terminated by Sponsor|65|||
164490292|NCT04551053|594164018|FG000|Overall Study|Withdrawal by Subject|12|||
164490293|NCT04551053|594164019|FG001|Overall Study|Withdrawal by Subject|5|||
164490294|NCT04551053|594164018|FG000|Overall Study|Adverse Event|2|||
164490295|NCT04551053|594164019|FG001|Overall Study|Adverse Event|0|||
164490296|NCT04551053|594164018|FG000|Overall Study|Lack of Efficacy|2|||
164490297|NCT04551053|594164019|FG001|Overall Study|Lack of Efficacy|1|||
164490298|NCT04551053|594164018|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
164490299|NCT04551053|594164019|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
164490300|NCT04551053|594164018|FG000|Overall Study|Splenapendectomi|1|||
164490301|NCT04551053|594164019|FG001|Overall Study|Splenapendectomi|0|||
164490302|NCT04551053|594164018|FG000|Overall Study|Medical Decision|1|||
164490303|NCT04551053|594164019|FG001|Overall Study|Medical Decision|1|||
164490304|NCT03861078|594164020|FG000|Overall Study|COVID-19 shut down|4|||
164490305|NCT03861078|594164020|FG000|Overall Study|Lost to Follow-up|1|||
164490306|NCT03861078|594164020|FG000|Overall Study|Protocol Violation|2|||
164490307|NCT03861078|594164020|FG000|Overall Study|lack of venous access|1|||
164490308|NCT00596960|594164023|FG000|Overall Study|Death|1|||
164490309|NCT00596960|594164024|FG001|Overall Study|Death|2|||
164490310|NCT00596960|594164023|FG000|Overall Study|Lost to Follow-up|6|||
164490311|NCT00596960|594164024|FG001|Overall Study|Lost to Follow-up|5|||
164490312|NCT00596960|594164023|FG000|Overall Study|Withdrawal by Subject|1|||
164490313|NCT00596960|594164024|FG001|Overall Study|Withdrawal by Subject|0|||
164490314|NCT00596960|594164023|FG000|Overall Study|Incarcerated|2|||
164490315|NCT00596960|594164024|FG001|Overall Study|Incarcerated|0|||
164490316|NCT00596960|594164023|FG000|Overall Study|Physician Decision|1|||
164490317|NCT00596960|594164024|FG001|Overall Study|Physician Decision|0|||
164490318|NCT00596960|594164023|FG000|Overall Study|Protocol Violation|0|||
164490319|NCT00596960|594164024|FG001|Overall Study|Protocol Violation|1|||
164490320|NCT00596960|594164023|FG000|Overall Study|No alcohol use data|0|||
164490321|NCT00596960|594164024|FG001|Overall Study|No alcohol use data|1|||
164490322|NCT04016415|594164025|FG000|Overall Study|Adverse Event|2|||
164490323|NCT04016415|594164026|FG001|Overall Study|Adverse Event|1|||
164490324|NCT04016415|594164025|FG000|Overall Study|Lost to Follow-up|6|||
164490325|NCT04016415|594164026|FG001|Overall Study|Lost to Follow-up|2|||
164490326|NCT04016415|594164025|FG000|Overall Study|Physician Decision|5|||
164490327|NCT04016415|594164026|FG001|Overall Study|Physician Decision|1|||
164714811|NCT00856375|594978790|FG001|Overall Study|Lost to Follow-up|2|||
164714812|NCT02538965|594978795|FG000|Treatment Period|Other = Death due to disease progression|1|||
164714813|NCT02538965|594978795|FG000|Treatment Period|Adverse Event|2|||
164714814|NCT02538965|594978795|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
164714815|NCT02538965|594978795|FG000|Treatment Period|Treatment Failure|9|||
164714816|NCT02538965|594978795|FG000|Treatment Period|Disease Progression|1|||
164714817|NCT02538965|594978795|FG000|Treatment Period|Physician Decision|2|||
164714818|NCT02538965|594978795|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
164714819|NCT02538965|594978795|FG000|Follow-Up Period|Withdrawal by Parent|4|||
164714820|NCT00875797|594978796|FG000|Overall Study|Protocol Violation|6|||
164714821|NCT00875797|594978797|FG001|Overall Study|Protocol Violation|3|||
164490328|NCT04016415|594164025|FG000|Overall Study|Pregnancy|0|||
164490329|NCT04016415|594164026|FG001|Overall Study|Pregnancy|1|||
164490330|NCT04016415|594164025|FG000|Overall Study|Withdrawal by Subject|24|||
164490331|NCT04016415|594164026|FG001|Overall Study|Withdrawal by Subject|27|||
164490332|NCT04016415|594164025|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
164490333|NCT04016415|594164026|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
164490334|NCT01885559|594164027|FG000|Overall Study|Lost to Follow-up|15|||
164490335|NCT01885559|594164028|FG001|Overall Study|Lost to Follow-up|16|||
164490336|NCT01885559|594164027|FG000|Overall Study|Less than full participation|9|||
164490337|NCT01885559|594164028|FG001|Overall Study|Less than full participation|19|||
164490338|NCT01885559|594164027|FG000|Overall Study|Protocol Violation|0|||
164490339|NCT01885559|594164028|FG001|Overall Study|Protocol Violation|1|||
164490340|NCT00732498|594164031|FG000|Overall Study|Ineligible|1|||
164490341|NCT00732498|594164031|FG000|Overall Study|Adverse Event|2|||
164490342|NCT00732498|594164031|FG000|Overall Study|Physician Decision|3|||
164490343|NCT03070301|594164032|FG000|Overall Study|Progression of disease|16|||
164490344|NCT03070301|594164032|FG000|Overall Study|Physician Decision|3|||
164490345|NCT03070301|594164032|FG000|Overall Study|Withdrawal by Subject|1|||
164490346|NCT03820024|594164033|FG000|Overall Study|Physician Decision|1|||
164490347|NCT03820024|594164034|FG001|Overall Study|Physician Decision|2|||
164490348|NCT00705614|594166054|FG000|Initial Intervention|Adverse Event|40|||
164490349|NCT00705614|594166055|FG001|Initial Intervention|Adverse Event|21|||
164490350|NCT00705614|594166054|FG000|Initial Intervention|Lost to Follow-up|310|||
164490351|NCT00705614|594166055|FG001|Initial Intervention|Lost to Follow-up|191|||
164490352|NCT00705614|594166054|FG000|Initial Intervention|Withdrawal by Subject|114|||
164490353|NCT00705614|594166055|FG001|Initial Intervention|Withdrawal by Subject|71|||
164490354|NCT00705614|594166054|FG000|Initial Intervention|Administrative Reason|51|||
164490355|NCT00705614|594166055|FG001|Initial Intervention|Administrative Reason|38|||
164490356|NCT00705614|594166054|FG000|Initial Intervention|Status completion unknown|3|||
164490357|NCT00705614|594166055|FG001|Initial Intervention|Status completion unknown|0|||
164490358|NCT00705614|594166054|FG000|Switch to Remicade|Adverse Event|0|||
164490359|NCT00705614|594166055|FG001|Switch to Remicade|Adverse Event|5|||
164490360|NCT00705614|594166054|FG000|Switch to Remicade|Lost to Follow-up|0|||
164490361|NCT00705614|594166055|FG001|Switch to Remicade|Lost to Follow-up|23|||
164490362|NCT00705614|594166054|FG000|Switch to Remicade|Withdrawal by Subject|0|||
164490363|NCT00705614|594166055|FG001|Switch to Remicade|Withdrawal by Subject|12|||
164490364|NCT00705614|594166054|FG000|Switch to Remicade|Administrative Reason|0|||
164490365|NCT00705614|594166055|FG001|Switch to Remicade|Administrative Reason|9|||
164490366|NCT02661490|594166056|FG000|Overall Study|Lost to Follow-up|0|||
164490367|NCT02661490|594166057|FG001|Overall Study|Lost to Follow-up|1|||
164490368|NCT02661490|594166058|FG002|Overall Study|Lost to Follow-up|0|||
164490369|NCT02661490|594166059|FG003|Overall Study|Lost to Follow-up|0|||
164490370|NCT02661490|594166060|FG004|Overall Study|Lost to Follow-up|2|||
164490371|NCT02661490|594166056|FG000|Overall Study|Withdrawal by Subject|2|||
164490372|NCT02661490|594166057|FG001|Overall Study|Withdrawal by Subject|0|||
164490373|NCT02661490|594166058|FG002|Overall Study|Withdrawal by Subject|2|||
164490374|NCT02661490|594166059|FG003|Overall Study|Withdrawal by Subject|0|||
164490375|NCT02661490|594166060|FG004|Overall Study|Withdrawal by Subject|0|||
164490376|NCT02661490|594166056|FG000|Overall Study|Death|1|||
164490377|NCT02661490|594166057|FG001|Overall Study|Death|1|||
164490378|NCT02661490|594166058|FG002|Overall Study|Death|0|||
164490379|NCT02661490|594166059|FG003|Overall Study|Death|1|||
164490380|NCT02661490|594166060|FG004|Overall Study|Death|0|||
164490381|NCT02661490|594166056|FG000|Overall Study|Reason not Specified|0|||
164490382|NCT02661490|594166057|FG001|Overall Study|Reason not Specified|0|||
164490383|NCT02661490|594166058|FG002|Overall Study|Reason not Specified|0|||
164490384|NCT02661490|594166059|FG003|Overall Study|Reason not Specified|0|||
164490385|NCT02661490|594166060|FG004|Overall Study|Reason not Specified|1|||
164490386|NCT01232569|594166061|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
164490387|NCT01232569|594166062|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
164490388|NCT01232569|594166063|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
164490389|NCT01232569|594166064|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
164490390|NCT01232569|594166061|FG000|Double-blind Treatment Period|Escape|2|||
164490391|NCT01232569|594166062|FG001|Double-blind Treatment Period|Escape|2|||
164490392|NCT01232569|594166063|FG002|Double-blind Treatment Period|Escape|0|||
164490393|NCT01232569|594166064|FG003|Double-blind Treatment Period|Escape|0|||
164490394|NCT01232569|594166061|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
164490395|NCT01232569|594166062|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
164490396|NCT01232569|594166063|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
164490397|NCT01232569|594166064|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
164490398|NCT01232569|594166061|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
164490399|NCT01232569|594166062|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
164490400|NCT01232569|594166063|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
164490401|NCT01232569|594166064|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
164490402|NCT01232569|594166061|FG000|Double-blind Treatment Period|Physician Decision|1|||
164490403|NCT01232569|594166062|FG001|Double-blind Treatment Period|Physician Decision|0|||
164490404|NCT01232569|594166063|FG002|Double-blind Treatment Period|Physician Decision|0|||
164490405|NCT01232569|594166064|FG003|Double-blind Treatment Period|Physician Decision|0|||
164490406|NCT01232569|594166061|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
164490407|NCT01232569|594166062|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
164490408|NCT01232569|594166063|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
164490409|NCT01232569|594166064|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
164490410|NCT01232569|594166061|FG000|Double-blind Treatment Period|Death|2|||
164490411|NCT01232569|594166062|FG001|Double-blind Treatment Period|Death|0|||
164490412|NCT01232569|594166063|FG002|Double-blind Treatment Period|Death|0|||
164490413|NCT01232569|594166064|FG003|Double-blind Treatment Period|Death|0|||
164490414|NCT00489489|594166065|FG000|Overall Study|Not treated due to protocol violation|0|||
164490415|NCT00489489|594166066|FG001|Overall Study|Not treated due to protocol violation|1|||
164490416|NCT00489489|594166067|FG002|Overall Study|Not treated due to protocol violation|1|||
164490417|NCT00489489|594166065|FG000|Overall Study|Adverse Event|1|||
164490418|NCT00489489|594166066|FG001|Overall Study|Adverse Event|1|||
164490419|NCT00489489|594166067|FG002|Overall Study|Adverse Event|1|||
164490420|NCT00489489|594166065|FG000|Overall Study|Protocol Violation|1|||
164490421|NCT00489489|594166066|FG001|Overall Study|Protocol Violation|0|||
164490422|NCT00489489|594166067|FG002|Overall Study|Protocol Violation|1|||
164490423|NCT00489489|594166065|FG000|Overall Study|Progressive disease|0|||
164490424|NCT00489489|594166066|FG001|Overall Study|Progressive disease|1|||
164490425|NCT00489489|594166067|FG002|Overall Study|Progressive disease|0|||
164490426|NCT00489489|594166065|FG000|Overall Study|Participant did not wish to continue|1|||
164490427|NCT00489489|594166066|FG001|Overall Study|Participant did not wish to continue|1|||
164490428|NCT00489489|594166067|FG002|Overall Study|Participant did not wish to continue|0|||
164490429|NCT00489489|594166065|FG000|Overall Study|Other than above|0|||
164490430|NCT00489489|594166066|FG001|Overall Study|Other than above|1|||
164490431|NCT00489489|594166067|FG002|Overall Study|Other than above|0|||
164490432|NCT02388932|594166070|FG000|Overall Study|Death|1|||
164490433|NCT05335005|594166073|FG000|Overall Study|Lost to Follow-up|1|||
164490434|NCT05927753|594166074|FG000|Overall Study|Withdrawal by Subject|0|||
164490435|NCT05927753|594166075|FG001|Overall Study|Withdrawal by Subject|2|||
164490436|NCT05927753|594166074|FG000|Overall Study|Physician Decision|0|||
164490437|NCT05927753|594166075|FG001|Overall Study|Physician Decision|1|||
164490438|NCT04198428|594166076|FG000|Overall Study|Withdrawal by Subject|150|||
164490439|NCT04198428|594166077|FG001|Overall Study|Withdrawal by Subject|156|||
164490440|NCT02123797|594166079|FG000|Baseline Intervention|Death|9|||
164490441|NCT02123797|594166080|FG001|Baseline Intervention|Death|16|||
164490442|NCT02123797|594166081|FG002|Baseline Intervention|Death|0|||
164490443|NCT02123797|594166082|FG003|Baseline Intervention|Death|0|||
164490444|NCT02123797|594166083|FG004|Baseline Intervention|Death|0|||
164490445|NCT02123797|594166079|FG000|Baseline Intervention|Withdrawal by Subject|2|||
164490446|NCT02123797|594166080|FG001|Baseline Intervention|Withdrawal by Subject|8|||
164490447|NCT02123797|594166081|FG002|Baseline Intervention|Withdrawal by Subject|0|||
164490448|NCT02123797|594166082|FG003|Baseline Intervention|Withdrawal by Subject|0|||
164490449|NCT02123797|594166083|FG004|Baseline Intervention|Withdrawal by Subject|0|||
164490450|NCT02123797|594166079|FG000|Baseline Intervention|Relocation|2|||
164490451|NCT02123797|594166080|FG001|Baseline Intervention|Relocation|0|||
164490452|NCT02123797|594166081|FG002|Baseline Intervention|Relocation|0|||
164490453|NCT02123797|594166082|FG003|Baseline Intervention|Relocation|0|||
164490454|NCT02123797|594166083|FG004|Baseline Intervention|Relocation|0|||
164490455|NCT02123797|594166079|FG000|Baseline Intervention|Out of window for initial survey|6|||
164490456|NCT02123797|594166080|FG001|Baseline Intervention|Out of window for initial survey|13|||
164490457|NCT02123797|594166081|FG002|Baseline Intervention|Out of window for initial survey|0|||
164490458|NCT02123797|594166082|FG003|Baseline Intervention|Out of window for initial survey|0|||
164490459|NCT02123797|594166083|FG004|Baseline Intervention|Out of window for initial survey|0|||
164490460|NCT02123797|594166079|FG000|Baseline Intervention|Lost to Follow-up|0|||
164490461|NCT02123797|594166080|FG001|Baseline Intervention|Lost to Follow-up|5|||
164490462|NCT02123797|594166081|FG002|Baseline Intervention|Lost to Follow-up|0|||
164490463|NCT02123797|594166082|FG003|Baseline Intervention|Lost to Follow-up|0|||
164490464|NCT02123797|594166083|FG004|Baseline Intervention|Lost to Follow-up|0|||
164490465|NCT02123797|594166079|FG000|Baseline Intervention|Other Disease|3|||
164490466|NCT02123797|594166080|FG001|Baseline Intervention|Other Disease|0|||
164490467|NCT02123797|594166081|FG002|Baseline Intervention|Other Disease|0|||
164490468|NCT02123797|594166082|FG003|Baseline Intervention|Other Disease|0|||
164490469|NCT02123797|594166083|FG004|Baseline Intervention|Other Disease|0|||
164490470|NCT02123797|594166079|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
164490471|NCT02123797|594166080|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
164490472|NCT02123797|594166081|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
164490473|NCT02123797|594166082|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
164490474|NCT02123797|594166083|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
164490475|NCT02123797|594166079|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
164490476|NCT02123797|594166080|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
164490477|NCT02123797|594166081|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
164490478|NCT02123797|594166082|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
164490479|NCT02123797|594166083|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
164490480|NCT02123797|594166079|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
164490481|NCT02123797|594166080|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
164490482|NCT02123797|594166081|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
164490483|NCT02123797|594166082|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
164490484|NCT02123797|594166083|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
164490485|NCT02123797|594166079|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
164490486|NCT02123797|594166080|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
164490487|NCT02123797|594166081|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
164490488|NCT02123797|594166082|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
164490489|NCT02123797|594166083|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
164490490|NCT02123797|594166079|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
164602314|NCT01885078|594564805|FG000|Treatment Period|Other|0|||
164490491|NCT02123797|594166080|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
164490492|NCT02123797|594166081|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
164490493|NCT02123797|594166082|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
164490494|NCT02123797|594166083|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
164490495|NCT02123797|594166079|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
164490496|NCT02123797|594166080|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
164490497|NCT02123797|594166081|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
164490498|NCT02123797|594166082|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
164490499|NCT02123797|594166083|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
164490500|NCT02123797|594166079|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
164490501|NCT02123797|594166080|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
164490502|NCT02123797|594166081|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
164490503|NCT02123797|594166082|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
164490504|NCT02123797|594166083|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
164490505|NCT02123797|594166079|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
164490506|NCT02123797|594166080|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
164490507|NCT02123797|594166081|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
164490508|NCT02123797|594166082|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
164490509|NCT02123797|594166083|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
164490510|NCT02123797|594166079|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
164490511|NCT02123797|594166080|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
164490512|NCT02123797|594166081|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
164490513|NCT02123797|594166082|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
164490514|NCT02123797|594166083|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
164490515|NCT00627523|594166085|FG000|Overall Study|Lack of Efficacy|1|||
164490516|NCT00627523|594166086|FG001|Overall Study|Lack of Efficacy|0|||
164490517|NCT00627523|594166085|FG000|Overall Study|Withdrawal by Subject|0|||
164490518|NCT00627523|594166086|FG001|Overall Study|Withdrawal by Subject|2|||
164490519|NCT00627523|594166085|FG000|Overall Study|Other|1|||
164490520|NCT00627523|594166086|FG001|Overall Study|Other|0|||
164490521|NCT01375777|594166089|FG000|Overall Study|Withdrawal by Subject|0|||
164490522|NCT01375777|594166090|FG001|Overall Study|Withdrawal by Subject|2|||
164490523|NCT01375777|594166091|FG002|Overall Study|Withdrawal by Subject|1|||
164490524|NCT01375777|594166092|FG003|Overall Study|Withdrawal by Subject|0|||
164490525|NCT01375777|594166093|FG004|Overall Study|Withdrawal by Subject|1|||
164490526|NCT01375777|594166094|FG005|Overall Study|Withdrawal by Subject|1|||
164490527|NCT01375777|594166095|FG006|Overall Study|Withdrawal by Subject|1|||
164490528|NCT01375777|594166096|FG007|Overall Study|Withdrawal by Subject|2|||
164490529|NCT01375777|594166097|FG008|Overall Study|Withdrawal by Subject|1|||
164490530|NCT01375777|594166089|FG000|Overall Study|Lost to Follow-up|1|||
164490531|NCT01375777|594166090|FG001|Overall Study|Lost to Follow-up|0|||
164490532|NCT01375777|594166091|FG002|Overall Study|Lost to Follow-up|0|||
164490533|NCT01375777|594166092|FG003|Overall Study|Lost to Follow-up|0|||
164490534|NCT01375777|594166093|FG004|Overall Study|Lost to Follow-up|0|||
164490535|NCT01375777|594166094|FG005|Overall Study|Lost to Follow-up|0|||
164490536|NCT01375777|594166095|FG006|Overall Study|Lost to Follow-up|1|||
164602315|NCT01885078|594564806|FG001|Treatment Period|Other|0|||
164602316|NCT01885078|594564807|FG002|Treatment Period|Other|0|||
164602317|NCT01885078|594564808|FG003|Treatment Period|Other|1|||
164602318|NCT01885078|594564809|FG004|Treatment Period|Other|0|||
164602319|NCT01885078|594564810|FG005|Treatment Period|Other|0|||
164602320|NCT01885078|594564811|FG006|Treatment Period|Other|0|||
164602321|NCT01885078|594564812|FG007|Treatment Period|Other|0|||
164602322|NCT01885078|594564813|FG008|Treatment Period|Other|0|||
164602323|NCT01885078|594564814|FG009|Treatment Period|Other|0|||
164602324|NCT01885078|594564805|FG000|Step-down Period|Sponsor Decision|0|||
164602325|NCT01885078|594564806|FG001|Step-down Period|Sponsor Decision|0|||
164602326|NCT01885078|594564807|FG002|Step-down Period|Sponsor Decision|0|||
164714822|NCT00741286|594978800|FG000|Overall Study|Lost to Follow-up|15|||
164714823|NCT00741286|594978801|FG001|Overall Study|Lost to Follow-up|10|||
164714824|NCT00741286|594978800|FG000|Overall Study|Adverse Event|1|||
164714825|NCT00741286|594978801|FG001|Overall Study|Adverse Event|6|||
164714826|NCT00741286|594978800|FG000|Overall Study|Protocol Violation|3|||
164714827|NCT00741286|594978801|FG001|Overall Study|Protocol Violation|2|||
164714828|NCT00741286|594978800|FG000|Overall Study|Primary Outcome|1|||
164714829|NCT00741286|594978801|FG001|Overall Study|Primary Outcome|1|||
164490537|NCT01375777|594166096|FG007|Overall Study|Lost to Follow-up|0|||
164490538|NCT01375777|594166097|FG008|Overall Study|Lost to Follow-up|0|||
164490539|NCT01375777|594166089|FG000|Overall Study|Other|1|||
164490540|NCT01375777|594166090|FG001|Overall Study|Other|1|||
164490541|NCT01375777|594166091|FG002|Overall Study|Other|0|||
164490542|NCT01375777|594166092|FG003|Overall Study|Other|0|||
164490543|NCT01375777|594166093|FG004|Overall Study|Other|0|||
164490544|NCT01375777|594166094|FG005|Overall Study|Other|0|||
164490545|NCT01375777|594166095|FG006|Overall Study|Other|0|||
164602327|NCT01885078|594564808|FG003|Step-down Period|Sponsor Decision|0|||
164714830|NCT01307111|594978802|FG000|IUD Insertion|Lost to Follow-up|2|||
164714831|NCT01307111|594978803|FG001|IUD Insertion|Lost to Follow-up|0|||
164714832|NCT01307111|594978802|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
164714833|NCT01307111|594978803|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
164714834|NCT02892149|594978805|FG000|Overall Study|Death|262|||
164714835|NCT02892149|594978806|FG001|Overall Study|Death|278|||
164714836|NCT02892149|594978805|FG000|Overall Study|Withdrawal by Subject|53|||
164490546|NCT01375777|594166096|FG007|Overall Study|Other|0|||
164490547|NCT01375777|594166097|FG008|Overall Study|Other|1|||
164490548|NCT00355784|594166098|FG000|Overall Study|Withdrawal by Subject|0|||
164490549|NCT00355784|594166099|FG001|Overall Study|Withdrawal by Subject|0|||
164490550|NCT00355784|594166100|FG002|Overall Study|Withdrawal by Subject|2|||
164490551|NCT03602053|594166107|FG000|Overall Study|Withdrawal by Subject|7|||
164490552|NCT03602053|594166108|FG001|Overall Study|Withdrawal by Subject|9|||
164490553|NCT03602053|594166109|FG002|Overall Study|Withdrawal by Subject|7|||
164490554|NCT03602053|594166107|FG000|Overall Study|Lost to Follow-up|5|||
164490555|NCT03602053|594166108|FG001|Overall Study|Lost to Follow-up|6|||
164490556|NCT03602053|594166109|FG002|Overall Study|Lost to Follow-up|0|||
164490557|NCT03602053|594166107|FG000|Overall Study|Protocol Violation|3|||
164490558|NCT03602053|594166108|FG001|Overall Study|Protocol Violation|0|||
164490559|NCT03602053|594166109|FG002|Overall Study|Protocol Violation|4|||
164490560|NCT03602053|594166107|FG000|Overall Study|Physician Decision|1|||
164490561|NCT03602053|594166108|FG001|Overall Study|Physician Decision|0|||
164490562|NCT03602053|594166109|FG002|Overall Study|Physician Decision|0|||
164490563|NCT03602053|594166107|FG000|Overall Study|migration|2|||
164490564|NCT03602053|594166108|FG001|Overall Study|migration|3|||
164490565|NCT03602053|594166109|FG002|Overall Study|migration|0|||
164490566|NCT03602053|594166107|FG000|Overall Study|Other|1|||
164490567|NCT03602053|594166108|FG001|Overall Study|Other|0|||
164490568|NCT03602053|594166109|FG002|Overall Study|Other|0|||
164490569|NCT03672188|594166116|FG000|Overall Study|Withdrawal by Subject|0|||
164490570|NCT03672188|594166117|FG001|Overall Study|Withdrawal by Subject|0|||
164490571|NCT03672188|594166118|FG002|Overall Study|Withdrawal by Subject|0|||
164490572|NCT03672188|594166119|FG003|Overall Study|Withdrawal by Subject|3|||
164490573|NCT03672188|594166120|FG004|Overall Study|Withdrawal by Subject|0|||
164490574|NCT03672188|594166121|FG005|Overall Study|Withdrawal by Subject|0|||
164490575|NCT03672188|594166122|FG006|Overall Study|Withdrawal by Subject|0|||
164490576|NCT03672188|594166123|FG007|Overall Study|Withdrawal by Subject|0|||
164490577|NCT03672188|594166124|FG008|Overall Study|Withdrawal by Subject|0|||
164490578|NCT03672188|594166125|FG009|Overall Study|Withdrawal by Subject|0|||
164490579|NCT03672188|594166126|FG010|Overall Study|Withdrawal by Subject|0|||
164490580|NCT03672188|594166127|FG011|Overall Study|Withdrawal by Subject|0|||
164490581|NCT03672188|594166128|FG012|Overall Study|Withdrawal by Subject|0|||
164490582|NCT03672188|594166129|FG013|Overall Study|Withdrawal by Subject|0|||
164490583|NCT03672188|594166130|FG014|Overall Study|Withdrawal by Subject|0|||
164490584|NCT03672188|594166116|FG000|Overall Study|Death|0|||
164490585|NCT03672188|594166117|FG001|Overall Study|Death|0|||
164490586|NCT03672188|594166118|FG002|Overall Study|Death|0|||
164490587|NCT03672188|594166119|FG003|Overall Study|Death|0|||
164490588|NCT03672188|594166120|FG004|Overall Study|Death|0|||
164490589|NCT03672188|594166121|FG005|Overall Study|Death|0|||
164490590|NCT03672188|594166122|FG006|Overall Study|Death|0|||
164490591|NCT03672188|594166123|FG007|Overall Study|Death|0|||
164490592|NCT03672188|594166124|FG008|Overall Study|Death|0|||
164490593|NCT03672188|594166125|FG009|Overall Study|Death|0|||
164490594|NCT03672188|594166126|FG010|Overall Study|Death|0|||
164490595|NCT03672188|594166127|FG011|Overall Study|Death|0|||
164490596|NCT03672188|594166128|FG012|Overall Study|Death|1|||
164490597|NCT03672188|594166129|FG013|Overall Study|Death|0|||
164490598|NCT03672188|594166130|FG014|Overall Study|Death|0|||
164490599|NCT03672188|594166116|FG000|Overall Study|Lost to Follow-up|0|||
164490600|NCT03672188|594166117|FG001|Overall Study|Lost to Follow-up|0|||
164714837|NCT02892149|594978806|FG001|Overall Study|Withdrawal by Subject|47|||
164490601|NCT03672188|594166118|FG002|Overall Study|Lost to Follow-up|1|||
164490602|NCT03672188|594166119|FG003|Overall Study|Lost to Follow-up|0|||
164490603|NCT03672188|594166120|FG004|Overall Study|Lost to Follow-up|0|||
164490604|NCT03672188|594166121|FG005|Overall Study|Lost to Follow-up|0|||
164490605|NCT03672188|594166122|FG006|Overall Study|Lost to Follow-up|0|||
164490606|NCT03672188|594166123|FG007|Overall Study|Lost to Follow-up|0|||
164490607|NCT03672188|594166124|FG008|Overall Study|Lost to Follow-up|0|||
164490608|NCT03672188|594166125|FG009|Overall Study|Lost to Follow-up|0|||
164490609|NCT03672188|594166126|FG010|Overall Study|Lost to Follow-up|0|||
164490610|NCT03672188|594166127|FG011|Overall Study|Lost to Follow-up|0|||
164490611|NCT03672188|594166128|FG012|Overall Study|Lost to Follow-up|0|||
164490612|NCT03672188|594166129|FG013|Overall Study|Lost to Follow-up|0|||
164490613|NCT03672188|594166130|FG014|Overall Study|Lost to Follow-up|0|||
164490614|NCT01234675|594166131|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
164490615|NCT01234675|594166132|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
164490616|NCT01234675|594166131|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
164490617|NCT01234675|594166132|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
164490618|NCT03997409|594166133|FG000|Overall Study|Protocol Violation|1|||
164490619|NCT03997409|594166134|FG001|Overall Study|Protocol Violation|1|||
164490620|NCT03997409|594166135|FG002|Overall Study|Protocol Violation|0|||
164490621|NCT03997409|594166133|FG000|Overall Study|Withdrawal by Subject|3|||
164490622|NCT03997409|594166134|FG001|Overall Study|Withdrawal by Subject|0|||
164490623|NCT03997409|594166135|FG002|Overall Study|Withdrawal by Subject|0|||
164490624|NCT03997409|594166133|FG000|Overall Study|Lost to Follow-up|0|||
164490625|NCT03997409|594166134|FG001|Overall Study|Lost to Follow-up|0|||
164490626|NCT03997409|594166135|FG002|Overall Study|Lost to Follow-up|1|||
164490627|NCT03696342|594166136|FG000|Overall Study|Lost to Follow-up|1|||
164490628|NCT03696342|594166137|FG001|Overall Study|Lost to Follow-up|0|||
164490629|NCT02409732|594166140|FG000|Overall Study|Withdrawal by Subject|4|||
164490630|NCT02409732|594166140|FG000|Overall Study|Lost to Follow-up|2|||
164490631|NCT04203199|594166141|FG000|First Intervention Period|Lost to Follow-up|0|||
164490632|NCT04203199|594166142|FG001|First Intervention Period|Lost to Follow-up|1|||
164490633|NCT04203199|594166141|FG000|Second Intervention Period|Medication change|1|||
164490634|NCT04203199|594166142|FG001|Second Intervention Period|Medication change|0|||
164490635|NCT01753323|594166144|FG000|Overall Study|Lack of Efficacy|0|||
164490636|NCT01753323|594166145|FG001|Overall Study|Lack of Efficacy|0|||
164490637|NCT01753323|594166146|FG002|Overall Study|Lack of Efficacy|8|||
164490638|NCT01753323|594166144|FG000|Overall Study|Protocol deviation|1|||
164490639|NCT01753323|594166145|FG001|Overall Study|Protocol deviation|0|||
164490640|NCT01753323|594166146|FG002|Overall Study|Protocol deviation|0|||
164490641|NCT01753323|594166144|FG000|Overall Study|Adverse Event|0|||
164490642|NCT01753323|594166145|FG001|Overall Study|Adverse Event|0|||
164490643|NCT01753323|594166146|FG002|Overall Study|Adverse Event|1|||
164490644|NCT01870999|594166147|FG000|Overall Study|Adverse Event|0|||
164490645|NCT01870999|594166148|FG001|Overall Study|Adverse Event|4|||
164490646|NCT01870999|594166149|FG002|Overall Study|Adverse Event|1|||
164490647|NCT01870999|594166147|FG000|Overall Study|Subject met withdrawal criteria|3|||
164490648|NCT01870999|594166148|FG001|Overall Study|Subject met withdrawal criteria|2|||
164490649|NCT01870999|594166149|FG002|Overall Study|Subject met withdrawal criteria|0|||
164490650|NCT01870999|594166147|FG000|Overall Study|Subject withdrawn by Investigator|1|||
164490651|NCT01870999|594166148|FG001|Overall Study|Subject withdrawn by Investigator|0|||
164490652|NCT01870999|594166149|FG002|Overall Study|Subject withdrawn by Investigator|0|||
164490653|NCT01870999|594166147|FG000|Overall Study|Withdrawal by Subject|0|||
164490654|NCT01870999|594166148|FG001|Overall Study|Withdrawal by Subject|2|||
164490655|NCT01870999|594166149|FG002|Overall Study|Withdrawal by Subject|5|||
164490656|NCT01870999|594166147|FG000|Overall Study|Protocol Violation|0|||
164490657|NCT01870999|594166148|FG001|Overall Study|Protocol Violation|0|||
164490658|NCT01870999|594166149|FG002|Overall Study|Protocol Violation|1|||
164490659|NCT01636258|594166150|FG000|Overall Study|Lost to Follow-up|1|||
164490660|NCT01636258|594166151|FG001|Overall Study|Lost to Follow-up|0|||
164490661|NCT01838499|594166152|FG000|Overall Study|Protocol Violation|0|||
164490662|NCT01838499|594166153|FG001|Overall Study|Protocol Violation|1|||
164490663|NCT01838499|594166152|FG000|Overall Study|Lost to Follow-up|2|||
164490664|NCT01838499|594166153|FG001|Overall Study|Lost to Follow-up|4|||
164490665|NCT01838499|594166152|FG000|Overall Study|Lack of Efficacy|1|||
164490666|NCT01838499|594166153|FG001|Overall Study|Lack of Efficacy|2|||
164490667|NCT01838499|594166152|FG000|Overall Study|Adverse Event|2|||
164490668|NCT01838499|594166153|FG001|Overall Study|Adverse Event|1|||
164490669|NCT01838499|594166152|FG000|Overall Study|Withdrawal by Subject|19|||
164490670|NCT01838499|594166153|FG001|Overall Study|Withdrawal by Subject|9|||
164490671|NCT03614923|594166154|FG000|Overall Study|Withdrawal by Subject|2|||
164714838|NCT02892149|594978805|FG000|Overall Study|Lost to Follow-up|37|||
164714839|NCT02892149|594978806|FG001|Overall Study|Lost to Follow-up|31|||
164714840|NCT02165735|594978807|FG000|Overall Study|Lost to Follow-up|12|||
164714841|NCT02165735|594978808|FG001|Overall Study|Lost to Follow-up|10|||
164714842|NCT02165735|594978807|FG000|Overall Study|Withdrawal by Subject|3|||
164714843|NCT02165735|594978808|FG001|Overall Study|Withdrawal by Subject|0|||
164714844|NCT02165735|594978807|FG000|Overall Study|Participant indicated lack of time|1|||
164714845|NCT02165735|594978808|FG001|Overall Study|Participant indicated lack of time|3|||
164714846|NCT02165735|594978807|FG000|Overall Study|Protocol Violation|0|||
164714847|NCT02165735|594978808|FG001|Overall Study|Protocol Violation|1|||
164714848|NCT00101283|594978809|FG000|Overall Study|Withdrawal by Subject|0|||
164714849|NCT00101283|594978810|FG001|Overall Study|Withdrawal by Subject|1|||
164714850|NCT00101283|594978809|FG000|Overall Study|Insurance Refusal|0|||
164490672|NCT03614923|594166155|FG001|Overall Study|Withdrawal by Subject|1|||
164490673|NCT03614923|594166156|FG002|Overall Study|Withdrawal by Subject|1|||
164490674|NCT03614923|594166154|FG000|Overall Study|Adverse Event|0|||
164490675|NCT03614923|594166155|FG001|Overall Study|Adverse Event|2|||
164490676|NCT03614923|594166156|FG002|Overall Study|Adverse Event|1|||
164490677|NCT03614923|594166154|FG000|Overall Study|Lost to Follow-up|1|||
164490678|NCT03614923|594166155|FG001|Overall Study|Lost to Follow-up|0|||
164490679|NCT03614923|594166156|FG002|Overall Study|Lost to Follow-up|1|||
164490680|NCT03614923|594166154|FG000|Overall Study|Lack of Efficacy|2|||
164490681|NCT03614923|594166155|FG001|Overall Study|Lack of Efficacy|0|||
164490682|NCT03614923|594166156|FG002|Overall Study|Lack of Efficacy|1|||
164490683|NCT03614923|594166154|FG000|Overall Study|Non-compliance|0|||
164490684|NCT03614923|594166155|FG001|Overall Study|Non-compliance|1|||
164490685|NCT03614923|594166156|FG002|Overall Study|Non-compliance|0|||
164490686|NCT03614923|594166154|FG000|Overall Study|Other|0|||
164490687|NCT03614923|594166155|FG001|Overall Study|Other|1|||
164490688|NCT03614923|594166156|FG002|Overall Study|Other|1|||
164490689|NCT03034772|594166167|FG000|Overall Study|Adverse Event|0|||
164490690|NCT03034772|594166168|FG001|Overall Study|Adverse Event|1|||
164490691|NCT03034772|594166167|FG000|Overall Study|Withdrawal by Subject|0|||
164490692|NCT03034772|594166168|FG001|Overall Study|Withdrawal by Subject|1|||
164490693|NCT00116584|594166169|FG000|Overall Study|Withdrawal by Subject|1|||
164490694|NCT00116584|594166170|FG001|Overall Study|Withdrawal by Subject|0|||
164490695|NCT00116584|594166169|FG000|Overall Study|Protocol Violation|1|||
164490696|NCT00116584|594166170|FG001|Overall Study|Protocol Violation|1|||
164490697|NCT01745380|594166172|FG000|Overall Study|Lost to Follow-up|1|||
164490698|NCT01745380|594166173|FG001|Overall Study|Lost to Follow-up|0|||
164490699|NCT01745380|594166172|FG000|Overall Study|Lack of Efficacy|0|||
164490700|NCT01745380|594166173|FG001|Overall Study|Lack of Efficacy|1|||
164490701|NCT01882088|594166174|FG000|Overall Study|Intolerance of esophageal manometry|1|||
164490702|NCT01882088|594166174|FG000|Overall Study|no possibility to place the catheter|1|||
164490703|NCT01882088|594166174|FG000|Overall Study|Protocol Violation|1|||
164490704|NCT01882088|594166174|FG000|Overall Study|inadequate pH-impedance tracings|2|||
164490705|NCT02186015|594166175|FG000|Overall Study|Physician Decision|1|||
164490706|NCT02186015|594166176|FG001|Overall Study|Physician Decision|0|||
164490707|NCT02660034|594166179|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
164490708|NCT02660034|594166180|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
164490709|NCT02660034|594166181|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
164490710|NCT02660034|594166182|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
164490711|NCT02660034|594166183|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
164490712|NCT02660034|594166184|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
164490713|NCT02660034|594166185|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
164490714|NCT02660034|594166186|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
164490715|NCT02660034|594166187|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
164490716|NCT02660034|594166188|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
164490717|NCT02660034|594166189|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
164490718|NCT02660034|594166190|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
164490719|NCT02660034|594166191|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
164490720|NCT02660034|594166192|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
164490721|NCT02660034|594166179|FG000|Overall Study|Progressive Disease (Clinical)|7|||
164490722|NCT02660034|594166180|FG001|Overall Study|Progressive Disease (Clinical)|8|||
164490723|NCT02660034|594166181|FG002|Overall Study|Progressive Disease (Clinical)|3|||
164490724|NCT02660034|594166182|FG003|Overall Study|Progressive Disease (Clinical)|9|||
164490725|NCT02660034|594166183|FG004|Overall Study|Progressive Disease (Clinical)|3|||
164490726|NCT02660034|594166184|FG005|Overall Study|Progressive Disease (Clinical)|0|||
164490727|NCT02660034|594166185|FG006|Overall Study|Progressive Disease (Clinical)|0|||
164490728|NCT02660034|594166186|FG007|Overall Study|Progressive Disease (Clinical)|0|||
164490729|NCT02660034|594166187|FG008|Overall Study|Progressive Disease (Clinical)|0|||
164490730|NCT02660034|594166188|FG009|Overall Study|Progressive Disease (Clinical)|0|||
164490731|NCT02660034|594166189|FG010|Overall Study|Progressive Disease (Clinical)|0|||
164490732|NCT02660034|594166190|FG011|Overall Study|Progressive Disease (Clinical)|0|||
164490733|NCT02660034|594166191|FG012|Overall Study|Progressive Disease (Clinical)|0|||
164490734|NCT02660034|594166192|FG013|Overall Study|Progressive Disease (Clinical)|0|||
164490735|NCT02660034|594166179|FG000|Overall Study|Lost to Follow-up|0|||
164490736|NCT02660034|594166180|FG001|Overall Study|Lost to Follow-up|0|||
164490737|NCT02660034|594166181|FG002|Overall Study|Lost to Follow-up|1|||
164490738|NCT02660034|594166182|FG003|Overall Study|Lost to Follow-up|1|||
164490739|NCT02660034|594166183|FG004|Overall Study|Lost to Follow-up|0|||
164490740|NCT02660034|594166184|FG005|Overall Study|Lost to Follow-up|0|||
164490741|NCT02660034|594166185|FG006|Overall Study|Lost to Follow-up|0|||
164490742|NCT02660034|594166186|FG007|Overall Study|Lost to Follow-up|0|||
164490743|NCT02660034|594166187|FG008|Overall Study|Lost to Follow-up|0|||
164490744|NCT02660034|594166188|FG009|Overall Study|Lost to Follow-up|1|||
164490745|NCT02660034|594166189|FG010|Overall Study|Lost to Follow-up|1|||
164490746|NCT02660034|594166190|FG011|Overall Study|Lost to Follow-up|1|||
164490747|NCT02660034|594166191|FG012|Overall Study|Lost to Follow-up|0|||
164490748|NCT02660034|594166192|FG013|Overall Study|Lost to Follow-up|0|||
164490749|NCT02660034|594166179|FG000|Overall Study|Participant moved into special access scheme|1|||
164490750|NCT02660034|594166180|FG001|Overall Study|Participant moved into special access scheme|2|||
164602328|NCT01885078|594564809|FG004|Step-down Period|Sponsor Decision|0|||
164602329|NCT01885078|594564810|FG005|Step-down Period|Sponsor Decision|0|||
164490751|NCT02660034|594166181|FG002|Overall Study|Participant moved into special access scheme|0|||
164490752|NCT02660034|594166182|FG003|Overall Study|Participant moved into special access scheme|0|||
164602330|NCT01885078|594564811|FG006|Step-down Period|Sponsor Decision|0|||
164602331|NCT01885078|594564812|FG007|Step-down Period|Sponsor Decision|0|||
164602332|NCT01885078|594564813|FG008|Step-down Period|Sponsor Decision|1|||
164490753|NCT02660034|594166183|FG004|Overall Study|Participant moved into special access scheme|0|||
164490754|NCT02660034|594166184|FG005|Overall Study|Participant moved into special access scheme|0|||
164490755|NCT02660034|594166185|FG006|Overall Study|Participant moved into special access scheme|0|||
164490756|NCT02660034|594166186|FG007|Overall Study|Participant moved into special access scheme|0|||
164490757|NCT02660034|594166187|FG008|Overall Study|Participant moved into special access scheme|0|||
164490758|NCT02660034|594166188|FG009|Overall Study|Participant moved into special access scheme|0|||
164490759|NCT02660034|594166189|FG010|Overall Study|Participant moved into special access scheme|0|||
164490760|NCT02660034|594166190|FG011|Overall Study|Participant moved into special access scheme|0|||
164490761|NCT02660034|594166191|FG012|Overall Study|Participant moved into special access scheme|0|||
164490762|NCT02660034|594166192|FG013|Overall Study|Participant moved into special access scheme|0|||
164490763|NCT02660034|594166179|FG000|Overall Study|Adverse Event|1|||
164490764|NCT02660034|594166180|FG001|Overall Study|Adverse Event|0|||
164490765|NCT02660034|594166181|FG002|Overall Study|Adverse Event|0|||
164490766|NCT02660034|594166182|FG003|Overall Study|Adverse Event|0|||
164490767|NCT02660034|594166183|FG004|Overall Study|Adverse Event|0|||
164490768|NCT02660034|594166184|FG005|Overall Study|Adverse Event|0|||
164490769|NCT02660034|594166185|FG006|Overall Study|Adverse Event|0|||
164490770|NCT02660034|594166186|FG007|Overall Study|Adverse Event|0|||
164490771|NCT02660034|594166187|FG008|Overall Study|Adverse Event|0|||
164490772|NCT02660034|594166188|FG009|Overall Study|Adverse Event|0|||
164490773|NCT02660034|594166189|FG010|Overall Study|Adverse Event|0|||
164490774|NCT02660034|594166190|FG011|Overall Study|Adverse Event|0|||
164490775|NCT02660034|594166191|FG012|Overall Study|Adverse Event|0|||
164490776|NCT02660034|594166192|FG013|Overall Study|Adverse Event|0|||
164490777|NCT02660034|594166179|FG000|Overall Study|Sponsor Decision|0|||
164490778|NCT02660034|594166180|FG001|Overall Study|Sponsor Decision|1|||
164490779|NCT02660034|594166181|FG002|Overall Study|Sponsor Decision|2|||
164490780|NCT02660034|594166182|FG003|Overall Study|Sponsor Decision|2|||
164490781|NCT02660034|594166183|FG004|Overall Study|Sponsor Decision|3|||
164490782|NCT02660034|594166184|FG005|Overall Study|Sponsor Decision|0|||
164490783|NCT02660034|594166185|FG006|Overall Study|Sponsor Decision|0|||
164490784|NCT02660034|594166186|FG007|Overall Study|Sponsor Decision|0|||
164490785|NCT02660034|594166187|FG008|Overall Study|Sponsor Decision|0|||
164490786|NCT02660034|594166188|FG009|Overall Study|Sponsor Decision|0|||
164490787|NCT02660034|594166189|FG010|Overall Study|Sponsor Decision|0|||
164490788|NCT02660034|594166190|FG011|Overall Study|Sponsor Decision|0|||
164490789|NCT02660034|594166191|FG012|Overall Study|Sponsor Decision|0|||
164490790|NCT02660034|594166192|FG013|Overall Study|Sponsor Decision|1|||
164490791|NCT02660034|594166179|FG000|Overall Study|Withdrawal by Subject|0|||
164490792|NCT02660034|594166180|FG001|Overall Study|Withdrawal by Subject|0|||
164490793|NCT02660034|594166181|FG002|Overall Study|Withdrawal by Subject|0|||
164490794|NCT02660034|594166182|FG003|Overall Study|Withdrawal by Subject|0|||
164490795|NCT02660034|594166183|FG004|Overall Study|Withdrawal by Subject|0|||
164490796|NCT02660034|594166184|FG005|Overall Study|Withdrawal by Subject|0|||
164490797|NCT02660034|594166185|FG006|Overall Study|Withdrawal by Subject|1|||
164490798|NCT02660034|594166186|FG007|Overall Study|Withdrawal by Subject|1|||
164490799|NCT02660034|594166187|FG008|Overall Study|Withdrawal by Subject|1|||
164490800|NCT02660034|594166188|FG009|Overall Study|Withdrawal by Subject|0|||
164602333|NCT01885078|594564814|FG009|Step-down Period|Sponsor Decision|1|||
164490801|NCT02660034|594166189|FG010|Overall Study|Withdrawal by Subject|0|||
164490802|NCT02660034|594166190|FG011|Overall Study|Withdrawal by Subject|1|||
164490803|NCT02660034|594166191|FG012|Overall Study|Withdrawal by Subject|2|||
164490804|NCT02660034|594166192|FG013|Overall Study|Withdrawal by Subject|0|||
164490805|NCT02660034|594166179|FG000|Overall Study|Death|0|||
164602334|NCT01885078|594564805|FG000|Step-down Period|Adverse Event|0|||
164602335|NCT01885078|594564806|FG001|Step-down Period|Adverse Event|0|||
164602336|NCT01885078|594564807|FG002|Step-down Period|Adverse Event|0|||
164490806|NCT02660034|594166180|FG001|Overall Study|Death|0|||
164490807|NCT02660034|594166181|FG002|Overall Study|Death|0|||
164602337|NCT01885078|594564808|FG003|Step-down Period|Adverse Event|0|||
164602338|NCT01885078|594564809|FG004|Step-down Period|Adverse Event|0|||
164490808|NCT02660034|594166182|FG003|Overall Study|Death|0|||
164490809|NCT02660034|594166183|FG004|Overall Study|Death|0|||
164490810|NCT02660034|594166184|FG005|Overall Study|Death|13|||
164490811|NCT02660034|594166185|FG006|Overall Study|Death|14|||
164490812|NCT02660034|594166186|FG007|Overall Study|Death|10|||
164490813|NCT02660034|594166187|FG008|Overall Study|Death|9|||
164490814|NCT02660034|594166188|FG009|Overall Study|Death|21|||
164490815|NCT02660034|594166189|FG010|Overall Study|Death|17|||
164602339|NCT01885078|594564810|FG005|Step-down Period|Adverse Event|0|||
164602340|NCT01885078|594564811|FG006|Step-down Period|Adverse Event|0|||
164602341|NCT01885078|594564812|FG007|Step-down Period|Adverse Event|0|||
164602342|NCT01885078|594564813|FG008|Step-down Period|Adverse Event|29|||
164602343|NCT01885078|594564814|FG009|Step-down Period|Adverse Event|38|||
164602344|NCT01885078|594564805|FG000|Step-down Period|Withdrawal by Subject|0|||
164602345|NCT01885078|594564806|FG001|Step-down Period|Withdrawal by Subject|0|||
164602346|NCT01885078|594564807|FG002|Step-down Period|Withdrawal by Subject|0|||
164602347|NCT01885078|594564808|FG003|Step-down Period|Withdrawal by Subject|0|||
164602348|NCT01885078|594564809|FG004|Step-down Period|Withdrawal by Subject|0|||
164602349|NCT01885078|594564810|FG005|Step-down Period|Withdrawal by Subject|0|||
164602350|NCT01885078|594564811|FG006|Step-down Period|Withdrawal by Subject|0|||
164602351|NCT01885078|594564812|FG007|Step-down Period|Withdrawal by Subject|0|||
164602352|NCT01885078|594564813|FG008|Step-down Period|Withdrawal by Subject|25|||
164602353|NCT01885078|594564814|FG009|Step-down Period|Withdrawal by Subject|15|||
164602354|NCT01885078|594564805|FG000|Step-down Period|Physician Decision|0|||
164602355|NCT01885078|594564806|FG001|Step-down Period|Physician Decision|0|||
164602356|NCT01885078|594564807|FG002|Step-down Period|Physician Decision|0|||
164602357|NCT01885078|594564808|FG003|Step-down Period|Physician Decision|0|||
164602358|NCT01885078|594564809|FG004|Step-down Period|Physician Decision|0|||
164602359|NCT01885078|594564810|FG005|Step-down Period|Physician Decision|0|||
164602360|NCT01885078|594564811|FG006|Step-down Period|Physician Decision|0|||
164602361|NCT01885078|594564812|FG007|Step-down Period|Physician Decision|0|||
164602362|NCT01885078|594564813|FG008|Step-down Period|Physician Decision|7|||
164602363|NCT01885078|594564814|FG009|Step-down Period|Physician Decision|2|||
164602364|NCT01885078|594564805|FG000|Step-down Period|Death|0|||
164602365|NCT01885078|594564806|FG001|Step-down Period|Death|0|||
164602366|NCT01885078|594564807|FG002|Step-down Period|Death|0|||
164602367|NCT01885078|594564808|FG003|Step-down Period|Death|0|||
164490816|NCT02660034|594166190|FG011|Overall Study|Death|15|||
164490817|NCT02660034|594166191|FG012|Overall Study|Death|18|||
164490818|NCT02660034|594166192|FG013|Overall Study|Death|7|||
164490819|NCT02660034|594166179|FG000|Overall Study|Physician Decision|0|||
164490820|NCT02660034|594166180|FG001|Overall Study|Physician Decision|0|||
164490821|NCT02660034|594166181|FG002|Overall Study|Physician Decision|0|||
164490822|NCT02660034|594166182|FG003|Overall Study|Physician Decision|0|||
164490823|NCT02660034|594166183|FG004|Overall Study|Physician Decision|0|||
164490824|NCT02660034|594166184|FG005|Overall Study|Physician Decision|0|||
164490825|NCT02660034|594166185|FG006|Overall Study|Physician Decision|0|||
164490826|NCT02660034|594166186|FG007|Overall Study|Physician Decision|0|||
164490827|NCT02660034|594166187|FG008|Overall Study|Physician Decision|0|||
164490828|NCT02660034|594166188|FG009|Overall Study|Physician Decision|0|||
164490829|NCT02660034|594166189|FG010|Overall Study|Physician Decision|0|||
164490830|NCT02660034|594166190|FG011|Overall Study|Physician Decision|0|||
164490831|NCT02660034|594166191|FG012|Overall Study|Physician Decision|0|||
164490832|NCT02660034|594166192|FG013|Overall Study|Physician Decision|1|||
164490833|NCT02660034|594166179|FG000|Overall Study|Participants transferred to LTE|0|||
164490834|NCT02660034|594166180|FG001|Overall Study|Participants transferred to LTE|0|||
164490835|NCT02660034|594166181|FG002|Overall Study|Participants transferred to LTE|0|||
164490836|NCT02660034|594166182|FG003|Overall Study|Participants transferred to LTE|0|||
164490837|NCT02660034|594166183|FG004|Overall Study|Participants transferred to LTE|0|||
164490838|NCT02660034|594166184|FG005|Overall Study|Participants transferred to LTE|10|||
164490839|NCT02660034|594166185|FG006|Overall Study|Participants transferred to LTE|8|||
164490840|NCT02660034|594166186|FG007|Overall Study|Participants transferred to LTE|8|||
164490841|NCT02660034|594166187|FG008|Overall Study|Participants transferred to LTE|10|||
164490842|NCT02660034|594166188|FG009|Overall Study|Participants transferred to LTE|1|||
164490843|NCT02660034|594166189|FG010|Overall Study|Participants transferred to LTE|2|||
164490844|NCT02660034|594166190|FG011|Overall Study|Participants transferred to LTE|4|||
164490845|NCT02660034|594166191|FG012|Overall Study|Participants transferred to LTE|1|||
164490846|NCT02660034|594166192|FG013|Overall Study|Participants transferred to LTE|1|||
164490847|NCT02720198|594166197|FG000|Overall Study|Withdrawal by Subject|0|||
164490848|NCT02720198|594166198|FG001|Overall Study|Withdrawal by Subject|1|||
164490849|NCT02592434|594166199|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
164490850|NCT02592434|594166200|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
164490851|NCT02592434|594166201|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
164490852|NCT02592434|594166199|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
164490853|NCT02592434|594166200|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
164490854|NCT02592434|594166201|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
164490855|NCT02592434|594166199|FG000|Open-Label Phase (18 Weeks)|Other|3|||
164490856|NCT02592434|594166200|FG001|Open-Label Phase (18 Weeks)|Other|0|||
164490857|NCT02592434|594166201|FG002|Open-Label Phase (18 Weeks)|Other|0|||
164602368|NCT01885078|594564809|FG004|Step-down Period|Death|0|||
164602369|NCT01885078|594564810|FG005|Step-down Period|Death|0|||
164714851|NCT00101283|594978810|FG001|Overall Study|Insurance Refusal|1|||
164714852|NCT00101283|594978809|FG000|Overall Study|Prostate Cancer Recurrence|0|||
164714853|NCT00101283|594978810|FG001|Overall Study|Prostate Cancer Recurrence|1|||
164602370|NCT01885078|594564811|FG006|Step-down Period|Death|0|||
164602371|NCT01885078|594564812|FG007|Step-down Period|Death|0|||
164714854|NCT00595309|594978811|FG000|Overall Study|Lost to Follow-up|1|||
164490858|NCT02592434|594166199|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
164490859|NCT02592434|594166200|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
164490860|NCT02592434|594166201|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
164490861|NCT02592434|594166199|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
164602372|NCT01885078|594564813|FG008|Step-down Period|Death|4|||
164490862|NCT02592434|594166200|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
164490863|NCT02592434|594166201|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
164490864|NCT02592434|594166199|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
164490865|NCT02592434|594166200|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
164490866|NCT02592434|594166201|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
164490867|NCT02592434|594166199|FG000|Double Blind Phase (26 Weeks)|Other|0|||
164490868|NCT02592434|594166200|FG001|Double Blind Phase (26 Weeks)|Other|1|||
164490869|NCT02592434|594166201|FG002|Double Blind Phase (26 Weeks)|Other|0|||
164490870|NCT02592434|594166199|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
164490871|NCT02592434|594166200|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
164490872|NCT02592434|594166201|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
164490873|NCT02592434|594166199|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
164490874|NCT02592434|594166200|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
164490875|NCT02592434|594166201|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
164490876|NCT02592434|594166199|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
164490877|NCT02592434|594166200|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
164490878|NCT02592434|594166201|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
164490879|NCT00147745|594166204|FG000|Overall Study|Withdrawal by Subject|1|||
164490880|NCT00147745|594166205|FG001|Overall Study|Withdrawal by Subject|0|||
164490881|NCT00147745|594166206|FG002|Overall Study|Withdrawal by Subject|0|||
164490882|NCT01106586|594166207|FG000|Overall Study|Adverse Event|9|||
164490883|NCT01106586|594166208|FG001|Overall Study|Adverse Event|15|||
164490884|NCT01106586|594166207|FG000|Overall Study|Death|1|||
164490885|NCT01106586|594166208|FG001|Overall Study|Death|3|||
164490886|NCT01106586|594166207|FG000|Overall Study|Pregnancy|2|||
164490887|NCT01106586|594166208|FG001|Overall Study|Pregnancy|2|||
164490888|NCT01106586|594166207|FG000|Overall Study|Lack of Efficacy|1|||
164490889|NCT01106586|594166208|FG001|Overall Study|Lack of Efficacy|0|||
164490890|NCT01106586|594166207|FG000|Overall Study|Investigator's Discretion|5|||
164490891|NCT01106586|594166208|FG001|Overall Study|Investigator's Discretion|8|||
164490892|NCT01106586|594166207|FG000|Overall Study|Withdrew Consent|18|||
164490893|NCT01106586|594166208|FG001|Overall Study|Withdrew Consent|30|||
164490894|NCT01106586|594166207|FG000|Overall Study|Lost to Follow-up|24|||
164490895|NCT01106586|594166208|FG001|Overall Study|Lost to Follow-up|20|||
164490896|NCT01106586|594166207|FG000|Overall Study|Participant Noncompliance|12|||
164490897|NCT01106586|594166208|FG001|Overall Study|Participant Noncompliance|10|||
164490898|NCT01106586|594166207|FG000|Overall Study|Protocol Violation|1|||
164490899|NCT01106586|594166208|FG001|Overall Study|Protocol Violation|0|||
164490900|NCT01106586|594166207|FG000|Overall Study|Participant Transferred to Another Study|212|||
164490901|NCT01106586|594166208|FG001|Overall Study|Participant Transferred to Another Study|197|||
164490902|NCT01757171|594166209|FG000|Overall Study|Adverse Event|5|||
164490903|NCT01757171|594166210|FG001|Overall Study|Adverse Event|1|||
164490904|NCT01757171|594166209|FG000|Overall Study|Disease Progression|1|||
164490905|NCT01757171|594166210|FG001|Overall Study|Disease Progression|0|||
164490906|NCT01757171|594166209|FG000|Overall Study|Hospitalization|1|||
164490907|NCT01757171|594166210|FG001|Overall Study|Hospitalization|0|||
164490908|NCT01757171|594166209|FG000|Overall Study|ECOG decline|1|||
164490909|NCT01757171|594166210|FG001|Overall Study|ECOG decline|0|||
164490910|NCT00105521|594166211|FG000|Overall Study|Other|1|||
164490911|NCT00105521|594166212|FG001|Overall Study|Other|1|||
164490912|NCT00105521|594166213|FG002|Overall Study|Other|2|||
164490913|NCT00105521|594166214|FG003|Overall Study|Other|0|||
164490914|NCT00105521|594166211|FG000|Overall Study|Adverse Event|10|||
164490915|NCT00105521|594166212|FG001|Overall Study|Adverse Event|4|||
164490916|NCT00105521|594166213|FG002|Overall Study|Adverse Event|10|||
164490917|NCT00105521|594166214|FG003|Overall Study|Adverse Event|8|||
164490918|NCT00105521|594166211|FG000|Overall Study|Withdrawal by Subject|1|||
164490919|NCT00105521|594166212|FG001|Overall Study|Withdrawal by Subject|0|||
164490920|NCT00105521|594166213|FG002|Overall Study|Withdrawal by Subject|1|||
164490921|NCT00105521|594166214|FG003|Overall Study|Withdrawal by Subject|4|||
164490922|NCT00105521|594166211|FG000|Overall Study|Lack of Efficacy|0|||
164490923|NCT00105521|594166212|FG001|Overall Study|Lack of Efficacy|0|||
164490924|NCT00105521|594166213|FG002|Overall Study|Lack of Efficacy|0|||
164490925|NCT00105521|594166214|FG003|Overall Study|Lack of Efficacy|1|||
164490926|NCT00105521|594166211|FG000|Overall Study|Protocol Violation|3|||
164490927|NCT00105521|594166212|FG001|Overall Study|Protocol Violation|5|||
164490928|NCT00105521|594166213|FG002|Overall Study|Protocol Violation|4|||
164490929|NCT00105521|594166214|FG003|Overall Study|Protocol Violation|4|||
164490930|NCT00105521|594166211|FG000|Overall Study|Lost to Follow-up|0|||
164490931|NCT00105521|594166212|FG001|Overall Study|Lost to Follow-up|1|||
164490932|NCT00105521|594166213|FG002|Overall Study|Lost to Follow-up|0|||
164490933|NCT00105521|594166214|FG003|Overall Study|Lost to Follow-up|0|||
164490934|NCT00385697|594166215|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
164602373|NCT01885078|594564814|FG009|Step-down Period|Death|3|||
164602374|NCT01885078|594564805|FG000|Step-down Period|Lost to Follow-up|0|||
164602375|NCT01885078|594564806|FG001|Step-down Period|Lost to Follow-up|0|||
164602376|NCT01885078|594564807|FG002|Step-down Period|Lost to Follow-up|0|||
164602377|NCT01885078|594564808|FG003|Step-down Period|Lost to Follow-up|0|||
164602378|NCT01885078|594564809|FG004|Step-down Period|Lost to Follow-up|0|||
164602379|NCT01885078|594564810|FG005|Step-down Period|Lost to Follow-up|0|||
164602380|NCT01885078|594564811|FG006|Step-down Period|Lost to Follow-up|0|||
164602381|NCT01885078|594564812|FG007|Step-down Period|Lost to Follow-up|0|||
164602382|NCT01885078|594564813|FG008|Step-down Period|Lost to Follow-up|1|||
164602383|NCT01885078|594564814|FG009|Step-down Period|Lost to Follow-up|1|||
164602384|NCT01885078|594564805|FG000|Step-down Period|Lack of Efficacy|0|||
164602385|NCT01885078|594564806|FG001|Step-down Period|Lack of Efficacy|0|||
164602386|NCT01885078|594564807|FG002|Step-down Period|Lack of Efficacy|0|||
164602387|NCT01885078|594564808|FG003|Step-down Period|Lack of Efficacy|0|||
164602388|NCT01885078|594564809|FG004|Step-down Period|Lack of Efficacy|0|||
164602389|NCT01885078|594564810|FG005|Step-down Period|Lack of Efficacy|0|||
164602390|NCT01885078|594564811|FG006|Step-down Period|Lack of Efficacy|0|||
164602391|NCT01885078|594564812|FG007|Step-down Period|Lack of Efficacy|0|||
164602392|NCT01885078|594564813|FG008|Step-down Period|Lack of Efficacy|1|||
164602393|NCT01885078|594564814|FG009|Step-down Period|Lack of Efficacy|0|||
164602394|NCT01885078|594564805|FG000|Step-down Period|Protocol Violation|0|||
164602395|NCT01885078|594564806|FG001|Step-down Period|Protocol Violation|0|||
164602396|NCT01885078|594564807|FG002|Step-down Period|Protocol Violation|0|||
164602397|NCT01885078|594564808|FG003|Step-down Period|Protocol Violation|0|||
164602398|NCT01885078|594564809|FG004|Step-down Period|Protocol Violation|0|||
164602399|NCT01885078|594564810|FG005|Step-down Period|Protocol Violation|0|||
164602400|NCT01885078|594564811|FG006|Step-down Period|Protocol Violation|0|||
164602401|NCT01885078|594564812|FG007|Step-down Period|Protocol Violation|0|||
164602402|NCT01885078|594564813|FG008|Step-down Period|Protocol Violation|1|||
164602403|NCT01885078|594564814|FG009|Step-down Period|Protocol Violation|1|||
164602404|NCT02680587|594564815|FG000|Overall Study|Withdrawal by Subject|1|||
164602405|NCT02680587|594564816|FG001|Overall Study|Withdrawal by Subject|0|||
164602406|NCT00571688|594564820|FG000|Overall Study|Lost to Follow-up|3|||
164602407|NCT00571688|594564821|FG001|Overall Study|Lost to Follow-up|6|||
164602408|NCT00571688|594564820|FG000|Overall Study|subject did not tolerate Consta|1|||
164602409|NCT00571688|594564821|FG001|Overall Study|subject did not tolerate Consta|0|||
164602410|NCT00571688|594564820|FG000|Overall Study|subject moved out of the area|1|||
164602411|NCT00571688|594564821|FG001|Overall Study|subject moved out of the area|0|||
164602412|NCT00259740|594564822|FG000|Overall Study|Physician Decision|1|||
164602413|NCT00259740|594564823|FG001|Overall Study|Physician Decision|1|||
164602414|NCT00259740|594564822|FG000|Overall Study|Adverse Event|0|||
164602415|NCT00259740|594564823|FG001|Overall Study|Adverse Event|2|||
164602416|NCT00259740|594564822|FG000|Overall Study|Withdrawal by Subject|2|||
164602417|NCT00259740|594564823|FG001|Overall Study|Withdrawal by Subject|6|||
164602418|NCT00259740|594564822|FG000|Overall Study|Death|1|||
164602419|NCT00259740|594564823|FG001|Overall Study|Death|1|||
164602420|NCT00259740|594564822|FG000|Overall Study|Disease progression|19|||
164602421|NCT00259740|594564823|FG001|Overall Study|Disease progression|36|||
164602422|NCT00259740|594564822|FG000|Overall Study|Ongoing|17|||
164714855|NCT00595309|594978811|FG000|Overall Study|planned vaccination against yellow fever|1|||
164714856|NCT00595309|594978811|FG000|Overall Study|acute infection after V0|1|||
164714857|NCT00595309|594978811|FG000|Overall Study|personal reason|1|||
164714858|NCT00182325|594978818|FG000|Overall Study|Lost to Follow-up|7|||
164714859|NCT00182325|594978819|FG001|Overall Study|Lost to Follow-up|7|||
164714860|NCT00182325|594978818|FG000|Overall Study|Miscarriage|5|||
164714861|NCT00182325|594978819|FG001|Overall Study|Miscarriage|3|||
164714862|NCT00182325|594978818|FG000|Overall Study|Did not complete survey|22|||
164714863|NCT00182325|594978819|FG001|Overall Study|Did not complete survey|43|||
164714864|NCT02613182|594978822|FG000|Overall Study|Death|6|||
164714865|NCT02613182|594978822|FG000|Overall Study|Physician Decision|1|||
164714866|NCT02613182|594978822|FG000|Overall Study|Study Terminated by Sponsor|21|||
164602423|NCT00259740|594564823|FG001|Overall Study|Ongoing|3|||
164602424|NCT00259740|594564822|FG000|Overall Study|Other|3|||
164602425|NCT00259740|594564823|FG001|Overall Study|Other|0|||
164602426|NCT00259740|594564822|FG000|Overall Study|Requirement for alternative therapy|0|||
164602427|NCT00259740|594564823|FG001|Overall Study|Requirement for alternative therapy|4|||
164602428|NCT01844830|594564828|FG000|Overall Study|Withdrawal by Subject|1|||
164602429|NCT01844830|594564829|FG001|Overall Study|Withdrawal by Subject|0|||
164602430|NCT04735393|594564833|FG000|Overall Study|Lost to Follow-up|46|||
164602431|NCT04735393|594564834|FG001|Overall Study|Lost to Follow-up|24|||
164714867|NCT02613182|594978822|FG000|Overall Study|Withdrawal by Subject|6|||
164602432|NCT04735393|594564833|FG000|Overall Study|Physician Decision|2|||
164602433|NCT04735393|594564834|FG001|Overall Study|Physician Decision|1|||
164602434|NCT04735393|594564833|FG000|Overall Study|Not Detailed|1|||
164602435|NCT04735393|594564834|FG001|Overall Study|Not Detailed|2|||
164714868|NCT02785952|594978823|FG000|Overall Study|Adverse Event|31|||
164602436|NCT04735393|594564833|FG000|Overall Study|Withdrawal by Subject|71|||
164490935|NCT00385697|594166216|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
164490936|NCT00385697|594166217|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
164490937|NCT00385697|594166218|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
164490938|NCT00385697|594166219|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
164490939|NCT00385697|594166215|FG000|Open-label Segment 1|Lost to Follow-up|1|||
164490940|NCT00385697|594166216|FG001|Open-label Segment 1|Lost to Follow-up|0|||
164490941|NCT00385697|594166217|FG002|Open-label Segment 1|Lost to Follow-up|0|||
164490942|NCT00385697|594166218|FG003|Open-label Segment 1|Lost to Follow-up|0|||
164490943|NCT00385697|594166219|FG004|Open-label Segment 1|Lost to Follow-up|0|||
164490944|NCT00385697|594166215|FG000|Double-blind Segment 2|Adverse Event|0|||
164490945|NCT00385697|594166216|FG001|Double-blind Segment 2|Adverse Event|3|||
164490946|NCT00385697|594166217|FG002|Double-blind Segment 2|Adverse Event|1|||
164490947|NCT00385697|594166218|FG003|Double-blind Segment 2|Adverse Event|0|||
164490948|NCT00385697|594166219|FG004|Double-blind Segment 2|Adverse Event|0|||
164490949|NCT00385697|594166215|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
164490950|NCT00385697|594166216|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
164490951|NCT00385697|594166217|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
164490952|NCT00385697|594166218|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
164490953|NCT00385697|594166219|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
164490954|NCT00385697|594166215|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
164490955|NCT00385697|594166216|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
164490956|NCT00385697|594166217|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
164490957|NCT00385697|594166218|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
164490958|NCT00385697|594166219|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
164490959|NCT00385697|594166215|FG000|Double-blind Segment 2|Other|0|||
164490960|NCT00385697|594166216|FG001|Double-blind Segment 2|Other|2|||
164490961|NCT00385697|594166217|FG002|Double-blind Segment 2|Other|0|||
164490962|NCT00385697|594166218|FG003|Double-blind Segment 2|Other|0|||
164490963|NCT00385697|594166219|FG004|Double-blind Segment 2|Other|0|||
164490964|NCT00510783|594166223|FG000|Overall Study|Lost to Follow-up|29|||
164490965|NCT00510783|594166224|FG001|Overall Study|Lost to Follow-up|25|||
164490966|NCT00510783|594166223|FG000|Overall Study|Withdrawal by Subject|2|||
164490967|NCT00510783|594166224|FG001|Overall Study|Withdrawal by Subject|3|||
164490968|NCT00510783|594166223|FG000|Overall Study|Protocol Violation|0|||
164490969|NCT00510783|594166224|FG001|Overall Study|Protocol Violation|1|||
164490970|NCT00316121|594166225|FG000|Overall Study|Death|1|||
164490971|NCT00316121|594166226|FG001|Overall Study|Death|0|||
164490972|NCT00316121|594166225|FG000|Overall Study|Lost to Follow-up|14|||
164490973|NCT00316121|594166226|FG001|Overall Study|Lost to Follow-up|8|||
164490974|NCT00316121|594166225|FG000|Overall Study|Withdrawal by Subject|2|||
164490975|NCT00316121|594166226|FG001|Overall Study|Withdrawal by Subject|0|||
164490976|NCT00316121|594166225|FG000|Overall Study|Reason is missing|1|||
164490977|NCT00316121|594166226|FG001|Overall Study|Reason is missing|0|||
164490978|NCT00316121|594166225|FG000|Overall Study|Subject relocated|1|||
164490979|NCT00316121|594166226|FG001|Overall Study|Subject relocated|1|||
164490980|NCT00316121|594166225|FG000|Overall Study|Subject refused to return|1|||
164490981|NCT00316121|594166226|FG001|Overall Study|Subject refused to return|0|||
164490982|NCT00316121|594166225|FG000|Overall Study|Subject no show for visit x 3|1|||
164490983|NCT00316121|594166226|FG001|Overall Study|Subject no show for visit x 3|0|||
164490984|NCT00316121|594166225|FG000|Overall Study|Subject did not have 24 month visit|1|||
164490985|NCT00316121|594166226|FG001|Overall Study|Subject did not have 24 month visit|0|||
164490986|NCT03045302|594166230|FG000|Overall Study|Pre-treatment adverse event|1|||
164490987|NCT05878522|594166234|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
164490988|NCT05878522|594166235|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
164490989|NCT05878522|594166236|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
164490990|NCT05878522|594166237|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
164490991|NCT05878522|594166238|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
164490992|NCT05878522|594166239|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
164490993|NCT05878522|594166240|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
164490994|NCT05878522|594166241|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
164490995|NCT05878522|594166242|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
164490996|NCT05878522|594166243|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
164490997|NCT05878522|594166244|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
164490998|NCT05878522|594166245|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
164490999|NCT05878522|594166234|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
164491000|NCT05878522|594166235|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
164491001|NCT05878522|594166236|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
164491002|NCT05878522|594166237|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
164491003|NCT05878522|594166238|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
164491004|NCT05878522|594166239|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
164145297|NCT00025259|592894264|FG001|Overall Study|Protocol Violation|2|||
164491005|NCT05878522|594166240|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
164714869|NCT02785952|594978824|FG001|Overall Study|Adverse Event|19|||
164491006|NCT05878522|594166241|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
164491007|NCT05878522|594166242|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
164491008|NCT05878522|594166243|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
164491009|NCT05878522|594166244|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
164491010|NCT05878522|594166245|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
164491011|NCT05878522|594166234|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
164491012|NCT05878522|594166235|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
164491013|NCT05878522|594166236|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
164491014|NCT05878522|594166237|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
164491015|NCT05878522|594166238|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
164491016|NCT05878522|594166239|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
164491017|NCT05878522|594166240|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
164491018|NCT05878522|594166241|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
164491019|NCT05878522|594166242|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
164491020|NCT05878522|594166243|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
164491021|NCT05878522|594166244|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
164491022|NCT05878522|594166245|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
164491023|NCT05878522|594166234|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
164491024|NCT05878522|594166235|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
164491025|NCT05878522|594166236|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
164491026|NCT05878522|594166237|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
164491027|NCT05878522|594166238|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
164491028|NCT05878522|594166239|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
164491029|NCT05878522|594166240|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
164491030|NCT05878522|594166241|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
164491031|NCT05878522|594166242|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
164491032|NCT05878522|594166243|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
164491033|NCT05878522|594166244|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
164491034|NCT05878522|594166245|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
164491035|NCT05263492|594166246|FG000|Overall Study|Adverse Event|1|||
164491036|NCT05263492|594166246|FG000|Overall Study|Disease progression during active treatment|3|||
164491037|NCT03747575|594166247|FG000|Overall Study|Withdrawal by Subject|6|||
164491038|NCT03747575|594166248|FG001|Overall Study|Withdrawal by Subject|3|||
164491039|NCT03747575|594166247|FG000|Overall Study|Lost to Follow-up|3|||
164491040|NCT03747575|594166248|FG001|Overall Study|Lost to Follow-up|3|||
164491041|NCT03747575|594166247|FG000|Overall Study|Adverse Event|0|||
164491042|NCT03747575|594166248|FG001|Overall Study|Adverse Event|1|||
164491043|NCT04295499|594166249|FG000|Overall Study|moving out of state|1|||
164491044|NCT04295499|594166250|FG001|Overall Study|moving out of state|0|||
164491045|NCT04295499|594166249|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
164491046|NCT04295499|594166250|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
164491047|NCT00308113|594166251|FG000|Overall Study|Protocol closure|0|||
164491048|NCT00308113|594166252|FG001|Overall Study|Protocol closure|0|||
164491049|NCT00308113|594166253|FG002|Overall Study|Protocol closure|0|||
164491050|NCT00308113|594166254|FG003|Overall Study|Protocol closure|1|||
164491051|NCT01002547|594167842|FG000|Overall Study|Withdrawal by Subject|4|||
164491052|NCT01002547|594167843|FG001|Overall Study|Withdrawal by Subject|0|||
164491053|NCT01002547|594167844|FG002|Overall Study|Withdrawal by Subject|5|||
164491054|NCT01002547|594167842|FG000|Overall Study|Lost to Follow-up|2|||
164491055|NCT01002547|594167843|FG001|Overall Study|Lost to Follow-up|1|||
164491056|NCT01002547|594167844|FG002|Overall Study|Lost to Follow-up|1|||
164491057|NCT01002547|594167842|FG000|Overall Study|Physician Decision|1|||
164491058|NCT01002547|594167843|FG001|Overall Study|Physician Decision|0|||
164491059|NCT01002547|594167844|FG002|Overall Study|Physician Decision|0|||
164491060|NCT01002547|594167842|FG000|Overall Study|Death|0|||
164491061|NCT01002547|594167843|FG001|Overall Study|Death|2|||
164491062|NCT01002547|594167844|FG002|Overall Study|Death|2|||
164714870|NCT02785952|594978823|FG000|Overall Study|Refusal unrelated to adverse events|10|||
164714871|NCT02785952|594978824|FG001|Overall Study|Refusal unrelated to adverse events|5|||
164714872|NCT02785952|594978823|FG000|Overall Study|Disease progression/relapse|61|||
164714873|NCT02785952|594978824|FG001|Overall Study|Disease progression/relapse|89|||
164491063|NCT01002547|594167842|FG000|Overall Study|Adverse Event|1|||
164491064|NCT01002547|594167843|FG001|Overall Study|Adverse Event|0|||
164491065|NCT01002547|594167844|FG002|Overall Study|Adverse Event|0|||
164491066|NCT01184859|594167852|FG000|Period 1: Single Dose|Insufficient urine production|0|||
164491067|NCT01184859|594167853|FG001|Period 1: Single Dose|Insufficient urine production|1|||
164491068|NCT01184859|594167854|FG002|Period 1: Single Dose|Insufficient urine production|0|||
164491069|NCT01184859|594167855|FG003|Period 1: Single Dose|Insufficient urine production|0|||
164491070|NCT01184859|594167856|FG004|Period 1: Single Dose|Insufficient urine production|0|||
164491071|NCT01184859|594167852|FG000|Period 1: Single Dose|Protocol Violation|0|||
164491072|NCT01184859|594167853|FG001|Period 1: Single Dose|Protocol Violation|1|||
164714874|NCT02785952|594978823|FG000|Overall Study|Death|11|||
164714875|NCT02785952|594978824|FG001|Overall Study|Death|7|||
164491073|NCT01184859|594167854|FG002|Period 1: Single Dose|Protocol Violation|0|||
164491074|NCT01184859|594167855|FG003|Period 1: Single Dose|Protocol Violation|0|||
164491075|NCT01184859|594167856|FG004|Period 1: Single Dose|Protocol Violation|0|||
164491076|NCT01184859|594167852|FG000|Period 1: Single Dose|Adverse Event|0|||
164491077|NCT01184859|594167853|FG001|Period 1: Single Dose|Adverse Event|0|||
164491078|NCT01184859|594167854|FG002|Period 1: Single Dose|Adverse Event|0|||
164491079|NCT01184859|594167855|FG003|Period 1: Single Dose|Adverse Event|0|||
164491080|NCT01184859|594167856|FG004|Period 1: Single Dose|Adverse Event|1|||
164491081|NCT01184859|594167852|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
164491082|NCT01184859|594167853|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
164491083|NCT01184859|594167854|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
164491084|NCT01184859|594167855|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
164491085|NCT01184859|594167856|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
164491086|NCT01184859|594167852|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
164491087|NCT01184859|594167853|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
164491088|NCT01184859|594167854|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
164491089|NCT01184859|594167855|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
164491090|NCT01184859|594167856|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
164491091|NCT00434577|594167859|FG000|Months 0-3|Serious Adverse Event|0|||
164491092|NCT00434577|594167860|FG001|Months 0-3|Serious Adverse Event|0|||
164491093|NCT00434577|594167861|FG002|Months 0-3|Serious Adverse Event|1|||
164491094|NCT00434577|594167862|FG003|Months 0-3|Serious Adverse Event|0|||
164491095|NCT00434577|594167863|FG004|Months 0-3|Serious Adverse Event|0|||
164491096|NCT00434577|594167859|FG000|Months 0-3|Adverse Event|0|||
164491097|NCT00434577|594167860|FG001|Months 0-3|Adverse Event|1|||
164491098|NCT00434577|594167861|FG002|Months 0-3|Adverse Event|1|||
164491099|NCT00434577|594167862|FG003|Months 0-3|Adverse Event|0|||
164491100|NCT00434577|594167863|FG004|Months 0-3|Adverse Event|0|||
164491101|NCT00434577|594167859|FG000|Months 0-3|Lost to Follow-up|0|||
164491102|NCT00434577|594167860|FG001|Months 0-3|Lost to Follow-up|0|||
164491103|NCT00434577|594167861|FG002|Months 0-3|Lost to Follow-up|0|||
164491104|NCT00434577|594167862|FG003|Months 0-3|Lost to Follow-up|0|||
164491105|NCT00434577|594167863|FG004|Months 0-3|Lost to Follow-up|2|||
164491106|NCT00434577|594167859|FG000|Months 0-3|Protocol Violation|1|||
164491107|NCT00434577|594167860|FG001|Months 0-3|Protocol Violation|0|||
164491108|NCT00434577|594167861|FG002|Months 0-3|Protocol Violation|1|||
164491109|NCT00434577|594167862|FG003|Months 0-3|Protocol Violation|0|||
164491110|NCT00434577|594167863|FG004|Months 0-3|Protocol Violation|0|||
164491111|NCT00434577|594167859|FG000|Months 0-3|Withdrawal by Subject|2|||
164491112|NCT00434577|594167860|FG001|Months 0-3|Withdrawal by Subject|1|||
164491113|NCT00434577|594167861|FG002|Months 0-3|Withdrawal by Subject|1|||
164491114|NCT00434577|594167862|FG003|Months 0-3|Withdrawal by Subject|1|||
164491115|NCT00434577|594167863|FG004|Months 0-3|Withdrawal by Subject|1|||
164491116|NCT00635570|594167868|FG000|Overall Study|Lost to Follow-up|8|||
164491117|NCT00635570|594167869|FG001|Overall Study|Lost to Follow-up|8|||
164491118|NCT00635570|594167868|FG000|Overall Study|Withdrawal by Subject|1|||
164491119|NCT00635570|594167869|FG001|Overall Study|Withdrawal by Subject|1|||
164491120|NCT00635570|594167868|FG000|Overall Study|Adverse Event|2|||
164491121|NCT00635570|594167869|FG001|Overall Study|Adverse Event|0|||
164491122|NCT00635570|594167868|FG000|Overall Study|Physician Decision|1|||
164491123|NCT00635570|594167869|FG001|Overall Study|Physician Decision|0|||
164491124|NCT00635570|594167868|FG000|Overall Study|Did not complete survey|2|||
164491125|NCT00635570|594167869|FG001|Overall Study|Did not complete survey|1|||
164491126|NCT00635570|594167868|FG000|Overall Study|Early termination(No sexual activity)|1|||
164491127|NCT00635570|594167869|FG001|Overall Study|Early termination(No sexual activity)|1|||
164491128|NCT02176356|594167870|FG000|Overall Study|Screen Failure|14|||
164491129|NCT02176356|594167870|FG000|Overall Study|Lost to Follow-up|4|||
164491130|NCT02176356|594167870|FG000|Overall Study|Personal Reasons|3|||
164491131|NCT02176356|594167870|FG000|Overall Study|Other Miscellaneous Reasons|2|||
164491132|NCT00381888|594167874|FG000|Overall Study|Death|1|||
164491133|NCT00381888|594167874|FG000|Overall Study|Withdrawal by Subject|1|||
164491134|NCT00381888|594167874|FG000|Overall Study|Physician Decision|1|||
164491135|NCT00381888|594167874|FG000|Overall Study|Protocol Violation|9|||
164491136|NCT00381888|594167874|FG000|Overall Study|Had laparoscopic surgery|2|||
164491137|NCT00381888|594167874|FG000|Overall Study|Surgery was cancelled|2|||
164491138|NCT00381888|594167874|FG000|Overall Study|Adverse Event|1|||
164491139|NCT01537120|594167878|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
164491140|NCT01537120|594167878|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
164491141|NCT00958711|594167882|FG000|Overall Study|Withdrawal by Subject|0|||
164491142|NCT00958711|594167883|FG001|Overall Study|Withdrawal by Subject|4|||
164491143|NCT00958711|594167882|FG000|Overall Study|Physician Decision|5|||
164491144|NCT00958711|594167883|FG001|Overall Study|Physician Decision|7|||
164602437|NCT04735393|594564834|FG001|Overall Study|Withdrawal by Subject|28|||
164491145|NCT00958711|594167882|FG000|Overall Study|Lost to Follow-up|4|||
164491146|NCT00958711|594167883|FG001|Overall Study|Lost to Follow-up|1|||
164491147|NCT00958711|594167882|FG000|Overall Study|Other|2|||
164491148|NCT00958711|594167883|FG001|Overall Study|Other|5|||
164602438|NCT04735393|594564833|FG000|Overall Study|Adverse Event|56|||
164491149|NCT00958711|594167882|FG000|Overall Study|Death|1|||
164491150|NCT00958711|594167883|FG001|Overall Study|Death|2|||
164491151|NCT00958711|594167882|FG000|Overall Study|Adverse Event|1|||
164491152|NCT00958711|594167883|FG001|Overall Study|Adverse Event|2|||
164714876|NCT02785952|594978823|FG000|Overall Study|Other- not protocol specified|6|||
164714877|NCT02785952|594978824|FG001|Overall Study|Other- not protocol specified|4|||
164714878|NCT02785952|594978823|FG000|Overall Study|On protocol treatment|6|||
164714879|NCT02785952|594978824|FG001|Overall Study|On protocol treatment|3|||
164491153|NCT03722485|594167884|FG000|Overall Study|Withdrawal by Subject|1|||
164491154|NCT03722485|594167885|FG001|Overall Study|Withdrawal by Subject|0|||
164491155|NCT03722485|594167884|FG000|Overall Study|Adverse Event|0|||
164491156|NCT03722485|594167885|FG001|Overall Study|Adverse Event|2|||
164491157|NCT03722485|594167884|FG000|Overall Study|subject discharged prior to study completion|1|||
164491158|NCT03722485|594167885|FG001|Overall Study|subject discharged prior to study completion|5|||
164491159|NCT03722485|594167884|FG000|Overall Study|eligibility criteria not met|2|||
164491160|NCT03722485|594167885|FG001|Overall Study|eligibility criteria not met|0|||
164491161|NCT03087851|594167890|FG000|Overall Study|Withdraw on medical grounds|0|||
164491162|NCT03087851|594167891|FG001|Overall Study|Withdraw on medical grounds|1|||
164491163|NCT03087851|594167892|FG002|Overall Study|Withdraw on medical grounds|2|||
164491164|NCT00644332|594167893|FG000|Overall Study|Adverse Event|11|||
164491165|NCT00644332|594167893|FG000|Overall Study|Withdrawal by Subject|6|||
164491166|NCT00644332|594167893|FG000|Overall Study|Completion Status Unknown|2|||
164491167|NCT00644332|594167893|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
164491168|NCT00644332|594167893|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
164491169|NCT00409006|594167895|FG000|Overall Study|Death|15|||
164491170|NCT00409006|594167896|FG001|Overall Study|Death|6|||
164491171|NCT00409006|594167895|FG000|Overall Study|Lost to Follow-up|1|||
164491172|NCT00409006|594167896|FG001|Overall Study|Lost to Follow-up|2|||
164491173|NCT00409006|594167895|FG000|Overall Study|Withdrawal by Subject|3|||
164491174|NCT00409006|594167896|FG001|Overall Study|Withdrawal by Subject|2|||
164491175|NCT00409006|594167895|FG000|Overall Study|Physician Decision|1|||
164491176|NCT00409006|594167896|FG001|Overall Study|Physician Decision|2|||
164491177|NCT03050372|594167897|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
164491178|NCT03050372|594167898|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
164491179|NCT03050372|594167897|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
164602439|NCT04735393|594564834|FG001|Overall Study|Adverse Event|7|||
164602440|NCT04735393|594564833|FG000|Overall Study|Protocol Violation|6|||
164602441|NCT04735393|594564834|FG001|Overall Study|Protocol Violation|1|||
164602442|NCT04735393|594564833|FG000|Overall Study|Trial terminated by Sponsor|49|||
164602443|NCT04735393|594564834|FG001|Overall Study|Trial terminated by Sponsor|29|||
164602444|NCT00209170|594564835|FG000|Overall Study|Adverse Event|0|||
164602445|NCT00209170|594564836|FG001|Overall Study|Adverse Event|1|||
164602446|NCT00209170|594564835|FG000|Overall Study|Withdrawal by Subject|2|||
164602447|NCT00209170|594564836|FG001|Overall Study|Withdrawal by Subject|1|||
164602448|NCT00209170|594564835|FG000|Overall Study|Lack of Efficacy|0|||
164602449|NCT00209170|594564836|FG001|Overall Study|Lack of Efficacy|1|||
164602450|NCT03224104|594564840|FG000|Overall Study|Lack of Efficacy|2|||
164602451|NCT03224104|594564841|FG001|Overall Study|Lack of Efficacy|6|||
164602452|NCT03224104|594564842|FG002|Overall Study|Lack of Efficacy|3|||
164602453|NCT03224104|594564843|FG003|Overall Study|Lack of Efficacy|4|||
164602454|NCT03224104|594564844|FG004|Overall Study|Lack of Efficacy|42|||
164602455|NCT03224104|594564840|FG000|Overall Study|Withdrawal by Subject|0|||
164602456|NCT03224104|594564841|FG001|Overall Study|Withdrawal by Subject|2|||
164602457|NCT03224104|594564842|FG002|Overall Study|Withdrawal by Subject|0|||
164602458|NCT03224104|594564843|FG003|Overall Study|Withdrawal by Subject|1|||
164714880|NCT00090363|594978827|FG000|Overall Study|Lost to Follow-up|1|||
164714881|NCT00090363|594978828|FG001|Overall Study|Lost to Follow-up|2|||
164714882|NCT00090363|594978829|FG002|Overall Study|Lost to Follow-up|1|||
164714883|NCT00090363|594978827|FG000|Overall Study|Withdrawal by Subject|7|||
164714884|NCT00090363|594978828|FG001|Overall Study|Withdrawal by Subject|7|||
164602459|NCT03224104|594564844|FG004|Overall Study|Withdrawal by Subject|3|||
164602460|NCT03224104|594564840|FG000|Overall Study|Death|0|||
164602461|NCT03224104|594564841|FG001|Overall Study|Death|1|||
164602462|NCT03224104|594564842|FG002|Overall Study|Death|0|||
164602463|NCT03224104|594564843|FG003|Overall Study|Death|0|||
164714885|NCT00090363|594978829|FG002|Overall Study|Withdrawal by Subject|6|||
164491180|NCT03050372|594167898|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
164491181|NCT00443755|594167901|FG000|Overall Study|Withdrawal by Subject|2|||
164491182|NCT00443755|594167902|FG001|Overall Study|Withdrawal by Subject|1|||
164491183|NCT02991456|594167908|FG000|Overall Study|Adverse Event|2|||
164491184|NCT02991456|594167909|FG001|Overall Study|Adverse Event|0|||
164602464|NCT03224104|594564844|FG004|Overall Study|Death|0|||
164602465|NCT03224104|594564840|FG000|Overall Study|Adverse Event|1|||
164602466|NCT03224104|594564841|FG001|Overall Study|Adverse Event|0|||
164714886|NCT00090363|594978827|FG000|Overall Study|Study-specific discontinuation criteria|75|||
164714887|NCT00090363|594978828|FG001|Overall Study|Study-specific discontinuation criteria|74|||
164714888|NCT00090363|594978829|FG002|Overall Study|Study-specific discontinuation criteria|62|||
164714889|NCT00090363|594978827|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164714890|NCT00090363|594978828|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164714891|NCT00090363|594978829|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
164714892|NCT00090363|594978827|FG000|Overall Study|Consent expired|7|||
164491185|NCT02991456|594167908|FG000|Overall Study|Lost to Follow-up|0|||
164491186|NCT02991456|594167909|FG001|Overall Study|Lost to Follow-up|2|||
164491187|NCT02991456|594167908|FG000|Overall Study|Withdrawal by Subject|1|||
164491188|NCT02991456|594167909|FG001|Overall Study|Withdrawal by Subject|0|||
164491189|NCT02058992|594167910|FG000|Overall Study|Lost to Follow-up|4|||
164491190|NCT02058992|594167910|FG000|Overall Study|Protocol Violation|92|||
164491191|NCT02058992|594167910|FG000|Overall Study|CRF Uncollected|20|||
164491192|NCT03953079|594167912|FG000|Core Study|Withdrawal by Subject|1|||
164491193|NCT03953079|594167913|FG001|Core Study|Withdrawal by Subject|2|||
164491194|NCT03953079|594167914|FG002|Core Study|Withdrawal by Subject|1|||
164491195|NCT03953079|594167912|FG000|Core Study|COVID-19|0|||
164491196|NCT03953079|594167913|FG001|Core Study|COVID-19|1|||
164491197|NCT03953079|594167914|FG002|Core Study|COVID-19|0|||
164491198|NCT03953079|594167912|FG000|Core Study|Difficulties leaving the house|0|||
164491199|NCT03953079|594167913|FG001|Core Study|Difficulties leaving the house|1|||
164491200|NCT03953079|594167914|FG002|Core Study|Difficulties leaving the house|0|||
164491201|NCT03953079|594167912|FG000|Extension Study|Withdrawal by Subject|1|||
164491202|NCT03953079|594167913|FG001|Extension Study|Withdrawal by Subject|0|||
164491203|NCT03953079|594167914|FG002|Extension Study|Withdrawal by Subject|0|||
164491204|NCT03953079|594167912|FG000|Extension Study|Received Rescue Treatment|5|||
164491205|NCT03953079|594167913|FG001|Extension Study|Received Rescue Treatment|6|||
164491206|NCT03953079|594167914|FG002|Extension Study|Received Rescue Treatment|5|||
164491207|NCT00936065|594167915|FG000|Overall Study|Adverse Event|1|||
164491208|NCT00936065|594167916|FG001|Overall Study|Adverse Event|0|||
164491209|NCT00936065|594167917|FG002|Overall Study|Adverse Event|1|||
164491210|NCT00936065|594167915|FG000|Overall Study|Lack of Efficacy|1|||
164491211|NCT00936065|594167916|FG001|Overall Study|Lack of Efficacy|0|||
164491212|NCT00936065|594167917|FG002|Overall Study|Lack of Efficacy|1|||
164491213|NCT00936065|594167915|FG000|Overall Study|Lost to Follow-up|1|||
164491214|NCT00936065|594167916|FG001|Overall Study|Lost to Follow-up|0|||
164491215|NCT00936065|594167917|FG002|Overall Study|Lost to Follow-up|0|||
164491216|NCT00936065|594167915|FG000|Overall Study|Protocol Violation|1|||
164491217|NCT00936065|594167916|FG001|Overall Study|Protocol Violation|2|||
164491218|NCT00936065|594167917|FG002|Overall Study|Protocol Violation|1|||
164491219|NCT00936065|594167915|FG000|Overall Study|Withdrawal by Subject|0|||
164491220|NCT00936065|594167916|FG001|Overall Study|Withdrawal by Subject|2|||
164491221|NCT00936065|594167917|FG002|Overall Study|Withdrawal by Subject|4|||
164491222|NCT02260154|594167921|FG000|Overall Study|Screening failure|2|||
164491223|NCT03560206|594167922|FG000|Overall Study|Lost to Follow-up|19|||
164491224|NCT03560206|594167923|FG001|Overall Study|Lost to Follow-up|11|||
164491225|NCT03560206|594167922|FG000|Overall Study|Withdrawal by Subject|2|||
164491226|NCT03560206|594167923|FG001|Overall Study|Withdrawal by Subject|4|||
164491227|NCT03560206|594167922|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
164491228|NCT03560206|594167923|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
164491229|NCT03560206|594167922|FG000|Overall Study|Busy schedule|14|||
164491230|NCT03560206|594167923|FG001|Overall Study|Busy schedule|2|||
164491231|NCT03560206|594167922|FG000|Overall Study|patients' new health condition such as cancer|10|||
164491232|NCT03560206|594167923|FG001|Overall Study|patients' new health condition such as cancer|1|||
164491233|NCT01549951|594167924|FG000|Overall Study|Adverse Event|15|||
164491234|NCT01549951|594167924|FG000|Overall Study|Withdrawal by Subject|2|||
164491235|NCT01549951|594167924|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
164491236|NCT01549951|594167924|FG000|Overall Study|Progressive disease|29|||
164491237|NCT01549951|594167924|FG000|Overall Study|Symptomatic deterioration|1|||
164491238|NCT01549951|594167924|FG000|Overall Study|Other|2|||
164491239|NCT00738400|594167927|FG000|Overall Study|Adverse Event|3|||
164491240|NCT00738400|594167928|FG001|Overall Study|Adverse Event|1|||
164491241|NCT00738400|594167927|FG000|Overall Study|Withdrawal by Subject|0|||
164491242|NCT00738400|594167928|FG001|Overall Study|Withdrawal by Subject|1|||
164714893|NCT00090363|594978828|FG001|Overall Study|Consent expired|10|||
164714894|NCT00090363|594978829|FG002|Overall Study|Consent expired|9|||
164714895|NCT00090363|594978827|FG000|Overall Study|Reasons not specified|2|||
164714896|NCT00090363|594978828|FG001|Overall Study|Reasons not specified|1|||
164491243|NCT00738400|594167927|FG000|Overall Study|Lack of Efficacy|0|||
164491244|NCT00738400|594167928|FG001|Overall Study|Lack of Efficacy|1|||
164491245|NCT00738400|594167927|FG000|Overall Study|Lost to Follow-up|0|||
164714897|NCT00090363|594978829|FG002|Overall Study|Reasons not specified|1|||
164491246|NCT00738400|594167928|FG001|Overall Study|Lost to Follow-up|3|||
164491247|NCT00738400|594167927|FG000|Overall Study|Protocol Violation|1|||
164491248|NCT00738400|594167928|FG001|Overall Study|Protocol Violation|0|||
164491249|NCT00738400|594167927|FG000|Overall Study|Non-compliant with study medication|0|||
164491250|NCT00738400|594167928|FG001|Overall Study|Non-compliant with study medication|1|||
164491251|NCT02255474|594167929|FG000|Overall Study|Lost to Follow-up|1|||
164714898|NCT00090363|594978827|FG000|Overall Study|Continuing on study off treatment|14|||
164491252|NCT02255474|594167930|FG001|Overall Study|Lost to Follow-up|1|||
164491253|NCT02255474|594167931|FG002|Overall Study|Lost to Follow-up|3|||
164491254|NCT02255474|594167929|FG000|Overall Study|Withdrawal by Subject|1|||
164491255|NCT02255474|594167930|FG001|Overall Study|Withdrawal by Subject|1|||
164491256|NCT02255474|594167931|FG002|Overall Study|Withdrawal by Subject|0|||
164491257|NCT02993926|594167935|FG000|Enantone Treatment Phase|Adverse Event|1|||
164491258|NCT02993926|594167936|FG001|Enantone Treatment Phase|Adverse Event|0|||
164491259|NCT02993926|594167937|FG002|Enantone Treatment Phase|Adverse Event|0|||
164491260|NCT02993926|594167935|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
164491261|NCT02993926|594167936|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
164491262|NCT02993926|594167937|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
164491263|NCT02993926|594167935|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
164491264|NCT02993926|594167936|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
164491265|NCT02993926|594167937|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
164491266|NCT02993926|594167935|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
164300978|NCT02392624|593478384|FG001|Overall Study|Pregnancy|0|||
164300979|NCT02392624|593478385|FG002|Overall Study|Pregnancy|0|||
164300980|NCT02392624|593478383|FG000|Overall Study|Protocol Violation|0|||
164300981|NCT02392624|593478384|FG001|Overall Study|Protocol Violation|0|||
164300982|NCT02392624|593478385|FG002|Overall Study|Protocol Violation|1|||
164300983|NCT02392624|593478383|FG000|Overall Study|Sponsor/Investigator Decision|2|||
164300984|NCT02392624|593478384|FG001|Overall Study|Sponsor/Investigator Decision|1|||
164300985|NCT02392624|593478385|FG002|Overall Study|Sponsor/Investigator Decision|0|||
164491267|NCT02993926|594167936|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
164491268|NCT02993926|594167937|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
164491269|NCT02009865|594167941|FG000|Overall Study|Adverse Event|0|||
164491270|NCT02009865|594167942|FG001|Overall Study|Adverse Event|2|||
164491271|NCT02009865|594167941|FG000|Overall Study|Protocol Violation|0|||
164491272|NCT02009865|594167942|FG001|Overall Study|Protocol Violation|2|||
164491273|NCT02009865|594167941|FG000|Overall Study|Withdrawal by Subject|1|||
164491274|NCT02009865|594167942|FG001|Overall Study|Withdrawal by Subject|1|||
164491275|NCT01760876|594167943|FG000|Overall Study|Non-cardiac death (head injury)|1|||
164491276|NCT01760876|594167943|FG000|Overall Study|Carcinoma of prostate|1|||
164491277|NCT01760876|594167943|FG000|Overall Study|Impaired renal function|1|||
164491278|NCT01760876|594167943|FG000|Overall Study|Major depression|1|||
164491279|NCT01760876|594167943|FG000|Overall Study|Very poor baseline OCT quality|2|||
164491280|NCT03689452|594167947|FG000|Overall Study|Lost to Follow-up|1|||
164491281|NCT03689452|594167948|FG001|Overall Study|Lost to Follow-up|1|||
164491282|NCT00525915|594167949|FG000|Overall Study|Non-Compliance|0|||
164491283|NCT00525915|594167950|FG001|Overall Study|Non-Compliance|1|||
164491284|NCT00525915|594167949|FG000|Overall Study|Disease Progression|5|||
164491285|NCT00525915|594167950|FG001|Overall Study|Disease Progression|6|||
164491286|NCT00525915|594167949|FG000|Overall Study|Withdrawal by Subject|1|||
164491287|NCT00525915|594167950|FG001|Overall Study|Withdrawal by Subject|0|||
164491288|NCT00525915|594167949|FG000|Overall Study|Refused Surgery|1|||
164491289|NCT00525915|594167950|FG001|Overall Study|Refused Surgery|2|||
164491290|NCT00525915|594167949|FG000|Overall Study|Unrelated illness|1|||
164491291|NCT00525915|594167950|FG001|Overall Study|Unrelated illness|0|||
164491292|NCT03394508|594167953|FG000|Overall Study|Protocol Violation|0|||
164491293|NCT03394508|594167954|FG001|Overall Study|Protocol Violation|3|||
164491294|NCT03394508|594167953|FG000|Overall Study|Lost to Follow-up|1|||
164491295|NCT03394508|594167954|FG001|Overall Study|Lost to Follow-up|0|||
164491296|NCT00267865|594167955|FG000|Induction Treatment|Died before completing.|2|||
164491297|NCT00267865|594167955|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
164491298|NCT01755598|594167959|FG000|Overall Study|Other|109|||
164491299|NCT01755598|594167960|FG001|Overall Study|Other|109|||
164491300|NCT01755598|594167959|FG000|Overall Study|Lost to Follow-up|32|||
164491301|NCT01755598|594167960|FG001|Overall Study|Lost to Follow-up|43|||
164491302|NCT01755598|594167959|FG000|Overall Study|Migrated/moved from study area|76|||
164491303|NCT01755598|594167960|FG001|Overall Study|Migrated/moved from study area|65|||
164491304|NCT01755598|594167959|FG000|Overall Study|Withdrawal by Subject|22|||
164491305|NCT01755598|594167960|FG001|Overall Study|Withdrawal by Subject|31|||
164491306|NCT01755598|594167959|FG000|Overall Study|Protocol Violation|7|||
164491307|NCT01755598|594167960|FG001|Overall Study|Protocol Violation|7|||
164491308|NCT01755598|594167959|FG000|Overall Study|Adverse Event|19|||
164491309|NCT01755598|594167960|FG001|Overall Study|Adverse Event|28|||
164491310|NCT02332889|594167961|FG000|Overall Study|Physician Decision|1|||
164491311|NCT02135445|594167962|FG000|Overall Study|Lost to Follow-up|1|||
164491312|NCT02135445|594167963|FG001|Overall Study|Lost to Follow-up|0|||
164491313|NCT02135445|594167962|FG000|Overall Study|Withdrawal by Subject|1|||
164491314|NCT02135445|594167963|FG001|Overall Study|Withdrawal by Subject|0|||
164491315|NCT03556891|594167964|FG000|Initial Pivotal Study|Adverse Event|4|||
164491316|NCT03556891|594167964|FG000|Initial Pivotal Study|MRI Need|3|||
164491317|NCT03556891|594167964|FG000|Initial Pivotal Study|Device Failure|1|||
164491318|NCT03556891|594167964|FG000|Initial Pivotal Study|Death|1|||
164491319|NCT03556891|594167964|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
164602467|NCT03224104|594564842|FG002|Overall Study|Adverse Event|0|||
164602468|NCT03224104|594564843|FG003|Overall Study|Adverse Event|1|||
164602469|NCT03224104|594564844|FG004|Overall Study|Adverse Event|3|||
164602470|NCT03224104|594564840|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
164602471|NCT03224104|594564841|FG001|Overall Study|Start of a new anti-cancer treatment|0|||
164602472|NCT03224104|594564842|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
164602473|NCT03224104|594564843|FG003|Overall Study|Start of a new anti-cancer treatment|0|||
164602474|NCT03224104|594564844|FG004|Overall Study|Start of a new anti-cancer treatment|1|||
164602475|NCT03224104|594564840|FG000|Overall Study|Treatment ongoing|0|||
164602476|NCT03224104|594564841|FG001|Overall Study|Treatment ongoing|0|||
164602477|NCT03224104|594564842|FG002|Overall Study|Treatment ongoing|0|||
164602478|NCT03224104|594564843|FG003|Overall Study|Treatment ongoing|0|||
164602479|NCT03224104|594564844|FG004|Overall Study|Treatment ongoing|1|||
164602480|NCT04397718|594564845|FG000|Overall Study|Death|7|||
164602481|NCT04397718|594564846|FG001|Overall Study|Death|11|||
164602482|NCT04397718|594564845|FG000|Overall Study|Lost to Follow-up|0|||
164602483|NCT04397718|594564846|FG001|Overall Study|Lost to Follow-up|4|||
164602484|NCT01371981|594564847|FG000|Overall Study|Adverse Event|12|||
164602485|NCT01371981|594564848|FG001|Overall Study|Adverse Event|17|||
164602486|NCT01371981|594564849|FG002|Overall Study|Adverse Event|0|||
164602487|NCT01371981|594564850|FG003|Overall Study|Adverse Event|4|||
164602488|NCT01371981|594564851|FG004|Overall Study|Adverse Event|1|||
164602489|NCT01371981|594564852|FG005|Overall Study|Adverse Event|0|||
164602490|NCT01371981|594564847|FG000|Overall Study|Death|22|||
164602491|NCT01371981|594564848|FG001|Overall Study|Death|16|||
164602492|NCT01371981|594564849|FG002|Overall Study|Death|0|||
164602493|NCT01371981|594564850|FG003|Overall Study|Death|0|||
164602494|NCT01371981|594564851|FG004|Overall Study|Death|2|||
164602495|NCT01371981|594564852|FG005|Overall Study|Death|2|||
164602496|NCT01371981|594564847|FG000|Overall Study|Lack of Efficacy|69|||
164602497|NCT01371981|594564848|FG001|Overall Study|Lack of Efficacy|61|||
164602498|NCT01371981|594564849|FG002|Overall Study|Lack of Efficacy|4|||
164602499|NCT01371981|594564850|FG003|Overall Study|Lack of Efficacy|8|||
164602500|NCT01371981|594564851|FG004|Overall Study|Lack of Efficacy|5|||
164602501|NCT01371981|594564852|FG005|Overall Study|Lack of Efficacy|0|||
164491320|NCT03556891|594167964|FG000|Initial Pivotal Study|Missing at random|1|||
164491321|NCT03556891|594167964|FG000|Initial Pivotal Study|Missing due to COVID|1|||
164491322|NCT03556891|594167964|FG000|Initial Pivotal Study|Protocol Violation|1|||
164491323|NCT01809691|594169874|FG000|Overall Study|Currently on Treatment|192|||
164491324|NCT01809691|594169875|FG001|Overall Study|Currently on Treatment|100|||
164491325|NCT01809691|594169874|FG000|Overall Study|No Protocol Treatment|10|||
164491326|NCT01809691|594169875|FG001|Overall Study|No Protocol Treatment|11|||
164491327|NCT01809691|594169874|FG000|Overall Study|Adverse Event|80|||
164491328|NCT01809691|594169875|FG001|Overall Study|Adverse Event|21|||
164491329|NCT01809691|594169874|FG000|Overall Study|Disease Progression|226|||
164491330|NCT01809691|594169875|FG001|Overall Study|Disease Progression|372|||
164491331|NCT01809691|594169874|FG000|Overall Study|Death|26|||
164491332|NCT01809691|594169875|FG001|Overall Study|Death|13|||
164491333|NCT01809691|594169874|FG000|Overall Study|Participant Refusal|70|||
164491334|NCT01809691|594169875|FG001|Overall Study|Participant Refusal|72|||
164491335|NCT01809691|594169874|FG000|Overall Study|Other, Not Specified|34|||
164491336|NCT01809691|594169875|FG001|Overall Study|Other, Not Specified|52|||
164602502|NCT01371981|594564847|FG000|Overall Study|Physician Decision|48|||
164602503|NCT01371981|594564848|FG001|Overall Study|Physician Decision|63|||
164602504|NCT01371981|594564849|FG002|Overall Study|Physician Decision|1|||
164602505|NCT01371981|594564850|FG003|Overall Study|Physician Decision|7|||
164602506|NCT01371981|594564851|FG004|Overall Study|Physician Decision|14|||
164602507|NCT01371981|594564852|FG005|Overall Study|Physician Decision|3|||
164602508|NCT01371981|594564847|FG000|Overall Study|Withdrawal by Subject|12|||
164602509|NCT01371981|594564848|FG001|Overall Study|Withdrawal by Subject|19|||
164491337|NCT03694210|594169876|FG000|Overall Study|Death|1|||
164491338|NCT03694210|594169876|FG000|Overall Study|Screen Failure|7|||
164602510|NCT01371981|594564849|FG002|Overall Study|Withdrawal by Subject|1|||
164602511|NCT01371981|594564850|FG003|Overall Study|Withdrawal by Subject|2|||
164602512|NCT01371981|594564851|FG004|Overall Study|Withdrawal by Subject|10|||
164602513|NCT01371981|594564852|FG005|Overall Study|Withdrawal by Subject|3|||
164602514|NCT01371981|594564847|FG000|Overall Study|Ineligible|19|||
164602515|NCT01371981|594564848|FG001|Overall Study|Ineligible|13|||
164602516|NCT01371981|594564849|FG002|Overall Study|Ineligible|0|||
164602517|NCT01371981|594564850|FG003|Overall Study|Ineligible|0|||
164602518|NCT01371981|594564851|FG004|Overall Study|Ineligible|0|||
164602519|NCT01371981|594564852|FG005|Overall Study|Ineligible|4|||
164602520|NCT01371981|594564847|FG000|Overall Study|Did not start treatment|2|||
164491339|NCT02775214|594169879|FG000|Overall Study|Withdrawal by Subject|2|||
164491340|NCT02775214|594169880|FG001|Overall Study|Withdrawal by Subject|0|||
164602521|NCT01371981|594564848|FG001|Overall Study|Did not start treatment|3|||
164602522|NCT01371981|594564849|FG002|Overall Study|Did not start treatment|0|||
164602523|NCT01371981|594564850|FG003|Overall Study|Did not start treatment|0|||
164714899|NCT00090363|594978828|FG001|Overall Study|Continuing on study off treatment|13|||
164491341|NCT02706834|594169882|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
164491342|NCT02706834|594169883|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
164491343|NCT02706834|594169884|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
164491344|NCT02706834|594169885|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
164491345|NCT02706834|594169886|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
164491346|NCT02706834|594169887|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
164491347|NCT02706834|594169888|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
164491348|NCT02706834|594169889|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
164491349|NCT02706834|594169890|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
164491350|NCT02706834|594169891|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
164491351|NCT02706834|594169892|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
164491352|NCT02706834|594169882|FG000|Overall Study|Lost to Follow-up|0|||
164491353|NCT02706834|594169883|FG001|Overall Study|Lost to Follow-up|0|||
164491354|NCT02706834|594169884|FG002|Overall Study|Lost to Follow-up|1|||
164491355|NCT02706834|594169885|FG003|Overall Study|Lost to Follow-up|0|||
164491356|NCT02706834|594169886|FG004|Overall Study|Lost to Follow-up|0|||
164491357|NCT02706834|594169887|FG005|Overall Study|Lost to Follow-up|0|||
164491358|NCT02706834|594169888|FG006|Overall Study|Lost to Follow-up|0|||
164491359|NCT02706834|594169889|FG007|Overall Study|Lost to Follow-up|0|||
164491360|NCT02706834|594169890|FG008|Overall Study|Lost to Follow-up|0|||
164491361|NCT02706834|594169891|FG009|Overall Study|Lost to Follow-up|0|||
164491362|NCT02706834|594169892|FG010|Overall Study|Lost to Follow-up|0|||
164491363|NCT02706834|594169882|FG000|Overall Study|Voluntary Withdrawal|1|||
164491364|NCT02706834|594169883|FG001|Overall Study|Voluntary Withdrawal|0|||
164491365|NCT02706834|594169884|FG002|Overall Study|Voluntary Withdrawal|0|||
164491366|NCT02706834|594169885|FG003|Overall Study|Voluntary Withdrawal|0|||
164491367|NCT02706834|594169886|FG004|Overall Study|Voluntary Withdrawal|0|||
164491368|NCT02706834|594169887|FG005|Overall Study|Voluntary Withdrawal|0|||
164491369|NCT02706834|594169888|FG006|Overall Study|Voluntary Withdrawal|0|||
164491370|NCT02706834|594169889|FG007|Overall Study|Voluntary Withdrawal|0|||
164491371|NCT02706834|594169890|FG008|Overall Study|Voluntary Withdrawal|0|||
164491372|NCT02706834|594169891|FG009|Overall Study|Voluntary Withdrawal|1|||
164491373|NCT02706834|594169892|FG010|Overall Study|Voluntary Withdrawal|0|||
164491374|NCT02706834|594169882|FG000|Overall Study|Other Reason Not Specified|1|||
164491375|NCT02706834|594169883|FG001|Overall Study|Other Reason Not Specified|0|||
164491376|NCT02706834|594169884|FG002|Overall Study|Other Reason Not Specified|0|||
164491377|NCT02706834|594169885|FG003|Overall Study|Other Reason Not Specified|0|||
164491378|NCT02706834|594169886|FG004|Overall Study|Other Reason Not Specified|1|||
164491379|NCT02706834|594169887|FG005|Overall Study|Other Reason Not Specified|0|||
164491380|NCT02706834|594169888|FG006|Overall Study|Other Reason Not Specified|0|||
164491381|NCT02706834|594169889|FG007|Overall Study|Other Reason Not Specified|0|||
164491382|NCT02706834|594169890|FG008|Overall Study|Other Reason Not Specified|0|||
164491383|NCT02706834|594169891|FG009|Overall Study|Other Reason Not Specified|0|||
164491384|NCT02706834|594169892|FG010|Overall Study|Other Reason Not Specified|0|||
164491385|NCT00678899|594169897|FG000|Overall Study|Adverse Event|1|||
164491386|NCT02543294|594169898|FG000|Overall Study|Lost to Follow-up|3|||
164491387|NCT02543294|594169898|FG000|Overall Study|Physician Decision|2|||
164491388|NCT02543294|594169898|FG000|Overall Study|Withdrawal by Subject|7|||
164491389|NCT01107353|594169902|FG000|Overall Study|Positive Drug Screen|1|||
164491390|NCT01107353|594169903|FG001|Overall Study|Positive Drug Screen|0|||
164491391|NCT02798861|594169906|FG000|Overall Study|Lost to Follow-up|22|||
164491392|NCT02798861|594169906|FG000|Overall Study|Withdrawal by Subject|1|||
164491393|NCT04879823|594169914|FG000|Overall Study|Physician Decision|3|||
164491394|NCT04879823|594169915|FG001|Overall Study|Physician Decision|1|||
164491395|NCT04879823|594169914|FG000|Overall Study|Protocol Violation|2|||
164491396|NCT04879823|594169915|FG001|Overall Study|Protocol Violation|3|||
164491397|NCT04879823|594169914|FG000|Overall Study|Lost to Follow-up|43|||
164491398|NCT04879823|594169915|FG001|Overall Study|Lost to Follow-up|35|||
164491399|NCT00730925|594169916|FG000|Overall Study|Progressive Disease|21|||
164491400|NCT00730925|594169916|FG000|Overall Study|Dose reducing Event|2|||
164491401|NCT00730925|594169916|FG000|Overall Study|Other Averse Event|7|||
164491402|NCT00730925|594169916|FG000|Overall Study|Protocol Violation|1|||
164491403|NCT00730925|594169916|FG000|Overall Study|Withdrawal by Subject|1|||
164491404|NCT00730925|594169916|FG000|Overall Study|Switch to combination therapy|8|||
164602524|NCT01371981|594564851|FG004|Overall Study|Did not start treatment|0|||
164491405|NCT00730925|594169916|FG000|Overall Study|Other|1|||
164491406|NCT02137239|594169917|FG000|Overall Study|Discontinued Study Treatment|0|||
164491407|NCT02137239|594169918|FG001|Overall Study|Discontinued Study Treatment|3|||
164491408|NCT02137239|594169917|FG000|Overall Study|Withdrew Consent|1|||
164491409|NCT02137239|594169918|FG001|Overall Study|Withdrew Consent|1|||
164491410|NCT02137239|594169917|FG000|Overall Study|Adverse Event|2|||
164491411|NCT02137239|594169918|FG001|Overall Study|Adverse Event|2|||
164491412|NCT04057937|594169919|FG000|Placebo-controlled Phase|Adverse Event|3|||
164602525|NCT01371981|594564852|FG005|Overall Study|Did not start treatment|2|||
164602526|NCT02493426|594564853|FG000|Overall Study|Withdrawal by Subject|0|||
164602527|NCT02493426|594564854|FG001|Overall Study|Withdrawal by Subject|1|||
164491413|NCT04057937|594169920|FG001|Placebo-controlled Phase|Adverse Event|0|||
164491414|NCT04057937|594169919|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
164491415|NCT04057937|594169920|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
164491416|NCT04057937|594169919|FG000|Active-treatment Phase|Pregnancy|0|||
164491417|NCT04057937|594169920|FG001|Active-treatment Phase|Pregnancy|1|||
164491418|NCT04057937|594169919|FG000|Active-treatment Phase|Physician Decision|0|||
164491419|NCT04057937|594169920|FG001|Active-treatment Phase|Physician Decision|1|||
164491420|NCT02029521|594169921|FG000|Overall Study|Protocol Violation|1|||
164491421|NCT02029521|594169922|FG001|Overall Study|Protocol Violation|0|||
164491422|NCT02029521|594169921|FG000|Overall Study|Withdrawal by Subject|1|||
164491423|NCT02029521|594169922|FG001|Overall Study|Withdrawal by Subject|1|||
164491424|NCT01072396|594169923|FG000|Period One|Adverse Event|1|||
164491425|NCT01072396|594169924|FG001|Period One|Adverse Event|1|||
164491426|NCT01072396|594169923|FG000|Period One|Protocol Violation|2|||
164491427|NCT01072396|594169924|FG001|Period One|Protocol Violation|1|||
164491428|NCT01072396|594169923|FG000|Period One|Withdrawal by Subject|2|||
164491429|NCT01072396|594169924|FG001|Period One|Withdrawal by Subject|0|||
164491430|NCT01072396|594169923|FG000|Washout Period|Missing termination information|0|||
164491431|NCT01072396|594169924|FG001|Washout Period|Missing termination information|1|||
164491432|NCT01072396|594169923|FG000|Period Two|Adverse Event|0|||
164491433|NCT01072396|594169924|FG001|Period Two|Adverse Event|3|||
164491434|NCT01072396|594169923|FG000|Period Two|Lost to Follow-up|1|||
164491435|NCT01072396|594169924|FG001|Period Two|Lost to Follow-up|0|||
164491436|NCT02446912|594169925|FG000|Overall Study|Adverse Event|3|||
164491437|NCT02446912|594169926|FG001|Overall Study|Adverse Event|13|||
164491438|NCT02446912|594169927|FG002|Overall Study|Adverse Event|5|||
164491439|NCT02446912|594169925|FG000|Overall Study|Condition under investigation worsened|0|||
164491440|NCT02446912|594169926|FG001|Overall Study|Condition under investigation worsened|1|||
164491441|NCT02446912|594169927|FG002|Overall Study|Condition under investigation worsened|1|||
164491442|NCT02446912|594169925|FG000|Overall Study|Study-specific withdrawal criteria|1|||
164491443|NCT02446912|594169926|FG001|Overall Study|Study-specific withdrawal criteria|0|||
164491444|NCT02446912|594169927|FG002|Overall Study|Study-specific withdrawal criteria|0|||
164491445|NCT02446912|594169925|FG000|Overall Study|Lack of Efficacy|1|||
164491446|NCT02446912|594169926|FG001|Overall Study|Lack of Efficacy|4|||
164491447|NCT02446912|594169927|FG002|Overall Study|Lack of Efficacy|7|||
164491448|NCT02446912|594169925|FG000|Overall Study|Lost to Follow-up|0|||
164491449|NCT02446912|594169926|FG001|Overall Study|Lost to Follow-up|0|||
164491450|NCT02446912|594169927|FG002|Overall Study|Lost to Follow-up|2|||
164491451|NCT02446912|594169925|FG000|Overall Study|Severe non-compliance to protocol|1|||
164491452|NCT02446912|594169926|FG001|Overall Study|Severe non-compliance to protocol|0|||
164491453|NCT02446912|594169927|FG002|Overall Study|Severe non-compliance to protocol|1|||
164491454|NCT02446912|594169925|FG000|Overall Study|Withdrawal by Subject|10|||
164491455|NCT02446912|594169926|FG001|Overall Study|Withdrawal by Subject|15|||
164491456|NCT02446912|594169927|FG002|Overall Study|Withdrawal by Subject|15|||
164491457|NCT02446912|594169925|FG000|Overall Study|Miscellaneous|2|||
164491458|NCT02446912|594169926|FG001|Overall Study|Miscellaneous|2|||
164491459|NCT02446912|594169927|FG002|Overall Study|Miscellaneous|4|||
164491460|NCT01268488|594169928|FG000|Overall Study|Adverse Event|3|||
164491461|NCT01268488|594169928|FG000|Overall Study|Physician Decision|2|||
164491462|NCT00442559|594169929|FG000|Overall Study|Lost to Follow-up|32|||
164491463|NCT00442559|594169930|FG001|Overall Study|Lost to Follow-up|34|||
164491464|NCT00442559|594169929|FG000|Overall Study|Protocol Violation|1|||
164491465|NCT00442559|594169930|FG001|Overall Study|Protocol Violation|1|||
164491466|NCT00442559|594169929|FG000|Overall Study|Withdrawal by Subject|1|||
164491467|NCT00442559|594169930|FG001|Overall Study|Withdrawal by Subject|0|||
164491468|NCT03508830|594169931|FG000|Overall Study|Withdrawal by Subject|3|||
164491469|NCT03508830|594169932|FG001|Overall Study|Withdrawal by Subject|4|||
164491470|NCT03508830|594169931|FG000|Overall Study|Physician Decision|2|||
164491471|NCT03508830|594169932|FG001|Overall Study|Physician Decision|2|||
164491472|NCT03906240|594169933|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
164491473|NCT03906240|594169934|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
164491474|NCT03906240|594169933|FG000|Overall Study|Lost to Follow-up|1|||
164491475|NCT03906240|594169934|FG001|Overall Study|Lost to Follow-up|0|||
164491476|NCT03906240|594169933|FG000|Overall Study|Withdrawal by Subject|0|||
164491477|NCT03906240|594169934|FG001|Overall Study|Withdrawal by Subject|1|||
164491478|NCT03575572|594169935|FG000|Overall Study|Withdrawal by Subject|2|||
164491479|NCT03575572|594169935|FG000|Overall Study|Physician Decision|2|||
164491480|NCT04908800|594169936|FG000|Overall Study|Adverse Event|0|||
164491481|NCT04908800|594169937|FG001|Overall Study|Adverse Event|0|||
164491482|NCT04908800|594169938|FG002|Overall Study|Adverse Event|0|||
164491483|NCT04908800|594169939|FG003|Overall Study|Adverse Event|0|||
164491484|NCT04908800|594169940|FG004|Overall Study|Adverse Event|0|||
164491485|NCT04908800|594169941|FG005|Overall Study|Adverse Event|0|||
164491486|NCT04908800|594169942|FG006|Overall Study|Adverse Event|0|||
164491487|NCT04908800|594169943|FG007|Overall Study|Adverse Event|0|||
164491488|NCT04908800|594169944|FG008|Overall Study|Adverse Event|0|||
164491489|NCT04908800|594169945|FG009|Overall Study|Adverse Event|0|||
164602528|NCT01153893|594564855|FG000|Overall Study|Adverse Event|1|||
164602529|NCT01153893|594564856|FG001|Overall Study|Adverse Event|0|||
164602530|NCT02998554|594564859|FG000|Overall Study|Adverse Event|8|||
164602531|NCT02998554|594564860|FG001|Overall Study|Adverse Event|3|||
164602532|NCT02998554|594564859|FG000|Overall Study|Protocol deviation|1|||
164602533|NCT02998554|594564860|FG001|Overall Study|Protocol deviation|0|||
164602534|NCT02998554|594564859|FG000|Overall Study|Withdrawal by Subject|2|||
164602535|NCT02998554|594564860|FG001|Overall Study|Withdrawal by Subject|6|||
164602536|NCT02998554|594564859|FG000|Overall Study|Lost to Follow-up|0|||
164602537|NCT02998554|594564860|FG001|Overall Study|Lost to Follow-up|1|||
164602538|NCT02998554|594564859|FG000|Overall Study|Lack of Efficacy|0|||
164602539|NCT02998554|594564860|FG001|Overall Study|Lack of Efficacy|1|||
164602540|NCT01778127|594564861|FG000|Overall Study|Lost to Follow-up|5|||
164602541|NCT01778127|594564862|FG001|Overall Study|Lost to Follow-up|1|||
164602542|NCT01778127|594564863|FG002|Overall Study|Lost to Follow-up|2|||
164602543|NCT01778127|594564861|FG000|Overall Study|Withdrawal by Subject|3|||
164602544|NCT01778127|594564862|FG001|Overall Study|Withdrawal by Subject|1|||
164602545|NCT01778127|594564863|FG002|Overall Study|Withdrawal by Subject|4|||
164602546|NCT01348425|594564869|FG000|Overall Study|Imaging was not taken.|1|||
164602547|NCT01348425|594564870|FG001|Overall Study|Imaging was not taken.|1|||
164714900|NCT00090363|594978829|FG002|Overall Study|Continuing on study off treatment|16|||
164714901|NCT04642365|594978831|FG000|Overall Study|Death|3|||
164714902|NCT04642365|594978832|FG001|Overall Study|Death|2|||
164714903|NCT04642365|594978833|FG002|Overall Study|Death|4|||
164714904|NCT04642365|594978834|FG003|Overall Study|Death|5|||
164714905|NCT04642365|594978835|FG004|Overall Study|Death|5|||
164491490|NCT04908800|594169946|FG010|Overall Study|Adverse Event|1|||
164491491|NCT04908800|594169947|FG011|Overall Study|Adverse Event|0|||
164491492|NCT04908800|594169948|FG012|Overall Study|Adverse Event|0|||
164491493|NCT02162771|594169949|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
164491494|NCT02162771|594169950|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
164491495|NCT02162771|594169949|FG000|Core Study Period (Part 2)|Adverse Event|4|||
164491496|NCT02162771|594169950|FG001|Core Study Period (Part 2)|Adverse Event|1|||
164491497|NCT02162771|594169949|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
164491498|NCT02162771|594169950|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
164491499|NCT02162771|594169949|FG000|Core Study Period (Part 2)|Physician Decision|0|||
164491500|NCT02162771|594169950|FG001|Core Study Period (Part 2)|Physician Decision|2|||
164491501|NCT02162771|594169949|FG000|Core Study Period (Part 2)|Death|1|||
164491502|NCT02162771|594169950|FG001|Core Study Period (Part 2)|Death|0|||
164491503|NCT02162771|594169949|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
164491504|NCT02162771|594169950|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
164491505|NCT02162771|594169949|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
164491506|NCT02162771|594169950|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
164491507|NCT02162771|594169949|FG000|Maintenance Study Period (Part 2)|Death|2|||
164491508|NCT02162771|594169950|FG001|Maintenance Study Period (Part 2)|Death|1|||
164491509|NCT02162771|594169949|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
164491510|NCT02162771|594169950|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
164491511|NCT02162771|594169949|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
164491512|NCT02162771|594169950|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
164491513|NCT02162771|594169949|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
164491514|NCT02162771|594169950|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
164491515|NCT01047306|594169951|FG000|Overall Study|Withdrawal by Subject|2|||
164491516|NCT01047306|594169952|FG001|Overall Study|Withdrawal by Subject|0|||
164491517|NCT01047306|594169951|FG000|Overall Study|Lost to Follow-up|1|||
164491518|NCT01047306|594169952|FG001|Overall Study|Lost to Follow-up|0|||
164491519|NCT03647709|594169954|FG000|Overall Study|Lost to Follow-up|5|||
164491520|NCT03647709|594169954|FG000|Overall Study|Physician Decision|6|||
164491521|NCT03647709|594169954|FG000|Overall Study|Withdrawal by Subject|3|||
164491522|NCT05287178|594169955|FG000|Overall Study|Lost to Follow-up|2|||
164491523|NCT01426217|594169956|FG000|Overall Study|lost sample|8|||
164491524|NCT01426217|594169957|FG001|Overall Study|lost sample|14|||
164491525|NCT01920178|594169958|FG000|Overall Study|Lost to Follow-up|2|||
164602548|NCT01968954|594564877|FG000|Overall Study|Adverse Event|6|||
164602549|NCT01968954|594564878|FG001|Overall Study|Adverse Event|3|||
164714906|NCT04642365|594978836|FG005|Overall Study|Death|3|||
164602550|NCT01968954|594564877|FG000|Overall Study|Death|1|||
164714907|NCT04642365|594978837|FG006|Overall Study|Death|2|||
164714908|NCT04642365|594978838|FG007|Overall Study|Death|1|||
164491526|NCT01920178|594169959|FG001|Overall Study|Lost to Follow-up|1|||
164491527|NCT03023878|594169960|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
164491528|NCT03023878|594169960|FG000|Pre-Study Run-In Period|Death|1|||
164602551|NCT01968954|594564878|FG001|Overall Study|Death|2|||
164602552|NCT01968954|594564877|FG000|Overall Study|Lost to Follow-up|6|||
164602553|NCT01968954|594564878|FG001|Overall Study|Lost to Follow-up|4|||
164714909|NCT04642365|594978831|FG000|Overall Study|Physician Decision|1|||
164602554|NCT01968954|594564877|FG000|Overall Study|Withdrawal by Subject|20|||
164602555|NCT01968954|594564878|FG001|Overall Study|Withdrawal by Subject|23|||
164602556|NCT01968954|594564877|FG000|Overall Study|Other|7|||
164602557|NCT01968954|594564878|FG001|Overall Study|Other|8|||
164602558|NCT01968954|594564877|FG000|Overall Study|Protocol Violation|0|||
164602559|NCT01968954|594564878|FG001|Overall Study|Protocol Violation|1|||
164602560|NCT01968954|594564877|FG000|Overall Study|Did not met inclusion criteria|0|||
164602561|NCT01968954|594564878|FG001|Overall Study|Did not met inclusion criteria|2|||
164602562|NCT00645567|594564879|FG000|Overall Study|Adverse Event|1|||
164602563|NCT00255086|594564885|FG000|Overall Study|Adverse Event|1|||
164602564|NCT00255086|594564886|FG001|Overall Study|Adverse Event|1|||
164602565|NCT00255086|594564885|FG000|Overall Study|Protocol Violation|1|||
164602566|NCT00255086|594564886|FG001|Overall Study|Protocol Violation|1|||
164602567|NCT01208038|594564889|FG000|Overall Study|Withdrawal by Subject|1|||
164602568|NCT01337167|594567055|FG000|Infant Series|Adverse Event|1|||
164602569|NCT01337167|594567056|FG001|Infant Series|Adverse Event|1|||
164602570|NCT01337167|594567055|FG000|Infant Series|Death|1|||
164602571|NCT01337167|594567056|FG001|Infant Series|Death|1|||
164602572|NCT01337167|594567055|FG000|Infant Series|Lost to Follow-up|13|||
164602573|NCT01337167|594567056|FG001|Infant Series|Lost to Follow-up|7|||
164602574|NCT01337167|594567055|FG000|Infant Series|Non-compliance with study drug|2|||
164602575|NCT01337167|594567056|FG001|Infant Series|Non-compliance with study drug|1|||
164602576|NCT01337167|594567055|FG000|Infant Series|Physician Decision|3|||
164602577|NCT01337167|594567056|FG001|Infant Series|Physician Decision|1|||
164602578|NCT01337167|594567055|FG000|Infant Series|Protocol Violation|22|||
164602579|NCT01337167|594567056|FG001|Infant Series|Protocol Violation|9|||
164602580|NCT01337167|594567055|FG000|Infant Series|Withdrawal by Subject|15|||
164602581|NCT01337167|594567056|FG001|Infant Series|Withdrawal by Subject|4|||
164602582|NCT01337167|594567055|FG000|Infant Series|Randomized but not vaccinated|5|||
164602583|NCT01337167|594567056|FG001|Infant Series|Randomized but not vaccinated|3|||
164602584|NCT01337167|594567055|FG000|Interim Period|Lost to Follow-up|51|||
164602585|NCT01337167|594567056|FG001|Interim Period|Lost to Follow-up|23|||
164602586|NCT01337167|594567055|FG000|Interim Period|Non-compliance with study drug|1|||
164602587|NCT01337167|594567056|FG001|Interim Period|Non-compliance with study drug|0|||
164602588|NCT01337167|594567055|FG000|Interim Period|Physician Decision|6|||
164602589|NCT01337167|594567056|FG001|Interim Period|Physician Decision|3|||
164602590|NCT01337167|594567055|FG000|Interim Period|Protocol Violation|5|||
164602591|NCT01337167|594567056|FG001|Interim Period|Protocol Violation|3|||
164602592|NCT01337167|594567055|FG000|Interim Period|Withdrawal by Subject|18|||
164602593|NCT01337167|594567056|FG001|Interim Period|Withdrawal by Subject|10|||
164602594|NCT01337167|594567055|FG000|Interim Period|Other protocol criterion not met|0|||
164602595|NCT01337167|594567056|FG001|Interim Period|Other protocol criterion not met|1|||
164602596|NCT01337167|594567055|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
164714910|NCT04642365|594978832|FG001|Overall Study|Physician Decision|0|||
164714911|NCT04642365|594978833|FG002|Overall Study|Physician Decision|0|||
164714912|NCT04642365|594978834|FG003|Overall Study|Physician Decision|0|||
164714913|NCT04642365|594978835|FG004|Overall Study|Physician Decision|0|||
164714914|NCT04642365|594978836|FG005|Overall Study|Physician Decision|0|||
164714915|NCT04642365|594978837|FG006|Overall Study|Physician Decision|0|||
164714916|NCT04642365|594978838|FG007|Overall Study|Physician Decision|0|||
164714917|NCT04642365|594978831|FG000|Overall Study|Progressive Disease|1|||
164714918|NCT04642365|594978832|FG001|Overall Study|Progressive Disease|1|||
164714919|NCT04642365|594978833|FG002|Overall Study|Progressive Disease|1|||
164714920|NCT04642365|594978834|FG003|Overall Study|Progressive Disease|0|||
164714921|NCT04642365|594978835|FG004|Overall Study|Progressive Disease|0|||
164714922|NCT04642365|594978836|FG005|Overall Study|Progressive Disease|0|||
164714923|NCT04642365|594978837|FG006|Overall Study|Progressive Disease|1|||
164714924|NCT04642365|594978838|FG007|Overall Study|Progressive Disease|0|||
164714925|NCT04642365|594978831|FG000|Overall Study|Study Terminated By Sponsor|0|||
164714926|NCT04642365|594978832|FG001|Overall Study|Study Terminated By Sponsor|2|||
164714927|NCT04642365|594978833|FG002|Overall Study|Study Terminated By Sponsor|1|||
164714928|NCT04642365|594978834|FG003|Overall Study|Study Terminated By Sponsor|1|||
164714929|NCT04642365|594978835|FG004|Overall Study|Study Terminated By Sponsor|1|||
164714930|NCT04642365|594978836|FG005|Overall Study|Study Terminated By Sponsor|2|||
164714931|NCT04642365|594978837|FG006|Overall Study|Study Terminated By Sponsor|2|||
164714932|NCT04642365|594978838|FG007|Overall Study|Study Terminated By Sponsor|1|||
164714933|NCT04642365|594978831|FG000|Overall Study|Symptomatic Deterioration|1|||
164602597|NCT01337167|594567056|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
164602598|NCT01337167|594567055|FG000|Toddler Vaccinations|Protocol Violation|0|||
164602599|NCT01337167|594567056|FG001|Toddler Vaccinations|Protocol Violation|1|||
164602600|NCT01337167|594567055|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
164602601|NCT01337167|594567056|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
164602602|NCT02126670|594567057|FG000|Overall Study|Withdrawal by Subject|1|||
164602603|NCT02126670|594567058|FG001|Overall Study|Withdrawal by Subject|0|||
164602604|NCT02126670|594567059|FG002|Overall Study|Withdrawal by Subject|0|||
164602605|NCT02126670|594567060|FG003|Overall Study|Withdrawal by Subject|1|||
164602606|NCT01646398|594567061|FG000|Overall Study|Withdrawal by Subject|1|||
164714934|NCT04642365|594978832|FG001|Overall Study|Symptomatic Deterioration|1|||
164491529|NCT03023878|594169960|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
164491530|NCT03023878|594169960|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
164491531|NCT03023878|594169960|FG000|Treatment Period|Disease Progression|1|||
164491532|NCT03023878|594169960|FG000|Treatment Period|Withdrawal by Subject|1|||
164491533|NCT03023878|594169960|FG000|Treatment Period|Adverse Event|1|||
164491534|NCT03023878|594169960|FG000|Long Term Follow-Up Period|Death|2|||
164491535|NCT05234632|594169961|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
164491536|NCT05234632|594169962|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
164491537|NCT05234632|594169961|FG000|Overall Study|Withdrawal by Subject|2|||
164491538|NCT05234632|594169962|FG001|Overall Study|Withdrawal by Subject|0|||
164491539|NCT05234632|594169961|FG000|Overall Study|Adverse Event|0|||
164491540|NCT05234632|594169962|FG001|Overall Study|Adverse Event|4|||
164491541|NCT05234632|594169961|FG000|Overall Study|Physician Decision|1|||
164491542|NCT05234632|594169962|FG001|Overall Study|Physician Decision|1|||
164491543|NCT05234632|594169961|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
164491544|NCT05234632|594169962|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
164491545|NCT05234632|594169961|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
164491546|NCT05234632|594169962|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
164491547|NCT04799587|594169963|FG000|Overall Study|Withdrawal by Subject|0|||
164491548|NCT04799587|594169964|FG001|Overall Study|Withdrawal by Subject|1|||
164491549|NCT00728884|594169965|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
164491550|NCT00728884|594169965|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
164491551|NCT05216835|594169967|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
164491552|NCT05216835|594169968|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
164491553|NCT05216835|594169969|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
164491554|NCT05216835|594169970|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
164491555|NCT05216835|594169971|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
164491556|NCT05216835|594169972|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
164491557|NCT05216835|594169973|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
164491558|NCT05216835|594169974|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
164491559|NCT05216835|594169967|FG000|Overall Study|Death|0|||
164491560|NCT05216835|594169968|FG001|Overall Study|Death|0|||
164491561|NCT05216835|594169969|FG002|Overall Study|Death|0|||
164491562|NCT05216835|594169970|FG003|Overall Study|Death|1|||
164491563|NCT05216835|594169971|FG004|Overall Study|Death|1|||
164491564|NCT05216835|594169972|FG005|Overall Study|Death|1|||
164491565|NCT05216835|594169973|FG006|Overall Study|Death|1|||
164491566|NCT05216835|594169974|FG007|Overall Study|Death|1|||
164491567|NCT05216835|594169967|FG000|Overall Study|Physician Decision|0|||
164491568|NCT05216835|594169968|FG001|Overall Study|Physician Decision|0|||
164491569|NCT05216835|594169969|FG002|Overall Study|Physician Decision|0|||
164491570|NCT05216835|594169970|FG003|Overall Study|Physician Decision|0|||
164491571|NCT05216835|594169971|FG004|Overall Study|Physician Decision|0|||
164491572|NCT05216835|594169972|FG005|Overall Study|Physician Decision|1|||
164491573|NCT05216835|594169973|FG006|Overall Study|Physician Decision|1|||
164491574|NCT05216835|594169974|FG007|Overall Study|Physician Decision|0|||
164491575|NCT05216835|594169967|FG000|Overall Study|Study terminated by Sponsor|0|||
164491576|NCT05216835|594169968|FG001|Overall Study|Study terminated by Sponsor|0|||
164491577|NCT05216835|594169969|FG002|Overall Study|Study terminated by Sponsor|0|||
164491578|NCT05216835|594169970|FG003|Overall Study|Study terminated by Sponsor|0|||
164491579|NCT05216835|594169971|FG004|Overall Study|Study terminated by Sponsor|0|||
164491580|NCT05216835|594169972|FG005|Overall Study|Study terminated by Sponsor|0|||
164491581|NCT05216835|594169973|FG006|Overall Study|Study terminated by Sponsor|0|||
164491582|NCT05216835|594169974|FG007|Overall Study|Study terminated by Sponsor|1|||
164491583|NCT05216835|594169967|FG000|Overall Study|Withdrawal by Subject|1|||
164491584|NCT05216835|594169968|FG001|Overall Study|Withdrawal by Subject|0|||
164491585|NCT05216835|594169969|FG002|Overall Study|Withdrawal by Subject|1|||
164491586|NCT05216835|594169970|FG003|Overall Study|Withdrawal by Subject|0|||
164491587|NCT05216835|594169971|FG004|Overall Study|Withdrawal by Subject|1|||
164491588|NCT05216835|594169972|FG005|Overall Study|Withdrawal by Subject|0|||
164491589|NCT05216835|594169973|FG006|Overall Study|Withdrawal by Subject|0|||
164491590|NCT05216835|594169974|FG007|Overall Study|Withdrawal by Subject|1|||
164491591|NCT05216835|594169967|FG000|Overall Study|Other|0|||
164491592|NCT05216835|594169968|FG001|Overall Study|Other|1|||
164491593|NCT05216835|594169969|FG002|Overall Study|Other|0|||
164491594|NCT05216835|594169970|FG003|Overall Study|Other|0|||
164491595|NCT05216835|594169971|FG004|Overall Study|Other|0|||
164491596|NCT05216835|594169972|FG005|Overall Study|Other|0|||
164491597|NCT05216835|594169973|FG006|Overall Study|Other|0|||
164491598|NCT05216835|594169974|FG007|Overall Study|Other|0|||
164491599|NCT02849509|594169975|FG000|Overall Study|Worsening of disease under study|1|||
164491600|NCT02849509|594169976|FG001|Overall Study|Worsening of disease under study|1|||
164491601|NCT02849509|594169977|FG002|Overall Study|Worsening of disease under study|1|||
164491602|NCT02849509|594169975|FG000|Overall Study|Worsening of other pre-existing disease|0|||
164491603|NCT02849509|594169976|FG001|Overall Study|Worsening of other pre-existing disease|1|||
164491604|NCT02849509|594169977|FG002|Overall Study|Worsening of other pre-existing disease|2|||
164491605|NCT02849509|594169975|FG000|Overall Study|Other adverse event|36|||
164491606|NCT02849509|594169976|FG001|Overall Study|Other adverse event|41|||
164491607|NCT02849509|594169977|FG002|Overall Study|Other adverse event|8|||
164491608|NCT02849509|594169975|FG000|Overall Study|Withdrawal by Subject|6|||
164491609|NCT02849509|594169976|FG001|Overall Study|Withdrawal by Subject|17|||
164491610|NCT02849509|594169977|FG002|Overall Study|Withdrawal by Subject|12|||
164491611|NCT02849509|594169975|FG000|Overall Study|Lost to Follow-up|27|||
164491612|NCT02849509|594169976|FG001|Overall Study|Lost to Follow-up|67|||
164491613|NCT02849509|594169977|FG002|Overall Study|Lost to Follow-up|36|||
164491614|NCT02849509|594169975|FG000|Overall Study|Other, reason not specified|14|||
164491615|NCT02849509|594169976|FG001|Overall Study|Other, reason not specified|29|||
164491616|NCT02849509|594169977|FG002|Overall Study|Other, reason not specified|25|||
164491617|NCT02849509|594169975|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
164491618|NCT02849509|594169976|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
164491619|NCT02849509|594169977|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
164491620|NCT04930445|594169978|FG000|Overall Study|Adverse Event|7|||
164491621|NCT04930445|594169978|FG000|Overall Study|Lost to Follow-up|1|||
164491622|NCT04930445|594169978|FG000|Overall Study|Physician Decision|1|||
164491623|NCT04930445|594169978|FG000|Overall Study|Lack of Efficacy|1|||
164491624|NCT04930445|594169978|FG000|Overall Study|Study Terminated by Sponsor|245|||
164491625|NCT04930445|594169978|FG000|Overall Study|Screen Failure|8|||
164491626|NCT04930445|594169978|FG000|Overall Study|Other|2|||
164491627|NCT00975130|594169979|FG000|Study Part 1|Adverse Event|150|||
164491628|NCT00975130|594169980|FG001|Study Part 1|Adverse Event|0|||
164491629|NCT00975130|594169981|FG002|Study Part 1|Adverse Event|0|||
164491630|NCT00975130|594169979|FG000|Study Part 1|Lost to Follow-up|19|||
164491631|NCT00975130|594169980|FG001|Study Part 1|Lost to Follow-up|0|||
164491632|NCT00975130|594169981|FG002|Study Part 1|Lost to Follow-up|0|||
164491633|NCT00975130|594169979|FG000|Study Part 1|Withdrawal by Subject|61|||
164491634|NCT00975130|594169980|FG001|Study Part 1|Withdrawal by Subject|0|||
164491635|NCT00975130|594169981|FG002|Study Part 1|Withdrawal by Subject|0|||
164491636|NCT00975130|594169979|FG000|Study Part 1|Protocol Violation|13|||
164491637|NCT00975130|594169980|FG001|Study Part 1|Protocol Violation|0|||
164491638|NCT00975130|594169981|FG002|Study Part 1|Protocol Violation|0|||
164491639|NCT00975130|594169979|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
164491640|NCT00975130|594169980|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
164491641|NCT00975130|594169981|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
164491642|NCT00975130|594169979|FG000|Study Part 1|Administrative|4|||
164491643|NCT00975130|594169980|FG001|Study Part 1|Administrative|0|||
164491644|NCT00975130|594169981|FG002|Study Part 1|Administrative|0|||
164491645|NCT00975130|594169979|FG000|Study Part 1|Withdrew Consent|24|||
164491646|NCT00975130|594169980|FG001|Study Part 1|Withdrew Consent|0|||
164491647|NCT00975130|594169981|FG002|Study Part 1|Withdrew Consent|0|||
164491648|NCT00975130|594169979|FG000|Study Part 2|Adverse Event|0|||
164491649|NCT00975130|594169980|FG001|Study Part 2|Adverse Event|14|||
164491650|NCT00975130|594169981|FG002|Study Part 2|Adverse Event|7|||
164491651|NCT00975130|594169979|FG000|Study Part 2|Lost to Follow-up|0|||
164602607|NCT01646398|594567062|FG001|Overall Study|Withdrawal by Subject|0|||
164602608|NCT00424346|594567063|FG000|Core Study|Adverse Event|5|||
164602609|NCT00424346|594567064|FG001|Core Study|Adverse Event|3|||
164602610|NCT00424346|594567065|FG002|Core Study|Adverse Event|1|||
164491652|NCT00975130|594169980|FG001|Study Part 2|Lost to Follow-up|0|||
164491653|NCT00975130|594169981|FG002|Study Part 2|Lost to Follow-up|1|||
164491654|NCT00975130|594169979|FG000|Study Part 2|Withdrawal by Subject|0|||
164491655|NCT00975130|594169980|FG001|Study Part 2|Withdrawal by Subject|13|||
164491656|NCT00975130|594169981|FG002|Study Part 2|Withdrawal by Subject|5|||
164491657|NCT00975130|594169979|FG000|Study Part 2|Withdrew Consent|0|||
164491658|NCT00975130|594169980|FG001|Study Part 2|Withdrew Consent|6|||
164491659|NCT00975130|594169981|FG002|Study Part 2|Withdrew Consent|2|||
164491660|NCT00975130|594169979|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
164491661|NCT00975130|594169980|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
164491662|NCT00975130|594169981|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
164491663|NCT00975130|594169979|FG000|Study Part 2|Administrative|0|||
164491664|NCT00975130|594169980|FG001|Study Part 2|Administrative|1|||
164491665|NCT00975130|594169981|FG002|Study Part 2|Administrative|0|||
164491666|NCT00975130|594169979|FG000|Study Part 2|Protocol Violation|0|||
164491667|NCT00975130|594169980|FG001|Study Part 2|Protocol Violation|0|||
164491668|NCT00975130|594169981|FG002|Study Part 2|Protocol Violation|1|||
164491669|NCT01075815|594169982|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
164491670|NCT01075815|594169983|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
164602611|NCT00424346|594567066|FG003|Core Study|Adverse Event|1|||
164602612|NCT00424346|594567063|FG000|Core Study|Abnormal Laboratory Values|0|||
164602613|NCT00424346|594567064|FG001|Core Study|Abnormal Laboratory Values|1|||
164602614|NCT00424346|594567065|FG002|Core Study|Abnormal Laboratory Values|0|||
164602615|NCT00424346|594567066|FG003|Core Study|Abnormal Laboratory Values|0|||
164602616|NCT00424346|594567063|FG000|Core Study|Lack of Efficacy|1|||
164602617|NCT00424346|594567064|FG001|Core Study|Lack of Efficacy|3|||
164602618|NCT00424346|594567065|FG002|Core Study|Lack of Efficacy|0|||
164602619|NCT00424346|594567066|FG003|Core Study|Lack of Efficacy|4|||
164602620|NCT00424346|594567063|FG000|Core Study|Withdrawal by Subject|1|||
164602621|NCT00424346|594567064|FG001|Core Study|Withdrawal by Subject|0|||
164602622|NCT00424346|594567065|FG002|Core Study|Withdrawal by Subject|0|||
164602623|NCT00424346|594567066|FG003|Core Study|Withdrawal by Subject|2|||
164602624|NCT00424346|594567063|FG000|Core Study|Lost to Follow-up|1|||
164602625|NCT00424346|594567064|FG001|Core Study|Lost to Follow-up|1|||
164602626|NCT00424346|594567065|FG002|Core Study|Lost to Follow-up|0|||
164602627|NCT00424346|594567066|FG003|Core Study|Lost to Follow-up|0|||
164602628|NCT00424346|594567063|FG000|Core Study|Administrative Problems|1|||
164491671|NCT01075815|594169982|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
164491672|NCT01075815|594169983|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
164491673|NCT01075815|594169982|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
164491674|NCT01075815|594169983|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
164491675|NCT00617708|594169984|FG000|Overall Study|Adverse Event|0|||
164491676|NCT00617708|594169985|FG001|Overall Study|Adverse Event|6|||
164491677|NCT00617708|594169986|FG002|Overall Study|Adverse Event|9|||
164491678|NCT00617708|594169984|FG000|Overall Study|Withdrawal by Subject|1|||
164491679|NCT00617708|594169985|FG001|Overall Study|Withdrawal by Subject|1|||
164491680|NCT00617708|594169986|FG002|Overall Study|Withdrawal by Subject|7|||
164491681|NCT00617708|594169984|FG000|Overall Study|Death|0|||
164491682|NCT00617708|594169985|FG001|Overall Study|Death|6|||
164491683|NCT00617708|594169986|FG002|Overall Study|Death|5|||
164491684|NCT00617708|594169984|FG000|Overall Study|Progression/Relapse|7|||
164491685|NCT00617708|594169985|FG001|Overall Study|Progression/Relapse|40|||
164491686|NCT00617708|594169986|FG002|Overall Study|Progression/Relapse|36|||
164491687|NCT00617708|594169984|FG000|Overall Study|Not protocol specified|1|||
164491688|NCT00617708|594169985|FG001|Overall Study|Not protocol specified|4|||
164491689|NCT00617708|594169986|FG002|Overall Study|Not protocol specified|2|||
164491690|NCT00617708|594169984|FG000|Overall Study|Not eligible|1|||
164491691|NCT00617708|594169985|FG001|Overall Study|Not eligible|3|||
164491692|NCT00617708|594169986|FG002|Overall Study|Not eligible|5|||
164491693|NCT01261793|594169993|FG000|Overall Study|Lack of Efficacy|44|||
164491694|NCT01261793|594169994|FG001|Overall Study|Lack of Efficacy|37|||
164491695|NCT01261793|594169995|FG002|Overall Study|Lack of Efficacy|32|||
164491696|NCT01261793|594169993|FG000|Overall Study|Protocol Violation|3|||
164491697|NCT01261793|594169994|FG001|Overall Study|Protocol Violation|5|||
164491698|NCT01261793|594169995|FG002|Overall Study|Protocol Violation|6|||
164491699|NCT01261793|594169993|FG000|Overall Study|Lost to Follow-up|10|||
164491700|NCT01261793|594169994|FG001|Overall Study|Lost to Follow-up|3|||
164491701|NCT01261793|594169995|FG002|Overall Study|Lost to Follow-up|7|||
164491702|NCT01261793|594169993|FG000|Overall Study|Withdrawal by Subject|12|||
164491703|NCT01261793|594169994|FG001|Overall Study|Withdrawal by Subject|14|||
164491704|NCT01261793|594169995|FG002|Overall Study|Withdrawal by Subject|14|||
164491705|NCT01261793|594169993|FG000|Overall Study|Death|3|||
164491706|NCT01261793|594169994|FG001|Overall Study|Death|1|||
164491707|NCT01261793|594169995|FG002|Overall Study|Death|0|||
164491708|NCT01261793|594169993|FG000|Overall Study|Adverse Event|9|||
164491709|NCT01261793|594169994|FG001|Overall Study|Adverse Event|24|||
164491710|NCT01261793|594169995|FG002|Overall Study|Adverse Event|19|||
164491711|NCT01261793|594169993|FG000|Overall Study|Patient non-availability|1|||
164491712|NCT01261793|594169994|FG001|Overall Study|Patient non-availability|1|||
164491713|NCT01261793|594169995|FG002|Overall Study|Patient non-availability|1|||
164491714|NCT01261793|594169993|FG000|Overall Study|Suspected pregnancy|1|||
164491715|NCT01261793|594169994|FG001|Overall Study|Suspected pregnancy|1|||
164491716|NCT01261793|594169995|FG002|Overall Study|Suspected pregnancy|0|||
164491717|NCT01261793|594169993|FG000|Overall Study|Patient non-compliance|1|||
164491718|NCT01261793|594169994|FG001|Overall Study|Patient non-compliance|0|||
164491719|NCT01261793|594169995|FG002|Overall Study|Patient non-compliance|1|||
164491720|NCT01261793|594169993|FG000|Overall Study|Patient pregnant|1|||
164491721|NCT01261793|594169994|FG001|Overall Study|Patient pregnant|0|||
164491722|NCT01261793|594169995|FG002|Overall Study|Patient pregnant|0|||
164491723|NCT01261793|594169993|FG000|Overall Study|Outside the study area|0|||
164491724|NCT01261793|594169994|FG001|Overall Study|Outside the study area|2|||
164491725|NCT01261793|594169995|FG002|Overall Study|Outside the study area|1|||
164491726|NCT01261793|594169993|FG000|Overall Study|Lack of efficacy & patient not available|0|||
164491727|NCT01261793|594169994|FG001|Overall Study|Lack of efficacy & patient not available|1|||
164491728|NCT01261793|594169995|FG002|Overall Study|Lack of efficacy & patient not available|0|||
164491729|NCT01261793|594169993|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
164491730|NCT01261793|594169994|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
164491731|NCT01261793|594169995|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
164491732|NCT01261793|594169993|FG000|Overall Study|Randomization error|0|||
164491733|NCT01261793|594169994|FG001|Overall Study|Randomization error|1|||
164491734|NCT01261793|594169995|FG002|Overall Study|Randomization error|0|||
164602629|NCT00424346|594567064|FG001|Core Study|Administrative Problems|0|||
164602630|NCT00424346|594567065|FG002|Core Study|Administrative Problems|1|||
164602631|NCT00424346|594567066|FG003|Core Study|Administrative Problems|0|||
164491735|NCT01261793|594169993|FG000|Overall Study|Patient unable to start IV line|0|||
164491736|NCT01261793|594169994|FG001|Overall Study|Patient unable to start IV line|0|||
164491737|NCT01261793|594169995|FG002|Overall Study|Patient unable to start IV line|1|||
164491738|NCT02374476|594169998|FG000|VT Induced Ablation|Screening Failures|36|||
164491739|NCT02374476|594169999|FG001|VT Induced Ablation|Screening Failures|0|||
164491740|NCT02374476|594170000|FG002|VT Induced Ablation|Screening Failures|0|||
164491741|NCT02374476|594169998|FG000|Arm Assignment|Withdrawal by Subject|0|||
164491742|NCT02374476|594169999|FG001|Arm Assignment|Withdrawal by Subject|0|||
164491743|NCT02374476|594170000|FG002|Arm Assignment|Withdrawal by Subject|1|||
164491744|NCT05431543|594170003|FG000|Overall Study|Medical History|1|||
164491745|NCT05431543|594170004|FG001|Overall Study|Medical History|0|||
164491746|NCT05431543|594170005|FG002|Overall Study|Medical History|0|||
164491747|NCT02924051|594170006|FG000|Overall Study|Withdrawal by Subject|1|||
164491748|NCT02924051|594170007|FG001|Overall Study|Withdrawal by Subject|9|||
164491749|NCT02784535|594170008|FG000|Overall Study|Adverse Event|1|||
164491750|NCT02784535|594170009|FG001|Overall Study|Adverse Event|0|||
164491751|NCT02784535|594170008|FG000|Overall Study|Withdrawal by Subject|0|||
164491752|NCT02784535|594170009|FG001|Overall Study|Withdrawal by Subject|1|||
164491753|NCT02784535|594170008|FG000|Overall Study|Physician Decision|0|||
164491754|NCT02784535|594170009|FG001|Overall Study|Physician Decision|1|||
164491755|NCT00914732|594170010|FG000|Overall Study|Lost to Follow-up|6|||
164491756|NCT00914732|594170011|FG001|Overall Study|Lost to Follow-up|7|||
164491757|NCT00914732|594170012|FG002|Overall Study|Lost to Follow-up|9|||
164491758|NCT00914732|594170010|FG000|Overall Study|Withdrawal by Subject|3|||
164491759|NCT00914732|594170011|FG001|Overall Study|Withdrawal by Subject|0|||
164491760|NCT00914732|594170012|FG002|Overall Study|Withdrawal by Subject|2|||
164491761|NCT00914732|594170010|FG000|Overall Study|Adverse Event|1|||
164491762|NCT00914732|594170011|FG001|Overall Study|Adverse Event|0|||
164491763|NCT00914732|594170012|FG002|Overall Study|Adverse Event|0|||
164491764|NCT02130401|594170013|FG000|Overall Study|Poor enrollment|6|||
164491765|NCT03005106|594170014|FG000|Overall Study|Lost to Follow-up|16|||
164491766|NCT03005106|594170014|FG000|Overall Study|Adverse Event|1|||
164491767|NCT03005106|594170014|FG000|Overall Study|Physician Decision|1|||
164491768|NCT03005106|594170014|FG000|Overall Study|Death|2|||
164491769|NCT00321672|594170017|FG000|Overall Study|Withdrawal by Subject|5|||
164491770|NCT00321672|594170018|FG001|Overall Study|Withdrawal by Subject|1|||
164491771|NCT00321672|594170019|FG002|Overall Study|Withdrawal by Subject|2|||
164491772|NCT00321672|594170020|FG003|Overall Study|Withdrawal by Subject|0|||
164491773|NCT00321672|594170017|FG000|Overall Study|Noncompliance|1|||
164491774|NCT00321672|594170018|FG001|Overall Study|Noncompliance|2|||
164491775|NCT00321672|594170019|FG002|Overall Study|Noncompliance|1|||
164491776|NCT00321672|594170020|FG003|Overall Study|Noncompliance|0|||
164491777|NCT00321672|594170017|FG000|Overall Study|Adverse Event|1|||
164491778|NCT00321672|594170018|FG001|Overall Study|Adverse Event|1|||
164491779|NCT00321672|594170019|FG002|Overall Study|Adverse Event|0|||
164491780|NCT00321672|594170020|FG003|Overall Study|Adverse Event|0|||
164491781|NCT00321672|594170017|FG000|Overall Study|Lack of Efficacy|1|||
164491782|NCT00321672|594170018|FG001|Overall Study|Lack of Efficacy|1|||
164491783|NCT00321672|594170019|FG002|Overall Study|Lack of Efficacy|0|||
164491784|NCT00321672|594170020|FG003|Overall Study|Lack of Efficacy|0|||
164491785|NCT00321672|594170017|FG000|Overall Study|Lost to Follow-up|2|||
164491786|NCT00321672|594170018|FG001|Overall Study|Lost to Follow-up|0|||
164491787|NCT00321672|594170019|FG002|Overall Study|Lost to Follow-up|4|||
164491788|NCT00321672|594170020|FG003|Overall Study|Lost to Follow-up|2|||
164491789|NCT00321672|594170017|FG000|Overall Study|Death|1|||
164491790|NCT00321672|594170018|FG001|Overall Study|Death|0|||
164491791|NCT00321672|594170019|FG002|Overall Study|Death|0|||
164491792|NCT00321672|594170020|FG003|Overall Study|Death|0|||
164491793|NCT00321672|594170017|FG000|Overall Study|Too far to travel for visits|1|||
164491794|NCT00321672|594170018|FG001|Overall Study|Too far to travel for visits|0|||
164491795|NCT00321672|594170019|FG002|Overall Study|Too far to travel for visits|0|||
164491796|NCT00321672|594170020|FG003|Overall Study|Too far to travel for visits|0|||
164491797|NCT00321672|594170017|FG000|Overall Study|Incarcerated|0|||
164491798|NCT00321672|594170018|FG001|Overall Study|Incarcerated|0|||
164491799|NCT00321672|594170019|FG002|Overall Study|Incarcerated|2|||
164491800|NCT00321672|594170020|FG003|Overall Study|Incarcerated|0|||
164491801|NCT00321672|594170017|FG000|Overall Study|Moved out of state|0|||
164491802|NCT00321672|594170018|FG001|Overall Study|Moved out of state|1|||
164491803|NCT00321672|594170019|FG002|Overall Study|Moved out of state|1|||
164491804|NCT00321672|594170020|FG003|Overall Study|Moved out of state|0|||
164491805|NCT00321672|594170017|FG000|Overall Study|Protocol Violation|0|||
164491806|NCT00321672|594170018|FG001|Overall Study|Protocol Violation|0|||
164491807|NCT00321672|594170019|FG002|Overall Study|Protocol Violation|1|||
164491808|NCT00321672|594170020|FG003|Overall Study|Protocol Violation|0|||
164491809|NCT00321672|594170017|FG000|Overall Study|Diagnosis of testicular cancer|0|||
164491810|NCT00321672|594170018|FG001|Overall Study|Diagnosis of testicular cancer|1|||
164602632|NCT00424346|594567063|FG000|Core Study|Protocol Violation|0|||
164602633|NCT00424346|594567064|FG001|Core Study|Protocol Violation|0|||
164602634|NCT00424346|594567065|FG002|Core Study|Protocol Violation|2|||
164491811|NCT00321672|594170019|FG002|Overall Study|Diagnosis of testicular cancer|0|||
164491812|NCT00321672|594170020|FG003|Overall Study|Diagnosis of testicular cancer|0|||
164491813|NCT00321672|594170017|FG000|Overall Study|Extensive travel required for new job|0|||
164491814|NCT00321672|594170018|FG001|Overall Study|Extensive travel required for new job|1|||
164491815|NCT00321672|594170019|FG002|Overall Study|Extensive travel required for new job|0|||
164491816|NCT00321672|594170020|FG003|Overall Study|Extensive travel required for new job|0|||
164491817|NCT01429285|594170024|FG000|Overall Study|Protocol Violation|9|||
164491818|NCT01429285|594170025|FG001|Overall Study|Protocol Violation|4|||
164491819|NCT01429285|594170024|FG000|Overall Study|Missing Data|5|||
164491820|NCT01429285|594170025|FG001|Overall Study|Missing Data|3|||
164491821|NCT01429285|594170024|FG000|Overall Study|Erroneously Enrolled Twice|8|||
164491822|NCT01429285|594170025|FG001|Overall Study|Erroneously Enrolled Twice|2|||
164491823|NCT00990314|594170028|FG000|Overall Study|Death|2|||
164491824|NCT00990314|594170028|FG000|Overall Study|Adverse Event|2|||
164491825|NCT00990314|594170028|FG000|Overall Study|Withdrawal by Subject|3|||
164491826|NCT00990314|594170028|FG000|Overall Study|Non-Compliance|1|||
164491827|NCT00990314|594170028|FG000|Overall Study|Physician Decision|3|||
164491828|NCT00990314|594170028|FG000|Overall Study|Lack of Efficacy|1|||
164491829|NCT02819141|594170031|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
164491830|NCT02819141|594170032|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
164491831|NCT00925288|594171534|FG000|Overall Study|Lost to Follow-up|9|||
164491832|NCT00925288|594171535|FG001|Overall Study|Lost to Follow-up|7|||
164491833|NCT02151643|594171536|FG000|Overall Study|Adverse Event|2|||
164491834|NCT02151643|594171537|FG001|Overall Study|Adverse Event|0|||
164491835|NCT02151643|594171538|FG002|Overall Study|Adverse Event|1|||
164491836|NCT02151643|594171539|FG003|Overall Study|Adverse Event|4|||
164491837|NCT02151643|594171540|FG004|Overall Study|Adverse Event|0|||
164491838|NCT02151643|594171536|FG000|Overall Study|Withdrawal by Subject|0|||
164491839|NCT02151643|594171537|FG001|Overall Study|Withdrawal by Subject|1|||
164491840|NCT02151643|594171538|FG002|Overall Study|Withdrawal by Subject|1|||
164491841|NCT02151643|594171539|FG003|Overall Study|Withdrawal by Subject|1|||
164491842|NCT02151643|594171540|FG004|Overall Study|Withdrawal by Subject|1|||
164491843|NCT02151643|594171536|FG000|Overall Study|Hyperphosphataemia|1|||
164491844|NCT02151643|594171537|FG001|Overall Study|Hyperphosphataemia|0|||
164491845|NCT02151643|594171538|FG002|Overall Study|Hyperphosphataemia|0|||
164491846|NCT02151643|594171539|FG003|Overall Study|Hyperphosphataemia|0|||
164491847|NCT02151643|594171540|FG004|Overall Study|Hyperphosphataemia|1|||
164491848|NCT02151643|594171536|FG000|Overall Study|High Ferritin levels|3|||
164491849|NCT02151643|594171537|FG001|Overall Study|High Ferritin levels|3|||
164491850|NCT02151643|594171538|FG002|Overall Study|High Ferritin levels|2|||
164491851|NCT02151643|594171539|FG003|Overall Study|High Ferritin levels|2|||
164491852|NCT02151643|594171540|FG004|Overall Study|High Ferritin levels|1|||
164491853|NCT04307134|594171541|FG000|Overall Study|Lost to Follow-up|2|||
164491854|NCT04307134|594171541|FG000|Overall Study|Withdrawal by Subject|3|||
164491855|NCT04307134|594171541|FG000|Overall Study|Other|3|||
164491856|NCT04307134|594171541|FG000|Overall Study|Death|21|||
164491857|NCT04307134|594171541|FG000|Overall Study|Enrolled but not Treated|1|||
164491858|NCT00907517|594171544|FG000|Overall Study|Progressive Disease|3|||
164491859|NCT00907517|594171545|FG001|Overall Study|Progressive Disease|3|||
164491860|NCT00907517|594171546|FG002|Overall Study|Progressive Disease|4|||
164491861|NCT00907517|594171547|FG003|Overall Study|Progressive Disease|4|||
164491862|NCT00907517|594171548|FG004|Overall Study|Progressive Disease|4|||
164491863|NCT00907517|594171544|FG000|Overall Study|Symptomatic Deterioration|0|||
164491864|NCT00907517|594171545|FG001|Overall Study|Symptomatic Deterioration|0|||
164491865|NCT00907517|594171546|FG002|Overall Study|Symptomatic Deterioration|0|||
164491866|NCT00907517|594171547|FG003|Overall Study|Symptomatic Deterioration|0|||
164491867|NCT00907517|594171548|FG004|Overall Study|Symptomatic Deterioration|1|||
164491868|NCT01732627|594171571|FG000|Overall Study|Withdrawal by Subject|1|||
164491869|NCT01732627|594171572|FG001|Overall Study|Withdrawal by Subject|0|||
164491870|NCT02475733|594171573|FG000|Overall Study|Withdrawal by Subject|1|||
164491871|NCT02475733|594171574|FG001|Overall Study|Withdrawal by Subject|0|||
164491872|NCT02475733|594171573|FG000|Overall Study|Physician Decision|1|||
164491873|NCT02475733|594171574|FG001|Overall Study|Physician Decision|0|||
164491874|NCT02131155|594171575|FG000|Overall Study|Adverse Event|1|||
164491875|NCT02131155|594171576|FG001|Overall Study|Adverse Event|0|||
164491876|NCT02131155|594171575|FG000|Overall Study|Treatment completed|1|||
164491877|NCT02131155|594171576|FG001|Overall Study|Treatment completed|0|||
164491878|NCT02131155|594171575|FG000|Overall Study|Primary tumour recurrence|2|||
164491879|NCT02131155|594171576|FG001|Overall Study|Primary tumour recurrence|1|||
164491880|NCT02131155|594171575|FG000|Overall Study|Refused to continue study medication|1|||
164491881|NCT02131155|594171576|FG001|Overall Study|Refused to continue study medication|0|||
164491882|NCT02131155|594171575|FG000|Overall Study|Study early termination|20|||
164491883|NCT02131155|594171576|FG001|Overall Study|Study early termination|10|||
164491884|NCT01887418|594171577|FG000|Overall Study|Travelling difficulties|0|||
164491885|NCT01887418|594171578|FG001|Overall Study|Travelling difficulties|0|||
164491886|NCT01887418|594171579|FG002|Overall Study|Travelling difficulties|1|||
164491887|NCT01014013|594171582|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
164491888|NCT01014013|594171583|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
164491889|NCT01014013|594171582|FG000|Overall Study|Clinical adverse experience|4|||
164491890|NCT01014013|594171583|FG001|Overall Study|Clinical adverse experience|2|||
164491891|NCT01014013|594171582|FG000|Overall Study|Laboratory adverse experience|1|||
164491892|NCT01014013|594171583|FG001|Overall Study|Laboratory adverse experience|1|||
164491893|NCT01014013|594171582|FG000|Overall Study|Protocol Violation|1|||
164491894|NCT01014013|594171583|FG001|Overall Study|Protocol Violation|3|||
164491895|NCT01014013|594171582|FG000|Overall Study|Withdrawal by Subject|7|||
164491896|NCT01014013|594171583|FG001|Overall Study|Withdrawal by Subject|4|||
164491897|NCT01014013|594171582|FG000|Overall Study|Clinical/microbiologic failure|1|||
164491898|NCT01014013|594171583|FG001|Overall Study|Clinical/microbiologic failure|2|||
164491899|NCT01014013|594171582|FG000|Overall Study|Pathogen culture = no growth|26|||
164491900|NCT01014013|594171583|FG001|Overall Study|Pathogen culture = no growth|34|||
164491901|NCT01014013|594171582|FG000|Overall Study|Negative urine culture|2|||
164491902|NCT01014013|594171583|FG001|Overall Study|Negative urine culture|0|||
164491903|NCT01014013|594171582|FG000|Overall Study|Pathogen resistant|7|||
164491904|NCT01014013|594171583|FG001|Overall Study|Pathogen resistant|4|||
164491905|NCT01014013|594171582|FG000|Overall Study|Physician Decision|0|||
164491906|NCT01014013|594171583|FG001|Overall Study|Physician Decision|1|||
164491907|NCT01014013|594171582|FG000|Overall Study|Another antibiotic therapy required|0|||
164491908|NCT01014013|594171583|FG001|Overall Study|Another antibiotic therapy required|1|||
164491909|NCT01014013|594171582|FG000|Overall Study|Appendectomy|1|||
164491910|NCT01014013|594171583|FG001|Overall Study|Appendectomy|0|||
164491911|NCT01014013|594171582|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
164491912|NCT01014013|594171583|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
164491913|NCT02305797|594171593|FG000|Overall Study|Adverse Event|11|||
164491914|NCT02305797|594171594|FG001|Overall Study|Adverse Event|2|||
164491915|NCT02305797|594171593|FG000|Overall Study|Withdrawal by Subject|9|||
164491916|NCT02305797|594171594|FG001|Overall Study|Withdrawal by Subject|10|||
164491917|NCT02305797|594171593|FG000|Overall Study|Lack of Efficacy|6|||
164491918|NCT02305797|594171594|FG001|Overall Study|Lack of Efficacy|0|||
164491919|NCT02305797|594171593|FG000|Overall Study|Lost to Follow-up|5|||
164491920|NCT02305797|594171594|FG001|Overall Study|Lost to Follow-up|11|||
164491921|NCT02305797|594171593|FG000|Overall Study|Pregnancy|0|||
164491922|NCT02305797|594171594|FG001|Overall Study|Pregnancy|2|||
164491923|NCT02305797|594171593|FG000|Overall Study|Noncompliance|14|||
164491924|NCT02305797|594171594|FG001|Overall Study|Noncompliance|12|||
164491925|NCT02305797|594171593|FG000|Overall Study|Reason not collected|0|||
164491926|NCT02305797|594171594|FG001|Overall Study|Reason not collected|1|||
164491927|NCT02522299|594171595|FG000|Overall Study|Adverse Event|2|||
164491928|NCT02522299|594171596|FG001|Overall Study|Adverse Event|0|||
164491929|NCT02522299|594171595|FG000|Overall Study|Physician Decision|0|||
164491930|NCT02522299|594171596|FG001|Overall Study|Physician Decision|1|||
164491931|NCT02522299|594171595|FG000|Overall Study|Withdrawal by Subject|2|||
164491932|NCT02522299|594171596|FG001|Overall Study|Withdrawal by Subject|0|||
164491933|NCT02097056|594171597|FG000|Overall Study|Protocol Violation|2|||
164491934|NCT02097056|594171597|FG000|Overall Study|Withdrawal by Subject|15|||
164491935|NCT02097056|594171597|FG000|Overall Study|Lost to Follow-up|2|||
164491936|NCT02097056|594171597|FG000|Overall Study|Adverse Event|37|||
164714935|NCT04642365|594978833|FG002|Overall Study|Symptomatic Deterioration|0|||
164714936|NCT04642365|594978834|FG003|Overall Study|Symptomatic Deterioration|0|||
164714937|NCT04642365|594978835|FG004|Overall Study|Symptomatic Deterioration|0|||
164714938|NCT04642365|594978836|FG005|Overall Study|Symptomatic Deterioration|1|||
164714939|NCT04642365|594978837|FG006|Overall Study|Symptomatic Deterioration|0|||
164714940|NCT04642365|594978838|FG007|Overall Study|Symptomatic Deterioration|0|||
164714941|NCT04642365|594978831|FG000|Overall Study|Withdrawal by Subject|0|||
164714942|NCT04642365|594978832|FG001|Overall Study|Withdrawal by Subject|0|||
164714943|NCT04642365|594978833|FG002|Overall Study|Withdrawal by Subject|1|||
164491937|NCT02097056|594171597|FG000|Overall Study|Other|2|||
164491938|NCT03751280|594171600|FG000|Overall Study|Adverse Event|0|||
164491939|NCT03751280|594171601|FG001|Overall Study|Adverse Event|1|||
164491940|NCT03751280|594171600|FG000|Overall Study|Lost to Follow-up|3|||
164491941|NCT03751280|594171601|FG001|Overall Study|Lost to Follow-up|5|||
164491942|NCT03751280|594171600|FG000|Overall Study|Physician Decision|0|||
164491943|NCT03751280|594171601|FG001|Overall Study|Physician Decision|2|||
164491944|NCT03751280|594171600|FG000|Overall Study|Protocol Violation|0|||
164491945|NCT03751280|594171601|FG001|Overall Study|Protocol Violation|2|||
164491946|NCT03751280|594171600|FG000|Overall Study|Withdrawal by Subject|5|||
164491947|NCT03751280|594171601|FG001|Overall Study|Withdrawal by Subject|2|||
164491948|NCT00296504|594171602|FG000|Interim Analysis|Withdrawal by Subject|8|||
164491949|NCT00296504|594171603|FG001|Interim Analysis|Withdrawal by Subject|0|||
164491950|NCT00296504|594171604|FG002|Interim Analysis|Withdrawal by Subject|12|||
164491951|NCT00296504|594171605|FG003|Interim Analysis|Withdrawal by Subject|0|||
164714944|NCT04642365|594978834|FG003|Overall Study|Withdrawal by Subject|1|||
164491952|NCT00296504|594171606|FG004|Interim Analysis|Withdrawal by Subject|5|||
164491953|NCT00296504|594171607|FG005|Interim Analysis|Withdrawal by Subject|5|||
164491954|NCT00296504|594171608|FG006|Interim Analysis|Withdrawal by Subject|9|||
164491955|NCT00296504|594171609|FG007|Interim Analysis|Withdrawal by Subject|3|||
164491956|NCT00296504|594171610|FG008|Interim Analysis|Withdrawal by Subject|0|||
164491957|NCT00296504|594171602|FG000|Interim Analysis|Lost to Follow-up|13|||
164491958|NCT00296504|594171603|FG001|Interim Analysis|Lost to Follow-up|3|||
164491959|NCT00296504|594171604|FG002|Interim Analysis|Lost to Follow-up|26|||
164491960|NCT00296504|594171605|FG003|Interim Analysis|Lost to Follow-up|8|||
164491961|NCT00296504|594171606|FG004|Interim Analysis|Lost to Follow-up|14|||
164491962|NCT00296504|594171607|FG005|Interim Analysis|Lost to Follow-up|4|||
164491963|NCT00296504|594171608|FG006|Interim Analysis|Lost to Follow-up|11|||
164491964|NCT00296504|594171609|FG007|Interim Analysis|Lost to Follow-up|4|||
164491965|NCT00296504|594171610|FG008|Interim Analysis|Lost to Follow-up|0|||
164491966|NCT00296504|594171602|FG000|Interim Analysis|Clinical Progression|1|||
164491967|NCT00296504|594171603|FG001|Interim Analysis|Clinical Progression|0|||
164491968|NCT00296504|594171604|FG002|Interim Analysis|Clinical Progression|1|||
164491969|NCT00296504|594171605|FG003|Interim Analysis|Clinical Progression|1|||
164491970|NCT00296504|594171606|FG004|Interim Analysis|Clinical Progression|0|||
164491971|NCT00296504|594171607|FG005|Interim Analysis|Clinical Progression|2|||
164491972|NCT00296504|594171608|FG006|Interim Analysis|Clinical Progression|1|||
164491973|NCT00296504|594171609|FG007|Interim Analysis|Clinical Progression|2|||
164491974|NCT00296504|594171610|FG008|Interim Analysis|Clinical Progression|0|||
164491975|NCT00296504|594171602|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
164491976|NCT00296504|594171603|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
164491977|NCT00296504|594171604|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
164491978|NCT00296504|594171605|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
164491979|NCT00296504|594171606|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
164491980|NCT00296504|594171607|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
164491981|NCT00296504|594171608|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
164491982|NCT00296504|594171609|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
164491983|NCT00296504|594171610|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
164491984|NCT00296504|594171602|FG000|Interim Analysis|Adverse Event|0|||
164491985|NCT00296504|594171603|FG001|Interim Analysis|Adverse Event|0|||
164491986|NCT00296504|594171604|FG002|Interim Analysis|Adverse Event|13|||
164491987|NCT00296504|594171605|FG003|Interim Analysis|Adverse Event|4|||
164491988|NCT00296504|594171606|FG004|Interim Analysis|Adverse Event|6|||
164491989|NCT00296504|594171607|FG005|Interim Analysis|Adverse Event|3|||
164491990|NCT00296504|594171608|FG006|Interim Analysis|Adverse Event|4|||
164491991|NCT00296504|594171609|FG007|Interim Analysis|Adverse Event|5|||
164491992|NCT00296504|594171610|FG008|Interim Analysis|Adverse Event|0|||
164491993|NCT00296504|594171602|FG000|Interim Analysis|Protocol Violation|0|||
164491994|NCT00296504|594171603|FG001|Interim Analysis|Protocol Violation|0|||
164491995|NCT00296504|594171604|FG002|Interim Analysis|Protocol Violation|2|||
164491996|NCT00296504|594171605|FG003|Interim Analysis|Protocol Violation|0|||
164491997|NCT00296504|594171606|FG004|Interim Analysis|Protocol Violation|1|||
164491998|NCT00296504|594171607|FG005|Interim Analysis|Protocol Violation|0|||
164491999|NCT00296504|594171608|FG006|Interim Analysis|Protocol Violation|0|||
164492000|NCT00296504|594171609|FG007|Interim Analysis|Protocol Violation|1|||
164492001|NCT00296504|594171610|FG008|Interim Analysis|Protocol Violation|0|||
164492002|NCT00296504|594171602|FG000|Interim Analysis|Insufficient CD4 Response|0|||
164492003|NCT00296504|594171603|FG001|Interim Analysis|Insufficient CD4 Response|0|||
164492004|NCT00296504|594171604|FG002|Interim Analysis|Insufficient CD4 Response|0|||
164492005|NCT00296504|594171605|FG003|Interim Analysis|Insufficient CD4 Response|0|||
164492006|NCT00296504|594171606|FG004|Interim Analysis|Insufficient CD4 Response|1|||
164492007|NCT00296504|594171607|FG005|Interim Analysis|Insufficient CD4 Response|1|||
164492008|NCT00296504|594171608|FG006|Interim Analysis|Insufficient CD4 Response|0|||
164492009|NCT00296504|594171609|FG007|Interim Analysis|Insufficient CD4 Response|0|||
164492010|NCT00296504|594171610|FG008|Interim Analysis|Insufficient CD4 Response|0|||
164492011|NCT00296504|594171602|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
164492012|NCT00296504|594171603|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
164492013|NCT00296504|594171604|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
164492014|NCT00296504|594171605|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
164492015|NCT00296504|594171606|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
164492016|NCT00296504|594171607|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
164492017|NCT00296504|594171608|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
164492018|NCT00296504|594171609|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
164492019|NCT00296504|594171610|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
164492020|NCT00296504|594171602|FG000|Interim Analysis|Pregnancy|4|||
164492021|NCT00296504|594171603|FG001|Interim Analysis|Pregnancy|1|||
164492022|NCT00296504|594171604|FG002|Interim Analysis|Pregnancy|4|||
164492023|NCT00296504|594171605|FG003|Interim Analysis|Pregnancy|2|||
164492024|NCT00296504|594171606|FG004|Interim Analysis|Pregnancy|0|||
164492025|NCT00296504|594171607|FG005|Interim Analysis|Pregnancy|1|||
164492026|NCT00296504|594171608|FG006|Interim Analysis|Pregnancy|1|||
164492027|NCT00296504|594171609|FG007|Interim Analysis|Pregnancy|1|||
164492028|NCT00296504|594171610|FG008|Interim Analysis|Pregnancy|0|||
164492029|NCT00296504|594171602|FG000|Interim Analysis|Death|1|||
164492030|NCT00296504|594171603|FG001|Interim Analysis|Death|0|||
164492031|NCT00296504|594171604|FG002|Interim Analysis|Death|3|||
164492032|NCT00296504|594171605|FG003|Interim Analysis|Death|0|||
164492033|NCT00296504|594171606|FG004|Interim Analysis|Death|0|||
164492034|NCT00296504|594171607|FG005|Interim Analysis|Death|0|||
164492035|NCT00296504|594171608|FG006|Interim Analysis|Death|0|||
164492036|NCT00296504|594171609|FG007|Interim Analysis|Death|0|||
164492037|NCT00296504|594171610|FG008|Interim Analysis|Death|0|||
164492038|NCT00296504|594171602|FG000|Interim Analysis|Participant Non-compliant|0|||
164492039|NCT00296504|594171603|FG001|Interim Analysis|Participant Non-compliant|1|||
164492040|NCT00296504|594171604|FG002|Interim Analysis|Participant Non-compliant|2|||
164492041|NCT00296504|594171605|FG003|Interim Analysis|Participant Non-compliant|1|||
164492042|NCT00296504|594171606|FG004|Interim Analysis|Participant Non-compliant|1|||
164492043|NCT00296504|594171607|FG005|Interim Analysis|Participant Non-compliant|3|||
164492044|NCT00296504|594171608|FG006|Interim Analysis|Participant Non-compliant|6|||
164492045|NCT00296504|594171609|FG007|Interim Analysis|Participant Non-compliant|2|||
164492046|NCT00296504|594171610|FG008|Interim Analysis|Participant Non-compliant|0|||
164492047|NCT00296504|594171602|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
164492048|NCT00296504|594171603|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
164492049|NCT00296504|594171604|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
164492050|NCT00296504|594171605|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
164492051|NCT00296504|594171606|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
164492052|NCT00296504|594171607|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
164492053|NCT00296504|594171608|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
164492054|NCT00296504|594171609|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
164492055|NCT00296504|594171610|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
164492056|NCT00296504|594171602|FG000|Interim Analysis|To Simplify Treatment|0|||
164492057|NCT00296504|594171603|FG001|Interim Analysis|To Simplify Treatment|0|||
164492058|NCT00296504|594171604|FG002|Interim Analysis|To Simplify Treatment|1|||
164492059|NCT00296504|594171605|FG003|Interim Analysis|To Simplify Treatment|0|||
164492060|NCT00296504|594171606|FG004|Interim Analysis|To Simplify Treatment|0|||
164492061|NCT00296504|594171607|FG005|Interim Analysis|To Simplify Treatment|0|||
164492062|NCT00296504|594171608|FG006|Interim Analysis|To Simplify Treatment|2|||
164492063|NCT00296504|594171609|FG007|Interim Analysis|To Simplify Treatment|0|||
164492064|NCT00296504|594171610|FG008|Interim Analysis|To Simplify Treatment|0|||
164492065|NCT00296504|594171602|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
164492066|NCT00296504|594171603|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
164492067|NCT00296504|594171604|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
164492068|NCT00296504|594171605|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
164492069|NCT00296504|594171606|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
164492070|NCT00296504|594171607|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
164492071|NCT00296504|594171608|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
164492072|NCT00296504|594171609|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
164492073|NCT00296504|594171610|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
164492074|NCT00296504|594171602|FG000|Interim Analysis|Participant Moved|1|||
164492075|NCT00296504|594171603|FG001|Interim Analysis|Participant Moved|0|||
164492076|NCT00296504|594171604|FG002|Interim Analysis|Participant Moved|1|||
164492077|NCT00296504|594171605|FG003|Interim Analysis|Participant Moved|0|||
164492078|NCT00296504|594171606|FG004|Interim Analysis|Participant Moved|0|||
164492079|NCT00296504|594171607|FG005|Interim Analysis|Participant Moved|1|||
164492080|NCT00296504|594171608|FG006|Interim Analysis|Participant Moved|1|||
164602635|NCT00424346|594567066|FG003|Core Study|Protocol Violation|0|||
164602636|NCT00424346|594567063|FG000|Extension Phase|Adverse Event|0|||
164602637|NCT00424346|594567064|FG001|Extension Phase|Adverse Event|9|||
164602638|NCT00424346|594567065|FG002|Extension Phase|Adverse Event|5|||
164602639|NCT00424346|594567066|FG003|Extension Phase|Adverse Event|4|||
164602640|NCT00424346|594567063|FG000|Extension Phase|Lack of Efficacy|0|||
164602641|NCT00424346|594567064|FG001|Extension Phase|Lack of Efficacy|16|||
164602642|NCT00424346|594567065|FG002|Extension Phase|Lack of Efficacy|14|||
164602643|NCT00424346|594567066|FG003|Extension Phase|Lack of Efficacy|11|||
164602644|NCT00424346|594567063|FG000|Extension Phase|Withdrawal by Subject|0|||
164602645|NCT00424346|594567064|FG001|Extension Phase|Withdrawal by Subject|5|||
164602646|NCT00424346|594567065|FG002|Extension Phase|Withdrawal by Subject|3|||
164602647|NCT00424346|594567066|FG003|Extension Phase|Withdrawal by Subject|4|||
164602648|NCT00424346|594567063|FG000|Extension Phase|Lost to Follow-up|0|||
164602649|NCT00424346|594567064|FG001|Extension Phase|Lost to Follow-up|2|||
164602650|NCT00424346|594567065|FG002|Extension Phase|Lost to Follow-up|0|||
164602651|NCT00424346|594567066|FG003|Extension Phase|Lost to Follow-up|0|||
164602652|NCT00424346|594567063|FG000|Extension Phase|Administrative Problems|0|||
164602653|NCT00424346|594567064|FG001|Extension Phase|Administrative Problems|69|||
164602654|NCT00424346|594567065|FG002|Extension Phase|Administrative Problems|32|||
164602655|NCT00424346|594567066|FG003|Extension Phase|Administrative Problems|35|||
164602656|NCT00424346|594567063|FG000|Extension Phase|Death|0|||
164602657|NCT00424346|594567064|FG001|Extension Phase|Death|0|||
164602658|NCT00424346|594567065|FG002|Extension Phase|Death|0|||
164602659|NCT00424346|594567066|FG003|Extension Phase|Death|1|||
164602660|NCT00424346|594567063|FG000|Extension Phase|Protocol Violation|0|||
164602661|NCT00424346|594567064|FG001|Extension Phase|Protocol Violation|1|||
164602662|NCT00424346|594567065|FG002|Extension Phase|Protocol Violation|1|||
164602663|NCT00424346|594567066|FG003|Extension Phase|Protocol Violation|0|||
164602664|NCT01827319|594567067|FG000|Overall Study|Lost to Follow-up|3|||
164602665|NCT00571519|594567068|FG000|Overall Study|Subject withdrew consent|0|||
164602666|NCT00571519|594567069|FG001|Overall Study|Subject withdrew consent|1|||
164602667|NCT00571519|594567070|FG002|Overall Study|Subject withdrew consent|0|||
164602668|NCT00571519|594567071|FG003|Overall Study|Subject withdrew consent|2|||
164602669|NCT00571519|594567072|FG004|Overall Study|Subject withdrew consent|1|||
164602670|NCT00571519|594567073|FG005|Overall Study|Subject withdrew consent|1|||
164602671|NCT00571519|594567074|FG006|Overall Study|Subject withdrew consent|2|||
164602672|NCT00571519|594567068|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
164602673|NCT00571519|594567069|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
164602674|NCT00571519|594567070|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
164602675|NCT00571519|594567071|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
164602676|NCT00571519|594567072|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
164602677|NCT00571519|594567073|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
164602678|NCT00571519|594567074|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
164602679|NCT00571519|594567068|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
164602680|NCT00571519|594567069|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
164602681|NCT00571519|594567070|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
164602682|NCT00571519|594567071|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
164602683|NCT00571519|594567072|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
164602684|NCT00571519|594567073|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
164602685|NCT00571519|594567074|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
164492081|NCT00296504|594171609|FG007|Interim Analysis|Participant Moved|0|||
164492082|NCT00296504|594171610|FG008|Interim Analysis|Participant Moved|0|||
164492083|NCT00296504|594171602|FG000|Interim Analysis|Participant Was Incarcerated|2|||
164492084|NCT00296504|594171603|FG001|Interim Analysis|Participant Was Incarcerated|0|||
164492085|NCT00296504|594171604|FG002|Interim Analysis|Participant Was Incarcerated|1|||
164492086|NCT00296504|594171605|FG003|Interim Analysis|Participant Was Incarcerated|0|||
164492087|NCT00296504|594171606|FG004|Interim Analysis|Participant Was Incarcerated|0|||
164492088|NCT00296504|594171607|FG005|Interim Analysis|Participant Was Incarcerated|0|||
164492089|NCT00296504|594171608|FG006|Interim Analysis|Participant Was Incarcerated|0|||
164492090|NCT00296504|594171609|FG007|Interim Analysis|Participant Was Incarcerated|0|||
164602686|NCT00571519|594567068|FG000|Overall Study|Termination of study by Sponsor|2|||
164602687|NCT00571519|594567069|FG001|Overall Study|Termination of study by Sponsor|7|||
164602688|NCT00571519|594567070|FG002|Overall Study|Termination of study by Sponsor|10|||
164602689|NCT00571519|594567071|FG003|Overall Study|Termination of study by Sponsor|24|||
164602690|NCT00571519|594567072|FG004|Overall Study|Termination of study by Sponsor|8|||
164602691|NCT00571519|594567073|FG005|Overall Study|Termination of study by Sponsor|9|||
164602692|NCT00571519|594567074|FG006|Overall Study|Termination of study by Sponsor|22|||
164602693|NCT00571519|594567068|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
164602694|NCT00571519|594567069|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
164492091|NCT00296504|594171610|FG008|Interim Analysis|Participant Was Incarcerated|0|||
164492092|NCT00296504|594171602|FG000|Interim Analysis|Resistance to FPV|0|||
164492093|NCT00296504|594171603|FG001|Interim Analysis|Resistance to FPV|0|||
164492094|NCT00296504|594171604|FG002|Interim Analysis|Resistance to FPV|1|||
164492095|NCT00296504|594171605|FG003|Interim Analysis|Resistance to FPV|0|||
164492096|NCT00296504|594171606|FG004|Interim Analysis|Resistance to FPV|0|||
164492097|NCT00296504|594171607|FG005|Interim Analysis|Resistance to FPV|0|||
164492098|NCT00296504|594171608|FG006|Interim Analysis|Resistance to FPV|0|||
164492099|NCT00296504|594171609|FG007|Interim Analysis|Resistance to FPV|0|||
164492100|NCT00296504|594171610|FG008|Interim Analysis|Resistance to FPV|0|||
164492101|NCT00296504|594171602|FG000|Interim Analysis|Physician Decision|0|||
164492102|NCT00296504|594171603|FG001|Interim Analysis|Physician Decision|0|||
164492103|NCT00296504|594171604|FG002|Interim Analysis|Physician Decision|1|||
164492104|NCT00296504|594171605|FG003|Interim Analysis|Physician Decision|0|||
164492105|NCT00296504|594171606|FG004|Interim Analysis|Physician Decision|0|||
164492106|NCT00296504|594171607|FG005|Interim Analysis|Physician Decision|0|||
164492107|NCT00296504|594171608|FG006|Interim Analysis|Physician Decision|0|||
164492108|NCT00296504|594171609|FG007|Interim Analysis|Physician Decision|0|||
164492109|NCT00296504|594171610|FG008|Interim Analysis|Physician Decision|0|||
164492110|NCT00296504|594171602|FG000|Interim Analysis|Principle Investigator Discretion|2|||
164492111|NCT00296504|594171603|FG001|Interim Analysis|Principle Investigator Discretion|0|||
164492112|NCT00296504|594171604|FG002|Interim Analysis|Principle Investigator Discretion|1|||
164492113|NCT00296504|594171605|FG003|Interim Analysis|Principle Investigator Discretion|1|||
164492114|NCT00296504|594171606|FG004|Interim Analysis|Principle Investigator Discretion|0|||
164492115|NCT00296504|594171607|FG005|Interim Analysis|Principle Investigator Discretion|0|||
164492116|NCT00296504|594171608|FG006|Interim Analysis|Principle Investigator Discretion|0|||
164492117|NCT00296504|594171609|FG007|Interim Analysis|Principle Investigator Discretion|0|||
164492118|NCT00296504|594171610|FG008|Interim Analysis|Principle Investigator Discretion|0|||
164492119|NCT00296504|594171602|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
164492120|NCT00296504|594171603|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
164492121|NCT00296504|594171604|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
164492122|NCT00296504|594171605|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
164492123|NCT00296504|594171606|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
164492124|NCT00296504|594171607|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
164492125|NCT00296504|594171608|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
164492126|NCT00296504|594171609|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
164492127|NCT00296504|594171610|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
164492128|NCT00296504|594171602|FG000|Interim Analysis|Non-adherence|2|||
164492129|NCT00296504|594171603|FG001|Interim Analysis|Non-adherence|0|||
164492130|NCT00296504|594171604|FG002|Interim Analysis|Non-adherence|0|||
164492131|NCT00296504|594171605|FG003|Interim Analysis|Non-adherence|0|||
164492132|NCT00296504|594171606|FG004|Interim Analysis|Non-adherence|1|||
164492133|NCT00296504|594171607|FG005|Interim Analysis|Non-adherence|0|||
164492134|NCT00296504|594171608|FG006|Interim Analysis|Non-adherence|0|||
164492135|NCT00296504|594171609|FG007|Interim Analysis|Non-adherence|1|||
164492136|NCT00296504|594171610|FG008|Interim Analysis|Non-adherence|0|||
164492137|NCT00296504|594171602|FG000|Interim Analysis|Site Closing|1|||
164492138|NCT00296504|594171603|FG001|Interim Analysis|Site Closing|0|||
164492139|NCT00296504|594171604|FG002|Interim Analysis|Site Closing|0|||
164492140|NCT00296504|594171605|FG003|Interim Analysis|Site Closing|0|||
164492141|NCT00296504|594171606|FG004|Interim Analysis|Site Closing|0|||
164492142|NCT00296504|594171607|FG005|Interim Analysis|Site Closing|1|||
164492143|NCT00296504|594171608|FG006|Interim Analysis|Site Closing|2|||
164492144|NCT00296504|594171609|FG007|Interim Analysis|Site Closing|0|||
164492145|NCT00296504|594171610|FG008|Interim Analysis|Site Closing|0|||
164492146|NCT00296504|594171602|FG000|Interim Analysis|Lack of Personnel at Site|1|||
164492147|NCT00296504|594171603|FG001|Interim Analysis|Lack of Personnel at Site|0|||
164492148|NCT00296504|594171604|FG002|Interim Analysis|Lack of Personnel at Site|0|||
164492149|NCT00296504|594171605|FG003|Interim Analysis|Lack of Personnel at Site|0|||
164492150|NCT00296504|594171606|FG004|Interim Analysis|Lack of Personnel at Site|0|||
164492151|NCT00296504|594171607|FG005|Interim Analysis|Lack of Personnel at Site|0|||
164492152|NCT00296504|594171608|FG006|Interim Analysis|Lack of Personnel at Site|0|||
164492153|NCT00296504|594171609|FG007|Interim Analysis|Lack of Personnel at Site|0|||
164492154|NCT00296504|594171610|FG008|Interim Analysis|Lack of Personnel at Site|0|||
164492155|NCT00296504|594171602|FG000|Interim Analysis|Missed Schedule Date|1|||
164492156|NCT00296504|594171603|FG001|Interim Analysis|Missed Schedule Date|0|||
164492157|NCT00296504|594171604|FG002|Interim Analysis|Missed Schedule Date|0|||
164492158|NCT00296504|594171605|FG003|Interim Analysis|Missed Schedule Date|0|||
164492159|NCT00296504|594171606|FG004|Interim Analysis|Missed Schedule Date|0|||
164492160|NCT00296504|594171607|FG005|Interim Analysis|Missed Schedule Date|0|||
164492161|NCT00296504|594171608|FG006|Interim Analysis|Missed Schedule Date|0|||
164492162|NCT00296504|594171609|FG007|Interim Analysis|Missed Schedule Date|0|||
164492163|NCT00296504|594171610|FG008|Interim Analysis|Missed Schedule Date|0|||
164492164|NCT00296504|594171602|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
164492165|NCT00296504|594171603|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
164492166|NCT00296504|594171604|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
164492167|NCT00296504|594171605|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
164492168|NCT00296504|594171606|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
164492169|NCT00296504|594171607|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
164492170|NCT00296504|594171608|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
164492171|NCT00296504|594171609|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
164492172|NCT00296504|594171610|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
164492173|NCT00296504|594171602|FG000|Interim Analysis|Participant Stopped|0|||
164492174|NCT00296504|594171603|FG001|Interim Analysis|Participant Stopped|0|||
164492175|NCT00296504|594171604|FG002|Interim Analysis|Participant Stopped|0|||
164492176|NCT00296504|594171605|FG003|Interim Analysis|Participant Stopped|0|||
164492177|NCT00296504|594171606|FG004|Interim Analysis|Participant Stopped|1|||
164492178|NCT00296504|594171607|FG005|Interim Analysis|Participant Stopped|0|||
164492179|NCT00296504|594171608|FG006|Interim Analysis|Participant Stopped|0|||
164492180|NCT00296504|594171609|FG007|Interim Analysis|Participant Stopped|0|||
164492181|NCT00296504|594171610|FG008|Interim Analysis|Participant Stopped|0|||
164492182|NCT00296504|594171602|FG000|Interim Analysis|Physician and Participant Decision|0|||
164492183|NCT00296504|594171603|FG001|Interim Analysis|Physician and Participant Decision|0|||
164492184|NCT00296504|594171604|FG002|Interim Analysis|Physician and Participant Decision|0|||
164492185|NCT00296504|594171605|FG003|Interim Analysis|Physician and Participant Decision|0|||
164492186|NCT00296504|594171606|FG004|Interim Analysis|Physician and Participant Decision|0|||
164492187|NCT00296504|594171607|FG005|Interim Analysis|Physician and Participant Decision|1|||
164492188|NCT00296504|594171608|FG006|Interim Analysis|Physician and Participant Decision|0|||
164492189|NCT00296504|594171609|FG007|Interim Analysis|Physician and Participant Decision|0|||
164492190|NCT00296504|594171610|FG008|Interim Analysis|Physician and Participant Decision|0|||
164492191|NCT00296504|594171602|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
164492192|NCT00296504|594171603|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
164492193|NCT00296504|594171604|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
164492194|NCT00296504|594171605|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
164492195|NCT00296504|594171606|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
164492196|NCT00296504|594171607|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
164492197|NCT00296504|594171608|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
164492198|NCT00296504|594171609|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
164492199|NCT00296504|594171610|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
164492200|NCT00296504|594171602|FG000|Interim Analysis|Study Ended|0|||
164492201|NCT00296504|594171603|FG001|Interim Analysis|Study Ended|0|||
164492202|NCT00296504|594171604|FG002|Interim Analysis|Study Ended|0|||
164492203|NCT00296504|594171605|FG003|Interim Analysis|Study Ended|0|||
164492204|NCT00296504|594171606|FG004|Interim Analysis|Study Ended|0|||
164492205|NCT00296504|594171607|FG005|Interim Analysis|Study Ended|0|||
164492206|NCT00296504|594171608|FG006|Interim Analysis|Study Ended|1|||
164492207|NCT00296504|594171609|FG007|Interim Analysis|Study Ended|0|||
164492208|NCT00296504|594171610|FG008|Interim Analysis|Study Ended|0|||
164492209|NCT00296504|594171602|FG000|Interim Analysis|Participant Needed Interferon|0|||
164492210|NCT00296504|594171603|FG001|Interim Analysis|Participant Needed Interferon|0|||
164492211|NCT00296504|594171604|FG002|Interim Analysis|Participant Needed Interferon|0|||
164492212|NCT00296504|594171605|FG003|Interim Analysis|Participant Needed Interferon|0|||
164492213|NCT00296504|594171606|FG004|Interim Analysis|Participant Needed Interferon|0|||
164492214|NCT00296504|594171607|FG005|Interim Analysis|Participant Needed Interferon|0|||
164492215|NCT00296504|594171608|FG006|Interim Analysis|Participant Needed Interferon|0|||
164492216|NCT00296504|594171609|FG007|Interim Analysis|Participant Needed Interferon|1|||
164492217|NCT00296504|594171610|FG008|Interim Analysis|Participant Needed Interferon|0|||
164492218|NCT00296504|594171602|FG000|Interim Analysis|Ongoing|32|||
164492219|NCT00296504|594171603|FG001|Interim Analysis|Ongoing|12|||
164492220|NCT00296504|594171604|FG002|Interim Analysis|Ongoing|16|||
164492221|NCT00296504|594171605|FG003|Interim Analysis|Ongoing|22|||
164492222|NCT00296504|594171606|FG004|Interim Analysis|Ongoing|0|||
164492223|NCT00296504|594171607|FG005|Interim Analysis|Ongoing|0|||
164492224|NCT00296504|594171608|FG006|Interim Analysis|Ongoing|30|||
164492225|NCT00296504|594171609|FG007|Interim Analysis|Ongoing|1|||
164492226|NCT00296504|594171610|FG008|Interim Analysis|Ongoing|0|||
164492227|NCT00296504|594171602|FG000|Final Analysis|Withdrawal by Subject|0|||
164492228|NCT00296504|594171603|FG001|Final Analysis|Withdrawal by Subject|0|||
164492229|NCT00296504|594171604|FG002|Final Analysis|Withdrawal by Subject|0|||
164492230|NCT00296504|594171605|FG003|Final Analysis|Withdrawal by Subject|0|||
164492231|NCT00296504|594171606|FG004|Final Analysis|Withdrawal by Subject|0|||
164492232|NCT00296504|594171607|FG005|Final Analysis|Withdrawal by Subject|0|||
164492233|NCT00296504|594171608|FG006|Final Analysis|Withdrawal by Subject|0|||
164492234|NCT00296504|594171609|FG007|Final Analysis|Withdrawal by Subject|0|||
164492235|NCT00296504|594171610|FG008|Final Analysis|Withdrawal by Subject|1|||
164492236|NCT00296504|594171602|FG000|Final Analysis|Lost to Follow-up|0|||
164492237|NCT00296504|594171603|FG001|Final Analysis|Lost to Follow-up|0|||
164492238|NCT00296504|594171604|FG002|Final Analysis|Lost to Follow-up|0|||
164492239|NCT00296504|594171605|FG003|Final Analysis|Lost to Follow-up|0|||
164492240|NCT00296504|594171606|FG004|Final Analysis|Lost to Follow-up|0|||
164492241|NCT00296504|594171607|FG005|Final Analysis|Lost to Follow-up|0|||
164492242|NCT00296504|594171608|FG006|Final Analysis|Lost to Follow-up|0|||
164492243|NCT00296504|594171609|FG007|Final Analysis|Lost to Follow-up|0|||
164492244|NCT00296504|594171610|FG008|Final Analysis|Lost to Follow-up|5|||
164492245|NCT00296504|594171602|FG000|Final Analysis|Insufficient Viral Load Response|0|||
164492246|NCT00296504|594171603|FG001|Final Analysis|Insufficient Viral Load Response|0|||
164492247|NCT00296504|594171604|FG002|Final Analysis|Insufficient Viral Load Response|0|||
164492248|NCT00296504|594171605|FG003|Final Analysis|Insufficient Viral Load Response|0|||
164492249|NCT00296504|594171606|FG004|Final Analysis|Insufficient Viral Load Response|0|||
164492250|NCT00296504|594171607|FG005|Final Analysis|Insufficient Viral Load Response|0|||
164492251|NCT00296504|594171608|FG006|Final Analysis|Insufficient Viral Load Response|0|||
164492252|NCT00296504|594171609|FG007|Final Analysis|Insufficient Viral Load Response|0|||
164492253|NCT00296504|594171610|FG008|Final Analysis|Insufficient Viral Load Response|6|||
164492254|NCT00296504|594171602|FG000|Final Analysis|Adverse Event|0|||
164492255|NCT00296504|594171603|FG001|Final Analysis|Adverse Event|0|||
164492256|NCT00296504|594171604|FG002|Final Analysis|Adverse Event|0|||
164492257|NCT00296504|594171605|FG003|Final Analysis|Adverse Event|0|||
164492258|NCT00296504|594171606|FG004|Final Analysis|Adverse Event|0|||
164492259|NCT00296504|594171607|FG005|Final Analysis|Adverse Event|0|||
164492260|NCT00296504|594171608|FG006|Final Analysis|Adverse Event|0|||
164492261|NCT00296504|594171609|FG007|Final Analysis|Adverse Event|0|||
164492262|NCT00296504|594171610|FG008|Final Analysis|Adverse Event|2|||
164492263|NCT00296504|594171602|FG000|Final Analysis|Pregnancy|0|||
164492264|NCT00296504|594171603|FG001|Final Analysis|Pregnancy|0|||
164492265|NCT00296504|594171604|FG002|Final Analysis|Pregnancy|0|||
164492266|NCT00296504|594171605|FG003|Final Analysis|Pregnancy|0|||
164492267|NCT00296504|594171606|FG004|Final Analysis|Pregnancy|0|||
164492268|NCT00296504|594171607|FG005|Final Analysis|Pregnancy|0|||
164492269|NCT00296504|594171608|FG006|Final Analysis|Pregnancy|0|||
164492270|NCT00296504|594171609|FG007|Final Analysis|Pregnancy|0|||
164492271|NCT00296504|594171610|FG008|Final Analysis|Pregnancy|4|||
164492272|NCT00296504|594171602|FG000|Final Analysis|Tuberculosis|0|||
164492273|NCT00296504|594171603|FG001|Final Analysis|Tuberculosis|0|||
164492274|NCT00296504|594171604|FG002|Final Analysis|Tuberculosis|0|||
164492275|NCT00296504|594171605|FG003|Final Analysis|Tuberculosis|0|||
164492276|NCT00296504|594171606|FG004|Final Analysis|Tuberculosis|0|||
164492277|NCT00296504|594171607|FG005|Final Analysis|Tuberculosis|0|||
164492278|NCT00296504|594171608|FG006|Final Analysis|Tuberculosis|0|||
164492279|NCT00296504|594171609|FG007|Final Analysis|Tuberculosis|0|||
164492280|NCT00296504|594171610|FG008|Final Analysis|Tuberculosis|1|||
164492281|NCT00296504|594171602|FG000|Final Analysis|Participant Moved to Another Country|0|||
164492282|NCT00296504|594171603|FG001|Final Analysis|Participant Moved to Another Country|0|||
164492283|NCT00296504|594171604|FG002|Final Analysis|Participant Moved to Another Country|0|||
164492284|NCT00296504|594171605|FG003|Final Analysis|Participant Moved to Another Country|0|||
164492285|NCT00296504|594171606|FG004|Final Analysis|Participant Moved to Another Country|0|||
164492286|NCT00296504|594171607|FG005|Final Analysis|Participant Moved to Another Country|0|||
164492287|NCT00296504|594171608|FG006|Final Analysis|Participant Moved to Another Country|0|||
164492288|NCT00296504|594171609|FG007|Final Analysis|Participant Moved to Another Country|0|||
164492289|NCT00296504|594171610|FG008|Final Analysis|Participant Moved to Another Country|1|||
164492290|NCT00296504|594171602|FG000|Final Analysis|Poor Adherence|0|||
164492291|NCT00296504|594171603|FG001|Final Analysis|Poor Adherence|0|||
164492292|NCT00296504|594171604|FG002|Final Analysis|Poor Adherence|0|||
164492293|NCT00296504|594171605|FG003|Final Analysis|Poor Adherence|0|||
164492294|NCT00296504|594171606|FG004|Final Analysis|Poor Adherence|0|||
164492295|NCT00296504|594171607|FG005|Final Analysis|Poor Adherence|0|||
164492296|NCT00296504|594171608|FG006|Final Analysis|Poor Adherence|0|||
164492297|NCT00296504|594171609|FG007|Final Analysis|Poor Adherence|0|||
164492298|NCT00296504|594171610|FG008|Final Analysis|Poor Adherence|1|||
164492299|NCT01878253|594171611|FG000|Overall Study|Death|1|||
164492300|NCT01878253|594171611|FG000|Overall Study|SIdus System Removal|3|||
164492301|NCT01878253|594171611|FG000|Overall Study|Withdrawal by Subject|1|||
164492302|NCT01878253|594171611|FG000|Overall Study|Lost to Follow-up|2|||
164492303|NCT01878253|594171611|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
164492304|NCT04393779|594171614|FG000|Overall Study|Death|1|||
164492305|NCT04393779|594171614|FG000|Overall Study|Device reintervention or explant|4|||
164492306|NCT01190228|594171617|FG000|Overall Study|Protocol Violation|4|||
164492307|NCT01190228|594171618|FG001|Overall Study|Protocol Violation|0|||
164492308|NCT01190228|594171619|FG002|Overall Study|Protocol Violation|0|||
164492309|NCT01190228|594171617|FG000|Overall Study|Withdrawal by Subject|1|||
164492310|NCT01190228|594171618|FG001|Overall Study|Withdrawal by Subject|0|||
164492311|NCT01190228|594171619|FG002|Overall Study|Withdrawal by Subject|0|||
164492312|NCT01395914|594171625|FG000|Overall Study|Unrelated to study drug AE|6|||
164492313|NCT01395914|594171626|FG001|Overall Study|Unrelated to study drug AE|1|||
164492314|NCT01395914|594171625|FG000|Overall Study|Death|23|||
164492315|NCT01395914|594171626|FG001|Overall Study|Death|17|||
164492316|NCT01395914|594171625|FG000|Overall Study|Other|9|||
164492317|NCT01395914|594171626|FG001|Overall Study|Other|3|||
164492318|NCT01395914|594171625|FG000|Overall Study|Withdrawal by patient|27|||
164492319|NCT01395914|594171626|FG001|Overall Study|Withdrawal by patient|14|||
164492320|NCT01395914|594171625|FG000|Overall Study|Study drug-related AE|1|||
164492321|NCT01395914|594171626|FG001|Overall Study|Study drug-related AE|0|||
164492322|NCT01395914|594171625|FG000|Overall Study|Lost to Follow-up|6|||
164492323|NCT01395914|594171626|FG001|Overall Study|Lost to Follow-up|2|||
164492324|NCT01648699|594171627|FG000|Overall Study|Death|1|||
164492325|NCT01648699|594171627|FG000|Overall Study|Lost to Follow-up|2|||
164492326|NCT01648699|594171627|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
164492327|NCT01812837|594171628|FG000|Overall Study|Lost to Follow-up|1|||
164492328|NCT01812837|594171629|FG001|Overall Study|Lost to Follow-up|1|||
164492329|NCT01812837|594171630|FG002|Overall Study|Lost to Follow-up|0|||
164492330|NCT01812837|594171628|FG000|Overall Study|Protocol Violation|1|||
164492331|NCT01812837|594171629|FG001|Overall Study|Protocol Violation|0|||
164492332|NCT01812837|594171630|FG002|Overall Study|Protocol Violation|0|||
164492333|NCT00288353|594171635|FG000|Overall Study|Lack of Efficacy|2|||
164492334|NCT00288353|594171636|FG001|Overall Study|Lack of Efficacy|2|||
164492335|NCT00288353|594171635|FG000|Overall Study|Withdrawal by Subject|5|||
164492336|NCT00288353|594171636|FG001|Overall Study|Withdrawal by Subject|5|||
164492337|NCT03219216|594171640|FG000|Overall Study|Lost to Follow-up|0|||
164492338|NCT03219216|594171641|FG001|Overall Study|Lost to Follow-up|1|||
164492339|NCT00512902|594171647|FG000|Overall Study|Adverse Event|7|||
164492340|NCT00512902|594171647|FG000|Overall Study|Lost to Follow-up|1|||
164492341|NCT02389894|594171648|FG000|Overall Study|Death|4|||
164492342|NCT02389894|594171649|FG001|Overall Study|Death|5|||
164492343|NCT02389894|594171650|FG002|Overall Study|Death|3|||
164492344|NCT02389894|594171648|FG000|Overall Study|Withdrawal by Subject|2|||
164492345|NCT02389894|594171649|FG001|Overall Study|Withdrawal by Subject|4|||
164492346|NCT02389894|594171650|FG002|Overall Study|Withdrawal by Subject|5|||
164492347|NCT02389894|594171648|FG000|Overall Study|Lost to Follow-up|2|||
164492348|NCT02389894|594171649|FG001|Overall Study|Lost to Follow-up|1|||
164492349|NCT02389894|594171650|FG002|Overall Study|Lost to Follow-up|1|||
164492350|NCT00145496|594171651|FG000|Overall Study|Adverse Event|42|||
164492351|NCT00145496|594171652|FG001|Overall Study|Adverse Event|30|||
164492352|NCT00145496|594171651|FG000|Overall Study|Lack of Efficacy|12|||
164492353|NCT00145496|594171652|FG001|Overall Study|Lack of Efficacy|7|||
164492354|NCT00145496|594171651|FG000|Overall Study|Withdrawal by Subject|32|||
164492355|NCT00145496|594171652|FG001|Overall Study|Withdrawal by Subject|26|||
164492356|NCT00145496|594171651|FG000|Overall Study|Lost to Follow-up|12|||
164492357|NCT00145496|594171652|FG001|Overall Study|Lost to Follow-up|5|||
164492358|NCT00145496|594171651|FG000|Overall Study|Other|25|||
164492359|NCT00145496|594171652|FG001|Overall Study|Other|13|||
164492360|NCT02312245|594171654|FG000|Overall Study|Death|0|||
164492361|NCT02312245|594171655|FG001|Overall Study|Death|0|||
164492362|NCT02312245|594171656|FG002|Overall Study|Death|0|||
164492363|NCT02312245|594171657|FG003|Overall Study|Death|1|||
164492364|NCT02312245|594171654|FG000|Overall Study|Withdrawal by Subject|1|||
164492365|NCT02312245|594171655|FG001|Overall Study|Withdrawal by Subject|1|||
164492366|NCT02312245|594171656|FG002|Overall Study|Withdrawal by Subject|0|||
164492367|NCT02312245|594171657|FG003|Overall Study|Withdrawal by Subject|2|||
164492368|NCT02312245|594171654|FG000|Overall Study|Alternative Therapy|1|||
164492369|NCT02312245|594171655|FG001|Overall Study|Alternative Therapy|0|||
164492370|NCT02312245|594171656|FG002|Overall Study|Alternative Therapy|0|||
164492371|NCT02312245|594171657|FG003|Overall Study|Alternative Therapy|0|||
164492372|NCT02312245|594171654|FG000|Overall Study|Progression|0|||
164492373|NCT02312245|594171655|FG001|Overall Study|Progression|0|||
164492374|NCT02312245|594171656|FG002|Overall Study|Progression|0|||
164492375|NCT02312245|594171657|FG003|Overall Study|Progression|5|||
164492376|NCT02312245|594171654|FG000|Overall Study|Patient went to hospice|0|||
164492377|NCT02312245|594171655|FG001|Overall Study|Patient went to hospice|0|||
164492378|NCT02312245|594171656|FG002|Overall Study|Patient went to hospice|0|||
164492379|NCT02312245|594171657|FG003|Overall Study|Patient went to hospice|1|||
164492380|NCT02312245|594171654|FG000|Overall Study|Ineligible|1|||
164492381|NCT02312245|594171655|FG001|Overall Study|Ineligible|0|||
164492382|NCT02312245|594171656|FG002|Overall Study|Ineligible|0|||
164492383|NCT02312245|594171657|FG003|Overall Study|Ineligible|0|||
164602695|NCT00571519|594567070|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
164492384|NCT01123200|594171658|FG000|Overall Study|Withdrawal by Subject|1|||
164492385|NCT02676778|594171660|FG000|Overall Study|Disease Progression|7|||
164492386|NCT02676778|594171661|FG001|Overall Study|Disease Progression|3|||
164492387|NCT02676778|594171662|FG002|Overall Study|Disease Progression|1|||
164492388|NCT02676778|594171660|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
164492389|NCT02676778|594171661|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
164492390|NCT02676778|594171662|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
164492391|NCT02676778|594171660|FG000|Overall Study|Withdrawal by Subject|3|||
164492392|NCT02676778|594171661|FG001|Overall Study|Withdrawal by Subject|2|||
164492393|NCT02676778|594171662|FG002|Overall Study|Withdrawal by Subject|0|||
164492394|NCT02676778|594171660|FG000|Overall Study|Other|4|||
164492395|NCT02676778|594171661|FG001|Overall Study|Other|3|||
164492396|NCT02676778|594171662|FG002|Overall Study|Other|0|||
164492397|NCT02676778|594171660|FG000|Overall Study|Adverse Event|2|||
164492398|NCT02676778|594171661|FG001|Overall Study|Adverse Event|3|||
164492399|NCT02676778|594171662|FG002|Overall Study|Adverse Event|0|||
164492400|NCT02577315|594171669|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
164492401|NCT02577315|594171670|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
164492402|NCT03686176|594171671|FG000|Overall Study|Procedure cancelled|1|||
164492403|NCT03686176|594171672|FG001|Overall Study|Procedure cancelled|0|||
164492404|NCT03686176|594171673|FG002|Overall Study|Procedure cancelled|0|||
164492405|NCT03686176|594171671|FG000|Overall Study|VR Malfunction|1|||
164492406|NCT03686176|594171672|FG001|Overall Study|VR Malfunction|0|||
164492407|NCT03686176|594171673|FG002|Overall Study|VR Malfunction|0|||
164492408|NCT02938520|594171674|FG000|Overall Study|On-going at the time of analysis|258|||
164492409|NCT02938520|594171675|FG001|Overall Study|On-going at the time of analysis|261|||
164492410|NCT02938520|594171674|FG000|Overall Study|Physician Decision|2|||
164492411|NCT02938520|594171675|FG001|Overall Study|Physician Decision|5|||
164492412|NCT02938520|594171674|FG000|Overall Study|Lost to Follow-up|2|||
164492413|NCT02938520|594171675|FG001|Overall Study|Lost to Follow-up|2|||
164492414|NCT02938520|594171674|FG000|Overall Study|Withdrawal by Subject|7|||
164492415|NCT02938520|594171675|FG001|Overall Study|Withdrawal by Subject|7|||
164492416|NCT02938520|594171674|FG000|Overall Study|Protocol Violation|0|||
164492417|NCT02938520|594171675|FG001|Overall Study|Protocol Violation|1|||
164492418|NCT02938520|594171674|FG000|Overall Study|Lack of Efficacy|5|||
164492419|NCT02938520|594171675|FG001|Overall Study|Lack of Efficacy|3|||
164492420|NCT02938520|594171674|FG000|Overall Study|Adverse Event|9|||
164492421|NCT02938520|594171675|FG001|Overall Study|Adverse Event|4|||
164492422|NCT00197106|594172943|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
164492423|NCT00197106|594172944|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
164492424|NCT00197106|594172945|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
164492425|NCT00197106|594172943|FG000|Overall Treatment Period|Lack of Efficacy|0|||
164492426|NCT00197106|594172944|FG001|Overall Treatment Period|Lack of Efficacy|1|||
164492427|NCT00197106|594172945|FG002|Overall Treatment Period|Lack of Efficacy|0|||
164492428|NCT00197106|594172943|FG000|Overall Treatment Period|Lost to Follow-up|0|||
164492429|NCT00197106|594172944|FG001|Overall Treatment Period|Lost to Follow-up|0|||
164492430|NCT00197106|594172945|FG002|Overall Treatment Period|Lost to Follow-up|2|||
164492431|NCT00197106|594172943|FG000|Overall Treatment Period|Protocol Violation|0|||
164492432|NCT00197106|594172944|FG001|Overall Treatment Period|Protocol Violation|0|||
164492433|NCT00197106|594172945|FG002|Overall Treatment Period|Protocol Violation|2|||
164492434|NCT00197106|594172943|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
164492435|NCT00197106|594172944|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
164492436|NCT00197106|594172945|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
164492437|NCT00111839|594172946|FG000|Overall Study|Disease Progression|30|||
164492438|NCT00111839|594172947|FG001|Overall Study|Disease Progression|33|||
164492439|NCT00111839|594172948|FG002|Overall Study|Disease Progression|33|||
164492440|NCT00111839|594172946|FG000|Overall Study|Adverse Event|5|||
164492441|NCT00111839|594172947|FG001|Overall Study|Adverse Event|3|||
164492442|NCT00111839|594172948|FG002|Overall Study|Adverse Event|1|||
164492443|NCT00111839|594172946|FG000|Overall Study|Protocol Violation|2|||
164492444|NCT00111839|594172947|FG001|Overall Study|Protocol Violation|4|||
164492445|NCT00111839|594172948|FG002|Overall Study|Protocol Violation|2|||
164492446|NCT00111839|594172946|FG000|Overall Study|Death|1|||
164492447|NCT00111839|594172947|FG001|Overall Study|Death|1|||
164492448|NCT00111839|594172948|FG002|Overall Study|Death|6|||
164492449|NCT00111839|594172946|FG000|Overall Study|Withdrawal by Subject|2|||
164492450|NCT00111839|594172947|FG001|Overall Study|Withdrawal by Subject|2|||
164492451|NCT00111839|594172948|FG002|Overall Study|Withdrawal by Subject|2|||
164492452|NCT00111839|594172946|FG000|Overall Study|Lost to Follow-up|1|||
164492453|NCT00111839|594172947|FG001|Overall Study|Lost to Follow-up|0|||
164492454|NCT00111839|594172948|FG002|Overall Study|Lost to Follow-up|0|||
164492455|NCT00111839|594172946|FG000|Overall Study|Logistical Constraint|1|||
164492456|NCT00111839|594172947|FG001|Overall Study|Logistical Constraint|0|||
164492457|NCT00111839|594172948|FG002|Overall Study|Logistical Constraint|0|||
164492458|NCT00111839|594172946|FG000|Overall Study|Other|6|||
164492459|NCT00111839|594172947|FG001|Overall Study|Other|3|||
164492460|NCT00111839|594172948|FG002|Overall Study|Other|3|||
164492461|NCT00111839|594172946|FG000|Overall Study|Randomized but Not Treated|0|||
164492462|NCT00111839|594172947|FG001|Overall Study|Randomized but Not Treated|0|||
164492463|NCT00111839|594172948|FG002|Overall Study|Randomized but Not Treated|2|||
164492464|NCT00762723|594172949|FG000|Overall Study|Study Terminated slow enrollement|5|||
164492465|NCT00762723|594172950|FG001|Overall Study|Study Terminated slow enrollement|5|||
164492466|NCT00762723|594172951|FG002|Overall Study|Study Terminated slow enrollement|3|||
164492467|NCT01078571|594172956|FG000|Overall Study|Adverse Event|36|||
164492468|NCT01078571|594172956|FG000|Overall Study|Lack of effectiveness|36|||
164492469|NCT01078571|594172956|FG000|Overall Study|Reason not reported|21|||
164492470|NCT01078571|594172956|FG000|Overall Study|Withdrawal by Subject|12|||
164492471|NCT01078571|594172956|FG000|Overall Study|Lost to Follow-up|8|||
164492472|NCT01078571|594172956|FG000|Overall Study|Protocol Violation|2|||
164492473|NCT00449033|594172966|FG000|Treatment Period|Adverse Event|117|||
164492474|NCT00449033|594172967|FG001|Treatment Period|Adverse Event|83|||
164492475|NCT00449033|594172966|FG000|Treatment Period|Death|21|||
164492476|NCT00449033|594172967|FG001|Treatment Period|Death|12|||
164492477|NCT00449033|594172966|FG000|Treatment Period|Lost to Follow-up|0|||
164492478|NCT00449033|594172967|FG001|Treatment Period|Lost to Follow-up|2|||
164492479|NCT00449033|594172966|FG000|Treatment Period|Physician Decision|4|||
164492480|NCT00449033|594172967|FG001|Treatment Period|Physician Decision|5|||
164492481|NCT00449033|594172966|FG000|Treatment Period|Protocol Violation|8|||
164492482|NCT00449033|594172967|FG001|Treatment Period|Protocol Violation|7|||
164492483|NCT00449033|594172966|FG000|Treatment Period|Disease Progression|231|||
164492484|NCT00449033|594172967|FG001|Treatment Period|Disease Progression|288|||
164492485|NCT00449033|594172966|FG000|Treatment Period|Consent Withdrawn|36|||
164492486|NCT00449033|594172967|FG001|Treatment Period|Consent Withdrawn|20|||
164492487|NCT00449033|594172966|FG000|Treatment Period|Amended Protocol Criteria|22|||
164492488|NCT00449033|594172967|FG001|Treatment Period|Amended Protocol Criteria|18|||
164492489|NCT00449033|594172966|FG000|Treatment Period|Non-compliance|7|||
164492490|NCT00449033|594172967|FG001|Treatment Period|Non-compliance|8|||
164492491|NCT00449033|594172966|FG000|Treatment Period|Second Malignancy|0|||
164492492|NCT00449033|594172967|FG001|Treatment Period|Second Malignancy|1|||
164492493|NCT00449033|594172966|FG000|Treatment Period|Reason Missing|0|||
164492494|NCT00449033|594172967|FG001|Treatment Period|Reason Missing|4|||
164492495|NCT00449033|594172966|FG000|Treatment Period|Treatment Ongoing|6|||
164492496|NCT00449033|594172967|FG001|Treatment Period|Treatment Ongoing|4|||
164492497|NCT00449033|594172966|FG000|Follow-up Period|Death|299|||
164492498|NCT00449033|594172967|FG001|Follow-up Period|Death|311|||
164492499|NCT00449033|594172966|FG000|Follow-up Period|Lost to Follow-up|6|||
164492500|NCT00449033|594172967|FG001|Follow-up Period|Lost to Follow-up|10|||
164492501|NCT00449033|594172966|FG000|Follow-up Period|Reason Missing|120|||
164492502|NCT00449033|594172967|FG001|Follow-up Period|Reason Missing|113|||
164492503|NCT03802513|594172969|FG000|Overall Study|Lost to Follow-up|1|||
164492504|NCT04115319|594172973|FG000|Overall Study|Randomized, but Withdrawn From Study Prior to Treatment|2|||
164492505|NCT04115319|594172974|FG001|Overall Study|Randomized, but Withdrawn From Study Prior to Treatment|0|||
164492506|NCT04115319|594172973|FG000|Overall Study|Withdrawal by participant|17|||
164492507|NCT04115319|594172974|FG001|Overall Study|Withdrawal by participant|9|||
164492508|NCT04115319|594172973|FG000|Overall Study|Geopolitical Conflict Related|2|||
164492509|NCT04115319|594172974|FG001|Overall Study|Geopolitical Conflict Related|1|||
164492510|NCT04115319|594172973|FG000|Overall Study|COVID-19 Related|1|||
164492511|NCT04115319|594172974|FG001|Overall Study|COVID-19 Related|0|||
164492512|NCT04115319|594172973|FG000|Overall Study|Adverse Event|48|||
164492513|NCT04115319|594172974|FG001|Overall Study|Adverse Event|21|||
164492514|NCT04115319|594172973|FG000|Overall Study|Noncompliance with Study Drug|5|||
164492515|NCT04115319|594172974|FG001|Overall Study|Noncompliance with Study Drug|1|||
164492516|NCT04115319|594172973|FG000|Overall Study|Lack of Efficacy|6|||
164492517|NCT04115319|594172974|FG001|Overall Study|Lack of Efficacy|2|||
164492518|NCT04115319|594172973|FG000|Overall Study|Lost to Follow-up|6|||
164492519|NCT04115319|594172974|FG001|Overall Study|Lost to Follow-up|7|||
164492520|NCT04115319|594172973|FG000|Overall Study|Protocol Deviation|5|||
164492521|NCT04115319|594172974|FG001|Overall Study|Protocol Deviation|1|||
164492522|NCT04115319|594172973|FG000|Overall Study|Participant relocated|5|||
164492523|NCT04115319|594172974|FG001|Overall Study|Participant relocated|2|||
164492524|NCT04115319|594172973|FG000|Overall Study|Personal Reasons|0|||
164492525|NCT04115319|594172974|FG001|Overall Study|Personal Reasons|1|||
164492526|NCT04115319|594172973|FG000|Overall Study|Deemed Unsuitable for Participation|1|||
164492527|NCT04115319|594172974|FG001|Overall Study|Deemed Unsuitable for Participation|0|||
164492528|NCT02256488|594172979|FG000|Overall Study|Lost to Follow-up|6|||
164492529|NCT02256488|594172980|FG001|Overall Study|Lost to Follow-up|6|||
164492530|NCT02256488|594172981|FG002|Overall Study|Lost to Follow-up|9|||
164492531|NCT02256488|594172982|FG003|Overall Study|Lost to Follow-up|3|||
164492532|NCT02256488|594172979|FG000|Overall Study|OTHER|1|||
164492533|NCT02256488|594172980|FG001|Overall Study|OTHER|0|||
164492534|NCT02256488|594172981|FG002|Overall Study|OTHER|1|||
164492535|NCT02256488|594172982|FG003|Overall Study|OTHER|1|||
164492536|NCT02256488|594172979|FG000|Overall Study|Withdrawal by Subject|1|||
164492537|NCT02256488|594172980|FG001|Overall Study|Withdrawal by Subject|0|||
164492538|NCT02256488|594172981|FG002|Overall Study|Withdrawal by Subject|0|||
164492539|NCT02256488|594172982|FG003|Overall Study|Withdrawal by Subject|2|||
164492540|NCT03305458|594172985|FG000|Overall Study|Withdrawal by Subject|50|||
164492541|NCT03305458|594172986|FG001|Overall Study|Withdrawal by Subject|46|||
164492542|NCT03305458|594172987|FG002|Overall Study|Withdrawal by Subject|93|||
164492543|NCT03305458|594172985|FG000|Overall Study|Lost to Follow-up|85|||
164492544|NCT03305458|594172986|FG001|Overall Study|Lost to Follow-up|85|||
164492545|NCT03305458|594172987|FG002|Overall Study|Lost to Follow-up|35|||
164602696|NCT00571519|594567071|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
164602697|NCT00571519|594567072|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
164492546|NCT03562117|594172988|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
164492547|NCT03562117|594172989|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
164492548|NCT03562117|594172990|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
164492549|NCT03928821|594172991|FG000|Overall Study|Death|0|||
164492550|NCT03928821|594172992|FG001|Overall Study|Death|1|||
164492551|NCT03928821|594172993|FG002|Overall Study|Death|0|||
164492552|NCT03928821|594172994|FG003|Overall Study|Death|0|||
164492553|NCT03928821|594172991|FG000|Overall Study|Lost to Follow-up|0|||
164492554|NCT03928821|594172992|FG001|Overall Study|Lost to Follow-up|2|||
164492555|NCT03928821|594172993|FG002|Overall Study|Lost to Follow-up|3|||
164492556|NCT03928821|594172994|FG003|Overall Study|Lost to Follow-up|0|||
164492557|NCT03928821|594172991|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
164492558|NCT03928821|594172992|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
164492559|NCT03928821|594172993|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
164492560|NCT03928821|594172994|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
164492561|NCT05615870|594173002|FG000|Overall Study|Lost to Follow-up|10|||
164492562|NCT05615870|594173003|FG001|Overall Study|Lost to Follow-up|13|||
164492563|NCT05615870|594173002|FG000|Overall Study|Physician Decision|2|||
164492564|NCT05615870|594173003|FG001|Overall Study|Physician Decision|0|||
164492565|NCT05615870|594173002|FG000|Overall Study|Withdrawal by Subject|0|||
164492566|NCT05615870|594173003|FG001|Overall Study|Withdrawal by Subject|2|||
164492567|NCT05615870|594173002|FG000|Overall Study|Protocol Violation|0|||
164492568|NCT05615870|594173003|FG001|Overall Study|Protocol Violation|3|||
164492569|NCT05615870|594173002|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
164492570|NCT05615870|594173003|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
164492571|NCT05615870|594173002|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
164492572|NCT05615870|594173003|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
164492573|NCT05615870|594173002|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
164492574|NCT05615870|594173003|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
164492575|NCT03520036|594173004|FG000|Overall Study|Adverse Event|1|||
164492576|NCT03520036|594173005|FG001|Overall Study|Adverse Event|2|||
164492577|NCT03520036|594173006|FG002|Overall Study|Adverse Event|0|||
164492578|NCT03520036|594173004|FG000|Overall Study|Protocol Violation|1|||
164492579|NCT03520036|594173005|FG001|Overall Study|Protocol Violation|0|||
164492580|NCT03520036|594173006|FG002|Overall Study|Protocol Violation|0|||
164492581|NCT03520036|594173004|FG000|Overall Study|Withdrawal by Subject|0|||
164492582|NCT03520036|594173005|FG001|Overall Study|Withdrawal by Subject|1|||
164492583|NCT03520036|594173006|FG002|Overall Study|Withdrawal by Subject|4|||
164492584|NCT03520036|594173004|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
164492585|NCT03520036|594173005|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
164492586|NCT03520036|594173006|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
164492587|NCT01855399|594173007|FG000|6 Month|Lost to Follow-up|12|||
164492588|NCT01855399|594173008|FG001|6 Month|Lost to Follow-up|9|||
164492589|NCT01855399|594173007|FG000|6 Month|Withdrawal by Subject|8|||
164492590|NCT01855399|594173008|FG001|6 Month|Withdrawal by Subject|6|||
164492591|NCT01855399|594173007|FG000|12 Month|Lost to Follow-up|7|||
164492592|NCT01855399|594173008|FG001|12 Month|Lost to Follow-up|11|||
164492593|NCT03019289|594173009|FG000|Overall Study|Adverse Event|1|||
164492594|NCT03019289|594173010|FG001|Overall Study|Adverse Event|0|||
164492595|NCT03019289|594173011|FG002|Overall Study|Adverse Event|0|||
164492596|NCT03019289|594173012|FG003|Overall Study|Adverse Event|0|||
164492597|NCT03019289|594173013|FG004|Overall Study|Adverse Event|0|||
164492598|NCT03019289|594173014|FG005|Overall Study|Adverse Event|0|||
164492599|NCT03019289|594173015|FG006|Overall Study|Adverse Event|0|||
164492600|NCT03019289|594173016|FG007|Overall Study|Adverse Event|0|||
164492601|NCT03019289|594173017|FG008|Overall Study|Adverse Event|1|||
164492602|NCT03019289|594173009|FG000|Overall Study|Other|1|||
164492603|NCT03019289|594173010|FG001|Overall Study|Other|0|||
164492604|NCT03019289|594173011|FG002|Overall Study|Other|0|||
164492605|NCT03019289|594173012|FG003|Overall Study|Other|0|||
164602698|NCT00571519|594567073|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
164492606|NCT03019289|594173013|FG004|Overall Study|Other|0|||
164492607|NCT03019289|594173014|FG005|Overall Study|Other|0|||
164492608|NCT03019289|594173015|FG006|Overall Study|Other|0|||
164492609|NCT03019289|594173016|FG007|Overall Study|Other|0|||
164492610|NCT03019289|594173017|FG008|Overall Study|Other|0|||
164492611|NCT04743999|594173018|FG000|3-month Questionnaire|Death|1|||
164602699|NCT00571519|594567074|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
164602700|NCT03057951|594567080|FG000|Overall Study|Adverse Event|553|||
164602701|NCT03057951|594567081|FG001|Overall Study|Adverse Event|575|||
164602702|NCT03057951|594567080|FG000|Overall Study|Protocol Violation|30|||
164602703|NCT03057951|594567081|FG001|Overall Study|Protocol Violation|24|||
164492612|NCT04743999|594173018|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
164492613|NCT04743999|594173018|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
164492614|NCT04743999|594173018|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
164492615|NCT01721759|594173019|FG000|Treatment Period|Disease Progression|85|||
164492616|NCT01721759|594173019|FG000|Treatment Period|Study drug toxicity|14|||
164492617|NCT01721759|594173019|FG000|Treatment Period|Death|1|||
164492618|NCT01721759|594173019|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
164492619|NCT01721759|594173019|FG000|Treatment Period|Participant request to withdraw|3|||
164492620|NCT01721759|594173019|FG000|Treatment Period|Other Reasons|3|||
164492621|NCT01721759|594173019|FG000|End of Study Period|Participant Withdrew Consent|5|||
164492622|NCT01721759|594173019|FG000|End of Study Period|Death|101|||
164492623|NCT01721759|594173019|FG000|End of Study Period|Lost to Follow-up|1|||
164492624|NCT01721759|594173019|FG000|End of Study Period|Other Reasons|10|||
164492625|NCT03926117|594173020|FG000|Overall Study|Unclassified|1|||
164492626|NCT03926117|594173021|FG001|Overall Study|Unclassified|4|||
164492627|NCT03926117|594173022|FG002|Overall Study|Unclassified|1|||
164492628|NCT03926117|594173023|FG003|Overall Study|Unclassified|4|||
164492629|NCT03926117|594173020|FG000|Overall Study|Withdrawal by Subject|3|||
164492630|NCT03926117|594173021|FG001|Overall Study|Withdrawal by Subject|0|||
164492631|NCT03926117|594173022|FG002|Overall Study|Withdrawal by Subject|1|||
164492632|NCT03926117|594173023|FG003|Overall Study|Withdrawal by Subject|1|||
164492633|NCT03926117|594173020|FG000|Overall Study|Lost to Follow-up|0|||
164492634|NCT03926117|594173021|FG001|Overall Study|Lost to Follow-up|2|||
164492635|NCT03926117|594173022|FG002|Overall Study|Lost to Follow-up|1|||
164492636|NCT03926117|594173023|FG003|Overall Study|Lost to Follow-up|0|||
164492637|NCT03926117|594173020|FG000|Overall Study|Adverse Event|1|||
164492638|NCT03926117|594173021|FG001|Overall Study|Adverse Event|2|||
164492639|NCT03926117|594173022|FG002|Overall Study|Adverse Event|3|||
164492640|NCT03926117|594173023|FG003|Overall Study|Adverse Event|1|||
164492641|NCT03926117|594173020|FG000|Overall Study|Randomized but not treated|1|||
164492642|NCT03926117|594173021|FG001|Overall Study|Randomized but not treated|1|||
164492643|NCT03926117|594173022|FG002|Overall Study|Randomized but not treated|0|||
164492644|NCT03926117|594173023|FG003|Overall Study|Randomized but not treated|1|||
164492645|NCT03138499|594173024|FG000|Overall Study|Lost to Follow-up|1|||
164492646|NCT03138499|594173025|FG001|Overall Study|Lost to Follow-up|0|||
164492647|NCT03138499|594173024|FG000|Overall Study|Participants withdrew consent|1|||
164492648|NCT03138499|594173025|FG001|Overall Study|Participants withdrew consent|0|||
164492649|NCT03138499|594173024|FG000|Overall Study|Participant discontinued study before treatment|0|||
164492650|NCT03138499|594173025|FG001|Overall Study|Participant discontinued study before treatment|1|||
164492651|NCT03138499|594173024|FG000|Overall Study|Disease Progression|2|||
164492652|NCT03138499|594173025|FG001|Overall Study|Disease Progression|6|||
164492653|NCT03138499|594173024|FG000|Overall Study|Study drug toxicity|2|||
164492654|NCT03138499|594173025|FG001|Overall Study|Study drug toxicity|2|||
164492655|NCT03138499|594173024|FG000|Overall Study|Participant request to discontinue study treatment|1|||
164492656|NCT03138499|594173025|FG001|Overall Study|Participant request to discontinue study treatment|1|||
164492657|NCT03138499|594173024|FG000|Overall Study|Other reasons|2|||
164492658|NCT03138499|594173025|FG001|Overall Study|Other reasons|0|||
164492659|NCT01334606|594173026|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
164492660|NCT01288729|594173030|FG000|Overall Study|Withdrawal by Subject|1|||
164492661|NCT01288729|594173031|FG001|Overall Study|Withdrawal by Subject|0|||
164492662|NCT03214198|594173032|FG000|Overall Study|Case Report Forms Uncollected|18|||
164492663|NCT03214198|594173032|FG000|Overall Study|Protocol Deviation|18|||
164492664|NCT01636778|594173037|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
164492665|NCT01636778|594173038|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
164492666|NCT01636778|594173039|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
164492667|NCT01636778|594173037|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
164492668|NCT01636778|594173038|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
164492669|NCT01636778|594173039|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
164492670|NCT01636778|594173037|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
164492671|NCT01636778|594173038|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
164492672|NCT01636778|594173039|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
164492673|NCT01636778|594173037|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
164492674|NCT01636778|594173038|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
164602704|NCT03057951|594567080|FG000|Overall Study|Lost to Follow-up|6|||
164602705|NCT03057951|594567081|FG001|Overall Study|Lost to Follow-up|16|||
164602706|NCT03057951|594567080|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
164602707|NCT03057951|594567081|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
164602708|NCT03057951|594567080|FG000|Overall Study|Study drug stopped, reason missing|6|||
164602709|NCT03057951|594567081|FG001|Overall Study|Study drug stopped, reason missing|1|||
164602710|NCT03057951|594567080|FG000|Overall Study|Medical advice|6|||
164602711|NCT03057951|594567081|FG001|Overall Study|Medical advice|2|||
164602712|NCT03057951|594567080|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
164602713|NCT03057951|594567081|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
164602714|NCT03057951|594567080|FG000|Overall Study|Investigator decision|2|||
164602715|NCT03057951|594567081|FG001|Overall Study|Investigator decision|0|||
164602716|NCT03057951|594567080|FG000|Overall Study|Patient decision|5|||
164602717|NCT03057951|594567081|FG001|Overall Study|Patient decision|2|||
164602718|NCT03057951|594567080|FG000|Overall Study|Not attending study visits|3|||
164602719|NCT03057951|594567081|FG001|Overall Study|Not attending study visits|0|||
164602720|NCT03057951|594567080|FG000|Overall Study|Patient moved away|3|||
164602721|NCT03057951|594567081|FG001|Overall Study|Patient moved away|4|||
164602722|NCT03057951|594567080|FG000|Overall Study|Other reason than stated above|23|||
164602723|NCT03057951|594567081|FG001|Overall Study|Other reason than stated above|29|||
164602724|NCT03057951|594567080|FG000|Overall Study|Not treated|2|||
164602725|NCT03057951|594567081|FG001|Overall Study|Not treated|1|||
164602726|NCT03434418|594567082|FG000|Overall Study|Disease Progression|11|||
164602727|NCT03434418|594567082|FG000|Overall Study|Adverse Event|2|||
164602728|NCT03434418|594567082|FG000|Overall Study|Physician Decision|1|||
164602729|NCT03434418|594567082|FG000|Overall Study|Decline in Performance Status (PS)|1|||
164602730|NCT00696436|594567084|FG000|Overall Study|Adverse Event|7|||
164602731|NCT00696436|594567085|FG001|Overall Study|Adverse Event|9|||
164602732|NCT00696436|594567086|FG002|Overall Study|Adverse Event|8|||
164602733|NCT00696436|594567087|FG003|Overall Study|Adverse Event|6|||
164602734|NCT00696436|594567088|FG004|Overall Study|Adverse Event|4|||
164602735|NCT00696436|594567084|FG000|Overall Study|Protocol Violation|3|||
164602736|NCT00696436|594567085|FG001|Overall Study|Protocol Violation|2|||
164602737|NCT00696436|594567086|FG002|Overall Study|Protocol Violation|2|||
164602738|NCT00696436|594567087|FG003|Overall Study|Protocol Violation|0|||
164602739|NCT00696436|594567088|FG004|Overall Study|Protocol Violation|1|||
164602740|NCT00696436|594567084|FG000|Overall Study|Lost to Follow-up|1|||
164602741|NCT00696436|594567085|FG001|Overall Study|Lost to Follow-up|6|||
164602742|NCT00696436|594567086|FG002|Overall Study|Lost to Follow-up|2|||
164602743|NCT00696436|594567087|FG003|Overall Study|Lost to Follow-up|4|||
164602744|NCT00696436|594567088|FG004|Overall Study|Lost to Follow-up|3|||
164602745|NCT00696436|594567084|FG000|Overall Study|Withdrawal by Subject|4|||
164602746|NCT00696436|594567085|FG001|Overall Study|Withdrawal by Subject|11|||
164602747|NCT00696436|594567086|FG002|Overall Study|Withdrawal by Subject|5|||
164602748|NCT00696436|594567087|FG003|Overall Study|Withdrawal by Subject|7|||
164602749|NCT00696436|594567088|FG004|Overall Study|Withdrawal by Subject|1|||
164602750|NCT00696436|594567084|FG000|Overall Study|Lack of Efficacy|3|||
164602751|NCT00696436|594567085|FG001|Overall Study|Lack of Efficacy|1|||
164602752|NCT00696436|594567086|FG002|Overall Study|Lack of Efficacy|5|||
164602753|NCT00696436|594567087|FG003|Overall Study|Lack of Efficacy|2|||
164602754|NCT00696436|594567088|FG004|Overall Study|Lack of Efficacy|4|||
164602755|NCT00696436|594567084|FG000|Overall Study|Participant Unavailability|2|||
164602756|NCT00696436|594567085|FG001|Overall Study|Participant Unavailability|0|||
164602757|NCT00696436|594567086|FG002|Overall Study|Participant Unavailability|2|||
164602758|NCT00696436|594567087|FG003|Overall Study|Participant Unavailability|1|||
164602759|NCT00696436|594567088|FG004|Overall Study|Participant Unavailability|0|||
164492675|NCT01636778|594173039|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
164492676|NCT01636778|594173037|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
164492677|NCT01636778|594173038|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
164492678|NCT01636778|594173039|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
164492679|NCT01636778|594173037|FG000|Follow-up Period After Part 2|Other|0|||
164492680|NCT01636778|594173038|FG001|Follow-up Period After Part 2|Other|0|||
164492681|NCT01636778|594173039|FG002|Follow-up Period After Part 2|Other|1|||
164492682|NCT01636778|594173037|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
164602760|NCT00696436|594567084|FG000|Overall Study|Administrative Error|2|||
164602761|NCT00696436|594567085|FG001|Overall Study|Administrative Error|0|||
164602762|NCT00696436|594567086|FG002|Overall Study|Administrative Error|2|||
164602763|NCT00696436|594567087|FG003|Overall Study|Administrative Error|0|||
164602764|NCT00696436|594567088|FG004|Overall Study|Administrative Error|0|||
164602765|NCT00696436|594567084|FG000|Overall Study|Participant Non-compliance|0|||
164602766|NCT00696436|594567085|FG001|Overall Study|Participant Non-compliance|0|||
164492683|NCT01636778|594173038|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
164492684|NCT01636778|594173039|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
164602767|NCT00696436|594567086|FG002|Overall Study|Participant Non-compliance|1|||
164602768|NCT00696436|594567087|FG003|Overall Study|Participant Non-compliance|2|||
164602769|NCT00696436|594567088|FG004|Overall Study|Participant Non-compliance|0|||
164602770|NCT00696436|594567084|FG000|Overall Study|Administrative Decision|1|||
164602771|NCT00696436|594567085|FG001|Overall Study|Administrative Decision|0|||
164602772|NCT00696436|594567086|FG002|Overall Study|Administrative Decision|0|||
164602773|NCT00696436|594567087|FG003|Overall Study|Administrative Decision|0|||
164602774|NCT00696436|594567088|FG004|Overall Study|Administrative Decision|0|||
164602775|NCT00696436|594567084|FG000|Overall Study|Missing|0|||
164602776|NCT00696436|594567085|FG001|Overall Study|Missing|1|||
164602777|NCT00696436|594567086|FG002|Overall Study|Missing|1|||
164492685|NCT01636778|594173037|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
164492686|NCT01636778|594173038|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
164602778|NCT00696436|594567087|FG003|Overall Study|Missing|0|||
164602779|NCT00696436|594567088|FG004|Overall Study|Missing|0|||
164602780|NCT03039738|594567090|FG000|Overall Study|Incomplete data sets|54|||
164602781|NCT03039738|594567091|FG001|Overall Study|Incomplete data sets|0|||
164602782|NCT01293006|594567095|FG000|Period 2|Lost to Follow-up|1|||
164602783|NCT01293006|594567096|FG001|Period 2|Lost to Follow-up|0|||
164602784|NCT01293006|594567097|FG002|Period 2|Lost to Follow-up|0|||
164602785|NCT01293006|594567098|FG003|Period 2|Lost to Follow-up|0|||
164602786|NCT01494987|594567099|FG000|Overall Study|Adverse Event|6|||
164602787|NCT01494987|594567100|FG001|Overall Study|Adverse Event|5|||
164602788|NCT01494987|594567099|FG000|Overall Study|Hyperglycemia|6|||
164602789|NCT01494987|594567100|FG001|Overall Study|Hyperglycemia|4|||
164602790|NCT01494987|594567099|FG000|Overall Study|Investigator's Discretion|1|||
164602791|NCT01494987|594567100|FG001|Overall Study|Investigator's Discretion|2|||
164602792|NCT01494987|594567099|FG000|Overall Study|Lost to Follow-up|1|||
164602793|NCT01494987|594567100|FG001|Overall Study|Lost to Follow-up|1|||
164602794|NCT01494987|594567099|FG000|Overall Study|Protocol Violation|3|||
164602795|NCT01494987|594567100|FG001|Overall Study|Protocol Violation|3|||
164602796|NCT01494987|594567099|FG000|Overall Study|Subject Non-Compliance|9|||
164602797|NCT01494987|594567100|FG001|Overall Study|Subject Non-Compliance|10|||
164602798|NCT01494987|594567099|FG000|Overall Study|Subject Withdrew Consent|2|||
164492687|NCT01636778|594173039|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
164492688|NCT00990821|594173043|FG000|Overall Study|Withdrawal by Subject|0|||
164492689|NCT00990821|594173044|FG001|Overall Study|Withdrawal by Subject|2|||
164492690|NCT00990821|594173045|FG002|Overall Study|Withdrawal by Subject|0|||
164492691|NCT00990821|594173046|FG003|Overall Study|Withdrawal by Subject|0|||
164492692|NCT00990821|594173047|FG004|Overall Study|Withdrawal by Subject|3|||
164492693|NCT00990821|594173048|FG005|Overall Study|Withdrawal by Subject|3|||
164492694|NCT00990821|594173049|FG006|Overall Study|Withdrawal by Subject|1|||
164492695|NCT00990821|594173050|FG007|Overall Study|Withdrawal by Subject|0|||
164492696|NCT00990821|594173051|FG008|Overall Study|Withdrawal by Subject|0|||
164492697|NCT00990821|594173052|FG009|Overall Study|Withdrawal by Subject|1|||
164492698|NCT00990821|594173053|FG010|Overall Study|Withdrawal by Subject|3|||
164492699|NCT00990821|594173054|FG011|Overall Study|Withdrawal by Subject|5|||
164492700|NCT00990821|594173055|FG012|Overall Study|Withdrawal by Subject|2|||
164492701|NCT00990821|594173056|FG013|Overall Study|Withdrawal by Subject|1|||
164492702|NCT03530345|594173057|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
164492703|NCT03530345|594173058|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
164492704|NCT03530345|594173057|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
164492705|NCT03530345|594173058|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
164492706|NCT03530345|594173057|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
164492707|NCT03530345|594173058|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
164492708|NCT03530345|594173057|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
164492709|NCT03530345|594173058|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
164492710|NCT04150250|594173059|FG000|Overall Study|Lost to Follow-up|0|||
164492711|NCT04150250|594173060|FG001|Overall Study|Lost to Follow-up|2|||
164492712|NCT00170950|594173066|FG000|Overall Study|Death|236|||
164492713|NCT00170950|594173067|FG001|Overall Study|Death|274|||
164492714|NCT00170950|594173066|FG000|Overall Study|Withdrawal by Subject|496|||
164492715|NCT00170950|594173067|FG001|Overall Study|Withdrawal by Subject|498|||
164492716|NCT00170950|594173066|FG000|Overall Study|Lost to Follow-up|134|||
164492717|NCT00170950|594173067|FG001|Overall Study|Lost to Follow-up|115|||
164492718|NCT00170950|594173066|FG000|Overall Study|Missing|2|||
164492719|NCT00170950|594173067|FG001|Overall Study|Missing|1|||
164492720|NCT00170950|594173066|FG000|Overall Study|Termination Data Not Recorded|17|||
164492721|NCT00170950|594173067|FG001|Overall Study|Termination Data Not Recorded|22|||
164492722|NCT00748098|594173068|FG000|First Treatment Intervention Period|Adverse Event|1|||
164492723|NCT00748098|594173069|FG001|First Treatment Intervention Period|Adverse Event|1|||
164492724|NCT00748098|594173068|FG000|First Treatment Intervention Period|Protocol Violation|1|||
164492725|NCT00748098|594173069|FG001|First Treatment Intervention Period|Protocol Violation|0|||
164492726|NCT00748098|594173068|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
164492727|NCT00748098|594173069|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
164492728|NCT00748098|594173068|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
164492729|NCT00748098|594173069|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
164492730|NCT00748098|594173068|FG000|First Taper Period|Protocol Violation|1|||
164492731|NCT00748098|594173069|FG001|First Taper Period|Protocol Violation|0|||
164492732|NCT00748098|594173068|FG000|First Taper Period|Withdrawal by Subject|2|||
164492733|NCT00748098|594173069|FG001|First Taper Period|Withdrawal by Subject|0|||
164492734|NCT00748098|594173068|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
164602799|NCT01494987|594567100|FG001|Overall Study|Subject Withdrew Consent|3|||
164602800|NCT02716194|594567106|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
164602801|NCT02716194|594567107|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
164602802|NCT02716194|594567108|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
164492735|NCT00748098|594173069|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
164492736|NCT00748098|594173068|FG000|1-Week Washout Period|Adverse Event|0|||
164492737|NCT00748098|594173069|FG001|1-Week Washout Period|Adverse Event|1|||
164492738|NCT00748098|594173068|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
164492739|NCT00748098|594173069|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
164492740|NCT00748098|594173068|FG000|Second Treatment Intervention Period|Adverse Event|4|||
164492741|NCT00748098|594173069|FG001|Second Treatment Intervention Period|Adverse Event|1|||
164492742|NCT00748098|594173068|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
164492743|NCT00748098|594173069|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
164492744|NCT00748098|594173068|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
164492745|NCT00748098|594173069|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
164492746|NCT02442622|594173072|FG000|Overall Study|Withdrawal by Subject|3|||
164492747|NCT02442622|594173073|FG001|Overall Study|Withdrawal by Subject|1|||
164492748|NCT00506922|594174095|FG000|Overall Study|Physician Decision|0|||
164492749|NCT00506922|594174096|FG001|Overall Study|Physician Decision|0|||
164492750|NCT00506922|594174097|FG002|Overall Study|Physician Decision|0|||
164492751|NCT00506922|594174098|FG003|Overall Study|Physician Decision|2|||
164492752|NCT00506922|594174099|FG004|Overall Study|Physician Decision|0|||
164492753|NCT00506922|594174095|FG000|Overall Study|Withdrawal by Subject|0|||
164492754|NCT00506922|594174096|FG001|Overall Study|Withdrawal by Subject|0|||
164492755|NCT00506922|594174097|FG002|Overall Study|Withdrawal by Subject|0|||
164492756|NCT00506922|594174098|FG003|Overall Study|Withdrawal by Subject|0|||
164492757|NCT00506922|594174099|FG004|Overall Study|Withdrawal by Subject|1|||
164492758|NCT04816708|594174105|FG000|Overall Study|Lost to Follow-up|10|||
164492759|NCT04816708|594174106|FG001|Overall Study|Lost to Follow-up|4|||
164492760|NCT03596905|594174107|FG000|Overall Study|Protocol Violation|0|||
164492761|NCT03596905|594174108|FG001|Overall Study|Protocol Violation|0|||
164492762|NCT03596905|594174109|FG002|Overall Study|Protocol Violation|0|||
164492763|NCT03596905|594174110|FG003|Overall Study|Protocol Violation|0|||
164492764|NCT03596905|594174111|FG004|Overall Study|Protocol Violation|1|||
164492765|NCT03596905|594174112|FG005|Overall Study|Protocol Violation|0|||
164492766|NCT03596905|594174113|FG006|Overall Study|Protocol Violation|0|||
164492767|NCT03596905|594174107|FG000|Overall Study|Withdrawal by Subject|0|||
164492768|NCT03596905|594174108|FG001|Overall Study|Withdrawal by Subject|2|||
164492769|NCT03596905|594174109|FG002|Overall Study|Withdrawal by Subject|1|||
164492770|NCT03596905|594174110|FG003|Overall Study|Withdrawal by Subject|0|||
164492771|NCT03596905|594174111|FG004|Overall Study|Withdrawal by Subject|2|||
164492772|NCT03596905|594174112|FG005|Overall Study|Withdrawal by Subject|0|||
164492773|NCT03596905|594174113|FG006|Overall Study|Withdrawal by Subject|0|||
164492774|NCT03596905|594174107|FG000|Overall Study|Participant moved and was unable to complete study|0|||
164492775|NCT03596905|594174108|FG001|Overall Study|Participant moved and was unable to complete study|1|||
164492776|NCT03596905|594174109|FG002|Overall Study|Participant moved and was unable to complete study|0|||
164492777|NCT03596905|594174110|FG003|Overall Study|Participant moved and was unable to complete study|0|||
164492778|NCT03596905|594174111|FG004|Overall Study|Participant moved and was unable to complete study|0|||
164492779|NCT03596905|594174112|FG005|Overall Study|Participant moved and was unable to complete study|0|||
164492780|NCT03596905|594174113|FG006|Overall Study|Participant moved and was unable to complete study|0|||
164492781|NCT03596905|594174107|FG000|Overall Study|Adverse Event|0|||
164492782|NCT03596905|594174108|FG001|Overall Study|Adverse Event|0|||
164492783|NCT03596905|594174109|FG002|Overall Study|Adverse Event|0|||
164492784|NCT03596905|594174110|FG003|Overall Study|Adverse Event|0|||
164492785|NCT03596905|594174111|FG004|Overall Study|Adverse Event|0|||
164492786|NCT03596905|594174112|FG005|Overall Study|Adverse Event|0|||
164492787|NCT03596905|594174113|FG006|Overall Study|Adverse Event|1|||
164492788|NCT03596905|594174107|FG000|Overall Study|Non-Compliance with eDiary|1|||
164492789|NCT03596905|594174108|FG001|Overall Study|Non-Compliance with eDiary|0|||
164492790|NCT03596905|594174109|FG002|Overall Study|Non-Compliance with eDiary|0|||
164492791|NCT03596905|594174110|FG003|Overall Study|Non-Compliance with eDiary|0|||
164492792|NCT03596905|594174111|FG004|Overall Study|Non-Compliance with eDiary|1|||
164492793|NCT03596905|594174112|FG005|Overall Study|Non-Compliance with eDiary|0|||
164492794|NCT03596905|594174113|FG006|Overall Study|Non-Compliance with eDiary|2|||
164492795|NCT03596905|594174107|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164492796|NCT03596905|594174108|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164492797|NCT03596905|594174109|FG002|Overall Study|Non-Compliance with Study Drug|0|||
164492798|NCT03596905|594174110|FG003|Overall Study|Non-Compliance with Study Drug|0|||
164492799|NCT03596905|594174111|FG004|Overall Study|Non-Compliance with Study Drug|1|||
164492800|NCT03596905|594174112|FG005|Overall Study|Non-Compliance with Study Drug|0|||
164492801|NCT03596905|594174113|FG006|Overall Study|Non-Compliance with Study Drug|0|||
164492802|NCT03596905|594174107|FG000|Overall Study|Lost to Follow-up|0|||
164492803|NCT03596905|594174108|FG001|Overall Study|Lost to Follow-up|0|||
164492804|NCT03596905|594174109|FG002|Overall Study|Lost to Follow-up|0|||
164492805|NCT03596905|594174110|FG003|Overall Study|Lost to Follow-up|0|||
164492806|NCT03596905|594174111|FG004|Overall Study|Lost to Follow-up|0|||
164492807|NCT03596905|594174112|FG005|Overall Study|Lost to Follow-up|1|||
164492808|NCT03596905|594174113|FG006|Overall Study|Lost to Follow-up|0|||
164602803|NCT00363051|594567109|FG000|Overall Study|Adminstrative problems|1|||
164602804|NCT00363051|594567110|FG001|Overall Study|Adminstrative problems|1|||
164602805|NCT00363051|594567109|FG000|Overall Study|Adverse Event|21|||
164602806|NCT00363051|594567110|FG001|Overall Study|Adverse Event|12|||
164602807|NCT00363051|594567109|FG000|Overall Study|New Cancer Therapy|2|||
164602808|NCT00363051|594567110|FG001|Overall Study|New Cancer Therapy|1|||
164602809|NCT00363051|594567109|FG000|Overall Study|Withdrawal by Subject|11|||
164602810|NCT00363051|594567110|FG001|Overall Study|Withdrawal by Subject|3|||
164602811|NCT00363051|594567109|FG000|Overall Study|Lost to Follow-up|0|||
164602812|NCT00363051|594567110|FG001|Overall Study|Lost to Follow-up|1|||
164602813|NCT00363051|594567109|FG000|Overall Study|Protocol Violation|0|||
164602814|NCT00363051|594567110|FG001|Overall Study|Protocol Violation|2|||
164602815|NCT00363051|594567109|FG000|Overall Study|Death|3|||
164602816|NCT00363051|594567110|FG001|Overall Study|Death|2|||
164602817|NCT02293993|594567111|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
164602818|NCT02293993|594567112|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
164602819|NCT02293993|594567113|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
164602820|NCT02293993|594567114|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
164602821|NCT02293993|594567111|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
164602822|NCT02293993|594567112|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
164602823|NCT02293993|594567113|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
164602824|NCT02293993|594567114|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
164602825|NCT02293993|594567111|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
164602826|NCT02293993|594567112|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
164602827|NCT02293993|594567113|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
164602828|NCT02293993|594567114|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
164602829|NCT02293993|594567111|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
164602830|NCT02293993|594567112|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
164602831|NCT02293993|594567113|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
164602832|NCT02293993|594567114|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
164602833|NCT02293993|594567111|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
164602834|NCT02293993|594567112|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
164602835|NCT02293993|594567113|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
164602836|NCT02293993|594567114|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
164602837|NCT00205699|594567115|FG000|Overall Study|Lost to Follow-up|1|||
164602838|NCT00205699|594567116|FG001|Overall Study|Lost to Follow-up|3|||
164602839|NCT00205699|594567117|FG002|Overall Study|Lost to Follow-up|5|||
164602840|NCT00205699|594567115|FG000|Overall Study|Adverse Event|1|||
164602841|NCT00205699|594567116|FG001|Overall Study|Adverse Event|0|||
164602842|NCT00205699|594567117|FG002|Overall Study|Adverse Event|0|||
164602843|NCT00205699|594567115|FG000|Overall Study|Withdrawal by Subject|1|||
164714945|NCT04642365|594978835|FG004|Overall Study|Withdrawal by Subject|0|||
164714946|NCT04642365|594978836|FG005|Overall Study|Withdrawal by Subject|0|||
164714947|NCT04642365|594978837|FG006|Overall Study|Withdrawal by Subject|2|||
164492809|NCT00508274|594174114|FG000|Overall Study|Adverse Event|5|||
164492810|NCT00508274|594174114|FG000|Overall Study|Death|7|||
164492811|NCT00508274|594174114|FG000|Overall Study|Disease progression|32|||
164492812|NCT00508274|594174114|FG000|Overall Study|Withdrawal by Subject|1|||
164492813|NCT00508274|594174114|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
164492814|NCT00508274|594174114|FG000|Overall Study|Missing|3|||
164492815|NCT02531126|594174118|FG000|Overall Study|Non-compliance with protocol/protocol deviation|5|||
164492816|NCT02531126|594174119|FG001|Overall Study|Non-compliance with protocol/protocol deviation|0|||
164492817|NCT02531126|594174120|FG002|Overall Study|Non-compliance with protocol/protocol deviation|3|||
164492818|NCT02531126|594174121|FG003|Overall Study|Non-compliance with protocol/protocol deviation|0|||
164492819|NCT02531126|594174118|FG000|Overall Study|Adverse Event|16|||
164492820|NCT02531126|594174119|FG001|Overall Study|Adverse Event|13|||
164492821|NCT02531126|594174120|FG002|Overall Study|Adverse Event|27|||
164492822|NCT02531126|594174121|FG003|Overall Study|Adverse Event|4|||
164602844|NCT00205699|594567116|FG001|Overall Study|Withdrawal by Subject|2|||
164602845|NCT00205699|594567117|FG002|Overall Study|Withdrawal by Subject|1|||
164602846|NCT00205699|594567115|FG000|Overall Study|Lack of Efficacy|0|||
164602847|NCT00205699|594567116|FG001|Overall Study|Lack of Efficacy|1|||
164602848|NCT00205699|594567117|FG002|Overall Study|Lack of Efficacy|0|||
164714948|NCT04642365|594978838|FG007|Overall Study|Withdrawal by Subject|0|||
164602849|NCT03587584|594567118|FG000|Overall Study|SOC deviations|4|||
164602850|NCT03587584|594567119|FG001|Overall Study|SOC deviations|6|||
164602851|NCT03587584|594567118|FG000|Overall Study|Incomplete data|0|||
164714949|NCT04642365|594978831|FG000|Overall Study|Adverse Event|0|||
164602852|NCT03587584|594567119|FG001|Overall Study|Incomplete data|3|||
164602853|NCT01207388|594567126|FG000|Overall Study|Death|67|||
164602854|NCT01207388|594567126|FG000|Overall Study|Withdrawal by Subject|1|||
164602855|NCT01677507|594567127|FG000|Initial Assignment|Adverse Event|0|||
164602856|NCT01677507|594567128|FG001|Initial Assignment|Adverse Event|1|||
164602857|NCT01677507|594567127|FG000|Initial Assignment|Protocol Violation|0|||
164602858|NCT01677507|594567128|FG001|Initial Assignment|Protocol Violation|1|||
164602859|NCT01677507|594567127|FG000|Second Assigment|Withdrawal by Subject|2|||
164602860|NCT01677507|594567128|FG001|Second Assigment|Withdrawal by Subject|2|||
164602861|NCT01677507|594567127|FG000|Second Assigment|Adverse Event|1|||
164602862|NCT01677507|594567128|FG001|Second Assigment|Adverse Event|3|||
164602863|NCT00469209|594567129|FG000|Overall Study|Adverse Event|1|||
164602864|NCT00469209|594567130|FG001|Overall Study|Adverse Event|0|||
164602865|NCT00469209|594567131|FG002|Overall Study|Adverse Event|1|||
164602866|NCT01194869|594567134|FG000|Overall Study|Disease Progression|2|||
164602867|NCT01194869|594567134|FG000|Overall Study|Toxicity|2|||
164602868|NCT06087328|594567138|FG000|28-Day Treatment|Lost to Follow-up|7|||
164602869|NCT06087328|594567139|FG001|28-Day Treatment|Lost to Follow-up|3|||
164602870|NCT06087328|594567140|FG002|28-Day Treatment|Lost to Follow-up|4|||
164602871|NCT06087328|594567138|FG000|1-month Follow-up|Lost to Follow-up|0|||
164602872|NCT06087328|594567139|FG001|1-month Follow-up|Lost to Follow-up|1|||
164602873|NCT06087328|594567140|FG002|1-month Follow-up|Lost to Follow-up|1|||
164602874|NCT03589326|594567141|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
164602875|NCT03589326|594567142|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
164602876|NCT03589326|594567141|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
164602877|NCT03589326|594567142|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
164602878|NCT03589326|594567141|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
164602879|NCT03589326|594567142|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
164602880|NCT03589326|594567141|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
164602881|NCT03589326|594567142|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
164602882|NCT03589326|594567141|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
164602883|NCT03589326|594567142|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
164602884|NCT04465396|594567145|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
164602885|NCT04465396|594567146|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
164602886|NCT04465396|594567147|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
164602887|NCT04465396|594567148|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
164602888|NCT00434122|594567149|FG000|Overall Study|Non-compliance with protocol|0|||
164602889|NCT00434122|594567150|FG001|Overall Study|Non-compliance with protocol|1|||
164602890|NCT00434122|594567149|FG000|Overall Study|loss of subject contact|1|||
164602891|NCT00434122|594567150|FG001|Overall Study|loss of subject contact|1|||
164602892|NCT00434122|594567149|FG000|Overall Study|Personal reasons|1|||
164602893|NCT00434122|594567150|FG001|Overall Study|Personal reasons|1|||
164602894|NCT00434122|594567149|FG000|Overall Study|Large follicle size|2|||
164714950|NCT04642365|594978832|FG001|Overall Study|Adverse Event|0|||
164492823|NCT02531126|594174118|FG000|Overall Study|Lack of Efficacy|50|||
164492824|NCT02531126|594174119|FG001|Overall Study|Lack of Efficacy|32|||
164492825|NCT02531126|594174120|FG002|Overall Study|Lack of Efficacy|121|||
164492826|NCT02531126|594174121|FG003|Overall Study|Lack of Efficacy|0|||
164492827|NCT02531126|594174118|FG000|Overall Study|Withdrawal by Subject|38|||
164492828|NCT02531126|594174119|FG001|Overall Study|Withdrawal by Subject|31|||
164492829|NCT02531126|594174120|FG002|Overall Study|Withdrawal by Subject|96|||
164492830|NCT02531126|594174121|FG003|Overall Study|Withdrawal by Subject|6|||
164492831|NCT02531126|594174118|FG000|Overall Study|Pregnancy|2|||
164492832|NCT02531126|594174119|FG001|Overall Study|Pregnancy|3|||
164492833|NCT02531126|594174120|FG002|Overall Study|Pregnancy|2|||
164492834|NCT02531126|594174121|FG003|Overall Study|Pregnancy|0|||
164492835|NCT02531126|594174118|FG000|Overall Study|Switched to commercial drug|2|||
164492836|NCT02531126|594174119|FG001|Overall Study|Switched to commercial drug|4|||
164492837|NCT02531126|594174120|FG002|Overall Study|Switched to commercial drug|4|||
164492838|NCT02531126|594174121|FG003|Overall Study|Switched to commercial drug|0|||
164492839|NCT02531126|594174118|FG000|Overall Study|Other reasons|23|||
164492840|NCT02531126|594174119|FG001|Overall Study|Other reasons|29|||
164492841|NCT02531126|594174120|FG002|Overall Study|Other reasons|27|||
164492842|NCT02531126|594174121|FG003|Overall Study|Other reasons|15|||
164602895|NCT00434122|594567150|FG001|Overall Study|Large follicle size|2|||
164602896|NCT00434122|594567149|FG000|Overall Study|Low follicular response.|1|||
164602897|NCT00434122|594567150|FG001|Overall Study|Low follicular response.|2|||
164602898|NCT00434122|594567149|FG000|Overall Study|Travelling of subject.|1|||
164602899|NCT00434122|594567150|FG001|Overall Study|Travelling of subject.|0|||
164602900|NCT01963208|594567151|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
164602901|NCT01963208|594567152|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
164602902|NCT01963208|594567153|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
164602903|NCT01963208|594567154|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
164492843|NCT02531126|594174118|FG000|Overall Study|Physician Decision|6|||
164492844|NCT02531126|594174119|FG001|Overall Study|Physician Decision|6|||
164492845|NCT02531126|594174120|FG002|Overall Study|Physician Decision|28|||
164492846|NCT02531126|594174121|FG003|Overall Study|Physician Decision|0|||
164492847|NCT02531126|594174118|FG000|Overall Study|Non-compliance with investigational drug|1|||
164492848|NCT02531126|594174119|FG001|Overall Study|Non-compliance with investigational drug|0|||
164492849|NCT02531126|594174120|FG002|Overall Study|Non-compliance with investigational drug|0|||
164492850|NCT02531126|594174121|FG003|Overall Study|Non-compliance with investigational drug|0|||
164492851|NCT00377312|594174122|FG000|Overall Study|Adverse Event|1|||
164492852|NCT00377312|594174123|FG001|Overall Study|Adverse Event|1|||
164492853|NCT00382408|594174126|FG000|Overall Study|Did not meet protocol requirement|3|||
164492854|NCT00382408|594174127|FG001|Overall Study|Did not meet protocol requirement|3|||
164492855|NCT00382408|594174126|FG000|Overall Study|Protocol Violation|2|||
164492856|NCT00382408|594174127|FG001|Overall Study|Protocol Violation|2|||
164492857|NCT00382408|594174126|FG000|Overall Study|Physician Decision|1|||
164492858|NCT00382408|594174127|FG001|Overall Study|Physician Decision|0|||
164492859|NCT00382408|594174126|FG000|Overall Study|Withdrawal by Subject|17|||
164492860|NCT00382408|594174127|FG001|Overall Study|Withdrawal by Subject|6|||
164492861|NCT00382408|594174126|FG000|Overall Study|Pregnancy|2|||
164492862|NCT00382408|594174127|FG001|Overall Study|Pregnancy|0|||
164492863|NCT00382408|594174126|FG000|Overall Study|Lost to Follow-up|19|||
164492864|NCT00382408|594174127|FG001|Overall Study|Lost to Follow-up|8|||
164492865|NCT00382408|594174126|FG000|Overall Study|Other|100|||
164492866|NCT00382408|594174127|FG001|Overall Study|Other|35|||
164492867|NCT01572493|594174130|FG000|Overall Study|Physician Decision|1|||
164492868|NCT01572493|594174131|FG001|Overall Study|Physician Decision|0|||
164492869|NCT01572493|594174132|FG002|Overall Study|Physician Decision|0|||
164492870|NCT01572493|594174133|FG003|Overall Study|Physician Decision|0|||
164492871|NCT01572493|594174134|FG004|Overall Study|Physician Decision|0|||
164492872|NCT01572493|594174135|FG005|Overall Study|Physician Decision|0|||
164492873|NCT01572493|594174136|FG006|Overall Study|Physician Decision|0|||
164492874|NCT01572493|594174137|FG007|Overall Study|Physician Decision|0|||
164492875|NCT01572493|594174138|FG008|Overall Study|Physician Decision|0|||
164492876|NCT01572493|594174130|FG000|Overall Study|Switched to alternative treatment|0|||
164492877|NCT01572493|594174131|FG001|Overall Study|Switched to alternative treatment|1|||
164492878|NCT01572493|594174132|FG002|Overall Study|Switched to alternative treatment|2|||
164492879|NCT01572493|594174133|FG003|Overall Study|Switched to alternative treatment|1|||
164492880|NCT01572493|594174134|FG004|Overall Study|Switched to alternative treatment|2|||
164492881|NCT01572493|594174135|FG005|Overall Study|Switched to alternative treatment|0|||
164492882|NCT01572493|594174136|FG006|Overall Study|Switched to alternative treatment|2|||
164492883|NCT01572493|594174137|FG007|Overall Study|Switched to alternative treatment|0|||
164492884|NCT01572493|594174138|FG008|Overall Study|Switched to alternative treatment|2|||
164492885|NCT01572493|594174130|FG000|Overall Study|Death|0|||
164492886|NCT01572493|594174131|FG001|Overall Study|Death|0|||
164492887|NCT01572493|594174132|FG002|Overall Study|Death|0|||
164492888|NCT01572493|594174133|FG003|Overall Study|Death|1|||
164492889|NCT01572493|594174134|FG004|Overall Study|Death|0|||
164492890|NCT01572493|594174135|FG005|Overall Study|Death|1|||
164492891|NCT01572493|594174136|FG006|Overall Study|Death|0|||
164492892|NCT01572493|594174137|FG007|Overall Study|Death|0|||
164492893|NCT01572493|594174138|FG008|Overall Study|Death|0|||
164492894|NCT01572493|594174130|FG000|Overall Study|Adverse Event|0|||
164492895|NCT01572493|594174131|FG001|Overall Study|Adverse Event|0|||
164492896|NCT01572493|594174132|FG002|Overall Study|Adverse Event|0|||
164492897|NCT01572493|594174133|FG003|Overall Study|Adverse Event|0|||
164492898|NCT01572493|594174134|FG004|Overall Study|Adverse Event|0|||
164492899|NCT01572493|594174135|FG005|Overall Study|Adverse Event|0|||
164492900|NCT01572493|594174136|FG006|Overall Study|Adverse Event|1|||
164492901|NCT01572493|594174137|FG007|Overall Study|Adverse Event|0|||
164492902|NCT01572493|594174138|FG008|Overall Study|Adverse Event|0|||
164492903|NCT00609245|594174139|FG000|Overall Study|Adverse Event|1|||
164492904|NCT02236598|594174140|FG000|Overall Study|Adverse Event|0|||
164492905|NCT02236598|594174141|FG001|Overall Study|Adverse Event|1|||
164492906|NCT02236598|594174140|FG000|Overall Study|Withdrawal by Subject|0|||
164492907|NCT02236598|594174141|FG001|Overall Study|Withdrawal by Subject|1|||
164492908|NCT01475370|594174144|FG000|Overall Study|Exacerbation of primary disease|2|||
164492909|NCT01475370|594174145|FG001|Overall Study|Exacerbation of primary disease|2|||
164492910|NCT01475370|594174146|FG002|Overall Study|Exacerbation of primary disease|2|||
164492911|NCT01475370|594174144|FG000|Overall Study|Study drug administration difficult|0|||
164492912|NCT01475370|594174145|FG001|Overall Study|Study drug administration difficult|1|||
164602904|NCT01963208|594567155|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
164492913|NCT01475370|594174146|FG002|Overall Study|Study drug administration difficult|1|||
164492914|NCT01475370|594174144|FG000|Overall Study|Other than specified|1|||
164492915|NCT01475370|594174145|FG001|Overall Study|Other than specified|0|||
164492916|NCT01475370|594174146|FG002|Overall Study|Other than specified|0|||
164492917|NCT03132753|594174147|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
164492918|NCT03132753|594174148|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
164492919|NCT03132753|594174147|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
164492920|NCT03132753|594174148|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
164492921|NCT00084747|594174149|FG000|Overall Study|Relapsed|8|||
164492922|NCT00084747|594174149|FG000|Overall Study|Death|3|||
164492923|NCT00084747|594174149|FG000|Overall Study|Withdrawal by Subject|2|||
164492924|NCT00679549|594174151|FG000|Overall Study|dropout|2|||
164492925|NCT00679549|594174152|FG001|Overall Study|dropout|4|||
164492926|NCT00679549|594174151|FG000|Overall Study|missing outcome echocardiograms|4|||
164492927|NCT00679549|594174152|FG001|Overall Study|missing outcome echocardiograms|5|||
164492928|NCT01446042|594174158|FG000|Overall Study|Withdrawal by Subject|12|||
164492929|NCT01446042|594174159|FG001|Overall Study|Withdrawal by Subject|2|||
164492930|NCT01446042|594174160|FG002|Overall Study|Withdrawal by Subject|4|||
164492931|NCT01446042|594174158|FG000|Overall Study|Adverse Event|1|||
164492932|NCT01446042|594174159|FG001|Overall Study|Adverse Event|0|||
164492933|NCT01446042|594174160|FG002|Overall Study|Adverse Event|4|||
164492934|NCT01446042|594174158|FG000|Overall Study|Lost to Follow-up|5|||
164492935|NCT01446042|594174159|FG001|Overall Study|Lost to Follow-up|0|||
164492936|NCT01446042|594174160|FG002|Overall Study|Lost to Follow-up|0|||
164492937|NCT01446042|594174158|FG000|Overall Study|Other reasons|2|||
164492938|NCT01446042|594174159|FG001|Overall Study|Other reasons|1|||
164492939|NCT01446042|594174160|FG002|Overall Study|Other reasons|1|||
164492940|NCT05714345|594174168|FG000|Overall Study|Death|1|||
164492941|NCT05714345|594174169|FG001|Overall Study|Death|1|||
164492942|NCT04474691|594174170|FG000|Overall Study|Withdrawal by Subject|9|||
164492943|NCT01323309|594174171|FG000|Overall Study|Death|9|||
164492944|NCT01323309|594174172|FG001|Overall Study|Death|15|||
164492945|NCT01323309|594174173|FG002|Overall Study|Death|5|||
164492946|NCT01323309|594174171|FG000|Overall Study|Lost to Follow-up|11|||
164492947|NCT01323309|594174172|FG001|Overall Study|Lost to Follow-up|14|||
164492948|NCT01323309|594174173|FG002|Overall Study|Lost to Follow-up|24|||
164492949|NCT01323309|594174171|FG000|Overall Study|Withdrawal by Subject|14|||
164492950|NCT01323309|594174172|FG001|Overall Study|Withdrawal by Subject|14|||
164492951|NCT01323309|594174173|FG002|Overall Study|Withdrawal by Subject|18|||
164492952|NCT01323309|594174171|FG000|Overall Study|Disease progression|5|||
164492953|NCT01323309|594174172|FG001|Overall Study|Disease progression|11|||
164492954|NCT01323309|594174173|FG002|Overall Study|Disease progression|4|||
164492955|NCT03048058|594174180|FG000|Overall Study|Lost to Follow-up|4|||
164492956|NCT03048058|594174181|FG001|Overall Study|Lost to Follow-up|0|||
164492957|NCT03048058|594174180|FG000|Overall Study|Withdrawal by Subject|0|||
164492958|NCT03048058|594174181|FG001|Overall Study|Withdrawal by Subject|4|||
164492959|NCT01257698|594174190|FG000|Overall Study|Protocol Violation|4|||
164492960|NCT01257698|594174191|FG001|Overall Study|Protocol Violation|0|||
164492961|NCT00274846|594174194|FG000|Overall Study|Did not receive adequate NK cells|1|||
164492962|NCT04448561|594174198|FG000|Overall Study|Noncompliance|1|||
164492963|NCT04448561|594174199|FG001|Overall Study|Noncompliance|0|||
164492964|NCT03602859|594174204|FG000|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|10|||
164492965|NCT03602859|594174205|FG001|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
164492966|NCT03602859|594174206|FG002|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
164492967|NCT03602859|594174207|FG003|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
164492968|NCT03602859|594174204|FG000|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|2|||
164492969|NCT03602859|594174205|FG001|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
164602905|NCT01963208|594567156|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
164602906|NCT01963208|594567151|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
164602907|NCT01963208|594567152|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
164602908|NCT01963208|594567153|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
164602909|NCT01963208|594567154|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
164602910|NCT01963208|594567155|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
164602911|NCT01963208|594567156|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
164602912|NCT01963208|594567151|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
164602913|NCT01963208|594567152|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
164602914|NCT01963208|594567153|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
164602915|NCT01963208|594567154|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
164602916|NCT01963208|594567155|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
164492970|NCT03602859|594174206|FG002|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
164492971|NCT03602859|594174207|FG003|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
164602917|NCT01963208|594567156|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
164492972|NCT03602859|594174204|FG000|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|3|||
164492973|NCT03602859|594174205|FG001|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
164492974|NCT03602859|594174206|FG002|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
164492975|NCT03602859|594174207|FG003|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
164492976|NCT03602859|594174204|FG000|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|6|||
164492977|NCT03602859|594174205|FG001|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
164492978|NCT03602859|594174206|FG002|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
164492979|NCT03602859|594174207|FG003|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
164492980|NCT03602859|594174204|FG000|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|10|||
164492981|NCT03602859|594174205|FG001|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
164492982|NCT03602859|594174206|FG002|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
164492983|NCT03602859|594174207|FG003|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
164492984|NCT03602859|594174204|FG000|Chemotherapy Run-In Period (Cycle 1)|Death|10|||
164492985|NCT03602859|594174205|FG001|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
164492986|NCT03602859|594174206|FG002|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
164492987|NCT03602859|594174207|FG003|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
164492988|NCT03602859|594174204|FG000|Chemotherapy Run-In Period (Cycle 1)|Other|27|||
164492989|NCT03602859|594174205|FG001|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
164492990|NCT03602859|594174206|FG002|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
164492991|NCT03602859|594174207|FG003|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
164492992|NCT03602859|594174204|FG000|Chemotherapy Run-In Period (Cycle 1)|Missing|1|||
164492993|NCT03602859|594174205|FG001|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
164492994|NCT03602859|594174206|FG002|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
164492995|NCT03602859|594174207|FG003|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
164492996|NCT03602859|594174204|FG000|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|10|||
164492997|NCT03602859|594174205|FG001|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
164492998|NCT03602859|594174206|FG002|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
164492999|NCT03602859|594174207|FG003|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
164493000|NCT03602859|594174204|FG000|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|0|||
164493001|NCT03602859|594174205|FG001|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|1|||
164493002|NCT03602859|594174206|FG002|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|5|||
164493003|NCT03602859|594174207|FG003|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|3|||
164493004|NCT03602859|594174204|FG000|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|0|||
164493005|NCT03602859|594174205|FG001|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|7|||
164493006|NCT03602859|594174206|FG002|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|11|||
164493007|NCT03602859|594174207|FG003|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|25|||
164493008|NCT03602859|594174204|FG000|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|0|||
164493009|NCT03602859|594174205|FG001|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|7|||
164493010|NCT03602859|594174206|FG002|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|14|||
164493011|NCT03602859|594174207|FG003|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|15|||
164493012|NCT03602859|594174204|FG000|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|0|||
164493013|NCT03602859|594174205|FG001|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|2|||
164493014|NCT03602859|594174206|FG002|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|1|||
164493015|NCT03602859|594174207|FG003|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|5|||
164493016|NCT03602859|594174204|FG000|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|0|||
164493017|NCT03602859|594174205|FG001|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|2|||
164493018|NCT03602859|594174206|FG002|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|2|||
164493019|NCT03602859|594174207|FG003|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|8|||
164493020|NCT03602859|594174204|FG000|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|0|||
164493021|NCT03602859|594174205|FG001|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|9|||
164493022|NCT03602859|594174206|FG002|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|11|||
164493023|NCT03602859|594174207|FG003|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|29|||
164493024|NCT03602859|594174204|FG000|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
164493025|NCT03602859|594174205|FG001|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
164493026|NCT03602859|594174206|FG002|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
164493027|NCT03602859|594174207|FG003|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|1|||
164493028|NCT03602859|594174204|FG000|Chemo Treatment Period (Cycle 2 to 6)|Death|0|||
164493029|NCT03602859|594174205|FG001|Chemo Treatment Period (Cycle 2 to 6)|Death|1|||
164493030|NCT03602859|594174206|FG002|Chemo Treatment Period (Cycle 2 to 6)|Death|1|||
164493031|NCT03602859|594174207|FG003|Chemo Treatment Period (Cycle 2 to 6)|Death|5|||
164493032|NCT03602859|594174204|FG000|Chemo Treatment Period (Cycle 2 to 6)|Other|0|||
164493033|NCT03602859|594174205|FG001|Chemo Treatment Period (Cycle 2 to 6)|Other|1|||
164493034|NCT03602859|594174206|FG002|Chemo Treatment Period (Cycle 2 to 6)|Other|1|||
164493035|NCT03602859|594174207|FG003|Chemo Treatment Period (Cycle 2 to 6)|Other|9|||
164493036|NCT03602859|594174204|FG000|Maintenance Period (Cycle 7 to 89)|Ongoing|0|||
164493037|NCT03602859|594174205|FG001|Maintenance Period (Cycle 7 to 89)|Ongoing|3|||
164493038|NCT03602859|594174206|FG002|Maintenance Period (Cycle 7 to 89)|Ongoing|23|||
164493039|NCT03602859|594174207|FG003|Maintenance Period (Cycle 7 to 89)|Ongoing|42|||
164493040|NCT03602859|594174204|FG000|Maintenance Period (Cycle 7 to 89)|Adverse Event|0|||
164493041|NCT03602859|594174205|FG001|Maintenance Period (Cycle 7 to 89)|Adverse Event|6|||
164602918|NCT01963208|594567151|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
164602919|NCT01963208|594567152|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
164602920|NCT01963208|594567153|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
164602921|NCT01963208|594567154|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
164602922|NCT01963208|594567155|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
164602923|NCT01963208|594567156|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
164602924|NCT01963208|594567151|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
164602925|NCT01963208|594567152|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
164602926|NCT01963208|594567153|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
164602927|NCT01963208|594567154|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
164602928|NCT01963208|594567155|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
164602929|NCT01963208|594567156|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
164602930|NCT01963208|594567151|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
164602931|NCT01963208|594567152|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
164602932|NCT01963208|594567153|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
164602933|NCT01963208|594567154|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
164602934|NCT01963208|594567155|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
164602935|NCT01963208|594567156|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
164602936|NCT01963208|594567151|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
164602937|NCT01963208|594567152|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
164602938|NCT01963208|594567153|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
164602939|NCT01963208|594567154|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
164493042|NCT03602859|594174206|FG002|Maintenance Period (Cycle 7 to 89)|Adverse Event|24|||
164602940|NCT01963208|594567155|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
164602941|NCT01963208|594567156|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
164493043|NCT03602859|594174207|FG003|Maintenance Period (Cycle 7 to 89)|Adverse Event|91|||
164493044|NCT03602859|594174204|FG000|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|0|||
164493045|NCT03602859|594174205|FG001|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|0|||
164493046|NCT03602859|594174206|FG002|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|1|||
164493047|NCT03602859|594174207|FG003|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|2|||
164493048|NCT03602859|594174204|FG000|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|0|||
164493049|NCT03602859|594174205|FG001|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|83|||
164493050|NCT03602859|594174206|FG002|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|251|||
164493051|NCT03602859|594174207|FG003|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|356|||
164493052|NCT03602859|594174204|FG000|Maintenance Period (Cycle 7 to 89)|Risk to Patient|0|||
164493053|NCT03602859|594174205|FG001|Maintenance Period (Cycle 7 to 89)|Risk to Patient|2|||
164493054|NCT03602859|594174206|FG002|Maintenance Period (Cycle 7 to 89)|Risk to Patient|1|||
164493055|NCT03602859|594174207|FG003|Maintenance Period (Cycle 7 to 89)|Risk to Patient|2|||
164493056|NCT03602859|594174204|FG000|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|0|||
164493057|NCT03602859|594174205|FG001|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|3|||
164493058|NCT03602859|594174206|FG002|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|3|||
164493059|NCT03602859|594174207|FG003|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|5|||
164493060|NCT03602859|594174204|FG000|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|0|||
164493061|NCT03602859|594174205|FG001|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|7|||
164493062|NCT03602859|594174206|FG002|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|22|||
164493063|NCT03602859|594174207|FG003|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|48|||
164493064|NCT03602859|594174204|FG000|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|0|||
164493065|NCT03602859|594174205|FG001|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|0|||
164493066|NCT03602859|594174206|FG002|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|2|||
164493067|NCT03602859|594174207|FG003|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|2|||
164493068|NCT03602859|594174204|FG000|Maintenance Period (Cycle 7 to 89)|Death|0|||
164493069|NCT03602859|594174205|FG001|Maintenance Period (Cycle 7 to 89)|Death|0|||
164493070|NCT03602859|594174206|FG002|Maintenance Period (Cycle 7 to 89)|Death|1|||
164493071|NCT03602859|594174207|FG003|Maintenance Period (Cycle 7 to 89)|Death|7|||
164493072|NCT03602859|594174204|FG000|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
164493073|NCT03602859|594174205|FG001|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|18|||
164602942|NCT01963208|594567151|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
164602943|NCT01963208|594567152|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
164602944|NCT01963208|594567153|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
164602945|NCT01963208|594567154|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
164714951|NCT04642365|594978833|FG002|Overall Study|Adverse Event|0|||
164714952|NCT04642365|594978834|FG003|Overall Study|Adverse Event|0|||
164714953|NCT04642365|594978835|FG004|Overall Study|Adverse Event|0|||
164714954|NCT04642365|594978836|FG005|Overall Study|Adverse Event|0|||
164493074|NCT03602859|594174206|FG002|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
164493075|NCT03602859|594174207|FG003|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
164493076|NCT03602859|594174204|FG000|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
164493077|NCT03602859|594174205|FG001|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
164493078|NCT03602859|594174206|FG002|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
164493079|NCT03602859|594174207|FG003|Maintenance Period (Cycle 7 to 89)|Investigator decision|1|||
164493080|NCT03602859|594174204|FG000|Maintenance Period (Cycle 7 to 89)|Other|0|||
164493081|NCT03602859|594174205|FG001|Maintenance Period (Cycle 7 to 89)|Other|2|||
164493082|NCT03602859|594174206|FG002|Maintenance Period (Cycle 7 to 89)|Other|2|||
164493083|NCT03602859|594174207|FG003|Maintenance Period (Cycle 7 to 89)|Other|12|||
164493084|NCT01904019|594175591|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
164493085|NCT01904019|594175591|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
164493086|NCT01904019|594175591|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
164493087|NCT01904019|594175591|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
164493088|NCT01904019|594175591|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
164493089|NCT01904019|594175591|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
164493090|NCT00509821|594175592|FG000|Study Period 1 (Induction)|Death|0|||
164493091|NCT00509821|594175593|FG001|Study Period 1 (Induction)|Death|1|||
164493092|NCT00509821|594175592|FG000|Study Period 1 (Induction)|Adverse Event|0|||
164493093|NCT00509821|594175593|FG001|Study Period 1 (Induction)|Adverse Event|2|||
164493094|NCT00509821|594175592|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
164493095|NCT00509821|594175593|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
164493096|NCT01816685|594175594|FG000|Overall Study|Lost to Follow-up|7|||
164493097|NCT01816685|594175595|FG001|Overall Study|Lost to Follow-up|9|||
164493098|NCT01816685|594175594|FG000|Overall Study|Surgery Cancelled|3|||
164493099|NCT01816685|594175595|FG001|Overall Study|Surgery Cancelled|2|||
164493100|NCT01157351|594175596|FG000|Overall Study|Adverse Event|5|||
164493101|NCT01157351|594175597|FG001|Overall Study|Adverse Event|4|||
164493102|NCT01157351|594175596|FG000|Overall Study|Death|1|||
164493103|NCT01157351|594175597|FG001|Overall Study|Death|0|||
164493104|NCT01157351|594175596|FG000|Overall Study|Lost to Follow-up|53|||
164493105|NCT01157351|594175597|FG001|Overall Study|Lost to Follow-up|55|||
164493106|NCT01157351|594175596|FG000|Overall Study|Withdrawal by Subject|37|||
164493107|NCT01157351|594175597|FG001|Overall Study|Withdrawal by Subject|27|||
164493108|NCT01157351|594175596|FG000|Overall Study|Physician Decision|5|||
164493109|NCT01157351|594175597|FG001|Overall Study|Physician Decision|4|||
164493110|NCT01157351|594175596|FG000|Overall Study|Protocol Violation|0|||
164493111|NCT01157351|594175597|FG001|Overall Study|Protocol Violation|1|||
164493112|NCT01157351|594175596|FG000|Overall Study|Other|32|||
164493113|NCT01157351|594175597|FG001|Overall Study|Other|36|||
164493114|NCT01157351|594175596|FG000|Overall Study|Noncompliance with Study Drug|0|||
164493115|NCT01157351|594175597|FG001|Overall Study|Noncompliance with Study Drug|3|||
164493116|NCT01157351|594175596|FG000|Overall Study|Randomized but not Treated|4|||
164493117|NCT01157351|594175597|FG001|Overall Study|Randomized but not Treated|2|||
164493118|NCT02675998|594175598|FG000|8-Week Treatment Period|Adverse Event|6|||
164493119|NCT02675998|594175599|FG001|8-Week Treatment Period|Adverse Event|5|||
164493120|NCT02675998|594175600|FG002|8-Week Treatment Period|Adverse Event|6|||
164493121|NCT02675998|594175601|FG003|8-Week Treatment Period|Adverse Event|0|||
164493122|NCT02675998|594175598|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
164493123|NCT02675998|594175599|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
164493124|NCT02675998|594175600|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
164493125|NCT02675998|594175601|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
164493126|NCT02675998|594175598|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
164493127|NCT02675998|594175599|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
164493128|NCT02675998|594175600|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
164493129|NCT02675998|594175601|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
164493130|NCT02675998|594175598|FG000|8-Week Treatment Period|Physician Decision|1|||
164493131|NCT02675998|594175599|FG001|8-Week Treatment Period|Physician Decision|0|||
164493132|NCT02675998|594175600|FG002|8-Week Treatment Period|Physician Decision|2|||
164493133|NCT02675998|594175601|FG003|8-Week Treatment Period|Physician Decision|0|||
164493134|NCT02675998|594175598|FG000|8-Week Treatment Period|GI side Effects|1|||
164493135|NCT02675998|594175599|FG001|8-Week Treatment Period|GI side Effects|4|||
164493136|NCT02675998|594175600|FG002|8-Week Treatment Period|GI side Effects|2|||
164493137|NCT02675998|594175601|FG003|8-Week Treatment Period|GI side Effects|0|||
164493138|NCT02675998|594175598|FG000|8-Week Treatment Period|Protocol Violation|1|||
164493139|NCT02675998|594175599|FG001|8-Week Treatment Period|Protocol Violation|1|||
164493140|NCT02675998|594175600|FG002|8-Week Treatment Period|Protocol Violation|1|||
164493141|NCT02675998|594175601|FG003|8-Week Treatment Period|Protocol Violation|0|||
164493142|NCT02675998|594175598|FG000|8-Week Treatment Period|Other|3|||
164493143|NCT02675998|594175599|FG001|8-Week Treatment Period|Other|1|||
164493144|NCT02675998|594175600|FG002|8-Week Treatment Period|Other|2|||
164493145|NCT02675998|594175601|FG003|8-Week Treatment Period|Other|0|||
164493146|NCT02675998|594175598|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
164493147|NCT02675998|594175599|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
164493148|NCT02675998|594175600|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
164493149|NCT02675998|594175601|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
164493150|NCT02675998|594175598|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
164493151|NCT02675998|594175599|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
164493152|NCT02675998|594175600|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
164493153|NCT02675998|594175601|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
164493154|NCT02675998|594175598|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
164493155|NCT02675998|594175599|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
164493156|NCT02675998|594175600|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
164493157|NCT02675998|594175601|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
164493158|NCT02675998|594175598|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
164493159|NCT02675998|594175599|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
164493160|NCT02675998|594175600|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
164493161|NCT02675998|594175601|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
164493162|NCT02675998|594175598|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
164493163|NCT02675998|594175599|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
164493164|NCT02675998|594175600|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
164493165|NCT02675998|594175601|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
164493166|NCT02561078|594175610|FG000|Overall Study|Adverse Event|5|||
164493167|NCT02561078|594175611|FG001|Overall Study|Adverse Event|2|||
164493168|NCT02561078|594175610|FG000|Overall Study|Death|2|||
164493169|NCT02561078|594175611|FG001|Overall Study|Death|1|||
164493170|NCT02561078|594175610|FG000|Overall Study|Lost to Follow-up|2|||
164493171|NCT02561078|594175611|FG001|Overall Study|Lost to Follow-up|6|||
164493172|NCT02561078|594175610|FG000|Overall Study|Non-Compliance with Study Drug|6|||
164493173|NCT02561078|594175611|FG001|Overall Study|Non-Compliance with Study Drug|3|||
164493174|NCT02561078|594175610|FG000|Overall Study|Physician Decision|2|||
164493175|NCT02561078|594175611|FG001|Overall Study|Physician Decision|3|||
164493176|NCT02561078|594175610|FG000|Overall Study|Withdrawal by Subject|13|||
164493177|NCT02561078|594175611|FG001|Overall Study|Withdrawal by Subject|10|||
164493178|NCT00598871|594175612|FG000|Overall Study|Adverse Event|0|||
164493179|NCT00598871|594175613|FG001|Overall Study|Adverse Event|1|||
164493180|NCT00443898|594175614|FG000|Overall Study|Adverse Event|0|||
164493181|NCT00443898|594175615|FG001|Overall Study|Adverse Event|0|||
164493182|NCT00443898|594175616|FG002|Overall Study|Adverse Event|1|||
164493183|NCT00443898|594175617|FG003|Overall Study|Adverse Event|1|||
164493184|NCT00443898|594175614|FG000|Overall Study|Lack of Efficacy|2|||
164493185|NCT00443898|594175615|FG001|Overall Study|Lack of Efficacy|3|||
164493186|NCT00443898|594175616|FG002|Overall Study|Lack of Efficacy|3|||
164493187|NCT00443898|594175617|FG003|Overall Study|Lack of Efficacy|1|||
164493188|NCT00443898|594175614|FG000|Overall Study|Protocol Violation|1|||
164493189|NCT00443898|594175615|FG001|Overall Study|Protocol Violation|1|||
164493190|NCT00443898|594175616|FG002|Overall Study|Protocol Violation|1|||
164493191|NCT00443898|594175617|FG003|Overall Study|Protocol Violation|0|||
164493192|NCT00443898|594175614|FG000|Overall Study|Withdrawal by Subject|11|||
164493193|NCT00443898|594175615|FG001|Overall Study|Withdrawal by Subject|10|||
164493194|NCT00443898|594175616|FG002|Overall Study|Withdrawal by Subject|10|||
164493195|NCT00443898|594175617|FG003|Overall Study|Withdrawal by Subject|6|||
164493196|NCT00443898|594175614|FG000|Overall Study|Lost to Follow-up|10|||
164493197|NCT00443898|594175615|FG001|Overall Study|Lost to Follow-up|10|||
164493198|NCT00443898|594175616|FG002|Overall Study|Lost to Follow-up|14|||
164493199|NCT00443898|594175617|FG003|Overall Study|Lost to Follow-up|10|||
164493200|NCT00443898|594175614|FG000|Overall Study|Death|0|||
164493201|NCT00443898|594175615|FG001|Overall Study|Death|1|||
164493202|NCT00443898|594175616|FG002|Overall Study|Death|0|||
164493203|NCT00443898|594175617|FG003|Overall Study|Death|0|||
164493204|NCT00043186|594175618|FG000|Overall Study|Physician Decision|0|||
164493205|NCT00043186|594175619|FG001|Overall Study|Physician Decision|0|||
164493206|NCT00043186|594175620|FG002|Overall Study|Physician Decision|3|||
164493207|NCT00043186|594175621|FG003|Overall Study|Physician Decision|0|||
164493208|NCT00043186|594175622|FG004|Overall Study|Physician Decision|1|||
164493209|NCT00043186|594175623|FG005|Overall Study|Physician Decision|0|||
164493210|NCT00043186|594175624|FG006|Overall Study|Physician Decision|0|||
164493211|NCT00043186|594175625|FG007|Overall Study|Physician Decision|1|||
164493212|NCT00043186|594175626|FG008|Overall Study|Physician Decision|1|||
164493213|NCT00043186|594175618|FG000|Overall Study|Adverse Event|2|||
164493214|NCT00043186|594175619|FG001|Overall Study|Adverse Event|2|||
164493215|NCT00043186|594175620|FG002|Overall Study|Adverse Event|2|||
164602946|NCT01963208|594567155|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
164714955|NCT04642365|594978837|FG006|Overall Study|Adverse Event|0|||
164493216|NCT00043186|594175621|FG003|Overall Study|Adverse Event|3|||
164493217|NCT00043186|594175622|FG004|Overall Study|Adverse Event|2|||
164493218|NCT00043186|594175623|FG005|Overall Study|Adverse Event|1|||
164493219|NCT00043186|594175624|FG006|Overall Study|Adverse Event|2|||
164493220|NCT00043186|594175625|FG007|Overall Study|Adverse Event|1|||
164493221|NCT00043186|594175626|FG008|Overall Study|Adverse Event|3|||
164493222|NCT00043186|594175618|FG000|Overall Study|Withdrawal by Subject|11|||
164602947|NCT01963208|594567156|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
164602948|NCT01963208|594567151|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
164602949|NCT01963208|594567152|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
164602950|NCT01963208|594567153|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
164602951|NCT01963208|594567154|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
164602952|NCT01963208|594567155|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
164602953|NCT01963208|594567156|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
164602954|NCT01963208|594567151|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
164602955|NCT01963208|594567152|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
164602956|NCT01963208|594567153|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
164602957|NCT01963208|594567154|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
164602958|NCT01963208|594567155|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
164602959|NCT01963208|594567156|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
164602960|NCT01963208|594567151|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
164602961|NCT01963208|594567152|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
164602962|NCT01963208|594567153|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
164602963|NCT01963208|594567154|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
164602964|NCT01963208|594567155|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
164602965|NCT01963208|594567156|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
164602966|NCT01963208|594567151|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
164602967|NCT01963208|594567152|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
164602968|NCT01963208|594567153|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
164602969|NCT01963208|594567154|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
164602970|NCT01963208|594567155|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
164602971|NCT01963208|594567156|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
164602972|NCT01963208|594567151|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
164602973|NCT01963208|594567152|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
164602974|NCT01963208|594567153|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
164602975|NCT01963208|594567154|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
164602976|NCT01963208|594567155|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
164602977|NCT01963208|594567156|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
164602978|NCT01963208|594567151|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
164602979|NCT01963208|594567152|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
164602980|NCT01963208|594567153|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
164602981|NCT01963208|594567154|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
164602982|NCT01963208|594567155|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
164602983|NCT01963208|594567156|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
164602984|NCT00438399|594567157|FG000|Overall Study|Lost to Follow-up|2|||
164602985|NCT00438399|594567158|FG001|Overall Study|Lost to Follow-up|2|||
164602986|NCT00438399|594567159|FG002|Overall Study|Lost to Follow-up|1|||
164602987|NCT00438399|594567160|FG003|Overall Study|Lost to Follow-up|1|||
164602988|NCT00438399|594567161|FG004|Overall Study|Lost to Follow-up|1|||
164602989|NCT00438399|594567162|FG005|Overall Study|Lost to Follow-up|1|||
164602990|NCT00438399|594567157|FG000|Overall Study|Adverse Event|0|||
164602991|NCT00438399|594567158|FG001|Overall Study|Adverse Event|0|||
164602992|NCT00438399|594567159|FG002|Overall Study|Adverse Event|1|||
164602993|NCT00438399|594567160|FG003|Overall Study|Adverse Event|1|||
164602994|NCT00438399|594567161|FG004|Overall Study|Adverse Event|0|||
164602995|NCT00438399|594567162|FG005|Overall Study|Adverse Event|1|||
164714956|NCT04642365|594978838|FG007|Overall Study|Adverse Event|1|||
164714957|NCT02728843|594978839|FG000|Overall Study|Adverse Event|0|||
164714958|NCT02728843|594978840|FG001|Overall Study|Adverse Event|2|||
164714959|NCT02728843|594978841|FG002|Overall Study|Adverse Event|3|||
164714960|NCT02728843|594978842|FG003|Overall Study|Adverse Event|1|||
164493223|NCT00043186|594175619|FG001|Overall Study|Withdrawal by Subject|8|||
164493224|NCT00043186|594175620|FG002|Overall Study|Withdrawal by Subject|11|||
164493225|NCT00043186|594175621|FG003|Overall Study|Withdrawal by Subject|13|||
164493226|NCT00043186|594175622|FG004|Overall Study|Withdrawal by Subject|14|||
164493227|NCT00043186|594175623|FG005|Overall Study|Withdrawal by Subject|6|||
164493228|NCT00043186|594175624|FG006|Overall Study|Withdrawal by Subject|12|||
164493229|NCT00043186|594175625|FG007|Overall Study|Withdrawal by Subject|9|||
164493230|NCT00043186|594175626|FG008|Overall Study|Withdrawal by Subject|10|||
164602996|NCT00438399|594567157|FG000|Overall Study|Withdrawal by Subject|5|||
164714961|NCT02728843|594978843|FG004|Overall Study|Adverse Event|2|||
164714962|NCT02728843|594978839|FG000|Overall Study|Lack of Efficacy|0|||
164602997|NCT00438399|594567158|FG001|Overall Study|Withdrawal by Subject|6|||
164602998|NCT00438399|594567159|FG002|Overall Study|Withdrawal by Subject|3|||
164602999|NCT00438399|594567160|FG003|Overall Study|Withdrawal by Subject|2|||
164603000|NCT00438399|594567161|FG004|Overall Study|Withdrawal by Subject|2|||
164714963|NCT02728843|594978840|FG001|Overall Study|Lack of Efficacy|1|||
164714964|NCT02728843|594978841|FG002|Overall Study|Lack of Efficacy|1|||
164493231|NCT00043186|594175618|FG000|Overall Study|Death|0|||
164493232|NCT00043186|594175619|FG001|Overall Study|Death|0|||
164714965|NCT02728843|594978842|FG003|Overall Study|Lack of Efficacy|0|||
164714966|NCT02728843|594978843|FG004|Overall Study|Lack of Efficacy|0|||
164714967|NCT02728843|594978839|FG000|Overall Study|Protocol Violation|2|||
164714968|NCT02728843|594978840|FG001|Overall Study|Protocol Violation|0|||
164714969|NCT02728843|594978841|FG002|Overall Study|Protocol Violation|4|||
164714970|NCT02728843|594978842|FG003|Overall Study|Protocol Violation|2|||
164714971|NCT02728843|594978843|FG004|Overall Study|Protocol Violation|2|||
164714972|NCT02728843|594978839|FG000|Overall Study|Withdrawal by Subject|1|||
164714973|NCT02728843|594978840|FG001|Overall Study|Withdrawal by Subject|0|||
164493233|NCT00043186|594175620|FG002|Overall Study|Death|1|||
164493234|NCT00043186|594175621|FG003|Overall Study|Death|0|||
164493235|NCT00043186|594175622|FG004|Overall Study|Death|0|||
164493236|NCT00043186|594175623|FG005|Overall Study|Death|0|||
164493237|NCT00043186|594175624|FG006|Overall Study|Death|2|||
164493238|NCT00043186|594175625|FG007|Overall Study|Death|0|||
164493239|NCT00043186|594175626|FG008|Overall Study|Death|0|||
164493240|NCT00043186|594175618|FG000|Overall Study|Disease progression|1|||
164493241|NCT00043186|594175619|FG001|Overall Study|Disease progression|0|||
164493242|NCT00043186|594175620|FG002|Overall Study|Disease progression|0|||
164493243|NCT00043186|594175621|FG003|Overall Study|Disease progression|3|||
164493244|NCT00043186|594175622|FG004|Overall Study|Disease progression|0|||
164493245|NCT00043186|594175623|FG005|Overall Study|Disease progression|0|||
164493246|NCT00043186|594175624|FG006|Overall Study|Disease progression|0|||
164493247|NCT00043186|594175625|FG007|Overall Study|Disease progression|4|||
164493248|NCT00043186|594175626|FG008|Overall Study|Disease progression|0|||
164493249|NCT00043186|594175618|FG000|Overall Study|Ineligibility determined|0|||
164493250|NCT00043186|594175619|FG001|Overall Study|Ineligibility determined|0|||
164493251|NCT00043186|594175620|FG002|Overall Study|Ineligibility determined|0|||
164493252|NCT00043186|594175621|FG003|Overall Study|Ineligibility determined|0|||
164493253|NCT00043186|594175622|FG004|Overall Study|Ineligibility determined|0|||
164493254|NCT00043186|594175623|FG005|Overall Study|Ineligibility determined|0|||
164493255|NCT00043186|594175624|FG006|Overall Study|Ineligibility determined|0|||
164493256|NCT00043186|594175625|FG007|Overall Study|Ineligibility determined|0|||
164493257|NCT00043186|594175626|FG008|Overall Study|Ineligibility determined|1|||
164493258|NCT00043186|594175618|FG000|Overall Study|Lost to Follow-up|3|||
164493259|NCT00043186|594175619|FG001|Overall Study|Lost to Follow-up|5|||
164493260|NCT00043186|594175620|FG002|Overall Study|Lost to Follow-up|1|||
164493261|NCT00043186|594175621|FG003|Overall Study|Lost to Follow-up|1|||
164493262|NCT00043186|594175622|FG004|Overall Study|Lost to Follow-up|1|||
164493263|NCT00043186|594175623|FG005|Overall Study|Lost to Follow-up|1|||
164493264|NCT00043186|594175624|FG006|Overall Study|Lost to Follow-up|1|||
164493265|NCT00043186|594175625|FG007|Overall Study|Lost to Follow-up|1|||
164493266|NCT00043186|594175626|FG008|Overall Study|Lost to Follow-up|2|||
164493267|NCT00043186|594175618|FG000|Overall Study|Noncompliance|0|||
164493268|NCT00043186|594175619|FG001|Overall Study|Noncompliance|0|||
164493269|NCT00043186|594175620|FG002|Overall Study|Noncompliance|1|||
164493270|NCT00043186|594175621|FG003|Overall Study|Noncompliance|1|||
164493271|NCT00043186|594175622|FG004|Overall Study|Noncompliance|0|||
164493272|NCT00043186|594175623|FG005|Overall Study|Noncompliance|0|||
164493273|NCT00043186|594175624|FG006|Overall Study|Noncompliance|0|||
164493274|NCT00043186|594175625|FG007|Overall Study|Noncompliance|0|||
164493275|NCT00043186|594175626|FG008|Overall Study|Noncompliance|0|||
164493276|NCT00043186|594175618|FG000|Overall Study|Other|0|||
164493277|NCT00043186|594175619|FG001|Overall Study|Other|0|||
164493278|NCT00043186|594175620|FG002|Overall Study|Other|1|||
164493279|NCT00043186|594175621|FG003|Overall Study|Other|1|||
164493280|NCT00043186|594175622|FG004|Overall Study|Other|0|||
164493281|NCT00043186|594175623|FG005|Overall Study|Other|0|||
164493282|NCT00043186|594175624|FG006|Overall Study|Other|0|||
164493283|NCT00043186|594175625|FG007|Overall Study|Other|0|||
164493284|NCT00043186|594175626|FG008|Overall Study|Other|0|||
164493285|NCT04050722|594175630|FG000|Overall Study|Withdrawal by Subject|1|||
164493286|NCT04050722|594175631|FG001|Overall Study|Withdrawal by Subject|0|||
164493287|NCT03451292|594175632|FG000|Overall Study|Death|44|||
164493288|NCT03451292|594175633|FG001|Overall Study|Death|59|||
164493289|NCT03451292|594175632|FG000|Overall Study|Withdrawal by Subject|18|||
164493290|NCT03451292|594175633|FG001|Overall Study|Withdrawal by Subject|13|||
164493291|NCT03451292|594175632|FG000|Overall Study|Transplantation|18|||
164493292|NCT03451292|594175633|FG001|Overall Study|Transplantation|12|||
164493293|NCT03451292|594175632|FG000|Overall Study|Lost to Follow-up|4|||
164493294|NCT03451292|594175633|FG001|Overall Study|Lost to Follow-up|12|||
164493295|NCT03451292|594175632|FG000|Overall Study|Physician Decision|4|||
164714974|NCT02728843|594978841|FG002|Overall Study|Withdrawal by Subject|0|||
164714975|NCT02728843|594978842|FG003|Overall Study|Withdrawal by Subject|1|||
164493296|NCT03451292|594175633|FG001|Overall Study|Physician Decision|3|||
164493297|NCT03451292|594175632|FG000|Overall Study|Adverse Event|3|||
164493298|NCT03451292|594175633|FG001|Overall Study|Adverse Event|3|||
164493299|NCT03451292|594175632|FG000|Overall Study|Non-compliance with Study Drug|2|||
164493300|NCT03451292|594175633|FG001|Overall Study|Non-compliance with Study Drug|0|||
164493301|NCT05271552|594175634|FG000|Overall Study|Adverse Event|4|||
164714976|NCT02728843|594978843|FG004|Overall Study|Withdrawal by Subject|0|||
164714977|NCT02728843|594978839|FG000|Overall Study|Use of rescue medication|0|||
164714978|NCT02728843|594978840|FG001|Overall Study|Use of rescue medication|2|||
164714979|NCT02728843|594978841|FG002|Overall Study|Use of rescue medication|0|||
164714980|NCT02728843|594978842|FG003|Overall Study|Use of rescue medication|2|||
164714981|NCT02728843|594978843|FG004|Overall Study|Use of rescue medication|1|||
164493302|NCT05271552|594175635|FG001|Overall Study|Adverse Event|6|||
164493303|NCT05271552|594175636|FG002|Overall Study|Adverse Event|3|||
164493304|NCT05271552|594175634|FG000|Overall Study|Death|1|||
164493305|NCT05271552|594175635|FG001|Overall Study|Death|1|||
164493306|NCT05271552|594175636|FG002|Overall Study|Death|1|||
164493307|NCT05271552|594175634|FG000|Overall Study|Lost to Follow-up|1|||
164493308|NCT05271552|594175635|FG001|Overall Study|Lost to Follow-up|5|||
164493309|NCT05271552|594175636|FG002|Overall Study|Lost to Follow-up|4|||
164493310|NCT05271552|594175634|FG000|Overall Study|Withdrawal by Subject|0|||
164493311|NCT05271552|594175635|FG001|Overall Study|Withdrawal by Subject|4|||
164493312|NCT05271552|594175636|FG002|Overall Study|Withdrawal by Subject|7|||
164493313|NCT05271552|594175634|FG000|Overall Study|Other medical reason.|1|||
164493314|NCT05271552|594175635|FG001|Overall Study|Other medical reason.|2|||
164493315|NCT05271552|594175636|FG002|Overall Study|Other medical reason.|0|||
164493316|NCT05271552|594175634|FG000|Overall Study|Other|3|||
164493317|NCT05271552|594175635|FG001|Overall Study|Other|3|||
164493318|NCT05271552|594175636|FG002|Overall Study|Other|6|||
164493319|NCT03840993|594175642|FG000|Overall Study|Adverse Event|1|||
164493320|NCT03840993|594175643|FG001|Overall Study|Adverse Event|0|||
164493321|NCT03840993|594175642|FG000|Overall Study|Lost to Follow-up|4|||
164493322|NCT03840993|594175643|FG001|Overall Study|Lost to Follow-up|0|||
164493323|NCT03840993|594175642|FG000|Overall Study|Physician Decision|0|||
164493324|NCT03840993|594175643|FG001|Overall Study|Physician Decision|1|||
164493325|NCT03840993|594175642|FG000|Overall Study|Pregnancy|0|||
164493326|NCT03840993|594175643|FG001|Overall Study|Pregnancy|1|||
164493327|NCT03840993|594175642|FG000|Overall Study|Withdrawal by Subject|1|||
164493328|NCT03840993|594175643|FG001|Overall Study|Withdrawal by Subject|3|||
164493329|NCT03840993|594175642|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
164493330|NCT03840993|594175643|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
164493331|NCT01090076|594175644|FG000|Overall Study|Death|1|||
164493332|NCT01090076|594175645|FG001|Overall Study|Death|1|||
164493333|NCT01090076|594175644|FG000|Overall Study|Withdrawal by Subject|0|||
164493334|NCT01090076|594175645|FG001|Overall Study|Withdrawal by Subject|1|||
164493335|NCT02176018|594175646|FG000|Overall Study|Adverse Event|0|||
164493336|NCT02176018|594175647|FG001|Overall Study|Adverse Event|2|||
164493337|NCT02176018|594175646|FG000|Overall Study|Lost to Follow-up|3|||
164493338|NCT02176018|594175647|FG001|Overall Study|Lost to Follow-up|1|||
164493339|NCT02176018|594175646|FG000|Overall Study|Protocol Violation|1|||
164493340|NCT02176018|594175647|FG001|Overall Study|Protocol Violation|1|||
164493341|NCT02176018|594175646|FG000|Overall Study|Withdrawal by Subject|1|||
164493342|NCT02176018|594175647|FG001|Overall Study|Withdrawal by Subject|2|||
164493343|NCT03022045|594175649|FG000|Overall Study|Adverse Event|0|||
164493344|NCT03022045|594175650|FG001|Overall Study|Adverse Event|1|||
164493345|NCT03022045|594175649|FG000|Overall Study|Withdrawal by Subject|1|||
164493346|NCT03022045|594175650|FG001|Overall Study|Withdrawal by Subject|1|||
164493347|NCT03275402|594175651|FG000|Overall Study|Death|17|||
164493348|NCT03275402|594175651|FG000|Overall Study|Study terminated by sponsor|21|||
164493349|NCT03275402|594175651|FG000|Overall Study|Withdrawal by Subject|1|||
164493350|NCT02986659|594175653|FG000|First Intervention Period|Adverse Event|3|||
164493351|NCT02986659|594175654|FG001|First Intervention Period|Adverse Event|1|||
164493352|NCT02986659|594175653|FG000|First Intervention Period|Lost to Follow-up|1|||
164493353|NCT02986659|594175654|FG001|First Intervention Period|Lost to Follow-up|0|||
164493354|NCT02986659|594175653|FG000|First Intervention Period|Withdrawal by Subject|0|||
164493355|NCT02986659|594175654|FG001|First Intervention Period|Withdrawal by Subject|1|||
164493356|NCT02986659|594175653|FG000|Second Intervention Period|Adverse Event|0|||
164493357|NCT02986659|594175654|FG001|Second Intervention Period|Adverse Event|6|||
164493358|NCT02253147|594175655|FG000|Overall Study|Protocol Violation|30|||
164493359|NCT02253147|594175655|FG000|Overall Study|Did not consent to study extension|9|||
164493360|NCT02253147|594175655|FG000|Overall Study|Conditional re-treatment at W52|5|||
164493361|NCT02253147|594175655|FG000|Overall Study|Lost to Follow-up|2|||
164714982|NCT03185013|594978844|FG000|Overall Study|Withdrawal by Subject|5|||
164714983|NCT03185013|594978845|FG001|Overall Study|Withdrawal by Subject|3|||
164714984|NCT03185013|594978844|FG000|Overall Study|Adverse Event|1|||
164714985|NCT03185013|594978845|FG001|Overall Study|Adverse Event|0|||
164714986|NCT03185013|594978844|FG000|Overall Study|Progressive Disease|1|||
164714987|NCT03185013|594978845|FG001|Overall Study|Progressive Disease|0|||
164714988|NCT03185013|594978844|FG000|Overall Study|Lost to Follow-up|8|||
164493362|NCT02253147|594175655|FG000|Overall Study|Withdrawal by Subject|1|||
164493363|NCT02469077|594175657|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
164493364|NCT02469077|594175658|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
164714989|NCT03185013|594978845|FG001|Overall Study|Lost to Follow-up|2|||
164714990|NCT03185013|594978844|FG000|Overall Study|Physician Decision|1|||
164603001|NCT00438399|594567162|FG005|Overall Study|Withdrawal by Subject|2|||
164603002|NCT00438399|594567157|FG000|Overall Study|Protocol Violation|0|||
164603003|NCT00438399|594567158|FG001|Overall Study|Protocol Violation|0|||
164603004|NCT00438399|594567159|FG002|Overall Study|Protocol Violation|1|||
164603005|NCT00438399|594567160|FG003|Overall Study|Protocol Violation|0|||
164603006|NCT00438399|594567161|FG004|Overall Study|Protocol Violation|0|||
164603007|NCT00438399|594567162|FG005|Overall Study|Protocol Violation|1|||
164603008|NCT00438399|594567157|FG000|Overall Study|Subje stopped study|0|||
164603009|NCT00438399|594567158|FG001|Overall Study|Subje stopped study|0|||
164603010|NCT00438399|594567159|FG002|Overall Study|Subje stopped study|1|||
164603011|NCT00438399|594567160|FG003|Overall Study|Subje stopped study|0|||
164603012|NCT00438399|594567161|FG004|Overall Study|Subje stopped study|0|||
164603013|NCT00438399|594567162|FG005|Overall Study|Subje stopped study|0|||
164603014|NCT00438399|594567157|FG000|Overall Study|Pregnancy|0|||
164603015|NCT00438399|594567158|FG001|Overall Study|Pregnancy|0|||
164603016|NCT00438399|594567159|FG002|Overall Study|Pregnancy|0|||
164603017|NCT00438399|594567160|FG003|Overall Study|Pregnancy|0|||
164603018|NCT00438399|594567161|FG004|Overall Study|Pregnancy|0|||
164603019|NCT00438399|594567162|FG005|Overall Study|Pregnancy|1|||
164603020|NCT00438399|594567157|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
164603021|NCT00438399|594567158|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
164603022|NCT00438399|594567159|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
164603023|NCT00438399|594567160|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
164603024|NCT00438399|594567161|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
164603025|NCT00438399|594567162|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
164603026|NCT01364233|594567163|FG000|Overall Study|Lost to Follow-up|1|||
164603027|NCT00349752|594567166|FG000|Overall Study|Adverse Event|8|||
164603028|NCT00349752|594567167|FG001|Overall Study|Adverse Event|12|||
164603029|NCT00349752|594567166|FG000|Overall Study|Lack of Efficacy|37|||
164603030|NCT00349752|594567167|FG001|Overall Study|Lack of Efficacy|42|||
164603031|NCT00349752|594567166|FG000|Overall Study|Lost to Follow-up|4|||
164603032|NCT00349752|594567167|FG001|Overall Study|Lost to Follow-up|2|||
164603033|NCT00349752|594567166|FG000|Overall Study|Personal reasons|6|||
164603034|NCT00349752|594567167|FG001|Overall Study|Personal reasons|5|||
164603035|NCT00349752|594567166|FG000|Overall Study|Other: Required exclusionary medication|0|||
164603036|NCT00349752|594567167|FG001|Overall Study|Other: Required exclusionary medication|1|||
164603037|NCT00349752|594567166|FG000|Overall Study|Other: Non compliance|0|||
164603038|NCT00349752|594567167|FG001|Overall Study|Other: Non compliance|1|||
164603039|NCT00349752|594567166|FG000|Overall Study|Other: Patient stopped steroids|0|||
164603040|NCT00349752|594567167|FG001|Overall Study|Other: Patient stopped steroids|1|||
164603041|NCT00349752|594567166|FG000|Overall Study|Other: Patient's steroid use|1|||
164603042|NCT00349752|594567167|FG001|Overall Study|Other: Patient's steroid use|0|||
164603043|NCT00349752|594567166|FG000|Overall Study|Other: Ineligible|1|||
164603044|NCT00349752|594567167|FG001|Overall Study|Other: Ineligible|0|||
164603045|NCT00349752|594567166|FG000|Overall Study|Other: Inadvertently unblinded|1|||
164603046|NCT00349752|594567167|FG001|Overall Study|Other: Inadvertently unblinded|0|||
164714991|NCT03185013|594978845|FG001|Overall Study|Physician Decision|0|||
164714992|NCT03185013|594978844|FG000|Overall Study|Protocol Deviation|2|||
164714993|NCT03185013|594978845|FG001|Overall Study|Protocol Deviation|0|||
164714994|NCT03185013|594978844|FG000|Overall Study|Reason not Specified|3|||
164603047|NCT00349752|594567166|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
164603048|NCT00349752|594567167|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
164603049|NCT00406783|594567168|FG000|Overall Study|Adverse Event|4|||
164603050|NCT00406783|594567169|FG001|Overall Study|Adverse Event|4|||
164603051|NCT00406783|594567168|FG000|Overall Study|Treatment Failure|2|||
164603052|NCT00406783|594567169|FG001|Overall Study|Treatment Failure|3|||
164603053|NCT00406783|594567168|FG000|Overall Study|Lost to Follow-up|3|||
164603054|NCT00406783|594567169|FG001|Overall Study|Lost to Follow-up|0|||
164603055|NCT00406783|594567168|FG000|Overall Study|Withdrawal by Subject|1|||
164714995|NCT03185013|594978845|FG001|Overall Study|Reason not Specified|2|||
164714996|NCT03185013|594978844|FG000|Overall Study|Death|1|||
164714997|NCT03185013|594978845|FG001|Overall Study|Death|0|||
164714998|NCT00197496|594978849|FG000|Baseline to Discharge|not interested|1|||
164714999|NCT00197496|594978850|FG001|Baseline to Discharge|not interested|0|||
164715000|NCT00197496|594978849|FG000|Baseline to Discharge|MRSA|1|||
164715001|NCT00197496|594978850|FG001|Baseline to Discharge|MRSA|0|||
164603056|NCT00406783|594567169|FG001|Overall Study|Withdrawal by Subject|4|||
164603057|NCT00406783|594567168|FG000|Overall Study|Protocol Violation|4|||
164603058|NCT00406783|594567169|FG001|Overall Study|Protocol Violation|4|||
164603059|NCT05294211|594567170|FG000|Overall Study|Withdrawal by Subject|3|||
164603060|NCT05294211|594567170|FG000|Overall Study|Physician Decision|2|||
164715002|NCT00197496|594978849|FG000|Baseline to Discharge|Physician Decision|0|||
164715003|NCT00197496|594978850|FG001|Baseline to Discharge|Physician Decision|1|||
164603061|NCT05294211|594567170|FG000|Overall Study|Progressed to active labor|1|||
164603062|NCT05294211|594567170|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
164603063|NCT05294211|594567170|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
164715004|NCT00197496|594978849|FG000|Baseline to Discharge|Protocol Violation|0|||
164715005|NCT00197496|594978850|FG001|Baseline to Discharge|Protocol Violation|1|||
164493365|NCT02469077|594175657|FG000|Post Randomization/Intervention Period|Relocated|1|||
164493366|NCT02469077|594175658|FG001|Post Randomization/Intervention Period|Relocated|1|||
164493367|NCT02469077|594175657|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
164493368|NCT02469077|594175658|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
164493369|NCT02469077|594175657|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
164493370|NCT02469077|594175658|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
164493371|NCT02973477|594175659|FG000|First Intervention|Lost to Follow-up|0|||
164493372|NCT02973477|594175660|FG001|First Intervention|Lost to Follow-up|2|||
164493373|NCT02973477|594175659|FG000|Washout|Withdrawal by Subject|1|||
164493374|NCT02973477|594175660|FG001|Washout|Withdrawal by Subject|0|||
164493375|NCT02973477|594175659|FG000|Second Intervention|Lost to Follow-up|1|||
164493376|NCT02973477|594175660|FG001|Second Intervention|Lost to Follow-up|0|||
164493377|NCT02402465|594175662|FG000|Overall Study|Withdrawal by Subject|0|||
164493378|NCT02402465|594175663|FG001|Overall Study|Withdrawal by Subject|0|||
164493379|NCT02402465|594175664|FG002|Overall Study|Withdrawal by Subject|0|||
164493380|NCT02402465|594175665|FG003|Overall Study|Withdrawal by Subject|0|||
164493381|NCT02402465|594175666|FG004|Overall Study|Withdrawal by Subject|0|||
164493382|NCT02402465|594175667|FG005|Overall Study|Withdrawal by Subject|1|||
164493383|NCT02402465|594175662|FG000|Overall Study|Lost to Follow-up|0|||
164493384|NCT02402465|594175663|FG001|Overall Study|Lost to Follow-up|1|||
164493385|NCT02402465|594175664|FG002|Overall Study|Lost to Follow-up|0|||
164493386|NCT02402465|594175665|FG003|Overall Study|Lost to Follow-up|0|||
164493387|NCT02402465|594175666|FG004|Overall Study|Lost to Follow-up|1|||
164493388|NCT02402465|594175667|FG005|Overall Study|Lost to Follow-up|0|||
164493389|NCT01284634|594175668|FG000|Overall Study|Adverse Event|1|||
164493390|NCT01284634|594175669|FG001|Overall Study|Adverse Event|0|||
164493391|NCT01284634|594175670|FG002|Overall Study|Adverse Event|2|||
164493392|NCT01284634|594175671|FG003|Overall Study|Adverse Event|1|||
164493393|NCT03807700|594175672|FG000|Overall Study|Withdrawal by Subject|2|||
164493394|NCT03807700|594175673|FG001|Overall Study|Withdrawal by Subject|1|||
164493395|NCT01059526|594175674|FG000|Overall Study|Patient enrolled but not treated|20|||
164493396|NCT01059526|594175675|FG001|Overall Study|Patient enrolled but not treated|17|||
164493397|NCT01059526|594175674|FG000|Overall Study|Adverse Event|2|||
164493398|NCT01059526|594175675|FG001|Overall Study|Adverse Event|2|||
164493399|NCT01059526|594175674|FG000|Overall Study|Protocol Violation|0|||
164493400|NCT01059526|594175675|FG001|Overall Study|Protocol Violation|1|||
164493401|NCT01059526|594175674|FG000|Overall Study|Withdrawal by Subject|3|||
164493402|NCT01059526|594175675|FG001|Overall Study|Withdrawal by Subject|1|||
164493403|NCT01059526|594175674|FG000|Overall Study|Lost to Follow-up|4|||
164493404|NCT01059526|594175675|FG001|Overall Study|Lost to Follow-up|1|||
164493405|NCT01059526|594175674|FG000|Overall Study|Patient found to be dermatographic|1|||
164493406|NCT01059526|594175675|FG001|Overall Study|Patient found to be dermatographic|0|||
164493407|NCT02720081|594175676|FG000|Overall Study|Adverse Event|0|||
164493408|NCT02720081|594175677|FG001|Overall Study|Adverse Event|3|||
164493409|NCT02720081|594175676|FG000|Overall Study|Protocol Violation|4|||
164493410|NCT02720081|594175677|FG001|Overall Study|Protocol Violation|1|||
164493411|NCT01732588|594175678|FG000|First Intervention (7 Days)|Adverse Event|0|||
164493412|NCT01732588|594175679|FG001|First Intervention (7 Days)|Adverse Event|1|||
164493413|NCT01732588|594175680|FG002|First Intervention (7 Days)|Adverse Event|0|||
164493414|NCT04601857|594175681|FG000|Overall Study|Adverse Event/Serious Adverse Event|3|||
164493415|NCT04601857|594175682|FG001|Overall Study|Adverse Event/Serious Adverse Event|7|||
164493416|NCT04601857|594175681|FG000|Overall Study|Disease Progression|2|||
164493417|NCT04601857|594175682|FG001|Overall Study|Disease Progression|4|||
164493418|NCT04601857|594175681|FG000|Overall Study|Clinical Disease Progression|2|||
164493419|NCT04601857|594175682|FG001|Overall Study|Clinical Disease Progression|1|||
164493420|NCT04601857|594175681|FG000|Overall Study|Radiological Progression|4|||
164493421|NCT04601857|594175682|FG001|Overall Study|Radiological Progression|11|||
164493422|NCT04601857|594175681|FG000|Overall Study|Death|1|||
164493423|NCT04601857|594175682|FG001|Overall Study|Death|0|||
164493424|NCT04601857|594175681|FG000|Overall Study|Reason Not Specified|0|||
164493425|NCT04601857|594175682|FG001|Overall Study|Reason Not Specified|1|||
164493426|NCT04601857|594175681|FG000|Overall Study|At the Participant's Request|0|||
164493427|NCT04601857|594175682|FG001|Overall Study|At the Participant's Request|1|||
164493428|NCT00980954|594175683|FG000|Overall Study|Protocol Violation|9|||
164493429|NCT00980954|594175684|FG001|Overall Study|Protocol Violation|15|||
164493430|NCT04372186|594175685|FG000|Overall Study|Death|24|||
164493431|NCT04372186|594175686|FG001|Overall Study|Death|11|||
164493432|NCT04372186|594175685|FG000|Overall Study|Transferred to a different facility for care|0|||
164493433|NCT04372186|594175686|FG001|Overall Study|Transferred to a different facility for care|2|||
164493434|NCT04736472|594175687|FG000|Overall Study|Lost to Follow-up|1|||
164715006|NCT00197496|594978849|FG000|Follow-up|Lost to Follow-up|2|||
164493435|NCT04736472|594175688|FG001|Overall Study|Lost to Follow-up|0|||
164493436|NCT04736472|594175689|FG002|Overall Study|Lost to Follow-up|0|||
164715007|NCT00197496|594978850|FG001|Follow-up|Lost to Follow-up|1|||
164715008|NCT03255655|594978851|FG000|Overall Study|Lost to Follow-up|7|||
164493437|NCT04736472|594175687|FG000|Overall Study|Withdrawal by Subject|2|||
164493438|NCT04736472|594175688|FG001|Overall Study|Withdrawal by Subject|0|||
164493439|NCT04736472|594175689|FG002|Overall Study|Withdrawal by Subject|0|||
164493440|NCT04736472|594175687|FG000|Overall Study|Protocol Violation|48|||
164493441|NCT04736472|594175688|FG001|Overall Study|Protocol Violation|0|||
164493442|NCT04736472|594175689|FG002|Overall Study|Protocol Violation|6|||
164493443|NCT02268526|594175690|FG000|Overall Study|Adverse Event|0|||
164493444|NCT02268526|594175691|FG001|Overall Study|Adverse Event|2|||
164493445|NCT02268526|594175692|FG002|Overall Study|Adverse Event|1|||
164493446|NCT02268526|594175690|FG000|Overall Study|Death|1|||
164493447|NCT02268526|594175691|FG001|Overall Study|Death|11|||
164493448|NCT02268526|594175692|FG002|Overall Study|Death|0|||
164493449|NCT02268526|594175690|FG000|Overall Study|protocol deviation|0|||
164493450|NCT02268526|594175691|FG001|Overall Study|protocol deviation|1|||
164493451|NCT02268526|594175692|FG002|Overall Study|protocol deviation|0|||
164493452|NCT02268526|594175690|FG000|Overall Study|Physician Decision|0|||
164493453|NCT02268526|594175691|FG001|Overall Study|Physician Decision|0|||
164493454|NCT02268526|594175692|FG002|Overall Study|Physician Decision|1|||
164493455|NCT02268526|594175690|FG000|Overall Study|Subject/guardian decision|0|||
164493456|NCT02268526|594175691|FG001|Overall Study|Subject/guardian decision|7|||
164493457|NCT02268526|594175692|FG002|Overall Study|Subject/guardian decision|3|||
164493458|NCT02332824|594175695|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
164493459|NCT02332824|594175696|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
164493460|NCT02332824|594175697|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
164493461|NCT02332824|594175698|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
164493462|NCT02332824|594175699|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
164493463|NCT02332824|594175700|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
164493464|NCT02332824|594175695|FG000|Overall Study|Voluntary Withdrawal|1|||
164493465|NCT02332824|594175696|FG001|Overall Study|Voluntary Withdrawal|0|||
164493466|NCT02332824|594175697|FG002|Overall Study|Voluntary Withdrawal|0|||
164493467|NCT02332824|594175698|FG003|Overall Study|Voluntary Withdrawal|0|||
164493468|NCT02332824|594175699|FG004|Overall Study|Voluntary Withdrawal|0|||
164493469|NCT02332824|594175700|FG005|Overall Study|Voluntary Withdrawal|0|||
164493470|NCT02332824|594175695|FG000|Overall Study|Inconvenient schedule|1|||
164493471|NCT02332824|594175696|FG001|Overall Study|Inconvenient schedule|1|||
164493472|NCT02332824|594175697|FG002|Overall Study|Inconvenient schedule|0|||
164493473|NCT02332824|594175698|FG003|Overall Study|Inconvenient schedule|0|||
164493474|NCT02332824|594175699|FG004|Overall Study|Inconvenient schedule|0|||
164493475|NCT02332824|594175700|FG005|Overall Study|Inconvenient schedule|0|||
164493476|NCT02332824|594175695|FG000|Overall Study|Transfer|0|||
164493477|NCT02332824|594175696|FG001|Overall Study|Transfer|0|||
164493478|NCT02332824|594175697|FG002|Overall Study|Transfer|1|||
164493479|NCT02332824|594175698|FG003|Overall Study|Transfer|1|||
164493480|NCT02332824|594175699|FG004|Overall Study|Transfer|0|||
164493481|NCT02332824|594175700|FG005|Overall Study|Transfer|0|||
164493482|NCT00498797|594175701|FG000|Overall Study|Withdrawal by Subject|4|||
164493483|NCT00498797|594175702|FG001|Overall Study|Withdrawal by Subject|2|||
164493484|NCT00498797|594175701|FG000|Overall Study|Adverse Event|12|||
164493485|NCT00498797|594175702|FG001|Overall Study|Adverse Event|5|||
164493486|NCT00498797|594175701|FG000|Overall Study|Condition under investigation worsened|19|||
164493487|NCT00498797|594175702|FG001|Overall Study|Condition under investigation worsened|21|||
164493488|NCT00498797|594175701|FG000|Overall Study|Other|3|||
164493489|NCT00498797|594175702|FG001|Overall Study|Other|1|||
164493490|NCT01052714|594175707|FG000|Overall Study|Adverse Event|6|||
164493491|NCT01052714|594175708|FG001|Overall Study|Adverse Event|3|||
164493492|NCT01052714|594175709|FG002|Overall Study|Adverse Event|0|||
164493493|NCT01052714|594175707|FG000|Overall Study|Death|1|||
164493494|NCT01052714|594175708|FG001|Overall Study|Death|2|||
164493495|NCT01052714|594175709|FG002|Overall Study|Death|0|||
164493496|NCT01052714|594175707|FG000|Overall Study|Lost to Follow-up|2|||
164493497|NCT01052714|594175708|FG001|Overall Study|Lost to Follow-up|3|||
164493498|NCT01052714|594175709|FG002|Overall Study|Lost to Follow-up|0|||
164493499|NCT01052714|594175707|FG000|Overall Study|Physician Decision|9|||
164493500|NCT01052714|594175708|FG001|Overall Study|Physician Decision|9|||
164493501|NCT01052714|594175709|FG002|Overall Study|Physician Decision|1|||
164493502|NCT01052714|594175707|FG000|Overall Study|Withdrawal by Subject|7|||
164493503|NCT01052714|594175708|FG001|Overall Study|Withdrawal by Subject|12|||
164493504|NCT01052714|594175709|FG002|Overall Study|Withdrawal by Subject|1|||
164493505|NCT00417989|594175713|FG000|Overall Study|Withdrawal by Subject|13|||
164493506|NCT00417989|594175714|FG001|Overall Study|Withdrawal by Subject|13|||
164493507|NCT00417989|594175713|FG000|Overall Study|Lost to Follow-up|1|||
164493508|NCT00417989|594175714|FG001|Overall Study|Lost to Follow-up|6|||
164493509|NCT00417989|594175713|FG000|Overall Study|Protocol Violation|1|||
164493510|NCT00417989|594175714|FG001|Overall Study|Protocol Violation|0|||
164493511|NCT00417989|594175713|FG000|Overall Study|Death|0|||
164493512|NCT00417989|594175714|FG001|Overall Study|Death|1|||
164493513|NCT00417989|594175713|FG000|Overall Study|Physician Decision|5|||
164493514|NCT00417989|594175714|FG001|Overall Study|Physician Decision|2|||
164493515|NCT04212299|594175718|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
164715009|NCT03255655|594978852|FG001|Overall Study|Lost to Follow-up|4|||
164715010|NCT01806506|594978856|FG000|Overall Study|Lost to Follow-up|2|||
164715011|NCT01806506|594978857|FG001|Overall Study|Lost to Follow-up|1|||
164715012|NCT02099682|594978860|FG000|Overall Study|Data Not Available|51|||
164493516|NCT05379023|594175719|FG000|Overall Study|Lost to Follow-up|1|||
164493517|NCT05379023|594175720|FG001|Overall Study|Lost to Follow-up|0|||
164493518|NCT05379023|594175721|FG002|Overall Study|Lost to Follow-up|0|||
164493519|NCT05379023|594175719|FG000|Overall Study|Withdrawal by Subject|2|||
164493520|NCT05379023|594175720|FG001|Overall Study|Withdrawal by Subject|0|||
164493521|NCT05379023|594175721|FG002|Overall Study|Withdrawal by Subject|0|||
164493522|NCT01589523|594177247|FG000|Overall Study|Withdrawal by Subject|1|||
164493523|NCT00332488|594177248|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
164493524|NCT00332488|594177249|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
164493525|NCT00332488|594177250|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
164493526|NCT00332488|594177248|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
164493527|NCT00332488|594177249|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
164493528|NCT00332488|594177250|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
164493529|NCT00332488|594177248|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
164493530|NCT00332488|594177249|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
164493531|NCT00332488|594177250|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
164493532|NCT00332488|594177248|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
164493533|NCT00332488|594177249|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
164493534|NCT00332488|594177250|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
164493535|NCT00332488|594177248|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
164493536|NCT00332488|594177249|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
164493537|NCT00332488|594177250|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
164493538|NCT00332488|594177248|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
164493539|NCT00332488|594177249|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
164493540|NCT00332488|594177250|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
164493541|NCT00332488|594177248|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
164493542|NCT00332488|594177249|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
164493543|NCT00332488|594177250|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
164493544|NCT00332488|594177248|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
164493545|NCT00332488|594177249|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
164493546|NCT00332488|594177250|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
164493547|NCT00332488|594177248|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
164493548|NCT00332488|594177249|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
164493549|NCT00332488|594177250|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
164493550|NCT00332488|594177248|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
164493551|NCT00332488|594177249|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
164493552|NCT00332488|594177250|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
164493553|NCT00332488|594177248|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
164493554|NCT00332488|594177249|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
164493555|NCT00332488|594177250|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
164493556|NCT00332488|594177248|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
164493557|NCT00332488|594177249|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
164493558|NCT00332488|594177250|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
164493559|NCT00792259|594177251|FG000|Overall Study|Poor Quality Scans|1|||
164493560|NCT00792259|594177252|FG001|Overall Study|Poor Quality Scans|0|||
164493561|NCT00792259|594177253|FG002|Overall Study|Poor Quality Scans|0|||
164493562|NCT00371462|594177254|FG000|Overall Study|Withdrawal by Subject|1|||
164493563|NCT00371462|594177255|FG001|Overall Study|Withdrawal by Subject|0|||
164493564|NCT00371462|594177254|FG000|Overall Study|Other|7|||
164493565|NCT00371462|594177255|FG001|Overall Study|Other|8|||
164493566|NCT03721978|594177256|FG000|Overall Study|Withdrawal by Subject|6|||
164493567|NCT03721978|594177257|FG001|Overall Study|Withdrawal by Subject|1|||
164493568|NCT03721978|594177256|FG000|Overall Study|Adverse Event|1|||
164493569|NCT03721978|594177257|FG001|Overall Study|Adverse Event|1|||
164493570|NCT03721978|594177256|FG000|Overall Study|Progressive Disease|1|||
164493571|NCT03721978|594177257|FG001|Overall Study|Progressive Disease|0|||
164715013|NCT02099682|594978860|FG000|Overall Study|Lost to Follow-up|31|||
164715014|NCT02099682|594978860|FG000|Overall Study|Other|29|||
164493572|NCT03721978|594177256|FG000|Overall Study|Lost to Follow-up|5|||
164493573|NCT03721978|594177257|FG001|Overall Study|Lost to Follow-up|1|||
164493574|NCT03721978|594177256|FG000|Overall Study|Reason not Specified|0|||
164493575|NCT03721978|594177257|FG001|Overall Study|Reason not Specified|2|||
164493576|NCT05244226|594177258|FG000|Overall Study|Adverse Event|1|||
164493577|NCT05244226|594177259|FG001|Overall Study|Adverse Event|0|||
164715015|NCT02203331|594978861|FG000|Overall Study|Pregnancy|1|||
164715016|NCT02203331|594978862|FG001|Overall Study|Pregnancy|0|||
164715017|NCT02203331|594978863|FG002|Overall Study|Pregnancy|0|||
164715018|NCT02203331|594978864|FG003|Overall Study|Pregnancy|0|||
164493578|NCT05244226|594177260|FG002|Overall Study|Adverse Event|0|||
164493579|NCT05244226|594177258|FG000|Overall Study|Lost to Follow-up|0|||
164493580|NCT05244226|594177259|FG001|Overall Study|Lost to Follow-up|0|||
164493581|NCT05244226|594177260|FG002|Overall Study|Lost to Follow-up|1|||
164493582|NCT05244226|594177258|FG000|Overall Study|Protocol Violation|0|||
164493583|NCT05244226|594177259|FG001|Overall Study|Protocol Violation|2|||
164493584|NCT05244226|594177260|FG002|Overall Study|Protocol Violation|2|||
164493585|NCT01194271|594177261|FG000|Overall Study|Withdrawal by Subject|1|||
164493586|NCT01194271|594177261|FG000|Overall Study|Ineligible, Screen Failure|1|||
164493587|NCT01194271|594177261|FG000|Overall Study|Death|1|||
164493588|NCT03924947|594177262|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
164493589|NCT03924947|594177263|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
164493590|NCT03924947|594177264|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
164493591|NCT03924947|594177265|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
164493592|NCT03924947|594177266|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
164493593|NCT03924947|594177267|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
164493594|NCT01145417|594177268|FG000|Overall Study|Death|1|||
164493595|NCT01145417|594177269|FG001|Overall Study|Death|0|||
164493596|NCT01145417|594177268|FG000|Overall Study|Lost to Follow-up|2|||
164493597|NCT01145417|594177269|FG001|Overall Study|Lost to Follow-up|1|||
164493598|NCT01145417|594177268|FG000|Overall Study|Withdrawal by Subject|1|||
164493599|NCT01145417|594177269|FG001|Overall Study|Withdrawal by Subject|2|||
164493600|NCT01145417|594177268|FG000|Overall Study|Pregnancy|1|||
164493601|NCT01145417|594177269|FG001|Overall Study|Pregnancy|0|||
164493602|NCT01145417|594177268|FG000|Overall Study|Adverse Event|0|||
164493603|NCT01145417|594177269|FG001|Overall Study|Adverse Event|1|||
164493604|NCT01145417|594177268|FG000|Overall Study|Study terminated by sponsor|35|||
164493605|NCT01145417|594177269|FG001|Overall Study|Study terminated by sponsor|43|||
164493606|NCT01145417|594177268|FG000|Overall Study|Other|1|||
164493607|NCT01145417|594177269|FG001|Overall Study|Other|0|||
164493608|NCT03085433|594177270|FG000|Overall Study|Withdrawal by Subject|2|||
164493609|NCT03085433|594177271|FG001|Overall Study|Withdrawal by Subject|4|||
164493610|NCT03085433|594177270|FG000|Overall Study|Physician Decision|33|||
164493611|NCT03085433|594177271|FG001|Overall Study|Physician Decision|50|||
164493612|NCT01797562|594177272|FG000|Overall Study|Protocol Violation|5|||
164493613|NCT00917462|594177273|FG000|Overall Study|Clinical Deterioration|1|||
164603064|NCT03334396|594567171|FG000|Overall Study|Adverse Event|1|||
164603065|NCT03334396|594567172|FG001|Overall Study|Adverse Event|0|||
164603066|NCT03334396|594567173|FG002|Overall Study|Adverse Event|1|||
164603067|NCT03334396|594567174|FG003|Overall Study|Adverse Event|0|||
164603068|NCT03334396|594567175|FG004|Overall Study|Adverse Event|0|||
164603069|NCT03334396|594567176|FG005|Overall Study|Adverse Event|0|||
164603070|NCT03334396|594567177|FG006|Overall Study|Adverse Event|0|||
164603071|NCT03334396|594567178|FG007|Overall Study|Adverse Event|0|||
164603072|NCT03334396|594567171|FG000|Overall Study|Lack of Efficacy|10|||
164603073|NCT03334396|594567172|FG001|Overall Study|Lack of Efficacy|4|||
164603074|NCT03334396|594567173|FG002|Overall Study|Lack of Efficacy|1|||
164603075|NCT03334396|594567174|FG003|Overall Study|Lack of Efficacy|3|||
164603076|NCT03334396|594567175|FG004|Overall Study|Lack of Efficacy|1|||
164603077|NCT03334396|594567176|FG005|Overall Study|Lack of Efficacy|0|||
164603078|NCT03334396|594567177|FG006|Overall Study|Lack of Efficacy|0|||
164603079|NCT03334396|594567178|FG007|Overall Study|Lack of Efficacy|1|||
164603080|NCT03334396|594567171|FG000|Overall Study|Lost to Follow-up|0|||
164603081|NCT03334396|594567172|FG001|Overall Study|Lost to Follow-up|0|||
164603082|NCT03334396|594567173|FG002|Overall Study|Lost to Follow-up|1|||
164603083|NCT03334396|594567174|FG003|Overall Study|Lost to Follow-up|0|||
164603084|NCT03334396|594567175|FG004|Overall Study|Lost to Follow-up|0|||
164603085|NCT03334396|594567176|FG005|Overall Study|Lost to Follow-up|0|||
164603086|NCT03334396|594567177|FG006|Overall Study|Lost to Follow-up|1|||
164603087|NCT03334396|594567178|FG007|Overall Study|Lost to Follow-up|0|||
164603088|NCT03334396|594567171|FG000|Overall Study|Physician Decision|1|||
164603089|NCT03334396|594567172|FG001|Overall Study|Physician Decision|0|||
164603090|NCT03334396|594567173|FG002|Overall Study|Physician Decision|0|||
164603091|NCT03334396|594567174|FG003|Overall Study|Physician Decision|0|||
164603092|NCT03334396|594567175|FG004|Overall Study|Physician Decision|0|||
164603093|NCT03334396|594567176|FG005|Overall Study|Physician Decision|0|||
164603094|NCT03334396|594567177|FG006|Overall Study|Physician Decision|0|||
164603095|NCT03334396|594567178|FG007|Overall Study|Physician Decision|0|||
164603096|NCT03334396|594567171|FG000|Overall Study|Withdrawal by Subject|10|||
164603097|NCT03334396|594567172|FG001|Overall Study|Withdrawal by Subject|5|||
164603098|NCT03334396|594567173|FG002|Overall Study|Withdrawal by Subject|7|||
164603099|NCT03334396|594567174|FG003|Overall Study|Withdrawal by Subject|2|||
164493614|NCT01441583|594177274|FG000|Overall Study|Withdrawal by Subject|1|||
164493615|NCT01441583|594177275|FG001|Overall Study|Withdrawal by Subject|1|||
164493616|NCT01441583|594177276|FG002|Overall Study|Withdrawal by Subject|1|||
164493617|NCT01441583|594177274|FG000|Overall Study|Death|1|||
164493618|NCT01441583|594177275|FG001|Overall Study|Death|0|||
164603100|NCT03334396|594567175|FG004|Overall Study|Withdrawal by Subject|2|||
164603101|NCT03334396|594567176|FG005|Overall Study|Withdrawal by Subject|1|||
164715019|NCT02203331|594978865|FG004|Overall Study|Pregnancy|2|||
164715020|NCT02203331|594978866|FG005|Overall Study|Pregnancy|0|||
164715021|NCT02203331|594978861|FG000|Overall Study|Withdrawal by Subject|1|||
164715022|NCT02203331|594978862|FG001|Overall Study|Withdrawal by Subject|0|||
164715023|NCT02203331|594978863|FG002|Overall Study|Withdrawal by Subject|1|||
164715024|NCT02203331|594978864|FG003|Overall Study|Withdrawal by Subject|0|||
164715025|NCT02203331|594978865|FG004|Overall Study|Withdrawal by Subject|0|||
164493619|NCT01441583|594177276|FG002|Overall Study|Death|4|||
164493620|NCT01441583|594177274|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
164603102|NCT03334396|594567177|FG006|Overall Study|Withdrawal by Subject|2|||
164603103|NCT03334396|594567178|FG007|Overall Study|Withdrawal by Subject|0|||
164603104|NCT03334396|594567171|FG000|Overall Study|Pregnancy|0|||
164603105|NCT03334396|594567172|FG001|Overall Study|Pregnancy|1|||
164603106|NCT03334396|594567173|FG002|Overall Study|Pregnancy|0|||
164603107|NCT03334396|594567174|FG003|Overall Study|Pregnancy|0|||
164603108|NCT03334396|594567175|FG004|Overall Study|Pregnancy|0|||
164603109|NCT03334396|594567176|FG005|Overall Study|Pregnancy|0|||
164603110|NCT03334396|594567177|FG006|Overall Study|Pregnancy|0|||
164603111|NCT03334396|594567178|FG007|Overall Study|Pregnancy|0|||
164603112|NCT03334396|594567171|FG000|Overall Study|Ineligible|0|||
164603113|NCT03334396|594567172|FG001|Overall Study|Ineligible|1|||
164603114|NCT03334396|594567173|FG002|Overall Study|Ineligible|0|||
164603115|NCT03334396|594567174|FG003|Overall Study|Ineligible|0|||
164603116|NCT03334396|594567175|FG004|Overall Study|Ineligible|0|||
164603117|NCT03334396|594567176|FG005|Overall Study|Ineligible|0|||
164493621|NCT01441583|594177275|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
164493622|NCT01441583|594177276|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
164493623|NCT03809039|594177277|FG000|Part 1|Withdrawal by Subject|1|||
164493624|NCT03809039|594177278|FG001|Part 1|Withdrawal by Subject|0|||
164493625|NCT03809039|594177279|FG002|Part 1|Withdrawal by Subject|0|||
164493626|NCT03809039|594177280|FG003|Part 1|Withdrawal by Subject|1|||
164493627|NCT03809039|594177281|FG004|Part 1|Withdrawal by Subject|0|||
164493628|NCT03809039|594177282|FG005|Part 1|Withdrawal by Subject|0|||
164493629|NCT03809039|594177283|FG006|Part 1|Withdrawal by Subject|0|||
164493630|NCT03809039|594177284|FG007|Part 1|Withdrawal by Subject|0|||
164493631|NCT03809039|594177285|FG008|Part 1|Withdrawal by Subject|0|||
164493632|NCT03809039|594177277|FG000|Part 3|Withdrawn by study termination|0|||
164493633|NCT03809039|594177278|FG001|Part 3|Withdrawn by study termination|0|||
164493634|NCT03809039|594177279|FG002|Part 3|Withdrawn by study termination|0|||
164493635|NCT03809039|594177280|FG003|Part 3|Withdrawn by study termination|0|||
164493636|NCT03809039|594177281|FG004|Part 3|Withdrawn by study termination|0|||
164493637|NCT03809039|594177282|FG005|Part 3|Withdrawn by study termination|0|||
164493638|NCT03809039|594177283|FG006|Part 3|Withdrawn by study termination|0|||
164493639|NCT03809039|594177284|FG007|Part 3|Withdrawn by study termination|2|||
164493640|NCT03809039|594177285|FG008|Part 3|Withdrawn by study termination|6|||
164493641|NCT03341312|594177286|FG000|Period 1|Withdrawal by Subject|0|||
164493642|NCT03341312|594177287|FG001|Period 1|Withdrawal by Subject|1|||
164493643|NCT03341312|594177288|FG002|Period 1|Withdrawal by Subject|0|||
164493644|NCT03341312|594177289|FG003|Period 1|Withdrawal by Subject|0|||
164493645|NCT00744796|594177294|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
164493646|NCT05372913|594177298|FG000|Overall Study|Withdrawal by Subject|0|||
164493647|NCT05372913|594177299|FG001|Overall Study|Withdrawal by Subject|2|||
164493648|NCT05372913|594177298|FG000|Overall Study|Protocol Violation|2|||
164493649|NCT05372913|594177299|FG001|Overall Study|Protocol Violation|2|||
164493650|NCT05372913|594177298|FG000|Overall Study|Adverse Event|0|||
164493651|NCT05372913|594177299|FG001|Overall Study|Adverse Event|1|||
164493652|NCT05012397|594177302|FG000|Overall Study|Death|10|||
164493653|NCT05012397|594177302|FG000|Overall Study|Physician Decision|9|||
164603118|NCT03334396|594567177|FG006|Overall Study|Ineligible|0|||
164603119|NCT03334396|594567178|FG007|Overall Study|Ineligible|0|||
164603120|NCT03334396|594567171|FG000|Overall Study|Started New Job|1|||
164715026|NCT02203331|594978866|FG005|Overall Study|Withdrawal by Subject|3|||
164715027|NCT02203331|594978861|FG000|Overall Study|Adverse Event|4|||
164715028|NCT02203331|594978862|FG001|Overall Study|Adverse Event|8|||
164493654|NCT05012397|594177302|FG000|Overall Study|Withdrawal by Subject|5|||
164493655|NCT05012397|594177302|FG000|Overall Study|Lost to Follow-up|2|||
164493656|NCT03334747|594177305|FG000|Treatment Phase|Technical problems|0|||
164493657|NCT03334747|594177306|FG001|Treatment Phase|Technical problems|0|||
164493658|NCT03334747|594177307|FG002|Treatment Phase|Technical problems|0|||
164715029|NCT02203331|594978863|FG002|Overall Study|Adverse Event|3|||
164715030|NCT02203331|594978864|FG003|Overall Study|Adverse Event|4|||
164493659|NCT03334747|594177308|FG003|Treatment Phase|Technical problems|0|||
164493660|NCT03334747|594177309|FG004|Treatment Phase|Technical problems|1|||
164493661|NCT03334747|594177310|FG005|Treatment Phase|Technical problems|0|||
164493662|NCT03334747|594177311|FG006|Treatment Phase|Technical problems|0|||
164603121|NCT03334396|594567172|FG001|Overall Study|Started New Job|0|||
164603122|NCT03334396|594567173|FG002|Overall Study|Started New Job|0|||
164603123|NCT03334396|594567174|FG003|Overall Study|Started New Job|0|||
164603124|NCT03334396|594567175|FG004|Overall Study|Started New Job|0|||
164603125|NCT03334396|594567176|FG005|Overall Study|Started New Job|0|||
164603126|NCT03334396|594567177|FG006|Overall Study|Started New Job|0|||
164603127|NCT03334396|594567178|FG007|Overall Study|Started New Job|0|||
164603128|NCT01842607|594567180|FG000|Overall Study|Adverse Event|11|||
164603129|NCT01842607|594567180|FG000|Overall Study|Lack of Efficacy|19|||
164603130|NCT01842607|594567180|FG000|Overall Study|Protocol Violation|8|||
164603131|NCT01842607|594567180|FG000|Overall Study|Protocol defined stopping criteria|2|||
164603132|NCT01842607|594567180|FG000|Overall Study|Lost to Follow-up|3|||
164603133|NCT01842607|594567180|FG000|Overall Study|Physician Decision|9|||
164603134|NCT01842607|594567180|FG000|Overall Study|Withdrawal by Subject|14|||
164603135|NCT00012012|594567181|FG000|Overall Study|Protocol Violation|1|||
164603136|NCT00012012|594567182|FG001|Overall Study|Protocol Violation|1|||
164603137|NCT00012012|594567181|FG000|Overall Study|Withdrawal by Subject|0|||
164603138|NCT00012012|594567182|FG001|Overall Study|Withdrawal by Subject|2|||
164603139|NCT02159469|594567183|FG000|Overall Study|Missing Completion status|1|||
164603140|NCT02159469|594567183|FG000|Overall Study|Adverse Event|5|||
164603141|NCT02159469|594567183|FG000|Overall Study|Non-compliance|2|||
164603142|NCT02159469|594567183|FG000|Overall Study|Withdrawal by Subject|9|||
164603143|NCT02159469|594567183|FG000|Overall Study|Lost to Follow-up|1|||
164603144|NCT02159469|594567183|FG000|Overall Study|Sponsor's request|2|||
164603145|NCT02159469|594567183|FG000|Overall Study|Met Stopping Criteria|3|||
164603146|NCT02159469|594567183|FG000|Overall Study|Other|1|||
164603147|NCT02159469|594567183|FG000|Overall Study|Multiple|29|||
164603148|NCT02034474|594567184|FG000|Overall Study|Adverse Event|3|||
164603149|NCT02034474|594567185|FG001|Overall Study|Adverse Event|2|||
164603150|NCT02034474|594567184|FG000|Overall Study|Withdrawal by Subject|1|||
164603151|NCT02034474|594567185|FG001|Overall Study|Withdrawal by Subject|2|||
164603152|NCT03629041|594567191|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
164603153|NCT03629041|594567192|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
164603154|NCT03629041|594567193|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
164603155|NCT03629041|594567194|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
164603156|NCT01391819|594567195|FG000|Overall Study|Withdrawal by Subject|56|||
164603157|NCT01391819|594567195|FG000|Overall Study|Migrated/moved from study area|82|||
164603158|NCT01391819|594567195|FG000|Overall Study|Lost to Follow-up|252|||
164603159|NCT01391819|594567195|FG000|Overall Study|Death|3|||
164603160|NCT01391819|594567195|FG000|Overall Study|Other|9|||
164603161|NCT03488251|594567197|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
164603162|NCT03488251|594567198|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
164603163|NCT03488251|594567199|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
164603164|NCT03488251|594567200|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
164603165|NCT03488251|594567197|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
164603166|NCT03488251|594567198|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
164603167|NCT03488251|594567199|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
164603168|NCT03488251|594567200|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
164603169|NCT03488251|594567197|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
164603170|NCT03488251|594567198|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
164603171|NCT03488251|594567199|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
164603172|NCT03488251|594567200|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
164493663|NCT03334747|594177312|FG007|Treatment Phase|Technical problems|0|||
164493664|NCT03334747|594177313|FG008|Treatment Phase|Technical problems|0|||
164493665|NCT03334747|594177305|FG000|Treatment Phase|Subject/guardian decision|1|||
164493666|NCT03334747|594177306|FG001|Treatment Phase|Subject/guardian decision|0|||
164493667|NCT03334747|594177307|FG002|Treatment Phase|Subject/guardian decision|0|||
164493668|NCT03334747|594177308|FG003|Treatment Phase|Subject/guardian decision|0|||
164493669|NCT03334747|594177309|FG004|Treatment Phase|Subject/guardian decision|0|||
164493670|NCT03334747|594177310|FG005|Treatment Phase|Subject/guardian decision|1|||
164493671|NCT03334747|594177311|FG006|Treatment Phase|Subject/guardian decision|0|||
164493672|NCT03334747|594177312|FG007|Treatment Phase|Subject/guardian decision|0|||
164493673|NCT03334747|594177313|FG008|Treatment Phase|Subject/guardian decision|0|||
164603173|NCT03488251|594567197|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
164493674|NCT03334747|594177305|FG000|Follow-Up Phase|Subject/guardian decision|0|||
164493675|NCT03334747|594177306|FG001|Follow-Up Phase|Subject/guardian decision|0|||
164603174|NCT03488251|594567198|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
164603175|NCT03488251|594567199|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
164603176|NCT03488251|594567200|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
164603177|NCT03488251|594567197|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
164603178|NCT03488251|594567198|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
164603179|NCT03488251|594567199|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
164603180|NCT03488251|594567200|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
164493676|NCT03334747|594177307|FG002|Follow-Up Phase|Subject/guardian decision|0|||
164493677|NCT03334747|594177308|FG003|Follow-Up Phase|Subject/guardian decision|0|||
164603181|NCT03730194|594567201|FG000|First Stage Treatment|Withdrawal by Subject|1|||
164603182|NCT03730194|594567202|FG001|First Stage Treatment|Withdrawal by Subject|1|||
164603183|NCT03730194|594567203|FG002|First Stage Treatment|Withdrawal by Subject|0|||
164603184|NCT03730194|594567204|FG003|First Stage Treatment|Withdrawal by Subject|0|||
164603185|NCT03730194|594567205|FG004|First Stage Treatment|Withdrawal by Subject|0|||
164603186|NCT03730194|594567206|FG005|First Stage Treatment|Withdrawal by Subject|0|||
164603187|NCT03730194|594567201|FG000|First Stage Treatment|Protocol Violation|3|||
164603188|NCT03730194|594567202|FG001|First Stage Treatment|Protocol Violation|3|||
164603189|NCT03730194|594567203|FG002|First Stage Treatment|Protocol Violation|0|||
164603190|NCT03730194|594567204|FG003|First Stage Treatment|Protocol Violation|0|||
164603191|NCT03730194|594567205|FG004|First Stage Treatment|Protocol Violation|0|||
164603192|NCT03730194|594567206|FG005|First Stage Treatment|Protocol Violation|0|||
164603193|NCT01766817|594567209|FG000|Overall Study|Drug-related adverse event|1|||
164603194|NCT01766817|594567210|FG001|Overall Study|Drug-related adverse event|2|||
164603195|NCT01766817|594567211|FG002|Overall Study|Drug-related adverse event|1|||
164603196|NCT01766817|594567209|FG000|Overall Study|Drug-unrelated adverse event|3|||
164603197|NCT01766817|594567210|FG001|Overall Study|Drug-unrelated adverse event|3|||
164603198|NCT01766817|594567211|FG002|Overall Study|Drug-unrelated adverse event|3|||
164603199|NCT01766817|594567209|FG000|Overall Study|Death|1|||
164603200|NCT01766817|594567210|FG001|Overall Study|Death|1|||
164603201|NCT01766817|594567211|FG002|Overall Study|Death|0|||
164603202|NCT01766817|594567209|FG000|Overall Study|Unable to take study drug|0|||
164603203|NCT01766817|594567210|FG001|Overall Study|Unable to take study drug|1|||
164603204|NCT01766817|594567211|FG002|Overall Study|Unable to take study drug|0|||
164603205|NCT01766817|594567209|FG000|Overall Study|Withdrawal by Subject|2|||
164603206|NCT01766817|594567210|FG001|Overall Study|Withdrawal by Subject|0|||
164603207|NCT01766817|594567211|FG002|Overall Study|Withdrawal by Subject|3|||
164603208|NCT01766817|594567209|FG000|Overall Study|Subject non-compliance|0|||
164603209|NCT01766817|594567210|FG001|Overall Study|Subject non-compliance|1|||
164603210|NCT01766817|594567211|FG002|Overall Study|Subject non-compliance|2|||
164603211|NCT01766817|594567209|FG000|Overall Study|Physician Decision|3|||
164603212|NCT01766817|594567210|FG001|Overall Study|Physician Decision|3|||
164603213|NCT01766817|594567211|FG002|Overall Study|Physician Decision|4|||
164603214|NCT01766817|594567209|FG000|Overall Study|Other|1|||
164603215|NCT01766817|594567210|FG001|Overall Study|Other|0|||
164603216|NCT01766817|594567211|FG002|Overall Study|Other|0|||
164603217|NCT00995670|594567212|FG000|Overall Study|Failed arterial cannulation|1|||
164603218|NCT00995670|594567213|FG001|Overall Study|Failed arterial cannulation|0|||
164603219|NCT00995670|594567214|FG002|Overall Study|Failed arterial cannulation|3|||
164603220|NCT00675103|594567215|FG000|Overall Study|Lack of Efficacy|2|||
164603221|NCT00675103|594567215|FG000|Overall Study|Adverse Event|1|||
164603222|NCT03600714|594567216|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
164603223|NCT03814590|594567219|FG000|Overall Study|Adverse Event|0|||
164603224|NCT03814590|594567220|FG001|Overall Study|Adverse Event|0|||
164603225|NCT03814590|594567221|FG002|Overall Study|Adverse Event|0|||
164603226|NCT03814590|594567222|FG003|Overall Study|Adverse Event|0|||
164603227|NCT03814590|594567223|FG004|Overall Study|Adverse Event|0|||
164603228|NCT03814590|594567224|FG005|Overall Study|Adverse Event|1|||
164603229|NCT03814590|594567225|FG006|Overall Study|Adverse Event|1|||
164603230|NCT03814590|594567226|FG007|Overall Study|Adverse Event|1|||
164603231|NCT03814590|594567227|FG008|Overall Study|Adverse Event|0|||
164603232|NCT03814590|594567228|FG009|Overall Study|Adverse Event|0|||
164603233|NCT03814590|594567229|FG010|Overall Study|Adverse Event|1|||
164603234|NCT03814590|594567230|FG011|Overall Study|Adverse Event|0|||
164603235|NCT03814590|594567231|FG012|Overall Study|Adverse Event|3|||
164603236|NCT03814590|594567232|FG013|Overall Study|Adverse Event|0|||
164603237|NCT03814590|594567219|FG000|Overall Study|Lost to Follow-up|0|||
164603238|NCT03814590|594567220|FG001|Overall Study|Lost to Follow-up|2|||
164603239|NCT03814590|594567221|FG002|Overall Study|Lost to Follow-up|1|||
164603240|NCT03814590|594567222|FG003|Overall Study|Lost to Follow-up|0|||
164603241|NCT03814590|594567223|FG004|Overall Study|Lost to Follow-up|1|||
164603242|NCT03814590|594567224|FG005|Overall Study|Lost to Follow-up|1|||
164603243|NCT03814590|594567225|FG006|Overall Study|Lost to Follow-up|1|||
164603244|NCT03814590|594567226|FG007|Overall Study|Lost to Follow-up|1|||
164603245|NCT03814590|594567227|FG008|Overall Study|Lost to Follow-up|0|||
164603246|NCT03814590|594567228|FG009|Overall Study|Lost to Follow-up|0|||
164603247|NCT03814590|594567229|FG010|Overall Study|Lost to Follow-up|1|||
164603248|NCT03814590|594567230|FG011|Overall Study|Lost to Follow-up|0|||
164603249|NCT03814590|594567231|FG012|Overall Study|Lost to Follow-up|0|||
164603250|NCT03814590|594567232|FG013|Overall Study|Lost to Follow-up|1|||
164603251|NCT03814590|594567219|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
164603252|NCT03814590|594567220|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
164603253|NCT03814590|594567221|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
164603254|NCT03814590|594567222|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
164603255|NCT03814590|594567223|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
164715031|NCT02203331|594978865|FG004|Overall Study|Adverse Event|3|||
164603256|NCT03814590|594567224|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
164603257|NCT03814590|594567225|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
164603258|NCT03814590|594567226|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
164603259|NCT03814590|594567227|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
164603260|NCT03814590|594567228|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
164603261|NCT03814590|594567229|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
164603262|NCT03814590|594567230|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
164603263|NCT03814590|594567231|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
164603264|NCT03814590|594567232|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
164603265|NCT03814590|594567219|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
164603266|NCT03814590|594567220|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
164603267|NCT03814590|594567221|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
164603268|NCT03814590|594567222|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
164603269|NCT03814590|594567223|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
164603270|NCT03814590|594567224|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
164603271|NCT03814590|594567225|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
164603272|NCT03814590|594567226|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
164603273|NCT03814590|594567227|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
164603274|NCT03814590|594567228|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
164603275|NCT03814590|594567229|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
164603276|NCT03814590|594567230|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
164603277|NCT03814590|594567231|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
164603278|NCT03814590|594567232|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
164603279|NCT03814590|594567219|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164603280|NCT03814590|594567220|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164603281|NCT03814590|594567221|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164603282|NCT03814590|594567222|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164603283|NCT03814590|594567223|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164603284|NCT03814590|594567224|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164603285|NCT03814590|594567225|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164603286|NCT03814590|594567226|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164603287|NCT03814590|594567227|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164603288|NCT03814590|594567228|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164603289|NCT03814590|594567229|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164603290|NCT03814590|594567230|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164603291|NCT03814590|594567231|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164603292|NCT03814590|594567232|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164603293|NCT03814590|594567219|FG000|Overall Study|UNKNOWN REASON|0|||
164603294|NCT03814590|594567220|FG001|Overall Study|UNKNOWN REASON|0|||
164603295|NCT03814590|594567221|FG002|Overall Study|UNKNOWN REASON|0|||
164603296|NCT03814590|594567222|FG003|Overall Study|UNKNOWN REASON|0|||
164603297|NCT03814590|594567223|FG004|Overall Study|UNKNOWN REASON|0|||
164603298|NCT03814590|594567224|FG005|Overall Study|UNKNOWN REASON|0|||
164603299|NCT03814590|594567225|FG006|Overall Study|UNKNOWN REASON|0|||
164603300|NCT03814590|594567226|FG007|Overall Study|UNKNOWN REASON|1|||
164603301|NCT03814590|594567227|FG008|Overall Study|UNKNOWN REASON|0|||
164603302|NCT03814590|594567228|FG009|Overall Study|UNKNOWN REASON|0|||
164493678|NCT03334747|594177309|FG004|Follow-Up Phase|Subject/guardian decision|0|||
164493679|NCT03334747|594177310|FG005|Follow-Up Phase|Subject/guardian decision|0|||
164493680|NCT03334747|594177311|FG006|Follow-Up Phase|Subject/guardian decision|1|||
164493681|NCT03334747|594177312|FG007|Follow-Up Phase|Subject/guardian decision|0|||
164493682|NCT03334747|594177313|FG008|Follow-Up Phase|Subject/guardian decision|1|||
164493683|NCT03303521|594177320|FG000|Overall Study|Withdrawal by Subject|2|||
164493684|NCT03303521|594177321|FG001|Overall Study|Withdrawal by Subject|0|||
164493685|NCT03303521|594177320|FG000|Overall Study|Death|1|||
164493686|NCT03303521|594177321|FG001|Overall Study|Death|0|||
164603303|NCT03814590|594567229|FG010|Overall Study|UNKNOWN REASON|0|||
164603304|NCT03814590|594567230|FG011|Overall Study|UNKNOWN REASON|0|||
164603305|NCT03814590|594567231|FG012|Overall Study|UNKNOWN REASON|0|||
164603306|NCT03814590|594567232|FG013|Overall Study|UNKNOWN REASON|0|||
164493687|NCT03303521|594177320|FG000|Overall Study|Kidney transplantation|0|||
164493688|NCT03303521|594177321|FG001|Overall Study|Kidney transplantation|1|||
164493689|NCT03303521|594177320|FG000|Overall Study|Investigational product discontinuation|0|||
164493690|NCT03303521|594177321|FG001|Overall Study|Investigational product discontinuation|1|||
164493691|NCT03303521|594177320|FG000|Overall Study|Transferred to non-study dialysis center|1|||
164493692|NCT03303521|594177321|FG001|Overall Study|Transferred to non-study dialysis center|0|||
164493693|NCT03303521|594177320|FG000|Overall Study|Non-comliance to study protocol|0|||
164493694|NCT03303521|594177321|FG001|Overall Study|Non-comliance to study protocol|1|||
164493695|NCT03303521|594177320|FG000|Overall Study|Adverse Event|1|||
164493696|NCT03303521|594177321|FG001|Overall Study|Adverse Event|0|||
164493697|NCT00191984|594177322|FG000|Overall Study|Disease Progression|21|||
164493698|NCT00191984|594177322|FG000|Overall Study|Adverse Event|4|||
164493699|NCT00191984|594177322|FG000|Overall Study|Death|2|||
164493700|NCT00191984|594177322|FG000|Overall Study|Entry Criteria Exclusion|1|||
164493701|NCT00191984|594177322|FG000|Overall Study|Withdrawal by Subject|7|||
164493702|NCT00191984|594177322|FG000|Overall Study|Physician Decision|4|||
164493703|NCT01654289|594177323|FG000|Overall Study|Withdrawal by Subject|10|||
164493704|NCT01654289|594177324|FG001|Overall Study|Withdrawal by Subject|8|||
164493705|NCT01654289|594177325|FG002|Overall Study|Withdrawal by Subject|5|||
164493706|NCT01654289|594177323|FG000|Overall Study|Withdrew from intervention only|17|||
164493707|NCT01654289|594177324|FG001|Overall Study|Withdrew from intervention only|20|||
164493708|NCT01654289|594177325|FG002|Overall Study|Withdrew from intervention only|0|||
164493709|NCT00005908|594177327|FG000|Overall Study|Withdrawal by Subject|1|||
164493710|NCT00005908|594177328|FG001|Overall Study|Withdrawal by Subject|0|||
164493711|NCT04748445|594177331|FG000|Overall Study|No longer met eligibility criteria|12|||
164493712|NCT04748445|594177331|FG000|Overall Study|Other|36|||
164493713|NCT04748445|594177331|FG000|Overall Study|Withdrawal by Subject|553|||
164493714|NCT04748445|594177331|FG000|Overall Study|Lost to Follow-up|30|||
164493715|NCT04736602|594177332|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
164493716|NCT04736602|594177332|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
164493717|NCT00938041|594177339|FG000|Overall Study|Lost to Follow-up|6|||
164493718|NCT00938041|594177339|FG000|Overall Study|Received Alternative Therapy|1|||
164493719|NCT00938041|594177339|FG000|Overall Study|Progressive Disease|5|||
164493720|NCT00938041|594177339|FG000|Overall Study|Death|12|||
164493721|NCT00938041|594177339|FG000|Overall Study|Adrenal Insufficiency|3|||
164493722|NCT02504502|594177340|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
164493723|NCT02504502|594177341|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
164493724|NCT02504502|594177340|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
164493725|NCT02504502|594177341|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
164493726|NCT03042559|594177345|FG000|Overall Study|drop out|1|||
164493727|NCT03042559|594177346|FG001|Overall Study|drop out|1|||
164493728|NCT01536535|594177350|FG000|Overall Study|Withdrawal by Subject|10|||
164493729|NCT01536535|594177351|FG001|Overall Study|Withdrawal by Subject|5|||
164493730|NCT01536535|594177350|FG000|Overall Study|Lost to Follow-up|4|||
164493731|NCT01536535|594177351|FG001|Overall Study|Lost to Follow-up|6|||
164493732|NCT01536535|594177350|FG000|Overall Study|Physician Decision|1|||
164493733|NCT01536535|594177351|FG001|Overall Study|Physician Decision|1|||
164493734|NCT01536535|594177350|FG000|Overall Study|Participant moved|0|||
164493735|NCT01536535|594177351|FG001|Overall Study|Participant moved|1|||
164493736|NCT00428441|594177354|FG000|Overall Study|Lost to Follow-up|1|||
164493737|NCT01485991|594177355|FG000|Overall Study|Adverse Event|0|||
164493738|NCT01485991|594177356|FG001|Overall Study|Adverse Event|4|||
164493739|NCT01485991|594177355|FG000|Overall Study|Lost to Follow-up|13|||
164493740|NCT01485991|594177356|FG001|Overall Study|Lost to Follow-up|10|||
164493741|NCT01485991|594177355|FG000|Overall Study|Withdrawal by Subject|13|||
164493742|NCT01485991|594177356|FG001|Overall Study|Withdrawal by Subject|20|||
164493743|NCT01485991|594177355|FG000|Overall Study|randomized but not treated|6|||
164493744|NCT01485991|594177356|FG001|Overall Study|randomized but not treated|2|||
164493745|NCT02538471|594177357|FG000|Overall Study|Progression of disease|2|||
164493746|NCT04203160|594177358|FG000|Overall Study|Alternative Therapy|3|||
164493747|NCT04203160|594177359|FG001|Overall Study|Alternative Therapy|0|||
164493748|NCT04203160|594177360|FG002|Overall Study|Alternative Therapy|1|||
164493749|NCT04203160|594177361|FG003|Overall Study|Alternative Therapy|0|||
164493750|NCT04203160|594177362|FG004|Overall Study|Alternative Therapy|0|||
164493751|NCT04203160|594177363|FG005|Overall Study|Alternative Therapy|2|||
164493752|NCT04203160|594177358|FG000|Overall Study|Withdrawal by Subject|4|||
164493753|NCT04203160|594177359|FG001|Overall Study|Withdrawal by Subject|5|||
164493754|NCT04203160|594177360|FG002|Overall Study|Withdrawal by Subject|0|||
164493755|NCT04203160|594177361|FG003|Overall Study|Withdrawal by Subject|0|||
164493756|NCT04203160|594177362|FG004|Overall Study|Withdrawal by Subject|0|||
164493757|NCT04203160|594177363|FG005|Overall Study|Withdrawal by Subject|4|||
164493758|NCT04203160|594177358|FG000|Overall Study|Adverse Event|7|||
164493759|NCT04203160|594177359|FG001|Overall Study|Adverse Event|5|||
164493760|NCT04203160|594177360|FG002|Overall Study|Adverse Event|0|||
164493761|NCT04203160|594177361|FG003|Overall Study|Adverse Event|0|||
164493762|NCT04203160|594177362|FG004|Overall Study|Adverse Event|0|||
164493763|NCT04203160|594177363|FG005|Overall Study|Adverse Event|0|||
164493764|NCT04203160|594177358|FG000|Overall Study|Sponsor Termination|1|||
164493765|NCT04203160|594177359|FG001|Overall Study|Sponsor Termination|0|||
164493766|NCT04203160|594177360|FG002|Overall Study|Sponsor Termination|0|||
164493767|NCT04203160|594177361|FG003|Overall Study|Sponsor Termination|0|||
164603307|NCT00592553|594567234|FG000|Overall Study|Protocol Noncompliance|1|||
164603308|NCT00592553|594567235|FG001|Overall Study|Protocol Noncompliance|0|||
164603309|NCT00592553|594567236|FG002|Overall Study|Protocol Noncompliance|0|||
164603310|NCT01810042|594567241|FG000|Overall Study|Lost to Follow-up|10|||
164603311|NCT01283997|594568552|FG000|Overall Study|Physician Decision|8|||
164603312|NCT01283997|594568553|FG001|Overall Study|Physician Decision|10|||
164603313|NCT01283997|594568552|FG000|Overall Study|Withdrawal by Subject|3|||
164603314|NCT01283997|594568553|FG001|Overall Study|Withdrawal by Subject|2|||
164603315|NCT01283997|594568552|FG000|Overall Study|Physically unable to continue|0|||
164603316|NCT01283997|594568553|FG001|Overall Study|Physically unable to continue|1|||
164603317|NCT01283997|594568552|FG000|Overall Study|Progressive disease|1|||
164603318|NCT01283997|594568553|FG001|Overall Study|Progressive disease|0|||
164603319|NCT01283997|594568552|FG000|Overall Study|Other|4|||
164603320|NCT01283997|594568553|FG001|Overall Study|Other|4|||
164603321|NCT02109744|594568554|FG000|Overall Study|Death|1|||
164603322|NCT02109744|594568555|FG001|Overall Study|Death|1|||
164603323|NCT02109744|594568554|FG000|Overall Study|no marrow exam|1|||
164603324|NCT02109744|594568555|FG001|Overall Study|no marrow exam|0|||
164493768|NCT04203160|594177362|FG004|Overall Study|Sponsor Termination|0|||
164493769|NCT04203160|594177363|FG005|Overall Study|Sponsor Termination|0|||
164493770|NCT04203160|594177358|FG000|Overall Study|Physician Decision|3|||
164493771|NCT04203160|594177359|FG001|Overall Study|Physician Decision|2|||
164493772|NCT04203160|594177360|FG002|Overall Study|Physician Decision|0|||
164493773|NCT04203160|594177361|FG003|Overall Study|Physician Decision|0|||
164493774|NCT04203160|594177362|FG004|Overall Study|Physician Decision|0|||
164493775|NCT04203160|594177363|FG005|Overall Study|Physician Decision|0|||
164493776|NCT01713998|594177364|FG000|Overall Study|Lost to Follow-up|2|||
164493777|NCT01713998|594177365|FG001|Overall Study|Lost to Follow-up|0|||
164493778|NCT01713998|594177366|FG002|Overall Study|Lost to Follow-up|2|||
164493779|NCT01713998|594177364|FG000|Overall Study|Withdrawal by Subject|1|||
164493780|NCT01713998|594177365|FG001|Overall Study|Withdrawal by Subject|0|||
164493781|NCT01713998|594177366|FG002|Overall Study|Withdrawal by Subject|0|||
164493782|NCT02744898|594177367|FG000|Overall Study|Progressive Disease|2|||
164493783|NCT02744898|594177367|FG000|Overall Study|Physician Decision|1|||
164493784|NCT02744898|594177367|FG000|Overall Study|Toxicity|1|||
164493785|NCT02350127|594177368|FG000|4-Month Assessment|Withdrawal by Subject|10|||
164493786|NCT02350127|594177369|FG001|4-Month Assessment|Withdrawal by Subject|9|||
164493787|NCT02350127|594177368|FG000|4-Month Assessment|Death|1|||
164493788|NCT02350127|594177369|FG001|4-Month Assessment|Death|0|||
164493789|NCT02350127|594177368|FG000|8-Month Assessment|Death|1|||
164493790|NCT02350127|594177369|FG001|8-Month Assessment|Death|1|||
164493791|NCT02350127|594177368|FG000|8-Month Assessment|Withdrawal by Subject|5|||
164493792|NCT02350127|594177369|FG001|8-Month Assessment|Withdrawal by Subject|8|||
164493793|NCT01348763|594177370|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
164493794|NCT01348763|594177370|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
164493795|NCT01911819|594177379|FG000|Overall Study|Adverse Event|0|||
164493796|NCT01911819|594177380|FG001|Overall Study|Adverse Event|1|||
164493797|NCT01911819|594177381|FG002|Overall Study|Adverse Event|0|||
164493798|NCT01911819|594177379|FG000|Overall Study|Withdrawal by Subject|1|||
164493799|NCT01911819|594177380|FG001|Overall Study|Withdrawal by Subject|1|||
164493800|NCT01911819|594177381|FG002|Overall Study|Withdrawal by Subject|0|||
164493801|NCT01207453|594177382|FG000|First Intervention|Adverse Event|2|||
164493802|NCT01207453|594177383|FG001|First Intervention|Adverse Event|1|||
164493803|NCT01207453|594177382|FG000|Washout|Adverse Event|1|||
164493804|NCT01207453|594177383|FG001|Washout|Adverse Event|0|||
164493805|NCT01207453|594177382|FG000|Washout|Lost to Follow-up|1|||
164493806|NCT01207453|594177383|FG001|Washout|Lost to Follow-up|0|||
164493807|NCT01207453|594177382|FG000|2nd Intervention|Adverse Event|1|||
164493808|NCT01207453|594177383|FG001|2nd Intervention|Adverse Event|2|||
164493809|NCT01207453|594177382|FG000|2nd Intervention|Lost to Follow-up|1|||
164493810|NCT01207453|594177383|FG001|2nd Intervention|Lost to Follow-up|0|||
164493811|NCT04382053|594177389|FG000|Overall Study|Death|6|||
164493812|NCT04382053|594177390|FG001|Overall Study|Death|8|||
164493813|NCT04382053|594177389|FG000|Overall Study|Lost to Follow-up|0|||
164493814|NCT04382053|594177390|FG001|Overall Study|Lost to Follow-up|2|||
164493815|NCT04382053|594177389|FG000|Overall Study|Protocol Deviation|1|||
164493816|NCT04382053|594177390|FG001|Overall Study|Protocol Deviation|2|||
164603325|NCT04095442|594568559|FG000|Overall Study|Lost to Follow-up|0|||
164603326|NCT04095442|594568560|FG001|Overall Study|Lost to Follow-up|1|||
164603327|NCT04095442|594568559|FG000|Overall Study|Screen failure|1|||
164603328|NCT04095442|594568560|FG001|Overall Study|Screen failure|0|||
164493817|NCT04382053|594177389|FG000|Overall Study|Withdrawal by Subject|2|||
164493818|NCT04382053|594177390|FG001|Overall Study|Withdrawal by Subject|1|||
164493819|NCT01399905|594177393|FG000|Overall Study|Withdrawal by Subject|1|||
164603329|NCT00884221|594568565|FG000|Overall Study|Withdrawal by Subject|0|||
164603330|NCT00884221|594568566|FG001|Overall Study|Withdrawal by Subject|3|||
164603331|NCT00884221|594568565|FG000|Overall Study|Adverse Event|6|||
164493820|NCT01399905|594177394|FG001|Overall Study|Withdrawal by Subject|1|||
164493821|NCT01945086|594177395|FG000|Overall Study|Withdrawal by Subject|1|||
164603332|NCT00884221|594568566|FG001|Overall Study|Adverse Event|3|||
164603333|NCT00884221|594568565|FG000|Overall Study|Protocol Violation|16|||
164603334|NCT00884221|594568566|FG001|Overall Study|Protocol Violation|13|||
164603335|NCT00884221|594568565|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
164603336|NCT00884221|594568566|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
164603337|NCT00255034|594568567|FG000|Overall Study|Withdrawal by Subject|15|||
164603338|NCT00255034|594568568|FG001|Overall Study|Withdrawal by Subject|38|||
164603339|NCT01263093|594568569|FG000|Washout|Physician Decision|1|||
164603340|NCT01263093|594568570|FG001|Washout|Physician Decision|0|||
164603341|NCT01263093|594568569|FG000|Period 2|Adverse Event|1|||
164603342|NCT01263093|594568570|FG001|Period 2|Adverse Event|0|||
164603343|NCT03947255|594568572|FG000|Overall Study|Study Closure by Sponsor|2|||
164603344|NCT03947255|594568573|FG001|Overall Study|Study Closure by Sponsor|2|||
164603345|NCT03947255|594568572|FG000|Overall Study|Withdrawal by Subject|2|||
164603346|NCT03947255|594568573|FG001|Overall Study|Withdrawal by Subject|2|||
164603347|NCT03947255|594568572|FG000|Overall Study|Lost to Follow-up|2|||
164603348|NCT03947255|594568573|FG001|Overall Study|Lost to Follow-up|0|||
164603349|NCT03947255|594568572|FG000|Overall Study|Death|0|||
164603350|NCT03947255|594568573|FG001|Overall Study|Death|2|||
164603351|NCT02499575|594568574|FG000|Overall Study|Protocol Violation|0|||
164603352|NCT02499575|594568575|FG001|Overall Study|Protocol Violation|1|||
164603353|NCT02690207|594568577|FG000|Overall Study|Lost to Follow-up|48|||
164603354|NCT02690207|594568577|FG000|Overall Study|Withdrawal by Subject|46|||
164603355|NCT02690207|594568577|FG000|Overall Study|Protocol Violation|2|||
164603356|NCT02690207|594568577|FG000|Overall Study|Serious adverse event|110|||
164603357|NCT02690207|594568577|FG000|Overall Study|Non-serious Adverse Event|18|||
164603358|NCT02690207|594568577|FG000|Overall Study|Migrated/moved from study area|5|||
164603359|NCT02690207|594568577|FG000|Overall Study|Suspected HZ Episode|1|||
164603360|NCT02690207|594568577|FG000|Overall Study|Other reasons for withdrawal|23|||
164603361|NCT04656418|594568580|FG000|Overall Study|Withdrawal by Subject|1|||
164603362|NCT04656418|594568581|FG001|Overall Study|Withdrawal by Subject|3|||
164603363|NCT02586077|594568582|FG000|Overall Study|Withdrawal by Subject|1|||
164603364|NCT02586077|594568582|FG000|Overall Study|Physician Decision|4|||
164603365|NCT02586077|594568582|FG000|Overall Study|Lost to Follow-up|3|||
164603366|NCT02701192|594568583|FG000|Overall Study|Protocol Violation|2|||
164603367|NCT02701192|594568583|FG000|Overall Study|Lost to Follow-up|4|||
164603368|NCT01245764|594568585|FG000|Study Phase A|Other|3|||
164603369|NCT01245764|594568586|FG001|Study Phase A|Other|2|||
164603370|NCT01245764|594568587|FG002|Study Phase A|Other|3|||
164603371|NCT01245764|594568588|FG003|Study Phase A|Other|1|||
164603372|NCT01245764|594568585|FG000|Study Phase A|Protocol Violation|6|||
164603373|NCT01245764|594568586|FG001|Study Phase A|Protocol Violation|3|||
164603374|NCT01245764|594568587|FG002|Study Phase A|Protocol Violation|2|||
164603375|NCT01245764|594568588|FG003|Study Phase A|Protocol Violation|2|||
164603376|NCT01245764|594568585|FG000|Study Phase A|Lost to Follow-up|0|||
164603377|NCT01245764|594568586|FG001|Study Phase A|Lost to Follow-up|0|||
164603378|NCT01245764|594568587|FG002|Study Phase A|Lost to Follow-up|5|||
164603379|NCT01245764|594568588|FG003|Study Phase A|Lost to Follow-up|0|||
164603380|NCT00003476|594568589|FG000|Overall Study|Not evaluable|1|||
164603381|NCT02475850|594568590|FG000|Overall Study|Death|155|||
164603382|NCT02475850|594568591|FG001|Overall Study|Death|141|||
164603383|NCT02475850|594568590|FG000|Overall Study|Lost to Follow-up|217|||
164603384|NCT02475850|594568591|FG001|Overall Study|Lost to Follow-up|188|||
164603385|NCT02475850|594568590|FG000|Overall Study|Withdrawal by Subject|221|||
164603386|NCT02475850|594568591|FG001|Overall Study|Withdrawal by Subject|155|||
164603387|NCT02667457|594568592|FG000|Overall Study|Withdrawal by Subject|1|||
164603388|NCT02667457|594568593|FG001|Overall Study|Withdrawal by Subject|0|||
164603389|NCT02667457|594568592|FG000|Overall Study|Other Reason|0|||
164603390|NCT02667457|594568593|FG001|Overall Study|Other Reason|2|||
164603391|NCT00912340|594568594|FG000|Overall Study|Adverse Event|2|||
164603392|NCT00912340|594568595|FG001|Overall Study|Adverse Event|4|||
164603393|NCT00912340|594568596|FG002|Overall Study|Adverse Event|0|||
164603394|NCT00912340|594568594|FG000|Overall Study|Protocol revised to remove arm|0|||
164603395|NCT00912340|594568595|FG001|Overall Study|Protocol revised to remove arm|0|||
164603396|NCT00912340|594568596|FG002|Overall Study|Protocol revised to remove arm|4|||
164603397|NCT00436982|594568599|FG000|Overall Study|Withdrawal by Subject|3|||
164603398|NCT00436982|594568600|FG001|Overall Study|Withdrawal by Subject|1|||
164603399|NCT00436982|594568599|FG000|Overall Study|Did not receive allocated intervention|0|||
164603400|NCT00436982|594568600|FG001|Overall Study|Did not receive allocated intervention|1|||
164603401|NCT00436982|594568599|FG000|Overall Study|no RSA data|1|||
164603402|NCT00436982|594568600|FG001|Overall Study|no RSA data|2|||
164603403|NCT00953225|594568601|FG000|Overall Study|Withdrawal by Subject|2|||
164603404|NCT00953225|594568602|FG001|Overall Study|Withdrawal by Subject|0|||
164603405|NCT02254551|594568606|FG000|Dose Escalation|Physician Decision|1|||
164603406|NCT02254551|594568606|FG000|Dose Escalation|Dose-limiting toxicity|2|||
164603407|NCT02215616|594568607|FG000|Overall Study|Sponsor requested to stop study drug|0|||
164603408|NCT02215616|594568608|FG001|Overall Study|Sponsor requested to stop study drug|0|||
164603409|NCT02215616|594568609|FG002|Overall Study|Sponsor requested to stop study drug|1|||
164603410|NCT02215616|594568610|FG003|Overall Study|Sponsor requested to stop study drug|4|||
164603411|NCT02215616|594568607|FG000|Overall Study|Death|1|||
164603412|NCT02215616|594568608|FG001|Overall Study|Death|0|||
164603413|NCT02215616|594568609|FG002|Overall Study|Death|0|||
164603414|NCT02215616|594568610|FG003|Overall Study|Death|0|||
164603415|NCT02215616|594568607|FG000|Overall Study|Adverse Event|7|||
164603416|NCT02215616|594568608|FG001|Overall Study|Adverse Event|4|||
164603417|NCT02215616|594568609|FG002|Overall Study|Adverse Event|9|||
164603418|NCT02215616|594568610|FG003|Overall Study|Adverse Event|2|||
164603419|NCT02215616|594568607|FG000|Overall Study|Withdrawal by Subject|1|||
164603420|NCT02215616|594568608|FG001|Overall Study|Withdrawal by Subject|8|||
164603421|NCT02215616|594568609|FG002|Overall Study|Withdrawal by Subject|2|||
164603422|NCT02215616|594568610|FG003|Overall Study|Withdrawal by Subject|5|||
164603423|NCT02215616|594568607|FG000|Overall Study|Non-compliance|0|||
164603424|NCT02215616|594568608|FG001|Overall Study|Non-compliance|2|||
164603425|NCT02215616|594568609|FG002|Overall Study|Non-compliance|1|||
164603426|NCT02215616|594568610|FG003|Overall Study|Non-compliance|0|||
164603427|NCT02215616|594568607|FG000|Overall Study|Protocol Violation|0|||
164603428|NCT02215616|594568608|FG001|Overall Study|Protocol Violation|2|||
164603429|NCT02215616|594568609|FG002|Overall Study|Protocol Violation|0|||
164603430|NCT02215616|594568610|FG003|Overall Study|Protocol Violation|0|||
164603431|NCT02215616|594568607|FG000|Overall Study|Lost to Follow-up|1|||
164603432|NCT02215616|594568608|FG001|Overall Study|Lost to Follow-up|1|||
164603433|NCT02215616|594568609|FG002|Overall Study|Lost to Follow-up|0|||
164603434|NCT02215616|594568610|FG003|Overall Study|Lost to Follow-up|1|||
164603435|NCT02215616|594568607|FG000|Overall Study|Other than specified|1|||
164603436|NCT02215616|594568608|FG001|Overall Study|Other than specified|0|||
164603437|NCT02215616|594568609|FG002|Overall Study|Other than specified|1|||
164603438|NCT02215616|594568610|FG003|Overall Study|Other than specified|1|||
164603439|NCT04058158|594568611|FG000|Period 1|Death|1|||
164603440|NCT04058158|594568612|FG001|Period 1|Death|0|||
164603441|NCT04058158|594568611|FG000|Period 1|Adverse Event|1|||
164603442|NCT04058158|594568612|FG001|Period 1|Adverse Event|1|||
164603443|NCT04058158|594568611|FG000|Period 1|Pregnancy|0|||
164603444|NCT04058158|594568612|FG001|Period 1|Pregnancy|1|||
164603445|NCT01634113|594568613|FG000|Overall Study|Not treated|0|||
164603446|NCT01634113|594568614|FG001|Overall Study|Not treated|0|||
164603447|NCT01634113|594568615|FG002|Overall Study|Not treated|1|||
164603448|NCT00520299|594568618|FG000|Overall Study|Withdrawal by Subject|0|||
164603449|NCT00520299|594568619|FG001|Overall Study|Withdrawal by Subject|0|||
164603450|NCT00520299|594568620|FG002|Overall Study|Withdrawal by Subject|2|||
164603451|NCT00520299|594568618|FG000|Overall Study|Progressive disease|0|||
164603452|NCT00520299|594568619|FG001|Overall Study|Progressive disease|3|||
164603453|NCT00520299|594568620|FG002|Overall Study|Progressive disease|4|||
164603454|NCT01352845|594568621|FG000|Overall Study|Lost to Follow-up|313|||
164603455|NCT01352845|594568622|FG001|Overall Study|Lost to Follow-up|92|||
164603456|NCT01352845|594568621|FG000|Overall Study|No Longer Willing to Participate|205|||
164603457|NCT01352845|594568622|FG001|Overall Study|No Longer Willing to Participate|58|||
164603458|NCT01352845|594568621|FG000|Overall Study|Withdrawal by Subject|48|||
164603459|NCT01352845|594568622|FG001|Overall Study|Withdrawal by Subject|16|||
164603460|NCT01352845|594568621|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
164603461|NCT01352845|594568622|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
164603462|NCT01352845|594568621|FG000|Overall Study|Pregnancy|27|||
164603463|NCT01352845|594568622|FG001|Overall Study|Pregnancy|7|||
164603464|NCT01352845|594568621|FG000|Overall Study|Adverse Event|22|||
164603465|NCT01352845|594568622|FG001|Overall Study|Adverse Event|6|||
164603466|NCT01352845|594568621|FG000|Overall Study|Other|17|||
164603467|NCT01352845|594568622|FG001|Overall Study|Other|7|||
164603468|NCT01352845|594568621|FG000|Overall Study|Protocol Violation|12|||
164603469|NCT01352845|594568622|FG001|Overall Study|Protocol Violation|6|||
164603470|NCT01352845|594568621|FG000|Overall Study|Death|3|||
164603471|NCT01352845|594568622|FG001|Overall Study|Death|0|||
164603472|NCT02062463|594568623|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
164603473|NCT02062463|594568624|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
164603474|NCT02062463|594568625|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
164603475|NCT02062463|594568626|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
164603476|NCT02062463|594568623|FG000|Stage 2|Adverse Event|0|||
164603477|NCT02062463|594568624|FG001|Stage 2|Adverse Event|0|||
164603478|NCT02062463|594568625|FG002|Stage 2|Adverse Event|12|||
164603479|NCT02062463|594568626|FG003|Stage 2|Adverse Event|20|||
164603480|NCT02062463|594568623|FG000|Stage 2|Lack of Efficacy|0|||
164603481|NCT02062463|594568624|FG001|Stage 2|Lack of Efficacy|0|||
164603482|NCT02062463|594568625|FG002|Stage 2|Lack of Efficacy|3|||
164603483|NCT02062463|594568626|FG003|Stage 2|Lack of Efficacy|4|||
164493822|NCT01945086|594177396|FG001|Overall Study|Withdrawal by Subject|0|||
164493823|NCT01945086|594177397|FG002|Overall Study|Withdrawal by Subject|1|||
164493824|NCT01945086|594177395|FG000|Overall Study|Adverse Event|0|||
164493825|NCT01945086|594177396|FG001|Overall Study|Adverse Event|0|||
164493826|NCT01945086|594177397|FG002|Overall Study|Adverse Event|1|||
164493827|NCT01524887|594177400|FG000|Overall Study|Withdrawal by Subject|6|||
164493828|NCT01524887|594177401|FG001|Overall Study|Withdrawal by Subject|2|||
164493829|NCT01524887|594177402|FG002|Overall Study|Withdrawal by Subject|3|||
164493830|NCT01524887|594177400|FG000|Overall Study|Adverse Event|5|||
164493831|NCT01524887|594177401|FG001|Overall Study|Adverse Event|1|||
164493832|NCT01524887|594177402|FG002|Overall Study|Adverse Event|1|||
164493833|NCT01524887|594177400|FG000|Overall Study|Protocol Violation|0|||
164493834|NCT01524887|594177401|FG001|Overall Study|Protocol Violation|0|||
164493835|NCT01524887|594177402|FG002|Overall Study|Protocol Violation|1|||
164493836|NCT01524887|594177400|FG000|Overall Study|Study termination|73|||
164493837|NCT01524887|594177401|FG001|Overall Study|Study termination|87|||
164493838|NCT01524887|594177402|FG002|Overall Study|Study termination|79|||
164493839|NCT01524887|594177400|FG000|Overall Study|Withdrawal by Caregiver|0|||
164493840|NCT01524887|594177401|FG001|Overall Study|Withdrawal by Caregiver|0|||
164493841|NCT01524887|594177402|FG002|Overall Study|Withdrawal by Caregiver|2|||
164493842|NCT01524887|594177400|FG000|Overall Study|Use of prohibited medication|1|||
164493843|NCT01524887|594177401|FG001|Overall Study|Use of prohibited medication|0|||
164493844|NCT01524887|594177402|FG002|Overall Study|Use of prohibited medication|0|||
164493845|NCT01808144|594177403|FG000|Overall Study|Death|1|||
164493846|NCT01808144|594177404|FG001|Overall Study|Death|0|||
164493847|NCT01808144|594177403|FG000|Overall Study|Withdrawal by Subject|16|||
164493848|NCT01808144|594177404|FG001|Overall Study|Withdrawal by Subject|23|||
164493849|NCT01808144|594177403|FG000|Overall Study|Lost to Follow-up|6|||
164493850|NCT01808144|594177404|FG001|Overall Study|Lost to Follow-up|3|||
164493851|NCT01808144|594177403|FG000|Overall Study|Protocol Violation|6|||
164493852|NCT01808144|594177404|FG001|Overall Study|Protocol Violation|6|||
164493853|NCT01808144|594177403|FG000|Overall Study|Gout flare|0|||
164493854|NCT01808144|594177404|FG001|Overall Study|Gout flare|1|||
164493855|NCT01808144|594177403|FG000|Overall Study|Adverse Event|11|||
164493856|NCT01808144|594177404|FG001|Overall Study|Adverse Event|15|||
164493857|NCT00383500|594177405|FG000|Overall Study|Withdrawal by Subject|8|||
164493858|NCT00383500|594177406|FG001|Overall Study|Withdrawal by Subject|3|||
164493859|NCT00383500|594177407|FG002|Overall Study|Withdrawal by Subject|0|||
164493860|NCT00383500|594177405|FG000|Overall Study|Lost to Follow-up|0|||
164493861|NCT00383500|594177406|FG001|Overall Study|Lost to Follow-up|0|||
164493862|NCT00383500|594177407|FG002|Overall Study|Lost to Follow-up|2|||
164493863|NCT02951052|594177408|FG000|Overall Study|Adverse Event|13|||
164493864|NCT02951052|594177409|FG001|Overall Study|Adverse Event|5|||
164493865|NCT02951052|594177408|FG000|Overall Study|Withdrawal by Subject|1|||
164493866|NCT02951052|594177409|FG001|Overall Study|Withdrawal by Subject|5|||
164493867|NCT02951052|594177408|FG000|Overall Study|Physician Decision|2|||
164493868|NCT02951052|594177409|FG001|Overall Study|Physician Decision|0|||
164493869|NCT02951052|594177408|FG000|Overall Study|Lost to Follow-up|1|||
164493870|NCT02951052|594177409|FG001|Overall Study|Lost to Follow-up|1|||
164493871|NCT02951052|594177408|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
164493872|NCT02951052|594177409|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
164493873|NCT02951052|594177408|FG000|Overall Study|Protocol Violation|5|||
164493874|NCT02951052|594177409|FG001|Overall Study|Protocol Violation|3|||
164493875|NCT02951052|594177408|FG000|Overall Study|Lack of Efficacy|3|||
164493876|NCT02951052|594177409|FG001|Overall Study|Lack of Efficacy|4|||
164493877|NCT02951052|594177408|FG000|Overall Study|Ongoing|1|||
164493878|NCT02951052|594177409|FG001|Overall Study|Ongoing|0|||
164493879|NCT02093897|594179229|FG000|Overall Study|Physician Decision|1|||
164493880|NCT02093897|594179229|FG000|Overall Study|Planned age group closure - no's reached|17|||
164493881|NCT02093897|594179229|FG000|Overall Study|Adverse event, non-fatal|1|||
164493882|NCT02972242|594179230|FG000|Overall Study|Withdrawal by Subject|1|||
164493883|NCT02972242|594179231|FG001|Overall Study|Withdrawal by Subject|0|||
164493884|NCT04572997|594179235|FG000|Overall Study|Adverse Event|1|||
164493885|NCT03098797|594179236|FG000|Part 2 Open Label Extension|Adverse Event|2|||
164493886|NCT03098797|594179237|FG001|Part 2 Open Label Extension|Adverse Event|0|||
164493887|NCT02956278|594179238|FG000|Overall Study|Withdrawal by Subject|6|||
164493888|NCT02956278|594179239|FG001|Overall Study|Withdrawal by Subject|2|||
164493889|NCT02956278|594179240|FG002|Overall Study|Withdrawal by Subject|0|||
164493890|NCT01967719|594179241|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
164493891|NCT01967719|594179242|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
164493892|NCT01967719|594179243|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
164603484|NCT02062463|594568623|FG000|Stage 2|Lost to Follow-up|0|||
164603485|NCT02062463|594568624|FG001|Stage 2|Lost to Follow-up|0|||
164603486|NCT02062463|594568625|FG002|Stage 2|Lost to Follow-up|20|||
164603487|NCT02062463|594568626|FG003|Stage 2|Lost to Follow-up|20|||
164603488|NCT02062463|594568623|FG000|Stage 2|Non-Compliance|0|||
164603489|NCT02062463|594568624|FG001|Stage 2|Non-Compliance|0|||
164603490|NCT02062463|594568625|FG002|Stage 2|Non-Compliance|0|||
164603491|NCT02062463|594568626|FG003|Stage 2|Non-Compliance|1|||
164603492|NCT02062463|594568623|FG000|Stage 2|Other than specified|0|||
164603493|NCT02062463|594568624|FG001|Stage 2|Other than specified|0|||
164493893|NCT01967719|594179244|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
164493894|NCT01967719|594179241|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
164493895|NCT01967719|594179242|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
164493896|NCT01967719|594179243|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
164493897|NCT01967719|594179244|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
164493898|NCT02329223|594179245|FG000|Overall Study|Withdrawal by Subject|1|||
164493899|NCT02329223|594179246|FG001|Overall Study|Withdrawal by Subject|2|||
164493900|NCT02329223|594179247|FG002|Overall Study|Withdrawal by Subject|5|||
164493901|NCT02329223|594179245|FG000|Overall Study|Physician Decision|0|||
164493902|NCT02329223|594179246|FG001|Overall Study|Physician Decision|0|||
164493903|NCT02329223|594179247|FG002|Overall Study|Physician Decision|1|||
164493904|NCT02329223|594179245|FG000|Overall Study|Adverse Event|0|||
164493905|NCT02329223|594179246|FG001|Overall Study|Adverse Event|1|||
164493906|NCT02329223|594179247|FG002|Overall Study|Adverse Event|0|||
164493907|NCT00651937|594179248|FG000|Overall Study|Withdrawal by Subject|4|||
164493908|NCT00651937|594179249|FG001|Overall Study|Withdrawal by Subject|1|||
164493909|NCT00552513|594179255|FG000|Overall Study|Lost to Follow-up|5|||
164493910|NCT00552513|594179256|FG001|Overall Study|Lost to Follow-up|1|||
164493911|NCT02720185|594179259|FG000|Overall Study|Lost to Follow-up|1|||
164493912|NCT00726388|594179262|FG000|Overall Study|Withdrawal by Subject|5|||
164493913|NCT00726388|594179262|FG000|Overall Study|Adverse Event|3|||
164493914|NCT00726388|594179262|FG000|Overall Study|Lost to Follow-up|10|||
164493915|NCT00726388|594179262|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
164493916|NCT00726388|594179262|FG000|Overall Study|Other|5|||
164493917|NCT00726388|594179262|FG000|Overall Study|Enrolled, Not Treated|79|||
164493918|NCT01116440|594179270|FG000|Treatment|Withdrawal by Subject|2|||
164493919|NCT01116440|594179271|FG001|Treatment|Withdrawal by Subject|2|||
164493920|NCT01116440|594179270|FG000|Treatment|Lost to Follow-up|1|||
164493921|NCT01116440|594179271|FG001|Treatment|Lost to Follow-up|1|||
164493922|NCT01116440|594179270|FG000|Treatment|Protocol Violation|0|||
164493923|NCT01116440|594179271|FG001|Treatment|Protocol Violation|2|||
164493924|NCT01116440|594179270|FG000|Treatment|Lack of Efficacy|0|||
164493925|NCT01116440|594179271|FG001|Treatment|Lack of Efficacy|1|||
164493926|NCT01116440|594179270|FG000|Treatment|Adverse Event|0|||
164493927|NCT01116440|594179271|FG001|Treatment|Adverse Event|1|||
164493928|NCT01116440|594179270|FG000|Withdrawal|Withdrawal by Subject|0|||
164493929|NCT01116440|594179271|FG001|Withdrawal|Withdrawal by Subject|1|||
164493930|NCT01116440|594179270|FG000|Withdrawal|Lost to Follow-up|0|||
164493931|NCT01116440|594179271|FG001|Withdrawal|Lost to Follow-up|1|||
164493932|NCT01116440|594179270|FG000|Follow-up|Lost to Follow-up|0|||
164493933|NCT01116440|594179271|FG001|Follow-up|Lost to Follow-up|1|||
164493934|NCT01116440|594179270|FG000|Follow-up|Withdrawal by Subject|0|||
164493935|NCT01116440|594179271|FG001|Follow-up|Withdrawal by Subject|1|||
164493936|NCT01126879|594179272|FG000|Overall Study|Progressive Disease|3|||
164493937|NCT01126879|594179273|FG001|Overall Study|Progressive Disease|1|||
164493938|NCT01126879|594179272|FG000|Overall Study|Withdrawal by Subject|1|||
164493939|NCT01126879|594179273|FG001|Overall Study|Withdrawal by Subject|0|||
164493940|NCT01126879|594179272|FG000|Overall Study|Adverse Event|0|||
164493941|NCT01126879|594179273|FG001|Overall Study|Adverse Event|1|||
164493942|NCT01126879|594179272|FG000|Overall Study|Physician Decision|1|||
164493943|NCT01126879|594179273|FG001|Overall Study|Physician Decision|0|||
164493944|NCT03441789|594179279|FG000|Overall Study|Withdrawal by Subject|1|||
164493945|NCT03441789|594179280|FG001|Overall Study|Withdrawal by Subject|1|||
164493946|NCT03441789|594179279|FG000|Overall Study|Adverse Event|0|||
164493947|NCT03441789|594179280|FG001|Overall Study|Adverse Event|1|||
164493948|NCT03441789|594179279|FG000|Overall Study|Protocol Violation|0|||
164493949|NCT03441789|594179280|FG001|Overall Study|Protocol Violation|1|||
164493950|NCT03441789|594179279|FG000|Overall Study|Lost to Follow-up|0|||
164493951|NCT03441789|594179280|FG001|Overall Study|Lost to Follow-up|1|||
164493952|NCT01780545|594179281|FG000|Overall Study|Withdrawal by Subject|3|||
164493953|NCT01780545|594179282|FG001|Overall Study|Withdrawal by Subject|1|||
164493954|NCT01780545|594179281|FG000|Overall Study|Lost to Follow-up|1|||
164493955|NCT01780545|594179282|FG001|Overall Study|Lost to Follow-up|1|||
164493956|NCT02581189|594179283|FG000|Overall Study|Failure to return|36|||
164603494|NCT02062463|594568625|FG002|Stage 2|Other than specified|3|||
164603495|NCT02062463|594568626|FG003|Stage 2|Other than specified|1|||
164603496|NCT02062463|594568623|FG000|Stage 2|Withdrawal by Subject|0|||
164603497|NCT02062463|594568624|FG001|Stage 2|Withdrawal by Subject|0|||
164603498|NCT02062463|594568625|FG002|Stage 2|Withdrawal by Subject|15|||
164493957|NCT02581189|594179283|FG000|Overall Study|Withdrew consent|5|||
164493958|NCT02581189|594179283|FG000|Overall Study|Death|3|||
164493959|NCT02581189|594179283|FG000|Overall Study|Insufficient virological response|2|||
164493960|NCT02581189|594179283|FG000|Overall Study|Other, not specified|7|||
164493961|NCT01514864|594179284|FG000|Overall Study|Disease progression|7|||
164493962|NCT01514864|594179285|FG001|Overall Study|Disease progression|5|||
164493963|NCT01514864|594179284|FG000|Overall Study|Study drug toxicity|2|||
164493964|NCT01514864|594179285|FG001|Overall Study|Study drug toxicity|0|||
164603499|NCT02062463|594568626|FG003|Stage 2|Withdrawal by Subject|10|||
164603500|NCT01956240|594568635|FG000|Overall Study|Lost to Follow-up|6|||
164493965|NCT05135156|594179286|FG000|Overall Study|Lost to Follow-up|0|||
164493966|NCT05135156|594179287|FG001|Overall Study|Lost to Follow-up|0|||
164493967|NCT05135156|594179288|FG002|Overall Study|Lost to Follow-up|2|||
164493968|NCT03746483|594179296|FG000|Overall Study|Adverse Event|0|||
164493969|NCT03746483|594179297|FG001|Overall Study|Adverse Event|1|||
164493970|NCT03746483|594179296|FG000|Overall Study|Lack of Efficacy|3|||
164493971|NCT03746483|594179297|FG001|Overall Study|Lack of Efficacy|2|||
164493972|NCT03746483|594179296|FG000|Overall Study|Lost to Follow-up|1|||
164493973|NCT03746483|594179297|FG001|Overall Study|Lost to Follow-up|0|||
164493974|NCT03746483|594179296|FG000|Overall Study|Protocol Violation|2|||
164493975|NCT03746483|594179297|FG001|Overall Study|Protocol Violation|0|||
164493976|NCT01379521|594179298|FG000|Overall Study -Treatment Period|Adverse Event|3|||
164493977|NCT01379521|594179299|FG001|Overall Study -Treatment Period|Adverse Event|0|||
164493978|NCT01379521|594179298|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
164493979|NCT01379521|594179299|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
164493980|NCT01379521|594179298|FG000|Overall Study -Treatment Period|Disease Progression|23|||
164493981|NCT01379521|594179299|FG001|Overall Study -Treatment Period|Disease Progression|22|||
164493982|NCT01379521|594179298|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
164493983|NCT01379521|594179299|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
164493984|NCT01379521|594179298|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
164493985|NCT01379521|594179299|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
164493986|NCT01379521|594179298|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
164493987|NCT01379521|594179299|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
164493988|NCT01379521|594179298|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
164493989|NCT01379521|594179299|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
164493990|NCT01379521|594179298|FG000|Overall Study -Treatment Period|Death|2|||
164493991|NCT01379521|594179299|FG001|Overall Study -Treatment Period|Death|1|||
164493992|NCT01379521|594179298|FG000|Post-Treatment Evaluations|Disease Progression|22|||
164493993|NCT01379521|594179299|FG001|Post-Treatment Evaluations|Disease Progression|20|||
164493994|NCT01379521|594179298|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
164493995|NCT01379521|594179299|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
164493996|NCT01379521|594179298|FG000|Post-Treatment Evaluations|Death|1|||
164493997|NCT01379521|594179299|FG001|Post-Treatment Evaluations|Death|0|||
164493998|NCT00404547|594179300|FG000|Overall Study|Adverse Event|39|||
164493999|NCT00404547|594179301|FG001|Overall Study|Adverse Event|6|||
164494000|NCT00404547|594179300|FG000|Overall Study|Withdrawal by Subject|19|||
164494001|NCT00404547|594179301|FG001|Overall Study|Withdrawal by Subject|2|||
164494002|NCT00404547|594179300|FG000|Overall Study|Protocol Violation|0|||
164494003|NCT00404547|594179301|FG001|Overall Study|Protocol Violation|1|||
164494004|NCT00404547|594179300|FG000|Overall Study|Lost to Follow-up|20|||
164494005|NCT00404547|594179301|FG001|Overall Study|Lost to Follow-up|9|||
164494006|NCT00404547|594179300|FG000|Overall Study|Lack of compliance|5|||
164494007|NCT00404547|594179301|FG001|Overall Study|Lack of compliance|1|||
164494008|NCT00404547|594179300|FG000|Overall Study|Other|4|||
164494009|NCT00404547|594179301|FG001|Overall Study|Other|0|||
164494010|NCT00404547|594179300|FG000|Overall Study|Reason not stated|3|||
164494011|NCT00404547|594179301|FG001|Overall Study|Reason not stated|6|||
164494012|NCT00475735|594179302|FG000|Treatment Period 1|Adverse Event|2|||
164494013|NCT00475735|594179303|FG001|Treatment Period 1|Adverse Event|0|||
164494014|NCT00475735|594179304|FG002|Treatment Period 1|Adverse Event|0|||
164494015|NCT00475735|594179305|FG003|Treatment Period 1|Adverse Event|0|||
164494016|NCT00475735|594179306|FG004|Treatment Period 1|Adverse Event|0|||
164494017|NCT00475735|594179307|FG005|Treatment Period 1|Adverse Event|0|||
164494018|NCT00475735|594179302|FG000|Treatment Period 1|Lack of Efficacy|1|||
164494019|NCT00475735|594179303|FG001|Treatment Period 1|Lack of Efficacy|0|||
164494020|NCT00475735|594179304|FG002|Treatment Period 1|Lack of Efficacy|0|||
164494021|NCT00475735|594179305|FG003|Treatment Period 1|Lack of Efficacy|0|||
164494022|NCT00475735|594179306|FG004|Treatment Period 1|Lack of Efficacy|0|||
164494023|NCT00475735|594179307|FG005|Treatment Period 1|Lack of Efficacy|0|||
164494024|NCT00475735|594179302|FG000|Treatment Period 1|Lost to Follow-up|0|||
164494025|NCT00475735|594179303|FG001|Treatment Period 1|Lost to Follow-up|0|||
164494026|NCT00475735|594179304|FG002|Treatment Period 1|Lost to Follow-up|0|||
164494027|NCT00475735|594179305|FG003|Treatment Period 1|Lost to Follow-up|0|||
164494028|NCT00475735|594179306|FG004|Treatment Period 1|Lost to Follow-up|0|||
164494029|NCT00475735|594179307|FG005|Treatment Period 1|Lost to Follow-up|1|||
164494030|NCT00475735|594179302|FG000|Treatment Period 1|Protocol Violation|0|||
164603501|NCT01956240|594568636|FG001|Overall Study|Lost to Follow-up|20|||
164603502|NCT01956240|594568635|FG000|Overall Study|Adverse Event|17|||
164603503|NCT01956240|594568636|FG001|Overall Study|Adverse Event|4|||
164603504|NCT03172481|594568640|FG000|Double-blind|Withdrawal by Subject|1|||
164603505|NCT03172481|594568641|FG001|Double-blind|Withdrawal by Subject|0|||
164603506|NCT02759562|594568645|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
164603507|NCT02759562|594568646|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
164715032|NCT02203331|594978866|FG005|Overall Study|Adverse Event|3|||
164715033|NCT02203331|594978861|FG000|Overall Study|Other Reasons|1|||
164715034|NCT02203331|594978862|FG001|Overall Study|Other Reasons|2|||
164715035|NCT02203331|594978863|FG002|Overall Study|Other Reasons|0|||
164715036|NCT02203331|594978864|FG003|Overall Study|Other Reasons|2|||
164715037|NCT02203331|594978865|FG004|Overall Study|Other Reasons|0|||
164715038|NCT02203331|594978866|FG005|Overall Study|Other Reasons|0|||
164715039|NCT02203331|594978861|FG000|Overall Study|Lack of Efficacy|0|||
164715040|NCT02203331|594978862|FG001|Overall Study|Lack of Efficacy|2|||
164715041|NCT02203331|594978863|FG002|Overall Study|Lack of Efficacy|1|||
164715042|NCT02203331|594978864|FG003|Overall Study|Lack of Efficacy|0|||
164715043|NCT02203331|594978865|FG004|Overall Study|Lack of Efficacy|0|||
164715044|NCT02203331|594978866|FG005|Overall Study|Lack of Efficacy|1|||
164494031|NCT00475735|594179303|FG001|Treatment Period 1|Protocol Violation|0|||
164494032|NCT00475735|594179304|FG002|Treatment Period 1|Protocol Violation|0|||
164494033|NCT00475735|594179305|FG003|Treatment Period 1|Protocol Violation|1|||
164494034|NCT00475735|594179306|FG004|Treatment Period 1|Protocol Violation|0|||
164494035|NCT00475735|594179307|FG005|Treatment Period 1|Protocol Violation|0|||
164494036|NCT00475735|594179302|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164494037|NCT00475735|594179303|FG001|Treatment Period 1|Withdrawal by Subject|1|||
164494038|NCT00475735|594179304|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164494039|NCT00475735|594179305|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164494040|NCT00475735|594179306|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164494041|NCT00475735|594179307|FG005|Treatment Period 1|Withdrawal by Subject|0|||
164494042|NCT00475735|594179302|FG000|Treatment Period 1|DC due to AE but continuing|0|||
164494043|NCT00475735|594179303|FG001|Treatment Period 1|DC due to AE but continuing|0|||
164494044|NCT00475735|594179304|FG002|Treatment Period 1|DC due to AE but continuing|0|||
164494045|NCT00475735|594179305|FG003|Treatment Period 1|DC due to AE but continuing|1|||
164494046|NCT00475735|594179306|FG004|Treatment Period 1|DC due to AE but continuing|2|||
164494047|NCT00475735|594179307|FG005|Treatment Period 1|DC due to AE but continuing|2|||
164494048|NCT00475735|594179302|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
164494049|NCT00475735|594179303|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
164494050|NCT00475735|594179304|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
164494051|NCT00475735|594179305|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
164494052|NCT00475735|594179306|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
164494053|NCT00475735|594179307|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
164494054|NCT00475735|594179302|FG000|Treatment Washout|Lost to Follow-up|0|||
164494055|NCT00475735|594179303|FG001|Treatment Washout|Lost to Follow-up|1|||
164494056|NCT00475735|594179304|FG002|Treatment Washout|Lost to Follow-up|0|||
164494057|NCT00475735|594179305|FG003|Treatment Washout|Lost to Follow-up|0|||
164494058|NCT00475735|594179306|FG004|Treatment Washout|Lost to Follow-up|0|||
164494059|NCT00475735|594179307|FG005|Treatment Washout|Lost to Follow-up|0|||
164494060|NCT00475735|594179302|FG000|Treatment Washout|Protocol Violation|0|||
164494061|NCT00475735|594179303|FG001|Treatment Washout|Protocol Violation|1|||
164494062|NCT00475735|594179304|FG002|Treatment Washout|Protocol Violation|0|||
164494063|NCT00475735|594179305|FG003|Treatment Washout|Protocol Violation|0|||
164494064|NCT00475735|594179306|FG004|Treatment Washout|Protocol Violation|0|||
164494065|NCT00475735|594179307|FG005|Treatment Washout|Protocol Violation|0|||
164494066|NCT00475735|594179302|FG000|Treatment Period 2|Adverse Event|0|||
164494067|NCT00475735|594179303|FG001|Treatment Period 2|Adverse Event|1|||
164494068|NCT00475735|594179304|FG002|Treatment Period 2|Adverse Event|0|||
164494069|NCT00475735|594179305|FG003|Treatment Period 2|Adverse Event|2|||
164494070|NCT00475735|594179306|FG004|Treatment Period 2|Adverse Event|0|||
164494071|NCT00475735|594179307|FG005|Treatment Period 2|Adverse Event|0|||
164494072|NCT00475735|594179302|FG000|Treatment Period 2|Lack of Efficacy|0|||
164494073|NCT00475735|594179303|FG001|Treatment Period 2|Lack of Efficacy|0|||
164494074|NCT00475735|594179304|FG002|Treatment Period 2|Lack of Efficacy|0|||
164715045|NCT02203331|594978861|FG000|Overall Study|Protocol Violation|0|||
164715046|NCT02203331|594978862|FG001|Overall Study|Protocol Violation|2|||
164715047|NCT02203331|594978863|FG002|Overall Study|Protocol Violation|0|||
164715048|NCT02203331|594978864|FG003|Overall Study|Protocol Violation|1|||
164715049|NCT02203331|594978865|FG004|Overall Study|Protocol Violation|1|||
164715050|NCT02203331|594978866|FG005|Overall Study|Protocol Violation|0|||
164494075|NCT00475735|594179305|FG003|Treatment Period 2|Lack of Efficacy|0|||
164494076|NCT00475735|594179306|FG004|Treatment Period 2|Lack of Efficacy|0|||
164494077|NCT00475735|594179307|FG005|Treatment Period 2|Lack of Efficacy|1|||
164494078|NCT00475735|594179302|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164494079|NCT00475735|594179303|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164494080|NCT00475735|594179304|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164715051|NCT02203331|594978861|FG000|Overall Study|Lost to Follow-up|0|||
164715052|NCT02203331|594978862|FG001|Overall Study|Lost to Follow-up|0|||
164715053|NCT02203331|594978863|FG002|Overall Study|Lost to Follow-up|0|||
164715054|NCT02203331|594978864|FG003|Overall Study|Lost to Follow-up|0|||
164715055|NCT02203331|594978865|FG004|Overall Study|Lost to Follow-up|1|||
164715056|NCT02203331|594978866|FG005|Overall Study|Lost to Follow-up|0|||
164715057|NCT02542605|594978867|FG000|Part B: Challenge Phase|Sponsor decision|1|||
164603508|NCT02759562|594568645|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
164603509|NCT02759562|594568646|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
164603510|NCT01957709|594568647|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
164603511|NCT01107405|594568650|FG000|Overall Study|Adverse Event|1|||
164603512|NCT01107405|594568651|FG001|Overall Study|Adverse Event|1|||
164603513|NCT01107405|594568652|FG002|Overall Study|Adverse Event|0|||
164603514|NCT01107405|594568653|FG003|Overall Study|Adverse Event|0|||
164603515|NCT01107405|594568654|FG004|Overall Study|Adverse Event|2|||
164603516|NCT01107405|594568650|FG000|Overall Study|Withdrawal by Subject|1|||
164603517|NCT01107405|594568651|FG001|Overall Study|Withdrawal by Subject|0|||
164603518|NCT01107405|594568652|FG002|Overall Study|Withdrawal by Subject|1|||
164603519|NCT01107405|594568653|FG003|Overall Study|Withdrawal by Subject|2|||
164603520|NCT01107405|594568654|FG004|Overall Study|Withdrawal by Subject|1|||
164603521|NCT01107405|594568650|FG000|Overall Study|Protocol Violation|0|||
164603522|NCT01107405|594568651|FG001|Overall Study|Protocol Violation|0|||
164603523|NCT01107405|594568652|FG002|Overall Study|Protocol Violation|1|||
164603524|NCT01107405|594568653|FG003|Overall Study|Protocol Violation|1|||
164603525|NCT01107405|594568654|FG004|Overall Study|Protocol Violation|0|||
164603526|NCT01895452|594568658|FG000|Overall Study|Adverse Event|1|||
164603527|NCT01895452|594568659|FG001|Overall Study|Adverse Event|4|||
164603528|NCT01895452|594568658|FG000|Overall Study|Lost to Follow-up|1|||
164603529|NCT01895452|594568659|FG001|Overall Study|Lost to Follow-up|5|||
164603530|NCT01895452|594568658|FG000|Overall Study|Pregnancy|0|||
164603531|NCT01895452|594568659|FG001|Overall Study|Pregnancy|1|||
164603532|NCT01895452|594568658|FG000|Overall Study|Withdrawal by Subject|2|||
164603533|NCT01895452|594568659|FG001|Overall Study|Withdrawal by Subject|14|||
164603534|NCT01895452|594568658|FG000|Overall Study|Underlying disease|0|||
164603535|NCT01895452|594568659|FG001|Overall Study|Underlying disease|3|||
164603536|NCT01895452|594568658|FG000|Overall Study|Noncompliance with study drug|0|||
164603537|NCT01895452|594568659|FG001|Overall Study|Noncompliance with study drug|1|||
164603538|NCT00980343|594568660|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
164715058|NCT02542605|594978868|FG001|Part B: Challenge Phase|Sponsor decision|0|||
164715059|NCT02542605|594978869|FG002|Part B: Challenge Phase|Sponsor decision|0|||
164603539|NCT00980343|594568661|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
164603540|NCT01188538|594568664|FG000|Overall Study|Lost to Follow-up|0|||
164603541|NCT01188538|594568665|FG001|Overall Study|Lost to Follow-up|1|||
164603542|NCT01170702|594568668|FG000|Overall Study|Exclusion criteria met after consent|1|||
164603543|NCT01170702|594568669|FG001|Overall Study|Exclusion criteria met after consent|2|||
164603544|NCT01170702|594568670|FG002|Overall Study|Exclusion criteria met after consent|0|||
164603545|NCT01170702|594568671|FG003|Overall Study|Exclusion criteria met after consent|2|||
164603546|NCT04999969|594568672|FG000|Overall Study|Death|76|||
164603547|NCT04999969|594568672|FG000|Overall Study|Progressive Disease|1|||
164603548|NCT04999969|594568672|FG000|Overall Study|Withdrawal by Subject|8|||
164603549|NCT06964165|594568673|FG000|Overall Study|Death|4|||
164603550|NCT06964165|594568674|FG001|Overall Study|Death|4|||
164603551|NCT06964165|594568673|FG000|Overall Study|Physician Decision|1|||
164603552|NCT06964165|594568674|FG001|Overall Study|Physician Decision|1|||
164603553|NCT06964165|594568673|FG000|Overall Study|Withdrawal by Subject|0|||
164603554|NCT06964165|594568674|FG001|Overall Study|Withdrawal by Subject|2|||
164603555|NCT06964165|594568673|FG000|Overall Study|Study terminated by sponsor|12|||
164603556|NCT06964165|594568674|FG001|Overall Study|Study terminated by sponsor|10|||
164715060|NCT02542605|594978867|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
164715061|NCT02542605|594978868|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
164715062|NCT02542605|594978869|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
164715063|NCT00278889|594978871|FG000|Overall Study|Withdrawal by Subject|0|||
164715064|NCT00278889|594978872|FG001|Overall Study|Withdrawal by Subject|5|||
164715065|NCT00278889|594978873|FG002|Overall Study|Withdrawal by Subject|3|||
164603557|NCT06964165|594568673|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
164603558|NCT06964165|594568674|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
164603559|NCT06964165|594568673|FG000|Overall Study|Participant removed due to non-compliance|0|||
164603560|NCT06964165|594568674|FG001|Overall Study|Participant removed due to non-compliance|1|||
164603561|NCT01551758|594568675|FG000|Overall Study|Adverse Event|29|||
164603562|NCT01551758|594568676|FG001|Overall Study|Adverse Event|43|||
164603563|NCT01551758|594568675|FG000|Overall Study|Lack of Efficacy|0|||
164603564|NCT01551758|594568676|FG001|Overall Study|Lack of Efficacy|1|||
164603565|NCT01551758|594568675|FG000|Overall Study|Protocol Violation|5|||
164603566|NCT01551758|594568676|FG001|Overall Study|Protocol Violation|6|||
164603567|NCT01551758|594568675|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
164603568|NCT01551758|594568676|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
164715066|NCT00278889|594978871|FG000|Overall Study|Lost to Follow-up|1|||
164603569|NCT01551758|594568675|FG000|Overall Study|Lost to Follow-up|29|||
164603570|NCT01551758|594568676|FG001|Overall Study|Lost to Follow-up|25|||
164603571|NCT01551758|594568675|FG000|Overall Study|Physician Decision|9|||
164603572|NCT01551758|594568676|FG001|Overall Study|Physician Decision|3|||
164603573|NCT01551758|594568675|FG000|Overall Study|Withdrawal by Subject|14|||
164494081|NCT00475735|594179305|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164494082|NCT00475735|594179306|FG004|Treatment Period 2|Withdrawal by Subject|1|||
164494083|NCT00475735|594179307|FG005|Treatment Period 2|Withdrawal by Subject|0|||
164494084|NCT01187407|594179308|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
164494085|NCT01187407|594179309|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
164494086|NCT01187407|594179310|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
164494087|NCT01187407|594179311|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
164494088|NCT01187407|594179312|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
164494089|NCT01187407|594179308|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
164494090|NCT01187407|594179309|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
164494091|NCT01187407|594179310|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
164494092|NCT01187407|594179311|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
164494093|NCT01187407|594179312|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
164494094|NCT01187407|594179308|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
164494095|NCT01187407|594179309|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
164494096|NCT01187407|594179310|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
164494097|NCT01187407|594179311|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
164494098|NCT01187407|594179312|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
164494099|NCT01187407|594179308|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
164494100|NCT01187407|594179309|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
164494101|NCT01187407|594179310|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
164494102|NCT01187407|594179311|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
164494103|NCT01187407|594179312|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
164494104|NCT01187407|594179308|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
164494105|NCT01187407|594179309|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
164494106|NCT01187407|594179310|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
164494107|NCT01187407|594179311|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
164494108|NCT01187407|594179312|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
164494109|NCT01187407|594179308|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
164494110|NCT01187407|594179309|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
164494111|NCT01187407|594179310|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
164494112|NCT01187407|594179311|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
164494113|NCT01187407|594179312|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
164494114|NCT01187407|594179308|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
164494115|NCT01187407|594179309|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
164494116|NCT01187407|594179310|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
164494117|NCT01187407|594179311|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
164494118|NCT01187407|594179312|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
164494119|NCT01187407|594179308|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
164494120|NCT01187407|594179309|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
164494121|NCT01187407|594179310|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
164494122|NCT01187407|594179311|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
164494123|NCT01187407|594179312|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
164494124|NCT01187407|594179308|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
164494125|NCT01187407|594179309|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
164494126|NCT01187407|594179310|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
164494127|NCT01187407|594179311|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
164494128|NCT01187407|594179312|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
164494129|NCT01187407|594179308|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
164494130|NCT01187407|594179309|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
164494131|NCT01187407|594179310|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
164494132|NCT01187407|594179311|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
164494133|NCT01187407|594179312|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
164494134|NCT01187407|594179308|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
164494135|NCT01187407|594179309|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
164494136|NCT01187407|594179310|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
164494137|NCT01187407|594179311|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
164494138|NCT01187407|594179312|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
164494139|NCT01187407|594179308|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
164494140|NCT01187407|594179309|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
164494141|NCT01187407|594179310|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
164603574|NCT01551758|594568676|FG001|Overall Study|Withdrawal by Subject|17|||
164603575|NCT01586156|594568677|FG000|Overall Study|Pregnancy|0|||
164603576|NCT01586156|594568678|FG001|Overall Study|Pregnancy|1|||
164603577|NCT01586156|594568679|FG002|Overall Study|Pregnancy|0|||
164603578|NCT01244191|594568680|FG000|Overall Study|Progressive disease|295|||
164603579|NCT01244191|594568681|FG001|Overall Study|Progressive disease|350|||
164603580|NCT01244191|594568680|FG000|Overall Study|Clinical disease progression|54|||
164603581|NCT01244191|594568681|FG001|Overall Study|Clinical disease progression|36|||
164603582|NCT01244191|594568680|FG000|Overall Study|Adverse Event|65|||
164603583|NCT01244191|594568681|FG001|Overall Study|Adverse Event|48|||
164603584|NCT01244191|594568680|FG000|Overall Study|Death|22|||
164603585|NCT01244191|594568681|FG001|Overall Study|Death|29|||
164603586|NCT01244191|594568680|FG000|Overall Study|Lost to Follow-up|0|||
164603587|NCT01244191|594568681|FG001|Overall Study|Lost to Follow-up|2|||
164603588|NCT01244191|594568680|FG000|Overall Study|Protocol Violation|1|||
164603589|NCT01244191|594568681|FG001|Overall Study|Protocol Violation|2|||
164603590|NCT01244191|594568680|FG000|Overall Study|Withdrawal by Subject|31|||
164603591|NCT01244191|594568681|FG001|Overall Study|Withdrawal by Subject|23|||
164603592|NCT01244191|594568680|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
164715067|NCT00278889|594978872|FG001|Overall Study|Lost to Follow-up|1|||
164715068|NCT00278889|594978873|FG002|Overall Study|Lost to Follow-up|0|||
164715069|NCT00278889|594978871|FG000|Overall Study|Death|24|||
164715070|NCT00278889|594978872|FG001|Overall Study|Death|21|||
164715071|NCT00278889|594978873|FG002|Overall Study|Death|17|||
164715072|NCT00704730|594978874|FG000|Overall Study|Adverse Event|35|||
164715073|NCT00704730|594978875|FG001|Overall Study|Adverse Event|9|||
164715074|NCT00704730|594978874|FG000|Overall Study|Death|11|||
164494142|NCT01187407|594179311|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
164494143|NCT01187407|594179312|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
164494144|NCT01187407|594179308|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
164494145|NCT01187407|594179309|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
164494146|NCT01187407|594179310|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
164494147|NCT01187407|594179311|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
164494148|NCT01187407|594179312|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
164494149|NCT01187407|594179308|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
164494150|NCT01187407|594179309|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
164494151|NCT01187407|594179310|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
164494152|NCT01187407|594179311|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
164494153|NCT01187407|594179312|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
164494154|NCT02382406|594179315|FG000|Study Treatment|Disease Progression|8|||
164494155|NCT02382406|594179316|FG001|Study Treatment|Disease Progression|0|||
164494156|NCT02382406|594179317|FG002|Study Treatment|Disease Progression|20|||
164494157|NCT02382406|594179315|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
164494158|NCT02382406|594179316|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
164494159|NCT02382406|594179317|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
164494160|NCT02382406|594179315|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
164494161|NCT02382406|594179316|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
164494162|NCT02382406|594179317|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
164494163|NCT02382406|594179315|FG000|Study Treatment|symptomatic deterioration|1|||
164494164|NCT02382406|594179316|FG001|Study Treatment|symptomatic deterioration|0|||
164494165|NCT02382406|594179317|FG002|Study Treatment|symptomatic deterioration|1|||
164494166|NCT02382406|594179315|FG000|Study Treatment|Death|0|||
164494167|NCT02382406|594179316|FG001|Study Treatment|Death|0|||
164494168|NCT02382406|594179317|FG002|Study Treatment|Death|2|||
164494169|NCT02382406|594179315|FG000|Follow up|Death|11|||
164494170|NCT02382406|594179316|FG001|Follow up|Death|0|||
164494171|NCT02382406|594179317|FG002|Follow up|Death|19|||
164494172|NCT02382406|594179315|FG000|Follow up|Symptomatic deterioration|1|||
164494173|NCT02382406|594179316|FG001|Follow up|Symptomatic deterioration|0|||
164494174|NCT02382406|594179317|FG002|Follow up|Symptomatic deterioration|1|||
164494175|NCT02382406|594179315|FG000|Follow up|Patient Refused Follow-up|1|||
164494176|NCT02382406|594179316|FG001|Follow up|Patient Refused Follow-up|0|||
164494177|NCT02382406|594179317|FG002|Follow up|Patient Refused Follow-up|0|||
164494178|NCT02382406|594179315|FG000|Follow up|Study Terminated|1|||
164494179|NCT02382406|594179316|FG001|Follow up|Study Terminated|0|||
164494180|NCT02382406|594179317|FG002|Follow up|Study Terminated|8|||
164494181|NCT02382406|594179315|FG000|Follow up|Withdrawal by Subject|0|||
164494182|NCT02382406|594179316|FG001|Follow up|Withdrawal by Subject|0|||
164494183|NCT02382406|594179317|FG002|Follow up|Withdrawal by Subject|2|||
164494184|NCT00125853|594179318|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
164494185|NCT00125853|594179319|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
164603593|NCT01244191|594568681|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
164494186|NCT00157209|594179320|FG000|Overall Study|Ongoing at data cut-off|10|||
164494187|NCT00157209|594179321|FG001|Overall Study|Ongoing at data cut-off|0|||
164603594|NCT01752842|594568682|FG000|Overall Study|Adverse Event|3|||
164715075|NCT00704730|594978875|FG001|Overall Study|Death|5|||
164603595|NCT01752842|594568683|FG001|Overall Study|Adverse Event|0|||
164603596|NCT01752842|594568682|FG000|Overall Study|Withdrawal by Subject|0|||
164603597|NCT01752842|594568683|FG001|Overall Study|Withdrawal by Subject|2|||
164603598|NCT02164513|594568684|FG000|Overall Study|Adverse Event|162|||
164603599|NCT02164513|594568685|FG001|Overall Study|Adverse Event|180|||
164603600|NCT02164513|594568686|FG002|Overall Study|Adverse Event|111|||
164603601|NCT02164513|594568684|FG000|Overall Study|Other: Study Closed or terminated|5|||
164603602|NCT02164513|594568685|FG001|Overall Study|Other: Study Closed or terminated|2|||
164603603|NCT02164513|594568686|FG002|Overall Study|Other: Study Closed or terminated|4|||
164603604|NCT02164513|594568684|FG000|Overall Study|Lost to Follow-up|30|||
164603605|NCT02164513|594568685|FG001|Overall Study|Lost to Follow-up|36|||
164603606|NCT02164513|594568686|FG002|Overall Study|Lost to Follow-up|22|||
164603607|NCT02164513|594568684|FG000|Overall Study|Physician Decision|47|||
164603608|NCT02164513|594568685|FG001|Overall Study|Physician Decision|57|||
164603609|NCT02164513|594568686|FG002|Overall Study|Physician Decision|28|||
164603610|NCT02164513|594568684|FG000|Overall Study|Withdrawal by Subject|192|||
164603611|NCT02164513|594568685|FG001|Overall Study|Withdrawal by Subject|261|||
164603612|NCT02164513|594568686|FG002|Overall Study|Withdrawal by Subject|130|||
164603613|NCT02164513|594568684|FG000|Overall Study|Other: Reason not provided by site|1|||
164603614|NCT02164513|594568685|FG001|Overall Study|Other: Reason not provided by site|0|||
164603615|NCT02164513|594568686|FG002|Overall Study|Other: Reason not provided by site|0|||
164603616|NCT05301322|594568687|FG000|Overall Study|Adverse Event|7|||
164603617|NCT05301322|594568688|FG001|Overall Study|Adverse Event|3|||
164603618|NCT05301322|594568687|FG000|Overall Study|Death|0|||
164603619|NCT05301322|594568688|FG001|Overall Study|Death|1|||
164603620|NCT05301322|594568687|FG000|Overall Study|Lost to Follow-up|2|||
164603621|NCT05301322|594568688|FG001|Overall Study|Lost to Follow-up|1|||
164603622|NCT05301322|594568687|FG000|Overall Study|Protocol Violation|3|||
164603623|NCT05301322|594568688|FG001|Overall Study|Protocol Violation|1|||
164603624|NCT05301322|594568687|FG000|Overall Study|Withdrawal by Subject|3|||
164603625|NCT05301322|594568688|FG001|Overall Study|Withdrawal by Subject|0|||
164603626|NCT05301322|594568687|FG000|Overall Study|Other|4|||
164603627|NCT05301322|594568688|FG001|Overall Study|Other|0|||
164603628|NCT04971785|594568689|FG000|Overall Study|Withdrew Consent|5|||
164603629|NCT04971785|594568690|FG001|Overall Study|Withdrew Consent|5|||
164603630|NCT04971785|594568691|FG002|Overall Study|Withdrew Consent|17|||
164603631|NCT04971785|594568692|FG003|Overall Study|Withdrew Consent|7|||
164603632|NCT04971785|594568689|FG000|Overall Study|Adverse Event|7|||
164603633|NCT04971785|594568690|FG001|Overall Study|Adverse Event|8|||
164603634|NCT04971785|594568691|FG002|Overall Study|Adverse Event|6|||
164603635|NCT04971785|594568692|FG003|Overall Study|Adverse Event|3|||
164603636|NCT04971785|594568689|FG000|Overall Study|Lost to Follow-up|2|||
164603637|NCT04971785|594568690|FG001|Overall Study|Lost to Follow-up|1|||
164603638|NCT04971785|594568691|FG002|Overall Study|Lost to Follow-up|6|||
164603639|NCT04971785|594568692|FG003|Overall Study|Lost to Follow-up|7|||
164603640|NCT04971785|594568689|FG000|Overall Study|Protocol Violation|3|||
164603641|NCT04971785|594568690|FG001|Overall Study|Protocol Violation|1|||
164603642|NCT04971785|594568691|FG002|Overall Study|Protocol Violation|1|||
164603643|NCT04971785|594568692|FG003|Overall Study|Protocol Violation|2|||
164603644|NCT04971785|594568689|FG000|Overall Study|Investigator's Discretion|3|||
164603645|NCT04971785|594568690|FG001|Overall Study|Investigator's Discretion|1|||
164603646|NCT04971785|594568691|FG002|Overall Study|Investigator's Discretion|1|||
164603647|NCT04971785|594568692|FG003|Overall Study|Investigator's Discretion|0|||
164603648|NCT04971785|594568689|FG000|Overall Study|Randomized but Never Treated|1|||
164603649|NCT04971785|594568690|FG001|Overall Study|Randomized but Never Treated|2|||
164603650|NCT04971785|594568691|FG002|Overall Study|Randomized but Never Treated|0|||
164603651|NCT04971785|594568692|FG003|Overall Study|Randomized but Never Treated|1|||
164603652|NCT04971785|594568689|FG000|Overall Study|Death|0|||
164603653|NCT04971785|594568690|FG001|Overall Study|Death|1|||
164715076|NCT00704730|594978874|FG000|Overall Study|Physician Decision|2|||
164715077|NCT00704730|594978875|FG001|Overall Study|Physician Decision|0|||
164715078|NCT00704730|594978874|FG000|Overall Study|Did not receive drug|5|||
164603654|NCT04971785|594568691|FG002|Overall Study|Death|1|||
164603655|NCT04971785|594568692|FG003|Overall Study|Death|0|||
164603656|NCT04971785|594568689|FG000|Overall Study|Site Terminated by Sponsor|1|||
164603657|NCT04971785|594568690|FG001|Overall Study|Site Terminated by Sponsor|1|||
164603658|NCT04971785|594568691|FG002|Overall Study|Site Terminated by Sponsor|0|||
164603659|NCT04971785|594568692|FG003|Overall Study|Site Terminated by Sponsor|0|||
164603660|NCT03829332|594568693|FG000|Overall Study|Death|225|||
164603661|NCT03829332|594568694|FG001|Overall Study|Death|230|||
164603662|NCT03829332|594568693|FG000|Overall Study|Lost to Follow-up|1|||
164715079|NCT00704730|594978875|FG001|Overall Study|Did not receive drug|2|||
164715080|NCT00704730|594978874|FG000|Overall Study|Disease progression per PI|58|||
164603663|NCT03829332|594568694|FG001|Overall Study|Lost to Follow-up|3|||
164603664|NCT03829332|594568693|FG000|Overall Study|Physician Decision|1|||
164603665|NCT03829332|594568694|FG001|Overall Study|Physician Decision|0|||
164603666|NCT03829332|594568693|FG000|Overall Study|Sponsor Decision|71|||
164603667|NCT03829332|594568694|FG001|Overall Study|Sponsor Decision|72|||
164715081|NCT00704730|594978875|FG001|Overall Study|Disease progression per PI|67|||
164715082|NCT00704730|594978874|FG000|Overall Study|data unavailable|1|||
164715083|NCT00704730|594978875|FG001|Overall Study|data unavailable|0|||
164715084|NCT00704730|594978874|FG000|Overall Study|Withdrawal by Subject|9|||
164715085|NCT00704730|594978875|FG001|Overall Study|Withdrawal by Subject|13|||
164715086|NCT01810302|594980316|FG000|Overall Study|Death|1|||
164715087|NCT01810302|594980317|FG001|Overall Study|Death|0|||
164715088|NCT01810302|594980316|FG000|Overall Study|Physician Decision|0|||
164494188|NCT00050167|594179330|FG000|Overall Study|not eligible not invasive|1|||
164494189|NCT00050167|594179331|FG001|Overall Study|not eligible not invasive|1|||
164494190|NCT01363297|594179332|FG000|Overall Study|Other|0|||
164494191|NCT01363297|594179333|FG001|Overall Study|Other|0|||
164494192|NCT01363297|594179334|FG002|Overall Study|Other|0|||
164494193|NCT01363297|594179335|FG003|Overall Study|Other|0|||
164494194|NCT01363297|594179336|FG004|Overall Study|Other|1|||
164494195|NCT01363297|594179332|FG000|Overall Study|Death|3|||
164494196|NCT01363297|594179333|FG001|Overall Study|Death|6|||
164494197|NCT01363297|594179334|FG002|Overall Study|Death|6|||
164494198|NCT01363297|594179335|FG003|Overall Study|Death|10|||
164494199|NCT01363297|594179336|FG004|Overall Study|Death|30|||
164494200|NCT02038803|594179337|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
164494201|NCT02038803|594179337|FG000|Overall Study|Lost to Follow-up|1|||
164494202|NCT04754594|594179338|FG000|Blinded Period|Withdrawal by Subject|4|||
164494203|NCT04754594|594179339|FG001|Blinded Period|Withdrawal by Subject|9|||
164494204|NCT04754594|594179340|FG002|Blinded Period|Withdrawal by Subject|0|||
164494205|NCT04754594|594179341|FG003|Blinded Period|Withdrawal by Subject|0|||
164494206|NCT04754594|594179338|FG000|Blinded Period|Protocol Violation|2|||
164494207|NCT04754594|594179339|FG001|Blinded Period|Protocol Violation|2|||
164494208|NCT04754594|594179340|FG002|Blinded Period|Protocol Violation|0|||
164494209|NCT04754594|594179341|FG003|Blinded Period|Protocol Violation|0|||
164494210|NCT04754594|594179338|FG000|Blinded Period|Lost to Follow-up|1|||
164494211|NCT04754594|594179339|FG001|Blinded Period|Lost to Follow-up|1|||
164494212|NCT04754594|594179340|FG002|Blinded Period|Lost to Follow-up|0|||
164494213|NCT04754594|594179341|FG003|Blinded Period|Lost to Follow-up|0|||
164494214|NCT04754594|594179338|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
164494215|NCT04754594|594179339|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
164494216|NCT04754594|594179340|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
164494217|NCT04754594|594179341|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
164494218|NCT04754594|594179338|FG000|Unblinded Period|Withdrawal by Subject|6|||
164494219|NCT04754594|594179339|FG001|Unblinded Period|Withdrawal by Subject|8|||
164494220|NCT04754594|594179340|FG002|Unblinded Period|Withdrawal by Subject|0|||
164494221|NCT04754594|594179341|FG003|Unblinded Period|Withdrawal by Subject|0|||
164494222|NCT04754594|594179338|FG000|Unblinded Period|Lost to Follow-up|5|||
164494223|NCT04754594|594179339|FG001|Unblinded Period|Lost to Follow-up|3|||
164494224|NCT04754594|594179340|FG002|Unblinded Period|Lost to Follow-up|0|||
164494225|NCT04754594|594179341|FG003|Unblinded Period|Lost to Follow-up|0|||
164494226|NCT04754594|594179338|FG000|Unblinded Period|Protocol Violation|2|||
164494227|NCT04754594|594179339|FG001|Unblinded Period|Protocol Violation|4|||
164494228|NCT04754594|594179340|FG002|Unblinded Period|Protocol Violation|0|||
164494229|NCT04754594|594179341|FG003|Unblinded Period|Protocol Violation|0|||
164494230|NCT04754594|594179338|FG000|Unblinded Period|Other|3|||
164494231|NCT04754594|594179339|FG001|Unblinded Period|Other|0|||
164494232|NCT04754594|594179340|FG002|Unblinded Period|Other|0|||
164494233|NCT04754594|594179341|FG003|Unblinded Period|Other|0|||
164494234|NCT04754594|594179338|FG000|Infant Participants|Withdrawal by Subject|0|||
164494235|NCT04754594|594179339|FG001|Infant Participants|Withdrawal by Subject|0|||
164494236|NCT04754594|594179340|FG002|Infant Participants|Withdrawal by Subject|9|||
164494237|NCT04754594|594179341|FG003|Infant Participants|Withdrawal by Subject|17|||
164494238|NCT04754594|594179338|FG000|Infant Participants|Lost to Follow-up|0|||
164494239|NCT04754594|594179339|FG001|Infant Participants|Lost to Follow-up|0|||
164494240|NCT04754594|594179340|FG002|Infant Participants|Lost to Follow-up|4|||
164494241|NCT04754594|594179341|FG003|Infant Participants|Lost to Follow-up|10|||
164494242|NCT04754594|594179338|FG000|Infant Participants|Death|0|||
164494243|NCT04754594|594179339|FG001|Infant Participants|Death|0|||
164494244|NCT04754594|594179340|FG002|Infant Participants|Death|1|||
164494245|NCT04754594|594179341|FG003|Infant Participants|Death|1|||
164494246|NCT04754594|594179338|FG000|Infant Participants|Other|0|||
164494247|NCT04754594|594179339|FG001|Infant Participants|Other|0|||
164494248|NCT04754594|594179340|FG002|Infant Participants|Other|1|||
164494249|NCT04754594|594179341|FG003|Infant Participants|Other|1|||
164494250|NCT01247922|594179342|FG000|Overall Study|Disease progression|4|||
164494251|NCT02116582|594179343|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
164494252|NCT02116582|594179343|FG000|Overall Study|Adverse Event|22|||
164494253|NCT02116582|594179343|FG000|Overall Study|Death|9|||
164494254|NCT02116582|594179343|FG000|Overall Study|Progressive Disease|148|||
164494255|NCT02116582|594179343|FG000|Overall Study|Protocol Violation|3|||
164494256|NCT02116582|594179343|FG000|Overall Study|Withdrawal by Subject|8|||
164494257|NCT02116582|594179343|FG000|Overall Study|Other: Miscellaneous|11|||
164494258|NCT02116582|594179343|FG000|Overall Study|Lost to Follow-up|1|||
164715089|NCT01810302|594980317|FG001|Overall Study|Physician Decision|1|||
164715090|NCT00287586|594980318|FG000|Overall Study|Withdrew Consent|19|||
164715091|NCT00287586|594980319|FG001|Overall Study|Withdrew Consent|30|||
164715092|NCT00287586|594980318|FG000|Overall Study|Lost to Follow-up|5|||
164715093|NCT00287586|594980319|FG001|Overall Study|Lost to Follow-up|4|||
164715094|NCT00287586|594980318|FG000|Overall Study|Death|2|||
164715095|NCT00287586|594980319|FG001|Overall Study|Death|3|||
164603668|NCT03829332|594568693|FG000|Overall Study|Withdrawal by Subject|11|||
164603669|NCT03829332|594568694|FG001|Overall Study|Withdrawal by Subject|9|||
164603670|NCT00646113|594570113|FG000|Overall Study|Lost to Follow-up|5|||
164603671|NCT00646113|594570113|FG000|Overall Study|Adverse Event|3|||
164603672|NCT05458011|594570114|FG000|DB Period (12 Weeks)|Adverse Event|2|||
164603673|NCT05458011|594570115|FG001|DB Period (12 Weeks)|Adverse Event|1|||
164603674|NCT05458011|594570116|FG002|DB Period (12 Weeks)|Adverse Event|1|||
164603675|NCT05458011|594570114|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
164603676|NCT05458011|594570115|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
164603677|NCT05458011|594570116|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
164603678|NCT05458011|594570114|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
164603679|NCT05458011|594570115|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
164603680|NCT05458011|594570116|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
164603681|NCT05458011|594570114|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
164603682|NCT05458011|594570115|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
164603683|NCT05458011|594570116|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
164603684|NCT05458011|594570114|FG000|OL Period (12 Weeks)|Adverse Event|1|||
164603685|NCT05458011|594570115|FG001|OL Period (12 Weeks)|Adverse Event|2|||
164603686|NCT05458011|594570116|FG002|OL Period (12 Weeks)|Adverse Event|1|||
164715096|NCT00287586|594980318|FG000|Overall Study|Elevated Hematocrit|3|||
164715097|NCT00287586|594980319|FG001|Overall Study|Elevated Hematocrit|0|||
164715098|NCT00287586|594980318|FG000|Overall Study|Rash|3|||
164715099|NCT00287586|594980319|FG001|Overall Study|Rash|0|||
164494259|NCT02116582|594179343|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
164494260|NCT01876823|594179344|FG000|Overall Study|Withdrawal by Subject|5|||
164494261|NCT01876823|594179344|FG000|Overall Study|Physician Decision|2|||
164494262|NCT01876823|594179344|FG000|Overall Study|Patients moved|2|||
164494263|NCT00853021|594179345|FG000|Overall Study|Adverse Event|2|||
164494264|NCT00853021|594179345|FG000|Overall Study|Withdrawal by Subject|2|||
164494265|NCT00853021|594179345|FG000|Overall Study|Death|1|||
164494266|NCT02864147|594179346|FG000|Overall Study|Withdrawal by Subject|3|||
164494267|NCT02864147|594179347|FG001|Overall Study|Withdrawal by Subject|2|||
164494268|NCT02864147|594179348|FG002|Overall Study|Withdrawal by Subject|1|||
164494269|NCT02864147|594179346|FG000|Overall Study|Lost to Follow-up|0|||
164494270|NCT02864147|594179347|FG001|Overall Study|Lost to Follow-up|4|||
164494271|NCT02864147|594179348|FG002|Overall Study|Lost to Follow-up|0|||
164494272|NCT02864147|594179346|FG000|Overall Study|Adverse Event|0|||
164494273|NCT02864147|594179347|FG001|Overall Study|Adverse Event|1|||
164494274|NCT02864147|594179348|FG002|Overall Study|Adverse Event|0|||
164494275|NCT02864147|594179346|FG000|Overall Study|Pregnancy|4|||
164494276|NCT02864147|594179347|FG001|Overall Study|Pregnancy|0|||
164494277|NCT02864147|594179348|FG002|Overall Study|Pregnancy|0|||
164494278|NCT02864147|594179346|FG000|Overall Study|Physician Decision|0|||
164494279|NCT02864147|594179347|FG001|Overall Study|Physician Decision|0|||
164494280|NCT02864147|594179348|FG002|Overall Study|Physician Decision|1|||
164494281|NCT02864147|594179346|FG000|Overall Study|Opted for excisional procedures|0|||
164494282|NCT02864147|594179347|FG001|Overall Study|Opted for excisional procedures|0|||
164494283|NCT02864147|594179348|FG002|Overall Study|Opted for excisional procedures|3|||
164494284|NCT02269917|594179349|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
164494285|NCT02269917|594179350|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
164494286|NCT02269917|594179351|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
164494287|NCT02269917|594179349|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
164494288|NCT02269917|594179350|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
164494289|NCT02269917|594179351|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
164494290|NCT02269917|594179349|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
164494291|NCT02269917|594179350|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
164494292|NCT02269917|594179351|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
164494293|NCT02269917|594179349|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
164494294|NCT02269917|594179350|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
164494295|NCT02269917|594179351|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
164494296|NCT02269917|594179349|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
164603687|NCT05458011|594570114|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
164603688|NCT05458011|594570115|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
164603689|NCT05458011|594570116|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
164603690|NCT03097614|594570125|FG000|Overall Study|Adverse Event|3|||
164715100|NCT00287586|594980318|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
164715101|NCT00287586|594980319|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
164715102|NCT00287586|594980318|FG000|Overall Study|Stroke|2|||
164715103|NCT00287586|594980319|FG001|Overall Study|Stroke|0|||
164715104|NCT00287586|594980318|FG000|Overall Study|Myocardial Infarction|1|||
164715105|NCT00287586|594980319|FG001|Overall Study|Myocardial Infarction|0|||
164715106|NCT00287586|594980318|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
164715107|NCT00287586|594980319|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
164715108|NCT00287586|594980318|FG000|Overall Study|Cognitive Impairment|1|||
164715109|NCT00287586|594980319|FG001|Overall Study|Cognitive Impairment|0|||
164715110|NCT00287586|594980318|FG000|Overall Study|Pancreatic Cancer|1|||
164715111|NCT00287586|594980319|FG001|Overall Study|Pancreatic Cancer|3|||
164715112|NCT00287586|594980318|FG000|Overall Study|Sleep Apnea|1|||
164715113|NCT00287586|594980319|FG001|Overall Study|Sleep Apnea|0|||
164715114|NCT00287586|594980318|FG000|Overall Study|Shoulder Pain|1|||
164715115|NCT00287586|594980319|FG001|Overall Study|Shoulder Pain|0|||
164715116|NCT00287586|594980318|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
164715117|NCT00287586|594980319|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
164715118|NCT00287586|594980318|FG000|Overall Study|Nonadherence|1|||
164715119|NCT00287586|594980319|FG001|Overall Study|Nonadherence|1|||
164715120|NCT00287586|594980318|FG000|Overall Study|Enrolled in Another Study|1|||
164715121|NCT00287586|594980319|FG001|Overall Study|Enrolled in Another Study|0|||
164715122|NCT00287586|594980318|FG000|Overall Study|Major Depression|0|||
164715123|NCT00287586|594980319|FG001|Overall Study|Major Depression|2|||
164715124|NCT00287586|594980318|FG000|Overall Study|Lung Cancer|0|||
164715125|NCT00287586|594980319|FG001|Overall Study|Lung Cancer|2|||
164715126|NCT00287586|594980318|FG000|Overall Study|Elevated IPSS Score|0|||
164715127|NCT00287586|594980319|FG001|Overall Study|Elevated IPSS Score|1|||
164715128|NCT00287586|594980318|FG000|Overall Study|Retroperitoneal Cancer|0|||
164715129|NCT00287586|594980319|FG001|Overall Study|Retroperitoneal Cancer|1|||
164715130|NCT00287586|594980318|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
164715131|NCT00287586|594980319|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
164715132|NCT00287586|594980318|FG000|Overall Study|Mood Swings and Irritability|0|||
164715133|NCT00287586|594980319|FG001|Overall Study|Mood Swings and Irritability|1|||
164715134|NCT00287586|594980318|FG000|Overall Study|Bradycardia|0|||
164715135|NCT00287586|594980319|FG001|Overall Study|Bradycardia|1|||
164715136|NCT00287586|594980318|FG000|Overall Study|Itchy Swollen Eyes|0|||
164715137|NCT00287586|594980319|FG001|Overall Study|Itchy Swollen Eyes|1|||
164715138|NCT00287586|594980318|FG000|Overall Study|Recurrent Melanoma|0|||
164715139|NCT00287586|594980319|FG001|Overall Study|Recurrent Melanoma|1|||
164715140|NCT03743415|594980322|FG000|Overall Study|Death|5|||
164715141|NCT03743415|594980323|FG001|Overall Study|Death|3|||
164715142|NCT03743415|594980324|FG002|Overall Study|Death|1|||
164715143|NCT03743415|594980325|FG003|Overall Study|Death|4|||
164715144|NCT03743415|594980326|FG004|Overall Study|Death|0|||
164715145|NCT03743415|594980327|FG005|Overall Study|Death|0|||
164715146|NCT03743415|594980328|FG006|Overall Study|Death|0|||
164715147|NCT03743415|594980329|FG007|Overall Study|Death|0|||
164715148|NCT03743415|594980330|FG008|Overall Study|Death|1|||
164715149|NCT03743415|594980331|FG009|Overall Study|Death|0|||
164715150|NCT03743415|594980322|FG000|Overall Study|Withdrawal by Subject|1|||
164715151|NCT03743415|594980323|FG001|Overall Study|Withdrawal by Subject|0|||
164715152|NCT03743415|594980324|FG002|Overall Study|Withdrawal by Subject|4|||
164494297|NCT02269917|594179350|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
164494298|NCT02269917|594179351|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
164494299|NCT02269917|594179349|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
164494300|NCT02269917|594179350|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
164494301|NCT02269917|594179351|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
164494302|NCT02269917|594179349|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
164494303|NCT02269917|594179350|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
164494304|NCT02269917|594179351|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
164494305|NCT02269917|594179349|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
164494306|NCT02269917|594179350|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
164494307|NCT02269917|594179351|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
164494308|NCT02269917|594179349|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
164494309|NCT02269917|594179350|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
164715153|NCT03743415|594980325|FG003|Overall Study|Withdrawal by Subject|5|||
164715154|NCT03743415|594980326|FG004|Overall Study|Withdrawal by Subject|5|||
164715155|NCT03743415|594980327|FG005|Overall Study|Withdrawal by Subject|2|||
164715156|NCT03743415|594980328|FG006|Overall Study|Withdrawal by Subject|2|||
164715157|NCT03743415|594980329|FG007|Overall Study|Withdrawal by Subject|5|||
164715158|NCT03743415|594980330|FG008|Overall Study|Withdrawal by Subject|9|||
164715159|NCT03743415|594980331|FG009|Overall Study|Withdrawal by Subject|10|||
164715160|NCT03743415|594980322|FG000|Overall Study|Lost to Follow-up|2|||
164715161|NCT03743415|594980323|FG001|Overall Study|Lost to Follow-up|0|||
164715162|NCT03743415|594980324|FG002|Overall Study|Lost to Follow-up|2|||
164715163|NCT03743415|594980325|FG003|Overall Study|Lost to Follow-up|1|||
164715164|NCT03743415|594980326|FG004|Overall Study|Lost to Follow-up|1|||
164715165|NCT03743415|594980327|FG005|Overall Study|Lost to Follow-up|0|||
164715166|NCT03743415|594980328|FG006|Overall Study|Lost to Follow-up|1|||
164603691|NCT03297216|594570126|FG000|Overall Study|Death|0|||
164603692|NCT03297216|594570127|FG001|Overall Study|Death|1|||
164603693|NCT03297216|594570126|FG000|Overall Study|Miscarriage|0|||
164603694|NCT03297216|594570127|FG001|Overall Study|Miscarriage|2|||
164603695|NCT03297216|594570126|FG000|Overall Study|Lost to Follow-up|3|||
164603696|NCT03297216|594570127|FG001|Overall Study|Lost to Follow-up|2|||
164603697|NCT00603733|594570128|FG000|Active Phase ITT|Adverse Event|8|||
164603698|NCT00603733|594570129|FG001|Active Phase ITT|Adverse Event|7|||
164603699|NCT00603733|594570128|FG000|Active Phase ITT|Withdrawal by Subject|0|||
164603700|NCT00603733|594570129|FG001|Active Phase ITT|Withdrawal by Subject|3|||
164603701|NCT00603733|594570128|FG000|Active Phase ITT|Lost to Follow-up|0|||
164603702|NCT00603733|594570129|FG001|Active Phase ITT|Lost to Follow-up|1|||
164603703|NCT00603733|594570128|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
164603704|NCT00603733|594570129|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
164603705|NCT00603733|594570128|FG000|Active Phase ITT|Lack of Efficacy|1|||
164603706|NCT00603733|594570129|FG001|Active Phase ITT|Lack of Efficacy|2|||
164603707|NCT00603733|594570128|FG000|Active Phase ITT|Subject moved, site closed|1|||
164603708|NCT00603733|594570129|FG001|Active Phase ITT|Subject moved, site closed|1|||
164603709|NCT00603733|594570128|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
164603710|NCT00603733|594570129|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
164603711|NCT00603733|594570128|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
164603712|NCT00603733|594570129|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
164603713|NCT00603733|594570128|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
164603714|NCT00603733|594570129|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
164603715|NCT00603733|594570128|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
164603716|NCT00603733|594570129|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
164603717|NCT00603733|594570128|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
164603718|NCT00603733|594570129|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
164603719|NCT00603733|594570128|FG000|Maintenance Phase ITT|Adverse Event|3|||
164603720|NCT00603733|594570129|FG001|Maintenance Phase ITT|Adverse Event|6|||
164603721|NCT00603733|594570128|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
164603722|NCT00603733|594570129|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
164603723|NCT00603733|594570128|FG000|Maintenance Phase ITT|Protocol Violation|1|||
164603724|NCT00603733|594570129|FG001|Maintenance Phase ITT|Protocol Violation|1|||
164603725|NCT00603733|594570128|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
164603726|NCT00603733|594570129|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
164603727|NCT00603733|594570128|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
164603728|NCT00603733|594570129|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
164603729|NCT00603733|594570128|FG000|Maintenance Phase ITT|Physician Decision|0|||
164603730|NCT00603733|594570129|FG001|Maintenance Phase ITT|Physician Decision|1|||
164603731|NCT00603733|594570128|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
164603732|NCT00603733|594570129|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
164603733|NCT00830115|594570138|FG000|Overall Study|Adverse Event|2|||
164603734|NCT00830115|594570138|FG000|Overall Study|Improvement/recovery|1|||
164603735|NCT01061736|594570139|FG000|Overall Study|Dose regimen not selected|0|||
164603736|NCT01061736|594570140|FG001|Overall Study|Dose regimen not selected|0|||
164603737|NCT01061736|594570141|FG002|Overall Study|Dose regimen not selected|0|||
164603738|NCT01061736|594570142|FG003|Overall Study|Dose regimen not selected|0|||
164603739|NCT01061736|594570143|FG004|Overall Study|Dose regimen not selected|0|||
164603740|NCT01061736|594570144|FG005|Overall Study|Dose regimen not selected|0|||
164603741|NCT01061736|594570145|FG006|Overall Study|Dose regimen not selected|79|||
164603742|NCT01061736|594570146|FG007|Overall Study|Dose regimen not selected|0|||
164603743|NCT01061736|594570147|FG008|Overall Study|Dose regimen not selected|0|||
164603744|NCT01061736|594570148|FG009|Overall Study|Dose regimen not selected|0|||
164715167|NCT03743415|594980329|FG007|Overall Study|Lost to Follow-up|4|||
164715168|NCT03743415|594980330|FG008|Overall Study|Lost to Follow-up|13|||
164715169|NCT03743415|594980331|FG009|Overall Study|Lost to Follow-up|13|||
164715170|NCT02847260|594980332|FG000|Overall Study|Adverse Event|3|||
164715171|NCT02847260|594980332|FG000|Overall Study|Withdrawal by Subject|2|||
164715172|NCT02847260|594980332|FG000|Overall Study|Clinical Deterioration|1|||
164715173|NCT02847260|594980332|FG000|Overall Study|Physician Decision|1|||
164715174|NCT03104400|594980333|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
164715175|NCT03104400|594980334|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
164603745|NCT01061736|594570139|FG000|Overall Study|Adverse Event|13|||
164603746|NCT01061736|594570140|FG001|Overall Study|Adverse Event|1|||
164603747|NCT01061736|594570141|FG002|Overall Study|Adverse Event|3|||
164603748|NCT01061736|594570142|FG003|Overall Study|Adverse Event|2|||
164603749|NCT01061736|594570143|FG004|Overall Study|Adverse Event|4|||
164603750|NCT01061736|594570144|FG005|Overall Study|Adverse Event|1|||
164603751|NCT01061736|594570145|FG006|Overall Study|Adverse Event|4|||
164603752|NCT01061736|594570146|FG007|Overall Study|Adverse Event|63|||
164603753|NCT01061736|594570147|FG008|Overall Study|Adverse Event|67|||
164603754|NCT01061736|594570148|FG009|Overall Study|Adverse Event|34|||
164603755|NCT01061736|594570139|FG000|Overall Study|Lack of Efficacy|0|||
164603756|NCT01061736|594570140|FG001|Overall Study|Lack of Efficacy|2|||
164715176|NCT03104400|594980335|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
164494310|NCT02269917|594179351|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
164494311|NCT02269917|594179349|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
164494312|NCT02269917|594179350|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
164494313|NCT02269917|594179351|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
164494314|NCT02269917|594179349|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
164494315|NCT02269917|594179350|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
164494316|NCT02269917|594179351|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
164494317|NCT02269917|594179349|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
164494318|NCT02269917|594179350|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
164494319|NCT02269917|594179351|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
164494320|NCT02269917|594179349|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
164494321|NCT02269917|594179350|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
164494322|NCT02269917|594179351|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
164494323|NCT02269917|594179349|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
164494324|NCT02269917|594179350|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
164494325|NCT02269917|594179351|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
164494326|NCT02269917|594179349|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
164494327|NCT02269917|594179350|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
164494328|NCT02269917|594179351|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
164494329|NCT02269917|594179349|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
164494330|NCT02269917|594179350|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
164494331|NCT02269917|594179351|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
164494332|NCT00577096|594179352|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
164494333|NCT00577096|594179353|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
164494334|NCT00577096|594179352|FG000|Short Term Participation|Withdrawal by Subject|3|||
164494335|NCT00577096|594179353|FG001|Short Term Participation|Withdrawal by Subject|5|||
164494336|NCT00577096|594179352|FG000|Short Term Participation|Death|1|||
164494337|NCT00577096|594179353|FG001|Short Term Participation|Death|1|||
164494338|NCT01770509|594179354|FG000|Overall Study|Injury|0|||
164494339|NCT01770509|594179355|FG001|Overall Study|Injury|1|||
164494340|NCT01770509|594179354|FG000|Overall Study|Lost to Follow-up|1|||
164494341|NCT01770509|594179355|FG001|Overall Study|Lost to Follow-up|2|||
164494342|NCT00832650|594179356|FG000|Overall Study|Randomized but not treated|0|||
164494343|NCT00832650|594179357|FG001|Overall Study|Randomized but not treated|0|||
164494344|NCT00832650|594179358|FG002|Overall Study|Randomized but not treated|1|||
164494345|NCT00440037|594179364|FG000|Overall Study|Withdrawal by Subject|6|||
164494346|NCT00440037|594179364|FG000|Overall Study|Administrative decision|3|||
164494347|NCT00794573|594179365|FG000|Overall Study|Death|3|||
164494348|NCT00794573|594179366|FG001|Overall Study|Death|0|||
164494349|NCT00794573|594179365|FG000|Overall Study|Withdrawal by Subject|9|||
164494350|NCT00794573|594179366|FG001|Overall Study|Withdrawal by Subject|12|||
164494351|NCT00794573|594179365|FG000|Overall Study|Lost to Follow-up|26|||
164494352|NCT00794573|594179366|FG001|Overall Study|Lost to Follow-up|33|||
164494353|NCT03356145|594179367|FG000|Overall Study|Withdrawal by Subject|2|||
164494354|NCT03356145|594179368|FG001|Overall Study|Withdrawal by Subject|1|||
164494355|NCT03356145|594179367|FG000|Overall Study|Did not meet inclusion criteria|1|||
164494356|NCT03356145|594179368|FG001|Overall Study|Did not meet inclusion criteria|0|||
164494357|NCT03740919|594179369|FG000|Lead-in Period|Lost to Follow-up|1|||
164494358|NCT03740919|594179370|FG001|Lead-in Period|Lost to Follow-up|0|||
164494359|NCT03740919|594179371|FG002|Lead-in Period|Lost to Follow-up|0|||
164494360|NCT03740919|594179372|FG003|Lead-in Period|Lost to Follow-up|0|||
164494361|NCT03740919|594179369|FG000|Lead-in Period|Physician Decision|2|||
164494362|NCT03740919|594179370|FG001|Lead-in Period|Physician Decision|0|||
164494363|NCT03740919|594179371|FG002|Lead-in Period|Physician Decision|0|||
164494364|NCT03740919|594179372|FG003|Lead-in Period|Physician Decision|0|||
164494365|NCT03740919|594179369|FG000|Lead-in Period|Protocol Violation|1|||
164494366|NCT03740919|594179370|FG001|Lead-in Period|Protocol Violation|0|||
164494367|NCT03740919|594179371|FG002|Lead-in Period|Protocol Violation|0|||
164494368|NCT03740919|594179372|FG003|Lead-in Period|Protocol Violation|0|||
164494369|NCT03740919|594179369|FG000|Lead-in Period|Withdrawal by Subject|10|||
164494370|NCT03740919|594179370|FG001|Lead-in Period|Withdrawal by Subject|0|||
164715177|NCT03104400|594980336|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
164494371|NCT03740919|594179371|FG002|Lead-in Period|Withdrawal by Subject|0|||
164494372|NCT03740919|594179372|FG003|Lead-in Period|Withdrawal by Subject|0|||
164715178|NCT03104400|594980337|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
164715179|NCT03104400|594980338|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
164494373|NCT03740919|594179369|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
164494374|NCT03740919|594179370|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
164494375|NCT03740919|594179371|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
164494376|NCT03740919|594179372|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
164494377|NCT03740919|594179369|FG000|Lead-in Period|Study Task Too Burdensome|1|||
164494378|NCT03740919|594179370|FG001|Lead-in Period|Study Task Too Burdensome|0|||
164494379|NCT03740919|594179371|FG002|Lead-in Period|Study Task Too Burdensome|0|||
164715180|NCT03104400|594980339|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
164494380|NCT03740919|594179372|FG003|Lead-in Period|Study Task Too Burdensome|0|||
164494381|NCT03740919|594179369|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
164494382|NCT03740919|594179370|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
164494383|NCT03740919|594179371|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
164494384|NCT03740919|594179372|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
164494385|NCT03740919|594179369|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
164494386|NCT03740919|594179370|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
164494387|NCT03740919|594179371|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
164494388|NCT03740919|594179372|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
164494389|NCT03740919|594179369|FG000|Treatment Period|Adverse Event|0|||
164494390|NCT03740919|594179370|FG001|Treatment Period|Adverse Event|0|||
164494391|NCT03740919|594179371|FG002|Treatment Period|Adverse Event|2|||
164494392|NCT03740919|594179372|FG003|Treatment Period|Adverse Event|0|||
164494393|NCT03740919|594179369|FG000|Treatment Period|Protocol Violation|0|||
164494394|NCT03740919|594179370|FG001|Treatment Period|Protocol Violation|1|||
164494395|NCT03740919|594179371|FG002|Treatment Period|Protocol Violation|0|||
164494396|NCT03740919|594179372|FG003|Treatment Period|Protocol Violation|0|||
164494397|NCT03740919|594179369|FG000|Treatment Period|Withdrawal by Subject|0|||
164494398|NCT03740919|594179370|FG001|Treatment Period|Withdrawal by Subject|7|||
164494399|NCT03740919|594179371|FG002|Treatment Period|Withdrawal by Subject|6|||
164494400|NCT03740919|594179372|FG003|Treatment Period|Withdrawal by Subject|2|||
164494401|NCT03740919|594179369|FG000|Treatment Period|Terminated by Sponsor|0|||
164494402|NCT03740919|594179370|FG001|Treatment Period|Terminated by Sponsor|1|||
164494403|NCT03740919|594179371|FG002|Treatment Period|Terminated by Sponsor|0|||
164494404|NCT03740919|594179372|FG003|Treatment Period|Terminated by Sponsor|0|||
164494405|NCT03740919|594179369|FG000|Treatment Period|Issue with Insulin Pump|0|||
164494406|NCT03740919|594179370|FG001|Treatment Period|Issue with Insulin Pump|1|||
164494407|NCT03740919|594179371|FG002|Treatment Period|Issue with Insulin Pump|0|||
164494408|NCT03740919|594179372|FG003|Treatment Period|Issue with Insulin Pump|0|||
164494409|NCT03740919|594179369|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
164494410|NCT03740919|594179370|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
164494411|NCT03740919|594179371|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
164494412|NCT03740919|594179372|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
164494413|NCT03740919|594179369|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
164494414|NCT03740919|594179370|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
164494415|NCT03740919|594179371|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
164494416|NCT03740919|594179372|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
164494417|NCT03740919|594179369|FG000|Treatment Period|Not Completing Diary|0|||
164494418|NCT03740919|594179370|FG001|Treatment Period|Not Completing Diary|0|||
164494419|NCT03740919|594179371|FG002|Treatment Period|Not Completing Diary|1|||
164494420|NCT03740919|594179372|FG003|Treatment Period|Not Completing Diary|0|||
164494421|NCT03740919|594179369|FG000|Treatment Period|Insulin Painful to Participant|0|||
164494422|NCT03740919|594179370|FG001|Treatment Period|Insulin Painful to Participant|0|||
164494423|NCT03740919|594179371|FG002|Treatment Period|Insulin Painful to Participant|1|||
164494424|NCT03740919|594179372|FG003|Treatment Period|Insulin Painful to Participant|0|||
164494425|NCT02418819|594179377|FG000|Overall Study|Adverse Event|0|||
164494426|NCT02418819|594179378|FG001|Overall Study|Adverse Event|0|||
164494427|NCT02418819|594179379|FG002|Overall Study|Adverse Event|1|||
164494428|NCT02418819|594179380|FG003|Overall Study|Adverse Event|0|||
164494429|NCT02418819|594179377|FG000|Overall Study|Lost to Follow-up|1|||
164494430|NCT02418819|594179378|FG001|Overall Study|Lost to Follow-up|0|||
164494431|NCT02418819|594179379|FG002|Overall Study|Lost to Follow-up|0|||
164494432|NCT02418819|594179380|FG003|Overall Study|Lost to Follow-up|0|||
164494433|NCT02418819|594179377|FG000|Overall Study|No longer meets eligibility criteria|0|||
164494434|NCT02418819|594179378|FG001|Overall Study|No longer meets eligibility criteria|0|||
164494435|NCT02418819|594179379|FG002|Overall Study|No longer meets eligibility criteria|1|||
164494436|NCT02418819|594179380|FG003|Overall Study|No longer meets eligibility criteria|0|||
164494437|NCT02418819|594179377|FG000|Overall Study|No longer willing to participate|0|||
164494438|NCT02418819|594179378|FG001|Overall Study|No longer willing to participate|0|||
164494439|NCT02418819|594179379|FG002|Overall Study|No longer willing to participate|2|||
164494440|NCT02418819|594179380|FG003|Overall Study|No longer willing to participate|1|||
164494441|NCT04374253|594179386|FG000|Overall Study|Adverse Event|0|||
164494442|NCT04374253|594179387|FG001|Overall Study|Adverse Event|26|||
164494443|NCT04374253|594179388|FG002|Overall Study|Adverse Event|2|||
164494444|NCT04374253|594179389|FG003|Overall Study|Adverse Event|12|||
164494445|NCT04374253|594179386|FG000|Overall Study|Study terminated by sponsor|13|||
164494446|NCT04374253|594179387|FG001|Overall Study|Study terminated by sponsor|593|||
164494447|NCT04374253|594179388|FG002|Overall Study|Study terminated by sponsor|21|||
164494448|NCT04374253|594179389|FG003|Overall Study|Study terminated by sponsor|567|||
164494449|NCT04374253|594179386|FG000|Overall Study|Withdrawal by Subject|0|||
164494450|NCT04374253|594179387|FG001|Overall Study|Withdrawal by Subject|55|||
164494451|NCT04374253|594179388|FG002|Overall Study|Withdrawal by Subject|3|||
164494452|NCT04374253|594179389|FG003|Overall Study|Withdrawal by Subject|40|||
164603757|NCT01061736|594570141|FG002|Overall Study|Lack of Efficacy|1|||
164603758|NCT01061736|594570142|FG003|Overall Study|Lack of Efficacy|1|||
164603759|NCT01061736|594570143|FG004|Overall Study|Lack of Efficacy|1|||
164603760|NCT01061736|594570144|FG005|Overall Study|Lack of Efficacy|2|||
164603761|NCT01061736|594570145|FG006|Overall Study|Lack of Efficacy|1|||
164603762|NCT01061736|594570146|FG007|Overall Study|Lack of Efficacy|9|||
164603763|NCT01061736|594570147|FG008|Overall Study|Lack of Efficacy|9|||
164603764|NCT01061736|594570148|FG009|Overall Study|Lack of Efficacy|10|||
164603765|NCT01061736|594570139|FG000|Overall Study|Poor compliance to protocol|0|||
164603766|NCT01061736|594570140|FG001|Overall Study|Poor compliance to protocol|0|||
164603767|NCT01061736|594570141|FG002|Overall Study|Poor compliance to protocol|0|||
164603768|NCT01061736|594570142|FG003|Overall Study|Poor compliance to protocol|0|||
164603769|NCT01061736|594570143|FG004|Overall Study|Poor compliance to protocol|0|||
164603770|NCT01061736|594570144|FG005|Overall Study|Poor compliance to protocol|0|||
164603771|NCT01061736|594570145|FG006|Overall Study|Poor compliance to protocol|0|||
164603772|NCT01061736|594570146|FG007|Overall Study|Poor compliance to protocol|2|||
164603773|NCT01061736|594570147|FG008|Overall Study|Poor compliance to protocol|5|||
164603774|NCT01061736|594570148|FG009|Overall Study|Poor compliance to protocol|9|||
164603775|NCT01061736|594570139|FG000|Overall Study|Not treated|0|||
164603776|NCT01061736|594570140|FG001|Overall Study|Not treated|0|||
164603777|NCT01061736|594570141|FG002|Overall Study|Not treated|0|||
164603778|NCT01061736|594570142|FG003|Overall Study|Not treated|0|||
164603779|NCT01061736|594570143|FG004|Overall Study|Not treated|1|||
164603780|NCT01061736|594570144|FG005|Overall Study|Not treated|0|||
164603781|NCT01061736|594570145|FG006|Overall Study|Not treated|0|||
164603782|NCT01061736|594570146|FG007|Overall Study|Not treated|2|||
164603783|NCT01061736|594570147|FG008|Overall Study|Not treated|1|||
164603784|NCT01061736|594570148|FG009|Overall Study|Not treated|0|||
164603785|NCT01061736|594570139|FG000|Overall Study|Other than specified above|0|||
164715181|NCT03104400|594980340|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
164494453|NCT04374253|594179386|FG000|Overall Study|Physician Decision|1|||
164494454|NCT04374253|594179387|FG001|Overall Study|Physician Decision|10|||
164494455|NCT04374253|594179388|FG002|Overall Study|Physician Decision|1|||
164494456|NCT04374253|594179389|FG003|Overall Study|Physician Decision|10|||
164494457|NCT04374253|594179386|FG000|Overall Study|Protocol Violation|0|||
164494458|NCT04374253|594179387|FG001|Overall Study|Protocol Violation|0|||
164494459|NCT04374253|594179388|FG002|Overall Study|Protocol Violation|0|||
164494460|NCT04374253|594179389|FG003|Overall Study|Protocol Violation|2|||
164494461|NCT04374253|594179386|FG000|Overall Study|Death|0|||
164494462|NCT04374253|594179387|FG001|Overall Study|Death|3|||
164494463|NCT04374253|594179388|FG002|Overall Study|Death|1|||
164494464|NCT04374253|594179389|FG003|Overall Study|Death|1|||
164494465|NCT04374253|594179386|FG000|Overall Study|Lack of Efficacy|0|||
164494466|NCT04374253|594179387|FG001|Overall Study|Lack of Efficacy|0|||
164494467|NCT04374253|594179388|FG002|Overall Study|Lack of Efficacy|0|||
164494468|NCT04374253|594179389|FG003|Overall Study|Lack of Efficacy|1|||
164494469|NCT04374253|594179386|FG000|Overall Study|Lost to Follow-up|1|||
164494470|NCT04374253|594179387|FG001|Overall Study|Lost to Follow-up|1|||
164494471|NCT04374253|594179388|FG002|Overall Study|Lost to Follow-up|0|||
164494472|NCT04374253|594179389|FG003|Overall Study|Lost to Follow-up|2|||
164494473|NCT04374253|594179386|FG000|Overall Study|Reason Not Specified|0|||
164494474|NCT04374253|594179387|FG001|Overall Study|Reason Not Specified|8|||
164494475|NCT04374253|594179388|FG002|Overall Study|Reason Not Specified|0|||
164494476|NCT04374253|594179389|FG003|Overall Study|Reason Not Specified|8|||
164494477|NCT00448344|594179393|FG000|Overall Study|Lost to Follow-up|20|||
164494478|NCT00448344|594179394|FG001|Overall Study|Lost to Follow-up|22|||
164494479|NCT00448344|594179393|FG000|Overall Study|Withdrawal by Subject|6|||
164494480|NCT00448344|594179394|FG001|Overall Study|Withdrawal by Subject|8|||
164494481|NCT00448344|594179393|FG000|Overall Study|Death|3|||
164494482|NCT00448344|594179394|FG001|Overall Study|Death|4|||
164494483|NCT00448344|594179393|FG000|Overall Study|Physician Decision|1|||
164494484|NCT00448344|594179394|FG001|Overall Study|Physician Decision|2|||
164494485|NCT00961896|594180904|FG000|Overall Study|Abnormal laboratory value|0|||
164494486|NCT00961896|594180905|FG001|Overall Study|Abnormal laboratory value|0|||
164494487|NCT00961896|594180906|FG002|Overall Study|Abnormal laboratory value|1|||
164494488|NCT02507687|594180907|FG000|Overall Study|Adverse Event|3|||
164494489|NCT02507687|594180908|FG001|Overall Study|Adverse Event|2|||
164494490|NCT02507687|594180909|FG002|Overall Study|Adverse Event|2|||
164494491|NCT02507687|594180910|FG003|Overall Study|Adverse Event|2|||
164494492|NCT02507687|594180907|FG000|Overall Study|Withdrawal by Subject|1|||
164494493|NCT02507687|594180908|FG001|Overall Study|Withdrawal by Subject|4|||
164494494|NCT02507687|594180909|FG002|Overall Study|Withdrawal by Subject|6|||
164603786|NCT01061736|594570140|FG001|Overall Study|Other than specified above|1|||
164603787|NCT01061736|594570141|FG002|Overall Study|Other than specified above|2|||
164603788|NCT01061736|594570142|FG003|Overall Study|Other than specified above|0|||
164603789|NCT01061736|594570143|FG004|Overall Study|Other than specified above|1|||
164494495|NCT02507687|594180910|FG003|Overall Study|Withdrawal by Subject|6|||
164494496|NCT02507687|594180907|FG000|Overall Study|Protocol Violation|1|||
164494497|NCT02507687|594180908|FG001|Overall Study|Protocol Violation|0|||
164603790|NCT01061736|594570144|FG005|Overall Study|Other than specified above|0|||
164494498|NCT02507687|594180909|FG002|Overall Study|Protocol Violation|2|||
164494499|NCT02507687|594180910|FG003|Overall Study|Protocol Violation|0|||
164494500|NCT02507687|594180907|FG000|Overall Study|Lost to Follow-up|0|||
164494501|NCT02507687|594180908|FG001|Overall Study|Lost to Follow-up|0|||
164715182|NCT03104400|594980341|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
164715183|NCT03104400|594980342|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
164715184|NCT03104400|594980333|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
164715185|NCT03104400|594980334|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
164715186|NCT03104400|594980335|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
164715187|NCT03104400|594980336|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
164715188|NCT03104400|594980337|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
164715189|NCT03104400|594980338|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
164715190|NCT03104400|594980339|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
164715191|NCT03104400|594980340|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
164715192|NCT03104400|594980341|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
164715193|NCT03104400|594980342|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
164715194|NCT03104400|594980333|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
164715195|NCT03104400|594980334|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
164715196|NCT03104400|594980335|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
164715197|NCT03104400|594980336|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
164715198|NCT03104400|594980337|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
164715199|NCT03104400|594980338|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
164715200|NCT03104400|594980339|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
164715201|NCT03104400|594980340|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
164715202|NCT03104400|594980341|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
164715203|NCT03104400|594980342|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
164715204|NCT03104400|594980333|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
164715205|NCT03104400|594980334|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
164715206|NCT03104400|594980335|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
164715207|NCT03104400|594980336|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
164715208|NCT03104400|594980337|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
164715209|NCT03104400|594980338|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
164715210|NCT03104400|594980339|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
164715211|NCT03104400|594980340|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
164715212|NCT03104400|594980341|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
164715213|NCT03104400|594980342|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
164494502|NCT02507687|594180909|FG002|Overall Study|Lost to Follow-up|2|||
164494503|NCT02507687|594180910|FG003|Overall Study|Lost to Follow-up|1|||
164494504|NCT02507687|594180907|FG000|Overall Study|Screen Failure|0|||
164494505|NCT02507687|594180908|FG001|Overall Study|Screen Failure|0|||
164494506|NCT02507687|594180909|FG002|Overall Study|Screen Failure|1|||
164494507|NCT02507687|594180910|FG003|Overall Study|Screen Failure|0|||
164494508|NCT02507687|594180907|FG000|Overall Study|Other, Not Specified|0|||
164494509|NCT02507687|594180908|FG001|Overall Study|Other, Not Specified|0|||
164494510|NCT02507687|594180909|FG002|Overall Study|Other, Not Specified|2|||
164494511|NCT02507687|594180910|FG003|Overall Study|Other, Not Specified|4|||
164494512|NCT00275301|594180911|FG000|Overall Study|Adverse Event|5|||
164494513|NCT04357964|594180912|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
164494514|NCT04357964|594180913|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
164494515|NCT04357964|594180912|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
164494516|NCT04357964|594180913|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
164494517|NCT04357964|594180912|FG000|Overall Study|Adipose sample was insufficient quality|0|||
164494518|NCT04357964|594180913|FG001|Overall Study|Adipose sample was insufficient quality|1|||
164494519|NCT00733226|594180914|FG000|Overall Study|Withdrawal by Subject|1|||
164494520|NCT00733226|594180915|FG001|Overall Study|Withdrawal by Subject|0|||
164494521|NCT00733226|594180914|FG000|Overall Study|Lost to Follow-up|2|||
164494522|NCT00733226|594180915|FG001|Overall Study|Lost to Follow-up|0|||
164494523|NCT00733226|594180914|FG000|Overall Study|moved to another place|2|||
164494524|NCT00733226|594180915|FG001|Overall Study|moved to another place|0|||
164494525|NCT00848393|594180918|FG000|Overall Study|Protocol Violation|0|||
164494526|NCT00848393|594180919|FG001|Overall Study|Protocol Violation|0|||
164494527|NCT00848393|594180920|FG002|Overall Study|Protocol Violation|1|||
164494528|NCT00848393|594180918|FG000|Overall Study|surgical complications unrelated to stud|0|||
164494529|NCT00848393|594180919|FG001|Overall Study|surgical complications unrelated to stud|0|||
164494530|NCT00848393|594180920|FG002|Overall Study|surgical complications unrelated to stud|2|||
164494531|NCT00349622|594180927|FG000|Overall Study|Death|168|||
164494532|NCT00349622|594180928|FG001|Overall Study|Death|86|||
164494533|NCT00349622|594180927|FG000|Overall Study|Lost to Follow-up|5|||
164494534|NCT00349622|594180928|FG001|Overall Study|Lost to Follow-up|1|||
164494535|NCT00349622|594180927|FG000|Overall Study|Withdrawal by Subject|5|||
164494536|NCT00349622|594180928|FG001|Overall Study|Withdrawal by Subject|9|||
164494537|NCT03296566|594180931|FG000|Overall Study|Lost to Follow-up|19|||
164494538|NCT03296566|594180932|FG001|Overall Study|Lost to Follow-up|46|||
164494539|NCT03296566|594180931|FG000|Overall Study|Withdrawal by Subject|0|||
164494540|NCT03296566|594180932|FG001|Overall Study|Withdrawal by Subject|3|||
164494541|NCT03511378|594180936|FG000|Overall Study|Withdrawal by Subject|2|||
164494542|NCT03511378|594180937|FG001|Overall Study|Withdrawal by Subject|2|||
164494543|NCT03511378|594180936|FG000|Overall Study|Patient not coming or schedule visit|1|||
164494544|NCT03511378|594180937|FG001|Overall Study|Patient not coming or schedule visit|0|||
164494545|NCT01503515|594180940|FG000|Overall Study|Adverse Event|4|||
164494546|NCT01503515|594180941|FG001|Overall Study|Adverse Event|5|||
164494547|NCT01503515|594180940|FG000|Overall Study|Death|0|||
164494548|NCT01503515|594180941|FG001|Overall Study|Death|1|||
164494549|NCT01503515|594180940|FG000|Overall Study|Physician Decision|14|||
164494550|NCT01503515|594180941|FG001|Overall Study|Physician Decision|23|||
164494551|NCT01503515|594180940|FG000|Overall Study|Withdrawal by Subject|0|||
164494552|NCT01503515|594180941|FG001|Overall Study|Withdrawal by Subject|1|||
164494553|NCT01503515|594180940|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
164494554|NCT01503515|594180941|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
164494555|NCT01503515|594180940|FG000|Overall Study|Ineligible|1|||
164494556|NCT01503515|594180941|FG001|Overall Study|Ineligible|1|||
164494557|NCT00755716|594180942|FG000|Overall Study|Adverse Event|1|||
164494558|NCT00755716|594180943|FG001|Overall Study|Adverse Event|4|||
164494559|NCT00755716|594180944|FG002|Overall Study|Adverse Event|1|||
164494560|NCT00755716|594180942|FG000|Overall Study|Lack of Efficacy|2|||
164494561|NCT00755716|594180943|FG001|Overall Study|Lack of Efficacy|0|||
164494562|NCT00755716|594180944|FG002|Overall Study|Lack of Efficacy|0|||
164494563|NCT00755716|594180942|FG000|Overall Study|Lost to Follow-up|5|||
164494564|NCT00755716|594180943|FG001|Overall Study|Lost to Follow-up|3|||
164494565|NCT00755716|594180944|FG002|Overall Study|Lost to Follow-up|1|||
164494566|NCT00755716|594180942|FG000|Overall Study|work schedule issues|0|||
164494567|NCT00755716|594180943|FG001|Overall Study|work schedule issues|1|||
164494568|NCT00755716|594180944|FG002|Overall Study|work schedule issues|1|||
164494569|NCT01350102|594180945|FG000|Overall Study|Adverse Event|0|||
164494570|NCT01350102|594180946|FG001|Overall Study|Adverse Event|0|||
164494571|NCT01350102|594180947|FG002|Overall Study|Adverse Event|1|||
164494572|NCT01350102|594180948|FG003|Overall Study|Adverse Event|0|||
164494573|NCT00550771|594180950|FG000|Overall Study|Adverse Event|11|||
164494574|NCT00550771|594180951|FG001|Overall Study|Adverse Event|3|||
164494575|NCT00550771|594180950|FG000|Overall Study|Discontinued for study-related reasons|0|||
164494576|NCT00550771|594180951|FG001|Overall Study|Discontinued for study-related reasons|1|||
164494577|NCT00550771|594180950|FG000|Overall Study|Physician Decision|2|||
164494578|NCT00550771|594180951|FG001|Overall Study|Physician Decision|0|||
164494579|NCT00550771|594180950|FG000|Overall Study|Withdrawal by Subject|0|||
164494580|NCT00550771|594180951|FG001|Overall Study|Withdrawal by Subject|1|||
164494581|NCT00550771|594180950|FG000|Overall Study|Protocol Violation|4|||
164494582|NCT00550771|594180951|FG001|Overall Study|Protocol Violation|5|||
164494583|NCT02229396|594180952|FG000|Overall Study|Adverse Event|6|||
164494584|NCT02229396|594180953|FG001|Overall Study|Adverse Event|12|||
164494585|NCT02229396|594180954|FG002|Overall Study|Adverse Event|12|||
164494586|NCT02229396|594180952|FG000|Overall Study|Death|2|||
164494587|NCT02229396|594180953|FG001|Overall Study|Death|3|||
164494588|NCT02229396|594180954|FG002|Overall Study|Death|1|||
164494589|NCT02229396|594180952|FG000|Overall Study|Lost to Follow-up|14|||
164494590|NCT02229396|594180953|FG001|Overall Study|Lost to Follow-up|14|||
164494591|NCT02229396|594180954|FG002|Overall Study|Lost to Follow-up|21|||
164494592|NCT02229396|594180952|FG000|Overall Study|Protocol Violation|2|||
164494593|NCT02229396|594180953|FG001|Overall Study|Protocol Violation|1|||
164494594|NCT02229396|594180954|FG002|Overall Study|Protocol Violation|0|||
164494595|NCT02229396|594180952|FG000|Overall Study|Patient Incorrectly Randomized|0|||
164715214|NCT03104400|594980333|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
164715215|NCT03104400|594980334|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
164715216|NCT03104400|594980335|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
164494596|NCT02229396|594180953|FG001|Overall Study|Patient Incorrectly Randomized|0|||
164494597|NCT02229396|594180954|FG002|Overall Study|Patient Incorrectly Randomized|1|||
164494598|NCT02229396|594180952|FG000|Overall Study|Other|10|||
164494599|NCT02229396|594180953|FG001|Overall Study|Other|18|||
164494600|NCT02229396|594180954|FG002|Overall Study|Other|15|||
164494601|NCT02229396|594180952|FG000|Overall Study|Withdrawal by Subject|42|||
164494602|NCT02229396|594180953|FG001|Overall Study|Withdrawal by Subject|28|||
164494603|NCT02229396|594180954|FG002|Overall Study|Withdrawal by Subject|41|||
164494604|NCT02229396|594180952|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
164494605|NCT02229396|594180953|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
164494606|NCT02229396|594180954|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
164494607|NCT02229396|594180952|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
164494608|NCT02229396|594180953|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
164494609|NCT02229396|594180954|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
164494610|NCT03022578|594180960|FG000|Overall Study|Adverse Event|1|||
164494611|NCT03022578|594180960|FG000|Overall Study|Lack of Efficacy|2|||
164494612|NCT03022578|594180960|FG000|Overall Study|Withdrawal by Subject|1|||
164494613|NCT03681353|594180961|FG000|Overall Study|Lost to Follow-up|2|||
164494614|NCT03681353|594180961|FG000|Overall Study|Withdrawal by Subject|3|||
164494615|NCT03681353|594180961|FG000|Overall Study|withdrawn by PI|2|||
164494616|NCT02679079|594180964|FG000|Overall Study|Adverse Event|2|||
164494617|NCT02679079|594180965|FG001|Overall Study|Adverse Event|0|||
164494618|NCT02679079|594180966|FG002|Overall Study|Adverse Event|2|||
164494619|NCT02679079|594180964|FG000|Overall Study|Protocol Violation|0|||
164494620|NCT02679079|594180965|FG001|Overall Study|Protocol Violation|1|||
164494621|NCT02679079|594180966|FG002|Overall Study|Protocol Violation|0|||
164494622|NCT02679079|594180964|FG000|Overall Study|Withdrawal by Subject|2|||
164494623|NCT02679079|594180965|FG001|Overall Study|Withdrawal by Subject|1|||
164494624|NCT02679079|594180966|FG002|Overall Study|Withdrawal by Subject|0|||
164494625|NCT00520403|594180967|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
164494626|NCT00520403|594180967|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
164494627|NCT00520403|594180967|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
164494628|NCT00520403|594180967|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
164494629|NCT00520403|594180967|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
164494630|NCT00520403|594180967|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
164494631|NCT00520403|594180967|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
164494632|NCT00520403|594180967|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
164715217|NCT03104400|594980336|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
164715218|NCT03104400|594980337|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
164494633|NCT00805285|594180970|FG000|Overall Study|Lack of Efficacy|1|||
164494634|NCT00839306|594180974|FG000|Overall Study|Adverse Event|3|||
164494635|NCT00839306|594180975|FG001|Overall Study|Adverse Event|5|||
164494636|NCT00839306|594180974|FG000|Overall Study|Lost to Follow-up|6|||
164494637|NCT00839306|594180975|FG001|Overall Study|Lost to Follow-up|9|||
164494638|NCT00839306|594180974|FG000|Overall Study|Withdrawal by Subject|5|||
164494639|NCT00839306|594180975|FG001|Overall Study|Withdrawal by Subject|7|||
164494640|NCT00839306|594180974|FG000|Overall Study|Lack of Efficacy|5|||
164494641|NCT00839306|594180975|FG001|Overall Study|Lack of Efficacy|4|||
164494642|NCT00839306|594180974|FG000|Overall Study|Other|6|||
164494643|NCT00839306|594180975|FG001|Overall Study|Other|18|||
164494644|NCT01812707|594180976|FG000|Overall Study|Adverse Event|0|||
164494645|NCT01812707|594180977|FG001|Overall Study|Adverse Event|0|||
164494646|NCT01812707|594180978|FG002|Overall Study|Adverse Event|0|||
164494647|NCT01812707|594180979|FG003|Overall Study|Adverse Event|2|||
164494648|NCT01812707|594180976|FG000|Overall Study|Poor compliance to protocol|1|||
164494649|NCT01812707|594180977|FG001|Overall Study|Poor compliance to protocol|0|||
164494650|NCT01812707|594180978|FG002|Overall Study|Poor compliance to protocol|0|||
164494651|NCT01812707|594180979|FG003|Overall Study|Poor compliance to protocol|0|||
164494652|NCT01812707|594180976|FG000|Overall Study|Consent withdrawn by participant|1|||
164494653|NCT01812707|594180977|FG001|Overall Study|Consent withdrawn by participant|0|||
164494654|NCT01812707|594180978|FG002|Overall Study|Consent withdrawn by participant|0|||
164494655|NCT01812707|594180979|FG003|Overall Study|Consent withdrawn by participant|0|||
164494656|NCT05060237|594180981|FG000|Overall Study|Withdrawal by Subject|4|||
164494657|NCT05060237|594180981|FG000|Overall Study|Screening failure|8|||
164494658|NCT01066897|594180982|FG000|Overall Study|Withdrawal by Subject|1|||
164494659|NCT01066897|594180983|FG001|Overall Study|Withdrawal by Subject|0|||
164494660|NCT01066897|594180982|FG000|Overall Study|stopped study after developing the flu.|1|||
164494661|NCT01066897|594180983|FG001|Overall Study|stopped study after developing the flu.|0|||
164494662|NCT01697592|594180986|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
164494663|NCT01697592|594180987|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
164494664|NCT01697592|594180988|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
164494665|NCT01697592|594180989|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
164494666|NCT01697592|594180990|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
164494667|NCT01697592|594180991|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
164494668|NCT01697592|594180992|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
164494669|NCT01697592|594180993|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
164494670|NCT01697592|594180994|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
164494671|NCT01697592|594180995|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
164494672|NCT01697592|594180986|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
164494673|NCT01697592|594180987|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
164494674|NCT01697592|594180988|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
164494675|NCT01697592|594180989|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
164494676|NCT01697592|594180990|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
164494677|NCT01697592|594180991|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
164494678|NCT01697592|594180992|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
164494679|NCT01697592|594180993|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
164494680|NCT01697592|594180994|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
164494681|NCT01697592|594180995|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
164715219|NCT03104400|594980338|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
164715220|NCT03104400|594980339|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
164715221|NCT03104400|594980340|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
164715222|NCT03104400|594980341|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
164715223|NCT03104400|594980342|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
164715224|NCT03104400|594980333|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
164715225|NCT03104400|594980334|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
164715226|NCT03104400|594980335|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
164715227|NCT03104400|594980336|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
164715228|NCT03104400|594980337|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
164715229|NCT03104400|594980338|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
164715230|NCT03104400|594980339|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
164715231|NCT03104400|594980340|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
164715232|NCT03104400|594980341|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
164715233|NCT03104400|594980342|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
164715234|NCT03104400|594980333|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
164715235|NCT03104400|594980334|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
164715236|NCT03104400|594980335|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
164715237|NCT03104400|594980336|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
164715238|NCT03104400|594980337|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
164715239|NCT03104400|594980338|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
164715240|NCT03104400|594980339|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
164715241|NCT03104400|594980340|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
164715242|NCT03104400|594980341|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
164715243|NCT03104400|594980342|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
164715244|NCT03104400|594980333|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
164715245|NCT03104400|594980334|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
164715246|NCT03104400|594980335|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
164715247|NCT03104400|594980336|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
164715248|NCT03104400|594980337|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
164715249|NCT03104400|594980338|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
164715250|NCT03104400|594980339|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
164715251|NCT03104400|594980340|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
164715252|NCT03104400|594980341|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
164715253|NCT03104400|594980342|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
164715254|NCT03104400|594980333|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
164715255|NCT03104400|594980334|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
164715256|NCT03104400|594980335|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
164715257|NCT03104400|594980336|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
164715258|NCT03104400|594980337|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
164715259|NCT03104400|594980338|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
164715260|NCT03104400|594980339|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
164715261|NCT03104400|594980340|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
164715262|NCT03104400|594980341|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
164494682|NCT01697592|594180986|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
164494683|NCT01697592|594180987|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
164494684|NCT01697592|594180988|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
164494685|NCT01697592|594180989|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
164494686|NCT01697592|594180990|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
164715263|NCT03104400|594980342|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
164715264|NCT03104400|594980333|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
164715265|NCT03104400|594980334|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
164715266|NCT03104400|594980335|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
164715267|NCT03104400|594980336|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
164715268|NCT03104400|594980337|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
164715269|NCT03104400|594980338|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
164715270|NCT03104400|594980339|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
164715271|NCT03104400|594980340|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
164715272|NCT03104400|594980341|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
164715273|NCT03104400|594980342|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
164715274|NCT03104400|594980333|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
164715275|NCT03104400|594980334|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
164715276|NCT03104400|594980335|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
164715277|NCT03104400|594980336|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
164715278|NCT03104400|594980337|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
164715279|NCT03104400|594980338|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
164715280|NCT03104400|594980339|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
164715281|NCT03104400|594980340|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
164715282|NCT03104400|594980341|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
164715283|NCT03104400|594980342|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
164715284|NCT03104400|594980333|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
164715285|NCT03104400|594980334|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
164715286|NCT03104400|594980335|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
164494687|NCT01697592|594180991|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
164494688|NCT01697592|594180992|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
164494689|NCT01697592|594180993|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
164494690|NCT01697592|594180994|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
164494691|NCT01697592|594180995|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
164494692|NCT01697592|594180986|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
164494693|NCT01697592|594180987|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
164494694|NCT01697592|594180988|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
164494695|NCT01697592|594180989|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
164494696|NCT01697592|594180990|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
164494697|NCT01697592|594180991|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
164494698|NCT01697592|594180992|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
164494699|NCT01697592|594180993|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
164494700|NCT01697592|594180994|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
164494701|NCT01697592|594180995|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
164494702|NCT01697592|594180986|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
164494703|NCT01697592|594180987|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
164494704|NCT01697592|594180988|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
164494705|NCT01697592|594180989|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
164494706|NCT01697592|594180990|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
164494707|NCT01697592|594180991|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
164494708|NCT01697592|594180992|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
164494709|NCT01697592|594180993|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
164494710|NCT01697592|594180994|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
164494711|NCT01697592|594180995|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
164494712|NCT01697592|594180986|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
164494713|NCT01697592|594180987|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
164494714|NCT01697592|594180988|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
164494715|NCT01697592|594180989|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
164494716|NCT01697592|594180990|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
164494717|NCT01697592|594180991|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
164494718|NCT01697592|594180992|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
164494719|NCT01697592|594180993|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
164494720|NCT01697592|594180994|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
164494721|NCT01697592|594180995|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
164494722|NCT01697592|594180986|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
164494723|NCT01697592|594180987|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
164494724|NCT01697592|594180988|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
164494725|NCT01697592|594180989|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
164494726|NCT01697592|594180990|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
164494727|NCT01697592|594180991|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
164494728|NCT01697592|594180992|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
164494729|NCT01697592|594180993|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
164494730|NCT01697592|594180994|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
164494731|NCT01697592|594180995|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
164494732|NCT01697592|594180986|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
164494733|NCT01697592|594180987|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
164494734|NCT01697592|594180988|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
164494735|NCT01697592|594180989|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
164494736|NCT01697592|594180990|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
164494737|NCT01697592|594180991|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
164494738|NCT01697592|594180992|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
164494739|NCT01697592|594180993|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
164494740|NCT01697592|594180994|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
164494741|NCT01697592|594180995|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
164494742|NCT02396758|594180996|FG000|Overall Study|Withdrawal by Subject|2|||
164494743|NCT02396758|594180997|FG001|Overall Study|Withdrawal by Subject|0|||
164494744|NCT02396758|594180998|FG002|Overall Study|Withdrawal by Subject|0|||
164494745|NCT02396758|594180999|FG003|Overall Study|Withdrawal by Subject|1|||
164494746|NCT02396758|594180996|FG000|Overall Study|Lost to Follow-up|8|||
164494747|NCT02396758|594180997|FG001|Overall Study|Lost to Follow-up|5|||
164494748|NCT02396758|594180998|FG002|Overall Study|Lost to Follow-up|3|||
164494749|NCT02396758|594180999|FG003|Overall Study|Lost to Follow-up|3|||
164494750|NCT02396758|594180996|FG000|Overall Study|Death|1|||
164494751|NCT02396758|594180997|FG001|Overall Study|Death|1|||
164494752|NCT02396758|594180998|FG002|Overall Study|Death|0|||
164494753|NCT02396758|594180999|FG003|Overall Study|Death|1|||
164494754|NCT02396758|594180996|FG000|Overall Study|Randomized but not treated|1|||
164494755|NCT02396758|594180997|FG001|Overall Study|Randomized but not treated|0|||
164494756|NCT02396758|594180998|FG002|Overall Study|Randomized but not treated|1|||
164494757|NCT02396758|594180999|FG003|Overall Study|Randomized but not treated|0|||
164494758|NCT01631825|594181000|FG000|Overall Study|Adverse Event|42|||
164494759|NCT01631825|594181000|FG000|Overall Study|Lack of Efficacy|7|||
164494760|NCT01631825|594181000|FG000|Overall Study|Withdrawal by Subject|9|||
164494761|NCT01631825|594181000|FG000|Overall Study|Protocol Violation|4|||
164494762|NCT01631825|594181000|FG000|Overall Study|Discontinuation criteria|1|||
164494763|NCT01631825|594181000|FG000|Overall Study|Physician Decision|2|||
164494764|NCT02110225|594181001|FG000|Overall Study|Lost to Follow-up|0|||
164494765|NCT02110225|594181002|FG001|Overall Study|Lost to Follow-up|1|||
164494766|NCT02110225|594181003|FG002|Overall Study|Lost to Follow-up|0|||
164494767|NCT00265096|594181004|FG000|Overall Study|Adverse Event|14|||
164494768|NCT00265096|594181005|FG001|Overall Study|Adverse Event|18|||
164494769|NCT00265096|594181006|FG002|Overall Study|Adverse Event|18|||
164494770|NCT00265096|594181004|FG000|Overall Study|Lost to Follow-up|2|||
164494771|NCT00265096|594181005|FG001|Overall Study|Lost to Follow-up|5|||
164494772|NCT00265096|594181006|FG002|Overall Study|Lost to Follow-up|3|||
164494773|NCT00265096|594181004|FG000|Overall Study|Death|0|||
164494774|NCT00265096|594181005|FG001|Overall Study|Death|1|||
164494775|NCT00265096|594181006|FG002|Overall Study|Death|2|||
164494776|NCT00265096|594181004|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
164494777|NCT00265096|594181005|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
164494778|NCT00265096|594181006|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
164494779|NCT00265096|594181004|FG000|Overall Study|Other|11|||
164494780|NCT00265096|594181005|FG001|Overall Study|Other|19|||
164494781|NCT00265096|594181006|FG002|Overall Study|Other|10|||
164494782|NCT00774306|594181007|FG000|Overall Study|Adverse Event|3|||
164494783|NCT00774306|594181008|FG001|Overall Study|Adverse Event|0|||
164494784|NCT00774306|594181009|FG002|Overall Study|Adverse Event|0|||
164494785|NCT00774306|594181010|FG003|Overall Study|Adverse Event|0|||
164494786|NCT00774306|594181007|FG000|Overall Study|Protocol Violation|2|||
164494787|NCT00774306|594181008|FG001|Overall Study|Protocol Violation|0|||
164494788|NCT00774306|594181009|FG002|Overall Study|Protocol Violation|3|||
164494789|NCT00774306|594181010|FG003|Overall Study|Protocol Violation|0|||
164494790|NCT00774306|594181007|FG000|Overall Study|Withdrawal by Subject|6|||
164494791|NCT00774306|594181008|FG001|Overall Study|Withdrawal by Subject|1|||
164494792|NCT00774306|594181009|FG002|Overall Study|Withdrawal by Subject|1|||
164494793|NCT00774306|594181010|FG003|Overall Study|Withdrawal by Subject|0|||
164494794|NCT00774306|594181007|FG000|Overall Study|Lost to Follow-up|6|||
164494795|NCT00774306|594181008|FG001|Overall Study|Lost to Follow-up|0|||
164494796|NCT00774306|594181009|FG002|Overall Study|Lost to Follow-up|4|||
164494797|NCT00774306|594181010|FG003|Overall Study|Lost to Follow-up|5|||
164494798|NCT00774306|594181007|FG000|Overall Study|Death|1|||
164494799|NCT00774306|594181008|FG001|Overall Study|Death|1|||
164494800|NCT00774306|594181009|FG002|Overall Study|Death|0|||
164494801|NCT00774306|594181010|FG003|Overall Study|Death|0|||
164494802|NCT03568708|594181014|FG000|Overall Study|Withdrawal by Subject|1|||
164494803|NCT03568708|594181015|FG001|Overall Study|Withdrawal by Subject|1|||
164494804|NCT03568708|594181014|FG000|Overall Study|Lost to Follow-up|0|||
164494805|NCT03568708|594181015|FG001|Overall Study|Lost to Follow-up|1|||
164494806|NCT00666835|594181016|FG000|Overall Study|Withdrawal by Subject|5|||
164494807|NCT00666835|594181017|FG001|Overall Study|Withdrawal by Subject|2|||
164494808|NCT00666835|594181016|FG000|Overall Study|Lack of Efficacy|0|||
164494809|NCT00666835|594181017|FG001|Overall Study|Lack of Efficacy|1|||
164494810|NCT00666835|594181016|FG000|Overall Study|Incl./excl. not fulfilled|7|||
164494811|NCT00666835|594181017|FG001|Overall Study|Incl./excl. not fulfilled|2|||
164494812|NCT00666835|594181016|FG000|Overall Study|Adverse Event|7|||
164494813|NCT00666835|594181017|FG001|Overall Study|Adverse Event|6|||
164494814|NCT00666835|594181016|FG000|Overall Study|Protocol Violation|2|||
164494815|NCT00666835|594181017|FG001|Overall Study|Protocol Violation|0|||
164494816|NCT00666835|594181016|FG000|Overall Study|Death|15|||
164494817|NCT00666835|594181017|FG001|Overall Study|Death|4|||
164715287|NCT03104400|594980336|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
164715288|NCT03104400|594980337|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
164715289|NCT03104400|594980338|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
164715290|NCT03104400|594980339|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
164494818|NCT00666835|594181016|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
164494819|NCT00666835|594181017|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
164494820|NCT00666835|594181016|FG000|Overall Study|Hemoglobulin concentration|4|||
164494821|NCT00666835|594181017|FG001|Overall Study|Hemoglobulin concentration|3|||
164494822|NCT00666835|594181016|FG000|Overall Study|Planned operation|2|||
164494823|NCT00666835|594181017|FG001|Overall Study|Planned operation|0|||
164494824|NCT00666835|594181016|FG000|Overall Study|Physician Decision|1|||
164494825|NCT00666835|594181017|FG001|Overall Study|Physician Decision|2|||
164494826|NCT00511147|594181018|FG000|Overall Study|Withdrawal by Subject|1|||
164494827|NCT00511147|594181018|FG000|Overall Study|Disease progression|5|||
164494828|NCT00511147|594181018|FG000|Overall Study|Required platelet transfusion|1|||
164494829|NCT00899379|594181019|FG000|Overall Study|Adverse Event|2|||
164494830|NCT00899379|594181020|FG001|Overall Study|Adverse Event|2|||
164494831|NCT00899379|594181021|FG002|Overall Study|Adverse Event|1|||
164494832|NCT00899379|594181022|FG003|Overall Study|Adverse Event|1|||
164494833|NCT00899379|594181023|FG004|Overall Study|Adverse Event|2|||
164494834|NCT00899379|594181019|FG000|Overall Study|Lack of Efficacy|0|||
164494835|NCT00899379|594181020|FG001|Overall Study|Lack of Efficacy|4|||
164494836|NCT00899379|594181021|FG002|Overall Study|Lack of Efficacy|3|||
164494837|NCT00899379|594181022|FG003|Overall Study|Lack of Efficacy|0|||
164494838|NCT00899379|594181023|FG004|Overall Study|Lack of Efficacy|1|||
164494839|NCT00899379|594181019|FG000|Overall Study|Lost to Follow-up|9|||
164494840|NCT00899379|594181020|FG001|Overall Study|Lost to Follow-up|3|||
164494841|NCT00899379|594181021|FG002|Overall Study|Lost to Follow-up|0|||
164494842|NCT00899379|594181022|FG003|Overall Study|Lost to Follow-up|6|||
164494843|NCT00899379|594181023|FG004|Overall Study|Lost to Follow-up|2|||
164494844|NCT00899379|594181019|FG000|Overall Study|Protocol Violation|0|||
164494845|NCT00899379|594181020|FG001|Overall Study|Protocol Violation|0|||
164494846|NCT00899379|594181021|FG002|Overall Study|Protocol Violation|1|||
164494847|NCT00899379|594181022|FG003|Overall Study|Protocol Violation|1|||
164494848|NCT00899379|594181023|FG004|Overall Study|Protocol Violation|0|||
164494849|NCT00899379|594181019|FG000|Overall Study|Withdrawal by Subject|2|||
164494850|NCT00899379|594181020|FG001|Overall Study|Withdrawal by Subject|4|||
164494851|NCT00899379|594181021|FG002|Overall Study|Withdrawal by Subject|2|||
164494852|NCT00899379|594181022|FG003|Overall Study|Withdrawal by Subject|3|||
164494853|NCT00899379|594181023|FG004|Overall Study|Withdrawal by Subject|6|||
164494854|NCT00899379|594181019|FG000|Overall Study|Pregnancy|0|||
164494855|NCT00899379|594181020|FG001|Overall Study|Pregnancy|0|||
164494856|NCT00899379|594181021|FG002|Overall Study|Pregnancy|1|||
164494857|NCT00899379|594181022|FG003|Overall Study|Pregnancy|0|||
164494858|NCT00899379|594181023|FG004|Overall Study|Pregnancy|1|||
164494859|NCT00899379|594181019|FG000|Overall Study|Patient Uncooperative|0|||
164494860|NCT00899379|594181020|FG001|Overall Study|Patient Uncooperative|1|||
164494861|NCT00899379|594181021|FG002|Overall Study|Patient Uncooperative|0|||
164494862|NCT00899379|594181022|FG003|Overall Study|Patient Uncooperative|1|||
164494863|NCT00899379|594181023|FG004|Overall Study|Patient Uncooperative|2|||
164494864|NCT00899379|594181019|FG000|Overall Study|Abnormal Baseline ECG|0|||
164494865|NCT00899379|594181020|FG001|Overall Study|Abnormal Baseline ECG|0|||
164494866|NCT00899379|594181021|FG002|Overall Study|Abnormal Baseline ECG|0|||
164494867|NCT00899379|594181022|FG003|Overall Study|Abnormal Baseline ECG|1|||
164494868|NCT00899379|594181023|FG004|Overall Study|Abnormal Baseline ECG|0|||
164494869|NCT00899379|594181019|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
164494870|NCT00899379|594181020|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
164494871|NCT00899379|594181021|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
164494872|NCT00899379|594181022|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
164494873|NCT00899379|594181023|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
164494874|NCT00899379|594181019|FG000|Overall Study|Not Completed/Entered Extn|5|||
164494875|NCT00899379|594181020|FG001|Overall Study|Not Completed/Entered Extn|1|||
164494876|NCT00899379|594181021|FG002|Overall Study|Not Completed/Entered Extn|6|||
164494877|NCT00899379|594181022|FG003|Overall Study|Not Completed/Entered Extn|4|||
164494878|NCT00899379|594181023|FG004|Overall Study|Not Completed/Entered Extn|3|||
164494879|NCT00899379|594181019|FG000|Overall Study|Study Terminated|3|||
164494880|NCT00899379|594181020|FG001|Overall Study|Study Terminated|0|||
164494881|NCT00899379|594181021|FG002|Overall Study|Study Terminated|3|||
164494882|NCT00899379|594181022|FG003|Overall Study|Study Terminated|3|||
164494883|NCT00899379|594181023|FG004|Overall Study|Study Terminated|1|||
164494884|NCT00899379|594181019|FG000|Overall Study|Lost to Follow-up|3|||
164494885|NCT00899379|594181020|FG001|Overall Study|Lost to Follow-up|1|||
164494886|NCT00899379|594181021|FG002|Overall Study|Lost to Follow-up|0|||
164494887|NCT00899379|594181022|FG003|Overall Study|Lost to Follow-up|2|||
164494888|NCT00899379|594181023|FG004|Overall Study|Lost to Follow-up|5|||
164494889|NCT00899379|594181019|FG000|Overall Study|Withdrawal by Subject|4|||
164494890|NCT00899379|594181020|FG001|Overall Study|Withdrawal by Subject|7|||
164494891|NCT00899379|594181021|FG002|Overall Study|Withdrawal by Subject|4|||
164494892|NCT00899379|594181022|FG003|Overall Study|Withdrawal by Subject|7|||
164494893|NCT00899379|594181023|FG004|Overall Study|Withdrawal by Subject|2|||
164494894|NCT00899379|594181019|FG000|Overall Study|Pregnancy|1|||
164494895|NCT00899379|594181020|FG001|Overall Study|Pregnancy|0|||
164494896|NCT00899379|594181021|FG002|Overall Study|Pregnancy|0|||
164494897|NCT00899379|594181022|FG003|Overall Study|Pregnancy|0|||
164494898|NCT00899379|594181023|FG004|Overall Study|Pregnancy|0|||
164494899|NCT00899379|594181019|FG000|Overall Study|Patient Uncooperative|0|||
164494900|NCT00899379|594181020|FG001|Overall Study|Patient Uncooperative|0|||
164494901|NCT00899379|594181021|FG002|Overall Study|Patient Uncooperative|0|||
164494902|NCT00899379|594181022|FG003|Overall Study|Patient Uncooperative|1|||
164494903|NCT00899379|594181023|FG004|Overall Study|Patient Uncooperative|0|||
164494904|NCT00899379|594181019|FG000|Overall Study|Abnormal Prestudy Labs|0|||
164494905|NCT00899379|594181020|FG001|Overall Study|Abnormal Prestudy Labs|0|||
164494906|NCT00899379|594181021|FG002|Overall Study|Abnormal Prestudy Labs|0|||
164494907|NCT00899379|594181022|FG003|Overall Study|Abnormal Prestudy Labs|0|||
164494908|NCT00899379|594181023|FG004|Overall Study|Abnormal Prestudy Labs|2|||
164494909|NCT00899379|594181019|FG000|Overall Study|Abnormal Baseline ECG|0|||
164494910|NCT00899379|594181020|FG001|Overall Study|Abnormal Baseline ECG|0|||
164494911|NCT00899379|594181021|FG002|Overall Study|Abnormal Baseline ECG|1|||
164494912|NCT00899379|594181022|FG003|Overall Study|Abnormal Baseline ECG|1|||
164494913|NCT00899379|594181023|FG004|Overall Study|Abnormal Baseline ECG|0|||
164494914|NCT00899379|594181019|FG000|Overall Study|No Attack Pretreatment|3|||
164494915|NCT00899379|594181020|FG001|Overall Study|No Attack Pretreatment|5|||
164494916|NCT00899379|594181021|FG002|Overall Study|No Attack Pretreatment|5|||
164494917|NCT00899379|594181022|FG003|Overall Study|No Attack Pretreatment|6|||
164494918|NCT00899379|594181023|FG004|Overall Study|No Attack Pretreatment|4|||
164494919|NCT00899379|594181019|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
164494920|NCT00899379|594181020|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
164494921|NCT00899379|594181021|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
164494922|NCT00899379|594181022|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
164494923|NCT00899379|594181023|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
164494924|NCT00899379|594181019|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
164494925|NCT00899379|594181020|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
164494926|NCT00899379|594181021|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
164494927|NCT00899379|594181022|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
164494928|NCT00899379|594181023|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
164494929|NCT00809783|594181024|FG000|Overall Study|Death|1|||
164494930|NCT00809783|594181025|FG001|Overall Study|Death|0|||
164494931|NCT00809783|594181026|FG002|Overall Study|Death|0|||
164494932|NCT00809783|594181024|FG000|Overall Study|Adverse Event|34|||
164494933|NCT00809783|594181025|FG001|Overall Study|Adverse Event|52|||
164494934|NCT00809783|594181026|FG002|Overall Study|Adverse Event|71|||
164494935|NCT00809783|594181024|FG000|Overall Study|Lack of Efficacy|39|||
164494936|NCT00809783|594181025|FG001|Overall Study|Lack of Efficacy|52|||
164494937|NCT00809783|594181026|FG002|Overall Study|Lack of Efficacy|63|||
164494938|NCT00809783|594181024|FG000|Overall Study|Lost to Follow-up|0|||
164494939|NCT00809783|594181025|FG001|Overall Study|Lost to Follow-up|3|||
164494940|NCT00809783|594181026|FG002|Overall Study|Lost to Follow-up|4|||
164494941|NCT00809783|594181024|FG000|Overall Study|Withdrawal by Subject|47|||
164494942|NCT00809783|594181025|FG001|Overall Study|Withdrawal by Subject|72|||
164494943|NCT00809783|594181026|FG002|Overall Study|Withdrawal by Subject|64|||
164494944|NCT00809783|594181024|FG000|Overall Study|Protocol Violation|2|||
164494945|NCT00809783|594181025|FG001|Overall Study|Protocol Violation|6|||
164494946|NCT00809783|594181026|FG002|Overall Study|Protocol Violation|5|||
164494947|NCT00809783|594181024|FG000|Overall Study|Randomized, but not treated|3|||
164494948|NCT00809783|594181025|FG001|Overall Study|Randomized, but not treated|0|||
164494949|NCT00809783|594181026|FG002|Overall Study|Randomized, but not treated|2|||
164494950|NCT00809783|594181024|FG000|Overall Study|Study Terminated by Sponsor|378|||
164494951|NCT00809783|594181025|FG001|Overall Study|Study Terminated by Sponsor|626|||
164494952|NCT00809783|594181026|FG002|Overall Study|Study Terminated by Sponsor|565|||
164494953|NCT00809783|594181024|FG000|Overall Study|Other|21|||
164494954|NCT00809783|594181025|FG001|Overall Study|Other|21|||
164494955|NCT00809783|594181026|FG002|Overall Study|Other|16|||
164494956|NCT00126555|594181027|FG000|Overall Study|Withdrawal by Subject|1|||
164494957|NCT00126555|594181027|FG000|Overall Study|Adverse Event|2|||
164494958|NCT00126555|594181027|FG000|Overall Study|Progressive Disease|3|||
164494959|NCT02254681|594181044|FG000|Overall Study|Lack of Efficacy|6|||
164494960|NCT00396097|594181045|FG000|Overall Study|Withdrawal by Subject|17|||
164494961|NCT00396097|594181046|FG001|Overall Study|Withdrawal by Subject|17|||
164494962|NCT00396097|594181045|FG000|Overall Study|Lost to Follow-up|4|||
164494963|NCT00396097|594181046|FG001|Overall Study|Lost to Follow-up|9|||
164494964|NCT00396097|594181045|FG000|Overall Study|Other|3|||
164494965|NCT00396097|594181046|FG001|Overall Study|Other|5|||
164494966|NCT00396097|594181045|FG000|Overall Study|Protocol Violation|0|||
164494967|NCT00396097|594181046|FG001|Overall Study|Protocol Violation|6|||
164494968|NCT00396097|594181045|FG000|Overall Study|Adverse Event|1|||
164494969|NCT00396097|594181046|FG001|Overall Study|Adverse Event|5|||
164494970|NCT00396097|594181045|FG000|Overall Study|Insufficient Clinical Response|1|||
164494971|NCT00396097|594181046|FG001|Overall Study|Insufficient Clinical Response|4|||
164494972|NCT03461211|594181047|FG000|Overall Study|Adverse Event|1|||
164494973|NCT03461211|594181048|FG001|Overall Study|Adverse Event|1|||
164494974|NCT03461211|594181047|FG000|Overall Study|Lack of Efficacy|0|||
164494975|NCT03461211|594181048|FG001|Overall Study|Lack of Efficacy|1|||
164494976|NCT02316847|594181050|FG000|Overall Study|Adverse Event|0|||
164494977|NCT02316847|594181051|FG001|Overall Study|Adverse Event|3|||
164494978|NCT02316847|594181050|FG000|Overall Study|Lost to Follow-up|0|||
164494979|NCT02316847|594181051|FG001|Overall Study|Lost to Follow-up|2|||
164494980|NCT02316847|594181050|FG000|Overall Study|Physician Decision|0|||
164494981|NCT02316847|594181051|FG001|Overall Study|Physician Decision|1|||
164494982|NCT02316847|594181050|FG000|Overall Study|Pregnancy|0|||
164494983|NCT02316847|594181051|FG001|Overall Study|Pregnancy|1|||
164494984|NCT02316847|594181050|FG000|Overall Study|Withdrawal by Subject|2|||
164603791|NCT01061736|594570145|FG006|Overall Study|Other than specified above|0|||
164603792|NCT01061736|594570146|FG007|Overall Study|Other than specified above|18|||
164603793|NCT01061736|594570147|FG008|Overall Study|Other than specified above|15|||
164603794|NCT01061736|594570148|FG009|Overall Study|Other than specified above|21|||
164603795|NCT01925612|594570149|FG000|Overall Study|Progressive Disease|1|||
164603796|NCT01925612|594570150|FG001|Overall Study|Progressive Disease|1|||
164494985|NCT02316847|594181051|FG001|Overall Study|Withdrawal by Subject|9|||
164494986|NCT02316847|594181050|FG000|Overall Study|Noncompliance with study drug|0|||
164494987|NCT02316847|594181051|FG001|Overall Study|Noncompliance with study drug|3|||
164494988|NCT02316847|594181050|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
164494989|NCT02316847|594181051|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
164494990|NCT01370018|594181052|FG000|Overall Study|Did not meet criteria for analysis|1|||
164494991|NCT01525641|594181053|FG000|Overall Study|Case report form not collected|25|||
164494992|NCT01525641|594181053|FG000|Overall Study|No visit since the first visit|16|||
164494993|NCT01525641|594181053|FG000|Overall Study|Adverse Event|73|||
164494994|NCT01525641|594181053|FG000|Overall Study|Lack of Efficacy|24|||
164494995|NCT01525641|594181053|FG000|Overall Study|Improvement|5|||
164494996|NCT01525641|594181053|FG000|Overall Study|Lost to follow-up (relocation)|1|||
164494997|NCT01525641|594181053|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
164494998|NCT01525641|594181053|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
164494999|NCT01525641|594181053|FG000|Overall Study|Other than stated above|7|||
164495000|NCT02204319|594181058|FG000|Overall Study|Pregnancy|1|||
164495001|NCT02204319|594181058|FG000|Overall Study|Withdrawal by Subject|2|||
164495002|NCT00714688|594181060|FG000|Overall Study|Lack of Efficacy|14|||
164495003|NCT00714688|594181061|FG001|Overall Study|Lack of Efficacy|1|||
164495004|NCT00714688|594181062|FG002|Overall Study|Lack of Efficacy|4|||
164495005|NCT00714688|594181060|FG000|Overall Study|Withdrawal by Subject|4|||
164495006|NCT00714688|594181061|FG001|Overall Study|Withdrawal by Subject|3|||
164495007|NCT00714688|594181062|FG002|Overall Study|Withdrawal by Subject|3|||
164495008|NCT00714688|594181060|FG000|Overall Study|Lost to Follow-up|5|||
164495009|NCT00714688|594181061|FG001|Overall Study|Lost to Follow-up|2|||
164495010|NCT00714688|594181062|FG002|Overall Study|Lost to Follow-up|0|||
164495011|NCT00714688|594181060|FG000|Overall Study|Adverse Event|2|||
164495012|NCT00714688|594181061|FG001|Overall Study|Adverse Event|15|||
164495013|NCT00714688|594181062|FG002|Overall Study|Adverse Event|19|||
164495014|NCT00714688|594181060|FG000|Overall Study|Subject Non-compliant|3|||
164495015|NCT00714688|594181061|FG001|Overall Study|Subject Non-compliant|5|||
164495016|NCT00714688|594181062|FG002|Overall Study|Subject Non-compliant|5|||
164495017|NCT00714688|594181060|FG000|Overall Study|Ineligible to Continue the Study|0|||
164495018|NCT00714688|594181061|FG001|Overall Study|Ineligible to Continue the Study|1|||
164495019|NCT00714688|594181062|FG002|Overall Study|Ineligible to Continue the Study|1|||
164495020|NCT00714688|594181060|FG000|Overall Study|Sponsor's Decision|0|||
164495021|NCT00714688|594181061|FG001|Overall Study|Sponsor's Decision|2|||
164495022|NCT00714688|594181062|FG002|Overall Study|Sponsor's Decision|0|||
164495023|NCT00714688|594181060|FG000|Overall Study|Other|1|||
164495024|NCT00714688|594181061|FG001|Overall Study|Other|6|||
164495025|NCT00714688|594181062|FG002|Overall Study|Other|5|||
164495026|NCT01786551|594181063|FG000|Overall Study|Participant withdrew consent|2|||
164495027|NCT03993054|594181064|FG000|Overall Study|PI Decision|1|||
164495028|NCT01983462|594182942|FG000|Overall Study|Adverse Event|1|||
164495029|NCT01983462|594182943|FG001|Overall Study|Adverse Event|0|||
164495030|NCT01983462|594182944|FG002|Overall Study|Adverse Event|0|||
164495031|NCT01902381|594182945|FG000|Overall Study|Withdrawal by Subject|1|||
164495032|NCT00730847|594182948|FG000|Overall Study|Adverse Event|1|||
164495033|NCT00730847|594182948|FG000|Overall Study|Protocol Violation|2|||
164495034|NCT00730847|594182948|FG000|Overall Study|Withdrawal by Subject|16|||
164495035|NCT00730847|594182948|FG000|Overall Study|Lost to Follow-up|67|||
164495036|NCT00730847|594182948|FG000|Overall Study|Unknown completion status|21|||
164495037|NCT00730847|594182948|FG000|Overall Study|Other|24|||
164495038|NCT00280683|594182949|FG000|Overall Study|Withdrawal by Subject|1|||
164495039|NCT00280683|594182950|FG001|Overall Study|Withdrawal by Subject|2|||
164495040|NCT00280683|594182949|FG000|Overall Study|Adverse Event|1|||
164495041|NCT00280683|594182950|FG001|Overall Study|Adverse Event|1|||
164495042|NCT01243411|594182951|FG000|Overall Study|Withdrawal by Subject|18|||
164495043|NCT01243411|594182951|FG000|Overall Study|Lost to Follow-up|10|||
164495044|NCT01243411|594182951|FG000|Overall Study|Adverse Event|5|||
164495045|NCT01243411|594182951|FG000|Overall Study|Other|8|||
164495046|NCT00488319|594182952|FG000|Overall Study|Adverse Event|1|||
164495047|NCT00488319|594182953|FG001|Overall Study|Adverse Event|2|||
164495048|NCT00488319|594182954|FG002|Overall Study|Adverse Event|23|||
164495049|NCT00488319|594182952|FG000|Overall Study|Lack of Efficacy|6|||
164715291|NCT03104400|594980340|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
164715292|NCT03104400|594980341|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
164715293|NCT03104400|594980342|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
164715294|NCT03104400|594980333|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
164495050|NCT00488319|594182953|FG001|Overall Study|Lack of Efficacy|12|||
164495051|NCT00488319|594182954|FG002|Overall Study|Lack of Efficacy|27|||
164495052|NCT00488319|594182952|FG000|Overall Study|Lost to Follow-up|3|||
164495053|NCT00488319|594182953|FG001|Overall Study|Lost to Follow-up|5|||
164495054|NCT00488319|594182954|FG002|Overall Study|Lost to Follow-up|16|||
164495055|NCT00488319|594182952|FG000|Overall Study|Withdrawal by Subject|5|||
164495056|NCT00488319|594182953|FG001|Overall Study|Withdrawal by Subject|20|||
164715295|NCT03104400|594980334|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
164495057|NCT00488319|594182954|FG002|Overall Study|Withdrawal by Subject|44|||
164495058|NCT00488319|594182952|FG000|Overall Study|Other reasons for withdrawal|0|||
164495059|NCT00488319|594182953|FG001|Overall Study|Other reasons for withdrawal|4|||
164495060|NCT00488319|594182954|FG002|Overall Study|Other reasons for withdrawal|12|||
164495061|NCT02959177|594182955|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
164495062|NCT02959177|594182956|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
164495063|NCT02959177|594182957|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
164495064|NCT02959177|594182955|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
164495065|NCT02959177|594182956|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
164495066|NCT02959177|594182957|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
164495067|NCT02959177|594182955|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
164495068|NCT02959177|594182956|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
164495069|NCT02959177|594182957|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
164495070|NCT02959177|594182955|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
164495071|NCT02959177|594182956|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
164495072|NCT02959177|594182957|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
164495073|NCT02959177|594182955|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
164495074|NCT02959177|594182956|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
164495075|NCT02959177|594182957|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
164495076|NCT02959177|594182955|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
164495077|NCT02959177|594182956|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
164495078|NCT02959177|594182957|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
164495079|NCT02959177|594182955|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
164495080|NCT02959177|594182956|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
164495081|NCT02959177|594182957|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
164495082|NCT03544229|594182959|FG000|Overall Study|Adverse Event|1|||
164495083|NCT03544229|594182960|FG001|Overall Study|Adverse Event|0|||
164495084|NCT03544229|594182961|FG002|Overall Study|Adverse Event|1|||
164495085|NCT03544229|594182962|FG003|Overall Study|Adverse Event|0|||
164495086|NCT03544229|594182959|FG000|Overall Study|Protocol Deviation|0|||
164495087|NCT03544229|594182960|FG001|Overall Study|Protocol Deviation|0|||
164495088|NCT03544229|594182961|FG002|Overall Study|Protocol Deviation|1|||
164495089|NCT03544229|594182962|FG003|Overall Study|Protocol Deviation|0|||
164495090|NCT03544229|594182959|FG000|Overall Study|Lost to Follow-up|3|||
164495091|NCT03544229|594182960|FG001|Overall Study|Lost to Follow-up|0|||
164495092|NCT03544229|594182961|FG002|Overall Study|Lost to Follow-up|0|||
164495093|NCT03544229|594182962|FG003|Overall Study|Lost to Follow-up|2|||
164495094|NCT03544229|594182959|FG000|Overall Study|Voluntary Withdrawal|2|||
164495095|NCT03544229|594182960|FG001|Overall Study|Voluntary Withdrawal|1|||
164495096|NCT03544229|594182961|FG002|Overall Study|Voluntary Withdrawal|3|||
164495097|NCT03544229|594182962|FG003|Overall Study|Voluntary Withdrawal|0|||
164495098|NCT03544229|594182959|FG000|Overall Study|Lack of Efficacy|0|||
164495099|NCT03544229|594182960|FG001|Overall Study|Lack of Efficacy|1|||
164495100|NCT03544229|594182961|FG002|Overall Study|Lack of Efficacy|0|||
164495101|NCT03544229|594182962|FG003|Overall Study|Lack of Efficacy|0|||
164495102|NCT02460562|594182967|FG000|Overall Study|Lost to Follow-up|15|||
164495103|NCT02460562|594182968|FG001|Overall Study|Lost to Follow-up|16|||
164495104|NCT01061775|594182969|FG000|Overall Study|Physician Decision|2|||
164495105|NCT01061775|594182969|FG000|Overall Study|Lost to Follow-up|1|||
164495106|NCT00784277|594182970|FG000|IR Treatment|Adverse Event|4|||
164495107|NCT00784277|594182971|FG001|IR Treatment|Adverse Event|8|||
164495108|NCT00784277|594182972|FG002|IR Treatment|Adverse Event|19|||
164495109|NCT00784277|594182973|FG003|IR Treatment|Adverse Event|35|||
164495110|NCT00784277|594182974|FG004|IR Treatment|Adverse Event|0|||
164495111|NCT00784277|594182975|FG005|IR Treatment|Adverse Event|0|||
164495112|NCT00784277|594182976|FG006|IR Treatment|Adverse Event|0|||
164495113|NCT00784277|594182970|FG000|IR Treatment|Lack of Efficacy|4|||
164495114|NCT00784277|594182971|FG001|IR Treatment|Lack of Efficacy|4|||
164495115|NCT00784277|594182972|FG002|IR Treatment|Lack of Efficacy|1|||
164495116|NCT00784277|594182973|FG003|IR Treatment|Lack of Efficacy|0|||
164495117|NCT00784277|594182974|FG004|IR Treatment|Lack of Efficacy|0|||
164495118|NCT00784277|594182975|FG005|IR Treatment|Lack of Efficacy|0|||
164495119|NCT00784277|594182976|FG006|IR Treatment|Lack of Efficacy|0|||
164495120|NCT00784277|594182970|FG000|IR Treatment|Lost to Follow-up|1|||
164495121|NCT00784277|594182971|FG001|IR Treatment|Lost to Follow-up|0|||
164495122|NCT00784277|594182972|FG002|IR Treatment|Lost to Follow-up|1|||
164495123|NCT00784277|594182973|FG003|IR Treatment|Lost to Follow-up|0|||
164495124|NCT00784277|594182974|FG004|IR Treatment|Lost to Follow-up|0|||
164495125|NCT00784277|594182975|FG005|IR Treatment|Lost to Follow-up|0|||
164495126|NCT00784277|594182976|FG006|IR Treatment|Lost to Follow-up|0|||
164495127|NCT00784277|594182970|FG000|IR Treatment|Withdrawal by Subject|5|||
164495128|NCT00784277|594182971|FG001|IR Treatment|Withdrawal by Subject|1|||
164495129|NCT00784277|594182972|FG002|IR Treatment|Withdrawal by Subject|4|||
164495130|NCT00784277|594182973|FG003|IR Treatment|Withdrawal by Subject|6|||
164715296|NCT03104400|594980335|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
164495131|NCT00784277|594182974|FG004|IR Treatment|Withdrawal by Subject|0|||
164495132|NCT00784277|594182975|FG005|IR Treatment|Withdrawal by Subject|0|||
164495133|NCT00784277|594182976|FG006|IR Treatment|Withdrawal by Subject|0|||
164495134|NCT00784277|594182970|FG000|IR Treatment|Resolution Of Pain|0|||
164495135|NCT00784277|594182971|FG001|IR Treatment|Resolution Of Pain|1|||
164495136|NCT00784277|594182972|FG002|IR Treatment|Resolution Of Pain|0|||
164495137|NCT00784277|594182973|FG003|IR Treatment|Resolution Of Pain|0|||
164495138|NCT00784277|594182974|FG004|IR Treatment|Resolution Of Pain|0|||
164495139|NCT00784277|594182975|FG005|IR Treatment|Resolution Of Pain|0|||
164495140|NCT00784277|594182976|FG006|IR Treatment|Resolution Of Pain|0|||
164495141|NCT00784277|594182970|FG000|IR Treatment|Other|2|||
164495142|NCT00784277|594182971|FG001|IR Treatment|Other|3|||
164495143|NCT00784277|594182972|FG002|IR Treatment|Other|3|||
164495144|NCT00784277|594182973|FG003|IR Treatment|Other|2|||
164495145|NCT00784277|594182974|FG004|IR Treatment|Other|0|||
164495146|NCT00784277|594182975|FG005|IR Treatment|Other|0|||
164495147|NCT00784277|594182976|FG006|IR Treatment|Other|0|||
164495148|NCT00784277|594182970|FG000|ER Treatment|Adverse Event|0|||
164495149|NCT00784277|594182971|FG001|ER Treatment|Adverse Event|0|||
164495150|NCT00784277|594182972|FG002|ER Treatment|Adverse Event|0|||
164495151|NCT00784277|594182973|FG003|ER Treatment|Adverse Event|0|||
164495152|NCT00784277|594182974|FG004|ER Treatment|Adverse Event|1|||
164495153|NCT00784277|594182975|FG005|ER Treatment|Adverse Event|7|||
164495154|NCT00784277|594182976|FG006|ER Treatment|Adverse Event|7|||
164495155|NCT00784277|594182970|FG000|ER Treatment|Lack of Efficacy|0|||
164495156|NCT00784277|594182971|FG001|ER Treatment|Lack of Efficacy|0|||
164495157|NCT00784277|594182972|FG002|ER Treatment|Lack of Efficacy|0|||
164495158|NCT00784277|594182973|FG003|ER Treatment|Lack of Efficacy|0|||
164495159|NCT00784277|594182974|FG004|ER Treatment|Lack of Efficacy|3|||
164495160|NCT00784277|594182975|FG005|ER Treatment|Lack of Efficacy|4|||
164495161|NCT00784277|594182976|FG006|ER Treatment|Lack of Efficacy|0|||
164495162|NCT00784277|594182970|FG000|ER Treatment|Lost to Follow-up|0|||
164495163|NCT00784277|594182971|FG001|ER Treatment|Lost to Follow-up|0|||
164495164|NCT00784277|594182972|FG002|ER Treatment|Lost to Follow-up|0|||
164495165|NCT00784277|594182973|FG003|ER Treatment|Lost to Follow-up|0|||
164495166|NCT00784277|594182974|FG004|ER Treatment|Lost to Follow-up|0|||
164495167|NCT00784277|594182975|FG005|ER Treatment|Lost to Follow-up|2|||
164495168|NCT00784277|594182976|FG006|ER Treatment|Lost to Follow-up|0|||
164495169|NCT00784277|594182970|FG000|ER Treatment|Withdrawal by Subject|0|||
164495170|NCT00784277|594182971|FG001|ER Treatment|Withdrawal by Subject|0|||
164495171|NCT00784277|594182972|FG002|ER Treatment|Withdrawal by Subject|0|||
164495172|NCT00784277|594182973|FG003|ER Treatment|Withdrawal by Subject|0|||
164495173|NCT00784277|594182974|FG004|ER Treatment|Withdrawal by Subject|2|||
164495174|NCT00784277|594182975|FG005|ER Treatment|Withdrawal by Subject|5|||
164495175|NCT00784277|594182976|FG006|ER Treatment|Withdrawal by Subject|3|||
164495176|NCT00784277|594182970|FG000|ER Treatment|Study Medication Non-Compliant|0|||
164495177|NCT00784277|594182971|FG001|ER Treatment|Study Medication Non-Compliant|0|||
164495178|NCT00784277|594182972|FG002|ER Treatment|Study Medication Non-Compliant|0|||
164495179|NCT00784277|594182973|FG003|ER Treatment|Study Medication Non-Compliant|0|||
164495180|NCT00784277|594182974|FG004|ER Treatment|Study Medication Non-Compliant|2|||
164495181|NCT00784277|594182975|FG005|ER Treatment|Study Medication Non-Compliant|3|||
164495182|NCT00784277|594182976|FG006|ER Treatment|Study Medication Non-Compliant|3|||
164495183|NCT00784277|594182970|FG000|ER Treatment|Other|0|||
164495184|NCT00784277|594182971|FG001|ER Treatment|Other|0|||
164495185|NCT00784277|594182972|FG002|ER Treatment|Other|0|||
164495186|NCT00784277|594182973|FG003|ER Treatment|Other|0|||
164495187|NCT00784277|594182974|FG004|ER Treatment|Other|1|||
164495188|NCT00784277|594182975|FG005|ER Treatment|Other|3|||
164495189|NCT00784277|594182976|FG006|ER Treatment|Other|2|||
164495190|NCT01093222|594182977|FG000|Overall Study|Ineligible|6|||
164495191|NCT01093222|594182977|FG000|Overall Study|Adverse Event|7|||
164495192|NCT01093222|594182977|FG000|Overall Study|Progression/relapse|24|||
164495193|NCT01093222|594182977|FG000|Overall Study|Death|2|||
164495194|NCT01093222|594182977|FG000|Overall Study|Not protocol specified|1|||
164495195|NCT04194541|594182978|FG000|Day 1 Through 13|Lost to Follow-up|3|||
164495196|NCT04194541|594182978|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
164495197|NCT04194541|594182978|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
164495198|NCT02642159|594182979|FG000|Overall Study|Randomized but not treated|1|||
164495199|NCT02642159|594182980|FG001|Overall Study|Randomized but not treated|0|||
164495200|NCT02642159|594182979|FG000|Overall Study|Adverse Event|10|||
164495201|NCT02642159|594182980|FG001|Overall Study|Adverse Event|4|||
164495202|NCT02642159|594182979|FG000|Overall Study|Withdrawal by Subject|9|||
164495203|NCT02642159|594182980|FG001|Overall Study|Withdrawal by Subject|1|||
164495204|NCT02642159|594182979|FG000|Overall Study|Poor compliance to study protocol|1|||
164495205|NCT02642159|594182980|FG001|Overall Study|Poor compliance to study protocol|0|||
164495206|NCT02642159|594182979|FG000|Overall Study|Other than specified above|10|||
164495207|NCT02642159|594182980|FG001|Overall Study|Other than specified above|3|||
164495208|NCT00588341|594182981|FG000|Overall Study|Withdrawal by Subject|3|||
164495209|NCT00588341|594182981|FG000|Overall Study|Not treated due to metastatic disease|1|||
164495210|NCT00588341|594182981|FG000|Overall Study|Patient ineligible|1|||
164495211|NCT02567227|594182982|FG000|9 Weeks|Adverse Event|5|||
164495212|NCT02567227|594182983|FG001|9 Weeks|Adverse Event|5|||
164495213|NCT02567227|594182982|FG000|9 Weeks|Withdrawal by Subject|18|||
164495214|NCT02567227|594182983|FG001|9 Weeks|Withdrawal by Subject|8|||
164495215|NCT02567227|594182982|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
164495216|NCT02567227|594182983|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
164495217|NCT02567227|594182982|FG000|6 Month|Death|2|||
164495218|NCT02567227|594182983|FG001|6 Month|Death|0|||
164495219|NCT02567227|594182982|FG000|6 Month|Lost to Follow-up|43|||
164495220|NCT02567227|594182983|FG001|6 Month|Lost to Follow-up|40|||
164495221|NCT02567227|594182982|FG000|12 Months|Lost to Follow-up|31|||
164495222|NCT02567227|594182983|FG001|12 Months|Lost to Follow-up|32|||
164495223|NCT02567227|594182982|FG000|12 Months|Death|0|||
164495224|NCT02567227|594182983|FG001|12 Months|Death|2|||
164495225|NCT00187135|594182984|FG000|Visit One|Withdrawal by Subject|1|||
164495226|NCT00187135|594182985|FG001|Visit One|Withdrawal by Subject|0|||
164495227|NCT00187135|594182986|FG002|Visit One|Withdrawal by Subject|0|||
164495228|NCT00187135|594182987|FG003|Visit One|Withdrawal by Subject|0|||
164495229|NCT00187135|594182988|FG004|Visit One|Withdrawal by Subject|0|||
164495230|NCT00187135|594182989|FG005|Visit One|Withdrawal by Subject|1|||
164495231|NCT00187135|594182984|FG000|Visit One|Physician Decision|3|||
164495232|NCT00187135|594182985|FG001|Visit One|Physician Decision|1|||
164495233|NCT00187135|594182986|FG002|Visit One|Physician Decision|0|||
164495234|NCT00187135|594182987|FG003|Visit One|Physician Decision|0|||
164495235|NCT00187135|594182988|FG004|Visit One|Physician Decision|0|||
164495236|NCT00187135|594182989|FG005|Visit One|Physician Decision|1|||
164495237|NCT00187135|594182984|FG000|Visit Two|Death|0|||
164495238|NCT00187135|594182985|FG001|Visit Two|Death|0|||
164495239|NCT00187135|594182986|FG002|Visit Two|Death|0|||
164495240|NCT00187135|594182987|FG003|Visit Two|Death|1|||
164495241|NCT00187135|594182988|FG004|Visit Two|Death|0|||
164495242|NCT00187135|594182989|FG005|Visit Two|Death|1|||
164495243|NCT00187135|594182984|FG000|Visit Two|Physician Decision|1|||
164495244|NCT00187135|594182985|FG001|Visit Two|Physician Decision|0|||
164495245|NCT00187135|594182986|FG002|Visit Two|Physician Decision|0|||
164495246|NCT00187135|594182987|FG003|Visit Two|Physician Decision|0|||
164495247|NCT00187135|594182988|FG004|Visit Two|Physician Decision|0|||
164495248|NCT00187135|594182989|FG005|Visit Two|Physician Decision|0|||
164495249|NCT00187135|594182984|FG000|Visit Two|Withdrawal by Subject|1|||
164495250|NCT00187135|594182985|FG001|Visit Two|Withdrawal by Subject|1|||
164495251|NCT00187135|594182986|FG002|Visit Two|Withdrawal by Subject|1|||
164495252|NCT00187135|594182987|FG003|Visit Two|Withdrawal by Subject|0|||
164495253|NCT00187135|594182988|FG004|Visit Two|Withdrawal by Subject|1|||
164495254|NCT00187135|594182989|FG005|Visit Two|Withdrawal by Subject|1|||
164495255|NCT00187135|594182984|FG000|Visit Two|Study Discontinued|3|||
164495256|NCT00187135|594182985|FG001|Visit Two|Study Discontinued|2|||
164495257|NCT00187135|594182986|FG002|Visit Two|Study Discontinued|1|||
164495258|NCT00187135|594182987|FG003|Visit Two|Study Discontinued|7|||
164495259|NCT00187135|594182988|FG004|Visit Two|Study Discontinued|5|||
164495260|NCT00187135|594182989|FG005|Visit Two|Study Discontinued|6|||
164495261|NCT00187135|594182984|FG000|Visit Three|Death|0|||
164495262|NCT00187135|594182985|FG001|Visit Three|Death|0|||
164495263|NCT00187135|594182986|FG002|Visit Three|Death|1|||
164495264|NCT00187135|594182987|FG003|Visit Three|Death|0|||
164495265|NCT00187135|594182988|FG004|Visit Three|Death|1|||
164495266|NCT00187135|594182989|FG005|Visit Three|Death|0|||
164495267|NCT00187135|594182984|FG000|Visit Three|Withdrawal by Subject|0|||
164495268|NCT00187135|594182985|FG001|Visit Three|Withdrawal by Subject|1|||
164495269|NCT00187135|594182986|FG002|Visit Three|Withdrawal by Subject|1|||
164495270|NCT00187135|594182987|FG003|Visit Three|Withdrawal by Subject|2|||
164495271|NCT00187135|594182988|FG004|Visit Three|Withdrawal by Subject|0|||
164495272|NCT00187135|594182989|FG005|Visit Three|Withdrawal by Subject|0|||
164495273|NCT00187135|594182984|FG000|Visit Three|Study Discontinued|7|||
164495274|NCT00187135|594182985|FG001|Visit Three|Study Discontinued|6|||
164495275|NCT00187135|594182986|FG002|Visit Three|Study Discontinued|7|||
164495276|NCT00187135|594182987|FG003|Visit Three|Study Discontinued|7|||
164495277|NCT00187135|594182988|FG004|Visit Three|Study Discontinued|7|||
164495278|NCT00187135|594182989|FG005|Visit Three|Study Discontinued|6|||
164495279|NCT01924806|594182994|FG000|Overall Study|Physician Decision|2|||
164495280|NCT01924806|594182995|FG001|Overall Study|Physician Decision|1|||
164495281|NCT01954771|594182996|FG000|Overall Study|Missing HbA1c of end-point|1|||
164495282|NCT01954771|594182997|FG001|Overall Study|Missing HbA1c of end-point|1|||
164495283|NCT01954771|594182998|FG002|Overall Study|Missing HbA1c of end-point|0|||
164495284|NCT01954771|594182996|FG000|Overall Study|Missing CGMS of end-point|1|||
164495285|NCT01954771|594182997|FG001|Overall Study|Missing CGMS of end-point|1|||
164495286|NCT01954771|594182998|FG002|Overall Study|Missing CGMS of end-point|0|||
164495287|NCT01954771|594182996|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
164495288|NCT01954771|594182997|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
164495289|NCT01954771|594182998|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
164495290|NCT03635775|594183002|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
164495291|NCT03635775|594183003|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
164495292|NCT03635775|594183004|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
164495293|NCT03635775|594183005|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
164495294|NCT01026103|594183007|FG000|Overall Study|Physician Decision|1|||
164715297|NCT03104400|594980336|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
164715298|NCT03104400|594980337|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
164715299|NCT03104400|594980338|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
164715300|NCT03104400|594980339|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
164715301|NCT03104400|594980340|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
164715302|NCT03104400|594980341|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
164715303|NCT03104400|594980342|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
164715304|NCT03104400|594980333|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
164715305|NCT03104400|594980334|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
164715306|NCT03104400|594980335|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
164715307|NCT03104400|594980336|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
164715308|NCT03104400|594980337|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
164715309|NCT03104400|594980338|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
164715310|NCT03104400|594980339|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
164715311|NCT03104400|594980340|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
164715312|NCT03104400|594980341|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
164715313|NCT03104400|594980342|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
164715314|NCT03104400|594980333|FG000|Period 2 Week 56 - 260)|Other|0|||
164715315|NCT03104400|594980334|FG001|Period 2 Week 56 - 260)|Other|0|||
164715316|NCT03104400|594980335|FG002|Period 2 Week 56 - 260)|Other|0|||
164715317|NCT03104400|594980336|FG003|Period 2 Week 56 - 260)|Other|0|||
164715318|NCT03104400|594980337|FG004|Period 2 Week 56 - 260)|Other|0|||
164715319|NCT03104400|594980338|FG005|Period 2 Week 56 - 260)|Other|0|||
164715320|NCT03104400|594980339|FG006|Period 2 Week 56 - 260)|Other|0|||
164715321|NCT03104400|594980340|FG007|Period 2 Week 56 - 260)|Other|0|||
164715322|NCT03104400|594980341|FG008|Period 2 Week 56 - 260)|Other|1|||
164715323|NCT03104400|594980342|FG009|Period 2 Week 56 - 260)|Other|1|||
164715324|NCT00264550|594980345|FG000|Overall Study|Death|0|||
164715325|NCT00264550|594980346|FG001|Overall Study|Death|3|||
164715326|NCT00264550|594980347|FG002|Overall Study|Death|0|||
164715327|NCT00264550|594980348|FG003|Overall Study|Death|0|||
164715328|NCT00264550|594980345|FG000|Overall Study|Lost to Follow-up|3|||
164715329|NCT00264550|594980346|FG001|Overall Study|Lost to Follow-up|1|||
164715330|NCT00264550|594980347|FG002|Overall Study|Lost to Follow-up|1|||
164715331|NCT00264550|594980348|FG003|Overall Study|Lost to Follow-up|1|||
164715332|NCT00264550|594980345|FG000|Overall Study|Adverse Event|23|||
164715333|NCT00264550|594980346|FG001|Overall Study|Adverse Event|18|||
164715334|NCT00264550|594980347|FG002|Overall Study|Adverse Event|9|||
164715335|NCT00264550|594980348|FG003|Overall Study|Adverse Event|14|||
164715336|NCT00264550|594980345|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
164715337|NCT00264550|594980346|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
164715338|NCT00264550|594980347|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
164715339|NCT00264550|594980348|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
164715340|NCT00264550|594980345|FG000|Overall Study|Discontinued oral study agent|0|||
164715341|NCT00264550|594980346|FG001|Overall Study|Discontinued oral study agent|1|||
164715342|NCT00264550|594980347|FG002|Overall Study|Discontinued oral study agent|0|||
164715343|NCT00264550|594980348|FG003|Overall Study|Discontinued oral study agent|0|||
164715344|NCT00264550|594980345|FG000|Overall Study|Other|13|||
164715345|NCT00264550|594980346|FG001|Overall Study|Other|7|||
164715346|NCT00264550|594980347|FG002|Overall Study|Other|3|||
164715347|NCT00264550|594980348|FG003|Overall Study|Other|9|||
164715348|NCT02129608|594980349|FG000|Overall Study|Lost to Follow-up|0|||
164715349|NCT02129608|594980350|FG001|Overall Study|Lost to Follow-up|1|||
164715350|NCT02129608|594980351|FG002|Overall Study|Lost to Follow-up|1|||
164715351|NCT02129608|594980349|FG000|Overall Study|Withdrawal by Subject|0|||
164495295|NCT01026103|594183007|FG000|Overall Study|did not receive study device bc of error|1|||
164495296|NCT02498418|594183008|FG000|Overall Study|Lack of Efficacy|0|||
164495297|NCT02498418|594183009|FG001|Overall Study|Lack of Efficacy|0|||
164495298|NCT02498418|594183010|FG002|Overall Study|Lack of Efficacy|1|||
164715352|NCT02129608|594980350|FG001|Overall Study|Withdrawal by Subject|0|||
164715353|NCT02129608|594980351|FG002|Overall Study|Withdrawal by Subject|2|||
164715354|NCT00129389|594980352|FG000|Overall Study|Adverse Event|19|||
164715355|NCT00129389|594980353|FG001|Overall Study|Adverse Event|87|||
164715356|NCT00129389|594980352|FG000|Overall Study|Death|0|||
164715357|NCT00129389|594980353|FG001|Overall Study|Death|1|||
164715358|NCT00129389|594980352|FG000|Overall Study|Lost to Follow-up|2|||
164715359|NCT00129389|594980353|FG001|Overall Study|Lost to Follow-up|1|||
164715360|NCT00129389|594980352|FG000|Overall Study|Physician Decision|0|||
164715361|NCT00129389|594980353|FG001|Overall Study|Physician Decision|4|||
164715362|NCT00129389|594980352|FG000|Overall Study|Protocol Violation|0|||
164495299|NCT02498418|594183008|FG000|Overall Study|Withdrawal by Subject|2|||
164495300|NCT02498418|594183009|FG001|Overall Study|Withdrawal by Subject|0|||
164495301|NCT02498418|594183010|FG002|Overall Study|Withdrawal by Subject|3|||
164495302|NCT02498418|594183008|FG000|Overall Study|Lost to Follow-up|0|||
164495303|NCT02498418|594183009|FG001|Overall Study|Lost to Follow-up|1|||
164495304|NCT02498418|594183010|FG002|Overall Study|Lost to Follow-up|1|||
164495305|NCT02498418|594183008|FG000|Overall Study|Participant taken prohibited medication|0|||
164495306|NCT02498418|594183009|FG001|Overall Study|Participant taken prohibited medication|1|||
164495307|NCT02498418|594183010|FG002|Overall Study|Participant taken prohibited medication|1|||
164495308|NCT00762502|594183011|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
164495309|NCT00762502|594183012|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
164495310|NCT00762502|594183013|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
164495311|NCT00762502|594183011|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
164495312|NCT00762502|594183012|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
164495313|NCT00762502|594183013|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
164495314|NCT00762502|594183011|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
164495315|NCT00762502|594183012|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
164495316|NCT00762502|594183013|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
164495317|NCT01675050|594183018|FG000|Period One Treatment|Withdrawal by Subject|1|||
164495318|NCT01675050|594183019|FG001|Period One Treatment|Withdrawal by Subject|0|||
164495319|NCT00745121|594183020|FG000|Overall Study|Death|3|||
164495320|NCT00745121|594183021|FG001|Overall Study|Death|0|||
164495321|NCT00745121|594183020|FG000|Overall Study|Adverse Event|1|||
164495322|NCT00745121|594183021|FG001|Overall Study|Adverse Event|0|||
164495323|NCT00745121|594183020|FG000|Overall Study|Lost to Follow-up|1|||
164495324|NCT00745121|594183021|FG001|Overall Study|Lost to Follow-up|0|||
164495325|NCT00745121|594183020|FG000|Overall Study|Withdrawal by Subject|4|||
164495326|NCT00745121|594183021|FG001|Overall Study|Withdrawal by Subject|2|||
164495327|NCT03280108|594183025|FG000|Overall Study|Lost to Follow-up|2|||
164495328|NCT03280108|594183026|FG001|Overall Study|Lost to Follow-up|0|||
164495329|NCT02996097|594183027|FG000|Overall Study|Lost to Follow-up|11|||
164495330|NCT02996097|594183028|FG001|Overall Study|Lost to Follow-up|11|||
164495331|NCT01820637|594183029|FG000|Overall Study|Death|2|||
164495332|NCT01820637|594183029|FG000|Overall Study|Withdrawal by Subject|1|||
164495333|NCT00264498|594183030|FG000|Randomized Treatment|Death|0|||
164495334|NCT00264498|594183031|FG001|Randomized Treatment|Death|3|||
164495335|NCT00264498|594183030|FG000|Randomized Treatment|Withdrawal by Subject|0|||
164495336|NCT00264498|594183031|FG001|Randomized Treatment|Withdrawal by Subject|1|||
164495337|NCT00264498|594183030|FG000|Randomized Treatment|Objective disease Progression|13|||
164495338|NCT00264498|594183031|FG001|Randomized Treatment|Objective disease Progression|14|||
164495339|NCT00264498|594183030|FG000|Randomized Treatment|Physician Decision|1|||
164495340|NCT00264498|594183031|FG001|Randomized Treatment|Physician Decision|0|||
164495341|NCT00264498|594183030|FG000|Randomized Treatment|Incorrectly randomized|1|||
164495342|NCT00264498|594183031|FG001|Randomized Treatment|Incorrectly randomized|0|||
164495343|NCT00264498|594183030|FG000|Randomized Treatment|Study Closure|1|||
164495344|NCT00264498|594183031|FG001|Randomized Treatment|Study Closure|0|||
164495345|NCT00264498|594183030|FG000|Randomized Treatment|Protocol Violation|1|||
164495346|NCT00264498|594183031|FG001|Randomized Treatment|Protocol Violation|0|||
164495347|NCT00264498|594183030|FG000|Crossover Treatment|Death|1|||
164495348|NCT00264498|594183031|FG001|Crossover Treatment|Death|3|||
164495349|NCT00264498|594183030|FG000|Crossover Treatment|Objective disease progression|4|||
164495350|NCT00264498|594183031|FG001|Crossover Treatment|Objective disease progression|5|||
164495351|NCT00264498|594183030|FG000|Crossover Treatment|Study closure|0|||
164495352|NCT00264498|594183031|FG001|Crossover Treatment|Study closure|1|||
164495353|NCT00264498|594183030|FG000|Crossover Treatment|Withdrawal by Subject|1|||
164495354|NCT00264498|594183031|FG001|Crossover Treatment|Withdrawal by Subject|0|||
164495355|NCT03794609|594183032|FG000|Overall Study|Other|10|||
164495356|NCT03794609|594183032|FG000|Overall Study|Withdrawal by Subject|66|||
164495357|NCT03794609|594183032|FG000|Overall Study|The child is enrolled in an interventional study|70|||
164495358|NCT03794609|594183032|FG000|Overall Study|Inclusion/exclusion criteria|8|||
164495359|NCT03794609|594183032|FG000|Overall Study|At sponsor's request|151|||
164495360|NCT03794609|594183032|FG000|Overall Study|Physician Decision|1|||
164495361|NCT03794609|594183032|FG000|Overall Study|Lost to Follow-up|5|||
164495362|NCT03638258|594183033|FG000|Overall Study|Adverse Event|1|||
164495363|NCT03638258|594183034|FG001|Overall Study|Adverse Event|0|||
164495364|NCT03638258|594183035|FG002|Overall Study|Adverse Event|2|||
164495365|NCT03638258|594183033|FG000|Overall Study|Lost to Follow-up|2|||
164495366|NCT03638258|594183034|FG001|Overall Study|Lost to Follow-up|4|||
164495367|NCT03638258|594183035|FG002|Overall Study|Lost to Follow-up|5|||
164495368|NCT03638258|594183033|FG000|Overall Study|Pregnancy|0|||
164715363|NCT00129389|594980353|FG001|Overall Study|Protocol Violation|6|||
164495369|NCT03638258|594183034|FG001|Overall Study|Pregnancy|0|||
164715364|NCT00129389|594980352|FG000|Overall Study|Withdrawal by Subject|9|||
164715365|NCT00129389|594980353|FG001|Overall Study|Withdrawal by Subject|23|||
164715366|NCT00129389|594980352|FG000|Overall Study|Relapse|1|||
164715367|NCT00129389|594980353|FG001|Overall Study|Relapse|0|||
164715368|NCT00129389|594980352|FG000|Overall Study|Not eligible|1|||
164715369|NCT00129389|594980353|FG001|Overall Study|Not eligible|2|||
164495370|NCT03638258|594183035|FG002|Overall Study|Pregnancy|1|||
164495371|NCT03638258|594183033|FG000|Overall Study|Protocol Violation|0|||
164495372|NCT03638258|594183034|FG001|Overall Study|Protocol Violation|0|||
164495373|NCT03638258|594183035|FG002|Overall Study|Protocol Violation|1|||
164495374|NCT03638258|594183033|FG000|Overall Study|Withdrawal by Subject|4|||
164495375|NCT03638258|594183034|FG001|Overall Study|Withdrawal by Subject|5|||
164495376|NCT03638258|594183035|FG002|Overall Study|Withdrawal by Subject|12|||
164495377|NCT03638258|594183033|FG000|Overall Study|Lack of Efficacy|0|||
164495378|NCT03638258|594183034|FG001|Overall Study|Lack of Efficacy|0|||
164495379|NCT03638258|594183035|FG002|Overall Study|Lack of Efficacy|2|||
164495380|NCT04543942|594183036|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
164495381|NCT04543942|594183037|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
164495382|NCT04543942|594183036|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
164495383|NCT04543942|594183037|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
164495384|NCT02205476|594183038|FG000|Overall Study|Study termination by Sponsor|7|||
164495385|NCT02205476|594183039|FG001|Overall Study|Study termination by Sponsor|3|||
164495386|NCT01313299|594183046|FG000|Overall Study|Adverse Event|3|||
164495387|NCT01313299|594183047|FG001|Overall Study|Adverse Event|1|||
164495388|NCT01313299|594183048|FG002|Overall Study|Adverse Event|1|||
164495389|NCT01313299|594183046|FG000|Overall Study|Lost to Follow-up|1|||
164495390|NCT01313299|594183047|FG001|Overall Study|Lost to Follow-up|0|||
164495391|NCT01313299|594183048|FG002|Overall Study|Lost to Follow-up|0|||
164495392|NCT01313299|594183046|FG000|Overall Study|Protocol Violation|2|||
164495393|NCT01313299|594183047|FG001|Overall Study|Protocol Violation|0|||
164495394|NCT01313299|594183048|FG002|Overall Study|Protocol Violation|0|||
164495395|NCT01313299|594183046|FG000|Overall Study|Withdrawal by Subject|1|||
164495396|NCT01313299|594183047|FG001|Overall Study|Withdrawal by Subject|0|||
164495397|NCT01313299|594183048|FG002|Overall Study|Withdrawal by Subject|2|||
164495398|NCT01313299|594183046|FG000|Overall Study|Family reason and moved out of state|0|||
164495399|NCT01313299|594183047|FG001|Overall Study|Family reason and moved out of state|2|||
164495400|NCT01313299|594183048|FG002|Overall Study|Family reason and moved out of state|0|||
164495401|NCT01313299|594183046|FG000|Overall Study|Lack of subject compliance|0|||
164495402|NCT01313299|594183047|FG001|Overall Study|Lack of subject compliance|0|||
164495403|NCT01313299|594183048|FG002|Overall Study|Lack of subject compliance|1|||
164495404|NCT02506881|594183049|FG000|First Intervention (Day 1)|Protocol Violation|0|||
164495405|NCT02506881|594183050|FG001|First Intervention (Day 1)|Protocol Violation|0|||
164495406|NCT02506881|594183051|FG002|First Intervention (Day 1)|Protocol Violation|1|||
164495407|NCT02506881|594183052|FG003|First Intervention (Day 1)|Protocol Violation|0|||
164495408|NCT02506881|594183049|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
164495409|NCT02506881|594183050|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
164495410|NCT02506881|594183051|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
164495411|NCT02506881|594183052|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
164495412|NCT02506881|594183049|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
164495413|NCT02506881|594183050|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
164495414|NCT02506881|594183051|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
164495415|NCT02506881|594183052|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
164495416|NCT01919398|594183053|FG000|Overall Study|Progressive Disease|0|||
164495417|NCT01919398|594183054|FG001|Overall Study|Progressive Disease|0|||
164495418|NCT01919398|594183055|FG002|Overall Study|Progressive Disease|4|||
164495419|NCT02391545|594183059|FG000|Overall Study|Death|0|||
164495420|NCT02391545|594183060|FG001|Overall Study|Death|2|||
164495421|NCT02391545|594183059|FG000|Overall Study|Lost to Follow-up|0|||
164495422|NCT02391545|594183060|FG001|Overall Study|Lost to Follow-up|1|||
164495423|NCT02391545|594183059|FG000|Overall Study|Termination of study by sponsor|20|||
164495424|NCT02391545|594183060|FG001|Overall Study|Termination of study by sponsor|20|||
164495425|NCT02391545|594183059|FG000|Overall Study|Withdrawal by Subject|0|||
164495426|NCT02391545|594183060|FG001|Overall Study|Withdrawal by Subject|1|||
164495427|NCT02391545|594183059|FG000|Overall Study|Other Reasons|6|||
164715370|NCT00129389|594980352|FG000|Overall Study|Crossed to the other arm|1|||
164495428|NCT02391545|594183060|FG001|Overall Study|Other Reasons|4|||
164495429|NCT02016690|594183061|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
164495430|NCT02016690|594183061|FG000|Overall Study|Excluded from SAS: Duplication|2|||
164495431|NCT02016690|594183061|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
164715371|NCT00129389|594980353|FG001|Overall Study|Crossed to the other arm|16|||
164495432|NCT02016690|594183061|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
164495433|NCT02016690|594183061|FG000|Overall Study|Did not meet inclusion criteria|13|||
164495434|NCT02016690|594183061|FG000|Overall Study|Hospitalized for RSV at study start|3|||
164495435|NCT02865135|594183072|FG000|Overall Study|Death|0|||
164495436|NCT02865135|594183073|FG001|Overall Study|Death|1|||
164715372|NCT01191944|594980358|FG000|Overall Study|Adverse Event|11|||
164715373|NCT01191944|594980359|FG001|Overall Study|Adverse Event|12|||
164715374|NCT01191944|594980358|FG000|Overall Study|Protocol Violation|1|||
164715375|NCT01191944|594980359|FG001|Overall Study|Protocol Violation|2|||
164715376|NCT01191944|594980358|FG000|Overall Study|Withdrawal by Subject|4|||
164715377|NCT01191944|594980359|FG001|Overall Study|Withdrawal by Subject|2|||
164715378|NCT01191944|594980358|FG000|Overall Study|Other|1|||
164715379|NCT01191944|594980359|FG001|Overall Study|Other|3|||
164715380|NCT04602546|594980364|FG000|Overall Study|Training|2|||
164715381|NCT04602546|594980365|FG001|Overall Study|Training|2|||
164715382|NCT04602546|594980366|FG002|Overall Study|Training|1|||
164715383|NCT04602546|594980367|FG003|Overall Study|Training|2|||
164715384|NCT04602546|594980368|FG004|Overall Study|Training|0|||
164715385|NCT04602546|594980364|FG000|Overall Study|Randomized with disqualified data|2|||
164715386|NCT04602546|594980365|FG001|Overall Study|Randomized with disqualified data|0|||
164715387|NCT04602546|594980366|FG002|Overall Study|Randomized with disqualified data|2|||
164715388|NCT04602546|594980367|FG003|Overall Study|Randomized with disqualified data|5|||
164715389|NCT04602546|594980368|FG004|Overall Study|Randomized with disqualified data|3|||
164715390|NCT00425373|594980378|FG000|Overall Study|Adverse Event|2|||
164715391|NCT00425373|594980379|FG001|Overall Study|Adverse Event|2|||
164715392|NCT00425373|594980380|FG002|Overall Study|Adverse Event|0|||
164715393|NCT00425373|594980381|FG003|Overall Study|Adverse Event|1|||
164715394|NCT00425373|594980382|FG004|Overall Study|Adverse Event|4|||
164715395|NCT00425373|594980383|FG005|Overall Study|Adverse Event|6|||
164715396|NCT00425373|594980384|FG006|Overall Study|Adverse Event|2|||
164715397|NCT00425373|594980385|FG007|Overall Study|Adverse Event|3|||
164715398|NCT00425373|594980386|FG008|Overall Study|Adverse Event|8|||
164715399|NCT00425373|594980378|FG000|Overall Study|Lost to Follow-up|0|||
164715400|NCT00425373|594980379|FG001|Overall Study|Lost to Follow-up|1|||
164715401|NCT00425373|594980380|FG002|Overall Study|Lost to Follow-up|0|||
164715402|NCT00425373|594980381|FG003|Overall Study|Lost to Follow-up|0|||
164715403|NCT00425373|594980382|FG004|Overall Study|Lost to Follow-up|1|||
164715404|NCT00425373|594980383|FG005|Overall Study|Lost to Follow-up|0|||
164715405|NCT00425373|594980384|FG006|Overall Study|Lost to Follow-up|0|||
164715406|NCT00425373|594980385|FG007|Overall Study|Lost to Follow-up|0|||
164715407|NCT00425373|594980386|FG008|Overall Study|Lost to Follow-up|0|||
164715408|NCT00425373|594980378|FG000|Overall Study|Protocol Violation|1|||
164715409|NCT00425373|594980379|FG001|Overall Study|Protocol Violation|0|||
164715410|NCT00425373|594980380|FG002|Overall Study|Protocol Violation|1|||
164715411|NCT00425373|594980381|FG003|Overall Study|Protocol Violation|0|||
164715412|NCT00425373|594980382|FG004|Overall Study|Protocol Violation|0|||
164715413|NCT00425373|594980383|FG005|Overall Study|Protocol Violation|0|||
164715414|NCT00425373|594980384|FG006|Overall Study|Protocol Violation|0|||
164715415|NCT00425373|594980385|FG007|Overall Study|Protocol Violation|5|||
164715416|NCT00425373|594980386|FG008|Overall Study|Protocol Violation|3|||
164715417|NCT00425373|594980378|FG000|Overall Study|Withdrawal by Subject|2|||
164715418|NCT00425373|594980379|FG001|Overall Study|Withdrawal by Subject|0|||
164715419|NCT00425373|594980380|FG002|Overall Study|Withdrawal by Subject|2|||
164715420|NCT00425373|594980381|FG003|Overall Study|Withdrawal by Subject|1|||
164715421|NCT00425373|594980382|FG004|Overall Study|Withdrawal by Subject|4|||
164715422|NCT00425373|594980383|FG005|Overall Study|Withdrawal by Subject|0|||
164715423|NCT00425373|594980384|FG006|Overall Study|Withdrawal by Subject|2|||
164495437|NCT02865135|594183074|FG002|Overall Study|Death|0|||
164715424|NCT00425373|594980385|FG007|Overall Study|Withdrawal by Subject|2|||
164715425|NCT00425373|594980386|FG008|Overall Study|Withdrawal by Subject|2|||
164715426|NCT00425373|594980378|FG000|Overall Study|Lack of Efficacy|0|||
164715427|NCT00425373|594980379|FG001|Overall Study|Lack of Efficacy|0|||
164715428|NCT00425373|594980380|FG002|Overall Study|Lack of Efficacy|0|||
164715429|NCT00425373|594980381|FG003|Overall Study|Lack of Efficacy|0|||
164715430|NCT00425373|594980382|FG004|Overall Study|Lack of Efficacy|1|||
164715431|NCT00425373|594980383|FG005|Overall Study|Lack of Efficacy|3|||
164715432|NCT00425373|594980384|FG006|Overall Study|Lack of Efficacy|3|||
164715433|NCT00425373|594980385|FG007|Overall Study|Lack of Efficacy|0|||
164715434|NCT00425373|594980386|FG008|Overall Study|Lack of Efficacy|5|||
164715435|NCT00582010|594980390|FG000|Overall Study|Death|0|||
164715436|NCT00582010|594980391|FG001|Overall Study|Death|1|||
164715437|NCT02463357|594980396|FG000|Overall Study|Withdrawal by Subject|1|||
164495438|NCT02865135|594183072|FG000|Overall Study|Progression|6|||
164715438|NCT02463357|594980397|FG001|Overall Study|Withdrawal by Subject|0|||
164715439|NCT02463357|594980398|FG002|Overall Study|Withdrawal by Subject|0|||
164715440|NCT02463357|594980399|FG003|Overall Study|Withdrawal by Subject|0|||
164715441|NCT02463357|594980400|FG004|Overall Study|Withdrawal by Subject|0|||
164715442|NCT02463357|594980396|FG000|Overall Study|Withdrawal by Subject|0|||
164715443|NCT02463357|594980397|FG001|Overall Study|Withdrawal by Subject|0|||
164715444|NCT02463357|594980398|FG002|Overall Study|Withdrawal by Subject|0|||
164715445|NCT02463357|594980399|FG003|Overall Study|Withdrawal by Subject|0|||
164715446|NCT02463357|594980400|FG004|Overall Study|Withdrawal by Subject|1|||
164715447|NCT01371539|594980403|FG000|Period One: One Week|Lost to Follow-up|0|||
164715448|NCT01371539|594980404|FG001|Period One: One Week|Lost to Follow-up|1|||
164495439|NCT02865135|594183073|FG001|Overall Study|Progression|2|||
164495440|NCT02865135|594183074|FG002|Overall Study|Progression|2|||
164495441|NCT00985621|594183075|FG000|Overall Study|Adverse Event|2|||
164495442|NCT00985621|594183076|FG001|Overall Study|Adverse Event|3|||
164495443|NCT00985621|594183077|FG002|Overall Study|Adverse Event|4|||
164495444|NCT00985621|594183078|FG003|Overall Study|Adverse Event|16|||
164495445|NCT00985621|594183075|FG000|Overall Study|Lack of Efficacy|10|||
164495446|NCT00985621|594183076|FG001|Overall Study|Lack of Efficacy|6|||
164495447|NCT00985621|594183077|FG002|Overall Study|Lack of Efficacy|5|||
164495448|NCT00985621|594183078|FG003|Overall Study|Lack of Efficacy|12|||
164495449|NCT00985621|594183075|FG000|Overall Study|Lost to Follow-up|2|||
164495450|NCT00985621|594183076|FG001|Overall Study|Lost to Follow-up|3|||
164495451|NCT00985621|594183077|FG002|Overall Study|Lost to Follow-up|4|||
164495452|NCT00985621|594183078|FG003|Overall Study|Lost to Follow-up|4|||
164495453|NCT00985621|594183075|FG000|Overall Study|Study Terminated by Sponsor|89|||
164495454|NCT00985621|594183076|FG001|Overall Study|Study Terminated by Sponsor|108|||
164495455|NCT00985621|594183077|FG002|Overall Study|Study Terminated by Sponsor|99|||
164495456|NCT00985621|594183078|FG003|Overall Study|Study Terminated by Sponsor|92|||
164495457|NCT00985621|594183075|FG000|Overall Study|Protocol Violation|1|||
164495458|NCT00985621|594183076|FG001|Overall Study|Protocol Violation|1|||
164603797|NCT01925612|594570151|FG002|Overall Study|Progressive Disease|1|||
164603798|NCT01925612|594570152|FG003|Overall Study|Progressive Disease|0|||
164603799|NCT01925612|594570153|FG004|Overall Study|Progressive Disease|0|||
164603800|NCT01925612|594570149|FG000|Overall Study|Adverse Event|3|||
164603801|NCT01925612|594570150|FG001|Overall Study|Adverse Event|3|||
164603802|NCT01925612|594570151|FG002|Overall Study|Adverse Event|0|||
164603803|NCT01925612|594570152|FG003|Overall Study|Adverse Event|1|||
164603804|NCT01925612|594570153|FG004|Overall Study|Adverse Event|2|||
164603805|NCT01093755|594570154|FG000|Overall Study|Withdrawal by Subject|3|||
164603806|NCT01093755|594570155|FG001|Overall Study|Withdrawal by Subject|4|||
164603807|NCT03115112|594570156|FG000|Overall Study|Adverse Event|5|||
164603808|NCT03115112|594570157|FG001|Overall Study|Adverse Event|1|||
164603809|NCT03115112|594570156|FG000|Overall Study|Withdrawal by Subject|4|||
164603810|NCT03115112|594570157|FG001|Overall Study|Withdrawal by Subject|2|||
164603811|NCT03115112|594570156|FG000|Overall Study|Lost to Follow-up|0|||
164603812|NCT03115112|594570157|FG001|Overall Study|Lost to Follow-up|1|||
164603813|NCT03115112|594570156|FG000|Overall Study|Death|1|||
164603814|NCT03115112|594570157|FG001|Overall Study|Death|0|||
164603815|NCT03115112|594570156|FG000|Overall Study|Pregnancy|1|||
164603816|NCT03115112|594570157|FG001|Overall Study|Pregnancy|0|||
164603817|NCT03115112|594570156|FG000|Overall Study|Site closure|1|||
164603818|NCT03115112|594570157|FG001|Overall Study|Site closure|1|||
164603819|NCT01610076|594570158|FG000|Overall Study|Technical issue with video|0|||
164603820|NCT01610076|594570159|FG001|Overall Study|Technical issue with video|1|||
164603821|NCT01610076|594570158|FG000|Overall Study|Lost to Follow-up|3|||
164603822|NCT01610076|594570159|FG001|Overall Study|Lost to Follow-up|4|||
164603823|NCT02168803|594570163|FG000|Overall Study|Lost to Follow-up|1|||
164603824|NCT02168803|594570164|FG001|Overall Study|Lost to Follow-up|0|||
164603825|NCT02168803|594570165|FG002|Overall Study|Lost to Follow-up|1|||
164603826|NCT02168803|594570163|FG000|Overall Study|Withdrawal by Subject|1|||
164603827|NCT02168803|594570164|FG001|Overall Study|Withdrawal by Subject|1|||
164603828|NCT02168803|594570165|FG002|Overall Study|Withdrawal by Subject|2|||
164603829|NCT02168803|594570163|FG000|Overall Study|Physician Decision|0|||
164603830|NCT02168803|594570164|FG001|Overall Study|Physician Decision|1|||
164603831|NCT02168803|594570165|FG002|Overall Study|Physician Decision|0|||
164603832|NCT02168803|594570163|FG000|Overall Study|Adverse Event|0|||
164603833|NCT02168803|594570164|FG001|Overall Study|Adverse Event|1|||
164603834|NCT02168803|594570165|FG002|Overall Study|Adverse Event|1|||
164603835|NCT02168803|594570163|FG000|Overall Study|Death|0|||
164603836|NCT02168803|594570164|FG001|Overall Study|Death|0|||
164603837|NCT02168803|594570165|FG002|Overall Study|Death|1|||
164603838|NCT02168803|594570163|FG000|Overall Study|Sponsor Decision|0|||
164603839|NCT02168803|594570164|FG001|Overall Study|Sponsor Decision|0|||
164603840|NCT02168803|594570165|FG002|Overall Study|Sponsor Decision|1|||
164603841|NCT02310906|594570173|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
164603842|NCT02310906|594570174|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
164603843|NCT02310906|594570175|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
164603844|NCT02310906|594570176|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
164603845|NCT02310906|594570173|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
164603846|NCT02310906|594570174|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
164603847|NCT02310906|594570175|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
164603848|NCT02310906|594570176|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
164145298|NCT00025259|592894265|FG002|Overall Study|Protocol Violation|2|||
164603849|NCT02310906|594570173|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
164603850|NCT02310906|594570174|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
164495459|NCT00985621|594183077|FG002|Overall Study|Protocol Violation|1|||
164495460|NCT00985621|594183078|FG003|Overall Study|Protocol Violation|0|||
164603851|NCT02310906|594570175|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
164603852|NCT02310906|594570176|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
164603853|NCT02310906|594570173|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
164603854|NCT02310906|594570174|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
164603855|NCT02310906|594570175|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
164603856|NCT02310906|594570176|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
164603857|NCT00433446|594570177|FG000|Overall Study|Adverse Event|4|||
164603858|NCT00433446|594570177|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
164603859|NCT00433446|594570177|FG000|Overall Study|Progression|44|||
164603860|NCT00433446|594570177|FG000|Overall Study|Other - Not Protocol specified|3|||
164603861|NCT00433446|594570177|FG000|Overall Study|Ineligible|9|||
164603862|NCT02899377|594570178|FG000|Overall Study|Adverse Event|1|||
164603863|NCT02899377|594570179|FG001|Overall Study|Adverse Event|0|||
164603864|NCT01231607|594570180|FG000|Overall Study|Adverse Event|0|||
164603865|NCT01231607|594570181|FG001|Overall Study|Adverse Event|8|||
164603866|NCT01231607|594570182|FG002|Overall Study|Adverse Event|4|||
164603867|NCT01231607|594570183|FG003|Overall Study|Adverse Event|4|||
164603868|NCT01231607|594570184|FG004|Overall Study|Adverse Event|5|||
164603869|NCT01231607|594570180|FG000|Overall Study|Lost to Follow-up|13|||
164603870|NCT01231607|594570181|FG001|Overall Study|Lost to Follow-up|11|||
164603871|NCT01231607|594570182|FG002|Overall Study|Lost to Follow-up|10|||
164603872|NCT01231607|594570183|FG003|Overall Study|Lost to Follow-up|10|||
164603873|NCT01231607|594570184|FG004|Overall Study|Lost to Follow-up|4|||
164603874|NCT01231607|594570180|FG000|Overall Study|Physician Decision|4|||
164603875|NCT01231607|594570181|FG001|Overall Study|Physician Decision|4|||
164603876|NCT01231607|594570182|FG002|Overall Study|Physician Decision|3|||
164603877|NCT01231607|594570183|FG003|Overall Study|Physician Decision|5|||
164603878|NCT01231607|594570184|FG004|Overall Study|Physician Decision|4|||
164603879|NCT01231607|594570180|FG000|Overall Study|Protocol Violation|3|||
164603880|NCT01231607|594570181|FG001|Overall Study|Protocol Violation|2|||
164603881|NCT01231607|594570182|FG002|Overall Study|Protocol Violation|0|||
164603882|NCT01231607|594570183|FG003|Overall Study|Protocol Violation|2|||
164603883|NCT01231607|594570184|FG004|Overall Study|Protocol Violation|2|||
164603884|NCT01231607|594570180|FG000|Overall Study|Withdrawal by Subject|9|||
164603885|NCT01231607|594570181|FG001|Overall Study|Withdrawal by Subject|9|||
164603886|NCT01231607|594570182|FG002|Overall Study|Withdrawal by Subject|14|||
164603887|NCT01231607|594570183|FG003|Overall Study|Withdrawal by Subject|17|||
164603888|NCT01231607|594570184|FG004|Overall Study|Withdrawal by Subject|9|||
164603889|NCT01082367|594570189|FG000|Double-blind Period|Administrative problems|0|||
164603890|NCT01082367|594570190|FG001|Double-blind Period|Administrative problems|1|||
164603891|NCT01082367|594570189|FG000|Double-blind Period|Lack of Efficacy|5|||
164603892|NCT01082367|594570190|FG001|Double-blind Period|Lack of Efficacy|11|||
164603893|NCT01082367|594570189|FG000|Double-blind Period|Adverse Event|0|||
164603894|NCT01082367|594570190|FG001|Double-blind Period|Adverse Event|1|||
164603895|NCT01082367|594570189|FG000|Follow-up (F-U) Period|Administrative problems|1|||
164603896|NCT01082367|594570190|FG001|Follow-up (F-U) Period|Administrative problems|0|||
164603897|NCT01082367|594570189|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
164603898|NCT01082367|594570190|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
164603899|NCT01082367|594570189|FG000|Follow-up (F-U) Period|Adverse Event|0|||
164603900|NCT01082367|594570190|FG001|Follow-up (F-U) Period|Adverse Event|1|||
164603901|NCT00098020|594570193|FG000|Overall Study|Adverse Event|2|||
164603902|NCT00098020|594570193|FG000|Overall Study|Lost to Follow-up|1|||
164603903|NCT00098020|594570193|FG000|Overall Study|elevated liver enzymes|1|||
164603904|NCT00098020|594570193|FG000|Overall Study|Low urine PCR|1|||
164603905|NCT00098020|594570193|FG000|Overall Study|Low epidermal growth factor receptor|1|||
164603906|NCT00085917|594570200|FG000|Overall Study|Adverse Event|4|||
164603907|NCT00085917|594570201|FG001|Overall Study|Adverse Event|3|||
164603908|NCT01658579|594570202|FG000|Treatment Period A|Other|0|||
164603909|NCT01658579|594570203|FG001|Treatment Period A|Other|0|||
164603910|NCT01658579|594570204|FG002|Treatment Period A|Other|1|||
164603911|NCT01658579|594570205|FG003|Treatment Period A|Other|1|||
164603912|NCT01658579|594570202|FG000|Treatment Period A|Adverse Event|1|||
164603913|NCT01658579|594570203|FG001|Treatment Period A|Adverse Event|0|||
164603914|NCT01658579|594570204|FG002|Treatment Period A|Adverse Event|0|||
164603915|NCT01658579|594570205|FG003|Treatment Period A|Adverse Event|0|||
164603916|NCT01658579|594570202|FG000|Treatment Period B|Other|0|||
164603917|NCT01658579|594570203|FG001|Treatment Period B|Other|0|||
164603918|NCT01658579|594570204|FG002|Treatment Period B|Other|0|||
164603919|NCT01658579|594570205|FG003|Treatment Period B|Other|1|||
164603920|NCT01464788|594570206|FG000|Overall Study|Lost to Follow-up|0|||
164603921|NCT01464788|594570207|FG001|Overall Study|Lost to Follow-up|1|||
164603922|NCT01464788|594570208|FG002|Overall Study|Lost to Follow-up|0|||
164603923|NCT01464788|594570206|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
164603924|NCT01464788|594570207|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
164603925|NCT01464788|594570208|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
164603926|NCT00418379|594570211|FG000|Year 1|Adverse Event|9|||
164603927|NCT00418379|594570212|FG001|Year 1|Adverse Event|15|||
164603928|NCT00418379|594570213|FG002|Year 1|Adverse Event|3|||
164495461|NCT00985621|594183075|FG000|Overall Study|Withdrawal by Subject|8|||
164495462|NCT00985621|594183076|FG001|Overall Study|Withdrawal by Subject|10|||
164495463|NCT00985621|594183077|FG002|Overall Study|Withdrawal by Subject|8|||
164495464|NCT00985621|594183078|FG003|Overall Study|Withdrawal by Subject|12|||
164495465|NCT00985621|594183075|FG000|Overall Study|Other|1|||
164495466|NCT00985621|594183076|FG001|Overall Study|Other|0|||
164495467|NCT00985621|594183077|FG002|Overall Study|Other|0|||
164495468|NCT00985621|594183078|FG003|Overall Study|Other|0|||
164495469|NCT00985621|594183075|FG000|Overall Study|Randomized but not Treated|1|||
164495470|NCT00985621|594183076|FG001|Overall Study|Randomized but not Treated|0|||
164495471|NCT00985621|594183077|FG002|Overall Study|Randomized but not Treated|2|||
164495472|NCT00985621|594183078|FG003|Overall Study|Randomized but not Treated|1|||
164495473|NCT04394624|594183082|FG000|Overall Study|Adverse Event|6|||
164495474|NCT04394624|594183083|FG001|Overall Study|Adverse Event|0|||
164495475|NCT04394624|594183082|FG000|Overall Study|Progressive disease|24|||
164495476|NCT04394624|594183083|FG001|Overall Study|Progressive disease|0|||
164495477|NCT04394624|594183082|FG000|Overall Study|Not related to COVID-19|1|||
164495478|NCT04394624|594183083|FG001|Overall Study|Not related to COVID-19|0|||
164495479|NCT00905255|594183084|FG000|Overall Study|Adverse Event|7|||
164495480|NCT00905255|594183085|FG001|Overall Study|Adverse Event|5|||
164495481|NCT00905255|594183084|FG000|Overall Study|Withdrawal by Subject|5|||
164495482|NCT00905255|594183085|FG001|Overall Study|Withdrawal by Subject|4|||
164495483|NCT00905255|594183084|FG000|Overall Study|Familial and Personal Reasons|1|||
164495484|NCT00905255|594183085|FG001|Overall Study|Familial and Personal Reasons|0|||
164495485|NCT01774929|594183086|FG000|Overall Study|Adverse Event|3|||
164495486|NCT01332318|594183087|FG000|Overall Study|Adverse Event|0|||
164495487|NCT01332318|594183088|FG001|Overall Study|Adverse Event|3|||
164495488|NCT01332318|594183089|FG002|Overall Study|Adverse Event|0|||
164495489|NCT01332318|594183090|FG003|Overall Study|Adverse Event|0|||
164495490|NCT01332318|594183087|FG000|Overall Study|Withdrawal by Subject|1|||
164495491|NCT01332318|594183088|FG001|Overall Study|Withdrawal by Subject|1|||
164495492|NCT01332318|594183089|FG002|Overall Study|Withdrawal by Subject|0|||
164495493|NCT01332318|594183090|FG003|Overall Study|Withdrawal by Subject|1|||
164495494|NCT01332318|594183087|FG000|Overall Study|Protocol Violation|1|||
164495495|NCT01332318|594183088|FG001|Overall Study|Protocol Violation|0|||
164495496|NCT01332318|594183089|FG002|Overall Study|Protocol Violation|1|||
164495497|NCT01332318|594183090|FG003|Overall Study|Protocol Violation|1|||
164495498|NCT02040532|594183091|FG000|Overall Study|Lost to Follow-up|1|||
164495499|NCT02040532|594183091|FG000|Overall Study|Physician Decision|4|||
164495500|NCT02040532|594183091|FG000|Overall Study|Adverse Event|4|||
164495501|NCT02040532|594183091|FG000|Overall Study|Withdrawal by Subject|3|||
164495502|NCT00676663|594183092|FG000|Overall Study|Death|43|||
164495503|NCT00676663|594183093|FG001|Overall Study|Death|27|||
164495504|NCT00676663|594183092|FG000|Overall Study|Withdrew Consent|1|||
164495505|NCT00676663|594183093|FG001|Overall Study|Withdrew Consent|8|||
164495506|NCT00676663|594183092|FG000|Overall Study|Lost to Follow-up|1|||
164495507|NCT00676663|594183093|FG001|Overall Study|Lost to Follow-up|3|||
164495508|NCT00500539|594183097|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
164495509|NCT00500539|594183097|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
164495510|NCT00500539|594183097|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
164495511|NCT00500539|594183097|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
164495512|NCT00500539|594183097|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
164495513|NCT00500539|594183097|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
164495514|NCT00500539|594183097|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
164495515|NCT00500539|594183097|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
164495516|NCT00500539|594183097|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
164495517|NCT00500539|594183097|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
164495518|NCT00500539|594183097|FG000|Follow-up Period (16 Weeks)|Death|1|||
164495519|NCT00500539|594183097|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
164495520|NCT00500539|594183097|FG000|Follow-up Period (16 Weeks)|Missing|3|||
164495521|NCT01772147|594184859|FG000|Overall Study|Adverse Event|13|||
164495522|NCT01772147|594184860|FG001|Overall Study|Adverse Event|10|||
164603929|NCT00418379|594570211|FG000|Year 1|Withdrawal by Subject|7|||
164495523|NCT01772147|594184861|FG002|Overall Study|Adverse Event|6|||
164495524|NCT01772147|594184859|FG000|Overall Study|Withdrew Consent|7|||
164495525|NCT01772147|594184860|FG001|Overall Study|Withdrew Consent|8|||
164495526|NCT01772147|594184861|FG002|Overall Study|Withdrew Consent|4|||
164495527|NCT01772147|594184859|FG000|Overall Study|Lost to Follow-up|1|||
164495528|NCT01772147|594184860|FG001|Overall Study|Lost to Follow-up|0|||
164495529|NCT01772147|594184861|FG002|Overall Study|Lost to Follow-up|1|||
164495530|NCT01772147|594184859|FG000|Overall Study|Protocol Deviation|2|||
164495531|NCT01772147|594184860|FG001|Overall Study|Protocol Deviation|1|||
164495532|NCT01772147|594184861|FG002|Overall Study|Protocol Deviation|1|||
164495533|NCT01772147|594184859|FG000|Overall Study|Lack of Efficacy|8|||
164603930|NCT00418379|594570212|FG001|Year 1|Withdrawal by Subject|8|||
164603931|NCT00418379|594570213|FG002|Year 1|Withdrawal by Subject|5|||
164495534|NCT01772147|594184860|FG001|Overall Study|Lack of Efficacy|6|||
164495535|NCT01772147|594184861|FG002|Overall Study|Lack of Efficacy|6|||
164495536|NCT00796614|594184862|FG000|Overall Study|Adverse Event|1|||
164495537|NCT00796614|594184863|FG001|Overall Study|Adverse Event|2|||
164495538|NCT00796614|594184864|FG002|Overall Study|Adverse Event|0|||
164495539|NCT00796614|594184865|FG003|Overall Study|Adverse Event|0|||
164495540|NCT00796614|594184862|FG000|Overall Study|Protocol Violation|0|||
164495541|NCT00796614|594184863|FG001|Overall Study|Protocol Violation|0|||
164495542|NCT00796614|594184864|FG002|Overall Study|Protocol Violation|2|||
164495543|NCT00796614|594184865|FG003|Overall Study|Protocol Violation|0|||
164495544|NCT00796614|594184862|FG000|Overall Study|Lost to Follow-up|2|||
164495545|NCT00796614|594184863|FG001|Overall Study|Lost to Follow-up|2|||
164495546|NCT00796614|594184864|FG002|Overall Study|Lost to Follow-up|1|||
164495547|NCT00796614|594184865|FG003|Overall Study|Lost to Follow-up|0|||
164495548|NCT00796614|594184862|FG000|Overall Study|Withdrawal by Subject|1|||
164495549|NCT00796614|594184863|FG001|Overall Study|Withdrawal by Subject|0|||
164495550|NCT00796614|594184864|FG002|Overall Study|Withdrawal by Subject|0|||
164495551|NCT00796614|594184865|FG003|Overall Study|Withdrawal by Subject|1|||
164495552|NCT00796614|594184862|FG000|Overall Study|Other than stated|1|||
164495553|NCT00796614|594184863|FG001|Overall Study|Other than stated|0|||
164495554|NCT00796614|594184864|FG002|Overall Study|Other than stated|0|||
164495555|NCT00796614|594184865|FG003|Overall Study|Other than stated|0|||
164495556|NCT00740597|594184866|FG000|Overall Study|insurance would not cover treatment|1|||
164495557|NCT02762500|594184868|FG000|Overall Study|Lack of Efficacy|1|||
164495558|NCT02762500|594184869|FG001|Overall Study|Lack of Efficacy|0|||
164495559|NCT02762500|594184868|FG000|Overall Study|Withdrawal by Subject|1|||
164495560|NCT02762500|594184869|FG001|Overall Study|Withdrawal by Subject|1|||
164495561|NCT02762500|594184868|FG000|Overall Study|Adverse Event|0|||
164495562|NCT02762500|594184869|FG001|Overall Study|Adverse Event|2|||
164495563|NCT00632931|594184884|FG000|Part 1, Period 1|Protocol Violation|1|||
164495564|NCT00632931|594184885|FG001|Part 1, Period 1|Protocol Violation|0|||
164495565|NCT00632931|594184886|FG002|Part 1, Period 1|Protocol Violation|0|||
164495566|NCT00632931|594184884|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
164495567|NCT00632931|594184885|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
164495568|NCT00632931|594184886|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
164495569|NCT00632931|594184884|FG000|Part 2|Adverse Event|0|||
164495570|NCT00632931|594184885|FG001|Part 2|Adverse Event|0|||
164495571|NCT00632931|594184886|FG002|Part 2|Adverse Event|3|||
164495572|NCT00632931|594184884|FG000|Part 2|Death|0|||
164495573|NCT00632931|594184885|FG001|Part 2|Death|0|||
164495574|NCT00632931|594184886|FG002|Part 2|Death|1|||
164495575|NCT00632931|594184884|FG000|Part 2|Lack of Efficacy|0|||
164495576|NCT00632931|594184885|FG001|Part 2|Lack of Efficacy|0|||
164495577|NCT00632931|594184886|FG002|Part 2|Lack of Efficacy|17|||
164495578|NCT00632931|594184884|FG000|Part 2|Withdrawal by Subject|0|||
164495579|NCT00632931|594184885|FG001|Part 2|Withdrawal by Subject|0|||
164495580|NCT00632931|594184886|FG002|Part 2|Withdrawal by Subject|3|||
164495581|NCT02499835|594184892|FG000|Overall Study|Withdrawal by Subject|1|||
164495582|NCT02499835|594184893|FG001|Overall Study|Withdrawal by Subject|0|||
164495583|NCT02499835|594184894|FG002|Overall Study|Withdrawal by Subject|0|||
164495584|NCT02499835|594184895|FG003|Overall Study|Withdrawal by Subject|1|||
164495585|NCT02499835|594184892|FG000|Overall Study|Physician Decision|0|||
164495586|NCT02499835|594184893|FG001|Overall Study|Physician Decision|3|||
164495587|NCT02499835|594184894|FG002|Overall Study|Physician Decision|18|||
164495588|NCT02499835|594184895|FG003|Overall Study|Physician Decision|7|||
164495589|NCT02499835|594184892|FG000|Overall Study|Adverse Event|0|||
164495590|NCT02499835|594184893|FG001|Overall Study|Adverse Event|0|||
164495591|NCT02499835|594184894|FG002|Overall Study|Adverse Event|0|||
164495592|NCT02499835|594184895|FG003|Overall Study|Adverse Event|1|||
164495593|NCT02499835|594184892|FG000|Overall Study|Disease progression|2|||
164495594|NCT02499835|594184893|FG001|Overall Study|Disease progression|1|||
164495595|NCT02499835|594184894|FG002|Overall Study|Disease progression|0|||
164495596|NCT02499835|594184895|FG003|Overall Study|Disease progression|7|||
164495597|NCT03319719|594184903|FG000|Overall Study|Lost to Follow-up|1|||
164495598|NCT03193216|594184904|FG000|Overall Study|Lost to Follow-up|1|||
164495599|NCT03193216|594184905|FG001|Overall Study|Lost to Follow-up|0|||
164495600|NCT03193216|594184904|FG000|Overall Study|Withdrawal by Subject|5|||
164495601|NCT03193216|594184905|FG001|Overall Study|Withdrawal by Subject|0|||
164495602|NCT03193216|594184904|FG000|Overall Study|Physician Decision|4|||
164495603|NCT03193216|594184905|FG001|Overall Study|Physician Decision|0|||
164495604|NCT02490878|594184906|FG000|Overall Study|deemed ineligible|0|||
164495605|NCT02490878|594184907|FG001|Overall Study|deemed ineligible|1|||
164495606|NCT02490878|594184906|FG000|Overall Study|progression prior to treatment|0|||
164495607|NCT02490878|594184907|FG001|Overall Study|progression prior to treatment|1|||
164495608|NCT02490878|594184906|FG000|Overall Study|only submitted baseline QOL|0|||
164495609|NCT02490878|594184907|FG001|Overall Study|only submitted baseline QOL|1|||
164495610|NCT00922441|594184908|FG000|Overall Study|Protocol Violation|0|||
164495611|NCT00922441|594184909|FG001|Overall Study|Protocol Violation|0|||
164495612|NCT00922441|594184910|FG002|Overall Study|Protocol Violation|2|||
164495613|NCT00922441|594184908|FG000|Overall Study|Withdrawal by Subject|0|||
164495614|NCT00922441|594184909|FG001|Overall Study|Withdrawal by Subject|0|||
164495615|NCT00922441|594184910|FG002|Overall Study|Withdrawal by Subject|1|||
164495616|NCT00317603|594184911|FG000|Overall Study|Progressive Disease|3|||
164495617|NCT00523549|594184914|FG000|Overall Study|Adverse Event|6|||
164495618|NCT00523549|594184915|FG001|Overall Study|Adverse Event|3|||
164495619|NCT00523549|594184914|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164495620|NCT00523549|594184915|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
164495621|NCT00523549|594184914|FG000|Overall Study|Protocol Deviation|3|||
164495622|NCT00523549|594184915|FG001|Overall Study|Protocol Deviation|1|||
164495623|NCT00523549|594184914|FG000|Overall Study|Patient withdrew consent|7|||
164495624|NCT00523549|594184915|FG001|Overall Study|Patient withdrew consent|6|||
164495625|NCT00523549|594184914|FG000|Overall Study|Lost to Follow-up|3|||
164495626|NCT00523549|594184915|FG001|Overall Study|Lost to Follow-up|5|||
164495627|NCT00439647|594184916|FG000|Overall Study|Withdrawal by Subject|25|||
164495628|NCT00439647|594184917|FG001|Overall Study|Withdrawal by Subject|22|||
164495629|NCT00439647|594184916|FG000|Overall Study|Death|15|||
164495630|NCT00439647|594184917|FG001|Overall Study|Death|18|||
164495631|NCT00439647|594184916|FG000|Overall Study|Adverse Event|11|||
164495632|NCT00439647|594184917|FG001|Overall Study|Adverse Event|11|||
164495633|NCT00439647|594184916|FG000|Overall Study|Lost to Follow-up|4|||
164495634|NCT00439647|594184917|FG001|Overall Study|Lost to Follow-up|12|||
164495635|NCT00439647|594184916|FG000|Overall Study|Protocol Violation|3|||
164495636|NCT00439647|594184917|FG001|Overall Study|Protocol Violation|4|||
164495637|NCT00439647|594184916|FG000|Overall Study|Lack of Efficacy|0|||
164495638|NCT00439647|594184917|FG001|Overall Study|Lack of Efficacy|4|||
164495639|NCT02005029|594184918|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
164495640|NCT02005029|594184919|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
164495641|NCT02621047|594184920|FG000|Overall Study|Adverse Event|0|||
164495642|NCT02621047|594184921|FG001|Overall Study|Adverse Event|0|||
164495643|NCT02621047|594184922|FG002|Overall Study|Adverse Event|1|||
164495644|NCT03371485|594184923|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
164495645|NCT03371485|594184923|FG000|2-year Follow-up|Death|5|||
164495646|NCT01264887|594184924|FG000|Overall Study|Adverse Event|5|||
164495647|NCT01264887|594184924|FG000|Overall Study|Death|7|||
164495648|NCT01264887|594184924|FG000|Overall Study|Lack of Efficacy|5|||
164495649|NCT01264887|594184924|FG000|Overall Study|Physician Decision|4|||
164495650|NCT01264887|594184924|FG000|Overall Study|Withdrawal by Subject|6|||
164495651|NCT01264887|594184924|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
164495652|NCT01264887|594184924|FG000|Overall Study|Other|2|||
164495653|NCT02853305|594184930|FG000|Overall Study|Death|287|||
164495654|NCT02853305|594184931|FG001|Overall Study|Death|249|||
164495655|NCT02853305|594184932|FG002|Overall Study|Death|300|||
164495656|NCT02853305|594184930|FG000|Overall Study|Withdrawal by Subject|2|||
164495657|NCT02853305|594184931|FG001|Overall Study|Withdrawal by Subject|8|||
164495658|NCT02853305|594184932|FG002|Overall Study|Withdrawal by Subject|3|||
164495659|NCT02853305|594184930|FG000|Overall Study|Transferred to Extension Study|46|||
164495660|NCT02853305|594184931|FG001|Overall Study|Transferred to Extension Study|30|||
164495661|NCT02853305|594184932|FG002|Overall Study|Transferred to Extension Study|25|||
164495662|NCT02853305|594184930|FG000|Overall Study|Did Not Continue on Extension Study|16|||
164495663|NCT02853305|594184931|FG001|Overall Study|Did Not Continue on Extension Study|20|||
164495664|NCT02853305|594184932|FG002|Overall Study|Did Not Continue on Extension Study|24|||
164603932|NCT00418379|594570211|FG000|Year 1|Any other reason not above-mentioned|2|||
164603933|NCT00418379|594570212|FG001|Year 1|Any other reason not above-mentioned|5|||
164603934|NCT00418379|594570213|FG002|Year 1|Any other reason not above-mentioned|7|||
164603935|NCT00418379|594570211|FG000|Year 2|Adverse Event|5|||
164603936|NCT00418379|594570212|FG001|Year 2|Adverse Event|2|||
164603937|NCT00418379|594570213|FG002|Year 2|Adverse Event|1|||
164603938|NCT00418379|594570211|FG000|Year 2|Withdrawal by Subject|1|||
164603939|NCT00418379|594570212|FG001|Year 2|Withdrawal by Subject|1|||
164603940|NCT00418379|594570213|FG002|Year 2|Withdrawal by Subject|3|||
164603941|NCT00418379|594570211|FG000|Year 2|Any other reason not above-mentioned|2|||
164603942|NCT00418379|594570212|FG001|Year 2|Any other reason not above-mentioned|1|||
164603943|NCT00418379|594570213|FG002|Year 2|Any other reason not above-mentioned|6|||
164603944|NCT00418379|594570211|FG000|Year 3|Withdrawal by Subject|1|||
164603945|NCT00418379|594570212|FG001|Year 3|Withdrawal by Subject|1|||
164603946|NCT00418379|594570213|FG002|Year 3|Withdrawal by Subject|2|||
164603947|NCT00418379|594570211|FG000|Year 3|Any other reason not above-mentioned|2|||
164603948|NCT00418379|594570212|FG001|Year 3|Any other reason not above-mentioned|1|||
164603949|NCT00418379|594570213|FG002|Year 3|Any other reason not above-mentioned|1|||
164603950|NCT00418379|594570211|FG000|Year 4|Adverse Event|0|||
164603951|NCT00418379|594570212|FG001|Year 4|Adverse Event|1|||
164603952|NCT00418379|594570213|FG002|Year 4|Adverse Event|0|||
164603953|NCT00418379|594570211|FG000|Year 4|Withdrawal by Subject|2|||
164603954|NCT00418379|594570212|FG001|Year 4|Withdrawal by Subject|3|||
164603955|NCT00418379|594570213|FG002|Year 4|Withdrawal by Subject|2|||
164603956|NCT00418379|594570211|FG000|Year 4|Any other reason not above-mentioned|1|||
164603957|NCT00418379|594570212|FG001|Year 4|Any other reason not above-mentioned|1|||
164603958|NCT00418379|594570213|FG002|Year 4|Any other reason not above-mentioned|0|||
164495665|NCT00677092|594184935|FG000|Overall Study|Adverse Event|1|||
164495666|NCT00677092|594184935|FG000|Overall Study|Lost to Follow-up|1|||
164495667|NCT00677092|594184935|FG000|Overall Study|Withdrawal by Subject|3|||
164495668|NCT00677092|594184935|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
164495669|NCT03187353|594184938|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
164495670|NCT03187353|594184939|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
164495671|NCT03187353|594184938|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
164495672|NCT03187353|594184939|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
164495673|NCT03187353|594184938|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
164495674|NCT03187353|594184939|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
164495675|NCT03187353|594184938|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
164495676|NCT03187353|594184939|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
164495677|NCT03187353|594184938|FG000|Washout (2 Weeks)|Adverse Event|2|||
164495678|NCT03187353|594184939|FG001|Washout (2 Weeks)|Adverse Event|0|||
164495679|NCT03187353|594184938|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
164495680|NCT03187353|594184939|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
164495681|NCT02215954|594184940|FG000|Overall Study|Adverse Event|0|||
164495682|NCT02215954|594184941|FG001|Overall Study|Adverse Event|0|||
164495683|NCT02215954|594184942|FG002|Overall Study|Adverse Event|1|||
164495684|NCT02215954|594184940|FG000|Overall Study|Withdrawal by Subject|0|||
164495685|NCT02215954|594184941|FG001|Overall Study|Withdrawal by Subject|0|||
164495686|NCT02215954|594184942|FG002|Overall Study|Withdrawal by Subject|2|||
164495687|NCT02215954|594184940|FG000|Overall Study|Not exposed|1|||
164495688|NCT02215954|594184941|FG001|Overall Study|Not exposed|1|||
164495689|NCT02215954|594184942|FG002|Overall Study|Not exposed|3|||
164495690|NCT01222078|594184949|FG000|Overall Study|Early termination of the study|1|||
164495691|NCT04089332|594184950|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
164495692|NCT04089332|594184950|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
164495693|NCT04089332|594184950|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
164495694|NCT06016127|594184951|FG000|Overall Study|Withdrawal by Subject|4|||
164495695|NCT06016127|594184952|FG001|Overall Study|Withdrawal by Subject|3|||
164495696|NCT02588027|594184954|FG000|Overall Study|Withdrawal by Subject|1|||
164495697|NCT02588027|594184955|FG001|Overall Study|Withdrawal by Subject|3|||
164495698|NCT02588027|594184954|FG000|Overall Study|Protocol Violation|4|||
164495699|NCT02588027|594184955|FG001|Overall Study|Protocol Violation|1|||
164495700|NCT03340766|594184956|FG000|Overall Study|Withdrawal by Subject|2|||
164495701|NCT03340766|594184957|FG001|Overall Study|Withdrawal by Subject|1|||
164495702|NCT03340766|594184958|FG002|Overall Study|Withdrawal by Subject|3|||
164495703|NCT03340766|594184956|FG000|Overall Study|Lost to Follow-up|0|||
164495704|NCT03340766|594184957|FG001|Overall Study|Lost to Follow-up|0|||
164495705|NCT03340766|594184958|FG002|Overall Study|Lost to Follow-up|1|||
164495706|NCT03340766|594184956|FG000|Overall Study|Death|6|||
164495707|NCT03340766|594184957|FG001|Overall Study|Death|7|||
164495708|NCT03340766|594184958|FG002|Overall Study|Death|4|||
164495709|NCT00240097|594184962|FG000|Part I|Adverse Event|1|||
164495710|NCT00240097|594184962|FG000|Part I|Death|1|||
164495711|NCT00240097|594184962|FG000|Part I|histology|1|||
164495712|NCT00240097|594184962|FG000|Part I|unevaluable|1|||
164495713|NCT00240097|594184962|FG000|Part II|did not continue from Part I|23|||
164495714|NCT01294358|594184963|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
164495715|NCT01294358|594184964|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
164495716|NCT01294358|594184965|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
164495717|NCT01294358|594184966|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
164495718|NCT01294358|594184967|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
164495719|NCT01294358|594184963|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
164495720|NCT01294358|594184964|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
164495721|NCT01294358|594184965|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
164495722|NCT01294358|594184966|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
164495723|NCT01294358|594184967|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
164603959|NCT00418379|594570211|FG000|Year 5|Adverse Event|0|||
164603960|NCT00418379|594570212|FG001|Year 5|Adverse Event|1|||
164603961|NCT00418379|594570213|FG002|Year 5|Adverse Event|0|||
164145299|NCT00025259|592894266|FG003|Overall Study|Protocol Violation|1|||
164603962|NCT00418379|594570211|FG000|Year 5|Any other reason not above-mentioned|2|||
164495724|NCT01294358|594184963|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
164495725|NCT01294358|594184964|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
164495726|NCT01294358|594184965|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
164495727|NCT01294358|594184966|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
164495728|NCT01294358|594184967|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
164495729|NCT01294358|594184963|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
164495730|NCT01294358|594184964|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
164495731|NCT01294358|594184965|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
164495732|NCT01294358|594184966|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
164603963|NCT00418379|594570212|FG001|Year 5|Any other reason not above-mentioned|4|||
164715449|NCT01371539|594980403|FG000|Period Two: One Week|Lost to Follow-up|0|||
164715450|NCT01371539|594980404|FG001|Period Two: One Week|Lost to Follow-up|1|||
164715451|NCT01371539|594980403|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
164715452|NCT01371539|594980404|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
164715453|NCT01371539|594980403|FG000|Period Two: One Week|Time/job conflict|0|||
164715454|NCT01371539|594980404|FG001|Period Two: One Week|Time/job conflict|1|||
164715455|NCT01399658|594980405|FG000|Overall Study|Ineligible|1|||
164715456|NCT01399658|594980405|FG000|Overall Study|Machine Technical Issue|3|||
164715457|NCT01399658|594980405|FG000|Overall Study|Alternative therapy|1|||
164715458|NCT01399658|594980405|FG000|Overall Study|No reason given|1|||
164715459|NCT02620579|594980408|FG000|Overall Study|Physician Decision|0|||
164715460|NCT02620579|594980409|FG001|Overall Study|Physician Decision|0|||
164715461|NCT02620579|594980410|FG002|Overall Study|Physician Decision|0|||
164715462|NCT02620579|594980411|FG003|Overall Study|Physician Decision|1|||
164715463|NCT02620579|594980408|FG000|Overall Study|Withdrawal by Subject|0|||
164715464|NCT02620579|594980409|FG001|Overall Study|Withdrawal by Subject|1|||
164715465|NCT02620579|594980410|FG002|Overall Study|Withdrawal by Subject|1|||
164715466|NCT02620579|594980411|FG003|Overall Study|Withdrawal by Subject|0|||
164715467|NCT04315506|594980413|FG000|Overall Study|Lost to Follow-up|74|||
164715468|NCT04315506|594980414|FG001|Overall Study|Lost to Follow-up|82|||
164715469|NCT04315506|594980413|FG000|Overall Study|Withdrawal by Subject|8|||
164495733|NCT01294358|594184967|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
164495734|NCT03613454|594184968|FG000|Overall Study|Protocol Violation|1|||
164495735|NCT03613454|594184969|FG001|Overall Study|Protocol Violation|0|||
164495736|NCT03613454|594184968|FG000|Overall Study|Protocol Violation|0|||
164495737|NCT03613454|594184969|FG001|Overall Study|Protocol Violation|1|||
164495738|NCT02963922|594184970|FG000|Overall Study|Adverse Event|15|||
164495739|NCT02963922|594184971|FG001|Overall Study|Adverse Event|6|||
164495740|NCT02963922|594184970|FG000|Overall Study|Protocol deviation|6|||
164495741|NCT02963922|594184971|FG001|Overall Study|Protocol deviation|6|||
164495742|NCT02963922|594184970|FG000|Overall Study|Lack of Efficacy|1|||
164495743|NCT02963922|594184971|FG001|Overall Study|Lack of Efficacy|1|||
164495744|NCT02963922|594184970|FG000|Overall Study|Lost to Follow-up|2|||
164495745|NCT02963922|594184971|FG001|Overall Study|Lost to Follow-up|3|||
164495746|NCT02963922|594184970|FG000|Overall Study|Other|8|||
164495747|NCT02963922|594184971|FG001|Overall Study|Other|14|||
164495748|NCT03873038|594184980|FG000|Part 2|Withdrawal by Subject|0|||
164495749|NCT03873038|594184981|FG001|Part 2|Withdrawal by Subject|0|||
164495750|NCT03873038|594184982|FG002|Part 2|Withdrawal by Subject|0|||
164495751|NCT03873038|594184983|FG003|Part 2|Withdrawal by Subject|0|||
164495752|NCT03873038|594184984|FG004|Part 2|Withdrawal by Subject|0|||
164495753|NCT03873038|594184985|FG005|Part 2|Withdrawal by Subject|1|||
164495754|NCT03873038|594184980|FG000|Part 2|Unknon|0|||
164495755|NCT03873038|594184981|FG001|Part 2|Unknon|0|||
164495756|NCT03873038|594184982|FG002|Part 2|Unknon|0|||
164495757|NCT03873038|594184983|FG003|Part 2|Unknon|0|||
164495758|NCT03873038|594184984|FG004|Part 2|Unknon|1|||
164495759|NCT03873038|594184985|FG005|Part 2|Unknon|0|||
164495760|NCT04222088|594184986|FG000|Overall Study|Lost to Follow-up|5|||
164495761|NCT04222088|594184987|FG001|Overall Study|Lost to Follow-up|1|||
164495762|NCT04222088|594184986|FG000|Overall Study|Withdrawal by Subject|4|||
164495763|NCT04222088|594184987|FG001|Overall Study|Withdrawal by Subject|0|||
164495764|NCT00595764|594184988|FG000|Overall Study|Protocol Violation|24|||
164495765|NCT00595764|594184989|FG001|Overall Study|Protocol Violation|19|||
164495766|NCT00595764|594184988|FG000|Overall Study|Missed Medication >1 week|10|||
164495767|NCT00595764|594184989|FG001|Overall Study|Missed Medication >1 week|17|||
164495768|NCT00595764|594184988|FG000|Overall Study|Missed 3 PM visits|1|||
164495769|NCT00595764|594184989|FG001|Overall Study|Missed 3 PM visits|7|||
164495770|NCT00595764|594184988|FG000|Overall Study|Withdrawal by Subject|4|||
164495771|NCT00595764|594184989|FG001|Overall Study|Withdrawal by Subject|0|||
164495772|NCT00603278|594184990|FG000|Overall Study|Lack of Efficacy|35|||
164495773|NCT00603278|594184991|FG001|Overall Study|Lack of Efficacy|10|||
164495774|NCT00603278|594184992|FG002|Overall Study|Lack of Efficacy|11|||
164495775|NCT00603278|594184993|FG003|Overall Study|Lack of Efficacy|8|||
164495776|NCT00603278|594184994|FG004|Overall Study|Lack of Efficacy|7|||
164495777|NCT00603278|594184995|FG005|Overall Study|Lack of Efficacy|14|||
164715470|NCT04315506|594980414|FG001|Overall Study|Withdrawal by Subject|8|||
164715471|NCT04315506|594980413|FG000|Overall Study|Physician Decision|0|||
164495778|NCT00603278|594184990|FG000|Overall Study|Adverse Event|0|||
164495779|NCT00603278|594184991|FG001|Overall Study|Adverse Event|3|||
164495780|NCT00603278|594184992|FG002|Overall Study|Adverse Event|1|||
164495781|NCT00603278|594184993|FG003|Overall Study|Adverse Event|0|||
164495782|NCT00603278|594184994|FG004|Overall Study|Adverse Event|2|||
164495783|NCT00603278|594184995|FG005|Overall Study|Adverse Event|1|||
164495784|NCT00603278|594184990|FG000|Overall Study|Withdrawal by Subject|2|||
164495785|NCT00603278|594184991|FG001|Overall Study|Withdrawal by Subject|3|||
164715472|NCT04315506|594980414|FG001|Overall Study|Physician Decision|1|||
164715473|NCT01721317|594980415|FG000|Overall Study|Study Closed / Terminated|2|||
164495786|NCT00603278|594184992|FG002|Overall Study|Withdrawal by Subject|1|||
164495787|NCT00603278|594184993|FG003|Overall Study|Withdrawal by Subject|2|||
164495788|NCT00603278|594184994|FG004|Overall Study|Withdrawal by Subject|1|||
164495789|NCT00603278|594184995|FG005|Overall Study|Withdrawal by Subject|2|||
164495790|NCT00603278|594184990|FG000|Overall Study|Protocol Violation|3|||
164495791|NCT00603278|594184991|FG001|Overall Study|Protocol Violation|0|||
164495792|NCT00603278|594184992|FG002|Overall Study|Protocol Violation|1|||
164495793|NCT00603278|594184993|FG003|Overall Study|Protocol Violation|1|||
164495794|NCT00603278|594184994|FG004|Overall Study|Protocol Violation|0|||
164495795|NCT00603278|594184995|FG005|Overall Study|Protocol Violation|1|||
164495796|NCT00603278|594184990|FG000|Overall Study|Physician Decision|0|||
164495797|NCT00603278|594184991|FG001|Overall Study|Physician Decision|1|||
164495798|NCT00603278|594184992|FG002|Overall Study|Physician Decision|0|||
164603964|NCT00418379|594570213|FG002|Year 5|Any other reason not above-mentioned|3|||
164603965|NCT00843843|594570214|FG000|Overall Study|Physician Decision|1|||
164603966|NCT00843843|594570215|FG001|Overall Study|Physician Decision|1|||
164603967|NCT00843843|594570214|FG000|Overall Study|Protocol Violation|1|||
164603968|NCT00843843|594570215|FG001|Overall Study|Protocol Violation|1|||
164603969|NCT00565058|594570216|FG000|Overall Study|Adverse Event|1|||
164603970|NCT00565058|594570217|FG001|Overall Study|Adverse Event|0|||
164603971|NCT00400712|594570236|FG000|Overall Study|Death|1|||
164603972|NCT00400712|594570237|FG001|Overall Study|Death|0|||
164603973|NCT00400712|594570236|FG000|Overall Study|Withdrawal by Subject|11|||
164603974|NCT00400712|594570237|FG001|Overall Study|Withdrawal by Subject|12|||
164603975|NCT00400712|594570236|FG000|Overall Study|Physician Decision|5|||
164603976|NCT00400712|594570237|FG001|Overall Study|Physician Decision|4|||
164603977|NCT02670330|594570238|FG000|Overall Study|Protocol Deviation|1|||
164603978|NCT02670330|594570239|FG001|Overall Study|Protocol Deviation|0|||
164603979|NCT02670330|594570238|FG000|Overall Study|Study Terminated By Sponsor|36|||
164603980|NCT02670330|594570239|FG001|Overall Study|Study Terminated By Sponsor|43|||
164603981|NCT02670330|594570238|FG000|Overall Study|Adverse Event|1|||
164603982|NCT02670330|594570239|FG001|Overall Study|Adverse Event|3|||
164603983|NCT02670330|594570238|FG000|Overall Study|Withdrawal by Subject|34|||
164603984|NCT02670330|594570239|FG001|Overall Study|Withdrawal by Subject|29|||
164603985|NCT02670330|594570238|FG000|Overall Study|Lost to Follow-up|3|||
164603986|NCT02670330|594570239|FG001|Overall Study|Lost to Follow-up|2|||
164603987|NCT00634114|594570240|FG000|Overall Study|Adverse Event|6|||
164603988|NCT00634114|594570241|FG001|Overall Study|Adverse Event|8|||
164603989|NCT00634114|594570242|FG002|Overall Study|Adverse Event|3|||
164603990|NCT00634114|594570240|FG000|Overall Study|Withdrawal by Subject|9|||
164603991|NCT00634114|594570241|FG001|Overall Study|Withdrawal by Subject|6|||
164603992|NCT00634114|594570242|FG002|Overall Study|Withdrawal by Subject|11|||
164603993|NCT00634114|594570240|FG000|Overall Study|Lost to Follow-up|0|||
164603994|NCT00634114|594570241|FG001|Overall Study|Lost to Follow-up|0|||
164603995|NCT00634114|594570242|FG002|Overall Study|Lost to Follow-up|1|||
164603996|NCT00634114|594570240|FG000|Overall Study|Protocol Violation|3|||
164603997|NCT00634114|594570241|FG001|Overall Study|Protocol Violation|3|||
164603998|NCT00634114|594570242|FG002|Overall Study|Protocol Violation|1|||
164603999|NCT00634114|594570240|FG000|Overall Study|Pregnancy|1|||
164604000|NCT00634114|594570241|FG001|Overall Study|Pregnancy|0|||
164604001|NCT00634114|594570242|FG002|Overall Study|Pregnancy|0|||
164604002|NCT00634114|594570240|FG000|Overall Study|Incorrect enrolment|0|||
164604003|NCT00634114|594570241|FG001|Overall Study|Incorrect enrolment|1|||
164604004|NCT00634114|594570242|FG002|Overall Study|Incorrect enrolment|0|||
164604005|NCT00634114|594570240|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
164604006|NCT00634114|594570241|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
164604007|NCT00634114|594570242|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
164604008|NCT00634114|594570240|FG000|Overall Study|Difficult to continue|3|||
164604009|NCT00634114|594570241|FG001|Overall Study|Difficult to continue|1|||
164604010|NCT00634114|594570242|FG002|Overall Study|Difficult to continue|1|||
164604011|NCT00634114|594570240|FG000|Overall Study|Other reason|1|||
164604012|NCT00634114|594570241|FG001|Overall Study|Other reason|1|||
164604013|NCT00634114|594570242|FG002|Overall Study|Other reason|1|||
164604014|NCT03670641|594570247|FG000|Overall Study|Lost to Follow-up|3|||
164604015|NCT00916370|594570254|FG000|Overall Study|Death|3|||
164604016|NCT00916370|594570255|FG001|Overall Study|Death|1|||
164604017|NCT00916370|594570254|FG000|Overall Study|Withdrawal by Subject|2|||
164604018|NCT00916370|594570255|FG001|Overall Study|Withdrawal by Subject|0|||
164604019|NCT00916370|594570254|FG000|Overall Study|Physician Decision|0|||
164604020|NCT00916370|594570255|FG001|Overall Study|Physician Decision|1|||
164604021|NCT00264849|594570257|FG000|Overall Study|Adverse Event|7|||
164604022|NCT00264849|594570258|FG001|Overall Study|Adverse Event|2|||
164604023|NCT00264849|594570257|FG000|Overall Study|Withdrawal by Subject|7|||
164495799|NCT00603278|594184993|FG003|Overall Study|Physician Decision|0|||
164495800|NCT00603278|594184994|FG004|Overall Study|Physician Decision|2|||
164604024|NCT00264849|594570258|FG001|Overall Study|Withdrawal by Subject|11|||
164604025|NCT00264849|594570257|FG000|Overall Study|Protocol Violation|5|||
164604026|NCT00264849|594570258|FG001|Overall Study|Protocol Violation|3|||
164604027|NCT00264849|594570257|FG000|Overall Study|Lack of Efficacy|1|||
164604028|NCT00264849|594570258|FG001|Overall Study|Lack of Efficacy|6|||
164495801|NCT00603278|594184995|FG005|Overall Study|Physician Decision|1|||
164604029|NCT00264849|594570257|FG000|Overall Study|Lost to Follow-up|0|||
164715474|NCT01721317|594980416|FG001|Overall Study|Study Closed / Terminated|2|||
164495802|NCT00603278|594184990|FG000|Overall Study|Lost to Follow-up|1|||
164495803|NCT00603278|594184991|FG001|Overall Study|Lost to Follow-up|0|||
164495804|NCT00603278|594184992|FG002|Overall Study|Lost to Follow-up|0|||
164495805|NCT00603278|594184993|FG003|Overall Study|Lost to Follow-up|0|||
164495806|NCT00603278|594184994|FG004|Overall Study|Lost to Follow-up|1|||
164495807|NCT00603278|594184995|FG005|Overall Study|Lost to Follow-up|0|||
164495808|NCT03169530|594184996|FG000|Overall Study|Study ended by NIH|15|||
164495809|NCT03169530|594184997|FG001|Overall Study|Study ended by NIH|17|||
164495810|NCT01032200|594184998|FG000|Overall Study|Death|1|||
164495811|NCT01032200|594184999|FG001|Overall Study|Death|1|||
164495812|NCT01032200|594184998|FG000|Overall Study|Withdrawal by Subject|1|||
164495813|NCT01032200|594184999|FG001|Overall Study|Withdrawal by Subject|3|||
164495814|NCT01032200|594184998|FG000|Overall Study|Toxicity|0|||
164495815|NCT01032200|594184999|FG001|Overall Study|Toxicity|2|||
164495816|NCT01032200|594184998|FG000|Overall Study|Progression|1|||
164495817|NCT01032200|594184999|FG001|Overall Study|Progression|0|||
164495818|NCT01032200|594184998|FG000|Overall Study|Multiple|1|||
164495819|NCT01032200|594184999|FG001|Overall Study|Multiple|1|||
164495820|NCT02273180|594185003|FG000|Overall Study|Adverse Event|2|||
164495821|NCT02273180|594185004|FG001|Overall Study|Adverse Event|2|||
164495822|NCT02273180|594185003|FG000|Overall Study|Lack of Efficacy|1|||
164495823|NCT02273180|594185004|FG001|Overall Study|Lack of Efficacy|0|||
164495824|NCT02273180|594185003|FG000|Overall Study|Protocol Violation|1|||
164495825|NCT02273180|594185004|FG001|Overall Study|Protocol Violation|7|||
164495826|NCT02273180|594185003|FG000|Overall Study|Randomized but not treated|1|||
164495827|NCT02273180|594185004|FG001|Overall Study|Randomized but not treated|0|||
164495828|NCT02273180|594185003|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
164495829|NCT02273180|594185004|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
164495830|NCT02273180|594185003|FG000|Overall Study|Other than specified above|21|||
164495831|NCT02273180|594185004|FG001|Overall Study|Other than specified above|10|||
164495832|NCT04853394|594185005|FG000|Follow-up Interviews|Lost to Follow-up|22|||
164495833|NCT04853394|594185006|FG001|Follow-up Interviews|Lost to Follow-up|15|||
164495834|NCT04341584|594185009|FG000|Overall Study|Withdrew consent|0|||
164495835|NCT04341584|594185010|FG001|Overall Study|Withdrew consent|2|||
164495836|NCT04341584|594185011|FG002|Overall Study|Withdrew consent|2|||
164495837|NCT04341584|594185012|FG003|Overall Study|Withdrew consent|1|||
164495838|NCT01123642|594185013|FG000|Overall Study|Lost to Follow-up|23|||
164495839|NCT01123642|594185013|FG000|Overall Study|Withdrawal by Subject|9|||
164495840|NCT01123642|594185013|FG000|Overall Study|ineligible at baseline assessment|36|||
164495841|NCT04853238|594185014|FG000|Overall Study|Death|4|||
164495842|NCT04853238|594185015|FG001|Overall Study|Death|0|||
164495843|NCT04853238|594185016|FG002|Overall Study|Death|2|||
164495844|NCT04853238|594185014|FG000|Overall Study|Lost to Follow-up|16|||
164495845|NCT04853238|594185015|FG001|Overall Study|Lost to Follow-up|2|||
164495846|NCT04853238|594185016|FG002|Overall Study|Lost to Follow-up|37|||
164495847|NCT04853238|594185014|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
164495848|NCT04853238|594185015|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
164495849|NCT04853238|594185016|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
164495850|NCT04853238|594185014|FG000|Overall Study|Withdrawal by Subject|6|||
164495851|NCT04853238|594185015|FG001|Overall Study|Withdrawal by Subject|0|||
164495852|NCT04853238|594185016|FG002|Overall Study|Withdrawal by Subject|21|||
164495853|NCT04853238|594185014|FG000|Overall Study|Physician Decision|0|||
164495854|NCT04853238|594185015|FG001|Overall Study|Physician Decision|0|||
164495855|NCT04853238|594185016|FG002|Overall Study|Physician Decision|2|||
164495856|NCT04853238|594185014|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
164495857|NCT04853238|594185015|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
164495858|NCT04853238|594185016|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
164495859|NCT00957996|594186898|FG000|Overall Study|Death|4|||
164495860|NCT00957996|594186899|FG001|Overall Study|Death|10|||
164495861|NCT00957996|594186898|FG000|Overall Study|Lost to Follow-up|4|||
164495862|NCT00957996|594186899|FG001|Overall Study|Lost to Follow-up|7|||
164495863|NCT00957996|594186898|FG000|Overall Study|Withdrawal by Subject|9|||
164495864|NCT00957996|594186899|FG001|Overall Study|Withdrawal by Subject|2|||
164495865|NCT00957996|594186898|FG000|Overall Study|Adverse Event|2|||
164495866|NCT00957996|594186899|FG001|Overall Study|Adverse Event|1|||
164495867|NCT00957996|594186898|FG000|Overall Study|Physician Decision|1|||
164495868|NCT00957996|594186899|FG001|Overall Study|Physician Decision|1|||
164604030|NCT00264849|594570258|FG001|Overall Study|Lost to Follow-up|2|||
164604031|NCT00264849|594570257|FG000|Overall Study|Death|0|||
164604032|NCT00264849|594570258|FG001|Overall Study|Death|1|||
164604033|NCT00264849|594570257|FG000|Overall Study|Administrative Problems|2|||
164604034|NCT00264849|594570258|FG001|Overall Study|Administrative Problems|0|||
164604035|NCT00383721|594570264|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
164604036|NCT00383721|594570265|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
164604037|NCT00383721|594570266|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
164604038|NCT00383721|594570267|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
164495869|NCT00957996|594186898|FG000|Overall Study|Influenza-related complication|0|||
164604039|NCT00383721|594570268|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
164604040|NCT00383721|594570264|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
164604041|NCT00383721|594570265|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
164604042|NCT00383721|594570266|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
164604043|NCT00383721|594570267|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
164604044|NCT00383721|594570268|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
164604045|NCT00383721|594570264|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
164604046|NCT00383721|594570265|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
164604047|NCT00383721|594570266|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
164604048|NCT00383721|594570267|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
164604049|NCT00383721|594570268|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
164495870|NCT00957996|594186899|FG001|Overall Study|Influenza-related complication|1|||
164495871|NCT00957996|594186898|FG000|Overall Study|Missing|1|||
164495872|NCT00957996|594186899|FG001|Overall Study|Missing|0|||
164495873|NCT00957996|594186898|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
164495874|NCT00957996|594186899|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
164495875|NCT00684203|594186906|FG000|Overall Study|Adverse Event|6|||
164495876|NCT00684203|594186907|FG001|Overall Study|Adverse Event|4|||
164495877|NCT00684203|594186908|FG002|Overall Study|Adverse Event|8|||
164495878|NCT00684203|594186909|FG003|Overall Study|Adverse Event|0|||
164495879|NCT00684203|594186910|FG004|Overall Study|Adverse Event|0|||
164495880|NCT00684203|594186911|FG005|Overall Study|Adverse Event|0|||
164495881|NCT00684203|594186906|FG000|Overall Study|Protocol-defined clinical event|3|||
164495882|NCT00684203|594186907|FG001|Overall Study|Protocol-defined clinical event|1|||
164495883|NCT00684203|594186908|FG002|Overall Study|Protocol-defined clinical event|0|||
164495884|NCT00684203|594186909|FG003|Overall Study|Protocol-defined clinical event|0|||
164495885|NCT00684203|594186910|FG004|Overall Study|Protocol-defined clinical event|0|||
164495886|NCT00684203|594186911|FG005|Overall Study|Protocol-defined clinical event|0|||
164495887|NCT00684203|594186906|FG000|Overall Study|Withdrawal by Subject|0|||
164495888|NCT00684203|594186907|FG001|Overall Study|Withdrawal by Subject|2|||
164495889|NCT00684203|594186908|FG002|Overall Study|Withdrawal by Subject|1|||
164495890|NCT00684203|594186909|FG003|Overall Study|Withdrawal by Subject|0|||
164495891|NCT00684203|594186910|FG004|Overall Study|Withdrawal by Subject|0|||
164495892|NCT00684203|594186911|FG005|Overall Study|Withdrawal by Subject|0|||
164495893|NCT00684203|594186906|FG000|Overall Study|Did not meet protocol eligibility|0|||
164495894|NCT00684203|594186907|FG001|Overall Study|Did not meet protocol eligibility|1|||
164495895|NCT00684203|594186908|FG002|Overall Study|Did not meet protocol eligibility|0|||
164495896|NCT00684203|594186909|FG003|Overall Study|Did not meet protocol eligibility|0|||
164495897|NCT00684203|594186910|FG004|Overall Study|Did not meet protocol eligibility|0|||
164495898|NCT00684203|594186911|FG005|Overall Study|Did not meet protocol eligibility|0|||
164495899|NCT00307164|594186917|FG000|Overall Study|Death|1|||
164495900|NCT00307164|594186918|FG001|Overall Study|Death|0|||
164495901|NCT00307164|594186917|FG000|Overall Study|Severe debilitation, unable to continue|1|||
164495902|NCT00307164|594186918|FG001|Overall Study|Severe debilitation, unable to continue|0|||
164495903|NCT00307164|594186917|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
164495904|NCT00307164|594186918|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
164495905|NCT00307164|594186917|FG000|Overall Study|Withdrawal by Subject|1|||
164495906|NCT00307164|594186918|FG001|Overall Study|Withdrawal by Subject|8|||
164495907|NCT00307164|594186917|FG000|Overall Study|Not compliant with requirements|4|||
164495908|NCT00307164|594186918|FG001|Overall Study|Not compliant with requirements|4|||
164495909|NCT00307164|594186917|FG000|Overall Study|Lost to Follow-up|6|||
164495910|NCT00307164|594186918|FG001|Overall Study|Lost to Follow-up|1|||
164495911|NCT03712449|594186920|FG000|Overall Study|Withdraw Consent|0|||
164495912|NCT03712449|594186921|FG001|Overall Study|Withdraw Consent|1|||
164495913|NCT03972137|594186925|FG000|Overall Study|Lost to Follow-up|2|||
164495914|NCT03972137|594186925|FG000|Overall Study|Withdrawal by Subject|4|||
164495915|NCT03226353|594186926|FG000|Overall Study|Withdrawal by Subject|1|||
164495916|NCT03226353|594186926|FG000|Overall Study|Screen Failure|5|||
164495917|NCT03168425|594186929|FG000|Overall Study|Lost to Follow-up|5|||
164495918|NCT03168425|594186930|FG001|Overall Study|Lost to Follow-up|8|||
164495919|NCT03168425|594186929|FG000|Overall Study|unable to confirm post op opioids|2|||
164495920|NCT03168425|594186930|FG001|Overall Study|unable to confirm post op opioids|3|||
164495921|NCT03029234|594186931|FG000|Overall Study|Sponsor Decision|1|||
164604050|NCT00383721|594570264|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
164604051|NCT00383721|594570265|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
164715475|NCT01721317|594980415|FG000|Overall Study|Physician Decision|0|||
164495922|NCT03029234|594186931|FG000|Overall Study|Withdrawal by Subject|5|||
164495923|NCT03029234|594186931|FG000|Overall Study|Death|91|||
164495924|NCT03029234|594186931|FG000|Overall Study|Lost to Follow-up|2|||
164495925|NCT00498433|594186932|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
164495926|NCT00498433|594186933|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
164495927|NCT00498433|594186934|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
164604052|NCT00383721|594570266|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
164604053|NCT00383721|594570267|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
164604054|NCT00383721|594570268|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
164604055|NCT00383721|594570264|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
164604056|NCT00383721|594570265|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
164604057|NCT00383721|594570266|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
164604058|NCT00383721|594570267|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
164604059|NCT00383721|594570268|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
164604060|NCT00383721|594570264|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
164604061|NCT00383721|594570265|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
164604062|NCT00383721|594570266|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
164604063|NCT00383721|594570267|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
164604064|NCT00383721|594570268|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
164604065|NCT00383721|594570264|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
164604066|NCT00383721|594570265|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
164604067|NCT00383721|594570266|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
164604068|NCT00383721|594570267|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
164604069|NCT00383721|594570268|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
164604070|NCT00383721|594570264|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
164604071|NCT00383721|594570265|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
164604072|NCT00383721|594570266|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
164604073|NCT00383721|594570267|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
164604074|NCT00383721|594570268|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
164604075|NCT00383721|594570264|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
164604076|NCT00383721|594570265|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
164604077|NCT00383721|594570266|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
164604078|NCT00383721|594570267|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
164604079|NCT00383721|594570268|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
164604080|NCT00383721|594570264|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
164604081|NCT00383721|594570265|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
164604082|NCT00383721|594570266|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
164604083|NCT00383721|594570267|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
164604084|NCT00383721|594570268|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
164604085|NCT00383721|594570264|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
164604086|NCT00383721|594570265|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
164604087|NCT00383721|594570266|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
164604088|NCT00383721|594570267|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
164604089|NCT00383721|594570268|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
164604090|NCT00383721|594570264|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
164604091|NCT00383721|594570265|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
164604092|NCT00383721|594570266|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
164604093|NCT00383721|594570267|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
164604094|NCT00383721|594570268|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
164604095|NCT00383721|594570264|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
164604096|NCT00383721|594570265|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
164604097|NCT00383721|594570266|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
164604098|NCT00383721|594570267|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
164604099|NCT00383721|594570268|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
164604100|NCT00383721|594570264|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
164604101|NCT00383721|594570265|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
164604102|NCT00383721|594570266|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
164604103|NCT00383721|594570267|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
164604104|NCT00383721|594570268|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
164604105|NCT00383721|594570264|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
164604106|NCT00383721|594570265|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
164715476|NCT01721317|594980416|FG001|Overall Study|Physician Decision|1|||
164715477|NCT01721317|594980415|FG000|Overall Study|Withdrawal by Subject|0|||
164715478|NCT01721317|594980416|FG001|Overall Study|Withdrawal by Subject|1|||
164715479|NCT02661217|594980417|FG000|Overall Study|Physician Decision|12|||
164715480|NCT02661217|594980418|FG001|Overall Study|Physician Decision|15|||
164715481|NCT02661217|594980417|FG000|Overall Study|Lost to Follow-up|1|||
164715482|NCT02661217|594980418|FG001|Overall Study|Lost to Follow-up|4|||
164715483|NCT02661217|594980417|FG000|Overall Study|Protocol Deviation|0|||
164715484|NCT02661217|594980418|FG001|Overall Study|Protocol Deviation|4|||
164495928|NCT00498433|594186932|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
164495929|NCT00498433|594186933|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
164495930|NCT00498433|594186934|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
164495931|NCT00498433|594186932|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
164495932|NCT00498433|594186933|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
164495933|NCT00498433|594186934|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
164495934|NCT00498433|594186932|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
164495935|NCT00498433|594186933|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
164495936|NCT00498433|594186934|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
164495937|NCT00468858|594186943|FG000|Overall Study|Adverse Event|0|||
164495938|NCT00468858|594186944|FG001|Overall Study|Adverse Event|1|||
164495939|NCT00468858|594186945|FG002|Overall Study|Adverse Event|0|||
164495940|NCT00468858|594186943|FG000|Overall Study|Withdrawal by Subject|7|||
164495941|NCT00468858|594186944|FG001|Overall Study|Withdrawal by Subject|4|||
164495942|NCT00468858|594186945|FG002|Overall Study|Withdrawal by Subject|5|||
164495943|NCT00468858|594186943|FG000|Overall Study|Relocation|1|||
164495944|NCT00468858|594186944|FG001|Overall Study|Relocation|3|||
164495945|NCT00468858|594186945|FG002|Overall Study|Relocation|3|||
164495946|NCT00468858|594186943|FG000|Overall Study|Lost to Follow-up|1|||
164495947|NCT00468858|594186944|FG001|Overall Study|Lost to Follow-up|2|||
164495948|NCT00468858|594186945|FG002|Overall Study|Lost to Follow-up|5|||
164495949|NCT00468858|594186943|FG000|Overall Study|Other|0|||
164495950|NCT00468858|594186944|FG001|Overall Study|Other|0|||
164495951|NCT00468858|594186945|FG002|Overall Study|Other|1|||
164495952|NCT00797511|594186948|FG000|Overall Study|Withdrawal by Subject|1|||
164495953|NCT00843115|594186949|FG000|Overall Study|Death|4|||
164495954|NCT00843115|594186949|FG000|Overall Study|Adverse Event|30|||
164495955|NCT00843115|594186949|FG000|Overall Study|Lost to Follow-up|4|||
164495956|NCT00843115|594186949|FG000|Overall Study|Withdrawal by Subject|17|||
164495957|NCT00843115|594186949|FG000|Overall Study|Family wanted meds stopped|1|||
164495958|NCT00843115|594186949|FG000|Overall Study|Family does not want continuation|1|||
164495959|NCT00843115|594186949|FG000|Overall Study|Patient forgot to take meds|1|||
164495960|NCT00843115|594186949|FG000|Overall Study|Does not meet entrance criteria|1|||
164495961|NCT00843115|594186949|FG000|Overall Study|Physician Decision|1|||
164495962|NCT00843115|594186949|FG000|Overall Study|Family discontinued meds|1|||
164495963|NCT00843115|594186949|FG000|Overall Study|patient took for 2 days then stopped|1|||
164495964|NCT00843115|594186949|FG000|Overall Study|patient never took the medication|1|||
164495965|NCT00843115|594186949|FG000|Overall Study|hospitalized due to deterioration|1|||
164495966|NCT00843115|594186949|FG000|Overall Study|week 12 not done|1|||
164495967|NCT00843115|594186949|FG000|Overall Study|Syndrome De Glissement|1|||
164495968|NCT03772041|594186952|FG000|Overall Study|Adverse Event|8|||
164495969|NCT03772041|594186953|FG001|Overall Study|Adverse Event|3|||
164495970|NCT03772041|594186952|FG000|Overall Study|Withdrawal by Subject|0|||
164495971|NCT03772041|594186953|FG001|Overall Study|Withdrawal by Subject|2|||
164495972|NCT03772041|594186952|FG000|Overall Study|Protocol Violation|4|||
164495973|NCT03772041|594186953|FG001|Overall Study|Protocol Violation|2|||
164495974|NCT03772041|594186952|FG000|Overall Study|Physician Decision|2|||
164495975|NCT03772041|594186953|FG001|Overall Study|Physician Decision|3|||
164495976|NCT02381652|594186956|FG000|Overall Study|Withdrawal by Subject|0|||
164495977|NCT02381652|594186957|FG001|Overall Study|Withdrawal by Subject|0|||
164495978|NCT02381652|594186958|FG002|Overall Study|Withdrawal by Subject|1|||
164495979|NCT04772313|594186959|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
164495980|NCT04772313|594186959|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
164495981|NCT01836198|594186960|FG000|Part A, Period 2|Protocol Violation|0|||
164495982|NCT01836198|594186961|FG001|Part A, Period 2|Protocol Violation|1|||
164495983|NCT01836198|594186962|FG002|Part A, Period 2|Protocol Violation|0|||
164495984|NCT03927222|594186964|FG000|Overall Study|Progression|3|||
164495985|NCT03927222|594186964|FG000|Overall Study|CMV testing results inconclusive|1|||
164495986|NCT03927222|594186964|FG000|Overall Study|Unable to generate enough vaccines|1|||
164495987|NCT03927222|594186964|FG000|Overall Study|Early study termination|1|||
164495988|NCT02201771|594186967|FG000|Overall Study|Death|3|||
164495989|NCT02201771|594186968|FG001|Overall Study|Death|2|||
164495990|NCT02201771|594186969|FG002|Overall Study|Death|0|||
164495991|NCT02201771|594186967|FG000|Overall Study|Protocol Violation|10|||
164495992|NCT02201771|594186968|FG001|Overall Study|Protocol Violation|8|||
164495993|NCT02201771|594186969|FG002|Overall Study|Protocol Violation|10|||
164495994|NCT00139659|594186970|FG000|Overall Study|Adverse Event|12|||
164495995|NCT00139659|594186971|FG001|Overall Study|Adverse Event|1|||
164495996|NCT00139659|594186970|FG000|Overall Study|Lack of Efficacy|1|||
164495997|NCT00139659|594186971|FG001|Overall Study|Lack of Efficacy|1|||
164495998|NCT00139659|594186970|FG000|Overall Study|Lost to Follow-up|7|||
164495999|NCT00139659|594186971|FG001|Overall Study|Lost to Follow-up|3|||
164715485|NCT02661217|594980417|FG000|Overall Study|Non-compliance with study treatment|5|||
164496000|NCT00139659|594186970|FG000|Overall Study|Reason not Specified|6|||
164496001|NCT00139659|594186971|FG001|Overall Study|Reason not Specified|3|||
164496002|NCT00139659|594186970|FG000|Overall Study|Withdrawal by Subject|14|||
164604107|NCT00383721|594570266|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
164604108|NCT00383721|594570267|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
164604109|NCT00383721|594570268|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
164604110|NCT00383721|594570264|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
164604111|NCT00383721|594570265|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
164604112|NCT00383721|594570266|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
164604113|NCT00383721|594570267|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
164604114|NCT00383721|594570268|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
164604115|NCT00383721|594570264|FG000|26-Week Treatment Safety Extension|Administrative|1|||
164604116|NCT00383721|594570265|FG001|26-Week Treatment Safety Extension|Administrative|2|||
164604117|NCT00383721|594570266|FG002|26-Week Treatment Safety Extension|Administrative|3|||
164604118|NCT00383721|594570267|FG003|26-Week Treatment Safety Extension|Administrative|1|||
164604119|NCT00383721|594570268|FG004|26-Week Treatment Safety Extension|Administrative|0|||
164496003|NCT00139659|594186971|FG001|Overall Study|Withdrawal by Subject|10|||
164496004|NCT02625922|594186977|FG000|Overall Study|Non-availability of IMP|1|||
164496005|NCT02625922|594186978|FG001|Overall Study|Non-availability of IMP|1|||
164496006|NCT02625922|594186977|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
164496007|NCT02625922|594186978|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
164496008|NCT00640042|594186979|FG000|Enrollment|Did not receive study drug|83|||
164496009|NCT01287416|594186982|FG000|Pre-post Training|Withdrawal by Subject|17|||
164496010|NCT01287416|594186983|FG001|Pre-post Training|Withdrawal by Subject|24|||
164496011|NCT01287416|594186982|FG000|Pre-post Training|Lost to Follow-up|5|||
164496012|NCT01287416|594186983|FG001|Pre-post Training|Lost to Follow-up|1|||
164496013|NCT01287416|594186982|FG000|6 Month Follow-up|Lost to Follow-up|3|||
164496014|NCT01287416|594186983|FG001|6 Month Follow-up|Lost to Follow-up|2|||
164496015|NCT02359552|594186984|FG000|Overall Study|Lost to Follow-up|3|||
164496016|NCT02359552|594186985|FG001|Overall Study|Lost to Follow-up|4|||
164496017|NCT02391116|594186998|FG000|Treatment|Withdrawal by Subject|1|||
164496018|NCT02391116|594186998|FG000|Treatment|Protocol Violation|1|||
164496019|NCT02391116|594186998|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
164496020|NCT02391116|594186998|FG000|Treatment|AE with Clinical PD|3|||
164496021|NCT02391116|594186998|FG000|Safety Follow-up|Adverse Event|1|||
164496022|NCT02391116|594186998|FG000|Safety Follow-up|Withdrawal by Subject|4|||
164496023|NCT02391116|594186998|FG000|Safety Follow-up|Switching to Other Therapy|4|||
164496024|NCT02391116|594186998|FG000|Safety Follow-up|No Follow Up|1|||
164496025|NCT02391116|594186998|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
164496026|NCT02391116|594186998|FG000|Active Follow-up|Withdrawal by Subject|1|||
164496027|NCT02391116|594186998|FG000|Active Follow-up|Switching to Other Therapy|2|||
164496028|NCT02391116|594186998|FG000|Survival Follow-up|Withdrawal by Subject|3|||
164496029|NCT02391116|594186998|FG000|Survival Follow-up|Switching to Other Therapy|1|||
164496030|NCT02109107|594187000|FG000|Overall Study|Lost to Follow-up|2|||
164496031|NCT01747629|594187004|FG000|Overall Study|Adverse Event|1|||
164496032|NCT01747629|594187005|FG001|Overall Study|Adverse Event|2|||
164496033|NCT01747629|594187004|FG000|Overall Study|Withdrawal by Subject|2|||
164496034|NCT01747629|594187005|FG001|Overall Study|Withdrawal by Subject|2|||
164496035|NCT01747629|594187004|FG000|Overall Study|Noncompliance|1|||
164496036|NCT01747629|594187005|FG001|Overall Study|Noncompliance|1|||
164496037|NCT01747629|594187004|FG000|Overall Study|Inclusion criteria not met|1|||
164496038|NCT01747629|594187005|FG001|Overall Study|Inclusion criteria not met|0|||
164496039|NCT01747629|594187004|FG000|Overall Study|Not treated|1|||
164496040|NCT01747629|594187005|FG001|Overall Study|Not treated|0|||
164496041|NCT01747629|594187004|FG000|Overall Study|Other|2|||
164496042|NCT01747629|594187005|FG001|Overall Study|Other|1|||
164496043|NCT00607789|594187006|FG000|Overall Study|Adverse Event|3|||
164496044|NCT00607789|594187007|FG001|Overall Study|Adverse Event|0|||
164604120|NCT03519516|594570269|FG000|Overall Study|Adverse Event|0|||
164604121|NCT03519516|594570270|FG001|Overall Study|Adverse Event|1|||
164604122|NCT05584202|594570272|FG000|Overall Study|Withdrawal of Consent|3|||
164604123|NCT05584202|594570273|FG001|Overall Study|Withdrawal of Consent|2|||
164604124|NCT05584202|594570272|FG000|Overall Study|Lost to Follow-up|2|||
164604125|NCT05584202|594570273|FG001|Overall Study|Lost to Follow-up|1|||
164604126|NCT05584202|594570272|FG000|Overall Study|Death|0|||
164604127|NCT05584202|594570273|FG001|Overall Study|Death|1|||
164604128|NCT00781963|594572009|FG000|Overall Study|Death|3|||
164604129|NCT00781963|594572010|FG001|Overall Study|Death|0|||
164604130|NCT00781963|594572009|FG000|Overall Study|Lost to Follow-up|2|||
164496045|NCT00607789|594187006|FG000|Overall Study|Lack of Efficacy|0|||
164496046|NCT00607789|594187007|FG001|Overall Study|Lack of Efficacy|1|||
164496047|NCT00607789|594187006|FG000|Overall Study|Inadequate adherence|3|||
164604131|NCT00781963|594572010|FG001|Overall Study|Lost to Follow-up|1|||
164496048|NCT00607789|594187007|FG001|Overall Study|Inadequate adherence|0|||
164496049|NCT00607789|594187006|FG000|Overall Study|Lost to Follow-up|0|||
164496050|NCT00607789|594187007|FG001|Overall Study|Lost to Follow-up|5|||
164496051|NCT00607789|594187006|FG000|Overall Study|Withdrawal by Subject|1|||
164496052|NCT00607789|594187007|FG001|Overall Study|Withdrawal by Subject|0|||
164496053|NCT00495612|594187008|FG000|Overall Study|Lost to Follow-up|1|||
164496054|NCT00495612|594187009|FG001|Overall Study|Lost to Follow-up|0|||
164496055|NCT00495612|594187008|FG000|Overall Study|Subject's Decision to Withdraw|3|||
164496056|NCT00495612|594187009|FG001|Overall Study|Subject's Decision to Withdraw|0|||
164496057|NCT00818519|594187010|FG000|Overall Study|Adverse Event|2|||
164496058|NCT00818519|594187011|FG001|Overall Study|Adverse Event|2|||
164496059|NCT00818519|594187010|FG000|Overall Study|Lost to Follow-up|4|||
164496060|NCT00818519|594187011|FG001|Overall Study|Lost to Follow-up|6|||
164496061|NCT00818519|594187010|FG000|Overall Study|Protocol Violation|2|||
164496062|NCT00818519|594187011|FG001|Overall Study|Protocol Violation|1|||
164496063|NCT00818519|594187010|FG000|Overall Study|Pregnancy|0|||
164496064|NCT00818519|594187011|FG001|Overall Study|Pregnancy|1|||
164496065|NCT00818519|594187010|FG000|Overall Study|Withdrawal by Subject|4|||
164496066|NCT00818519|594187011|FG001|Overall Study|Withdrawal by Subject|9|||
164496067|NCT00818519|594187010|FG000|Overall Study|participant recovered completely|1|||
164496068|NCT00818519|594187011|FG001|Overall Study|participant recovered completely|0|||
164496069|NCT00818519|594187010|FG000|Overall Study|participant will leave for long tme|1|||
164496070|NCT00818519|594187011|FG001|Overall Study|participant will leave for long tme|0|||
164496071|NCT01180790|594187015|FG000|Overall Study|Adverse Event|1|||
164496072|NCT01180790|594187016|FG001|Overall Study|Adverse Event|1|||
164496073|NCT01180790|594187017|FG002|Overall Study|Adverse Event|2|||
164496074|NCT01180790|594187018|FG003|Overall Study|Adverse Event|0|||
164496075|NCT01180790|594187019|FG004|Overall Study|Adverse Event|1|||
164496076|NCT01180790|594187020|FG005|Overall Study|Adverse Event|3|||
164496077|NCT01180790|594187021|FG006|Overall Study|Adverse Event|0|||
164496078|NCT01180790|594187015|FG000|Overall Study|Withdrawal by Subject|3|||
164496079|NCT01180790|594187016|FG001|Overall Study|Withdrawal by Subject|0|||
164496080|NCT01180790|594187017|FG002|Overall Study|Withdrawal by Subject|5|||
164496081|NCT01180790|594187018|FG003|Overall Study|Withdrawal by Subject|0|||
164496082|NCT01180790|594187019|FG004|Overall Study|Withdrawal by Subject|2|||
164496083|NCT01180790|594187020|FG005|Overall Study|Withdrawal by Subject|1|||
164496084|NCT01180790|594187021|FG006|Overall Study|Withdrawal by Subject|0|||
164496085|NCT01180790|594187015|FG000|Overall Study|Lost to Follow-up|3|||
164496086|NCT01180790|594187016|FG001|Overall Study|Lost to Follow-up|1|||
164496087|NCT01180790|594187017|FG002|Overall Study|Lost to Follow-up|0|||
164496088|NCT01180790|594187018|FG003|Overall Study|Lost to Follow-up|2|||
164496089|NCT01180790|594187019|FG004|Overall Study|Lost to Follow-up|1|||
164496090|NCT01180790|594187020|FG005|Overall Study|Lost to Follow-up|0|||
164496091|NCT01180790|594187021|FG006|Overall Study|Lost to Follow-up|1|||
164496092|NCT01180790|594187015|FG000|Overall Study|Physician Decision|1|||
164496093|NCT01180790|594187016|FG001|Overall Study|Physician Decision|0|||
164496094|NCT01180790|594187017|FG002|Overall Study|Physician Decision|0|||
164496095|NCT01180790|594187018|FG003|Overall Study|Physician Decision|1|||
164496096|NCT01180790|594187019|FG004|Overall Study|Physician Decision|0|||
164496097|NCT01180790|594187020|FG005|Overall Study|Physician Decision|0|||
164496098|NCT01180790|594187021|FG006|Overall Study|Physician Decision|0|||
164496099|NCT01180790|594187015|FG000|Overall Study|Lack of Efficacy|1|||
164496100|NCT01180790|594187016|FG001|Overall Study|Lack of Efficacy|2|||
164496101|NCT01180790|594187017|FG002|Overall Study|Lack of Efficacy|5|||
164496102|NCT01180790|594187018|FG003|Overall Study|Lack of Efficacy|6|||
164496103|NCT01180790|594187019|FG004|Overall Study|Lack of Efficacy|1|||
164496104|NCT01180790|594187020|FG005|Overall Study|Lack of Efficacy|3|||
164604132|NCT00781963|594572009|FG000|Overall Study|Withdrawal by Subject|3|||
164496105|NCT01180790|594187021|FG006|Overall Study|Lack of Efficacy|0|||
164496106|NCT01180790|594187015|FG000|Overall Study|compliance|0|||
164496107|NCT01180790|594187016|FG001|Overall Study|compliance|1|||
164496108|NCT01180790|594187017|FG002|Overall Study|compliance|0|||
164496109|NCT01180790|594187018|FG003|Overall Study|compliance|0|||
164496110|NCT01180790|594187019|FG004|Overall Study|compliance|0|||
164496111|NCT01180790|594187020|FG005|Overall Study|compliance|0|||
164496112|NCT01180790|594187021|FG006|Overall Study|compliance|0|||
164496113|NCT01180790|594187015|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
164496114|NCT01180790|594187016|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
164496115|NCT01180790|594187017|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
164496116|NCT01180790|594187018|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
164496117|NCT01180790|594187019|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
164496118|NCT01180790|594187020|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
164496119|NCT01180790|594187021|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
164496120|NCT00655668|594187022|FG000|Overall Study|Adverse Event|6|||
164496121|NCT00655668|594187022|FG000|Overall Study|Death|5|||
164496122|NCT00655668|594187022|FG000|Overall Study|Disease Progression|27|||
164604133|NCT00781963|594572010|FG001|Overall Study|Withdrawal by Subject|1|||
164604134|NCT00781963|594572009|FG000|Overall Study|Refused follow-up|9|||
164604135|NCT00781963|594572010|FG001|Overall Study|Refused follow-up|0|||
164604136|NCT02700919|594572011|FG000|Overall Study|Physician Decision|1|||
164604137|NCT02700919|594572012|FG001|Overall Study|Physician Decision|0|||
164604138|NCT02700919|594572013|FG002|Overall Study|Physician Decision|0|||
164604139|NCT02700919|594572011|FG000|Overall Study|Protocol Violation|1|||
164496123|NCT00655668|594187022|FG000|Overall Study|Study Terminated|9|||
164496124|NCT00655668|594187022|FG000|Overall Study|Other|1|||
164496125|NCT00655668|594187022|FG000|Overall Study|New Lymphoma Treatment Started|4|||
164496126|NCT00655668|594187022|FG000|Overall Study|Withdrawal by Subject|2|||
164496127|NCT02335242|594187023|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
164496128|NCT02335242|594187024|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
164496129|NCT02335242|594187023|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
164496130|NCT02335242|594187024|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
164496131|NCT02335242|594187023|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
164496132|NCT02335242|594187024|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
164496133|NCT04167085|594187025|FG000|Baseline|Withdrawal by Subject|2|||
164496134|NCT04167085|594187026|FG001|Baseline|Withdrawal by Subject|1|||
164496135|NCT04167085|594187025|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
164496136|NCT04167085|594187026|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
164496137|NCT03840148|594187027|FG000|Study Drug Disposition|Adverse Event|13|||
164496138|NCT03840148|594187028|FG001|Study Drug Disposition|Adverse Event|2|||
164496139|NCT03840148|594187027|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
164496140|NCT03840148|594187028|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
164496141|NCT03840148|594187027|FG000|Study Drug Disposition|Lack of Efficacy|3|||
164496142|NCT03840148|594187028|FG001|Study Drug Disposition|Lack of Efficacy|0|||
164496143|NCT03840148|594187027|FG000|Study Drug Disposition|Physician Decision|2|||
164496144|NCT03840148|594187028|FG001|Study Drug Disposition|Physician Decision|0|||
164496145|NCT03840148|594187027|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
164496146|NCT03840148|594187028|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
164496147|NCT03840148|594187027|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
164496148|NCT03840148|594187028|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
164496149|NCT03840148|594187027|FG000|Study Completion Disposition|Physician Decision|2|||
164496150|NCT03840148|594187028|FG001|Study Completion Disposition|Physician Decision|0|||
164496151|NCT03840148|594187027|FG000|Study Completion Disposition|Covid-19 related|2|||
164496152|NCT03840148|594187028|FG001|Study Completion Disposition|Covid-19 related|0|||
164496153|NCT03840148|594187027|FG000|Study Completion Disposition|Lost to Follow-up|1|||
164496154|NCT03840148|594187028|FG001|Study Completion Disposition|Lost to Follow-up|1|||
164496155|NCT03840148|594187027|FG000|Study Completion Disposition|Death|1|||
164496156|NCT03840148|594187028|FG001|Study Completion Disposition|Death|0|||
164496157|NCT03840148|594187027|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
164496158|NCT03840148|594187028|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
164496159|NCT03615404|594187029|FG000|Overall Study|Death|1|||
164496160|NCT03615404|594187029|FG000|Overall Study|vaccine did not pass quality assurance|1|||
164496161|NCT00257556|594187030|FG000|Overall Study|Adverse Event|1|||
164496162|NCT00257556|594187031|FG001|Overall Study|Adverse Event|4|||
164496163|NCT00257556|594187030|FG000|Overall Study|Physician Decision|6|||
164496164|NCT00257556|594187031|FG001|Overall Study|Physician Decision|0|||
164496165|NCT00257556|594187030|FG000|Overall Study|Did not meet hCG criterion|3|||
164496166|NCT00257556|594187031|FG001|Overall Study|Did not meet hCG criterion|0|||
164496167|NCT00257556|594187030|FG000|Overall Study|other reason|4|||
164496168|NCT00257556|594187031|FG001|Overall Study|other reason|6|||
164496169|NCT03849300|594187033|FG000|Overall Study|move out to different area|1|||
164496170|NCT03849300|594187034|FG001|Overall Study|move out to different area|3|||
164496171|NCT03849300|594187035|FG002|Overall Study|move out to different area|1|||
164496172|NCT03849300|594187036|FG003|Overall Study|move out to different area|4|||
164496173|NCT03849300|594187033|FG000|Overall Study|scheduling/transportation conflict|4|||
164496174|NCT03849300|594187034|FG001|Overall Study|scheduling/transportation conflict|4|||
164496175|NCT03849300|594187035|FG002|Overall Study|scheduling/transportation conflict|3|||
164496176|NCT03849300|594187036|FG003|Overall Study|scheduling/transportation conflict|2|||
164496177|NCT04839289|594187037|FG000|Overall Study|Withdrawal by Subject|1|||
164496178|NCT04839289|594187038|FG001|Overall Study|Withdrawal by Subject|0|||
164496179|NCT00464737|594187040|FG000|Overall Study|Adverse Event|12|||
164496180|NCT00464737|594187041|FG001|Overall Study|Adverse Event|17|||
164496181|NCT00464737|594187042|FG002|Overall Study|Adverse Event|33|||
164496182|NCT00464737|594187040|FG000|Overall Study|Lack of Efficacy|7|||
164604140|NCT02700919|594572012|FG001|Overall Study|Protocol Violation|0|||
164604141|NCT02700919|594572013|FG002|Overall Study|Protocol Violation|0|||
164604142|NCT02700919|594572011|FG000|Overall Study|Adverse Event|1|||
164604143|NCT02700919|594572012|FG001|Overall Study|Adverse Event|3|||
164496183|NCT00464737|594187041|FG001|Overall Study|Lack of Efficacy|7|||
164496184|NCT00464737|594187042|FG002|Overall Study|Lack of Efficacy|4|||
164496185|NCT00464737|594187040|FG000|Overall Study|Withdrawal by Subject|5|||
164496186|NCT00464737|594187041|FG001|Overall Study|Withdrawal by Subject|3|||
164496187|NCT00464737|594187042|FG002|Overall Study|Withdrawal by Subject|5|||
164496188|NCT00464737|594187040|FG000|Overall Study|Protocol Violation|1|||
164496189|NCT00464737|594187041|FG001|Overall Study|Protocol Violation|1|||
164145300|NCT00025259|592894267|FG004|Overall Study|Protocol Violation|2|||
164715486|NCT02661217|594980418|FG001|Overall Study|Non-compliance with study treatment|5|||
164715487|NCT02661217|594980417|FG000|Overall Study|Death|21|||
164715488|NCT02661217|594980418|FG001|Overall Study|Death|15|||
164715489|NCT02661217|594980417|FG000|Overall Study|Adverse Event|10|||
164715490|NCT02661217|594980418|FG001|Overall Study|Adverse Event|8|||
164715491|NCT02661217|594980417|FG000|Overall Study|Withdrawal by Subject|15|||
164496190|NCT00464737|594187042|FG002|Overall Study|Protocol Violation|5|||
164496191|NCT00464737|594187040|FG000|Overall Study|Non-compliance|0|||
164496192|NCT00464737|594187041|FG001|Overall Study|Non-compliance|1|||
164496193|NCT00464737|594187042|FG002|Overall Study|Non-compliance|1|||
164496194|NCT00464737|594187040|FG000|Overall Study|Lost to Follow-up|5|||
164496195|NCT00464737|594187041|FG001|Overall Study|Lost to Follow-up|2|||
164496196|NCT00464737|594187042|FG002|Overall Study|Lost to Follow-up|5|||
164496197|NCT00464737|594187040|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
164496198|NCT00464737|594187041|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
164496199|NCT00464737|594187042|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
164496200|NCT00464737|594187040|FG000|Overall Study|Other: Subject left town; family illness|1|||
164496201|NCT00464737|594187041|FG001|Overall Study|Other: Subject left town; family illness|0|||
164496202|NCT00464737|594187042|FG002|Overall Study|Other: Subject left town; family illness|0|||
164496203|NCT00464737|594187040|FG000|Overall Study|Other: Study demands too great|0|||
164496204|NCT00464737|594187041|FG001|Overall Study|Other: Study demands too great|1|||
164496205|NCT00464737|594187042|FG002|Overall Study|Other: Study demands too great|0|||
164496206|NCT00464737|594187040|FG000|Overall Study|Other: Personal family reasons|0|||
164496207|NCT00464737|594187041|FG001|Overall Study|Other: Personal family reasons|0|||
164496208|NCT00464737|594187042|FG002|Overall Study|Other: Personal family reasons|1|||
164496209|NCT00464737|594187040|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
164496210|NCT00464737|594187041|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
164496211|NCT00464737|594187042|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
164496212|NCT00141271|594187043|FG000|Overall Study|Adverse Event|31|||
164496213|NCT00141271|594187044|FG001|Overall Study|Adverse Event|19|||
164496214|NCT00141271|594187045|FG002|Overall Study|Adverse Event|17|||
164496215|NCT00141271|594187043|FG000|Overall Study|Laboratory Abnormality|2|||
164496216|NCT00141271|594187044|FG001|Overall Study|Laboratory Abnormality|1|||
164496217|NCT00141271|594187045|FG002|Overall Study|Laboratory Abnormality|1|||
164496218|NCT00141271|594187043|FG000|Overall Study|Lack of Efficacy|7|||
164496219|NCT00141271|594187044|FG001|Overall Study|Lack of Efficacy|7|||
164496220|NCT00141271|594187045|FG002|Overall Study|Lack of Efficacy|3|||
164496221|NCT00141271|594187043|FG000|Overall Study|Lost to Follow-up|15|||
164496222|NCT00141271|594187044|FG001|Overall Study|Lost to Follow-up|15|||
164496223|NCT00141271|594187045|FG002|Overall Study|Lost to Follow-up|21|||
164496224|NCT00141271|594187043|FG000|Overall Study|Withdrawal by Subject|14|||
164496225|NCT00141271|594187044|FG001|Overall Study|Withdrawal by Subject|9|||
164496226|NCT00141271|594187045|FG002|Overall Study|Withdrawal by Subject|10|||
164496227|NCT00141271|594187043|FG000|Overall Study|Other|11|||
164496228|NCT00141271|594187044|FG001|Overall Study|Other|12|||
164496229|NCT00141271|594187045|FG002|Overall Study|Other|5|||
164496230|NCT01544153|594187046|FG000|Overall Study|Under 18|0|||
164496231|NCT01544153|594187047|FG001|Overall Study|Under 18|1|||
164496232|NCT01544153|594187048|FG002|Overall Study|Under 18|0|||
164496233|NCT01544153|594187049|FG003|Overall Study|Under 18|0|||
164496234|NCT01544153|594187046|FG000|Overall Study|Non-smoker|0|||
164496235|NCT01544153|594187047|FG001|Overall Study|Non-smoker|0|||
164496236|NCT01544153|594187048|FG002|Overall Study|Non-smoker|1|||
164496237|NCT01544153|594187049|FG003|Overall Study|Non-smoker|0|||
164496238|NCT00390806|594187050|FG000|Overall Study|Lost to Follow-up|7|||
164496239|NCT00390806|594187051|FG001|Overall Study|Lost to Follow-up|6|||
164496240|NCT00390806|594187050|FG000|Overall Study|Protocol Violation|2|||
164496241|NCT00390806|594187051|FG001|Overall Study|Protocol Violation|2|||
164496242|NCT00390806|594187050|FG000|Overall Study|Withdrawal by Subject|12|||
164496243|NCT00390806|594187051|FG001|Overall Study|Withdrawal by Subject|15|||
164715492|NCT02661217|594980418|FG001|Overall Study|Withdrawal by Subject|19|||
164715493|NCT02661217|594980417|FG000|Overall Study|Did not enter follow-up epoch|7|||
164496244|NCT00390806|594187050|FG000|Overall Study|Investigator Decision|4|||
164496245|NCT00390806|594187051|FG001|Overall Study|Investigator Decision|6|||
164496246|NCT00390806|594187050|FG000|Overall Study|Death|1|||
164496247|NCT00390806|594187051|FG001|Overall Study|Death|0|||
164496248|NCT00390806|594187050|FG000|Overall Study|Physician Decision|0|||
164496249|NCT00390806|594187051|FG001|Overall Study|Physician Decision|1|||
164496250|NCT00390806|594187050|FG000|Overall Study|Ongoing|4|||
164496251|NCT00390806|594187051|FG001|Overall Study|Ongoing|2|||
164496252|NCT04783519|594187054|FG000|Overall Study|Withdrawal by Subject|2|||
164496253|NCT04783519|594187055|FG001|Overall Study|Withdrawal by Subject|7|||
164496254|NCT04783519|594187056|FG002|Overall Study|Withdrawal by Subject|3|||
164496255|NCT04783519|594187054|FG000|Overall Study|Lost to Follow-up|9|||
164715494|NCT02661217|594980418|FG001|Overall Study|Did not enter follow-up epoch|10|||
164715495|NCT02661217|594980417|FG000|Overall Study|Death - no study drug received|1|||
164715496|NCT02661217|594980418|FG001|Overall Study|Death - no study drug received|2|||
164496256|NCT04783519|594187055|FG001|Overall Study|Lost to Follow-up|7|||
164496257|NCT04783519|594187056|FG002|Overall Study|Lost to Follow-up|6|||
164496258|NCT00884793|594187057|FG000|Overall Study|Withdrawal by Subject|1|||
164496259|NCT04531813|594187058|FG000|Overall Study|Protocol Violation|1|||
164496260|NCT04531813|594187058|FG000|Overall Study|Withdrawal by Subject|1|||
164496261|NCT00746785|594188109|FG000|Overall Study|Lost to Follow-up|29|||
164496262|NCT00746785|594188110|FG001|Overall Study|Lost to Follow-up|25|||
164496263|NCT00746785|594188111|FG002|Overall Study|Lost to Follow-up|27|||
164496264|NCT01231464|594188112|FG000|Overall Study|Adverse Event|0|||
164496265|NCT01231464|594188113|FG001|Overall Study|Adverse Event|1|||
164496266|NCT01231464|594188112|FG000|Overall Study|Protocol Violation|1|||
164496267|NCT01231464|594188113|FG001|Overall Study|Protocol Violation|2|||
164496268|NCT01231464|594188112|FG000|Overall Study|Lost to Follow-up|1|||
164496269|NCT01231464|594188113|FG001|Overall Study|Lost to Follow-up|2|||
164496270|NCT01231464|594188112|FG000|Overall Study|Withdrawal by Subject|3|||
164496271|NCT01231464|594188113|FG001|Overall Study|Withdrawal by Subject|2|||
164496272|NCT01821729|594188117|FG000|Overall Study|Withdrawal by Subject|1|||
164496273|NCT01845649|594188118|FG000|Overall Study|Adverse Event|7|||
164496274|NCT01845649|594188119|FG001|Overall Study|Adverse Event|10|||
164496275|NCT01845649|594188118|FG000|Overall Study|Lack of Efficacy|1|||
164496276|NCT01845649|594188119|FG001|Overall Study|Lack of Efficacy|1|||
164496277|NCT01845649|594188118|FG000|Overall Study|Lost to Follow-up|2|||
164496278|NCT01845649|594188119|FG001|Overall Study|Lost to Follow-up|2|||
164496279|NCT01845649|594188118|FG000|Overall Study|Withdrew Consent|12|||
164496280|NCT01845649|594188119|FG001|Overall Study|Withdrew Consent|4|||
164496281|NCT01845649|594188118|FG000|Overall Study|Protocol Deviation|7|||
164496282|NCT01845649|594188119|FG001|Overall Study|Protocol Deviation|4|||
164496283|NCT01845649|594188118|FG000|Overall Study|Reason not Specified|2|||
164496284|NCT01845649|594188119|FG001|Overall Study|Reason not Specified|1|||
164496285|NCT02171130|594188123|FG000|Overall Study|Death|1|||
164496286|NCT02171130|594188123|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
164496287|NCT02171130|594188123|FG000|Overall Study|Discontinued; Site Termination|5|||
164496288|NCT02171130|594188123|FG000|Overall Study|Withdrawal by Subject|3|||
164496289|NCT02171130|594188123|FG000|Overall Study|Physician Decision|1|||
164496290|NCT02171130|594188123|FG000|Overall Study|Lost to Follow-up|1|||
164496291|NCT02171130|594188123|FG000|Overall Study|Met Exclusion Criteria|1|||
164496292|NCT01951261|594188124|FG000|Overall Study|Death|1|||
164496293|NCT01951261|594188125|FG001|Overall Study|Death|0|||
164496294|NCT01951261|594188124|FG000|Overall Study|Lost to Follow-up|4|||
164496295|NCT01951261|594188125|FG001|Overall Study|Lost to Follow-up|3|||
164496296|NCT01951261|594188124|FG000|Overall Study|Protocol Violation|4|||
164496297|NCT01951261|594188125|FG001|Overall Study|Protocol Violation|3|||
164496298|NCT03723915|594188132|FG000|Screening|Failed to meet screening requirements.|2|||
164496299|NCT03723915|594188132|FG000|On Treatment|Failed to meet treatment requirements|2|||
164496300|NCT03569475|594188133|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
164496301|NCT03569475|594188134|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
164496302|NCT03569475|594188135|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
164496303|NCT03569475|594188133|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
164496304|NCT03569475|594188134|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
164496305|NCT03569475|594188135|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
164496306|NCT03569475|594188133|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
164496307|NCT03569475|594188134|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
164496308|NCT03569475|594188135|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
164496309|NCT03569475|594188133|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
164496310|NCT03569475|594188134|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
164496311|NCT03569475|594188135|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
164496312|NCT03569475|594188133|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
164496313|NCT03569475|594188134|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
164496314|NCT03569475|594188135|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
164496315|NCT03569475|594188133|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
164496316|NCT03569475|594188134|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
164496317|NCT03569475|594188135|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
164496318|NCT03569475|594188133|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
164496319|NCT03569475|594188134|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
164496320|NCT03569475|594188135|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
164496321|NCT03569475|594188133|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
164496322|NCT03569475|594188134|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
164496323|NCT03569475|594188135|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
164496324|NCT03569475|594188133|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
164496325|NCT03569475|594188134|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
164496326|NCT03569475|594188135|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
164604144|NCT02700919|594572013|FG002|Overall Study|Adverse Event|1|||
164496327|NCT02630706|594188136|FG000|Overall Study|Adverse Event|2|||
164496328|NCT02630706|594188137|FG001|Overall Study|Adverse Event|1|||
164496329|NCT02630706|594188138|FG002|Overall Study|Adverse Event|1|||
164496330|NCT02630706|594188136|FG000|Overall Study|Lost to Follow-up|0|||
164496331|NCT02630706|594188137|FG001|Overall Study|Lost to Follow-up|1|||
164496332|NCT02630706|594188138|FG002|Overall Study|Lost to Follow-up|2|||
164496333|NCT02630706|594188136|FG000|Overall Study|Physician Decision|1|||
164496334|NCT02630706|594188137|FG001|Overall Study|Physician Decision|1|||
164496335|NCT02630706|594188138|FG002|Overall Study|Physician Decision|0|||
164496336|NCT02630706|594188136|FG000|Overall Study|Pregnancy|0|||
164496337|NCT02630706|594188137|FG001|Overall Study|Pregnancy|1|||
164496338|NCT02630706|594188138|FG002|Overall Study|Pregnancy|0|||
164496339|NCT02630706|594188136|FG000|Overall Study|Withdrawal by Subject|4|||
164496340|NCT02630706|594188137|FG001|Overall Study|Withdrawal by Subject|5|||
164496341|NCT02630706|594188138|FG002|Overall Study|Withdrawal by Subject|7|||
164496342|NCT02383927|594188153|FG000|Overall Study|Disease Progression|8|||
164496343|NCT02383927|594188154|FG001|Overall Study|Disease Progression|8|||
164496344|NCT02383927|594188155|FG002|Overall Study|Disease Progression|15|||
164496345|NCT02383927|594188156|FG003|Overall Study|Disease Progression|4|||
164496346|NCT02383927|594188153|FG000|Overall Study|Physician Decision|0|||
164496347|NCT02383927|594188154|FG001|Overall Study|Physician Decision|0|||
164496348|NCT02383927|594188155|FG002|Overall Study|Physician Decision|2|||
164496349|NCT02383927|594188156|FG003|Overall Study|Physician Decision|0|||
164496350|NCT02383927|594188153|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
164496351|NCT02383927|594188154|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
164496352|NCT02383927|594188155|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
164496353|NCT02383927|594188156|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
164496354|NCT02383927|594188153|FG000|Overall Study|Adverse Event|4|||
164496355|NCT02383927|594188154|FG001|Overall Study|Adverse Event|1|||
164496356|NCT02383927|594188155|FG002|Overall Study|Adverse Event|3|||
164496357|NCT02383927|594188156|FG003|Overall Study|Adverse Event|5|||
164496358|NCT02383927|594188153|FG000|Overall Study|Miscellaneous|1|||
164496359|NCT02383927|594188154|FG001|Overall Study|Miscellaneous|0|||
164496360|NCT02383927|594188155|FG002|Overall Study|Miscellaneous|0|||
164496361|NCT02383927|594188156|FG003|Overall Study|Miscellaneous|1|||
164496362|NCT02383927|594188153|FG000|Overall Study|Withdrawal by Subject|0|||
164496363|NCT02383927|594188154|FG001|Overall Study|Withdrawal by Subject|1|||
164496364|NCT02383927|594188155|FG002|Overall Study|Withdrawal by Subject|4|||
164496365|NCT02383927|594188156|FG003|Overall Study|Withdrawal by Subject|0|||
164496366|NCT00734851|594188157|FG000|Overall Study|Withdrawal by Subject|2|||
164496367|NCT00734851|594188157|FG000|Overall Study|Lost to Follow-up|1|||
164496368|NCT00734851|594188157|FG000|Overall Study|Physician Decision|18|||
164496369|NCT00981578|594188161|FG000|Overall Study|Death|1|||
164496370|NCT00981578|594188161|FG000|Overall Study|Withdrawal by Subject|2|||
164496371|NCT00580047|594188168|FG000|Overall Study|Lost to Follow-up|1|||
164496372|NCT00580047|594188169|FG001|Overall Study|Lost to Follow-up|1|||
164496373|NCT00580047|594188170|FG002|Overall Study|Lost to Follow-up|0|||
164496374|NCT00580047|594188168|FG000|Overall Study|Withdrawal by Subject|1|||
164496375|NCT00580047|594188169|FG001|Overall Study|Withdrawal by Subject|1|||
164496376|NCT00580047|594188170|FG002|Overall Study|Withdrawal by Subject|2|||
164496377|NCT00580047|594188168|FG000|Overall Study|Withdrawal by Subject|1|||
164496378|NCT00580047|594188169|FG001|Overall Study|Withdrawal by Subject|0|||
164496379|NCT00580047|594188170|FG002|Overall Study|Withdrawal by Subject|0|||
164496380|NCT02820298|594188171|FG000|Overall Study|Withdrawal by Subject|0|||
164496381|NCT02820298|594188172|FG001|Overall Study|Withdrawal by Subject|1|||
164496382|NCT02820298|594188171|FG000|Overall Study|Physician Decision|1|||
164496383|NCT02820298|594188172|FG001|Overall Study|Physician Decision|0|||
164496384|NCT02820298|594188171|FG000|Overall Study|Protocol Violation|0|||
164496385|NCT02820298|594188172|FG001|Overall Study|Protocol Violation|1|||
164496386|NCT01894256|594188175|FG000|Part A|Adverse Event|0|||
164496387|NCT01894256|594188176|FG001|Part A|Adverse Event|1|||
164496388|NCT01894256|594188177|FG002|Part A|Adverse Event|0|||
164604145|NCT02700919|594572011|FG000|Overall Study|Withdrawal by Subject|5|||
164604146|NCT02700919|594572012|FG001|Overall Study|Withdrawal by Subject|8|||
164604147|NCT02700919|594572013|FG002|Overall Study|Withdrawal by Subject|2|||
164604148|NCT02700919|594572011|FG000|Overall Study|Lost to Follow-up|2|||
164496389|NCT01894256|594188175|FG000|Part B|Death|0|||
164496390|NCT01894256|594188176|FG001|Part B|Death|1|||
164496391|NCT01894256|594188177|FG002|Part B|Death|1|||
164496392|NCT01894256|594188175|FG000|Part B|Withdrawal by Subject|0|||
164496393|NCT01894256|594188176|FG001|Part B|Withdrawal by Subject|1|||
164604149|NCT02700919|594572012|FG001|Overall Study|Lost to Follow-up|0|||
164496394|NCT01894256|594188177|FG002|Part B|Withdrawal by Subject|0|||
164496395|NCT01894256|594188175|FG000|Part B|Lack of Efficacy|15|||
164496396|NCT01894256|594188176|FG001|Part B|Lack of Efficacy|12|||
164496397|NCT01894256|594188177|FG002|Part B|Lack of Efficacy|13|||
164496398|NCT01780584|594188178|FG000|Overall Study|Death|1|||
164496399|NCT01780584|594188179|FG001|Overall Study|Death|0|||
164496400|NCT01780584|594188180|FG002|Overall Study|Death|1|||
164604150|NCT02700919|594572013|FG002|Overall Study|Lost to Follow-up|0|||
164496401|NCT01780584|594188178|FG000|Overall Study|Adverse Event|0|||
164496402|NCT01780584|594188179|FG001|Overall Study|Adverse Event|1|||
164496403|NCT01780584|594188180|FG002|Overall Study|Adverse Event|0|||
164496404|NCT01780584|594188178|FG000|Overall Study|Protocol Violation|0|||
164496405|NCT01780584|594188179|FG001|Overall Study|Protocol Violation|0|||
164496406|NCT01780584|594188180|FG002|Overall Study|Protocol Violation|1|||
164496407|NCT00727259|594188194|FG000|Overall Study|Not all questionnaires completed|1055|||
164496408|NCT01021683|594188195|FG000|Overall Study|Lack of Efficacy|12|||
164496409|NCT01021683|594188195|FG000|Overall Study|Recovery of neutrophil count|51|||
164496410|NCT01021683|594188195|FG000|Overall Study|Other|8|||
164496411|NCT01374971|594188196|FG000|Overall Study|Withdrawal by Subject|1|||
164496412|NCT00645099|594188197|FG000|Overall Study|Lack of Efficacy|15|||
164496413|NCT00645099|594188198|FG001|Overall Study|Lack of Efficacy|6|||
164496414|NCT00645099|594188197|FG000|Overall Study|Withdrawal by Subject|30|||
164496415|NCT00645099|594188198|FG001|Overall Study|Withdrawal by Subject|22|||
164496416|NCT00645099|594188197|FG000|Overall Study|Lost to Follow-up|6|||
164496417|NCT00645099|594188198|FG001|Overall Study|Lost to Follow-up|4|||
164496418|NCT00645099|594188197|FG000|Overall Study|Adverse Event|11|||
164496419|NCT00645099|594188198|FG001|Overall Study|Adverse Event|5|||
164496420|NCT00645099|594188197|FG000|Overall Study|Other|9|||
164496421|NCT00645099|594188198|FG001|Overall Study|Other|5|||
164496422|NCT01201915|594188199|FG000|Overall Study|Adverse Event|2|||
164496423|NCT01201915|594188200|FG001|Overall Study|Adverse Event|1|||
164496424|NCT01201915|594188201|FG002|Overall Study|Adverse Event|1|||
164496425|NCT01201915|594188199|FG000|Overall Study|Lost to Follow-up|0|||
164496426|NCT01201915|594188200|FG001|Overall Study|Lost to Follow-up|4|||
164496427|NCT01201915|594188201|FG002|Overall Study|Lost to Follow-up|0|||
164496428|NCT01201915|594188199|FG000|Overall Study|Physician Decision|3|||
164496429|NCT01201915|594188200|FG001|Overall Study|Physician Decision|0|||
164496430|NCT01201915|594188201|FG002|Overall Study|Physician Decision|0|||
164496431|NCT01201915|594188199|FG000|Overall Study|Subject Decision|3|||
164496432|NCT01201915|594188200|FG001|Overall Study|Subject Decision|3|||
164496433|NCT01201915|594188201|FG002|Overall Study|Subject Decision|5|||
164496434|NCT01201915|594188199|FG000|Overall Study|Target Lesion Progression|0|||
164496435|NCT01201915|594188200|FG001|Overall Study|Target Lesion Progression|3|||
164496436|NCT01201915|594188201|FG002|Overall Study|Target Lesion Progression|0|||
164496437|NCT02154516|594188202|FG000|Overall Study|Withdrawal by Subject|0|||
164496438|NCT02154516|594188203|FG001|Overall Study|Withdrawal by Subject|1|||
164496439|NCT02154516|594188202|FG000|Overall Study|Lost to Follow-up|1|||
164496440|NCT02154516|594188203|FG001|Overall Study|Lost to Follow-up|0|||
164496441|NCT02154516|594188202|FG000|Overall Study|Removal/revision of device|1|||
164496442|NCT02154516|594188203|FG001|Overall Study|Removal/revision of device|0|||
164496443|NCT02154516|594188202|FG000|Overall Study|Death|2|||
164496444|NCT02154516|594188203|FG001|Overall Study|Death|1|||
164496445|NCT03406507|594188204|FG000|Extension Period|Lack of Efficacy|0|||
164496446|NCT03406507|594188205|FG001|Extension Period|Lack of Efficacy|1|||
164496447|NCT00663923|594188206|FG000|Overall Study|Lost to Follow-up|2|||
164496448|NCT02316171|594188210|FG000|Overall Study|difficulties with urinary catheter|1|||
164496449|NCT02316171|594188211|FG001|Overall Study|difficulties with urinary catheter|0|||
164496450|NCT02316171|594188212|FG002|Overall Study|difficulties with urinary catheter|0|||
164496451|NCT02316171|594188213|FG003|Overall Study|difficulties with urinary catheter|0|||
164496452|NCT01804140|594188215|FG000|Overall Study|No sampling or biopsy procedures done|114|||
164496453|NCT02785900|594188218|FG000|Overall Study|Study Termination by Sponsor|64|||
164496454|NCT02785900|594188219|FG001|Overall Study|Study Termination by Sponsor|81|||
164496455|NCT02785900|594188218|FG000|Overall Study|Death|46|||
164496456|NCT02785900|594188219|FG001|Overall Study|Death|32|||
164496457|NCT02785900|594188218|FG000|Overall Study|Withdrawal by Subject|4|||
164496458|NCT02785900|594188219|FG001|Overall Study|Withdrawal by Subject|8|||
164496459|NCT02785900|594188218|FG000|Overall Study|Physician Decision|3|||
164496460|NCT02785900|594188219|FG001|Overall Study|Physician Decision|2|||
164496461|NCT00547300|594188220|FG000|Overall Study|Study was Administratively Terminated|25|||
164496462|NCT00547300|594188221|FG001|Overall Study|Study was Administratively Terminated|24|||
164496463|NCT00547300|594188220|FG000|Overall Study|Did not Meet Entry Criteria|0|||
164496464|NCT00547300|594188221|FG001|Overall Study|Did not Meet Entry Criteria|2|||
164496465|NCT04435522|594188222|FG000|Overall Study|Withdrawal by Subject|2|||
164496466|NCT00092521|594190039|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
164496467|NCT00092521|594190040|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
164496468|NCT00092521|594190041|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
164496469|NCT00092521|594190042|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
164496470|NCT00092521|594190039|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
164496471|NCT00092521|594190040|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
164496472|NCT00092521|594190041|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
164496473|NCT00092521|594190042|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
164496474|NCT00092521|594190039|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
164496475|NCT00092521|594190040|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
164496476|NCT00092521|594190041|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
164604151|NCT02700919|594572011|FG000|Overall Study|Other|2|||
164604152|NCT02700919|594572012|FG001|Overall Study|Other|1|||
164604153|NCT02700919|594572013|FG002|Overall Study|Other|1|||
164604154|NCT00132314|594572016|FG000|Overall Study|Lost to Follow-up|70|||
164604155|NCT00132314|594572017|FG001|Overall Study|Lost to Follow-up|62|||
164604156|NCT00132314|594572016|FG000|Overall Study|Lacked SSN|1|||
164604157|NCT00132314|594572017|FG001|Overall Study|Lacked SSN|3|||
164604158|NCT00132314|594572016|FG000|Overall Study|Refused intervention at baseline|2|||
164604159|NCT00132314|594572017|FG001|Overall Study|Refused intervention at baseline|7|||
164604160|NCT01653158|594572035|FG000|Overall Study|Death|0|||
164604161|NCT01653158|594572036|FG001|Overall Study|Death|0|||
164604162|NCT01653158|594572037|FG002|Overall Study|Death|0|||
164604163|NCT01653158|594572038|FG003|Overall Study|Death|1|||
164604164|NCT01653158|594572039|FG004|Overall Study|Death|0|||
164604165|NCT01653158|594572040|FG005|Overall Study|Death|0|||
164604166|NCT01653158|594572041|FG006|Overall Study|Death|0|||
164604167|NCT01653158|594572042|FG007|Overall Study|Death|2|||
164604168|NCT01653158|594572035|FG000|Overall Study|Adverse Event|0|||
164604169|NCT01653158|594572036|FG001|Overall Study|Adverse Event|0|||
164604170|NCT01653158|594572037|FG002|Overall Study|Adverse Event|0|||
164604171|NCT01653158|594572038|FG003|Overall Study|Adverse Event|1|||
164604172|NCT01653158|594572039|FG004|Overall Study|Adverse Event|0|||
164604173|NCT01653158|594572040|FG005|Overall Study|Adverse Event|0|||
164604174|NCT01653158|594572041|FG006|Overall Study|Adverse Event|0|||
164604175|NCT01653158|594572042|FG007|Overall Study|Adverse Event|3|||
164604176|NCT01653158|594572035|FG000|Overall Study|Other|0|||
164604177|NCT01653158|594572036|FG001|Overall Study|Other|0|||
164604178|NCT01653158|594572037|FG002|Overall Study|Other|0|||
164604179|NCT01653158|594572038|FG003|Overall Study|Other|0|||
164604180|NCT01653158|594572039|FG004|Overall Study|Other|0|||
164604181|NCT01653158|594572040|FG005|Overall Study|Other|0|||
164604182|NCT01653158|594572041|FG006|Overall Study|Other|0|||
164604183|NCT01653158|594572042|FG007|Overall Study|Other|1|||
164604184|NCT01653158|594572035|FG000|Overall Study|Progressive disease|0|||
164604185|NCT01653158|594572036|FG001|Overall Study|Progressive disease|0|||
164604186|NCT01653158|594572037|FG002|Overall Study|Progressive disease|0|||
164604187|NCT01653158|594572038|FG003|Overall Study|Progressive disease|0|||
164604188|NCT01653158|594572039|FG004|Overall Study|Progressive disease|1|||
164604189|NCT01653158|594572040|FG005|Overall Study|Progressive disease|1|||
164604190|NCT01653158|594572041|FG006|Overall Study|Progressive disease|2|||
164604191|NCT01653158|594572042|FG007|Overall Study|Progressive disease|9|||
164604192|NCT01653158|594572035|FG000|Overall Study|Withdrawal by Subject|1|||
164604193|NCT01653158|594572036|FG001|Overall Study|Withdrawal by Subject|0|||
164604194|NCT01653158|594572037|FG002|Overall Study|Withdrawal by Subject|0|||
164604195|NCT01653158|594572038|FG003|Overall Study|Withdrawal by Subject|0|||
164604196|NCT01653158|594572039|FG004|Overall Study|Withdrawal by Subject|0|||
164604197|NCT01653158|594572040|FG005|Overall Study|Withdrawal by Subject|0|||
164604198|NCT01653158|594572041|FG006|Overall Study|Withdrawal by Subject|0|||
164604199|NCT01653158|594572042|FG007|Overall Study|Withdrawal by Subject|0|||
164604200|NCT03819218|594572049|FG000|Overall Study|Protocol Violation|1|||
164604201|NCT04116073|594572053|FG000|Overall Study|Withdrawal by Subject|2|||
164604202|NCT04116073|594572053|FG000|Overall Study|failed to maintained eligibility|1|||
164604203|NCT03779334|594572057|FG000|Overall Study|Withdrawal by Subject|3|||
164604204|NCT03779334|594572058|FG001|Overall Study|Withdrawal by Subject|0|||
164604205|NCT03779334|594572059|FG002|Overall Study|Withdrawal by Subject|0|||
164604206|NCT03779334|594572057|FG000|Overall Study|Ongoing in Study|5|||
164604207|NCT03779334|594572058|FG001|Overall Study|Ongoing in Study|13|||
164604208|NCT03779334|594572059|FG002|Overall Study|Ongoing in Study|5|||
164604209|NCT04321252|594572066|FG000|Overall Study|Withdrawal by Subject|0|||
164604210|NCT04321252|594572067|FG001|Overall Study|Withdrawal by Subject|0|||
164604211|NCT04321252|594572068|FG002|Overall Study|Withdrawal by Subject|0|||
164604212|NCT04321252|594572069|FG003|Overall Study|Withdrawal by Subject|0|||
164715497|NCT02661217|594980417|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
164715498|NCT02661217|594980418|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
164715499|NCT00958893|594980424|FG000|Overall Study|Study prematurely terminated|4|||
164604213|NCT04321252|594572070|FG004|Overall Study|Withdrawal by Subject|0|||
164604214|NCT04321252|594572071|FG005|Overall Study|Withdrawal by Subject|1|||
164604215|NCT04321252|594572072|FG006|Overall Study|Withdrawal by Subject|0|||
164604216|NCT04321252|594572073|FG007|Overall Study|Withdrawal by Subject|0|||
164604217|NCT04321252|594572074|FG008|Overall Study|Withdrawal by Subject|0|||
164604218|NCT06245044|594572075|FG000|No MI help|Technical issues|18|||
164604219|NCT01840228|594572078|FG000|Overall Study|Lost to Follow-up|1|||
164604220|NCT01840228|594572079|FG001|Overall Study|Lost to Follow-up|1|||
164604221|NCT02022033|594572080|FG000|Overall Study|Physician Decision|1|||
164604222|NCT01413542|594572081|FG000|Overall Study|Physician Decision|1|||
164604223|NCT01413542|594572082|FG001|Overall Study|Physician Decision|0|||
164604224|NCT01413542|594572083|FG002|Overall Study|Physician Decision|3|||
164604225|NCT01413542|594572084|FG003|Overall Study|Physician Decision|0|||
164604226|NCT01413542|594572081|FG000|Overall Study|Adverse Event|0|||
164604227|NCT01413542|594572082|FG001|Overall Study|Adverse Event|0|||
164604228|NCT01413542|594572083|FG002|Overall Study|Adverse Event|0|||
164604229|NCT01413542|594572084|FG003|Overall Study|Adverse Event|1|||
164604230|NCT00865189|594572085|FG000|Overall Study|Other|1|||
164604231|NCT00865189|594572086|FG001|Overall Study|Other|2|||
164604232|NCT00865189|594572085|FG000|Overall Study|Death|4|||
164604233|NCT00865189|594572086|FG001|Overall Study|Death|11|||
164604234|NCT00865189|594572085|FG000|Overall Study|Lost to Follow-up|6|||
164604235|NCT00865189|594572086|FG001|Overall Study|Lost to Follow-up|6|||
164604236|NCT00865189|594572085|FG000|Overall Study|Withdrawal by Subject|1|||
164604237|NCT00865189|594572086|FG001|Overall Study|Withdrawal by Subject|0|||
164496477|NCT00092521|594190042|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
164496478|NCT00092521|594190039|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
164496479|NCT00092521|594190040|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
164496480|NCT00092521|594190041|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
164496481|NCT00092521|594190042|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
164604238|NCT05590767|594572088|FG000|Overall Study|Protocol Violation|1|||
164604239|NCT05590767|594572088|FG000|Overall Study|surgery canceled|1|||
164604240|NCT05590767|594572088|FG000|Overall Study|interscalene brachial block not performed|1|||
164604241|NCT02767856|594572089|FG000|Overall Study|Lost to Follow-up|9|||
164604242|NCT02767856|594572090|FG001|Overall Study|Lost to Follow-up|1|||
164604243|NCT02767856|594572089|FG000|Overall Study|Withdrawal by Subject|2|||
164604244|NCT02767856|594572090|FG001|Overall Study|Withdrawal by Subject|1|||
164604245|NCT00304915|594572091|FG000|Overall Study|Lost to Follow-up|11|||
164604246|NCT00304915|594572092|FG001|Overall Study|Lost to Follow-up|11|||
164496482|NCT00092521|594190039|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
164496483|NCT00092521|594190040|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
164496484|NCT00092521|594190041|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
164496485|NCT00092521|594190042|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
164496486|NCT00092521|594190039|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
164496487|NCT00092521|594190040|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
164496488|NCT00092521|594190041|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
164496489|NCT00092521|594190042|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
164496490|NCT00092521|594190039|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
164496491|NCT00092521|594190040|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
164496492|NCT00092521|594190041|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
164496493|NCT00092521|594190042|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
164496494|NCT00092521|594190039|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
164496495|NCT00092521|594190040|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
164496496|NCT00092521|594190041|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
164496497|NCT00092521|594190042|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
164496498|NCT00092521|594190039|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
164496499|NCT00092521|594190040|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
164496500|NCT00092521|594190041|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
164496501|NCT00092521|594190042|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
164496502|NCT00092521|594190039|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
164496503|NCT00092521|594190040|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
164496504|NCT00092521|594190041|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
164496505|NCT00092521|594190042|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
164496506|NCT00092521|594190039|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
164496507|NCT00092521|594190040|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
164496508|NCT00092521|594190041|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
164496509|NCT00092521|594190042|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
164496510|NCT00092521|594190039|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
164496511|NCT00092521|594190040|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
164496512|NCT00092521|594190041|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
164604247|NCT00304915|594572091|FG000|Overall Study|Death|4|||
164604248|NCT00304915|594572092|FG001|Overall Study|Death|5|||
164604249|NCT00304915|594572091|FG000|Overall Study|Withdrawal by Subject|3|||
164604250|NCT00304915|594572092|FG001|Overall Study|Withdrawal by Subject|0|||
164604251|NCT02029638|594572093|FG000|Overall Study|Death|0|||
164604252|NCT02029638|594572094|FG001|Overall Study|Death|0|||
164604253|NCT02029638|594572095|FG002|Overall Study|Death|1|||
164604254|NCT02029638|594572093|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
164604255|NCT02029638|594572094|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
164604256|NCT02029638|594572095|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
164604257|NCT05489081|594572096|FG000|Overall Study|student left classroom|0|||
164604258|NCT05489081|594572097|FG001|Overall Study|student left classroom|1|||
164604259|NCT05489081|594572096|FG000|Overall Study|teacher left school|0|||
164604260|NCT05489081|594572097|FG001|Overall Study|teacher left school|2|||
164604261|NCT00125190|594572100|FG000|Overall Study|Subject/Parent Decision|7|||
164604262|NCT00125190|594572100|FG000|Overall Study|Non-compliance|2|||
164604263|NCT00125190|594572100|FG000|Overall Study|Adverse Event|1|||
164604264|NCT00125190|594572100|FG000|Overall Study|Other|1|||
164604265|NCT00125190|594572100|FG000|Overall Study|Lost to Follow-up|4|||
164604266|NCT00414960|594572101|FG000|Overall Study|Adverse Event|4|||
164496513|NCT00092521|594190042|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
164604267|NCT00414960|594572102|FG001|Overall Study|Adverse Event|0|||
164604268|NCT00414960|594572101|FG000|Overall Study|Withdrawal by Subject|3|||
164604269|NCT00414960|594572102|FG001|Overall Study|Withdrawal by Subject|0|||
164604270|NCT00414960|594572101|FG000|Overall Study|Physician Decision|0|||
164604271|NCT00414960|594572102|FG001|Overall Study|Physician Decision|1|||
164604272|NCT01318512|594572103|FG000|Maintenance Period (6 Months)|Death|2|||
164604273|NCT01318512|594572103|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
164604274|NCT00363246|594572104|FG000|Overall Study|Death|40|||
164604275|NCT00363246|594572104|FG000|Overall Study|Withdrawal by Subject|19|||
164604276|NCT00363246|594572104|FG000|Overall Study|Lost to Follow-up|14|||
164604277|NCT00363246|594572104|FG000|Overall Study|Bad health|6|||
164604278|NCT00363246|594572104|FG000|Overall Study|Stopped using wheelchair|11|||
164604279|NCT00363246|594572104|FG000|Overall Study|Subject expressed security concerns|2|||
164604280|NCT00363246|594572104|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
164604281|NCT02756650|594572109|FG000|Overall Study|Physician Decision|1|||
164604282|NCT02756650|594572109|FG000|Overall Study|Adverse Event|1|||
164496514|NCT00092521|594190039|FG000|Follow-Up (After Month 7)|Death|2|||
164496515|NCT00092521|594190040|FG001|Follow-Up (After Month 7)|Death|0|||
164496516|NCT00092521|594190041|FG002|Follow-Up (After Month 7)|Death|1|||
164496517|NCT00092521|594190042|FG003|Follow-Up (After Month 7)|Death|0|||
164496518|NCT00092521|594190039|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
164496519|NCT00092521|594190040|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
164496520|NCT00092521|594190041|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
164496521|NCT00092521|594190042|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
164496522|NCT00092521|594190039|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
164496523|NCT00092521|594190040|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
164496524|NCT00092521|594190041|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
164496525|NCT00092521|594190042|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
164496526|NCT00092521|594190039|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
164496527|NCT00092521|594190040|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
164496528|NCT00092521|594190041|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
164496529|NCT00092521|594190042|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
164496530|NCT00092521|594190039|FG000|Follow-Up (After Month 7)|Moved|32|||
164496531|NCT00092521|594190040|FG001|Follow-Up (After Month 7)|Moved|2|||
164496532|NCT00092521|594190041|FG002|Follow-Up (After Month 7)|Moved|28|||
164496533|NCT00092521|594190042|FG003|Follow-Up (After Month 7)|Moved|0|||
164496534|NCT00092521|594190039|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
164496535|NCT00092521|594190040|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
164496536|NCT00092521|594190041|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
164496537|NCT00092521|594190042|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
164496538|NCT00092521|594190039|FG000|Follow-Up (After Month 7)|Travel|2|||
164496539|NCT00092521|594190040|FG001|Follow-Up (After Month 7)|Travel|0|||
164496540|NCT00092521|594190041|FG002|Follow-Up (After Month 7)|Travel|0|||
164496541|NCT00092521|594190042|FG003|Follow-Up (After Month 7)|Travel|0|||
164496542|NCT00092521|594190039|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
164496543|NCT00092521|594190040|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
164604283|NCT04348591|594572112|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
164604284|NCT04348591|594572113|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
164604285|NCT04348591|594572112|FG000|Imaging Session (120 Min)|Physician Decision|0|||
164604286|NCT04348591|594572113|FG001|Imaging Session (120 Min)|Physician Decision|1|||
164604287|NCT04348591|594572112|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
164604288|NCT04348591|594572113|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
164604289|NCT00622869|594572115|FG000|Overall Study|Subject Withdrew Consent|13|||
164604290|NCT00622869|594572116|FG001|Overall Study|Subject Withdrew Consent|17|||
164604291|NCT00622869|594572117|FG002|Overall Study|Subject Withdrew Consent|11|||
164604292|NCT00622869|594572115|FG000|Overall Study|Administrative Problems|11|||
164604293|NCT00622869|594572116|FG001|Overall Study|Administrative Problems|17|||
164604294|NCT00622869|594572117|FG002|Overall Study|Administrative Problems|13|||
164604295|NCT00622869|594572115|FG000|Overall Study|Death|12|||
164496544|NCT00092521|594190041|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
164496545|NCT00092521|594190042|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
164604296|NCT00622869|594572116|FG001|Overall Study|Death|15|||
164604297|NCT00622869|594572117|FG002|Overall Study|Death|10|||
164604298|NCT00622869|594572115|FG000|Overall Study|Lost to Follow-up|2|||
164604299|NCT00622869|594572116|FG001|Overall Study|Lost to Follow-up|4|||
164496546|NCT00092521|594190039|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
164496547|NCT00092521|594190040|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
164496548|NCT00092521|594190041|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
164496549|NCT00092521|594190042|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
164604300|NCT00622869|594572117|FG002|Overall Study|Lost to Follow-up|2|||
164604301|NCT00622869|594572115|FG000|Overall Study|Graft Loss|5|||
164496550|NCT00092521|594190039|FG000|Extension Study (Group 4)|Adverse Event|0|||
164496551|NCT00092521|594190040|FG001|Extension Study (Group 4)|Adverse Event|0|||
164496552|NCT00092521|594190041|FG002|Extension Study (Group 4)|Adverse Event|0|||
164496553|NCT00092521|594190042|FG003|Extension Study (Group 4)|Adverse Event|2|||
164496554|NCT00092521|594190039|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
164496555|NCT00092521|594190040|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
164496556|NCT00092521|594190041|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
164496557|NCT00092521|594190042|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
164496558|NCT00092521|594190039|FG000|Extension Study (Group 4)|Pregnancy|0|||
164715500|NCT00378573|594980426|FG000|Treatment Period|Adverse Event|9|||
164715501|NCT00378573|594980426|FG000|Treatment Period|Physician Decision|1|||
164496559|NCT00092521|594190040|FG001|Extension Study (Group 4)|Pregnancy|0|||
164496560|NCT00092521|594190041|FG002|Extension Study (Group 4)|Pregnancy|0|||
164496561|NCT00092521|594190042|FG003|Extension Study (Group 4)|Pregnancy|4|||
164496562|NCT00092521|594190039|FG000|Extension Study (Group 4)|Protocol Violation|0|||
164496563|NCT00092521|594190040|FG001|Extension Study (Group 4)|Protocol Violation|0|||
164496564|NCT00092521|594190041|FG002|Extension Study (Group 4)|Protocol Violation|0|||
164496565|NCT00092521|594190042|FG003|Extension Study (Group 4)|Protocol Violation|2|||
164496566|NCT00092521|594190039|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
164496567|NCT00092521|594190040|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
164496568|NCT00092521|594190041|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
164496569|NCT00092521|594190042|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
164496570|NCT00092521|594190039|FG000|Extension Study (Group 4)|Moved|0|||
164496571|NCT00092521|594190040|FG001|Extension Study (Group 4)|Moved|0|||
164496572|NCT00092521|594190041|FG002|Extension Study (Group 4)|Moved|0|||
164496573|NCT00092521|594190042|FG003|Extension Study (Group 4)|Moved|16|||
164496574|NCT00092521|594190039|FG000|Extension Study (Group 4)|Site Terminated|0|||
164496575|NCT00092521|594190040|FG001|Extension Study (Group 4)|Site Terminated|0|||
164496576|NCT00092521|594190041|FG002|Extension Study (Group 4)|Site Terminated|0|||
164496577|NCT00092521|594190042|FG003|Extension Study (Group 4)|Site Terminated|4|||
164496578|NCT00092521|594190039|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
164496579|NCT00092521|594190040|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
164496580|NCT00092521|594190041|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
164496581|NCT00092521|594190042|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
164496582|NCT01878383|594190043|FG000|Overall Study|Lost to Follow-up|0|||
164496583|NCT01878383|594190044|FG001|Overall Study|Lost to Follow-up|1499|||
164496584|NCT03464383|594190045|FG000|Overall Study|Lost to Follow-up|1|||
164496585|NCT03464383|594190046|FG001|Overall Study|Lost to Follow-up|0|||
164496586|NCT03464383|594190047|FG002|Overall Study|Lost to Follow-up|0|||
164496587|NCT03464383|594190045|FG000|Overall Study|Withdrawal by Subject|0|||
164496588|NCT03464383|594190046|FG001|Overall Study|Withdrawal by Subject|1|||
164496589|NCT03464383|594190047|FG002|Overall Study|Withdrawal by Subject|0|||
164496590|NCT00560313|594190048|FG000|Overall Study|Adverse Events or Death|2|||
164496591|NCT00560313|594190048|FG000|Overall Study|Withdrawal by Subject|2|||
164496592|NCT00560313|594190048|FG000|Overall Study|Lost to Follow-up|1|||
164496593|NCT00560313|594190048|FG000|Overall Study|Protocol Violation|1|||
164496594|NCT00605566|594190049|FG000|Overall Study|Adverse Event|1|||
164496595|NCT00605566|594190049|FG000|Overall Study|Clinical deterioration|1|||
164496596|NCT00605566|594190049|FG000|Overall Study|Poor compliance in run-in period|1|||
164496597|NCT03449134|594190050|FG000|52-Week Treatment Period|Death|2|||
164496598|NCT03449134|594190051|FG001|52-Week Treatment Period|Death|1|||
164496599|NCT03449134|594190052|FG002|52-Week Treatment Period|Death|0|||
164496600|NCT03449134|594190050|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
164496601|NCT03449134|594190051|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
164496602|NCT03449134|594190052|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
164496603|NCT03449134|594190050|FG000|52-Week Treatment Period|Physician Decision|2|||
164496604|NCT03449134|594190051|FG001|52-Week Treatment Period|Physician Decision|3|||
164496605|NCT03449134|594190052|FG002|52-Week Treatment Period|Physician Decision|3|||
164496606|NCT03449134|594190050|FG000|52-Week Treatment Period|Screen Failure|1|||
164496607|NCT03449134|594190051|FG001|52-Week Treatment Period|Screen Failure|0|||
164715502|NCT00378573|594980426|FG000|Treatment Period|Withdrawal by Subject|2|||
164715503|NCT00378573|594980426|FG000|Treatment Period|Disease Progression|4|||
164715504|NCT00378573|594980426|FG000|Treatment Period|Sponsor decision to close study|1|||
164715505|NCT00378573|594980426|FG000|Follow-up|Death|12|||
164496608|NCT03449134|594190052|FG002|52-Week Treatment Period|Screen Failure|1|||
164496609|NCT03449134|594190050|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
164496610|NCT03449134|594190051|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
164496611|NCT03449134|594190052|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
164496612|NCT03449134|594190050|FG000|52-Week Treatment Period|Site Closure|1|||
164496613|NCT03449134|594190051|FG001|52-Week Treatment Period|Site Closure|0|||
164496614|NCT03449134|594190052|FG002|52-Week Treatment Period|Site Closure|0|||
164496615|NCT03475056|594190053|FG000|Overall Study|Lost to Follow-up|0|||
164496616|NCT03475056|594190054|FG001|Overall Study|Lost to Follow-up|1|||
164496617|NCT03475056|594190053|FG000|Overall Study|Moved from Area|0|||
164715506|NCT00378573|594980426|FG000|Follow-up|Lost to Follow-up|1|||
164496618|NCT03475056|594190054|FG001|Overall Study|Moved from Area|2|||
164496619|NCT00113269|594190057|FG000|Overall Study|Not transplanted, donor issues|4|||
164496620|NCT00113269|594190058|FG001|Overall Study|Not transplanted, donor issues|0|||
164496621|NCT00113269|594190059|FG002|Overall Study|Not transplanted, donor issues|2|||
164496622|NCT00113269|594190060|FG003|Overall Study|Not transplanted, donor issues|2|||
164496623|NCT00113269|594190057|FG000|Overall Study|Not transplanted, recipient issues|2|||
164496624|NCT00113269|594190058|FG001|Overall Study|Not transplanted, recipient issues|1|||
164496625|NCT00113269|594190059|FG002|Overall Study|Not transplanted, recipient issues|7|||
164496626|NCT00113269|594190060|FG003|Overall Study|Not transplanted, recipient issues|4|||
164496627|NCT00113269|594190057|FG000|Overall Study|Early graft loss, technical|0|||
164496628|NCT00113269|594190058|FG001|Overall Study|Early graft loss, technical|0|||
164496629|NCT00113269|594190059|FG002|Overall Study|Early graft loss, technical|2|||
164496630|NCT00113269|594190060|FG003|Overall Study|Early graft loss, technical|0|||
164496631|NCT00113269|594190057|FG000|Overall Study|Death in operating room|0|||
164496632|NCT00113269|594190058|FG001|Overall Study|Death in operating room|0|||
164496633|NCT00113269|594190059|FG002|Overall Study|Death in operating room|0|||
164496634|NCT00113269|594190060|FG003|Overall Study|Death in operating room|1|||
164496635|NCT00113269|594190057|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
164496636|NCT00113269|594190058|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
164496637|NCT00113269|594190059|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
164496638|NCT00113269|594190060|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
164496639|NCT00113269|594190057|FG000|Overall Study|Adverse Event|2|||
164496640|NCT00113269|594190058|FG001|Overall Study|Adverse Event|7|||
164496641|NCT00113269|594190059|FG002|Overall Study|Adverse Event|11|||
164496642|NCT00113269|594190060|FG003|Overall Study|Adverse Event|7|||
164496643|NCT00113269|594190057|FG000|Overall Study|Withdrawal by Subject|4|||
164496644|NCT00113269|594190058|FG001|Overall Study|Withdrawal by Subject|3|||
164496645|NCT00113269|594190059|FG002|Overall Study|Withdrawal by Subject|4|||
164496646|NCT00113269|594190060|FG003|Overall Study|Withdrawal by Subject|2|||
164496647|NCT00113269|594190057|FG000|Overall Study|Graft loss|6|||
164496648|NCT00113269|594190058|FG001|Overall Study|Graft loss|6|||
164496649|NCT00113269|594190059|FG002|Overall Study|Graft loss|4|||
164496650|NCT00113269|594190060|FG003|Overall Study|Graft loss|9|||
164496651|NCT00113269|594190057|FG000|Overall Study|Protocol Violation|1|||
164496652|NCT00113269|594190058|FG001|Overall Study|Protocol Violation|0|||
164496653|NCT00113269|594190059|FG002|Overall Study|Protocol Violation|4|||
164496654|NCT00113269|594190060|FG003|Overall Study|Protocol Violation|2|||
164496655|NCT00113269|594190057|FG000|Overall Study|Lost to Follow-up|2|||
164496656|NCT00113269|594190058|FG001|Overall Study|Lost to Follow-up|3|||
164496657|NCT00113269|594190059|FG002|Overall Study|Lost to Follow-up|6|||
164496658|NCT00113269|594190060|FG003|Overall Study|Lost to Follow-up|3|||
164496659|NCT00113269|594190057|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
164496660|NCT00113269|594190058|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
164496661|NCT00113269|594190059|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
164496662|NCT00113269|594190060|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
164496663|NCT00113269|594190057|FG000|Overall Study|Discontinued due to rejection|0|||
164496664|NCT00113269|594190058|FG001|Overall Study|Discontinued due to rejection|0|||
164496665|NCT00113269|594190059|FG002|Overall Study|Discontinued due to rejection|1|||
164496666|NCT00113269|594190060|FG003|Overall Study|Discontinued due to rejection|0|||
164496667|NCT00113269|594190057|FG000|Overall Study|Moved|0|||
164496668|NCT00113269|594190058|FG001|Overall Study|Moved|1|||
164496669|NCT00113269|594190059|FG002|Overall Study|Moved|0|||
164496670|NCT00113269|594190060|FG003|Overall Study|Moved|3|||
164496671|NCT00113269|594190057|FG000|Overall Study|Received pancreas transplant|0|||
164496672|NCT00113269|594190058|FG001|Overall Study|Received pancreas transplant|0|||
164496673|NCT00113269|594190059|FG002|Overall Study|Received pancreas transplant|0|||
164496674|NCT00113269|594190060|FG003|Overall Study|Received pancreas transplant|2|||
164496675|NCT00113269|594190057|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
164604302|NCT00622869|594572116|FG001|Overall Study|Graft Loss|3|||
164604303|NCT00622869|594572117|FG002|Overall Study|Graft Loss|2|||
164604304|NCT00622869|594572115|FG000|Overall Study|Missing|0|||
164604305|NCT00622869|594572116|FG001|Overall Study|Missing|1|||
164604306|NCT00622869|594572117|FG002|Overall Study|Missing|1|||
164604307|NCT03722784|594572118|FG000|Overall Study|Withdrawal by Subject|1|||
164604308|NCT03722784|594572119|FG001|Overall Study|Withdrawal by Subject|0|||
164604309|NCT03722784|594572118|FG000|Overall Study|Physician Decision|1|||
164604310|NCT03722784|594572119|FG001|Overall Study|Physician Decision|1|||
164604311|NCT03722784|594572118|FG000|Overall Study|Protocol Violation|0|||
164604312|NCT03722784|594572119|FG001|Overall Study|Protocol Violation|1|||
164604313|NCT01317615|594572122|FG000|Overall Study|Disease progression|25|||
164604314|NCT01317615|594572122|FG000|Overall Study|New cancer therapy|5|||
164604315|NCT01317615|594572122|FG000|Overall Study|Death|6|||
164604316|NCT01317615|594572122|FG000|Overall Study|Withdrawal by Subject|5|||
164604317|NCT01317615|594572122|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164604318|NCT01317615|594572122|FG000|Overall Study|Adverse Event|7|||
164604319|NCT02648724|594572126|FG000|Overall Study|Withdrawal by Subject|0|||
164496676|NCT00113269|594190058|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
164496677|NCT00113269|594190059|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
164496678|NCT00113269|594190060|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
164496679|NCT00113269|594190057|FG000|Overall Study|Did not meet eligibility criteria|1|||
164496680|NCT00113269|594190058|FG001|Overall Study|Did not meet eligibility criteria|0|||
164496681|NCT00113269|594190059|FG002|Overall Study|Did not meet eligibility criteria|0|||
164496682|NCT00113269|594190060|FG003|Overall Study|Did not meet eligibility criteria|1|||
164496683|NCT00113269|594190057|FG000|Overall Study|Unable to return for follow up|2|||
164496684|NCT00113269|594190058|FG001|Overall Study|Unable to return for follow up|1|||
164496685|NCT00113269|594190059|FG002|Overall Study|Unable to return for follow up|0|||
164496686|NCT00113269|594190060|FG003|Overall Study|Unable to return for follow up|0|||
164496687|NCT03864341|594190067|FG000|Overall Study|Withdrawal by Subject|1|||
164496688|NCT01066936|594190068|FG000|Overall Study|Death|2|||
164496689|NCT01066936|594190068|FG000|Overall Study|Device revised/removed|1|||
164496690|NCT01066936|594190068|FG000|Overall Study|Lost to Follow-up|3|||
164496691|NCT01066936|594190068|FG000|Overall Study|Withdrawal by Subject|4|||
164496692|NCT01904136|594190069|FG000|Overall Study|Physician Decision|0|||
164496693|NCT01904136|594190070|FG001|Overall Study|Physician Decision|0|||
164496694|NCT01904136|594190071|FG002|Overall Study|Physician Decision|0|||
164496695|NCT01904136|594190072|FG003|Overall Study|Physician Decision|0|||
164496696|NCT01904136|594190073|FG004|Overall Study|Physician Decision|0|||
164496697|NCT01904136|594190074|FG005|Overall Study|Physician Decision|1|||
164496698|NCT01904136|594190075|FG006|Overall Study|Physician Decision|0|||
164496699|NCT01904136|594190076|FG007|Overall Study|Physician Decision|0|||
164496700|NCT01904136|594190077|FG008|Overall Study|Physician Decision|0|||
164496701|NCT01960348|594190079|FG000|Overall Study|Adverse event, not serious|2|||
164496702|NCT01960348|594190080|FG001|Overall Study|Adverse event, not serious|2|||
164604320|NCT02648724|594572127|FG001|Overall Study|Withdrawal by Subject|1|||
164604321|NCT02648724|594572128|FG002|Overall Study|Withdrawal by Subject|1|||
164604322|NCT02648724|594572129|FG003|Overall Study|Withdrawal by Subject|0|||
164604323|NCT02648724|594572130|FG004|Overall Study|Withdrawal by Subject|1|||
164604324|NCT02648724|594572131|FG005|Overall Study|Withdrawal by Subject|0|||
164604325|NCT02648724|594572132|FG006|Overall Study|Withdrawal by Subject|0|||
164604326|NCT02648724|594572126|FG000|Overall Study|Progressive disease|2|||
164604327|NCT02648724|594572127|FG001|Overall Study|Progressive disease|2|||
164604328|NCT02648724|594572128|FG002|Overall Study|Progressive disease|2|||
164604329|NCT02648724|594572129|FG003|Overall Study|Progressive disease|3|||
164604330|NCT02648724|594572130|FG004|Overall Study|Progressive disease|22|||
164604331|NCT02648724|594572131|FG005|Overall Study|Progressive disease|7|||
164604332|NCT02648724|594572132|FG006|Overall Study|Progressive disease|8|||
164604333|NCT02648724|594572126|FG000|Overall Study|Other reason (unknown)|1|||
164604334|NCT02648724|594572127|FG001|Overall Study|Other reason (unknown)|0|||
164604335|NCT02648724|594572128|FG002|Overall Study|Other reason (unknown)|0|||
164604336|NCT02648724|594572129|FG003|Overall Study|Other reason (unknown)|0|||
164604337|NCT02648724|594572130|FG004|Overall Study|Other reason (unknown)|0|||
164604338|NCT02648724|594572131|FG005|Overall Study|Other reason (unknown)|0|||
164604339|NCT02648724|594572132|FG006|Overall Study|Other reason (unknown)|0|||
164604340|NCT02648724|594572126|FG000|Overall Study|Protocol Violation|0|||
164604341|NCT02648724|594572127|FG001|Overall Study|Protocol Violation|0|||
164604342|NCT02648724|594572128|FG002|Overall Study|Protocol Violation|0|||
164604343|NCT02648724|594572129|FG003|Overall Study|Protocol Violation|0|||
164604344|NCT02648724|594572130|FG004|Overall Study|Protocol Violation|1|||
164604345|NCT02648724|594572131|FG005|Overall Study|Protocol Violation|0|||
164604346|NCT02648724|594572132|FG006|Overall Study|Protocol Violation|0|||
164604347|NCT02648724|594572126|FG000|Overall Study|Death|0|||
164604348|NCT02648724|594572127|FG001|Overall Study|Death|0|||
164604349|NCT02648724|594572128|FG002|Overall Study|Death|0|||
164604350|NCT02648724|594572129|FG003|Overall Study|Death|0|||
164604351|NCT02648724|594572130|FG004|Overall Study|Death|0|||
164604352|NCT02648724|594572131|FG005|Overall Study|Death|0|||
164604353|NCT02648724|594572132|FG006|Overall Study|Death|3|||
164604354|NCT02648724|594572126|FG000|Overall Study|Physician Decision|0|||
164604355|NCT02648724|594572127|FG001|Overall Study|Physician Decision|0|||
164496703|NCT01960348|594190079|FG000|Overall Study|Adverse event, serious fatal|6|||
164496704|NCT01960348|594190080|FG001|Overall Study|Adverse event, serious fatal|5|||
164496705|NCT01960348|594190079|FG000|Overall Study|Adverse event, serious non-fatal|0|||
164496706|NCT01960348|594190080|FG001|Overall Study|Adverse event, serious non-fatal|3|||
164496707|NCT01960348|594190079|FG000|Overall Study|Withdrawal by Subject|1|||
164604356|NCT02648724|594572128|FG002|Overall Study|Physician Decision|0|||
164604357|NCT02648724|594572129|FG003|Overall Study|Physician Decision|0|||
164604358|NCT02648724|594572130|FG004|Overall Study|Physician Decision|1|||
164604359|NCT02648724|594572131|FG005|Overall Study|Physician Decision|0|||
164604360|NCT02648724|594572132|FG006|Overall Study|Physician Decision|1|||
164715507|NCT00378573|594980426|FG000|Follow-up|Withdrawal by Subject|1|||
164715508|NCT02015065|594980435|FG000|Overall Study|Death on study|1|||
164715509|NCT02015065|594980436|FG001|Overall Study|Death on study|2|||
164715510|NCT02015065|594980437|FG002|Overall Study|Death on study|1|||
164715511|NCT01420965|594980438|FG000|Overall Study|Withdrawal by Subject|1|||
164715512|NCT01420965|594980439|FG001|Overall Study|Withdrawal by Subject|0|||
164715513|NCT01420965|594980440|FG002|Overall Study|Withdrawal by Subject|0|||
164715514|NCT01420965|594980438|FG000|Overall Study|Adverse Event|0|||
164715515|NCT01420965|594980439|FG001|Overall Study|Adverse Event|1|||
164715516|NCT01420965|594980440|FG002|Overall Study|Adverse Event|0|||
164715517|NCT00252239|594980445|FG000|Overall Study|Withdrawal by Subject|1|||
164715518|NCT00252239|594980446|FG001|Overall Study|Withdrawal by Subject|0|||
164715519|NCT00252239|594980447|FG002|Overall Study|Withdrawal by Subject|0|||
164715520|NCT00252239|594980448|FG003|Overall Study|Withdrawal by Subject|1|||
164715521|NCT00252239|594980445|FG000|Overall Study|Lost to Follow-up|0|||
164715522|NCT00252239|594980446|FG001|Overall Study|Lost to Follow-up|0|||
164715523|NCT00252239|594980447|FG002|Overall Study|Lost to Follow-up|2|||
164715524|NCT00252239|594980448|FG003|Overall Study|Lost to Follow-up|0|||
164715525|NCT03485365|594980451|FG000|Overall Study|Protocol Violation|0|||
164715526|NCT03485365|594980452|FG001|Overall Study|Protocol Violation|0|||
164715527|NCT03485365|594980453|FG002|Overall Study|Protocol Violation|0|||
164715528|NCT03485365|594980454|FG003|Overall Study|Protocol Violation|1|||
164715529|NCT03485365|594980455|FG004|Overall Study|Protocol Violation|0|||
164715530|NCT03485365|594980456|FG005|Overall Study|Protocol Violation|0|||
164715531|NCT03485365|594980457|FG006|Overall Study|Protocol Violation|1|||
164715532|NCT03485365|594980458|FG007|Overall Study|Protocol Violation|0|||
164715533|NCT03485365|594980459|FG008|Overall Study|Protocol Violation|0|||
164496708|NCT01960348|594190080|FG001|Overall Study|Withdrawal by Subject|11|||
164496709|NCT01960348|594190079|FG000|Overall Study|Physician Decision|0|||
164496710|NCT01960348|594190080|FG001|Overall Study|Physician Decision|1|||
164496711|NCT01960348|594190079|FG000|Overall Study|Protocol Violation|1|||
164496712|NCT01960348|594190080|FG001|Overall Study|Protocol Violation|0|||
164496713|NCT00853372|594190081|FG000|Overall Study|Death|30|||
164496714|NCT00853372|594190082|FG001|Overall Study|Death|26|||
164496715|NCT00853372|594190081|FG000|Overall Study|Lost to Follow-up|1|||
164496716|NCT00853372|594190082|FG001|Overall Study|Lost to Follow-up|2|||
164496717|NCT00853372|594190081|FG000|Overall Study|Full Consent Withdrawn|1|||
164496718|NCT00853372|594190082|FG001|Overall Study|Full Consent Withdrawn|1|||
164496719|NCT01580995|594190083|FG000|Overall Study|Lost to Follow-up|2|||
164496720|NCT01580995|594190084|FG001|Overall Study|Lost to Follow-up|2|||
164496721|NCT02517528|594190086|FG000|Overall Study|Withdrawal by Subject|1|||
164496722|NCT02202109|594190090|FG000|Overall Study|Lost to Follow-up|88|||
164604361|NCT02648724|594572126|FG000|Overall Study|Transferred to named patient program|0|||
164604362|NCT02648724|594572127|FG001|Overall Study|Transferred to named patient program|0|||
164604363|NCT02648724|594572128|FG002|Overall Study|Transferred to named patient program|0|||
164604364|NCT02648724|594572129|FG003|Overall Study|Transferred to named patient program|0|||
164604365|NCT02648724|594572130|FG004|Overall Study|Transferred to named patient program|0|||
164604366|NCT02648724|594572131|FG005|Overall Study|Transferred to named patient program|1|||
164604367|NCT02648724|594572132|FG006|Overall Study|Transferred to named patient program|0|||
164604368|NCT00302718|594572133|FG000|Overall Study|Participant left the hospital|1|||
164604369|NCT00302718|594572134|FG001|Overall Study|Participant left the hospital|0|||
164604370|NCT00302718|594572135|FG002|Overall Study|Participant left the hospital|0|||
164604371|NCT00302718|594572136|FG003|Overall Study|Participant left the hospital|1|||
164604372|NCT00302718|594572133|FG000|Overall Study|Withdrawal by Subject|0|||
164604373|NCT00302718|594572134|FG001|Overall Study|Withdrawal by Subject|1|||
164604374|NCT00302718|594572135|FG002|Overall Study|Withdrawal by Subject|0|||
164604375|NCT00302718|594572136|FG003|Overall Study|Withdrawal by Subject|0|||
164604376|NCT00302718|594572133|FG000|Overall Study|Participant left primary care setting|0|||
164604377|NCT00302718|594572134|FG001|Overall Study|Participant left primary care setting|0|||
164604378|NCT00302718|594572135|FG002|Overall Study|Participant left primary care setting|2|||
164604379|NCT00302718|594572136|FG003|Overall Study|Participant left primary care setting|1|||
164604380|NCT00738374|594572137|FG000|Induction Treatment Phase|Adverse Event|14|||
164604381|NCT00738374|594572138|FG001|Induction Treatment Phase|Adverse Event|0|||
164604382|NCT00738374|594572139|FG002|Induction Treatment Phase|Adverse Event|0|||
164604383|NCT00738374|594572140|FG003|Induction Treatment Phase|Adverse Event|0|||
164604384|NCT00738374|594572137|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
164604385|NCT00738374|594572138|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
164604386|NCT00738374|594572139|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
164604387|NCT00738374|594572140|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
164604388|NCT00738374|594572137|FG000|Induction Treatment Phase|Physician Decision|2|||
164604389|NCT00738374|594572138|FG001|Induction Treatment Phase|Physician Decision|0|||
164604390|NCT00738374|594572139|FG002|Induction Treatment Phase|Physician Decision|0|||
164604391|NCT00738374|594572140|FG003|Induction Treatment Phase|Physician Decision|0|||
164715534|NCT02181790|594980460|FG000|Overall Study|study terminated|2|||
164715535|NCT02181790|594980461|FG001|Overall Study|study terminated|0|||
164715536|NCT03276078|594980462|FG000|Overall Study|Adverse Event|1|||
164715537|NCT01275430|594980468|FG000|Overall Study|Adverse Event|1|||
164715538|NCT01275430|594980468|FG000|Overall Study|No Contrast Injection|6|||
164715539|NCT01275430|594980468|FG000|Overall Study|Device Malfunction|1|||
164715540|NCT01275430|594980468|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
164715541|NCT04988087|594980469|FG000|Overall Study|Adverse Event|4|||
164715542|NCT04988087|594980470|FG001|Overall Study|Adverse Event|0|||
164715543|NCT04988087|594980471|FG002|Overall Study|Adverse Event|0|||
164715544|NCT04988087|594980472|FG003|Overall Study|Adverse Event|0|||
164715545|NCT04988087|594980469|FG000|Overall Study|Withdrawal by Subject|1|||
164715546|NCT04988087|594980470|FG001|Overall Study|Withdrawal by Subject|1|||
164715547|NCT04988087|594980471|FG002|Overall Study|Withdrawal by Subject|0|||
164715548|NCT04988087|594980472|FG003|Overall Study|Withdrawal by Subject|0|||
164715549|NCT04988087|594980469|FG000|Overall Study|Technical problems|7|||
164715550|NCT04988087|594980470|FG001|Overall Study|Technical problems|9|||
164715551|NCT04988087|594980471|FG002|Overall Study|Technical problems|1|||
164715552|NCT04988087|594980472|FG003|Overall Study|Technical problems|2|||
164715553|NCT03968978|594980473|FG000|Overall Study|Adverse Event|1|||
164715554|NCT03968978|594980474|FG001|Overall Study|Adverse Event|0|||
164715555|NCT00121134|594980478|FG000|Overall Study|Progression of Disease|5|||
164715556|NCT00121134|594980479|FG001|Overall Study|Progression of Disease|3|||
164715557|NCT00121134|594980480|FG002|Overall Study|Progression of Disease|4|||
164496723|NCT02202109|594190091|FG001|Overall Study|Lost to Follow-up|87|||
164496724|NCT02202109|594190090|FG000|Overall Study|Withdrawal by Subject|2|||
164496725|NCT02202109|594190091|FG001|Overall Study|Withdrawal by Subject|0|||
164496726|NCT01268098|594190094|FG000|Overall Study|Adverse Event|1|||
164496727|NCT01268098|594190095|FG001|Overall Study|Adverse Event|0|||
164496728|NCT04156399|594190103|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
164496729|NCT04156399|594190103|FG000|Overall Study|study suspension due to COVID pandemic|3|||
164496730|NCT00381797|594190104|FG000|Overall Study|Withdrawal by Subject|1|||
164496731|NCT00381797|594190105|FG001|Overall Study|Withdrawal by Subject|1|||
164496732|NCT00381797|594190106|FG002|Overall Study|Withdrawal by Subject|0|||
164496733|NCT00381797|594190107|FG003|Overall Study|Withdrawal by Subject|0|||
164496734|NCT00381797|594190108|FG004|Overall Study|Withdrawal by Subject|2|||
164496735|NCT00381797|594190104|FG000|Overall Study|Ineligible|0|||
164496736|NCT00381797|594190105|FG001|Overall Study|Ineligible|0|||
164496737|NCT00381797|594190106|FG002|Overall Study|Ineligible|0|||
164496738|NCT00381797|594190107|FG003|Overall Study|Ineligible|1|||
164496739|NCT00381797|594190108|FG004|Overall Study|Ineligible|0|||
164496740|NCT03418493|594190111|FG000|Overall Study|Adverse Event|1|||
164496741|NCT03418493|594190112|FG001|Overall Study|Adverse Event|0|||
164496742|NCT03418493|594190113|FG002|Overall Study|Adverse Event|0|||
164496743|NCT03418493|594190114|FG003|Overall Study|Adverse Event|0|||
164496744|NCT03418493|594190115|FG004|Overall Study|Adverse Event|0|||
164496745|NCT03418493|594190116|FG005|Overall Study|Adverse Event|0|||
164496746|NCT03418493|594190117|FG006|Overall Study|Adverse Event|0|||
164496747|NCT03418493|594190118|FG007|Overall Study|Adverse Event|0|||
164496748|NCT03418493|594190119|FG008|Overall Study|Adverse Event|0|||
164496749|NCT03418493|594190120|FG009|Overall Study|Adverse Event|0|||
164496750|NCT03418493|594190121|FG010|Overall Study|Adverse Event|0|||
164496751|NCT03418493|594190111|FG000|Overall Study|Protocol Violation|0|||
164496752|NCT03418493|594190112|FG001|Overall Study|Protocol Violation|0|||
164496753|NCT03418493|594190113|FG002|Overall Study|Protocol Violation|0|||
164496754|NCT03418493|594190114|FG003|Overall Study|Protocol Violation|0|||
164496755|NCT03418493|594190115|FG004|Overall Study|Protocol Violation|0|||
164496756|NCT03418493|594190116|FG005|Overall Study|Protocol Violation|0|||
164496757|NCT03418493|594190117|FG006|Overall Study|Protocol Violation|0|||
164496758|NCT03418493|594190118|FG007|Overall Study|Protocol Violation|0|||
164496759|NCT03418493|594190119|FG008|Overall Study|Protocol Violation|0|||
164496760|NCT03418493|594190120|FG009|Overall Study|Protocol Violation|1|||
164496761|NCT03418493|594190121|FG010|Overall Study|Protocol Violation|0|||
164496762|NCT00526097|594190122|FG000|Overall Study|Adverse Event|6|||
164496763|NCT00526097|594190123|FG001|Overall Study|Adverse Event|44|||
164496764|NCT00526097|594190122|FG000|Overall Study|Protocol Violation|4|||
164496765|NCT00526097|594190123|FG001|Overall Study|Protocol Violation|10|||
164496766|NCT00526097|594190122|FG000|Overall Study|Withdrawal by Subject|3|||
164496767|NCT00526097|594190123|FG001|Overall Study|Withdrawal by Subject|1|||
164496768|NCT00526097|594190122|FG000|Overall Study|Other|2|||
164496769|NCT00526097|594190123|FG001|Overall Study|Other|1|||
164496770|NCT00460564|594190124|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
164496771|NCT00460564|594190125|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
164496772|NCT00460564|594190126|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
164496773|NCT00460564|594190127|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
164496774|NCT00460564|594190128|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
164496775|NCT00460564|594190129|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
164496776|NCT00460564|594190130|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
164496777|NCT00460564|594190131|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
164496778|NCT00460564|594190124|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
164496779|NCT00460564|594190125|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
164496780|NCT00460564|594190126|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
164496781|NCT00460564|594190127|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
164496782|NCT00460564|594190128|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
164496783|NCT00460564|594190129|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
164496784|NCT00460564|594190130|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
164496785|NCT00460564|594190131|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
164496786|NCT00460564|594190124|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
164496787|NCT00460564|594190125|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
164496788|NCT00460564|594190126|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
164496789|NCT00460564|594190127|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
164496790|NCT00460564|594190128|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
164496791|NCT00460564|594190129|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
164496792|NCT00460564|594190130|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
164496793|NCT00460564|594190131|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
164496794|NCT00460564|594190124|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
164496795|NCT00460564|594190125|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
164496796|NCT00460564|594190126|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
164496797|NCT00460564|594190127|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
164496798|NCT00460564|594190128|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
164496799|NCT00460564|594190129|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
164496800|NCT00460564|594190130|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
164496801|NCT00460564|594190131|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
164496802|NCT00460564|594190124|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
164496803|NCT00460564|594190125|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
164496804|NCT00460564|594190126|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
164496805|NCT00460564|594190127|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
164496806|NCT00460564|594190128|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
164496807|NCT00460564|594190129|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
164496808|NCT00460564|594190130|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
164496809|NCT00460564|594190131|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
164496810|NCT00966979|594190134|FG000|Overall Study|Death|1|||
164496811|NCT00966979|594190134|FG000|Overall Study|Lost to Follow-up|6|||
164496812|NCT00966979|594190134|FG000|Overall Study|Withdrawal by Subject|14|||
164496813|NCT00966979|594190134|FG000|Overall Study|Adverse Event|5|||
164496814|NCT00966979|594190134|FG000|Overall Study|Sponsor terminated early|49|||
164496815|NCT00966979|594190134|FG000|Overall Study|Censored because surgery not done|2|||
164496816|NCT00966979|594190134|FG000|Overall Study|Censored because study device was not implanted|14|||
164496817|NCT00966979|594190134|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
164496818|NCT04140266|594190135|FG000|Overall Study|Physician Decision|2|||
164496819|NCT04140266|594190136|FG001|Overall Study|Physician Decision|0|||
164496820|NCT04140266|594190135|FG000|Overall Study|Withdrawal by Subject|4|||
164496821|NCT04140266|594190136|FG001|Overall Study|Withdrawal by Subject|2|||
164496822|NCT01990313|594190144|FG000|Overall Study|Lost to Follow-up|1|||
164496823|NCT02412111|594190145|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
164496824|NCT02412111|594190146|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
164496825|NCT02412111|594190147|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
164496826|NCT02412111|594190145|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
164496827|NCT02412111|594190146|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
164496828|NCT02412111|594190147|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
164496829|NCT02412111|594190145|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
164496830|NCT02412111|594190146|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
164496831|NCT02412111|594190147|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
164496832|NCT02412111|594190145|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
164496833|NCT02412111|594190146|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
164496834|NCT02412111|594190147|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
164496835|NCT02412111|594190145|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
164496836|NCT02412111|594190146|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
164496837|NCT02412111|594190147|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
164496838|NCT02412111|594190145|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
164496839|NCT02412111|594190146|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
164496840|NCT02412111|594190147|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
164496841|NCT02412111|594190145|FG000|Active Comparator Period (8 Weeks)|Other|0|||
164496842|NCT02412111|594190146|FG001|Active Comparator Period (8 Weeks)|Other|0|||
164496843|NCT02412111|594190147|FG002|Active Comparator Period (8 Weeks)|Other|2|||
164496844|NCT00837096|594190149|FG000|Overall Study|Physician Decision|1|||
164496845|NCT00837096|594190150|FG001|Overall Study|Physician Decision|1|||
164496846|NCT00837096|594190149|FG000|Overall Study|Not reported|9|||
164604392|NCT00738374|594572137|FG000|Induction Treatment Phase|Protocol Violation|2|||
164604393|NCT00738374|594572138|FG001|Induction Treatment Phase|Protocol Violation|0|||
164604394|NCT00738374|594572139|FG002|Induction Treatment Phase|Protocol Violation|0|||
164604395|NCT00738374|594572140|FG003|Induction Treatment Phase|Protocol Violation|0|||
164604396|NCT00738374|594572137|FG000|Induction Treatment Phase|Non-compliance|1|||
164604397|NCT00738374|594572138|FG001|Induction Treatment Phase|Non-compliance|0|||
164604398|NCT00738374|594572139|FG002|Induction Treatment Phase|Non-compliance|0|||
164604399|NCT00738374|594572140|FG003|Induction Treatment Phase|Non-compliance|0|||
164604400|NCT00738374|594572137|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
164604401|NCT00738374|594572138|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
164604402|NCT00738374|594572139|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
164604403|NCT00738374|594572140|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
164604404|NCT00738374|594572137|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
164604405|NCT00738374|594572138|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
164604406|NCT00738374|594572139|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
164604407|NCT00738374|594572140|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
164604408|NCT00738374|594572137|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
164604409|NCT00738374|594572138|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
164604410|NCT00738374|594572139|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
164604411|NCT00738374|594572140|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
164604412|NCT00738374|594572137|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
164604413|NCT00738374|594572138|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
164604414|NCT00738374|594572139|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
164604415|NCT00738374|594572140|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
164604416|NCT00738374|594572137|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
164604417|NCT00738374|594572138|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
164604418|NCT00738374|594572139|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
164604419|NCT00738374|594572140|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
164604420|NCT00738374|594572137|FG000|Maintenance Treatment/Observation Phase|Other|0|||
164604421|NCT00738374|594572138|FG001|Maintenance Treatment/Observation Phase|Other|1|||
164604422|NCT00738374|594572139|FG002|Maintenance Treatment/Observation Phase|Other|0|||
164604423|NCT00738374|594572140|FG003|Maintenance Treatment/Observation Phase|Other|0|||
164604424|NCT00632541|594572141|FG000|Overall Study|Adverse Event|7|||
164604425|NCT02927873|594572143|FG000|Overall Study|Lost to Follow-up|0|||
164604426|NCT02927873|594572144|FG001|Overall Study|Lost to Follow-up|1|||
164604427|NCT02927873|594572145|FG002|Overall Study|Lost to Follow-up|0|||
164604428|NCT02927873|594572146|FG003|Overall Study|Lost to Follow-up|0|||
164604429|NCT02927873|594572147|FG004|Overall Study|Lost to Follow-up|0|||
164604430|NCT02927873|594572148|FG005|Overall Study|Lost to Follow-up|0|||
164604431|NCT02927873|594572143|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
164604432|NCT02927873|594572144|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
164604433|NCT02927873|594572145|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
164604434|NCT02927873|594572146|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
164604435|NCT02927873|594572147|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
164604436|NCT02927873|594572148|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
164604437|NCT02927873|594572143|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164604438|NCT02927873|594572144|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164604439|NCT02927873|594572145|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164604440|NCT02927873|594572146|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164604441|NCT02927873|594572147|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164604442|NCT02927873|594572148|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164604443|NCT02927873|594572143|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
164604444|NCT02927873|594572144|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
164604445|NCT02927873|594572145|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
164604446|NCT02927873|594572146|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
164604447|NCT02927873|594572147|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
164604448|NCT02927873|594572148|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
164604449|NCT02927873|594572143|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
164604450|NCT02927873|594572144|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
164604451|NCT02927873|594572145|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
164604452|NCT02927873|594572146|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
164604453|NCT02927873|594572147|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
164604454|NCT02927873|594572148|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
164604455|NCT02927873|594572143|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
164604456|NCT02927873|594572144|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
164496847|NCT00837096|594190150|FG001|Overall Study|Not reported|8|||
164496848|NCT00721214|594190151|FG000|Overall Study|Chose another center for transplant|1|||
164496849|NCT00721214|594190151|FG000|Overall Study|Death|3|||
164496850|NCT00983905|594190152|FG000|Theophylline Alone|Adverse Event|1|||
164496851|NCT00983905|594190152|FG000|Colchicine Alone|Adverse Event|2|||
164496852|NCT01169636|594190153|FG000|Overall Study|Adverse Event|0|||
164496853|NCT01169636|594190154|FG001|Overall Study|Adverse Event|0|||
164496854|NCT01169636|594190155|FG002|Overall Study|Adverse Event|1|||
164496855|NCT01169636|594190156|FG003|Overall Study|Adverse Event|1|||
164496856|NCT01169636|594190157|FG004|Overall Study|Adverse Event|0|||
164496857|NCT01169636|594190153|FG000|Overall Study|Screen failure|0|||
164496858|NCT01169636|594190154|FG001|Overall Study|Screen failure|0|||
164496859|NCT01169636|594190155|FG002|Overall Study|Screen failure|2|||
164496860|NCT01169636|594190156|FG003|Overall Study|Screen failure|0|||
164496861|NCT01169636|594190157|FG004|Overall Study|Screen failure|0|||
164496862|NCT01169636|594190153|FG000|Overall Study|Withdrawal by Subject|0|||
164496863|NCT01169636|594190154|FG001|Overall Study|Withdrawal by Subject|0|||
164496864|NCT01169636|594190155|FG002|Overall Study|Withdrawal by Subject|0|||
164496865|NCT01169636|594190156|FG003|Overall Study|Withdrawal by Subject|0|||
164496866|NCT01169636|594190157|FG004|Overall Study|Withdrawal by Subject|3|||
164496867|NCT02396953|594190158|FG000|Overall Study|Withdrawal by Subject|0|||
164496868|NCT02396953|594190159|FG001|Overall Study|Withdrawal by Subject|0|||
164496869|NCT02396953|594190160|FG002|Overall Study|Withdrawal by Subject|1|||
164496870|NCT02396953|594190158|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
164496871|NCT02396953|594190159|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
164496872|NCT02396953|594190160|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
164496873|NCT02396953|594190158|FG000|Overall Study|Personal Reasons|1|||
164496874|NCT02396953|594190159|FG001|Overall Study|Personal Reasons|1|||
164496875|NCT02396953|594190160|FG002|Overall Study|Personal Reasons|0|||
164496876|NCT02624869|594190161|FG000|Overall Study|Lost to Follow-up|0|||
164496877|NCT02624869|594190162|FG001|Overall Study|Lost to Follow-up|0|||
164496878|NCT02624869|594190163|FG002|Overall Study|Lost to Follow-up|1|||
164496879|NCT02624869|594190161|FG000|Overall Study|Withdrawal by Subject|1|||
164496880|NCT02624869|594190162|FG001|Overall Study|Withdrawal by Subject|3|||
164496881|NCT02624869|594190163|FG002|Overall Study|Withdrawal by Subject|1|||
164496882|NCT00510198|594190164|FG000|Overall Study|Withdrawal by Subject|5|||
164496883|NCT00510198|594190165|FG001|Overall Study|Withdrawal by Subject|4|||
164496884|NCT02994784|594190167|FG000|6 Months Follow-up|Lost to Follow-up|3|||
164496885|NCT00494026|594190168|FG000|Overall Study|Sponsor Decision|4|||
164496886|NCT02466243|594190169|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
164496887|NCT02466243|594190170|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
164496888|NCT02466243|594190169|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
164496889|NCT02466243|594190170|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
164496890|NCT02466243|594190169|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
164496891|NCT02466243|594190170|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
164496892|NCT02466243|594190169|FG000|Part B Open-label Treatment Period|Missing|2|||
164496893|NCT02466243|594190170|FG001|Part B Open-label Treatment Period|Missing|2|||
164496894|NCT02637856|594190174|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
164496895|NCT02637856|594190175|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
164496896|NCT02637856|594190174|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
164496897|NCT02637856|594190175|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
164496898|NCT02637856|594190174|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
164496899|NCT02637856|594190175|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
164496900|NCT02637856|594190174|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
164496901|NCT02637856|594190175|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
164496902|NCT02637856|594190174|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
164496903|NCT02637856|594190175|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
164496904|NCT02637856|594190174|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
164496905|NCT02637856|594190175|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
164496906|NCT02637856|594190174|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
164496907|NCT02637856|594190175|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
164496908|NCT02637856|594190174|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
164496909|NCT02637856|594190175|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
164496910|NCT02637856|594190174|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
164496911|NCT02637856|594190175|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
164496912|NCT02637856|594190174|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
164496913|NCT02637856|594190175|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
164496914|NCT02637856|594190174|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
164496915|NCT02637856|594190175|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
164496916|NCT02637856|594190174|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
164496917|NCT02637856|594190175|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
164496918|NCT02637856|594190174|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
164715558|NCT00121134|594980481|FG003|Overall Study|Progression of Disease|2|||
164715559|NCT00121134|594980478|FG000|Overall Study|Toxicity|4|||
164715560|NCT00121134|594980479|FG001|Overall Study|Toxicity|7|||
164715561|NCT00121134|594980480|FG002|Overall Study|Toxicity|13|||
164715562|NCT00121134|594980481|FG003|Overall Study|Toxicity|5|||
164715563|NCT00121134|594980478|FG000|Overall Study|Physician Decision|6|||
164715564|NCT00121134|594980479|FG001|Overall Study|Physician Decision|4|||
164715565|NCT00121134|594980480|FG002|Overall Study|Physician Decision|4|||
164715566|NCT00121134|594980481|FG003|Overall Study|Physician Decision|1|||
164715567|NCT00121134|594980478|FG000|Overall Study|Treatment Delay|1|||
164715568|NCT00121134|594980479|FG001|Overall Study|Treatment Delay|0|||
164496919|NCT02637856|594190175|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
164496920|NCT02435381|594190176|FG000|Overall Study|Lost to Follow-up|2|||
164496921|NCT02435381|594190177|FG001|Overall Study|Lost to Follow-up|1|||
164496922|NCT00833898|594190181|FG000|Overall Study|Withdrawal by Subject|33|||
164496923|NCT00833898|594190182|FG001|Overall Study|Withdrawal by Subject|27|||
164496924|NCT00833898|594190181|FG000|Overall Study|Lost to Follow-up|7|||
164496925|NCT00833898|594190182|FG001|Overall Study|Lost to Follow-up|7|||
164496926|NCT00833898|594190181|FG000|Overall Study|Patient did not receive transplant|0|||
164496927|NCT00833898|594190182|FG001|Overall Study|Patient did not receive transplant|2|||
164715569|NCT00121134|594980480|FG002|Overall Study|Treatment Delay|0|||
164715570|NCT00121134|594980481|FG003|Overall Study|Treatment Delay|0|||
164496928|NCT02895360|594190187|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
164496929|NCT02895360|594190188|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
164496930|NCT02895360|594190189|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
164496931|NCT02895360|594190190|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
164496932|NCT02895360|594190191|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
164496933|NCT02895360|594190192|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
164496934|NCT02895360|594190187|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
164496935|NCT02895360|594190188|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
164496936|NCT02895360|594190189|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
164496937|NCT02895360|594190190|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
164496938|NCT02895360|594190191|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
164496939|NCT02895360|594190192|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
164496940|NCT02895360|594190187|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
164496941|NCT02895360|594190188|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
164496942|NCT02895360|594190189|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
164496943|NCT02895360|594190190|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
164496944|NCT02895360|594190191|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
164496945|NCT02895360|594190192|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
164496946|NCT02895360|594190187|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
164496947|NCT02895360|594190188|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
164496948|NCT02895360|594190189|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
164496949|NCT02895360|594190190|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
164496950|NCT02895360|594190191|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
164496951|NCT02895360|594190192|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
164496952|NCT02895360|594190187|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
164496953|NCT02895360|594190188|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
164496954|NCT02895360|594190189|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
164496955|NCT02895360|594190190|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
164496956|NCT02895360|594190191|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
164496957|NCT02895360|594190192|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
164496958|NCT02895360|594190187|FG000|Phase 2a|Adverse Event|0|||
164496959|NCT02895360|594190188|FG001|Phase 2a|Adverse Event|0|||
164496960|NCT02895360|594190189|FG002|Phase 2a|Adverse Event|0|||
164496961|NCT02895360|594190190|FG003|Phase 2a|Adverse Event|0|||
164496962|NCT02895360|594190191|FG004|Phase 2a|Adverse Event|0|||
164496963|NCT02895360|594190192|FG005|Phase 2a|Adverse Event|1|||
164496964|NCT02895360|594190187|FG000|Phase 2a|Progressive disease|0|||
164496965|NCT02895360|594190188|FG001|Phase 2a|Progressive disease|0|||
164496966|NCT02895360|594190189|FG002|Phase 2a|Progressive disease|0|||
164496967|NCT02895360|594190190|FG003|Phase 2a|Progressive disease|0|||
164496968|NCT02895360|594190191|FG004|Phase 2a|Progressive disease|11|||
164496969|NCT02895360|594190192|FG005|Phase 2a|Progressive disease|11|||
164496970|NCT05153499|594190195|FG000|Overall Study|Withdrawal by Subject|1|||
164496971|NCT05153499|594190196|FG001|Overall Study|Withdrawal by Subject|0|||
164496972|NCT05153499|594190195|FG000|Overall Study|Clinical Hold|1|||
164496973|NCT05153499|594190196|FG001|Overall Study|Clinical Hold|0|||
164496974|NCT05153499|594190195|FG000|Overall Study|Study Termination|6|||
164715571|NCT00121134|594980478|FG000|Overall Study|Intercurrent Illness|0|||
164715572|NCT00121134|594980479|FG001|Overall Study|Intercurrent Illness|0|||
164715573|NCT00121134|594980480|FG002|Overall Study|Intercurrent Illness|0|||
164715574|NCT00121134|594980481|FG003|Overall Study|Intercurrent Illness|1|||
164604457|NCT02927873|594572145|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
164604458|NCT02927873|594572146|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
164604459|NCT02927873|594572147|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
164604460|NCT02927873|594572148|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
164604461|NCT00393913|594572149|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
164604462|NCT00393913|594572149|FG000|Initial Assessment|Withdrawal by Subject|16|||
164604463|NCT00393913|594572149|FG000|CPAP|Withdrawal by Subject|3|||
164604464|NCT00393913|594572149|FG000|CPAP|Physician Decision|1|||
164604465|NCT00393913|594572149|FG000|CPAP|TEchnical problem with CPAP|3|||
164496975|NCT05153499|594190196|FG001|Overall Study|Study Termination|5|||
164496976|NCT01885936|594190200|FG000|Overall Study|Withdrawal by Subject|1|||
164496977|NCT01885936|594190201|FG001|Overall Study|Withdrawal by Subject|0|||
164496978|NCT03214250|594190202|FG000|Overall Study|Death|5|||
164496979|NCT03214250|594190203|FG001|Overall Study|Death|5|||
164496980|NCT03214250|594190204|FG002|Overall Study|Death|7|||
164496981|NCT03214250|594190205|FG003|Overall Study|Death|4|||
164496982|NCT03214250|594190206|FG004|Overall Study|Death|23|||
164496983|NCT03214250|594190207|FG005|Overall Study|Death|23|||
164496984|NCT03214250|594190208|FG006|Overall Study|Death|24|||
164496985|NCT03214250|594190202|FG000|Overall Study|Lost to Follow-up|0|||
164496986|NCT03214250|594190203|FG001|Overall Study|Lost to Follow-up|0|||
164496987|NCT03214250|594190204|FG002|Overall Study|Lost to Follow-up|0|||
164496988|NCT03214250|594190205|FG003|Overall Study|Lost to Follow-up|1|||
164496989|NCT03214250|594190206|FG004|Overall Study|Lost to Follow-up|1|||
164496990|NCT03214250|594190207|FG005|Overall Study|Lost to Follow-up|2|||
164496991|NCT03214250|594190208|FG006|Overall Study|Lost to Follow-up|0|||
164496992|NCT03214250|594190202|FG000|Overall Study|Other|0|||
164496993|NCT03214250|594190203|FG001|Overall Study|Other|0|||
164496994|NCT03214250|594190204|FG002|Overall Study|Other|0|||
164496995|NCT03214250|594190205|FG003|Overall Study|Other|0|||
164496996|NCT03214250|594190206|FG004|Overall Study|Other|1|||
164496997|NCT03214250|594190207|FG005|Overall Study|Other|1|||
164496998|NCT03214250|594190208|FG006|Overall Study|Other|2|||
164496999|NCT03214250|594190202|FG000|Overall Study|Remains on Study|2|||
164604466|NCT01518244|594572150|FG000|Overall Study|Adverse Event|3|||
164604467|NCT04900038|594572152|FG000|Overall Study|Adverse Event|1|||
164604468|NCT04900038|594572153|FG001|Overall Study|Adverse Event|0|||
164604469|NCT04900038|594572154|FG002|Overall Study|Adverse Event|1|||
164604470|NCT04900038|594572155|FG003|Overall Study|Adverse Event|1|||
164497000|NCT03214250|594190203|FG001|Overall Study|Remains on Study|2|||
164497001|NCT03214250|594190204|FG002|Overall Study|Remains on Study|0|||
164497002|NCT03214250|594190205|FG003|Overall Study|Remains on Study|1|||
164497003|NCT03214250|594190206|FG004|Overall Study|Remains on Study|7|||
164497004|NCT03214250|594190207|FG005|Overall Study|Remains on Study|5|||
164715575|NCT00121134|594980478|FG000|Overall Study|Patient Personal Reasons|0|||
164715576|NCT00121134|594980479|FG001|Overall Study|Patient Personal Reasons|1|||
164715577|NCT00121134|594980480|FG002|Overall Study|Patient Personal Reasons|0|||
164715578|NCT00121134|594980481|FG003|Overall Study|Patient Personal Reasons|0|||
164715579|NCT02478320|594980487|FG000|Overall Study|Adverse Event|2|||
164715580|NCT02478320|594980488|FG001|Overall Study|Adverse Event|0|||
164715581|NCT02478320|594980487|FG000|Overall Study|Death|1|||
164715582|NCT02478320|594980488|FG001|Overall Study|Death|0|||
164715583|NCT02478320|594980487|FG000|Overall Study|Lack of Efficacy|4|||
164715584|NCT02478320|594980488|FG001|Overall Study|Lack of Efficacy|0|||
164715585|NCT02478320|594980487|FG000|Overall Study|Withdrawal by Subject|2|||
164715586|NCT02478320|594980488|FG001|Overall Study|Withdrawal by Subject|0|||
164715587|NCT02478320|594980487|FG000|Overall Study|Screen Failure|3|||
164715588|NCT02478320|594980488|FG001|Overall Study|Screen Failure|0|||
164715589|NCT04400682|594980491|FG000|Period 1|Withdrawal by Subject|1|||
164497005|NCT03214250|594190208|FG006|Overall Study|Remains on Study|3|||
164497006|NCT03214250|594190202|FG000|Overall Study|Withdrawal by Subject|0|||
164497007|NCT03214250|594190203|FG001|Overall Study|Withdrawal by Subject|0|||
164497008|NCT03214250|594190204|FG002|Overall Study|Withdrawal by Subject|1|||
164497009|NCT03214250|594190205|FG003|Overall Study|Withdrawal by Subject|2|||
164497010|NCT03214250|594190206|FG004|Overall Study|Withdrawal by Subject|5|||
164497011|NCT03214250|594190207|FG005|Overall Study|Withdrawal by Subject|0|||
164497012|NCT03214250|594190208|FG006|Overall Study|Withdrawal by Subject|2|||
164497013|NCT00427778|594190213|FG000|First Intervention (4 Weeks)|no longer interested|1|||
164497014|NCT00427778|594190214|FG001|First Intervention (4 Weeks)|no longer interested|0|||
164497015|NCT00427778|594190213|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
164497016|NCT00427778|594190214|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
164497017|NCT00427778|594190213|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
164497018|NCT00427778|594190214|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
164497019|NCT00427778|594190213|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
164497020|NCT00427778|594190214|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
164497021|NCT02845375|594190215|FG000|Overall Study|upper airway obstruction|1|||
164497022|NCT02845375|594190216|FG001|Overall Study|upper airway obstruction|2|||
164497023|NCT02845375|594190217|FG002|Overall Study|upper airway obstruction|1|||
164497024|NCT00591409|594190223|FG000|Overall Study|Not Treated|0|||
164497025|NCT00591409|594190224|FG001|Overall Study|Not Treated|0|||
164497026|NCT00591409|594190225|FG002|Overall Study|Not Treated|0|||
164497027|NCT00591409|594190226|FG003|Overall Study|Not Treated|0|||
164497028|NCT00591409|594190227|FG004|Overall Study|Not Treated|1|||
164497029|NCT00591409|594190228|FG005|Overall Study|Not Treated|0|||
164497030|NCT00591409|594190229|FG006|Overall Study|Not Treated|0|||
164497031|NCT00591409|594190230|FG007|Overall Study|Not Treated|0|||
164497032|NCT00591409|594190231|FG008|Overall Study|Not Treated|0|||
164497033|NCT00591409|594190232|FG009|Overall Study|Not Treated|1|||
164497034|NCT01093599|594192358|FG000|Overall Study|Lost to Follow-up|32|||
164497035|NCT01093599|594192359|FG001|Overall Study|Lost to Follow-up|46|||
164497036|NCT01703845|594192360|FG000|Overall Study|Adverse Event|1|||
164497037|NCT01703845|594192361|FG001|Overall Study|Adverse Event|0|||
164497038|NCT01703845|594192360|FG000|Overall Study|Protocol Violation|1|||
164497039|NCT01703845|594192361|FG001|Overall Study|Protocol Violation|0|||
164497040|NCT01703845|594192360|FG000|Overall Study|other than stated above|1|||
164497041|NCT01703845|594192361|FG001|Overall Study|other than stated above|0|||
164497042|NCT01644188|594192362|FG000|Overall Study|Adverse Event|44|||
164497043|NCT01644188|594192363|FG001|Overall Study|Adverse Event|20|||
164497044|NCT01644188|594192362|FG000|Overall Study|Poor compliance to protocol|26|||
164497045|NCT01644188|594192363|FG001|Overall Study|Poor compliance to protocol|14|||
164497046|NCT01644188|594192362|FG000|Overall Study|Physician Decision|1|||
164497047|NCT01644188|594192363|FG001|Overall Study|Physician Decision|3|||
164497048|NCT01644188|594192362|FG000|Overall Study|Participant moved|7|||
164715590|NCT04400682|594980492|FG001|Period 1|Withdrawal by Subject|4|||
164715591|NCT03597464|594980493|FG000|Overall Study|Withdrawal by Subject|4|||
164715592|NCT03597464|594980494|FG001|Overall Study|Withdrawal by Subject|5|||
164715593|NCT03597464|594980493|FG000|Overall Study|Lost to Follow-up|3|||
164715594|NCT03597464|594980494|FG001|Overall Study|Lost to Follow-up|1|||
164715595|NCT03597464|594980493|FG000|Overall Study|Pregnancy|3|||
164497049|NCT01644188|594192363|FG001|Overall Study|Participant moved|2|||
164497050|NCT01644188|594192362|FG000|Overall Study|Related to auto-injector administration|2|||
164497051|NCT01644188|594192363|FG001|Overall Study|Related to auto-injector administration|2|||
164497052|NCT01644188|594192362|FG000|Overall Study|Consent withdrawn by participant|14|||
164497053|NCT01644188|594192363|FG001|Overall Study|Consent withdrawn by participant|7|||
164497054|NCT01644188|594192362|FG000|Overall Study|Selection criteria finally not met|2|||
164497055|NCT01644188|594192363|FG001|Overall Study|Selection criteria finally not met|0|||
164497056|NCT01644188|594192362|FG000|Overall Study|Lost to Follow-up|1|||
164497057|NCT01644188|594192363|FG001|Overall Study|Lost to Follow-up|0|||
164715596|NCT03597464|594980494|FG001|Overall Study|Pregnancy|1|||
164715597|NCT03597464|594980493|FG000|Overall Study|Lack of Efficacy|2|||
164715598|NCT03597464|594980494|FG001|Overall Study|Lack of Efficacy|0|||
164497058|NCT01644188|594192362|FG000|Overall Study|Death|4|||
164497059|NCT01644188|594192363|FG001|Overall Study|Death|3|||
164497060|NCT01644188|594192362|FG000|Overall Study|Last visit outside protocol visit window|14|||
164497061|NCT01644188|594192363|FG001|Overall Study|Last visit outside protocol visit window|16|||
164497062|NCT01644188|594192362|FG000|Overall Study|Site closure|1|||
164497063|NCT01644188|594192363|FG001|Overall Study|Site closure|1|||
164497064|NCT01644188|594192362|FG000|Overall Study|Other than specified above|6|||
164497065|NCT01644188|594192363|FG001|Overall Study|Other than specified above|7|||
164497066|NCT01222533|594192370|FG000|Overall Study|Adverse Event|5|||
164497067|NCT01222533|594192370|FG000|Overall Study|Withdrawal by Subject|5|||
164497068|NCT01222533|594192370|FG000|Overall Study|Other|4|||
164497069|NCT03834623|594192371|FG000|Overall Study|Progression|0|||
164497070|NCT03834623|594192372|FG001|Overall Study|Progression|1|||
164497071|NCT01947517|594192373|FG000|Overall Study|Withdrawal by Subject|1|||
164497072|NCT01947517|594192374|FG001|Overall Study|Withdrawal by Subject|1|||
164497073|NCT00719212|594192375|FG000|Overall Study|Death|41|||
164497074|NCT00719212|594192375|FG000|Overall Study|Lost to Follow-up|2|||
164497075|NCT00719212|594192375|FG000|Overall Study|Withdrawal by Subject|1|||
164497076|NCT00943618|594192383|FG000|Overall Study|Lost to Follow-up|38|||
164497077|NCT00943618|594192384|FG001|Overall Study|Lost to Follow-up|48|||
164497078|NCT00943618|594192385|FG002|Overall Study|Lost to Follow-up|20|||
164497079|NCT00943618|594192383|FG000|Overall Study|Discontinued Medication|17|||
164497080|NCT00943618|594192384|FG001|Overall Study|Discontinued Medication|29|||
164497081|NCT00943618|594192385|FG002|Overall Study|Discontinued Medication|11|||
164497082|NCT03713281|594192386|FG000|Overall Study|Lens handling difficuluties|2|||
164497083|NCT03713281|594192386|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
164497084|NCT03226106|594192388|FG000|Overall Study|Withdrawal by Subject|2|||
164497085|NCT03226106|594192389|FG001|Overall Study|Withdrawal by Subject|0|||
164497086|NCT03226106|594192388|FG000|Overall Study|Adverse Event|1|||
164497087|NCT03226106|594192389|FG001|Overall Study|Adverse Event|0|||
164497088|NCT03226106|594192388|FG000|Overall Study|Lost to Follow-up|2|||
164497089|NCT03226106|594192389|FG001|Overall Study|Lost to Follow-up|0|||
164497090|NCT04349644|594192390|FG000|Allocation/Pretest|Lost to pretest|0|||
164497091|NCT04349644|594192391|FG001|Allocation/Pretest|Lost to pretest|3|||
164497092|NCT04349644|594192390|FG000|Posttest|Lost to posttest|0|||
164497093|NCT04349644|594192391|FG001|Posttest|Lost to posttest|8|||
164497094|NCT04349644|594192390|FG000|Posttest|Discontinued intervention|6|||
164497095|NCT04349644|594192391|FG001|Posttest|Discontinued intervention|0|||
164497096|NCT04349644|594192390|FG000|Follow-up|Lost to Follow-up|0|||
164497097|NCT04349644|594192391|FG001|Follow-up|Lost to Follow-up|2|||
164497098|NCT00329550|594192392|FG000|Overall Study|Adverse Event|3|||
164497099|NCT00329550|594192393|FG001|Overall Study|Adverse Event|4|||
164497100|NCT00329550|594192394|FG002|Overall Study|Adverse Event|2|||
164497101|NCT00329550|594192392|FG000|Overall Study|Withdrawal of Consent|1|||
164497102|NCT00329550|594192393|FG001|Overall Study|Withdrawal of Consent|0|||
164497103|NCT00329550|594192394|FG002|Overall Study|Withdrawal of Consent|1|||
164497104|NCT00329550|594192392|FG000|Overall Study|Due to Relocation|0|||
164497105|NCT00329550|594192393|FG001|Overall Study|Due to Relocation|0|||
164715599|NCT03597464|594980493|FG000|Overall Study|Physician Decision|2|||
164497106|NCT00329550|594192394|FG002|Overall Study|Due to Relocation|1|||
164497107|NCT01649557|594192395|FG000|Overall Study|Lost to Follow-up|5|||
164497108|NCT01649557|594192396|FG001|Overall Study|Lost to Follow-up|0|||
164497109|NCT01649557|594192397|FG002|Overall Study|Lost to Follow-up|3|||
164497110|NCT01649557|594192395|FG000|Overall Study|Adverse Event|7|||
164497111|NCT01649557|594192396|FG001|Overall Study|Adverse Event|5|||
164497112|NCT01649557|594192397|FG002|Overall Study|Adverse Event|1|||
164497113|NCT01649557|594192395|FG000|Overall Study|Met withdrawal criteria|4|||
164497114|NCT01649557|594192396|FG001|Overall Study|Met withdrawal criteria|0|||
164497115|NCT01649557|594192397|FG002|Overall Study|Met withdrawal criteria|0|||
164497116|NCT01649557|594192395|FG000|Overall Study|Physician Decision|8|||
164497117|NCT01649557|594192396|FG001|Overall Study|Physician Decision|2|||
164497118|NCT01649557|594192397|FG002|Overall Study|Physician Decision|1|||
164497119|NCT01649557|594192395|FG000|Overall Study|Withdrawal by Subject|15|||
164497120|NCT01649557|594192396|FG001|Overall Study|Withdrawal by Subject|5|||
164497121|NCT01649557|594192397|FG002|Overall Study|Withdrawal by Subject|4|||
164497122|NCT01649557|594192395|FG000|Overall Study|Protocol deviation|0|||
164497123|NCT01649557|594192396|FG001|Overall Study|Protocol deviation|2|||
164497124|NCT01649557|594192397|FG002|Overall Study|Protocol deviation|0|||
164497125|NCT01649557|594192395|FG000|Overall Study|Lack of Efficacy|5|||
164497126|NCT01649557|594192396|FG001|Overall Study|Lack of Efficacy|0|||
164497127|NCT01649557|594192397|FG002|Overall Study|Lack of Efficacy|0|||
164497128|NCT01011049|594192398|FG000|Overall Study|Protocol Violation|0|||
164497129|NCT01011049|594192399|FG001|Overall Study|Protocol Violation|0|||
164497130|NCT01011049|594192400|FG002|Overall Study|Protocol Violation|2|||
164497131|NCT01011049|594192401|FG003|Overall Study|Protocol Violation|0|||
164497132|NCT01011049|594192398|FG000|Overall Study|Lost to Follow-up|1|||
164497133|NCT01011049|594192399|FG001|Overall Study|Lost to Follow-up|2|||
164497134|NCT01011049|594192400|FG002|Overall Study|Lost to Follow-up|1|||
164497135|NCT01011049|594192401|FG003|Overall Study|Lost to Follow-up|0|||
164497136|NCT01011049|594192398|FG000|Overall Study|Withdrawal by Subject|0|||
164497137|NCT01011049|594192399|FG001|Overall Study|Withdrawal by Subject|0|||
164497138|NCT01011049|594192400|FG002|Overall Study|Withdrawal by Subject|1|||
164497139|NCT01011049|594192401|FG003|Overall Study|Withdrawal by Subject|0|||
164497140|NCT02815735|594192402|FG000|First Intervention (4 Weeks)|Discomfort|1|||
164497141|NCT02815735|594192403|FG001|First Intervention (4 Weeks)|Discomfort|0|||
164497142|NCT02815735|594192402|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
164497143|NCT02815735|594192403|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
164497144|NCT02815735|594192402|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
164497145|NCT02815735|594192403|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
164497146|NCT02815735|594192402|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
164497147|NCT02815735|594192403|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
164497148|NCT00352053|594192404|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
164497149|NCT00352053|594192405|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
164497150|NCT00352053|594192404|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
164497151|NCT00352053|594192405|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
164497152|NCT00352053|594192404|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
164497153|NCT00352053|594192405|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
164497154|NCT00352053|594192404|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
164497155|NCT00352053|594192405|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
164497156|NCT00352053|594192404|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
164497157|NCT00352053|594192405|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
164497158|NCT00352053|594192404|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
164497159|NCT00352053|594192405|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
164497160|NCT00352053|594192404|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
164497161|NCT00352053|594192405|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
164497162|NCT00352053|594192404|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
164497163|NCT00352053|594192405|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
164497164|NCT00352053|594192404|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
164497165|NCT00352053|594192405|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
164497166|NCT00352053|594192404|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
164497167|NCT00352053|594192405|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
164497168|NCT00352053|594192404|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
164497169|NCT00352053|594192405|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
164497170|NCT00352053|594192404|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
164497171|NCT00352053|594192405|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
164497172|NCT00352053|594192404|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
164497173|NCT00352053|594192405|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
164497174|NCT04150341|594192406|FG000|Overall Study|Physician Decision|0|||
164497175|NCT04150341|594192407|FG001|Overall Study|Physician Decision|0|||
164497176|NCT04150341|594192408|FG002|Overall Study|Physician Decision|1|||
164497177|NCT04150341|594192409|FG003|Overall Study|Physician Decision|0|||
164497178|NCT04150341|594192410|FG004|Overall Study|Physician Decision|0|||
164497179|NCT04150341|594192411|FG005|Overall Study|Physician Decision|0|||
164497180|NCT04150341|594192406|FG000|Overall Study|Adverse Event|0|||
164497181|NCT04150341|594192407|FG001|Overall Study|Adverse Event|0|||
164497182|NCT04150341|594192408|FG002|Overall Study|Adverse Event|0|||
164497183|NCT04150341|594192409|FG003|Overall Study|Adverse Event|0|||
164497184|NCT04150341|594192410|FG004|Overall Study|Adverse Event|1|||
164497185|NCT04150341|594192411|FG005|Overall Study|Adverse Event|0|||
164497186|NCT00875615|594192412|FG000|Overall Study|Withdrawal by Subject|1|||
164497187|NCT00702650|594192413|FG000|Overall Study|Withdrawal by Subject|9|||
164497188|NCT00702650|594192413|FG000|Overall Study|Non-Compliance of Study Drug|3|||
164497189|NCT00702650|594192413|FG000|Overall Study|Lost to Follow-up|2|||
164497190|NCT00702650|594192413|FG000|Overall Study|Non-Compliance with Site Directives|1|||
164497191|NCT00702650|594192413|FG000|Overall Study|Sponsor Request|1|||
164497192|NCT00702650|594192413|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
164497193|NCT00702650|594192413|FG000|Overall Study|Adverse Event|3|||
164497194|NCT00405912|594192414|FG000|Overall Study|Withdrawal by Subject|12|||
164497195|NCT00405912|594192415|FG001|Overall Study|Withdrawal by Subject|11|||
164497196|NCT00405912|594192416|FG002|Overall Study|Withdrawal by Subject|12|||
164497197|NCT00405912|594192414|FG000|Overall Study|Lost to Follow-up|4|||
164497198|NCT00405912|594192415|FG001|Overall Study|Lost to Follow-up|8|||
164497199|NCT00405912|594192416|FG002|Overall Study|Lost to Follow-up|4|||
164497200|NCT03730662|594192417|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
164497201|NCT03730662|594192418|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
164497202|NCT03730662|594192419|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
164497203|NCT03730662|594192420|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
164497204|NCT03730662|594192417|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
164497205|NCT03730662|594192418|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
164497206|NCT03730662|594192419|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
164497207|NCT03730662|594192420|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
164497208|NCT03730662|594192417|FG000|Treatment Period (52 Weeks)|Death|6|||
164497209|NCT03730662|594192418|FG001|Treatment Period (52 Weeks)|Death|2|||
164497210|NCT03730662|594192419|FG002|Treatment Period (52 Weeks)|Death|2|||
164497211|NCT03730662|594192420|FG003|Treatment Period (52 Weeks)|Death|9|||
164497212|NCT03730662|594192417|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
164497213|NCT03730662|594192418|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
164497214|NCT03730662|594192419|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
164497215|NCT03730662|594192420|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
164497216|NCT03730662|594192417|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
164497217|NCT03730662|594192418|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
164497218|NCT03730662|594192419|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
164497219|NCT03730662|594192420|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
164497220|NCT03730662|594192417|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
164497221|NCT03730662|594192418|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
164497222|NCT03730662|594192419|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
164497223|NCT03730662|594192420|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
164497224|NCT03730662|594192417|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
164497225|NCT03730662|594192418|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
164497226|NCT03730662|594192419|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
164604471|NCT04900038|594572152|FG000|Overall Study|Withdrawal by Subject|0|||
164604472|NCT04900038|594572153|FG001|Overall Study|Withdrawal by Subject|1|||
164604473|NCT04900038|594572154|FG002|Overall Study|Withdrawal by Subject|0|||
164604474|NCT04900038|594572155|FG003|Overall Study|Withdrawal by Subject|0|||
164604475|NCT04900038|594572152|FG000|Overall Study|Study terminated by sponsor|18|||
164604476|NCT04900038|594572153|FG001|Overall Study|Study terminated by sponsor|15|||
164604477|NCT04900038|594572154|FG002|Overall Study|Study terminated by sponsor|17|||
164604478|NCT04900038|594572155|FG003|Overall Study|Study terminated by sponsor|14|||
164604479|NCT04900038|594572152|FG000|Overall Study|Protocol Deviation|1|||
164497227|NCT03730662|594192420|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
164604480|NCT04900038|594572153|FG001|Overall Study|Protocol Deviation|1|||
164604481|NCT04900038|594572154|FG002|Overall Study|Protocol Deviation|0|||
164604482|NCT04900038|594572155|FG003|Overall Study|Protocol Deviation|0|||
164604483|NCT04900038|594572152|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
164604484|NCT04900038|594572153|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
164604485|NCT04900038|594572154|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
164604486|NCT04900038|594572155|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
164604487|NCT04900038|594572152|FG000|Overall Study|Lost to Follow-up|0|||
164604488|NCT04900038|594572153|FG001|Overall Study|Lost to Follow-up|0|||
164604489|NCT04900038|594572154|FG002|Overall Study|Lost to Follow-up|0|||
164604490|NCT04900038|594572155|FG003|Overall Study|Lost to Follow-up|1|||
164604491|NCT00077376|594572160|FG000|Overall Study|Adverse Event|8|||
164604492|NCT00077376|594572160|FG000|Overall Study|Withdrawal by Subject|2|||
164604493|NCT00077376|594572160|FG000|Overall Study|Death|1|||
164604494|NCT00077376|594572160|FG000|Overall Study|Physician Decision|1|||
164604495|NCT00077376|594572160|FG000|Overall Study|Alternative therapy|5|||
164604496|NCT00077376|594572160|FG000|Overall Study|Complicating disease|1|||
164604497|NCT00077376|594572160|FG000|Overall Study|Still on treatment|1|||
164604498|NCT00077376|594572160|FG000|Overall Study|Symptomatic deterioration|1|||
164604499|NCT00077376|594572160|FG000|Overall Study|Surgery|1|||
164604500|NCT00077376|594572160|FG000|Overall Study|Insurance ran out|1|||
164604501|NCT02843178|594573844|FG000|Overall Study|Lost to Follow-up|8|||
164604502|NCT02843178|594573845|FG001|Overall Study|Lost to Follow-up|8|||
164604503|NCT02843178|594573846|FG002|Overall Study|Lost to Follow-up|6|||
164604504|NCT02843178|594573847|FG003|Overall Study|Lost to Follow-up|3|||
164604505|NCT02843178|594573844|FG000|Overall Study|Withdrawal by Subject|0|||
164604506|NCT02843178|594573845|FG001|Overall Study|Withdrawal by Subject|0|||
164497228|NCT03730662|594192417|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
164497229|NCT03730662|594192418|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
164497230|NCT03730662|594192419|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
164497231|NCT03730662|594192420|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
164497232|NCT03730662|594192417|FG000|Variable Treatment Period|Adverse Event|1|||
164497233|NCT03730662|594192418|FG001|Variable Treatment Period|Adverse Event|2|||
164497234|NCT03730662|594192419|FG002|Variable Treatment Period|Adverse Event|0|||
164497235|NCT03730662|594192420|FG003|Variable Treatment Period|Adverse Event|7|||
164497236|NCT03730662|594192417|FG000|Variable Treatment Period|Death|9|||
164497237|NCT03730662|594192418|FG001|Variable Treatment Period|Death|0|||
164497238|NCT03730662|594192419|FG002|Variable Treatment Period|Death|6|||
164604507|NCT02843178|594573846|FG002|Overall Study|Withdrawal by Subject|1|||
164604508|NCT02843178|594573847|FG003|Overall Study|Withdrawal by Subject|1|||
164604509|NCT02420795|594573850|FG000|Overall Study|Withdrawal by Subject|1|||
164604510|NCT02420795|594573851|FG001|Overall Study|Withdrawal by Subject|0|||
164604511|NCT02420795|594573852|FG002|Overall Study|Withdrawal by Subject|0|||
164604512|NCT02420795|594573850|FG000|Overall Study|Adverse Event|1|||
164604513|NCT02420795|594573851|FG001|Overall Study|Adverse Event|0|||
164497239|NCT03730662|594192420|FG003|Variable Treatment Period|Death|26|||
164497240|NCT03730662|594192417|FG000|Variable Treatment Period|Lost to Follow-up|2|||
164497241|NCT03730662|594192418|FG001|Variable Treatment Period|Lost to Follow-up|1|||
164497242|NCT03730662|594192419|FG002|Variable Treatment Period|Lost to Follow-up|4|||
164497243|NCT03730662|594192420|FG003|Variable Treatment Period|Lost to Follow-up|11|||
164497244|NCT03730662|594192417|FG000|Variable Treatment Period|Personal Reason|0|||
164497245|NCT03730662|594192418|FG001|Variable Treatment Period|Personal Reason|2|||
164497246|NCT03730662|594192419|FG002|Variable Treatment Period|Personal Reason|1|||
164497247|NCT03730662|594192420|FG003|Variable Treatment Period|Personal Reason|6|||
164497248|NCT03730662|594192417|FG000|Variable Treatment Period|Physician Decision|0|||
164497249|NCT03730662|594192418|FG001|Variable Treatment Period|Physician Decision|0|||
164497250|NCT03730662|594192419|FG002|Variable Treatment Period|Physician Decision|0|||
164497251|NCT03730662|594192420|FG003|Variable Treatment Period|Physician Decision|3|||
164497252|NCT03730662|594192417|FG000|Variable Treatment Period|Protocol Violation|0|||
164497253|NCT03730662|594192418|FG001|Variable Treatment Period|Protocol Violation|1|||
164497254|NCT03730662|594192419|FG002|Variable Treatment Period|Protocol Violation|1|||
164497255|NCT03730662|594192420|FG003|Variable Treatment Period|Protocol Violation|1|||
164497256|NCT03730662|594192417|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
164497257|NCT03730662|594192418|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
164497258|NCT03730662|594192419|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
164497259|NCT03730662|594192420|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
164497260|NCT01309243|594192421|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
164497261|NCT01309243|594192422|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
164497262|NCT01309243|594192421|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
164497263|NCT01309243|594192422|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
164497264|NCT01309243|594192421|FG000|Randomized Phase Through Week 96|Death|0|||
164497265|NCT01309243|594192422|FG001|Randomized Phase Through Week 96|Death|1|||
164497266|NCT01309243|594192421|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
164497267|NCT01309243|594192422|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
164497268|NCT01309243|594192421|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
164497269|NCT01309243|594192422|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
164497270|NCT01309243|594192421|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
164497271|NCT01309243|594192422|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
164497272|NCT01309243|594192421|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
164497273|NCT01309243|594192422|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
164497274|NCT01309243|594192421|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
164497275|NCT01309243|594192422|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
164497276|NCT01309243|594192421|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
164497277|NCT01309243|594192422|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
164497278|NCT01309243|594192421|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
164497279|NCT01309243|594192422|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
164497280|NCT01309243|594192421|FG000|Extension Phase|Lost to Follow-up|6|||
164497281|NCT01309243|594192422|FG001|Extension Phase|Lost to Follow-up|0|||
164497282|NCT00943722|594192424|FG000|Base Study|Adverse Event|0|||
164497283|NCT00943722|594192425|FG001|Base Study|Adverse Event|0|||
164497284|NCT00943722|594192426|FG002|Base Study|Adverse Event|0|||
164497285|NCT00943722|594192427|FG003|Base Study|Adverse Event|1|||
164497286|NCT00943722|594192428|FG004|Base Study|Adverse Event|0|||
164497287|NCT00943722|594192429|FG005|Base Study|Adverse Event|0|||
164497288|NCT00943722|594192430|FG006|Base Study|Adverse Event|0|||
164497289|NCT00943722|594192424|FG000|Base Study|Lost to Follow-up|12|||
164497290|NCT00943722|594192425|FG001|Base Study|Lost to Follow-up|8|||
164497291|NCT00943722|594192426|FG002|Base Study|Lost to Follow-up|10|||
164497292|NCT00943722|594192427|FG003|Base Study|Lost to Follow-up|8|||
164497293|NCT00943722|594192428|FG004|Base Study|Lost to Follow-up|11|||
164497294|NCT00943722|594192429|FG005|Base Study|Lost to Follow-up|0|||
164497295|NCT00943722|594192430|FG006|Base Study|Lost to Follow-up|0|||
164604514|NCT02420795|594573852|FG002|Overall Study|Adverse Event|0|||
164604515|NCT02420795|594573850|FG000|Overall Study|Progressive disease|2|||
164604516|NCT02420795|594573851|FG001|Overall Study|Progressive disease|2|||
164604517|NCT02420795|594573852|FG002|Overall Study|Progressive disease|4|||
164604518|NCT02420795|594573850|FG000|Overall Study|Death|0|||
164604519|NCT02420795|594573851|FG001|Overall Study|Death|0|||
164604520|NCT02420795|594573852|FG002|Overall Study|Death|1|||
164604521|NCT02034552|594573853|FG000|Overall Study|Never treated|3|||
164604522|NCT02034552|594573854|FG001|Overall Study|Never treated|2|||
164604523|NCT02034552|594573855|FG002|Overall Study|Never treated|0|||
164604524|NCT02034552|594573853|FG000|Overall Study|Radiological progression|3|||
164604525|NCT02034552|594573854|FG001|Overall Study|Radiological progression|5|||
164604526|NCT02034552|594573855|FG002|Overall Study|Radiological progression|4|||
164604527|NCT02034552|594573853|FG000|Overall Study|AE not assoc. with disease progression|1|||
164604528|NCT02034552|594573854|FG001|Overall Study|AE not assoc. with disease progression|4|||
164604529|NCT02034552|594573855|FG002|Overall Study|AE not assoc. with disease progression|2|||
164604530|NCT02034552|594573853|FG000|Overall Study|AE associated with disease progression|0|||
164604531|NCT02034552|594573854|FG001|Overall Study|AE associated with disease progression|1|||
164604532|NCT02034552|594573855|FG002|Overall Study|AE associated with disease progression|0|||
164604533|NCT02034552|594573853|FG000|Overall Study|Withdrawal by Subject|2|||
164604534|NCT02034552|594573854|FG001|Overall Study|Withdrawal by Subject|1|||
164604535|NCT02034552|594573855|FG002|Overall Study|Withdrawal by Subject|1|||
164604536|NCT02034552|594573853|FG000|Overall Study|Non-compliance with study drug|0|||
164604537|NCT02034552|594573854|FG001|Overall Study|Non-compliance with study drug|0|||
164604538|NCT02034552|594573855|FG002|Overall Study|Non-compliance with study drug|1|||
164604539|NCT02034552|594573853|FG000|Overall Study|Clinical progression|5|||
164604540|NCT02034552|594573854|FG001|Overall Study|Clinical progression|7|||
164604541|NCT02034552|594573855|FG002|Overall Study|Clinical progression|9|||
164604542|NCT02501902|594573858|FG000|Overall Study|Subject Refused Further Follow-up|0|||
164604543|NCT02501902|594573859|FG001|Overall Study|Subject Refused Further Follow-up|0|||
164604544|NCT02501902|594573860|FG002|Overall Study|Subject Refused Further Follow-up|0|||
164604545|NCT02501902|594573861|FG003|Overall Study|Subject Refused Further Follow-up|0|||
164604546|NCT02501902|594573862|FG004|Overall Study|Subject Refused Further Follow-up|0|||
164604547|NCT02501902|594573863|FG005|Overall Study|Subject Refused Further Follow-up|0|||
164604548|NCT02501902|594573864|FG006|Overall Study|Subject Refused Further Follow-up|0|||
164604549|NCT02501902|594573865|FG007|Overall Study|Subject Refused Further Follow-up|1|||
164604550|NCT02501902|594573858|FG000|Overall Study|Study Terminated by Sponsor|0|||
164604551|NCT02501902|594573859|FG001|Overall Study|Study Terminated by Sponsor|3|||
164604552|NCT02501902|594573860|FG002|Overall Study|Study Terminated by Sponsor|0|||
164604553|NCT02501902|594573861|FG003|Overall Study|Study Terminated by Sponsor|1|||
164604554|NCT02501902|594573862|FG004|Overall Study|Study Terminated by Sponsor|1|||
164604555|NCT02501902|594573863|FG005|Overall Study|Study Terminated by Sponsor|0|||
164604556|NCT02501902|594573864|FG006|Overall Study|Study Terminated by Sponsor|2|||
164604557|NCT02501902|594573865|FG007|Overall Study|Study Terminated by Sponsor|4|||
164604558|NCT02501902|594573858|FG000|Overall Study|Death|3|||
164604559|NCT02501902|594573859|FG001|Overall Study|Death|4|||
164604560|NCT02501902|594573860|FG002|Overall Study|Death|4|||
164604561|NCT02501902|594573861|FG003|Overall Study|Death|10|||
164604562|NCT02501902|594573862|FG004|Overall Study|Death|10|||
164604563|NCT02501902|594573863|FG005|Overall Study|Death|11|||
164604564|NCT02501902|594573864|FG006|Overall Study|Death|7|||
164604565|NCT02501902|594573865|FG007|Overall Study|Death|15|||
164604566|NCT00650091|594573866|FG000|Amended Study Design|Withdrawal by Subject|12|||
164604567|NCT00650091|594573867|FG001|Amended Study Design|Withdrawal by Subject|11|||
164604568|NCT00650091|594573868|FG002|Amended Study Design|Withdrawal by Subject|0|||
164604569|NCT00650091|594573866|FG000|Amended Study Design|Physician Decision|5|||
164604570|NCT00650091|594573867|FG001|Amended Study Design|Physician Decision|0|||
164604571|NCT00650091|594573868|FG002|Amended Study Design|Physician Decision|0|||
164604572|NCT00650091|594573866|FG000|Amended Study Design|Adverse Event|1|||
164604573|NCT00650091|594573867|FG001|Amended Study Design|Adverse Event|4|||
164604574|NCT00650091|594573868|FG002|Amended Study Design|Adverse Event|0|||
164604575|NCT00650091|594573866|FG000|Amended Study Design|Lung transplantation|4|||
164604576|NCT00650091|594573867|FG001|Amended Study Design|Lung transplantation|2|||
164604577|NCT00650091|594573868|FG002|Amended Study Design|Lung transplantation|0|||
164604578|NCT00650091|594573866|FG000|Amended Study Design|Other|1|||
164604579|NCT00650091|594573867|FG001|Amended Study Design|Other|3|||
164604580|NCT00650091|594573868|FG002|Amended Study Design|Other|0|||
164604581|NCT04295356|594573869|FG000|Overall Study|Physician Decision|1|||
164604582|NCT04295356|594573870|FG001|Overall Study|Physician Decision|0|||
164604583|NCT04295356|594573869|FG000|Overall Study|Lost to Follow-up|0|||
164604584|NCT04295356|594573870|FG001|Overall Study|Lost to Follow-up|3|||
164604585|NCT04295356|594573869|FG000|Overall Study|Protocol Violation|0|||
164604586|NCT04295356|594573870|FG001|Overall Study|Protocol Violation|1|||
164604587|NCT04268004|594573879|FG000|Overall Study|Excluded from analyses|0|||
164604588|NCT04268004|594573880|FG001|Overall Study|Excluded from analyses|1|||
164604589|NCT01453998|594573881|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
164497296|NCT00943722|594192424|FG000|Base Study|Physician Decision|1|||
164497297|NCT00943722|594192425|FG001|Base Study|Physician Decision|0|||
164497298|NCT00943722|594192426|FG002|Base Study|Physician Decision|0|||
164497299|NCT00943722|594192427|FG003|Base Study|Physician Decision|0|||
164497300|NCT00943722|594192428|FG004|Base Study|Physician Decision|1|||
164497301|NCT00943722|594192429|FG005|Base Study|Physician Decision|0|||
164497302|NCT00943722|594192430|FG006|Base Study|Physician Decision|0|||
164497303|NCT00943722|594192424|FG000|Base Study|Pregnancy|0|||
164497304|NCT00943722|594192425|FG001|Base Study|Pregnancy|0|||
164497305|NCT00943722|594192426|FG002|Base Study|Pregnancy|1|||
164497306|NCT00943722|594192427|FG003|Base Study|Pregnancy|0|||
164604590|NCT01453998|594573882|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
164604591|NCT01453998|594573883|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
164604592|NCT00712933|594573890|FG000|Overall Study|Adverse Event|69|||
164604593|NCT00712933|594573890|FG000|Overall Study|Lack of Efficacy|6|||
164604594|NCT00712933|594573890|FG000|Overall Study|Lost to Follow-up|22|||
164497307|NCT00943722|594192428|FG004|Base Study|Pregnancy|2|||
164604595|NCT00712933|594573890|FG000|Overall Study|Non-compliance with study drug|13|||
164497308|NCT00943722|594192429|FG005|Base Study|Pregnancy|0|||
164497309|NCT00943722|594192430|FG006|Base Study|Pregnancy|0|||
164497310|NCT00943722|594192424|FG000|Base Study|Protocol Violation|0|||
164497311|NCT00943722|594192425|FG001|Base Study|Protocol Violation|1|||
164497312|NCT00943722|594192426|FG002|Base Study|Protocol Violation|0|||
164497313|NCT00943722|594192427|FG003|Base Study|Protocol Violation|0|||
164497314|NCT00943722|594192428|FG004|Base Study|Protocol Violation|2|||
164497315|NCT00943722|594192429|FG005|Base Study|Protocol Violation|0|||
164497316|NCT00943722|594192430|FG006|Base Study|Protocol Violation|0|||
164497317|NCT00943722|594192424|FG000|Base Study|Withdrawal by Subject|12|||
164497318|NCT00943722|594192425|FG001|Base Study|Withdrawal by Subject|13|||
164497319|NCT00943722|594192426|FG002|Base Study|Withdrawal by Subject|2|||
164497320|NCT00943722|594192427|FG003|Base Study|Withdrawal by Subject|13|||
164497321|NCT00943722|594192428|FG004|Base Study|Withdrawal by Subject|8|||
164497322|NCT00943722|594192429|FG005|Base Study|Withdrawal by Subject|0|||
164497323|NCT00943722|594192430|FG006|Base Study|Withdrawal by Subject|0|||
164497324|NCT00943722|594192424|FG000|Base Study|Month 12 visit not completed|0|||
164497325|NCT00943722|594192425|FG001|Base Study|Month 12 visit not completed|0|||
164497326|NCT00943722|594192426|FG002|Base Study|Month 12 visit not completed|0|||
164497327|NCT00943722|594192427|FG003|Base Study|Month 12 visit not completed|0|||
164497328|NCT00943722|594192428|FG004|Base Study|Month 12 visit not completed|2|||
164497329|NCT00943722|594192429|FG005|Base Study|Month 12 visit not completed|0|||
164497330|NCT00943722|594192430|FG006|Base Study|Month 12 visit not completed|0|||
164497331|NCT00943722|594192424|FG000|First Extension Study: EXT 1|Adverse Event|0|||
164497332|NCT00943722|594192425|FG001|First Extension Study: EXT 1|Adverse Event|0|||
164497333|NCT00943722|594192426|FG002|First Extension Study: EXT 1|Adverse Event|0|||
164497334|NCT00943722|594192427|FG003|First Extension Study: EXT 1|Adverse Event|0|||
164497335|NCT00943722|594192428|FG004|First Extension Study: EXT 1|Adverse Event|0|||
164497336|NCT00943722|594192429|FG005|First Extension Study: EXT 1|Adverse Event|1|||
164497337|NCT00943722|594192430|FG006|First Extension Study: EXT 1|Adverse Event|0|||
164497338|NCT00943722|594192424|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
164497339|NCT00943722|594192425|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
164497340|NCT00943722|594192426|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
164497341|NCT00943722|594192427|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
164497342|NCT00943722|594192428|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
164497343|NCT00943722|594192429|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
164497344|NCT00943722|594192430|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
164497345|NCT00943722|594192424|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
164497346|NCT00943722|594192425|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
164497347|NCT00943722|594192426|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
164497348|NCT00943722|594192427|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
164497349|NCT00943722|594192428|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
164497350|NCT00943722|594192429|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
164497351|NCT00943722|594192430|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
164497352|NCT00943722|594192424|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
164497353|NCT00943722|594192425|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
164497354|NCT00943722|594192426|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
164497355|NCT00943722|594192427|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
164497356|NCT00943722|594192428|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
164497357|NCT00943722|594192429|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
164497358|NCT00943722|594192430|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
164497359|NCT00943722|594192424|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
164497360|NCT00943722|594192425|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
164497361|NCT00943722|594192426|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
164497362|NCT00943722|594192427|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
164497363|NCT00943722|594192428|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
164497364|NCT00943722|594192429|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
164497365|NCT00943722|594192430|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
164497366|NCT00943722|594192424|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
164497367|NCT00943722|594192425|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
164497368|NCT00943722|594192426|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
164497369|NCT00943722|594192427|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
164497370|NCT00943722|594192428|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
164497371|NCT00943722|594192429|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
164497372|NCT00943722|594192430|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
164497373|NCT00943722|594192424|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
164497374|NCT00943722|594192425|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
164497375|NCT00943722|594192426|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
164497376|NCT00943722|594192427|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
164497377|NCT00943722|594192428|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
164497378|NCT00943722|594192429|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
164497379|NCT00943722|594192430|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
164497380|NCT00943722|594192424|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
164497381|NCT00943722|594192425|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
164497382|NCT00943722|594192426|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
164497383|NCT00943722|594192427|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
164497384|NCT00943722|594192428|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
164497385|NCT00943722|594192429|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
164497386|NCT00943722|594192430|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
164497387|NCT00943722|594192424|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
164497388|NCT00943722|594192425|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
164497389|NCT00943722|594192426|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
164497390|NCT00943722|594192427|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
164497391|NCT00943722|594192428|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
164497392|NCT00943722|594192429|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
164497393|NCT00943722|594192430|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
164497394|NCT01772823|594192435|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
164497395|NCT01772823|594192436|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
164497396|NCT01772823|594192435|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
164497397|NCT01772823|594192436|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
164497398|NCT01772823|594192435|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
164497399|NCT01772823|594192436|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
164497400|NCT01772823|594192435|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
164497401|NCT01772823|594192436|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
164497402|NCT01772823|594192435|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
164497403|NCT01772823|594192436|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
164497404|NCT01772823|594192435|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
164497405|NCT01772823|594192436|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
164497406|NCT01772823|594192435|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
164497407|NCT01772823|594192436|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
164497408|NCT01772823|594192435|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
164497409|NCT01772823|594192436|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
164497410|NCT01772823|594192435|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
164497411|NCT01772823|594192436|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
164497412|NCT01772823|594192435|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
164497413|NCT01772823|594192436|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
164497414|NCT01772823|594192435|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
164497415|NCT01772823|594192436|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
164497416|NCT01772823|594192435|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
164497417|NCT01772823|594192436|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
164497418|NCT01772823|594192435|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
164497419|NCT01772823|594192436|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
164497420|NCT01772823|594192435|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
164497421|NCT01772823|594192436|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
164497422|NCT01772823|594192435|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
164497423|NCT01772823|594192436|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
164497424|NCT01772823|594192435|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
164497425|NCT01772823|594192436|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
164497426|NCT01402063|594192439|FG000|Overall Study|Withdrawal by Subject|3|||
164497427|NCT01402063|594192440|FG001|Overall Study|Withdrawal by Subject|3|||
164497428|NCT00666198|594192441|FG000|Overall Study|Protocol Violation|10|||
164497429|NCT00666198|594192441|FG000|Overall Study|No Visit After First Day of Treatment|13|||
164497430|NCT00666198|594192441|FG000|Overall Study|Safety Not Assessable|6|||
164497431|NCT00666198|594192441|FG000|Overall Study|No Drug Administration|4|||
164497432|NCT05109117|594192442|FG000|Overall Study|Lost to Follow-up|1|||
164497433|NCT05109117|594192442|FG000|Overall Study|Discontinued for non-compliance|1|||
164497434|NCT03220776|594192445|FG000|Overall Study|Claustrophobia|0|||
164497435|NCT03220776|594192446|FG001|Overall Study|Claustrophobia|1|||
164497436|NCT03220776|594192447|FG002|Overall Study|Claustrophobia|1|||
164497437|NCT03220776|594192448|FG003|Overall Study|Claustrophobia|0|||
164497438|NCT03220776|594192449|FG004|Overall Study|Claustrophobia|1|||
164497439|NCT03220776|594192450|FG005|Overall Study|Claustrophobia|0|||
164497440|NCT03220776|594192445|FG000|Overall Study|MRI Equipment Failure|1|||
164497441|NCT03220776|594192446|FG001|Overall Study|MRI Equipment Failure|0|||
164497442|NCT03220776|594192447|FG002|Overall Study|MRI Equipment Failure|0|||
164497443|NCT03220776|594192448|FG003|Overall Study|MRI Equipment Failure|0|||
164497444|NCT03220776|594192449|FG004|Overall Study|MRI Equipment Failure|0|||
164497445|NCT03220776|594192450|FG005|Overall Study|MRI Equipment Failure|0|||
164497446|NCT03220776|594192445|FG000|Overall Study|Inclimate Weather|0|||
164497447|NCT03220776|594192446|FG001|Overall Study|Inclimate Weather|0|||
164497448|NCT03220776|594192447|FG002|Overall Study|Inclimate Weather|0|||
164497449|NCT03220776|594192448|FG003|Overall Study|Inclimate Weather|0|||
164497450|NCT03220776|594192449|FG004|Overall Study|Inclimate Weather|0|||
164497451|NCT03220776|594192450|FG005|Overall Study|Inclimate Weather|1|||
164497452|NCT03220776|594192445|FG000|Overall Study|Physician Decision|0|||
164497453|NCT03220776|594192446|FG001|Overall Study|Physician Decision|0|||
164497454|NCT03220776|594192447|FG002|Overall Study|Physician Decision|0|||
164497455|NCT03220776|594192448|FG003|Overall Study|Physician Decision|1|||
164497456|NCT03220776|594192449|FG004|Overall Study|Physician Decision|0|||
164497457|NCT03220776|594192450|FG005|Overall Study|Physician Decision|0|||
164497458|NCT03220776|594192445|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
164497459|NCT03220776|594192446|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
164497460|NCT03220776|594192447|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
164497461|NCT03220776|594192448|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
164497462|NCT03220776|594192449|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
164497463|NCT03220776|594192450|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
164497464|NCT03220776|594192445|FG000|Overall Study|Protocol Violation|0|||
164497465|NCT03220776|594192446|FG001|Overall Study|Protocol Violation|0|||
164497466|NCT03220776|594192447|FG002|Overall Study|Protocol Violation|0|||
164497467|NCT03220776|594192448|FG003|Overall Study|Protocol Violation|2|||
164497468|NCT03220776|594192449|FG004|Overall Study|Protocol Violation|0|||
164497469|NCT03220776|594192450|FG005|Overall Study|Protocol Violation|1|||
164497470|NCT03220776|594192445|FG000|Overall Study|Withdrawal by Subject|1|||
164497471|NCT03220776|594192446|FG001|Overall Study|Withdrawal by Subject|0|||
164497472|NCT03220776|594192447|FG002|Overall Study|Withdrawal by Subject|0|||
164497473|NCT03220776|594192448|FG003|Overall Study|Withdrawal by Subject|0|||
164497474|NCT03220776|594192449|FG004|Overall Study|Withdrawal by Subject|0|||
164497475|NCT03220776|594192450|FG005|Overall Study|Withdrawal by Subject|0|||
164497476|NCT04491006|594192452|FG000|Overall Study|Adverse Event|0|||
164497477|NCT04491006|594192453|FG001|Overall Study|Adverse Event|3|||
164497478|NCT04491006|594192454|FG002|Overall Study|Adverse Event|5|||
164497479|NCT04491006|594192452|FG000|Overall Study|Withdrawal by Subject|1|||
164497480|NCT04491006|594192453|FG001|Overall Study|Withdrawal by Subject|0|||
164497481|NCT04491006|594192454|FG002|Overall Study|Withdrawal by Subject|2|||
164497482|NCT02166047|594192455|FG000|Overall Study|Withdrawal by Participant|0|||
164497483|NCT02166047|594192456|FG001|Overall Study|Withdrawal by Participant|1|||
164497484|NCT02166047|594192457|FG002|Overall Study|Withdrawal by Participant|2|||
164497485|NCT02166047|594192458|FG003|Overall Study|Withdrawal by Participant|0|||
164497486|NCT02166047|594192459|FG004|Overall Study|Withdrawal by Participant|0|||
164497487|NCT02166047|594192460|FG005|Overall Study|Withdrawal by Participant|0|||
164497488|NCT02166047|594192461|FG006|Overall Study|Withdrawal by Participant|1|||
164497489|NCT02166047|594192462|FG007|Overall Study|Withdrawal by Participant|0|||
164497490|NCT02166047|594192463|FG008|Overall Study|Withdrawal by Participant|0|||
164497491|NCT02166047|594192464|FG009|Overall Study|Withdrawal by Participant|0|||
164497492|NCT02166047|594192465|FG010|Overall Study|Withdrawal by Participant|0|||
164497493|NCT02166047|594192466|FG011|Overall Study|Withdrawal by Participant|0|||
164497494|NCT02166047|594192455|FG000|Overall Study|Adverse Event|0|||
164497495|NCT02166047|594192456|FG001|Overall Study|Adverse Event|0|||
164497496|NCT02166047|594192457|FG002|Overall Study|Adverse Event|0|||
164497497|NCT02166047|594192458|FG003|Overall Study|Adverse Event|0|||
164497498|NCT02166047|594192459|FG004|Overall Study|Adverse Event|1|||
164497499|NCT02166047|594192460|FG005|Overall Study|Adverse Event|0|||
164497500|NCT02166047|594192461|FG006|Overall Study|Adverse Event|1|||
164497501|NCT02166047|594192462|FG007|Overall Study|Adverse Event|0|||
164497502|NCT02166047|594192463|FG008|Overall Study|Adverse Event|0|||
164497503|NCT02166047|594192464|FG009|Overall Study|Adverse Event|0|||
164497504|NCT02166047|594192465|FG010|Overall Study|Adverse Event|2|||
164497505|NCT02166047|594192466|FG011|Overall Study|Adverse Event|0|||
164497506|NCT01960114|594192471|FG000|Overall Study|Adverse Event|1|||
164497507|NCT01960114|594192472|FG001|Overall Study|Adverse Event|0|||
164497508|NCT01960114|594192471|FG000|Overall Study|Could not swallow study medication|0|||
164497509|NCT01960114|594192472|FG001|Overall Study|Could not swallow study medication|1|||
164497510|NCT00451555|594192474|FG000|Overall Study|Protocol Violation|2|||
164497511|NCT00451555|594192475|FG001|Overall Study|Protocol Violation|2|||
164497512|NCT00451555|594192474|FG000|Overall Study|Adverse Event|3|||
164497513|NCT00451555|594192475|FG001|Overall Study|Adverse Event|1|||
164497514|NCT00451555|594192474|FG000|Overall Study|Withdrawal by Subject|6|||
164497515|NCT00451555|594192475|FG001|Overall Study|Withdrawal by Subject|0|||
164497516|NCT00451555|594192474|FG000|Overall Study|Physician Decision|2|||
164497517|NCT00451555|594192475|FG001|Overall Study|Physician Decision|1|||
164497518|NCT01004185|594192478|FG000|Overall Study|Adverse Event|1|||
164497519|NCT01004185|594192479|FG001|Overall Study|Adverse Event|1|||
164497520|NCT01004185|594192478|FG000|Overall Study|Lost to Follow-up|0|||
164497521|NCT01004185|594192479|FG001|Overall Study|Lost to Follow-up|1|||
164497522|NCT01004185|594192478|FG000|Overall Study|Lack of Efficacy|2|||
164497523|NCT01004185|594192479|FG001|Overall Study|Lack of Efficacy|1|||
164604596|NCT00712933|594573890|FG000|Overall Study|Other Pregnancy|37|||
164604597|NCT00712933|594573890|FG000|Overall Study|Sponsor decision|14|||
164604598|NCT00712933|594573890|FG000|Overall Study|Withdrew consent|4|||
164604599|NCT00712933|594573890|FG000|Overall Study|Hip replacement surgery|1|||
164604600|NCT00712933|594573890|FG000|Overall Study|Involved in Clinical research|3|||
164604601|NCT00712933|594573890|FG000|Overall Study|Participant hospitalized|1|||
164604602|NCT00712933|594573890|FG000|Overall Study|Participant travelled overseas|2|||
164604603|NCT00712933|594573890|FG000|Overall Study|Death of patient|1|||
164604604|NCT00712933|594573890|FG000|Overall Study|Other Physician decision|1|||
164604605|NCT00712933|594573890|FG000|Overall Study|Not committed to contraception|1|||
164604606|NCT00712933|594573890|FG000|Overall Study|Participant received medication|1|||
164604607|NCT00712933|594573890|FG000|Overall Study|Physician Decision|36|||
164604608|NCT00712933|594573890|FG000|Overall Study|Protocol Violation|4|||
164604609|NCT00712933|594573890|FG000|Overall Study|Withdrawal by Subject|151|||
164604610|NCT01360762|594573901|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
164604611|NCT01360762|594573901|FG000|Main Study Period (12-month Treatment)|Death|5|||
164604612|NCT01360762|594573901|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
164604613|NCT01360762|594573901|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
164604614|NCT01360762|594573901|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
164604615|NCT01360762|594573901|FG000|Whole Study Period|Lost to Follow-up|10|||
164604616|NCT01360762|594573901|FG000|Whole Study Period|Death|7|||
164604617|NCT01360762|594573901|FG000|Whole Study Period|Patient relapsed|18|||
164604618|NCT01360762|594573901|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
164604619|NCT04724733|594573902|FG000|Overall Study|Lost to Follow-up|1|||
164604620|NCT04724733|594573903|FG001|Overall Study|Lost to Follow-up|1|||
164604621|NCT04724733|594573904|FG002|Overall Study|Lost to Follow-up|1|||
164497524|NCT01004185|594192478|FG000|Overall Study|Sponsor Terminated Study|4|||
164497525|NCT01004185|594192479|FG001|Overall Study|Sponsor Terminated Study|5|||
164497526|NCT01004185|594192478|FG000|Overall Study|Withdrawal by Subject|2|||
164497527|NCT01004185|594192479|FG001|Overall Study|Withdrawal by Subject|1|||
164497528|NCT01388478|594192484|FG000|Overall Study|Adverse Event|4|||
164497529|NCT01388478|594192484|FG000|Overall Study|Withdrawal by Subject|1|||
164497530|NCT01037413|594192485|FG000|Part A: Skin Testing|Adverse Event|1|||
164497531|NCT01037413|594192486|FG001|Part A: Skin Testing|Adverse Event|0|||
164497532|NCT01037413|594192485|FG000|Part A: Skin Testing|Protocol Violation|1|||
164497533|NCT01037413|594192486|FG001|Part A: Skin Testing|Protocol Violation|0|||
164497534|NCT01037413|594192485|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
164497535|NCT01037413|594192486|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
164497536|NCT01037413|594192485|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
164497537|NCT01037413|594192486|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
164497538|NCT01990664|594192487|FG000|Overall Study|Lost to Follow-up|2|||
164497539|NCT01990664|594192488|FG001|Overall Study|Lost to Follow-up|6|||
164497540|NCT01990664|594192487|FG000|Overall Study|Withdrawal by Subject|2|||
164497541|NCT01990664|594192488|FG001|Overall Study|Withdrawal by Subject|3|||
164497542|NCT01990664|594192487|FG000|Overall Study|Protocol Violation|1|||
164497543|NCT01990664|594192488|FG001|Overall Study|Protocol Violation|0|||
164497544|NCT01990664|594192487|FG000|Overall Study|Lens Discomfort|1|||
164497545|NCT01990664|594192488|FG001|Overall Study|Lens Discomfort|1|||
164497546|NCT01990664|594192487|FG000|Overall Study|Lens Handling Difficulties|1|||
164497547|NCT01990664|594192488|FG001|Overall Study|Lens Handling Difficulties|0|||
164497548|NCT01990664|594192487|FG000|Overall Study|Unsatisfactory Visual Response|0|||
164497549|NCT01990664|594192488|FG001|Overall Study|Unsatisfactory Visual Response|1|||
164497550|NCT00619983|594192489|FG000|Test Drug Alone|Withdrawal by Subject|1|||
164497551|NCT00619983|594192490|FG001|Test Drug Alone|Withdrawal by Subject|0|||
164497552|NCT00619983|594192491|FG002|Test Drug Alone|Withdrawal by Subject|0|||
164497553|NCT00619983|594192492|FG003|Test Drug Alone|Withdrawal by Subject|1|||
164497554|NCT00619983|594192489|FG000|Test Drug Alone|Failure of daily diary device|1|||
164497555|NCT00619983|594192490|FG001|Test Drug Alone|Failure of daily diary device|1|||
164497556|NCT00619983|594192491|FG002|Test Drug Alone|Failure of daily diary device|2|||
164497557|NCT00619983|594192492|FG003|Test Drug Alone|Failure of daily diary device|2|||
164497558|NCT00225277|594192494|FG000|Overall Study|Adverse Event|30|||
164497559|NCT00225277|594192495|FG001|Overall Study|Adverse Event|34|||
164497560|NCT00225277|594192494|FG000|Overall Study|Lack of Efficacy|4|||
164604622|NCT03372603|594573905|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
164604623|NCT03372603|594573906|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
164604624|NCT03372603|594573905|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
164497561|NCT00225277|594192495|FG001|Overall Study|Lack of Efficacy|1|||
164497562|NCT00225277|594192494|FG000|Overall Study|Lost to Follow-up|4|||
164497563|NCT00225277|594192495|FG001|Overall Study|Lost to Follow-up|6|||
164604625|NCT03372603|594573906|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
164604626|NCT03341923|594573907|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
164497564|NCT00225277|594192494|FG000|Overall Study|Physician Decision|6|||
164497565|NCT00225277|594192495|FG001|Overall Study|Physician Decision|8|||
164497566|NCT00225277|594192494|FG000|Overall Study|Protocol Violation|6|||
164497567|NCT00225277|594192495|FG001|Overall Study|Protocol Violation|3|||
164497568|NCT00225277|594192494|FG000|Overall Study|Withdrawal by Subject|40|||
164497569|NCT00225277|594192495|FG001|Overall Study|Withdrawal by Subject|34|||
164497570|NCT00225277|594192494|FG000|Overall Study|Other|7|||
164497571|NCT00225277|594192495|FG001|Overall Study|Other|9|||
164497572|NCT01177137|594192496|FG000|Overall Study|Withdrawal by Subject|10|||
164497573|NCT01177137|594192497|FG001|Overall Study|Withdrawal by Subject|10|||
164497574|NCT01177137|594192498|FG002|Overall Study|Withdrawal by Subject|2|||
164497575|NCT01340300|594192501|FG000|Overall Study|Lost to Follow-up|3|||
164497576|NCT01340300|594192502|FG001|Overall Study|Lost to Follow-up|0|||
164497577|NCT01340300|594192503|FG002|Overall Study|Lost to Follow-up|5|||
164497578|NCT01340300|594192504|FG003|Overall Study|Lost to Follow-up|10|||
164497579|NCT01340300|594192501|FG000|Overall Study|Withdrawal by Subject|5|||
164497580|NCT01340300|594192502|FG001|Overall Study|Withdrawal by Subject|6|||
164497581|NCT01340300|594192503|FG002|Overall Study|Withdrawal by Subject|6|||
164497582|NCT01340300|594192504|FG003|Overall Study|Withdrawal by Subject|3|||
164497583|NCT01340300|594192501|FG000|Overall Study|Adverse Event|1|||
164497584|NCT01340300|594192502|FG001|Overall Study|Adverse Event|0|||
164497585|NCT01340300|594192503|FG002|Overall Study|Adverse Event|4|||
164497586|NCT01340300|594192504|FG003|Overall Study|Adverse Event|0|||
164497587|NCT01340300|594192501|FG000|Overall Study|Physician Decision|0|||
164497588|NCT01340300|594192502|FG001|Overall Study|Physician Decision|1|||
164497589|NCT01340300|594192503|FG002|Overall Study|Physician Decision|0|||
164497590|NCT01340300|594192504|FG003|Overall Study|Physician Decision|0|||
164497591|NCT01340300|594192501|FG000|Overall Study|Unrelated sickness|0|||
164497592|NCT01340300|594192502|FG001|Overall Study|Unrelated sickness|2|||
164497593|NCT01340300|594192503|FG002|Overall Study|Unrelated sickness|0|||
164497594|NCT01340300|594192504|FG003|Overall Study|Unrelated sickness|1|||
164497595|NCT02560389|594192507|FG000|Overall Study|Lost to Follow-up|1|||
164497596|NCT02560389|594192508|FG001|Overall Study|Lost to Follow-up|2|||
164497597|NCT02560389|594192509|FG002|Overall Study|Lost to Follow-up|2|||
164497598|NCT02560389|594192507|FG000|Overall Study|Tested positive for illicit substance|0|||
164497599|NCT02560389|594192508|FG001|Overall Study|Tested positive for illicit substance|1|||
164497600|NCT02560389|594192509|FG002|Overall Study|Tested positive for illicit substance|0|||
164497601|NCT02716298|594192510|FG000|First Intervention (1 Month)|Lens discomfort|1|||
164497602|NCT02716298|594192511|FG001|First Intervention (1 Month)|Lens discomfort|1|||
164497603|NCT00713206|594192512|FG000|Overall Study|Lost to Follow-up|4|||
164497604|NCT00713206|594192513|FG001|Overall Study|Lost to Follow-up|4|||
164497605|NCT00713206|594192512|FG000|Overall Study|Death|1|||
164497606|NCT00713206|594192513|FG001|Overall Study|Death|0|||
164497607|NCT01114672|594192516|FG000|Overall Study|Death|0|||
164497608|NCT01114672|594192517|FG001|Overall Study|Death|1|||
164497609|NCT01114672|594192516|FG000|Overall Study|Withdrawal by Subject|2|||
164497610|NCT01114672|594192517|FG001|Overall Study|Withdrawal by Subject|1|||
164497611|NCT01114672|594192516|FG000|Overall Study|Lost to Follow-up|1|||
164497612|NCT01114672|594192517|FG001|Overall Study|Lost to Follow-up|0|||
164497613|NCT01114672|594192516|FG000|Overall Study|transplanted|1|||
164497614|NCT01114672|594192517|FG001|Overall Study|transplanted|0|||
164497615|NCT00827775|594192518|FG000|Overall Study|Withdrawal by Subject|0|||
164497616|NCT00827775|594192519|FG001|Overall Study|Withdrawal by Subject|5|||
164497617|NCT03041701|594192520|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
164497618|NCT03041701|594192521|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
164497619|NCT03041701|594192522|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
164497620|NCT03041701|594192520|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
164497621|NCT03041701|594192521|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
164497622|NCT03041701|594192522|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
164497623|NCT00297778|594192533|FG000|Overall Study|Adverse Event|16|||
164497624|NCT00297778|594192534|FG001|Overall Study|Adverse Event|10|||
164497625|NCT00297778|594192533|FG000|Overall Study|Withdrawal by Subject|1|||
164497626|NCT00297778|594192534|FG001|Overall Study|Withdrawal by Subject|5|||
164497627|NCT00297778|594192533|FG000|Overall Study|Lack of Efficacy|2|||
164497628|NCT00297778|594192534|FG001|Overall Study|Lack of Efficacy|1|||
164497629|NCT00297778|594192533|FG000|Overall Study|Non-compliant with trial protocol|0|||
164497630|NCT00297778|594192534|FG001|Overall Study|Non-compliant with trial protocol|3|||
164497631|NCT00297778|594192533|FG000|Overall Study|Other|0|||
164497632|NCT00297778|594192534|FG001|Overall Study|Other|1|||
164497633|NCT00951171|594192535|FG000|Overall Study|Adverse Event|2|||
164497634|NCT00951171|594192536|FG001|Overall Study|Adverse Event|0|||
164497635|NCT02973802|594193772|FG000|Overall Study|Lost to Follow-up|1|||
164497636|NCT02973802|594193772|FG000|Overall Study|Withdrawal by Subject|1|||
164497637|NCT00706914|594193773|FG000|Overall Study|Lack of Efficacy|0|||
164497638|NCT00706914|594193774|FG001|Overall Study|Lack of Efficacy|1|||
164497639|NCT00706914|594193775|FG002|Overall Study|Lack of Efficacy|0|||
164497640|NCT00706914|594193773|FG000|Overall Study|Lost to Follow-up|1|||
164497641|NCT00706914|594193774|FG001|Overall Study|Lost to Follow-up|0|||
164497642|NCT00706914|594193775|FG002|Overall Study|Lost to Follow-up|0|||
164497643|NCT00706914|594193773|FG000|Overall Study|Adverse Event|2|||
164497644|NCT00706914|594193774|FG001|Overall Study|Adverse Event|2|||
164497645|NCT00706914|594193775|FG002|Overall Study|Adverse Event|0|||
164497646|NCT00706914|594193773|FG000|Overall Study|Protocol Violation|3|||
164497647|NCT00706914|594193774|FG001|Overall Study|Protocol Violation|1|||
164497648|NCT00706914|594193775|FG002|Overall Study|Protocol Violation|1|||
164497649|NCT01850823|594193776|FG000|Overall Study|Early Visit Window|0|||
164497650|NCT01850823|594193777|FG001|Overall Study|Early Visit Window|1|||
164497651|NCT01850823|594193778|FG002|Overall Study|Early Visit Window|4|||
164497652|NCT01850823|594193776|FG000|Overall Study|Enrolled in Error|0|||
164497653|NCT01850823|594193777|FG001|Overall Study|Enrolled in Error|1|||
164497654|NCT01850823|594193778|FG002|Overall Study|Enrolled in Error|2|||
164497655|NCT01850823|594193776|FG000|Overall Study|Lack of Efficacy|1|||
164497656|NCT01850823|594193777|FG001|Overall Study|Lack of Efficacy|0|||
164497657|NCT01850823|594193778|FG002|Overall Study|Lack of Efficacy|0|||
164497658|NCT01850823|594193776|FG000|Overall Study|Lost to Follow-up|0|||
164497659|NCT01850823|594193777|FG001|Overall Study|Lost to Follow-up|0|||
164497660|NCT01850823|594193778|FG002|Overall Study|Lost to Follow-up|1|||
164497661|NCT01850823|594193776|FG000|Overall Study|Restricted Medication|0|||
164497662|NCT01850823|594193777|FG001|Overall Study|Restricted Medication|0|||
164497663|NCT01850823|594193778|FG002|Overall Study|Restricted Medication|2|||
164497664|NCT01850823|594193776|FG000|Overall Study|Significant worstening of SAR|0|||
164497665|NCT01850823|594193777|FG001|Overall Study|Significant worstening of SAR|1|||
164497666|NCT01850823|594193778|FG002|Overall Study|Significant worstening of SAR|0|||
164497667|NCT01850823|594193776|FG000|Overall Study|Withdrawal by Subject|2|||
164497668|NCT01850823|594193777|FG001|Overall Study|Withdrawal by Subject|0|||
164497669|NCT01850823|594193778|FG002|Overall Study|Withdrawal by Subject|1|||
164497670|NCT00053352|594193780|FG000|Overall Study|Lost to Follow-up|0|||
164497671|NCT00053352|594193781|FG001|Overall Study|Lost to Follow-up|1|||
164497672|NCT00053352|594193780|FG000|Overall Study|Physician Decision|11|||
164497673|NCT00053352|594193781|FG001|Overall Study|Physician Decision|1|||
164497674|NCT00053352|594193780|FG000|Overall Study|Withdrawal by Subject|1|||
164497675|NCT00053352|594193781|FG001|Overall Study|Withdrawal by Subject|0|||
164497676|NCT00053352|594193780|FG000|Overall Study|Ineligible|8|||
164497677|NCT00053352|594193781|FG001|Overall Study|Ineligible|8|||
164497678|NCT00053352|594193780|FG000|Overall Study|Disease at new site|1|||
164497679|NCT00053352|594193781|FG001|Overall Study|Disease at new site|0|||
164497680|NCT00931918|594193784|FG000|Overall Study|Adverse Event|4|||
164497681|NCT00931918|594193785|FG001|Overall Study|Adverse Event|6|||
164497682|NCT00931918|594193784|FG000|Overall Study|Progressive Disease|2|||
164497683|NCT00931918|594193785|FG001|Overall Study|Progressive Disease|1|||
164497684|NCT00931918|594193784|FG000|Overall Study|Symptomatic Deterioration|1|||
164497685|NCT00931918|594193785|FG001|Overall Study|Symptomatic Deterioration|0|||
164497686|NCT00931918|594193784|FG000|Overall Study|Withdrawal by Patient|3|||
164497687|NCT00931918|594193785|FG001|Overall Study|Withdrawal by Patient|4|||
164497688|NCT00931918|594193784|FG000|Overall Study|Other Reason not Specified|4|||
164497689|NCT00931918|594193785|FG001|Overall Study|Other Reason not Specified|4|||
164497690|NCT00931918|594193784|FG000|Overall Study|Did not receive study drug|3|||
164497691|NCT00931918|594193785|FG001|Overall Study|Did not receive study drug|2|||
164497692|NCT00809341|594193786|FG000|Overall Study|Physician Decision|0|||
164497693|NCT00809341|594193787|FG001|Overall Study|Physician Decision|1|||
164497694|NCT04081389|594193792|FG000|Overall Study|Withdrawal by Subject|0|||
164497695|NCT04081389|594193793|FG001|Overall Study|Withdrawal by Subject|0|||
164497696|NCT04081389|594193794|FG002|Overall Study|Withdrawal by Subject|1|||
164604627|NCT03341923|594573908|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
164497697|NCT04081389|594193795|FG003|Overall Study|Withdrawal by Subject|0|||
164497698|NCT00527514|594193796|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
164497699|NCT00527514|594193796|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
164497700|NCT00527514|594193796|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
164497701|NCT00527514|594193796|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
164497702|NCT00527514|594193796|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
164497703|NCT00527514|594193796|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
164497704|NCT00527514|594193796|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
164497705|NCT00802438|594193799|FG000|Overall Study|Screen Failure|20|||
164604628|NCT03986190|594573909|FG000|Overall Study|Withdrawal by Subject|12|||
164604629|NCT03986190|594573910|FG001|Overall Study|Withdrawal by Subject|0|||
164715600|NCT03597464|594980494|FG001|Overall Study|Physician Decision|2|||
164497706|NCT00802438|594193799|FG000|Overall Study|Withdrawal by Subject|7|||
164497707|NCT00802438|594193799|FG000|Overall Study|Physician Decision|1|||
164497708|NCT01281917|594193800|FG000|Overall Study|Withdrawal by Subject|1|||
164497709|NCT04016805|594193802|FG000|Overall Study|Sponsor's Discretion|30|||
164497710|NCT04016805|594193803|FG001|Overall Study|Sponsor's Discretion|6|||
164497711|NCT04016805|594193804|FG002|Overall Study|Sponsor's Discretion|5|||
164497712|NCT00583115|594193807|FG000|Overall Study|Death|1|||
164497713|NCT02101268|594193808|FG000|Randomized Treatment Phase|Subject Decision|8|||
164497714|NCT02101268|594193809|FG001|Randomized Treatment Phase|Subject Decision|4|||
164497715|NCT02101268|594193810|FG002|Randomized Treatment Phase|Subject Decision|0|||
164497716|NCT02101268|594193811|FG003|Randomized Treatment Phase|Subject Decision|0|||
164497717|NCT02101268|594193808|FG000|Randomized Treatment Phase|Physician Decision|4|||
164497718|NCT02101268|594193809|FG001|Randomized Treatment Phase|Physician Decision|1|||
164497719|NCT02101268|594193810|FG002|Randomized Treatment Phase|Physician Decision|0|||
164497720|NCT02101268|594193811|FG003|Randomized Treatment Phase|Physician Decision|0|||
164497721|NCT02101268|594193808|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
164497722|NCT02101268|594193809|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
164497723|NCT02101268|594193810|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
164497724|NCT02101268|594193811|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
164497725|NCT02101268|594193808|FG000|Randomized Treatment Phase|Adverse Event|6|||
164497726|NCT02101268|594193809|FG001|Randomized Treatment Phase|Adverse Event|0|||
164497727|NCT02101268|594193810|FG002|Randomized Treatment Phase|Adverse Event|0|||
164497728|NCT02101268|594193811|FG003|Randomized Treatment Phase|Adverse Event|0|||
164497729|NCT02101268|594193808|FG000|Randomized Treatment Phase|Death|5|||
164497730|NCT02101268|594193809|FG001|Randomized Treatment Phase|Death|4|||
164497731|NCT02101268|594193810|FG002|Randomized Treatment Phase|Death|0|||
164497732|NCT02101268|594193811|FG003|Randomized Treatment Phase|Death|0|||
164497733|NCT02101268|594193808|FG000|Randomized Treatment Phase|Disease Progression|4|||
164497734|NCT02101268|594193809|FG001|Randomized Treatment Phase|Disease Progression|1|||
164497735|NCT02101268|594193810|FG002|Randomized Treatment Phase|Disease Progression|0|||
164497736|NCT02101268|594193811|FG003|Randomized Treatment Phase|Disease Progression|0|||
164497737|NCT02101268|594193808|FG000|Extended Treatment Phase|Subject Decision|0|||
164497738|NCT02101268|594193809|FG001|Extended Treatment Phase|Subject Decision|0|||
164497739|NCT02101268|594193810|FG002|Extended Treatment Phase|Subject Decision|3|||
164497740|NCT02101268|594193811|FG003|Extended Treatment Phase|Subject Decision|2|||
164497741|NCT02101268|594193808|FG000|Extended Treatment Phase|Physician Decision|0|||
164497742|NCT02101268|594193809|FG001|Extended Treatment Phase|Physician Decision|0|||
164497743|NCT02101268|594193810|FG002|Extended Treatment Phase|Physician Decision|5|||
164497744|NCT02101268|594193811|FG003|Extended Treatment Phase|Physician Decision|2|||
164497745|NCT02101268|594193808|FG000|Extended Treatment Phase|Adverse Event|0|||
164497746|NCT02101268|594193809|FG001|Extended Treatment Phase|Adverse Event|0|||
164497747|NCT02101268|594193810|FG002|Extended Treatment Phase|Adverse Event|14|||
164497748|NCT02101268|594193811|FG003|Extended Treatment Phase|Adverse Event|18|||
164497749|NCT02101268|594193808|FG000|Extended Treatment Phase|Death|0|||
164497750|NCT02101268|594193809|FG001|Extended Treatment Phase|Death|0|||
164497751|NCT02101268|594193810|FG002|Extended Treatment Phase|Death|5|||
164497752|NCT02101268|594193811|FG003|Extended Treatment Phase|Death|1|||
164497753|NCT02101268|594193808|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
164497754|NCT02101268|594193809|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
164497755|NCT02101268|594193810|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
164497756|NCT02101268|594193811|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
164497757|NCT02101268|594193808|FG000|Extended Treatment Phase|Disease Progression|0|||
164497758|NCT02101268|594193809|FG001|Extended Treatment Phase|Disease Progression|0|||
164497759|NCT02101268|594193810|FG002|Extended Treatment Phase|Disease Progression|13|||
164497760|NCT02101268|594193811|FG003|Extended Treatment Phase|Disease Progression|6|||
164497761|NCT02101268|594193808|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
164715601|NCT03597464|594980493|FG000|Overall Study|Protocol Violation|1|||
164715602|NCT03597464|594980494|FG001|Overall Study|Protocol Violation|1|||
164715603|NCT03597464|594980493|FG000|Overall Study|Adverse Event|0|||
164715604|NCT03597464|594980494|FG001|Overall Study|Adverse Event|2|||
164715605|NCT03597464|594980493|FG000|Overall Study|Death|0|||
164715606|NCT03597464|594980494|FG001|Overall Study|Death|3|||
164715607|NCT03316547|594980502|FG000|Overall Study|Death|3|||
164715608|NCT03316547|594980503|FG001|Overall Study|Death|1|||
164715609|NCT03316547|594980502|FG000|Overall Study|Lost to Follow-up|6|||
164715610|NCT03316547|594980503|FG001|Overall Study|Lost to Follow-up|6|||
164497762|NCT02101268|594193809|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
164497763|NCT02101268|594193810|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
164497764|NCT02101268|594193811|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
164497765|NCT00740870|594193812|FG000|Overall Study|Not Catheterized|4|||
164497766|NCT00740870|594193812|FG000|Overall Study|Further testing contraindicated implant|17|||
164497767|NCT00819013|594193814|FG000|Overall Study|Not meeting continuing study eligibility|2|||
164497768|NCT00819013|594193815|FG001|Overall Study|Not meeting continuing study eligibility|1|||
164497769|NCT00819013|594193816|FG002|Overall Study|Not meeting continuing study eligibility|2|||
164715611|NCT03316547|594980502|FG000|Overall Study|Withdrawal by Subject|3|||
164497770|NCT00819013|594193817|FG003|Overall Study|Not meeting continuing study eligibility|1|||
164497771|NCT00819013|594193814|FG000|Overall Study|Adverse Event|0|||
164497772|NCT00819013|594193815|FG001|Overall Study|Adverse Event|0|||
164497773|NCT00819013|594193816|FG002|Overall Study|Adverse Event|1|||
164497774|NCT00819013|594193817|FG003|Overall Study|Adverse Event|0|||
164715612|NCT03316547|594980503|FG001|Overall Study|Withdrawal by Subject|2|||
164715613|NCT03316547|594980502|FG000|Overall Study|Transfer to another hospital|6|||
164497775|NCT00819013|594193814|FG000|Overall Study|Withdrawal by Subject|1|||
164497776|NCT00819013|594193815|FG001|Overall Study|Withdrawal by Subject|0|||
164497777|NCT00819013|594193816|FG002|Overall Study|Withdrawal by Subject|1|||
164497778|NCT00819013|594193817|FG003|Overall Study|Withdrawal by Subject|0|||
164497779|NCT00819013|594193814|FG000|Overall Study|Lost to Follow-up|0|||
164497780|NCT00819013|594193815|FG001|Overall Study|Lost to Follow-up|0|||
164497781|NCT00819013|594193816|FG002|Overall Study|Lost to Follow-up|1|||
164497782|NCT00819013|594193817|FG003|Overall Study|Lost to Follow-up|2|||
164497783|NCT00819013|594193814|FG000|Overall Study|Death|0|||
164497784|NCT00819013|594193815|FG001|Overall Study|Death|0|||
164497785|NCT00819013|594193816|FG002|Overall Study|Death|0|||
164497786|NCT00819013|594193817|FG003|Overall Study|Death|1|||
164497787|NCT03811834|594193818|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
164497788|NCT00576823|594193819|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
164497789|NCT00576823|594193820|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
164497790|NCT00576823|594193821|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
164497791|NCT00576823|594193819|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
164497792|NCT00576823|594193820|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
164497793|NCT00576823|594193821|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
164497794|NCT00839332|594193822|FG000|Phase 1|Disease Progression|38|||
164497795|NCT00839332|594193823|FG001|Phase 1|Disease Progression|0|||
164497796|NCT00839332|594193824|FG002|Phase 1|Disease Progression|0|||
164497797|NCT00839332|594193822|FG000|Phase 1|Adverse Event|6|||
164497798|NCT00839332|594193823|FG001|Phase 1|Adverse Event|0|||
164497799|NCT00839332|594193824|FG002|Phase 1|Adverse Event|0|||
164497800|NCT00839332|594193822|FG000|Phase 1|Withdrawal by Subject|4|||
164497801|NCT00839332|594193823|FG001|Phase 1|Withdrawal by Subject|0|||
164497802|NCT00839332|594193824|FG002|Phase 1|Withdrawal by Subject|0|||
164497803|NCT00839332|594193822|FG000|Phase 1|Physician Decision|2|||
164497804|NCT00839332|594193823|FG001|Phase 1|Physician Decision|0|||
164497805|NCT00839332|594193824|FG002|Phase 1|Physician Decision|0|||
164497806|NCT00839332|594193822|FG000|Phase 2|Protocol Violation|0|||
164604630|NCT02806947|594573911|FG000|Overall Study|Withdrawal by Subject|5|||
164604631|NCT02806947|594573912|FG001|Overall Study|Withdrawal by Subject|1|||
164604632|NCT04929613|594573913|FG000|Overall Study|Withdrawal by Subject|12|||
164604633|NCT00084929|594573916|FG000|Overall Study|ineligible - medical contraindication|1|||
164604634|NCT00084929|594573916|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
164604635|NCT00084929|594573916|FG000|Overall Study|Ineligible - Medical history|6|||
164604636|NCT00084929|594573916|FG000|Overall Study|Withdrawal by Subject|10|||
164604637|NCT00084929|594573916|FG000|Overall Study|Missing/incomplete CTC exam|9|||
164604638|NCT00084929|594573916|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
164604639|NCT00844649|594573918|FG000|Overall Study|Progressive Disease|196|||
164604640|NCT00844649|594573919|FG001|Overall Study|Progressive Disease|245|||
164604641|NCT00844649|594573918|FG000|Overall Study|Adverse Event|128|||
164604642|NCT00844649|594573919|FG001|Overall Study|Adverse Event|73|||
164604643|NCT00844649|594573918|FG000|Overall Study|Physician Decision|25|||
164604644|NCT00844649|594573919|FG001|Overall Study|Physician Decision|18|||
164604645|NCT00844649|594573918|FG000|Overall Study|Protocol Violation|10|||
164604646|NCT00844649|594573919|FG001|Overall Study|Protocol Violation|6|||
164604647|NCT00844649|594573918|FG000|Overall Study|Withdrawal by Subject|28|||
164604648|NCT00844649|594573919|FG001|Overall Study|Withdrawal by Subject|39|||
164604649|NCT00844649|594573918|FG000|Overall Study|Other|7|||
164604650|NCT00844649|594573919|FG001|Overall Study|Other|10|||
164604651|NCT00844649|594573918|FG000|Overall Study|Withdrew prior to starting treatment|11|||
164604652|NCT00844649|594573919|FG001|Overall Study|Withdrew prior to starting treatment|27|||
164604653|NCT00664209|594573920|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
164604654|NCT00664209|594573920|FG000|Study Treatment Period|Physician Decision|4|||
164604655|NCT00664209|594573920|FG000|Study Treatment Period|Withdrawal by Subject|2|||
164604656|NCT00091026|594573933|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
164604657|NCT00091026|594573934|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
164497807|NCT00839332|594193823|FG001|Phase 2|Protocol Violation|1|||
164497808|NCT00839332|594193824|FG002|Phase 2|Protocol Violation|0|||
164497809|NCT00839332|594193822|FG000|Phase 2|Disease Progression|0|||
164497810|NCT00839332|594193823|FG001|Phase 2|Disease Progression|46|||
164497811|NCT00839332|594193824|FG002|Phase 2|Disease Progression|21|||
164497812|NCT00839332|594193822|FG000|Phase 2|Adverse Event|0|||
164497813|NCT00839332|594193823|FG001|Phase 2|Adverse Event|8|||
164604658|NCT00091026|594573933|FG000|Overall Study|Patient withdrew and never received trea|0|||
164497814|NCT00839332|594193824|FG002|Phase 2|Adverse Event|6|||
164497815|NCT00839332|594193822|FG000|Phase 2|Death|0|||
164497816|NCT00839332|594193823|FG001|Phase 2|Death|4|||
164497817|NCT00839332|594193824|FG002|Phase 2|Death|2|||
164497818|NCT00839332|594193822|FG000|Phase 2|Withdrawal by Subject|0|||
164497819|NCT00839332|594193823|FG001|Phase 2|Withdrawal by Subject|5|||
164497820|NCT00839332|594193824|FG002|Phase 2|Withdrawal by Subject|8|||
164497821|NCT00839332|594193822|FG000|Phase 2|Physician Decision|0|||
164497822|NCT00839332|594193823|FG001|Phase 2|Physician Decision|4|||
164497823|NCT00839332|594193824|FG002|Phase 2|Physician Decision|1|||
164497824|NCT00839332|594193822|FG000|Phase 2|Lost to Follow-up|0|||
164497825|NCT00839332|594193823|FG001|Phase 2|Lost to Follow-up|0|||
164497826|NCT00839332|594193824|FG002|Phase 2|Lost to Follow-up|1|||
164497827|NCT01200485|594193825|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
164497828|NCT01200485|594193826|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
164497829|NCT01200485|594193827|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
164497830|NCT01200485|594193825|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
164497831|NCT01200485|594193826|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
164497832|NCT01200485|594193827|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
164497833|NCT02132117|594193829|FG000|Overall Study|Adverse Event|6|||
164497834|NCT02132117|594193830|FG001|Overall Study|Adverse Event|1|||
164497835|NCT02132117|594193829|FG000|Overall Study|Lost to Follow-up|2|||
164497836|NCT02132117|594193830|FG001|Overall Study|Lost to Follow-up|2|||
164497837|NCT02132117|594193829|FG000|Overall Study|Personal Reasons|1|||
164497838|NCT02132117|594193830|FG001|Overall Study|Personal Reasons|2|||
164604659|NCT00091026|594573934|FG001|Overall Study|Patient withdrew and never received trea|2|||
164604660|NCT00091026|594573933|FG000|Overall Study|Unknown-never received treatment|0|||
164604661|NCT00091026|594573934|FG001|Overall Study|Unknown-never received treatment|1|||
164604662|NCT00065442|594573935|FG000|Overall Study|Lost to Follow-up|1|||
164604663|NCT00065442|594573936|FG001|Overall Study|Lost to Follow-up|1|||
164604664|NCT00065442|594573935|FG000|Overall Study|Death|121|||
164604665|NCT00065442|594573936|FG001|Overall Study|Death|210|||
164604666|NCT00065442|594573935|FG000|Overall Study|Withdrawal by Subject|3|||
164604667|NCT00065442|594573936|FG001|Overall Study|Withdrawal by Subject|9|||
164604668|NCT01797965|594573937|FG000|Overall Study|Adverse Event|104|||
164497839|NCT02132117|594193829|FG000|Overall Study|Other Miscellaneous Reasons|2|||
164497840|NCT02132117|594193830|FG001|Overall Study|Other Miscellaneous Reasons|0|||
164497841|NCT04947436|594193832|FG000|Overall Study|Lost to Follow-up|3|||
164497842|NCT04947436|594193833|FG001|Overall Study|Lost to Follow-up|7|||
164497843|NCT04947436|594193834|FG002|Overall Study|Lost to Follow-up|5|||
164497844|NCT04947436|594193832|FG000|Overall Study|Death|1|||
164497845|NCT04947436|594193833|FG001|Overall Study|Death|1|||
164497846|NCT04947436|594193834|FG002|Overall Study|Death|1|||
164497847|NCT01678898|594193840|FG000|PB-102-F01|Adverse Event|0|||
164497848|NCT01678898|594193841|FG001|PB-102-F01|Adverse Event|1|||
164497849|NCT01678898|594193842|FG002|PB-102-F01|Adverse Event|0|||
164497850|NCT01678898|594193840|FG000|PB-102-F01|Physician Decision|0|||
164497851|NCT01678898|594193841|FG001|PB-102-F01|Physician Decision|1|||
164497852|NCT01678898|594193842|FG002|PB-102-F01|Physician Decision|0|||
164497853|NCT02551692|594193849|FG000|Overall Study|Lost to Follow-up|0|||
164497854|NCT02551692|594193850|FG001|Overall Study|Lost to Follow-up|1|||
164497855|NCT02551692|594193851|FG002|Overall Study|Lost to Follow-up|4|||
164497856|NCT02551692|594193849|FG000|Overall Study|Withdrawal by Subject|1|||
164497857|NCT02551692|594193850|FG001|Overall Study|Withdrawal by Subject|0|||
164497858|NCT02551692|594193851|FG002|Overall Study|Withdrawal by Subject|1|||
164497859|NCT01196741|594193852|FG000|Overall Study|Disease progression|34|||
164497860|NCT01196741|594193853|FG001|Overall Study|Disease progression|14|||
164497861|NCT01196741|594193852|FG000|Overall Study|Adverse Event|10|||
164497862|NCT01196741|594193853|FG001|Overall Study|Adverse Event|6|||
164497863|NCT01196741|594193852|FG000|Overall Study|Serious Adverse Event|3|||
164497864|NCT01196741|594193853|FG001|Overall Study|Serious Adverse Event|1|||
164497865|NCT01196741|594193852|FG000|Overall Study|Dose limiting Adverse Event|2|||
164497866|NCT01196741|594193853|FG001|Overall Study|Dose limiting Adverse Event|1|||
164497867|NCT01196741|594193852|FG000|Overall Study|Withdrawal by Subject|3|||
164497868|NCT01196741|594193853|FG001|Overall Study|Withdrawal by Subject|0|||
164604669|NCT01797965|594573938|FG001|Overall Study|Adverse Event|129|||
164604670|NCT01797965|594573939|FG002|Overall Study|Adverse Event|4|||
164604671|NCT01797965|594573940|FG003|Overall Study|Adverse Event|21|||
164604672|NCT01797965|594573937|FG000|Overall Study|Lost to Follow-up|9|||
164604673|NCT01797965|594573938|FG001|Overall Study|Lost to Follow-up|8|||
164604674|NCT01797965|594573939|FG002|Overall Study|Lost to Follow-up|1|||
164604675|NCT01797965|594573940|FG003|Overall Study|Lost to Follow-up|2|||
164604676|NCT01797965|594573937|FG000|Overall Study|Consent withdrawn|130|||
164715614|NCT03316547|594980503|FG001|Overall Study|Transfer to another hospital|4|||
164715615|NCT04725890|594982043|FG000|Overall Study|Lost to Follow-up|2|||
164497869|NCT01196741|594193852|FG000|Overall Study|Other reason|3|||
164497870|NCT01196741|594193853|FG001|Overall Study|Other reason|3|||
164497871|NCT01196741|594193852|FG000|Overall Study|Other|3|||
164497872|NCT01196741|594193853|FG001|Overall Study|Other|2|||
164497873|NCT01196741|594193852|FG000|Overall Study|Protocol Violation|2|||
164497874|NCT01196741|594193853|FG001|Overall Study|Protocol Violation|1|||
164497875|NCT03030599|594193854|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
164497876|NCT03030599|594193855|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
164497877|NCT03030599|594193856|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
164497878|NCT03030599|594193854|FG000|Open Label Treatment and Titration|Other|1|||
164604677|NCT01797965|594573938|FG001|Overall Study|Consent withdrawn|117|||
164604678|NCT01797965|594573939|FG002|Overall Study|Consent withdrawn|3|||
164604679|NCT01797965|594573940|FG003|Overall Study|Consent withdrawn|35|||
164497879|NCT03030599|594193855|FG001|Open Label Treatment and Titration|Other|0|||
164497880|NCT03030599|594193856|FG002|Open Label Treatment and Titration|Other|0|||
164497881|NCT03030599|594193854|FG000|Open Label Treatment and Titration|Physician Decision|3|||
164497882|NCT03030599|594193855|FG001|Open Label Treatment and Titration|Physician Decision|0|||
164497883|NCT03030599|594193856|FG002|Open Label Treatment and Titration|Physician Decision|0|||
164497884|NCT03030599|594193854|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
164497885|NCT03030599|594193855|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
164497886|NCT03030599|594193856|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
164497887|NCT03030599|594193854|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
164497888|NCT03030599|594193855|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
164497889|NCT03030599|594193856|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
164497890|NCT03030599|594193854|FG000|Open Label Treatment and Titration|Adverse Event|18|||
164497891|NCT03030599|594193855|FG001|Open Label Treatment and Titration|Adverse Event|0|||
164497892|NCT03030599|594193856|FG002|Open Label Treatment and Titration|Adverse Event|0|||
164497893|NCT03030599|594193854|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
164497894|NCT03030599|594193855|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
164497895|NCT03030599|594193856|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
164497896|NCT03030599|594193854|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
164497897|NCT03030599|594193855|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
164497898|NCT03030599|594193856|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
164497899|NCT03030599|594193854|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
164497900|NCT03030599|594193855|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
164497901|NCT03030599|594193856|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
164497902|NCT03030599|594193854|FG000|Stable Dose|Protocol deviation|3|||
164497903|NCT03030599|594193855|FG001|Stable Dose|Protocol deviation|0|||
164497904|NCT03030599|594193856|FG002|Stable Dose|Protocol deviation|0|||
164497905|NCT03030599|594193854|FG000|Stable Dose|Adverse Event|1|||
164497906|NCT03030599|594193855|FG001|Stable Dose|Adverse Event|0|||
164497907|NCT03030599|594193856|FG002|Stable Dose|Adverse Event|0|||
164497908|NCT03030599|594193854|FG000|Stable Dose|Lost to Follow-up|1|||
164497909|NCT03030599|594193855|FG001|Stable Dose|Lost to Follow-up|0|||
164497910|NCT03030599|594193856|FG002|Stable Dose|Lost to Follow-up|0|||
164497911|NCT03030599|594193854|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
164497912|NCT03030599|594193855|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
164497913|NCT03030599|594193856|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
164497914|NCT03030599|594193854|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
164497915|NCT03030599|594193855|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
164497916|NCT03030599|594193856|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
164497917|NCT03030599|594193854|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
164497918|NCT03030599|594193855|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
164497919|NCT03030599|594193856|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
164497920|NCT03030599|594193854|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
164497921|NCT03030599|594193855|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
164497922|NCT03030599|594193856|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
164497923|NCT03030599|594193854|FG000|Open-label Extension|Adverse Event|3|||
164497924|NCT03030599|594193855|FG001|Open-label Extension|Adverse Event|0|||
164497925|NCT03030599|594193856|FG002|Open-label Extension|Adverse Event|0|||
164497926|NCT03030599|594193854|FG000|Open-label Extension|Lost to Follow-up|2|||
164497927|NCT03030599|594193855|FG001|Open-label Extension|Lost to Follow-up|0|||
164497928|NCT03030599|594193856|FG002|Open-label Extension|Lost to Follow-up|0|||
164497929|NCT03030599|594193854|FG000|Open-label Extension|Lack of Efficacy|1|||
164497930|NCT03030599|594193855|FG001|Open-label Extension|Lack of Efficacy|0|||
164497931|NCT03030599|594193856|FG002|Open-label Extension|Lack of Efficacy|0|||
164497932|NCT03030599|594193854|FG000|Open-label Extension|Other Reason|1|||
164497933|NCT03030599|594193855|FG001|Open-label Extension|Other Reason|0|||
164497934|NCT03030599|594193856|FG002|Open-label Extension|Other Reason|0|||
164497935|NCT00356759|594193857|FG000|Overall Study|Death|5|||
164497936|NCT00356759|594193858|FG001|Overall Study|Death|2|||
164497937|NCT00356759|594193857|FG000|Overall Study|Withdrawal by Subject|2|||
164497938|NCT00356759|594193858|FG001|Overall Study|Withdrawal by Subject|2|||
164497939|NCT00356759|594193857|FG000|Overall Study|Adverse Event|1|||
164497940|NCT00356759|594193858|FG001|Overall Study|Adverse Event|3|||
164497941|NCT00356759|594193857|FG000|Overall Study|Lost to Follow-up|1|||
164497942|NCT00356759|594193858|FG001|Overall Study|Lost to Follow-up|1|||
164497943|NCT00356759|594193857|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
164497944|NCT00356759|594193858|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
164497945|NCT01592383|594193859|FG000|Overall Study|Adverse Event|1|||
164497946|NCT04582864|594193860|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
164497947|NCT04582864|594193860|FG000|Overall Study|Death|1|||
164497948|NCT01064856|594193861|FG000|Double-blind (DB) Period|Adverse Event|1|||
164497949|NCT01064856|594193862|FG001|Double-blind (DB) Period|Adverse Event|0|||
164497950|NCT01064856|594193863|FG002|Double-blind (DB) Period|Adverse Event|0|||
164497951|NCT01064856|594193864|FG003|Double-blind (DB) Period|Adverse Event|0|||
164497952|NCT01064856|594193861|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
164497953|NCT01064856|594193862|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
164497954|NCT01064856|594193863|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
164497955|NCT01064856|594193864|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
164497956|NCT01064856|594193861|FG000|Open-label (OL) Period|Adverse Event|0|||
164497957|NCT01064856|594193862|FG001|Open-label (OL) Period|Adverse Event|0|||
164497958|NCT01064856|594193863|FG002|Open-label (OL) Period|Adverse Event|12|||
164497959|NCT01064856|594193864|FG003|Open-label (OL) Period|Adverse Event|6|||
164497960|NCT01064856|594193861|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
164497961|NCT01064856|594193862|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
164497962|NCT01064856|594193863|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
164497963|NCT01064856|594193864|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
164497964|NCT01064856|594193861|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
164497965|NCT01064856|594193862|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
164497966|NCT01064856|594193863|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
164497967|NCT01064856|594193864|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
164497968|NCT01064856|594193861|FG000|Open-label (OL) Period|Other|0|||
164497969|NCT01064856|594193862|FG001|Open-label (OL) Period|Other|0|||
164497970|NCT01064856|594193863|FG002|Open-label (OL) Period|Other|7|||
164497971|NCT01064856|594193864|FG003|Open-label (OL) Period|Other|7|||
164497972|NCT02133131|594193865|FG000|Overall Study|Adverse Event|0|||
164497973|NCT02133131|594193866|FG001|Overall Study|Adverse Event|0|||
164497974|NCT02133131|594193867|FG002|Overall Study|Adverse Event|0|||
164497975|NCT02133131|594193868|FG003|Overall Study|Adverse Event|1|||
164497976|NCT02133131|594193869|FG004|Overall Study|Adverse Event|0|||
164497977|NCT02133131|594193870|FG005|Overall Study|Adverse Event|0|||
164497978|NCT02133131|594193871|FG006|Overall Study|Adverse Event|0|||
164497979|NCT02133131|594193865|FG000|Overall Study|Lost to Follow-up|1|||
164497980|NCT02133131|594193866|FG001|Overall Study|Lost to Follow-up|0|||
164497981|NCT02133131|594193867|FG002|Overall Study|Lost to Follow-up|0|||
164497982|NCT02133131|594193868|FG003|Overall Study|Lost to Follow-up|1|||
164497983|NCT02133131|594193869|FG004|Overall Study|Lost to Follow-up|0|||
164497984|NCT02133131|594193870|FG005|Overall Study|Lost to Follow-up|0|||
164497985|NCT02133131|594193871|FG006|Overall Study|Lost to Follow-up|0|||
164497986|NCT02133131|594193865|FG000|Overall Study|Status not recorded|4|||
164497987|NCT02133131|594193866|FG001|Overall Study|Status not recorded|5|||
164497988|NCT02133131|594193867|FG002|Overall Study|Status not recorded|1|||
164497989|NCT02133131|594193868|FG003|Overall Study|Status not recorded|4|||
164497990|NCT02133131|594193869|FG004|Overall Study|Status not recorded|0|||
164497991|NCT02133131|594193870|FG005|Overall Study|Status not recorded|0|||
164497992|NCT02133131|594193871|FG006|Overall Study|Status not recorded|0|||
164497993|NCT02133131|594193865|FG000|Overall Study|Ongoing in study|0|||
164497994|NCT02133131|594193866|FG001|Overall Study|Ongoing in study|0|||
164497995|NCT02133131|594193867|FG002|Overall Study|Ongoing in study|0|||
164497996|NCT02133131|594193868|FG003|Overall Study|Ongoing in study|0|||
164497997|NCT02133131|594193869|FG004|Overall Study|Ongoing in study|15|||
164497998|NCT02133131|594193870|FG005|Overall Study|Ongoing in study|14|||
164497999|NCT02133131|594193871|FG006|Overall Study|Ongoing in study|11|||
164498000|NCT02133131|594193865|FG000|Overall Study|Protocol Violation|0|||
164498001|NCT02133131|594193866|FG001|Overall Study|Protocol Violation|0|||
164498002|NCT02133131|594193867|FG002|Overall Study|Protocol Violation|0|||
164498003|NCT02133131|594193868|FG003|Overall Study|Protocol Violation|0|||
164498004|NCT02133131|594193869|FG004|Overall Study|Protocol Violation|0|||
164498005|NCT02133131|594193870|FG005|Overall Study|Protocol Violation|0|||
164498006|NCT02133131|594193871|FG006|Overall Study|Protocol Violation|1|||
164498007|NCT01679613|594193874|FG000|Overall Study|other than stated above|0|||
164498008|NCT01679613|594193875|FG001|Overall Study|other than stated above|1|||
164498009|NCT01679613|594193876|FG002|Overall Study|other than stated above|2|||
164498010|NCT01679613|594193877|FG003|Overall Study|other than stated above|2|||
164498011|NCT02965599|594193879|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
164498012|NCT02965599|594193880|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
164498013|NCT00230971|594193882|FG000|Randomization|No study drug administered|3|||
164498014|NCT00230971|594193883|FG001|Randomization|No study drug administered|3|||
164498015|NCT00230971|594193882|FG000|Baseline Participants|Lost to Follow-up|5|||
164498016|NCT00230971|594193883|FG001|Baseline Participants|Lost to Follow-up|12|||
164498017|NCT00230971|594193882|FG000|Baseline Participants|Death|6|||
164498018|NCT00230971|594193883|FG001|Baseline Participants|Death|5|||
164498019|NCT00230971|594193882|FG000|Baseline Participants|Withdrawal by Subject|7|||
164498020|NCT00230971|594193883|FG001|Baseline Participants|Withdrawal by Subject|1|||
164498021|NCT00230971|594193882|FG000|Baseline Participants|Adverse Event|1|||
164498022|NCT00230971|594193883|FG001|Baseline Participants|Adverse Event|0|||
164498023|NCT00230971|594193882|FG000|Baseline Participants|No bacteria observed|1|||
164498024|NCT00230971|594193883|FG001|Baseline Participants|No bacteria observed|0|||
164498025|NCT00230971|594193882|FG000|Baseline Participants|Failure to return|1|||
164498026|NCT00230971|594193883|FG001|Baseline Participants|Failure to return|1|||
164715616|NCT04725890|594982043|FG000|Overall Study|Withdrawal by Subject|3|||
164715617|NCT04725890|594982043|FG000|Overall Study|Physician Decision|1|||
164715618|NCT04480840|594982049|FG000|Overall Study|Adverse Event|2|||
164498027|NCT00230971|594193882|FG000|Baseline Participants|Reintervention|1|||
164498028|NCT00230971|594193883|FG001|Baseline Participants|Reintervention|0|||
164498029|NCT04130061|594193885|FG000|Overall Study|OR team forgot to request membrane|1|||
164498030|NCT04130061|594193886|FG001|Overall Study|OR team forgot to request membrane|0|||
164498031|NCT04267393|594193889|FG000|Randomization|Adverse Event|1|||
164498032|NCT04267393|594193890|FG001|Randomization|Adverse Event|0|||
164498033|NCT04267393|594193891|FG002|Randomization|Adverse Event|0|||
164498034|NCT04267393|594193889|FG000|Randomization|Administrative Reasons by Sponsor|0|||
164498035|NCT04267393|594193890|FG001|Randomization|Administrative Reasons by Sponsor|1|||
164498036|NCT04267393|594193891|FG002|Randomization|Administrative Reasons by Sponsor|0|||
164498037|NCT04267393|594193889|FG000|Treatment Period|Adverse Event|0|||
164498038|NCT04267393|594193890|FG001|Treatment Period|Adverse Event|2|||
164498039|NCT04267393|594193891|FG002|Treatment Period|Adverse Event|3|||
164498040|NCT04267393|594193889|FG000|Treatment Period|Participant Withdrew Consent|0|||
164498041|NCT04267393|594193890|FG001|Treatment Period|Participant Withdrew Consent|0|||
164498042|NCT04267393|594193891|FG002|Treatment Period|Participant Withdrew Consent|1|||
164498043|NCT04267393|594193889|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
164498044|NCT04267393|594193890|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
164498045|NCT04267393|594193891|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
164498046|NCT01932762|594195553|FG000|Overall Study|Withdrawal by Subject|1|||
164498047|NCT01932762|594195554|FG001|Overall Study|Withdrawal by Subject|2|||
164498048|NCT01932762|594195555|FG002|Overall Study|Withdrawal by Subject|0|||
164498049|NCT01932762|594195556|FG003|Overall Study|Withdrawal by Subject|0|||
164498050|NCT01932762|594195553|FG000|Overall Study|Lost to Follow-up|4|||
164498051|NCT01932762|594195554|FG001|Overall Study|Lost to Follow-up|0|||
164498052|NCT01932762|594195555|FG002|Overall Study|Lost to Follow-up|0|||
164498053|NCT01932762|594195556|FG003|Overall Study|Lost to Follow-up|1|||
164498054|NCT01932762|594195553|FG000|Overall Study|Physician Decision|1|||
164498055|NCT01932762|594195554|FG001|Overall Study|Physician Decision|0|||
164498056|NCT01932762|594195555|FG002|Overall Study|Physician Decision|0|||
164498057|NCT01932762|594195556|FG003|Overall Study|Physician Decision|0|||
164498058|NCT02210208|594195557|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
164498059|NCT02210208|594195557|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
164498060|NCT02210208|594195557|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
164498061|NCT00695136|594195558|FG000|Overall Study|Withdrawal by Subject|1|||
164498062|NCT00695136|594195558|FG000|Overall Study|unrelated adverse event|1|||
164498063|NCT01726049|594195560|FG000|Overall Study|Death|1|||
164498064|NCT01726049|594195561|FG001|Overall Study|Death|1|||
164498065|NCT01726049|594195560|FG000|Overall Study|Adverse Event|4|||
164498066|NCT01726049|594195561|FG001|Overall Study|Adverse Event|1|||
164498067|NCT01726049|594195560|FG000|Overall Study|refused second HC|0|||
164498068|NCT01726049|594195561|FG001|Overall Study|refused second HC|2|||
164498069|NCT02161406|594195562|FG000|Overall Study|Death|2|||
164498070|NCT02161406|594195563|FG001|Overall Study|Death|1|||
164498071|NCT02161406|594195562|FG000|Overall Study|Lost to Follow-up|2|||
164498072|NCT02161406|594195563|FG001|Overall Study|Lost to Follow-up|1|||
164498073|NCT02161406|594195562|FG000|Overall Study|Withdrawal by Subject|2|||
164498074|NCT02161406|594195563|FG001|Overall Study|Withdrawal by Subject|4|||
164498075|NCT02161406|594195562|FG000|Overall Study|investigator withdrew subject|3|||
164498076|NCT02161406|594195563|FG001|Overall Study|investigator withdrew subject|1|||
164498077|NCT02161406|594195562|FG000|Overall Study|Lack of Efficacy|1|||
164498078|NCT02161406|594195563|FG001|Overall Study|Lack of Efficacy|1|||
164498079|NCT02161406|594195562|FG000|Overall Study|relocation|0|||
164498080|NCT02161406|594195563|FG001|Overall Study|relocation|1|||
164498081|NCT03024996|594195566|FG000|Overall Study|Death|57|||
164498082|NCT03024996|594195567|FG001|Overall Study|Death|55|||
164498083|NCT03024996|594195566|FG000|Overall Study|Disease relapse|1|||
164498084|NCT03024996|594195567|FG001|Overall Study|Disease relapse|0|||
164498085|NCT03024996|594195566|FG000|Overall Study|Lost to Follow-up|5|||
164498086|NCT03024996|594195567|FG001|Overall Study|Lost to Follow-up|10|||
164498087|NCT03024996|594195566|FG000|Overall Study|Other|3|||
164498088|NCT03024996|594195567|FG001|Overall Study|Other|3|||
164715619|NCT04480840|594982050|FG001|Overall Study|Adverse Event|1|||
164715620|NCT04480840|594982051|FG002|Overall Study|Adverse Event|1|||
164498089|NCT03024996|594195566|FG000|Overall Study|Physician Decision|0|||
164498090|NCT03024996|594195567|FG001|Overall Study|Physician Decision|1|||
164498091|NCT03024996|594195566|FG000|Overall Study|Study terminated by sponsor|303|||
164498092|NCT03024996|594195567|FG001|Overall Study|Study terminated by sponsor|283|||
164498093|NCT03024996|594195566|FG000|Overall Study|Withdrawal by Subject|21|||
164498094|NCT03024996|594195567|FG001|Overall Study|Withdrawal by Subject|36|||
164498095|NCT02418845|594195570|FG000|Overall Study|Lost to Follow-up|7|||
164498096|NCT02418845|594195571|FG001|Overall Study|Lost to Follow-up|2|||
164498097|NCT02418845|594195570|FG000|Overall Study|Lack of Efficacy|0|||
164715621|NCT04480840|594982052|FG003|Overall Study|Adverse Event|1|||
164715622|NCT04480840|594982053|FG004|Overall Study|Adverse Event|1|||
164715623|NCT04480840|594982049|FG000|Overall Study|Withdrawal by Subject|0|||
164498098|NCT02418845|594195571|FG001|Overall Study|Lack of Efficacy|3|||
164498099|NCT02418845|594195570|FG000|Overall Study|Physician Decision|5|||
164498100|NCT02418845|594195571|FG001|Overall Study|Physician Decision|5|||
164498101|NCT02418845|594195570|FG000|Overall Study|Protocol Violation|1|||
164498102|NCT02418845|594195571|FG001|Overall Study|Protocol Violation|0|||
164498103|NCT02418845|594195570|FG000|Overall Study|Withdrawal by Subject|3|||
164498104|NCT02418845|594195571|FG001|Overall Study|Withdrawal by Subject|2|||
164498105|NCT00478647|594195572|FG000|Overall Study|Adverse Event|1|||
164498106|NCT00478647|594195572|FG000|Overall Study|Withdrawal by Subject|1|||
164498107|NCT00487552|594195582|FG000|Overall Study|Unsuccessful magnet placements|3|||
164498108|NCT00487552|594195582|FG000|Overall Study|Death due to progressive malignancy|2|||
164498109|NCT00487552|594195582|FG000|Overall Study|Stent not placed|1|||
164498110|NCT03119688|594195583|FG000|Overall Study|Adverse Event|4|||
164498111|NCT00320398|594195584|FG000|Overall Study|Adverse Event|1|||
164498112|NCT00320398|594195585|FG001|Overall Study|Adverse Event|4|||
164498113|NCT00320398|594195584|FG000|Overall Study|Other|1|||
164498114|NCT00320398|594195585|FG001|Overall Study|Other|0|||
164498115|NCT00630552|594195586|FG000|Overall Study|Adverse Event|0|||
164498116|NCT00630552|594195587|FG001|Overall Study|Adverse Event|1|||
164498117|NCT00630552|594195588|FG002|Overall Study|Adverse Event|5|||
164498118|NCT00630552|594195589|FG003|Overall Study|Adverse Event|4|||
164498119|NCT00630552|594195590|FG004|Overall Study|Adverse Event|2|||
164498120|NCT00630552|594195586|FG000|Overall Study|Disease progression|5|||
164498121|NCT00630552|594195587|FG001|Overall Study|Disease progression|6|||
164498122|NCT00630552|594195588|FG002|Overall Study|Disease progression|27|||
164498123|NCT00630552|594195589|FG003|Overall Study|Disease progression|22|||
164498124|NCT00630552|594195590|FG004|Overall Study|Disease progression|31|||
164498125|NCT00630552|594195586|FG000|Overall Study|Never received IP|0|||
164498126|NCT00630552|594195587|FG001|Overall Study|Never received IP|0|||
164498127|NCT00630552|594195588|FG002|Overall Study|Never received IP|0|||
164498128|NCT00630552|594195589|FG003|Overall Study|Never received IP|2|||
164498129|NCT00630552|594195590|FG004|Overall Study|Never received IP|2|||
164498130|NCT00630552|594195586|FG000|Overall Study|Ineligibility determined|0|||
164498131|NCT00630552|594195587|FG001|Overall Study|Ineligibility determined|0|||
164498132|NCT00630552|594195588|FG002|Overall Study|Ineligibility determined|0|||
164498133|NCT00630552|594195589|FG003|Overall Study|Ineligibility determined|0|||
164498134|NCT00630552|594195590|FG004|Overall Study|Ineligibility determined|1|||
164498135|NCT00630552|594195586|FG000|Overall Study|Protocol Violation|0|||
164498136|NCT00630552|594195587|FG001|Overall Study|Protocol Violation|0|||
164498137|NCT00630552|594195588|FG002|Overall Study|Protocol Violation|0|||
164498138|NCT00630552|594195589|FG003|Overall Study|Protocol Violation|1|||
164498139|NCT00630552|594195590|FG004|Overall Study|Protocol Violation|0|||
164498140|NCT00630552|594195586|FG000|Overall Study|Physician Decision|0|||
164498141|NCT00630552|594195587|FG001|Overall Study|Physician Decision|0|||
164498142|NCT00630552|594195588|FG002|Overall Study|Physician Decision|0|||
164498143|NCT00630552|594195589|FG003|Overall Study|Physician Decision|0|||
164498144|NCT00630552|594195590|FG004|Overall Study|Physician Decision|1|||
164498145|NCT00630552|594195586|FG000|Overall Study|Death|0|||
164498146|NCT00630552|594195587|FG001|Overall Study|Death|0|||
164498147|NCT00630552|594195588|FG002|Overall Study|Death|1|||
164498148|NCT00630552|594195589|FG003|Overall Study|Death|2|||
164498149|NCT00630552|594195590|FG004|Overall Study|Death|2|||
164498150|NCT00630552|594195586|FG000|Overall Study|Withdrawal by Subject|0|||
164498151|NCT00630552|594195587|FG001|Overall Study|Withdrawal by Subject|0|||
164498152|NCT00630552|594195588|FG002|Overall Study|Withdrawal by Subject|0|||
164498153|NCT00630552|594195589|FG003|Overall Study|Withdrawal by Subject|1|||
164498154|NCT00630552|594195590|FG004|Overall Study|Withdrawal by Subject|0|||
164498155|NCT00630552|594195586|FG000|Overall Study|Other|0|||
164498156|NCT00630552|594195587|FG001|Overall Study|Other|0|||
164715624|NCT04480840|594982050|FG001|Overall Study|Withdrawal by Subject|0|||
164715625|NCT04480840|594982051|FG002|Overall Study|Withdrawal by Subject|0|||
164715626|NCT04480840|594982052|FG003|Overall Study|Withdrawal by Subject|0|||
164715627|NCT04480840|594982053|FG004|Overall Study|Withdrawal by Subject|2|||
164498157|NCT00630552|594195588|FG002|Overall Study|Other|4|||
164498158|NCT00630552|594195589|FG003|Overall Study|Other|2|||
164498159|NCT00630552|594195590|FG004|Overall Study|Other|0|||
164498160|NCT01084239|594195591|FG000|28-Day Follow-up|Lost to Follow-up|4|||
164498161|NCT01084239|594195592|FG001|28-Day Follow-up|Lost to Follow-up|9|||
164498162|NCT00863798|594195593|FG000|Overall Study|Adverse Event|5|||
164498163|NCT00863798|594195594|FG001|Overall Study|Adverse Event|2|||
164498164|NCT00863798|594195595|FG002|Overall Study|Adverse Event|4|||
164498165|NCT00863798|594195593|FG000|Overall Study|Participant failed to return|2|||
164498166|NCT00863798|594195594|FG001|Overall Study|Participant failed to return|1|||
164498167|NCT00863798|594195595|FG002|Overall Study|Participant failed to return|0|||
164498168|NCT00863798|594195593|FG000|Overall Study|Investigator request|1|||
164498169|NCT00863798|594195594|FG001|Overall Study|Investigator request|2|||
164498170|NCT00863798|594195595|FG002|Overall Study|Investigator request|1|||
164715628|NCT04480840|594982049|FG000|Overall Study|Protocol Violation|0|||
164715629|NCT04480840|594982050|FG001|Overall Study|Protocol Violation|1|||
164498171|NCT00863798|594195593|FG000|Overall Study|Lack of Efficacy|4|||
164498172|NCT00863798|594195594|FG001|Overall Study|Lack of Efficacy|3|||
164498173|NCT00863798|594195595|FG002|Overall Study|Lack of Efficacy|6|||
164498174|NCT00863798|594195593|FG000|Overall Study|Lost to Follow-up|6|||
164498175|NCT00863798|594195594|FG001|Overall Study|Lost to Follow-up|9|||
164498176|NCT00863798|594195595|FG002|Overall Study|Lost to Follow-up|5|||
164498177|NCT00863798|594195593|FG000|Overall Study|Other|2|||
164498178|NCT00863798|594195594|FG001|Overall Study|Other|3|||
164498179|NCT00863798|594195595|FG002|Overall Study|Other|1|||
164498180|NCT00863798|594195593|FG000|Overall Study|Protocol Violation|0|||
164498181|NCT00863798|594195594|FG001|Overall Study|Protocol Violation|1|||
164498182|NCT00863798|594195595|FG002|Overall Study|Protocol Violation|1|||
164498183|NCT00863798|594195593|FG000|Overall Study|Withdrawal by Subject|8|||
164498184|NCT00863798|594195594|FG001|Overall Study|Withdrawal by Subject|7|||
164498185|NCT00863798|594195595|FG002|Overall Study|Withdrawal by Subject|4|||
164498186|NCT00863798|594195593|FG000|Overall Study|Randomized not treated|4|||
164498187|NCT00863798|594195594|FG001|Overall Study|Randomized not treated|2|||
164498188|NCT00863798|594195595|FG002|Overall Study|Randomized not treated|3|||
164498189|NCT04238520|594195596|FG000|Overall Study|Withdrawal by Subject|1|||
164498190|NCT04238520|594195597|FG001|Overall Study|Withdrawal by Subject|1|||
164498191|NCT04238520|594195596|FG000|Overall Study|Lost to Follow-up|1|||
164498192|NCT04238520|594195597|FG001|Overall Study|Lost to Follow-up|2|||
164498193|NCT04238520|594195596|FG000|Overall Study|Death|0|||
164498194|NCT04238520|594195597|FG001|Overall Study|Death|2|||
164498195|NCT04238520|594195596|FG000|Overall Study|Unsafe home environment for research staff|0|||
164498196|NCT04238520|594195597|FG001|Overall Study|Unsafe home environment for research staff|1|||
164498197|NCT01470599|594195598|FG000|Overall Study|Did not meet entrance criteria|1|||
164498198|NCT01470599|594195599|FG001|Overall Study|Did not meet entrance criteria|0|||
164498199|NCT01470599|594195598|FG000|Overall Study|Lost to Follow-up|2|||
164498200|NCT01470599|594195599|FG001|Overall Study|Lost to Follow-up|1|||
164498201|NCT01470599|594195598|FG000|Overall Study|Withdrawal by Subject|3|||
164498202|NCT01470599|594195599|FG001|Overall Study|Withdrawal by Subject|4|||
164498203|NCT01470599|594195598|FG000|Overall Study|Other|1|||
164498204|NCT01470599|594195599|FG001|Overall Study|Other|0|||
164498205|NCT01470599|594195598|FG000|Overall Study|Protocol Violation|3|||
164498206|NCT01470599|594195599|FG001|Overall Study|Protocol Violation|1|||
164498207|NCT01470599|594195598|FG000|Overall Study|Adverse event related to study drug|2|||
164498208|NCT01470599|594195599|FG001|Overall Study|Adverse event related to study drug|5|||
164498209|NCT01470599|594195598|FG000|Overall Study|Insufficient clinical response|6|||
164498210|NCT01470599|594195599|FG001|Overall Study|Insufficient clinical response|27|||
164498211|NCT01470599|594195598|FG000|Overall Study|Adverse event not related to study drug|1|||
164498212|NCT01470599|594195599|FG001|Overall Study|Adverse event not related to study drug|5|||
164498213|NCT02158247|594195605|FG000|Overall Study|Invisible vocal cords|5|||
164498214|NCT01057251|594195607|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
164498215|NCT01057251|594195608|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
164498216|NCT01057251|594195607|FG000|Overall Study|Adverse Event|4|||
164498217|NCT01057251|594195608|FG001|Overall Study|Adverse Event|2|||
164498218|NCT01057251|594195607|FG000|Overall Study|Lack of Efficacy|2|||
164498219|NCT01057251|594195608|FG001|Overall Study|Lack of Efficacy|11|||
164498220|NCT01057251|594195607|FG000|Overall Study|Protocol Violation|6|||
164498221|NCT01057251|594195608|FG001|Overall Study|Protocol Violation|2|||
164498222|NCT01057251|594195607|FG000|Overall Study|Withdrawal by Subject|4|||
164604680|NCT01797965|594573937|FG000|Overall Study|Investigator decision|21|||
164498223|NCT01057251|594195608|FG001|Overall Study|Withdrawal by Subject|5|||
164498224|NCT01057251|594195607|FG000|Overall Study|Lost to Follow-up|7|||
164498225|NCT01057251|594195608|FG001|Overall Study|Lost to Follow-up|6|||
164498226|NCT01057251|594195607|FG000|Overall Study|Other Reason|1|||
164498227|NCT01057251|594195608|FG001|Overall Study|Other Reason|1|||
164498228|NCT00784147|594195609|FG000|Overall Study|Lost to Follow-up|2|||
164498229|NCT00784147|594195610|FG001|Overall Study|Lost to Follow-up|4|||
164604681|NCT01797965|594573938|FG001|Overall Study|Investigator decision|15|||
164498230|NCT00784147|594195609|FG000|Overall Study|Withdrawal by Subject|1|||
164498231|NCT00784147|594195610|FG001|Overall Study|Withdrawal by Subject|3|||
164498232|NCT00784147|594195609|FG000|Overall Study|Physician Decision|2|||
164498233|NCT00784147|594195610|FG001|Overall Study|Physician Decision|1|||
164498234|NCT00784147|594195609|FG000|Overall Study|Protocol Violation|1|||
164498235|NCT00784147|594195610|FG001|Overall Study|Protocol Violation|1|||
164498236|NCT00784147|594195609|FG000|Overall Study|Death|2|||
164604682|NCT01797965|594573939|FG002|Overall Study|Investigator decision|0|||
164604683|NCT01797965|594573940|FG003|Overall Study|Investigator decision|0|||
164604684|NCT01797965|594573937|FG000|Overall Study|Death|2|||
164604685|NCT01797965|594573938|FG001|Overall Study|Death|4|||
164604686|NCT01797965|594573939|FG002|Overall Study|Death|0|||
164604687|NCT01797965|594573940|FG003|Overall Study|Death|0|||
164604688|NCT01797965|594573937|FG000|Overall Study|Disease progression, defined by protocol|3|||
164604689|NCT01797965|594573938|FG001|Overall Study|Disease progression, defined by protocol|1|||
164604690|NCT01797965|594573939|FG002|Overall Study|Disease progression, defined by protocol|0|||
164498237|NCT00784147|594195610|FG001|Overall Study|Death|0|||
164498238|NCT03596242|594195612|FG000|Overall Study|Lost to Follow-up|2|||
164498239|NCT03596242|594195613|FG001|Overall Study|Lost to Follow-up|2|||
164715630|NCT04480840|594982051|FG002|Overall Study|Protocol Violation|0|||
164715631|NCT04480840|594982052|FG003|Overall Study|Protocol Violation|0|||
164715632|NCT04480840|594982053|FG004|Overall Study|Protocol Violation|0|||
164715633|NCT04480840|594982049|FG000|Overall Study|illicit drug use|0|||
164715634|NCT04480840|594982050|FG001|Overall Study|illicit drug use|0|||
164715635|NCT04480840|594982051|FG002|Overall Study|illicit drug use|0|||
164715636|NCT04480840|594982052|FG003|Overall Study|illicit drug use|0|||
164715637|NCT04480840|594982053|FG004|Overall Study|illicit drug use|1|||
164715638|NCT03246347|594982061|FG000|Overall Study|On Study|23|||
164715639|NCT03291067|594982062|FG000|Overall Study|Adverse Event|0|||
164715640|NCT03291067|594982063|FG001|Overall Study|Adverse Event|2|||
164715641|NCT03291067|594982064|FG002|Overall Study|Adverse Event|17|||
164715642|NCT03291067|594982065|FG003|Overall Study|Adverse Event|3|||
164715643|NCT03291067|594982062|FG000|Overall Study|Lost to Follow-up|2|||
164715644|NCT03291067|594982063|FG001|Overall Study|Lost to Follow-up|1|||
164715645|NCT03291067|594982064|FG002|Overall Study|Lost to Follow-up|0|||
164715646|NCT03291067|594982065|FG003|Overall Study|Lost to Follow-up|1|||
164715647|NCT03291067|594982062|FG000|Overall Study|Physician Decision|0|||
164715648|NCT03291067|594982063|FG001|Overall Study|Physician Decision|0|||
164715649|NCT03291067|594982064|FG002|Overall Study|Physician Decision|1|||
164715650|NCT03291067|594982065|FG003|Overall Study|Physician Decision|0|||
164715651|NCT03291067|594982062|FG000|Overall Study|Protocol Violation|5|||
164715652|NCT03291067|594982063|FG001|Overall Study|Protocol Violation|3|||
164715653|NCT03291067|594982064|FG002|Overall Study|Protocol Violation|4|||
164715654|NCT03291067|594982065|FG003|Overall Study|Protocol Violation|2|||
164715655|NCT03291067|594982062|FG000|Overall Study|Withdrawal by Subject|3|||
164715656|NCT03291067|594982063|FG001|Overall Study|Withdrawal by Subject|4|||
164715657|NCT03291067|594982064|FG002|Overall Study|Withdrawal by Subject|7|||
164715658|NCT03291067|594982065|FG003|Overall Study|Withdrawal by Subject|5|||
164715659|NCT03291067|594982062|FG000|Overall Study|Other|0|||
164715660|NCT03291067|594982063|FG001|Overall Study|Other|4|||
164715661|NCT03291067|594982064|FG002|Overall Study|Other|4|||
164715662|NCT03291067|594982065|FG003|Overall Study|Other|6|||
164715663|NCT02255435|594982066|FG000|Overall Study|Patient's Limited Time Availability|0|||
164715664|NCT02255435|594982067|FG001|Overall Study|Patient's Limited Time Availability|0|||
164715665|NCT02255435|594982068|FG002|Overall Study|Patient's Limited Time Availability|0|||
164715666|NCT02255435|594982069|FG003|Overall Study|Patient's Limited Time Availability|0|||
164715667|NCT02255435|594982070|FG004|Overall Study|Patient's Limited Time Availability|0|||
164715668|NCT02255435|594982071|FG005|Overall Study|Patient's Limited Time Availability|0|||
164715669|NCT02255435|594982072|FG006|Overall Study|Patient's Limited Time Availability|0|||
164715670|NCT02255435|594982073|FG007|Overall Study|Patient's Limited Time Availability|1|||
164715671|NCT02255435|594982074|FG008|Overall Study|Patient's Limited Time Availability|0|||
164715672|NCT02255435|594982075|FG009|Overall Study|Patient's Limited Time Availability|0|||
164715673|NCT02255435|594982066|FG000|Overall Study|Withdrawal by Subject|0|||
164715674|NCT02255435|594982067|FG001|Overall Study|Withdrawal by Subject|0|||
164715675|NCT02255435|594982068|FG002|Overall Study|Withdrawal by Subject|0|||
164715676|NCT02255435|594982069|FG003|Overall Study|Withdrawal by Subject|0|||
164715677|NCT02255435|594982070|FG004|Overall Study|Withdrawal by Subject|0|||
164715678|NCT02255435|594982071|FG005|Overall Study|Withdrawal by Subject|0|||
164715679|NCT02255435|594982072|FG006|Overall Study|Withdrawal by Subject|0|||
164715680|NCT02255435|594982073|FG007|Overall Study|Withdrawal by Subject|0|||
164715681|NCT02255435|594982074|FG008|Overall Study|Withdrawal by Subject|1|||
164715682|NCT02255435|594982075|FG009|Overall Study|Withdrawal by Subject|4|||
164715683|NCT02255435|594982066|FG000|Overall Study|Administrative reasons|0|||
164715684|NCT02255435|594982067|FG001|Overall Study|Administrative reasons|0|||
164715685|NCT02255435|594982068|FG002|Overall Study|Administrative reasons|0|||
164715686|NCT02255435|594982069|FG003|Overall Study|Administrative reasons|0|||
164715687|NCT02255435|594982070|FG004|Overall Study|Administrative reasons|0|||
164715688|NCT02255435|594982071|FG005|Overall Study|Administrative reasons|0|||
164715689|NCT02255435|594982072|FG006|Overall Study|Administrative reasons|0|||
164715690|NCT02255435|594982073|FG007|Overall Study|Administrative reasons|0|||
164715691|NCT02255435|594982074|FG008|Overall Study|Administrative reasons|0|||
164715692|NCT02255435|594982075|FG009|Overall Study|Administrative reasons|2|||
164715693|NCT03945773|594982076|FG000|Overall Study|Consent Withdrawn|1|||
164715694|NCT03945773|594982077|FG001|Overall Study|Consent Withdrawn|1|||
164715695|NCT03945773|594982076|FG000|Overall Study|Lost to Follow-up|1|||
164715696|NCT03945773|594982077|FG001|Overall Study|Lost to Follow-up|0|||
164715697|NCT03945773|594982076|FG000|Overall Study|Death|46|||
164715698|NCT03945773|594982077|FG001|Overall Study|Death|22|||
164715699|NCT03945773|594982076|FG000|Overall Study|Physician Decision|1|||
164498240|NCT02509312|594195614|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
164498241|NCT02509312|594195615|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
164498242|NCT02509312|594195614|FG000|Overall Study|Obstetrician refusal|0|||
164498243|NCT02509312|594195615|FG001|Overall Study|Obstetrician refusal|1|||
164498244|NCT02509312|594195614|FG000|Overall Study|Patient elected for TOLAC|1|||
164498245|NCT02509312|594195615|FG001|Overall Study|Patient elected for TOLAC|0|||
164498246|NCT02509312|594195614|FG000|Overall Study|Cesarean deemed stat|1|||
164498247|NCT02509312|594195615|FG001|Overall Study|Cesarean deemed stat|0|||
164498248|NCT02509312|594195614|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
164498249|NCT02509312|594195615|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
164498250|NCT04544865|594195616|FG000|Overall Study|Death|0|||
164604691|NCT01797965|594573940|FG003|Overall Study|Disease progression, defined by protocol|0|||
164604692|NCT01797965|594573937|FG000|Overall Study|Reason Not Specified|280|||
164604693|NCT01797965|594573938|FG001|Overall Study|Reason Not Specified|295|||
164604694|NCT01797965|594573939|FG002|Overall Study|Reason Not Specified|0|||
164604695|NCT01797965|594573940|FG003|Overall Study|Reason Not Specified|15|||
164604696|NCT01764256|594573941|FG000|Received All Vaccinations|Adverse Event|1|||
164604697|NCT01764256|594573942|FG001|Received All Vaccinations|Adverse Event|1|||
164604698|NCT01764256|594573943|FG002|Received All Vaccinations|Adverse Event|0|||
164604699|NCT01764256|594573944|FG003|Received All Vaccinations|Adverse Event|0|||
164604700|NCT01764256|594573941|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
164604701|NCT01764256|594573942|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
164604702|NCT01764256|594573943|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
164604703|NCT01764256|594573944|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
164604704|NCT01764256|594573941|FG000|Received All Vaccinations|Lost to Follow-up|1|||
164604705|NCT01764256|594573942|FG001|Received All Vaccinations|Lost to Follow-up|0|||
164604706|NCT01764256|594573943|FG002|Received All Vaccinations|Lost to Follow-up|0|||
164604707|NCT01764256|594573944|FG003|Received All Vaccinations|Lost to Follow-up|0|||
164604708|NCT01764256|594573941|FG000|Completed Study|Lost to Follow-up|0|||
164604709|NCT01764256|594573942|FG001|Completed Study|Lost to Follow-up|0|||
164604710|NCT01764256|594573943|FG002|Completed Study|Lost to Follow-up|0|||
164604711|NCT01764256|594573944|FG003|Completed Study|Lost to Follow-up|1|||
164604712|NCT01153841|594573945|FG000|Overall Study|Adverse Event|1|||
164604713|NCT01153841|594573946|FG001|Overall Study|Adverse Event|0|||
164604714|NCT01153841|594573945|FG000|Overall Study|Withdrawal by Subject|1|||
164604715|NCT01153841|594573946|FG001|Overall Study|Withdrawal by Subject|0|||
164604716|NCT01153841|594573945|FG000|Overall Study|Protocol Violation|2|||
164604717|NCT01153841|594573946|FG001|Overall Study|Protocol Violation|0|||
164604718|NCT01153841|594573945|FG000|Overall Study|Lost to Follow-up|2|||
164604719|NCT01153841|594573946|FG001|Overall Study|Lost to Follow-up|0|||
164604720|NCT00712322|594573955|FG000|Overall Study|Protocol deviation|0|||
164604721|NCT00712322|594573956|FG001|Overall Study|Protocol deviation|1|||
164604722|NCT00712322|594573957|FG002|Overall Study|Protocol deviation|0|||
164604723|NCT00973921|594573958|FG000|Overall Study|IVUS results were not available|9|||
164604724|NCT04404010|594573959|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
164604725|NCT04404010|594573960|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
164604726|NCT01599754|594573964|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
164604727|NCT01599754|594573965|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
164604728|NCT01599754|594573964|FG000|Overall Study|Participant noncompliance|4|||
164604729|NCT01599754|594573965|FG001|Overall Study|Participant noncompliance|4|||
164604730|NCT01599754|594573964|FG000|Overall Study|Lost to Follow-up|13|||
164604731|NCT01599754|594573965|FG001|Overall Study|Lost to Follow-up|6|||
164604732|NCT01599754|594573964|FG000|Overall Study|Death|31|||
164604733|NCT01599754|594573965|FG001|Overall Study|Death|33|||
164604734|NCT01599754|594573964|FG000|Overall Study|Adverse Event|3|||
164604735|NCT01599754|594573965|FG001|Overall Study|Adverse Event|2|||
164604736|NCT01599754|594573964|FG000|Overall Study|Investigator decision|1|||
164604737|NCT01599754|594573965|FG001|Overall Study|Investigator decision|3|||
164604738|NCT01599754|594573964|FG000|Overall Study|Withdrawal by Subject|24|||
164604739|NCT01599754|594573965|FG001|Overall Study|Withdrawal by Subject|25|||
164604740|NCT01599754|594573964|FG000|Overall Study|Study terminated by sponsor|282|||
164604741|NCT01599754|594573965|FG001|Overall Study|Study terminated by sponsor|285|||
164604742|NCT00242580|594573966|FG000|Overall Study|Adverse Event|3|||
164604743|NCT00242580|594573967|FG001|Overall Study|Adverse Event|0|||
164604744|NCT00242580|594573968|FG002|Overall Study|Adverse Event|2|||
164604745|NCT00242580|594573966|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
164604746|NCT00242580|594573967|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
164604747|NCT00242580|594573968|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
164604748|NCT00242580|594573966|FG000|Overall Study|Protocol Violation|0|||
164604749|NCT00242580|594573967|FG001|Overall Study|Protocol Violation|0|||
164604750|NCT00242580|594573968|FG002|Overall Study|Protocol Violation|1|||
164604751|NCT00242580|594573966|FG000|Overall Study|Subject withdrew consent|2|||
164604752|NCT00242580|594573967|FG001|Overall Study|Subject withdrew consent|2|||
164715700|NCT03945773|594982077|FG001|Overall Study|Physician Decision|0|||
164715701|NCT03945773|594982076|FG000|Overall Study|Other|1|||
164715702|NCT03945773|594982077|FG001|Overall Study|Other|0|||
164715703|NCT03945773|594982076|FG000|Overall Study|Ongoing at the time of DCO|4|||
164715704|NCT03945773|594982077|FG001|Overall Study|Ongoing at the time of DCO|3|||
164715705|NCT04165317|594982080|FG000|Treatment Phase|Adverse Event|131|||
164715706|NCT04165317|594982081|FG001|Treatment Phase|Adverse Event|89|||
164715707|NCT04165317|594982082|FG002|Treatment Phase|Adverse Event|37|||
164715708|NCT04165317|594982083|FG003|Treatment Phase|Adverse Event|0|||
164715709|NCT04165317|594982084|FG004|Treatment Phase|Adverse Event|2|||
164715710|NCT04165317|594982080|FG000|Treatment Phase|Death|8|||
164715711|NCT04165317|594982081|FG001|Treatment Phase|Death|8|||
164715712|NCT04165317|594982082|FG002|Treatment Phase|Death|6|||
164715713|NCT04165317|594982083|FG003|Treatment Phase|Death|0|||
164715714|NCT04165317|594982084|FG004|Treatment Phase|Death|0|||
164715715|NCT04165317|594982080|FG000|Treatment Phase|Lack of Efficacy|32|||
164715716|NCT04165317|594982081|FG001|Treatment Phase|Lack of Efficacy|50|||
164715717|NCT04165317|594982082|FG002|Treatment Phase|Lack of Efficacy|54|||
164715718|NCT04165317|594982083|FG003|Treatment Phase|Lack of Efficacy|3|||
164715719|NCT04165317|594982084|FG004|Treatment Phase|Lack of Efficacy|2|||
164715720|NCT04165317|594982080|FG000|Treatment Phase|Lost to Follow-up|3|||
164715721|NCT04165317|594982081|FG001|Treatment Phase|Lost to Follow-up|0|||
164715722|NCT04165317|594982082|FG002|Treatment Phase|Lost to Follow-up|2|||
164715723|NCT04165317|594982083|FG003|Treatment Phase|Lost to Follow-up|0|||
164715724|NCT04165317|594982084|FG004|Treatment Phase|Lost to Follow-up|0|||
164715725|NCT04165317|594982080|FG000|Treatment Phase|Withdrawal by Subject|41|||
164715726|NCT04165317|594982081|FG001|Treatment Phase|Withdrawal by Subject|26|||
164715727|NCT04165317|594982082|FG002|Treatment Phase|Withdrawal by Subject|29|||
164715728|NCT04165317|594982083|FG003|Treatment Phase|Withdrawal by Subject|1|||
164715729|NCT04165317|594982084|FG004|Treatment Phase|Withdrawal by Subject|0|||
164715730|NCT04165317|594982080|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
164715731|NCT04165317|594982081|FG001|Treatment Phase|Global Deterioration of Health Status|2|||
164715732|NCT04165317|594982082|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
164715733|NCT04165317|594982083|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
164715734|NCT04165317|594982084|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
164715735|NCT04165317|594982080|FG000|Treatment Phase|Other|14|||
164715736|NCT04165317|594982081|FG001|Treatment Phase|Other|13|||
164715737|NCT04165317|594982082|FG002|Treatment Phase|Other|18|||
164715738|NCT04165317|594982083|FG003|Treatment Phase|Other|0|||
164715739|NCT04165317|594982084|FG004|Treatment Phase|Other|0|||
164715740|NCT04165317|594982080|FG000|Treatment Phase|Randomized, not treated|2|||
164715741|NCT04165317|594982081|FG001|Treatment Phase|Randomized, not treated|4|||
164715742|NCT04165317|594982082|FG002|Treatment Phase|Randomized, not treated|2|||
164715743|NCT04165317|594982083|FG003|Treatment Phase|Randomized, not treated|0|||
164715744|NCT04165317|594982084|FG004|Treatment Phase|Randomized, not treated|0|||
164715745|NCT04165317|594982080|FG000|Follow up Phase|Death|23|||
164715746|NCT04165317|594982081|FG001|Follow up Phase|Death|20|||
164715747|NCT04165317|594982082|FG002|Follow up Phase|Death|23|||
164715748|NCT04165317|594982083|FG003|Follow up Phase|Death|0|||
164715749|NCT04165317|594982084|FG004|Follow up Phase|Death|0|||
164715750|NCT04165317|594982080|FG000|Follow up Phase|Lost to Follow-up|4|||
164715751|NCT04165317|594982081|FG001|Follow up Phase|Lost to Follow-up|6|||
164715752|NCT04165317|594982082|FG002|Follow up Phase|Lost to Follow-up|1|||
164715753|NCT04165317|594982083|FG003|Follow up Phase|Lost to Follow-up|0|||
164715754|NCT04165317|594982084|FG004|Follow up Phase|Lost to Follow-up|0|||
164715755|NCT04165317|594982080|FG000|Follow up Phase|Withdrawal by Subject|12|||
164715756|NCT04165317|594982081|FG001|Follow up Phase|Withdrawal by Subject|27|||
164715757|NCT04165317|594982082|FG002|Follow up Phase|Withdrawal by Subject|21|||
164715758|NCT04165317|594982083|FG003|Follow up Phase|Withdrawal by Subject|0|||
164715759|NCT04165317|594982084|FG004|Follow up Phase|Withdrawal by Subject|0|||
164715760|NCT04165317|594982080|FG000|Follow up Phase|Ongoing|280|||
164715761|NCT04165317|594982081|FG001|Follow up Phase|Ongoing|277|||
164715762|NCT04165317|594982082|FG002|Follow up Phase|Ongoing|289|||
164715763|NCT04165317|594982083|FG003|Follow up Phase|Ongoing|0|||
164715764|NCT04165317|594982084|FG004|Follow up Phase|Ongoing|0|||
164715765|NCT04165317|594982080|FG000|Follow up Phase|Other|0|||
164715766|NCT04165317|594982081|FG001|Follow up Phase|Other|0|||
164715767|NCT04165317|594982082|FG002|Follow up Phase|Other|0|||
164715768|NCT04165317|594982083|FG003|Follow up Phase|Other|5|||
164715769|NCT04165317|594982084|FG004|Follow up Phase|Other|7|||
164715770|NCT03377491|594982086|FG000|Overall Study|Death|193|||
164715771|NCT03377491|594982087|FG001|Overall Study|Death|211|||
164715772|NCT03377491|594982086|FG000|Overall Study|Lost to Follow-up|2|||
164715773|NCT03377491|594982087|FG001|Overall Study|Lost to Follow-up|3|||
164715774|NCT03377491|594982086|FG000|Overall Study|Withdrawal by Subject|42|||
164715775|NCT03377491|594982087|FG001|Overall Study|Withdrawal by Subject|26|||
164715776|NCT03377491|594982086|FG000|Overall Study|Study closure|40|||
164715777|NCT03377491|594982087|FG001|Overall Study|Study closure|37|||
164715778|NCT03377491|594982086|FG000|Overall Study|Other|8|||
164604753|NCT00242580|594573968|FG002|Overall Study|Subject withdrew consent|5|||
164604754|NCT00242580|594573966|FG000|Overall Study|Lost to Follow-up|0|||
164604755|NCT00242580|594573967|FG001|Overall Study|Lost to Follow-up|3|||
164604756|NCT00242580|594573968|FG002|Overall Study|Lost to Follow-up|0|||
164604757|NCT00242580|594573966|FG000|Overall Study|Death|1|||
164604758|NCT00242580|594573967|FG001|Overall Study|Death|2|||
164604759|NCT00242580|594573968|FG002|Overall Study|Death|1|||
164604760|NCT03666858|594573971|FG000|Cohort 1|Adverse Event|1|||
164604761|NCT03666858|594573972|FG001|Cohort 1|Adverse Event|0|||
164604762|NCT03666858|594573971|FG000|Cohort 2|Adverse Event|0|||
164604763|NCT03666858|594573972|FG001|Cohort 2|Adverse Event|1|||
164604764|NCT03282357|594573973|FG000|Overall Study|Lost to Follow-up|3|||
164604765|NCT03282357|594573973|FG000|Overall Study|Withdrawal by Subject|4|||
164604766|NCT03282357|594573973|FG000|Overall Study|Adverse Event|1|||
164604767|NCT03282357|594573973|FG000|Overall Study|Other|9|||
164604768|NCT03550131|594573974|FG000|Overall Study|Lost to Follow-up|16|||
164604769|NCT03550131|594573975|FG001|Overall Study|Lost to Follow-up|24|||
164604770|NCT03550131|594573974|FG000|Overall Study|Withdrawal by Subject|36|||
164604771|NCT03550131|594573975|FG001|Overall Study|Withdrawal by Subject|28|||
164604772|NCT03550131|594573974|FG000|Overall Study|Illness of dyad member|10|||
164604773|NCT03550131|594573975|FG001|Overall Study|Illness of dyad member|2|||
164604774|NCT03550131|594573974|FG000|Overall Study|Death of person with dementia|4|||
164604775|NCT03550131|594573975|FG001|Overall Study|Death of person with dementia|8|||
164604776|NCT00910429|594573980|FG000|Overall Study|Death|18|||
164604777|NCT00910429|594573981|FG001|Overall Study|Death|12|||
164604778|NCT00910429|594573980|FG000|Overall Study|Withdrawal by Subject|3|||
164604779|NCT00910429|594573981|FG001|Overall Study|Withdrawal by Subject|2|||
164604780|NCT00910429|594573980|FG000|Overall Study|Protocol Violation|1|||
164604781|NCT00910429|594573981|FG001|Overall Study|Protocol Violation|0|||
164604782|NCT00910429|594573980|FG000|Overall Study|Lost to Follow-up|2|||
164604783|NCT00910429|594573981|FG001|Overall Study|Lost to Follow-up|1|||
164604784|NCT00910429|594573980|FG000|Overall Study|Adverse Event|10|||
164604785|NCT00910429|594573981|FG001|Overall Study|Adverse Event|5|||
164604786|NCT00910429|594573980|FG000|Overall Study|Drug non-compliance|1|||
164604787|NCT00910429|594573981|FG001|Overall Study|Drug non-compliance|0|||
164604788|NCT00910429|594573980|FG000|Overall Study|Lack of Efficacy|4|||
164604789|NCT00910429|594573981|FG001|Overall Study|Lack of Efficacy|1|||
164604790|NCT00594204|594573982|FG000|Overall Study|Adverse Event|15|||
164604791|NCT00594204|594573983|FG001|Overall Study|Adverse Event|3|||
164604792|NCT00594204|594573982|FG000|Overall Study|Lost to Follow-up|9|||
164604793|NCT00594204|594573983|FG001|Overall Study|Lost to Follow-up|5|||
164604794|NCT00594204|594573982|FG000|Overall Study|Withdrawal by Subject|23|||
164604795|NCT00594204|594573983|FG001|Overall Study|Withdrawal by Subject|29|||
164604796|NCT00594204|594573982|FG000|Overall Study|Other|4|||
164604797|NCT00594204|594573983|FG001|Overall Study|Other|3|||
164604798|NCT00594204|594573982|FG000|Overall Study|Lack of Efficacy|3|||
164604799|NCT00594204|594573983|FG001|Overall Study|Lack of Efficacy|4|||
164604800|NCT00594204|594573982|FG000|Overall Study|Randomized but not treated|4|||
164604801|NCT00594204|594573983|FG001|Overall Study|Randomized but not treated|1|||
164604802|NCT01740388|594573984|FG000|Overall Study|Withdrawal by Subject|1|||
164604803|NCT01740388|594573985|FG001|Overall Study|Withdrawal by Subject|2|||
164604804|NCT01740388|594573984|FG000|Overall Study|Lost to Follow-up|2|||
164604805|NCT01740388|594573985|FG001|Overall Study|Lost to Follow-up|0|||
164604806|NCT01740388|594573984|FG000|Overall Study|Physician Decision|2|||
164604807|NCT01740388|594573985|FG001|Overall Study|Physician Decision|6|||
164604808|NCT01740388|594573984|FG000|Overall Study|Subjects missing data, completed|41|||
164604809|NCT01740388|594573985|FG001|Overall Study|Subjects missing data, completed|36|||
164604810|NCT05757427|594573988|FG000|Overall Study|Adverse Event|1|||
164604811|NCT05757427|594573988|FG000|Overall Study|Device deficiency|1|||
164604812|NCT05757427|594573988|FG000|Overall Study|All cysts aspirated before Wavelia scan|1|||
164604813|NCT05757427|594573988|FG000|Overall Study|MWBI scan of only 1 breast|3|||
164604814|NCT05757427|594573988|FG000|Overall Study|Invalid MWBI scan - various reasons - positioning, breast too large, patient movement|5|||
164604815|NCT02017899|594575827|FG000|Overall Study|Withdrawal by Subject|0|||
164604816|NCT02017899|594575828|FG001|Overall Study|Withdrawal by Subject|0|||
164604817|NCT02017899|594575829|FG002|Overall Study|Withdrawal by Subject|0|||
164604818|NCT02017899|594575830|FG003|Overall Study|Withdrawal by Subject|1|||
164604819|NCT02017899|594575831|FG004|Overall Study|Withdrawal by Subject|1|||
164604820|NCT02017899|594575832|FG005|Overall Study|Withdrawal by Subject|0|||
164604821|NCT03927911|594575837|FG000|Overall Study|problems with eDiary|0|||
164604822|NCT03927911|594575838|FG001|Overall Study|problems with eDiary|1|||
164604823|NCT03927911|594575839|FG002|Overall Study|problems with eDiary|0|||
164604824|NCT03927911|594575840|FG003|Overall Study|problems with eDiary|1|||
164604825|NCT03927911|594575841|FG004|Overall Study|problems with eDiary|0|||
164604826|NCT03927911|594575842|FG005|Overall Study|problems with eDiary|4|||
164604827|NCT03927911|594575837|FG000|Overall Study|Adverse Event|0|||
164604828|NCT03927911|594575838|FG001|Overall Study|Adverse Event|0|||
164604829|NCT03927911|594575839|FG002|Overall Study|Adverse Event|0|||
164604830|NCT03927911|594575840|FG003|Overall Study|Adverse Event|0|||
164498251|NCT04544865|594195617|FG001|Overall Study|Death|2|||
164498252|NCT04544865|594195616|FG000|Overall Study|Lost to Follow-up|11|||
164498253|NCT04544865|594195617|FG001|Overall Study|Lost to Follow-up|7|||
164498254|NCT04544865|594195616|FG000|Overall Study|Withdrawal by Subject|0|||
164498255|NCT04544865|594195617|FG001|Overall Study|Withdrawal by Subject|1|||
164498256|NCT04544865|594195616|FG000|Overall Study|Other|0|||
164498257|NCT04544865|594195617|FG001|Overall Study|Other|1|||
164498258|NCT03357471|594195618|FG000|Overall Study|Adverse Event|1|||
164498259|NCT03357471|594195619|FG001|Overall Study|Adverse Event|0|||
164498260|NCT03357471|594195618|FG000|Overall Study|Lost to Follow-up|1|||
164498261|NCT03357471|594195619|FG001|Overall Study|Lost to Follow-up|0|||
164604831|NCT03927911|594575841|FG004|Overall Study|Adverse Event|0|||
164604832|NCT03927911|594575842|FG005|Overall Study|Adverse Event|1|||
164604833|NCT03927911|594575837|FG000|Overall Study|not treated -study terminated by sponsor|0|||
164604834|NCT03927911|594575838|FG001|Overall Study|not treated -study terminated by sponsor|1|||
164604835|NCT03927911|594575839|FG002|Overall Study|not treated -study terminated by sponsor|0|||
164604836|NCT03927911|594575840|FG003|Overall Study|not treated -study terminated by sponsor|0|||
164604837|NCT03927911|594575841|FG004|Overall Study|not treated -study terminated by sponsor|0|||
164604838|NCT03927911|594575842|FG005|Overall Study|not treated -study terminated by sponsor|0|||
164604839|NCT03927911|594575837|FG000|Overall Study|Surgery cancelled|0|||
164604840|NCT03927911|594575838|FG001|Overall Study|Surgery cancelled|0|||
164604841|NCT03927911|594575839|FG002|Overall Study|Surgery cancelled|0|||
164604842|NCT03927911|594575840|FG003|Overall Study|Surgery cancelled|1|||
164604843|NCT03927911|594575841|FG004|Overall Study|Surgery cancelled|0|||
164604844|NCT03927911|594575842|FG005|Overall Study|Surgery cancelled|1|||
164604845|NCT03927911|594575837|FG000|Overall Study|Protocol Violation|0|||
164604846|NCT03927911|594575838|FG001|Overall Study|Protocol Violation|0|||
164604847|NCT03927911|594575839|FG002|Overall Study|Protocol Violation|0|||
164604848|NCT03927911|594575840|FG003|Overall Study|Protocol Violation|0|||
164604849|NCT03927911|594575841|FG004|Overall Study|Protocol Violation|0|||
164604850|NCT03927911|594575842|FG005|Overall Study|Protocol Violation|1|||
164604851|NCT02658968|594575843|FG000|Received Rituximab|Adverse Event|0|||
164604852|NCT02658968|594575844|FG001|Received Rituximab|Adverse Event|0|||
164604853|NCT02658968|594575845|FG002|Received Rituximab|Adverse Event|0|||
164604854|NCT02658968|594575846|FG003|Received Rituximab|Adverse Event|0|||
164604855|NCT02658968|594575847|FG004|Received Rituximab|Adverse Event|1|||
164604856|NCT02658968|594575843|FG000|Received Rituximab|Progressive disease|0|||
164604857|NCT02658968|594575844|FG001|Received Rituximab|Progressive disease|0|||
164604858|NCT02658968|594575845|FG002|Received Rituximab|Progressive disease|0|||
164604859|NCT02658968|594575846|FG003|Received Rituximab|Progressive disease|0|||
164604860|NCT02658968|594575847|FG004|Received Rituximab|Progressive disease|1|||
164604861|NCT02658968|594575843|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
164604862|NCT02658968|594575844|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
164604863|NCT02658968|594575845|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
164604864|NCT02658968|594575846|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
164604865|NCT02658968|594575847|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
164604866|NCT02658968|594575843|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
164604867|NCT02658968|594575844|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
164604868|NCT02658968|594575845|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
164604869|NCT02658968|594575846|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
164604870|NCT02658968|594575847|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
164604871|NCT02658968|594575843|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
164604872|NCT02658968|594575844|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
164604873|NCT02658968|594575845|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
164604874|NCT02658968|594575846|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
164604875|NCT02658968|594575847|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
164604876|NCT02658968|594575843|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
164604877|NCT02658968|594575844|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
164604878|NCT02658968|594575845|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
164498262|NCT00394589|594195624|FG000|Overall Study|Adverse Event|2|||
164498263|NCT00394589|594195625|FG001|Overall Study|Adverse Event|1|||
164604879|NCT02658968|594575846|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
164604880|NCT02658968|594575847|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
164604881|NCT02658968|594575843|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
164604882|NCT02658968|594575844|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
164604883|NCT02658968|594575845|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
164604884|NCT02658968|594575846|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
164604885|NCT02658968|594575847|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
164498264|NCT00394589|594195626|FG002|Overall Study|Adverse Event|2|||
164498265|NCT00394589|594195624|FG000|Overall Study|Lack of Efficacy|2|||
164604886|NCT00949910|594575850|FG000|Overall Study|Progressive Disease|3750|||
164604887|NCT00949910|594575850|FG000|Overall Study|Symptomatic Deterioration|1088|||
164604888|NCT00949910|594575850|FG000|Overall Study|Lost to Follow-up|100|||
164604889|NCT00949910|594575850|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
164604890|NCT00949910|594575850|FG000|Overall Study|Participant Refusal|390|||
164604891|NCT00949910|594575850|FG000|Overall Study|Death Due to Malignant Disease|456|||
164604892|NCT00949910|594575850|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
164604893|NCT00949910|594575850|FG000|Overall Study|Death Due to Adverse Event|115|||
164604894|NCT00949910|594575850|FG000|Overall Study|Death Due to Toxicity|3|||
164604895|NCT00949910|594575850|FG000|Overall Study|Death from Unknown Cause|5|||
164604896|NCT00949910|594575850|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
164604897|NCT00949910|594575850|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
164604898|NCT00949910|594575850|FG000|Overall Study|Switched to Commercial Treatment|4|||
164604899|NCT00949910|594575850|FG000|Overall Study|Violation of Eligibility|23|||
164604900|NCT00949910|594575850|FG000|Overall Study|Logistical Reasons|13|||
164604901|NCT00949910|594575850|FG000|Overall Study|Non-Compliance|10|||
164604902|NCT00949910|594575850|FG000|Overall Study|Prolonged Dosing Interruption|4|||
164604903|NCT00949910|594575850|FG000|Overall Study|Adverse Event|83|||
164604904|NCT00949910|594575850|FG000|Overall Study|Serious Adverse Event|6|||
164604905|NCT00949910|594575850|FG000|Overall Study|Physician/Participant Decision|7|||
164604906|NCT00949910|594575850|FG000|Overall Study|Other|4|||
164604907|NCT00949910|594575850|FG000|Overall Study|No Data|9|||
164604908|NCT00971425|594575851|FG000|Overall Study|Adverse Event|1|||
164604909|NCT00971425|594575852|FG001|Overall Study|Adverse Event|1|||
164604910|NCT00971425|594575851|FG000|Overall Study|Withdrawal by Subject|0|||
164604911|NCT00971425|594575852|FG001|Overall Study|Withdrawal by Subject|1|||
164604912|NCT02528253|594575855|FG000|Overall Study|Adverse Event|3|||
164604913|NCT02528253|594575856|FG001|Overall Study|Adverse Event|4|||
164604914|NCT02528253|594575857|FG002|Overall Study|Adverse Event|4|||
164604915|NCT02528253|594575858|FG003|Overall Study|Adverse Event|8|||
164604916|NCT02528253|594575859|FG004|Overall Study|Adverse Event|18|||
164604917|NCT02528253|594575855|FG000|Overall Study|Death|2|||
164604918|NCT02528253|594575856|FG001|Overall Study|Death|2|||
164604919|NCT02528253|594575857|FG002|Overall Study|Death|1|||
164604920|NCT02528253|594575858|FG003|Overall Study|Death|0|||
164604921|NCT02528253|594575859|FG004|Overall Study|Death|1|||
164604922|NCT02528253|594575855|FG000|Overall Study|Insufficient clinical response|7|||
164604923|NCT02528253|594575856|FG001|Overall Study|Insufficient clinical response|10|||
164604924|NCT02528253|594575857|FG002|Overall Study|Insufficient clinical response|13|||
164604925|NCT02528253|594575858|FG003|Overall Study|Insufficient clinical response|12|||
164604926|NCT02528253|594575859|FG004|Overall Study|Insufficient clinical response|16|||
164604927|NCT02528253|594575855|FG000|Overall Study|Lost to Follow-up|16|||
164604928|NCT02528253|594575856|FG001|Overall Study|Lost to Follow-up|9|||
164604929|NCT02528253|594575857|FG002|Overall Study|Lost to Follow-up|31|||
164604930|NCT02528253|594575858|FG003|Overall Study|Lost to Follow-up|16|||
164715779|NCT03377491|594982087|FG001|Overall Study|Other|9|||
164715780|NCT04377932|594982097|FG000|Dose Level 1|Death|7|||
164715781|NCT04377932|594982098|FG001|Dose Level 1|Death|0|||
164715782|NCT04377932|594982099|FG002|Dose Level 1|Death|0|||
164715783|NCT04377932|594982097|FG000|Dose Level 1|On long term follow up|1|||
164715784|NCT04377932|594982098|FG001|Dose Level 1|On long term follow up|0|||
164715785|NCT04377932|594982099|FG002|Dose Level 1|On long term follow up|0|||
164715786|NCT04377932|594982097|FG000|Dose Level 2|Death|0|||
164715787|NCT04377932|594982098|FG001|Dose Level 2|Death|3|||
164715788|NCT04377932|594982099|FG002|Dose Level 2|Death|0|||
164715789|NCT04377932|594982097|FG000|Dose Level 3|Death|0|||
164715790|NCT04377932|594982098|FG001|Dose Level 3|Death|0|||
164715791|NCT04377932|594982099|FG002|Dose Level 3|Death|2|||
164715792|NCT04377932|594982097|FG000|Dose Level 3|On long term follow up|0|||
164604931|NCT02528253|594575859|FG004|Overall Study|Lost to Follow-up|34|||
164715793|NCT04377932|594982098|FG001|Dose Level 3|On long term follow up|0|||
164715794|NCT04377932|594982099|FG002|Dose Level 3|On long term follow up|1|||
164715795|NCT03729830|594982101|FG000|Overall Study|Active at study close|136|||
164715796|NCT03729830|594982101|FG000|Overall Study|Subject withdrew consent|40|||
164715797|NCT03729830|594982101|FG000|Overall Study|Intent|32|||
164715798|NCT03729830|594982101|FG000|Overall Study|Lost to Follow-up|31|||
164715799|NCT03729830|594982101|FG000|Overall Study|research facility closed down|9|||
164604932|NCT02528253|594575855|FG000|Overall Study|Other|21|||
164604933|NCT02528253|594575856|FG001|Overall Study|Other|22|||
164604934|NCT02528253|594575857|FG002|Overall Study|Other|58|||
164604935|NCT02528253|594575858|FG003|Overall Study|Other|52|||
164715800|NCT03729830|594982101|FG000|Overall Study|Death|5|||
164715801|NCT03729830|594982101|FG000|Overall Study|Physician Decision|4|||
164604936|NCT02528253|594575859|FG004|Overall Study|Other|76|||
164604937|NCT02528253|594575855|FG000|Overall Study|Withdrawal by Subject|25|||
164604938|NCT02528253|594575856|FG001|Overall Study|Withdrawal by Subject|20|||
164604939|NCT02528253|594575857|FG002|Overall Study|Withdrawal by Subject|29|||
164715802|NCT03729830|594982101|FG000|Overall Study|No longer meets protocol criteria|3|||
164715803|NCT03729830|594982101|FG000|Overall Study|Protocol Violation|6|||
164715804|NCT03729830|594982101|FG000|Overall Study|Sponsor withdrew subject|1|||
164498266|NCT00394589|594195625|FG001|Overall Study|Lack of Efficacy|2|||
164498267|NCT00394589|594195626|FG002|Overall Study|Lack of Efficacy|3|||
164498268|NCT00394589|594195624|FG000|Overall Study|Protocol Violation|4|||
164498269|NCT00394589|594195625|FG001|Overall Study|Protocol Violation|0|||
164498270|NCT00394589|594195626|FG002|Overall Study|Protocol Violation|2|||
164498271|NCT01710800|594195634|FG000|Overall Study|Withdrawal by Subject|21|||
164498272|NCT01710800|594195634|FG000|Overall Study|Protocol Violation|1|||
164498273|NCT03891641|594195638|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
164498274|NCT03891641|594195639|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
164498275|NCT02212301|594195640|FG000|Period 1|Lost to Follow-up|0|||
164498276|NCT02212301|594195641|FG001|Period 1|Lost to Follow-up|1|||
164498277|NCT02025985|594195642|FG000|Overall Study|Consent withdrawn|0|||
164498278|NCT02025985|594195643|FG001|Overall Study|Consent withdrawn|0|||
164498279|NCT02025985|594195644|FG002|Overall Study|Consent withdrawn|1|||
164498280|NCT02025985|594195645|FG003|Overall Study|Consent withdrawn|0|||
164498281|NCT02025985|594195646|FG004|Overall Study|Consent withdrawn|0|||
164498282|NCT02025985|594195642|FG000|Overall Study|Termination of study by Sponsor|4|||
164498283|NCT02025985|594195643|FG001|Overall Study|Termination of study by Sponsor|3|||
164498284|NCT02025985|594195644|FG002|Overall Study|Termination of study by Sponsor|1|||
164498285|NCT02025985|594195645|FG003|Overall Study|Termination of study by Sponsor|1|||
164498286|NCT02025985|594195646|FG004|Overall Study|Termination of study by Sponsor|3|||
164498287|NCT02025985|594195642|FG000|Overall Study|Death|21|||
164498288|NCT02025985|594195643|FG001|Overall Study|Death|20|||
164498289|NCT02025985|594195644|FG002|Overall Study|Death|23|||
164498290|NCT02025985|594195645|FG003|Overall Study|Death|20|||
164498291|NCT02025985|594195646|FG004|Overall Study|Death|17|||
164498292|NCT00866918|594195647|FG000|Overall Study|Death|1|||
164498293|NCT00866918|594195648|FG001|Overall Study|Death|5|||
164498294|NCT00866918|594195647|FG000|Overall Study|Lack of Efficacy|1|||
164498295|NCT00866918|594195648|FG001|Overall Study|Lack of Efficacy|1|||
164498296|NCT00866918|594195647|FG000|Overall Study|Physician Decision|10|||
164498297|NCT00866918|594195648|FG001|Overall Study|Physician Decision|2|||
164498298|NCT00866918|594195647|FG000|Overall Study|Ineligible|2|||
164498299|NCT00866918|594195648|FG001|Overall Study|Ineligible|4|||
164498300|NCT00866918|594195647|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
164498301|NCT00866918|594195648|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
164498302|NCT00866918|594195647|FG000|Overall Study|Secondary malignancy|1|||
164498303|NCT00866918|594195648|FG001|Overall Study|Secondary malignancy|0|||
164498304|NCT00920699|594195652|FG000|Overall Study|Withdrawal by Subject|2|||
164498305|NCT00920699|594195653|FG001|Overall Study|Withdrawal by Subject|0|||
164498306|NCT00920699|594195654|FG002|Overall Study|Withdrawal by Subject|2|||
164498307|NCT00920699|594195652|FG000|Overall Study|no longer met eligibility|0|||
164498308|NCT00920699|594195653|FG001|Overall Study|no longer met eligibility|1|||
164498309|NCT00920699|594195654|FG002|Overall Study|no longer met eligibility|0|||
164145301|NCT00025259|592894268|FG005|Overall Study|Protocol Violation|1|||
164498310|NCT00920699|594195652|FG000|Overall Study|Lost to Follow-up|0|||
164498311|NCT00920699|594195653|FG001|Overall Study|Lost to Follow-up|0|||
164498312|NCT00920699|594195654|FG002|Overall Study|Lost to Follow-up|2|||
164498313|NCT00001941|594195658|FG000|Overall Study|not treated- rapidly progressing disease|0|||
164498314|NCT00001941|594195659|FG001|Overall Study|not treated- rapidly progressing disease|0|||
164604940|NCT02528253|594575858|FG003|Overall Study|Withdrawal by Subject|48|||
164604941|NCT02528253|594575859|FG004|Overall Study|Withdrawal by Subject|73|||
164604942|NCT02528253|594575855|FG000|Overall Study|Protocol Violation|1|||
164604943|NCT02528253|594575856|FG001|Overall Study|Protocol Violation|2|||
164604944|NCT02528253|594575857|FG002|Overall Study|Protocol Violation|4|||
164604945|NCT02528253|594575858|FG003|Overall Study|Protocol Violation|0|||
164604946|NCT02528253|594575859|FG004|Overall Study|Protocol Violation|4|||
164604947|NCT02528253|594575855|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
164604948|NCT02528253|594575856|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
164604949|NCT02528253|594575857|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
164604950|NCT02528253|594575858|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
164604951|NCT02528253|594575859|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
164604952|NCT00505752|594575860|FG000|Overall Study|Adverse Event|1|||
164604953|NCT00505752|594575861|FG001|Overall Study|Adverse Event|0|||
164604954|NCT00505752|594575862|FG002|Overall Study|Adverse Event|1|||
164604955|NCT00505752|594575863|FG003|Overall Study|Adverse Event|0|||
164715805|NCT04249596|594982102|FG000|Overall Study|Withdrawal by Subject|5|||
164715806|NCT04249596|594982102|FG000|Overall Study|Lost to Follow-up|3|||
164498315|NCT00001941|594195660|FG002|Overall Study|not treated- rapidly progressing disease|0|||
164498316|NCT00001941|594195661|FG003|Overall Study|not treated- rapidly progressing disease|0|||
164498317|NCT00001941|594195662|FG004|Overall Study|not treated- rapidly progressing disease|1|||
164498318|NCT02287883|594195663|FG000|Overall Study|Death|8|||
164498319|NCT02287883|594195664|FG001|Overall Study|Death|7|||
164498320|NCT02287883|594195663|FG000|Overall Study|No longer eligible|222|||
164498321|NCT02287883|594195664|FG001|Overall Study|No longer eligible|182|||
164498322|NCT02287883|594195663|FG000|Overall Study|Non-response to survey|229|||
164498323|NCT02287883|594195664|FG001|Overall Study|Non-response to survey|237|||
164498324|NCT03175198|594195668|FG000|Overall Study|Adverse Event|480|||
164498325|NCT03175198|594195668|FG000|Overall Study|No actual visit|120|||
164498326|NCT03175198|594195668|FG000|Overall Study|Registration rule not followed|4|||
164498327|NCT03175198|594195668|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
164498328|NCT03175198|594195668|FG000|Overall Study|Other personal reason|509|||
164498329|NCT03175198|594195668|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
164498330|NCT03175198|594195668|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
164498331|NCT03175198|594195668|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
164498332|NCT03175198|594195668|FG000|Overall Study|To conduct invasive treatment of operation|53|||
164498333|NCT03175198|594195668|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
164498334|NCT00545571|594195669|FG000|Overall Study|Administrative Reasons|1|||
164498335|NCT00545571|594195669|FG000|Overall Study|Adverse Event|2|||
164498336|NCT00545571|594195669|FG000|Overall Study|Death|5|||
164498337|NCT00545571|594195669|FG000|Overall Study|Lack of Efficacy|1|||
164498338|NCT00545571|594195669|FG000|Overall Study|Protocol Violation|2|||
164498339|NCT00545571|594195669|FG000|Overall Study|Refused Treatment|1|||
164498340|NCT00545571|594195669|FG000|Overall Study|Screen Failure|16|||
164498341|NCT00545571|594195669|FG000|Overall Study|Transfusion|12|||
164498342|NCT00545571|594195669|FG000|Overall Study|Early Termination of Study|24|||
164498343|NCT00545571|594195669|FG000|Overall Study|Kidney Transplantation|3|||
164498344|NCT00874497|594195670|FG000|Overall Study|Lost to Follow-up|2|||
164498345|NCT00874497|594195671|FG001|Overall Study|Lost to Follow-up|4|||
164498346|NCT00874497|594195670|FG000|Overall Study|Adverse Event|9|||
164498347|NCT00874497|594195671|FG001|Overall Study|Adverse Event|4|||
164498348|NCT00874497|594195670|FG000|Overall Study|Sponsor Discontinued Trial|7|||
164498349|NCT00874497|594195671|FG001|Overall Study|Sponsor Discontinued Trial|3|||
164498350|NCT00874497|594195670|FG000|Overall Study|Met Withdrawal Criteria|4|||
164604956|NCT00505752|594575860|FG000|Overall Study|Lost to Follow-up|1|||
164604957|NCT00505752|594575861|FG001|Overall Study|Lost to Follow-up|0|||
164604958|NCT00505752|594575862|FG002|Overall Study|Lost to Follow-up|0|||
164604959|NCT00505752|594575863|FG003|Overall Study|Lost to Follow-up|0|||
164604960|NCT00505752|594575860|FG000|Overall Study|Lack of ovarian response|1|||
164604961|NCT00505752|594575861|FG001|Overall Study|Lack of ovarian response|3|||
164604962|NCT00505752|594575862|FG002|Overall Study|Lack of ovarian response|0|||
164604963|NCT00505752|594575863|FG003|Overall Study|Lack of ovarian response|0|||
164715807|NCT03289039|594982103|FG000|Overall Study|Withdrawal by Subject|0|||
164715808|NCT03289039|594982104|FG001|Overall Study|Withdrawal by Subject|1|||
164715809|NCT03289039|594982103|FG000|Overall Study|Became ineligible prior to treatment start|0|||
164715810|NCT03289039|594982104|FG001|Overall Study|Became ineligible prior to treatment start|1|||
164498351|NCT00874497|594195671|FG001|Overall Study|Met Withdrawal Criteria|2|||
164498352|NCT00874497|594195670|FG000|Overall Study|Physician Decision|1|||
164498353|NCT00874497|594195671|FG001|Overall Study|Physician Decision|1|||
164498354|NCT00874497|594195670|FG000|Overall Study|Withdrawal by Subject|5|||
164498355|NCT00874497|594195671|FG001|Overall Study|Withdrawal by Subject|4|||
164604964|NCT00505752|594575860|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
164604965|NCT00505752|594575861|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
164604966|NCT00505752|594575862|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
164604967|NCT00505752|594575863|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
164498356|NCT01013740|594195672|FG000|Overall Study|Lost to Follow-up|3|||
164498357|NCT01013740|594195673|FG001|Overall Study|Lost to Follow-up|5|||
164498358|NCT01013740|594195672|FG000|Overall Study|Physician Decision|2|||
164498359|NCT01013740|594195673|FG001|Overall Study|Physician Decision|0|||
164498360|NCT01013740|594195672|FG000|Overall Study|Withdrawal by Subject|2|||
164498361|NCT01013740|594195673|FG001|Overall Study|Withdrawal by Subject|10|||
164498362|NCT01013740|594195672|FG000|Overall Study|study close / terminated : done in error|2|||
164498363|NCT01013740|594195673|FG001|Overall Study|study close / terminated : done in error|1|||
164498364|NCT01013740|594195672|FG000|Overall Study|Missing|2|||
164498365|NCT01013740|594195673|FG001|Overall Study|Missing|1|||
164498366|NCT01013740|594195672|FG000|Overall Study|Ongoing: Study records not completed|0|||
164498367|NCT01013740|594195673|FG001|Overall Study|Ongoing: Study records not completed|2|||
164498368|NCT00607997|594195674|FG000|Overall Study|Lack of Efficacy|6|||
164498369|NCT00607997|594195675|FG001|Overall Study|Lack of Efficacy|20|||
164498370|NCT00607997|594195676|FG002|Overall Study|Lack of Efficacy|14|||
164498371|NCT00607997|594195677|FG003|Overall Study|Lack of Efficacy|10|||
164498372|NCT00607997|594195674|FG000|Overall Study|Death|8|||
164498373|NCT00607997|594195675|FG001|Overall Study|Death|5|||
164498374|NCT00607997|594195676|FG002|Overall Study|Death|2|||
164498375|NCT00607997|594195677|FG003|Overall Study|Death|5|||
164498376|NCT00607997|594195674|FG000|Overall Study|Adverse Event|3|||
164498377|NCT00607997|594195675|FG001|Overall Study|Adverse Event|1|||
164498378|NCT00607997|594195676|FG002|Overall Study|Adverse Event|2|||
164498379|NCT00607997|594195677|FG003|Overall Study|Adverse Event|0|||
164498380|NCT00607997|594195674|FG000|Overall Study|Physician Decision|4|||
164498381|NCT00607997|594195675|FG001|Overall Study|Physician Decision|1|||
164498382|NCT00607997|594195676|FG002|Overall Study|Physician Decision|0|||
164498383|NCT00607997|594195677|FG003|Overall Study|Physician Decision|0|||
164498384|NCT00607997|594195674|FG000|Overall Study|Relapse, recurrent illness|4|||
164498385|NCT00607997|594195675|FG001|Overall Study|Relapse, recurrent illness|0|||
164498386|NCT00607997|594195676|FG002|Overall Study|Relapse, recurrent illness|2|||
164498387|NCT00607997|594195677|FG003|Overall Study|Relapse, recurrent illness|0|||
164498388|NCT00607997|594195674|FG000|Overall Study|Other without explanation|2|||
164498389|NCT00607997|594195675|FG001|Overall Study|Other without explanation|0|||
164498390|NCT00607997|594195676|FG002|Overall Study|Other without explanation|4|||
164498391|NCT00607997|594195677|FG003|Overall Study|Other without explanation|1|||
164498392|NCT01527500|594195679|FG000|Part A|Administrative|11|||
164498393|NCT01527500|594195680|FG001|Part A|Administrative|7|||
164498394|NCT01527500|594195679|FG000|Part A|Adverse Event|4|||
164715811|NCT03289039|594982103|FG000|Overall Study|progressed before treatment start|1|||
164715812|NCT03289039|594982104|FG001|Overall Study|progressed before treatment start|0|||
164715813|NCT06492226|594982117|FG000|Overall Study|Protocol Violation|1|||
164715814|NCT06492226|594982118|FG001|Overall Study|Protocol Violation|0|||
164715815|NCT06492226|594982119|FG002|Overall Study|Protocol Violation|1|||
164715816|NCT06492226|594982120|FG003|Overall Study|Protocol Violation|0|||
164498395|NCT01527500|594195680|FG001|Part A|Adverse Event|2|||
164498396|NCT01527500|594195679|FG000|Part A|Death|4|||
164498397|NCT01527500|594195680|FG001|Part A|Death|1|||
164498398|NCT01527500|594195679|FG000|Part A|Lost to Follow-up|0|||
164498399|NCT01527500|594195680|FG001|Part A|Lost to Follow-up|1|||
164498400|NCT01527500|594195679|FG000|Part A|Protocol Deviation|9|||
164498401|NCT01527500|594195680|FG001|Part A|Protocol Deviation|2|||
164498402|NCT01527500|594195679|FG000|Part A|Withdrawal by Subject|2|||
164498403|NCT01527500|594195680|FG001|Part A|Withdrawal by Subject|0|||
164498404|NCT01527500|594195679|FG000|Part B|Adverse Event|1|||
164498405|NCT01527500|594195680|FG001|Part B|Adverse Event|0|||
164498406|NCT00372255|594195681|FG000|Overall Study|Withdrawn for other reasons|2|||
164498407|NCT00372255|594195682|FG001|Overall Study|Withdrawn for other reasons|1|||
164498408|NCT00776984|594195683|FG000|Overall Study|Adverse Event|8|||
164498409|NCT00776984|594195684|FG001|Overall Study|Adverse Event|2|||
164498410|NCT00776984|594195683|FG000|Overall Study|Protocol Violation|4|||
164498411|NCT00776984|594195684|FG001|Overall Study|Protocol Violation|2|||
164498412|NCT00776984|594195683|FG000|Overall Study|Lost to Follow-up|2|||
164715817|NCT06492226|594982121|FG004|Overall Study|Protocol Violation|0|||
164715818|NCT06492226|594982122|FG005|Overall Study|Protocol Violation|0|||
164715819|NCT05016960|594982123|FG000|Overall Study|Withdrawal by Subject|1|||
164498413|NCT00776984|594195684|FG001|Overall Study|Lost to Follow-up|0|||
164498414|NCT00776984|594195683|FG000|Overall Study|Withdrawal by Subject|12|||
164715820|NCT05016960|594982124|FG001|Overall Study|Withdrawal by Subject|9|||
164498415|NCT00776984|594195684|FG001|Overall Study|Withdrawal by Subject|7|||
164498416|NCT00776984|594195683|FG000|Overall Study|Lack of Efficacy|0|||
164498417|NCT00776984|594195684|FG001|Overall Study|Lack of Efficacy|1|||
164498418|NCT00776984|594195683|FG000|Overall Study|Other|5|||
164498419|NCT00776984|594195684|FG001|Overall Study|Other|9|||
164498420|NCT01544309|594195690|FG000|Overall Study|Withdrawal by Subject|12|||
164498421|NCT01544309|594195691|FG001|Overall Study|Withdrawal by Subject|7|||
164498422|NCT01544309|594195690|FG000|Overall Study|Protocol Violation|2|||
164498423|NCT01544309|594195691|FG001|Overall Study|Protocol Violation|1|||
164498424|NCT01544309|594195690|FG000|Overall Study|Physician Decision|4|||
164715821|NCT04825275|594982125|FG000|Overall Study|Withdrawal by Subject|1|||
164604968|NCT00505752|594575860|FG000|Overall Study|No oocytes retrieved|0|||
164604969|NCT00505752|594575861|FG001|Overall Study|No oocytes retrieved|2|||
164604970|NCT00505752|594575862|FG002|Overall Study|No oocytes retrieved|0|||
164604971|NCT00505752|594575863|FG003|Overall Study|No oocytes retrieved|1|||
164604972|NCT00505752|594575860|FG000|Overall Study|No Fertilization|1|||
164604973|NCT00505752|594575861|FG001|Overall Study|No Fertilization|1|||
164498425|NCT01544309|594195691|FG001|Overall Study|Physician Decision|1|||
164498426|NCT01544309|594195690|FG000|Overall Study|Not performed pre-dose examination|1|||
164498427|NCT01544309|594195691|FG001|Overall Study|Not performed pre-dose examination|2|||
164498428|NCT01544309|594195690|FG000|Overall Study|Administered prohibit prior medication|1|||
164498429|NCT01544309|594195691|FG001|Overall Study|Administered prohibit prior medication|0|||
164498430|NCT03078751|594195692|FG000|Overall Study|Adverse Event|4|||
164498431|NCT03078751|594195693|FG001|Overall Study|Adverse Event|0|||
164498432|NCT03078751|594195692|FG000|Overall Study|Physician Decision|1|||
164498433|NCT03078751|594195693|FG001|Overall Study|Physician Decision|0|||
164498434|NCT03078751|594195692|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
164498435|NCT03078751|594195693|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
164498436|NCT03078751|594195692|FG000|Overall Study|Subject/guardian decision|8|||
164498437|NCT03078751|594195693|FG001|Overall Study|Subject/guardian decision|1|||
164498438|NCT03078751|594195692|FG000|Overall Study|Untreated|0|||
164498439|NCT03078751|594195693|FG001|Overall Study|Untreated|4|||
164498440|NCT04414397|594195694|FG000|Control Period|Withdrawal by Subject|2|||
164498441|NCT04414397|594195695|FG001|Control Period|Withdrawal by Subject|2|||
164498442|NCT04414397|594195694|FG000|Control Period|Lost to Follow-up|0|||
164498443|NCT04414397|594195695|FG001|Control Period|Lost to Follow-up|4|||
164498444|NCT04414397|594195694|FG000|Control Period|Protocol deviation|0|||
164498445|NCT04414397|594195695|FG001|Control Period|Protocol deviation|1|||
164498446|NCT04414397|594195694|FG000|Post-Control Period|Withdrawal by Subject|3|||
164498447|NCT04414397|594195695|FG001|Post-Control Period|Withdrawal by Subject|6|||
164498448|NCT04414397|594195694|FG000|Post-Control Period|Lost to Follow-up|4|||
164498449|NCT04414397|594195695|FG001|Post-Control Period|Lost to Follow-up|9|||
164498450|NCT04414397|594195694|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
164498451|NCT04414397|594195695|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
164498452|NCT04414397|594195694|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
164498453|NCT04414397|594195695|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
164498454|NCT02515097|594195700|FG000|Overall Study|Lost to Follow-up|4|||
164498455|NCT02515097|594195701|FG001|Overall Study|Lost to Follow-up|2|||
164498456|NCT02515097|594195700|FG000|Overall Study|Withdrawal by Subject|1|||
164498457|NCT02515097|594195701|FG001|Overall Study|Withdrawal by Subject|3|||
164498458|NCT02515097|594195700|FG000|Overall Study|Adverse Event|2|||
164498459|NCT02515097|594195701|FG001|Overall Study|Adverse Event|1|||
164498460|NCT03640754|594195702|FG000|Overall Study|Withdrawal by Subject|1|||
164498461|NCT03640754|594195703|FG001|Overall Study|Withdrawal by Subject|0|||
164498462|NCT03640754|594195702|FG000|Overall Study|Lost to Follow-up|0|||
164498463|NCT03640754|594195703|FG001|Overall Study|Lost to Follow-up|1|||
164498464|NCT01204775|594195704|FG000|Overall Study|Poor/non-compliance|0|||
164498465|NCT01204775|594195705|FG001|Overall Study|Poor/non-compliance|1|||
164498466|NCT01204775|594195704|FG000|Overall Study|Withdrawal by Subject|1|||
164498467|NCT01204775|594195705|FG001|Overall Study|Withdrawal by Subject|0|||
164498468|NCT00276016|594195706|FG000|Intervention 1|Withdrawal by Subject|0|||
164498469|NCT00276016|594195707|FG001|Intervention 1|Withdrawal by Subject|1|||
164498470|NCT00276016|594195708|FG002|Intervention 1|Withdrawal by Subject|0|||
164498471|NCT00276016|594195709|FG003|Intervention 1|Withdrawal by Subject|0|||
164498472|NCT00276016|594195710|FG004|Intervention 1|Withdrawal by Subject|0|||
164498473|NCT00276016|594195711|FG005|Intervention 1|Withdrawal by Subject|0|||
164498474|NCT00509925|594195712|FG000|Overall Study|Personal reasons|0|||
164604974|NCT00505752|594575862|FG002|Overall Study|No Fertilization|2|||
164604975|NCT00505752|594575863|FG003|Overall Study|No Fertilization|1|||
164498475|NCT00509925|594195713|FG001|Overall Study|Personal reasons|1|||
164498476|NCT02799745|594195716|FG000|Overall Study|Participant moved out of state|1|||
164498477|NCT02799745|594195717|FG001|Overall Study|Participant moved out of state|0|||
164498478|NCT02799745|594195716|FG000|Overall Study|Discontinued due to planned surgery|1|||
164498479|NCT02799745|594195717|FG001|Overall Study|Discontinued due to planned surgery|0|||
164498480|NCT02799745|594195716|FG000|Overall Study|Withdrawal by Subject|16|||
164498481|NCT02799745|594195717|FG001|Overall Study|Withdrawal by Subject|25|||
164498482|NCT02799745|594195716|FG000|Overall Study|Protocol Deviation|4|||
164715822|NCT04825275|594982126|FG001|Overall Study|Withdrawal by Subject|0|||
164498483|NCT02799745|594195717|FG001|Overall Study|Protocol Deviation|5|||
164604976|NCT00505752|594575860|FG000|Overall Study|All embryos/blastocysts discarded|0|||
164604977|NCT00505752|594575861|FG001|Overall Study|All embryos/blastocysts discarded|0|||
164604978|NCT00505752|594575862|FG002|Overall Study|All embryos/blastocysts discarded|1|||
164604979|NCT00505752|594575863|FG003|Overall Study|All embryos/blastocysts discarded|1|||
164715823|NCT04993079|594982127|FG000|Overall Study|Screen Failure|4|||
164715824|NCT04993079|594982127|FG000|Overall Study|Failure to provide full consent|2|||
164498484|NCT02799745|594195716|FG000|Overall Study|Progressive Disease|28|||
164498485|NCT02799745|594195717|FG001|Overall Study|Progressive Disease|38|||
164498486|NCT02799745|594195716|FG000|Overall Study|Lost to Follow-up|3|||
164498487|NCT02799745|594195717|FG001|Overall Study|Lost to Follow-up|2|||
164498488|NCT02799745|594195716|FG000|Overall Study|Death|3|||
164498489|NCT02799745|594195717|FG001|Overall Study|Death|0|||
164498490|NCT02799745|594195716|FG000|Overall Study|Adverse Event|0|||
164498491|NCT02799745|594195717|FG001|Overall Study|Adverse Event|1|||
164498492|NCT01181609|594197670|FG000|Overall Study|Adverse Event|1|||
164498493|NCT01181609|594197670|FG000|Overall Study|Withdrawal by Subject|1|||
164498494|NCT01181609|594197670|FG000|Overall Study|Lost to Follow-up|1|||
164498495|NCT01181609|594197670|FG000|Overall Study|Death|50|||
164498496|NCT01333111|594197673|FG000|Overall Study|patient undergoing major surgery|0|||
164498497|NCT01333111|594197674|FG001|Overall Study|patient undergoing major surgery|2|||
164498498|NCT01333111|594197675|FG002|Overall Study|patient undergoing major surgery|0|||
164498499|NCT01333111|594197673|FG000|Overall Study|personal reasons|0|||
164498500|NCT01333111|594197674|FG001|Overall Study|personal reasons|0|||
164498501|NCT01333111|594197675|FG002|Overall Study|personal reasons|1|||
164498502|NCT01333111|594197673|FG000|Overall Study|unclassified|1|||
164498503|NCT01333111|594197674|FG001|Overall Study|unclassified|0|||
164498504|NCT01333111|594197675|FG002|Overall Study|unclassified|0|||
164498505|NCT01333111|594197673|FG000|Overall Study|withdrawal criteria|0|||
164498506|NCT01333111|594197674|FG001|Overall Study|withdrawal criteria|1|||
164498507|NCT01333111|594197675|FG002|Overall Study|withdrawal criteria|0|||
164498508|NCT01333111|594197673|FG000|Overall Study|Non-compliance|1|||
164498509|NCT01333111|594197674|FG001|Overall Study|Non-compliance|0|||
164498510|NCT01333111|594197675|FG002|Overall Study|Non-compliance|0|||
164498511|NCT01333111|594197673|FG000|Overall Study|Ineffective therapy|0|||
164498512|NCT01333111|594197674|FG001|Overall Study|Ineffective therapy|0|||
164498513|NCT01333111|594197675|FG002|Overall Study|Ineffective therapy|1|||
164498514|NCT00664105|594197678|FG000|Overall Study|Death|3|||
164498515|NCT00664105|594197678|FG000|Overall Study|Withdrawal by Subject|5|||
164498516|NCT00664105|594197678|FG000|Overall Study|Adverse Event|9|||
164498517|NCT00664105|594197678|FG000|Overall Study|Disease progression|7|||
164498518|NCT01929876|594197679|FG000|Period 2|Non-Compliance|1|||
164498519|NCT01468077|594197681|FG000|Overall Study|Adverse Event|2|||
164498520|NCT01468077|594197682|FG001|Overall Study|Adverse Event|2|||
164498521|NCT01468077|594197681|FG000|Overall Study|Lack of Efficacy|1|||
164498522|NCT01468077|594197682|FG001|Overall Study|Lack of Efficacy|1|||
164498523|NCT01468077|594197681|FG000|Overall Study|Physician Decision|1|||
164498524|NCT01468077|594197682|FG001|Overall Study|Physician Decision|0|||
164498525|NCT03991988|594197683|FG000|Overall Study|Withdrawal by Subject|2|||
164498526|NCT03991988|594197684|FG001|Overall Study|Withdrawal by Subject|2|||
164498527|NCT05446714|594197685|FG000|Overall Study|Lost to Follow-up|1|||
164498528|NCT05446714|594197686|FG001|Overall Study|Lost to Follow-up|3|||
164498529|NCT05446714|594197687|FG002|Overall Study|Lost to Follow-up|2|||
164498530|NCT05446714|594197685|FG000|Overall Study|Protocol Violation|2|||
164498531|NCT05446714|594197686|FG001|Overall Study|Protocol Violation|0|||
164498532|NCT05446714|594197687|FG002|Overall Study|Protocol Violation|0|||
164498533|NCT04333147|594197691|FG000|Overall Study|Adverse Event|43|||
164498534|NCT04333147|594197692|FG001|Overall Study|Adverse Event|40|||
164498535|NCT04333147|594197691|FG000|Overall Study|Lack of Efficacy|49|||
164498536|NCT04333147|594197692|FG001|Overall Study|Lack of Efficacy|48|||
164498537|NCT04333147|594197691|FG000|Overall Study|Lost to Follow-up|19|||
164498538|NCT04333147|594197692|FG001|Overall Study|Lost to Follow-up|16|||
164498539|NCT04333147|594197691|FG000|Overall Study|Physician Decision|17|||
164498540|NCT04333147|594197692|FG001|Overall Study|Physician Decision|20|||
164498541|NCT04333147|594197691|FG000|Overall Study|Withdrawal by Subject|65|||
164498542|NCT04333147|594197692|FG001|Overall Study|Withdrawal by Subject|68|||
164498543|NCT04333147|594197691|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
164498544|NCT04333147|594197692|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
164498545|NCT04333147|594197691|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
164604980|NCT00505752|594575860|FG000|Overall Study|Other|1|||
164498546|NCT04333147|594197692|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
164498547|NCT04333147|594197691|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
164498548|NCT04333147|594197692|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
164498549|NCT05006417|594197696|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
164498550|NCT02705625|594197697|FG000|Overall Study|Protocol Violation|1|||
164498551|NCT02705625|594197698|FG001|Overall Study|Protocol Violation|0|||
164498552|NCT02705625|594197699|FG002|Overall Study|Protocol Violation|0|||
164498553|NCT02705625|594197697|FG000|Overall Study|Adverse Event|6|||
164498554|NCT02705625|594197698|FG001|Overall Study|Adverse Event|5|||
164498555|NCT02705625|594197699|FG002|Overall Study|Adverse Event|2|||
164498556|NCT02705625|594197697|FG000|Overall Study|Death|0|||
164498557|NCT02705625|594197698|FG001|Overall Study|Death|0|||
164498558|NCT02705625|594197699|FG002|Overall Study|Death|1|||
164498559|NCT02705625|594197697|FG000|Overall Study|Withdrawal by Subject|1|||
164498560|NCT02705625|594197698|FG001|Overall Study|Withdrawal by Subject|4|||
164498561|NCT02705625|594197699|FG002|Overall Study|Withdrawal by Subject|5|||
164498562|NCT02705625|594197697|FG000|Overall Study|Lost to Follow-up|0|||
164604981|NCT00505752|594575861|FG001|Overall Study|Other|2|||
164604982|NCT00505752|594575862|FG002|Overall Study|Other|1|||
164498563|NCT02705625|594197698|FG001|Overall Study|Lost to Follow-up|0|||
164498564|NCT02705625|594197699|FG002|Overall Study|Lost to Follow-up|1|||
164498565|NCT02705625|594197697|FG000|Overall Study|Non-compliance|0|||
164498566|NCT02705625|594197698|FG001|Overall Study|Non-compliance|1|||
164498567|NCT02705625|594197699|FG002|Overall Study|Non-compliance|1|||
164498568|NCT02705625|594197697|FG000|Overall Study|Overdosing|0|||
164498569|NCT02705625|594197698|FG001|Overall Study|Overdosing|0|||
164604983|NCT00505752|594575863|FG003|Overall Study|Other|2|||
164604984|NCT01624506|594575864|FG000|Overall Study|Lost to Follow-up|29|||
164604985|NCT01624506|594575865|FG001|Overall Study|Lost to Follow-up|15|||
164604986|NCT01624506|594575864|FG000|Overall Study|Withdrawal by Subject|9|||
164498570|NCT02705625|594197699|FG002|Overall Study|Overdosing|1|||
164498571|NCT00195442|594197701|FG000|Overall Study|Less than expected therapeutic effect|38|||
164498572|NCT00195442|594197701|FG000|Overall Study|Lost to Follow-up|27|||
164498573|NCT00195442|594197701|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
164498574|NCT00195442|594197701|FG000|Overall Study|Intermittent product shortage|21|||
164498575|NCT00195442|594197701|FG000|Overall Study|Death|7|||
164498576|NCT00195442|594197701|FG000|Overall Study|No reason specified|4|||
164498577|NCT00195442|594197701|FG000|Overall Study|Poor cooperation|2|||
164498578|NCT00195442|594197701|FG000|Overall Study|Other|14|||
164498579|NCT01917006|594197702|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
164498580|NCT01917006|594197703|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
164498581|NCT01917006|594197704|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
164498582|NCT01917006|594197705|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
164498583|NCT01917006|594197706|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
164498584|NCT01917006|594197707|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
164498585|NCT01917006|594197708|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
164498586|NCT01917006|594197709|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
164498587|NCT01917006|594197702|FG000|Randomized-treatment Period|Personal Reasons|0|||
164498588|NCT01917006|594197703|FG001|Randomized-treatment Period|Personal Reasons|0|||
164498589|NCT01917006|594197704|FG002|Randomized-treatment Period|Personal Reasons|0|||
164498590|NCT01917006|594197705|FG003|Randomized-treatment Period|Personal Reasons|0|||
164498591|NCT01917006|594197706|FG004|Randomized-treatment Period|Personal Reasons|0|||
164498592|NCT01917006|594197707|FG005|Randomized-treatment Period|Personal Reasons|1|||
164498593|NCT01917006|594197708|FG006|Randomized-treatment Period|Personal Reasons|0|||
164498594|NCT01917006|594197709|FG007|Randomized-treatment Period|Personal Reasons|0|||
164498595|NCT01917006|594197702|FG000|Randomized-treatment Period|Protocol Violation|1|||
164498596|NCT01917006|594197703|FG001|Randomized-treatment Period|Protocol Violation|0|||
164498597|NCT01917006|594197704|FG002|Randomized-treatment Period|Protocol Violation|0|||
164498598|NCT01917006|594197705|FG003|Randomized-treatment Period|Protocol Violation|0|||
164498599|NCT01917006|594197706|FG004|Randomized-treatment Period|Protocol Violation|0|||
164498600|NCT01917006|594197707|FG005|Randomized-treatment Period|Protocol Violation|0|||
164498601|NCT01917006|594197708|FG006|Randomized-treatment Period|Protocol Violation|0|||
164498602|NCT01917006|594197709|FG007|Randomized-treatment Period|Protocol Violation|0|||
164498603|NCT01917006|594197702|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
164498604|NCT01917006|594197703|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
164498605|NCT01917006|594197704|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
164498606|NCT01917006|594197705|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
164498607|NCT01917006|594197706|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
164498608|NCT01917006|594197707|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
164498609|NCT01917006|594197708|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
164498610|NCT01917006|594197709|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
164604987|NCT01624506|594575865|FG001|Overall Study|Withdrawal by Subject|2|||
164604988|NCT01624506|594575864|FG000|Overall Study|Death|1|||
164604989|NCT01624506|594575865|FG001|Overall Study|Death|0|||
164604990|NCT01624506|594575864|FG000|Overall Study|LINX explants|23|||
164604991|NCT01624506|594575865|FG001|Overall Study|LINX explants|0|||
164604992|NCT01624506|594575864|FG000|Overall Study|Adverse Event|3|||
164604993|NCT01624506|594575865|FG001|Overall Study|Adverse Event|0|||
164604994|NCT01149343|594575866|FG000|Overall Study|Withdrawal by Subject|1|||
164604995|NCT01149343|594575867|FG001|Overall Study|Withdrawal by Subject|1|||
164604996|NCT01149343|594575868|FG002|Overall Study|Withdrawal by Subject|1|||
164604997|NCT01149343|594575869|FG003|Overall Study|Withdrawal by Subject|5|||
164498611|NCT01917006|594197702|FG000|Open-label Period|Adverse Event|0|||
164498612|NCT01917006|594197703|FG001|Open-label Period|Adverse Event|0|||
164498613|NCT01917006|594197704|FG002|Open-label Period|Adverse Event|0|||
164498614|NCT01917006|594197705|FG003|Open-label Period|Adverse Event|0|||
164498615|NCT01917006|594197706|FG004|Open-label Period|Adverse Event|0|||
164498616|NCT01917006|594197707|FG005|Open-label Period|Adverse Event|0|||
164498617|NCT01917006|594197708|FG006|Open-label Period|Adverse Event|0|||
164498618|NCT01917006|594197709|FG007|Open-label Period|Adverse Event|1|||
164498619|NCT01917006|594197702|FG000|Open-label Period|Lost to Follow-up|0|||
164498620|NCT01917006|594197703|FG001|Open-label Period|Lost to Follow-up|0|||
164498621|NCT01917006|594197704|FG002|Open-label Period|Lost to Follow-up|0|||
164498622|NCT01917006|594197705|FG003|Open-label Period|Lost to Follow-up|0|||
164498623|NCT01917006|594197706|FG004|Open-label Period|Lost to Follow-up|0|||
164498624|NCT01917006|594197707|FG005|Open-label Period|Lost to Follow-up|0|||
164498625|NCT01917006|594197708|FG006|Open-label Period|Lost to Follow-up|0|||
164498626|NCT01917006|594197709|FG007|Open-label Period|Lost to Follow-up|1|||
164498627|NCT00847132|594197710|FG000|Overall Study|Death|1|||
164498628|NCT00847132|594197711|FG001|Overall Study|Death|1|||
164498629|NCT01751165|594197713|FG000|Overall Study|Adverse event, serious fatal|1|||
164498630|NCT01751165|594197714|FG001|Overall Study|Adverse event, serious fatal|0|||
164498631|NCT01751165|594197715|FG002|Overall Study|Adverse event, serious fatal|1|||
164498632|NCT01751165|594197713|FG000|Overall Study|Withdrawal by Subject|0|||
164498633|NCT01751165|594197714|FG001|Overall Study|Withdrawal by Subject|0|||
164604998|NCT01149343|594575866|FG000|Overall Study|Death|10|||
164604999|NCT01149343|594575867|FG001|Overall Study|Death|13|||
164605000|NCT01149343|594575868|FG002|Overall Study|Death|18|||
164605001|NCT01149343|594575869|FG003|Overall Study|Death|18|||
164605002|NCT01149343|594575866|FG000|Overall Study|Lost to Follow-up|1|||
164605003|NCT01149343|594575867|FG001|Overall Study|Lost to Follow-up|0|||
164605004|NCT01149343|594575868|FG002|Overall Study|Lost to Follow-up|0|||
164605005|NCT01149343|594575869|FG003|Overall Study|Lost to Follow-up|1|||
164605006|NCT01149343|594575866|FG000|Overall Study|Other|8|||
164605007|NCT01149343|594575867|FG001|Overall Study|Other|10|||
164605008|NCT01149343|594575868|FG002|Overall Study|Other|2|||
164605009|NCT01149343|594575869|FG003|Overall Study|Other|14|||
164605010|NCT01149343|594575866|FG000|Overall Study|Sponsor study termination|0|||
164605011|NCT01149343|594575867|FG001|Overall Study|Sponsor study termination|0|||
164605012|NCT01149343|594575868|FG002|Overall Study|Sponsor study termination|0|||
164605013|NCT01149343|594575869|FG003|Overall Study|Sponsor study termination|2|||
164605014|NCT01149343|594575866|FG000|Overall Study|Recurrence / Progressive disease|0|||
164605015|NCT01149343|594575867|FG001|Overall Study|Recurrence / Progressive disease|0|||
164605016|NCT01149343|594575868|FG002|Overall Study|Recurrence / Progressive disease|1|||
164605017|NCT01149343|594575869|FG003|Overall Study|Recurrence / Progressive disease|0|||
164605018|NCT03472040|594575883|FG000|Overall Study|Physician Decision|0|||
164605019|NCT03472040|594575884|FG001|Overall Study|Physician Decision|3|||
164605020|NCT03472040|594575883|FG000|Overall Study|Withdrawal by Subject|10|||
164605021|NCT03472040|594575884|FG001|Overall Study|Withdrawal by Subject|23|||
164605022|NCT03472040|594575883|FG000|Overall Study|Perceived Lack of Efficacy|29|||
164605023|NCT03472040|594575884|FG001|Overall Study|Perceived Lack of Efficacy|30|||
164605024|NCT03472040|594575883|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
164605025|NCT03472040|594575884|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
164605026|NCT03472040|594575883|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
164605027|NCT03472040|594575884|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
164605028|NCT03472040|594575883|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
164605029|NCT03472040|594575884|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
164605030|NCT03472040|594575883|FG000|Overall Study|Subject Non-compliance|2|||
164605031|NCT03472040|594575884|FG001|Overall Study|Subject Non-compliance|5|||
164605032|NCT03472040|594575883|FG000|Overall Study|Discontinuation due to Rash|0|||
164605033|NCT03472040|594575884|FG001|Overall Study|Discontinuation due to Rash|1|||
164605034|NCT03472040|594575883|FG000|Overall Study|Subsequent Ineligibility|0|||
164605035|NCT03472040|594575884|FG001|Overall Study|Subsequent Ineligibility|2|||
164605036|NCT03472040|594575883|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
164605037|NCT03472040|594575884|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
164605038|NCT02769832|594575885|FG000|Overall Study|Death|30|||
164605039|NCT01114373|594575887|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
164605040|NCT01114373|594575888|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
164605041|NCT01114373|594575887|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
164605042|NCT01114373|594575888|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
164605043|NCT01114373|594575887|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
164605044|NCT01114373|594575888|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
164605045|NCT01114373|594575887|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
164605046|NCT01114373|594575888|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
164605047|NCT03444870|594575889|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
164605048|NCT03444870|594575890|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
164605049|NCT03444870|594575891|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
164605050|NCT03444870|594575892|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
164605051|NCT03444870|594575893|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
164605052|NCT03444870|594575894|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
164605053|NCT03444870|594575889|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
164605054|NCT03444870|594575890|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
164498634|NCT01751165|594197715|FG002|Overall Study|Withdrawal by Subject|1|||
164498635|NCT01751165|594197713|FG000|Overall Study|Serious adverse event|0|||
164605055|NCT03444870|594575891|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
164605056|NCT03444870|594575892|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
164605057|NCT03444870|594575893|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
164605058|NCT03444870|594575894|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
164605059|NCT03444870|594575889|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
164605060|NCT03444870|594575890|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
164605061|NCT03444870|594575891|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
164605062|NCT03444870|594575892|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
164605063|NCT03444870|594575893|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
164605064|NCT03444870|594575894|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
164605065|NCT03444870|594575889|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
164605066|NCT03444870|594575890|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
164605067|NCT03444870|594575891|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
164605068|NCT03444870|594575892|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
164605069|NCT03444870|594575893|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
164605070|NCT03444870|594575894|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
164605071|NCT03444870|594575889|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
164605072|NCT03444870|594575890|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
164605073|NCT03444870|594575891|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
164605074|NCT03444870|594575892|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
164605075|NCT03444870|594575893|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
164498636|NCT01751165|594197714|FG001|Overall Study|Serious adverse event|2|||
164498637|NCT01751165|594197715|FG002|Overall Study|Serious adverse event|0|||
164498638|NCT01751165|594197713|FG000|Overall Study|Lost to Follow-up|1|||
164498639|NCT01751165|594197714|FG001|Overall Study|Lost to Follow-up|1|||
164498640|NCT01751165|594197715|FG002|Overall Study|Lost to Follow-up|1|||
164498641|NCT00988533|594197716|FG000|Overall Study|Lost to Follow-up|3|||
164498642|NCT01036165|594197717|FG000|Overall Study|Adverse Event|6|||
164498643|NCT01036165|594197717|FG000|Overall Study|Lost to Follow-up|2|||
164498644|NCT01036165|594197717|FG000|Overall Study|Withdrawal by Subject|3|||
164498645|NCT01036165|594197717|FG000|Overall Study|Device Related Issues|3|||
164498646|NCT01036165|594197717|FG000|Overall Study|Problems finding proper area to inject|1|||
164498647|NCT00913523|594197720|FG000|Overall Study|Withdrawal by Subject|3|||
164498648|NCT00913523|594197721|FG001|Overall Study|Withdrawal by Subject|2|||
164498649|NCT00913523|594197722|FG002|Overall Study|Withdrawal by Subject|2|||
164498650|NCT00913523|594197720|FG000|Overall Study|Lost to Follow-up|1|||
164498651|NCT00913523|594197721|FG001|Overall Study|Lost to Follow-up|1|||
164498652|NCT00913523|594197722|FG002|Overall Study|Lost to Follow-up|1|||
164498653|NCT00913523|594197720|FG000|Overall Study|Adverse Event|1|||
164498654|NCT00913523|594197721|FG001|Overall Study|Adverse Event|0|||
164498655|NCT00913523|594197722|FG002|Overall Study|Adverse Event|0|||
164498656|NCT00913523|594197720|FG000|Overall Study|Protocol Violation|5|||
164498657|NCT00913523|594197721|FG001|Overall Study|Protocol Violation|8|||
164498658|NCT00913523|594197722|FG002|Overall Study|Protocol Violation|8|||
164498659|NCT00913523|594197720|FG000|Overall Study|Pregnancy|1|||
164498660|NCT00913523|594197721|FG001|Overall Study|Pregnancy|3|||
164498661|NCT00913523|594197722|FG002|Overall Study|Pregnancy|0|||
164498662|NCT00913523|594197720|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
164498663|NCT00913523|594197721|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
164498664|NCT00913523|594197722|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
164498665|NCT01202409|594197724|FG000|Overall Study|Adverse Event|1|||
164498666|NCT01202409|594197724|FG000|Overall Study|Ineligible - KRAS mutants|7|||
164498667|NCT01732926|594197727|FG000|Overall Study|Study Terminated by Sponsor|168|||
164498668|NCT01732926|594197728|FG001|Overall Study|Study Terminated by Sponsor|80|||
164498669|NCT01732926|594197727|FG000|Overall Study|Withdrawal by Subject|46|||
164605076|NCT03444870|594575894|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
164605077|NCT03444870|594575889|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
164715825|NCT05569174|594982139|FG000|Overall Study|Adverse Event|0|||
164498670|NCT01732926|594197728|FG001|Overall Study|Withdrawal by Subject|8|||
164498671|NCT01732926|594197727|FG000|Overall Study|Physician Decision|24|||
164498672|NCT01732926|594197728|FG001|Overall Study|Physician Decision|11|||
164498673|NCT01732926|594197727|FG000|Overall Study|Other Reason|21|||
164498674|NCT01732926|594197728|FG001|Overall Study|Other Reason|4|||
164498675|NCT01732926|594197727|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
164498676|NCT01732926|594197728|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
164498677|NCT01732926|594197727|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
164498678|NCT01732926|594197728|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
164498679|NCT03036150|594197731|FG000|Overall Study|Withdrawal by Subject|8|||
164498680|NCT03036150|594197732|FG001|Overall Study|Withdrawal by Subject|3|||
164498681|NCT03036150|594197731|FG000|Overall Study|Lost to Follow-up|2|||
164498682|NCT03036150|594197732|FG001|Overall Study|Lost to Follow-up|2|||
164498683|NCT02741713|594197741|FG000|Overall Study|Surgery type changed intra-operatively|2|||
164498684|NCT02741713|594197742|FG001|Overall Study|Surgery type changed intra-operatively|1|||
164498685|NCT00496626|594197743|FG000|Overall Study|Lost to Follow-up|0|||
164498686|NCT00496626|594197744|FG001|Overall Study|Lost to Follow-up|1|||
164498687|NCT00496626|594197743|FG000|Overall Study|Protocol Violation|1|||
164498688|NCT00496626|594197744|FG001|Overall Study|Protocol Violation|0|||
164498689|NCT00496626|594197743|FG000|Overall Study|Withdrawal by Subject|5|||
164498690|NCT00496626|594197744|FG001|Overall Study|Withdrawal by Subject|4|||
164498691|NCT00496626|594197743|FG000|Overall Study|Relocated|0|||
164498692|NCT00496626|594197744|FG001|Overall Study|Relocated|1|||
164498693|NCT00570921|594197745|FG000|Overall Study|Protocol Violation|1|||
164498694|NCT00570921|594197745|FG000|Overall Study|Physician Decision|1|||
164498695|NCT04191148|594197746|FG000|Overall Study|Withdrawal by Subject|1|||
164498696|NCT04191148|594197747|FG001|Overall Study|Withdrawal by Subject|0|||
164498697|NCT04191148|594197746|FG000|Overall Study|Adverse Event|1|||
164498698|NCT04191148|594197747|FG001|Overall Study|Adverse Event|0|||
164498699|NCT02447432|594197748|FG000|Epoch 001|Adverse Event|1|||
164498700|NCT02447432|594197749|FG001|Epoch 001|Adverse Event|1|||
164498701|NCT02447432|594197748|FG000|Epoch 001|Withdrawal by Subject|0|||
164498702|NCT02447432|594197749|FG001|Epoch 001|Withdrawal by Subject|4|||
164498703|NCT02447432|594197748|FG000|Epoch 001|Migrated/moved from study area|3|||
164498704|NCT02447432|594197749|FG001|Epoch 001|Migrated/moved from study area|5|||
164498705|NCT02447432|594197748|FG000|Epoch 001|Lost to Follow-up|1|||
164498706|NCT02447432|594197749|FG001|Epoch 001|Lost to Follow-up|3|||
164498707|NCT02647788|594197750|FG000|Overall Study|Lost to Follow-up|13|||
164498708|NCT02647788|594197751|FG001|Overall Study|Lost to Follow-up|11|||
164498709|NCT02647788|594197750|FG000|Overall Study|Did not want opiate|0|||
164498710|NCT02647788|594197751|FG001|Overall Study|Did not want opiate|1|||
164498711|NCT02647788|594197750|FG000|Overall Study|Withdrawal by Subject|1|||
164498712|NCT02647788|594197751|FG001|Overall Study|Withdrawal by Subject|0|||
164498713|NCT02647788|594197750|FG000|Overall Study|Felt itchy with assigned medication|1|||
164498714|NCT02647788|594197751|FG001|Overall Study|Felt itchy with assigned medication|0|||
164498715|NCT02647788|594197750|FG000|Overall Study|Felt nauseous with assigned medication|1|||
164498716|NCT02647788|594197751|FG001|Overall Study|Felt nauseous with assigned medication|1|||
164498717|NCT01274559|594197754|FG000|Overall Study|Adverse Event|57|||
164498718|NCT01274559|594197755|FG001|Overall Study|Adverse Event|13|||
164498719|NCT01274559|594197754|FG000|Overall Study|Death|1|||
164498720|NCT01274559|594197755|FG001|Overall Study|Death|1|||
164498721|NCT01274559|594197754|FG000|Overall Study|Lost to Follow-up|3|||
164498722|NCT01274559|594197755|FG001|Overall Study|Lost to Follow-up|3|||
164498723|NCT01274559|594197754|FG000|Overall Study|Non-compliance with Study Drug|2|||
164715826|NCT05569174|594982140|FG001|Overall Study|Adverse Event|1|||
164715827|NCT05569174|594982139|FG000|Overall Study|Lack of compliance|0|||
164715828|NCT05569174|594982140|FG001|Overall Study|Lack of compliance|1|||
164715829|NCT05569174|594982139|FG000|Overall Study|Withdrawal of consent|0|||
164715830|NCT05569174|594982140|FG001|Overall Study|Withdrawal of consent|1|||
164715831|NCT05569174|594982139|FG000|Overall Study|Participant wish|0|||
164715832|NCT05569174|594982140|FG001|Overall Study|Participant wish|1|||
164715833|NCT05569174|594982139|FG000|Overall Study|Lost to Follow-up|0|||
164715834|NCT05569174|594982140|FG001|Overall Study|Lost to Follow-up|1|||
164715835|NCT03794349|594982144|FG000|Overall Study|Adverse Event|2|||
164715836|NCT03794349|594982145|FG001|Overall Study|Adverse Event|3|||
164715837|NCT03794349|594982144|FG000|Overall Study|Death|0|||
164715838|NCT03794349|594982145|FG001|Overall Study|Death|2|||
164715839|NCT03794349|594982144|FG000|Overall Study|Physician Decision|10|||
164715840|NCT03794349|594982145|FG001|Overall Study|Physician Decision|8|||
164498724|NCT01274559|594197755|FG001|Overall Study|Non-compliance with Study Drug|4|||
164715841|NCT03794349|594982144|FG000|Overall Study|Withdrawal by Subject|1|||
164498725|NCT01274559|594197754|FG000|Overall Study|Physician Decision|2|||
164498726|NCT01274559|594197755|FG001|Overall Study|Physician Decision|1|||
164498727|NCT01274559|594197754|FG000|Overall Study|Protocol Violation|28|||
164715842|NCT03794349|594982145|FG001|Overall Study|Withdrawal by Subject|3|||
164715843|NCT03794349|594982144|FG000|Overall Study|Ineligible|2|||
164715844|NCT03794349|594982145|FG001|Overall Study|Ineligible|1|||
164498728|NCT01274559|594197755|FG001|Overall Study|Protocol Violation|23|||
164498729|NCT01274559|594197754|FG000|Overall Study|Study Terminated by Sponsor|79|||
164498730|NCT01274559|594197755|FG001|Overall Study|Study Terminated by Sponsor|87|||
164498731|NCT01274559|594197754|FG000|Overall Study|Withdrawal by Subject|25|||
164498732|NCT01274559|594197755|FG001|Overall Study|Withdrawal by Subject|13|||
164498733|NCT02482935|594197769|FG000|Period 1|Withdrawal by Subject|1|||
164498734|NCT02482935|594197770|FG001|Period 1|Withdrawal by Subject|0|||
164715845|NCT03794349|594982144|FG000|Overall Study|Refusal|2|||
164715846|NCT03794349|594982145|FG001|Overall Study|Refusal|3|||
164715847|NCT03794349|594982144|FG000|Overall Study|Progressive Disease|7|||
164498735|NCT03503162|594197771|FG000|Overall Study|did not meet eligibility|1|||
164498736|NCT02835092|594197772|FG000|Overall Study|Withdrawal by Subject|3|||
164498737|NCT02835092|594197773|FG001|Overall Study|Withdrawal by Subject|6|||
164498738|NCT02835092|594197774|FG002|Overall Study|Withdrawal by Subject|3|||
164498739|NCT02835092|594197772|FG000|Overall Study|Lost to Follow-up|0|||
164498740|NCT02835092|594197773|FG001|Overall Study|Lost to Follow-up|2|||
164498741|NCT02835092|594197774|FG002|Overall Study|Lost to Follow-up|0|||
164498742|NCT00025506|594197775|FG000|Overall Study|Ineligible: clerical error|1|||
164498743|NCT00025506|594197775|FG000|Overall Study|Ineligible: wrong cell type|5|||
164498744|NCT00025506|594197775|FG000|Overall Study|Ineligible: inadequate pathology|2|||
164498745|NCT00025506|594197775|FG000|Overall Study|Never Treated|2|||
164498746|NCT02561806|594197776|FG000|Induction Period|Adverse Event|0|||
164498747|NCT02561806|594197777|FG001|Induction Period|Adverse Event|2|||
164498748|NCT02561806|594197776|FG000|Induction Period|Lack of Efficacy|1|||
164498749|NCT02561806|594197777|FG001|Induction Period|Lack of Efficacy|0|||
164498750|NCT02561806|594197776|FG000|Induction Period|Withdrawal by Subject|0|||
164498751|NCT02561806|594197777|FG001|Induction Period|Withdrawal by Subject|2|||
164498752|NCT02561806|594197776|FG000|Induction Period|Site staff became unblinded|1|||
164498753|NCT02561806|594197777|FG001|Induction Period|Site staff became unblinded|0|||
164498754|NCT02561806|594197776|FG000|Induction Period|Randomized but not treated|0|||
164498755|NCT02561806|594197777|FG001|Induction Period|Randomized but not treated|1|||
164498756|NCT02561806|594197776|FG000|Maintenance Period|Adverse Event|2|||
164498757|NCT02561806|594197777|FG001|Maintenance Period|Adverse Event|1|||
164498758|NCT02561806|594197776|FG000|Maintenance Period|Lack of Efficacy|3|||
164498759|NCT02561806|594197777|FG001|Maintenance Period|Lack of Efficacy|1|||
164498760|NCT02561806|594197776|FG000|Maintenance Period|Lost to Follow-up|2|||
164498761|NCT02561806|594197777|FG001|Maintenance Period|Lost to Follow-up|2|||
164498762|NCT02561806|594197776|FG000|Maintenance Period|Protocol Violation|1|||
164498763|NCT02561806|594197777|FG001|Maintenance Period|Protocol Violation|0|||
164498764|NCT02561806|594197776|FG000|Maintenance Period|Withdrawal by Subject|5|||
164498765|NCT02561806|594197777|FG001|Maintenance Period|Withdrawal by Subject|3|||
164498766|NCT02561806|594197776|FG000|Maintenance Period|Site staff became unblinded|0|||
164498767|NCT02561806|594197777|FG001|Maintenance Period|Site staff became unblinded|1|||
164498768|NCT02561806|594197776|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
164498769|NCT02561806|594197777|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
164498770|NCT02561806|594197776|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
164498771|NCT02561806|594197777|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
164498772|NCT01585298|594197779|FG000|Overall Study|Study completion was not documented.|1|||
164498773|NCT01585298|594197779|FG000|Overall Study|Protocol deviation|1|||
164498774|NCT01585298|594197779|FG000|Overall Study|Administrative problems|4|||
164498775|NCT01585298|594197779|FG000|Overall Study|Lost to Follow-up|2|||
164498776|NCT01585298|594197779|FG000|Overall Study|Withdrawal by Subject|4|||
164498777|NCT01585298|594197779|FG000|Overall Study|Abnormal test procedure results|1|||
164498778|NCT01585298|594197779|FG000|Overall Study|Adverse Event|24|||
164498779|NCT01670188|594197782|FG000|Overall Study|Death|0|||
164498780|NCT01670188|594197783|FG001|Overall Study|Death|1|||
164498781|NCT02427958|594197788|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
164498782|NCT02427958|594197788|FG000|Overall Study|Lost to Follow-up|6|||
164498783|NCT02427958|594197788|FG000|Overall Study|Withdrawal by Subject|14|||
164498784|NCT02427958|594197788|FG000|Overall Study|Lack of Efficacy|1|||
164498785|NCT00578318|594197789|FG000|Overall Study|Lost to Follow-up|2|||
164498786|NCT00578318|594197790|FG001|Overall Study|Lost to Follow-up|0|||
164498787|NCT00578318|594197789|FG000|Overall Study|Physician Decision|1|||
164498788|NCT00578318|594197790|FG001|Overall Study|Physician Decision|0|||
164498789|NCT00591591|594197794|FG000|Overall Study|Withdrawal by Subject|1|||
164498790|NCT00591591|594197795|FG001|Overall Study|Withdrawal by Subject|37|||
164498791|NCT00591591|594197794|FG000|Overall Study|Lack of Efficacy|10|||
164498792|NCT00591591|594197795|FG001|Overall Study|Lack of Efficacy|2|||
164498793|NCT00002597|594197796|FG000|Overall Study|Protocol Violation|19|||
164498794|NCT00002597|594197797|FG001|Overall Study|Protocol Violation|17|||
164498795|NCT00002597|594197796|FG000|Overall Study|Withdrawal by Subject|7|||
164498796|NCT00002597|594197797|FG001|Overall Study|Withdrawal by Subject|6|||
164498797|NCT00912223|594197798|FG000|Overall Study|Withdrawal by Subject|1|||
164498798|NCT00912223|594197798|FG000|Overall Study|Not transplanted|1|||
164498799|NCT00912223|594197798|FG000|Overall Study|Transformed disease|1|||
164715848|NCT03794349|594982145|FG001|Overall Study|Progressive Disease|10|||
164715849|NCT03794349|594982144|FG000|Overall Study|Stable Disease after 6 Cycles|4|||
164498800|NCT01242371|594197802|FG000|Overall Study|Withdrawal by Subject|2|||
164498801|NCT01242371|594197803|FG001|Overall Study|Withdrawal by Subject|2|||
164498802|NCT01242371|594197802|FG000|Overall Study|Protocol Violation|0|||
164498803|NCT01242371|594197803|FG001|Overall Study|Protocol Violation|3|||
164498804|NCT00510146|594197804|FG000|Double-Blind Treatment|Adverse Event|30|||
164498805|NCT00510146|594197805|FG001|Double-Blind Treatment|Adverse Event|13|||
164498806|NCT00510146|594197804|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
164498807|NCT00510146|594197805|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
164498808|NCT00510146|594197804|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
164498809|NCT00510146|594197805|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
164498810|NCT00510146|594197804|FG000|Double-Blind Treatment|Physician Decision|6|||
164498811|NCT00510146|594197805|FG001|Double-Blind Treatment|Physician Decision|0|||
164498812|NCT00510146|594197804|FG000|Double-Blind Treatment|Protocol Violation|1|||
164498813|NCT00510146|594197805|FG001|Double-Blind Treatment|Protocol Violation|2|||
164498814|NCT00510146|594197804|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
164498815|NCT00510146|594197805|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
164498816|NCT00510146|594197804|FG000|Double-Blind Treatment|Clinical Relapse|0|||
164498817|NCT00510146|594197805|FG001|Double-Blind Treatment|Clinical Relapse|1|||
164498818|NCT00510146|594197804|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
164498819|NCT00510146|594197805|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
164498820|NCT00510146|594197804|FG000|Open-Label Treatment|Adverse Event|22|||
164498821|NCT00510146|594197805|FG001|Open-Label Treatment|Adverse Event|8|||
164498822|NCT00510146|594197804|FG000|Open-Label Treatment|Death|1|||
164498823|NCT00510146|594197805|FG001|Open-Label Treatment|Death|1|||
164498824|NCT00510146|594197804|FG000|Open-Label Treatment|Lack of Efficacy|4|||
164498825|NCT00510146|594197805|FG001|Open-Label Treatment|Lack of Efficacy|0|||
164498826|NCT00510146|594197804|FG000|Open-Label Treatment|Lost to Follow-up|10|||
164498827|NCT00510146|594197805|FG001|Open-Label Treatment|Lost to Follow-up|1|||
164498828|NCT00510146|594197804|FG000|Open-Label Treatment|Physician Decision|3|||
164498829|NCT00510146|594197805|FG001|Open-Label Treatment|Physician Decision|1|||
164498830|NCT00510146|594197804|FG000|Open-Label Treatment|Protocol Violation|4|||
164498831|NCT00510146|594197805|FG001|Open-Label Treatment|Protocol Violation|2|||
164498832|NCT00510146|594197804|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
164498833|NCT00510146|594197805|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
164498834|NCT00510146|594197804|FG000|Open-Label Treatment|Clinical Relapse|1|||
164498835|NCT00510146|594197805|FG001|Open-Label Treatment|Clinical Relapse|1|||
164498836|NCT00510146|594197804|FG000|Open-Label Treatment|Sponsor Decision|2|||
164498837|NCT00510146|594197805|FG001|Open-Label Treatment|Sponsor Decision|0|||
164498838|NCT06080438|594197808|FG000|Overall Study|Lost to Follow-up|2|||
164498839|NCT00025662|594197809|FG000|Overall Study|Withdrawal by Subject|2|||
164498840|NCT00025662|594197809|FG000|Overall Study|Technical failure of manipulation|1|||
164498841|NCT00808899|594197811|FG000|Overall Study|Death|1|||
164498842|NCT00808899|594197811|FG000|Overall Study|Physician Decision|3|||
164498843|NCT04088500|594197812|FG000|Overall Study|Reason unknown|1|||
164498844|NCT04088500|594197812|FG000|Overall Study|Participant withdrew consent|1|||
164498845|NCT04088500|594197812|FG000|Overall Study|Disease progression|3|||
164498846|NCT02212197|594197813|FG000|Overall Study|Need for radiotherapy|1|||
164498847|NCT02212197|594197814|FG001|Overall Study|Need for radiotherapy|0|||
164498848|NCT02212197|594197815|FG002|Overall Study|Need for radiotherapy|0|||
164498849|NCT01078584|594197818|FG000|Overall Study|Final Status Unknown|1073|||
164498850|NCT01078584|594197818|FG000|Overall Study|Lost to Follow-up|670|||
164498851|NCT01078584|594197818|FG000|Overall Study|Non-serious Adverse Event|577|||
164498852|NCT01078584|594197818|FG000|Overall Study|Withdrawal of Consent|244|||
164498853|NCT01078584|594197818|FG000|Overall Study|Physician Withdrew from Study|90|||
164498854|NCT01078584|594197818|FG000|Overall Study|Non-compliance|67|||
164498855|NCT01078584|594197818|FG000|Overall Study|Blood Pressure Controlled|49|||
164498856|NCT01078584|594197818|FG000|Overall Study|Physician Switched Medication|26|||
164498857|NCT01078584|594197818|FG000|Overall Study|Physician Discontinued Patient|12|||
164498858|NCT01078584|594197818|FG000|Overall Study|Lack of Efficacy|98|||
164605078|NCT03444870|594575890|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
164498859|NCT01078584|594197818|FG000|Overall Study|Protocol Violation|75|||
164605079|NCT03444870|594575891|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
164605080|NCT03444870|594575892|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
164605081|NCT03444870|594575893|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
164605082|NCT03444870|594575894|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
164605083|NCT03444870|594575889|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
164605084|NCT03444870|594575890|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
164605085|NCT03444870|594575891|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
164605086|NCT03444870|594575892|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
164605087|NCT03444870|594575893|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
164605088|NCT03444870|594575894|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
164605089|NCT03444870|594575889|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
164605090|NCT03444870|594575890|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
164605091|NCT03444870|594575891|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
164605092|NCT03444870|594575892|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
164605093|NCT03444870|594575893|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
164605094|NCT03444870|594575894|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
164605095|NCT03444870|594575889|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
164605096|NCT03444870|594575890|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
164605097|NCT03444870|594575891|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
164605098|NCT03444870|594575892|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
164605099|NCT03444870|594575893|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
164715850|NCT03794349|594982145|FG001|Overall Study|Stable Disease after 6 Cycles|1|||
164715851|NCT03794349|594982144|FG000|Overall Study|Did not meet criteria to start next treatment cycle within 21 days after planned start of next cycle|4|||
164715852|NCT03794349|594982145|FG001|Overall Study|Did not meet criteria to start next treatment cycle within 21 days after planned start of next cycle|1|||
164715853|NCT03794349|594982144|FG000|Overall Study|Repeat eligibility studies before start of protocol therapy outside required eligibility parameters|1|||
164715854|NCT03794349|594982145|FG001|Overall Study|Repeat eligibility studies before start of protocol therapy outside required eligibility parameters|0|||
164715855|NCT05755711|594982146|FG000|Overall Study|Death|8|||
164715856|NCT05755711|594982146|FG000|Overall Study|Withdrawal by Subject|2|||
164715857|NCT05467397|594982152|FG000|Overall Study|One patient became ineligible after undergoing a renal procedure.|1|||
164498860|NCT01078584|594197818|FG000|Overall Study|Serious Adverse Event|27|||
164498861|NCT01078584|594197818|FG000|Overall Study|Multiple Reasons|2|||
164498862|NCT01208870|594197819|FG000|Overall Study|Lost to Follow-up|2|||
164498863|NCT01208870|594197820|FG001|Overall Study|Lost to Follow-up|8|||
164498864|NCT02979613|594197821|FG000|Double-Blind Phase|Withdrew Consent|2|||
164498865|NCT02979613|594197822|FG001|Double-Blind Phase|Withdrew Consent|4|||
164498866|NCT02979613|594197821|FG000|Double-Blind Phase|Pregnancy|2|||
164498867|NCT02979613|594197822|FG001|Double-Blind Phase|Pregnancy|2|||
164498868|NCT02979613|594197821|FG000|Double-Blind Phase|Adverse Event|2|||
164498869|NCT02979613|594197822|FG001|Double-Blind Phase|Adverse Event|0|||
164498870|NCT02979613|594197821|FG000|Double-Blind Phase|Lost to Follow-up|1|||
164498871|NCT02979613|594197822|FG001|Double-Blind Phase|Lost to Follow-up|1|||
164498872|NCT02979613|594197821|FG000|Double-Blind Phase|Protocol Violation|1|||
164498873|NCT02979613|594197822|FG001|Double-Blind Phase|Protocol Violation|1|||
164498874|NCT02979613|594197821|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
164498875|NCT02979613|594197822|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
164498876|NCT02979613|594197821|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
164498877|NCT02979613|594197822|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
164498878|NCT02979613|594197821|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
164498879|NCT02979613|594197822|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
164498880|NCT02979613|594197821|FG000|Open-Label Extension (OLE) Phase|Death|0|||
164498881|NCT02979613|594197822|FG001|Open-Label Extension (OLE) Phase|Death|1|||
164498882|NCT02979613|594197821|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
164498883|NCT02979613|594197822|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
164498884|NCT04380688|594197823|FG000|Overall Study|Death|2|||
164498885|NCT04380688|594197824|FG001|Overall Study|Death|2|||
164498886|NCT04380688|594197823|FG000|Overall Study|Lost to Follow-up|2|||
164498887|NCT04380688|594197824|FG001|Overall Study|Lost to Follow-up|4|||
164498888|NCT04380688|594197823|FG000|Overall Study|Withdrawal by Subject|3|||
164498889|NCT04380688|594197824|FG001|Overall Study|Withdrawal by Subject|3|||
164498890|NCT00919061|594197827|FG000|Overall Study|Adverse Event|1|||
164498891|NCT00919061|594197827|FG000|Overall Study|Withdrawal by Subject|1|||
164498892|NCT02056873|594197828|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
164498893|NCT02388347|594200021|FG000|Overall Study|Withdrawal by Subject|0|||
164498894|NCT02388347|594200022|FG001|Overall Study|Withdrawal by Subject|0|||
164498895|NCT02388347|594200023|FG002|Overall Study|Withdrawal by Subject|1|||
164498896|NCT02388347|594200024|FG003|Overall Study|Withdrawal by Subject|0|||
164498897|NCT02388347|594200025|FG004|Overall Study|Withdrawal by Subject|0|||
164498898|NCT04051242|594200026|FG000|Overall Study|Withdrawal by Subject|1|||
164498899|NCT04051242|594200026|FG000|Overall Study|Physician Decision|1|||
164498900|NCT01649297|594200027|FG000|Overall Study|Adverse Event|5|||
164498901|NCT01649297|594200028|FG001|Overall Study|Adverse Event|5|||
164498902|NCT01649297|594200029|FG002|Overall Study|Adverse Event|4|||
164715858|NCT01494662|594982156|FG000|Overall Study|Withdrawal by Subject|0|||
164715859|NCT01494662|594982157|FG001|Overall Study|Withdrawal by Subject|0|||
164715860|NCT01494662|594982158|FG002|Overall Study|Withdrawal by Subject|1|||
164715861|NCT01494662|594982159|FG003|Overall Study|Withdrawal by Subject|0|||
164715862|NCT01494662|594982160|FG004|Overall Study|Withdrawal by Subject|0|||
164715863|NCT01494662|594982161|FG005|Overall Study|Withdrawal by Subject|0|||
164715864|NCT01494662|594982162|FG006|Overall Study|Withdrawal by Subject|0|||
164498903|NCT01649297|594200030|FG003|Overall Study|Adverse Event|13|||
164498904|NCT01649297|594200031|FG004|Overall Study|Adverse Event|1|||
164498905|NCT01649297|594200027|FG000|Overall Study|Lack of Efficacy|0|||
164498906|NCT01649297|594200028|FG001|Overall Study|Lack of Efficacy|0|||
164498907|NCT01649297|594200029|FG002|Overall Study|Lack of Efficacy|0|||
164498908|NCT01649297|594200030|FG003|Overall Study|Lack of Efficacy|0|||
164498909|NCT01649297|594200031|FG004|Overall Study|Lack of Efficacy|1|||
164498910|NCT01649297|594200027|FG000|Overall Study|Non compliant with Protocol|1|||
164498911|NCT01649297|594200028|FG001|Overall Study|Non compliant with Protocol|0|||
164498912|NCT01649297|594200029|FG002|Overall Study|Non compliant with Protocol|3|||
164498913|NCT01649297|594200030|FG003|Overall Study|Non compliant with Protocol|2|||
164498914|NCT01649297|594200031|FG004|Overall Study|Non compliant with Protocol|1|||
164498915|NCT01649297|594200027|FG000|Overall Study|Lost to Follow-up|1|||
164498916|NCT01649297|594200028|FG001|Overall Study|Lost to Follow-up|1|||
164498917|NCT01649297|594200029|FG002|Overall Study|Lost to Follow-up|4|||
164715865|NCT01494662|594982156|FG000|Overall Study|Physician Decision|0|||
164498918|NCT01649297|594200030|FG003|Overall Study|Lost to Follow-up|3|||
164498919|NCT01649297|594200031|FG004|Overall Study|Lost to Follow-up|0|||
164498920|NCT01649297|594200027|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
164498921|NCT01649297|594200028|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
164498922|NCT01649297|594200029|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
164498923|NCT01649297|594200030|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
164498924|NCT01649297|594200031|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
164498925|NCT01649297|594200027|FG000|Overall Study|For other reason|4|||
164498926|NCT01649297|594200028|FG001|Overall Study|For other reason|1|||
164498927|NCT01649297|594200029|FG002|Overall Study|For other reason|2|||
164498928|NCT01649297|594200030|FG003|Overall Study|For other reason|0|||
164498929|NCT01649297|594200031|FG004|Overall Study|For other reason|0|||
164498930|NCT01685047|594200032|FG000|Overall Study|Withdrawal by Subject|20|||
164498931|NCT01685047|594200032|FG000|Overall Study|Death|26|||
164498932|NCT01685047|594200032|FG000|Overall Study|Lost to Follow-up|8|||
164498933|NCT01685047|594200032|FG000|Overall Study|Physician Decision|25|||
164498934|NCT01685047|594200032|FG000|Overall Study|Adverse Event|5|||
164498935|NCT01685047|594200032|FG000|Overall Study|patient withdrawn by sponsor|1|||
164498936|NCT02544113|594200033|FG000|Overall Study|Death|3|||
164498937|NCT02544113|594200034|FG001|Overall Study|Death|4|||
164498938|NCT02847637|594200038|FG000|Overall Study|Withdrawal by Subject|0|||
164498939|NCT02847637|594200039|FG001|Overall Study|Withdrawal by Subject|1|||
164498940|NCT02847637|594200040|FG002|Overall Study|Withdrawal by Subject|1|||
164498941|NCT02847637|594200041|FG003|Overall Study|Withdrawal by Subject|0|||
164498942|NCT02847637|594200038|FG000|Overall Study|Lost to Follow-up|1|||
164498943|NCT02847637|594200039|FG001|Overall Study|Lost to Follow-up|1|||
164498944|NCT02847637|594200040|FG002|Overall Study|Lost to Follow-up|0|||
164498945|NCT02847637|594200041|FG003|Overall Study|Lost to Follow-up|0|||
164498946|NCT00337285|594200042|FG000|Overall Study|Withdrawal by Subject|42|||
164498947|NCT00337285|594200042|FG000|Overall Study|Lost to Follow-up|41|||
164498948|NCT00337285|594200042|FG000|Overall Study|Adverse Event|28|||
164498949|NCT00337285|594200042|FG000|Overall Study|Protocol Violation|27|||
164498950|NCT00337285|594200042|FG000|Overall Study|Lack of Efficacy|11|||
164498951|NCT00337285|594200042|FG000|Overall Study|Death|1|||
164498952|NCT00337285|594200042|FG000|Overall Study|Physician Decision|1|||
164498953|NCT00337285|594200042|FG000|Overall Study|Lack of protocol compliance|7|||
164498954|NCT01746108|594200043|FG000|Overall Study|Migrated /moved from study area|0|||
164498955|NCT01746108|594200044|FG001|Overall Study|Migrated /moved from study area|1|||
164498956|NCT01746108|594200045|FG002|Overall Study|Migrated /moved from study area|0|||
164498957|NCT01746108|594200043|FG000|Overall Study|Adverse event, non-fatal|0|||
164498958|NCT01746108|594200044|FG001|Overall Study|Adverse event, non-fatal|1|||
164498959|NCT01746108|594200045|FG002|Overall Study|Adverse event, non-fatal|0|||
164498960|NCT01746108|594200043|FG000|Overall Study|Withdrawal by Subject|0|||
164498961|NCT01746108|594200044|FG001|Overall Study|Withdrawal by Subject|1|||
164498962|NCT01746108|594200045|FG002|Overall Study|Withdrawal by Subject|0|||
164498963|NCT01746108|594200043|FG000|Overall Study|Lost to Follow-up|0|||
164498964|NCT01746108|594200044|FG001|Overall Study|Lost to Follow-up|1|||
164498965|NCT01746108|594200045|FG002|Overall Study|Lost to Follow-up|0|||
164498966|NCT00553605|594200046|FG000|Overall Study|Did not meet entrance criteria|1|||
164498967|NCT00553605|594200047|FG001|Overall Study|Did not meet entrance criteria|3|||
164498968|NCT00553605|594200046|FG000|Overall Study|Did not receive full dose|1|||
164498969|NCT00553605|594200047|FG001|Overall Study|Did not receive full dose|0|||
164498970|NCT00553605|594200046|FG000|Overall Study|Randomized but not treated|2|||
164715866|NCT01494662|594982157|FG001|Overall Study|Physician Decision|0|||
164715867|NCT01494662|594982158|FG002|Overall Study|Physician Decision|1|||
164715868|NCT01494662|594982159|FG003|Overall Study|Physician Decision|0|||
164715869|NCT01494662|594982160|FG004|Overall Study|Physician Decision|0|||
164715870|NCT01494662|594982161|FG005|Overall Study|Physician Decision|0|||
164715871|NCT01494662|594982162|FG006|Overall Study|Physician Decision|0|||
164498971|NCT00553605|594200047|FG001|Overall Study|Randomized but not treated|0|||
164498972|NCT01040403|594200051|FG000|Overall Study|Adverse Event|10|||
164498973|NCT01040403|594200051|FG000|Overall Study|Protocol Violation|2|||
164498974|NCT01040403|594200051|FG000|Overall Study|Lost to Follow-up|1|||
164498975|NCT01040403|594200051|FG000|Overall Study|Not treated|1|||
164498976|NCT01040403|594200051|FG000|Overall Study|Other reason not defined above|6|||
164498977|NCT01085812|594200053|FG000|Open-Label Period|Adverse Event|0|||
164498978|NCT01085812|594200054|FG001|Open-Label Period|Adverse Event|80|||
164498979|NCT01085812|594200053|FG000|Open-Label Period|Lack of Efficacy|0|||
164498980|NCT01085812|594200054|FG001|Open-Label Period|Lack of Efficacy|26|||
164498981|NCT01085812|594200053|FG000|Open-Label Period|Protocol Violation|0|||
164498982|NCT01085812|594200054|FG001|Open-Label Period|Protocol Violation|39|||
164498983|NCT01085812|594200053|FG000|Open-Label Period|Withdrawal by Subject|0|||
164498984|NCT01085812|594200054|FG001|Open-Label Period|Withdrawal by Subject|53|||
164498985|NCT01085812|594200053|FG000|Open-Label Period|Lost to Follow-up|0|||
164715872|NCT03361306|594982168|FG000|Overall Study|Death|6|||
164715873|NCT04530552|594982171|FG000|Overall Study|Physician Decision|0|||
164498986|NCT01085812|594200054|FG001|Open-Label Period|Lost to Follow-up|42|||
164498987|NCT01085812|594200053|FG000|Double-Blind Period|Adverse Event|3|||
164498988|NCT01085812|594200054|FG001|Double-Blind Period|Adverse Event|8|||
164498989|NCT01085812|594200053|FG000|Double-Blind Period|Protocol Violation|2|||
164498990|NCT01085812|594200054|FG001|Double-Blind Period|Protocol Violation|7|||
164498991|NCT01085812|594200053|FG000|Double-Blind Period|Withdrawal by Subject|11|||
164498992|NCT01085812|594200054|FG001|Double-Blind Period|Withdrawal by Subject|24|||
164498993|NCT01085812|594200053|FG000|Double-Blind Period|Lost to Follow-up|5|||
164498994|NCT01085812|594200054|FG001|Double-Blind Period|Lost to Follow-up|17|||
164498995|NCT01085812|594200053|FG000|Double-Blind Period|Other Reasons|0|||
164498996|NCT01085812|594200054|FG001|Double-Blind Period|Other Reasons|2|||
164498997|NCT01085812|594200053|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
164498998|NCT01085812|594200054|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
164498999|NCT01085812|594200053|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
164499000|NCT01085812|594200054|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
164499001|NCT01085812|594200053|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
164499002|NCT01085812|594200054|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
164499003|NCT01085812|594200053|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
164499004|NCT01085812|594200054|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
164499005|NCT01085812|594200053|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
164499006|NCT01085812|594200054|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
164499007|NCT00594178|594200055|FG000|Overall Study|Physician Decision|5|||
164499008|NCT01874665|594200059|FG000|Overall Study|Adverse Event|6|||
164499009|NCT01874665|594200060|FG001|Overall Study|Adverse Event|2|||
164499010|NCT01874665|594200059|FG000|Overall Study|Withdrawal by Subject|4|||
164499011|NCT01874665|594200060|FG001|Overall Study|Withdrawal by Subject|1|||
164499012|NCT01874665|594200059|FG000|Overall Study|Physician Decision|3|||
164499013|NCT01874665|594200060|FG001|Overall Study|Physician Decision|0|||
164499014|NCT01874665|594200059|FG000|Overall Study|Clinical Progressive Disease|4|||
164499015|NCT01874665|594200060|FG001|Overall Study|Clinical Progressive Disease|3|||
164499016|NCT01874665|594200059|FG000|Overall Study|Study Terminated by Sponsor|0|||
164499017|NCT01874665|594200060|FG001|Overall Study|Study Terminated by Sponsor|2|||
164499018|NCT01874665|594200059|FG000|Overall Study|Documented Progressive Disease|11|||
164499019|NCT01874665|594200060|FG001|Overall Study|Documented Progressive Disease|7|||
164499020|NCT01874665|594200059|FG000|Overall Study|Other|2|||
164499021|NCT01874665|594200060|FG001|Overall Study|Other|0|||
164499022|NCT00550446|594200061|FG000|Up To Week 12|Adverse Event|2|||
164499023|NCT00550446|594200062|FG001|Up To Week 12|Adverse Event|2|||
164499024|NCT00550446|594200063|FG002|Up To Week 12|Adverse Event|0|||
164499025|NCT00550446|594200064|FG003|Up To Week 12|Adverse Event|0|||
164499026|NCT00550446|594200065|FG004|Up To Week 12|Adverse Event|2|||
164499027|NCT00550446|594200066|FG005|Up To Week 12|Adverse Event|2|||
164499028|NCT00550446|594200067|FG006|Up To Week 12|Adverse Event|1|||
164499029|NCT00550446|594200068|FG007|Up To Week 12|Adverse Event|0|||
164499030|NCT00550446|594200069|FG008|Up To Week 12|Adverse Event|0|||
164499031|NCT00550446|594200070|FG009|Up To Week 12|Adverse Event|0|||
164499032|NCT00550446|594200071|FG010|Up To Week 12|Adverse Event|0|||
164499033|NCT00550446|594200061|FG000|Up To Week 12|Lack of Efficacy|3|||
164499034|NCT00550446|594200062|FG001|Up To Week 12|Lack of Efficacy|1|||
164499035|NCT00550446|594200063|FG002|Up To Week 12|Lack of Efficacy|0|||
164499036|NCT00550446|594200064|FG003|Up To Week 12|Lack of Efficacy|1|||
164499037|NCT00550446|594200065|FG004|Up To Week 12|Lack of Efficacy|0|||
164499038|NCT00550446|594200066|FG005|Up To Week 12|Lack of Efficacy|3|||
164499039|NCT00550446|594200067|FG006|Up To Week 12|Lack of Efficacy|3|||
164499040|NCT00550446|594200068|FG007|Up To Week 12|Lack of Efficacy|0|||
164499041|NCT00550446|594200069|FG008|Up To Week 12|Lack of Efficacy|0|||
164499042|NCT00550446|594200070|FG009|Up To Week 12|Lack of Efficacy|0|||
164499043|NCT00550446|594200071|FG010|Up To Week 12|Lack of Efficacy|0|||
164499044|NCT00550446|594200061|FG000|Up To Week 12|Lost to Follow-up|0|||
164499045|NCT00550446|594200062|FG001|Up To Week 12|Lost to Follow-up|1|||
164499046|NCT00550446|594200063|FG002|Up To Week 12|Lost to Follow-up|0|||
164499047|NCT00550446|594200064|FG003|Up To Week 12|Lost to Follow-up|0|||
164499048|NCT00550446|594200065|FG004|Up To Week 12|Lost to Follow-up|1|||
164499049|NCT00550446|594200066|FG005|Up To Week 12|Lost to Follow-up|1|||
164499050|NCT00550446|594200067|FG006|Up To Week 12|Lost to Follow-up|2|||
164499051|NCT00550446|594200068|FG007|Up To Week 12|Lost to Follow-up|0|||
164499052|NCT00550446|594200069|FG008|Up To Week 12|Lost to Follow-up|0|||
164499053|NCT00550446|594200070|FG009|Up To Week 12|Lost to Follow-up|0|||
164499054|NCT00550446|594200071|FG010|Up To Week 12|Lost to Follow-up|0|||
164499055|NCT00550446|594200061|FG000|Up To Week 12|Withdrawal by Subject|2|||
164499056|NCT00550446|594200062|FG001|Up To Week 12|Withdrawal by Subject|0|||
164499057|NCT00550446|594200063|FG002|Up To Week 12|Withdrawal by Subject|3|||
164499058|NCT00550446|594200064|FG003|Up To Week 12|Withdrawal by Subject|2|||
164499059|NCT00550446|594200065|FG004|Up To Week 12|Withdrawal by Subject|0|||
164499060|NCT00550446|594200066|FG005|Up To Week 12|Withdrawal by Subject|1|||
164499061|NCT00550446|594200067|FG006|Up To Week 12|Withdrawal by Subject|3|||
164605100|NCT03444870|594575894|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
164605101|NCT03444870|594575889|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
164605102|NCT03444870|594575890|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
164605103|NCT03444870|594575891|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
164605104|NCT03444870|594575892|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
164605105|NCT03444870|594575893|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
164605106|NCT03444870|594575894|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
164605107|NCT03444870|594575889|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
164605108|NCT03444870|594575890|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
164605109|NCT03444870|594575891|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
164605110|NCT03444870|594575892|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
164605111|NCT03444870|594575893|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
164605112|NCT03444870|594575894|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
164605113|NCT03444870|594575889|FG000|Open-Label Extension (OLE) Period|Death|0|||
164605114|NCT03444870|594575890|FG001|Open-Label Extension (OLE) Period|Death|0|||
164605115|NCT03444870|594575891|FG002|Open-Label Extension (OLE) Period|Death|0|||
164605116|NCT03444870|594575892|FG003|Open-Label Extension (OLE) Period|Death|0|||
164605117|NCT03444870|594575893|FG004|Open-Label Extension (OLE) Period|Death|1|||
164605118|NCT03444870|594575894|FG005|Open-Label Extension (OLE) Period|Death|0|||
164605119|NCT02197897|594575895|FG000|Overall Study|not eligible|1|||
164605120|NCT02267278|594575896|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
164605121|NCT02267278|594575896|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
164605122|NCT02267278|594575896|FG000|Overall Study|Developed new cancer diagnoses|2|||
164605123|NCT02267278|594575896|FG000|Overall Study|prescribed prohibited medication|1|||
164605124|NCT02513771|594575897|FG000|Overall Study|Lost to Follow-up|1|||
164605125|NCT02513771|594575898|FG001|Overall Study|Lost to Follow-up|1|||
164605126|NCT02513771|594575897|FG000|Overall Study|Not being able to get to clinic|1|||
164605127|NCT02513771|594575898|FG001|Overall Study|Not being able to get to clinic|0|||
164605128|NCT01280266|594575906|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
164605129|NCT01280266|594575907|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
164605130|NCT01280266|594575906|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
164605131|NCT01280266|594575907|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
164605132|NCT03495453|594575913|FG000|Overall Study|Withdrawal by Subject|0|||
164605133|NCT03495453|594575914|FG001|Overall Study|Withdrawal by Subject|1|||
164605134|NCT01429077|594575915|FG000|Overall Study|Lost to Follow-up|0|||
164605135|NCT01429077|594575916|FG001|Overall Study|Lost to Follow-up|3|||
164605136|NCT01879319|594575917|FG000|Overall Study|Withdrawal by Subject|1|||
164605137|NCT01879319|594575918|FG001|Overall Study|Withdrawal by Subject|0|||
164605138|NCT01879319|594575917|FG000|Overall Study|Lost to Follow-up|1|||
164605139|NCT01879319|594575918|FG001|Overall Study|Lost to Follow-up|5|||
164605140|NCT01103778|594575921|FG000|Overall Study|Lost to Follow-up|1|||
164605141|NCT01103778|594575921|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
164605142|NCT01103778|594575921|FG000|Overall Study|Screen failure|1|||
164605143|NCT03067129|594575922|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
164605144|NCT03067129|594575923|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
164605145|NCT03067129|594575924|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
164605146|NCT03067129|594575925|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
164605147|NCT03067129|594575922|FG000|Overall Study|Withdrawal by Subject|0|||
164605148|NCT03067129|594575923|FG001|Overall Study|Withdrawal by Subject|0|||
164605149|NCT03067129|594575924|FG002|Overall Study|Withdrawal by Subject|1|||
164605150|NCT03067129|594575925|FG003|Overall Study|Withdrawal by Subject|2|||
164499062|NCT00550446|594200068|FG007|Up To Week 12|Withdrawal by Subject|0|||
164499063|NCT00550446|594200069|FG008|Up To Week 12|Withdrawal by Subject|0|||
164499064|NCT00550446|594200070|FG009|Up To Week 12|Withdrawal by Subject|0|||
164499065|NCT00550446|594200071|FG010|Up To Week 12|Withdrawal by Subject|0|||
164499066|NCT00550446|594200061|FG000|Up To Week 12|Other|3|||
164499067|NCT00550446|594200062|FG001|Up To Week 12|Other|0|||
164499068|NCT00550446|594200063|FG002|Up To Week 12|Other|0|||
164499069|NCT00550446|594200064|FG003|Up To Week 12|Other|0|||
164499070|NCT00550446|594200065|FG004|Up To Week 12|Other|0|||
164499071|NCT00550446|594200066|FG005|Up To Week 12|Other|1|||
164499072|NCT00550446|594200067|FG006|Up To Week 12|Other|4|||
164499073|NCT00550446|594200068|FG007|Up To Week 12|Other|0|||
164605151|NCT03067129|594575922|FG000|Overall Study|Lost to Follow-up|5|||
164605152|NCT03067129|594575923|FG001|Overall Study|Lost to Follow-up|5|||
164605153|NCT03067129|594575924|FG002|Overall Study|Lost to Follow-up|4|||
164605154|NCT03067129|594575925|FG003|Overall Study|Lost to Follow-up|3|||
164605155|NCT04511819|594575926|FG000|Overall Study|Non-compliance with study drug|5|||
164499074|NCT00550446|594200069|FG008|Up To Week 12|Other|0|||
164499075|NCT00550446|594200070|FG009|Up To Week 12|Other|0|||
164499076|NCT00550446|594200071|FG010|Up To Week 12|Other|0|||
164715874|NCT04530552|594982172|FG001|Overall Study|Physician Decision|1|||
164715875|NCT04530552|594982171|FG000|Overall Study|Withdrawal by Subject|0|||
164715876|NCT04530552|594982172|FG001|Overall Study|Withdrawal by Subject|1|||
164715877|NCT04530552|594982171|FG000|Overall Study|Adverse Event|0|||
164499077|NCT00550446|594200061|FG000|Up To Week 12|Randomized not treated|0|||
164499078|NCT00550446|594200062|FG001|Up To Week 12|Randomized not treated|1|||
164499079|NCT00550446|594200063|FG002|Up To Week 12|Randomized not treated|1|||
164499080|NCT00550446|594200064|FG003|Up To Week 12|Randomized not treated|0|||
164499081|NCT00550446|594200065|FG004|Up To Week 12|Randomized not treated|0|||
164499082|NCT00550446|594200066|FG005|Up To Week 12|Randomized not treated|0|||
164499083|NCT00550446|594200067|FG006|Up To Week 12|Randomized not treated|0|||
164499084|NCT00550446|594200068|FG007|Up To Week 12|Randomized not treated|0|||
164499085|NCT00550446|594200069|FG008|Up To Week 12|Randomized not treated|0|||
164499086|NCT00550446|594200070|FG009|Up To Week 12|Randomized not treated|0|||
164499087|NCT00550446|594200071|FG010|Up To Week 12|Randomized not treated|0|||
164499088|NCT00550446|594200061|FG000|Post Week 12|Adverse Event|2|||
164499089|NCT00550446|594200062|FG001|Post Week 12|Adverse Event|1|||
164499090|NCT00550446|594200063|FG002|Post Week 12|Adverse Event|1|||
164499091|NCT00550446|594200064|FG003|Post Week 12|Adverse Event|1|||
164499092|NCT00550446|594200065|FG004|Post Week 12|Adverse Event|1|||
164499093|NCT00550446|594200066|FG005|Post Week 12|Adverse Event|1|||
164499094|NCT00550446|594200067|FG006|Post Week 12|Adverse Event|0|||
164499095|NCT00550446|594200068|FG007|Post Week 12|Adverse Event|0|||
164499096|NCT00550446|594200069|FG008|Post Week 12|Adverse Event|0|||
164499097|NCT00550446|594200070|FG009|Post Week 12|Adverse Event|4|||
164499098|NCT00550446|594200071|FG010|Post Week 12|Adverse Event|0|||
164499099|NCT00550446|594200061|FG000|Post Week 12|Lack of Efficacy|0|||
164499100|NCT00550446|594200062|FG001|Post Week 12|Lack of Efficacy|0|||
164499101|NCT00550446|594200063|FG002|Post Week 12|Lack of Efficacy|1|||
164499102|NCT00550446|594200064|FG003|Post Week 12|Lack of Efficacy|0|||
164499103|NCT00550446|594200065|FG004|Post Week 12|Lack of Efficacy|0|||
164499104|NCT00550446|594200066|FG005|Post Week 12|Lack of Efficacy|0|||
164499105|NCT00550446|594200067|FG006|Post Week 12|Lack of Efficacy|0|||
164499106|NCT00550446|594200068|FG007|Post Week 12|Lack of Efficacy|1|||
164499107|NCT00550446|594200069|FG008|Post Week 12|Lack of Efficacy|1|||
164499108|NCT00550446|594200070|FG009|Post Week 12|Lack of Efficacy|2|||
164499109|NCT00550446|594200071|FG010|Post Week 12|Lack of Efficacy|1|||
164499110|NCT00550446|594200061|FG000|Post Week 12|Lost to Follow-up|0|||
164499111|NCT00550446|594200062|FG001|Post Week 12|Lost to Follow-up|0|||
164499112|NCT00550446|594200063|FG002|Post Week 12|Lost to Follow-up|1|||
164499113|NCT00550446|594200064|FG003|Post Week 12|Lost to Follow-up|1|||
164499114|NCT00550446|594200065|FG004|Post Week 12|Lost to Follow-up|0|||
164499115|NCT00550446|594200066|FG005|Post Week 12|Lost to Follow-up|0|||
164499116|NCT00550446|594200067|FG006|Post Week 12|Lost to Follow-up|1|||
164499117|NCT00550446|594200068|FG007|Post Week 12|Lost to Follow-up|0|||
164499118|NCT00550446|594200069|FG008|Post Week 12|Lost to Follow-up|0|||
164499119|NCT00550446|594200070|FG009|Post Week 12|Lost to Follow-up|0|||
164499120|NCT00550446|594200071|FG010|Post Week 12|Lost to Follow-up|0|||
164499121|NCT00550446|594200061|FG000|Post Week 12|Withdrawal by Subject|0|||
164499122|NCT00550446|594200062|FG001|Post Week 12|Withdrawal by Subject|0|||
164499123|NCT00550446|594200063|FG002|Post Week 12|Withdrawal by Subject|0|||
164499124|NCT00550446|594200064|FG003|Post Week 12|Withdrawal by Subject|0|||
164499125|NCT00550446|594200065|FG004|Post Week 12|Withdrawal by Subject|1|||
164499126|NCT00550446|594200066|FG005|Post Week 12|Withdrawal by Subject|0|||
164499127|NCT00550446|594200067|FG006|Post Week 12|Withdrawal by Subject|0|||
164499128|NCT00550446|594200068|FG007|Post Week 12|Withdrawal by Subject|0|||
164499129|NCT00550446|594200069|FG008|Post Week 12|Withdrawal by Subject|0|||
164499130|NCT00550446|594200070|FG009|Post Week 12|Withdrawal by Subject|0|||
164499131|NCT00550446|594200071|FG010|Post Week 12|Withdrawal by Subject|0|||
164499132|NCT00550446|594200061|FG000|Post Week 12|Other|1|||
164499133|NCT00550446|594200062|FG001|Post Week 12|Other|1|||
164499134|NCT00550446|594200063|FG002|Post Week 12|Other|0|||
164499135|NCT00550446|594200064|FG003|Post Week 12|Other|1|||
164499136|NCT00550446|594200065|FG004|Post Week 12|Other|0|||
164715878|NCT04530552|594982172|FG001|Overall Study|Adverse Event|1|||
164715879|NCT04530552|594982171|FG000|Overall Study|No surgery|0|||
164499137|NCT00550446|594200066|FG005|Post Week 12|Other|0|||
164499138|NCT00550446|594200067|FG006|Post Week 12|Other|1|||
164499139|NCT00550446|594200068|FG007|Post Week 12|Other|0|||
164499140|NCT00550446|594200069|FG008|Post Week 12|Other|1|||
164499141|NCT00550446|594200070|FG009|Post Week 12|Other|1|||
164499142|NCT00550446|594200071|FG010|Post Week 12|Other|0|||
164499143|NCT01321723|594200072|FG000|Overall Study|Adverse Event|3|||
164499144|NCT01321723|594200073|FG001|Overall Study|Adverse Event|5|||
164499145|NCT01321723|594200074|FG002|Overall Study|Adverse Event|2|||
164715880|NCT04530552|594982172|FG001|Overall Study|No surgery|1|||
164499146|NCT01321723|594200072|FG000|Overall Study|Withdrawal by Subject|2|||
164499147|NCT01321723|594200073|FG001|Overall Study|Withdrawal by Subject|0|||
164499148|NCT01321723|594200074|FG002|Overall Study|Withdrawal by Subject|2|||
164715881|NCT03468218|594982173|FG000|Overall Study|Adverse Event|5|||
164499149|NCT02246218|594200075|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164499150|NCT02246218|594200076|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
164499151|NCT02246218|594200075|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
164499152|NCT02246218|594200076|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
164499153|NCT02246218|594200075|FG000|Overall Study|Adverse Event|1|||
164499154|NCT02246218|594200076|FG001|Overall Study|Adverse Event|1|||
164499155|NCT02246218|594200075|FG000|Overall Study|Lost to Follow-up|1|||
164499156|NCT02246218|594200076|FG001|Overall Study|Lost to Follow-up|0|||
164499157|NCT00905034|594200077|FG000|Overall Study|Withdrawal by Subject|1|||
164499158|NCT03409731|594200079|FG000|Overall Study|Withdrawal by Subject|17|||
164499159|NCT03409731|594200079|FG000|Overall Study|Death|4|||
164499160|NCT00505414|594200081|FG000|Titration Phase|Adverse Event|0|||
164499161|NCT00505414|594200082|FG001|Titration Phase|Adverse Event|0|||
164499162|NCT00505414|594200083|FG002|Titration Phase|Adverse Event|0|||
164499163|NCT00505414|594200084|FG003|Titration Phase|Adverse Event|8|||
164499164|NCT00505414|594200085|FG004|Titration Phase|Adverse Event|3|||
164499165|NCT00505414|594200081|FG000|Titration Phase|Death|0|||
164499166|NCT00505414|594200082|FG001|Titration Phase|Death|0|||
164499167|NCT00505414|594200083|FG002|Titration Phase|Death|0|||
164499168|NCT00505414|594200084|FG003|Titration Phase|Death|2|||
164499169|NCT00505414|594200085|FG004|Titration Phase|Death|0|||
164499170|NCT00505414|594200081|FG000|Titration Phase|Lack of Efficacy|0|||
164499171|NCT00505414|594200082|FG001|Titration Phase|Lack of Efficacy|0|||
164499172|NCT00505414|594200083|FG002|Titration Phase|Lack of Efficacy|0|||
164499173|NCT00505414|594200084|FG003|Titration Phase|Lack of Efficacy|10|||
164499174|NCT00505414|594200085|FG004|Titration Phase|Lack of Efficacy|1|||
164499175|NCT00505414|594200081|FG000|Titration Phase|Protocol Violation|0|||
164499176|NCT00505414|594200082|FG001|Titration Phase|Protocol Violation|0|||
164499177|NCT00505414|594200083|FG002|Titration Phase|Protocol Violation|0|||
164499178|NCT00505414|594200084|FG003|Titration Phase|Protocol Violation|0|||
164499179|NCT00505414|594200085|FG004|Titration Phase|Protocol Violation|1|||
164499180|NCT00505414|594200081|FG000|Titration Phase|Withdrawal by Subject|0|||
164499181|NCT00505414|594200082|FG001|Titration Phase|Withdrawal by Subject|0|||
164499182|NCT00505414|594200083|FG002|Titration Phase|Withdrawal by Subject|0|||
164499183|NCT00505414|594200084|FG003|Titration Phase|Withdrawal by Subject|3|||
164499184|NCT00505414|594200085|FG004|Titration Phase|Withdrawal by Subject|4|||
164499185|NCT00505414|594200081|FG000|Titration Phase|Underlying disease and therapy required|0|||
164499186|NCT00505414|594200082|FG001|Titration Phase|Underlying disease and therapy required|0|||
164499187|NCT00505414|594200083|FG002|Titration Phase|Underlying disease and therapy required|0|||
164499188|NCT00505414|594200084|FG003|Titration Phase|Underlying disease and therapy required|7|||
164499189|NCT00505414|594200085|FG004|Titration Phase|Underlying disease and therapy required|3|||
164499190|NCT00505414|594200081|FG000|Maintenance Phase|Adverse Event|2|||
164499191|NCT00505414|594200082|FG001|Maintenance Phase|Adverse Event|2|||
164499192|NCT00505414|594200083|FG002|Maintenance Phase|Adverse Event|3|||
164499193|NCT00505414|594200084|FG003|Maintenance Phase|Adverse Event|0|||
164499194|NCT00505414|594200085|FG004|Maintenance Phase|Adverse Event|0|||
164499195|NCT00505414|594200081|FG000|Maintenance Phase|Death|2|||
164499196|NCT00505414|594200082|FG001|Maintenance Phase|Death|0|||
164499197|NCT00505414|594200083|FG002|Maintenance Phase|Death|1|||
164499198|NCT00505414|594200084|FG003|Maintenance Phase|Death|0|||
164499199|NCT00505414|594200085|FG004|Maintenance Phase|Death|0|||
164499200|NCT00505414|594200081|FG000|Maintenance Phase|Lack of Efficacy|2|||
164499201|NCT00505414|594200082|FG001|Maintenance Phase|Lack of Efficacy|1|||
164499202|NCT00505414|594200083|FG002|Maintenance Phase|Lack of Efficacy|1|||
164499203|NCT00505414|594200084|FG003|Maintenance Phase|Lack of Efficacy|0|||
164499204|NCT00505414|594200085|FG004|Maintenance Phase|Lack of Efficacy|0|||
164499205|NCT00505414|594200081|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164499206|NCT00505414|594200082|FG001|Maintenance Phase|Withdrawal by Subject|0|||
164499207|NCT00505414|594200083|FG002|Maintenance Phase|Withdrawal by Subject|1|||
164499208|NCT00505414|594200084|FG003|Maintenance Phase|Withdrawal by Subject|0|||
164499209|NCT00505414|594200085|FG004|Maintenance Phase|Withdrawal by Subject|0|||
164499210|NCT00505414|594200081|FG000|Maintenance Phase|underlying disease and therapy required|0|||
164499211|NCT00505414|594200082|FG001|Maintenance Phase|underlying disease and therapy required|2|||
164499212|NCT00505414|594200083|FG002|Maintenance Phase|underlying disease and therapy required|2|||
164499213|NCT00505414|594200084|FG003|Maintenance Phase|underlying disease and therapy required|0|||
164499214|NCT00505414|594200085|FG004|Maintenance Phase|underlying disease and therapy required|0|||
164499215|NCT04358068|594200086|FG000|Overall Study|Did not initiate study treatment|2|||
164499216|NCT04358068|594200087|FG001|Overall Study|Did not initiate study treatment|2|||
164499217|NCT01193218|594200088|FG000|0-12 Weeks|Adverse Event|6|||
164499218|NCT01193218|594200089|FG001|0-12 Weeks|Adverse Event|0|||
164499219|NCT01193218|594200090|FG002|0-12 Weeks|Adverse Event|1|||
164499220|NCT01193218|594200091|FG003|0-12 Weeks|Adverse Event|0|||
164499221|NCT01193218|594200092|FG004|0-12 Weeks|Adverse Event|0|||
164499222|NCT01193218|594200093|FG005|0-12 Weeks|Adverse Event|2|||
164499223|NCT01193218|594200094|FG006|0-12 Weeks|Adverse Event|2|||
164499224|NCT01193218|594200095|FG007|0-12 Weeks|Adverse Event|0|||
164499225|NCT01193218|594200088|FG000|0-12 Weeks|Protocol Violation|0|||
164499226|NCT01193218|594200089|FG001|0-12 Weeks|Protocol Violation|0|||
164499227|NCT01193218|594200090|FG002|0-12 Weeks|Protocol Violation|0|||
164499228|NCT01193218|594200091|FG003|0-12 Weeks|Protocol Violation|0|||
164499229|NCT01193218|594200092|FG004|0-12 Weeks|Protocol Violation|1|||
164499230|NCT01193218|594200093|FG005|0-12 Weeks|Protocol Violation|1|||
164499231|NCT01193218|594200094|FG006|0-12 Weeks|Protocol Violation|0|||
164499232|NCT01193218|594200095|FG007|0-12 Weeks|Protocol Violation|0|||
164499233|NCT01193218|594200088|FG000|0-12 Weeks|Withdrawal by Subject|3|||
164499234|NCT01193218|594200089|FG001|0-12 Weeks|Withdrawal by Subject|0|||
164499235|NCT01193218|594200090|FG002|0-12 Weeks|Withdrawal by Subject|2|||
164499236|NCT01193218|594200091|FG003|0-12 Weeks|Withdrawal by Subject|0|||
164499237|NCT01193218|594200092|FG004|0-12 Weeks|Withdrawal by Subject|0|||
164499238|NCT01193218|594200093|FG005|0-12 Weeks|Withdrawal by Subject|0|||
164499239|NCT01193218|594200094|FG006|0-12 Weeks|Withdrawal by Subject|1|||
164499240|NCT01193218|594200095|FG007|0-12 Weeks|Withdrawal by Subject|0|||
164499241|NCT01193218|594200088|FG000|12-52 Weeks|Adverse Event|1|||
164499242|NCT01193218|594200089|FG001|12-52 Weeks|Adverse Event|0|||
164499243|NCT01193218|594200090|FG002|12-52 Weeks|Adverse Event|1|||
164499244|NCT01193218|594200091|FG003|12-52 Weeks|Adverse Event|2|||
164499245|NCT01193218|594200092|FG004|12-52 Weeks|Adverse Event|3|||
164499246|NCT01193218|594200093|FG005|12-52 Weeks|Adverse Event|3|||
164499247|NCT01193218|594200094|FG006|12-52 Weeks|Adverse Event|1|||
164499248|NCT01193218|594200095|FG007|12-52 Weeks|Adverse Event|2|||
164499249|NCT01193218|594200088|FG000|12-52 Weeks|Lack of Efficacy|0|||
164499250|NCT01193218|594200089|FG001|12-52 Weeks|Lack of Efficacy|0|||
164499251|NCT01193218|594200090|FG002|12-52 Weeks|Lack of Efficacy|0|||
164499252|NCT01193218|594200091|FG003|12-52 Weeks|Lack of Efficacy|0|||
164499253|NCT01193218|594200092|FG004|12-52 Weeks|Lack of Efficacy|0|||
164499254|NCT01193218|594200093|FG005|12-52 Weeks|Lack of Efficacy|0|||
164499255|NCT01193218|594200094|FG006|12-52 Weeks|Lack of Efficacy|1|||
164499256|NCT01193218|594200095|FG007|12-52 Weeks|Lack of Efficacy|0|||
164499257|NCT01193218|594200088|FG000|12-52 Weeks|Withdrawal by Subject|3|||
164499258|NCT01193218|594200089|FG001|12-52 Weeks|Withdrawal by Subject|0|||
164499259|NCT01193218|594200090|FG002|12-52 Weeks|Withdrawal by Subject|3|||
164499260|NCT01193218|594200091|FG003|12-52 Weeks|Withdrawal by Subject|0|||
164499261|NCT01193218|594200092|FG004|12-52 Weeks|Withdrawal by Subject|0|||
164499262|NCT01193218|594200093|FG005|12-52 Weeks|Withdrawal by Subject|2|||
164499263|NCT01193218|594200094|FG006|12-52 Weeks|Withdrawal by Subject|1|||
164499264|NCT01193218|594200095|FG007|12-52 Weeks|Withdrawal by Subject|2|||
164499265|NCT01193218|594200088|FG000|12-52 Weeks|Other reason than above|1|||
164499266|NCT01193218|594200089|FG001|12-52 Weeks|Other reason than above|0|||
164499267|NCT01193218|594200090|FG002|12-52 Weeks|Other reason than above|0|||
164499268|NCT01193218|594200091|FG003|12-52 Weeks|Other reason than above|1|||
164499269|NCT01193218|594200092|FG004|12-52 Weeks|Other reason than above|1|||
164499270|NCT01193218|594200093|FG005|12-52 Weeks|Other reason than above|0|||
164499271|NCT01193218|594200094|FG006|12-52 Weeks|Other reason than above|0|||
164499272|NCT01193218|594200095|FG007|12-52 Weeks|Other reason than above|0|||
164499273|NCT00665223|594200098|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
164499274|NCT00665223|594200099|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
164499275|NCT00665223|594200100|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
164499276|NCT00665223|594200098|FG000|Randomized Phase (26 Weeks)|Death|0|||
164499277|NCT00665223|594200099|FG001|Randomized Phase (26 Weeks)|Death|0|||
164499278|NCT00665223|594200100|FG002|Randomized Phase (26 Weeks)|Death|1|||
164499279|NCT00665223|594200098|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
164499280|NCT00665223|594200099|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
164499281|NCT00665223|594200100|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
164499282|NCT00665223|594200098|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
164715882|NCT03468218|594982173|FG000|Overall Study|Progressive Disease|16|||
164499283|NCT00665223|594200099|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
164499284|NCT00665223|594200100|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
164499285|NCT00665223|594200098|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
164499286|NCT00665223|594200099|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
164499287|NCT00665223|594200100|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
164499288|NCT00665223|594200098|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
164499289|NCT00665223|594200099|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
164499290|NCT00665223|594200100|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
164499291|NCT00665223|594200098|FG000|Open-Label Period (26 Weeks)|Death|0|||
164499292|NCT00665223|594200099|FG001|Open-Label Period (26 Weeks)|Death|1|||
164499293|NCT00665223|594200100|FG002|Open-Label Period (26 Weeks)|Death|0|||
164499294|NCT00665223|594200098|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
164499295|NCT00665223|594200099|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
164499296|NCT00665223|594200100|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
164499297|NCT00665223|594200098|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
164499298|NCT00665223|594200099|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
164499299|NCT00665223|594200100|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
164499300|NCT00665223|594200098|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
164499301|NCT00665223|594200099|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
164499302|NCT00665223|594200100|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
164499303|NCT00665223|594200098|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
164499304|NCT00665223|594200099|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
164499305|NCT00665223|594200100|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
164499306|NCT00363649|594200101|FG000|Overall Study|Withdrawal by Subject|1|||
164499307|NCT00363649|594200102|FG001|Overall Study|Withdrawal by Subject|1|||
164499308|NCT00363649|594200101|FG000|Overall Study|Adverse Event|6|||
164499309|NCT00363649|594200102|FG001|Overall Study|Adverse Event|0|||
164499310|NCT03589300|594200103|FG000|Overall Study|Adverse Event|2|||
164499311|NCT03589300|594200103|FG000|Overall Study|Death|4|||
164499312|NCT03589300|594200103|FG000|Overall Study|Lost to Follow-up|12|||
164499313|NCT03589300|594200103|FG000|Overall Study|Withdrawal by Subject|5|||
164499314|NCT02161185|594200104|FG000|Treatment Phase|Administrative/Other|7|||
164499315|NCT02573883|594200105|FG000|Six Month Follow Up|Lost to Follow-up|1|||
164499316|NCT02573883|594200106|FG001|Six Month Follow Up|Lost to Follow-up|0|||
164499317|NCT02573883|594200107|FG002|Six Month Follow Up|Lost to Follow-up|0|||
164499318|NCT02573883|594200108|FG003|Six Month Follow Up|Lost to Follow-up|0|||
164499319|NCT02573883|594200105|FG000|One Year Follow Up|Lost to Follow-up|2|||
164499320|NCT02573883|594200106|FG001|One Year Follow Up|Lost to Follow-up|1|||
164499321|NCT02573883|594200107|FG002|One Year Follow Up|Lost to Follow-up|0|||
164499322|NCT02573883|594200108|FG003|One Year Follow Up|Lost to Follow-up|0|||
164499323|NCT00582114|594200109|FG000|Overall Study|Death|4|||
164499324|NCT00582114|594200110|FG001|Overall Study|Death|4|||
164499325|NCT00582114|594200109|FG000|Overall Study|Kidney Transplant|3|||
164499326|NCT00582114|594200110|FG001|Overall Study|Kidney Transplant|1|||
164499327|NCT00582114|594200109|FG000|Overall Study|Lost to Follow-up|7|||
164499328|NCT00582114|594200110|FG001|Overall Study|Lost to Follow-up|6|||
164499329|NCT00582114|594200109|FG000|Overall Study|Withdrawal by Subject|8|||
164499330|NCT00582114|594200110|FG001|Overall Study|Withdrawal by Subject|16|||
164499331|NCT00582114|594200109|FG000|Overall Study|Adverse Event|1|||
164499332|NCT00582114|594200110|FG001|Overall Study|Adverse Event|1|||
164499333|NCT00582114|594200109|FG000|Overall Study|Physician Decision|0|||
164499334|NCT00582114|594200110|FG001|Overall Study|Physician Decision|6|||
164499335|NCT00582114|594200109|FG000|Overall Study|Stopped by data safety monitoring board|19|||
164499336|NCT00582114|594200110|FG001|Overall Study|Stopped by data safety monitoring board|20|||
164499337|NCT00130728|594200118|FG000|Overall Study|Death|258|||
164499338|NCT00130728|594200119|FG001|Overall Study|Death|258|||
164499339|NCT00130728|594200118|FG000|Overall Study|Lost to Follow-up|4|||
164499340|NCT00130728|594200119|FG001|Overall Study|Lost to Follow-up|0|||
164499341|NCT00130728|594200118|FG000|Overall Study|Withdrawal by Subject|0|||
164499342|NCT00130728|594200119|FG001|Overall Study|Withdrawal by Subject|2|||
164499343|NCT01349036|594200121|FG000|Overall Study|Disease progression|13|||
164499344|NCT01349036|594200122|FG001|Overall Study|Disease progression|22|||
164499345|NCT01349036|594200121|FG000|Overall Study|Other|1|||
164499346|NCT01349036|594200122|FG001|Overall Study|Other|0|||
164499347|NCT01349036|594200121|FG000|Overall Study|Withdrawal by Subject|0|||
164499348|NCT01349036|594200122|FG001|Overall Study|Withdrawal by Subject|2|||
164499349|NCT03796208|594200123|FG000|Overall Study|Withdrawal by Subject|3|||
164499350|NCT03796208|594200124|FG001|Overall Study|Withdrawal by Subject|0|||
164499351|NCT03796208|594200123|FG000|Overall Study|Loss of pregnancy|1|||
164499352|NCT03796208|594200124|FG001|Overall Study|Loss of pregnancy|1|||
164499353|NCT03796208|594200123|FG000|Overall Study|Changed prenatal clinics|0|||
164499354|NCT03796208|594200124|FG001|Overall Study|Changed prenatal clinics|5|||
164499355|NCT03796208|594200123|FG000|Overall Study|Lost to Follow-up|20|||
164499356|NCT03796208|594200124|FG001|Overall Study|Lost to Follow-up|16|||
164499357|NCT01161628|594200125|FG000|Overall Study|Death|6|||
164499358|NCT01161628|594200125|FG000|Overall Study|Lack of Efficacy|2|||
164499359|NCT00519285|594200132|FG000|Overall Study|Adverse Event|127|||
164499360|NCT00519285|594200133|FG001|Overall Study|Adverse Event|266|||
164499361|NCT00519285|594200132|FG000|Overall Study|Disease progression|334|||
164499362|NCT00519285|594200133|FG001|Overall Study|Disease progression|186|||
164499363|NCT00519285|594200132|FG000|Overall Study|Physician Decision|75|||
164499364|NCT00519285|594200133|FG001|Overall Study|Physician Decision|47|||
164499365|NCT00519285|594200132|FG000|Overall Study|Participant's request|53|||
164499366|NCT00519285|594200133|FG001|Overall Study|Participant's request|84|||
164499367|NCT00519285|594200132|FG000|Overall Study|Consent withdrawn|4|||
164499368|NCT00519285|594200133|FG001|Overall Study|Consent withdrawn|5|||
164499369|NCT00519285|594200132|FG000|Overall Study|Poor compliance to protocol|5|||
164499370|NCT00519285|594200133|FG001|Overall Study|Poor compliance to protocol|7|||
164499371|NCT00519285|594200132|FG000|Overall Study|Reason unspecified|5|||
164499372|NCT00519285|594200133|FG001|Overall Study|Reason unspecified|8|||
164499373|NCT00519285|594200132|FG000|Overall Study|Not treated|8|||
164499374|NCT00519285|594200133|FG001|Overall Study|Not treated|7|||
164499375|NCT00519285|594200132|FG000|Overall Study|Treatment ongoing|1|||
164499376|NCT00519285|594200133|FG001|Overall Study|Treatment ongoing|2|||
164499377|NCT02970305|594200134|FG000|Overall Study|Adverse Event|10|||
164499378|NCT02970305|594200135|FG001|Overall Study|Adverse Event|6|||
164499379|NCT02970305|594200134|FG000|Overall Study|Lack of Efficacy|1|||
164499380|NCT02970305|594200135|FG001|Overall Study|Lack of Efficacy|1|||
164499381|NCT02970305|594200134|FG000|Overall Study|Noncompliance with study drug|2|||
164499382|NCT02970305|594200135|FG001|Overall Study|Noncompliance with study drug|4|||
164499383|NCT02970305|594200134|FG000|Overall Study|Protocol Violation|2|||
164499384|NCT02970305|594200135|FG001|Overall Study|Protocol Violation|2|||
164499385|NCT02970305|594200134|FG000|Overall Study|Withdrawal by Subject|12|||
164499386|NCT02970305|594200135|FG001|Overall Study|Withdrawal by Subject|11|||
164499387|NCT02970305|594200134|FG000|Overall Study|Not further specified|1|||
164499388|NCT02970305|594200135|FG001|Overall Study|Not further specified|2|||
164499389|NCT02970305|594200134|FG000|Overall Study|Lost to Follow-up|1|||
164499390|NCT02970305|594200135|FG001|Overall Study|Lost to Follow-up|2|||
164499391|NCT02175745|594200136|FG000|Overall Study|Not Eligible|1|||
164499392|NCT01121185|594200137|FG000|Overall Study|Not infused|0|||
164499393|NCT01121185|594200138|FG001|Overall Study|Not infused|1|||
164499394|NCT01121185|594200137|FG000|Overall Study|Not transplanted|1|||
164499395|NCT01121185|594200138|FG001|Overall Study|Not transplanted|0|||
164499396|NCT01260142|594200140|FG000|Treatment Period 1|Study on hold|1|||
164499397|NCT01260142|594200141|FG001|Treatment Period 1|Study on hold|1|||
164499398|NCT01260142|594200142|FG002|Treatment Period 1|Study on hold|0|||
164499399|NCT01260142|594200143|FG003|Treatment Period 1|Study on hold|0|||
164499400|NCT01260142|594200144|FG004|Treatment Period 1|Study on hold|1|||
164499401|NCT01260142|594200145|FG005|Treatment Period 1|Study on hold|2|||
164499402|NCT01260142|594200140|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
164499403|NCT01260142|594200141|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
164499404|NCT01260142|594200142|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
164499405|NCT01260142|594200143|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
164499406|NCT01260142|594200144|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
164499407|NCT01260142|594200145|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
164499408|NCT01260142|594200140|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164499409|NCT01260142|594200141|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164499410|NCT01260142|594200142|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164499411|NCT01260142|594200143|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164499412|NCT01260142|594200144|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164499413|NCT01260142|594200145|FG005|Treatment Period 1|Withdrawal by Subject|1|||
164499414|NCT00496834|594200153|FG000|Overall Study|Withdrawal by Subject|4|||
164499415|NCT00496834|594200154|FG001|Overall Study|Withdrawal by Subject|6|||
164499416|NCT00496834|594200153|FG000|Overall Study|Contraindicated medication administered|0|||
164499417|NCT00496834|594200154|FG001|Overall Study|Contraindicated medication administered|1|||
164499418|NCT00496834|594200153|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
164499419|NCT00496834|594200154|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
164499420|NCT00496834|594200153|FG000|Overall Study|Adverse Event|5|||
164499421|NCT00496834|594200154|FG001|Overall Study|Adverse Event|3|||
164499422|NCT00496834|594200153|FG000|Overall Study|IP administration violation|2|||
164499423|NCT00496834|594200154|FG001|Overall Study|IP administration violation|0|||
164499424|NCT00496834|594200153|FG000|Overall Study|Lost to Follow-up|2|||
164499425|NCT00496834|594200154|FG001|Overall Study|Lost to Follow-up|0|||
164499426|NCT00496834|594200153|FG000|Overall Study|Blood Pressure control failure|2|||
164499427|NCT00496834|594200154|FG001|Overall Study|Blood Pressure control failure|1|||
164499428|NCT01503164|594200155|FG000|Overall Study|Withdrawal by Subject|2|||
164499429|NCT01503164|594200156|FG001|Overall Study|Withdrawal by Subject|1|||
164499430|NCT01227928|594200157|FG000|Overall Study|Lost to Follow-up|4|||
164499431|NCT01227928|594200158|FG001|Overall Study|Lost to Follow-up|2|||
164499432|NCT01227928|594200157|FG000|Overall Study|Withdrawal by Subject|4|||
164499433|NCT01227928|594200158|FG001|Overall Study|Withdrawal by Subject|3|||
164715883|NCT03468218|594982173|FG000|Overall Study|Death|1|||
164715884|NCT03468218|594982173|FG000|Overall Study|Alternate therapy|1|||
164499434|NCT01227928|594200157|FG000|Overall Study|Death|14|||
164499435|NCT01227928|594200158|FG001|Overall Study|Death|12|||
164499436|NCT04088136|594200161|FG000|Overall Study|Withdrawal by Subject|5|||
164499437|NCT04088136|594200162|FG001|Overall Study|Withdrawal by Subject|0|||
164499438|NCT04088136|594200161|FG000|Overall Study|Lack of Efficacy|0|||
164499439|NCT04088136|594200162|FG001|Overall Study|Lack of Efficacy|1|||
164499440|NCT01494298|594200163|FG000|Overall Study|Protocol Violation|2|||
164499441|NCT01494298|594200164|FG001|Overall Study|Protocol Violation|8|||
164499442|NCT04159805|594200165|FG000|Overall Study|Withdrawal by Subject|0|||
164499443|NCT04159805|594200166|FG001|Overall Study|Withdrawal by Subject|2|||
164499444|NCT04159805|594200167|FG002|Overall Study|Withdrawal by Subject|2|||
164499445|NCT02930837|594200168|FG000|Overall Study|Adverse Event|6|||
164499446|NCT02930837|594200168|FG000|Overall Study|Lost to Follow-up|5|||
164499447|NCT02930837|594200168|FG000|Overall Study|Withdrawal by Subject|1|||
164499448|NCT01393613|594200169|FG000|Overall Study|Adverse Event|11|||
164499449|NCT01393613|594200170|FG001|Overall Study|Adverse Event|11|||
164499450|NCT01393613|594200171|FG002|Overall Study|Adverse Event|13|||
164499451|NCT01393613|594200172|FG003|Overall Study|Adverse Event|22|||
164499452|NCT01393613|594200169|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
164499453|NCT01393613|594200170|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
164499454|NCT01393613|594200171|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
164499455|NCT01393613|594200172|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
164499456|NCT01393613|594200169|FG000|Overall Study|Physician Decision|2|||
164499457|NCT01393613|594200170|FG001|Overall Study|Physician Decision|0|||
164499458|NCT01393613|594200171|FG002|Overall Study|Physician Decision|0|||
164499459|NCT01393613|594200172|FG003|Overall Study|Physician Decision|1|||
164499460|NCT01393613|594200169|FG000|Overall Study|Withdrawal by Subject|15|||
164499461|NCT01393613|594200170|FG001|Overall Study|Withdrawal by Subject|25|||
164499462|NCT01393613|594200171|FG002|Overall Study|Withdrawal by Subject|23|||
164499463|NCT01393613|594200172|FG003|Overall Study|Withdrawal by Subject|21|||
164499464|NCT01393613|594200169|FG000|Overall Study|Protocol Deviation|2|||
164499465|NCT01393613|594200170|FG001|Overall Study|Protocol Deviation|1|||
164499466|NCT01393613|594200171|FG002|Overall Study|Protocol Deviation|0|||
164499467|NCT01393613|594200172|FG003|Overall Study|Protocol Deviation|0|||
164499468|NCT01393613|594200169|FG000|Overall Study|Lack of Efficacy|9|||
164499469|NCT01393613|594200170|FG001|Overall Study|Lack of Efficacy|20|||
164499470|NCT01393613|594200171|FG002|Overall Study|Lack of Efficacy|16|||
164499471|NCT01393613|594200172|FG003|Overall Study|Lack of Efficacy|21|||
164499472|NCT02998918|594200176|FG000|Overall Study|Withdrawal by Subject|1|||
164499473|NCT02998918|594200177|FG001|Overall Study|Withdrawal by Subject|0|||
164499474|NCT05294328|594200182|FG000|Overall Study|Adverse Event|1|||
164499475|NCT05294328|594200183|FG001|Overall Study|Adverse Event|0|||
164499476|NCT05294328|594200184|FG002|Overall Study|Adverse Event|0|||
164499477|NCT05294328|594200182|FG000|Overall Study|Physician Decision|1|||
164499478|NCT05294328|594200183|FG001|Overall Study|Physician Decision|1|||
164499479|NCT05294328|594200184|FG002|Overall Study|Physician Decision|0|||
164499480|NCT05294328|594200182|FG000|Overall Study|Withdrawal by Subject|0|||
164499481|NCT05294328|594200183|FG001|Overall Study|Withdrawal by Subject|2|||
164499482|NCT05294328|594200184|FG002|Overall Study|Withdrawal by Subject|1|||
164499483|NCT05294328|594200182|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
164499484|NCT05294328|594200183|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
164499485|NCT05294328|594200184|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
164499486|NCT00497874|594201937|FG000|Overall Study|Withdrawal by Subject|48|||
164499487|NCT00497874|594201938|FG001|Overall Study|Withdrawal by Subject|17|||
164499488|NCT00497874|594201937|FG000|Overall Study|Illness|8|||
164499489|NCT00497874|594201938|FG001|Overall Study|Illness|4|||
164499490|NCT00497874|594201937|FG000|Overall Study|Death|2|||
164499491|NCT00497874|594201938|FG001|Overall Study|Death|4|||
164499492|NCT00497874|594201937|FG000|Overall Study|Unable to contact|52|||
164499493|NCT00497874|594201938|FG001|Overall Study|Unable to contact|67|||
164499494|NCT00497874|594201937|FG000|Overall Study|Unable to schedule|37|||
164499495|NCT00497874|594201938|FG001|Overall Study|Unable to schedule|24|||
164499496|NCT01101334|594201939|FG000|Overall Study|Adverse Event|9|||
164499497|NCT01101334|594201940|FG001|Overall Study|Adverse Event|4|||
164499498|NCT01101334|594201939|FG000|Overall Study|Death|7|||
164499499|NCT01101334|594201940|FG001|Overall Study|Death|1|||
164499500|NCT01101334|594201939|FG000|Overall Study|Withdrawal by Subject|4|||
164499501|NCT01101334|594201940|FG001|Overall Study|Withdrawal by Subject|3|||
164499502|NCT01101334|594201939|FG000|Overall Study|Withdrawal by Sponsor|1|||
164499503|NCT01101334|594201940|FG001|Overall Study|Withdrawal by Sponsor|1|||
164499504|NCT01101334|594201939|FG000|Overall Study|Progressive Disease|22|||
164499505|NCT01101334|594201940|FG001|Overall Study|Progressive Disease|35|||
164499506|NCT01101334|594201939|FG000|Overall Study|Other|2|||
164499507|NCT01101334|594201940|FG001|Overall Study|Other|1|||
164499508|NCT02820597|594201941|FG000|Overall Study|Lost to Follow-up|12|||
164499509|NCT01114139|594201942|FG000|Overall Study|Adverse Event|3|||
164499510|NCT01114139|594201943|FG001|Overall Study|Adverse Event|2|||
164499511|NCT01114139|594201942|FG000|Overall Study|Lost to Follow-up|15|||
164499512|NCT01114139|594201943|FG001|Overall Study|Lost to Follow-up|3|||
164499513|NCT01114139|594201942|FG000|Overall Study|Withdrawal by Subject|17|||
164499514|NCT01114139|594201943|FG001|Overall Study|Withdrawal by Subject|6|||
164499515|NCT01114139|594201942|FG000|Overall Study|Other-Missed 1 visit|1|||
164499516|NCT01114139|594201943|FG001|Overall Study|Other-Missed 1 visit|0|||
164499517|NCT01114139|594201942|FG000|Overall Study|Other-Protocol Violation|1|||
164499518|NCT01114139|594201943|FG001|Overall Study|Other-Protocol Violation|0|||
164499519|NCT01114139|594201942|FG000|Overall Study|Other-Out of window for study drug dose|1|||
164499520|NCT01114139|594201943|FG001|Overall Study|Other-Out of window for study drug dose|0|||
164499521|NCT01114139|594201942|FG000|Overall Study|Other-Participant falsified records|0|||
164499522|NCT01114139|594201943|FG001|Overall Study|Other-Participant falsified records|1|||
164499523|NCT01114139|594201942|FG000|Overall Study|Other-Participant went on hospice|0|||
164499524|NCT01114139|594201943|FG001|Overall Study|Other-Participant went on hospice|1|||
164499525|NCT01114139|594201942|FG000|Overall Study|Other-Physician changed treatment|1|||
164499526|NCT01114139|594201943|FG001|Overall Study|Other-Physician changed treatment|0|||
164499527|NCT01114139|594201942|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
164499528|NCT01114139|594201943|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
164145302|NCT00025259|592894269|FG006|Overall Study|Protocol Violation|3|||
164499529|NCT01951378|594201944|FG000|Overall Study|Study Terminated-Not completed|23|||
164499530|NCT01951378|594201945|FG001|Overall Study|Study Terminated-Not completed|17|||
164499531|NCT01475461|594201951|FG000|Run-in Period|Not meet eligibility criteria|16|||
164499532|NCT01475461|594201952|FG001|Run-in Period|Not meet eligibility criteria|0|||
164499533|NCT01475461|594201953|FG002|Run-in Period|Not meet eligibility criteria|0|||
164499534|NCT01475461|594201954|FG003|Run-in Period|Not meet eligibility criteria|0|||
164499535|NCT01475461|594201955|FG004|Run-in Period|Not meet eligibility criteria|0|||
164499536|NCT01475461|594201956|FG005|Run-in Period|Not meet eligibility criteria|0|||
164499537|NCT01475461|594201957|FG006|Run-in Period|Not meet eligibility criteria|0|||
164499538|NCT01475461|594201951|FG000|Run-in Period|Lost to Follow-up|7|||
164499539|NCT01475461|594201952|FG001|Run-in Period|Lost to Follow-up|0|||
164499540|NCT01475461|594201953|FG002|Run-in Period|Lost to Follow-up|0|||
164499541|NCT01475461|594201954|FG003|Run-in Period|Lost to Follow-up|0|||
164499542|NCT01475461|594201955|FG004|Run-in Period|Lost to Follow-up|0|||
164499543|NCT01475461|594201956|FG005|Run-in Period|Lost to Follow-up|0|||
164499544|NCT01475461|594201957|FG006|Run-in Period|Lost to Follow-up|0|||
164499545|NCT01475461|594201951|FG000|Run-in Period|Withdrawal by Subject|11|||
164499546|NCT01475461|594201952|FG001|Run-in Period|Withdrawal by Subject|0|||
164499547|NCT01475461|594201953|FG002|Run-in Period|Withdrawal by Subject|0|||
164499548|NCT01475461|594201954|FG003|Run-in Period|Withdrawal by Subject|0|||
164499549|NCT01475461|594201955|FG004|Run-in Period|Withdrawal by Subject|0|||
164499550|NCT01475461|594201956|FG005|Run-in Period|Withdrawal by Subject|0|||
164499551|NCT01475461|594201957|FG006|Run-in Period|Withdrawal by Subject|0|||
164499552|NCT01475461|594201951|FG000|Run-in Period|Other|3|||
164499553|NCT01475461|594201952|FG001|Run-in Period|Other|0|||
164499554|NCT01475461|594201953|FG002|Run-in Period|Other|0|||
164499555|NCT01475461|594201954|FG003|Run-in Period|Other|0|||
164499556|NCT01475461|594201955|FG004|Run-in Period|Other|0|||
164499557|NCT01475461|594201956|FG005|Run-in Period|Other|0|||
164499558|NCT01475461|594201957|FG006|Run-in Period|Other|0|||
164499559|NCT01475461|594201951|FG000|Run-in Period|Protocol Violation|4|||
164499560|NCT01475461|594201952|FG001|Run-in Period|Protocol Violation|0|||
164499561|NCT01475461|594201953|FG002|Run-in Period|Protocol Violation|0|||
164499562|NCT01475461|594201954|FG003|Run-in Period|Protocol Violation|0|||
164499563|NCT01475461|594201955|FG004|Run-in Period|Protocol Violation|0|||
164499564|NCT01475461|594201956|FG005|Run-in Period|Protocol Violation|0|||
164499565|NCT01475461|594201957|FG006|Run-in Period|Protocol Violation|0|||
164499566|NCT01475461|594201951|FG000|Treatment Period|Death|0|||
164499567|NCT01475461|594201952|FG001|Treatment Period|Death|0|||
164499568|NCT01475461|594201953|FG002|Treatment Period|Death|0|||
164499569|NCT01475461|594201954|FG003|Treatment Period|Death|1|||
164499570|NCT01475461|594201955|FG004|Treatment Period|Death|0|||
164499571|NCT01475461|594201956|FG005|Treatment Period|Death|0|||
164499572|NCT01475461|594201957|FG006|Treatment Period|Death|0|||
164499573|NCT01475461|594201951|FG000|Treatment Period|Lost to Follow-up|0|||
164499574|NCT01475461|594201952|FG001|Treatment Period|Lost to Follow-up|3|||
164499575|NCT01475461|594201953|FG002|Treatment Period|Lost to Follow-up|2|||
164499576|NCT01475461|594201954|FG003|Treatment Period|Lost to Follow-up|3|||
164499577|NCT01475461|594201955|FG004|Treatment Period|Lost to Follow-up|1|||
164499578|NCT01475461|594201956|FG005|Treatment Period|Lost to Follow-up|2|||
164499579|NCT01475461|594201957|FG006|Treatment Period|Lost to Follow-up|1|||
164499580|NCT01475461|594201951|FG000|Treatment Period|Withdrawal by Subject|0|||
164499581|NCT01475461|594201952|FG001|Treatment Period|Withdrawal by Subject|2|||
164499582|NCT01475461|594201953|FG002|Treatment Period|Withdrawal by Subject|2|||
164499583|NCT01475461|594201954|FG003|Treatment Period|Withdrawal by Subject|0|||
164499584|NCT01475461|594201955|FG004|Treatment Period|Withdrawal by Subject|2|||
164499585|NCT01475461|594201956|FG005|Treatment Period|Withdrawal by Subject|2|||
164499586|NCT01475461|594201957|FG006|Treatment Period|Withdrawal by Subject|0|||
164499587|NCT01475461|594201951|FG000|Treatment Period|Other|0|||
164499588|NCT01475461|594201952|FG001|Treatment Period|Other|1|||
164499589|NCT01475461|594201953|FG002|Treatment Period|Other|0|||
164499590|NCT01475461|594201954|FG003|Treatment Period|Other|0|||
164499591|NCT01475461|594201955|FG004|Treatment Period|Other|0|||
164499592|NCT01475461|594201956|FG005|Treatment Period|Other|0|||
164499593|NCT01475461|594201957|FG006|Treatment Period|Other|0|||
164499594|NCT01475461|594201951|FG000|Treatment Period|Protocol Violation|0|||
164499595|NCT01475461|594201952|FG001|Treatment Period|Protocol Violation|1|||
164499596|NCT01475461|594201953|FG002|Treatment Period|Protocol Violation|0|||
164499597|NCT01475461|594201954|FG003|Treatment Period|Protocol Violation|0|||
164499598|NCT01475461|594201955|FG004|Treatment Period|Protocol Violation|0|||
164499599|NCT01475461|594201956|FG005|Treatment Period|Protocol Violation|0|||
164499600|NCT01475461|594201957|FG006|Treatment Period|Protocol Violation|1|||
164499601|NCT01475461|594201951|FG000|Treatment Period|Lack of Efficacy|0|||
164499602|NCT01475461|594201952|FG001|Treatment Period|Lack of Efficacy|2|||
164499603|NCT01475461|594201953|FG002|Treatment Period|Lack of Efficacy|0|||
164499604|NCT01475461|594201954|FG003|Treatment Period|Lack of Efficacy|2|||
164499605|NCT01475461|594201955|FG004|Treatment Period|Lack of Efficacy|1|||
164499606|NCT01475461|594201956|FG005|Treatment Period|Lack of Efficacy|1|||
164499607|NCT01475461|594201957|FG006|Treatment Period|Lack of Efficacy|0|||
164499608|NCT01475461|594201951|FG000|Treatment Period|Medication Error|0|||
164499609|NCT01475461|594201952|FG001|Treatment Period|Medication Error|0|||
164499610|NCT01475461|594201953|FG002|Treatment Period|Medication Error|0|||
164499611|NCT01475461|594201954|FG003|Treatment Period|Medication Error|1|||
164499612|NCT01475461|594201955|FG004|Treatment Period|Medication Error|0|||
164499613|NCT01475461|594201956|FG005|Treatment Period|Medication Error|0|||
164499614|NCT01475461|594201957|FG006|Treatment Period|Medication Error|0|||
164499615|NCT01475461|594201951|FG000|Treatment Period|Adverse Event|0|||
164499616|NCT01475461|594201952|FG001|Treatment Period|Adverse Event|0|||
164499617|NCT01475461|594201953|FG002|Treatment Period|Adverse Event|0|||
164499618|NCT01475461|594201954|FG003|Treatment Period|Adverse Event|1|||
164499619|NCT01475461|594201955|FG004|Treatment Period|Adverse Event|0|||
164499620|NCT01475461|594201956|FG005|Treatment Period|Adverse Event|0|||
164499621|NCT01475461|594201957|FG006|Treatment Period|Adverse Event|0|||
164499622|NCT02262364|594201958|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
164499623|NCT01049984|594201959|FG000|Overall Study|Withdrawal by Subject|1|||
164499624|NCT01049984|594201960|FG001|Overall Study|Withdrawal by Subject|5|||
164499625|NCT01049984|594201959|FG000|Overall Study|Protocol Violation|3|||
164499626|NCT01049984|594201960|FG001|Overall Study|Protocol Violation|4|||
164499627|NCT01049984|594201959|FG000|Overall Study|Lost to Follow-up|2|||
164499628|NCT01049984|594201960|FG001|Overall Study|Lost to Follow-up|1|||
164499629|NCT01049984|594201959|FG000|Overall Study|Adverse Event|13|||
164499630|NCT01049984|594201960|FG001|Overall Study|Adverse Event|7|||
164499631|NCT01049984|594201959|FG000|Overall Study|Treatment failure|0|||
164499632|NCT01049984|594201960|FG001|Overall Study|Treatment failure|2|||
164499633|NCT02512861|594201961|FG000|Overall Study|Protocol Violation|3|||
164499634|NCT02512861|594201962|FG001|Overall Study|Protocol Violation|7|||
164499635|NCT02512861|594201961|FG000|Overall Study|Physician Decision|3|||
164499636|NCT02512861|594201962|FG001|Overall Study|Physician Decision|1|||
164499637|NCT02512861|594201961|FG000|Overall Study|Withdrawal by Subject|0|||
164499638|NCT02512861|594201962|FG001|Overall Study|Withdrawal by Subject|1|||
164499639|NCT01774019|594201963|FG000|Overall Study|No longer meets protocol criteria|2|||
164499640|NCT01774019|594201964|FG001|Overall Study|No longer meets protocol criteria|0|||
164499641|NCT01774019|594201963|FG000|Overall Study|Withdrawal by Subject|1|||
164499642|NCT01774019|594201964|FG001|Overall Study|Withdrawal by Subject|0|||
164499643|NCT01774019|594201963|FG000|Overall Study|Surgery delayed > 120 days|1|||
164499644|NCT01774019|594201964|FG001|Overall Study|Surgery delayed > 120 days|0|||
164499645|NCT01774019|594201963|FG000|Overall Study|Patient refused surgery|1|||
164499646|NCT01774019|594201964|FG001|Overall Study|Patient refused surgery|1|||
164499647|NCT01774019|594201963|FG000|Overall Study|Unable to implant study device|1|||
164499648|NCT01774019|594201964|FG001|Overall Study|Unable to implant study device|0|||
164499649|NCT01774019|594201963|FG000|Overall Study|Lost to Follow-up|0|||
164499650|NCT01774019|594201964|FG001|Overall Study|Lost to Follow-up|3|||
164499651|NCT00292981|594201965|FG000|Overall Study|Adverse Event|1|||
164499652|NCT00292981|594201965|FG000|Overall Study|Lost to Follow-up|13|||
164499653|NCT00292981|594201965|FG000|Overall Study|Withdrawal by Subject|22|||
164499654|NCT00292981|594201965|FG000|Overall Study|Other|3|||
164499655|NCT04582669|594201977|FG000|Overall Study|Subject missed appointment(s).|1|||
164499656|NCT04582669|594201978|FG001|Overall Study|Subject missed appointment(s).|0|||
164499657|NCT04582669|594201979|FG002|Overall Study|Subject missed appointment(s).|1|||
164499658|NCT04582669|594201980|FG003|Overall Study|Subject missed appointment(s).|2|||
164499659|NCT04582669|594201977|FG000|Overall Study|Protocol Violation|0|||
164499660|NCT04582669|594201978|FG001|Overall Study|Protocol Violation|1|||
164499661|NCT04582669|594201979|FG002|Overall Study|Protocol Violation|1|||
164499662|NCT04582669|594201980|FG003|Overall Study|Protocol Violation|0|||
164499663|NCT03245619|594201984|FG000|Part A (Up to Day 22)|Physician Decision|4|||
164499664|NCT03245619|594201985|FG001|Part A (Up to Day 22)|Physician Decision|6|||
164499665|NCT03245619|594201986|FG002|Part A (Up to Day 22)|Physician Decision|6|||
164499666|NCT03245619|594201987|FG003|Part A (Up to Day 22)|Physician Decision|0|||
164499667|NCT03245619|594201988|FG004|Part A (Up to Day 22)|Physician Decision|0|||
164499668|NCT03245619|594201989|FG005|Part A (Up to Day 22)|Physician Decision|0|||
164499669|NCT03245619|594201990|FG006|Part A (Up to Day 22)|Physician Decision|0|||
164499670|NCT03245619|594201991|FG007|Part A (Up to Day 22)|Physician Decision|0|||
164499671|NCT03245619|594201992|FG008|Part A (Up to Day 22)|Physician Decision|0|||
164499672|NCT03245619|594201993|FG009|Part A (Up to Day 22)|Physician Decision|0|||
164499673|NCT03245619|594201994|FG010|Part A (Up to Day 22)|Physician Decision|0|||
164499674|NCT03245619|594201995|FG011|Part A (Up to Day 22)|Physician Decision|0|||
164499675|NCT03245619|594201996|FG012|Part A (Up to Day 22)|Physician Decision|0|||
164499676|NCT03245619|594201997|FG013|Part A (Up to Day 22)|Physician Decision|0|||
164499677|NCT03245619|594201998|FG014|Part A (Up to Day 22)|Physician Decision|0|||
164499678|NCT03245619|594201999|FG015|Part A (Up to Day 22)|Physician Decision|0|||
164499679|NCT03245619|594202000|FG016|Part A (Up to Day 22)|Physician Decision|0|||
164499680|NCT03201900|594202001|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
164499681|NCT03201900|594202001|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
164499682|NCT03201900|594202001|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
164499683|NCT03201900|594202001|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
164499684|NCT03201900|594202001|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
164499685|NCT03201900|594202001|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
164499686|NCT03201900|594202001|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
164499687|NCT03201900|594202001|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
164499688|NCT03201900|594202001|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
164499689|NCT03201900|594202001|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
164499690|NCT03201900|594202001|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
164499691|NCT03201900|594202001|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
164499692|NCT03201900|594202001|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
164499693|NCT03470545|594202002|FG000|Overall Study|Death|0|||
164499694|NCT03470545|594202003|FG001|Overall Study|Death|1|||
164499695|NCT03470545|594202002|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
164499696|NCT03470545|594202003|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
164499697|NCT03470545|594202002|FG000|Overall Study|Adverse Event|2|||
164499698|NCT03470545|594202003|FG001|Overall Study|Adverse Event|0|||
164499699|NCT03470545|594202002|FG000|Overall Study|Withdrawal by Subject|1|||
164499700|NCT03470545|594202003|FG001|Overall Study|Withdrawal by Subject|1|||
164499701|NCT03470545|594202002|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
164499702|NCT03470545|594202003|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
164499703|NCT00776659|594202019|FG000|Overall Study|Lost to Follow-up|15|||
164499704|NCT00776659|594202019|FG000|Overall Study|Withdrawal by Subject|10|||
164499705|NCT00776659|594202019|FG000|Overall Study|Study Terminated by Sponsor|1|||
164499706|NCT02971228|594202020|FG000|Overall Study|Withdrawal by Subject|1|||
164499707|NCT02971228|594202021|FG001|Overall Study|Withdrawal by Subject|1|||
164499708|NCT02971228|594202022|FG002|Overall Study|Withdrawal by Subject|0|||
164499709|NCT02971228|594202023|FG003|Overall Study|Withdrawal by Subject|0|||
164499710|NCT02971228|594202024|FG004|Overall Study|Withdrawal by Subject|0|||
164499711|NCT02971228|594202020|FG000|Overall Study|Logistical challenges|0|||
164499712|NCT02971228|594202021|FG001|Overall Study|Logistical challenges|1|||
164499713|NCT02971228|594202022|FG002|Overall Study|Logistical challenges|0|||
164499714|NCT02971228|594202023|FG003|Overall Study|Logistical challenges|0|||
164499715|NCT02971228|594202024|FG004|Overall Study|Logistical challenges|0|||
164499716|NCT01664923|594202025|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
164499717|NCT01664923|594202026|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
164499718|NCT01664923|594202025|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
164499719|NCT01664923|594202026|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
164499720|NCT01664923|594202025|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
164499721|NCT01664923|594202026|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
164499722|NCT01664923|594202025|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
164499723|NCT01664923|594202026|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
164499724|NCT01664923|594202025|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
164499725|NCT01664923|594202026|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
164499726|NCT01664923|594202025|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
164499727|NCT01664923|594202026|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
164499728|NCT01664923|594202025|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
164499729|NCT01664923|594202026|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
164499730|NCT01664923|594202025|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
164499731|NCT01664923|594202026|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
164499732|NCT01664923|594202025|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
164499733|NCT01664923|594202026|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
164499734|NCT01664923|594202025|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
164499735|NCT01664923|594202026|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
164499736|NCT01664923|594202025|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
164499737|NCT01664923|594202026|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
164499738|NCT01664923|594202025|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
164499739|NCT01664923|594202026|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
164499740|NCT01664923|594202025|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
164499741|NCT01664923|594202026|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
164499742|NCT01664923|594202025|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
164499743|NCT01664923|594202026|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
164499744|NCT01233999|594202029|FG000|Overall Study|Withdrawal by Subject|1|||
164499745|NCT01233999|594202029|FG000|Overall Study|Lost to Follow-up|1|||
164499746|NCT01167192|594202030|FG000|Overall Study|Adverse Event|1|||
164499747|NCT01167192|594202030|FG000|Overall Study|Death|1|||
164715885|NCT03468218|594982173|FG000|Overall Study|Withdrawal by Subject|2|||
164499748|NCT01167192|594202030|FG000|Overall Study|Withdrawal by Subject|1|||
164715886|NCT02503657|594982175|FG000|Open-label Period|Physician Decision|0|||
164715887|NCT02503657|594982176|FG001|Open-label Period|Physician Decision|1|||
164499749|NCT01167192|594202030|FG000|Overall Study|Insurance denial|1|||
164499750|NCT01336205|594202031|FG000|Overall Study|Other|22|||
164499751|NCT01336205|594202032|FG001|Overall Study|Other|9|||
164499752|NCT01336205|594202031|FG000|Overall Study|Lost to Follow-up|40|||
164499753|NCT01336205|594202032|FG001|Overall Study|Lost to Follow-up|20|||
164499754|NCT01336205|594202031|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
164499755|NCT01336205|594202032|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
164499756|NCT01336205|594202031|FG000|Overall Study|Lack of Efficacy|4|||
164499757|NCT01336205|594202032|FG001|Overall Study|Lack of Efficacy|0|||
164499758|NCT01336205|594202031|FG000|Overall Study|Severe noncompliance with protocol|9|||
164499759|NCT01336205|594202032|FG001|Overall Study|Severe noncompliance with protocol|2|||
164499760|NCT01336205|594202031|FG000|Overall Study|Adverse Event|56|||
164499761|NCT01336205|594202032|FG001|Overall Study|Adverse Event|6|||
164499762|NCT01336205|594202031|FG000|Overall Study|Death|1|||
164499763|NCT01336205|594202032|FG001|Overall Study|Death|1|||
164499764|NCT01336205|594202031|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
164499765|NCT01336205|594202032|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
164499766|NCT01336205|594202031|FG000|Overall Study|Withdrawal by Subject|72|||
164499767|NCT01336205|594202032|FG001|Overall Study|Withdrawal by Subject|38|||
164499768|NCT01336205|594202031|FG000|Overall Study|Did not receive treatment|4|||
164499769|NCT01336205|594202032|FG001|Overall Study|Did not receive treatment|0|||
164499770|NCT00129649|594202033|FG000|Overall Study|Withdrawal by Subject|76|||
164499771|NCT00129649|594202034|FG001|Overall Study|Withdrawal by Subject|65|||
164499772|NCT04952701|594202035|FG000|Control Lens|Physician Decision|4|||
164499773|NCT04952701|594202035|FG000|Test Lens|Physician Decision|1|||
164499774|NCT02547441|594202036|FG000|Double-Blind Study Period|Adverse Event|4|||
164499775|NCT02547441|594202037|FG001|Double-Blind Study Period|Adverse Event|9|||
164499776|NCT02547441|594202036|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
164499777|NCT02547441|594202037|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
164499778|NCT02547441|594202036|FG000|Double-Blind Study Period|Physician Decision|1|||
164499779|NCT02547441|594202037|FG001|Double-Blind Study Period|Physician Decision|0|||
164499780|NCT02547441|594202036|FG000|Double-Blind Study Period|Protocol Violation|1|||
164499781|NCT02547441|594202037|FG001|Double-Blind Study Period|Protocol Violation|2|||
164499782|NCT02547441|594202036|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
164499783|NCT02547441|594202037|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
164499784|NCT02547441|594202036|FG000|Double-Blind Study Period|Sponsor Decision|1|||
164499785|NCT02547441|594202037|FG001|Double-Blind Study Period|Sponsor Decision|0|||
164499786|NCT02547441|594202036|FG000|Open-Label Study Period|Adverse Event|10|||
164499787|NCT02547441|594202037|FG001|Open-Label Study Period|Adverse Event|11|||
164499788|NCT02547441|594202036|FG000|Open-Label Study Period|Lack of Efficacy|3|||
164499789|NCT02547441|594202037|FG001|Open-Label Study Period|Lack of Efficacy|2|||
164499790|NCT02547441|594202036|FG000|Open-Label Study Period|Lost to Follow-up|7|||
164499791|NCT02547441|594202037|FG001|Open-Label Study Period|Lost to Follow-up|8|||
164499792|NCT02547441|594202036|FG000|Open-Label Study Period|Physician Decision|1|||
164499793|NCT02547441|594202037|FG001|Open-Label Study Period|Physician Decision|0|||
164499794|NCT02547441|594202036|FG000|Open-Label Study Period|Protocol Violation|2|||
164499795|NCT02547441|594202037|FG001|Open-Label Study Period|Protocol Violation|0|||
164499796|NCT02547441|594202036|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
164499797|NCT02547441|594202037|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
164499798|NCT02547441|594202036|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
164499799|NCT02547441|594202037|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
164499800|NCT01322009|594202038|FG000|Overall Study|Death|0|||
164499801|NCT01322009|594202039|FG001|Overall Study|Death|1|||
164499802|NCT01322009|594202038|FG000|Overall Study|Adverse Event|0|||
164499803|NCT01322009|594202039|FG001|Overall Study|Adverse Event|1|||
164499804|NCT01322009|594202038|FG000|Overall Study|ng tube discontinued|0|||
164499805|NCT01322009|594202039|FG001|Overall Study|ng tube discontinued|1|||
164499806|NCT01657877|594202040|FG000|Overall Study|Withdrawal by Subject|4|||
164499807|NCT01657877|594202040|FG000|Overall Study|Protocol Violation|6|||
164499808|NCT01657877|594202040|FG000|Overall Study|Adverse Event|2|||
164499809|NCT01657877|594202040|FG000|Overall Study|Other Reason|2|||
164605156|NCT04511819|594575927|FG001|Overall Study|Non-compliance with study drug|1|||
164605157|NCT04511819|594575926|FG000|Overall Study|Withdrawal by Subject|0|||
164499810|NCT04545476|594202041|FG000|Overall Study|Lost to Follow-up|1|||
164499811|NCT04545476|594202042|FG001|Overall Study|Lost to Follow-up|1|||
164499812|NCT04545476|594202043|FG002|Overall Study|Lost to Follow-up|0|||
164499813|NCT04545476|594202044|FG003|Overall Study|Lost to Follow-up|0|||
164499814|NCT00937521|594202049|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
164499815|NCT00937521|594202050|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
164499816|NCT00937521|594202051|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
164605158|NCT04511819|594575927|FG001|Overall Study|Withdrawal by Subject|3|||
164499817|NCT00937521|594202052|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
164499818|NCT00937521|594202053|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
164499819|NCT00937521|594202054|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
164499820|NCT00937521|594202055|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
164499821|NCT00937521|594202056|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
164499822|NCT00937521|594202049|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
164499823|NCT00937521|594202050|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
164499824|NCT00937521|594202051|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
164499825|NCT00937521|594202052|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
164499826|NCT00937521|594202053|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
164499827|NCT00937521|594202054|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
164499828|NCT00937521|594202055|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
164499829|NCT00937521|594202056|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
164499830|NCT00937521|594202049|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
164499831|NCT00937521|594202050|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
164499832|NCT00937521|594202051|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
164499833|NCT00937521|594202052|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
164499834|NCT00937521|594202053|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
164499835|NCT00937521|594202054|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
164499836|NCT00937521|594202055|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
164499837|NCT00937521|594202056|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
164499838|NCT00937521|594202049|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
164499839|NCT00937521|594202050|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
164499840|NCT00937521|594202051|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
164499841|NCT00937521|594202052|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
164499842|NCT00937521|594202053|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
164499843|NCT00937521|594202054|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
164499844|NCT00937521|594202055|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
164499845|NCT00937521|594202056|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
164499846|NCT00937521|594202049|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
164499847|NCT00937521|594202050|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
164499848|NCT00937521|594202051|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
164499849|NCT00937521|594202052|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
164499850|NCT00937521|594202053|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
164499851|NCT00937521|594202054|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
164499852|NCT00937521|594202055|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
164499853|NCT00937521|594202056|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
164499854|NCT00937521|594202049|FG000|Booster Phase|Adverse Event|0|||
164499855|NCT00937521|594202050|FG001|Booster Phase|Adverse Event|0|||
164499856|NCT00937521|594202051|FG002|Booster Phase|Adverse Event|0|||
164499857|NCT00937521|594202052|FG003|Booster Phase|Adverse Event|0|||
164499858|NCT00937521|594202053|FG004|Booster Phase|Adverse Event|0|||
164499859|NCT00937521|594202054|FG005|Booster Phase|Adverse Event|0|||
164499860|NCT00937521|594202055|FG006|Booster Phase|Adverse Event|1|||
164499861|NCT00937521|594202056|FG007|Booster Phase|Adverse Event|0|||
164499862|NCT00937521|594202049|FG000|Booster Phase|Withdrawal by Subject|1|||
164499863|NCT00937521|594202050|FG001|Booster Phase|Withdrawal by Subject|0|||
164499864|NCT00937521|594202051|FG002|Booster Phase|Withdrawal by Subject|0|||
164499865|NCT00937521|594202052|FG003|Booster Phase|Withdrawal by Subject|1|||
164499866|NCT00937521|594202053|FG004|Booster Phase|Withdrawal by Subject|0|||
164499867|NCT00937521|594202054|FG005|Booster Phase|Withdrawal by Subject|0|||
164499868|NCT00937521|594202055|FG006|Booster Phase|Withdrawal by Subject|0|||
164499869|NCT00937521|594202056|FG007|Booster Phase|Withdrawal by Subject|2|||
164499870|NCT00937521|594202049|FG000|Booster Phase|Lost to Follow-up|2|||
164499871|NCT00937521|594202050|FG001|Booster Phase|Lost to Follow-up|2|||
164499872|NCT00937521|594202051|FG002|Booster Phase|Lost to Follow-up|4|||
164499873|NCT00937521|594202052|FG003|Booster Phase|Lost to Follow-up|2|||
164499874|NCT00937521|594202053|FG004|Booster Phase|Lost to Follow-up|4|||
164499875|NCT00937521|594202054|FG005|Booster Phase|Lost to Follow-up|4|||
164499876|NCT00937521|594202055|FG006|Booster Phase|Lost to Follow-up|3|||
164499877|NCT00937521|594202056|FG007|Booster Phase|Lost to Follow-up|0|||
164499878|NCT00937521|594202049|FG000|Booster Phase|Administrative Reason|0|||
164499879|NCT00937521|594202050|FG001|Booster Phase|Administrative Reason|0|||
164499880|NCT00937521|594202051|FG002|Booster Phase|Administrative Reason|1|||
164499881|NCT00937521|594202052|FG003|Booster Phase|Administrative Reason|0|||
164499882|NCT00937521|594202053|FG004|Booster Phase|Administrative Reason|1|||
164715888|NCT04757519|594982177|FG000|Overall Study|Lost to Follow-up|17|||
164715889|NCT04757519|594982178|FG001|Overall Study|Lost to Follow-up|18|||
164499883|NCT00937521|594202054|FG005|Booster Phase|Administrative Reason|1|||
164499884|NCT00937521|594202055|FG006|Booster Phase|Administrative Reason|0|||
164499885|NCT00937521|594202056|FG007|Booster Phase|Administrative Reason|0|||
164499886|NCT00937521|594202049|FG000|Booster Phase|Protocol Deviation|0|||
164715890|NCT03829722|594982179|FG000|Overall Study|Adverse Event|1|||
164715891|NCT03829722|594982179|FG000|Overall Study|Withdrawal by Subject|7|||
164715892|NCT03829722|594982179|FG000|Overall Study|Physician Decision|5|||
164605159|NCT04511819|594575926|FG000|Overall Study|Adverse Event|0|||
164605160|NCT04511819|594575927|FG001|Overall Study|Adverse Event|1|||
164605161|NCT04511819|594575926|FG000|Overall Study|Protocol deviation|1|||
164605162|NCT04511819|594575927|FG001|Overall Study|Protocol deviation|0|||
164605163|NCT00589979|594575932|FG000|Run-In Period|Adverse Event|5|||
164605164|NCT00589979|594575933|FG001|Run-In Period|Adverse Event|0|||
164605165|NCT00589979|594575934|FG002|Run-In Period|Adverse Event|0|||
164605166|NCT00589979|594575932|FG000|Run-In Period|Protocol Violation|3|||
164605167|NCT00589979|594575933|FG001|Run-In Period|Protocol Violation|0|||
164605168|NCT00589979|594575934|FG002|Run-In Period|Protocol Violation|0|||
164605169|NCT00589979|594575932|FG000|Run-In Period|Did not qualify for randomization|54|||
164605170|NCT00589979|594575933|FG001|Run-In Period|Did not qualify for randomization|0|||
164605171|NCT00589979|594575934|FG002|Run-In Period|Did not qualify for randomization|0|||
164605172|NCT00589979|594575932|FG000|Run-In Period|Withdrawal by Subject|10|||
164605173|NCT00589979|594575933|FG001|Run-In Period|Withdrawal by Subject|0|||
164605174|NCT00589979|594575934|FG002|Run-In Period|Withdrawal by Subject|0|||
164605175|NCT00589979|594575932|FG000|Run-In Period|Informed Consent Withdrawn|4|||
164605176|NCT00589979|594575933|FG001|Run-In Period|Informed Consent Withdrawn|0|||
164605177|NCT00589979|594575934|FG002|Run-In Period|Informed Consent Withdrawn|0|||
164605178|NCT00589979|594575932|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
164605179|NCT00589979|594575933|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
164605180|NCT00589979|594575934|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
164605181|NCT00589979|594575932|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
164605182|NCT00589979|594575933|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
164605183|NCT00589979|594575934|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
164605184|NCT00589979|594575932|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
164605185|NCT00589979|594575933|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
164605186|NCT00589979|594575934|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
164605187|NCT00589979|594575932|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
164605188|NCT00589979|594575933|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
164605189|NCT00589979|594575934|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
164605190|NCT00589979|594575932|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
164605191|NCT00589979|594575933|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
164605192|NCT00589979|594575934|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
164605193|NCT00589979|594575932|FG000|Double-Blind Treatment Period 2|Other|0|||
164605194|NCT00589979|594575933|FG001|Double-Blind Treatment Period 2|Other|0|||
164605195|NCT00589979|594575934|FG002|Double-Blind Treatment Period 2|Other|1|||
164605196|NCT00589979|594575932|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
164605197|NCT00589979|594575933|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
164605198|NCT00589979|594575934|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
164605199|NCT00589979|594575932|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
164605200|NCT00589979|594575933|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
164605201|NCT00589979|594575934|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
164605202|NCT03428997|594575935|FG000|Overall Study|Sponsor decision.|1|||
164605203|NCT03428997|594575935|FG000|Overall Study|Withdrawal by Subject|3|||
164605204|NCT03428997|594575935|FG000|Overall Study|Lost to Follow-up|4|||
164605205|NCT02120157|594575939|FG000|Overall Study|Death|8|||
164605206|NCT02553317|594575940|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
164605207|NCT02553317|594575941|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
164605208|NCT02553317|594575940|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
164605209|NCT02553317|594575941|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
164605210|NCT02553317|594575940|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
164605211|NCT02553317|594575941|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
164605212|NCT02553317|594575940|FG000|Overall Treatment Period + Follow-up|Death|1|||
164605213|NCT02553317|594575941|FG001|Overall Treatment Period + Follow-up|Death|3|||
164605214|NCT02553317|594575940|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
164605215|NCT02553317|594575941|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
164605216|NCT02553317|594575940|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
164605217|NCT02553317|594575941|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
164605218|NCT02553317|594575940|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
164605219|NCT02553317|594575941|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
164605220|NCT02553317|594575940|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
164605221|NCT02553317|594575941|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
164605222|NCT02553317|594575940|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
164605223|NCT02553317|594575941|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
164605224|NCT02553317|594575940|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
164605225|NCT02553317|594575941|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
164605226|NCT01354431|594575943|FG000|Pre-Treatment Period|Not reported|1|||
164605227|NCT01354431|594575944|FG001|Pre-Treatment Period|Not reported|0|||
164499887|NCT00937521|594202050|FG001|Booster Phase|Protocol Deviation|0|||
164499888|NCT00937521|594202051|FG002|Booster Phase|Protocol Deviation|0|||
164499889|NCT00937521|594202052|FG003|Booster Phase|Protocol Deviation|0|||
164499890|NCT00937521|594202053|FG004|Booster Phase|Protocol Deviation|0|||
164499891|NCT00937521|594202054|FG005|Booster Phase|Protocol Deviation|0|||
164499892|NCT00937521|594202055|FG006|Booster Phase|Protocol Deviation|1|||
164499893|NCT00937521|594202056|FG007|Booster Phase|Protocol Deviation|0|||
164499894|NCT01978236|594202057|FG000|Overall Study|Discontinued due to study close|2|||
164499895|NCT04035577|594202058|FG000|Overall Study|Lost to Follow-up|1|||
164499896|NCT04035577|594202058|FG000|Overall Study|Withdrawal by Subject|1|||
164499897|NCT00846768|594202060|FG000|Overall Study|Adverse Event|0|||
164499898|NCT00846768|594202061|FG001|Overall Study|Adverse Event|1|||
164499899|NCT00846768|594202062|FG002|Overall Study|Adverse Event|0|||
164499900|NCT00846768|594202063|FG003|Overall Study|Adverse Event|0|||
164499901|NCT00634920|594202065|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
164499902|NCT00634920|594202066|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
164499903|NCT00634920|594202067|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
164499904|NCT00634920|594202065|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
164499905|NCT00634920|594202066|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
164499906|NCT00634920|594202067|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
164499907|NCT00634920|594202065|FG000|Period 1 - Pre-Randomization|Rejections|0|||
164499908|NCT00634920|594202066|FG001|Period 1 - Pre-Randomization|Rejections|0|||
164499909|NCT00634920|594202067|FG002|Period 1 - Pre-Randomization|Rejections|55|||
164499910|NCT00634920|594202065|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
164499911|NCT00634920|594202066|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
164499912|NCT00634920|594202067|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
164499913|NCT00634920|594202065|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
164499914|NCT00634920|594202066|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
164499915|NCT00634920|594202067|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
164499916|NCT00634920|594202065|FG000|Period 1 - Pre-Randomization|Other issues|0|||
164499917|NCT00634920|594202066|FG001|Period 1 - Pre-Randomization|Other issues|0|||
164499918|NCT00634920|594202067|FG002|Period 1 - Pre-Randomization|Other issues|6|||
164499919|NCT00634920|594202065|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
164499920|NCT00634920|594202066|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
164499921|NCT00634920|594202067|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
164499922|NCT00634920|594202065|FG000|Period 2 - Post-Randomization|Rejection|11|||
164499923|NCT00634920|594202066|FG001|Period 2 - Post-Randomization|Rejection|5|||
164499924|NCT00634920|594202067|FG002|Period 2 - Post-Randomization|Rejection|0|||
164499925|NCT00634920|594202065|FG000|Period 2 - Post-Randomization|Death|2|||
164499926|NCT00634920|594202066|FG001|Period 2 - Post-Randomization|Death|5|||
164499927|NCT00634920|594202067|FG002|Period 2 - Post-Randomization|Death|0|||
164499928|NCT00634920|594202065|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
164499929|NCT00634920|594202066|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
164499930|NCT00634920|594202067|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
164499931|NCT00634920|594202065|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
164499932|NCT00634920|594202066|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
164499933|NCT00634920|594202067|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
164499934|NCT00644878|594202068|FG000|Overall Study|Adverse Event|2|||
164499935|NCT00644878|594202068|FG000|Overall Study|Abnormal laboratory value|3|||
164499936|NCT00644878|594202068|FG000|Overall Study|Protocol deviation|2|||
164499937|NCT00644878|594202068|FG000|Overall Study|Treatment duration completed as per protocol|11|||
164499938|NCT04353817|594202069|FG000|Overall Study|Adverse Event|0|||
164499939|NCT04353817|594202070|FG001|Overall Study|Adverse Event|1|||
164499940|NCT00878553|594202075|FG000|Sleep Study|Withdrawal by Subject|2|||
164715893|NCT04933474|594982180|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
164499941|NCT00878553|594202076|FG001|Sleep Study|Withdrawal by Subject|0|||
164499942|NCT00878553|594202077|FG002|Sleep Study|Withdrawal by Subject|0|||
164499943|NCT00878553|594202078|FG003|Sleep Study|Withdrawal by Subject|0|||
164499944|NCT00878553|594202079|FG004|Sleep Study|Withdrawal by Subject|0|||
164499945|NCT00878553|594202075|FG000|Sleep Study|Lost to Follow-up|1|||
164499946|NCT00878553|594202076|FG001|Sleep Study|Lost to Follow-up|0|||
164499947|NCT00878553|594202077|FG002|Sleep Study|Lost to Follow-up|0|||
164499948|NCT00878553|594202078|FG003|Sleep Study|Lost to Follow-up|0|||
164715894|NCT04933474|594982181|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
164499949|NCT00878553|594202079|FG004|Sleep Study|Lost to Follow-up|0|||
164499950|NCT00878553|594202075|FG000|Sleep Study|car accident|1|||
164499951|NCT00878553|594202076|FG001|Sleep Study|car accident|0|||
164499952|NCT00878553|594202077|FG002|Sleep Study|car accident|0|||
164499953|NCT00878553|594202078|FG003|Sleep Study|car accident|0|||
164499954|NCT00878553|594202079|FG004|Sleep Study|car accident|0|||
164499955|NCT00878553|594202075|FG000|Sleep Study|family emergency|1|||
164499956|NCT00878553|594202076|FG001|Sleep Study|family emergency|0|||
164499957|NCT00878553|594202077|FG002|Sleep Study|family emergency|0|||
164499958|NCT00878553|594202078|FG003|Sleep Study|family emergency|0|||
164499959|NCT00878553|594202079|FG004|Sleep Study|family emergency|0|||
164605228|NCT01354431|594575945|FG002|Pre-Treatment Period|Not reported|0|||
164605229|NCT01354431|594575943|FG000|Treatment Period|Disease Progression|50|||
164605230|NCT01354431|594575944|FG001|Treatment Period|Disease Progression|40|||
164605231|NCT01354431|594575945|FG002|Treatment Period|Disease Progression|44|||
164605232|NCT01354431|594575943|FG000|Treatment Period|Study Drug Toxicity|5|||
164605233|NCT01354431|594575944|FG001|Treatment Period|Study Drug Toxicity|8|||
164605234|NCT01354431|594575945|FG002|Treatment Period|Study Drug Toxicity|4|||
164605235|NCT01354431|594575943|FG000|Treatment Period|Death|0|||
164605236|NCT01354431|594575944|FG001|Treatment Period|Death|1|||
164605237|NCT01354431|594575945|FG002|Treatment Period|Death|0|||
164605238|NCT01354431|594575943|FG000|Treatment Period|AE unrelated to study drug|1|||
164605239|NCT01354431|594575944|FG001|Treatment Period|AE unrelated to study drug|2|||
164605240|NCT01354431|594575945|FG002|Treatment Period|AE unrelated to study drug|5|||
164605241|NCT01354431|594575943|FG000|Treatment Period|Participant request to discontinue|2|||
164605242|NCT01354431|594575944|FG001|Treatment Period|Participant request to discontinue|2|||
164605243|NCT01354431|594575945|FG002|Treatment Period|Participant request to discontinue|1|||
164605244|NCT01354431|594575943|FG000|Treatment Period|Participant withdrew consent|0|||
164605245|NCT01354431|594575944|FG001|Treatment Period|Participant withdrew consent|1|||
164605246|NCT01354431|594575945|FG002|Treatment Period|Participant withdrew consent|0|||
164605247|NCT01354431|594575943|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
164605248|NCT01354431|594575944|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
164605249|NCT01354431|594575945|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
164605250|NCT03176277|594575946|FG000|Part A Dose Escalation Study|Adverse Event|1|||
164605251|NCT03176277|594575947|FG001|Part A Dose Escalation Study|Adverse Event|0|||
164605252|NCT03176277|594575948|FG002|Part A Dose Escalation Study|Adverse Event|1|||
164605253|NCT03176277|594575949|FG003|Part A Dose Escalation Study|Adverse Event|0|||
164605254|NCT03176277|594575946|FG000|Part A Dose Escalation Study|Physician Decision|1|||
164605255|NCT03176277|594575947|FG001|Part A Dose Escalation Study|Physician Decision|1|||
164605256|NCT03176277|594575948|FG002|Part A Dose Escalation Study|Physician Decision|2|||
164605257|NCT03176277|594575949|FG003|Part A Dose Escalation Study|Physician Decision|0|||
164605258|NCT03176277|594575946|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
164605259|NCT03176277|594575947|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
164605260|NCT03176277|594575948|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
164605261|NCT03176277|594575949|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
164605262|NCT03176277|594575946|FG000|Part A Dose Escalation Study|Progressive disease|3|||
164605263|NCT03176277|594575947|FG001|Part A Dose Escalation Study|Progressive disease|1|||
164605264|NCT03176277|594575948|FG002|Part A Dose Escalation Study|Progressive disease|3|||
164605265|NCT03176277|594575949|FG003|Part A Dose Escalation Study|Progressive disease|0|||
164605266|NCT00702052|594575950|FG000|Overall Study|Adverse Event|23|||
164605267|NCT00702052|594575950|FG000|Overall Study|Disease Progression|30|||
164605268|NCT00702052|594575950|FG000|Overall Study|Withdrawal by Subject|5|||
164605269|NCT03691610|594575951|FG000|Overall Study|Adverse Event|0|||
164605270|NCT03691610|594575952|FG001|Overall Study|Adverse Event|1|||
164605271|NCT03691610|594575953|FG002|Overall Study|Adverse Event|0|||
164605272|NCT03691610|594575954|FG003|Overall Study|Adverse Event|0|||
164605273|NCT03691610|594575951|FG000|Overall Study|Protocol Deviation|15|||
164605274|NCT03691610|594575952|FG001|Overall Study|Protocol Deviation|8|||
164605275|NCT03691610|594575953|FG002|Overall Study|Protocol Deviation|1|||
164605276|NCT03691610|594575954|FG003|Overall Study|Protocol Deviation|2|||
164605277|NCT03691610|594575951|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
164605278|NCT03691610|594575952|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
164605279|NCT03691610|594575953|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
164605280|NCT03691610|594575954|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
164605281|NCT03691610|594575951|FG000|Overall Study|Lost to Follow-up|20|||
164605282|NCT03691610|594575952|FG001|Overall Study|Lost to Follow-up|11|||
164605283|NCT03691610|594575953|FG002|Overall Study|Lost to Follow-up|5|||
164605284|NCT03691610|594575954|FG003|Overall Study|Lost to Follow-up|2|||
164605285|NCT02921919|594575955|FG000|Overall Study|Other|5|||
164605286|NCT02921919|594575956|FG001|Overall Study|Other|6|||
164605287|NCT02921919|594575955|FG000|Overall Study|Lost to Follow-up|0|||
164605288|NCT02921919|594575956|FG001|Overall Study|Lost to Follow-up|1|||
164605289|NCT02921919|594575955|FG000|Overall Study|Withdrawal by Subject|5|||
164605290|NCT02921919|594575956|FG001|Overall Study|Withdrawal by Subject|1|||
164605291|NCT02921919|594575955|FG000|Overall Study|Disease Progression|47|||
164605292|NCT02921919|594575956|FG001|Overall Study|Disease Progression|38|||
164605293|NCT02921919|594575955|FG000|Overall Study|Physician Decision|3|||
164605294|NCT02921919|594575956|FG001|Overall Study|Physician Decision|2|||
164605295|NCT02921919|594575955|FG000|Overall Study|Adverse Event|6|||
164605296|NCT02921919|594575956|FG001|Overall Study|Adverse Event|4|||
164605297|NCT01115738|594575959|FG000|Overall Study|Death|1|||
164605298|NCT01115738|594575960|FG001|Overall Study|Death|0|||
164605299|NCT01115738|594575961|FG002|Overall Study|Death|0|||
164605300|NCT01115738|594575959|FG000|Overall Study|Lost to Follow-up|0|||
164605301|NCT01115738|594575960|FG001|Overall Study|Lost to Follow-up|0|||
164605302|NCT01115738|594575961|FG002|Overall Study|Lost to Follow-up|1|||
164499960|NCT00878553|594202075|FG000|PK Study|Withdrawal by Subject|0|||
164499961|NCT00878553|594202076|FG001|PK Study|Withdrawal by Subject|0|||
164499962|NCT00878553|594202077|FG002|PK Study|Withdrawal by Subject|0|||
164499963|NCT00878553|594202078|FG003|PK Study|Withdrawal by Subject|1|||
164499964|NCT00878553|594202079|FG004|PK Study|Withdrawal by Subject|0|||
164499965|NCT02143063|594202080|FG000|Overall Study|Lost to Follow-up|16|||
164499966|NCT02143063|594202081|FG001|Overall Study|Lost to Follow-up|28|||
164499967|NCT02143063|594202082|FG002|Overall Study|Lost to Follow-up|29|||
164499968|NCT02143063|594202080|FG000|Overall Study|Withdrawal by Subject|0|||
164499969|NCT02143063|594202081|FG001|Overall Study|Withdrawal by Subject|1|||
164499970|NCT02143063|594202082|FG002|Overall Study|Withdrawal by Subject|0|||
164499971|NCT02143063|594202080|FG000|Overall Study|Death|0|||
164499972|NCT02143063|594202081|FG001|Overall Study|Death|1|||
164499973|NCT02143063|594202082|FG002|Overall Study|Death|1|||
164499974|NCT02864342|594202084|FG000|Overall Study|Eligibility Criteria Deviation|2|||
164499975|NCT02864342|594202085|FG001|Overall Study|Eligibility Criteria Deviation|3|||
164499976|NCT02864342|594202084|FG000|Overall Study|Withdrawal by Subject|4|||
164499977|NCT02864342|594202085|FG001|Overall Study|Withdrawal by Subject|2|||
164499978|NCT02864342|594202084|FG000|Overall Study|Device Technology Issue|6|||
164499979|NCT02864342|594202085|FG001|Overall Study|Device Technology Issue|7|||
164499980|NCT02864342|594202084|FG000|Overall Study|Death|0|||
164499981|NCT02864342|594202085|FG001|Overall Study|Death|1|||
164499982|NCT02864342|594202084|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
164499983|NCT02864342|594202085|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
164499984|NCT02864342|594202084|FG000|Overall Study|Lost to Follow-up|1|||
164499985|NCT02864342|594202085|FG001|Overall Study|Lost to Follow-up|5|||
164499986|NCT02864342|594202084|FG000|Overall Study|Lost Device|1|||
164499987|NCT02864342|594202085|FG001|Overall Study|Lost Device|0|||
164499988|NCT02864342|594202084|FG000|Overall Study|Adverse Event|1|||
164499989|NCT02864342|594202085|FG001|Overall Study|Adverse Event|0|||
164499990|NCT00118703|594202088|FG000|Overall Study|Protocol Violation|1|||
164499991|NCT00118703|594202089|FG001|Overall Study|Protocol Violation|0|||
164499992|NCT00118703|594202088|FG000|Overall Study|Adverse Event|1|||
164499993|NCT00118703|594202089|FG001|Overall Study|Adverse Event|1|||
164499994|NCT00118703|594202088|FG000|Overall Study|Participant took two different treatment|0|||
164499995|NCT00118703|594202089|FG001|Overall Study|Participant took two different treatment|1|||
164499996|NCT00118703|594202088|FG000|Overall Study|Withdrawal by Subject|2|||
164499997|NCT00118703|594202089|FG001|Overall Study|Withdrawal by Subject|5|||
164499998|NCT00118703|594202088|FG000|Overall Study|Lost to Follow-up|1|||
164499999|NCT00118703|594202089|FG001|Overall Study|Lost to Follow-up|2|||
164500000|NCT01125566|594202090|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
164500001|NCT01125566|594202091|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
164500002|NCT01125566|594202092|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
164500003|NCT01125566|594202090|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
164500004|NCT01125566|594202091|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
164500005|NCT01125566|594202092|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
164500006|NCT01125566|594202090|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
164500007|NCT01125566|594202091|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
164500008|NCT01125566|594202092|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
164500009|NCT01125566|594202090|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
164500010|NCT01125566|594202091|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
164500011|NCT01125566|594202092|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
164500012|NCT01125566|594202090|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
164500013|NCT01125566|594202091|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
164500014|NCT01125566|594202092|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
164500015|NCT01125566|594202090|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
164500016|NCT01125566|594202091|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
164500017|NCT01125566|594202092|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
164500018|NCT01125566|594202090|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
164500019|NCT01125566|594202091|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
164605303|NCT01115738|594575959|FG000|Overall Study|Physician Decision|18|||
164605304|NCT01115738|594575960|FG001|Overall Study|Physician Decision|15|||
164605305|NCT01115738|594575961|FG002|Overall Study|Physician Decision|17|||
164605306|NCT01115738|594575959|FG000|Overall Study|Withdrawal by Subject|6|||
164605307|NCT01115738|594575960|FG001|Overall Study|Withdrawal by Subject|6|||
164605308|NCT01115738|594575961|FG002|Overall Study|Withdrawal by Subject|9|||
164500020|NCT01125566|594202092|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
164500021|NCT01125566|594202090|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
164500022|NCT01125566|594202091|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
164500023|NCT01125566|594202092|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
164605309|NCT04142216|594575964|FG000|Overall Study|Hospitalization|0|||
164500024|NCT01125566|594202090|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
164500025|NCT01125566|594202091|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
164500026|NCT01125566|594202092|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
164500027|NCT01125566|594202090|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
164500028|NCT01125566|594202091|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
164500029|NCT01125566|594202092|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
164500030|NCT01125566|594202090|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
164500031|NCT01125566|594202091|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
164500032|NCT01125566|594202092|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
164500033|NCT01125566|594202090|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
164500034|NCT01125566|594202091|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
164500035|NCT01125566|594202092|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
164500036|NCT01560585|594202093|FG000|Overall Study|Physician Decision|3|||
164500037|NCT03028012|594202094|FG000|Overall Study|Lost to Follow-up|2|||
164500038|NCT03028012|594202095|FG001|Overall Study|Lost to Follow-up|3|||
164500039|NCT03028012|594202096|FG002|Overall Study|Lost to Follow-up|3|||
164500040|NCT01726517|594202097|FG000|Overall Study|Withdrawal by Subject|0|||
164500041|NCT01726517|594202098|FG001|Overall Study|Withdrawal by Subject|0|||
164500042|NCT01726517|594202099|FG002|Overall Study|Withdrawal by Subject|1|||
164500043|NCT01726517|594202100|FG003|Overall Study|Withdrawal by Subject|0|||
164500044|NCT01726517|594202101|FG004|Overall Study|Withdrawal by Subject|0|||
164500045|NCT00770588|594202107|FG000|Overall Study|Adverse Event|9|||
164500046|NCT00770588|594202108|FG001|Overall Study|Adverse Event|2|||
164500047|NCT00770588|594202107|FG000|Overall Study|Death caused by progression of disease|70|||
164500048|NCT00770588|594202108|FG001|Overall Study|Death caused by progression of disease|91|||
164500049|NCT00770588|594202107|FG000|Overall Study|Lost to Follow-up|1|||
164500050|NCT00770588|594202108|FG001|Overall Study|Lost to Follow-up|1|||
164500051|NCT00770588|594202107|FG000|Overall Study|Withdrawal by Subject|1|||
164500052|NCT00770588|594202108|FG001|Overall Study|Withdrawal by Subject|1|||
164500053|NCT01424189|594202109|FG000|Overall Study|Adverse Event|1|||
164500054|NCT01424189|594202110|FG001|Overall Study|Adverse Event|0|||
164500055|NCT01424189|594202109|FG000|Overall Study|Lost to Follow-up|4|||
164500056|NCT01424189|594202110|FG001|Overall Study|Lost to Follow-up|1|||
164500057|NCT01424189|594202109|FG000|Overall Study|Withdrawal by Subject|4|||
164500058|NCT01424189|594202110|FG001|Overall Study|Withdrawal by Subject|4|||
164500059|NCT01424189|594202109|FG000|Overall Study|Subject moved|1|||
164500060|NCT01424189|594202110|FG001|Overall Study|Subject moved|0|||
164500061|NCT01424189|594202109|FG000|Overall Study|Death|3|||
164500062|NCT01424189|594202110|FG001|Overall Study|Death|1|||
164500063|NCT01203956|594202111|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
164500064|NCT01203956|594202112|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
164500065|NCT02230306|594202115|FG000|Overall Study|Did not receive study treatment|1|||
164500066|NCT00312845|594202116|FG000|Overall Study|Adverse Event|19|||
164500067|NCT00312845|594202117|FG001|Overall Study|Adverse Event|5|||
164500068|NCT00312845|594202116|FG000|Overall Study|Death|2|||
164500069|NCT00312845|594202117|FG001|Overall Study|Death|2|||
164500070|NCT00312845|594202116|FG000|Overall Study|Withdrawal by Subject|14|||
164500071|NCT00312845|594202117|FG001|Overall Study|Withdrawal by Subject|6|||
164500072|NCT00312845|594202116|FG000|Overall Study|Disease Progression|56|||
164500073|NCT00312845|594202117|FG001|Overall Study|Disease Progression|77|||
164500074|NCT00312845|594202116|FG000|Overall Study|Lost to Follow-up|2|||
164500075|NCT00312845|594202117|FG001|Overall Study|Lost to Follow-up|0|||
164500076|NCT00312845|594202116|FG000|Overall Study|Other|6|||
164500077|NCT00312845|594202117|FG001|Overall Study|Other|5|||
164500078|NCT04206384|594202119|FG000|Overall Study|Withdrawal by Subject|8|||
164500079|NCT04206384|594202119|FG000|Overall Study|Adverse Event|2|||
164500080|NCT01071317|594202120|FG000|Overall Study|Lost to Follow-up|2|||
164500081|NCT01071317|594202121|FG001|Overall Study|Lost to Follow-up|2|||
164500082|NCT05041439|594202124|FG000|Overall Study|Withdrawal by Subject|1|||
164500083|NCT05041439|594202125|FG001|Overall Study|Withdrawal by Subject|1|||
164500084|NCT05041439|594202124|FG000|Overall Study|Death|1|||
164500085|NCT05041439|594202125|FG001|Overall Study|Death|0|||
164500086|NCT00612352|594204075|FG000|Overall Study|Adverse Event|1|||
164500087|NCT00612352|594204076|FG001|Overall Study|Adverse Event|0|||
164500088|NCT00612352|594204075|FG000|Overall Study|Withdrawal by Subject|3|||
164500089|NCT00612352|594204076|FG001|Overall Study|Withdrawal by Subject|5|||
164500090|NCT00612352|594204075|FG000|Overall Study|moved out of state|1|||
164500091|NCT00612352|594204076|FG001|Overall Study|moved out of state|0|||
164500092|NCT00612352|594204075|FG000|Overall Study|didn't return calls/show up on test date|4|||
164500093|NCT00612352|594204076|FG001|Overall Study|didn't return calls/show up on test date|1|||
164500094|NCT00263211|594204077|FG000|Overall Study|Death|1|||
164500095|NCT00263211|594204078|FG001|Overall Study|Death|0|||
164500096|NCT00263211|594204077|FG000|Overall Study|Withdrawal by Subject|3|||
164500097|NCT00263211|594204078|FG001|Overall Study|Withdrawal by Subject|0|||
164500098|NCT00263211|594204077|FG000|Overall Study|Protocol Violation|1|||
164500099|NCT00263211|594204078|FG001|Overall Study|Protocol Violation|0|||
164500100|NCT00263211|594204077|FG000|Overall Study|Disease Progression|0|||
164500101|NCT00263211|594204078|FG001|Overall Study|Disease Progression|1|||
164500102|NCT01053247|594204083|FG000|Overall Study|Withdrawal by Subject|9|||
164500103|NCT01053247|594204084|FG001|Overall Study|Withdrawal by Subject|4|||
164500104|NCT01053247|594204085|FG002|Overall Study|Withdrawal by Subject|15|||
164500105|NCT01053247|594204083|FG000|Overall Study|Lack of Efficacy|1|||
164500106|NCT01053247|594204084|FG001|Overall Study|Lack of Efficacy|0|||
164500107|NCT01053247|594204085|FG002|Overall Study|Lack of Efficacy|1|||
164500108|NCT01053247|594204083|FG000|Overall Study|Protocol Violation|2|||
164500109|NCT01053247|594204084|FG001|Overall Study|Protocol Violation|1|||
164500110|NCT01053247|594204085|FG002|Overall Study|Protocol Violation|2|||
164500111|NCT01053247|594204083|FG000|Overall Study|Lost to Follow-up|8|||
164500112|NCT01053247|594204084|FG001|Overall Study|Lost to Follow-up|5|||
164500113|NCT01053247|594204085|FG002|Overall Study|Lost to Follow-up|7|||
164500114|NCT01053247|594204083|FG000|Overall Study|Adverse Event|0|||
164500115|NCT01053247|594204084|FG001|Overall Study|Adverse Event|9|||
164500116|NCT01053247|594204085|FG002|Overall Study|Adverse Event|3|||
164500117|NCT03458728|594204086|FG000|Overall Study|Adverse Event|1|||
164500118|NCT03458728|594204087|FG001|Overall Study|Adverse Event|0|||
164500119|NCT03458728|594204086|FG000|Overall Study|Physician Decision|1|||
164500120|NCT03458728|594204087|FG001|Overall Study|Physician Decision|0|||
164500121|NCT03458728|594204086|FG000|Overall Study|Progressive disease - clinical assessment|1|||
164500122|NCT03458728|594204087|FG001|Overall Study|Progressive disease - clinical assessment|0|||
164500123|NCT03458728|594204086|FG000|Overall Study|Progressive disease - radiological progression|21|||
164500124|NCT03458728|594204087|FG001|Overall Study|Progressive disease - radiological progression|6|||
164500125|NCT03458728|594204086|FG000|Overall Study|Withdrawal by Subject|0|||
164500126|NCT03458728|594204087|FG001|Overall Study|Withdrawal by Subject|1|||
164500127|NCT00908349|594204090|FG000|Overall Study|Adverse Event|10|||
164500128|NCT00908349|594204090|FG000|Overall Study|Withdrawal by Subject|9|||
164500129|NCT00908349|594204090|FG000|Overall Study|Physician Decision|5|||
164500130|NCT00908349|594204090|FG000|Overall Study|Lost to Follow-up|5|||
164500131|NCT00908349|594204090|FG000|Overall Study|Various|6|||
164500132|NCT04606199|594204091|FG000|Overall Study|Withdrawal by Subject|2|||
164500133|NCT00408928|594204092|FG000|Overall Study|Withdrawal by Subject|1|||
164500134|NCT00408928|594204092|FG000|Overall Study|Death|1|||
164500135|NCT00408928|594204092|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
164500136|NCT00477464|594204095|FG000|Overall Study|Lost to Follow-up|1|||
164500137|NCT00477464|594204095|FG000|Overall Study|Death|36|||
164500138|NCT00477464|594204095|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
164500139|NCT03568812|594204096|FG000|Overall Study|Physician Decision|0|||
164500140|NCT03568812|594204097|FG001|Overall Study|Physician Decision|1|||
164500141|NCT03318783|594204099|FG000|Overall Study|Withdrawal by Subject|0|||
164500142|NCT03318783|594204100|FG001|Overall Study|Withdrawal by Subject|1|||
164500143|NCT03318783|594204099|FG000|Overall Study|Death|0|||
164500144|NCT03318783|594204100|FG001|Overall Study|Death|1|||
164500145|NCT03856047|594204101|FG000|Overall Study|Withdrawal by Subject|0|||
164500146|NCT03856047|594204102|FG001|Overall Study|Withdrawal by Subject|1|||
164500147|NCT03856047|594204103|FG002|Overall Study|Withdrawal by Subject|1|||
164500148|NCT03856047|594204104|FG003|Overall Study|Withdrawal by Subject|0|||
164500149|NCT03856047|594204105|FG004|Overall Study|Withdrawal by Subject|3|||
164500150|NCT03856047|594204106|FG005|Overall Study|Withdrawal by Subject|0|||
164500151|NCT03856047|594204107|FG006|Overall Study|Withdrawal by Subject|2|||
164500152|NCT03856047|594204101|FG000|Overall Study|Lost to Follow-up|4|||
164500153|NCT03856047|594204102|FG001|Overall Study|Lost to Follow-up|2|||
164500154|NCT03856047|594204103|FG002|Overall Study|Lost to Follow-up|3|||
164500155|NCT03856047|594204104|FG003|Overall Study|Lost to Follow-up|1|||
164500156|NCT03856047|594204105|FG004|Overall Study|Lost to Follow-up|4|||
164500157|NCT03856047|594204106|FG005|Overall Study|Lost to Follow-up|4|||
164500158|NCT03856047|594204107|FG006|Overall Study|Lost to Follow-up|4|||
164500159|NCT01426113|594204110|FG000|Overall Study|Study Discontinued|1|||
164500160|NCT01426113|594204111|FG001|Overall Study|Study Discontinued|1|||
164500161|NCT01426113|594204110|FG000|Overall Study|Adverse Event|0|||
164500162|NCT01426113|594204111|FG001|Overall Study|Adverse Event|1|||
164500163|NCT00338949|594204112|FG000|Subject Screening|Screen failures|11|||
164500164|NCT00338949|594204113|FG001|Subject Screening|Screen failures|11|||
164500165|NCT00338949|594204112|FG000|Randomization|Withdrawal by Subject|1|||
164500166|NCT00338949|594204113|FG001|Randomization|Withdrawal by Subject|0|||
164500167|NCT00338949|594204112|FG000|Randomization|Adverse Event|0|||
164500168|NCT00338949|594204113|FG001|Randomization|Adverse Event|5|||
164500169|NCT00436956|594204116|FG000|Overall Study|Not evaluable|1|||
164500170|NCT00436956|594204117|FG001|Overall Study|Not evaluable|0|||
164500171|NCT03517111|594204118|FG000|Enrolled|Withdrawal by Subject|0|||
164500172|NCT03517111|594204119|FG001|Enrolled|Withdrawal by Subject|1|||
164500173|NCT03517111|594204120|FG002|Enrolled|Withdrawal by Subject|0|||
164500174|NCT03517111|594204118|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
164500175|NCT03517111|594204119|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
164500176|NCT03517111|594204120|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
164500177|NCT03517111|594204118|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
164500178|NCT03517111|594204119|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
164500179|NCT03517111|594204120|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
164500180|NCT03517111|594204118|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
164500181|NCT03517111|594204119|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
164500182|NCT03517111|594204120|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
164500183|NCT03517111|594204118|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
164500184|NCT03517111|594204119|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
164500185|NCT03517111|594204120|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
164500186|NCT00909532|594204125|FG000|Overall Study|Adverse Event|4|||
164500187|NCT00909532|594204126|FG001|Overall Study|Adverse Event|1|||
164500188|NCT00909532|594204125|FG000|Overall Study|Pregnancy|0|||
164500189|NCT00909532|594204126|FG001|Overall Study|Pregnancy|1|||
164500190|NCT00909532|594204125|FG000|Overall Study|Prohibited Medication|2|||
164500191|NCT00909532|594204126|FG001|Overall Study|Prohibited Medication|1|||
164500192|NCT00909532|594204125|FG000|Overall Study|Withdrawal of Consent|1|||
164500193|NCT00909532|594204126|FG001|Overall Study|Withdrawal of Consent|1|||
164500194|NCT00909532|594204125|FG000|Overall Study|Noncompliance with Study Requirements|0|||
164500195|NCT00909532|594204126|FG001|Overall Study|Noncompliance with Study Requirements|2|||
164500196|NCT00909532|594204125|FG000|Overall Study|Physician Decision|1|||
164500197|NCT00909532|594204126|FG001|Overall Study|Physician Decision|0|||
164500198|NCT00909532|594204125|FG000|Overall Study|Wrong Genotype|1|||
164500199|NCT00909532|594204126|FG001|Overall Study|Wrong Genotype|0|||
164500200|NCT00909532|594204125|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
164500201|NCT00909532|594204126|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
164500202|NCT03188536|594204129|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
164500203|NCT03188536|594204129|FG000|Overall Study|Not participated/met inclusion criteria|1|||
164500204|NCT02719743|594204130|FG000|Overall Study|Consent withdrawal|0|||
164500205|NCT02719743|594204131|FG001|Overall Study|Consent withdrawal|2|||
164500206|NCT02719743|594204132|FG002|Overall Study|Consent withdrawal|0|||
164500207|NCT02719743|594204133|FG003|Overall Study|Consent withdrawal|1|||
164500208|NCT02719743|594204134|FG004|Overall Study|Consent withdrawal|0|||
164500209|NCT02719743|594204130|FG000|Overall Study|Migrated/moved from study area|0|||
164500210|NCT02719743|594204131|FG001|Overall Study|Migrated/moved from study area|0|||
164500211|NCT02719743|594204132|FG002|Overall Study|Migrated/moved from study area|0|||
164500212|NCT02719743|594204133|FG003|Overall Study|Migrated/moved from study area|0|||
164500213|NCT02719743|594204134|FG004|Overall Study|Migrated/moved from study area|2|||
164500214|NCT02719743|594204130|FG000|Overall Study|Lost to Follow-up|1|||
164500215|NCT02719743|594204131|FG001|Overall Study|Lost to Follow-up|1|||
164500216|NCT02719743|594204132|FG002|Overall Study|Lost to Follow-up|0|||
164500217|NCT02719743|594204133|FG003|Overall Study|Lost to Follow-up|0|||
164500218|NCT02719743|594204134|FG004|Overall Study|Lost to Follow-up|0|||
164500219|NCT01930214|594204135|FG000|Overall Study|Death|4|||
164500220|NCT01930214|594204136|FG001|Overall Study|Death|4|||
164500221|NCT01930214|594204137|FG002|Overall Study|Death|11|||
164500222|NCT01930214|594204135|FG000|Overall Study|Lost to Follow-up|12|||
164500223|NCT01930214|594204136|FG001|Overall Study|Lost to Follow-up|13|||
164500224|NCT01930214|594204137|FG002|Overall Study|Lost to Follow-up|12|||
164500225|NCT01930214|594204135|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
164500226|NCT01930214|594204136|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
164500227|NCT01930214|594204137|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
164500228|NCT01930214|594204135|FG000|Overall Study|Physician Decision|2|||
164500229|NCT01930214|594204136|FG001|Overall Study|Physician Decision|0|||
164500230|NCT01930214|594204137|FG002|Overall Study|Physician Decision|0|||
164500231|NCT02601209|594204138|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
164500232|NCT02601209|594204139|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
164500233|NCT02601209|594204140|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
164500234|NCT02601209|594204141|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
164500235|NCT02601209|594204142|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
164500236|NCT02601209|594204143|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
164500237|NCT02601209|594204144|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
164500238|NCT02601209|594204145|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
164500239|NCT02601209|594204146|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
164500240|NCT02601209|594204138|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
164500241|NCT02601209|594204139|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
164605310|NCT04142216|594575965|FG001|Overall Study|Hospitalization|2|||
164605311|NCT04142216|594575964|FG000|Overall Study|Death|3|||
164605312|NCT04142216|594575965|FG001|Overall Study|Death|1|||
164605313|NCT04142216|594575964|FG000|Overall Study|Referral to another hemodialysis unit|3|||
164605314|NCT04142216|594575965|FG001|Overall Study|Referral to another hemodialysis unit|2|||
164500242|NCT02601209|594204140|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
164500243|NCT02601209|594204141|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
164500244|NCT02601209|594204142|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
164500245|NCT02601209|594204143|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
164500246|NCT02601209|594204144|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
164500247|NCT02601209|594204145|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
164500248|NCT02601209|594204146|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
164500249|NCT02062645|594204149|FG000|Overall Study|Adverse Event|2|||
164500250|NCT02062645|594204149|FG000|Overall Study|Protocol Violation|8|||
164500251|NCT02062645|594204149|FG000|Overall Study|Lost to Follow-up|5|||
164500252|NCT00461123|594204151|FG000|Overall Study|Adverse Event|1|||
164500253|NCT00461123|594204152|FG001|Overall Study|Adverse Event|0|||
164500254|NCT00461123|594204151|FG000|Overall Study|Lost to Follow-up|1|||
164500255|NCT00461123|594204152|FG001|Overall Study|Lost to Follow-up|1|||
164500256|NCT00461123|594204151|FG000|Overall Study|Protocol Violation|3|||
164500257|NCT00461123|594204152|FG001|Overall Study|Protocol Violation|2|||
164500258|NCT00461123|594204151|FG000|Overall Study|Withdrawal by Subject|1|||
164500259|NCT00461123|594204152|FG001|Overall Study|Withdrawal by Subject|3|||
164500260|NCT02024750|594204153|FG000|Overall Study|Withdrawal by Subject|2|||
164500261|NCT02024750|594204154|FG001|Overall Study|Withdrawal by Subject|1|||
164500262|NCT02261285|594204155|FG000|Overall Study|Disease progression|0|||
164500263|NCT02261285|594204156|FG001|Overall Study|Disease progression|0|||
164500264|NCT02261285|594204157|FG002|Overall Study|Disease progression|1|||
164500265|NCT00927901|594204158|FG000|Treatment Period 1|Subject withdrew consent|0|||
164500266|NCT00927901|594204159|FG001|Treatment Period 1|Subject withdrew consent|0|||
164500267|NCT00927901|594204160|FG002|Treatment Period 1|Subject withdrew consent|1|||
164500268|NCT00927901|594204161|FG003|Treatment Period 1|Subject withdrew consent|0|||
164500269|NCT00927901|594204158|FG000|Treatment Period 4|Adverse Event|0|||
164500270|NCT00927901|594204159|FG001|Treatment Period 4|Adverse Event|0|||
164500271|NCT00927901|594204160|FG002|Treatment Period 4|Adverse Event|0|||
164500272|NCT00927901|594204161|FG003|Treatment Period 4|Adverse Event|1|||
164500273|NCT00927901|594204158|FG000|Treatment Period 4|Subject withdrew consent|0|||
164500274|NCT00927901|594204159|FG001|Treatment Period 4|Subject withdrew consent|0|||
164500275|NCT00927901|594204160|FG002|Treatment Period 4|Subject withdrew consent|1|||
164500276|NCT00927901|594204161|FG003|Treatment Period 4|Subject withdrew consent|0|||
164500277|NCT02344173|594204162|FG000|Procedure|Ablation Procedure Not Performed|7|||
164500278|NCT02344173|594204162|FG000|12-month Visit|Death|8|||
164500279|NCT02344173|594204162|FG000|12-month Visit|Withdrawal by Subject|30|||
164500280|NCT02344173|594204162|FG000|12-month Visit|Lost to Follow-up|58|||
164500281|NCT00746356|594204167|FG000|Overall Study|Withdrawal by Subject|2|||
164500282|NCT00746356|594204168|FG001|Overall Study|Withdrawal by Subject|3|||
164500283|NCT00746356|594204167|FG000|Overall Study|Death|7|||
164500284|NCT00746356|594204168|FG001|Overall Study|Death|3|||
164500285|NCT00746356|594204167|FG000|Overall Study|Lost to Follow-up|1|||
164500286|NCT00746356|594204168|FG001|Overall Study|Lost to Follow-up|0|||
164500287|NCT00746356|594204167|FG000|Overall Study|Removal of Device|0|||
164500288|NCT00746356|594204168|FG001|Overall Study|Removal of Device|1|||
164500289|NCT00746356|594204167|FG000|Overall Study|Patient relocated|1|||
164500290|NCT00746356|594204168|FG001|Overall Study|Patient relocated|0|||
164500291|NCT01263925|594204169|FG000|Overall Study|Protocol Violation|1|||
164500292|NCT01263925|594204170|FG001|Overall Study|Protocol Violation|0|||
164500293|NCT01263925|594204169|FG000|Overall Study|Lack of Efficacy|0|||
164500294|NCT01263925|594204170|FG001|Overall Study|Lack of Efficacy|1|||
164500295|NCT01263925|594204169|FG000|Overall Study|Adverse Event|23|||
164500296|NCT01263925|594204170|FG001|Overall Study|Adverse Event|22|||
164500297|NCT01263925|594204169|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
164500298|NCT01263925|594204170|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
164500299|NCT01263925|594204169|FG000|Overall Study|Withdrawal by Subject|6|||
164500300|NCT01263925|594204170|FG001|Overall Study|Withdrawal by Subject|8|||
164500301|NCT01263925|594204169|FG000|Overall Study|Other|4|||
164500302|NCT01263925|594204170|FG001|Overall Study|Other|4|||
164500303|NCT01263925|594204169|FG000|Overall Study|Lost to Follow-up|3|||
164500304|NCT01263925|594204170|FG001|Overall Study|Lost to Follow-up|1|||
164500305|NCT01263925|594204169|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
164500306|NCT01263925|594204170|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
164500307|NCT01263925|594204169|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
164500308|NCT01263925|594204170|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
164500309|NCT01263925|594204169|FG000|Overall Study|AE/ Withdrawal|1|||
164500310|NCT01263925|594204170|FG001|Overall Study|AE/ Withdrawal|4|||
164605315|NCT04142216|594575964|FG000|Overall Study|Use of clove|0|||
164500311|NCT01263925|594204169|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
164500312|NCT01263925|594204170|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
164500313|NCT01263925|594204169|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
164500314|NCT01263925|594204170|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
164500315|NCT01263925|594204169|FG000|Overall Study|Withdrawal/ Not specified|0|||
164500316|NCT01263925|594204170|FG001|Overall Study|Withdrawal/ Not specified|1|||
164500317|NCT02484547|594204175|FG000|Placebo-Controlled Period|Adverse Event|10|||
164500318|NCT02484547|594204176|FG001|Placebo-Controlled Period|Adverse Event|13|||
164500319|NCT02484547|594204177|FG002|Placebo-Controlled Period|Adverse Event|20|||
164500320|NCT02484547|594204178|FG003|Placebo-Controlled Period|Adverse Event|0|||
164500321|NCT02484547|594204179|FG004|Placebo-Controlled Period|Adverse Event|0|||
164500322|NCT02484547|594204180|FG005|Placebo-Controlled Period|Adverse Event|0|||
164500323|NCT02484547|594204181|FG006|Placebo-Controlled Period|Adverse Event|0|||
164500324|NCT02484547|594204175|FG000|Placebo-Controlled Period|Change of Treatment|0|||
164500325|NCT02484547|594204176|FG001|Placebo-Controlled Period|Change of Treatment|0|||
164500326|NCT02484547|594204177|FG002|Placebo-Controlled Period|Change of Treatment|1|||
164500327|NCT02484547|594204178|FG003|Placebo-Controlled Period|Change of Treatment|0|||
164500328|NCT02484547|594204179|FG004|Placebo-Controlled Period|Change of Treatment|0|||
164500329|NCT02484547|594204180|FG005|Placebo-Controlled Period|Change of Treatment|0|||
164500330|NCT02484547|594204181|FG006|Placebo-Controlled Period|Change of Treatment|0|||
164500331|NCT02484547|594204175|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
164500332|NCT02484547|594204176|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
164500333|NCT02484547|594204177|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
164500334|NCT02484547|594204178|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
164500335|NCT02484547|594204179|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
164500336|NCT02484547|594204180|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
164500337|NCT02484547|594204181|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
164715895|NCT04933474|594982180|FG000|Overall Study|Lost to Follow-up|19|||
164715896|NCT04933474|594982181|FG001|Overall Study|Lost to Follow-up|9|||
164715897|NCT04933474|594982180|FG000|Overall Study|Life Burden - unable to participate|6|||
164715898|NCT04933474|594982181|FG001|Overall Study|Life Burden - unable to participate|2|||
164715899|NCT04933474|594982180|FG000|Overall Study|Disease Burden - unable to participate|4|||
164715900|NCT04933474|594982181|FG001|Overall Study|Disease Burden - unable to participate|1|||
164715901|NCT04933474|594982180|FG000|Overall Study|Surgery/Hospitalization|1|||
164715902|NCT04933474|594982181|FG001|Overall Study|Surgery/Hospitalization|2|||
164715903|NCT04933474|594982180|FG000|Overall Study|Dissatisfied with Intervention|1|||
164715904|NCT04933474|594982181|FG001|Overall Study|Dissatisfied with Intervention|1|||
164715905|NCT04933474|594982180|FG000|Overall Study|Withdrew interest in participation|1|||
164715906|NCT04933474|594982181|FG001|Overall Study|Withdrew interest in participation|0|||
164715907|NCT04933474|594982180|FG000|Overall Study|Had previously enrolled in the study|0|||
164715908|NCT04933474|594982181|FG001|Overall Study|Had previously enrolled in the study|1|||
164715909|NCT03701308|594982184|FG000|Overall Study|Ineligible|2|||
164715910|NCT03701308|594982185|FG001|Overall Study|Ineligible|2|||
164715911|NCT04504942|594982186|FG000|Overall Study|Withdrawal by Subject|2|||
164715912|NCT04504942|594982186|FG000|Overall Study|7 patients were on-going at the time when study was closed by sponsor.|7|||
164715913|NCT04504942|594982186|FG000|Overall Study|Disease Progression|1|||
164500338|NCT02484547|594204175|FG000|Placebo-Controlled Period|Death|5|||
164500339|NCT02484547|594204176|FG001|Placebo-Controlled Period|Death|0|||
164500340|NCT02484547|594204177|FG002|Placebo-Controlled Period|Death|6|||
164500341|NCT02484547|594204178|FG003|Placebo-Controlled Period|Death|0|||
164500342|NCT02484547|594204179|FG004|Placebo-Controlled Period|Death|0|||
164500343|NCT02484547|594204180|FG005|Placebo-Controlled Period|Death|0|||
164500344|NCT02484547|594204181|FG006|Placebo-Controlled Period|Death|0|||
164500345|NCT02484547|594204175|FG000|Placebo-Controlled Period|Disease Progression|2|||
164500346|NCT02484547|594204176|FG001|Placebo-Controlled Period|Disease Progression|0|||
164715914|NCT04118088|594982189|FG000|Overall Study|Study Terminated by Sponsor|38|||
164500347|NCT02484547|594204177|FG002|Placebo-Controlled Period|Disease Progression|1|||
164500348|NCT02484547|594204178|FG003|Placebo-Controlled Period|Disease Progression|0|||
164500349|NCT02484547|594204179|FG004|Placebo-Controlled Period|Disease Progression|0|||
164500350|NCT02484547|594204180|FG005|Placebo-Controlled Period|Disease Progression|0|||
164500351|NCT02484547|594204181|FG006|Placebo-Controlled Period|Disease Progression|0|||
164715915|NCT04118088|594982189|FG000|Overall Study|Lost to Follow-up|2|||
164715916|NCT04118088|594982189|FG000|Overall Study|Withdrawal by Subject|1|||
164715917|NCT04118088|594982189|FG000|Overall Study|Reason Not Specified|1|||
164500352|NCT02484547|594204175|FG000|Placebo-Controlled Period|Investigator Decision|2|||
164500353|NCT02484547|594204176|FG001|Placebo-Controlled Period|Investigator Decision|2|||
164715918|NCT05411393|594982196|FG000|Overall Study|Illness or loss of interest|2|||
164715919|NCT05411393|594982197|FG001|Overall Study|Illness or loss of interest|0|||
164715920|NCT05411393|594982196|FG000|Overall Study|Withdrawal by Subject|1|||
164145461|NCT01198132|592894312|FG001|Overall Study|Lack of Efficacy|3|||
164500354|NCT02484547|594204177|FG002|Placebo-Controlled Period|Investigator Decision|5|||
164500355|NCT02484547|594204178|FG003|Placebo-Controlled Period|Investigator Decision|0|||
164500356|NCT02484547|594204179|FG004|Placebo-Controlled Period|Investigator Decision|0|||
164500357|NCT02484547|594204180|FG005|Placebo-Controlled Period|Investigator Decision|0|||
164500358|NCT02484547|594204181|FG006|Placebo-Controlled Period|Investigator Decision|0|||
164500359|NCT02484547|594204175|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
164500360|NCT02484547|594204176|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
164500361|NCT02484547|594204177|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
164500362|NCT02484547|594204178|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
164500363|NCT02484547|594204179|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
164500364|NCT02484547|594204180|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
164500365|NCT02484547|594204181|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
164500366|NCT02484547|594204175|FG000|Placebo-Controlled Period|Relocation|1|||
164500367|NCT02484547|594204176|FG001|Placebo-Controlled Period|Relocation|1|||
164500368|NCT02484547|594204177|FG002|Placebo-Controlled Period|Relocation|1|||
164500369|NCT02484547|594204178|FG003|Placebo-Controlled Period|Relocation|0|||
164500370|NCT02484547|594204179|FG004|Placebo-Controlled Period|Relocation|0|||
164500371|NCT02484547|594204180|FG005|Placebo-Controlled Period|Relocation|0|||
164500372|NCT02484547|594204181|FG006|Placebo-Controlled Period|Relocation|0|||
164500373|NCT02484547|594204175|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
164500374|NCT02484547|594204176|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
164500375|NCT02484547|594204177|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
164500376|NCT02484547|594204178|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
164500377|NCT02484547|594204179|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
164500378|NCT02484547|594204180|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
164500379|NCT02484547|594204181|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
164500380|NCT02484547|594204175|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
164500381|NCT02484547|594204176|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
164605316|NCT04142216|594575965|FG001|Overall Study|Use of clove|1|||
164605317|NCT01054976|594575970|FG000|Overall Study|Adverse Event|16|||
164605318|NCT01054976|594575970|FG000|Overall Study|Uncooperative participations to study|7|||
164605319|NCT01054976|594575970|FG000|Overall Study|Withdrawal by Subject|4|||
164605320|NCT01054976|594575970|FG000|Overall Study|Other|8|||
164605321|NCT01641991|594575971|FG000|Overall Study|Physician Decision|0|||
164605322|NCT01641991|594575972|FG001|Overall Study|Physician Decision|1|||
164605323|NCT01641991|594575973|FG002|Overall Study|Physician Decision|7|||
164605324|NCT01641991|594575974|FG003|Overall Study|Physician Decision|5|||
164605325|NCT01641991|594575971|FG000|Overall Study|Withdrawal by Subject|4|||
164605326|NCT01641991|594575972|FG001|Overall Study|Withdrawal by Subject|2|||
164605327|NCT01641991|594575973|FG002|Overall Study|Withdrawal by Subject|1|||
164605328|NCT01641991|594575974|FG003|Overall Study|Withdrawal by Subject|5|||
164605329|NCT01641991|594575971|FG000|Overall Study|Adverse Event|2|||
164605330|NCT01641991|594575972|FG001|Overall Study|Adverse Event|1|||
164605331|NCT01641991|594575973|FG002|Overall Study|Adverse Event|2|||
164605332|NCT01641991|594575974|FG003|Overall Study|Adverse Event|1|||
164605333|NCT01641991|594575971|FG000|Overall Study|Lost to Follow-up|0|||
164605334|NCT01641991|594575972|FG001|Overall Study|Lost to Follow-up|2|||
164605335|NCT01641991|594575973|FG002|Overall Study|Lost to Follow-up|3|||
164605336|NCT01641991|594575974|FG003|Overall Study|Lost to Follow-up|1|||
164605337|NCT01641991|594575971|FG000|Overall Study|Protocol Violation|1|||
164605338|NCT01641991|594575972|FG001|Overall Study|Protocol Violation|1|||
164605339|NCT01641991|594575973|FG002|Overall Study|Protocol Violation|3|||
164605340|NCT01641991|594575974|FG003|Overall Study|Protocol Violation|0|||
164605341|NCT01641991|594575971|FG000|Overall Study|Pregnancy|0|||
164605342|NCT01641991|594575972|FG001|Overall Study|Pregnancy|0|||
164605343|NCT01641991|594575973|FG002|Overall Study|Pregnancy|1|||
164605344|NCT01641991|594575974|FG003|Overall Study|Pregnancy|0|||
164605345|NCT01641991|594575971|FG000|Overall Study|no longer eligible|2|||
164605346|NCT01641991|594575972|FG001|Overall Study|no longer eligible|1|||
164605347|NCT01641991|594575973|FG002|Overall Study|no longer eligible|0|||
164605348|NCT01641991|594575974|FG003|Overall Study|no longer eligible|4|||
164605349|NCT00475540|594575978|FG000|36 Months|Lost to Follow-up|4|||
164605350|NCT00475540|594575979|FG001|36 Months|Lost to Follow-up|4|||
164605351|NCT00475540|594575978|FG000|36 Months|Death|1|||
164605352|NCT00475540|594575979|FG001|36 Months|Death|2|||
164605353|NCT00475540|594575978|FG000|36 Months|Censored due to reoperation|3|||
164605354|NCT00475540|594575979|FG001|36 Months|Censored due to reoperation|0|||
164605355|NCT03245723|594575983|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
164605356|NCT03245723|594575984|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
164605357|NCT03245723|594575983|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
164605358|NCT03245723|594575984|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
164605359|NCT03245723|594575983|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
164605360|NCT03245723|594575984|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
164605361|NCT03245723|594575983|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
164605362|NCT03245723|594575984|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
164500382|NCT02484547|594204177|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
164500383|NCT02484547|594204178|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
164500384|NCT02484547|594204179|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
164500385|NCT02484547|594204180|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
164500386|NCT02484547|594204181|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
164500387|NCT02484547|594204175|FG000|Placebo-Controlled Period|Reason not Specified|216|||
164500388|NCT02484547|594204176|FG001|Placebo-Controlled Period|Reason not Specified|194|||
164500389|NCT02484547|594204177|FG002|Placebo-Controlled Period|Reason not Specified|183|||
164500390|NCT02484547|594204178|FG003|Placebo-Controlled Period|Reason not Specified|0|||
164500391|NCT02484547|594204179|FG004|Placebo-Controlled Period|Reason not Specified|0|||
164500392|NCT02484547|594204180|FG005|Placebo-Controlled Period|Reason not Specified|0|||
164500393|NCT02484547|594204181|FG006|Placebo-Controlled Period|Reason not Specified|0|||
164500394|NCT02484547|594204175|FG000|Long-Term Extension Period|Adverse Event|0|||
164500395|NCT02484547|594204176|FG001|Long-Term Extension Period|Adverse Event|0|||
164500396|NCT02484547|594204177|FG002|Long-Term Extension Period|Adverse Event|0|||
164500397|NCT02484547|594204178|FG003|Long-Term Extension Period|Adverse Event|0|||
164500398|NCT02484547|594204179|FG004|Long-Term Extension Period|Adverse Event|1|||
164500399|NCT02484547|594204180|FG005|Long-Term Extension Period|Adverse Event|3|||
164500400|NCT02484547|594204181|FG006|Long-Term Extension Period|Adverse Event|2|||
164500401|NCT02484547|594204175|FG000|Long-Term Extension Period|Death|0|||
164500402|NCT02484547|594204176|FG001|Long-Term Extension Period|Death|0|||
164500403|NCT02484547|594204177|FG002|Long-Term Extension Period|Death|0|||
164500404|NCT02484547|594204178|FG003|Long-Term Extension Period|Death|0|||
164500405|NCT02484547|594204179|FG004|Long-Term Extension Period|Death|0|||
164500406|NCT02484547|594204180|FG005|Long-Term Extension Period|Death|3|||
164500407|NCT02484547|594204181|FG006|Long-Term Extension Period|Death|0|||
164500408|NCT02484547|594204175|FG000|Long-Term Extension Period|Disease Progression|0|||
164500409|NCT02484547|594204176|FG001|Long-Term Extension Period|Disease Progression|0|||
164500410|NCT02484547|594204177|FG002|Long-Term Extension Period|Disease Progression|0|||
164500411|NCT02484547|594204178|FG003|Long-Term Extension Period|Disease Progression|0|||
164500412|NCT02484547|594204179|FG004|Long-Term Extension Period|Disease Progression|2|||
164500413|NCT02484547|594204180|FG005|Long-Term Extension Period|Disease Progression|4|||
164500414|NCT02484547|594204181|FG006|Long-Term Extension Period|Disease Progression|0|||
164500415|NCT02484547|594204175|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
164500416|NCT02484547|594204176|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
164500417|NCT02484547|594204177|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
164500418|NCT02484547|594204178|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
164500419|NCT02484547|594204179|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
164500420|NCT02484547|594204180|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
164500421|NCT02484547|594204181|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
164500422|NCT02484547|594204175|FG000|Long-Term Extension Period|Loss of Capacity|0|||
164500423|NCT02484547|594204176|FG001|Long-Term Extension Period|Loss of Capacity|0|||
164500424|NCT02484547|594204177|FG002|Long-Term Extension Period|Loss of Capacity|0|||
164500425|NCT02484547|594204178|FG003|Long-Term Extension Period|Loss of Capacity|0|||
164500426|NCT02484547|594204179|FG004|Long-Term Extension Period|Loss of Capacity|1|||
164500427|NCT02484547|594204180|FG005|Long-Term Extension Period|Loss of Capacity|0|||
164500428|NCT02484547|594204181|FG006|Long-Term Extension Period|Loss of Capacity|0|||
164500429|NCT02484547|594204175|FG000|Long-Term Extension Period|Change of Treatment|0|||
164500430|NCT02484547|594204176|FG001|Long-Term Extension Period|Change of Treatment|0|||
164500431|NCT02484547|594204177|FG002|Long-Term Extension Period|Change of Treatment|0|||
164500432|NCT02484547|594204178|FG003|Long-Term Extension Period|Change of Treatment|0|||
164500433|NCT02484547|594204179|FG004|Long-Term Extension Period|Change of Treatment|0|||
164500434|NCT02484547|594204180|FG005|Long-Term Extension Period|Change of Treatment|0|||
164500435|NCT02484547|594204181|FG006|Long-Term Extension Period|Change of Treatment|1|||
164500436|NCT02484547|594204175|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
164500437|NCT02484547|594204176|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
164500438|NCT02484547|594204177|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
164500439|NCT02484547|594204178|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
164500440|NCT02484547|594204179|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
164500441|NCT02484547|594204180|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
164605363|NCT03784027|594575987|FG000|Period 1|Withdrawal by Subject|0|||
164605364|NCT03784027|594575988|FG001|Period 1|Withdrawal by Subject|1|||
164605365|NCT01512108|594577512|FG000|Overall Study|Adverse Event|9|||
164605366|NCT01512108|594577513|FG001|Overall Study|Adverse Event|4|||
164605367|NCT01512108|594577512|FG000|Overall Study|Protocol Violation|1|||
164605368|NCT01512108|594577513|FG001|Overall Study|Protocol Violation|2|||
164605369|NCT01512108|594577512|FG000|Overall Study|Withdrawal Criteria|1|||
164605370|NCT01512108|594577513|FG001|Overall Study|Withdrawal Criteria|0|||
164500442|NCT02484547|594204181|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
164500443|NCT02484547|594204175|FG000|Long-Term Extension Period|Investigator Decision|0|||
164500444|NCT02484547|594204176|FG001|Long-Term Extension Period|Investigator Decision|0|||
164605371|NCT01512108|594577512|FG000|Overall Study|Unclassified|11|||
164715921|NCT05411393|594982197|FG001|Overall Study|Withdrawal by Subject|0|||
164715922|NCT05411393|594982196|FG000|Overall Study|Lost to Follow-up|3|||
164715923|NCT05411393|594982197|FG001|Overall Study|Lost to Follow-up|2|||
164715924|NCT04035499|594982198|FG000|Overall Study|Death|2|||
164500445|NCT02484547|594204177|FG002|Long-Term Extension Period|Investigator Decision|0|||
164500446|NCT02484547|594204178|FG003|Long-Term Extension Period|Investigator Decision|2|||
164500447|NCT02484547|594204179|FG004|Long-Term Extension Period|Investigator Decision|1|||
164500448|NCT02484547|594204180|FG005|Long-Term Extension Period|Investigator Decision|0|||
164500449|NCT02484547|594204181|FG006|Long-Term Extension Period|Investigator Decision|1|||
164500450|NCT02484547|594204175|FG000|Long-Term Extension Period|Relocation|0|||
164500451|NCT02484547|594204176|FG001|Long-Term Extension Period|Relocation|0|||
164500452|NCT02484547|594204177|FG002|Long-Term Extension Period|Relocation|0|||
164500453|NCT02484547|594204178|FG003|Long-Term Extension Period|Relocation|1|||
164500454|NCT02484547|594204179|FG004|Long-Term Extension Period|Relocation|1|||
164500455|NCT02484547|594204180|FG005|Long-Term Extension Period|Relocation|0|||
164500456|NCT02484547|594204181|FG006|Long-Term Extension Period|Relocation|0|||
164500457|NCT02484547|594204175|FG000|Long-Term Extension Period|Study Visit Burden|0|||
164500458|NCT02484547|594204176|FG001|Long-Term Extension Period|Study Visit Burden|0|||
164500459|NCT02484547|594204177|FG002|Long-Term Extension Period|Study Visit Burden|0|||
164500460|NCT02484547|594204178|FG003|Long-Term Extension Period|Study Visit Burden|2|||
164500461|NCT02484547|594204179|FG004|Long-Term Extension Period|Study Visit Burden|0|||
164500462|NCT02484547|594204180|FG005|Long-Term Extension Period|Study Visit Burden|0|||
164500463|NCT02484547|594204181|FG006|Long-Term Extension Period|Study Visit Burden|3|||
164500464|NCT02484547|594204175|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
164500465|NCT02484547|594204176|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
164500466|NCT02484547|594204177|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
164500467|NCT02484547|594204178|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
164500468|NCT02484547|594204179|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
164500469|NCT02484547|594204180|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
164500470|NCT02484547|594204181|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
164500471|NCT02484547|594204175|FG000|Long-Term Extension Period|Reason not Specified|0|||
164500472|NCT02484547|594204176|FG001|Long-Term Extension Period|Reason not Specified|0|||
164500473|NCT02484547|594204177|FG002|Long-Term Extension Period|Reason not Specified|0|||
164500474|NCT02484547|594204178|FG003|Long-Term Extension Period|Reason not Specified|119|||
164500475|NCT02484547|594204179|FG004|Long-Term Extension Period|Reason not Specified|117|||
164500476|NCT02484547|594204180|FG005|Long-Term Extension Period|Reason not Specified|223|||
164500477|NCT02484547|594204181|FG006|Long-Term Extension Period|Reason not Specified|231|||
164500478|NCT03765164|594204182|FG000|Pre-intervention|Withdrawal by Subject|5|||
164500479|NCT03765164|594204183|FG001|Pre-intervention|Withdrawal by Subject|6|||
164500480|NCT03448536|594204184|FG000|Overall Study|Protocol Violation|2|||
164500481|NCT03448536|594204185|FG001|Overall Study|Protocol Violation|0|||
164500482|NCT03448536|594204184|FG000|Overall Study|Pregnancy|1|||
164500483|NCT03448536|594204185|FG001|Overall Study|Pregnancy|0|||
164500484|NCT03448536|594204184|FG000|Overall Study|Withdrawal by Subject|1|||
164500485|NCT03448536|594204185|FG001|Overall Study|Withdrawal by Subject|2|||
164500486|NCT03448536|594204184|FG000|Overall Study|Lost to Follow-up|3|||
164500487|NCT03448536|594204185|FG001|Overall Study|Lost to Follow-up|2|||
164500488|NCT03448536|594204184|FG000|Overall Study|Inadequate pain reporter|1|||
164500489|NCT03448536|594204185|FG001|Overall Study|Inadequate pain reporter|0|||
164500490|NCT03448536|594204184|FG000|Overall Study|Other|3|||
164500491|NCT03448536|594204185|FG001|Overall Study|Other|0|||
164500492|NCT03448536|594204184|FG000|Overall Study|Physician Decision|1|||
164500493|NCT03448536|594204185|FG001|Overall Study|Physician Decision|0|||
164500494|NCT01813305|594204186|FG000|Overall Study|Withdrawal by Subject|12|||
164500495|NCT01813305|594204187|FG001|Overall Study|Withdrawal by Subject|5|||
164500496|NCT01813305|594204186|FG000|Overall Study|Safety Concern|4|||
164500497|NCT01813305|594204187|FG001|Overall Study|Safety Concern|0|||
164715925|NCT04035499|594982198|FG000|Overall Study|Withdrawal by Subject|1|||
164500498|NCT01813305|594204186|FG000|Overall Study|Ulcer became worse|4|||
164500499|NCT01813305|594204187|FG001|Overall Study|Ulcer became worse|0|||
164500500|NCT01813305|594204186|FG000|Overall Study|Physician Decision|4|||
164500501|NCT01813305|594204187|FG001|Overall Study|Physician Decision|0|||
164500502|NCT01813305|594204186|FG000|Overall Study|Lost to Follow-up|3|||
164500503|NCT01813305|594204187|FG001|Overall Study|Lost to Follow-up|1|||
164500504|NCT01813305|594204186|FG000|Overall Study|Protocol Violation|1|||
164500505|NCT01813305|594204187|FG001|Overall Study|Protocol Violation|0|||
164500506|NCT01813305|594204186|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
164500507|NCT01813305|594204187|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
164500508|NCT01665599|594204188|FG000|Overall Study|Adverse Event|1|||
164500509|NCT01665599|594204188|FG000|Overall Study|Consent Withdrawn|1|||
164500510|NCT01665599|594204188|FG000|Overall Study|Investigator/Sponsor decision|1|||
164500511|NCT01665599|594204188|FG000|Overall Study|Death|1|||
164500512|NCT01665599|594204188|FG000|Overall Study|Lost to Follow-up|2|||
164500513|NCT01665599|594204188|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
164500514|NCT01665599|594204188|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
164500515|NCT01091519|594204190|FG000|Overall Study|Adverse Event|12|||
164500516|NCT01091519|594204191|FG001|Overall Study|Adverse Event|16|||
164500517|NCT01091519|594204190|FG000|Overall Study|Death|1|||
164500518|NCT01091519|594204191|FG001|Overall Study|Death|0|||
164500519|NCT01091519|594204190|FG000|Overall Study|Lack of Efficacy|16|||
164500520|NCT01091519|594204191|FG001|Overall Study|Lack of Efficacy|19|||
164500521|NCT01091519|594204190|FG000|Overall Study|Lost to Follow-up|14|||
164500522|NCT01091519|594204191|FG001|Overall Study|Lost to Follow-up|24|||
164500523|NCT01091519|594204190|FG000|Overall Study|Withdrawal by Subject|2|||
164500524|NCT01091519|594204191|FG001|Overall Study|Withdrawal by Subject|2|||
164500525|NCT01091519|594204190|FG000|Overall Study|Other|6|||
164500526|NCT01091519|594204191|FG001|Overall Study|Other|8|||
164500527|NCT01091519|594204190|FG000|Overall Study|Randomized not treated|4|||
164500528|NCT01091519|594204191|FG001|Overall Study|Randomized not treated|4|||
164500529|NCT01177228|594204196|FG000|Overall Study|Positive tuberculosis test|0|||
164500530|NCT01177228|594204197|FG001|Overall Study|Positive tuberculosis test|1|||
164500531|NCT01177228|594204198|FG002|Overall Study|Positive tuberculosis test|0|||
164500532|NCT01177228|594204199|FG003|Overall Study|Positive tuberculosis test|0|||
164500533|NCT01177228|594204196|FG000|Overall Study|Worsening disease activity|1|||
164500534|NCT01177228|594204197|FG001|Overall Study|Worsening disease activity|0|||
164500535|NCT01177228|594204198|FG002|Overall Study|Worsening disease activity|0|||
164500536|NCT01177228|594204199|FG003|Overall Study|Worsening disease activity|0|||
164500537|NCT01177228|594204196|FG000|Overall Study|Withdrawal by Subject|0|||
164500538|NCT01177228|594204197|FG001|Overall Study|Withdrawal by Subject|1|||
164500539|NCT01177228|594204198|FG002|Overall Study|Withdrawal by Subject|0|||
164500540|NCT01177228|594204199|FG003|Overall Study|Withdrawal by Subject|0|||
164500541|NCT01251887|594204200|FG000|Overall Study|Scheduling conflict|1|||
164500542|NCT01251887|594204201|FG001|Overall Study|Scheduling conflict|2|||
164500543|NCT01251887|594204202|FG002|Overall Study|Scheduling conflict|2|||
164500544|NCT01251887|594204200|FG000|Overall Study|Physician Decision|0|||
164500545|NCT01251887|594204201|FG001|Overall Study|Physician Decision|1|||
164500546|NCT01251887|594204202|FG002|Overall Study|Physician Decision|0|||
164500547|NCT00316589|594204205|FG000|Overall Study|Withdrawal by Subject|0|||
164500548|NCT00316589|594204206|FG001|Overall Study|Withdrawal by Subject|5|||
164500549|NCT00316589|594204207|FG002|Overall Study|Withdrawal by Subject|0|||
164500550|NCT00316589|594204208|FG003|Overall Study|Withdrawal by Subject|1|||
164500551|NCT00316589|594204205|FG000|Overall Study|Subject unwilling/unable to comply|0|||
164500552|NCT00316589|594204206|FG001|Overall Study|Subject unwilling/unable to comply|6|||
164500553|NCT00316589|594204207|FG002|Overall Study|Subject unwilling/unable to comply|0|||
164500554|NCT00316589|594204208|FG003|Overall Study|Subject unwilling/unable to comply|2|||
164500555|NCT00316589|594204205|FG000|Overall Study|Adverse Event|1|||
164500556|NCT00316589|594204206|FG001|Overall Study|Adverse Event|0|||
164500557|NCT00316589|594204207|FG002|Overall Study|Adverse Event|0|||
164500558|NCT00316589|594204208|FG003|Overall Study|Adverse Event|1|||
164500559|NCT00316589|594204205|FG000|Overall Study|Physician Decision|0|||
164500560|NCT00316589|594204206|FG001|Overall Study|Physician Decision|1|||
164500561|NCT00316589|594204207|FG002|Overall Study|Physician Decision|0|||
164500562|NCT00316589|594204208|FG003|Overall Study|Physician Decision|0|||
164500563|NCT00316589|594204205|FG000|Overall Study|Other reason|0|||
164500564|NCT00316589|594204206|FG001|Overall Study|Other reason|12|||
164500565|NCT00316589|594204207|FG002|Overall Study|Other reason|1|||
164500566|NCT00316589|594204208|FG003|Overall Study|Other reason|1|||
164500567|NCT01283971|594204211|FG000|Overall Study|Adverse Event|3|||
164500568|NCT01283971|594204212|FG001|Overall Study|Adverse Event|5|||
164500569|NCT01283971|594204211|FG000|Overall Study|Insufficient therapeutic responses|3|||
164500570|NCT01283971|594204212|FG001|Overall Study|Insufficient therapeutic responses|3|||
164500571|NCT01283971|594204211|FG000|Overall Study|Protocol Violation|5|||
164500572|NCT01283971|594204212|FG001|Overall Study|Protocol Violation|1|||
164500573|NCT01283971|594204211|FG000|Overall Study|Refused treatment|3|||
164500574|NCT01283971|594204212|FG001|Overall Study|Refused treatment|1|||
164500575|NCT01283971|594204211|FG000|Overall Study|Failure to return|0|||
164500576|NCT01283971|594204212|FG001|Overall Study|Failure to return|1|||
164500577|NCT01283971|594204211|FG000|Overall Study|Administrative reasons|1|||
164500578|NCT01283971|594204212|FG001|Overall Study|Administrative reasons|1|||
164500579|NCT00562484|594204218|FG000|Overall Study|Adverse Event|6|||
164500580|NCT00562484|594204219|FG001|Overall Study|Adverse Event|1|||
164500581|NCT00562484|594204218|FG000|Overall Study|Protocol Violation|11|||
164500582|NCT00562484|594204219|FG001|Overall Study|Protocol Violation|2|||
164500583|NCT00562484|594204218|FG000|Overall Study|Withdrawal by Subject|12|||
164500584|NCT00562484|594204219|FG001|Overall Study|Withdrawal by Subject|9|||
164500585|NCT00562484|594204218|FG000|Overall Study|Moved away from the study area|20|||
164500586|NCT00562484|594204219|FG001|Overall Study|Moved away from the study area|9|||
164500587|NCT00562484|594204218|FG000|Overall Study|Lost to Follow-up|132|||
164500588|NCT00562484|594204219|FG001|Overall Study|Lost to Follow-up|71|||
164500589|NCT00562484|594204218|FG000|Overall Study|Reason not provided or not specified|25|||
164500590|NCT00562484|594204219|FG001|Overall Study|Reason not provided or not specified|12|||
164500591|NCT02598934|594204223|FG000|Overall Study|Adverse Event|11|||
164500592|NCT02598934|594204224|FG001|Overall Study|Adverse Event|13|||
164500593|NCT02598934|594204223|FG000|Overall Study|Failure to Return|3|||
164500594|NCT02598934|594204224|FG001|Overall Study|Failure to Return|3|||
164500595|NCT02598934|594204223|FG000|Overall Study|Withdrawal by Subject|2|||
164500596|NCT02598934|594204224|FG001|Overall Study|Withdrawal by Subject|3|||
164500597|NCT02598934|594204223|FG000|Overall Study|Administrative|2|||
164500598|NCT02598934|594204224|FG001|Overall Study|Administrative|1|||
164500599|NCT02598934|594204223|FG000|Overall Study|Protocol Violation|1|||
164500600|NCT02598934|594204224|FG001|Overall Study|Protocol Violation|2|||
164500601|NCT00702520|594204226|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
164500602|NCT00702520|594204227|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
164500603|NCT00702520|594204228|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
164500604|NCT00702520|594204229|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
164500605|NCT00702520|594204226|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
164500606|NCT00702520|594204227|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
164500607|NCT00702520|594204228|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
164500608|NCT00702520|594204229|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
164500609|NCT00702520|594204226|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
164500610|NCT00702520|594204227|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
164500611|NCT00702520|594204228|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
164500612|NCT00702520|594204229|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
164500613|NCT02154347|594204230|FG000|Double-blind Period|Adverse Event|1|||
164500614|NCT02154347|594204231|FG001|Double-blind Period|Adverse Event|2|||
164500615|NCT02154347|594204230|FG000|Double-blind Period|Lack of Efficacy|1|||
164500616|NCT02154347|594204231|FG001|Double-blind Period|Lack of Efficacy|0|||
164500617|NCT02154347|594204230|FG000|Double-blind Period|Physician Decision|0|||
164500618|NCT02154347|594204231|FG001|Double-blind Period|Physician Decision|1|||
164500619|NCT02154347|594204230|FG000|Double-blind Period|Withdrawal by Subject|1|||
164500620|NCT02154347|594204231|FG001|Double-blind Period|Withdrawal by Subject|1|||
164500621|NCT02154347|594204230|FG000|Open-label Period|Adverse Event|3|||
164500622|NCT02154347|594204231|FG001|Open-label Period|Adverse Event|4|||
164500623|NCT02154347|594204230|FG000|Open-label Period|Lack of Efficacy|4|||
164500624|NCT02154347|594204231|FG001|Open-label Period|Lack of Efficacy|19|||
164500625|NCT02154347|594204230|FG000|Open-label Period|Protocol Violation|0|||
164500626|NCT02154347|594204231|FG001|Open-label Period|Protocol Violation|1|||
164500627|NCT02154347|594204230|FG000|Open-label Period|Withdrawal by Subject|0|||
164500628|NCT02154347|594204231|FG001|Open-label Period|Withdrawal by Subject|1|||
164500629|NCT02481934|594204232|FG000|Overall Study|Death|2|||
164500630|NCT02473913|594204233|FG000|Overall Study|Lost to Follow-up|3|||
164500631|NCT02473913|594204234|FG001|Overall Study|Lost to Follow-up|3|||
164500632|NCT02250183|594204242|FG000|Overall Study|Withdrawal by Subject|2|||
164500633|NCT02250183|594204242|FG000|Overall Study|Adverse Event|5|||
164500634|NCT02250183|594204242|FG000|Overall Study|Lost to Follow-up|1|||
164500635|NCT03282799|594204243|FG000|Overall Study|Pregnancy|1|||
164500636|NCT03282799|594204244|FG001|Overall Study|Pregnancy|0|||
164500637|NCT03282799|594204243|FG000|Overall Study|Physician Decision|1|||
164500638|NCT03282799|594204244|FG001|Overall Study|Physician Decision|0|||
164500639|NCT03749616|594204248|FG000|Overall Study|Lost to Follow-up|4|||
164500640|NCT03749616|594204249|FG001|Overall Study|Lost to Follow-up|7|||
164500641|NCT03749616|594204248|FG000|Overall Study|Screen Failure|1|||
164500642|NCT03749616|594204249|FG001|Overall Study|Screen Failure|1|||
164500643|NCT03749616|594204248|FG000|Overall Study|Withdrawal by Subject|2|||
164500644|NCT03749616|594204249|FG001|Overall Study|Withdrawal by Subject|0|||
164500645|NCT03302559|594204250|FG000|Overall Study|Adverse Event|2|||
164500646|NCT03302559|594204250|FG000|Overall Study|Lost to Follow-up|1|||
164500647|NCT03302559|594204250|FG000|Overall Study|Withdrew Consent|3|||
164500648|NCT02080403|594205859|FG000|Overall Study|Adverse Event|5|||
164500649|NCT02080403|594205860|FG001|Overall Study|Adverse Event|1|||
164500650|NCT02080403|594205859|FG000|Overall Study|Death|0|||
164500651|NCT02080403|594205860|FG001|Overall Study|Death|2|||
164500652|NCT02080403|594205859|FG000|Overall Study|Lost to Follow-up|2|||
164500653|NCT02080403|594205860|FG001|Overall Study|Lost to Follow-up|0|||
164500654|NCT02080403|594205859|FG000|Overall Study|Pregnancy|0|||
164500655|NCT02080403|594205860|FG001|Overall Study|Pregnancy|1|||
164500656|NCT02080403|594205859|FG000|Overall Study|Protocol Violation|3|||
164500657|NCT02080403|594205860|FG001|Overall Study|Protocol Violation|7|||
164500658|NCT02080403|594205859|FG000|Overall Study|Withdrawal by Subject|5|||
164500659|NCT02080403|594205860|FG001|Overall Study|Withdrawal by Subject|1|||
164500660|NCT01999972|594205861|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
164500661|NCT01999972|594205862|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
164500662|NCT01999972|594205863|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
164500663|NCT01999972|594205864|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
164500664|NCT01999972|594205865|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
164500665|NCT01999972|594205866|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
164500666|NCT01999972|594205861|FG000|Dose Escalation Part|Death|0|||
164715926|NCT06507566|594982207|FG000|Overall Study|Lost to Follow-up|9|||
164715927|NCT06507566|594982208|FG001|Overall Study|Lost to Follow-up|7|||
164715928|NCT06507566|594982207|FG000|Overall Study|Withdrawal by Subject|5|||
164715929|NCT06507566|594982208|FG001|Overall Study|Withdrawal by Subject|2|||
164715930|NCT05101317|594982209|FG000|Week1-13|Adverse Event|0|||
164715931|NCT05101317|594982210|FG001|Week1-13|Adverse Event|1|||
164715932|NCT05101317|594982211|FG002|Week1-13|Adverse Event|0|||
164715933|NCT05101317|594982212|FG003|Week1-13|Adverse Event|0|||
164715934|NCT05101317|594982209|FG000|Week1-13|Withdrawal by Subject|0|||
164715935|NCT05101317|594982210|FG001|Week1-13|Withdrawal by Subject|2|||
164715936|NCT05101317|594982211|FG002|Week1-13|Withdrawal by Subject|0|||
164715937|NCT05101317|594982212|FG003|Week1-13|Withdrawal by Subject|0|||
164715938|NCT05101317|594982209|FG000|Week1-13|Early Withdrawl|0|||
164715939|NCT05101317|594982210|FG001|Week1-13|Early Withdrawl|0|||
164715940|NCT05101317|594982211|FG002|Week1-13|Early Withdrawl|0|||
164715941|NCT05101317|594982212|FG003|Week1-13|Early Withdrawl|1|||
164715942|NCT05101317|594982209|FG000|Week 13-25|Lost to Follow-up|0|||
164715943|NCT05101317|594982210|FG001|Week 13-25|Lost to Follow-up|0|||
164715944|NCT05101317|594982211|FG002|Week 13-25|Lost to Follow-up|1|||
164715945|NCT05101317|594982212|FG003|Week 13-25|Lost to Follow-up|0|||
164715946|NCT05101317|594982209|FG000|Week 13-25|Withdrawal by Subject|1|||
164715947|NCT05101317|594982210|FG001|Week 13-25|Withdrawal by Subject|1|||
164715948|NCT05101317|594982211|FG002|Week 13-25|Withdrawal by Subject|0|||
164715949|NCT05101317|594982212|FG003|Week 13-25|Withdrawal by Subject|0|||
164500667|NCT01999972|594205862|FG001|Dose Escalation Part|Death|1|||
164500668|NCT01999972|594205863|FG002|Dose Escalation Part|Death|0|||
164500669|NCT01999972|594205864|FG003|Dose Escalation Part|Death|0|||
164500670|NCT01999972|594205865|FG004|Dose Escalation Part|Death|0|||
164500671|NCT01999972|594205866|FG005|Dose Escalation Part|Death|0|||
164500672|NCT01999972|594205861|FG000|Dose Escalation Part|Enrolled but not treated|0|||
164500673|NCT01999972|594205862|FG001|Dose Escalation Part|Enrolled but not treated|0|||
164500674|NCT01999972|594205863|FG002|Dose Escalation Part|Enrolled but not treated|1|||
164500675|NCT01999972|594205864|FG003|Dose Escalation Part|Enrolled but not treated|1|||
164500676|NCT01999972|594205865|FG004|Dose Escalation Part|Enrolled but not treated|0|||
164500677|NCT01999972|594205866|FG005|Dose Escalation Part|Enrolled but not treated|0|||
164500678|NCT01999972|594205861|FG000|Dose Escalation Part|Disease progression|3|||
164500679|NCT01999972|594205862|FG001|Dose Escalation Part|Disease progression|2|||
164500680|NCT01999972|594205863|FG002|Dose Escalation Part|Disease progression|3|||
164500681|NCT01999972|594205864|FG003|Dose Escalation Part|Disease progression|6|||
164500682|NCT01999972|594205865|FG004|Dose Escalation Part|Disease progression|0|||
164500683|NCT01999972|594205866|FG005|Dose Escalation Part|Disease progression|0|||
164500684|NCT01999972|594205861|FG000|Dose Escalation Part|Adverse Event|0|||
164500685|NCT01999972|594205862|FG001|Dose Escalation Part|Adverse Event|0|||
164500686|NCT01999972|594205863|FG002|Dose Escalation Part|Adverse Event|0|||
164500687|NCT01999972|594205864|FG003|Dose Escalation Part|Adverse Event|2|||
164500688|NCT01999972|594205865|FG004|Dose Escalation Part|Adverse Event|0|||
164500689|NCT01999972|594205866|FG005|Dose Escalation Part|Adverse Event|0|||
164500690|NCT01999972|594205861|FG000|Dose Escalation Part|Global deterioration of health status|1|||
164500691|NCT01999972|594205862|FG001|Dose Escalation Part|Global deterioration of health status|0|||
164500692|NCT01999972|594205863|FG002|Dose Escalation Part|Global deterioration of health status|0|||
164500693|NCT01999972|594205864|FG003|Dose Escalation Part|Global deterioration of health status|1|||
164500694|NCT01999972|594205865|FG004|Dose Escalation Part|Global deterioration of health status|0|||
164500695|NCT01999972|594205866|FG005|Dose Escalation Part|Global deterioration of health status|0|||
164500696|NCT01999972|594205861|FG000|Dose Expansion Part|Death|0|||
164500697|NCT01999972|594205862|FG001|Dose Expansion Part|Death|0|||
164500698|NCT01999972|594205863|FG002|Dose Expansion Part|Death|0|||
164500699|NCT01999972|594205864|FG003|Dose Expansion Part|Death|0|||
164500700|NCT01999972|594205865|FG004|Dose Expansion Part|Death|2|||
164500701|NCT01999972|594205866|FG005|Dose Expansion Part|Death|1|||
164500702|NCT01999972|594205861|FG000|Dose Expansion Part|Disease progression|0|||
164715950|NCT05101317|594982209|FG000|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
164715951|NCT05101317|594982210|FG001|Week 13-25|Patient decide to have oral contraception/refuse to come back|2|||
164715952|NCT05101317|594982211|FG002|Week 13-25|Patient decide to have oral contraception/refuse to come back|1|||
164500703|NCT01999972|594205862|FG001|Dose Expansion Part|Disease progression|0|||
164500704|NCT01999972|594205863|FG002|Dose Expansion Part|Disease progression|0|||
164500705|NCT01999972|594205864|FG003|Dose Expansion Part|Disease progression|0|||
164500706|NCT01999972|594205865|FG004|Dose Expansion Part|Disease progression|9|||
164500707|NCT01999972|594205866|FG005|Dose Expansion Part|Disease progression|3|||
164500708|NCT01999972|594205861|FG000|Dose Expansion Part|Sponsor decision|0|||
164715953|NCT05101317|594982212|FG003|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
164715954|NCT03541200|594982213|FG000|Overall Study|Adverse Event|19|||
164715955|NCT03541200|594982213|FG000|Overall Study|Death|1|||
164715956|NCT03541200|594982213|FG000|Overall Study|Lost to Follow-up|10|||
164715957|NCT03541200|594982213|FG000|Overall Study|Physician Decision|1|||
164715958|NCT03541200|594982213|FG000|Overall Study|Protocol Violation|51|||
164715959|NCT03541200|594982213|FG000|Overall Study|Withdrawal by Subject|23|||
164605372|NCT01512108|594577513|FG001|Overall Study|Unclassified|3|||
164605373|NCT03287869|594577518|FG000|Overall Study|Adverse Event|14|||
164605374|NCT03287869|594577519|FG001|Overall Study|Adverse Event|12|||
164605375|NCT03287869|594577518|FG000|Overall Study|Lack of Efficacy|1|||
164605376|NCT03287869|594577519|FG001|Overall Study|Lack of Efficacy|0|||
164605377|NCT03287869|594577518|FG000|Overall Study|Lost to Follow-up|13|||
164605378|NCT03287869|594577519|FG001|Overall Study|Lost to Follow-up|19|||
164605379|NCT03287869|594577518|FG000|Overall Study|Non-Compliance With Study Drug|5|||
164605380|NCT03287869|594577519|FG001|Overall Study|Non-Compliance With Study Drug|9|||
164605381|NCT03287869|594577518|FG000|Overall Study|Progressive Disease|1|||
164605382|NCT03287869|594577519|FG001|Overall Study|Progressive Disease|0|||
164605383|NCT03287869|594577518|FG000|Overall Study|Protocol Deviation|2|||
164605384|NCT03287869|594577519|FG001|Overall Study|Protocol Deviation|1|||
164605385|NCT03287869|594577518|FG000|Overall Study|Withdrawal by Subject|36|||
164605386|NCT03287869|594577519|FG001|Overall Study|Withdrawal by Subject|43|||
164605387|NCT03287869|594577518|FG000|Overall Study|Early Closure of the Site|0|||
164605388|NCT03287869|594577519|FG001|Overall Study|Early Closure of the Site|1|||
164605389|NCT03287869|594577518|FG000|Overall Study|Physician Decision|5|||
164605390|NCT03287869|594577519|FG001|Overall Study|Physician Decision|5|||
164605391|NCT03287869|594577518|FG000|Overall Study|Reason not Specified|6|||
164605392|NCT03287869|594577519|FG001|Overall Study|Reason not Specified|3|||
164605393|NCT04847141|594577520|FG000|Overall Study|Adverse Event|1|||
164605394|NCT04847141|594577521|FG001|Overall Study|Adverse Event|0|||
164605395|NCT04847141|594577522|FG002|Overall Study|Adverse Event|1|||
164605396|NCT04847141|594577520|FG000|Overall Study|Withdrawal by Subject|2|||
164605397|NCT04847141|594577521|FG001|Overall Study|Withdrawal by Subject|4|||
164605398|NCT04847141|594577522|FG002|Overall Study|Withdrawal by Subject|3|||
164605399|NCT04847141|594577520|FG000|Overall Study|Lost to Follow-up|7|||
164605400|NCT04847141|594577521|FG001|Overall Study|Lost to Follow-up|5|||
164605401|NCT04847141|594577522|FG002|Overall Study|Lost to Follow-up|7|||
164605402|NCT04847141|594577520|FG000|Overall Study|Reason not Specified|0|||
164605403|NCT04847141|594577521|FG001|Overall Study|Reason not Specified|1|||
164605404|NCT04847141|594577522|FG002|Overall Study|Reason not Specified|0|||
164605405|NCT00324740|594577523|FG000|Overall Study|Withdrawal by Subject|1|||
164605406|NCT00324740|594577524|FG001|Overall Study|Withdrawal by Subject|0|||
164605407|NCT00324740|594577525|FG002|Overall Study|Withdrawal by Subject|1|||
164605408|NCT01357980|594577530|FG000|Overall Study|Lack of Efficacy|0|||
164605409|NCT01357980|594577531|FG001|Overall Study|Lack of Efficacy|1|||
164605410|NCT01357980|594577532|FG002|Overall Study|Lack of Efficacy|0|||
164605411|NCT01357980|594577533|FG003|Overall Study|Lack of Efficacy|0|||
164605412|NCT01357980|594577530|FG000|Overall Study|Consent withdrawn|0|||
164605413|NCT01357980|594577531|FG001|Overall Study|Consent withdrawn|0|||
164605414|NCT01357980|594577532|FG002|Overall Study|Consent withdrawn|1|||
164605415|NCT01357980|594577533|FG003|Overall Study|Consent withdrawn|0|||
164605416|NCT04507776|594577534|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
164605417|NCT00094835|594577538|FG000|Overall Study|Physician Decision|1|||
164605418|NCT00094835|594577539|FG001|Overall Study|Physician Decision|0|||
164605419|NCT00094835|594577540|FG002|Overall Study|Physician Decision|0|||
164605420|NCT00094835|594577541|FG003|Overall Study|Physician Decision|0|||
164605421|NCT00094835|594577542|FG004|Overall Study|Physician Decision|0|||
164605422|NCT00094835|594577543|FG005|Overall Study|Physician Decision|1|||
164605423|NCT00094835|594577544|FG006|Overall Study|Physician Decision|0|||
164605424|NCT00094835|594577538|FG000|Overall Study|Withdrawal by Subject|0|||
164715960|NCT03541200|594982213|FG000|Overall Study|other|8|||
164715961|NCT04338893|594982215|FG000|Overall Study|Withdrawal by Subject|10|||
164715962|NCT04338893|594982216|FG001|Overall Study|Withdrawal by Subject|10|||
164605425|NCT00094835|594577539|FG001|Overall Study|Withdrawal by Subject|0|||
164605426|NCT00094835|594577540|FG002|Overall Study|Withdrawal by Subject|0|||
164605427|NCT00094835|594577541|FG003|Overall Study|Withdrawal by Subject|0|||
164605428|NCT00094835|594577542|FG004|Overall Study|Withdrawal by Subject|0|||
164605429|NCT00094835|594577543|FG005|Overall Study|Withdrawal by Subject|0|||
164605430|NCT00094835|594577544|FG006|Overall Study|Withdrawal by Subject|1|||
164605431|NCT00094835|594577538|FG000|Overall Study|Lost to Follow-up|0|||
164605432|NCT00094835|594577539|FG001|Overall Study|Lost to Follow-up|0|||
164605433|NCT00094835|594577540|FG002|Overall Study|Lost to Follow-up|0|||
164605434|NCT00094835|594577541|FG003|Overall Study|Lost to Follow-up|0|||
164715963|NCT04338893|594982215|FG000|Overall Study|Death|0|||
164605435|NCT00094835|594577542|FG004|Overall Study|Lost to Follow-up|1|||
164605436|NCT00094835|594577543|FG005|Overall Study|Lost to Follow-up|0|||
164605437|NCT00094835|594577544|FG006|Overall Study|Lost to Follow-up|0|||
164605438|NCT00094835|594577538|FG000|Overall Study|Death|1|||
164605439|NCT00094835|594577539|FG001|Overall Study|Death|0|||
164605440|NCT00094835|594577540|FG002|Overall Study|Death|0|||
164605441|NCT00094835|594577541|FG003|Overall Study|Death|0|||
164605442|NCT00094835|594577542|FG004|Overall Study|Death|1|||
164605443|NCT00094835|594577543|FG005|Overall Study|Death|0|||
164605444|NCT00094835|594577544|FG006|Overall Study|Death|0|||
164715964|NCT04338893|594982216|FG001|Overall Study|Death|1|||
164605445|NCT00094835|594577538|FG000|Overall Study|Non-compliance|1|||
164715965|NCT04338893|594982215|FG000|Overall Study|Adverse Event|2|||
164500709|NCT01999972|594205862|FG001|Dose Expansion Part|Sponsor decision|0|||
164500710|NCT01999972|594205863|FG002|Dose Expansion Part|Sponsor decision|0|||
164500711|NCT01999972|594205864|FG003|Dose Expansion Part|Sponsor decision|0|||
164500712|NCT01999972|594205865|FG004|Dose Expansion Part|Sponsor decision|1|||
164500713|NCT01999972|594205866|FG005|Dose Expansion Part|Sponsor decision|0|||
164500714|NCT01999972|594205861|FG000|Dose Expansion Part|Adverse Event|0|||
164500715|NCT01999972|594205862|FG001|Dose Expansion Part|Adverse Event|0|||
164500716|NCT01999972|594205863|FG002|Dose Expansion Part|Adverse Event|0|||
164500717|NCT01999972|594205864|FG003|Dose Expansion Part|Adverse Event|0|||
164500718|NCT01999972|594205865|FG004|Dose Expansion Part|Adverse Event|4|||
164500719|NCT01999972|594205866|FG005|Dose Expansion Part|Adverse Event|2|||
164500720|NCT01999972|594205861|FG000|Dose Expansion Part|Participant's non-compliance|0|||
164500721|NCT01999972|594205862|FG001|Dose Expansion Part|Participant's non-compliance|0|||
164500722|NCT01999972|594205863|FG002|Dose Expansion Part|Participant's non-compliance|0|||
164500723|NCT01999972|594205864|FG003|Dose Expansion Part|Participant's non-compliance|0|||
164500724|NCT01999972|594205865|FG004|Dose Expansion Part|Participant's non-compliance|0|||
164500725|NCT01999972|594205866|FG005|Dose Expansion Part|Participant's non-compliance|1|||
164500726|NCT01999972|594205861|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
164500727|NCT01999972|594205862|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
164500728|NCT01999972|594205863|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
164500729|NCT01999972|594205864|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
164500730|NCT01999972|594205865|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
164500731|NCT01999972|594205866|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
164500732|NCT01999972|594205861|FG000|Dose Expansion Part|Changed to standard of care|0|||
164500733|NCT01999972|594205862|FG001|Dose Expansion Part|Changed to standard of care|0|||
164500734|NCT01999972|594205863|FG002|Dose Expansion Part|Changed to standard of care|0|||
164500735|NCT01999972|594205864|FG003|Dose Expansion Part|Changed to standard of care|0|||
164500736|NCT01999972|594205865|FG004|Dose Expansion Part|Changed to standard of care|1|||
164500737|NCT01999972|594205866|FG005|Dose Expansion Part|Changed to standard of care|0|||
164500738|NCT01171183|594205867|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
164500739|NCT01171183|594205868|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
164500740|NCT01171183|594205867|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
164500741|NCT01171183|594205868|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
164500742|NCT01171183|594205867|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
164500743|NCT01171183|594205868|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
164500744|NCT01171183|594205867|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
164500745|NCT01171183|594205868|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
164500746|NCT01171183|594205867|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
164500747|NCT01171183|594205868|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
164500748|NCT01171183|594205867|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
164500749|NCT01171183|594205868|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
164500750|NCT02826798|594205875|FG000|Overall Study|Withdrawal by Subject|0|||
164500751|NCT02826798|594205876|FG001|Overall Study|Withdrawal by Subject|1|||
164500752|NCT02826798|594205877|FG002|Overall Study|Withdrawal by Subject|0|||
164500753|NCT02826798|594205878|FG003|Overall Study|Withdrawal by Subject|1|||
164500754|NCT02826798|594205879|FG004|Overall Study|Withdrawal by Subject|0|||
164500755|NCT02806505|594205881|FG000|Overall Study|Adverse event/intercurrent illness|1|||
164500756|NCT02806505|594205882|FG001|Overall Study|Adverse event/intercurrent illness|3|||
164500757|NCT02806505|594205881|FG000|Overall Study|Death|4|||
164500758|NCT02806505|594205882|FG001|Overall Study|Death|0|||
164500759|NCT02806505|594205881|FG000|Overall Study|Did not cooperate/refused treatment|3|||
164500760|NCT02806505|594205882|FG001|Overall Study|Did not cooperate/refused treatment|3|||
164500761|NCT02806505|594205881|FG000|Overall Study|Failure to return|0|||
164500762|NCT02806505|594205882|FG001|Overall Study|Failure to return|1|||
164500763|NCT02806505|594205881|FG000|Overall Study|Insufficient therapeutic response|2|||
164500764|NCT02806505|594205882|FG001|Overall Study|Insufficient therapeutic response|4|||
164500765|NCT03440047|594205884|FG000|Overall Study|Withdrawal by Subject|2|||
164500766|NCT01722045|594205885|FG000|Overall Study|Adverse Event|8|||
164500767|NCT01722045|594205885|FG000|Overall Study|Death|3|||
164500768|NCT01722045|594205885|FG000|Overall Study|Withdrawal by Subject|8|||
164500769|NCT01722045|594205885|FG000|Overall Study|Lost to Follow-up|4|||
164715966|NCT04338893|594982216|FG001|Overall Study|Adverse Event|0|||
164715967|NCT04338893|594982215|FG000|Overall Study|Lost to Follow-up|23|||
164500770|NCT01722045|594205885|FG000|Overall Study|Protocol Deviation|1|||
164500771|NCT01722045|594205885|FG000|Overall Study|Physician Decision|3|||
164500772|NCT01722045|594205885|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
164500773|NCT03898700|594205887|FG000|Overall Study|Withdrawal by Subject|2|||
164715968|NCT04338893|594982216|FG001|Overall Study|Lost to Follow-up|15|||
164715969|NCT01175356|594982228|FG000|Overall Study|Death|1|||
164500774|NCT00701909|594205891|FG000|Overall Study|Withdrawal by Subject|0|||
164500775|NCT00701909|594205892|FG001|Overall Study|Withdrawal by Subject|1|||
164500776|NCT00971997|594205895|FG000|Overall Study|Adverse Event|2|||
164500777|NCT00971997|594205895|FG000|Overall Study|Death|1|||
164500778|NCT00971997|594205895|FG000|Overall Study|Protocol Violation|4|||
164500779|NCT00971997|594205895|FG000|Overall Study|Withdrawal by Subject|5|||
164500780|NCT00971997|594205895|FG000|Overall Study|Physician Decision|7|||
164500781|NCT04843579|594205899|FG000|Overall Study|Adverse Event|1|||
164500782|NCT04843579|594205899|FG000|Overall Study|Disease Progression|1|||
164500783|NCT04009629|594205900|FG000|Overall Study|Withdrawal by Subject|2|||
164500784|NCT04009629|594205901|FG001|Overall Study|Withdrawal by Subject|0|||
164500785|NCT00761956|594205906|FG000|Overall Study|Lost to Follow-up|6|||
164500786|NCT00761956|594205907|FG001|Overall Study|Lost to Follow-up|11|||
164500787|NCT00761956|594205906|FG000|Overall Study|Withdrawal by Subject|3|||
164500788|NCT00761956|594205907|FG001|Overall Study|Withdrawal by Subject|8|||
164500789|NCT00761956|594205906|FG000|Overall Study|Death|0|||
164500790|NCT00761956|594205907|FG001|Overall Study|Death|1|||
164500791|NCT00761956|594205906|FG000|Overall Study|Adverse Event|26|||
164500792|NCT00761956|594205907|FG001|Overall Study|Adverse Event|34|||
164500793|NCT04702893|594205908|FG000|Overall Study|Other reasons than listed|11|||
164500794|NCT04702893|594205908|FG000|Overall Study|Withdrawal by Subject|3|||
164500795|NCT04702893|594205908|FG000|Overall Study|Lost to Follow-up|7|||
164500796|NCT04702893|594205908|FG000|Overall Study|Death|10|||
164500797|NCT04702893|594205908|FG000|Overall Study|Not treated|6|||
164500798|NCT00639769|594205909|FG000|Overall Study|Death|2|||
164500799|NCT00639769|594205909|FG000|Overall Study|Adverse Event|7|||
164500800|NCT00639769|594205909|FG000|Overall Study|Lack of Efficacy|1|||
164500801|NCT00639769|594205909|FG000|Overall Study|Disease progression|26|||
164500802|NCT00639769|594205909|FG000|Overall Study|Withdrawal by Subject|4|||
164500803|NCT00634842|594205910|FG000|Overall Study|Adverse Event|2|||
164500804|NCT00634842|594205911|FG001|Overall Study|Adverse Event|3|||
164500805|NCT00634842|594205910|FG000|Overall Study|Protocol Violation|8|||
164500806|NCT00634842|594205911|FG001|Overall Study|Protocol Violation|4|||
164500807|NCT00634842|594205910|FG000|Overall Study|Move to another state|1|||
164500808|NCT00634842|594205911|FG001|Overall Study|Move to another state|0|||
164500809|NCT00634842|594205910|FG000|Overall Study|Inclusion criteria were not met|1|||
164500810|NCT00634842|594205911|FG001|Overall Study|Inclusion criteria were not met|0|||
164500811|NCT00634842|594205910|FG000|Overall Study|Lost to Follow-up|1|||
164500812|NCT00634842|594205911|FG001|Overall Study|Lost to Follow-up|2|||
164500813|NCT00634842|594205910|FG000|Overall Study|Physician Decision|1|||
164500814|NCT00634842|594205911|FG001|Overall Study|Physician Decision|0|||
164500815|NCT00634842|594205910|FG000|Overall Study|Withdrawal by Subject|1|||
164500816|NCT00634842|594205911|FG001|Overall Study|Withdrawal by Subject|3|||
164500817|NCT00634842|594205910|FG000|Overall Study|Lack of time and intolerance to drug|0|||
164500818|NCT00634842|594205911|FG001|Overall Study|Lack of time and intolerance to drug|1|||
164500819|NCT00634842|594205910|FG000|Overall Study|Discontinued due to injection|0|||
164500820|NCT00634842|594205911|FG001|Overall Study|Discontinued due to injection|2|||
164500821|NCT00634842|594205910|FG000|Overall Study|No need of study drug to treat diabetes|0|||
164500822|NCT00634842|594205911|FG001|Overall Study|No need of study drug to treat diabetes|1|||
164500823|NCT00634842|594205910|FG000|Overall Study|No wish to keep taking Avandia|0|||
164500824|NCT00634842|594205911|FG001|Overall Study|No wish to keep taking Avandia|1|||
164500825|NCT00634842|594205910|FG000|Overall Study|Subject off study drug for too long|0|||
164500826|NCT00634842|594205911|FG001|Overall Study|Subject off study drug for too long|1|||
164500827|NCT03294941|594205912|FG000|Overall Study|Withdrawal by Subject|0|||
164605446|NCT00094835|594577539|FG001|Overall Study|Non-compliance|2|||
164605447|NCT00094835|594577540|FG002|Overall Study|Non-compliance|2|||
164605448|NCT00094835|594577541|FG003|Overall Study|Non-compliance|0|||
164605449|NCT00094835|594577542|FG004|Overall Study|Non-compliance|2|||
164605450|NCT00094835|594577543|FG005|Overall Study|Non-compliance|2|||
164605451|NCT00094835|594577544|FG006|Overall Study|Non-compliance|1|||
164605452|NCT00094835|594577538|FG000|Overall Study|Other|1|||
164605453|NCT00094835|594577539|FG001|Overall Study|Other|1|||
164605454|NCT00094835|594577540|FG002|Overall Study|Other|1|||
164605455|NCT00094835|594577541|FG003|Overall Study|Other|1|||
164605456|NCT00094835|594577542|FG004|Overall Study|Other|0|||
164605457|NCT00094835|594577543|FG005|Overall Study|Other|0|||
164605458|NCT00094835|594577544|FG006|Overall Study|Other|0|||
164605459|NCT00387348|594577545|FG000|Overall Study|Death|1|||
164605460|NCT00387348|594577546|FG001|Overall Study|Death|1|||
164605461|NCT00387348|594577547|FG002|Overall Study|Death|0|||
164500828|NCT03294941|594205913|FG001|Overall Study|Withdrawal by Subject|2|||
164500829|NCT04629443|594205914|FG000|Overall Study|Adverse Event|2|||
164500830|NCT04629443|594205915|FG001|Overall Study|Adverse Event|1|||
164605462|NCT00387348|594577545|FG000|Overall Study|Physician Decision|1|||
164605463|NCT00387348|594577546|FG001|Overall Study|Physician Decision|0|||
164500831|NCT04629443|594205916|FG002|Overall Study|Adverse Event|2|||
164500832|NCT04629443|594205914|FG000|Overall Study|Progressive Disease|2|||
164500833|NCT04629443|594205915|FG001|Overall Study|Progressive Disease|3|||
164605464|NCT00387348|594577547|FG002|Overall Study|Physician Decision|1|||
164500834|NCT04629443|594205916|FG002|Overall Study|Progressive Disease|3|||
164500835|NCT04629443|594205914|FG000|Overall Study|Physician Decision|1|||
164715970|NCT01175356|594982228|FG000|Overall Study|Lack of Efficacy|12|||
164715971|NCT01175356|594982228|FG000|Overall Study|Lost to Follow-up|1|||
164715972|NCT01175356|594982228|FG000|Overall Study|Physician Decision|23|||
164715973|NCT01175356|594982228|FG000|Overall Study|Ineligible|1|||
164715974|NCT01175356|594982228|FG000|Overall Study|Treatment Slot Not Available|18|||
164715975|NCT01175356|594982228|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
164715976|NCT01175356|594982228|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
164715977|NCT01175356|594982228|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
164715978|NCT01175356|594982228|FG000|Overall Study|Inadequate stem cell for transplant|1|||
164715979|NCT01175356|594982228|FG000|Overall Study|Initiation other tx prior to completion|9|||
164715980|NCT02750202|594982229|FG000|Overall Study|Lost to Follow-up|3|||
164715981|NCT02750202|594982230|FG001|Overall Study|Lost to Follow-up|1|||
164715982|NCT07265245|594984191|FG000|Overall Study|Lost to Follow-up|17|||
164715983|NCT05770895|594984194|FG000|Overall Study|Randomized but never treated|0|||
164715984|NCT05770895|594984195|FG001|Overall Study|Randomized but never treated|0|||
164715985|NCT05770895|594984196|FG002|Overall Study|Randomized but never treated|2|||
164715986|NCT05770895|594984197|FG003|Overall Study|Randomized but never treated|0|||
164715987|NCT05770895|594984198|FG004|Overall Study|Randomized but never treated|0|||
164715988|NCT05770895|594984199|FG005|Overall Study|Randomized but never treated|0|||
164715989|NCT05770895|594984200|FG006|Overall Study|Randomized but never treated|0|||
164715990|NCT05770895|594984201|FG007|Overall Study|Randomized but never treated|0|||
164715991|NCT05770895|594984202|FG008|Overall Study|Randomized but never treated|0|||
164715992|NCT05770895|594984203|FG009|Overall Study|Randomized but never treated|0|||
164715993|NCT05770895|594984194|FG000|Overall Study|Withdrew consent|0|||
164500836|NCT04629443|594205915|FG001|Overall Study|Physician Decision|3|||
164500837|NCT04629443|594205916|FG002|Overall Study|Physician Decision|0|||
164500838|NCT01172639|594205922|FG000|Overall Study|Death|1|||
164500839|NCT01172639|594205923|FG001|Overall Study|Death|1|||
164500840|NCT01172639|594205924|FG002|Overall Study|Death|0|||
164500841|NCT01172639|594205925|FG003|Overall Study|Death|0|||
164500842|NCT01172639|594205926|FG004|Overall Study|Death|0|||
164500843|NCT01172639|594205922|FG000|Overall Study|Lost to Follow-up|9|||
164500844|NCT01172639|594205923|FG001|Overall Study|Lost to Follow-up|7|||
164500845|NCT01172639|594205924|FG002|Overall Study|Lost to Follow-up|11|||
164500846|NCT01172639|594205925|FG003|Overall Study|Lost to Follow-up|6|||
164500847|NCT01172639|594205926|FG004|Overall Study|Lost to Follow-up|6|||
164500848|NCT01172639|594205922|FG000|Overall Study|Withdrawal by Subject|3|||
164500849|NCT01172639|594205923|FG001|Overall Study|Withdrawal by Subject|3|||
164500850|NCT01172639|594205924|FG002|Overall Study|Withdrawal by Subject|5|||
164500851|NCT01172639|594205925|FG003|Overall Study|Withdrawal by Subject|5|||
164500852|NCT01172639|594205926|FG004|Overall Study|Withdrawal by Subject|0|||
164500853|NCT01316887|594205927|FG000|Overall Study|Adverse Event|13|||
164500854|NCT01316887|594205928|FG001|Overall Study|Adverse Event|21|||
164605465|NCT00387348|594577545|FG000|Overall Study|Withdrawal by Subject|0|||
164605466|NCT00387348|594577546|FG001|Overall Study|Withdrawal by Subject|2|||
164605467|NCT00387348|594577547|FG002|Overall Study|Withdrawal by Subject|2|||
164605468|NCT00387348|594577545|FG000|Overall Study|Adverse Event|1|||
164605469|NCT00387348|594577546|FG001|Overall Study|Adverse Event|0|||
164605470|NCT00387348|594577547|FG002|Overall Study|Adverse Event|1|||
164605471|NCT03628599|594577548|FG000|Overall Study|Adverse Event|0|||
164605472|NCT03628599|594577549|FG001|Overall Study|Adverse Event|1|||
164605473|NCT05905601|594577557|FG000|Overall Study|Lost to Follow-up|1|||
164605474|NCT05905601|594577558|FG001|Overall Study|Lost to Follow-up|3|||
164605475|NCT00225147|594577559|FG000|Open-label Phase|Lost to Follow-up|0|||
164605476|NCT00225147|594577560|FG001|Open-label Phase|Lost to Follow-up|0|||
164605477|NCT00225147|594577561|FG002|Open-label Phase|Lost to Follow-up|0|||
164605478|NCT00225147|594577562|FG003|Open-label Phase|Lost to Follow-up|4|||
164605479|NCT00225147|594577559|FG000|Open-label Phase|Withdrawal by Subject|0|||
164605480|NCT00225147|594577560|FG001|Open-label Phase|Withdrawal by Subject|0|||
164605481|NCT00225147|594577561|FG002|Open-label Phase|Withdrawal by Subject|0|||
164605482|NCT00225147|594577562|FG003|Open-label Phase|Withdrawal by Subject|6|||
164605483|NCT04019795|594577563|FG000|Overall Study|Withdrawal by Subject|1|||
164605484|NCT04019795|594577564|FG001|Overall Study|Withdrawal by Subject|2|||
164605485|NCT04019795|594577565|FG002|Overall Study|Withdrawal by Subject|2|||
164605486|NCT04019795|594577566|FG003|Overall Study|Withdrawal by Subject|1|||
164605487|NCT04019795|594577563|FG000|Overall Study|Lost to Follow-up|0|||
164605488|NCT04019795|594577564|FG001|Overall Study|Lost to Follow-up|1|||
164605489|NCT04019795|594577565|FG002|Overall Study|Lost to Follow-up|1|||
164605490|NCT04019795|594577566|FG003|Overall Study|Lost to Follow-up|2|||
164605491|NCT04019795|594577563|FG000|Overall Study|Treatment non-compliance|3|||
164605492|NCT04019795|594577564|FG001|Overall Study|Treatment non-compliance|1|||
164605493|NCT04019795|594577565|FG002|Overall Study|Treatment non-compliance|2|||
164605494|NCT04019795|594577566|FG003|Overall Study|Treatment non-compliance|0|||
164605495|NCT04019795|594577563|FG000|Overall Study|Physician Decision|0|||
164605496|NCT04019795|594577564|FG001|Overall Study|Physician Decision|0|||
164605497|NCT04019795|594577565|FG002|Overall Study|Physician Decision|1|||
164605498|NCT04019795|594577566|FG003|Overall Study|Physician Decision|0|||
164500855|NCT01316887|594205929|FG002|Overall Study|Adverse Event|17|||
164715994|NCT05770895|594984195|FG001|Overall Study|Withdrew consent|0|||
164715995|NCT05770895|594984196|FG002|Overall Study|Withdrew consent|0|||
164715996|NCT05770895|594984197|FG003|Overall Study|Withdrew consent|0|||
164715997|NCT05770895|594984198|FG004|Overall Study|Withdrew consent|2|||
164500856|NCT01316887|594205927|FG000|Overall Study|Lack of Efficacy|9|||
164500857|NCT01316887|594205928|FG001|Overall Study|Lack of Efficacy|3|||
164500858|NCT01316887|594205929|FG002|Overall Study|Lack of Efficacy|1|||
164500859|NCT01316887|594205927|FG000|Overall Study|Protocol Violation|2|||
164500860|NCT01316887|594205928|FG001|Overall Study|Protocol Violation|6|||
164500861|NCT01316887|594205929|FG002|Overall Study|Protocol Violation|6|||
164500862|NCT01316887|594205927|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
164500863|NCT01316887|594205928|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
164500864|NCT01316887|594205929|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
164500865|NCT01316887|594205927|FG000|Overall Study|Study Closed/Terminated|2|||
164500866|NCT01316887|594205928|FG001|Overall Study|Study Closed/Terminated|4|||
164500867|NCT01316887|594205929|FG002|Overall Study|Study Closed/Terminated|3|||
164500868|NCT01316887|594205927|FG000|Overall Study|Lost to Follow-up|1|||
164500869|NCT01316887|594205928|FG001|Overall Study|Lost to Follow-up|7|||
164500870|NCT01316887|594205929|FG002|Overall Study|Lost to Follow-up|5|||
164500871|NCT01316887|594205927|FG000|Overall Study|Withdrawal by Subject|8|||
164500872|NCT01316887|594205928|FG001|Overall Study|Withdrawal by Subject|16|||
164500873|NCT01316887|594205929|FG002|Overall Study|Withdrawal by Subject|15|||
164500874|NCT02172950|594205930|FG000|Overall Study|Physician Decision|3|||
164500875|NCT02172950|594205931|FG001|Overall Study|Physician Decision|3|||
164500876|NCT02172950|594205930|FG000|Overall Study|Lack of Efficacy|1|||
164500877|NCT02172950|594205931|FG001|Overall Study|Lack of Efficacy|0|||
164500878|NCT02172950|594205930|FG000|Overall Study|Adverse Event|4|||
164500879|NCT02172950|594205931|FG001|Overall Study|Adverse Event|1|||
164500880|NCT02172950|594205930|FG000|Overall Study|Withdrawal by Subject|10|||
164500881|NCT02172950|594205931|FG001|Overall Study|Withdrawal by Subject|0|||
164500882|NCT02172950|594205930|FG000|Overall Study|Protocol Violation|1|||
164500883|NCT02172950|594205931|FG001|Overall Study|Protocol Violation|0|||
164500884|NCT02172950|594205930|FG000|Overall Study|Lost to Follow-up|1|||
164500885|NCT02172950|594205931|FG001|Overall Study|Lost to Follow-up|0|||
164500886|NCT02172950|594205930|FG000|Overall Study|Death|1|||
164500887|NCT02172950|594205931|FG001|Overall Study|Death|0|||
164500888|NCT02172950|594205930|FG000|Overall Study|Patient traveling|1|||
164500889|NCT02172950|594205931|FG001|Overall Study|Patient traveling|0|||
164500890|NCT02172950|594205930|FG000|Overall Study|Patient went to other country|1|||
164500891|NCT02172950|594205931|FG001|Overall Study|Patient went to other country|0|||
164500892|NCT02172950|594205930|FG000|Overall Study|Patient relocated overseas|1|||
164500893|NCT02172950|594205931|FG001|Overall Study|Patient relocated overseas|1|||
164500894|NCT02172950|594205930|FG000|Overall Study|Patient moving|1|||
164500895|NCT02172950|594205931|FG001|Overall Study|Patient moving|0|||
164500896|NCT01086384|594205934|FG000|2-week Run-in Period|Adverse Event|1|||
164500897|NCT01086384|594205935|FG001|2-week Run-in Period|Adverse Event|0|||
164500898|NCT01086384|594205936|FG002|2-week Run-in Period|Adverse Event|0|||
164500899|NCT01086384|594205934|FG000|2-week Run-in Period|Protocol Violation|1|||
164500900|NCT01086384|594205935|FG001|2-week Run-in Period|Protocol Violation|0|||
164500901|NCT01086384|594205936|FG002|2-week Run-in Period|Protocol Violation|0|||
164500902|NCT01086384|594205934|FG000|2-week Run-in Period|Lost to Follow-up|1|||
164500903|NCT01086384|594205935|FG001|2-week Run-in Period|Lost to Follow-up|0|||
164500904|NCT01086384|594205936|FG002|2-week Run-in Period|Lost to Follow-up|0|||
164500905|NCT01086384|594205934|FG000|2-week Run-in Period|Physician Decision|6|||
164500906|NCT01086384|594205935|FG001|2-week Run-in Period|Physician Decision|0|||
164500907|NCT01086384|594205936|FG002|2-week Run-in Period|Physician Decision|0|||
164500908|NCT01086384|594205934|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
164500909|NCT01086384|594205935|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
164500910|NCT01086384|594205936|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
164500911|NCT01086384|594205934|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
164715998|NCT05770895|594984199|FG005|Overall Study|Withdrew consent|0|||
164715999|NCT05770895|594984200|FG006|Overall Study|Withdrew consent|0|||
164500912|NCT01086384|594205935|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
164500913|NCT01086384|594205936|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
164500914|NCT01086384|594205934|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
164500915|NCT01086384|594205935|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
164500916|NCT01086384|594205936|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
164500917|NCT01086384|594205934|FG000|2-week Run-in Period|Randomized in Error|1|||
164500918|NCT01086384|594205935|FG001|2-week Run-in Period|Randomized in Error|0|||
164500919|NCT01086384|594205936|FG002|2-week Run-in Period|Randomized in Error|0|||
164500920|NCT01086384|594205934|FG000|Treatment Period|Withdrawal by Subject|0|||
164716000|NCT05770895|594984201|FG007|Overall Study|Withdrew consent|0|||
164716001|NCT05770895|594984202|FG008|Overall Study|Withdrew consent|0|||
164500921|NCT01086384|594205935|FG001|Treatment Period|Withdrawal by Subject|53|||
164500922|NCT01086384|594205936|FG002|Treatment Period|Withdrawal by Subject|55|||
164716002|NCT05770895|594984203|FG009|Overall Study|Withdrew consent|0|||
164500923|NCT01086384|594205934|FG000|Treatment Period|Protocol Violation|0|||
164500924|NCT01086384|594205935|FG001|Treatment Period|Protocol Violation|26|||
164500925|NCT01086384|594205936|FG002|Treatment Period|Protocol Violation|17|||
164500926|NCT01086384|594205934|FG000|Treatment Period|Lack of Efficacy|0|||
164500927|NCT01086384|594205935|FG001|Treatment Period|Lack of Efficacy|22|||
164500928|NCT01086384|594205936|FG002|Treatment Period|Lack of Efficacy|13|||
164500929|NCT01086384|594205934|FG000|Treatment Period|Adverse Event|0|||
164500930|NCT01086384|594205935|FG001|Treatment Period|Adverse Event|19|||
164500931|NCT01086384|594205936|FG002|Treatment Period|Adverse Event|15|||
164500932|NCT01086384|594205934|FG000|Treatment Period|Lost to Follow-up|0|||
164500933|NCT01086384|594205935|FG001|Treatment Period|Lost to Follow-up|11|||
164500934|NCT01086384|594205936|FG002|Treatment Period|Lost to Follow-up|9|||
164500935|NCT01086384|594205934|FG000|Treatment Period|Physician Decision|0|||
164500936|NCT01086384|594205935|FG001|Treatment Period|Physician Decision|9|||
164500937|NCT01086384|594205936|FG002|Treatment Period|Physician Decision|6|||
164500938|NCT01086384|594205934|FG000|Treatment Period|Study Closed/Terminated|0|||
164500939|NCT01086384|594205935|FG001|Treatment Period|Study Closed/Terminated|7|||
164500940|NCT01086384|594205936|FG002|Treatment Period|Study Closed/Terminated|8|||
164500941|NCT01086384|594205934|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
164500942|NCT01086384|594205935|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
164500943|NCT01086384|594205936|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
164500944|NCT01086384|594205934|FG000|Treatment Period|Received Treatment in Error|0|||
164500945|NCT01086384|594205935|FG001|Treatment Period|Received Treatment in Error|1|||
164500946|NCT01086384|594205936|FG002|Treatment Period|Received Treatment in Error|0|||
164500947|NCT02586415|594205939|FG000|Overall Study|Death|13|||
164500948|NCT02586415|594205940|FG001|Overall Study|Death|23|||
164500949|NCT02586415|594205939|FG000|Overall Study|Lost to Follow-up|1|||
164500950|NCT02586415|594205940|FG001|Overall Study|Lost to Follow-up|2|||
164500951|NCT00832000|594205941|FG000|Overall Study|Adverse Event|2|||
164500952|NCT00832000|594205942|FG001|Overall Study|Adverse Event|0|||
164500953|NCT00832000|594205941|FG000|Overall Study|Withdrawal by Subject|1|||
164500954|NCT00832000|594205942|FG001|Overall Study|Withdrawal by Subject|0|||
164500955|NCT00832000|594205941|FG000|Overall Study|No calls to IVR in either period|1|||
164500956|NCT00832000|594205942|FG001|Overall Study|No calls to IVR in either period|1|||
164500957|NCT00832000|594205941|FG000|Overall Study|No calls to IVR in period 2|2|||
164500958|NCT00832000|594205942|FG001|Overall Study|No calls to IVR in period 2|0|||
164500959|NCT03974100|594205943|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
164500960|NCT03974100|594205944|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
164500961|NCT03974100|594205945|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
164500962|NCT03974100|594205946|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
164500963|NCT03974100|594205947|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
164500964|NCT03974100|594205943|FG000|TP1 - Day 1 to Week 52|Death|1|||
164500965|NCT03974100|594205944|FG001|TP1 - Day 1 to Week 52|Death|0|||
164500966|NCT03974100|594205945|FG002|TP1 - Day 1 to Week 52|Death|0|||
164500967|NCT03974100|594205946|FG003|TP1 - Day 1 to Week 52|Death|0|||
164500968|NCT03974100|594205947|FG004|TP1 - Day 1 to Week 52|Death|0|||
164500969|NCT03974100|594205943|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
164500970|NCT03974100|594205944|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
164500971|NCT03974100|594205945|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
164500972|NCT03974100|594205946|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
164500973|NCT03974100|594205947|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
164500974|NCT03974100|594205943|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
164500975|NCT03974100|594205944|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
164500976|NCT03974100|594205945|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
164500977|NCT03974100|594205946|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
164500978|NCT03974100|594205947|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
164500979|NCT03974100|594205943|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
164500980|NCT03974100|594205944|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
164500981|NCT03974100|594205945|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
164500982|NCT03974100|594205946|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
164500983|NCT03974100|594205947|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
164500984|NCT03974100|594205943|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
164605499|NCT04019795|594577563|FG000|Overall Study|Adverse Event|1|||
164500985|NCT03974100|594205944|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
164500986|NCT03974100|594205945|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
164500987|NCT03974100|594205946|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
164500988|NCT03974100|594205947|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
164500989|NCT03974100|594205943|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
164500990|NCT03974100|594205944|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
164500991|NCT03974100|594205945|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
164500992|NCT03974100|594205946|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
164500993|NCT03974100|594205947|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
164500994|NCT00263575|594205955|FG000|Titration Period|Adverse Event|14|||
164500995|NCT00263575|594205955|FG000|Titration Period|Withdrawal by Subject|10|||
164605500|NCT04019795|594577564|FG001|Overall Study|Adverse Event|0|||
164605501|NCT04019795|594577565|FG002|Overall Study|Adverse Event|0|||
164716003|NCT04523714|594984204|FG000|Overall Study|Death|3|||
164500996|NCT00263575|594205955|FG000|Titration Period|Protocol Violation|9|||
164500997|NCT00263575|594205955|FG000|Titration Period|Sponsor Decision|2|||
164500998|NCT00263575|594205955|FG000|Titration Period|Other|2|||
164500999|NCT00263575|594205955|FG000|Titration Period|Lack of Efficacy|6|||
164501000|NCT00263575|594205955|FG000|Maintence Period|Adverse Event|23|||
164501001|NCT00263575|594205955|FG000|Maintence Period|Withdrawal by Subject|8|||
164501002|NCT00263575|594205955|FG000|Maintence Period|Protocol Violation|4|||
164501003|NCT00263575|594205955|FG000|Maintence Period|Lack of Efficacy|4|||
164501004|NCT00263575|594205955|FG000|Maintence Period|Physician Decision|6|||
164501005|NCT00263575|594205955|FG000|Maintence Period|Lost to Follow-up|1|||
164501006|NCT00263575|594205955|FG000|Maintence Period|Sponsor Decision|24|||
164501007|NCT00263575|594205955|FG000|Maintence Period|Other|7|||
164501008|NCT01209286|594205956|FG000|Overall Study|Adverse Event|4|||
164501009|NCT01209286|594205957|FG001|Overall Study|Adverse Event|3|||
164501010|NCT01209286|594205958|FG002|Overall Study|Adverse Event|1|||
164501011|NCT01209286|594205956|FG000|Overall Study|Hematological Relapse After Remission|0|||
164501012|NCT01209286|594205957|FG001|Overall Study|Hematological Relapse After Remission|1|||
164501013|NCT01209286|594205958|FG002|Overall Study|Hematological Relapse After Remission|1|||
164501014|NCT01209286|594205956|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
164501015|NCT01209286|594205957|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
164501016|NCT01209286|594205958|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
164501017|NCT01209286|594205956|FG000|Overall Study|Physician Decision|0|||
164501018|NCT01209286|594205957|FG001|Overall Study|Physician Decision|2|||
164501019|NCT01209286|594205958|FG002|Overall Study|Physician Decision|0|||
164501020|NCT01209286|594205956|FG000|Overall Study|Other|0|||
164501021|NCT01209286|594205957|FG001|Overall Study|Other|1|||
164501022|NCT01209286|594205958|FG002|Overall Study|Other|0|||
164501023|NCT01891890|594205959|FG000|Overall Study|Lost to Follow-up|0|||
164501024|NCT01891890|594205960|FG001|Overall Study|Lost to Follow-up|0|||
164501025|NCT01891890|594205961|FG002|Overall Study|Lost to Follow-up|1|||
164501026|NCT01891890|594205959|FG000|Overall Study|Study ended before endpoint reached|7|||
164501027|NCT01891890|594205960|FG001|Overall Study|Study ended before endpoint reached|3|||
164501028|NCT01891890|594205961|FG002|Overall Study|Study ended before endpoint reached|6|||
164501029|NCT03029819|594205962|FG000|Overall Study|Lost to Follow-up|3|||
164501030|NCT03029819|594205963|FG001|Overall Study|Lost to Follow-up|5|||
164501031|NCT03029819|594205962|FG000|Overall Study|Removed due to disruptive behavior|0|||
164501032|NCT03029819|594205963|FG001|Overall Study|Removed due to disruptive behavior|1|||
164501033|NCT03605368|594205965|FG000|Overall Study|Lost to Follow-up|2|||
164501034|NCT03605368|594205966|FG001|Overall Study|Lost to Follow-up|1|||
164501035|NCT03605368|594205967|FG002|Overall Study|Lost to Follow-up|3|||
164501036|NCT03605368|594205968|FG003|Overall Study|Lost to Follow-up|2|||
164501037|NCT03605368|594205965|FG000|Overall Study|Withdrawal by Subject|0|||
164501038|NCT03605368|594205966|FG001|Overall Study|Withdrawal by Subject|0|||
164501039|NCT03605368|594205967|FG002|Overall Study|Withdrawal by Subject|4|||
164501040|NCT03605368|594205968|FG003|Overall Study|Withdrawal by Subject|3|||
164501041|NCT01215032|594205969|FG000|Overall Study|Adverse Event|3|||
164501042|NCT01215032|594205969|FG000|Overall Study|Lack of Efficacy|17|||
164501043|NCT01020747|594205974|FG000|Overall Study|Withdrawal by Subject|1|||
164501044|NCT00983892|594205975|FG000|Overall Study|Withdrawal by Subject|10|||
164501045|NCT00983892|594205976|FG001|Overall Study|Withdrawal by Subject|12|||
164501046|NCT02881047|594205977|FG000|Overall Study|Adverse Event|1|||
164501047|NCT02881047|594205977|FG000|Overall Study|Withdrawal by Subject|1|||
164501048|NCT03120949|594205984|FG000|Overall Study|randomized in error|1|||
164501049|NCT03120949|594205985|FG001|Overall Study|randomized in error|0|||
164501050|NCT03120949|594205984|FG000|Overall Study|Death|13|||
164501051|NCT03120949|594205985|FG001|Overall Study|Death|13|||
164501052|NCT03120949|594205984|FG000|Overall Study|Lost to Follow-up|23|||
164501053|NCT03120949|594205985|FG001|Overall Study|Lost to Follow-up|13|||
164501054|NCT03120949|594205984|FG000|Overall Study|Withdrawal by Subject|139|||
164716004|NCT04523714|594984205|FG001|Overall Study|Death|7|||
164716005|NCT04523714|594984206|FG002|Overall Study|Death|7|||
164716006|NCT04523714|594984204|FG000|Overall Study|Withdrawal by Subject|43|||
164716007|NCT04523714|594984205|FG001|Overall Study|Withdrawal by Subject|45|||
164501055|NCT03120949|594205985|FG001|Overall Study|Withdrawal by Subject|124|||
164501056|NCT03120949|594205984|FG000|Overall Study|Covid-19|43|||
164501057|NCT03120949|594205985|FG001|Overall Study|Covid-19|34|||
164501058|NCT03120949|594205984|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
164501059|NCT03120949|594205985|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
164716008|NCT04523714|594984206|FG002|Overall Study|Withdrawal by Subject|16|||
164501060|NCT03120949|594205984|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
164501061|NCT03120949|594205985|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
164501062|NCT03120949|594205984|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
164501063|NCT03120949|594205985|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
164716009|NCT04523714|594984204|FG000|Overall Study|Randomized in error|0|||
164716010|NCT04523714|594984205|FG001|Overall Study|Randomized in error|0|||
164716011|NCT04523714|594984206|FG002|Overall Study|Randomized in error|2|||
164716012|NCT04233424|594984207|FG000|Overall Study|Death|15|||
164501064|NCT03120949|594205984|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
164501065|NCT03120949|594205985|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
164501066|NCT03120949|594205984|FG000|Overall Study|Site was closed|2|||
164501067|NCT03120949|594205985|FG001|Overall Study|Site was closed|3|||
164501068|NCT03120949|594205984|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
164501069|NCT03120949|594205985|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
164501070|NCT03120949|594205984|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
164501071|NCT03120949|594205985|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
164501072|NCT03120949|594205984|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
164501073|NCT03120949|594205985|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
164501074|NCT03120949|594205984|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
164501075|NCT03120949|594205985|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
164501076|NCT03120949|594205984|FG000|Overall Study|Other: Adverse Event|0|||
164501077|NCT03120949|594205985|FG001|Overall Study|Other: Adverse Event|1|||
164501078|NCT03120949|594205984|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
164501079|NCT03120949|594205985|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
164501080|NCT03120949|594205984|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
164501081|NCT03120949|594205985|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
164501082|NCT03120949|594205984|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
164501083|NCT03120949|594205985|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
164501084|NCT03120949|594205984|FG000|Overall Study|Personal Reasons|0|||
164501085|NCT03120949|594205985|FG001|Overall Study|Personal Reasons|1|||
164501086|NCT03120949|594205984|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
164501087|NCT03120949|594205985|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
164501088|NCT03120949|594205984|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
164501089|NCT03120949|594205985|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
164501090|NCT03120949|594205984|FG000|Overall Study|Compliance With Medication|0|||
164501091|NCT03120949|594205985|FG001|Overall Study|Compliance With Medication|1|||
164501092|NCT03120949|594205984|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
164501093|NCT03120949|594205985|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
164501094|NCT03120949|594205984|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
164501095|NCT03120949|594205985|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
164501096|NCT03120949|594205984|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
164501097|NCT03120949|594205985|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
164501098|NCT01705145|594205986|FG000|Part B|Adverse Event|1|||
164501099|NCT00988117|594205987|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
164501100|NCT00988117|594205987|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
164501101|NCT01329419|594205990|FG000|Overall Study|Protocol Violation|235|||
164501102|NCT03015181|594205994|FG000|Overall Study|Enrolled, but product never administered|1|||
164501103|NCT03015181|594205995|FG001|Overall Study|Enrolled, but product never administered|0|||
164501104|NCT03015181|594205996|FG002|Overall Study|Enrolled, but product never administered|0|||
164501105|NCT03015181|594205997|FG003|Overall Study|Enrolled, but product never administered|0|||
164501106|NCT03015181|594205998|FG004|Overall Study|Enrolled, but product never administered|0|||
164501107|NCT03015181|594205999|FG005|Overall Study|Enrolled, but product never administered|0|||
164501108|NCT03015181|594206000|FG006|Overall Study|Enrolled, but product never administered|0|||
164501109|NCT03015181|594205994|FG000|Overall Study|Withdrawal by Subject|0|||
164501110|NCT03015181|594205995|FG001|Overall Study|Withdrawal by Subject|0|||
164501111|NCT03015181|594205996|FG002|Overall Study|Withdrawal by Subject|0|||
164501112|NCT03015181|594205997|FG003|Overall Study|Withdrawal by Subject|0|||
164501113|NCT03015181|594205998|FG004|Overall Study|Withdrawal by Subject|0|||
164501114|NCT03015181|594205999|FG005|Overall Study|Withdrawal by Subject|1|||
164501115|NCT03015181|594206000|FG006|Overall Study|Withdrawal by Subject|0|||
164501116|NCT03015181|594205994|FG000|Overall Study|Physician Decision|0|||
164501117|NCT03015181|594205995|FG001|Overall Study|Physician Decision|0|||
164501118|NCT03015181|594205996|FG002|Overall Study|Physician Decision|0|||
164501119|NCT03015181|594205997|FG003|Overall Study|Physician Decision|0|||
164501120|NCT03015181|594205998|FG004|Overall Study|Physician Decision|0|||
164501121|NCT03015181|594205999|FG005|Overall Study|Physician Decision|0|||
164501122|NCT03015181|594206000|FG006|Overall Study|Physician Decision|1|||
164501123|NCT01077622|594206001|FG000|Overall Study|Physician Decision|2|||
164716013|NCT04233424|594984208|FG001|Overall Study|Death|16|||
164501124|NCT01077622|594206001|FG000|Overall Study|Withdrawal by Subject|1|||
164501125|NCT00424177|594206002|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
164501126|NCT00424177|594206002|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
164501127|NCT00424177|594206002|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
164501128|NCT00424177|594206002|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
164501129|NCT00424177|594206002|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
164501130|NCT00424177|594206002|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
164501131|NCT00424177|594206002|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
164501132|NCT00424177|594206002|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
164501133|NCT00424177|594206002|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
164501134|NCT00424177|594206002|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
164501135|NCT00966264|594207148|FG000|Overall Study|Lost to Follow-up|4|||
164501136|NCT00966264|594207149|FG001|Overall Study|Lost to Follow-up|3|||
164501137|NCT03614676|594207150|FG000|Overall Study|Delivery before planned visit|2|||
164501138|NCT03614676|594207151|FG001|Overall Study|Delivery before planned visit|0|||
164501139|NCT03614676|594207150|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
164501140|NCT03614676|594207151|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
164501141|NCT03614676|594207150|FG000|Overall Study|Migrated / moved from the study area|30|||
164501142|NCT03614676|594207151|FG001|Overall Study|Migrated / moved from the study area|22|||
164501143|NCT03614676|594207150|FG000|Overall Study|Lost to Follow-up|17|||
164501144|NCT03614676|594207151|FG001|Overall Study|Lost to Follow-up|42|||
164501145|NCT03614676|594207150|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
164501146|NCT03614676|594207151|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
164501147|NCT03614676|594207150|FG000|Overall Study|Other|16|||
164501148|NCT03614676|594207151|FG001|Overall Study|Other|47|||
164501149|NCT03614676|594207150|FG000|Overall Study|Protocol Violation|0|||
164501150|NCT03614676|594207151|FG001|Overall Study|Protocol Violation|2|||
164501151|NCT03614676|594207150|FG000|Overall Study|Neonatal event of interest|0|||
164501152|NCT03614676|594207151|FG001|Overall Study|Neonatal event of interest|6|||
164501153|NCT03614676|594207150|FG000|Overall Study|Death in infant greater than 28 days old|0|||
164501154|NCT03614676|594207151|FG001|Overall Study|Death in infant greater than 28 days old|12|||
164501155|NCT03614676|594207150|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
164501156|NCT03614676|594207151|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
164501157|NCT04398368|594207154|FG000|Overall Study|Withdrawal by Subject|2|||
164501158|NCT03602586|594207155|FG000|Overall Study|Withdrawal by Subject|3|||
164501159|NCT01755546|594207158|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
164501160|NCT01755546|594207158|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
164501161|NCT01755546|594207158|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
164501162|NCT01755546|594207158|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
164501163|NCT01755546|594207158|FG000|Titration Phase|Adverse Event|11|||
164501164|NCT01755546|594207158|FG000|Titration Phase|Lack of Efficacy|18|||
164501165|NCT01755546|594207158|FG000|Titration Phase|Protocol Violation|9|||
164501166|NCT01755546|594207158|FG000|Titration Phase|Lost to Follow-up|2|||
164501167|NCT01755546|594207158|FG000|Titration Phase|Other and Continuing|22|||
164501168|NCT01755546|594207158|FG000|Titration Phase|Withdrawal by Subject|8|||
164501169|NCT01755546|594207158|FG000|Long Term Treatment|Adverse Event|12|||
164501170|NCT01755546|594207158|FG000|Long Term Treatment|Lack of Efficacy|6|||
164501171|NCT01755546|594207158|FG000|Long Term Treatment|Protocol Violation|10|||
164501172|NCT01755546|594207158|FG000|Long Term Treatment|Withdrawal by Subject|35|||
164501173|NCT01755546|594207158|FG000|Long Term Treatment|Lost to Follow-up|17|||
164501174|NCT01755546|594207158|FG000|Long Term Treatment|other and ongoing|41|||
164716014|NCT04233424|594984207|FG000|Overall Study|Withdrawal by Subject|2|||
164716015|NCT04233424|594984208|FG001|Overall Study|Withdrawal by Subject|8|||
164716016|NCT04233424|594984207|FG000|Overall Study|Physician Decision|1|||
164716017|NCT04233424|594984208|FG001|Overall Study|Physician Decision|3|||
164501175|NCT00891046|594207159|FG000|Overall Study|Protocol Violation|1|||
164501176|NCT00891046|594207160|FG001|Overall Study|Protocol Violation|1|||
164501177|NCT00891046|594207161|FG002|Overall Study|Protocol Violation|0|||
164501178|NCT00891046|594207162|FG003|Overall Study|Protocol Violation|0|||
164501179|NCT00891046|594207163|FG004|Overall Study|Protocol Violation|1|||
164501180|NCT00891046|594207159|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
164501181|NCT00891046|594207160|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164501182|NCT00891046|594207161|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
164501183|NCT00891046|594207162|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
164501184|NCT00891046|594207163|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
164501185|NCT00891046|594207159|FG000|Overall Study|Administrative problems|0|||
164501186|NCT00891046|594207160|FG001|Overall Study|Administrative problems|0|||
164501187|NCT00891046|594207161|FG002|Overall Study|Administrative problems|0|||
164501188|NCT00891046|594207162|FG003|Overall Study|Administrative problems|0|||
164501189|NCT00891046|594207163|FG004|Overall Study|Administrative problems|1|||
164501190|NCT00891046|594207159|FG000|Overall Study|Participant no longer required drug|0|||
164501191|NCT00891046|594207160|FG001|Overall Study|Participant no longer required drug|2|||
164501192|NCT00891046|594207161|FG002|Overall Study|Participant no longer required drug|0|||
164501193|NCT00891046|594207162|FG003|Overall Study|Participant no longer required drug|0|||
164501194|NCT00891046|594207163|FG004|Overall Study|Participant no longer required drug|1|||
164501195|NCT00891046|594207159|FG000|Overall Study|Adverse Event|4|||
164501196|NCT00891046|594207160|FG001|Overall Study|Adverse Event|3|||
164501197|NCT00891046|594207161|FG002|Overall Study|Adverse Event|2|||
164501198|NCT00891046|594207162|FG003|Overall Study|Adverse Event|0|||
164501199|NCT00891046|594207163|FG004|Overall Study|Adverse Event|14|||
164501200|NCT00891046|594207159|FG000|Overall Study|Withdrawal by Subject|2|||
164501201|NCT00891046|594207160|FG001|Overall Study|Withdrawal by Subject|1|||
164501202|NCT00891046|594207161|FG002|Overall Study|Withdrawal by Subject|2|||
164501203|NCT00891046|594207162|FG003|Overall Study|Withdrawal by Subject|1|||
164501204|NCT00891046|594207163|FG004|Overall Study|Withdrawal by Subject|1|||
164501205|NCT00891046|594207159|FG000|Overall Study|Lost to Follow-up|0|||
164501206|NCT00891046|594207160|FG001|Overall Study|Lost to Follow-up|0|||
164501207|NCT00891046|594207161|FG002|Overall Study|Lost to Follow-up|0|||
164501208|NCT00891046|594207162|FG003|Overall Study|Lost to Follow-up|0|||
164501209|NCT00891046|594207163|FG004|Overall Study|Lost to Follow-up|1|||
164501210|NCT02166476|594207164|FG000|Overall Study|Withdrawal by Subject|5|||
164501211|NCT02166476|594207165|FG001|Overall Study|Withdrawal by Subject|7|||
164501212|NCT02166476|594207164|FG000|Overall Study|Adverse Event|3|||
164501213|NCT02166476|594207165|FG001|Overall Study|Adverse Event|3|||
164501214|NCT02166476|594207164|FG000|Overall Study|Lost to Follow-up|5|||
164501215|NCT02166476|594207165|FG001|Overall Study|Lost to Follow-up|10|||
164501216|NCT02166476|594207164|FG000|Overall Study|Physician Decision|1|||
164501217|NCT02166476|594207165|FG001|Overall Study|Physician Decision|0|||
164501218|NCT02166476|594207164|FG000|Overall Study|Unable to Come for Visit|0|||
164501219|NCT02166476|594207165|FG001|Overall Study|Unable to Come for Visit|3|||
164501220|NCT00362375|594207168|FG000|Overall Study|Lost to Follow-up|40|||
164501221|NCT00362375|594207169|FG001|Overall Study|Lost to Follow-up|35|||
164501222|NCT02106195|594207170|FG000|Overall Study|Adverse Event|2|||
164501223|NCT02106195|594207170|FG000|Overall Study|Protocol Violation|1|||
164501224|NCT04984239|594207171|FG000|Overall Study|Lost to Follow-up|1|||
164501225|NCT04523207|594207174|FG000|Overall Study|Adverse Event|5|||
164501226|NCT04523207|594207175|FG001|Overall Study|Adverse Event|1|||
164501227|NCT04523207|594207174|FG000|Overall Study|Lost to Follow-up|2|||
164501228|NCT04523207|594207175|FG001|Overall Study|Lost to Follow-up|0|||
164501229|NCT04523207|594207174|FG000|Overall Study|Withdrawal by Subject|2|||
164501230|NCT04523207|594207175|FG001|Overall Study|Withdrawal by Subject|0|||
164501231|NCT04523207|594207174|FG000|Overall Study|Progressive Disease|2|||
164501232|NCT04523207|594207175|FG001|Overall Study|Progressive Disease|1|||
164501233|NCT04523207|594207174|FG000|Overall Study|Other|7|||
164501234|NCT04523207|594207175|FG001|Overall Study|Other|1|||
164501235|NCT03113383|594207176|FG000|Overall Study|Death|4|||
164501236|NCT03113383|594207177|FG001|Overall Study|Death|0|||
164501237|NCT01513330|594207178|FG000|SenSura Mio First,|Adverse Event|2|||
164501238|NCT01513330|594207179|FG001|SenSura Mio First,|Adverse Event|0|||
164501239|NCT01513330|594207178|FG000|SenSura Mio First,|Lack of Efficacy|0|||
164501240|NCT01513330|594207179|FG001|SenSura Mio First,|Lack of Efficacy|1|||
164501241|NCT01513330|594207178|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
164501242|NCT01513330|594207179|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
164501243|NCT01513330|594207178|FG000|SenSura Mio First,|Other|1|||
164501244|NCT01513330|594207179|FG001|SenSura Mio First,|Other|0|||
164501245|NCT01513330|594207178|FG000|Standard Care First,|Lack of Efficacy|2|||
164605502|NCT04019795|594577566|FG003|Overall Study|Adverse Event|0|||
164501246|NCT01513330|594207179|FG001|Standard Care First,|Lack of Efficacy|2|||
164501247|NCT01513330|594207178|FG000|Standard Care First,|Withdrawal by Subject|1|||
164501248|NCT01513330|594207179|FG001|Standard Care First,|Withdrawal by Subject|2|||
164501249|NCT01513330|594207178|FG000|Standard Care First,|Other|1|||
164501250|NCT01513330|594207179|FG001|Standard Care First,|Other|0|||
164501251|NCT00916305|594207182|FG000|Overall Study|Lost to Follow-up|21|||
164501252|NCT00916305|594207183|FG001|Overall Study|Lost to Follow-up|27|||
164501253|NCT00916305|594207182|FG000|Overall Study|Withdrawal by Subject|0|||
164605503|NCT03024255|594577567|FG000|Overall Study|Adverse Event|1|||
164605504|NCT03024255|594577568|FG001|Overall Study|Adverse Event|4|||
164605505|NCT03024255|594577569|FG002|Overall Study|Adverse Event|8|||
164605506|NCT03024255|594577570|FG003|Overall Study|Adverse Event|0|||
164605507|NCT03024255|594577567|FG000|Overall Study|Withdrawal by Subject|3|||
164605508|NCT03024255|594577568|FG001|Overall Study|Withdrawal by Subject|1|||
164605509|NCT03024255|594577569|FG002|Overall Study|Withdrawal by Subject|0|||
164605510|NCT03024255|594577570|FG003|Overall Study|Withdrawal by Subject|3|||
164605511|NCT03024255|594577567|FG000|Overall Study|Protocol Violation|0|||
164501254|NCT00916305|594207183|FG001|Overall Study|Withdrawal by Subject|1|||
164501255|NCT01379703|594207184|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
164501256|NCT01379703|594207185|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
164501257|NCT01379703|594207186|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
164501258|NCT01379703|594207184|FG000|Study Start Through 9 Months|Adverse Event|0|||
164501259|NCT01379703|594207185|FG001|Study Start Through 9 Months|Adverse Event|14|||
164501260|NCT01379703|594207186|FG002|Study Start Through 9 Months|Adverse Event|10|||
164501261|NCT01379703|594207184|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
164501262|NCT01379703|594207185|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
164501263|NCT01379703|594207186|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
164501264|NCT01379703|594207184|FG000|Study Start Through 9 Months|Treatment Failure|0|||
164501265|NCT01379703|594207185|FG001|Study Start Through 9 Months|Treatment Failure|2|||
164501266|NCT01379703|594207186|FG002|Study Start Through 9 Months|Treatment Failure|2|||
164501267|NCT01379703|594207184|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
164501268|NCT01379703|594207185|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
164501269|NCT01379703|594207186|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
164501270|NCT01379703|594207184|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
164501271|NCT01379703|594207185|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
164501272|NCT01379703|594207186|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
164501273|NCT01379703|594207184|FG000|Study Start Through 9 Months|Medication not available|0|||
164501274|NCT01379703|594207185|FG001|Study Start Through 9 Months|Medication not available|2|||
164501275|NCT01379703|594207186|FG002|Study Start Through 9 Months|Medication not available|1|||
164501276|NCT01379703|594207184|FG000|Study Start Through 9 Months|Poor general condition|0|||
164501277|NCT01379703|594207185|FG001|Study Start Through 9 Months|Poor general condition|1|||
164501278|NCT01379703|594207186|FG002|Study Start Through 9 Months|Poor general condition|0|||
164501279|NCT01379703|594207184|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
164501280|NCT01379703|594207185|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
164501281|NCT01379703|594207186|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
164501282|NCT01379703|594207184|FG000|Study Start Through 9 Months|Reason unknown|2|||
164501283|NCT01379703|594207185|FG001|Study Start Through 9 Months|Reason unknown|31|||
164501284|NCT01379703|594207186|FG002|Study Start Through 9 Months|Reason unknown|24|||
164501285|NCT01379703|594207184|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
164501286|NCT01379703|594207185|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
164501287|NCT01379703|594207186|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
164501288|NCT01379703|594207184|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
164501289|NCT01379703|594207185|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
164501290|NCT01379703|594207186|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
164501291|NCT01379703|594207184|FG000|9 Months Through 18 Months|Adverse Event|0|||
164501292|NCT01379703|594207185|FG001|9 Months Through 18 Months|Adverse Event|6|||
164501293|NCT01379703|594207186|FG002|9 Months Through 18 Months|Adverse Event|0|||
164501294|NCT01379703|594207184|FG000|9 Months Through 18 Months|Treatment failure|0|||
164501295|NCT01379703|594207185|FG001|9 Months Through 18 Months|Treatment failure|5|||
164501296|NCT01379703|594207186|FG002|9 Months Through 18 Months|Treatment failure|0|||
164501297|NCT01379703|594207184|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
164501298|NCT01379703|594207185|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
164501299|NCT01379703|594207186|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
164501300|NCT01379703|594207184|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
164501301|NCT01379703|594207185|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
164501302|NCT01379703|594207186|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
164501303|NCT01379703|594207184|FG000|9 Months Through 18 Months|Fatigue|0|||
164501304|NCT01379703|594207185|FG001|9 Months Through 18 Months|Fatigue|1|||
164501305|NCT01379703|594207186|FG002|9 Months Through 18 Months|Fatigue|0|||
164501306|NCT01379703|594207184|FG000|9 Months Through 18 Months|Reason Unknown|0|||
164501307|NCT01379703|594207185|FG001|9 Months Through 18 Months|Reason Unknown|23|||
164501308|NCT01379703|594207186|FG002|9 Months Through 18 Months|Reason Unknown|0|||
164501309|NCT03481556|594207187|FG000|Overall Study|Adverse Event|1|||
164501310|NCT03481556|594207188|FG001|Overall Study|Adverse Event|0|||
164501311|NCT03481556|594207189|FG002|Overall Study|Adverse Event|0|||
164501312|NCT03481556|594207190|FG003|Overall Study|Adverse Event|0|||
164501313|NCT03481556|594207187|FG000|Overall Study|Death|4|||
164501314|NCT03481556|594207188|FG001|Overall Study|Death|2|||
164501315|NCT03481556|594207189|FG002|Overall Study|Death|3|||
164501316|NCT03481556|594207190|FG003|Overall Study|Death|16|||
164501317|NCT03481556|594207187|FG000|Overall Study|Study Terminated by Sponsor|10|||
164501318|NCT03481556|594207188|FG001|Overall Study|Study Terminated by Sponsor|5|||
164501319|NCT03481556|594207189|FG002|Overall Study|Study Terminated by Sponsor|2|||
164501320|NCT03481556|594207190|FG003|Overall Study|Study Terminated by Sponsor|9|||
164605512|NCT03024255|594577568|FG001|Overall Study|Protocol Violation|0|||
164605513|NCT03024255|594577569|FG002|Overall Study|Protocol Violation|2|||
164605514|NCT03024255|594577570|FG003|Overall Study|Protocol Violation|0|||
164501321|NCT03463577|594207191|FG000|Overall Study|Lost to Follow-up|238|||
164501322|NCT03463577|594207192|FG001|Overall Study|Lost to Follow-up|435|||
164501323|NCT03463577|594207193|FG002|Overall Study|Lost to Follow-up|0|||
164501324|NCT03463577|594207194|FG003|Overall Study|Lost to Follow-up|0|||
164501325|NCT03463577|594207195|FG004|Overall Study|Lost to Follow-up|0|||
164716018|NCT04233424|594984207|FG000|Overall Study|Protocol Violation|3|||
164716019|NCT04233424|594984208|FG001|Overall Study|Protocol Violation|1|||
164716020|NCT04233424|594984207|FG000|Overall Study|Lost to Follow-up|1|||
164716021|NCT04233424|594984208|FG001|Overall Study|Lost to Follow-up|3|||
164716022|NCT04233424|594984207|FG000|Overall Study|subject refuse to visit site|2|||
164716023|NCT04233424|594984208|FG001|Overall Study|subject refuse to visit site|0|||
164716024|NCT02971748|594984209|FG000|Overall Study|Adverse Event|12|||
164716025|NCT02971748|594984209|FG000|Overall Study|Withdrawal by Subject|1|||
164716026|NCT02971748|594984209|FG000|Overall Study|Financial issue|2|||
164716027|NCT02971748|594984209|FG000|Overall Study|Clinical progression|8|||
164716028|NCT05965778|594984210|FG000|Overall Study|Adverse Event|2|||
164716029|NCT05965778|594984211|FG001|Overall Study|Adverse Event|3|||
164716030|NCT05965778|594984210|FG000|Overall Study|Lack of Efficacy|0|||
164716031|NCT05965778|594984211|FG001|Overall Study|Lack of Efficacy|2|||
164716032|NCT05965778|594984210|FG000|Overall Study|Protocol Violation|1|||
164716033|NCT05965778|594984211|FG001|Overall Study|Protocol Violation|1|||
164716034|NCT05965778|594984210|FG000|Overall Study|Withdrawal by Subject|0|||
164716035|NCT05965778|594984211|FG001|Overall Study|Withdrawal by Subject|2|||
164716036|NCT05965778|594984210|FG000|Overall Study|divers reasons(patient or doctor not available for visit...),|9|||
164716037|NCT05965778|594984211|FG001|Overall Study|divers reasons(patient or doctor not available for visit...),|7|||
164716038|NCT04803214|594984212|FG000|Overall Study|Adverse Event|1|||
164716039|NCT04803214|594984213|FG001|Overall Study|Adverse Event|0|||
164716040|NCT04803214|594984212|FG000|Overall Study|Withdrawal by Subject|1|||
164716041|NCT04803214|594984213|FG001|Overall Study|Withdrawal by Subject|2|||
164716042|NCT04803214|594984212|FG000|Overall Study|Lost to Follow-up|2|||
164716043|NCT04803214|594984213|FG001|Overall Study|Lost to Follow-up|4|||
164716044|NCT04803214|594984212|FG000|Overall Study|Physician Decision|1|||
164716045|NCT04803214|594984213|FG001|Overall Study|Physician Decision|1|||
164716046|NCT04803214|594984212|FG000|Overall Study|Missed 12 month visit|0|||
164501326|NCT03463577|594207196|FG005|Overall Study|Lost to Follow-up|0|||
164501327|NCT03463577|594207191|FG000|Overall Study|With unknown pregnancy outcome|0|||
164501328|NCT03463577|594207192|FG001|Overall Study|With unknown pregnancy outcome|5|||
164501329|NCT03463577|594207193|FG002|Overall Study|With unknown pregnancy outcome|0|||
164501330|NCT03463577|594207194|FG003|Overall Study|With unknown pregnancy outcome|0|||
164501331|NCT03463577|594207195|FG004|Overall Study|With unknown pregnancy outcome|0|||
164501332|NCT03463577|594207196|FG005|Overall Study|With unknown pregnancy outcome|0|||
164501333|NCT03463577|594207191|FG000|Overall Study|Maternal death|2|||
164501334|NCT03463577|594207192|FG001|Overall Study|Maternal death|0|||
164501335|NCT03463577|594207193|FG002|Overall Study|Maternal death|0|||
164501336|NCT03463577|594207194|FG003|Overall Study|Maternal death|0|||
164501337|NCT03463577|594207195|FG004|Overall Study|Maternal death|0|||
164501338|NCT03463577|594207196|FG005|Overall Study|Maternal death|0|||
164501339|NCT03463577|594207191|FG000|Overall Study|Neonatal death|0|||
164501340|NCT03463577|594207192|FG001|Overall Study|Neonatal death|0|||
164501341|NCT03463577|594207193|FG002|Overall Study|Neonatal death|0|||
164501342|NCT03463577|594207194|FG003|Overall Study|Neonatal death|15|||
164501343|NCT03463577|594207195|FG004|Overall Study|Neonatal death|17|||
164501344|NCT03463577|594207196|FG005|Overall Study|Neonatal death|0|||
164501345|NCT00236184|594207197|FG000|Overall Study|Adverse Event|5|||
164501346|NCT00236184|594207198|FG001|Overall Study|Adverse Event|2|||
164501347|NCT00236184|594207197|FG000|Overall Study|Lack of Efficacy|0|||
164501348|NCT00236184|594207198|FG001|Overall Study|Lack of Efficacy|1|||
164501349|NCT00236184|594207197|FG000|Overall Study|Lost to Follow-up|3|||
164501350|NCT00236184|594207198|FG001|Overall Study|Lost to Follow-up|4|||
164501351|NCT00236184|594207197|FG000|Overall Study|Physician Decision|1|||
164501352|NCT00236184|594207198|FG001|Overall Study|Physician Decision|1|||
164501353|NCT00236184|594207197|FG000|Overall Study|Withdrawal by Subject|3|||
164501354|NCT00236184|594207198|FG001|Overall Study|Withdrawal by Subject|0|||
164501355|NCT00236184|594207197|FG000|Overall Study|Protocol Violation|3|||
164501356|NCT00236184|594207198|FG001|Overall Study|Protocol Violation|0|||
164501357|NCT00236184|594207197|FG000|Overall Study|non-compliance with study drug|2|||
164501358|NCT00236184|594207198|FG001|Overall Study|non-compliance with study drug|1|||
164501359|NCT00236184|594207197|FG000|Overall Study|other|1|||
164501360|NCT00236184|594207198|FG001|Overall Study|other|2|||
164501361|NCT01101997|594207199|FG000|Overall Study|Withdrawal by Subject|2|||
164501362|NCT00469456|594207200|FG000|Overall Study|Adverse Event|4|||
164501363|NCT00469456|594207201|FG001|Overall Study|Adverse Event|3|||
164501364|NCT00469456|594207200|FG000|Overall Study|Protocol Violation|1|||
164501365|NCT00469456|594207201|FG001|Overall Study|Protocol Violation|0|||
164716047|NCT04803214|594984213|FG001|Overall Study|Missed 12 month visit|3|||
164716048|NCT02389517|594984214|FG000|Overall Study|Withdrawal by Subject|3|||
164716049|NCT02389517|594984215|FG001|Overall Study|Withdrawal by Subject|2|||
164716050|NCT02389517|594984214|FG000|Overall Study|Adverse Event|3|||
164716051|NCT02389517|594984215|FG001|Overall Study|Adverse Event|1|||
164716052|NCT02389517|594984214|FG000|Overall Study|Physician Decision|0|||
164716053|NCT02389517|594984215|FG001|Overall Study|Physician Decision|1|||
164716054|NCT02389517|594984214|FG000|Overall Study|Progressive disease|0|||
164501366|NCT00469456|594207200|FG000|Overall Study|Withdrawal by Subject|4|||
164501367|NCT00469456|594207201|FG001|Overall Study|Withdrawal by Subject|1|||
164501368|NCT00704171|594207206|FG000|Overall Study|Withdrawal by Subject|1|||
164501369|NCT00704171|594207207|FG001|Overall Study|Withdrawal by Subject|0|||
164501370|NCT00813098|594207212|FG000|Overall Study|Adverse Event|2|||
164501371|NCT00813098|594207213|FG001|Overall Study|Adverse Event|4|||
164501372|NCT00813098|594207214|FG002|Overall Study|Adverse Event|1|||
164501373|NCT00813098|594207212|FG000|Overall Study|Withdrawal by Subject|0|||
164501374|NCT00813098|594207213|FG001|Overall Study|Withdrawal by Subject|1|||
164501375|NCT00813098|594207214|FG002|Overall Study|Withdrawal by Subject|0|||
164501376|NCT00813098|594207212|FG000|Overall Study|Inability to complete study procedures|1|||
164501377|NCT00813098|594207213|FG001|Overall Study|Inability to complete study procedures|0|||
164501378|NCT00813098|594207214|FG002|Overall Study|Inability to complete study procedures|0|||
164501379|NCT00813098|594207212|FG000|Overall Study|Lost to Follow-up|0|||
164501380|NCT00813098|594207213|FG001|Overall Study|Lost to Follow-up|1|||
164501381|NCT00813098|594207214|FG002|Overall Study|Lost to Follow-up|0|||
164501382|NCT00813098|594207212|FG000|Overall Study|Protocol Violation|0|||
164501383|NCT00813098|594207213|FG001|Overall Study|Protocol Violation|0|||
164501384|NCT00813098|594207214|FG002|Overall Study|Protocol Violation|1|||
164501385|NCT00813098|594207212|FG000|Overall Study|Principal Investigator decision|0|||
164501386|NCT00813098|594207213|FG001|Overall Study|Principal Investigator decision|1|||
164501387|NCT00813098|594207214|FG002|Overall Study|Principal Investigator decision|0|||
164501388|NCT00813098|594207212|FG000|Overall Study|Withdrew Consent|0|||
164501389|NCT00813098|594207213|FG001|Overall Study|Withdrew Consent|1|||
164501390|NCT00813098|594207214|FG002|Overall Study|Withdrew Consent|0|||
164501391|NCT01777490|594207217|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
164501392|NCT01777490|594207218|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
164501393|NCT01777490|594207219|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
164501394|NCT01777490|594207220|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
164501395|NCT00255944|594207222|FG000|Overall Study|Lost to Follow-up|797|||
164501396|NCT00255944|594207223|FG001|Overall Study|Lost to Follow-up|834|||
164501397|NCT00935259|594207230|FG000|Period 1|Administrative (scheduling conflict)|1|||
164501398|NCT00935259|594207231|FG001|Period 1|Administrative (scheduling conflict)|1|||
164501399|NCT02980705|594207234|FG000|Overall Study|Adverse Event|0|||
164501400|NCT02980705|594207235|FG001|Overall Study|Adverse Event|1|||
164605515|NCT03024255|594577567|FG000|Overall Study|Lost to Follow-up|1|||
164605516|NCT03024255|594577568|FG001|Overall Study|Lost to Follow-up|2|||
164605517|NCT03024255|594577569|FG002|Overall Study|Lost to Follow-up|1|||
164605518|NCT03024255|594577570|FG003|Overall Study|Lost to Follow-up|1|||
164605519|NCT03024255|594577567|FG000|Overall Study|Lack of Efficacy|1|||
164605520|NCT03024255|594577568|FG001|Overall Study|Lack of Efficacy|0|||
164605521|NCT03024255|594577569|FG002|Overall Study|Lack of Efficacy|0|||
164605522|NCT03024255|594577570|FG003|Overall Study|Lack of Efficacy|0|||
164605523|NCT03024255|594577567|FG000|Overall Study|Protocol Noncompliance|1|||
164605524|NCT03024255|594577568|FG001|Overall Study|Protocol Noncompliance|1|||
164605525|NCT03024255|594577569|FG002|Overall Study|Protocol Noncompliance|0|||
164605526|NCT03024255|594577570|FG003|Overall Study|Protocol Noncompliance|1|||
164605527|NCT03625141|594577574|FG000|Overall Study|Adverse Event|0|||
164605528|NCT03625141|594577575|FG001|Overall Study|Adverse Event|2|||
164605529|NCT03625141|594577574|FG000|Overall Study|Study Terminated By Sponsor|1|||
164605530|NCT03625141|594577575|FG001|Overall Study|Study Terminated By Sponsor|13|||
164605531|NCT03625141|594577574|FG000|Overall Study|Withdrawal by Subject|3|||
164605532|NCT03625141|594577575|FG001|Overall Study|Withdrawal by Subject|0|||
164605533|NCT03625141|594577574|FG000|Overall Study|Withdrawal Of Consent|0|||
164605534|NCT03625141|594577575|FG001|Overall Study|Withdrawal Of Consent|1|||
164605535|NCT03625141|594577574|FG000|Overall Study|Death|11|||
164605536|NCT03625141|594577575|FG001|Overall Study|Death|47|||
164605537|NCT03625141|594577574|FG000|Overall Study|Progressive Disease|0|||
164605538|NCT03625141|594577575|FG001|Overall Study|Progressive Disease|2|||
164605539|NCT03250377|594577576|FG000|Overall Study|Adverse Event|2|||
164605540|NCT03250377|594577577|FG001|Overall Study|Adverse Event|4|||
164605541|NCT03250377|594577578|FG002|Overall Study|Adverse Event|0|||
164605542|NCT03250377|594577579|FG003|Overall Study|Adverse Event|4|||
164716055|NCT02389517|594984215|FG001|Overall Study|Progressive disease|1|||
164716056|NCT01208662|594984217|FG000|Induction and Consolidation|Disease Progression|23|||
164605543|NCT03250377|594577576|FG000|Overall Study|Lack of Efficacy|5|||
164605544|NCT03250377|594577577|FG001|Overall Study|Lack of Efficacy|14|||
164605545|NCT03250377|594577578|FG002|Overall Study|Lack of Efficacy|1|||
164605546|NCT03250377|594577579|FG003|Overall Study|Lack of Efficacy|3|||
164605547|NCT03250377|594577576|FG000|Overall Study|Protocol Violation|0|||
164716057|NCT01208662|594984218|FG001|Induction and Consolidation|Disease Progression|13|||
164501401|NCT02980705|594207234|FG000|Overall Study|Withdrawal by Subject|6|||
164501402|NCT02980705|594207235|FG001|Overall Study|Withdrawal by Subject|9|||
164501403|NCT02980705|594207234|FG000|Overall Study|withdrew participation|0|||
164501404|NCT02980705|594207235|FG001|Overall Study|withdrew participation|1|||
164501405|NCT02980705|594207234|FG000|Overall Study|Lost to Follow-up|2|||
164501406|NCT02980705|594207235|FG001|Overall Study|Lost to Follow-up|0|||
164605548|NCT03250377|594577577|FG001|Overall Study|Protocol Violation|2|||
164501407|NCT01721746|594207236|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
164501408|NCT01721746|594207237|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
164501409|NCT01721746|594207236|FG000|Pre-Treatment|Withdrawal by Subject|1|||
164501410|NCT01721746|594207237|FG001|Pre-Treatment|Withdrawal by Subject|16|||
164501411|NCT01721746|594207236|FG000|Pre-Treatment|Poor/Non-compliance|1|||
164501412|NCT01721746|594207237|FG001|Pre-Treatment|Poor/Non-compliance|0|||
164501413|NCT01721746|594207236|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
164501414|NCT01721746|594207237|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
164501415|NCT01721746|594207236|FG000|Treatment|Disease Progression|192|||
164501416|NCT01721746|594207237|FG001|Treatment|Disease Progression|74|||
164501417|NCT01721746|594207236|FG000|Treatment|Study Drug Toxicity|19|||
164501418|NCT01721746|594207237|FG001|Treatment|Study Drug Toxicity|11|||
164501419|NCT01721746|594207236|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
164501420|NCT01721746|594207237|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
164501421|NCT01721746|594207236|FG000|Treatment|Participant request to discontinue Study treatment|26|||
164501422|NCT01721746|594207237|FG001|Treatment|Participant request to discontinue Study treatment|7|||
164501423|NCT01721746|594207236|FG000|Treatment|Participant withdrew consent|4|||
164501424|NCT01721746|594207237|FG001|Treatment|Participant withdrew consent|2|||
164501425|NCT01721746|594207236|FG000|Treatment|Maximum Clinical Benefit|9|||
164501426|NCT01721746|594207237|FG001|Treatment|Maximum Clinical Benefit|3|||
164501427|NCT01721746|594207236|FG000|Treatment|Poor/Non-compliance|2|||
164501428|NCT01721746|594207237|FG001|Treatment|Poor/Non-compliance|0|||
164501429|NCT01721746|594207236|FG000|Treatment|Participant no longer met Study criteria|4|||
164501430|NCT01721746|594207237|FG001|Treatment|Participant no longer met Study criteria|0|||
164501431|NCT01721746|594207236|FG000|Treatment|Other reasons|6|||
164501432|NCT01721746|594207237|FG001|Treatment|Other reasons|2|||
164501433|NCT01841112|594207241|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
164501434|NCT01841112|594207242|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
164501435|NCT01841112|594207243|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
164501436|NCT01841112|594207244|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
164501437|NCT01841112|594207245|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
164501438|NCT01880437|594207249|FG000|Overall Study|Death|12|||
164501439|NCT01880437|594207250|FG001|Overall Study|Death|4|||
164501440|NCT01880437|594207251|FG002|Overall Study|Death|17|||
164501441|NCT01880437|594207249|FG000|Overall Study|Study terminated by Sponsor|3|||
164501442|NCT01880437|594207250|FG001|Overall Study|Study terminated by Sponsor|0|||
164501443|NCT01880437|594207251|FG002|Overall Study|Study terminated by Sponsor|2|||
164501444|NCT02604342|594207252|FG000|Overall Study|Death|32|||
164501445|NCT02604342|594207253|FG001|Overall Study|Death|16|||
164501446|NCT02604342|594207252|FG000|Overall Study|Progression of disease|1|||
164501447|NCT02604342|594207253|FG001|Overall Study|Progression of disease|0|||
164501448|NCT02604342|594207252|FG000|Overall Study|Withdrawal by Subject|5|||
164501449|NCT02604342|594207253|FG001|Overall Study|Withdrawal by Subject|6|||
164501450|NCT02604342|594207252|FG000|Overall Study|Other|1|||
164501451|NCT02604342|594207253|FG001|Overall Study|Other|0|||
164501452|NCT02604342|594207252|FG000|Overall Study|Study Termination by Sponsor|1|||
164501453|NCT02604342|594207253|FG001|Overall Study|Study Termination by Sponsor|0|||
164501454|NCT02604342|594207252|FG000|Overall Study|Lost to Follow-up|1|||
164501455|NCT02604342|594207253|FG001|Overall Study|Lost to Follow-up|1|||
164501456|NCT02604342|594207252|FG000|Overall Study|Physician Decision|2|||
164501457|NCT02604342|594207253|FG001|Overall Study|Physician Decision|0|||
164501458|NCT01702519|594207254|FG000|Washout Period|Lost to Follow-up|1|||
164501459|NCT01702519|594207255|FG001|Washout Period|Lost to Follow-up|0|||
164501460|NCT01702519|594207254|FG000|Washout Period|Withdrawal by Subject|0|||
164501461|NCT01702519|594207255|FG001|Washout Period|Withdrawal by Subject|2|||
164501462|NCT00514813|594207263|FG000|Overall Study|Study terminated|14|||
164501463|NCT00514813|594207264|FG001|Overall Study|Study terminated|74|||
164605549|NCT03250377|594577578|FG002|Overall Study|Protocol Violation|0|||
164605550|NCT03250377|594577579|FG003|Overall Study|Protocol Violation|1|||
164605551|NCT03250377|594577576|FG000|Overall Study|Lost to Follow-up|0|||
164605552|NCT03250377|594577577|FG001|Overall Study|Lost to Follow-up|1|||
164605553|NCT03250377|594577578|FG002|Overall Study|Lost to Follow-up|0|||
164605554|NCT03250377|594577579|FG003|Overall Study|Lost to Follow-up|0|||
164605555|NCT03250377|594577576|FG000|Overall Study|Withdrawal by Subject|7|||
164605556|NCT03250377|594577577|FG001|Overall Study|Withdrawal by Subject|7|||
164605557|NCT03250377|594577578|FG002|Overall Study|Withdrawal by Subject|0|||
164605558|NCT03250377|594577579|FG003|Overall Study|Withdrawal by Subject|4|||
164605559|NCT03250377|594577576|FG000|Overall Study|Investigator's Judgment|1|||
164605560|NCT03250377|594577577|FG001|Overall Study|Investigator's Judgment|0|||
164605561|NCT03250377|594577578|FG002|Overall Study|Investigator's Judgment|0|||
164605562|NCT03250377|594577579|FG003|Overall Study|Investigator's Judgment|0|||
164605563|NCT03250377|594577576|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
164605564|NCT03250377|594577577|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
164605565|NCT03250377|594577578|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
164605566|NCT03250377|594577579|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
164716058|NCT01208662|594984219|FG002|Induction and Consolidation|Disease Progression|0|||
164716059|NCT01208662|594984217|FG000|Induction and Consolidation|Adverse Event|16|||
164716060|NCT01208662|594984218|FG001|Induction and Consolidation|Adverse Event|18|||
164716061|NCT01208662|594984219|FG002|Induction and Consolidation|Adverse Event|2|||
164716062|NCT01208662|594984217|FG000|Induction and Consolidation|MD or Participant Decision|16|||
164716063|NCT01208662|594984218|FG001|Induction and Consolidation|MD or Participant Decision|34|||
164716064|NCT01208662|594984219|FG002|Induction and Consolidation|MD or Participant Decision|4|||
164716065|NCT01208662|594984217|FG000|Induction and Consolidation|Death|1|||
164716066|NCT01208662|594984218|FG001|Induction and Consolidation|Death|3|||
164716067|NCT01208662|594984219|FG002|Induction and Consolidation|Death|1|||
164716068|NCT01208662|594984217|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
164716069|NCT01208662|594984218|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
164716070|NCT01208662|594984219|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
164716071|NCT01208662|594984217|FG000|Maintenance|Disease Progression|156|||
164716072|NCT01208662|594984218|FG001|Maintenance|Disease Progression|102|||
164716073|NCT01208662|594984219|FG002|Maintenance|Disease Progression|0|||
164716074|NCT01208662|594984217|FG000|Maintenance|Adverse Event|12|||
164716075|NCT01208662|594984218|FG001|Maintenance|Adverse Event|28|||
164716076|NCT01208662|594984219|FG002|Maintenance|Adverse Event|0|||
164716077|NCT01208662|594984217|FG000|Maintenance|MD or Participant Decision|24|||
164716078|NCT01208662|594984218|FG001|Maintenance|MD or Participant Decision|36|||
164716079|NCT01208662|594984219|FG002|Maintenance|MD or Participant Decision|0|||
164716080|NCT01208662|594984217|FG000|Maintenance|Death|0|||
164716081|NCT01208662|594984218|FG001|Maintenance|Death|3|||
164716082|NCT01208662|594984219|FG002|Maintenance|Death|0|||
164716083|NCT01208662|594984217|FG000|Maintenance|Discontinued for other reasons|21|||
164716084|NCT01208662|594984218|FG001|Maintenance|Discontinued for other reasons|31|||
164716085|NCT01208662|594984219|FG002|Maintenance|Discontinued for other reasons|0|||
164716086|NCT01208662|594984217|FG000|Maintenance|Still on Treatment|78|||
164716087|NCT01208662|594984218|FG001|Maintenance|Still on Treatment|89|||
164716088|NCT01208662|594984219|FG002|Maintenance|Still on Treatment|0|||
164716089|NCT06232018|594984222|FG000|Overall Study|withdrew due to trauma|0|||
164716090|NCT06232018|594984223|FG001|Overall Study|withdrew due to trauma|2|||
164716091|NCT00880594|594984225|FG000|Overall Study|Subject did not initiate desipramine therapy|5|||
164716092|NCT00880594|594984226|FG001|Overall Study|Subject did not initiate desipramine therapy|4|||
164716093|NCT05071209|594984227|FG000|Overall Study|Lack of Efficacy|8|||
164716094|NCT05071209|594984228|FG001|Overall Study|Lack of Efficacy|1|||
164716095|NCT05071209|594984229|FG002|Overall Study|Lack of Efficacy|9|||
164716096|NCT05071209|594984230|FG003|Overall Study|Lack of Efficacy|8|||
164716097|NCT05071209|594984231|FG004|Overall Study|Lack of Efficacy|2|||
164501464|NCT00514813|594207265|FG002|Overall Study|Study terminated|40|||
164501465|NCT00514813|594207266|FG003|Overall Study|Study terminated|2|||
164501466|NCT00514813|594207263|FG000|Overall Study|Adverse Event|0|||
164501467|NCT00514813|594207264|FG001|Overall Study|Adverse Event|2|||
164501468|NCT00514813|594207265|FG002|Overall Study|Adverse Event|2|||
164501469|NCT00514813|594207266|FG003|Overall Study|Adverse Event|0|||
164501470|NCT00514813|594207263|FG000|Overall Study|Protocol Violation|1|||
164501471|NCT00514813|594207264|FG001|Overall Study|Protocol Violation|0|||
164501472|NCT00514813|594207265|FG002|Overall Study|Protocol Violation|0|||
164501473|NCT00514813|594207266|FG003|Overall Study|Protocol Violation|0|||
164501474|NCT00514813|594207263|FG000|Overall Study|Withdrawal by Subject|0|||
164501475|NCT00514813|594207264|FG001|Overall Study|Withdrawal by Subject|1|||
164501476|NCT00514813|594207265|FG002|Overall Study|Withdrawal by Subject|0|||
164501477|NCT00514813|594207266|FG003|Overall Study|Withdrawal by Subject|0|||
164501478|NCT00514813|594207263|FG000|Overall Study|Lack of Efficacy|0|||
164501479|NCT00514813|594207264|FG001|Overall Study|Lack of Efficacy|1|||
164501480|NCT00514813|594207265|FG002|Overall Study|Lack of Efficacy|0|||
164501481|NCT00514813|594207266|FG003|Overall Study|Lack of Efficacy|0|||
164501482|NCT00514813|594207263|FG000|Overall Study|Kidney transplant|0|||
164501483|NCT00514813|594207264|FG001|Overall Study|Kidney transplant|6|||
164501484|NCT00514813|594207265|FG002|Overall Study|Kidney transplant|2|||
164501485|NCT00514813|594207266|FG003|Overall Study|Kidney transplant|0|||
164501486|NCT00514813|594207263|FG000|Overall Study|Death|0|||
164501487|NCT00514813|594207264|FG001|Overall Study|Death|2|||
164716098|NCT05071209|594984227|FG000|Overall Study|Withdrawal by Subject|0|||
164716099|NCT05071209|594984228|FG001|Overall Study|Withdrawal by Subject|0|||
164716100|NCT05071209|594984229|FG002|Overall Study|Withdrawal by Subject|1|||
164716101|NCT05071209|594984230|FG003|Overall Study|Withdrawal by Subject|1|||
164716102|NCT05071209|594984231|FG004|Overall Study|Withdrawal by Subject|1|||
164716103|NCT04294641|594984232|FG000|Overall Study|Screen failure|4|||
164716104|NCT02411656|594984233|FG000|Overall Study|Adverse Event|4|||
164716105|NCT02411656|594984233|FG000|Overall Study|Clinical Progression|33|||
164716106|NCT04588428|594984237|FG000|Overall Study|Withdrawal by Subject|0|||
164716107|NCT04588428|594984238|FG001|Overall Study|Withdrawal by Subject|0|||
164716108|NCT04588428|594984239|FG002|Overall Study|Withdrawal by Subject|1|||
164716109|NCT04588428|594984240|FG003|Overall Study|Withdrawal by Subject|0|||
164145680|NCT00996892|592894358|FG019|Dose-Escalation Stage 1A|Death|0|||
164501488|NCT00514813|594207265|FG002|Overall Study|Death|3|||
164501489|NCT00514813|594207266|FG003|Overall Study|Death|2|||
164501490|NCT01075100|594207269|FG000|Overall Study|Adverse Event|15|||
164501491|NCT01075100|594207270|FG001|Overall Study|Adverse Event|18|||
164501492|NCT01075100|594207269|FG000|Overall Study|Patient Request|4|||
164501493|NCT01075100|594207270|FG001|Overall Study|Patient Request|4|||
164501494|NCT01075100|594207269|FG000|Overall Study|Investigator Request|2|||
164501495|NCT01075100|594207270|FG001|Overall Study|Investigator Request|1|||
164501496|NCT01075100|594207269|FG000|Overall Study|Disease Progression|25|||
164501497|NCT01075100|594207270|FG001|Overall Study|Disease Progression|29|||
164501498|NCT01075100|594207269|FG000|Overall Study|Other|3|||
164501499|NCT01075100|594207270|FG001|Overall Study|Other|1|||
164501500|NCT02034162|594208386|FG000|Double-blind|Lost to Follow-up|3|||
164501501|NCT02034162|594208387|FG001|Double-blind|Lost to Follow-up|0|||
164716110|NCT04588428|594984241|FG004|Overall Study|Withdrawal by Subject|0|||
164716111|NCT04588428|594984242|FG005|Overall Study|Withdrawal by Subject|1|||
164716112|NCT04588428|594984243|FG006|Overall Study|Withdrawal by Subject|0|||
164716113|NCT04588428|594984244|FG007|Overall Study|Withdrawal by Subject|0|||
164716114|NCT04588428|594984245|FG008|Overall Study|Withdrawal by Subject|0|||
164716115|NCT04588428|594984237|FG000|Overall Study|Protocol Deviation|0|||
164716116|NCT04588428|594984238|FG001|Overall Study|Protocol Deviation|0|||
164716117|NCT04588428|594984239|FG002|Overall Study|Protocol Deviation|2|||
164716118|NCT04588428|594984240|FG003|Overall Study|Protocol Deviation|0|||
164716119|NCT04588428|594984241|FG004|Overall Study|Protocol Deviation|0|||
164716120|NCT04588428|594984242|FG005|Overall Study|Protocol Deviation|0|||
164716121|NCT04588428|594984243|FG006|Overall Study|Protocol Deviation|0|||
164716122|NCT04588428|594984244|FG007|Overall Study|Protocol Deviation|0|||
164716123|NCT04588428|594984245|FG008|Overall Study|Protocol Deviation|0|||
164716124|NCT04588428|594984237|FG000|Overall Study|Reason Not Specified|0|||
164716125|NCT04588428|594984238|FG001|Overall Study|Reason Not Specified|0|||
164716126|NCT04588428|594984239|FG002|Overall Study|Reason Not Specified|0|||
164716127|NCT04588428|594984240|FG003|Overall Study|Reason Not Specified|1|||
164716128|NCT04588428|594984241|FG004|Overall Study|Reason Not Specified|0|||
164716129|NCT04588428|594984242|FG005|Overall Study|Reason Not Specified|0|||
164716130|NCT04588428|594984243|FG006|Overall Study|Reason Not Specified|0|||
164716131|NCT04588428|594984244|FG007|Overall Study|Reason Not Specified|0|||
164716132|NCT04588428|594984245|FG008|Overall Study|Reason Not Specified|0|||
164716133|NCT04050293|594984246|FG000|Overall Study|Lost to Follow-up|1|||
164716134|NCT04050293|594984247|FG001|Overall Study|Lost to Follow-up|2|||
164716135|NCT04050293|594984246|FG000|Overall Study|Withdrawal by Subject|2|||
164716136|NCT04050293|594984247|FG001|Overall Study|Withdrawal by Subject|0|||
164716137|NCT05339087|594984248|FG000|Overall Study|Withdrawal by Subject|1|||
164716138|NCT05339087|594984249|FG001|Overall Study|Withdrawal by Subject|1|||
164716139|NCT05339087|594984248|FG000|Overall Study|Early study termination|0|||
164716140|NCT05339087|594984249|FG001|Overall Study|Early study termination|1|||
164501502|NCT02034162|594208388|FG002|Double-blind|Lost to Follow-up|0|||
164501503|NCT02034162|594208386|FG000|Double-blind|Physician Decision|1|||
164501504|NCT02034162|594208387|FG001|Double-blind|Physician Decision|0|||
164501505|NCT02034162|594208388|FG002|Double-blind|Physician Decision|0|||
164501506|NCT02034162|594208386|FG000|Double-blind|Protocol Violation|0|||
164501507|NCT02034162|594208387|FG001|Double-blind|Protocol Violation|1|||
164501508|NCT02034162|594208388|FG002|Double-blind|Protocol Violation|0|||
164501509|NCT02034162|594208386|FG000|Double-blind|Withdrawal by Subject|5|||
164501510|NCT02034162|594208387|FG001|Double-blind|Withdrawal by Subject|7|||
164501511|NCT02034162|594208388|FG002|Double-blind|Withdrawal by Subject|0|||
164501512|NCT00760513|594208389|FG000|Overall Study|Withdrawal by Subject|5|||
164501513|NCT00760513|594208390|FG001|Overall Study|Withdrawal by Subject|7|||
164501514|NCT02808975|594208395|FG000|Overall Study|Adverse Event|3|||
164501515|NCT02808975|594208396|FG001|Overall Study|Adverse Event|4|||
164501516|NCT02808975|594208395|FG000|Overall Study|Withdrew consent|9|||
164501517|NCT02808975|594208396|FG001|Overall Study|Withdrew consent|8|||
164501518|NCT02808975|594208395|FG000|Overall Study|Lost to Follow-up|4|||
164501519|NCT02808975|594208396|FG001|Overall Study|Lost to Follow-up|6|||
164501520|NCT02808975|594208395|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
164716141|NCT04751383|594984250|FG000|Overall Study|Adverse Event|1|||
164716142|NCT04751383|594984251|FG001|Overall Study|Adverse Event|1|||
164716143|NCT04751383|594984252|FG002|Overall Study|Adverse Event|0|||
164716144|NCT04751383|594984253|FG003|Overall Study|Adverse Event|0|||
164716145|NCT04751383|594984254|FG004|Overall Study|Adverse Event|0|||
164716146|NCT04751383|594984255|FG005|Overall Study|Adverse Event|0|||
164716147|NCT04751383|594984250|FG000|Overall Study|Lack of Efficacy|6|||
164716148|NCT04751383|594984251|FG001|Overall Study|Lack of Efficacy|3|||
164716149|NCT04751383|594984252|FG002|Overall Study|Lack of Efficacy|0|||
164716150|NCT04751383|594984253|FG003|Overall Study|Lack of Efficacy|0|||
164716151|NCT04751383|594984254|FG004|Overall Study|Lack of Efficacy|0|||
164716152|NCT04751383|594984255|FG005|Overall Study|Lack of Efficacy|0|||
164716153|NCT04751383|594984250|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164501521|NCT02808975|594208396|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
164501522|NCT02808975|594208395|FG000|Overall Study|Other, not specified|5|||
164501523|NCT02808975|594208396|FG001|Overall Study|Other, not specified|1|||
164501524|NCT00511836|594208399|FG000|Double-blind Period|Lost to Follow-up|1|||
164501525|NCT00511836|594208400|FG001|Double-blind Period|Lost to Follow-up|0|||
164501526|NCT00416598|594208401|FG000|Induction & Intensification|Adverse Event|38|||
164501527|NCT00416598|594208401|FG000|Induction & Intensification|Death|32|||
164501528|NCT00416598|594208401|FG000|Induction & Intensification|Withdrawal by Subject|46|||
164501529|NCT00416598|594208401|FG000|Induction & Intensification|Alternative Treatment|135|||
164501530|NCT00416598|594208401|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
164501531|NCT00416598|594208401|FG000|Induction & Intensification|Relapse/progression|29|||
164501532|NCT00416598|594208401|FG000|Induction & Intensification|Failed induction|87|||
164501533|NCT00416598|594208401|FG000|Decitabine Maintenance|Adverse Event|5|||
164501534|NCT00416598|594208401|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
164501535|NCT00416598|594208401|FG000|Decitabine Maintenance|Progression/relapse|38|||
164501536|NCT00416598|594208401|FG000|Decitabine Maintenance|Alternative treatment|2|||
164501537|NCT00416598|594208401|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
164501538|NCT00030823|594208402|FG000|Overall Study|Withdrawal by Subject|1|||
164501539|NCT04469465|594208414|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
164501540|NCT04469465|594208415|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
164501541|NCT04469465|594208414|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
164501542|NCT04469465|594208415|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
164501543|NCT04469465|594208414|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
164501544|NCT04469465|594208415|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
164501545|NCT04469465|594208414|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
164501546|NCT04469465|594208415|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
164501547|NCT04469465|594208414|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
164501548|NCT04469465|594208415|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
164501549|NCT04469465|594208414|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
164501550|NCT04469465|594208415|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
164501551|NCT04469465|594208414|FG000|Long-Term Extension (LTE)|Death|0|||
164501552|NCT04469465|594208415|FG001|Long-Term Extension (LTE)|Death|1|||
164501553|NCT04469465|594208414|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
164501554|NCT04469465|594208415|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
164501555|NCT02641587|594208416|FG000|Confinement Period|Adverse Event|1|||
164501556|NCT02641587|594208417|FG001|Confinement Period|Adverse Event|0|||
164501557|NCT02641587|594208416|FG000|Confinement Period|Withdrawal by Subject|2|||
164501558|NCT02641587|594208417|FG001|Confinement Period|Withdrawal by Subject|1|||
164501559|NCT02641587|594208416|FG000|Ambulatory Period|Withdrawal by Subject|1|||
164501560|NCT02641587|594208417|FG001|Ambulatory Period|Withdrawal by Subject|0|||
164501561|NCT01150045|594208421|FG000|Overall Study|Protocol Violation|0|||
164501562|NCT01150045|594208422|FG001|Overall Study|Protocol Violation|1|||
164501563|NCT01150045|594208423|FG002|Overall Study|Protocol Violation|0|||
164501564|NCT01150045|594208424|FG003|Overall Study|Protocol Violation|1|||
164501565|NCT03194867|594208425|FG000|Overall Study|Incorrect completion of end of study form|0|||
164501566|NCT03194867|594208426|FG001|Overall Study|Incorrect completion of end of study form|0|||
164501567|NCT03194867|594208427|FG002|Overall Study|Incorrect completion of end of study form|1|||
164501568|NCT03194867|594208428|FG003|Overall Study|Incorrect completion of end of study form|0|||
164501569|NCT00464945|594208429|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
164501570|NCT00464945|594208430|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
164501571|NCT00464945|594208429|FG000|Infant Series|Protocol Violation|1|||
164501572|NCT00464945|594208430|FG001|Infant Series|Protocol Violation|0|||
164501573|NCT00464945|594208429|FG000|Infant Series|Lost to Follow-up|1|||
164501574|NCT00464945|594208430|FG001|Infant Series|Lost to Follow-up|0|||
164501575|NCT00464945|594208429|FG000|After Infant Series|Withdrawal by Subject|0|||
164501576|NCT00464945|594208430|FG001|After Infant Series|Withdrawal by Subject|2|||
164501577|NCT00464945|594208429|FG000|Toddler Dose|Lost to Follow-up|0|||
164501578|NCT00464945|594208430|FG001|Toddler Dose|Lost to Follow-up|1|||
164501579|NCT02438371|594208434|FG000|Overall Study|Lost to Follow-up|3|||
164501580|NCT02438371|594208435|FG001|Overall Study|Lost to Follow-up|2|||
164501581|NCT02438371|594208434|FG000|Overall Study|Withdrawal by Subject|1|||
164501582|NCT02438371|594208435|FG001|Overall Study|Withdrawal by Subject|1|||
164501583|NCT03065933|594208437|FG000|Overall Study|study terminated|5|||
164605567|NCT03250377|594577576|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
164605568|NCT03250377|594577577|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
164605569|NCT03250377|594577578|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
164605570|NCT03250377|594577579|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
164605571|NCT03250377|594577576|FG000|Overall Study|Epilepsy Surgery|0|||
164605572|NCT03250377|594577577|FG001|Overall Study|Epilepsy Surgery|1|||
164501584|NCT02536742|594208438|FG000|Overall Study|Did not start protocol therapy|1|||
164501585|NCT02536742|594208438|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
164501586|NCT01010204|594208439|FG000|Overall Study|Lost to Follow-up|2|||
164501587|NCT01010204|594208440|FG001|Overall Study|Lost to Follow-up|2|||
164501588|NCT01010204|594208439|FG000|Overall Study|Adverse Event|1|||
164605573|NCT03250377|594577578|FG002|Overall Study|Epilepsy Surgery|2|||
164605574|NCT03250377|594577579|FG003|Overall Study|Epilepsy Surgery|0|||
164501589|NCT01010204|594208440|FG001|Overall Study|Adverse Event|3|||
164501590|NCT01010204|594208439|FG000|Overall Study|Withdrawal by Subject|2|||
164501591|NCT01010204|594208440|FG001|Overall Study|Withdrawal by Subject|3|||
164501592|NCT01010204|594208439|FG000|Overall Study|psychiatric hospitalization|2|||
164501593|NCT01010204|594208440|FG001|Overall Study|psychiatric hospitalization|1|||
164501594|NCT01519778|594208441|FG000|Overall Study|Withdrawal by Subject|3|||
164501595|NCT01519778|594208441|FG000|Overall Study|Lost to Follow-up|10|||
164501596|NCT01519778|594208441|FG000|Overall Study|Physician Decision|1|||
164501597|NCT01547117|594208447|FG000|Overall Study|Physician Decision|0|||
164501598|NCT01547117|594208448|FG001|Overall Study|Physician Decision|1|||
164501599|NCT01547117|594208449|FG002|Overall Study|Physician Decision|1|||
164501600|NCT01547117|594208450|FG003|Overall Study|Physician Decision|3|||
164501601|NCT01547117|594208447|FG000|Overall Study|Withdrawal by Subject|1|||
164501602|NCT01547117|594208448|FG001|Overall Study|Withdrawal by Subject|2|||
164501603|NCT01547117|594208449|FG002|Overall Study|Withdrawal by Subject|1|||
164501604|NCT01547117|594208450|FG003|Overall Study|Withdrawal by Subject|2|||
164501605|NCT01844726|594208451|FG000|Overall Study|Withdrawal by Subject|0|||
164501606|NCT01844726|594208452|FG001|Overall Study|Withdrawal by Subject|1|||
164501607|NCT01844726|594208451|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
164501608|NCT01844726|594208452|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
164501609|NCT02229578|594208453|FG000|Overall Study|Withdrawal by Subject|1|||
164501610|NCT02229578|594208454|FG001|Overall Study|Withdrawal by Subject|3|||
164501611|NCT02229578|594208453|FG000|Overall Study|Protocol Violation|2|||
164501612|NCT02229578|594208454|FG001|Overall Study|Protocol Violation|0|||
164501613|NCT03603639|594208457|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
164501614|NCT03603639|594208458|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
164501615|NCT03603639|594208459|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
164501616|NCT03603639|594208460|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
164501617|NCT03603639|594208461|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
164501618|NCT03603639|594208462|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
164501619|NCT03603639|594208457|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
164501620|NCT03603639|594208458|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
164501621|NCT03603639|594208459|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
164501622|NCT03603639|594208460|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
164501623|NCT03603639|594208461|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
164501624|NCT03603639|594208462|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
164501625|NCT02165397|594208468|FG000|Overall Study|Death|7|||
164501626|NCT02165397|594208469|FG001|Overall Study|Death|10|||
164501627|NCT02165397|594208470|FG002|Overall Study|Death|8|||
164501628|NCT02165397|594208468|FG000|Overall Study|Lost to Follow-up|1|||
164501629|NCT02165397|594208469|FG001|Overall Study|Lost to Follow-up|3|||
164501630|NCT02165397|594208470|FG002|Overall Study|Lost to Follow-up|0|||
164501631|NCT02165397|594208468|FG000|Overall Study|Withdrawal by Subject|6|||
164501632|NCT02165397|594208469|FG001|Overall Study|Withdrawal by Subject|6|||
164501633|NCT02165397|594208470|FG002|Overall Study|Withdrawal by Subject|1|||
164501634|NCT02165397|594208468|FG000|Overall Study|Other, Not Specified|0|||
164501635|NCT02165397|594208469|FG001|Overall Study|Other, Not Specified|0|||
164501636|NCT02165397|594208470|FG002|Overall Study|Other, Not Specified|1|||
164501637|NCT03898960|594208471|FG000|Overall Study|Death|10|||
164501638|NCT01841697|594208474|FG000|Overall Study|Death|0|||
164501639|NCT01841697|594208475|FG001|Overall Study|Death|1|||
164501640|NCT01841697|594208474|FG000|Overall Study|Lost to Follow-up|4|||
164501641|NCT01841697|594208475|FG001|Overall Study|Lost to Follow-up|1|||
164501642|NCT01841697|594208474|FG000|Overall Study|Withdrawal by Subject|16|||
164501643|NCT01841697|594208475|FG001|Overall Study|Withdrawal by Subject|16|||
164501644|NCT01772563|594208476|FG000|Cycle 1|Dose limiting toxicity|2|||
164501645|NCT01772563|594208476|FG000|Cycle 1|Progressive disease|2|||
164501646|NCT01772563|594208476|FG000|Cycle 2 and Beyond|Progressive disease|17|||
164501647|NCT01772563|594208476|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
164501648|NCT01772563|594208476|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
164501649|NCT01209598|594208478|FG000|Overall Study|Withdrawal by Subject|1|||
164605575|NCT03250377|594577576|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
164501650|NCT01209598|594208479|FG001|Overall Study|Withdrawal by Subject|0|||
164501651|NCT01438840|594208480|FG000|Core Study|Adverse Event|0|||
164501652|NCT01438840|594208481|FG001|Core Study|Adverse Event|3|||
164605576|NCT03250377|594577577|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
164605577|NCT03250377|594577578|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
164501653|NCT01438840|594208482|FG002|Core Study|Adverse Event|0|||
164501654|NCT01438840|594208480|FG000|Core Study|Lack of Efficacy|15|||
164501655|NCT01438840|594208481|FG001|Core Study|Lack of Efficacy|7|||
164501656|NCT01438840|594208482|FG002|Core Study|Lack of Efficacy|0|||
164605578|NCT03250377|594577579|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
164605579|NCT03250377|594577576|FG000|Overall Study|Request From The Sponsor|0|||
164605580|NCT03250377|594577577|FG001|Overall Study|Request From The Sponsor|1|||
164501657|NCT01438840|594208480|FG000|Core Study|Withdrawal of consent|1|||
164501658|NCT01438840|594208481|FG001|Core Study|Withdrawal of consent|0|||
164501659|NCT01438840|594208482|FG002|Core Study|Withdrawal of consent|0|||
164716154|NCT04751383|594984251|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
164716155|NCT04751383|594984252|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164716156|NCT04751383|594984253|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164716157|NCT04751383|594984254|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164716158|NCT04751383|594984255|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164501660|NCT01438840|594208480|FG000|Extension Phase|Adverse Event|0|||
164501661|NCT01438840|594208481|FG001|Extension Phase|Adverse Event|0|||
164501662|NCT01438840|594208482|FG002|Extension Phase|Adverse Event|3|||
164501663|NCT01438840|594208480|FG000|Extension Phase|Lost to Follow-up|0|||
164501664|NCT01438840|594208481|FG001|Extension Phase|Lost to Follow-up|0|||
164501665|NCT01438840|594208482|FG002|Extension Phase|Lost to Follow-up|1|||
164501666|NCT01438840|594208480|FG000|Extension Phase|Withdrawal by Subject|0|||
164501667|NCT01438840|594208481|FG001|Extension Phase|Withdrawal by Subject|0|||
164501668|NCT01438840|594208482|FG002|Extension Phase|Withdrawal by Subject|3|||
164501669|NCT01438840|594208480|FG000|Extension Phase|Lack of Efficacy|0|||
164501670|NCT01438840|594208481|FG001|Extension Phase|Lack of Efficacy|0|||
164501671|NCT01438840|594208482|FG002|Extension Phase|Lack of Efficacy|2|||
164501672|NCT01438840|594208480|FG000|Extension Phase|Other|0|||
164501673|NCT01438840|594208481|FG001|Extension Phase|Other|0|||
164501674|NCT01438840|594208482|FG002|Extension Phase|Other|1|||
164501675|NCT00085566|594208484|FG000|Overall Study|Adverse Event|0|||
164501676|NCT00085566|594208485|FG001|Overall Study|Adverse Event|0|||
164501677|NCT00085566|594208486|FG002|Overall Study|Adverse Event|10|||
164501678|NCT00085566|594208484|FG000|Overall Study|Patient Not treated|0|||
164501679|NCT00085566|594208485|FG001|Overall Study|Patient Not treated|0|||
164501680|NCT00085566|594208486|FG002|Overall Study|Patient Not treated|3|||
164501681|NCT00085566|594208484|FG000|Overall Study|Clinical progression|0|||
164501682|NCT00085566|594208485|FG001|Overall Study|Clinical progression|0|||
164501683|NCT00085566|594208486|FG002|Overall Study|Clinical progression|1|||
164501684|NCT04688086|594208489|FG000|Overall Study|Lost to Follow-up|164|||
164501685|NCT04688086|594208489|FG000|Overall Study|Imaging error;|64|||
164501686|NCT04052997|594208491|FG000|Overall Study|Withdrawal by Subject|17|||
164501687|NCT04052997|594208491|FG000|Overall Study|Physician Decision|50|||
164501688|NCT04052997|594208491|FG000|Overall Study|Death|43|||
164501689|NCT04052997|594208491|FG000|Overall Study|Lost to Follow-up|5|||
164501690|NCT04052997|594208491|FG000|Overall Study|Progression of Disease|1|||
164501691|NCT04522778|594208492|FG000|Overall Study|Patient did not want to wear the device|1|||
164501692|NCT04522778|594208493|FG001|Overall Study|Patient did not want to wear the device|0|||
164501693|NCT04522778|594208492|FG000|Overall Study|Lost to Follow-up|0|||
164501694|NCT04522778|594208493|FG001|Overall Study|Lost to Follow-up|1|||
164501695|NCT00069277|594208494|FG000|Overall Study|Adverse Event|3|||
164501696|NCT00069277|594208494|FG000|Overall Study|Withdrawal by Subject|1|||
164501697|NCT00069277|594208494|FG000|Overall Study|Progressive Disease|15|||
164501698|NCT00069277|594208494|FG000|Overall Study|Physician Decision|2|||
164501699|NCT01831726|594208495|FG000|Overall Study|Adverse Event|16|||
164501700|NCT01831726|594208495|FG000|Overall Study|Death|7|||
164501701|NCT01831726|594208495|FG000|Overall Study|Disease Progression|49|||
164501702|NCT01831726|594208495|FG000|Overall Study|Physician Decision|1|||
164501703|NCT01831726|594208495|FG000|Overall Study|Subject/guardian decision|7|||
164501704|NCT03821064|594208496|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
164501705|NCT01482819|594208498|FG000|Overall Study|Lost to Follow-up|2|||
164501706|NCT00942188|594208503|FG000|Overall Study|Adverse Event|0|||
164501707|NCT00942188|594208504|FG001|Overall Study|Adverse Event|3|||
164501708|NCT00942188|594208505|FG002|Overall Study|Adverse Event|2|||
164501709|NCT00942188|594208506|FG003|Overall Study|Adverse Event|0|||
164501710|NCT00942188|594208503|FG000|Overall Study|Lack of Efficacy|0|||
164716159|NCT04619004|594984259|FG000|Overall Study|Death|114|||
164716160|NCT04619004|594984260|FG001|Overall Study|Death|28|||
164716161|NCT04619004|594984259|FG000|Overall Study|Lost to Follow-up|1|||
164501711|NCT00942188|594208504|FG001|Overall Study|Lack of Efficacy|0|||
164501712|NCT00942188|594208505|FG002|Overall Study|Lack of Efficacy|0|||
164501713|NCT00942188|594208506|FG003|Overall Study|Lack of Efficacy|1|||
164501714|NCT00942188|594208503|FG000|Overall Study|Protocol Violation|1|||
164501715|NCT00942188|594208504|FG001|Overall Study|Protocol Violation|1|||
164501716|NCT00942188|594208505|FG002|Overall Study|Protocol Violation|0|||
164501717|NCT00942188|594208506|FG003|Overall Study|Protocol Violation|0|||
164501718|NCT00942188|594208503|FG000|Overall Study|Lost to Follow-up|2|||
164501719|NCT00942188|594208504|FG001|Overall Study|Lost to Follow-up|1|||
164501720|NCT00942188|594208505|FG002|Overall Study|Lost to Follow-up|2|||
164501721|NCT00942188|594208506|FG003|Overall Study|Lost to Follow-up|0|||
164501722|NCT00942188|594208503|FG000|Overall Study|Withdrawal by Subject|1|||
164501723|NCT00942188|594208504|FG001|Overall Study|Withdrawal by Subject|3|||
164716162|NCT04619004|594984260|FG001|Overall Study|Lost to Follow-up|1|||
164716163|NCT04619004|594984259|FG000|Overall Study|Withdrawal by Subject|24|||
164501724|NCT00942188|594208505|FG002|Overall Study|Withdrawal by Subject|4|||
164501725|NCT00942188|594208506|FG003|Overall Study|Withdrawal by Subject|2|||
164501726|NCT00942188|594208503|FG000|Overall Study|Physician Decision|0|||
164501727|NCT00942188|594208504|FG001|Overall Study|Physician Decision|0|||
164501728|NCT00942188|594208505|FG002|Overall Study|Physician Decision|1|||
164501729|NCT00942188|594208506|FG003|Overall Study|Physician Decision|0|||
164501730|NCT00942188|594208503|FG000|Overall Study|Sponsor Decision|0|||
164501731|NCT00942188|594208504|FG001|Overall Study|Sponsor Decision|2|||
164501732|NCT00942188|594208505|FG002|Overall Study|Sponsor Decision|0|||
164501733|NCT00942188|594208506|FG003|Overall Study|Sponsor Decision|1|||
164501734|NCT04811339|594208508|FG000|Overall Study|lack of transportation not wanting to return|4|||
164501735|NCT04811339|594208509|FG001|Overall Study|lack of transportation not wanting to return|8|||
164501736|NCT04811339|594208510|FG002|Overall Study|lack of transportation not wanting to return|0|||
164501737|NCT04811339|594208508|FG000|Overall Study|Adverse Event|3|||
164501738|NCT04811339|594208509|FG001|Overall Study|Adverse Event|0|||
164501739|NCT04811339|594208510|FG002|Overall Study|Adverse Event|0|||
164501740|NCT04811339|594208508|FG000|Overall Study|Lost to Follow-up|1|||
164501741|NCT04811339|594208509|FG001|Overall Study|Lost to Follow-up|0|||
164501742|NCT04811339|594208510|FG002|Overall Study|Lost to Follow-up|0|||
164501743|NCT04811339|594208508|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
164501744|NCT04811339|594208509|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
164501745|NCT04811339|594208510|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
164501746|NCT04811339|594208508|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
164501747|NCT04811339|594208509|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
164501748|NCT04811339|594208510|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
164501749|NCT04811339|594208508|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
164501750|NCT04811339|594208509|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
164501751|NCT04811339|594208510|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
164501752|NCT04811339|594208508|FG000|Overall Study|Withdrawal by Subject|0|||
164501753|NCT04811339|594208509|FG001|Overall Study|Withdrawal by Subject|3|||
164501754|NCT04811339|594208510|FG002|Overall Study|Withdrawal by Subject|0|||
164501755|NCT04811339|594208508|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
164501756|NCT04811339|594208509|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
164501757|NCT04811339|594208510|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
164501758|NCT04811339|594208508|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
164501759|NCT04811339|594208509|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
164501760|NCT04811339|594208510|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
164501761|NCT00143598|594208511|FG000|Overall Study|Lost to Follow-up|23|||
164501762|NCT00143598|594208512|FG001|Overall Study|Lost to Follow-up|21|||
164501763|NCT00143598|594208511|FG000|Overall Study|Withdrawal by Subject|33|||
164501764|NCT00143598|594208512|FG001|Overall Study|Withdrawal by Subject|37|||
164501765|NCT00143598|594208511|FG000|Overall Study|Death|36|||
164501766|NCT00143598|594208512|FG001|Overall Study|Death|36|||
164501767|NCT04944784|594208513|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
164501768|NCT04944784|594208514|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
164501769|NCT04944784|594208515|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
164501770|NCT04944784|594208516|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
164501771|NCT04944784|594208513|FG000|Double-blind Period|Adverse Event|20|||
164501772|NCT04944784|594208514|FG001|Double-blind Period|Adverse Event|4|||
164501773|NCT04944784|594208515|FG002|Double-blind Period|Adverse Event|0|||
164501774|NCT04944784|594208516|FG003|Double-blind Period|Adverse Event|0|||
164501775|NCT04944784|594208513|FG000|Double-blind Period|Withdrawal by Subject|15|||
164501776|NCT04944784|594208514|FG001|Double-blind Period|Withdrawal by Subject|4|||
164501777|NCT04944784|594208515|FG002|Double-blind Period|Withdrawal by Subject|0|||
164501778|NCT04944784|594208516|FG003|Double-blind Period|Withdrawal by Subject|0|||
164501779|NCT04944784|594208513|FG000|Double-blind Period|Death|7|||
164501780|NCT04944784|594208514|FG001|Double-blind Period|Death|2|||
164501781|NCT04944784|594208515|FG002|Double-blind Period|Death|0|||
164501782|NCT04944784|594208516|FG003|Double-blind Period|Death|0|||
164501783|NCT04944784|594208513|FG000|Double-blind Period|Physician Decision|2|||
164501784|NCT04944784|594208514|FG001|Double-blind Period|Physician Decision|1|||
164501785|NCT04944784|594208515|FG002|Double-blind Period|Physician Decision|0|||
164501786|NCT04944784|594208516|FG003|Double-blind Period|Physician Decision|0|||
164501787|NCT04944784|594208513|FG000|Double-blind Period|Lack of Efficacy|0|||
164501788|NCT04944784|594208514|FG001|Double-blind Period|Lack of Efficacy|1|||
164501789|NCT04944784|594208515|FG002|Double-blind Period|Lack of Efficacy|0|||
164501790|NCT04944784|594208516|FG003|Double-blind Period|Lack of Efficacy|0|||
164501791|NCT04944784|594208513|FG000|Double-blind Period|Sponsor Request|2|||
164501792|NCT04944784|594208514|FG001|Double-blind Period|Sponsor Request|1|||
164501793|NCT04944784|594208515|FG002|Double-blind Period|Sponsor Request|0|||
164501794|NCT04944784|594208516|FG003|Double-blind Period|Sponsor Request|0|||
164501795|NCT04944784|594208513|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
164501796|NCT04944784|594208514|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
164501797|NCT04944784|594208515|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
164501798|NCT04944784|594208516|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
164501799|NCT04944784|594208513|FG000|Double-blind Period|Participant Choice|1|||
164501800|NCT04944784|594208514|FG001|Double-blind Period|Participant Choice|1|||
164501801|NCT04944784|594208515|FG002|Double-blind Period|Participant Choice|0|||
164501802|NCT04944784|594208516|FG003|Double-blind Period|Participant Choice|0|||
164501803|NCT04944784|594208513|FG000|Double-blind Period|Progressive Disease|2|||
164501804|NCT04944784|594208514|FG001|Double-blind Period|Progressive Disease|2|||
164501805|NCT04944784|594208515|FG002|Double-blind Period|Progressive Disease|0|||
164501806|NCT04944784|594208516|FG003|Double-blind Period|Progressive Disease|0|||
164501807|NCT04944784|594208513|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
164501808|NCT04944784|594208514|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
164501809|NCT04944784|594208515|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
164501810|NCT04944784|594208516|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
164501811|NCT04944784|594208513|FG000|Active Drug Period|Adverse Event|0|||
164501812|NCT04944784|594208514|FG001|Active Drug Period|Adverse Event|0|||
164501813|NCT04944784|594208515|FG002|Active Drug Period|Adverse Event|3|||
164501814|NCT04944784|594208516|FG003|Active Drug Period|Adverse Event|6|||
164501815|NCT04944784|594208513|FG000|Active Drug Period|Withdrawal by Subject|0|||
164501816|NCT04944784|594208514|FG001|Active Drug Period|Withdrawal by Subject|0|||
164501817|NCT04944784|594208515|FG002|Active Drug Period|Withdrawal by Subject|4|||
164501818|NCT04944784|594208516|FG003|Active Drug Period|Withdrawal by Subject|7|||
164501819|NCT04944784|594208513|FG000|Active Drug Period|Death|0|||
164501820|NCT04944784|594208514|FG001|Active Drug Period|Death|0|||
164501821|NCT04944784|594208515|FG002|Active Drug Period|Death|3|||
164501822|NCT04944784|594208516|FG003|Active Drug Period|Death|4|||
164501823|NCT04944784|594208513|FG000|Active Drug Period|Lack of Efficacy|0|||
164501824|NCT04944784|594208514|FG001|Active Drug Period|Lack of Efficacy|0|||
164501825|NCT04944784|594208515|FG002|Active Drug Period|Lack of Efficacy|2|||
164501826|NCT04944784|594208516|FG003|Active Drug Period|Lack of Efficacy|2|||
164501827|NCT04944784|594208513|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
164501828|NCT04944784|594208514|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
164501829|NCT04944784|594208515|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
164501830|NCT04944784|594208516|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
164501831|NCT04944784|594208513|FG000|Active Drug Period|Participant Choice|0|||
164501832|NCT04944784|594208514|FG001|Active Drug Period|Participant Choice|0|||
164501833|NCT04944784|594208515|FG002|Active Drug Period|Participant Choice|0|||
164501834|NCT04944784|594208516|FG003|Active Drug Period|Participant Choice|1|||
164501835|NCT04944784|594208513|FG000|Active Drug Period|Progressive Disease|0|||
164501836|NCT04944784|594208514|FG001|Active Drug Period|Progressive Disease|0|||
164501837|NCT04944784|594208515|FG002|Active Drug Period|Progressive Disease|4|||
164501838|NCT04944784|594208516|FG003|Active Drug Period|Progressive Disease|4|||
164501839|NCT04944784|594208513|FG000|Active Drug Period|Lost to Follow-up|0|||
164501840|NCT04944784|594208514|FG001|Active Drug Period|Lost to Follow-up|0|||
164501841|NCT04944784|594208515|FG002|Active Drug Period|Lost to Follow-up|0|||
164501842|NCT04944784|594208516|FG003|Active Drug Period|Lost to Follow-up|1|||
164501843|NCT04367480|594211019|FG000|Overall Study|Adverse Event|1|||
164501844|NCT04367480|594211020|FG001|Overall Study|Adverse Event|1|||
164501845|NCT04367480|594211019|FG000|Overall Study|Death|1|||
164501846|NCT04367480|594211020|FG001|Overall Study|Death|0|||
164501847|NCT04367480|594211019|FG000|Overall Study|Lost to Follow-up|1|||
164501848|NCT04367480|594211020|FG001|Overall Study|Lost to Follow-up|1|||
164501849|NCT04367480|594211019|FG000|Overall Study|Withdrawal by Subject|0|||
164501850|NCT04367480|594211020|FG001|Overall Study|Withdrawal by Subject|3|||
164501851|NCT04367480|594211019|FG000|Overall Study|App glitch during the study|1|||
164501852|NCT04367480|594211020|FG001|Overall Study|App glitch during the study|0|||
164501853|NCT04367480|594211019|FG000|Overall Study|Device Distribution Error|0|||
164501854|NCT04367480|594211020|FG001|Overall Study|Device Distribution Error|2|||
164501855|NCT04367480|594211019|FG000|Overall Study|Ineligible after Randomization|0|||
164501856|NCT04367480|594211020|FG001|Overall Study|Ineligible after Randomization|1|||
164501857|NCT04367480|594211019|FG000|Overall Study|Other Medical Reasons|0|||
164501858|NCT04367480|594211020|FG001|Overall Study|Other Medical Reasons|2|||
164501859|NCT03382561|594211021|FG000|Overall Study|Disease progression|47|||
164501860|NCT03382561|594211022|FG001|Overall Study|Disease progression|6|||
164501861|NCT03382561|594211021|FG000|Overall Study|Adverse Event|10|||
164501862|NCT03382561|594211022|FG001|Overall Study|Adverse Event|2|||
164501863|NCT03382561|594211021|FG000|Overall Study|Death|8|||
164501864|NCT03382561|594211022|FG001|Overall Study|Death|3|||
164501865|NCT03382561|594211021|FG000|Overall Study|Withdrawal by Subject|6|||
164501866|NCT03382561|594211022|FG001|Overall Study|Withdrawal by Subject|5|||
164501867|NCT03382561|594211021|FG000|Overall Study|Alternative therapy|2|||
164501868|NCT03382561|594211022|FG001|Overall Study|Alternative therapy|8|||
164716164|NCT04619004|594984260|FG001|Overall Study|Withdrawal by Subject|7|||
164716165|NCT04619004|594984259|FG000|Overall Study|Other - Not specified|0|||
164716166|NCT04619004|594984260|FG001|Overall Study|Other - Not specified|1|||
164716167|NCT05763576|594984261|FG000|Overall Study|Study Terminated by Sponsor|0|||
164716168|NCT05763576|594984262|FG001|Overall Study|Study Terminated by Sponsor|0|||
164716169|NCT05763576|594984263|FG002|Overall Study|Study Terminated by Sponsor|0|||
164716170|NCT05763576|594984264|FG003|Overall Study|Study Terminated by Sponsor|0|||
164716171|NCT05763576|594984265|FG004|Overall Study|Study Terminated by Sponsor|0|||
164716172|NCT05763576|594984266|FG005|Overall Study|Study Terminated by Sponsor|0|||
164716173|NCT05763576|594984267|FG006|Overall Study|Study Terminated by Sponsor|0|||
164716174|NCT05763576|594984268|FG007|Overall Study|Study Terminated by Sponsor|2|||
164501869|NCT03382561|594211021|FG000|Overall Study|Never started treatment|3|||
164501870|NCT03382561|594211022|FG001|Overall Study|Never started treatment|6|||
164501871|NCT03382561|594211021|FG000|Overall Study|Lack of Efficacy|0|||
164501872|NCT03382561|594211022|FG001|Overall Study|Lack of Efficacy|1|||
164501873|NCT03382561|594211021|FG000|Overall Study|Physician Decision|0|||
164501874|NCT03382561|594211022|FG001|Overall Study|Physician Decision|1|||
164501875|NCT03382561|594211021|FG000|Overall Study|Other complicating disease|0|||
164501876|NCT03382561|594211022|FG001|Overall Study|Other complicating disease|1|||
164501877|NCT01131104|594211023|FG000|Overall Study|Withdrawal by Subject|3|||
164501878|NCT01131104|594211023|FG000|Overall Study|Physician Decision|4|||
164501879|NCT01131104|594211023|FG000|Overall Study|Information Not Available|5|||
164501880|NCT01131104|594211023|FG000|Overall Study|No Information on Index Date of Onset|1|||
164501881|NCT02370251|594211025|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
164501882|NCT02370251|594211025|FG000|Overall Study|Death|4|||
164501883|NCT04120376|594211026|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
164501884|NCT04120376|594211027|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
164501885|NCT01165177|594211028|FG000|Overall Study|Serious Adverse Event|227|||
164501886|NCT01165177|594211029|FG001|Overall Study|Serious Adverse Event|235|||
164501887|NCT01165177|594211028|FG000|Overall Study|Withdrawal by Subject|368|||
164501888|NCT01165177|594211029|FG001|Overall Study|Withdrawal by Subject|354|||
164501889|NCT01165177|594211028|FG000|Overall Study|Protocol Violation|19|||
164501890|NCT01165177|594211029|FG001|Overall Study|Protocol Violation|21|||
164501891|NCT01165177|594211028|FG000|Overall Study|Non-serious adverse event|30|||
164501892|NCT01165177|594211029|FG001|Overall Study|Non-serious adverse event|18|||
164501893|NCT01165177|594211028|FG000|Overall Study|Other unspecified reasons|47|||
164501894|NCT01165177|594211029|FG001|Overall Study|Other unspecified reasons|35|||
164501895|NCT01165177|594211028|FG000|Overall Study|Suspected HZ episode|0|||
164501896|NCT01165177|594211029|FG001|Overall Study|Suspected HZ episode|2|||
164501897|NCT01165177|594211028|FG000|Overall Study|Lost to Follow-up|183|||
164501898|NCT01165177|594211029|FG001|Overall Study|Lost to Follow-up|194|||
164501899|NCT01165177|594211028|FG000|Overall Study|Migrated/ moved from study area|48|||
164501900|NCT01165177|594211029|FG001|Overall Study|Migrated/ moved from study area|43|||
164501901|NCT05499130|594211030|FG000|Overall Study|Adverse Event|2|||
164501902|NCT05499130|594211031|FG001|Overall Study|Adverse Event|0|||
164501903|NCT05499130|594211032|FG002|Overall Study|Adverse Event|1|||
164501904|NCT05499130|594211033|FG003|Overall Study|Adverse Event|0|||
164501905|NCT05499130|594211034|FG004|Overall Study|Adverse Event|1|||
164501906|NCT05499130|594211035|FG005|Overall Study|Adverse Event|4|||
164501907|NCT05499130|594211036|FG006|Overall Study|Adverse Event|1|||
164501908|NCT05499130|594211037|FG007|Overall Study|Adverse Event|0|||
164501909|NCT05499130|594211030|FG000|Overall Study|Lack of Efficacy|1|||
164501910|NCT05499130|594211031|FG001|Overall Study|Lack of Efficacy|0|||
164501911|NCT05499130|594211032|FG002|Overall Study|Lack of Efficacy|0|||
164501912|NCT05499130|594211033|FG003|Overall Study|Lack of Efficacy|0|||
164501913|NCT05499130|594211034|FG004|Overall Study|Lack of Efficacy|5|||
164501914|NCT05499130|594211035|FG005|Overall Study|Lack of Efficacy|0|||
164501915|NCT05499130|594211036|FG006|Overall Study|Lack of Efficacy|1|||
164501916|NCT05499130|594211037|FG007|Overall Study|Lack of Efficacy|0|||
164501917|NCT05499130|594211030|FG000|Overall Study|Withdrawal by Subject|2|||
164501918|NCT05499130|594211031|FG001|Overall Study|Withdrawal by Subject|0|||
164501919|NCT05499130|594211032|FG002|Overall Study|Withdrawal by Subject|0|||
164501920|NCT05499130|594211033|FG003|Overall Study|Withdrawal by Subject|0|||
164716175|NCT05763576|594984269|FG008|Overall Study|Study Terminated by Sponsor|6|||
164501921|NCT05499130|594211034|FG004|Overall Study|Withdrawal by Subject|1|||
164501922|NCT05499130|594211035|FG005|Overall Study|Withdrawal by Subject|2|||
164501923|NCT05499130|594211036|FG006|Overall Study|Withdrawal by Subject|0|||
164501924|NCT05499130|594211037|FG007|Overall Study|Withdrawal by Subject|0|||
164501925|NCT05499130|594211030|FG000|Overall Study|Lost to Follow-up|0|||
164501926|NCT05499130|594211031|FG001|Overall Study|Lost to Follow-up|0|||
164501927|NCT05499130|594211032|FG002|Overall Study|Lost to Follow-up|0|||
164501928|NCT05499130|594211033|FG003|Overall Study|Lost to Follow-up|0|||
164716176|NCT05763576|594984261|FG000|Overall Study|Withdrawal by Subject|0|||
164501929|NCT05499130|594211034|FG004|Overall Study|Lost to Follow-up|0|||
164501930|NCT05499130|594211035|FG005|Overall Study|Lost to Follow-up|2|||
164716177|NCT05763576|594984262|FG001|Overall Study|Withdrawal by Subject|0|||
164501931|NCT05499130|594211036|FG006|Overall Study|Lost to Follow-up|0|||
164501932|NCT05499130|594211037|FG007|Overall Study|Lost to Follow-up|0|||
164501933|NCT05499130|594211030|FG000|Overall Study|Other Than Specified|0|||
164501934|NCT05499130|594211031|FG001|Overall Study|Other Than Specified|0|||
164501935|NCT05499130|594211032|FG002|Overall Study|Other Than Specified|0|||
164501936|NCT05499130|594211033|FG003|Overall Study|Other Than Specified|0|||
164501937|NCT05499130|594211034|FG004|Overall Study|Other Than Specified|1|||
164501938|NCT05499130|594211035|FG005|Overall Study|Other Than Specified|1|||
164501939|NCT05499130|594211036|FG006|Overall Study|Other Than Specified|2|||
164501940|NCT05499130|594211037|FG007|Overall Study|Other Than Specified|0|||
164501941|NCT05499130|594211030|FG000|Overall Study|Protocol Violation|0|||
164501942|NCT05499130|594211031|FG001|Overall Study|Protocol Violation|0|||
164501943|NCT05499130|594211032|FG002|Overall Study|Protocol Violation|0|||
164501944|NCT05499130|594211033|FG003|Overall Study|Protocol Violation|0|||
164501945|NCT05499130|594211034|FG004|Overall Study|Protocol Violation|1|||
164501946|NCT05499130|594211035|FG005|Overall Study|Protocol Violation|0|||
164501947|NCT05499130|594211036|FG006|Overall Study|Protocol Violation|0|||
164501948|NCT05499130|594211037|FG007|Overall Study|Protocol Violation|0|||
164501949|NCT00781937|594211039|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
164501950|NCT00781937|594211040|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
164501951|NCT00781937|594211039|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
164501952|NCT00781937|594211040|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
164501953|NCT00781937|594211039|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
164501954|NCT00781937|594211040|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
164501955|NCT00781937|594211039|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
164501956|NCT00781937|594211040|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
164501957|NCT00781937|594211039|FG000|Main Trial Period Through Week 56|Unclassified|10|||
164501958|NCT00781937|594211040|FG001|Main Trial Period Through Week 56|Unclassified|15|||
164501959|NCT00781937|594211039|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
164501960|NCT00781937|594211040|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
164501961|NCT00781937|594211039|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
164501962|NCT00781937|594211040|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
164501963|NCT00013611|594211041|FG000|Overall Study|Lost to Follow-up|91|||
164501964|NCT00013611|594211042|FG001|Overall Study|Lost to Follow-up|100|||
164501965|NCT01663506|594211043|FG000|Overall Study|Lack of Efficacy|3|||
164501966|NCT01663506|594211043|FG000|Overall Study|Consent Withdrawal by Subject|1|||
164501967|NCT01663506|594211043|FG000|Overall Study|Lost to Follow-up|1|||
164501968|NCT01663506|594211043|FG000|Overall Study|Adverse Event|1|||
164501969|NCT01663506|594211043|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
164501970|NCT02094898|594211044|FG000|Overall Study|Clinical Worsening|2|||
164501971|NCT02094898|594211044|FG000|Overall Study|Adverse Event|2|||
164501972|NCT02094898|594211044|FG000|Overall Study|Lack of Efficacy|1|||
164501973|NCT03520075|594211045|FG000|Phase 1 (Dose Escalation)|Death|2|||
164501974|NCT03520075|594211046|FG001|Phase 1 (Dose Escalation)|Death|2|||
164501975|NCT03520075|594211047|FG002|Phase 1 (Dose Escalation)|Death|3|||
164501976|NCT03520075|594211048|FG003|Phase 1 (Dose Escalation)|Death|2|||
164501977|NCT03520075|594211049|FG004|Phase 1 (Dose Escalation)|Death|6|||
164501978|NCT03520075|594211050|FG005|Phase 1 (Dose Escalation)|Death|5|||
164501979|NCT03520075|594211051|FG006|Phase 1 (Dose Escalation)|Death|3|||
164501980|NCT03520075|594211052|FG007|Phase 1 (Dose Escalation)|Death|2|||
164501981|NCT03520075|594211053|FG008|Phase 1 (Dose Escalation)|Death|3|||
164501982|NCT03520075|594211054|FG009|Phase 1 (Dose Escalation)|Death|1|||
164501983|NCT03520075|594211055|FG010|Phase 1 (Dose Escalation)|Death|5|||
164501984|NCT03520075|594211056|FG011|Phase 1 (Dose Escalation)|Death|7|||
164501985|NCT03520075|594211057|FG012|Phase 1 (Dose Escalation)|Death|11|||
164501986|NCT03520075|594211058|FG013|Phase 1 (Dose Escalation)|Death|0|||
164501987|NCT03520075|594211059|FG014|Phase 1 (Dose Escalation)|Death|0|||
164501988|NCT03520075|594211060|FG015|Phase 1 (Dose Escalation)|Death|0|||
164501989|NCT03520075|594211061|FG016|Phase 1 (Dose Escalation)|Death|0|||
164501990|NCT03520075|594211062|FG017|Phase 1 (Dose Escalation)|Death|0|||
164501991|NCT03520075|594211063|FG018|Phase 1 (Dose Escalation)|Death|0|||
164501992|NCT03520075|594211045|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
164501993|NCT03520075|594211046|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
164501994|NCT03520075|594211047|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
164501995|NCT03520075|594211048|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
164501996|NCT03520075|594211049|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
164501997|NCT03520075|594211050|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
164501998|NCT03520075|594211051|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
164501999|NCT03520075|594211052|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
164502000|NCT03520075|594211053|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
164502001|NCT03520075|594211054|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
164502002|NCT03520075|594211055|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
164605581|NCT03250377|594577578|FG002|Overall Study|Request From The Sponsor|0|||
164605582|NCT03250377|594577579|FG003|Overall Study|Request From The Sponsor|0|||
164605583|NCT03250377|594577576|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
164605584|NCT03250377|594577577|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
164605585|NCT03250377|594577578|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
164605586|NCT03250377|594577579|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
164605587|NCT03250377|594577576|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
164605588|NCT03250377|594577577|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
164605589|NCT03250377|594577578|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
164605590|NCT03250377|594577579|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
164605591|NCT03250377|594577576|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
164605592|NCT03250377|594577577|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
164605593|NCT03250377|594577578|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
164605594|NCT03250377|594577579|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
164605595|NCT03250377|594577576|FG000|Overall Study|Pregnancy Event|0|||
164605596|NCT03250377|594577577|FG001|Overall Study|Pregnancy Event|1|||
164605597|NCT03250377|594577578|FG002|Overall Study|Pregnancy Event|0|||
164605598|NCT03250377|594577579|FG003|Overall Study|Pregnancy Event|0|||
164605599|NCT03250377|594577576|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
164605600|NCT03250377|594577577|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
164605601|NCT03250377|594577578|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
164605602|NCT03250377|594577579|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
164605603|NCT03250377|594577576|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
164605604|NCT03250377|594577577|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
164605605|NCT03250377|594577578|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
164605606|NCT03250377|594577579|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
164605607|NCT03250377|594577576|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
164605608|NCT03250377|594577577|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
164605609|NCT03250377|594577578|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
164605610|NCT03250377|594577579|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
164605611|NCT03250377|594577576|FG000|Overall Study|Patient requested to change hospital|0|||
164605612|NCT03250377|594577577|FG001|Overall Study|Patient requested to change hospital|0|||
164605613|NCT03250377|594577578|FG002|Overall Study|Patient requested to change hospital|0|||
164605614|NCT03250377|594577579|FG003|Overall Study|Patient requested to change hospital|1|||
164605615|NCT03250377|594577576|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
164605616|NCT03250377|594577577|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
164605617|NCT03250377|594577578|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
164605618|NCT03250377|594577579|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
164605619|NCT00868166|594577580|FG000|Overall Study|Death|58|||
164605620|NCT00868166|594577581|FG001|Overall Study|Death|65|||
164605621|NCT00868166|594577580|FG000|Overall Study|Withdrawal by Subject|33|||
164605622|NCT00868166|594577581|FG001|Overall Study|Withdrawal by Subject|25|||
164605623|NCT00868166|594577580|FG000|Overall Study|Protocol Violation|1|||
164605624|NCT00868166|594577581|FG001|Overall Study|Protocol Violation|0|||
164605625|NCT00868166|594577580|FG000|Overall Study|Lost to Follow-up|1|||
164605626|NCT00868166|594577581|FG001|Overall Study|Lost to Follow-up|3|||
164605627|NCT00868166|594577580|FG000|Overall Study|Adverse Event|9|||
164605628|NCT00868166|594577581|FG001|Overall Study|Adverse Event|10|||
164605629|NCT00868166|594577580|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
164605630|NCT00868166|594577581|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
164605631|NCT00868166|594577580|FG000|Overall Study|Non-compliance with IMP|1|||
164605632|NCT00868166|594577581|FG001|Overall Study|Non-compliance with IMP|1|||
164605633|NCT01797445|594577587|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
164605634|NCT01797445|594577588|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
164605635|NCT01797445|594577587|FG000|Double-Blind Phase|Adverse Event|3|||
164605636|NCT01797445|594577588|FG001|Double-Blind Phase|Adverse Event|0|||
164605637|NCT01797445|594577587|FG000|Double-Blind Phase|Death|5|||
164605638|NCT01797445|594577588|FG001|Double-Blind Phase|Death|4|||
164605639|NCT01797445|594577587|FG000|Double-Blind Phase|Pregnancy|0|||
164605640|NCT01797445|594577588|FG001|Double-Blind Phase|Pregnancy|1|||
164716178|NCT05763576|594984263|FG002|Overall Study|Withdrawal by Subject|0|||
164716179|NCT05763576|594984264|FG003|Overall Study|Withdrawal by Subject|0|||
164716180|NCT05763576|594984265|FG004|Overall Study|Withdrawal by Subject|0|||
164605641|NCT01797445|594577587|FG000|Double-Blind Phase|Lack of Efficacy|1|||
164605642|NCT01797445|594577588|FG001|Double-Blind Phase|Lack of Efficacy|2|||
164605643|NCT01797445|594577587|FG000|Double-Blind Phase|Investigator's Discretion|15|||
164605644|NCT01797445|594577588|FG001|Double-Blind Phase|Investigator's Discretion|17|||
164605645|NCT01797445|594577587|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
164716181|NCT05763576|594984266|FG005|Overall Study|Withdrawal by Subject|1|||
164716182|NCT05763576|594984267|FG006|Overall Study|Withdrawal by Subject|0|||
164502003|NCT03520075|594211056|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
164502004|NCT03520075|594211057|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
164502005|NCT03520075|594211058|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
164502006|NCT03520075|594211059|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
164502007|NCT03520075|594211060|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
164502008|NCT03520075|594211061|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
164502009|NCT03520075|594211062|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
164502010|NCT03520075|594211063|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
164502011|NCT03520075|594211045|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
164502012|NCT03520075|594211046|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
164502013|NCT03520075|594211047|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
164502014|NCT03520075|594211048|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
164502015|NCT03520075|594211049|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
164502016|NCT03520075|594211050|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
164502017|NCT03520075|594211051|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
164502018|NCT03520075|594211052|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
164502019|NCT03520075|594211053|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
164502020|NCT03520075|594211054|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
164502021|NCT03520075|594211055|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
164502022|NCT03520075|594211056|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
164502023|NCT03520075|594211057|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
164502024|NCT03520075|594211058|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
164502025|NCT03520075|594211059|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
164502026|NCT03520075|594211060|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
164502027|NCT03520075|594211061|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
164502028|NCT03520075|594211062|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
164502029|NCT03520075|594211063|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
164502030|NCT03520075|594211045|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
164502031|NCT03520075|594211046|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
164502032|NCT03520075|594211047|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
164502033|NCT03520075|594211048|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
164502034|NCT03520075|594211049|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
164502035|NCT03520075|594211050|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
164502036|NCT03520075|594211051|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
164502037|NCT03520075|594211052|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
164502038|NCT03520075|594211053|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
164502039|NCT03520075|594211054|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
164502040|NCT03520075|594211055|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
164502041|NCT03520075|594211056|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
164502042|NCT03520075|594211057|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
164502043|NCT03520075|594211058|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
164502044|NCT03520075|594211059|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
164502045|NCT03520075|594211060|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
164502046|NCT03520075|594211061|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
164502047|NCT03520075|594211062|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
164502048|NCT03520075|594211063|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
164502049|NCT03520075|594211045|FG000|Phase 2 (Dose Expansion)|Death|0|||
164502050|NCT03520075|594211046|FG001|Phase 2 (Dose Expansion)|Death|0|||
164502051|NCT03520075|594211047|FG002|Phase 2 (Dose Expansion)|Death|0|||
164502052|NCT03520075|594211048|FG003|Phase 2 (Dose Expansion)|Death|0|||
164502053|NCT03520075|594211049|FG004|Phase 2 (Dose Expansion)|Death|0|||
164502054|NCT03520075|594211050|FG005|Phase 2 (Dose Expansion)|Death|0|||
164502055|NCT03520075|594211051|FG006|Phase 2 (Dose Expansion)|Death|0|||
164502056|NCT03520075|594211052|FG007|Phase 2 (Dose Expansion)|Death|0|||
164502057|NCT03520075|594211053|FG008|Phase 2 (Dose Expansion)|Death|0|||
164502058|NCT03520075|594211054|FG009|Phase 2 (Dose Expansion)|Death|0|||
164502059|NCT03520075|594211055|FG010|Phase 2 (Dose Expansion)|Death|0|||
164502060|NCT03520075|594211056|FG011|Phase 2 (Dose Expansion)|Death|0|||
164502061|NCT03520075|594211057|FG012|Phase 2 (Dose Expansion)|Death|0|||
164502062|NCT03520075|594211058|FG013|Phase 2 (Dose Expansion)|Death|20|||
164502063|NCT03520075|594211059|FG014|Phase 2 (Dose Expansion)|Death|13|||
164502064|NCT03520075|594211060|FG015|Phase 2 (Dose Expansion)|Death|9|||
164502065|NCT03520075|594211061|FG016|Phase 2 (Dose Expansion)|Death|5|||
164502066|NCT03520075|594211062|FG017|Phase 2 (Dose Expansion)|Death|14|||
164502067|NCT03520075|594211063|FG018|Phase 2 (Dose Expansion)|Death|12|||
164502068|NCT03520075|594211045|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
164502069|NCT03520075|594211046|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
164502070|NCT03520075|594211047|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
164502071|NCT03520075|594211048|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
164502072|NCT03520075|594211049|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
164502073|NCT03520075|594211050|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
164502074|NCT03520075|594211051|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
164502075|NCT03520075|594211052|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
164502076|NCT03520075|594211053|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
164502077|NCT03520075|594211054|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
164502078|NCT03520075|594211055|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
164502079|NCT03520075|594211056|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
164502080|NCT03520075|594211057|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
164502081|NCT03520075|594211058|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
164502082|NCT03520075|594211059|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
164502083|NCT03520075|594211060|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
164502084|NCT03520075|594211061|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
164502085|NCT03520075|594211062|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
164502086|NCT03520075|594211063|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
164502087|NCT03520075|594211045|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
164502088|NCT03520075|594211046|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
164502089|NCT03520075|594211047|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
164502090|NCT03520075|594211048|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
164502091|NCT03520075|594211049|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
164502092|NCT03520075|594211050|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
164502093|NCT03520075|594211051|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
164502094|NCT03520075|594211052|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
164502095|NCT03520075|594211053|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
164502096|NCT03520075|594211054|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
164502097|NCT03520075|594211055|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
164502098|NCT03520075|594211056|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
164502099|NCT03520075|594211057|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
164502100|NCT03520075|594211058|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
164502101|NCT03520075|594211059|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
164502102|NCT03520075|594211060|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
164502103|NCT03520075|594211061|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
164502104|NCT03520075|594211062|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
164502105|NCT03520075|594211063|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
164502106|NCT03520075|594211045|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
164502107|NCT03520075|594211046|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
164502108|NCT03520075|594211047|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
164502109|NCT03520075|594211048|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
164502110|NCT03520075|594211049|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
164502111|NCT03520075|594211050|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
164502112|NCT03520075|594211051|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
164502113|NCT03520075|594211052|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
164502114|NCT03520075|594211053|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
164502115|NCT03520075|594211054|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
164502116|NCT03520075|594211055|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
164502117|NCT03520075|594211056|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
164502118|NCT03520075|594211057|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
164502119|NCT03520075|594211058|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
164502120|NCT03520075|594211059|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
164502121|NCT03520075|594211060|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
164502122|NCT03520075|594211061|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
164502123|NCT03520075|594211062|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
164502124|NCT03520075|594211063|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
164502125|NCT01432626|594211066|FG000|Overall Study|LV function recovered|2|||
164502126|NCT01432626|594211066|FG000|Overall Study|Withdrawal by Subject|2|||
164502127|NCT01432626|594211066|FG000|Overall Study|Only 1 image competed|2|||
164502128|NCT01432626|594211066|FG000|Overall Study|Imaging agent not available|1|||
164502129|NCT03305809|594211067|FG000|Overall Study|Adverse Event|2|||
164502130|NCT03305809|594211068|FG001|Overall Study|Adverse Event|2|||
164502131|NCT03305809|594211069|FG002|Overall Study|Adverse Event|6|||
164502132|NCT03305809|594211070|FG003|Overall Study|Adverse Event|6|||
164502133|NCT03305809|594211067|FG000|Overall Study|Death|0|||
164502134|NCT03305809|594211068|FG001|Overall Study|Death|0|||
164502135|NCT03305809|594211069|FG002|Overall Study|Death|1|||
164502136|NCT03305809|594211070|FG003|Overall Study|Death|1|||
164502137|NCT03305809|594211067|FG000|Overall Study|Lost to Follow-up|1|||
164502138|NCT03305809|594211068|FG001|Overall Study|Lost to Follow-up|2|||
164502139|NCT03305809|594211069|FG002|Overall Study|Lost to Follow-up|0|||
164502140|NCT03305809|594211070|FG003|Overall Study|Lost to Follow-up|0|||
164502141|NCT03305809|594211067|FG000|Overall Study|Sponsor Decision|1|||
164502142|NCT03305809|594211068|FG001|Overall Study|Sponsor Decision|0|||
164502143|NCT03305809|594211069|FG002|Overall Study|Sponsor Decision|1|||
164502144|NCT03305809|594211070|FG003|Overall Study|Sponsor Decision|8|||
164502145|NCT03305809|594211067|FG000|Overall Study|Physician Decision|0|||
164502146|NCT03305809|594211068|FG001|Overall Study|Physician Decision|0|||
164502147|NCT03305809|594211069|FG002|Overall Study|Physician Decision|2|||
164502148|NCT03305809|594211070|FG003|Overall Study|Physician Decision|4|||
164502149|NCT03305809|594211067|FG000|Overall Study|Progressive Disease|0|||
164502150|NCT03305809|594211068|FG001|Overall Study|Progressive Disease|0|||
164502151|NCT03305809|594211069|FG002|Overall Study|Progressive Disease|1|||
164502152|NCT03305809|594211070|FG003|Overall Study|Progressive Disease|0|||
164502153|NCT03305809|594211067|FG000|Overall Study|Protocol Violation|1|||
164502154|NCT03305809|594211068|FG001|Overall Study|Protocol Violation|0|||
164502155|NCT03305809|594211069|FG002|Overall Study|Protocol Violation|2|||
164502156|NCT03305809|594211070|FG003|Overall Study|Protocol Violation|3|||
164502157|NCT03305809|594211067|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
164502158|NCT03305809|594211068|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
164502159|NCT03305809|594211069|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
164502160|NCT03305809|594211070|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
164502161|NCT03305809|594211067|FG000|Overall Study|Withdrawal by Subject|2|||
164502162|NCT03305809|594211068|FG001|Overall Study|Withdrawal by Subject|4|||
164502163|NCT03305809|594211069|FG002|Overall Study|Withdrawal by Subject|5|||
164502164|NCT03305809|594211070|FG003|Overall Study|Withdrawal by Subject|2|||
164502165|NCT03305809|594211067|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
164502166|NCT03305809|594211068|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
164502167|NCT03305809|594211069|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
164502168|NCT03305809|594211070|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
164502169|NCT00816556|594211073|FG000|Overall Study|Adverse Event|1|||
164605646|NCT01797445|594577588|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
164605647|NCT01797445|594577587|FG000|Double-Blind Phase|Protocol Violation|0|||
164605648|NCT01797445|594577588|FG001|Double-Blind Phase|Protocol Violation|1|||
164605649|NCT01797445|594577587|FG000|Double-Blind Phase|Withdrew Consent|20|||
164605650|NCT01797445|594577588|FG001|Double-Blind Phase|Withdrew Consent|35|||
164605651|NCT01797445|594577587|FG000|Double-Blind Phase|Lost to Follow-up|34|||
164605652|NCT01797445|594577588|FG001|Double-Blind Phase|Lost to Follow-up|26|||
164605653|NCT01797445|594577587|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
164605654|NCT01797445|594577588|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
164605655|NCT03084718|594577589|FG000|Overall Study|Withdrawal by Subject|4|||
164605656|NCT03084718|594577590|FG001|Overall Study|Withdrawal by Subject|3|||
164605657|NCT03084718|594577591|FG002|Overall Study|Withdrawal by Subject|4|||
164605658|NCT03084718|594577592|FG003|Overall Study|Withdrawal by Subject|0|||
164605659|NCT03084718|594577593|FG004|Overall Study|Withdrawal by Subject|0|||
164605660|NCT03084718|594577589|FG000|Overall Study|Physician Decision|1|||
164605661|NCT03084718|594577590|FG001|Overall Study|Physician Decision|0|||
164605662|NCT03084718|594577591|FG002|Overall Study|Physician Decision|0|||
164605663|NCT03084718|594577592|FG003|Overall Study|Physician Decision|0|||
164605664|NCT03084718|594577593|FG004|Overall Study|Physician Decision|0|||
164605665|NCT03084718|594577589|FG000|Overall Study|Adverse Event|3|||
164605666|NCT03084718|594577590|FG001|Overall Study|Adverse Event|5|||
164605667|NCT03084718|594577591|FG002|Overall Study|Adverse Event|5|||
164605668|NCT03084718|594577592|FG003|Overall Study|Adverse Event|8|||
164605669|NCT03084718|594577593|FG004|Overall Study|Adverse Event|2|||
164605670|NCT03084718|594577589|FG000|Overall Study|Lack of Efficacy|2|||
164605671|NCT03084718|594577590|FG001|Overall Study|Lack of Efficacy|0|||
164605672|NCT03084718|594577591|FG002|Overall Study|Lack of Efficacy|1|||
164605673|NCT03084718|594577592|FG003|Overall Study|Lack of Efficacy|4|||
164605674|NCT03084718|594577593|FG004|Overall Study|Lack of Efficacy|0|||
164605675|NCT03084718|594577589|FG000|Overall Study|Lost to Follow-up|0|||
164605676|NCT03084718|594577590|FG001|Overall Study|Lost to Follow-up|1|||
164605677|NCT03084718|594577591|FG002|Overall Study|Lost to Follow-up|0|||
164605678|NCT03084718|594577592|FG003|Overall Study|Lost to Follow-up|0|||
164605679|NCT03084718|594577593|FG004|Overall Study|Lost to Follow-up|2|||
164605680|NCT03084718|594577589|FG000|Overall Study|Protocol Violation|0|||
164605681|NCT03084718|594577590|FG001|Overall Study|Protocol Violation|0|||
164605682|NCT03084718|594577591|FG002|Overall Study|Protocol Violation|1|||
164605683|NCT03084718|594577592|FG003|Overall Study|Protocol Violation|0|||
164605684|NCT03084718|594577593|FG004|Overall Study|Protocol Violation|0|||
164605685|NCT03084718|594577589|FG000|Overall Study|Death|0|||
164605686|NCT03084718|594577590|FG001|Overall Study|Death|1|||
164605687|NCT03084718|594577591|FG002|Overall Study|Death|0|||
164605688|NCT03084718|594577592|FG003|Overall Study|Death|0|||
164605689|NCT03084718|594577593|FG004|Overall Study|Death|0|||
164605690|NCT03084718|594577589|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
164605691|NCT03084718|594577590|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
164605692|NCT03084718|594577591|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
164502170|NCT00816556|594211074|FG001|Overall Study|Adverse Event|1|||
164716183|NCT05763576|594984268|FG007|Overall Study|Withdrawal by Subject|0|||
164502171|NCT00816556|594211075|FG002|Overall Study|Adverse Event|1|||
164502172|NCT00816556|594211073|FG000|Overall Study|Withdrawal by Subject|1|||
164502173|NCT00816556|594211074|FG001|Overall Study|Withdrawal by Subject|1|||
164502174|NCT00816556|594211075|FG002|Overall Study|Withdrawal by Subject|1|||
164502175|NCT00816556|594211073|FG000|Overall Study|Lost to Follow-up|0|||
164502176|NCT00816556|594211074|FG001|Overall Study|Lost to Follow-up|0|||
164502177|NCT00816556|594211075|FG002|Overall Study|Lost to Follow-up|1|||
164502178|NCT01288209|594211080|FG000|Overall Study|Withdrawal by Subject|1|||
164502179|NCT01288209|594211081|FG001|Overall Study|Withdrawal by Subject|3|||
164502180|NCT01288209|594211080|FG000|Overall Study|Other|1|||
164502181|NCT01288209|594211081|FG001|Overall Study|Other|0|||
164502182|NCT01496365|594211082|FG000|Overall Study|Adverse Event|2|||
164502183|NCT01496365|594211083|FG001|Overall Study|Adverse Event|3|||
164502184|NCT01496365|594211084|FG002|Overall Study|Adverse Event|3|||
164502185|NCT01496365|594211085|FG003|Overall Study|Adverse Event|2|||
164502186|NCT01496365|594211086|FG004|Overall Study|Adverse Event|5|||
164502187|NCT01496365|594211087|FG005|Overall Study|Adverse Event|6|||
164502188|NCT01496365|594211088|FG006|Overall Study|Adverse Event|4|||
164502189|NCT01496365|594211082|FG000|Overall Study|Withdrawal by Subject|6|||
164502190|NCT01496365|594211083|FG001|Overall Study|Withdrawal by Subject|6|||
164502191|NCT01496365|594211084|FG002|Overall Study|Withdrawal by Subject|0|||
164502192|NCT01496365|594211085|FG003|Overall Study|Withdrawal by Subject|1|||
164502193|NCT01496365|594211086|FG004|Overall Study|Withdrawal by Subject|3|||
164502194|NCT01496365|594211087|FG005|Overall Study|Withdrawal by Subject|2|||
164502195|NCT01496365|594211088|FG006|Overall Study|Withdrawal by Subject|1|||
164502196|NCT01496365|594211082|FG000|Overall Study|Protocol Violation|2|||
164502197|NCT01496365|594211083|FG001|Overall Study|Protocol Violation|1|||
164502198|NCT01496365|594211084|FG002|Overall Study|Protocol Violation|1|||
164502199|NCT01496365|594211085|FG003|Overall Study|Protocol Violation|0|||
164502200|NCT01496365|594211086|FG004|Overall Study|Protocol Violation|0|||
164502201|NCT01496365|594211087|FG005|Overall Study|Protocol Violation|1|||
164502202|NCT01496365|594211088|FG006|Overall Study|Protocol Violation|0|||
164502203|NCT01496365|594211082|FG000|Overall Study|Lack of Efficacy|1|||
164502204|NCT01496365|594211083|FG001|Overall Study|Lack of Efficacy|0|||
164502205|NCT01496365|594211084|FG002|Overall Study|Lack of Efficacy|0|||
164502206|NCT01496365|594211085|FG003|Overall Study|Lack of Efficacy|0|||
164502207|NCT01496365|594211086|FG004|Overall Study|Lack of Efficacy|0|||
164502208|NCT01496365|594211087|FG005|Overall Study|Lack of Efficacy|1|||
164502209|NCT01496365|594211088|FG006|Overall Study|Lack of Efficacy|0|||
164502210|NCT01496365|594211082|FG000|Overall Study|Lost to Follow-up|0|||
164502211|NCT01496365|594211083|FG001|Overall Study|Lost to Follow-up|1|||
164502212|NCT01496365|594211084|FG002|Overall Study|Lost to Follow-up|0|||
164502213|NCT01496365|594211085|FG003|Overall Study|Lost to Follow-up|0|||
164502214|NCT01496365|594211086|FG004|Overall Study|Lost to Follow-up|2|||
164502215|NCT01496365|594211087|FG005|Overall Study|Lost to Follow-up|0|||
164502216|NCT01496365|594211088|FG006|Overall Study|Lost to Follow-up|0|||
164502217|NCT01496365|594211082|FG000|Overall Study|Other|4|||
164502218|NCT01496365|594211083|FG001|Overall Study|Other|4|||
164502219|NCT01496365|594211084|FG002|Overall Study|Other|2|||
164502220|NCT01496365|594211085|FG003|Overall Study|Other|1|||
164502221|NCT01496365|594211086|FG004|Overall Study|Other|3|||
164502222|NCT01496365|594211087|FG005|Overall Study|Other|0|||
164502223|NCT01496365|594211088|FG006|Overall Study|Other|1|||
164502224|NCT01015677|594211089|FG000|Overall Study|Adverse Event|0|||
164502225|NCT01015677|594211090|FG001|Overall Study|Adverse Event|1|||
164502226|NCT01015677|594211091|FG002|Overall Study|Adverse Event|0|||
164502227|NCT01015677|594211089|FG000|Overall Study|Lack of Efficacy|0|||
164502228|NCT01015677|594211090|FG001|Overall Study|Lack of Efficacy|1|||
164502229|NCT01015677|594211091|FG002|Overall Study|Lack of Efficacy|0|||
164502230|NCT01015677|594211089|FG000|Overall Study|Protocol Violation|0|||
164502231|NCT01015677|594211090|FG001|Overall Study|Protocol Violation|1|||
164502232|NCT01015677|594211091|FG002|Overall Study|Protocol Violation|0|||
164502233|NCT01015677|594211089|FG000|Overall Study|Withdrawal by Subject|1|||
164605693|NCT03084718|594577592|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
164605694|NCT03084718|594577593|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
164605695|NCT00168064|594577597|FG000|Overall Study|Adverse Event|26|||
164605696|NCT00168064|594577598|FG001|Overall Study|Adverse Event|22|||
164605697|NCT00168064|594577597|FG000|Overall Study|Withdrawal by Subject|3|||
164605698|NCT00168064|594577598|FG001|Overall Study|Withdrawal by Subject|4|||
164502234|NCT01015677|594211090|FG001|Overall Study|Withdrawal by Subject|1|||
164502235|NCT01015677|594211091|FG002|Overall Study|Withdrawal by Subject|0|||
164502236|NCT01660256|594211092|FG000|Overall Study|Adverse Event|4|||
164502237|NCT01660256|594211093|FG001|Overall Study|Adverse Event|0|||
164502238|NCT01660256|594211094|FG002|Overall Study|Adverse Event|2|||
164605699|NCT00168064|594577597|FG000|Overall Study|Lack of Efficacy|4|||
164502239|NCT01660256|594211092|FG000|Overall Study|Withdrawal by Subject|1|||
164502240|NCT01660256|594211093|FG001|Overall Study|Withdrawal by Subject|0|||
164502241|NCT01660256|594211094|FG002|Overall Study|Withdrawal by Subject|2|||
164502242|NCT01646385|594211096|FG000|Overall Study|Death|202|||
164502243|NCT01646385|594211097|FG001|Overall Study|Death|222|||
164502244|NCT01646385|594211096|FG000|Overall Study|Switched to alternate biologic|636|||
164502245|NCT01646385|594211097|FG001|Overall Study|Switched to alternate biologic|649|||
164502246|NCT04599855|594211101|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
164502247|NCT04599855|594211102|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
164502248|NCT04599855|594211103|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
164502249|NCT04599855|594211101|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
164502250|NCT04599855|594211102|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
164502251|NCT04599855|594211103|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
164502252|NCT04599855|594211101|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
164502253|NCT04599855|594211102|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
164502254|NCT04599855|594211103|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
164502255|NCT04599855|594211101|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
164502256|NCT04599855|594211102|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
164502257|NCT04599855|594211103|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
164502258|NCT04599855|594211101|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
164502259|NCT04599855|594211102|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
164502260|NCT04599855|594211103|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
164502261|NCT04599855|594211101|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
164502262|NCT04599855|594211102|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
164502263|NCT04599855|594211103|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
164502264|NCT04599855|594211101|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
164502265|NCT04599855|594211102|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
164502266|NCT04599855|594211103|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
164502267|NCT04599855|594211101|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
164502268|NCT04599855|594211102|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
164502269|NCT04599855|594211103|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
164502270|NCT04599855|594211101|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
164502271|NCT04599855|594211102|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
164502272|NCT04599855|594211103|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
164502273|NCT04599855|594211101|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
164502274|NCT04599855|594211102|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
164502275|NCT04599855|594211103|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
164502276|NCT04599855|594211101|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
164502277|NCT04599855|594211102|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
164502278|NCT04599855|594211103|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
164502279|NCT04599855|594211101|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
164502280|NCT04599855|594211102|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
164502281|NCT04599855|594211103|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
164502282|NCT04599855|594211101|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
164502283|NCT04599855|594211102|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
164502284|NCT04599855|594211103|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
164502285|NCT04599855|594211101|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
164502286|NCT04599855|594211102|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
164502287|NCT04599855|594211103|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
164502288|NCT00858247|594211104|FG000|Baseline Assessment|Withdrawal by Subject|1|||
164502289|NCT00858247|594211105|FG001|Baseline Assessment|Withdrawal by Subject|1|||
164502290|NCT00858247|594211104|FG000|Baseline Assessment|Poor IV access|1|||
164502291|NCT00858247|594211105|FG001|Baseline Assessment|Poor IV access|0|||
164502292|NCT00858247|594211104|FG000|Baseline Assessment|Protocol Violation|0|||
164502293|NCT00858247|594211105|FG001|Baseline Assessment|Protocol Violation|1|||
164502294|NCT00858247|594211104|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
164502295|NCT00858247|594211105|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
164502296|NCT03414047|594211106|FG000|Overall Study|Adverse Event|0|||
164605700|NCT00168064|594577598|FG001|Overall Study|Lack of Efficacy|4|||
164605701|NCT00168064|594577597|FG000|Overall Study|Lost to Follow-up|4|||
164605702|NCT00168064|594577598|FG001|Overall Study|Lost to Follow-up|3|||
164605703|NCT00168064|594577597|FG000|Overall Study|Non-compliance|2|||
164605704|NCT00168064|594577598|FG001|Overall Study|Non-compliance|3|||
164605705|NCT00168064|594577597|FG000|Overall Study|Concurrent Illness|4|||
164605706|NCT00168064|594577598|FG001|Overall Study|Concurrent Illness|3|||
164605707|NCT00168064|594577597|FG000|Overall Study|Subject's Best interest|2|||
164605708|NCT00168064|594577598|FG001|Overall Study|Subject's Best interest|2|||
164605709|NCT00168064|594577597|FG000|Overall Study|Various|4|||
164605710|NCT00168064|594577598|FG001|Overall Study|Various|3|||
164605711|NCT01594333|594577599|FG000|Overall Study|Death|96|||
164605712|NCT01594333|594577600|FG001|Overall Study|Death|83|||
164605713|NCT01594333|594577599|FG000|Overall Study|Lost to Follow-up|5|||
164605714|NCT01594333|594577600|FG001|Overall Study|Lost to Follow-up|5|||
164605715|NCT01594333|594577599|FG000|Overall Study|Withdrawal by Subject|60|||
164605716|NCT01594333|594577600|FG001|Overall Study|Withdrawal by Subject|63|||
164605717|NCT00510068|594577606|FG000|Double-blind Period|Disease progression|98|||
164605718|NCT00510068|594577607|FG001|Double-blind Period|Disease progression|169|||
164605719|NCT00510068|594577606|FG000|Double-blind Period|Final primary analysis|52|||
164605720|NCT00510068|594577607|FG001|Double-blind Period|Final primary analysis|18|||
164605721|NCT00510068|594577606|FG000|Double-blind Period|Adverse Event|37|||
164605722|NCT00510068|594577607|FG001|Double-blind Period|Adverse Event|7|||
164605723|NCT00510068|594577606|FG000|Double-blind Period|Withdrawal by Subject|8|||
164716184|NCT05763576|594984269|FG008|Overall Study|Withdrawal by Subject|0|||
164716185|NCT06187909|594984270|FG000|Overall Study|Withdrawal by Subject|2|||
164716186|NCT06187909|594984271|FG001|Overall Study|Withdrawal by Subject|2|||
164716187|NCT04818671|594984277|FG000|Overall Study|Withdrawal by Subject|16|||
164716188|NCT04818671|594984277|FG000|Overall Study|Adverse Event|5|||
164716189|NCT04818671|594984277|FG000|Overall Study|Lack of Efficacy|5|||
164605724|NCT00510068|594577607|FG001|Double-blind Period|Withdrawal by Subject|6|||
164605725|NCT00510068|594577606|FG000|Double-blind Period|Death|4|||
164605726|NCT00510068|594577607|FG001|Double-blind Period|Death|3|||
164605727|NCT00510068|594577606|FG000|Double-blind Period|Abnormal test result (s)|1|||
164605728|NCT00510068|594577607|FG001|Double-blind Period|Abnormal test result (s)|0|||
164605729|NCT00510068|594577606|FG000|Double-blind Period|Lost to Follow-up|1|||
164605730|NCT00510068|594577607|FG001|Double-blind Period|Lost to Follow-up|0|||
164605731|NCT00510068|594577606|FG000|Double-blind Period|Protocol Violation|6|||
164605732|NCT00510068|594577607|FG001|Double-blind Period|Protocol Violation|0|||
164605733|NCT00510068|594577606|FG000|Open-label Period|Disease Progression|124|||
164605734|NCT00510068|594577607|FG001|Open-label Period|Disease Progression|0|||
164605735|NCT00510068|594577606|FG000|Open-label Period|Adverse Event|46|||
164605736|NCT00510068|594577607|FG001|Open-label Period|Adverse Event|0|||
164605737|NCT00510068|594577606|FG000|Open-label Period|Withdrawal by Subject|21|||
164605738|NCT00510068|594577607|FG001|Open-label Period|Withdrawal by Subject|0|||
164605739|NCT00510068|594577606|FG000|Open-label Period|Administrative problems|17|||
164605740|NCT00510068|594577607|FG001|Open-label Period|Administrative problems|0|||
164605741|NCT00510068|594577606|FG000|Open-label Period|Death|7|||
164605742|NCT00510068|594577607|FG001|Open-label Period|Death|0|||
164605743|NCT00510068|594577606|FG000|Open-label Period|New cancer therapy|7|||
164605744|NCT00510068|594577607|FG001|Open-label Period|New cancer therapy|0|||
164605745|NCT00510068|594577606|FG000|Open-label Period|Protocol Violation|2|||
164605746|NCT00510068|594577607|FG001|Open-label Period|Protocol Violation|0|||
164605747|NCT00510068|594577606|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
164605748|NCT00510068|594577607|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
164605749|NCT00776555|594577608|FG000|Overall Study|Study terminated|3|||
164605750|NCT00776555|594577609|FG001|Overall Study|Study terminated|0|||
164605751|NCT03483116|594577613|FG000|Overall Study|Adverse Event|0|||
164605752|NCT03483116|594577614|FG001|Overall Study|Adverse Event|1|||
164605753|NCT03483116|594577615|FG002|Overall Study|Adverse Event|0|||
164605754|NCT03483116|594577616|FG003|Overall Study|Adverse Event|1|||
164605755|NCT03483116|594577613|FG000|Overall Study|Protocol Violation|1|||
164605756|NCT03483116|594577614|FG001|Overall Study|Protocol Violation|0|||
164605757|NCT03483116|594577615|FG002|Overall Study|Protocol Violation|0|||
164605758|NCT03483116|594577616|FG003|Overall Study|Protocol Violation|7|||
164605759|NCT03483116|594577613|FG000|Overall Study|Lost to Follow-up|9|||
164605760|NCT03483116|594577614|FG001|Overall Study|Lost to Follow-up|4|||
164605761|NCT03483116|594577615|FG002|Overall Study|Lost to Follow-up|9|||
164605762|NCT03483116|594577616|FG003|Overall Study|Lost to Follow-up|5|||
164605763|NCT03483116|594577613|FG000|Overall Study|Death|1|||
164605764|NCT03483116|594577614|FG001|Overall Study|Death|0|||
164605765|NCT03483116|594577615|FG002|Overall Study|Death|2|||
164605766|NCT03483116|594577616|FG003|Overall Study|Death|1|||
164605767|NCT03483116|594577613|FG000|Overall Study|Withdrawal by Subject|14|||
164716190|NCT04818671|594984277|FG000|Overall Study|Death|4|||
164146139|NCT02439970|592896043|FG001|Overall Study|Study Terminated|3|||
164605768|NCT03483116|594577614|FG001|Overall Study|Withdrawal by Subject|16|||
164605769|NCT03483116|594577615|FG002|Overall Study|Withdrawal by Subject|14|||
164605770|NCT03483116|594577616|FG003|Overall Study|Withdrawal by Subject|16|||
164605771|NCT03483116|594577613|FG000|Overall Study|Unknown other reason|3|||
164605772|NCT03483116|594577614|FG001|Overall Study|Unknown other reason|2|||
164605773|NCT03483116|594577615|FG002|Overall Study|Unknown other reason|1|||
164716191|NCT04818671|594984277|FG000|Overall Study|Physician Decision|4|||
164716192|NCT04818671|594984277|FG000|Overall Study|Requires Prohibited Medication|4|||
164716193|NCT04818671|594984277|FG000|Overall Study|Lost to Follow-up|2|||
164716194|NCT04818671|594984277|FG000|Overall Study|Approved Drug Available for Indication|1|||
164605774|NCT03483116|594577616|FG003|Overall Study|Unknown other reason|1|||
164605775|NCT01181102|594577617|FG000|Overall Study|Adverse Event|28|||
164605776|NCT01181102|594577618|FG001|Overall Study|Adverse Event|26|||
164605777|NCT01181102|594577617|FG000|Overall Study|Lack of Efficacy|3|||
164605778|NCT01181102|594577618|FG001|Overall Study|Lack of Efficacy|1|||
164605779|NCT01181102|594577617|FG000|Overall Study|Lost to Follow-up|2|||
164605780|NCT01181102|594577618|FG001|Overall Study|Lost to Follow-up|0|||
164605781|NCT01181102|594577617|FG000|Overall Study|Physician Decision|3|||
164605782|NCT01181102|594577618|FG001|Overall Study|Physician Decision|1|||
164605783|NCT01181102|594577617|FG000|Overall Study|Protocol Violation|5|||
164605784|NCT01181102|594577618|FG001|Overall Study|Protocol Violation|6|||
164605785|NCT01181102|594577617|FG000|Overall Study|Withdrawal by Subject|10|||
164605786|NCT01181102|594577618|FG001|Overall Study|Withdrawal by Subject|12|||
164605787|NCT00239837|594577623|FG000|Overall Study|Lost to Follow-up|3|||
164605788|NCT00239837|594577624|FG001|Overall Study|Lost to Follow-up|7|||
164605789|NCT01838590|594577625|FG000|Overall Study|Lack of Efficacy|12|||
164605790|NCT01838590|594577626|FG001|Overall Study|Lack of Efficacy|4|||
164716195|NCT04818671|594984277|FG000|Overall Study|Sponsor Request|1|||
164716196|NCT04745676|594984278|FG000|Overall Study|Death|1|||
164716197|NCT04745676|594984279|FG001|Overall Study|Death|0|||
164716198|NCT04745676|594984280|FG002|Overall Study|Death|0|||
164716199|NCT04158648|594984285|FG000|Overall Study|Ongoing in the Study|69|||
164716200|NCT04158648|594984285|FG000|Overall Study|Withdrawal by Subject|4|||
164716201|NCT04625413|594984291|FG000|Overall Study|Hospice|2|||
164605791|NCT01838590|594577625|FG000|Overall Study|Lost to Follow-up|0|||
164605792|NCT01838590|594577626|FG001|Overall Study|Lost to Follow-up|1|||
164605793|NCT04685499|594577627|FG000|Overall Study|Study Terminated Early|1|||
164605794|NCT02802878|594577628|FG000|Overall Study|Withdrawal by Subject|3|||
164605795|NCT02802878|594577629|FG001|Overall Study|Withdrawal by Subject|3|||
164605796|NCT02802878|594577628|FG000|Overall Study|Protocol Violation|1|||
164605797|NCT02802878|594577629|FG001|Overall Study|Protocol Violation|0|||
164605798|NCT00101192|594577630|FG000|Overall Study|Ineligible|6|||
164605799|NCT00101192|594577630|FG000|Overall Study|Inevaluable|1|||
164605800|NCT00536978|594577631|FG000|Overall Study|Not eligible for Adback Infusion|22|||
164605801|NCT01232894|594577632|FG000|Overall Study|Lost to Follow-up|0|||
164605802|NCT01232894|594577633|FG001|Overall Study|Lost to Follow-up|1|||
164605803|NCT01232894|594577632|FG000|Overall Study|Death|1|||
164605804|NCT01232894|594577633|FG001|Overall Study|Death|0|||
164605805|NCT01232894|594577632|FG000|Overall Study|Protocol Violation|1|||
164605806|NCT01232894|594577633|FG001|Overall Study|Protocol Violation|1|||
164605807|NCT01232894|594577632|FG000|Overall Study|Withdrawal by Subject|8|||
164605808|NCT01232894|594577633|FG001|Overall Study|Withdrawal by Subject|5|||
164605809|NCT01232894|594577632|FG000|Overall Study|Physician Decision|2|||
164605810|NCT01232894|594577633|FG001|Overall Study|Physician Decision|1|||
164605811|NCT03970395|594577634|FG000|Overall Study|Withdrawal by Subject|3|||
164605812|NCT03970395|594577635|FG001|Overall Study|Withdrawal by Subject|4|||
164605813|NCT03970395|594577634|FG000|Overall Study|Lost to Follow-up|4|||
164605814|NCT03970395|594577635|FG001|Overall Study|Lost to Follow-up|8|||
164605815|NCT01996904|594577636|FG000|Overall Study|Lost to Follow-up|38|||
164605816|NCT01996904|594577637|FG001|Overall Study|Lost to Follow-up|27|||
164605817|NCT00929734|594577641|FG000|Overall Study|Lost to Follow-up|2|||
164605818|NCT00929734|594577642|FG001|Overall Study|Lost to Follow-up|1|||
164605819|NCT00929734|594577641|FG000|Overall Study|Withdrawal by Subject|0|||
164605820|NCT00929734|594577642|FG001|Overall Study|Withdrawal by Subject|2|||
164605821|NCT00980980|594577643|FG000|Overall Study|Withdrawal by Hospital|0|||
164605822|NCT00980980|594577644|FG001|Overall Study|Withdrawal by Hospital|1|||
164605823|NCT00980980|594577645|FG002|Overall Study|Withdrawal by Hospital|0|||
164605824|NCT00121992|594577646|FG000|Overall Study|Treatment not received|2|||
164605825|NCT00121992|594577647|FG001|Overall Study|Treatment not received|11|||
164605826|NCT04664855|594577648|FG000|Overall Study|Withdrawal by Subject|0|||
164605827|NCT04664855|594577649|FG001|Overall Study|Withdrawal by Subject|2|||
164605828|NCT03076190|594577650|FG000|Overall Study|Lost to Follow-up|9|||
164605829|NCT03076190|594577651|FG001|Overall Study|Lost to Follow-up|34|||
164605830|NCT03076190|594577650|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
164605831|NCT03076190|594577651|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
164605832|NCT01441115|594577652|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
164716202|NCT04625413|594984291|FG000|Overall Study|Distress|1|||
164716203|NCT04625413|594984291|FG000|Overall Study|Not feeling well|1|||
164605833|NCT01086150|594577658|FG000|Overall Study|Withdrawal by Subject|0|||
164605834|NCT01086150|594577659|FG001|Overall Study|Withdrawal by Subject|4|||
164605835|NCT01086150|594577660|FG002|Overall Study|Withdrawal by Subject|1|||
164605836|NCT01086150|594577658|FG000|Overall Study|Lost to Follow-up|0|||
164605837|NCT01086150|594577659|FG001|Overall Study|Lost to Follow-up|1|||
164716204|NCT02617563|594984292|FG000|4 Weeks|Withdrawal by Subject|2|||
164716205|NCT02617563|594984293|FG001|4 Weeks|Withdrawal by Subject|0|||
164716206|NCT02617563|594984292|FG000|3 Months|Lost to Follow-up|1|||
164716207|NCT02617563|594984293|FG001|3 Months|Lost to Follow-up|0|||
164605838|NCT01086150|594577660|FG002|Overall Study|Lost to Follow-up|0|||
164605839|NCT01086150|594577658|FG000|Overall Study|Screen Failure|0|||
164605840|NCT01086150|594577659|FG001|Overall Study|Screen Failure|1|||
164502297|NCT03414047|594211107|FG001|Overall Study|Adverse Event|0|||
164502298|NCT03414047|594211108|FG002|Overall Study|Adverse Event|1|||
164502299|NCT03414047|594211109|FG003|Overall Study|Adverse Event|1|||
164502300|NCT03414047|594211106|FG000|Overall Study|Physician Decision|1|||
164502301|NCT03414047|594211107|FG001|Overall Study|Physician Decision|0|||
164502302|NCT03414047|594211108|FG002|Overall Study|Physician Decision|0|||
164502303|NCT03414047|594211109|FG003|Overall Study|Physician Decision|1|||
164502304|NCT03414047|594211106|FG000|Overall Study|Withdrawal by Subject|1|||
164502305|NCT03414047|594211107|FG001|Overall Study|Withdrawal by Subject|0|||
164502306|NCT03414047|594211108|FG002|Overall Study|Withdrawal by Subject|2|||
164502307|NCT03414047|594211109|FG003|Overall Study|Withdrawal by Subject|0|||
164502308|NCT01898442|594211113|FG000|Overall Study|Hemolysis/technical problems|1|||
164502309|NCT01898442|594211114|FG001|Overall Study|Hemolysis/technical problems|2|||
164502310|NCT01898442|594211115|FG002|Overall Study|Hemolysis/technical problems|2|||
164502311|NCT01898442|594211113|FG000|Overall Study|Patient vomited pills|0|||
164502312|NCT01898442|594211114|FG001|Overall Study|Patient vomited pills|0|||
164502313|NCT01898442|594211115|FG002|Overall Study|Patient vomited pills|1|||
164502314|NCT01747837|594211117|FG000|Overall Study|Lost to Follow-up|5|||
164502315|NCT01747837|594211118|FG001|Overall Study|Lost to Follow-up|2|||
164502316|NCT01747837|594211117|FG000|Overall Study|Death|4|||
164502317|NCT01747837|594211118|FG001|Overall Study|Death|4|||
164502318|NCT01121913|594211120|FG000|First Intervention Period|Adverse Event|0|||
164502319|NCT01121913|594211121|FG001|First Intervention Period|Adverse Event|0|||
164502320|NCT01121913|594211122|FG002|First Intervention Period|Adverse Event|1|||
164502321|NCT01121913|594211123|FG003|First Intervention Period|Adverse Event|0|||
164502322|NCT01121913|594211120|FG000|First Washout Period|Withdrawal by Subject|1|||
164502323|NCT01121913|594211121|FG001|First Washout Period|Withdrawal by Subject|0|||
164502324|NCT01121913|594211122|FG002|First Washout Period|Withdrawal by Subject|0|||
164502325|NCT01121913|594211123|FG003|First Washout Period|Withdrawal by Subject|0|||
164502326|NCT01121913|594211120|FG000|Second Intervention Period|Adverse Event|0|||
164502327|NCT01121913|594211121|FG001|Second Intervention Period|Adverse Event|0|||
164502328|NCT01121913|594211122|FG002|Second Intervention Period|Adverse Event|1|||
164502329|NCT01121913|594211123|FG003|Second Intervention Period|Adverse Event|0|||
164502330|NCT01121913|594211120|FG000|Second Washout Period|Withdrawal by Subject|0|||
164502331|NCT01121913|594211121|FG001|Second Washout Period|Withdrawal by Subject|0|||
164502332|NCT01121913|594211122|FG002|Second Washout Period|Withdrawal by Subject|1|||
164502333|NCT01121913|594211123|FG003|Second Washout Period|Withdrawal by Subject|0|||
164502334|NCT01121913|594211120|FG000|Third Washout Period|Adverse Event|1|||
164502335|NCT01121913|594211121|FG001|Third Washout Period|Adverse Event|0|||
164502336|NCT01121913|594211122|FG002|Third Washout Period|Adverse Event|0|||
164502337|NCT01121913|594211123|FG003|Third Washout Period|Adverse Event|0|||
164502338|NCT03269695|594211130|FG000|Overall Study|Adverse Event|2|||
164502339|NCT03269695|594211131|FG001|Overall Study|Adverse Event|1|||
164502340|NCT03269695|594211130|FG000|Overall Study|Lack of Efficacy|0|||
164502341|NCT03269695|594211131|FG001|Overall Study|Lack of Efficacy|1|||
164502342|NCT03269695|594211130|FG000|Overall Study|Withdrawal by Subject|0|||
164502343|NCT03269695|594211131|FG001|Overall Study|Withdrawal by Subject|1|||
164502344|NCT01017263|594211132|FG000|Overall Study|not eligible|12|||
164502345|NCT05043883|594211133|FG000|Overall Study|Minimum required measurements could not be taken|4|||
164502346|NCT02447718|594211136|FG000|Overall Study|Lost to Follow-up|8|||
164502347|NCT02447718|594211137|FG001|Overall Study|Lost to Follow-up|0|||
164502348|NCT02447718|594211136|FG000|Overall Study|Withdrawal by Subject|3|||
164502349|NCT02447718|594211137|FG001|Overall Study|Withdrawal by Subject|0|||
164502350|NCT02447718|594211136|FG000|Overall Study|Screen Failure|1|||
164502351|NCT02447718|594211137|FG001|Overall Study|Screen Failure|0|||
164502352|NCT00239681|594211138|FG000|Overall Study|Adverse Event|100|||
164502353|NCT00239681|594211139|FG001|Overall Study|Adverse Event|99|||
164502354|NCT00239681|594211138|FG000|Overall Study|Withdrawal by Subject|458|||
164502355|NCT00239681|594211139|FG001|Overall Study|Withdrawal by Subject|489|||
164502356|NCT00239681|594211138|FG000|Overall Study|Lost to Follow-up|28|||
164502357|NCT00239681|594211139|FG001|Overall Study|Lost to Follow-up|22|||
164502358|NCT00239681|594211138|FG000|Overall Study|Protocol Violation|4|||
164502359|NCT00239681|594211139|FG001|Overall Study|Protocol Violation|4|||
164502360|NCT00239681|594211138|FG000|Overall Study|Physician Decision|13|||
164502361|NCT00239681|594211139|FG001|Overall Study|Physician Decision|17|||
164502362|NCT00239681|594211138|FG000|Overall Study|No information chacked on CaseReportForm|90|||
164502363|NCT00239681|594211139|FG001|Overall Study|No information chacked on CaseReportForm|84|||
164502364|NCT03599622|594211140|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
164502365|NCT03599622|594211141|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
164502366|NCT03599622|594211142|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
164502367|NCT03599622|594211143|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
164502368|NCT03599622|594211140|FG000|Pre-Treatment Period|Other reasons|1|||
164502369|NCT03599622|594211141|FG001|Pre-Treatment Period|Other reasons|1|||
164502370|NCT03599622|594211142|FG002|Pre-Treatment Period|Other reasons|1|||
164502371|NCT03599622|594211143|FG003|Pre-Treatment Period|Other reasons|0|||
164502372|NCT03599622|594211140|FG000|Treatment Period|Adverse Event|11|||
164605841|NCT01086150|594577660|FG002|Overall Study|Screen Failure|0|||
164605842|NCT00178464|594577662|FG000|Overall Study|Withdrawal by Subject|1|||
164605843|NCT00178464|594577662|FG000|Overall Study|Physician Decision|1|||
164605844|NCT01890512|594577663|FG000|Overall Study|Physician Decision|1|||
164605845|NCT01890512|594577663|FG000|Overall Study|Withdrawal by Subject|1|||
164605846|NCT01890512|594577663|FG000|Overall Study|Protocol Violation|1|||
164605847|NCT03543358|594577664|FG000|Overall Study|Death|1|||
164605848|NCT03543358|594577665|FG001|Overall Study|Death|0|||
164605849|NCT03543358|594577664|FG000|Overall Study|Disease Progression|1|||
164605850|NCT03543358|594577665|FG001|Overall Study|Disease Progression|0|||
164605851|NCT03543358|594577664|FG000|Overall Study|Parent Study Closure|1|||
164605852|NCT03543358|594577665|FG001|Overall Study|Parent Study Closure|0|||
164605853|NCT01401465|594577666|FG000|Treatment Period 1|Adverse Event|4|||
164605854|NCT01401465|594577667|FG001|Treatment Period 1|Adverse Event|1|||
164605855|NCT01401465|594577666|FG000|Treatment Period 1|Pregnancy|0|||
164605856|NCT01401465|594577667|FG001|Treatment Period 1|Pregnancy|1|||
164605857|NCT01401465|594577666|FG000|Treatment Period 1|Protocol Violation|5|||
164605858|NCT01401465|594577667|FG001|Treatment Period 1|Protocol Violation|0|||
164605859|NCT01401465|594577666|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164605860|NCT01401465|594577667|FG001|Treatment Period 1|Withdrawal by Subject|4|||
164605861|NCT01401465|594577666|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
164605862|NCT01401465|594577667|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
164605863|NCT01401465|594577666|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
164605864|NCT01401465|594577667|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
164605865|NCT01401465|594577666|FG000|Treatment Period 1|Scheduling Difficulties|1|||
164605866|NCT01401465|594577667|FG001|Treatment Period 1|Scheduling Difficulties|1|||
164605867|NCT01401465|594577666|FG000|Treatment Period 2|Lost to Follow-up|0|||
164605868|NCT01401465|594577667|FG001|Treatment Period 2|Lost to Follow-up|1|||
164605869|NCT01401465|594577666|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164605870|NCT01401465|594577667|FG001|Treatment Period 2|Withdrawal by Subject|1|||
164605871|NCT00643604|594577669|FG000|Overall Study|Death|1|||
164605872|NCT02702011|594577672|FG000|Overall Study|Withdrawal by Subject|0|||
164605873|NCT02702011|594577673|FG001|Overall Study|Withdrawal by Subject|1|||
164605874|NCT02702011|594577674|FG002|Overall Study|Withdrawal by Subject|0|||
164605875|NCT02702011|594577675|FG003|Overall Study|Withdrawal by Subject|0|||
164605876|NCT02721251|594577677|FG000|Overall Study|Withdrawal by Subject|8|||
164605877|NCT02721251|594577678|FG001|Overall Study|Withdrawal by Subject|7|||
164605878|NCT02721251|594577679|FG002|Overall Study|Withdrawal by Subject|9|||
164605879|NCT02721251|594577677|FG000|Overall Study|poor adherence|2|||
164605880|NCT02721251|594577678|FG001|Overall Study|poor adherence|2|||
164605881|NCT02721251|594577679|FG002|Overall Study|poor adherence|2|||
164605882|NCT02921763|594577680|FG000|Overall Study|Adverse Event|4|||
164605883|NCT02921763|594577680|FG000|Overall Study|Lost to Follow-up|4|||
164605884|NCT02921763|594577680|FG000|Overall Study|Lack of Efficacy|3|||
164605885|NCT02921763|594577680|FG000|Overall Study|Protocol Violation|2|||
164605886|NCT02921763|594577680|FG000|Overall Study|Withdrawal by Subject|2|||
164605887|NCT02921763|594577680|FG000|Overall Study|Physician Decision|1|||
164605888|NCT02921763|594577680|FG000|Overall Study|No data obtained|2|||
164605889|NCT01582971|594577683|FG000|Overall Study|Death|2|||
164605890|NCT01582971|594577684|FG001|Overall Study|Death|1|||
164605891|NCT01582971|594577683|FG000|Overall Study|Lost to Follow-up|18|||
164605892|NCT01582971|594577684|FG001|Overall Study|Lost to Follow-up|21|||
164605893|NCT01582971|594577683|FG000|Overall Study|Withdrawal by Subject|4|||
164605894|NCT01582971|594577684|FG001|Overall Study|Withdrawal by Subject|2|||
164605895|NCT01582971|594577683|FG000|Overall Study|Other|15|||
164605896|NCT01582971|594577684|FG001|Overall Study|Other|13|||
164605897|NCT02394795|594577685|FG000|Overall Study|Adverse Event|92|||
164605898|NCT02394795|594577686|FG001|Overall Study|Adverse Event|70|||
164605899|NCT02394795|594577685|FG000|Overall Study|Lost to Follow-up|0|||
164605900|NCT02394795|594577686|FG001|Overall Study|Lost to Follow-up|1|||
164605901|NCT02394795|594577685|FG000|Overall Study|Withdrawal by Subject|17|||
164605902|NCT02394795|594577686|FG001|Overall Study|Withdrawal by Subject|26|||
164605903|NCT02394795|594577685|FG000|Overall Study|Lack of Efficacy|181|||
164605904|NCT02394795|594577686|FG001|Overall Study|Lack of Efficacy|211|||
164605905|NCT02394795|594577685|FG000|Overall Study|Death|4|||
164605906|NCT02394795|594577686|FG001|Overall Study|Death|5|||
164605907|NCT02394795|594577685|FG000|Overall Study|Physician Decision|109|||
164605908|NCT02394795|594577686|FG001|Overall Study|Physician Decision|93|||
164605909|NCT06025396|594579217|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
164605910|NCT06025396|594579218|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
164605911|NCT06025396|594579219|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
164605912|NCT06025396|594579220|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
164605913|NCT06025396|594579221|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
164605914|NCT06025396|594579217|FG000|Overall Study|Withdrawal by Subject|0|||
164605915|NCT06025396|594579218|FG001|Overall Study|Withdrawal by Subject|1|||
164605916|NCT06025396|594579219|FG002|Overall Study|Withdrawal by Subject|1|||
164605917|NCT06025396|594579220|FG003|Overall Study|Withdrawal by Subject|0|||
164605918|NCT06025396|594579221|FG004|Overall Study|Withdrawal by Subject|0|||
164605919|NCT06422377|594579222|FG000|Overall Study|Study Terminated by Sponsor|1|||
164605920|NCT00453180|594579223|FG000|Overall Study|Lost to Follow-up|2|||
164605921|NCT00453180|594579224|FG001|Overall Study|Lost to Follow-up|1|||
164605922|NCT00453180|594579223|FG000|Overall Study|Adverse Event|1|||
164605923|NCT00453180|594579224|FG001|Overall Study|Adverse Event|2|||
164605924|NCT03326869|594579226|FG000|Overall Study|Study data has been lost to natural disa|1|||
164605925|NCT03326869|594579227|FG001|Overall Study|Study data has been lost to natural disa|1|||
164605926|NCT01002742|594579230|FG000|Overall Study|Determined to be ineligible|0|||
164605927|NCT01002742|594579231|FG001|Overall Study|Determined to be ineligible|1|||
164605928|NCT00562640|594579232|FG000|Overall Study|Death|0|||
164605929|NCT00562640|594579233|FG001|Overall Study|Death|1|||
164605930|NCT00562640|594579234|FG002|Overall Study|Death|1|||
164605931|NCT00562640|594579235|FG003|Overall Study|Death|0|||
164605932|NCT05263921|594579236|FG000|Overall Study|Other: family emergency.|0|||
164605933|NCT05263921|594579237|FG001|Overall Study|Other: family emergency.|0|||
164605934|NCT05263921|594579238|FG002|Overall Study|Other: family emergency.|1|||
164605935|NCT05263921|594579239|FG003|Overall Study|Other: family emergency.|0|||
164605936|NCT01297309|594579242|FG000|Overall Study|Eligibility failure|2|||
164605937|NCT01297309|594579242|FG000|Overall Study|Screen failure|2|||
164605938|NCT01297309|594579242|FG000|Overall Study|Withdrawal by Subject|5|||
164605939|NCT01297309|594579242|FG000|Overall Study|Adverse Event|1|||
164605940|NCT01297309|594579242|FG000|Overall Study|Investigator Decision|2|||
164605941|NCT01297309|594579242|FG000|Overall Study|Death|1|||
164605942|NCT01297309|594579242|FG000|Overall Study|Participant not entering extensionperiod|1|||
164605943|NCT02591238|594579243|FG000|Overall Study|Pregnancy|1|||
164605944|NCT02591238|594579244|FG001|Overall Study|Pregnancy|0|||
164605945|NCT02591238|594579245|FG002|Overall Study|Pregnancy|0|||
164605946|NCT02591238|594579246|FG003|Overall Study|Pregnancy|0|||
164605947|NCT02591238|594579243|FG000|Overall Study|Withdrawal by Subject|0|||
164605948|NCT02591238|594579244|FG001|Overall Study|Withdrawal by Subject|0|||
164605949|NCT02591238|594579245|FG002|Overall Study|Withdrawal by Subject|0|||
164605950|NCT02591238|594579246|FG003|Overall Study|Withdrawal by Subject|1|||
164605951|NCT02591238|594579243|FG000|Overall Study|influenza|0|||
164605952|NCT02591238|594579244|FG001|Overall Study|influenza|0|||
164605953|NCT02591238|594579245|FG002|Overall Study|influenza|0|||
164605954|NCT02591238|594579246|FG003|Overall Study|influenza|1|||
164605955|NCT02591238|594579243|FG000|Overall Study|personal circumstances|0|||
164605956|NCT02591238|594579244|FG001|Overall Study|personal circumstances|0|||
164605957|NCT02591238|594579245|FG002|Overall Study|personal circumstances|0|||
164605958|NCT02591238|594579246|FG003|Overall Study|personal circumstances|1|||
164605959|NCT02591238|594579243|FG000|Overall Study|personal circumstances|0|||
164605960|NCT02591238|594579244|FG001|Overall Study|personal circumstances|1|||
164605961|NCT02591238|594579245|FG002|Overall Study|personal circumstances|0|||
164605962|NCT02591238|594579246|FG003|Overall Study|personal circumstances|0|||
164605963|NCT00640146|594579249|FG000|Overall Study|Adverse Event|2|||
164605964|NCT00640146|594579250|FG001|Overall Study|Adverse Event|0|||
164605965|NCT00640146|594579249|FG000|Overall Study|Lost to Follow-up|0|||
164605966|NCT00640146|594579250|FG001|Overall Study|Lost to Follow-up|1|||
164605967|NCT00640146|594579249|FG000|Overall Study|Lack of Efficacy|0|||
164605968|NCT00640146|594579250|FG001|Overall Study|Lack of Efficacy|1|||
164605969|NCT00640146|594579249|FG000|Overall Study|Withdrawal by Subject|1|||
164605970|NCT00640146|594579250|FG001|Overall Study|Withdrawal by Subject|1|||
164605971|NCT00640146|594579249|FG000|Overall Study|Randomized but not treated|1|||
164605972|NCT00640146|594579250|FG001|Overall Study|Randomized but not treated|3|||
164605973|NCT00525785|594579251|FG000|Overall Study|Withdrawal by Subject|1|||
164605974|NCT00525785|594579251|FG000|Overall Study|Lack of Efficacy|1|||
164605975|NCT00525785|594579251|FG000|Overall Study|Physician Decision|1|||
164605976|NCT01204697|594579255|FG000|Overall Study|Death|26|||
164605977|NCT01204697|594579256|FG001|Overall Study|Death|27|||
164605978|NCT01204697|594579255|FG000|Overall Study|Lost to Follow-up|3|||
164716208|NCT02617563|594984292|FG000|3 Months|Withdrawal by Subject|0|||
164605979|NCT01204697|594579256|FG001|Overall Study|Lost to Follow-up|4|||
164605980|NCT01204697|594579255|FG000|Overall Study|Withdrawal by Subject|2|||
164605981|NCT01204697|594579256|FG001|Overall Study|Withdrawal by Subject|4|||
164605982|NCT01204697|594579255|FG000|Overall Study|Randomized, but not treated|0|||
164605983|NCT01204697|594579256|FG001|Overall Study|Randomized, but not treated|1|||
164605984|NCT02119026|594579257|FG000|1st-line Treatment|Adverse Event|9|||
164605985|NCT02119026|594579258|FG001|1st-line Treatment|Adverse Event|14|||
164605986|NCT02119026|594579257|FG000|1st-line Treatment|Physician Decision|3|||
164605987|NCT02119026|594579258|FG001|1st-line Treatment|Physician Decision|8|||
164605988|NCT02119026|594579257|FG000|1st-line Treatment|Withdrawal by Subject|4|||
164605989|NCT02119026|594579258|FG001|1st-line Treatment|Withdrawal by Subject|10|||
164605990|NCT02119026|594579257|FG000|1st-line Treatment|Patient condition or compliance|6|||
164605991|NCT02119026|594579258|FG001|1st-line Treatment|Patient condition or compliance|4|||
164605992|NCT02119026|594579257|FG000|1st-line Treatment|Surgery of metastases|2|||
164605993|NCT02119026|594579258|FG001|1st-line Treatment|Surgery of metastases|1|||
164605994|NCT02119026|594579257|FG000|1st-line Treatment|Death|2|||
164605995|NCT02119026|594579258|FG001|1st-line Treatment|Death|1|||
164605996|NCT02119026|594579257|FG000|2nd-line Treatment|Lost to Follow-up|2|||
164605997|NCT02119026|594579258|FG001|2nd-line Treatment|Lost to Follow-up|0|||
164605998|NCT02119026|594579257|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
164605999|NCT02119026|594579258|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
164606000|NCT02119026|594579257|FG000|2nd-line Treatment|Adverse Event|4|||
164606001|NCT02119026|594579258|FG001|2nd-line Treatment|Adverse Event|1|||
164606002|NCT01143714|594579261|FG000|Overall Study|Adverse Event|4|||
164606003|NCT01143714|594579262|FG001|Overall Study|Adverse Event|2|||
164606004|NCT01143714|594579261|FG000|Overall Study|Withdrawal by Subject|1|||
164606005|NCT01143714|594579262|FG001|Overall Study|Withdrawal by Subject|0|||
164606006|NCT01143714|594579261|FG000|Overall Study|Subject non-compliance|0|||
164606007|NCT01143714|594579262|FG001|Overall Study|Subject non-compliance|1|||
164606008|NCT01143714|594579261|FG000|Overall Study|wound closed = deemed healed|1|||
164606009|NCT01143714|594579262|FG001|Overall Study|wound closed = deemed healed|0|||
164606010|NCT01143714|594579261|FG000|Overall Study|wound size increased|1|||
164606011|NCT01143714|594579262|FG001|Overall Study|wound size increased|0|||
164606012|NCT03939637|594579266|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
164606013|NCT03939637|594579267|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
164606014|NCT03939637|594579266|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
164606015|NCT03939637|594579267|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
164606016|NCT03783442|594579268|FG000|Overall Study|Death|252|||
164606017|NCT03783442|594579269|FG001|Overall Study|Death|268|||
164606018|NCT03783442|594579268|FG000|Overall Study|Withdrawal by Subject|19|||
164606019|NCT03783442|594579269|FG001|Overall Study|Withdrawal by Subject|21|||
164606020|NCT03783442|594579268|FG000|Overall Study|Lost to Follow-up|7|||
164606021|NCT03783442|594579269|FG001|Overall Study|Lost to Follow-up|6|||
164606022|NCT03783442|594579268|FG000|Overall Study|Sponsor Ended Study|48|||
164606023|NCT03783442|594579269|FG001|Overall Study|Sponsor Ended Study|28|||
164606024|NCT04190186|594579270|FG000|Overall Study|ILR is no longer functioning|0|||
164606025|NCT04190186|594579271|FG001|Overall Study|ILR is no longer functioning|1|||
164606026|NCT04190186|594579270|FG000|Overall Study|Lost to Follow-up|0|||
164606027|NCT04190186|594579271|FG001|Overall Study|Lost to Follow-up|1|||
164606028|NCT04190186|594579270|FG000|Overall Study|Withdrawal by Subject|2|||
164606029|NCT04190186|594579271|FG001|Overall Study|Withdrawal by Subject|0|||
164606030|NCT04190186|594579270|FG000|Overall Study|Subject choice to explant|1|||
164606031|NCT04190186|594579271|FG001|Overall Study|Subject choice to explant|0|||
164606032|NCT04190186|594579270|FG000|Overall Study|Physician Decision|0|||
164606033|NCT04190186|594579271|FG001|Overall Study|Physician Decision|1|||
164606034|NCT04190186|594579270|FG000|Overall Study|Study was stopped|4|||
164606035|NCT04190186|594579271|FG001|Overall Study|Study was stopped|5|||
164606036|NCT01381718|594579272|FG000|Overall Study|Withdrawal by Subject|2|||
164606037|NCT01381718|594579273|FG001|Overall Study|Withdrawal by Subject|5|||
164606038|NCT01381718|594579272|FG000|Overall Study|Lost to Follow-up|3|||
164606039|NCT01381718|594579273|FG001|Overall Study|Lost to Follow-up|5|||
164606040|NCT01381718|594579272|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
164606041|NCT01381718|594579273|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
164606042|NCT03017846|594579276|FG000|Overall Study|Lost to Follow-up|3|||
164606043|NCT03017846|594579276|FG000|Overall Study|Adverse Event|2|||
164606044|NCT02505542|594579277|FG000|Part A: Open-Label Period|Adverse Event|31|||
164606045|NCT02505542|594579278|FG001|Part A: Open-Label Period|Adverse Event|0|||
164606046|NCT02505542|594579279|FG002|Part A: Open-Label Period|Adverse Event|0|||
164606047|NCT02505542|594579280|FG003|Part A: Open-Label Period|Adverse Event|0|||
164606048|NCT02505542|594579277|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
164606049|NCT02505542|594579278|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
164606050|NCT02505542|594579279|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
164716209|NCT02617563|594984293|FG001|3 Months|Withdrawal by Subject|1|||
164716210|NCT02617563|594984292|FG000|1 Year|Lost to Follow-up|1|||
164716211|NCT02617563|594984293|FG001|1 Year|Lost to Follow-up|2|||
164606051|NCT02505542|594579280|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
164606052|NCT02505542|594579277|FG000|Part A: Open-Label Period|Protocol Violation|1|||
164606053|NCT02505542|594579278|FG001|Part A: Open-Label Period|Protocol Violation|0|||
164606054|NCT02505542|594579279|FG002|Part A: Open-Label Period|Protocol Violation|0|||
164606055|NCT02505542|594579280|FG003|Part A: Open-Label Period|Protocol Violation|0|||
164606056|NCT02505542|594579277|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
164606057|NCT02505542|594579278|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
164606058|NCT02505542|594579279|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
164606059|NCT02505542|594579280|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
164606060|NCT02505542|594579277|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
164716212|NCT02617563|594984292|FG000|2 Year|Death|1|||
164606061|NCT02505542|594579278|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
164606062|NCT02505542|594579279|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
164606063|NCT02505542|594579280|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
164606064|NCT02505542|594579277|FG000|Part A: Open-Label Period|New medical history available|1|||
164606065|NCT02505542|594579278|FG001|Part A: Open-Label Period|New medical history available|0|||
164606066|NCT02505542|594579279|FG002|Part A: Open-Label Period|New medical history available|0|||
164606067|NCT02505542|594579280|FG003|Part A: Open-Label Period|New medical history available|0|||
164606068|NCT02505542|594579277|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
164606069|NCT02505542|594579278|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
164606070|NCT02505542|594579279|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
164606071|NCT02505542|594579280|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
164606072|NCT02505542|594579277|FG000|Part A: Open-Label Period|Pregnancy|2|||
164606073|NCT02505542|594579278|FG001|Part A: Open-Label Period|Pregnancy|0|||
164606074|NCT02505542|594579279|FG002|Part A: Open-Label Period|Pregnancy|0|||
164606075|NCT02505542|594579280|FG003|Part A: Open-Label Period|Pregnancy|0|||
164606076|NCT02505542|594579277|FG000|Part A: Open-Label Period|Sponsor directive|1|||
164606077|NCT02505542|594579278|FG001|Part A: Open-Label Period|Sponsor directive|0|||
164606078|NCT02505542|594579279|FG002|Part A: Open-Label Period|Sponsor directive|0|||
164606079|NCT02505542|594579280|FG003|Part A: Open-Label Period|Sponsor directive|0|||
164606080|NCT02505542|594579277|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
164606081|NCT02505542|594579278|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
164606082|NCT02505542|594579279|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
164606083|NCT02505542|594579280|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
164606084|NCT02505542|594579277|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
164606085|NCT02505542|594579278|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
164606086|NCT02505542|594579279|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
164606087|NCT02505542|594579280|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
164606088|NCT02505542|594579277|FG000|Part A: Open-Label Period|Non-compliance|1|||
164606089|NCT02505542|594579278|FG001|Part A: Open-Label Period|Non-compliance|0|||
164606090|NCT02505542|594579279|FG002|Part A: Open-Label Period|Non-compliance|0|||
164606091|NCT02505542|594579280|FG003|Part A: Open-Label Period|Non-compliance|0|||
164606092|NCT02505542|594579277|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
164606093|NCT02505542|594579278|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
164606094|NCT02505542|594579279|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
164606095|NCT02505542|594579280|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
164606096|NCT02505542|594579277|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
164606097|NCT02505542|594579278|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
164606098|NCT02505542|594579279|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
164606099|NCT02505542|594579280|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
164606100|NCT02505542|594579277|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
164606101|NCT02505542|594579278|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
164606102|NCT02505542|594579279|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
164606103|NCT02505542|594579280|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
164606104|NCT02505542|594579277|FG000|Part B: Double-Blind Period|Adverse Event|0|||
164606105|NCT02505542|594579278|FG001|Part B: Double-Blind Period|Adverse Event|0|||
164606106|NCT02505542|594579279|FG002|Part B: Double-Blind Period|Adverse Event|1|||
164606107|NCT02505542|594579280|FG003|Part B: Double-Blind Period|Adverse Event|3|||
164606108|NCT02505542|594579277|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
164606109|NCT02505542|594579278|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
164606110|NCT02505542|594579279|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
164606111|NCT02505542|594579280|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
164606112|NCT02505542|594579277|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
164606113|NCT02505542|594579278|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
164606114|NCT02505542|594579279|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
164606115|NCT02505542|594579280|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
164606116|NCT02505542|594579277|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
164606117|NCT02505542|594579278|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
164606118|NCT02505542|594579279|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
164606119|NCT02505542|594579280|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
164606120|NCT02505542|594579277|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
164606121|NCT02505542|594579278|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
164606122|NCT02505542|594579279|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
164606123|NCT02505542|594579280|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
164606124|NCT02505542|594579277|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
164606125|NCT02505542|594579278|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
164606126|NCT02505542|594579279|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
164716213|NCT02617563|594984293|FG001|2 Year|Death|0|||
164716214|NCT02617563|594984292|FG000|2 Year|Lost to Follow-up|2|||
164716215|NCT02617563|594984293|FG001|2 Year|Lost to Follow-up|1|||
164716216|NCT02617563|594984292|FG000|2 Year|Withdrawal by Subject|0|||
164502373|NCT03599622|594211141|FG001|Treatment Period|Adverse Event|20|||
164502374|NCT03599622|594211142|FG002|Treatment Period|Adverse Event|18|||
164502375|NCT03599622|594211143|FG003|Treatment Period|Adverse Event|2|||
164502376|NCT03599622|594211140|FG000|Treatment Period|Lack of Efficacy|18|||
164502377|NCT03599622|594211141|FG001|Treatment Period|Lack of Efficacy|12|||
164502378|NCT03599622|594211142|FG002|Treatment Period|Lack of Efficacy|13|||
164502379|NCT03599622|594211143|FG003|Treatment Period|Lack of Efficacy|2|||
164502380|NCT03599622|594211140|FG000|Treatment Period|Withdrawal by Subject|5|||
164502381|NCT03599622|594211141|FG001|Treatment Period|Withdrawal by Subject|11|||
164502382|NCT03599622|594211142|FG002|Treatment Period|Withdrawal by Subject|16|||
164502383|NCT03599622|594211143|FG003|Treatment Period|Withdrawal by Subject|1|||
164502384|NCT03599622|594211140|FG000|Treatment Period|Other reasons|4|||
164502385|NCT03599622|594211141|FG001|Treatment Period|Other reasons|6|||
164502386|NCT03599622|594211142|FG002|Treatment Period|Other reasons|7|||
164502387|NCT03599622|594211143|FG003|Treatment Period|Other reasons|0|||
164502388|NCT03599622|594211140|FG000|Treatment Period|Lost to Follow-up|1|||
164502389|NCT03599622|594211141|FG001|Treatment Period|Lost to Follow-up|0|||
164502390|NCT03599622|594211142|FG002|Treatment Period|Lost to Follow-up|0|||
164502391|NCT03599622|594211143|FG003|Treatment Period|Lost to Follow-up|0|||
164502392|NCT03599622|594211140|FG000|Treatment Period|Study terminated by sponsor|7|||
164502393|NCT03599622|594211141|FG001|Treatment Period|Study terminated by sponsor|20|||
164502394|NCT03599622|594211142|FG002|Treatment Period|Study terminated by sponsor|15|||
164502395|NCT03599622|594211143|FG003|Treatment Period|Study terminated by sponsor|0|||
164502396|NCT03599622|594211140|FG000|Treatment Period|Site terminated by sponsor|0|||
164502397|NCT03599622|594211141|FG001|Treatment Period|Site terminated by sponsor|1|||
164502398|NCT03599622|594211142|FG002|Treatment Period|Site terminated by sponsor|0|||
164502399|NCT03599622|594211143|FG003|Treatment Period|Site terminated by sponsor|0|||
164502400|NCT00905359|594211148|FG000|Overall Study|Lost to Follow-up|17|||
164502401|NCT00905359|594211149|FG001|Overall Study|Lost to Follow-up|10|||
164502402|NCT00905359|594211148|FG000|Overall Study|Death|2|||
164502403|NCT00905359|594211149|FG001|Overall Study|Death|0|||
164502404|NCT00905359|594211148|FG000|Overall Study|Withdrawal consent|5|||
164502405|NCT00905359|594211149|FG001|Overall Study|Withdrawal consent|6|||
164502406|NCT00468130|594211150|FG000|Overall Study|Adverse Event|2|||
164502407|NCT00468130|594211151|FG001|Overall Study|Adverse Event|1|||
164502408|NCT00468130|594211150|FG000|Overall Study|Withdrawal by Subject|0|||
164502409|NCT00468130|594211151|FG001|Overall Study|Withdrawal by Subject|1|||
164502410|NCT03713320|594211152|FG000|Randomized Period|Adverse Event|1|||
164502411|NCT03713320|594211153|FG001|Randomized Period|Adverse Event|5|||
164502412|NCT03713320|594211154|FG002|Randomized Period|Adverse Event|0|||
164502413|NCT03713320|594211152|FG000|Randomized Period|Physician Decision|1|||
164502414|NCT03713320|594211153|FG001|Randomized Period|Physician Decision|1|||
164502415|NCT03713320|594211154|FG002|Randomized Period|Physician Decision|0|||
164502416|NCT03713320|594211152|FG000|Randomized Period|Withdrawal by Subject|4|||
164502417|NCT03713320|594211153|FG001|Randomized Period|Withdrawal by Subject|0|||
164502418|NCT03713320|594211154|FG002|Randomized Period|Withdrawal by Subject|0|||
164502419|NCT03713320|594211152|FG000|Randomized Period|Participant decision|3|||
164502420|NCT03713320|594211153|FG001|Randomized Period|Participant decision|1|||
164502421|NCT03713320|594211154|FG002|Randomized Period|Participant decision|0|||
164502422|NCT03713320|594211152|FG000|Randomized Period|Study terminated by sponsor|6|||
164502423|NCT03713320|594211153|FG001|Randomized Period|Study terminated by sponsor|3|||
164502424|NCT03713320|594211154|FG002|Randomized Period|Study terminated by sponsor|0|||
164502425|NCT03713320|594211152|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
164502426|NCT03713320|594211153|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
164502427|NCT03713320|594211154|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
164502428|NCT03713320|594211152|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
164502429|NCT03713320|594211153|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
164502430|NCT03713320|594211154|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
164502431|NCT02725528|594211155|FG000|Overall Study|Lost to Follow-up|1|||
164716217|NCT02617563|594984293|FG001|2 Year|Withdrawal by Subject|4|||
164716218|NCT02617563|594984292|FG000|3 Year|Death|2|||
164716219|NCT02617563|594984293|FG001|3 Year|Death|1|||
164716220|NCT02617563|594984292|FG000|3 Year|Lost to Follow-up|1|||
164502432|NCT02725528|594211156|FG001|Overall Study|Lost to Follow-up|4|||
164502433|NCT02725528|594211155|FG000|Overall Study|Withdrawal by Subject|0|||
164502434|NCT02725528|594211156|FG001|Overall Study|Withdrawal by Subject|1|||
164502435|NCT02706847|594211157|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
164502436|NCT02706847|594211158|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
164502437|NCT02706847|594211159|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
164502438|NCT02706847|594211160|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
164502439|NCT02706847|594211157|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
164502440|NCT02706847|594211158|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
164502441|NCT02706847|594211159|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
164606127|NCT02505542|594579280|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
164606128|NCT02505542|594579277|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
164606129|NCT02505542|594579278|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
164606130|NCT02505542|594579279|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
164606131|NCT02505542|594579280|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
164606132|NCT02505542|594579277|FG000|Part B: Double-Blind Period|Miscalculation|0|||
164606133|NCT02505542|594579278|FG001|Part B: Double-Blind Period|Miscalculation|1|||
164606134|NCT02505542|594579279|FG002|Part B: Double-Blind Period|Miscalculation|0|||
164606135|NCT02505542|594579280|FG003|Part B: Double-Blind Period|Miscalculation|0|||
164606136|NCT02505542|594579277|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
164606137|NCT02505542|594579278|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
164606138|NCT02505542|594579279|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
164606139|NCT02505542|594579280|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
164606140|NCT00992186|594579283|FG000|Overall Study|Withdrawal by Subject|2|||
164606141|NCT00992186|594579283|FG000|Overall Study|Protocol Violation|1|||
164606142|NCT00992186|594579283|FG000|Overall Study|Physician Decision|1|||
164606143|NCT00992186|594579283|FG000|Overall Study|Adverse Event|9|||
164606144|NCT00992186|594579283|FG000|Overall Study|Progressive Disease|30|||
164606145|NCT00992186|594579283|FG000|Overall Study|Refusal To Receive Study Agent|3|||
164606146|NCT00830804|594579289|FG000|Overall Study|Lost to Follow-up|4|||
164606147|NCT00830804|594579289|FG000|Overall Study|Death|1|||
164606148|NCT00830804|594579289|FG000|Overall Study|Unable to get to clinic|7|||
164606149|NCT00830804|594579289|FG000|Overall Study|Consent withdrawn|2|||
164606150|NCT00830804|594579289|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
164606151|NCT01438307|594579290|FG000|Overall Study|Death|1|||
164606152|NCT01438307|594579291|FG001|Overall Study|Death|1|||
164606153|NCT02378883|594579292|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
164606154|NCT02378883|594579292|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
164606155|NCT02378883|594579292|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
164606156|NCT02378883|594579292|FG000|30 Day Follow-Up|Physician Decision|2|||
164606157|NCT02378883|594579292|FG000|30 Day Follow-Up|Missed Visit|2|||
164606158|NCT02378883|594579292|FG000|30 Day Follow-Up|Death|1|||
164606159|NCT02378883|594579292|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
164606160|NCT02378883|594579292|FG000|12 Months Follow-Up|Death|2|||
164606161|NCT00318565|594579293|FG000|Overall Study|Excluded per protocol|24|||
164606162|NCT01588353|594579294|FG000|Step2|Withdrawal by Subject|0|||
164606163|NCT01588353|594579295|FG001|Step2|Withdrawal by Subject|1|||
164606164|NCT01588353|594579296|FG002|Step2|Withdrawal by Subject|0|||
164606165|NCT01588353|594579294|FG000|Step3|Adverse Event|0|||
164606166|NCT01588353|594579295|FG001|Step3|Adverse Event|0|||
164606167|NCT01588353|594579296|FG002|Step3|Adverse Event|2|||
164606168|NCT00493467|594579297|FG000|Overall Study|Death|1|||
164606169|NCT00830960|594579304|FG000|Overall Study|Death|5|||
164606170|NCT00830960|594579305|FG001|Overall Study|Death|4|||
164606171|NCT00830960|594579306|FG002|Overall Study|Death|3|||
164606172|NCT00830960|594579307|FG003|Overall Study|Death|2|||
164606173|NCT00830960|594579308|FG004|Overall Study|Death|6|||
164606174|NCT00830960|594579309|FG005|Overall Study|Death|1|||
164606175|NCT00830960|594579304|FG000|Overall Study|Lost to Follow-up|1|||
164606176|NCT00830960|594579305|FG001|Overall Study|Lost to Follow-up|1|||
164606177|NCT00830960|594579306|FG002|Overall Study|Lost to Follow-up|1|||
164606178|NCT00830960|594579307|FG003|Overall Study|Lost to Follow-up|0|||
164606179|NCT00830960|594579308|FG004|Overall Study|Lost to Follow-up|0|||
164606180|NCT00830960|594579309|FG005|Overall Study|Lost to Follow-up|1|||
164606181|NCT00830960|594579304|FG000|Overall Study|Withdrawal by Subject|19|||
164606182|NCT00830960|594579305|FG001|Overall Study|Withdrawal by Subject|19|||
164606183|NCT00830960|594579306|FG002|Overall Study|Withdrawal by Subject|18|||
164606184|NCT00830960|594579307|FG003|Overall Study|Withdrawal by Subject|23|||
164606185|NCT00830960|594579308|FG004|Overall Study|Withdrawal by Subject|16|||
164606186|NCT00830960|594579309|FG005|Overall Study|Withdrawal by Subject|21|||
164606187|NCT00830960|594579304|FG000|Overall Study|Sponsor Decision|1|||
164606188|NCT00830960|594579305|FG001|Overall Study|Sponsor Decision|2|||
164606189|NCT00830960|594579306|FG002|Overall Study|Sponsor Decision|3|||
164606190|NCT00830960|594579307|FG003|Overall Study|Sponsor Decision|4|||
164606191|NCT00830960|594579308|FG004|Overall Study|Sponsor Decision|5|||
164606192|NCT00830960|594579309|FG005|Overall Study|Sponsor Decision|7|||
164606193|NCT00830960|594579304|FG000|Overall Study|No study drug received|7|||
164606194|NCT00830960|594579305|FG001|Overall Study|No study drug received|2|||
164606195|NCT00830960|594579306|FG002|Overall Study|No study drug received|4|||
164606196|NCT00830960|594579307|FG003|Overall Study|No study drug received|3|||
164606197|NCT00830960|594579308|FG004|Overall Study|No study drug received|5|||
164606198|NCT00830960|594579309|FG005|Overall Study|No study drug received|7|||
164606199|NCT02180217|594579310|FG000|Overall Study|Adverse Event|3|||
164606200|NCT02180217|594579311|FG001|Overall Study|Adverse Event|2|||
164716221|NCT02617563|594984293|FG001|3 Year|Lost to Follow-up|3|||
164716222|NCT02617563|594984292|FG000|3 Year|Withdrawal by Subject|1|||
164716223|NCT02617563|594984293|FG001|3 Year|Withdrawal by Subject|1|||
164716224|NCT02617563|594984292|FG000|4 Year|Death|1|||
164716225|NCT02617563|594984293|FG001|4 Year|Death|0|||
164716226|NCT02617563|594984292|FG000|4 Year|Lost to Follow-up|3|||
164716227|NCT02617563|594984293|FG001|4 Year|Lost to Follow-up|1|||
164716228|NCT02617563|594984292|FG000|4 Year|Withdrawal by Subject|3|||
164716229|NCT02617563|594984293|FG001|4 Year|Withdrawal by Subject|1|||
164716230|NCT02617563|594984292|FG000|5 Year|Death|0|||
164716231|NCT02617563|594984293|FG001|5 Year|Death|1|||
164716232|NCT02617563|594984292|FG000|5 Year|Lost to Follow-up|9|||
164716233|NCT02617563|594984293|FG001|5 Year|Lost to Follow-up|5|||
164716234|NCT02617563|594984292|FG000|5 Year|Withdrawal by Subject|1|||
164716235|NCT02617563|594984293|FG001|5 Year|Withdrawal by Subject|0|||
164716236|NCT03879577|594984294|FG000|Overall Study|Withdrawal by Subject|4|||
164716237|NCT03879577|594984294|FG000|Overall Study|Declined surgery|2|||
164716238|NCT01231906|594984295|FG000|Overall Study|Lack of Efficacy|75|||
164716239|NCT01231906|594984296|FG001|Overall Study|Lack of Efficacy|68|||
164716240|NCT01231906|594984295|FG000|Overall Study|Lost to Follow-up|1|||
164716241|NCT01231906|594984296|FG001|Overall Study|Lost to Follow-up|0|||
164716242|NCT01231906|594984295|FG000|Overall Study|Physician Decision|34|||
164716243|NCT01231906|594984296|FG001|Overall Study|Physician Decision|24|||
164716244|NCT01231906|594984295|FG000|Overall Study|Withdrawal by Subject|0|||
164716245|NCT01231906|594984296|FG001|Overall Study|Withdrawal by Subject|4|||
164716246|NCT01231906|594984295|FG000|Overall Study|Ineligible|10|||
164716247|NCT01231906|594984296|FG001|Overall Study|Ineligible|3|||
164716248|NCT01231906|594984295|FG000|Overall Study|No treatment|1|||
164716249|NCT01231906|594984296|FG001|Overall Study|No treatment|2|||
164716250|NCT04564339|594984297|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
164716251|NCT04564339|594984298|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
164716252|NCT04564339|594984299|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
164716253|NCT04564339|594984300|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
164716254|NCT04564339|594984297|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
164716255|NCT04564339|594984298|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
164716256|NCT04564339|594984299|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
164716257|NCT04564339|594984300|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
164716258|NCT04564339|594984297|FG000|Extension Period (Week 26 to Week 50)|Physician Decision|1|||
164716259|NCT04564339|594984298|FG001|Extension Period (Week 26 to Week 50)|Physician Decision|0|||
164502442|NCT02706847|594211160|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
164502443|NCT02706847|594211157|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
164502444|NCT02706847|594211158|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
164502445|NCT02706847|594211159|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
164502446|NCT02706847|594211160|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
164502447|NCT02706847|594211157|FG000|Period 1: Day 1 to Week 12|Other|4|||
164502448|NCT02706847|594211158|FG001|Period 1: Day 1 to Week 12|Other|4|||
164502449|NCT02706847|594211159|FG002|Period 1: Day 1 to Week 12|Other|2|||
164502450|NCT02706847|594211160|FG003|Period 1: Day 1 to Week 12|Other|2|||
164502451|NCT02706847|594211157|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
164502452|NCT02706847|594211158|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
164502453|NCT02706847|594211159|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
164502454|NCT02706847|594211160|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
164502455|NCT02706847|594211157|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
164502456|NCT02706847|594211158|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
164502457|NCT02706847|594211159|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
164502458|NCT02706847|594211160|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
164502459|NCT02706847|594211157|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
164502460|NCT02706847|594211158|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
164502461|NCT02706847|594211159|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
164502462|NCT02706847|594211160|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
164502463|NCT02706847|594211157|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
164502464|NCT02706847|594211158|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
164502465|NCT02706847|594211159|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
164502466|NCT02706847|594211160|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
164502467|NCT02706847|594211157|FG000|Period 1: Week 12 to Week 24|Other|1|||
164502468|NCT02706847|594211158|FG001|Period 1: Week 12 to Week 24|Other|0|||
164502469|NCT02706847|594211159|FG002|Period 1: Week 12 to Week 24|Other|1|||
164502470|NCT02706847|594211160|FG003|Period 1: Week 12 to Week 24|Other|4|||
164502471|NCT02706847|594211157|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
164502472|NCT02706847|594211158|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
164502473|NCT02706847|594211159|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
164502474|NCT02706847|594211160|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
164502475|NCT02706847|594211157|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
164502476|NCT02706847|594211158|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
164716260|NCT04564339|594984299|FG002|Extension Period (Week 26 to Week 50)|Physician Decision|1|||
164716261|NCT04564339|594984300|FG003|Extension Period (Week 26 to Week 50)|Physician Decision|0|||
164716262|NCT04564339|594984297|FG000|Extension Period (Week 26 to Week 50)|Withdrawal by Subject|1|||
164716263|NCT04564339|594984298|FG001|Extension Period (Week 26 to Week 50)|Withdrawal by Subject|0|||
164502477|NCT02706847|594211159|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
164502478|NCT02706847|594211160|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
164502479|NCT02706847|594211157|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
164502480|NCT02706847|594211158|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
164502481|NCT02706847|594211159|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
164502482|NCT02706847|594211160|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
164502483|NCT02706847|594211157|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
164502484|NCT02706847|594211158|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
164502485|NCT02706847|594211159|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
164502486|NCT02706847|594211160|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
164502487|NCT02706847|594211157|FG000|Period 2: Week 24 to Week 260|Other|8|||
164502488|NCT02706847|594211158|FG001|Period 2: Week 24 to Week 260|Other|5|||
164502489|NCT02706847|594211159|FG002|Period 2: Week 24 to Week 260|Other|15|||
164502490|NCT02706847|594211160|FG003|Period 2: Week 24 to Week 260|Other|15|||
164502491|NCT01174264|594211161|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
164502492|NCT01174264|594211162|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
164502493|NCT01174264|594211163|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
164502494|NCT01174264|594211161|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
164502495|NCT01174264|594211162|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
164502496|NCT01174264|594211163|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
164502497|NCT01174264|594211161|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
164502498|NCT01174264|594211162|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
164502499|NCT01174264|594211163|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
164502500|NCT03432390|594211164|FG000|Apnea Period|Protocol Violation|2|||
164502501|NCT03432390|594211165|FG001|Apnea Period|Protocol Violation|2|||
164502502|NCT01774305|594211168|FG000|Overall Study|Physician Decision|1|||
164502503|NCT01774305|594211169|FG001|Overall Study|Physician Decision|0|||
164502504|NCT03772613|594211176|FG000|Overall Study|Lost to Follow-up|0|||
164502505|NCT03772613|594211177|FG001|Overall Study|Lost to Follow-up|1|||
164502506|NCT03772613|594211178|FG002|Overall Study|Lost to Follow-up|1|||
164502507|NCT01185171|594211181|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
164502508|NCT01185171|594211181|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
164502509|NCT01185171|594211181|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
164502510|NCT01185171|594211181|FG000|Maintenance|Elevated liver transaminases|3|||
164502511|NCT01185171|594211181|FG000|Maintenance|Rush|2|||
164502512|NCT01185171|594211181|FG000|Maintenance|Diarrhea|1|||
164502513|NCT01185171|594211181|FG000|Maintenance|Xerostomia|1|||
164502514|NCT01185171|594211181|FG000|Maintenance|Nausea|1|||
164502515|NCT01185171|594211181|FG000|Maintenance|Comorbid Illness|2|||
164502516|NCT01185171|594211181|FG000|Maintenance|Withdrawal by Subject|1|||
164502517|NCT01185171|594211181|FG000|Maintenance|Disease Recurrence|1|||
164502518|NCT02725008|594211185|FG000|Overall Study|Lost to Follow-up|7|||
164502519|NCT02725008|594211186|FG001|Overall Study|Lost to Follow-up|9|||
164502520|NCT02725008|594211185|FG000|Overall Study|Withdrawal by Subject|2|||
164502521|NCT02725008|594211186|FG001|Overall Study|Withdrawal by Subject|2|||
164502522|NCT02725008|594211185|FG000|Overall Study|Admitted to hospital|0|||
164502523|NCT02725008|594211186|FG001|Overall Study|Admitted to hospital|1|||
164502524|NCT01482429|594211187|FG000|Care Usual|Protocol Violation|0|||
164502525|NCT01482429|594211188|FG001|Care Usual|Protocol Violation|172|||
164502526|NCT01482429|594211187|FG000|Care Usual|Lost to Follow-up|0|||
164502527|NCT01482429|594211188|FG001|Care Usual|Lost to Follow-up|1|||
164502528|NCT01482429|594211187|FG000|Protocol|Protocol Violation|275|||
164502529|NCT01482429|594211188|FG001|Protocol|Protocol Violation|0|||
164502530|NCT01837797|594211194|FG000|Period 1|Adverse Event|9|||
164502531|NCT01837797|594211195|FG001|Period 1|Adverse Event|0|||
164502532|NCT01837797|594211196|FG002|Period 1|Adverse Event|0|||
164502533|NCT01837797|594211197|FG003|Period 1|Adverse Event|0|||
164502534|NCT01837797|594211198|FG004|Period 1|Adverse Event|0|||
164502535|NCT01837797|594211194|FG000|Period 1|Withdrawal by Subject|6|||
164502536|NCT01837797|594211195|FG001|Period 1|Withdrawal by Subject|0|||
164502537|NCT01837797|594211196|FG002|Period 1|Withdrawal by Subject|0|||
164502538|NCT01837797|594211197|FG003|Period 1|Withdrawal by Subject|0|||
164502539|NCT01837797|594211198|FG004|Period 1|Withdrawal by Subject|0|||
164502540|NCT01837797|594211194|FG000|Period 1|Administrative reasons|76|||
164502541|NCT01837797|594211195|FG001|Period 1|Administrative reasons|0|||
164502542|NCT01837797|594211196|FG002|Period 1|Administrative reasons|0|||
164502543|NCT01837797|594211197|FG003|Period 1|Administrative reasons|0|||
164502544|NCT01837797|594211198|FG004|Period 1|Administrative reasons|0|||
164502545|NCT01837797|594211194|FG000|Period 1|Withdrawal of consent before treatment|1|||
164502546|NCT01837797|594211195|FG001|Period 1|Withdrawal of consent before treatment|0|||
164502547|NCT01837797|594211196|FG002|Period 1|Withdrawal of consent before treatment|0|||
164606201|NCT02180217|594579312|FG002|Overall Study|Adverse Event|22|||
164606202|NCT02180217|594579310|FG000|Overall Study|Death|1|||
164606203|NCT02180217|594579311|FG001|Overall Study|Death|1|||
164606204|NCT02180217|594579312|FG002|Overall Study|Death|0|||
164606205|NCT02180217|594579310|FG000|Overall Study|Withdrawal by Subject|1|||
164606206|NCT02180217|594579311|FG001|Overall Study|Withdrawal by Subject|1|||
164606207|NCT02180217|594579312|FG002|Overall Study|Withdrawal by Subject|4|||
164606208|NCT02180217|594579310|FG000|Overall Study|Subject/Guardian decision|5|||
164606209|NCT02180217|594579311|FG001|Overall Study|Subject/Guardian decision|3|||
164606210|NCT02180217|594579312|FG002|Overall Study|Subject/Guardian decision|6|||
164606211|NCT02180217|594579310|FG000|Overall Study|Physician Decision|1|||
164606212|NCT02180217|594579311|FG001|Overall Study|Physician Decision|1|||
164606213|NCT02180217|594579312|FG002|Overall Study|Physician Decision|6|||
164606214|NCT02180217|594579310|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164606215|NCT02180217|594579311|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164606216|NCT02180217|594579312|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
164606217|NCT01504971|594579314|FG000|Overall Study|Physician Decision|13|||
164606218|NCT01309841|594579317|FG000|Overall Study|Other|0|||
164606219|NCT01309841|594579318|FG001|Overall Study|Other|1|||
164606220|NCT01309841|594579319|FG002|Overall Study|Other|1|||
164606221|NCT01309841|594579317|FG000|Overall Study|Lost to Follow-up|7|||
164606222|NCT01309841|594579318|FG001|Overall Study|Lost to Follow-up|6|||
164606223|NCT01309841|594579319|FG002|Overall Study|Lost to Follow-up|4|||
164606224|NCT01309841|594579317|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
164606225|NCT01309841|594579318|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
164606226|NCT01309841|594579319|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
164606227|NCT01309841|594579317|FG000|Overall Study|Lack of Efficacy|0|||
164606228|NCT01309841|594579318|FG001|Overall Study|Lack of Efficacy|0|||
164606229|NCT01309841|594579319|FG002|Overall Study|Lack of Efficacy|2|||
164606230|NCT01309841|594579317|FG000|Overall Study|Adverse Event|9|||
164606231|NCT01309841|594579318|FG001|Overall Study|Adverse Event|22|||
164606232|NCT01309841|594579319|FG002|Overall Study|Adverse Event|11|||
164606233|NCT01309841|594579317|FG000|Overall Study|Death|1|||
164606234|NCT01309841|594579318|FG001|Overall Study|Death|0|||
164606235|NCT01309841|594579319|FG002|Overall Study|Death|0|||
164606236|NCT01309841|594579317|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
164606237|NCT01309841|594579318|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
164606238|NCT01309841|594579319|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
164606239|NCT01309841|594579317|FG000|Overall Study|Withdrawal by Subject|17|||
164606240|NCT01309841|594579318|FG001|Overall Study|Withdrawal by Subject|6|||
164606241|NCT01309841|594579319|FG002|Overall Study|Withdrawal by Subject|13|||
164606242|NCT01309841|594579317|FG000|Overall Study|Did Not Receive Treatment|2|||
164606243|NCT01309841|594579318|FG001|Overall Study|Did Not Receive Treatment|0|||
164606244|NCT01309841|594579319|FG002|Overall Study|Did Not Receive Treatment|1|||
164606245|NCT01309841|594579317|FG000|Overall Study|Severe non-compliance with protocol|0|||
164606246|NCT01309841|594579318|FG001|Overall Study|Severe non-compliance with protocol|5|||
164606247|NCT01309841|594579319|FG002|Overall Study|Severe non-compliance with protocol|2|||
164606248|NCT02475395|594579320|FG000|Overall Study|Protocol Violation|30|||
164606249|NCT02475395|594579321|FG001|Overall Study|Protocol Violation|3|||
164606250|NCT01681576|594579322|FG000|Period 1|Adverse Event|1|||
164606251|NCT01681576|594579323|FG001|Period 1|Adverse Event|0|||
164606252|NCT01681576|594579322|FG000|Period 1|Protocol Deviation|1|||
164606253|NCT01681576|594579323|FG001|Period 1|Protocol Deviation|0|||
164606254|NCT01681576|594579322|FG000|Period 2|subject/guardian decision|3|||
164606255|NCT01681576|594579323|FG001|Period 2|subject/guardian decision|1|||
164606256|NCT01681576|594579322|FG000|Period 2|Non-compliance with study treatment|1|||
164606257|NCT01681576|594579323|FG001|Period 2|Non-compliance with study treatment|0|||
164606258|NCT00870818|594579324|FG000|Overall Study|Lost to Follow-up|3|||
164606259|NCT00870818|594579325|FG001|Overall Study|Lost to Follow-up|2|||
164606260|NCT00870818|594579326|FG002|Overall Study|Lost to Follow-up|1|||
164606261|NCT00870818|594579327|FG003|Overall Study|Lost to Follow-up|0|||
164606262|NCT00870818|594579328|FG004|Overall Study|Lost to Follow-up|0|||
164606263|NCT00870818|594579324|FG000|Overall Study|Withdrawal by Subject|0|||
164606264|NCT00870818|594579325|FG001|Overall Study|Withdrawal by Subject|0|||
164606265|NCT00870818|594579326|FG002|Overall Study|Withdrawal by Subject|1|||
164606266|NCT00870818|594579327|FG003|Overall Study|Withdrawal by Subject|2|||
164606267|NCT00870818|594579328|FG004|Overall Study|Withdrawal by Subject|0|||
164606268|NCT00870818|594579324|FG000|Overall Study|Terminated by sponsor|29|||
164606269|NCT00870818|594579325|FG001|Overall Study|Terminated by sponsor|70|||
164606270|NCT00870818|594579326|FG002|Overall Study|Terminated by sponsor|36|||
164606271|NCT00870818|594579327|FG003|Overall Study|Terminated by sponsor|36|||
164606272|NCT00870818|594579328|FG004|Overall Study|Terminated by sponsor|38|||
164606273|NCT00870818|594579324|FG000|Overall Study|Other|0|||
164606274|NCT00870818|594579325|FG001|Overall Study|Other|1|||
164606275|NCT00870818|594579326|FG002|Overall Study|Other|0|||
164606276|NCT00870818|594579327|FG003|Overall Study|Other|0|||
164606277|NCT00870818|594579328|FG004|Overall Study|Other|0|||
164606278|NCT02260648|594579331|FG000|Overall Study|Adverse Event|3|||
164606279|NCT02260648|594579332|FG001|Overall Study|Adverse Event|0|||
164606280|NCT02260648|594579333|FG002|Overall Study|Adverse Event|1|||
164606281|NCT02260648|594579331|FG000|Overall Study|Withdrawal by Subject|1|||
164606282|NCT02260648|594579332|FG001|Overall Study|Withdrawal by Subject|1|||
164606283|NCT02260648|594579333|FG002|Overall Study|Withdrawal by Subject|0|||
164606284|NCT02260648|594579331|FG000|Overall Study|Protocol Violation|1|||
164606285|NCT02260648|594579332|FG001|Overall Study|Protocol Violation|0|||
164606286|NCT02260648|594579333|FG002|Overall Study|Protocol Violation|0|||
164606287|NCT02260648|594579331|FG000|Overall Study|Discontinue Due to Study Termination|13|||
164606288|NCT02260648|594579332|FG001|Overall Study|Discontinue Due to Study Termination|12|||
164606289|NCT02260648|594579333|FG002|Overall Study|Discontinue Due to Study Termination|7|||
164606290|NCT04093258|594579334|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
164606291|NCT04093258|594579335|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
164606292|NCT01529385|594579336|FG000|Overall Study|Lost to Follow-up|2|||
164606293|NCT01529385|594579337|FG001|Overall Study|Lost to Follow-up|1|||
164606294|NCT00805545|594579338|FG000|Overall Study|Protocol Violation|3|||
164606295|NCT00805545|594579339|FG001|Overall Study|Protocol Violation|2|||
164606296|NCT00805545|594579338|FG000|Overall Study|Protocol Violation|3|||
164606297|NCT00805545|594579339|FG001|Overall Study|Protocol Violation|1|||
164606298|NCT00986427|594579340|FG000|Overall Study|Lost to Follow-up|2|||
164606299|NCT00986427|594579341|FG001|Overall Study|Lost to Follow-up|0|||
164606300|NCT00986427|594579340|FG000|Overall Study|Lack of Efficacy|1|||
164606301|NCT00986427|594579341|FG001|Overall Study|Lack of Efficacy|0|||
164606302|NCT00986427|594579340|FG000|Overall Study|Withdrawal by Subject|1|||
164606303|NCT00986427|594579341|FG001|Overall Study|Withdrawal by Subject|0|||
164606304|NCT03448224|594579342|FG000|Overall Study|Provided same answer to every question|1|||
164606305|NCT03448224|594579343|FG001|Overall Study|Provided same answer to every question|0|||
164606306|NCT02379390|594579346|FG000|Overall Study|Adverse Event|1|||
164606307|NCT02379390|594579347|FG001|Overall Study|Adverse Event|1|||
164606308|NCT02379390|594579346|FG000|Overall Study|Investigator's decision|1|||
164606309|NCT02379390|594579347|FG001|Overall Study|Investigator's decision|0|||
164606310|NCT02379390|594579346|FG000|Overall Study|Study Termination|0|||
164606311|NCT02379390|594579347|FG001|Overall Study|Study Termination|1|||
164606312|NCT03103906|594579348|FG000|Overall Study|Adverse Event|2|||
164606313|NCT03103906|594579349|FG001|Overall Study|Adverse Event|3|||
164606314|NCT03103906|594579348|FG000|Overall Study|Other|2|||
164606315|NCT03103906|594579349|FG001|Overall Study|Other|0|||
164606316|NCT00764478|594579350|FG000|Overall Study|Adverse Event|1|||
164606317|NCT00764478|594579351|FG001|Overall Study|Adverse Event|1|||
164606318|NCT00764478|594579352|FG002|Overall Study|Adverse Event|1|||
164606319|NCT00764478|594579350|FG000|Overall Study|Withdrawal by Subject|7|||
164606320|NCT00764478|594579351|FG001|Overall Study|Withdrawal by Subject|12|||
164606321|NCT00764478|594579352|FG002|Overall Study|Withdrawal by Subject|1|||
164606322|NCT00764478|594579350|FG000|Overall Study|Lost to Follow-up|7|||
164606323|NCT00764478|594579351|FG001|Overall Study|Lost to Follow-up|8|||
164606324|NCT00764478|594579352|FG002|Overall Study|Lost to Follow-up|5|||
164606325|NCT00764478|594579350|FG000|Overall Study|Protocol Violation|0|||
164606326|NCT00764478|594579351|FG001|Overall Study|Protocol Violation|1|||
164606327|NCT00764478|594579352|FG002|Overall Study|Protocol Violation|1|||
164606328|NCT00575094|594579353|FG000|Overall Study|Adverse Event|2|||
164606329|NCT00575094|594579353|FG000|Overall Study|Withdrawal by Subject|1|||
164606330|NCT00862121|594579356|FG000|Overall Study|Adverse Event|1|||
164606331|NCT00862121|594579357|FG001|Overall Study|Adverse Event|2|||
164606332|NCT00862121|594579356|FG000|Overall Study|Lack of Efficacy|0|||
164606333|NCT00862121|594579357|FG001|Overall Study|Lack of Efficacy|3|||
164606334|NCT00862121|594579356|FG000|Overall Study|Protocol Violation|0|||
164606335|NCT00862121|594579357|FG001|Overall Study|Protocol Violation|1|||
164606336|NCT00862121|594579356|FG000|Overall Study|Exclusion criterion violation|0|||
164606337|NCT00862121|594579357|FG001|Overall Study|Exclusion criterion violation|1|||
164606338|NCT00862121|594579356|FG000|Overall Study|Incorrect randomisation|0|||
164606339|NCT00862121|594579357|FG001|Overall Study|Incorrect randomisation|1|||
164606340|NCT01195363|594579359|FG000|Overall Study|Lost to Follow-up|7|||
164716264|NCT04564339|594984299|FG002|Extension Period (Week 26 to Week 50)|Withdrawal by Subject|0|||
164716265|NCT04564339|594984300|FG003|Extension Period (Week 26 to Week 50)|Withdrawal by Subject|0|||
164606341|NCT01195363|594579360|FG001|Overall Study|Lost to Follow-up|4|||
164606342|NCT01195363|594579359|FG000|Overall Study|Adverse Event|3|||
164606343|NCT01195363|594579360|FG001|Overall Study|Adverse Event|1|||
164606344|NCT01195363|594579359|FG000|Overall Study|Lack of Efficacy|0|||
164606345|NCT01195363|594579360|FG001|Overall Study|Lack of Efficacy|4|||
164606346|NCT01195363|594579359|FG000|Overall Study|incarceration|1|||
164606347|NCT01195363|594579360|FG001|Overall Study|incarceration|0|||
164606348|NCT01164865|594579362|FG000|Overall Study|Lost to Follow-up|2|||
164606349|NCT01164865|594579363|FG001|Overall Study|Lost to Follow-up|1|||
164606350|NCT00377429|594579365|FG000|Overall Study|Withdrawal by Subject|5|||
164716266|NCT04564339|594984297|FG000|Extension Period (Week 26 to Week 50)|Study Terminated by Sponsor|0|||
164606351|NCT00377429|594579365|FG000|Overall Study|Adverse Event|8|||
164606352|NCT00377429|594579365|FG000|Overall Study|Physician Decision|1|||
164716267|NCT04564339|594984298|FG001|Extension Period (Week 26 to Week 50)|Study Terminated by Sponsor|1|||
164716268|NCT04564339|594984299|FG002|Extension Period (Week 26 to Week 50)|Study Terminated by Sponsor|0|||
164716269|NCT04564339|594984300|FG003|Extension Period (Week 26 to Week 50)|Study Terminated by Sponsor|0|||
164716270|NCT04158739|594984304|FG000|Overall Study|Adverse Event|1|||
164716271|NCT04158739|594984305|FG001|Overall Study|Adverse Event|0|||
164716272|NCT04158739|594984304|FG000|Overall Study|Death|0|||
164716273|NCT04158739|594984305|FG001|Overall Study|Death|1|||
164716274|NCT04158739|594984304|FG000|Overall Study|Lack of Efficacy|3|||
164716275|NCT04158739|594984305|FG001|Overall Study|Lack of Efficacy|7|||
164716276|NCT04158739|594984304|FG000|Overall Study|Physician Decision|0|||
164716277|NCT04158739|594984305|FG001|Overall Study|Physician Decision|1|||
164716278|NCT04158739|594984304|FG000|Overall Study|Withdrawal by Subject|3|||
164502548|NCT01837797|594211197|FG003|Period 1|Withdrawal of consent before treatment|0|||
164502549|NCT01837797|594211198|FG004|Period 1|Withdrawal of consent before treatment|0|||
164606353|NCT00377429|594579365|FG000|Overall Study|Patient non-compliance|1|||
164606354|NCT05691829|594580934|FG000|Overall Study|Physician Decision|2|||
164606355|NCT05691829|594580934|FG000|Overall Study|Eligibility criteria not met|3|||
164606356|NCT00804843|594580935|FG000|Overall Study|Protocol Violation|1|||
164606357|NCT00804843|594580936|FG001|Overall Study|Protocol Violation|0|||
164606358|NCT00804843|594580935|FG000|Overall Study|Adverse Event|8|||
164606359|NCT00804843|594580936|FG001|Overall Study|Adverse Event|5|||
164606360|NCT00804843|594580935|FG000|Overall Study|Withdrawal by Subject|1|||
164606361|NCT00804843|594580936|FG001|Overall Study|Withdrawal by Subject|2|||
164606362|NCT02670928|594580943|FG000|Overall Study|Adverse Event|3|||
164606363|NCT02670928|594580944|FG001|Overall Study|Adverse Event|1|||
164606364|NCT02670928|594580943|FG000|Overall Study|Withdrawal by Subject|4|||
164606365|NCT02670928|594580944|FG001|Overall Study|Withdrawal by Subject|0|||
164606366|NCT02670928|594580943|FG000|Overall Study|Lost to Follow-up|1|||
164716279|NCT04158739|594984305|FG001|Overall Study|Withdrawal by Subject|0|||
164502550|NCT01837797|594211194|FG000|Period 1|Other|10|||
164502551|NCT01837797|594211195|FG001|Period 1|Other|0|||
164502552|NCT01837797|594211196|FG002|Period 1|Other|0|||
164502553|NCT01837797|594211197|FG003|Period 1|Other|0|||
164502554|NCT01837797|594211198|FG004|Period 1|Other|0|||
164502555|NCT01837797|594211194|FG000|Period 2|Administrative or other reasons|0|||
164502556|NCT01837797|594211195|FG001|Period 2|Administrative or other reasons|5|||
164502557|NCT01837797|594211196|FG002|Period 2|Administrative or other reasons|2|||
164502558|NCT01837797|594211197|FG003|Period 2|Administrative or other reasons|4|||
164502559|NCT01837797|594211198|FG004|Period 2|Administrative or other reasons|0|||
164502560|NCT01837797|594211194|FG000|Period 2|Adverse Event|0|||
164502561|NCT01837797|594211195|FG001|Period 2|Adverse Event|0|||
164502562|NCT01837797|594211196|FG002|Period 2|Adverse Event|0|||
164502563|NCT01837797|594211197|FG003|Period 2|Adverse Event|1|||
164502564|NCT01837797|594211198|FG004|Period 2|Adverse Event|0|||
164502565|NCT01837797|594211194|FG000|Period 3|Adverse Event|0|||
164502566|NCT01837797|594211195|FG001|Period 3|Adverse Event|0|||
164502567|NCT01837797|594211196|FG002|Period 3|Adverse Event|0|||
164502568|NCT01837797|594211197|FG003|Period 3|Adverse Event|0|||
164502569|NCT01837797|594211198|FG004|Period 3|Adverse Event|1|||
164502570|NCT01837797|594211194|FG000|Period 3|Administrative reasons|0|||
164502571|NCT01837797|594211195|FG001|Period 3|Administrative reasons|0|||
164502572|NCT01837797|594211196|FG002|Period 3|Administrative reasons|0|||
164502573|NCT01837797|594211197|FG003|Period 3|Administrative reasons|0|||
164502574|NCT01837797|594211198|FG004|Period 3|Administrative reasons|20|||
164502575|NCT01837797|594211194|FG000|Period 3|Other|0|||
164502576|NCT01837797|594211195|FG001|Period 3|Other|0|||
164502577|NCT01837797|594211196|FG002|Period 3|Other|0|||
164502578|NCT01837797|594211197|FG003|Period 3|Other|0|||
164502579|NCT01837797|594211198|FG004|Period 3|Other|2|||
164502580|NCT03797989|594211219|FG000|VAC069A|Withdrawal by Subject|0|||
164502581|NCT03797989|594211220|FG001|VAC069A|Withdrawal by Subject|0|||
164606367|NCT02670928|594580944|FG001|Overall Study|Lost to Follow-up|0|||
164606368|NCT02670928|594580943|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
164606369|NCT02670928|594580944|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
164606370|NCT02678312|594580945|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
164606371|NCT02678312|594580946|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
164606372|NCT02678312|594580947|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
164716280|NCT02405221|594984306|FG000|Overall Study|Adverse Event|1|||
164716281|NCT02405221|594984307|FG001|Overall Study|Adverse Event|0|||
164716282|NCT02405221|594984306|FG000|Overall Study|Lost to Follow-up|1|||
164502582|NCT03797989|594211221|FG002|VAC069A|Withdrawal by Subject|1|||
164502583|NCT03797989|594211222|FG003|VAC069A|Withdrawal by Subject|0|||
164502584|NCT03797989|594211223|FG004|VAC069A|Withdrawal by Subject|0|||
164502585|NCT03797989|594211224|FG005|VAC069A|Withdrawal by Subject|0|||
164502586|NCT03797989|594211225|FG006|VAC069A|Withdrawal by Subject|0|||
164502587|NCT03797989|594211226|FG007|VAC069A|Withdrawal by Subject|0|||
164502588|NCT03797989|594211227|FG008|VAC069A|Withdrawal by Subject|0|||
164502589|NCT03797989|594211228|FG009|VAC069A|Withdrawal by Subject|0|||
164502590|NCT03797989|594211229|FG010|VAC069A|Withdrawal by Subject|0|||
164502591|NCT03797989|594211230|FG011|VAC069A|Withdrawal by Subject|0|||
164606373|NCT02678312|594580948|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
164606374|NCT02678312|594580949|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
164606375|NCT02678312|594580945|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
164606376|NCT02678312|594580946|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
164606377|NCT02678312|594580947|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
164606378|NCT02678312|594580948|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
164606379|NCT02678312|594580949|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
164606380|NCT02678312|594580945|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
164606381|NCT02678312|594580946|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
164606382|NCT02678312|594580947|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
164606383|NCT02678312|594580948|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
164606384|NCT02678312|594580949|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
164606385|NCT02678312|594580945|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
164606386|NCT02678312|594580946|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
164716283|NCT02405221|594984307|FG001|Overall Study|Lost to Follow-up|1|||
164716284|NCT03972488|594984308|FG000|Overall Study|Progressive disease|42|||
164716285|NCT03972488|594984309|FG001|Overall Study|Progressive disease|44|||
164716286|NCT03972488|594984308|FG000|Overall Study|Physician Decision|13|||
164716287|NCT03972488|594984309|FG001|Overall Study|Physician Decision|7|||
164716288|NCT03972488|594984308|FG000|Overall Study|Adverse Event|8|||
164716289|NCT03972488|594984309|FG001|Overall Study|Adverse Event|1|||
164716290|NCT03972488|594984308|FG000|Overall Study|Death|4|||
164716291|NCT03972488|594984309|FG001|Overall Study|Death|4|||
164716292|NCT03972488|594984308|FG000|Overall Study|Withdrawal by Subject|3|||
164716293|NCT03972488|594984309|FG001|Overall Study|Withdrawal by Subject|4|||
164716294|NCT03972488|594984308|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
164716295|NCT03972488|594984309|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
164716296|NCT04526665|594984311|FG000|Overall Study|Withdrawal by Subject|6|||
164716297|NCT04526665|594984312|FG001|Overall Study|Withdrawal by Subject|3|||
164716298|NCT04526665|594984311|FG000|Overall Study|Adverse Event|4|||
164716299|NCT04526665|594984312|FG001|Overall Study|Adverse Event|1|||
164716300|NCT04526665|594984311|FG000|Overall Study|Physician Decision|2|||
164716301|NCT04526665|594984312|FG001|Overall Study|Physician Decision|2|||
164716302|NCT04526665|594984311|FG000|Overall Study|Death|2|||
164716303|NCT04526665|594984312|FG001|Overall Study|Death|0|||
164716304|NCT04526665|594984311|FG000|Overall Study|Other|0|||
164716305|NCT04526665|594984312|FG001|Overall Study|Other|1|||
164716306|NCT05070247|594984313|FG000|Overall Study|Death|1|||
164716307|NCT05070247|594984314|FG001|Overall Study|Death|1|||
164716308|NCT05070247|594984315|FG002|Overall Study|Death|1|||
164716309|NCT05070247|594984316|FG003|Overall Study|Death|1|||
164716310|NCT05070247|594984317|FG004|Overall Study|Death|0|||
164606387|NCT02678312|594580947|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
164606388|NCT02678312|594580948|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
164716311|NCT05070247|594984318|FG005|Overall Study|Death|2|||
164716312|NCT05070247|594984319|FG006|Overall Study|Death|0|||
164502592|NCT04594733|594211231|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
164502593|NCT04594733|594211232|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
164502594|NCT04594733|594211231|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
164502595|NCT04594733|594211232|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
164502596|NCT04594733|594211231|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
164502597|NCT04594733|594211232|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
164502598|NCT01024036|594211241|FG000|Blinded Treatment|Adverse Event|1|||
164502599|NCT01024036|594211242|FG001|Blinded Treatment|Adverse Event|1|||
164502600|NCT01024036|594211241|FG000|Blinded Treatment|Lack of Efficacy|16|||
164502601|NCT01024036|594211242|FG001|Blinded Treatment|Lack of Efficacy|14|||
164502602|NCT01024036|594211241|FG000|Blinded Treatment|Physician Decision|1|||
164502603|NCT01024036|594211242|FG001|Blinded Treatment|Physician Decision|0|||
164502604|NCT01024036|594211241|FG000|Blinded Treatment|Death|0|||
164502605|NCT01024036|594211242|FG001|Blinded Treatment|Death|2|||
164502606|NCT01024036|594211241|FG000|Blinded Treatment|Withdrawal by Subject|4|||
164502607|NCT01024036|594211242|FG001|Blinded Treatment|Withdrawal by Subject|3|||
164502608|NCT01024036|594211241|FG000|Unblinded Treatment|Adverse Event|0|||
164606389|NCT02678312|594580949|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
164716313|NCT05070247|594984320|FG007|Overall Study|Death|0|||
164716314|NCT05070247|594984321|FG008|Overall Study|Death|2|||
164716315|NCT05070247|594984322|FG009|Overall Study|Death|1|||
164716316|NCT05070247|594984323|FG010|Overall Study|Death|2|||
164502609|NCT01024036|594211242|FG001|Unblinded Treatment|Adverse Event|1|||
164716317|NCT05070247|594984324|FG011|Overall Study|Death|2|||
164502610|NCT01024036|594211241|FG000|Unblinded Treatment|Lack of Efficacy|0|||
164502611|NCT01024036|594211242|FG001|Unblinded Treatment|Lack of Efficacy|2|||
164716318|NCT05070247|594984325|FG012|Overall Study|Death|1|||
164716319|NCT05070247|594984326|FG013|Overall Study|Death|0|||
164716320|NCT05070247|594984327|FG014|Overall Study|Death|0|||
164716321|NCT05070247|594984313|FG000|Overall Study|Withdrawal by Subject|1|||
164716322|NCT05070247|594984314|FG001|Overall Study|Withdrawal by Subject|1|||
164716323|NCT05070247|594984315|FG002|Overall Study|Withdrawal by Subject|1|||
164716324|NCT05070247|594984316|FG003|Overall Study|Withdrawal by Subject|1|||
164716325|NCT05070247|594984317|FG004|Overall Study|Withdrawal by Subject|0|||
164716326|NCT05070247|594984318|FG005|Overall Study|Withdrawal by Subject|4|||
164716327|NCT05070247|594984319|FG006|Overall Study|Withdrawal by Subject|0|||
164716328|NCT05070247|594984320|FG007|Overall Study|Withdrawal by Subject|1|||
164716329|NCT05070247|594984321|FG008|Overall Study|Withdrawal by Subject|2|||
164716330|NCT05070247|594984322|FG009|Overall Study|Withdrawal by Subject|1|||
164716331|NCT05070247|594984323|FG010|Overall Study|Withdrawal by Subject|0|||
164502612|NCT01024036|594211241|FG000|Follow-Up Period|Lost to Follow-up|1|||
164502613|NCT01024036|594211242|FG001|Follow-Up Period|Lost to Follow-up|1|||
164502614|NCT01024036|594211241|FG000|Follow-Up Period|Withdrawal by Subject|0|||
164502615|NCT01024036|594211242|FG001|Follow-Up Period|Withdrawal by Subject|1|||
164502616|NCT01024036|594211241|FG000|Follow-Up Period|Adverse Event|4|||
164502617|NCT01024036|594211242|FG001|Follow-Up Period|Adverse Event|1|||
164502618|NCT00361842|594211243|FG000|Overall Study|Withdrawal by Subject|2|||
164502619|NCT00361842|594211244|FG001|Overall Study|Withdrawal by Subject|3|||
164502620|NCT00361842|594211243|FG000|Overall Study|Death|2|||
164502621|NCT00361842|594211244|FG001|Overall Study|Death|1|||
164502622|NCT00361842|594211243|FG000|Overall Study|Disease progression|19|||
164502623|NCT00361842|594211244|FG001|Overall Study|Disease progression|20|||
164502624|NCT00361842|594211243|FG000|Overall Study|Adverse Event|2|||
164502625|NCT00361842|594211244|FG001|Overall Study|Adverse Event|3|||
164502626|NCT00361842|594211243|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
164502627|NCT00361842|594211244|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
164502628|NCT00361842|594211243|FG000|Overall Study|Other|1|||
164502629|NCT00361842|594211244|FG001|Overall Study|Other|0|||
164502630|NCT00361842|594211243|FG000|Overall Study|Other|0|||
164502631|NCT00361842|594211244|FG001|Overall Study|Other|2|||
164502632|NCT03512288|594211245|FG000|Overall Study|Adverse Event|1|||
164502633|NCT03512288|594211246|FG001|Overall Study|Adverse Event|0|||
164502634|NCT03512288|594211245|FG000|Overall Study|Lost to Follow-up|12|||
164502635|NCT03512288|594211246|FG001|Overall Study|Lost to Follow-up|15|||
164502636|NCT03512288|594211245|FG000|Overall Study|Physician Decision|0|||
164502637|NCT03512288|594211246|FG001|Overall Study|Physician Decision|2|||
164502638|NCT03512288|594211245|FG000|Overall Study|Protocol Violation|6|||
164502639|NCT03512288|594211246|FG001|Overall Study|Protocol Violation|4|||
164502640|NCT03512288|594211245|FG000|Overall Study|Medication error without associated adverse event|1|||
164502641|NCT03512288|594211246|FG001|Overall Study|Medication error without associated adverse event|0|||
164502642|NCT03512288|594211245|FG000|Overall Study|No longer met eligibility criteria|5|||
164502643|NCT03512288|594211246|FG001|Overall Study|No longer met eligibility criteria|2|||
164502644|NCT03512288|594211245|FG000|Overall Study|Withdrawal by parent/guardian|14|||
164502645|NCT03512288|594211246|FG001|Overall Study|Withdrawal by parent/guardian|18|||
164502646|NCT03512288|594211245|FG000|Overall Study|Other|1|||
164502647|NCT03512288|594211246|FG001|Overall Study|Other|1|||
164502648|NCT03512288|594211245|FG000|Overall Study|Randomized but not treated|1|||
164502649|NCT03512288|594211246|FG001|Overall Study|Randomized but not treated|1|||
164502650|NCT00934700|594211249|FG000|Overall Study|missing scan|5|||
164502651|NCT00934700|594211250|FG001|Overall Study|missing scan|9|||
164502652|NCT00934700|594211249|FG000|Overall Study|Death|8|||
164502653|NCT00934700|594211250|FG001|Overall Study|Death|3|||
164502654|NCT00474383|594211251|FG000|Main Study|Adverse Event|11|||
164502655|NCT00474383|594211252|FG001|Main Study|Adverse Event|0|||
164716332|NCT05070247|594984324|FG011|Overall Study|Withdrawal by Subject|0|||
164502656|NCT00474383|594211251|FG000|Main Study|Symptomatic Deterioration|1|||
164502657|NCT00474383|594211252|FG001|Main Study|Symptomatic Deterioration|0|||
164502658|NCT00474383|594211251|FG000|Main Study|Progressive Disease|23|||
164502659|NCT00474383|594211252|FG001|Main Study|Progressive Disease|0|||
164502660|NCT00474383|594211251|FG000|Main Study|Other|1|||
164502661|NCT00474383|594211252|FG001|Main Study|Other|0|||
164502662|NCT00474383|594211251|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
164502663|NCT00474383|594211252|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
164502664|NCT00474383|594211251|FG000|Extension|Progressive Disease|0|||
164502665|NCT00474383|594211252|FG001|Extension|Progressive Disease|5|||
164502666|NCT01502371|594211253|FG000|Overall Study|Withdrawal by Subject|1|||
164502667|NCT01502371|594211254|FG001|Overall Study|Withdrawal by Subject|2|||
164716333|NCT05070247|594984325|FG012|Overall Study|Withdrawal by Subject|3|||
164502668|NCT01502371|594211255|FG002|Overall Study|Withdrawal by Subject|1|||
164502669|NCT01502371|594211256|FG003|Overall Study|Withdrawal by Subject|1|||
164716334|NCT05070247|594984326|FG013|Overall Study|Withdrawal by Subject|4|||
164716335|NCT05070247|594984327|FG014|Overall Study|Withdrawal by Subject|0|||
164716336|NCT05070247|594984313|FG000|Overall Study|Reason Not Specified|0|||
164716337|NCT05070247|594984314|FG001|Overall Study|Reason Not Specified|0|||
164716338|NCT05070247|594984315|FG002|Overall Study|Reason Not Specified|2|||
164716339|NCT05070247|594984316|FG003|Overall Study|Reason Not Specified|0|||
164716340|NCT05070247|594984317|FG004|Overall Study|Reason Not Specified|0|||
164716341|NCT05070247|594984318|FG005|Overall Study|Reason Not Specified|0|||
164716342|NCT05070247|594984319|FG006|Overall Study|Reason Not Specified|1|||
164716343|NCT05070247|594984320|FG007|Overall Study|Reason Not Specified|1|||
164716344|NCT05070247|594984321|FG008|Overall Study|Reason Not Specified|1|||
164716345|NCT05070247|594984322|FG009|Overall Study|Reason Not Specified|1|||
164716346|NCT05070247|594984323|FG010|Overall Study|Reason Not Specified|2|||
164716347|NCT05070247|594984324|FG011|Overall Study|Reason Not Specified|2|||
164716348|NCT05070247|594984325|FG012|Overall Study|Reason Not Specified|2|||
164716349|NCT05070247|594984326|FG013|Overall Study|Reason Not Specified|0|||
164716350|NCT05070247|594984327|FG014|Overall Study|Reason Not Specified|0|||
164716351|NCT04544995|594984329|FG000|Overall Study|Death|7|||
164716352|NCT04544995|594984330|FG001|Overall Study|Death|3|||
164716353|NCT04544995|594984331|FG002|Overall Study|Death|3|||
164716354|NCT04544995|594984332|FG003|Overall Study|Death|3|||
164716355|NCT04544995|594984333|FG004|Overall Study|Death|1|||
164716356|NCT04544995|594984334|FG005|Overall Study|Death|2|||
164716357|NCT04544995|594984335|FG006|Overall Study|Death|1|||
164716358|NCT04544995|594984329|FG000|Overall Study|Lost to Follow-up|0|||
164716359|NCT04544995|594984330|FG001|Overall Study|Lost to Follow-up|0|||
164716360|NCT04544995|594984331|FG002|Overall Study|Lost to Follow-up|0|||
164716361|NCT04544995|594984332|FG003|Overall Study|Lost to Follow-up|0|||
164716362|NCT04544995|594984333|FG004|Overall Study|Lost to Follow-up|1|||
164716363|NCT04544995|594984334|FG005|Overall Study|Lost to Follow-up|0|||
164716364|NCT04544995|594984335|FG006|Overall Study|Lost to Follow-up|0|||
164716365|NCT04544995|594984329|FG000|Overall Study|Physician Decision|0|||
164716366|NCT04544995|594984330|FG001|Overall Study|Physician Decision|0|||
164716367|NCT04544995|594984331|FG002|Overall Study|Physician Decision|0|||
164716368|NCT04544995|594984332|FG003|Overall Study|Physician Decision|0|||
164716369|NCT04544995|594984333|FG004|Overall Study|Physician Decision|5|||
164716370|NCT04544995|594984334|FG005|Overall Study|Physician Decision|0|||
164716371|NCT04544995|594984335|FG006|Overall Study|Physician Decision|0|||
164716372|NCT04544995|594984329|FG000|Overall Study|Withdrawal by Subject|0|||
164716373|NCT04544995|594984330|FG001|Overall Study|Withdrawal by Subject|0|||
164716374|NCT04544995|594984331|FG002|Overall Study|Withdrawal by Subject|0|||
164716375|NCT04544995|594984332|FG003|Overall Study|Withdrawal by Subject|0|||
164716376|NCT04544995|594984333|FG004|Overall Study|Withdrawal by Subject|0|||
164716377|NCT04544995|594984334|FG005|Overall Study|Withdrawal by Subject|1|||
164716378|NCT04544995|594984335|FG006|Overall Study|Withdrawal by Subject|0|||
164716379|NCT04544995|594984329|FG000|Overall Study|Study Terminated by Sponsor|1|||
164716380|NCT04544995|594984330|FG001|Overall Study|Study Terminated by Sponsor|0|||
164716381|NCT04544995|594984331|FG002|Overall Study|Study Terminated by Sponsor|0|||
164716382|NCT04544995|594984332|FG003|Overall Study|Study Terminated by Sponsor|0|||
164716383|NCT04544995|594984333|FG004|Overall Study|Study Terminated by Sponsor|0|||
164716384|NCT04544995|594984334|FG005|Overall Study|Study Terminated by Sponsor|0|||
164502670|NCT01502371|594211257|FG004|Overall Study|Withdrawal by Subject|1|||
164502671|NCT01502371|594211253|FG000|Overall Study|Adverse Event|2|||
164502672|NCT01502371|594211254|FG001|Overall Study|Adverse Event|1|||
164502673|NCT01502371|594211255|FG002|Overall Study|Adverse Event|0|||
164502674|NCT01502371|594211256|FG003|Overall Study|Adverse Event|4|||
164502675|NCT01502371|594211257|FG004|Overall Study|Adverse Event|3|||
164502676|NCT01502371|594211253|FG000|Overall Study|Treatment Failure|22|||
164502677|NCT01502371|594211254|FG001|Overall Study|Treatment Failure|20|||
164502678|NCT01502371|594211255|FG002|Overall Study|Treatment Failure|12|||
164502679|NCT01502371|594211256|FG003|Overall Study|Treatment Failure|19|||
164502680|NCT01502371|594211257|FG004|Overall Study|Treatment Failure|30|||
164502681|NCT01502371|594211253|FG000|Overall Study|Lack of Efficacy|3|||
164502682|NCT01502371|594211254|FG001|Overall Study|Lack of Efficacy|3|||
164716385|NCT04544995|594984335|FG006|Overall Study|Study Terminated by Sponsor|1|||
164716386|NCT04544995|594984329|FG000|Overall Study|Reached protocol-defined stopping criteria|3|||
164716387|NCT04544995|594984330|FG001|Overall Study|Reached protocol-defined stopping criteria|4|||
164716388|NCT04544995|594984331|FG002|Overall Study|Reached protocol-defined stopping criteria|2|||
164716389|NCT04544995|594984332|FG003|Overall Study|Reached protocol-defined stopping criteria|0|||
164716390|NCT04544995|594984333|FG004|Overall Study|Reached protocol-defined stopping criteria|4|||
164716391|NCT04544995|594984334|FG005|Overall Study|Reached protocol-defined stopping criteria|4|||
164716392|NCT04544995|594984335|FG006|Overall Study|Reached protocol-defined stopping criteria|1|||
164716393|NCT06865677|594984336|FG000|Overall Study|Screen failure|1|||
164716394|NCT06865677|594984337|FG001|Overall Study|Screen failure|0|||
164716395|NCT06865677|594984336|FG000|Overall Study|Participant no longer eligible before start of conditioning|0|||
164606390|NCT02678312|594580945|FG000|Part 2 Double Blind Epoch|Death|0|||
164606391|NCT02678312|594580946|FG001|Part 2 Double Blind Epoch|Death|0|||
164606392|NCT02678312|594580947|FG002|Part 2 Double Blind Epoch|Death|0|||
164606393|NCT02678312|594580948|FG003|Part 2 Double Blind Epoch|Death|8|||
164606394|NCT02678312|594580949|FG004|Part 2 Double Blind Epoch|Death|12|||
164606395|NCT02678312|594580945|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
164606396|NCT02678312|594580946|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
164606397|NCT02678312|594580947|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
164606398|NCT02678312|594580948|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
164606399|NCT02678312|594580949|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
164606400|NCT02678312|594580945|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
164606401|NCT02678312|594580946|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
164606402|NCT02678312|594580947|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
164606403|NCT02678312|594580948|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
164606404|NCT02678312|594580949|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
164606405|NCT02678312|594580945|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
164606406|NCT02678312|594580946|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
164606407|NCT02678312|594580947|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
164606408|NCT02678312|594580948|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
164606409|NCT02678312|594580949|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
164606410|NCT04624672|594580952|FG000|Overall Study|Early Study Closure|2|||
164606411|NCT04624672|594580953|FG001|Overall Study|Early Study Closure|1|||
164606412|NCT00010803|594580958|FG000|Overall Study|Withdrawal by Subject|97|||
164606413|NCT00010803|594580959|FG001|Overall Study|Withdrawal by Subject|98|||
164606414|NCT01415908|594580960|FG000|Overall Study|Withdrawal by Subject|1|||
164606415|NCT01415908|594580961|FG001|Overall Study|Withdrawal by Subject|0|||
164606416|NCT01779648|594580965|FG000|Overall Study|Protocol Violation|1|||
164606417|NCT01779648|594580966|FG001|Overall Study|Protocol Violation|0|||
164606418|NCT01878097|594580967|FG000|Baseline|Surveys not fully completed|2497|||
164606419|NCT01878097|594580968|FG001|Baseline|Surveys not fully completed|1800|||
164606420|NCT01878097|594580967|FG000|Implementation Year 1|Surveys not fully completed|3202|||
164606421|NCT01878097|594580968|FG001|Implementation Year 1|Surveys not fully completed|2549|||
164606422|NCT01878097|594580967|FG000|Implementation Year 2|Surveys not fully completed|3281|||
164606423|NCT01878097|594580968|FG001|Implementation Year 2|Surveys not fully completed|2841|||
164606424|NCT01878097|594580967|FG000|Implementation Year 3|Surveys not fully completed|3494|||
164606425|NCT01878097|594580968|FG001|Implementation Year 3|Surveys not fully completed|2980|||
164606426|NCT01878097|594580967|FG000|Implementation Year 4|Surveys not fully completed|3604|||
164606427|NCT01878097|594580968|FG001|Implementation Year 4|Surveys not fully completed|3007|||
164606428|NCT01595438|594580969|FG000|Overall Study|Lost to Follow-up|20|||
164606429|NCT01595438|594580970|FG001|Overall Study|Lost to Follow-up|20|||
164606430|NCT01595438|594580969|FG000|Overall Study|Withdrawal by Subject|12|||
164606431|NCT01595438|594580970|FG001|Overall Study|Withdrawal by Subject|12|||
164606432|NCT01595438|594580969|FG000|Overall Study|Other Eligibility criteria|11|||
164606433|NCT01595438|594580970|FG001|Overall Study|Other Eligibility criteria|9|||
164606434|NCT01373918|594580974|FG000|Overall Study|Physician Decision|0|||
164606435|NCT01373918|594580975|FG001|Overall Study|Physician Decision|1|||
164606436|NCT02786836|594580977|FG000|Overall Study|Death|1|||
164606437|NCT02786836|594580977|FG000|Overall Study|Lack of Efficacy|2|||
164606438|NCT02786836|594580977|FG000|Overall Study|Protocol Violation|3|||
164606439|NCT02786836|594580977|FG000|Overall Study|Withdrawal by Subject|3|||
164606440|NCT02786836|594580977|FG000|Overall Study|Liver Transplantation|2|||
164606441|NCT02786836|594580977|FG000|Overall Study|Device or Pharmacy Issues|3|||
164606442|NCT02016898|594580985|FG000|Overall Study|Death|1|||
164606443|NCT02016898|594580986|FG001|Overall Study|Death|1|||
164606444|NCT02016898|594580985|FG000|Overall Study|Lost to Follow-up|4|||
164606445|NCT02016898|594580986|FG001|Overall Study|Lost to Follow-up|4|||
164606446|NCT00171314|594580987|FG000|Overall Study|Adverse Event|44|||
164606447|NCT00171314|594580988|FG001|Overall Study|Adverse Event|41|||
164716396|NCT06865677|594984337|FG001|Overall Study|Participant no longer eligible before start of conditioning|1|||
164716397|NCT03299166|594984338|FG000|Overall Study|Adverse Event|9|||
164716398|NCT03299166|594984339|FG001|Overall Study|Adverse Event|4|||
164716399|NCT03299166|594984338|FG000|Overall Study|Withdrawal by Subject|6|||
164716400|NCT03299166|594984339|FG001|Overall Study|Withdrawal by Subject|5|||
164716401|NCT03299166|594984338|FG000|Overall Study|Physician Decision|1|||
164716402|NCT03299166|594984339|FG001|Overall Study|Physician Decision|1|||
164606448|NCT00171314|594580987|FG000|Overall Study|Lack of Efficacy|19|||
164606449|NCT00171314|594580988|FG001|Overall Study|Lack of Efficacy|14|||
164606450|NCT00171314|594580987|FG000|Overall Study|Withdrawal by Subject|9|||
164606451|NCT00171314|594580988|FG001|Overall Study|Withdrawal by Subject|6|||
164716403|NCT03299166|594984338|FG000|Overall Study|Sponsor Decision|3|||
164606452|NCT00171314|594580987|FG000|Overall Study|Abnormal Test Procedure Results|9|||
164606453|NCT00171314|594580988|FG001|Overall Study|Abnormal Test Procedure Results|3|||
164716404|NCT03299166|594984339|FG001|Overall Study|Sponsor Decision|0|||
164716405|NCT03299166|594984338|FG000|Overall Study|Lost to Follow-up|2|||
164606454|NCT00171314|594580987|FG000|Overall Study|Protocol Violation|3|||
164716406|NCT03299166|594984339|FG001|Overall Study|Lost to Follow-up|4|||
164716407|NCT03299166|594984338|FG000|Overall Study|Randomization Error|0|||
164716408|NCT03299166|594984339|FG001|Overall Study|Randomization Error|1|||
164716409|NCT03299166|594984338|FG000|Overall Study|Subject unable to return due to COVID|1|||
164716410|NCT03299166|594984339|FG001|Overall Study|Subject unable to return due to COVID|0|||
164716411|NCT03299166|594984338|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
164716412|NCT03299166|594984339|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
164716413|NCT02408861|594984340|FG000|Overall Study|Death|0|||
164502683|NCT01502371|594211255|FG002|Overall Study|Lack of Efficacy|2|||
164502684|NCT01502371|594211256|FG003|Overall Study|Lack of Efficacy|2|||
164502685|NCT01502371|594211257|FG004|Overall Study|Lack of Efficacy|4|||
164502686|NCT01502371|594211253|FG000|Overall Study|Physician Decision|3|||
164502687|NCT01502371|594211254|FG001|Overall Study|Physician Decision|0|||
164502688|NCT01502371|594211255|FG002|Overall Study|Physician Decision|0|||
164502689|NCT01502371|594211256|FG003|Overall Study|Physician Decision|0|||
164502690|NCT01502371|594211257|FG004|Overall Study|Physician Decision|1|||
164502691|NCT01502371|594211253|FG000|Overall Study|Noncompliance with Study Drug|0|||
164502692|NCT01502371|594211254|FG001|Overall Study|Noncompliance with Study Drug|0|||
164502693|NCT01502371|594211255|FG002|Overall Study|Noncompliance with Study Drug|1|||
164502694|NCT01502371|594211256|FG003|Overall Study|Noncompliance with Study Drug|2|||
164502695|NCT01502371|594211257|FG004|Overall Study|Noncompliance with Study Drug|1|||
164502696|NCT01502371|594211253|FG000|Overall Study|Technical Problems|1|||
164502697|NCT01502371|594211254|FG001|Overall Study|Technical Problems|0|||
164502698|NCT01502371|594211255|FG002|Overall Study|Technical Problems|2|||
164502699|NCT01502371|594211256|FG003|Overall Study|Technical Problems|4|||
164502700|NCT01502371|594211257|FG004|Overall Study|Technical Problems|1|||
164502701|NCT01502371|594211253|FG000|Overall Study|Protocol Violation|9|||
164502702|NCT01502371|594211254|FG001|Overall Study|Protocol Violation|5|||
164502703|NCT01502371|594211255|FG002|Overall Study|Protocol Violation|6|||
164502704|NCT01502371|594211256|FG003|Overall Study|Protocol Violation|5|||
164502705|NCT01502371|594211257|FG004|Overall Study|Protocol Violation|10|||
164502706|NCT01502371|594211253|FG000|Overall Study|Excluded Medication|0|||
164502707|NCT01502371|594211254|FG001|Overall Study|Excluded Medication|1|||
164502708|NCT01502371|594211255|FG002|Overall Study|Excluded Medication|1|||
164502709|NCT01502371|594211256|FG003|Overall Study|Excluded Medication|0|||
164502710|NCT01502371|594211257|FG004|Overall Study|Excluded Medication|1|||
164502711|NCT03325608|594211258|FG000|Overall Study|Lost to Follow-up|23|||
164502712|NCT03325608|594211259|FG001|Overall Study|Lost to Follow-up|23|||
164502713|NCT03325608|594211260|FG002|Overall Study|Lost to Follow-up|30|||
164502714|NCT03325608|594211261|FG003|Overall Study|Lost to Follow-up|30|||
164502715|NCT03325608|594211258|FG000|Overall Study|Death of Caregiver|0|||
164502716|NCT03325608|594211259|FG001|Overall Study|Death of Caregiver|0|||
164502717|NCT03325608|594211260|FG002|Overall Study|Death of Caregiver|2|||
164502718|NCT03325608|594211261|FG003|Overall Study|Death of Caregiver|2|||
164502719|NCT03325608|594211258|FG000|Overall Study|Death of Care Recipient|34|||
164502720|NCT03325608|594211259|FG001|Overall Study|Death of Care Recipient|34|||
164502721|NCT03325608|594211260|FG002|Overall Study|Death of Care Recipient|28|||
164502722|NCT03325608|594211261|FG003|Overall Study|Death of Care Recipient|28|||
164502723|NCT03325608|594211258|FG000|Overall Study|Withdrawal by Subject|49|||
164502724|NCT03325608|594211259|FG001|Overall Study|Withdrawal by Subject|49|||
164502725|NCT03325608|594211260|FG002|Overall Study|Withdrawal by Subject|35|||
164502726|NCT03325608|594211261|FG003|Overall Study|Withdrawal by Subject|35|||
164502727|NCT03325608|594211258|FG000|Overall Study|Ineligible|7|||
164502728|NCT03325608|594211259|FG001|Overall Study|Ineligible|7|||
164502729|NCT03325608|594211260|FG002|Overall Study|Ineligible|5|||
164502730|NCT03325608|594211261|FG003|Overall Study|Ineligible|5|||
164502731|NCT03900715|594211264|FG000|Overall Study|Protocol Deviation|1|||
164502732|NCT03900715|594211264|FG000|Overall Study|Lack of Efficacy|1|||
164502733|NCT03900715|594211264|FG000|Overall Study|Progressive Disease|6|||
164502734|NCT03900715|594211264|FG000|Overall Study|Adverse Event|2|||
164502735|NCT03900715|594211264|FG000|Overall Study|Other reasons|11|||
164502736|NCT01639742|594213141|FG000|Overall Study|Study Ongoing|17|||
164502737|NCT01639742|594213141|FG000|Overall Study|Lost to Follow-up|1|||
164502738|NCT01986114|594213142|FG000|Overall Study|Adverse Event|59|||
164716414|NCT02408861|594984341|FG001|Overall Study|Death|3|||
164716415|NCT02408861|594984342|FG002|Overall Study|Death|1|||
164502739|NCT01986114|594213142|FG000|Overall Study|Lack of Efficacy|23|||
164502740|NCT01986114|594213142|FG000|Overall Study|Withdrawal by Subject|58|||
164502741|NCT01986114|594213142|FG000|Overall Study|Noncompliance|3|||
164502742|NCT01986114|594213142|FG000|Overall Study|Protocol Violation|1|||
164502743|NCT01986114|594213142|FG000|Overall Study|Lost to Follow-up|5|||
164716416|NCT02408861|594984343|FG003|Overall Study|Death|2|||
164716417|NCT02408861|594984344|FG004|Overall Study|Death|4|||
164716418|NCT02408861|594984345|FG005|Overall Study|Death|1|||
164502744|NCT01986114|594213142|FG000|Overall Study|Other reason|7|||
164502745|NCT04411186|594213143|FG000|Overall Study|Withdrawn due to protocol violation|0|||
164502746|NCT04411186|594213144|FG001|Overall Study|Withdrawn due to protocol violation|1|||
164502747|NCT02172911|594213145|FG000|Overall Study|Serious Adverse Event|0|||
164502748|NCT02172911|594213146|FG001|Overall Study|Serious Adverse Event|1|||
164716419|NCT02408861|594984346|FG006|Overall Study|Death|0|||
164716420|NCT02408861|594984340|FG000|Overall Study|Lost to Follow-up|0|||
164716421|NCT02408861|594984341|FG001|Overall Study|Lost to Follow-up|0|||
164716422|NCT02408861|594984342|FG002|Overall Study|Lost to Follow-up|1|||
164716423|NCT02408861|594984343|FG003|Overall Study|Lost to Follow-up|1|||
164716424|NCT02408861|594984344|FG004|Overall Study|Lost to Follow-up|4|||
164716425|NCT02408861|594984345|FG005|Overall Study|Lost to Follow-up|2|||
164716426|NCT02408861|594984346|FG006|Overall Study|Lost to Follow-up|1|||
164502749|NCT02172911|594213145|FG000|Overall Study|Progression of Disease|0|||
164502750|NCT02172911|594213146|FG001|Overall Study|Progression of Disease|1|||
164502751|NCT02172911|594213145|FG000|Overall Study|Loss of insurance coverage|1|||
164502752|NCT02172911|594213146|FG001|Overall Study|Loss of insurance coverage|0|||
164502753|NCT00575042|594213149|FG000|Overall Study|Adverse Event|2|||
164502754|NCT00575042|594213149|FG000|Overall Study|Lost to Follow-up|1|||
164502755|NCT04795336|594213152|FG000|Overall Study|Withdrawal by Subject|3|||
164502756|NCT04795336|594213153|FG001|Overall Study|Withdrawal by Subject|4|||
164502757|NCT04795336|594213154|FG002|Overall Study|Withdrawal by Subject|3|||
164502758|NCT04795336|594213155|FG003|Overall Study|Withdrawal by Subject|12|||
164502759|NCT04795336|594213152|FG000|Overall Study|Lost study logs|0|||
164502760|NCT04795336|594213153|FG001|Overall Study|Lost study logs|1|||
164502761|NCT04795336|594213154|FG002|Overall Study|Lost study logs|0|||
164502762|NCT04795336|594213155|FG003|Overall Study|Lost study logs|2|||
164502763|NCT04795336|594213152|FG000|Overall Study|Did not take study medication|2|||
164502764|NCT04795336|594213153|FG001|Overall Study|Did not take study medication|0|||
164502765|NCT04795336|594213154|FG002|Overall Study|Did not take study medication|0|||
164502766|NCT04795336|594213155|FG003|Overall Study|Did not take study medication|0|||
164502767|NCT01266018|594213156|FG000|Overall Study|Physician Decision|1|||
164502768|NCT01266018|594213157|FG001|Overall Study|Physician Decision|0|||
164502769|NCT01266018|594213156|FG000|Overall Study|Progressive disease|0|||
164502770|NCT01266018|594213157|FG001|Overall Study|Progressive disease|1|||
164502771|NCT03167151|594213158|FG000|Overall Study|Withdrawal by Subject|1|||
164502772|NCT03167151|594213159|FG001|Overall Study|Withdrawal by Subject|0|||
164502773|NCT03167151|594213160|FG002|Overall Study|Withdrawal by Subject|0|||
164502774|NCT03167151|594213158|FG000|Overall Study|No evidence of tumour at surgery|0|||
164502775|NCT03167151|594213159|FG001|Overall Study|No evidence of tumour at surgery|1|||
164502776|NCT03167151|594213160|FG002|Overall Study|No evidence of tumour at surgery|1|||
164502777|NCT01458522|594213161|FG000|Overall Study|Withdrawal by Subject|2|||
164502778|NCT01458522|594213162|FG001|Overall Study|Withdrawal by Subject|2|||
164502779|NCT01458522|594213161|FG000|Overall Study|Physician Decision|1|||
164502780|NCT01458522|594213162|FG001|Overall Study|Physician Decision|9|||
164502781|NCT00516139|594213163|FG000|Overall Study|Adverse Event|27|||
164502782|NCT00516139|594213163|FG000|Overall Study|Lost to Follow-up|1|||
164502783|NCT00516139|594213163|FG000|Overall Study|Protocol Violation|1|||
164502784|NCT00516139|594213163|FG000|Overall Study|Withdrawal by Subject|8|||
164502785|NCT00516139|594213163|FG000|Overall Study|Lack of Efficacy|1|||
164502786|NCT00589303|594213164|FG000|Overall Study|Withdrawal by Subject|2|||
164502787|NCT00589303|594213165|FG001|Overall Study|Withdrawal by Subject|1|||
164502788|NCT00730015|594213166|FG000|Overall Study|Adverse Event|11|||
164502789|NCT00730015|594213167|FG001|Overall Study|Adverse Event|10|||
164502790|NCT00730015|594213168|FG002|Overall Study|Adverse Event|8|||
164502791|NCT00730015|594213166|FG000|Overall Study|Protocol Violation|2|||
164502792|NCT00730015|594213167|FG001|Overall Study|Protocol Violation|6|||
164502793|NCT00730015|594213168|FG002|Overall Study|Protocol Violation|4|||
164502794|NCT00730015|594213166|FG000|Overall Study|Withdrawal by Subject|12|||
164502795|NCT00730015|594213167|FG001|Overall Study|Withdrawal by Subject|12|||
164502796|NCT00730015|594213168|FG002|Overall Study|Withdrawal by Subject|8|||
164502797|NCT00730015|594213166|FG000|Overall Study|Lost to Follow-up|4|||
164502798|NCT00730015|594213167|FG001|Overall Study|Lost to Follow-up|10|||
164502799|NCT00730015|594213168|FG002|Overall Study|Lost to Follow-up|3|||
164502800|NCT00730015|594213166|FG000|Overall Study|Lack of Efficacy|1|||
164502801|NCT00730015|594213167|FG001|Overall Study|Lack of Efficacy|2|||
164502802|NCT00730015|594213168|FG002|Overall Study|Lack of Efficacy|8|||
164502803|NCT00730015|594213166|FG000|Overall Study|Other Reason|1|||
164502804|NCT00730015|594213167|FG001|Overall Study|Other Reason|0|||
164502805|NCT00730015|594213168|FG002|Overall Study|Other Reason|1|||
164716427|NCT02408861|594984340|FG000|Overall Study|Disease Progression|0|||
164716428|NCT02408861|594984341|FG001|Overall Study|Disease Progression|0|||
164716429|NCT02408861|594984342|FG002|Overall Study|Disease Progression|1|||
164502806|NCT03062449|594213170|FG000|Overall Study|Withdrawal by Subject|7|||
164502807|NCT03062449|594213171|FG001|Overall Study|Withdrawal by Subject|1|||
164502808|NCT02053610|594213173|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
164502809|NCT02053610|594213174|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
164502810|NCT02053610|594213173|FG000|Overall Study|Withdrew Consent|2|||
164502811|NCT02053610|594213174|FG001|Overall Study|Withdrew Consent|9|||
164716430|NCT02408861|594984343|FG003|Overall Study|Disease Progression|0|||
164716431|NCT02408861|594984344|FG004|Overall Study|Disease Progression|3|||
164716432|NCT02408861|594984345|FG005|Overall Study|Disease Progression|1|||
164716433|NCT02408861|594984346|FG006|Overall Study|Disease Progression|1|||
164716434|NCT02408861|594984340|FG000|Overall Study|Adverse Event|1|||
164716435|NCT02408861|594984341|FG001|Overall Study|Adverse Event|0|||
164716436|NCT02408861|594984342|FG002|Overall Study|Adverse Event|1|||
164716437|NCT02408861|594984343|FG003|Overall Study|Adverse Event|0|||
164502812|NCT02053610|594213173|FG000|Overall Study|Death|5|||
164502813|NCT02053610|594213174|FG001|Overall Study|Death|5|||
164502814|NCT02053610|594213173|FG000|Overall Study|Administrative/Other|1|||
164502815|NCT02053610|594213174|FG001|Overall Study|Administrative/Other|1|||
164502816|NCT02053610|594213173|FG000|Overall Study|Disease Progression|2|||
164502817|NCT02053610|594213174|FG001|Overall Study|Disease Progression|3|||
164502818|NCT02053610|594213173|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
164502819|NCT02053610|594213174|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
164502820|NCT02053610|594213173|FG000|Overall Study|Did not Receive Treatment|4|||
164502821|NCT02053610|594213174|FG001|Overall Study|Did not Receive Treatment|2|||
164502822|NCT02053610|594213173|FG000|Overall Study|Insufficient Therapeutic Response|1|||
164502823|NCT02053610|594213174|FG001|Overall Study|Insufficient Therapeutic Response|1|||
164502824|NCT02053610|594213173|FG000|Overall Study|Violation of Selection Criteria|1|||
164502825|NCT02053610|594213174|FG001|Overall Study|Violation of Selection Criteria|0|||
164502826|NCT00810342|594213175|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
164502827|NCT00810342|594213176|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
164502828|NCT00810342|594213175|FG000|Month 1 Follow-up|Pregnancy|1|||
164502829|NCT00810342|594213176|FG001|Month 1 Follow-up|Pregnancy|0|||
164502830|NCT00810342|594213175|FG000|6-month Follow-up|Lost to Follow-up|18|||
164502831|NCT00810342|594213176|FG001|6-month Follow-up|Lost to Follow-up|6|||
164502832|NCT00810342|594213175|FG000|6-month Follow-up|Pregnancy|6|||
164502833|NCT00810342|594213176|FG001|6-month Follow-up|Pregnancy|2|||
164502834|NCT00810342|594213175|FG000|12-month Followup|Pregnancy|9|||
164502835|NCT00810342|594213176|FG001|12-month Followup|Pregnancy|10|||
164502836|NCT00810342|594213175|FG000|12-month Followup|Lost to Follow-up|3|||
164502837|NCT00810342|594213176|FG001|12-month Followup|Lost to Follow-up|1|||
164502838|NCT02330562|594213177|FG000|Overall Study|Adverse Event|0|||
164502839|NCT02330562|594213178|FG001|Overall Study|Adverse Event|0|||
164502840|NCT02330562|594213179|FG002|Overall Study|Adverse Event|3|||
164502841|NCT02330562|594213180|FG003|Overall Study|Adverse Event|0|||
164502842|NCT02330562|594213181|FG004|Overall Study|Adverse Event|3|||
164502843|NCT02330562|594213182|FG005|Overall Study|Adverse Event|1|||
164502844|NCT02330562|594213183|FG006|Overall Study|Adverse Event|0|||
164502845|NCT02330562|594213184|FG007|Overall Study|Adverse Event|0|||
164502846|NCT02330562|594213185|FG008|Overall Study|Adverse Event|0|||
164502847|NCT02330562|594213186|FG009|Overall Study|Adverse Event|1|||
164502848|NCT02330562|594213187|FG010|Overall Study|Adverse Event|1|||
164502849|NCT02330562|594213177|FG000|Overall Study|Participant decision|1|||
164502850|NCT02330562|594213178|FG001|Overall Study|Participant decision|0|||
164502851|NCT02330562|594213179|FG002|Overall Study|Participant decision|4|||
164502852|NCT02330562|594213180|FG003|Overall Study|Participant decision|1|||
164502853|NCT02330562|594213181|FG004|Overall Study|Participant decision|5|||
164502854|NCT02330562|594213182|FG005|Overall Study|Participant decision|2|||
164502855|NCT02330562|594213183|FG006|Overall Study|Participant decision|0|||
164502856|NCT02330562|594213184|FG007|Overall Study|Participant decision|0|||
164502857|NCT02330562|594213185|FG008|Overall Study|Participant decision|0|||
164502858|NCT02330562|594213186|FG009|Overall Study|Participant decision|3|||
164502859|NCT02330562|594213187|FG010|Overall Study|Participant decision|0|||
164502860|NCT02330562|594213177|FG000|Overall Study|Disease progression|5|||
164502861|NCT02330562|594213178|FG001|Overall Study|Disease progression|3|||
164502862|NCT02330562|594213179|FG002|Overall Study|Disease progression|20|||
164502863|NCT02330562|594213180|FG003|Overall Study|Disease progression|28|||
164502864|NCT02330562|594213181|FG004|Overall Study|Disease progression|23|||
164502865|NCT02330562|594213182|FG005|Overall Study|Disease progression|7|||
164502866|NCT02330562|594213183|FG006|Overall Study|Disease progression|1|||
164502867|NCT02330562|594213184|FG007|Overall Study|Disease progression|1|||
164502868|NCT02330562|594213185|FG008|Overall Study|Disease progression|1|||
164502869|NCT02330562|594213186|FG009|Overall Study|Disease progression|0|||
164502870|NCT02330562|594213187|FG010|Overall Study|Disease progression|5|||
164502871|NCT02330562|594213177|FG000|Overall Study|Other reasons|0|||
164502872|NCT02330562|594213178|FG001|Overall Study|Other reasons|0|||
164502873|NCT02330562|594213179|FG002|Overall Study|Other reasons|0|||
164502874|NCT02330562|594213180|FG003|Overall Study|Other reasons|1|||
164502875|NCT02330562|594213181|FG004|Overall Study|Other reasons|0|||
164502876|NCT02330562|594213182|FG005|Overall Study|Other reasons|0|||
164502877|NCT02330562|594213183|FG006|Overall Study|Other reasons|0|||
164502878|NCT02330562|594213184|FG007|Overall Study|Other reasons|0|||
164502879|NCT02330562|594213185|FG008|Overall Study|Other reasons|0|||
164502880|NCT02330562|594213186|FG009|Overall Study|Other reasons|0|||
164716438|NCT02408861|594984344|FG004|Overall Study|Adverse Event|2|||
164502881|NCT02330562|594213187|FG010|Overall Study|Other reasons|0|||
164716439|NCT02408861|594984345|FG005|Overall Study|Adverse Event|0|||
164716440|NCT02408861|594984346|FG006|Overall Study|Adverse Event|0|||
164716441|NCT02408861|594984340|FG000|Overall Study|Physician Decision|1|||
164716442|NCT02408861|594984341|FG001|Overall Study|Physician Decision|1|||
164716443|NCT02408861|594984342|FG002|Overall Study|Physician Decision|1|||
164716444|NCT02408861|594984343|FG003|Overall Study|Physician Decision|0|||
164716445|NCT02408861|594984344|FG004|Overall Study|Physician Decision|0|||
164716446|NCT02408861|594984345|FG005|Overall Study|Physician Decision|1|||
164716447|NCT02408861|594984346|FG006|Overall Study|Physician Decision|0|||
164716448|NCT02408861|594984340|FG000|Overall Study|Protocol Violation|1|||
164716449|NCT02408861|594984341|FG001|Overall Study|Protocol Violation|0|||
164716450|NCT02408861|594984342|FG002|Overall Study|Protocol Violation|0|||
164716451|NCT02408861|594984343|FG003|Overall Study|Protocol Violation|0|||
164716452|NCT02408861|594984344|FG004|Overall Study|Protocol Violation|0|||
164716453|NCT02408861|594984345|FG005|Overall Study|Protocol Violation|0|||
164716454|NCT02408861|594984346|FG006|Overall Study|Protocol Violation|0|||
164716455|NCT02408861|594984340|FG000|Overall Study|Withdrawal by Subject|0|||
164716456|NCT02408861|594984341|FG001|Overall Study|Withdrawal by Subject|0|||
164716457|NCT02408861|594984342|FG002|Overall Study|Withdrawal by Subject|0|||
164716458|NCT02408861|594984343|FG003|Overall Study|Withdrawal by Subject|0|||
164716459|NCT02408861|594984344|FG004|Overall Study|Withdrawal by Subject|1|||
164716460|NCT02408861|594984345|FG005|Overall Study|Withdrawal by Subject|1|||
164716461|NCT02408861|594984346|FG006|Overall Study|Withdrawal by Subject|0|||
164716462|NCT02408861|594984340|FG000|Overall Study|Other Treatment|0|||
164716463|NCT02408861|594984341|FG001|Overall Study|Other Treatment|0|||
164716464|NCT02408861|594984342|FG002|Overall Study|Other Treatment|0|||
164716465|NCT02408861|594984343|FG003|Overall Study|Other Treatment|0|||
164716466|NCT02408861|594984344|FG004|Overall Study|Other Treatment|0|||
164716467|NCT02408861|594984345|FG005|Overall Study|Other Treatment|1|||
164716468|NCT02408861|594984346|FG006|Overall Study|Other Treatment|1|||
164716469|NCT05147662|594984349|FG000|Overall Study|Withdrawal by parent/guardian|3|||
164716470|NCT05147662|594984349|FG000|Overall Study|Assigned to treatment but never treated|1|||
164606455|NCT00171314|594580988|FG001|Overall Study|Protocol Violation|7|||
164606456|NCT00171314|594580987|FG000|Overall Study|Administrative Problems|4|||
164606457|NCT00171314|594580988|FG001|Overall Study|Administrative Problems|3|||
164606458|NCT00171314|594580987|FG000|Overall Study|Lost to Follow-up|1|||
164606459|NCT00171314|594580988|FG001|Overall Study|Lost to Follow-up|3|||
164606460|NCT00171314|594580987|FG000|Overall Study|Death|2|||
164606461|NCT00171314|594580988|FG001|Overall Study|Death|1|||
164606462|NCT01397448|594580991|FG000|Overall Study|Adverse Event|4|||
164606463|NCT01397448|594580992|FG001|Overall Study|Adverse Event|4|||
164606464|NCT01397448|594580993|FG002|Overall Study|Adverse Event|6|||
164606465|NCT01397448|594580991|FG000|Overall Study|Withdrawal by Subject|4|||
164606466|NCT01397448|594580992|FG001|Overall Study|Withdrawal by Subject|4|||
164606467|NCT01397448|594580993|FG002|Overall Study|Withdrawal by Subject|3|||
164606468|NCT01397448|594580991|FG000|Overall Study|Lack of Efficacy|2|||
164606469|NCT01397448|594580992|FG001|Overall Study|Lack of Efficacy|0|||
164606470|NCT01397448|594580993|FG002|Overall Study|Lack of Efficacy|5|||
164606471|NCT01397448|594580991|FG000|Overall Study|Other|8|||
164606472|NCT01397448|594580992|FG001|Overall Study|Other|7|||
164606473|NCT01397448|594580993|FG002|Overall Study|Other|4|||
164606474|NCT01409993|594580996|FG000|Overall Study|Adverse Event|4|||
164606475|NCT01409993|594580997|FG001|Overall Study|Adverse Event|4|||
164606476|NCT01409993|594580998|FG002|Overall Study|Adverse Event|3|||
164606477|NCT01409993|594580999|FG003|Overall Study|Adverse Event|1|||
164606478|NCT01409993|594580996|FG000|Overall Study|Withdrawal by Subject|0|||
164606479|NCT01409993|594580997|FG001|Overall Study|Withdrawal by Subject|0|||
164606480|NCT01409993|594580998|FG002|Overall Study|Withdrawal by Subject|0|||
164606481|NCT01409993|594580999|FG003|Overall Study|Withdrawal by Subject|4|||
164606482|NCT01409993|594580996|FG000|Overall Study|Lost to Follow-up|0|||
164606483|NCT01409993|594580997|FG001|Overall Study|Lost to Follow-up|1|||
164606484|NCT01409993|594580998|FG002|Overall Study|Lost to Follow-up|0|||
164606485|NCT01409993|594580999|FG003|Overall Study|Lost to Follow-up|0|||
164606486|NCT03074149|594581003|FG000|Overall Study|Reason unknown|22|||
164606487|NCT03074149|594581004|FG001|Overall Study|Reason unknown|35|||
164606488|NCT03074149|594581003|FG000|Overall Study|Death|10|||
164606489|NCT03074149|594581004|FG001|Overall Study|Death|45|||
164716471|NCT03091192|594985108|FG000|Overall Study|Study terminated by sponsor|21|||
164716472|NCT03091192|594985109|FG001|Overall Study|Study terminated by sponsor|14|||
164716473|NCT03091192|594985108|FG000|Overall Study|Death|9|||
164716474|NCT03091192|594985109|FG001|Overall Study|Death|13|||
164716475|NCT03091192|594985108|FG000|Overall Study|Withdrawal by Subject|2|||
164716476|NCT03091192|594985109|FG001|Overall Study|Withdrawal by Subject|0|||
164716477|NCT03091192|594985108|FG000|Overall Study|Lost to Follow-up|1|||
164716478|NCT03091192|594985109|FG001|Overall Study|Lost to Follow-up|0|||
164716479|NCT06602466|594985115|FG000|Overall Study|Adverse Event|2|||
164606490|NCT02855450|594581005|FG000|Overall Study|Adverse Event|1|||
164606491|NCT02855450|594581006|FG001|Overall Study|Adverse Event|0|||
164606492|NCT02855450|594581005|FG000|Overall Study|Lost to Follow-up|4|||
164606493|NCT02855450|594581006|FG001|Overall Study|Lost to Follow-up|0|||
164606494|NCT01803711|594581007|FG000|Overall Study|Adverse Event|1|||
164606495|NCT01803711|594581008|FG001|Overall Study|Adverse Event|1|||
164606496|NCT01376245|594581013|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
164606497|NCT01376245|594581014|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
164606498|NCT01376245|594581015|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
164606499|NCT01376245|594581016|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
164606500|NCT01376245|594581017|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
164606501|NCT01376245|594581013|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
164606502|NCT01376245|594581014|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
164606503|NCT01376245|594581015|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
164606504|NCT01376245|594581016|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
164606505|NCT01376245|594581017|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
164606506|NCT01376245|594581013|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
164606507|NCT01376245|594581014|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
164606508|NCT01376245|594581015|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
164606509|NCT01376245|594581016|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
164606510|NCT01376245|594581017|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
164606511|NCT01376245|594581013|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
164606512|NCT01376245|594581014|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
164606513|NCT01376245|594581015|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
164606514|NCT01376245|594581016|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
164606515|NCT01376245|594581017|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
164606516|NCT01376245|594581013|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
164606517|NCT01376245|594581014|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
164606518|NCT01376245|594581015|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
164606519|NCT01376245|594581016|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
164606520|NCT01376245|594581017|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
164606521|NCT01376245|594581013|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
164606522|NCT01376245|594581014|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
164606523|NCT01376245|594581015|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
164606524|NCT01376245|594581016|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
164606525|NCT01376245|594581017|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
164606526|NCT01376245|594581013|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
164606527|NCT01376245|594581014|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
164606528|NCT01376245|594581015|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
164606529|NCT01376245|594581016|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
164606530|NCT01376245|594581017|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
164606531|NCT01376245|594581013|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
164606532|NCT01376245|594581014|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
164606533|NCT01376245|594581015|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
164606534|NCT01376245|594581016|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
164606535|NCT01376245|594581017|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
164606536|NCT01376245|594581013|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
164606537|NCT01376245|594581014|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
164606538|NCT01376245|594581015|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
164606539|NCT01376245|594581016|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
164606540|NCT01376245|594581017|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
164606541|NCT01376245|594581013|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164606542|NCT01376245|594581014|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
164606543|NCT01376245|594581015|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164606544|NCT01376245|594581016|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
164606545|NCT01376245|594581017|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
164606546|NCT01376245|594581013|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
164606547|NCT01376245|594581014|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
164606548|NCT01376245|594581015|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
164606549|NCT01376245|594581016|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
164606550|NCT01376245|594581017|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
164606551|NCT01376245|594581013|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
164606552|NCT01376245|594581014|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
164606553|NCT01376245|594581015|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
164606554|NCT01376245|594581016|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
164716480|NCT06602466|594985116|FG001|Overall Study|Adverse Event|0|||
164716481|NCT06602466|594985115|FG000|Overall Study|Lost to Follow-up|1|||
164716482|NCT06602466|594985116|FG001|Overall Study|Lost to Follow-up|3|||
164716483|NCT06602466|594985115|FG000|Overall Study|Withdrawal by Subject|1|||
164502882|NCT02330562|594213177|FG000|Overall Study|Withdrawal by Subject|0|||
164502883|NCT02330562|594213178|FG001|Overall Study|Withdrawal by Subject|0|||
164502884|NCT02330562|594213179|FG002|Overall Study|Withdrawal by Subject|0|||
164502885|NCT02330562|594213180|FG003|Overall Study|Withdrawal by Subject|0|||
164502886|NCT02330562|594213181|FG004|Overall Study|Withdrawal by Subject|0|||
164502887|NCT02330562|594213182|FG005|Overall Study|Withdrawal by Subject|0|||
164502888|NCT02330562|594213183|FG006|Overall Study|Withdrawal by Subject|0|||
164502889|NCT02330562|594213184|FG007|Overall Study|Withdrawal by Subject|0|||
164502890|NCT02330562|594213185|FG008|Overall Study|Withdrawal by Subject|0|||
164502891|NCT02330562|594213186|FG009|Overall Study|Withdrawal by Subject|1|||
164502892|NCT02330562|594213187|FG010|Overall Study|Withdrawal by Subject|0|||
164502893|NCT01657799|594213189|FG000|Overall Study|Adverse Event Related to progression|6|||
164502894|NCT01657799|594213190|FG001|Overall Study|Adverse Event Related to progression|8|||
164502895|NCT01657799|594213191|FG002|Overall Study|Adverse Event Related to progression|12|||
164502896|NCT01657799|594213189|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
164502897|NCT01657799|594213190|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
164502898|NCT01657799|594213191|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
164502899|NCT01657799|594213189|FG000|Overall Study|Withdrawal by Subject|13|||
164502900|NCT01657799|594213190|FG001|Overall Study|Withdrawal by Subject|10|||
164502901|NCT01657799|594213191|FG002|Overall Study|Withdrawal by Subject|10|||
164502902|NCT01657799|594213189|FG000|Overall Study|Lost to Follow-up|1|||
164502903|NCT01657799|594213190|FG001|Overall Study|Lost to Follow-up|0|||
164502904|NCT01657799|594213191|FG002|Overall Study|Lost to Follow-up|1|||
164502905|NCT01657799|594213189|FG000|Overall Study|Disease Progression|2|||
164502906|NCT01657799|594213190|FG001|Overall Study|Disease Progression|4|||
164502907|NCT01657799|594213191|FG002|Overall Study|Disease Progression|4|||
164502908|NCT01657799|594213189|FG000|Overall Study|Progressive Disease Clinical|7|||
164502909|NCT01657799|594213190|FG001|Overall Study|Progressive Disease Clinical|4|||
164502910|NCT01657799|594213191|FG002|Overall Study|Progressive Disease Clinical|7|||
164502911|NCT01657799|594213189|FG000|Overall Study|Radiographic & Clinical Progression|16|||
164502912|NCT01657799|594213190|FG001|Overall Study|Radiographic & Clinical Progression|11|||
164606555|NCT01376245|594581017|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
164606556|NCT05159362|594581018|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
164606557|NCT05159362|594581019|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
164606558|NCT05159362|594581020|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
164606559|NCT01357889|594581021|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
164606560|NCT01357889|594581022|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
164606561|NCT01357889|594581021|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
164606562|NCT01357889|594581022|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
164606563|NCT01357889|594581021|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
164606564|NCT01357889|594581022|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
164606565|NCT01357889|594581021|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
164606566|NCT01357889|594581022|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
164606567|NCT01357889|594581021|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
164606568|NCT01357889|594581022|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
164606569|NCT01357889|594581021|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
164606570|NCT01357889|594581022|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
164606571|NCT01357889|594581021|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
164606572|NCT01357889|594581022|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
164606573|NCT01357889|594581021|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
164606574|NCT01357889|594581022|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
164606575|NCT01357889|594581021|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
164606576|NCT01357889|594581022|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
164606577|NCT01357889|594581021|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
164606578|NCT01357889|594581022|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
164606579|NCT01357889|594581021|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
164606580|NCT01357889|594581022|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
164606581|NCT01357889|594581021|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
164606582|NCT01357889|594581022|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
164606583|NCT01357889|594581021|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
164606584|NCT01357889|594581022|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
164606585|NCT01335698|594581023|FG000|Treatment Stage 1|Lack of Efficacy|3|||
164606586|NCT01335698|594581024|FG001|Treatment Stage 1|Lack of Efficacy|1|||
164606587|NCT01335698|594581025|FG002|Treatment Stage 1|Lack of Efficacy|3|||
164606588|NCT01335698|594581026|FG003|Treatment Stage 1|Lack of Efficacy|3|||
164606589|NCT01335698|594581027|FG004|Treatment Stage 1|Lack of Efficacy|1|||
164606590|NCT01335698|594581023|FG000|Treatment Stage 1|Adverse Event|1|||
164606591|NCT01335698|594581024|FG001|Treatment Stage 1|Adverse Event|2|||
164716484|NCT06602466|594985116|FG001|Overall Study|Withdrawal by Subject|0|||
164606592|NCT01335698|594581025|FG002|Treatment Stage 1|Adverse Event|2|||
164606593|NCT01335698|594581026|FG003|Treatment Stage 1|Adverse Event|1|||
164606594|NCT01335698|594581027|FG004|Treatment Stage 1|Adverse Event|1|||
164606595|NCT01335698|594581023|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
164606596|NCT01335698|594581024|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
164606597|NCT01335698|594581025|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
164606598|NCT01335698|594581026|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
164606599|NCT01335698|594581027|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
164606600|NCT01335698|594581023|FG000|Treatment Stage 1|Lost to Follow-up|1|||
164606601|NCT01335698|594581024|FG001|Treatment Stage 1|Lost to Follow-up|1|||
164606602|NCT01335698|594581025|FG002|Treatment Stage 1|Lost to Follow-up|0|||
164606603|NCT01335698|594581026|FG003|Treatment Stage 1|Lost to Follow-up|0|||
164606604|NCT01335698|594581027|FG004|Treatment Stage 1|Lost to Follow-up|0|||
164606605|NCT01335698|594581023|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
164606606|NCT01335698|594581024|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
164606607|NCT01335698|594581025|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
164606608|NCT01335698|594581026|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
164606609|NCT01335698|594581027|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
164606610|NCT01335698|594581023|FG000|Treatment Stage 1|No longer meets study criteria|1|||
164606611|NCT01335698|594581024|FG001|Treatment Stage 1|No longer meets study criteria|1|||
164606612|NCT01335698|594581025|FG002|Treatment Stage 1|No longer meets study criteria|0|||
164606613|NCT01335698|594581026|FG003|Treatment Stage 1|No longer meets study criteria|1|||
164606614|NCT01335698|594581027|FG004|Treatment Stage 1|No longer meets study criteria|0|||
164606615|NCT01335698|594581023|FG000|Treatment Stage 1|Other|1|||
164606616|NCT01335698|594581024|FG001|Treatment Stage 1|Other|0|||
164606617|NCT01335698|594581025|FG002|Treatment Stage 1|Other|0|||
164606618|NCT01335698|594581026|FG003|Treatment Stage 1|Other|1|||
164606619|NCT01335698|594581027|FG004|Treatment Stage 1|Other|0|||
164606620|NCT01335698|594581023|FG000|Treatment Stage 2|Lack of Efficacy|2|||
164606621|NCT01335698|594581024|FG001|Treatment Stage 2|Lack of Efficacy|1|||
164606622|NCT01335698|594581025|FG002|Treatment Stage 2|Lack of Efficacy|3|||
164606623|NCT01335698|594581026|FG003|Treatment Stage 2|Lack of Efficacy|1|||
164606624|NCT01335698|594581027|FG004|Treatment Stage 2|Lack of Efficacy|0|||
164606625|NCT01335698|594581023|FG000|Treatment Stage 2|Adverse Event|2|||
164606626|NCT01335698|594581024|FG001|Treatment Stage 2|Adverse Event|0|||
164606627|NCT01335698|594581025|FG002|Treatment Stage 2|Adverse Event|0|||
164606628|NCT01335698|594581026|FG003|Treatment Stage 2|Adverse Event|3|||
164606629|NCT01335698|594581027|FG004|Treatment Stage 2|Adverse Event|0|||
164606630|NCT01335698|594581023|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
164606631|NCT01335698|594581024|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
164606632|NCT01335698|594581025|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
164606633|NCT01335698|594581026|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
164606634|NCT01335698|594581027|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
164606635|NCT01335698|594581023|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
164606636|NCT01335698|594581024|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
164606637|NCT01335698|594581025|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
164606638|NCT01335698|594581026|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
164606639|NCT01335698|594581027|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
164606640|NCT01335698|594581023|FG000|Treatment Stage 2|Lost to Follow-up|1|||
164606641|NCT01335698|594581024|FG001|Treatment Stage 2|Lost to Follow-up|0|||
164606642|NCT01335698|594581025|FG002|Treatment Stage 2|Lost to Follow-up|0|||
164606643|NCT01335698|594581026|FG003|Treatment Stage 2|Lost to Follow-up|0|||
164606644|NCT01335698|594581027|FG004|Treatment Stage 2|Lost to Follow-up|0|||
164606645|NCT01335698|594581023|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
164716485|NCT03818035|594985117|FG000|Part 1: Open-label (Week 0 to Week 8)|Lack of Efficacy|3|||
164716486|NCT03818035|594985118|FG001|Part 1: Open-label (Week 0 to Week 8)|Lack of Efficacy|0|||
164716487|NCT03818035|594985119|FG002|Part 1: Open-label (Week 0 to Week 8)|Lack of Efficacy|0|||
164716488|NCT03818035|594985120|FG003|Part 1: Open-label (Week 0 to Week 8)|Lack of Efficacy|0|||
164716489|NCT03818035|594985121|FG004|Part 1: Open-label (Week 0 to Week 8)|Lack of Efficacy|0|||
164606646|NCT01335698|594581024|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
164606647|NCT01335698|594581025|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
164606648|NCT01335698|594581026|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
164606649|NCT01335698|594581027|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
164606650|NCT01335698|594581023|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
164606651|NCT01335698|594581024|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
164606652|NCT01335698|594581025|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
164606653|NCT01335698|594581026|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
164606654|NCT01335698|594581027|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
164716490|NCT03818035|594985122|FG005|Part 1: Open-label (Week 0 to Week 8)|Lack of Efficacy|0|||
164606655|NCT01335698|594581023|FG000|Treatment Stage 2|Switched to another formulation|1|||
164606656|NCT01335698|594581024|FG001|Treatment Stage 2|Switched to another formulation|1|||
164606657|NCT01335698|594581025|FG002|Treatment Stage 2|Switched to another formulation|0|||
164606658|NCT01335698|594581026|FG003|Treatment Stage 2|Switched to another formulation|0|||
164606659|NCT01335698|594581027|FG004|Treatment Stage 2|Switched to another formulation|0|||
164606660|NCT01170221|594581028|FG000|Overall Study|Lost to Follow-up|22|||
164606661|NCT01170221|594581029|FG001|Overall Study|Lost to Follow-up|21|||
164606662|NCT01170221|594581028|FG000|Overall Study|Withdrawal by Subject|9|||
164606663|NCT01170221|594581029|FG001|Overall Study|Withdrawal by Subject|7|||
164606664|NCT01170221|594581028|FG000|Overall Study|Subject completed only screening and LFU|1|||
164606665|NCT01170221|594581029|FG001|Overall Study|Subject completed only screening and LFU|0|||
164606666|NCT01170221|594581028|FG000|Overall Study|Randomized but not treated|1|||
164606667|NCT01170221|594581029|FG001|Overall Study|Randomized but not treated|0|||
164606668|NCT02693691|594581030|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
164606669|NCT02693691|594581030|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
164606670|NCT02693691|594581030|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
164606671|NCT02693691|594581030|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
164606672|NCT02693691|594581030|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
164606673|NCT02693691|594581030|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
164606674|NCT02693691|594581030|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
164606675|NCT02727660|594581031|FG000|Overall Study|Lack of Efficacy|40|||
164606676|NCT02727660|594581032|FG001|Overall Study|Lack of Efficacy|40|||
164606677|NCT02727660|594581033|FG002|Overall Study|Lack of Efficacy|70|||
164606678|NCT02727660|594581031|FG000|Overall Study|Adverse Event|28|||
164606679|NCT02727660|594581032|FG001|Overall Study|Adverse Event|21|||
164606680|NCT02727660|594581033|FG002|Overall Study|Adverse Event|32|||
164606681|NCT02727660|594581031|FG000|Overall Study|Withdrawal by Subject|26|||
164606682|NCT02727660|594581032|FG001|Overall Study|Withdrawal by Subject|25|||
164606683|NCT02727660|594581033|FG002|Overall Study|Withdrawal by Subject|30|||
164606684|NCT02727660|594581031|FG000|Overall Study|Physician Decision|3|||
164606685|NCT02727660|594581032|FG001|Overall Study|Physician Decision|8|||
164606686|NCT02727660|594581033|FG002|Overall Study|Physician Decision|14|||
164606687|NCT02727660|594581031|FG000|Overall Study|Lost to Follow-up|5|||
164606688|NCT02727660|594581032|FG001|Overall Study|Lost to Follow-up|9|||
164606689|NCT02727660|594581033|FG002|Overall Study|Lost to Follow-up|8|||
164606690|NCT02727660|594581031|FG000|Overall Study|Protocol Violation|7|||
164606691|NCT02727660|594581032|FG001|Overall Study|Protocol Violation|5|||
164606692|NCT02727660|594581033|FG002|Overall Study|Protocol Violation|5|||
164606693|NCT02727660|594581031|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
164606694|NCT02727660|594581032|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
164606695|NCT02727660|594581033|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
164606696|NCT02727660|594581031|FG000|Overall Study|Administrative Reasons|2|||
164606697|NCT02727660|594581032|FG001|Overall Study|Administrative Reasons|3|||
164606698|NCT02727660|594581033|FG002|Overall Study|Administrative Reasons|4|||
164606699|NCT00050960|594581034|FG000|Overall Study|Progressive Disease|137|||
164606700|NCT00050960|594581035|FG001|Overall Study|Progressive Disease|93|||
164606701|NCT00050960|594581034|FG000|Overall Study|Stable Disease|19|||
164606702|NCT00050960|594581035|FG001|Overall Study|Stable Disease|48|||
164502913|NCT01657799|594213191|FG002|Overall Study|Radiographic & Clinical Progression|15|||
164502914|NCT01657799|594213189|FG000|Overall Study|Other|52|||
164502915|NCT01657799|594213190|FG001|Overall Study|Other|62|||
164502916|NCT01657799|594213191|FG002|Overall Study|Other|49|||
164502917|NCT00551135|594213192|FG000|Overall Study|Adverse Event|1|||
164502918|NCT00551135|594213193|FG001|Overall Study|Adverse Event|0|||
164606703|NCT00050960|594581034|FG000|Overall Study|Partial Response|14|||
164606704|NCT00050960|594581035|FG001|Overall Study|Partial Response|19|||
164606705|NCT00050960|594581034|FG000|Overall Study|Complete Response|0|||
164606706|NCT00050960|594581035|FG001|Overall Study|Complete Response|2|||
164606707|NCT00050960|594581034|FG000|Overall Study|Adverse Event|62|||
164606708|NCT00050960|594581035|FG001|Overall Study|Adverse Event|61|||
164502919|NCT00551135|594213194|FG002|Overall Study|Adverse Event|1|||
164502920|NCT00551135|594213195|FG003|Overall Study|Adverse Event|1|||
164502921|NCT00551135|594213192|FG000|Overall Study|Lost to Follow-up|0|||
164502922|NCT00551135|594213193|FG001|Overall Study|Lost to Follow-up|0|||
164502923|NCT00551135|594213194|FG002|Overall Study|Lost to Follow-up|0|||
164502924|NCT00551135|594213195|FG003|Overall Study|Lost to Follow-up|1|||
164502925|NCT00551135|594213192|FG000|Overall Study|Other|3|||
164502926|NCT00551135|594213193|FG001|Overall Study|Other|2|||
164502927|NCT00551135|594213194|FG002|Overall Study|Other|1|||
164502928|NCT00551135|594213195|FG003|Overall Study|Other|2|||
164606709|NCT00050960|594581034|FG000|Overall Study|Lost to Follow-up|0|||
164606710|NCT00050960|594581035|FG001|Overall Study|Lost to Follow-up|1|||
164606711|NCT00050960|594581034|FG000|Overall Study|Withdrawal by Subject|23|||
164606712|NCT00050960|594581035|FG001|Overall Study|Withdrawal by Subject|18|||
164606713|NCT00050960|594581034|FG000|Overall Study|Administrative|31|||
164606714|NCT00050960|594581035|FG001|Overall Study|Administrative|46|||
164502929|NCT00551135|594213192|FG000|Overall Study|Withdrawal by Subject|1|||
164502930|NCT00551135|594213193|FG001|Overall Study|Withdrawal by Subject|0|||
164502931|NCT00551135|594213194|FG002|Overall Study|Withdrawal by Subject|3|||
164502932|NCT00551135|594213195|FG003|Overall Study|Withdrawal by Subject|1|||
164502933|NCT00548847|594213196|FG000|Overall Study|Disease progression|7|||
164502934|NCT00727415|594213197|FG000|Phase I|Dose Limiting Toxicity|2|||
164502935|NCT03634839|594213200|FG000|First Intervention (2 Hours)|Adverse Event|0|||
164502936|NCT03634839|594213201|FG001|First Intervention (2 Hours)|Adverse Event|2|||
164502937|NCT01588366|594213204|FG000|Overall Study|Adverse Event|0|||
164502938|NCT01588366|594213205|FG001|Overall Study|Adverse Event|1|||
164502939|NCT01588366|594213206|FG002|Overall Study|Adverse Event|0|||
164502940|NCT01588366|594213207|FG003|Overall Study|Adverse Event|1|||
164502941|NCT01588366|594213208|FG004|Overall Study|Adverse Event|0|||
164502942|NCT01588366|594213209|FG005|Overall Study|Adverse Event|2|||
164502943|NCT00302159|594213210|FG000|Overall Study|pt declined before treatment started|1|||
164502944|NCT00302159|594213210|FG000|Overall Study|pt started Avastin|1|||
164502945|NCT04962698|594213213|FG000|Motor Imagery|Technical difficulty|1|||
164502946|NCT04962698|594213214|FG001|Motor Imagery|Technical difficulty|0|||
164502947|NCT04962698|594213213|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
164502948|NCT04962698|594213214|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
164502949|NCT04962698|594213213|FG000|Kinesthetic MI|Technical difficulty|1|||
164502950|NCT04962698|594213214|FG001|Kinesthetic MI|Technical difficulty|0|||
164502951|NCT04962698|594213213|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
164502952|NCT04962698|594213214|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
164502953|NCT04962698|594213213|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
164502954|NCT04962698|594213214|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
164502955|NCT04962698|594213213|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
164502956|NCT04962698|594213214|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
164502957|NCT04962698|594213213|FG000|Virtual-hand Interaction|Technical difficulty|1|||
164502958|NCT04962698|594213214|FG001|Virtual-hand Interaction|Technical difficulty|0|||
164502959|NCT04962698|594213213|FG000|Robotic Action Observation|Technical difficulty|1|||
164502960|NCT04962698|594213214|FG001|Robotic Action Observation|Technical difficulty|0|||
164502961|NCT04962698|594213213|FG000|Rest|Technical difficulty|1|||
164502962|NCT04962698|594213214|FG001|Rest|Technical difficulty|0|||
164502963|NCT04962698|594213213|FG000|Rest|Exclusion criteria met after enrollment|0|||
164502964|NCT04962698|594213214|FG001|Rest|Exclusion criteria met after enrollment|2|||
164502965|NCT00853229|594213215|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
164502966|NCT00853229|594213216|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
164502967|NCT02312206|594213223|FG000|Overall Study|Adverse Event|3|||
164502968|NCT02312206|594213224|FG001|Overall Study|Adverse Event|6|||
164502969|NCT02312206|594213223|FG000|Overall Study|Withdrawal by Subject|6|||
164502970|NCT02312206|594213224|FG001|Overall Study|Withdrawal by Subject|6|||
164502971|NCT02312206|594213223|FG000|Overall Study|Physician Decision|7|||
164502972|NCT02312206|594213224|FG001|Overall Study|Physician Decision|6|||
164502973|NCT02312206|594213223|FG000|Overall Study|Death|31|||
164502974|NCT02312206|594213224|FG001|Overall Study|Death|36|||
164502975|NCT02312206|594213223|FG000|Overall Study|Study Terminated by Sponsor|81|||
164502976|NCT02312206|594213224|FG001|Overall Study|Study Terminated by Sponsor|74|||
164502977|NCT02312206|594213223|FG000|Overall Study|Patient transferred to hospice|0|||
164502978|NCT02312206|594213224|FG001|Overall Study|Patient transferred to hospice|1|||
164502979|NCT02312206|594213223|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
164502980|NCT02312206|594213224|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
164502981|NCT02312206|594213223|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
164502982|NCT02312206|594213224|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
164502983|NCT02312206|594213223|FG000|Overall Study|Disease Progression|1|||
164502984|NCT02312206|594213224|FG001|Overall Study|Disease Progression|0|||
164502985|NCT00585975|594213225|FG000|Overall Study|Withdrawal by Subject|3|||
164502986|NCT00585975|594213226|FG001|Overall Study|Withdrawal by Subject|3|||
164502987|NCT00585975|594213225|FG000|Overall Study|Lost to Follow-up|2|||
164502988|NCT00585975|594213226|FG001|Overall Study|Lost to Follow-up|1|||
164502989|NCT00585975|594213225|FG000|Overall Study|Enrollment met/over-enrolled|10|||
164502990|NCT00585975|594213226|FG001|Overall Study|Enrollment met/over-enrolled|9|||
164502991|NCT03082612|594213229|FG000|Overall Study|Lost to Follow-up|2|||
164502992|NCT03082612|594213230|FG001|Overall Study|Lost to Follow-up|0|||
164502993|NCT01006616|594213233|FG000|Period 1 (6 Months)|Adverse Event|10|||
164502994|NCT01006616|594213234|FG001|Period 1 (6 Months)|Adverse Event|31|||
164502995|NCT01006616|594213235|FG002|Period 1 (6 Months)|Adverse Event|37|||
164502996|NCT01006616|594213236|FG003|Period 1 (6 Months)|Adverse Event|9|||
164502997|NCT01006616|594213233|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
164502998|NCT01006616|594213234|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
164502999|NCT01006616|594213235|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
164503000|NCT01006616|594213236|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
164606715|NCT00050960|594581034|FG000|Overall Study|Non-compliance|3|||
164606716|NCT00050960|594581035|FG001|Overall Study|Non-compliance|1|||
164606717|NCT00050960|594581034|FG000|Overall Study|Death|13|||
164606718|NCT00050960|594581035|FG001|Overall Study|Death|15|||
164606719|NCT00764946|594581040|FG000|Overall Study|Lack of Efficacy|1|||
164606720|NCT00764946|594581041|FG001|Overall Study|Lack of Efficacy|0|||
164606721|NCT00764946|594581042|FG002|Overall Study|Lack of Efficacy|0|||
164503001|NCT01006616|594213233|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
164503002|NCT01006616|594213234|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
164503003|NCT01006616|594213235|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
164503004|NCT01006616|594213236|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
164503005|NCT01006616|594213233|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
164503006|NCT01006616|594213234|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
164503007|NCT01006616|594213235|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
164503008|NCT01006616|594213236|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
164503009|NCT01006616|594213233|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
164503010|NCT01006616|594213234|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
164503011|NCT01006616|594213235|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
164503012|NCT01006616|594213236|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
164503013|NCT01006616|594213233|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
164503014|NCT01006616|594213234|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
164503015|NCT01006616|594213235|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
164503016|NCT01006616|594213236|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
164503017|NCT01006616|594213233|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
164503018|NCT01006616|594213234|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
164503019|NCT01006616|594213235|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
164503020|NCT01006616|594213236|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
164503021|NCT01006616|594213233|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
164503022|NCT01006616|594213234|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
164503023|NCT01006616|594213235|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
164503024|NCT01006616|594213236|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
164503025|NCT01006616|594213233|FG000|Period 1 (6 Months)|Not Treated|0|||
164503026|NCT01006616|594213234|FG001|Period 1 (6 Months)|Not Treated|0|||
164503027|NCT01006616|594213235|FG002|Period 1 (6 Months)|Not Treated|1|||
164503028|NCT01006616|594213236|FG003|Period 1 (6 Months)|Not Treated|1|||
164503029|NCT01006616|594213233|FG000|Period 2 (18 Months)|Adverse Event|6|||
164503030|NCT01006616|594213234|FG001|Period 2 (18 Months)|Adverse Event|6|||
164503031|NCT01006616|594213235|FG002|Period 2 (18 Months)|Adverse Event|6|||
164503032|NCT01006616|594213236|FG003|Period 2 (18 Months)|Adverse Event|4|||
164503033|NCT01006616|594213233|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
164503034|NCT01006616|594213234|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
164503035|NCT01006616|594213235|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
164503036|NCT01006616|594213236|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
164503037|NCT01006616|594213233|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
164503038|NCT01006616|594213234|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
164503039|NCT01006616|594213235|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
164503040|NCT01006616|594213236|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
164503041|NCT01006616|594213233|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
164503042|NCT01006616|594213234|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
164503043|NCT01006616|594213235|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
164503044|NCT01006616|594213236|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
164503045|NCT01006616|594213233|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
164503046|NCT01006616|594213234|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
164503047|NCT01006616|594213235|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
164503048|NCT01006616|594213236|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
164503049|NCT01006616|594213233|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
164503050|NCT01006616|594213234|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
164503051|NCT01006616|594213235|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
164503052|NCT01006616|594213236|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
164503053|NCT01006616|594213233|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
164503054|NCT01006616|594213234|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
164503055|NCT01006616|594213235|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
164503056|NCT01006616|594213236|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
164503057|NCT01006616|594213233|FG000|Period 2 (18 Months)|Study Terminated|63|||
164503058|NCT01006616|594213234|FG001|Period 2 (18 Months)|Study Terminated|46|||
164503059|NCT01006616|594213235|FG002|Period 2 (18 Months)|Study Terminated|44|||
164503060|NCT01006616|594213236|FG003|Period 2 (18 Months)|Study Terminated|70|||
164503061|NCT03672175|594213237|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
164503062|NCT03672175|594213238|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
164503063|NCT03672175|594213239|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
164503064|NCT03672175|594213237|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
164503065|NCT03672175|594213238|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
164503066|NCT03672175|594213239|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
164503067|NCT03672175|594213237|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
164606722|NCT00764946|594581040|FG000|Overall Study|Lost to Follow-up|3|||
164146442|NCT05026177|592898060|FG002|Overall Study|Adverse Event|17|||
164606723|NCT00764946|594581041|FG001|Overall Study|Lost to Follow-up|4|||
164606724|NCT00764946|594581042|FG002|Overall Study|Lost to Follow-up|0|||
164606725|NCT00764946|594581040|FG000|Overall Study|Physician Decision|2|||
164606726|NCT00764946|594581041|FG001|Overall Study|Physician Decision|4|||
164606727|NCT00764946|594581042|FG002|Overall Study|Physician Decision|0|||
164606728|NCT00764946|594581040|FG000|Overall Study|Adverse Event|3|||
164606729|NCT00764946|594581041|FG001|Overall Study|Adverse Event|2|||
164606730|NCT00764946|594581042|FG002|Overall Study|Adverse Event|1|||
164606731|NCT00764946|594581040|FG000|Overall Study|Withdrawal by Subject|3|||
164606732|NCT00764946|594581041|FG001|Overall Study|Withdrawal by Subject|6|||
164606733|NCT00764946|594581042|FG002|Overall Study|Withdrawal by Subject|2|||
164606734|NCT00764946|594581040|FG000|Overall Study|Never Treated|1|||
164606735|NCT00764946|594581041|FG001|Overall Study|Never Treated|1|||
164606736|NCT00764946|594581042|FG002|Overall Study|Never Treated|1|||
164606737|NCT01162304|594581043|FG000|Overall Study|Beck scale to high|11|||
164606738|NCT01315847|594581044|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
164606739|NCT01315847|594581045|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
164606740|NCT01315847|594581044|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
164606741|NCT01315847|594581045|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
164606742|NCT02940626|594581046|FG000|Overall Study|Death|40|||
164606743|NCT02940626|594581047|FG001|Overall Study|Death|32|||
164606744|NCT02940626|594581046|FG000|Overall Study|Lost to Follow-up|5|||
164503068|NCT03672175|594213238|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
164503069|NCT03672175|594213239|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
164503070|NCT03672175|594213237|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
164503071|NCT03672175|594213238|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
164503072|NCT03672175|594213239|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
164503073|NCT03672175|594213237|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
164503074|NCT03672175|594213238|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
164503075|NCT03672175|594213239|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
164606745|NCT02940626|594581047|FG001|Overall Study|Lost to Follow-up|2|||
164606746|NCT02940626|594581046|FG000|Overall Study|Withdrawal by Subject|1|||
164606747|NCT02940626|594581047|FG001|Overall Study|Withdrawal by Subject|0|||
164606748|NCT02940626|594581046|FG000|Overall Study|Transfer to Hospice Care|1|||
164606749|NCT02940626|594581047|FG001|Overall Study|Transfer to Hospice Care|0|||
164606750|NCT02940626|594581046|FG000|Overall Study|Prohibited Concomitant Medication|0|||
164606751|NCT02940626|594581047|FG001|Overall Study|Prohibited Concomitant Medication|1|||
164606752|NCT00585923|594581049|FG000|Overall Study|Physician decided not to continue|31|||
164606753|NCT00585923|594581050|FG001|Overall Study|Physician decided not to continue|33|||
164606754|NCT01324622|594581051|FG000|Overall Study|Lost to Follow-up|7|||
164606755|NCT01324622|594581052|FG001|Overall Study|Lost to Follow-up|7|||
164606756|NCT01324622|594581051|FG000|Overall Study|Death|1|||
164606757|NCT01324622|594581052|FG001|Overall Study|Death|0|||
164606758|NCT01324622|594581051|FG000|Overall Study|Lack of Efficacy|1|||
164606759|NCT01324622|594581052|FG001|Overall Study|Lack of Efficacy|0|||
164606760|NCT00878215|594581053|FG000|Overall Study|Determined to be ineligible|0|||
164606761|NCT00878215|594581054|FG001|Overall Study|Determined to be ineligible|10|||
164606762|NCT00878215|594581055|FG002|Overall Study|Determined to be ineligible|0|||
164606763|NCT00878215|594581056|FG003|Overall Study|Determined to be ineligible|0|||
164606764|NCT00138424|594581057|FG000|Overall Study|Physician Decision|0|||
164606765|NCT00138424|594581058|FG001|Overall Study|Physician Decision|1|||
164606766|NCT00138424|594581059|FG002|Overall Study|Physician Decision|0|||
164606767|NCT00138424|594581060|FG003|Overall Study|Physician Decision|0|||
164606768|NCT00413062|594581067|FG000|Overall Study|Adverse event/serious adverse event|289|||
164606769|NCT00413062|594581068|FG001|Overall Study|Adverse event/serious adverse event|56|||
164606770|NCT00413062|594581067|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
164606771|NCT00413062|594581068|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
164503076|NCT03672175|594213237|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
164503077|NCT03672175|594213238|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
164503078|NCT03672175|594213239|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
164606772|NCT00413062|594581067|FG000|Overall Study|Withdrawal of informed consent|111|||
164606773|NCT00413062|594581068|FG001|Overall Study|Withdrawal of informed consent|36|||
164606774|NCT00413062|594581067|FG000|Overall Study|Pregnancy|15|||
164606775|NCT00413062|594581068|FG001|Overall Study|Pregnancy|5|||
164606776|NCT00413062|594581067|FG000|Overall Study|Pregnancy wish|17|||
164606777|NCT00413062|594581068|FG001|Overall Study|Pregnancy wish|6|||
164606778|NCT00413062|594581067|FG000|Overall Study|Lost to Follow-up|175|||
164503079|NCT03672175|594213237|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
164503080|NCT03672175|594213238|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
164503081|NCT03672175|594213239|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
164606779|NCT00413062|594581068|FG001|Overall Study|Lost to Follow-up|73|||
164606780|NCT00413062|594581067|FG000|Overall Study|Other reason|70|||
164606781|NCT00413062|594581068|FG001|Overall Study|Other reason|34|||
164606782|NCT02176291|594581069|FG000|Overall Study|Death|1|||
164606783|NCT02176291|594581070|FG001|Overall Study|Death|0|||
164606784|NCT02176291|594581069|FG000|Overall Study|non compliance with protocol|2|||
164503082|NCT03672175|594213237|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
164503083|NCT03672175|594213238|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
164503084|NCT03672175|594213239|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
164503085|NCT03672175|594213237|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
164503086|NCT03672175|594213238|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
164503087|NCT03672175|594213239|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
164503088|NCT03672175|594213237|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
164503089|NCT03672175|594213238|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
164503090|NCT03672175|594213239|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
164503091|NCT03672175|594213237|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
164503092|NCT03672175|594213238|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
164503093|NCT03672175|594213239|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
164503094|NCT03672175|594213237|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
164503095|NCT03672175|594213238|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
164503096|NCT03672175|594213239|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
164503097|NCT01129115|594213242|FG000|Overall Study|Adverse Event|1|||
164503098|NCT01129115|594213243|FG001|Overall Study|Adverse Event|2|||
164503099|NCT01129115|594213244|FG002|Overall Study|Adverse Event|3|||
164503100|NCT01129115|594213245|FG003|Overall Study|Adverse Event|3|||
164503101|NCT01129115|594213242|FG000|Overall Study|Withdrawal by Subject|1|||
164503102|NCT01129115|594213243|FG001|Overall Study|Withdrawal by Subject|3|||
164503103|NCT01129115|594213244|FG002|Overall Study|Withdrawal by Subject|1|||
164503104|NCT01129115|594213245|FG003|Overall Study|Withdrawal by Subject|4|||
164503105|NCT01129115|594213242|FG000|Overall Study|Protocol Violation|0|||
164503106|NCT01129115|594213243|FG001|Overall Study|Protocol Violation|2|||
164503107|NCT01129115|594213244|FG002|Overall Study|Protocol Violation|2|||
164503108|NCT01129115|594213245|FG003|Overall Study|Protocol Violation|2|||
164503109|NCT00690378|594213247|FG000|Overall Study|Adverse Event|1|||
164503110|NCT00690378|594213248|FG001|Overall Study|Adverse Event|0|||
164503111|NCT00690378|594213247|FG000|Overall Study|Withdrawal by Subject|2|||
164503112|NCT00690378|594213248|FG001|Overall Study|Withdrawal by Subject|0|||
164503113|NCT00690378|594213247|FG000|Overall Study|Protocol Violation|1|||
164503114|NCT00690378|594213248|FG001|Overall Study|Protocol Violation|0|||
164503115|NCT00690378|594213247|FG000|Overall Study|Lost to Follow-up|2|||
164503116|NCT00690378|594213248|FG001|Overall Study|Lost to Follow-up|3|||
164503117|NCT00690378|594213247|FG000|Overall Study|Did not meet inc/exc criteria|13|||
164503118|NCT00690378|594213248|FG001|Overall Study|Did not meet inc/exc criteria|11|||
164503119|NCT00690378|594213247|FG000|Overall Study|Social problem|1|||
164503120|NCT00690378|594213248|FG001|Overall Study|Social problem|0|||
164503121|NCT02019641|594213249|FG000|10-Week Follow up|Withdrawal by investigator|2|||
164503122|NCT02019641|594213250|FG001|10-Week Follow up|Withdrawal by investigator|0|||
164503123|NCT02019641|594213251|FG002|10-Week Follow up|Withdrawal by investigator|0|||
164503124|NCT02019641|594213249|FG000|10-Week Follow up|Withdrawal by Subject|1|||
164503125|NCT02019641|594213250|FG001|10-Week Follow up|Withdrawal by Subject|1|||
164503126|NCT02019641|594213251|FG002|10-Week Follow up|Withdrawal by Subject|0|||
164503127|NCT02019641|594213249|FG000|20-Week Follow up|Withdrawal by investigator|0|||
164503128|NCT02019641|594213250|FG001|20-Week Follow up|Withdrawal by investigator|0|||
164606785|NCT02176291|594581070|FG001|Overall Study|non compliance with protocol|0|||
164606786|NCT02176291|594581069|FG000|Overall Study|Withdrawal by Subject|2|||
164606787|NCT02176291|594581070|FG001|Overall Study|Withdrawal by Subject|0|||
164606788|NCT02815293|594581071|FG000|Overall Study|Study termination by sponsor|10|||
164606789|NCT02815293|594581072|FG001|Overall Study|Study termination by sponsor|7|||
164606790|NCT02815293|594581073|FG002|Overall Study|Study termination by sponsor|0|||
164606791|NCT02815293|594581071|FG000|Overall Study|Participants not randomized|0|||
164606792|NCT02815293|594581072|FG001|Overall Study|Participants not randomized|0|||
164606793|NCT02815293|594581073|FG002|Overall Study|Participants not randomized|18|||
164606794|NCT02815293|594581071|FG000|Overall Study|Adverse Event|0|||
164606795|NCT02815293|594581072|FG001|Overall Study|Adverse Event|1|||
164606796|NCT02815293|594581073|FG002|Overall Study|Adverse Event|0|||
164606797|NCT00006604|594581074|FG000|Overall Study|Met study objective - no further FU|1|||
164606798|NCT00006604|594581075|FG001|Overall Study|Met study objective - no further FU|0|||
164606799|NCT00006604|594581076|FG002|Overall Study|Met study objective - no further FU|0|||
164606800|NCT00006604|594581077|FG003|Overall Study|Met study objective - no further FU|0|||
164606801|NCT00006604|594581078|FG004|Overall Study|Met study objective - no further FU|0|||
164606802|NCT00006604|594581079|FG005|Overall Study|Met study objective - no further FU|0|||
164606803|NCT00006604|594581080|FG006|Overall Study|Met study objective - no further FU|0|||
164606804|NCT00006604|594581081|FG007|Overall Study|Met study objective - no further FU|0|||
164606805|NCT00006604|594581082|FG008|Overall Study|Met study objective - no further FU|0|||
164606806|NCT00006604|594581083|FG009|Overall Study|Met study objective - no further FU|0|||
164606807|NCT00006604|594581084|FG010|Overall Study|Met study objective - no further FU|0|||
164606808|NCT00006604|594581085|FG011|Overall Study|Met study objective - no further FU|0|||
164606809|NCT00006604|594581086|FG012|Overall Study|Met study objective - no further FU|0|||
164606810|NCT00006604|594581087|FG013|Overall Study|Met study objective - no further FU|0|||
164606811|NCT00006604|594581088|FG014|Overall Study|Met study objective - no further FU|1|||
164606812|NCT00006604|594581089|FG015|Overall Study|Met study objective - no further FU|1|||
164606813|NCT00006604|594581090|FG016|Overall Study|Met study objective - no further FU|0|||
164606814|NCT00006604|594581074|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
164606815|NCT00006604|594581075|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
164606816|NCT00006604|594581076|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
164606817|NCT00006604|594581077|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
164606818|NCT00006604|594581078|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
164606819|NCT00006604|594581079|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
164606820|NCT00006604|594581080|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
164716491|NCT03818035|594985123|FG006|Part 1: Open-label (Week 0 to Week 8)|Lack of Efficacy|0|||
164716492|NCT03818035|594985124|FG007|Part 1: Open-label (Week 0 to Week 8)|Lack of Efficacy|0|||
164716493|NCT03818035|594985117|FG000|Part 1: Open-label (Week 0 to Week 8)|Lost to Follow-up|10|||
164716494|NCT03818035|594985118|FG001|Part 1: Open-label (Week 0 to Week 8)|Lost to Follow-up|0|||
164716495|NCT03818035|594985119|FG002|Part 1: Open-label (Week 0 to Week 8)|Lost to Follow-up|0|||
164716496|NCT03818035|594985120|FG003|Part 1: Open-label (Week 0 to Week 8)|Lost to Follow-up|0|||
164716497|NCT03818035|594985121|FG004|Part 1: Open-label (Week 0 to Week 8)|Lost to Follow-up|0|||
164716498|NCT03818035|594985122|FG005|Part 1: Open-label (Week 0 to Week 8)|Lost to Follow-up|0|||
164716499|NCT03818035|594985123|FG006|Part 1: Open-label (Week 0 to Week 8)|Lost to Follow-up|0|||
164716500|NCT03818035|594985124|FG007|Part 1: Open-label (Week 0 to Week 8)|Lost to Follow-up|0|||
164716501|NCT03818035|594985117|FG000|Part 1: Open-label (Week 0 to Week 8)|Protocol Violation|11|||
164716502|NCT03818035|594985118|FG001|Part 1: Open-label (Week 0 to Week 8)|Protocol Violation|0|||
164716503|NCT03818035|594985119|FG002|Part 1: Open-label (Week 0 to Week 8)|Protocol Violation|0|||
164716504|NCT03818035|594985120|FG003|Part 1: Open-label (Week 0 to Week 8)|Protocol Violation|0|||
164716505|NCT03818035|594985121|FG004|Part 1: Open-label (Week 0 to Week 8)|Protocol Violation|0|||
164716506|NCT03818035|594985122|FG005|Part 1: Open-label (Week 0 to Week 8)|Protocol Violation|0|||
164716507|NCT03818035|594985123|FG006|Part 1: Open-label (Week 0 to Week 8)|Protocol Violation|0|||
164716508|NCT03818035|594985124|FG007|Part 1: Open-label (Week 0 to Week 8)|Protocol Violation|0|||
164716509|NCT03818035|594985117|FG000|Part 1: Open-label (Week 0 to Week 8)|Withdrawal by Subject|8|||
164716510|NCT03818035|594985118|FG001|Part 1: Open-label (Week 0 to Week 8)|Withdrawal by Subject|0|||
164716511|NCT03818035|594985119|FG002|Part 1: Open-label (Week 0 to Week 8)|Withdrawal by Subject|0|||
164716512|NCT03818035|594985120|FG003|Part 1: Open-label (Week 0 to Week 8)|Withdrawal by Subject|0|||
164716513|NCT03818035|594985121|FG004|Part 1: Open-label (Week 0 to Week 8)|Withdrawal by Subject|0|||
164716514|NCT03818035|594985122|FG005|Part 1: Open-label (Week 0 to Week 8)|Withdrawal by Subject|0|||
164716515|NCT03818035|594985123|FG006|Part 1: Open-label (Week 0 to Week 8)|Withdrawal by Subject|0|||
164716516|NCT03818035|594985124|FG007|Part 1: Open-label (Week 0 to Week 8)|Withdrawal by Subject|0|||
164716517|NCT03818035|594985117|FG000|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Worsening of Psoriasis|1|||
164716518|NCT03818035|594985118|FG001|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Worsening of Psoriasis|0|||
164606821|NCT00006604|594581081|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
164606822|NCT00006604|594581082|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
164606823|NCT00006604|594581083|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
164716519|NCT03818035|594985119|FG002|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Worsening of Psoriasis|0|||
164716520|NCT03818035|594985120|FG003|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Worsening of Psoriasis|0|||
164716521|NCT03818035|594985121|FG004|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Worsening of Psoriasis|0|||
164503129|NCT02019641|594213251|FG002|20-Week Follow up|Withdrawal by investigator|1|||
164503130|NCT03410108|594213252|FG000|Overall Study|Ongoing|41|||
164503131|NCT03410108|594213252|FG000|Overall Study|Adverse Event|4|||
164503132|NCT03410108|594213252|FG000|Overall Study|Progressive Disease|58|||
164503133|NCT03410108|594213252|FG000|Overall Study|Withdrawal by Subject|1|||
164503134|NCT01313624|594213253|FG000|Double-Blind Phase|Adverse Event|27|||
164503135|NCT01313624|594213254|FG001|Double-Blind Phase|Adverse Event|4|||
164503136|NCT01313624|594213253|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
164503137|NCT01313624|594213254|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
164503138|NCT01313624|594213253|FG000|Double-Blind Phase|Lost to Follow-up|0|||
164503139|NCT01313624|594213254|FG001|Double-Blind Phase|Lost to Follow-up|2|||
164503140|NCT01313624|594213253|FG000|Double-Blind Phase|Physician Decision|1|||
164503141|NCT01313624|594213254|FG001|Double-Blind Phase|Physician Decision|0|||
164503142|NCT01313624|594213253|FG000|Double-Blind Phase|Lack of Efficacy|1|||
164503143|NCT01313624|594213254|FG001|Double-Blind Phase|Lack of Efficacy|0|||
164503144|NCT01313624|594213253|FG000|Open-Label Phase|Adverse Event|1|||
164503145|NCT01313624|594213254|FG001|Open-Label Phase|Adverse Event|10|||
164503146|NCT01313624|594213253|FG000|Open-Label Phase|Withdrawal by Subject|2|||
164503147|NCT01313624|594213254|FG001|Open-Label Phase|Withdrawal by Subject|2|||
164503148|NCT01313624|594213253|FG000|Open-Label Phase|Lost to Follow-up|1|||
164503149|NCT01313624|594213254|FG001|Open-Label Phase|Lost to Follow-up|1|||
164503150|NCT02654132|594213255|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
164503151|NCT02654132|594213256|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
164503152|NCT02654132|594213255|FG000|Treatment Period|Disease progression|43|||
164503153|NCT02654132|594213256|FG001|Treatment Period|Disease progression|38|||
164503154|NCT02654132|594213255|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
164503155|NCT02654132|594213256|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
164503156|NCT02654132|594213255|FG000|Treatment Period|Other reasons|4|||
164503157|NCT02654132|594213256|FG001|Treatment Period|Other reasons|2|||
164503158|NCT02654132|594213255|FG000|Treatment Period|Study drug toxicity|2|||
164503159|NCT02654132|594213256|FG001|Treatment Period|Study drug toxicity|2|||
164503160|NCT02654132|594213255|FG000|Treatment Period|Withdrawal by Subject|2|||
164503161|NCT02654132|594213256|FG001|Treatment Period|Withdrawal by Subject|1|||
164503162|NCT02654132|594213255|FG000|Treatment Period|Maximum Clinical Benefit|0|||
164503163|NCT02654132|594213256|FG001|Treatment Period|Maximum Clinical Benefit|2|||
164503164|NCT02654132|594213255|FG000|Treatment Period|Participant request to discontinue|2|||
164503165|NCT02654132|594213256|FG001|Treatment Period|Participant request to discontinue|0|||
164503166|NCT02654132|594213255|FG000|Treatment Period|Administrative reasons by sponsor|0|||
164503167|NCT02654132|594213256|FG001|Treatment Period|Administrative reasons by sponsor|1|||
164503168|NCT02654132|594213255|FG000|Treatment Period|Death|1|||
164503169|NCT02654132|594213256|FG001|Treatment Period|Death|0|||
164503170|NCT02485899|594213257|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
164503171|NCT02485899|594213258|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164503172|NCT02485899|594213257|FG000|Overall Study|Withdrawal by Subject|1|||
164503173|NCT02485899|594213258|FG001|Overall Study|Withdrawal by Subject|0|||
164503174|NCT02485899|594213257|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
164503175|NCT02485899|594213258|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
164503176|NCT01006889|594213259|FG000|Overall Study|Withdrawal by Subject|3|||
164503177|NCT00623363|594213260|FG000|Overall Study|Adverse Event|2|||
164503178|NCT00623363|594213261|FG001|Overall Study|Adverse Event|2|||
164503179|NCT04706793|594213262|FG000|Treatment|Disease worsening|10|||
164503180|NCT04706793|594213263|FG001|Treatment|Disease worsening|10|||
164503181|NCT04706793|594213262|FG000|Follow-up|Lack of Efficacy|1|||
164503182|NCT04706793|594213263|FG001|Follow-up|Lack of Efficacy|0|||
164503183|NCT04706793|594213262|FG000|Follow-up|Disease worsening|8|||
164503184|NCT04706793|594213263|FG001|Follow-up|Disease worsening|10|||
164503185|NCT04706793|594213262|FG000|Follow-up|Adverse Event|1|||
164503186|NCT04706793|594213263|FG001|Follow-up|Adverse Event|0|||
164503187|NCT00823836|594213264|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
164503188|NCT00823836|594213265|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
164503189|NCT00823836|594213264|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
164503190|NCT00823836|594213265|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
164503191|NCT00823836|594213264|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
164503192|NCT00823836|594213265|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
164503193|NCT00823836|594213264|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
164503194|NCT00823836|594213265|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
164503195|NCT00823836|594213264|FG000|Long-term Phase|Adverse Event|3|||
164503196|NCT00823836|594213265|FG001|Long-term Phase|Adverse Event|2|||
164503197|NCT00823836|594213264|FG000|Long-term Phase|Physician Decision|1|||
164503198|NCT00823836|594213265|FG001|Long-term Phase|Physician Decision|2|||
164716522|NCT03818035|594985122|FG005|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Worsening of Psoriasis|0|||
164716523|NCT03818035|594985123|FG006|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Worsening of Psoriasis|0|||
164716524|NCT03818035|594985124|FG007|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Worsening of Psoriasis|0|||
164716525|NCT03818035|594985117|FG000|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Other|16|||
164716526|NCT03818035|594985118|FG001|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Other|0|||
164716527|NCT03818035|594985119|FG002|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Other|0|||
164716528|NCT03818035|594985120|FG003|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Other|0|||
164716529|NCT03818035|594985121|FG004|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Other|0|||
164716530|NCT03818035|594985122|FG005|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Other|0|||
164716531|NCT03818035|594985123|FG006|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Other|0|||
164716532|NCT03818035|594985124|FG007|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Other|0|||
164716533|NCT03818035|594985117|FG000|Part 1: Open-label (Week 0 to Week 8)|Non-Compliance with Study Drug|1|||
164716534|NCT03818035|594985118|FG001|Part 1: Open-label (Week 0 to Week 8)|Non-Compliance with Study Drug|0|||
164716535|NCT03818035|594985119|FG002|Part 1: Open-label (Week 0 to Week 8)|Non-Compliance with Study Drug|0|||
164716536|NCT03818035|594985120|FG003|Part 1: Open-label (Week 0 to Week 8)|Non-Compliance with Study Drug|0|||
164716537|NCT03818035|594985121|FG004|Part 1: Open-label (Week 0 to Week 8)|Non-Compliance with Study Drug|0|||
164716538|NCT03818035|594985122|FG005|Part 1: Open-label (Week 0 to Week 8)|Non-Compliance with Study Drug|0|||
164716539|NCT03818035|594985123|FG006|Part 1: Open-label (Week 0 to Week 8)|Non-Compliance with Study Drug|0|||
164716540|NCT03818035|594985124|FG007|Part 1: Open-label (Week 0 to Week 8)|Non-Compliance with Study Drug|0|||
164716541|NCT03818035|594985117|FG000|Part 1: Open-label (Week 0 to Week 8)|Other|7|||
164716542|NCT03818035|594985118|FG001|Part 1: Open-label (Week 0 to Week 8)|Other|0|||
164716543|NCT03818035|594985119|FG002|Part 1: Open-label (Week 0 to Week 8)|Other|0|||
164716544|NCT03818035|594985120|FG003|Part 1: Open-label (Week 0 to Week 8)|Other|0|||
164716545|NCT03818035|594985121|FG004|Part 1: Open-label (Week 0 to Week 8)|Other|0|||
164716546|NCT03818035|594985122|FG005|Part 1: Open-label (Week 0 to Week 8)|Other|0|||
164716547|NCT03818035|594985123|FG006|Part 1: Open-label (Week 0 to Week 8)|Other|0|||
164716548|NCT03818035|594985124|FG007|Part 1: Open-label (Week 0 to Week 8)|Other|0|||
164716549|NCT03818035|594985117|FG000|Part 1: Open-label (Week 0 to Week 8)|Death|1|||
164716550|NCT03818035|594985118|FG001|Part 1: Open-label (Week 0 to Week 8)|Death|0|||
164716551|NCT03818035|594985119|FG002|Part 1: Open-label (Week 0 to Week 8)|Death|0|||
164716552|NCT03818035|594985120|FG003|Part 1: Open-label (Week 0 to Week 8)|Death|0|||
164716553|NCT03818035|594985121|FG004|Part 1: Open-label (Week 0 to Week 8)|Death|0|||
164716554|NCT03818035|594985122|FG005|Part 1: Open-label (Week 0 to Week 8)|Death|0|||
164716555|NCT03818035|594985123|FG006|Part 1: Open-label (Week 0 to Week 8)|Death|0|||
164716556|NCT03818035|594985124|FG007|Part 1: Open-label (Week 0 to Week 8)|Death|0|||
164716557|NCT03818035|594985117|FG000|Part 2: Double-blind (Week28 to Week68)|Lack of Efficacy|0|||
164716558|NCT03818035|594985118|FG001|Part 2: Double-blind (Week28 to Week68)|Lack of Efficacy|0|||
164716559|NCT03818035|594985119|FG002|Part 2: Double-blind (Week28 to Week68)|Lack of Efficacy|0|||
164716560|NCT03818035|594985120|FG003|Part 2: Double-blind (Week28 to Week68)|Lack of Efficacy|4|||
164716561|NCT03818035|594985121|FG004|Part 2: Double-blind (Week28 to Week68)|Lack of Efficacy|0|||
164716562|NCT03818035|594985122|FG005|Part 2: Double-blind (Week28 to Week68)|Lack of Efficacy|0|||
164716563|NCT03818035|594985123|FG006|Part 2: Double-blind (Week28 to Week68)|Lack of Efficacy|0|||
164716564|NCT03818035|594985124|FG007|Part 2: Double-blind (Week28 to Week68)|Lack of Efficacy|0|||
164716565|NCT03818035|594985117|FG000|Part 2: Double-blind (Week28 to Week68)|Lost to Follow-up|0|||
164716566|NCT03818035|594985118|FG001|Part 2: Double-blind (Week28 to Week68)|Lost to Follow-up|6|||
164716567|NCT03818035|594985119|FG002|Part 2: Double-blind (Week28 to Week68)|Lost to Follow-up|1|||
164716568|NCT03818035|594985120|FG003|Part 2: Double-blind (Week28 to Week68)|Lost to Follow-up|9|||
164716569|NCT03818035|594985121|FG004|Part 2: Double-blind (Week28 to Week68)|Lost to Follow-up|0|||
164716570|NCT03818035|594985122|FG005|Part 2: Double-blind (Week28 to Week68)|Lost to Follow-up|0|||
164716571|NCT03818035|594985123|FG006|Part 2: Double-blind (Week28 to Week68)|Lost to Follow-up|0|||
164716572|NCT03818035|594985124|FG007|Part 2: Double-blind (Week28 to Week68)|Lost to Follow-up|0|||
164716573|NCT03818035|594985117|FG000|Part 2: Double-blind (Week28 to Week68)|Withdrawal by Subject|0|||
164716574|NCT03818035|594985118|FG001|Part 2: Double-blind (Week28 to Week68)|Withdrawal by Subject|0|||
164716575|NCT03818035|594985119|FG002|Part 2: Double-blind (Week28 to Week68)|Withdrawal by Subject|0|||
164716576|NCT03818035|594985120|FG003|Part 2: Double-blind (Week28 to Week68)|Withdrawal by Subject|8|||
164716577|NCT03818035|594985121|FG004|Part 2: Double-blind (Week28 to Week68)|Withdrawal by Subject|0|||
164716578|NCT03818035|594985122|FG005|Part 2: Double-blind (Week28 to Week68)|Withdrawal by Subject|0|||
164716579|NCT03818035|594985123|FG006|Part 2: Double-blind (Week28 to Week68)|Withdrawal by Subject|0|||
164503199|NCT00823836|594213264|FG000|Long-term Phase|Withdrawal by Subject|1|||
164503200|NCT00823836|594213265|FG001|Long-term Phase|Withdrawal by Subject|1|||
164503201|NCT01130168|594213266|FG000|Period 1|Withdrawal by Subject|0|||
164503202|NCT01130168|594213267|FG001|Period 1|Withdrawal by Subject|1|||
164503203|NCT01130168|594213268|FG002|Period 1|Withdrawal by Subject|0|||
164503204|NCT01130168|594213269|FG003|Period 1|Withdrawal by Subject|1|||
164503205|NCT01130168|594213270|FG004|Period 1|Withdrawal by Subject|0|||
164503206|NCT01130168|594213271|FG005|Period 1|Withdrawal by Subject|0|||
164503207|NCT01130168|594213266|FG000|Period 1|Discontinued For Other Reason|0|||
164503208|NCT01130168|594213267|FG001|Period 1|Discontinued For Other Reason|0|||
164503209|NCT01130168|594213268|FG002|Period 1|Discontinued For Other Reason|1|||
164503210|NCT01130168|594213269|FG003|Period 1|Discontinued For Other Reason|1|||
164503211|NCT01130168|594213270|FG004|Period 1|Discontinued For Other Reason|0|||
164503212|NCT01130168|594213271|FG005|Period 1|Discontinued For Other Reason|0|||
164503213|NCT01130168|594213266|FG000|Period 1|Adverse Event|0|||
164503214|NCT01130168|594213267|FG001|Period 1|Adverse Event|0|||
164503215|NCT01130168|594213268|FG002|Period 1|Adverse Event|0|||
164503216|NCT01130168|594213269|FG003|Period 1|Adverse Event|1|||
164503217|NCT01130168|594213270|FG004|Period 1|Adverse Event|0|||
164503218|NCT01130168|594213271|FG005|Period 1|Adverse Event|0|||
164503219|NCT04354168|594213272|FG000|Overall Study|Lost to Follow-up|22|||
164503220|NCT01781832|594213273|FG000|Overall Study|Withdrawal by Subject|1|||
164503221|NCT02287233|594213274|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
164503222|NCT02287233|594213275|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
164503223|NCT02287233|594213276|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
164503224|NCT02287233|594213274|FG000|Overall Study|Adverse Event Related to Progression|0|||
164503225|NCT02287233|594213275|FG001|Overall Study|Adverse Event Related to Progression|2|||
164503226|NCT02287233|594213276|FG002|Overall Study|Adverse Event Related to Progression|8|||
164503227|NCT02287233|594213274|FG000|Overall Study|Physician Decision|1|||
164503228|NCT02287233|594213275|FG001|Overall Study|Physician Decision|2|||
164503229|NCT02287233|594213276|FG002|Overall Study|Physician Decision|4|||
164503230|NCT02287233|594213274|FG000|Overall Study|Progressive Disease with Death|0|||
164503231|NCT02287233|594213275|FG001|Overall Study|Progressive Disease with Death|0|||
164503232|NCT02287233|594213276|FG002|Overall Study|Progressive Disease with Death|10|||
164503233|NCT02287233|594213274|FG000|Overall Study|Progressive Disease Without Death|2|||
164503234|NCT02287233|594213275|FG001|Overall Study|Progressive Disease Without Death|3|||
164503235|NCT02287233|594213276|FG002|Overall Study|Progressive Disease Without Death|20|||
164503236|NCT02287233|594213274|FG000|Overall Study|Withdrawal by Subject|1|||
164503237|NCT02287233|594213275|FG001|Overall Study|Withdrawal by Subject|1|||
164503238|NCT02287233|594213276|FG002|Overall Study|Withdrawal by Subject|7|||
164503239|NCT02287233|594213274|FG000|Overall Study|Other|3|||
164503240|NCT02287233|594213275|FG001|Overall Study|Other|0|||
164503241|NCT02287233|594213276|FG002|Overall Study|Other|15|||
164503242|NCT02287233|594213274|FG000|Overall Study|Did Not Receive Treatment|0|||
164503243|NCT02287233|594213275|FG001|Overall Study|Did Not Receive Treatment|0|||
164503244|NCT02287233|594213276|FG002|Overall Study|Did Not Receive Treatment|2|||
164503245|NCT02804399|594213279|FG000|Period 2|Adverse Event|0|||
164503246|NCT02804399|594213280|FG001|Period 2|Adverse Event|1|||
164503247|NCT02058836|594213281|FG000|Overall Study|Withdrawal by Subject|1|||
164606824|NCT00006604|594581084|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
164606825|NCT00006604|594581085|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
164606826|NCT00006604|594581086|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
164606827|NCT00006604|594581087|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
164606828|NCT00006604|594581088|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
164606829|NCT00006604|594581089|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
164606830|NCT00006604|594581090|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
164606831|NCT00006604|594581074|FG000|Overall Study|Death|0|||
164606832|NCT00006604|594581075|FG001|Overall Study|Death|0|||
164606833|NCT00006604|594581076|FG002|Overall Study|Death|0|||
164606834|NCT00006604|594581077|FG003|Overall Study|Death|0|||
164606835|NCT00006604|594581078|FG004|Overall Study|Death|0|||
164606836|NCT00006604|594581079|FG005|Overall Study|Death|0|||
164606837|NCT00006604|594581080|FG006|Overall Study|Death|0|||
164606838|NCT00006604|594581081|FG007|Overall Study|Death|0|||
164606839|NCT00006604|594581082|FG008|Overall Study|Death|0|||
164606840|NCT00006604|594581083|FG009|Overall Study|Death|1|||
164606841|NCT00006604|594581084|FG010|Overall Study|Death|1|||
164606842|NCT00006604|594581085|FG011|Overall Study|Death|1|||
164606843|NCT00006604|594581086|FG012|Overall Study|Death|0|||
164606844|NCT00006604|594581087|FG013|Overall Study|Death|0|||
164606845|NCT00006604|594581088|FG014|Overall Study|Death|0|||
164606846|NCT00006604|594581089|FG015|Overall Study|Death|0|||
164606847|NCT00006604|594581090|FG016|Overall Study|Death|0|||
164606848|NCT00006604|594581074|FG000|Overall Study|Severe debilitation, unable to continue|0|||
164606849|NCT00006604|594581075|FG001|Overall Study|Severe debilitation, unable to continue|0|||
164606850|NCT00006604|594581076|FG002|Overall Study|Severe debilitation, unable to continue|0|||
164606851|NCT00006604|594581077|FG003|Overall Study|Severe debilitation, unable to continue|0|||
164606852|NCT00006604|594581078|FG004|Overall Study|Severe debilitation, unable to continue|0|||
164606853|NCT00006604|594581079|FG005|Overall Study|Severe debilitation, unable to continue|0|||
164606854|NCT00006604|594581080|FG006|Overall Study|Severe debilitation, unable to continue|3|||
164606855|NCT00006604|594581081|FG007|Overall Study|Severe debilitation, unable to continue|0|||
164606856|NCT00006604|594581082|FG008|Overall Study|Severe debilitation, unable to continue|0|||
164606857|NCT00006604|594581083|FG009|Overall Study|Severe debilitation, unable to continue|5|||
164503248|NCT02058836|594213282|FG001|Overall Study|Withdrawal by Subject|1|||
164503249|NCT00573651|594213284|FG000|Overall Study|Lost to Follow-up|3|||
164503250|NCT00573651|594213284|FG000|Overall Study|Withdrawal by Subject|1|||
164503251|NCT01225159|594213287|FG000|Overall Study|Change operation|1|||
164503252|NCT01225159|594213288|FG001|Overall Study|Change operation|0|||
164503253|NCT01220856|594213293|FG000|Overall Study|graft loss|3|||
164503254|NCT01220856|594213294|FG001|Overall Study|graft loss|3|||
164503255|NCT01220856|594213293|FG000|Overall Study|Lost to Follow-up|1|||
164503256|NCT01220856|594213294|FG001|Overall Study|Lost to Follow-up|0|||
164503257|NCT00903760|594215485|FG000|Overall Study|Disease Progression/Death|8|||
164503258|NCT00903760|594215486|FG001|Overall Study|Disease Progression/Death|6|||
164503259|NCT00903760|594215485|FG000|Overall Study|Stem Cell Transplant|8|||
164503260|NCT00903760|594215486|FG001|Overall Study|Stem Cell Transplant|4|||
164503261|NCT00903760|594215485|FG000|Overall Study|Physician Decision|1|||
164503262|NCT00903760|594215486|FG001|Overall Study|Physician Decision|2|||
164503263|NCT00903760|594215485|FG000|Overall Study|Death|0|||
164503264|NCT00903760|594215486|FG001|Overall Study|Death|1|||
164503265|NCT00903760|594215485|FG000|Overall Study|Lost to Follow-up|1|||
164503266|NCT00903760|594215486|FG001|Overall Study|Lost to Follow-up|0|||
164503267|NCT00903760|594215485|FG000|Overall Study|Withdrawal by Subject|1|||
164503268|NCT00903760|594215486|FG001|Overall Study|Withdrawal by Subject|2|||
164503269|NCT00903760|594215485|FG000|Overall Study|Off treatment for long period|0|||
164503270|NCT00903760|594215486|FG001|Overall Study|Off treatment for long period|1|||
164503271|NCT00487825|594215487|FG000|Overall Study|Adverse Event|2|||
164503272|NCT00487825|594215488|FG001|Overall Study|Adverse Event|2|||
164503273|NCT00487825|594215487|FG000|Overall Study|Lack of Efficacy|1|||
164503274|NCT00487825|594215488|FG001|Overall Study|Lack of Efficacy|1|||
164503275|NCT00487825|594215487|FG000|Overall Study|Other|3|||
164503276|NCT00487825|594215488|FG001|Overall Study|Other|2|||
164503277|NCT01256671|594215489|FG000|Overall Study|Adverse Event|29|||
164503278|NCT01256671|594215489|FG000|Overall Study|Lost to Follow-up|16|||
164503279|NCT01256671|594215489|FG000|Overall Study|Withdrawal by Subject|31|||
164503280|NCT01256671|594215489|FG000|Overall Study|Physician Decision|3|||
164503281|NCT01256671|594215489|FG000|Overall Study|Lack of Efficacy|4|||
164503282|NCT01256671|594215489|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
164503283|NCT01190644|594215490|FG000|Overall Study|Death|2|||
164503284|NCT01190644|594215490|FG000|Overall Study|Disease progression|1|||
164503285|NCT02366143|594215491|FG000|Overall Study|Death|307|||
164503286|NCT02366143|594215492|FG001|Overall Study|Death|278|||
164503287|NCT02366143|594215493|FG002|Overall Study|Death|280|||
164503288|NCT02366143|594215491|FG000|Overall Study|Lost to Follow-up|2|||
164503289|NCT02366143|594215492|FG001|Overall Study|Lost to Follow-up|4|||
164503290|NCT02366143|594215493|FG002|Overall Study|Lost to Follow-up|2|||
164503291|NCT02366143|594215491|FG000|Overall Study|Physician Decision|1|||
164503292|NCT02366143|594215492|FG001|Overall Study|Physician Decision|2|||
164503293|NCT02366143|594215493|FG002|Overall Study|Physician Decision|1|||
164503294|NCT02366143|594215491|FG000|Overall Study|Protocol Violation|0|||
164503295|NCT02366143|594215492|FG001|Overall Study|Protocol Violation|0|||
164503296|NCT02366143|594215493|FG002|Overall Study|Protocol Violation|2|||
164503297|NCT02366143|594215491|FG000|Overall Study|Withdrawal by Subject|16|||
164503298|NCT02366143|594215492|FG001|Overall Study|Withdrawal by Subject|17|||
164503299|NCT02366143|594215493|FG002|Overall Study|Withdrawal by Subject|22|||
164503300|NCT02366143|594215491|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
164503301|NCT02366143|594215492|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
164503302|NCT02366143|594215493|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
164503303|NCT02366143|594215491|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
164503304|NCT02366143|594215492|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
164503305|NCT02366143|594215493|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
164503306|NCT02366143|594215491|FG000|Overall Study|Randomization Error|1|||
164503307|NCT02366143|594215492|FG001|Overall Study|Randomization Error|0|||
164503308|NCT02366143|594215493|FG002|Overall Study|Randomization Error|0|||
164503309|NCT02366143|594215491|FG000|Overall Study|PI Move and Site Closure|1|||
164503310|NCT02366143|594215492|FG001|Overall Study|PI Move and Site Closure|0|||
164503311|NCT02366143|594215493|FG002|Overall Study|PI Move and Site Closure|1|||
164503312|NCT02366143|594215491|FG000|Overall Study|Study Terminated By Sponsor|0|||
164503313|NCT02366143|594215492|FG001|Overall Study|Study Terminated By Sponsor|0|||
164503314|NCT02366143|594215493|FG002|Overall Study|Study Terminated By Sponsor|2|||
164503315|NCT02366143|594215491|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
164503316|NCT02366143|594215492|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
164503317|NCT02366143|594215493|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
164503318|NCT02366143|594215491|FG000|Overall Study|Patient moved to roll-over study|1|||
164503319|NCT02366143|594215492|FG001|Overall Study|Patient moved to roll-over study|19|||
164503320|NCT02366143|594215493|FG002|Overall Study|Patient moved to roll-over study|28|||
164503321|NCT02366143|594215491|FG000|Overall Study|Patient moved to commercial stock|0|||
164503322|NCT02366143|594215492|FG001|Overall Study|Patient moved to commercial stock|0|||
164503323|NCT02366143|594215493|FG002|Overall Study|Patient moved to commercial stock|1|||
164503324|NCT02366143|594215491|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
164503325|NCT02366143|594215492|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
164503326|NCT02366143|594215493|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
164503327|NCT02366143|594215491|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
164503328|NCT02366143|594215492|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
164503329|NCT02366143|594215493|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
164503330|NCT02366143|594215491|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
164503331|NCT02366143|594215492|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
164503332|NCT02366143|594215493|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
164503333|NCT02366143|594215491|FG000|Overall Study|Requester's instructions|1|||
164503334|NCT02366143|594215492|FG001|Overall Study|Requester's instructions|1|||
164503335|NCT02366143|594215493|FG002|Overall Study|Requester's instructions|1|||
164503336|NCT02366143|594215491|FG000|Overall Study|Uneligible|0|||
164503337|NCT02366143|594215492|FG001|Overall Study|Uneligible|1|||
164503338|NCT02366143|594215493|FG002|Overall Study|Uneligible|0|||
164503339|NCT02366143|594215491|FG000|Overall Study|Post Trial Migration|0|||
164503340|NCT02366143|594215492|FG001|Overall Study|Post Trial Migration|1|||
164503341|NCT02366143|594215493|FG002|Overall Study|Post Trial Migration|0|||
164503342|NCT02366143|594215491|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
164503343|NCT02366143|594215492|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
164503344|NCT02366143|594215493|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
164503345|NCT02366143|594215491|FG000|Overall Study|Patient switched to PTAP|0|||
164503346|NCT02366143|594215492|FG001|Overall Study|Patient switched to PTAP|1|||
164503347|NCT02366143|594215493|FG002|Overall Study|Patient switched to PTAP|0|||
164503348|NCT02366143|594215491|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
164503349|NCT02366143|594215492|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
164503350|NCT02366143|594215493|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
164503351|NCT01536587|594215496|FG000|Overall Study|Adverse Event|2|||
164503352|NCT02666664|594215497|FG000|Overall Study|Physician Decision|0|||
164503353|NCT02666664|594215498|FG001|Overall Study|Physician Decision|1|||
164503354|NCT02666664|594215497|FG000|Overall Study|Protocol Violation|0|||
164503355|NCT02666664|594215498|FG001|Overall Study|Protocol Violation|2|||
164503356|NCT02666664|594215497|FG000|Overall Study|Other|0|||
164503357|NCT02666664|594215498|FG001|Overall Study|Other|1|||
164503358|NCT02666664|594215497|FG000|Overall Study|Adverse Event|12|||
164503359|NCT02666664|594215498|FG001|Overall Study|Adverse Event|37|||
164503360|NCT02666664|594215497|FG000|Overall Study|Withdrawal by participant|23|||
164503361|NCT02666664|594215498|FG001|Overall Study|Withdrawal by participant|40|||
164503362|NCT02666664|594215497|FG000|Overall Study|Sponsor decision|0|||
164503363|NCT02666664|594215498|FG001|Overall Study|Sponsor decision|1|||
164503364|NCT02666664|594215497|FG000|Overall Study|Lost to Follow-up|1|||
164503365|NCT02666664|594215498|FG001|Overall Study|Lost to Follow-up|2|||
164503366|NCT00543062|594215499|FG000|Overall Study|Withdrawal by Subject|1|||
164503367|NCT00543062|594215500|FG001|Overall Study|Withdrawal by Subject|0|||
164503368|NCT00543062|594215501|FG002|Overall Study|Withdrawal by Subject|2|||
164503369|NCT00543062|594215502|FG003|Overall Study|Withdrawal by Subject|0|||
164503370|NCT00543062|594215499|FG000|Overall Study|Adverse Event|0|||
164503371|NCT00543062|594215500|FG001|Overall Study|Adverse Event|1|||
164503372|NCT00543062|594215501|FG002|Overall Study|Adverse Event|1|||
164503373|NCT00543062|594215502|FG003|Overall Study|Adverse Event|1|||
164503374|NCT00543062|594215499|FG000|Overall Study|Protocol Violation|1|||
164503375|NCT00543062|594215500|FG001|Overall Study|Protocol Violation|0|||
164503376|NCT00543062|594215501|FG002|Overall Study|Protocol Violation|0|||
164503377|NCT00543062|594215502|FG003|Overall Study|Protocol Violation|0|||
164503378|NCT00328562|594215508|FG000|Overall Study|Disease progression|1|||
164503379|NCT04014790|594215509|FG000|Overall Study|Death|4|||
164503380|NCT04014790|594215509|FG000|Overall Study|Adverse Event|1|||
164503381|NCT04014790|594215509|FG000|Overall Study|Withdrawal by Subject|1|||
164503382|NCT03546816|594215510|FG000|Overall Study|Adverse Event|5|||
164503383|NCT03546816|594215511|FG001|Overall Study|Adverse Event|3|||
164503384|NCT03546816|594215510|FG000|Overall Study|Lack of Efficacy|2|||
164503385|NCT03546816|594215511|FG001|Overall Study|Lack of Efficacy|4|||
164503386|NCT03546816|594215510|FG000|Overall Study|Pregnancy|1|||
164503387|NCT03546816|594215511|FG001|Overall Study|Pregnancy|0|||
164503388|NCT03546816|594215510|FG000|Overall Study|Physician Decision|2|||
164503389|NCT03546816|594215511|FG001|Overall Study|Physician Decision|0|||
164503390|NCT03546816|594215510|FG000|Overall Study|Withdrawal by Subject|8|||
164503391|NCT03546816|594215511|FG001|Overall Study|Withdrawal by Subject|10|||
164503392|NCT03546816|594215510|FG000|Overall Study|Lost to Follow-up|3|||
164503393|NCT03546816|594215511|FG001|Overall Study|Lost to Follow-up|2|||
164503394|NCT01161446|594215512|FG000|Overall Study|Lost to Follow-up|18|||
164503395|NCT01161446|594215513|FG001|Overall Study|Lost to Follow-up|14|||
164503396|NCT01161446|594215512|FG000|Overall Study|Withdrawal by Subject|0|||
164503397|NCT01161446|594215513|FG001|Overall Study|Withdrawal by Subject|1|||
164503398|NCT02270671|594215516|FG000|Overall Study|Withdrawal by Subject|1|||
164503399|NCT02270671|594215517|FG001|Overall Study|Withdrawal by Subject|1|||
164503400|NCT02270671|594215516|FG000|Overall Study|Protocol Violation|0|||
164503401|NCT02270671|594215517|FG001|Overall Study|Protocol Violation|1|||
164503402|NCT02270671|594215516|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
164503403|NCT02270671|594215517|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
164503404|NCT02270671|594215516|FG000|Overall Study|Lost to Follow-up|2|||
164503405|NCT02270671|594215517|FG001|Overall Study|Lost to Follow-up|1|||
164503406|NCT03927690|594215520|FG000|Overall Study|Withdrawal by Subject|3|||
164503407|NCT03927690|594215521|FG001|Overall Study|Withdrawal by Subject|1|||
164503408|NCT03927690|594215522|FG002|Overall Study|Withdrawal by Subject|1|||
164503409|NCT03927690|594215520|FG000|Overall Study|Adverse Event|1|||
164503410|NCT03927690|594215521|FG001|Overall Study|Adverse Event|0|||
164503411|NCT03927690|594215522|FG002|Overall Study|Adverse Event|0|||
164503412|NCT03927690|594215520|FG000|Overall Study|Death|1|||
164503413|NCT03927690|594215521|FG001|Overall Study|Death|0|||
164503414|NCT03927690|594215522|FG002|Overall Study|Death|0|||
164503415|NCT03927690|594215520|FG000|Overall Study|Lost to Follow-up|2|||
164503416|NCT03927690|594215521|FG001|Overall Study|Lost to Follow-up|2|||
164503417|NCT03927690|594215522|FG002|Overall Study|Lost to Follow-up|1|||
164503418|NCT00126659|594215525|FG000|Overall Study|Adverse Event|0|||
164503419|NCT00126659|594215526|FG001|Overall Study|Adverse Event|0|||
164503420|NCT00126659|594215527|FG002|Overall Study|Adverse Event|2|||
164503421|NCT00174447|594215530|FG000|Overall Study|Adverse Event|19|||
164606858|NCT00006604|594581084|FG010|Overall Study|Severe debilitation, unable to continue|0|||
164606859|NCT00006604|594581085|FG011|Overall Study|Severe debilitation, unable to continue|2|||
164606860|NCT00006604|594581086|FG012|Overall Study|Severe debilitation, unable to continue|1|||
164606861|NCT00006604|594581087|FG013|Overall Study|Severe debilitation, unable to continue|0|||
164300986|NCT02392624|593478383|FG000|Overall Study|Other|49|||
164300987|NCT02392624|593478384|FG001|Overall Study|Other|1|||
164300988|NCT02392624|593478385|FG002|Overall Study|Other|1|||
164300989|NCT03841604|593478388|FG000|Overall Study|Withdrawal by Subject|3|||
164300990|NCT03841604|593478389|FG001|Overall Study|Withdrawal by Subject|1|||
164300991|NCT03841604|593478388|FG000|Overall Study|Adverse Event|4|||
164300992|NCT03841604|593478389|FG001|Overall Study|Adverse Event|2|||
164300993|NCT03841604|593478388|FG000|Overall Study|Physician Decision|1|||
164300994|NCT03841604|593478389|FG001|Overall Study|Physician Decision|0|||
164300995|NCT01337960|593478390|FG000|Overall Study|Lost to Follow-up|1|||
164300996|NCT01337960|593478391|FG001|Overall Study|Lost to Follow-up|0|||
164300997|NCT01337960|593478392|FG002|Overall Study|Lost to Follow-up|0|||
164300998|NCT01337960|593478390|FG000|Overall Study|Withdrawal by Subject|1|||
164300999|NCT01337960|593478391|FG001|Overall Study|Withdrawal by Subject|0|||
164301000|NCT01337960|593478392|FG002|Overall Study|Withdrawal by Subject|0|||
164301001|NCT03877510|593478393|FG000|Overall Study|Death|6|||
164301002|NCT03877510|593478393|FG000|Overall Study|Lost to Follow-up|2|||
164301003|NCT03877510|593478393|FG000|Overall Study|Non-compliance with study drug|2|||
164301004|NCT03877510|593478393|FG000|Overall Study|Lack of Efficacy|14|||
164301005|NCT03877510|593478393|FG000|Overall Study|Adverse Event|20|||
164301006|NCT03877510|593478393|FG000|Overall Study|Withdrawal by Subject|22|||
164301007|NCT03877510|593478393|FG000|Overall Study|Miscellaneous|1|||
164301008|NCT03763877|593478394|FG000|Overall Study|Withdrawal by Subject|3|||
164301009|NCT03763877|593478395|FG001|Overall Study|Withdrawal by Subject|1|||
164301010|NCT03763877|593478396|FG002|Overall Study|Withdrawal by Subject|3|||
164301011|NCT03763877|593478397|FG003|Overall Study|Withdrawal by Subject|4|||
164301012|NCT03763877|593478394|FG000|Overall Study|Adverse Event|1|||
164301013|NCT03763877|593478395|FG001|Overall Study|Adverse Event|1|||
164301014|NCT03763877|593478396|FG002|Overall Study|Adverse Event|3|||
164301015|NCT03763877|593478397|FG003|Overall Study|Adverse Event|1|||
164606862|NCT00006604|594581088|FG014|Overall Study|Severe debilitation, unable to continue|2|||
164606863|NCT00006604|594581089|FG015|Overall Study|Severe debilitation, unable to continue|0|||
164606864|NCT00006604|594581090|FG016|Overall Study|Severe debilitation, unable to continue|0|||
164301016|NCT03763877|593478394|FG000|Overall Study|Protocol Violation|1|||
164301017|NCT03763877|593478395|FG001|Overall Study|Protocol Violation|1|||
164503422|NCT00174447|594215530|FG000|Overall Study|Withdrawal by Subject|15|||
164606865|NCT00006604|594581074|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
164606866|NCT00006604|594581075|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
164606867|NCT00006604|594581076|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
164606868|NCT00006604|594581077|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
164606869|NCT00006604|594581078|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
164606870|NCT00006604|594581079|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
164606871|NCT00006604|594581080|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
164606872|NCT00006604|594581081|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
164503423|NCT00174447|594215530|FG000|Overall Study|Protocol Violation|1|||
164503424|NCT00174447|594215530|FG000|Overall Study|Lack of Efficacy|1|||
164503425|NCT00174447|594215530|FG000|Overall Study|Administrative reason/Other|2|||
164503426|NCT02232399|594215548|FG000|Overall Study|Adverse Event|1|||
164503427|NCT02232399|594215549|FG001|Overall Study|Adverse Event|0|||
164503428|NCT02232399|594215548|FG000|Overall Study|Withdrawal by Subject|0|||
164503429|NCT02232399|594215549|FG001|Overall Study|Withdrawal by Subject|1|||
164503430|NCT03491215|594215550|FG000|Overall Study|Death|6|||
164503431|NCT03491215|594215551|FG001|Overall Study|Death|2|||
164503432|NCT03491215|594215552|FG002|Overall Study|Death|1|||
164503433|NCT03491215|594215553|FG003|Overall Study|Death|0|||
164503434|NCT03491215|594215550|FG000|Overall Study|Physician Decision|1|||
164503435|NCT03491215|594215551|FG001|Overall Study|Physician Decision|0|||
164503436|NCT03491215|594215552|FG002|Overall Study|Physician Decision|0|||
164503437|NCT03491215|594215553|FG003|Overall Study|Physician Decision|0|||
164503438|NCT04294667|594215568|FG000|Overall Study|Lack of Efficacy|4|||
164503439|NCT04294667|594215569|FG001|Overall Study|Lack of Efficacy|4|||
164503440|NCT04294667|594215568|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
164503441|NCT04294667|594215569|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
164503442|NCT04294667|594215568|FG000|Overall Study|Patient has a Renal Flare|1|||
164503443|NCT04294667|594215569|FG001|Overall Study|Patient has a Renal Flare|0|||
164503444|NCT04294667|594215568|FG000|Overall Study|SLE Worsening|0|||
164503445|NCT04294667|594215569|FG001|Overall Study|SLE Worsening|1|||
164503446|NCT04294667|594215568|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
164503447|NCT04294667|594215569|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
164503448|NCT04294667|594215568|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
164503449|NCT04294667|594215569|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
164503450|NCT04294667|594215568|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
164503451|NCT04294667|594215569|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
164503452|NCT04294667|594215568|FG000|Overall Study|Subject Moved to Another State|0|||
164503453|NCT04294667|594215569|FG001|Overall Study|Subject Moved to Another State|1|||
164503454|NCT04294667|594215568|FG000|Overall Study|Adverse event, serious fatal|0|||
164503455|NCT04294667|594215569|FG001|Overall Study|Adverse event, serious fatal|1|||
164503456|NCT04294667|594215568|FG000|Overall Study|Adverse event, non-fatal|3|||
164503457|NCT04294667|594215569|FG001|Overall Study|Adverse event, non-fatal|4|||
164503458|NCT04799418|594215570|FG000|Overall Study|Death|1|||
164503459|NCT04799418|594215571|FG001|Overall Study|Death|1|||
164503460|NCT04799418|594215570|FG000|Overall Study|Lack of Efficacy|14|||
164503461|NCT04799418|594215571|FG001|Overall Study|Lack of Efficacy|14|||
164503462|NCT04799418|594215570|FG000|Overall Study|Withdrawal by Subject|10|||
164503463|NCT04799418|594215571|FG001|Overall Study|Withdrawal by Subject|7|||
164503464|NCT04799418|594215570|FG000|Overall Study|Adverse Event|3|||
164503465|NCT04799418|594215571|FG001|Overall Study|Adverse Event|2|||
164503466|NCT03297398|594215572|FG000|Overall Study|Sponsor's decision|6|||
164503467|NCT03297398|594215573|FG001|Overall Study|Sponsor's decision|9|||
164503468|NCT03297398|594215574|FG002|Overall Study|Sponsor's decision|7|||
164503469|NCT03297398|594215572|FG000|Overall Study|Adverse Event|1|||
164503470|NCT03297398|594215573|FG001|Overall Study|Adverse Event|4|||
164503471|NCT03297398|594215574|FG002|Overall Study|Adverse Event|4|||
164503472|NCT03297398|594215572|FG000|Overall Study|Withdrawal by Subject|1|||
164503473|NCT03297398|594215573|FG001|Overall Study|Withdrawal by Subject|2|||
164503474|NCT03297398|594215574|FG002|Overall Study|Withdrawal by Subject|2|||
164503475|NCT03297398|594215572|FG000|Overall Study|Protocol Violation|0|||
164503476|NCT03297398|594215573|FG001|Overall Study|Protocol Violation|2|||
164503477|NCT03297398|594215574|FG002|Overall Study|Protocol Violation|0|||
164503478|NCT03297398|594215572|FG000|Overall Study|Physician Decision|0|||
164503479|NCT03297398|594215573|FG001|Overall Study|Physician Decision|0|||
164503480|NCT03297398|594215574|FG002|Overall Study|Physician Decision|1|||
164503481|NCT03297398|594215572|FG000|Overall Study|Lost to Follow-up|0|||
164503482|NCT03297398|594215573|FG001|Overall Study|Lost to Follow-up|0|||
164503483|NCT03297398|594215574|FG002|Overall Study|Lost to Follow-up|1|||
164716580|NCT03818035|594985124|FG007|Part 2: Double-blind (Week28 to Week68)|Withdrawal by Subject|0|||
164503484|NCT00611715|594215579|FG000|Overall Study|Disease Progression|24|||
164503485|NCT00611715|594215580|FG001|Overall Study|Disease Progression|4|||
164503486|NCT00611715|594215579|FG000|Overall Study|Withdrawal by Subject|5|||
164503487|NCT00611715|594215580|FG001|Overall Study|Withdrawal by Subject|1|||
164503488|NCT00611715|594215579|FG000|Overall Study|Adverse Event|9|||
164503489|NCT00611715|594215580|FG001|Overall Study|Adverse Event|1|||
164503490|NCT00611715|594215579|FG000|Overall Study|Death|1|||
164503491|NCT00611715|594215580|FG001|Overall Study|Death|0|||
164503492|NCT00611715|594215579|FG000|Overall Study|two patients are still on treatment|2|||
164503493|NCT00611715|594215580|FG001|Overall Study|two patients are still on treatment|0|||
164503494|NCT00107978|594215581|FG000|Overall Study|Adverse Event|1|||
164503495|NCT00107978|594215582|FG001|Overall Study|Adverse Event|5|||
164503496|NCT00107978|594215581|FG000|Overall Study|Death|3|||
164503497|NCT00107978|594215582|FG001|Overall Study|Death|3|||
164503498|NCT00107978|594215581|FG000|Overall Study|Lost to Follow-up|20|||
164716581|NCT03818035|594985117|FG000|Part 2: Double-blind (Week28 to Week68)|Other Adverse Events|0|||
164716582|NCT03818035|594985118|FG001|Part 2: Double-blind (Week28 to Week68)|Other Adverse Events|3|||
164716583|NCT03818035|594985119|FG002|Part 2: Double-blind (Week28 to Week68)|Other Adverse Events|4|||
164716584|NCT03818035|594985120|FG003|Part 2: Double-blind (Week28 to Week68)|Other Adverse Events|6|||
164716585|NCT03818035|594985121|FG004|Part 2: Double-blind (Week28 to Week68)|Other Adverse Events|0|||
164716586|NCT03818035|594985122|FG005|Part 2: Double-blind (Week28 to Week68)|Other Adverse Events|0|||
164716587|NCT03818035|594985123|FG006|Part 2: Double-blind (Week28 to Week68)|Other Adverse Events|0|||
164716588|NCT03818035|594985124|FG007|Part 2: Double-blind (Week28 to Week68)|Other Adverse Events|0|||
164716589|NCT03818035|594985117|FG000|Part 2: Double-blind (Week28 to Week68)|Adverse Event, serious fatal|0|||
164716590|NCT03818035|594985118|FG001|Part 2: Double-blind (Week28 to Week68)|Adverse Event, serious fatal|0|||
164716591|NCT03818035|594985119|FG002|Part 2: Double-blind (Week28 to Week68)|Adverse Event, serious fatal|0|||
164716592|NCT03818035|594985120|FG003|Part 2: Double-blind (Week28 to Week68)|Adverse Event, serious fatal|1|||
164716593|NCT03818035|594985121|FG004|Part 2: Double-blind (Week28 to Week68)|Adverse Event, serious fatal|0|||
164716594|NCT03818035|594985122|FG005|Part 2: Double-blind (Week28 to Week68)|Adverse Event, serious fatal|0|||
164716595|NCT03818035|594985123|FG006|Part 2: Double-blind (Week28 to Week68)|Adverse Event, serious fatal|0|||
164716596|NCT03818035|594985124|FG007|Part 2: Double-blind (Week28 to Week68)|Adverse Event, serious fatal|0|||
164716597|NCT03818035|594985117|FG000|Part 2: Double-blind (Week28 to Week68)|Participants Started Retreatment Phase Within Study Part 2 before Week 68|0|||
164716598|NCT03818035|594985118|FG001|Part 2: Double-blind (Week28 to Week68)|Participants Started Retreatment Phase Within Study Part 2 before Week 68|1|||
164716599|NCT03818035|594985119|FG002|Part 2: Double-blind (Week28 to Week68)|Participants Started Retreatment Phase Within Study Part 2 before Week 68|2|||
164716600|NCT03818035|594985120|FG003|Part 2: Double-blind (Week28 to Week68)|Participants Started Retreatment Phase Within Study Part 2 before Week 68|0|||
164503499|NCT00107978|594215582|FG001|Overall Study|Lost to Follow-up|28|||
164503500|NCT00107978|594215581|FG000|Overall Study|Withdrawal by Subject|4|||
164503501|NCT00107978|594215582|FG001|Overall Study|Withdrawal by Subject|9|||
164503502|NCT00107978|594215581|FG000|Overall Study|Protocol Violation|0|||
164503503|NCT00107978|594215582|FG001|Overall Study|Protocol Violation|1|||
164503504|NCT00107978|594215581|FG000|Overall Study|Other|5|||
164503505|NCT00107978|594215582|FG001|Overall Study|Other|4|||
164503506|NCT02669407|594215583|FG000|Overall Study|Physician Decision|3|||
164503507|NCT00350298|594215586|FG000|Overall Study|Death|7|||
164503508|NCT00350298|594215587|FG001|Overall Study|Death|8|||
164503509|NCT00350298|594215586|FG000|Overall Study|Lost to Follow-up|1|||
164503510|NCT00350298|594215587|FG001|Overall Study|Lost to Follow-up|2|||
164503511|NCT00350298|594215586|FG000|Overall Study|Withdrawal by Subject|1|||
164503512|NCT00350298|594215587|FG001|Overall Study|Withdrawal by Subject|3|||
164503513|NCT00233389|594215588|FG000|Overall Study|Adverse Event|5|||
164503514|NCT00233389|594215589|FG001|Overall Study|Adverse Event|5|||
164503515|NCT00233389|594215588|FG000|Overall Study|Lack of Efficacy|11|||
164503516|NCT00233389|594215589|FG001|Overall Study|Lack of Efficacy|8|||
164503517|NCT00233389|594215588|FG000|Overall Study|Lost to Follow-up|1|||
164503518|NCT00233389|594215589|FG001|Overall Study|Lost to Follow-up|1|||
164503519|NCT00233389|594215588|FG000|Overall Study|Physician Decision|1|||
164503520|NCT00233389|594215589|FG001|Overall Study|Physician Decision|0|||
164503521|NCT00233389|594215588|FG000|Overall Study|Protocol Violation|0|||
164503522|NCT00233389|594215589|FG001|Overall Study|Protocol Violation|1|||
164503523|NCT00233389|594215588|FG000|Overall Study|Withdrawal by Subject|0|||
164503524|NCT00233389|594215589|FG001|Overall Study|Withdrawal by Subject|1|||
164503525|NCT00719043|594215595|FG000|Overall Study|Adverse Event|5|||
164503526|NCT00719043|594215596|FG001|Overall Study|Adverse Event|1|||
164503527|NCT00719043|594215597|FG002|Overall Study|Adverse Event|2|||
164503528|NCT00719043|594215598|FG003|Overall Study|Adverse Event|2|||
164503529|NCT00719043|594215599|FG004|Overall Study|Adverse Event|1|||
164503530|NCT00719043|594215600|FG005|Overall Study|Adverse Event|4|||
164503531|NCT00719043|594215601|FG006|Overall Study|Adverse Event|4|||
164503532|NCT00719043|594215595|FG000|Overall Study|Lost to Follow-up|14|||
164503533|NCT00719043|594215596|FG001|Overall Study|Lost to Follow-up|10|||
164503534|NCT00719043|594215597|FG002|Overall Study|Lost to Follow-up|8|||
164503535|NCT00719043|594215598|FG003|Overall Study|Lost to Follow-up|9|||
164503536|NCT00719043|594215599|FG004|Overall Study|Lost to Follow-up|10|||
164503537|NCT00719043|594215600|FG005|Overall Study|Lost to Follow-up|9|||
164503538|NCT00719043|594215601|FG006|Overall Study|Lost to Follow-up|9|||
164503539|NCT00719043|594215595|FG000|Overall Study|Protocol Violation|0|||
164503540|NCT00719043|594215596|FG001|Overall Study|Protocol Violation|0|||
164503541|NCT00719043|594215597|FG002|Overall Study|Protocol Violation|0|||
164503542|NCT00719043|594215598|FG003|Overall Study|Protocol Violation|0|||
164503543|NCT00719043|594215599|FG004|Overall Study|Protocol Violation|0|||
164503544|NCT00719043|594215600|FG005|Overall Study|Protocol Violation|1|||
164503545|NCT00719043|594215601|FG006|Overall Study|Protocol Violation|0|||
164503546|NCT00719043|594215595|FG000|Overall Study|Other|1|||
164503547|NCT00719043|594215596|FG001|Overall Study|Other|0|||
164503548|NCT00719043|594215597|FG002|Overall Study|Other|1|||
164503549|NCT00719043|594215598|FG003|Overall Study|Other|2|||
164503550|NCT00719043|594215599|FG004|Overall Study|Other|0|||
164503551|NCT00719043|594215600|FG005|Overall Study|Other|2|||
164503552|NCT00719043|594215601|FG006|Overall Study|Other|1|||
164503553|NCT00719043|594215595|FG000|Overall Study|Withdrawal by Subject|12|||
164503554|NCT00719043|594215596|FG001|Overall Study|Withdrawal by Subject|14|||
164503555|NCT00719043|594215597|FG002|Overall Study|Withdrawal by Subject|9|||
164503556|NCT00719043|594215598|FG003|Overall Study|Withdrawal by Subject|10|||
164503557|NCT00719043|594215599|FG004|Overall Study|Withdrawal by Subject|16|||
164503558|NCT00719043|594215600|FG005|Overall Study|Withdrawal by Subject|18|||
164503559|NCT00719043|594215601|FG006|Overall Study|Withdrawal by Subject|14|||
164503560|NCT00822770|594215602|FG000|Overall Study|Not treated|1|||
164503561|NCT00822770|594215603|FG001|Overall Study|Not treated|0|||
164503562|NCT00822770|594215602|FG000|Overall Study|Complication/Incomplete treatment|1|||
164503563|NCT00822770|594215603|FG001|Overall Study|Complication/Incomplete treatment|0|||
164503564|NCT00822770|594215602|FG000|Overall Study|Death|1|||
164503565|NCT00822770|594215603|FG001|Overall Study|Death|1|||
164503566|NCT04593823|594215604|FG000|Overall Study|Withdrawal by Subject|1|||
164503567|NCT04593823|594215605|FG001|Overall Study|Withdrawal by Subject|1|||
164503568|NCT04593823|594215604|FG000|Overall Study|Lost to Follow-up|0|||
164503569|NCT04593823|594215605|FG001|Overall Study|Lost to Follow-up|1|||
164503570|NCT01704547|594215608|FG000|Overall Study|Physician Decision|4|||
164503571|NCT01704547|594215608|FG000|Overall Study|Withdrawal by Subject|1|||
164503572|NCT02413593|594215609|FG000|Overall Study|Lost to Follow-up|3|||
164503573|NCT02413593|594215609|FG000|Overall Study|Adverse Event|1|||
164503574|NCT03845075|594215610|FG000|Part 1 - DB|Withdrawal by Subject|1|||
164503575|NCT03845075|594215611|FG001|Part 1 - DB|Withdrawal by Subject|1|||
164503576|NCT03845075|594215612|FG002|Part 1 - DB|Withdrawal by Subject|0|||
164503577|NCT03845075|594215613|FG003|Part 1 - DB|Withdrawal by Subject|0|||
164503578|NCT03845075|594215610|FG000|Part 1 - DB|Adverse Event|0|||
164503579|NCT03845075|594215611|FG001|Part 1 - DB|Adverse Event|1|||
164503580|NCT03845075|594215612|FG002|Part 1 - DB|Adverse Event|0|||
164503581|NCT03845075|594215613|FG003|Part 1 - DB|Adverse Event|0|||
164503582|NCT03845075|594215610|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
164503583|NCT03845075|594215611|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
164503584|NCT03845075|594215612|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
164503585|NCT03845075|594215613|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
164503586|NCT02564718|594215614|FG000|Overall Study|Withdrew from treatment|0|||
164503587|NCT02564718|594215615|FG001|Overall Study|Withdrew from treatment|1|||
164503588|NCT00104637|594215616|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
164503589|NCT00104637|594215617|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
164503590|NCT00409409|594215618|FG000|Overall Study|Adverse Event|7|||
164503591|NCT00409409|594215619|FG001|Overall Study|Adverse Event|2|||
164503592|NCT00409409|594215618|FG000|Overall Study|Withdrawal by Subject|1|||
164503593|NCT00409409|594215619|FG001|Overall Study|Withdrawal by Subject|1|||
164503594|NCT00409409|594215618|FG000|Overall Study|Any other reason not above-mentioned|0|||
164503595|NCT00409409|594215619|FG001|Overall Study|Any other reason not above-mentioned|1|||
164503596|NCT01918371|594215623|FG000|Overall Study|Missing Data|1|||
164503597|NCT01918371|594215624|FG001|Overall Study|Missing Data|1|||
164503598|NCT03802617|594215629|FG000|Overall Study|Adverse Event|0|||
164503599|NCT03802617|594215630|FG001|Overall Study|Adverse Event|4|||
164503600|NCT03802617|594215631|FG002|Overall Study|Adverse Event|5|||
164503601|NCT03802617|594215632|FG003|Overall Study|Adverse Event|1|||
164503602|NCT03802617|594215629|FG000|Overall Study|Lack of Efficacy|0|||
164503603|NCT03802617|594215630|FG001|Overall Study|Lack of Efficacy|1|||
164503604|NCT03802617|594215631|FG002|Overall Study|Lack of Efficacy|0|||
164503605|NCT03802617|594215632|FG003|Overall Study|Lack of Efficacy|2|||
164503606|NCT03802617|594215629|FG000|Overall Study|Protocol Violation|1|||
164503607|NCT03802617|594215630|FG001|Overall Study|Protocol Violation|1|||
164503608|NCT03802617|594215631|FG002|Overall Study|Protocol Violation|1|||
164503609|NCT03802617|594215632|FG003|Overall Study|Protocol Violation|0|||
164503610|NCT03802617|594215629|FG000|Overall Study|Withdrawal by Subject|1|||
164503611|NCT03802617|594215630|FG001|Overall Study|Withdrawal by Subject|1|||
164503612|NCT03802617|594215631|FG002|Overall Study|Withdrawal by Subject|1|||
164503613|NCT03802617|594215632|FG003|Overall Study|Withdrawal by Subject|0|||
164503614|NCT03802617|594215629|FG000|Overall Study|Four consecutive missed doses of the study drug|0|||
164503615|NCT03802617|594215630|FG001|Overall Study|Four consecutive missed doses of the study drug|1|||
164503616|NCT03802617|594215631|FG002|Overall Study|Four consecutive missed doses of the study drug|1|||
164503617|NCT03802617|594215632|FG003|Overall Study|Four consecutive missed doses of the study drug|1|||
164503618|NCT00621192|594215633|FG000|Overall Study|Withdrawal by Subject|0|||
164503619|NCT00621192|594215634|FG001|Overall Study|Withdrawal by Subject|0|||
164503620|NCT00621192|594215635|FG002|Overall Study|Withdrawal by Subject|2|||
164606873|NCT00006604|594581082|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
164503621|NCT00621192|594215636|FG003|Overall Study|Withdrawal by Subject|0|||
164503622|NCT00621192|594215633|FG000|Overall Study|Physician Decision|1|||
164503623|NCT00621192|594215634|FG001|Overall Study|Physician Decision|3|||
164503624|NCT00621192|594215635|FG002|Overall Study|Physician Decision|0|||
164503625|NCT00621192|594215636|FG003|Overall Study|Physician Decision|0|||
164503626|NCT00621192|594215633|FG000|Overall Study|Protocol Violation|1|||
164503627|NCT00621192|594215634|FG001|Overall Study|Protocol Violation|0|||
164503628|NCT00621192|594215635|FG002|Overall Study|Protocol Violation|0|||
164503629|NCT00621192|594215636|FG003|Overall Study|Protocol Violation|1|||
164503630|NCT00621192|594215633|FG000|Overall Study|Adverse Event|0|||
164503631|NCT00621192|594215634|FG001|Overall Study|Adverse Event|1|||
164503632|NCT00621192|594215635|FG002|Overall Study|Adverse Event|0|||
164503633|NCT00621192|594215636|FG003|Overall Study|Adverse Event|1|||
164503634|NCT00621192|594215633|FG000|Overall Study|Death|2|||
164503635|NCT00621192|594215634|FG001|Overall Study|Death|5|||
164503636|NCT00621192|594215635|FG002|Overall Study|Death|0|||
164503637|NCT00621192|594215636|FG003|Overall Study|Death|0|||
164503638|NCT00621192|594215633|FG000|Overall Study|Final Assessments not Completed|0|||
164503639|NCT00621192|594215634|FG001|Overall Study|Final Assessments not Completed|0|||
164503640|NCT00621192|594215635|FG002|Overall Study|Final Assessments not Completed|3|||
164503641|NCT00621192|594215636|FG003|Overall Study|Final Assessments not Completed|1|||
164503642|NCT02635386|594215639|FG000|Overall Study|Pregnancy|2|||
164503643|NCT02635386|594215640|FG001|Overall Study|Pregnancy|0|||
164503644|NCT02635386|594215641|FG002|Overall Study|Pregnancy|0|||
164503645|NCT02635386|594215642|FG003|Overall Study|Pregnancy|0|||
164503646|NCT02635386|594215643|FG004|Overall Study|Pregnancy|2|||
164503647|NCT02635386|594215639|FG000|Overall Study|Withdrawal by Subject|1|||
164503648|NCT02635386|594215640|FG001|Overall Study|Withdrawal by Subject|1|||
164503649|NCT02635386|594215641|FG002|Overall Study|Withdrawal by Subject|0|||
164503650|NCT02635386|594215642|FG003|Overall Study|Withdrawal by Subject|1|||
164503651|NCT02635386|594215643|FG004|Overall Study|Withdrawal by Subject|0|||
164503652|NCT02635386|594215639|FG000|Overall Study|Physician Decision|0|||
164503653|NCT02635386|594215640|FG001|Overall Study|Physician Decision|1|||
164503654|NCT02635386|594215641|FG002|Overall Study|Physician Decision|0|||
164503655|NCT02635386|594215642|FG003|Overall Study|Physician Decision|0|||
164503656|NCT02635386|594215643|FG004|Overall Study|Physician Decision|0|||
164503657|NCT02635386|594215639|FG000|Overall Study|Moved Out of State|0|||
164503658|NCT02635386|594215640|FG001|Overall Study|Moved Out of State|1|||
164503659|NCT02635386|594215641|FG002|Overall Study|Moved Out of State|0|||
164503660|NCT02635386|594215642|FG003|Overall Study|Moved Out of State|0|||
164503661|NCT02635386|594215643|FG004|Overall Study|Moved Out of State|0|||
164503662|NCT02635386|594215639|FG000|Overall Study|Noncompliant|0|||
164503663|NCT02635386|594215640|FG001|Overall Study|Noncompliant|2|||
164503664|NCT02635386|594215641|FG002|Overall Study|Noncompliant|1|||
164503665|NCT02635386|594215642|FG003|Overall Study|Noncompliant|1|||
164503666|NCT02635386|594215643|FG004|Overall Study|Noncompliant|1|||
164503667|NCT02635386|594215639|FG000|Overall Study|side effects|0|||
164503668|NCT02635386|594215640|FG001|Overall Study|side effects|0|||
164503669|NCT02635386|594215641|FG002|Overall Study|side effects|1|||
164503670|NCT02635386|594215642|FG003|Overall Study|side effects|4|||
164503671|NCT02635386|594215643|FG004|Overall Study|side effects|6|||
164503672|NCT02635386|594215639|FG000|Overall Study|needed other major surgery|0|||
164503673|NCT02635386|594215640|FG001|Overall Study|needed other major surgery|1|||
164503674|NCT02635386|594215641|FG002|Overall Study|needed other major surgery|0|||
164503675|NCT02635386|594215642|FG003|Overall Study|needed other major surgery|0|||
164503676|NCT02635386|594215643|FG004|Overall Study|needed other major surgery|0|||
164503677|NCT02635386|594215639|FG000|Overall Study|Other medical problems not drug related|0|||
164503678|NCT02635386|594215640|FG001|Overall Study|Other medical problems not drug related|0|||
164503679|NCT02635386|594215641|FG002|Overall Study|Other medical problems not drug related|0|||
164503680|NCT02635386|594215642|FG003|Overall Study|Other medical problems not drug related|1|||
164503681|NCT02635386|594215643|FG004|Overall Study|Other medical problems not drug related|0|||
164503682|NCT00745498|594215644|FG000|Overall Study|Lost to Follow-up|1|||
164503683|NCT00745498|594215645|FG001|Overall Study|Lost to Follow-up|1|||
164503684|NCT00745498|594215646|FG002|Overall Study|Lost to Follow-up|3|||
164503685|NCT00745498|594215644|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
164503686|NCT00745498|594215645|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
164503687|NCT00745498|594215646|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
164503688|NCT00745498|594215644|FG000|Overall Study|Non-PDR related VH|0|||
164503689|NCT00745498|594215645|FG001|Overall Study|Non-PDR related VH|1|||
164503690|NCT00745498|594215646|FG002|Overall Study|Non-PDR related VH|1|||
164503691|NCT00745498|594215644|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
164606874|NCT00006604|594581083|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
164503692|NCT00745498|594215645|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
164503693|NCT00745498|594215646|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
164606875|NCT00006604|594581084|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
164606876|NCT00006604|594581085|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
164606877|NCT00006604|594581086|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
164606878|NCT00006604|594581087|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
164606879|NCT00006604|594581088|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
164606880|NCT00006604|594581089|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
164606881|NCT00006604|594581090|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
164716601|NCT03818035|594985121|FG004|Part 2: Double-blind (Week28 to Week68)|Participants Started Retreatment Phase Within Study Part 2 before Week 68|0|||
164716602|NCT03818035|594985122|FG005|Part 2: Double-blind (Week28 to Week68)|Participants Started Retreatment Phase Within Study Part 2 before Week 68|0|||
164716603|NCT03818035|594985123|FG006|Part 2: Double-blind (Week28 to Week68)|Participants Started Retreatment Phase Within Study Part 2 before Week 68|0|||
164716604|NCT03818035|594985124|FG007|Part 2: Double-blind (Week28 to Week68)|Participants Started Retreatment Phase Within Study Part 2 before Week 68|0|||
164716605|NCT03818035|594985117|FG000|Part 2: Double-blind (Week28 to Week68)|Other|0|||
164716606|NCT03818035|594985118|FG001|Part 2: Double-blind (Week28 to Week68)|Other|1|||
164716607|NCT03818035|594985119|FG002|Part 2: Double-blind (Week28 to Week68)|Other|1|||
164716608|NCT03818035|594985120|FG003|Part 2: Double-blind (Week28 to Week68)|Other|1|||
164716609|NCT03818035|594985121|FG004|Part 2: Double-blind (Week28 to Week68)|Other|0|||
164716610|NCT03818035|594985122|FG005|Part 2: Double-blind (Week28 to Week68)|Other|0|||
164716611|NCT03818035|594985123|FG006|Part 2: Double-blind (Week28 to Week68)|Other|0|||
164716612|NCT03818035|594985124|FG007|Part 2: Double-blind (Week28 to Week68)|Other|0|||
164716613|NCT03818035|594985117|FG000|Part3: Withdrawal (Week 68 to Week 220)|Lost to Follow-up|0|||
164716614|NCT03818035|594985118|FG001|Part3: Withdrawal (Week 68 to Week 220)|Lost to Follow-up|0|||
164716615|NCT03818035|594985119|FG002|Part3: Withdrawal (Week 68 to Week 220)|Lost to Follow-up|0|||
164716616|NCT03818035|594985120|FG003|Part3: Withdrawal (Week 68 to Week 220)|Lost to Follow-up|0|||
164716617|NCT03818035|594985121|FG004|Part3: Withdrawal (Week 68 to Week 220)|Lost to Follow-up|0|||
164716618|NCT03818035|594985122|FG005|Part3: Withdrawal (Week 68 to Week 220)|Lost to Follow-up|0|||
164716619|NCT03818035|594985123|FG006|Part3: Withdrawal (Week 68 to Week 220)|Lost to Follow-up|5|||
164716620|NCT03818035|594985124|FG007|Part3: Withdrawal (Week 68 to Week 220)|Lost to Follow-up|0|||
164716621|NCT03818035|594985117|FG000|Part3: Withdrawal (Week 68 to Week 220)|Withdrawal by Subject|0|||
164716622|NCT03818035|594985118|FG001|Part3: Withdrawal (Week 68 to Week 220)|Withdrawal by Subject|0|||
164716623|NCT03818035|594985119|FG002|Part3: Withdrawal (Week 68 to Week 220)|Withdrawal by Subject|0|||
164716624|NCT03818035|594985120|FG003|Part3: Withdrawal (Week 68 to Week 220)|Withdrawal by Subject|0|||
164716625|NCT03818035|594985121|FG004|Part3: Withdrawal (Week 68 to Week 220)|Withdrawal by Subject|0|||
164716626|NCT03818035|594985122|FG005|Part3: Withdrawal (Week 68 to Week 220)|Withdrawal by Subject|9|||
164716627|NCT03818035|594985123|FG006|Part3: Withdrawal (Week 68 to Week 220)|Withdrawal by Subject|3|||
164716628|NCT03818035|594985124|FG007|Part3: Withdrawal (Week 68 to Week 220)|Withdrawal by Subject|0|||
164716629|NCT03818035|594985117|FG000|Part3: Withdrawal (Week 68 to Week 220)|Other Adverse Events|0|||
164716630|NCT03818035|594985118|FG001|Part3: Withdrawal (Week 68 to Week 220)|Other Adverse Events|0|||
164716631|NCT03818035|594985119|FG002|Part3: Withdrawal (Week 68 to Week 220)|Other Adverse Events|0|||
164716632|NCT03818035|594985120|FG003|Part3: Withdrawal (Week 68 to Week 220)|Other Adverse Events|0|||
164716633|NCT03818035|594985121|FG004|Part3: Withdrawal (Week 68 to Week 220)|Other Adverse Events|0|||
164716634|NCT03818035|594985122|FG005|Part3: Withdrawal (Week 68 to Week 220)|Other Adverse Events|0|||
164716635|NCT03818035|594985123|FG006|Part3: Withdrawal (Week 68 to Week 220)|Other Adverse Events|2|||
164716636|NCT03818035|594985124|FG007|Part3: Withdrawal (Week 68 to Week 220)|Other Adverse Events|0|||
164716637|NCT03818035|594985117|FG000|Part3: Withdrawal (Week 68 to Week 220)|Non-compliance with study drug|0|||
164716638|NCT03818035|594985118|FG001|Part3: Withdrawal (Week 68 to Week 220)|Non-compliance with study drug|0|||
164716639|NCT03818035|594985119|FG002|Part3: Withdrawal (Week 68 to Week 220)|Non-compliance with study drug|0|||
164716640|NCT03818035|594985120|FG003|Part3: Withdrawal (Week 68 to Week 220)|Non-compliance with study drug|0|||
164716641|NCT03818035|594985121|FG004|Part3: Withdrawal (Week 68 to Week 220)|Non-compliance with study drug|0|||
164716642|NCT03818035|594985122|FG005|Part3: Withdrawal (Week 68 to Week 220)|Non-compliance with study drug|3|||
164716643|NCT03818035|594985123|FG006|Part3: Withdrawal (Week 68 to Week 220)|Non-compliance with study drug|0|||
164716644|NCT03818035|594985124|FG007|Part3: Withdrawal (Week 68 to Week 220)|Non-compliance with study drug|0|||
164716645|NCT03818035|594985117|FG000|Part3: Withdrawal (Week 68 to Week 220)|Not Signed ICF|0|||
164716646|NCT03818035|594985118|FG001|Part3: Withdrawal (Week 68 to Week 220)|Not Signed ICF|0|||
164716647|NCT03818035|594985119|FG002|Part3: Withdrawal (Week 68 to Week 220)|Not Signed ICF|0|||
164716648|NCT03818035|594985120|FG003|Part3: Withdrawal (Week 68 to Week 220)|Not Signed ICF|0|||
164716649|NCT03818035|594985121|FG004|Part3: Withdrawal (Week 68 to Week 220)|Not Signed ICF|0|||
164716650|NCT03818035|594985122|FG005|Part3: Withdrawal (Week 68 to Week 220)|Not Signed ICF|5|||
164716651|NCT03818035|594985123|FG006|Part3: Withdrawal (Week 68 to Week 220)|Not Signed ICF|4|||
164716652|NCT03818035|594985124|FG007|Part3: Withdrawal (Week 68 to Week 220)|Not Signed ICF|0|||
164716653|NCT03818035|594985117|FG000|Part3: Withdrawal (Week 68 to Week 220)|Other|0|||
164716654|NCT03818035|594985118|FG001|Part3: Withdrawal (Week 68 to Week 220)|Other|0|||
164716655|NCT03818035|594985119|FG002|Part3: Withdrawal (Week 68 to Week 220)|Other|0|||
164503694|NCT00267098|594215648|FG000|Overall Study|Death|0|||
164503695|NCT00267098|594215649|FG001|Overall Study|Death|0|||
164503696|NCT00267098|594215650|FG002|Overall Study|Death|57|||
164503697|NCT00267098|594215651|FG003|Overall Study|Death|66|||
164716656|NCT03818035|594985120|FG003|Part3: Withdrawal (Week 68 to Week 220)|Other|0|||
164503698|NCT00267098|594215652|FG004|Overall Study|Death|14|||
164503699|NCT00267098|594215653|FG005|Overall Study|Death|23|||
164503700|NCT00267098|594215654|FG006|Overall Study|Death|28|||
164503701|NCT00267098|594215655|FG007|Overall Study|Death|9|||
164503702|NCT00267098|594215648|FG000|Overall Study|Lost to Follow-up|0|||
164503703|NCT00267098|594215649|FG001|Overall Study|Lost to Follow-up|0|||
164503704|NCT00267098|594215650|FG002|Overall Study|Lost to Follow-up|6|||
164503705|NCT00267098|594215651|FG003|Overall Study|Lost to Follow-up|5|||
164503706|NCT00267098|594215652|FG004|Overall Study|Lost to Follow-up|2|||
164503707|NCT00267098|594215653|FG005|Overall Study|Lost to Follow-up|3|||
164503708|NCT00267098|594215654|FG006|Overall Study|Lost to Follow-up|1|||
164503709|NCT00267098|594215655|FG007|Overall Study|Lost to Follow-up|1|||
164503710|NCT00267098|594215648|FG000|Overall Study|Withdrawal by Subject|8|||
164503711|NCT00267098|594215649|FG001|Overall Study|Withdrawal by Subject|0|||
164503712|NCT00267098|594215650|FG002|Overall Study|Withdrawal by Subject|24|||
164503713|NCT00267098|594215651|FG003|Overall Study|Withdrawal by Subject|21|||
164503714|NCT00267098|594215652|FG004|Overall Study|Withdrawal by Subject|12|||
164503715|NCT00267098|594215653|FG005|Overall Study|Withdrawal by Subject|9|||
164503716|NCT00267098|594215654|FG006|Overall Study|Withdrawal by Subject|12|||
164503717|NCT00267098|594215655|FG007|Overall Study|Withdrawal by Subject|5|||
164503718|NCT00267098|594215648|FG000|Overall Study|Physician Decision|5|||
164503719|NCT00267098|594215649|FG001|Overall Study|Physician Decision|0|||
164503720|NCT00267098|594215650|FG002|Overall Study|Physician Decision|7|||
164503721|NCT00267098|594215651|FG003|Overall Study|Physician Decision|11|||
164503722|NCT00267098|594215652|FG004|Overall Study|Physician Decision|5|||
164503723|NCT00267098|594215653|FG005|Overall Study|Physician Decision|4|||
164503724|NCT00267098|594215654|FG006|Overall Study|Physician Decision|3|||
164503725|NCT00267098|594215655|FG007|Overall Study|Physician Decision|0|||
164503726|NCT00267098|594215648|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
164503727|NCT00267098|594215649|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
164503728|NCT00267098|594215650|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
164503729|NCT00267098|594215651|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
164503730|NCT00267098|594215652|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
164503731|NCT00267098|594215653|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
164503732|NCT00267098|594215654|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
164503733|NCT00267098|594215655|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
164503734|NCT00267098|594215648|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
164503735|NCT00267098|594215649|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
164503736|NCT00267098|594215650|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
164503737|NCT00267098|594215651|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
164503738|NCT00267098|594215652|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
164503739|NCT00267098|594215653|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
164503740|NCT00267098|594215654|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
164503741|NCT00267098|594215655|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
164503742|NCT00267098|594215648|FG000|Overall Study|Site closure|0|||
164503743|NCT00267098|594215649|FG001|Overall Study|Site closure|0|||
164503744|NCT00267098|594215650|FG002|Overall Study|Site closure|0|||
164503745|NCT00267098|594215651|FG003|Overall Study|Site closure|1|||
164503746|NCT00267098|594215652|FG004|Overall Study|Site closure|0|||
164503747|NCT00267098|594215653|FG005|Overall Study|Site closure|1|||
164503748|NCT00267098|594215654|FG006|Overall Study|Site closure|1|||
164503749|NCT00267098|594215655|FG007|Overall Study|Site closure|0|||
164503750|NCT00267098|594215648|FG000|Overall Study|Explanted Medtronic device|0|||
164503751|NCT00267098|594215649|FG001|Overall Study|Explanted Medtronic device|0|||
164503752|NCT00267098|594215650|FG002|Overall Study|Explanted Medtronic device|0|||
164503753|NCT00267098|594215651|FG003|Overall Study|Explanted Medtronic device|1|||
164503754|NCT00267098|594215652|FG004|Overall Study|Explanted Medtronic device|0|||
164503755|NCT00267098|594215653|FG005|Overall Study|Explanted Medtronic device|0|||
164503756|NCT00267098|594215654|FG006|Overall Study|Explanted Medtronic device|0|||
164503757|NCT00267098|594215655|FG007|Overall Study|Explanted Medtronic device|0|||
164503758|NCT00267098|594215648|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
164503759|NCT00267098|594215649|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
164503760|NCT00267098|594215650|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
164503761|NCT00267098|594215651|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
164503762|NCT00267098|594215652|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
164503763|NCT00267098|594215653|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
164503764|NCT00267098|594215654|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
164503765|NCT00267098|594215655|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
164503766|NCT00267098|594215648|FG000|Overall Study|Subject listed for heart transplant|0|||
164503767|NCT00267098|594215649|FG001|Overall Study|Subject listed for heart transplant|0|||
164503768|NCT00267098|594215650|FG002|Overall Study|Subject listed for heart transplant|0|||
164503769|NCT00267098|594215651|FG003|Overall Study|Subject listed for heart transplant|0|||
164503770|NCT00267098|594215652|FG004|Overall Study|Subject listed for heart transplant|0|||
164503771|NCT00267098|594215653|FG005|Overall Study|Subject listed for heart transplant|0|||
164503772|NCT00267098|594215654|FG006|Overall Study|Subject listed for heart transplant|1|||
164503773|NCT00267098|594215655|FG007|Overall Study|Subject listed for heart transplant|0|||
164503774|NCT00267098|594215648|FG000|Overall Study|Sponsor withdrew subject|0|||
164716657|NCT03818035|594985121|FG004|Part3: Withdrawal (Week 68 to Week 220)|Other|0|||
164716658|NCT03818035|594985122|FG005|Part3: Withdrawal (Week 68 to Week 220)|Other|0|||
164716659|NCT03818035|594985123|FG006|Part3: Withdrawal (Week 68 to Week 220)|Other|2|||
164716660|NCT03818035|594985124|FG007|Part3: Withdrawal (Week 68 to Week 220)|Other|0|||
164716661|NCT03818035|594985117|FG000|Part3: Withdrawal (Week 68 to Week 220)|Retreatment started|0|||
164716662|NCT03818035|594985118|FG001|Part3: Withdrawal (Week 68 to Week 220)|Retreatment started|0|||
164716663|NCT03818035|594985119|FG002|Part3: Withdrawal (Week 68 to Week 220)|Retreatment started|0|||
164503775|NCT00267098|594215649|FG001|Overall Study|Sponsor withdrew subject|0|||
164503776|NCT00267098|594215650|FG002|Overall Study|Sponsor withdrew subject|0|||
164503777|NCT00267098|594215651|FG003|Overall Study|Sponsor withdrew subject|1|||
164503778|NCT00267098|594215652|FG004|Overall Study|Sponsor withdrew subject|0|||
164503779|NCT00267098|594215653|FG005|Overall Study|Sponsor withdrew subject|0|||
164503780|NCT00267098|594215654|FG006|Overall Study|Sponsor withdrew subject|0|||
164503781|NCT00267098|594215655|FG007|Overall Study|Sponsor withdrew subject|0|||
164503782|NCT00547534|594215656|FG000|Overall Study|Adverse Event|7|||
164503783|NCT00547534|594215656|FG000|Overall Study|Disease Progression|4|||
164503784|NCT01157377|594215657|FG000|Overall Study|Lost to Follow-up|0|||
164503785|NCT01157377|594215658|FG001|Overall Study|Lost to Follow-up|0|||
164716664|NCT03818035|594985120|FG003|Part3: Withdrawal (Week 68 to Week 220)|Retreatment started|0|||
164716665|NCT03818035|594985121|FG004|Part3: Withdrawal (Week 68 to Week 220)|Retreatment started|0|||
164503786|NCT01157377|594215659|FG002|Overall Study|Lost to Follow-up|1|||
164503787|NCT01157377|594215660|FG003|Overall Study|Lost to Follow-up|0|||
164503788|NCT01157377|594215661|FG004|Overall Study|Lost to Follow-up|1|||
164503789|NCT01157377|594215662|FG005|Overall Study|Lost to Follow-up|1|||
164503790|NCT01157377|594215663|FG006|Overall Study|Lost to Follow-up|0|||
164503791|NCT01157377|594215657|FG000|Overall Study|Personal Reasons|2|||
164503792|NCT01157377|594215658|FG001|Overall Study|Personal Reasons|1|||
164503793|NCT01157377|594215659|FG002|Overall Study|Personal Reasons|0|||
164503794|NCT01157377|594215660|FG003|Overall Study|Personal Reasons|1|||
164503795|NCT01157377|594215661|FG004|Overall Study|Personal Reasons|0|||
164503796|NCT01157377|594215662|FG005|Overall Study|Personal Reasons|0|||
164503797|NCT01157377|594215663|FG006|Overall Study|Personal Reasons|0|||
164503798|NCT01157377|594215657|FG000|Overall Study|Protocol Violation|0|||
164503799|NCT01157377|594215658|FG001|Overall Study|Protocol Violation|0|||
164503800|NCT01157377|594215659|FG002|Overall Study|Protocol Violation|0|||
164503801|NCT01157377|594215660|FG003|Overall Study|Protocol Violation|0|||
164503802|NCT01157377|594215661|FG004|Overall Study|Protocol Violation|0|||
164503803|NCT01157377|594215662|FG005|Overall Study|Protocol Violation|1|||
164503804|NCT01157377|594215663|FG006|Overall Study|Protocol Violation|0|||
164503805|NCT01157377|594215657|FG000|Overall Study|Lack of Efficacy|0|||
164503806|NCT01157377|594215658|FG001|Overall Study|Lack of Efficacy|0|||
164503807|NCT01157377|594215659|FG002|Overall Study|Lack of Efficacy|0|||
164503808|NCT01157377|594215660|FG003|Overall Study|Lack of Efficacy|0|||
164503809|NCT01157377|594215661|FG004|Overall Study|Lack of Efficacy|0|||
164503810|NCT01157377|594215662|FG005|Overall Study|Lack of Efficacy|0|||
164503811|NCT01157377|594215663|FG006|Overall Study|Lack of Efficacy|1|||
164503812|NCT01157377|594215657|FG000|Overall Study|Other Miscellaneous Reasons|0|||
164503813|NCT01157377|594215658|FG001|Overall Study|Other Miscellaneous Reasons|2|||
164503814|NCT01157377|594215659|FG002|Overall Study|Other Miscellaneous Reasons|0|||
164503815|NCT01157377|594215660|FG003|Overall Study|Other Miscellaneous Reasons|0|||
164503816|NCT01157377|594215661|FG004|Overall Study|Other Miscellaneous Reasons|1|||
164503817|NCT01157377|594215662|FG005|Overall Study|Other Miscellaneous Reasons|1|||
164503818|NCT01157377|594215663|FG006|Overall Study|Other Miscellaneous Reasons|1|||
164503819|NCT00904722|594215664|FG000|Overall Study|Physician Decision|1|||
164503820|NCT03561597|594215665|FG000|Overall Study|Lost to Follow-up|20|||
164503821|NCT04814992|594215666|FG000|Overall Study|Withdrawal by Subject|6|||
164503822|NCT04814992|594215667|FG001|Overall Study|Withdrawal by Subject|3|||
164503823|NCT04814992|594215666|FG000|Overall Study|Lost to Follow-up|1|||
164503824|NCT04814992|594215667|FG001|Overall Study|Lost to Follow-up|4|||
164503825|NCT00691678|594215668|FG000|Overall Study|Adverse Event|5|||
164503826|NCT00691678|594215668|FG000|Overall Study|life events, pain|11|||
164503827|NCT02188784|594215670|FG000|Overall Study|Death|3|||
164716666|NCT03818035|594985122|FG005|Part3: Withdrawal (Week 68 to Week 220)|Retreatment started|112|||
164716667|NCT03818035|594985123|FG006|Part3: Withdrawal (Week 68 to Week 220)|Retreatment started|115|||
164503828|NCT02188784|594215671|FG001|Overall Study|Death|1|||
164503829|NCT02188784|594215670|FG000|Overall Study|Lost to Follow-up|1|||
164503830|NCT02188784|594215671|FG001|Overall Study|Lost to Follow-up|0|||
164503831|NCT02188784|594215670|FG000|Overall Study|Withdrawal by Subject|3|||
164503832|NCT02188784|594215671|FG001|Overall Study|Withdrawal by Subject|9|||
164503833|NCT02188784|594215670|FG000|Overall Study|Physician Decision|2|||
164503834|NCT02188784|594215671|FG001|Overall Study|Physician Decision|3|||
164503835|NCT01568112|594215676|FG000|Overall Study|Randomized But Not Treated|0|||
164503836|NCT01568112|594215677|FG001|Overall Study|Randomized But Not Treated|1|||
164503837|NCT01568112|594215678|FG002|Overall Study|Randomized But Not Treated|0|||
164503838|NCT01568112|594215679|FG003|Overall Study|Randomized But Not Treated|0|||
164503839|NCT01568112|594215676|FG000|Overall Study|Withdrew due to Adverse Event|2|||
164503840|NCT01568112|594215677|FG001|Overall Study|Withdrew due to Adverse Event|4|||
164503841|NCT01568112|594215678|FG002|Overall Study|Withdrew due to Adverse Event|6|||
164503842|NCT01568112|594215679|FG003|Overall Study|Withdrew due to Adverse Event|3|||
164503843|NCT01568112|594215676|FG000|Overall Study|Lost to Follow-up|0|||
164503844|NCT01568112|594215677|FG001|Overall Study|Lost to Follow-up|0|||
164503845|NCT01568112|594215678|FG002|Overall Study|Lost to Follow-up|0|||
164503846|NCT01568112|594215679|FG003|Overall Study|Lost to Follow-up|1|||
164503847|NCT01568112|594215676|FG000|Overall Study|Withdrawal by Subject|2|||
164503848|NCT01568112|594215677|FG001|Overall Study|Withdrawal by Subject|3|||
164503849|NCT01568112|594215678|FG002|Overall Study|Withdrawal by Subject|0|||
164503850|NCT01568112|594215679|FG003|Overall Study|Withdrawal by Subject|7|||
164503851|NCT01568112|594215676|FG000|Overall Study|Withdrawal by Physician|1|||
164503852|NCT01568112|594215677|FG001|Overall Study|Withdrawal by Physician|0|||
164503853|NCT01568112|594215678|FG002|Overall Study|Withdrawal by Physician|1|||
164503854|NCT01568112|594215679|FG003|Overall Study|Withdrawal by Physician|1|||
164503855|NCT01638390|594217507|FG000|Overall Study|screening failures|21|||
164503856|NCT02783573|594217508|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
164503857|NCT02783573|594217509|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
164503858|NCT02783573|594217510|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
164503859|NCT02783573|594217508|FG000|Placebo-Controlled Treatment Period|Death|4|||
164503860|NCT02783573|594217509|FG001|Placebo-Controlled Treatment Period|Death|2|||
164503861|NCT02783573|594217510|FG002|Placebo-Controlled Treatment Period|Death|3|||
164503862|NCT02783573|594217508|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
164503863|NCT02783573|594217509|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
164503864|NCT02783573|594217510|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
164503865|NCT02783573|594217508|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
164503866|NCT02783573|594217509|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
164503867|NCT02783573|594217510|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
164503868|NCT02783573|594217508|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
164503869|NCT02783573|594217509|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
164503870|NCT02783573|594217510|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
164503871|NCT02783573|594217508|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
164503872|NCT02783573|594217509|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
164503873|NCT02783573|594217510|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
164503874|NCT02783573|594217508|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
164503875|NCT02783573|594217509|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
164503876|NCT02783573|594217510|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
164503877|NCT02783573|594217508|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
164503878|NCT02783573|594217509|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
164503879|NCT02783573|594217510|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
164503880|NCT02783573|594217508|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
164503881|NCT02783573|594217509|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
164503882|NCT02783573|594217510|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
164503883|NCT02783573|594217508|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
164503884|NCT02783573|594217509|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
164503885|NCT02783573|594217510|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
164503886|NCT02783573|594217508|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
164503887|NCT02783573|594217509|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
164503888|NCT02783573|594217510|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
164503889|NCT02783573|594217508|FG000|Delayed-Start Period|Sponsor Decision|0|||
164503890|NCT02783573|594217509|FG001|Delayed-Start Period|Sponsor Decision|17|||
164503891|NCT02783573|594217510|FG002|Delayed-Start Period|Sponsor Decision|12|||
164503892|NCT00590564|594217511|FG000|Overall Study|Withdrawal by Subject|4|||
164503893|NCT00590564|594217511|FG000|Overall Study|Lost to Follow-up|6|||
164503894|NCT00590564|594217511|FG000|Overall Study|Protocol Violation|1|||
164503895|NCT00590564|594217511|FG000|Overall Study|Patient Found to be Ineligible|1|||
164503896|NCT00590564|594217511|FG000|Overall Study|Patient Non-compliance|6|||
164503897|NCT05923112|594217512|FG000|Overall Study|Protocol Violation|4|||
164503898|NCT05923112|594217512|FG000|Overall Study|No informed consent on publication of study results|243|||
164503899|NCT04991766|594217513|FG000|Overall Study|Withdrawal by Subject|2|||
164503900|NCT04991766|594217514|FG001|Overall Study|Withdrawal by Subject|0|||
164503901|NCT03210519|594217520|FG000|Overall Study|Adverse Event|2|||
164503902|NCT03210519|594217521|FG001|Overall Study|Adverse Event|0|||
164503903|NCT03865953|594217524|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
164503904|NCT03865953|594217525|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
164606882|NCT00006604|594581074|FG000|Overall Study|Site closing|0|||
164606883|NCT00006604|594581075|FG001|Overall Study|Site closing|0|||
164606884|NCT00006604|594581076|FG002|Overall Study|Site closing|1|||
164606885|NCT00006604|594581077|FG003|Overall Study|Site closing|1|||
164503905|NCT03865953|594217524|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
164503906|NCT03865953|594217525|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
164503907|NCT03865953|594217524|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
164503908|NCT03865953|594217525|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
164503909|NCT03021551|594217526|FG000|Overall Study|Equipment Issues|2|||
164503910|NCT03021551|594217526|FG000|Overall Study|Protocol Violation|1|||
164503911|NCT00490945|594217529|FG000|Overall Study|Adverse Event|0|||
164503912|NCT00490945|594217530|FG001|Overall Study|Adverse Event|1|||
164503913|NCT00490945|594217531|FG002|Overall Study|Adverse Event|0|||
164503914|NCT00490945|594217532|FG003|Overall Study|Adverse Event|0|||
164503915|NCT00490945|594217533|FG004|Overall Study|Adverse Event|0|||
164503916|NCT00412880|594217534|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
164503917|NCT00412880|594217534|FG000|Overall Study|Consent withdrawn|1|||
164503918|NCT00412880|594217534|FG000|Overall Study|Adverse Event|1|||
164503919|NCT00412880|594217534|FG000|Overall Study|Progressive disease|20|||
164503920|NCT02706951|594217543|FG000|Period 1|Adverse Event|1|||
164503921|NCT02706951|594217544|FG001|Period 1|Adverse Event|5|||
164503922|NCT02706951|594217545|FG002|Period 1|Adverse Event|3|||
164503923|NCT02706951|594217546|FG003|Period 1|Adverse Event|0|||
164503924|NCT02706951|594217547|FG004|Period 1|Adverse Event|0|||
164503925|NCT02706951|594217543|FG000|Period 1|Withdrawal by Subject|10|||
164503926|NCT02706951|594217544|FG001|Period 1|Withdrawal by Subject|6|||
164503927|NCT02706951|594217545|FG002|Period 1|Withdrawal by Subject|6|||
164503928|NCT02706951|594217546|FG003|Period 1|Withdrawal by Subject|0|||
164503929|NCT02706951|594217547|FG004|Period 1|Withdrawal by Subject|0|||
164503930|NCT02706951|594217543|FG000|Period 1|Lost to Follow-up|0|||
164503931|NCT02706951|594217544|FG001|Period 1|Lost to Follow-up|4|||
164503932|NCT02706951|594217545|FG002|Period 1|Lost to Follow-up|1|||
164503933|NCT02706951|594217546|FG003|Period 1|Lost to Follow-up|0|||
164503934|NCT02706951|594217547|FG004|Period 1|Lost to Follow-up|0|||
164503935|NCT02706951|594217543|FG000|Period 1|Other|2|||
164503936|NCT02706951|594217544|FG001|Period 1|Other|1|||
164503937|NCT02706951|594217545|FG002|Period 1|Other|0|||
164503938|NCT02706951|594217546|FG003|Period 1|Other|0|||
164503939|NCT02706951|594217547|FG004|Period 1|Other|0|||
164503940|NCT02706951|594217543|FG000|Period 2|Adverse Event|0|||
164503941|NCT02706951|594217544|FG001|Period 2|Adverse Event|0|||
164503942|NCT02706951|594217545|FG002|Period 2|Adverse Event|0|||
164503943|NCT02706951|594217546|FG003|Period 2|Adverse Event|25|||
164503944|NCT02706951|594217547|FG004|Period 2|Adverse Event|34|||
164503945|NCT02706951|594217543|FG000|Period 2|Withdrawal by Subject|0|||
164503946|NCT02706951|594217544|FG001|Period 2|Withdrawal by Subject|0|||
164503947|NCT02706951|594217545|FG002|Period 2|Withdrawal by Subject|0|||
164503948|NCT02706951|594217546|FG003|Period 2|Withdrawal by Subject|38|||
164503949|NCT02706951|594217547|FG004|Period 2|Withdrawal by Subject|44|||
164503950|NCT02706951|594217543|FG000|Period 2|Lost to Follow-up|0|||
164503951|NCT02706951|594217544|FG001|Period 2|Lost to Follow-up|0|||
164503952|NCT02706951|594217545|FG002|Period 2|Lost to Follow-up|0|||
164503953|NCT02706951|594217546|FG003|Period 2|Lost to Follow-up|17|||
164503954|NCT02706951|594217547|FG004|Period 2|Lost to Follow-up|9|||
164503955|NCT02706951|594217543|FG000|Period 2|COVID-19 Related|0|||
164503956|NCT02706951|594217544|FG001|Period 2|COVID-19 Related|0|||
164503957|NCT02706951|594217545|FG002|Period 2|COVID-19 Related|0|||
164503958|NCT02706951|594217546|FG003|Period 2|COVID-19 Related|1|||
164503959|NCT02706951|594217547|FG004|Period 2|COVID-19 Related|2|||
164503960|NCT02706951|594217543|FG000|Period 2|Other|0|||
164503961|NCT02706951|594217544|FG001|Period 2|Other|0|||
164503962|NCT02706951|594217545|FG002|Period 2|Other|0|||
164503963|NCT02706951|594217546|FG003|Period 2|Other|37|||
164503964|NCT02706951|594217547|FG004|Period 2|Other|31|||
164503965|NCT01162135|594217548|FG000|Overall Study|Withdrawal by Subject|1|||
164503966|NCT01162135|594217548|FG000|Overall Study|Severe back pain|1|||
164503967|NCT01162135|594217548|FG000|Overall Study|Ineligible|1|||
164503968|NCT01777334|594217549|FG000|Overall Study|Adverse Event|18|||
164503969|NCT01777334|594217550|FG001|Overall Study|Adverse Event|14|||
164503970|NCT01777334|594217549|FG000|Overall Study|Lack of Efficacy|15|||
164503971|NCT01777334|594217550|FG001|Overall Study|Lack of Efficacy|29|||
164503972|NCT01777334|594217549|FG000|Overall Study|Protocol Violation|3|||
164503973|NCT01777334|594217550|FG001|Overall Study|Protocol Violation|7|||
164503974|NCT01777334|594217549|FG000|Overall Study|Lost to Follow-up|3|||
164503975|NCT01777334|594217550|FG001|Overall Study|Lost to Follow-up|2|||
164503976|NCT01777334|594217549|FG000|Overall Study|Withdrawal by Subject|14|||
164503977|NCT01777334|594217550|FG001|Overall Study|Withdrawal by Subject|11|||
164503978|NCT01216072|594217553|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
164503979|NCT01216072|594217554|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
164503980|NCT01216072|594217553|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
164503981|NCT01216072|594217554|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
164503982|NCT01216072|594217553|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
164606886|NCT00006604|594581078|FG004|Overall Study|Site closing|0|||
164716668|NCT03818035|594985124|FG007|Part3: Withdrawal (Week 68 to Week 220)|Retreatment started|0|||
164716669|NCT03818035|594985117|FG000|Re-treatment (Week R0 Through Week R28)|Lost to Follow-up|0|||
164716670|NCT03818035|594985118|FG001|Re-treatment (Week R0 Through Week R28)|Lost to Follow-up|0|||
164716671|NCT03818035|594985119|FG002|Re-treatment (Week R0 Through Week R28)|Lost to Follow-up|0|||
164716672|NCT03818035|594985120|FG003|Re-treatment (Week R0 Through Week R28)|Lost to Follow-up|0|||
164716673|NCT03818035|594985121|FG004|Re-treatment (Week R0 Through Week R28)|Lost to Follow-up|0|||
164716674|NCT03818035|594985122|FG005|Re-treatment (Week R0 Through Week R28)|Lost to Follow-up|0|||
164716675|NCT03818035|594985123|FG006|Re-treatment (Week R0 Through Week R28)|Lost to Follow-up|0|||
164716676|NCT03818035|594985124|FG007|Re-treatment (Week R0 Through Week R28)|Lost to Follow-up|3|||
164503983|NCT01216072|594217554|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
164503984|NCT01216072|594217553|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
164503985|NCT01216072|594217554|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
164503986|NCT01216072|594217553|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
164503987|NCT01216072|594217554|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
164503988|NCT01216072|594217553|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
164503989|NCT01216072|594217554|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
164503990|NCT01216072|594217553|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
164503991|NCT01216072|594217554|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
164503992|NCT01216072|594217553|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
164503993|NCT01216072|594217554|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
164503994|NCT01216072|594217553|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
164503995|NCT01216072|594217554|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
164503996|NCT01216072|594217553|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
164503997|NCT01216072|594217554|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
164503998|NCT06136897|594217555|FG000|Overall Study|Ineligible|3|||
164503999|NCT06136897|594217555|FG000|Overall Study|Mutation status not confirmed|7|||
164504000|NCT06136897|594217555|FG000|Overall Study|Adverse Event|2|||
164504001|NCT06136897|594217555|FG000|Overall Study|Death|1|||
164504002|NCT06136897|594217555|FG000|Overall Study|Disease progression|18|||
164504003|NCT06136897|594217555|FG000|Overall Study|Other complicating disease|1|||
164504004|NCT06136897|594217555|FG000|Overall Study|Withdrawal by Subject|1|||
164504005|NCT06136897|594217555|FG000|Overall Study|Still on treatment|1|||
164504006|NCT06136897|594217555|FG000|Overall Study|Lost to Follow-up|1|||
164504007|NCT00952848|594217562|FG000|Overall Study|Withdrawal by Subject|4|||
164504008|NCT00217022|594217563|FG000|Overall Study|Withdrawal by Subject|1|||
164504009|NCT00217022|594217564|FG001|Overall Study|Withdrawal by Subject|1|||
164504010|NCT00458393|594217565|FG000|Overall Study|Withdrawal by Subject|67|||
164504011|NCT00458393|594217566|FG001|Overall Study|Withdrawal by Subject|80|||
164504012|NCT00458393|594217565|FG000|Overall Study|Physician Decision|31|||
164504013|NCT00458393|594217566|FG001|Overall Study|Physician Decision|22|||
164504014|NCT00458393|594217565|FG000|Overall Study|Relocated|77|||
164504015|NCT00458393|594217566|FG001|Overall Study|Relocated|81|||
164504016|NCT00458393|594217565|FG000|Overall Study|Lost to Follow-up|115|||
164504017|NCT00458393|594217566|FG001|Overall Study|Lost to Follow-up|92|||
164504018|NCT00458393|594217565|FG000|Overall Study|Sites marked other on the form.|19|||
164504019|NCT00458393|594217566|FG001|Overall Study|Sites marked other on the form.|20|||
164504020|NCT02725567|594217567|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
164504021|NCT02725567|594217568|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
164504022|NCT02725567|594217567|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
164504023|NCT02725567|594217568|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
164504024|NCT02725567|594217567|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
164504025|NCT02725567|594217568|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
164504026|NCT02777242|594217569|FG000|Overall Study|Other|2|||
164504027|NCT02777242|594217569|FG000|Overall Study|Lost to Follow-up|1|||
164504028|NCT02777242|594217569|FG000|Overall Study|Multiple|1|||
164504029|NCT02777242|594217569|FG000|Overall Study|Sponsor's request|1|||
164504030|NCT02777242|594217569|FG000|Overall Study|Withdrawal by Subject|1|||
164504031|NCT05178979|594217570|FG000|Overall Study|Death|0|||
164504032|NCT05178979|594217571|FG001|Overall Study|Death|5|||
164504033|NCT05178979|594217572|FG002|Overall Study|Death|0|||
164504034|NCT05178979|594217573|FG003|Overall Study|Death|3|||
164716677|NCT03818035|594985117|FG000|Re-treatment (Week R0 Through Week R28)|Withdrawal by Subject|0|||
164504035|NCT05178979|594217570|FG000|Overall Study|Adverse Event|0|||
164504036|NCT05178979|594217571|FG001|Overall Study|Adverse Event|1|||
164716678|NCT03818035|594985118|FG001|Re-treatment (Week R0 Through Week R28)|Withdrawal by Subject|0|||
164716679|NCT03818035|594985119|FG002|Re-treatment (Week R0 Through Week R28)|Withdrawal by Subject|0|||
164504037|NCT05178979|594217572|FG002|Overall Study|Adverse Event|0|||
164504038|NCT05178979|594217573|FG003|Overall Study|Adverse Event|0|||
164504039|NCT05178979|594217570|FG000|Overall Study|Lost to Follow-up|1|||
164504040|NCT05178979|594217571|FG001|Overall Study|Lost to Follow-up|8|||
164504041|NCT05178979|594217572|FG002|Overall Study|Lost to Follow-up|3|||
164504042|NCT05178979|594217573|FG003|Overall Study|Lost to Follow-up|8|||
164504043|NCT00817336|594217574|FG000|Overall Study|Withdrawal by Subject|1|||
164504044|NCT00817336|594217575|FG001|Overall Study|Withdrawal by Subject|1|||
164504045|NCT02299427|594217576|FG000|Overall Study|Withdrawal by Subject|1|||
164504046|NCT02299427|594217577|FG001|Overall Study|Withdrawal by Subject|0|||
164504047|NCT02299427|594217576|FG000|Overall Study|Lost to Follow-up|1|||
164504048|NCT02299427|594217577|FG001|Overall Study|Lost to Follow-up|3|||
164504049|NCT02299427|594217576|FG000|Overall Study|not adherent to dog website use|21|||
164504050|NCT02299427|594217577|FG001|Overall Study|not adherent to dog website use|0|||
164504051|NCT02108652|594217578|FG000|Overall Study|Death|253|||
164504052|NCT02108652|594217578|FG000|Overall Study|Lost to Follow-up|2|||
164504053|NCT02108652|594217578|FG000|Overall Study|Withdrawal by Subject|16|||
164504054|NCT02108652|594217578|FG000|Overall Study|Study Terminated By Sponsor|31|||
164504055|NCT02108652|594217578|FG000|Overall Study|Non-Compliance|1|||
164504056|NCT02108652|594217578|FG000|Overall Study|Physician Decision|6|||
164504057|NCT02108652|594217578|FG000|Overall Study|Progression Of Disease|1|||
164504058|NCT01182181|594217586|FG000|First Intervention|Adverse Event|1|||
164504059|NCT01182181|594217587|FG001|First Intervention|Adverse Event|0|||
164504060|NCT01182181|594217586|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
164504061|NCT01182181|594217587|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
164504062|NCT00511797|594217588|FG000|Overall Study|Adverse Event|1|||
164504063|NCT00511797|594217589|FG001|Overall Study|Adverse Event|2|||
164504064|NCT00511797|594217590|FG002|Overall Study|Adverse Event|2|||
164504065|NCT00511797|594217591|FG003|Overall Study|Adverse Event|2|||
164504066|NCT00511797|594217588|FG000|Overall Study|Lost to Follow-up|1|||
164504067|NCT00511797|594217589|FG001|Overall Study|Lost to Follow-up|0|||
164504068|NCT00511797|594217590|FG002|Overall Study|Lost to Follow-up|0|||
164504069|NCT00511797|594217591|FG003|Overall Study|Lost to Follow-up|1|||
164504070|NCT00511797|594217588|FG000|Overall Study|Pregnancy|0|||
164504071|NCT00511797|594217589|FG001|Overall Study|Pregnancy|0|||
164504072|NCT00511797|594217590|FG002|Overall Study|Pregnancy|0|||
164504073|NCT00511797|594217591|FG003|Overall Study|Pregnancy|1|||
164504074|NCT00511797|594217588|FG000|Overall Study|Protocol Violation|0|||
164504075|NCT00511797|594217589|FG001|Overall Study|Protocol Violation|2|||
164504076|NCT00511797|594217590|FG002|Overall Study|Protocol Violation|2|||
164504077|NCT00511797|594217591|FG003|Overall Study|Protocol Violation|3|||
164504078|NCT00511797|594217588|FG000|Overall Study|Withdrawal by Subject|3|||
164504079|NCT00511797|594217589|FG001|Overall Study|Withdrawal by Subject|3|||
164504080|NCT00511797|594217590|FG002|Overall Study|Withdrawal by Subject|4|||
164504081|NCT00511797|594217591|FG003|Overall Study|Withdrawal by Subject|2|||
164504082|NCT00511797|594217588|FG000|Overall Study|Never dispensed|1|||
164504083|NCT00511797|594217589|FG001|Overall Study|Never dispensed|0|||
164504084|NCT00511797|594217590|FG002|Overall Study|Never dispensed|1|||
164504085|NCT00511797|594217591|FG003|Overall Study|Never dispensed|3|||
164504086|NCT00511797|594217588|FG000|Overall Study|Study drug not taken|0|||
164504087|NCT00511797|594217589|FG001|Overall Study|Study drug not taken|1|||
164504088|NCT00511797|594217590|FG002|Overall Study|Study drug not taken|0|||
164504089|NCT00511797|594217591|FG003|Overall Study|Study drug not taken|1|||
164504090|NCT00511797|594217588|FG000|Overall Study|Partially missing diary|0|||
164504091|NCT00511797|594217589|FG001|Overall Study|Partially missing diary|0|||
164504092|NCT00511797|594217590|FG002|Overall Study|Partially missing diary|1|||
164504093|NCT00511797|594217591|FG003|Overall Study|Partially missing diary|0|||
164504094|NCT00511797|594217588|FG000|Overall Study|Other (moving etc)|1|||
164504095|NCT00511797|594217589|FG001|Overall Study|Other (moving etc)|0|||
164504096|NCT00511797|594217590|FG002|Overall Study|Other (moving etc)|1|||
164504097|NCT00511797|594217591|FG003|Overall Study|Other (moving etc)|2|||
164504098|NCT01278615|594217592|FG000|Overall Study|Withdrawal by Subject|2|||
164504099|NCT02138253|594217593|FG000|Overall Study|Adverse Event|3|||
164504100|NCT02138253|594217594|FG001|Overall Study|Adverse Event|3|||
164504101|NCT02138253|594217593|FG000|Overall Study|Lost to Follow-up|2|||
164606887|NCT00006604|594581079|FG005|Overall Study|Site closing|0|||
164606888|NCT00006604|594581080|FG006|Overall Study|Site closing|0|||
164504102|NCT02138253|594217594|FG001|Overall Study|Lost to Follow-up|1|||
164504103|NCT02138253|594217593|FG000|Overall Study|Physician Decision|2|||
164504104|NCT02138253|594217594|FG001|Overall Study|Physician Decision|0|||
164504105|NCT02138253|594217593|FG000|Overall Study|Non compliance|1|||
164504106|NCT02138253|594217594|FG001|Overall Study|Non compliance|0|||
164504107|NCT02138253|594217593|FG000|Overall Study|Withdrawal by Subject|1|||
164504108|NCT02138253|594217594|FG001|Overall Study|Withdrawal by Subject|0|||
164504109|NCT01390441|594217595|FG000|Treatment Period|Protocol Violation|0|||
164504110|NCT01390441|594217596|FG001|Treatment Period|Protocol Violation|1|||
164504111|NCT01390441|594217597|FG002|Treatment Period|Protocol Violation|0|||
164504112|NCT01390441|594217598|FG003|Treatment Period|Protocol Violation|0|||
164504113|NCT01390441|594217599|FG004|Treatment Period|Protocol Violation|0|||
164606889|NCT00006604|594581081|FG007|Overall Study|Site closing|1|||
164606890|NCT00006604|594581082|FG008|Overall Study|Site closing|0|||
164606891|NCT00006604|594581083|FG009|Overall Study|Site closing|0|||
164606892|NCT00006604|594581084|FG010|Overall Study|Site closing|0|||
164606893|NCT00006604|594581085|FG011|Overall Study|Site closing|1|||
164716680|NCT03818035|594985120|FG003|Re-treatment (Week R0 Through Week R28)|Withdrawal by Subject|0|||
164716681|NCT03818035|594985121|FG004|Re-treatment (Week R0 Through Week R28)|Withdrawal by Subject|0|||
164716682|NCT03818035|594985122|FG005|Re-treatment (Week R0 Through Week R28)|Withdrawal by Subject|0|||
164716683|NCT03818035|594985123|FG006|Re-treatment (Week R0 Through Week R28)|Withdrawal by Subject|0|||
164716684|NCT03818035|594985124|FG007|Re-treatment (Week R0 Through Week R28)|Withdrawal by Subject|1|||
164716685|NCT03818035|594985117|FG000|Re-treatment (Week R0 Through Week R28)|Other Adverse Events|0|||
164716686|NCT03818035|594985118|FG001|Re-treatment (Week R0 Through Week R28)|Other Adverse Events|0|||
164504114|NCT01390441|594217595|FG000|Treatment Period|Physician Decision|0|||
164504115|NCT01390441|594217596|FG001|Treatment Period|Physician Decision|0|||
164716687|NCT03818035|594985119|FG002|Re-treatment (Week R0 Through Week R28)|Other Adverse Events|0|||
164504116|NCT01390441|594217597|FG002|Treatment Period|Physician Decision|0|||
164504117|NCT01390441|594217598|FG003|Treatment Period|Physician Decision|1|||
164504118|NCT01390441|594217599|FG004|Treatment Period|Physician Decision|0|||
164504119|NCT01390441|594217595|FG000|Treatment Period|Lack of Efficacy|0|||
164504120|NCT01390441|594217596|FG001|Treatment Period|Lack of Efficacy|0|||
164504121|NCT01390441|594217597|FG002|Treatment Period|Lack of Efficacy|0|||
164504122|NCT01390441|594217598|FG003|Treatment Period|Lack of Efficacy|0|||
164504123|NCT01390441|594217599|FG004|Treatment Period|Lack of Efficacy|1|||
164504124|NCT01390441|594217595|FG000|Treatment Period|Unknown due to early stopping of study|0|||
164504125|NCT01390441|594217596|FG001|Treatment Period|Unknown due to early stopping of study|0|||
164504126|NCT01390441|594217597|FG002|Treatment Period|Unknown due to early stopping of study|8|||
164504127|NCT01390441|594217598|FG003|Treatment Period|Unknown due to early stopping of study|11|||
164504128|NCT01390441|594217599|FG004|Treatment Period|Unknown due to early stopping of study|7|||
164504129|NCT01390441|594217595|FG000|Treatment Period|Adverse Event|0|||
164504130|NCT01390441|594217596|FG001|Treatment Period|Adverse Event|0|||
164504131|NCT01390441|594217597|FG002|Treatment Period|Adverse Event|1|||
164504132|NCT01390441|594217598|FG003|Treatment Period|Adverse Event|1|||
164504133|NCT01390441|594217599|FG004|Treatment Period|Adverse Event|2|||
164504134|NCT01390441|594217595|FG000|Treatment Period|Withdrawal by Subject|0|||
164504135|NCT01390441|594217596|FG001|Treatment Period|Withdrawal by Subject|0|||
164504136|NCT01390441|594217597|FG002|Treatment Period|Withdrawal by Subject|1|||
164504137|NCT01390441|594217598|FG003|Treatment Period|Withdrawal by Subject|0|||
164504138|NCT01390441|594217599|FG004|Treatment Period|Withdrawal by Subject|1|||
164504139|NCT01390441|594217595|FG000|Treatment Period|Lost to Follow-up|1|||
164504140|NCT01390441|594217596|FG001|Treatment Period|Lost to Follow-up|0|||
164504141|NCT01390441|594217597|FG002|Treatment Period|Lost to Follow-up|0|||
164504142|NCT01390441|594217598|FG003|Treatment Period|Lost to Follow-up|0|||
164504143|NCT01390441|594217599|FG004|Treatment Period|Lost to Follow-up|0|||
164504144|NCT01390441|594217595|FG000|Extension Period|Protocol Violation|3|||
164504145|NCT01390441|594217596|FG001|Extension Period|Protocol Violation|1|||
164504146|NCT01390441|594217597|FG002|Extension Period|Protocol Violation|0|||
164504147|NCT01390441|594217598|FG003|Extension Period|Protocol Violation|1|||
164504148|NCT01390441|594217599|FG004|Extension Period|Protocol Violation|0|||
164504149|NCT04788511|594217602|FG000|Overall Study|Withdrawal by Subject|2|||
164504150|NCT04788511|594217603|FG001|Overall Study|Withdrawal by Subject|1|||
164504151|NCT04788511|594217602|FG000|Overall Study|Lost to Follow-up|2|||
164504152|NCT04788511|594217603|FG001|Overall Study|Lost to Follow-up|7|||
164504153|NCT04788511|594217602|FG000|Overall Study|Death|3|||
164504154|NCT04788511|594217603|FG001|Overall Study|Death|4|||
164504155|NCT03174782|594217604|FG000|Overall Study|Protocol Violation|1|||
164504156|NCT03174782|594217605|FG001|Overall Study|Protocol Violation|0|||
164504157|NCT03174782|594217604|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
164504158|NCT03174782|594217605|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
164504159|NCT00778921|594217606|FG000|Overall Study|Adverse Event|9|||
164504160|NCT00778921|594217607|FG001|Overall Study|Adverse Event|10|||
164504161|NCT00778921|594217608|FG002|Overall Study|Adverse Event|14|||
164504162|NCT00778921|594217606|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
164504163|NCT00778921|594217607|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
164504164|NCT00778921|594217608|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
164504165|NCT00778921|594217606|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
164504166|NCT00778921|594217607|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
164504167|NCT00778921|594217608|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
164504168|NCT00778921|594217606|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
164504169|NCT00778921|594217607|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
164504170|NCT00778921|594217608|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
164504171|NCT00778921|594217606|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
164504172|NCT00778921|594217607|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
164504173|NCT00778921|594217608|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
164504174|NCT00778921|594217606|FG000|Overall Study|Patient withdrew request|3|||
164504175|NCT00778921|594217607|FG001|Overall Study|Patient withdrew request|1|||
164504176|NCT00778921|594217608|FG002|Overall Study|Patient withdrew request|6|||
164504177|NCT00778921|594217606|FG000|Overall Study|Lost to Follow-up|0|||
164504178|NCT00778921|594217607|FG001|Overall Study|Lost to Follow-up|2|||
164504179|NCT00778921|594217608|FG002|Overall Study|Lost to Follow-up|1|||
164504180|NCT00778921|594217606|FG000|Overall Study|Administrative Problems|1|||
164504181|NCT00778921|594217607|FG001|Overall Study|Administrative Problems|2|||
164504182|NCT00778921|594217608|FG002|Overall Study|Administrative Problems|0|||
164504183|NCT00778921|594217606|FG000|Overall Study|Protocol Violation|3|||
164504184|NCT00778921|594217607|FG001|Overall Study|Protocol Violation|0|||
164504185|NCT00778921|594217608|FG002|Overall Study|Protocol Violation|2|||
164504186|NCT00778921|594217606|FG000|Overall Study|Not treated|0|||
164504187|NCT00778921|594217607|FG001|Overall Study|Not treated|2|||
164504188|NCT00778921|594217608|FG002|Overall Study|Not treated|2|||
164504189|NCT03178045|594217609|FG000|Overall Study|Withdrawal by Subject|5|||
164504190|NCT03178045|594217610|FG001|Overall Study|Withdrawal by Subject|7|||
164716688|NCT03818035|594985120|FG003|Re-treatment (Week R0 Through Week R28)|Other Adverse Events|0|||
164716689|NCT03818035|594985121|FG004|Re-treatment (Week R0 Through Week R28)|Other Adverse Events|0|||
164716690|NCT03818035|594985122|FG005|Re-treatment (Week R0 Through Week R28)|Other Adverse Events|0|||
164716691|NCT03818035|594985123|FG006|Re-treatment (Week R0 Through Week R28)|Other Adverse Events|0|||
164716692|NCT03818035|594985124|FG007|Re-treatment (Week R0 Through Week R28)|Other Adverse Events|1|||
164716693|NCT03818035|594985117|FG000|Re-treatment (Week R0 Through Week R28)|Other|0|||
164716694|NCT03818035|594985118|FG001|Re-treatment (Week R0 Through Week R28)|Other|0|||
164716695|NCT03818035|594985119|FG002|Re-treatment (Week R0 Through Week R28)|Other|0|||
164716696|NCT03818035|594985120|FG003|Re-treatment (Week R0 Through Week R28)|Other|0|||
164716697|NCT03818035|594985121|FG004|Re-treatment (Week R0 Through Week R28)|Other|0|||
164716698|NCT03818035|594985122|FG005|Re-treatment (Week R0 Through Week R28)|Other|0|||
164716699|NCT03818035|594985123|FG006|Re-treatment (Week R0 Through Week R28)|Other|0|||
164716700|NCT03818035|594985124|FG007|Re-treatment (Week R0 Through Week R28)|Other|3|||
164716701|NCT00336024|594985126|FG000|Overall Study|Death|2|||
164716702|NCT00336024|594985127|FG001|Overall Study|Death|1|||
164716703|NCT00336024|594985126|FG000|Overall Study|Physician Decision|4|||
164716704|NCT00336024|594985127|FG001|Overall Study|Physician Decision|1|||
164716705|NCT00336024|594985126|FG000|Overall Study|Protocol Violation|1|||
164716706|NCT00336024|594985127|FG001|Overall Study|Protocol Violation|0|||
164716707|NCT00336024|594985126|FG000|Overall Study|Withdrawal by Subject|1|||
164716708|NCT00336024|594985127|FG001|Overall Study|Withdrawal by Subject|2|||
164716709|NCT00336024|594985126|FG000|Overall Study|Failure to fulfill consolidation|1|||
164716710|NCT00336024|594985127|FG001|Overall Study|Failure to fulfill consolidation|1|||
164716711|NCT00336024|594985126|FG000|Overall Study|Progressive Disease|4|||
164716712|NCT00336024|594985127|FG001|Overall Study|Progressive Disease|7|||
164716713|NCT00336024|594985126|FG000|Overall Study|Ineligible|7|||
164716714|NCT00336024|594985127|FG001|Overall Study|Ineligible|7|||
164716715|NCT05008484|594985134|FG000|Overall Study|Withdrawal by Subject|1|||
164716716|NCT05008484|594985135|FG001|Overall Study|Withdrawal by Subject|1|||
164716717|NCT04095689|594985139|FG000|Overall Study|Adverse Event|3|||
164716718|NCT04095689|594985139|FG000|Overall Study|Lack of Efficacy|1|||
164716719|NCT04095689|594985139|FG000|Overall Study|Death|1|||
164716720|NCT05985304|594985140|FG000|Overall Study|Protocol Violation|1|||
164716721|NCT05985304|594985141|FG001|Overall Study|Protocol Violation|0|||
164716722|NCT05985304|594985140|FG000|Overall Study|Withdrawal by Subject|0|||
164716723|NCT05985304|594985141|FG001|Overall Study|Withdrawal by Subject|2|||
164716724|NCT05985304|594985140|FG000|Overall Study|Subject was not implanted with the study device|0|||
164716725|NCT05985304|594985141|FG001|Overall Study|Subject was not implanted with the study device|2|||
164716726|NCT04497844|594985142|FG000|Overall Study|Ongoing|231|||
164716727|NCT04497844|594985143|FG001|Overall Study|Ongoing|249|||
164716728|NCT04497844|594985142|FG000|Overall Study|Death|106|||
164716729|NCT04497844|594985143|FG001|Overall Study|Death|84|||
164716730|NCT04497844|594985142|FG000|Overall Study|Lost to Follow-up|2|||
164716731|NCT04497844|594985143|FG001|Overall Study|Lost to Follow-up|0|||
164716732|NCT04497844|594985142|FG000|Overall Study|Withdrawal by Subject|6|||
164716733|NCT04497844|594985143|FG001|Overall Study|Withdrawal by Subject|14|||
164716734|NCT04497844|594985142|FG000|Overall Study|Regional Crisis|3|||
164716735|NCT04497844|594985143|FG001|Overall Study|Regional Crisis|1|||
164504191|NCT03178045|594217609|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
164504192|NCT03178045|594217610|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
164504193|NCT03178045|594217609|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
164504194|NCT03178045|594217610|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
164504195|NCT01078922|594217611|FG000|Overall Study|Adverse Event|1|||
164504196|NCT02353468|594217612|FG000|Overall Study|Study terminated|3|||
164504197|NCT01182207|594217614|FG000|First Intervention|Positive Hepatitis Results|0|||
164504198|NCT01182207|594217615|FG001|First Intervention|Positive Hepatitis Results|1|||
164504199|NCT01182207|594217614|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
164504200|NCT01182207|594217615|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
164504201|NCT01427738|594217616|FG000|Overall Study|Death|12|||
164504202|NCT01427738|594217617|FG001|Overall Study|Death|9|||
164504203|NCT01427738|594217616|FG000|Overall Study|Severe debilitation, unable to continue|0|||
164504204|NCT01427738|594217617|FG001|Overall Study|Severe debilitation, unable to continue|1|||
164504205|NCT01427738|594217616|FG000|Overall Study|Subject unable to get to clinic|5|||
164504206|NCT01427738|594217617|FG001|Overall Study|Subject unable to get to clinic|2|||
164504207|NCT01427738|594217616|FG000|Overall Study|Withdrawal by Subject|0|||
164504208|NCT01427738|594217617|FG001|Overall Study|Withdrawal by Subject|2|||
164504209|NCT01427738|594217616|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
164504210|NCT01427738|594217617|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
164504211|NCT01427738|594217616|FG000|Overall Study|Lost to Follow-up|1|||
164504212|NCT01427738|594217617|FG001|Overall Study|Lost to Follow-up|5|||
164504213|NCT01801982|594217620|FG000|Overall Study|Lost to Follow-up|1|||
164504214|NCT00727506|594217621|FG000|Overall Study|Adverse Event|0|||
164504215|NCT00727506|594217622|FG001|Overall Study|Adverse Event|0|||
164504216|NCT00727506|594217623|FG002|Overall Study|Adverse Event|4|||
164504217|NCT00727506|594217624|FG003|Overall Study|Adverse Event|4|||
164504218|NCT00727506|594217625|FG004|Overall Study|Adverse Event|1|||
164504219|NCT00727506|594217626|FG005|Overall Study|Adverse Event|8|||
164504220|NCT00727506|594217621|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
164504221|NCT00727506|594217622|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164504222|NCT00727506|594217623|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
164504223|NCT00727506|594217624|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164504224|NCT00727506|594217625|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164504225|NCT00727506|594217626|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164504226|NCT00727506|594217621|FG000|Overall Study|Progressive disease|4|||
164504227|NCT00727506|594217622|FG001|Overall Study|Progressive disease|7|||
164504228|NCT00727506|594217623|FG002|Overall Study|Progressive disease|9|||
164504229|NCT00727506|594217624|FG003|Overall Study|Progressive disease|28|||
164504230|NCT00727506|594217625|FG004|Overall Study|Progressive disease|38|||
164504231|NCT00727506|594217626|FG005|Overall Study|Progressive disease|28|||
164504232|NCT00727506|594217621|FG000|Overall Study|Refused to continue medication|0|||
164504233|NCT00727506|594217622|FG001|Overall Study|Refused to continue medication|1|||
164504234|NCT00727506|594217623|FG002|Overall Study|Refused to continue medication|2|||
164504235|NCT00727506|594217624|FG003|Overall Study|Refused to continue medication|3|||
164504236|NCT00727506|594217625|FG004|Overall Study|Refused to continue medication|1|||
164504237|NCT00727506|594217626|FG005|Overall Study|Refused to continue medication|2|||
164504238|NCT00727506|594217621|FG000|Overall Study|Other reason not described above|0|||
164504239|NCT00727506|594217622|FG001|Overall Study|Other reason not described above|0|||
164504240|NCT00727506|594217623|FG002|Overall Study|Other reason not described above|1|||
164504241|NCT00727506|594217624|FG003|Overall Study|Other reason not described above|4|||
164504242|NCT00727506|594217625|FG004|Overall Study|Other reason not described above|1|||
164504243|NCT00727506|594217626|FG005|Overall Study|Other reason not described above|1|||
164504244|NCT02650466|594217628|FG000|Overall Study|Physician Decision|1|||
164504245|NCT02650466|594217628|FG000|Overall Study|Withdrawal by Subject|5|||
164504246|NCT02650466|594217628|FG000|Overall Study|Lost to Follow-up|1|||
164504247|NCT01214421|594217632|FG000|Overall Study|Lost to Follow-up|7|||
164504248|NCT01214421|594217633|FG001|Overall Study|Lost to Follow-up|3|||
164504249|NCT01214421|594217634|FG002|Overall Study|Lost to Follow-up|7|||
164504250|NCT01214421|594217635|FG003|Overall Study|Lost to Follow-up|3|||
164504251|NCT01214421|594217632|FG000|Overall Study|Adverse Event|16|||
164504252|NCT01214421|594217633|FG001|Overall Study|Adverse Event|35|||
164504253|NCT01214421|594217634|FG002|Overall Study|Adverse Event|14|||
164504254|NCT01214421|594217635|FG003|Overall Study|Adverse Event|3|||
164504255|NCT01214421|594217632|FG000|Overall Study|Sponsor Discontinued Site|1|||
164504256|NCT01214421|594217633|FG001|Overall Study|Sponsor Discontinued Site|2|||
164504257|NCT01214421|594217634|FG002|Overall Study|Sponsor Discontinued Site|0|||
164504258|NCT01214421|594217635|FG003|Overall Study|Sponsor Discontinued Site|0|||
164504259|NCT01214421|594217632|FG000|Overall Study|Withdrawal Criteria Met|3|||
164504260|NCT01214421|594217633|FG001|Overall Study|Withdrawal Criteria Met|0|||
164504261|NCT01214421|594217634|FG002|Overall Study|Withdrawal Criteria Met|2|||
164504262|NCT01214421|594217635|FG003|Overall Study|Withdrawal Criteria Met|1|||
164504263|NCT01214421|594217632|FG000|Overall Study|Physician Decision|2|||
164504264|NCT01214421|594217633|FG001|Overall Study|Physician Decision|0|||
164504265|NCT01214421|594217634|FG002|Overall Study|Physician Decision|4|||
164504266|NCT01214421|594217635|FG003|Overall Study|Physician Decision|0|||
164504267|NCT01214421|594217632|FG000|Overall Study|Withdrawal by Subject|21|||
164504268|NCT01214421|594217633|FG001|Overall Study|Withdrawal by Subject|18|||
164504269|NCT01214421|594217634|FG002|Overall Study|Withdrawal by Subject|11|||
164504270|NCT01214421|594217635|FG003|Overall Study|Withdrawal by Subject|2|||
164504271|NCT03912532|594217636|FG000|Overall Study|Adverse Event|3|||
164504272|NCT03912532|594217637|FG001|Overall Study|Adverse Event|3|||
164504273|NCT03912532|594217638|FG002|Overall Study|Adverse Event|2|||
164504274|NCT03912532|594217639|FG003|Overall Study|Adverse Event|2|||
164504275|NCT03912532|594217636|FG000|Overall Study|Lost to Follow-up|3|||
164504276|NCT03912532|594217637|FG001|Overall Study|Lost to Follow-up|2|||
164504277|NCT03912532|594217638|FG002|Overall Study|Lost to Follow-up|1|||
164504278|NCT03912532|594217639|FG003|Overall Study|Lost to Follow-up|2|||
164504279|NCT03912532|594217636|FG000|Overall Study|Withdrawal by Subject|1|||
164504280|NCT03912532|594217637|FG001|Overall Study|Withdrawal by Subject|1|||
164504281|NCT03912532|594217638|FG002|Overall Study|Withdrawal by Subject|2|||
164504282|NCT03912532|594217639|FG003|Overall Study|Withdrawal by Subject|0|||
164504283|NCT03912532|594217636|FG000|Overall Study|Physician Decision|1|||
164504284|NCT03912532|594217637|FG001|Overall Study|Physician Decision|0|||
164504285|NCT03912532|594217638|FG002|Overall Study|Physician Decision|0|||
164504286|NCT03912532|594217639|FG003|Overall Study|Physician Decision|3|||
164504287|NCT03912532|594217636|FG000|Overall Study|Other|0|||
164504288|NCT03912532|594217637|FG001|Overall Study|Other|1|||
164504289|NCT03912532|594217638|FG002|Overall Study|Other|1|||
164504290|NCT03912532|594217639|FG003|Overall Study|Other|0|||
164504291|NCT03522389|594217642|FG000|Overall Study|Lost to Follow-up|1|||
164504292|NCT03522389|594217643|FG001|Overall Study|Lost to Follow-up|1|||
164504293|NCT03522389|594217644|FG002|Overall Study|Lost to Follow-up|2|||
164504294|NCT03522389|594217642|FG000|Overall Study|had herniated nucleus pulposus|0|||
164504295|NCT03522389|594217643|FG001|Overall Study|had herniated nucleus pulposus|1|||
164504296|NCT03522389|594217644|FG002|Overall Study|had herniated nucleus pulposus|0|||
164504297|NCT03522389|594217642|FG000|Overall Study|go to work in other province|1|||
164504298|NCT03522389|594217643|FG001|Overall Study|go to work in other province|0|||
164606894|NCT00006604|594581086|FG012|Overall Study|Site closing|1|||
164606895|NCT00006604|594581087|FG013|Overall Study|Site closing|1|||
164606896|NCT00006604|594581088|FG014|Overall Study|Site closing|0|||
164606897|NCT00006604|594581089|FG015|Overall Study|Site closing|0|||
164606898|NCT00006604|594581090|FG016|Overall Study|Site closing|1|||
164606899|NCT00006604|594581074|FG000|Overall Study|Withdrawal by Subject|1|||
164606900|NCT00006604|594581075|FG001|Overall Study|Withdrawal by Subject|0|||
164606901|NCT00006604|594581076|FG002|Overall Study|Withdrawal by Subject|2|||
164606902|NCT00006604|594581077|FG003|Overall Study|Withdrawal by Subject|0|||
164606903|NCT00006604|594581078|FG004|Overall Study|Withdrawal by Subject|1|||
164606904|NCT00006604|594581079|FG005|Overall Study|Withdrawal by Subject|2|||
164606905|NCT00006604|594581080|FG006|Overall Study|Withdrawal by Subject|2|||
164606906|NCT00006604|594581081|FG007|Overall Study|Withdrawal by Subject|0|||
164606907|NCT00006604|594581082|FG008|Overall Study|Withdrawal by Subject|1|||
164606908|NCT00006604|594581083|FG009|Overall Study|Withdrawal by Subject|3|||
164606909|NCT00006604|594581084|FG010|Overall Study|Withdrawal by Subject|2|||
164606910|NCT00006604|594581085|FG011|Overall Study|Withdrawal by Subject|0|||
164606911|NCT00006604|594581086|FG012|Overall Study|Withdrawal by Subject|1|||
164606912|NCT00006604|594581087|FG013|Overall Study|Withdrawal by Subject|2|||
164606913|NCT00006604|594581088|FG014|Overall Study|Withdrawal by Subject|1|||
164606914|NCT00006604|594581089|FG015|Overall Study|Withdrawal by Subject|0|||
164504299|NCT03522389|594217644|FG002|Overall Study|go to work in other province|0|||
164504300|NCT02473042|594217650|FG000|Overall Study|Withdrawal by Subject|1|||
164504301|NCT02473042|594217651|FG001|Overall Study|Withdrawal by Subject|0|||
164504302|NCT02473042|594217650|FG000|Overall Study|Patient became ineligible after enrollment|2|||
164504303|NCT02473042|594217651|FG001|Overall Study|Patient became ineligible after enrollment|5|||
164504304|NCT02473042|594217650|FG000|Overall Study|Surgery started before study preparation could be completed|0|||
164504305|NCT02473042|594217651|FG001|Overall Study|Surgery started before study preparation could be completed|1|||
164504306|NCT02473042|594217650|FG000|Overall Study|PACU data unable to be collected|3|||
164504307|NCT02473042|594217651|FG001|Overall Study|PACU data unable to be collected|0|||
164504308|NCT00604188|594217654|FG000|Overall Study|Adverse Event|1|||
164504309|NCT00604188|594217655|FG001|Overall Study|Adverse Event|4|||
164504310|NCT00604188|594217654|FG000|Overall Study|Lost to Follow-up|17|||
164504311|NCT00604188|594217655|FG001|Overall Study|Lost to Follow-up|15|||
164504312|NCT00604188|594217654|FG000|Overall Study|Withdrawal by Subject|5|||
164504313|NCT00604188|594217655|FG001|Overall Study|Withdrawal by Subject|1|||
164504314|NCT00604188|594217654|FG000|Overall Study|Non-compliance with protocol|4|||
164504315|NCT00604188|594217655|FG001|Overall Study|Non-compliance with protocol|4|||
164504316|NCT00604188|594217654|FG000|Overall Study|Did not receive study drug|0|||
164504317|NCT00604188|594217655|FG001|Overall Study|Did not receive study drug|1|||
164504318|NCT04680637|594217656|FG000|Overall Study|Lost to Follow-up|0|||
164504319|NCT04680637|594217657|FG001|Overall Study|Lost to Follow-up|1|||
164504320|NCT04680637|594217658|FG002|Overall Study|Lost to Follow-up|0|||
164504321|NCT04680637|594217659|FG003|Overall Study|Lost to Follow-up|1|||
164504322|NCT04680637|594217656|FG000|Overall Study|Death|1|||
164504323|NCT04680637|594217657|FG001|Overall Study|Death|0|||
164504324|NCT04680637|594217658|FG002|Overall Study|Death|0|||
164504325|NCT04680637|594217659|FG003|Overall Study|Death|0|||
164504326|NCT04680637|594217656|FG000|Overall Study|Withdrawal by Subject|7|||
164504327|NCT04680637|594217657|FG001|Overall Study|Withdrawal by Subject|10|||
164504328|NCT04680637|594217658|FG002|Overall Study|Withdrawal by Subject|17|||
164504329|NCT04680637|594217659|FG003|Overall Study|Withdrawal by Subject|15|||
164504330|NCT04680637|594217656|FG000|Overall Study|Decision by Sponsor|21|||
164504331|NCT04680637|594217657|FG001|Overall Study|Decision by Sponsor|15|||
164504332|NCT04680637|594217658|FG002|Overall Study|Decision by Sponsor|7|||
164504333|NCT04680637|594217659|FG003|Overall Study|Decision by Sponsor|32|||
164504334|NCT02242643|594217664|FG000|Overall Study|Protocol Violation|1|||
164504335|NCT02242643|594217665|FG001|Overall Study|Protocol Violation|2|||
164504336|NCT02242643|594217664|FG000|Overall Study|Withdrawal by Subject|15|||
164504337|NCT02242643|594217665|FG001|Overall Study|Withdrawal by Subject|10|||
164504338|NCT02242643|594217664|FG000|Overall Study|Migrated/moved from study area|1|||
164504339|NCT02242643|594217665|FG001|Overall Study|Migrated/moved from study area|3|||
164504340|NCT02242643|594217664|FG000|Overall Study|Lost to Follow-up|54|||
164504341|NCT02242643|594217665|FG001|Overall Study|Lost to Follow-up|61|||
164504342|NCT02242643|594217664|FG000|Overall Study|Child placed in foster care by family|0|||
164504343|NCT02242643|594217665|FG001|Overall Study|Child placed in foster care by family|1|||
164504344|NCT02242643|594217664|FG000|Overall Study|Non-compliance|1|||
164504345|NCT02242643|594217665|FG001|Overall Study|Non-compliance|0|||
164504346|NCT02242643|594217664|FG000|Overall Study|Consent withdrawal by parent|1|||
164504347|NCT02242643|594217665|FG001|Overall Study|Consent withdrawal by parent|0|||
164504348|NCT02242643|594217664|FG000|Overall Study|Protocol requirements not followed|1|||
164504349|NCT02242643|594217665|FG001|Overall Study|Protocol requirements not followed|0|||
164504350|NCT02242643|594217664|FG000|Overall Study|Language barrier|1|||
164504351|NCT02242643|594217665|FG001|Overall Study|Language barrier|0|||
164504352|NCT02242643|594217664|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
164504353|NCT02242643|594217665|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
164504354|NCT01103232|594217669|FG000|Overall Study|Withdrawal by Subject|1|||
164504355|NCT01103232|594217670|FG001|Overall Study|Withdrawal by Subject|1|||
164504356|NCT01103232|594217669|FG000|Overall Study|Protocol Violation|0|||
164504357|NCT01103232|594217670|FG001|Overall Study|Protocol Violation|1|||
164504358|NCT00443599|594217674|FG000|Overall Study|Physician Decision|2|||
164504359|NCT00443599|594217675|FG001|Overall Study|Physician Decision|1|||
164504360|NCT00443599|594217674|FG000|Overall Study|Death|1|||
164504361|NCT00443599|594217675|FG001|Overall Study|Death|1|||
164504362|NCT00443599|594217674|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
164504363|NCT00443599|594217675|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
164504364|NCT03049306|594217676|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
164504365|NCT03049306|594217677|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
164504366|NCT05093504|594217678|FG000|Overall Study|Death|0|||
164504367|NCT05093504|594217679|FG001|Overall Study|Death|1|||
164504368|NCT03151551|594217680|FG000|Open-Label Treatment Period|Adverse Event|0|||
164504369|NCT03151551|594217681|FG001|Open-Label Treatment Period|Adverse Event|2|||
164504370|NCT03151551|594217680|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
164504371|NCT03151551|594217681|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
164504372|NCT03151551|594217680|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
164504373|NCT03151551|594217681|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
164504374|NCT03151551|594217680|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
164504375|NCT03151551|594217681|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
164504376|NCT03151551|594217680|FG000|Open-Label Treatment Period|Physician Decision|3|||
164504377|NCT03151551|594217681|FG001|Open-Label Treatment Period|Physician Decision|0|||
164504378|NCT03151551|594217680|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
164504379|NCT03151551|594217681|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
164504380|NCT03151551|594217680|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
164504381|NCT03151551|594217681|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
164504382|NCT03151551|594217680|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
164504383|NCT03151551|594217681|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
164504384|NCT03151551|594217680|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
164504385|NCT03151551|594217681|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
164504386|NCT03151551|594217680|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
164504387|NCT03151551|594217681|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
164504388|NCT05347485|594217682|FG000|Overall Study|Death|14|||
164504389|NCT05347485|594217682|FG000|Overall Study|Lost to Follow-up|2|||
164504390|NCT05347485|594217682|FG000|Overall Study|Withdrawal by Subject|13|||
164504391|NCT05347485|594217682|FG000|Overall Study|Progressive Disease|1|||
164504392|NCT05347485|594217682|FG000|Overall Study|Study Terminated by Sponsor|49|||
164504393|NCT05347485|594217682|FG000|Overall Study|Other|1|||
164504394|NCT05347485|594217682|FG000|Overall Study|Enrolled (consented) but not treated|4|||
164504395|NCT05347485|594217682|FG000|Overall Study|Disease Relapse|2|||
164504396|NCT05896696|594217683|FG000|Overall Study|Screening Failure|7|||
164504397|NCT05896696|594217683|FG000|Overall Study|Withdrawal by Subject|2|||
164532291|NCT02075541|594320522|FG000|Overall Study|Withdrawal by Subject|1|||
164532292|NCT02075541|594320523|FG001|Overall Study|Withdrawal by Subject|3|||
164532293|NCT02075541|594320522|FG000|Overall Study|Sponsor study termination|0|||
164532294|NCT02075541|594320523|FG001|Overall Study|Sponsor study termination|1|||
164532295|NCT02075541|594320522|FG000|Overall Study|Other- unable to perform study procedure|1|||
164532296|NCT02075541|594320523|FG001|Overall Study|Other- unable to perform study procedure|0|||
164532297|NCT01054846|594320526|FG000|Overall Study|Lost to Follow-up|76|||
164532298|NCT01054846|594320527|FG001|Overall Study|Lost to Follow-up|17|||
164532299|NCT02434939|594320528|FG000|Overall Study|Lack of Efficacy|34|||
164532300|NCT02434939|594320529|FG001|Overall Study|Lack of Efficacy|48|||
164532301|NCT02434939|594320528|FG000|Overall Study|Withdrawal by Subject|3|||
164532302|NCT02434939|594320529|FG001|Overall Study|Withdrawal by Subject|0|||
164532303|NCT02434939|594320528|FG000|Overall Study|Adverse Event|0|||
164532304|NCT02434939|594320529|FG001|Overall Study|Adverse Event|1|||
164532305|NCT00394953|594320530|FG000|First Treatment Period|Adverse Event|1|||
164532306|NCT00394953|594320531|FG001|First Treatment Period|Adverse Event|2|||
164532307|NCT00394953|594320530|FG000|First Treatment Period|Death|6|||
164532308|NCT00394953|594320531|FG001|First Treatment Period|Death|7|||
164532309|NCT00394953|594320530|FG000|First Treatment Period|Lack of Efficacy|1|||
164532310|NCT00394953|594320531|FG001|First Treatment Period|Lack of Efficacy|1|||
164532311|NCT00394953|594320530|FG000|First Treatment Period|Withdrawal by Subject|6|||
164532312|NCT00394953|594320531|FG001|First Treatment Period|Withdrawal by Subject|3|||
164532313|NCT00394953|594320530|FG000|First Treatment Period|Lost to Follow-up|0|||
164532314|NCT00394953|594320531|FG001|First Treatment Period|Lost to Follow-up|1|||
164532315|NCT00394953|594320530|FG000|First Treatment Period|Renal transplant|11|||
164532316|NCT00394953|594320531|FG001|First Treatment Period|Renal transplant|7|||
164504398|NCT00129935|594219149|FG000|Overall Study|Adverse Event|18|||
164504399|NCT00129935|594219150|FG001|Overall Study|Adverse Event|56|||
164504400|NCT00129935|594219149|FG000|Overall Study|Death|1|||
164504401|NCT00129935|594219150|FG001|Overall Study|Death|1|||
164504402|NCT00129935|594219149|FG000|Overall Study|Withdrawal by Subject|7|||
164504403|NCT00129935|594219150|FG001|Overall Study|Withdrawal by Subject|20|||
164504404|NCT00129935|594219149|FG000|Overall Study|Protocol Violation|0|||
164504405|NCT00129935|594219150|FG001|Overall Study|Protocol Violation|4|||
164504406|NCT00129935|594219149|FG000|Overall Study|Physician Decision|3|||
164504407|NCT00129935|594219150|FG001|Overall Study|Physician Decision|4|||
164504408|NCT00129935|594219149|FG000|Overall Study|Recurrence|1|||
164504409|NCT00129935|594219150|FG001|Overall Study|Recurrence|3|||
164504410|NCT00129935|594219149|FG000|Overall Study|Second primary|0|||
164504411|NCT00129935|594219150|FG001|Overall Study|Second primary|1|||
164504412|NCT00129935|594219149|FG000|Overall Study|Other|3|||
164504413|NCT00129935|594219150|FG001|Overall Study|Other|2|||
164504414|NCT00129935|594219149|FG000|Overall Study|Crossed to the other arm|2|||
164504415|NCT00129935|594219150|FG001|Overall Study|Crossed to the other arm|1|||
164504416|NCT00129935|594219149|FG000|Overall Study|Incorrect study treatment|1|||
164504417|NCT00129935|594219150|FG001|Overall Study|Incorrect study treatment|0|||
164504418|NCT01434680|594219154|FG000|Overall Study|Withdrawal by Subject|1|||
164504419|NCT01434680|594219155|FG001|Overall Study|Withdrawal by Subject|0|||
164504420|NCT01434680|594219156|FG002|Overall Study|Withdrawal by Subject|2|||
164504421|NCT01434680|594219157|FG003|Overall Study|Withdrawal by Subject|0|||
164504422|NCT01434680|594219154|FG000|Overall Study|Lost to Follow-up|1|||
164504423|NCT01434680|594219155|FG001|Overall Study|Lost to Follow-up|1|||
164504424|NCT01434680|594219156|FG002|Overall Study|Lost to Follow-up|0|||
164504425|NCT01434680|594219157|FG003|Overall Study|Lost to Follow-up|0|||
164504426|NCT01434680|594219154|FG000|Overall Study|Protocol Violation|1|||
164504427|NCT01434680|594219155|FG001|Overall Study|Protocol Violation|1|||
164504428|NCT01434680|594219156|FG002|Overall Study|Protocol Violation|0|||
164504429|NCT01434680|594219157|FG003|Overall Study|Protocol Violation|0|||
164504430|NCT01367847|594219159|FG000|Overall Study|Withdrawal by Subject|2|||
164504431|NCT01367847|594219160|FG001|Overall Study|Withdrawal by Subject|2|||
164504432|NCT04978350|594219163|FG000|Overall Study|Lost to Follow-up|6|||
164504433|NCT00756457|594219164|FG000|Overall Study|Lost to Follow-up|1|||
164504434|NCT00756457|594219165|FG001|Overall Study|Lost to Follow-up|2|||
164504435|NCT01296555|594219169|FG000|Overall Study|Adverse Event|0|||
164504436|NCT01296555|594219170|FG001|Overall Study|Adverse Event|0|||
164504437|NCT01296555|594219171|FG002|Overall Study|Adverse Event|1|||
164504438|NCT01296555|594219172|FG003|Overall Study|Adverse Event|1|||
164504439|NCT01296555|594219173|FG004|Overall Study|Adverse Event|2|||
164504440|NCT01296555|594219174|FG005|Overall Study|Adverse Event|4|||
164504441|NCT01296555|594219175|FG006|Overall Study|Adverse Event|1|||
164504442|NCT01296555|594219176|FG007|Overall Study|Adverse Event|4|||
164504443|NCT01296555|594219177|FG008|Overall Study|Adverse Event|3|||
164504444|NCT01296555|594219178|FG009|Overall Study|Adverse Event|1|||
164504445|NCT01296555|594219179|FG010|Overall Study|Adverse Event|0|||
164504446|NCT01296555|594219180|FG011|Overall Study|Adverse Event|4|||
164504447|NCT01296555|594219181|FG012|Overall Study|Adverse Event|1|||
164504448|NCT01296555|594219182|FG013|Overall Study|Adverse Event|4|||
164504449|NCT01296555|594219183|FG014|Overall Study|Adverse Event|0|||
164504450|NCT01296555|594219184|FG015|Overall Study|Adverse Event|0|||
164504451|NCT01296555|594219185|FG016|Overall Study|Adverse Event|0|||
164504452|NCT01296555|594219186|FG017|Overall Study|Adverse Event|0|||
164504453|NCT01296555|594219187|FG018|Overall Study|Adverse Event|0|||
164504454|NCT01296555|594219188|FG019|Overall Study|Adverse Event|1|||
164504455|NCT01296555|594219189|FG020|Overall Study|Adverse Event|0|||
164504456|NCT01296555|594219190|FG021|Overall Study|Adverse Event|0|||
164504457|NCT01296555|594219191|FG022|Overall Study|Adverse Event|0|||
164504458|NCT01296555|594219192|FG023|Overall Study|Adverse Event|0|||
164606915|NCT00006604|594581090|FG016|Overall Study|Withdrawal by Subject|1|||
164606916|NCT00006604|594581074|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
164606917|NCT00006604|594581075|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
164606918|NCT00006604|594581076|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
164606919|NCT00006604|594581077|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
164606920|NCT00006604|594581078|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
164606921|NCT00006604|594581079|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
164606922|NCT00006604|594581080|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
164606923|NCT00006604|594581081|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
164504459|NCT01296555|594219193|FG024|Overall Study|Adverse Event|0|||
164504460|NCT01296555|594219194|FG025|Overall Study|Adverse Event|0|||
164504461|NCT01296555|594219195|FG026|Overall Study|Adverse Event|0|||
164504462|NCT01296555|594219196|FG027|Overall Study|Adverse Event|0|||
164504463|NCT01296555|594219197|FG028|Overall Study|Adverse Event|0|||
164504464|NCT01296555|594219169|FG000|Overall Study|Reason Not Specified|0|||
164504465|NCT01296555|594219170|FG001|Overall Study|Reason Not Specified|0|||
164504466|NCT01296555|594219171|FG002|Overall Study|Reason Not Specified|0|||
164504467|NCT01296555|594219172|FG003|Overall Study|Reason Not Specified|0|||
164504468|NCT01296555|594219173|FG004|Overall Study|Reason Not Specified|0|||
164504469|NCT01296555|594219174|FG005|Overall Study|Reason Not Specified|0|||
164504470|NCT01296555|594219175|FG006|Overall Study|Reason Not Specified|0|||
164504471|NCT01296555|594219176|FG007|Overall Study|Reason Not Specified|0|||
164504472|NCT01296555|594219177|FG008|Overall Study|Reason Not Specified|0|||
164504473|NCT01296555|594219178|FG009|Overall Study|Reason Not Specified|0|||
164504474|NCT01296555|594219179|FG010|Overall Study|Reason Not Specified|0|||
164504475|NCT01296555|594219180|FG011|Overall Study|Reason Not Specified|0|||
164504476|NCT01296555|594219181|FG012|Overall Study|Reason Not Specified|0|||
164504477|NCT01296555|594219182|FG013|Overall Study|Reason Not Specified|1|||
164504478|NCT01296555|594219183|FG014|Overall Study|Reason Not Specified|2|||
164504479|NCT01296555|594219184|FG015|Overall Study|Reason Not Specified|3|||
164504480|NCT01296555|594219185|FG016|Overall Study|Reason Not Specified|7|||
164504481|NCT01296555|594219186|FG017|Overall Study|Reason Not Specified|4|||
164504482|NCT01296555|594219187|FG018|Overall Study|Reason Not Specified|3|||
164504483|NCT01296555|594219188|FG019|Overall Study|Reason Not Specified|7|||
164504484|NCT01296555|594219189|FG020|Overall Study|Reason Not Specified|11|||
164504485|NCT01296555|594219190|FG021|Overall Study|Reason Not Specified|5|||
164504486|NCT01296555|594219191|FG022|Overall Study|Reason Not Specified|5|||
164504487|NCT01296555|594219192|FG023|Overall Study|Reason Not Specified|7|||
164504488|NCT01296555|594219193|FG024|Overall Study|Reason Not Specified|2|||
164504489|NCT01296555|594219194|FG025|Overall Study|Reason Not Specified|2|||
164504490|NCT01296555|594219195|FG026|Overall Study|Reason Not Specified|19|||
164504491|NCT01296555|594219196|FG027|Overall Study|Reason Not Specified|11|||
164504492|NCT01296555|594219197|FG028|Overall Study|Reason Not Specified|9|||
164504493|NCT01296555|594219169|FG000|Overall Study|Physician Decision|0|||
164504494|NCT01296555|594219170|FG001|Overall Study|Physician Decision|0|||
164504495|NCT01296555|594219171|FG002|Overall Study|Physician Decision|0|||
164504496|NCT01296555|594219172|FG003|Overall Study|Physician Decision|0|||
164504497|NCT01296555|594219173|FG004|Overall Study|Physician Decision|1|||
164504498|NCT01296555|594219174|FG005|Overall Study|Physician Decision|0|||
164504499|NCT01296555|594219175|FG006|Overall Study|Physician Decision|0|||
164504500|NCT01296555|594219176|FG007|Overall Study|Physician Decision|0|||
164504501|NCT01296555|594219177|FG008|Overall Study|Physician Decision|0|||
164504502|NCT01296555|594219178|FG009|Overall Study|Physician Decision|0|||
164504503|NCT01296555|594219179|FG010|Overall Study|Physician Decision|0|||
164504504|NCT01296555|594219180|FG011|Overall Study|Physician Decision|0|||
164504505|NCT01296555|594219181|FG012|Overall Study|Physician Decision|0|||
164504506|NCT01296555|594219182|FG013|Overall Study|Physician Decision|1|||
164504507|NCT01296555|594219183|FG014|Overall Study|Physician Decision|0|||
164504508|NCT01296555|594219184|FG015|Overall Study|Physician Decision|0|||
164504509|NCT01296555|594219185|FG016|Overall Study|Physician Decision|0|||
164504510|NCT01296555|594219186|FG017|Overall Study|Physician Decision|0|||
164504511|NCT01296555|594219187|FG018|Overall Study|Physician Decision|0|||
164504512|NCT01296555|594219188|FG019|Overall Study|Physician Decision|1|||
164504513|NCT01296555|594219189|FG020|Overall Study|Physician Decision|0|||
164504514|NCT01296555|594219190|FG021|Overall Study|Physician Decision|0|||
164504515|NCT01296555|594219191|FG022|Overall Study|Physician Decision|0|||
164504516|NCT01296555|594219192|FG023|Overall Study|Physician Decision|0|||
164504517|NCT01296555|594219193|FG024|Overall Study|Physician Decision|0|||
164504518|NCT01296555|594219194|FG025|Overall Study|Physician Decision|0|||
164504519|NCT01296555|594219195|FG026|Overall Study|Physician Decision|0|||
164504520|NCT01296555|594219196|FG027|Overall Study|Physician Decision|0|||
164504521|NCT01296555|594219197|FG028|Overall Study|Physician Decision|0|||
164504522|NCT01296555|594219169|FG000|Overall Study|Progressive Disease|6|||
164504523|NCT01296555|594219170|FG001|Overall Study|Progressive Disease|3|||
164504524|NCT01296555|594219171|FG002|Overall Study|Progressive Disease|3|||
164504525|NCT01296555|594219172|FG003|Overall Study|Progressive Disease|7|||
164504526|NCT01296555|594219173|FG004|Overall Study|Progressive Disease|6|||
164504527|NCT01296555|594219174|FG005|Overall Study|Progressive Disease|16|||
164504528|NCT01296555|594219175|FG006|Overall Study|Progressive Disease|16|||
164504529|NCT01296555|594219176|FG007|Overall Study|Progressive Disease|8|||
164504530|NCT01296555|594219177|FG008|Overall Study|Progressive Disease|7|||
164504531|NCT01296555|594219178|FG009|Overall Study|Progressive Disease|18|||
164504532|NCT01296555|594219179|FG010|Overall Study|Progressive Disease|7|||
164504533|NCT01296555|594219180|FG011|Overall Study|Progressive Disease|14|||
164504534|NCT01296555|594219181|FG012|Overall Study|Progressive Disease|5|||
164504535|NCT01296555|594219182|FG013|Overall Study|Progressive Disease|12|||
164504536|NCT01296555|594219183|FG014|Overall Study|Progressive Disease|1|||
164504537|NCT01296555|594219184|FG015|Overall Study|Progressive Disease|1|||
164504538|NCT01296555|594219185|FG016|Overall Study|Progressive Disease|0|||
164504539|NCT01296555|594219186|FG017|Overall Study|Progressive Disease|0|||
164504540|NCT01296555|594219187|FG018|Overall Study|Progressive Disease|0|||
164504541|NCT01296555|594219188|FG019|Overall Study|Progressive Disease|1|||
164504542|NCT01296555|594219189|FG020|Overall Study|Progressive Disease|0|||
164504543|NCT01296555|594219190|FG021|Overall Study|Progressive Disease|0|||
164504544|NCT01296555|594219191|FG022|Overall Study|Progressive Disease|0|||
164504545|NCT01296555|594219192|FG023|Overall Study|Progressive Disease|0|||
164504546|NCT01296555|594219193|FG024|Overall Study|Progressive Disease|1|||
164504547|NCT01296555|594219194|FG025|Overall Study|Progressive Disease|0|||
164504548|NCT01296555|594219195|FG026|Overall Study|Progressive Disease|5|||
164504549|NCT01296555|594219196|FG027|Overall Study|Progressive Disease|1|||
164504550|NCT01296555|594219197|FG028|Overall Study|Progressive Disease|0|||
164504551|NCT01296555|594219169|FG000|Overall Study|Protocol Violation|0|||
164504552|NCT01296555|594219170|FG001|Overall Study|Protocol Violation|0|||
164504553|NCT01296555|594219171|FG002|Overall Study|Protocol Violation|0|||
164504554|NCT01296555|594219172|FG003|Overall Study|Protocol Violation|0|||
164504555|NCT01296555|594219173|FG004|Overall Study|Protocol Violation|0|||
164504556|NCT01296555|594219174|FG005|Overall Study|Protocol Violation|0|||
164504557|NCT01296555|594219175|FG006|Overall Study|Protocol Violation|0|||
164504558|NCT01296555|594219176|FG007|Overall Study|Protocol Violation|0|||
164504559|NCT01296555|594219177|FG008|Overall Study|Protocol Violation|0|||
164504560|NCT01296555|594219178|FG009|Overall Study|Protocol Violation|0|||
164504561|NCT01296555|594219179|FG010|Overall Study|Protocol Violation|0|||
164504562|NCT01296555|594219180|FG011|Overall Study|Protocol Violation|0|||
164504563|NCT01296555|594219181|FG012|Overall Study|Protocol Violation|0|||
164504564|NCT01296555|594219182|FG013|Overall Study|Protocol Violation|1|||
164504565|NCT01296555|594219183|FG014|Overall Study|Protocol Violation|0|||
164504566|NCT01296555|594219184|FG015|Overall Study|Protocol Violation|0|||
164504567|NCT01296555|594219185|FG016|Overall Study|Protocol Violation|0|||
164504568|NCT01296555|594219186|FG017|Overall Study|Protocol Violation|0|||
164504569|NCT01296555|594219187|FG018|Overall Study|Protocol Violation|0|||
164504570|NCT01296555|594219188|FG019|Overall Study|Protocol Violation|0|||
164504571|NCT01296555|594219189|FG020|Overall Study|Protocol Violation|0|||
164504572|NCT01296555|594219190|FG021|Overall Study|Protocol Violation|0|||
164504573|NCT01296555|594219191|FG022|Overall Study|Protocol Violation|0|||
164504574|NCT01296555|594219192|FG023|Overall Study|Protocol Violation|0|||
164504575|NCT01296555|594219193|FG024|Overall Study|Protocol Violation|0|||
164504576|NCT01296555|594219194|FG025|Overall Study|Protocol Violation|0|||
164504577|NCT01296555|594219195|FG026|Overall Study|Protocol Violation|0|||
164504578|NCT01296555|594219196|FG027|Overall Study|Protocol Violation|0|||
164504579|NCT01296555|594219197|FG028|Overall Study|Protocol Violation|0|||
164504580|NCT01296555|594219169|FG000|Overall Study|Study Terminated By Sponsor|0|||
164504581|NCT01296555|594219170|FG001|Overall Study|Study Terminated By Sponsor|0|||
164504582|NCT01296555|594219171|FG002|Overall Study|Study Terminated By Sponsor|0|||
164504583|NCT01296555|594219172|FG003|Overall Study|Study Terminated By Sponsor|0|||
164504584|NCT01296555|594219173|FG004|Overall Study|Study Terminated By Sponsor|0|||
164504585|NCT01296555|594219174|FG005|Overall Study|Study Terminated By Sponsor|0|||
164504586|NCT01296555|594219175|FG006|Overall Study|Study Terminated By Sponsor|0|||
164504587|NCT01296555|594219176|FG007|Overall Study|Study Terminated By Sponsor|0|||
164504588|NCT01296555|594219177|FG008|Overall Study|Study Terminated By Sponsor|0|||
164504589|NCT01296555|594219178|FG009|Overall Study|Study Terminated By Sponsor|0|||
164504590|NCT01296555|594219179|FG010|Overall Study|Study Terminated By Sponsor|0|||
164504591|NCT01296555|594219180|FG011|Overall Study|Study Terminated By Sponsor|0|||
164504592|NCT01296555|594219181|FG012|Overall Study|Study Terminated By Sponsor|0|||
164504593|NCT01296555|594219182|FG013|Overall Study|Study Terminated By Sponsor|0|||
164504594|NCT01296555|594219183|FG014|Overall Study|Study Terminated By Sponsor|0|||
164504595|NCT01296555|594219184|FG015|Overall Study|Study Terminated By Sponsor|0|||
164504596|NCT01296555|594219185|FG016|Overall Study|Study Terminated By Sponsor|0|||
164504597|NCT01296555|594219186|FG017|Overall Study|Study Terminated By Sponsor|0|||
164504598|NCT01296555|594219187|FG018|Overall Study|Study Terminated By Sponsor|0|||
164504599|NCT01296555|594219188|FG019|Overall Study|Study Terminated By Sponsor|0|||
164504600|NCT01296555|594219189|FG020|Overall Study|Study Terminated By Sponsor|0|||
164504601|NCT01296555|594219190|FG021|Overall Study|Study Terminated By Sponsor|0|||
164504602|NCT01296555|594219191|FG022|Overall Study|Study Terminated By Sponsor|0|||
164504603|NCT01296555|594219192|FG023|Overall Study|Study Terminated By Sponsor|0|||
164504604|NCT01296555|594219193|FG024|Overall Study|Study Terminated By Sponsor|0|||
164504605|NCT01296555|594219194|FG025|Overall Study|Study Terminated By Sponsor|1|||
164504606|NCT01296555|594219195|FG026|Overall Study|Study Terminated By Sponsor|0|||
164504607|NCT01296555|594219196|FG027|Overall Study|Study Terminated By Sponsor|0|||
164504608|NCT01296555|594219197|FG028|Overall Study|Study Terminated By Sponsor|0|||
164504609|NCT01296555|594219169|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504610|NCT01296555|594219170|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504611|NCT01296555|594219171|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504612|NCT01296555|594219172|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504613|NCT01296555|594219173|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504614|NCT01296555|594219174|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504615|NCT01296555|594219175|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504616|NCT01296555|594219176|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504617|NCT01296555|594219177|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504618|NCT01296555|594219178|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504619|NCT01296555|594219179|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504620|NCT01296555|594219180|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504621|NCT01296555|594219181|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504622|NCT01296555|594219182|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504623|NCT01296555|594219183|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504624|NCT01296555|594219184|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504625|NCT01296555|594219185|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504626|NCT01296555|594219186|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504627|NCT01296555|594219187|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504628|NCT01296555|594219188|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
164504629|NCT01296555|594219189|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504630|NCT01296555|594219190|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504631|NCT01296555|594219191|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504632|NCT01296555|594219192|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504633|NCT01296555|594219193|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504634|NCT01296555|594219194|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504635|NCT01296555|594219195|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504636|NCT01296555|594219196|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504637|NCT01296555|594219197|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164504638|NCT01296555|594219169|FG000|Overall Study|Death|0|||
164504639|NCT01296555|594219170|FG001|Overall Study|Death|0|||
164504640|NCT01296555|594219171|FG002|Overall Study|Death|0|||
164504641|NCT01296555|594219172|FG003|Overall Study|Death|2|||
164504642|NCT01296555|594219173|FG004|Overall Study|Death|1|||
164504643|NCT01296555|594219174|FG005|Overall Study|Death|0|||
164504644|NCT01296555|594219175|FG006|Overall Study|Death|2|||
164504645|NCT01296555|594219176|FG007|Overall Study|Death|0|||
164504646|NCT01296555|594219177|FG008|Overall Study|Death|0|||
164504647|NCT01296555|594219178|FG009|Overall Study|Death|1|||
164504648|NCT01296555|594219179|FG010|Overall Study|Death|0|||
164504649|NCT01296555|594219180|FG011|Overall Study|Death|1|||
164504650|NCT01296555|594219181|FG012|Overall Study|Death|0|||
164504651|NCT01296555|594219182|FG013|Overall Study|Death|2|||
164504652|NCT01296555|594219183|FG014|Overall Study|Death|27|||
164504653|NCT01296555|594219184|FG015|Overall Study|Death|15|||
164504654|NCT01296555|594219185|FG016|Overall Study|Death|11|||
164504655|NCT01296555|594219186|FG017|Overall Study|Death|11|||
164504656|NCT01296555|594219187|FG018|Overall Study|Death|17|||
164504657|NCT01296555|594219188|FG019|Overall Study|Death|12|||
164504658|NCT01296555|594219189|FG020|Overall Study|Death|13|||
164504659|NCT01296555|594219190|FG021|Overall Study|Death|12|||
164504660|NCT01296555|594219191|FG022|Overall Study|Death|12|||
164504661|NCT01296555|594219192|FG023|Overall Study|Death|13|||
164504662|NCT01296555|594219193|FG024|Overall Study|Death|7|||
164504663|NCT01296555|594219194|FG025|Overall Study|Death|7|||
164504664|NCT01296555|594219195|FG026|Overall Study|Death|35|||
164504665|NCT01296555|594219196|FG027|Overall Study|Death|92|||
164504666|NCT01296555|594219197|FG028|Overall Study|Death|44|||
164504667|NCT01296555|594219169|FG000|Overall Study|Lost to Follow-up|0|||
164504668|NCT01296555|594219170|FG001|Overall Study|Lost to Follow-up|0|||
164504669|NCT01296555|594219171|FG002|Overall Study|Lost to Follow-up|0|||
164504670|NCT01296555|594219172|FG003|Overall Study|Lost to Follow-up|0|||
164504671|NCT01296555|594219173|FG004|Overall Study|Lost to Follow-up|0|||
164504672|NCT01296555|594219174|FG005|Overall Study|Lost to Follow-up|0|||
164504673|NCT01296555|594219175|FG006|Overall Study|Lost to Follow-up|0|||
164504674|NCT01296555|594219176|FG007|Overall Study|Lost to Follow-up|0|||
164504675|NCT01296555|594219177|FG008|Overall Study|Lost to Follow-up|0|||
164606924|NCT00006604|594581082|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
164606925|NCT00006604|594581083|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
164606926|NCT00006604|594581084|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
164606927|NCT00006604|594581085|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
164606928|NCT00006604|594581086|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
164504676|NCT01296555|594219178|FG009|Overall Study|Lost to Follow-up|0|||
164504677|NCT01296555|594219179|FG010|Overall Study|Lost to Follow-up|0|||
164504678|NCT01296555|594219180|FG011|Overall Study|Lost to Follow-up|0|||
164504679|NCT01296555|594219181|FG012|Overall Study|Lost to Follow-up|0|||
164504680|NCT01296555|594219182|FG013|Overall Study|Lost to Follow-up|0|||
164504681|NCT01296555|594219183|FG014|Overall Study|Lost to Follow-up|2|||
164504682|NCT01296555|594219184|FG015|Overall Study|Lost to Follow-up|1|||
164504683|NCT01296555|594219185|FG016|Overall Study|Lost to Follow-up|0|||
164504684|NCT01296555|594219186|FG017|Overall Study|Lost to Follow-up|2|||
164504685|NCT01296555|594219187|FG018|Overall Study|Lost to Follow-up|0|||
164504686|NCT01296555|594219188|FG019|Overall Study|Lost to Follow-up|2|||
164504687|NCT01296555|594219189|FG020|Overall Study|Lost to Follow-up|3|||
164504688|NCT01296555|594219190|FG021|Overall Study|Lost to Follow-up|2|||
164504689|NCT01296555|594219191|FG022|Overall Study|Lost to Follow-up|0|||
164504690|NCT01296555|594219192|FG023|Overall Study|Lost to Follow-up|0|||
164504691|NCT01296555|594219193|FG024|Overall Study|Lost to Follow-up|0|||
164504692|NCT01296555|594219194|FG025|Overall Study|Lost to Follow-up|0|||
164504693|NCT01296555|594219195|FG026|Overall Study|Lost to Follow-up|3|||
164504694|NCT01296555|594219196|FG027|Overall Study|Lost to Follow-up|13|||
164504695|NCT01296555|594219197|FG028|Overall Study|Lost to Follow-up|5|||
164504696|NCT01296555|594219169|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164504697|NCT01296555|594219170|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164504698|NCT01296555|594219171|FG002|Overall Study|Non-Compliance With Study Drug|0|||
164504699|NCT01296555|594219172|FG003|Overall Study|Non-Compliance With Study Drug|0|||
164504700|NCT01296555|594219173|FG004|Overall Study|Non-Compliance With Study Drug|0|||
164504701|NCT01296555|594219174|FG005|Overall Study|Non-Compliance With Study Drug|0|||
164504702|NCT01296555|594219175|FG006|Overall Study|Non-Compliance With Study Drug|0|||
164504703|NCT01296555|594219176|FG007|Overall Study|Non-Compliance With Study Drug|1|||
164504704|NCT01296555|594219177|FG008|Overall Study|Non-Compliance With Study Drug|0|||
164504705|NCT01296555|594219178|FG009|Overall Study|Non-Compliance With Study Drug|0|||
164504706|NCT01296555|594219179|FG010|Overall Study|Non-Compliance With Study Drug|0|||
164504707|NCT01296555|594219180|FG011|Overall Study|Non-Compliance With Study Drug|0|||
164504708|NCT01296555|594219181|FG012|Overall Study|Non-Compliance With Study Drug|0|||
164504709|NCT01296555|594219182|FG013|Overall Study|Non-Compliance With Study Drug|0|||
164504710|NCT01296555|594219183|FG014|Overall Study|Non-Compliance With Study Drug|0|||
164504711|NCT01296555|594219184|FG015|Overall Study|Non-Compliance With Study Drug|0|||
164504712|NCT01296555|594219185|FG016|Overall Study|Non-Compliance With Study Drug|0|||
164504713|NCT01296555|594219186|FG017|Overall Study|Non-Compliance With Study Drug|0|||
164504714|NCT01296555|594219187|FG018|Overall Study|Non-Compliance With Study Drug|0|||
164504715|NCT01296555|594219188|FG019|Overall Study|Non-Compliance With Study Drug|0|||
164504716|NCT01296555|594219189|FG020|Overall Study|Non-Compliance With Study Drug|0|||
164504717|NCT01296555|594219190|FG021|Overall Study|Non-Compliance With Study Drug|0|||
164504718|NCT01296555|594219191|FG022|Overall Study|Non-Compliance With Study Drug|0|||
164504719|NCT01296555|594219192|FG023|Overall Study|Non-Compliance With Study Drug|0|||
164504720|NCT01296555|594219193|FG024|Overall Study|Non-Compliance With Study Drug|0|||
164504721|NCT01296555|594219194|FG025|Overall Study|Non-Compliance With Study Drug|0|||
164504722|NCT01296555|594219195|FG026|Overall Study|Non-Compliance With Study Drug|0|||
164504723|NCT01296555|594219196|FG027|Overall Study|Non-Compliance With Study Drug|0|||
164504724|NCT01296555|594219197|FG028|Overall Study|Non-Compliance With Study Drug|0|||
164504725|NCT01296555|594219169|FG000|Overall Study|Withdrawal by Subject|0|||
164504726|NCT01296555|594219170|FG001|Overall Study|Withdrawal by Subject|0|||
164504727|NCT01296555|594219171|FG002|Overall Study|Withdrawal by Subject|0|||
164504728|NCT01296555|594219172|FG003|Overall Study|Withdrawal by Subject|0|||
164504729|NCT01296555|594219173|FG004|Overall Study|Withdrawal by Subject|1|||
164504730|NCT01296555|594219174|FG005|Overall Study|Withdrawal by Subject|0|||
164504731|NCT01296555|594219175|FG006|Overall Study|Withdrawal by Subject|1|||
164504732|NCT01296555|594219176|FG007|Overall Study|Withdrawal by Subject|0|||
164504733|NCT01296555|594219177|FG008|Overall Study|Withdrawal by Subject|0|||
164504734|NCT01296555|594219178|FG009|Overall Study|Withdrawal by Subject|0|||
164504735|NCT01296555|594219179|FG010|Overall Study|Withdrawal by Subject|1|||
164504736|NCT01296555|594219180|FG011|Overall Study|Withdrawal by Subject|1|||
164504737|NCT01296555|594219181|FG012|Overall Study|Withdrawal by Subject|0|||
164504738|NCT01296555|594219182|FG013|Overall Study|Withdrawal by Subject|0|||
164504739|NCT01296555|594219183|FG014|Overall Study|Withdrawal by Subject|3|||
164504740|NCT01296555|594219184|FG015|Overall Study|Withdrawal by Subject|0|||
164504741|NCT01296555|594219185|FG016|Overall Study|Withdrawal by Subject|2|||
164504742|NCT01296555|594219186|FG017|Overall Study|Withdrawal by Subject|1|||
164504743|NCT01296555|594219187|FG018|Overall Study|Withdrawal by Subject|0|||
164504744|NCT01296555|594219188|FG019|Overall Study|Withdrawal by Subject|1|||
164504745|NCT01296555|594219189|FG020|Overall Study|Withdrawal by Subject|1|||
164504746|NCT01296555|594219190|FG021|Overall Study|Withdrawal by Subject|1|||
164504747|NCT01296555|594219191|FG022|Overall Study|Withdrawal by Subject|3|||
164504748|NCT01296555|594219192|FG023|Overall Study|Withdrawal by Subject|0|||
164504749|NCT01296555|594219193|FG024|Overall Study|Withdrawal by Subject|0|||
164504750|NCT01296555|594219194|FG025|Overall Study|Withdrawal by Subject|0|||
164504751|NCT01296555|594219195|FG026|Overall Study|Withdrawal by Subject|8|||
164504752|NCT01296555|594219196|FG027|Overall Study|Withdrawal by Subject|4|||
164504753|NCT01296555|594219197|FG028|Overall Study|Withdrawal by Subject|2|||
164504754|NCT00992992|594219198|FG000|Overall Study|Lost to Follow-up|3|||
164504755|NCT00992992|594219198|FG000|Overall Study|Death|16|||
164504756|NCT00992992|594219198|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
164504757|NCT00992992|594219198|FG000|Overall Study|Sponsor Closed the Study|4|||
164504758|NCT02250534|594219201|FG000|Overall Study|Lost to Follow-up|18|||
164504759|NCT02250534|594219202|FG001|Overall Study|Lost to Follow-up|28|||
164504760|NCT02250534|594219203|FG002|Overall Study|Lost to Follow-up|33|||
164504761|NCT02250534|594219201|FG000|Overall Study|Personal reasons|7|||
164504762|NCT02250534|594219202|FG001|Overall Study|Personal reasons|8|||
164504763|NCT02250534|594219203|FG002|Overall Study|Personal reasons|14|||
164504764|NCT02250534|594219201|FG000|Overall Study|Adverse Event|6|||
164504765|NCT02250534|594219202|FG001|Overall Study|Adverse Event|3|||
164504766|NCT02250534|594219203|FG002|Overall Study|Adverse Event|8|||
164504767|NCT02250534|594219201|FG000|Overall Study|incarcerated|2|||
164504768|NCT02250534|594219202|FG001|Overall Study|incarcerated|1|||
164504769|NCT02250534|594219203|FG002|Overall Study|incarcerated|2|||
164504770|NCT02250534|594219201|FG000|Overall Study|Withdrawal by Subject|0|||
164504771|NCT02250534|594219202|FG001|Overall Study|Withdrawal by Subject|1|||
164504772|NCT02250534|594219203|FG002|Overall Study|Withdrawal by Subject|2|||
164504773|NCT02250534|594219201|FG000|Overall Study|Death|0|||
164504774|NCT02250534|594219202|FG001|Overall Study|Death|1|||
164504775|NCT02250534|594219203|FG002|Overall Study|Death|1|||
164504776|NCT02250534|594219201|FG000|Overall Study|Physician Decision|1|||
164504777|NCT02250534|594219202|FG001|Overall Study|Physician Decision|3|||
164504778|NCT02250534|594219203|FG002|Overall Study|Physician Decision|1|||
164504779|NCT02250534|594219201|FG000|Overall Study|Protocol Violation|1|||
164504780|NCT02250534|594219202|FG001|Overall Study|Protocol Violation|0|||
164504781|NCT02250534|594219203|FG002|Overall Study|Protocol Violation|1|||
164504782|NCT02250534|594219201|FG000|Overall Study|Reason unknown|1|||
164504783|NCT02250534|594219202|FG001|Overall Study|Reason unknown|0|||
164504784|NCT02250534|594219203|FG002|Overall Study|Reason unknown|0|||
164504785|NCT01628692|594219206|FG000|Overall Study|Lack of Efficacy|4|||
164504786|NCT01628692|594219207|FG001|Overall Study|Lack of Efficacy|4|||
164504787|NCT01628692|594219208|FG002|Overall Study|Lack of Efficacy|5|||
164504788|NCT01628692|594219209|FG003|Overall Study|Lack of Efficacy|1|||
164504789|NCT01628692|594219210|FG004|Overall Study|Lack of Efficacy|4|||
164504790|NCT01628692|594219211|FG005|Overall Study|Lack of Efficacy|7|||
164504791|NCT01628692|594219206|FG000|Overall Study|Adverse Event|2|||
164504792|NCT01628692|594219207|FG001|Overall Study|Adverse Event|0|||
164504793|NCT01628692|594219208|FG002|Overall Study|Adverse Event|2|||
164504794|NCT01628692|594219209|FG003|Overall Study|Adverse Event|0|||
164504795|NCT01628692|594219210|FG004|Overall Study|Adverse Event|0|||
164504796|NCT01628692|594219211|FG005|Overall Study|Adverse Event|0|||
164504797|NCT01628692|594219206|FG000|Overall Study|Withdrawal by Subject|0|||
164504798|NCT01628692|594219207|FG001|Overall Study|Withdrawal by Subject|1|||
164504799|NCT01628692|594219208|FG002|Overall Study|Withdrawal by Subject|1|||
164504800|NCT01628692|594219209|FG003|Overall Study|Withdrawal by Subject|0|||
164504801|NCT01628692|594219210|FG004|Overall Study|Withdrawal by Subject|0|||
164504802|NCT01628692|594219211|FG005|Overall Study|Withdrawal by Subject|0|||
164504803|NCT01628692|594219206|FG000|Overall Study|Death|0|||
164504804|NCT01628692|594219207|FG001|Overall Study|Death|1|||
164504805|NCT01628692|594219208|FG002|Overall Study|Death|0|||
164504806|NCT01628692|594219209|FG003|Overall Study|Death|0|||
164504807|NCT01628692|594219210|FG004|Overall Study|Death|0|||
164504808|NCT01628692|594219211|FG005|Overall Study|Death|0|||
164504809|NCT01628692|594219206|FG000|Overall Study|Poor compliance/noncompliance|1|||
164504810|NCT01628692|594219207|FG001|Overall Study|Poor compliance/noncompliance|0|||
164504811|NCT01628692|594219208|FG002|Overall Study|Poor compliance/noncompliance|0|||
164504812|NCT01628692|594219209|FG003|Overall Study|Poor compliance/noncompliance|0|||
164504813|NCT01628692|594219210|FG004|Overall Study|Poor compliance/noncompliance|0|||
164504814|NCT01628692|594219211|FG005|Overall Study|Poor compliance/noncompliance|0|||
164504815|NCT01628692|594219206|FG000|Overall Study|Administrative reason by sponsor|0|||
164504816|NCT01628692|594219207|FG001|Overall Study|Administrative reason by sponsor|0|||
164504817|NCT01628692|594219208|FG002|Overall Study|Administrative reason by sponsor|0|||
164504818|NCT01628692|594219209|FG003|Overall Study|Administrative reason by sponsor|0|||
164504819|NCT01628692|594219210|FG004|Overall Study|Administrative reason by sponsor|0|||
164504820|NCT01628692|594219211|FG005|Overall Study|Administrative reason by sponsor|1|||
164504821|NCT01628692|594219206|FG000|Overall Study|Completed 12 Week only|0|||
164504822|NCT01628692|594219207|FG001|Overall Study|Completed 12 Week only|0|||
164504823|NCT01628692|594219208|FG002|Overall Study|Completed 12 Week only|0|||
164504824|NCT01628692|594219209|FG003|Overall Study|Completed 12 Week only|0|||
164504825|NCT01628692|594219210|FG004|Overall Study|Completed 12 Week only|0|||
164504826|NCT01628692|594219211|FG005|Overall Study|Completed 12 Week only|1|||
164504827|NCT01253447|594219212|FG000|Overall Study|Adverse Event|2|||
164504828|NCT00857233|594219213|FG000|Overall Study|Adverse Event|24|||
164504829|NCT00857233|594219213|FG000|Overall Study|Lack of Efficacy|1|||
164504830|NCT00857233|594219213|FG000|Overall Study|Non-compliance|1|||
164504831|NCT00857233|594219213|FG000|Overall Study|Withdrawal of Consent|9|||
164504832|NCT00857233|594219213|FG000|Overall Study|Lost to Follow-up|4|||
164504833|NCT00857233|594219213|FG000|Overall Study|Nursing Home Placement|14|||
164504834|NCT00857233|594219213|FG000|Overall Study|Other Reasons|2|||
164504835|NCT01560871|594219214|FG000|Overall Study|transportation issues|2|||
164504836|NCT01560871|594219215|FG001|Overall Study|transportation issues|1|||
164504837|NCT01560871|594219214|FG000|Overall Study|relocation|1|||
164504838|NCT01560871|594219215|FG001|Overall Study|relocation|0|||
164504839|NCT01560871|594219214|FG000|Overall Study|readmission to a hospital|2|||
164504840|NCT01560871|594219215|FG001|Overall Study|readmission to a hospital|1|||
164504841|NCT01560871|594219214|FG000|Overall Study|Lost to Follow-up|1|||
164504842|NCT01560871|594219215|FG001|Overall Study|Lost to Follow-up|0|||
164504843|NCT00572533|594219218|FG000|Overall Study|Death|4|||
164504844|NCT00572533|594219219|FG001|Overall Study|Death|1|||
164504845|NCT00572533|594219218|FG000|Overall Study|Received Kidney Transplant|2|||
164504846|NCT00572533|594219219|FG001|Overall Study|Received Kidney Transplant|1|||
164504847|NCT00572533|594219218|FG000|Overall Study|Social Issues|1|||
164504848|NCT00572533|594219219|FG001|Overall Study|Social Issues|0|||
164504849|NCT00572533|594219218|FG000|Overall Study|Transfer out of Facility|0|||
164504850|NCT00572533|594219219|FG001|Overall Study|Transfer out of Facility|1|||
164504851|NCT00003477|594219222|FG000|Overall Study|Not evalauable|4|||
164504852|NCT00798304|594219224|FG000|Overall Study|Adverse Event|0|||
164504853|NCT00798304|594219225|FG001|Overall Study|Adverse Event|1|||
164504854|NCT00798304|594219226|FG002|Overall Study|Adverse Event|1|||
164504855|NCT00798304|594219224|FG000|Overall Study|Discontinuation by Sponsor|14|||
164504856|NCT00798304|594219225|FG001|Overall Study|Discontinuation by Sponsor|21|||
164504857|NCT00798304|594219226|FG002|Overall Study|Discontinuation by Sponsor|9|||
164504858|NCT02031536|594219227|FG000|Overall Study|ineligible|1|||
164504859|NCT02031536|594219228|FG001|Overall Study|ineligible|0|||
164504860|NCT04211389|594219229|FG000|Overall Study|Adverse Event|1|||
164504861|NCT04211389|594219230|FG001|Overall Study|Adverse Event|2|||
164504862|NCT04211389|594219229|FG000|Overall Study|Lost to Follow-up|15|||
164504863|NCT04211389|594219230|FG001|Overall Study|Lost to Follow-up|7|||
164504864|NCT04211389|594219229|FG000|Overall Study|Protocol Violation|0|||
164504865|NCT04211389|594219230|FG001|Overall Study|Protocol Violation|1|||
164504866|NCT04211389|594219229|FG000|Overall Study|Withdrawal by Subject|10|||
164504867|NCT04211389|594219230|FG001|Overall Study|Withdrawal by Subject|11|||
164504868|NCT04206085|594219236|FG000|Overall Study|Lost to Follow-up|0|||
164504869|NCT04206085|594219237|FG001|Overall Study|Lost to Follow-up|1|||
164504870|NCT04206085|594219238|FG002|Overall Study|Lost to Follow-up|0|||
164504871|NCT04206085|594219236|FG000|Overall Study|Lost to Follow-up|0|||
164504872|NCT04206085|594219237|FG001|Overall Study|Lost to Follow-up|0|||
164504873|NCT04206085|594219238|FG002|Overall Study|Lost to Follow-up|1|||
164504874|NCT00725543|594219242|FG000|Overall Study|Adverse Event|10|||
164504875|NCT00725543|594219242|FG000|Overall Study|Lack of Efficacy|3|||
164504876|NCT00725543|594219242|FG000|Overall Study|Withdrawal by Subject|10|||
164504877|NCT00725543|594219242|FG000|Overall Study|Physician Decision|5|||
164504878|NCT00725543|594219242|FG000|Overall Study|Lost to Follow-up|4|||
164504879|NCT00725543|594219242|FG000|Overall Study|Non-compliance|2|||
164504880|NCT00725543|594219242|FG000|Overall Study|Other|119|||
164504881|NCT02168478|594219249|FG000|Overall Study|Withdrawal by Subject|1|||
164504882|NCT02168478|594219249|FG000|Overall Study|Did Not Consent to Participation|2|||
164504883|NCT02168478|594219249|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
164504884|NCT01062971|594219250|FG000|Overall Study|Protocol Violation|1|||
164504885|NCT01062971|594219251|FG001|Overall Study|Protocol Violation|3|||
164504886|NCT01062971|594219250|FG000|Overall Study|Lost to Follow-up|3|||
164504887|NCT01062971|594219251|FG001|Overall Study|Lost to Follow-up|4|||
164504888|NCT01530087|594219252|FG000|Overall Study|Physician Decision|2|||
164504889|NCT05523219|594219253|FG000|Overall Study|Wrong inclusion|1|||
164504890|NCT05523219|594219253|FG000|Overall Study|Lost to Follow-up|7|||
164504891|NCT02760485|594219262|FG000|Phase 1|Death|3|||
164504892|NCT02760485|594219263|FG001|Phase 1|Death|6|||
164504893|NCT02760485|594219264|FG002|Phase 1|Death|0|||
164504894|NCT02760485|594219262|FG000|Phase 1|Withdrawal by Subject|2|||
164504895|NCT02760485|594219263|FG001|Phase 1|Withdrawal by Subject|0|||
164504896|NCT02760485|594219264|FG002|Phase 1|Withdrawal by Subject|0|||
164504897|NCT02760485|594219262|FG000|Phase 1|Progressive Disease|1|||
164504898|NCT02760485|594219263|FG001|Phase 1|Progressive Disease|0|||
164504899|NCT02760485|594219264|FG002|Phase 1|Progressive Disease|0|||
164504900|NCT02760485|594219262|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
164504901|NCT02760485|594219263|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
164504902|NCT02760485|594219264|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
164504903|NCT02760485|594219262|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
164504904|NCT02760485|594219263|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
164504905|NCT02760485|594219264|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
164504906|NCT02760485|594219262|FG000|Phase 2|Death|0|||
164504907|NCT02760485|594219263|FG001|Phase 2|Death|0|||
164504908|NCT02760485|594219264|FG002|Phase 2|Death|12|||
164504909|NCT02760485|594219262|FG000|Phase 2|Withdrawal by Subject|0|||
164504910|NCT02760485|594219263|FG001|Phase 2|Withdrawal by Subject|0|||
164504911|NCT02760485|594219264|FG002|Phase 2|Withdrawal by Subject|3|||
164504912|NCT02760485|594219262|FG000|Phase 2|Progressive Disease|0|||
164504913|NCT02760485|594219263|FG001|Phase 2|Progressive Disease|0|||
164504914|NCT02760485|594219264|FG002|Phase 2|Progressive Disease|1|||
164504915|NCT02760485|594219262|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
164504916|NCT02760485|594219263|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
164504917|NCT02760485|594219264|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
164504918|NCT03845023|594219265|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
164504919|NCT03845023|594219266|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
164504920|NCT03845023|594219267|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
164504921|NCT03845023|594219268|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
164504922|NCT03845023|594219265|FG000|Follow-Up (14 Days)|Adverse Event|0|||
164504923|NCT03845023|594219266|FG001|Follow-Up (14 Days)|Adverse Event|0|||
164504924|NCT03845023|594219267|FG002|Follow-Up (14 Days)|Adverse Event|1|||
164504925|NCT03845023|594219268|FG003|Follow-Up (14 Days)|Adverse Event|1|||
164504926|NCT03738397|594219271|FG000|Overall Study|Adverse Event|3|||
164504927|NCT03738397|594219272|FG001|Overall Study|Adverse Event|7|||
164504928|NCT03738397|594219271|FG000|Overall Study|Withdrawal by Subject|8|||
164504929|NCT03738397|594219272|FG001|Overall Study|Withdrawal by Subject|11|||
164504930|NCT03738397|594219271|FG000|Overall Study|Lost to Follow-up|7|||
164504931|NCT03738397|594219272|FG001|Overall Study|Lost to Follow-up|5|||
164504932|NCT03738397|594219271|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
164504933|NCT03738397|594219272|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
164504934|NCT03738397|594219271|FG000|Overall Study|Other|4|||
164504935|NCT03738397|594219272|FG001|Overall Study|Other|6|||
164504936|NCT01087814|594219273|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
164504937|NCT01087814|594219274|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
164504938|NCT01087814|594219273|FG000|Second Intervention (5 Days)|Physician Decision|1|||
164504939|NCT01087814|594219274|FG001|Second Intervention (5 Days)|Physician Decision|0|||
164504940|NCT00661713|594219275|FG000|Overall Study|Death|1|||
164504941|NCT00661713|594219276|FG001|Overall Study|Death|0|||
164504942|NCT00661713|594219277|FG002|Overall Study|Death|0|||
164504943|NCT00661713|594219278|FG003|Overall Study|Death|0|||
164504944|NCT00661713|594219279|FG004|Overall Study|Death|1|||
164504945|NCT00661713|594219280|FG005|Overall Study|Death|0|||
164504946|NCT00661713|594219281|FG006|Overall Study|Death|0|||
164504947|NCT00661713|594219282|FG007|Overall Study|Death|0|||
164504948|NCT00661713|594219275|FG000|Overall Study|Unable to Classify|1|||
164504949|NCT00661713|594219276|FG001|Overall Study|Unable to Classify|0|||
164504950|NCT00661713|594219277|FG002|Overall Study|Unable to Classify|0|||
164504951|NCT00661713|594219278|FG003|Overall Study|Unable to Classify|0|||
164504952|NCT00661713|594219279|FG004|Overall Study|Unable to Classify|0|||
164504953|NCT00661713|594219280|FG005|Overall Study|Unable to Classify|0|||
164504954|NCT00661713|594219281|FG006|Overall Study|Unable to Classify|0|||
164504955|NCT00661713|594219282|FG007|Overall Study|Unable to Classify|0|||
164504956|NCT00661713|594219275|FG000|Overall Study|Protocol Violation|1|||
164504957|NCT00661713|594219276|FG001|Overall Study|Protocol Violation|6|||
164504958|NCT00661713|594219277|FG002|Overall Study|Protocol Violation|3|||
164504959|NCT00661713|594219278|FG003|Overall Study|Protocol Violation|3|||
164504960|NCT00661713|594219279|FG004|Overall Study|Protocol Violation|0|||
164504961|NCT00661713|594219280|FG005|Overall Study|Protocol Violation|2|||
164504962|NCT00661713|594219281|FG006|Overall Study|Protocol Violation|2|||
164504963|NCT00661713|594219282|FG007|Overall Study|Protocol Violation|1|||
164504964|NCT00661713|594219275|FG000|Overall Study|Withdrawal by Subject|11|||
164504965|NCT00661713|594219276|FG001|Overall Study|Withdrawal by Subject|25|||
164504966|NCT00661713|594219277|FG002|Overall Study|Withdrawal by Subject|12|||
164504967|NCT00661713|594219278|FG003|Overall Study|Withdrawal by Subject|21|||
164504968|NCT00661713|594219279|FG004|Overall Study|Withdrawal by Subject|12|||
164504969|NCT00661713|594219280|FG005|Overall Study|Withdrawal by Subject|26|||
164504970|NCT00661713|594219281|FG006|Overall Study|Withdrawal by Subject|45|||
164504971|NCT00661713|594219282|FG007|Overall Study|Withdrawal by Subject|9|||
164504972|NCT00661713|594219275|FG000|Overall Study|Lost to Follow-up|2|||
164504973|NCT00661713|594219276|FG001|Overall Study|Lost to Follow-up|7|||
164504974|NCT00661713|594219277|FG002|Overall Study|Lost to Follow-up|2|||
164504975|NCT00661713|594219278|FG003|Overall Study|Lost to Follow-up|2|||
164504976|NCT00661713|594219279|FG004|Overall Study|Lost to Follow-up|5|||
164504977|NCT00661713|594219280|FG005|Overall Study|Lost to Follow-up|7|||
164504978|NCT00661713|594219281|FG006|Overall Study|Lost to Follow-up|14|||
164504979|NCT00661713|594219282|FG007|Overall Study|Lost to Follow-up|1|||
164504980|NCT00661713|594219275|FG000|Overall Study|Administrative Reason|0|||
164504981|NCT00661713|594219276|FG001|Overall Study|Administrative Reason|1|||
164504982|NCT00661713|594219277|FG002|Overall Study|Administrative Reason|0|||
164504983|NCT00661713|594219278|FG003|Overall Study|Administrative Reason|2|||
164504984|NCT00661713|594219279|FG004|Overall Study|Administrative Reason|2|||
164504985|NCT00661713|594219280|FG005|Overall Study|Administrative Reason|2|||
164504986|NCT00661713|594219281|FG006|Overall Study|Administrative Reason|1|||
164504987|NCT00661713|594219282|FG007|Overall Study|Administrative Reason|0|||
164504988|NCT00661713|594219275|FG000|Overall Study|Adverse Event|0|||
164504989|NCT00661713|594219276|FG001|Overall Study|Adverse Event|0|||
164504990|NCT00661713|594219277|FG002|Overall Study|Adverse Event|0|||
164504991|NCT00661713|594219278|FG003|Overall Study|Adverse Event|0|||
164504992|NCT00661713|594219279|FG004|Overall Study|Adverse Event|0|||
164504993|NCT00661713|594219280|FG005|Overall Study|Adverse Event|0|||
164504994|NCT00661713|594219281|FG006|Overall Study|Adverse Event|1|||
164504995|NCT00661713|594219282|FG007|Overall Study|Adverse Event|0|||
164504996|NCT00661713|594219275|FG000|Overall Study|Inappropriate Enrollment|0|||
164504997|NCT00661713|594219276|FG001|Overall Study|Inappropriate Enrollment|0|||
164504998|NCT00661713|594219277|FG002|Overall Study|Inappropriate Enrollment|0|||
164504999|NCT00661713|594219278|FG003|Overall Study|Inappropriate Enrollment|0|||
164505000|NCT00661713|594219279|FG004|Overall Study|Inappropriate Enrollment|0|||
164505001|NCT00661713|594219280|FG005|Overall Study|Inappropriate Enrollment|0|||
164505002|NCT00661713|594219281|FG006|Overall Study|Inappropriate Enrollment|1|||
164505003|NCT00661713|594219282|FG007|Overall Study|Inappropriate Enrollment|0|||
164505004|NCT02353871|594219283|FG000|Overall Study|Protocol deviation|0|||
164505005|NCT02353871|594219284|FG001|Overall Study|Protocol deviation|1|||
164505006|NCT02353871|594219283|FG000|Overall Study|Consent withdrawn|1|||
164505007|NCT02353871|594219284|FG001|Overall Study|Consent withdrawn|8|||
164505008|NCT02353871|594219283|FG000|Overall Study|Lost to Follow-up|2|||
164505009|NCT02353871|594219284|FG001|Overall Study|Lost to Follow-up|0|||
164505010|NCT05314374|594219285|FG000|Overall Study|Adverse Event|2|||
164505011|NCT05314374|594219286|FG001|Overall Study|Adverse Event|2|||
164505012|NCT02658175|594219287|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
164505013|NCT02658175|594219288|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
164505014|NCT02658175|594219289|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
164505015|NCT02658175|594219287|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
164505016|NCT02658175|594219288|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
164505017|NCT02658175|594219289|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
164505018|NCT02658175|594219287|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
164505019|NCT02658175|594219288|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
164505020|NCT02658175|594219289|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
164505021|NCT02658175|594219287|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
164505022|NCT02658175|594219288|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
164505023|NCT02658175|594219289|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
164505024|NCT02658175|594219287|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
164505025|NCT02658175|594219288|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
164505026|NCT02658175|594219289|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
164505027|NCT02658175|594219287|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
164505028|NCT02658175|594219288|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
164505029|NCT02658175|594219289|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
164505030|NCT02658175|594219287|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
164505031|NCT02658175|594219288|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
164505032|NCT02658175|594219289|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
164505033|NCT02658175|594219287|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
164505034|NCT02658175|594219288|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
164505035|NCT02658175|594219289|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
164505036|NCT02658175|594219287|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
164505037|NCT02658175|594219288|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
164505038|NCT02658175|594219289|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
164505039|NCT02658175|594219287|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
164505040|NCT02658175|594219288|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
164505041|NCT02658175|594219289|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
164505042|NCT02554383|594219293|FG000|Overall Study|Ineligible|3|||
164505043|NCT02554383|594219294|FG001|Overall Study|Ineligible|2|||
164505044|NCT02554383|594219293|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
164505045|NCT02554383|594219294|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
164505046|NCT02554383|594219293|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
164505047|NCT02554383|594219294|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
164505048|NCT02554383|594219293|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
164505049|NCT02554383|594219294|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
164505050|NCT02918292|594219297|FG000|Study Enrollment Prior to Transplant|Death|1|||
164505051|NCT02918292|594219297|FG000|Study Follow up After Transplant|Death|6|||
164505052|NCT03783689|594219299|FG000|Overall Study|Adverse Event|2|||
164505053|NCT03783689|594219300|FG001|Overall Study|Adverse Event|0|||
164505054|NCT03783689|594219299|FG000|Overall Study|Lost to Follow-up|2|||
164505055|NCT03783689|594219300|FG001|Overall Study|Lost to Follow-up|1|||
164505056|NCT03783689|594219299|FG000|Overall Study|Physician Decision|2|||
164505057|NCT03783689|594219300|FG001|Overall Study|Physician Decision|1|||
164505058|NCT03783689|594219299|FG000|Overall Study|Withdrawal by Subject|3|||
164505059|NCT03783689|594219300|FG001|Overall Study|Withdrawal by Subject|3|||
164505060|NCT02165826|594219302|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
164505061|NCT02165826|594219303|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
164505062|NCT02165826|594219304|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
164505063|NCT02165826|594219302|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
164505064|NCT02165826|594219303|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
164505065|NCT02165826|594219304|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
164505066|NCT02165826|594219302|FG000|Main Treatment Period|Lost to Follow-up|4|||
164505067|NCT02165826|594219303|FG001|Main Treatment Period|Lost to Follow-up|2|||
164505068|NCT02165826|594219304|FG002|Main Treatment Period|Lost to Follow-up|1|||
164505069|NCT02165826|594219302|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
164505070|NCT02165826|594219303|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
164505071|NCT02165826|594219304|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
164505072|NCT02165826|594219302|FG000|Main Treatment Period|Lack of Efficacy|2|||
164505073|NCT02165826|594219303|FG001|Main Treatment Period|Lack of Efficacy|0|||
164505074|NCT02165826|594219304|FG002|Main Treatment Period|Lack of Efficacy|0|||
164505075|NCT02165826|594219302|FG000|Main Treatment Period|Reason Not Specified|8|||
164505076|NCT02165826|594219303|FG001|Main Treatment Period|Reason Not Specified|5|||
164505077|NCT02165826|594219304|FG002|Main Treatment Period|Reason Not Specified|16|||
164505078|NCT02165826|594219302|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
164505079|NCT02165826|594219303|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
164505080|NCT02165826|594219304|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
164505081|NCT02165826|594219302|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
164505082|NCT02165826|594219303|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
164505083|NCT02165826|594219304|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
164505084|NCT02165826|594219302|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
164505085|NCT02165826|594219303|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
164505086|NCT02165826|594219304|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
164606929|NCT00006604|594581087|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
164606930|NCT00006604|594581088|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
164606931|NCT00006604|594581089|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
164606932|NCT00006604|594581090|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
164606933|NCT00006604|594581074|FG000|Overall Study|Lost to Follow-up|0|||
164606934|NCT00006604|594581075|FG001|Overall Study|Lost to Follow-up|0|||
164606935|NCT00006604|594581076|FG002|Overall Study|Lost to Follow-up|0|||
164606936|NCT00006604|594581077|FG003|Overall Study|Lost to Follow-up|0|||
164606937|NCT00006604|594581078|FG004|Overall Study|Lost to Follow-up|0|||
164606938|NCT00006604|594581079|FG005|Overall Study|Lost to Follow-up|0|||
164606939|NCT00006604|594581080|FG006|Overall Study|Lost to Follow-up|0|||
164606940|NCT00006604|594581081|FG007|Overall Study|Lost to Follow-up|1|||
164606941|NCT00006604|594581082|FG008|Overall Study|Lost to Follow-up|0|||
164606942|NCT00006604|594581083|FG009|Overall Study|Lost to Follow-up|2|||
164606943|NCT00006604|594581084|FG010|Overall Study|Lost to Follow-up|0|||
164606944|NCT00006604|594581085|FG011|Overall Study|Lost to Follow-up|0|||
164606945|NCT00006604|594581086|FG012|Overall Study|Lost to Follow-up|0|||
164606946|NCT00006604|594581087|FG013|Overall Study|Lost to Follow-up|0|||
164606947|NCT00006604|594581088|FG014|Overall Study|Lost to Follow-up|0|||
164606948|NCT00006604|594581089|FG015|Overall Study|Lost to Follow-up|1|||
164606949|NCT00006604|594581090|FG016|Overall Study|Lost to Follow-up|3|||
164606950|NCT00006604|594581074|FG000|Overall Study|Other Reason|0|||
164606951|NCT00006604|594581075|FG001|Overall Study|Other Reason|0|||
164606952|NCT00006604|594581076|FG002|Overall Study|Other Reason|0|||
164606953|NCT00006604|594581077|FG003|Overall Study|Other Reason|0|||
164606954|NCT00006604|594581078|FG004|Overall Study|Other Reason|0|||
164606955|NCT00006604|594581079|FG005|Overall Study|Other Reason|1|||
164606956|NCT00006604|594581080|FG006|Overall Study|Other Reason|0|||
164606957|NCT00006604|594581081|FG007|Overall Study|Other Reason|0|||
164606958|NCT00006604|594581082|FG008|Overall Study|Other Reason|0|||
164606959|NCT00006604|594581083|FG009|Overall Study|Other Reason|1|||
164606960|NCT00006604|594581084|FG010|Overall Study|Other Reason|0|||
164606961|NCT00006604|594581085|FG011|Overall Study|Other Reason|0|||
164606962|NCT00006604|594581086|FG012|Overall Study|Other Reason|0|||
164606963|NCT00006604|594581087|FG013|Overall Study|Other Reason|0|||
164606964|NCT00006604|594581088|FG014|Overall Study|Other Reason|0|||
164606965|NCT00006604|594581089|FG015|Overall Study|Other Reason|0|||
164606966|NCT00006604|594581090|FG016|Overall Study|Other Reason|0|||
164606967|NCT02431468|594581091|FG000|Overall Study|Adverse Event|2|||
164606968|NCT02431468|594581092|FG001|Overall Study|Adverse Event|4|||
164606969|NCT02431468|594581093|FG002|Overall Study|Adverse Event|5|||
164606970|NCT02431468|594581091|FG000|Overall Study|Withdrawal by Subject|4|||
164606971|NCT02431468|594581092|FG001|Overall Study|Withdrawal by Subject|12|||
164606972|NCT02431468|594581093|FG002|Overall Study|Withdrawal by Subject|2|||
164606973|NCT02431468|594581091|FG000|Overall Study|noncompliance, investigator termination,|2|||
164606974|NCT02431468|594581092|FG001|Overall Study|noncompliance, investigator termination,|2|||
164606975|NCT02431468|594581093|FG002|Overall Study|noncompliance, investigator termination,|2|||
164606976|NCT01056341|594581094|FG000|Overall Study|Treatment Intolerance|0|||
164606977|NCT01056341|594581095|FG001|Overall Study|Treatment Intolerance|2|||
164606978|NCT01056341|594581096|FG002|Overall Study|Treatment Intolerance|0|||
164606979|NCT01056341|594581097|FG003|Overall Study|Treatment Intolerance|2|||
164606980|NCT01056341|594581098|FG004|Overall Study|Treatment Intolerance|0|||
164606981|NCT01056341|594581094|FG000|Overall Study|Lack of Efficacy|32|||
164606982|NCT01056341|594581095|FG001|Overall Study|Lack of Efficacy|30|||
164606983|NCT01056341|594581096|FG002|Overall Study|Lack of Efficacy|7|||
164606984|NCT01056341|594581097|FG003|Overall Study|Lack of Efficacy|25|||
164606985|NCT01056341|594581098|FG004|Overall Study|Lack of Efficacy|9|||
164606986|NCT01056341|594581094|FG000|Overall Study|Other reasons|4|||
164606987|NCT01056341|594581095|FG001|Overall Study|Other reasons|4|||
164606988|NCT01056341|594581096|FG002|Overall Study|Other reasons|8|||
164606989|NCT01056341|594581097|FG003|Overall Study|Other reasons|9|||
164606990|NCT01056341|594581098|FG004|Overall Study|Other reasons|5|||
164606991|NCT01361919|594581099|FG000|Overall Study|technical issues|10|||
164606992|NCT01361919|594581100|FG001|Overall Study|technical issues|12|||
164606993|NCT01361919|594581101|FG002|Overall Study|technical issues|10|||
164606994|NCT03454412|594581102|FG000|Baseline Assesment|Physician Decision|12|||
164606995|NCT01167582|594581105|FG000|Overall Study|Lost to Follow-up|0|||
164606996|NCT01167582|594581106|FG001|Overall Study|Lost to Follow-up|1|||
164606997|NCT02007954|594581112|FG000|Overall Study|Received liver transplant|3|||
164606998|NCT02007954|594581112|FG000|Overall Study|Switch in treatment modality|2|||
164606999|NCT02007954|594581112|FG000|Overall Study|Disease progression and unrelated AE|1|||
164607000|NCT02007954|594581112|FG000|Overall Study|Death|1|||
164607001|NCT00656084|594583409|FG000|Overall Study|Adverse Event|4|||
164607002|NCT00656084|594583409|FG000|Overall Study|Withdrawal by Subject|1|||
164607003|NCT00656084|594583409|FG000|Overall Study|Patient Request|1|||
164505087|NCT02165826|594219302|FG000|Down-Titration Period|Reason Not Specified|1|||
164505088|NCT02165826|594219303|FG001|Down-Titration Period|Reason Not Specified|0|||
164505089|NCT02165826|594219304|FG002|Down-Titration Period|Reason Not Specified|2|||
164505090|NCT02392104|594219305|FG000|Overall Study|discontinuation of warfarin|3|||
164505091|NCT02392104|594219305|FG000|Overall Study|bleeding event|1|||
164505092|NCT02392104|594219305|FG000|Overall Study|transferred care to another doctor|2|||
164505093|NCT02392104|594219305|FG000|Overall Study|INR goal range changed|1|||
164505094|NCT02392104|594219305|FG000|Overall Study|admitted to skilled nursing facility|3|||
164505095|NCT02392104|594219305|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
164505096|NCT02581059|594219306|FG000|Study Treatment|Disease Progression|1|||
164505097|NCT02581059|594219307|FG001|Study Treatment|Disease Progression|1|||
164505098|NCT02581059|594219306|FG000|Study Treatment|Adverse Event|2|||
164505099|NCT02581059|594219307|FG001|Study Treatment|Adverse Event|1|||
164505100|NCT02581059|594219306|FG000|Study Treatment|Death|1|||
164505101|NCT02581059|594219307|FG001|Study Treatment|Death|1|||
164505102|NCT02581059|594219306|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
164505103|NCT02581059|594219307|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
164505104|NCT02581059|594219306|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
164505105|NCT02581059|594219307|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
164505106|NCT02581059|594219306|FG000|Follow up|Death|1|||
164505107|NCT02581059|594219307|FG001|Follow up|Death|3|||
164505108|NCT02581059|594219306|FG000|Follow up|study terminated|1|||
164505109|NCT02581059|594219307|FG001|Follow up|study terminated|1|||
164505110|NCT02581059|594219306|FG000|Follow up|screen failure|0|||
164505111|NCT02581059|594219307|FG001|Follow up|screen failure|1|||
164505112|NCT02581059|594219306|FG000|Follow up|Patient started new clinical trial|1|||
164505113|NCT02581059|594219307|FG001|Follow up|Patient started new clinical trial|0|||
164505114|NCT04887506|594219308|FG000|Overall Study|Death|1|||
164505115|NCT04887506|594219309|FG001|Overall Study|Death|1|||
164505116|NCT04887506|594219308|FG000|Overall Study|Withdrawal by Subject|0|||
164505117|NCT04887506|594219309|FG001|Overall Study|Withdrawal by Subject|3|||
164505118|NCT04887506|594219308|FG000|Overall Study|Adverse Event|4|||
164505119|NCT04887506|594219309|FG001|Overall Study|Adverse Event|3|||
164505120|NCT04887506|594219308|FG000|Overall Study|Other - Not Reported|1|||
164505121|NCT04887506|594219309|FG001|Overall Study|Other - Not Reported|1|||
164505122|NCT02636608|594219313|FG000|Overall Study|Failure to Return|4|||
164505123|NCT02636608|594219313|FG000|Overall Study|Insufficient Virological Response|1|||
164505124|NCT02636608|594219313|FG000|Overall Study|Death|3|||
164505125|NCT02636608|594219313|FG000|Overall Study|Other|2|||
164505126|NCT02636608|594219313|FG000|Overall Study|Did Not Receive Treatment|1|||
164505127|NCT04590404|594219315|FG000|Overall Study|Death|16|||
164505128|NCT04590404|594219316|FG001|Overall Study|Death|17|||
164505129|NCT04590404|594219315|FG000|Overall Study|Withdrawal by Subject|7|||
164505130|NCT04590404|594219316|FG001|Overall Study|Withdrawal by Subject|2|||
164505131|NCT04913948|594219317|FG000|Overall Study|Withdrawal by Subject|2|||
164505132|NCT04913948|594219317|FG000|Overall Study|Sample processing issues|1|||
164505133|NCT04913948|594219317|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
164505134|NCT03783871|594219318|FG000|Overall Study|Withdrawal by Subject|15|||
164505135|NCT03783871|594219318|FG000|Overall Study|Death|13|||
164505136|NCT03783871|594219318|FG000|Overall Study|Lost to Follow-up|2|||
164505137|NCT05739994|594219322|FG000|Overall Study|Withdrawal by Subject|2|||
164505138|NCT05739994|594219323|FG001|Overall Study|Withdrawal by Subject|2|||
164505139|NCT05739994|594219324|FG002|Overall Study|Withdrawal by Subject|4|||
164505140|NCT05990387|594219325|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
164505141|NCT05990387|594219326|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
164505142|NCT00815919|594219327|FG000|Overall Study|Unrelated Fungal Infection|1|||
164505143|NCT00815919|594219327|FG000|Overall Study|AML Relapse|1|||
164505144|NCT00815919|594219327|FG000|Overall Study|Lack of Efficacy|2|||
164505145|NCT04750577|594219328|FG000|Overall Study|Adverse Event|2|||
164505146|NCT04750577|594219329|FG001|Overall Study|Adverse Event|10|||
164505147|NCT04750577|594219330|FG002|Overall Study|Adverse Event|8|||
164505148|NCT04750577|594219331|FG003|Overall Study|Adverse Event|1|||
164505149|NCT04750577|594219328|FG000|Overall Study|Change of residence|0|||
164505150|NCT04750577|594219329|FG001|Overall Study|Change of residence|0|||
164505151|NCT04750577|594219330|FG002|Overall Study|Change of residence|1|||
164505152|NCT04750577|594219331|FG003|Overall Study|Change of residence|0|||
164505153|NCT04750577|594219328|FG000|Overall Study|Burden of study procedures|0|||
164505154|NCT04750577|594219329|FG001|Overall Study|Burden of study procedures|2|||
164505155|NCT04750577|594219330|FG002|Overall Study|Burden of study procedures|2|||
164505156|NCT04750577|594219331|FG003|Overall Study|Burden of study procedures|0|||
164505157|NCT04750577|594219328|FG000|Overall Study|Prematurely discontinued|0|||
164505158|NCT04750577|594219329|FG001|Overall Study|Prematurely discontinued|0|||
164505159|NCT04750577|594219330|FG002|Overall Study|Prematurely discontinued|0|||
164505160|NCT04750577|594219331|FG003|Overall Study|Prematurely discontinued|2|||
164505161|NCT04750577|594219328|FG000|Overall Study|Protocol deviation|1|||
164505162|NCT04750577|594219329|FG001|Overall Study|Protocol deviation|1|||
164505163|NCT04750577|594219330|FG002|Overall Study|Protocol deviation|1|||
164505164|NCT04750577|594219331|FG003|Overall Study|Protocol deviation|1|||
164505165|NCT04750577|594219328|FG000|Overall Study|Other than listed|3|||
164505166|NCT04750577|594219329|FG001|Overall Study|Other than listed|2|||
164505167|NCT04750577|594219330|FG002|Overall Study|Other than listed|2|||
164505168|NCT04750577|594219331|FG003|Overall Study|Other than listed|1|||
164505169|NCT04750577|594219328|FG000|Overall Study|Not treated|0|||
164505170|NCT04750577|594219329|FG001|Overall Study|Not treated|0|||
164505171|NCT04750577|594219330|FG002|Overall Study|Not treated|0|||
164505172|NCT04750577|594219331|FG003|Overall Study|Not treated|2|||
164505173|NCT01190449|594219332|FG000|Overall Study|Ineligible|0|||
164505174|NCT01190449|594219333|FG001|Overall Study|Ineligible|4|||
164505175|NCT04021043|594221053|FG000|Overall Study|Adverse Event|3|||
164505176|NCT04021043|594221054|FG001|Overall Study|Adverse Event|1|||
164505177|NCT04021043|594221055|FG002|Overall Study|Adverse Event|1|||
164505178|NCT04021043|594221056|FG003|Overall Study|Adverse Event|0|||
164505179|NCT04021043|594221053|FG000|Overall Study|Death|2|||
164505180|NCT04021043|594221054|FG001|Overall Study|Death|3|||
164505181|NCT04021043|594221055|FG002|Overall Study|Death|1|||
164505182|NCT04021043|594221056|FG003|Overall Study|Death|3|||
164505183|NCT04021043|594221053|FG000|Overall Study|Withdrawal by Subject|1|||
164505184|NCT04021043|594221054|FG001|Overall Study|Withdrawal by Subject|1|||
164505185|NCT04021043|594221055|FG002|Overall Study|Withdrawal by Subject|1|||
164505186|NCT04021043|594221056|FG003|Overall Study|Withdrawal by Subject|6|||
164505187|NCT04021043|594221053|FG000|Overall Study|Discontinued due to disease progression|4|||
164505188|NCT04021043|594221054|FG001|Overall Study|Discontinued due to disease progression|5|||
164505189|NCT04021043|594221055|FG002|Overall Study|Discontinued due to disease progression|7|||
164505190|NCT04021043|594221056|FG003|Overall Study|Discontinued due to disease progression|10|||
164505191|NCT00826228|594221057|FG000|Overall Study|Withdrawal by Subject|1|||
164505192|NCT03526679|594221058|FG000|Overall Study|still under treatment|2|||
164505193|NCT01246999|594221059|FG000|Overall Study|Lost to Follow-up|0|||
164505194|NCT01246999|594221060|FG001|Overall Study|Lost to Follow-up|1|||
164505195|NCT01246999|594221061|FG002|Overall Study|Lost to Follow-up|0|||
164505196|NCT01246999|594221062|FG003|Overall Study|Lost to Follow-up|0|||
164505197|NCT01246999|594221059|FG000|Overall Study|Withdrawal by Subject|0|||
164505198|NCT01246999|594221060|FG001|Overall Study|Withdrawal by Subject|0|||
164505199|NCT01246999|594221061|FG002|Overall Study|Withdrawal by Subject|0|||
164505200|NCT01246999|594221062|FG003|Overall Study|Withdrawal by Subject|2|||
164505201|NCT01867047|594221063|FG000|Overall Study|Lost to Follow-up|3|||
164505202|NCT01867047|594221064|FG001|Overall Study|Lost to Follow-up|3|||
164505203|NCT01867047|594221063|FG000|Overall Study|Withdrawal by Subject|2|||
164505204|NCT01867047|594221064|FG001|Overall Study|Withdrawal by Subject|0|||
164505205|NCT01867047|594221063|FG000|Overall Study|Physician Decision|2|||
164505206|NCT01867047|594221064|FG001|Overall Study|Physician Decision|0|||
164505207|NCT01867047|594221063|FG000|Overall Study|surgery not indicated in protocol|1|||
164505208|NCT01867047|594221064|FG001|Overall Study|surgery not indicated in protocol|2|||
164505209|NCT00307047|594221065|FG000|Overall Study|Lost to Follow-up|35|||
164505210|NCT00307047|594221066|FG001|Overall Study|Lost to Follow-up|24|||
164505211|NCT00307047|594221065|FG000|Overall Study|Withdrawal by Subject|6|||
164505212|NCT00307047|594221066|FG001|Overall Study|Withdrawal by Subject|6|||
164505213|NCT00307047|594221065|FG000|Overall Study|Physician Decision|1|||
164505214|NCT00307047|594221066|FG001|Overall Study|Physician Decision|2|||
164505215|NCT00307047|594221065|FG000|Overall Study|Lost to follow-up for other reasons|0|||
164505216|NCT00307047|594221066|FG001|Overall Study|Lost to follow-up for other reasons|1|||
164505217|NCT00307047|594221065|FG000|Overall Study|All death, all MI, all Revascularization|27|||
164505218|NCT00307047|594221066|FG001|Overall Study|All death, all MI, all Revascularization|16|||
164505219|NCT02825251|594221069|FG000|Overall Study|Adverse Event|0|||
164505220|NCT02825251|594221070|FG001|Overall Study|Adverse Event|1|||
164505221|NCT02825251|594221069|FG000|Overall Study|Lost to Follow-up|0|||
164505222|NCT02825251|594221070|FG001|Overall Study|Lost to Follow-up|1|||
164505223|NCT02825251|594221069|FG000|Overall Study|Withdrawal by Subject|1|||
164505224|NCT02825251|594221070|FG001|Overall Study|Withdrawal by Subject|4|||
164505225|NCT02825251|594221069|FG000|Overall Study|Unclassified|2|||
164505226|NCT02825251|594221070|FG001|Overall Study|Unclassified|0|||
164505227|NCT03023722|594221071|FG000|Overall Study|No follow-up assessment|4|||
164505228|NCT03616964|594221072|FG000|Overall Study|Adverse Event|15|||
164505229|NCT03616964|594221073|FG001|Overall Study|Adverse Event|10|||
164505230|NCT03616964|594221074|FG002|Overall Study|Adverse Event|16|||
164505231|NCT03616964|594221072|FG000|Overall Study|Death|3|||
164505232|NCT03616964|594221073|FG001|Overall Study|Death|0|||
164505233|NCT03616964|594221074|FG002|Overall Study|Death|4|||
164505234|NCT03616964|594221072|FG000|Overall Study|Lack of Efficacy|4|||
164505235|NCT03616964|594221073|FG001|Overall Study|Lack of Efficacy|8|||
164505236|NCT03616964|594221074|FG002|Overall Study|Lack of Efficacy|8|||
164505237|NCT03616964|594221072|FG000|Overall Study|Lost to Follow-up|2|||
164505238|NCT03616964|594221073|FG001|Overall Study|Lost to Follow-up|1|||
164505239|NCT03616964|594221074|FG002|Overall Study|Lost to Follow-up|3|||
164505240|NCT03616964|594221072|FG000|Overall Study|Withdrawal by Subject|18|||
164505241|NCT03616964|594221073|FG001|Overall Study|Withdrawal by Subject|14|||
164505242|NCT03616964|594221074|FG002|Overall Study|Withdrawal by Subject|21|||
164505243|NCT03616964|594221072|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
164505244|NCT03616964|594221073|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
164505245|NCT03616964|594221074|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
164505246|NCT03616964|594221072|FG000|Overall Study|Sponsor's Decision|1|||
164505247|NCT03616964|594221073|FG001|Overall Study|Sponsor's Decision|0|||
164505248|NCT03616964|594221074|FG002|Overall Study|Sponsor's Decision|0|||
164505249|NCT03616964|594221072|FG000|Overall Study|Physician Decision|0|||
164505250|NCT03616964|594221073|FG001|Overall Study|Physician Decision|2|||
164505251|NCT03616964|594221074|FG002|Overall Study|Physician Decision|0|||
164505252|NCT03616964|594221072|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
164505253|NCT03616964|594221073|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
164505254|NCT03616964|594221074|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
164505255|NCT03616964|594221072|FG000|Overall Study|Protocol Violation|0|||
164505256|NCT03616964|594221073|FG001|Overall Study|Protocol Violation|1|||
164505257|NCT03616964|594221074|FG002|Overall Study|Protocol Violation|0|||
164505258|NCT03616964|594221072|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
164505259|NCT03616964|594221073|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
164505260|NCT03616964|594221074|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
164505261|NCT03616964|594221072|FG000|Overall Study|Randomized but Never Treated|1|||
164505262|NCT03616964|594221073|FG001|Overall Study|Randomized but Never Treated|1|||
164505263|NCT03616964|594221074|FG002|Overall Study|Randomized but Never Treated|1|||
164505264|NCT04596995|594221075|FG000|Overall Study|Lack of Efficacy|8|||
164505265|NCT04596995|594221075|FG000|Overall Study|Lost to Follow-up|3|||
164505266|NCT04596995|594221075|FG000|Overall Study|Withdrawal by Subject|12|||
164505267|NCT04596995|594221075|FG000|Overall Study|Sponsor decision|3|||
164505268|NCT04596995|594221075|FG000|Overall Study|Enrolled in managed access program|3|||
164505269|NCT02056626|594221076|FG000|Overall Study|patient did not follow directions|3|||
164505270|NCT02056626|594221077|FG001|Overall Study|patient did not follow directions|1|||
164505271|NCT02056626|594221078|FG002|Overall Study|patient did not follow directions|0|||
164505272|NCT02056626|594221079|FG003|Overall Study|patient did not follow directions|0|||
164505273|NCT02037477|594221083|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
164505274|NCT02037477|594221084|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
164505275|NCT02037477|594221085|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
164505276|NCT02037477|594221086|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
164505277|NCT01245140|594221087|FG000|Overall Study|Adverse Event|1|||
164505278|NCT01245140|594221088|FG001|Overall Study|Adverse Event|3|||
164505279|NCT01245140|594221087|FG000|Overall Study|Lack of Efficacy|2|||
164505280|NCT01245140|594221088|FG001|Overall Study|Lack of Efficacy|4|||
164505281|NCT01245140|594221087|FG000|Overall Study|Protocol Violation|0|||
164505282|NCT01245140|594221088|FG001|Overall Study|Protocol Violation|1|||
164505283|NCT01245140|594221087|FG000|Overall Study|Withdrawal by Subject|0|||
164505284|NCT01245140|594221088|FG001|Overall Study|Withdrawal by Subject|1|||
164505285|NCT01245140|594221087|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
164505286|NCT01245140|594221088|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
164505287|NCT04916002|594221089|FG000|Overall Study|Adverse Event|0|||
164505288|NCT04916002|594221090|FG001|Overall Study|Adverse Event|1|||
164505289|NCT04916002|594221091|FG002|Overall Study|Adverse Event|0|||
164505290|NCT04916002|594221092|FG003|Overall Study|Adverse Event|1|||
164505291|NCT04916002|594221093|FG004|Overall Study|Adverse Event|0|||
164505292|NCT04916002|594221089|FG000|Overall Study|Withdrawal by Subject|3|||
164505293|NCT04916002|594221090|FG001|Overall Study|Withdrawal by Subject|1|||
164505294|NCT04916002|594221091|FG002|Overall Study|Withdrawal by Subject|0|||
164505295|NCT04916002|594221092|FG003|Overall Study|Withdrawal by Subject|1|||
164505296|NCT04916002|594221093|FG004|Overall Study|Withdrawal by Subject|0|||
164505297|NCT04916002|594221089|FG000|Overall Study|Death|8|||
164505298|NCT04916002|594221090|FG001|Overall Study|Death|7|||
164505299|NCT04916002|594221091|FG002|Overall Study|Death|4|||
164505300|NCT04916002|594221092|FG003|Overall Study|Death|9|||
164505301|NCT04916002|594221093|FG004|Overall Study|Death|0|||
164505302|NCT04916002|594221089|FG000|Overall Study|Study Terminated by Sponsor|11|||
164505303|NCT04916002|594221090|FG001|Overall Study|Study Terminated by Sponsor|10|||
164505304|NCT04916002|594221091|FG002|Overall Study|Study Terminated by Sponsor|8|||
164505305|NCT04916002|594221092|FG003|Overall Study|Study Terminated by Sponsor|5|||
164505306|NCT04916002|594221093|FG004|Overall Study|Study Terminated by Sponsor|4|||
164505307|NCT04916002|594221089|FG000|Overall Study|End of trial|1|||
164505308|NCT04916002|594221090|FG001|Overall Study|End of trial|0|||
164505309|NCT04916002|594221091|FG002|Overall Study|End of trial|0|||
164505310|NCT04916002|594221092|FG003|Overall Study|End of trial|0|||
164505311|NCT04916002|594221093|FG004|Overall Study|End of trial|0|||
164505312|NCT04916002|594221089|FG000|Overall Study|Progressive disease|0|||
164505313|NCT04916002|594221090|FG001|Overall Study|Progressive disease|0|||
164505314|NCT04916002|594221091|FG002|Overall Study|Progressive disease|1|||
164505315|NCT04916002|594221092|FG003|Overall Study|Progressive disease|0|||
164505316|NCT04916002|594221093|FG004|Overall Study|Progressive disease|0|||
164505317|NCT04916002|594221089|FG000|Overall Study|Participant non-compliance|2|||
164505318|NCT04916002|594221090|FG001|Overall Study|Participant non-compliance|0|||
164505319|NCT04916002|594221091|FG002|Overall Study|Participant non-compliance|0|||
164505320|NCT04916002|594221092|FG003|Overall Study|Participant non-compliance|0|||
164505321|NCT04916002|594221093|FG004|Overall Study|Participant non-compliance|0|||
164505322|NCT04836559|594221094|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
164505323|NCT04836559|594221095|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
164146443|NCT05026177|592898058|FG000|Overall Study|Lost to Follow-up|7|||
164505324|NCT04836559|594221096|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
164505325|NCT04836559|594221097|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
164505326|NCT04836559|594221098|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
164505327|NCT04836559|594221099|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
164505328|NCT04836559|594221100|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
164505329|NCT04836559|594221101|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
164505330|NCT04836559|594221094|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
164505331|NCT04836559|594221095|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
164505332|NCT04836559|594221096|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
164505333|NCT04836559|594221097|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
164505334|NCT04836559|594221098|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
164505335|NCT04836559|594221099|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
164505336|NCT04836559|594221100|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
164505337|NCT04836559|594221101|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
164505338|NCT04836559|594221094|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
164505339|NCT04836559|594221095|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
164505340|NCT04836559|594221096|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
164505341|NCT04836559|594221097|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
164505342|NCT04836559|594221098|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
164505343|NCT04836559|594221099|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
164505344|NCT04836559|594221100|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
164505345|NCT04836559|594221101|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
164505346|NCT04836559|594221094|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
164505347|NCT04836559|594221095|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
164505348|NCT04836559|594221096|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
164505349|NCT04836559|594221097|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
164505350|NCT04836559|594221098|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
164505351|NCT04836559|594221099|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
164505352|NCT04836559|594221100|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
164505353|NCT04836559|594221101|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
164505354|NCT04836559|594221094|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
164505355|NCT04836559|594221095|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
164505356|NCT04836559|594221096|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
164505357|NCT04836559|594221097|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
164505358|NCT04836559|594221098|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
164505359|NCT04836559|594221099|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
164505360|NCT04836559|594221100|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
164505361|NCT04836559|594221101|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
164505362|NCT04836559|594221094|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
164505363|NCT04836559|594221095|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
164505364|NCT04836559|594221096|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
164505365|NCT04836559|594221097|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
164505366|NCT04836559|594221098|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
164505367|NCT04836559|594221099|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
164505368|NCT04836559|594221100|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
164505369|NCT04836559|594221101|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
164505370|NCT04836559|594221094|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
164505371|NCT04836559|594221095|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
164505372|NCT04836559|594221096|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
164505373|NCT04836559|594221097|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
164505374|NCT04836559|594221098|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
164505375|NCT04836559|594221099|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
164505376|NCT04836559|594221100|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
164505377|NCT04836559|594221101|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
164505378|NCT04836559|594221094|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
164505379|NCT04836559|594221095|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
164505380|NCT04836559|594221096|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
164505381|NCT04836559|594221097|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
164505382|NCT04836559|594221098|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
164505383|NCT04836559|594221099|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
164505384|NCT04836559|594221100|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
164505385|NCT04836559|594221101|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
164505386|NCT04836559|594221094|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
164505387|NCT04836559|594221095|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
164505388|NCT04836559|594221096|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
164505389|NCT04836559|594221097|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
164505390|NCT04836559|594221098|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
164505391|NCT04836559|594221099|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
164505392|NCT04836559|594221100|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
164505393|NCT04836559|594221101|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
164505394|NCT02635360|594221102|FG000|Overall Study|Adverse Event|0|||
164505395|NCT02635360|594221103|FG001|Overall Study|Adverse Event|3|||
164505396|NCT02635360|594221102|FG000|Overall Study|Withdrawal by Subject|2|||
164505397|NCT02635360|594221103|FG001|Overall Study|Withdrawal by Subject|0|||
164505398|NCT02635360|594221102|FG000|Overall Study|Non-Compliance|3|||
164505399|NCT02635360|594221103|FG001|Overall Study|Non-Compliance|1|||
164505400|NCT02635360|594221102|FG000|Overall Study|Disease Progression|0|||
164505401|NCT02635360|594221103|FG001|Overall Study|Disease Progression|2|||
164505402|NCT02635360|594221102|FG000|Overall Study|Lost to Follow-up|1|||
164505403|NCT02635360|594221103|FG001|Overall Study|Lost to Follow-up|1|||
164505404|NCT03118050|594221104|FG000|Overall Study|Did not meet inclusion criteria after signing consent form|14|||
164505405|NCT03118050|594221105|FG001|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
164505406|NCT03118050|594221106|FG002|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
164505407|NCT03118050|594221107|FG003|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
164505408|NCT03118050|594221108|FG004|Overall Study|Did not meet inclusion criteria after signing consent form|4|||
164505409|NCT03118050|594221109|FG005|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
164505410|NCT03118050|594221110|FG006|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
164505411|NCT01952847|594221113|FG000|Overall Study|Ineligible|1|||
164505412|NCT01952847|594221114|FG001|Overall Study|Ineligible|0|||
164505413|NCT01952847|594221115|FG002|Overall Study|Ineligible|0|||
164505414|NCT01952847|594221116|FG003|Overall Study|Ineligible|0|||
164505415|NCT01952847|594221113|FG000|Overall Study|Lack of Insurance Coverage|0|||
164505416|NCT01952847|594221114|FG001|Overall Study|Lack of Insurance Coverage|1|||
164505417|NCT01952847|594221115|FG002|Overall Study|Lack of Insurance Coverage|0|||
164505418|NCT01952847|594221116|FG003|Overall Study|Lack of Insurance Coverage|0|||
164505419|NCT01952847|594221113|FG000|Overall Study|Withdrawal by Subject|1|||
164505420|NCT01952847|594221114|FG001|Overall Study|Withdrawal by Subject|1|||
164505421|NCT01952847|594221115|FG002|Overall Study|Withdrawal by Subject|0|||
164505422|NCT01952847|594221116|FG003|Overall Study|Withdrawal by Subject|1|||
164505423|NCT05382039|594221117|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
164505424|NCT05382039|594221118|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
164505425|NCT05382039|594221119|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
164505426|NCT05382039|594221117|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
164505427|NCT05382039|594221118|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
164505428|NCT05382039|594221119|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
164505429|NCT05382039|594221117|FG000|Overall Study|waiting for confirmation|0|||
164505430|NCT05382039|594221118|FG001|Overall Study|waiting for confirmation|0|||
164505431|NCT05382039|594221119|FG002|Overall Study|waiting for confirmation|1|||
164505432|NCT04464421|594221120|FG000|Overall Study|Lost to Follow-up|2|||
164505433|NCT04464421|594221121|FG001|Overall Study|Lost to Follow-up|2|||
164505434|NCT02577003|594221122|FG000|Overall Study|Adverse Event|2|||
164505435|NCT02577003|594221123|FG001|Overall Study|Adverse Event|4|||
164505436|NCT02577003|594221122|FG000|Overall Study|Withdrawal by Subject|0|||
164505437|NCT02577003|594221123|FG001|Overall Study|Withdrawal by Subject|1|||
164505438|NCT02786004|594221124|FG000|Overall Study|Withdrawal by Subject|0|||
164505439|NCT02786004|594221125|FG001|Overall Study|Withdrawal by Subject|1|||
164505440|NCT01234883|594221126|FG000|Overall Study|Early treatment release|8|||
164505441|NCT01234883|594221127|FG001|Overall Study|Early treatment release|10|||
164505442|NCT01234883|594221126|FG000|Overall Study|Parent/guardian withdrew consent|1|||
164505443|NCT01234883|594221127|FG001|Overall Study|Parent/guardian withdrew consent|2|||
164505444|NCT01234883|594221126|FG000|Overall Study|Technical difficulties with IV infusion|0|||
164505445|NCT01234883|594221127|FG001|Overall Study|Technical difficulties with IV infusion|1|||
164505446|NCT01234883|594221126|FG000|Overall Study|Inclusion/exclusion failure|1|||
164505447|NCT01234883|594221127|FG001|Overall Study|Inclusion/exclusion failure|0|||
164607004|NCT00656084|594583409|FG000|Overall Study|Investigator Request|1|||
164607005|NCT02455388|594583413|FG000|Overall Study|Protocol Violation|1|||
164607006|NCT02455388|594583414|FG001|Overall Study|Protocol Violation|0|||
164505448|NCT01013961|594221128|FG000|Overall Study|Adverse Event|2|||
164505449|NCT01013961|594221129|FG001|Overall Study|Adverse Event|2|||
164505450|NCT01013961|594221128|FG000|Overall Study|Withdrawal by Subject|1|||
164505451|NCT01013961|594221129|FG001|Overall Study|Withdrawal by Subject|0|||
164505452|NCT01013961|594221128|FG000|Overall Study|Physician Decision|0|||
164505453|NCT01013961|594221129|FG001|Overall Study|Physician Decision|1|||
164505454|NCT01271504|594221130|FG000|Overall Study|Death|7|||
164505455|NCT01271504|594221131|FG001|Overall Study|Death|6|||
164505456|NCT01271504|594221132|FG002|Overall Study|Death|32|||
164505457|NCT01271504|594221133|FG003|Overall Study|Death|32|||
164505458|NCT01271504|594221130|FG000|Overall Study|Lost to Follow-up|0|||
164505459|NCT01271504|594221131|FG001|Overall Study|Lost to Follow-up|1|||
164505460|NCT01271504|594221132|FG002|Overall Study|Lost to Follow-up|3|||
164505461|NCT01271504|594221133|FG003|Overall Study|Lost to Follow-up|1|||
164505462|NCT01271504|594221130|FG000|Overall Study|Protocol Violation|0|||
164505463|NCT01271504|594221131|FG001|Overall Study|Protocol Violation|0|||
164505464|NCT01271504|594221132|FG002|Overall Study|Protocol Violation|0|||
164505465|NCT01271504|594221133|FG003|Overall Study|Protocol Violation|2|||
164505466|NCT01271504|594221130|FG000|Overall Study|Administrative Reasons|0|||
164505467|NCT01271504|594221131|FG001|Overall Study|Administrative Reasons|0|||
164505468|NCT01271504|594221132|FG002|Overall Study|Administrative Reasons|6|||
164505469|NCT01271504|594221133|FG003|Overall Study|Administrative Reasons|5|||
164505470|NCT01271504|594221130|FG000|Overall Study|Withdrawal by Subject|0|||
164505471|NCT01271504|594221131|FG001|Overall Study|Withdrawal by Subject|0|||
164505472|NCT01271504|594221132|FG002|Overall Study|Withdrawal by Subject|1|||
164505473|NCT01271504|594221133|FG003|Overall Study|Withdrawal by Subject|3|||
164505474|NCT01271504|594221130|FG000|Overall Study|Other|0|||
164505475|NCT01271504|594221131|FG001|Overall Study|Other|1|||
164505476|NCT01271504|594221132|FG002|Overall Study|Other|2|||
164505477|NCT01271504|594221133|FG003|Overall Study|Other|0|||
164505478|NCT03912662|594221140|FG000|Overall Study|Adverse Event|3|||
164505479|NCT03912662|594221140|FG000|Overall Study|Adverse Event and Death|1|||
164505480|NCT03912662|594221140|FG000|Overall Study|Death|1|||
164505481|NCT03912662|594221140|FG000|Overall Study|Screen Failure: Subjects who provide study consent, but then were determined to be ineligible.|1|||
164505482|NCT03912662|594221140|FG000|Overall Study|Mesh Removal|1|||
164505483|NCT03912662|594221140|FG000|Overall Study|Discontinued: Eligible consented subjects who did not undergo the procedure with the study device.|2|||
164505484|NCT03912662|594221140|FG000|Overall Study|Early study termination|20|||
164505485|NCT03845140|594221141|FG000|Overall Study|Participant travelled outside study area|0|||
164505486|NCT03845140|594221142|FG001|Overall Study|Participant travelled outside study area|1|||
164505487|NCT03845140|594221143|FG002|Overall Study|Participant travelled outside study area|0|||
164505488|NCT03845140|594221144|FG003|Overall Study|Participant travelled outside study area|0|||
164505489|NCT03845140|594221145|FG004|Overall Study|Participant travelled outside study area|0|||
164505490|NCT03845140|594221146|FG005|Overall Study|Participant travelled outside study area|0|||
164505491|NCT01592045|594221147|FG000|Overall Study|Disease Progression|1|||
164505492|NCT01592045|594221148|FG001|Overall Study|Disease Progression|1|||
164505493|NCT01592045|594221147|FG000|Overall Study|Adverse Event|1|||
164505494|NCT01592045|594221148|FG001|Overall Study|Adverse Event|1|||
164505495|NCT01592045|594221147|FG000|Overall Study|Withdrawal by Subject|1|||
164505496|NCT01592045|594221148|FG001|Overall Study|Withdrawal by Subject|0|||
164505497|NCT01592045|594221147|FG000|Overall Study|Moved out of country|2|||
164505498|NCT01592045|594221148|FG001|Overall Study|Moved out of country|0|||
164505499|NCT01790295|594221149|FG000|Overall Study|Adverse Event|1|||
164505500|NCT01790295|594221149|FG000|Overall Study|Death|4|||
164505501|NCT01790295|594221149|FG000|Overall Study|Lack of Efficacy|2|||
164505502|NCT01790295|594221149|FG000|Overall Study|Study closure|4|||
164505503|NCT01843777|594221150|FG000|Overall Study|Withdrawal by Subject|1|||
164505504|NCT01843777|594221151|FG001|Overall Study|Withdrawal by Subject|0|||
164505505|NCT00420784|594221157|FG000|Overall Study|Adverse Event|11|||
164505506|NCT00420784|594221158|FG001|Overall Study|Adverse Event|29|||
164505507|NCT00420784|594221159|FG002|Overall Study|Adverse Event|10|||
164505508|NCT00420784|594221160|FG003|Overall Study|Adverse Event|5|||
164505509|NCT00420784|594221157|FG000|Overall Study|Withdrawal by Subject|0|||
164505510|NCT00420784|594221158|FG001|Overall Study|Withdrawal by Subject|1|||
164505511|NCT00420784|594221159|FG002|Overall Study|Withdrawal by Subject|0|||
164505512|NCT00420784|594221160|FG003|Overall Study|Withdrawal by Subject|0|||
164505513|NCT00420784|594221157|FG000|Overall Study|Lost to Follow-up|0|||
164505514|NCT00420784|594221158|FG001|Overall Study|Lost to Follow-up|0|||
164505515|NCT00420784|594221159|FG002|Overall Study|Lost to Follow-up|2|||
164505516|NCT00420784|594221160|FG003|Overall Study|Lost to Follow-up|1|||
164505517|NCT00420784|594221157|FG000|Overall Study|Virologic Stopping Rule|17|||
164505518|NCT00420784|594221158|FG001|Overall Study|Virologic Stopping Rule|26|||
164505519|NCT00420784|594221159|FG002|Overall Study|Virologic Stopping Rule|41|||
164505520|NCT00420784|594221160|FG003|Overall Study|Virologic Stopping Rule|67|||
164505521|NCT00420784|594221157|FG000|Overall Study|Other|1|||
164505522|NCT00420784|594221158|FG001|Overall Study|Other|2|||
164505523|NCT00420784|594221159|FG002|Overall Study|Other|0|||
164505524|NCT00420784|594221160|FG003|Overall Study|Other|5|||
164505525|NCT05147350|594221163|FG000|Overall Study|Death|2|||
164505526|NCT05147350|594221164|FG001|Overall Study|Death|3|||
164505527|NCT05147350|594221165|FG002|Overall Study|Death|3|||
164505528|NCT05147350|594221166|FG003|Overall Study|Death|2|||
164505529|NCT05147350|594221167|FG004|Overall Study|Death|2|||
164505530|NCT05147350|594221168|FG005|Overall Study|Death|1|||
164505531|NCT05147350|594221169|FG006|Overall Study|Death|1|||
164505532|NCT05147350|594221170|FG007|Overall Study|Death|3|||
164505533|NCT05147350|594221163|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
164505534|NCT05147350|594221164|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
164505535|NCT05147350|594221165|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
164505536|NCT05147350|594221166|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
164505537|NCT05147350|594221167|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
164505538|NCT05147350|594221168|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
164505539|NCT05147350|594221169|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
164505540|NCT05147350|594221170|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
164505541|NCT05147350|594221163|FG000|Overall Study|Withdrawal by Subject|0|||
164505542|NCT05147350|594221164|FG001|Overall Study|Withdrawal by Subject|0|||
164505543|NCT05147350|594221165|FG002|Overall Study|Withdrawal by Subject|3|||
164505544|NCT05147350|594221166|FG003|Overall Study|Withdrawal by Subject|1|||
164505545|NCT05147350|594221167|FG004|Overall Study|Withdrawal by Subject|1|||
164505546|NCT05147350|594221168|FG005|Overall Study|Withdrawal by Subject|0|||
164505547|NCT05147350|594221169|FG006|Overall Study|Withdrawal by Subject|1|||
164505548|NCT05147350|594221170|FG007|Overall Study|Withdrawal by Subject|0|||
164505549|NCT05147350|594221163|FG000|Overall Study|Other Reasons|0|||
164505550|NCT05147350|594221164|FG001|Overall Study|Other Reasons|0|||
164505551|NCT05147350|594221165|FG002|Overall Study|Other Reasons|2|||
164505552|NCT05147350|594221166|FG003|Overall Study|Other Reasons|0|||
164505553|NCT05147350|594221167|FG004|Overall Study|Other Reasons|0|||
164505554|NCT05147350|594221168|FG005|Overall Study|Other Reasons|2|||
164505555|NCT05147350|594221169|FG006|Overall Study|Other Reasons|1|||
164505556|NCT05147350|594221170|FG007|Overall Study|Other Reasons|1|||
164505557|NCT02599688|594221173|FG000|Overall Study|Lack of Efficacy|1|||
164505558|NCT02599688|594221173|FG000|Overall Study|Withdrawal by Subject|1|||
164505559|NCT02599688|594221173|FG000|Overall Study|Termination by Sponsor|2|||
164505560|NCT02947100|594221179|FG000|Overall Study|study terminated early|3|||
164505561|NCT02947100|594221179|FG000|Overall Study|did not meet inclusion criteria|1|||
164505562|NCT02472145|594221180|FG000|Overall Study|Death|10|||
164505563|NCT02472145|594221181|FG001|Overall Study|Death|101|||
164505564|NCT02472145|594221182|FG002|Overall Study|Death|99|||
164505565|NCT02472145|594221180|FG000|Overall Study|Lost to Follow-up|0|||
164505566|NCT02472145|594221181|FG001|Overall Study|Lost to Follow-up|1|||
164505567|NCT02472145|594221182|FG002|Overall Study|Lost to Follow-up|0|||
164505568|NCT02472145|594221180|FG000|Overall Study|Withdrawal by Subject|0|||
164505569|NCT02472145|594221181|FG001|Overall Study|Withdrawal by Subject|9|||
164505570|NCT02472145|594221182|FG002|Overall Study|Withdrawal by Subject|13|||
164505571|NCT02472145|594221180|FG000|Overall Study|Sponsor decision|0|||
164505572|NCT02472145|594221181|FG001|Overall Study|Sponsor decision|3|||
164505573|NCT02472145|594221182|FG002|Overall Study|Sponsor decision|2|||
164505574|NCT02472145|594221180|FG000|Overall Study|Other|0|||
164505575|NCT02472145|594221181|FG001|Overall Study|Other|45|||
164505576|NCT02472145|594221182|FG002|Overall Study|Other|43|||
164505577|NCT01080326|594221183|FG000|Overall Study|Patient deterioration prior to procedure|3|||
164505578|NCT01080326|594221183|FG000|Overall Study|Surgeon decision|1|||
164505579|NCT00632021|594221185|FG000|Overall Study|Withdrawal/death|4|||
164505580|NCT00632021|594221186|FG001|Overall Study|Withdrawal/death|7|||
164505581|NCT01318876|594221187|FG000|Day 8 Survey|email address invalid|96|||
164505582|NCT01318876|594221187|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
164505583|NCT01318876|594221187|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
164505584|NCT00443209|594221188|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
164505585|NCT00443209|594221189|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
164505586|NCT00443209|594221188|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
164505587|NCT00443209|594221189|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
164505588|NCT00443209|594221188|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
164505589|NCT00443209|594221189|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
164505590|NCT00443209|594221188|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
164505591|NCT00443209|594221189|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
164505592|NCT00443209|594221188|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
164505593|NCT00443209|594221189|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
164505594|NCT00443209|594221188|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
164505595|NCT00443209|594221189|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
164505596|NCT00443209|594221188|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
164505597|NCT00443209|594221189|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
164505598|NCT00443209|594221188|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
164505599|NCT00443209|594221189|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
164505600|NCT00443209|594221188|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
164505601|NCT00443209|594221189|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
164505602|NCT00443209|594221188|FG000|Months 1 to 12 Treatment Period|Missing|2|||
164505603|NCT00443209|594221189|FG001|Months 1 to 12 Treatment Period|Missing|1|||
164505604|NCT00443209|594221188|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
164505605|NCT00443209|594221189|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
164505606|NCT00443209|594221188|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
164505607|NCT00443209|594221189|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
164505608|NCT00443209|594221188|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
164505609|NCT00443209|594221189|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
164505610|NCT00443209|594221188|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
164505611|NCT00443209|594221189|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
164505612|NCT00443209|594221188|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
164505613|NCT00443209|594221189|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
164505614|NCT00443209|594221188|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
164505615|NCT00443209|594221189|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
164505616|NCT00443209|594221188|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
164505617|NCT00443209|594221189|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
164505618|NCT01575873|594221190|FG000|Overall Study|Withdrawal by Subject|15|||
164505619|NCT01575873|594221191|FG001|Overall Study|Withdrawal by Subject|20|||
164505620|NCT01575873|594221192|FG002|Overall Study|Withdrawal by Subject|34|||
164505621|NCT01575873|594221193|FG003|Overall Study|Withdrawal by Subject|34|||
164505622|NCT01575873|594221190|FG000|Overall Study|Adverse Event|7|||
164505623|NCT01575873|594221191|FG001|Overall Study|Adverse Event|7|||
164505624|NCT01575873|594221192|FG002|Overall Study|Adverse Event|9|||
164505625|NCT01575873|594221193|FG003|Overall Study|Adverse Event|12|||
164505626|NCT01575873|594221190|FG000|Overall Study|Lost to Follow-up|1|||
164505627|NCT01575873|594221191|FG001|Overall Study|Lost to Follow-up|3|||
164505628|NCT01575873|594221192|FG002|Overall Study|Lost to Follow-up|13|||
164505629|NCT01575873|594221193|FG003|Overall Study|Lost to Follow-up|5|||
164505630|NCT01575873|594221190|FG000|Overall Study|Death|3|||
164505631|NCT01575873|594221191|FG001|Overall Study|Death|2|||
164505632|NCT01575873|594221192|FG002|Overall Study|Death|8|||
164505633|NCT01575873|594221193|FG003|Overall Study|Death|9|||
164505634|NCT01575873|594221190|FG000|Overall Study|Noncompliance|1|||
164505635|NCT01575873|594221191|FG001|Overall Study|Noncompliance|2|||
164505636|NCT01575873|594221192|FG002|Overall Study|Noncompliance|4|||
164505637|NCT01575873|594221193|FG003|Overall Study|Noncompliance|3|||
164505638|NCT01575873|594221190|FG000|Overall Study|Administrative decision|1|||
164505639|NCT01575873|594221191|FG001|Overall Study|Administrative decision|1|||
164505640|NCT01575873|594221192|FG002|Overall Study|Administrative decision|1|||
164505641|NCT01575873|594221193|FG003|Overall Study|Administrative decision|0|||
164505642|NCT01575873|594221190|FG000|Overall Study|Protocol deviation|0|||
164505643|NCT01575873|594221191|FG001|Overall Study|Protocol deviation|1|||
164505644|NCT01575873|594221192|FG002|Overall Study|Protocol deviation|0|||
164505645|NCT01575873|594221193|FG003|Overall Study|Protocol deviation|1|||
164505646|NCT01575873|594221190|FG000|Overall Study|Requirement for Alternative Therapy|0|||
164505647|NCT01575873|594221191|FG001|Overall Study|Requirement for Alternative Therapy|0|||
164505648|NCT01575873|594221192|FG002|Overall Study|Requirement for Alternative Therapy|1|||
164505649|NCT01575873|594221193|FG003|Overall Study|Requirement for Alternative Therapy|1|||
164505650|NCT01575873|594221190|FG000|Overall Study|Other|0|||
164505651|NCT01575873|594221191|FG001|Overall Study|Other|0|||
164505652|NCT01575873|594221192|FG002|Overall Study|Other|4|||
164505653|NCT01575873|594221193|FG003|Overall Study|Other|2|||
164505654|NCT01850030|594221194|FG000|Overall Study|Adverse Event|64|||
164505655|NCT01850030|594221195|FG001|Overall Study|Adverse Event|82|||
164505656|NCT01850030|594221194|FG000|Overall Study|Lack of Efficacy|3|||
164505657|NCT01850030|594221195|FG001|Overall Study|Lack of Efficacy|1|||
164505658|NCT01850030|594221194|FG000|Overall Study|Lost to Follow-up|5|||
164505659|NCT01850030|594221195|FG001|Overall Study|Lost to Follow-up|5|||
164505660|NCT01850030|594221194|FG000|Overall Study|Withdrawal by Subject|3|||
164505661|NCT01850030|594221195|FG001|Overall Study|Withdrawal by Subject|4|||
164505662|NCT01850030|594221194|FG000|Overall Study|Protocol Violation|24|||
164505663|NCT01850030|594221195|FG001|Overall Study|Protocol Violation|28|||
164505664|NCT01850030|594221194|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
164505665|NCT01850030|594221195|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
164505666|NCT02688530|594221199|FG000|Overall Study|Withdrawal by Subject|0|||
164505667|NCT02688530|594221200|FG001|Overall Study|Withdrawal by Subject|1|||
164505668|NCT02688530|594221201|FG002|Overall Study|Withdrawal by Subject|0|||
164505669|NCT02688530|594221202|FG003|Overall Study|Withdrawal by Subject|0|||
164505670|NCT02688530|594221199|FG000|Overall Study|Lost to Follow-up|0|||
164505671|NCT02688530|594221200|FG001|Overall Study|Lost to Follow-up|0|||
164505672|NCT02688530|594221201|FG002|Overall Study|Lost to Follow-up|2|||
164505673|NCT02688530|594221202|FG003|Overall Study|Lost to Follow-up|0|||
164505674|NCT01658020|594221203|FG000|Overall Study|Adverse Event|3|||
164505675|NCT01658020|594221204|FG001|Overall Study|Adverse Event|3|||
164505676|NCT01658020|594221203|FG000|Overall Study|Lost to Follow-up|1|||
164505677|NCT01658020|594221204|FG001|Overall Study|Lost to Follow-up|0|||
164505678|NCT01658020|594221203|FG000|Overall Study|Withdrawal by Subject|4|||
164505679|NCT01658020|594221204|FG001|Overall Study|Withdrawal by Subject|5|||
164505680|NCT01658020|594221203|FG000|Overall Study|Protocol Violation|0|||
164505681|NCT01658020|594221204|FG001|Overall Study|Protocol Violation|1|||
164505682|NCT00087555|594221205|FG000|Overall Study|Adverse Event|3|||
164505683|NCT00087555|594221206|FG001|Overall Study|Adverse Event|6|||
164505684|NCT00087555|594221207|FG002|Overall Study|Adverse Event|14|||
164505685|NCT00087555|594221205|FG000|Overall Study|Lost to Follow-up|0|||
164505686|NCT00087555|594221206|FG001|Overall Study|Lost to Follow-up|1|||
164505687|NCT00087555|594221207|FG002|Overall Study|Lost to Follow-up|1|||
164505688|NCT00087555|594221205|FG000|Overall Study|Non - Compliance|1|||
164505689|NCT00087555|594221206|FG001|Overall Study|Non - Compliance|0|||
164505690|NCT00087555|594221207|FG002|Overall Study|Non - Compliance|0|||
164505691|NCT00087555|594221205|FG000|Overall Study|Protocol Violation|0|||
164505692|NCT00087555|594221206|FG001|Overall Study|Protocol Violation|0|||
164505693|NCT00087555|594221207|FG002|Overall Study|Protocol Violation|2|||
164505694|NCT00087555|594221205|FG000|Overall Study|Screen Failure|1|||
164505695|NCT00087555|594221206|FG001|Overall Study|Screen Failure|1|||
164505696|NCT00087555|594221207|FG002|Overall Study|Screen Failure|0|||
164505697|NCT00087555|594221205|FG000|Overall Study|Pregnancy|0|||
164505698|NCT00087555|594221206|FG001|Overall Study|Pregnancy|1|||
164505699|NCT00087555|594221207|FG002|Overall Study|Pregnancy|1|||
164505700|NCT00087555|594221205|FG000|Overall Study|Withdrawal by Subject|3|||
164505701|NCT00087555|594221206|FG001|Overall Study|Withdrawal by Subject|2|||
164505702|NCT00087555|594221207|FG002|Overall Study|Withdrawal by Subject|1|||
164505703|NCT00087555|594221205|FG000|Overall Study|Lack of Efficacy|2|||
164505704|NCT00087555|594221206|FG001|Overall Study|Lack of Efficacy|0|||
164505705|NCT00087555|594221207|FG002|Overall Study|Lack of Efficacy|1|||
164505706|NCT00087555|594221205|FG000|Overall Study|Non Compliance|0|||
164505707|NCT00087555|594221206|FG001|Overall Study|Non Compliance|0|||
164505708|NCT00087555|594221207|FG002|Overall Study|Non Compliance|1|||
164505709|NCT00087555|594221205|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
164505710|NCT00087555|594221206|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
164505711|NCT00087555|594221207|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
164505712|NCT00087555|594221205|FG000|Overall Study|Patient wanted to go back on Med|1|||
164505713|NCT00087555|594221206|FG001|Overall Study|Patient wanted to go back on Med|0|||
164505714|NCT00087555|594221207|FG002|Overall Study|Patient wanted to go back on Med|0|||
164607007|NCT02455388|594583415|FG002|Overall Study|Protocol Violation|4|||
164505715|NCT03698019|594221212|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
164607008|NCT02455388|594583413|FG000|Overall Study|Withdrawal by Subject|0|||
164607009|NCT02455388|594583414|FG001|Overall Study|Withdrawal by Subject|0|||
164505716|NCT03698019|594221213|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
164505717|NCT03698019|594221212|FG000|Step 1: Registration|Withdrawal by Subject|7|||
164505718|NCT03698019|594221213|FG001|Step 1: Registration|Withdrawal by Subject|2|||
164505719|NCT03698019|594221212|FG000|Step 1: Registration|Toxicity|0|||
164505720|NCT03698019|594221213|FG001|Step 1: Registration|Toxicity|1|||
164505721|NCT03698019|594221212|FG000|Step 1: Registration|Disease Progression|0|||
164505722|NCT03698019|594221213|FG001|Step 1: Registration|Disease Progression|12|||
164505723|NCT03698019|594221212|FG000|Step 1: Registration|Co-morbidities|0|||
164505724|NCT03698019|594221213|FG001|Step 1: Registration|Co-morbidities|1|||
164505725|NCT03698019|594221212|FG000|Step 1: Registration|Scheduling Issues|1|||
164505726|NCT03698019|594221213|FG001|Step 1: Registration|Scheduling Issues|0|||
164505727|NCT03698019|594221212|FG000|Step 1: Registration|Participant Refusal|0|||
164505728|NCT03698019|594221213|FG001|Step 1: Registration|Participant Refusal|1|||
164505729|NCT03698019|594221212|FG000|Step 2: Surgery|Participant Refusal|2|||
164505730|NCT03698019|594221213|FG001|Step 2: Surgery|Participant Refusal|1|||
164505731|NCT03698019|594221212|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
164505732|NCT03698019|594221213|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
164505733|NCT03698019|594221212|FG000|Step 2: Surgery|Metastatic Disease|16|||
164505734|NCT03698019|594221213|FG001|Step 2: Surgery|Metastatic Disease|9|||
164505735|NCT03698019|594221212|FG000|Step 2: Surgery|Residual Disease|2|||
164505736|NCT03698019|594221213|FG001|Step 2: Surgery|Residual Disease|1|||
164505737|NCT03698019|594221212|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
164505738|NCT03698019|594221213|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
164505739|NCT03698019|594221212|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
164505740|NCT03698019|594221213|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
164505741|NCT03698019|594221212|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
164505742|NCT03698019|594221213|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
164505743|NCT03698019|594221212|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
164505744|NCT03698019|594221213|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
164505745|NCT03698019|594221212|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
164505746|NCT03698019|594221213|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
164505747|NCT03698019|594221212|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
164505748|NCT03698019|594221213|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
164505749|NCT03698019|594221212|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
164505750|NCT03698019|594221213|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
164505751|NCT03698019|594221212|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
164505752|NCT03698019|594221213|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
164505753|NCT03668223|594221214|FG000|Overall Study|Death|10|||
164505754|NCT03668223|594221215|FG001|Overall Study|Death|5|||
164505755|NCT03668223|594221214|FG000|Overall Study|Lost to Follow-up|12|||
164505756|NCT03668223|594221215|FG001|Overall Study|Lost to Follow-up|12|||
164505757|NCT03668223|594221214|FG000|Overall Study|Withdrawal by Subject|8|||
164505758|NCT03668223|594221215|FG001|Overall Study|Withdrawal by Subject|3|||
164505759|NCT05502783|594221216|FG000|Overall Study|Lack of Efficacy|1|||
164505760|NCT02035696|594223096|FG000|Overall Study|Lost to Follow-up|0|||
164505761|NCT02035696|594223097|FG001|Overall Study|Lost to Follow-up|3|||
164505762|NCT02035696|594223098|FG002|Overall Study|Lost to Follow-up|1|||
164505763|NCT02035696|594223099|FG003|Overall Study|Lost to Follow-up|2|||
164505764|NCT02035696|594223096|FG000|Overall Study|Withdrawal by Subject|3|||
164505765|NCT02035696|594223097|FG001|Overall Study|Withdrawal by Subject|0|||
164505766|NCT02035696|594223098|FG002|Overall Study|Withdrawal by Subject|2|||
164505767|NCT02035696|594223099|FG003|Overall Study|Withdrawal by Subject|1|||
164505768|NCT00379769|594223100|FG000|Main Study|Death|57|||
164505769|NCT00379769|594223101|FG001|Main Study|Death|67|||
164505770|NCT00379769|594223102|FG002|Main Study|Death|54|||
164505771|NCT00379769|594223103|FG003|Main Study|Death|72|||
164505772|NCT00379769|594223104|FG004|Main Study|Death|0|||
164505773|NCT00379769|594223105|FG005|Main Study|Death|0|||
164505774|NCT00379769|594223100|FG000|Main Study|Adverse Event|5|||
164505775|NCT00379769|594223101|FG001|Main Study|Adverse Event|8|||
164505776|NCT00379769|594223102|FG002|Main Study|Adverse Event|10|||
164505777|NCT00379769|594223103|FG003|Main Study|Adverse Event|11|||
164505778|NCT00379769|594223104|FG004|Main Study|Adverse Event|0|||
164505779|NCT00379769|594223105|FG005|Main Study|Adverse Event|0|||
164505780|NCT00379769|594223100|FG000|Main Study|Lost to Follow-up|29|||
164505781|NCT00379769|594223101|FG001|Main Study|Lost to Follow-up|29|||
164505782|NCT00379769|594223102|FG002|Main Study|Lost to Follow-up|25|||
164505783|NCT00379769|594223103|FG003|Main Study|Lost to Follow-up|26|||
164505784|NCT00379769|594223104|FG004|Main Study|Lost to Follow-up|0|||
164505785|NCT00379769|594223105|FG005|Main Study|Lost to Follow-up|0|||
164505786|NCT00379769|594223100|FG000|Main Study|Withdrawal by Subject|46|||
164505787|NCT00379769|594223101|FG001|Main Study|Withdrawal by Subject|56|||
164505788|NCT00379769|594223102|FG002|Main Study|Withdrawal by Subject|72|||
164505789|NCT00379769|594223103|FG003|Main Study|Withdrawal by Subject|70|||
164505790|NCT00379769|594223104|FG004|Main Study|Withdrawal by Subject|0|||
164505791|NCT00379769|594223105|FG005|Main Study|Withdrawal by Subject|0|||
164505792|NCT00379769|594223100|FG000|Main Study|Moved to survival status follow-up only|27|||
164505793|NCT00379769|594223101|FG001|Main Study|Moved to survival status follow-up only|25|||
164505794|NCT00379769|594223102|FG002|Main Study|Moved to survival status follow-up only|32|||
164505795|NCT00379769|594223103|FG003|Main Study|Moved to survival status follow-up only|36|||
164505796|NCT00379769|594223104|FG004|Main Study|Moved to survival status follow-up only|0|||
164505797|NCT00379769|594223105|FG005|Main Study|Moved to survival status follow-up only|0|||
164505798|NCT00379769|594223100|FG000|Main Study|Participant moved|3|||
164505799|NCT00379769|594223101|FG001|Main Study|Participant moved|2|||
164505800|NCT00379769|594223102|FG002|Main Study|Participant moved|3|||
164505801|NCT00379769|594223103|FG003|Main Study|Participant moved|3|||
164505802|NCT00379769|594223104|FG004|Main Study|Participant moved|0|||
164505803|NCT00379769|594223105|FG005|Main Study|Participant moved|0|||
164505804|NCT00379769|594223100|FG000|Main Study|Poor compliance|3|||
164505805|NCT00379769|594223101|FG001|Main Study|Poor compliance|2|||
164505806|NCT00379769|594223102|FG002|Main Study|Poor compliance|2|||
164505807|NCT00379769|594223103|FG003|Main Study|Poor compliance|1|||
164505808|NCT00379769|594223104|FG004|Main Study|Poor compliance|0|||
164505809|NCT00379769|594223105|FG005|Main Study|Poor compliance|0|||
164505810|NCT00379769|594223100|FG000|Main Study|Prohibited glucose lowering medication|0|||
164505811|NCT00379769|594223101|FG001|Main Study|Prohibited glucose lowering medication|3|||
164505812|NCT00379769|594223102|FG002|Main Study|Prohibited glucose lowering medication|0|||
164505813|NCT00379769|594223103|FG003|Main Study|Prohibited glucose lowering medication|1|||
164505814|NCT00379769|594223104|FG004|Main Study|Prohibited glucose lowering medication|0|||
164505815|NCT00379769|594223105|FG005|Main Study|Prohibited glucose lowering medication|0|||
164505816|NCT00379769|594223100|FG000|Main Study|Site closed|4|||
164505817|NCT00379769|594223101|FG001|Main Study|Site closed|4|||
164505818|NCT00379769|594223102|FG002|Main Study|Site closed|4|||
164505819|NCT00379769|594223103|FG003|Main Study|Site closed|8|||
164505820|NCT00379769|594223104|FG004|Main Study|Site closed|0|||
164505821|NCT00379769|594223105|FG005|Main Study|Site closed|0|||
164505822|NCT00379769|594223100|FG000|Main Study|Entry criteria violation|0|||
164505823|NCT00379769|594223101|FG001|Main Study|Entry criteria violation|0|||
164505824|NCT00379769|594223102|FG002|Main Study|Entry criteria violation|1|||
164505825|NCT00379769|594223103|FG003|Main Study|Entry criteria violation|1|||
164505826|NCT00379769|594223104|FG004|Main Study|Entry criteria violation|0|||
164505827|NCT00379769|594223105|FG005|Main Study|Entry criteria violation|0|||
164505828|NCT00379769|594223100|FG000|Main Study|Participant did not take study drug|0|||
164505829|NCT00379769|594223101|FG001|Main Study|Participant did not take study drug|0|||
164505830|NCT00379769|594223102|FG002|Main Study|Participant did not take study drug|1|||
164505831|NCT00379769|594223103|FG003|Main Study|Participant did not take study drug|0|||
164505832|NCT00379769|594223104|FG004|Main Study|Participant did not take study drug|0|||
164505833|NCT00379769|594223105|FG005|Main Study|Participant did not take study drug|0|||
164505834|NCT00379769|594223100|FG000|Main Study|Physician Decision|2|||
164505835|NCT00379769|594223101|FG001|Main Study|Physician Decision|2|||
164505836|NCT00379769|594223102|FG002|Main Study|Physician Decision|1|||
164505837|NCT00379769|594223103|FG003|Main Study|Physician Decision|1|||
164505838|NCT00379769|594223104|FG004|Main Study|Physician Decision|0|||
164505839|NCT00379769|594223105|FG005|Main Study|Physician Decision|0|||
164505840|NCT00379769|594223100|FG000|Main Study|Participant completed study at visit 27|1|||
164505841|NCT00379769|594223101|FG001|Main Study|Participant completed study at visit 27|0|||
164505842|NCT00379769|594223102|FG002|Main Study|Participant completed study at visit 27|0|||
164505843|NCT00379769|594223103|FG003|Main Study|Participant completed study at visit 27|0|||
164505844|NCT00379769|594223104|FG004|Main Study|Participant completed study at visit 27|0|||
164505845|NCT00379769|594223105|FG005|Main Study|Participant completed study at visit 27|0|||
164505846|NCT00379769|594223100|FG000|Main Study|Personal reasons|1|||
164505847|NCT00379769|594223101|FG001|Main Study|Personal reasons|0|||
164505848|NCT00379769|594223102|FG002|Main Study|Personal reasons|0|||
164505849|NCT00379769|594223103|FG003|Main Study|Personal reasons|0|||
164505850|NCT00379769|594223104|FG004|Main Study|Personal reasons|0|||
164505851|NCT00379769|594223105|FG005|Main Study|Personal reasons|0|||
164505852|NCT00379769|594223100|FG000|Main Study|Risk of heart failure|0|||
164505853|NCT00379769|594223101|FG001|Main Study|Risk of heart failure|1|||
164505854|NCT00379769|594223102|FG002|Main Study|Risk of heart failure|0|||
164505855|NCT00379769|594223103|FG003|Main Study|Risk of heart failure|0|||
164505856|NCT00379769|594223104|FG004|Main Study|Risk of heart failure|0|||
164505857|NCT00379769|594223105|FG005|Main Study|Risk of heart failure|0|||
164505858|NCT00379769|594223100|FG000|Main Study|Investigator refused to log temperature|0|||
164505859|NCT00379769|594223101|FG001|Main Study|Investigator refused to log temperature|0|||
164505860|NCT00379769|594223102|FG002|Main Study|Investigator refused to log temperature|1|||
164505861|NCT00379769|594223103|FG003|Main Study|Investigator refused to log temperature|0|||
164505862|NCT00379769|594223104|FG004|Main Study|Investigator refused to log temperature|0|||
164505863|NCT00379769|594223105|FG005|Main Study|Investigator refused to log temperature|0|||
164505864|NCT00379769|594223100|FG000|Main Study|Reason unspecified|0|||
164505865|NCT00379769|594223101|FG001|Main Study|Reason unspecified|0|||
164505866|NCT00379769|594223102|FG002|Main Study|Reason unspecified|1|||
164505867|NCT00379769|594223103|FG003|Main Study|Reason unspecified|0|||
164505868|NCT00379769|594223104|FG004|Main Study|Reason unspecified|0|||
164505869|NCT00379769|594223105|FG005|Main Study|Reason unspecified|0|||
164505870|NCT00379769|594223100|FG000|Observational Follow-up|Death|0|||
164505871|NCT00379769|594223101|FG001|Observational Follow-up|Death|0|||
164505872|NCT00379769|594223102|FG002|Observational Follow-up|Death|0|||
164505873|NCT00379769|594223103|FG003|Observational Follow-up|Death|0|||
164505874|NCT00379769|594223104|FG004|Observational Follow-up|Death|78|||
164505875|NCT00379769|594223105|FG005|Observational Follow-up|Death|70|||
164505876|NCT00379769|594223100|FG000|Observational Follow-up|Adverse Event|0|||
164505877|NCT00379769|594223101|FG001|Observational Follow-up|Adverse Event|0|||
164505878|NCT00379769|594223102|FG002|Observational Follow-up|Adverse Event|0|||
164505879|NCT00379769|594223103|FG003|Observational Follow-up|Adverse Event|0|||
164505880|NCT00379769|594223104|FG004|Observational Follow-up|Adverse Event|1|||
164505881|NCT00379769|594223105|FG005|Observational Follow-up|Adverse Event|0|||
164505882|NCT00379769|594223100|FG000|Observational Follow-up|Lost to Follow-up|0|||
164505883|NCT00379769|594223101|FG001|Observational Follow-up|Lost to Follow-up|0|||
164505884|NCT00379769|594223102|FG002|Observational Follow-up|Lost to Follow-up|0|||
164505885|NCT00379769|594223103|FG003|Observational Follow-up|Lost to Follow-up|0|||
164505886|NCT00379769|594223104|FG004|Observational Follow-up|Lost to Follow-up|25|||
164505887|NCT00379769|594223105|FG005|Observational Follow-up|Lost to Follow-up|27|||
164505888|NCT00379769|594223100|FG000|Observational Follow-up|Withdrawal by Subject|0|||
164505889|NCT00379769|594223101|FG001|Observational Follow-up|Withdrawal by Subject|0|||
164505890|NCT00379769|594223102|FG002|Observational Follow-up|Withdrawal by Subject|0|||
164505891|NCT00379769|594223103|FG003|Observational Follow-up|Withdrawal by Subject|0|||
164505892|NCT00379769|594223104|FG004|Observational Follow-up|Withdrawal by Subject|12|||
164505893|NCT00379769|594223105|FG005|Observational Follow-up|Withdrawal by Subject|12|||
164505894|NCT00379769|594223100|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
164505895|NCT00379769|594223101|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
164505896|NCT00379769|594223102|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
164505897|NCT00379769|594223103|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
164505898|NCT00379769|594223104|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
164505899|NCT00379769|594223105|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
164505900|NCT00379769|594223100|FG000|Observational Follow-up|Physician Decision|0|||
164505901|NCT00379769|594223101|FG001|Observational Follow-up|Physician Decision|0|||
164505902|NCT00379769|594223102|FG002|Observational Follow-up|Physician Decision|0|||
164505903|NCT00379769|594223103|FG003|Observational Follow-up|Physician Decision|0|||
164505904|NCT00379769|594223104|FG004|Observational Follow-up|Physician Decision|8|||
164505905|NCT00379769|594223105|FG005|Observational Follow-up|Physician Decision|8|||
164505906|NCT00379769|594223100|FG000|Observational Follow-up|Site Closed Early|0|||
164505907|NCT00379769|594223101|FG001|Observational Follow-up|Site Closed Early|0|||
164505908|NCT00379769|594223102|FG002|Observational Follow-up|Site Closed Early|0|||
164505909|NCT00379769|594223103|FG003|Observational Follow-up|Site Closed Early|0|||
164505910|NCT00379769|594223104|FG004|Observational Follow-up|Site Closed Early|6|||
164505911|NCT00379769|594223105|FG005|Observational Follow-up|Site Closed Early|7|||
164505912|NCT00379769|594223100|FG000|Observational Follow-up|Participant Moved|0|||
164505913|NCT00379769|594223101|FG001|Observational Follow-up|Participant Moved|0|||
164505914|NCT00379769|594223102|FG002|Observational Follow-up|Participant Moved|0|||
164505915|NCT00379769|594223103|FG003|Observational Follow-up|Participant Moved|0|||
164505916|NCT00379769|594223104|FG004|Observational Follow-up|Participant Moved|0|||
164505917|NCT00379769|594223105|FG005|Observational Follow-up|Participant Moved|1|||
164505918|NCT00379769|594223100|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
164505919|NCT00379769|594223101|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
164505920|NCT00379769|594223102|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
164505921|NCT00379769|594223103|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
164505922|NCT00379769|594223104|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
164505923|NCT00379769|594223105|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
164505924|NCT01689363|594223112|FG000|Overall Study|Protocol Violation|0|||
164505925|NCT01689363|594223113|FG001|Overall Study|Protocol Violation|1|||
164505926|NCT01689363|594223114|FG002|Overall Study|Protocol Violation|0|||
164505927|NCT01689363|594223115|FG003|Overall Study|Protocol Violation|0|||
164505928|NCT01689363|594223116|FG004|Overall Study|Protocol Violation|0|||
164505929|NCT01689363|594223117|FG005|Overall Study|Protocol Violation|0|||
164505930|NCT01689363|594223118|FG006|Overall Study|Protocol Violation|0|||
164505931|NCT01689363|594223119|FG007|Overall Study|Protocol Violation|0|||
164505932|NCT00321685|594223120|FG000|Overall Study|Adverse Event|18|||
164505933|NCT00321685|594223120|FG000|Overall Study|Death|2|||
164505934|NCT00321685|594223120|FG000|Overall Study|Withdrawal by Subject|8|||
164505935|NCT00321685|594223120|FG000|Overall Study|Alternative therapy|1|||
164505936|NCT00321685|594223120|FG000|Overall Study|Complicating disese|1|||
164505937|NCT00321685|594223120|FG000|Overall Study|Other|5|||
164505938|NCT00321685|594223120|FG000|Overall Study|Not start protocol therapy|2|||
164505939|NCT00321685|594223120|FG000|Overall Study|Ineligible|2|||
164505940|NCT05064488|594223124|FG000|Overall Study|Withdrawal by Subject|2|||
164505941|NCT05064488|594223125|FG001|Overall Study|Withdrawal by Subject|0|||
164505942|NCT00667459|594223129|FG000|Overall Study|Death|0|||
164505943|NCT00667459|594223130|FG001|Overall Study|Death|2|||
164505944|NCT00667459|594223129|FG000|Overall Study|Lost to Follow-up|8|||
164505945|NCT00667459|594223130|FG001|Overall Study|Lost to Follow-up|43|||
164505946|NCT04546217|594223133|FG000|Overall Study|Withdrawal by Subject|2|||
164505947|NCT04546217|594223134|FG001|Overall Study|Withdrawal by Subject|0|||
164505948|NCT04546217|594223133|FG000|Overall Study|Uncontrolled hypertension|1|||
164505949|NCT04546217|594223134|FG001|Overall Study|Uncontrolled hypertension|0|||
164505950|NCT02550938|594223135|FG000|Overall Study|Lost to Follow-up|8|||
164505951|NCT02550938|594223136|FG001|Overall Study|Lost to Follow-up|7|||
164505952|NCT02550938|594223137|FG002|Overall Study|Lost to Follow-up|12|||
164505953|NCT02550938|594223138|FG003|Overall Study|Lost to Follow-up|11|||
164505954|NCT04082429|594223141|FG000|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
164505955|NCT04082429|594223142|FG001|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
164505956|NCT04082429|594223143|FG002|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
164505957|NCT04082429|594223144|FG003|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
164505958|NCT04082429|594223145|FG004|Main Part (Before the Treatment Pause)|Withdrawal by Subject|3|||
164505959|NCT04082429|594223146|FG005|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
164505960|NCT04082429|594223147|FG006|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
164505961|NCT04082429|594223148|FG007|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
164505962|NCT04082429|594223149|FG008|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
164505963|NCT04082429|594223141|FG000|Main Part (Before the Treatment Pause)|Physician Decision|0|||
164505964|NCT04082429|594223142|FG001|Main Part (Before the Treatment Pause)|Physician Decision|0|||
164505965|NCT04082429|594223143|FG002|Main Part (Before the Treatment Pause)|Physician Decision|0|||
164505966|NCT04082429|594223144|FG003|Main Part (Before the Treatment Pause)|Physician Decision|0|||
164505967|NCT04082429|594223145|FG004|Main Part (Before the Treatment Pause)|Physician Decision|2|||
164505968|NCT04082429|594223146|FG005|Main Part (Before the Treatment Pause)|Physician Decision|0|||
164505969|NCT04082429|594223147|FG006|Main Part (Before the Treatment Pause)|Physician Decision|0|||
164505970|NCT04082429|594223148|FG007|Main Part (Before the Treatment Pause)|Physician Decision|0|||
164505971|NCT04082429|594223149|FG008|Main Part (Before the Treatment Pause)|Physician Decision|0|||
164505972|NCT04082429|594223141|FG000|Main Part (After the Treatment Pause)|Death|0|||
164505973|NCT04082429|594223142|FG001|Main Part (After the Treatment Pause)|Death|0|||
164505974|NCT04082429|594223143|FG002|Main Part (After the Treatment Pause)|Death|0|||
164505975|NCT04082429|594223144|FG003|Main Part (After the Treatment Pause)|Death|0|||
164505976|NCT04082429|594223145|FG004|Main Part (After the Treatment Pause)|Death|1|||
164505977|NCT04082429|594223146|FG005|Main Part (After the Treatment Pause)|Death|0|||
164505978|NCT04082429|594223147|FG006|Main Part (After the Treatment Pause)|Death|0|||
164505979|NCT04082429|594223148|FG007|Main Part (After the Treatment Pause)|Death|0|||
164505980|NCT04082429|594223149|FG008|Main Part (After the Treatment Pause)|Death|0|||
164505981|NCT04082429|594223141|FG000|Main Part (After the Treatment Pause)|Physician Decision|0|||
164505982|NCT04082429|594223142|FG001|Main Part (After the Treatment Pause)|Physician Decision|0|||
164505983|NCT04082429|594223143|FG002|Main Part (After the Treatment Pause)|Physician Decision|0|||
164505984|NCT04082429|594223144|FG003|Main Part (After the Treatment Pause)|Physician Decision|2|||
164505985|NCT04082429|594223145|FG004|Main Part (After the Treatment Pause)|Physician Decision|0|||
164505986|NCT04082429|594223146|FG005|Main Part (After the Treatment Pause)|Physician Decision|1|||
164505987|NCT04082429|594223147|FG006|Main Part (After the Treatment Pause)|Physician Decision|0|||
164505988|NCT04082429|594223148|FG007|Main Part (After the Treatment Pause)|Physician Decision|0|||
164505989|NCT04082429|594223149|FG008|Main Part (After the Treatment Pause)|Physician Decision|0|||
164505990|NCT04082429|594223141|FG000|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
164505991|NCT04082429|594223142|FG001|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
164505992|NCT04082429|594223143|FG002|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
164505993|NCT04082429|594223144|FG003|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
164505994|NCT04082429|594223145|FG004|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
164505995|NCT04082429|594223146|FG005|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
164505996|NCT04082429|594223147|FG006|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
164505997|NCT04082429|594223148|FG007|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
164505998|NCT04082429|594223149|FG008|Main Part (After the Treatment Pause)|Withdrawal by Subject|5|||
164505999|NCT04082429|594223141|FG000|Main Part (After the Treatment Pause)|Unspecified reason|2|||
164506000|NCT04082429|594223142|FG001|Main Part (After the Treatment Pause)|Unspecified reason|0|||
164506001|NCT04082429|594223143|FG002|Main Part (After the Treatment Pause)|Unspecified reason|0|||
164506002|NCT04082429|594223144|FG003|Main Part (After the Treatment Pause)|Unspecified reason|0|||
164506003|NCT04082429|594223145|FG004|Main Part (After the Treatment Pause)|Unspecified reason|0|||
164506004|NCT04082429|594223146|FG005|Main Part (After the Treatment Pause)|Unspecified reason|1|||
164506005|NCT04082429|594223147|FG006|Main Part (After the Treatment Pause)|Unspecified reason|0|||
164506006|NCT04082429|594223148|FG007|Main Part (After the Treatment Pause)|Unspecified reason|0|||
164506007|NCT04082429|594223149|FG008|Main Part (After the Treatment Pause)|Unspecified reason|0|||
164506008|NCT04082429|594223141|FG000|Extension Part|Ongoing|0|||
164506009|NCT04082429|594223142|FG001|Extension Part|Ongoing|7|||
164506010|NCT04082429|594223143|FG002|Extension Part|Ongoing|17|||
164506011|NCT04082429|594223144|FG003|Extension Part|Ongoing|6|||
164506012|NCT04082429|594223145|FG004|Extension Part|Ongoing|45|||
164506013|NCT04082429|594223146|FG005|Extension Part|Ongoing|0|||
164506014|NCT04082429|594223147|FG006|Extension Part|Ongoing|10|||
164506015|NCT04082429|594223148|FG007|Extension Part|Ongoing|23|||
164506016|NCT04082429|594223149|FG008|Extension Part|Ongoing|25|||
164506017|NCT00334542|594223150|FG000|Overall Study|Adverse Event|3|||
164506018|NCT00334542|594223150|FG000|Overall Study|Withdrawal by Subject|1|||
164506019|NCT00334542|594223150|FG000|Overall Study|New cancer diagnosis|1|||
164506020|NCT01454739|594223154|FG000|Overall Study|Protocol Violation|2|||
164506021|NCT01454739|594223155|FG001|Overall Study|Protocol Violation|3|||
164506022|NCT01454739|594223154|FG000|Overall Study|Withdrawal by Subject|2|||
164506023|NCT01454739|594223155|FG001|Overall Study|Withdrawal by Subject|6|||
164506024|NCT01454739|594223154|FG000|Overall Study|Other|3|||
164506025|NCT01454739|594223155|FG001|Overall Study|Other|5|||
164506026|NCT01454739|594223154|FG000|Overall Study|Physician Decision|0|||
164506027|NCT01454739|594223155|FG001|Overall Study|Physician Decision|5|||
164506028|NCT01454739|594223154|FG000|Overall Study|Lost to Follow-up|0|||
164506029|NCT01454739|594223155|FG001|Overall Study|Lost to Follow-up|1|||
164506030|NCT01454739|594223154|FG000|Overall Study|Adverse Event|0|||
164506031|NCT01454739|594223155|FG001|Overall Study|Adverse Event|1|||
164506032|NCT05765435|594223156|FG000|Overall Study|Lost to Follow-up|0|||
164506033|NCT05765435|594223157|FG001|Overall Study|Lost to Follow-up|1|||
164506034|NCT05765435|594223158|FG002|Overall Study|Lost to Follow-up|0|||
164506035|NCT05765435|594223156|FG000|Overall Study|Withdrawal by Subject|0|||
164506036|NCT05765435|594223157|FG001|Overall Study|Withdrawal by Subject|0|||
164506037|NCT05765435|594223158|FG002|Overall Study|Withdrawal by Subject|1|||
164506038|NCT04328623|594223159|FG000|Overall Study|Protocol Violation|0|||
164506039|NCT04328623|594223160|FG001|Overall Study|Protocol Violation|1|||
164506040|NCT02312557|594223161|FG000|Overall Study|Survival follow-up|4|||
164506041|NCT04351269|594223162|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
164506042|NCT04351269|594223163|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
164506043|NCT04351269|594223164|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
164506044|NCT04351269|594223162|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
164506045|NCT04351269|594223163|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
164506046|NCT04351269|594223164|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
164506047|NCT04351269|594223162|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
164506048|NCT04351269|594223163|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
164506049|NCT04351269|594223164|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
164506050|NCT04351269|594223162|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
164506051|NCT04351269|594223163|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
164506052|NCT04351269|594223164|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
164506053|NCT04351269|594223162|FG000|Overall Study|Lost to Follow-up|1|||
164506054|NCT04351269|594223163|FG001|Overall Study|Lost to Follow-up|3|||
164506055|NCT04351269|594223164|FG002|Overall Study|Lost to Follow-up|0|||
164506056|NCT04486313|594223169|FG000|Overall Study|Lost to Follow-up|7|||
164506057|NCT04486313|594223170|FG001|Overall Study|Lost to Follow-up|9|||
164506058|NCT04486313|594223169|FG000|Overall Study|Withdrawal by Subject|8|||
164506059|NCT04486313|594223170|FG001|Overall Study|Withdrawal by Subject|6|||
164506060|NCT04486313|594223169|FG000|Overall Study|Physician Decision|1|||
164506061|NCT04486313|594223170|FG001|Overall Study|Physician Decision|1|||
164506062|NCT04486313|594223169|FG000|Overall Study|Death|2|||
164506063|NCT04486313|594223170|FG001|Overall Study|Death|0|||
164506064|NCT04486313|594223169|FG000|Overall Study|Protocol Violation|1|||
164506065|NCT04486313|594223170|FG001|Overall Study|Protocol Violation|1|||
164506066|NCT02980523|594223176|FG000|Overall Study|Lost to Follow-up|1|||
164506067|NCT02980523|594223177|FG001|Overall Study|Lost to Follow-up|4|||
164506068|NCT02980523|594223178|FG002|Overall Study|Lost to Follow-up|1|||
164506069|NCT02980523|594223179|FG003|Overall Study|Lost to Follow-up|2|||
164506070|NCT02980523|594223180|FG004|Overall Study|Lost to Follow-up|1|||
164506071|NCT02980523|594223176|FG000|Overall Study|Excluded from analysis|1|||
164506072|NCT02980523|594223177|FG001|Overall Study|Excluded from analysis|3|||
164506073|NCT02980523|594223178|FG002|Overall Study|Excluded from analysis|1|||
164506074|NCT02980523|594223179|FG003|Overall Study|Excluded from analysis|1|||
164506075|NCT02980523|594223180|FG004|Overall Study|Excluded from analysis|1|||
164506076|NCT02980523|594223176|FG000|Overall Study|Lack of Efficacy|1|||
164506077|NCT02980523|594223177|FG001|Overall Study|Lack of Efficacy|4|||
164506078|NCT02980523|594223178|FG002|Overall Study|Lack of Efficacy|4|||
164506079|NCT02980523|594223179|FG003|Overall Study|Lack of Efficacy|5|||
164506080|NCT02980523|594223180|FG004|Overall Study|Lack of Efficacy|8|||
164506081|NCT02980523|594223176|FG000|Overall Study|Did not receive intervention|0|||
164506082|NCT02980523|594223177|FG001|Overall Study|Did not receive intervention|0|||
164506083|NCT02980523|594223178|FG002|Overall Study|Did not receive intervention|0|||
164506084|NCT02980523|594223179|FG003|Overall Study|Did not receive intervention|1|||
164506085|NCT02980523|594223180|FG004|Overall Study|Did not receive intervention|0|||
164506086|NCT01850589|594223181|FG000|Overall Study|Withdrawal by Subject|8|||
164506087|NCT01850589|594223182|FG001|Overall Study|Withdrawal by Subject|0|||
164506088|NCT03721705|594223192|FG000|Overall Study|Adverse Event|2|||
164506089|NCT03721705|594223193|FG001|Overall Study|Adverse Event|0|||
164506090|NCT03721705|594223192|FG000|Overall Study|Withdrawal by Subject|4|||
164506091|NCT03721705|594223193|FG001|Overall Study|Withdrawal by Subject|10|||
164506092|NCT03721705|594223192|FG000|Overall Study|No Suitable Study Partner|1|||
164506093|NCT03721705|594223193|FG001|Overall Study|No Suitable Study Partner|0|||
164506094|NCT03721705|594223192|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
164506095|NCT03721705|594223193|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
164506096|NCT03721705|594223192|FG000|Overall Study|Death|0|||
164506097|NCT03721705|594223193|FG001|Overall Study|Death|1|||
164506098|NCT02402322|594223196|FG000|Pretreatment|Withdrawal by Subject|3|||
164506099|NCT02402322|594223197|FG001|Pretreatment|Withdrawal by Subject|1|||
164506100|NCT02402322|594223198|FG002|Pretreatment|Withdrawal by Subject|1|||
164506101|NCT02402322|594223196|FG000|Follow-up|Withdrawal by Subject|6|||
164506102|NCT02402322|594223197|FG001|Follow-up|Withdrawal by Subject|3|||
164506103|NCT02402322|594223198|FG002|Follow-up|Withdrawal by Subject|24|||
164506104|NCT02818998|594223199|FG000|Overall Study|Adverse Event|3|||
164506105|NCT02818998|594223200|FG001|Overall Study|Adverse Event|2|||
164506106|NCT02818998|594223201|FG002|Overall Study|Adverse Event|1|||
164506107|NCT02818998|594223199|FG000|Overall Study|Lost to Follow-up|4|||
164506108|NCT02818998|594223200|FG001|Overall Study|Lost to Follow-up|1|||
164506109|NCT02818998|594223201|FG002|Overall Study|Lost to Follow-up|2|||
164506110|NCT02818998|594223199|FG000|Overall Study|Withdrawal by sponsor|0|||
164506111|NCT02818998|594223200|FG001|Overall Study|Withdrawal by sponsor|1|||
164506112|NCT02818998|594223201|FG002|Overall Study|Withdrawal by sponsor|1|||
164506113|NCT02818998|594223199|FG000|Overall Study|Death|3|||
164506114|NCT02818998|594223200|FG001|Overall Study|Death|6|||
164506115|NCT02818998|594223201|FG002|Overall Study|Death|8|||
164506116|NCT02818998|594223199|FG000|Overall Study|Withdrawal by Subject|7|||
164506117|NCT02818998|594223200|FG001|Overall Study|Withdrawal by Subject|6|||
164506118|NCT02818998|594223201|FG002|Overall Study|Withdrawal by Subject|6|||
164506119|NCT02818998|594223199|FG000|Overall Study|Physician Decision|1|||
164506120|NCT02818998|594223200|FG001|Overall Study|Physician Decision|0|||
164506121|NCT02818998|594223201|FG002|Overall Study|Physician Decision|0|||
164506122|NCT02437071|594223202|FG000|Overall Study|Withdrawal by Subject|1|||
164506123|NCT02437071|594223203|FG001|Overall Study|Withdrawal by Subject|0|||
164506124|NCT01587118|594223206|FG000|Overall Study|Adverse Event|3|||
164506125|NCT01587118|594223206|FG000|Overall Study|Lost to Follow-up|2|||
164506126|NCT01587118|594223206|FG000|Overall Study|Relocation|1|||
164506127|NCT01587118|594223206|FG000|Overall Study|nonresponse|1|||
164506128|NCT00537329|594223207|FG000|Overall Study|Death|10|||
164506129|NCT00537329|594223207|FG000|Overall Study|Adverse Event|3|||
164506130|NCT00537329|594223207|FG000|Overall Study|Lack of Efficacy|2|||
164506131|NCT00537329|594223207|FG000|Overall Study|Lost to Follow-up|6|||
164506132|NCT00537329|594223207|FG000|Overall Study|Withdrawal by Subject|4|||
164506133|NCT00537329|594223207|FG000|Overall Study|Other|1|||
164506134|NCT02049515|594223208|FG000|Overall Study|Adverse Event|46|||
164506135|NCT02049515|594223209|FG001|Overall Study|Adverse Event|2|||
164506136|NCT02049515|594223208|FG000|Overall Study|Protocol-specified Disease Progression|23|||
164506137|NCT02049515|594223209|FG001|Overall Study|Protocol-specified Disease Progression|2|||
164506138|NCT02049515|594223208|FG000|Overall Study|Death|6|||
164506139|NCT02049515|594223209|FG001|Overall Study|Death|0|||
164506140|NCT02049515|594223208|FG000|Overall Study|Physician Decision|5|||
164506141|NCT02049515|594223209|FG001|Overall Study|Physician Decision|1|||
164506142|NCT02049515|594223208|FG000|Overall Study|Withdrawal by Subject|3|||
164506143|NCT02049515|594223209|FG001|Overall Study|Withdrawal by Subject|0|||
164506144|NCT02049515|594223208|FG000|Overall Study|Termination of the Study by Sponsor|2|||
164506145|NCT02049515|594223209|FG001|Overall Study|Termination of the Study by Sponsor|0|||
164506146|NCT02049515|594223208|FG000|Overall Study|Protocol Violation|1|||
164506147|NCT02049515|594223209|FG001|Overall Study|Protocol Violation|1|||
164506148|NCT02049515|594223208|FG000|Overall Study|Clinical Deterioration|1|||
164506149|NCT02049515|594223209|FG001|Overall Study|Clinical Deterioration|0|||
164506150|NCT02049515|594223208|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
164506151|NCT02049515|594223209|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
164506152|NCT02049515|594223208|FG000|Overall Study|Treatment Interruption >42 Days|1|||
164506153|NCT02049515|594223209|FG001|Overall Study|Treatment Interruption >42 Days|0|||
164506154|NCT02049515|594223208|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
164506155|NCT02049515|594223209|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
164506156|NCT00224029|594223213|FG000|Overall Study|Lost to Follow-up|1|||
164506157|NCT00224029|594223213|FG000|Overall Study|Withdrawal by Subject|4|||
164506158|NCT00224029|594223213|FG000|Overall Study|Other|1|||
164506159|NCT00243022|594223214|FG000|Overall Study|Withdrawal by Subject|1|||
164506160|NCT00243022|594223215|FG001|Overall Study|Withdrawal by Subject|0|||
164506161|NCT00243022|594223214|FG000|Overall Study|Death|1|||
164506162|NCT00243022|594223215|FG001|Overall Study|Death|0|||
164506163|NCT00243022|594223214|FG000|Overall Study|Difficult Travel Distance|0|||
164506164|NCT00243022|594223215|FG001|Overall Study|Difficult Travel Distance|1|||
164506165|NCT01099579|594223216|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
164506166|NCT01099579|594223217|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
164506167|NCT01099579|594223218|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
164506168|NCT01099579|594223216|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
164506169|NCT01099579|594223217|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
164506170|NCT01099579|594223218|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
164506171|NCT01099579|594223216|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
164506172|NCT01099579|594223217|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
164506173|NCT01099579|594223218|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
164506174|NCT01099579|594223216|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
164506175|NCT01099579|594223217|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
164506176|NCT01099579|594223218|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
164506177|NCT01099579|594223216|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
164506178|NCT01099579|594223217|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
164506179|NCT01099579|594223218|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
164506180|NCT01099579|594223216|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
164506181|NCT01099579|594223217|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
164506182|NCT01099579|594223218|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
164506183|NCT01099579|594223216|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
164506184|NCT01099579|594223217|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
164506185|NCT01099579|594223218|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
164506186|NCT01099579|594223216|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
164506187|NCT01099579|594223217|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
164506188|NCT01099579|594223218|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
164506189|NCT01099579|594223216|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
164506190|NCT01099579|594223217|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
164506191|NCT01099579|594223218|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
164506192|NCT01099579|594223216|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
164506193|NCT01099579|594223217|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
164506194|NCT01099579|594223218|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
164506195|NCT02569957|594223219|FG000|Overall Study|Withdrawal by Subject|0|||
164506196|NCT02569957|594223220|FG001|Overall Study|Withdrawal by Subject|1|||
164506197|NCT03513068|594223221|FG000|Overall Study|Death|1|||
164506198|NCT03513068|594223222|FG001|Overall Study|Death|0|||
164506199|NCT03513068|594223221|FG000|Overall Study|Withdrawal by Subject|4|||
164506200|NCT03513068|594223222|FG001|Overall Study|Withdrawal by Subject|6|||
164506201|NCT03636373|594223224|FG000|Overall Study|Study closure due to Covid-19|1|||
164506202|NCT03636373|594223225|FG001|Overall Study|Study closure due to Covid-19|0|||
164506203|NCT01236352|594223232|FG000|Overall Study|Death|0|||
164506204|NCT01236352|594223233|FG001|Overall Study|Death|0|||
164506205|NCT01236352|594223234|FG002|Overall Study|Death|0|||
164506206|NCT01236352|594223235|FG003|Overall Study|Death|0|||
164506207|NCT01236352|594223236|FG004|Overall Study|Death|0|||
164506208|NCT01236352|594223237|FG005|Overall Study|Death|0|||
164506209|NCT01236352|594223238|FG006|Overall Study|Death|0|||
164506210|NCT01236352|594223239|FG007|Overall Study|Death|1|||
164506211|NCT01236352|594223240|FG008|Overall Study|Death|0|||
164506212|NCT01236352|594223241|FG009|Overall Study|Death|0|||
164506213|NCT01236352|594223242|FG010|Overall Study|Death|0|||
164506214|NCT01236352|594223232|FG000|Overall Study|Withdrawal by Subject|0|||
164506215|NCT01236352|594223233|FG001|Overall Study|Withdrawal by Subject|0|||
164506216|NCT01236352|594223234|FG002|Overall Study|Withdrawal by Subject|0|||
164506217|NCT01236352|594223235|FG003|Overall Study|Withdrawal by Subject|0|||
164506218|NCT01236352|594223236|FG004|Overall Study|Withdrawal by Subject|0|||
164506219|NCT01236352|594223237|FG005|Overall Study|Withdrawal by Subject|0|||
164506220|NCT01236352|594223238|FG006|Overall Study|Withdrawal by Subject|0|||
164506221|NCT01236352|594223239|FG007|Overall Study|Withdrawal by Subject|0|||
164506222|NCT01236352|594223240|FG008|Overall Study|Withdrawal by Subject|0|||
164506223|NCT01236352|594223241|FG009|Overall Study|Withdrawal by Subject|2|||
164506224|NCT01236352|594223242|FG010|Overall Study|Withdrawal by Subject|1|||
164506225|NCT01236352|594223232|FG000|Overall Study|Adverse Event|0|||
164506226|NCT01236352|594223233|FG001|Overall Study|Adverse Event|0|||
164506227|NCT01236352|594223234|FG002|Overall Study|Adverse Event|0|||
164506228|NCT01236352|594223235|FG003|Overall Study|Adverse Event|0|||
164506229|NCT01236352|594223236|FG004|Overall Study|Adverse Event|0|||
164506230|NCT01236352|594223237|FG005|Overall Study|Adverse Event|0|||
164506231|NCT01236352|594223238|FG006|Overall Study|Adverse Event|2|||
164506232|NCT01236352|594223239|FG007|Overall Study|Adverse Event|0|||
164506233|NCT01236352|594223240|FG008|Overall Study|Adverse Event|0|||
164506234|NCT01236352|594223241|FG009|Overall Study|Adverse Event|4|||
164506235|NCT01236352|594223242|FG010|Overall Study|Adverse Event|1|||
164506236|NCT01236352|594223232|FG000|Overall Study|Study drug toxicity|0|||
164506237|NCT01236352|594223233|FG001|Overall Study|Study drug toxicity|0|||
164506238|NCT01236352|594223234|FG002|Overall Study|Study drug toxicity|0|||
164506239|NCT01236352|594223235|FG003|Overall Study|Study drug toxicity|0|||
164506240|NCT01236352|594223236|FG004|Overall Study|Study drug toxicity|0|||
164506241|NCT01236352|594223237|FG005|Overall Study|Study drug toxicity|1|||
164506242|NCT01236352|594223238|FG006|Overall Study|Study drug toxicity|1|||
164506243|NCT01236352|594223239|FG007|Overall Study|Study drug toxicity|0|||
164506244|NCT01236352|594223240|FG008|Overall Study|Study drug toxicity|0|||
164506245|NCT01236352|594223241|FG009|Overall Study|Study drug toxicity|2|||
164506246|NCT01236352|594223242|FG010|Overall Study|Study drug toxicity|2|||
164506247|NCT01236352|594223232|FG000|Overall Study|Disease progression|1|||
164506248|NCT01236352|594223233|FG001|Overall Study|Disease progression|2|||
164506249|NCT01236352|594223234|FG002|Overall Study|Disease progression|1|||
164506250|NCT01236352|594223235|FG003|Overall Study|Disease progression|2|||
164506251|NCT01236352|594223236|FG004|Overall Study|Disease progression|2|||
164506252|NCT01236352|594223237|FG005|Overall Study|Disease progression|2|||
164506253|NCT01236352|594223238|FG006|Overall Study|Disease progression|1|||
164506254|NCT01236352|594223239|FG007|Overall Study|Disease progression|3|||
164506255|NCT01236352|594223240|FG008|Overall Study|Disease progression|2|||
164506256|NCT01236352|594223241|FG009|Overall Study|Disease progression|2|||
164506257|NCT01236352|594223242|FG010|Overall Study|Disease progression|2|||
164506258|NCT01236352|594223232|FG000|Overall Study|Poor/Non-compliance|1|||
164506259|NCT01236352|594223233|FG001|Overall Study|Poor/Non-compliance|0|||
164506260|NCT01236352|594223234|FG002|Overall Study|Poor/Non-compliance|0|||
164506261|NCT01236352|594223235|FG003|Overall Study|Poor/Non-compliance|0|||
164506262|NCT01236352|594223236|FG004|Overall Study|Poor/Non-compliance|0|||
164506263|NCT01236352|594223237|FG005|Overall Study|Poor/Non-compliance|0|||
164506264|NCT01236352|594223238|FG006|Overall Study|Poor/Non-compliance|0|||
164506265|NCT01236352|594223239|FG007|Overall Study|Poor/Non-compliance|0|||
164506266|NCT01236352|594223240|FG008|Overall Study|Poor/Non-compliance|0|||
164506267|NCT01236352|594223241|FG009|Overall Study|Poor/Non-compliance|0|||
164506268|NCT01236352|594223242|FG010|Overall Study|Poor/Non-compliance|0|||
164506269|NCT01236352|594223232|FG000|Overall Study|Maximum clinical benefit|1|||
164506270|NCT01236352|594223233|FG001|Overall Study|Maximum clinical benefit|1|||
164506271|NCT01236352|594223234|FG002|Overall Study|Maximum clinical benefit|1|||
164506272|NCT01236352|594223235|FG003|Overall Study|Maximum clinical benefit|0|||
164506273|NCT01236352|594223236|FG004|Overall Study|Maximum clinical benefit|2|||
164506274|NCT01236352|594223237|FG005|Overall Study|Maximum clinical benefit|0|||
164506275|NCT01236352|594223238|FG006|Overall Study|Maximum clinical benefit|3|||
164506276|NCT01236352|594223239|FG007|Overall Study|Maximum clinical benefit|1|||
164506277|NCT01236352|594223240|FG008|Overall Study|Maximum clinical benefit|1|||
164506278|NCT01236352|594223241|FG009|Overall Study|Maximum clinical benefit|4|||
164506279|NCT01236352|594223242|FG010|Overall Study|Maximum clinical benefit|2|||
164506280|NCT01236352|594223232|FG000|Overall Study|Subject request to discontinue treatment|0|||
164506281|NCT01236352|594223233|FG001|Overall Study|Subject request to discontinue treatment|0|||
164506282|NCT01236352|594223234|FG002|Overall Study|Subject request to discontinue treatment|1|||
164506283|NCT01236352|594223235|FG003|Overall Study|Subject request to discontinue treatment|1|||
164506284|NCT01236352|594223236|FG004|Overall Study|Subject request to discontinue treatment|0|||
164506285|NCT01236352|594223237|FG005|Overall Study|Subject request to discontinue treatment|1|||
164506286|NCT01236352|594223238|FG006|Overall Study|Subject request to discontinue treatment|0|||
164506287|NCT01236352|594223239|FG007|Overall Study|Subject request to discontinue treatment|0|||
164506288|NCT01236352|594223240|FG008|Overall Study|Subject request to discontinue treatment|0|||
164506289|NCT01236352|594223241|FG009|Overall Study|Subject request to discontinue treatment|1|||
164506290|NCT01236352|594223242|FG010|Overall Study|Subject request to discontinue treatment|4|||
164506291|NCT01236352|594223232|FG000|Overall Study|Subject to receive drug via EAP|1|||
164506292|NCT01236352|594223233|FG001|Overall Study|Subject to receive drug via EAP|1|||
164506293|NCT01236352|594223234|FG002|Overall Study|Subject to receive drug via EAP|1|||
164506294|NCT01236352|594223235|FG003|Overall Study|Subject to receive drug via EAP|0|||
164506295|NCT01236352|594223236|FG004|Overall Study|Subject to receive drug via EAP|0|||
164506296|NCT01236352|594223237|FG005|Overall Study|Subject to receive drug via EAP|0|||
164506297|NCT01236352|594223238|FG006|Overall Study|Subject to receive drug via EAP|0|||
164506298|NCT01236352|594223239|FG007|Overall Study|Subject to receive drug via EAP|2|||
164506299|NCT01236352|594223240|FG008|Overall Study|Subject to receive drug via EAP|0|||
164506300|NCT01236352|594223241|FG009|Overall Study|Subject to receive drug via EAP|4|||
164506301|NCT01236352|594223242|FG010|Overall Study|Subject to receive drug via EAP|0|||
164506302|NCT01236352|594223232|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
164506303|NCT01236352|594223233|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
164506304|NCT01236352|594223234|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
164506305|NCT01236352|594223235|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
164506306|NCT01236352|594223236|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
164506307|NCT01236352|594223237|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
164506308|NCT01236352|594223238|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
164506309|NCT01236352|594223239|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
164506310|NCT01236352|594223240|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
164506311|NCT01236352|594223241|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
164506312|NCT01236352|594223242|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
164506313|NCT01236352|594223232|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
164506314|NCT01236352|594223233|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
164506315|NCT01236352|594223234|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
164506316|NCT01236352|594223235|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
164506317|NCT01236352|594223236|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
164506318|NCT01236352|594223237|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
164506319|NCT01236352|594223238|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
164506320|NCT01236352|594223239|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
164506321|NCT01236352|594223240|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
164506322|NCT01236352|594223241|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
164506323|NCT01236352|594223242|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
164506324|NCT01236352|594223232|FG000|Overall Study|Lack of response to drug|0|||
164506325|NCT01236352|594223233|FG001|Overall Study|Lack of response to drug|0|||
164506326|NCT01236352|594223234|FG002|Overall Study|Lack of response to drug|0|||
164506327|NCT01236352|594223235|FG003|Overall Study|Lack of response to drug|0|||
164506328|NCT01236352|594223236|FG004|Overall Study|Lack of response to drug|0|||
164506329|NCT01236352|594223237|FG005|Overall Study|Lack of response to drug|0|||
164506330|NCT01236352|594223238|FG006|Overall Study|Lack of response to drug|0|||
164506331|NCT01236352|594223239|FG007|Overall Study|Lack of response to drug|0|||
164506332|NCT01236352|594223240|FG008|Overall Study|Lack of response to drug|0|||
164506333|NCT01236352|594223241|FG009|Overall Study|Lack of response to drug|1|||
164506334|NCT01236352|594223242|FG010|Overall Study|Lack of response to drug|1|||
164506335|NCT01236352|594223232|FG000|Overall Study|Patient transferred to IST|0|||
164506336|NCT01236352|594223233|FG001|Overall Study|Patient transferred to IST|0|||
164506337|NCT01236352|594223234|FG002|Overall Study|Patient transferred to IST|0|||
164506338|NCT01236352|594223235|FG003|Overall Study|Patient transferred to IST|0|||
164506339|NCT01236352|594223236|FG004|Overall Study|Patient transferred to IST|0|||
164506340|NCT01236352|594223237|FG005|Overall Study|Patient transferred to IST|0|||
164506341|NCT01236352|594223238|FG006|Overall Study|Patient transferred to IST|0|||
164506342|NCT01236352|594223239|FG007|Overall Study|Patient transferred to IST|0|||
164506343|NCT01236352|594223240|FG008|Overall Study|Patient transferred to IST|0|||
164506344|NCT01236352|594223241|FG009|Overall Study|Patient transferred to IST|2|||
164506345|NCT01236352|594223242|FG010|Overall Study|Patient transferred to IST|6|||
164506346|NCT05903183|594223247|FG000|Main Trial Part (365 Days)|Death|1|||
164506347|NCT05903183|594223248|FG001|Main Trial Part (365 Days)|Death|0|||
164506348|NCT05903183|594223249|FG002|Main Trial Part (365 Days)|Death|0|||
164506349|NCT05903183|594223250|FG003|Main Trial Part (365 Days)|Death|0|||
164506350|NCT05903183|594223251|FG004|Main Trial Part (365 Days)|Death|0|||
164506351|NCT05903183|594223247|FG000|Main Trial Part (365 Days)|Other|1|||
164506352|NCT05903183|594223248|FG001|Main Trial Part (365 Days)|Other|2|||
164506353|NCT05903183|594223249|FG002|Main Trial Part (365 Days)|Other|1|||
164506354|NCT05903183|594223250|FG003|Main Trial Part (365 Days)|Other|0|||
164506355|NCT05903183|594223251|FG004|Main Trial Part (365 Days)|Other|0|||
164506356|NCT05903183|594223247|FG000|Main Trial Part (365 Days)|Lost to Follow-up|0|||
164506357|NCT05903183|594223248|FG001|Main Trial Part (365 Days)|Lost to Follow-up|0|||
164506358|NCT05903183|594223249|FG002|Main Trial Part (365 Days)|Lost to Follow-up|1|||
164506359|NCT05903183|594223250|FG003|Main Trial Part (365 Days)|Lost to Follow-up|0|||
164506360|NCT05903183|594223251|FG004|Main Trial Part (365 Days)|Lost to Follow-up|0|||
164506361|NCT05903183|594223247|FG000|Main Trial Part (365 Days)|Withdrawal by Subject|1|||
164506362|NCT05903183|594223248|FG001|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
164506363|NCT05903183|594223249|FG002|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
164506364|NCT05903183|594223250|FG003|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
164506365|NCT05903183|594223251|FG004|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
164506366|NCT05903183|594223247|FG000|Observation Extension Part (144 Days)|Sponsor's decision|0|||
164506367|NCT05903183|594223248|FG001|Observation Extension Part (144 Days)|Sponsor's decision|0|||
164506368|NCT05903183|594223249|FG002|Observation Extension Part (144 Days)|Sponsor's decision|0|||
164506369|NCT05903183|594223250|FG003|Observation Extension Part (144 Days)|Sponsor's decision|35|||
164506370|NCT05903183|594223251|FG004|Observation Extension Part (144 Days)|Sponsor's decision|20|||
164506371|NCT03149029|594223252|FG000|Overall Study|Adverse Event|2|||
164506372|NCT03149029|594223253|FG001|Overall Study|Adverse Event|0|||
164506373|NCT03735121|594223254|FG000|Overall Study|Death|3|||
164506374|NCT03735121|594223255|FG001|Overall Study|Death|6|||
164506375|NCT03735121|594223256|FG002|Overall Study|Death|19|||
164506376|NCT03735121|594223257|FG003|Overall Study|Death|97|||
164506377|NCT03735121|594223258|FG004|Overall Study|Death|205|||
164506378|NCT03735121|594223254|FG000|Overall Study|Lost to Follow-up|0|||
164506379|NCT03735121|594223255|FG001|Overall Study|Lost to Follow-up|0|||
164506380|NCT03735121|594223256|FG002|Overall Study|Lost to Follow-up|0|||
164506381|NCT03735121|594223257|FG003|Overall Study|Lost to Follow-up|2|||
164506382|NCT03735121|594223258|FG004|Overall Study|Lost to Follow-up|3|||
164506383|NCT03735121|594223254|FG000|Overall Study|New Therapy|0|||
164506384|NCT03735121|594223255|FG001|Overall Study|New Therapy|1|||
164506385|NCT03735121|594223256|FG002|Overall Study|New Therapy|0|||
164506386|NCT03735121|594223257|FG003|Overall Study|New Therapy|0|||
164506387|NCT03735121|594223258|FG004|Overall Study|New Therapy|0|||
164506388|NCT03735121|594223254|FG000|Overall Study|Study Ended by Sponsor|1|||
164506389|NCT03735121|594223255|FG001|Overall Study|Study Ended by Sponsor|0|||
164506390|NCT03735121|594223256|FG002|Overall Study|Study Ended by Sponsor|1|||
164506391|NCT03735121|594223257|FG003|Overall Study|Study Ended by Sponsor|17|||
164506392|NCT03735121|594223258|FG004|Overall Study|Study Ended by Sponsor|28|||
164506393|NCT03735121|594223254|FG000|Overall Study|Withdrawal by Subject|1|||
164506394|NCT03735121|594223255|FG001|Overall Study|Withdrawal by Subject|1|||
164506395|NCT03735121|594223256|FG002|Overall Study|Withdrawal by Subject|6|||
164506396|NCT03735121|594223257|FG003|Overall Study|Withdrawal by Subject|8|||
164506397|NCT03735121|594223258|FG004|Overall Study|Withdrawal by Subject|11|||
164506398|NCT02176863|594223259|FG000|Overall Study|Physician Decision|1|||
164506399|NCT02176863|594223260|FG001|Overall Study|Physician Decision|0|||
164506400|NCT02176863|594223261|FG002|Overall Study|Physician Decision|0|||
164506401|NCT02176863|594223262|FG003|Overall Study|Physician Decision|0|||
164506402|NCT02176863|594223263|FG004|Overall Study|Physician Decision|0|||
164506403|NCT02176863|594223259|FG000|Overall Study|Adverse Event|10|||
164506404|NCT02176863|594223260|FG001|Overall Study|Adverse Event|4|||
164506405|NCT02176863|594223261|FG002|Overall Study|Adverse Event|4|||
164506406|NCT02176863|594223262|FG003|Overall Study|Adverse Event|1|||
164506407|NCT02176863|594223263|FG004|Overall Study|Adverse Event|1|||
164506408|NCT02176863|594223259|FG000|Overall Study|Protocol Violation|2|||
164506409|NCT02176863|594223260|FG001|Overall Study|Protocol Violation|0|||
164506410|NCT02176863|594223261|FG002|Overall Study|Protocol Violation|1|||
164506411|NCT02176863|594223262|FG003|Overall Study|Protocol Violation|1|||
164506412|NCT02176863|594223263|FG004|Overall Study|Protocol Violation|0|||
164506413|NCT02176863|594223259|FG000|Overall Study|Withdrawal by Subject|4|||
164506414|NCT02176863|594223260|FG001|Overall Study|Withdrawal by Subject|2|||
164506415|NCT02176863|594223261|FG002|Overall Study|Withdrawal by Subject|2|||
164506416|NCT02176863|594223262|FG003|Overall Study|Withdrawal by Subject|3|||
164506417|NCT02176863|594223263|FG004|Overall Study|Withdrawal by Subject|4|||
164506418|NCT02176863|594223259|FG000|Overall Study|Reason not specified|0|||
164506419|NCT02176863|594223260|FG001|Overall Study|Reason not specified|1|||
164506420|NCT02176863|594223261|FG002|Overall Study|Reason not specified|1|||
164506421|NCT02176863|594223262|FG003|Overall Study|Reason not specified|2|||
164506422|NCT02176863|594223263|FG004|Overall Study|Reason not specified|1|||
164506423|NCT02176863|594223259|FG000|Overall Study|Lost to Follow-up|0|||
164506424|NCT02176863|594223260|FG001|Overall Study|Lost to Follow-up|1|||
164506425|NCT02176863|594223261|FG002|Overall Study|Lost to Follow-up|1|||
164506426|NCT02176863|594223262|FG003|Overall Study|Lost to Follow-up|0|||
164506427|NCT02176863|594223263|FG004|Overall Study|Lost to Follow-up|0|||
164506428|NCT02647645|594223264|FG000|Overall Study|Lost to Follow-up|2|||
164506429|NCT02647645|594223265|FG001|Overall Study|Lost to Follow-up|1|||
164506430|NCT02037256|594223268|FG000|Overall Study|Protocol Violation|0|||
164506431|NCT02037256|594223269|FG001|Overall Study|Protocol Violation|1|||
164506432|NCT02037256|594223268|FG000|Overall Study|Withdrawn prior to Velcade|0|||
164506433|NCT02037256|594223269|FG001|Overall Study|Withdrawn prior to Velcade|2|||
164506434|NCT03007732|594223270|FG000|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
164506435|NCT03007732|594223271|FG001|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
164506436|NCT03007732|594223272|FG002|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
164506437|NCT03007732|594223273|FG003|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
164506438|NCT04124471|594223274|FG000|Overall Study|screen failure|1|||
164506439|NCT04650698|594224744|FG000|Overall Study|Protocol Violation|2|||
164506440|NCT04650698|594224745|FG001|Overall Study|Protocol Violation|1|||
164506441|NCT04650698|594224744|FG000|Overall Study|Withdrawal by Subject|0|||
164506442|NCT04650698|594224745|FG001|Overall Study|Withdrawal by Subject|1|||
164506443|NCT02358668|594224746|FG000|Overall Study|Adverse Event|2|||
164506444|NCT02358668|594224747|FG001|Overall Study|Adverse Event|0|||
164506445|NCT02358668|594224748|FG002|Overall Study|Adverse Event|0|||
164506446|NCT02358668|594224746|FG000|Overall Study|Withdrawal by Subject|0|||
164506447|NCT02358668|594224747|FG001|Overall Study|Withdrawal by Subject|1|||
164506448|NCT02358668|594224748|FG002|Overall Study|Withdrawal by Subject|0|||
164506449|NCT02104505|594224749|FG000|First Intervention (14 Days)|Adverse Event|2|||
164506450|NCT02104505|594224750|FG001|First Intervention (14 Days)|Adverse Event|0|||
164506451|NCT02104505|594224749|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
164506452|NCT02104505|594224750|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
164506453|NCT02104505|594224749|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
164506454|NCT02104505|594224750|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
164506455|NCT02104505|594224749|FG000|First Intervention (14 Days)|exclusionary condition|0|||
164506456|NCT02104505|594224750|FG001|First Intervention (14 Days)|exclusionary condition|1|||
164506457|NCT02104505|594224749|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
164506458|NCT02104505|594224750|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
164506459|NCT02104505|594224749|FG000|Second Intervention (14 Days)|Adverse Event|2|||
164506460|NCT02104505|594224750|FG001|Second Intervention (14 Days)|Adverse Event|0|||
164506461|NCT02859064|594224751|FG000|Overall Study|Progressive Disease|3|||
164506462|NCT02859064|594224751|FG000|Overall Study|Physician Decision|1|||
164506463|NCT02859064|594224751|FG000|Overall Study|Withdrawal by Subject|1|||
164506464|NCT02859064|594224751|FG000|Overall Study|Death|1|||
164506465|NCT01730950|594224754|FG000|Overall Study|Protocol Violation|6|||
164506466|NCT01730950|594224755|FG001|Overall Study|Protocol Violation|6|||
164506467|NCT02737826|594224756|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
164506468|NCT02737826|594224757|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
164506469|NCT02737826|594224758|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
164506470|NCT02568397|594224759|FG000|Period 2|Withdrawal by Subject|0|||
164506471|NCT02568397|594224760|FG001|Period 2|Withdrawal by Subject|1|||
164506472|NCT02568397|594224759|FG000|Period 2|Physician Decision|0|||
164506473|NCT02568397|594224760|FG001|Period 2|Physician Decision|1|||
164506474|NCT00078377|594224761|FG000|Overall Study|Adverse Event|2|||
164506475|NCT00078377|594224762|FG001|Overall Study|Adverse Event|5|||
164506476|NCT00078377|594224763|FG002|Overall Study|Adverse Event|1|||
164506477|NCT00078377|594224761|FG000|Overall Study|Lack of Efficacy|2|||
164506478|NCT00078377|594224762|FG001|Overall Study|Lack of Efficacy|0|||
164506479|NCT00078377|594224763|FG002|Overall Study|Lack of Efficacy|2|||
164506480|NCT00078377|594224761|FG000|Overall Study|Lost to Follow-up|0|||
164506481|NCT00078377|594224762|FG001|Overall Study|Lost to Follow-up|1|||
164506482|NCT00078377|594224763|FG002|Overall Study|Lost to Follow-up|1|||
164506483|NCT00078377|594224761|FG000|Overall Study|Physician Decision|2|||
164506484|NCT00078377|594224762|FG001|Overall Study|Physician Decision|0|||
164506485|NCT00078377|594224763|FG002|Overall Study|Physician Decision|0|||
164506486|NCT00078377|594224761|FG000|Overall Study|Withdrawal by Subject|3|||
164506487|NCT00078377|594224762|FG001|Overall Study|Withdrawal by Subject|4|||
164506488|NCT00078377|594224763|FG002|Overall Study|Withdrawal by Subject|4|||
164506489|NCT00078377|594224761|FG000|Overall Study|Miscellaneous|2|||
164506490|NCT00078377|594224762|FG001|Overall Study|Miscellaneous|6|||
164506491|NCT00078377|594224763|FG002|Overall Study|Miscellaneous|1|||
164506492|NCT02354651|594224764|FG000|Overall Study|Withdrawal by Subject|2|||
164506493|NCT02354651|594224764|FG000|Overall Study|Physician Decision|1|||
164506494|NCT01317875|594224765|FG000|Overall Study|Other|0|||
164506495|NCT01317875|594224766|FG001|Overall Study|Other|0|||
164506496|NCT01317875|594224767|FG002|Overall Study|Other|1|||
164506497|NCT01317875|594224768|FG003|Overall Study|Other|0|||
164506498|NCT01317875|594224769|FG004|Overall Study|Other|0|||
164506499|NCT01317875|594224770|FG005|Overall Study|Other|0|||
164506500|NCT01317875|594224771|FG006|Overall Study|Other|0|||
164506501|NCT01317875|594224772|FG007|Overall Study|Other|0|||
164506502|NCT01317875|594224773|FG008|Overall Study|Other|0|||
164506503|NCT01317875|594224774|FG009|Overall Study|Other|0|||
164506504|NCT01317875|594224765|FG000|Overall Study|Noncompliance with study drug|0|||
164506505|NCT01317875|594224766|FG001|Overall Study|Noncompliance with study drug|0|||
164506506|NCT01317875|594224767|FG002|Overall Study|Noncompliance with study drug|1|||
164506507|NCT01317875|594224768|FG003|Overall Study|Noncompliance with study drug|0|||
164506508|NCT01317875|594224769|FG004|Overall Study|Noncompliance with study drug|0|||
164506509|NCT01317875|594224770|FG005|Overall Study|Noncompliance with study drug|0|||
164506510|NCT01317875|594224771|FG006|Overall Study|Noncompliance with study drug|0|||
164506511|NCT01317875|594224772|FG007|Overall Study|Noncompliance with study drug|0|||
164506512|NCT01317875|594224773|FG008|Overall Study|Noncompliance with study drug|0|||
164506513|NCT01317875|594224774|FG009|Overall Study|Noncompliance with study drug|0|||
164506514|NCT01317875|594224765|FG000|Overall Study|Progressive Disease|1|||
164506515|NCT01317875|594224766|FG001|Overall Study|Progressive Disease|0|||
164506516|NCT01317875|594224767|FG002|Overall Study|Progressive Disease|2|||
164506517|NCT01317875|594224768|FG003|Overall Study|Progressive Disease|0|||
164506518|NCT01317875|594224769|FG004|Overall Study|Progressive Disease|1|||
164506519|NCT01317875|594224770|FG005|Overall Study|Progressive Disease|0|||
164506520|NCT01317875|594224771|FG006|Overall Study|Progressive Disease|0|||
164506521|NCT01317875|594224772|FG007|Overall Study|Progressive Disease|1|||
164506522|NCT01317875|594224773|FG008|Overall Study|Progressive Disease|0|||
164506523|NCT01317875|594224774|FG009|Overall Study|Progressive Disease|0|||
164506524|NCT01317875|594224765|FG000|Overall Study|Withdrawal by Subject|0|||
164506525|NCT01317875|594224766|FG001|Overall Study|Withdrawal by Subject|0|||
164506526|NCT01317875|594224767|FG002|Overall Study|Withdrawal by Subject|0|||
164506527|NCT01317875|594224768|FG003|Overall Study|Withdrawal by Subject|0|||
164506528|NCT01317875|594224769|FG004|Overall Study|Withdrawal by Subject|1|||
164506529|NCT01317875|594224770|FG005|Overall Study|Withdrawal by Subject|0|||
164506530|NCT01317875|594224771|FG006|Overall Study|Withdrawal by Subject|0|||
164506531|NCT01317875|594224772|FG007|Overall Study|Withdrawal by Subject|3|||
164506532|NCT01317875|594224773|FG008|Overall Study|Withdrawal by Subject|0|||
164506533|NCT01317875|594224774|FG009|Overall Study|Withdrawal by Subject|0|||
164506534|NCT01317875|594224765|FG000|Overall Study|Physician Decision|0|||
164506535|NCT01317875|594224766|FG001|Overall Study|Physician Decision|1|||
164506536|NCT01317875|594224767|FG002|Overall Study|Physician Decision|1|||
164506537|NCT01317875|594224768|FG003|Overall Study|Physician Decision|0|||
164506538|NCT01317875|594224769|FG004|Overall Study|Physician Decision|2|||
164506539|NCT01317875|594224770|FG005|Overall Study|Physician Decision|0|||
164506540|NCT01317875|594224771|FG006|Overall Study|Physician Decision|0|||
164506541|NCT01317875|594224772|FG007|Overall Study|Physician Decision|2|||
164506542|NCT01317875|594224773|FG008|Overall Study|Physician Decision|0|||
164506543|NCT01317875|594224774|FG009|Overall Study|Physician Decision|0|||
164506544|NCT01317875|594224765|FG000|Overall Study|Death|0|||
164506545|NCT01317875|594224766|FG001|Overall Study|Death|0|||
164506546|NCT01317875|594224767|FG002|Overall Study|Death|2|||
164506547|NCT01317875|594224768|FG003|Overall Study|Death|1|||
164506548|NCT01317875|594224769|FG004|Overall Study|Death|0|||
164506549|NCT01317875|594224770|FG005|Overall Study|Death|1|||
164506550|NCT01317875|594224771|FG006|Overall Study|Death|0|||
164506551|NCT01317875|594224772|FG007|Overall Study|Death|4|||
164506552|NCT01317875|594224773|FG008|Overall Study|Death|0|||
164506553|NCT01317875|594224774|FG009|Overall Study|Death|0|||
164506554|NCT01317875|594224765|FG000|Overall Study|Adverse Event|2|||
164506555|NCT01317875|594224766|FG001|Overall Study|Adverse Event|1|||
164506556|NCT01317875|594224767|FG002|Overall Study|Adverse Event|2|||
164506557|NCT01317875|594224768|FG003|Overall Study|Adverse Event|1|||
164506558|NCT01317875|594224769|FG004|Overall Study|Adverse Event|5|||
164506559|NCT01317875|594224770|FG005|Overall Study|Adverse Event|1|||
164506560|NCT01317875|594224771|FG006|Overall Study|Adverse Event|2|||
164506561|NCT01317875|594224772|FG007|Overall Study|Adverse Event|5|||
164506562|NCT01317875|594224773|FG008|Overall Study|Adverse Event|0|||
164506563|NCT01317875|594224774|FG009|Overall Study|Adverse Event|0|||
164506564|NCT00581893|594224775|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
164506565|NCT00581893|594224776|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
164506566|NCT01381575|594224777|FG000|Overall Study|Serious Adverse Event|1|||
164506567|NCT01381575|594224778|FG001|Overall Study|Serious Adverse Event|0|||
164506568|NCT01381575|594224779|FG002|Overall Study|Serious Adverse Event|0|||
164506569|NCT01381575|594224777|FG000|Overall Study|Non-Serious Adverse Event|0|||
164506570|NCT01381575|594224778|FG001|Overall Study|Non-Serious Adverse Event|0|||
164506571|NCT01381575|594224779|FG002|Overall Study|Non-Serious Adverse Event|1|||
164506572|NCT01381575|594224777|FG000|Overall Study|Protocol Violation|0|||
164506573|NCT01381575|594224778|FG001|Overall Study|Protocol Violation|1|||
164506574|NCT01381575|594224779|FG002|Overall Study|Protocol Violation|1|||
164506575|NCT01381575|594224777|FG000|Overall Study|Withdrawal by Subject|15|||
164506576|NCT01381575|594224778|FG001|Overall Study|Withdrawal by Subject|9|||
164506577|NCT01381575|594224779|FG002|Overall Study|Withdrawal by Subject|7|||
164506578|NCT01381575|594224777|FG000|Overall Study|Migrated/moved from study area|2|||
164506579|NCT01381575|594224778|FG001|Overall Study|Migrated/moved from study area|12|||
164506580|NCT01381575|594224779|FG002|Overall Study|Migrated/moved from study area|2|||
164506581|NCT01381575|594224777|FG000|Overall Study|Lost to Follow-up|8|||
164506582|NCT01381575|594224778|FG001|Overall Study|Lost to Follow-up|17|||
164506583|NCT01381575|594224779|FG002|Overall Study|Lost to Follow-up|9|||
164506584|NCT01377389|594224780|FG000|Overall Study|Withdrawal by Subject|1|||
164506585|NCT01377389|594224780|FG000|Overall Study|Screen failure|2|||
164506586|NCT04090528|594224781|FG000|Overall Study|participants still on study|9|||
164506587|NCT04090528|594224782|FG001|Overall Study|participants still on study|13|||
164506588|NCT03020069|594224783|FG000|Overall Study|Lost to Follow-up|0|||
164506589|NCT03020069|594224784|FG001|Overall Study|Lost to Follow-up|1|||
164506590|NCT02684123|594224787|FG000|Phase 1|Lack of Efficacy|5|||
164506591|NCT02684123|594224788|FG001|Phase 1|Lack of Efficacy|0|||
164506592|NCT02684123|594224787|FG000|Phase 1|Adverse Event|3|||
164506593|NCT02684123|594224788|FG001|Phase 1|Adverse Event|0|||
164506594|NCT02684123|594224787|FG000|Phase 1|Lost to Follow-up|0|||
164506595|NCT02684123|594224788|FG001|Phase 1|Lost to Follow-up|1|||
164506596|NCT02684123|594224787|FG000|Phase 2|Lack of Efficacy|1|||
164506597|NCT02684123|594224788|FG001|Phase 2|Lack of Efficacy|8|||
164506598|NCT05274750|594224791|FG000|Overall Study|Adverse Event|0|||
164506599|NCT05274750|594224792|FG001|Overall Study|Adverse Event|1|||
164506600|NCT05274750|594224791|FG000|Overall Study|Lost to Follow-up|2|||
164506601|NCT05274750|594224792|FG001|Overall Study|Lost to Follow-up|3|||
164506602|NCT05274750|594224791|FG000|Overall Study|Physician Decision|3|||
164506603|NCT05274750|594224792|FG001|Overall Study|Physician Decision|0|||
164506604|NCT05274750|594224791|FG000|Overall Study|Withdrawal by Subject|10|||
164506605|NCT05274750|594224792|FG001|Overall Study|Withdrawal by Subject|9|||
164506606|NCT05274750|594224791|FG000|Overall Study|GCP Violation|0|||
164506607|NCT05274750|594224792|FG001|Overall Study|GCP Violation|4|||
164506608|NCT05274750|594224791|FG000|Overall Study|Randomized, not treated|0|||
164506609|NCT05274750|594224792|FG001|Overall Study|Randomized, not treated|1|||
164506610|NCT04340947|594224797|FG000|7-day Washout Period|Lost to Follow-up|5|||
164506611|NCT04340947|594224798|FG001|7-day Washout Period|Lost to Follow-up|4|||
164506612|NCT01437423|594224801|FG000|Overall Study|Lost to Follow-up|12|||
164506613|NCT01437423|594224801|FG000|Overall Study|Off label usage|3|||
164506614|NCT01375751|594224802|FG000|Overall Study|Other|0|||
164506615|NCT01375751|594224803|FG001|Overall Study|Other|1|||
164506616|NCT01375751|594224804|FG002|Overall Study|Other|0|||
164506617|NCT02552147|594224805|FG000|First Intervention (7 Days)|Protocol Violation|1|||
164506618|NCT02552147|594224806|FG001|First Intervention (7 Days)|Protocol Violation|0|||
164506619|NCT02552147|594224805|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
164506620|NCT02552147|594224806|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
164506621|NCT00940875|594224807|FG000|Treatment Phase|Adverse Event|9|||
164506622|NCT00940875|594224808|FG001|Treatment Phase|Adverse Event|3|||
164506623|NCT00940875|594224807|FG000|Treatment Phase|Death|3|||
164506624|NCT00940875|594224808|FG001|Treatment Phase|Death|5|||
164506625|NCT00940875|594224807|FG000|Treatment Phase|Lack of Efficacy|1|||
164506626|NCT00940875|594224808|FG001|Treatment Phase|Lack of Efficacy|0|||
164506627|NCT00940875|594224807|FG000|Treatment Phase|Withdrawal by Subject|3|||
164506628|NCT00940875|594224808|FG001|Treatment Phase|Withdrawal by Subject|0|||
164506629|NCT00940875|594224807|FG000|Treatment Phase|Disease progression|9|||
164506630|NCT00940875|594224808|FG001|Treatment Phase|Disease progression|11|||
164506631|NCT00940875|594224807|FG000|Treatment Phase|Physician Decision|1|||
164506632|NCT00940875|594224808|FG001|Treatment Phase|Physician Decision|0|||
164506633|NCT00940875|594224807|FG000|Post-Study Treatment|Death|0|||
164506634|NCT00940875|594224808|FG001|Post-Study Treatment|Death|1|||
164506635|NCT00940875|594224807|FG000|Post-Study Treatment|Disease Progression|0|||
164506636|NCT00940875|594224808|FG001|Post-Study Treatment|Disease Progression|2|||
164506637|NCT04071301|594224810|FG000|Overall Study|Withdrawal by Subject|6|||
164506638|NCT04071301|594224810|FG000|Overall Study|Death|1|||
164506639|NCT05186311|594224811|FG000|Part A: Serum|Withdrawal by Subject|1|||
164506640|NCT02879383|594224812|FG000|First 24 Weeks|Physician Decision|0|||
164506641|NCT02879383|594224813|FG001|First 24 Weeks|Physician Decision|1|||
164506642|NCT02879383|594224814|FG002|First 24 Weeks|Physician Decision|0|||
164506643|NCT02879383|594224815|FG003|First 24 Weeks|Physician Decision|0|||
164506644|NCT03721172|594224818|FG000|Placebo-controlled Phase|Adverse Event|7|||
164506645|NCT03721172|594224819|FG001|Placebo-controlled Phase|Adverse Event|7|||
164506646|NCT03721172|594224820|FG002|Placebo-controlled Phase|Adverse Event|0|||
164506647|NCT03721172|594224818|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
164506648|NCT03721172|594224819|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
164506649|NCT03721172|594224820|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
164506650|NCT03721172|594224818|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
164506651|NCT03721172|594224819|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
164506652|NCT03721172|594224820|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
164506653|NCT03721172|594224818|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
164506654|NCT03721172|594224819|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
164506655|NCT03721172|594224820|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
164607010|NCT02455388|594583415|FG002|Overall Study|Withdrawal by Subject|7|||
164607011|NCT01136746|594583416|FG000|Overall Study|Lost to Follow-up|0|||
164607012|NCT01136746|594583417|FG001|Overall Study|Lost to Follow-up|2|||
164607013|NCT01136746|594583416|FG000|Overall Study|Protocol Violation|2|||
164607014|NCT01136746|594583417|FG001|Overall Study|Protocol Violation|1|||
164607015|NCT01136746|594583416|FG000|Overall Study|Death|1|||
164607016|NCT01136746|594583417|FG001|Overall Study|Death|0|||
164607017|NCT00092677|594583423|FG000|Overall Study|Lost to Follow-up|0|||
164607018|NCT00092677|594583424|FG001|Overall Study|Lost to Follow-up|2|||
164607019|NCT00092677|594583423|FG000|Overall Study|Adminstrative|5|||
164506656|NCT03721172|594224818|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
164506657|NCT03721172|594224819|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
164506658|NCT03721172|594224820|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
164506659|NCT03721172|594224818|FG000|Placebo-controlled Phase|Other|3|||
164506660|NCT03721172|594224819|FG001|Placebo-controlled Phase|Other|0|||
164506661|NCT03721172|594224820|FG002|Placebo-controlled Phase|Other|0|||
164506662|NCT03721172|594224818|FG000|Apremilast Extension Phase|Adverse Event|0|||
164506663|NCT03721172|594224819|FG001|Apremilast Extension Phase|Adverse Event|0|||
164607020|NCT00092677|594583424|FG001|Overall Study|Adminstrative|9|||
164506664|NCT03721172|594224820|FG002|Apremilast Extension Phase|Adverse Event|10|||
164506665|NCT03721172|594224818|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
164506666|NCT03721172|594224819|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
164506667|NCT03721172|594224820|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
164506668|NCT03721172|594224818|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
164506669|NCT03721172|594224819|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
164506670|NCT03721172|594224820|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
164506671|NCT03721172|594224818|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
164506672|NCT03721172|594224819|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
164506673|NCT03721172|594224820|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
164506674|NCT03721172|594224818|FG000|Apremilast Extension Phase|Protocol Violation|0|||
164506675|NCT03721172|594224819|FG001|Apremilast Extension Phase|Protocol Violation|0|||
164506676|NCT03721172|594224820|FG002|Apremilast Extension Phase|Protocol Violation|1|||
164506677|NCT03721172|594224818|FG000|Apremilast Extension Phase|Physician Decision|0|||
164506678|NCT03721172|594224819|FG001|Apremilast Extension Phase|Physician Decision|0|||
164506679|NCT03721172|594224820|FG002|Apremilast Extension Phase|Physician Decision|1|||
164506680|NCT03721172|594224818|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
164506681|NCT03721172|594224819|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
164506682|NCT03721172|594224820|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
164506683|NCT03721172|594224818|FG000|Apremilast Extension Phase|Other|0|||
164506684|NCT03721172|594224819|FG001|Apremilast Extension Phase|Other|0|||
164506685|NCT03721172|594224820|FG002|Apremilast Extension Phase|Other|3|||
164506686|NCT03721172|594224818|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
164506687|NCT03721172|594224819|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
164506688|NCT03721172|594224820|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
164506689|NCT02417441|594224821|FG000|Overall Study|Inconclusive due to missing data|52|||
164506690|NCT02417441|594224822|FG001|Overall Study|Inconclusive due to missing data|19|||
164506691|NCT05628285|594224823|FG000|Overall Study|Lost to Follow-up|1|||
164506692|NCT00983853|594224824|FG000|Overall Study|Lost to Follow-up|1|||
164506693|NCT00983853|594224825|FG001|Overall Study|Lost to Follow-up|1|||
164506694|NCT00983853|594224826|FG002|Overall Study|Lost to Follow-up|2|||
164506695|NCT00983853|594224827|FG003|Overall Study|Lost to Follow-up|2|||
164506696|NCT00983853|594224828|FG004|Overall Study|Lost to Follow-up|2|||
164506697|NCT00983853|594224829|FG005|Overall Study|Lost to Follow-up|1|||
164506698|NCT00983853|594224824|FG000|Overall Study|Withdrawal by Subject|0|||
164506699|NCT00983853|594224825|FG001|Overall Study|Withdrawal by Subject|0|||
164506700|NCT00983853|594224826|FG002|Overall Study|Withdrawal by Subject|1|||
164506701|NCT00983853|594224827|FG003|Overall Study|Withdrawal by Subject|0|||
164506702|NCT00983853|594224828|FG004|Overall Study|Withdrawal by Subject|1|||
164506703|NCT00983853|594224829|FG005|Overall Study|Withdrawal by Subject|0|||
164506704|NCT00983853|594224824|FG000|Overall Study|Unable to come to study follow-up visits|0|||
164506705|NCT00983853|594224825|FG001|Overall Study|Unable to come to study follow-up visits|1|||
164506706|NCT00983853|594224826|FG002|Overall Study|Unable to come to study follow-up visits|0|||
164506707|NCT00983853|594224827|FG003|Overall Study|Unable to come to study follow-up visits|0|||
164506708|NCT00983853|594224828|FG004|Overall Study|Unable to come to study follow-up visits|0|||
164506709|NCT00983853|594224829|FG005|Overall Study|Unable to come to study follow-up visits|0|||
164506710|NCT02339506|594224830|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
164506711|NCT02339506|594224831|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
164506712|NCT02339506|594224830|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
164506713|NCT02339506|594224831|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
164506714|NCT03016598|594224835|FG000|Overall Study|Lost to Follow-up|0|||
164506715|NCT03016598|594224836|FG001|Overall Study|Lost to Follow-up|2|||
164506716|NCT02282917|594224846|FG000|Overall Study|Withdrawal by Subject|1|||
164506717|NCT02282917|594224846|FG000|Overall Study|Screen Failure/Not Eligible|1|||
164506718|NCT00115336|594224847|FG000|Overall Study|Hospital discharge before study drug|0|||
164506719|NCT00115336|594224848|FG001|Overall Study|Hospital discharge before study drug|1|||
164506720|NCT00715117|594224857|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
164506721|NCT00715117|594224858|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
164506722|NCT01018732|594224861|FG000|Overall Study|Lost to Follow-up|0|||
164506723|NCT01018732|594224862|FG001|Overall Study|Lost to Follow-up|0|||
164506724|NCT01018732|594224863|FG002|Overall Study|Lost to Follow-up|3|||
164506725|NCT01018732|594224861|FG000|Overall Study|Protocol Violation|1|||
164506726|NCT01018732|594224862|FG001|Overall Study|Protocol Violation|1|||
164506727|NCT01018732|594224863|FG002|Overall Study|Protocol Violation|0|||
164506728|NCT01018732|594224861|FG000|Overall Study|Inappropriate Enrollment|0|||
164506729|NCT01018732|594224862|FG001|Overall Study|Inappropriate Enrollment|1|||
164506730|NCT01018732|594224863|FG002|Overall Study|Inappropriate Enrollment|0|||
164506731|NCT01018732|594224861|FG000|Overall Study|Unable to Classify|0|||
164506732|NCT01018732|594224862|FG001|Overall Study|Unable to Classify|0|||
164607021|NCT00093470|594583432|FG000|Overall Study|Disease progression|39|||
164607022|NCT00093470|594583433|FG001|Overall Study|Disease progression|0|||
164506733|NCT01018732|594224863|FG002|Overall Study|Unable to Classify|1|||
164607023|NCT00093470|594583432|FG000|Overall Study|Adverse Event|15|||
164506734|NCT01536171|594224864|FG000|Overall Study|Withdrawal by Subject|1|||
164506735|NCT03566979|594224865|FG000|Overall Study|Withdrawal by Subject|2|||
164506736|NCT03566979|594224866|FG001|Overall Study|Withdrawal by Subject|0|||
164506737|NCT03566979|594224867|FG002|Overall Study|Withdrawal by Subject|1|||
164506738|NCT03566979|594224868|FG003|Overall Study|Withdrawal by Subject|1|||
164506739|NCT03566979|594224865|FG000|Overall Study|Lost to Follow-up|2|||
164506740|NCT03566979|594224866|FG001|Overall Study|Lost to Follow-up|7|||
164506741|NCT03566979|594224867|FG002|Overall Study|Lost to Follow-up|9|||
164506742|NCT03566979|594224868|FG003|Overall Study|Lost to Follow-up|5|||
164506743|NCT03566979|594224865|FG000|Overall Study|Adverse Event|1|||
164506744|NCT03566979|594224866|FG001|Overall Study|Adverse Event|0|||
164506745|NCT03566979|594224867|FG002|Overall Study|Adverse Event|0|||
164506746|NCT03566979|594224868|FG003|Overall Study|Adverse Event|0|||
164506747|NCT04599907|594224871|FG000|Overall Study|Withdrawal by Subject|1|||
164506748|NCT04599907|594224872|FG001|Overall Study|Withdrawal by Subject|7|||
164506749|NCT04599907|594224873|FG002|Overall Study|Withdrawal by Subject|6|||
164506750|NCT04599907|594224871|FG000|Overall Study|Lost to Follow-up|0|||
164506751|NCT04599907|594224872|FG001|Overall Study|Lost to Follow-up|1|||
164506752|NCT04599907|594224873|FG002|Overall Study|Lost to Follow-up|0|||
164506753|NCT03371823|594224874|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
164506754|NCT03371823|594224875|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
164506755|NCT01466790|594224877|FG000|Overall Study|Adverse Event|1|||
164506756|NCT01466790|594224878|FG001|Overall Study|Adverse Event|0|||
164506757|NCT01466790|594224879|FG002|Overall Study|Adverse Event|0|||
164506758|NCT01466790|594224880|FG003|Overall Study|Adverse Event|0|||
164506759|NCT01466790|594224881|FG004|Overall Study|Adverse Event|2|||
164506760|NCT01466790|594224882|FG005|Overall Study|Adverse Event|0|||
164506761|NCT01466790|594224883|FG006|Overall Study|Adverse Event|0|||
164506762|NCT01466790|594224884|FG007|Overall Study|Adverse Event|0|||
164506763|NCT01466790|594224877|FG000|Overall Study|Lost to Follow-up|2|||
164506764|NCT01466790|594224878|FG001|Overall Study|Lost to Follow-up|0|||
164506765|NCT01466790|594224879|FG002|Overall Study|Lost to Follow-up|0|||
164506766|NCT01466790|594224880|FG003|Overall Study|Lost to Follow-up|0|||
164506767|NCT01466790|594224881|FG004|Overall Study|Lost to Follow-up|0|||
164506768|NCT01466790|594224882|FG005|Overall Study|Lost to Follow-up|0|||
164506769|NCT01466790|594224883|FG006|Overall Study|Lost to Follow-up|0|||
164506770|NCT01466790|594224884|FG007|Overall Study|Lost to Follow-up|0|||
164506771|NCT01466790|594224877|FG000|Overall Study|Withdrawal by Subject|1|||
164506772|NCT01466790|594224878|FG001|Overall Study|Withdrawal by Subject|1|||
164506773|NCT01466790|594224879|FG002|Overall Study|Withdrawal by Subject|0|||
164506774|NCT01466790|594224880|FG003|Overall Study|Withdrawal by Subject|0|||
164506775|NCT01466790|594224881|FG004|Overall Study|Withdrawal by Subject|1|||
164506776|NCT01466790|594224882|FG005|Overall Study|Withdrawal by Subject|0|||
164506777|NCT01466790|594224883|FG006|Overall Study|Withdrawal by Subject|1|||
164506778|NCT01466790|594224884|FG007|Overall Study|Withdrawal by Subject|1|||
164506779|NCT01310699|594224885|FG000|Overall Study|Patients did not complete tandem.|4|||
164506780|NCT01310699|594224886|FG001|Overall Study|Patients did not complete tandem.|6|||
164506781|NCT02386839|594224887|FG000|Overall Study|Death|1|||
164506782|NCT02386839|594224888|FG001|Overall Study|Death|0|||
164506783|NCT02386839|594224887|FG000|Overall Study|Withdrawal by Subject|9|||
164506784|NCT02386839|594224888|FG001|Overall Study|Withdrawal by Subject|10|||
164506785|NCT02386839|594224887|FG000|Overall Study|Lost to Follow-up|4|||
164506786|NCT02386839|594224888|FG001|Overall Study|Lost to Follow-up|4|||
164506787|NCT02386839|594224887|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
164506788|NCT02386839|594224888|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
164506789|NCT02386839|594224887|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
164506790|NCT02386839|594224888|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
164506791|NCT02386839|594224887|FG000|Overall Study|Other (unspecified)|1|||
164506792|NCT02386839|594224888|FG001|Overall Study|Other (unspecified)|0|||
164506793|NCT00926575|594224889|FG000|Overall Study|Adverse Event|1|||
164506794|NCT00926575|594224890|FG001|Overall Study|Adverse Event|1|||
164506795|NCT00926575|594224889|FG000|Overall Study|Death|4|||
164506796|NCT00926575|594224890|FG001|Overall Study|Death|4|||
164506797|NCT00926575|594224889|FG000|Overall Study|Lost to Follow-up|1|||
164506798|NCT00926575|594224890|FG001|Overall Study|Lost to Follow-up|1|||
164506799|NCT00926575|594224889|FG000|Overall Study|Physician Decision|1|||
164506800|NCT00926575|594224890|FG001|Overall Study|Physician Decision|2|||
164506801|NCT00926575|594224889|FG000|Overall Study|Protocol Violation|1|||
164506802|NCT00926575|594224890|FG001|Overall Study|Protocol Violation|0|||
164506803|NCT00926575|594224889|FG000|Overall Study|Withdrawal by Subject|8|||
164506804|NCT00926575|594224890|FG001|Overall Study|Withdrawal by Subject|9|||
164506805|NCT00490698|594224891|FG000|Overall Study|Withdrawal by Subject|1|||
164506806|NCT00490698|594224891|FG000|Overall Study|Disease Progression|7|||
164506807|NCT00490698|594224891|FG000|Overall Study|Physician Decision|2|||
164506808|NCT02101983|594224896|FG000|Overall Study|Physician Decision|1|||
164506809|NCT02101983|594224897|FG001|Overall Study|Physician Decision|0|||
164506810|NCT04870957|594224898|FG000|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
164506811|NCT04870957|594224899|FG001|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
164607024|NCT00093470|594583433|FG001|Overall Study|Adverse Event|0|||
164607025|NCT00093470|594583432|FG000|Overall Study|Death|2|||
164607026|NCT00093470|594583433|FG001|Overall Study|Death|0|||
164607027|NCT00093470|594583432|FG000|Overall Study|Withdrawal by Subject|8|||
164607028|NCT00093470|594583433|FG001|Overall Study|Withdrawal by Subject|0|||
164607029|NCT00093470|594583432|FG000|Overall Study|Alternative therapy|2|||
164607030|NCT00093470|594583433|FG001|Overall Study|Alternative therapy|0|||
164607031|NCT00093470|594583432|FG000|Overall Study|Other complicating disease|3|||
164607032|NCT00093470|594583433|FG001|Overall Study|Other complicating disease|0|||
164607033|NCT00093470|594583432|FG000|Overall Study|Physician Decision|2|||
164607034|NCT00093470|594583433|FG001|Overall Study|Physician Decision|0|||
164607035|NCT00093470|594583432|FG000|Overall Study|Never started treatment|1|||
164607036|NCT00093470|594583433|FG001|Overall Study|Never started treatment|0|||
164607037|NCT00093470|594583432|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
164607038|NCT00093470|594583433|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
164607039|NCT01019252|594583439|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
164607040|NCT01019252|594583440|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
164607041|NCT01019252|594583439|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
164607042|NCT01019252|594583440|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
164607043|NCT01019252|594583439|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
164607044|NCT01019252|594583440|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
164607045|NCT01019252|594583439|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
164607046|NCT01019252|594583440|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
164607047|NCT02514772|594583441|FG000|Overall Study|Adverse Event|1|||
164607048|NCT02514772|594583442|FG001|Overall Study|Adverse Event|0|||
164607049|NCT02514772|594583441|FG000|Overall Study|Death|0|||
164607050|NCT02514772|594583442|FG001|Overall Study|Death|1|||
164607051|NCT02514772|594583441|FG000|Overall Study|Withdrawal by Subject|2|||
164607052|NCT02514772|594583442|FG001|Overall Study|Withdrawal by Subject|1|||
164607053|NCT00877006|594583443|FG000|Treatment Period|Death|2|||
164607054|NCT00877006|594583444|FG001|Treatment Period|Death|1|||
164607055|NCT00877006|594583443|FG000|Treatment Period|Adverse Event|10|||
164607056|NCT00877006|594583444|FG001|Treatment Period|Adverse Event|3|||
164607057|NCT00877006|594583443|FG000|Treatment Period|Withdrawal by Subject|2|||
164607058|NCT00877006|594583444|FG001|Treatment Period|Withdrawal by Subject|3|||
164607059|NCT00877006|594583443|FG000|Treatment Period|Protocol Violation|1|||
164607060|NCT00877006|594583444|FG001|Treatment Period|Protocol Violation|0|||
164607061|NCT00877006|594583443|FG000|Treatment Period|Lost to Follow-up|0|||
164607062|NCT00877006|594583444|FG001|Treatment Period|Lost to Follow-up|1|||
164607063|NCT00877006|594583443|FG000|Treatment Period|Disease Progression|1|||
164607064|NCT00877006|594583444|FG001|Treatment Period|Disease Progression|2|||
164607065|NCT00877006|594583443|FG000|Treatment Period|Started New Treatment Regimen|2|||
164607066|NCT00877006|594583444|FG001|Treatment Period|Started New Treatment Regimen|5|||
164607067|NCT00877006|594583443|FG000|Treatment Period|Other|4|||
164607068|NCT00877006|594583444|FG001|Treatment Period|Other|4|||
164607069|NCT00877006|594583443|FG000|Treatment Period|Randomized but Not Treated|3|||
164607070|NCT00877006|594583444|FG001|Treatment Period|Randomized but Not Treated|8|||
164607071|NCT00877006|594583443|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
164607072|NCT00877006|594583444|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
164607073|NCT00877006|594583443|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
164607074|NCT00877006|594583444|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
164607075|NCT00877006|594583443|FG000|Long-Term Follow-up Period|Death|26|||
164607076|NCT00877006|594583444|FG001|Long-Term Follow-up Period|Death|18|||
164607077|NCT00877006|594583443|FG000|Long-Term Follow-up Period|Other|7|||
164607078|NCT00877006|594583444|FG001|Long-Term Follow-up Period|Other|9|||
164607079|NCT04671342|594583445|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
164607080|NCT04671342|594583445|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
164607081|NCT04671342|594583445|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
164607082|NCT04671342|594583445|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
164607083|NCT04671342|594583445|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
164607084|NCT04671342|594583445|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
164607085|NCT03583606|594583446|FG000|Overall Study|Lost to Follow-up|0|||
164607086|NCT03583606|594583447|FG001|Overall Study|Lost to Follow-up|1|||
164607087|NCT03583606|594583448|FG002|Overall Study|Lost to Follow-up|0|||
164607088|NCT03583606|594583446|FG000|Overall Study|Ineligible at baseline|1|||
164607089|NCT03583606|594583447|FG001|Overall Study|Ineligible at baseline|0|||
164607090|NCT03583606|594583448|FG002|Overall Study|Ineligible at baseline|0|||
164607091|NCT02685995|594583449|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
164607092|NCT02685995|594583450|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
164607093|NCT00817206|594583451|FG000|Overall Study|Adverse Event|10|||
164607094|NCT00817206|594583452|FG001|Overall Study|Adverse Event|3|||
164607095|NCT00817206|594583451|FG000|Overall Study|Protocol Violation|0|||
164607096|NCT00817206|594583452|FG001|Overall Study|Protocol Violation|2|||
164607097|NCT00817206|594583451|FG000|Overall Study|Lost to Follow-up|0|||
164506812|NCT04870957|594224900|FG002|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
164506813|NCT04870957|594224901|FG003|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
164506814|NCT04870957|594224902|FG004|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|35|||
164506815|NCT04870957|594224903|FG005|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
164506816|NCT04870957|594224898|FG000|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
164506817|NCT04870957|594224899|FG001|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
164506818|NCT04870957|594224900|FG002|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
164506819|NCT04870957|594224901|FG003|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
164506820|NCT04870957|594224902|FG004|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|2|||
164506821|NCT04870957|594224903|FG005|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
164506822|NCT04870957|594224898|FG000|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
164506823|NCT04870957|594224899|FG001|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
164506824|NCT04870957|594224900|FG002|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
164506825|NCT04870957|594224901|FG003|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
164506826|NCT04870957|594224902|FG004|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|37|||
164506827|NCT04870957|594224903|FG005|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
164506828|NCT04870957|594224898|FG000|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
164506829|NCT04870957|594224899|FG001|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
164506830|NCT04870957|594224900|FG002|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
164506831|NCT04870957|594224901|FG003|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
164506832|NCT04870957|594224902|FG004|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|3|||
164506833|NCT04870957|594224903|FG005|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
164506834|NCT04870957|594224898|FG000|T2 (Randomization) - T3|Adverse Event|1|||
164506835|NCT04870957|594224899|FG001|T2 (Randomization) - T3|Adverse Event|1|||
164506836|NCT04870957|594224900|FG002|T2 (Randomization) - T3|Adverse Event|0|||
164506837|NCT04870957|594224901|FG003|T2 (Randomization) - T3|Adverse Event|0|||
164506838|NCT04870957|594224902|FG004|T2 (Randomization) - T3|Adverse Event|0|||
164506839|NCT04870957|594224903|FG005|T2 (Randomization) - T3|Adverse Event|0|||
164506840|NCT04870957|594224898|FG000|T2 (Randomization) - T3|Lost to Follow-up|7|||
164506841|NCT04870957|594224899|FG001|T2 (Randomization) - T3|Lost to Follow-up|0|||
164506842|NCT04870957|594224900|FG002|T2 (Randomization) - T3|Lost to Follow-up|7|||
164506843|NCT04870957|594224901|FG003|T2 (Randomization) - T3|Lost to Follow-up|3|||
164506844|NCT04870957|594224902|FG004|T2 (Randomization) - T3|Lost to Follow-up|0|||
164506845|NCT04870957|594224903|FG005|T2 (Randomization) - T3|Lost to Follow-up|0|||
164506846|NCT04870957|594224898|FG000|T2 (Randomization) - T3|Withdrawal by Subject|11|||
164506847|NCT04870957|594224899|FG001|T2 (Randomization) - T3|Withdrawal by Subject|8|||
164506848|NCT04870957|594224900|FG002|T2 (Randomization) - T3|Withdrawal by Subject|11|||
164506849|NCT04870957|594224901|FG003|T2 (Randomization) - T3|Withdrawal by Subject|7|||
164506850|NCT04870957|594224902|FG004|T2 (Randomization) - T3|Withdrawal by Subject|0|||
164506851|NCT04870957|594224903|FG005|T2 (Randomization) - T3|Withdrawal by Subject|1|||
164506852|NCT04870957|594224898|FG000|T2 (Randomization) - T3|Physician Decision|0|||
164506853|NCT04870957|594224899|FG001|T2 (Randomization) - T3|Physician Decision|0|||
164506854|NCT04870957|594224900|FG002|T2 (Randomization) - T3|Physician Decision|2|||
164506855|NCT04870957|594224901|FG003|T2 (Randomization) - T3|Physician Decision|1|||
164506856|NCT04870957|594224902|FG004|T2 (Randomization) - T3|Physician Decision|0|||
164506857|NCT04870957|594224903|FG005|T2 (Randomization) - T3|Physician Decision|0|||
164506858|NCT04870957|594224898|FG000|T2 (Randomization) - T3|Missed Timepoint|4|||
164506859|NCT04870957|594224899|FG001|T2 (Randomization) - T3|Missed Timepoint|3|||
164506860|NCT04870957|594224900|FG002|T2 (Randomization) - T3|Missed Timepoint|3|||
164506861|NCT04870957|594224901|FG003|T2 (Randomization) - T3|Missed Timepoint|2|||
164506862|NCT04870957|594224902|FG004|T2 (Randomization) - T3|Missed Timepoint|0|||
164506863|NCT04870957|594224903|FG005|T2 (Randomization) - T3|Missed Timepoint|12|||
164506864|NCT04870957|594224898|FG000|T3 (Re-randomization) - T4|Adverse Event|0|||
164506865|NCT04870957|594224899|FG001|T3 (Re-randomization) - T4|Adverse Event|1|||
164506866|NCT04870957|594224900|FG002|T3 (Re-randomization) - T4|Adverse Event|0|||
164506867|NCT04870957|594224901|FG003|T3 (Re-randomization) - T4|Adverse Event|1|||
164506868|NCT04870957|594224902|FG004|T3 (Re-randomization) - T4|Adverse Event|0|||
164506869|NCT04870957|594224903|FG005|T3 (Re-randomization) - T4|Adverse Event|0|||
164506870|NCT04870957|594224898|FG000|T3 (Re-randomization) - T4|Lost to Follow-up|8|||
164506871|NCT04870957|594224899|FG001|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
164506872|NCT04870957|594224900|FG002|T3 (Re-randomization) - T4|Lost to Follow-up|7|||
164506873|NCT04870957|594224901|FG003|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
164506874|NCT04870957|594224902|FG004|T3 (Re-randomization) - T4|Lost to Follow-up|0|||
164506875|NCT04870957|594224903|FG005|T3 (Re-randomization) - T4|Lost to Follow-up|2|||
164506876|NCT04870957|594224898|FG000|T3 (Re-randomization) - T4|Withdrawal by Subject|11|||
164506877|NCT04870957|594224899|FG001|T3 (Re-randomization) - T4|Withdrawal by Subject|5|||
164607098|NCT00817206|594583452|FG001|Overall Study|Lost to Follow-up|1|||
164607099|NCT00817206|594583451|FG000|Overall Study|Death|2|||
164607100|NCT00817206|594583452|FG001|Overall Study|Death|0|||
164506878|NCT04870957|594224900|FG002|T3 (Re-randomization) - T4|Withdrawal by Subject|10|||
164506879|NCT04870957|594224901|FG003|T3 (Re-randomization) - T4|Withdrawal by Subject|3|||
164506880|NCT04870957|594224902|FG004|T3 (Re-randomization) - T4|Withdrawal by Subject|0|||
164506881|NCT04870957|594224903|FG005|T3 (Re-randomization) - T4|Withdrawal by Subject|1|||
164506882|NCT04870957|594224898|FG000|T3 (Re-randomization) - T4|Physician Decision|2|||
164506883|NCT04870957|594224899|FG001|T3 (Re-randomization) - T4|Physician Decision|0|||
164506884|NCT04870957|594224900|FG002|T3 (Re-randomization) - T4|Physician Decision|0|||
164506885|NCT04870957|594224901|FG003|T3 (Re-randomization) - T4|Physician Decision|0|||
164506886|NCT04870957|594224902|FG004|T3 (Re-randomization) - T4|Physician Decision|0|||
164506887|NCT04870957|594224903|FG005|T3 (Re-randomization) - T4|Physician Decision|0|||
164506888|NCT04870957|594224898|FG000|T3 (Re-randomization) - T4|Missed Timepoint|3|||
164506889|NCT04870957|594224899|FG001|T3 (Re-randomization) - T4|Missed Timepoint|1|||
164506890|NCT04870957|594224900|FG002|T3 (Re-randomization) - T4|Missed Timepoint|2|||
164506891|NCT04870957|594224901|FG003|T3 (Re-randomization) - T4|Missed Timepoint|2|||
164506892|NCT04870957|594224902|FG004|T3 (Re-randomization) - T4|Missed Timepoint|0|||
164506893|NCT04870957|594224903|FG005|T3 (Re-randomization) - T4|Missed Timepoint|23|||
164506894|NCT04870957|594224898|FG000|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
164506895|NCT04870957|594224899|FG001|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
164506896|NCT04870957|594224900|FG002|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
164506897|NCT04870957|594224901|FG003|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
164506898|NCT04870957|594224902|FG004|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
164506899|NCT04870957|594224903|FG005|T4 - T5 (Follow-Up)|Lost to Follow-up|21|||
164506900|NCT04870957|594224898|FG000|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
164506901|NCT04870957|594224899|FG001|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
164506902|NCT04870957|594224900|FG002|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
164506903|NCT04870957|594224901|FG003|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
164506904|NCT04870957|594224902|FG004|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
164506905|NCT04870957|594224903|FG005|T4 - T5 (Follow-Up)|Withdrawal by Subject|7|||
164506906|NCT04870957|594224898|FG000|T4 - T5 (Follow-Up)|Physician Decision|0|||
164506907|NCT04870957|594224899|FG001|T4 - T5 (Follow-Up)|Physician Decision|0|||
164506908|NCT04870957|594224900|FG002|T4 - T5 (Follow-Up)|Physician Decision|0|||
164506909|NCT04870957|594224901|FG003|T4 - T5 (Follow-Up)|Physician Decision|0|||
164506910|NCT04870957|594224902|FG004|T4 - T5 (Follow-Up)|Physician Decision|0|||
164506911|NCT04870957|594224903|FG005|T4 - T5 (Follow-Up)|Physician Decision|2|||
164506912|NCT05970640|594224904|FG000|Overall Study|Adverse Event|1|||
164506913|NCT05970640|594224905|FG001|Overall Study|Adverse Event|3|||
164506914|NCT05970640|594224906|FG002|Overall Study|Adverse Event|1|||
164506915|NCT05970640|594224907|FG003|Overall Study|Adverse Event|0|||
164506916|NCT05970640|594224904|FG000|Overall Study|Withdrawal by Subject|0|||
164506917|NCT05970640|594224905|FG001|Overall Study|Withdrawal by Subject|0|||
164506918|NCT05970640|594224906|FG002|Overall Study|Withdrawal by Subject|1|||
164506919|NCT05970640|594224907|FG003|Overall Study|Withdrawal by Subject|1|||
164506920|NCT05970640|594224904|FG000|Overall Study|Sponsor decision|0|||
164506921|NCT05970640|594224905|FG001|Overall Study|Sponsor decision|0|||
164506922|NCT05970640|594224906|FG002|Overall Study|Sponsor decision|1|||
164506923|NCT05970640|594224907|FG003|Overall Study|Sponsor decision|1|||
164506924|NCT02394925|594224908|FG000|Overall Study|Adverse Event|1|||
164506925|NCT02394925|594224908|FG000|Overall Study|Lens Discomfort|3|||
164506926|NCT02394925|594224908|FG000|Overall Study|Lens handling difficulities|5|||
164506927|NCT02394925|594224908|FG000|Overall Study|Lost to Follow-up|9|||
164506928|NCT02394925|594224908|FG000|Overall Study|Protocol Violation|5|||
164506929|NCT02394925|594224908|FG000|Overall Study|No longer meet eligibility criteria|1|||
164506930|NCT02394925|594224908|FG000|Overall Study|Unsatisfactory Visual Response|5|||
164506931|NCT04340843|594224912|FG000|Overall Study|Adverse Event|0|||
164506932|NCT04340843|594224913|FG001|Overall Study|Adverse Event|2|||
164506933|NCT04340843|594224912|FG000|Overall Study|Withdrawal by Subject|0|||
164506934|NCT04340843|594224913|FG001|Overall Study|Withdrawal by Subject|2|||
164506935|NCT03733899|594224916|FG000|Period 1|Protocol Violation|0|||
164506936|NCT03733899|594224917|FG001|Period 1|Protocol Violation|0|||
164506937|NCT03733899|594224918|FG002|Period 1|Protocol Violation|0|||
164506938|NCT03733899|594224919|FG003|Period 1|Protocol Violation|0|||
164506939|NCT03733899|594224920|FG004|Period 1|Protocol Violation|0|||
164506940|NCT03733899|594224921|FG005|Period 1|Protocol Violation|1|||
164506941|NCT03733899|594224916|FG000|Period 2|Unscuccessful Treatment|0|||
164506942|NCT03733899|594224917|FG001|Period 2|Unscuccessful Treatment|1|||
164506943|NCT03733899|594224918|FG002|Period 2|Unscuccessful Treatment|0|||
164506944|NCT03733899|594224919|FG003|Period 2|Unscuccessful Treatment|0|||
164506945|NCT03733899|594224920|FG004|Period 2|Unscuccessful Treatment|0|||
164506946|NCT03733899|594224921|FG005|Period 2|Unscuccessful Treatment|0|||
164506947|NCT03733899|594224916|FG000|Period 3|Withdrawal by Subject|1|||
164506948|NCT03733899|594224917|FG001|Period 3|Withdrawal by Subject|0|||
164506949|NCT03733899|594224918|FG002|Period 3|Withdrawal by Subject|0|||
164506950|NCT03733899|594224919|FG003|Period 3|Withdrawal by Subject|0|||
164506951|NCT03733899|594224920|FG004|Period 3|Withdrawal by Subject|0|||
164607101|NCT00817206|594583451|FG000|Overall Study|Withdrawal by Subject|7|||
164607102|NCT00817206|594583452|FG001|Overall Study|Withdrawal by Subject|3|||
164607103|NCT00817206|594583451|FG000|Overall Study|Physician Decision|2|||
164607104|NCT00817206|594583452|FG001|Overall Study|Physician Decision|0|||
164607105|NCT00793182|594583453|FG000|Overall Study|Adverse Event|0|||
164607106|NCT00793182|594583454|FG001|Overall Study|Adverse Event|1|||
164607107|NCT01188096|594583455|FG000|Overall Study|progression of disease|4|||
164607108|NCT01188096|594583455|FG000|Overall Study|Withdrawal by Subject|2|||
164607109|NCT02273037|594583456|FG000|Overall Study|Lost to Follow-up|1|||
164607110|NCT02273037|594583457|FG001|Overall Study|Lost to Follow-up|0|||
164607111|NCT02273037|594583456|FG000|Overall Study|Delivered before monitoring initiated|1|||
164607112|NCT02273037|594583457|FG001|Overall Study|Delivered before monitoring initiated|3|||
164607113|NCT02273037|594583456|FG000|Overall Study|Breech delivery|2|||
164607114|NCT02273037|594583457|FG001|Overall Study|Breech delivery|3|||
164607115|NCT02273037|594583456|FG000|Overall Study|Multiple delivery|2|||
164607116|NCT02273037|594583457|FG001|Overall Study|Multiple delivery|2|||
164607117|NCT02273037|594583456|FG000|Overall Study|Other complication|2|||
164607118|NCT02273037|594583457|FG001|Overall Study|Other complication|0|||
164607119|NCT00851253|594583458|FG000|Overall Study|Disease Progression|1|||
164607120|NCT00851253|594583459|FG001|Overall Study|Disease Progression|0|||
164506952|NCT03733899|594224921|FG005|Period 3|Withdrawal by Subject|0|||
164506953|NCT02419417|594226780|FG000|Overall Study|Disease progression|5|||
164506954|NCT02419417|594226781|FG001|Overall Study|Disease progression|4|||
164506955|NCT02419417|594226782|FG002|Overall Study|Disease progression|13|||
164506956|NCT02419417|594226783|FG003|Overall Study|Disease progression|10|||
164506957|NCT02419417|594226784|FG004|Overall Study|Disease progression|10|||
164506958|NCT02419417|594226785|FG005|Overall Study|Disease progression|3|||
164506959|NCT02419417|594226786|FG006|Overall Study|Disease progression|4|||
164506960|NCT02419417|594226787|FG007|Overall Study|Disease progression|5|||
164506961|NCT02419417|594226788|FG008|Overall Study|Disease progression|13|||
164506962|NCT02419417|594226789|FG009|Overall Study|Disease progression|9|||
164506963|NCT02419417|594226790|FG010|Overall Study|Disease progression|0|||
164506964|NCT02419417|594226780|FG000|Overall Study|Study drug toxicity|0|||
164506965|NCT02419417|594226781|FG001|Overall Study|Study drug toxicity|0|||
164506966|NCT02419417|594226782|FG002|Overall Study|Study drug toxicity|0|||
164506967|NCT02419417|594226783|FG003|Overall Study|Study drug toxicity|0|||
164506968|NCT02419417|594226784|FG004|Overall Study|Study drug toxicity|1|||
164506969|NCT02419417|594226785|FG005|Overall Study|Study drug toxicity|0|||
164506970|NCT02419417|594226786|FG006|Overall Study|Study drug toxicity|0|||
164506971|NCT02419417|594226787|FG007|Overall Study|Study drug toxicity|0|||
164506972|NCT02419417|594226788|FG008|Overall Study|Study drug toxicity|0|||
164506973|NCT02419417|594226789|FG009|Overall Study|Study drug toxicity|0|||
164506974|NCT02419417|594226790|FG010|Overall Study|Study drug toxicity|0|||
164506975|NCT02419417|594226780|FG000|Overall Study|Adverse event unrelated to study drug|0|||
164506976|NCT02419417|594226781|FG001|Overall Study|Adverse event unrelated to study drug|0|||
164506977|NCT02419417|594226782|FG002|Overall Study|Adverse event unrelated to study drug|0|||
164506978|NCT02419417|594226783|FG003|Overall Study|Adverse event unrelated to study drug|0|||
164506979|NCT02419417|594226784|FG004|Overall Study|Adverse event unrelated to study drug|2|||
164506980|NCT02419417|594226785|FG005|Overall Study|Adverse event unrelated to study drug|1|||
164506981|NCT02419417|594226786|FG006|Overall Study|Adverse event unrelated to study drug|0|||
164506982|NCT02419417|594226787|FG007|Overall Study|Adverse event unrelated to study drug|1|||
164506983|NCT02419417|594226788|FG008|Overall Study|Adverse event unrelated to study drug|0|||
164506984|NCT02419417|594226789|FG009|Overall Study|Adverse event unrelated to study drug|0|||
164506985|NCT02419417|594226790|FG010|Overall Study|Adverse event unrelated to study drug|0|||
164506986|NCT02419417|594226780|FG000|Overall Study|Participant request to discontinue|0|||
164506987|NCT02419417|594226781|FG001|Overall Study|Participant request to discontinue|0|||
164506988|NCT02419417|594226782|FG002|Overall Study|Participant request to discontinue|0|||
164506989|NCT02419417|594226783|FG003|Overall Study|Participant request to discontinue|0|||
164506990|NCT02419417|594226784|FG004|Overall Study|Participant request to discontinue|0|||
164506991|NCT02419417|594226785|FG005|Overall Study|Participant request to discontinue|0|||
164506992|NCT02419417|594226786|FG006|Overall Study|Participant request to discontinue|0|||
164506993|NCT02419417|594226787|FG007|Overall Study|Participant request to discontinue|0|||
164506994|NCT02419417|594226788|FG008|Overall Study|Participant request to discontinue|0|||
164506995|NCT02419417|594226789|FG009|Overall Study|Participant request to discontinue|1|||
164607121|NCT02384395|594583460|FG000|Overall Study|Physician Decision|4|||
164607122|NCT02384395|594583460|FG000|Overall Study|Withdrawal by Subject|3|||
164607123|NCT02384395|594583460|FG000|Overall Study|Lost to Follow-up|3|||
164506996|NCT02419417|594226790|FG010|Overall Study|Participant request to discontinue|0|||
164506997|NCT02419417|594226780|FG000|Overall Study|Withdrawal by Subject|0|||
164506998|NCT02419417|594226781|FG001|Overall Study|Withdrawal by Subject|0|||
164506999|NCT02419417|594226782|FG002|Overall Study|Withdrawal by Subject|0|||
164507000|NCT02419417|594226783|FG003|Overall Study|Withdrawal by Subject|0|||
164607124|NCT03485222|594583461|FG000|Overall Study|Death|0|||
164607125|NCT03485222|594583462|FG001|Overall Study|Death|1|||
164607126|NCT03485222|594583461|FG000|Overall Study|Lost to Follow-up|2|||
164607127|NCT03485222|594583462|FG001|Overall Study|Lost to Follow-up|1|||
164607128|NCT03657810|594583463|FG000|Overall Study|Adverse Event|0|||
164607129|NCT03657810|594583464|FG001|Overall Study|Adverse Event|1|||
164607130|NCT03657810|594583465|FG002|Overall Study|Adverse Event|0|||
164607131|NCT03657810|594583463|FG000|Overall Study|Lack of Efficacy|4|||
164607132|NCT03657810|594583464|FG001|Overall Study|Lack of Efficacy|1|||
164607133|NCT03657810|594583465|FG002|Overall Study|Lack of Efficacy|3|||
164607134|NCT03657810|594583463|FG000|Overall Study|Protocol Violation|1|||
164607135|NCT03657810|594583464|FG001|Overall Study|Protocol Violation|0|||
164607136|NCT03657810|594583465|FG002|Overall Study|Protocol Violation|0|||
164607137|NCT03657810|594583463|FG000|Overall Study|Lost to Follow-up|0|||
164607138|NCT03657810|594583464|FG001|Overall Study|Lost to Follow-up|1|||
164607139|NCT03657810|594583465|FG002|Overall Study|Lost to Follow-up|0|||
164607140|NCT03657810|594583463|FG000|Overall Study|Not provided|0|||
164607141|NCT03657810|594583464|FG001|Overall Study|Not provided|1|||
164607142|NCT03657810|594583465|FG002|Overall Study|Not provided|0|||
164607143|NCT00688545|594583466|FG000|Overall Study|Lost to Follow-up|1|||
164607144|NCT00688545|594583467|FG001|Overall Study|Lost to Follow-up|4|||
164607145|NCT00688545|594583466|FG000|Overall Study|Insurance/cost of drug|0|||
164607146|NCT00688545|594583467|FG001|Overall Study|Insurance/cost of drug|1|||
164607147|NCT00688545|594583466|FG000|Overall Study|Withdrawal by Subject|2|||
164607148|NCT00688545|594583467|FG001|Overall Study|Withdrawal by Subject|3|||
164607149|NCT00688545|594583466|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
164607150|NCT00688545|594583467|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
164607151|NCT00985738|594583468|FG000|Overall Study|Study closed prematurely|8|||
164607152|NCT00985738|594583469|FG001|Overall Study|Study closed prematurely|8|||
164607153|NCT00340834|594583474|FG000|Core Phase of Study|Adverse Event|26|||
164607154|NCT00340834|594583475|FG001|Core Phase of Study|Adverse Event|9|||
164607155|NCT00340834|594583476|FG002|Core Phase of Study|Adverse Event|9|||
164607156|NCT00340834|594583477|FG003|Core Phase of Study|Adverse Event|0|||
164607157|NCT00340834|594583478|FG004|Core Phase of Study|Adverse Event|0|||
164607158|NCT00340834|594583474|FG000|Core Phase of Study|Withdrawal by Subject|11|||
164607159|NCT00340834|594583475|FG001|Core Phase of Study|Withdrawal by Subject|9|||
164607160|NCT00340834|594583476|FG002|Core Phase of Study|Withdrawal by Subject|16|||
164607161|NCT00340834|594583477|FG003|Core Phase of Study|Withdrawal by Subject|0|||
164607162|NCT00340834|594583478|FG004|Core Phase of Study|Withdrawal by Subject|0|||
164607163|NCT00340834|594583474|FG000|Core Phase of Study|Administrative Problems|6|||
164607164|NCT00340834|594583475|FG001|Core Phase of Study|Administrative Problems|2|||
164607165|NCT00340834|594583476|FG002|Core Phase of Study|Administrative Problems|7|||
164607166|NCT00340834|594583477|FG003|Core Phase of Study|Administrative Problems|0|||
164607167|NCT00340834|594583478|FG004|Core Phase of Study|Administrative Problems|0|||
164607168|NCT00340834|594583474|FG000|Core Phase of Study|Lack of Efficacy|3|||
164607169|NCT00340834|594583475|FG001|Core Phase of Study|Lack of Efficacy|3|||
164607170|NCT00340834|594583476|FG002|Core Phase of Study|Lack of Efficacy|7|||
164607171|NCT00340834|594583477|FG003|Core Phase of Study|Lack of Efficacy|0|||
164607172|NCT00340834|594583478|FG004|Core Phase of Study|Lack of Efficacy|0|||
164607173|NCT00340834|594583474|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
164607174|NCT00340834|594583475|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
164607175|NCT00340834|594583476|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
164607176|NCT00340834|594583477|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
164607177|NCT00340834|594583478|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
164607178|NCT00340834|594583474|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
164507001|NCT02419417|594226784|FG004|Overall Study|Withdrawal by Subject|0|||
164507002|NCT02419417|594226785|FG005|Overall Study|Withdrawal by Subject|0|||
164507003|NCT02419417|594226786|FG006|Overall Study|Withdrawal by Subject|0|||
164507004|NCT02419417|594226787|FG007|Overall Study|Withdrawal by Subject|0|||
164507005|NCT02419417|594226788|FG008|Overall Study|Withdrawal by Subject|0|||
164507006|NCT02419417|594226789|FG009|Overall Study|Withdrawal by Subject|0|||
164507007|NCT02419417|594226790|FG010|Overall Study|Withdrawal by Subject|1|||
164507008|NCT01240551|594226791|FG000|Overall Study|Refused further treatment|3|||
164507009|NCT01240551|594226792|FG001|Overall Study|Refused further treatment|2|||
164507010|NCT01240551|594226791|FG000|Overall Study|Lost to Follow-up|1|||
164507011|NCT01240551|594226792|FG001|Overall Study|Lost to Follow-up|1|||
164507012|NCT01385748|594226793|FG000|Overall Study|Withdrawal by Subject|7|||
164507013|NCT01385748|594226794|FG001|Overall Study|Withdrawal by Subject|4|||
164507014|NCT01385748|594226795|FG002|Overall Study|Withdrawal by Subject|5|||
164507015|NCT01385748|594226793|FG000|Overall Study|Noncompliance|3|||
164507016|NCT01385748|594226794|FG001|Overall Study|Noncompliance|1|||
164507017|NCT01385748|594226795|FG002|Overall Study|Noncompliance|6|||
164507018|NCT01385748|594226793|FG000|Overall Study|Other|1|||
164507019|NCT01385748|594226794|FG001|Overall Study|Other|7|||
164507020|NCT01385748|594226795|FG002|Overall Study|Other|1|||
164507021|NCT01385748|594226793|FG000|Overall Study|Adverse Event|4|||
164507022|NCT01385748|594226794|FG001|Overall Study|Adverse Event|2|||
164507023|NCT01385748|594226795|FG002|Overall Study|Adverse Event|1|||
164507024|NCT01200342|594226802|FG000|Overall Study|Disease Progression|1|||
164507025|NCT01920932|594226803|FG000|Overall Study|Death|1|||
164507026|NCT01920932|594226803|FG000|Overall Study|Withdrawal of consent|1|||
164507027|NCT00633945|594226807|FG000|Overall Study|Physician Decision|2|||
164507028|NCT00882115|594226808|FG000|Overall Study|Withdrawal by Subject|3|||
164507029|NCT00882115|594226808|FG000|Overall Study|did not respond to DEP challe|6|||
164507030|NCT00943787|594226809|FG000|Overall Study|Physician Decision|4|||
164507031|NCT00943787|594226809|FG000|Overall Study|Withdrawal by Subject|3|||
164507032|NCT01547598|594226810|FG000|Overall Study|Withdrew consent|1|||
164507033|NCT01547598|594226811|FG001|Overall Study|Withdrew consent|1|||
164507034|NCT01547598|594226810|FG000|Overall Study|Lost to Follow-up|1|||
164507035|NCT01547598|594226811|FG001|Overall Study|Lost to Follow-up|1|||
164507036|NCT01547598|594226810|FG000|Overall Study|Adverse Event|1|||
164507037|NCT01547598|594226811|FG001|Overall Study|Adverse Event|1|||
164507038|NCT01547598|594226810|FG000|Overall Study|Protocol Violation|1|||
164507039|NCT01547598|594226811|FG001|Overall Study|Protocol Violation|1|||
164507040|NCT01547598|594226810|FG000|Overall Study|Other Miscellaneous Reasons|2|||
164507041|NCT01547598|594226811|FG001|Overall Study|Other Miscellaneous Reasons|1|||
164507042|NCT00872001|594226814|FG000|Overall Study|Adverse Event|34|||
164507043|NCT00872001|594226815|FG001|Overall Study|Adverse Event|23|||
164507044|NCT00872001|594226814|FG000|Overall Study|Protocol Defined Clinical Event|5|||
164507045|NCT00872001|594226815|FG001|Overall Study|Protocol Defined Clinical Event|7|||
164507046|NCT00872001|594226814|FG000|Overall Study|Lost to Follow-up|13|||
164507047|NCT00872001|594226815|FG001|Overall Study|Lost to Follow-up|12|||
164507048|NCT00872001|594226814|FG000|Overall Study|Withdrawal by Subject|18|||
164507049|NCT00872001|594226815|FG001|Overall Study|Withdrawal by Subject|30|||
164507050|NCT00872001|594226814|FG000|Overall Study|Protocol Violation|5|||
164507051|NCT00872001|594226815|FG001|Overall Study|Protocol Violation|8|||
164507052|NCT00872001|594226814|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
164507053|NCT00872001|594226815|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
164507054|NCT00872001|594226814|FG000|Overall Study|Administrative|23|||
164507055|NCT00872001|594226815|FG001|Overall Study|Administrative|15|||
164507056|NCT02125279|594226816|FG000|Overall Study|Lack of Efficacy|2|||
164507057|NCT02125279|594226816|FG000|Overall Study|Withdrawal by Subject|6|||
164507058|NCT02125279|594226816|FG000|Overall Study|Protocol Violation|1|||
164507059|NCT02125279|594226816|FG000|Overall Study|Lost to Follow-up|4|||
164507060|NCT01607879|594226821|FG000|Overall Study|Death|1|||
164507061|NCT01607879|594226822|FG001|Overall Study|Death|0|||
164507062|NCT01101061|594226823|FG000|Overall Study|Adverse Event|0|||
164507063|NCT01101061|594226824|FG001|Overall Study|Adverse Event|0|||
164507064|NCT01101061|594226825|FG002|Overall Study|Adverse Event|1|||
164507065|NCT01101061|594226826|FG003|Overall Study|Adverse Event|0|||
164507066|NCT01101061|594226827|FG004|Overall Study|Adverse Event|0|||
164507067|NCT01101061|594226828|FG005|Overall Study|Adverse Event|0|||
164507068|NCT00478205|594226830|FG000|Overall Study|Adverse Event|182|||
164507069|NCT00478205|594226831|FG001|Overall Study|Adverse Event|39|||
164507070|NCT00478205|594226830|FG000|Overall Study|Medication Non-compliance|9|||
164507071|NCT00478205|594226831|FG001|Overall Study|Medication Non-compliance|4|||
164507072|NCT00478205|594226830|FG000|Overall Study|Protocol Violation|15|||
164507073|NCT00478205|594226831|FG001|Overall Study|Protocol Violation|5|||
164507074|NCT00478205|594226830|FG000|Overall Study|Request of Investigator or Sponsor|4|||
164507075|NCT00478205|594226831|FG001|Overall Study|Request of Investigator or Sponsor|5|||
164507076|NCT00478205|594226830|FG000|Overall Study|Withdrawal by Subject|61|||
164607179|NCT00340834|594583475|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
164507077|NCT00478205|594226831|FG001|Overall Study|Withdrawal by Subject|22|||
164607180|NCT00340834|594583476|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
164607181|NCT00340834|594583477|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
164607182|NCT00340834|594583478|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
164607183|NCT00340834|594583474|FG000|Core Phase of Study|Lost to Follow-up|1|||
164607184|NCT00340834|594583475|FG001|Core Phase of Study|Lost to Follow-up|1|||
164607185|NCT00340834|594583476|FG002|Core Phase of Study|Lost to Follow-up|4|||
164607186|NCT00340834|594583477|FG003|Core Phase of Study|Lost to Follow-up|0|||
164607187|NCT00340834|594583478|FG004|Core Phase of Study|Lost to Follow-up|0|||
164607188|NCT00340834|594583474|FG000|Core Phase of Study|Death|2|||
164607189|NCT00340834|594583475|FG001|Core Phase of Study|Death|0|||
164607190|NCT00340834|594583476|FG002|Core Phase of Study|Death|0|||
164607191|NCT00340834|594583477|FG003|Core Phase of Study|Death|0|||
164607192|NCT00340834|594583478|FG004|Core Phase of Study|Death|0|||
164607193|NCT00340834|594583474|FG000|Core Phase of Study|Protocol Violation|0|||
164607194|NCT00340834|594583475|FG001|Core Phase of Study|Protocol Violation|0|||
164607195|NCT00340834|594583476|FG002|Core Phase of Study|Protocol Violation|2|||
164607196|NCT00340834|594583477|FG003|Core Phase of Study|Protocol Violation|0|||
164607197|NCT00340834|594583478|FG004|Core Phase of Study|Protocol Violation|0|||
164607198|NCT00340834|594583474|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
164607199|NCT00340834|594583475|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
164607200|NCT00340834|594583476|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
164607201|NCT00340834|594583477|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
164607202|NCT00340834|594583478|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
164607203|NCT00340834|594583474|FG000|Extension Phase of Study|Subject withdrew consent|26|||
164607204|NCT00340834|594583475|FG001|Extension Phase of Study|Subject withdrew consent|31|||
164607205|NCT00340834|594583476|FG002|Extension Phase of Study|Subject withdrew consent|0|||
164607206|NCT00340834|594583477|FG003|Extension Phase of Study|Subject withdrew consent|12|||
164607207|NCT00340834|594583478|FG004|Extension Phase of Study|Subject withdrew consent|15|||
164607208|NCT00340834|594583474|FG000|Extension Phase of Study|Adverse Event|21|||
164607209|NCT00340834|594583475|FG001|Extension Phase of Study|Adverse Event|22|||
164607210|NCT00340834|594583476|FG002|Extension Phase of Study|Adverse Event|0|||
164607211|NCT00340834|594583477|FG003|Extension Phase of Study|Adverse Event|19|||
164607212|NCT00340834|594583478|FG004|Extension Phase of Study|Adverse Event|7|||
164607213|NCT00340834|594583474|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
164607214|NCT00340834|594583475|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
164607215|NCT00340834|594583476|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
164607216|NCT00340834|594583477|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
164607217|NCT00340834|594583478|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
164607218|NCT00340834|594583474|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
164607219|NCT00340834|594583475|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
164607220|NCT00340834|594583476|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
164607221|NCT00340834|594583477|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
164607222|NCT00340834|594583478|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
164607223|NCT00340834|594583474|FG000|Extension Phase of Study|Lost to Follow-up|1|||
164607224|NCT00340834|594583475|FG001|Extension Phase of Study|Lost to Follow-up|1|||
164607225|NCT00340834|594583476|FG002|Extension Phase of Study|Lost to Follow-up|0|||
164607226|NCT00340834|594583477|FG003|Extension Phase of Study|Lost to Follow-up|2|||
164607227|NCT00340834|594583478|FG004|Extension Phase of Study|Lost to Follow-up|3|||
164607228|NCT00340834|594583474|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
164607229|NCT00340834|594583475|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
164607230|NCT00340834|594583476|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
164607231|NCT00340834|594583477|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
164607232|NCT00340834|594583478|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
164607233|NCT00340834|594583474|FG000|Extension Phase of Study|Administrative problems|3|||
164607234|NCT00340834|594583475|FG001|Extension Phase of Study|Administrative problems|0|||
164607235|NCT00340834|594583476|FG002|Extension Phase of Study|Administrative problems|0|||
164607236|NCT00340834|594583477|FG003|Extension Phase of Study|Administrative problems|1|||
164607237|NCT00340834|594583478|FG004|Extension Phase of Study|Administrative problems|1|||
164607238|NCT00340834|594583474|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
164607239|NCT00340834|594583475|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
164607240|NCT00340834|594583476|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
164607241|NCT00340834|594583477|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
164607242|NCT00340834|594583478|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
164607243|NCT00340834|594583474|FG000|Extension Phase of Study|Protocol Violation|3|||
164607244|NCT00340834|594583475|FG001|Extension Phase of Study|Protocol Violation|0|||
164607245|NCT00340834|594583476|FG002|Extension Phase of Study|Protocol Violation|0|||
164607246|NCT00340834|594583477|FG003|Extension Phase of Study|Protocol Violation|0|||
164607247|NCT00340834|594583478|FG004|Extension Phase of Study|Protocol Violation|0|||
164607248|NCT00340834|594583474|FG000|Extension Phase of Study|Death|0|||
164607249|NCT00340834|594583475|FG001|Extension Phase of Study|Death|0|||
164607250|NCT00340834|594583476|FG002|Extension Phase of Study|Death|0|||
164607251|NCT00340834|594583477|FG003|Extension Phase of Study|Death|0|||
164607252|NCT00340834|594583478|FG004|Extension Phase of Study|Death|1|||
164607253|NCT00291499|594583479|FG000|Overall Study|Adverse Event|3|||
164607254|NCT00291499|594583480|FG001|Overall Study|Adverse Event|8|||
164607255|NCT00291499|594583479|FG000|Overall Study|Change to other therapy|2|||
164607256|NCT00291499|594583480|FG001|Overall Study|Change to other therapy|1|||
164607257|NCT00291499|594583479|FG000|Overall Study|Intercurrent illness|1|||
164607258|NCT00291499|594583480|FG001|Overall Study|Intercurrent illness|0|||
164607259|NCT00291499|594583479|FG000|Overall Study|Protocol Violation|2|||
164607260|NCT00291499|594583480|FG001|Overall Study|Protocol Violation|2|||
164607261|NCT00291499|594583479|FG000|Overall Study|Other reasons|1|||
164607262|NCT00291499|594583480|FG001|Overall Study|Other reasons|4|||
164607263|NCT01457924|594583481|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
164607264|NCT01457924|594583482|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
164607265|NCT01457924|594583483|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
164607266|NCT01457924|594583484|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
164607267|NCT01457924|594583485|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
164607268|NCT01457924|594583481|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
164607269|NCT01457924|594583482|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
164607270|NCT01457924|594583483|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
164607271|NCT01457924|594583484|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
164607272|NCT01457924|594583485|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
164607273|NCT01457924|594583481|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
164607274|NCT01457924|594583482|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
164607275|NCT01457924|594583483|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
164607276|NCT01457924|594583484|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
164607277|NCT01457924|594583485|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
164607278|NCT01457924|594583481|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
164607279|NCT01457924|594583482|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
164607280|NCT01457924|594583483|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
164607281|NCT01457924|594583484|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
164607282|NCT01457924|594583485|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
164607283|NCT01457924|594583481|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
164607284|NCT01457924|594583482|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
164607285|NCT01457924|594583483|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
164607286|NCT01457924|594583484|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
164607287|NCT01457924|594583485|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
164607288|NCT01457924|594583481|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
164607289|NCT01457924|594583482|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
164607290|NCT01457924|594583483|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
164607291|NCT01457924|594583484|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
164607292|NCT01457924|594583485|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
164607293|NCT01457924|594583481|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
164607294|NCT01457924|594583482|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
164607295|NCT01457924|594583483|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
164607296|NCT01457924|594583484|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
164607297|NCT01457924|594583485|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
164607298|NCT01457924|594583481|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
164607299|NCT01457924|594583482|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
164607300|NCT01457924|594583483|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
164607301|NCT01457924|594583484|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
164607302|NCT01457924|594583485|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
164607303|NCT01457924|594583481|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
164607304|NCT01457924|594583482|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
164607305|NCT01457924|594583483|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
164607306|NCT01457924|594583484|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
164607307|NCT01457924|594583485|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
164607308|NCT01457924|594583481|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
164607309|NCT01457924|594583482|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
164607310|NCT01457924|594583483|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
164607311|NCT01457924|594583484|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
164607312|NCT01457924|594583485|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
164607313|NCT01457924|594583481|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
164607314|NCT01457924|594583482|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
164607315|NCT01457924|594583483|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
164607316|NCT01457924|594583484|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
164607317|NCT01457924|594583485|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
164607318|NCT01457924|594583481|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
164607319|NCT01457924|594583482|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
164607320|NCT01457924|594583483|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
164607321|NCT01457924|594583484|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
164607322|NCT01457924|594583485|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
164607323|NCT01457924|594583481|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
164607324|NCT01457924|594583482|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
164607325|NCT01457924|594583483|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
164607326|NCT01457924|594583484|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
164607327|NCT01457924|594583485|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
164607328|NCT00936117|594583486|FG000|Overall Study|Adverse Event|7|||
164607329|NCT00936117|594583486|FG000|Overall Study|Unable to continue oral medication|3|||
164607330|NCT04581863|594583487|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
164607331|NCT04581863|594583488|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
164607332|NCT00225212|594583497|FG000|Overall Study|Disease progression|2|||
164607333|NCT00225212|594583497|FG000|Overall Study|Death|1|||
164607334|NCT00225212|594583497|FG000|Overall Study|Adverse Event|2|||
164607335|NCT00225212|594583497|FG000|Overall Study|Intercurrent illness|1|||
164607336|NCT00574496|594583500|FG000|Overall Study|Withdrawal by Subject|1|||
164607337|NCT02486952|594583501|FG000|Overall Study|Not Started Induction Therapy|3|||
164607338|NCT02486952|594583501|FG000|Overall Study|Adverse Event|1|||
164607339|NCT02486952|594583501|FG000|Overall Study|Death|15|||
164607340|NCT02486952|594583501|FG000|Overall Study|Lack of Efficacy|3|||
164607341|NCT02486952|594583501|FG000|Overall Study|Lost to Follow-up|26|||
164607342|NCT02486952|594583501|FG000|Overall Study|Other|2|||
164607343|NCT03589885|594583502|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
164607344|NCT03589885|594583503|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
164607345|NCT03589885|594583504|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
164607346|NCT03589885|594583505|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
164607347|NCT03589885|594583506|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
164607348|NCT03589885|594583502|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
164607349|NCT03589885|594583503|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
164607350|NCT03589885|594583504|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
164607351|NCT03589885|594583505|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
164607352|NCT03589885|594583506|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
164607353|NCT03589885|594583502|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
164607354|NCT03589885|594583503|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
164607355|NCT03589885|594583504|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
164607356|NCT03589885|594583505|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
164607357|NCT03589885|594583506|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
164607358|NCT03589885|594583502|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
164607359|NCT03589885|594583503|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
164607360|NCT03589885|594583504|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
164607361|NCT03589885|594583505|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
164607362|NCT03589885|594583506|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
164607363|NCT03589885|594583502|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
164607364|NCT03589885|594583503|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
164607365|NCT03589885|594583504|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
164607366|NCT03589885|594583505|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
164607367|NCT03589885|594583506|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
164607368|NCT03589885|594583502|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
164607369|NCT03589885|594583503|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
164607370|NCT03589885|594583504|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
164607371|NCT03589885|594583505|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
164607372|NCT03589885|594583506|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
164607373|NCT03589885|594583502|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
164607374|NCT03589885|594583503|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
164607375|NCT03589885|594583504|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
164607376|NCT03589885|594583505|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
164607377|NCT03589885|594583506|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
164607378|NCT03589885|594583502|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
164607379|NCT03589885|594583503|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
164607380|NCT03589885|594583504|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
164607381|NCT03589885|594583505|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
164607382|NCT03589885|594583506|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
164607383|NCT04111107|594583507|FG000|Overall Study|Withdrawal by Subject|6|||
164607384|NCT04111107|594583507|FG000|Overall Study|Declining Health|5|||
164607385|NCT01928485|594583508|FG000|Overall Study|Physician Decision|0|||
164607386|NCT01928485|594583509|FG001|Overall Study|Physician Decision|1|||
164607387|NCT03956225|594583510|FG000|Overall Study|Lack of Efficacy|1|||
164607388|NCT03956225|594583511|FG001|Overall Study|Lack of Efficacy|1|||
164607389|NCT03956225|594583510|FG000|Overall Study|Lost to Follow-up|0|||
164607390|NCT03956225|594583511|FG001|Overall Study|Lost to Follow-up|1|||
164607391|NCT03956225|594583510|FG000|Overall Study|Withdrawal by Subject|2|||
164607392|NCT03956225|594583511|FG001|Overall Study|Withdrawal by Subject|1|||
164607393|NCT03956225|594583510|FG000|Overall Study|Other Reasons|2|||
164607394|NCT03956225|594583511|FG001|Overall Study|Other Reasons|1|||
164607395|NCT00039741|594583514|FG000|Overall Study|Death|0|||
164607396|NCT00039741|594583515|FG001|Overall Study|Death|1|||
164607397|NCT00039741|594583516|FG002|Overall Study|Death|0|||
164607398|NCT00039741|594583517|FG003|Overall Study|Death|0|||
164607399|NCT00039741|594583514|FG000|Overall Study|Lost to Follow-up|3|||
164607400|NCT00039741|594583515|FG001|Overall Study|Lost to Follow-up|1|||
164607401|NCT00039741|594583516|FG002|Overall Study|Lost to Follow-up|5|||
164607402|NCT00039741|594583517|FG003|Overall Study|Lost to Follow-up|2|||
164607403|NCT00039741|594583514|FG000|Overall Study|Confounding medical condition|1|||
164607404|NCT00039741|594583515|FG001|Overall Study|Confounding medical condition|0|||
164607405|NCT00039741|594583516|FG002|Overall Study|Confounding medical condition|0|||
164607406|NCT00039741|594583517|FG003|Overall Study|Confounding medical condition|0|||
164607407|NCT00039741|594583514|FG000|Overall Study|Not able to get to clinic|5|||
164607408|NCT00039741|594583515|FG001|Overall Study|Not able to get to clinic|2|||
164607409|NCT00039741|594583516|FG002|Overall Study|Not able to get to clinic|0|||
164607410|NCT00039741|594583517|FG003|Overall Study|Not able to get to clinic|3|||
164607411|NCT00039741|594583514|FG000|Overall Study|Moved|3|||
164607412|NCT00039741|594583515|FG001|Overall Study|Moved|2|||
164607413|NCT00039741|594583516|FG002|Overall Study|Moved|3|||
164607414|NCT00039741|594583517|FG003|Overall Study|Moved|6|||
164607415|NCT00039741|594583514|FG000|Overall Study|Non-compliance with protocol|1|||
164607416|NCT00039741|594583515|FG001|Overall Study|Non-compliance with protocol|0|||
164607417|NCT00039741|594583516|FG002|Overall Study|Non-compliance with protocol|1|||
164607418|NCT00039741|594583517|FG003|Overall Study|Non-compliance with protocol|0|||
164607419|NCT00039741|594583514|FG000|Overall Study|Withdrew consent|0|||
164607420|NCT00039741|594583515|FG001|Overall Study|Withdrew consent|5|||
164607421|NCT00039741|594583516|FG002|Overall Study|Withdrew consent|0|||
164607422|NCT00039741|594583517|FG003|Overall Study|Withdrew consent|1|||
164607423|NCT00039741|594583514|FG000|Overall Study|Missed final visit|2|||
164607424|NCT00039741|594583515|FG001|Overall Study|Missed final visit|1|||
164607425|NCT00039741|594583516|FG002|Overall Study|Missed final visit|2|||
164607426|NCT00039741|594583517|FG003|Overall Study|Missed final visit|2|||
164607427|NCT00567541|594583518|FG000|Overall Study|Adverse Event|0|||
164607428|NCT00567541|594583519|FG001|Overall Study|Adverse Event|1|||
164607429|NCT00946881|594583520|FG000|First Treatment|Withdrawal by Subject|1|||
164607430|NCT00946881|594583520|FG000|First Treatment|Patient relocated to another state|1|||
164607431|NCT00946881|594583520|FG000|Retreatment|Withdrawal by Subject|1|||
164607432|NCT00293423|594583521|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
164607433|NCT00293423|594583522|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
164607434|NCT00293423|594583521|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
164607435|NCT00293423|594583522|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
164607436|NCT00293423|594583521|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
164607437|NCT00293423|594583522|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
164607438|NCT00293423|594583521|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
164607439|NCT00293423|594583522|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
164607440|NCT00293423|594583521|FG000|Surgical Resection|processing error during surgical resection|1|||
164607441|NCT00293423|594583522|FG001|Surgical Resection|processing error during surgical resection|0|||
164607442|NCT00293423|594583521|FG000|Surgical Resection|Withdrawal by Subject|4|||
164607443|NCT00293423|594583522|FG001|Surgical Resection|Withdrawal by Subject|0|||
164607444|NCT00293423|594583521|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
164607445|NCT00293423|594583522|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
164607446|NCT02157506|594583529|FG000|Overall Study|Adverse Event|0|||
164607447|NCT02157506|594583530|FG001|Overall Study|Adverse Event|1|||
164607448|NCT02157506|594583531|FG002|Overall Study|Adverse Event|0|||
164607449|NCT02157506|594583532|FG003|Overall Study|Adverse Event|0|||
164607450|NCT02157506|594583533|FG004|Overall Study|Adverse Event|0|||
164607451|NCT02157506|594583529|FG000|Overall Study|Lost to Follow-up|0|||
164607452|NCT02157506|594583530|FG001|Overall Study|Lost to Follow-up|0|||
164607453|NCT02157506|594583531|FG002|Overall Study|Lost to Follow-up|1|||
164607454|NCT02157506|594583532|FG003|Overall Study|Lost to Follow-up|0|||
164607455|NCT02157506|594583533|FG004|Overall Study|Lost to Follow-up|0|||
164607456|NCT01182337|594583534|FG000|Overall Study|Withdrawal by Subject|3|||
164607457|NCT01182337|594583535|FG001|Overall Study|Withdrawal by Subject|1|||
164607458|NCT01182337|594583534|FG000|Overall Study|Lost to Follow-up|0|||
164607459|NCT01182337|594583535|FG001|Overall Study|Lost to Follow-up|1|||
164607460|NCT03571256|594583536|FG000|Overall Study|Adverse Event|3|||
164607461|NCT03571256|594583537|FG001|Overall Study|Adverse Event|0|||
164607462|NCT03571256|594583538|FG002|Overall Study|Adverse Event|1|||
164607463|NCT03571256|594583536|FG000|Overall Study|Withdrawal by Subject|3|||
164607464|NCT03571256|594583537|FG001|Overall Study|Withdrawal by Subject|1|||
164607465|NCT03571256|594583538|FG002|Overall Study|Withdrawal by Subject|1|||
164607466|NCT03571256|594583536|FG000|Overall Study|Other than specified|0|||
164607467|NCT03571256|594583537|FG001|Overall Study|Other than specified|1|||
164607468|NCT03571256|594583538|FG002|Overall Study|Other than specified|1|||
164607469|NCT03571256|594583536|FG000|Overall Study|Protocol Violation|0|||
164607470|NCT03571256|594583537|FG001|Overall Study|Protocol Violation|1|||
164607471|NCT03571256|594583538|FG002|Overall Study|Protocol Violation|1|||
164607472|NCT02270684|594583539|FG000|Overall Study|Lost to Follow-up|0|||
164607473|NCT02270684|594583540|FG001|Overall Study|Lost to Follow-up|3|||
164607474|NCT02270684|594583539|FG000|Overall Study|Study terminated|1|||
164607475|NCT02270684|594583540|FG001|Overall Study|Study terminated|0|||
164607476|NCT02247401|594583543|FG000|Overall Study|Adverse Event|1|||
164607477|NCT02247401|594583544|FG001|Overall Study|Adverse Event|0|||
164607478|NCT02247401|594583545|FG002|Overall Study|Adverse Event|0|||
164607479|NCT02247401|594583543|FG000|Overall Study|Withdrawal by Subject|4|||
164607480|NCT02247401|594583544|FG001|Overall Study|Withdrawal by Subject|1|||
164607481|NCT02247401|594583545|FG002|Overall Study|Withdrawal by Subject|1|||
164607482|NCT02247401|594583543|FG000|Overall Study|Lost to Follow-up|1|||
164607483|NCT02247401|594583544|FG001|Overall Study|Lost to Follow-up|1|||
164607484|NCT02247401|594583545|FG002|Overall Study|Lost to Follow-up|1|||
164607485|NCT03498287|594583549|FG000|Overall Study|Withdrawal by Subject|3|||
164607486|NCT03498287|594583550|FG001|Overall Study|Withdrawal by Subject|0|||
164607487|NCT03498287|594583549|FG000|Overall Study|Protocol Violation|0|||
164607488|NCT03498287|594583550|FG001|Overall Study|Protocol Violation|4|||
164607489|NCT03498287|594583549|FG000|Overall Study|Adverse Event|0|||
164607490|NCT03498287|594583550|FG001|Overall Study|Adverse Event|1|||
164607491|NCT04169061|594583551|FG000|Overall Study|Adverse Event|2|||
164607492|NCT04169061|594583551|FG000|Overall Study|Death|1|||
164607493|NCT04169061|594583551|FG000|Overall Study|Withdrawal by Subject|1|||
164607494|NCT04169061|594583551|FG000|Overall Study|Protocol Violation|1|||
164607495|NCT02807363|594583554|FG000|Dosing Period|Adverse Event|0|||
164607496|NCT02807363|594583555|FG001|Dosing Period|Adverse Event|1|||
164607497|NCT02807363|594583556|FG002|Dosing Period|Adverse Event|0|||
164607498|NCT02807363|594583557|FG003|Dosing Period|Adverse Event|0|||
164607499|NCT02188719|594583558|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
164607500|NCT02188719|594583559|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
164607501|NCT02188719|594583560|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
164607502|NCT02188719|594583561|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
164607503|NCT01763866|594583563|FG000|Overall Study|Withdrawal by Subject|2|||
164607504|NCT01763866|594583564|FG001|Overall Study|Withdrawal by Subject|1|||
164607505|NCT01763866|594583565|FG002|Overall Study|Withdrawal by Subject|4|||
164607506|NCT01763866|594583566|FG003|Overall Study|Withdrawal by Subject|0|||
164607507|NCT01763866|594583567|FG004|Overall Study|Withdrawal by Subject|0|||
164607508|NCT01763866|594583568|FG005|Overall Study|Withdrawal by Subject|3|||
164507078|NCT00478205|594226830|FG000|Overall Study|Lack of Efficacy|1|||
164507079|NCT00478205|594226831|FG001|Overall Study|Lack of Efficacy|0|||
164507080|NCT00478205|594226830|FG000|Overall Study|Other|24|||
164507081|NCT00478205|594226831|FG001|Overall Study|Other|12|||
164507082|NCT01012947|594226839|FG000|Overall Study|Lost to Follow-up|131|||
164507083|NCT01012947|594226840|FG001|Overall Study|Lost to Follow-up|135|||
164507084|NCT01012947|594226841|FG002|Overall Study|Lost to Follow-up|130|||
164507085|NCT01012947|594226842|FG003|Overall Study|Lost to Follow-up|118|||
164507086|NCT01012947|594226843|FG004|Overall Study|Lost to Follow-up|142|||
164507087|NCT01791413|594226844|FG000|Overall Study|Lost to Follow-up|5|||
164507088|NCT01791413|594226845|FG001|Overall Study|Lost to Follow-up|1|||
164507089|NCT00825305|594226853|FG000|Overall Study|Adverse Event|1|||
164507090|NCT00825305|594226854|FG001|Overall Study|Adverse Event|1|||
164507091|NCT00825305|594226853|FG000|Overall Study|Withdrawal by Subject|6|||
164507092|NCT00825305|594226854|FG001|Overall Study|Withdrawal by Subject|12|||
164507093|NCT00825305|594226853|FG000|Overall Study|Inappropriate inclusion|1|||
164507094|NCT00825305|594226854|FG001|Overall Study|Inappropriate inclusion|0|||
164507095|NCT00825305|594226853|FG000|Overall Study|Protocol Violation|9|||
164507096|NCT00825305|594226854|FG001|Overall Study|Protocol Violation|9|||
164507097|NCT00825305|594226853|FG000|Overall Study|Can not be classified|0|||
164507098|NCT00825305|594226854|FG001|Overall Study|Can not be classified|1|||
164507099|NCT04016272|594226855|FG000|Overall Study|Withdrawal by Subject|1|||
164507100|NCT04016272|594226856|FG001|Overall Study|Withdrawal by Subject|2|||
164507101|NCT00246090|594226859|FG000|Overall Study|Adverse Event|25|||
164507102|NCT00246090|594226859|FG000|Overall Study|Withdrawal by Subject|7|||
164507103|NCT00246090|594226859|FG000|Overall Study|Progressive Disease|212|||
164507104|NCT00246090|594226859|FG000|Overall Study|Clinical Progression|30|||
164507105|NCT00246090|594226859|FG000|Overall Study|Physician Decision|11|||
164507106|NCT00246090|594226859|FG000|Overall Study|Not Otherwise Specified|10|||
164507107|NCT03332784|594226862|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
164507108|NCT03332784|594226863|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
164507109|NCT03332784|594226864|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
164507110|NCT03332784|594226865|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
164507111|NCT03332784|594226866|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
164507112|NCT03332784|594226867|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
164507113|NCT03332784|594226868|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
164507114|NCT03332784|594226869|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
164507115|NCT03332784|594226870|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
164507116|NCT03332784|594226871|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
164507117|NCT03332784|594226872|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
164507118|NCT03332784|594226873|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
164507119|NCT03332784|594226874|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
164507120|NCT03332784|594226875|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
164507121|NCT03332784|594226876|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
164507122|NCT03332784|594226877|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
164507123|NCT03332784|594226878|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
164507124|NCT03332784|594226879|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
164507125|NCT03332784|594226880|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
164507126|NCT03332784|594226881|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
164507127|NCT01827046|594226882|FG000|Overall Study|Lost to Follow-up|1|||
164507128|NCT01827046|594226883|FG001|Overall Study|Lost to Follow-up|5|||
164507129|NCT01827046|594226882|FG000|Overall Study|Withdrawal by Subject|0|||
164507130|NCT01827046|594226883|FG001|Overall Study|Withdrawal by Subject|4|||
164507131|NCT00658606|594226888|FG000|Overall Study|Adverse Event|2|||
164507132|NCT00658606|594226889|FG001|Overall Study|Adverse Event|1|||
164507133|NCT00658606|594226888|FG000|Overall Study|Lack of Efficacy|6|||
164507134|NCT00658606|594226889|FG001|Overall Study|Lack of Efficacy|3|||
164507135|NCT00658606|594226888|FG000|Overall Study|Lost to Follow-up|1|||
164507136|NCT00658606|594226889|FG001|Overall Study|Lost to Follow-up|0|||
164507137|NCT00658606|594226888|FG000|Overall Study|Withdrawal by Subject|7|||
164507138|NCT00658606|594226889|FG001|Overall Study|Withdrawal by Subject|16|||
164507139|NCT00658606|594226888|FG000|Overall Study|Lack of Compliance|0|||
164507140|NCT00658606|594226889|FG001|Overall Study|Lack of Compliance|3|||
164507141|NCT01191008|594226890|FG000|Overall Study|Protocol Violation|7|||
164507142|NCT01191008|594226890|FG000|Overall Study|Lost to Follow-up|8|||
164507143|NCT00569127|594226891|FG000|Overall Study|Adverse Event|57|||
164507144|NCT00569127|594226892|FG001|Overall Study|Adverse Event|47|||
164507145|NCT00569127|594226891|FG000|Overall Study|Withdrawal by Subject|13|||
164607509|NCT01763866|594583569|FG006|Overall Study|Withdrawal by Subject|4|||
164507146|NCT00569127|594226892|FG001|Overall Study|Withdrawal by Subject|27|||
164607510|NCT01763866|594583570|FG007|Overall Study|Withdrawal by Subject|0|||
164507147|NCT00569127|594226891|FG000|Overall Study|Progression|99|||
164507148|NCT00569127|594226892|FG001|Overall Study|Progression|100|||
164607511|NCT01763866|594583571|FG008|Overall Study|Withdrawal by Subject|1|||
164607512|NCT01763866|594583572|FG009|Overall Study|Withdrawal by Subject|1|||
164507149|NCT00569127|594226891|FG000|Overall Study|Death|4|||
164507150|NCT00569127|594226892|FG001|Overall Study|Death|3|||
164146444|NCT05026177|592898059|FG001|Overall Study|Lost to Follow-up|6|||
164507151|NCT00569127|594226891|FG000|Overall Study|Other|20|||
164507152|NCT00569127|594226892|FG001|Overall Study|Other|19|||
164507153|NCT00569127|594226891|FG000|Overall Study|Lost to Follow-up|0|||
164507154|NCT00569127|594226892|FG001|Overall Study|Lost to Follow-up|3|||
164507155|NCT00569127|594226891|FG000|Overall Study|Not Eligible|14|||
164507156|NCT00569127|594226892|FG001|Overall Study|Not Eligible|11|||
164507157|NCT00569127|594226891|FG000|Overall Study|Still on Treatment|7|||
164507158|NCT00569127|594226892|FG001|Overall Study|Still on Treatment|3|||
164607513|NCT01763866|594583573|FG010|Overall Study|Withdrawal by Subject|2|||
164607514|NCT01763866|594583574|FG011|Overall Study|Withdrawal by Subject|2|||
164607515|NCT01763866|594583575|FG012|Overall Study|Withdrawal by Subject|2|||
164607516|NCT01763866|594583576|FG013|Overall Study|Withdrawal by Subject|0|||
164607517|NCT01763866|594583577|FG014|Overall Study|Withdrawal by Subject|6|||
164607518|NCT01763866|594583578|FG015|Overall Study|Withdrawal by Subject|3|||
164607519|NCT01763866|594583579|FG016|Overall Study|Withdrawal by Subject|0|||
164607520|NCT01763866|594583580|FG017|Overall Study|Withdrawal by Subject|1|||
164607521|NCT01763866|594583581|FG018|Overall Study|Withdrawal by Subject|1|||
164607522|NCT01763866|594583582|FG019|Overall Study|Withdrawal by Subject|1|||
164607523|NCT01763866|594583583|FG020|Overall Study|Withdrawal by Subject|2|||
164607524|NCT01763866|594583584|FG021|Overall Study|Withdrawal by Subject|1|||
164607525|NCT01763866|594583585|FG022|Overall Study|Withdrawal by Subject|2|||
164607526|NCT01763866|594583586|FG023|Overall Study|Withdrawal by Subject|1|||
164607527|NCT01763866|594583563|FG000|Overall Study|Decision by sponsor|0|||
164607528|NCT01763866|594583564|FG001|Overall Study|Decision by sponsor|0|||
164607529|NCT01763866|594583565|FG002|Overall Study|Decision by sponsor|1|||
164607530|NCT01763866|594583566|FG003|Overall Study|Decision by sponsor|0|||
164607531|NCT01763866|594583567|FG004|Overall Study|Decision by sponsor|2|||
164607532|NCT01763866|594583568|FG005|Overall Study|Decision by sponsor|0|||
164607533|NCT01763866|594583569|FG006|Overall Study|Decision by sponsor|2|||
164607534|NCT01763866|594583570|FG007|Overall Study|Decision by sponsor|0|||
164607535|NCT01763866|594583571|FG008|Overall Study|Decision by sponsor|2|||
164607536|NCT01763866|594583572|FG009|Overall Study|Decision by sponsor|0|||
164607537|NCT01763866|594583573|FG010|Overall Study|Decision by sponsor|6|||
164607538|NCT01763866|594583574|FG011|Overall Study|Decision by sponsor|0|||
164607539|NCT01763866|594583575|FG012|Overall Study|Decision by sponsor|1|||
164607540|NCT01763866|594583576|FG013|Overall Study|Decision by sponsor|0|||
164607541|NCT01763866|594583577|FG014|Overall Study|Decision by sponsor|5|||
164607542|NCT01763866|594583578|FG015|Overall Study|Decision by sponsor|0|||
164607543|NCT01763866|594583579|FG016|Overall Study|Decision by sponsor|0|||
164607544|NCT01763866|594583580|FG017|Overall Study|Decision by sponsor|0|||
164607545|NCT01763866|594583581|FG018|Overall Study|Decision by sponsor|4|||
164607546|NCT01763866|594583582|FG019|Overall Study|Decision by sponsor|0|||
164607547|NCT01763866|594583583|FG020|Overall Study|Decision by sponsor|2|||
164607548|NCT01763866|594583584|FG021|Overall Study|Decision by sponsor|0|||
164607549|NCT01763866|594583585|FG022|Overall Study|Decision by sponsor|1|||
164607550|NCT01763866|594583586|FG023|Overall Study|Decision by sponsor|0|||
164607551|NCT01763866|594583563|FG000|Overall Study|Lost to Follow-up|0|||
164607552|NCT01763866|594583564|FG001|Overall Study|Lost to Follow-up|0|||
164607553|NCT01763866|594583565|FG002|Overall Study|Lost to Follow-up|0|||
164607554|NCT01763866|594583566|FG003|Overall Study|Lost to Follow-up|0|||
164607555|NCT01763866|594583567|FG004|Overall Study|Lost to Follow-up|0|||
164607556|NCT01763866|594583568|FG005|Overall Study|Lost to Follow-up|0|||
164607557|NCT01763866|594583569|FG006|Overall Study|Lost to Follow-up|1|||
164607558|NCT01763866|594583570|FG007|Overall Study|Lost to Follow-up|0|||
164607559|NCT01763866|594583571|FG008|Overall Study|Lost to Follow-up|0|||
164607560|NCT01763866|594583572|FG009|Overall Study|Lost to Follow-up|0|||
164607561|NCT01763866|594583573|FG010|Overall Study|Lost to Follow-up|0|||
164607562|NCT01763866|594583574|FG011|Overall Study|Lost to Follow-up|0|||
164607563|NCT01763866|594583575|FG012|Overall Study|Lost to Follow-up|1|||
164607564|NCT01763866|594583576|FG013|Overall Study|Lost to Follow-up|0|||
164607565|NCT01763866|594583577|FG014|Overall Study|Lost to Follow-up|1|||
164607566|NCT01763866|594583578|FG015|Overall Study|Lost to Follow-up|0|||
164607567|NCT01763866|594583579|FG016|Overall Study|Lost to Follow-up|0|||
164607568|NCT01763866|594583580|FG017|Overall Study|Lost to Follow-up|0|||
164607569|NCT01763866|594583581|FG018|Overall Study|Lost to Follow-up|1|||
164607570|NCT01763866|594583582|FG019|Overall Study|Lost to Follow-up|1|||
164607571|NCT01763866|594583583|FG020|Overall Study|Lost to Follow-up|0|||
164607572|NCT01763866|594583584|FG021|Overall Study|Lost to Follow-up|0|||
164607573|NCT01763866|594583585|FG022|Overall Study|Lost to Follow-up|0|||
164607574|NCT01763866|594583586|FG023|Overall Study|Lost to Follow-up|1|||
164607575|NCT01763866|594583563|FG000|Overall Study|Death|0|||
164607576|NCT01763866|594583564|FG001|Overall Study|Death|0|||
164607577|NCT01763866|594583565|FG002|Overall Study|Death|0|||
164607578|NCT01763866|594583566|FG003|Overall Study|Death|0|||
164607579|NCT01763866|594583567|FG004|Overall Study|Death|0|||
164607580|NCT01763866|594583568|FG005|Overall Study|Death|0|||
164607581|NCT01763866|594583569|FG006|Overall Study|Death|0|||
164607582|NCT01763866|594583570|FG007|Overall Study|Death|0|||
164607583|NCT01763866|594583571|FG008|Overall Study|Death|0|||
164607584|NCT01763866|594583572|FG009|Overall Study|Death|0|||
164607585|NCT01763866|594583573|FG010|Overall Study|Death|0|||
164607586|NCT01763866|594583574|FG011|Overall Study|Death|0|||
164607587|NCT01763866|594583575|FG012|Overall Study|Death|0|||
164607588|NCT01763866|594583576|FG013|Overall Study|Death|0|||
164607589|NCT01763866|594583577|FG014|Overall Study|Death|0|||
164607590|NCT01763866|594583578|FG015|Overall Study|Death|0|||
164607591|NCT01763866|594583579|FG016|Overall Study|Death|1|||
164607592|NCT01763866|594583580|FG017|Overall Study|Death|0|||
164607593|NCT01763866|594583581|FG018|Overall Study|Death|0|||
164607594|NCT01763866|594583582|FG019|Overall Study|Death|0|||
164607595|NCT01763866|594583583|FG020|Overall Study|Death|0|||
164607596|NCT01763866|594583584|FG021|Overall Study|Death|0|||
164607597|NCT01763866|594583585|FG022|Overall Study|Death|0|||
164607598|NCT01763866|594583586|FG023|Overall Study|Death|0|||
164607599|NCT03371732|594583591|FG000|Overall Study|Withdrawal by Subject|9|||
164607600|NCT03371732|594583592|FG001|Overall Study|Withdrawal by Subject|3|||
164607601|NCT03371732|594583591|FG000|Overall Study|Refusal to continue|3|||
164607602|NCT03371732|594583592|FG001|Overall Study|Refusal to continue|4|||
164607603|NCT00599027|594583595|FG000|Overall Study|Withdrawal by Subject|1|||
164607604|NCT00599027|594583596|FG001|Overall Study|Withdrawal by Subject|1|||
164607605|NCT00599027|594583595|FG000|Overall Study|Adverse Event|0|||
164607606|NCT00599027|594583596|FG001|Overall Study|Adverse Event|1|||
164607607|NCT00599027|594583595|FG000|Overall Study|Treatment Failure|0|||
164607608|NCT00599027|594583596|FG001|Overall Study|Treatment Failure|1|||
164607609|NCT00476996|594583598|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
164607610|NCT00476996|594583599|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
164607611|NCT00476996|594583600|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
164607612|NCT00476996|594583601|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
164607613|NCT00476996|594583598|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
164607614|NCT00476996|594583599|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
164607615|NCT00476996|594583600|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
164507159|NCT03569891|594226893|FG000|Lead-in|Ineligible during lead-in|8|||
164507160|NCT03569891|594226893|FG000|Lead-in|Withdrawal by Subject|3|||
164507161|NCT03569891|594226893|FG000|Lead-in|Risks related to COVID-19|2|||
164507162|NCT03569891|594226893|FG000|AMT-061|Adverse Event|1|||
164507163|NCT03299959|594226896|FG000|Overall Study|Lost to Follow-up|7|||
164507164|NCT03299959|594226897|FG001|Overall Study|Lost to Follow-up|9|||
164507165|NCT03299959|594226896|FG000|Overall Study|Death|1|||
164507166|NCT03299959|594226897|FG001|Overall Study|Death|0|||
164507167|NCT03299959|594226896|FG000|Overall Study|Withdrawal by Subject|13|||
164507168|NCT03299959|594226897|FG001|Overall Study|Withdrawal by Subject|9|||
164507169|NCT03299959|594226896|FG000|Overall Study|Changes in study team and government regulations|1|||
164507170|NCT03299959|594226897|FG001|Overall Study|Changes in study team and government regulations|1|||
164507171|NCT03299959|594226896|FG000|Overall Study|Participant underwent surgical intervention in the index knee|15|||
164507172|NCT03299959|594226897|FG001|Overall Study|Participant underwent surgical intervention in the index knee|8|||
164507173|NCT03170518|594226898|FG000|Overall Study|Lost to Follow-up|4|||
164507174|NCT03170518|594226899|FG001|Overall Study|Lost to Follow-up|1|||
164507175|NCT03170518|594226900|FG002|Overall Study|Lost to Follow-up|0|||
164507176|NCT03170518|594226898|FG000|Overall Study|Physician Decision|1|||
164507177|NCT03170518|594226899|FG001|Overall Study|Physician Decision|0|||
164507178|NCT03170518|594226900|FG002|Overall Study|Physician Decision|0|||
164507179|NCT03170518|594226898|FG000|Overall Study|Withdrawal by Subject|4|||
164507180|NCT03170518|594226899|FG001|Overall Study|Withdrawal by Subject|5|||
164507181|NCT03170518|594226900|FG002|Overall Study|Withdrawal by Subject|2|||
164507182|NCT03170518|594226898|FG000|Overall Study|Site terminated by sponsor|0|||
164507183|NCT03170518|594226899|FG001|Overall Study|Site terminated by sponsor|1|||
164507184|NCT03170518|594226900|FG002|Overall Study|Site terminated by sponsor|0|||
164507185|NCT03170518|594226898|FG000|Overall Study|Non-compliance with study drug|1|||
164507186|NCT03170518|594226899|FG001|Overall Study|Non-compliance with study drug|0|||
164507187|NCT03170518|594226900|FG002|Overall Study|Non-compliance with study drug|1|||
164507188|NCT03170518|594226898|FG000|Overall Study|Withdrawal by parent/guardian|2|||
164507189|NCT03170518|594226899|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164507190|NCT03170518|594226900|FG002|Overall Study|Withdrawal by parent/guardian|0|||
164507191|NCT00356811|594226901|FG000|Overall Study|Death|35|||
164507192|NCT00356811|594226901|FG000|Overall Study|Lost to Follow-up|2|||
164507193|NCT00356811|594226901|FG000|Overall Study|Withdrawal by Subject|6|||
164507194|NCT00356811|594226901|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
164507195|NCT00356811|594226901|FG000|Overall Study|Study Is Terminating|3|||
164507196|NCT00356811|594226901|FG000|Overall Study|Site Closed during Follow-up|2|||
164507197|NCT02201901|594226906|FG000|Overall Study|Randomized but never treated|0|||
164507198|NCT02201901|594226907|FG001|Overall Study|Randomized but never treated|1|||
164507199|NCT02201901|594226908|FG002|Overall Study|Randomized but never treated|0|||
164507200|NCT02201901|594226906|FG000|Overall Study|Lack of Efficacy|7|||
164507201|NCT02201901|594226907|FG001|Overall Study|Lack of Efficacy|1|||
164507202|NCT02201901|594226908|FG002|Overall Study|Lack of Efficacy|6|||
164507203|NCT02201901|594226906|FG000|Overall Study|Death|3|||
164507204|NCT02201901|594226907|FG001|Overall Study|Death|3|||
164507205|NCT02201901|594226908|FG002|Overall Study|Death|3|||
164507206|NCT02201901|594226906|FG000|Overall Study|Lost to Follow-up|2|||
164507207|NCT02201901|594226907|FG001|Overall Study|Lost to Follow-up|3|||
164507208|NCT02201901|594226908|FG002|Overall Study|Lost to Follow-up|2|||
164507209|NCT02201901|594226906|FG000|Overall Study|Withdrew Consent|2|||
164507210|NCT02201901|594226907|FG001|Overall Study|Withdrew Consent|0|||
164507211|NCT02201901|594226908|FG002|Overall Study|Withdrew Consent|2|||
164507212|NCT02201901|594226906|FG000|Overall Study|Adverse Event|1|||
164507213|NCT02201901|594226907|FG001|Overall Study|Adverse Event|1|||
164507214|NCT02201901|594226908|FG002|Overall Study|Adverse Event|0|||
164507215|NCT01431950|594226909|FG000|Overall Study|Study Site Closed/Terminated|7|||
164507216|NCT01431950|594226910|FG001|Overall Study|Study Site Closed/Terminated|3|||
164507217|NCT01431950|594226909|FG000|Overall Study|Withdrawal by Subject|4|||
164507218|NCT01431950|594226910|FG001|Overall Study|Withdrawal by Subject|3|||
164507219|NCT01431950|594226909|FG000|Overall Study|Protocol Violation|2|||
164507220|NCT01431950|594226910|FG001|Overall Study|Protocol Violation|3|||
164507221|NCT01431950|594226909|FG000|Overall Study|Adverse Event|2|||
164507222|NCT01431950|594226910|FG001|Overall Study|Adverse Event|2|||
164507223|NCT01431950|594226909|FG000|Overall Study|Physician Decision|2|||
164507224|NCT01431950|594226910|FG001|Overall Study|Physician Decision|1|||
164507225|NCT01431950|594226909|FG000|Overall Study|Lack of Efficacy|2|||
164507226|NCT01431950|594226910|FG001|Overall Study|Lack of Efficacy|1|||
164507227|NCT01431950|594226909|FG000|Overall Study|Lost to Follow-up|0|||
164507228|NCT01431950|594226910|FG001|Overall Study|Lost to Follow-up|1|||
164507229|NCT01431950|594226909|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
164507230|NCT01431950|594226910|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
164507231|NCT03725605|594226911|FG000|Overall Study|Unsuccessful TIL expansion|2|||
164507232|NCT00738283|594226912|FG000|Overall Study|Death|1|||
164507233|NCT00738283|594226912|FG000|Overall Study|Transfer to another facility|2|||
164507234|NCT00738283|594226912|FG000|Overall Study|Discharge home prior to end of study|1|||
164507235|NCT03494985|594226913|FG000|Overall Study|Adverse Event|3|||
164507236|NCT03494985|594226914|FG001|Overall Study|Adverse Event|2|||
164507237|NCT03494985|594226915|FG002|Overall Study|Adverse Event|3|||
164507238|NCT03494985|594226916|FG003|Overall Study|Adverse Event|0|||
164507239|NCT03494985|594226913|FG000|Overall Study|Other (Withdrawal of consent)|2|||
164507240|NCT03494985|594226914|FG001|Overall Study|Other (Withdrawal of consent)|3|||
164507241|NCT03494985|594226915|FG002|Overall Study|Other (Withdrawal of consent)|2|||
164507242|NCT03494985|594226916|FG003|Overall Study|Other (Withdrawal of consent)|5|||
164507243|NCT03494985|594226913|FG000|Overall Study|Other (Not specified)|0|||
164507244|NCT03494985|594226914|FG001|Overall Study|Other (Not specified)|1|||
164507245|NCT03494985|594226915|FG002|Overall Study|Other (Not specified)|1|||
164507246|NCT03494985|594226916|FG003|Overall Study|Other (Not specified)|0|||
164507247|NCT01503086|594226917|FG000|Overall Study|Lost to Follow-up|0|||
164507248|NCT01503086|594226918|FG001|Overall Study|Lost to Follow-up|1|||
164507249|NCT01503086|594226919|FG002|Overall Study|Lost to Follow-up|0|||
164507250|NCT01503086|594226917|FG000|Overall Study|Did Not Start Treatment|4|||
164507251|NCT01503086|594226918|FG001|Overall Study|Did Not Start Treatment|3|||
164507252|NCT01503086|594226919|FG002|Overall Study|Did Not Start Treatment|3|||
164507253|NCT01503086|594226917|FG000|Overall Study|Progressive disease|3|||
164507254|NCT01503086|594226918|FG001|Overall Study|Progressive disease|1|||
164507255|NCT01503086|594226919|FG002|Overall Study|Progressive disease|0|||
164507256|NCT01503086|594226917|FG000|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
164507257|NCT01503086|594226918|FG001|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
164507258|NCT01503086|594226919|FG002|Overall Study|Patient did not complete cognitive training within 9 weeks|0|||
164507259|NCT01503086|594226917|FG000|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
164507260|NCT01503086|594226918|FG001|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|2|||
164507261|NCT01503086|594226919|FG002|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
164507262|NCT02282059|594226920|FG000|Overall Study|Other|15|||
164507263|NCT02282059|594226921|FG001|Overall Study|Other|3|||
164507264|NCT02282059|594226920|FG000|Overall Study|Participant refused further follow-up|8|||
164507265|NCT02282059|594226921|FG001|Overall Study|Participant refused further follow-up|4|||
164507266|NCT02282059|594226920|FG000|Overall Study|Lost to Follow-up|19|||
164507267|NCT02282059|594226921|FG001|Overall Study|Lost to Follow-up|3|||
164507268|NCT02282059|594226920|FG000|Overall Study|Death|40|||
164507269|NCT02282059|594226921|FG001|Overall Study|Death|8|||
164507270|NCT03459846|594226924|FG000|Overall Study|Death|52|||
164507271|NCT03459846|594226925|FG001|Overall Study|Death|46|||
164507272|NCT03459846|594226924|FG000|Overall Study|Study terminated by sponsor|24|||
164507273|NCT03459846|594226925|FG001|Overall Study|Study terminated by sponsor|28|||
164507274|NCT03459846|594226924|FG000|Overall Study|Withdrawal by Subject|2|||
164507275|NCT03459846|594226925|FG001|Overall Study|Withdrawal by Subject|2|||
164507276|NCT04886518|594226932|FG000|Overall Study|Noncompliance with study drug|1|||
164507277|NCT04886518|594226933|FG001|Overall Study|Noncompliance with study drug|0|||
164507278|NCT04886518|594226934|FG002|Overall Study|Noncompliance with study drug|0|||
164507279|NCT04886518|594226932|FG000|Overall Study|Adverse Event|0|||
164507280|NCT04886518|594226933|FG001|Overall Study|Adverse Event|1|||
164507281|NCT04886518|594226934|FG002|Overall Study|Adverse Event|0|||
164507282|NCT04886518|594226932|FG000|Overall Study|Withdrawal by Subject|1|||
164507283|NCT04886518|594226933|FG001|Overall Study|Withdrawal by Subject|0|||
164507284|NCT04886518|594226934|FG002|Overall Study|Withdrawal by Subject|0|||
164507285|NCT01443403|594229008|FG000|Overall Study|Adverse Event|1|||
164507286|NCT01443403|594229009|FG001|Overall Study|Adverse Event|1|||
164507287|NCT01443403|594229010|FG002|Overall Study|Adverse Event|4|||
164507288|NCT01443403|594229011|FG003|Overall Study|Adverse Event|5|||
164507289|NCT01443403|594229008|FG000|Overall Study|Withdrawal by Subject|0|||
164507290|NCT01443403|594229009|FG001|Overall Study|Withdrawal by Subject|1|||
164507291|NCT01443403|594229010|FG002|Overall Study|Withdrawal by Subject|2|||
164507292|NCT01443403|594229011|FG003|Overall Study|Withdrawal by Subject|1|||
164507293|NCT01443403|594229008|FG000|Overall Study|Lost to Follow-up|0|||
164507294|NCT01443403|594229009|FG001|Overall Study|Lost to Follow-up|0|||
164507295|NCT01443403|594229010|FG002|Overall Study|Lost to Follow-up|0|||
164507296|NCT01443403|594229011|FG003|Overall Study|Lost to Follow-up|1|||
164507297|NCT01443403|594229008|FG000|Overall Study|Protocol Violation|2|||
164507298|NCT01443403|594229009|FG001|Overall Study|Protocol Violation|1|||
164507299|NCT01443403|594229010|FG002|Overall Study|Protocol Violation|1|||
164507300|NCT01443403|594229011|FG003|Overall Study|Protocol Violation|1|||
164507301|NCT01443403|594229008|FG000|Overall Study|Use of Prohibited Treatment|2|||
164507302|NCT01443403|594229009|FG001|Overall Study|Use of Prohibited Treatment|3|||
164507303|NCT01443403|594229010|FG002|Overall Study|Use of Prohibited Treatment|0|||
164507304|NCT01443403|594229011|FG003|Overall Study|Use of Prohibited Treatment|0|||
164507305|NCT01443403|594229008|FG000|Overall Study|Other - Miscellaneous|1|||
164507306|NCT01443403|594229009|FG001|Overall Study|Other - Miscellaneous|0|||
164507307|NCT01443403|594229010|FG002|Overall Study|Other - Miscellaneous|0|||
164507308|NCT01443403|594229011|FG003|Overall Study|Other - Miscellaneous|1|||
164507309|NCT00725712|594229014|FG000|Overall Study|Withdrawal by Subject|2|||
164507310|NCT00725712|594229015|FG001|Overall Study|Withdrawal by Subject|1|||
164507311|NCT00725712|594229014|FG000|Overall Study|Protocol Violation|1|||
164507312|NCT00725712|594229015|FG001|Overall Study|Protocol Violation|0|||
164507313|NCT00725712|594229014|FG000|Overall Study|Progressive disease|37|||
164507314|NCT00725712|594229015|FG001|Overall Study|Progressive disease|16|||
164507315|NCT00725712|594229014|FG000|Overall Study|Clinical progression not based on RECIST|0|||
164507316|NCT00725712|594229015|FG001|Overall Study|Clinical progression not based on RECIST|3|||
164507317|NCT00725712|594229014|FG000|Overall Study|Adverse Event|5|||
164507318|NCT00725712|594229015|FG001|Overall Study|Adverse Event|5|||
164507319|NCT00725712|594229014|FG000|Overall Study|Death|2|||
164507320|NCT00725712|594229015|FG001|Overall Study|Death|0|||
164507321|NCT00725712|594229014|FG000|Overall Study|Other: Death|1|||
164507322|NCT00725712|594229015|FG001|Overall Study|Other: Death|0|||
164507323|NCT00725712|594229014|FG000|Overall Study|Hospitalized, unable to continue|0|||
164507324|NCT00725712|594229015|FG001|Overall Study|Hospitalized, unable to continue|1|||
164507325|NCT03607422|594229018|FG000|Overall Study|Adverse Event|7|||
164507326|NCT03607422|594229019|FG001|Overall Study|Adverse Event|3|||
164507327|NCT03607422|594229020|FG002|Overall Study|Adverse Event|2|||
164507328|NCT03607422|594229021|FG003|Overall Study|Adverse Event|0|||
164507329|NCT03607422|594229022|FG004|Overall Study|Adverse Event|2|||
164507330|NCT03607422|594229023|FG005|Overall Study|Adverse Event|0|||
164507331|NCT03607422|594229018|FG000|Overall Study|Withdrawal by Subject|11|||
164507332|NCT03607422|594229019|FG001|Overall Study|Withdrawal by Subject|3|||
164507333|NCT03607422|594229020|FG002|Overall Study|Withdrawal by Subject|6|||
164507334|NCT03607422|594229021|FG003|Overall Study|Withdrawal by Subject|2|||
164507335|NCT03607422|594229022|FG004|Overall Study|Withdrawal by Subject|0|||
164507336|NCT03607422|594229023|FG005|Overall Study|Withdrawal by Subject|0|||
164507337|NCT03607422|594229018|FG000|Overall Study|Lost to Follow-up|0|||
164507338|NCT03607422|594229019|FG001|Overall Study|Lost to Follow-up|0|||
164507339|NCT03607422|594229020|FG002|Overall Study|Lost to Follow-up|1|||
164507340|NCT03607422|594229021|FG003|Overall Study|Lost to Follow-up|0|||
164507341|NCT03607422|594229022|FG004|Overall Study|Lost to Follow-up|0|||
164507342|NCT03607422|594229023|FG005|Overall Study|Lost to Follow-up|0|||
164507343|NCT03607422|594229018|FG000|Overall Study|Other|12|||
164507344|NCT03607422|594229019|FG001|Overall Study|Other|4|||
164507345|NCT03607422|594229020|FG002|Overall Study|Other|1|||
164507346|NCT03607422|594229021|FG003|Overall Study|Other|2|||
164507347|NCT03607422|594229022|FG004|Overall Study|Other|0|||
164507348|NCT03607422|594229023|FG005|Overall Study|Other|2|||
164507349|NCT03607422|594229018|FG000|Overall Study|Ongoing at Time of Analysis|8|||
164507350|NCT03607422|594229019|FG001|Overall Study|Ongoing at Time of Analysis|0|||
164507351|NCT03607422|594229020|FG002|Overall Study|Ongoing at Time of Analysis|2|||
164507352|NCT03607422|594229021|FG003|Overall Study|Ongoing at Time of Analysis|1|||
164507353|NCT03607422|594229022|FG004|Overall Study|Ongoing at Time of Analysis|1|||
164507354|NCT03607422|594229023|FG005|Overall Study|Ongoing at Time of Analysis|1|||
164507355|NCT03258723|594229026|FG000|Overall Study|COVID Interruption of study|54|||
164507356|NCT03258723|594229026|FG000|Overall Study|Lost to Follow-up|8|||
164507357|NCT04832971|594229027|FG000|Double-Blind (DB) Treatment Period|Death|1|||
164507358|NCT04832971|594229028|FG001|Double-Blind (DB) Treatment Period|Death|0|||
164507359|NCT04832971|594229029|FG002|Double-Blind (DB) Treatment Period|Death|0|||
164507360|NCT04832971|594229030|FG003|Double-Blind (DB) Treatment Period|Death|0|||
164507361|NCT04832971|594229031|FG004|Double-Blind (DB) Treatment Period|Death|0|||
164507362|NCT04832971|594229032|FG005|Double-Blind (DB) Treatment Period|Death|0|||
164507363|NCT04832971|594229033|FG006|Double-Blind (DB) Treatment Period|Death|0|||
164507364|NCT04832971|594229034|FG007|Double-Blind (DB) Treatment Period|Death|0|||
164507365|NCT04832971|594229035|FG008|Double-Blind (DB) Treatment Period|Death|0|||
164507366|NCT04832971|594229036|FG009|Double-Blind (DB) Treatment Period|Death|0|||
164507367|NCT04832971|594229027|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
164507368|NCT04832971|594229028|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
164507369|NCT04832971|594229029|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
164507370|NCT04832971|594229030|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164507371|NCT04832971|594229031|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164507372|NCT04832971|594229032|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164507373|NCT04832971|594229033|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164507374|NCT04832971|594229034|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164507375|NCT04832971|594229035|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164507376|NCT04832971|594229036|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164507377|NCT04832971|594229027|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
164507378|NCT04832971|594229028|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
164507379|NCT04832971|594229029|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
164507380|NCT04832971|594229030|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
164507381|NCT04832971|594229031|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164507382|NCT04832971|594229032|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164507383|NCT04832971|594229033|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164507384|NCT04832971|594229034|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164507385|NCT04832971|594229035|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164507386|NCT04832971|594229036|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164507387|NCT04832971|594229027|FG000|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
164507388|NCT04832971|594229028|FG001|Double-Blind (DB) Treatment Period|Other, Not Specified|1|||
164507389|NCT04832971|594229029|FG002|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
164507390|NCT04832971|594229030|FG003|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
164507391|NCT04832971|594229031|FG004|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
164507392|NCT04832971|594229032|FG005|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
164507393|NCT04832971|594229033|FG006|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
164507394|NCT04832971|594229034|FG007|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
164507395|NCT04832971|594229035|FG008|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
164507396|NCT04832971|594229036|FG009|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
164507397|NCT04832971|594229027|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
164507398|NCT04832971|594229028|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
164507399|NCT04832971|594229029|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
164507400|NCT04832971|594229030|FG003|Open-Label Extension (OLE) Period|Adverse Event|0|||
164507401|NCT04832971|594229031|FG004|Open-Label Extension (OLE) Period|Adverse Event|0|||
164507402|NCT04832971|594229032|FG005|Open-Label Extension (OLE) Period|Adverse Event|0|||
164507403|NCT04832971|594229033|FG006|Open-Label Extension (OLE) Period|Adverse Event|2|||
164507404|NCT04832971|594229034|FG007|Open-Label Extension (OLE) Period|Adverse Event|1|||
164507405|NCT04832971|594229035|FG008|Open-Label Extension (OLE) Period|Adverse Event|1|||
164507406|NCT04832971|594229036|FG009|Open-Label Extension (OLE) Period|Adverse Event|1|||
164507407|NCT04832971|594229027|FG000|Open-Label Extension (OLE) Period|Death|0|||
164507408|NCT04832971|594229028|FG001|Open-Label Extension (OLE) Period|Death|0|||
164507409|NCT04832971|594229029|FG002|Open-Label Extension (OLE) Period|Death|0|||
164507410|NCT04832971|594229030|FG003|Open-Label Extension (OLE) Period|Death|0|||
164507411|NCT04832971|594229031|FG004|Open-Label Extension (OLE) Period|Death|0|||
164507412|NCT04832971|594229032|FG005|Open-Label Extension (OLE) Period|Death|0|||
164507413|NCT04832971|594229033|FG006|Open-Label Extension (OLE) Period|Death|0|||
164507414|NCT04832971|594229034|FG007|Open-Label Extension (OLE) Period|Death|1|||
164507415|NCT04832971|594229035|FG008|Open-Label Extension (OLE) Period|Death|0|||
164507416|NCT04832971|594229036|FG009|Open-Label Extension (OLE) Period|Death|0|||
164507417|NCT04832971|594229027|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
164507418|NCT04832971|594229028|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
164507419|NCT04832971|594229029|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
164507420|NCT04832971|594229030|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
164507421|NCT04832971|594229031|FG004|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
164507422|NCT04832971|594229032|FG005|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
164507423|NCT04832971|594229033|FG006|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
164507424|NCT04832971|594229034|FG007|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
164507425|NCT04832971|594229035|FG008|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
164507426|NCT04832971|594229036|FG009|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
164507427|NCT04832971|594229027|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
164507428|NCT04832971|594229028|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
164507429|NCT04832971|594229029|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
164507430|NCT04832971|594229030|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
164507431|NCT04832971|594229031|FG004|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
164507432|NCT04832971|594229032|FG005|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|18|||
164507433|NCT04832971|594229033|FG006|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
164507434|NCT04832971|594229034|FG007|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
164507435|NCT04832971|594229035|FG008|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
164507436|NCT04832971|594229036|FG009|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
164507437|NCT04832971|594229027|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
164507438|NCT04832971|594229028|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
164507439|NCT04832971|594229029|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
164507440|NCT04832971|594229030|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
164507441|NCT04832971|594229031|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
164507442|NCT04832971|594229032|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
164507443|NCT04832971|594229033|FG006|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
164507444|NCT04832971|594229034|FG007|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
164507445|NCT04832971|594229035|FG008|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
164507446|NCT04832971|594229036|FG009|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
164507447|NCT04832971|594229027|FG000|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
164507448|NCT04832971|594229028|FG001|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
164507449|NCT04832971|594229029|FG002|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
164507450|NCT04832971|594229030|FG003|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
164507451|NCT04832971|594229031|FG004|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
164507452|NCT04832971|594229032|FG005|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
164507453|NCT04832971|594229033|FG006|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
164507454|NCT04832971|594229034|FG007|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
164507455|NCT04832971|594229035|FG008|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
164507456|NCT04832971|594229036|FG009|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
164507457|NCT01107899|594229037|FG000|Overall Study|Physician Decision|5|||
164507458|NCT01107899|594229038|FG001|Overall Study|Physician Decision|0|||
164507459|NCT01107899|594229039|FG002|Overall Study|Physician Decision|3|||
164507460|NCT01107899|594229037|FG000|Overall Study|Withdrawal by Subject|0|||
164507461|NCT01107899|594229038|FG001|Overall Study|Withdrawal by Subject|0|||
164507462|NCT01107899|594229039|FG002|Overall Study|Withdrawal by Subject|1|||
164507463|NCT03584152|594229040|FG000|Overall Study|Discontinued intervention|7|||
164607616|NCT00476996|594583601|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
164607617|NCT00476996|594583598|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
164607618|NCT00476996|594583599|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
164607619|NCT00476996|594583600|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
164607620|NCT00476996|594583601|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
164607621|NCT00476996|594583598|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
164607622|NCT00476996|594583599|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
164607623|NCT00476996|594583600|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
164607624|NCT00476996|594583601|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
164607625|NCT00476996|594583598|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
164607626|NCT00476996|594583599|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
164607627|NCT00476996|594583600|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
164607628|NCT00476996|594583601|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
164607629|NCT00476996|594583598|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
164607630|NCT00476996|594583599|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
164607631|NCT00476996|594583600|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
164607632|NCT00476996|594583601|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
164607633|NCT00476996|594583598|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
164607634|NCT00476996|594583599|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
164607635|NCT00476996|594583600|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
164607636|NCT00476996|594583601|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
164301018|NCT03763877|593478396|FG002|Overall Study|Protocol Violation|0|||
164301019|NCT03763877|593478397|FG003|Overall Study|Protocol Violation|0|||
164301020|NCT03763877|593478394|FG000|Overall Study|Lost to Follow-up|0|||
164301021|NCT03763877|593478395|FG001|Overall Study|Lost to Follow-up|1|||
164301022|NCT03763877|593478396|FG002|Overall Study|Lost to Follow-up|1|||
164301023|NCT03763877|593478397|FG003|Overall Study|Lost to Follow-up|0|||
164301024|NCT01524796|593478406|FG000|Overall Study|Adverse Event|13|||
164607637|NCT00476996|594583598|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
164607638|NCT00476996|594583599|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
164607639|NCT00476996|594583600|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
164607640|NCT00476996|594583601|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
164607641|NCT00476996|594583598|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
164607642|NCT00476996|594583599|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
164607643|NCT00476996|594583600|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
164607644|NCT00476996|594583601|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
164607645|NCT00476996|594583598|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
164607646|NCT00476996|594583599|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
164607647|NCT00476996|594583600|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
164607648|NCT00476996|594583601|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
164607649|NCT00476996|594583598|FG000|OLE Phase (From Week 48)|Death|0|||
164607650|NCT00476996|594583599|FG001|OLE Phase (From Week 48)|Death|0|||
164607651|NCT00476996|594583600|FG002|OLE Phase (From Week 48)|Death|0|||
164607652|NCT00476996|594583601|FG003|OLE Phase (From Week 48)|Death|7|||
164607653|NCT00476996|594583598|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
164607654|NCT00476996|594583599|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
164607655|NCT00476996|594583600|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
164607656|NCT00476996|594583601|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
164607657|NCT00476996|594583598|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
164607658|NCT00476996|594583599|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
164607659|NCT00476996|594583600|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
164607660|NCT00476996|594583601|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
164607661|NCT00476996|594583598|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
164607662|NCT00476996|594583599|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
164607663|NCT00476996|594583600|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
164607664|NCT00476996|594583601|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
164607665|NCT00476996|594583598|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
164507464|NCT03584152|594229041|FG001|Overall Study|Discontinued intervention|4|||
164507465|NCT04024462|594229042|FG000|Overall Study|Withdrawal by Subject|6|||
164507466|NCT04024462|594229043|FG001|Overall Study|Withdrawal by Subject|7|||
164507467|NCT04024462|594229042|FG000|Overall Study|Progressive Disease|0|||
164507468|NCT04024462|594229043|FG001|Overall Study|Progressive Disease|1|||
164507469|NCT04024462|594229042|FG000|Overall Study|Adverse Event|0|||
164507470|NCT04024462|594229043|FG001|Overall Study|Adverse Event|1|||
164507471|NCT04024462|594229042|FG000|Overall Study|Death|0|||
164507472|NCT04024462|594229043|FG001|Overall Study|Death|1|||
164507473|NCT04024462|594229042|FG000|Overall Study|Lost to Follow-up|1|||
164507474|NCT04024462|594229043|FG001|Overall Study|Lost to Follow-up|0|||
164507475|NCT04024462|594229042|FG000|Overall Study|Ongoing in the Study|94|||
164507476|NCT04024462|594229043|FG001|Overall Study|Ongoing in the Study|89|||
164507477|NCT00983749|594229048|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
164507478|NCT00983749|594229049|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
164507479|NCT04292470|594229050|FG000|Overall Study|Withdrawal by Subject|0|||
164507480|NCT04292470|594229051|FG001|Overall Study|Withdrawal by Subject|1|||
164507481|NCT02906020|594229065|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
164507482|NCT02906020|594229066|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
164507483|NCT02906020|594229067|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
164507484|NCT02906020|594229068|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
164507485|NCT02906020|594229069|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
164507486|NCT02906020|594229070|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
164507487|NCT02906020|594229071|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
164507488|NCT02906020|594229072|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
164507489|NCT02906020|594229073|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
164507490|NCT02906020|594229074|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
164507491|NCT02906020|594229075|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
164507492|NCT02906020|594229076|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
164507493|NCT02906020|594229077|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
164507494|NCT02906020|594229078|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
164507495|NCT02906020|594229079|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
164507496|NCT02906020|594229080|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
164507497|NCT02906020|594229065|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
164507498|NCT02906020|594229066|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
164507499|NCT02906020|594229067|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
164507500|NCT02906020|594229068|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
164507501|NCT02906020|594229069|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
164507502|NCT02906020|594229070|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
164507503|NCT02906020|594229071|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
164507504|NCT02906020|594229072|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
164507505|NCT02906020|594229073|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
164507506|NCT02906020|594229074|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
164507507|NCT02906020|594229075|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
164507508|NCT02906020|594229076|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
164507509|NCT02906020|594229077|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
164507510|NCT02906020|594229078|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
164507511|NCT02906020|594229079|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
164507512|NCT02906020|594229080|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
164507513|NCT02906020|594229065|FG000|Part 2: Double-blind Treatment Period|Other|0|||
164507514|NCT02906020|594229066|FG001|Part 2: Double-blind Treatment Period|Other|0|||
164507515|NCT02906020|594229067|FG002|Part 2: Double-blind Treatment Period|Other|0|||
164507516|NCT02906020|594229068|FG003|Part 2: Double-blind Treatment Period|Other|0|||
164507517|NCT02906020|594229069|FG004|Part 2: Double-blind Treatment Period|Other|0|||
164507518|NCT02906020|594229070|FG005|Part 2: Double-blind Treatment Period|Other|0|||
164507519|NCT02906020|594229071|FG006|Part 2: Double-blind Treatment Period|Other|0|||
164507520|NCT02906020|594229072|FG007|Part 2: Double-blind Treatment Period|Other|0|||
164507521|NCT02906020|594229073|FG008|Part 2: Double-blind Treatment Period|Other|6|||
164507522|NCT02906020|594229074|FG009|Part 2: Double-blind Treatment Period|Other|10|||
164507523|NCT02906020|594229075|FG010|Part 2: Double-blind Treatment Period|Other|0|||
164507524|NCT02906020|594229076|FG011|Part 2: Double-blind Treatment Period|Other|0|||
164507525|NCT02906020|594229077|FG012|Part 2: Double-blind Treatment Period|Other|0|||
164507526|NCT02906020|594229078|FG013|Part 2: Double-blind Treatment Period|Other|0|||
164507527|NCT02906020|594229079|FG014|Part 2: Double-blind Treatment Period|Other|0|||
164607666|NCT00476996|594583599|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
164607667|NCT00476996|594583600|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
164607668|NCT00476996|594583601|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
164607669|NCT02939599|594583603|FG000|Overall Study|Adverse Event|1|||
164607670|NCT02939599|594583604|FG001|Overall Study|Adverse Event|0|||
164607671|NCT02939599|594583603|FG000|Overall Study|Study Terminated By Sponsor|2|||
164507528|NCT02906020|594229080|FG015|Part 2: Double-blind Treatment Period|Other|0|||
164507529|NCT02906020|594229065|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
164507530|NCT02906020|594229066|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
164507531|NCT02906020|594229067|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
164507532|NCT02906020|594229068|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
164507533|NCT02906020|594229069|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
164507534|NCT02906020|594229070|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
164507535|NCT02906020|594229071|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
164507536|NCT02906020|594229072|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
164507537|NCT02906020|594229073|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
164507538|NCT02906020|594229074|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
164507539|NCT02906020|594229075|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
164507540|NCT02906020|594229076|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
164507541|NCT02906020|594229077|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
164507542|NCT02906020|594229078|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
164507543|NCT02906020|594229079|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
164507544|NCT02906020|594229080|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
164507545|NCT02906020|594229065|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
164507546|NCT02906020|594229066|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
164507547|NCT02906020|594229067|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
164507548|NCT02906020|594229068|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
164507549|NCT02906020|594229069|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
164507550|NCT02906020|594229070|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
164507551|NCT02906020|594229071|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
164507552|NCT02906020|594229072|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
164507553|NCT02906020|594229073|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
164507554|NCT02906020|594229074|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
164507555|NCT02906020|594229075|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
164507556|NCT02906020|594229076|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
164507557|NCT02906020|594229077|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
164507558|NCT02906020|594229078|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
164507559|NCT02906020|594229079|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
164507560|NCT02906020|594229080|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
164507561|NCT02906020|594229065|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
164507562|NCT02906020|594229066|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
164507563|NCT02906020|594229067|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
164507564|NCT02906020|594229068|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
164507565|NCT02906020|594229069|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
164507566|NCT02906020|594229070|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
164507567|NCT02906020|594229071|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
164507568|NCT02906020|594229072|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
164507569|NCT02906020|594229073|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
164507570|NCT02906020|594229074|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
164507571|NCT02906020|594229075|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
164507572|NCT02906020|594229076|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
164507573|NCT02906020|594229077|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
164507574|NCT02906020|594229078|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
164507575|NCT02906020|594229079|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
164507576|NCT02906020|594229080|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
164507577|NCT02906020|594229065|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
164507578|NCT02906020|594229066|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
164507579|NCT02906020|594229067|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
164507580|NCT02906020|594229068|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
164507581|NCT02906020|594229069|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
164507582|NCT02906020|594229070|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
164507583|NCT02906020|594229071|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
164507584|NCT02906020|594229072|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
164507585|NCT02906020|594229073|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
164507586|NCT02906020|594229074|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
164507587|NCT02906020|594229075|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
164507588|NCT02906020|594229076|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
164507589|NCT02906020|594229077|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
164507590|NCT02906020|594229078|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
164507591|NCT02906020|594229079|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
164507592|NCT02906020|594229080|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
164507593|NCT02906020|594229065|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
164507594|NCT02906020|594229066|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
164507595|NCT02906020|594229067|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
164507596|NCT02906020|594229068|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
164507597|NCT02906020|594229069|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
164507598|NCT02906020|594229070|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
164507599|NCT02906020|594229071|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
164507600|NCT02906020|594229072|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
164507601|NCT02906020|594229073|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
164507602|NCT02906020|594229074|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
164507603|NCT02906020|594229075|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
164507604|NCT02906020|594229076|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
164507605|NCT02906020|594229077|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
164507606|NCT02906020|594229078|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
164507607|NCT02906020|594229079|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
164507608|NCT02906020|594229080|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
164507609|NCT02906020|594229065|FG000|Part 2: Long-term Follow-up Period|Other|0|||
164507610|NCT02906020|594229066|FG001|Part 2: Long-term Follow-up Period|Other|0|||
164507611|NCT02906020|594229067|FG002|Part 2: Long-term Follow-up Period|Other|0|||
164507612|NCT02906020|594229068|FG003|Part 2: Long-term Follow-up Period|Other|0|||
164507613|NCT02906020|594229069|FG004|Part 2: Long-term Follow-up Period|Other|0|||
164507614|NCT02906020|594229070|FG005|Part 2: Long-term Follow-up Period|Other|0|||
164507615|NCT02906020|594229071|FG006|Part 2: Long-term Follow-up Period|Other|0|||
164507616|NCT02906020|594229072|FG007|Part 2: Long-term Follow-up Period|Other|0|||
164507617|NCT02906020|594229073|FG008|Part 2: Long-term Follow-up Period|Other|0|||
164507618|NCT02906020|594229074|FG009|Part 2: Long-term Follow-up Period|Other|0|||
164507619|NCT02906020|594229075|FG010|Part 2: Long-term Follow-up Period|Other|0|||
164507620|NCT02906020|594229076|FG011|Part 2: Long-term Follow-up Period|Other|0|||
164507621|NCT02906020|594229077|FG012|Part 2: Long-term Follow-up Period|Other|13|||
164507622|NCT02906020|594229078|FG013|Part 2: Long-term Follow-up Period|Other|8|||
164507623|NCT02906020|594229079|FG014|Part 2: Long-term Follow-up Period|Other|3|||
164507624|NCT02906020|594229080|FG015|Part 2: Long-term Follow-up Period|Other|2|||
164507625|NCT00979953|594229086|FG000|Overall Study|Adverse Event|5|||
164507626|NCT00979953|594229087|FG001|Overall Study|Adverse Event|2|||
164507627|NCT00979953|594229088|FG002|Overall Study|Adverse Event|17|||
164507628|NCT00979953|594229089|FG003|Overall Study|Adverse Event|4|||
164507629|NCT00979953|594229086|FG000|Overall Study|Lack of Efficacy|1|||
164507630|NCT00979953|594229087|FG001|Overall Study|Lack of Efficacy|2|||
164507631|NCT00979953|594229088|FG002|Overall Study|Lack of Efficacy|0|||
164507632|NCT00979953|594229089|FG003|Overall Study|Lack of Efficacy|0|||
164507633|NCT00979953|594229086|FG000|Overall Study|Lost to Follow-up|1|||
164507634|NCT00979953|594229087|FG001|Overall Study|Lost to Follow-up|1|||
164507635|NCT00979953|594229088|FG002|Overall Study|Lost to Follow-up|1|||
164507636|NCT00979953|594229089|FG003|Overall Study|Lost to Follow-up|0|||
164507637|NCT00979953|594229086|FG000|Overall Study|Withdrawal by Subject|0|||
164507638|NCT00979953|594229087|FG001|Overall Study|Withdrawal by Subject|0|||
164507639|NCT00979953|594229088|FG002|Overall Study|Withdrawal by Subject|2|||
164507640|NCT00979953|594229089|FG003|Overall Study|Withdrawal by Subject|1|||
164507641|NCT00979953|594229086|FG000|Overall Study|Protocol Violation|1|||
164507642|NCT00979953|594229087|FG001|Overall Study|Protocol Violation|0|||
164507643|NCT00979953|594229088|FG002|Overall Study|Protocol Violation|2|||
164507644|NCT00979953|594229089|FG003|Overall Study|Protocol Violation|2|||
164507645|NCT01124097|594229090|FG000|Overall Study|Withdrawal by Subject|4|||
164507646|NCT01124097|594229091|FG001|Overall Study|Withdrawal by Subject|3|||
164507647|NCT01124097|594229092|FG002|Overall Study|Withdrawal by Subject|2|||
164507648|NCT01124097|594229093|FG003|Overall Study|Withdrawal by Subject|3|||
164507649|NCT01124097|594229090|FG000|Overall Study|Lack of Efficacy|2|||
164507650|NCT01124097|594229091|FG001|Overall Study|Lack of Efficacy|3|||
164507651|NCT01124097|594229092|FG002|Overall Study|Lack of Efficacy|1|||
164507652|NCT01124097|594229093|FG003|Overall Study|Lack of Efficacy|3|||
164507653|NCT01124097|594229090|FG000|Overall Study|Adverse Event|24|||
164507654|NCT01124097|594229091|FG001|Overall Study|Adverse Event|15|||
164507655|NCT01124097|594229092|FG002|Overall Study|Adverse Event|15|||
164507656|NCT01124097|594229093|FG003|Overall Study|Adverse Event|7|||
164507657|NCT01124097|594229090|FG000|Overall Study|Protocol Violation|2|||
164507658|NCT01124097|594229091|FG001|Overall Study|Protocol Violation|0|||
164507659|NCT01124097|594229092|FG002|Overall Study|Protocol Violation|2|||
164507660|NCT01124097|594229093|FG003|Overall Study|Protocol Violation|1|||
164507661|NCT01124097|594229090|FG000|Overall Study|Physician Decision|2|||
164507662|NCT01124097|594229091|FG001|Overall Study|Physician Decision|1|||
164507663|NCT01124097|594229092|FG002|Overall Study|Physician Decision|0|||
164507664|NCT01124097|594229093|FG003|Overall Study|Physician Decision|0|||
164507665|NCT00559377|594229099|FG000|Overall Study|Withdrawal by Subject|9|||
164507666|NCT02229227|594229100|FG000|Overall Study|Adverse Event|14|||
164507667|NCT02229227|594229101|FG001|Overall Study|Adverse Event|9|||
164507668|NCT02229227|594229100|FG000|Overall Study|Lack of Efficacy|3|||
164507669|NCT02229227|594229101|FG001|Overall Study|Lack of Efficacy|3|||
164507670|NCT02229227|594229100|FG000|Overall Study|Protocol Violation|6|||
164507671|NCT02229227|594229101|FG001|Overall Study|Protocol Violation|8|||
164507672|NCT02229227|594229100|FG000|Overall Study|Protocol defined stopping criteria|1|||
164507673|NCT02229227|594229101|FG001|Overall Study|Protocol defined stopping criteria|3|||
164507674|NCT02229227|594229100|FG000|Overall Study|Lost to Follow-up|3|||
164507675|NCT02229227|594229101|FG001|Overall Study|Lost to Follow-up|3|||
164507676|NCT02229227|594229100|FG000|Overall Study|Study terminated by sponsor|11|||
164507677|NCT02229227|594229101|FG001|Overall Study|Study terminated by sponsor|11|||
164507678|NCT02229227|594229100|FG000|Overall Study|Withdrawal by Subject|8|||
164507679|NCT02229227|594229101|FG001|Overall Study|Withdrawal by Subject|12|||
164507680|NCT02229227|594229100|FG000|Overall Study|Other|0|||
164507681|NCT02229227|594229101|FG001|Overall Study|Other|1|||
164507682|NCT02229227|594229100|FG000|Overall Study|Physician Decision|5|||
164507683|NCT02229227|594229101|FG001|Overall Study|Physician Decision|12|||
164507684|NCT01453023|594229102|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
164507685|NCT01453023|594229103|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
164507686|NCT01453023|594229102|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
164507687|NCT01453023|594229103|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
164507688|NCT01453023|594229102|FG000|Treatment Period 2|Protocol Violation|0|||
164507689|NCT01453023|594229103|FG001|Treatment Period 2|Protocol Violation|1|||
164507690|NCT03934099|594229106|FG000|Overall Study|Adverse Event|0|||
164507691|NCT03934099|594229107|FG001|Overall Study|Adverse Event|3|||
164507692|NCT03934099|594229108|FG002|Overall Study|Adverse Event|1|||
164507693|NCT03934099|594229109|FG003|Overall Study|Adverse Event|0|||
164507694|NCT03934099|594229106|FG000|Overall Study|Lost to Follow-up|1|||
164507695|NCT03934099|594229107|FG001|Overall Study|Lost to Follow-up|2|||
164507696|NCT03934099|594229108|FG002|Overall Study|Lost to Follow-up|1|||
164507697|NCT03934099|594229109|FG003|Overall Study|Lost to Follow-up|1|||
164507698|NCT03934099|594229106|FG000|Overall Study|Protocol Violation|1|||
164507699|NCT03934099|594229107|FG001|Overall Study|Protocol Violation|0|||
164507700|NCT03934099|594229108|FG002|Overall Study|Protocol Violation|0|||
164507701|NCT03934099|594229109|FG003|Overall Study|Protocol Violation|0|||
164507702|NCT03934099|594229106|FG000|Overall Study|Withdrawal by Subject|2|||
164507703|NCT03934099|594229107|FG001|Overall Study|Withdrawal by Subject|0|||
164507704|NCT03934099|594229108|FG002|Overall Study|Withdrawal by Subject|1|||
164507705|NCT03934099|594229109|FG003|Overall Study|Withdrawal by Subject|1|||
164507706|NCT03934099|594229106|FG000|Overall Study|Other reasons|0|||
164507707|NCT03934099|594229107|FG001|Overall Study|Other reasons|1|||
164507708|NCT03934099|594229108|FG002|Overall Study|Other reasons|0|||
164507709|NCT03934099|594229109|FG003|Overall Study|Other reasons|0|||
164507710|NCT02869867|594229110|FG000|Overall Study|Protocol Violation|1|||
164507711|NCT02869867|594229111|FG001|Overall Study|Protocol Violation|0|||
164507712|NCT02869867|594229110|FG000|Overall Study|Lost to Follow-up|5|||
164507713|NCT02869867|594229111|FG001|Overall Study|Lost to Follow-up|5|||
164507714|NCT05555615|594229113|FG000|Overall Study|Adverse Event|7|||
164507715|NCT05555615|594229113|FG000|Overall Study|Lack of Efficacy|12|||
164507716|NCT05555615|594229113|FG000|Overall Study|Lost to Follow-up|10|||
164507717|NCT05555615|594229113|FG000|Overall Study|Noncompliance with study drug|5|||
164507718|NCT05555615|594229113|FG000|Overall Study|Physician Decision|2|||
164507719|NCT05555615|594229113|FG000|Overall Study|Study terminated by sponsor|80|||
164507720|NCT05555615|594229113|FG000|Overall Study|Prohibited medication use|2|||
164507721|NCT05555615|594229113|FG000|Overall Study|Withdrawal by Subject|20|||
164507722|NCT05555615|594229113|FG000|Overall Study|Not further specified|4|||
164507723|NCT02872012|594229115|FG000|Overall Study|Withdrawal by Subject|1|||
164507724|NCT02872012|594229116|FG001|Overall Study|Withdrawal by Subject|0|||
164507725|NCT02872012|594229117|FG002|Overall Study|Withdrawal by Subject|0|||
164507726|NCT02872012|594229118|FG003|Overall Study|Withdrawal by Subject|0|||
164507727|NCT02872012|594229119|FG004|Overall Study|Withdrawal by Subject|0|||
164507728|NCT01728623|594229120|FG000|Overall Study|Disease progression|26|||
164507729|NCT01728623|594229120|FG000|Overall Study|Adverse Event|1|||
164507730|NCT01728623|594229120|FG000|Overall Study|Withdrawal by Subject|1|||
164507731|NCT00723125|594229121|FG000|Overall Study|Met Dx|1|||
164507732|NCT00723125|594229122|FG001|Overall Study|Met Dx|0|||
164507733|NCT00723125|594229121|FG000|Overall Study|Withdrawal by Subject|15|||
164507734|NCT00723125|594229122|FG001|Overall Study|Withdrawal by Subject|6|||
164507735|NCT00723125|594229121|FG000|Overall Study|Adverse Event|2|||
164507736|NCT00723125|594229122|FG001|Overall Study|Adverse Event|0|||
164507737|NCT02127125|594229125|FG000|Overall Study|Lost to Follow-up|0|||
164507738|NCT02127125|594229126|FG001|Overall Study|Lost to Follow-up|0|||
164507739|NCT02127125|594229127|FG002|Overall Study|Lost to Follow-up|0|||
164507740|NCT02127125|594229128|FG003|Overall Study|Lost to Follow-up|0|||
164507741|NCT02127125|594229129|FG004|Overall Study|Lost to Follow-up|2|||
164507742|NCT02127125|594229130|FG005|Overall Study|Lost to Follow-up|1|||
164507743|NCT02127125|594229131|FG006|Overall Study|Lost to Follow-up|0|||
164507744|NCT02127125|594229132|FG007|Overall Study|Lost to Follow-up|0|||
164507745|NCT02127125|594229133|FG008|Overall Study|Lost to Follow-up|0|||
164507746|NCT02127125|594229125|FG000|Overall Study|Withdrawal by Subject|0|||
164507747|NCT02127125|594229126|FG001|Overall Study|Withdrawal by Subject|0|||
164507748|NCT02127125|594229127|FG002|Overall Study|Withdrawal by Subject|0|||
164507749|NCT02127125|594229128|FG003|Overall Study|Withdrawal by Subject|1|||
164507750|NCT02127125|594229129|FG004|Overall Study|Withdrawal by Subject|0|||
164507751|NCT02127125|594229130|FG005|Overall Study|Withdrawal by Subject|0|||
164507752|NCT02127125|594229131|FG006|Overall Study|Withdrawal by Subject|0|||
164507753|NCT02127125|594229132|FG007|Overall Study|Withdrawal by Subject|0|||
164507754|NCT02127125|594229133|FG008|Overall Study|Withdrawal by Subject|0|||
164507755|NCT02127125|594229125|FG000|Overall Study|Physician Decision|0|||
164507756|NCT02127125|594229126|FG001|Overall Study|Physician Decision|0|||
164507757|NCT02127125|594229127|FG002|Overall Study|Physician Decision|1|||
164507758|NCT02127125|594229128|FG003|Overall Study|Physician Decision|0|||
164507759|NCT02127125|594229129|FG004|Overall Study|Physician Decision|1|||
164507760|NCT02127125|594229130|FG005|Overall Study|Physician Decision|2|||
164507761|NCT02127125|594229131|FG006|Overall Study|Physician Decision|0|||
164507762|NCT02127125|594229132|FG007|Overall Study|Physician Decision|0|||
164507763|NCT02127125|594229133|FG008|Overall Study|Physician Decision|0|||
164507764|NCT00763451|594229139|FG000|Overall Study|Adverse Event|4|||
164507765|NCT00763451|594229140|FG001|Overall Study|Adverse Event|6|||
164507766|NCT00763451|594229141|FG002|Overall Study|Adverse Event|19|||
164507767|NCT00763451|594229142|FG003|Overall Study|Adverse Event|14|||
164507768|NCT00763451|594229139|FG000|Overall Study|Lack of Efficacy|1|||
164507769|NCT00763451|594229140|FG001|Overall Study|Lack of Efficacy|4|||
164507770|NCT00763451|594229141|FG002|Overall Study|Lack of Efficacy|3|||
164507771|NCT00763451|594229142|FG003|Overall Study|Lack of Efficacy|2|||
164507772|NCT00763451|594229139|FG000|Overall Study|Withdrawal by Subject|1|||
164507773|NCT00763451|594229140|FG001|Overall Study|Withdrawal by Subject|6|||
164507774|NCT00763451|594229141|FG002|Overall Study|Withdrawal by Subject|9|||
164507775|NCT00763451|594229142|FG003|Overall Study|Withdrawal by Subject|7|||
164507776|NCT00763451|594229139|FG000|Overall Study|Protocol Violation|0|||
164507777|NCT00763451|594229140|FG001|Overall Study|Protocol Violation|0|||
164507778|NCT00763451|594229141|FG002|Overall Study|Protocol Violation|1|||
164507779|NCT00763451|594229142|FG003|Overall Study|Protocol Violation|0|||
164507780|NCT00763451|594229139|FG000|Overall Study|Poor Compliance to Protocol|1|||
164507781|NCT00763451|594229140|FG001|Overall Study|Poor Compliance to Protocol|1|||
164507782|NCT00763451|594229141|FG002|Overall Study|Poor Compliance to Protocol|2|||
164507783|NCT00763451|594229142|FG003|Overall Study|Poor Compliance to Protocol|2|||
164507784|NCT00763451|594229139|FG000|Overall Study|Familial and Personal Reasons|5|||
164507785|NCT00763451|594229140|FG001|Overall Study|Familial and Personal Reasons|3|||
164507786|NCT00763451|594229141|FG002|Overall Study|Familial and Personal Reasons|5|||
164507787|NCT00763451|594229142|FG003|Overall Study|Familial and Personal Reasons|4|||
164507788|NCT00763451|594229139|FG000|Overall Study|Randomized but not Treated|1|||
164507789|NCT00763451|594229140|FG001|Overall Study|Randomized but not Treated|1|||
164507790|NCT00763451|594229141|FG002|Overall Study|Randomized but not Treated|0|||
164507791|NCT00763451|594229142|FG003|Overall Study|Randomized but not Treated|0|||
164507792|NCT00763451|594229139|FG000|Overall Study|Study Site Reason|0|||
164507793|NCT00763451|594229140|FG001|Overall Study|Study Site Reason|1|||
164507794|NCT00763451|594229141|FG002|Overall Study|Study Site Reason|1|||
164507795|NCT00763451|594229142|FG003|Overall Study|Study Site Reason|1|||
164507796|NCT05594589|594229144|FG000|Overall Study|Other|0|||
164507797|NCT05594589|594229145|FG001|Overall Study|Other|1|||
164507798|NCT05594589|594229146|FG002|Overall Study|Other|0|||
164607672|NCT02939599|594583604|FG001|Overall Study|Study Terminated By Sponsor|2|||
164507799|NCT02498236|594229147|FG000|Overall Study|Did not show for testing|1|||
164507800|NCT02498236|594229148|FG001|Overall Study|Did not show for testing|0|||
164507801|NCT02498236|594229149|FG002|Overall Study|Did not show for testing|0|||
164507802|NCT02498236|594229150|FG003|Overall Study|Did not show for testing|0|||
164507803|NCT02498236|594229151|FG004|Overall Study|Did not show for testing|0|||
164507804|NCT02498236|594229152|FG005|Overall Study|Did not show for testing|0|||
164507805|NCT02498236|594229153|FG006|Overall Study|Did not show for testing|0|||
164607673|NCT01669811|594583605|FG000|Overall Study|Investigator decision|0|||
164607674|NCT01669811|594583606|FG001|Overall Study|Investigator decision|1|||
164607675|NCT01669811|594583605|FG000|Overall Study|Withdrawal by Subject|1|||
164607676|NCT01669811|594583606|FG001|Overall Study|Withdrawal by Subject|2|||
164607677|NCT01669811|594583605|FG000|Overall Study|Adverse Event|2|||
164607678|NCT01669811|594583606|FG001|Overall Study|Adverse Event|6|||
164607679|NCT01669811|594583605|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
164607680|NCT01669811|594583606|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
164607681|NCT02133742|594583615|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
164607682|NCT02133742|594583615|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
164607683|NCT02133742|594583615|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
164507806|NCT02498236|594229154|FG007|Overall Study|Did not show for testing|1|||
164507807|NCT02498236|594229147|FG000|Overall Study|Equipment failure|0|||
164507808|NCT02498236|594229148|FG001|Overall Study|Equipment failure|0|||
164507809|NCT02498236|594229149|FG002|Overall Study|Equipment failure|0|||
164507810|NCT02498236|594229150|FG003|Overall Study|Equipment failure|0|||
164507811|NCT02498236|594229151|FG004|Overall Study|Equipment failure|0|||
164507812|NCT02498236|594229152|FG005|Overall Study|Equipment failure|0|||
164507813|NCT02498236|594229153|FG006|Overall Study|Equipment failure|1|||
164507814|NCT02498236|594229154|FG007|Overall Study|Equipment failure|0|||
164507815|NCT02498236|594229147|FG000|Overall Study|Withdrawal by Subject|0|||
164507816|NCT02498236|594229148|FG001|Overall Study|Withdrawal by Subject|0|||
164507817|NCT02498236|594229149|FG002|Overall Study|Withdrawal by Subject|0|||
164507818|NCT02498236|594229150|FG003|Overall Study|Withdrawal by Subject|0|||
164507819|NCT02498236|594229151|FG004|Overall Study|Withdrawal by Subject|1|||
164507820|NCT02498236|594229152|FG005|Overall Study|Withdrawal by Subject|0|||
164507821|NCT02498236|594229153|FG006|Overall Study|Withdrawal by Subject|0|||
164507822|NCT02498236|594229154|FG007|Overall Study|Withdrawal by Subject|0|||
164507823|NCT01262092|594229156|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
164507824|NCT01262092|594229157|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
164507825|NCT01262092|594229156|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
164507826|NCT01262092|594229157|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
164507827|NCT01262092|594229156|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
164507828|NCT01262092|594229157|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
164507829|NCT01262092|594229156|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
164507830|NCT01262092|594229157|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
164507831|NCT03784820|594229158|FG000|Overall Study|Lost to Follow-up|5|||
164507832|NCT03784820|594229159|FG001|Overall Study|Lost to Follow-up|5|||
164507833|NCT03784820|594229160|FG002|Overall Study|Lost to Follow-up|3|||
164507834|NCT03784820|594229161|FG003|Overall Study|Lost to Follow-up|3|||
164507835|NCT01255761|594229162|FG000|Overall Study|Adverse Event|29|||
164507836|NCT01255761|594229163|FG001|Overall Study|Adverse Event|43|||
164507837|NCT01255761|594229162|FG000|Overall Study|Lack of Efficacy|86|||
164507838|NCT01255761|594229163|FG001|Overall Study|Lack of Efficacy|74|||
164507839|NCT01255761|594229162|FG000|Overall Study|Protocol Violation|9|||
164507840|NCT01255761|594229163|FG001|Overall Study|Protocol Violation|5|||
164507841|NCT01255761|594229162|FG000|Overall Study|Lost to Follow-up|10|||
164507842|NCT01255761|594229163|FG001|Overall Study|Lost to Follow-up|8|||
164507843|NCT01255761|594229162|FG000|Overall Study|Withdrawal by Subject|11|||
164507844|NCT01255761|594229163|FG001|Overall Study|Withdrawal by Subject|27|||
164507845|NCT01255761|594229162|FG000|Overall Study|Other Reasons|37|||
164507846|NCT01255761|594229163|FG001|Overall Study|Other Reasons|18|||
164507847|NCT02336425|594229164|FG000|Overall Study|Study terminated.|2|||
164507848|NCT02336425|594229165|FG001|Overall Study|Study terminated.|2|||
164507849|NCT02336425|594229166|FG002|Overall Study|Study terminated.|3|||
164507850|NCT02336425|594229167|FG003|Overall Study|Study terminated.|3|||
164507851|NCT00978562|594229168|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
164507852|NCT02394665|594229171|FG000|Overall Study|Physician Decision|1|||
164507853|NCT02394665|594229172|FG001|Overall Study|Physician Decision|0|||
164507854|NCT02394665|594229173|FG002|Overall Study|Physician Decision|0|||
164507855|NCT03348631|594229188|FG000|Overall Study|Not Eligible, No treatment|0|||
164507856|NCT03348631|594229189|FG001|Overall Study|Not Eligible, No treatment|1|||
164507857|NCT03348631|594229188|FG000|Overall Study|Not Eligible, Treated|2|||
164507858|NCT03348631|594229189|FG001|Overall Study|Not Eligible, Treated|0|||
164507859|NCT03348631|594229188|FG000|Overall Study|Eligible, No Treatment|1|||
164507860|NCT03348631|594229189|FG001|Overall Study|Eligible, No Treatment|0|||
164507861|NCT01068210|594229190|FG000|Overall Study|Lost to Follow-up|1|||
164507862|NCT01068210|594229191|FG001|Overall Study|Lost to Follow-up|2|||
164507863|NCT01068210|594229192|FG002|Overall Study|Lost to Follow-up|2|||
164507864|NCT01068210|594229193|FG003|Overall Study|Lost to Follow-up|1|||
164507865|NCT01068210|594229190|FG000|Overall Study|Second cancer|0|||
164507866|NCT01068210|594229191|FG001|Overall Study|Second cancer|1|||
164507867|NCT01068210|594229192|FG002|Overall Study|Second cancer|0|||
164507868|NCT01068210|594229193|FG003|Overall Study|Second cancer|0|||
164607684|NCT02133742|594583615|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
164607685|NCT02133742|594583615|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
164507869|NCT01068210|594229190|FG000|Overall Study|Disease progression|0|||
164607686|NCT03479216|594583616|FG000|Overall Study|Withdrawal by Subject|3|||
164607687|NCT03479216|594583617|FG001|Overall Study|Withdrawal by Subject|2|||
164607688|NCT03479216|594583616|FG000|Overall Study|Physician Decision|2|||
164607689|NCT03479216|594583617|FG001|Overall Study|Physician Decision|3|||
164607690|NCT02031432|594583622|FG000|Overall Study|Protocol Violation|1|||
164607691|NCT02031432|594583622|FG000|Overall Study|Lack of Efficacy|5|||
164607692|NCT02031432|594583622|FG000|Overall Study|Cancer Progression|2|||
164607693|NCT02031432|594583622|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
164607694|NCT02031432|594583622|FG000|Overall Study|Adverse Event|8|||
164507870|NCT01068210|594229191|FG001|Overall Study|Disease progression|0|||
164507871|NCT01068210|594229192|FG002|Overall Study|Disease progression|0|||
164507872|NCT01068210|594229193|FG003|Overall Study|Disease progression|2|||
164507873|NCT03842436|594229194|FG000|Overall Study|Lost to Follow-up|1|||
164507874|NCT01948076|594229195|FG000|Overall Study|Withdrawal by Subject|0|||
164507875|NCT01948076|594229196|FG001|Overall Study|Withdrawal by Subject|1|||
164507876|NCT00936598|594229197|FG000|Overall Study|Withdrawal by Subject|1|||
164507877|NCT00936598|594229198|FG001|Overall Study|Withdrawal by Subject|0|||
164507878|NCT00936598|594229197|FG000|Overall Study|Ineligible after consent|1|||
164507879|NCT00936598|594229198|FG001|Overall Study|Ineligible after consent|0|||
164507880|NCT00486252|594229201|FG000|Overall Study|Adverse Event|7|||
164507881|NCT00486252|594229201|FG000|Overall Study|Lack of Efficacy|9|||
164507882|NCT00486252|594229201|FG000|Overall Study|Lost to Follow-up|24|||
164507883|NCT00486252|594229201|FG000|Overall Study|Other|18|||
164507884|NCT01210651|594229202|FG000|Overall Study|Lost to Follow-up|1|||
164507885|NCT01210651|594229203|FG001|Overall Study|Lost to Follow-up|1|||
164507886|NCT01210651|594229202|FG000|Overall Study|schedule conflicts|1|||
164507887|NCT01210651|594229203|FG001|Overall Study|schedule conflicts|5|||
164507888|NCT01210651|594229202|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
164507889|NCT01210651|594229203|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
164507890|NCT01210651|594229202|FG000|Overall Study|Withdrawal by Subject|1|||
164507891|NCT01210651|594229203|FG001|Overall Study|Withdrawal by Subject|1|||
164507892|NCT01210651|594229202|FG000|Overall Study|Injury outside study|2|||
164507893|NCT01210651|594229203|FG001|Overall Study|Injury outside study|0|||
164507894|NCT02559310|594229204|FG000|Overall Study|Death|4|||
164507895|NCT02559310|594229205|FG001|Overall Study|Death|3|||
164507896|NCT02559310|594229204|FG000|Overall Study|Lost to Follow-up|5|||
164507897|NCT02559310|594229205|FG001|Overall Study|Lost to Follow-up|3|||
164507898|NCT02559310|594229204|FG000|Overall Study|Physician Decision|2|||
164507899|NCT02559310|594229205|FG001|Overall Study|Physician Decision|1|||
164507900|NCT02559310|594229204|FG000|Overall Study|Withdrawal by Subject|13|||
164507901|NCT02559310|594229205|FG001|Overall Study|Withdrawal by Subject|9|||
164507902|NCT02559310|594229204|FG000|Overall Study|Sponsor Decision|0|||
164507903|NCT02559310|594229205|FG001|Overall Study|Sponsor Decision|1|||
164507904|NCT02559310|594229204|FG000|Overall Study|Randomized but not treated|3|||
164507905|NCT02559310|594229205|FG001|Overall Study|Randomized but not treated|2|||
164507906|NCT04596540|594229206|FG000|Overall Study|Withdrawal by Subject|9|||
164507907|NCT04596540|594229207|FG001|Overall Study|Withdrawal by Subject|8|||
164507908|NCT04596540|594229208|FG002|Overall Study|Withdrawal by Subject|5|||
164507909|NCT04596540|594229206|FG000|Overall Study|Lost to Follow-up|1|||
164507910|NCT04596540|594229207|FG001|Overall Study|Lost to Follow-up|2|||
164507911|NCT04596540|594229208|FG002|Overall Study|Lost to Follow-up|1|||
164507912|NCT04596540|594229206|FG000|Overall Study|Sponsor Decision|2|||
164507913|NCT04596540|594229207|FG001|Overall Study|Sponsor Decision|0|||
164507914|NCT04596540|594229208|FG002|Overall Study|Sponsor Decision|0|||
164507915|NCT04596540|594229206|FG000|Overall Study|Physician Decision|0|||
164507916|NCT04596540|594229207|FG001|Overall Study|Physician Decision|1|||
164507917|NCT04596540|594229208|FG002|Overall Study|Physician Decision|1|||
164507918|NCT04596540|594229206|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
164507919|NCT04596540|594229207|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
164507920|NCT04596540|594229208|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
164507921|NCT04596540|594229206|FG000|Overall Study|Other Than Specified|5|||
164507922|NCT04596540|594229207|FG001|Overall Study|Other Than Specified|5|||
164507923|NCT04596540|594229208|FG002|Overall Study|Other Than Specified|2|||
164507924|NCT00469859|594229209|FG000|Overall Study|Inevaluable|0|||
164507925|NCT00469859|594229210|FG001|Overall Study|Inevaluable|2|||
164507926|NCT01090011|594230989|FG000|Overall Study|Progressive disease|128|||
164507927|NCT01090011|594230989|FG000|Overall Study|Adverse Event|32|||
164507928|NCT01090011|594230989|FG000|Overall Study|Protocol Violation|1|||
164507929|NCT01090011|594230989|FG000|Overall Study|Refusal to start/continue medication|5|||
164507930|NCT01090011|594230989|FG000|Overall Study|Other reason not defined above|5|||
164507931|NCT00863512|594230990|FG000|Overall Study|Adverse Event|2|||
164507932|NCT00863512|594230991|FG001|Overall Study|Adverse Event|0|||
164507933|NCT00863512|594230990|FG000|Overall Study|Withdrawal by Subject|11|||
164507934|NCT00863512|594230991|FG001|Overall Study|Withdrawal by Subject|0|||
164607695|NCT02031432|594583622|FG000|Overall Study|Withdrawal by Subject|5|||
164607696|NCT02031432|594583622|FG000|Overall Study|Lost to Follow-up|1|||
164507935|NCT00863512|594230990|FG000|Overall Study|Physician Decision|1|||
164507936|NCT00863512|594230991|FG001|Overall Study|Physician Decision|0|||
164507937|NCT00433511|594230992|FG000|Step 1|Adverse Event|50|||
164507938|NCT00433511|594230993|FG001|Step 1|Adverse Event|157|||
164507939|NCT00433511|594230994|FG002|Step 1|Adverse Event|153|||
164507940|NCT00433511|594230992|FG000|Step 1|Withdrawal by Subject|45|||
164507941|NCT00433511|594230993|FG001|Step 1|Withdrawal by Subject|143|||
164507942|NCT00433511|594230994|FG002|Step 1|Withdrawal by Subject|154|||
164507943|NCT00433511|594230992|FG000|Step 1|Death|3|||
164507944|NCT00433511|594230993|FG001|Step 1|Death|1|||
164507945|NCT00433511|594230994|FG002|Step 1|Death|1|||
164507946|NCT00433511|594230992|FG000|Step 1|Physician Decision|1|||
164507947|NCT00433511|594230993|FG001|Step 1|Physician Decision|4|||
164507948|NCT00433511|594230994|FG002|Step 1|Physician Decision|3|||
164507949|NCT00433511|594230992|FG000|Step 1|Never started protocol therapy|28|||
164507950|NCT00433511|594230993|FG001|Step 1|Never started protocol therapy|64|||
164507951|NCT00433511|594230994|FG002|Step 1|Never started protocol therapy|66|||
164507952|NCT00433511|594230992|FG000|Step 1|Alternative therapy|2|||
164507953|NCT00433511|594230993|FG001|Step 1|Alternative therapy|1|||
164507954|NCT00433511|594230994|FG002|Step 1|Alternative therapy|3|||
164507955|NCT00433511|594230992|FG000|Step 1|Disease progression, relapse|5|||
164507956|NCT00433511|594230993|FG001|Step 1|Disease progression, relapse|3|||
164507957|NCT00433511|594230994|FG002|Step 1|Disease progression, relapse|3|||
164507958|NCT00433511|594230992|FG000|Step 1|Other complicating disease|2|||
164507959|NCT00433511|594230993|FG001|Step 1|Other complicating disease|6|||
164507960|NCT00433511|594230994|FG002|Step 1|Other complicating disease|3|||
164507961|NCT00433511|594230992|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
164507962|NCT00433511|594230993|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
164507963|NCT00433511|594230994|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
164507964|NCT00433511|594230992|FG000|Step 1|Suspected recurrence|0|||
164507965|NCT00433511|594230993|FG001|Step 1|Suspected recurrence|1|||
164507966|NCT00433511|594230994|FG002|Step 1|Suspected recurrence|0|||
164507967|NCT00433511|594230992|FG000|Step 1|Insurance/drug distribution issues|0|||
164507968|NCT00433511|594230993|FG001|Step 1|Insurance/drug distribution issues|1|||
164507969|NCT00433511|594230994|FG002|Step 1|Insurance/drug distribution issues|2|||
164507970|NCT00433511|594230992|FG000|Step 1|Patient moved|0|||
164507971|NCT00433511|594230993|FG001|Step 1|Patient moved|0|||
164507972|NCT00433511|594230994|FG002|Step 1|Patient moved|1|||
164507973|NCT00433511|594230992|FG000|Step 2 (Arm D)|Adverse Event|0|||
164507974|NCT00433511|594230993|FG001|Step 2 (Arm D)|Adverse Event|0|||
164507975|NCT00433511|594230994|FG002|Step 2 (Arm D)|Adverse Event|135|||
164507976|NCT00433511|594230992|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
164507977|NCT00433511|594230993|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
164507978|NCT00433511|594230994|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
164507979|NCT00433511|594230992|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
164507980|NCT00433511|594230993|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
164507981|NCT00433511|594230994|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
164507982|NCT00433511|594230992|FG000|Step 2 (Arm D)|Physician Decision|0|||
164507983|NCT00433511|594230993|FG001|Step 2 (Arm D)|Physician Decision|0|||
164507984|NCT00433511|594230994|FG002|Step 2 (Arm D)|Physician Decision|9|||
164507985|NCT00433511|594230992|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
164507986|NCT00433511|594230993|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
164507987|NCT00433511|594230994|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
164507988|NCT00433511|594230992|FG000|Step 2 (Arm D)|Other complicating disease|0|||
164507989|NCT00433511|594230993|FG001|Step 2 (Arm D)|Other complicating disease|0|||
164507990|NCT00433511|594230994|FG002|Step 2 (Arm D)|Other complicating disease|3|||
164507991|NCT00433511|594230992|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
164507992|NCT00433511|594230993|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
164507993|NCT00433511|594230994|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
164507994|NCT00433511|594230992|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
164507995|NCT00433511|594230993|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
164507996|NCT00433511|594230994|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
164507997|NCT00433511|594230992|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
164607697|NCT02031432|594583622|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
164607698|NCT02031432|594583622|FG000|Overall Study|Death|10|||
164607699|NCT02148211|594583623|FG000|Overall Study|Lost to Follow-up|352|||
164607700|NCT01617187|594583625|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
164607701|NCT01617187|594583626|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
164607702|NCT01617187|594583627|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
164607703|NCT01617187|594583628|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
164607704|NCT01617187|594583625|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
164607705|NCT01617187|594583626|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
164607706|NCT01617187|594583627|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
164607707|NCT01617187|594583628|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
164607708|NCT01617187|594583625|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
164607709|NCT01617187|594583626|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
164607710|NCT01617187|594583627|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
164607711|NCT01617187|594583628|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
164607712|NCT01617187|594583625|FG000|Treatment Through Study Completion|Adverse Event|1|||
164507998|NCT00433511|594230993|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
164507999|NCT00433511|594230994|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
164508000|NCT00433511|594230992|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
164508001|NCT00433511|594230993|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
164508002|NCT00433511|594230994|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
164508003|NCT01375673|594230995|FG000|Overall Study|Withdrawal by Subject|0|||
164508004|NCT01375673|594230996|FG001|Overall Study|Withdrawal by Subject|1|||
164508005|NCT04698915|594231001|FG000|Overall Study|Adverse Event|2|||
164508006|NCT04698915|594231002|FG001|Overall Study|Adverse Event|0|||
164508007|NCT04698915|594231001|FG000|Overall Study|Death|23|||
164508008|NCT04698915|594231002|FG001|Overall Study|Death|20|||
164508009|NCT04698915|594231001|FG000|Overall Study|Physician Decision|1|||
164508010|NCT04698915|594231002|FG001|Overall Study|Physician Decision|1|||
164508011|NCT04698915|594231001|FG000|Overall Study|Lost to Follow-up|1|||
164508012|NCT04698915|594231002|FG001|Overall Study|Lost to Follow-up|0|||
164508013|NCT04698915|594231001|FG000|Overall Study|Study Terminated by Sponsor|55|||
164508014|NCT04698915|594231002|FG001|Overall Study|Study Terminated by Sponsor|60|||
164508015|NCT04698915|594231001|FG000|Overall Study|Withdrawal by Subject|2|||
164508016|NCT04698915|594231002|FG001|Overall Study|Withdrawal by Subject|3|||
164508017|NCT01907906|594231005|FG000|Overall Study|Withdrawal by Subject|1|||
164508018|NCT01907906|594231006|FG001|Overall Study|Withdrawal by Subject|0|||
164508019|NCT01907906|594231005|FG000|Overall Study|Physician Decision|3|||
164508020|NCT01907906|594231006|FG001|Overall Study|Physician Decision|1|||
164508021|NCT05687032|594231009|FG000|Treatment Phase|Adverse Event|13|||
164508022|NCT05687032|594231009|FG000|Treatment Phase|Death|1|||
164508023|NCT05687032|594231009|FG000|Treatment Phase|Physician Decision|3|||
164508024|NCT05687032|594231009|FG000|Treatment Phase|Progressive disease|9|||
164607713|NCT01617187|594583626|FG001|Treatment Through Study Completion|Adverse Event|1|||
164607714|NCT01617187|594583627|FG002|Treatment Through Study Completion|Adverse Event|0|||
164607715|NCT01617187|594583628|FG003|Treatment Through Study Completion|Adverse Event|1|||
164607716|NCT01617187|594583625|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
164607717|NCT01617187|594583626|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
164607718|NCT01617187|594583627|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
164607719|NCT01617187|594583628|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
164607720|NCT01617187|594583625|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
164607721|NCT01617187|594583626|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
164607722|NCT01617187|594583627|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
164607723|NCT01617187|594583628|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
164607724|NCT01617187|594583625|FG000|Treatment Through Study Completion|Protocol Violation|1|||
164607725|NCT01617187|594583626|FG001|Treatment Through Study Completion|Protocol Violation|0|||
164607726|NCT01617187|594583627|FG002|Treatment Through Study Completion|Protocol Violation|0|||
164607727|NCT01617187|594583628|FG003|Treatment Through Study Completion|Protocol Violation|1|||
164607728|NCT01265420|594583629|FG000|Overall Study|Lost to Follow-up|1|||
164607729|NCT03127852|594585431|FG000|Overall Study|Withdrawal by Subject|4|||
164607730|NCT03127852|594585432|FG001|Overall Study|Withdrawal by Subject|1|||
164607731|NCT03127852|594585431|FG000|Overall Study|Death|1|||
164607732|NCT03127852|594585432|FG001|Overall Study|Death|1|||
164607733|NCT03382262|594585433|FG000|Overall Study|Physician Decision|0|||
164607734|NCT03382262|594585434|FG001|Overall Study|Physician Decision|0|||
164607735|NCT03382262|594585435|FG002|Overall Study|Physician Decision|1|||
164607736|NCT03382262|594585436|FG003|Overall Study|Physician Decision|0|||
164607737|NCT03382262|594585433|FG000|Overall Study|Withdrawal by Subject|0|||
164607738|NCT03382262|594585434|FG001|Overall Study|Withdrawal by Subject|0|||
164607739|NCT03382262|594585435|FG002|Overall Study|Withdrawal by Subject|0|||
164607740|NCT03382262|594585436|FG003|Overall Study|Withdrawal by Subject|1|||
164607741|NCT00126581|594585437|FG000|Overall Study|Adverse Event|3|||
164607742|NCT00126581|594585438|FG001|Overall Study|Adverse Event|7|||
164607743|NCT00126581|594585437|FG000|Overall Study|Death|3|||
164607744|NCT00126581|594585438|FG001|Overall Study|Death|2|||
164607745|NCT00126581|594585437|FG000|Overall Study|Withdrawal by Subject|1|||
164607746|NCT00126581|594585438|FG001|Overall Study|Withdrawal by Subject|4|||
164607747|NCT00126581|594585437|FG000|Overall Study|Alternative therapy|3|||
164607748|NCT00126581|594585438|FG001|Overall Study|Alternative therapy|3|||
164508025|NCT05687032|594231009|FG000|Treatment Phase|Withdrawal by Subject|5|||
164508026|NCT05687032|594231009|FG000|Follow-Up Phase|Death|16|||
164508027|NCT05687032|594231009|FG000|Follow-Up Phase|Ongoing|26|||
164508028|NCT02367352|594231016|FG000|Overall Study|Progressive disease|7|||
164607749|NCT00126581|594585437|FG000|Overall Study|Other illness/MD discretion|3|||
164607750|NCT00126581|594585438|FG001|Overall Study|Other illness/MD discretion|4|||
164607751|NCT03325556|594585440|FG000|Open-label Period|Lack of Response in OL period|70|||
164607752|NCT03325556|594585441|FG001|Open-label Period|Lack of Response in OL period|0|||
164607753|NCT03325556|594585442|FG002|Open-label Period|Lack of Response in OL period|0|||
164607754|NCT03325556|594585440|FG000|Open-label Period|Adverse Event|27|||
164607755|NCT03325556|594585441|FG001|Open-label Period|Adverse Event|0|||
164607756|NCT03325556|594585442|FG002|Open-label Period|Adverse Event|0|||
164607757|NCT03325556|594585440|FG000|Open-label Period|Death|1|||
164607758|NCT03325556|594585441|FG001|Open-label Period|Death|0|||
164607759|NCT03325556|594585442|FG002|Open-label Period|Death|0|||
164607760|NCT03325556|594585440|FG000|Open-label Period|Lost to Follow-up|1|||
164607761|NCT03325556|594585441|FG001|Open-label Period|Lost to Follow-up|0|||
164607762|NCT03325556|594585442|FG002|Open-label Period|Lost to Follow-up|0|||
164607763|NCT03325556|594585440|FG000|Open-label Period|Non-compliance with study drug|5|||
164607764|NCT03325556|594585441|FG001|Open-label Period|Non-compliance with study drug|0|||
164508029|NCT02367352|594231017|FG001|Overall Study|Progressive disease|0|||
164508030|NCT02367352|594231018|FG002|Overall Study|Progressive disease|0|||
164508031|NCT02367352|594231016|FG000|Overall Study|Participant Received Alternative Therapy|1|||
164508032|NCT02367352|594231017|FG001|Overall Study|Participant Received Alternative Therapy|0|||
164508033|NCT02367352|594231018|FG002|Overall Study|Participant Received Alternative Therapy|0|||
164508034|NCT02367352|594231016|FG000|Overall Study|Adverse Event|1|||
164508035|NCT02367352|594231017|FG001|Overall Study|Adverse Event|0|||
164508036|NCT02367352|594231018|FG002|Overall Study|Adverse Event|0|||
164508037|NCT02375347|594231024|FG000|Overall Study|Protocol Violation|1|||
164508038|NCT00193479|594231025|FG000|Induction Chemotherapy|Adverse Event|2|||
164508039|NCT00193479|594231025|FG000|Induction Chemotherapy|Disease Progression|1|||
164508040|NCT00193479|594231025|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
164508041|NCT00193479|594231025|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
164508042|NCT00425607|594231026|FG000|Overall Study|Death|1|||
164508043|NCT00425607|594231026|FG000|Overall Study|Withdrawal by Subject|1|||
164508044|NCT00079339|594231027|FG000|Overall Study|Adverse Event|1|||
164508045|NCT00079339|594231028|FG001|Overall Study|Adverse Event|7|||
164508046|NCT00079339|594231029|FG002|Overall Study|Adverse Event|2|||
164508047|NCT00079339|594231027|FG000|Overall Study|Death|1|||
164508048|NCT00079339|594231028|FG001|Overall Study|Death|0|||
164508049|NCT00079339|594231029|FG002|Overall Study|Death|0|||
164508050|NCT00079339|594231027|FG000|Overall Study|Non-compliance|0|||
164508051|NCT00079339|594231028|FG001|Overall Study|Non-compliance|0|||
164508052|NCT00079339|594231029|FG002|Overall Study|Non-compliance|1|||
164508053|NCT00079339|594231027|FG000|Overall Study|Withdrawal by Subject|0|||
164508054|NCT00079339|594231028|FG001|Overall Study|Withdrawal by Subject|4|||
164508055|NCT00079339|594231029|FG002|Overall Study|Withdrawal by Subject|1|||
164508056|NCT00079339|594231027|FG000|Overall Study|Disease progression|3|||
164508057|NCT00079339|594231028|FG001|Overall Study|Disease progression|28|||
164508058|NCT00079339|594231029|FG002|Overall Study|Disease progression|2|||
164508059|NCT02563548|594231030|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
164508060|NCT02563548|594231031|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
164508061|NCT02563548|594231032|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
164508062|NCT02563548|594231033|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
164508063|NCT02563548|594231034|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
164508064|NCT02563548|594231035|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
164508065|NCT02563548|594231030|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
164508066|NCT02563548|594231031|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
164508067|NCT02563548|594231032|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
164508068|NCT02563548|594231033|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
164508069|NCT02563548|594231034|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
164508070|NCT02563548|594231035|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
164508071|NCT02563548|594231030|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
164508072|NCT02563548|594231031|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
164508073|NCT02563548|594231032|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
164508074|NCT02563548|594231033|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
164508075|NCT02563548|594231034|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
164508076|NCT02563548|594231035|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
164508077|NCT02563548|594231030|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
164508078|NCT02563548|594231031|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
164508079|NCT02563548|594231032|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
164508080|NCT02563548|594231033|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
164508081|NCT02563548|594231034|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
164508082|NCT02563548|594231035|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
164607765|NCT03325556|594585442|FG002|Open-label Period|Non-compliance with study drug|0|||
164607766|NCT03325556|594585440|FG000|Open-label Period|Use of prohibited medication|1|||
164607767|NCT03325556|594585441|FG001|Open-label Period|Use of prohibited medication|0|||
164607768|NCT03325556|594585442|FG002|Open-label Period|Use of prohibited medication|0|||
164607769|NCT03325556|594585440|FG000|Open-label Period|Protocol Violation|4|||
164607770|NCT03325556|594585441|FG001|Open-label Period|Protocol Violation|0|||
164607771|NCT03325556|594585442|FG002|Open-label Period|Protocol Violation|0|||
164607772|NCT03325556|594585440|FG000|Open-label Period|Withdrawal by Subject|17|||
164607773|NCT03325556|594585441|FG001|Open-label Period|Withdrawal by Subject|0|||
164607774|NCT03325556|594585442|FG002|Open-label Period|Withdrawal by Subject|0|||
164607775|NCT03325556|594585440|FG000|Open-label Period|Not otherwise specified|8|||
164607776|NCT03325556|594585441|FG001|Open-label Period|Not otherwise specified|0|||
164607777|NCT03325556|594585442|FG002|Open-label Period|Not otherwise specified|0|||
164607778|NCT03325556|594585440|FG000|Open-label Period|Administrative discont. at study termination|41|||
164607779|NCT03325556|594585441|FG001|Open-label Period|Administrative discont. at study termination|0|||
164607780|NCT03325556|594585442|FG002|Open-label Period|Administrative discont. at study termination|0|||
164607781|NCT03325556|594585440|FG000|Double-blind Period|Relapse|0|||
164607782|NCT03325556|594585441|FG001|Double-blind Period|Relapse|15|||
164607783|NCT03325556|594585442|FG002|Double-blind Period|Relapse|34|||
164607784|NCT03325556|594585440|FG000|Double-blind Period|Adverse Event|0|||
164607785|NCT03325556|594585441|FG001|Double-blind Period|Adverse Event|3|||
164607786|NCT03325556|594585442|FG002|Double-blind Period|Adverse Event|1|||
164607787|NCT03325556|594585440|FG000|Double-blind Period|Noncompliance with study drug|0|||
164607788|NCT03325556|594585441|FG001|Double-blind Period|Noncompliance with study drug|0|||
164607789|NCT03325556|594585442|FG002|Double-blind Period|Noncompliance with study drug|1|||
164607790|NCT03325556|594585440|FG000|Double-blind Period|Use of prohibited medication|0|||
164607791|NCT03325556|594585441|FG001|Double-blind Period|Use of prohibited medication|1|||
164607792|NCT03325556|594585442|FG002|Double-blind Period|Use of prohibited medication|0|||
164607793|NCT03325556|594585440|FG000|Double-blind Period|Physician Decision|0|||
164607794|NCT03325556|594585441|FG001|Double-blind Period|Physician Decision|0|||
164607795|NCT03325556|594585442|FG002|Double-blind Period|Physician Decision|1|||
164607796|NCT03325556|594585440|FG000|Double-blind Period|Withdrawal by Subject|0|||
164607797|NCT03325556|594585441|FG001|Double-blind Period|Withdrawal by Subject|6|||
164607798|NCT03325556|594585442|FG002|Double-blind Period|Withdrawal by Subject|4|||
164607799|NCT03325556|594585440|FG000|Double-blind Period|Not otherwise specified|0|||
164607800|NCT03325556|594585441|FG001|Double-blind Period|Not otherwise specified|1|||
164607801|NCT03325556|594585442|FG002|Double-blind Period|Not otherwise specified|5|||
164607802|NCT03325556|594585440|FG000|Double-blind Period|Administrative discont. at study termination|0|||
164607803|NCT03325556|594585441|FG001|Double-blind Period|Administrative discont. at study termination|35|||
164607804|NCT03325556|594585442|FG002|Double-blind Period|Administrative discont. at study termination|31|||
164607805|NCT00762268|594585443|FG000|Overall Study|Withdrawal by Subject|3|||
164607806|NCT00762268|594585444|FG001|Overall Study|Withdrawal by Subject|3|||
164607807|NCT03892707|594585449|FG000|Overall Study|Screen failure|6|||
164607808|NCT03892707|594585450|FG001|Overall Study|Screen failure|0|||
164607809|NCT03892707|594585449|FG000|Overall Study|Pain resolution|0|||
164607810|NCT03892707|594585450|FG001|Overall Study|Pain resolution|4|||
164607811|NCT03892707|594585449|FG000|Overall Study|Withdrawal by Subject|0|||
164607812|NCT03892707|594585450|FG001|Overall Study|Withdrawal by Subject|1|||
164607813|NCT03892707|594585449|FG000|Overall Study|Other (long business trip)|0|||
164607814|NCT03892707|594585450|FG001|Overall Study|Other (long business trip)|1|||
164607815|NCT05224076|594585453|FG000|Overall Study|Lost to Follow-up|24|||
164607816|NCT04325906|594585455|FG000|Overall Study|Withdrawal by Subject|2|||
164607817|NCT04325906|594585456|FG001|Overall Study|Withdrawal by Subject|0|||
164607818|NCT01628393|594585459|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
164607819|NCT01628393|594585460|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
164607820|NCT01628393|594585461|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
164607821|NCT01628393|594585462|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
164607822|NCT01628393|594585463|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
164607823|NCT01628393|594585459|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
164607824|NCT01628393|594585460|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
164607825|NCT01628393|594585461|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
164607826|NCT01628393|594585462|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
164607827|NCT01628393|594585463|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
164607828|NCT01628393|594585459|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
164607829|NCT01628393|594585460|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
164607830|NCT01628393|594585461|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
164146445|NCT05026177|592898060|FG002|Overall Study|Lost to Follow-up|8|||
164508083|NCT02563548|594231030|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
164508084|NCT02563548|594231031|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
164508085|NCT02563548|594231032|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
164508086|NCT02563548|594231033|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
164508087|NCT02563548|594231034|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
164508088|NCT02563548|594231035|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
164508089|NCT02563548|594231030|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
164508090|NCT02563548|594231031|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
164508091|NCT02563548|594231032|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
164508092|NCT02563548|594231033|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
164508093|NCT02563548|594231034|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
164508094|NCT02563548|594231035|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
164508095|NCT02563548|594231030|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
164508096|NCT02563548|594231031|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
164508097|NCT02563548|594231032|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
164508098|NCT02563548|594231033|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
164508099|NCT02563548|594231034|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
164508100|NCT02563548|594231035|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
164508101|NCT02563548|594231030|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
164508102|NCT02563548|594231031|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
164508103|NCT02563548|594231032|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
164508104|NCT02563548|594231033|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
164508105|NCT02563548|594231034|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
164508106|NCT02563548|594231035|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
164508107|NCT02563548|594231030|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
164508108|NCT02563548|594231031|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
164508109|NCT02563548|594231032|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
164508110|NCT02563548|594231033|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
164508111|NCT02563548|594231034|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
164508112|NCT02563548|594231035|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
164508113|NCT02563548|594231030|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
164508114|NCT02563548|594231031|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
164508115|NCT02563548|594231032|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
164508116|NCT02563548|594231033|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
164508117|NCT02563548|594231034|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
164508118|NCT02563548|594231035|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
164508119|NCT02563548|594231030|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
164508120|NCT02563548|594231031|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
164508121|NCT02563548|594231032|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
164508122|NCT02563548|594231033|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
164508123|NCT02563548|594231034|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
164508124|NCT02563548|594231035|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
164508125|NCT02563548|594231030|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
164508126|NCT02563548|594231031|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
164508127|NCT02563548|594231032|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
164508128|NCT02563548|594231033|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
164508129|NCT02563548|594231034|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
164508130|NCT02563548|594231035|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
164508131|NCT00203047|594231041|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
164508132|NCT00203047|594231042|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
164508133|NCT00203047|594231041|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
164508134|NCT00203047|594231042|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
164508135|NCT00203047|594231041|FG000|Overall Study|Withdrawal by Subject|13|||
164508136|NCT00203047|594231042|FG001|Overall Study|Withdrawal by Subject|47|||
164508137|NCT00203047|594231041|FG000|Overall Study|Teva requested participant withdrawal|1|||
164508138|NCT00203047|594231042|FG001|Overall Study|Teva requested participant withdrawal|1|||
164508139|NCT00203047|594231041|FG000|Overall Study|Physician Decision|8|||
164508140|NCT00203047|594231042|FG001|Overall Study|Physician Decision|7|||
164508141|NCT00203047|594231041|FG000|Overall Study|Non-compliance|4|||
164508142|NCT00203047|594231042|FG001|Overall Study|Non-compliance|8|||
164508143|NCT00203047|594231041|FG000|Overall Study|Protocol Violation|1|||
164508144|NCT00203047|594231042|FG001|Overall Study|Protocol Violation|0|||
164508145|NCT00203047|594231041|FG000|Overall Study|Lost to Follow-up|11|||
164508146|NCT00203047|594231042|FG001|Overall Study|Lost to Follow-up|5|||
164508147|NCT00203047|594231041|FG000|Overall Study|Adverse Event|8|||
164508148|NCT00203047|594231042|FG001|Overall Study|Adverse Event|18|||
164508149|NCT00203047|594231041|FG000|Overall Study|Death|1|||
164508150|NCT00203047|594231042|FG001|Overall Study|Death|2|||
164508151|NCT00203047|594231041|FG000|Overall Study|Pregnancy|3|||
164508152|NCT00203047|594231042|FG001|Overall Study|Pregnancy|0|||
164508153|NCT00203047|594231041|FG000|Overall Study|Other|5|||
164508154|NCT00203047|594231042|FG001|Overall Study|Other|5|||
164508155|NCT00340704|594231043|FG000|PK Study|Adverse Event|0|||
164508156|NCT00340704|594231044|FG001|PK Study|Adverse Event|1|||
164508157|NCT00340704|594231045|FG002|PK Study|Adverse Event|0|||
164508158|NCT00340704|594231046|FG003|PK Study|Adverse Event|0|||
164508159|NCT00340704|594231047|FG004|PK Study|Adverse Event|0|||
164508160|NCT00340704|594231048|FG005|PK Study|Adverse Event|0|||
164508161|NCT00340704|594231049|FG006|PK Study|Adverse Event|0|||
164508162|NCT00340704|594231050|FG007|PK Study|Adverse Event|0|||
164508163|NCT00340704|594231051|FG008|PK Study|Adverse Event|0|||
164508164|NCT00340704|594231043|FG000|PK Study|Not treated|0|||
164508165|NCT00340704|594231044|FG001|PK Study|Not treated|0|||
164508166|NCT00340704|594231045|FG002|PK Study|Not treated|1|||
164508167|NCT00340704|594231046|FG003|PK Study|Not treated|0|||
164508168|NCT00340704|594231047|FG004|PK Study|Not treated|0|||
164508169|NCT00340704|594231048|FG005|PK Study|Not treated|0|||
164508170|NCT00340704|594231049|FG006|PK Study|Not treated|0|||
164508171|NCT00340704|594231050|FG007|PK Study|Not treated|0|||
164508172|NCT00340704|594231051|FG008|PK Study|Not treated|0|||
164508173|NCT00340704|594231043|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
164508174|NCT00340704|594231044|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
164508175|NCT00340704|594231045|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
164508176|NCT00340704|594231046|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
164508177|NCT00340704|594231047|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
164508178|NCT00340704|594231048|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
164508179|NCT00340704|594231049|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
164508180|NCT00340704|594231050|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
164508181|NCT00340704|594231051|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
164508182|NCT00340704|594231043|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
164508183|NCT00340704|594231044|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
164508184|NCT00340704|594231045|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
164508185|NCT00340704|594231046|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
164508186|NCT00340704|594231047|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
164508187|NCT00340704|594231048|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
164508188|NCT00340704|594231049|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
164508189|NCT00340704|594231050|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
164508190|NCT00340704|594231051|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
164508191|NCT00340704|594231043|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
164508192|NCT00340704|594231044|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
164508193|NCT00340704|594231045|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
164508194|NCT00340704|594231046|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
164508195|NCT00340704|594231047|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
164508196|NCT00340704|594231048|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
164508197|NCT00340704|594231049|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
164508198|NCT00340704|594231050|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
164508199|NCT00340704|594231051|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
164508200|NCT00340704|594231043|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
164508201|NCT00340704|594231044|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
164508202|NCT00340704|594231045|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
164508203|NCT00340704|594231046|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
164508204|NCT00340704|594231047|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
164508205|NCT00340704|594231048|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
164508206|NCT00340704|594231049|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
164508207|NCT00340704|594231050|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
164508208|NCT00340704|594231051|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
164508209|NCT04468230|594231057|FG000|Overall Study|Adverse Event|2|||
164508210|NCT03994731|594231060|FG000|Pegloticase + IMM Period|Death|2|||
164508211|NCT03994731|594231061|FG001|Pegloticase + IMM Period|Death|0|||
164508212|NCT03994731|594231060|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
164508213|NCT03994731|594231061|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
164508214|NCT03994731|594231060|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
164508215|NCT03994731|594231061|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
164508216|NCT03377361|594231067|FG000|Pre-Treatment|Subject withdrew consent|0|||
164508217|NCT03377361|594231068|FG001|Pre-Treatment|Subject withdrew consent|0|||
164508218|NCT03377361|594231069|FG002|Pre-Treatment|Subject withdrew consent|0|||
164508219|NCT03377361|594231070|FG003|Pre-Treatment|Subject withdrew consent|0|||
164508220|NCT03377361|594231071|FG004|Pre-Treatment|Subject withdrew consent|0|||
164508221|NCT03377361|594231072|FG005|Pre-Treatment|Subject withdrew consent|0|||
164508222|NCT03377361|594231073|FG006|Pre-Treatment|Subject withdrew consent|0|||
164508223|NCT03377361|594231074|FG007|Pre-Treatment|Subject withdrew consent|3|||
164508224|NCT03377361|594231075|FG008|Pre-Treatment|Subject withdrew consent|1|||
164508225|NCT03377361|594231076|FG009|Pre-Treatment|Subject withdrew consent|0|||
164508226|NCT03377361|594231067|FG000|Pre-Treatment|Not Reported|0|||
164508227|NCT03377361|594231068|FG001|Pre-Treatment|Not Reported|0|||
164508228|NCT03377361|594231069|FG002|Pre-Treatment|Not Reported|0|||
164508229|NCT03377361|594231070|FG003|Pre-Treatment|Not Reported|0|||
164508230|NCT03377361|594231071|FG004|Pre-Treatment|Not Reported|0|||
164508231|NCT03377361|594231072|FG005|Pre-Treatment|Not Reported|0|||
164508232|NCT03377361|594231073|FG006|Pre-Treatment|Not Reported|0|||
164508233|NCT03377361|594231074|FG007|Pre-Treatment|Not Reported|0|||
164508234|NCT03377361|594231075|FG008|Pre-Treatment|Not Reported|3|||
164508235|NCT03377361|594231076|FG009|Pre-Treatment|Not Reported|0|||
164508236|NCT03377361|594231067|FG000|Treatment Period|Disease Progression|3|||
164508237|NCT03377361|594231068|FG001|Treatment Period|Disease Progression|2|||
164508238|NCT03377361|594231069|FG002|Treatment Period|Disease Progression|5|||
164508239|NCT03377361|594231070|FG003|Treatment Period|Disease Progression|3|||
164508240|NCT03377361|594231071|FG004|Treatment Period|Disease Progression|3|||
164508241|NCT03377361|594231072|FG005|Treatment Period|Disease Progression|3|||
164508242|NCT03377361|594231073|FG006|Treatment Period|Disease Progression|6|||
164508243|NCT03377361|594231074|FG007|Treatment Period|Disease Progression|106|||
164508244|NCT03377361|594231075|FG008|Treatment Period|Disease Progression|48|||
164508245|NCT03377361|594231076|FG009|Treatment Period|Disease Progression|59|||
164508246|NCT03377361|594231067|FG000|Treatment Period|Study Drug Toxicity|0|||
164508247|NCT03377361|594231068|FG001|Treatment Period|Study Drug Toxicity|0|||
164508248|NCT03377361|594231069|FG002|Treatment Period|Study Drug Toxicity|0|||
164508249|NCT03377361|594231070|FG003|Treatment Period|Study Drug Toxicity|1|||
164508250|NCT03377361|594231071|FG004|Treatment Period|Study Drug Toxicity|0|||
164508251|NCT03377361|594231072|FG005|Treatment Period|Study Drug Toxicity|0|||
164508252|NCT03377361|594231073|FG006|Treatment Period|Study Drug Toxicity|0|||
164508253|NCT03377361|594231074|FG007|Treatment Period|Study Drug Toxicity|7|||
164508254|NCT03377361|594231075|FG008|Treatment Period|Study Drug Toxicity|2|||
164508255|NCT03377361|594231076|FG009|Treatment Period|Study Drug Toxicity|16|||
164508256|NCT03377361|594231067|FG000|Treatment Period|Death|0|||
164508257|NCT03377361|594231068|FG001|Treatment Period|Death|0|||
164508258|NCT03377361|594231069|FG002|Treatment Period|Death|1|||
164508259|NCT03377361|594231070|FG003|Treatment Period|Death|0|||
164508260|NCT03377361|594231071|FG004|Treatment Period|Death|0|||
164508261|NCT03377361|594231072|FG005|Treatment Period|Death|0|||
164508262|NCT03377361|594231073|FG006|Treatment Period|Death|0|||
164508263|NCT03377361|594231074|FG007|Treatment Period|Death|2|||
164508264|NCT03377361|594231075|FG008|Treatment Period|Death|1|||
164508265|NCT03377361|594231076|FG009|Treatment Period|Death|3|||
164508266|NCT03377361|594231067|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
164508267|NCT03377361|594231068|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
164508268|NCT03377361|594231069|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
164508269|NCT03377361|594231070|FG003|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
164508270|NCT03377361|594231071|FG004|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
164508271|NCT03377361|594231072|FG005|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
164508272|NCT03377361|594231073|FG006|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
164508273|NCT03377361|594231074|FG007|Treatment Period|Adverse Event Unrelated to Study Drug|2|||
164508274|NCT03377361|594231075|FG008|Treatment Period|Adverse Event Unrelated to Study Drug|3|||
164508275|NCT03377361|594231076|FG009|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
164508276|NCT03377361|594231067|FG000|Treatment Period|Subject request to discontinue study treatment|0|||
164508277|NCT03377361|594231068|FG001|Treatment Period|Subject request to discontinue study treatment|0|||
164508278|NCT03377361|594231069|FG002|Treatment Period|Subject request to discontinue study treatment|0|||
164508279|NCT03377361|594231070|FG003|Treatment Period|Subject request to discontinue study treatment|0|||
164508280|NCT03377361|594231071|FG004|Treatment Period|Subject request to discontinue study treatment|0|||
164508281|NCT03377361|594231072|FG005|Treatment Period|Subject request to discontinue study treatment|0|||
164508282|NCT03377361|594231073|FG006|Treatment Period|Subject request to discontinue study treatment|0|||
164508283|NCT03377361|594231074|FG007|Treatment Period|Subject request to discontinue study treatment|0|||
164508284|NCT03377361|594231075|FG008|Treatment Period|Subject request to discontinue study treatment|1|||
164508285|NCT03377361|594231076|FG009|Treatment Period|Subject request to discontinue study treatment|1|||
164508286|NCT03377361|594231067|FG000|Treatment Period|Subject Withdrew Consent|0|||
164508287|NCT03377361|594231068|FG001|Treatment Period|Subject Withdrew Consent|0|||
164508288|NCT03377361|594231069|FG002|Treatment Period|Subject Withdrew Consent|0|||
164508289|NCT03377361|594231070|FG003|Treatment Period|Subject Withdrew Consent|0|||
164508290|NCT03377361|594231071|FG004|Treatment Period|Subject Withdrew Consent|0|||
164508291|NCT03377361|594231072|FG005|Treatment Period|Subject Withdrew Consent|0|||
164508292|NCT03377361|594231073|FG006|Treatment Period|Subject Withdrew Consent|0|||
164508293|NCT03377361|594231074|FG007|Treatment Period|Subject Withdrew Consent|0|||
164508294|NCT03377361|594231075|FG008|Treatment Period|Subject Withdrew Consent|2|||
164508295|NCT03377361|594231076|FG009|Treatment Period|Subject Withdrew Consent|1|||
164508296|NCT03377361|594231067|FG000|Treatment Period|No longer meets study criteria|0|||
164508297|NCT03377361|594231068|FG001|Treatment Period|No longer meets study criteria|1|||
164508298|NCT03377361|594231069|FG002|Treatment Period|No longer meets study criteria|0|||
164607831|NCT01628393|594585462|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
164607832|NCT01628393|594585463|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
164607833|NCT01628393|594585459|FG000|Blinded Active Extension Period|Adverse Event|0|||
164607834|NCT01628393|594585460|FG001|Blinded Active Extension Period|Adverse Event|1|||
164607835|NCT01628393|594585461|FG002|Blinded Active Extension Period|Adverse Event|0|||
164508299|NCT03377361|594231070|FG003|Treatment Period|No longer meets study criteria|0|||
164508300|NCT03377361|594231071|FG004|Treatment Period|No longer meets study criteria|0|||
164607836|NCT01628393|594585462|FG003|Blinded Active Extension Period|Adverse Event|2|||
164607837|NCT01628393|594585463|FG004|Blinded Active Extension Period|Adverse Event|2|||
164607838|NCT01628393|594585459|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
164607839|NCT01628393|594585460|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
164607840|NCT01628393|594585461|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
164607841|NCT01628393|594585462|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
164607842|NCT01628393|594585463|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
164607843|NCT01628393|594585459|FG000|Blinded Active Extension Period|Physician Decision|0|||
164607844|NCT01628393|594585460|FG001|Blinded Active Extension Period|Physician Decision|3|||
164607845|NCT01628393|594585461|FG002|Blinded Active Extension Period|Physician Decision|0|||
164607846|NCT01628393|594585462|FG003|Blinded Active Extension Period|Physician Decision|1|||
164607847|NCT01628393|594585463|FG004|Blinded Active Extension Period|Physician Decision|0|||
164607848|NCT01628393|594585459|FG000|Blinded Active Extension Period|Protocol Violation|0|||
164607849|NCT01628393|594585460|FG001|Blinded Active Extension Period|Protocol Violation|0|||
164607850|NCT01628393|594585461|FG002|Blinded Active Extension Period|Protocol Violation|2|||
164607851|NCT01628393|594585462|FG003|Blinded Active Extension Period|Protocol Violation|1|||
164607852|NCT01628393|594585463|FG004|Blinded Active Extension Period|Protocol Violation|0|||
164607853|NCT01628393|594585459|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
164607854|NCT01628393|594585460|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
164607855|NCT01628393|594585461|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
164607856|NCT01628393|594585462|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
164607857|NCT01628393|594585463|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
164607858|NCT04603391|594585468|FG000|First Intervention (4 Days)|Adverse Event|1|||
164607859|NCT04603391|594585469|FG001|First Intervention (4 Days)|Adverse Event|0|||
164607860|NCT04603391|594585468|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
164607861|NCT04603391|594585469|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
164607862|NCT02759861|594585472|FG000|Overall Study|Death|1|||
164607863|NCT02151682|594585473|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
164607864|NCT02151682|594585474|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
164607865|NCT02151682|594585475|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
164607866|NCT02151682|594585476|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
164607867|NCT02151682|594585477|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
164607868|NCT02151682|594585478|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
164607869|NCT02151682|594585473|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
164607870|NCT02151682|594585474|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
164607871|NCT02151682|594585475|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
164607872|NCT02151682|594585476|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
164607873|NCT02151682|594585477|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
164607874|NCT02151682|594585478|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
164607875|NCT02151682|594585473|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
164607876|NCT02151682|594585474|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
164607877|NCT02151682|594585475|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
164607878|NCT02151682|594585476|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
164607879|NCT02151682|594585477|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
164508301|NCT03377361|594231072|FG005|Treatment Period|No longer meets study criteria|0|||
164508302|NCT03377361|594231073|FG006|Treatment Period|No longer meets study criteria|0|||
164508303|NCT03377361|594231074|FG007|Treatment Period|No longer meets study criteria|1|||
164508304|NCT03377361|594231075|FG008|Treatment Period|No longer meets study criteria|0|||
164508305|NCT03377361|594231076|FG009|Treatment Period|No longer meets study criteria|0|||
164508306|NCT03377361|594231067|FG000|Treatment Period|Other Reasons|0|||
164508307|NCT03377361|594231068|FG001|Treatment Period|Other Reasons|0|||
164508308|NCT03377361|594231069|FG002|Treatment Period|Other Reasons|0|||
164508309|NCT03377361|594231070|FG003|Treatment Period|Other Reasons|3|||
164508310|NCT03377361|594231071|FG004|Treatment Period|Other Reasons|0|||
164508311|NCT03377361|594231072|FG005|Treatment Period|Other Reasons|0|||
164508312|NCT03377361|594231073|FG006|Treatment Period|Other Reasons|0|||
164508313|NCT03377361|594231074|FG007|Treatment Period|Other Reasons|2|||
164508314|NCT03377361|594231075|FG008|Treatment Period|Other Reasons|0|||
164508315|NCT03377361|594231076|FG009|Treatment Period|Other Reasons|1|||
164508316|NCT00742326|594231077|FG000|Overall Study|Physician Decision|0|||
164508317|NCT00742326|594231078|FG001|Overall Study|Physician Decision|1|||
164508318|NCT03698994|594231089|FG000|Overall Study|Adverse Event|2|||
164508319|NCT03698994|594231089|FG000|Overall Study|Death|1|||
164508320|NCT03698994|594231089|FG000|Overall Study|Physician Decision|1|||
164508321|NCT03698994|594231089|FG000|Overall Study|Withdrawal by Subject|3|||
164508322|NCT03698994|594231089|FG000|Overall Study|Progressive Disease|12|||
164508323|NCT03635086|594231095|FG000|Overall Study|Withdrawal of consent|0|||
164508324|NCT03635086|594231096|FG001|Overall Study|Withdrawal of consent|0|||
164508325|NCT03635086|594231097|FG002|Overall Study|Withdrawal of consent|1|||
164508326|NCT03635086|594231098|FG003|Overall Study|Withdrawal of consent|0|||
164508327|NCT03635086|594231099|FG004|Overall Study|Withdrawal of consent|0|||
164508328|NCT03635086|594231095|FG000|Overall Study|Adverse Event|0|||
164508329|NCT03635086|594231096|FG001|Overall Study|Adverse Event|1|||
164508330|NCT03635086|594231097|FG002|Overall Study|Adverse Event|0|||
164508331|NCT03635086|594231098|FG003|Overall Study|Adverse Event|0|||
164508332|NCT03635086|594231099|FG004|Overall Study|Adverse Event|0|||
164508333|NCT03635086|594231095|FG000|Overall Study|Lost to Follow-up|1|||
164508334|NCT03635086|594231096|FG001|Overall Study|Lost to Follow-up|0|||
164508335|NCT03635086|594231097|FG002|Overall Study|Lost to Follow-up|0|||
164508336|NCT03635086|594231098|FG003|Overall Study|Lost to Follow-up|0|||
164508337|NCT03635086|594231099|FG004|Overall Study|Lost to Follow-up|0|||
164508338|NCT03000348|594231100|FG000|Overall Study|Adverse Event|1|||
164508339|NCT03000348|594231101|FG001|Overall Study|Adverse Event|1|||
164508340|NCT03000348|594231102|FG002|Overall Study|Adverse Event|1|||
164508341|NCT03000348|594231103|FG003|Overall Study|Adverse Event|1|||
164508342|NCT03000348|594231104|FG004|Overall Study|Adverse Event|1|||
164508343|NCT03000348|594231105|FG005|Overall Study|Adverse Event|1|||
164508344|NCT03000348|594231100|FG000|Overall Study|Lost to Follow-up|0|||
164508345|NCT03000348|594231101|FG001|Overall Study|Lost to Follow-up|0|||
164508346|NCT03000348|594231102|FG002|Overall Study|Lost to Follow-up|1|||
164508347|NCT03000348|594231103|FG003|Overall Study|Lost to Follow-up|0|||
164508348|NCT03000348|594231104|FG004|Overall Study|Lost to Follow-up|0|||
164508349|NCT03000348|594231105|FG005|Overall Study|Lost to Follow-up|0|||
164508350|NCT03000348|594231100|FG000|Overall Study|Withdrawal by Subject|0|||
164508351|NCT03000348|594231101|FG001|Overall Study|Withdrawal by Subject|1|||
164508352|NCT03000348|594231102|FG002|Overall Study|Withdrawal by Subject|0|||
164508353|NCT03000348|594231103|FG003|Overall Study|Withdrawal by Subject|0|||
164508354|NCT03000348|594231104|FG004|Overall Study|Withdrawal by Subject|0|||
164508355|NCT03000348|594231105|FG005|Overall Study|Withdrawal by Subject|0|||
164508356|NCT03000348|594231100|FG000|Overall Study|Consent|0|||
164508357|NCT03000348|594231101|FG001|Overall Study|Consent|0|||
164508358|NCT03000348|594231102|FG002|Overall Study|Consent|0|||
164508359|NCT03000348|594231103|FG003|Overall Study|Consent|0|||
164508360|NCT03000348|594231104|FG004|Overall Study|Consent|1|||
164508361|NCT03000348|594231105|FG005|Overall Study|Consent|0|||
164508362|NCT03000348|594231100|FG000|Overall Study|Failure to expectorate sputum|1|||
164508363|NCT03000348|594231101|FG001|Overall Study|Failure to expectorate sputum|0|||
164508364|NCT03000348|594231102|FG002|Overall Study|Failure to expectorate sputum|1|||
164508365|NCT03000348|594231103|FG003|Overall Study|Failure to expectorate sputum|0|||
164508366|NCT03000348|594231104|FG004|Overall Study|Failure to expectorate sputum|1|||
164508367|NCT03000348|594231105|FG005|Overall Study|Failure to expectorate sputum|0|||
164508368|NCT03000348|594231100|FG000|Overall Study|No gram negative|1|||
164508369|NCT03000348|594231101|FG001|Overall Study|No gram negative|2|||
164508370|NCT03000348|594231102|FG002|Overall Study|No gram negative|1|||
164508371|NCT03000348|594231103|FG003|Overall Study|No gram negative|1|||
164508372|NCT03000348|594231104|FG004|Overall Study|No gram negative|1|||
164508373|NCT03000348|594231105|FG005|Overall Study|No gram negative|1|||
164508374|NCT03000348|594231100|FG000|Overall Study|Patient had no transport|0|||
164508375|NCT03000348|594231101|FG001|Overall Study|Patient had no transport|0|||
164508376|NCT03000348|594231102|FG002|Overall Study|Patient had no transport|0|||
164508377|NCT03000348|594231103|FG003|Overall Study|Patient had no transport|1|||
164508378|NCT03000348|594231104|FG004|Overall Study|Patient had no transport|0|||
164508379|NCT03000348|594231105|FG005|Overall Study|Patient had no transport|0|||
164508380|NCT03000348|594231100|FG000|Overall Study|Dosing|0|||
164508381|NCT03000348|594231101|FG001|Overall Study|Dosing|0|||
164508382|NCT03000348|594231102|FG002|Overall Study|Dosing|0|||
164508383|NCT03000348|594231103|FG003|Overall Study|Dosing|0|||
164508384|NCT03000348|594231104|FG004|Overall Study|Dosing|1|||
164508385|NCT03000348|594231105|FG005|Overall Study|Dosing|0|||
164508386|NCT01667549|594231108|FG000|Overall Study|Withdrawal by Subject|3|||
164508387|NCT01667549|594231109|FG001|Overall Study|Withdrawal by Subject|5|||
164508388|NCT01667549|594231110|FG002|Overall Study|Withdrawal by Subject|7|||
164508389|NCT01667549|594231111|FG003|Overall Study|Withdrawal by Subject|6|||
164508390|NCT01667549|594231112|FG004|Overall Study|Withdrawal by Subject|1|||
164508391|NCT01407276|594231113|FG000|Overall Study|Withdrawal by Subject|0|||
164508392|NCT01407276|594231114|FG001|Overall Study|Withdrawal by Subject|0|||
164508393|NCT01407276|594231115|FG002|Overall Study|Withdrawal by Subject|0|||
164508394|NCT01407276|594231116|FG003|Overall Study|Withdrawal by Subject|0|||
164508395|NCT01407276|594231117|FG004|Overall Study|Withdrawal by Subject|0|||
164508396|NCT01407276|594231118|FG005|Overall Study|Withdrawal by Subject|0|||
164508397|NCT01407276|594231119|FG006|Overall Study|Withdrawal by Subject|0|||
164508398|NCT01407276|594231120|FG007|Overall Study|Withdrawal by Subject|1|||
164508399|NCT03482752|594231124|FG000|Overall Study|Withdrawal by Subject|2|||
164508400|NCT03482752|594231124|FG000|Overall Study|Lost to Follow-up|1|||
164508401|NCT03482752|594231124|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
164508402|NCT01807182|594231126|FG000|Overall Study|Death|1|||
164508403|NCT01807182|594231126|FG000|Overall Study|New therapy|1|||
164508404|NCT01807182|594231126|FG000|Overall Study|Moved to hospice care|1|||
164508405|NCT02844777|594231127|FG000|Overall Study|Withdrawal by Subject|2|||
164508406|NCT02844777|594231128|FG001|Overall Study|Withdrawal by Subject|0|||
164508407|NCT02844777|594231129|FG002|Overall Study|Withdrawal by Subject|0|||
164607880|NCT02151682|594585478|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
164607881|NCT02151682|594585473|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
164607882|NCT02151682|594585474|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
164607883|NCT02151682|594585475|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
164607884|NCT02151682|594585476|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
164607885|NCT02151682|594585477|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
164607886|NCT02151682|594585478|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
164607887|NCT02151682|594585473|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
164607888|NCT02151682|594585474|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
164607889|NCT02151682|594585475|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
164607890|NCT02151682|594585476|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
164607891|NCT02151682|594585477|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
164607892|NCT02151682|594585478|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
164607893|NCT02151682|594585473|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
164607894|NCT02151682|594585474|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
164607895|NCT02151682|594585475|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
164607896|NCT02151682|594585476|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
164607897|NCT02151682|594585477|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
164607898|NCT02151682|594585478|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
164607899|NCT02151682|594585473|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
164607900|NCT02151682|594585474|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
164607901|NCT02151682|594585475|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
164607902|NCT02151682|594585476|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
164607903|NCT02151682|594585477|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
164607904|NCT02151682|594585478|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
164607905|NCT02151682|594585473|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
164607906|NCT02151682|594585474|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
164607907|NCT02151682|594585475|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
164607908|NCT02151682|594585476|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
164607909|NCT02151682|594585477|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
164607910|NCT02151682|594585478|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
164607911|NCT02151682|594585473|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
164607912|NCT02151682|594585474|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
164607913|NCT02151682|594585475|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
164607914|NCT02151682|594585476|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
164607915|NCT02151682|594585477|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
164607916|NCT02151682|594585478|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
164607917|NCT02151682|594585473|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
164607918|NCT02151682|594585474|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
164607919|NCT02151682|594585475|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
164607920|NCT02151682|594585476|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
164607921|NCT02151682|594585477|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
164607922|NCT02151682|594585478|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
164607923|NCT02151682|594585473|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
164607924|NCT02151682|594585474|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
164607925|NCT02151682|594585475|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
164607926|NCT02151682|594585476|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
164607927|NCT02151682|594585477|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
164607928|NCT02151682|594585478|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
164607929|NCT02151682|594585473|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
164607930|NCT02151682|594585474|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
164607931|NCT02151682|594585475|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
164607932|NCT02151682|594585476|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
164607933|NCT02151682|594585477|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
164607934|NCT02151682|594585478|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
164607935|NCT02151682|594585473|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
164607936|NCT02151682|594585474|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
164607937|NCT02151682|594585475|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
164607938|NCT02151682|594585476|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
164607939|NCT02151682|594585477|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
164607940|NCT02151682|594585478|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
164607941|NCT02151682|594585473|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
164607942|NCT02151682|594585474|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
164607943|NCT02151682|594585475|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
164607944|NCT02151682|594585476|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
164508408|NCT01776008|594231130|FG000|Overall Study|ineligible|2|||
164508409|NCT00150618|594231131|FG000|Overall Study|Adverse Event|2|||
164508410|NCT00150618|594231132|FG001|Overall Study|Adverse Event|2|||
164508411|NCT00150618|594231133|FG002|Overall Study|Adverse Event|6|||
164508412|NCT00150618|594231134|FG003|Overall Study|Adverse Event|9|||
164508413|NCT00150618|594231135|FG004|Overall Study|Adverse Event|5|||
164508414|NCT00150618|594231131|FG000|Overall Study|Withdrawal by Subject|6|||
164508415|NCT00150618|594231132|FG001|Overall Study|Withdrawal by Subject|8|||
164508416|NCT00150618|594231133|FG002|Overall Study|Withdrawal by Subject|8|||
164508417|NCT00150618|594231134|FG003|Overall Study|Withdrawal by Subject|4|||
164508418|NCT00150618|594231135|FG004|Overall Study|Withdrawal by Subject|5|||
164508419|NCT00150618|594231131|FG000|Overall Study|Lost to Follow-up|4|||
164508420|NCT00150618|594231132|FG001|Overall Study|Lost to Follow-up|1|||
164508421|NCT00150618|594231133|FG002|Overall Study|Lost to Follow-up|5|||
164508422|NCT00150618|594231134|FG003|Overall Study|Lost to Follow-up|8|||
164508423|NCT00150618|594231135|FG004|Overall Study|Lost to Follow-up|4|||
164508424|NCT00150618|594231131|FG000|Overall Study|Protocol Violation|1|||
164508425|NCT00150618|594231132|FG001|Overall Study|Protocol Violation|0|||
164508426|NCT00150618|594231133|FG002|Overall Study|Protocol Violation|0|||
164508427|NCT00150618|594231134|FG003|Overall Study|Protocol Violation|0|||
164508428|NCT00150618|594231135|FG004|Overall Study|Protocol Violation|1|||
164508429|NCT00150618|594231131|FG000|Overall Study|Lack of Efficacy|1|||
164508430|NCT00150618|594231132|FG001|Overall Study|Lack of Efficacy|4|||
164508431|NCT00150618|594231133|FG002|Overall Study|Lack of Efficacy|7|||
164508432|NCT00150618|594231134|FG003|Overall Study|Lack of Efficacy|4|||
164508433|NCT00150618|594231135|FG004|Overall Study|Lack of Efficacy|6|||
164508434|NCT00150618|594231131|FG000|Overall Study|No study meds|0|||
164508435|NCT00150618|594231132|FG001|Overall Study|No study meds|0|||
164508436|NCT00150618|594231133|FG002|Overall Study|No study meds|0|||
164508437|NCT00150618|594231134|FG003|Overall Study|No study meds|0|||
164508438|NCT00150618|594231135|FG004|Overall Study|No study meds|2|||
164508439|NCT00150618|594231131|FG000|Overall Study|Physician Decision|0|||
164508440|NCT00150618|594231132|FG001|Overall Study|Physician Decision|2|||
164508441|NCT00150618|594231133|FG002|Overall Study|Physician Decision|0|||
164508442|NCT00150618|594231134|FG003|Overall Study|Physician Decision|0|||
164508443|NCT00150618|594231135|FG004|Overall Study|Physician Decision|1|||
164508444|NCT00150618|594231131|FG000|Overall Study|Lack of compliance|2|||
164508445|NCT00150618|594231132|FG001|Overall Study|Lack of compliance|1|||
164508446|NCT00150618|594231133|FG002|Overall Study|Lack of compliance|1|||
164508447|NCT00150618|594231134|FG003|Overall Study|Lack of compliance|0|||
164508448|NCT00150618|594231135|FG004|Overall Study|Lack of compliance|1|||
164508449|NCT00150618|594231131|FG000|Overall Study|Abnormal ECG|1|||
164508450|NCT00150618|594231132|FG001|Overall Study|Abnormal ECG|0|||
164508451|NCT00150618|594231133|FG002|Overall Study|Abnormal ECG|0|||
164508452|NCT00150618|594231134|FG003|Overall Study|Abnormal ECG|0|||
164508453|NCT00150618|594231135|FG004|Overall Study|Abnormal ECG|0|||
164508454|NCT00150618|594231131|FG000|Overall Study|Sponsor's decision|0|||
164508455|NCT00150618|594231132|FG001|Overall Study|Sponsor's decision|0|||
164508456|NCT00150618|594231133|FG002|Overall Study|Sponsor's decision|0|||
164508457|NCT00150618|594231134|FG003|Overall Study|Sponsor's decision|1|||
164508458|NCT00150618|594231135|FG004|Overall Study|Sponsor's decision|0|||
164508459|NCT04092452|594231136|FG000|Overall Study|Adverse Event|1|||
164508460|NCT04092452|594231137|FG001|Overall Study|Adverse Event|3|||
164508461|NCT04092452|594231138|FG002|Overall Study|Adverse Event|3|||
164508462|NCT04092452|594231139|FG003|Overall Study|Adverse Event|7|||
164508463|NCT04092452|594231136|FG000|Overall Study|Lack of Efficacy|1|||
164508464|NCT04092452|594231137|FG001|Overall Study|Lack of Efficacy|1|||
164508465|NCT04092452|594231138|FG002|Overall Study|Lack of Efficacy|1|||
164508466|NCT04092452|594231139|FG003|Overall Study|Lack of Efficacy|0|||
164508467|NCT04092452|594231136|FG000|Overall Study|Lost to Follow-up|4|||
164508468|NCT04092452|594231137|FG001|Overall Study|Lost to Follow-up|3|||
164508469|NCT04092452|594231138|FG002|Overall Study|Lost to Follow-up|5|||
164508470|NCT04092452|594231139|FG003|Overall Study|Lost to Follow-up|1|||
164508471|NCT04092452|594231136|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164607945|NCT02151682|594585477|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
164607946|NCT02151682|594585478|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
164607947|NCT02151682|594585473|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
164607948|NCT02151682|594585474|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
164607949|NCT02151682|594585475|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
164607950|NCT02151682|594585476|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
164607951|NCT02151682|594585477|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
164607952|NCT02151682|594585478|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
164607953|NCT02151682|594585473|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
164607954|NCT02151682|594585474|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
164607955|NCT02151682|594585475|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
164607956|NCT02151682|594585476|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
164607957|NCT02151682|594585477|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
164607958|NCT02151682|594585478|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
164607959|NCT02151682|594585473|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
164607960|NCT02151682|594585474|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
164607961|NCT02151682|594585475|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
164607962|NCT02151682|594585476|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
164607963|NCT02151682|594585477|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
164607964|NCT02151682|594585478|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
164607965|NCT02151682|594585473|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
164607966|NCT02151682|594585474|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
164607967|NCT02151682|594585475|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
164607968|NCT02151682|594585476|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
164607969|NCT02151682|594585477|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
164607970|NCT02151682|594585478|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
164607971|NCT02988219|594585479|FG000|Overall Study|Lack of Efficacy|1|||
164607972|NCT02988219|594585480|FG001|Overall Study|Lack of Efficacy|1|||
164607973|NCT02988219|594585479|FG000|Overall Study|Withdrawal by Subject|0|||
164607974|NCT02988219|594585480|FG001|Overall Study|Withdrawal by Subject|2|||
164607975|NCT01306032|594585481|FG000|First Intervention|Adverse Event|1|||
164607976|NCT01306032|594585482|FG001|First Intervention|Adverse Event|0|||
164607977|NCT01306032|594585483|FG002|First Intervention|Adverse Event|1|||
164607978|NCT01306032|594585484|FG003|First Intervention|Adverse Event|0|||
164607979|NCT01306032|594585485|FG004|First Intervention|Adverse Event|0|||
164607980|NCT01306032|594585486|FG005|First Intervention|Adverse Event|1|||
164607981|NCT01306032|594585481|FG000|First Intervention|Withdrawal by Subject|0|||
164607982|NCT01306032|594585482|FG001|First Intervention|Withdrawal by Subject|2|||
164607983|NCT01306032|594585483|FG002|First Intervention|Withdrawal by Subject|0|||
164607984|NCT01306032|594585484|FG003|First Intervention|Withdrawal by Subject|1|||
164607985|NCT01306032|594585485|FG004|First Intervention|Withdrawal by Subject|0|||
164607986|NCT01306032|594585486|FG005|First Intervention|Withdrawal by Subject|0|||
164607987|NCT01306032|594585481|FG000|First Intervention|Death|0|||
164607988|NCT01306032|594585482|FG001|First Intervention|Death|0|||
164607989|NCT01306032|594585483|FG002|First Intervention|Death|1|||
164607990|NCT01306032|594585484|FG003|First Intervention|Death|0|||
164607991|NCT01306032|594585485|FG004|First Intervention|Death|0|||
164607992|NCT01306032|594585486|FG005|First Intervention|Death|0|||
164607993|NCT01306032|594585481|FG000|First Intervention|Ineligible|0|||
164607994|NCT01306032|594585482|FG001|First Intervention|Ineligible|0|||
164607995|NCT01306032|594585483|FG002|First Intervention|Ineligible|0|||
164607996|NCT01306032|594585484|FG003|First Intervention|Ineligible|0|||
164607997|NCT01306032|594585485|FG004|First Intervention|Ineligible|0|||
164607998|NCT01306032|594585486|FG005|First Intervention|Ineligible|1|||
164607999|NCT01306032|594585481|FG000|First Intervention|Progressive disease|0|||
164608000|NCT01306032|594585482|FG001|First Intervention|Progressive disease|0|||
164608001|NCT01306032|594585483|FG002|First Intervention|Progressive disease|0|||
164608002|NCT01306032|594585484|FG003|First Intervention|Progressive disease|0|||
164608003|NCT01306032|594585485|FG004|First Intervention|Progressive disease|2|||
164608004|NCT01306032|594585486|FG005|First Intervention|Progressive disease|0|||
164608005|NCT01306032|594585481|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
164608006|NCT01306032|594585482|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
164608007|NCT01306032|594585483|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
164608008|NCT01306032|594585484|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
164608009|NCT01306032|594585485|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
164608010|NCT01306032|594585486|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
164608011|NCT01306032|594585481|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
164608012|NCT01306032|594585482|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
164508472|NCT04092452|594231137|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164508473|NCT04092452|594231138|FG002|Overall Study|Non-Compliance With Study Drug|1|||
164508474|NCT04092452|594231139|FG003|Overall Study|Non-Compliance With Study Drug|1|||
164508475|NCT04092452|594231136|FG000|Overall Study|Physician Decision|1|||
164508476|NCT04092452|594231137|FG001|Overall Study|Physician Decision|0|||
164508477|NCT04092452|594231138|FG002|Overall Study|Physician Decision|1|||
164508478|NCT04092452|594231139|FG003|Overall Study|Physician Decision|0|||
164508479|NCT04092452|594231136|FG000|Overall Study|Pregnancy|2|||
164508480|NCT04092452|594231137|FG001|Overall Study|Pregnancy|0|||
164508481|NCT04092452|594231138|FG002|Overall Study|Pregnancy|0|||
164508482|NCT04092452|594231139|FG003|Overall Study|Pregnancy|0|||
164508483|NCT04092452|594231136|FG000|Overall Study|Protocol Deviation|1|||
164508484|NCT04092452|594231137|FG001|Overall Study|Protocol Deviation|0|||
164508485|NCT04092452|594231138|FG002|Overall Study|Protocol Deviation|0|||
164508486|NCT04092452|594231139|FG003|Overall Study|Protocol Deviation|0|||
164508487|NCT04092452|594231136|FG000|Overall Study|Withdrawal by Subject|3|||
164508488|NCT04092452|594231137|FG001|Overall Study|Withdrawal by Subject|10|||
164508489|NCT04092452|594231138|FG002|Overall Study|Withdrawal by Subject|3|||
164508490|NCT04092452|594231139|FG003|Overall Study|Withdrawal by Subject|5|||
164508491|NCT04092452|594231136|FG000|Overall Study|Other|0|||
164508492|NCT04092452|594231137|FG001|Overall Study|Other|0|||
164508493|NCT04092452|594231138|FG002|Overall Study|Other|1|||
164508494|NCT04092452|594231139|FG003|Overall Study|Other|2|||
164508495|NCT01162486|594231141|FG000|Overall Study|low ANC|1|||
164508496|NCT01162486|594231142|FG001|Overall Study|low ANC|0|||
164508497|NCT01162486|594231143|FG002|Overall Study|low ANC|0|||
164508498|NCT01162486|594231144|FG003|Overall Study|low ANC|0|||
164508499|NCT01162486|594231145|FG004|Overall Study|low ANC|0|||
164508500|NCT01162486|594231141|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
164508501|NCT01162486|594231142|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
164508502|NCT01162486|594231143|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
164508503|NCT01162486|594231144|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
164508504|NCT01162486|594231145|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
164508505|NCT01162486|594231141|FG000|Overall Study|elevated LFTs|0|||
164508506|NCT01162486|594231142|FG001|Overall Study|elevated LFTs|0|||
164508507|NCT01162486|594231143|FG002|Overall Study|elevated LFTs|1|||
164508508|NCT01162486|594231144|FG003|Overall Study|elevated LFTs|0|||
164508509|NCT01162486|594231145|FG004|Overall Study|elevated LFTs|0|||
164508510|NCT01162486|594231141|FG000|Overall Study|Pregnancy|0|||
164508511|NCT01162486|594231142|FG001|Overall Study|Pregnancy|0|||
164508512|NCT01162486|594231143|FG002|Overall Study|Pregnancy|0|||
164508513|NCT01162486|594231144|FG003|Overall Study|Pregnancy|1|||
164508514|NCT01162486|594231145|FG004|Overall Study|Pregnancy|0|||
164508515|NCT02296892|594231150|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
164508516|NCT02296892|594231151|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
164508517|NCT02296892|594231152|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
164508518|NCT02296892|594231150|FG000|Overall Study|Lost to Follow-up|5|||
164508519|NCT02296892|594231151|FG001|Overall Study|Lost to Follow-up|0|||
164508520|NCT02296892|594231152|FG002|Overall Study|Lost to Follow-up|1|||
164508521|NCT01056263|594231157|FG000|Overall Study|Adverse Event|12|||
164508522|NCT01056263|594231157|FG000|Overall Study|Death|1|||
164508523|NCT01056263|594231157|FG000|Overall Study|Withdrawal by Subject|1|||
164508524|NCT01056263|594231157|FG000|Overall Study|Lack of Efficacy|29|||
164508525|NCT01056263|594231157|FG000|Overall Study|Progressive disease|2|||
164508526|NCT01056263|594231157|FG000|Overall Study|Neoplasm progression|1|||
164508527|NCT01056263|594231157|FG000|Overall Study|Objective progression or relapse|1|||
164508528|NCT01056263|594231157|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
164508529|NCT03375320|594231162|FG000|Overall Study|Adverse Event|34|||
164508530|NCT03375320|594231163|FG001|Overall Study|Adverse Event|9|||
164508531|NCT03375320|594231164|FG002|Overall Study|Adverse Event|10|||
164508532|NCT03375320|594231165|FG003|Overall Study|Adverse Event|0|||
164508533|NCT03375320|594231162|FG000|Overall Study|Death|6|||
164508534|NCT03375320|594231163|FG001|Overall Study|Death|3|||
164508535|NCT03375320|594231164|FG002|Overall Study|Death|0|||
164508536|NCT03375320|594231165|FG003|Overall Study|Death|0|||
164508537|NCT03375320|594231162|FG000|Overall Study|Withdrawal by Subject|7|||
164508538|NCT03375320|594231163|FG001|Overall Study|Withdrawal by Subject|4|||
164508539|NCT03375320|594231164|FG002|Overall Study|Withdrawal by Subject|5|||
164508540|NCT03375320|594231165|FG003|Overall Study|Withdrawal by Subject|4|||
164508541|NCT03375320|594231162|FG000|Overall Study|Progressive disease|55|||
164508542|NCT03375320|594231163|FG001|Overall Study|Progressive disease|41|||
164508543|NCT03375320|594231164|FG002|Overall Study|Progressive disease|29|||
164508544|NCT03375320|594231165|FG003|Overall Study|Progressive disease|24|||
164508545|NCT03375320|594231162|FG000|Overall Study|Alternative treatment|6|||
164508546|NCT03375320|594231163|FG001|Overall Study|Alternative treatment|1|||
164508547|NCT03375320|594231164|FG002|Overall Study|Alternative treatment|1|||
164508548|NCT03375320|594231165|FG003|Overall Study|Alternative treatment|0|||
164508549|NCT03375320|594231162|FG000|Overall Study|Other disease|1|||
164508550|NCT03375320|594231163|FG001|Overall Study|Other disease|1|||
164508551|NCT03375320|594231164|FG002|Overall Study|Other disease|3|||
164508552|NCT03375320|594231165|FG003|Overall Study|Other disease|0|||
164508553|NCT03375320|594231162|FG000|Overall Study|Withdrawal prior to initiation|2|||
164508554|NCT03375320|594231163|FG001|Overall Study|Withdrawal prior to initiation|2|||
164508555|NCT03375320|594231164|FG002|Overall Study|Withdrawal prior to initiation|1|||
164508556|NCT03375320|594231165|FG003|Overall Study|Withdrawal prior to initiation|0|||
164508557|NCT03375320|594231162|FG000|Overall Study|Physician Decision|1|||
164508558|NCT03375320|594231163|FG001|Overall Study|Physician Decision|1|||
164508559|NCT03375320|594231164|FG002|Overall Study|Physician Decision|1|||
164508560|NCT03375320|594231165|FG003|Overall Study|Physician Decision|1|||
164508561|NCT03375320|594231162|FG000|Overall Study|Non-compliance|1|||
164508562|NCT03375320|594231163|FG001|Overall Study|Non-compliance|0|||
164508563|NCT03375320|594231164|FG002|Overall Study|Non-compliance|0|||
164508564|NCT03375320|594231165|FG003|Overall Study|Non-compliance|0|||
164508565|NCT01845805|594232816|FG000|Overall Study|Withdrawal by Subject|1|||
164508566|NCT01845805|594232817|FG001|Overall Study|Withdrawal by Subject|2|||
164508567|NCT01845805|594232816|FG000|Overall Study|Disease Progression|13|||
164508568|NCT01845805|594232817|FG001|Overall Study|Disease Progression|14|||
164508569|NCT01845805|594232816|FG000|Overall Study|Drug-related Toxicity|4|||
164508570|NCT01845805|594232817|FG001|Overall Study|Drug-related Toxicity|0|||
164508571|NCT03595124|594232821|FG000|Overall Study|Physician Decision|1|||
164508572|NCT03595124|594232822|FG001|Overall Study|Physician Decision|1|||
164508573|NCT03595124|594232823|FG002|Overall Study|Physician Decision|1|||
164508574|NCT03595124|594232821|FG000|Overall Study|Ineligible|1|||
164508575|NCT03595124|594232822|FG001|Overall Study|Ineligible|1|||
164508576|NCT03595124|594232823|FG002|Overall Study|Ineligible|0|||
164508577|NCT03595124|594232821|FG000|Overall Study|Disease Progression|4|||
164508578|NCT03595124|594232822|FG001|Overall Study|Disease Progression|1|||
164508579|NCT03595124|594232823|FG002|Overall Study|Disease Progression|4|||
164508580|NCT01888874|594232824|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
164508581|NCT01888874|594232825|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
164508582|NCT01888874|594232826|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
164508583|NCT01888874|594232827|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
164508584|NCT01888874|594232828|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
164508585|NCT01888874|594232829|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
164508586|NCT01888874|594232830|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
164508587|NCT01888874|594232824|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
164508588|NCT01888874|594232825|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
164508589|NCT01888874|594232826|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
164508590|NCT01888874|594232827|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
164508591|NCT01888874|594232828|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
164508592|NCT01888874|594232829|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
164508593|NCT01888874|594232830|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
164508594|NCT01888874|594232824|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
164508595|NCT01888874|594232825|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
164508596|NCT01888874|594232826|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
164508597|NCT01888874|594232827|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
164508598|NCT01888874|594232828|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
164508599|NCT01888874|594232829|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
164508600|NCT01888874|594232830|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
164508601|NCT01888874|594232824|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
164508602|NCT01888874|594232825|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
164508603|NCT01888874|594232826|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
164508604|NCT01888874|594232827|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
164508605|NCT01888874|594232828|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
164508606|NCT01888874|594232829|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
164508607|NCT01888874|594232830|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
164508608|NCT01888874|594232824|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
164508609|NCT01888874|594232825|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
164508610|NCT01888874|594232826|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
164508611|NCT01888874|594232827|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
164508612|NCT01888874|594232828|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
164508613|NCT01888874|594232829|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
164608013|NCT01306032|594585483|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
164608014|NCT01306032|594585484|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
164508614|NCT01888874|594232830|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
164508615|NCT01888874|594232824|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
164508616|NCT01888874|594232825|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
164508617|NCT01888874|594232826|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
164508618|NCT01888874|594232827|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
164508619|NCT01888874|594232828|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
164508620|NCT01888874|594232829|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
164508621|NCT01888874|594232830|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
164508622|NCT01888874|594232824|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
164508623|NCT01888874|594232825|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
164508624|NCT01888874|594232826|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
164508625|NCT01888874|594232827|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
164508626|NCT01888874|594232828|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
164508627|NCT01888874|594232829|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
164508628|NCT01888874|594232830|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
164508629|NCT01888874|594232824|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
164508630|NCT01888874|594232825|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
164508631|NCT01888874|594232826|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
164508632|NCT01888874|594232827|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
164508633|NCT01888874|594232828|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
164508634|NCT01888874|594232829|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
164508635|NCT01888874|594232830|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
164508636|NCT01888874|594232824|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
164508637|NCT01888874|594232825|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
164508638|NCT01888874|594232826|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
164508639|NCT01888874|594232827|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
164508640|NCT01888874|594232828|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
164508641|NCT01888874|594232829|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
164508642|NCT01888874|594232830|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
164508643|NCT01888874|594232824|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
164508644|NCT01888874|594232825|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
164508645|NCT01888874|594232826|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
164508646|NCT01888874|594232827|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
164508647|NCT01888874|594232828|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
164508648|NCT01888874|594232829|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
164508649|NCT01888874|594232830|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
164508650|NCT01888874|594232824|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
164508651|NCT01888874|594232825|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
164508652|NCT01888874|594232826|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
164508653|NCT01888874|594232827|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
164508654|NCT01888874|594232828|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
164508655|NCT01888874|594232829|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
164508656|NCT01888874|594232830|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
164508657|NCT01888874|594232824|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
164508658|NCT01888874|594232825|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
164508659|NCT01888874|594232826|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
164508660|NCT01888874|594232827|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
164508661|NCT01888874|594232828|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
164508662|NCT01888874|594232829|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
164508663|NCT01888874|594232830|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
164508664|NCT01888874|594232824|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
164508665|NCT01888874|594232825|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
164508666|NCT01888874|594232826|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
164508667|NCT01888874|594232827|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
164508668|NCT01888874|594232828|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
164508669|NCT01888874|594232829|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
164508670|NCT01888874|594232830|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
164508671|NCT02763215|594232831|FG000|Overall Study|Participants withdrew from study|3|||
164508672|NCT02763215|594232831|FG000|Overall Study|Missed visit|1|||
164508673|NCT02763215|594232831|FG000|Overall Study|Visit outside visit-window|1|||
164508674|NCT02763215|594232831|FG000|Overall Study|Death|1|||
164508675|NCT02763215|594232831|FG000|Overall Study|Lost to Follow-up|1|||
164508676|NCT02963090|594232835|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
164508677|NCT02963090|594232836|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
164608015|NCT01306032|594585485|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
164608016|NCT01306032|594585486|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
164608017|NCT01213264|594585487|FG000|Overall Study|Adverse Event|1|||
164608018|NCT01213264|594585488|FG001|Overall Study|Adverse Event|0|||
164608019|NCT01213264|594585489|FG002|Overall Study|Adverse Event|0|||
164608020|NCT01213264|594585487|FG000|Overall Study|Lost to Follow-up|1|||
164608021|NCT01213264|594585488|FG001|Overall Study|Lost to Follow-up|2|||
164608022|NCT01213264|594585489|FG002|Overall Study|Lost to Follow-up|6|||
164608023|NCT01522443|594585492|FG000|Overall Study|No longer receiving clinical benefit|36|||
164608024|NCT01522443|594585493|FG001|Overall Study|No longer receiving clinical benefit|28|||
164608025|NCT01522443|594585492|FG000|Overall Study|Adverse Event|10|||
164608026|NCT01522443|594585493|FG001|Overall Study|Adverse Event|15|||
164608027|NCT01522443|594585492|FG000|Overall Study|Withdrawal by Subject|5|||
164608028|NCT01522443|594585493|FG001|Overall Study|Withdrawal by Subject|8|||
164608029|NCT01522443|594585492|FG000|Overall Study|No study treatment given|1|||
164608030|NCT01522443|594585493|FG001|Overall Study|No study treatment given|1|||
164608031|NCT01522443|594585492|FG000|Overall Study|Other|1|||
164608032|NCT01522443|594585493|FG001|Overall Study|Other|3|||
164608033|NCT03260894|594585494|FG000|Overall Study|Death|6|||
164608034|NCT03260894|594585495|FG001|Overall Study|Death|8|||
164608035|NCT03260894|594585494|FG000|Overall Study|Withdrawal by Subject|4|||
164608036|NCT03260894|594585495|FG001|Overall Study|Withdrawal by Subject|11|||
164608037|NCT03260894|594585494|FG000|Overall Study|On-going at clinical cut off date|36|||
164608038|NCT03260894|594585495|FG001|Overall Study|On-going at clinical cut off date|31|||
164608039|NCT01700985|594585496|FG000|Overall Study|Incarcerated|0|||
164608040|NCT01700985|594585497|FG001|Overall Study|Incarcerated|1|||
164608041|NCT02677220|594585498|FG000|Overall Study|Adverse Event|1|||
164608042|NCT00067470|594585499|FG000|Overall Study|Withdrawal by Subject|0|||
164608043|NCT00067470|594585500|FG001|Overall Study|Withdrawal by Subject|1|||
164608044|NCT01148693|594585501|FG000|Overall Study|Attempts for cannulation were failed|13|||
164608045|NCT01148693|594585502|FG001|Overall Study|Attempts for cannulation were failed|10|||
164608046|NCT01074658|594585504|FG000|Overall Study|No implant attempted|19|||
164608047|NCT00050622|594585505|FG000|Overall Study|Adverse Event|1|||
164608048|NCT01342952|594585506|FG000|Overall Study|Adverse Event|0|||
164608049|NCT01342952|594585507|FG001|Overall Study|Adverse Event|5|||
164608050|NCT01342952|594585508|FG002|Overall Study|Adverse Event|1|||
164608051|NCT01342952|594585509|FG003|Overall Study|Adverse Event|0|||
164608052|NCT01342952|594585506|FG000|Overall Study|Lost to Follow-up|0|||
164608053|NCT01342952|594585507|FG001|Overall Study|Lost to Follow-up|2|||
164608054|NCT01342952|594585508|FG002|Overall Study|Lost to Follow-up|0|||
164608055|NCT01342952|594585509|FG003|Overall Study|Lost to Follow-up|0|||
164608056|NCT01342952|594585506|FG000|Overall Study|Withdrawal by Subject|1|||
164608057|NCT01342952|594585507|FG001|Overall Study|Withdrawal by Subject|1|||
164608058|NCT01342952|594585508|FG002|Overall Study|Withdrawal by Subject|0|||
164608059|NCT01342952|594585509|FG003|Overall Study|Withdrawal by Subject|0|||
164608060|NCT01342952|594585506|FG000|Overall Study|Physician Decision|3|||
164608061|NCT01342952|594585507|FG001|Overall Study|Physician Decision|3|||
164608062|NCT01342952|594585508|FG002|Overall Study|Physician Decision|1|||
164608063|NCT01342952|594585509|FG003|Overall Study|Physician Decision|0|||
164608064|NCT00426556|594585510|FG000|Phase I - Core Phase|Disease Progression|0|||
164608065|NCT00426556|594585511|FG001|Phase I - Core Phase|Disease Progression|6|||
164608066|NCT00426556|594585512|FG002|Phase I - Core Phase|Disease Progression|2|||
164608067|NCT00426556|594585513|FG003|Phase I - Core Phase|Disease Progression|0|||
164608068|NCT00426556|594585510|FG000|Phase I - Core Phase|Adverse Event|1|||
164608069|NCT00426556|594585511|FG001|Phase I - Core Phase|Adverse Event|3|||
164608070|NCT00426556|594585512|FG002|Phase I - Core Phase|Adverse Event|1|||
164608071|NCT00426556|594585513|FG003|Phase I - Core Phase|Adverse Event|0|||
164608072|NCT00426556|594585510|FG000|Phase I - Core Phase|Death|0|||
164608073|NCT00426556|594585511|FG001|Phase I - Core Phase|Death|1|||
164608074|NCT00426556|594585512|FG002|Phase I - Core Phase|Death|0|||
164608075|NCT00426556|594585513|FG003|Phase I - Core Phase|Death|0|||
164608076|NCT00426556|594585510|FG000|Phase I - Extension Phase|Adverse Event|0|||
164608077|NCT00426556|594585511|FG001|Phase I - Extension Phase|Adverse Event|1|||
164608078|NCT00426556|594585512|FG002|Phase I - Extension Phase|Adverse Event|1|||
164608079|NCT00426556|594585513|FG003|Phase I - Extension Phase|Adverse Event|0|||
164508678|NCT01784523|594232837|FG000|Overall Study|Study closed early|7|||
164508679|NCT01784523|594232838|FG001|Overall Study|Study closed early|4|||
164508680|NCT00709228|594232839|FG000|Overall Study|Not treated|14|||
164508681|NCT00709228|594232839|FG000|Overall Study|Eligibility criteria not met|281|||
164508682|NCT00709228|594232839|FG000|Overall Study|Adverse events|2|||
164508683|NCT00709228|594232839|FG000|Overall Study|Discontinued treatment|14|||
164508684|NCT00709228|594232839|FG000|Overall Study|Did not enter follow-up|4|||
164508685|NCT00709228|594232839|FG000|Overall Study|Discontinued follow-up|5|||
164508686|NCT00709228|594232839|FG000|Overall Study|Disease progression|1|||
164508687|NCT00709228|594232839|FG000|Overall Study|Lost to Follow-up|6|||
164508688|NCT00709228|594232839|FG000|Overall Study|Non-compliance|5|||
164508689|NCT02179177|594232840|FG000|Overall Study|Lost to Follow-up|1|||
164508690|NCT02179177|594232841|FG001|Overall Study|Lost to Follow-up|1|||
164508691|NCT02179177|594232840|FG000|Overall Study|Withdrawal by Subject|1|||
164508692|NCT02179177|594232841|FG001|Overall Study|Withdrawal by Subject|1|||
164508693|NCT00022659|594232842|FG000|Overall Study|Ineligible: wrong primary|1|||
164508694|NCT00022659|594232842|FG000|Overall Study|Never treated|1|||
164508695|NCT00884650|594232843|FG000|Overall Study|Did not return complete pain diaries|7|||
164508696|NCT00884650|594232844|FG001|Overall Study|Did not return complete pain diaries|7|||
164508697|NCT00884650|594232843|FG000|Overall Study|Admitted Post-Op|1|||
164508698|NCT00884650|594232844|FG001|Overall Study|Admitted Post-Op|0|||
164508699|NCT00884650|594232843|FG000|Overall Study|Femoral Stress Fracture|1|||
164508700|NCT00884650|594232844|FG001|Overall Study|Femoral Stress Fracture|0|||
164508701|NCT00884650|594232843|FG000|Overall Study|Pain Pump Complication|0|||
164508702|NCT00884650|594232844|FG001|Overall Study|Pain Pump Complication|1|||
164508703|NCT04334278|594232845|FG000|Overall Study|Lost to Follow-up|0|||
164508704|NCT04334278|594232846|FG001|Overall Study|Lost to Follow-up|3|||
164508705|NCT04334278|594232845|FG000|Overall Study|Withdrawal by Subject|4|||
164508706|NCT04334278|594232846|FG001|Overall Study|Withdrawal by Subject|2|||
164508707|NCT04829747|594232847|FG000|Overall Study|Protocol Violation|1|||
164508708|NCT05878873|594232848|FG000|Overall Study|Lost to Follow-up|2|||
164508709|NCT05878873|594232849|FG001|Overall Study|Lost to Follow-up|0|||
164508710|NCT01516749|594232854|FG000|Active Therapy|Lost to Follow-up|1|||
164508711|NCT01516749|594232854|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
164508712|NCT01732549|594232855|FG000|Overall Study|Adverse Event|13|||
164508713|NCT01732549|594232856|FG001|Overall Study|Adverse Event|3|||
164508714|NCT01732549|594232855|FG000|Overall Study|Consent withdrawn|13|||
164508715|NCT01732549|594232856|FG001|Overall Study|Consent withdrawn|6|||
164508716|NCT01732549|594232855|FG000|Overall Study|Disease progression|37|||
164508717|NCT01732549|594232856|FG001|Overall Study|Disease progression|50|||
164508718|NCT01732549|594232855|FG000|Overall Study|Other|8|||
164508719|NCT01732549|594232856|FG001|Overall Study|Other|14|||
164508720|NCT00121667|594232857|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
164508721|NCT00121667|594232858|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
164508722|NCT00121667|594232859|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
164508723|NCT00121667|594232860|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
164508724|NCT00121667|594232857|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
164508725|NCT00121667|594232858|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
164508726|NCT00121667|594232859|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
164508727|NCT00121667|594232860|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
164508728|NCT00121667|594232857|FG000|Short Term (ST) Period|Adverse Event|5|||
164508729|NCT00121667|594232858|FG001|Short Term (ST) Period|Adverse Event|6|||
164508730|NCT00121667|594232859|FG002|Short Term (ST) Period|Adverse Event|5|||
164508731|NCT00121667|594232860|FG003|Short Term (ST) Period|Adverse Event|3|||
164508732|NCT00121667|594232857|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
164508733|NCT00121667|594232858|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
164508734|NCT00121667|594232859|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
164508735|NCT00121667|594232860|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
164508736|NCT00121667|594232857|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
164508737|NCT00121667|594232858|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
164608080|NCT00426556|594585510|FG000|Phase I - Extension Phase|Disease Progression|5|||
164608081|NCT00426556|594585511|FG001|Phase I - Extension Phase|Disease Progression|5|||
164608082|NCT00426556|594585512|FG002|Phase I - Extension Phase|Disease Progression|6|||
164608083|NCT00426556|594585513|FG003|Phase I - Extension Phase|Disease Progression|0|||
164608084|NCT00426556|594585510|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
164608085|NCT00426556|594585511|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
164608086|NCT00426556|594585512|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
164608087|NCT00426556|594585513|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
164608088|NCT00426556|594585510|FG000|Phase II - Core Phase|Disease Progression|0|||
164608089|NCT00426556|594585511|FG001|Phase II - Core Phase|Disease Progression|0|||
164608090|NCT00426556|594585512|FG002|Phase II - Core Phase|Disease Progression|0|||
164608091|NCT00426556|594585513|FG003|Phase II - Core Phase|Disease Progression|16|||
164608092|NCT00426556|594585510|FG000|Phase II - Core Phase|Adverse Event|0|||
164608093|NCT00426556|594585511|FG001|Phase II - Core Phase|Adverse Event|0|||
164608094|NCT00426556|594585512|FG002|Phase II - Core Phase|Adverse Event|0|||
164608095|NCT00426556|594585513|FG003|Phase II - Core Phase|Adverse Event|8|||
164608096|NCT00426556|594585510|FG000|Phase II - Extension Phase|Disease Progression|0|||
164608097|NCT00426556|594585511|FG001|Phase II - Extension Phase|Disease Progression|0|||
164608098|NCT00426556|594585512|FG002|Phase II - Extension Phase|Disease Progression|0|||
164608099|NCT00426556|594585513|FG003|Phase II - Extension Phase|Disease Progression|21|||
164608100|NCT00426556|594585510|FG000|Phase II - Extension Phase|Adverse Event|0|||
164608101|NCT00426556|594585511|FG001|Phase II - Extension Phase|Adverse Event|0|||
164608102|NCT00426556|594585512|FG002|Phase II - Extension Phase|Adverse Event|0|||
164608103|NCT00426556|594585513|FG003|Phase II - Extension Phase|Adverse Event|2|||
164608104|NCT03970824|594585517|FG000|Overall Study|Withdrawal by Subject|1|||
164608105|NCT03970824|594585518|FG001|Overall Study|Withdrawal by Subject|1|||
164608106|NCT03970824|594585519|FG002|Overall Study|Withdrawal by Subject|3|||
164608107|NCT03970824|594585517|FG000|Overall Study|Lost to Follow-up|0|||
164608108|NCT03970824|594585518|FG001|Overall Study|Lost to Follow-up|2|||
164608109|NCT03970824|594585519|FG002|Overall Study|Lost to Follow-up|1|||
164608110|NCT03970824|594585517|FG000|Overall Study|Adverse Event|1|||
164608111|NCT03970824|594585518|FG001|Overall Study|Adverse Event|0|||
164608112|NCT03970824|594585519|FG002|Overall Study|Adverse Event|0|||
164608113|NCT00416312|594585520|FG000|Overall Study|tumors not visible on imaging|2|||
164608114|NCT02146248|594585522|FG000|Overall Study|Withdrawal by Subject|2|||
164608115|NCT00425100|594585523|FG000|Overall Study|Adverse Event|36|||
164608116|NCT00425100|594585523|FG000|Overall Study|Lack of Efficacy|4|||
164608117|NCT00425100|594585523|FG000|Overall Study|Lost to Follow-up|2|||
164608118|NCT00425100|594585523|FG000|Overall Study|Protocol Violation|4|||
164608119|NCT00425100|594585523|FG000|Overall Study|Withdrawal by Subject|7|||
164608120|NCT01969799|594585526|FG000|Overall Study|Adverse Event|0|||
164608121|NCT01969799|594585527|FG001|Overall Study|Adverse Event|1|||
164608122|NCT01969799|594585526|FG000|Overall Study|Death|16|||
164608123|NCT01969799|594585527|FG001|Overall Study|Death|11|||
164608124|NCT01969799|594585526|FG000|Overall Study|Lost to Follow-up|0|||
164608125|NCT01969799|594585527|FG001|Overall Study|Lost to Follow-up|2|||
164608126|NCT01969799|594585526|FG000|Overall Study|Physician Decision|1|||
164608127|NCT01969799|594585527|FG001|Overall Study|Physician Decision|0|||
164608128|NCT02227108|594585530|FG000|Overall Study|Did not receive treatment|2|||
164608129|NCT02227108|594585530|FG000|Overall Study|Other|3|||
164608130|NCT02227108|594585530|FG000|Overall Study|Progressive disease|17|||
164608131|NCT02227108|594585530|FG000|Overall Study|Initiation of alternative therapy|2|||
164608132|NCT02227108|594585530|FG000|Overall Study|Investigator discretion|1|||
164608133|NCT02227108|594585530|FG000|Overall Study|Adverse Event|6|||
164608134|NCT01714817|594585531|FG000|Year 1 Period|Lack of Efficacy|11|||
164608135|NCT01714817|594585532|FG001|Year 1 Period|Lack of Efficacy|9|||
164508738|NCT00121667|594232859|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
164508739|NCT00121667|594232860|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
164508740|NCT00121667|594232857|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
164508741|NCT00121667|594232858|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
164508742|NCT00121667|594232859|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
164508743|NCT00121667|594232860|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
164508744|NCT00121667|594232857|FG000|Short Term (ST) Period|Other Reason|3|||
164508745|NCT00121667|594232858|FG001|Short Term (ST) Period|Other Reason|0|||
164508746|NCT00121667|594232859|FG002|Short Term (ST) Period|Other Reason|0|||
164508747|NCT00121667|594232860|FG003|Short Term (ST) Period|Other Reason|0|||
164608136|NCT01714817|594585531|FG000|Year 1 Period|Adverse Event|20|||
164608137|NCT01714817|594585532|FG001|Year 1 Period|Adverse Event|17|||
164508748|NCT00121667|594232857|FG000|Short Term (ST) Period|Death|0|||
164608138|NCT01714817|594585531|FG000|Year 1 Period|Withdrawal by Subject|6|||
164608139|NCT01714817|594585532|FG001|Year 1 Period|Withdrawal by Subject|7|||
164608140|NCT01714817|594585531|FG000|Year 1 Period|Death|1|||
164608141|NCT01714817|594585532|FG001|Year 1 Period|Death|1|||
164608142|NCT01714817|594585531|FG000|Year 1 Period|Lost to Follow-up|0|||
164608143|NCT01714817|594585532|FG001|Year 1 Period|Lost to Follow-up|2|||
164608144|NCT01714817|594585531|FG000|Year 1 Period|Poor / non-compliance|0|||
164608145|NCT01714817|594585532|FG001|Year 1 Period|Poor / non-compliance|1|||
164608146|NCT01714817|594585531|FG000|Year 1 Period|Pregnancy|2|||
164608147|NCT01714817|594585532|FG001|Year 1 Period|Pregnancy|0|||
164608148|NCT01714817|594585531|FG000|Year 1 Period|Participant no longer meets criteria|6|||
164608149|NCT01714817|594585532|FG001|Year 1 Period|Participant no longer meets criteria|2|||
164608150|NCT01714817|594585531|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
164608151|NCT01714817|594585532|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
164608152|NCT01714817|594585531|FG000|Year 1 Period|Change in Concomitant Medication|0|||
164608153|NCT01714817|594585532|FG001|Year 1 Period|Change in Concomitant Medication|1|||
164608154|NCT01714817|594585531|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
164608155|NCT01714817|594585532|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
164608156|NCT01714817|594585531|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
164608157|NCT01714817|594585532|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
164608158|NCT01714817|594585531|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
164608159|NCT01714817|594585532|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
164608160|NCT01714817|594585531|FG000|Year 2 Period|Lack of Efficacy|4|||
164608161|NCT01714817|594585532|FG001|Year 2 Period|Lack of Efficacy|12|||
164608162|NCT01714817|594585531|FG000|Year 2 Period|Adverse Event|7|||
164608163|NCT01714817|594585532|FG001|Year 2 Period|Adverse Event|6|||
164608164|NCT01714817|594585531|FG000|Year 2 Period|Participant request to stop treatment|4|||
164608165|NCT01714817|594585532|FG001|Year 2 Period|Participant request to stop treatment|4|||
164608166|NCT01714817|594585531|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
164608167|NCT01714817|594585532|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
164608168|NCT01714817|594585531|FG000|Year 2 Period|Participant withdrew consent|1|||
164608169|NCT01714817|594585532|FG001|Year 2 Period|Participant withdrew consent|5|||
164608170|NCT01714817|594585531|FG000|Year 2 Period|Participant no longer meets criteria|1|||
164608171|NCT01714817|594585532|FG001|Year 2 Period|Participant no longer meets criteria|4|||
164608172|NCT01714817|594585531|FG000|Year 2 Period|Lost to Follow-up|2|||
164608173|NCT01714817|594585532|FG001|Year 2 Period|Lost to Follow-up|0|||
164608174|NCT01714817|594585531|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
164608175|NCT01714817|594585532|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
164608176|NCT01714817|594585531|FG000|Year 2 Period|Pregnancy|1|||
164608177|NCT01714817|594585532|FG001|Year 2 Period|Pregnancy|1|||
164608178|NCT01714817|594585531|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
164608179|NCT01714817|594585532|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
164608180|NCT01714817|594585531|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
164608181|NCT01714817|594585532|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
164608182|NCT01714817|594585531|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
164608183|NCT01714817|594585532|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
164608184|NCT01714817|594585531|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
164608185|NCT01714817|594585532|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
164608186|NCT01714817|594585531|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
164608187|NCT01714817|594585532|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
164608188|NCT01714817|594585531|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
164608189|NCT01714817|594585532|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
164608190|NCT01714817|594585531|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
164608191|NCT01714817|594585532|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
164608192|NCT01714817|594585531|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
164608193|NCT01714817|594585532|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
164608194|NCT01714817|594585531|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
164608195|NCT01714817|594585532|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
164608196|NCT01714817|594585531|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
164608197|NCT01714817|594585532|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
164608198|NCT01714817|594585531|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
164608199|NCT01714817|594585532|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
164608200|NCT01714817|594585531|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
164608201|NCT01714817|594585532|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
164608202|NCT01714817|594585531|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
164608203|NCT01714817|594585532|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
164608204|NCT01714817|594585531|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
164608205|NCT01714817|594585532|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
164508749|NCT00121667|594232858|FG001|Short Term (ST) Period|Death|0|||
164508750|NCT00121667|594232859|FG002|Short Term (ST) Period|Death|0|||
164508751|NCT00121667|594232860|FG003|Short Term (ST) Period|Death|1|||
164508752|NCT00121667|594232857|FG000|Short Term (ST) Period|Pregnancy|0|||
164508753|NCT00121667|594232858|FG001|Short Term (ST) Period|Pregnancy|0|||
164508754|NCT00121667|594232859|FG002|Short Term (ST) Period|Pregnancy|0|||
164508755|NCT00121667|594232860|FG003|Short Term (ST) Period|Pregnancy|1|||
164508756|NCT00121667|594232857|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
164508757|NCT00121667|594232858|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
164508758|NCT00121667|594232859|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
164508759|NCT00121667|594232860|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
164508760|NCT00121667|594232857|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
164508761|NCT00121667|594232858|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
164508762|NCT00121667|594232859|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
164508763|NCT00121667|594232860|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
164508764|NCT00121667|594232857|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
164508765|NCT00121667|594232858|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
164508766|NCT00121667|594232859|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
164508767|NCT00121667|594232860|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
164508768|NCT00121667|594232857|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
164508769|NCT00121667|594232858|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
164508770|NCT00121667|594232859|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
164508771|NCT00121667|594232860|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
164508772|NCT00121667|594232857|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
164508773|NCT00121667|594232858|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
164508774|NCT00121667|594232859|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
164508775|NCT00121667|594232860|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
164508776|NCT00121667|594232857|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
164508777|NCT00121667|594232858|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
164508778|NCT00121667|594232859|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
164508779|NCT00121667|594232860|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
164508780|NCT00121667|594232857|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
164508781|NCT00121667|594232858|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
164508782|NCT00121667|594232859|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
164508783|NCT00121667|594232860|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
164508784|NCT00121667|594232857|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
164508785|NCT00121667|594232858|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
164508786|NCT00121667|594232859|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
164508787|NCT00121667|594232860|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
164508788|NCT00121667|594232857|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
164508789|NCT00121667|594232858|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
164508790|NCT00121667|594232859|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
164508791|NCT00121667|594232860|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
164508792|NCT02196077|594232872|FG000|Overall Study|Adverse Event|4|||
164508793|NCT02196077|594232872|FG000|Overall Study|Lack of Efficacy|1|||
164508794|NCT02196077|594232872|FG000|Overall Study|Withdrawal by Subject|14|||
164508795|NCT02196077|594232872|FG000|Overall Study|Physician Decision|1|||
164508796|NCT02196077|594232872|FG000|Overall Study|Lost to Follow-up|3|||
164508797|NCT02196077|594232872|FG000|Overall Study|Protocol Violation|24|||
164508798|NCT01163474|594232875|FG000|Overall Study|Withdrawal by Subject|1|||
164508799|NCT01163474|594232875|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
164508800|NCT01163474|594232875|FG000|Overall Study|Lost to Follow-up|3|||
164508801|NCT00965497|594232876|FG000|Overall Study|Physician Decision|1|||
164508802|NCT00794924|594232877|FG000|Overall Study|Lost to Follow-up|6|||
164508803|NCT00794924|594232878|FG001|Overall Study|Lost to Follow-up|8|||
164508804|NCT00794924|594232877|FG000|Overall Study|Withdrawal by Subject|48|||
164508805|NCT00794924|594232878|FG001|Overall Study|Withdrawal by Subject|60|||
164508806|NCT00794924|594232877|FG000|Overall Study|Adverse Event|6|||
164508807|NCT00794924|594232878|FG001|Overall Study|Adverse Event|2|||
164508808|NCT02389764|594232879|FG000|Overall Study|Lack of Efficacy|9|||
164508809|NCT00585078|594232882|FG000|Overall Study|Withdrawal by Subject|4|||
164508810|NCT00585078|594232882|FG000|Overall Study|Poor performance status|1|||
164508811|NCT00585078|594232882|FG000|Overall Study|Disease Progression|24|||
164508812|NCT00585078|594232882|FG000|Overall Study|Adverse Event|10|||
164508813|NCT00585078|594232882|FG000|Overall Study|Death|1|||
164508814|NCT01814072|594232885|FG000|Overall Study|Lost to Follow-up|2|||
164508815|NCT01814072|594232886|FG001|Overall Study|Lost to Follow-up|2|||
164508816|NCT01814072|594232887|FG002|Overall Study|Lost to Follow-up|2|||
164508817|NCT01814072|594232888|FG003|Overall Study|Lost to Follow-up|0|||
164508818|NCT01814072|594232889|FG004|Overall Study|Lost to Follow-up|2|||
164508819|NCT01814072|594232890|FG005|Overall Study|Lost to Follow-up|3|||
164508820|NCT01814072|594232891|FG006|Overall Study|Lost to Follow-up|3|||
164508821|NCT01814072|594232892|FG007|Overall Study|Lost to Follow-up|1|||
164608206|NCT01714817|594585531|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
164608207|NCT01714817|594585532|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
164608208|NCT01714817|594585531|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
164608209|NCT01714817|594585532|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
164608210|NCT01374217|594585533|FG000|Overall Study|Lack of Efficacy|13|||
164608211|NCT02555657|594585534|FG000|Overall Study|Death|274|||
164608212|NCT02555657|594585535|FG001|Overall Study|Death|262|||
164608213|NCT02555657|594585534|FG000|Overall Study|Physician Decision|0|||
164608214|NCT02555657|594585535|FG001|Overall Study|Physician Decision|1|||
164608215|NCT02555657|594585534|FG000|Overall Study|Sponsor Decision|27|||
164608216|NCT02555657|594585535|FG001|Overall Study|Sponsor Decision|15|||
164608217|NCT02555657|594585534|FG000|Overall Study|Withdrawal by Subject|11|||
164608218|NCT02555657|594585535|FG001|Overall Study|Withdrawal by Subject|32|||
164608219|NCT00192036|594585536|FG000|Overall Study|Protocol Violation|3|||
164608220|NCT00192036|594585536|FG000|Overall Study|Adverse Event|6|||
164608221|NCT00192036|594585536|FG000|Overall Study|Patient/Physician Perception|1|||
164608222|NCT00192036|594585536|FG000|Overall Study|Objective Tumor Progression|4|||
164608223|NCT00192036|594585536|FG000|Overall Study|Clinical Disease Progression|1|||
164608224|NCT00192036|594585536|FG000|Overall Study|Death|1|||
164608225|NCT00192036|594585536|FG000|Overall Study|Unknown or Not Specified|5|||
164608226|NCT03337139|594585554|FG000|Phase I|Withdrawal by Subject|10|||
164608227|NCT03337139|594585555|FG001|Phase I|Withdrawal by Subject|0|||
164608228|NCT02554253|594585561|FG000|Overall Study|ineligible after enrollment|1|||
164508822|NCT01814072|594232893|FG008|Overall Study|Lost to Follow-up|2|||
164508823|NCT01814072|594232894|FG009|Overall Study|Lost to Follow-up|3|||
164508824|NCT01814072|594232895|FG010|Overall Study|Lost to Follow-up|1|||
164508825|NCT01814072|594232896|FG011|Overall Study|Lost to Follow-up|2|||
164508826|NCT01814072|594232897|FG012|Overall Study|Lost to Follow-up|2|||
164508827|NCT01814072|594232898|FG013|Overall Study|Lost to Follow-up|1|||
164508828|NCT01814072|594232899|FG014|Overall Study|Lost to Follow-up|2|||
164508829|NCT01814072|594232900|FG015|Overall Study|Lost to Follow-up|1|||
164508830|NCT01814072|594232901|FG016|Overall Study|Lost to Follow-up|3|||
164508831|NCT01814072|594232902|FG017|Overall Study|Lost to Follow-up|1|||
164508832|NCT01814072|594232903|FG018|Overall Study|Lost to Follow-up|3|||
164508833|NCT01814072|594232904|FG019|Overall Study|Lost to Follow-up|3|||
164508834|NCT01814072|594232905|FG020|Overall Study|Lost to Follow-up|2|||
164508835|NCT01814072|594232906|FG021|Overall Study|Lost to Follow-up|1|||
164508836|NCT01814072|594232907|FG022|Overall Study|Lost to Follow-up|3|||
164508837|NCT01814072|594232908|FG023|Overall Study|Lost to Follow-up|1|||
164508838|NCT01814072|594232909|FG024|Overall Study|Lost to Follow-up|4|||
164508839|NCT01814072|594232910|FG025|Overall Study|Lost to Follow-up|1|||
164508840|NCT01814072|594232911|FG026|Overall Study|Lost to Follow-up|1|||
164508841|NCT01814072|594232912|FG027|Overall Study|Lost to Follow-up|2|||
164508842|NCT01814072|594232913|FG028|Overall Study|Lost to Follow-up|3|||
164508843|NCT01814072|594232914|FG029|Overall Study|Lost to Follow-up|3|||
164508844|NCT01814072|594232915|FG030|Overall Study|Lost to Follow-up|2|||
164508845|NCT01814072|594232916|FG031|Overall Study|Lost to Follow-up|0|||
164508846|NCT01814072|594232885|FG000|Overall Study|Withdrawal by Subject|2|||
164508847|NCT01814072|594232886|FG001|Overall Study|Withdrawal by Subject|0|||
164508848|NCT01814072|594232887|FG002|Overall Study|Withdrawal by Subject|1|||
164508849|NCT01814072|594232888|FG003|Overall Study|Withdrawal by Subject|0|||
164508850|NCT01814072|594232889|FG004|Overall Study|Withdrawal by Subject|2|||
164508851|NCT01814072|594232890|FG005|Overall Study|Withdrawal by Subject|3|||
164508852|NCT01814072|594232891|FG006|Overall Study|Withdrawal by Subject|1|||
164508853|NCT01814072|594232892|FG007|Overall Study|Withdrawal by Subject|0|||
164508854|NCT01814072|594232893|FG008|Overall Study|Withdrawal by Subject|1|||
164508855|NCT01814072|594232894|FG009|Overall Study|Withdrawal by Subject|2|||
164508856|NCT01814072|594232895|FG010|Overall Study|Withdrawal by Subject|0|||
164508857|NCT01814072|594232896|FG011|Overall Study|Withdrawal by Subject|0|||
164508858|NCT01814072|594232897|FG012|Overall Study|Withdrawal by Subject|1|||
164508859|NCT01814072|594232898|FG013|Overall Study|Withdrawal by Subject|1|||
164508860|NCT01814072|594232899|FG014|Overall Study|Withdrawal by Subject|1|||
164508861|NCT01814072|594232900|FG015|Overall Study|Withdrawal by Subject|1|||
164508862|NCT01814072|594232901|FG016|Overall Study|Withdrawal by Subject|0|||
164508863|NCT01814072|594232902|FG017|Overall Study|Withdrawal by Subject|0|||
164508864|NCT01814072|594232903|FG018|Overall Study|Withdrawal by Subject|0|||
164508865|NCT01814072|594232904|FG019|Overall Study|Withdrawal by Subject|2|||
164508866|NCT01814072|594232905|FG020|Overall Study|Withdrawal by Subject|0|||
164508867|NCT01814072|594232906|FG021|Overall Study|Withdrawal by Subject|0|||
164508868|NCT01814072|594232907|FG022|Overall Study|Withdrawal by Subject|1|||
164508869|NCT01814072|594232908|FG023|Overall Study|Withdrawal by Subject|0|||
164508870|NCT01814072|594232909|FG024|Overall Study|Withdrawal by Subject|2|||
164508871|NCT01814072|594232910|FG025|Overall Study|Withdrawal by Subject|1|||
164508872|NCT01814072|594232911|FG026|Overall Study|Withdrawal by Subject|1|||
164508873|NCT01814072|594232912|FG027|Overall Study|Withdrawal by Subject|2|||
164508874|NCT01814072|594232913|FG028|Overall Study|Withdrawal by Subject|1|||
164508875|NCT01814072|594232914|FG029|Overall Study|Withdrawal by Subject|0|||
164508876|NCT01814072|594232915|FG030|Overall Study|Withdrawal by Subject|0|||
164508877|NCT01814072|594232916|FG031|Overall Study|Withdrawal by Subject|0|||
164508878|NCT00383123|594232917|FG000|Overall Study|Adverse Event|1|||
164508879|NCT00383123|594232918|FG001|Overall Study|Adverse Event|0|||
164508880|NCT00383123|594232917|FG000|Overall Study|Lost to Follow-up|68|||
164508881|NCT00383123|594232918|FG001|Overall Study|Lost to Follow-up|61|||
164508882|NCT00383123|594232917|FG000|Overall Study|Protocol Violation|5|||
164508883|NCT00383123|594232918|FG001|Overall Study|Protocol Violation|1|||
164508884|NCT00383123|594232917|FG000|Overall Study|Withdrawal by Subject|27|||
164508885|NCT00383123|594232918|FG001|Overall Study|Withdrawal by Subject|18|||
164508886|NCT00383123|594232917|FG000|Overall Study|Other reason|10|||
164508887|NCT00383123|594232918|FG001|Overall Study|Other reason|6|||
164508888|NCT02781311|594232919|FG000|Overall Study|Adverse Event|2|||
164508889|NCT02781311|594232920|FG001|Overall Study|Adverse Event|6|||
164508890|NCT02781311|594232921|FG002|Overall Study|Adverse Event|1|||
164508891|NCT02781311|594232919|FG000|Overall Study|Withdrawal of Consent|11|||
164508892|NCT02781311|594232920|FG001|Overall Study|Withdrawal of Consent|12|||
164508893|NCT02781311|594232921|FG002|Overall Study|Withdrawal of Consent|2|||
164508894|NCT02781311|594232919|FG000|Overall Study|Lost to Follow-up|11|||
164508895|NCT02781311|594232920|FG001|Overall Study|Lost to Follow-up|8|||
164508896|NCT02781311|594232921|FG002|Overall Study|Lost to Follow-up|1|||
164508897|NCT02781311|594232919|FG000|Overall Study|Non-Compliance with Study Drug|2|||
164508898|NCT02781311|594232920|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164508899|NCT02781311|594232921|FG002|Overall Study|Non-Compliance with Study Drug|0|||
164508900|NCT00250432|594232928|FG000|Overall Study|Adverse Event|25|||
164508901|NCT00250432|594232929|FG001|Overall Study|Adverse Event|29|||
164508902|NCT00250432|594232928|FG000|Overall Study|Lack of Efficacy|2|||
164508903|NCT00250432|594232929|FG001|Overall Study|Lack of Efficacy|1|||
164508904|NCT00250432|594232928|FG000|Overall Study|Lost to Follow-up|6|||
164608229|NCT02554253|594585562|FG001|Overall Study|ineligible after enrollment|0|||
164608230|NCT02554253|594585561|FG000|Overall Study|converted to transcatheter procedure|0|||
164608231|NCT02554253|594585562|FG001|Overall Study|converted to transcatheter procedure|1|||
164608232|NCT02554253|594585561|FG000|Overall Study|received both drugs|0|||
164608233|NCT02554253|594585562|FG001|Overall Study|received both drugs|1|||
164608234|NCT03288493|594585564|FG000|Overall Study|Withdrawal by Subject|4|||
164608235|NCT03288493|594585565|FG001|Overall Study|Withdrawal by Subject|0|||
164608236|NCT03288493|594585566|FG002|Overall Study|Withdrawal by Subject|0|||
164608237|NCT03288493|594585567|FG003|Overall Study|Withdrawal by Subject|0|||
164608238|NCT03288493|594585568|FG004|Overall Study|Withdrawal by Subject|0|||
164608239|NCT03288493|594585569|FG005|Overall Study|Withdrawal by Subject|2|||
164608240|NCT03288493|594585570|FG006|Overall Study|Withdrawal by Subject|0|||
164608241|NCT03288493|594585564|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
164608242|NCT03288493|594585565|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
164608243|NCT03288493|594585566|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
164608244|NCT03288493|594585567|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
164608245|NCT03288493|594585568|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
164608246|NCT03288493|594585569|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
164608247|NCT03288493|594585570|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
164608248|NCT03288493|594585564|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
164608249|NCT03288493|594585565|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
164608250|NCT03288493|594585566|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
164608251|NCT03288493|594585567|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
164608252|NCT03288493|594585568|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
164608253|NCT03288493|594585569|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
164608254|NCT03288493|594585570|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
164608255|NCT03288493|594585564|FG000|Overall Study|Death|2|||
164608256|NCT03288493|594585565|FG001|Overall Study|Death|0|||
164608257|NCT03288493|594585566|FG002|Overall Study|Death|0|||
164608258|NCT03288493|594585567|FG003|Overall Study|Death|0|||
164608259|NCT03288493|594585568|FG004|Overall Study|Death|0|||
164608260|NCT03288493|594585569|FG005|Overall Study|Death|0|||
164608261|NCT03288493|594585570|FG006|Overall Study|Death|0|||
164608262|NCT03288493|594585564|FG000|Overall Study|other reason not listed above|2|||
164608263|NCT03288493|594585565|FG001|Overall Study|other reason not listed above|0|||
164608264|NCT03288493|594585566|FG002|Overall Study|other reason not listed above|0|||
164608265|NCT03288493|594585567|FG003|Overall Study|other reason not listed above|0|||
164608266|NCT03288493|594585568|FG004|Overall Study|other reason not listed above|0|||
164608267|NCT03288493|594585569|FG005|Overall Study|other reason not listed above|0|||
164608268|NCT03288493|594585570|FG006|Overall Study|other reason not listed above|0|||
164608269|NCT02559206|594585571|FG000|Overall Study|Adverse Event|0|||
164608270|NCT02559206|594585572|FG001|Overall Study|Adverse Event|4|||
164608271|NCT02559206|594585573|FG002|Overall Study|Adverse Event|1|||
164301025|NCT01524796|593478406|FG000|Overall Study|Lack of Efficacy|3|||
164301026|NCT01524796|593478406|FG000|Overall Study|Lost to Follow-up|1|||
164301027|NCT01524796|593478406|FG000|Overall Study|The price|1|||
164301028|NCT01524796|593478406|FG000|Overall Study|Withdrawal by Subject|4|||
164301029|NCT01524796|593478406|FG000|Overall Study|Move|1|||
164301030|NCT01524796|593478406|FG000|Overall Study|Deterioration of pains|1|||
164301031|NCT01524796|593478406|FG000|Overall Study|Gall stone surgery|1|||
164301032|NCT01524796|593478406|FG000|Overall Study|Nervous about confidentiality|1|||
164301033|NCT01524796|593478406|FG000|Overall Study|Switch to carbamazapine|1|||
164301034|NCT01524796|593478406|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
164608272|NCT02559206|594585574|FG003|Overall Study|Adverse Event|5|||
164608273|NCT02559206|594585575|FG004|Overall Study|Adverse Event|3|||
164608274|NCT02559206|594585576|FG005|Overall Study|Adverse Event|0|||
164608275|NCT02559206|594585577|FG006|Overall Study|Adverse Event|1|||
164608276|NCT02559206|594585578|FG007|Overall Study|Adverse Event|0|||
164608277|NCT02559206|594585571|FG000|Overall Study|Protocol Violation|1|||
164608278|NCT02559206|594585572|FG001|Overall Study|Protocol Violation|0|||
164608279|NCT02559206|594585573|FG002|Overall Study|Protocol Violation|1|||
164508905|NCT00250432|594232929|FG001|Overall Study|Lost to Follow-up|5|||
164508906|NCT00250432|594232928|FG000|Overall Study|Patient Moved|0|||
164508907|NCT00250432|594232929|FG001|Overall Study|Patient Moved|1|||
164508908|NCT00250432|594232928|FG000|Overall Study|Protocol Violation|0|||
164508909|NCT00250432|594232929|FG001|Overall Study|Protocol Violation|3|||
164508910|NCT00250432|594232928|FG000|Overall Study|Withdrawal by Subject|6|||
164508911|NCT00250432|594232929|FG001|Overall Study|Withdrawal by Subject|2|||
164508912|NCT00250432|594232928|FG000|Overall Study|Pt died out of posttherapy report period|6|||
164508913|NCT00250432|594232929|FG001|Overall Study|Pt died out of posttherapy report period|5|||
164508914|NCT00250432|594232928|FG000|Overall Study|Pt was considered untreatable|0|||
164508915|NCT00250432|594232929|FG001|Overall Study|Pt was considered untreatable|1|||
164508916|NCT01011868|594232930|FG000|After Week 18 Follow-up|Adverse Event|8|||
164508917|NCT01011868|594232931|FG001|After Week 18 Follow-up|Adverse Event|6|||
164508918|NCT01011868|594232932|FG002|After Week 18 Follow-up|Adverse Event|13|||
164508919|NCT01011868|594232930|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
164508920|NCT01011868|594232931|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
164508921|NCT01011868|594232932|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
164508922|NCT01011868|594232930|FG000|After Week 18 Follow-up|Protocol Violation|1|||
164508923|NCT01011868|594232931|FG001|After Week 18 Follow-up|Protocol Violation|1|||
164508924|NCT01011868|594232932|FG002|After Week 18 Follow-up|Protocol Violation|1|||
164508925|NCT01011868|594232930|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
164508926|NCT01011868|594232931|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
164508927|NCT01011868|594232932|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
164508928|NCT01011868|594232930|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
164508929|NCT01011868|594232931|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
164508930|NCT01011868|594232932|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
164508931|NCT01011868|594232930|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
164508932|NCT01011868|594232931|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
164508933|NCT01011868|594232932|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
164508934|NCT01011868|594232930|FG000|After Week 78 Follow-up|Adverse Event|14|||
164508935|NCT01011868|594232931|FG001|After Week 78 Follow-up|Adverse Event|18|||
164508936|NCT01011868|594232932|FG002|After Week 78 Follow-up|Adverse Event|21|||
164508937|NCT01011868|594232930|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
164508938|NCT01011868|594232931|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
164508939|NCT01011868|594232932|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
164508940|NCT01011868|594232930|FG000|After Week 78 Follow-up|Protocol Violation|9|||
164508941|NCT01011868|594232931|FG001|After Week 78 Follow-up|Protocol Violation|1|||
164508942|NCT01011868|594232932|FG002|After Week 78 Follow-up|Protocol Violation|2|||
164508943|NCT01011868|594232930|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
164508944|NCT01011868|594232931|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
164508945|NCT01011868|594232932|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
164508946|NCT01011868|594232930|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
164508947|NCT01011868|594232931|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
164508948|NCT01011868|594232932|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
164508949|NCT01011868|594232930|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
164508950|NCT01011868|594232931|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
164508951|NCT01011868|594232932|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
164508952|NCT04147858|594232933|FG000|Overall Study|Adverse Event|6|||
164508953|NCT04147858|594232934|FG001|Overall Study|Adverse Event|6|||
164508954|NCT04147858|594232935|FG002|Overall Study|Adverse Event|6|||
164508955|NCT04147858|594232933|FG000|Overall Study|Lack of Efficacy|3|||
164508956|NCT04147858|594232934|FG001|Overall Study|Lack of Efficacy|3|||
164508957|NCT04147858|594232935|FG002|Overall Study|Lack of Efficacy|1|||
164508958|NCT04147858|594232933|FG000|Overall Study|Lost to Follow-up|1|||
164508959|NCT04147858|594232934|FG001|Overall Study|Lost to Follow-up|6|||
164508960|NCT04147858|594232935|FG002|Overall Study|Lost to Follow-up|2|||
164508961|NCT04147858|594232933|FG000|Overall Study|Withdrawal by Subject|3|||
164508962|NCT04147858|594232934|FG001|Overall Study|Withdrawal by Subject|4|||
164508963|NCT04147858|594232935|FG002|Overall Study|Withdrawal by Subject|10|||
164508964|NCT04147858|594232933|FG000|Overall Study|Subject Noncompliance, Other|4|||
164508965|NCT04147858|594232934|FG001|Overall Study|Subject Noncompliance, Other|3|||
164508966|NCT04147858|594232935|FG002|Overall Study|Subject Noncompliance, Other|1|||
164608280|NCT02559206|594585574|FG003|Overall Study|Protocol Violation|0|||
164608281|NCT02559206|594585575|FG004|Overall Study|Protocol Violation|0|||
164608282|NCT02559206|594585576|FG005|Overall Study|Protocol Violation|2|||
164608283|NCT02559206|594585577|FG006|Overall Study|Protocol Violation|0|||
164608284|NCT02559206|594585578|FG007|Overall Study|Protocol Violation|0|||
164608285|NCT02559206|594585571|FG000|Overall Study|Withdrawal by Subject|3|||
164608286|NCT02559206|594585572|FG001|Overall Study|Withdrawal by Subject|3|||
164608287|NCT02559206|594585573|FG002|Overall Study|Withdrawal by Subject|1|||
164608288|NCT02559206|594585574|FG003|Overall Study|Withdrawal by Subject|3|||
164608289|NCT02559206|594585575|FG004|Overall Study|Withdrawal by Subject|5|||
164608290|NCT02559206|594585576|FG005|Overall Study|Withdrawal by Subject|4|||
164608291|NCT02559206|594585577|FG006|Overall Study|Withdrawal by Subject|1|||
164608292|NCT02559206|594585578|FG007|Overall Study|Withdrawal by Subject|2|||
164608293|NCT02559206|594585571|FG000|Overall Study|Lost to Follow-up|3|||
164608294|NCT02559206|594585572|FG001|Overall Study|Lost to Follow-up|5|||
164608295|NCT02559206|594585573|FG002|Overall Study|Lost to Follow-up|3|||
164608296|NCT02559206|594585574|FG003|Overall Study|Lost to Follow-up|3|||
164608297|NCT02559206|594585575|FG004|Overall Study|Lost to Follow-up|2|||
164608298|NCT02559206|594585576|FG005|Overall Study|Lost to Follow-up|5|||
164608299|NCT02559206|594585577|FG006|Overall Study|Lost to Follow-up|1|||
164608300|NCT02559206|594585578|FG007|Overall Study|Lost to Follow-up|4|||
164608301|NCT02559206|594585571|FG000|Overall Study|Lack of Efficacy|1|||
164608302|NCT02559206|594585572|FG001|Overall Study|Lack of Efficacy|0|||
164608303|NCT02559206|594585573|FG002|Overall Study|Lack of Efficacy|3|||
164608304|NCT02559206|594585574|FG003|Overall Study|Lack of Efficacy|2|||
164608305|NCT02559206|594585575|FG004|Overall Study|Lack of Efficacy|2|||
164608306|NCT02559206|594585576|FG005|Overall Study|Lack of Efficacy|3|||
164608307|NCT02559206|594585577|FG006|Overall Study|Lack of Efficacy|3|||
164608308|NCT02559206|594585578|FG007|Overall Study|Lack of Efficacy|3|||
164608309|NCT02559206|594585571|FG000|Overall Study|Other Not Specified|0|||
164608310|NCT02559206|594585572|FG001|Overall Study|Other Not Specified|0|||
164608311|NCT02559206|594585573|FG002|Overall Study|Other Not Specified|0|||
164608312|NCT02559206|594585574|FG003|Overall Study|Other Not Specified|1|||
164608313|NCT02559206|594585575|FG004|Overall Study|Other Not Specified|0|||
164608314|NCT02559206|594585576|FG005|Overall Study|Other Not Specified|0|||
164608315|NCT02559206|594585577|FG006|Overall Study|Other Not Specified|0|||
164608316|NCT02559206|594585578|FG007|Overall Study|Other Not Specified|0|||
164608317|NCT01561560|594585579|FG000|First Two Weeks of Wear|Time/job conflict|0|||
164608318|NCT01561560|594585580|FG001|First Two Weeks of Wear|Time/job conflict|1|||
164608319|NCT01561560|594585579|FG000|First Two Weeks of Wear|Adverse Event|0|||
164608320|NCT01561560|594585580|FG001|First Two Weeks of Wear|Adverse Event|1|||
164608321|NCT01561560|594585579|FG000|Second Two Weeks of Wear|Adverse Event|0|||
164608322|NCT01561560|594585580|FG001|Second Two Weeks of Wear|Adverse Event|1|||
164608323|NCT03862131|594585581|FG000|Overall Study|Lost to Follow-up|1|||
164608324|NCT03862131|594585582|FG001|Overall Study|Lost to Follow-up|0|||
164608325|NCT03862131|594585583|FG002|Overall Study|Lost to Follow-up|1|||
164608326|NCT03862131|594585581|FG000|Overall Study|Determined to be ineligible|0|||
164608327|NCT03862131|594585582|FG001|Overall Study|Determined to be ineligible|0|||
164608328|NCT03862131|594585583|FG002|Overall Study|Determined to be ineligible|5|||
164608329|NCT03862131|594585581|FG000|Overall Study|Death|4|||
164608330|NCT03862131|594585582|FG001|Overall Study|Death|4|||
164608331|NCT03862131|594585583|FG002|Overall Study|Death|0|||
164508967|NCT04905849|594232936|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
164508968|NCT04905849|594232937|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
164508969|NCT04907357|594232956|FG000|Overall Study|Death|0|||
164508970|NCT04907357|594232957|FG001|Overall Study|Death|1|||
164508971|NCT04907357|594232956|FG000|Overall Study|Lost to Follow-up|9|||
164508972|NCT04907357|594232957|FG001|Overall Study|Lost to Follow-up|18|||
164508973|NCT04907357|594232956|FG000|Overall Study|Physician Decision|1|||
164508974|NCT04907357|594232957|FG001|Overall Study|Physician Decision|0|||
164508975|NCT04907357|594232956|FG000|Overall Study|Withdrawal by Subject|0|||
164508976|NCT04907357|594232957|FG001|Overall Study|Withdrawal by Subject|1|||
164508977|NCT04907357|594232956|FG000|Overall Study|Unable to attend visits|1|||
164508978|NCT04907357|594232957|FG001|Overall Study|Unable to attend visits|0|||
164508979|NCT04907357|594232956|FG000|Overall Study|Incarcerated|1|||
164508980|NCT04907357|594232957|FG001|Overall Study|Incarcerated|1|||
164608332|NCT03862131|594585581|FG000|Overall Study|Withdrawal by Subject|5|||
164608333|NCT03862131|594585582|FG001|Overall Study|Withdrawal by Subject|3|||
164608334|NCT03862131|594585583|FG002|Overall Study|Withdrawal by Subject|0|||
164608335|NCT03862131|594585581|FG000|Overall Study|Physician Decision|0|||
164608336|NCT03862131|594585582|FG001|Overall Study|Physician Decision|1|||
164608337|NCT03862131|594585583|FG002|Overall Study|Physician Decision|0|||
164608338|NCT01871896|594585586|FG000|Overall Study|Lost to Follow-up|1|||
164608339|NCT01770145|594587811|FG000|Baseline|Adverse Event|20|||
164608340|NCT01770145|594587811|FG000|Baseline|Withdrawal by Subject|1|||
164608341|NCT01770145|594587811|FG000|Baseline|Lost to Follow-up|1|||
164608342|NCT01770145|594587811|FG000|Baseline|Unable to define optimal dose|4|||
164608343|NCT01770145|594587811|FG000|Treatment|Adverse Event|3|||
164508981|NCT00365547|594232958|FG000|Overall Study|Insurance did not cover Avastin|1|||
164508982|NCT00365547|594232958|FG000|Overall Study|Screen failure|1|||
164508983|NCT00365547|594232958|FG000|Overall Study|Withdrawal by Subject|1|||
164508984|NCT00546078|594232959|FG000|Overall Study|Lost to Follow-up|1|||
164508985|NCT00546078|594232960|FG001|Overall Study|Lost to Follow-up|3|||
164508986|NCT00546078|594232959|FG000|Overall Study|Withdrawal by Subject|2|||
164508987|NCT00546078|594232960|FG001|Overall Study|Withdrawal by Subject|3|||
164508988|NCT00546078|594232959|FG000|Overall Study|Other reason|1|||
164508989|NCT00546078|594232960|FG001|Overall Study|Other reason|1|||
164508990|NCT03512197|594232961|FG000|Overall Study|Guardian decision|1|||
164508991|NCT03512197|594232962|FG001|Overall Study|Guardian decision|1|||
164508992|NCT03512197|594232961|FG000|Overall Study|Lack of Efficacy|19|||
164508993|NCT03512197|594232962|FG001|Overall Study|Lack of Efficacy|11|||
164508994|NCT03512197|594232961|FG000|Overall Study|New Therapy for Study Indication|16|||
164508995|NCT03512197|594232962|FG001|Overall Study|New Therapy for Study Indication|16|||
164508996|NCT03512197|594232961|FG000|Overall Study|Physician Decision|60|||
164508997|NCT03512197|594232962|FG001|Overall Study|Physician Decision|60|||
164508998|NCT03512197|594232961|FG000|Overall Study|Protocol Violation|0|||
164508999|NCT03512197|594232962|FG001|Overall Study|Protocol Violation|2|||
164509000|NCT03512197|594232961|FG000|Overall Study|Terminated by Sponsored|46|||
164509001|NCT03512197|594232962|FG001|Overall Study|Terminated by Sponsored|50|||
164509002|NCT03512197|594232961|FG000|Overall Study|Subject Decision|15|||
164509003|NCT03512197|594232962|FG001|Overall Study|Subject Decision|12|||
164509004|NCT03512197|594232961|FG000|Overall Study|Withdrawal of informed consent|20|||
164509005|NCT03512197|594232962|FG001|Overall Study|Withdrawal of informed consent|14|||
164509006|NCT03512197|594232961|FG000|Overall Study|Adverse Event|30|||
164509007|NCT03512197|594232962|FG001|Overall Study|Adverse Event|34|||
164509008|NCT03512197|594232961|FG000|Overall Study|Death|14|||
164509009|NCT03512197|594232962|FG001|Overall Study|Death|9|||
164509010|NCT03512197|594232961|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
164509011|NCT03512197|594232962|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
164509012|NCT03512197|594232961|FG000|Overall Study|Missing|3|||
164509013|NCT03512197|594232962|FG001|Overall Study|Missing|13|||
164509014|NCT01806389|594232963|FG000|Overall Study|Withdrawal by Subject|4|||
164509015|NCT03358238|594232968|FG000|Overall Study|Withdrawal by Subject|0|||
164509016|NCT03358238|594232969|FG001|Overall Study|Withdrawal by Subject|1|||
164509017|NCT02633397|594232970|FG000|Overall Study|Adverse Event|8|||
164509018|NCT02633397|594232971|FG001|Overall Study|Adverse Event|8|||
164509019|NCT02633397|594232970|FG000|Overall Study|Study Burden|4|||
164509020|NCT02633397|594232971|FG001|Overall Study|Study Burden|1|||
164509021|NCT02633397|594232970|FG000|Overall Study|Treatment interruption|2|||
164509022|NCT02633397|594232971|FG001|Overall Study|Treatment interruption|5|||
164509023|NCT02633397|594232970|FG000|Overall Study|Death|2|||
164509024|NCT02633397|594232971|FG001|Overall Study|Death|2|||
164509025|NCT02633397|594232970|FG000|Overall Study|Physician Decision|0|||
164509026|NCT02633397|594232971|FG001|Overall Study|Physician Decision|1|||
164509027|NCT03595878|594232972|FG000|Overall Study|Death|2|||
164509028|NCT03595878|594232973|FG001|Overall Study|Death|1|||
164509029|NCT03595878|594232974|FG002|Overall Study|Death|0|||
164509030|NCT03595878|594232972|FG000|Overall Study|Disease progression|2|||
164509031|NCT03595878|594232973|FG001|Overall Study|Disease progression|1|||
164509032|NCT03595878|594232974|FG002|Overall Study|Disease progression|2|||
164509033|NCT03036124|594232975|FG000|Overall Study|Lost to Follow-up|0|||
164509034|NCT03036124|594232976|FG001|Overall Study|Lost to Follow-up|2|||
164509035|NCT03036124|594232975|FG000|Overall Study|Withdrawal by Subject|5|||
164509036|NCT03036124|594232976|FG001|Overall Study|Withdrawal by Subject|4|||
164509037|NCT01340014|594232977|FG000|Period 1, First 7 Days|Adverse Event|1|||
164509038|NCT01340014|594232978|FG001|Period 1, First 7 Days|Adverse Event|0|||
164509039|NCT01340014|594232977|FG000|Period 1, First 7 Days|Personal Reasons|1|||
164509040|NCT01340014|594232978|FG001|Period 1, First 7 Days|Personal Reasons|0|||
164509041|NCT01340014|594232977|FG000|Period 2, Second 7 Days|Adverse Event|0|||
164509042|NCT01340014|594232978|FG001|Period 2, Second 7 Days|Adverse Event|1|||
164509043|NCT05101993|594232983|FG000|Overall Study|Withdrawal by Subject|1|||
164509044|NCT04577573|594232984|FG000|Overall Study|Technical - invalid protocol|0|||
164509045|NCT04577573|594232985|FG001|Overall Study|Technical - invalid protocol|2|||
164509046|NCT04577573|594232986|FG002|Overall Study|Technical - invalid protocol|0|||
164509047|NCT04949802|594234260|FG000|Overall Study|Lost to Follow-up|3|||
164509048|NCT03778294|594234261|FG000|Overall Study|Death|1|||
164509049|NCT03778294|594234261|FG000|Overall Study|Issues with insurance|1|||
164509050|NCT03778294|594234261|FG000|Overall Study|disease progression before treatment|2|||
164509051|NCT00127842|594234262|FG000|Overall Study|Adverse Event|15|||
164509052|NCT00127842|594234262|FG000|Overall Study|Withdrawal by Subject|3|||
164509053|NCT00127842|594234262|FG000|Overall Study|Lost to Follow-up|1|||
164509054|NCT00127842|594234262|FG000|Overall Study|Lack of Efficacy|12|||
164509055|NCT00127842|594234262|FG000|Overall Study|Noncompliance|2|||
164509056|NCT00127842|594234262|FG000|Overall Study|Protocol Violation|1|||
164509057|NCT00127842|594234262|FG000|Overall Study|Other|5|||
164509058|NCT02113124|594234263|FG000|Overall Study|Unable to retrieve blood sample|1|||
164509059|NCT02113124|594234264|FG001|Overall Study|Unable to retrieve blood sample|1|||
164509060|NCT01439867|594234265|FG000|Overall Study|Non-compliance|0|||
164509061|NCT01439867|594234266|FG001|Overall Study|Non-compliance|1|||
164608344|NCT01770145|594587811|FG000|Treatment|Withdrawal by Subject|1|||
164608345|NCT01102140|594587812|FG000|Overall Study|Lost to Follow-up|1|||
164608346|NCT01102140|594587813|FG001|Overall Study|Lost to Follow-up|0|||
164608347|NCT01102140|594587812|FG000|Overall Study|Investigator terminated study|2|||
164608348|NCT01102140|594587813|FG001|Overall Study|Investigator terminated study|2|||
164608349|NCT05406440|594587814|FG000|Overall Study|Lost to Follow-up|0|||
164608350|NCT05406440|594587815|FG001|Overall Study|Lost to Follow-up|0|||
164608351|NCT05406440|594587816|FG002|Overall Study|Lost to Follow-up|0|||
164608352|NCT05406440|594587817|FG003|Overall Study|Lost to Follow-up|0|||
164608353|NCT05406440|594587818|FG004|Overall Study|Lost to Follow-up|2|||
164608354|NCT05406440|594587819|FG005|Overall Study|Lost to Follow-up|0|||
164608355|NCT05406440|594587820|FG006|Overall Study|Lost to Follow-up|0|||
164608356|NCT05406440|594587814|FG000|Overall Study|Physician Decision|0|||
164608357|NCT05406440|594587815|FG001|Overall Study|Physician Decision|0|||
164608358|NCT05406440|594587816|FG002|Overall Study|Physician Decision|0|||
164608359|NCT05406440|594587817|FG003|Overall Study|Physician Decision|0|||
164608360|NCT05406440|594587818|FG004|Overall Study|Physician Decision|1|||
164608361|NCT05406440|594587819|FG005|Overall Study|Physician Decision|0|||
164608362|NCT05406440|594587820|FG006|Overall Study|Physician Decision|0|||
164608363|NCT05406440|594587814|FG000|Overall Study|Withdrawal by Subject|0|||
164608364|NCT05406440|594587815|FG001|Overall Study|Withdrawal by Subject|0|||
164608365|NCT05406440|594587816|FG002|Overall Study|Withdrawal by Subject|0|||
164608366|NCT05406440|594587817|FG003|Overall Study|Withdrawal by Subject|0|||
164608367|NCT05406440|594587818|FG004|Overall Study|Withdrawal by Subject|0|||
164608368|NCT05406440|594587819|FG005|Overall Study|Withdrawal by Subject|2|||
164608369|NCT05406440|594587820|FG006|Overall Study|Withdrawal by Subject|0|||
164608370|NCT01412151|594587821|FG000|Week 0 - 306 - Treatment Period|Death|1|||
164608371|NCT01412151|594587821|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
164608372|NCT01412151|594587821|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
164608373|NCT01412151|594587821|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
164608374|NCT03621189|594587824|FG000|Overall Study|Withdrawal by Subject|0|||
164608375|NCT03621189|594587825|FG001|Overall Study|Withdrawal by Subject|3|||
164608376|NCT03621189|594587824|FG000|Overall Study|Physician Decision|0|||
164608377|NCT03621189|594587825|FG001|Overall Study|Physician Decision|2|||
164608378|NCT02150213|594587826|FG000|Overall Study|Lost to Follow-up|1|||
164608379|NCT02150213|594587826|FG000|Overall Study|Withdrawal by Subject|1|||
164608380|NCT04134728|594587827|FG000|Overall Study|Adverse Event|3|||
164608381|NCT04134728|594587828|FG001|Overall Study|Adverse Event|2|||
164608382|NCT04134728|594587829|FG002|Overall Study|Adverse Event|9|||
164608383|NCT04134728|594587830|FG003|Overall Study|Adverse Event|0|||
164608384|NCT04134728|594587831|FG004|Overall Study|Adverse Event|0|||
164608385|NCT04134728|594587832|FG005|Overall Study|Adverse Event|0|||
164608386|NCT04134728|594587827|FG000|Overall Study|Lack of Efficacy|3|||
164608387|NCT04134728|594587828|FG001|Overall Study|Lack of Efficacy|3|||
164608388|NCT04134728|594587829|FG002|Overall Study|Lack of Efficacy|1|||
164608389|NCT04134728|594587830|FG003|Overall Study|Lack of Efficacy|2|||
164608390|NCT04134728|594587831|FG004|Overall Study|Lack of Efficacy|0|||
164608391|NCT04134728|594587832|FG005|Overall Study|Lack of Efficacy|0|||
164608392|NCT04134728|594587827|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
164608393|NCT04134728|594587828|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164608394|NCT04134728|594587829|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
164608395|NCT04134728|594587830|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164608396|NCT04134728|594587831|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164608397|NCT04134728|594587832|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164608398|NCT04134728|594587827|FG000|Overall Study|Protocol Deviation|0|||
164608399|NCT04134728|594587828|FG001|Overall Study|Protocol Deviation|0|||
164608400|NCT04134728|594587829|FG002|Overall Study|Protocol Deviation|1|||
164608401|NCT04134728|594587830|FG003|Overall Study|Protocol Deviation|0|||
164608402|NCT04134728|594587831|FG004|Overall Study|Protocol Deviation|0|||
164608403|NCT04134728|594587832|FG005|Overall Study|Protocol Deviation|0|||
164608404|NCT04134728|594587827|FG000|Overall Study|Informed Consent Withdrawn|3|||
164608405|NCT04134728|594587828|FG001|Overall Study|Informed Consent Withdrawn|6|||
164608406|NCT04134728|594587829|FG002|Overall Study|Informed Consent Withdrawn|8|||
164608407|NCT04134728|594587830|FG003|Overall Study|Informed Consent Withdrawn|1|||
164608408|NCT04134728|594587831|FG004|Overall Study|Informed Consent Withdrawn|1|||
164608409|NCT04134728|594587832|FG005|Overall Study|Informed Consent Withdrawn|0|||
164608410|NCT04134728|594587827|FG000|Overall Study|Physician Decision|2|||
164608411|NCT04134728|594587828|FG001|Overall Study|Physician Decision|0|||
164608412|NCT04134728|594587829|FG002|Overall Study|Physician Decision|0|||
164608413|NCT04134728|594587830|FG003|Overall Study|Physician Decision|0|||
164608414|NCT04134728|594587831|FG004|Overall Study|Physician Decision|0|||
164608415|NCT04134728|594587832|FG005|Overall Study|Physician Decision|0|||
164608416|NCT04134728|594587827|FG000|Overall Study|Lost to Follow-up|1|||
164608417|NCT04134728|594587828|FG001|Overall Study|Lost to Follow-up|2|||
164608418|NCT04134728|594587829|FG002|Overall Study|Lost to Follow-up|1|||
164608419|NCT04134728|594587830|FG003|Overall Study|Lost to Follow-up|0|||
164509062|NCT01439867|594234265|FG000|Overall Study|Withdrawal by Subject|1|||
164509063|NCT01439867|594234266|FG001|Overall Study|Withdrawal by Subject|2|||
164509064|NCT01439867|594234265|FG000|Overall Study|Administrative Decision|4|||
164509065|NCT01439867|594234266|FG001|Overall Study|Administrative Decision|5|||
164509066|NCT01439867|594234265|FG000|Overall Study|Protocol-specified Criteria|1|||
164509067|NCT01439867|594234266|FG001|Overall Study|Protocol-specified Criteria|0|||
164509068|NCT01667926|594234267|FG000|Overall Study|Withdrawal by Subject|1|||
164509069|NCT01667926|594234268|FG001|Overall Study|Withdrawal by Subject|2|||
164509070|NCT01667926|594234269|FG002|Overall Study|Withdrawal by Subject|2|||
164509071|NCT01667926|594234267|FG000|Overall Study|Physician Decision|0|||
164509072|NCT01667926|594234268|FG001|Overall Study|Physician Decision|0|||
164509073|NCT01667926|594234269|FG002|Overall Study|Physician Decision|1|||
164509074|NCT01667926|594234267|FG000|Overall Study|Time committment|0|||
164509075|NCT01667926|594234268|FG001|Overall Study|Time committment|0|||
164509076|NCT01667926|594234269|FG002|Overall Study|Time committment|2|||
164509077|NCT01667926|594234267|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
164509078|NCT01667926|594234268|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
164509079|NCT01667926|594234269|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
164509080|NCT01667926|594234267|FG000|Overall Study|Lost to Follow-up|1|||
164509081|NCT01667926|594234268|FG001|Overall Study|Lost to Follow-up|2|||
164509082|NCT01667926|594234269|FG002|Overall Study|Lost to Follow-up|1|||
164509083|NCT01667926|594234267|FG000|Overall Study|Side effects|3|||
164509084|NCT01667926|594234268|FG001|Overall Study|Side effects|0|||
164509085|NCT01667926|594234269|FG002|Overall Study|Side effects|0|||
164509086|NCT01020877|594234271|FG000|Second Intervention|Withdrawal by Subject|1|||
164509087|NCT01020877|594234272|FG001|Second Intervention|Withdrawal by Subject|0|||
164509088|NCT02870972|594234273|FG000|Overall Study|Adverse Event|1|||
164509089|NCT02870972|594234274|FG001|Overall Study|Adverse Event|0|||
164509090|NCT02870972|594234275|FG002|Overall Study|Adverse Event|0|||
164509091|NCT02870972|594234276|FG003|Overall Study|Adverse Event|0|||
164509092|NCT02870972|594234277|FG004|Overall Study|Adverse Event|0|||
164509093|NCT00732992|594234278|FG000|Overall Study|Adverse Event|1|||
164509094|NCT00732992|594234279|FG001|Overall Study|Adverse Event|1|||
164509095|NCT00732992|594234278|FG000|Overall Study|Objective Progression or Relapse|3|||
164509096|NCT00732992|594234279|FG001|Overall Study|Objective Progression or Relapse|5|||
164509097|NCT00732992|594234278|FG000|Overall Study|Global Deterioration of Health Status|1|||
164509098|NCT00732992|594234279|FG001|Overall Study|Global Deterioration of Health Status|0|||
164509099|NCT00732992|594234278|FG000|Overall Study|Withdrawal by Subject|1|||
164509100|NCT00732992|594234279|FG001|Overall Study|Withdrawal by Subject|0|||
164509101|NCT04042077|594234282|FG000|Overall Study|Adverse Event|0|||
164509102|NCT04042077|594234283|FG001|Overall Study|Adverse Event|1|||
164509103|NCT04042077|594234282|FG000|Overall Study|Death|2|||
164509104|NCT04042077|594234283|FG001|Overall Study|Death|1|||
164509105|NCT04042077|594234282|FG000|Overall Study|Physician Decision|2|||
164509106|NCT04042077|594234283|FG001|Overall Study|Physician Decision|0|||
164509107|NCT04042077|594234282|FG000|Overall Study|Withdrawal by Subject|3|||
164509108|NCT04042077|594234283|FG001|Overall Study|Withdrawal by Subject|2|||
164509109|NCT04042077|594234282|FG000|Overall Study|Lack of Efficacy|0|||
164509110|NCT04042077|594234283|FG001|Overall Study|Lack of Efficacy|1|||
164509111|NCT02493946|594234285|FG000|DB Period|Withdrawal by Subject|8|||
164509112|NCT02493946|594234286|FG001|DB Period|Withdrawal by Subject|5|||
164509113|NCT02493946|594234287|FG002|DB Period|Withdrawal by Subject|0|||
164509114|NCT02493946|594234285|FG000|Open Label Period|Withdrawal by Subject|0|||
164509115|NCT02493946|594234286|FG001|Open Label Period|Withdrawal by Subject|0|||
164509116|NCT02493946|594234287|FG002|Open Label Period|Withdrawal by Subject|74|||
164509117|NCT02493946|594234285|FG000|Open Label Period|Adverse Event|0|||
164509118|NCT02493946|594234286|FG001|Open Label Period|Adverse Event|0|||
164509119|NCT02493946|594234287|FG002|Open Label Period|Adverse Event|4|||
164509120|NCT02493946|594234285|FG000|Open Label Period|Lost to Follow-up|0|||
164509121|NCT02493946|594234286|FG001|Open Label Period|Lost to Follow-up|0|||
164509122|NCT02493946|594234287|FG002|Open Label Period|Lost to Follow-up|1|||
164509123|NCT02493946|594234285|FG000|Open Label Period|Investigator decision, non-compliance|0|||
164509124|NCT02493946|594234286|FG001|Open Label Period|Investigator decision, non-compliance|0|||
164509125|NCT02493946|594234287|FG002|Open Label Period|Investigator decision, non-compliance|2|||
164509126|NCT02493946|594234285|FG000|Open Label Period|Investigator decision, non-availability|0|||
164509127|NCT02493946|594234286|FG001|Open Label Period|Investigator decision, non-availability|0|||
164509128|NCT02493946|594234287|FG002|Open Label Period|Investigator decision, non-availability|1|||
164509129|NCT02493946|594234285|FG000|Open Label Period|Pregnancy|0|||
164509130|NCT02493946|594234286|FG001|Open Label Period|Pregnancy|0|||
164509131|NCT02493946|594234287|FG002|Open Label Period|Pregnancy|3|||
164509132|NCT02493946|594234285|FG000|Open Label Period|Site error|0|||
164509133|NCT02493946|594234286|FG001|Open Label Period|Site error|0|||
164509134|NCT02493946|594234287|FG002|Open Label Period|Site error|1|||
164509135|NCT02878603|594234289|FG000|Overall Study|Lost to Follow-up|4|||
164509136|NCT02878603|594234290|FG001|Overall Study|Lost to Follow-up|1|||
164146821|NCT00352417|592898172|FG000|Overall Study|Adverse Event|1|||
164509137|NCT02878603|594234289|FG000|Overall Study|Withdrawal by Subject|1|||
164509138|NCT02878603|594234290|FG001|Overall Study|Withdrawal by Subject|1|||
164608420|NCT04134728|594587831|FG004|Overall Study|Lost to Follow-up|0|||
164608421|NCT04134728|594587832|FG005|Overall Study|Lost to Follow-up|1|||
164509139|NCT02878603|594234289|FG000|Overall Study|Death|1|||
164509140|NCT02878603|594234290|FG001|Overall Study|Death|0|||
164509141|NCT02878603|594234289|FG000|Overall Study|Physician Decision|0|||
164509142|NCT02878603|594234290|FG001|Overall Study|Physician Decision|3|||
164509143|NCT02689453|594234291|FG000|Overall Study|Progressive disease|0|||
164509144|NCT02689453|594234292|FG001|Overall Study|Progressive disease|1|||
164509145|NCT02689453|594234293|FG002|Overall Study|Progressive disease|1|||
164509146|NCT00953615|594234294|FG000|Overall Study|Adverse Event|1|||
164608422|NCT04134728|594587827|FG000|Overall Study|Investigator Site Closed|0|||
164608423|NCT04134728|594587828|FG001|Overall Study|Investigator Site Closed|1|||
164608424|NCT04134728|594587829|FG002|Overall Study|Investigator Site Closed|1|||
164608425|NCT04134728|594587830|FG003|Overall Study|Investigator Site Closed|0|||
164608426|NCT04134728|594587831|FG004|Overall Study|Investigator Site Closed|0|||
164608427|NCT04134728|594587832|FG005|Overall Study|Investigator Site Closed|0|||
164608428|NCT01175590|594587833|FG000|Overall Study|Lost to Follow-up|1|||
164608429|NCT01175590|594587834|FG001|Overall Study|Lost to Follow-up|0|||
164608430|NCT01175590|594587833|FG000|Overall Study|Withdrawal by Subject|0|||
164608431|NCT01175590|594587834|FG001|Overall Study|Withdrawal by Subject|2|||
164608432|NCT01175590|594587833|FG000|Overall Study|Adverse Event|4|||
164608433|NCT01175590|594587834|FG001|Overall Study|Adverse Event|0|||
164608434|NCT01175590|594587833|FG000|Overall Study|Physician Decision|1|||
164608435|NCT01175590|594587834|FG001|Overall Study|Physician Decision|4|||
164608436|NCT01175590|594587833|FG000|Overall Study|Lack of Efficacy|1|||
164608437|NCT01175590|594587834|FG001|Overall Study|Lack of Efficacy|1|||
164608438|NCT01175590|594587833|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
164608439|NCT01175590|594587834|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
164608440|NCT01175590|594587833|FG000|Overall Study|Treated not as randomized|3|||
164608441|NCT01175590|594587834|FG001|Overall Study|Treated not as randomized|2|||
164608442|NCT01175590|594587833|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
164608443|NCT01175590|594587834|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
164608444|NCT01175590|594587833|FG000|Overall Study|Protocol Violation|0|||
164608445|NCT01175590|594587834|FG001|Overall Study|Protocol Violation|1|||
164608446|NCT01090102|594587835|FG000|First 12 Weeks|Withdrawal by Subject|1|||
164608447|NCT01090102|594587836|FG001|First 12 Weeks|Withdrawal by Subject|1|||
164608448|NCT01090102|594587835|FG000|First 12 Weeks|Adverse Event|2|||
164509147|NCT03274895|594234295|FG000|Overall Study|Lack of Efficacy|1|||
164509148|NCT03274895|594234296|FG001|Overall Study|Lack of Efficacy|0|||
164509149|NCT03274895|594234295|FG000|Overall Study|Adverse Event|8|||
164509150|NCT03274895|594234296|FG001|Overall Study|Adverse Event|7|||
164608449|NCT01090102|594587836|FG001|First 12 Weeks|Adverse Event|0|||
164608450|NCT01090102|594587835|FG000|First 12 Weeks|Death|1|||
164608451|NCT01090102|594587836|FG001|First 12 Weeks|Death|1|||
164608452|NCT01090102|594587835|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
164608453|NCT01090102|594587836|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
164608454|NCT03518034|594587839|FG000|Overall Study|Not Treated|5|||
164608455|NCT03518034|594587840|FG001|Overall Study|Not Treated|1|||
164608456|NCT03518034|594587839|FG000|Overall Study|Withdrawal by Subject|309|||
164608457|NCT03518034|594587840|FG001|Overall Study|Withdrawal by Subject|351|||
164509151|NCT03274895|594234295|FG000|Overall Study|Lost to Follow-up|1|||
164509152|NCT03274895|594234296|FG001|Overall Study|Lost to Follow-up|0|||
164509153|NCT03274895|594234295|FG000|Overall Study|Diagnosis not confirmed|3|||
164509154|NCT03274895|594234296|FG001|Overall Study|Diagnosis not confirmed|4|||
164509155|NCT01969851|594234297|FG000|Overall Study|Adverse Event|0|||
164509156|NCT01969851|594234298|FG001|Overall Study|Adverse Event|0|||
164509157|NCT01969851|594234299|FG002|Overall Study|Adverse Event|3|||
164509158|NCT01969851|594234297|FG000|Overall Study|Lack of Efficacy|0|||
164509159|NCT01969851|594234298|FG001|Overall Study|Lack of Efficacy|3|||
164509160|NCT01969851|594234299|FG002|Overall Study|Lack of Efficacy|1|||
164509161|NCT01969851|594234297|FG000|Overall Study|Withdrawal by Subject|1|||
164509162|NCT01969851|594234298|FG001|Overall Study|Withdrawal by Subject|0|||
164509163|NCT01969851|594234299|FG002|Overall Study|Withdrawal by Subject|1|||
164509164|NCT01969851|594234297|FG000|Overall Study|No effective dose in Titration period|0|||
164509165|NCT01969851|594234298|FG001|Overall Study|No effective dose in Titration period|0|||
164509166|NCT01969851|594234299|FG002|Overall Study|No effective dose in Titration period|1|||
164509167|NCT01969851|594234297|FG000|Overall Study|Sponsor decision|0|||
164509168|NCT01969851|594234298|FG001|Overall Study|Sponsor decision|0|||
164509169|NCT01969851|594234299|FG002|Overall Study|Sponsor decision|1|||
164509170|NCT01294436|594234304|FG000|Overall Study|Adverse Event|10|||
164509171|NCT01294436|594234305|FG001|Overall Study|Adverse Event|17|||
164509172|NCT01294436|594234304|FG000|Overall Study|Withdrawal by Subject|11|||
164509173|NCT01294436|594234305|FG001|Overall Study|Withdrawal by Subject|28|||
164509174|NCT01294436|594234304|FG000|Overall Study|subject no longer meets study criteria|5|||
164509175|NCT01294436|594234305|FG001|Overall Study|subject no longer meets study criteria|20|||
164509176|NCT01294436|594234304|FG000|Overall Study|poor/non-compliance|2|||
164509177|NCT01294436|594234305|FG001|Overall Study|poor/non-compliance|5|||
164509178|NCT01754753|594234306|FG000|Overall Study|Study close|43|||
164509179|NCT01754753|594234307|FG001|Overall Study|Study close|44|||
164509180|NCT01754753|594234306|FG000|Overall Study|Lost to Follow-up|9|||
164509181|NCT01754753|594234307|FG001|Overall Study|Lost to Follow-up|5|||
164509182|NCT03229486|594234308|FG000|Overall Study|Protocol Violation|0|||
164509183|NCT03229486|594234309|FG001|Overall Study|Protocol Violation|1|||
164509184|NCT02615938|594234312|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|3|||
164509185|NCT02615938|594234313|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|2|||
164509186|NCT02615938|594234314|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
164509187|NCT02615938|594234315|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
164509188|NCT02615938|594234312|FG000|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|1|||
164509189|NCT02615938|594234313|FG001|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
164509190|NCT02615938|594234314|FG002|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
164509191|NCT02615938|594234315|FG003|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
164509192|NCT02615938|594234312|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
164509193|NCT02615938|594234313|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
164509194|NCT02615938|594234314|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|1|||
164509195|NCT02615938|594234315|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
164509196|NCT01637077|594234319|FG000|Overall Study|Cancel|1|||
164509197|NCT01637077|594234320|FG001|Overall Study|Cancel|1|||
164509198|NCT01637077|594234319|FG000|Overall Study|Withdrawal by Subject|1|||
164509199|NCT01637077|594234320|FG001|Overall Study|Withdrawal by Subject|0|||
164509200|NCT01637077|594234319|FG000|Overall Study|No cycle 1 questionnaire data|2|||
164509201|NCT01637077|594234320|FG001|Overall Study|No cycle 1 questionnaire data|0|||
164509202|NCT02638103|594234321|FG000|Overall Study|Adverse Event|13|||
164509203|NCT02638103|594234322|FG001|Overall Study|Adverse Event|12|||
164509204|NCT02638103|594234323|FG002|Overall Study|Adverse Event|19|||
164509205|NCT02638103|594234324|FG003|Overall Study|Adverse Event|12|||
164509206|NCT02638103|594234321|FG000|Overall Study|Withdrawal by Subject|43|||
164509207|NCT02638103|594234322|FG001|Overall Study|Withdrawal by Subject|53|||
164509208|NCT02638103|594234323|FG002|Overall Study|Withdrawal by Subject|30|||
164509209|NCT02638103|594234324|FG003|Overall Study|Withdrawal by Subject|61|||
164509210|NCT02638103|594234321|FG000|Overall Study|Protocol Violation|1|||
164509211|NCT02638103|594234322|FG001|Overall Study|Protocol Violation|2|||
164509212|NCT02638103|594234323|FG002|Overall Study|Protocol Violation|1|||
164509213|NCT02638103|594234324|FG003|Overall Study|Protocol Violation|4|||
164509214|NCT02638103|594234321|FG000|Overall Study|Pregnancy|2|||
164608458|NCT03518034|594587839|FG000|Overall Study|Lost to Follow-up|446|||
164146822|NCT00352417|592898173|FG001|Overall Study|Adverse Event|0|||
164509215|NCT02638103|594234322|FG001|Overall Study|Pregnancy|3|||
164509216|NCT02638103|594234323|FG002|Overall Study|Pregnancy|0|||
164509217|NCT02638103|594234324|FG003|Overall Study|Pregnancy|1|||
164509218|NCT02638103|594234321|FG000|Overall Study|Non-compliance to Study Procedures|2|||
164509219|NCT02638103|594234322|FG001|Overall Study|Non-compliance to Study Procedures|1|||
164608459|NCT03518034|594587840|FG001|Overall Study|Lost to Follow-up|458|||
164608460|NCT03518034|594587839|FG000|Overall Study|Adverse Event|138|||
164509220|NCT02638103|594234323|FG002|Overall Study|Non-compliance to Study Procedures|1|||
164509221|NCT02638103|594234324|FG003|Overall Study|Non-compliance to Study Procedures|1|||
164608461|NCT03518034|594587840|FG001|Overall Study|Adverse Event|130|||
164509222|NCT02638103|594234321|FG000|Overall Study|Lost to Follow-up|26|||
164509223|NCT02638103|594234322|FG001|Overall Study|Lost to Follow-up|33|||
164509224|NCT02638103|594234323|FG002|Overall Study|Lost to Follow-up|20|||
164509225|NCT02638103|594234324|FG003|Overall Study|Lost to Follow-up|37|||
164509226|NCT02638103|594234321|FG000|Overall Study|Lack of Efficacy|14|||
164509227|NCT02638103|594234322|FG001|Overall Study|Lack of Efficacy|10|||
164509228|NCT02638103|594234323|FG002|Overall Study|Lack of Efficacy|12|||
164509229|NCT02638103|594234324|FG003|Overall Study|Lack of Efficacy|22|||
164509230|NCT02638103|594234321|FG000|Overall Study|Other than specified|5|||
164509231|NCT02638103|594234322|FG001|Overall Study|Other than specified|4|||
164509232|NCT02638103|594234323|FG002|Overall Study|Other than specified|2|||
164509233|NCT02638103|594234324|FG003|Overall Study|Other than specified|4|||
164509234|NCT00838929|594234325|FG000|Overall Study|Protocol Violation|0|||
164509235|NCT00838929|594234326|FG001|Overall Study|Protocol Violation|1|||
164509236|NCT00838929|594234327|FG002|Overall Study|Protocol Violation|0|||
164509237|NCT00838929|594234325|FG000|Overall Study|Disease progression|0|||
164509238|NCT00838929|594234326|FG001|Overall Study|Disease progression|2|||
164509239|NCT00838929|594234327|FG002|Overall Study|Disease progression|1|||
164509240|NCT01358331|594234328|FG000|Overall Study|Lost to Follow-up|0|||
164509241|NCT01358331|594234329|FG001|Overall Study|Lost to Follow-up|0|||
164509242|NCT01358331|594234330|FG002|Overall Study|Lost to Follow-up|0|||
164509243|NCT01358331|594234331|FG003|Overall Study|Lost to Follow-up|1|||
164509244|NCT01358331|594234332|FG004|Overall Study|Lost to Follow-up|0|||
164509245|NCT01358331|594234333|FG005|Overall Study|Lost to Follow-up|0|||
164509246|NCT01358331|594234328|FG000|Overall Study|Withdrawal by Subject|0|||
164509247|NCT01358331|594234329|FG001|Overall Study|Withdrawal by Subject|0|||
164509248|NCT01358331|594234330|FG002|Overall Study|Withdrawal by Subject|0|||
164509249|NCT01358331|594234331|FG003|Overall Study|Withdrawal by Subject|1|||
164509250|NCT01358331|594234332|FG004|Overall Study|Withdrawal by Subject|1|||
164509251|NCT01358331|594234333|FG005|Overall Study|Withdrawal by Subject|1|||
164509252|NCT01358331|594234328|FG000|Overall Study|Adverse Events|1|||
164509253|NCT01358331|594234329|FG001|Overall Study|Adverse Events|1|||
164509254|NCT01358331|594234330|FG002|Overall Study|Adverse Events|1|||
164509255|NCT01358331|594234331|FG003|Overall Study|Adverse Events|0|||
164509256|NCT01358331|594234332|FG004|Overall Study|Adverse Events|1|||
164509257|NCT01358331|594234333|FG005|Overall Study|Adverse Events|5|||
164509258|NCT01358331|594234328|FG000|Overall Study|Symptomatic Deterioration|0|||
164509259|NCT01358331|594234329|FG001|Overall Study|Symptomatic Deterioration|0|||
164509260|NCT01358331|594234330|FG002|Overall Study|Symptomatic Deterioration|0|||
164509261|NCT01358331|594234331|FG003|Overall Study|Symptomatic Deterioration|0|||
164509262|NCT01358331|594234332|FG004|Overall Study|Symptomatic Deterioration|1|||
164509263|NCT01358331|594234333|FG005|Overall Study|Symptomatic Deterioration|0|||
164509264|NCT01358331|594234328|FG000|Overall Study|Participants did not wish to continue|0|||
164509265|NCT01358331|594234329|FG001|Overall Study|Participants did not wish to continue|0|||
164509266|NCT01358331|594234330|FG002|Overall Study|Participants did not wish to continue|0|||
164509267|NCT01358331|594234331|FG003|Overall Study|Participants did not wish to continue|0|||
164509268|NCT01358331|594234332|FG004|Overall Study|Participants did not wish to continue|1|||
164509269|NCT01358331|594234333|FG005|Overall Study|Participants did not wish to continue|0|||
164509270|NCT01358331|594234328|FG000|Overall Study|Progress of disease under investigation|1|||
164509271|NCT01358331|594234329|FG001|Overall Study|Progress of disease under investigation|2|||
164509272|NCT01358331|594234330|FG002|Overall Study|Progress of disease under investigation|3|||
164509273|NCT01358331|594234331|FG003|Overall Study|Progress of disease under investigation|1|||
164509274|NCT01358331|594234332|FG004|Overall Study|Progress of disease under investigation|3|||
164509275|NCT01358331|594234333|FG005|Overall Study|Progress of disease under investigation|0|||
164509276|NCT04946942|594234334|FG000|Overall Study|Lost to Follow-up|6|||
164509277|NCT04946942|594234335|FG001|Overall Study|Lost to Follow-up|2|||
164509278|NCT04946942|594234336|FG002|Overall Study|Lost to Follow-up|0|||
164509279|NCT03342196|594234337|FG000|Overall Study|Physician Decision|1|||
164509280|NCT02257918|594234338|FG000|Overall Study|Lost to Follow-up|4|||
164509281|NCT02257918|594234339|FG001|Overall Study|Lost to Follow-up|1|||
164509282|NCT02257918|594234340|FG002|Overall Study|Lost to Follow-up|0|||
164509283|NCT02257918|594234338|FG000|Overall Study|Withdrawal by Subject|0|||
164509284|NCT02257918|594234339|FG001|Overall Study|Withdrawal by Subject|0|||
164509285|NCT02257918|594234340|FG002|Overall Study|Withdrawal by Subject|1|||
164509286|NCT02257918|594234338|FG000|Overall Study|Pregnancy|0|||
164509287|NCT02257918|594234339|FG001|Overall Study|Pregnancy|0|||
164509288|NCT02257918|594234340|FG002|Overall Study|Pregnancy|1|||
164509289|NCT03023423|594234343|FG000|Overall Study|Death|5|||
164509290|NCT03023423|594234344|FG001|Overall Study|Death|12|||
164509291|NCT03023423|594234345|FG002|Overall Study|Death|20|||
164509292|NCT03023423|594234343|FG000|Overall Study|Other|0|||
164608462|NCT03518034|594587839|FG000|Overall Study|Lack of Efficacy|11|||
164608463|NCT03518034|594587840|FG001|Overall Study|Lack of Efficacy|23|||
164608464|NCT03518034|594587839|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
164608465|NCT03518034|594587840|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
164608466|NCT03518034|594587839|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
164608467|NCT03518034|594587840|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
164608468|NCT03518034|594587839|FG000|Overall Study|Other, Not Specified|84|||
164608469|NCT03518034|594587840|FG001|Overall Study|Other, Not Specified|53|||
164608470|NCT03518034|594587839|FG000|Overall Study|Reason Missing|2|||
164608471|NCT03518034|594587840|FG001|Overall Study|Reason Missing|3|||
164608472|NCT03728140|594587841|FG000|Overall Study|Abnormal embryo transfer operation|10|||
164608473|NCT03728140|594587842|FG001|Overall Study|Abnormal embryo transfer operation|7|||
164608474|NCT02062398|594587843|FG000|Overall Study|Implant removal|1|||
164608475|NCT01527110|594587851|FG000|Overall Study|Adverse Event|1|||
164608476|NCT02007252|594587852|FG000|Overall Study|Administrative problems|3|||
164608477|NCT02007252|594587853|FG001|Overall Study|Administrative problems|7|||
164608478|NCT02007252|594587852|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164608479|NCT02007252|594587853|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164608480|NCT02007252|594587852|FG000|Overall Study|Adverse Event|7|||
164509293|NCT03023423|594234344|FG001|Overall Study|Other|2|||
164509294|NCT03023423|594234345|FG002|Overall Study|Other|2|||
164509295|NCT03023423|594234343|FG000|Overall Study|Ongoing|2|||
164509296|NCT03023423|594234344|FG001|Overall Study|Ongoing|32|||
164509297|NCT03023423|594234345|FG002|Overall Study|Ongoing|24|||
164509298|NCT01151423|594234346|FG000|Overall Study|Study terminated by Sponsor|9|||
164509299|NCT01151423|594234347|FG001|Overall Study|Study terminated by Sponsor|10|||
164509300|NCT01151423|594234346|FG000|Overall Study|Protocol Violation|0|||
164509301|NCT01151423|594234347|FG001|Overall Study|Protocol Violation|1|||
164509302|NCT01151423|594234346|FG000|Overall Study|Physician Decision|1|||
164509303|NCT01151423|594234347|FG001|Overall Study|Physician Decision|1|||
164509304|NCT01151423|594234346|FG000|Overall Study|Pregnancy|0|||
164509305|NCT01151423|594234347|FG001|Overall Study|Pregnancy|1|||
164509306|NCT01151423|594234346|FG000|Overall Study|Death|0|||
164509307|NCT01151423|594234347|FG001|Overall Study|Death|1|||
164509308|NCT01151423|594234346|FG000|Overall Study|Adverse Event|3|||
164509309|NCT01151423|594234347|FG001|Overall Study|Adverse Event|0|||
164509310|NCT01151423|594234346|FG000|Overall Study|Withdrawal by Subject|1|||
164509311|NCT01151423|594234347|FG001|Overall Study|Withdrawal by Subject|3|||
164509312|NCT01151423|594234346|FG000|Overall Study|Lost to Follow-up|1|||
164509313|NCT01151423|594234347|FG001|Overall Study|Lost to Follow-up|0|||
164509314|NCT01151423|594234346|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
164509315|NCT01151423|594234347|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
164509316|NCT01151423|594234346|FG000|Overall Study|Participated in other clinical trial|1|||
164509317|NCT01151423|594234347|FG001|Overall Study|Participated in other clinical trial|0|||
164509318|NCT01263054|594234348|FG000|Overall Study|Death|1|||
164509319|NCT01263054|594234349|FG001|Overall Study|Death|0|||
164509320|NCT01263054|594234348|FG000|Overall Study|Lost to Follow-up|2|||
164509321|NCT01263054|594234349|FG001|Overall Study|Lost to Follow-up|2|||
164509322|NCT01263054|594234348|FG000|Overall Study|Withdrawal by Subject|1|||
164509323|NCT01263054|594234349|FG001|Overall Study|Withdrawal by Subject|3|||
164509324|NCT01263054|594234348|FG000|Overall Study|Qualification Violation|1|||
164509325|NCT01263054|594234349|FG001|Overall Study|Qualification Violation|0|||
164509326|NCT01263054|594234348|FG000|Overall Study|Other|0|||
164509327|NCT01263054|594234349|FG001|Overall Study|Other|1|||
164509328|NCT00681668|594234350|FG000|Overall Study|Protocol Violation|1|||
164509329|NCT00681668|594234350|FG000|Overall Study|Withdrawal by Subject|1|||
164509330|NCT04277507|594234354|FG000|Overall Study|Lost to Follow-up|17|||
164509331|NCT04277507|594234354|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
164509332|NCT04277507|594234354|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
164509333|NCT04277507|594234354|FG000|Overall Study|Withdrawal by Subject|3|||
164509334|NCT04277507|594234354|FG000|Overall Study|Death due to COVID-19|1|||
164509335|NCT04277507|594234354|FG000|Overall Study|Data missing for full evaluation|5|||
164509336|NCT01124838|594234358|FG000|Overall Study|Miscellaneous|4|||
164509337|NCT01124838|594234359|FG001|Overall Study|Miscellaneous|2|||
164509338|NCT01124838|594234358|FG000|Overall Study|Adverse Event|7|||
164509339|NCT01124838|594234359|FG001|Overall Study|Adverse Event|11|||
164509340|NCT01124838|594234358|FG000|Overall Study|Lack of Efficacy|2|||
164509341|NCT01124838|594234359|FG001|Overall Study|Lack of Efficacy|0|||
164509342|NCT01124838|594234358|FG000|Overall Study|Withdrawal by Subject|3|||
164509343|NCT01124838|594234359|FG001|Overall Study|Withdrawal by Subject|2|||
164608481|NCT02007252|594587853|FG001|Overall Study|Adverse Event|4|||
164608482|NCT00367341|594587854|FG000|Overall Study|Physician Decision|1|||
164608483|NCT00367341|594587855|FG001|Overall Study|Physician Decision|0|||
164608484|NCT00367341|594587854|FG000|Overall Study|Protocol Violation|1|||
164146823|NCT00352417|592898172|FG000|Overall Study|Protocol Violation|0|||
164608485|NCT00367341|594587855|FG001|Overall Study|Protocol Violation|0|||
164608486|NCT01705587|594587856|FG000|Overall Study|Withdrawal by Subject|0|||
164608487|NCT01705587|594587857|FG001|Overall Study|Withdrawal by Subject|1|||
164146824|NCT00352417|592898173|FG001|Overall Study|Protocol Violation|2|||
164509344|NCT01124838|594234358|FG000|Overall Study|Lost to Follow-up|2|||
164509345|NCT01124838|594234359|FG001|Overall Study|Lost to Follow-up|0|||
164509346|NCT02065882|594234360|FG000|Part I: PK/PD|Screening failure|5|||
164509347|NCT02065882|594234360|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
164509348|NCT02065882|594234360|FG000|Part I: PK/PD|Adverse Event|1|||
164509349|NCT02065882|594234360|FG000|Part II: Clinical Efficacy|Screening failure|7|||
164509350|NCT02065882|594234360|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
164509351|NCT02065882|594234360|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
164509352|NCT02065882|594234360|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
164509353|NCT02065882|594234360|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
164509354|NCT02065882|594234360|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
164509355|NCT03213704|594234362|FG000|Overall Study|Physician Decision|3|||
164509356|NCT03213704|594234362|FG000|Overall Study|Protocol Violation|1|||
164509357|NCT03213704|594234362|FG000|Overall Study|Progressive disease|4|||
164509358|NCT02514239|594236331|FG000|Overall Study|Refused to continue trial medication|0|||
164509359|NCT02514239|594236332|FG001|Overall Study|Refused to continue trial medication|0|||
164509360|NCT02514239|594236333|FG002|Overall Study|Refused to continue trial medication|0|||
164509361|NCT02514239|594236334|FG003|Overall Study|Refused to continue trial medication|0|||
164509362|NCT02514239|594236335|FG004|Overall Study|Refused to continue trial medication|0|||
164509363|NCT02514239|594236336|FG005|Overall Study|Refused to continue trial medication|0|||
164509364|NCT02514239|594236337|FG006|Overall Study|Refused to continue trial medication|0|||
164509365|NCT02514239|594236338|FG007|Overall Study|Refused to continue trial medication|0|||
164509366|NCT02514239|594236339|FG008|Overall Study|Refused to continue trial medication|0|||
164509367|NCT02514239|594236340|FG009|Overall Study|Refused to continue trial medication|1|||
164509368|NCT02514239|594236331|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
164509369|NCT02514239|594236332|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
164509370|NCT02514239|594236333|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
164509371|NCT02514239|594236334|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
164509372|NCT02514239|594236335|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
164509373|NCT02514239|594236336|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
164509374|NCT02514239|594236337|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
164509375|NCT02514239|594236338|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
164509376|NCT02514239|594236339|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
164509377|NCT02514239|594236340|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
164509378|NCT02514239|594236331|FG000|Overall Study|Not treated|0|||
164509379|NCT02514239|594236332|FG001|Overall Study|Not treated|1|||
164509380|NCT02514239|594236333|FG002|Overall Study|Not treated|0|||
164509381|NCT02514239|594236334|FG003|Overall Study|Not treated|0|||
164509382|NCT02514239|594236335|FG004|Overall Study|Not treated|0|||
164509383|NCT02514239|594236336|FG005|Overall Study|Not treated|0|||
164509384|NCT02514239|594236337|FG006|Overall Study|Not treated|0|||
164509385|NCT02514239|594236338|FG007|Overall Study|Not treated|0|||
164509386|NCT02514239|594236339|FG008|Overall Study|Not treated|0|||
164509387|NCT02514239|594236340|FG009|Overall Study|Not treated|0|||
164509388|NCT02514239|594236331|FG000|Overall Study|Other Adverse Events|2|||
164509389|NCT02514239|594236332|FG001|Overall Study|Other Adverse Events|0|||
164509390|NCT02514239|594236333|FG002|Overall Study|Other Adverse Events|0|||
164608488|NCT01387074|594587858|FG000|Overall Study|Lost to Follow-up|7|||
164608489|NCT01387074|594587858|FG000|Overall Study|Lack of Efficacy|1|||
164608490|NCT00150345|594587859|FG000|Overall Study|Death|5|||
164608491|NCT00150345|594587860|FG001|Overall Study|Death|2|||
164608492|NCT00150345|594587859|FG000|Overall Study|Adverse Event|8|||
164608493|NCT00150345|594587860|FG001|Overall Study|Adverse Event|6|||
164608494|NCT00150345|594587859|FG000|Overall Study|Lack of Efficacy|5|||
164608495|NCT00150345|594587860|FG001|Overall Study|Lack of Efficacy|4|||
164608496|NCT00150345|594587859|FG000|Overall Study|Withdrawal by Subject|3|||
164608497|NCT00150345|594587860|FG001|Overall Study|Withdrawal by Subject|4|||
164608498|NCT00150345|594587859|FG000|Overall Study|Laboratory abnormality|1|||
164608499|NCT00150345|594587860|FG001|Overall Study|Laboratory abnormality|2|||
164608500|NCT00150345|594587859|FG000|Overall Study|Other|12|||
164608501|NCT00150345|594587860|FG001|Overall Study|Other|14|||
164608502|NCT01392742|594587861|FG000|Overall Study|Premature study termination|42|||
164608503|NCT01392742|594587861|FG000|Overall Study|Failure to return|35|||
164608504|NCT01392742|594587861|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
164608505|NCT01392742|594587861|FG000|Overall Study|Lost to Follow-up|34|||
164608506|NCT01392742|594587861|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
164608507|NCT01392742|594587861|FG000|Overall Study|ITR and Protocol deviation|1|||
164608508|NCT01392742|594587861|FG000|Overall Study|Adverse event/intercurrent illness|17|||
164608509|NCT01392742|594587861|FG000|Overall Study|Protocol Violation|14|||
164608510|NCT01392742|594587861|FG000|Overall Study|Other|3|||
164608511|NCT01392742|594587861|FG000|Overall Study|Missing information|13|||
164608512|NCT01998958|594587862|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164509391|NCT02514239|594236334|FG003|Overall Study|Other Adverse Events|1|||
164509392|NCT02514239|594236335|FG004|Overall Study|Other Adverse Events|0|||
164509393|NCT02514239|594236336|FG005|Overall Study|Other Adverse Events|1|||
164509394|NCT02514239|594236337|FG006|Overall Study|Other Adverse Events|0|||
164509395|NCT02514239|594236338|FG007|Overall Study|Other Adverse Events|1|||
164509396|NCT02514239|594236339|FG008|Overall Study|Other Adverse Events|2|||
164509397|NCT02514239|594236340|FG009|Overall Study|Other Adverse Events|0|||
164509398|NCT02514239|594236331|FG000|Overall Study|Progressive disease|3|||
164509399|NCT02514239|594236332|FG001|Overall Study|Progressive disease|3|||
164509400|NCT02514239|594236333|FG002|Overall Study|Progressive disease|2|||
164509401|NCT02514239|594236334|FG003|Overall Study|Progressive disease|2|||
164509402|NCT02514239|594236335|FG004|Overall Study|Progressive disease|3|||
164509403|NCT02514239|594236336|FG005|Overall Study|Progressive disease|3|||
164509404|NCT02514239|594236337|FG006|Overall Study|Progressive disease|4|||
164509405|NCT02514239|594236338|FG007|Overall Study|Progressive disease|2|||
164509406|NCT02514239|594236339|FG008|Overall Study|Progressive disease|5|||
164509407|NCT02514239|594236340|FG009|Overall Study|Progressive disease|0|||
164509408|NCT03299049|594236341|FG000|Overall Study|On-going|486|||
164509409|NCT03299049|594236342|FG001|Overall Study|On-going|481|||
164509410|NCT03299049|594236341|FG000|Overall Study|Withdrawal by Subject|6|||
164509411|NCT03299049|594236342|FG001|Overall Study|Withdrawal by Subject|21|||
164509412|NCT03299049|594236341|FG000|Overall Study|Physician Decision|5|||
164509413|NCT03299049|594236342|FG001|Overall Study|Physician Decision|1|||
164509414|NCT03299049|594236341|FG000|Overall Study|Lost to Follow-up|2|||
164509415|NCT03299049|594236342|FG001|Overall Study|Lost to Follow-up|0|||
164509416|NCT03299049|594236341|FG000|Overall Study|Pregnancy|1|||
164509417|NCT03299049|594236342|FG001|Overall Study|Pregnancy|3|||
164509418|NCT03299049|594236341|FG000|Overall Study|Protocol Violation|1|||
164509419|NCT03299049|594236342|FG001|Overall Study|Protocol Violation|1|||
164509420|NCT03299049|594236341|FG000|Overall Study|Lack of Efficacy|9|||
164509421|NCT03299049|594236342|FG001|Overall Study|Lack of Efficacy|3|||
164509422|NCT03299049|594236341|FG000|Overall Study|Adverse Event|12|||
164509423|NCT03299049|594236342|FG001|Overall Study|Adverse Event|13|||
164509424|NCT01901419|594236343|FG000|Overall Study|Protocol Violation|2|||
164509425|NCT01901419|594236344|FG001|Overall Study|Protocol Violation|6|||
164509426|NCT01901419|594236343|FG000|Overall Study|unavailable researchers|6|||
164509427|NCT01901419|594236344|FG001|Overall Study|unavailable researchers|3|||
164509428|NCT01411241|594236347|FG000|Overall Study|Protocol Violation|0|||
164509429|NCT01411241|594236348|FG001|Overall Study|Protocol Violation|5|||
164509430|NCT01411241|594236347|FG000|Overall Study|Withdrawal by Subject|9|||
164509431|NCT01411241|594236348|FG001|Overall Study|Withdrawal by Subject|10|||
164509432|NCT01411241|594236347|FG000|Overall Study|Serious Adverse Event|0|||
164509433|NCT01411241|594236348|FG001|Overall Study|Serious Adverse Event|3|||
164509434|NCT01411241|594236347|FG000|Overall Study|Lost to Follow-up|2|||
164509435|NCT01411241|594236348|FG001|Overall Study|Lost to Follow-up|4|||
164509436|NCT02980042|594236349|FG000|Overall Study|Lost to Follow-up|5|||
164509437|NCT02980042|594236350|FG001|Overall Study|Lost to Follow-up|0|||
164509438|NCT02980042|594236349|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
164509439|NCT02980042|594236350|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
164509440|NCT02521363|594236353|FG000|Overall Study|Withdrawal by Subject|1|||
164509441|NCT02521363|594236354|FG001|Overall Study|Withdrawal by Subject|2|||
164509442|NCT00953771|594236355|FG000|Overall Study|Death|1|||
164509443|NCT00953771|594236356|FG001|Overall Study|Death|0|||
164509444|NCT00974259|594236357|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
164509445|NCT00974259|594236358|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
164509446|NCT00592293|594236362|FG000|Overall Study|Withdrawal by Subject|1|||
164608513|NCT01998958|594587863|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
164608514|NCT01998958|594587864|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608515|NCT01998958|594587865|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164509447|NCT01270828|594236365|FG000|Pregabalin CR SB|Reason Unspecified|0|||
164509448|NCT01270828|594236366|FG001|Pregabalin CR SB|Reason Unspecified|0|||
164509449|NCT01270828|594236367|FG002|Pregabalin CR SB|Reason Unspecified|8|||
164509450|NCT01270828|594236365|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
164509451|NCT01270828|594236366|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
164509452|NCT01270828|594236367|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
164509453|NCT01270828|594236365|FG000|Pregabalin CR SB|Related adverse event|0|||
164509454|NCT01270828|594236366|FG001|Pregabalin CR SB|Related adverse event|0|||
164509455|NCT01270828|594236367|FG002|Pregabalin CR SB|Related adverse event|46|||
164509456|NCT01270828|594236365|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
164509457|NCT01270828|594236366|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
164509458|NCT01270828|594236367|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
164509459|NCT01270828|594236365|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
164509460|NCT01270828|594236366|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
164509461|NCT01270828|594236367|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
164509462|NCT01270828|594236365|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
164608516|NCT01998958|594587866|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608517|NCT01998958|594587867|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608518|NCT01998958|594587868|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608519|NCT01998958|594587869|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608520|NCT01998958|594587870|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608521|NCT01998958|594587871|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608522|NCT01998958|594587872|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608523|NCT01998958|594587873|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608524|NCT01998958|594587874|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608525|NCT01998958|594587875|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608526|NCT01998958|594587876|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608527|NCT01998958|594587877|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608528|NCT01998958|594587878|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608529|NCT01998958|594587879|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608530|NCT01998958|594587880|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608531|NCT01998958|594587881|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608532|NCT01998958|594587882|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608533|NCT01998958|594587883|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608534|NCT01998958|594587884|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608535|NCT01998958|594587885|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608536|NCT01998958|594587886|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608537|NCT01998958|594587887|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608538|NCT01998958|594587888|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608539|NCT01998958|594587889|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608540|NCT01998958|594587890|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608541|NCT01998958|594587891|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608542|NCT01998958|594587892|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164608543|NCT01998958|594587893|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164509463|NCT01270828|594236366|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
164509464|NCT01270828|594236367|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
164509465|NCT01270828|594236365|FG000|Pregabalin CR SB|Unrelated AE|0|||
164509466|NCT01270828|594236366|FG001|Pregabalin CR SB|Unrelated AE|0|||
164509467|NCT01270828|594236367|FG002|Pregabalin CR SB|Unrelated AE|8|||
164509468|NCT01270828|594236365|FG000|Pregabalin CR SB|Protocol Violation|0|||
164509469|NCT01270828|594236366|FG001|Pregabalin CR SB|Protocol Violation|0|||
164509470|NCT01270828|594236367|FG002|Pregabalin CR SB|Protocol Violation|8|||
164509471|NCT01270828|594236365|FG000|Double Blind Phase|Death|0|||
164509472|NCT01270828|594236366|FG001|Double Blind Phase|Death|1|||
164509473|NCT01270828|594236367|FG002|Double Blind Phase|Death|0|||
164509474|NCT01270828|594236365|FG000|Double Blind Phase|Protocol Violation|0|||
164509475|NCT01270828|594236366|FG001|Double Blind Phase|Protocol Violation|1|||
164509476|NCT01270828|594236367|FG002|Double Blind Phase|Protocol Violation|0|||
164509477|NCT01270828|594236365|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
164509478|NCT01270828|594236366|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
164509479|NCT01270828|594236367|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
164509480|NCT01270828|594236365|FG000|Double Blind Phase|Reason Unspecified|7|||
164509481|NCT01270828|594236366|FG001|Double Blind Phase|Reason Unspecified|4|||
164509482|NCT01270828|594236367|FG002|Double Blind Phase|Reason Unspecified|0|||
164509483|NCT01270828|594236365|FG000|Double Blind Phase|Withdrawal by Subject|6|||
164509484|NCT01270828|594236366|FG001|Double Blind Phase|Withdrawal by Subject|15|||
164608544|NCT01998958|594587862|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608545|NCT01998958|594587863|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
164608546|NCT01998958|594587864|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608547|NCT01998958|594587865|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608548|NCT01998958|594587866|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164509485|NCT01270828|594236367|FG002|Double Blind Phase|Withdrawal by Subject|0|||
164509486|NCT01270828|594236365|FG000|Double Blind Phase|Lost to Follow-up|1|||
164509487|NCT01270828|594236366|FG001|Double Blind Phase|Lost to Follow-up|2|||
164509488|NCT01270828|594236367|FG002|Double Blind Phase|Lost to Follow-up|0|||
164509489|NCT01270828|594236365|FG000|Double Blind Phase|Lack of Efficacy|2|||
164509490|NCT01270828|594236366|FG001|Double Blind Phase|Lack of Efficacy|11|||
164509491|NCT01270828|594236367|FG002|Double Blind Phase|Lack of Efficacy|0|||
164509492|NCT01270828|594236365|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
164509493|NCT01270828|594236366|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
164509494|NCT01270828|594236367|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
164509495|NCT01270828|594236365|FG000|Double Blind Phase|Adverse event related to study drug|5|||
164509496|NCT01270828|594236366|FG001|Double Blind Phase|Adverse event related to study drug|7|||
164509497|NCT01270828|594236367|FG002|Double Blind Phase|Adverse event related to study drug|0|||
164509498|NCT04052425|594236376|FG000|24-Week Double-blind Period|Adverse Event|0|||
164509499|NCT04052425|594236377|FG001|24-Week Double-blind Period|Adverse Event|1|||
164509500|NCT04052425|594236378|FG002|24-Week Double-blind Period|Adverse Event|0|||
164509501|NCT04052425|594236379|FG003|24-Week Double-blind Period|Adverse Event|0|||
164509502|NCT04052425|594236376|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
164509503|NCT04052425|594236377|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
164509504|NCT04052425|594236378|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
164509505|NCT04052425|594236379|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
164509506|NCT04052425|594236376|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
164509507|NCT04052425|594236377|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
164509508|NCT04052425|594236378|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
164509509|NCT04052425|594236379|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
164509510|NCT04052425|594236376|FG000|24-Week Double-blind Period|Physician Decision|1|||
164509511|NCT04052425|594236377|FG001|24-Week Double-blind Period|Physician Decision|0|||
164509512|NCT04052425|594236378|FG002|24-Week Double-blind Period|Physician Decision|0|||
164509513|NCT04052425|594236379|FG003|24-Week Double-blind Period|Physician Decision|0|||
164509514|NCT04052425|594236376|FG000|24-Week Double-blind Period|Protocol Violation|1|||
164509515|NCT04052425|594236377|FG001|24-Week Double-blind Period|Protocol Violation|0|||
164509516|NCT04052425|594236378|FG002|24-Week Double-blind Period|Protocol Violation|0|||
164509517|NCT04052425|594236379|FG003|24-Week Double-blind Period|Protocol Violation|0|||
164509518|NCT04052425|594236376|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
164509519|NCT04052425|594236377|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
164509520|NCT04052425|594236378|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
164509521|NCT04052425|594236379|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
164509522|NCT04052425|594236376|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
164509523|NCT04052425|594236377|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
164509524|NCT04052425|594236378|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
164509525|NCT04052425|594236379|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
164509526|NCT04052425|594236376|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
164509527|NCT04052425|594236377|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
164509528|NCT04052425|594236378|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
164509529|NCT04052425|594236379|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
164608549|NCT01998958|594587867|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608550|NCT01998958|594587868|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608551|NCT01998958|594587869|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608552|NCT01998958|594587870|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608553|NCT01998958|594587871|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608554|NCT01998958|594587872|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608555|NCT01998958|594587873|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608556|NCT01998958|594587874|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608557|NCT01998958|594587875|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608558|NCT01998958|594587876|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608559|NCT01998958|594587877|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608560|NCT01998958|594587878|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608561|NCT01998958|594587879|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608562|NCT01998958|594587880|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608563|NCT01998958|594587881|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608564|NCT01998958|594587882|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608565|NCT01998958|594587883|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608566|NCT01998958|594587884|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608567|NCT01998958|594587885|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608568|NCT01998958|594587886|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608569|NCT01998958|594587887|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608570|NCT01998958|594587888|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608571|NCT01998958|594587889|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608572|NCT01998958|594587890|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608573|NCT01998958|594587891|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608574|NCT01998958|594587892|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608575|NCT01998958|594587893|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164608576|NCT01998958|594587862|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
164608577|NCT01998958|594587863|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
164608578|NCT01998958|594587864|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
164608579|NCT01998958|594587865|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
164608580|NCT01998958|594587866|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
164608581|NCT01998958|594587867|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
164608582|NCT01998958|594587868|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
164608583|NCT01998958|594587869|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
164608584|NCT01998958|594587870|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
164608585|NCT01998958|594587871|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
164608586|NCT01998958|594587872|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
164608587|NCT01998958|594587873|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
164608588|NCT01998958|594587874|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
164608589|NCT01998958|594587875|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
164509530|NCT04052425|594236376|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
164509531|NCT04052425|594236377|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
164509532|NCT04052425|594236378|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
164509533|NCT04052425|594236379|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
164509534|NCT04052425|594236376|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
164509535|NCT04052425|594236377|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
164509536|NCT04052425|594236378|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
164509537|NCT04052425|594236379|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
164509538|NCT04052425|594236376|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
164509539|NCT04052425|594236377|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
164509540|NCT04052425|594236378|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
164509541|NCT04052425|594236379|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
164509542|NCT04052425|594236376|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
164509543|NCT04052425|594236377|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
164509544|NCT04052425|594236378|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
164509545|NCT04052425|594236379|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
164509546|NCT04052425|594236376|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
164608590|NCT01998958|594587876|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
164608591|NCT01998958|594587877|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
164608592|NCT01998958|594587878|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
164608593|NCT01998958|594587879|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
164608594|NCT01998958|594587880|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
164608595|NCT01998958|594587881|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
164608596|NCT01998958|594587882|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
164608597|NCT01998958|594587883|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
164608598|NCT01998958|594587884|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
164608599|NCT01998958|594587885|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
164608600|NCT01998958|594587886|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
164608601|NCT01998958|594587887|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
164608602|NCT01998958|594587888|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
164608603|NCT01998958|594587889|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
164608604|NCT01998958|594587890|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
164608605|NCT01998958|594587891|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
164608606|NCT01998958|594587892|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
164608607|NCT01998958|594587893|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
164608608|NCT01998958|594587862|FG000|Period 1 (Panel A and B)|Other|1|||
164608609|NCT01998958|594587863|FG001|Period 1 (Panel A and B)|Other|0|||
164608610|NCT01998958|594587864|FG002|Period 1 (Panel A and B)|Other|0|||
164608611|NCT01998958|594587865|FG003|Period 1 (Panel A and B)|Other|0|||
164608612|NCT01998958|594587866|FG004|Period 1 (Panel A and B)|Other|0|||
164608613|NCT01998958|594587867|FG005|Period 1 (Panel A and B)|Other|0|||
164608614|NCT01998958|594587868|FG006|Period 1 (Panel A and B)|Other|0|||
164608615|NCT01998958|594587869|FG007|Period 1 (Panel A and B)|Other|0|||
164608616|NCT01998958|594587870|FG008|Period 1 (Panel A and B)|Other|0|||
164608617|NCT01998958|594587871|FG009|Period 1 (Panel A and B)|Other|0|||
164509547|NCT04052425|594236377|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
164509548|NCT04052425|594236378|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
164509549|NCT04052425|594236379|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
164509550|NCT04052425|594236376|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
164509551|NCT04052425|594236377|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
164509552|NCT04052425|594236378|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
164509553|NCT04052425|594236379|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
164509554|NCT00945672|594236382|FG000|Overall Study|Withdrawal by Subject|0|||
164509555|NCT00945672|594236383|FG001|Overall Study|Withdrawal by Subject|0|||
164509556|NCT00945672|594236384|FG002|Overall Study|Withdrawal by Subject|0|||
164509557|NCT00945672|594236385|FG003|Overall Study|Withdrawal by Subject|1|||
164509558|NCT01681992|594236388|FG000|Overall Study|Adverse Event|3|||
164509559|NCT01681992|594236389|FG001|Overall Study|Adverse Event|2|||
164509560|NCT01681992|594236390|FG002|Overall Study|Adverse Event|3|||
164509561|NCT01681992|594236388|FG000|Overall Study|Lost to Follow-up|36|||
164509562|NCT01681992|594236389|FG001|Overall Study|Lost to Follow-up|38|||
164509563|NCT01681992|594236390|FG002|Overall Study|Lost to Follow-up|53|||
164509564|NCT01681992|594236388|FG000|Overall Study|As Per Sponsor Decision|0|||
164509565|NCT01681992|594236389|FG001|Overall Study|As Per Sponsor Decision|0|||
164509566|NCT01681992|594236390|FG002|Overall Study|As Per Sponsor Decision|1|||
164509567|NCT01681992|594236388|FG000|Overall Study|Protocol Violation|0|||
164509568|NCT01681992|594236389|FG001|Overall Study|Protocol Violation|0|||
164509569|NCT01681992|594236390|FG002|Overall Study|Protocol Violation|1|||
164509570|NCT01681992|594236388|FG000|Overall Study|Withdrawal by Subject|27|||
164509571|NCT01681992|594236389|FG001|Overall Study|Withdrawal by Subject|30|||
164509572|NCT01681992|594236390|FG002|Overall Study|Withdrawal by Subject|25|||
164509573|NCT00447590|594236391|FG000|Overall Study|Withdrawal by Subject|26|||
164509574|NCT00447590|594236391|FG000|Overall Study|Lost to Follow-up|24|||
164509575|NCT00447590|594236391|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
164509576|NCT03880019|594236392|FG000|Overall Study|Competing disease|1|||
164509577|NCT03812029|594236397|FG000|Overall Study|Protocol Violation|1|||
164509578|NCT03812029|594236398|FG001|Overall Study|Protocol Violation|0|||
164509579|NCT03812029|594236399|FG002|Overall Study|Protocol Violation|0|||
164509580|NCT03812029|594236400|FG003|Overall Study|Protocol Violation|1|||
164509581|NCT03812029|594236401|FG004|Overall Study|Protocol Violation|0|||
164509582|NCT03812029|594236397|FG000|Overall Study|Withdrawal by Subject|1|||
164509583|NCT03812029|594236398|FG001|Overall Study|Withdrawal by Subject|0|||
164509584|NCT03812029|594236399|FG002|Overall Study|Withdrawal by Subject|0|||
164509585|NCT03812029|594236400|FG003|Overall Study|Withdrawal by Subject|2|||
164509586|NCT03812029|594236401|FG004|Overall Study|Withdrawal by Subject|2|||
164509587|NCT03812029|594236397|FG000|Overall Study|Stopping rules|0|||
164509588|NCT03812029|594236398|FG001|Overall Study|Stopping rules|1|||
164509589|NCT03812029|594236399|FG002|Overall Study|Stopping rules|0|||
164509590|NCT03812029|594236400|FG003|Overall Study|Stopping rules|0|||
164509591|NCT03812029|594236401|FG004|Overall Study|Stopping rules|0|||
164509592|NCT03812029|594236397|FG000|Overall Study|Adverse Event|0|||
164608618|NCT01998958|594587872|FG010|Period 1 (Panel A and B)|Other|0|||
164608619|NCT01998958|594587873|FG011|Period 1 (Panel A and B)|Other|0|||
164608620|NCT01998958|594587874|FG012|Period 1 (Panel A and B)|Other|0|||
164608621|NCT01998958|594587875|FG013|Period 1 (Panel A and B)|Other|0|||
164608622|NCT01998958|594587876|FG014|Period 1 (Panel A and B)|Other|0|||
164608623|NCT01998958|594587877|FG015|Period 1 (Panel A and B)|Other|0|||
164608624|NCT01998958|594587878|FG016|Period 1 (Panel A and B)|Other|0|||
164608625|NCT01998958|594587879|FG017|Period 1 (Panel A and B)|Other|0|||
164608626|NCT01998958|594587880|FG018|Period 1 (Panel A and B)|Other|0|||
164608627|NCT01998958|594587881|FG019|Period 1 (Panel A and B)|Other|0|||
164608628|NCT01998958|594587882|FG020|Period 1 (Panel A and B)|Other|0|||
164608629|NCT01998958|594587883|FG021|Period 1 (Panel A and B)|Other|0|||
164608630|NCT01998958|594587884|FG022|Period 1 (Panel A and B)|Other|0|||
164608631|NCT01998958|594587885|FG023|Period 1 (Panel A and B)|Other|0|||
164608632|NCT01998958|594587886|FG024|Period 1 (Panel A and B)|Other|0|||
164608633|NCT01998958|594587887|FG025|Period 1 (Panel A and B)|Other|0|||
164608634|NCT01998958|594587888|FG026|Period 1 (Panel A and B)|Other|0|||
164608635|NCT01998958|594587889|FG027|Period 1 (Panel A and B)|Other|0|||
164608636|NCT01998958|594587890|FG028|Period 1 (Panel A and B)|Other|0|||
164608637|NCT01998958|594587891|FG029|Period 1 (Panel A and B)|Other|0|||
164608638|NCT01998958|594587892|FG030|Period 1 (Panel A and B)|Other|0|||
164608639|NCT01998958|594587893|FG031|Period 1 (Panel A and B)|Other|0|||
164608640|NCT01998958|594587862|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
164608641|NCT01998958|594587863|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
164608642|NCT01998958|594587864|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
164608643|NCT01998958|594587865|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
164608644|NCT01998958|594587866|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
164608645|NCT01998958|594587867|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
164608646|NCT01998958|594587868|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
164608647|NCT01998958|594587869|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
164608648|NCT01998958|594587870|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
164608649|NCT01998958|594587871|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
164608650|NCT01998958|594587872|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
164608651|NCT01998958|594587873|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
164608652|NCT01998958|594587874|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
164608653|NCT01998958|594587875|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
164608654|NCT01998958|594587876|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
164608655|NCT01998958|594587877|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
164608656|NCT01998958|594587878|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
164608657|NCT01998958|594587879|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
164608658|NCT01998958|594587880|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
164608659|NCT01998958|594587881|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
164608660|NCT01998958|594587882|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
164608661|NCT01998958|594587883|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
164608662|NCT01998958|594587884|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
164608663|NCT01998958|594587885|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
164608664|NCT01998958|594587886|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
164608665|NCT01998958|594587887|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
164608666|NCT01998958|594587888|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
164608667|NCT01998958|594587889|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
164608668|NCT01998958|594587890|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
164608669|NCT01998958|594587891|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
164608670|NCT01998958|594587892|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
164608671|NCT01998958|594587893|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
164608672|NCT01998958|594587862|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608673|NCT01998958|594587863|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608674|NCT01998958|594587864|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608675|NCT01998958|594587865|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608676|NCT01998958|594587866|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608677|NCT01998958|594587867|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608678|NCT01998958|594587868|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608679|NCT01998958|594587869|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608680|NCT01998958|594587870|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608681|NCT01998958|594587871|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608682|NCT01998958|594587872|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608683|NCT01998958|594587873|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608684|NCT01998958|594587874|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608685|NCT01998958|594587875|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608686|NCT01998958|594587876|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
164608687|NCT01998958|594587877|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608688|NCT01998958|594587878|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608689|NCT01998958|594587879|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608690|NCT01998958|594587880|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
164608691|NCT01998958|594587881|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608692|NCT01998958|594587882|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608693|NCT01998958|594587883|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608694|NCT01998958|594587884|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608695|NCT01998958|594587885|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608696|NCT01998958|594587886|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608697|NCT01998958|594587887|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608698|NCT01998958|594587888|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608699|NCT01998958|594587889|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608700|NCT01998958|594587890|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608701|NCT01998958|594587891|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608702|NCT01998958|594587892|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608703|NCT01998958|594587893|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164608704|NCT01998958|594587862|FG000|Open Label Phase (Optional)|Adverse Event|0|||
164608705|NCT01998958|594587863|FG001|Open Label Phase (Optional)|Adverse Event|0|||
164608706|NCT01998958|594587864|FG002|Open Label Phase (Optional)|Adverse Event|0|||
164608707|NCT01998958|594587865|FG003|Open Label Phase (Optional)|Adverse Event|0|||
164608708|NCT01998958|594587866|FG004|Open Label Phase (Optional)|Adverse Event|0|||
164608709|NCT01998958|594587867|FG005|Open Label Phase (Optional)|Adverse Event|0|||
164608710|NCT01998958|594587868|FG006|Open Label Phase (Optional)|Adverse Event|0|||
164608711|NCT01998958|594587869|FG007|Open Label Phase (Optional)|Adverse Event|0|||
164608712|NCT01998958|594587870|FG008|Open Label Phase (Optional)|Adverse Event|0|||
164608713|NCT01998958|594587871|FG009|Open Label Phase (Optional)|Adverse Event|0|||
164608714|NCT01998958|594587872|FG010|Open Label Phase (Optional)|Adverse Event|0|||
164608715|NCT01998958|594587873|FG011|Open Label Phase (Optional)|Adverse Event|0|||
164608716|NCT01998958|594587874|FG012|Open Label Phase (Optional)|Adverse Event|0|||
164608717|NCT01998958|594587875|FG013|Open Label Phase (Optional)|Adverse Event|0|||
164608718|NCT01998958|594587876|FG014|Open Label Phase (Optional)|Adverse Event|0|||
164608719|NCT01998958|594587877|FG015|Open Label Phase (Optional)|Adverse Event|0|||
164509593|NCT03812029|594236398|FG001|Overall Study|Adverse Event|9|||
164509594|NCT03812029|594236399|FG002|Overall Study|Adverse Event|0|||
164509595|NCT03812029|594236400|FG003|Overall Study|Adverse Event|3|||
164509596|NCT03812029|594236401|FG004|Overall Study|Adverse Event|5|||
164509597|NCT03812029|594236397|FG000|Overall Study|Lost to Follow-up|0|||
164509598|NCT03812029|594236398|FG001|Overall Study|Lost to Follow-up|0|||
164509599|NCT03812029|594236399|FG002|Overall Study|Lost to Follow-up|0|||
164509600|NCT03812029|594236400|FG003|Overall Study|Lost to Follow-up|0|||
164509601|NCT03812029|594236401|FG004|Overall Study|Lost to Follow-up|3|||
164509602|NCT01080300|594236402|FG000|Overall Study|Adverse Event|49|||
164509603|NCT01080300|594236403|FG001|Overall Study|Adverse Event|35|||
164509604|NCT01080300|594236402|FG000|Overall Study|Lack of Efficacy|12|||
164509605|NCT01080300|594236403|FG001|Overall Study|Lack of Efficacy|15|||
164509606|NCT01080300|594236402|FG000|Overall Study|Protocol Violation|7|||
164509607|NCT01080300|594236403|FG001|Overall Study|Protocol Violation|13|||
164509608|NCT01080300|594236402|FG000|Overall Study|Lost to Follow-up|10|||
164509609|NCT01080300|594236403|FG001|Overall Study|Lost to Follow-up|6|||
164509610|NCT01080300|594236402|FG000|Overall Study|Death|0|||
164509611|NCT01080300|594236403|FG001|Overall Study|Death|1|||
164509612|NCT01080300|594236402|FG000|Overall Study|Withdrawal by Subject|12|||
164509613|NCT01080300|594236403|FG001|Overall Study|Withdrawal by Subject|28|||
164509614|NCT01080300|594236402|FG000|Overall Study|Reasons not specified|4|||
164608720|NCT01998958|594587878|FG016|Open Label Phase (Optional)|Adverse Event|0|||
164608721|NCT01998958|594587879|FG017|Open Label Phase (Optional)|Adverse Event|0|||
164608722|NCT01998958|594587880|FG018|Open Label Phase (Optional)|Adverse Event|0|||
164509615|NCT01080300|594236403|FG001|Overall Study|Reasons not specified|6|||
164509616|NCT02269423|594236411|FG000|Overall Study|Discontinued due to change in residence|0|||
164509617|NCT02269423|594236412|FG001|Overall Study|Discontinued due to change in residence|1|||
164509618|NCT02269423|594236413|FG002|Overall Study|Discontinued due to change in residence|0|||
164509619|NCT02269423|594236414|FG003|Overall Study|Discontinued due to change in residence|1|||
164509620|NCT01281839|594236415|FG000|Overall Study|Lost to Follow-up|6|||
164509621|NCT01281839|594236416|FG001|Overall Study|Lost to Follow-up|3|||
164509622|NCT01281839|594236415|FG000|Overall Study|Withdrawal by Subject|4|||
164509623|NCT01281839|594236416|FG001|Overall Study|Withdrawal by Subject|10|||
164509624|NCT01281839|594236415|FG000|Overall Study|Reason not specified|0|||
164509625|NCT01281839|594236416|FG001|Overall Study|Reason not specified|1|||
164509626|NCT00856245|594236417|FG000|Overall Study|Was not transplanted|5|||
164509627|NCT01782690|594236419|FG000|Overall Study|Not reported|7|||
164509628|NCT01782690|594236419|FG000|Overall Study|Toxicity of gemcitabine|1|||
164509629|NCT01782690|594236419|FG000|Overall Study|Toxicity of erlotinib|1|||
164509630|NCT01782690|594236419|FG000|Overall Study|Lost to Follow-up|31|||
164509631|NCT01782690|594236419|FG000|Overall Study|Withdrawal of informed consent|2|||
164509632|NCT01782690|594236419|FG000|Overall Study|Absent rash|9|||
164509633|NCT01782690|594236419|FG000|Overall Study|Physician Decision|13|||
164509634|NCT01782690|594236419|FG000|Overall Study|Patient's wish|21|||
164509635|NCT01782690|594236419|FG000|Overall Study|Tumor progression|74|||
164509636|NCT01782690|594236419|FG000|Overall Study|Death|133|||
164509637|NCT01782690|594236419|FG000|Overall Study|Study completion unknown|7|||
164509638|NCT04199052|594236427|FG000|Overall Study|Lost to Follow-up|11|||
164509639|NCT04199052|594236428|FG001|Overall Study|Lost to Follow-up|18|||
164509640|NCT00699842|594236429|FG000|Overall Study|Death|0|||
164509641|NCT00699842|594236430|FG001|Overall Study|Death|1|||
164509642|NCT00699842|594236431|FG002|Overall Study|Death|0|||
164509643|NCT00583947|594236439|FG000|Cross-over Period|Adverse Event|2|||
164509644|NCT00583947|594236440|FG001|Cross-over Period|Adverse Event|0|||
164509645|NCT00583947|594236439|FG000|Cross-over Period|Withdrawal by Subject|2|||
164509646|NCT00583947|594236440|FG001|Cross-over Period|Withdrawal by Subject|0|||
164509647|NCT00583947|594236439|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
164509648|NCT00583947|594236440|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
164509649|NCT00583947|594236439|FG000|Cross-over Period|Other|1|||
164509650|NCT00583947|594236440|FG001|Cross-over Period|Other|1|||
164509651|NCT01740154|594236441|FG000|Overall Study|Adverse Event|1|||
164509652|NCT03358472|594236445|FG000|Overall Study|Death|6|||
164509653|NCT03358472|594236446|FG001|Overall Study|Death|3|||
164509654|NCT03358472|594236447|FG002|Overall Study|Death|10|||
164509655|NCT03358472|594236445|FG000|Overall Study|Physician Decision|0|||
164509656|NCT03358472|594236446|FG001|Overall Study|Physician Decision|1|||
164509657|NCT03358472|594236447|FG002|Overall Study|Physician Decision|0|||
164509658|NCT03358472|594236445|FG000|Overall Study|Withdrawal by Subject|0|||
164509659|NCT03358472|594236446|FG001|Overall Study|Withdrawal by Subject|0|||
164509660|NCT03358472|594236447|FG002|Overall Study|Withdrawal by Subject|1|||
164509661|NCT03358472|594236445|FG000|Overall Study|On-going at clinical cut off date|9|||
164509662|NCT03358472|594236446|FG001|Overall Study|On-going at clinical cut off date|6|||
164509663|NCT03358472|594236447|FG002|Overall Study|On-going at clinical cut off date|5|||
164509664|NCT02520310|594236452|FG000|At 6 Months Clinical Follow-up|Death|1|||
164509665|NCT02520310|594236452|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
164509666|NCT02520310|594236452|FG000|AT 3 Year Clinical Follow-up|Death|2|||
164509667|NCT02520310|594236452|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
164509668|NCT02520310|594236452|FG000|AT 4 Year Clinical Follow-up|Death|1|||
164509669|NCT02520310|594236452|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
164509670|NCT05032066|594236453|FG000|Part 1: Core Phase|Withdrawal by Subject/Guardian|4|||
164509671|NCT05032066|594236454|FG001|Part 1: Core Phase|Withdrawal by Subject/Guardian|6|||
164509672|NCT05032066|594236455|FG002|Part 1: Core Phase|Withdrawal by Subject/Guardian|5|||
164509673|NCT05032066|594236453|FG000|Part 1: Core Phase|Physician Decision|0|||
164509674|NCT05032066|594236454|FG001|Part 1: Core Phase|Physician Decision|1|||
164509675|NCT05032066|594236455|FG002|Part 1: Core Phase|Physician Decision|1|||
164509676|NCT05032066|594236453|FG000|Part 1: Core Phase|Lost to Follow-up|0|||
164509677|NCT05032066|594236454|FG001|Part 1: Core Phase|Lost to Follow-up|0|||
164509678|NCT05032066|594236455|FG002|Part 1: Core Phase|Lost to Follow-up|1|||
164509679|NCT05032066|594236453|FG000|Part 1: Core Phase|Death|3|||
164509680|NCT05032066|594236454|FG001|Part 1: Core Phase|Death|4|||
164509681|NCT05032066|594236455|FG002|Part 1: Core Phase|Death|2|||
164509682|NCT05032066|594236453|FG000|Part 1: Core Phase|Adverse Event|2|||
164509683|NCT05032066|594236454|FG001|Part 1: Core Phase|Adverse Event|3|||
164509684|NCT05032066|594236455|FG002|Part 1: Core Phase|Adverse Event|0|||
164509685|NCT05032066|594236453|FG000|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
164509686|NCT05032066|594236454|FG001|Part 2: Extension Phase|Withdrawal by Subject/Guardian|1|||
164509687|NCT05032066|594236455|FG002|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
164509688|NCT05032066|594236453|FG000|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
164509689|NCT05032066|594236454|FG001|Part 2: Extension Phase|Study Terminated by Sponsor|22|||
164509690|NCT05032066|594236455|FG002|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
164509691|NCT05032066|594236453|FG000|Part 2: Extension Phase|Physician Decision|1|||
164509692|NCT05032066|594236454|FG001|Part 2: Extension Phase|Physician Decision|2|||
164509693|NCT05032066|594236455|FG002|Part 2: Extension Phase|Physician Decision|0|||
164509694|NCT05032066|594236453|FG000|Part 2: Extension Phase|Death|2|||
164509695|NCT05032066|594236454|FG001|Part 2: Extension Phase|Death|4|||
164509696|NCT05032066|594236455|FG002|Part 2: Extension Phase|Death|5|||
164509697|NCT06719986|594236458|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
164509698|NCT06719986|594236459|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
164509699|NCT06719986|594236460|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
164509700|NCT06719986|594236458|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
164509701|NCT06719986|594236459|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
164509702|NCT06719986|594236460|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
164509703|NCT00217737|594236463|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
164509704|NCT00217737|594236464|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
164509705|NCT00217737|594236465|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
164509706|NCT00217737|594236466|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
164509707|NCT00217737|594236463|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
164509708|NCT00217737|594236464|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
164509709|NCT00217737|594236465|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
164509710|NCT00217737|594236466|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
164509711|NCT00217737|594236463|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
164509712|NCT00217737|594236464|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
164509713|NCT00217737|594236465|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
164509714|NCT00217737|594236466|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
164509715|NCT00217737|594236463|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
164509716|NCT00217737|594236464|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
164509717|NCT00217737|594236465|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
164509718|NCT00217737|594236466|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
164509719|NCT00217737|594236463|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
164509720|NCT00217737|594236464|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
164509721|NCT00217737|594236465|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
164509722|NCT00217737|594236466|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
164509723|NCT00217737|594236463|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
164509724|NCT00217737|594236464|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
164509725|NCT00217737|594236465|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
164509726|NCT00217737|594236466|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
164509727|NCT00217737|594236463|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
164509728|NCT00217737|594236464|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
164509729|NCT00217737|594236465|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
164509730|NCT00217737|594236466|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
164509731|NCT00217737|594236463|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
164509732|NCT00217737|594236464|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
164509733|NCT00217737|594236465|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
164509734|NCT00217737|594236466|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
164509735|NCT00217737|594236463|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
164509736|NCT00217737|594236464|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
164509737|NCT00217737|594236465|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
164509738|NCT00217737|594236466|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
164509739|NCT00217737|594236463|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
164509740|NCT00217737|594236464|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
164509741|NCT00217737|594236465|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
164509742|NCT00217737|594236466|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
164509743|NCT00217737|594236463|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
164509744|NCT00217737|594236464|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
164509745|NCT00217737|594236465|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
164509746|NCT00217737|594236466|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
164509747|NCT00217737|594236463|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
164509748|NCT00217737|594236464|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
164509749|NCT00217737|594236465|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
164509750|NCT00217737|594236466|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
164509751|NCT00217737|594236463|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
164509752|NCT00217737|594236464|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
164509753|NCT00217737|594236465|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
164509754|NCT00217737|594236466|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
164509755|NCT00217737|594236463|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
164509756|NCT00217737|594236464|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
164509757|NCT00217737|594236465|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
164509758|NCT00217737|594236466|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
164509759|NCT00217737|594236463|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
164509760|NCT00217737|594236464|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
164509761|NCT00217737|594236465|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
164509762|NCT00217737|594236466|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
164509763|NCT00217737|594236463|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
164509764|NCT00217737|594236464|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
164509765|NCT00217737|594236465|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
164509766|NCT00217737|594236466|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
164509767|NCT00217737|594236463|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
164509768|NCT00217737|594236464|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
164509769|NCT00217737|594236465|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
164509770|NCT00217737|594236466|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
164509771|NCT00217737|594236463|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
164509772|NCT00217737|594236464|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
164509773|NCT00217737|594236465|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
164509774|NCT00217737|594236466|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
164509775|NCT00217737|594236463|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
164509776|NCT00217737|594236464|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
164509777|NCT00217737|594236465|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
164509778|NCT00217737|594236466|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
164509779|NCT00217737|594236463|FG000|Step 2 Randomization/Registration|Study suspension|0|||
164509780|NCT00217737|594236464|FG001|Step 2 Randomization/Registration|Study suspension|45|||
164509781|NCT00217737|594236465|FG002|Step 2 Randomization/Registration|Study suspension|0|||
164509782|NCT00217737|594236466|FG003|Step 2 Randomization/Registration|Study suspension|0|||
164509783|NCT00217737|594236463|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
164509784|NCT00217737|594236464|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
164509785|NCT00217737|594236465|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
164509786|NCT00217737|594236466|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
164509787|NCT00217737|594236463|FG000|Step 2 Randomization/Registration|Death|2|||
164509788|NCT00217737|594236464|FG001|Step 2 Randomization/Registration|Death|3|||
164509789|NCT00217737|594236465|FG002|Step 2 Randomization/Registration|Death|0|||
164608723|NCT01998958|594587881|FG019|Open Label Phase (Optional)|Adverse Event|0|||
164608724|NCT01998958|594587882|FG020|Open Label Phase (Optional)|Adverse Event|0|||
164608725|NCT01998958|594587883|FG021|Open Label Phase (Optional)|Adverse Event|0|||
164608726|NCT01998958|594587884|FG022|Open Label Phase (Optional)|Adverse Event|0|||
164608727|NCT01998958|594587885|FG023|Open Label Phase (Optional)|Adverse Event|1|||
164608728|NCT01998958|594587886|FG024|Open Label Phase (Optional)|Adverse Event|0|||
164608729|NCT01998958|594587887|FG025|Open Label Phase (Optional)|Adverse Event|0|||
164608730|NCT01998958|594587888|FG026|Open Label Phase (Optional)|Adverse Event|0|||
164608731|NCT01998958|594587889|FG027|Open Label Phase (Optional)|Adverse Event|0|||
164608732|NCT01998958|594587890|FG028|Open Label Phase (Optional)|Adverse Event|0|||
164608733|NCT01998958|594587891|FG029|Open Label Phase (Optional)|Adverse Event|0|||
164608734|NCT01998958|594587892|FG030|Open Label Phase (Optional)|Adverse Event|0|||
164608735|NCT01998958|594587893|FG031|Open Label Phase (Optional)|Adverse Event|0|||
164608736|NCT01998958|594587862|FG000|Open Label Phase (Optional)|Other|0|||
164608737|NCT01998958|594587863|FG001|Open Label Phase (Optional)|Other|0|||
164608738|NCT01998958|594587864|FG002|Open Label Phase (Optional)|Other|0|||
164608739|NCT01998958|594587865|FG003|Open Label Phase (Optional)|Other|0|||
164608740|NCT01998958|594587866|FG004|Open Label Phase (Optional)|Other|0|||
164608741|NCT01998958|594587867|FG005|Open Label Phase (Optional)|Other|0|||
164608742|NCT01998958|594587868|FG006|Open Label Phase (Optional)|Other|0|||
164608743|NCT01998958|594587869|FG007|Open Label Phase (Optional)|Other|0|||
164608744|NCT01998958|594587870|FG008|Open Label Phase (Optional)|Other|0|||
164608745|NCT01998958|594587871|FG009|Open Label Phase (Optional)|Other|0|||
164608746|NCT01998958|594587872|FG010|Open Label Phase (Optional)|Other|0|||
164608747|NCT01998958|594587873|FG011|Open Label Phase (Optional)|Other|0|||
164608748|NCT01998958|594587874|FG012|Open Label Phase (Optional)|Other|0|||
164608749|NCT01998958|594587875|FG013|Open Label Phase (Optional)|Other|0|||
164608750|NCT01998958|594587876|FG014|Open Label Phase (Optional)|Other|0|||
164608751|NCT01998958|594587877|FG015|Open Label Phase (Optional)|Other|0|||
164608752|NCT01998958|594587878|FG016|Open Label Phase (Optional)|Other|0|||
164608753|NCT01998958|594587879|FG017|Open Label Phase (Optional)|Other|0|||
164608754|NCT01998958|594587880|FG018|Open Label Phase (Optional)|Other|0|||
164608755|NCT01998958|594587881|FG019|Open Label Phase (Optional)|Other|0|||
164608756|NCT01998958|594587882|FG020|Open Label Phase (Optional)|Other|0|||
164608757|NCT01998958|594587883|FG021|Open Label Phase (Optional)|Other|0|||
164608758|NCT01998958|594587884|FG022|Open Label Phase (Optional)|Other|5|||
164608759|NCT01998958|594587885|FG023|Open Label Phase (Optional)|Other|1|||
164608760|NCT01998958|594587886|FG024|Open Label Phase (Optional)|Other|0|||
164608761|NCT01998958|594587887|FG025|Open Label Phase (Optional)|Other|0|||
164608762|NCT01998958|594587888|FG026|Open Label Phase (Optional)|Other|0|||
164608763|NCT01998958|594587889|FG027|Open Label Phase (Optional)|Other|0|||
164608764|NCT01998958|594587890|FG028|Open Label Phase (Optional)|Other|0|||
164608765|NCT01998958|594587891|FG029|Open Label Phase (Optional)|Other|0|||
164608766|NCT01998958|594587892|FG030|Open Label Phase (Optional)|Other|0|||
164608767|NCT01998958|594587893|FG031|Open Label Phase (Optional)|Other|0|||
164608768|NCT01998958|594587862|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608769|NCT01998958|594587863|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608770|NCT01998958|594587864|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608771|NCT01998958|594587865|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608772|NCT01998958|594587866|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608773|NCT01998958|594587867|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608774|NCT01998958|594587868|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608775|NCT01998958|594587869|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608776|NCT01998958|594587870|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608777|NCT01998958|594587871|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608778|NCT01998958|594587872|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608779|NCT01998958|594587873|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608780|NCT01998958|594587874|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608781|NCT01998958|594587875|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608782|NCT01998958|594587876|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608783|NCT01998958|594587877|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608784|NCT01998958|594587878|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608785|NCT01998958|594587879|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608786|NCT01998958|594587880|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608787|NCT01998958|594587881|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608788|NCT01998958|594587882|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608789|NCT01998958|594587883|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608790|NCT01998958|594587884|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
164608791|NCT01998958|594587885|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608792|NCT01998958|594587886|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608793|NCT01998958|594587887|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608794|NCT01998958|594587888|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608795|NCT01998958|594587889|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608796|NCT01998958|594587890|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608797|NCT01998958|594587891|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608798|NCT01998958|594587892|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608799|NCT01998958|594587893|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
164608800|NCT01998958|594587862|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608801|NCT01998958|594587863|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608802|NCT01998958|594587864|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608803|NCT01998958|594587865|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608804|NCT01998958|594587866|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608805|NCT01998958|594587867|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608806|NCT01998958|594587868|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608807|NCT01998958|594587869|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608808|NCT01998958|594587870|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608809|NCT01998958|594587871|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608810|NCT01998958|594587872|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608811|NCT01998958|594587873|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608812|NCT01998958|594587874|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608813|NCT01998958|594587875|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608814|NCT01998958|594587876|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608815|NCT01998958|594587877|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
164509790|NCT00217737|594236466|FG003|Step 2 Randomization/Registration|Death|0|||
164509791|NCT00217737|594236463|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
164509792|NCT00217737|594236464|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
164509793|NCT00217737|594236465|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
164509794|NCT00217737|594236466|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
164509795|NCT00217737|594236463|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
164509796|NCT00217737|594236464|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
164509797|NCT00217737|594236465|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
164509798|NCT00217737|594236466|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
164509799|NCT00217737|594236463|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
164509800|NCT00217737|594236464|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
164509801|NCT00217737|594236465|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
164509802|NCT00217737|594236466|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
164509803|NCT00217737|594236463|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
164509804|NCT00217737|594236464|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
164509805|NCT00217737|594236465|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
164509806|NCT00217737|594236466|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
164509807|NCT00217737|594236463|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
164509808|NCT00217737|594236464|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
164509809|NCT00217737|594236465|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
164509810|NCT00217737|594236466|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
164509811|NCT00217737|594236463|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
164509812|NCT00217737|594236464|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
164509813|NCT00217737|594236465|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
164509814|NCT00217737|594236466|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
164509815|NCT00217737|594236463|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
164509816|NCT00217737|594236464|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
164509817|NCT00217737|594236465|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
164509818|NCT00217737|594236466|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
164509819|NCT00217737|594236463|FG000|Step 2 Randomization/Registration|Other|1|||
164509820|NCT00217737|594236464|FG001|Step 2 Randomization/Registration|Other|2|||
164509821|NCT00217737|594236465|FG002|Step 2 Randomization/Registration|Other|0|||
164509822|NCT00217737|594236466|FG003|Step 2 Randomization/Registration|Other|0|||
164509823|NCT01183390|594237911|FG000|First Intervention|Adverse Event|0|||
164509824|NCT01183390|594237912|FG001|First Intervention|Adverse Event|1|||
164509825|NCT04057573|594237915|FG000|24-Week Double-Blind Period|Adverse Event|2|||
164509826|NCT04057573|594237916|FG001|24-Week Double-Blind Period|Adverse Event|0|||
164509827|NCT04057573|594237917|FG002|24-Week Double-Blind Period|Adverse Event|0|||
164509828|NCT04057573|594237918|FG003|24-Week Double-Blind Period|Adverse Event|0|||
164509829|NCT04057573|594237915|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
164509830|NCT04057573|594237916|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
164509831|NCT04057573|594237917|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
164509832|NCT04057573|594237918|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
164509833|NCT04057573|594237915|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
164509834|NCT04057573|594237916|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
164509835|NCT04057573|594237917|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
164509836|NCT04057573|594237918|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
164509837|NCT04057573|594237915|FG000|24-Week Double-Blind Period|Physician Decision|1|||
164608816|NCT01998958|594587878|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608817|NCT01998958|594587879|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608818|NCT01998958|594587880|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608819|NCT01998958|594587881|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608820|NCT01998958|594587882|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608821|NCT01998958|594587883|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
164608822|NCT01998958|594587884|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
164608823|NCT01998958|594587885|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608824|NCT01998958|594587886|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608825|NCT01998958|594587887|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608826|NCT01998958|594587888|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608827|NCT01998958|594587889|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608828|NCT01998958|594587890|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608829|NCT01998958|594587891|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608830|NCT01998958|594587892|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608831|NCT01998958|594587893|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
164608832|NCT01998958|594587862|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608833|NCT01998958|594587863|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608834|NCT01998958|594587864|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608835|NCT01998958|594587865|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608836|NCT01998958|594587866|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608837|NCT01998958|594587867|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608838|NCT01998958|594587868|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608839|NCT01998958|594587869|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608840|NCT01998958|594587870|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608841|NCT01998958|594587871|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608842|NCT01998958|594587872|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608843|NCT01998958|594587873|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608844|NCT01998958|594587874|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608845|NCT01998958|594587875|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608846|NCT01998958|594587876|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608847|NCT01998958|594587877|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608848|NCT01998958|594587878|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608849|NCT01998958|594587879|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164509838|NCT04057573|594237916|FG001|24-Week Double-Blind Period|Physician Decision|0|||
164509839|NCT04057573|594237917|FG002|24-Week Double-Blind Period|Physician Decision|0|||
164509840|NCT04057573|594237918|FG003|24-Week Double-Blind Period|Physician Decision|0|||
164509841|NCT04057573|594237915|FG000|24-Week Double-Blind Period|Pregnancy|1|||
164509842|NCT04057573|594237916|FG001|24-Week Double-Blind Period|Pregnancy|0|||
164509843|NCT04057573|594237917|FG002|24-Week Double-Blind Period|Pregnancy|0|||
164509844|NCT04057573|594237918|FG003|24-Week Double-Blind Period|Pregnancy|0|||
164509845|NCT04057573|594237915|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
164509846|NCT04057573|594237916|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
164509847|NCT04057573|594237917|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
164509848|NCT04057573|594237918|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
164509849|NCT04057573|594237915|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
164509850|NCT04057573|594237916|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
164509851|NCT04057573|594237917|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
164509852|NCT04057573|594237918|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
164509853|NCT04057573|594237915|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
164509854|NCT04057573|594237916|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
164509855|NCT04057573|594237917|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
164509856|NCT04057573|594237918|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
164509857|NCT04057573|594237915|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
164509858|NCT04057573|594237916|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
164509859|NCT04057573|594237917|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
164509860|NCT04057573|594237918|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
164509861|NCT04057573|594237915|FG000|24-Week Double-Blind Period|Not Treated|1|||
164509862|NCT04057573|594237916|FG001|24-Week Double-Blind Period|Not Treated|0|||
164608850|NCT01998958|594587880|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608851|NCT01998958|594587881|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608852|NCT01998958|594587882|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608853|NCT01998958|594587883|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
164608854|NCT01998958|594587884|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
164608855|NCT01998958|594587885|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
164608856|NCT01998958|594587886|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164509863|NCT04057573|594237917|FG002|24-Week Double-Blind Period|Not Treated|0|||
164509864|NCT04057573|594237918|FG003|24-Week Double-Blind Period|Not Treated|0|||
164509865|NCT04057573|594237915|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
164509866|NCT04057573|594237916|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
164509867|NCT04057573|594237917|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
164509868|NCT04057573|594237918|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
164509869|NCT04057573|594237915|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
164509870|NCT04057573|594237916|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
164509871|NCT04057573|594237917|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
164509872|NCT04057573|594237918|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
164509873|NCT04057573|594237915|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
164509874|NCT04057573|594237916|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
164509875|NCT04057573|594237917|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
164509876|NCT04057573|594237918|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
164509877|NCT04057573|594237915|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
164509878|NCT04057573|594237916|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
164509879|NCT04057573|594237917|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
164509880|NCT04057573|594237918|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
164509881|NCT04057573|594237915|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
164509882|NCT04057573|594237916|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
164509883|NCT04057573|594237917|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
164509884|NCT04057573|594237918|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
164509885|NCT04991753|594237919|FG000|Overall Study|Withdrawal by Subject|0|||
164509886|NCT04991753|594237920|FG001|Overall Study|Withdrawal by Subject|1|||
164509887|NCT00233480|594237923|FG000|Overall Study|Underwent status II heart transplant|0|||
164509888|NCT00233480|594237924|FG001|Overall Study|Underwent status II heart transplant|1|||
164509889|NCT01484431|594237930|FG000|Period 1: High Dose|Physician Decision|0|||
164509890|NCT01484431|594237931|FG001|Period 1: High Dose|Physician Decision|1|||
164509891|NCT01484431|594237932|FG002|Period 1: High Dose|Physician Decision|0|||
164509892|NCT01484431|594237930|FG000|Period 2|Death|0|||
164509893|NCT01484431|594237931|FG001|Period 2|Death|1|||
164509894|NCT01484431|594237932|FG002|Period 2|Death|1|||
164509895|NCT01484431|594237930|FG000|Period 2|Physician Decision|0|||
164509896|NCT01484431|594237931|FG001|Period 2|Physician Decision|0|||
164509897|NCT01484431|594237932|FG002|Period 2|Physician Decision|1|||
164509898|NCT01484431|594237930|FG000|Period 2|Non-Compliance with Study Drug|1|||
164509899|NCT01484431|594237931|FG001|Period 2|Non-Compliance with Study Drug|0|||
164509900|NCT01484431|594237932|FG002|Period 2|Non-Compliance with Study Drug|0|||
164509901|NCT01251770|594237933|FG000|Overall Study|Protocol Violation|13|||
164509902|NCT01251770|594237934|FG001|Overall Study|Protocol Violation|7|||
164509903|NCT00475644|594237938|FG000|Overall Study|Protocol Violation|13|||
164509904|NCT00790400|594237942|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
164509905|NCT00790400|594237943|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
164509906|NCT00790400|594237942|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
164509907|NCT00790400|594237943|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
164509908|NCT00790400|594237942|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
164509909|NCT00790400|594237943|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
164509910|NCT00790400|594237942|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
164509911|NCT00790400|594237943|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
164509912|NCT00790400|594237942|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
164509913|NCT00790400|594237943|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
164509914|NCT00790400|594237942|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
164509915|NCT00790400|594237943|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
164509916|NCT00790400|594237942|FG000|Double-blind Period (Core Phase)|Death|1|||
164509917|NCT00790400|594237943|FG001|Double-blind Period (Core Phase)|Death|0|||
164509918|NCT00790400|594237942|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
164509919|NCT00790400|594237943|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
164509920|NCT00790400|594237942|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
164509921|NCT00790400|594237943|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
164509922|NCT00790400|594237942|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
164509923|NCT00790400|594237943|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
164509924|NCT00790400|594237942|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
164509925|NCT00790400|594237943|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
164509926|NCT00790400|594237942|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
164509927|NCT00790400|594237943|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
164509928|NCT00790400|594237942|FG000|Everolimus Period (Core or Extension)|Death|1|||
164509929|NCT00790400|594237943|FG001|Everolimus Period (Core or Extension)|Death|0|||
164509930|NCT00790400|594237942|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
164608857|NCT01998958|594587887|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608858|NCT01998958|594587888|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608859|NCT01998958|594587889|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608860|NCT01998958|594587890|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608861|NCT01998958|594587891|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608862|NCT01998958|594587892|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608863|NCT01998958|594587893|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164608864|NCT02432703|594587894|FG000|Overall Study|Adverse Event|1|||
164608865|NCT02432703|594587895|FG001|Overall Study|Adverse Event|4|||
164608866|NCT02432703|594587894|FG000|Overall Study|Lack of Efficacy|1|||
164608867|NCT02432703|594587895|FG001|Overall Study|Lack of Efficacy|0|||
164608868|NCT02432703|594587894|FG000|Overall Study|Lost to Follow-up|5|||
164608869|NCT02432703|594587895|FG001|Overall Study|Lost to Follow-up|3|||
164608870|NCT02432703|594587894|FG000|Overall Study|Withdrawal by Subject|9|||
164608871|NCT02432703|594587895|FG001|Overall Study|Withdrawal by Subject|6|||
164608872|NCT02432703|594587894|FG000|Overall Study|Other|6|||
164608873|NCT02432703|594587895|FG001|Overall Study|Other|5|||
164608874|NCT01807949|594587903|FG000|Overall Study|Adverse Event|1|||
164608875|NCT01807949|594587904|FG001|Overall Study|Adverse Event|2|||
164608876|NCT01807949|594587905|FG002|Overall Study|Adverse Event|2|||
164608877|NCT01807949|594587903|FG000|Overall Study|Withdrawal by Subject|1|||
164608878|NCT01807949|594587904|FG001|Overall Study|Withdrawal by Subject|2|||
164608879|NCT01807949|594587905|FG002|Overall Study|Withdrawal by Subject|2|||
164608880|NCT01807949|594587903|FG000|Overall Study|Non-Compliance|0|||
164608881|NCT01807949|594587904|FG001|Overall Study|Non-Compliance|0|||
164608882|NCT01807949|594587905|FG002|Overall Study|Non-Compliance|1|||
164608883|NCT01807949|594587903|FG000|Overall Study|Undefined|0|||
164608884|NCT01807949|594587904|FG001|Overall Study|Undefined|1|||
164608885|NCT01807949|594587905|FG002|Overall Study|Undefined|2|||
164608886|NCT01807949|594587903|FG000|Overall Study|Randomized But Not Treated|0|||
164608887|NCT01807949|594587904|FG001|Overall Study|Randomized But Not Treated|2|||
164608888|NCT01807949|594587905|FG002|Overall Study|Randomized But Not Treated|2|||
164608889|NCT00881361|594587908|FG000|Overall Study|Terminated prior to surgery|27|||
164608890|NCT00881361|594587909|FG001|Overall Study|Terminated prior to surgery|7|||
164608891|NCT00881361|594587910|FG002|Overall Study|Terminated prior to surgery|0|||
164608892|NCT00881361|594587908|FG000|Overall Study|Ineligible|17|||
164608893|NCT00881361|594587909|FG001|Overall Study|Ineligible|2|||
164608894|NCT00881361|594587910|FG002|Overall Study|Ineligible|2|||
164608895|NCT02137837|594587911|FG000|Overall Study|Adverse Event|0|||
164608896|NCT02137837|594587912|FG001|Overall Study|Adverse Event|2|||
164608897|NCT02137837|594587913|FG002|Overall Study|Adverse Event|1|||
164608898|NCT02137837|594587911|FG000|Overall Study|Refusal unrelated to adverse event|2|||
164608899|NCT02137837|594587912|FG001|Overall Study|Refusal unrelated to adverse event|2|||
164608900|NCT02137837|594587913|FG002|Overall Study|Refusal unrelated to adverse event|1|||
164608901|NCT02137837|594587911|FG000|Overall Study|Progression/relapse|9|||
164608902|NCT02137837|594587912|FG001|Overall Study|Progression/relapse|7|||
164608903|NCT02137837|594587913|FG002|Overall Study|Progression/relapse|7|||
164608904|NCT02137837|594587911|FG000|Overall Study|Not protocol specified|2|||
164608905|NCT02137837|594587912|FG001|Overall Study|Not protocol specified|1|||
164608906|NCT02137837|594587913|FG002|Overall Study|Not protocol specified|3|||
164608907|NCT02141217|594587914|FG000|Overall Study|Adverse Event|1|||
164608908|NCT02141217|594587915|FG001|Overall Study|Adverse Event|2|||
164608909|NCT02141217|594587914|FG000|Overall Study|Protocol Violation|1|||
164608910|NCT02141217|594587915|FG001|Overall Study|Protocol Violation|4|||
164608911|NCT02141217|594587914|FG000|Overall Study|Withdrawal by Subject|6|||
164608912|NCT02141217|594587915|FG001|Overall Study|Withdrawal by Subject|0|||
164608913|NCT02141217|594587914|FG000|Overall Study|Lost to Follow-up|1|||
164608914|NCT02141217|594587915|FG001|Overall Study|Lost to Follow-up|1|||
164608915|NCT02141217|594587914|FG000|Overall Study|Physician Decision|1|||
164608916|NCT02141217|594587915|FG001|Overall Study|Physician Decision|0|||
164608917|NCT02141217|594587914|FG000|Overall Study|Surgical Intervention|1|||
164608918|NCT02141217|594587915|FG001|Overall Study|Surgical Intervention|1|||
164608919|NCT01329341|594587918|FG000|Overall Study|Withdrawal by Subject|44|||
164608920|NCT00448760|594587919|FG000|Overall Study|Death|3|||
164608921|NCT00561340|594587920|FG000|Overall Study|refused to drink pediasure|6|||
164608922|NCT00561340|594587921|FG001|Overall Study|refused to drink pediasure|0|||
164608923|NCT00618995|594587923|FG000|Period 1|Adverse Event|0|||
164608924|NCT00618995|594587924|FG001|Period 1|Adverse Event|0|||
164608925|NCT00618995|594587925|FG002|Period 1|Adverse Event|1|||
164608926|NCT00618995|594587926|FG003|Period 1|Adverse Event|0|||
164608927|NCT00618995|594587923|FG000|Period 1|Protocol Violation|0|||
164608928|NCT00618995|594587924|FG001|Period 1|Protocol Violation|1|||
164608929|NCT00618995|594587925|FG002|Period 1|Protocol Violation|1|||
164608930|NCT00618995|594587926|FG003|Period 1|Protocol Violation|0|||
164608931|NCT00618995|594587923|FG000|Period 2|Protocol Violation|0|||
164608932|NCT00618995|594587924|FG001|Period 2|Protocol Violation|0|||
164509931|NCT00790400|594237943|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
164509932|NCT00790400|594237942|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
164509933|NCT00790400|594237943|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
164509934|NCT00790400|594237942|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
164509935|NCT00790400|594237943|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
164509936|NCT00699153|594237944|FG000|Overall Study|Lost to Follow-up|1|||
164509937|NCT00699153|594237945|FG001|Overall Study|Lost to Follow-up|0|||
164509938|NCT00699153|594237944|FG000|Overall Study|Adverse Event|0|||
164509939|NCT00699153|594237945|FG001|Overall Study|Adverse Event|2|||
164509940|NCT00699153|594237944|FG000|Overall Study|Protocol Violation|1|||
164509941|NCT00699153|594237945|FG001|Overall Study|Protocol Violation|0|||
164509942|NCT00699153|594237944|FG000|Overall Study|Travel Problem|1|||
164509943|NCT00699153|594237945|FG001|Overall Study|Travel Problem|0|||
164509944|NCT00078338|594237949|FG000|Overall Study|Adverse Event|31|||
164509945|NCT00078338|594237950|FG001|Overall Study|Adverse Event|24|||
164509946|NCT00078338|594237949|FG000|Overall Study|Lost to Follow-up|17|||
164509947|NCT00078338|594237950|FG001|Overall Study|Lost to Follow-up|2|||
164608933|NCT00618995|594587925|FG002|Period 2|Protocol Violation|1|||
164608934|NCT00618995|594587926|FG003|Period 2|Protocol Violation|0|||
164608935|NCT00618995|594587923|FG000|Period 4|Adverse Event|1|||
164608936|NCT00618995|594587924|FG001|Period 4|Adverse Event|0|||
164608937|NCT00618995|594587925|FG002|Period 4|Adverse Event|0|||
164608938|NCT00618995|594587926|FG003|Period 4|Adverse Event|0|||
164608939|NCT00290589|594587928|FG000|Overall Study|Lost to Follow-up|2|||
164608940|NCT00290589|594587929|FG001|Overall Study|Lost to Follow-up|2|||
164608941|NCT00973622|594587930|FG000|Overall Study|did not attend MRI|14|||
164608942|NCT00973622|594587931|FG001|Overall Study|did not attend MRI|3|||
164608943|NCT00973622|594587930|FG000|Overall Study|did not pass MRI screen|6|||
164608944|NCT00973622|594587931|FG001|Overall Study|did not pass MRI screen|0|||
164608945|NCT00973622|594587930|FG000|Overall Study|did not complete rTMS sessions|11|||
164608946|NCT00973622|594587931|FG001|Overall Study|did not complete rTMS sessions|2|||
164608947|NCT00555568|594587932|FG000|Overall Study|Lost to Follow-up|26|||
164608948|NCT00555568|594587933|FG001|Overall Study|Lost to Follow-up|16|||
164608949|NCT00555568|594587934|FG002|Overall Study|Lost to Follow-up|16|||
164608950|NCT06000501|594587935|FG000|Overall Study|Screen failure|3|||
164608951|NCT06000501|594587935|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
164608952|NCT06000501|594587935|FG000|Overall Study|Physician Decision|4|||
164608953|NCT06000501|594587935|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
164608954|NCT06000501|594587935|FG000|Overall Study|Scheduling issues|2|||
164608955|NCT03814005|594587937|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
164608956|NCT03814005|594587938|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
164608957|NCT03814005|594587939|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
164608958|NCT03814005|594587937|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
164608959|NCT03814005|594587938|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
164608960|NCT03814005|594587939|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
164608961|NCT03814005|594587937|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
164608962|NCT03814005|594587938|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
164608963|NCT03814005|594587939|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
164608964|NCT03814005|594587937|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
164608965|NCT03814005|594587938|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
164608966|NCT03814005|594587939|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
164608967|NCT03814005|594587937|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
164608968|NCT03814005|594587938|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
164608969|NCT03814005|594587939|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
164608970|NCT03814005|594587937|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
164608971|NCT03814005|594587938|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
164608972|NCT03814005|594587939|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
164608973|NCT00965146|594587940|FG000|Overall Study|Death|7|||
164608974|NCT00965146|594587940|FG000|Overall Study|Lost to Follow-up|22|||
164608975|NCT00965146|594587940|FG000|Overall Study|Withdrawal by Subject|17|||
164608976|NCT00965146|594587940|FG000|Overall Study|Unable to return|1|||
164608977|NCT00965146|594587940|FG000|Overall Study|Unwilling to return|11|||
164608978|NCT00965146|594587940|FG000|Overall Study|Intercurrent illness|1|||
164608979|NCT00965146|594587940|FG000|Overall Study|Revision / Removal of Study Implant|6|||
164608980|NCT00965146|594587940|FG000|Overall Study|Overall Study Termination|145|||
164608981|NCT05067452|594587941|FG000|Overall Study|Lost to Follow-up|0|||
164608982|NCT05067452|594587942|FG001|Overall Study|Lost to Follow-up|4|||
164608983|NCT01135017|594587943|FG000|Overall Study|Adverse Event|3|||
164608984|NCT01135017|594587944|FG001|Overall Study|Adverse Event|8|||
164509948|NCT00078338|594237949|FG000|Overall Study|Protocol Violation|2|||
164509949|NCT00078338|594237950|FG001|Overall Study|Protocol Violation|2|||
164509950|NCT00078338|594237949|FG000|Overall Study|Disease Progression|4|||
164509951|NCT00078338|594237950|FG001|Overall Study|Disease Progression|7|||
164509952|NCT00078338|594237949|FG000|Overall Study|Other|28|||
164608985|NCT01135017|594587943|FG000|Overall Study|Other than above|3|||
164608986|NCT01135017|594587944|FG001|Overall Study|Other than above|4|||
164608987|NCT00432562|594587945|FG000|Overall Study|Death|3|||
164608988|NCT00432562|594587946|FG001|Overall Study|Death|0|||
164608989|NCT01192204|594587950|FG000|Overall Study|could not keep recall appointments|1|||
164608990|NCT01192204|594587951|FG001|Overall Study|could not keep recall appointments|0|||
164608991|NCT03699631|594587953|FG000|Overall Study|Adverse Event|3|||
164608992|NCT02219087|594587954|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
164608993|NCT02219087|594587955|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
164608994|NCT05127421|594587956|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
164608995|NCT05127421|594587957|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
164608996|NCT05127421|594587958|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
164608997|NCT05127421|594587959|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
164608998|NCT05127421|594587956|FG000|4-Week Double-Blind Period|Physician Decision|1|||
164608999|NCT05127421|594587957|FG001|4-Week Double-Blind Period|Physician Decision|0|||
164609000|NCT05127421|594587958|FG002|4-Week Double-Blind Period|Physician Decision|0|||
164609001|NCT05127421|594587959|FG003|4-Week Double-Blind Period|Physician Decision|0|||
164609002|NCT05127421|594587956|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
164609003|NCT05127421|594587957|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
164609004|NCT05127421|594587958|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
164609005|NCT05127421|594587959|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
164609006|NCT05127421|594587956|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
164609007|NCT05127421|594587957|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
164609008|NCT05127421|594587958|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
164609009|NCT05127421|594587959|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
164609010|NCT05127421|594587956|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
164609011|NCT05127421|594587957|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
164609012|NCT05127421|594587958|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
164609013|NCT05127421|594587959|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
164609014|NCT05127421|594587956|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
164609015|NCT05127421|594587957|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
164609016|NCT05127421|594587958|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
164609017|NCT05127421|594587959|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
164609018|NCT05127421|594587956|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
164609019|NCT05127421|594587957|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
164609020|NCT05127421|594587958|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
164609021|NCT05127421|594587959|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
164609022|NCT05127421|594587956|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
164609023|NCT05127421|594587957|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
164609024|NCT05127421|594587958|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
164609025|NCT05127421|594587959|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
164609026|NCT00618449|594587960|FG000|Overall Study|Lost to Follow-up|98|||
164609027|NCT00618449|594587961|FG001|Overall Study|Lost to Follow-up|110|||
164609028|NCT00964158|594587962|FG000|Overall Study|Lost to Follow-up|0|||
164609029|NCT00964158|594587963|FG001|Overall Study|Lost to Follow-up|1|||
164609030|NCT00964158|594587964|FG002|Overall Study|Lost to Follow-up|2|||
164609031|NCT00964158|594587962|FG000|Overall Study|Withdrawal by Subject|0|||
164609032|NCT00964158|594587963|FG001|Overall Study|Withdrawal by Subject|0|||
164609033|NCT00964158|594587964|FG002|Overall Study|Withdrawal by Subject|6|||
164609034|NCT04585451|594587969|FG000|Overall Study|Withdrawal by Subject|26|||
164609035|NCT04585451|594587970|FG001|Overall Study|Withdrawal by Subject|0|||
164609036|NCT00966693|594587973|FG000|Overall Study|Adverse Event|0|||
164609037|NCT00966693|594587974|FG001|Overall Study|Adverse Event|0|||
164609038|NCT00966693|594587975|FG002|Overall Study|Adverse Event|1|||
164609039|NCT00966693|594587976|FG003|Overall Study|Adverse Event|2|||
164609040|NCT00966693|594587973|FG000|Overall Study|Death|0|||
164609041|NCT00966693|594587974|FG001|Overall Study|Death|0|||
164609042|NCT00966693|594587975|FG002|Overall Study|Death|1|||
164609043|NCT00966693|594587976|FG003|Overall Study|Death|0|||
164609044|NCT00966693|594587973|FG000|Overall Study|Withdrawal by Subject|1|||
164609045|NCT00966693|594587974|FG001|Overall Study|Withdrawal by Subject|0|||
164609046|NCT00966693|594587975|FG002|Overall Study|Withdrawal by Subject|0|||
164609047|NCT00966693|594587976|FG003|Overall Study|Withdrawal by Subject|5|||
164609048|NCT00966693|594587973|FG000|Overall Study|Disease Progression|0|||
164509953|NCT00078338|594237950|FG001|Overall Study|Other|16|||
164509954|NCT00078338|594237949|FG000|Overall Study|Subjects randomized, but not treated|3|||
164509955|NCT00078338|594237950|FG001|Overall Study|Subjects randomized, but not treated|3|||
164509956|NCT02124811|594237951|FG000|Overall Study|Early termination|2|||
164509957|NCT02124811|594237952|FG001|Overall Study|Early termination|2|||
164509958|NCT02124811|594237951|FG000|Overall Study|Withdrawal by Subject|1|||
164509959|NCT02124811|594237952|FG001|Overall Study|Withdrawal by Subject|0|||
164509960|NCT04201288|594237960|FG000|Overall Study|Death|1|||
164509961|NCT04201288|594237961|FG001|Overall Study|Death|1|||
164509962|NCT04201288|594237960|FG000|Overall Study|Lost to Follow-up|5|||
164509963|NCT04201288|594237961|FG001|Overall Study|Lost to Follow-up|3|||
164509964|NCT04201288|594237960|FG000|Overall Study|Withdrawal by Subject|1|||
164509965|NCT04201288|594237961|FG001|Overall Study|Withdrawal by Subject|0|||
164509966|NCT01606319|594237962|FG000|Overall Study|Lost to Follow-up|17|||
164509967|NCT01606319|594237963|FG001|Overall Study|Lost to Follow-up|14|||
164509968|NCT01606319|594237962|FG000|Overall Study|Withdrawal by Subject|9|||
164509969|NCT01606319|594237963|FG001|Overall Study|Withdrawal by Subject|12|||
164509970|NCT01606319|594237962|FG000|Overall Study|Physician Decision|1|||
164509971|NCT01606319|594237963|FG001|Overall Study|Physician Decision|2|||
164509972|NCT01606319|594237962|FG000|Overall Study|Lack of Efficacy|6|||
164509973|NCT01606319|594237963|FG001|Overall Study|Lack of Efficacy|8|||
164509974|NCT01606319|594237962|FG000|Overall Study|Adverse Event|1|||
164509975|NCT01606319|594237963|FG001|Overall Study|Adverse Event|4|||
164509976|NCT01821937|594237965|FG000|Overall Study|Adverse Event|0|||
164509977|NCT01821937|594237966|FG001|Overall Study|Adverse Event|3|||
164509978|NCT02615509|594237967|FG000|Overall Study|Lost to Follow-up|134|||
164509979|NCT02615509|594237967|FG000|Overall Study|Death|4|||
164509980|NCT02615509|594237967|FG000|Overall Study|Withdrawal by Subject|8|||
164509981|NCT02030002|594237971|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
164509982|NCT02030002|594237971|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
164509983|NCT02030002|594237971|FG000|Follow-up|Lost to Follow-up|2|||
164509984|NCT01294397|594237972|FG000|Overall Study|Withdrawal by Subject|1|||
164509985|NCT01294397|594237972|FG000|Overall Study|Administrative Decision|1|||
164509986|NCT00504075|594237973|FG000|Overall Study|Adverse Event|1|||
164509987|NCT00504075|594237973|FG000|Overall Study|Lost to Follow-up|5|||
164509988|NCT00504075|594237973|FG000|Overall Study|Withdrawal by Subject|1|||
164509989|NCT00504075|594237973|FG000|Overall Study|Required other therapeutic intervention|1|||
164509990|NCT02406248|594237974|FG000|Overall Study|Death|7|||
164509991|NCT02406248|594237974|FG000|Overall Study|Withdrawal by Subject|2|||
164509992|NCT01023958|594237979|FG000|Overall Study|Progressive disease|48|||
164509993|NCT01023958|594237979|FG000|Overall Study|Other adverse event|1|||
164509994|NCT01023958|594237979|FG000|Overall Study|Refused to continue medication|1|||
164509995|NCT01031628|594237980|FG000|Overall Study|Study terminated early|0|||
164509996|NCT01031628|594237981|FG001|Overall Study|Study terminated early|1|||
164509997|NCT01031628|594237982|FG002|Overall Study|Study terminated early|3|||
164509998|NCT01031628|594237983|FG003|Overall Study|Study terminated early|0|||
164509999|NCT02362503|594237984|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
164510000|NCT02362503|594237985|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
164510001|NCT02362503|594237986|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
164510002|NCT02362503|594237984|FG000|Double-blind Period-Up to 8 Days|Death|1|||
164510003|NCT02362503|594237985|FG001|Double-blind Period-Up to 8 Days|Death|0|||
164510004|NCT02362503|594237986|FG002|Double-blind Period-Up to 8 Days|Death|0|||
164510005|NCT02362503|594237984|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
164510006|NCT02362503|594237985|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
164510007|NCT02362503|594237986|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
164510008|NCT02362503|594237984|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
164510009|NCT02362503|594237985|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
164510010|NCT02362503|594237986|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
164510011|NCT02362503|594237984|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
164510012|NCT02362503|594237985|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
164510013|NCT02362503|594237986|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
164510014|NCT02362503|594237984|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
164510015|NCT02362503|594237985|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
164510016|NCT02362503|594237986|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
164510017|NCT02362503|594237984|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
164510018|NCT02362503|594237985|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
164510019|NCT02362503|594237986|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
164510020|NCT02362503|594237984|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
164510021|NCT02362503|594237985|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
164510022|NCT02362503|594237986|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
164510023|NCT02362503|594237984|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
164510024|NCT02362503|594237985|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
164510025|NCT02362503|594237986|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
164510026|NCT02362503|594237984|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
164510027|NCT02362503|594237985|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
164510028|NCT02362503|594237986|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
164510029|NCT02362503|594237984|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
164510030|NCT02362503|594237985|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
164510031|NCT02362503|594237986|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
164510032|NCT02362503|594237984|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
164510033|NCT02362503|594237985|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
164510034|NCT02362503|594237986|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
164510035|NCT02362503|594237984|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
164510036|NCT02362503|594237985|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
164510037|NCT02362503|594237986|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
164510038|NCT02362503|594237984|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
164510039|NCT02362503|594237985|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
164510040|NCT02362503|594237986|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
164510041|NCT03017742|594237989|FG000|Overall Study|Protocol Violation|36|||
164510042|NCT03017742|594237989|FG000|Overall Study|Withdrawal by Subject|37|||
164510043|NCT04148651|594237990|FG000|Overall Study|Lost to Follow-up|2|||
164510044|NCT01001390|594237991|FG000|Overall Study|Failure to wear AFO device|2|||
164510045|NCT01001390|594237992|FG001|Overall Study|Failure to wear AFO device|0|||
164510046|NCT03690427|594237993|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
164510047|NCT03690427|594237994|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
164510048|NCT03519204|594237995|FG000|Overall Study|Lost to Follow-up|3|||
164510049|NCT03519204|594237996|FG001|Overall Study|Lost to Follow-up|8|||
164510050|NCT03519204|594237995|FG000|Overall Study|Withdrawal by Subject|9|||
164510051|NCT03519204|594237996|FG001|Overall Study|Withdrawal by Subject|7|||
164510052|NCT03519204|594237995|FG000|Overall Study|Other Miscellaneous Reasons|1|||
164510053|NCT03519204|594237996|FG001|Overall Study|Other Miscellaneous Reasons|0|||
164510054|NCT02609672|594238000|FG000|Overall Study|Lost to Follow-up|3|||
164510055|NCT02609672|594238001|FG001|Overall Study|Lost to Follow-up|1|||
164510056|NCT03392168|594238002|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
164510057|NCT03392168|594238003|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
164510058|NCT03392168|594238004|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
164510059|NCT03392168|594238005|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
164510060|NCT03392168|594238002|FG000|Period 2: Cohort 2|Other|0|||
164510061|NCT03392168|594238003|FG001|Period 2: Cohort 2|Other|1|||
164510062|NCT03392168|594238004|FG002|Period 2: Cohort 2|Other|0|||
164510063|NCT03392168|594238005|FG003|Period 2: Cohort 2|Other|0|||
164510064|NCT00762476|594238006|FG000|Overall Study|Adverse Event|7|||
164510065|NCT00762476|594238007|FG001|Overall Study|Adverse Event|1|||
164510066|NCT00762476|594238006|FG000|Overall Study|Lost to Follow-up|2|||
164510067|NCT00762476|594238007|FG001|Overall Study|Lost to Follow-up|0|||
164510068|NCT00762476|594238006|FG000|Overall Study|Protocol Violation|5|||
164510069|NCT00762476|594238007|FG001|Overall Study|Protocol Violation|6|||
164510070|NCT00762476|594238006|FG000|Overall Study|Physician Decision|2|||
164510071|NCT00762476|594238007|FG001|Overall Study|Physician Decision|14|||
164510072|NCT00762476|594238006|FG000|Overall Study|Withdrawal by Subject|6|||
164510073|NCT00762476|594238007|FG001|Overall Study|Withdrawal by Subject|12|||
164510074|NCT00762476|594238006|FG000|Overall Study|antibiotic use|0|||
164510075|NCT00762476|594238007|FG001|Overall Study|antibiotic use|1|||
164510076|NCT00762476|594238006|FG000|Overall Study|non-compliance with study visits|0|||
164510077|NCT00762476|594238007|FG001|Overall Study|non-compliance with study visits|2|||
164510078|NCT00762476|594238006|FG000|Overall Study|Seasonal allergies|1|||
164510079|NCT00762476|594238007|FG001|Overall Study|Seasonal allergies|0|||
164510080|NCT01441635|594238008|FG000|Overall Study|Adverse Event|4|||
164510081|NCT01441635|594238009|FG001|Overall Study|Adverse Event|3|||
164510082|NCT01441635|594238010|FG002|Overall Study|Adverse Event|1|||
164510083|NCT01441635|594238011|FG003|Overall Study|Adverse Event|5|||
164510084|NCT01441635|594238012|FG004|Overall Study|Adverse Event|1|||
164510085|NCT01441635|594238013|FG005|Overall Study|Adverse Event|2|||
164510086|NCT01441635|594238014|FG006|Overall Study|Adverse Event|2|||
164510087|NCT01441635|594238015|FG007|Overall Study|Adverse Event|2|||
164510088|NCT01441635|594238016|FG008|Overall Study|Adverse Event|1|||
164510089|NCT01441635|594238017|FG009|Overall Study|Adverse Event|0|||
164510090|NCT01441635|594238008|FG000|Overall Study|Withdrawal by Subject|1|||
164510091|NCT01441635|594238009|FG001|Overall Study|Withdrawal by Subject|1|||
164510092|NCT01441635|594238010|FG002|Overall Study|Withdrawal by Subject|0|||
164510093|NCT01441635|594238011|FG003|Overall Study|Withdrawal by Subject|1|||
164510094|NCT01441635|594238012|FG004|Overall Study|Withdrawal by Subject|0|||
164510095|NCT01441635|594238013|FG005|Overall Study|Withdrawal by Subject|0|||
164510096|NCT01441635|594238014|FG006|Overall Study|Withdrawal by Subject|2|||
164510097|NCT01441635|594238015|FG007|Overall Study|Withdrawal by Subject|0|||
164510098|NCT01441635|594238016|FG008|Overall Study|Withdrawal by Subject|1|||
164510099|NCT01441635|594238017|FG009|Overall Study|Withdrawal by Subject|1|||
164510100|NCT01441635|594238008|FG000|Overall Study|Lost to Follow-up|0|||
164510101|NCT01441635|594238009|FG001|Overall Study|Lost to Follow-up|1|||
164510102|NCT01441635|594238010|FG002|Overall Study|Lost to Follow-up|1|||
164510103|NCT01441635|594238011|FG003|Overall Study|Lost to Follow-up|1|||
164510104|NCT01441635|594238012|FG004|Overall Study|Lost to Follow-up|1|||
164510105|NCT01441635|594238013|FG005|Overall Study|Lost to Follow-up|3|||
164510106|NCT01441635|594238014|FG006|Overall Study|Lost to Follow-up|1|||
164510107|NCT01441635|594238015|FG007|Overall Study|Lost to Follow-up|1|||
164510108|NCT01441635|594238016|FG008|Overall Study|Lost to Follow-up|0|||
164510109|NCT01441635|594238017|FG009|Overall Study|Lost to Follow-up|1|||
164510110|NCT01441635|594238008|FG000|Overall Study|Noncompliance|0|||
164510111|NCT01441635|594238009|FG001|Overall Study|Noncompliance|1|||
164510112|NCT01441635|594238010|FG002|Overall Study|Noncompliance|0|||
164510113|NCT01441635|594238011|FG003|Overall Study|Noncompliance|0|||
164510114|NCT01441635|594238012|FG004|Overall Study|Noncompliance|0|||
164510115|NCT01441635|594238013|FG005|Overall Study|Noncompliance|0|||
164510116|NCT01441635|594238014|FG006|Overall Study|Noncompliance|1|||
164510117|NCT01441635|594238015|FG007|Overall Study|Noncompliance|0|||
164510118|NCT01441635|594238016|FG008|Overall Study|Noncompliance|0|||
164510119|NCT01441635|594238017|FG009|Overall Study|Noncompliance|0|||
164510120|NCT01441635|594238008|FG000|Overall Study|Surgery or Invasive Intervention|0|||
164510121|NCT01441635|594238009|FG001|Overall Study|Surgery or Invasive Intervention|0|||
164510122|NCT01441635|594238010|FG002|Overall Study|Surgery or Invasive Intervention|1|||
164510123|NCT01441635|594238011|FG003|Overall Study|Surgery or Invasive Intervention|0|||
164510124|NCT01441635|594238012|FG004|Overall Study|Surgery or Invasive Intervention|0|||
164510125|NCT01441635|594238013|FG005|Overall Study|Surgery or Invasive Intervention|0|||
164510126|NCT01441635|594238014|FG006|Overall Study|Surgery or Invasive Intervention|0|||
164510127|NCT01441635|594238015|FG007|Overall Study|Surgery or Invasive Intervention|0|||
164510128|NCT01441635|594238016|FG008|Overall Study|Surgery or Invasive Intervention|0|||
164510129|NCT01441635|594238017|FG009|Overall Study|Surgery or Invasive Intervention|0|||
164510130|NCT01441635|594238008|FG000|Overall Study|Received Exclusionary Medication|1|||
164510131|NCT01441635|594238009|FG001|Overall Study|Received Exclusionary Medication|0|||
164510132|NCT01441635|594238010|FG002|Overall Study|Received Exclusionary Medication|0|||
164510133|NCT01441635|594238011|FG003|Overall Study|Received Exclusionary Medication|0|||
164510134|NCT01441635|594238012|FG004|Overall Study|Received Exclusionary Medication|0|||
164510135|NCT01441635|594238013|FG005|Overall Study|Received Exclusionary Medication|0|||
164510136|NCT01441635|594238014|FG006|Overall Study|Received Exclusionary Medication|0|||
164510137|NCT01441635|594238015|FG007|Overall Study|Received Exclusionary Medication|0|||
164510138|NCT01441635|594238016|FG008|Overall Study|Received Exclusionary Medication|0|||
164510139|NCT01441635|594238017|FG009|Overall Study|Received Exclusionary Medication|0|||
164510140|NCT01441635|594238008|FG000|Overall Study|Other|0|||
164510141|NCT01441635|594238009|FG001|Overall Study|Other|0|||
164510142|NCT01441635|594238010|FG002|Overall Study|Other|0|||
164510143|NCT01441635|594238011|FG003|Overall Study|Other|0|||
164510144|NCT01441635|594238012|FG004|Overall Study|Other|0|||
164510145|NCT01441635|594238013|FG005|Overall Study|Other|0|||
164510146|NCT01441635|594238014|FG006|Overall Study|Other|0|||
164510147|NCT01441635|594238015|FG007|Overall Study|Other|1|||
164510148|NCT01441635|594238016|FG008|Overall Study|Other|0|||
164510149|NCT01441635|594238017|FG009|Overall Study|Other|0|||
164510150|NCT02637323|594238019|FG000|Overall Study|Lost to Follow-up|2|||
164510151|NCT02637323|594238020|FG001|Overall Study|Lost to Follow-up|0|||
164510152|NCT02637323|594238019|FG000|Overall Study|Protocol Violation|0|||
164510153|NCT02637323|594238020|FG001|Overall Study|Protocol Violation|1|||
164510154|NCT02838134|594238021|FG000|Overall Study|Lost to Follow-up|1|||
164510155|NCT02838134|594238022|FG001|Overall Study|Lost to Follow-up|2|||
164510156|NCT02838134|594238021|FG000|Overall Study|logistic problems|1|||
164510157|NCT02838134|594238022|FG001|Overall Study|logistic problems|1|||
164510158|NCT01305239|594238023|FG000|Overall Study|Adverse Event|22|||
164510159|NCT01305239|594238023|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
164510160|NCT04674189|594238025|FG000|Overall Study|Adverse Event|0|||
164510161|NCT04674189|594238026|FG001|Overall Study|Adverse Event|0|||
164510162|NCT04674189|594238027|FG002|Overall Study|Adverse Event|1|||
164510163|NCT04674189|594238025|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
164510164|NCT04674189|594238026|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
164510165|NCT04674189|594238027|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
164510166|NCT04674189|594238025|FG000|Overall Study|Physician Decision|1|||
164510167|NCT04674189|594238026|FG001|Overall Study|Physician Decision|0|||
164510168|NCT04674189|594238027|FG002|Overall Study|Physician Decision|0|||
164510169|NCT04674189|594238025|FG000|Overall Study|Withdrawal by Participant|83|||
164510170|NCT04674189|594238026|FG001|Overall Study|Withdrawal by Participant|71|||
164510171|NCT04674189|594238027|FG002|Overall Study|Withdrawal by Participant|142|||
164510172|NCT04674189|594238025|FG000|Overall Study|Lost to Follow-up|55|||
164510173|NCT04674189|594238026|FG001|Overall Study|Lost to Follow-up|53|||
164510174|NCT04674189|594238027|FG002|Overall Study|Lost to Follow-up|44|||
164510175|NCT04674189|594238025|FG000|Overall Study|Miscellaneous|27|||
164510176|NCT04674189|594238026|FG001|Overall Study|Miscellaneous|23|||
164510177|NCT04674189|594238027|FG002|Overall Study|Miscellaneous|207|||
164510178|NCT04674189|594238025|FG000|Overall Study|Did Not Receive Treatment|3|||
164510179|NCT04674189|594238026|FG001|Overall Study|Did Not Receive Treatment|1|||
164510180|NCT04674189|594238027|FG002|Overall Study|Did Not Receive Treatment|2|||
164510181|NCT01261247|594238028|FG000|Overall Study|Ineligible|2|||
164510182|NCT05226130|594238029|FG000|Overall Study|Lost to Follow-up|0|||
164510183|NCT05226130|594238030|FG001|Overall Study|Lost to Follow-up|1|||
164510184|NCT05226130|594238029|FG000|Overall Study|Not treatment adherent|0|||
164510185|NCT05226130|594238030|FG001|Overall Study|Not treatment adherent|2|||
164510186|NCT03974022|594238031|FG000|Overall Study|Death|0|||
164510187|NCT03974022|594238032|FG001|Overall Study|Death|1|||
164510188|NCT03974022|594238033|FG002|Overall Study|Death|0|||
164510189|NCT03974022|594238034|FG003|Overall Study|Death|2|||
164510190|NCT03974022|594238035|FG004|Overall Study|Death|0|||
164510191|NCT03974022|594238036|FG005|Overall Study|Death|1|||
164510192|NCT03974022|594238037|FG006|Overall Study|Death|0|||
164510193|NCT03974022|594238038|FG007|Overall Study|Death|2|||
164510194|NCT03974022|594238039|FG008|Overall Study|Death|1|||
164510195|NCT03974022|594238040|FG009|Overall Study|Death|4|||
164510196|NCT03974022|594238041|FG010|Overall Study|Death|0|||
164510197|NCT03974022|594238042|FG011|Overall Study|Death|0|||
164510198|NCT03974022|594238043|FG012|Overall Study|Death|0|||
164510199|NCT03974022|594238044|FG013|Overall Study|Death|33|||
164510200|NCT03974022|594238045|FG014|Overall Study|Death|40|||
164510201|NCT03974022|594238031|FG000|Overall Study|Withdrawal by Subject|0|||
164510202|NCT03974022|594238032|FG001|Overall Study|Withdrawal by Subject|0|||
164510203|NCT03974022|594238033|FG002|Overall Study|Withdrawal by Subject|0|||
164510204|NCT03974022|594238034|FG003|Overall Study|Withdrawal by Subject|0|||
164510205|NCT03974022|594238035|FG004|Overall Study|Withdrawal by Subject|0|||
164510206|NCT03974022|594238036|FG005|Overall Study|Withdrawal by Subject|4|||
164510207|NCT03974022|594238037|FG006|Overall Study|Withdrawal by Subject|4|||
164510208|NCT03974022|594238038|FG007|Overall Study|Withdrawal by Subject|2|||
164510209|NCT03974022|594238039|FG008|Overall Study|Withdrawal by Subject|2|||
164510210|NCT03974022|594238040|FG009|Overall Study|Withdrawal by Subject|3|||
164510211|NCT03974022|594238041|FG010|Overall Study|Withdrawal by Subject|0|||
164510212|NCT03974022|594238042|FG011|Overall Study|Withdrawal by Subject|1|||
164510213|NCT03974022|594238043|FG012|Overall Study|Withdrawal by Subject|0|||
164510214|NCT03974022|594238044|FG013|Overall Study|Withdrawal by Subject|3|||
164510215|NCT03974022|594238045|FG014|Overall Study|Withdrawal by Subject|9|||
164510216|NCT03974022|594238031|FG000|Overall Study|Lost to Follow-up|0|||
164510217|NCT03974022|594238032|FG001|Overall Study|Lost to Follow-up|0|||
164510218|NCT03974022|594238033|FG002|Overall Study|Lost to Follow-up|0|||
164510219|NCT03974022|594238034|FG003|Overall Study|Lost to Follow-up|0|||
164510220|NCT03974022|594238035|FG004|Overall Study|Lost to Follow-up|0|||
164510221|NCT03974022|594238036|FG005|Overall Study|Lost to Follow-up|0|||
164510222|NCT03974022|594238037|FG006|Overall Study|Lost to Follow-up|1|||
164510223|NCT03974022|594238038|FG007|Overall Study|Lost to Follow-up|0|||
164510224|NCT03974022|594238039|FG008|Overall Study|Lost to Follow-up|0|||
164510225|NCT03974022|594238040|FG009|Overall Study|Lost to Follow-up|0|||
164510226|NCT03974022|594238041|FG010|Overall Study|Lost to Follow-up|0|||
164510227|NCT03974022|594238042|FG011|Overall Study|Lost to Follow-up|0|||
164510228|NCT03974022|594238043|FG012|Overall Study|Lost to Follow-up|0|||
164510229|NCT03974022|594238044|FG013|Overall Study|Lost to Follow-up|1|||
164510230|NCT03974022|594238045|FG014|Overall Study|Lost to Follow-up|1|||
164510231|NCT03974022|594238031|FG000|Overall Study|site terminated by sponsor or non compliance|0|||
164510232|NCT03974022|594238032|FG001|Overall Study|site terminated by sponsor or non compliance|0|||
164510233|NCT03974022|594238033|FG002|Overall Study|site terminated by sponsor or non compliance|0|||
164510234|NCT03974022|594238034|FG003|Overall Study|site terminated by sponsor or non compliance|0|||
164510235|NCT03974022|594238035|FG004|Overall Study|site terminated by sponsor or non compliance|1|||
164510236|NCT03974022|594238036|FG005|Overall Study|site terminated by sponsor or non compliance|0|||
164510237|NCT03974022|594238037|FG006|Overall Study|site terminated by sponsor or non compliance|1|||
164510238|NCT03974022|594238038|FG007|Overall Study|site terminated by sponsor or non compliance|0|||
164510239|NCT03974022|594238039|FG008|Overall Study|site terminated by sponsor or non compliance|1|||
164510240|NCT03974022|594238040|FG009|Overall Study|site terminated by sponsor or non compliance|0|||
164510241|NCT03974022|594238041|FG010|Overall Study|site terminated by sponsor or non compliance|0|||
164510242|NCT03974022|594238042|FG011|Overall Study|site terminated by sponsor or non compliance|0|||
164510243|NCT03974022|594238043|FG012|Overall Study|site terminated by sponsor or non compliance|1|||
164510244|NCT03974022|594238044|FG013|Overall Study|site terminated by sponsor or non compliance|0|||
164510245|NCT03974022|594238045|FG014|Overall Study|site terminated by sponsor or non compliance|0|||
164510246|NCT04680533|594238046|FG000|Overall Study|Screen failure|1|||
164510247|NCT02412735|594239827|FG000|Overall Study|Adverse Event|0|||
164510248|NCT02412735|594239828|FG001|Overall Study|Adverse Event|1|||
164510249|NCT02412735|594239829|FG002|Overall Study|Adverse Event|2|||
164510250|NCT02412735|594239827|FG000|Overall Study|Withdrawal by Subject|23|||
164510251|NCT02412735|594239828|FG001|Overall Study|Withdrawal by Subject|27|||
164510252|NCT02412735|594239829|FG002|Overall Study|Withdrawal by Subject|22|||
164510253|NCT02412735|594239827|FG000|Overall Study|Investigator Decision|3|||
164510254|NCT02412735|594239828|FG001|Overall Study|Investigator Decision|3|||
164510255|NCT02412735|594239829|FG002|Overall Study|Investigator Decision|2|||
164510256|NCT02412735|594239827|FG000|Overall Study|Lost to Follow-up|17|||
164510257|NCT02412735|594239828|FG001|Overall Study|Lost to Follow-up|11|||
164510258|NCT02412735|594239829|FG002|Overall Study|Lost to Follow-up|18|||
164510259|NCT02412735|594239827|FG000|Overall Study|Reason not Specified|3|||
164510260|NCT02412735|594239828|FG001|Overall Study|Reason not Specified|2|||
164510261|NCT02412735|594239829|FG002|Overall Study|Reason not Specified|2|||
164510262|NCT01006980|594239830|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
164510263|NCT01006980|594239831|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
164510264|NCT01006980|594239830|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
164510265|NCT01006980|594239831|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
164510266|NCT01006980|594239830|FG000|Vemurafenib and Dacarbazine|Death|13|||
164609049|NCT00966693|594587974|FG001|Overall Study|Disease Progression|0|||
164609050|NCT00966693|594587975|FG002|Overall Study|Disease Progression|1|||
164609051|NCT00966693|594587976|FG003|Overall Study|Disease Progression|16|||
164609052|NCT01769469|594587977|FG000|Overall Study|Consent Withdrawn|5|||
164609053|NCT01769469|594587977|FG000|Overall Study|Moved Out Of Area|3|||
164609054|NCT01769469|594587977|FG000|Overall Study|Lost to Follow-up|17|||
164609055|NCT01769469|594587977|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
164609056|NCT01769469|594587977|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
164609057|NCT02713789|594587985|FG000|Overall Study|Lost to Follow-up|0|||
164609058|NCT02713789|594587986|FG001|Overall Study|Lost to Follow-up|1|||
164609059|NCT02713789|594587987|FG002|Overall Study|Lost to Follow-up|1|||
164609060|NCT00888615|594587991|FG000|Overall Study|No treatment|2|||
164609061|NCT00141037|594587992|FG000|Overall Study|Physician Decision|1|||
164609062|NCT00141037|594587993|FG001|Overall Study|Physician Decision|2|||
164609063|NCT00141037|594587992|FG000|Overall Study|Lost to Follow-up|3|||
164609064|NCT00141037|594587993|FG001|Overall Study|Lost to Follow-up|1|||
164609065|NCT00141037|594587992|FG000|Overall Study|Protocol Violation|0|||
164609066|NCT00141037|594587993|FG001|Overall Study|Protocol Violation|2|||
164609067|NCT00141037|594587992|FG000|Overall Study|Withdrawal by Subject|2|||
164609068|NCT00141037|594587993|FG001|Overall Study|Withdrawal by Subject|1|||
164609069|NCT00141037|594587992|FG000|Overall Study|Other|0|||
164609070|NCT00141037|594587993|FG001|Overall Study|Other|1|||
164609071|NCT00141037|594587992|FG000|Overall Study|Moved from area|1|||
164609072|NCT00141037|594587993|FG001|Overall Study|Moved from area|7|||
164609073|NCT00141037|594587992|FG000|Overall Study|Graft Failure|3|||
164609074|NCT00141037|594587993|FG001|Overall Study|Graft Failure|4|||
164609075|NCT01375647|594589533|FG000|Overall Study|Lost to Follow-up|3|||
164609076|NCT01375647|594589534|FG001|Overall Study|Lost to Follow-up|3|||
164609077|NCT01375647|594589535|FG002|Overall Study|Lost to Follow-up|7|||
164609078|NCT01375647|594589536|FG003|Overall Study|Lost to Follow-up|10|||
164609079|NCT01375647|594589533|FG000|Overall Study|Death|1|||
164609080|NCT01375647|594589534|FG001|Overall Study|Death|2|||
164609081|NCT01375647|594589535|FG002|Overall Study|Death|1|||
164609082|NCT01375647|594589536|FG003|Overall Study|Death|0|||
164609083|NCT01375647|594589533|FG000|Overall Study|Withdrawal by Subject|17|||
164609084|NCT01375647|594589534|FG001|Overall Study|Withdrawal by Subject|20|||
164609085|NCT01375647|594589535|FG002|Overall Study|Withdrawal by Subject|26|||
164609086|NCT01375647|594589536|FG003|Overall Study|Withdrawal by Subject|14|||
164609087|NCT01375647|594589533|FG000|Overall Study|Physician Decision|1|||
164609088|NCT01375647|594589534|FG001|Overall Study|Physician Decision|0|||
164609089|NCT01375647|594589535|FG002|Overall Study|Physician Decision|0|||
164609090|NCT01375647|594589536|FG003|Overall Study|Physician Decision|0|||
164609091|NCT03788967|594589539|FG000|Overall Study|Lost to Follow-up|14|||
164609092|NCT03788967|594589540|FG001|Overall Study|Lost to Follow-up|10|||
164609093|NCT03788967|594589539|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
164609094|NCT03788967|594589540|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
164609095|NCT03788967|594589539|FG000|Overall Study|Participant Withdrawal of Consent|13|||
164609096|NCT03788967|594589540|FG001|Overall Study|Participant Withdrawal of Consent|5|||
164609097|NCT03788967|594589539|FG000|Overall Study|Adverse Event|1|||
164609098|NCT03788967|594589540|FG001|Overall Study|Adverse Event|1|||
164609099|NCT03788967|594589539|FG000|Overall Study|COVID-19|1|||
164609100|NCT03788967|594589540|FG001|Overall Study|COVID-19|2|||
164609101|NCT01824693|594589544|FG000|Overall Study|Death|0|||
164609102|NCT01824693|594589545|FG001|Overall Study|Death|1|||
164609103|NCT01824693|594589546|FG002|Overall Study|Death|0|||
164609104|NCT01824693|594589544|FG000|Overall Study|Physician Decision|1|||
164609105|NCT01824693|594589545|FG001|Overall Study|Physician Decision|1|||
164609106|NCT01824693|594589546|FG002|Overall Study|Physician Decision|1|||
164609107|NCT01824693|594589544|FG000|Overall Study|Withdrawal by Subject|0|||
164609108|NCT01824693|594589545|FG001|Overall Study|Withdrawal by Subject|0|||
164609109|NCT01824693|594589546|FG002|Overall Study|Withdrawal by Subject|1|||
164609110|NCT01824693|594589544|FG000|Overall Study|Progressive Disease|0|||
164609111|NCT01824693|594589545|FG001|Overall Study|Progressive Disease|5|||
164609112|NCT01824693|594589546|FG002|Overall Study|Progressive Disease|0|||
164609113|NCT01824693|594589544|FG000|Overall Study|Ineligible|0|||
164609114|NCT01824693|594589545|FG001|Overall Study|Ineligible|0|||
164609115|NCT01824693|594589546|FG002|Overall Study|Ineligible|3|||
164609116|NCT01824693|594589544|FG000|Overall Study|No Transplant Planned|0|||
164609117|NCT01824693|594589545|FG001|Overall Study|No Transplant Planned|0|||
164609118|NCT01824693|594589546|FG002|Overall Study|No Transplant Planned|10|||
164609119|NCT03488238|594589547|FG000|Overall Study|Equipment malfunction|1|||
164609120|NCT03488238|594589547|FG000|Overall Study|Adverse Event|1|||
164609121|NCT01316939|594589550|FG000|Overall Study|Study closed/terminated|26|||
164609122|NCT01316939|594589551|FG001|Overall Study|Study closed/terminated|25|||
164609123|NCT01316939|594589552|FG002|Overall Study|Study closed/terminated|23|||
164609124|NCT01316939|594589550|FG000|Overall Study|Lack of Efficacy|24|||
164609125|NCT01316939|594589551|FG001|Overall Study|Lack of Efficacy|25|||
164609126|NCT01316939|594589552|FG002|Overall Study|Lack of Efficacy|25|||
164609127|NCT01316939|594589550|FG000|Overall Study|Adverse Event|9|||
164609128|NCT01316939|594589551|FG001|Overall Study|Adverse Event|12|||
164609129|NCT01316939|594589552|FG002|Overall Study|Adverse Event|11|||
164609130|NCT01316939|594589550|FG000|Overall Study|Withdrawal by Subject|1|||
164609131|NCT01316939|594589551|FG001|Overall Study|Withdrawal by Subject|3|||
164609132|NCT01316939|594589552|FG002|Overall Study|Withdrawal by Subject|6|||
164609133|NCT01316939|594589550|FG000|Overall Study|Physician Decision|2|||
164609134|NCT01316939|594589551|FG001|Overall Study|Physician Decision|2|||
164609135|NCT01316939|594589552|FG002|Overall Study|Physician Decision|1|||
164609136|NCT01316939|594589550|FG000|Overall Study|Lost to Follow-up|0|||
164609137|NCT01316939|594589551|FG001|Overall Study|Lost to Follow-up|0|||
164609138|NCT01316939|594589552|FG002|Overall Study|Lost to Follow-up|2|||
164609139|NCT01316939|594589550|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
164609140|NCT01316939|594589551|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
164609141|NCT01316939|594589552|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
164609142|NCT01316939|594589550|FG000|Overall Study|Protocol Violation|0|||
164609143|NCT01316939|594589551|FG001|Overall Study|Protocol Violation|1|||
164609144|NCT01316939|594589552|FG002|Overall Study|Protocol Violation|0|||
164609145|NCT01432457|594589553|FG000|Overall Study|Adverse Event|7|||
164609146|NCT01432457|594589554|FG001|Overall Study|Adverse Event|10|||
164609147|NCT01432457|594589555|FG002|Overall Study|Adverse Event|16|||
164609148|NCT01432457|594589553|FG000|Overall Study|Lack of Efficacy|2|||
164609149|NCT01432457|594589554|FG001|Overall Study|Lack of Efficacy|1|||
164609150|NCT01432457|594589555|FG002|Overall Study|Lack of Efficacy|1|||
164609151|NCT01432457|594589553|FG000|Overall Study|Lost to Follow-up|11|||
164609152|NCT01432457|594589554|FG001|Overall Study|Lost to Follow-up|15|||
164609153|NCT01432457|594589555|FG002|Overall Study|Lost to Follow-up|20|||
164609154|NCT01432457|594589553|FG000|Overall Study|Protocol Violation|3|||
164609155|NCT01432457|594589554|FG001|Overall Study|Protocol Violation|2|||
164609156|NCT01432457|594589555|FG002|Overall Study|Protocol Violation|6|||
164609157|NCT01432457|594589553|FG000|Overall Study|Withdrawal by Subject|6|||
164609158|NCT01432457|594589554|FG001|Overall Study|Withdrawal by Subject|11|||
164609159|NCT01432457|594589555|FG002|Overall Study|Withdrawal by Subject|9|||
164609160|NCT01432457|594589553|FG000|Overall Study|Reasons not defined|2|||
164609161|NCT01432457|594589554|FG001|Overall Study|Reasons not defined|3|||
164609162|NCT01432457|594589555|FG002|Overall Study|Reasons not defined|4|||
164609163|NCT01432457|594589553|FG000|Overall Study|Did not take study drug|6|||
164609164|NCT01432457|594589554|FG001|Overall Study|Did not take study drug|6|||
164609165|NCT01432457|594589555|FG002|Overall Study|Did not take study drug|3|||
164609166|NCT02715804|594589556|FG000|Overall Study|Death|222|||
164609167|NCT02715804|594589557|FG001|Overall Study|Death|106|||
164609168|NCT02715804|594589556|FG000|Overall Study|Withdrawal by Subject|5|||
164609169|NCT02715804|594589557|FG001|Overall Study|Withdrawal by Subject|4|||
164609170|NCT02715804|594589556|FG000|Overall Study|Other than specified|2|||
164609171|NCT02715804|594589557|FG001|Overall Study|Other than specified|3|||
164609172|NCT00801892|594589564|FG000|Main Study Period|Withdrawal by Subject|0|||
164609173|NCT00801892|594589565|FG001|Main Study Period|Withdrawal by Subject|1|||
164609174|NCT00801892|594589564|FG000|Sham Crossover Period|Lost to Follow-up|0|||
164609175|NCT00801892|594589565|FG001|Sham Crossover Period|Lost to Follow-up|2|||
164609176|NCT01281189|594589570|FG000|Overall Study|Adverse Event|7|||
164609177|NCT01281189|594589571|FG001|Overall Study|Adverse Event|9|||
164609178|NCT01281189|594589570|FG000|Overall Study|Lost to Follow-up|6|||
164609179|NCT01281189|594589571|FG001|Overall Study|Lost to Follow-up|4|||
164609180|NCT01281189|594589570|FG000|Overall Study|Withdrawal by Subject|21|||
164609181|NCT01281189|594589571|FG001|Overall Study|Withdrawal by Subject|24|||
164609182|NCT01281189|594589570|FG000|Overall Study|Physician Decision|2|||
164609183|NCT01281189|594589571|FG001|Overall Study|Physician Decision|3|||
164609184|NCT01281189|594589570|FG000|Overall Study|Death|103|||
164609185|NCT01281189|594589571|FG001|Overall Study|Death|91|||
164609186|NCT01281189|594589570|FG000|Overall Study|Other|8|||
164609187|NCT01281189|594589571|FG001|Overall Study|Other|12|||
164609188|NCT02966353|594589573|FG000|Overall Study|Withdrawal by Subject|7|||
164609189|NCT02966353|594589573|FG000|Overall Study|Adverse Event|4|||
164609190|NCT02966353|594589573|FG000|Overall Study|Death|4|||
164609191|NCT02966353|594589573|FG000|Overall Study|Physician Decision|3|||
164609192|NCT02966353|594589573|FG000|Overall Study|Progressive disease|2|||
164609193|NCT02966353|594589573|FG000|Overall Study|Protocol deviation|2|||
164609194|NCT03351478|594589574|FG000|Overall Study|At the subject's own request|11|||
164609195|NCT03351478|594589575|FG001|Overall Study|At the subject's own request|12|||
164609196|NCT03351478|594589576|FG002|Overall Study|At the subject's own request|5|||
164609197|NCT03351478|594589574|FG000|Overall Study|Adverse Event|1|||
164609198|NCT03351478|594589575|FG001|Overall Study|Adverse Event|2|||
164609199|NCT03351478|594589576|FG002|Overall Study|Adverse Event|1|||
164609200|NCT03351478|594589574|FG000|Overall Study|Poor compliance to protocol|1|||
164609201|NCT03351478|594589575|FG001|Overall Study|Poor compliance to protocol|0|||
164609202|NCT03351478|594589576|FG002|Overall Study|Poor compliance to protocol|0|||
164609203|NCT03351478|594589574|FG000|Overall Study|Reason not Specified|1|||
164609204|NCT03351478|594589575|FG001|Overall Study|Reason not Specified|3|||
164609205|NCT03351478|594589576|FG002|Overall Study|Reason not Specified|0|||
164609206|NCT03351478|594589574|FG000|Overall Study|Lost to Follow-up|0|||
164609207|NCT03351478|594589575|FG001|Overall Study|Lost to Follow-up|0|||
164609208|NCT03351478|594589576|FG002|Overall Study|Lost to Follow-up|1|||
164609209|NCT03911869|594589577|FG000|Safety Lead-in Phase|Death|7|||
164609210|NCT03911869|594589578|FG001|Safety Lead-in Phase|Death|0|||
164609211|NCT03911869|594589579|FG002|Safety Lead-in Phase|Death|0|||
164609212|NCT03911869|594589577|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
164609213|NCT03911869|594589578|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
164609214|NCT03911869|594589579|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
164609215|NCT03911869|594589577|FG000|Safety Lead-in Phase|Other|1|||
164609216|NCT03911869|594589578|FG001|Safety Lead-in Phase|Other|0|||
164609217|NCT03911869|594589579|FG002|Safety Lead-in Phase|Other|0|||
164609218|NCT03911869|594589577|FG000|Phase 2|Death|0|||
164609219|NCT03911869|594589578|FG001|Phase 2|Death|3|||
164609220|NCT03911869|594589579|FG002|Phase 2|Death|0|||
164609221|NCT00527072|594589580|FG000|Overall Study|Adverse Event|13|||
164609222|NCT00527072|594589580|FG000|Overall Study|Lack of Efficacy|11|||
164609223|NCT00527072|594589580|FG000|Overall Study|Lost to Follow-up|3|||
164609224|NCT00527072|594589580|FG000|Overall Study|Protocol Violation|2|||
164609225|NCT00527072|594589580|FG000|Overall Study|Withdrawal by Subject|7|||
164609226|NCT00608881|594589581|FG000|Overall Study|Death|22|||
164609227|NCT00608881|594589582|FG001|Overall Study|Death|13|||
164609228|NCT00608881|594589581|FG000|Overall Study|Adverse Event|5|||
164609229|NCT00608881|594589582|FG001|Overall Study|Adverse Event|3|||
164609230|NCT00608881|594589581|FG000|Overall Study|Lost to Follow-up|28|||
164609231|NCT00608881|594589582|FG001|Overall Study|Lost to Follow-up|14|||
164609232|NCT00608881|594589581|FG000|Overall Study|Withdrawal by Subject|18|||
164609233|NCT00608881|594589582|FG001|Overall Study|Withdrawal by Subject|29|||
164609234|NCT00608881|594589581|FG000|Overall Study|Physician Decision|5|||
164609235|NCT00608881|594589582|FG001|Overall Study|Physician Decision|5|||
164609236|NCT00608881|594589581|FG000|Overall Study|Institutionalized|1|||
164609237|NCT00608881|594589582|FG001|Overall Study|Institutionalized|2|||
164609238|NCT00510484|594589584|FG000|Wash-out Period|Adverse Event|0|||
164609239|NCT00510484|594589585|FG001|Wash-out Period|Adverse Event|1|||
164609240|NCT01590212|594589586|FG000|Overall Study|Withdrawal by Subject|2|||
164609241|NCT01590212|594589587|FG001|Overall Study|Withdrawal by Subject|2|||
164609242|NCT01590212|594589588|FG002|Overall Study|Withdrawal by Subject|2|||
164609243|NCT01590212|594589586|FG000|Overall Study|Lost to Follow-up|1|||
164609244|NCT01590212|594589587|FG001|Overall Study|Lost to Follow-up|2|||
164609245|NCT01590212|594589588|FG002|Overall Study|Lost to Follow-up|3|||
164609246|NCT02533401|594589589|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
164609247|NCT02533401|594589589|FG000|Overall Study|Death|5|||
164609248|NCT02533401|594589589|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
164609249|NCT02533401|594589589|FG000|Overall Study|Lost to Follow-up|1|||
164609250|NCT02533401|594589589|FG000|Overall Study|Violation of Selection Criteria|1|||
164609251|NCT01106391|594589590|FG000|Overall Study|Death|12|||
164609252|NCT01106391|594589590|FG000|Overall Study|Withdrawal by Subject|7|||
164609253|NCT02147691|594589593|FG000|Overall Study|Withdrawal by Subject|2|||
164609254|NCT02147691|594589594|FG001|Overall Study|Withdrawal by Subject|0|||
164609255|NCT02147691|594589593|FG000|Overall Study|Adverse Event|2|||
164609256|NCT02147691|594589594|FG001|Overall Study|Adverse Event|0|||
164609257|NCT02147691|594589593|FG000|Overall Study|Lost to Follow-up|0|||
164609258|NCT02147691|594589594|FG001|Overall Study|Lost to Follow-up|1|||
164609259|NCT01181141|594589597|FG000|Overall Study|Adverse Event|2|||
164609260|NCT01181141|594589598|FG001|Overall Study|Adverse Event|1|||
164609261|NCT01181141|594589597|FG000|Overall Study|Lack of Efficacy|1|||
164609262|NCT01181141|594589598|FG001|Overall Study|Lack of Efficacy|0|||
164609263|NCT01181141|594589597|FG000|Overall Study|Lost to Follow-up|1|||
164609264|NCT01181141|594589598|FG001|Overall Study|Lost to Follow-up|1|||
164609265|NCT01181141|594589597|FG000|Overall Study|Physician Decision|2|||
164609266|NCT01181141|594589598|FG001|Overall Study|Physician Decision|0|||
164510267|NCT01006980|594239831|FG001|Vemurafenib and Dacarbazine|Death|12|||
164510268|NCT01006980|594239830|FG000|Vemurafenib and Dacarbazine|Progression|257|||
164510269|NCT01006980|594239831|FG001|Vemurafenib and Dacarbazine|Progression|218|||
164510270|NCT01006980|594239830|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
164510271|NCT01006980|594239831|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
164510272|NCT01006980|594239830|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
164510273|NCT01006980|594239831|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
164510274|NCT01006980|594239830|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
164510275|NCT01006980|594239831|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
164510276|NCT01006980|594239830|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
164510277|NCT01006980|594239831|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
164510278|NCT01006980|594239830|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
164510279|NCT01006980|594239831|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
164510280|NCT01006980|594239830|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
164510281|NCT01006980|594239831|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
164510282|NCT01006980|594239830|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
164510283|NCT01006980|594239831|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
164510284|NCT01006980|594239830|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
164510285|NCT01006980|594239831|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
164510286|NCT01006980|594239830|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
164510287|NCT01006980|594239831|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
164510288|NCT04043143|594239832|FG000|Overall Study|Lost to Follow-up|5|||
164510289|NCT04043143|594239833|FG001|Overall Study|Lost to Follow-up|5|||
164510290|NCT04043143|594239832|FG000|Overall Study|screen failure|1|||
164510291|NCT04043143|594239833|FG001|Overall Study|screen failure|0|||
164510292|NCT04307940|594239834|FG000|Overall Study|Adverse Event|1|||
164510293|NCT04307940|594239835|FG001|Overall Study|Adverse Event|0|||
164510294|NCT04307940|594239836|FG002|Overall Study|Adverse Event|0|||
164510295|NCT04307940|594239834|FG000|Overall Study|Withdrawal by Subject|2|||
164510296|NCT04307940|594239835|FG001|Overall Study|Withdrawal by Subject|3|||
164510297|NCT04307940|594239836|FG002|Overall Study|Withdrawal by Subject|1|||
164510298|NCT04307940|594239834|FG000|Overall Study|Lost to Follow-up|2|||
164510299|NCT04307940|594239835|FG001|Overall Study|Lost to Follow-up|0|||
164510300|NCT04307940|594239836|FG002|Overall Study|Lost to Follow-up|1|||
164510301|NCT04896008|594239840|FG000|Overall Study|Ongoing|70|||
164510302|NCT04896008|594239841|FG001|Overall Study|Ongoing|38|||
164510303|NCT04896008|594239840|FG000|Overall Study|Adverse Event|0|||
164510304|NCT04896008|594239841|FG001|Overall Study|Adverse Event|2|||
164510305|NCT04896008|594239840|FG000|Overall Study|Death|5|||
164510306|NCT04896008|594239841|FG001|Overall Study|Death|10|||
164510307|NCT04896008|594239840|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
164510308|NCT04896008|594239841|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
164510309|NCT04896008|594239840|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
164510310|NCT04896008|594239841|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
164510311|NCT04896008|594239840|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
164510312|NCT04896008|594239841|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
164510313|NCT04896008|594239840|FG000|Overall Study|Withdrawal by Subject|1|||
164510314|NCT04896008|594239841|FG001|Overall Study|Withdrawal by Subject|4|||
164510315|NCT04896008|594239840|FG000|Overall Study|Investigator Decision|2|||
164510316|NCT04896008|594239841|FG001|Overall Study|Investigator Decision|0|||
164510317|NCT04896008|594239840|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
164510318|NCT04896008|594239841|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
164510319|NCT03322540|594239844|FG000|Overall Study|Death|21|||
164510320|NCT03322540|594239845|FG001|Overall Study|Death|28|||
164510321|NCT03322540|594239844|FG000|Overall Study|Lost to Follow-up|0|||
164510322|NCT03322540|594239845|FG001|Overall Study|Lost to Follow-up|1|||
164510323|NCT03322540|594239844|FG000|Overall Study|Physician Decision|7|||
164510324|NCT03322540|594239845|FG001|Overall Study|Physician Decision|6|||
164510325|NCT03322540|594239844|FG000|Overall Study|Withdrawal by Subject|3|||
164510326|NCT03322540|594239845|FG001|Overall Study|Withdrawal by Subject|1|||
164510327|NCT03322540|594239844|FG000|Overall Study|Study terminated by sponsor|0|||
164510328|NCT03322540|594239845|FG001|Overall Study|Study terminated by sponsor|1|||
164510329|NCT01594827|594239846|FG000|Overall Study|Adverse Event|1|||
164510330|NCT01594827|594239847|FG001|Overall Study|Adverse Event|0|||
164510331|NCT01594827|594239846|FG000|Overall Study|Physician Decision|3|||
164510332|NCT01594827|594239847|FG001|Overall Study|Physician Decision|0|||
164510333|NCT03445533|594239848|FG000|Overall Study|Progressive Disease|48|||
164510334|NCT03445533|594239849|FG001|Overall Study|Progressive Disease|81|||
164510335|NCT03445533|594239848|FG000|Overall Study|Adverse Event|60|||
164510336|NCT03445533|594239849|FG001|Overall Study|Adverse Event|64|||
164510337|NCT03445533|594239848|FG000|Overall Study|Death|9|||
164510338|NCT03445533|594239849|FG001|Overall Study|Death|19|||
164510339|NCT03445533|594239848|FG000|Overall Study|Miscellaneous|0|||
164510340|NCT03445533|594239849|FG001|Overall Study|Miscellaneous|16|||
164510341|NCT03445533|594239848|FG000|Overall Study|Withdrawal by Subject|3|||
164510342|NCT03445533|594239849|FG001|Overall Study|Withdrawal by Subject|4|||
164510343|NCT03445533|594239848|FG000|Overall Study|Physician Decision|1|||
164510344|NCT03445533|594239849|FG001|Overall Study|Physician Decision|3|||
164510345|NCT03445533|594239848|FG000|Overall Study|Sponsor Decision|0|||
164510346|NCT03445533|594239849|FG001|Overall Study|Sponsor Decision|1|||
164510347|NCT03445533|594239848|FG000|Overall Study|Lost to Follow-up|0|||
164510348|NCT03445533|594239849|FG001|Overall Study|Lost to Follow-up|1|||
164510349|NCT03445533|594239848|FG000|Overall Study|Never Received any Study Treatment|7|||
164510350|NCT03445533|594239849|FG001|Overall Study|Never Received any Study Treatment|4|||
164510351|NCT02153905|594239850|FG000|Overall Study|Death|1|||
164510352|NCT02153905|594239851|FG001|Overall Study|Death|0|||
164510353|NCT03334253|594239852|FG000|Overall Study|Withdrawal by Subject|1|||
164510354|NCT03334253|594239853|FG001|Overall Study|Withdrawal by Subject|0|||
164510355|NCT03334253|594239852|FG000|Overall Study|Lost to Follow-up|4|||
164510356|NCT03334253|594239853|FG001|Overall Study|Lost to Follow-up|3|||
164510357|NCT03334253|594239852|FG000|Overall Study|Moved residence|2|||
164510358|NCT03334253|594239853|FG001|Overall Study|Moved residence|2|||
164510359|NCT03274453|594239854|FG000|Overall Study|Lost to Follow-up|2|||
164510360|NCT03274453|594239855|FG001|Overall Study|Lost to Follow-up|5|||
164510361|NCT03274453|594239856|FG002|Overall Study|Lost to Follow-up|4|||
164510362|NCT03274453|594239857|FG003|Overall Study|Lost to Follow-up|1|||
164510363|NCT03274453|594239854|FG000|Overall Study|Physician Decision|2|||
164510364|NCT03274453|594239855|FG001|Overall Study|Physician Decision|0|||
164510365|NCT03274453|594239856|FG002|Overall Study|Physician Decision|0|||
164510366|NCT03274453|594239857|FG003|Overall Study|Physician Decision|3|||
164510367|NCT03274453|594239854|FG000|Overall Study|Surgery Cancelled|0|||
164510368|NCT03274453|594239855|FG001|Overall Study|Surgery Cancelled|1|||
164510369|NCT03274453|594239856|FG002|Overall Study|Surgery Cancelled|0|||
164510370|NCT03274453|594239857|FG003|Overall Study|Surgery Cancelled|0|||
164510371|NCT00968526|594239858|FG000|Overall Study|Adverse Event|2|||
164510372|NCT00968526|594239859|FG001|Overall Study|Adverse Event|0|||
164510373|NCT00968526|594239858|FG000|Overall Study|Migrated/moved from study area|1|||
164510374|NCT00968526|594239859|FG001|Overall Study|Migrated/moved from study area|0|||
164510375|NCT02493062|594239860|FG000|Overall Study|Physician Decision|12|||
164510376|NCT03054337|594239861|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
164510377|NCT03054337|594239862|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
164510378|NCT03054337|594239863|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
164510379|NCT03054337|594239864|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
164510380|NCT03054337|594239865|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
164510381|NCT03054337|594239866|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
164510382|NCT01967069|594239868|FG000|Overall Study|Adverse Event|2|||
164510383|NCT01967069|594239869|FG001|Overall Study|Adverse Event|2|||
164510384|NCT01967069|594239868|FG000|Overall Study|Lost to Follow-up|5|||
164510385|NCT01967069|594239869|FG001|Overall Study|Lost to Follow-up|2|||
164510386|NCT01967069|594239868|FG000|Overall Study|Withdrawal by Subject|1|||
164510387|NCT01967069|594239869|FG001|Overall Study|Withdrawal by Subject|3|||
164510388|NCT01967069|594239868|FG000|Overall Study|Lack of Efficacy|0|||
164510389|NCT01967069|594239869|FG001|Overall Study|Lack of Efficacy|1|||
164510390|NCT00609947|594239870|FG000|Overall Study|Death|1|||
164510391|NCT05569421|594239872|FG000|Overall Study|Withdrawal by Subject|1|||
164510392|NCT05569421|594239873|FG001|Overall Study|Withdrawal by Subject|0|||
164510393|NCT05569421|594239874|FG002|Overall Study|Withdrawal by Subject|0|||
164510394|NCT01689857|594239876|FG000|Overall Study|Lost to Follow-up|5|||
164510395|NCT01689857|594239877|FG001|Overall Study|Lost to Follow-up|2|||
164510396|NCT00874731|594239879|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
164510397|NCT00874731|594239880|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
164510398|NCT00874731|594239881|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
164510399|NCT00874731|594239879|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
164510400|NCT00874731|594239880|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
164510401|NCT00874731|594239881|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
164510402|NCT00874731|594239879|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
164510403|NCT00874731|594239880|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
164510404|NCT00874731|594239881|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
164510405|NCT01736540|594239882|FG000|Overall Study|Did not complete scan within 45 days|2|||
164510406|NCT01736540|594239882|FG000|Overall Study|Death|1|||
164510407|NCT01736540|594239882|FG000|Overall Study|Abnormal test procedure|1|||
164510408|NCT01736540|594239882|FG000|Overall Study|Withdrawal by Subject|5|||
164510409|NCT01736540|594239882|FG000|Overall Study|Protocol Violation|1|||
164510410|NCT01736540|594239882|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
164510411|NCT01736540|594239882|FG000|Overall Study|No show for MRI appointment|1|||
164510412|NCT01736540|594239882|FG000|Overall Study|Unable to make MRI appointment|3|||
164510413|NCT00479882|594239885|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
164510414|NCT00479882|594239886|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
164510415|NCT00479882|594239887|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
164510416|NCT00479882|594239888|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
164510417|NCT00479882|594239885|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
164510418|NCT00479882|594239886|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
164510419|NCT00479882|594239887|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
164510420|NCT00479882|594239888|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
164510421|NCT00479882|594239885|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
164510422|NCT00479882|594239886|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
164510423|NCT00479882|594239887|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
164510424|NCT00479882|594239888|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
164510425|NCT00479882|594239885|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
164510426|NCT00479882|594239886|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
164510427|NCT00479882|594239887|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
164510428|NCT00479882|594239888|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
164510429|NCT00479882|594239885|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
164510430|NCT00479882|594239886|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
164510431|NCT00479882|594239887|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
164510432|NCT00479882|594239888|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
164510433|NCT00479882|594239885|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
164510434|NCT00479882|594239886|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
164510435|NCT00479882|594239887|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
164510436|NCT00479882|594239888|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
164510437|NCT00479882|594239885|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
164510438|NCT00479882|594239886|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
164510439|NCT00479882|594239887|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
164510440|NCT00479882|594239888|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
164510441|NCT00479882|594239885|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
164510442|NCT00479882|594239886|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
164510443|NCT00479882|594239887|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
164510444|NCT00479882|594239888|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
164510445|NCT00479882|594239885|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
164510446|NCT00479882|594239886|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
164510447|NCT00479882|594239887|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
164510448|NCT00479882|594239888|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
164510449|NCT00479882|594239885|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
164510450|NCT00479882|594239886|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
164510451|NCT00479882|594239887|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
164510452|NCT00479882|594239888|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
164510453|NCT00479882|594239885|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
164510454|NCT00479882|594239886|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
164510455|NCT00479882|594239887|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
164510456|NCT00479882|594239888|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
164510457|NCT00479882|594239885|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
164510458|NCT00479882|594239886|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
164510459|NCT00479882|594239887|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
164510460|NCT00479882|594239888|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
164510461|NCT00479882|594239885|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
164510462|NCT00479882|594239886|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
164510463|NCT00479882|594239887|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
164510464|NCT00479882|594239888|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
164510465|NCT00479882|594239885|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
164510466|NCT00479882|594239886|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
164510467|NCT00479882|594239887|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
164510468|NCT00479882|594239888|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
164510469|NCT03106753|594239889|FG000|Overall Study|Withdrawal by Subject|0|||
164510470|NCT03106753|594239890|FG001|Overall Study|Withdrawal by Subject|1|||
164510471|NCT01643044|594239894|FG000|Overall Study|Lost to Follow-up|1|||
164510472|NCT01643044|594239895|FG001|Overall Study|Lost to Follow-up|1|||
164510473|NCT01643044|594239894|FG000|Overall Study|Miscarried baby|2|||
164510474|NCT01643044|594239895|FG001|Overall Study|Miscarried baby|2|||
164510475|NCT01643044|594239894|FG000|Overall Study|Delivered outside of hospital|1|||
164510476|NCT01643044|594239895|FG001|Overall Study|Delivered outside of hospital|2|||
164510477|NCT03149042|594239896|FG000|Overall Study|Invasive FFR not performed|21|||
164510478|NCT03149042|594239896|FG000|Overall Study|Poor CT Image Quality|1|||
164146983|NCT00443729|592899921|FG001|Overall Study|Lost to Follow-up|1|||
164510479|NCT03149042|594239896|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
164510480|NCT05143138|594239900|FG000|Overall Study|Death|5|||
164510481|NCT05143138|594239901|FG001|Overall Study|Death|35|||
164510482|NCT05143138|594239902|FG002|Overall Study|Death|1|||
164510483|NCT05143138|594239900|FG000|Overall Study|Lost to Follow-up|2|||
164510484|NCT05143138|594239901|FG001|Overall Study|Lost to Follow-up|4|||
164510485|NCT05143138|594239902|FG002|Overall Study|Lost to Follow-up|0|||
164510486|NCT05143138|594239900|FG000|Overall Study|withdrawal|1|||
164510487|NCT05143138|594239901|FG001|Overall Study|withdrawal|1|||
164510488|NCT05143138|594239902|FG002|Overall Study|withdrawal|0|||
164510489|NCT04245345|594239905|FG000|Overall Study|Death|1|||
164510490|NCT04245345|594239905|FG000|Overall Study|Exited prior to implant|5|||
164510491|NCT04245345|594239905|FG000|Overall Study|Exited prior to 1-month|9|||
164510492|NCT04245345|594239905|FG000|Overall Study|Missed 1-month visit|3|||
164510493|NCT04245345|594239905|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
164510494|NCT04245345|594239905|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
164510495|NCT04805073|594239912|FG000|Overall Study|study personnel not available|2|||
164510496|NCT04805073|594239913|FG001|Overall Study|study personnel not available|0|||
164510497|NCT04805073|594239912|FG000|Overall Study|spinal anesthesia failure|0|||
164510498|NCT04805073|594239913|FG001|Overall Study|spinal anesthesia failure|1|||
164510499|NCT04805073|594239912|FG000|Overall Study|Lost to Follow-up|0|||
164510500|NCT04805073|594239913|FG001|Overall Study|Lost to Follow-up|2|||
164510501|NCT00422734|594239917|FG000|Overall Study|Physician Decision|1|||
164510502|NCT00422734|594239918|FG001|Overall Study|Physician Decision|1|||
164510503|NCT00422734|594239917|FG000|Overall Study|Protocol Violation|1|||
164510504|NCT00422734|594239918|FG001|Overall Study|Protocol Violation|6|||
164510505|NCT00422734|594239917|FG000|Overall Study|Withdrawal by Subject|12|||
164510506|NCT00422734|594239918|FG001|Overall Study|Withdrawal by Subject|8|||
164510507|NCT00422734|594239917|FG000|Overall Study|Adverse Event|0|||
164510508|NCT00422734|594239918|FG001|Overall Study|Adverse Event|3|||
164510509|NCT00422734|594239917|FG000|Overall Study|Partner Decision|0|||
164510510|NCT00422734|594239918|FG001|Overall Study|Partner Decision|3|||
164510511|NCT00848484|594239919|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
164510512|NCT00848484|594239920|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
164510513|NCT00848484|594239919|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
164510514|NCT00848484|594239920|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
164510515|NCT00848484|594239919|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
164510516|NCT00848484|594239920|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
164510517|NCT00848484|594239919|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
164510518|NCT00848484|594239920|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
164510519|NCT00848484|594239919|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
164510520|NCT00848484|594239920|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
164510521|NCT01081886|594239922|FG000|Overall Study|Study termination|11|||
164510522|NCT01081886|594239923|FG001|Overall Study|Study termination|13|||
164510523|NCT02567708|594239924|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
164510524|NCT02567708|594239925|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
164510525|NCT02567708|594239924|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
164510526|NCT02567708|594239925|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
164510527|NCT02567708|594239924|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
164510528|NCT02567708|594239925|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
164510529|NCT02567708|594239924|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
164510530|NCT02567708|594239925|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
164510531|NCT00706654|594239926|FG000|Conversion Phase|Lost to Follow-up|4|||
164510532|NCT00706654|594239927|FG001|Conversion Phase|Lost to Follow-up|0|||
164510533|NCT00706654|594239928|FG002|Conversion Phase|Lost to Follow-up|0|||
164510534|NCT00706654|594239929|FG003|Conversion Phase|Lost to Follow-up|0|||
164510535|NCT00706654|594239926|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
164510536|NCT00706654|594239927|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
164510537|NCT00706654|594239928|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
164510538|NCT00706654|594239929|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
164510539|NCT00706654|594239926|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
164510540|NCT00706654|594239927|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
164510541|NCT00706654|594239928|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
164510542|NCT00706654|594239929|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
164510543|NCT00706654|594239926|FG000|Conversion Phase|Withdrawn by Investigator|14|||
164510544|NCT00706654|594239927|FG001|Conversion Phase|Withdrawn by Investigator|0|||
164510545|NCT00706654|594239928|FG002|Conversion Phase|Withdrawn by Investigator|0|||
164510546|NCT00706654|594239929|FG003|Conversion Phase|Withdrawn by Investigator|0|||
164510547|NCT00706654|594239926|FG000|Conversion Phase|Withdrew Consent|38|||
164510548|NCT00706654|594239927|FG001|Conversion Phase|Withdrew Consent|0|||
164510549|NCT00706654|594239928|FG002|Conversion Phase|Withdrew Consent|0|||
164510550|NCT00706654|594239929|FG003|Conversion Phase|Withdrew Consent|0|||
164510551|NCT00706654|594239926|FG000|Conversion Phase|Adverse Event|18|||
164510552|NCT00706654|594239927|FG001|Conversion Phase|Adverse Event|0|||
164510553|NCT00706654|594239928|FG002|Conversion Phase|Adverse Event|0|||
164510554|NCT00706654|594239929|FG003|Conversion Phase|Adverse Event|0|||
164510555|NCT00706654|594239926|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
164510556|NCT00706654|594239927|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
164510557|NCT00706654|594239928|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
164510558|NCT00706654|594239929|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
164510559|NCT00706654|594239926|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
164510560|NCT00706654|594239927|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
164510561|NCT00706654|594239928|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
164510562|NCT00706654|594239929|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
164510563|NCT00706654|594239926|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
164510564|NCT00706654|594239927|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
164510565|NCT00706654|594239928|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
164510566|NCT00706654|594239929|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
164510567|NCT00706654|594239926|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
164510568|NCT00706654|594239927|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
164510569|NCT00706654|594239928|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
164510570|NCT00706654|594239929|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
164510571|NCT00706654|594239926|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
164510572|NCT00706654|594239927|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
164510573|NCT00706654|594239928|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
164510574|NCT00706654|594239929|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
164510575|NCT00706654|594239926|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
164510576|NCT00706654|594239927|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
164510577|NCT00706654|594239928|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
164510578|NCT00706654|594239929|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
164510579|NCT00706654|594239926|FG000|Oral Stabilization Phase|Withdrew consent|55|||
164510580|NCT00706654|594239927|FG001|Oral Stabilization Phase|Withdrew consent|0|||
164510581|NCT00706654|594239928|FG002|Oral Stabilization Phase|Withdrew consent|0|||
164510582|NCT00706654|594239929|FG003|Oral Stabilization Phase|Withdrew consent|0|||
164510583|NCT00706654|594239926|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
164510584|NCT00706654|594239927|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
164510585|NCT00706654|594239928|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
164510586|NCT00706654|594239929|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
164510587|NCT00706654|594239926|FG000|Oral Stabilization Phase|Adverse Event|21|||
164510588|NCT00706654|594239927|FG001|Oral Stabilization Phase|Adverse Event|0|||
164510589|NCT00706654|594239928|FG002|Oral Stabilization Phase|Adverse Event|0|||
164510590|NCT00706654|594239929|FG003|Oral Stabilization Phase|Adverse Event|0|||
164510591|NCT00706654|594239926|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
164510592|NCT00706654|594239927|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
164510593|NCT00706654|594239928|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
164510594|NCT00706654|594239929|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
164510595|NCT00706654|594239926|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
164510596|NCT00706654|594239927|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
164510597|NCT00706654|594239928|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
164510598|NCT00706654|594239929|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
164510599|NCT00706654|594239926|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
164510600|NCT00706654|594239927|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
164510601|NCT00706654|594239928|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
164510602|NCT00706654|594239929|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
164510603|NCT00706654|594239926|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
164510604|NCT00706654|594239927|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
164510605|NCT00706654|594239928|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
164510606|NCT00706654|594239929|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
164510607|NCT00706654|594239926|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
164510608|NCT00706654|594239927|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
164510609|NCT00706654|594239928|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
164510610|NCT00706654|594239929|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
164510611|NCT00706654|594239926|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
164510612|NCT00706654|594239927|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
164510613|NCT00706654|594239928|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
164510614|NCT00706654|594239929|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
164510615|NCT00706654|594239926|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
164510616|NCT00706654|594239927|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
164510617|NCT00706654|594239928|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
164510618|NCT00706654|594239929|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
164510619|NCT00706654|594239926|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
164510620|NCT00706654|594239927|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
164510621|NCT00706654|594239928|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
164510622|NCT00706654|594239929|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
164510623|NCT00706654|594239926|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
164510624|NCT00706654|594239927|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
164510625|NCT00706654|594239928|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
164510626|NCT00706654|594239929|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
164510627|NCT00706654|594239926|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
164510628|NCT00706654|594239927|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
164510629|NCT00706654|594239928|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
164510630|NCT00706654|594239929|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
164510631|NCT05262751|594239932|FG000|Washout Period 2|Adverse Event|1|||
164510632|NCT05262751|594239933|FG001|Washout Period 2|Adverse Event|0|||
164510633|NCT05262751|594239934|FG002|Washout Period 2|Adverse Event|0|||
164510634|NCT05262751|594239935|FG003|Washout Period 2|Adverse Event|0|||
164510635|NCT05262751|594239936|FG004|Washout Period 2|Adverse Event|0|||
164510636|NCT05262751|594239937|FG005|Washout Period 2|Adverse Event|0|||
164510637|NCT05262751|594239932|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
164510638|NCT05262751|594239933|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
164510639|NCT05262751|594239934|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
164510640|NCT05262751|594239935|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
164510641|NCT05262751|594239936|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
164510642|NCT05262751|594239937|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
164510643|NCT02956837|594239940|FG000|Overall Study|Serious Adverse Events|0|||
164510644|NCT02956837|594239941|FG001|Overall Study|Serious Adverse Events|1|||
164510645|NCT02956837|594239942|FG002|Overall Study|Serious Adverse Events|0|||
164510646|NCT02956837|594239943|FG003|Overall Study|Serious Adverse Events|0|||
164510647|NCT02956837|594239940|FG000|Overall Study|Withdrawal by Subject|0|||
164510648|NCT02956837|594239941|FG001|Overall Study|Withdrawal by Subject|1|||
164510649|NCT02956837|594239942|FG002|Overall Study|Withdrawal by Subject|0|||
164510650|NCT02956837|594239943|FG003|Overall Study|Withdrawal by Subject|3|||
164510651|NCT02956837|594239940|FG000|Overall Study|Lost to Follow-up|0|||
164510652|NCT02956837|594239941|FG001|Overall Study|Lost to Follow-up|1|||
164510653|NCT02956837|594239942|FG002|Overall Study|Lost to Follow-up|2|||
164510654|NCT02956837|594239943|FG003|Overall Study|Lost to Follow-up|0|||
164510655|NCT01727505|594239948|FG000|First 24 Hours|Adverse Event|0|||
164510656|NCT01727505|594239949|FG001|First 24 Hours|Adverse Event|1|||
164510657|NCT01727505|594239948|FG000|Second 24 Hours|Missing data|0|||
164510658|NCT01727505|594239949|FG001|Second 24 Hours|Missing data|1|||
164510659|NCT01154140|594239950|FG000|Overall Study|Death|71|||
164510660|NCT01154140|594239951|FG001|Overall Study|Death|81|||
164510661|NCT01154140|594239950|FG000|Overall Study|Lost to Follow-up|4|||
164510662|NCT01154140|594239951|FG001|Overall Study|Lost to Follow-up|5|||
164510663|NCT01154140|594239950|FG000|Overall Study|Withdrawal by Subject|12|||
164510664|NCT01154140|594239951|FG001|Overall Study|Withdrawal by Subject|13|||
164510665|NCT01154140|594239950|FG000|Overall Study|Other|3|||
164510666|NCT01154140|594239951|FG001|Overall Study|Other|1|||
164510667|NCT01154140|594239950|FG000|Overall Study|Randomized but not treated|1|||
164510668|NCT01154140|594239951|FG001|Overall Study|Randomized but not treated|2|||
164510669|NCT00358644|594239952|FG000|Overall Study|Progressive Disease|21|||
164510670|NCT00358644|594239952|FG000|Overall Study|Adverse Event|7|||
164510671|NCT00358644|594239952|FG000|Overall Study|Death|11|||
164510672|NCT00358644|594239952|FG000|Overall Study|Withdrawal by Subject|4|||
164510673|NCT00358644|594239952|FG000|Overall Study|Physician Decision|6|||
164510674|NCT00358644|594239952|FG000|Overall Study|Patient not eligible for study|1|||
164510675|NCT00368875|594239953|FG000|Overall Study|Adverse Event|0|||
164510676|NCT00368875|594239954|FG001|Overall Study|Adverse Event|12|||
164510677|NCT00368875|594239953|FG000|Overall Study|Progressive disease|3|||
164510678|NCT00368875|594239954|FG001|Overall Study|Progressive disease|27|||
164510679|NCT00368875|594239953|FG000|Overall Study|Withdrawal by Subject|2|||
164510680|NCT00368875|594239954|FG001|Overall Study|Withdrawal by Subject|6|||
164510681|NCT00368875|594239953|FG000|Overall Study|Other Reason|0|||
164510682|NCT00368875|594239954|FG001|Overall Study|Other Reason|2|||
164510683|NCT00368875|594239953|FG000|Overall Study|Alternative Therapy|1|||
164510684|NCT00368875|594239954|FG001|Overall Study|Alternative Therapy|1|||
164510685|NCT03327831|594239955|FG000|Overall Study|Lost to Follow-up|2|||
164510686|NCT02595372|594239956|FG000|Overall Study|Adverse Event|6|||
164510687|NCT02595372|594239956|FG000|Overall Study|Physician Decision|2|||
164510688|NCT02595372|594239956|FG000|Overall Study|Disease Progression|1|||
164510689|NCT01912404|594239957|FG000|Overall Study|Due to personal reasons|1|||
164510690|NCT01912404|594239958|FG001|Overall Study|Due to personal reasons|0|||
164510691|NCT01430468|594239965|FG000|Overall Study|Physician Decision|2|||
164510692|NCT01430468|594239966|FG001|Overall Study|Physician Decision|1|||
164510693|NCT01430468|594239965|FG000|Overall Study|Withdrawal by Subject|5|||
164510694|NCT01430468|594239966|FG001|Overall Study|Withdrawal by Subject|5|||
164510695|NCT01443923|594239967|FG000|Overall Study|Adverse Event|1|||
164510696|NCT01443923|594239968|FG001|Overall Study|Adverse Event|0|||
164510697|NCT04547023|594239971|FG000|Overall Study|Did Not Receive Intervention|3|||
164510698|NCT04547023|594239972|FG001|Overall Study|Did Not Receive Intervention|2|||
164510699|NCT04547023|594239971|FG000|Overall Study|Lost to Follow-up|1|||
164510700|NCT04547023|594239972|FG001|Overall Study|Lost to Follow-up|1|||
164510701|NCT01245374|594239973|FG000|Overall Study|Protocol Violation|1|||
164510702|NCT01245374|594239973|FG000|Overall Study|Withdrawal by Subject|3|||
164510703|NCT04013971|594239978|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
164510704|NCT04013971|594239979|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
164510705|NCT04013971|594239978|FG000|Overall Study|Missing biomechanical data|0|||
164510706|NCT04013971|594239979|FG001|Overall Study|Missing biomechanical data|1|||
164510707|NCT04297618|594239980|FG000|Overall Study|Adverse Event|1|||
164510708|NCT04297618|594239980|FG000|Overall Study|Withdrawal by Subject|1|||
164510709|NCT04704219|594239981|FG000|Overall Study|Screen Failure|1|||
164510710|NCT04704219|594239981|FG000|Overall Study|Withdrawal by Subject|1|||
164510711|NCT04704219|594239981|FG000|Overall Study|Death|78|||
164510712|NCT04704219|594239981|FG000|Overall Study|Participants Ongoing|80|||
164510713|NCT02600897|594239982|FG000|Overall Study|Death|1|||
164510714|NCT02600897|594239983|FG001|Overall Study|Death|2|||
164510715|NCT02600897|594239984|FG002|Overall Study|Death|1|||
164510716|NCT02600897|594239985|FG003|Overall Study|Death|2|||
164510717|NCT02600897|594239986|FG004|Overall Study|Death|3|||
164510718|NCT02600897|594239987|FG005|Overall Study|Death|2|||
164510719|NCT02600897|594239988|FG006|Overall Study|Death|10|||
164510720|NCT02600897|594239989|FG007|Overall Study|Death|7|||
164510721|NCT02600897|594239990|FG008|Overall Study|Death|20|||
164510722|NCT02600897|594239982|FG000|Overall Study|Lost to Follow-up|1|||
164510723|NCT02600897|594239983|FG001|Overall Study|Lost to Follow-up|0|||
164510724|NCT02600897|594239984|FG002|Overall Study|Lost to Follow-up|0|||
164510725|NCT02600897|594239985|FG003|Overall Study|Lost to Follow-up|0|||
164510726|NCT02600897|594239986|FG004|Overall Study|Lost to Follow-up|0|||
164510727|NCT02600897|594239987|FG005|Overall Study|Lost to Follow-up|0|||
164510728|NCT02600897|594239988|FG006|Overall Study|Lost to Follow-up|0|||
164510729|NCT02600897|594239989|FG007|Overall Study|Lost to Follow-up|1|||
164510730|NCT02600897|594239990|FG008|Overall Study|Lost to Follow-up|0|||
164510731|NCT02600897|594239982|FG000|Overall Study|Withdrawal by Subject|0|||
164510732|NCT02600897|594239983|FG001|Overall Study|Withdrawal by Subject|0|||
164510733|NCT02600897|594239984|FG002|Overall Study|Withdrawal by Subject|0|||
164510734|NCT02600897|594239985|FG003|Overall Study|Withdrawal by Subject|0|||
164510735|NCT02600897|594239986|FG004|Overall Study|Withdrawal by Subject|0|||
164510736|NCT02600897|594239987|FG005|Overall Study|Withdrawal by Subject|0|||
164510737|NCT02600897|594239988|FG006|Overall Study|Withdrawal by Subject|0|||
164510738|NCT02600897|594239989|FG007|Overall Study|Withdrawal by Subject|4|||
164510739|NCT02600897|594239990|FG008|Overall Study|Withdrawal by Subject|2|||
164510740|NCT02600897|594239982|FG000|Overall Study|Reason Not Specified|0|||
164510741|NCT02600897|594239983|FG001|Overall Study|Reason Not Specified|0|||
164510742|NCT02600897|594239984|FG002|Overall Study|Reason Not Specified|0|||
164510743|NCT02600897|594239985|FG003|Overall Study|Reason Not Specified|0|||
164510744|NCT02600897|594239986|FG004|Overall Study|Reason Not Specified|0|||
164510745|NCT02600897|594239987|FG005|Overall Study|Reason Not Specified|0|||
164510746|NCT02600897|594239988|FG006|Overall Study|Reason Not Specified|0|||
164510747|NCT02600897|594239989|FG007|Overall Study|Reason Not Specified|0|||
164510748|NCT02600897|594239990|FG008|Overall Study|Reason Not Specified|1|||
164510749|NCT02614183|594239991|FG000|Double Blind Treatment Phase|Adverse Event|10|||
164510750|NCT02614183|594239992|FG001|Double Blind Treatment Phase|Adverse Event|9|||
164510751|NCT02614183|594239993|FG002|Double Blind Treatment Phase|Adverse Event|7|||
164510752|NCT02614183|594239991|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
164510753|NCT02614183|594239992|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
164609267|NCT01181141|594589597|FG000|Overall Study|Protocol Violation|3|||
164609268|NCT01181141|594589598|FG001|Overall Study|Protocol Violation|1|||
164609269|NCT01181141|594589597|FG000|Overall Study|Withdrawal by Subject|3|||
164510754|NCT02614183|594239993|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
164510755|NCT02614183|594239991|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
164510756|NCT02614183|594239992|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
164510757|NCT02614183|594239993|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
164510758|NCT02614183|594239991|FG000|Double Blind Treatment Phase|Physician Decision|7|||
164510759|NCT02614183|594239992|FG001|Double Blind Treatment Phase|Physician Decision|3|||
164510760|NCT02614183|594239993|FG002|Double Blind Treatment Phase|Physician Decision|2|||
164510761|NCT02614183|594239991|FG000|Double Blind Treatment Phase|Pregnancy|2|||
164510762|NCT02614183|594239992|FG001|Double Blind Treatment Phase|Pregnancy|1|||
164510763|NCT02614183|594239993|FG002|Double Blind Treatment Phase|Pregnancy|3|||
164510764|NCT02614183|594239991|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
164510765|NCT02614183|594239992|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
164510766|NCT02614183|594239993|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
164510767|NCT02614183|594239991|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
164510768|NCT02614183|594239992|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
164510769|NCT02614183|594239993|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
164510770|NCT02614183|594239991|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
164510771|NCT02614183|594239992|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
164510772|NCT02614183|594239993|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
164510773|NCT02614183|594239991|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
164510774|NCT02614183|594239992|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
164510775|NCT02614183|594239993|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
164510776|NCT02614183|594239991|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
164510777|NCT02614183|594239992|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
164510778|NCT02614183|594239993|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
164510779|NCT02614183|594239991|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
164510780|NCT02614183|594239992|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
164510781|NCT02614183|594239993|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
164510782|NCT02614183|594239991|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
164510783|NCT02614183|594239992|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
164510784|NCT02614183|594239993|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
164510785|NCT03816761|594241951|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
164510786|NCT03816761|594241952|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
164510787|NCT03816761|594241953|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
164510788|NCT03816761|594241954|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
164510789|NCT03816761|594241955|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
164510790|NCT03816761|594241956|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
164510791|NCT03816761|594241951|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
164510792|NCT03816761|594241952|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
164510793|NCT03816761|594241953|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
164510794|NCT03816761|594241954|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
164510795|NCT03816761|594241955|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
164510796|NCT03816761|594241956|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
164510797|NCT00474526|594241965|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
164510798|NCT00474526|594241966|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
164510799|NCT00474526|594241967|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
164510800|NCT00474526|594241968|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
164510801|NCT00474526|594241969|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
164510802|NCT00474526|594241970|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
164510803|NCT00474526|594241971|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
164510804|NCT00474526|594241972|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
164510805|NCT00474526|594241973|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
164510806|NCT00474526|594241974|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
164510807|NCT00474526|594241975|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
164510808|NCT00474526|594241976|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
164510809|NCT00474526|594241977|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
164510810|NCT00474526|594241978|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
164510811|NCT00474526|594241979|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
164510812|NCT00474526|594241980|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
164510813|NCT00474526|594241981|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
164510814|NCT00474526|594241965|FG000|Overall Study|Adverse Event|2|||
164510815|NCT00474526|594241966|FG001|Overall Study|Adverse Event|0|||
164510816|NCT00474526|594241967|FG002|Overall Study|Adverse Event|2|||
164510817|NCT00474526|594241968|FG003|Overall Study|Adverse Event|4|||
164510818|NCT00474526|594241969|FG004|Overall Study|Adverse Event|2|||
164510819|NCT00474526|594241970|FG005|Overall Study|Adverse Event|1|||
164510820|NCT00474526|594241971|FG006|Overall Study|Adverse Event|1|||
164510821|NCT00474526|594241972|FG007|Overall Study|Adverse Event|0|||
164510822|NCT00474526|594241973|FG008|Overall Study|Adverse Event|0|||
164510823|NCT00474526|594241974|FG009|Overall Study|Adverse Event|0|||
164510824|NCT00474526|594241975|FG010|Overall Study|Adverse Event|0|||
164510825|NCT00474526|594241976|FG011|Overall Study|Adverse Event|0|||
164510826|NCT00474526|594241977|FG012|Overall Study|Adverse Event|0|||
164510827|NCT00474526|594241978|FG013|Overall Study|Adverse Event|0|||
164510828|NCT00474526|594241979|FG014|Overall Study|Adverse Event|1|||
164510829|NCT00474526|594241980|FG015|Overall Study|Adverse Event|1|||
164510830|NCT00474526|594241981|FG016|Overall Study|Adverse Event|0|||
164510831|NCT00474526|594241965|FG000|Overall Study|Death|0|||
164510832|NCT00474526|594241966|FG001|Overall Study|Death|0|||
164510833|NCT00474526|594241967|FG002|Overall Study|Death|0|||
164510834|NCT00474526|594241968|FG003|Overall Study|Death|0|||
164510835|NCT00474526|594241969|FG004|Overall Study|Death|0|||
164510836|NCT00474526|594241970|FG005|Overall Study|Death|0|||
164510837|NCT00474526|594241971|FG006|Overall Study|Death|0|||
164510838|NCT00474526|594241972|FG007|Overall Study|Death|0|||
164510839|NCT00474526|594241973|FG008|Overall Study|Death|0|||
164510840|NCT00474526|594241974|FG009|Overall Study|Death|0|||
164510841|NCT00474526|594241975|FG010|Overall Study|Death|0|||
164510842|NCT00474526|594241976|FG011|Overall Study|Death|0|||
164510843|NCT00474526|594241977|FG012|Overall Study|Death|0|||
164510844|NCT00474526|594241978|FG013|Overall Study|Death|3|||
164510845|NCT00474526|594241979|FG014|Overall Study|Death|0|||
164510846|NCT00474526|594241980|FG015|Overall Study|Death|0|||
164510847|NCT00474526|594241981|FG016|Overall Study|Death|0|||
164510848|NCT00474526|594241965|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
164510849|NCT00474526|594241966|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
164510850|NCT00474526|594241967|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
164510851|NCT00474526|594241968|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
164510852|NCT00474526|594241969|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
164510853|NCT00474526|594241970|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
164510854|NCT00474526|594241971|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
164510855|NCT00474526|594241972|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
164510856|NCT00474526|594241973|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
164510857|NCT00474526|594241974|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
164510858|NCT00474526|594241975|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
164510859|NCT00474526|594241976|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
164510860|NCT00474526|594241977|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
164510861|NCT00474526|594241978|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
164510862|NCT00474526|594241979|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
164510863|NCT00474526|594241980|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
164510864|NCT00474526|594241981|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
164510865|NCT00474526|594241965|FG000|Overall Study|Lost to Follow-up|8|||
164510866|NCT00474526|594241966|FG001|Overall Study|Lost to Follow-up|6|||
164510867|NCT00474526|594241967|FG002|Overall Study|Lost to Follow-up|13|||
164510868|NCT00474526|594241968|FG003|Overall Study|Lost to Follow-up|29|||
164609270|NCT01181141|594589598|FG001|Overall Study|Withdrawal by Subject|1|||
164609271|NCT05014542|594589599|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
164609272|NCT05014542|594589600|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
164609273|NCT05014542|594589599|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
164609274|NCT05014542|594589600|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
164609275|NCT05014542|594589599|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
164609276|NCT05014542|594589600|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
164609277|NCT05014542|594589599|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
164609278|NCT05014542|594589600|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
164609279|NCT03496662|594589601|FG000|Overall Study|Adverse Event|0|||
164510869|NCT00474526|594241969|FG004|Overall Study|Lost to Follow-up|11|||
164510870|NCT00474526|594241970|FG005|Overall Study|Lost to Follow-up|5|||
164510871|NCT00474526|594241971|FG006|Overall Study|Lost to Follow-up|8|||
164510872|NCT00474526|594241972|FG007|Overall Study|Lost to Follow-up|1|||
164510873|NCT00474526|594241973|FG008|Overall Study|Lost to Follow-up|0|||
164609280|NCT03496662|594589602|FG001|Overall Study|Adverse Event|0|||
164609281|NCT03496662|594589603|FG002|Overall Study|Adverse Event|4|||
164510874|NCT00474526|594241974|FG009|Overall Study|Lost to Follow-up|6|||
164510875|NCT00474526|594241975|FG010|Overall Study|Lost to Follow-up|2|||
164510876|NCT00474526|594241976|FG011|Overall Study|Lost to Follow-up|4|||
164510877|NCT00474526|594241977|FG012|Overall Study|Lost to Follow-up|6|||
164510878|NCT00474526|594241978|FG013|Overall Study|Lost to Follow-up|74|||
164510879|NCT00474526|594241979|FG014|Overall Study|Lost to Follow-up|29|||
164510880|NCT00474526|594241980|FG015|Overall Study|Lost to Follow-up|4|||
164510881|NCT00474526|594241981|FG016|Overall Study|Lost to Follow-up|5|||
164510882|NCT00474526|594241965|FG000|Overall Study|Protocol Violation|2|||
164510883|NCT00474526|594241966|FG001|Overall Study|Protocol Violation|6|||
164510884|NCT00474526|594241967|FG002|Overall Study|Protocol Violation|4|||
164510885|NCT00474526|594241968|FG003|Overall Study|Protocol Violation|12|||
164510886|NCT00474526|594241969|FG004|Overall Study|Protocol Violation|3|||
164510887|NCT00474526|594241970|FG005|Overall Study|Protocol Violation|1|||
164510888|NCT00474526|594241971|FG006|Overall Study|Protocol Violation|3|||
164510889|NCT00474526|594241972|FG007|Overall Study|Protocol Violation|0|||
164510890|NCT00474526|594241973|FG008|Overall Study|Protocol Violation|0|||
164510891|NCT00474526|594241974|FG009|Overall Study|Protocol Violation|4|||
164510892|NCT00474526|594241975|FG010|Overall Study|Protocol Violation|2|||
164510893|NCT00474526|594241976|FG011|Overall Study|Protocol Violation|2|||
164510894|NCT00474526|594241977|FG012|Overall Study|Protocol Violation|4|||
164510895|NCT00474526|594241978|FG013|Overall Study|Protocol Violation|19|||
164510896|NCT00474526|594241979|FG014|Overall Study|Protocol Violation|9|||
164510897|NCT00474526|594241980|FG015|Overall Study|Protocol Violation|6|||
164510898|NCT00474526|594241981|FG016|Overall Study|Protocol Violation|2|||
164510899|NCT00474526|594241965|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
164510900|NCT00474526|594241966|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
164510901|NCT00474526|594241967|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
164510902|NCT00474526|594241968|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
164510903|NCT00474526|594241969|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
164510904|NCT00474526|594241970|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
164510905|NCT00474526|594241971|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
164510906|NCT00474526|594241972|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
164510907|NCT00474526|594241973|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
164609282|NCT03496662|594589601|FG000|Overall Study|Withdrawal by Subject|1|||
164609283|NCT03496662|594589602|FG001|Overall Study|Withdrawal by Subject|0|||
164609284|NCT03496662|594589603|FG002|Overall Study|Withdrawal by Subject|2|||
164609285|NCT03496662|594589601|FG000|Overall Study|Death|0|||
164609286|NCT03496662|594589602|FG001|Overall Study|Death|0|||
164609287|NCT03496662|594589603|FG002|Overall Study|Death|2|||
164609288|NCT03496662|594589601|FG000|Overall Study|Noncompliance|0|||
164609289|NCT03496662|594589602|FG001|Overall Study|Noncompliance|0|||
164609290|NCT03496662|594589603|FG002|Overall Study|Noncompliance|1|||
164609291|NCT01467661|594589604|FG000|Overall Study|Adverse Event|16|||
164609292|NCT01467661|594589604|FG000|Overall Study|Withdrawal by Subject|1|||
164609293|NCT01467661|594589604|FG000|Overall Study|Lack of Efficacy|3|||
164609294|NCT01467661|594589604|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
164609295|NCT00691093|594589606|FG000|Overall Study|Adverse Event|1|||
164609296|NCT00691093|594589606|FG000|Overall Study|Lost to Follow-up|1|||
164609297|NCT00691093|594589606|FG000|Overall Study|Lack of Efficacy|1|||
164609298|NCT00691093|594589606|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
164609299|NCT03395223|594589608|FG000|Overall Study|Lost to Follow-up|3|||
164609300|NCT03395223|594589608|FG000|Overall Study|Other|1|||
164609301|NCT00810810|594589609|FG000|Overall Study|Withdrawal by Subject|0|||
164609302|NCT00810810|594589610|FG001|Overall Study|Withdrawal by Subject|8|||
164609303|NCT00810810|594589611|FG002|Overall Study|Withdrawal by Subject|10|||
164609304|NCT00810810|594589612|FG003|Overall Study|Withdrawal by Subject|8|||
164609305|NCT00810810|594589609|FG000|Overall Study|Physician Decision|0|||
164609306|NCT00810810|594589610|FG001|Overall Study|Physician Decision|3|||
164609307|NCT00810810|594589611|FG002|Overall Study|Physician Decision|1|||
164609308|NCT00810810|594589612|FG003|Overall Study|Physician Decision|5|||
164609309|NCT01896856|594589613|FG000|Overall Study|Transportation issues / Non-compliance|0|||
164609310|NCT01896856|594589614|FG001|Overall Study|Transportation issues / Non-compliance|0|||
164609311|NCT01896856|594589615|FG002|Overall Study|Transportation issues / Non-compliance|1|||
164609312|NCT01896856|594589616|FG003|Overall Study|Transportation issues / Non-compliance|0|||
164609313|NCT01896856|594589617|FG004|Overall Study|Transportation issues / Non-compliance|0|||
164609314|NCT01896856|594589618|FG005|Overall Study|Transportation issues / Non-compliance|0|||
164609315|NCT01156532|594589619|FG000|Overall Study|Family Reasons|1|||
164510908|NCT00474526|594241974|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
164609316|NCT01156532|594589619|FG000|Overall Study|Lost to Follow-up|1|||
164609317|NCT02563925|594589622|FG000|Overall Study|Withdrawal by Subject|2|||
164609318|NCT00282867|594589626|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
164609319|NCT00282867|594589627|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
164609320|NCT00282867|594589628|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
164609321|NCT04311177|594589636|FG000|Overall Study|Adverse Event|3|||
164609322|NCT04311177|594589637|FG001|Overall Study|Adverse Event|1|||
164609323|NCT04311177|594589636|FG000|Overall Study|Physician Decision|4|||
164609324|NCT04311177|594589637|FG001|Overall Study|Physician Decision|3|||
164609325|NCT04311177|594589636|FG000|Overall Study|Withdrawal by Subject|1|||
164609326|NCT04311177|594589637|FG001|Overall Study|Withdrawal by Subject|0|||
164609327|NCT00507416|594589638|FG000|Overall Study|Adverse Event|58|||
164510909|NCT00474526|594241975|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
164510910|NCT00474526|594241976|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
164510911|NCT00474526|594241977|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
164510912|NCT00474526|594241978|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
164510913|NCT00474526|594241979|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
164510914|NCT00474526|594241980|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
164609328|NCT00507416|594589639|FG001|Overall Study|Adverse Event|67|||
164609329|NCT00507416|594589640|FG002|Overall Study|Adverse Event|65|||
164609330|NCT00507416|594589638|FG000|Overall Study|Protocol Violation|1|||
164609331|NCT00507416|594589639|FG001|Overall Study|Protocol Violation|2|||
164609332|NCT00507416|594589640|FG002|Overall Study|Protocol Violation|0|||
164609333|NCT00507416|594589638|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
164609334|NCT00507416|594589639|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
164609335|NCT00507416|594589640|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
164609336|NCT00507416|594589638|FG000|Overall Study|Progressive Disease|20|||
164609337|NCT00507416|594589639|FG001|Overall Study|Progressive Disease|10|||
164609338|NCT00507416|594589640|FG002|Overall Study|Progressive Disease|13|||
164609339|NCT00507416|594589638|FG000|Overall Study|Patient declined further treatment|18|||
164609340|NCT00507416|594589639|FG001|Overall Study|Patient declined further treatment|14|||
164609341|NCT00507416|594589640|FG002|Overall Study|Patient declined further treatment|11|||
164609342|NCT00507416|594589638|FG000|Overall Study|Other|11|||
164609343|NCT00507416|594589639|FG001|Overall Study|Other|16|||
164609344|NCT00507416|594589640|FG002|Overall Study|Other|13|||
164609345|NCT00507416|594589638|FG000|Overall Study|Did not Receive Study Treatment|3|||
164609346|NCT00507416|594589639|FG001|Overall Study|Did not Receive Study Treatment|9|||
164609347|NCT00507416|594589640|FG002|Overall Study|Did not Receive Study Treatment|4|||
164609348|NCT03695393|594589646|FG000|Overall Study|Death|3|||
164609349|NCT03695393|594589647|FG001|Overall Study|Death|1|||
164609350|NCT03695393|594589646|FG000|Overall Study|Lost to Follow-up|0|||
164609351|NCT03695393|594589647|FG001|Overall Study|Lost to Follow-up|1|||
164609352|NCT00673894|594589648|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
164609353|NCT00673894|594589649|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
164609354|NCT00673894|594589648|FG000|First Intervention 4 Weeks|Adverse Event|1|||
164609355|NCT00673894|594589649|FG001|First Intervention 4 Weeks|Adverse Event|0|||
164510915|NCT00474526|594241981|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
164510916|NCT00474526|594241965|FG000|Overall Study|Withdrawal by Subject|9|||
164510917|NCT00474526|594241966|FG001|Overall Study|Withdrawal by Subject|24|||
164510918|NCT00474526|594241967|FG002|Overall Study|Withdrawal by Subject|21|||
164510919|NCT00474526|594241968|FG003|Overall Study|Withdrawal by Subject|52|||
164510920|NCT00474526|594241969|FG004|Overall Study|Withdrawal by Subject|38|||
164510921|NCT00474526|594241970|FG005|Overall Study|Withdrawal by Subject|6|||
164510922|NCT00474526|594241971|FG006|Overall Study|Withdrawal by Subject|12|||
164510923|NCT00474526|594241972|FG007|Overall Study|Withdrawal by Subject|4|||
164510924|NCT00474526|594241973|FG008|Overall Study|Withdrawal by Subject|4|||
164510925|NCT00474526|594241974|FG009|Overall Study|Withdrawal by Subject|13|||
164510926|NCT00474526|594241975|FG010|Overall Study|Withdrawal by Subject|5|||
164510927|NCT00474526|594241976|FG011|Overall Study|Withdrawal by Subject|4|||
164510928|NCT00474526|594241977|FG012|Overall Study|Withdrawal by Subject|4|||
164510929|NCT00474526|594241978|FG013|Overall Study|Withdrawal by Subject|37|||
164510930|NCT00474526|594241979|FG014|Overall Study|Withdrawal by Subject|22|||
164510931|NCT00474526|594241980|FG015|Overall Study|Withdrawal by Subject|1|||
164510932|NCT00474526|594241981|FG016|Overall Study|Withdrawal by Subject|1|||
164510933|NCT00132678|594241982|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
164510934|NCT00132678|594241983|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
164510935|NCT00132678|594241984|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
164510936|NCT00132678|594241982|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
164510937|NCT00132678|594241983|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
164510938|NCT00132678|594241984|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
164510939|NCT00132678|594241982|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
164510940|NCT00132678|594241983|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
164510941|NCT00132678|594241984|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
164510942|NCT00132678|594241982|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
164510943|NCT00132678|594241983|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
164510944|NCT00132678|594241984|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
164510945|NCT00132678|594241982|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
164510946|NCT00132678|594241983|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
164510947|NCT00132678|594241984|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
164510948|NCT00132678|594241982|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
164510949|NCT00132678|594241983|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
164510950|NCT00132678|594241984|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
164609356|NCT01578785|594589650|FG000|Overall Study|Withdrawal by Subject|0|||
164609357|NCT01578785|594589651|FG001|Overall Study|Withdrawal by Subject|1|||
164609358|NCT01578785|594589650|FG000|Overall Study|Study terminated by sponsor|59|||
164609359|NCT01578785|594589651|FG001|Overall Study|Study terminated by sponsor|118|||
164609360|NCT02581982|594589652|FG000|Overall Study|Lack of Efficacy|12|||
164609361|NCT02581982|594589652|FG000|Overall Study|Adverse Event|3|||
164609362|NCT02581982|594589652|FG000|Overall Study|Physician Decision|1|||
164609363|NCT00405821|594589653|FG000|Overall Study|Death|5|||
164609364|NCT00405821|594589654|FG001|Overall Study|Death|7|||
164609365|NCT00405821|594589653|FG000|Overall Study|Lost to Follow-up|7|||
164609366|NCT00405821|594589654|FG001|Overall Study|Lost to Follow-up|7|||
164609367|NCT00405821|594589653|FG000|Overall Study|Protocol Violation|1|||
164609368|NCT00405821|594589654|FG001|Overall Study|Protocol Violation|0|||
164609369|NCT00405821|594589653|FG000|Overall Study|initiated ART|9|||
164609370|NCT00405821|594589654|FG001|Overall Study|initiated ART|8|||
164609371|NCT02726113|594589667|FG000|Total Enrollment|Physician Decision|0|||
164609372|NCT02726113|594589668|FG001|Total Enrollment|Physician Decision|1|||
164609373|NCT02726113|594589667|FG000|Total Enrollment|Protocol Violation|1|||
164609374|NCT02726113|594589668|FG001|Total Enrollment|Protocol Violation|0|||
164609375|NCT02726113|594589667|FG000|Total Enrollment|Withdrawal by Subject|2|||
164609376|NCT02726113|594589668|FG001|Total Enrollment|Withdrawal by Subject|1|||
164609377|NCT02726113|594589667|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
164609378|NCT02726113|594589668|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
164609379|NCT02726113|594589667|FG000|Genomic Analysis|Protocol Violation|1|||
164609380|NCT02726113|594589668|FG001|Genomic Analysis|Protocol Violation|0|||
164609381|NCT02726113|594589667|FG000|Genomic Analysis|Withdrawal by Subject|2|||
164609382|NCT02726113|594589668|FG001|Genomic Analysis|Withdrawal by Subject|1|||
164609383|NCT02726113|594589667|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
164609384|NCT02726113|594589668|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
164609385|NCT03549117|594589669|FG000|Overall Study|Withdrawal by Subject|1|||
164609386|NCT03549117|594589670|FG001|Overall Study|Withdrawal by Subject|0|||
164609387|NCT00861380|594589675|FG000|Overall Study|Withdrawal Information not recorded|8427|||
164609388|NCT00861380|594589676|FG001|Overall Study|Withdrawal Information not recorded|9112|||
164609389|NCT00861380|594589677|FG002|Overall Study|Withdrawal Information not recorded|8872|||
164609390|NCT00861380|594589678|FG003|Overall Study|Withdrawal Information not recorded|3689|||
164609391|NCT00861380|594589679|FG004|Overall Study|Withdrawal Information not recorded|1812|||
164609392|NCT00861380|594589680|FG005|Overall Study|Withdrawal Information not recorded|6249|||
164609393|NCT00861380|594589681|FG006|Overall Study|Withdrawal Information not recorded|3020|||
164609394|NCT00637377|594589682|FG000|Overall Study|Adverse Event|2|||
164609395|NCT00637377|594589683|FG001|Overall Study|Adverse Event|6|||
164609396|NCT00637377|594589684|FG002|Overall Study|Adverse Event|8|||
164609397|NCT00637377|594589685|FG003|Overall Study|Adverse Event|9|||
164609398|NCT00637377|594589682|FG000|Overall Study|Death|1|||
164609399|NCT00637377|594589683|FG001|Overall Study|Death|3|||
164609400|NCT00637377|594589684|FG002|Overall Study|Death|2|||
164609401|NCT00637377|594589685|FG003|Overall Study|Death|1|||
164510951|NCT00132678|594241982|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
164510952|NCT00132678|594241983|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
164510953|NCT00132678|594241984|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
164510954|NCT00132678|594241982|FG000|Period III (Open-Label Stabilization)|Death|2|||
164510955|NCT00132678|594241983|FG001|Period III (Open-Label Stabilization)|Death|0|||
164510956|NCT00132678|594241984|FG002|Period III (Open-Label Stabilization)|Death|0|||
164510957|NCT00132678|594241982|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
164510958|NCT00132678|594241983|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
164510959|NCT00132678|594241984|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
164510960|NCT00132678|594241982|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
164510961|NCT00132678|594241983|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
164510962|NCT00132678|594241984|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
164510963|NCT00132678|594241982|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
164510964|NCT00132678|594241983|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
164510965|NCT00132678|594241984|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
164510966|NCT00132678|594241982|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
164510967|NCT00132678|594241983|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
164510968|NCT00132678|594241984|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
164609402|NCT00637377|594589682|FG000|Overall Study|Lack of Efficacy|0|||
164609403|NCT00637377|594589683|FG001|Overall Study|Lack of Efficacy|0|||
164609404|NCT00637377|594589684|FG002|Overall Study|Lack of Efficacy|1|||
164609405|NCT00637377|594589685|FG003|Overall Study|Lack of Efficacy|1|||
164609406|NCT00637377|594589682|FG000|Overall Study|Lost to Follow-up|4|||
164609407|NCT00637377|594589683|FG001|Overall Study|Lost to Follow-up|1|||
164609408|NCT00637377|594589684|FG002|Overall Study|Lost to Follow-up|2|||
164609409|NCT00637377|594589685|FG003|Overall Study|Lost to Follow-up|2|||
164609410|NCT00637377|594589682|FG000|Overall Study|Protocol Violation|2|||
164609411|NCT00637377|594589683|FG001|Overall Study|Protocol Violation|1|||
164609412|NCT00637377|594589684|FG002|Overall Study|Protocol Violation|1|||
164609413|NCT00637377|594589685|FG003|Overall Study|Protocol Violation|0|||
164510969|NCT00132678|594241982|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
164510970|NCT00132678|594241983|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
164510971|NCT00132678|594241984|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
164510972|NCT00132678|594241982|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
164510973|NCT00132678|594241983|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
164510974|NCT00132678|594241984|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
164510975|NCT00132678|594241982|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
164510976|NCT00132678|594241983|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
164510977|NCT00132678|594241984|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
164510978|NCT00132678|594241982|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
164510979|NCT00132678|594241983|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
164510980|NCT00132678|594241984|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
164510981|NCT00132678|594241982|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
164510982|NCT00132678|594241983|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
164510983|NCT00132678|594241984|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
164510984|NCT00132678|594241982|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
164510985|NCT00132678|594241983|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
164510986|NCT00132678|594241984|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
164510987|NCT00132678|594241982|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
164510988|NCT00132678|594241983|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
164510989|NCT00132678|594241984|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
164510990|NCT00132678|594241982|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
164510991|NCT00132678|594241983|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
164510992|NCT00132678|594241984|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
164510993|NCT00132678|594241982|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
164510994|NCT00132678|594241983|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
164510995|NCT00132678|594241984|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
164510996|NCT00132678|594241982|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
164510997|NCT00132678|594241983|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
164510998|NCT00132678|594241984|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
164510999|NCT00132678|594241982|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
164511000|NCT00132678|594241983|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
164511001|NCT00132678|594241984|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
164511002|NCT00953147|594241985|FG000|Overall Study|Adverse Event|8|||
164511003|NCT00953147|594241986|FG001|Overall Study|Adverse Event|16|||
164511004|NCT00953147|594241987|FG002|Overall Study|Adverse Event|6|||
164511005|NCT00953147|594241985|FG000|Overall Study|Protocol Violation|2|||
164511006|NCT00953147|594241986|FG001|Overall Study|Protocol Violation|8|||
164511007|NCT00953147|594241987|FG002|Overall Study|Protocol Violation|4|||
164511008|NCT00953147|594241985|FG000|Overall Study|Withdrawal by Subject|13|||
164511009|NCT00953147|594241986|FG001|Overall Study|Withdrawal by Subject|15|||
164511010|NCT00953147|594241987|FG002|Overall Study|Withdrawal by Subject|12|||
164511011|NCT00953147|594241985|FG000|Overall Study|Lost to Follow-up|8|||
164511012|NCT00953147|594241986|FG001|Overall Study|Lost to Follow-up|9|||
164609414|NCT00637377|594589682|FG000|Overall Study|Withdrawal by Subject|11|||
164609415|NCT00637377|594589683|FG001|Overall Study|Withdrawal by Subject|15|||
164609416|NCT00637377|594589684|FG002|Overall Study|Withdrawal by Subject|13|||
164609417|NCT00637377|594589685|FG003|Overall Study|Withdrawal by Subject|11|||
164609418|NCT00637377|594589682|FG000|Overall Study|Other (no further information available)|7|||
164609419|NCT00637377|594589683|FG001|Overall Study|Other (no further information available)|6|||
164609420|NCT00637377|594589684|FG002|Overall Study|Other (no further information available)|10|||
164609421|NCT00637377|594589685|FG003|Overall Study|Other (no further information available)|5|||
164609422|NCT01293084|594589687|FG000|Overall Study|Physician Decision|3|||
164609423|NCT01293084|594589687|FG000|Overall Study|Withdrawal by Subject|2|||
164609424|NCT04186663|594589688|FG000|Overall Study|Lost to Follow-up|1|||
164609425|NCT04186663|594589688|FG000|Overall Study|Unable to complete blood draw|3|||
164609426|NCT04432376|594591386|FG000|Double-blind Treatment Period|Adverse Event|2|||
164609427|NCT04432376|594591387|FG001|Double-blind Treatment Period|Adverse Event|6|||
164609428|NCT04432376|594591388|FG002|Double-blind Treatment Period|Adverse Event|0|||
164609429|NCT04432376|594591386|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
164609430|NCT04432376|594591387|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
164609431|NCT04432376|594591388|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
164609432|NCT04432376|594591386|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
164609433|NCT04432376|594591387|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
164609434|NCT04432376|594591388|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
164609435|NCT04432376|594591386|FG000|Double-blind Treatment Period|Protocol Violation|0|||
164609436|NCT04432376|594591387|FG001|Double-blind Treatment Period|Protocol Violation|1|||
164609437|NCT04432376|594591388|FG002|Double-blind Treatment Period|Protocol Violation|0|||
164609438|NCT04432376|594591386|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
164511013|NCT00953147|594241987|FG002|Overall Study|Lost to Follow-up|4|||
164511014|NCT00953147|594241985|FG000|Overall Study|Physician Decision|2|||
164511015|NCT00953147|594241986|FG001|Overall Study|Physician Decision|7|||
164511016|NCT00953147|594241987|FG002|Overall Study|Physician Decision|3|||
164511017|NCT00953147|594241985|FG000|Overall Study|Other|4|||
164511018|NCT00953147|594241986|FG001|Overall Study|Other|11|||
164511019|NCT00953147|594241987|FG002|Overall Study|Other|13|||
164511020|NCT03838731|594241992|FG000|Overall Study|Pregnancy|0|||
164511021|NCT03838731|594241993|FG001|Overall Study|Pregnancy|1|||
164511022|NCT03838731|594241992|FG000|Overall Study|Withdrawal of consent|1|||
164511023|NCT03838731|594241993|FG001|Overall Study|Withdrawal of consent|0|||
164511024|NCT02460575|594242007|FG000|Overall Study|Lost to Follow-up|1|||
164511025|NCT02460575|594242008|FG001|Overall Study|Lost to Follow-up|0|||
164511026|NCT04996004|594242009|FG000|Phase I|Death|1|||
164511027|NCT04996004|594242010|FG001|Phase I|Death|2|||
164511028|NCT04996004|594242011|FG002|Phase I|Death|1|||
164511029|NCT04996004|594242012|FG003|Phase I|Death|0|||
164511030|NCT04996004|594242013|FG004|Phase I|Death|0|||
164511031|NCT04996004|594242014|FG005|Phase I|Death|0|||
164511032|NCT04996004|594242009|FG000|Phase I|Study terminated by sponsor|2|||
164511033|NCT04996004|594242010|FG001|Phase I|Study terminated by sponsor|1|||
164511034|NCT04996004|594242011|FG002|Phase I|Study terminated by sponsor|2|||
164511035|NCT04996004|594242012|FG003|Phase I|Study terminated by sponsor|0|||
164511036|NCT04996004|594242013|FG004|Phase I|Study terminated by sponsor|0|||
164511037|NCT04996004|594242014|FG005|Phase I|Study terminated by sponsor|0|||
164511038|NCT04996004|594242009|FG000|Phase II|Study terminated by sponsor|0|||
164511039|NCT04996004|594242010|FG001|Phase II|Study terminated by sponsor|0|||
164511040|NCT04996004|594242011|FG002|Phase II|Study terminated by sponsor|0|||
164511041|NCT04996004|594242012|FG003|Phase II|Study terminated by sponsor|20|||
164511042|NCT04996004|594242013|FG004|Phase II|Study terminated by sponsor|10|||
164511043|NCT04996004|594242014|FG005|Phase II|Study terminated by sponsor|10|||
164511044|NCT04996004|594242009|FG000|Phase II|Withdrawal by Subject|0|||
164511045|NCT04996004|594242010|FG001|Phase II|Withdrawal by Subject|0|||
164511046|NCT04996004|594242011|FG002|Phase II|Withdrawal by Subject|0|||
164511047|NCT04996004|594242012|FG003|Phase II|Withdrawal by Subject|0|||
164146984|NCT00443729|592899920|FG000|Overall Study|Physician Decision|2|||
164511048|NCT04996004|594242013|FG004|Phase II|Withdrawal by Subject|1|||
164511049|NCT04996004|594242014|FG005|Phase II|Withdrawal by Subject|2|||
164511050|NCT04996004|594242009|FG000|Phase II|Death|0|||
164511051|NCT04996004|594242010|FG001|Phase II|Death|0|||
164511052|NCT04996004|594242011|FG002|Phase II|Death|0|||
164511053|NCT04996004|594242012|FG003|Phase II|Death|12|||
164511054|NCT04996004|594242013|FG004|Phase II|Death|2|||
164511055|NCT04996004|594242014|FG005|Phase II|Death|9|||
164511056|NCT04996004|594242009|FG000|Phase II|Other|0|||
164511057|NCT04996004|594242010|FG001|Phase II|Other|0|||
164511058|NCT04996004|594242011|FG002|Phase II|Other|0|||
164511059|NCT04996004|594242012|FG003|Phase II|Other|0|||
164511060|NCT04996004|594242013|FG004|Phase II|Other|0|||
164511061|NCT04996004|594242014|FG005|Phase II|Other|1|||
164511062|NCT05543174|594242015|FG000|Overall Study|Ongoing|7|||
164511063|NCT03104075|594242016|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
164511064|NCT03104075|594242017|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
164511065|NCT00944229|594242018|FG000|Overall Study|Withdrawal by Subject|11|||
164511066|NCT00944229|594242018|FG000|Overall Study|Physician Decision|14|||
164511067|NCT01810939|594242021|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
164511068|NCT01810939|594242022|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
164511069|NCT01810939|594242023|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
164511070|NCT01810939|594242021|FG000|Part A Treatment Period|Protocol Violation|2|||
164511071|NCT01810939|594242022|FG001|Part A Treatment Period|Protocol Violation|0|||
164609439|NCT04432376|594591387|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
164609440|NCT04432376|594591388|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
164609441|NCT01673490|594591389|FG000|Overall Study|Lost to Follow-up|1|||
164609442|NCT01673490|594591389|FG000|Overall Study|Adverse Event|3|||
164609443|NCT01673490|594591389|FG000|Overall Study|Withdrawal by Subject|3|||
164609444|NCT00379236|594591390|FG000|Double-blind|Adverse Event|11|||
164609445|NCT00379236|594591391|FG001|Double-blind|Adverse Event|6|||
164609446|NCT00379236|594591392|FG002|Double-blind|Adverse Event|0|||
164609447|NCT00379236|594591390|FG000|Double-blind|Protocol Violation|3|||
164609448|NCT00379236|594591391|FG001|Double-blind|Protocol Violation|3|||
164609449|NCT00379236|594591392|FG002|Double-blind|Protocol Violation|0|||
164609450|NCT00379236|594591390|FG000|Double-blind|Withdrawal by Subject|12|||
164609451|NCT00379236|594591391|FG001|Double-blind|Withdrawal by Subject|13|||
164609452|NCT00379236|594591392|FG002|Double-blind|Withdrawal by Subject|0|||
164609453|NCT00379236|594591390|FG000|Double-blind|Lost to Follow-up|4|||
164609454|NCT00379236|594591391|FG001|Double-blind|Lost to Follow-up|3|||
164609455|NCT00379236|594591392|FG002|Double-blind|Lost to Follow-up|0|||
164609456|NCT00379236|594591390|FG000|Double-blind|Use of exclusionary medication|1|||
164511072|NCT01810939|594242023|FG002|Part A Treatment Period|Protocol Violation|0|||
164511073|NCT01810939|594242021|FG000|Part A Treatment Period|Adverse Event|10|||
164511074|NCT01810939|594242022|FG001|Part A Treatment Period|Adverse Event|0|||
164511075|NCT01810939|594242023|FG002|Part A Treatment Period|Adverse Event|0|||
164511076|NCT01810939|594242021|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
164511077|NCT01810939|594242022|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
164511078|NCT01810939|594242023|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
164511079|NCT01810939|594242021|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
164511080|NCT01810939|594242022|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
164511081|NCT01810939|594242023|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
164511082|NCT01810939|594242021|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
164511083|NCT01810939|594242022|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
164511084|NCT01810939|594242023|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
164511085|NCT01810939|594242021|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
164511086|NCT01810939|594242022|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
164511087|NCT01810939|594242023|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
164511088|NCT01810939|594242021|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
164511089|NCT01810939|594242022|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
164511090|NCT01810939|594242023|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
164511091|NCT01810939|594242021|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
164511092|NCT01810939|594242022|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
164511093|NCT01810939|594242023|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
164511094|NCT01810939|594242021|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
164511095|NCT01810939|594242022|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
164511096|NCT01810939|594242023|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
164511097|NCT01810939|594242021|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
164511098|NCT01810939|594242022|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
164511099|NCT01810939|594242023|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
164511100|NCT01810939|594242021|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
164511101|NCT01810939|594242022|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
164511102|NCT01810939|594242023|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
164511103|NCT01810939|594242021|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
164511104|NCT01810939|594242022|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
164511105|NCT01810939|594242023|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
164511106|NCT01810939|594242021|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
164511107|NCT01810939|594242022|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
164511108|NCT01810939|594242023|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
164511109|NCT01810939|594242021|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
164511110|NCT01810939|594242022|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
164511111|NCT01810939|594242023|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
164511112|NCT01810939|594242021|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
164609457|NCT00379236|594591391|FG001|Double-blind|Use of exclusionary medication|2|||
164609458|NCT00379236|594591392|FG002|Double-blind|Use of exclusionary medication|0|||
164609459|NCT00379236|594591390|FG000|Double-blind|Other|3|||
164609460|NCT00379236|594591391|FG001|Double-blind|Other|7|||
164609461|NCT00379236|594591392|FG002|Double-blind|Other|0|||
164609462|NCT00379236|594591390|FG000|Double-blind|Data could not be retrieved|2|||
164609463|NCT00379236|594591391|FG001|Double-blind|Data could not be retrieved|2|||
164609464|NCT00379236|594591392|FG002|Double-blind|Data could not be retrieved|0|||
164609465|NCT00379236|594591390|FG000|Open-label Extension|Adverse Event|0|||
164609466|NCT00379236|594591391|FG001|Open-label Extension|Adverse Event|0|||
164609467|NCT00379236|594591392|FG002|Open-label Extension|Adverse Event|13|||
164609468|NCT00379236|594591390|FG000|Open-label Extension|Protocol Violation|0|||
164609469|NCT00379236|594591391|FG001|Open-label Extension|Protocol Violation|0|||
164609470|NCT00379236|594591392|FG002|Open-label Extension|Protocol Violation|7|||
164609471|NCT00379236|594591390|FG000|Open-label Extension|Withdrawal by Subject|0|||
164609472|NCT00379236|594591391|FG001|Open-label Extension|Withdrawal by Subject|0|||
164609473|NCT00379236|594591392|FG002|Open-label Extension|Withdrawal by Subject|13|||
164511113|NCT01810939|594242022|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
164609474|NCT00379236|594591390|FG000|Open-label Extension|Lost to Follow-up|0|||
164609475|NCT00379236|594591391|FG001|Open-label Extension|Lost to Follow-up|0|||
164609476|NCT00379236|594591392|FG002|Open-label Extension|Lost to Follow-up|12|||
164609477|NCT00379236|594591390|FG000|Open-label Extension|Use of exclusionary medication|0|||
164609478|NCT00379236|594591391|FG001|Open-label Extension|Use of exclusionary medication|0|||
164609479|NCT00379236|594591392|FG002|Open-label Extension|Use of exclusionary medication|3|||
164511114|NCT01810939|594242023|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
164511115|NCT01810939|594242021|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
164511116|NCT01810939|594242022|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
164511117|NCT01810939|594242023|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
164511118|NCT04497389|594242026|FG000|Overall Study|Withdrawal by Subject|1|||
164511119|NCT04497389|594242027|FG001|Overall Study|Withdrawal by Subject|0|||
164511120|NCT00789360|594242030|FG000|Overall Study|Protocol Violation|3|||
164511121|NCT00789360|594242031|FG001|Overall Study|Protocol Violation|1|||
164511122|NCT04400487|594242032|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
164511123|NCT04400487|594242032|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
164511124|NCT04400487|594242032|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
164511125|NCT03559062|594242033|FG000|Overall Study|Other|0|||
164511126|NCT03559062|594242034|FG001|Overall Study|Other|1|||
164511127|NCT03559062|594242035|FG002|Overall Study|Other|0|||
164511128|NCT01757197|594242036|FG000|Overall Study|Death|2|||
164511129|NCT01677299|594242044|FG000|Overall Study|Adverse Event|0|||
164511130|NCT01677299|594242045|FG001|Overall Study|Adverse Event|2|||
164511131|NCT01677299|594242046|FG002|Overall Study|Adverse Event|1|||
164511132|NCT01677299|594242047|FG003|Overall Study|Adverse Event|0|||
164511133|NCT01677299|594242044|FG000|Overall Study|Withdrawal by Subject|0|||
164511134|NCT01677299|594242045|FG001|Overall Study|Withdrawal by Subject|1|||
164511135|NCT01677299|594242046|FG002|Overall Study|Withdrawal by Subject|0|||
164511136|NCT01677299|594242047|FG003|Overall Study|Withdrawal by Subject|1|||
164511137|NCT00520845|594242048|FG000|Overall Study|Death|3|||
164511138|NCT00520845|594242048|FG000|Overall Study|Adverse Event|4|||
164511139|NCT00520845|594242048|FG000|Overall Study|Disease Progression, relapse|13|||
164511140|NCT00520845|594242048|FG000|Overall Study|Withdrawal by Subject|1|||
164511141|NCT00520845|594242048|FG000|Overall Study|Alternative Therapy|1|||
164511142|NCT03057847|594242049|FG000|Overall Study|Lost to Follow-up|16|||
164511143|NCT00351377|594242051|FG000|Overall Study|Adverse Event|5|||
164511144|NCT00351377|594242051|FG000|Overall Study|Death|1|||
164511145|NCT00351377|594242051|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164511146|NCT03926195|594242053|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
164511147|NCT03926195|594242054|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
164511148|NCT03926195|594242053|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
164511149|NCT03926195|594242054|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
164511150|NCT03926195|594242053|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
164511151|NCT03926195|594242054|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
164511152|NCT03926195|594242053|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
164511153|NCT03926195|594242054|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
164511154|NCT03926195|594242053|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
164511155|NCT03926195|594242054|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
164511156|NCT03926195|594242053|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
164511157|NCT03926195|594242054|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
164511158|NCT02088957|594242055|FG000|Overall Study|Lack of Efficacy|1|||
164511159|NCT02088957|594242056|FG001|Overall Study|Lack of Efficacy|0|||
164511160|NCT01327612|594242057|FG000|Overall Study|Withdrawal by Subject|0|||
164511161|NCT01327612|594242058|FG001|Overall Study|Withdrawal by Subject|0|||
164609480|NCT00379236|594591390|FG000|Open-label Extension|Other|0|||
164609481|NCT00379236|594591391|FG001|Open-label Extension|Other|0|||
164609482|NCT00379236|594591392|FG002|Open-label Extension|Other|7|||
164609483|NCT00233324|594591393|FG000|Main Study|Death|68|||
164609484|NCT00233324|594591394|FG001|Main Study|Death|60|||
164609485|NCT00233324|594591395|FG002|Main Study|Death|62|||
164609486|NCT00233324|594591396|FG003|Main Study|Death|47|||
164609487|NCT00233324|594591393|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
164609488|NCT00233324|594591394|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
164609489|NCT00233324|594591395|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
164609490|NCT00233324|594591396|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
164609491|NCT00233324|594591393|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
164609492|NCT00233324|594591394|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
164609493|NCT00233324|594591395|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
164609494|NCT00233324|594591396|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
164609495|NCT02707601|594591400|FG000|Overall Study|Death|0|||
164609496|NCT02707601|594591401|FG001|Overall Study|Death|1|||
164609497|NCT02707601|594591400|FG000|Overall Study|Lack of Efficacy|0|||
164609498|NCT02707601|594591401|FG001|Overall Study|Lack of Efficacy|1|||
164609499|NCT02707601|594591400|FG000|Overall Study|Investigator's Discretion|1|||
164609500|NCT02707601|594591401|FG001|Overall Study|Investigator's Discretion|0|||
164609501|NCT02707601|594591400|FG000|Overall Study|Withdrew Consent|0|||
164609502|NCT02707601|594591401|FG001|Overall Study|Withdrew Consent|1|||
164609503|NCT02707601|594591400|FG000|Overall Study|Lost to Follow-up|1|||
164609504|NCT02707601|594591401|FG001|Overall Study|Lost to Follow-up|1|||
164609505|NCT02707601|594591400|FG000|Overall Study|Participants Randomized but Not Treated|2|||
164609506|NCT02707601|594591401|FG001|Overall Study|Participants Randomized but Not Treated|0|||
164609507|NCT02657434|594591409|FG000|Overall Study|Study Terminated By Sponsor|64|||
164609508|NCT02657434|594591410|FG001|Overall Study|Study Terminated By Sponsor|82|||
164609509|NCT02657434|594591409|FG000|Overall Study|Death|189|||
164609510|NCT02657434|594591410|FG001|Overall Study|Death|190|||
164609511|NCT02657434|594591409|FG000|Overall Study|Lost to Follow-up|2|||
164609512|NCT02657434|594591410|FG001|Overall Study|Lost to Follow-up|2|||
164609513|NCT02657434|594591409|FG000|Overall Study|Randomization by Error|2|||
164609514|NCT02657434|594591410|FG001|Overall Study|Randomization by Error|0|||
164609515|NCT02657434|594591409|FG000|Overall Study|Withdrawal by Subject|28|||
164609516|NCT02657434|594591410|FG001|Overall Study|Withdrawal by Subject|17|||
164609517|NCT02657434|594591409|FG000|Overall Study|Protocol Violation|1|||
164609518|NCT02657434|594591410|FG001|Overall Study|Protocol Violation|0|||
164609519|NCT02657434|594591409|FG000|Overall Study|Physician Decision|0|||
164609520|NCT02657434|594591410|FG001|Overall Study|Physician Decision|1|||
164609521|NCT03004976|594591411|FG000|Overall Study|Lost to Follow-up|7|||
164609522|NCT03004976|594591412|FG001|Overall Study|Lost to Follow-up|5|||
164609523|NCT03004976|594591411|FG000|Overall Study|Physician Decision|1|||
164609524|NCT03004976|594591412|FG001|Overall Study|Physician Decision|0|||
164609525|NCT03004976|594591411|FG000|Overall Study|Withdrawal by Subject|1|||
164609526|NCT03004976|594591412|FG001|Overall Study|Withdrawal by Subject|0|||
164609527|NCT03004976|594591411|FG000|Overall Study|Death|4|||
164609528|NCT03004976|594591412|FG001|Overall Study|Death|1|||
164609529|NCT04897594|594591415|FG000|Overall Study|Lost to Follow-up|0|||
164609530|NCT04897594|594591416|FG001|Overall Study|Lost to Follow-up|1|||
164609531|NCT04897594|594591417|FG002|Overall Study|Lost to Follow-up|1|||
164609532|NCT04897594|594591415|FG000|Overall Study|Sponsor Decision|0|||
164609533|NCT04897594|594591416|FG001|Overall Study|Sponsor Decision|0|||
164609534|NCT04897594|594591417|FG002|Overall Study|Sponsor Decision|1|||
164609535|NCT04897594|594591415|FG000|Overall Study|Withdrawal by Subject|1|||
164609536|NCT04897594|594591416|FG001|Overall Study|Withdrawal by Subject|0|||
164609537|NCT04897594|594591417|FG002|Overall Study|Withdrawal by Subject|1|||
164609538|NCT01665768|594591420|FG000|Overall Study|Adverse Event|3|||
164609539|NCT01665768|594591420|FG000|Overall Study|Lack of Efficacy|19|||
164609540|NCT01665768|594591420|FG000|Overall Study|Withdrawal by Subject|1|||
164609541|NCT00118911|594591421|FG000|Overall Study|Withdrawal by Subject|2|||
164609542|NCT00118911|594591422|FG001|Overall Study|Withdrawal by Subject|5|||
164609543|NCT03101514|594591425|FG000|Overall Study|Withdrawal by Subject|4|||
164609544|NCT03101514|594591425|FG000|Overall Study|Protocol Violation|2|||
164609545|NCT03101514|594591425|FG000|Overall Study|patient's information was incomplete|1|||
164609546|NCT01117012|594591428|FG000|Overall Study|Adverse Event|0|||
164609547|NCT01117012|594591429|FG001|Overall Study|Adverse Event|1|||
164609548|NCT01117012|594591428|FG000|Overall Study|Death|1|||
164609549|NCT01117012|594591429|FG001|Overall Study|Death|1|||
164609550|NCT01117012|594591428|FG000|Overall Study|Withdrawal by Subject|3|||
164609551|NCT01117012|594591429|FG001|Overall Study|Withdrawal by Subject|0|||
164609552|NCT01117012|594591428|FG000|Overall Study|Undefined|4|||
164609553|NCT01117012|594591429|FG001|Overall Study|Undefined|3|||
164609554|NCT00493974|594591433|FG000|Overall Study|Death|1|||
164609555|NCT00493974|594591434|FG001|Overall Study|Death|2|||
164609556|NCT00493974|594591433|FG000|Overall Study|Withdrawal by Subject|8|||
164511162|NCT01327612|594242059|FG002|Overall Study|Withdrawal by Subject|0|||
164511163|NCT01327612|594242060|FG003|Overall Study|Withdrawal by Subject|0|||
164511164|NCT01327612|594242061|FG004|Overall Study|Withdrawal by Subject|0|||
164511165|NCT01327612|594242062|FG005|Overall Study|Withdrawal by Subject|1|||
164511166|NCT01327612|594242063|FG006|Overall Study|Withdrawal by Subject|0|||
164511167|NCT01327612|594242057|FG000|Overall Study|Disease Progression|1|||
164511168|NCT01327612|594242058|FG001|Overall Study|Disease Progression|1|||
164511169|NCT01327612|594242059|FG002|Overall Study|Disease Progression|1|||
164511170|NCT01327612|594242060|FG003|Overall Study|Disease Progression|0|||
164511171|NCT01327612|594242061|FG004|Overall Study|Disease Progression|1|||
164511172|NCT01327612|594242062|FG005|Overall Study|Disease Progression|2|||
164511173|NCT01327612|594242063|FG006|Overall Study|Disease Progression|2|||
164511174|NCT01327612|594242057|FG000|Overall Study|Administrative Decision|0|||
164511175|NCT01327612|594242058|FG001|Overall Study|Administrative Decision|0|||
164511176|NCT01327612|594242059|FG002|Overall Study|Administrative Decision|0|||
164511177|NCT01327612|594242060|FG003|Overall Study|Administrative Decision|1|||
164511178|NCT01327612|594242061|FG004|Overall Study|Administrative Decision|0|||
164511179|NCT01327612|594242062|FG005|Overall Study|Administrative Decision|0|||
164511180|NCT01327612|594242063|FG006|Overall Study|Administrative Decision|0|||
164511181|NCT01327612|594242057|FG000|Overall Study|Death|0|||
164511182|NCT01327612|594242058|FG001|Overall Study|Death|0|||
164511183|NCT01327612|594242059|FG002|Overall Study|Death|0|||
164511184|NCT01327612|594242060|FG003|Overall Study|Death|0|||
164511185|NCT01327612|594242061|FG004|Overall Study|Death|1|||
164511186|NCT01327612|594242062|FG005|Overall Study|Death|0|||
164511187|NCT01327612|594242063|FG006|Overall Study|Death|0|||
164511188|NCT05105087|594242066|FG000|Overall Study|Withdrawal by Subject|2|||
164511189|NCT05105087|594242066|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
164511190|NCT00581477|594242067|FG000|Overall Study|Physician Decision|2|||
164511191|NCT00790205|594242071|FG000|Overall Study|Lost to Follow-up|61|||
164511192|NCT00790205|594242072|FG001|Overall Study|Lost to Follow-up|71|||
164511193|NCT00790205|594242071|FG000|Overall Study|Withdrawal by Subject|299|||
164511194|NCT00790205|594242072|FG001|Overall Study|Withdrawal by Subject|363|||
164511195|NCT00755417|594242073|FG000|Overall Study|Adverse Event|28|||
164511196|NCT00755417|594242074|FG001|Overall Study|Adverse Event|20|||
164511197|NCT00755417|594242075|FG002|Overall Study|Adverse Event|7|||
164511198|NCT00755417|594242073|FG000|Overall Study|Lack of Efficacy|8|||
164511199|NCT00755417|594242074|FG001|Overall Study|Lack of Efficacy|4|||
164511200|NCT00755417|594242075|FG002|Overall Study|Lack of Efficacy|9|||
164511201|NCT00755417|594242073|FG000|Overall Study|Protocol Violation|2|||
164511202|NCT00755417|594242074|FG001|Overall Study|Protocol Violation|1|||
164511203|NCT00755417|594242075|FG002|Overall Study|Protocol Violation|1|||
164511204|NCT00755417|594242073|FG000|Overall Study|Lost to Follow-up|3|||
164511205|NCT00755417|594242074|FG001|Overall Study|Lost to Follow-up|0|||
164511206|NCT00755417|594242075|FG002|Overall Study|Lost to Follow-up|1|||
164511207|NCT00755417|594242073|FG000|Overall Study|Withdrawal by Subject|12|||
164511208|NCT00755417|594242074|FG001|Overall Study|Withdrawal by Subject|12|||
164511209|NCT00755417|594242075|FG002|Overall Study|Withdrawal by Subject|12|||
164511210|NCT00755417|594242073|FG000|Overall Study|Not specified or missing data|9|||
164511211|NCT00755417|594242074|FG001|Overall Study|Not specified or missing data|18|||
164511212|NCT00755417|594242075|FG002|Overall Study|Not specified or missing data|12|||
164511213|NCT02643628|594242077|FG000|Overall Study|Lost to Follow-up|1|||
164511214|NCT02643628|594242078|FG001|Overall Study|Lost to Follow-up|4|||
164511215|NCT02643628|594242077|FG000|Overall Study|Withdrawal by Subject|0|||
164511216|NCT02643628|594242078|FG001|Overall Study|Withdrawal by Subject|1|||
164511217|NCT02643628|594242077|FG000|Overall Study|Relocated out of state|0|||
164511218|NCT02643628|594242078|FG001|Overall Study|Relocated out of state|1|||
164511219|NCT02803593|594242079|FG000|Overall Study|Lost to Follow-up|17|||
164511220|NCT02803593|594242080|FG001|Overall Study|Lost to Follow-up|35|||
164511221|NCT03443414|594242081|FG000|Overall Study|Adverse Event|6|||
164511222|NCT03443414|594242082|FG001|Overall Study|Adverse Event|0|||
164511223|NCT03443414|594242083|FG002|Overall Study|Adverse Event|4|||
164511224|NCT03443414|594242084|FG003|Overall Study|Adverse Event|2|||
164511225|NCT03443414|594242085|FG004|Overall Study|Adverse Event|3|||
164511226|NCT03443414|594242081|FG000|Overall Study|Withdrawal by Subject|3|||
164511227|NCT03443414|594242082|FG001|Overall Study|Withdrawal by Subject|2|||
164511228|NCT03443414|594242083|FG002|Overall Study|Withdrawal by Subject|2|||
164511229|NCT03443414|594242084|FG003|Overall Study|Withdrawal by Subject|2|||
164511230|NCT03443414|594242085|FG004|Overall Study|Withdrawal by Subject|1|||
164511231|NCT03443414|594242081|FG000|Overall Study|Death|0|||
164511232|NCT03443414|594242082|FG001|Overall Study|Death|1|||
164511233|NCT03443414|594242083|FG002|Overall Study|Death|0|||
164511234|NCT03443414|594242084|FG003|Overall Study|Death|1|||
164511235|NCT03443414|594242085|FG004|Overall Study|Death|0|||
164511236|NCT03443414|594242081|FG000|Overall Study|Reason not specified|2|||
164511237|NCT03443414|594242082|FG001|Overall Study|Reason not specified|0|||
164511238|NCT03443414|594242083|FG002|Overall Study|Reason not specified|0|||
164511239|NCT03443414|594242084|FG003|Overall Study|Reason not specified|0|||
164511240|NCT03443414|594242085|FG004|Overall Study|Reason not specified|1|||
164511241|NCT03933462|594242086|FG000|Overall Study|Adverse Event|2|||
164511242|NCT03933462|594242087|FG001|Overall Study|Adverse Event|0|||
164511243|NCT02522728|594242088|FG000|Overall Study|Withdrawal by Subject|6|||
164511244|NCT02522728|594242089|FG001|Overall Study|Withdrawal by Subject|6|||
164511245|NCT02522728|594242088|FG000|Overall Study|Death|4|||
164511246|NCT02522728|594242089|FG001|Overall Study|Death|3|||
164511247|NCT02522728|594242088|FG000|Overall Study|Adverse Event|2|||
164511248|NCT02522728|594242089|FG001|Overall Study|Adverse Event|1|||
164511249|NCT02522728|594242088|FG000|Overall Study|Did not receive randomized study device|0|||
164511250|NCT02522728|594242089|FG001|Overall Study|Did not receive randomized study device|1|||
164511251|NCT01436305|594242091|FG000|Overall Study|Death|1|||
164511252|NCT01436305|594242092|FG001|Overall Study|Death|0|||
164511253|NCT01436305|594242093|FG002|Overall Study|Death|0|||
164511254|NCT01436305|594242091|FG000|Overall Study|Lost to Follow-up|0|||
164511255|NCT01436305|594242092|FG001|Overall Study|Lost to Follow-up|1|||
164511256|NCT01436305|594242093|FG002|Overall Study|Lost to Follow-up|0|||
164511257|NCT01436305|594242091|FG000|Overall Study|Withdrawal by Subject|1|||
164511258|NCT01436305|594242092|FG001|Overall Study|Withdrawal by Subject|3|||
164511259|NCT01436305|594242093|FG002|Overall Study|Withdrawal by Subject|0|||
164511260|NCT01485120|594242094|FG000|Overall Study|Withdrawal by Subject|2|||
164511261|NCT02344342|594242095|FG000|Overall Study|Industry partner dropped out|11|||
164511262|NCT02344342|594242096|FG001|Overall Study|Industry partner dropped out|9|||
164511263|NCT02344342|594242097|FG002|Overall Study|Industry partner dropped out|14|||
164511264|NCT02344342|594242098|FG003|Overall Study|Industry partner dropped out|10|||
164511265|NCT03355209|594242099|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
164511266|NCT03355209|594242100|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
164511267|NCT03355209|594242101|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
164511268|NCT03355209|594242102|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
164511269|NCT03355209|594242103|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
164511270|NCT03355209|594242104|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
164511271|NCT03355209|594242099|FG000|Part 1: Double-Blind Period|Death|0|||
164511272|NCT03355209|594242100|FG001|Part 1: Double-Blind Period|Death|0|||
164511273|NCT03355209|594242101|FG002|Part 1: Double-Blind Period|Death|1|||
164511274|NCT03355209|594242102|FG003|Part 1: Double-Blind Period|Death|0|||
164511275|NCT03355209|594242103|FG004|Part 1: Double-Blind Period|Death|0|||
164511276|NCT03355209|594242104|FG005|Part 1: Double-Blind Period|Death|0|||
164511277|NCT03355209|594242099|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
164511278|NCT03355209|594242100|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
164511279|NCT03355209|594242101|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
164511280|NCT03355209|594242102|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
164511281|NCT03355209|594242103|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
164511282|NCT03355209|594242104|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
164511283|NCT03355209|594242099|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
164511284|NCT03355209|594242100|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
164511285|NCT03355209|594242101|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
164511286|NCT03355209|594242102|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
164511287|NCT03355209|594242103|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
164511288|NCT03355209|594242104|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
164511289|NCT03355209|594242099|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
164511290|NCT03355209|594242100|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
164511291|NCT03355209|594242101|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
164511292|NCT03355209|594242102|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
164511293|NCT03355209|594242103|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
164511294|NCT03355209|594242104|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
164511295|NCT03355209|594242099|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
164511296|NCT03355209|594242100|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
164511297|NCT03355209|594242101|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
164511298|NCT03355209|594242102|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
164511299|NCT03355209|594242103|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
164511300|NCT03355209|594242104|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
164511301|NCT03355209|594242099|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
164511302|NCT03355209|594242100|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
164511303|NCT03355209|594242101|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
164511304|NCT03355209|594242102|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
164511305|NCT03355209|594242103|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
164511306|NCT03355209|594242104|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
164511307|NCT03355209|594242099|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
164511308|NCT03355209|594242100|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
164511309|NCT03355209|594242101|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
164511310|NCT03355209|594242102|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
164511311|NCT03355209|594242103|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
164511312|NCT03355209|594242104|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
164511313|NCT03355209|594242099|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
164511314|NCT03355209|594242100|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
164511315|NCT03355209|594242101|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
164511316|NCT03355209|594242102|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
164511317|NCT03355209|594242103|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
164511318|NCT03355209|594242104|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
164511319|NCT03355209|594242099|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
164511320|NCT03355209|594242100|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
164511321|NCT03355209|594242101|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
164511322|NCT03355209|594242102|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
164511323|NCT03355209|594242103|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
164511324|NCT03355209|594242104|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
164511325|NCT03355209|594242099|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
164511326|NCT03355209|594242100|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
164511327|NCT03355209|594242101|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
164511328|NCT03355209|594242102|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
164511329|NCT03355209|594242103|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
164511330|NCT03355209|594242104|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
164511331|NCT02975102|594242106|FG000|Overall Study|Adverse Event|2|||
164511332|NCT02975102|594242107|FG001|Overall Study|Adverse Event|1|||
164511333|NCT01151215|594242113|FG000|Overall Study|Worsening of condition under study|1|||
164511334|NCT01151215|594242114|FG001|Overall Study|Worsening of condition under study|1|||
164511335|NCT01151215|594242115|FG002|Overall Study|Worsening of condition under study|1|||
164511336|NCT01151215|594242113|FG000|Overall Study|Death|16|||
164511337|NCT01151215|594242114|FG001|Overall Study|Death|20|||
164511338|NCT01151215|594242115|FG002|Overall Study|Death|11|||
164511339|NCT01151215|594242113|FG000|Overall Study|Lost to Follow-up|0|||
164511340|NCT01151215|594242114|FG001|Overall Study|Lost to Follow-up|0|||
164511341|NCT01151215|594242115|FG002|Overall Study|Lost to Follow-up|3|||
164511342|NCT01151215|594242113|FG000|Overall Study|Withdrawal by Subject|3|||
164511343|NCT01151215|594242114|FG001|Overall Study|Withdrawal by Subject|1|||
164511344|NCT01151215|594242115|FG002|Overall Study|Withdrawal by Subject|2|||
164511345|NCT01151215|594242113|FG000|Overall Study|Disease progression|0|||
164511346|NCT01151215|594242114|FG001|Overall Study|Disease progression|1|||
164511347|NCT01151215|594242115|FG002|Overall Study|Disease progression|1|||
164511348|NCT01151215|594242113|FG000|Overall Study|Safety as judged by the investigator|0|||
164511349|NCT01151215|594242114|FG001|Overall Study|Safety as judged by the investigator|0|||
164511350|NCT01151215|594242115|FG002|Overall Study|Safety as judged by the investigator|1|||
164511351|NCT00401258|594242121|FG000|Overall Study|Adverse Event|7|||
164511352|NCT00604708|594242129|FG000|Overall Study|Withdrawal by Subject|9|||
164511353|NCT00604708|594242130|FG001|Overall Study|Withdrawal by Subject|10|||
164511354|NCT00604708|594242129|FG000|Overall Study|Protocol Violation|2|||
164511355|NCT00604708|594242130|FG001|Overall Study|Protocol Violation|8|||
164511356|NCT00604708|594242129|FG000|Overall Study|Lost to Follow-up|5|||
164511357|NCT00604708|594242130|FG001|Overall Study|Lost to Follow-up|5|||
164511358|NCT00604708|594242129|FG000|Overall Study|administrative reasons|9|||
164511359|NCT00604708|594242130|FG001|Overall Study|administrative reasons|11|||
164511360|NCT00604708|594242129|FG000|Overall Study|Adverse Event|6|||
164511361|NCT00604708|594242130|FG001|Overall Study|Adverse Event|6|||
164511362|NCT04916730|594242131|FG000|Overall Study|Withdrawal by Subject|4|||
164511363|NCT04916730|594242132|FG001|Overall Study|Withdrawal by Subject|2|||
164511364|NCT04916730|594242131|FG000|Overall Study|Lost to Follow-up|0|||
164511365|NCT04916730|594242132|FG001|Overall Study|Lost to Follow-up|2|||
164511366|NCT04916730|594242131|FG000|Overall Study|Physician Decision|1|||
164511367|NCT04916730|594242132|FG001|Overall Study|Physician Decision|0|||
164511368|NCT00617929|594242133|FG000|Overall Study|Physician Decision|1|||
164511369|NCT00760747|594242137|FG000|Study Period II|Adverse Event|3|||
164511370|NCT00760747|594242138|FG001|Study Period II|Adverse Event|4|||
164511371|NCT00760747|594242137|FG000|Study Period II|Lack of Efficacy|0|||
164511372|NCT00760747|594242138|FG001|Study Period II|Lack of Efficacy|6|||
164511373|NCT00760747|594242137|FG000|Study Period II|Parent/Caregiver Decision|3|||
164511374|NCT00760747|594242138|FG001|Study Period II|Parent/Caregiver Decision|0|||
164511375|NCT00760747|594242137|FG000|Study Period II|Protocol Violation|6|||
164511376|NCT00760747|594242138|FG001|Study Period II|Protocol Violation|3|||
164511377|NCT00760747|594242137|FG000|Study Period II|Withdrawal by Subject|1|||
164511378|NCT00760747|594242138|FG001|Study Period II|Withdrawal by Subject|0|||
164511379|NCT00760747|594242137|FG000|Study Period II|No drug administered|0|||
164511380|NCT00760747|594242138|FG001|Study Period II|No drug administered|1|||
164511381|NCT00760747|594242137|FG000|Study Period III|Adverse Event|1|||
164511382|NCT00760747|594242138|FG001|Study Period III|Adverse Event|0|||
164511383|NCT00760747|594242137|FG000|Study Period III|Lack of Efficacy|1|||
164511384|NCT00760747|594242138|FG001|Study Period III|Lack of Efficacy|0|||
164511385|NCT00760747|594242137|FG000|Study Period III|Parent/Caregiver Decision|0|||
164511386|NCT00760747|594242138|FG001|Study Period III|Parent/Caregiver Decision|1|||
164511387|NCT00760747|594242137|FG000|Study Period III|Protocol Violation|1|||
164511388|NCT00760747|594242138|FG001|Study Period III|Protocol Violation|1|||
164511389|NCT00760747|594242137|FG000|Study Period III|Physician Decision|0|||
164511390|NCT00760747|594242138|FG001|Study Period III|Physician Decision|1|||
164511391|NCT02194829|594242142|FG000|Overall Study|Adverse Event|2|||
164511392|NCT02194829|594242143|FG001|Overall Study|Adverse Event|2|||
164511393|NCT02194829|594242142|FG000|Overall Study|Death|0|||
164511394|NCT02194829|594242143|FG001|Overall Study|Death|1|||
164511395|NCT02194829|594242142|FG000|Overall Study|Disease progression|0|||
164511396|NCT02194829|594242143|FG001|Overall Study|Disease progression|1|||
164511397|NCT02194829|594242142|FG000|Overall Study|Withdrawal by Subject|0|||
164511398|NCT02194829|594242143|FG001|Overall Study|Withdrawal by Subject|1|||
164511399|NCT02194829|594242142|FG000|Overall Study|Never started protocol therapy|0|||
164511400|NCT02194829|594242143|FG001|Overall Study|Never started protocol therapy|1|||
164511401|NCT02473965|594243857|FG000|Overall Study|Adverse Event|6|||
164511402|NCT02473965|594243858|FG001|Overall Study|Adverse Event|4|||
164511403|NCT02473965|594243857|FG000|Overall Study|MG worsening|4|||
164511404|NCT02473965|594243858|FG001|Overall Study|MG worsening|1|||
164511405|NCT02473965|594243857|FG000|Overall Study|Withdrawal by Subject|2|||
164511406|NCT02473965|594243858|FG001|Overall Study|Withdrawal by Subject|3|||
164511407|NCT02473965|594243857|FG000|Overall Study|Physician Decision|0|||
164511408|NCT02473965|594243858|FG001|Overall Study|Physician Decision|2|||
164511409|NCT02271984|594243863|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
164511410|NCT02271984|594243864|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
164511411|NCT02271984|594243865|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
164511412|NCT02271984|594243866|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
164511413|NCT02271984|594243867|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
164511414|NCT02271984|594243868|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
164511415|NCT02271984|594243869|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
164511416|NCT02271984|594243870|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
164511417|NCT02271984|594243871|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
164511418|NCT02271984|594243872|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
164511419|NCT02271984|594243873|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
164511420|NCT02271984|594243874|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
164511421|NCT01088984|594243875|FG000|Phase 1|Death|2|||
164511422|NCT01088984|594243876|FG001|Phase 1|Death|1|||
164511423|NCT01088984|594243875|FG000|Phase 1|Disease Progression|2|||
164511424|NCT01088984|594243876|FG001|Phase 1|Disease Progression|4|||
164511425|NCT01088984|594243875|FG000|Phase 1|Other|1|||
164511426|NCT01088984|594243876|FG001|Phase 1|Other|1|||
164511427|NCT01088984|594243875|FG000|Phase 2|Death|0|||
164511428|NCT01088984|594243876|FG001|Phase 2|Death|5|||
164511429|NCT01088984|594243875|FG000|Phase 2|Withdrawal by Subject|0|||
164511430|NCT01088984|594243876|FG001|Phase 2|Withdrawal by Subject|1|||
164511431|NCT01088984|594243875|FG000|Phase 2|DIsease Progression|0|||
164511432|NCT01088984|594243876|FG001|Phase 2|DIsease Progression|25|||
164511433|NCT01088984|594243875|FG000|Phase 2|Other|0|||
164511434|NCT01088984|594243876|FG001|Phase 2|Other|1|||
164511435|NCT02706405|594243877|FG000|Overall Study|Death|3|||
164511436|NCT02706405|594243878|FG001|Overall Study|Death|2|||
164511437|NCT02706405|594243879|FG002|Overall Study|Death|0|||
164511438|NCT02706405|594243880|FG003|Overall Study|Death|1|||
164511439|NCT02706405|594243881|FG004|Overall Study|Death|0|||
164511440|NCT02706405|594243882|FG005|Overall Study|Death|0|||
164511441|NCT02706405|594243883|FG006|Overall Study|Death|3|||
164511442|NCT02706405|594243884|FG007|Overall Study|Death|4|||
164511443|NCT02706405|594243877|FG000|Overall Study|Disease progression|0|||
164511444|NCT02706405|594243878|FG001|Overall Study|Disease progression|0|||
164511445|NCT02706405|594243879|FG002|Overall Study|Disease progression|0|||
164511446|NCT02706405|594243880|FG003|Overall Study|Disease progression|0|||
164511447|NCT02706405|594243881|FG004|Overall Study|Disease progression|0|||
164511448|NCT02706405|594243882|FG005|Overall Study|Disease progression|0|||
164511449|NCT02706405|594243883|FG006|Overall Study|Disease progression|0|||
164511450|NCT02706405|594243884|FG007|Overall Study|Disease progression|1|||
164511451|NCT02706405|594243877|FG000|Overall Study|Pt moved to new therapy|0|||
164511452|NCT02706405|594243878|FG001|Overall Study|Pt moved to new therapy|0|||
164511453|NCT02706405|594243879|FG002|Overall Study|Pt moved to new therapy|0|||
164511454|NCT02706405|594243880|FG003|Overall Study|Pt moved to new therapy|0|||
164511455|NCT02706405|594243881|FG004|Overall Study|Pt moved to new therapy|0|||
164511456|NCT02706405|594243882|FG005|Overall Study|Pt moved to new therapy|1|||
164511457|NCT02706405|594243883|FG006|Overall Study|Pt moved to new therapy|0|||
164511458|NCT02706405|594243884|FG007|Overall Study|Pt moved to new therapy|1|||
164511459|NCT02706405|594243877|FG000|Overall Study|Physician Decision|1|||
164511460|NCT02706405|594243878|FG001|Overall Study|Physician Decision|0|||
164511461|NCT02706405|594243879|FG002|Overall Study|Physician Decision|0|||
164511462|NCT02706405|594243880|FG003|Overall Study|Physician Decision|0|||
164511463|NCT02706405|594243881|FG004|Overall Study|Physician Decision|0|||
164511464|NCT02706405|594243882|FG005|Overall Study|Physician Decision|0|||
164511465|NCT02706405|594243883|FG006|Overall Study|Physician Decision|0|||
164511466|NCT02706405|594243884|FG007|Overall Study|Physician Decision|0|||
164511467|NCT00603525|594243885|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
164511468|NCT00603525|594243886|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
164511469|NCT00603525|594243887|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
164511470|NCT00603525|594243885|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
164511471|NCT00603525|594243886|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
164511472|NCT00603525|594243887|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
164511473|NCT00603525|594243885|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
164511474|NCT00603525|594243886|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
164511475|NCT00603525|594243887|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
164511476|NCT00603525|594243885|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
164511477|NCT00603525|594243886|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
164511478|NCT00603525|594243887|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164511479|NCT00603525|594243885|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
164511480|NCT00603525|594243886|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
164511481|NCT00603525|594243887|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164511482|NCT00603525|594243885|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
164511483|NCT00603525|594243886|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
164511484|NCT00603525|594243887|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
164511485|NCT00603525|594243885|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
164511486|NCT00603525|594243886|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
164511487|NCT00603525|594243887|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
164511488|NCT00603525|594243885|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
164511489|NCT00603525|594243886|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
164511490|NCT00603525|594243887|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
164511491|NCT00603525|594243885|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
164511492|NCT00603525|594243886|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
164511493|NCT00603525|594243887|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
164511494|NCT00603525|594243885|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
164511495|NCT00603525|594243886|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
164511496|NCT00603525|594243887|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
164511497|NCT00603525|594243885|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
164511498|NCT00603525|594243886|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
164511499|NCT00603525|594243887|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
164511500|NCT00603525|594243885|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
164511501|NCT00603525|594243886|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
164511502|NCT00603525|594243887|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
164511503|NCT00603525|594243885|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
164511504|NCT00603525|594243886|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
164511505|NCT00603525|594243887|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
164511506|NCT00603525|594243885|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
164511507|NCT00603525|594243886|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
164511508|NCT00603525|594243887|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
164511509|NCT00603525|594243885|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
164511510|NCT00603525|594243886|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
164511511|NCT00603525|594243887|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
164511512|NCT01483144|594243888|FG000|Overall Study|Adverse Event|9|||
164511513|NCT01483144|594243889|FG001|Overall Study|Adverse Event|4|||
164511514|NCT01483144|594243890|FG002|Overall Study|Adverse Event|6|||
164511515|NCT01483144|594243888|FG000|Overall Study|Withdrawal by Subject|0|||
164511516|NCT01483144|594243889|FG001|Overall Study|Withdrawal by Subject|2|||
164511517|NCT01483144|594243890|FG002|Overall Study|Withdrawal by Subject|5|||
164511518|NCT01483144|594243888|FG000|Overall Study|Physician Decision|1|||
164511519|NCT01483144|594243889|FG001|Overall Study|Physician Decision|0|||
164511520|NCT01483144|594243890|FG002|Overall Study|Physician Decision|0|||
164511521|NCT01483144|594243888|FG000|Overall Study|Lost to Follow-up|2|||
164511522|NCT01483144|594243889|FG001|Overall Study|Lost to Follow-up|4|||
164511523|NCT01483144|594243890|FG002|Overall Study|Lost to Follow-up|1|||
164511524|NCT01483144|594243888|FG000|Overall Study|Protocol Violation|3|||
164511525|NCT01483144|594243889|FG001|Overall Study|Protocol Violation|3|||
164511526|NCT01483144|594243890|FG002|Overall Study|Protocol Violation|3|||
164511527|NCT02304705|594243891|FG000|Overall Study|Withdrawal by Subject|2|||
164511528|NCT02304705|594243892|FG001|Overall Study|Withdrawal by Subject|0|||
164511529|NCT02304705|594243891|FG000|Overall Study|Physician Decision|2|||
164511530|NCT02304705|594243892|FG001|Overall Study|Physician Decision|4|||
164511531|NCT02304705|594243891|FG000|Overall Study|Death|0|||
164511532|NCT02304705|594243892|FG001|Overall Study|Death|1|||
164511533|NCT02304705|594243891|FG000|Overall Study|Lost to Follow-up|0|||
164511534|NCT02304705|594243892|FG001|Overall Study|Lost to Follow-up|2|||
164511535|NCT00770029|594243893|FG000|Overall Study|Lost to Follow-up|2|||
164511536|NCT00770029|594243894|FG001|Overall Study|Lost to Follow-up|0|||
164511537|NCT00770029|594243893|FG000|Overall Study|Withdrawal by Subject|3|||
164511538|NCT00770029|594243894|FG001|Overall Study|Withdrawal by Subject|3|||
164511539|NCT00770029|594243893|FG000|Overall Study|Adverse Event|1|||
164511540|NCT00770029|594243894|FG001|Overall Study|Adverse Event|0|||
164511541|NCT04624243|594243897|FG000|Overall Study|Death|0|||
164511542|NCT04624243|594243898|FG001|Overall Study|Death|1|||
164511543|NCT04624243|594243899|FG002|Overall Study|Death|0|||
164511544|NCT04624243|594243900|FG003|Overall Study|Death|0|||
164511545|NCT04624243|594243901|FG004|Overall Study|Death|0|||
164511546|NCT04624243|594243897|FG000|Overall Study|Lost to Follow-up|2|||
164511547|NCT04624243|594243898|FG001|Overall Study|Lost to Follow-up|3|||
164511548|NCT04624243|594243899|FG002|Overall Study|Lost to Follow-up|7|||
164511549|NCT04624243|594243900|FG003|Overall Study|Lost to Follow-up|1|||
164511550|NCT04624243|594243901|FG004|Overall Study|Lost to Follow-up|3|||
164511551|NCT04624243|594243897|FG000|Overall Study|Physician Decision|3|||
164511552|NCT04624243|594243898|FG001|Overall Study|Physician Decision|8|||
164511553|NCT04624243|594243899|FG002|Overall Study|Physician Decision|15|||
164511554|NCT04624243|594243900|FG003|Overall Study|Physician Decision|2|||
164511555|NCT04624243|594243901|FG004|Overall Study|Physician Decision|11|||
164511556|NCT04624243|594243897|FG000|Overall Study|Withdrawal by Subject|19|||
164511557|NCT04624243|594243898|FG001|Overall Study|Withdrawal by Subject|44|||
164511558|NCT04624243|594243899|FG002|Overall Study|Withdrawal by Subject|40|||
164511559|NCT04624243|594243900|FG003|Overall Study|Withdrawal by Subject|21|||
164511560|NCT04624243|594243901|FG004|Overall Study|Withdrawal by Subject|39|||
164511561|NCT04624243|594243897|FG000|Overall Study|Miscellaneous|3|||
164511562|NCT04624243|594243898|FG001|Overall Study|Miscellaneous|12|||
164511563|NCT04624243|594243899|FG002|Overall Study|Miscellaneous|9|||
164511564|NCT04624243|594243900|FG003|Overall Study|Miscellaneous|4|||
164511565|NCT04624243|594243901|FG004|Overall Study|Miscellaneous|6|||
164511566|NCT05620108|594243902|FG000|Overall Study|Physician Decision|1|||
164511567|NCT05620108|594243903|FG001|Overall Study|Physician Decision|2|||
164511568|NCT03374488|594243904|FG000|Overall Study|Death|13|||
164511569|NCT03374488|594243905|FG001|Overall Study|Death|13|||
164609557|NCT00493974|594591434|FG001|Overall Study|Withdrawal by Subject|6|||
164609558|NCT00493974|594591433|FG000|Overall Study|Lost to Follow-up|4|||
164609559|NCT00493974|594591434|FG001|Overall Study|Lost to Follow-up|6|||
164609560|NCT00326417|594591435|FG000|Overall Study|Withdrawal by Subject|0|||
164609561|NCT00326417|594591436|FG001|Overall Study|Withdrawal by Subject|0|||
164609562|NCT00326417|594591437|FG002|Overall Study|Withdrawal by Subject|1|||
164609563|NCT00326417|594591438|FG003|Overall Study|Withdrawal by Subject|0|||
164609564|NCT00326417|594591435|FG000|Overall Study|Arm Closed|7|||
164609565|NCT00326417|594591436|FG001|Overall Study|Arm Closed|0|||
164609566|NCT00326417|594591437|FG002|Overall Study|Arm Closed|0|||
164609567|NCT00326417|594591438|FG003|Overall Study|Arm Closed|3|||
164609568|NCT00326417|594591435|FG000|Overall Study|Death|7|||
164609569|NCT00326417|594591436|FG001|Overall Study|Death|0|||
164609570|NCT00326417|594591437|FG002|Overall Study|Death|0|||
164609571|NCT00326417|594591438|FG003|Overall Study|Death|0|||
164609572|NCT00844285|594591439|FG000|Overall Study|Other|0|||
164609573|NCT00844285|594591440|FG001|Overall Study|Other|1|||
164609574|NCT00844285|594591441|FG002|Overall Study|Other|0|||
164609575|NCT00844285|594591439|FG000|Overall Study|Other than specified|95|||
164609576|NCT00844285|594591440|FG001|Overall Study|Other than specified|129|||
164609577|NCT00844285|594591441|FG002|Overall Study|Other than specified|12|||
164609578|NCT00844285|594591439|FG000|Overall Study|Site closure|256|||
164609579|NCT00844285|594591440|FG001|Overall Study|Site closure|450|||
164609580|NCT00844285|594591441|FG002|Overall Study|Site closure|50|||
164609581|NCT00844285|594591439|FG000|Overall Study|Follow-up < 8 years|16|||
164609582|NCT00844285|594591440|FG001|Overall Study|Follow-up < 8 years|23|||
164609583|NCT00844285|594591441|FG002|Overall Study|Follow-up < 8 years|4|||
164609584|NCT00844285|594591439|FG000|Overall Study|Protocol Violation|26|||
164609585|NCT00844285|594591440|FG001|Overall Study|Protocol Violation|28|||
164609586|NCT00844285|594591441|FG002|Overall Study|Protocol Violation|54|||
164609587|NCT00844285|594591439|FG000|Overall Study|Death|22|||
164609588|NCT00844285|594591440|FG001|Overall Study|Death|21|||
164609589|NCT00844285|594591441|FG002|Overall Study|Death|8|||
164609590|NCT00844285|594591439|FG000|Overall Study|Withdrew Consent|344|||
164609591|NCT00844285|594591440|FG001|Overall Study|Withdrew Consent|466|||
164609592|NCT00844285|594591441|FG002|Overall Study|Withdrew Consent|70|||
164609593|NCT00844285|594591439|FG000|Overall Study|Lost to Follow-up|330|||
164609594|NCT00844285|594591440|FG001|Overall Study|Lost to Follow-up|486|||
164609595|NCT00844285|594591441|FG002|Overall Study|Lost to Follow-up|74|||
164609596|NCT04682353|594591446|FG000|Overall Study|Lost to Follow-up|0|||
164609597|NCT04682353|594591447|FG001|Overall Study|Lost to Follow-up|1|||
164609598|NCT04682353|594591448|FG002|Overall Study|Lost to Follow-up|0|||
164609599|NCT04682353|594591449|FG003|Overall Study|Lost to Follow-up|1|||
164609600|NCT04682353|594591446|FG000|Overall Study|Personal reasons|0|||
164609601|NCT04682353|594591447|FG001|Overall Study|Personal reasons|1|||
164609602|NCT04682353|594591448|FG002|Overall Study|Personal reasons|0|||
164609603|NCT04682353|594591449|FG003|Overall Study|Personal reasons|0|||
164609604|NCT00555906|594591450|FG000|Phase 1|Objective Progression or Relapse|3|||
164609605|NCT00555906|594591451|FG001|Phase 1|Objective Progression or Relapse|5|||
164609606|NCT00555906|594591452|FG002|Phase 1|Objective Progression or Relapse|3|||
164609607|NCT00555906|594591453|FG003|Phase 1|Objective Progression or Relapse|1|||
164609608|NCT00555906|594591454|FG004|Phase 1|Objective Progression or Relapse|0|||
164609609|NCT00555906|594591450|FG000|Phase 1|Global Deterioration of Health Status|0|||
164609610|NCT00555906|594591451|FG001|Phase 1|Global Deterioration of Health Status|1|||
164609611|NCT00555906|594591452|FG002|Phase 1|Global Deterioration of Health Status|1|||
164609612|NCT00555906|594591453|FG003|Phase 1|Global Deterioration of Health Status|1|||
164609613|NCT00555906|594591454|FG004|Phase 1|Global Deterioration of Health Status|0|||
164609614|NCT00555906|594591450|FG000|Phase 1|Adverse Event|0|||
164609615|NCT00555906|594591451|FG001|Phase 1|Adverse Event|0|||
164609616|NCT00555906|594591452|FG002|Phase 1|Adverse Event|3|||
164609617|NCT00555906|594591453|FG003|Phase 1|Adverse Event|2|||
164609618|NCT00555906|594591454|FG004|Phase 1|Adverse Event|0|||
164609619|NCT00555906|594591450|FG000|Phase 1|Withdrawal by Subject|0|||
164609620|NCT00555906|594591451|FG001|Phase 1|Withdrawal by Subject|0|||
164609621|NCT00555906|594591452|FG002|Phase 1|Withdrawal by Subject|0|||
164609622|NCT00555906|594591453|FG003|Phase 1|Withdrawal by Subject|1|||
164609623|NCT00555906|594591454|FG004|Phase 1|Withdrawal by Subject|0|||
164609624|NCT00555906|594591450|FG000|Phase 2|Adverse Event|0|||
164609625|NCT00555906|594591451|FG001|Phase 2|Adverse Event|0|||
164609626|NCT00555906|594591452|FG002|Phase 2|Adverse Event|0|||
164609627|NCT00555906|594591453|FG003|Phase 2|Adverse Event|0|||
164609628|NCT00555906|594591454|FG004|Phase 2|Adverse Event|4|||
164609629|NCT00555906|594591450|FG000|Phase 2|Global Deterioration of Health Status|0|||
164609630|NCT00555906|594591451|FG001|Phase 2|Global Deterioration of Health Status|0|||
164609631|NCT00555906|594591452|FG002|Phase 2|Global Deterioration of Health Status|0|||
164609632|NCT00555906|594591453|FG003|Phase 2|Global Deterioration of Health Status|0|||
164609633|NCT00555906|594591454|FG004|Phase 2|Global Deterioration of Health Status|2|||
164609634|NCT00555906|594591450|FG000|Phase 2|Objective Progression or Relapse|0|||
164609635|NCT00555906|594591451|FG001|Phase 2|Objective Progression or Relapse|0|||
164609636|NCT00555906|594591452|FG002|Phase 2|Objective Progression or Relapse|0|||
164609637|NCT00555906|594591453|FG003|Phase 2|Objective Progression or Relapse|0|||
164609638|NCT00555906|594591454|FG004|Phase 2|Objective Progression or Relapse|16|||
164609639|NCT00555906|594591450|FG000|Phase 2|Withdrawal by Subject|0|||
164609640|NCT00555906|594591451|FG001|Phase 2|Withdrawal by Subject|0|||
164609641|NCT00555906|594591452|FG002|Phase 2|Withdrawal by Subject|0|||
164609642|NCT00555906|594591453|FG003|Phase 2|Withdrawal by Subject|0|||
164609643|NCT00555906|594591454|FG004|Phase 2|Withdrawal by Subject|2|||
164609644|NCT00555906|594591450|FG000|Phase 2|Other|0|||
164609645|NCT00555906|594591451|FG001|Phase 2|Other|0|||
164609646|NCT00555906|594591452|FG002|Phase 2|Other|0|||
164609647|NCT00555906|594591453|FG003|Phase 2|Other|0|||
164609648|NCT00555906|594591454|FG004|Phase 2|Other|6|||
164609649|NCT00555906|594591450|FG000|Phase 2|Randomized but not Treated|0|||
164609650|NCT00555906|594591451|FG001|Phase 2|Randomized but not Treated|0|||
164609651|NCT00555906|594591452|FG002|Phase 2|Randomized but not Treated|0|||
164609652|NCT00555906|594591453|FG003|Phase 2|Randomized but not Treated|0|||
164609653|NCT00555906|594591454|FG004|Phase 2|Randomized but not Treated|2|||
164609654|NCT01586806|594591455|FG000|Overall Study|Protocol Violation|0|||
164609655|NCT01586806|594591456|FG001|Overall Study|Protocol Violation|1|||
164609656|NCT01586806|594591457|FG002|Overall Study|Protocol Violation|0|||
164609657|NCT01586806|594591455|FG000|Overall Study|Withdrawal by Subject|1|||
164609658|NCT01586806|594591456|FG001|Overall Study|Withdrawal by Subject|0|||
164609659|NCT01586806|594591457|FG002|Overall Study|Withdrawal by Subject|0|||
164609660|NCT01586806|594591455|FG000|Overall Study|Lost to Follow-up|2|||
164609661|NCT01586806|594591456|FG001|Overall Study|Lost to Follow-up|3|||
164609662|NCT01586806|594591457|FG002|Overall Study|Lost to Follow-up|2|||
164609663|NCT02193828|594591458|FG000|Overall Study|Withdrawal by Subject|0|||
164609664|NCT02193828|594591459|FG001|Overall Study|Withdrawal by Subject|0|||
164609665|NCT02193828|594591460|FG002|Overall Study|Withdrawal by Subject|1|||
164609666|NCT02193828|594591461|FG003|Overall Study|Withdrawal by Subject|1|||
164609667|NCT01313208|594591462|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
164609668|NCT01313208|594591463|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
164609669|NCT01313208|594591462|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
164609670|NCT01313208|594591463|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
164609671|NCT01313208|594591462|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
164511570|NCT03374488|594243904|FG000|Overall Study|Withdrawal by Subject|3|||
164511571|NCT03374488|594243905|FG001|Overall Study|Withdrawal by Subject|1|||
164511572|NCT03374488|594243904|FG000|Overall Study|Physician Decision|3|||
164511573|NCT03374488|594243905|FG001|Overall Study|Physician Decision|0|||
164511574|NCT05602727|594243906|FG000|Overall Study|Physician Decision|0|||
164511575|NCT05602727|594243907|FG001|Overall Study|Physician Decision|1|||
164511576|NCT05602727|594243908|FG002|Overall Study|Physician Decision|0|||
164511577|NCT05602727|594243906|FG000|Overall Study|Randomized by mistake without study medication|1|||
164511578|NCT05602727|594243907|FG001|Overall Study|Randomized by mistake without study medication|0|||
164511579|NCT05602727|594243908|FG002|Overall Study|Randomized by mistake without study medication|0|||
164511580|NCT05602727|594243906|FG000|Overall Study|Study termination by Sponsor|18|||
164511581|NCT05602727|594243907|FG001|Overall Study|Study termination by Sponsor|15|||
164511582|NCT05602727|594243908|FG002|Overall Study|Study termination by Sponsor|19|||
164511583|NCT05602727|594243906|FG000|Overall Study|Withdrawal by Subject|2|||
164511584|NCT05602727|594243907|FG001|Overall Study|Withdrawal by Subject|1|||
164511585|NCT05602727|594243908|FG002|Overall Study|Withdrawal by Subject|1|||
164511586|NCT05602727|594243906|FG000|Overall Study|Various reasons|1|||
164511587|NCT05602727|594243907|FG001|Overall Study|Various reasons|6|||
164511588|NCT05602727|594243908|FG002|Overall Study|Various reasons|1|||
164511589|NCT01661205|594243909|FG000|Overall Study|Physician Decision|2|||
164511590|NCT00955708|594243910|FG000|Overall Study|Death|269|||
164511591|NCT00955708|594243910|FG000|Overall Study|Lost to Follow-up|72|||
164511592|NCT00955708|594243910|FG000|Overall Study|Physician Decision|36|||
164511593|NCT00955708|594243910|FG000|Overall Study|Protocol Violation|134|||
164511594|NCT00955708|594243910|FG000|Overall Study|Registry Conclusion|186|||
164511595|NCT00955708|594243910|FG000|Overall Study|Product removed from service|94|||
164511596|NCT00955708|594243910|FG000|Overall Study|Patient Refused to participate further|116|||
164511597|NCT00955708|594243910|FG000|Overall Study|Closure of study location|60|||
164511598|NCT00955708|594243910|FG000|Overall Study|Patient changed care provider/moved|91|||
164511599|NCT01735175|594243922|FG000|Overall Study|Withdrawal by Subject|9|||
164511600|NCT01735175|594243923|FG001|Overall Study|Withdrawal by Subject|2|||
164511601|NCT01735175|594243922|FG000|Overall Study|Lost to Follow-up|4|||
164511602|NCT01735175|594243923|FG001|Overall Study|Lost to Follow-up|2|||
164511603|NCT01735175|594243922|FG000|Overall Study|Death|3|||
164511604|NCT01735175|594243923|FG001|Overall Study|Death|2|||
164511605|NCT01735175|594243922|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
164511606|NCT01735175|594243923|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
164511607|NCT04210843|594243926|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
164511608|NCT04210843|594243927|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
164511609|NCT04210843|594243926|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
164511610|NCT04210843|594243927|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
164511611|NCT04210843|594243926|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
164511612|NCT04210843|594243927|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
164511613|NCT04210843|594243926|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
164511614|NCT04210843|594243927|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
164511615|NCT04210843|594243926|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
164511616|NCT04210843|594243927|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
164511617|NCT04210843|594243926|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
164511618|NCT04210843|594243927|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
164511619|NCT04210843|594243926|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
164511620|NCT04210843|594243927|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
164511621|NCT04210843|594243926|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
164511622|NCT04210843|594243927|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
164511623|NCT04210843|594243926|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
164511624|NCT04210843|594243927|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
164511625|NCT04210843|594243926|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
164511626|NCT04210843|594243927|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
164511627|NCT04210843|594243926|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
164511628|NCT04210843|594243927|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
164511629|NCT04210843|594243926|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
164511630|NCT04210843|594243927|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
164511631|NCT04210843|594243926|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
164511632|NCT04210843|594243927|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
164511633|NCT04210843|594243926|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
164511634|NCT04210843|594243927|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
164511635|NCT04210843|594243926|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
164511636|NCT04210843|594243927|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
164511637|NCT04210843|594243926|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
164511638|NCT04210843|594243927|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
164511639|NCT04210843|594243926|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
164511640|NCT04210843|594243927|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
164511641|NCT04210843|594243926|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
164511642|NCT04210843|594243927|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
164511643|NCT04210843|594243926|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
164511644|NCT04210843|594243927|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
164511645|NCT04210843|594243926|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
164511646|NCT04210843|594243927|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
164511647|NCT04210843|594243926|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
164511648|NCT04210843|594243927|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
164511649|NCT04210843|594243926|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
164511650|NCT04210843|594243927|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
164511651|NCT04210843|594243926|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
164511652|NCT04210843|594243927|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
164511653|NCT04210843|594243926|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
164511654|NCT04210843|594243927|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
164511655|NCT01266161|594243928|FG000|Overall Study|Ineligible|1|||
164511656|NCT01266161|594243929|FG001|Overall Study|Ineligible|0|||
164511657|NCT01266161|594243928|FG000|Overall Study|Lack of Efficacy|0|||
164511658|NCT01266161|594243929|FG001|Overall Study|Lack of Efficacy|1|||
164511659|NCT01266161|594243928|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
164511660|NCT01266161|594243929|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
164511661|NCT02597712|594243932|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
164511662|NCT02597712|594243933|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
164511663|NCT02597712|594243932|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
164511664|NCT02597712|594243933|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
164511665|NCT02597712|594243932|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
164511666|NCT02597712|594243933|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
164511667|NCT00513708|594243934|FG000|Overall Study|Lost to Follow-up|4|||
164511668|NCT00513708|594243935|FG001|Overall Study|Lost to Follow-up|4|||
164511669|NCT00513708|594243936|FG002|Overall Study|Lost to Follow-up|4|||
164511670|NCT01564277|594243937|FG000|Overall Study|Protocol Violation|0|||
164511671|NCT01564277|594243938|FG001|Overall Study|Protocol Violation|1|||
164511672|NCT01564277|594243937|FG000|Overall Study|Physician Decision|1|||
164511673|NCT01564277|594243938|FG001|Overall Study|Physician Decision|0|||
164511674|NCT01594970|594243939|FG000|Overall Study|Non-Adverse Event Related|4|||
164511675|NCT01594970|594243940|FG001|Overall Study|Non-Adverse Event Related|5|||
164511676|NCT01594970|594243941|FG002|Overall Study|Non-Adverse Event Related|6|||
164511677|NCT01594970|594243939|FG000|Overall Study|Adverse Event|17|||
164511678|NCT01594970|594243940|FG001|Overall Study|Adverse Event|23|||
164511679|NCT01594970|594243941|FG002|Overall Study|Adverse Event|23|||
164511680|NCT01594970|594243939|FG000|Overall Study|Lost to Follow-up|54|||
164511681|NCT01594970|594243940|FG001|Overall Study|Lost to Follow-up|54|||
164511682|NCT01594970|594243941|FG002|Overall Study|Lost to Follow-up|37|||
164511683|NCT01427725|594243944|FG000|Overall Study|Lost to Follow-up|17|||
164511684|NCT01427725|594243944|FG000|Overall Study|Protocol Violation|1|||
164511685|NCT01427725|594243944|FG000|Overall Study|Drug not administered|1|||
164511686|NCT01427725|594243944|FG000|Overall Study|Failure to visit|7|||
164511687|NCT01427725|594243944|FG000|Overall Study|Adverse Event|46|||
164511688|NCT01427725|594243944|FG000|Overall Study|Failure to visit after administration|40|||
164511689|NCT01427725|594243944|FG000|Overall Study|Patient's rejection|27|||
164511690|NCT01427725|594243944|FG000|Overall Study|Transfer to a different hospital|17|||
164511691|NCT01427725|594243944|FG000|Overall Study|Lack of Efficacy|8|||
164511692|NCT01427725|594243944|FG000|Overall Study|Death|7|||
164511693|NCT01427725|594243944|FG000|Overall Study|Symptom improvement|6|||
164511694|NCT01427725|594243944|FG000|Overall Study|AE and Patient's rejection|5|||
164511695|NCT01427725|594243944|FG000|Overall Study|Physician Decision|5|||
164511696|NCT01427725|594243944|FG000|Overall Study|Exacerbation of underlying disease|5|||
164511697|NCT01427725|594243944|FG000|Overall Study|Oral feeding difficulty|5|||
164511698|NCT01427725|594243944|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
164511699|NCT01427725|594243944|FG000|Overall Study|Forgetting prescription|1|||
164511700|NCT01427725|594243944|FG000|Overall Study|Other|2|||
164511701|NCT04276051|594243945|FG000|Overall Study|Lost to Follow-up|0|||
164511702|NCT04276051|594243946|FG001|Overall Study|Lost to Follow-up|1|||
164511703|NCT04276051|594243945|FG000|Overall Study|Physician Decision|0|||
164511704|NCT04276051|594243946|FG001|Overall Study|Physician Decision|1|||
164511705|NCT04276051|594243945|FG000|Overall Study|Withdrawal by Subject|1|||
164511706|NCT04276051|594243946|FG001|Overall Study|Withdrawal by Subject|1|||
164511707|NCT01299480|594243947|FG000|Overall Study|No longer willing to participate|19|||
164511708|NCT01299480|594243948|FG001|Overall Study|No longer willing to participate|17|||
164511709|NCT01299480|594243949|FG002|Overall Study|No longer willing to participate|14|||
164511710|NCT01299480|594243950|FG003|Overall Study|No longer willing to participate|13|||
164511711|NCT01299480|594243951|FG004|Overall Study|No longer willing to participate|10|||
164609672|NCT01313208|594591463|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
164511712|NCT01299480|594243947|FG000|Overall Study|Protocol Violation|7|||
164511713|NCT01299480|594243948|FG001|Overall Study|Protocol Violation|5|||
164511714|NCT01299480|594243949|FG002|Overall Study|Protocol Violation|8|||
164511715|NCT01299480|594243950|FG003|Overall Study|Protocol Violation|1|||
164511716|NCT01299480|594243951|FG004|Overall Study|Protocol Violation|1|||
164511717|NCT01299480|594243947|FG000|Overall Study|Withdrawal by Subject|3|||
164511718|NCT01299480|594243948|FG001|Overall Study|Withdrawal by Subject|4|||
164511719|NCT01299480|594243949|FG002|Overall Study|Withdrawal by Subject|7|||
164511720|NCT01299480|594243950|FG003|Overall Study|Withdrawal by Subject|3|||
164511721|NCT01299480|594243951|FG004|Overall Study|Withdrawal by Subject|4|||
164511722|NCT01299480|594243947|FG000|Overall Study|Adverse Event|6|||
164511723|NCT01299480|594243948|FG001|Overall Study|Adverse Event|4|||
164511724|NCT01299480|594243949|FG002|Overall Study|Adverse Event|5|||
164511725|NCT01299480|594243950|FG003|Overall Study|Adverse Event|4|||
164511726|NCT01299480|594243951|FG004|Overall Study|Adverse Event|0|||
164511727|NCT01299480|594243947|FG000|Overall Study|Withdrawal due to pregnancy|0|||
164511728|NCT01299480|594243948|FG001|Overall Study|Withdrawal due to pregnancy|1|||
164511729|NCT01299480|594243949|FG002|Overall Study|Withdrawal due to pregnancy|1|||
164511730|NCT01299480|594243950|FG003|Overall Study|Withdrawal due to pregnancy|0|||
164511731|NCT01299480|594243951|FG004|Overall Study|Withdrawal due to pregnancy|0|||
164511732|NCT01299480|594243947|FG000|Overall Study|Physician Decision|1|||
164511733|NCT01299480|594243948|FG001|Overall Study|Physician Decision|1|||
164511734|NCT01299480|594243949|FG002|Overall Study|Physician Decision|0|||
164511735|NCT01299480|594243950|FG003|Overall Study|Physician Decision|2|||
164511736|NCT01299480|594243951|FG004|Overall Study|Physician Decision|0|||
164511737|NCT01299480|594243947|FG000|Overall Study|Lost to Follow-up|3|||
164511738|NCT01299480|594243948|FG001|Overall Study|Lost to Follow-up|1|||
164511739|NCT01299480|594243949|FG002|Overall Study|Lost to Follow-up|2|||
164511740|NCT01299480|594243950|FG003|Overall Study|Lost to Follow-up|1|||
164511741|NCT01299480|594243951|FG004|Overall Study|Lost to Follow-up|2|||
164511742|NCT01299480|594243947|FG000|Overall Study|Other|3|||
164511743|NCT01299480|594243948|FG001|Overall Study|Other|2|||
164511744|NCT01299480|594243949|FG002|Overall Study|Other|3|||
164511745|NCT01299480|594243950|FG003|Overall Study|Other|0|||
164511746|NCT01299480|594243951|FG004|Overall Study|Other|3|||
164511747|NCT01299480|594243947|FG000|Overall Study|Started, but not vaccinated|0|||
164511748|NCT01299480|594243948|FG001|Overall Study|Started, but not vaccinated|0|||
164511749|NCT01299480|594243949|FG002|Overall Study|Started, but not vaccinated|1|||
164511750|NCT01299480|594243950|FG003|Overall Study|Started, but not vaccinated|1|||
164511751|NCT01299480|594243951|FG004|Overall Study|Started, but not vaccinated|0|||
164511752|NCT01374568|594243952|FG000|Overall Study|Lab unable to analyze BTM|0|||
164511753|NCT01374568|594243953|FG001|Overall Study|Lab unable to analyze BTM|2|||
164511754|NCT00415051|594243955|FG000|Overall Study|Protocol Violation|1|||
164511755|NCT04160988|594243964|FG000|Overall Study|poor image quality|28|||
164511756|NCT00844597|594243965|FG000|Overall Study|Adverse Event|0|||
164511757|NCT00844597|594243966|FG001|Overall Study|Adverse Event|0|||
164511758|NCT00844597|594243967|FG002|Overall Study|Adverse Event|0|||
164511759|NCT00844597|594243968|FG003|Overall Study|Adverse Event|1|||
164511760|NCT00844597|594243969|FG004|Overall Study|Adverse Event|0|||
164511761|NCT00844597|594243970|FG005|Overall Study|Adverse Event|0|||
164511762|NCT01250509|594243971|FG000|Overall Study|Lost to Follow-up|5|||
164511763|NCT01250509|594243972|FG001|Overall Study|Lost to Follow-up|2|||
164511764|NCT01228175|594243978|FG000|Overall Study|Lost to Follow-up|64|||
164511765|NCT01228175|594243979|FG001|Overall Study|Lost to Follow-up|50|||
164511766|NCT01228175|594243978|FG000|Overall Study|Withdrawal by Subject|1|||
164511767|NCT01228175|594243979|FG001|Overall Study|Withdrawal by Subject|2|||
164511768|NCT01228175|594243978|FG000|Overall Study|Physician Decision|1|||
164511769|NCT01228175|594243979|FG001|Overall Study|Physician Decision|1|||
164511770|NCT00243074|594243981|FG000|Overall Study|Ineligible|6|||
164511771|NCT00243074|594243981|FG000|Overall Study|Adverse Event|6|||
164511772|NCT00243074|594243981|FG000|Overall Study|Withdrawal by Subject|2|||
164511773|NCT00243074|594243981|FG000|Overall Study|Lack of Efficacy|36|||
164511774|NCT00243074|594243981|FG000|Overall Study|Death|2|||
164609673|NCT01313208|594591462|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
164609674|NCT01313208|594591463|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
164609675|NCT01313208|594591462|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
164609676|NCT01313208|594591463|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
164609677|NCT01313208|594591462|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
164511775|NCT00243074|594243981|FG000|Overall Study|not protocol specified|1|||
164511776|NCT00243074|594243981|FG000|Overall Study|Did not receive any treatment|1|||
164511777|NCT00402051|594243984|FG000|Overall Study|Progressive Disease|13|||
164511778|NCT00402051|594243985|FG001|Overall Study|Progressive Disease|20|||
164511779|NCT00402051|594243984|FG000|Overall Study|Adverse Event|11|||
164511780|NCT00402051|594243985|FG001|Overall Study|Adverse Event|4|||
164511781|NCT00402051|594243984|FG000|Overall Study|Physician Decision|7|||
164511782|NCT00402051|594243985|FG001|Overall Study|Physician Decision|3|||
164511783|NCT00402051|594243984|FG000|Overall Study|Withdrawal by Subject|3|||
164511784|NCT00402051|594243985|FG001|Overall Study|Withdrawal by Subject|3|||
164511785|NCT00402051|594243984|FG000|Overall Study|Death - Related to Study Drug|1|||
164511786|NCT00402051|594243985|FG001|Overall Study|Death - Related to Study Drug|2|||
164511787|NCT00402051|594243984|FG000|Overall Study|Death Due to Study Disease|2|||
164511788|NCT00402051|594243985|FG001|Overall Study|Death Due to Study Disease|1|||
164511789|NCT00402051|594243984|FG000|Overall Study|Death Due to Adverse Event|0|||
164511790|NCT00402051|594243985|FG001|Overall Study|Death Due to Adverse Event|2|||
164511791|NCT00402051|594243984|FG000|Overall Study|Lost to Follow-up|1|||
164511792|NCT00402051|594243985|FG001|Overall Study|Lost to Follow-up|0|||
164511793|NCT00570908|594243986|FG000|Overall Study|Adverse Event|5|||
164511794|NCT00570908|594243986|FG000|Overall Study|Withdrawal by Subject|2|||
164511795|NCT01213524|594243987|FG000|Baseline|Withdrawal by Subject|5|||
164511796|NCT01213524|594243987|FG000|Baseline|high breath alcohol levels|1|||
164511797|NCT01213524|594243987|FG000|Baseline|Physician Decision|1|||
164511798|NCT01213524|594243987|FG000|Session 2|Withdrawal by Subject|5|||
164511799|NCT01213524|594243987|FG000|Session 3|Withdrawal by Subject|4|||
164511800|NCT01213524|594243987|FG000|Session 4|Physician Decision|1|||
164511801|NCT01213524|594243987|FG000|Session 4|Withdrawal by Subject|2|||
164511802|NCT05415748|594243988|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
164511803|NCT05415748|594243989|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
164511804|NCT05415748|594243990|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
164511805|NCT05415748|594243991|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
164511806|NCT05415748|594243988|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
164511807|NCT05415748|594243989|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
164511808|NCT05415748|594243990|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
164511809|NCT05415748|594243991|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
164511810|NCT01447576|594243992|FG000|Overall Study|Lost to Follow-up|52|||
164511811|NCT01447576|594243992|FG000|Overall Study|Adverse Event|127|||
164511812|NCT01447576|594243992|FG000|Overall Study|Participant met withdrawal criteria|40|||
164511813|NCT01447576|594243992|FG000|Overall Study|Withdrawal by Subject|100|||
164511814|NCT01447576|594243992|FG000|Overall Study|Protocol deviation|83|||
164511815|NCT01447576|594243992|FG000|Overall Study|Lack of Efficacy|68|||
164511816|NCT01447576|594243992|FG000|Overall Study|Physician Decision|6|||
164511817|NCT00975676|594243993|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
164511818|NCT00975676|594243994|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
164511819|NCT02209181|594243995|FG000|Overall Study|Adverse Event|1|||
164511820|NCT02209181|594243996|FG001|Overall Study|Adverse Event|0|||
164511821|NCT02209181|594243997|FG002|Overall Study|Adverse Event|1|||
164511822|NCT02209181|594243998|FG003|Overall Study|Adverse Event|0|||
164511823|NCT02209181|594243995|FG000|Overall Study|Withdrawal by Subject|0|||
164511824|NCT02209181|594243996|FG001|Overall Study|Withdrawal by Subject|1|||
164511825|NCT02209181|594243997|FG002|Overall Study|Withdrawal by Subject|0|||
164511826|NCT02209181|594243998|FG003|Overall Study|Withdrawal by Subject|0|||
164511827|NCT06840769|594244004|FG000|Overall Study|Withdrawal by Subject|1|||
164511828|NCT06840769|594244005|FG001|Overall Study|Withdrawal by Subject|0|||
164511829|NCT06840769|594244006|FG002|Overall Study|Withdrawal by Subject|0|||
164511830|NCT06840769|594244007|FG003|Overall Study|Withdrawal by Subject|0|||
164511831|NCT06840769|594244008|FG004|Overall Study|Withdrawal by Subject|0|||
164511832|NCT02726945|594244009|FG000|Overall Study|Withdrawal by Subject|0|||
164511833|NCT02726945|594244010|FG001|Overall Study|Withdrawal by Subject|0|||
164511834|NCT02726945|594244011|FG002|Overall Study|Withdrawal by Subject|1|||
164511835|NCT02726945|594244009|FG000|Overall Study|Elected to have total knee replacement|0|||
164511836|NCT02726945|594244010|FG001|Overall Study|Elected to have total knee replacement|1|||
164511837|NCT02726945|594244011|FG002|Overall Study|Elected to have total knee replacement|0|||
164511838|NCT05992922|594244012|FG000|Overall Study|Adverse Event|6|||
164511839|NCT05992922|594244013|FG001|Overall Study|Adverse Event|0|||
164511840|NCT05992922|594244012|FG000|Overall Study|Sponsor Termination of Study|14|||
164511841|NCT05992922|594244013|FG001|Overall Study|Sponsor Termination of Study|20|||
164511842|NCT04427280|594245835|FG000|Overall Study|Withdrawal by Subject|0|||
164511843|NCT04427280|594245836|FG001|Overall Study|Withdrawal by Subject|2|||
164511844|NCT01681277|594245839|FG000|Overall Study|Adverse Event|1|||
164511845|NCT01681277|594245840|FG001|Overall Study|Adverse Event|0|||
164511846|NCT01681277|594245841|FG002|Overall Study|Adverse Event|0|||
164511847|NCT01681277|594245842|FG003|Overall Study|Adverse Event|0|||
164511848|NCT01681277|594245843|FG004|Overall Study|Adverse Event|0|||
164511849|NCT03140280|594245844|FG000|Overall Study|Physician Decision|5|||
164511850|NCT02038842|594245846|FG000|Overall Study|Withdrawal by Subject|2|||
164511851|NCT02038842|594245847|FG001|Overall Study|Withdrawal by Subject|2|||
164511852|NCT02038842|594245848|FG002|Overall Study|Withdrawal by Subject|0|||
164511853|NCT02038842|594245849|FG003|Overall Study|Withdrawal by Subject|0|||
164511854|NCT02038842|594245846|FG000|Overall Study|Participant decision|0|||
164511855|NCT02038842|594245847|FG001|Overall Study|Participant decision|0|||
164511856|NCT02038842|594245848|FG002|Overall Study|Participant decision|2|||
164511857|NCT02038842|594245849|FG003|Overall Study|Participant decision|1|||
164511858|NCT02038842|594245846|FG000|Overall Study|Adverse Event|0|||
164511859|NCT02038842|594245847|FG001|Overall Study|Adverse Event|0|||
164511860|NCT02038842|594245848|FG002|Overall Study|Adverse Event|3|||
164511861|NCT02038842|594245849|FG003|Overall Study|Adverse Event|1|||
164511862|NCT02038842|594245846|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
164511863|NCT02038842|594245847|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
164511864|NCT02038842|594245848|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
164511865|NCT02038842|594245849|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
164511866|NCT03412773|594245852|FG000|Overall Study|Lost to Follow-up|0|||
164511867|NCT03412773|594245853|FG001|Overall Study|Lost to Follow-up|7|||
164511868|NCT03412773|594245854|FG002|Overall Study|Lost to Follow-up|6|||
164511869|NCT03412773|594245852|FG000|Overall Study|Withdrawal by Subject|0|||
164511870|NCT03412773|594245853|FG001|Overall Study|Withdrawal by Subject|15|||
164511871|NCT03412773|594245854|FG002|Overall Study|Withdrawal by Subject|19|||
164511872|NCT03412773|594245852|FG000|Overall Study|Study Closed By Sponsor|3|||
164511873|NCT03412773|594245853|FG001|Overall Study|Study Closed By Sponsor|46|||
164511874|NCT03412773|594245854|FG002|Overall Study|Study Closed By Sponsor|33|||
164511875|NCT03412773|594245852|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
164511876|NCT03412773|594245853|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
164511877|NCT03412773|594245854|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
164511878|NCT03412773|594245852|FG000|Overall Study|Death|7|||
164511879|NCT03412773|594245853|FG001|Overall Study|Death|259|||
164511880|NCT03412773|594245854|FG002|Overall Study|Death|273|||
164511881|NCT03412773|594245852|FG000|Overall Study|Physician Decision|0|||
164511882|NCT03412773|594245853|FG001|Overall Study|Physician Decision|0|||
164511883|NCT03412773|594245854|FG002|Overall Study|Physician Decision|1|||
164511884|NCT01250925|594245855|FG000|Overall Study|Lost to Follow-up|1|||
164511885|NCT01250925|594245856|FG001|Overall Study|Lost to Follow-up|1|||
164511886|NCT01250925|594245857|FG002|Overall Study|Lost to Follow-up|0|||
164511887|NCT01250925|594245855|FG000|Overall Study|Withdrawal by Subject|2|||
164511888|NCT01250925|594245856|FG001|Overall Study|Withdrawal by Subject|0|||
164511889|NCT01250925|594245857|FG002|Overall Study|Withdrawal by Subject|0|||
164511890|NCT01250925|594245855|FG000|Overall Study|Protocol Violation|2|||
164511891|NCT01250925|594245856|FG001|Overall Study|Protocol Violation|0|||
164511892|NCT01250925|594245857|FG002|Overall Study|Protocol Violation|0|||
164511893|NCT01250925|594245855|FG000|Overall Study|Physician Decision|0|||
164511894|NCT01250925|594245856|FG001|Overall Study|Physician Decision|2|||
164511895|NCT01250925|594245857|FG002|Overall Study|Physician Decision|1|||
164511896|NCT01250925|594245855|FG000|Overall Study|Adverse Event|0|||
164511897|NCT01250925|594245856|FG001|Overall Study|Adverse Event|0|||
164511898|NCT01250925|594245857|FG002|Overall Study|Adverse Event|1|||
164511899|NCT00678301|594245860|FG000|Overall Study|Non-compliance with study procedures|0|||
164511900|NCT00678301|594245861|FG001|Overall Study|Non-compliance with study procedures|1|||
164511901|NCT00678301|594245860|FG000|Overall Study|Adverse Event|1|||
164511902|NCT00678301|594245861|FG001|Overall Study|Adverse Event|0|||
164511903|NCT00678301|594245860|FG000|Overall Study|Withdrawal by Subject|4|||
164511904|NCT00678301|594245861|FG001|Overall Study|Withdrawal by Subject|0|||
164511905|NCT00678301|594245860|FG000|Overall Study|Lost to Follow-up|3|||
164511906|NCT00678301|594245861|FG001|Overall Study|Lost to Follow-up|1|||
164511907|NCT00426127|594245863|FG000|Overall Study|Adverse Event|1|||
164511908|NCT00426127|594245863|FG000|Overall Study|Removed due to disease progression|1|||
164511909|NCT03111095|594245866|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
164511910|NCT03111095|594245867|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
164511911|NCT03111095|594245866|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
164511912|NCT03111095|594245867|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
164511913|NCT03738475|594245868|FG000|Overall Study|Participant Non-Compliance|1|||
164511914|NCT03738475|594245869|FG001|Overall Study|Participant Non-Compliance|0|||
164511915|NCT00677534|594245870|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
164511916|NCT00677534|594245870|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
164511917|NCT00677534|594245870|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
164511918|NCT00667394|594245871|FG000|Overall Study|Adverse Event|3|||
164511919|NCT00667394|594245872|FG001|Overall Study|Adverse Event|0|||
164511920|NCT00667394|594245871|FG000|Overall Study|Progressive disease|1|||
164511921|NCT00667394|594245872|FG001|Overall Study|Progressive disease|0|||
164511922|NCT04638660|594245873|FG000|Overall Study|Withdrawal by Subject|2|||
164511923|NCT04638660|594245874|FG001|Overall Study|Withdrawal by Subject|0|||
164511924|NCT04638660|594245873|FG000|Overall Study|Lost to Follow-up|1|||
164511925|NCT04638660|594245874|FG001|Overall Study|Lost to Follow-up|0|||
164511926|NCT04076943|594245875|FG000|Overall Study|Withdrawal by Subject|12|||
164511927|NCT04076943|594245875|FG000|Overall Study|Adverse Event|1|||
164511928|NCT04076943|594245875|FG000|Overall Study|Progressive Disease|2|||
164511929|NCT04076943|594245875|FG000|Overall Study|Death|13|||
164511930|NCT04076943|594245875|FG000|Overall Study|Other than specified|6|||
164511931|NCT03004404|594245878|FG000|Period 2|Adverse Event|0|||
164511932|NCT03004404|594245879|FG001|Period 2|Adverse Event|0|||
164511933|NCT03004404|594245880|FG002|Period 2|Adverse Event|0|||
164511934|NCT03004404|594245881|FG003|Period 2|Adverse Event|0|||
164511935|NCT03004404|594245882|FG004|Period 2|Adverse Event|0|||
164511936|NCT03004404|594245883|FG005|Period 2|Adverse Event|0|||
164511937|NCT03004404|594245884|FG006|Period 2|Adverse Event|0|||
164511938|NCT03004404|594245885|FG007|Period 2|Adverse Event|0|||
164511939|NCT03004404|594245886|FG008|Period 2|Adverse Event|1|||
164511940|NCT03004404|594245887|FG009|Period 2|Adverse Event|0|||
164511941|NCT03004404|594245888|FG010|Period 2|Adverse Event|0|||
164511942|NCT03004404|594245889|FG011|Period 2|Adverse Event|0|||
164511943|NCT03004404|594245890|FG012|Period 2|Adverse Event|0|||
164511944|NCT03004404|594245891|FG013|Period 2|Adverse Event|0|||
164511945|NCT03004404|594245892|FG014|Period 2|Adverse Event|0|||
164511946|NCT03004404|594245893|FG015|Period 2|Adverse Event|1|||
164511947|NCT01099917|594245898|FG000|Overall Study|Adverse Event|3|||
164511948|NCT01099917|594245898|FG000|Overall Study|Not Treated|24|||
164511949|NCT02990468|594245899|FG000|Phase 2: MTD|Change in treatment|0|||
164511950|NCT02990468|594245900|FG001|Phase 2: MTD|Change in treatment|0|||
164511951|NCT02990468|594245901|FG002|Phase 2: MTD|Change in treatment|1|||
164511952|NCT01602510|594245906|FG000|Open Label Phase|Adverse Event|46|||
164511953|NCT01602510|594245907|FG001|Open Label Phase|Adverse Event|0|||
164511954|NCT01602510|594245908|FG002|Open Label Phase|Adverse Event|0|||
164511955|NCT01602510|594245906|FG000|Open Label Phase|Lack of Efficacy|22|||
164511956|NCT01602510|594245907|FG001|Open Label Phase|Lack of Efficacy|0|||
164511957|NCT01602510|594245908|FG002|Open Label Phase|Lack of Efficacy|0|||
164511958|NCT01602510|594245906|FG000|Open Label Phase|Protocol Violation|15|||
164511959|NCT01602510|594245907|FG001|Open Label Phase|Protocol Violation|0|||
164511960|NCT01602510|594245908|FG002|Open Label Phase|Protocol Violation|0|||
164511961|NCT01602510|594245906|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
164511962|NCT01602510|594245907|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
164511963|NCT01602510|594245908|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
164511964|NCT01602510|594245906|FG000|Open Label Phase|Lost to Follow-up|22|||
164511965|NCT01602510|594245907|FG001|Open Label Phase|Lost to Follow-up|0|||
164511966|NCT01602510|594245908|FG002|Open Label Phase|Lost to Follow-up|0|||
164511967|NCT01602510|594245906|FG000|Open Label Phase|Physician Decision|19|||
164511968|NCT01602510|594245907|FG001|Open Label Phase|Physician Decision|0|||
164511969|NCT01602510|594245908|FG002|Open Label Phase|Physician Decision|0|||
164511970|NCT01602510|594245906|FG000|Open Label Phase|Withdrawal by Subject|57|||
164511971|NCT01602510|594245907|FG001|Open Label Phase|Withdrawal by Subject|0|||
164511972|NCT01602510|594245908|FG002|Open Label Phase|Withdrawal by Subject|0|||
164511973|NCT01602510|594245906|FG000|Randomized Phase|Adverse Event|0|||
164511974|NCT01602510|594245907|FG001|Randomized Phase|Adverse Event|2|||
164511975|NCT01602510|594245908|FG002|Randomized Phase|Adverse Event|6|||
164511976|NCT01602510|594245906|FG000|Randomized Phase|Lack of Efficacy|0|||
164511977|NCT01602510|594245907|FG001|Randomized Phase|Lack of Efficacy|4|||
164511978|NCT01602510|594245908|FG002|Randomized Phase|Lack of Efficacy|4|||
164511979|NCT01602510|594245906|FG000|Randomized Phase|Protocol Violation|0|||
164511980|NCT01602510|594245907|FG001|Randomized Phase|Protocol Violation|3|||
164511981|NCT01602510|594245908|FG002|Randomized Phase|Protocol Violation|3|||
164511982|NCT01602510|594245906|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
164609678|NCT01313208|594591463|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
164511983|NCT01602510|594245907|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
164511984|NCT01602510|594245908|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
164511985|NCT01602510|594245906|FG000|Randomized Phase|Lost to Follow-up|0|||
164511986|NCT01602510|594245907|FG001|Randomized Phase|Lost to Follow-up|1|||
164511987|NCT01602510|594245908|FG002|Randomized Phase|Lost to Follow-up|3|||
164511988|NCT01602510|594245906|FG000|Randomized Phase|Physician Decision|0|||
164511989|NCT01602510|594245907|FG001|Randomized Phase|Physician Decision|0|||
164511990|NCT01602510|594245908|FG002|Randomized Phase|Physician Decision|2|||
164511991|NCT01602510|594245906|FG000|Randomized Phase|Withdrawal by Subject|0|||
164511992|NCT01602510|594245907|FG001|Randomized Phase|Withdrawal by Subject|6|||
164511993|NCT01602510|594245908|FG002|Randomized Phase|Withdrawal by Subject|7|||
164511994|NCT01825577|594245909|FG000|Overall Study|Physician Decision|2|||
164511995|NCT01825577|594245909|FG000|Overall Study|Withdrawal by Subject|1|||
164511996|NCT01825577|594245909|FG000|Overall Study|Withdrawn by family members|2|||
164511997|NCT01825577|594245909|FG000|Overall Study|Lack of Efficacy|3|||
164511998|NCT04191616|594245912|FG000|Pre-assignment Period|Did not receive study treatment|2|||
164511999|NCT04191616|594245912|FG000|Treatment Period|Death|37|||
164512000|NCT04191616|594245912|FG000|Treatment Period|Sponsor decision|11|||
164512001|NCT04191616|594245912|FG000|Treatment Period|Withdrawal by Subject|4|||
164609679|NCT01313208|594591462|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
164609680|NCT01313208|594591463|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
164512002|NCT04230122|594245913|FG000|Overall Study|Lost to Follow-up|1|||
164609681|NCT01313208|594591462|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
164609682|NCT01313208|594591463|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
164609683|NCT01313208|594591462|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
164512003|NCT04230122|594245914|FG001|Overall Study|Lost to Follow-up|0|||
164512004|NCT01361594|594245916|FG000|Overall Study|Withdrawal by Subject|1|||
164512005|NCT01361594|594245917|FG001|Overall Study|Withdrawal by Subject|2|||
164512006|NCT01277887|594245919|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
164512007|NCT01277887|594245920|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
164512008|NCT01277887|594245919|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
164512009|NCT01277887|594245920|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
164512010|NCT01277887|594245919|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
164512011|NCT01277887|594245920|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
164512012|NCT02670122|594245922|FG000|Overall Study|Lost to Follow-up|4|||
164512013|NCT02762903|594245923|FG000|Overall Study|Lost to Follow-up|0|||
164512014|NCT02762903|594245924|FG001|Overall Study|Lost to Follow-up|1|||
164512015|NCT00277095|594245925|FG000|Overall Study|Death|2|||
164512016|NCT00277095|594245925|FG000|Overall Study|Explanted|7|||
164512017|NCT00277095|594245925|FG000|Overall Study|Lost to Follow-up|2|||
164512018|NCT00277095|594245925|FG000|Overall Study|Missed Follow-up|9|||
164512019|NCT00277095|594245925|FG000|Overall Study|Physician Decision|1|||
164512020|NCT02548078|594245932|FG000|Overall Study|Serious adverse event/Adverse event|1|||
164512021|NCT02548078|594245933|FG001|Overall Study|Serious adverse event/Adverse event|0|||
164512022|NCT02548078|594245932|FG000|Overall Study|Moved from study area|3|||
164512023|NCT02548078|594245933|FG001|Overall Study|Moved from study area|3|||
164512024|NCT02548078|594245932|FG000|Overall Study|Lost to Follow-up|1|||
164512025|NCT02548078|594245933|FG001|Overall Study|Lost to Follow-up|3|||
164512026|NCT02579772|594245934|FG000|Overall Study|Withdrawal by Subject|0|||
164512027|NCT02579772|594245935|FG001|Overall Study|Withdrawal by Subject|1|||
164512028|NCT02579772|594245934|FG000|Overall Study|Usage of additional antioxidants|1|||
164512029|NCT02579772|594245935|FG001|Overall Study|Usage of additional antioxidants|0|||
164512030|NCT02579772|594245934|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
164512031|NCT02579772|594245935|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
164512032|NCT01040169|594245936|FG000|Overall Study|Lost to Follow-up|3|||
164512033|NCT01040169|594245937|FG001|Overall Study|Lost to Follow-up|8|||
164512034|NCT03128671|594245938|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
164512035|NCT03128671|594245939|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
164512036|NCT03128671|594245938|FG000|Allocation|Death|1|||
164512037|NCT03128671|594245939|FG001|Allocation|Death|0|||
164512038|NCT03128671|594245938|FG000|Allocation|Withdrawal by Subject|4|||
164512039|NCT03128671|594245939|FG001|Allocation|Withdrawal by Subject|0|||
164512040|NCT03128671|594245938|FG000|Intervention|Withdrawal by Subject|11|||
164512041|NCT03128671|594245939|FG001|Intervention|Withdrawal by Subject|10|||
164512042|NCT03128671|594245938|FG000|Intervention|Palliative/hospice care initiated|9|||
164512043|NCT03128671|594245939|FG001|Intervention|Palliative/hospice care initiated|10|||
164512044|NCT03128671|594245938|FG000|Intervention|Death|13|||
164512045|NCT03128671|594245939|FG001|Intervention|Death|11|||
164512046|NCT03128671|594245938|FG000|Intervention|Interrupted by hurricane|1|||
164512047|NCT03128671|594245939|FG001|Intervention|Interrupted by hurricane|0|||
164512048|NCT03128671|594245938|FG000|Intervention|Physician Decision|2|||
164512049|NCT03128671|594245939|FG001|Intervention|Physician Decision|3|||
164512050|NCT04641962|594245940|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
164512051|NCT04641962|594245941|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
164512052|NCT04641962|594245942|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
164512053|NCT04641962|594245943|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
164512054|NCT04641962|594245944|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
164512055|NCT04641962|594245940|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
164512056|NCT04641962|594245941|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
164512057|NCT04641962|594245942|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
164512058|NCT04641962|594245943|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
164512059|NCT04641962|594245944|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
164512060|NCT04641962|594245940|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
164512061|NCT04641962|594245941|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
164512062|NCT04641962|594245942|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
164512063|NCT04641962|594245943|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
164512064|NCT04641962|594245944|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
164512065|NCT04641962|594245940|FG000|DBT Period: Up to 52 Weeks|Death|1|||
164512066|NCT04641962|594245941|FG001|DBT Period: Up to 52 Weeks|Death|0|||
164512067|NCT04641962|594245942|FG002|DBT Period: Up to 52 Weeks|Death|0|||
164512068|NCT04641962|594245943|FG003|DBT Period: Up to 52 Weeks|Death|0|||
164512069|NCT04641962|594245944|FG004|DBT Period: Up to 52 Weeks|Death|0|||
164512070|NCT04641962|594245940|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
164512071|NCT04641962|594245941|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
164512072|NCT04641962|594245942|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
164512073|NCT04641962|594245943|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
164512074|NCT04641962|594245944|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
164512075|NCT04641962|594245940|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
164512076|NCT04641962|594245941|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
164512077|NCT04641962|594245942|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
164512078|NCT04641962|594245943|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
164512079|NCT04641962|594245944|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
164512080|NCT04641962|594245940|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
164512081|NCT04641962|594245941|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
164512082|NCT04641962|594245942|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
164512083|NCT04641962|594245943|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
164512084|NCT04641962|594245944|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
164512085|NCT00862836|594245945|FG000|Overall Study|Withdrawal by Subject|1|||
164512086|NCT04463680|594245946|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
164512087|NCT04463680|594245946|FG000|Overall Study|Not eligible due to implant duration of use|1|||
164512088|NCT04463680|594245946|FG000|Overall Study|Withdrawal by Subject|3|||
164512089|NCT05239598|594245951|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
164512090|NCT05239598|594245952|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
164512091|NCT05239598|594245951|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
164512092|NCT05239598|594245952|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
164512093|NCT02592707|594245953|FG000|Overall Study|Consent Withdrawn|0|||
164512094|NCT02592707|594245954|FG001|Overall Study|Consent Withdrawn|1|||
164512095|NCT02592707|594245955|FG002|Overall Study|Consent Withdrawn|2|||
164512096|NCT02592707|594245956|FG003|Overall Study|Consent Withdrawn|0|||
164512097|NCT02592707|594245953|FG000|Overall Study|Death|1|||
164512098|NCT02592707|594245954|FG001|Overall Study|Death|0|||
164512099|NCT02592707|594245955|FG002|Overall Study|Death|0|||
164512100|NCT02592707|594245956|FG003|Overall Study|Death|0|||
164512101|NCT02592707|594245953|FG000|Overall Study|Progressive Disease|4|||
164512102|NCT02592707|594245954|FG001|Overall Study|Progressive Disease|4|||
164512103|NCT02592707|594245955|FG002|Overall Study|Progressive Disease|3|||
164512104|NCT02592707|594245956|FG003|Overall Study|Progressive Disease|3|||
164512105|NCT02592707|594245953|FG000|Overall Study|Other|0|||
164512106|NCT02592707|594245954|FG001|Overall Study|Other|0|||
164512107|NCT02592707|594245955|FG002|Overall Study|Other|1|||
164512108|NCT02592707|594245956|FG003|Overall Study|Other|2|||
164512109|NCT02592707|594245953|FG000|Overall Study|Never entered LTFU period|1|||
164512110|NCT02592707|594245954|FG001|Overall Study|Never entered LTFU period|0|||
164512111|NCT02592707|594245955|FG002|Overall Study|Never entered LTFU period|0|||
164512112|NCT02592707|594245956|FG003|Overall Study|Never entered LTFU period|2|||
164512113|NCT02998476|594245961|FG000|Overall Study|Lost to Follow-up|1|||
164512114|NCT02998476|594245962|FG001|Overall Study|Lost to Follow-up|0|||
164512115|NCT02998476|594245961|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
164512116|NCT02998476|594245962|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
164512117|NCT02998476|594245961|FG000|Overall Study|Withdrawal by Subject|1|||
164512118|NCT02998476|594245962|FG001|Overall Study|Withdrawal by Subject|2|||
164512119|NCT02998476|594245961|FG000|Overall Study|Death|45|||
164512120|NCT02998476|594245962|FG001|Overall Study|Death|2|||
164512121|NCT02998476|594245961|FG000|Overall Study|Other|6|||
164512122|NCT02998476|594245962|FG001|Overall Study|Other|1|||
164512123|NCT04855734|594245963|FG000|Overall Study|Lost to Follow-up|2|||
164512124|NCT04855734|594245964|FG001|Overall Study|Lost to Follow-up|2|||
164512125|NCT03832595|594245965|FG000|Overall Study|Death|142|||
164512126|NCT03832595|594245966|FG001|Overall Study|Death|130|||
164512127|NCT03832595|594245965|FG000|Overall Study|Medical management without dialysis|37|||
164512128|NCT03832595|594245966|FG001|Overall Study|Medical management without dialysis|1|||
164512129|NCT03277352|594245967|FG000|Overall Study|Study Terminated By Sponsor|2|||
164512130|NCT03277352|594245967|FG000|Overall Study|Withdrawal by Subject|4|||
164512131|NCT03277352|594245967|FG000|Overall Study|Death|4|||
164512132|NCT00344032|594245970|FG000|Overall Study|Adverse Event|0|||
164512133|NCT00344032|594245971|FG001|Overall Study|Adverse Event|1|||
164512134|NCT00344032|594245970|FG000|Overall Study|Withdrawal by Subject|6|||
164512135|NCT00344032|594245971|FG001|Overall Study|Withdrawal by Subject|2|||
164512136|NCT00344032|594245970|FG000|Overall Study|Lost to Follow-up|4|||
164512137|NCT00344032|594245971|FG001|Overall Study|Lost to Follow-up|6|||
164512138|NCT00344032|594245970|FG000|Overall Study|Physician Decision|4|||
164512139|NCT00344032|594245971|FG001|Overall Study|Physician Decision|1|||
164512140|NCT05131477|594245976|FG000|PART 1|Withdrawal by Subject|2|||
164512141|NCT05131477|594245977|FG001|PART 1|Withdrawal by Subject|9|||
164512142|NCT05131477|594245978|FG002|PART 1|Withdrawal by Subject|6|||
164512143|NCT05131477|594245979|FG003|PART 1|Withdrawal by Subject|2|||
164512144|NCT05131477|594245980|FG004|PART 1|Withdrawal by Subject|8|||
164512145|NCT05131477|594245981|FG005|PART 1|Withdrawal by Subject|0|||
164512146|NCT05131477|594245982|FG006|PART 1|Withdrawal by Subject|0|||
164512147|NCT05131477|594245983|FG007|PART 1|Withdrawal by Subject|0|||
164512148|NCT05131477|594245984|FG008|PART 1|Withdrawal by Subject|0|||
164512149|NCT05131477|594245985|FG009|PART 1|Withdrawal by Subject|0|||
164512150|NCT05131477|594245986|FG010|PART 1|Withdrawal by Subject|0|||
164512151|NCT05131477|594245987|FG011|PART 1|Withdrawal by Subject|0|||
164512152|NCT05131477|594245988|FG012|PART 1|Withdrawal by Subject|0|||
164512153|NCT05131477|594245989|FG013|PART 1|Withdrawal by Subject|0|||
164512154|NCT05131477|594245976|FG000|PART 1|Physician Decision|1|||
164512155|NCT05131477|594245977|FG001|PART 1|Physician Decision|0|||
164512156|NCT05131477|594245978|FG002|PART 1|Physician Decision|0|||
164512157|NCT05131477|594245979|FG003|PART 1|Physician Decision|0|||
164512158|NCT05131477|594245980|FG004|PART 1|Physician Decision|0|||
164512159|NCT05131477|594245981|FG005|PART 1|Physician Decision|0|||
164512160|NCT05131477|594245982|FG006|PART 1|Physician Decision|0|||
164512161|NCT05131477|594245983|FG007|PART 1|Physician Decision|0|||
164512162|NCT05131477|594245984|FG008|PART 1|Physician Decision|0|||
164512163|NCT05131477|594245985|FG009|PART 1|Physician Decision|0|||
164512164|NCT05131477|594245986|FG010|PART 1|Physician Decision|0|||
164512165|NCT05131477|594245987|FG011|PART 1|Physician Decision|0|||
164512166|NCT05131477|594245988|FG012|PART 1|Physician Decision|0|||
164512167|NCT05131477|594245989|FG013|PART 1|Physician Decision|0|||
164512168|NCT05131477|594245976|FG000|PART 1|Adverse Event|3|||
164512169|NCT05131477|594245977|FG001|PART 1|Adverse Event|5|||
164512170|NCT05131477|594245978|FG002|PART 1|Adverse Event|1|||
164512171|NCT05131477|594245979|FG003|PART 1|Adverse Event|6|||
164512172|NCT05131477|594245980|FG004|PART 1|Adverse Event|4|||
164512173|NCT05131477|594245981|FG005|PART 1|Adverse Event|0|||
164512174|NCT05131477|594245982|FG006|PART 1|Adverse Event|0|||
164512175|NCT05131477|594245983|FG007|PART 1|Adverse Event|0|||
164512176|NCT05131477|594245984|FG008|PART 1|Adverse Event|0|||
164512177|NCT05131477|594245985|FG009|PART 1|Adverse Event|0|||
164512178|NCT05131477|594245986|FG010|PART 1|Adverse Event|0|||
164512179|NCT05131477|594245987|FG011|PART 1|Adverse Event|0|||
164512180|NCT05131477|594245988|FG012|PART 1|Adverse Event|0|||
164512181|NCT05131477|594245989|FG013|PART 1|Adverse Event|0|||
164512182|NCT05131477|594245976|FG000|PART 1|unclassified|1|||
164512183|NCT05131477|594245977|FG001|PART 1|unclassified|1|||
164512184|NCT05131477|594245978|FG002|PART 1|unclassified|0|||
164512185|NCT05131477|594245979|FG003|PART 1|unclassified|0|||
164512186|NCT05131477|594245980|FG004|PART 1|unclassified|4|||
164512187|NCT05131477|594245981|FG005|PART 1|unclassified|0|||
164512188|NCT05131477|594245982|FG006|PART 1|unclassified|0|||
164512189|NCT05131477|594245983|FG007|PART 1|unclassified|0|||
164512190|NCT05131477|594245984|FG008|PART 1|unclassified|0|||
164512191|NCT05131477|594245985|FG009|PART 1|unclassified|0|||
164512192|NCT05131477|594245986|FG010|PART 1|unclassified|0|||
164512193|NCT05131477|594245987|FG011|PART 1|unclassified|0|||
164512194|NCT05131477|594245988|FG012|PART 1|unclassified|0|||
164512195|NCT05131477|594245989|FG013|PART 1|unclassified|0|||
164512196|NCT05131477|594245976|FG000|PART 1|Randomized and not treated|0|||
164512197|NCT05131477|594245977|FG001|PART 1|Randomized and not treated|0|||
164512198|NCT05131477|594245978|FG002|PART 1|Randomized and not treated|0|||
164512199|NCT05131477|594245979|FG003|PART 1|Randomized and not treated|1|||
164512200|NCT05131477|594245980|FG004|PART 1|Randomized and not treated|1|||
164512201|NCT05131477|594245981|FG005|PART 1|Randomized and not treated|0|||
164512202|NCT05131477|594245982|FG006|PART 1|Randomized and not treated|0|||
164512203|NCT05131477|594245983|FG007|PART 1|Randomized and not treated|0|||
164512204|NCT05131477|594245984|FG008|PART 1|Randomized and not treated|0|||
164512205|NCT05131477|594245985|FG009|PART 1|Randomized and not treated|0|||
164512206|NCT05131477|594245986|FG010|PART 1|Randomized and not treated|0|||
164512207|NCT05131477|594245987|FG011|PART 1|Randomized and not treated|0|||
164512208|NCT05131477|594245988|FG012|PART 1|Randomized and not treated|0|||
164512209|NCT05131477|594245989|FG013|PART 1|Randomized and not treated|0|||
164512210|NCT05131477|594245976|FG000|PART 1|Protocol Violation|2|||
164512211|NCT05131477|594245977|FG001|PART 1|Protocol Violation|0|||
164512212|NCT05131477|594245978|FG002|PART 1|Protocol Violation|0|||
164512213|NCT05131477|594245979|FG003|PART 1|Protocol Violation|1|||
164512214|NCT05131477|594245980|FG004|PART 1|Protocol Violation|0|||
164512215|NCT05131477|594245981|FG005|PART 1|Protocol Violation|0|||
164512216|NCT05131477|594245982|FG006|PART 1|Protocol Violation|0|||
164512217|NCT05131477|594245983|FG007|PART 1|Protocol Violation|0|||
164512218|NCT05131477|594245984|FG008|PART 1|Protocol Violation|0|||
164512219|NCT05131477|594245985|FG009|PART 1|Protocol Violation|0|||
164609684|NCT01313208|594591463|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
164609685|NCT01412060|594591465|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
164512220|NCT05131477|594245986|FG010|PART 1|Protocol Violation|0|||
164512221|NCT05131477|594245987|FG011|PART 1|Protocol Violation|0|||
164512222|NCT05131477|594245988|FG012|PART 1|Protocol Violation|0|||
164512223|NCT05131477|594245989|FG013|PART 1|Protocol Violation|0|||
164512224|NCT05131477|594245976|FG000|PART 1|Lack of Efficacy|0|||
164512225|NCT05131477|594245977|FG001|PART 1|Lack of Efficacy|1|||
164512226|NCT05131477|594245978|FG002|PART 1|Lack of Efficacy|1|||
164609686|NCT01412060|594591466|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
164609687|NCT01412060|594591467|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
164512227|NCT05131477|594245979|FG003|PART 1|Lack of Efficacy|2|||
164512228|NCT05131477|594245980|FG004|PART 1|Lack of Efficacy|5|||
164512229|NCT05131477|594245981|FG005|PART 1|Lack of Efficacy|0|||
164512230|NCT05131477|594245982|FG006|PART 1|Lack of Efficacy|0|||
164512231|NCT05131477|594245983|FG007|PART 1|Lack of Efficacy|0|||
164512232|NCT05131477|594245984|FG008|PART 1|Lack of Efficacy|0|||
164512233|NCT05131477|594245985|FG009|PART 1|Lack of Efficacy|0|||
164512234|NCT05131477|594245986|FG010|PART 1|Lack of Efficacy|0|||
164512235|NCT05131477|594245987|FG011|PART 1|Lack of Efficacy|0|||
164512236|NCT05131477|594245988|FG012|PART 1|Lack of Efficacy|0|||
164512237|NCT05131477|594245989|FG013|PART 1|Lack of Efficacy|0|||
164512238|NCT05131477|594245976|FG000|PART 2|Withdrawal by Subject|0|||
164512239|NCT05131477|594245977|FG001|PART 2|Withdrawal by Subject|0|||
164512240|NCT05131477|594245978|FG002|PART 2|Withdrawal by Subject|0|||
164512241|NCT05131477|594245979|FG003|PART 2|Withdrawal by Subject|0|||
164512242|NCT05131477|594245980|FG004|PART 2|Withdrawal by Subject|0|||
164512243|NCT05131477|594245981|FG005|PART 2|Withdrawal by Subject|0|||
164512244|NCT05131477|594245982|FG006|PART 2|Withdrawal by Subject|2|||
164512245|NCT05131477|594245983|FG007|PART 2|Withdrawal by Subject|0|||
164512246|NCT05131477|594245984|FG008|PART 2|Withdrawal by Subject|0|||
164512247|NCT05131477|594245985|FG009|PART 2|Withdrawal by Subject|0|||
164512248|NCT05131477|594245986|FG010|PART 2|Withdrawal by Subject|2|||
164512249|NCT05131477|594245987|FG011|PART 2|Withdrawal by Subject|0|||
164512250|NCT05131477|594245988|FG012|PART 2|Withdrawal by Subject|2|||
164512251|NCT05131477|594245989|FG013|PART 2|Withdrawal by Subject|2|||
164512252|NCT05131477|594245976|FG000|PART 2|Other|0|||
164512253|NCT05131477|594245977|FG001|PART 2|Other|0|||
164512254|NCT05131477|594245978|FG002|PART 2|Other|0|||
164512255|NCT05131477|594245979|FG003|PART 2|Other|0|||
164512256|NCT05131477|594245980|FG004|PART 2|Other|0|||
164512257|NCT05131477|594245981|FG005|PART 2|Other|0|||
164512258|NCT05131477|594245982|FG006|PART 2|Other|0|||
164512259|NCT05131477|594245983|FG007|PART 2|Other|0|||
164512260|NCT05131477|594245984|FG008|PART 2|Other|1|||
164512261|NCT05131477|594245985|FG009|PART 2|Other|1|||
164512262|NCT05131477|594245986|FG010|PART 2|Other|0|||
164512263|NCT05131477|594245987|FG011|PART 2|Other|0|||
164512264|NCT05131477|594245988|FG012|PART 2|Other|1|||
164512265|NCT05131477|594245989|FG013|PART 2|Other|0|||
164512266|NCT05131477|594245976|FG000|PART 2|Lack of Efficacy|0|||
164512267|NCT05131477|594245977|FG001|PART 2|Lack of Efficacy|0|||
164512268|NCT05131477|594245978|FG002|PART 2|Lack of Efficacy|0|||
164512269|NCT05131477|594245979|FG003|PART 2|Lack of Efficacy|0|||
164512270|NCT05131477|594245980|FG004|PART 2|Lack of Efficacy|0|||
164512271|NCT05131477|594245981|FG005|PART 2|Lack of Efficacy|1|||
164512272|NCT05131477|594245982|FG006|PART 2|Lack of Efficacy|1|||
164512273|NCT05131477|594245983|FG007|PART 2|Lack of Efficacy|0|||
164512274|NCT05131477|594245984|FG008|PART 2|Lack of Efficacy|3|||
164512275|NCT05131477|594245985|FG009|PART 2|Lack of Efficacy|0|||
164512276|NCT05131477|594245986|FG010|PART 2|Lack of Efficacy|1|||
164512277|NCT05131477|594245987|FG011|PART 2|Lack of Efficacy|0|||
164512278|NCT05131477|594245988|FG012|PART 2|Lack of Efficacy|2|||
164512279|NCT05131477|594245989|FG013|PART 2|Lack of Efficacy|0|||
164512280|NCT05131477|594245976|FG000|PART 2|Unclassified|0|||
164512281|NCT05131477|594245977|FG001|PART 2|Unclassified|0|||
164512282|NCT05131477|594245978|FG002|PART 2|Unclassified|0|||
164512283|NCT05131477|594245979|FG003|PART 2|Unclassified|0|||
164512284|NCT05131477|594245980|FG004|PART 2|Unclassified|0|||
164512285|NCT05131477|594245981|FG005|PART 2|Unclassified|0|||
164512286|NCT05131477|594245982|FG006|PART 2|Unclassified|0|||
164512287|NCT05131477|594245983|FG007|PART 2|Unclassified|0|||
164512288|NCT05131477|594245984|FG008|PART 2|Unclassified|0|||
164512289|NCT05131477|594245985|FG009|PART 2|Unclassified|0|||
164512290|NCT05131477|594245986|FG010|PART 2|Unclassified|1|||
164512291|NCT05131477|594245987|FG011|PART 2|Unclassified|0|||
164512292|NCT05131477|594245988|FG012|PART 2|Unclassified|0|||
164512293|NCT05131477|594245989|FG013|PART 2|Unclassified|0|||
164512294|NCT05131477|594245976|FG000|PART 2|Re-randomized and not treated|0|||
164512295|NCT05131477|594245977|FG001|PART 2|Re-randomized and not treated|0|||
164512296|NCT05131477|594245978|FG002|PART 2|Re-randomized and not treated|0|||
164512297|NCT05131477|594245979|FG003|PART 2|Re-randomized and not treated|0|||
164512298|NCT05131477|594245980|FG004|PART 2|Re-randomized and not treated|0|||
164512299|NCT05131477|594245981|FG005|PART 2|Re-randomized and not treated|0|||
164512300|NCT05131477|594245982|FG006|PART 2|Re-randomized and not treated|0|||
164512301|NCT05131477|594245983|FG007|PART 2|Re-randomized and not treated|1|||
164609688|NCT01412060|594591465|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
164609689|NCT01412060|594591466|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
164512302|NCT05131477|594245984|FG008|PART 2|Re-randomized and not treated|0|||
164609690|NCT01412060|594591467|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
164512303|NCT05131477|594245985|FG009|PART 2|Re-randomized and not treated|0|||
164512304|NCT05131477|594245986|FG010|PART 2|Re-randomized and not treated|1|||
164512305|NCT05131477|594245987|FG011|PART 2|Re-randomized and not treated|0|||
164512306|NCT05131477|594245988|FG012|PART 2|Re-randomized and not treated|1|||
164512307|NCT05131477|594245989|FG013|PART 2|Re-randomized and not treated|1|||
164512308|NCT03939689|594247877|FG000|Overall Study|Radiographic progression|14|||
164512309|NCT03939689|594247878|FG001|Overall Study|Radiographic progression|17|||
164512310|NCT03939689|594247877|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
164512311|NCT03939689|594247878|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
164512312|NCT03939689|594247877|FG000|Overall Study|Adverse Event|1|||
164512313|NCT03939689|594247878|FG001|Overall Study|Adverse Event|8|||
164512314|NCT03939689|594247877|FG000|Overall Study|Unequivocal clinical progression|2|||
164512315|NCT03939689|594247878|FG001|Overall Study|Unequivocal clinical progression|5|||
164512316|NCT03939689|594247877|FG000|Overall Study|Other|1|||
164512317|NCT03939689|594247878|FG001|Overall Study|Other|4|||
164512318|NCT03939689|594247877|FG000|Overall Study|Death|0|||
164512319|NCT03939689|594247878|FG001|Overall Study|Death|3|||
164512320|NCT03939689|594247877|FG000|Overall Study|Participant decision|0|||
164512321|NCT03939689|594247878|FG001|Overall Study|Participant decision|3|||
164512322|NCT03939689|594247877|FG000|Overall Study|Withdrawal of consent|2|||
164512323|NCT03939689|594247878|FG001|Overall Study|Withdrawal of consent|1|||
164512324|NCT03939689|594247877|FG000|Overall Study|Investigator decision|1|||
164512325|NCT03939689|594247878|FG001|Overall Study|Investigator decision|0|||
164512326|NCT01920477|594247879|FG000|Overall Study|Adverse Event|0|||
164512327|NCT01920477|594247880|FG001|Overall Study|Adverse Event|1|||
164512328|NCT01920477|594247879|FG000|Overall Study|Lack of Efficacy|1|||
164512329|NCT01920477|594247880|FG001|Overall Study|Lack of Efficacy|0|||
164512330|NCT01920477|594247879|FG000|Overall Study|Study closed/terminated|14|||
164512331|NCT01920477|594247880|FG001|Overall Study|Study closed/terminated|15|||
164512332|NCT01920477|594247879|FG000|Overall Study|Withdrawal by Subject|0|||
164512333|NCT01920477|594247880|FG001|Overall Study|Withdrawal by Subject|1|||
164512334|NCT03554629|594247881|FG000|Overall Study|Inadequate data|6|||
164512335|NCT01228318|594247882|FG000|Overall Study|Clinic no show to receive intervention|1|||
164512336|NCT01228318|594247883|FG001|Overall Study|Clinic no show to receive intervention|0|||
164512337|NCT01228318|594247882|FG000|Overall Study|Unable to contact|2|||
164512338|NCT01228318|594247883|FG001|Overall Study|Unable to contact|5|||
164512339|NCT01228318|594247882|FG000|Overall Study|Moved|0|||
164512340|NCT01228318|594247883|FG001|Overall Study|Moved|2|||
164512341|NCT01228318|594247882|FG000|Overall Study|Incarcerated|1|||
164512342|NCT01228318|594247883|FG001|Overall Study|Incarcerated|0|||
164512343|NCT05577715|594247890|FG000|Overall Study|Withdrawal by Subject|1|||
164512344|NCT05577715|594247890|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
164512345|NCT05577715|594247890|FG000|Overall Study|Lost to Follow-up|1|||
164512346|NCT05577715|594247890|FG000|Overall Study|Death|6|||
164512347|NCT02643303|594247897|FG000|Overall Study|Progressive Disease|4|||
164512348|NCT02643303|594247898|FG001|Overall Study|Progressive Disease|4|||
164512349|NCT02643303|594247899|FG002|Overall Study|Progressive Disease|1|||
164512350|NCT02643303|594247900|FG003|Overall Study|Progressive Disease|12|||
164512351|NCT02643303|594247901|FG004|Overall Study|Progressive Disease|6|||
164512352|NCT02643303|594247902|FG005|Overall Study|Progressive Disease|4|||
164512353|NCT02643303|594247903|FG006|Overall Study|Progressive Disease|8|||
164512354|NCT02643303|594247904|FG007|Overall Study|Progressive Disease|2|||
164512355|NCT02643303|594247905|FG008|Overall Study|Progressive Disease|6|||
164512356|NCT02643303|594247897|FG000|Overall Study|Adverse Event|0|||
164512357|NCT02643303|594247898|FG001|Overall Study|Adverse Event|1|||
164512358|NCT02643303|594247899|FG002|Overall Study|Adverse Event|0|||
164512359|NCT02643303|594247900|FG003|Overall Study|Adverse Event|0|||
164512360|NCT02643303|594247901|FG004|Overall Study|Adverse Event|1|||
164512361|NCT02643303|594247902|FG005|Overall Study|Adverse Event|0|||
164512362|NCT02643303|594247903|FG006|Overall Study|Adverse Event|0|||
164512363|NCT02643303|594247904|FG007|Overall Study|Adverse Event|0|||
164512364|NCT02643303|594247905|FG008|Overall Study|Adverse Event|0|||
164512365|NCT02643303|594247897|FG000|Overall Study|Withdrawal by Subject|0|||
164512366|NCT02643303|594247898|FG001|Overall Study|Withdrawal by Subject|0|||
164512367|NCT02643303|594247899|FG002|Overall Study|Withdrawal by Subject|0|||
164512368|NCT02643303|594247900|FG003|Overall Study|Withdrawal by Subject|1|||
164512369|NCT02643303|594247901|FG004|Overall Study|Withdrawal by Subject|0|||
164512370|NCT02643303|594247902|FG005|Overall Study|Withdrawal by Subject|0|||
164512371|NCT02643303|594247903|FG006|Overall Study|Withdrawal by Subject|1|||
164512372|NCT02643303|594247904|FG007|Overall Study|Withdrawal by Subject|1|||
164512373|NCT02643303|594247905|FG008|Overall Study|Withdrawal by Subject|1|||
164512374|NCT05282121|594247912|FG000|Overall Study|Adverse Event|1|||
164512375|NCT05282121|594247913|FG001|Overall Study|Adverse Event|1|||
164512376|NCT05282121|594247914|FG002|Overall Study|Adverse Event|4|||
164512377|NCT05282121|594247915|FG003|Overall Study|Adverse Event|1|||
164512378|NCT05282121|594247912|FG000|Overall Study|Study Terminated by Sponsor|1|||
164512379|NCT05282121|594247913|FG001|Overall Study|Study Terminated by Sponsor|2|||
164512380|NCT05282121|594247914|FG002|Overall Study|Study Terminated by Sponsor|2|||
164512381|NCT05282121|594247915|FG003|Overall Study|Study Terminated by Sponsor|2|||
164512382|NCT05282121|594247912|FG000|Overall Study|Other than listed|0|||
164609691|NCT01412060|594591465|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
164609692|NCT01412060|594591466|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
164609693|NCT01412060|594591467|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
164609694|NCT01412060|594591465|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
164609695|NCT01412060|594591466|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
164609696|NCT01412060|594591467|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
164609697|NCT01412060|594591465|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
164609698|NCT01412060|594591466|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
164609699|NCT01412060|594591467|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
164609700|NCT01412060|594591465|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
164512383|NCT05282121|594247913|FG001|Overall Study|Other than listed|0|||
164512384|NCT05282121|594247914|FG002|Overall Study|Other than listed|1|||
164512385|NCT05282121|594247915|FG003|Overall Study|Other than listed|0|||
164512386|NCT05282121|594247912|FG000|Overall Study|No reason available|0|||
164512387|NCT05282121|594247913|FG001|Overall Study|No reason available|0|||
164512388|NCT05282121|594247914|FG002|Overall Study|No reason available|1|||
164512389|NCT05282121|594247915|FG003|Overall Study|No reason available|0|||
164512390|NCT00847626|594247921|FG000|Overall Study|Adverse Event|10|||
164512391|NCT00847626|594247922|FG001|Overall Study|Adverse Event|10|||
164512392|NCT00847626|594247923|FG002|Overall Study|Adverse Event|6|||
164512393|NCT00847626|594247924|FG003|Overall Study|Adverse Event|19|||
164512394|NCT00847626|594247925|FG004|Overall Study|Adverse Event|11|||
164512395|NCT00847626|594247926|FG005|Overall Study|Adverse Event|22|||
164512396|NCT00847626|594247927|FG006|Overall Study|Adverse Event|4|||
164512397|NCT00847626|594247928|FG007|Overall Study|Adverse Event|6|||
164512398|NCT00847626|594247929|FG008|Overall Study|Adverse Event|3|||
164512399|NCT00847626|594247930|FG009|Overall Study|Adverse Event|6|||
164512400|NCT00847626|594247931|FG010|Overall Study|Adverse Event|6|||
164512401|NCT00847626|594247921|FG000|Overall Study|Protocol Violation|2|||
164512402|NCT00847626|594247922|FG001|Overall Study|Protocol Violation|1|||
164512403|NCT00847626|594247923|FG002|Overall Study|Protocol Violation|2|||
164512404|NCT00847626|594247924|FG003|Overall Study|Protocol Violation|1|||
164512405|NCT00847626|594247925|FG004|Overall Study|Protocol Violation|1|||
164512406|NCT00847626|594247926|FG005|Overall Study|Protocol Violation|1|||
164512407|NCT00847626|594247927|FG006|Overall Study|Protocol Violation|1|||
164512408|NCT00847626|594247928|FG007|Overall Study|Protocol Violation|1|||
164512409|NCT00847626|594247929|FG008|Overall Study|Protocol Violation|0|||
164512410|NCT00847626|594247930|FG009|Overall Study|Protocol Violation|1|||
164512411|NCT00847626|594247931|FG010|Overall Study|Protocol Violation|1|||
164512412|NCT00847626|594247921|FG000|Overall Study|Lost to Follow-up|0|||
164512413|NCT00847626|594247922|FG001|Overall Study|Lost to Follow-up|1|||
164512414|NCT00847626|594247923|FG002|Overall Study|Lost to Follow-up|1|||
164512415|NCT00847626|594247924|FG003|Overall Study|Lost to Follow-up|1|||
164512416|NCT00847626|594247925|FG004|Overall Study|Lost to Follow-up|0|||
164512417|NCT00847626|594247926|FG005|Overall Study|Lost to Follow-up|3|||
164512418|NCT00847626|594247927|FG006|Overall Study|Lost to Follow-up|1|||
164512419|NCT00847626|594247928|FG007|Overall Study|Lost to Follow-up|3|||
164512420|NCT00847626|594247929|FG008|Overall Study|Lost to Follow-up|1|||
164512421|NCT00847626|594247930|FG009|Overall Study|Lost to Follow-up|0|||
164512422|NCT00847626|594247931|FG010|Overall Study|Lost to Follow-up|1|||
164512423|NCT00847626|594247921|FG000|Overall Study|Withdrawal by Subject|5|||
164512424|NCT00847626|594247922|FG001|Overall Study|Withdrawal by Subject|5|||
164512425|NCT00847626|594247923|FG002|Overall Study|Withdrawal by Subject|3|||
164512426|NCT00847626|594247924|FG003|Overall Study|Withdrawal by Subject|8|||
164512427|NCT00847626|594247925|FG004|Overall Study|Withdrawal by Subject|12|||
164512428|NCT00847626|594247926|FG005|Overall Study|Withdrawal by Subject|9|||
164512429|NCT00847626|594247927|FG006|Overall Study|Withdrawal by Subject|8|||
164512430|NCT00847626|594247928|FG007|Overall Study|Withdrawal by Subject|4|||
164512431|NCT00847626|594247929|FG008|Overall Study|Withdrawal by Subject|4|||
164512432|NCT00847626|594247930|FG009|Overall Study|Withdrawal by Subject|5|||
164512433|NCT00847626|594247931|FG010|Overall Study|Withdrawal by Subject|2|||
164512434|NCT00847626|594247921|FG000|Overall Study|Lack of Efficacy|3|||
164512435|NCT00847626|594247922|FG001|Overall Study|Lack of Efficacy|1|||
164512436|NCT00847626|594247923|FG002|Overall Study|Lack of Efficacy|0|||
164512437|NCT00847626|594247924|FG003|Overall Study|Lack of Efficacy|1|||
164512438|NCT00847626|594247925|FG004|Overall Study|Lack of Efficacy|2|||
164512439|NCT00847626|594247926|FG005|Overall Study|Lack of Efficacy|0|||
164512440|NCT00847626|594247927|FG006|Overall Study|Lack of Efficacy|6|||
164512441|NCT00847626|594247928|FG007|Overall Study|Lack of Efficacy|2|||
164512442|NCT00847626|594247929|FG008|Overall Study|Lack of Efficacy|5|||
164512443|NCT00847626|594247930|FG009|Overall Study|Lack of Efficacy|1|||
164512444|NCT00847626|594247931|FG010|Overall Study|Lack of Efficacy|7|||
164609701|NCT01412060|594591466|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
164512445|NCT00847626|594247921|FG000|Overall Study|Other|1|||
164512446|NCT00847626|594247922|FG001|Overall Study|Other|5|||
164512447|NCT00847626|594247923|FG002|Overall Study|Other|4|||
164512448|NCT00847626|594247924|FG003|Overall Study|Other|1|||
164512449|NCT00847626|594247925|FG004|Overall Study|Other|2|||
164512450|NCT00847626|594247926|FG005|Overall Study|Other|2|||
164512451|NCT00847626|594247927|FG006|Overall Study|Other|2|||
164512452|NCT00847626|594247928|FG007|Overall Study|Other|3|||
164512453|NCT00847626|594247929|FG008|Overall Study|Other|1|||
164512454|NCT00847626|594247930|FG009|Overall Study|Other|1|||
164512455|NCT00847626|594247931|FG010|Overall Study|Other|3|||
164512456|NCT03301155|594247932|FG000|Overall Study|Сompliance with exclusion criteria|8|||
164512457|NCT03301155|594247933|FG001|Overall Study|Сompliance with exclusion criteria|7|||
164512458|NCT00384189|594247937|FG000|Overall Study|Reason Not Specified|50|||
164512459|NCT00384189|594247938|FG001|Overall Study|Reason Not Specified|57|||
164512460|NCT00384189|594247939|FG002|Overall Study|Reason Not Specified|58|||
164512461|NCT00384189|594247940|FG003|Overall Study|Reason Not Specified|40|||
164512462|NCT04958642|594247941|FG000|Overall Study|Transferred to OLEX program|3|||
164512463|NCT04958642|594247942|FG001|Overall Study|Transferred to OLEX program|0|||
164512464|NCT04958642|594247943|FG002|Overall Study|Transferred to OLEX program|5|||
164512465|NCT04958642|594247941|FG000|Overall Study|Death|0|||
164512466|NCT04958642|594247942|FG001|Overall Study|Death|0|||
164512467|NCT04958642|594247943|FG002|Overall Study|Death|1|||
164512468|NCT04958642|594247941|FG000|Overall Study|Withdrawal by Subject|4|||
164512469|NCT04958642|594247942|FG001|Overall Study|Withdrawal by Subject|9|||
164512470|NCT04958642|594247943|FG002|Overall Study|Withdrawal by Subject|13|||
164512471|NCT04958642|594247941|FG000|Overall Study|Investigator's Decision|0|||
164512472|NCT04958642|594247942|FG001|Overall Study|Investigator's Decision|0|||
164512473|NCT04958642|594247943|FG002|Overall Study|Investigator's Decision|1|||
164512474|NCT04958642|594247941|FG000|Overall Study|Adverse Event|1|||
164512475|NCT04958642|594247942|FG001|Overall Study|Adverse Event|0|||
164512476|NCT04958642|594247943|FG002|Overall Study|Adverse Event|1|||
164512477|NCT04958642|594247941|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
164512478|NCT04958642|594247942|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
164512479|NCT04958642|594247943|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
164512480|NCT04958642|594247941|FG000|Overall Study|Lost to Follow-up|1|||
164512481|NCT04958642|594247942|FG001|Overall Study|Lost to Follow-up|0|||
164512482|NCT04958642|594247943|FG002|Overall Study|Lost to Follow-up|0|||
164512483|NCT04958642|594247941|FG000|Overall Study|Transferred to EAP following study termination|0|||
164512484|NCT04958642|594247942|FG001|Overall Study|Transferred to EAP following study termination|0|||
164512485|NCT04958642|594247943|FG002|Overall Study|Transferred to EAP following study termination|1|||
164512486|NCT04958642|594247941|FG000|Overall Study|Transferred to Expanded Access Program|1|||
164512487|NCT04958642|594247942|FG001|Overall Study|Transferred to Expanded Access Program|0|||
164512488|NCT04958642|594247943|FG002|Overall Study|Transferred to Expanded Access Program|0|||
164512489|NCT02942004|594247944|FG000|Overall Study|Withdrawal by Subject|0|||
164512490|NCT02942004|594247945|FG001|Overall Study|Withdrawal by Subject|2|||
164512491|NCT02942004|594247946|FG002|Overall Study|Withdrawal by Subject|3|||
164512492|NCT02942004|594247944|FG000|Overall Study|Lost to Follow-up|1|||
164512493|NCT02942004|594247945|FG001|Overall Study|Lost to Follow-up|1|||
164512494|NCT02942004|594247946|FG002|Overall Study|Lost to Follow-up|2|||
164512495|NCT02942004|594247944|FG000|Overall Study|Randomized but not dosed|3|||
164512496|NCT02942004|594247945|FG001|Overall Study|Randomized but not dosed|9|||
164512497|NCT02942004|594247946|FG002|Overall Study|Randomized but not dosed|4|||
164512498|NCT05627258|594247947|FG000|Overall Study|Lost to Follow-up|1|||
164512499|NCT05627258|594247948|FG001|Overall Study|Lost to Follow-up|0|||
164512500|NCT05627258|594247949|FG002|Overall Study|Lost to Follow-up|0|||
164512501|NCT05627258|594247950|FG003|Overall Study|Lost to Follow-up|0|||
164512502|NCT05627258|594247951|FG004|Overall Study|Lost to Follow-up|0|||
164512503|NCT05627258|594247952|FG005|Overall Study|Lost to Follow-up|0|||
164512504|NCT05627258|594247947|FG000|Overall Study|Withdrawal by Subject|0|||
164512505|NCT05627258|594247948|FG001|Overall Study|Withdrawal by Subject|0|||
164512506|NCT05627258|594247949|FG002|Overall Study|Withdrawal by Subject|0|||
164512507|NCT05627258|594247950|FG003|Overall Study|Withdrawal by Subject|0|||
164512508|NCT05627258|594247951|FG004|Overall Study|Withdrawal by Subject|2|||
164512509|NCT05627258|594247952|FG005|Overall Study|Withdrawal by Subject|0|||
164512510|NCT05627258|594247947|FG000|Overall Study|Enrolled, but product not administered|1|||
164512511|NCT05627258|594247948|FG001|Overall Study|Enrolled, but product not administered|0|||
164512512|NCT05627258|594247949|FG002|Overall Study|Enrolled, but product not administered|0|||
164512513|NCT05627258|594247950|FG003|Overall Study|Enrolled, but product not administered|0|||
164512514|NCT05627258|594247951|FG004|Overall Study|Enrolled, but product not administered|0|||
164512515|NCT05627258|594247952|FG005|Overall Study|Enrolled, but product not administered|0|||
164512516|NCT05627258|594247947|FG000|Overall Study|Other subject illness/injury|1|||
164512517|NCT05627258|594247948|FG001|Overall Study|Other subject illness/injury|0|||
164512518|NCT05627258|594247949|FG002|Overall Study|Other subject illness/injury|0|||
164512519|NCT05627258|594247950|FG003|Overall Study|Other subject illness/injury|0|||
164512520|NCT05627258|594247951|FG004|Overall Study|Other subject illness/injury|0|||
164512521|NCT05627258|594247952|FG005|Overall Study|Other subject illness/injury|0|||
164512522|NCT05627258|594247947|FG000|Overall Study|Subject moved from area|0|||
164512523|NCT05627258|594247948|FG001|Overall Study|Subject moved from area|0|||
164609702|NCT01412060|594591467|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
164609703|NCT01412060|594591465|FG000|Period Between RIP and SP|Adverse Event|4|||
164609704|NCT01412060|594591466|FG001|Period Between RIP and SP|Adverse Event|0|||
164609705|NCT01412060|594591467|FG002|Period Between RIP and SP|Adverse Event|0|||
164512524|NCT05627258|594247949|FG002|Overall Study|Subject moved from area|1|||
164512525|NCT05627258|594247950|FG003|Overall Study|Subject moved from area|0|||
164512526|NCT05627258|594247951|FG004|Overall Study|Subject moved from area|0|||
164512527|NCT05627258|594247952|FG005|Overall Study|Subject moved from area|0|||
164512528|NCT04517669|594247953|FG000|Overall Study|Lost to Follow-up|2|||
164512529|NCT04517669|594247953|FG000|Overall Study|Withdrawal by Subject|3|||
164512530|NCT04517669|594247953|FG000|Overall Study|Drug withdrawn|44|||
164512531|NCT04517669|594247953|FG000|Overall Study|Other|1|||
164512532|NCT04517669|594247953|FG000|Overall Study|Eligibility criteria not met|4|||
164512533|NCT04517669|594247953|FG000|Overall Study|Did not receive treatment|3|||
164512534|NCT02138786|594247954|FG000|Overall Study|Adverse Event|0|||
164512535|NCT02138786|594247955|FG001|Overall Study|Adverse Event|2|||
164512536|NCT02138786|594247956|FG002|Overall Study|Adverse Event|1|||
164512537|NCT02138786|594247954|FG000|Overall Study|Death|1|||
164512538|NCT02138786|594247955|FG001|Overall Study|Death|7|||
164512539|NCT02138786|594247956|FG002|Overall Study|Death|2|||
164512540|NCT02138786|594247954|FG000|Overall Study|Disease Progression|1|||
164512541|NCT02138786|594247955|FG001|Overall Study|Disease Progression|1|||
164512542|NCT02138786|594247956|FG002|Overall Study|Disease Progression|3|||
164512543|NCT02138786|594247954|FG000|Overall Study|Withdrawal by Subject|1|||
164512544|NCT02138786|594247955|FG001|Overall Study|Withdrawal by Subject|2|||
164512545|NCT02138786|594247956|FG002|Overall Study|Withdrawal by Subject|0|||
164512546|NCT02138786|594247954|FG000|Overall Study|Patient's Wish|0|||
164512547|NCT02138786|594247955|FG001|Overall Study|Patient's Wish|2|||
164512548|NCT02138786|594247956|FG002|Overall Study|Patient's Wish|0|||
164512549|NCT02138786|594247954|FG000|Overall Study|Sponsor Terminated Study|0|||
164512550|NCT02138786|594247955|FG001|Overall Study|Sponsor Terminated Study|1|||
164512551|NCT02138786|594247956|FG002|Overall Study|Sponsor Terminated Study|1|||
164512552|NCT02138786|594247954|FG000|Overall Study|Non-Compliance|0|||
164512553|NCT02138786|594247955|FG001|Overall Study|Non-Compliance|0|||
164512554|NCT02138786|594247956|FG002|Overall Study|Non-Compliance|1|||
164512555|NCT01923662|594247957|FG000|Overall Study|Withdrawal by Subject|1|||
164512556|NCT01199068|594247958|FG000|Overall Study|Unacceptable toxicity|0|||
164512557|NCT01199068|594247959|FG001|Overall Study|Unacceptable toxicity|0|||
164512558|NCT01199068|594247960|FG002|Overall Study|Unacceptable toxicity|2|||
164512559|NCT01199068|594247958|FG000|Overall Study|Progressive disease|3|||
164512560|NCT01199068|594247959|FG001|Overall Study|Progressive disease|3|||
164512561|NCT01199068|594247960|FG002|Overall Study|Progressive disease|6|||
164512562|NCT01199068|594247958|FG000|Overall Study|Withdrawal by Subject|0|||
164512563|NCT01199068|594247959|FG001|Overall Study|Withdrawal by Subject|0|||
164512564|NCT01199068|594247960|FG002|Overall Study|Withdrawal by Subject|1|||
164512565|NCT02476175|594247961|FG000|Overall Study|Adverse Event|2|||
164512566|NCT05048238|594247967|FG000|Overall Study|Withdrawal by Subject|1|||
164512567|NCT01016262|594247970|FG000|Double-blind Phase|Adverse Event|0|||
164512568|NCT01016262|594247971|FG001|Double-blind Phase|Adverse Event|0|||
164512569|NCT01016262|594247972|FG002|Double-blind Phase|Adverse Event|1|||
164512570|NCT01016262|594247973|FG003|Double-blind Phase|Adverse Event|0|||
164512571|NCT01016262|594247974|FG004|Double-blind Phase|Adverse Event|0|||
164512572|NCT01016262|594247975|FG005|Double-blind Phase|Adverse Event|0|||
164512573|NCT01016262|594247970|FG000|Double-blind Phase|Lack of Efficacy|1|||
164512574|NCT01016262|594247971|FG001|Double-blind Phase|Lack of Efficacy|0|||
164512575|NCT01016262|594247972|FG002|Double-blind Phase|Lack of Efficacy|5|||
164512576|NCT01016262|594247973|FG003|Double-blind Phase|Lack of Efficacy|0|||
164512577|NCT01016262|594247974|FG004|Double-blind Phase|Lack of Efficacy|0|||
164512578|NCT01016262|594247975|FG005|Double-blind Phase|Lack of Efficacy|0|||
164512579|NCT01016262|594247970|FG000|Double-blind Phase|Disease Progression|0|||
164512580|NCT01016262|594247971|FG001|Double-blind Phase|Disease Progression|1|||
164512581|NCT01016262|594247972|FG002|Double-blind Phase|Disease Progression|2|||
164512582|NCT01016262|594247973|FG003|Double-blind Phase|Disease Progression|0|||
164512583|NCT01016262|594247974|FG004|Double-blind Phase|Disease Progression|0|||
164512584|NCT01016262|594247975|FG005|Double-blind Phase|Disease Progression|0|||
164512585|NCT01016262|594247970|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
164512586|NCT01016262|594247971|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
164512587|NCT01016262|594247972|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
164512588|NCT01016262|594247973|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
164512589|NCT01016262|594247974|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
164512590|NCT01016262|594247975|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
164512591|NCT01016262|594247970|FG000|Open-Label Phase|Adverse Event|0|||
164512592|NCT01016262|594247971|FG001|Open-Label Phase|Adverse Event|0|||
164512593|NCT01016262|594247972|FG002|Open-Label Phase|Adverse Event|0|||
164512594|NCT01016262|594247973|FG003|Open-Label Phase|Adverse Event|1|||
164512595|NCT01016262|594247974|FG004|Open-Label Phase|Adverse Event|0|||
164512596|NCT01016262|594247975|FG005|Open-Label Phase|Adverse Event|0|||
164512597|NCT01016262|594247970|FG000|Open-Label Phase|Lost to Follow-up|0|||
164512598|NCT01016262|594247971|FG001|Open-Label Phase|Lost to Follow-up|0|||
164512599|NCT01016262|594247972|FG002|Open-Label Phase|Lost to Follow-up|0|||
164512600|NCT01016262|594247973|FG003|Open-Label Phase|Lost to Follow-up|0|||
164512601|NCT01016262|594247974|FG004|Open-Label Phase|Lost to Follow-up|1|||
164512602|NCT01016262|594247975|FG005|Open-Label Phase|Lost to Follow-up|0|||
164512603|NCT01016262|594247970|FG000|Open-Label Phase|Lack of Efficacy|0|||
164512604|NCT01016262|594247971|FG001|Open-Label Phase|Lack of Efficacy|0|||
164512605|NCT01016262|594247972|FG002|Open-Label Phase|Lack of Efficacy|0|||
164512606|NCT01016262|594247973|FG003|Open-Label Phase|Lack of Efficacy|1|||
164512607|NCT01016262|594247974|FG004|Open-Label Phase|Lack of Efficacy|0|||
164512608|NCT01016262|594247975|FG005|Open-Label Phase|Lack of Efficacy|0|||
164512609|NCT01016262|594247970|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
164512610|NCT01016262|594247971|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
164512611|NCT01016262|594247972|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
164512612|NCT01016262|594247973|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
164512613|NCT01016262|594247974|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
164512614|NCT01016262|594247975|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
164512615|NCT01370655|594247977|FG000|Period 1|Adverse Event|2|||
164512616|NCT01370655|594247978|FG001|Period 1|Adverse Event|0|||
164512617|NCT01370655|594247979|FG002|Period 1|Adverse Event|0|||
164512618|NCT01370655|594247980|FG003|Period 1|Adverse Event|0|||
164512619|NCT01370655|594247981|FG004|Period 1|Adverse Event|0|||
164512620|NCT01370655|594247982|FG005|Period 1|Adverse Event|0|||
164512621|NCT01370655|594247983|FG006|Period 1|Adverse Event|1|||
164512622|NCT01370655|594247984|FG007|Period 1|Adverse Event|0|||
164512623|NCT01370655|594247985|FG008|Period 1|Adverse Event|0|||
164609706|NCT01412060|594591465|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
164609707|NCT01412060|594591466|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
164512624|NCT01370655|594247986|FG009|Period 1|Adverse Event|0|||
164609708|NCT01412060|594591467|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
164609709|NCT01412060|594591465|FG000|Period Between RIP and SP|Protocol Violation|2|||
164609710|NCT01412060|594591466|FG001|Period Between RIP and SP|Protocol Violation|0|||
164609711|NCT01412060|594591467|FG002|Period Between RIP and SP|Protocol Violation|0|||
164609712|NCT01412060|594591465|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
164609713|NCT01412060|594591466|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
164609714|NCT01412060|594591467|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
164609715|NCT01412060|594591465|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
164609716|NCT01412060|594591466|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
164609717|NCT01412060|594591467|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
164609718|NCT01412060|594591465|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
164609719|NCT01412060|594591466|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
164609720|NCT01412060|594591467|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
164609721|NCT01412060|594591465|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
164609722|NCT01412060|594591466|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
164609723|NCT01412060|594591467|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
164609724|NCT01412060|594591465|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
164512625|NCT01370655|594247987|FG010|Period 1|Adverse Event|0|||
164512626|NCT01370655|594247988|FG011|Period 1|Adverse Event|0|||
164512627|NCT01370655|594247977|FG000|Period 2|Adverse Event|0|||
164512628|NCT01370655|594247978|FG001|Period 2|Adverse Event|0|||
164512629|NCT01370655|594247979|FG002|Period 2|Adverse Event|1|||
164512630|NCT01370655|594247980|FG003|Period 2|Adverse Event|0|||
164512631|NCT01370655|594247981|FG004|Period 2|Adverse Event|1|||
164512632|NCT01370655|594247982|FG005|Period 2|Adverse Event|0|||
164512633|NCT01370655|594247983|FG006|Period 2|Adverse Event|0|||
164512634|NCT01370655|594247984|FG007|Period 2|Adverse Event|1|||
164512635|NCT01370655|594247985|FG008|Period 2|Adverse Event|0|||
164609725|NCT01412060|594591466|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
164609726|NCT01412060|594591467|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
164512636|NCT01370655|594247986|FG009|Period 2|Adverse Event|0|||
164512637|NCT01370655|594247987|FG010|Period 2|Adverse Event|0|||
164512638|NCT01370655|594247988|FG011|Period 2|Adverse Event|0|||
164512639|NCT01370655|594247977|FG000|Period 2|met protocol specified stopping criteria|0|||
164512640|NCT01370655|594247978|FG001|Period 2|met protocol specified stopping criteria|0|||
164512641|NCT01370655|594247979|FG002|Period 2|met protocol specified stopping criteria|1|||
164512642|NCT01370655|594247980|FG003|Period 2|met protocol specified stopping criteria|0|||
164512643|NCT01370655|594247981|FG004|Period 2|met protocol specified stopping criteria|0|||
164512644|NCT01370655|594247982|FG005|Period 2|met protocol specified stopping criteria|0|||
164512645|NCT01370655|594247983|FG006|Period 2|met protocol specified stopping criteria|1|||
164512646|NCT01370655|594247984|FG007|Period 2|met protocol specified stopping criteria|0|||
164512647|NCT01370655|594247985|FG008|Period 2|met protocol specified stopping criteria|1|||
164512648|NCT01370655|594247986|FG009|Period 2|met protocol specified stopping criteria|0|||
164512649|NCT01370655|594247987|FG010|Period 2|met protocol specified stopping criteria|1|||
164512650|NCT01370655|594247988|FG011|Period 2|met protocol specified stopping criteria|0|||
164512651|NCT01370655|594247977|FG000|Period 2|Withdrawal by Subject|0|||
164512652|NCT01370655|594247978|FG001|Period 2|Withdrawal by Subject|0|||
164512653|NCT01370655|594247979|FG002|Period 2|Withdrawal by Subject|0|||
164512654|NCT01370655|594247980|FG003|Period 2|Withdrawal by Subject|0|||
164512655|NCT01370655|594247981|FG004|Period 2|Withdrawal by Subject|0|||
164512656|NCT01370655|594247982|FG005|Period 2|Withdrawal by Subject|0|||
164512657|NCT01370655|594247983|FG006|Period 2|Withdrawal by Subject|0|||
164512658|NCT01370655|594247984|FG007|Period 2|Withdrawal by Subject|0|||
164512659|NCT01370655|594247985|FG008|Period 2|Withdrawal by Subject|1|||
164512660|NCT01370655|594247986|FG009|Period 2|Withdrawal by Subject|0|||
164512661|NCT01370655|594247987|FG010|Period 2|Withdrawal by Subject|0|||
164512662|NCT01370655|594247988|FG011|Period 2|Withdrawal by Subject|0|||
164512663|NCT02922023|594247989|FG000|Overall Study|Lost to Follow-up|2|||
164512664|NCT02922023|594247990|FG001|Overall Study|Lost to Follow-up|0|||
164512665|NCT01125046|594247991|FG000|First 6 Months of Treatment|Death|1|||
164512666|NCT01125046|594247991|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
164512667|NCT01125046|594247991|FG000|First 6 Months of Treatment|Non-compliance|1|||
164512668|NCT01125046|594247991|FG000|First 6 Months of Treatment|Surgery|1|||
164512669|NCT01125046|594247991|FG000|First 6 Months of Treatment|Progressive Disease|7|||
164512670|NCT01125046|594247991|FG000|First 6 Months of Treatment|Adverse Event|2|||
164512671|NCT01125046|594247991|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
164512672|NCT01125046|594247991|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
164512673|NCT01125046|594247991|FG000|Follow-up/Data Cut Off Point|Death|29|||
164512674|NCT01125046|594247991|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
164512675|NCT02766777|594247995|FG000|Overall Study|Adverse Event|12|||
164512676|NCT02766777|594247995|FG000|Overall Study|Lost to Follow-up|16|||
164512677|NCT02766777|594247995|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164512678|NCT02766777|594247995|FG000|Overall Study|Protocol Violation|1|||
164512679|NCT02766777|594247995|FG000|Overall Study|Withdrawal by Subject|4|||
164512680|NCT01886287|594247996|FG000|Overall Study|Radiographic disease progression|1|||
164512681|NCT01886287|594247996|FG000|Overall Study|Clinical progression due to disease|1|||
164512682|NCT03080493|594247997|FG000|Overall Study|Did not provide NRS pain results|1|||
164512683|NCT03080493|594247998|FG001|Overall Study|Did not provide NRS pain results|0|||
164512684|NCT03080493|594247997|FG000|Overall Study|Adverse Event|0|||
164512685|NCT03080493|594247998|FG001|Overall Study|Adverse Event|1|||
164512686|NCT03080493|594247997|FG000|Overall Study|Randomization error (parity group)|0|||
164512687|NCT03080493|594247998|FG001|Overall Study|Randomization error (parity group)|1|||
164512688|NCT01304498|594247999|FG000|Overall Study|Adverse Event|1|||
164512689|NCT01304498|594248000|FG001|Overall Study|Adverse Event|1|||
164512690|NCT01304498|594247999|FG000|Overall Study|Withdrawal by Subject|2|||
164512691|NCT01304498|594248000|FG001|Overall Study|Withdrawal by Subject|3|||
164512692|NCT01304498|594247999|FG000|Overall Study|Protocol Violation|1|||
164512693|NCT01304498|594248000|FG001|Overall Study|Protocol Violation|0|||
164512694|NCT01304498|594247999|FG000|Overall Study|Lost to Follow-up|2|||
164512695|NCT01304498|594248000|FG001|Overall Study|Lost to Follow-up|1|||
164512696|NCT03325777|594248001|FG000|Overall Study|Lost to Follow-up|9|||
164512697|NCT03325777|594248002|FG001|Overall Study|Lost to Follow-up|12|||
164512698|NCT01371825|594248006|FG000|Overall Study|Death|4|||
164512699|NCT00895895|594248007|FG000|Period 1|Adverse Event|7|||
164512700|NCT00895895|594248008|FG001|Period 1|Adverse Event|6|||
164512701|NCT00895895|594248009|FG002|Period 1|Adverse Event|4|||
164512702|NCT00895895|594248010|FG003|Period 1|Adverse Event|6|||
164512703|NCT00895895|594248011|FG004|Period 1|Adverse Event|7|||
164512704|NCT00895895|594248007|FG000|Period 1|Death|0|||
164512705|NCT00895895|594248008|FG001|Period 1|Death|0|||
164512706|NCT00895895|594248009|FG002|Period 1|Death|0|||
164512707|NCT00895895|594248010|FG003|Period 1|Death|0|||
164512708|NCT00895895|594248011|FG004|Period 1|Death|1|||
164512709|NCT00895895|594248007|FG000|Period 1|discontinued by sponsor|2|||
164512710|NCT00895895|594248008|FG001|Period 1|discontinued by sponsor|1|||
164512711|NCT00895895|594248009|FG002|Period 1|discontinued by sponsor|2|||
164512712|NCT00895895|594248010|FG003|Period 1|discontinued by sponsor|1|||
164512713|NCT00895895|594248011|FG004|Period 1|discontinued by sponsor|1|||
164512714|NCT00895895|594248007|FG000|Period 1|failed to return|0|||
164512715|NCT00895895|594248008|FG001|Period 1|failed to return|0|||
164512716|NCT00895895|594248009|FG002|Period 1|failed to return|1|||
164512717|NCT00895895|594248010|FG003|Period 1|failed to return|0|||
164512718|NCT00895895|594248011|FG004|Period 1|failed to return|1|||
164512719|NCT00895895|594248007|FG000|Period 1|investigator request|0|||
164512720|NCT00895895|594248008|FG001|Period 1|investigator request|1|||
164512721|NCT00895895|594248009|FG002|Period 1|investigator request|0|||
164512722|NCT00895895|594248010|FG003|Period 1|investigator request|0|||
164512723|NCT00895895|594248011|FG004|Period 1|investigator request|0|||
164512724|NCT00895895|594248007|FG000|Period 1|Lost to Follow-up|2|||
164512725|NCT00895895|594248008|FG001|Period 1|Lost to Follow-up|1|||
164512726|NCT00895895|594248009|FG002|Period 1|Lost to Follow-up|3|||
164512727|NCT00895895|594248010|FG003|Period 1|Lost to Follow-up|2|||
164512728|NCT00895895|594248011|FG004|Period 1|Lost to Follow-up|3|||
164512729|NCT00895895|594248007|FG000|Period 1|Other|1|||
164512730|NCT00895895|594248008|FG001|Period 1|Other|2|||
164512731|NCT00895895|594248009|FG002|Period 1|Other|1|||
164512732|NCT00895895|594248010|FG003|Period 1|Other|1|||
164512733|NCT00895895|594248011|FG004|Period 1|Other|1|||
164512734|NCT00895895|594248007|FG000|Period 1|Protocol Violation|0|||
164512735|NCT00895895|594248008|FG001|Period 1|Protocol Violation|1|||
164512736|NCT00895895|594248009|FG002|Period 1|Protocol Violation|0|||
164512737|NCT00895895|594248010|FG003|Period 1|Protocol Violation|0|||
164512738|NCT00895895|594248011|FG004|Period 1|Protocol Violation|0|||
164512739|NCT00895895|594248007|FG000|Period 1|Withdrawal by Subject|6|||
164512740|NCT00895895|594248008|FG001|Period 1|Withdrawal by Subject|6|||
164512741|NCT00895895|594248009|FG002|Period 1|Withdrawal by Subject|8|||
164512742|NCT00895895|594248010|FG003|Period 1|Withdrawal by Subject|2|||
164512743|NCT00895895|594248011|FG004|Period 1|Withdrawal by Subject|4|||
164512744|NCT00895895|594248007|FG000|Period 1|unsatisfactory response-efficacy|2|||
164512745|NCT00895895|594248008|FG001|Period 1|unsatisfactory response-efficacy|0|||
164512746|NCT00895895|594248009|FG002|Period 1|unsatisfactory response-efficacy|0|||
164512747|NCT00895895|594248010|FG003|Period 1|unsatisfactory response-efficacy|0|||
164512748|NCT00895895|594248011|FG004|Period 1|unsatisfactory response-efficacy|0|||
164512749|NCT00895895|594248007|FG000|Period 1|randomized and not treated|1|||
164512750|NCT00895895|594248008|FG001|Period 1|randomized and not treated|3|||
164512751|NCT00895895|594248009|FG002|Period 1|randomized and not treated|1|||
164512752|NCT00895895|594248010|FG003|Period 1|randomized and not treated|1|||
164512753|NCT00895895|594248011|FG004|Period 1|randomized and not treated|2|||
164512754|NCT00895895|594248007|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
164512755|NCT00895895|594248008|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
164512756|NCT00895895|594248009|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
164512757|NCT00895895|594248010|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
164512758|NCT00895895|594248011|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
164512759|NCT00895895|594248007|FG000|After Period 1, Prior to Period 2|Other|0|||
164512760|NCT00895895|594248008|FG001|After Period 1, Prior to Period 2|Other|0|||
164512761|NCT00895895|594248009|FG002|After Period 1, Prior to Period 2|Other|1|||
164512762|NCT00895895|594248010|FG003|After Period 1, Prior to Period 2|Other|0|||
164512763|NCT00895895|594248011|FG004|After Period 1, Prior to Period 2|Other|0|||
164512764|NCT00895895|594248007|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
164512765|NCT00895895|594248008|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
164512766|NCT00895895|594248009|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
164512767|NCT00895895|594248010|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
164512768|NCT00895895|594248011|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
164512769|NCT00895895|594248007|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
164512770|NCT00895895|594248008|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
164512771|NCT00895895|594248009|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
164512772|NCT00895895|594248010|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
164512773|NCT00895895|594248011|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
164512774|NCT00895895|594248007|FG000|Period 2|Adverse Event|3|||
164512775|NCT00895895|594248008|FG001|Period 2|Adverse Event|3|||
164512776|NCT00895895|594248009|FG002|Period 2|Adverse Event|5|||
164512777|NCT00895895|594248010|FG003|Period 2|Adverse Event|2|||
164512778|NCT00895895|594248011|FG004|Period 2|Adverse Event|5|||
164512779|NCT00895895|594248007|FG000|Period 2|Death|0|||
164512780|NCT00895895|594248008|FG001|Period 2|Death|0|||
164512781|NCT00895895|594248009|FG002|Period 2|Death|1|||
164512782|NCT00895895|594248010|FG003|Period 2|Death|0|||
164512783|NCT00895895|594248011|FG004|Period 2|Death|0|||
164512784|NCT00895895|594248007|FG000|Period 2|discontinued by sponsor|44|||
164512785|NCT00895895|594248008|FG001|Period 2|discontinued by sponsor|44|||
164512786|NCT00895895|594248009|FG002|Period 2|discontinued by sponsor|38|||
164512787|NCT00895895|594248010|FG003|Period 2|discontinued by sponsor|46|||
164512788|NCT00895895|594248011|FG004|Period 2|discontinued by sponsor|37|||
164512789|NCT00895895|594248007|FG000|Period 2|failed to return|2|||
164512790|NCT00895895|594248008|FG001|Period 2|failed to return|0|||
164512791|NCT00895895|594248009|FG002|Period 2|failed to return|0|||
164512792|NCT00895895|594248010|FG003|Period 2|failed to return|0|||
164512793|NCT00895895|594248011|FG004|Period 2|failed to return|0|||
164512794|NCT00895895|594248007|FG000|Period 2|investigator request|2|||
164512795|NCT00895895|594248008|FG001|Period 2|investigator request|0|||
164512796|NCT00895895|594248009|FG002|Period 2|investigator request|0|||
164512797|NCT00895895|594248010|FG003|Period 2|investigator request|0|||
164512798|NCT00895895|594248011|FG004|Period 2|investigator request|0|||
164512799|NCT00895895|594248007|FG000|Period 2|Lost to Follow-up|1|||
164512800|NCT00895895|594248008|FG001|Period 2|Lost to Follow-up|2|||
164512801|NCT00895895|594248009|FG002|Period 2|Lost to Follow-up|1|||
164512802|NCT00895895|594248010|FG003|Period 2|Lost to Follow-up|1|||
164512803|NCT00895895|594248011|FG004|Period 2|Lost to Follow-up|0|||
164512804|NCT00895895|594248007|FG000|Period 2|Other|1|||
164512805|NCT00895895|594248008|FG001|Period 2|Other|1|||
164512806|NCT00895895|594248009|FG002|Period 2|Other|3|||
164512807|NCT00895895|594248010|FG003|Period 2|Other|1|||
164512808|NCT00895895|594248011|FG004|Period 2|Other|1|||
164512809|NCT00895895|594248007|FG000|Period 2|Protocol Violation|1|||
164512810|NCT00895895|594248008|FG001|Period 2|Protocol Violation|0|||
164512811|NCT00895895|594248009|FG002|Period 2|Protocol Violation|1|||
164512812|NCT00895895|594248010|FG003|Period 2|Protocol Violation|1|||
164512813|NCT00895895|594248011|FG004|Period 2|Protocol Violation|1|||
164512814|NCT00895895|594248007|FG000|Period 2|Withdrawal by Subject|0|||
164512815|NCT00895895|594248008|FG001|Period 2|Withdrawal by Subject|2|||
164512816|NCT00895895|594248009|FG002|Period 2|Withdrawal by Subject|0|||
164512817|NCT00895895|594248010|FG003|Period 2|Withdrawal by Subject|3|||
164512818|NCT00895895|594248011|FG004|Period 2|Withdrawal by Subject|5|||
164512819|NCT00895895|594248007|FG000|Period 2|unsatisfactory response-efficacy|2|||
164512820|NCT00895895|594248008|FG001|Period 2|unsatisfactory response-efficacy|1|||
164512821|NCT00895895|594248009|FG002|Period 2|unsatisfactory response-efficacy|0|||
164512822|NCT00895895|594248010|FG003|Period 2|unsatisfactory response-efficacy|0|||
164512823|NCT00895895|594248011|FG004|Period 2|unsatisfactory response-efficacy|0|||
164512824|NCT01261000|594248012|FG000|Overall Study|Screen failure|1|||
164512825|NCT03019640|594248013|FG000|Overall Study|Screen Failures|4|||
164512826|NCT03019640|594248013|FG000|Overall Study|Adverse Event|3|||
164512827|NCT03019640|594248013|FG000|Overall Study|Participant Relapsed|1|||
164512828|NCT01721954|594248014|FG000|Overall Study|Death|58|||
164512829|NCT01721954|594248015|FG001|Overall Study|Death|64|||
164512830|NCT01721954|594248014|FG000|Overall Study|Withdrawal by Subject|8|||
164512831|NCT01721954|594248015|FG001|Overall Study|Withdrawal by Subject|4|||
164512832|NCT01721954|594248014|FG000|Overall Study|Adverse Event|2|||
164512833|NCT01721954|594248015|FG001|Overall Study|Adverse Event|0|||
164512834|NCT01721954|594248014|FG000|Overall Study|Lost to Follow-up|2|||
164512835|NCT01721954|594248015|FG001|Overall Study|Lost to Follow-up|1|||
164512836|NCT01195623|594248016|FG000|Overall Study|Lost to Follow-up|35|||
164512837|NCT01195623|594248017|FG001|Overall Study|Lost to Follow-up|37|||
164512838|NCT00534495|594248018|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
164512839|NCT00534495|594248019|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
164512840|NCT00534495|594248020|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
164512841|NCT00534495|594248018|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
164512842|NCT00534495|594248019|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
164512843|NCT00534495|594248020|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
164512844|NCT00534495|594248018|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
164512845|NCT00534495|594248019|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
164512846|NCT00534495|594248020|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
164512847|NCT00534495|594248018|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
164512848|NCT00534495|594248019|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
164512849|NCT00534495|594248020|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
164512850|NCT00534495|594248018|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
164512851|NCT00534495|594248019|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
164512852|NCT00534495|594248020|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
164512853|NCT00534495|594248018|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
164512854|NCT00534495|594248019|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
164512855|NCT00534495|594248020|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
164512856|NCT00534495|594248018|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
164512857|NCT00534495|594248019|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
164512858|NCT00534495|594248020|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
164512859|NCT00534495|594248018|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
164512860|NCT00534495|594248019|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
164512861|NCT00534495|594248020|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
164512862|NCT00534495|594248018|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
164512863|NCT00534495|594248019|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
164512864|NCT00534495|594248020|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
164512865|NCT02920970|594248024|FG000|First Intervention|Protocol Violation|0|||
164512866|NCT02920970|594248025|FG001|First Intervention|Protocol Violation|1|||
164512867|NCT02920970|594248024|FG000|First Intervention|Adverse Event|0|||
164512868|NCT02920970|594248025|FG001|First Intervention|Adverse Event|1|||
164512869|NCT02920970|594248024|FG000|Second Intervention|Poor Lens Fit|1|||
164512870|NCT02920970|594248025|FG001|Second Intervention|Poor Lens Fit|0|||
164512871|NCT01711853|594248026|FG000|Overall Study|Not treated|3|||
164512872|NCT00108745|594248029|FG000|Overall Study|Withdrawal by Subject|19|||
164512873|NCT00108745|594248030|FG001|Overall Study|Withdrawal by Subject|12|||
164512874|NCT00108745|594248031|FG002|Overall Study|Withdrawal by Subject|12|||
164512875|NCT00108745|594248029|FG000|Overall Study|Never Treated|8|||
164512876|NCT00108745|594248030|FG001|Overall Study|Never Treated|10|||
164512877|NCT00108745|594248031|FG002|Overall Study|Never Treated|12|||
164512878|NCT00108745|594248029|FG000|Overall Study|Ineligible|7|||
164512879|NCT00108745|594248030|FG001|Overall Study|Ineligible|13|||
164512880|NCT00108745|594248031|FG002|Overall Study|Ineligible|13|||
164512881|NCT01889069|594248032|FG000|Overall Study|Death|18|||
164512882|NCT01889069|594248032|FG000|Overall Study|Progression of Disease|14|||
164512883|NCT01889069|594248032|FG000|Overall Study|Lost to Follow-up|6|||
164512884|NCT01889069|594248032|FG000|Overall Study|Other|4|||
164512885|NCT01889069|594248032|FG000|Overall Study|Consent Withdrawal|3|||
164512886|NCT04978090|594248034|FG000|Overall Study|unable to adequately fit device|2|||
164512887|NCT01509547|594248037|FG000|Overall Study|Lost to Follow-up|24|||
164512888|NCT01509547|594248038|FG001|Overall Study|Lost to Follow-up|14|||
164512889|NCT01509547|594248037|FG000|Overall Study|Withdrawal by Subject|11|||
164512890|NCT01509547|594248038|FG001|Overall Study|Withdrawal by Subject|24|||
164512891|NCT01509547|594248037|FG000|Overall Study|Physician Decision|0|||
164512892|NCT01509547|594248038|FG001|Overall Study|Physician Decision|1|||
164512893|NCT01371708|594248043|FG000|Overall Study|Insufficient clinical response|3|||
164512894|NCT01371708|594248044|FG001|Overall Study|Insufficient clinical response|2|||
164512895|NCT01371708|594248045|FG002|Overall Study|Insufficient clinical response|0|||
164512896|NCT01371708|594248043|FG000|Overall Study|Lost to Follow-up|5|||
164512897|NCT01371708|594248044|FG001|Overall Study|Lost to Follow-up|9|||
164512898|NCT01371708|594248045|FG002|Overall Study|Lost to Follow-up|7|||
164512899|NCT01371708|594248043|FG000|Overall Study|Protocol Violation|2|||
164512900|NCT01371708|594248044|FG001|Overall Study|Protocol Violation|1|||
164512901|NCT01371708|594248045|FG002|Overall Study|Protocol Violation|2|||
164512902|NCT01371708|594248043|FG000|Overall Study|No longer willing to participate|7|||
164512903|NCT01371708|594248044|FG001|Overall Study|No longer willing to participate|7|||
164512904|NCT01371708|594248045|FG002|Overall Study|No longer willing to participate|13|||
164512905|NCT01371708|594248043|FG000|Overall Study|Medication error/not related to AE|0|||
164512906|NCT01371708|594248044|FG001|Overall Study|Medication error/not related to AE|1|||
164512907|NCT01371708|594248045|FG002|Overall Study|Medication error/not related to AE|0|||
164512908|NCT01371708|594248043|FG000|Overall Study|Other|3|||
164512909|NCT01371708|594248044|FG001|Overall Study|Other|2|||
164512910|NCT01371708|594248045|FG002|Overall Study|Other|4|||
164512911|NCT01371708|594248043|FG000|Overall Study|Adverse Event|5|||
164512912|NCT01371708|594248044|FG001|Overall Study|Adverse Event|8|||
164512913|NCT01371708|594248045|FG002|Overall Study|Adverse Event|12|||
164512914|NCT01371708|594248043|FG000|Overall Study|Started but did not receive treatment|1|||
164512915|NCT01371708|594248044|FG001|Overall Study|Started but did not receive treatment|0|||
164512916|NCT01371708|594248045|FG002|Overall Study|Started but did not receive treatment|1|||
164512917|NCT02514551|594248046|FG000|Overall Study|Lost to Follow-up|0|||
164512918|NCT02514551|594248047|FG001|Overall Study|Lost to Follow-up|1|||
164512919|NCT02514551|594248046|FG000|Overall Study|Participant Never Treated|0|||
164512920|NCT02514551|594248047|FG001|Overall Study|Participant Never Treated|2|||
164512921|NCT00996606|594248058|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
164512922|NCT00996606|594248058|FG000|Overall Study|Insufficient Therapeutic Response|2|||
164512923|NCT00996606|594248058|FG000|Overall Study|Protocol Violation|1|||
164512924|NCT00996606|594248058|FG000|Overall Study|Withdrawal by Subject|3|||
164512925|NCT03197766|594248059|FG000|Overall Study|Withdrawal by Subject|2|||
164512926|NCT03197766|594248060|FG001|Overall Study|Withdrawal by Subject|0|||
164512927|NCT00632502|594248065|FG000|Overall Study|Adverse Event|0|||
164512928|NCT00632502|594248066|FG001|Overall Study|Adverse Event|1|||
164512929|NCT00632502|594248065|FG000|Overall Study|Randomized not treated|3|||
164512930|NCT00632502|594248066|FG001|Overall Study|Randomized not treated|0|||
164512931|NCT00350727|594248069|FG000|Phase I: Dose Escalation|Adverse Event|4|||
164512932|NCT00350727|594248070|FG001|Phase I: Dose Escalation|Adverse Event|0|||
164512933|NCT00350727|594248071|FG002|Phase I: Dose Escalation|Adverse Event|0|||
164512934|NCT00350727|594248069|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
164512935|NCT00350727|594248070|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
164512936|NCT00350727|594248071|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
164512937|NCT00350727|594248069|FG000|Phase I: Dose Escalation|Death|1|||
164512938|NCT00350727|594248070|FG001|Phase I: Dose Escalation|Death|0|||
164512939|NCT00350727|594248071|FG002|Phase I: Dose Escalation|Death|0|||
164512940|NCT00350727|594248069|FG000|Phase I: Dose Escalation|Physician Decision|1|||
164512941|NCT00350727|594248070|FG001|Phase I: Dose Escalation|Physician Decision|0|||
164512942|NCT00350727|594248071|FG002|Phase I: Dose Escalation|Physician Decision|0|||
164512943|NCT00350727|594248069|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
164512944|NCT00350727|594248070|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
164512945|NCT00350727|594248071|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
164512946|NCT00350727|594248069|FG000|Phase II|Disease Progression|0|||
164512947|NCT00350727|594248070|FG001|Phase II|Disease Progression|15|||
164512948|NCT00350727|594248071|FG002|Phase II|Disease Progression|16|||
164512949|NCT00350727|594248069|FG000|Phase II|Clinical Deterioration|0|||
164512950|NCT00350727|594248070|FG001|Phase II|Clinical Deterioration|1|||
164512951|NCT00350727|594248071|FG002|Phase II|Clinical Deterioration|0|||
164512952|NCT00350727|594248069|FG000|Phase II|Withdrawal by Subject|0|||
164512953|NCT00350727|594248070|FG001|Phase II|Withdrawal by Subject|2|||
164512954|NCT00350727|594248071|FG002|Phase II|Withdrawal by Subject|1|||
164512955|NCT00350727|594248069|FG000|Phase II|Adverse Event|0|||
164512956|NCT00350727|594248070|FG001|Phase II|Adverse Event|1|||
164512957|NCT00350727|594248071|FG002|Phase II|Adverse Event|1|||
164512958|NCT00350727|594248069|FG000|Phase II|Death|0|||
164512959|NCT00350727|594248070|FG001|Phase II|Death|0|||
164512960|NCT00350727|594248071|FG002|Phase II|Death|2|||
164512961|NCT00350727|594248069|FG000|Phase II|Sponsor Terminated Study|0|||
164512962|NCT00350727|594248070|FG001|Phase II|Sponsor Terminated Study|0|||
164512963|NCT00350727|594248071|FG002|Phase II|Sponsor Terminated Study|1|||
164512964|NCT00350727|594248069|FG000|Phase II|Enrolled in Rollover Study|0|||
164512965|NCT00350727|594248070|FG001|Phase II|Enrolled in Rollover Study|0|||
164512966|NCT00350727|594248071|FG002|Phase II|Enrolled in Rollover Study|1|||
164512967|NCT04535544|594248072|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
164512968|NCT04535544|594248073|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
164512969|NCT04535544|594248074|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
164512970|NCT04535544|594248075|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
164512971|NCT04535544|594248072|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
164512972|NCT04535544|594248073|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
164512973|NCT04535544|594248074|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
164512974|NCT04535544|594248075|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
164512975|NCT04535544|594248072|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
164512976|NCT04535544|594248073|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
164512977|NCT04535544|594248074|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
164512978|NCT04535544|594248075|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
164512979|NCT04535544|594248072|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
164512980|NCT04535544|594248073|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
164512981|NCT04535544|594248074|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
164512982|NCT04535544|594248075|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
164512983|NCT04535544|594248072|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
164512984|NCT04535544|594248073|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
164512985|NCT04535544|594248074|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
164512986|NCT04535544|594248075|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
164512987|NCT04535544|594248072|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
164512988|NCT04535544|594248073|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
164512989|NCT04535544|594248074|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
164512990|NCT04535544|594248075|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
164512991|NCT04535544|594248072|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
164512992|NCT04535544|594248073|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
164512993|NCT04535544|594248074|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
164512994|NCT04535544|594248075|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
164512995|NCT04535544|594248072|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
164512996|NCT04535544|594248073|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
164512997|NCT04535544|594248074|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
164512998|NCT04535544|594248075|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
164512999|NCT02964013|594250523|FG000|Overall Study|Death|58|||
164513000|NCT02964013|594250524|FG001|Overall Study|Death|239|||
164513001|NCT02964013|594250525|FG002|Overall Study|Death|38|||
164513002|NCT02964013|594250526|FG003|Overall Study|Death|10|||
164513003|NCT02964013|594250527|FG004|Overall Study|Death|33|||
164513004|NCT02964013|594250523|FG000|Overall Study|Lost to Follow-up|1|||
164513005|NCT02964013|594250524|FG001|Overall Study|Lost to Follow-up|4|||
164513006|NCT02964013|594250525|FG002|Overall Study|Lost to Follow-up|2|||
164513007|NCT02964013|594250526|FG003|Overall Study|Lost to Follow-up|0|||
164513008|NCT02964013|594250527|FG004|Overall Study|Lost to Follow-up|0|||
164513009|NCT02964013|594250523|FG000|Overall Study|Physician Decision|0|||
164513010|NCT02964013|594250524|FG001|Overall Study|Physician Decision|1|||
164609727|NCT01412060|594591465|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
164513011|NCT02964013|594250525|FG002|Overall Study|Physician Decision|0|||
164609728|NCT01412060|594591466|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
164609729|NCT01412060|594591467|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
164609730|NCT01412060|594591465|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
164609731|NCT01412060|594591466|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
164513012|NCT02964013|594250526|FG003|Overall Study|Physician Decision|0|||
164513013|NCT02964013|594250527|FG004|Overall Study|Physician Decision|0|||
164609732|NCT01412060|594591467|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
164513014|NCT02964013|594250523|FG000|Overall Study|Sponsor Decision|3|||
164513015|NCT02964013|594250524|FG001|Overall Study|Sponsor Decision|22|||
164513016|NCT02964013|594250525|FG002|Overall Study|Sponsor Decision|11|||
164513017|NCT02964013|594250526|FG003|Overall Study|Sponsor Decision|0|||
164513018|NCT02964013|594250527|FG004|Overall Study|Sponsor Decision|7|||
164513019|NCT02964013|594250523|FG000|Overall Study|Withdrawal by Subject|6|||
164513020|NCT02964013|594250524|FG001|Overall Study|Withdrawal by Subject|27|||
164513021|NCT02964013|594250525|FG002|Overall Study|Withdrawal by Subject|9|||
164513022|NCT02964013|594250526|FG003|Overall Study|Withdrawal by Subject|0|||
164513023|NCT02964013|594250527|FG004|Overall Study|Withdrawal by Subject|0|||
164513024|NCT02964013|594250523|FG000|Overall Study|Not Treated|0|||
164513025|NCT02964013|594250524|FG001|Overall Study|Not Treated|2|||
164513026|NCT02964013|594250525|FG002|Overall Study|Not Treated|0|||
164513027|NCT02964013|594250526|FG003|Overall Study|Not Treated|1|||
164513028|NCT02964013|594250527|FG004|Overall Study|Not Treated|0|||
164513029|NCT01123070|594250528|FG000|Part B Double Blind Period|Protocol Violation|0|||
164513030|NCT01123070|594250529|FG001|Part B Double Blind Period|Protocol Violation|0|||
164513031|NCT01123070|594250530|FG002|Part B Double Blind Period|Protocol Violation|0|||
164513032|NCT01123070|594250531|FG003|Part B Double Blind Period|Protocol Violation|1|||
164513033|NCT01123070|594250528|FG000|Part B Double Blind Period|Adverse Event|0|||
164513034|NCT01123070|594250529|FG001|Part B Double Blind Period|Adverse Event|0|||
164513035|NCT01123070|594250530|FG002|Part B Double Blind Period|Adverse Event|2|||
164513036|NCT01123070|594250531|FG003|Part B Double Blind Period|Adverse Event|0|||
164513037|NCT01123070|594250528|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
164513038|NCT01123070|594250529|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
164513039|NCT01123070|594250530|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
164513040|NCT01123070|594250531|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
164513041|NCT00918879|594250532|FG000|Overall Study|Withdrawal by Subject|4|||
164513042|NCT00918879|594250533|FG001|Overall Study|Withdrawal by Subject|4|||
164513043|NCT00918879|594250532|FG000|Overall Study|Lost to Follow-up|1|||
164513044|NCT00918879|594250533|FG001|Overall Study|Lost to Follow-up|1|||
164513045|NCT00918879|594250532|FG000|Overall Study|Severe non-compliance to protocol|1|||
164513046|NCT00918879|594250533|FG001|Overall Study|Severe non-compliance to protocol|1|||
164513047|NCT03339245|594250543|FG000|Overall Study|Adverse Event|1|||
164513048|NCT03339245|594250544|FG001|Overall Study|Adverse Event|1|||
164513049|NCT03339245|594250543|FG000|Overall Study|Withdrawal by Subject|1|||
164513050|NCT03339245|594250544|FG001|Overall Study|Withdrawal by Subject|0|||
164513051|NCT01182441|594250545|FG000|Overall Study|Patient Still in Follow-up|152|||
164513052|NCT01182441|594250546|FG001|Overall Study|Patient Still in Follow-up|72|||
164513053|NCT01182441|594250545|FG000|Overall Study|Death|37|||
164513054|NCT01182441|594250546|FG001|Overall Study|Death|25|||
164513055|NCT01182441|594250545|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
164513056|NCT01182441|594250546|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
164513057|NCT01182441|594250545|FG000|Overall Study|Lost to Follow-up|5|||
164513058|NCT01182441|594250546|FG001|Overall Study|Lost to Follow-up|8|||
164513059|NCT01182441|594250545|FG000|Overall Study|Withdrawal by Subject|6|||
164513060|NCT01182441|594250546|FG001|Overall Study|Withdrawal by Subject|13|||
164513061|NCT01182441|594250545|FG000|Overall Study|Implant Not Attempted|4|||
164513062|NCT01182441|594250546|FG001|Overall Study|Implant Not Attempted|0|||
164513063|NCT01182441|594250545|FG000|Overall Study|Adverse Event|2|||
164513064|NCT01182441|594250546|FG001|Overall Study|Adverse Event|0|||
164513065|NCT01182441|594250545|FG000|Overall Study|Physician Decision|1|||
164513066|NCT01182441|594250546|FG001|Overall Study|Physician Decision|1|||
164513067|NCT00288639|594250554|FG000|Overall Study|Adverse Event|5|||
164513068|NCT00288639|594250554|FG000|Overall Study|Lack of Efficacy|4|||
164513069|NCT00288639|594250554|FG000|Overall Study|Withdrawal by Subject|2|||
164513070|NCT00288639|594250554|FG000|Overall Study|Other|1|||
164513071|NCT03480932|594250563|FG000|Overall Study|Death|1|||
164513072|NCT03480932|594250564|FG001|Overall Study|Death|1|||
164513073|NCT03480932|594250565|FG002|Overall Study|Death|0|||
164513074|NCT03480932|594250563|FG000|Overall Study|Lost to Follow-up|0|||
164513075|NCT03480932|594250564|FG001|Overall Study|Lost to Follow-up|2|||
164513076|NCT03480932|594250565|FG002|Overall Study|Lost to Follow-up|3|||
164513077|NCT03480932|594250563|FG000|Overall Study|Incarcerated|2|||
164513078|NCT03480932|594250564|FG001|Overall Study|Incarcerated|2|||
164513079|NCT03480932|594250565|FG002|Overall Study|Incarcerated|2|||
164513080|NCT00663702|594250566|FG000|Overall Study|Adverse Event|8|||
164513081|NCT00663702|594250567|FG001|Overall Study|Adverse Event|4|||
164513082|NCT00663702|594250566|FG000|Overall Study|Withdrawal by Subject|3|||
164513083|NCT00663702|594250567|FG001|Overall Study|Withdrawal by Subject|1|||
164513084|NCT00663702|594250566|FG000|Overall Study|Pregnancy|0|||
164513085|NCT00663702|594250567|FG001|Overall Study|Pregnancy|1|||
164513086|NCT00663702|594250566|FG000|Overall Study|Lost to Follow-up|3|||
164513087|NCT00663702|594250567|FG001|Overall Study|Lost to Follow-up|0|||
164513088|NCT00663702|594250566|FG000|Overall Study|Death|1|||
164513089|NCT00663702|594250567|FG001|Overall Study|Death|1|||
164609733|NCT01412060|594591465|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
164609734|NCT01412060|594591466|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
164609735|NCT01412060|594591467|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
164609736|NCT01412060|594591465|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
164609737|NCT01412060|594591466|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
164609738|NCT01412060|594591467|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
164609739|NCT01412060|594591465|FG000|Period Between SP and DBP|Protocol Violation|2|||
164609740|NCT01412060|594591466|FG001|Period Between SP and DBP|Protocol Violation|0|||
164609741|NCT01412060|594591467|FG002|Period Between SP and DBP|Protocol Violation|0|||
164609742|NCT01412060|594591465|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
164609743|NCT01412060|594591466|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
164609744|NCT01412060|594591467|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
164609745|NCT01412060|594591465|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
164609746|NCT01412060|594591466|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
164609747|NCT01412060|594591467|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
164609748|NCT01412060|594591465|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
164609749|NCT01412060|594591466|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
164609750|NCT01412060|594591467|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
164609751|NCT01412060|594591465|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
164609752|NCT01412060|594591466|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
164609753|NCT01412060|594591467|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
164609754|NCT01412060|594591465|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
164609755|NCT01412060|594591466|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
164609756|NCT01412060|594591467|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
164609757|NCT01412060|594591465|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
164609758|NCT01412060|594591466|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
164609759|NCT01412060|594591467|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
164609760|NCT01412060|594591465|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
164609761|NCT01412060|594591466|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
164609762|NCT01412060|594591467|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
164609763|NCT01412060|594591465|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
164609764|NCT01412060|594591466|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
164609765|NCT01412060|594591467|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
164609766|NCT01412060|594591465|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
164609767|NCT01412060|594591466|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
164609768|NCT01412060|594591467|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
164609769|NCT01412060|594591465|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
164609770|NCT01412060|594591466|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
164609771|NCT01412060|594591467|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
164609772|NCT02661464|594591470|FG000|Overall Study|Lost to Follow-up|28|||
164513090|NCT00663702|594250566|FG000|Overall Study|Lack of Efficacy|3|||
164513091|NCT00663702|594250567|FG001|Overall Study|Lack of Efficacy|3|||
164513092|NCT03056300|594250568|FG000|Overall Study|Surgical reason per study protocol|3|||
164513093|NCT05262517|594250569|FG000|Overall Study|Randomized but not treated|5|||
164513094|NCT05262517|594250570|FG001|Overall Study|Randomized but not treated|11|||
164513095|NCT00626197|594250573|FG000|Overall Study|Did not cooperate|2|||
164513096|NCT00626197|594250574|FG001|Overall Study|Did not cooperate|6|||
164513097|NCT00626197|594250575|FG002|Overall Study|Did not cooperate|1|||
164513098|NCT00626197|594250573|FG000|Overall Study|Failure to return|6|||
164513099|NCT00626197|594250574|FG001|Overall Study|Failure to return|5|||
164513100|NCT00626197|594250575|FG002|Overall Study|Failure to return|6|||
164513101|NCT00626197|594250573|FG000|Overall Study|Adverse event, serious fatal|3|||
164513102|NCT00626197|594250574|FG001|Overall Study|Adverse event, serious fatal|6|||
164513103|NCT00626197|594250575|FG002|Overall Study|Adverse event, serious fatal|6|||
164513104|NCT00626197|594250573|FG000|Overall Study|Adverse Event|1|||
164513105|NCT00626197|594250574|FG001|Overall Study|Adverse Event|1|||
164513106|NCT00626197|594250575|FG002|Overall Study|Adverse Event|2|||
164513107|NCT00626197|594250573|FG000|Overall Study|Withdrawal by Subject|17|||
164513108|NCT00626197|594250574|FG001|Overall Study|Withdrawal by Subject|17|||
164513109|NCT00626197|594250575|FG002|Overall Study|Withdrawal by Subject|7|||
164513110|NCT00626197|594250573|FG000|Overall Study|Administrative reasons|15|||
164513111|NCT00626197|594250574|FG001|Overall Study|Administrative reasons|19|||
164609773|NCT02661464|594591471|FG001|Overall Study|Lost to Follow-up|0|||
164609774|NCT02661464|594591472|FG002|Overall Study|Lost to Follow-up|0|||
164609775|NCT02661464|594591473|FG003|Overall Study|Lost to Follow-up|0|||
164609776|NCT02661464|594591470|FG000|Overall Study|Withdrawal by Subject|3|||
164513112|NCT00626197|594250575|FG002|Overall Study|Administrative reasons|55|||
164609777|NCT02661464|594591471|FG001|Overall Study|Withdrawal by Subject|1|||
164609778|NCT02661464|594591472|FG002|Overall Study|Withdrawal by Subject|0|||
164609779|NCT02661464|594591473|FG003|Overall Study|Withdrawal by Subject|0|||
164609780|NCT02661464|594591470|FG000|Overall Study|Participants terminated prematurely|288|||
164609781|NCT02661464|594591471|FG001|Overall Study|Participants terminated prematurely|52|||
164609782|NCT02661464|594591472|FG002|Overall Study|Participants terminated prematurely|1|||
164609783|NCT02661464|594591473|FG003|Overall Study|Participants terminated prematurely|1|||
164609784|NCT02661464|594591470|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
164609785|NCT02661464|594591471|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
164609786|NCT02661464|594591472|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
164609787|NCT02661464|594591473|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
164609788|NCT03148756|594591475|FG000|Overall Study|Study Terminated|0|||
164609789|NCT03148756|594591476|FG001|Overall Study|Study Terminated|1|||
164609790|NCT05567393|594591477|FG000|Overall Study|Voluntary Withdrawal|0|||
164609791|NCT05567393|594591478|FG001|Overall Study|Voluntary Withdrawal|0|||
164609792|NCT05567393|594591479|FG002|Overall Study|Voluntary Withdrawal|0|||
164609793|NCT05567393|594591480|FG003|Overall Study|Voluntary Withdrawal|0|||
164609794|NCT05567393|594591481|FG004|Overall Study|Voluntary Withdrawal|0|||
164609795|NCT05567393|594591482|FG005|Overall Study|Voluntary Withdrawal|0|||
164609796|NCT05567393|594591483|FG006|Overall Study|Voluntary Withdrawal|0|||
164609797|NCT05567393|594591484|FG007|Overall Study|Voluntary Withdrawal|0|||
164609798|NCT05567393|594591485|FG008|Overall Study|Voluntary Withdrawal|0|||
164609799|NCT05567393|594591486|FG009|Overall Study|Voluntary Withdrawal|0|||
164609800|NCT05567393|594591487|FG010|Overall Study|Voluntary Withdrawal|0|||
164609801|NCT05567393|594591488|FG011|Overall Study|Voluntary Withdrawal|0|||
164609802|NCT05567393|594591489|FG012|Overall Study|Voluntary Withdrawal|0|||
164609803|NCT05567393|594591490|FG013|Overall Study|Voluntary Withdrawal|1|||
164609804|NCT05567393|594591491|FG014|Overall Study|Voluntary Withdrawal|0|||
164609805|NCT05567393|594591492|FG015|Overall Study|Voluntary Withdrawal|0|||
164609806|NCT05567393|594591493|FG016|Overall Study|Voluntary Withdrawal|0|||
164609807|NCT05567393|594591494|FG017|Overall Study|Voluntary Withdrawal|0|||
164609808|NCT02177175|594591498|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
164609809|NCT02177175|594591499|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
164609810|NCT01924299|594591500|FG000|Period 2|Withdrawal by Subject|1|||
164609811|NCT01924299|594591501|FG001|Period 2|Withdrawal by Subject|0|||
164609812|NCT01924299|594591500|FG000|Period 2|Adverse Event|0|||
164609813|NCT01924299|594591501|FG001|Period 2|Adverse Event|1|||
164609814|NCT04199793|594591502|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
164609815|NCT04199793|594591503|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
164609816|NCT04199793|594591502|FG000|Overall Study|Withdrawal by Subject|1|||
164609817|NCT04199793|594591503|FG001|Overall Study|Withdrawal by Subject|1|||
164609818|NCT03820726|594591504|FG000|Overall Study|Other than listed|23|||
164609819|NCT03820726|594591504|FG000|Overall Study|Withdrawal by Subject|37|||
164609820|NCT03820726|594591504|FG000|Overall Study|Lost to Follow-up|3|||
164609821|NCT03820726|594591504|FG000|Overall Study|Protocol deviation|1|||
164609822|NCT03820726|594591504|FG000|Overall Study|Adverse Event|146|||
164609823|NCT03820726|594591504|FG000|Overall Study|Not treated|1|||
164609824|NCT00628758|594591508|FG000|Overall Study|Adverse Event|2|||
164609825|NCT00628758|594591509|FG001|Overall Study|Adverse Event|3|||
164513113|NCT05332912|594250576|FG000|Overall Study|Withdrawal by Subject|0|||
164513114|NCT05332912|594250577|FG001|Overall Study|Withdrawal by Subject|1|||
164513115|NCT05332912|594250578|FG002|Overall Study|Withdrawal by Subject|2|||
164513116|NCT05332912|594250579|FG003|Overall Study|Withdrawal by Subject|0|||
164513117|NCT05332912|594250576|FG000|Overall Study|Lost to Follow-up|0|||
164513118|NCT05332912|594250577|FG001|Overall Study|Lost to Follow-up|0|||
164513119|NCT05332912|594250578|FG002|Overall Study|Lost to Follow-up|1|||
164513120|NCT05332912|594250579|FG003|Overall Study|Lost to Follow-up|0|||
164513121|NCT01174446|594250580|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
164513122|NCT01174446|594250581|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
164513123|NCT01174446|594250582|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
164513124|NCT01174446|594250583|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
164513125|NCT01174446|594250580|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
164513126|NCT01174446|594250581|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
164609826|NCT00628758|594591508|FG000|Overall Study|Withdrawal by Subject|6|||
164609827|NCT00628758|594591509|FG001|Overall Study|Withdrawal by Subject|3|||
164609828|NCT00628758|594591508|FG000|Overall Study|Death|1|||
164609829|NCT00628758|594591509|FG001|Overall Study|Death|0|||
164609830|NCT00628758|594591508|FG000|Overall Study|Protocol Violation|5|||
164609831|NCT00628758|594591509|FG001|Overall Study|Protocol Violation|1|||
164609832|NCT00628758|594591508|FG000|Overall Study|Lost to Follow-up|25|||
164609833|NCT00628758|594591509|FG001|Overall Study|Lost to Follow-up|31|||
164609834|NCT00628758|594591508|FG000|Overall Study|Pregnancy|2|||
164609835|NCT00628758|594591509|FG001|Overall Study|Pregnancy|2|||
164513127|NCT01174446|594250582|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
164513128|NCT01174446|594250583|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
164513129|NCT01174446|594250580|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
164513130|NCT01174446|594250581|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
164513131|NCT01174446|594250582|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
164513132|NCT01174446|594250583|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
164513133|NCT01174446|594250580|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
164513134|NCT01174446|594250581|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
164513135|NCT01174446|594250582|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
164513136|NCT01174446|594250583|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
164513137|NCT03510455|594250586|FG000|Overall Study|Physician Decision|1|||
164513138|NCT01730378|594250590|FG000|Overall Study|Lost to Follow-up|1|||
164513139|NCT01730378|594250591|FG001|Overall Study|Lost to Follow-up|0|||
164513140|NCT04481373|594250596|FG000|Overall Study|Protocol Violation|1|||
164513141|NCT04481373|594250597|FG001|Overall Study|Protocol Violation|0|||
164513142|NCT04481373|594250596|FG000|Overall Study|Viral load in hospital not over 1000|2|||
164513143|NCT04481373|594250597|FG001|Overall Study|Viral load in hospital not over 1000|1|||
164513144|NCT04481373|594250596|FG000|Overall Study|Death before hospital discharge|1|||
164513145|NCT04481373|594250597|FG001|Overall Study|Death before hospital discharge|0|||
164513146|NCT02224703|594250604|FG000|Overall Study|Adverse Event|0|||
164513147|NCT02224703|594250605|FG001|Overall Study|Adverse Event|5|||
164513148|NCT02224703|594250606|FG002|Overall Study|Adverse Event|0|||
164513149|NCT02224703|594250604|FG000|Overall Study|Withdrawn by investigator|1|||
164513150|NCT02224703|594250605|FG001|Overall Study|Withdrawn by investigator|0|||
164513151|NCT02224703|594250606|FG002|Overall Study|Withdrawn by investigator|0|||
164513152|NCT02224703|594250604|FG000|Overall Study|Advised by medical monitor|1|||
164513153|NCT02224703|594250605|FG001|Overall Study|Advised by medical monitor|0|||
164513154|NCT02224703|594250606|FG002|Overall Study|Advised by medical monitor|0|||
164513155|NCT02224703|594250604|FG000|Overall Study|Withdrawn by parent/guardian|0|||
164513156|NCT02224703|594250605|FG001|Overall Study|Withdrawn by parent/guardian|1|||
164513157|NCT02224703|594250606|FG002|Overall Study|Withdrawn by parent/guardian|0|||
164513158|NCT02224703|594250604|FG000|Overall Study|Lack of Efficacy|1|||
164513159|NCT02224703|594250605|FG001|Overall Study|Lack of Efficacy|0|||
164513160|NCT02224703|594250606|FG002|Overall Study|Lack of Efficacy|0|||
164513161|NCT02057575|594250607|FG000|Overall Study|Adverse Event|0|||
164513162|NCT02057575|594250608|FG001|Overall Study|Adverse Event|2|||
164513163|NCT02057575|594250609|FG002|Overall Study|Adverse Event|0|||
164513164|NCT02057575|594250610|FG003|Overall Study|Adverse Event|1|||
164513165|NCT02057575|594250607|FG000|Overall Study|Withdrawal by Subject|1|||
164513166|NCT02057575|594250608|FG001|Overall Study|Withdrawal by Subject|0|||
164513167|NCT02057575|594250609|FG002|Overall Study|Withdrawal by Subject|0|||
164513168|NCT02057575|594250610|FG003|Overall Study|Withdrawal by Subject|0|||
164513169|NCT02057575|594250607|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
164513170|NCT02057575|594250608|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
164513171|NCT02057575|594250609|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
164513172|NCT02057575|594250610|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
164513173|NCT02057575|594250607|FG000|Overall Study|Protocol Violation|0|||
164513174|NCT02057575|594250608|FG001|Overall Study|Protocol Violation|1|||
164513175|NCT02057575|594250609|FG002|Overall Study|Protocol Violation|0|||
164513176|NCT02057575|594250610|FG003|Overall Study|Protocol Violation|0|||
164513177|NCT00332462|594250611|FG000|Overall Study|Adverse Event|5|||
164513178|NCT00332462|594250611|FG000|Overall Study|Abnormal Lab Value|1|||
164513179|NCT00332462|594250611|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
164513180|NCT00332462|594250611|FG000|Overall Study|no longer requires study drug|1|||
164513181|NCT00332462|594250611|FG000|Overall Study|Death|3|||
164513182|NCT00332462|594250611|FG000|Overall Study|Graft Loss|2|||
164513183|NCT00863681|594250616|FG000|Overall Study|Other|2|||
164513184|NCT00863681|594250617|FG001|Overall Study|Other|0|||
164513185|NCT00863681|594250618|FG002|Overall Study|Other|0|||
164513186|NCT00863681|594250616|FG000|Overall Study|Missing|1|||
164513187|NCT00863681|594250617|FG001|Overall Study|Missing|0|||
164513188|NCT00863681|594250618|FG002|Overall Study|Missing|0|||
164513189|NCT00863681|594250616|FG000|Overall Study|Death|40|||
164513190|NCT00863681|594250617|FG001|Overall Study|Death|23|||
164513191|NCT00863681|594250618|FG002|Overall Study|Death|6|||
164513192|NCT00863681|594250616|FG000|Overall Study|Withdrawal by Subject|12|||
164513193|NCT00863681|594250617|FG001|Overall Study|Withdrawal by Subject|5|||
164513194|NCT00863681|594250618|FG002|Overall Study|Withdrawal by Subject|2|||
164513195|NCT00863681|594250616|FG000|Overall Study|Protocol Violation|2|||
164513196|NCT00863681|594250617|FG001|Overall Study|Protocol Violation|0|||
164513197|NCT00863681|594250618|FG002|Overall Study|Protocol Violation|0|||
164513198|NCT00863681|594250616|FG000|Overall Study|Lost to Follow-up|3|||
164513199|NCT00863681|594250617|FG001|Overall Study|Lost to Follow-up|0|||
164513200|NCT00863681|594250618|FG002|Overall Study|Lost to Follow-up|3|||
164513201|NCT00863681|594250616|FG000|Overall Study|Adverse Event|28|||
164513202|NCT00863681|594250617|FG001|Overall Study|Adverse Event|10|||
164513203|NCT00863681|594250618|FG002|Overall Study|Adverse Event|6|||
164513204|NCT00863681|594250616|FG000|Overall Study|Lack of Efficacy|2|||
164513205|NCT00863681|594250617|FG001|Overall Study|Lack of Efficacy|2|||
164513206|NCT00863681|594250618|FG002|Overall Study|Lack of Efficacy|1|||
164513207|NCT00863681|594250616|FG000|Overall Study|Non-compliance with study drug|1|||
164513208|NCT00863681|594250617|FG001|Overall Study|Non-compliance with study drug|3|||
164513209|NCT00863681|594250618|FG002|Overall Study|Non-compliance with study drug|0|||
164513210|NCT02979249|594250620|FG000|Overall Study|Lost to Follow-up|2|||
164513211|NCT02979249|594250620|FG000|Overall Study|Withdrawal by Subject|4|||
164513212|NCT01685229|594250621|FG000|Overall Study|Subjects missing Study Exit form|3|||
164513213|NCT01685229|594250622|FG001|Overall Study|Subjects missing Study Exit form|1|||
164513214|NCT01685229|594250621|FG000|Overall Study|Lost to Follow-up|16|||
164513215|NCT01685229|594250622|FG001|Overall Study|Lost to Follow-up|10|||
164513216|NCT01685229|594250621|FG000|Overall Study|Withdrawal by Subject|6|||
164513217|NCT01685229|594250622|FG001|Overall Study|Withdrawal by Subject|5|||
164513218|NCT01685229|594250621|FG000|Overall Study|Death|1|||
164513219|NCT01685229|594250622|FG001|Overall Study|Death|0|||
164513220|NCT00659880|594250637|FG000|Overall Study|Lost to Follow-up|5|||
164513221|NCT01853475|594250638|FG000|Overall Study|Withdrawal by Subject|0|||
164513222|NCT01853475|594250639|FG001|Overall Study|Withdrawal by Subject|1|||
164513223|NCT01853475|594250640|FG002|Overall Study|Withdrawal by Subject|0|||
164513224|NCT02159040|594250641|FG000|Overall Study|Death|1|||
164513225|NCT02964325|594250642|FG000|Overall Study|Lost to Follow-up|3|||
164513226|NCT02964325|594250643|FG001|Overall Study|Lost to Follow-up|3|||
164513227|NCT02964325|594250642|FG000|Overall Study|Physician Decision|5|||
164513228|NCT02964325|594250643|FG001|Overall Study|Physician Decision|4|||
164513229|NCT02964325|594250642|FG000|Overall Study|Death|1|||
164513230|NCT02964325|594250643|FG001|Overall Study|Death|3|||
164513231|NCT02964325|594250642|FG000|Overall Study|Withdrawal by Subject|2|||
164513232|NCT02964325|594250643|FG001|Overall Study|Withdrawal by Subject|1|||
164513233|NCT02964325|594250642|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
164513234|NCT02964325|594250643|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
164513235|NCT02510040|594250644|FG000|Overall Study|Deemed no longer eligible|18|||
164513236|NCT02510040|594250645|FG001|Overall Study|Deemed no longer eligible|3|||
164513237|NCT02510040|594250646|FG002|Overall Study|Deemed no longer eligible|1|||
164513238|NCT03596762|594250647|FG000|Overall Study|Protocol Violation|0|||
164513239|NCT03596762|594250648|FG001|Overall Study|Protocol Violation|0|||
164513240|NCT03596762|594250649|FG002|Overall Study|Protocol Violation|0|||
164513241|NCT03596762|594250650|FG003|Overall Study|Protocol Violation|0|||
164513242|NCT03596762|594250651|FG004|Overall Study|Protocol Violation|1|||
164513243|NCT03596762|594250647|FG000|Overall Study|Adverse Event|2|||
164513244|NCT03596762|594250648|FG001|Overall Study|Adverse Event|0|||
164513245|NCT03596762|594250649|FG002|Overall Study|Adverse Event|1|||
164513246|NCT03596762|594250650|FG003|Overall Study|Adverse Event|0|||
164513247|NCT03596762|594250651|FG004|Overall Study|Adverse Event|5|||
164513248|NCT03596762|594250647|FG000|Overall Study|Withdrawal by Subject|2|||
164513249|NCT03596762|594250648|FG001|Overall Study|Withdrawal by Subject|1|||
164513250|NCT03596762|594250649|FG002|Overall Study|Withdrawal by Subject|0|||
164513251|NCT03596762|594250650|FG003|Overall Study|Withdrawal by Subject|1|||
164513252|NCT03596762|594250651|FG004|Overall Study|Withdrawal by Subject|1|||
164513253|NCT03842228|594250652|FG000|Overall Study|Adverse Event|1|||
164513254|NCT03842228|594250653|FG001|Overall Study|Adverse Event|1|||
164513255|NCT03842228|594250654|FG002|Overall Study|Adverse Event|1|||
164513256|NCT03842228|594250655|FG003|Overall Study|Adverse Event|0|||
164513257|NCT03842228|594250656|FG004|Overall Study|Adverse Event|0|||
164513258|NCT03842228|594250657|FG005|Overall Study|Adverse Event|0|||
164513259|NCT03842228|594250658|FG006|Overall Study|Adverse Event|0|||
164513260|NCT03842228|594250652|FG000|Overall Study|Death|0|||
164513261|NCT03842228|594250653|FG001|Overall Study|Death|1|||
164513262|NCT03842228|594250654|FG002|Overall Study|Death|0|||
164513263|NCT03842228|594250655|FG003|Overall Study|Death|0|||
164513264|NCT03842228|594250656|FG004|Overall Study|Death|0|||
164513265|NCT03842228|594250657|FG005|Overall Study|Death|0|||
164513266|NCT03842228|594250658|FG006|Overall Study|Death|0|||
164513267|NCT03842228|594250652|FG000|Overall Study|Withdrawal by Subject|0|||
164609836|NCT00628758|594591508|FG000|Overall Study|Investigator Moved|3|||
164513268|NCT03842228|594250653|FG001|Overall Study|Withdrawal by Subject|0|||
164513269|NCT03842228|594250654|FG002|Overall Study|Withdrawal by Subject|2|||
164513270|NCT03842228|594250655|FG003|Overall Study|Withdrawal by Subject|1|||
164513271|NCT03842228|594250656|FG004|Overall Study|Withdrawal by Subject|0|||
164513272|NCT03842228|594250657|FG005|Overall Study|Withdrawal by Subject|0|||
164513273|NCT03842228|594250658|FG006|Overall Study|Withdrawal by Subject|2|||
164513274|NCT03842228|594250652|FG000|Overall Study|Progression|8|||
164513275|NCT03842228|594250653|FG001|Overall Study|Progression|1|||
164513276|NCT03842228|594250654|FG002|Overall Study|Progression|7|||
164513277|NCT03842228|594250655|FG003|Overall Study|Progression|5|||
164513278|NCT03842228|594250656|FG004|Overall Study|Progression|4|||
164513279|NCT03842228|594250657|FG005|Overall Study|Progression|2|||
164513280|NCT03842228|594250658|FG006|Overall Study|Progression|3|||
164513281|NCT02195479|594250671|FG000|Overall Study|Lost to Follow-up|18|||
164513282|NCT02195479|594250672|FG001|Overall Study|Lost to Follow-up|15|||
164513283|NCT02195479|594250671|FG000|Overall Study|Death|217|||
164513284|NCT02195479|594250672|FG001|Overall Study|Death|171|||
164513285|NCT02195479|594250671|FG000|Overall Study|Physician Decision|1|||
164513286|NCT02195479|594250672|FG001|Overall Study|Physician Decision|0|||
164513287|NCT02195479|594250671|FG000|Overall Study|Withdrawal by Subject|30|||
164513288|NCT02195479|594250672|FG001|Overall Study|Withdrawal by Subject|30|||
164513289|NCT02195479|594250671|FG000|Overall Study|Other|3|||
164513290|NCT02195479|594250672|FG001|Overall Study|Other|4|||
164513291|NCT02195479|594250671|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
164513292|NCT02195479|594250672|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
164513293|NCT01834586|594250673|FG000|Overall Study|Adverse Event|1|||
164513294|NCT01263509|594250676|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
164513295|NCT01263509|594250677|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
164513296|NCT01263509|594250678|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
164513297|NCT01263509|594250679|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
164513298|NCT01263509|594250676|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
164513299|NCT01263509|594250677|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
164513300|NCT01263509|594250678|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
164513301|NCT01263509|594250679|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
164513302|NCT01263509|594250676|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
164513303|NCT01263509|594250677|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
164513304|NCT01263509|594250678|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
164513305|NCT01263509|594250679|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
164513306|NCT01263509|594250676|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
164513307|NCT01263509|594250677|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
164513308|NCT01263509|594250678|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
164513309|NCT01263509|594250679|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
164513310|NCT01263509|594250676|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
164513311|NCT01263509|594250677|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
164513312|NCT01263509|594250678|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
164513313|NCT01263509|594250679|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
164513314|NCT01818531|594250689|FG000|Overall Study|Withdrawn for case delay after block|1|||
164513315|NCT01818531|594250690|FG001|Overall Study|Withdrawn for case delay after block|0|||
164513316|NCT01818531|594250689|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
164513317|NCT01818531|594250690|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
164513318|NCT01818531|594250689|FG000|Overall Study|Withdrawn for failure to place block|0|||
164513319|NCT01818531|594250690|FG001|Overall Study|Withdrawn for failure to place block|1|||
164513320|NCT00214019|594250691|FG000|Overall Study|Lost to Follow-up|11|||
164513321|NCT00214019|594250691|FG000|Overall Study|Withdrawal by Subject|2|||
164513322|NCT00214019|594250691|FG000|Overall Study|Screen Failed prior to randomization|17|||
164513323|NCT00477490|594250694|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
164513324|NCT00477490|594250695|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
164513325|NCT00477490|594250696|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
164513326|NCT00477490|594250697|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
164513327|NCT00477490|594250698|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
164513328|NCT00477490|594250699|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
164513329|NCT00477490|594250700|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
164513330|NCT00477490|594250701|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
164513331|NCT00477490|594250702|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
164513332|NCT00477490|594250694|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
164513333|NCT00477490|594250695|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
164513334|NCT00477490|594250696|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
164513335|NCT00477490|594250697|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
164513336|NCT00477490|594250698|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
164513337|NCT00477490|594250699|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
164513338|NCT00477490|594250700|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
164513339|NCT00477490|594250701|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
164513340|NCT00477490|594250702|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
164513341|NCT00477490|594250694|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
164513342|NCT00477490|594250695|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
164513343|NCT00477490|594250696|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
164513344|NCT00477490|594250697|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
164513345|NCT00477490|594250698|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
164513346|NCT00477490|594250699|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
164513347|NCT00477490|594250700|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
164513348|NCT00477490|594250701|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
164513349|NCT00477490|594250702|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
164513350|NCT00477490|594250694|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
164513351|NCT00477490|594250695|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
164513352|NCT00477490|594250696|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
164513353|NCT00477490|594250697|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
164513354|NCT00477490|594250698|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
164513355|NCT00477490|594250699|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
164513356|NCT00477490|594250700|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
164513357|NCT00477490|594250701|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
164513358|NCT00477490|594250702|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
164513359|NCT00477490|594250694|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
164513360|NCT00477490|594250695|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
164513361|NCT00477490|594250696|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
164513362|NCT00477490|594250697|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
164513363|NCT00477490|594250698|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
164513364|NCT00477490|594250699|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
164513365|NCT00477490|594250700|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
164513366|NCT00477490|594250701|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
164513367|NCT00477490|594250702|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
164513368|NCT00477490|594250694|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
164513369|NCT00477490|594250695|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
164513370|NCT00477490|594250696|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
164513371|NCT00477490|594250697|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
164513372|NCT00477490|594250698|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
164513373|NCT00477490|594250699|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
164513374|NCT00477490|594250700|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
164513375|NCT00477490|594250701|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
164513376|NCT00477490|594250702|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
164513377|NCT00477490|594250694|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
164513378|NCT00477490|594250695|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
164513379|NCT00477490|594250696|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
164513380|NCT00477490|594250697|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
164513381|NCT00477490|594250698|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
164513382|NCT00477490|594250699|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
164513383|NCT00477490|594250700|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
164513384|NCT00477490|594250701|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
164513385|NCT00477490|594250702|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
164513386|NCT00477490|594250694|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
164513387|NCT00477490|594250695|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
164513388|NCT00477490|594250696|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
164513389|NCT00477490|594250697|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
164513390|NCT00477490|594250698|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
164513391|NCT00477490|594250699|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
164513392|NCT00477490|594250700|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
164513393|NCT00477490|594250701|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
164513394|NCT00477490|594250702|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
164513395|NCT00477490|594250694|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
164513396|NCT00477490|594250695|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
164513397|NCT00477490|594250696|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
164513398|NCT00477490|594250697|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
164513399|NCT00477490|594250698|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
164513400|NCT00477490|594250699|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
164513401|NCT00477490|594250700|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
164513402|NCT00477490|594250701|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
164513403|NCT00477490|594250702|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
164513404|NCT00477490|594250694|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
164513405|NCT00477490|594250695|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
164513406|NCT00477490|594250696|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
164513407|NCT00477490|594250697|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
164513408|NCT00477490|594250698|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
164513409|NCT00477490|594250699|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
164609837|NCT00628758|594591509|FG001|Overall Study|Investigator Moved|0|||
164609838|NCT00628758|594591508|FG000|Overall Study|Treatment Failure|0|||
164609839|NCT00628758|594591509|FG001|Overall Study|Treatment Failure|2|||
164609840|NCT02983799|594591514|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
164609841|NCT02983799|594591515|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
164609842|NCT02983799|594591516|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
164609843|NCT02983799|594591517|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
164513410|NCT00477490|594250700|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
164513411|NCT00477490|594250701|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
164513412|NCT00477490|594250702|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
164513413|NCT00477490|594250694|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
164513414|NCT00477490|594250695|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
164513415|NCT00477490|594250696|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
164513416|NCT00477490|594250697|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
164609844|NCT02983799|594591518|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
164609845|NCT02983799|594591514|FG000|Overall Study|Death|20|||
164609846|NCT02983799|594591515|FG001|Overall Study|Death|5|||
164609847|NCT02983799|594591516|FG002|Overall Study|Death|23|||
164609848|NCT02983799|594591517|FG003|Overall Study|Death|47|||
164609849|NCT02983799|594591518|FG004|Overall Study|Death|7|||
164609850|NCT02983799|594591514|FG000|Overall Study|Withdrawal by Subject|1|||
164609851|NCT02983799|594591515|FG001|Overall Study|Withdrawal by Subject|0|||
164609852|NCT02983799|594591516|FG002|Overall Study|Withdrawal by Subject|3|||
164609853|NCT02983799|594591517|FG003|Overall Study|Withdrawal by Subject|4|||
164609854|NCT02983799|594591518|FG004|Overall Study|Withdrawal by Subject|1|||
164609855|NCT02983799|594591514|FG000|Overall Study|Protocol Violation|0|||
164609856|NCT02983799|594591515|FG001|Overall Study|Protocol Violation|1|||
164609857|NCT02983799|594591516|FG002|Overall Study|Protocol Violation|0|||
164609858|NCT02983799|594591517|FG003|Overall Study|Protocol Violation|0|||
164609859|NCT02983799|594591518|FG004|Overall Study|Protocol Violation|1|||
164609860|NCT02983799|594591514|FG000|Overall Study|Lost to Follow-up|1|||
164609861|NCT02983799|594591515|FG001|Overall Study|Lost to Follow-up|0|||
164609862|NCT02983799|594591516|FG002|Overall Study|Lost to Follow-up|1|||
164609863|NCT02983799|594591517|FG003|Overall Study|Lost to Follow-up|0|||
164609864|NCT02983799|594591518|FG004|Overall Study|Lost to Follow-up|0|||
164609865|NCT00719862|594591528|FG000|Overall Study|Adverse Event|1|||
164609866|NCT00719862|594591529|FG001|Overall Study|Adverse Event|2|||
164609867|NCT00719862|594591528|FG000|Overall Study|Lack of Efficacy|3|||
164609868|NCT00719862|594591529|FG001|Overall Study|Lack of Efficacy|0|||
164609869|NCT00719862|594591528|FG000|Overall Study|Non-Compliance|1|||
164609870|NCT00719862|594591529|FG001|Overall Study|Non-Compliance|0|||
164609871|NCT00719862|594591528|FG000|Overall Study|Withdrawal by Subject|1|||
164609872|NCT00719862|594591529|FG001|Overall Study|Withdrawal by Subject|0|||
164609873|NCT00719862|594591528|FG000|Overall Study|Lost to Follow-up|0|||
164609874|NCT00719862|594591529|FG001|Overall Study|Lost to Follow-up|1|||
164609875|NCT00719862|594591528|FG000|Overall Study|Other|2|||
164609876|NCT00719862|594591529|FG001|Overall Study|Other|3|||
164609877|NCT01184846|594591530|FG000|Overall Study|Adverse Event|2|||
164609878|NCT01184846|594591530|FG000|Overall Study|Insufficient response|1|||
164609879|NCT01736254|594591532|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
164609880|NCT01736254|594591532|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
164609881|NCT02293902|594591541|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
164609882|NCT02293902|594591542|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
164609883|NCT02293902|594591543|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
164609884|NCT02293902|594591544|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
164609885|NCT02293902|594591545|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
164609886|NCT02293902|594591541|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
164609887|NCT02293902|594591542|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
164609888|NCT02293902|594591543|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
164609889|NCT02293902|594591544|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
164609890|NCT02293902|594591545|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
164609891|NCT02293902|594591541|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
164513417|NCT00477490|594250698|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
164609892|NCT02293902|594591542|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
164609893|NCT02293902|594591543|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
164609894|NCT02293902|594591544|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
164609895|NCT02293902|594591545|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
164609896|NCT02293902|594591541|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
164609897|NCT02293902|594591542|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
164609898|NCT02293902|594591543|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
164609899|NCT02293902|594591544|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
164609900|NCT02293902|594591545|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
164609901|NCT02293902|594591541|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
164513418|NCT00477490|594250699|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
164513419|NCT00477490|594250700|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
164513420|NCT00477490|594250701|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
164513421|NCT00477490|594250702|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
164513422|NCT00477490|594250694|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
164513423|NCT00477490|594250695|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
164513424|NCT00477490|594250696|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
164513425|NCT00477490|594250697|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
164513426|NCT00477490|594250698|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
164513427|NCT00477490|594250699|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
164513428|NCT00477490|594250700|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
164513429|NCT00477490|594250701|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
164513430|NCT00477490|594250702|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
164513431|NCT00477490|594250694|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
164513432|NCT00477490|594250695|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
164513433|NCT00477490|594250696|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
164513434|NCT00477490|594250697|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
164513435|NCT00477490|594250698|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
164513436|NCT00477490|594250699|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
164513437|NCT00477490|594250700|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
164513438|NCT00477490|594250701|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
164513439|NCT00477490|594250702|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
164513440|NCT00477490|594250694|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
164513441|NCT00477490|594250695|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
164513442|NCT00477490|594250696|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
164513443|NCT00477490|594250697|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
164513444|NCT00477490|594250698|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
164513445|NCT00477490|594250699|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
164513446|NCT00477490|594250700|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
164513447|NCT00477490|594250701|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
164513448|NCT00477490|594250702|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
164513449|NCT01465763|594250703|FG000|Overall Study|Withdrawal by Subject|4|||
164513450|NCT01465763|594250704|FG001|Overall Study|Withdrawal by Subject|0|||
164513451|NCT01465763|594250705|FG002|Overall Study|Withdrawal by Subject|1|||
164513452|NCT01465763|594250703|FG000|Overall Study|Insufficient Clinical Response|11|||
164513453|NCT01465763|594250704|FG001|Overall Study|Insufficient Clinical Response|0|||
164513454|NCT01465763|594250705|FG002|Overall Study|Insufficient Clinical Response|1|||
164513455|NCT01465763|594250703|FG000|Overall Study|Adverse Event|9|||
164513456|NCT01465763|594250704|FG001|Overall Study|Adverse Event|0|||
164513457|NCT01465763|594250705|FG002|Overall Study|Adverse Event|1|||
164513458|NCT01465763|594250703|FG000|Overall Study|Other|2|||
164513459|NCT01465763|594250704|FG001|Overall Study|Other|0|||
164513460|NCT01465763|594250705|FG002|Overall Study|Other|0|||
164513461|NCT01465763|594250703|FG000|Overall Study|Protocol Violation|4|||
164513462|NCT01465763|594250704|FG001|Overall Study|Protocol Violation|1|||
164513463|NCT01465763|594250705|FG002|Overall Study|Protocol Violation|1|||
164513464|NCT01465763|594250703|FG000|Overall Study|Death|1|||
164513465|NCT01465763|594250704|FG001|Overall Study|Death|0|||
164513466|NCT01465763|594250705|FG002|Overall Study|Death|0|||
164513467|NCT01646177|594250706|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
164513468|NCT01646177|594250707|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
164513469|NCT01646177|594250708|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
164513470|NCT01646177|594250709|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
164513471|NCT01646177|594250710|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
164513472|NCT01646177|594250711|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
164513473|NCT01646177|594250712|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
164513474|NCT01646177|594250713|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
164513475|NCT01646177|594250714|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
164513476|NCT01646177|594250715|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
164513477|NCT01646177|594250716|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
164513478|NCT01646177|594250717|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
164513479|NCT01646177|594250706|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
164513480|NCT01646177|594250707|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
164513481|NCT01646177|594250708|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
164513482|NCT01646177|594250709|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
164513483|NCT01646177|594250710|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
164513484|NCT01646177|594250711|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
164513485|NCT01646177|594250712|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
164513486|NCT01646177|594250713|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
164513487|NCT01646177|594250714|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
164513488|NCT01646177|594250715|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
164513489|NCT01646177|594250716|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
164513490|NCT01646177|594250717|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
164513491|NCT01646177|594250706|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
164513492|NCT01646177|594250707|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
164513493|NCT01646177|594250708|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
164513494|NCT01646177|594250709|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
164513495|NCT01646177|594250710|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
164513496|NCT01646177|594250711|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
164513497|NCT01646177|594250712|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
164513498|NCT01646177|594250713|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
164513499|NCT01646177|594250714|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
164513500|NCT01646177|594250715|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
164513501|NCT01646177|594250716|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
164513502|NCT01646177|594250717|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
164513503|NCT01646177|594250706|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
164513504|NCT01646177|594250707|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
164513505|NCT01646177|594250708|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
164513506|NCT01646177|594250709|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
164513507|NCT01646177|594250710|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
164513508|NCT01646177|594250711|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
164513509|NCT01646177|594250712|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
164513510|NCT01646177|594250713|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
164513511|NCT01646177|594250714|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
164513512|NCT01646177|594250715|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
164513513|NCT01646177|594250716|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
164513514|NCT01646177|594250717|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
164513515|NCT01646177|594250706|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
164513516|NCT01646177|594250707|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
164513517|NCT01646177|594250708|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
164513518|NCT01646177|594250709|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
164513519|NCT01646177|594250710|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
164513520|NCT01646177|594250711|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
164513521|NCT01646177|594250712|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
164513522|NCT01646177|594250713|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
164513523|NCT01646177|594250714|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
164513524|NCT01646177|594250715|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
164513525|NCT01646177|594250716|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
164513526|NCT01646177|594250717|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
164513527|NCT01646177|594250706|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
164513528|NCT01646177|594250707|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
164513529|NCT01646177|594250708|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
164513530|NCT01646177|594250709|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
164513531|NCT01646177|594250710|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
164513532|NCT01646177|594250711|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
164513533|NCT01646177|594250712|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
164513534|NCT01646177|594250713|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
164513535|NCT01646177|594250714|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
164513536|NCT01646177|594250715|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
164513537|NCT01646177|594250716|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
164513538|NCT01646177|594250717|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
164513539|NCT01646177|594250706|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
164513540|NCT01646177|594250707|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
164513541|NCT01646177|594250708|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
164513542|NCT01646177|594250709|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
164513543|NCT01646177|594250710|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
164513544|NCT01646177|594250711|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
164513545|NCT01646177|594250712|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
164513546|NCT01646177|594250713|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
164513547|NCT01646177|594250714|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
164513548|NCT01646177|594250715|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
164513549|NCT01646177|594250716|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
164513550|NCT01646177|594250717|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
164513551|NCT01646177|594250706|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
164513552|NCT01646177|594250707|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
164513553|NCT01646177|594250708|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
164513554|NCT01646177|594250709|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
164513555|NCT01646177|594250710|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
164513556|NCT01646177|594250711|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
164513557|NCT01646177|594250712|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
164513558|NCT01646177|594250713|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
164513559|NCT01646177|594250714|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
164513560|NCT01646177|594250715|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
164513561|NCT01646177|594250716|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
164513562|NCT01646177|594250717|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
164513563|NCT01646177|594250706|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
164513564|NCT01646177|594250707|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
164513565|NCT01646177|594250708|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
164513566|NCT01646177|594250709|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
164513567|NCT01646177|594250710|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
164513568|NCT01646177|594250711|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
164513569|NCT01646177|594250712|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
164513570|NCT01646177|594250713|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
164513571|NCT01646177|594250714|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
164513572|NCT01646177|594250715|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
164513573|NCT01646177|594250716|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
164513574|NCT01646177|594250717|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
164513575|NCT01646177|594250706|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
164513576|NCT01646177|594250707|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
164513577|NCT01646177|594250708|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
164513578|NCT01646177|594250709|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
164513579|NCT01646177|594250710|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
164513580|NCT01646177|594250711|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
164513581|NCT01646177|594250712|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
164513582|NCT01646177|594250713|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
164513583|NCT01646177|594250714|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
164513584|NCT01646177|594250715|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
164513585|NCT01646177|594250716|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
164513586|NCT01646177|594250717|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
164513587|NCT01646177|594250706|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
164513588|NCT01646177|594250707|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
164513589|NCT01646177|594250708|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
164513590|NCT01646177|594250709|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
164513591|NCT01646177|594250710|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
164513592|NCT01646177|594250711|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
164513593|NCT01646177|594250712|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
164513594|NCT01646177|594250713|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
164513595|NCT01646177|594250714|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
164513596|NCT01646177|594250715|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
164513597|NCT01646177|594250716|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
164513598|NCT01646177|594250717|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
164513599|NCT01646177|594250706|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
164513600|NCT01646177|594250707|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
164513601|NCT01646177|594250708|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
164513602|NCT01646177|594250709|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
164513603|NCT01646177|594250710|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
164513604|NCT01646177|594250711|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
164513605|NCT01646177|594250712|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
164513606|NCT01646177|594250713|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
164513607|NCT01646177|594250714|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
164513608|NCT01646177|594250715|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
164513609|NCT01646177|594250716|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
164513610|NCT01646177|594250717|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
164513611|NCT01646177|594250706|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
164513612|NCT01646177|594250707|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
164513613|NCT01646177|594250708|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
164513614|NCT01646177|594250709|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
164513615|NCT01646177|594250710|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
164513616|NCT01646177|594250711|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
164513617|NCT01646177|594250712|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
164513618|NCT01646177|594250713|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
164513619|NCT01646177|594250714|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
164513620|NCT01646177|594250715|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
164513621|NCT01646177|594250716|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
164513622|NCT01646177|594250717|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
164513623|NCT01646177|594250706|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
164513624|NCT01646177|594250707|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
164513625|NCT01646177|594250708|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
164513626|NCT01646177|594250709|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
164513627|NCT01646177|594250710|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
164513628|NCT01646177|594250711|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
164513629|NCT01646177|594250712|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
164513630|NCT01646177|594250713|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
164513631|NCT01646177|594250714|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
164513632|NCT01646177|594250715|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
164513633|NCT01646177|594250716|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
164513634|NCT01646177|594250717|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
164513635|NCT01646177|594250706|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
164513636|NCT01646177|594250707|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
164513637|NCT01646177|594250708|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
164513638|NCT01646177|594250709|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
164513639|NCT01646177|594250710|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
164513640|NCT01646177|594250711|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
164513641|NCT01646177|594250712|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
164513642|NCT01646177|594250713|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
164513643|NCT01646177|594250714|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
164513644|NCT01646177|594250715|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
164513645|NCT01646177|594250716|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
164513646|NCT01646177|594250717|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
164513647|NCT01646177|594250706|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
164513648|NCT01646177|594250707|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
164513649|NCT01646177|594250708|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
164513650|NCT01646177|594250709|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
164513651|NCT01646177|594250710|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
164513652|NCT01646177|594250711|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
164513653|NCT01646177|594250712|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
164513654|NCT01646177|594250713|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
164513655|NCT01646177|594250714|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
164513656|NCT01646177|594250715|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
164513657|NCT01646177|594250716|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
164513658|NCT01646177|594250717|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
164513659|NCT01646177|594250706|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
164513660|NCT01646177|594250707|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
164513661|NCT01646177|594250708|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
164513662|NCT01646177|594250709|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
164146985|NCT00443729|592899921|FG001|Overall Study|Physician Decision|1|||
164513663|NCT01646177|594250710|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
164513664|NCT01646177|594250711|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
164513665|NCT01646177|594250712|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
164513666|NCT01646177|594250713|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
164513667|NCT01646177|594250714|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
164513668|NCT01646177|594250715|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
164513669|NCT01646177|594250716|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
164513670|NCT01646177|594250717|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
164513671|NCT01646177|594250706|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
164513672|NCT01646177|594250707|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
164513673|NCT01646177|594250708|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
164513674|NCT01646177|594250709|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
164513675|NCT01646177|594250710|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
164513676|NCT01646177|594250711|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
164513677|NCT01646177|594250712|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
164513678|NCT01646177|594250713|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
164513679|NCT01646177|594250714|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
164513680|NCT01646177|594250715|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
164513681|NCT01646177|594250716|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
164513682|NCT01646177|594250717|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
164513683|NCT01646177|594250706|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
164513684|NCT01646177|594250707|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
164513685|NCT01646177|594250708|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
164513686|NCT01646177|594250709|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
164513687|NCT01646177|594250710|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
164513688|NCT01646177|594250711|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
164513689|NCT01646177|594250712|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
164513690|NCT01646177|594250713|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
164513691|NCT01646177|594250714|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
164513692|NCT01646177|594250715|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
164513693|NCT01646177|594250716|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
164513694|NCT01646177|594250717|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
164513695|NCT01646177|594250706|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
164513696|NCT01646177|594250707|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
164513697|NCT01646177|594250708|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
164513698|NCT01646177|594250709|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
164513699|NCT01646177|594250710|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
164513700|NCT01646177|594250711|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
164513701|NCT01646177|594250712|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
164513702|NCT01646177|594250713|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
164513703|NCT01646177|594250714|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
164513704|NCT01646177|594250715|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
164513705|NCT01646177|594250716|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
164513706|NCT01646177|594250717|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
164513707|NCT01646177|594250706|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
164513708|NCT01646177|594250707|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
164513709|NCT01646177|594250708|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
164513710|NCT01646177|594250709|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
164513711|NCT01646177|594250710|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
164513712|NCT01646177|594250711|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
164513713|NCT01646177|594250712|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
164513714|NCT01646177|594250713|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
164513715|NCT01646177|594250714|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
164513716|NCT01646177|594250715|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
164513717|NCT01646177|594250716|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
164513718|NCT01646177|594250717|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
164513719|NCT01646177|594250706|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
164513720|NCT01646177|594250707|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
164513721|NCT01646177|594250708|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
164513722|NCT01646177|594250709|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
164513723|NCT01646177|594250710|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
164513724|NCT01646177|594250711|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
164513725|NCT01646177|594250712|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
164513726|NCT01646177|594250713|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
164513727|NCT01646177|594250714|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
164513728|NCT01646177|594250715|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
164513729|NCT01646177|594250716|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
164513730|NCT01646177|594250717|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
164513731|NCT01646177|594250706|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
164513732|NCT01646177|594250707|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
164513733|NCT01646177|594250708|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
164513734|NCT01646177|594250709|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
164513735|NCT01646177|594250710|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
164513736|NCT01646177|594250711|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
164513737|NCT01646177|594250712|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
164513738|NCT01646177|594250713|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
164513739|NCT01646177|594250714|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
164513740|NCT01646177|594250715|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
164513741|NCT01646177|594250716|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
164513742|NCT01646177|594250717|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
164513743|NCT01646177|594250706|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
164513744|NCT01646177|594250707|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
164513745|NCT01646177|594250708|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
164513746|NCT01646177|594250709|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
164513747|NCT01646177|594250710|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
164513748|NCT01646177|594250711|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
164513749|NCT01646177|594250712|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
164513750|NCT01646177|594250713|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
164513751|NCT01646177|594250714|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
164513752|NCT01646177|594250715|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
164513753|NCT01646177|594250716|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
164513754|NCT01646177|594250717|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
164513755|NCT01646177|594250706|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
164513756|NCT01646177|594250707|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
164513757|NCT01646177|594250708|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
164513758|NCT01646177|594250709|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
164513759|NCT01646177|594250710|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
164513760|NCT01646177|594250711|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
164513761|NCT01646177|594250712|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
164513762|NCT01646177|594250713|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
164513763|NCT01646177|594250714|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
164513764|NCT01646177|594250715|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
164513765|NCT01646177|594250716|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
164513766|NCT01646177|594250717|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
164513767|NCT01646177|594250706|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
164513768|NCT01646177|594250707|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
164513769|NCT01646177|594250708|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
164513770|NCT01646177|594250709|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
164513771|NCT01646177|594250710|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
164513772|NCT01646177|594250711|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
164513773|NCT01646177|594250712|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
164513774|NCT01646177|594250713|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
164513775|NCT01646177|594250714|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
164513776|NCT01646177|594250715|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
164513777|NCT01646177|594250716|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
164513778|NCT01646177|594250717|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
164513779|NCT01646177|594250706|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
164513780|NCT01646177|594250707|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
164513781|NCT01646177|594250708|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
164513782|NCT01646177|594250709|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
164513783|NCT01646177|594250710|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
164513784|NCT01646177|594250711|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
164513785|NCT01646177|594250712|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
164609902|NCT02293902|594591542|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
164609903|NCT02293902|594591543|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
164609904|NCT02293902|594591544|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
164609905|NCT02293902|594591545|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
164609906|NCT00107172|594592953|FG000|Overall Study|Withdrawal by Subject|1|||
164609907|NCT00107172|594592954|FG001|Overall Study|Withdrawal by Subject|0|||
164513786|NCT01646177|594250713|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
164513787|NCT01646177|594250714|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
164513788|NCT01646177|594250715|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
164513789|NCT01646177|594250716|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
164513790|NCT01646177|594250717|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
164513791|NCT02992691|594250720|FG000|Overall Study|Adverse Event|2|||
164513792|NCT02992691|594250720|FG000|Overall Study|Withdrawal by Subject|1|||
164513793|NCT00588692|594250721|FG000|Overall Study|Withdrawal by Subject|4|||
164513794|NCT00588692|594250722|FG001|Overall Study|Withdrawal by Subject|2|||
164513795|NCT00588692|594250721|FG000|Overall Study|Hip Surgery|0|||
164513796|NCT00588692|594250722|FG001|Overall Study|Hip Surgery|1|||
164513797|NCT00588692|594250721|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
164513798|NCT00588692|594250722|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
164513799|NCT00588692|594250721|FG000|Overall Study|Cancer|1|||
164513800|NCT00588692|594250722|FG001|Overall Study|Cancer|0|||
164513801|NCT00588692|594250721|FG000|Overall Study|Death|1|||
164513802|NCT00588692|594250722|FG001|Overall Study|Death|0|||
164513803|NCT02227992|594250727|FG000|Overall Study|Lost to Follow-up|1|||
164513804|NCT02227992|594250728|FG001|Overall Study|Lost to Follow-up|1|||
164513805|NCT01876082|594253556|FG000|Overall Study|Withdrawal by Subject|0|||
164513806|NCT01876082|594253557|FG001|Overall Study|Withdrawal by Subject|2|||
164513807|NCT01876082|594253556|FG000|Overall Study|Protocol Violation|1|||
164513808|NCT01876082|594253557|FG001|Overall Study|Protocol Violation|0|||
164513809|NCT01876082|594253556|FG000|Overall Study|Adverse Event|1|||
164513810|NCT01876082|594253557|FG001|Overall Study|Adverse Event|1|||
164513811|NCT01876082|594253556|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
164513812|NCT01876082|594253557|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
164513813|NCT03829501|594253559|FG000|Overall Study|Withdrawal of Consent|2|||
164513814|NCT03829501|594253560|FG001|Overall Study|Withdrawal of Consent|0|||
164513815|NCT03829501|594253561|FG002|Overall Study|Withdrawal of Consent|3|||
164513816|NCT03829501|594253562|FG003|Overall Study|Withdrawal of Consent|0|||
164513817|NCT03829501|594253563|FG004|Overall Study|Withdrawal of Consent|1|||
164513818|NCT03829501|594253564|FG005|Overall Study|Withdrawal of Consent|1|||
164513819|NCT03829501|594253565|FG006|Overall Study|Withdrawal of Consent|0|||
164513820|NCT03829501|594253566|FG007|Overall Study|Withdrawal of Consent|10|||
164513821|NCT03829501|594253567|FG008|Overall Study|Withdrawal of Consent|10|||
164513822|NCT03829501|594253568|FG009|Overall Study|Withdrawal of Consent|3|||
164513823|NCT03829501|594253569|FG010|Overall Study|Withdrawal of Consent|4|||
164513824|NCT03829501|594253570|FG011|Overall Study|Withdrawal of Consent|4|||
164513825|NCT03829501|594253571|FG012|Overall Study|Withdrawal of Consent|4|||
164513826|NCT03829501|594253572|FG013|Overall Study|Withdrawal of Consent|0|||
164513827|NCT03829501|594253573|FG014|Overall Study|Withdrawal of Consent|3|||
164513828|NCT03829501|594253574|FG015|Overall Study|Withdrawal of Consent|0|||
164513829|NCT03829501|594253575|FG016|Overall Study|Withdrawal of Consent|1|||
164513830|NCT03829501|594253576|FG017|Overall Study|Withdrawal of Consent|1|||
164513831|NCT03829501|594253577|FG018|Overall Study|Withdrawal of Consent|0|||
164513832|NCT03829501|594253578|FG019|Overall Study|Withdrawal of Consent|0|||
164513833|NCT03829501|594253579|FG020|Overall Study|Withdrawal of Consent|3|||
164513834|NCT03829501|594253580|FG021|Overall Study|Withdrawal of Consent|0|||
164513835|NCT03829501|594253581|FG022|Overall Study|Withdrawal of Consent|1|||
164513836|NCT03829501|594253559|FG000|Overall Study|PD|0|||
164513837|NCT03829501|594253560|FG001|Overall Study|PD|0|||
164513838|NCT03829501|594253561|FG002|Overall Study|PD|0|||
164513839|NCT03829501|594253562|FG003|Overall Study|PD|2|||
164513840|NCT03829501|594253563|FG004|Overall Study|PD|0|||
164513841|NCT03829501|594253564|FG005|Overall Study|PD|0|||
164513842|NCT03829501|594253565|FG006|Overall Study|PD|0|||
164513843|NCT03829501|594253566|FG007|Overall Study|PD|0|||
164513844|NCT03829501|594253567|FG008|Overall Study|PD|0|||
164513845|NCT03829501|594253568|FG009|Overall Study|PD|0|||
164513846|NCT03829501|594253569|FG010|Overall Study|PD|0|||
164513847|NCT03829501|594253570|FG011|Overall Study|PD|0|||
164513848|NCT03829501|594253571|FG012|Overall Study|PD|0|||
164513849|NCT03829501|594253572|FG013|Overall Study|PD|0|||
164513850|NCT03829501|594253573|FG014|Overall Study|PD|0|||
164513851|NCT03829501|594253574|FG015|Overall Study|PD|1|||
164513852|NCT03829501|594253575|FG016|Overall Study|PD|0|||
164513853|NCT03829501|594253576|FG017|Overall Study|PD|0|||
164513854|NCT03829501|594253577|FG018|Overall Study|PD|0|||
164513855|NCT03829501|594253578|FG019|Overall Study|PD|0|||
164513856|NCT03829501|594253579|FG020|Overall Study|PD|1|||
164513857|NCT03829501|594253580|FG021|Overall Study|PD|0|||
164513858|NCT03829501|594253581|FG022|Overall Study|PD|0|||
164513859|NCT03829501|594253559|FG000|Overall Study|Study Terminated by Sponsor|0|||
164513860|NCT03829501|594253560|FG001|Overall Study|Study Terminated by Sponsor|0|||
164513861|NCT03829501|594253561|FG002|Overall Study|Study Terminated by Sponsor|0|||
164513862|NCT03829501|594253562|FG003|Overall Study|Study Terminated by Sponsor|0|||
164513863|NCT03829501|594253563|FG004|Overall Study|Study Terminated by Sponsor|0|||
164513864|NCT03829501|594253564|FG005|Overall Study|Study Terminated by Sponsor|0|||
164513865|NCT03829501|594253565|FG006|Overall Study|Study Terminated by Sponsor|0|||
164513866|NCT03829501|594253566|FG007|Overall Study|Study Terminated by Sponsor|3|||
164513867|NCT03829501|594253567|FG008|Overall Study|Study Terminated by Sponsor|1|||
164513868|NCT03829501|594253568|FG009|Overall Study|Study Terminated by Sponsor|0|||
164513869|NCT03829501|594253569|FG010|Overall Study|Study Terminated by Sponsor|0|||
164513870|NCT03829501|594253570|FG011|Overall Study|Study Terminated by Sponsor|0|||
164513871|NCT03829501|594253571|FG012|Overall Study|Study Terminated by Sponsor|0|||
164513872|NCT03829501|594253572|FG013|Overall Study|Study Terminated by Sponsor|0|||
164513873|NCT03829501|594253573|FG014|Overall Study|Study Terminated by Sponsor|3|||
164513874|NCT03829501|594253574|FG015|Overall Study|Study Terminated by Sponsor|2|||
164513875|NCT03829501|594253575|FG016|Overall Study|Study Terminated by Sponsor|2|||
164513876|NCT03829501|594253576|FG017|Overall Study|Study Terminated by Sponsor|0|||
164513877|NCT03829501|594253577|FG018|Overall Study|Study Terminated by Sponsor|0|||
164513878|NCT03829501|594253578|FG019|Overall Study|Study Terminated by Sponsor|0|||
164513879|NCT03829501|594253579|FG020|Overall Study|Study Terminated by Sponsor|1|||
164513880|NCT03829501|594253580|FG021|Overall Study|Study Terminated by Sponsor|0|||
164513881|NCT03829501|594253581|FG022|Overall Study|Study Terminated by Sponsor|3|||
164513882|NCT03829501|594253559|FG000|Overall Study|Lost to Follow Up|0|||
164513883|NCT03829501|594253560|FG001|Overall Study|Lost to Follow Up|0|||
164513884|NCT03829501|594253561|FG002|Overall Study|Lost to Follow Up|0|||
164513885|NCT03829501|594253562|FG003|Overall Study|Lost to Follow Up|0|||
164513886|NCT03829501|594253563|FG004|Overall Study|Lost to Follow Up|1|||
164513887|NCT03829501|594253564|FG005|Overall Study|Lost to Follow Up|0|||
164513888|NCT03829501|594253565|FG006|Overall Study|Lost to Follow Up|0|||
164513889|NCT03829501|594253566|FG007|Overall Study|Lost to Follow Up|2|||
164513890|NCT03829501|594253567|FG008|Overall Study|Lost to Follow Up|2|||
164513891|NCT03829501|594253568|FG009|Overall Study|Lost to Follow Up|0|||
164513892|NCT03829501|594253569|FG010|Overall Study|Lost to Follow Up|2|||
164513893|NCT03829501|594253570|FG011|Overall Study|Lost to Follow Up|1|||
164513894|NCT03829501|594253571|FG012|Overall Study|Lost to Follow Up|0|||
164513895|NCT03829501|594253572|FG013|Overall Study|Lost to Follow Up|1|||
164513896|NCT03829501|594253573|FG014|Overall Study|Lost to Follow Up|1|||
164513897|NCT03829501|594253574|FG015|Overall Study|Lost to Follow Up|0|||
164513898|NCT03829501|594253575|FG016|Overall Study|Lost to Follow Up|0|||
164513899|NCT03829501|594253576|FG017|Overall Study|Lost to Follow Up|0|||
164513900|NCT03829501|594253577|FG018|Overall Study|Lost to Follow Up|0|||
164513901|NCT03829501|594253578|FG019|Overall Study|Lost to Follow Up|0|||
164513902|NCT03829501|594253579|FG020|Overall Study|Lost to Follow Up|0|||
164513903|NCT03829501|594253580|FG021|Overall Study|Lost to Follow Up|0|||
164513904|NCT03829501|594253581|FG022|Overall Study|Lost to Follow Up|1|||
164513905|NCT03829501|594253559|FG000|Overall Study|Death|2|||
164513906|NCT03829501|594253560|FG001|Overall Study|Death|4|||
164513907|NCT03829501|594253561|FG002|Overall Study|Death|5|||
164513908|NCT03829501|594253562|FG003|Overall Study|Death|6|||
164513909|NCT03829501|594253563|FG004|Overall Study|Death|5|||
164513910|NCT03829501|594253564|FG005|Overall Study|Death|4|||
164513911|NCT03829501|594253565|FG006|Overall Study|Death|5|||
164513912|NCT03829501|594253566|FG007|Overall Study|Death|24|||
164513913|NCT03829501|594253567|FG008|Overall Study|Death|22|||
164513914|NCT03829501|594253568|FG009|Overall Study|Death|6|||
164513915|NCT03829501|594253569|FG010|Overall Study|Death|3|||
164513916|NCT03829501|594253570|FG011|Overall Study|Death|10|||
164513917|NCT03829501|594253571|FG012|Overall Study|Death|10|||
164513918|NCT03829501|594253572|FG013|Overall Study|Death|5|||
164513919|NCT03829501|594253573|FG014|Overall Study|Death|7|||
164513920|NCT03829501|594253574|FG015|Overall Study|Death|2|||
164513921|NCT03829501|594253575|FG016|Overall Study|Death|2|||
164513922|NCT03829501|594253576|FG017|Overall Study|Death|1|||
164513923|NCT03829501|594253577|FG018|Overall Study|Death|1|||
164513924|NCT03829501|594253578|FG019|Overall Study|Death|1|||
164513925|NCT03829501|594253579|FG020|Overall Study|Death|1|||
164513926|NCT03829501|594253580|FG021|Overall Study|Death|2|||
164513927|NCT03829501|594253581|FG022|Overall Study|Death|3|||
164513928|NCT03829501|594253559|FG000|Overall Study|Miscellaneous|0|||
164513929|NCT03829501|594253560|FG001|Overall Study|Miscellaneous|0|||
164513930|NCT03829501|594253561|FG002|Overall Study|Miscellaneous|1|||
164513931|NCT03829501|594253562|FG003|Overall Study|Miscellaneous|0|||
164513932|NCT03829501|594253563|FG004|Overall Study|Miscellaneous|0|||
164513933|NCT03829501|594253564|FG005|Overall Study|Miscellaneous|0|||
164513934|NCT03829501|594253565|FG006|Overall Study|Miscellaneous|0|||
164513935|NCT03829501|594253566|FG007|Overall Study|Miscellaneous|1|||
164513936|NCT03829501|594253567|FG008|Overall Study|Miscellaneous|0|||
164513937|NCT03829501|594253568|FG009|Overall Study|Miscellaneous|0|||
164513938|NCT03829501|594253569|FG010|Overall Study|Miscellaneous|0|||
164513939|NCT03829501|594253570|FG011|Overall Study|Miscellaneous|0|||
164513940|NCT03829501|594253571|FG012|Overall Study|Miscellaneous|0|||
164513941|NCT03829501|594253572|FG013|Overall Study|Miscellaneous|0|||
164513942|NCT03829501|594253573|FG014|Overall Study|Miscellaneous|0|||
164513943|NCT03829501|594253574|FG015|Overall Study|Miscellaneous|0|||
164513944|NCT03829501|594253575|FG016|Overall Study|Miscellaneous|0|||
164513945|NCT03829501|594253576|FG017|Overall Study|Miscellaneous|0|||
164513946|NCT03829501|594253577|FG018|Overall Study|Miscellaneous|0|||
164513947|NCT03829501|594253578|FG019|Overall Study|Miscellaneous|0|||
164609908|NCT00107172|594592953|FG000|Overall Study|Death|0|||
164609909|NCT00107172|594592954|FG001|Overall Study|Death|2|||
164609910|NCT00107172|594592953|FG000|Overall Study|Other Reason|4|||
164609911|NCT00107172|594592954|FG001|Overall Study|Other Reason|3|||
164609912|NCT04268303|594592955|FG000|Overall Study|Lost to Follow-up|1|||
164609913|NCT04268303|594592956|FG001|Overall Study|Lost to Follow-up|1|||
164609914|NCT04268303|594592957|FG002|Overall Study|Lost to Follow-up|2|||
164609915|NCT04268303|594592955|FG000|Overall Study|Withdrawal by Subject|0|||
164609916|NCT04268303|594592956|FG001|Overall Study|Withdrawal by Subject|1|||
164609917|NCT04268303|594592957|FG002|Overall Study|Withdrawal by Subject|1|||
164609918|NCT04268303|594592955|FG000|Overall Study|Adverse Event|2|||
164609919|NCT04268303|594592956|FG001|Overall Study|Adverse Event|0|||
164609920|NCT04268303|594592957|FG002|Overall Study|Adverse Event|0|||
164609921|NCT00355134|594592958|FG000|Core Phase|Withdrawal by Subject|35|||
164609922|NCT00355134|594592959|FG001|Core Phase|Withdrawal by Subject|24|||
164609923|NCT00355134|594592960|FG002|Core Phase|Withdrawal by Subject|35|||
164609924|NCT00355134|594592961|FG003|Core Phase|Withdrawal by Subject|0|||
164609925|NCT00355134|594592962|FG004|Core Phase|Withdrawal by Subject|0|||
164609926|NCT00355134|594592958|FG000|Core Phase|Adverse Event|28|||
164609927|NCT00355134|594592959|FG001|Core Phase|Adverse Event|22|||
164609928|NCT00355134|594592960|FG002|Core Phase|Adverse Event|16|||
164609929|NCT00355134|594592961|FG003|Core Phase|Adverse Event|0|||
164609930|NCT00355134|594592962|FG004|Core Phase|Adverse Event|0|||
164609931|NCT00355134|594592958|FG000|Core Phase|Lost to Follow-up|17|||
164609932|NCT00355134|594592959|FG001|Core Phase|Lost to Follow-up|13|||
164609933|NCT00355134|594592960|FG002|Core Phase|Lost to Follow-up|21|||
164609934|NCT00355134|594592961|FG003|Core Phase|Lost to Follow-up|0|||
164609935|NCT00355134|594592962|FG004|Core Phase|Lost to Follow-up|0|||
164609936|NCT00355134|594592958|FG000|Core Phase|Abnormal laboratory value(s)|19|||
164609937|NCT00355134|594592959|FG001|Core Phase|Abnormal laboratory value(s)|14|||
164609938|NCT00355134|594592960|FG002|Core Phase|Abnormal laboratory value(s)|2|||
164609939|NCT00355134|594592961|FG003|Core Phase|Abnormal laboratory value(s)|0|||
164609940|NCT00355134|594592962|FG004|Core Phase|Abnormal laboratory value(s)|0|||
164609941|NCT00355134|594592958|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
164609942|NCT00355134|594592959|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
164609943|NCT00355134|594592960|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
164609944|NCT00355134|594592961|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
164609945|NCT00355134|594592962|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
164609946|NCT00355134|594592958|FG000|Core Phase|Administrative problems|5|||
164609947|NCT00355134|594592959|FG001|Core Phase|Administrative problems|3|||
164609948|NCT00355134|594592960|FG002|Core Phase|Administrative problems|5|||
164609949|NCT00355134|594592961|FG003|Core Phase|Administrative problems|0|||
164609950|NCT00355134|594592962|FG004|Core Phase|Administrative problems|0|||
164609951|NCT00355134|594592958|FG000|Core Phase|Protocol Violation|3|||
164609952|NCT00355134|594592959|FG001|Core Phase|Protocol Violation|2|||
164609953|NCT00355134|594592960|FG002|Core Phase|Protocol Violation|2|||
164609954|NCT00355134|594592961|FG003|Core Phase|Protocol Violation|0|||
164609955|NCT00355134|594592962|FG004|Core Phase|Protocol Violation|0|||
164609956|NCT00355134|594592958|FG000|Core Phase|Abnormal test procedure result(s)|1|||
164609957|NCT00355134|594592959|FG001|Core Phase|Abnormal test procedure result(s)|2|||
164609958|NCT00355134|594592960|FG002|Core Phase|Abnormal test procedure result(s)|1|||
164609959|NCT00355134|594592961|FG003|Core Phase|Abnormal test procedure result(s)|0|||
164609960|NCT00355134|594592962|FG004|Core Phase|Abnormal test procedure result(s)|0|||
164609961|NCT00355134|594592958|FG000|Core Phase|Condition no longer requires study drug|1|||
164609962|NCT00355134|594592959|FG001|Core Phase|Condition no longer requires study drug|0|||
164609963|NCT00355134|594592960|FG002|Core Phase|Condition no longer requires study drug|1|||
164609964|NCT00355134|594592961|FG003|Core Phase|Condition no longer requires study drug|0|||
164609965|NCT00355134|594592962|FG004|Core Phase|Condition no longer requires study drug|0|||
164609966|NCT00355134|594592958|FG000|Extension Phase|Withdrawal by Subject|7|||
164609967|NCT00355134|594592959|FG001|Extension Phase|Withdrawal by Subject|11|||
164609968|NCT00355134|594592960|FG002|Extension Phase|Withdrawal by Subject|0|||
164609969|NCT00355134|594592961|FG003|Extension Phase|Withdrawal by Subject|7|||
164609970|NCT00355134|594592962|FG004|Extension Phase|Withdrawal by Subject|5|||
164609971|NCT00355134|594592958|FG000|Extension Phase|Adverse Event|13|||
164609972|NCT00355134|594592959|FG001|Extension Phase|Adverse Event|9|||
164609973|NCT00355134|594592960|FG002|Extension Phase|Adverse Event|0|||
164609974|NCT00355134|594592961|FG003|Extension Phase|Adverse Event|3|||
164609975|NCT00355134|594592962|FG004|Extension Phase|Adverse Event|5|||
164609976|NCT00355134|594592958|FG000|Extension Phase|Lost to Follow-up|2|||
164609977|NCT00355134|594592959|FG001|Extension Phase|Lost to Follow-up|6|||
164609978|NCT00355134|594592960|FG002|Extension Phase|Lost to Follow-up|0|||
164609979|NCT00355134|594592961|FG003|Extension Phase|Lost to Follow-up|2|||
164609980|NCT00355134|594592962|FG004|Extension Phase|Lost to Follow-up|4|||
164609981|NCT00355134|594592958|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
164609982|NCT00355134|594592959|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
164513948|NCT03829501|594253579|FG020|Overall Study|Miscellaneous|0|||
164513949|NCT03829501|594253580|FG021|Overall Study|Miscellaneous|0|||
164513950|NCT03829501|594253581|FG022|Overall Study|Miscellaneous|1|||
164513951|NCT04942366|594253582|FG000|Overall Study|Withdrawal by Subject|5|||
164513952|NCT04942366|594253583|FG001|Overall Study|Withdrawal by Subject|5|||
164513953|NCT00747227|594253590|FG000|Overall Study|Death|3|||
164513954|NCT00747227|594253591|FG001|Overall Study|Death|1|||
164513955|NCT00747227|594253590|FG000|Overall Study|Withdrawal by Subject|1|||
164513956|NCT00747227|594253591|FG001|Overall Study|Withdrawal by Subject|0|||
164513957|NCT00747227|594253590|FG000|Overall Study|Lost to Follow-up|1|||
164513958|NCT00747227|594253591|FG001|Overall Study|Lost to Follow-up|2|||
164513959|NCT00747227|594253590|FG000|Overall Study|Illness|1|||
164513960|NCT00747227|594253591|FG001|Overall Study|Illness|1|||
164513961|NCT03284229|594253592|FG000|Overall Study|Lost to Follow-up|3|||
164513962|NCT04707664|594253594|FG000|Overall Study|Adverse Event|2|||
164513963|NCT04707664|594253595|FG001|Overall Study|Adverse Event|0|||
164513964|NCT04707664|594253594|FG000|Overall Study|Death|1|||
164513965|NCT04707664|594253595|FG001|Overall Study|Death|2|||
164513966|NCT04707664|594253594|FG000|Overall Study|Withdrawal by Subject|13|||
164513967|NCT04707664|594253595|FG001|Overall Study|Withdrawal by Subject|21|||
164513968|NCT04707664|594253594|FG000|Overall Study|Lost to Follow-up|11|||
164513969|NCT04707664|594253595|FG001|Overall Study|Lost to Follow-up|13|||
164513970|NCT04707664|594253594|FG000|Overall Study|Not treated|2|||
164513971|NCT04707664|594253595|FG001|Overall Study|Not treated|0|||
164513972|NCT00357110|594253596|FG000|Overall Study|Early study termination|5|||
164513973|NCT00357110|594253597|FG001|Overall Study|Early study termination|5|||
164513974|NCT04335591|594253598|FG000|Overall Study|Adverse Event|5|||
164513975|NCT04335591|594253599|FG001|Overall Study|Adverse Event|2|||
164513976|NCT04335591|594253600|FG002|Overall Study|Adverse Event|3|||
164513977|NCT04335591|594253601|FG003|Overall Study|Adverse Event|2|||
164513978|NCT04335591|594253598|FG000|Overall Study|Protocol Violation|1|||
164513979|NCT04335591|594253599|FG001|Overall Study|Protocol Violation|0|||
164513980|NCT04335591|594253600|FG002|Overall Study|Protocol Violation|0|||
164513981|NCT04335591|594253601|FG003|Overall Study|Protocol Violation|0|||
164513982|NCT04335591|594253598|FG000|Overall Study|Withdrawal by Subject|8|||
164513983|NCT04335591|594253599|FG001|Overall Study|Withdrawal by Subject|4|||
164513984|NCT04335591|594253600|FG002|Overall Study|Withdrawal by Subject|4|||
164513985|NCT04335591|594253601|FG003|Overall Study|Withdrawal by Subject|5|||
164513986|NCT04335591|594253598|FG000|Overall Study|Subject planning pregnancy|0|||
164513987|NCT04335591|594253599|FG001|Overall Study|Subject planning pregnancy|1|||
164513988|NCT04335591|594253600|FG002|Overall Study|Subject planning pregnancy|0|||
164513989|NCT04335591|594253601|FG003|Overall Study|Subject planning pregnancy|0|||
164513990|NCT04335591|594253598|FG000|Overall Study|Ukrainian Russian war conflict|4|||
164513991|NCT04335591|594253599|FG001|Overall Study|Ukrainian Russian war conflict|5|||
164513992|NCT04335591|594253600|FG002|Overall Study|Ukrainian Russian war conflict|2|||
164513993|NCT04335591|594253601|FG003|Overall Study|Ukrainian Russian war conflict|0|||
164513994|NCT01939353|594253609|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
164513995|NCT01939353|594253609|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
164513996|NCT01939353|594253609|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
164513997|NCT01939353|594253609|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
164513998|NCT01939353|594253609|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
164513999|NCT04421950|594253613|FG000|Overall Study|Dropped or lost to follow up|4|||
164514000|NCT04421950|594253614|FG001|Overall Study|Dropped or lost to follow up|2|||
164514001|NCT00335140|594253617|FG000|Overall Study|Ineligible|1|||
164514002|NCT04546425|594253618|FG000|Overall Study|Protocol Violation|1|||
164514003|NCT04546425|594253619|FG001|Overall Study|Protocol Violation|1|||
164514004|NCT04546425|594253620|FG002|Overall Study|Protocol Violation|0|||
164514005|NCT04546425|594253621|FG003|Overall Study|Protocol Violation|0|||
164514006|NCT04546425|594253618|FG000|Overall Study|Adverse Event|3|||
164514007|NCT04546425|594253619|FG001|Overall Study|Adverse Event|0|||
164514008|NCT04546425|594253620|FG002|Overall Study|Adverse Event|0|||
164514009|NCT04546425|594253621|FG003|Overall Study|Adverse Event|0|||
164514010|NCT04546425|594253618|FG000|Overall Study|Lost to Follow-up|5|||
164514011|NCT04546425|594253619|FG001|Overall Study|Lost to Follow-up|4|||
164514012|NCT04546425|594253620|FG002|Overall Study|Lost to Follow-up|0|||
164514013|NCT04546425|594253621|FG003|Overall Study|Lost to Follow-up|0|||
164514014|NCT04546425|594253618|FG000|Overall Study|No Longer met eligibility criteria|3|||
164514015|NCT04546425|594253619|FG001|Overall Study|No Longer met eligibility criteria|3|||
164514016|NCT04546425|594253620|FG002|Overall Study|No Longer met eligibility criteria|1|||
164514017|NCT04546425|594253621|FG003|Overall Study|No Longer met eligibility criteria|1|||
164514018|NCT04546425|594253618|FG000|Overall Study|Withdrawal by parent/guardian|6|||
164514019|NCT04546425|594253619|FG001|Overall Study|Withdrawal by parent/guardian|5|||
164514020|NCT04546425|594253620|FG002|Overall Study|Withdrawal by parent/guardian|1|||
164514021|NCT04546425|594253621|FG003|Overall Study|Withdrawal by parent/guardian|1|||
164514022|NCT00737477|594253625|FG000|Overall Study|Adverse Event|9|||
164514023|NCT00737477|594253625|FG000|Overall Study|Death|9|||
164514024|NCT00737477|594253625|FG000|Overall Study|Treatment Refusal|1|||
164514025|NCT00737477|594253625|FG000|Overall Study|Withdrawal by Subject|1|||
164514026|NCT00737477|594253625|FG000|Overall Study|Renal Transplantation|10|||
164514027|NCT00737477|594253625|FG000|Overall Study|Other|4|||
164514028|NCT01132820|594253626|FG000|Overall Study|Ineligible: wrong cell type|1|||
164514029|NCT01132820|594253626|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
164514030|NCT01132820|594253626|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
164514031|NCT01132820|594253626|FG000|Overall Study|Never treated|1|||
164514032|NCT01132820|594253626|FG000|Overall Study|Inadequate data|1|||
164514033|NCT02687035|594253627|FG000|Overall Study|Withdrawal by Subject|1|||
164514034|NCT02687035|594253627|FG000|Overall Study|Death|87|||
164514035|NCT02687035|594253627|FG000|Overall Study|Lost to Follow-up|1|||
164514036|NCT02687035|594253627|FG000|Overall Study|Missed Visit|87|||
164514037|NCT02687035|594253627|FG000|Overall Study|Did not receive Study Device|8|||
164514038|NCT05000216|594253628|FG000|Stage 1|Lost to Follow-up|0|||
164514039|NCT05000216|594253629|FG001|Stage 1|Lost to Follow-up|0|||
164514040|NCT05000216|594253630|FG002|Stage 1|Lost to Follow-up|0|||
164514041|NCT05000216|594253631|FG003|Stage 1|Lost to Follow-up|0|||
164514042|NCT05000216|594253632|FG004|Stage 1|Lost to Follow-up|0|||
164514043|NCT05000216|594253633|FG005|Stage 1|Lost to Follow-up|0|||
164514044|NCT05000216|594253634|FG006|Stage 1|Lost to Follow-up|1|||
164514045|NCT05000216|594253635|FG007|Stage 1|Lost to Follow-up|1|||
164514046|NCT05000216|594253636|FG008|Stage 1|Lost to Follow-up|0|||
164514047|NCT05000216|594253637|FG009|Stage 1|Lost to Follow-up|2|||
164514048|NCT05000216|594253638|FG010|Stage 1|Lost to Follow-up|3|||
164514049|NCT05000216|594253639|FG011|Stage 1|Lost to Follow-up|0|||
164514050|NCT05000216|594253640|FG012|Stage 1|Lost to Follow-up|0|||
164514051|NCT05000216|594253641|FG013|Stage 1|Lost to Follow-up|0|||
164514052|NCT05000216|594253642|FG014|Stage 1|Lost to Follow-up|0|||
164514053|NCT05000216|594253643|FG015|Stage 1|Lost to Follow-up|0|||
164514054|NCT05000216|594253644|FG016|Stage 1|Lost to Follow-up|0|||
164514055|NCT05000216|594253645|FG017|Stage 1|Lost to Follow-up|0|||
164514056|NCT05000216|594253646|FG018|Stage 1|Lost to Follow-up|0|||
164514057|NCT05000216|594253647|FG019|Stage 1|Lost to Follow-up|0|||
164514058|NCT05000216|594253648|FG020|Stage 1|Lost to Follow-up|0|||
164514059|NCT05000216|594253649|FG021|Stage 1|Lost to Follow-up|0|||
164514060|NCT05000216|594253628|FG000|Stage 1|Physician Decision|0|||
164514061|NCT05000216|594253629|FG001|Stage 1|Physician Decision|0|||
164514062|NCT05000216|594253630|FG002|Stage 1|Physician Decision|0|||
164514063|NCT05000216|594253631|FG003|Stage 1|Physician Decision|0|||
164514064|NCT05000216|594253632|FG004|Stage 1|Physician Decision|0|||
164514065|NCT05000216|594253633|FG005|Stage 1|Physician Decision|0|||
164514066|NCT05000216|594253634|FG006|Stage 1|Physician Decision|0|||
164514067|NCT05000216|594253635|FG007|Stage 1|Physician Decision|1|||
164514068|NCT05000216|594253636|FG008|Stage 1|Physician Decision|1|||
164514069|NCT05000216|594253637|FG009|Stage 1|Physician Decision|0|||
164514070|NCT05000216|594253638|FG010|Stage 1|Physician Decision|0|||
164514071|NCT05000216|594253639|FG011|Stage 1|Physician Decision|0|||
164514072|NCT05000216|594253640|FG012|Stage 1|Physician Decision|0|||
164514073|NCT05000216|594253641|FG013|Stage 1|Physician Decision|0|||
164514074|NCT05000216|594253642|FG014|Stage 1|Physician Decision|0|||
164514075|NCT05000216|594253643|FG015|Stage 1|Physician Decision|0|||
164514076|NCT05000216|594253644|FG016|Stage 1|Physician Decision|0|||
164514077|NCT05000216|594253645|FG017|Stage 1|Physician Decision|0|||
164514078|NCT05000216|594253646|FG018|Stage 1|Physician Decision|0|||
164514079|NCT05000216|594253647|FG019|Stage 1|Physician Decision|0|||
164514080|NCT05000216|594253648|FG020|Stage 1|Physician Decision|0|||
164514081|NCT05000216|594253649|FG021|Stage 1|Physician Decision|0|||
164514082|NCT05000216|594253628|FG000|Stage 1|Withdrawal by Subject|0|||
164514083|NCT05000216|594253629|FG001|Stage 1|Withdrawal by Subject|1|||
164514084|NCT05000216|594253630|FG002|Stage 1|Withdrawal by Subject|0|||
164514085|NCT05000216|594253631|FG003|Stage 1|Withdrawal by Subject|0|||
164514086|NCT05000216|594253632|FG004|Stage 1|Withdrawal by Subject|0|||
164514087|NCT05000216|594253633|FG005|Stage 1|Withdrawal by Subject|0|||
164514088|NCT05000216|594253634|FG006|Stage 1|Withdrawal by Subject|0|||
164514089|NCT05000216|594253635|FG007|Stage 1|Withdrawal by Subject|0|||
164514090|NCT05000216|594253636|FG008|Stage 1|Withdrawal by Subject|0|||
164514091|NCT05000216|594253637|FG009|Stage 1|Withdrawal by Subject|3|||
164514092|NCT05000216|594253638|FG010|Stage 1|Withdrawal by Subject|10|||
164514093|NCT05000216|594253639|FG011|Stage 1|Withdrawal by Subject|0|||
164514094|NCT05000216|594253640|FG012|Stage 1|Withdrawal by Subject|0|||
164514095|NCT05000216|594253641|FG013|Stage 1|Withdrawal by Subject|0|||
164514096|NCT05000216|594253642|FG014|Stage 1|Withdrawal by Subject|0|||
164514097|NCT05000216|594253643|FG015|Stage 1|Withdrawal by Subject|0|||
164514098|NCT05000216|594253644|FG016|Stage 1|Withdrawal by Subject|0|||
164514099|NCT05000216|594253645|FG017|Stage 1|Withdrawal by Subject|0|||
164514100|NCT05000216|594253646|FG018|Stage 1|Withdrawal by Subject|0|||
164514101|NCT05000216|594253647|FG019|Stage 1|Withdrawal by Subject|0|||
164514102|NCT05000216|594253648|FG020|Stage 1|Withdrawal by Subject|0|||
164514103|NCT05000216|594253649|FG021|Stage 1|Withdrawal by Subject|0|||
164514104|NCT05000216|594253628|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
164514105|NCT05000216|594253629|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
164514106|NCT05000216|594253630|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
164514107|NCT05000216|594253631|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
164514108|NCT05000216|594253632|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
164514109|NCT05000216|594253633|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
164514110|NCT05000216|594253634|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
164514111|NCT05000216|594253635|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
164514112|NCT05000216|594253636|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
164514113|NCT05000216|594253637|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
164514114|NCT05000216|594253638|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
164514115|NCT05000216|594253639|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
164514116|NCT05000216|594253640|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
164514117|NCT05000216|594253641|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
164514118|NCT05000216|594253642|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
164514119|NCT05000216|594253643|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
164514120|NCT05000216|594253644|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
164514121|NCT05000216|594253645|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
164514122|NCT05000216|594253646|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
164514123|NCT05000216|594253647|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
164514124|NCT05000216|594253648|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
164514125|NCT05000216|594253649|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
164514126|NCT05000216|594253628|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
164514127|NCT05000216|594253629|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
164514128|NCT05000216|594253630|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
164514129|NCT05000216|594253631|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
164514130|NCT05000216|594253632|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
164514131|NCT05000216|594253633|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
164514132|NCT05000216|594253634|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
164514133|NCT05000216|594253635|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
164514134|NCT05000216|594253636|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
164514135|NCT05000216|594253637|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
164514136|NCT05000216|594253638|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
164514137|NCT05000216|594253639|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
164514138|NCT05000216|594253640|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
164514139|NCT05000216|594253641|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
164514140|NCT05000216|594253642|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
164514141|NCT05000216|594253643|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
164514142|NCT05000216|594253644|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
164514143|NCT05000216|594253645|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
164514144|NCT05000216|594253646|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
164514145|NCT05000216|594253647|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
164514146|NCT05000216|594253648|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
164514147|NCT05000216|594253649|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
164514148|NCT05000216|594253628|FG000|Stage 1|Other|0|||
164514149|NCT05000216|594253629|FG001|Stage 1|Other|0|||
164514150|NCT05000216|594253630|FG002|Stage 1|Other|0|||
164514151|NCT05000216|594253631|FG003|Stage 1|Other|0|||
164514152|NCT05000216|594253632|FG004|Stage 1|Other|1|||
164514153|NCT05000216|594253633|FG005|Stage 1|Other|0|||
164514154|NCT05000216|594253634|FG006|Stage 1|Other|0|||
164514155|NCT05000216|594253635|FG007|Stage 1|Other|2|||
164514156|NCT05000216|594253636|FG008|Stage 1|Other|0|||
164514157|NCT05000216|594253637|FG009|Stage 1|Other|0|||
164514158|NCT05000216|594253638|FG010|Stage 1|Other|1|||
164514159|NCT05000216|594253639|FG011|Stage 1|Other|1|||
164514160|NCT05000216|594253640|FG012|Stage 1|Other|0|||
164514161|NCT05000216|594253641|FG013|Stage 1|Other|0|||
164514162|NCT05000216|594253642|FG014|Stage 1|Other|0|||
164514163|NCT05000216|594253643|FG015|Stage 1|Other|0|||
164514164|NCT05000216|594253644|FG016|Stage 1|Other|0|||
164514165|NCT05000216|594253645|FG017|Stage 1|Other|0|||
164514166|NCT05000216|594253646|FG018|Stage 1|Other|0|||
164514167|NCT05000216|594253647|FG019|Stage 1|Other|0|||
164514168|NCT05000216|594253648|FG020|Stage 1|Other|0|||
164514169|NCT05000216|594253649|FG021|Stage 1|Other|0|||
164514170|NCT05000216|594253628|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
164514171|NCT05000216|594253629|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
164514172|NCT05000216|594253630|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
164514173|NCT05000216|594253631|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
164514174|NCT05000216|594253632|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
164514175|NCT05000216|594253633|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
164514176|NCT05000216|594253634|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
164514177|NCT05000216|594253635|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
164514178|NCT05000216|594253636|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
164514179|NCT05000216|594253637|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
164514180|NCT05000216|594253638|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
164514181|NCT05000216|594253639|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
164514182|NCT05000216|594253640|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
164514183|NCT05000216|594253641|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
164514184|NCT05000216|594253642|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
164514185|NCT05000216|594253643|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
164514186|NCT05000216|594253644|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
164514187|NCT05000216|594253645|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
164514188|NCT05000216|594253646|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
164514189|NCT05000216|594253647|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
164514190|NCT05000216|594253648|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
164514191|NCT05000216|594253649|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
164514192|NCT05000216|594253628|FG000|Stage 2|Lost to Follow-up|0|||
164514193|NCT05000216|594253629|FG001|Stage 2|Lost to Follow-up|0|||
164514194|NCT05000216|594253630|FG002|Stage 2|Lost to Follow-up|0|||
164514195|NCT05000216|594253631|FG003|Stage 2|Lost to Follow-up|0|||
164514196|NCT05000216|594253632|FG004|Stage 2|Lost to Follow-up|0|||
164514197|NCT05000216|594253633|FG005|Stage 2|Lost to Follow-up|0|||
164514198|NCT05000216|594253634|FG006|Stage 2|Lost to Follow-up|0|||
164514199|NCT05000216|594253635|FG007|Stage 2|Lost to Follow-up|0|||
164514200|NCT05000216|594253636|FG008|Stage 2|Lost to Follow-up|0|||
164514201|NCT05000216|594253637|FG009|Stage 2|Lost to Follow-up|0|||
164514202|NCT05000216|594253638|FG010|Stage 2|Lost to Follow-up|0|||
164514203|NCT05000216|594253639|FG011|Stage 2|Lost to Follow-up|0|||
164514204|NCT05000216|594253640|FG012|Stage 2|Lost to Follow-up|0|||
164514205|NCT05000216|594253641|FG013|Stage 2|Lost to Follow-up|0|||
164514206|NCT05000216|594253642|FG014|Stage 2|Lost to Follow-up|0|||
164514207|NCT05000216|594253643|FG015|Stage 2|Lost to Follow-up|0|||
164514208|NCT05000216|594253644|FG016|Stage 2|Lost to Follow-up|4|||
164514209|NCT05000216|594253645|FG017|Stage 2|Lost to Follow-up|0|||
164514210|NCT05000216|594253646|FG018|Stage 2|Lost to Follow-up|0|||
164514211|NCT05000216|594253647|FG019|Stage 2|Lost to Follow-up|0|||
164514212|NCT05000216|594253648|FG020|Stage 2|Lost to Follow-up|0|||
164514213|NCT05000216|594253649|FG021|Stage 2|Lost to Follow-up|0|||
164514214|NCT05000216|594253628|FG000|Stage 2|Physician Decision|0|||
164514215|NCT05000216|594253629|FG001|Stage 2|Physician Decision|0|||
164514216|NCT05000216|594253630|FG002|Stage 2|Physician Decision|0|||
164514217|NCT05000216|594253631|FG003|Stage 2|Physician Decision|0|||
164514218|NCT05000216|594253632|FG004|Stage 2|Physician Decision|0|||
164514219|NCT05000216|594253633|FG005|Stage 2|Physician Decision|0|||
164514220|NCT05000216|594253634|FG006|Stage 2|Physician Decision|0|||
164514221|NCT05000216|594253635|FG007|Stage 2|Physician Decision|0|||
164514222|NCT05000216|594253636|FG008|Stage 2|Physician Decision|0|||
164514223|NCT05000216|594253637|FG009|Stage 2|Physician Decision|0|||
164514224|NCT05000216|594253638|FG010|Stage 2|Physician Decision|0|||
164514225|NCT05000216|594253639|FG011|Stage 2|Physician Decision|0|||
164514226|NCT05000216|594253640|FG012|Stage 2|Physician Decision|1|||
164514227|NCT05000216|594253641|FG013|Stage 2|Physician Decision|0|||
164514228|NCT05000216|594253642|FG014|Stage 2|Physician Decision|0|||
164514229|NCT05000216|594253643|FG015|Stage 2|Physician Decision|0|||
164514230|NCT05000216|594253644|FG016|Stage 2|Physician Decision|0|||
164514231|NCT05000216|594253645|FG017|Stage 2|Physician Decision|0|||
164514232|NCT05000216|594253646|FG018|Stage 2|Physician Decision|0|||
164514233|NCT05000216|594253647|FG019|Stage 2|Physician Decision|0|||
164514234|NCT05000216|594253648|FG020|Stage 2|Physician Decision|0|||
164514235|NCT05000216|594253649|FG021|Stage 2|Physician Decision|0|||
164514236|NCT05000216|594253628|FG000|Stage 2|Withdrawal by Subject|0|||
164514237|NCT05000216|594253629|FG001|Stage 2|Withdrawal by Subject|0|||
164514238|NCT05000216|594253630|FG002|Stage 2|Withdrawal by Subject|0|||
164514239|NCT05000216|594253631|FG003|Stage 2|Withdrawal by Subject|0|||
164514240|NCT05000216|594253632|FG004|Stage 2|Withdrawal by Subject|0|||
164514241|NCT05000216|594253633|FG005|Stage 2|Withdrawal by Subject|0|||
164514242|NCT05000216|594253634|FG006|Stage 2|Withdrawal by Subject|0|||
164514243|NCT05000216|594253635|FG007|Stage 2|Withdrawal by Subject|0|||
164514244|NCT05000216|594253636|FG008|Stage 2|Withdrawal by Subject|0|||
164514245|NCT05000216|594253637|FG009|Stage 2|Withdrawal by Subject|0|||
164514246|NCT05000216|594253638|FG010|Stage 2|Withdrawal by Subject|0|||
164514247|NCT05000216|594253639|FG011|Stage 2|Withdrawal by Subject|0|||
164514248|NCT05000216|594253640|FG012|Stage 2|Withdrawal by Subject|0|||
164514249|NCT05000216|594253641|FG013|Stage 2|Withdrawal by Subject|0|||
164514250|NCT05000216|594253642|FG014|Stage 2|Withdrawal by Subject|2|||
164514251|NCT05000216|594253643|FG015|Stage 2|Withdrawal by Subject|0|||
164514252|NCT05000216|594253644|FG016|Stage 2|Withdrawal by Subject|9|||
164514253|NCT05000216|594253645|FG017|Stage 2|Withdrawal by Subject|0|||
164514254|NCT05000216|594253646|FG018|Stage 2|Withdrawal by Subject|0|||
164514255|NCT05000216|594253647|FG019|Stage 2|Withdrawal by Subject|0|||
164514256|NCT05000216|594253648|FG020|Stage 2|Withdrawal by Subject|0|||
164514257|NCT05000216|594253649|FG021|Stage 2|Withdrawal by Subject|0|||
164514258|NCT05000216|594253628|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
164514259|NCT05000216|594253629|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
164514260|NCT05000216|594253630|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
164514261|NCT05000216|594253631|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
164514262|NCT05000216|594253632|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
164514263|NCT05000216|594253633|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
164514264|NCT05000216|594253634|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
164514265|NCT05000216|594253635|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
164514266|NCT05000216|594253636|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
164514267|NCT05000216|594253637|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
164514268|NCT05000216|594253638|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
164514269|NCT05000216|594253639|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
164514270|NCT05000216|594253640|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
164514271|NCT05000216|594253641|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
164514272|NCT05000216|594253642|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
164514273|NCT05000216|594253643|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
164514274|NCT05000216|594253644|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
164514275|NCT05000216|594253645|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
164514276|NCT05000216|594253646|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
164514277|NCT05000216|594253647|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
164514278|NCT05000216|594253648|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
164514279|NCT05000216|594253649|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
164514280|NCT05000216|594253628|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
164514281|NCT05000216|594253629|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
164514282|NCT05000216|594253630|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
164514283|NCT05000216|594253631|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
164514284|NCT05000216|594253632|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
164514285|NCT05000216|594253633|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
164514286|NCT05000216|594253634|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
164514287|NCT05000216|594253635|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
164514288|NCT05000216|594253636|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
164514289|NCT05000216|594253637|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
164514290|NCT05000216|594253638|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
164514291|NCT05000216|594253639|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
164514292|NCT05000216|594253640|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
164514293|NCT05000216|594253641|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
164514294|NCT05000216|594253642|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
164514295|NCT05000216|594253643|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
164514296|NCT05000216|594253644|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
164514297|NCT05000216|594253645|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
164514298|NCT05000216|594253646|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
164514299|NCT05000216|594253647|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
164514300|NCT05000216|594253648|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
164514301|NCT05000216|594253649|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
164514302|NCT05000216|594253628|FG000|Stage 2|Other reason|0|||
164514303|NCT05000216|594253629|FG001|Stage 2|Other reason|0|||
164514304|NCT05000216|594253630|FG002|Stage 2|Other reason|0|||
164514305|NCT05000216|594253631|FG003|Stage 2|Other reason|0|||
164514306|NCT05000216|594253632|FG004|Stage 2|Other reason|0|||
164514307|NCT05000216|594253633|FG005|Stage 2|Other reason|0|||
164514308|NCT05000216|594253634|FG006|Stage 2|Other reason|0|||
164514309|NCT05000216|594253635|FG007|Stage 2|Other reason|0|||
164514310|NCT05000216|594253636|FG008|Stage 2|Other reason|0|||
164514311|NCT05000216|594253637|FG009|Stage 2|Other reason|0|||
164514312|NCT05000216|594253638|FG010|Stage 2|Other reason|0|||
164514313|NCT05000216|594253639|FG011|Stage 2|Other reason|0|||
164514314|NCT05000216|594253640|FG012|Stage 2|Other reason|0|||
164514315|NCT05000216|594253641|FG013|Stage 2|Other reason|0|||
164514316|NCT05000216|594253642|FG014|Stage 2|Other reason|0|||
164514317|NCT05000216|594253643|FG015|Stage 2|Other reason|0|||
164146986|NCT00443729|592899920|FG000|Overall Study|Protocol Violation|1|||
164514318|NCT05000216|594253644|FG016|Stage 2|Other reason|1|||
164514319|NCT05000216|594253645|FG017|Stage 2|Other reason|0|||
164514320|NCT05000216|594253646|FG018|Stage 2|Other reason|0|||
164514321|NCT05000216|594253647|FG019|Stage 2|Other reason|0|||
164514322|NCT05000216|594253648|FG020|Stage 2|Other reason|0|||
164609983|NCT00355134|594592960|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
164609984|NCT00355134|594592961|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
164609985|NCT00355134|594592962|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
164609986|NCT00355134|594592958|FG000|Extension Phase|Administrative problems|2|||
164609987|NCT00355134|594592959|FG001|Extension Phase|Administrative problems|4|||
164609988|NCT00355134|594592960|FG002|Extension Phase|Administrative problems|0|||
164609989|NCT00355134|594592961|FG003|Extension Phase|Administrative problems|1|||
164609990|NCT00355134|594592962|FG004|Extension Phase|Administrative problems|1|||
164609991|NCT00355134|594592958|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
164609992|NCT00355134|594592959|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
164609993|NCT00355134|594592960|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
164609994|NCT00355134|594592961|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
164609995|NCT00355134|594592962|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
164609996|NCT00355134|594592958|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
164609997|NCT00355134|594592959|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
164609998|NCT00355134|594592960|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
164609999|NCT00355134|594592961|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
164610000|NCT00355134|594592962|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
164610001|NCT00355134|594592958|FG000|Extension Phase|Protocol Violation|0|||
164610002|NCT00355134|594592959|FG001|Extension Phase|Protocol Violation|0|||
164610003|NCT00355134|594592960|FG002|Extension Phase|Protocol Violation|0|||
164610004|NCT00355134|594592961|FG003|Extension Phase|Protocol Violation|1|||
164610005|NCT00355134|594592962|FG004|Extension Phase|Protocol Violation|0|||
164610006|NCT03706040|594592963|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
164514323|NCT05000216|594253649|FG021|Stage 2|Other reason|0|||
164514324|NCT05000216|594253628|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
164514325|NCT05000216|594253629|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
164514326|NCT05000216|594253630|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
164514327|NCT05000216|594253631|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
164514328|NCT05000216|594253632|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
164514329|NCT05000216|594253633|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
164514330|NCT05000216|594253634|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
164514331|NCT05000216|594253635|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
164514332|NCT05000216|594253636|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
164514333|NCT05000216|594253637|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
164514334|NCT05000216|594253638|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
164514335|NCT05000216|594253639|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
164514336|NCT05000216|594253640|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
164514337|NCT05000216|594253641|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
164514338|NCT05000216|594253642|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
164514339|NCT05000216|594253643|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
164514340|NCT05000216|594253644|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
164514341|NCT05000216|594253645|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
164514342|NCT05000216|594253646|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
164514343|NCT05000216|594253647|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
164514344|NCT05000216|594253648|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
164514345|NCT05000216|594253649|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
164514346|NCT05000216|594253628|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
164514347|NCT05000216|594253629|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
164514348|NCT05000216|594253630|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
164514349|NCT05000216|594253631|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
164514350|NCT05000216|594253632|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
164514351|NCT05000216|594253633|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
164514352|NCT05000216|594253634|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
164514353|NCT05000216|594253635|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
164514354|NCT05000216|594253636|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
164514355|NCT05000216|594253637|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
164514356|NCT05000216|594253638|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
164514357|NCT05000216|594253639|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
164514358|NCT05000216|594253640|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
164514359|NCT05000216|594253641|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
164514360|NCT05000216|594253642|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
164514361|NCT05000216|594253643|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
164514362|NCT05000216|594253644|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
164514363|NCT05000216|594253645|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
164610007|NCT03706040|594592964|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
164514364|NCT05000216|594253646|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
164514365|NCT05000216|594253647|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
164610008|NCT03706040|594592965|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
164610009|NCT03706040|594592966|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
164610010|NCT03706040|594592967|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
164514366|NCT05000216|594253648|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
164514367|NCT05000216|594253649|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
164514368|NCT05000216|594253628|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
164514369|NCT05000216|594253629|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
164514370|NCT05000216|594253630|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
164514371|NCT05000216|594253631|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
164514372|NCT05000216|594253632|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
164514373|NCT05000216|594253633|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
164514374|NCT05000216|594253634|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
164514375|NCT05000216|594253635|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
164514376|NCT05000216|594253636|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
164514377|NCT05000216|594253637|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
164514378|NCT05000216|594253638|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
164514379|NCT05000216|594253639|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
164514380|NCT05000216|594253640|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
164514381|NCT05000216|594253641|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
164514382|NCT05000216|594253642|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
164514383|NCT05000216|594253643|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
164514384|NCT05000216|594253644|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
164514385|NCT05000216|594253645|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
164514386|NCT05000216|594253646|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
164514387|NCT05000216|594253647|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
164514388|NCT05000216|594253648|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
164514389|NCT05000216|594253649|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
164514390|NCT00967005|594253650|FG000|Overall Study|Lost to Follow-up|7|||
164514391|NCT00967005|594253651|FG001|Overall Study|Lost to Follow-up|10|||
164514392|NCT02593123|594253652|FG000|Overall Study|Physician Decision|2|||
164514393|NCT02593123|594253653|FG001|Overall Study|Physician Decision|1|||
164514394|NCT02593123|594253652|FG000|Overall Study|Relapse|1|||
164514395|NCT02593123|594253653|FG001|Overall Study|Relapse|1|||
164514396|NCT00820170|594253655|FG000|Overall Study|Adverse Event|0|||
164514397|NCT00820170|594253656|FG001|Overall Study|Adverse Event|0|||
164514398|NCT00820170|594253657|FG002|Overall Study|Adverse Event|0|||
164514399|NCT00820170|594253658|FG003|Overall Study|Adverse Event|0|||
164514400|NCT00820170|594253659|FG004|Overall Study|Adverse Event|2|||
164610011|NCT03706040|594592968|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
164610012|NCT03706040|594592969|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
164610013|NCT03706040|594592963|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
164610014|NCT03706040|594592964|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
164610015|NCT03706040|594592965|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
164610016|NCT03706040|594592966|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
164610017|NCT03706040|594592967|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
164610018|NCT03706040|594592968|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
164610019|NCT03706040|594592969|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
164610020|NCT03706040|594592963|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
164610021|NCT03706040|594592964|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
164610022|NCT03706040|594592965|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
164610023|NCT03706040|594592966|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
164610024|NCT03706040|594592967|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
164610025|NCT03706040|594592968|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
164610026|NCT03706040|594592969|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
164610027|NCT03706040|594592963|FG000|Period A (Week 0 to Week 16)|Other|2|||
164610028|NCT03706040|594592964|FG001|Period A (Week 0 to Week 16)|Other|0|||
164610029|NCT03706040|594592965|FG002|Period A (Week 0 to Week 16)|Other|2|||
164610030|NCT03706040|594592966|FG003|Period A (Week 0 to Week 16)|Other|0|||
164610031|NCT03706040|594592967|FG004|Period A (Week 0 to Week 16)|Other|0|||
164610032|NCT03706040|594592968|FG005|Period A (Week 0 to Week 16)|Other|0|||
164610033|NCT03706040|594592969|FG006|Period A (Week 0 to Week 16)|Other|0|||
164610034|NCT03706040|594592963|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
164610035|NCT03706040|594592964|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
164610036|NCT03706040|594592965|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
164610037|NCT03706040|594592966|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
164610038|NCT03706040|594592967|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
164610039|NCT03706040|594592968|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
164610040|NCT03706040|594592969|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
164610041|NCT03706040|594592963|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
164610042|NCT03706040|594592964|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
164610043|NCT03706040|594592965|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
164610044|NCT03706040|594592966|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
164610045|NCT03706040|594592967|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
164610046|NCT03706040|594592968|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
164610047|NCT03706040|594592969|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
164610048|NCT03706040|594592963|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
164610049|NCT03706040|594592964|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
164610050|NCT03706040|594592965|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
164610051|NCT03706040|594592966|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
164610052|NCT03706040|594592967|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
164610053|NCT03706040|594592968|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
164610054|NCT03706040|594592969|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
164610055|NCT03706040|594592963|FG000|Period B (Week 16 to Week 52)|Other|0|||
164610056|NCT03706040|594592964|FG001|Period B (Week 16 to Week 52)|Other|0|||
164610057|NCT03706040|594592965|FG002|Period B (Week 16 to Week 52)|Other|0|||
164610058|NCT03706040|594592966|FG003|Period B (Week 16 to Week 52)|Other|4|||
164610059|NCT03706040|594592967|FG004|Period B (Week 16 to Week 52)|Other|5|||
164610060|NCT03706040|594592968|FG005|Period B (Week 16 to Week 52)|Other|23|||
164610061|NCT03706040|594592969|FG006|Period B (Week 16 to Week 52)|Other|17|||
164610062|NCT00927758|594592970|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
164610063|NCT00927758|594592971|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
164610064|NCT00927758|594592972|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
164610065|NCT00927758|594592973|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
164610066|NCT00927758|594592974|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
164610067|NCT00927758|594592975|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
164610068|NCT00927758|594592970|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
164610069|NCT00927758|594592971|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
164610070|NCT00927758|594592972|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
164610071|NCT00927758|594592973|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
164610072|NCT00927758|594592974|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
164610073|NCT00927758|594592975|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
164610074|NCT00439725|594592976|FG000|Treatment Period|Withdrawal by Subject|22|||
164514401|NCT00820170|594253655|FG000|Overall Study|Progressive Disease|0|||
164514402|NCT00820170|594253656|FG001|Overall Study|Progressive Disease|0|||
164514403|NCT00820170|594253657|FG002|Overall Study|Progressive Disease|0|||
164514404|NCT00820170|594253658|FG003|Overall Study|Progressive Disease|0|||
164514405|NCT00820170|594253659|FG004|Overall Study|Progressive Disease|2|||
164514406|NCT02180243|594253660|FG000|Overall Study|Withdrawal by Subject|12|||
164514407|NCT02180243|594253661|FG001|Overall Study|Withdrawal by Subject|12|||
164514408|NCT02180243|594253660|FG000|Overall Study|Lost to Follow-up|12|||
164514409|NCT02180243|594253661|FG001|Overall Study|Lost to Follow-up|2|||
164514410|NCT01137578|594253662|FG000|Overall Study|Participant requested to Discontinue|3|||
164514411|NCT01137578|594253663|FG001|Overall Study|Participant requested to Discontinue|0|||
164514412|NCT01137578|594253664|FG002|Overall Study|Participant requested to Discontinue|0|||
164514413|NCT01137578|594253662|FG000|Overall Study|Withdrawal by Subject|1|||
164514414|NCT01137578|594253663|FG001|Overall Study|Withdrawal by Subject|0|||
164514415|NCT01137578|594253664|FG002|Overall Study|Withdrawal by Subject|0|||
164514416|NCT01137578|594253662|FG000|Overall Study|Other|12|||
164514417|NCT01137578|594253663|FG001|Overall Study|Other|2|||
164514418|NCT01137578|594253664|FG002|Overall Study|Other|6|||
164514419|NCT03651700|594253669|FG000|Overall Study|Withdrawal by Subject|1|||
164514420|NCT03651700|594253670|FG001|Overall Study|Withdrawal by Subject|0|||
164514421|NCT05479734|594253673|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
164514422|NCT05479734|594253674|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
164514423|NCT05479734|594253673|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
164514424|NCT05479734|594253674|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
164514425|NCT05479734|594253673|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
164514426|NCT05479734|594253674|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
164514427|NCT05479734|594253673|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
164514428|NCT05479734|594253674|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
164514429|NCT03945825|594253675|FG000|Overall Study|Enrolled but treatment not administered|0|||
164514430|NCT03945825|594253676|FG001|Overall Study|Enrolled but treatment not administered|0|||
164514431|NCT03945825|594253677|FG002|Overall Study|Enrolled but treatment not administered|0|||
164514432|NCT03945825|594253678|FG003|Overall Study|Enrolled but treatment not administered|0|||
164514433|NCT03945825|594253679|FG004|Overall Study|Enrolled but treatment not administered|1|||
164514434|NCT03945825|594253680|FG005|Overall Study|Enrolled but treatment not administered|0|||
164514435|NCT03945825|594253675|FG000|Overall Study|Lost to Follow-up|1|||
164514436|NCT03945825|594253676|FG001|Overall Study|Lost to Follow-up|5|||
164514437|NCT03945825|594253677|FG002|Overall Study|Lost to Follow-up|0|||
164514438|NCT03945825|594253678|FG003|Overall Study|Lost to Follow-up|1|||
164514439|NCT03945825|594253679|FG004|Overall Study|Lost to Follow-up|2|||
164514440|NCT03945825|594253680|FG005|Overall Study|Lost to Follow-up|2|||
164514441|NCT03945825|594253675|FG000|Overall Study|Withdrawal by Subject|1|||
164514442|NCT03945825|594253676|FG001|Overall Study|Withdrawal by Subject|0|||
164514443|NCT03945825|594253677|FG002|Overall Study|Withdrawal by Subject|1|||
164514444|NCT03945825|594253678|FG003|Overall Study|Withdrawal by Subject|1|||
164514445|NCT03945825|594253679|FG004|Overall Study|Withdrawal by Subject|0|||
164514446|NCT03945825|594253680|FG005|Overall Study|Withdrawal by Subject|1|||
164514447|NCT01461005|594253681|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
164514448|NCT01426347|594253682|FG000|Overall Study|Lost to Follow-up|0|||
164514449|NCT01426347|594253683|FG001|Overall Study|Lost to Follow-up|3|||
164514450|NCT01426347|594253682|FG000|Overall Study|Protocol Violation|2|||
164514451|NCT01426347|594253683|FG001|Overall Study|Protocol Violation|0|||
164514452|NCT01426347|594253682|FG000|Overall Study|Withdrawal by Subject|5|||
164514453|NCT01426347|594253683|FG001|Overall Study|Withdrawal by Subject|0|||
164514454|NCT00455741|594253684|FG000|Overall Study|Physician Decision|0|||
164514455|NCT00455741|594253685|FG001|Overall Study|Physician Decision|1|||
164514456|NCT00203268|594253686|FG000|Early Treatment|only treated one headache|2|||
164514457|NCT00203268|594253686|FG000|Early Treatment|Lost to Follow-up|1|||
164514458|NCT00203268|594253686|FG000|Early Treatment|Withdrawal by Subject|1|||
164514459|NCT00664534|594253689|FG000|Overall Study|Adverse Event|2|||
164514460|NCT00664534|594253690|FG001|Overall Study|Adverse Event|3|||
164514461|NCT00664534|594253689|FG000|Overall Study|Lost to Follow-up|6|||
164514462|NCT00664534|594253690|FG001|Overall Study|Lost to Follow-up|10|||
164514463|NCT00664534|594253689|FG000|Overall Study|Protocol Violation|10|||
164514464|NCT00664534|594253690|FG001|Overall Study|Protocol Violation|8|||
164514465|NCT00664534|594253689|FG000|Overall Study|Withdrawal by Subject|7|||
164514466|NCT00664534|594253690|FG001|Overall Study|Withdrawal by Subject|6|||
164514467|NCT00664534|594253689|FG000|Overall Study|Physician Decision|8|||
164514468|NCT00664534|594253690|FG001|Overall Study|Physician Decision|0|||
164514469|NCT00664534|594253689|FG000|Overall Study|Sponsor decision|8|||
164514470|NCT00664534|594253690|FG001|Overall Study|Sponsor decision|6|||
164610075|NCT00439725|594592977|FG001|Treatment Period|Withdrawal by Subject|19|||
164610076|NCT00439725|594592976|FG000|Treatment Period|Study terminated by sponsor|156|||
164514471|NCT00600613|594253691|FG000|Overall Study|Protocol Deviation|1|||
164514472|NCT03041792|594253692|FG000|Overall Study|Adverse Event|4|||
164514473|NCT03041792|594253693|FG001|Overall Study|Adverse Event|0|||
164514474|NCT03041792|594253692|FG000|Overall Study|Death in the family|0|||
164514475|NCT03041792|594253693|FG001|Overall Study|Death in the family|2|||
164514476|NCT03041792|594253692|FG000|Overall Study|Randomized but not treated|0|||
164514477|NCT03041792|594253693|FG001|Overall Study|Randomized but not treated|1|||
164514478|NCT00935532|594253696|FG000|Overall Study|Adverse Event|11|||
164514479|NCT00935532|594253697|FG001|Overall Study|Adverse Event|6|||
164514480|NCT00935532|594253696|FG000|Overall Study|Death|1|||
164514481|NCT00935532|594253697|FG001|Overall Study|Death|0|||
164610077|NCT00439725|594592977|FG001|Treatment Period|Study terminated by sponsor|148|||
164610078|NCT00439725|594592976|FG000|Treatment Period|Site closed by investigator|1|||
164610079|NCT00439725|594592977|FG001|Treatment Period|Site closed by investigator|2|||
164610080|NCT00439725|594592976|FG000|Treatment Period|Adverse Event|39|||
164610081|NCT00439725|594592977|FG001|Treatment Period|Adverse Event|18|||
164610082|NCT00439725|594592976|FG000|Treatment Period|Physician Decision|1|||
164610083|NCT00439725|594592977|FG001|Treatment Period|Physician Decision|1|||
164610084|NCT00439725|594592976|FG000|Treatment Period|Protocol Violation|2|||
164610085|NCT00439725|594592977|FG001|Treatment Period|Protocol Violation|1|||
164610086|NCT00439725|594592976|FG000|Treatment Period|Clinical endpoint reached|6|||
164610087|NCT00439725|594592977|FG001|Treatment Period|Clinical endpoint reached|50|||
164610088|NCT00439725|594592976|FG000|Treatment Period|Technical problems|1|||
164610089|NCT00439725|594592977|FG001|Treatment Period|Technical problems|0|||
164610090|NCT00439725|594592976|FG000|Treatment Period|Lost to Follow-up|1|||
164610091|NCT00439725|594592977|FG001|Treatment Period|Lost to Follow-up|1|||
164610092|NCT00439725|594592976|FG000|Treatment Period|Participant convenience|1|||
164610093|NCT00439725|594592977|FG001|Treatment Period|Participant convenience|0|||
164610094|NCT00439725|594592976|FG000|Treatment Period|Protocol driven decision point|1|||
164610095|NCT00439725|594592977|FG001|Treatment Period|Protocol driven decision point|1|||
164610096|NCT00439725|594592976|FG000|Treatment Period|Death|1|||
164610097|NCT00439725|594592977|FG001|Treatment Period|Death|1|||
164610098|NCT00439725|594592976|FG000|Treatment Period|Participant did not receive treatment|4|||
164610099|NCT00439725|594592977|FG001|Treatment Period|Participant did not receive treatment|4|||
164610100|NCT00439725|594592976|FG000|Observational Period|Withdrawal by Subject|2|||
164610101|NCT00439725|594592977|FG001|Observational Period|Withdrawal by Subject|2|||
164610102|NCT00439725|594592976|FG000|Observational Period|Lost to Follow-up|0|||
164610103|NCT00439725|594592977|FG001|Observational Period|Lost to Follow-up|1|||
164610104|NCT00439725|594592976|FG000|Observational Period|Death|0|||
164610105|NCT00439725|594592977|FG001|Observational Period|Death|2|||
164610106|NCT00439725|594592976|FG000|Observational Period|Study termination by sponsor|1|||
164610107|NCT00439725|594592977|FG001|Observational Period|Study termination by sponsor|1|||
164610108|NCT00439725|594592976|FG000|Observational Period|Clinical endpoint reached|3|||
164610109|NCT00439725|594592977|FG001|Observational Period|Clinical endpoint reached|1|||
164610110|NCT00439725|594592976|FG000|Observational Period|Technical problems|1|||
164610111|NCT00439725|594592977|FG001|Observational Period|Technical problems|0|||
164610112|NCT00439725|594592976|FG000|Observational Period|Participant convenience|1|||
164610113|NCT00439725|594592977|FG001|Observational Period|Participant convenience|0|||
164610114|NCT03510910|594592978|FG000|Overall Study|Incomplete Survey|2|||
164610115|NCT03510910|594592979|FG001|Overall Study|Incomplete Survey|3|||
164610116|NCT02940860|594592985|FG000|Overall Study|Non-serious AE|1|||
164610117|NCT02940860|594592986|FG001|Overall Study|Non-serious AE|2|||
164610118|NCT02940860|594592985|FG000|Overall Study|Serious AE|7|||
164610119|NCT02940860|594592986|FG001|Overall Study|Serious AE|3|||
164610120|NCT02940860|594592985|FG000|Overall Study|Withdrawal by Subject|19|||
164610121|NCT02940860|594592986|FG001|Overall Study|Withdrawal by Subject|9|||
164610122|NCT02940860|594592985|FG000|Overall Study|Lost to Follow-up|13|||
164610123|NCT02940860|594592986|FG001|Overall Study|Lost to Follow-up|7|||
164610124|NCT02940860|594592985|FG000|Overall Study|Physician Decision|5|||
164610125|NCT02940860|594592986|FG001|Overall Study|Physician Decision|3|||
164610126|NCT02940860|594592985|FG000|Overall Study|Sponsor Decision|0|||
164610127|NCT02940860|594592986|FG001|Overall Study|Sponsor Decision|1|||
164610128|NCT02940860|594592985|FG000|Overall Study|Protocol Violation|0|||
164610129|NCT02940860|594592986|FG001|Overall Study|Protocol Violation|2|||
164610130|NCT02940860|594592985|FG000|Overall Study|Death|3|||
164610131|NCT02940860|594592986|FG001|Overall Study|Death|2|||
164610132|NCT02940860|594592985|FG000|Overall Study|Moved, poor venous access, transport|6|||
164610133|NCT02940860|594592986|FG001|Overall Study|Moved, poor venous access, transport|4|||
164610134|NCT02940860|594592985|FG000|Overall Study|Not treated|2|||
164610135|NCT02940860|594592986|FG001|Overall Study|Not treated|2|||
164610136|NCT04914819|594592987|FG000|Overall Study|Pregnancy|3|||
164610137|NCT04914819|594592988|FG001|Overall Study|Pregnancy|1|||
164610138|NCT04914819|594592987|FG000|Overall Study|Discontinued study|4|||
164610139|NCT04914819|594592988|FG001|Overall Study|Discontinued study|1|||
164610140|NCT04914819|594592987|FG000|Overall Study|Lost to Follow-up|7|||
164610141|NCT04914819|594592988|FG001|Overall Study|Lost to Follow-up|0|||
164610142|NCT01625611|594592992|FG000|Overall Study|No adlib drinks Lab 1|3|||
164610143|NCT01625611|594592993|FG001|Overall Study|No adlib drinks Lab 1|0|||
164610144|NCT01625611|594592992|FG000|Overall Study|Technical issues with PET|1|||
164610145|NCT01625611|594592993|FG001|Overall Study|Technical issues with PET|0|||
164610146|NCT01625611|594592992|FG000|Overall Study|Unable to complete study procedures|1|||
164610147|NCT01625611|594592993|FG001|Overall Study|Unable to complete study procedures|0|||
164610148|NCT01625611|594592992|FG000|Overall Study|Withdrawal by Subject|3|||
164610149|NCT01625611|594592993|FG001|Overall Study|Withdrawal by Subject|0|||
164514482|NCT00935532|594253696|FG000|Overall Study|Lost to Follow-up|1|||
164514483|NCT00935532|594253697|FG001|Overall Study|Lost to Follow-up|0|||
164514484|NCT00935532|594253696|FG000|Overall Study|Physician Decision|1|||
164514485|NCT00935532|594253697|FG001|Overall Study|Physician Decision|2|||
164514486|NCT00935532|594253696|FG000|Overall Study|Protocol Violation|2|||
164514487|NCT00935532|594253697|FG001|Overall Study|Protocol Violation|1|||
164514488|NCT00935532|594253696|FG000|Overall Study|Subject Decision|2|||
164514489|NCT00935532|594253697|FG001|Overall Study|Subject Decision|1|||
164514490|NCT00935532|594253696|FG000|Overall Study|Sponsor Decision|0|||
164514491|NCT00935532|594253697|FG001|Overall Study|Sponsor Decision|1|||
164514492|NCT00935532|594253696|FG000|Overall Study|Loss Glucose Control|4|||
164514493|NCT00935532|594253697|FG001|Overall Study|Loss Glucose Control|0|||
164514494|NCT01399918|594253699|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
164514495|NCT00245960|594253700|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
164514496|NCT00245960|594253701|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
164514497|NCT00245960|594253700|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
164514498|NCT00245960|594253701|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
164514499|NCT00245960|594253700|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
164514500|NCT00245960|594253701|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
164514501|NCT00245960|594253700|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
164514502|NCT00245960|594253701|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
164514503|NCT00245960|594253700|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
164514504|NCT00245960|594253701|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
164514505|NCT00245960|594253700|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
164514506|NCT00245960|594253701|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
164514507|NCT00245960|594253700|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
164514508|NCT00245960|594253701|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
164514509|NCT00245960|594253700|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
164514510|NCT00245960|594253701|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
164514511|NCT00245960|594253700|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
164514512|NCT00245960|594253701|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
164514513|NCT00245960|594253700|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
164514514|NCT00245960|594253701|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
164514515|NCT00245960|594253700|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
164514516|NCT00245960|594253701|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
164514517|NCT00245960|594253700|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
164514518|NCT00245960|594253701|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
164514519|NCT01436253|594253702|FG000|Overall Study|Lost to Follow-up|182|||
164514520|NCT01436253|594253702|FG000|Overall Study|Not meeting all eligibility criteria|117|||
164514521|NCT03083665|594253703|FG000|Double-Blind Period|Adverse Event|5|||
164514522|NCT03083665|594253704|FG001|Double-Blind Period|Adverse Event|4|||
164514523|NCT03083665|594253705|FG002|Double-Blind Period|Adverse Event|5|||
164514524|NCT03083665|594253706|FG003|Double-Blind Period|Adverse Event|0|||
164514525|NCT03083665|594253707|FG004|Double-Blind Period|Adverse Event|0|||
164514526|NCT03083665|594253708|FG005|Double-Blind Period|Adverse Event|0|||
164514527|NCT03083665|594253703|FG000|Double-Blind Period|Lack of Efficacy|0|||
164514528|NCT03083665|594253704|FG001|Double-Blind Period|Lack of Efficacy|0|||
164514529|NCT03083665|594253705|FG002|Double-Blind Period|Lack of Efficacy|1|||
164514530|NCT03083665|594253706|FG003|Double-Blind Period|Lack of Efficacy|0|||
164514531|NCT03083665|594253707|FG004|Double-Blind Period|Lack of Efficacy|0|||
164514532|NCT03083665|594253708|FG005|Double-Blind Period|Lack of Efficacy|0|||
164514533|NCT03083665|594253703|FG000|Double-Blind Period|Protocol Violation|1|||
164514534|NCT03083665|594253704|FG001|Double-Blind Period|Protocol Violation|0|||
164514535|NCT03083665|594253705|FG002|Double-Blind Period|Protocol Violation|1|||
164514536|NCT03083665|594253706|FG003|Double-Blind Period|Protocol Violation|0|||
164514537|NCT03083665|594253707|FG004|Double-Blind Period|Protocol Violation|0|||
164514538|NCT03083665|594253708|FG005|Double-Blind Period|Protocol Violation|0|||
164514539|NCT03083665|594253703|FG000|Double-Blind Period|Lost to Follow-up|1|||
164514540|NCT03083665|594253704|FG001|Double-Blind Period|Lost to Follow-up|0|||
164514541|NCT03083665|594253705|FG002|Double-Blind Period|Lost to Follow-up|1|||
164514542|NCT03083665|594253706|FG003|Double-Blind Period|Lost to Follow-up|0|||
164514543|NCT03083665|594253707|FG004|Double-Blind Period|Lost to Follow-up|0|||
164514544|NCT03083665|594253708|FG005|Double-Blind Period|Lost to Follow-up|0|||
164514545|NCT03083665|594253703|FG000|Double-Blind Period|Withdrawal by Subject|3|||
164514546|NCT03083665|594253704|FG001|Double-Blind Period|Withdrawal by Subject|0|||
164514547|NCT03083665|594253705|FG002|Double-Blind Period|Withdrawal by Subject|0|||
164514548|NCT03083665|594253706|FG003|Double-Blind Period|Withdrawal by Subject|0|||
164514549|NCT03083665|594253707|FG004|Double-Blind Period|Withdrawal by Subject|0|||
164514550|NCT03083665|594253708|FG005|Double-Blind Period|Withdrawal by Subject|0|||
164610150|NCT00948194|594592994|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
164610151|NCT00948194|594592995|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
164610152|NCT02431793|594592996|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
164514551|NCT03083665|594253703|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
164514552|NCT03083665|594253704|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
164514553|NCT03083665|594253705|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
164514554|NCT03083665|594253706|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
164514555|NCT03083665|594253707|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
164514556|NCT03083665|594253708|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
164514557|NCT03083665|594253703|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
164514558|NCT03083665|594253704|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
164514559|NCT03083665|594253705|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
164514560|NCT03083665|594253706|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
164514561|NCT03083665|594253707|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
164514562|NCT03083665|594253708|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
164514563|NCT03083665|594253703|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
164514564|NCT03083665|594253704|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
164514565|NCT03083665|594253705|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
164514566|NCT03083665|594253706|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
164514567|NCT03083665|594253707|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
164514568|NCT03083665|594253708|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
164514569|NCT03083665|594253703|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
164610153|NCT02431793|594592997|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
164610154|NCT02431793|594592998|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
164610155|NCT02431793|594592996|FG000|Overall Study|Withdrawal by Subject|7|||
164610156|NCT02431793|594592997|FG001|Overall Study|Withdrawal by Subject|5|||
164610157|NCT02431793|594592998|FG002|Overall Study|Withdrawal by Subject|5|||
164610158|NCT02431793|594592996|FG000|Overall Study|Lost to Follow-up|101|||
164610159|NCT02431793|594592997|FG001|Overall Study|Lost to Follow-up|122|||
164610160|NCT02431793|594592998|FG002|Overall Study|Lost to Follow-up|104|||
164610161|NCT01711541|594593002|FG000|Overall Study|Cancel prior to treatment|0|||
164610162|NCT01711541|594593003|FG001|Overall Study|Cancel prior to treatment|0|||
164610163|NCT01711541|594593004|FG002|Overall Study|Cancel prior to treatment|0|||
164610164|NCT01711541|594593005|FG003|Overall Study|Cancel prior to treatment|1|||
164610165|NCT01711541|594593006|FG004|Overall Study|Cancel prior to treatment|0|||
164610166|NCT01711541|594593002|FG000|Overall Study|Ineligible|0|||
164610167|NCT01711541|594593003|FG001|Overall Study|Ineligible|1|||
164610168|NCT01711541|594593004|FG002|Overall Study|Ineligible|0|||
164610169|NCT01711541|594593005|FG003|Overall Study|Ineligible|0|||
164610170|NCT01711541|594593006|FG004|Overall Study|Ineligible|0|||
164610171|NCT02905825|594593009|FG000|Overall Study|Protocol Violation|11|||
164610172|NCT02905825|594593009|FG000|Overall Study|Device Malfunction|1|||
164610173|NCT05355818|594593010|FG000|Overall Study|Adverse Event|1|||
164610174|NCT05355818|594593011|FG001|Overall Study|Adverse Event|1|||
164610175|NCT05355818|594593010|FG000|Overall Study|Lack of Efficacy|2|||
164610176|NCT05355818|594593011|FG001|Overall Study|Lack of Efficacy|1|||
164610177|NCT05355818|594593010|FG000|Overall Study|Lost to Follow-up|0|||
164610178|NCT05355818|594593011|FG001|Overall Study|Lost to Follow-up|1|||
164610179|NCT00247273|594593012|FG000|Overall Study|Adverse Event|85|||
164610180|NCT00247273|594593013|FG001|Overall Study|Adverse Event|80|||
164610181|NCT00247273|594593012|FG000|Overall Study|Physician Decision|6|||
164610182|NCT00247273|594593013|FG001|Overall Study|Physician Decision|3|||
164610183|NCT00247273|594593012|FG000|Overall Study|Lost to Follow-up|7|||
164610184|NCT00247273|594593013|FG001|Overall Study|Lost to Follow-up|7|||
164610185|NCT00247273|594593012|FG000|Overall Study|Withdrawal by Subject|46|||
164610186|NCT00247273|594593013|FG001|Overall Study|Withdrawal by Subject|47|||
164610187|NCT00247273|594593012|FG000|Overall Study|Did not take any study drug|2|||
164610188|NCT00247273|594593013|FG001|Overall Study|Did not take any study drug|0|||
164610189|NCT01709708|594593026|FG000|Overall Study|Protocol Violation|1|||
164610190|NCT01709708|594593027|FG001|Overall Study|Protocol Violation|2|||
164610191|NCT02954952|594593030|FG000|Overall Study|Withdrawal by Subject|1|||
164610192|NCT02954952|594593031|FG001|Overall Study|Withdrawal by Subject|0|||
164610193|NCT02954952|594593032|FG002|Overall Study|Withdrawal by Subject|0|||
164610194|NCT02954952|594593030|FG000|Overall Study|No data collected|0|||
164610195|NCT02954952|594593031|FG001|Overall Study|No data collected|1|||
164610196|NCT02954952|594593032|FG002|Overall Study|No data collected|0|||
164610197|NCT02911519|594593033|FG000|Overall Study|Lost to Follow-up|2|||
164610198|NCT02911519|594593034|FG001|Overall Study|Lost to Follow-up|2|||
164610199|NCT02911519|594593033|FG000|Overall Study|Death|0|||
164610200|NCT02911519|594593034|FG001|Overall Study|Death|2|||
164610201|NCT02443805|594593047|FG000|Overall Study|Adverse Event|100|||
164610202|NCT02443805|594593048|FG001|Overall Study|Adverse Event|18|||
164610203|NCT02443805|594593047|FG000|Overall Study|Withdrawal by Subject|73|||
164610204|NCT02443805|594593048|FG001|Overall Study|Withdrawal by Subject|74|||
164610205|NCT02443805|594593047|FG000|Overall Study|Lost to Follow-up|19|||
164610206|NCT02443805|594593048|FG001|Overall Study|Lost to Follow-up|14|||
164610207|NCT02443805|594593047|FG000|Overall Study|Pregnancy|6|||
164610208|NCT02443805|594593048|FG001|Overall Study|Pregnancy|5|||
164610209|NCT02443805|594593047|FG000|Overall Study|Protocol Violation|2|||
164610210|NCT02443805|594593048|FG001|Overall Study|Protocol Violation|4|||
164610211|NCT02443805|594593047|FG000|Overall Study|Lack of Efficacy|1|||
164610212|NCT02443805|594593048|FG001|Overall Study|Lack of Efficacy|1|||
164610213|NCT02443805|594593047|FG000|Overall Study|Non-compliance with study drug|6|||
164610214|NCT02443805|594593048|FG001|Overall Study|Non-compliance with study drug|4|||
164610215|NCT02443805|594593047|FG000|Overall Study|Withdrawal by parent/guardian|3|||
164610216|NCT02443805|594593048|FG001|Overall Study|Withdrawal by parent/guardian|5|||
164610217|NCT02443805|594593047|FG000|Overall Study|Any other reason not above-mentioned|3|||
164610218|NCT02443805|594593048|FG001|Overall Study|Any other reason not above-mentioned|2|||
164610219|NCT00961116|594593049|FG000|Washout Period of 7 Days|Adverse Event|1|||
164610220|NCT00961116|594593050|FG001|Washout Period of 7 Days|Adverse Event|1|||
164610221|NCT00961116|594593049|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
164610222|NCT00961116|594593050|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
164610223|NCT00961116|594593049|FG000|Washout Period of 7 Days|Protocol Violation|0|||
164610224|NCT00961116|594593050|FG001|Washout Period of 7 Days|Protocol Violation|1|||
164610225|NCT00968708|594593051|FG000|Overall Study|Adverse Event|169|||
164610226|NCT00968708|594593052|FG001|Overall Study|Adverse Event|150|||
164610227|NCT00968708|594593051|FG000|Overall Study|Major Protocol Deviation|0|||
164610228|NCT00968708|594593052|FG001|Overall Study|Major Protocol Deviation|1|||
164610229|NCT00968708|594593051|FG000|Overall Study|Lost to Follow-up|19|||
164610230|NCT00968708|594593052|FG001|Overall Study|Lost to Follow-up|11|||
164610231|NCT00968708|594593051|FG000|Overall Study|Voluntary Withdrawal|104|||
164610232|NCT00968708|594593052|FG001|Overall Study|Voluntary Withdrawal|101|||
164610233|NCT00968708|594593051|FG000|Overall Study|Investigator Discretion|0|||
164610234|NCT00968708|594593052|FG001|Overall Study|Investigator Discretion|1|||
164610235|NCT00968708|594593051|FG000|Overall Study|Other|26|||
164610236|NCT00968708|594593052|FG001|Overall Study|Other|34|||
164610237|NCT02708966|594593053|FG000|Overall Study|Lost to Follow-up|2|||
164610238|NCT02708966|594593054|FG001|Overall Study|Lost to Follow-up|2|||
164610239|NCT00389441|594593055|FG000|Overall Study|Adverse Event|7|||
164514570|NCT03083665|594253704|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
164514571|NCT03083665|594253705|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
164514572|NCT03083665|594253706|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
164514573|NCT03083665|594253707|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
164514574|NCT03083665|594253708|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
164514575|NCT03083665|594253703|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
164514576|NCT03083665|594253704|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
164514577|NCT03083665|594253705|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
164514578|NCT03083665|594253706|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
164514579|NCT03083665|594253707|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
164610240|NCT00389441|594593055|FG000|Overall Study|Death|4|||
164610241|NCT00389441|594593055|FG000|Overall Study|Lost to Follow-up|2|||
164610242|NCT00389441|594593055|FG000|Overall Study|Withdrawal by Subject|4|||
164610243|NCT00389441|594593055|FG000|Overall Study|Physician Decision|1|||
164610244|NCT00389441|594593055|FG000|Overall Study|Protocol Violation|1|||
164610245|NCT00389441|594593055|FG000|Overall Study|Global deterioration of health status|4|||
164610246|NCT00389441|594593055|FG000|Overall Study|Objective progression or relapse|26|||
164610247|NCT00389441|594593055|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
164610248|NCT00389441|594593055|FG000|Overall Study|Clinical progression|1|||
164610249|NCT03407170|594593056|FG000|Overall Study|Adverse Event|1|||
164610250|NCT00305604|594593059|FG000|Overall Study|Adverse Event|6|||
164610251|NCT00305604|594593060|FG001|Overall Study|Adverse Event|3|||
164610252|NCT00305604|594593059|FG000|Overall Study|Lack of Efficacy|11|||
164610253|NCT00305604|594593060|FG001|Overall Study|Lack of Efficacy|18|||
164610254|NCT00305604|594593059|FG000|Overall Study|Lost to Follow-up|0|||
164610255|NCT00305604|594593060|FG001|Overall Study|Lost to Follow-up|4|||
164610256|NCT00305604|594593059|FG000|Overall Study|Protocol Violation|2|||
164610257|NCT00305604|594593060|FG001|Overall Study|Protocol Violation|1|||
164610258|NCT00305604|594593059|FG000|Overall Study|Withdrawal by Subject|12|||
164610259|NCT00305604|594593060|FG001|Overall Study|Withdrawal by Subject|21|||
164610260|NCT00305604|594593059|FG000|Overall Study|Patient moved|1|||
164610261|NCT00305604|594593060|FG001|Overall Study|Patient moved|0|||
164610262|NCT00105560|594593061|FG000|Overall Study|Lost to Follow-up|1|||
164610263|NCT00636441|594593062|FG000|Overall Study|Adverse Event|0|||
164610264|NCT00636441|594593063|FG001|Overall Study|Adverse Event|1|||
164610265|NCT00636441|594593064|FG002|Overall Study|Adverse Event|1|||
164610266|NCT00636441|594593065|FG003|Overall Study|Adverse Event|0|||
164610267|NCT00636441|594593066|FG004|Overall Study|Adverse Event|0|||
164610268|NCT00636441|594593067|FG005|Overall Study|Adverse Event|1|||
164610269|NCT00636441|594593068|FG006|Overall Study|Adverse Event|0|||
164610270|NCT00636441|594593062|FG000|Overall Study|Late, ineligible|0|||
164610271|NCT00636441|594593063|FG001|Overall Study|Late, ineligible|0|||
164610272|NCT00636441|594593064|FG002|Overall Study|Late, ineligible|0|||
164610273|NCT00636441|594593065|FG003|Overall Study|Late, ineligible|0|||
164610274|NCT00636441|594593066|FG004|Overall Study|Late, ineligible|0|||
164610275|NCT00636441|594593067|FG005|Overall Study|Late, ineligible|0|||
164610276|NCT00636441|594593068|FG006|Overall Study|Late, ineligible|1|||
164610277|NCT00636441|594593062|FG000|Overall Study|Screen Failure|0|||
164610278|NCT00636441|594593063|FG001|Overall Study|Screen Failure|0|||
164610279|NCT00636441|594593064|FG002|Overall Study|Screen Failure|0|||
164610280|NCT00636441|594593065|FG003|Overall Study|Screen Failure|0|||
164610281|NCT00636441|594593066|FG004|Overall Study|Screen Failure|0|||
164610282|NCT00636441|594593067|FG005|Overall Study|Screen Failure|0|||
164610283|NCT00636441|594593068|FG006|Overall Study|Screen Failure|17|||
164610284|NCT02559713|594593072|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
164610285|NCT01021813|594593074|FG000|DB Treatment Phase|Adverse Event|60|||
164610286|NCT01021813|594593075|FG001|DB Treatment Phase|Adverse Event|22|||
164610287|NCT01021813|594593076|FG002|DB Treatment Phase|Adverse Event|0|||
164610288|NCT01021813|594593077|FG003|DB Treatment Phase|Adverse Event|0|||
164610289|NCT01021813|594593078|FG004|DB Treatment Phase|Adverse Event|0|||
164610290|NCT01021813|594593074|FG000|DB Treatment Phase|Lack of Efficacy|44|||
164610291|NCT01021813|594593075|FG001|DB Treatment Phase|Lack of Efficacy|28|||
164610292|NCT01021813|594593076|FG002|DB Treatment Phase|Lack of Efficacy|0|||
164610293|NCT01021813|594593077|FG003|DB Treatment Phase|Lack of Efficacy|0|||
164610294|NCT01021813|594593078|FG004|DB Treatment Phase|Lack of Efficacy|0|||
164610295|NCT01021813|594593074|FG000|DB Treatment Phase|Lost to Follow-up|14|||
164610296|NCT01021813|594593075|FG001|DB Treatment Phase|Lost to Follow-up|12|||
164610297|NCT01021813|594593076|FG002|DB Treatment Phase|Lost to Follow-up|0|||
164610298|NCT01021813|594593077|FG003|DB Treatment Phase|Lost to Follow-up|0|||
164610299|NCT01021813|594593078|FG004|DB Treatment Phase|Lost to Follow-up|0|||
164610300|NCT01021813|594593074|FG000|DB Treatment Phase|Physician Decision|17|||
164610301|NCT01021813|594593075|FG001|DB Treatment Phase|Physician Decision|8|||
164610302|NCT01021813|594593076|FG002|DB Treatment Phase|Physician Decision|0|||
164610303|NCT01021813|594593077|FG003|DB Treatment Phase|Physician Decision|0|||
164610304|NCT01021813|594593078|FG004|DB Treatment Phase|Physician Decision|0|||
164610305|NCT01021813|594593074|FG000|DB Treatment Phase|Pregnancy|1|||
164610306|NCT01021813|594593075|FG001|DB Treatment Phase|Pregnancy|0|||
164610307|NCT01021813|594593076|FG002|DB Treatment Phase|Pregnancy|0|||
164610308|NCT01021813|594593077|FG003|DB Treatment Phase|Pregnancy|0|||
164610309|NCT01021813|594593078|FG004|DB Treatment Phase|Pregnancy|0|||
164610310|NCT01021813|594593074|FG000|DB Treatment Phase|Protocol Violation|4|||
164610311|NCT01021813|594593075|FG001|DB Treatment Phase|Protocol Violation|3|||
164610312|NCT01021813|594593076|FG002|DB Treatment Phase|Protocol Violation|0|||
164610313|NCT01021813|594593077|FG003|DB Treatment Phase|Protocol Violation|0|||
164610314|NCT01021813|594593078|FG004|DB Treatment Phase|Protocol Violation|0|||
164610315|NCT01021813|594593074|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
164610316|NCT01021813|594593075|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
164610317|NCT01021813|594593076|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
164610318|NCT01021813|594593077|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
164610319|NCT01021813|594593078|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
164610320|NCT01021813|594593074|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
164610321|NCT01021813|594593075|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
164610322|NCT01021813|594593076|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
164610323|NCT01021813|594593077|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
164610324|NCT01021813|594593078|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
164514580|NCT03083665|594253708|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
164514581|NCT03083665|594253703|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
164514582|NCT03083665|594253704|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
164514583|NCT03083665|594253705|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
164514584|NCT03083665|594253706|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
164514585|NCT03083665|594253707|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
164514586|NCT03083665|594253708|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
164514587|NCT03083665|594253703|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
164514588|NCT03083665|594253704|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
164514589|NCT03083665|594253705|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
164514590|NCT03083665|594253706|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
164514591|NCT03083665|594253707|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
164514592|NCT03083665|594253708|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
164514593|NCT03083665|594253703|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
164514594|NCT03083665|594253704|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
164514595|NCT03083665|594253705|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
164514596|NCT03083665|594253706|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
164514597|NCT03083665|594253707|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
164514598|NCT03083665|594253708|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
164514599|NCT03083665|594253703|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
164514600|NCT03083665|594253704|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
164514601|NCT03083665|594253705|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
164514602|NCT03083665|594253706|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
164514603|NCT03083665|594253707|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
164514604|NCT03083665|594253708|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
164514605|NCT02519348|594253709|FG000|Overall Study|Death|31|||
164514606|NCT02519348|594253710|FG001|Overall Study|Death|74|||
164514607|NCT02519348|594253711|FG002|Overall Study|Death|47|||
164514608|NCT02519348|594253712|FG003|Overall Study|Death|54|||
164514609|NCT02519348|594253713|FG004|Overall Study|Death|63|||
164514610|NCT02519348|594253714|FG005|Overall Study|Death|18|||
164514611|NCT02519348|594253715|FG006|Overall Study|Death|2|||
164514612|NCT02519348|594253716|FG007|Overall Study|Death|5|||
164610325|NCT01021813|594593074|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
164610326|NCT01021813|594593075|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
164610327|NCT01021813|594593076|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
164610328|NCT01021813|594593077|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
164610329|NCT01021813|594593078|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
164610330|NCT01021813|594593074|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
164610331|NCT01021813|594593075|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
164610332|NCT01021813|594593076|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
164610333|NCT01021813|594593077|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
164610334|NCT01021813|594593078|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
164610335|NCT01021813|594593074|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
164610336|NCT01021813|594593075|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
164610337|NCT01021813|594593076|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
164610338|NCT01021813|594593077|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
164610339|NCT01021813|594593078|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
164610340|NCT01021813|594593074|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
164610341|NCT01021813|594593075|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
164610342|NCT01021813|594593076|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
164610343|NCT01021813|594593077|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
164610344|NCT01021813|594593078|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
164610345|NCT00862654|594593079|FG000|Overall Study|Lack of Efficacy|1|||
164610346|NCT00862654|594593080|FG001|Overall Study|Lack of Efficacy|0|||
164610347|NCT00862654|594593081|FG002|Overall Study|Lack of Efficacy|1|||
164610348|NCT00862654|594593082|FG003|Overall Study|Lack of Efficacy|0|||
164610349|NCT00862654|594593079|FG000|Overall Study|Lost to Follow-up|1|||
164610350|NCT00862654|594593080|FG001|Overall Study|Lost to Follow-up|2|||
164514613|NCT02519348|594253717|FG008|Overall Study|Death|5|||
164514614|NCT02519348|594253709|FG000|Overall Study|Withdrawal by Subject|4|||
164610351|NCT00862654|594593081|FG002|Overall Study|Lost to Follow-up|1|||
164610352|NCT00862654|594593082|FG003|Overall Study|Lost to Follow-up|3|||
164610353|NCT00862654|594593079|FG000|Overall Study|Adverse Event|0|||
164610354|NCT00862654|594593080|FG001|Overall Study|Adverse Event|1|||
164610355|NCT00862654|594593081|FG002|Overall Study|Adverse Event|1|||
164610356|NCT00862654|594593082|FG003|Overall Study|Adverse Event|0|||
164610357|NCT00862654|594593079|FG000|Overall Study|Pregnancy|1|||
164610358|NCT00862654|594593080|FG001|Overall Study|Pregnancy|1|||
164610359|NCT00862654|594593081|FG002|Overall Study|Pregnancy|0|||
164610360|NCT00862654|594593082|FG003|Overall Study|Pregnancy|0|||
164610361|NCT00862654|594593079|FG000|Overall Study|Withdrawal by Subject|2|||
164610362|NCT00862654|594593080|FG001|Overall Study|Withdrawal by Subject|2|||
164610363|NCT00862654|594593081|FG002|Overall Study|Withdrawal by Subject|2|||
164610364|NCT00862654|594593082|FG003|Overall Study|Withdrawal by Subject|3|||
164610365|NCT00862654|594593079|FG000|Overall Study|Subject mistake|0|||
164610366|NCT00862654|594593080|FG001|Overall Study|Subject mistake|1|||
164610367|NCT00862654|594593081|FG002|Overall Study|Subject mistake|0|||
164610368|NCT00862654|594593082|FG003|Overall Study|Subject mistake|0|||
164610369|NCT00862654|594593079|FG000|Overall Study|Familly constraint|0|||
164610370|NCT00862654|594593080|FG001|Overall Study|Familly constraint|1|||
164610371|NCT00862654|594593081|FG002|Overall Study|Familly constraint|0|||
164610372|NCT00862654|594593082|FG003|Overall Study|Familly constraint|0|||
164610373|NCT00862654|594593079|FG000|Overall Study|Never used study drugs|1|||
164610374|NCT00862654|594593080|FG001|Overall Study|Never used study drugs|0|||
164610375|NCT00862654|594593081|FG002|Overall Study|Never used study drugs|0|||
164610376|NCT00862654|594593082|FG003|Overall Study|Never used study drugs|0|||
164610377|NCT00862654|594593079|FG000|Overall Study|Included after end of inclusions|0|||
164610378|NCT00862654|594593080|FG001|Overall Study|Included after end of inclusions|0|||
164610379|NCT00862654|594593081|FG002|Overall Study|Included after end of inclusions|1|||
164610380|NCT00862654|594593082|FG003|Overall Study|Included after end of inclusions|0|||
164610381|NCT03219567|594593083|FG000|Overall Study|Withdrawal by Subject|0|||
164610382|NCT03219567|594593084|FG001|Overall Study|Withdrawal by Subject|1|||
164610383|NCT01151540|594593085|FG000|Overall Study|Other|2|||
164610384|NCT01151540|594593085|FG000|Overall Study|Adverse event, non-fatal|4|||
164610385|NCT01151540|594593085|FG000|Overall Study|Withdrawal by Subject|7|||
164610386|NCT02261883|594593089|FG000|Overall Study|Death|3|||
164610387|NCT02261883|594593090|FG001|Overall Study|Death|2|||
164610388|NCT02261883|594593089|FG000|Overall Study|Physician Decision|1|||
164610389|NCT02261883|594593090|FG001|Overall Study|Physician Decision|0|||
164610390|NCT02261883|594593089|FG000|Overall Study|Protocol Violation|1|||
164610391|NCT02261883|594593090|FG001|Overall Study|Protocol Violation|0|||
164610392|NCT02261883|594593089|FG000|Overall Study|Withdrawal by Subject|0|||
164610393|NCT02261883|594593090|FG001|Overall Study|Withdrawal by Subject|1|||
164610394|NCT02261883|594593089|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
164610395|NCT02261883|594593090|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
164610396|NCT00004732|594593091|FG000|Overall Study|Withdrawal by Subject|36|||
164610397|NCT00004732|594593092|FG001|Overall Study|Withdrawal by Subject|64|||
164610398|NCT00004732|594593091|FG000|Overall Study|Lost to Follow-up|33|||
164610399|NCT00004732|594593092|FG001|Overall Study|Lost to Follow-up|47|||
164610400|NCT01688635|594593093|FG000|Washout 1|Withdrawal by Subject|1|||
164610401|NCT01688635|594593094|FG001|Washout 1|Withdrawal by Subject|0|||
164610402|NCT01688635|594593093|FG000|Washout 1|Adverse Event|0|||
164610403|NCT01688635|594593094|FG001|Washout 1|Adverse Event|1|||
164610404|NCT01688635|594593093|FG000|Washout 1|Physician Decision|0|||
164514615|NCT02519348|594253710|FG001|Overall Study|Withdrawal by Subject|7|||
164514616|NCT02519348|594253711|FG002|Overall Study|Withdrawal by Subject|4|||
164514617|NCT02519348|594253712|FG003|Overall Study|Withdrawal by Subject|3|||
164514618|NCT02519348|594253713|FG004|Overall Study|Withdrawal by Subject|3|||
164514619|NCT02519348|594253714|FG005|Overall Study|Withdrawal by Subject|2|||
164514620|NCT02519348|594253715|FG006|Overall Study|Withdrawal by Subject|0|||
164514621|NCT02519348|594253716|FG007|Overall Study|Withdrawal by Subject|0|||
164514622|NCT02519348|594253717|FG008|Overall Study|Withdrawal by Subject|1|||
164514623|NCT02519348|594253709|FG000|Overall Study|Lost to Follow-up|0|||
164514624|NCT02519348|594253710|FG001|Overall Study|Lost to Follow-up|0|||
164514625|NCT02519348|594253711|FG002|Overall Study|Lost to Follow-up|1|||
164514626|NCT02519348|594253712|FG003|Overall Study|Lost to Follow-up|0|||
164514627|NCT02519348|594253713|FG004|Overall Study|Lost to Follow-up|2|||
164514628|NCT02519348|594253714|FG005|Overall Study|Lost to Follow-up|1|||
164514629|NCT02519348|594253715|FG006|Overall Study|Lost to Follow-up|1|||
164514630|NCT02519348|594253716|FG007|Overall Study|Lost to Follow-up|0|||
164514631|NCT02519348|594253717|FG008|Overall Study|Lost to Follow-up|0|||
164514632|NCT02519348|594253709|FG000|Overall Study|Other|0|||
164610405|NCT01688635|594593094|FG001|Washout 1|Physician Decision|1|||
164514633|NCT02519348|594253710|FG001|Overall Study|Other|3|||
164610406|NCT01688635|594593093|FG000|Washout 2|Physician Decision|1|||
164514634|NCT02519348|594253711|FG002|Overall Study|Other|0|||
164610407|NCT01688635|594593094|FG001|Washout 2|Physician Decision|0|||
164610408|NCT01688635|594593093|FG000|Washout 2|Withdrawal by Subject|1|||
164610409|NCT01688635|594593094|FG001|Washout 2|Withdrawal by Subject|0|||
164610410|NCT01688635|594593093|FG000|Washout 2|Sponsor Decision|1|||
164610411|NCT01688635|594593094|FG001|Washout 2|Sponsor Decision|2|||
164610412|NCT01688635|594593093|FG000|Washout 3|Withdrawal by Subject|1|||
164610413|NCT01688635|594593094|FG001|Washout 3|Withdrawal by Subject|0|||
164514635|NCT02519348|594253712|FG003|Overall Study|Other|0|||
164514636|NCT02519348|594253713|FG004|Overall Study|Other|1|||
164514637|NCT02519348|594253714|FG005|Overall Study|Other|0|||
164514638|NCT02519348|594253715|FG006|Overall Study|Other|0|||
164514639|NCT02519348|594253716|FG007|Overall Study|Other|0|||
164514640|NCT02519348|594253717|FG008|Overall Study|Other|0|||
164514641|NCT02519348|594253709|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
164514642|NCT02519348|594253710|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
164514643|NCT02519348|594253711|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
164514644|NCT02519348|594253712|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
164514645|NCT02519348|594253713|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
164514646|NCT02519348|594253714|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
164514647|NCT02519348|594253715|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
164514648|NCT02519348|594253716|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
164514649|NCT02519348|594253717|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
164514650|NCT03635099|594253718|FG000|Period 1|Adverse Event|1|||
164514651|NCT03635099|594253719|FG001|Period 1|Adverse Event|0|||
164514652|NCT03635099|594253720|FG002|Period 1|Adverse Event|0|||
164514653|NCT03635099|594253721|FG003|Period 1|Adverse Event|1|||
164514654|NCT03635099|594253722|FG004|Period 1|Adverse Event|0|||
164514655|NCT03635099|594253723|FG005|Period 1|Adverse Event|0|||
164514656|NCT03635099|594253724|FG006|Period 1|Adverse Event|0|||
164514657|NCT03635099|594253725|FG007|Period 1|Adverse Event|0|||
164514658|NCT03635099|594253718|FG000|Period 1|Protocol Violation|0|||
164514659|NCT03635099|594253719|FG001|Period 1|Protocol Violation|0|||
164514660|NCT03635099|594253720|FG002|Period 1|Protocol Violation|1|||
164514661|NCT03635099|594253721|FG003|Period 1|Protocol Violation|0|||
164514662|NCT03635099|594253722|FG004|Period 1|Protocol Violation|0|||
164514663|NCT03635099|594253723|FG005|Period 1|Protocol Violation|0|||
164514664|NCT03635099|594253724|FG006|Period 1|Protocol Violation|0|||
164514665|NCT03635099|594253725|FG007|Period 1|Protocol Violation|0|||
164514666|NCT03635099|594253718|FG000|Period 1|Lost to Follow-up|0|||
164514667|NCT03635099|594253719|FG001|Period 1|Lost to Follow-up|0|||
164514668|NCT03635099|594253720|FG002|Period 1|Lost to Follow-up|1|||
164514669|NCT03635099|594253721|FG003|Period 1|Lost to Follow-up|2|||
164514670|NCT03635099|594253722|FG004|Period 1|Lost to Follow-up|1|||
164514671|NCT03635099|594253723|FG005|Period 1|Lost to Follow-up|0|||
164514672|NCT03635099|594253724|FG006|Period 1|Lost to Follow-up|1|||
164514673|NCT03635099|594253725|FG007|Period 1|Lost to Follow-up|2|||
164514674|NCT03635099|594253718|FG000|Period 1|Withdrawal by Subject|3|||
164514675|NCT03635099|594253719|FG001|Period 1|Withdrawal by Subject|3|||
164514676|NCT03635099|594253720|FG002|Period 1|Withdrawal by Subject|5|||
164514677|NCT03635099|594253721|FG003|Period 1|Withdrawal by Subject|2|||
164514678|NCT03635099|594253722|FG004|Period 1|Withdrawal by Subject|2|||
164514679|NCT03635099|594253723|FG005|Period 1|Withdrawal by Subject|0|||
164514680|NCT03635099|594253724|FG006|Period 1|Withdrawal by Subject|3|||
164514681|NCT03635099|594253725|FG007|Period 1|Withdrawal by Subject|0|||
164514682|NCT03635099|594253718|FG000|Period 1|History of suicidal ideation|0|||
164514683|NCT03635099|594253719|FG001|Period 1|History of suicidal ideation|0|||
164514684|NCT03635099|594253720|FG002|Period 1|History of suicidal ideation|1|||
164514685|NCT03635099|594253721|FG003|Period 1|History of suicidal ideation|0|||
164514686|NCT03635099|594253722|FG004|Period 1|History of suicidal ideation|0|||
164514687|NCT03635099|594253723|FG005|Period 1|History of suicidal ideation|0|||
164514688|NCT03635099|594253724|FG006|Period 1|History of suicidal ideation|0|||
164514689|NCT03635099|594253725|FG007|Period 1|History of suicidal ideation|0|||
164514690|NCT03635099|594253718|FG000|Period 1|pursue other treatment options|0|||
164514691|NCT03635099|594253719|FG001|Period 1|pursue other treatment options|0|||
164514692|NCT03635099|594253720|FG002|Period 1|pursue other treatment options|0|||
164514693|NCT03635099|594253721|FG003|Period 1|pursue other treatment options|0|||
164514694|NCT03635099|594253722|FG004|Period 1|pursue other treatment options|0|||
164514695|NCT03635099|594253723|FG005|Period 1|pursue other treatment options|1|||
164514696|NCT03635099|594253724|FG006|Period 1|pursue other treatment options|0|||
164514697|NCT03635099|594253725|FG007|Period 1|pursue other treatment options|0|||
164514698|NCT03635099|594253718|FG000|Not Eligible for Period 2|Pregnancy|0|||
164514699|NCT03635099|594253719|FG001|Not Eligible for Period 2|Pregnancy|0|||
164514700|NCT03635099|594253720|FG002|Not Eligible for Period 2|Pregnancy|0|||
164514701|NCT03635099|594253721|FG003|Not Eligible for Period 2|Pregnancy|1|||
164514702|NCT03635099|594253722|FG004|Not Eligible for Period 2|Pregnancy|0|||
164514703|NCT03635099|594253723|FG005|Not Eligible for Period 2|Pregnancy|0|||
164514704|NCT03635099|594253724|FG006|Not Eligible for Period 2|Pregnancy|0|||
164610414|NCT02674685|594593095|FG000|Overall Study|Withdrawal by Subject|4|||
164610415|NCT01181778|594593096|FG000|Overall Study|Physician Decision|48|||
164514705|NCT03635099|594253725|FG007|Not Eligible for Period 2|Pregnancy|0|||
164514706|NCT03635099|594253718|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
164514707|NCT03635099|594253719|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
164514708|NCT03635099|594253720|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
164514709|NCT03635099|594253721|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
164610416|NCT01626989|594593104|FG000|Screening Period|Screen Failure|15|||
164610417|NCT01626989|594593105|FG001|Screening Period|Screen Failure|0|||
164610418|NCT01626989|594593106|FG002|Screening Period|Screen Failure|0|||
164610419|NCT01626989|594593104|FG000|Screening Period|Withdrawal by Subject|2|||
164610420|NCT01626989|594593105|FG001|Screening Period|Withdrawal by Subject|0|||
164610421|NCT01626989|594593106|FG002|Screening Period|Withdrawal by Subject|0|||
164610422|NCT04021706|594595423|FG000|Overall Study|Adverse Event|2|||
164610423|NCT04021706|594595424|FG001|Overall Study|Adverse Event|0|||
164610424|NCT04021706|594595423|FG000|Overall Study|Withdrawal by Subject|1|||
164610425|NCT04021706|594595424|FG001|Overall Study|Withdrawal by Subject|2|||
164610426|NCT04021706|594595423|FG000|Overall Study|Physician Decision|1|||
164610427|NCT04021706|594595424|FG001|Overall Study|Physician Decision|0|||
164610428|NCT02332798|594595425|FG000|Overall Study|Unwilling to Participate in Study|0|||
164610429|NCT02332798|594595426|FG001|Overall Study|Unwilling to Participate in Study|1|||
164610430|NCT02332798|594595427|FG002|Overall Study|Unwilling to Participate in Study|1|||
164610431|NCT02332798|594595425|FG000|Overall Study|Positive Urine Drug Test|0|||
164610432|NCT02332798|594595426|FG001|Overall Study|Positive Urine Drug Test|1|||
164610433|NCT02332798|594595427|FG002|Overall Study|Positive Urine Drug Test|0|||
164610434|NCT02332798|594595425|FG000|Overall Study|Abnormal Laboratory Findings|1|||
164610435|NCT02332798|594595426|FG001|Overall Study|Abnormal Laboratory Findings|0|||
164610436|NCT02332798|594595427|FG002|Overall Study|Abnormal Laboratory Findings|0|||
164514710|NCT03635099|594253722|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
164514711|NCT03635099|594253723|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
164514712|NCT03635099|594253724|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
164514713|NCT03635099|594253725|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
164514714|NCT03635099|594253718|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
164514715|NCT03635099|594253719|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
164514716|NCT03635099|594253720|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
164514717|NCT03635099|594253721|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
164514718|NCT03635099|594253722|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
164514719|NCT03635099|594253723|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
164514720|NCT03635099|594253724|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
164514721|NCT03635099|594253725|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
164514722|NCT03635099|594253718|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
164514723|NCT03635099|594253719|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
164514724|NCT03635099|594253720|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
164514725|NCT03635099|594253721|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
164514726|NCT03635099|594253722|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
164514727|NCT03635099|594253723|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
164514728|NCT03635099|594253724|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
164514729|NCT03635099|594253725|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
164514730|NCT03635099|594253718|FG000|Period 2|Adverse Event|0|||
164514731|NCT03635099|594253719|FG001|Period 2|Adverse Event|0|||
164514732|NCT03635099|594253720|FG002|Period 2|Adverse Event|1|||
164514733|NCT03635099|594253721|FG003|Period 2|Adverse Event|0|||
164514734|NCT03635099|594253722|FG004|Period 2|Adverse Event|1|||
164514735|NCT03635099|594253723|FG005|Period 2|Adverse Event|0|||
164514736|NCT03635099|594253724|FG006|Period 2|Adverse Event|0|||
164514737|NCT03635099|594253725|FG007|Period 2|Adverse Event|0|||
164514738|NCT03635099|594253718|FG000|Period 2|Lost to Follow-up|0|||
164514739|NCT03635099|594253719|FG001|Period 2|Lost to Follow-up|0|||
164514740|NCT03635099|594253720|FG002|Period 2|Lost to Follow-up|1|||
164514741|NCT03635099|594253721|FG003|Period 2|Lost to Follow-up|0|||
164514742|NCT03635099|594253722|FG004|Period 2|Lost to Follow-up|4|||
164514743|NCT03635099|594253723|FG005|Period 2|Lost to Follow-up|0|||
164514744|NCT03635099|594253724|FG006|Period 2|Lost to Follow-up|0|||
164514745|NCT03635099|594253725|FG007|Period 2|Lost to Follow-up|0|||
164514746|NCT03635099|594253718|FG000|Period 2|Withdrawal by Subject|0|||
164514747|NCT03635099|594253719|FG001|Period 2|Withdrawal by Subject|0|||
164514748|NCT03635099|594253720|FG002|Period 2|Withdrawal by Subject|7|||
164610437|NCT00859573|594595428|FG000|Overall Study|Withdrawal by Subject|4|||
164610438|NCT00859573|594595429|FG001|Overall Study|Withdrawal by Subject|1|||
164514749|NCT03635099|594253721|FG003|Period 2|Withdrawal by Subject|4|||
164514750|NCT03635099|594253722|FG004|Period 2|Withdrawal by Subject|7|||
164610439|NCT00859573|594595428|FG000|Overall Study|Physician Decision|1|||
164610440|NCT00859573|594595429|FG001|Overall Study|Physician Decision|1|||
164610441|NCT01135394|594595430|FG000|Screening|Lost to Follow-up|2|||
164610442|NCT01135394|594595430|FG000|Screening|Withdrawal by Subject|10|||
164610443|NCT01135394|594595430|FG000|Screening|Screening failure|16|||
164610444|NCT01135394|594595430|FG000|Screening|Physician Decision|5|||
164514751|NCT03635099|594253723|FG005|Period 2|Withdrawal by Subject|0|||
164514752|NCT03635099|594253724|FG006|Period 2|Withdrawal by Subject|0|||
164514753|NCT03635099|594253725|FG007|Period 2|Withdrawal by Subject|0|||
164514754|NCT01289210|594253726|FG000|Overall Study|Adverse Event|1|||
164514755|NCT04844879|594253729|FG000|Overall Study|Death|1|||
164514756|NCT04844879|594253729|FG000|Overall Study|Withdrawal by Subject|1|||
164514757|NCT04844879|594253729|FG000|Overall Study|Adverse Event|1|||
164514758|NCT04103892|594253732|FG000|Overall Study|Adverse Event|0|||
164514759|NCT04103892|594253733|FG001|Overall Study|Adverse Event|0|||
164514760|NCT04103892|594253734|FG002|Overall Study|Adverse Event|0|||
164514761|NCT04103892|594253735|FG003|Overall Study|Adverse Event|3|||
164514762|NCT04103892|594253732|FG000|Overall Study|Lost to Follow-up|0|||
164514763|NCT04103892|594253733|FG001|Overall Study|Lost to Follow-up|0|||
164514764|NCT04103892|594253734|FG002|Overall Study|Lost to Follow-up|2|||
164514765|NCT04103892|594253735|FG003|Overall Study|Lost to Follow-up|0|||
164514766|NCT04103892|594253732|FG000|Overall Study|Protocol Violation|0|||
164514767|NCT04103892|594253733|FG001|Overall Study|Protocol Violation|0|||
164514768|NCT04103892|594253734|FG002|Overall Study|Protocol Violation|1|||
164514769|NCT04103892|594253735|FG003|Overall Study|Protocol Violation|1|||
164514770|NCT04103892|594253732|FG000|Overall Study|Withdrawal by Subject|1|||
164514771|NCT04103892|594253733|FG001|Overall Study|Withdrawal by Subject|0|||
164514772|NCT04103892|594253734|FG002|Overall Study|Withdrawal by Subject|2|||
164514773|NCT04103892|594253735|FG003|Overall Study|Withdrawal by Subject|5|||
164514774|NCT04103892|594253732|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
164514775|NCT04103892|594253733|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
164514776|NCT04103892|594253734|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
164514777|NCT04103892|594253735|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
164514778|NCT05576662|594253736|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
164514779|NCT05576662|594253737|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
164514780|NCT05576662|594253736|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
164514781|NCT05576662|594253737|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
164514782|NCT05576662|594253736|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
164514783|NCT05576662|594253737|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
164514784|NCT05576662|594253736|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
164514785|NCT05576662|594253737|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
164514786|NCT00281320|594253738|FG000|Overall Study|Adverse Event|12|||
164514787|NCT00281320|594253739|FG001|Overall Study|Adverse Event|9|||
164514788|NCT00281320|594253738|FG000|Overall Study|Lack of Efficacy|4|||
164514789|NCT00281320|594253739|FG001|Overall Study|Lack of Efficacy|3|||
164514790|NCT00281320|594253738|FG000|Overall Study|Withdrawal by Subject|5|||
164514791|NCT00281320|594253739|FG001|Overall Study|Withdrawal by Subject|6|||
164514792|NCT00281320|594253738|FG000|Overall Study|Lost to Follow-up|1|||
164514793|NCT00281320|594253739|FG001|Overall Study|Lost to Follow-up|2|||
164514794|NCT00281320|594253738|FG000|Overall Study|Other|3|||
164514795|NCT00281320|594253739|FG001|Overall Study|Other|1|||
164514796|NCT03008005|594253746|FG000|Overall Study|Physician Decision|1|||
164514797|NCT03008005|594253747|FG001|Overall Study|Physician Decision|0|||
164514798|NCT03008005|594253748|FG002|Overall Study|Physician Decision|0|||
164514799|NCT03008005|594253746|FG000|Overall Study|Withdrawal by Subject|1|||
164514800|NCT03008005|594253747|FG001|Overall Study|Withdrawal by Subject|0|||
164514801|NCT03008005|594253748|FG002|Overall Study|Withdrawal by Subject|0|||
164514802|NCT03008005|594253746|FG000|Overall Study|Ineligible|0|||
164514803|NCT03008005|594253747|FG001|Overall Study|Ineligible|1|||
164514804|NCT03008005|594253748|FG002|Overall Study|Ineligible|0|||
164514805|NCT05292586|594253749|FG000|Overall Study|Withdrawal by Subject|3|||
164514806|NCT05292586|594253750|FG001|Overall Study|Withdrawal by Subject|10|||
164514807|NCT05292586|594253749|FG000|Overall Study|Randomization error|3|||
164514808|NCT05292586|594253750|FG001|Overall Study|Randomization error|7|||
164514809|NCT05292586|594253749|FG000|Overall Study|Adverse Event|3|||
164514810|NCT05292586|594253750|FG001|Overall Study|Adverse Event|0|||
164514811|NCT05292586|594253749|FG000|Overall Study|Lost to Follow-up|0|||
164514812|NCT05292586|594253750|FG001|Overall Study|Lost to Follow-up|1|||
164514813|NCT05292586|594253749|FG000|Overall Study|Patient refused treatment|1|||
164514814|NCT05292586|594253750|FG001|Overall Study|Patient refused treatment|0|||
164514815|NCT05292586|594253749|FG000|Overall Study|Patient could not travel to the study site|1|||
164514816|NCT05292586|594253750|FG001|Overall Study|Patient could not travel to the study site|0|||
164514817|NCT05292586|594253749|FG000|Overall Study|Technical issues with the masterscope|0|||
164514818|NCT05292586|594253750|FG001|Overall Study|Technical issues with the masterscope|3|||
164514819|NCT05292586|594253749|FG000|Overall Study|Patient moved to a different state|0|||
164514820|NCT05292586|594253750|FG001|Overall Study|Patient moved to a different state|1|||
164514821|NCT00475228|594253751|FG000|Overall Study|Lost to Follow-up|17|||
164514822|NCT00475228|594253752|FG001|Overall Study|Lost to Follow-up|17|||
164514823|NCT03633799|594253773|FG000|Overall Study|Adverse Event|349|||
164514824|NCT03633799|594253773|FG000|Overall Study|Withdrawal by Subject|288|||
164514825|NCT03633799|594253773|FG000|Overall Study|Lost to Follow-up|97|||
164514826|NCT03633799|594253773|FG000|Overall Study|Physician Decision|9|||
164514827|NCT03633799|594253773|FG000|Overall Study|Protocol Violation|4|||
164514828|NCT03633799|594253773|FG000|Overall Study|Pregnancy|20|||
164514829|NCT03633799|594253773|FG000|Overall Study|other|39|||
164514830|NCT03633799|594253773|FG000|Overall Study|ongoing within third year of study|106|||
164514831|NCT03633799|594253773|FG000|Overall Study|unsuccessful study drug placement|19|||
164514832|NCT03551691|594253776|FG000|Overall Study|Withdrawal by Subject|3|||
164514833|NCT03551691|594253777|FG001|Overall Study|Withdrawal by Subject|3|||
164514834|NCT02367040|594253778|FG000|Overall Study|Lost to Follow-up|1|||
164514835|NCT02367040|594253779|FG001|Overall Study|Lost to Follow-up|1|||
164514836|NCT02367040|594253778|FG000|Overall Study|Lack of Efficacy|1|||
164514837|NCT02367040|594253779|FG001|Overall Study|Lack of Efficacy|0|||
164514838|NCT02367040|594253778|FG000|Overall Study|Additional primary malignancy|1|||
164514839|NCT02367040|594253779|FG001|Overall Study|Additional primary malignancy|1|||
164514840|NCT02367040|594253778|FG000|Overall Study|AE not associated with clinical disease progression|117|||
164514841|NCT02367040|594253779|FG001|Overall Study|AE not associated with clinical disease progression|12|||
164514842|NCT02367040|594253778|FG000|Overall Study|AE associated with clinical disease progression|1|||
164514843|NCT02367040|594253779|FG001|Overall Study|AE associated with clinical disease progression|4|||
164514844|NCT02367040|594253778|FG000|Overall Study|Physician Decision|2|||
164514845|NCT02367040|594253779|FG001|Overall Study|Physician Decision|8|||
164514846|NCT02367040|594253778|FG000|Overall Study|Non-compliance to study drug|1|||
164514847|NCT02367040|594253779|FG001|Overall Study|Non-compliance to study drug|0|||
164514848|NCT02367040|594253778|FG000|Overall Study|Failure to meet continuation criteria|1|||
164514849|NCT02367040|594253779|FG001|Overall Study|Failure to meet continuation criteria|0|||
164514850|NCT02367040|594253778|FG000|Overall Study|Switching to other therapy|2|||
164514851|NCT02367040|594253779|FG001|Overall Study|Switching to other therapy|0|||
164514852|NCT02367040|594253778|FG000|Overall Study|Withdrawal by Subject|51|||
164514853|NCT02367040|594253779|FG001|Overall Study|Withdrawal by Subject|16|||
164610445|NCT01135394|594595430|FG000|Baseline Assessment|Withdrawal by Subject|9|||
164610446|NCT01135394|594595430|FG000|Baseline Assessment|Physician Decision|3|||
164610447|NCT01135394|594595430|FG000|Baseline Assessment|Lost to Follow-up|2|||
164610448|NCT01135394|594595430|FG000|Baseline Assessment|Adverse Event|1|||
164610449|NCT01135394|594595430|FG000|Study Treatment|Withdrawal by Subject|1|||
164610450|NCT01135394|594595430|FG000|Study Treatment|Physician Decision|1|||
164610451|NCT01135394|594595430|FG000|Study Treatment|Adverse Event|2|||
164610452|NCT00462488|594595431|FG000|Overall Study|Protocol Violation|1|||
164610453|NCT00462488|594595432|FG001|Overall Study|Protocol Violation|0|||
164610454|NCT00462488|594595431|FG000|Overall Study|Lack of Efficacy|19|||
164610455|NCT00462488|594595432|FG001|Overall Study|Lack of Efficacy|17|||
164610456|NCT01742091|594595433|FG000|Overall Study|Adverse Event|0|||
164610457|NCT01742091|594595434|FG001|Overall Study|Adverse Event|0|||
164610458|NCT01742091|594595435|FG002|Overall Study|Adverse Event|0|||
164610459|NCT01742091|594595436|FG003|Overall Study|Adverse Event|0|||
164610460|NCT01742091|594595437|FG004|Overall Study|Adverse Event|1|||
164610461|NCT01742091|594595438|FG005|Overall Study|Adverse Event|0|||
164610462|NCT01742091|594595433|FG000|Overall Study|Physician Decision|0|||
164610463|NCT01742091|594595434|FG001|Overall Study|Physician Decision|0|||
164610464|NCT01742091|594595435|FG002|Overall Study|Physician Decision|0|||
164610465|NCT01742091|594595436|FG003|Overall Study|Physician Decision|0|||
164610466|NCT01742091|594595437|FG004|Overall Study|Physician Decision|0|||
164610467|NCT01742091|594595438|FG005|Overall Study|Physician Decision|1|||
164610468|NCT01742091|594595433|FG000|Overall Study|Withdrawal by Subject|0|||
164610469|NCT01742091|594595434|FG001|Overall Study|Withdrawal by Subject|0|||
164610470|NCT01742091|594595435|FG002|Overall Study|Withdrawal by Subject|0|||
164610471|NCT01742091|594595436|FG003|Overall Study|Withdrawal by Subject|1|||
164610472|NCT01742091|594595437|FG004|Overall Study|Withdrawal by Subject|0|||
164610473|NCT01742091|594595438|FG005|Overall Study|Withdrawal by Subject|0|||
164610474|NCT01742091|594595433|FG000|Overall Study|Lost to Follow-up|0|||
164610475|NCT01742091|594595434|FG001|Overall Study|Lost to Follow-up|0|||
164610476|NCT01742091|594595435|FG002|Overall Study|Lost to Follow-up|0|||
164610477|NCT01742091|594595436|FG003|Overall Study|Lost to Follow-up|0|||
164514854|NCT02367040|594253778|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
164514855|NCT02367040|594253779|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
164514856|NCT02367040|594253778|FG000|Overall Study|Patient decision|40|||
164514857|NCT02367040|594253779|FG001|Overall Study|Patient decision|14|||
164514858|NCT02367040|594253778|FG000|Overall Study|Required procedure failed|1|||
164514859|NCT02367040|594253779|FG001|Overall Study|Required procedure failed|0|||
164610478|NCT01742091|594595437|FG004|Overall Study|Lost to Follow-up|0|||
164610479|NCT01742091|594595438|FG005|Overall Study|Lost to Follow-up|1|||
164610480|NCT05742841|594595439|FG000|Overall Study|Withdrawal by Subject|1|||
164610481|NCT05742841|594595439|FG000|Overall Study|Lost to Follow-up|1|||
164610482|NCT03984812|594595440|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
164610483|NCT03984812|594595441|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
164610484|NCT03984812|594595442|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
164610485|NCT03984812|594595443|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
164610486|NCT03984812|594595444|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
164610487|NCT03984812|594595445|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
164610488|NCT03984812|594595446|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
164610489|NCT03984812|594595447|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
164610490|NCT03984812|594595448|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
164610491|NCT03984812|594595449|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
164610492|NCT03984812|594595450|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
164610493|NCT02971007|594595453|FG000|Overall Study|Adverse Event|1|||
164610494|NCT02971007|594595454|FG001|Overall Study|Adverse Event|0|||
164610495|NCT02971007|594595455|FG002|Overall Study|Adverse Event|0|||
164610496|NCT02971007|594595453|FG000|Overall Study|Lost to Follow-up|0|||
164610497|NCT02971007|594595454|FG001|Overall Study|Lost to Follow-up|1|||
164610498|NCT02971007|594595455|FG002|Overall Study|Lost to Follow-up|1|||
164610499|NCT02971007|594595453|FG000|Overall Study|Withdrawal by Subject|0|||
164610500|NCT02971007|594595454|FG001|Overall Study|Withdrawal by Subject|1|||
164610501|NCT02971007|594595455|FG002|Overall Study|Withdrawal by Subject|0|||
164610502|NCT02971007|594595453|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
164610503|NCT02971007|594595454|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
164610504|NCT02971007|594595455|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
164610505|NCT02971007|594595453|FG000|Overall Study|Patient discontinued study drug|0|||
164610506|NCT02971007|594595454|FG001|Overall Study|Patient discontinued study drug|1|||
164610507|NCT02971007|594595455|FG002|Overall Study|Patient discontinued study drug|0|||
164610508|NCT00728936|594595456|FG000|Overall Study|Withdrawal by Subject|0|||
164610509|NCT00728936|594595457|FG001|Overall Study|Withdrawal by Subject|0|||
164610510|NCT00728936|594595458|FG002|Overall Study|Withdrawal by Subject|0|||
164610511|NCT00728936|594595459|FG003|Overall Study|Withdrawal by Subject|0|||
164610512|NCT00728936|594595460|FG004|Overall Study|Withdrawal by Subject|0|||
164610513|NCT00728936|594595461|FG005|Overall Study|Withdrawal by Subject|1|||
164610514|NCT00728936|594595462|FG006|Overall Study|Withdrawal by Subject|0|||
164610515|NCT00438464|594595463|FG000|Overall Study|Terminated Early|14|||
164610516|NCT00438464|594595464|FG001|Overall Study|Terminated Early|5|||
164610517|NCT00438464|594595463|FG000|Overall Study|Incomplete data submission|0|||
164610518|NCT00438464|594595464|FG001|Overall Study|Incomplete data submission|2|||
164610519|NCT03943446|594595465|FG000|Overall Study|Lost to Follow-up|0|||
164610520|NCT03943446|594595466|FG001|Overall Study|Lost to Follow-up|0|||
164610521|NCT03943446|594595467|FG002|Overall Study|Lost to Follow-up|1|||
164610522|NCT03943446|594595465|FG000|Overall Study|Withdrawal by Subject|1|||
164610523|NCT03943446|594595466|FG001|Overall Study|Withdrawal by Subject|1|||
164610524|NCT03943446|594595467|FG002|Overall Study|Withdrawal by Subject|2|||
164610525|NCT03943446|594595465|FG000|Overall Study|Study Terminated by Sponsor|1|||
164610526|NCT03943446|594595466|FG001|Overall Study|Study Terminated by Sponsor|2|||
164610527|NCT03943446|594595467|FG002|Overall Study|Study Terminated by Sponsor|1|||
164610528|NCT03943446|594595465|FG000|Overall Study|Reason not Specified|5|||
164610529|NCT03943446|594595466|FG001|Overall Study|Reason not Specified|1|||
164610530|NCT03943446|594595467|FG002|Overall Study|Reason not Specified|3|||
164610531|NCT01563107|594595468|FG000|Overall Study|Physician Decision|0|||
164610532|NCT01563107|594595469|FG001|Overall Study|Physician Decision|1|||
164610533|NCT01563107|594595470|FG002|Overall Study|Physician Decision|1|||
164610534|NCT01563107|594595471|FG003|Overall Study|Physician Decision|3|||
164610535|NCT01563107|594595468|FG000|Overall Study|Withdrawal by Subject|1|||
164610536|NCT01563107|594595469|FG001|Overall Study|Withdrawal by Subject|2|||
164610537|NCT01563107|594595470|FG002|Overall Study|Withdrawal by Subject|1|||
164610538|NCT01563107|594595471|FG003|Overall Study|Withdrawal by Subject|2|||
164610539|NCT00063986|594595474|FG000|Overall Study|Withdrawal by Subject|1|||
164610540|NCT00063986|594595474|FG000|Overall Study|Ineligible|1|||
164610541|NCT00063986|594595474|FG000|Overall Study|Intra-operatively ineligible|4|||
164610542|NCT02471586|594595475|FG000|Overall Study|Lost to Follow-up|3|||
164610543|NCT02471586|594595476|FG001|Overall Study|Lost to Follow-up|8|||
164610544|NCT02471586|594595477|FG002|Overall Study|Lost to Follow-up|4|||
164610545|NCT02471586|594595475|FG000|Overall Study|Death|2|||
164610546|NCT02471586|594595476|FG001|Overall Study|Death|2|||
164610547|NCT02471586|594595477|FG002|Overall Study|Death|0|||
164610548|NCT01601704|594595478|FG000|Overall Study|Randomized but not dispensed study med|1|||
164610549|NCT01601704|594595479|FG001|Overall Study|Randomized but not dispensed study med|4|||
164610550|NCT03276572|594595482|FG000|Overall Study|In follow-up|0|||
164610551|NCT03276572|594595483|FG001|Overall Study|In follow-up|0|||
164610552|NCT03276572|594595484|FG002|Overall Study|In follow-up|0|||
164610553|NCT03276572|594595485|FG003|Overall Study|In follow-up|0|||
164610554|NCT03276572|594595486|FG004|Overall Study|In follow-up|0|||
164610555|NCT03276572|594595487|FG005|Overall Study|In follow-up|1|||
164610556|NCT03276572|594595488|FG006|Overall Study|In follow-up|1|||
164610557|NCT03276572|594595482|FG000|Overall Study|Lost to Follow-up|0|||
164610558|NCT03276572|594595483|FG001|Overall Study|Lost to Follow-up|0|||
164610559|NCT03276572|594595484|FG002|Overall Study|Lost to Follow-up|0|||
164610560|NCT03276572|594595485|FG003|Overall Study|Lost to Follow-up|0|||
164610561|NCT03276572|594595486|FG004|Overall Study|Lost to Follow-up|0|||
164610562|NCT03276572|594595487|FG005|Overall Study|Lost to Follow-up|0|||
164610563|NCT03276572|594595488|FG006|Overall Study|Lost to Follow-up|1|||
164610564|NCT02580240|594595489|FG000|Overall Study|Physician Decision|2|||
164610565|NCT02580240|594595490|FG001|Overall Study|Physician Decision|0|||
164610566|NCT00607919|594595491|FG000|Acute Phase|Adverse Event|9|||
164610567|NCT00607919|594595492|FG001|Acute Phase|Adverse Event|2|||
164610568|NCT00607919|594595491|FG000|Acute Phase|Entry Criteria Not Met|1|||
164610569|NCT00607919|594595492|FG001|Acute Phase|Entry Criteria Not Met|1|||
164610570|NCT00607919|594595491|FG000|Acute Phase|Lack of Efficacy|1|||
164610571|NCT00607919|594595492|FG001|Acute Phase|Lack of Efficacy|2|||
164610572|NCT00607919|594595491|FG000|Acute Phase|Lost to Follow-up|9|||
164610573|NCT00607919|594595492|FG001|Acute Phase|Lost to Follow-up|3|||
164610574|NCT00607919|594595491|FG000|Acute Phase|Parent/Caregiver Decision|6|||
164610575|NCT00607919|594595492|FG001|Acute Phase|Parent/Caregiver Decision|4|||
164610576|NCT00607919|594595491|FG000|Acute Phase|Protocol Violation|5|||
164610577|NCT00607919|594595492|FG001|Acute Phase|Protocol Violation|1|||
164610578|NCT00607919|594595491|FG000|Acute Phase|Withdrawal by Subject|3|||
164610579|NCT00607919|594595492|FG001|Acute Phase|Withdrawal by Subject|3|||
164610580|NCT00607919|594595491|FG000|Open-Label Phase|Adverse Event|1|||
164610581|NCT00607919|594595492|FG001|Open-Label Phase|Adverse Event|5|||
164610582|NCT00607919|594595491|FG000|Open-Label Phase|Lost to Follow-up|4|||
164610583|NCT00607919|594595492|FG001|Open-Label Phase|Lost to Follow-up|1|||
164610584|NCT00607919|594595491|FG000|Open-Label Phase|Protocol Violation|2|||
164610585|NCT00607919|594595492|FG001|Open-Label Phase|Protocol Violation|2|||
164610586|NCT00607919|594595491|FG000|Open-Label Phase|Withdrawal by Subject|2|||
164610587|NCT00607919|594595492|FG001|Open-Label Phase|Withdrawal by Subject|2|||
164610588|NCT00607919|594595491|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
164610589|NCT00607919|594595492|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
164610590|NCT00239356|594595498|FG000|Overall Study|Lack of Efficacy|1|||
164610591|NCT00239356|594595499|FG001|Overall Study|Lack of Efficacy|0|||
164610592|NCT00239356|594595498|FG000|Overall Study|Adverse Event|6|||
164610593|NCT00239356|594595499|FG001|Overall Study|Adverse Event|0|||
164610594|NCT00239356|594595498|FG000|Overall Study|Withdrawal by Subject|15|||
164610595|NCT00239356|594595499|FG001|Overall Study|Withdrawal by Subject|6|||
164610596|NCT00239356|594595498|FG000|Overall Study|Lost to Follow-up|3|||
164610597|NCT00239356|594595499|FG001|Overall Study|Lost to Follow-up|0|||
164610598|NCT00239356|594595498|FG000|Overall Study|poor/non-compliance|2|||
164610599|NCT00239356|594595499|FG001|Overall Study|poor/non-compliance|0|||
164610600|NCT00239356|594595498|FG000|Overall Study|Pregnancy|1|||
164610601|NCT00239356|594595499|FG001|Overall Study|Pregnancy|0|||
164610602|NCT00239356|594595498|FG000|Overall Study|Administrative reason|0|||
164610603|NCT00239356|594595499|FG001|Overall Study|Administrative reason|1|||
164610604|NCT00239356|594595498|FG000|Overall Study|Drug available on market|11|||
164610605|NCT00239356|594595499|FG001|Overall Study|Drug available on market|2|||
164610606|NCT01001572|594595500|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
164610607|NCT01001572|594595501|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
164610608|NCT01001572|594595502|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
164610609|NCT01001572|594595500|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
164610610|NCT01001572|594595501|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
164610611|NCT01001572|594595502|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
164610612|NCT01001572|594595500|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
164514860|NCT02367040|594253778|FG000|Overall Study|Randomized by mistake with study treatment|1|||
164514861|NCT02367040|594253779|FG001|Overall Study|Randomized by mistake with study treatment|0|||
164514862|NCT02367040|594253778|FG000|Overall Study|Protocol Violation|1|||
164514863|NCT02367040|594253779|FG001|Overall Study|Protocol Violation|0|||
164514864|NCT02367040|594253778|FG000|Overall Study|Progressive disease - radiological progression|54|||
164514865|NCT02367040|594253779|FG001|Overall Study|Progressive disease - radiological progression|80|||
164514866|NCT02367040|594253778|FG000|Overall Study|Progressive disease - clinical progression|6|||
164514867|NCT02367040|594253779|FG001|Overall Study|Progressive disease - clinical progression|6|||
164514868|NCT02367040|594253778|FG000|Overall Study|Drug not administered|3|||
164514869|NCT02367040|594253779|FG001|Overall Study|Drug not administered|2|||
164514870|NCT02367040|594253778|FG000|Overall Study|Progressive disease|0|||
164514871|NCT02367040|594253779|FG001|Overall Study|Progressive disease|1|||
164514872|NCT02367040|594253778|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
164514873|NCT02367040|594253779|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
164514874|NCT02367040|594253778|FG000|Overall Study|Death|2|||
164514875|NCT02367040|594253779|FG001|Overall Study|Death|0|||
164514876|NCT02367040|594253778|FG000|Overall Study|Study terminated by sponsor|19|||
164514877|NCT02367040|594253779|FG001|Overall Study|Study terminated by sponsor|2|||
164514878|NCT02477618|594253780|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
164514879|NCT02477618|594253781|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
164514880|NCT02477618|594253780|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
164514881|NCT02477618|594253781|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
164514882|NCT02477618|594253780|FG000|Overall Study|Adverse Event|1|||
164610613|NCT01001572|594595501|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
164610614|NCT01001572|594595502|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
164610615|NCT01001572|594595500|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
164610616|NCT01001572|594595501|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
164610617|NCT01001572|594595502|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
164610618|NCT01001572|594595500|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
164610619|NCT01001572|594595501|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
164610620|NCT01001572|594595502|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
164610621|NCT01001572|594595500|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
164610622|NCT01001572|594595501|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
164610623|NCT01001572|594595502|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
164610624|NCT01001572|594595500|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
164610625|NCT01001572|594595501|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
164610626|NCT01001572|594595502|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
164610627|NCT01001572|594595500|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
164610628|NCT01001572|594595501|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
164610629|NCT01001572|594595502|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
164610630|NCT01001572|594595500|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
164610631|NCT01001572|594595501|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
164610632|NCT01001572|594595502|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
164610633|NCT01001572|594595500|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
164610634|NCT01001572|594595501|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
164610635|NCT01001572|594595502|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
164610636|NCT01001572|594595500|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
164610637|NCT01001572|594595501|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
164610638|NCT01001572|594595502|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
164610639|NCT01001572|594595500|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
164610640|NCT01001572|594595501|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
164610641|NCT01001572|594595502|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
164610642|NCT01001572|594595500|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
164610643|NCT01001572|594595501|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
164610644|NCT01001572|594595502|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
164610645|NCT01001572|594595500|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164610646|NCT01001572|594595501|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164610647|NCT01001572|594595502|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
164610648|NCT00511108|594595503|FG000|Overall Study|Adverse Event|2|||
164610649|NCT00511108|594595504|FG001|Overall Study|Adverse Event|0|||
164610650|NCT00511108|594595505|FG002|Overall Study|Adverse Event|1|||
164610651|NCT00511108|594595506|FG003|Overall Study|Adverse Event|2|||
164610652|NCT00511108|594595503|FG000|Overall Study|Lost to Follow-up|0|||
164610653|NCT00511108|594595504|FG001|Overall Study|Lost to Follow-up|2|||
164610654|NCT00511108|594595505|FG002|Overall Study|Lost to Follow-up|1|||
164610655|NCT00511108|594595506|FG003|Overall Study|Lost to Follow-up|0|||
164610656|NCT00511108|594595503|FG000|Overall Study|Physician Decision|0|||
164610657|NCT00511108|594595504|FG001|Overall Study|Physician Decision|0|||
164610658|NCT00511108|594595505|FG002|Overall Study|Physician Decision|0|||
164610659|NCT00511108|594595506|FG003|Overall Study|Physician Decision|1|||
164610660|NCT00511108|594595503|FG000|Overall Study|Withdrawal by Subject|4|||
164610661|NCT00511108|594595504|FG001|Overall Study|Withdrawal by Subject|0|||
164610662|NCT00511108|594595505|FG002|Overall Study|Withdrawal by Subject|3|||
164610663|NCT00511108|594595506|FG003|Overall Study|Withdrawal by Subject|2|||
164610664|NCT01237223|594595509|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
164610665|NCT01237223|594595510|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
164610666|NCT01237223|594595511|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
164610667|NCT01237223|594595512|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
164610668|NCT01237223|594595513|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
164610669|NCT01237223|594595514|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
164610670|NCT01237223|594595509|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
164610671|NCT01237223|594595510|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
164610672|NCT01237223|594595511|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
164610673|NCT01237223|594595512|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
164610674|NCT01237223|594595513|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
164610675|NCT01237223|594595514|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
164610676|NCT01237223|594595509|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
164610677|NCT01237223|594595510|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
164610678|NCT01237223|594595511|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
164610679|NCT01237223|594595512|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
164610680|NCT01237223|594595513|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
164610681|NCT01237223|594595514|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
164610682|NCT01237223|594595509|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
164610683|NCT01237223|594595510|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
164610684|NCT01237223|594595511|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
164610685|NCT01237223|594595512|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
164610686|NCT01237223|594595513|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
164610687|NCT01237223|594595514|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
164610688|NCT01237223|594595509|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
164610689|NCT01237223|594595510|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
164610690|NCT01237223|594595511|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
164610691|NCT01237223|594595512|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
164610692|NCT01237223|594595513|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
164610693|NCT01237223|594595514|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
164610694|NCT01237223|594595509|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
164610695|NCT01237223|594595510|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
164610696|NCT01237223|594595511|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
164610697|NCT01237223|594595512|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
164610698|NCT01237223|594595513|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
164610699|NCT01237223|594595514|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
164610700|NCT01237223|594595509|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
164610701|NCT01237223|594595510|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
164610702|NCT01237223|594595511|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
164610703|NCT01237223|594595512|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
164610704|NCT01237223|594595513|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
164610705|NCT01237223|594595514|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
164610706|NCT01237223|594595509|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
164610707|NCT01237223|594595510|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
164610708|NCT01237223|594595511|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
164610709|NCT01237223|594595512|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
164610710|NCT01237223|594595513|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
164610711|NCT01237223|594595514|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
164610712|NCT01237223|594595509|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
164610713|NCT01237223|594595510|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
164610714|NCT01237223|594595511|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
164610715|NCT01237223|594595512|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
164610716|NCT01237223|594595513|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
164610717|NCT01237223|594595514|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
164610718|NCT01237223|594595509|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
164610719|NCT01237223|594595510|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
164610720|NCT01237223|594595511|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
164610721|NCT01237223|594595512|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
164514883|NCT02477618|594253781|FG001|Overall Study|Adverse Event|1|||
164514884|NCT02477618|594253780|FG000|Overall Study|Transferred Away from Study Site|1|||
164514885|NCT02477618|594253781|FG001|Overall Study|Transferred Away from Study Site|0|||
164514886|NCT02477618|594253780|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
164514887|NCT02477618|594253781|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
164514888|NCT05855967|594253782|FG000|Overall Study|Withdrawal by Subject|7|||
164514889|NCT05855967|594253783|FG001|Overall Study|Withdrawal by Subject|5|||
164514890|NCT05855967|594253782|FG000|Overall Study|Lost to Follow-up|2|||
164514891|NCT05855967|594253783|FG001|Overall Study|Lost to Follow-up|1|||
164514892|NCT02446821|594253784|FG000|Overall Study|Adverse Event|28|||
164514893|NCT02446821|594253784|FG000|Overall Study|Withdrawal by Subject|6|||
164514894|NCT02446821|594253784|FG000|Overall Study|Lost to Follow-up|22|||
164514895|NCT02446821|594253784|FG000|Overall Study|other|9|||
164610722|NCT01237223|594595513|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
164610723|NCT01237223|594595514|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
164610724|NCT00724815|594595517|FG000|Overall Study|Randomized, not treated|31|||
164610725|NCT00724815|594595518|FG001|Overall Study|Randomized, not treated|30|||
164610726|NCT00724815|594595517|FG000|Overall Study|Adverse Event|5|||
164610727|NCT00724815|594595518|FG001|Overall Study|Adverse Event|3|||
164610728|NCT00724815|594595517|FG000|Overall Study|Lost to Follow-up|4|||
164610729|NCT00724815|594595518|FG001|Overall Study|Lost to Follow-up|1|||
164610730|NCT00724815|594595517|FG000|Overall Study|Other Various|3|||
164610731|NCT00724815|594595518|FG001|Overall Study|Other Various|5|||
164610732|NCT00810043|594595519|FG000|Overall Study|Withdrawal by Subject|1|||
164610733|NCT00810043|594595520|FG001|Overall Study|Withdrawal by Subject|0|||
164610734|NCT00810043|594595521|FG002|Overall Study|Withdrawal by Subject|2|||
164610735|NCT00810043|594595519|FG000|Overall Study|Lost to Follow-up|1|||
164610736|NCT00810043|594595520|FG001|Overall Study|Lost to Follow-up|0|||
164610737|NCT00810043|594595521|FG002|Overall Study|Lost to Follow-up|0|||
164610738|NCT00810043|594595519|FG000|Overall Study|Physician Decision|0|||
164610739|NCT00810043|594595520|FG001|Overall Study|Physician Decision|0|||
164610740|NCT00810043|594595521|FG002|Overall Study|Physician Decision|2|||
164610741|NCT00810043|594595519|FG000|Overall Study|Death|2|||
164610742|NCT00810043|594595520|FG001|Overall Study|Death|0|||
164610743|NCT00810043|594595521|FG002|Overall Study|Death|0|||
164610744|NCT00810043|594595519|FG000|Overall Study|Unrelated medical problem|0|||
164610745|NCT00810043|594595520|FG001|Overall Study|Unrelated medical problem|1|||
164610746|NCT00810043|594595521|FG002|Overall Study|Unrelated medical problem|0|||
164610747|NCT00810043|594595519|FG000|Overall Study|Non-medical problem|0|||
164610748|NCT00810043|594595520|FG001|Overall Study|Non-medical problem|0|||
164610749|NCT00810043|594595521|FG002|Overall Study|Non-medical problem|1|||
164610750|NCT00810043|594595519|FG000|Overall Study|No longer met enrollment criteria|0|||
164610751|NCT00810043|594595520|FG001|Overall Study|No longer met enrollment criteria|0|||
164610752|NCT00810043|594595521|FG002|Overall Study|No longer met enrollment criteria|3|||
164610753|NCT02001688|594595522|FG000|Overall Study|Withdrawal by Subject|0|||
164610754|NCT02001688|594595523|FG001|Overall Study|Withdrawal by Subject|0|||
164610755|NCT02001688|594595524|FG002|Overall Study|Withdrawal by Subject|1|||
164610756|NCT02001688|594595522|FG000|Overall Study|Adverse Event|0|||
164610757|NCT02001688|594595523|FG001|Overall Study|Adverse Event|1|||
164610758|NCT02001688|594595524|FG002|Overall Study|Adverse Event|0|||
164610759|NCT00445341|594595528|FG000|Overall Study|refused further treatment|1|||
164610760|NCT00445341|594595528|FG000|Overall Study|taken off treatment too early|1|||
164610761|NCT00641706|594595529|FG000|Overall Study|Adverse Event|2|||
164610762|NCT00641706|594595530|FG001|Overall Study|Adverse Event|1|||
164610763|NCT00641706|594595529|FG000|Overall Study|Withdrawal by Subject|6|||
164610764|NCT00641706|594595530|FG001|Overall Study|Withdrawal by Subject|1|||
164610765|NCT00641706|594595529|FG000|Overall Study|Clinical Decline|1|||
164610766|NCT00641706|594595530|FG001|Overall Study|Clinical Decline|0|||
164610767|NCT00641706|594595529|FG000|Overall Study|Lead Investigator Decision|0|||
164610768|NCT00641706|594595530|FG001|Overall Study|Lead Investigator Decision|1|||
164610769|NCT01675141|594595531|FG000|Overall Study|Lenalidomide outside NIH|3|||
164610770|NCT01675141|594595531|FG000|Overall Study|Withdrawal by Subject|3|||
164610771|NCT01675141|594595531|FG000|Overall Study|Physician Decision|4|||
164610772|NCT01675141|594595531|FG000|Overall Study|No treatment, per protocol|1|||
164610773|NCT00813917|594595532|FG000|Overall Study|Adverse Event|0|||
164610774|NCT00813917|594595533|FG001|Overall Study|Adverse Event|1|||
164610775|NCT00813917|594595532|FG000|Overall Study|Withdrawal by Subject|3|||
164610776|NCT00813917|594595533|FG001|Overall Study|Withdrawal by Subject|4|||
164610777|NCT00813917|594595532|FG000|Overall Study|Lost to Follow-up|3|||
164610778|NCT00813917|594595533|FG001|Overall Study|Lost to Follow-up|1|||
164610779|NCT05441540|594595534|FG000|Overall Study|Withdrawal by Subject|2|||
164610780|NCT01359046|594595535|FG000|Overall Study|Did not receive allocated intervention|6|||
164610781|NCT01359046|594595536|FG001|Overall Study|Did not receive allocated intervention|6|||
164610782|NCT01359046|594595535|FG000|Overall Study|Physician Decision|1|||
164610783|NCT01359046|594595536|FG001|Overall Study|Physician Decision|11|||
164610784|NCT00105183|594595540|FG000|Overall Study|Death|19|||
164610785|NCT00105183|594595541|FG001|Overall Study|Death|13|||
164610786|NCT00105183|594595542|FG002|Overall Study|Death|15|||
164610787|NCT00105183|594595540|FG000|Overall Study|Withdrawal by Subject|1|||
164610788|NCT00105183|594595541|FG001|Overall Study|Withdrawal by Subject|1|||
164610789|NCT00105183|594595542|FG002|Overall Study|Withdrawal by Subject|4|||
164610790|NCT00105183|594595540|FG000|Overall Study|Physician Decision|1|||
164610791|NCT00105183|594595541|FG001|Overall Study|Physician Decision|2|||
164610792|NCT00105183|594595542|FG002|Overall Study|Physician Decision|3|||
164610793|NCT00105183|594595540|FG000|Overall Study|Lost to Follow-up|0|||
164610794|NCT00105183|594595541|FG001|Overall Study|Lost to Follow-up|1|||
164610795|NCT00105183|594595542|FG002|Overall Study|Lost to Follow-up|1|||
164610796|NCT00105183|594595540|FG000|Overall Study|Other reason|1|||
164610797|NCT00105183|594595541|FG001|Overall Study|Other reason|2|||
164610798|NCT00105183|594595542|FG002|Overall Study|Other reason|0|||
164610799|NCT00615914|594595545|FG000|Overall Study|Adverse Event|274|||
164610800|NCT00615914|594595545|FG000|Overall Study|Death|20|||
164610801|NCT00615914|594595545|FG000|Overall Study|Lack of Efficacy|59|||
164610802|NCT00615914|594595545|FG000|Overall Study|Lost to Follow-up|187|||
164610803|NCT00615914|594595545|FG000|Overall Study|Withdrawal by Subject|16|||
164610804|NCT00615914|594595545|FG000|Overall Study|Physician Decision|4|||
164610805|NCT00615914|594595545|FG000|Overall Study|No data was collected.|65|||
164610806|NCT00615914|594595545|FG000|Overall Study|No treatment|2|||
164610807|NCT00615914|594595545|FG000|Overall Study|Irregularly enrolled patients|10|||
164610808|NCT00270998|594595546|FG000|3 Month Follow-up|Adverse Event|1|||
164610809|NCT00270998|594595547|FG001|3 Month Follow-up|Adverse Event|0|||
164610810|NCT00270998|594595548|FG002|3 Month Follow-up|Adverse Event|0|||
164610811|NCT00270998|594595546|FG000|3 Month Follow-up|Lack of Efficacy|1|||
164610812|NCT00270998|594595547|FG001|3 Month Follow-up|Lack of Efficacy|2|||
164610813|NCT00270998|594595548|FG002|3 Month Follow-up|Lack of Efficacy|1|||
164610814|NCT00270998|594595546|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
164610815|NCT00270998|594595547|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
164610816|NCT00270998|594595548|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
164610817|NCT00270998|594595546|FG000|3 Month Follow-up|Pessary did not fit|12|||
164610818|NCT00270998|594595547|FG001|3 Month Follow-up|Pessary did not fit|0|||
164610819|NCT00270998|594595548|FG002|3 Month Follow-up|Pessary did not fit|0|||
164610820|NCT00270998|594595546|FG000|3 Month Follow-up|Personal/family health|1|||
164610821|NCT00270998|594595547|FG001|3 Month Follow-up|Personal/family health|1|||
164610822|NCT00270998|594595548|FG002|3 Month Follow-up|Personal/family health|0|||
164610823|NCT00270998|594595546|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
164610824|NCT00270998|594595547|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
164610825|NCT00270998|594595548|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
164610826|NCT00270998|594595546|FG000|12 Month Follow-up|Lack of Efficacy|5|||
164610827|NCT00270998|594595547|FG001|12 Month Follow-up|Lack of Efficacy|4|||
164610828|NCT00270998|594595548|FG002|12 Month Follow-up|Lack of Efficacy|3|||
164610829|NCT00270998|594595546|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
164610830|NCT00270998|594595547|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
164610831|NCT00270998|594595548|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
164610832|NCT00270998|594595546|FG000|12 Month Follow-up|Pessary did not fit|1|||
164610833|NCT00270998|594595547|FG001|12 Month Follow-up|Pessary did not fit|0|||
164610834|NCT00270998|594595548|FG002|12 Month Follow-up|Pessary did not fit|0|||
164610835|NCT00270998|594595546|FG000|12 Month Follow-up|Personal/family health|0|||
164610836|NCT00270998|594595547|FG001|12 Month Follow-up|Personal/family health|5|||
164610837|NCT00270998|594595548|FG002|12 Month Follow-up|Personal/family health|1|||
164610838|NCT00270998|594595546|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
164610839|NCT00270998|594595547|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
164610840|NCT00270998|594595548|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
164610841|NCT04075396|594595549|FG000|Overall Study|Death|11|||
164610842|NCT04075396|594595550|FG001|Overall Study|Death|9|||
164610843|NCT04075396|594595549|FG000|Overall Study|Withdrawal by Subject|1|||
164610844|NCT04075396|594595550|FG001|Overall Study|Withdrawal by Subject|2|||
164610845|NCT04075396|594595549|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
164610846|NCT04075396|594595550|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
164610847|NCT04075396|594595549|FG000|Overall Study|Enrolled but not-treated|0|||
164610848|NCT04075396|594595550|FG001|Overall Study|Enrolled but not-treated|1|||
164610849|NCT04737759|594595551|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
164610850|NCT04737759|594595552|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
164610851|NCT04737759|594595551|FG000|Overall Study|Death|2|||
164610852|NCT04737759|594595552|FG001|Overall Study|Death|0|||
164610853|NCT04737759|594595551|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
164610854|NCT04737759|594595552|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
164610855|NCT04737759|594595551|FG000|Overall Study|Lost to Follow-up|4|||
164610856|NCT04737759|594595552|FG001|Overall Study|Lost to Follow-up|12|||
164610857|NCT00294684|594595553|FG000|Overall Study|Lost to Follow-up|5|||
164610858|NCT00294684|594595554|FG001|Overall Study|Lost to Follow-up|8|||
164610859|NCT01981109|594595557|FG000|Overall Study|Death|36|||
164610860|NCT01981109|594595557|FG000|Overall Study|Withdrawal by Subject|40|||
164610861|NCT01981109|594595557|FG000|Overall Study|Lost to Follow-up|9|||
164610862|NCT01981109|594595557|FG000|Overall Study|No Discontinuation Documentation|37|||
164610863|NCT01981109|594595557|FG000|Overall Study|Study Termination|100|||
164610864|NCT01981109|594595557|FG000|Overall Study|No data available|2|||
164610865|NCT01248364|594595558|FG000|Overall Study|Adverse Event|0|||
164610866|NCT01248364|594595559|FG001|Overall Study|Adverse Event|1|||
164610867|NCT01248364|594595560|FG002|Overall Study|Adverse Event|0|||
164610868|NCT01248364|594595561|FG003|Overall Study|Adverse Event|0|||
164610869|NCT01767519|594595562|FG000|Overall Study|Other Reasons|4|||
164610870|NCT01767519|594595563|FG001|Overall Study|Other Reasons|4|||
164610871|NCT01767519|594595564|FG002|Overall Study|Other Reasons|2|||
164610872|NCT01767519|594595562|FG000|Overall Study|Protocol Violation|0|||
164610873|NCT01767519|594595563|FG001|Overall Study|Protocol Violation|3|||
164610874|NCT01767519|594595564|FG002|Overall Study|Protocol Violation|0|||
164610875|NCT01767519|594595562|FG000|Overall Study|Personal Reasons|1|||
164610876|NCT01767519|594595563|FG001|Overall Study|Personal Reasons|0|||
164610877|NCT01767519|594595564|FG002|Overall Study|Personal Reasons|0|||
164610878|NCT01767519|594595562|FG000|Overall Study|Lost to Follow-up|3|||
164610879|NCT01767519|594595563|FG001|Overall Study|Lost to Follow-up|1|||
164610880|NCT01767519|594595564|FG002|Overall Study|Lost to Follow-up|2|||
164610881|NCT01767519|594595562|FG000|Overall Study|Lack of Efficacy|1|||
164610882|NCT01767519|594595563|FG001|Overall Study|Lack of Efficacy|0|||
164610883|NCT01767519|594595564|FG002|Overall Study|Lack of Efficacy|0|||
164610884|NCT01767519|594595562|FG000|Overall Study|Adverse Event|5|||
164610885|NCT01767519|594595563|FG001|Overall Study|Adverse Event|5|||
164610886|NCT01767519|594595564|FG002|Overall Study|Adverse Event|1|||
164610887|NCT00996593|594595567|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
164610888|NCT00996593|594595567|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
164610889|NCT00996593|594595567|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
164610890|NCT00996593|594595567|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
164610891|NCT00996593|594595567|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
164610892|NCT00996593|594595567|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
164610893|NCT00996593|594595567|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
164610894|NCT00996593|594595567|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
164610895|NCT00996593|594595567|FG000|Long-Term Follow-Up|Site Closed|1|||
164610896|NCT01033487|594595568|FG000|Fourth Intervention Period|Adverse Event|0|||
164610897|NCT01033487|594595569|FG001|Fourth Intervention Period|Adverse Event|0|||
164610898|NCT01033487|594595570|FG002|Fourth Intervention Period|Adverse Event|0|||
164610899|NCT01033487|594595571|FG003|Fourth Intervention Period|Adverse Event|0|||
164610900|NCT01033487|594595572|FG004|Fourth Intervention Period|Adverse Event|0|||
164610901|NCT01033487|594595573|FG005|Fourth Intervention Period|Adverse Event|0|||
164610902|NCT01033487|594595574|FG006|Fourth Intervention Period|Adverse Event|0|||
164610903|NCT01033487|594595575|FG007|Fourth Intervention Period|Adverse Event|0|||
164610904|NCT01033487|594595576|FG008|Fourth Intervention Period|Adverse Event|1|||
164610905|NCT01033487|594595577|FG009|Fourth Intervention Period|Adverse Event|0|||
164610906|NCT02849626|594595578|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
164610907|NCT02849626|594595579|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
164610908|NCT02849626|594595580|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
164610909|NCT02849626|594595581|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
164610910|NCT02849626|594595578|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
164610911|NCT02849626|594595579|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
164610912|NCT02849626|594595580|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
164610913|NCT02849626|594595581|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
164610914|NCT02849626|594595578|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
164610915|NCT02849626|594595579|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
164610916|NCT02849626|594595580|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
164610917|NCT02849626|594595581|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
164610918|NCT02849626|594595578|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
164610919|NCT02849626|594595579|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
164610920|NCT02849626|594595580|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
164610921|NCT02849626|594595581|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
164610922|NCT02849626|594595578|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
164610923|NCT02849626|594595579|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
164610924|NCT02849626|594595580|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
164610925|NCT02849626|594595581|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
164610926|NCT02849626|594595578|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
164610927|NCT02849626|594595579|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
164610928|NCT02849626|594595580|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
164610929|NCT02849626|594595581|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
164610930|NCT02849626|594595578|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
164610931|NCT02849626|594595579|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
164514896|NCT02446821|594253784|FG000|Overall Study|insertion failure|3|||
164514897|NCT01255631|594255202|FG000|Overall Study|poor enrollment, no data analyzed|9|||
164514898|NCT01255631|594255203|FG001|Overall Study|poor enrollment, no data analyzed|6|||
164514899|NCT00515671|594255204|FG000|Overall Study|Lost to Follow-up|13|||
164514900|NCT00515671|594255205|FG001|Overall Study|Lost to Follow-up|10|||
164514901|NCT00515671|594255204|FG000|Overall Study|Withdrawal by Subject|3|||
164514902|NCT00515671|594255205|FG001|Overall Study|Withdrawal by Subject|5|||
164514903|NCT00515671|594255204|FG000|Overall Study|incarcerated|1|||
164514904|NCT00515671|594255205|FG001|Overall Study|incarcerated|2|||
164514905|NCT01195948|594255208|FG000|Overall Study|Lost to Follow-up|0|||
164514906|NCT01195948|594255209|FG001|Overall Study|Lost to Follow-up|1|||
164514907|NCT01195948|594255210|FG002|Overall Study|Lost to Follow-up|2|||
164514908|NCT00818168|594255220|FG000|Overall Study|Lack of Efficacy|18|||
164514909|NCT00818168|594255220|FG000|Overall Study|Pregnancy|2|||
164514910|NCT00818168|594255220|FG000|Overall Study|Withdrawal by Subject|16|||
164514911|NCT00818168|594255220|FG000|Overall Study|Lost to Follow-up|7|||
164514912|NCT00818168|594255220|FG000|Overall Study|Adverse Event|19|||
164514913|NCT00818168|594255220|FG000|Overall Study|Reason for Non-completion Not reported|6|||
164514914|NCT00818168|594255220|FG000|Overall Study|Participant Moved|2|||
164514915|NCT04020185|594255223|FG000|Overall Study|Death|0|||
164514916|NCT04020185|594255224|FG001|Overall Study|Death|0|||
164514917|NCT04020185|594255225|FG002|Overall Study|Death|1|||
164514918|NCT04020185|594255226|FG003|Overall Study|Death|2|||
164514919|NCT04020185|594255227|FG004|Overall Study|Death|1|||
164514920|NCT04020185|594255228|FG005|Overall Study|Death|0|||
164514921|NCT04020185|594255229|FG006|Overall Study|Death|1|||
164514922|NCT04020185|594255230|FG007|Overall Study|Death|0|||
164514923|NCT04020185|594255223|FG000|Overall Study|Consent withdrawn|1|||
164514924|NCT04020185|594255224|FG001|Overall Study|Consent withdrawn|0|||
164514925|NCT04020185|594255225|FG002|Overall Study|Consent withdrawn|0|||
164514926|NCT04020185|594255226|FG003|Overall Study|Consent withdrawn|0|||
164514927|NCT04020185|594255227|FG004|Overall Study|Consent withdrawn|2|||
164514928|NCT04020185|594255228|FG005|Overall Study|Consent withdrawn|0|||
164514929|NCT04020185|594255229|FG006|Overall Study|Consent withdrawn|1|||
164514930|NCT04020185|594255230|FG007|Overall Study|Consent withdrawn|1|||
164514931|NCT04020185|594255223|FG000|Overall Study|Patient in hospice|0|||
164514932|NCT04020185|594255224|FG001|Overall Study|Patient in hospice|1|||
164514933|NCT04020185|594255225|FG002|Overall Study|Patient in hospice|0|||
164514934|NCT04020185|594255226|FG003|Overall Study|Patient in hospice|0|||
164514935|NCT04020185|594255227|FG004|Overall Study|Patient in hospice|0|||
164514936|NCT04020185|594255228|FG005|Overall Study|Patient in hospice|0|||
164514937|NCT04020185|594255229|FG006|Overall Study|Patient in hospice|0|||
164514938|NCT04020185|594255230|FG007|Overall Study|Patient in hospice|0|||
164514939|NCT04020185|594255223|FG000|Overall Study|Continuing on expanded access|0|||
164514940|NCT04020185|594255224|FG001|Overall Study|Continuing on expanded access|0|||
164514941|NCT04020185|594255225|FG002|Overall Study|Continuing on expanded access|0|||
164146987|NCT00443729|592899921|FG001|Overall Study|Protocol Violation|1|||
164514942|NCT04020185|594255226|FG003|Overall Study|Continuing on expanded access|0|||
164514943|NCT04020185|594255227|FG004|Overall Study|Continuing on expanded access|0|||
164514944|NCT04020185|594255228|FG005|Overall Study|Continuing on expanded access|0|||
164514945|NCT04020185|594255229|FG006|Overall Study|Continuing on expanded access|1|||
164610932|NCT02849626|594595580|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
164610933|NCT02849626|594595581|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
164610934|NCT02849626|594595578|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
164610935|NCT02849626|594595579|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
164610936|NCT02849626|594595580|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
164610937|NCT02849626|594595581|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
164610938|NCT02849626|594595578|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
164610939|NCT02849626|594595579|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
164610940|NCT02849626|594595580|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
164610941|NCT02849626|594595581|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
164610942|NCT02849626|594595578|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
164610943|NCT02849626|594595579|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
164610944|NCT02849626|594595580|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
164610945|NCT02849626|594595581|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
164610946|NCT02849626|594595578|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
164514946|NCT04020185|594255230|FG007|Overall Study|Continuing on expanded access|1|||
164514947|NCT00527787|594255232|FG000|Overall Study|Adverse Event|14|||
164514948|NCT00527787|594255233|FG001|Overall Study|Adverse Event|24|||
164514949|NCT00527787|594255232|FG000|Overall Study|Withdrawal by Subject|13|||
164514950|NCT00527787|594255233|FG001|Overall Study|Withdrawal by Subject|25|||
164514951|NCT00527787|594255232|FG000|Overall Study|Lost to Follow-up|5|||
164514952|NCT00527787|594255233|FG001|Overall Study|Lost to Follow-up|2|||
164514953|NCT00527787|594255232|FG000|Overall Study|Duodenal Ulcer|1|||
164514954|NCT00527787|594255233|FG001|Overall Study|Duodenal Ulcer|10|||
164514955|NCT00527787|594255232|FG000|Overall Study|misc|5|||
164514956|NCT00527787|594255233|FG001|Overall Study|misc|2|||
164514957|NCT01077128|594255242|FG000|Overall Study|Adverse Event|8|||
164514958|NCT01077128|594255242|FG000|Overall Study|Lack of Efficacy|1|||
164514959|NCT01077128|594255242|FG000|Overall Study|Disease exacerbation|1|||
164514960|NCT01077128|594255242|FG000|Overall Study|Adverse event and consent withdrawal|1|||
164514961|NCT01077128|594255242|FG000|Overall Study|Adverse event and disease exacerbation|1|||
164514962|NCT01077128|594255242|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
164514963|NCT01077128|594255242|FG000|Overall Study|Other|54|||
164514964|NCT01706705|594255244|FG000|Overall Study|Death|1|||
164514965|NCT01706705|594255244|FG000|Overall Study|Lack of Efficacy|13|||
164514966|NCT01706705|594255244|FG000|Overall Study|Non-clinical|6|||
164514967|NCT02242097|594255246|FG000|Ibrutinib Treatment|Adverse Event|16|||
164514968|NCT02242097|594255246|FG000|Ibrutinib Treatment|Physician Decision|1|||
164514969|NCT02242097|594255246|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
164514970|NCT02242097|594255246|FG000|Ibrutinib Treatment|Death|1|||
164514971|NCT02242097|594255246|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
164514972|NCT02242097|594255246|FG000|Post Therapy Follow Up|Death|3|||
164514973|NCT02242097|594255246|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
164514974|NCT03435692|594255248|FG000|Overall Study|Lack of Efficacy|2|||
164514975|NCT03435692|594255249|FG001|Overall Study|Lack of Efficacy|2|||
164514976|NCT03435692|594255250|FG002|Overall Study|Lack of Efficacy|0|||
164514977|NCT01712061|594255252|FG000|Overall Study|Adverse Event|4|||
164514978|NCT01712061|594255253|FG001|Overall Study|Adverse Event|9|||
164514979|NCT01712061|594255254|FG002|Overall Study|Adverse Event|5|||
164514980|NCT01712061|594255252|FG000|Overall Study|Death|0|||
164514981|NCT01712061|594255253|FG001|Overall Study|Death|0|||
164514982|NCT01712061|594255254|FG002|Overall Study|Death|1|||
164514983|NCT01712061|594255252|FG000|Overall Study|Lost to Follow-up|1|||
164514984|NCT01712061|594255253|FG001|Overall Study|Lost to Follow-up|0|||
164514985|NCT01712061|594255254|FG002|Overall Study|Lost to Follow-up|1|||
164514986|NCT01712061|594255252|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
164514987|NCT01712061|594255253|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
164514988|NCT01712061|594255254|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
164514989|NCT01712061|594255252|FG000|Overall Study|Medication Error Without Associated AE|0|||
164514990|NCT01712061|594255253|FG001|Overall Study|Medication Error Without Associated AE|1|||
164514991|NCT01712061|594255254|FG002|Overall Study|Medication Error Without Associated AE|0|||
164514992|NCT01712061|594255252|FG000|Overall Study|Withdrawal by Subject|1|||
164514993|NCT01712061|594255253|FG001|Overall Study|Withdrawal by Subject|7|||
164514994|NCT01712061|594255254|FG002|Overall Study|Withdrawal by Subject|1|||
164514995|NCT01712061|594255252|FG000|Overall Study|Other|0|||
164514996|NCT01712061|594255253|FG001|Overall Study|Other|3|||
164514997|NCT01712061|594255254|FG002|Overall Study|Other|0|||
164514998|NCT05071053|594255257|FG000|Overall Study|Progressive disease|30|||
164514999|NCT05071053|594255257|FG000|Overall Study|Adverse Event|5|||
164515000|NCT00504777|594255260|FG000|Overall Study|Adverse Event|1|||
164515001|NCT04868539|594255264|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
164515002|NCT04868539|594255265|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
164515003|NCT01572740|594255266|FG000|Overall Study|Adverse Event|1|||
164515004|NCT01572740|594255267|FG001|Overall Study|Adverse Event|1|||
164515005|NCT01572740|594255266|FG000|Overall Study|Withdrawal by Subject|1|||
164515006|NCT01572740|594255267|FG001|Overall Study|Withdrawal by Subject|1|||
164515007|NCT01572740|594255266|FG000|Overall Study|unclassified|4|||
164515008|NCT01572740|594255267|FG001|Overall Study|unclassified|3|||
164515009|NCT01068665|594255268|FG000|Overall Study|Adverse Event|5|||
164515010|NCT01068665|594255269|FG001|Overall Study|Adverse Event|4|||
164515011|NCT01068665|594255268|FG000|Overall Study|Lack of Efficacy|0|||
164515012|NCT01068665|594255269|FG001|Overall Study|Lack of Efficacy|2|||
164515013|NCT01068665|594255268|FG000|Overall Study|Protocol Violation|5|||
164515014|NCT01068665|594255269|FG001|Overall Study|Protocol Violation|2|||
164610947|NCT02849626|594595579|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
164610948|NCT02849626|594595580|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
164610949|NCT02849626|594595581|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
164610950|NCT04046341|594595586|FG000|Overall Study|Lost to Follow-up|2|||
164610951|NCT04046341|594595586|FG000|Overall Study|Withdrawal by Subject|1|||
164610952|NCT04377672|594595587|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
164610953|NCT02447458|594595588|FG000|Overall Study|Other|0|||
164610954|NCT02447458|594595589|FG001|Overall Study|Other|0|||
164610955|NCT02447458|594595590|FG002|Overall Study|Other|1|||
164610956|NCT02447458|594595591|FG003|Overall Study|Other|0|||
164610957|NCT02447458|594595592|FG004|Overall Study|Other|0|||
164610958|NCT02447458|594595593|FG005|Overall Study|Other|0|||
164610959|NCT00405652|594595594|FG000|Overall Study|Adverse Event|4|||
164610960|NCT00435994|594595596|FG000|Overall Study|Lost to Follow-up|7|||
164610961|NCT00435994|594595597|FG001|Overall Study|Lost to Follow-up|0|||
164610962|NCT00435994|594595598|FG002|Overall Study|Lost to Follow-up|0|||
164610963|NCT03505749|594595600|FG000|Overall Study|Lost to Follow-up|7|||
164610964|NCT03505749|594595601|FG001|Overall Study|Lost to Follow-up|11|||
164610965|NCT03505749|594595600|FG000|Overall Study|Withdrawal by Subject|6|||
164610966|NCT03505749|594595601|FG001|Overall Study|Withdrawal by Subject|0|||
164610967|NCT03505749|594595600|FG000|Overall Study|Discharged from treatment|3|||
164610968|NCT03505749|594595601|FG001|Overall Study|Discharged from treatment|6|||
164610969|NCT03846219|594595602|FG000|Overall Study|Withdrawal by Subject|3|||
164610970|NCT03846219|594595603|FG001|Overall Study|Withdrawal by Subject|2|||
164610971|NCT03846219|594595604|FG002|Overall Study|Withdrawal by Subject|2|||
164610972|NCT03846219|594595602|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
164610973|NCT03846219|594595603|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
164610974|NCT03846219|594595604|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
164610975|NCT03846219|594595602|FG000|Overall Study|Physician Decision|0|||
164610976|NCT03846219|594595603|FG001|Overall Study|Physician Decision|0|||
164610977|NCT03846219|594595604|FG002|Overall Study|Physician Decision|2|||
164610978|NCT05109702|594595605|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
164610979|NCT05109702|594595606|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
164610980|NCT05109702|594595607|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
164610981|NCT05109702|594595605|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
164610982|NCT05109702|594595606|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
164610983|NCT05109702|594595607|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
164610984|NCT05109702|594595605|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
164610985|NCT05109702|594595606|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
164610986|NCT05109702|594595607|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
164610987|NCT05109702|594595605|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
164610988|NCT05109702|594595606|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
164610989|NCT05109702|594595607|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
164610990|NCT05109702|594595605|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
164610991|NCT05109702|594595606|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
164610992|NCT05109702|594595607|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
164610993|NCT00788697|594595608|FG000|Overall Study|No study drug administered|12|||
164610994|NCT00788697|594595608|FG000|Overall Study|Training Patients|74|||
164610995|NCT00788697|594595608|FG000|Overall Study|no truth standard procedure available|5|||
164610996|NCT00788697|594595608|FG000|Overall Study|Technically inadequate truth standard|1|||
164610997|NCT00788697|594595608|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
164610998|NCT00903370|594595611|FG000|Overall Study|Death|13|||
164610999|NCT00903370|594595612|FG001|Overall Study|Death|10|||
164611000|NCT00903370|594595611|FG000|Overall Study|Withdrawal by Subject|9|||
164611001|NCT00903370|594595612|FG001|Overall Study|Withdrawal by Subject|6|||
164611002|NCT00903370|594595611|FG000|Overall Study|Lost to Follow-up|6|||
164611003|NCT00903370|594595612|FG001|Overall Study|Lost to Follow-up|8|||
164611004|NCT00367432|594595613|FG000|First Period (16 Weeks)|Adverse Event|6|||
164611005|NCT00367432|594595614|FG001|First Period (16 Weeks)|Adverse Event|0|||
164611006|NCT00367432|594595613|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
164611007|NCT00367432|594595614|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
164611008|NCT00367432|594595613|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
164611009|NCT00367432|594595614|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
164611010|NCT00367432|594595613|FG000|First Period (16 Weeks)|Other Reason|2|||
164611011|NCT00367432|594595614|FG001|First Period (16 Weeks)|Other Reason|0|||
164611012|NCT00367432|594595613|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
164611013|NCT00367432|594595614|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
164611014|NCT00367432|594595613|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
164611015|NCT00367432|594595614|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
164611016|NCT00367432|594595613|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
164611017|NCT00367432|594595614|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
164611018|NCT00367432|594595613|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
164611019|NCT00367432|594595614|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
164611020|NCT00367432|594595613|FG000|Second Period (up to 54 Months)|Other Reason|6|||
164515015|NCT01068665|594255268|FG000|Overall Study|Withdrawal Criteria|3|||
164515016|NCT01068665|594255269|FG001|Overall Study|Withdrawal Criteria|9|||
164515017|NCT01068665|594255268|FG000|Overall Study|Other|17|||
164515018|NCT01068665|594255269|FG001|Overall Study|Other|12|||
164515019|NCT01038427|594255270|FG000|Overall Study|Lost to follow up|1|||
164515020|NCT01038427|594255271|FG001|Overall Study|Lost to follow up|1|||
164515021|NCT01038427|594255272|FG002|Overall Study|Lost to follow up|0|||
164515022|NCT01038427|594255270|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
164515023|NCT01038427|594255271|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
164515024|NCT01038427|594255272|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
164515025|NCT01038427|594255270|FG000|Overall Study|Withdrew consent|0|||
164515026|NCT01038427|594255271|FG001|Overall Study|Withdrew consent|0|||
164515027|NCT01038427|594255272|FG002|Overall Study|Withdrew consent|1|||
164515028|NCT01038427|594255270|FG000|Overall Study|Adverse Event|2|||
164515029|NCT01038427|594255271|FG001|Overall Study|Adverse Event|2|||
164515030|NCT01038427|594255272|FG002|Overall Study|Adverse Event|1|||
164515031|NCT01038427|594255270|FG000|Overall Study|Enrolled in error|0|||
164515032|NCT01038427|594255271|FG001|Overall Study|Enrolled in error|1|||
164515033|NCT01038427|594255272|FG002|Overall Study|Enrolled in error|1|||
164515034|NCT01038427|594255270|FG000|Overall Study|Other|0|||
164515035|NCT01038427|594255271|FG001|Overall Study|Other|2|||
164515036|NCT01038427|594255272|FG002|Overall Study|Other|0|||
164515037|NCT03538938|594255273|FG000|Overall Study|Death|0|||
164515038|NCT03538938|594255274|FG001|Overall Study|Death|0|||
164515039|NCT03538938|594255275|FG002|Overall Study|Death|2|||
164515040|NCT03538938|594255276|FG003|Overall Study|Death|0|||
164515041|NCT03538938|594255277|FG004|Overall Study|Death|0|||
164515042|NCT03538938|594255278|FG005|Overall Study|Death|1|||
164515043|NCT03538938|594255279|FG006|Overall Study|Death|0|||
164515044|NCT03538938|594255280|FG007|Overall Study|Death|1|||
164515045|NCT03538938|594255281|FG008|Overall Study|Death|1|||
164515046|NCT03538938|594255282|FG009|Overall Study|Death|1|||
164515047|NCT03538938|594255283|FG010|Overall Study|Death|0|||
164515048|NCT03538938|594255284|FG011|Overall Study|Death|0|||
164515049|NCT03538938|594255285|FG012|Overall Study|Death|1|||
164515050|NCT03538938|594255286|FG013|Overall Study|Death|1|||
164515051|NCT03538938|594255287|FG014|Overall Study|Death|0|||
164515052|NCT03538938|594255288|FG015|Overall Study|Death|1|||
164515053|NCT03538938|594255273|FG000|Overall Study|Withdrawal by Subject|4|||
164515054|NCT03538938|594255274|FG001|Overall Study|Withdrawal by Subject|6|||
164515055|NCT03538938|594255275|FG002|Overall Study|Withdrawal by Subject|5|||
164515056|NCT03538938|594255276|FG003|Overall Study|Withdrawal by Subject|3|||
164515057|NCT03538938|594255277|FG004|Overall Study|Withdrawal by Subject|0|||
164515058|NCT03538938|594255278|FG005|Overall Study|Withdrawal by Subject|0|||
164515059|NCT03538938|594255279|FG006|Overall Study|Withdrawal by Subject|3|||
164515060|NCT03538938|594255280|FG007|Overall Study|Withdrawal by Subject|1|||
164515061|NCT03538938|594255281|FG008|Overall Study|Withdrawal by Subject|5|||
164515062|NCT03538938|594255282|FG009|Overall Study|Withdrawal by Subject|1|||
164515063|NCT03538938|594255283|FG010|Overall Study|Withdrawal by Subject|2|||
164515064|NCT03538938|594255284|FG011|Overall Study|Withdrawal by Subject|1|||
164515065|NCT03538938|594255285|FG012|Overall Study|Withdrawal by Subject|3|||
164515066|NCT03538938|594255286|FG013|Overall Study|Withdrawal by Subject|0|||
164515067|NCT03538938|594255287|FG014|Overall Study|Withdrawal by Subject|2|||
164515068|NCT03538938|594255288|FG015|Overall Study|Withdrawal by Subject|4|||
164515069|NCT03538938|594255273|FG000|Overall Study|Incarcerated|0|||
164515070|NCT03538938|594255274|FG001|Overall Study|Incarcerated|0|||
164515071|NCT03538938|594255275|FG002|Overall Study|Incarcerated|0|||
164515072|NCT03538938|594255276|FG003|Overall Study|Incarcerated|0|||
164515073|NCT03538938|594255277|FG004|Overall Study|Incarcerated|0|||
164515074|NCT03538938|594255278|FG005|Overall Study|Incarcerated|0|||
164515075|NCT03538938|594255279|FG006|Overall Study|Incarcerated|0|||
164515076|NCT03538938|594255280|FG007|Overall Study|Incarcerated|0|||
164515077|NCT03538938|594255281|FG008|Overall Study|Incarcerated|0|||
164515078|NCT03538938|594255282|FG009|Overall Study|Incarcerated|0|||
164515079|NCT03538938|594255283|FG010|Overall Study|Incarcerated|0|||
164515080|NCT03538938|594255284|FG011|Overall Study|Incarcerated|1|||
164515081|NCT03538938|594255285|FG012|Overall Study|Incarcerated|0|||
164515082|NCT03538938|594255286|FG013|Overall Study|Incarcerated|0|||
164515083|NCT03538938|594255287|FG014|Overall Study|Incarcerated|0|||
164515084|NCT03538938|594255288|FG015|Overall Study|Incarcerated|0|||
164515085|NCT00755105|594255289|FG000|Overall Study|Withdrawal by Subject|9|||
164515086|NCT00755105|594255290|FG001|Overall Study|Withdrawal by Subject|11|||
164515087|NCT00755105|594255291|FG002|Overall Study|Withdrawal by Subject|4|||
164515088|NCT03995316|594255292|FG000|Overall Study|Lost to Follow-up|10|||
164515089|NCT03995316|594255293|FG001|Overall Study|Lost to Follow-up|3|||
164515090|NCT02202785|594255294|FG000|Overall Study|Study Terminated by Sponsor|1|||
164515091|NCT02202785|594255295|FG001|Overall Study|Study Terminated by Sponsor|6|||
164147137|NCT02466685|592899987|FG000|Overall Study|Adverse Event|5|||
164611021|NCT00367432|594595614|FG001|Second Period (up to 54 Months)|Other Reason|2|||
164611022|NCT00014911|594595615|FG000|Overall Study|Adverse Event|1|||
164611023|NCT00014911|594595615|FG000|Overall Study|Lost to Follow-up|1|||
164611024|NCT00014911|594595615|FG000|Overall Study|Withdrawal by Subject|6|||
164611025|NCT00014911|594595615|FG000|Overall Study|Unknown Reasons|2|||
164611026|NCT00014911|594595615|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
164611027|NCT03366844|594598082|FG000|Overall Study|Physician Decision|1|||
164611028|NCT03366844|594598082|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
164611029|NCT00595868|594598085|FG000|Overall Study|Lost to Follow-up|45|||
164611030|NCT00595868|594598086|FG001|Overall Study|Lost to Follow-up|50|||
164611031|NCT02688153|594598087|FG000|Overall Study|Death|7|||
164611032|NCT02688153|594598088|FG001|Overall Study|Death|5|||
164611033|NCT02688153|594598087|FG000|Overall Study|Withdrawal by Subject|4|||
164611034|NCT02688153|594598088|FG001|Overall Study|Withdrawal by Subject|2|||
164611035|NCT02688153|594598087|FG000|Overall Study|Valve Explant|1|||
164611036|NCT02688153|594598088|FG001|Overall Study|Valve Explant|0|||
164611037|NCT02688153|594598087|FG000|Overall Study|Conversion to Commercial Valve|3|||
164611038|NCT02688153|594598088|FG001|Overall Study|Conversion to Commercial Valve|0|||
164611039|NCT02687711|594598100|FG000|Overall Study|Adverse Event|89|||
164611040|NCT02687711|594598100|FG000|Overall Study|Lack of Efficacy|70|||
164611041|NCT02687711|594598100|FG000|Overall Study|Lost to Follow-up|20|||
164611042|NCT02687711|594598100|FG000|Overall Study|Consent withdrawn|15|||
164611043|NCT02687711|594598100|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
164611044|NCT02687711|594598100|FG000|Overall Study|Too expensive|4|||
164611045|NCT02687711|594598100|FG000|Overall Study|Participant moved abroad|1|||
164611046|NCT02687711|594598100|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
164611047|NCT02687711|594598100|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
164611048|NCT02687711|594598100|FG000|Overall Study|Disliked taste|1|||
164611049|NCT02687711|594598100|FG000|Overall Study|Low mood|1|||
164611050|NCT02687711|594598100|FG000|Overall Study|Side effects|1|||
164611051|NCT02687711|594598100|FG000|Overall Study|Change of Hospital|1|||
164611052|NCT02687711|594598100|FG000|Overall Study|Liver Encephalopathy|1|||
164611053|NCT02687711|594598100|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
164611054|NCT02687711|594598100|FG000|Overall Study|Withdrawn due to intake interruption|1|||
164611055|NCT02687711|594598100|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
164611056|NCT02687711|594598100|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
164611057|NCT02687711|594598100|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
164611058|NCT02088541|594598105|FG000|Overall Study|Adverse Event|3|||
164611059|NCT02088541|594598106|FG001|Overall Study|Adverse Event|0|||
164611060|NCT02088541|594598107|FG002|Overall Study|Adverse Event|3|||
164611061|NCT02088541|594598108|FG003|Overall Study|Adverse Event|3|||
164611062|NCT02088541|594598109|FG004|Overall Study|Adverse Event|0|||
164611063|NCT02088541|594598105|FG000|Overall Study|Death|51|||
164611064|NCT02088541|594598106|FG001|Overall Study|Death|21|||
164611065|NCT02088541|594598107|FG002|Overall Study|Death|85|||
164611066|NCT02088541|594598108|FG003|Overall Study|Death|28|||
164611067|NCT02088541|594598109|FG004|Overall Study|Death|38|||
164611068|NCT02088541|594598105|FG000|Overall Study|Lost to Follow-up|2|||
164611069|NCT02088541|594598106|FG001|Overall Study|Lost to Follow-up|0|||
164611070|NCT02088541|594598107|FG002|Overall Study|Lost to Follow-up|1|||
164611071|NCT02088541|594598108|FG003|Overall Study|Lost to Follow-up|0|||
164611072|NCT02088541|594598109|FG004|Overall Study|Lost to Follow-up|0|||
164611073|NCT02088541|594598105|FG000|Overall Study|Physician Decision|2|||
164611074|NCT02088541|594598106|FG001|Overall Study|Physician Decision|1|||
164611075|NCT02088541|594598107|FG002|Overall Study|Physician Decision|2|||
164611076|NCT02088541|594598108|FG003|Overall Study|Physician Decision|0|||
164611077|NCT02088541|594598109|FG004|Overall Study|Physician Decision|2|||
164611078|NCT02088541|594598105|FG000|Overall Study|Disease progression|7|||
164611079|NCT02088541|594598106|FG001|Overall Study|Disease progression|1|||
164611080|NCT02088541|594598107|FG002|Overall Study|Disease progression|2|||
164611081|NCT02088541|594598108|FG003|Overall Study|Disease progression|3|||
164611082|NCT02088541|594598109|FG004|Overall Study|Disease progression|1|||
164611083|NCT02088541|594598105|FG000|Overall Study|Study terminated by sponsor|1|||
164611084|NCT02088541|594598106|FG001|Overall Study|Study terminated by sponsor|1|||
164611085|NCT02088541|594598107|FG002|Overall Study|Study terminated by sponsor|12|||
164611086|NCT02088541|594598108|FG003|Overall Study|Study terminated by sponsor|2|||
164611087|NCT02088541|594598109|FG004|Overall Study|Study terminated by sponsor|6|||
164147138|NCT02466685|592899988|FG001|Overall Study|Adverse Event|2|||
164611088|NCT02088541|594598105|FG000|Overall Study|Withdrawal by Subject|3|||
164611089|NCT02088541|594598106|FG001|Overall Study|Withdrawal by Subject|2|||
164611090|NCT02088541|594598107|FG002|Overall Study|Withdrawal by Subject|9|||
164611091|NCT02088541|594598108|FG003|Overall Study|Withdrawal by Subject|7|||
164611092|NCT02088541|594598109|FG004|Overall Study|Withdrawal by Subject|10|||
164611093|NCT02088541|594598105|FG000|Overall Study|Other|2|||
164611094|NCT02088541|594598106|FG001|Overall Study|Other|1|||
164611095|NCT02088541|594598107|FG002|Overall Study|Other|3|||
164611096|NCT02088541|594598108|FG003|Overall Study|Other|1|||
164611097|NCT02088541|594598109|FG004|Overall Study|Other|1|||
164611098|NCT03750240|594598111|FG000|Overall Study|Technical Difficulties|2|||
164611099|NCT02848313|594598112|FG000|Overall Study|Adverse Event|1|||
164611100|NCT02848313|594598113|FG001|Overall Study|Adverse Event|2|||
164611101|NCT02848313|594598112|FG000|Overall Study|Lack of Efficacy|0|||
164611102|NCT02848313|594598113|FG001|Overall Study|Lack of Efficacy|1|||
164611103|NCT02848313|594598112|FG000|Overall Study|Withdrawal by Subject|1|||
164611104|NCT02848313|594598113|FG001|Overall Study|Withdrawal by Subject|1|||
164611105|NCT02848313|594598112|FG000|Overall Study|Lost to follow up|1|||
164611106|NCT02848313|594598113|FG001|Overall Study|Lost to follow up|0|||
164611107|NCT04209530|594598121|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
164611108|NCT04209530|594598122|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
164611109|NCT04209530|594598121|FG000|Overall Study|Withdrawal by Subject|0|||
164611110|NCT04209530|594598122|FG001|Overall Study|Withdrawal by Subject|1|||
164611111|NCT01100658|594598123|FG000|Overall Study|Withdrawal by Subject|1|||
164611112|NCT01094808|594598124|FG000|Overall Study|Withdrawal by Subject|1|||
164611113|NCT01094808|594598125|FG001|Overall Study|Withdrawal by Subject|1|||
164611114|NCT01094808|594598126|FG002|Overall Study|Withdrawal by Subject|0|||
164611115|NCT02044822|594598127|FG000|Overall Study|Study Terminated by Sponsor|77|||
164611116|NCT02044822|594598127|FG000|Overall Study|Investigator's Discretion|10|||
164611117|NCT02044822|594598127|FG000|Overall Study|Withdrew Consent|3|||
164611118|NCT02044822|594598127|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
164611119|NCT02044822|594598127|FG000|Overall Study|Lost to Follow-up|1|||
164611120|NCT02025530|594598130|FG000|Overall Study|No longer met elligibility criteria|5|||
164611121|NCT02025530|594598131|FG001|Overall Study|No longer met elligibility criteria|1|||
164611122|NCT03551626|594598136|FG000|Overall Study|Adverse Event|88|||
164611123|NCT03551626|594598136|FG000|Overall Study|Disease relapse|18|||
164611124|NCT03551626|594598136|FG000|Overall Study|Withdrawal of informed consent|6|||
164611125|NCT03551626|594598136|FG000|Overall Study|Patient decision|5|||
164611126|NCT03551626|594598136|FG000|Overall Study|Physician Decision|4|||
164611127|NCT03551626|594598136|FG000|Overall Study|Lost to Follow-up|3|||
164611128|NCT03551626|594598136|FG000|Overall Study|Pregnancy|1|||
164611129|NCT03551626|594598136|FG000|Overall Study|Protocol deviation|1|||
164611130|NCT03551626|594598136|FG000|Overall Study|Technical problems|1|||
164611131|NCT00653328|594598137|FG000|Overall Study|Withdrawal by Subject|1|||
164611132|NCT00653328|594598137|FG000|Overall Study|Adverse Event|2|||
164611133|NCT00653328|594598137|FG000|Overall Study|Disease progression|10|||
164611134|NCT00653328|594598137|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
164611135|NCT00443846|594598145|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
164611136|NCT00443846|594598146|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
164611137|NCT00443846|594598145|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
164611138|NCT00443846|594598146|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
164611139|NCT00443846|594598145|FG000|Overall Study|Adverse Event|0|||
164611140|NCT00443846|594598146|FG001|Overall Study|Adverse Event|1|||
164611141|NCT00443846|594598145|FG000|Overall Study|Personal reason|8|||
164611142|NCT00443846|594598146|FG001|Overall Study|Personal reason|3|||
164611143|NCT00443846|594598145|FG000|Overall Study|Lost to Follow-up|1|||
164611144|NCT00443846|594598146|FG001|Overall Study|Lost to Follow-up|2|||
164611145|NCT03051217|594598150|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
164611146|NCT03051217|594598151|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164611147|NCT03051217|594598152|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
164611148|NCT03051217|594598153|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164611149|NCT03051217|594598154|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164611150|NCT03051217|594598155|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164611151|NCT03051217|594598156|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164611152|NCT03051217|594598150|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
164611153|NCT03051217|594598151|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
164611154|NCT03051217|594598152|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
164611155|NCT03051217|594598153|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
164611156|NCT03051217|594598154|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
164611157|NCT03051217|594598155|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
164611158|NCT03051217|594598156|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
164611159|NCT03051217|594598150|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
164611160|NCT03051217|594598151|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
164611161|NCT03051217|594598152|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
164611162|NCT03051217|594598153|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164611163|NCT03051217|594598154|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164611164|NCT03051217|594598155|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164611165|NCT03051217|594598156|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164611166|NCT03051217|594598150|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
164611167|NCT03051217|594598151|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
164611168|NCT03051217|594598152|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
164515092|NCT02202785|594255296|FG002|Overall Study|Study Terminated by Sponsor|4|||
164515093|NCT02202785|594255294|FG000|Overall Study|Withdrawal by Subject|0|||
164515094|NCT02202785|594255295|FG001|Overall Study|Withdrawal by Subject|1|||
164515095|NCT02202785|594255296|FG002|Overall Study|Withdrawal by Subject|0|||
164515096|NCT02202785|594255294|FG000|Overall Study|Lost to Follow-up|0|||
164515097|NCT02202785|594255295|FG001|Overall Study|Lost to Follow-up|1|||
164515098|NCT02202785|594255296|FG002|Overall Study|Lost to Follow-up|0|||
164515099|NCT02202785|594255294|FG000|Overall Study|Reason not Specified|10|||
164515100|NCT02202785|594255295|FG001|Overall Study|Reason not Specified|7|||
164515101|NCT02202785|594255296|FG002|Overall Study|Reason not Specified|13|||
164515102|NCT00737698|594255299|FG000|Overall Study|Withdrawal by Subject|6|||
164515103|NCT00737698|594255300|FG001|Overall Study|Withdrawal by Subject|5|||
164515104|NCT00737698|594255301|FG002|Overall Study|Withdrawal by Subject|3|||
164515105|NCT00737698|594255299|FG000|Overall Study|Death|0|||
164515106|NCT00737698|594255300|FG001|Overall Study|Death|0|||
164515107|NCT00737698|594255301|FG002|Overall Study|Death|1|||
164515108|NCT03686423|594255304|FG000|Overall Study|Withdrawal by Subject|9|||
164515109|NCT03686423|594255304|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
164515110|NCT01110408|594255307|FG000|Overall Study|Protocol Violation|1|||
164515111|NCT01110408|594255308|FG001|Overall Study|Protocol Violation|0|||
164515112|NCT06285240|594255309|FG000|Overall Study|Withdrawal by Subject|2|||
164515113|NCT06285240|594255310|FG001|Overall Study|Withdrawal by Subject|0|||
164515114|NCT06285240|594255311|FG002|Overall Study|Withdrawal by Subject|0|||
164515115|NCT06285240|594255312|FG003|Overall Study|Withdrawal by Subject|0|||
164515116|NCT06285240|594255309|FG000|Overall Study|Serious Adverse Event|0|||
164515117|NCT06285240|594255310|FG001|Overall Study|Serious Adverse Event|0|||
164515118|NCT06285240|594255311|FG002|Overall Study|Serious Adverse Event|1|||
164515119|NCT06285240|594255312|FG003|Overall Study|Serious Adverse Event|0|||
164515120|NCT05140915|594255313|FG000|Overall Study|Lost to Follow-up|2|||
164515121|NCT05140915|594255314|FG001|Overall Study|Lost to Follow-up|1|||
164515122|NCT01435772|594255319|FG000|Overall Study|Adverse Event|1|||
164611169|NCT03051217|594598153|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
164515123|NCT01435772|594255320|FG001|Overall Study|Adverse Event|0|||
164515124|NCT01435772|594255321|FG002|Overall Study|Adverse Event|2|||
164515125|NCT01435772|594255319|FG000|Overall Study|Withdrawal by Subject|0|||
164515126|NCT01435772|594255320|FG001|Overall Study|Withdrawal by Subject|1|||
164515127|NCT01435772|594255321|FG002|Overall Study|Withdrawal by Subject|3|||
164515128|NCT01435772|594255319|FG000|Overall Study|Other - study termination|2|||
164515129|NCT01435772|594255320|FG001|Overall Study|Other - study termination|2|||
164515130|NCT01435772|594255321|FG002|Overall Study|Other - study termination|10|||
164515131|NCT03238963|594255322|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
164515132|NCT03238963|594255323|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
164515133|NCT03238963|594255322|FG000|Overall Study|Withdrawal by Subject|1|||
164515134|NCT03238963|594255323|FG001|Overall Study|Withdrawal by Subject|1|||
164515135|NCT03238963|594255322|FG000|Overall Study|Lost to Follow-up|1|||
164515136|NCT03238963|594255323|FG001|Overall Study|Lost to Follow-up|0|||
164515137|NCT03238963|594255322|FG000|Overall Study|Protocol Violation|1|||
164515138|NCT03238963|594255323|FG001|Overall Study|Protocol Violation|1|||
164515139|NCT03238963|594255322|FG000|Overall Study|Adverse Event|1|||
164515140|NCT03238963|594255323|FG001|Overall Study|Adverse Event|0|||
164515141|NCT05823012|594255324|FG000|Titration Period|Adverse Event|1|||
164515142|NCT05823012|594255324|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
164515143|NCT05823012|594255324|FG000|Maintenance Period|Adverse Event|1|||
164515144|NCT05823012|594255324|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
164515145|NCT05823012|594255324|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
164515146|NCT01424813|594255325|FG000|Overall Study|Withdrawal by Subject|3|||
164515147|NCT01424813|594255326|FG001|Overall Study|Withdrawal by Subject|0|||
164515148|NCT01424813|594255325|FG000|Overall Study|Protocol Violation|1|||
164515149|NCT01424813|594255326|FG001|Overall Study|Protocol Violation|0|||
164515150|NCT01424813|594255325|FG000|Overall Study|Other|1|||
164515151|NCT01424813|594255326|FG001|Overall Study|Other|2|||
164515152|NCT07149155|594255330|FG000|Overall Study|Lost to Follow-up|10|||
164515153|NCT00608868|594257357|FG000|Overall Study|Withdrawal by Subject|7|||
164515154|NCT00608868|594257357|FG000|Overall Study|Protocol Violation|3|||
164515155|NCT00608868|594257357|FG000|Overall Study|Lost to Follow-up|2|||
164515156|NCT00608868|594257357|FG000|Overall Study|Adverse Event|1|||
164515157|NCT00608868|594257357|FG000|Overall Study|Physician Decision|2|||
164515158|NCT03338296|594257358|FG000|Overall Study|Adverse Event|0|||
164515159|NCT03338296|594257359|FG001|Overall Study|Adverse Event|1|||
164515160|NCT03338296|594257358|FG000|Overall Study|Withdrawal by Subject|14|||
164515161|NCT03338296|594257359|FG001|Overall Study|Withdrawal by Subject|13|||
164515162|NCT03338296|594257358|FG000|Overall Study|Lost to Follow-up|10|||
164515163|NCT03338296|594257359|FG001|Overall Study|Lost to Follow-up|10|||
164515164|NCT03338296|594257358|FG000|Overall Study|Study Terminated by Sponsor|77|||
164515165|NCT03338296|594257359|FG001|Overall Study|Study Terminated by Sponsor|76|||
164515166|NCT03338296|594257358|FG000|Overall Study|Other|2|||
164515167|NCT03338296|594257359|FG001|Overall Study|Other|7|||
164515168|NCT03338296|594257358|FG000|Overall Study|Missing|0|||
164515169|NCT03338296|594257359|FG001|Overall Study|Missing|1|||
164515170|NCT00702962|594257362|FG000|Overall Study|Progressive disease|0|||
164515171|NCT00702962|594257363|FG001|Overall Study|Progressive disease|1|||
164515172|NCT00702962|594257362|FG000|Overall Study|Hospitalized for other health disorder|1|||
164515173|NCT00702962|594257363|FG001|Overall Study|Hospitalized for other health disorder|0|||
164515174|NCT01252355|594257364|FG000|Overall Study|Adverse Event|9|||
164515175|NCT01252355|594257365|FG001|Overall Study|Adverse Event|17|||
164515176|NCT01252355|594257366|FG002|Overall Study|Adverse Event|22|||
164515177|NCT01252355|594257364|FG000|Overall Study|Lack of Efficacy|6|||
164515178|NCT01252355|594257365|FG001|Overall Study|Lack of Efficacy|4|||
164515179|NCT01252355|594257366|FG002|Overall Study|Lack of Efficacy|2|||
164515180|NCT01252355|594257364|FG000|Overall Study|Lost to Follow-up|0|||
164515181|NCT01252355|594257365|FG001|Overall Study|Lost to Follow-up|0|||
164515182|NCT01252355|594257366|FG002|Overall Study|Lost to Follow-up|1|||
164515183|NCT01252355|594257364|FG000|Overall Study|Poor Compliance to Protocol|1|||
164515184|NCT01252355|594257365|FG001|Overall Study|Poor Compliance to Protocol|1|||
164515185|NCT01252355|594257366|FG002|Overall Study|Poor Compliance to Protocol|1|||
164515186|NCT01252355|594257364|FG000|Overall Study|Progressive Disease|2|||
164515187|NCT01252355|594257365|FG001|Overall Study|Progressive Disease|0|||
164515188|NCT01252355|594257366|FG002|Overall Study|Progressive Disease|0|||
164515189|NCT01252355|594257364|FG000|Overall Study|Sponsor Early Termination of Study|149|||
164515190|NCT01252355|594257365|FG001|Overall Study|Sponsor Early Termination of Study|149|||
164515191|NCT01252355|594257366|FG002|Overall Study|Sponsor Early Termination of Study|146|||
164515192|NCT01252355|594257364|FG000|Overall Study|Randomized but not Treated|2|||
164515193|NCT01252355|594257365|FG001|Overall Study|Randomized but not Treated|0|||
164515194|NCT01252355|594257366|FG002|Overall Study|Randomized but not Treated|0|||
164515195|NCT01252355|594257364|FG000|Overall Study|Other Than Above|8|||
164515196|NCT01252355|594257365|FG001|Overall Study|Other Than Above|7|||
164515197|NCT01252355|594257366|FG002|Overall Study|Other Than Above|7|||
164515198|NCT02175641|594257367|FG000|Overall Study|Death|3|||
164515199|NCT02175641|594257368|FG001|Overall Study|Death|4|||
164515200|NCT02175641|594257367|FG000|Overall Study|Lost to Follow-up|4|||
164515201|NCT02175641|594257368|FG001|Overall Study|Lost to Follow-up|4|||
164515202|NCT02175641|594257367|FG000|Overall Study|Withdrawal by Subject|7|||
164515203|NCT02175641|594257368|FG001|Overall Study|Withdrawal by Subject|4|||
164515204|NCT02175641|594257367|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
164515205|NCT02175641|594257368|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
164515206|NCT02175641|594257367|FG000|Overall Study|Developed Contraindicated Condition|8|||
164515207|NCT02175641|594257368|FG001|Overall Study|Developed Contraindicated Condition|0|||
164611170|NCT03051217|594598154|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
164611171|NCT03051217|594598155|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
164611172|NCT03051217|594598156|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
164611173|NCT03051217|594598150|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
164611174|NCT03051217|594598151|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
164611175|NCT03051217|594598152|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
164611176|NCT03051217|594598153|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
164611177|NCT03051217|594598154|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
164611178|NCT03051217|594598155|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
164611179|NCT03051217|594598156|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
164611180|NCT03051217|594598150|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
164611181|NCT03051217|594598151|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
164611182|NCT03051217|594598152|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
164611183|NCT03051217|594598153|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
164611184|NCT03051217|594598154|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
164611185|NCT03051217|594598155|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
164611186|NCT03051217|594598156|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
164611187|NCT03051217|594598150|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
164611188|NCT03051217|594598151|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
164611189|NCT03051217|594598152|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
164611190|NCT03051217|594598153|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
164611191|NCT03051217|594598154|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
164611192|NCT03051217|594598155|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
164611193|NCT03051217|594598156|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
164611194|NCT03051217|594598150|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
164611195|NCT03051217|594598151|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
164611196|NCT03051217|594598152|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
164611197|NCT03051217|594598153|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
164611198|NCT03051217|594598154|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
164611199|NCT03051217|594598155|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
164611200|NCT03051217|594598156|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
164611201|NCT00109772|594598157|FG000|Double-blind Treatment|Adverse Event|14|||
164611202|NCT00109772|594598158|FG001|Double-blind Treatment|Adverse Event|5|||
164611203|NCT00109772|594598157|FG000|Double-blind Treatment|Lack of Efficacy|1|||
164611204|NCT00109772|594598158|FG001|Double-blind Treatment|Lack of Efficacy|0|||
164611205|NCT00109772|594598157|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
164611206|NCT00109772|594598158|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
164611207|NCT00109772|594598157|FG000|Double-blind Treatment|Lost to Follow-up|2|||
164611208|NCT00109772|594598158|FG001|Double-blind Treatment|Lost to Follow-up|3|||
164611209|NCT00109772|594598157|FG000|Double-blind Treatment|Protocol Violation|0|||
164611210|NCT00109772|594598158|FG001|Double-blind Treatment|Protocol Violation|1|||
164611211|NCT00109772|594598157|FG000|Double-blind Treatment|Other|0|||
164611212|NCT00109772|594598158|FG001|Double-blind Treatment|Other|4|||
164611213|NCT00109772|594598157|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
164611214|NCT00109772|594598158|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
164611215|NCT00109772|594598157|FG000|Open-label Extension|Adverse Event|10|||
164611216|NCT00109772|594598158|FG001|Open-label Extension|Adverse Event|19|||
164611217|NCT00109772|594598157|FG000|Open-label Extension|Lack of Efficacy|19|||
164611218|NCT00109772|594598158|FG001|Open-label Extension|Lack of Efficacy|11|||
164611219|NCT00109772|594598157|FG000|Open-label Extension|Withdrawal by Subject|9|||
164611220|NCT00109772|594598158|FG001|Open-label Extension|Withdrawal by Subject|6|||
164611221|NCT00109772|594598157|FG000|Open-label Extension|Lost to Follow-up|1|||
164611222|NCT00109772|594598158|FG001|Open-label Extension|Lost to Follow-up|0|||
164611223|NCT00109772|594598157|FG000|Open-label Extension|Death|0|||
164611224|NCT00109772|594598158|FG001|Open-label Extension|Death|1|||
164611225|NCT00109772|594598157|FG000|Open-label Extension|Protocol Violation|2|||
164611226|NCT00109772|594598158|FG001|Open-label Extension|Protocol Violation|2|||
164611227|NCT00109772|594598157|FG000|Open-label Extension|Other|4|||
164611228|NCT00109772|594598158|FG001|Open-label Extension|Other|10|||
164611229|NCT01989754|594598159|FG000|Overall Study|Withdrawal by Subject|10|||
164611230|NCT01989754|594598160|FG001|Overall Study|Withdrawal by Subject|14|||
164611231|NCT01989754|594598159|FG000|Overall Study|Lost to Follow-up|28|||
164611232|NCT01989754|594598160|FG001|Overall Study|Lost to Follow-up|20|||
164611233|NCT01989754|594598159|FG000|Overall Study|Closed Site|1|||
164611234|NCT01989754|594598160|FG001|Overall Study|Closed Site|1|||
164611235|NCT00391807|594598166|FG000|Overall Study|Did not receive study medication|23|||
164611236|NCT00391807|594598166|FG000|Overall Study|Adverse Event|177|||
164611237|NCT00391807|594598166|FG000|Overall Study|Pregnancy|25|||
164515208|NCT01876901|594257371|FG000|Overall Study|Protocol Violation|10|||
164515209|NCT01876901|594257372|FG001|Overall Study|Protocol Violation|2|||
164515210|NCT01876901|594257371|FG000|Overall Study|No or other surgical intervention|7|||
164515211|NCT01876901|594257372|FG001|Overall Study|No or other surgical intervention|5|||
164515212|NCT01399697|594257375|FG000|Overall Study|Adverse Event|13|||
164515213|NCT01399697|594257376|FG001|Overall Study|Adverse Event|3|||
164515214|NCT01399697|594257377|FG002|Overall Study|Adverse Event|1|||
164515215|NCT01399697|594257375|FG000|Overall Study|Lost to Follow-up|2|||
164515216|NCT01399697|594257376|FG001|Overall Study|Lost to Follow-up|0|||
164515217|NCT01399697|594257377|FG002|Overall Study|Lost to Follow-up|0|||
164515218|NCT01399697|594257375|FG000|Overall Study|Withdrawal by Subject|8|||
164515219|NCT01399697|594257376|FG001|Overall Study|Withdrawal by Subject|0|||
164515220|NCT01399697|594257377|FG002|Overall Study|Withdrawal by Subject|0|||
164515221|NCT01399697|594257375|FG000|Overall Study|Investigator Decisión|1|||
164515222|NCT01399697|594257376|FG001|Overall Study|Investigator Decisión|0|||
164515223|NCT01399697|594257377|FG002|Overall Study|Investigator Decisión|2|||
164515224|NCT01399697|594257375|FG000|Overall Study|Lack of Efficacy|9|||
164515225|NCT01399697|594257376|FG001|Overall Study|Lack of Efficacy|0|||
164515226|NCT01399697|594257377|FG002|Overall Study|Lack of Efficacy|1|||
164515227|NCT01399697|594257375|FG000|Overall Study|Protocol Violation|2|||
164515228|NCT01399697|594257376|FG001|Overall Study|Protocol Violation|0|||
164515229|NCT01399697|594257377|FG002|Overall Study|Protocol Violation|0|||
164515230|NCT01399697|594257375|FG000|Overall Study|Non-Compliant|1|||
164515231|NCT01399697|594257376|FG001|Overall Study|Non-Compliant|0|||
164515232|NCT01399697|594257377|FG002|Overall Study|Non-Compliant|0|||
164515233|NCT01399697|594257375|FG000|Overall Study|Inclusion Error|2|||
164515234|NCT01399697|594257376|FG001|Overall Study|Inclusion Error|0|||
164515235|NCT01399697|594257377|FG002|Overall Study|Inclusion Error|0|||
164515236|NCT01399697|594257375|FG000|Overall Study|Positive result for hepatitis B|1|||
164515237|NCT01399697|594257376|FG001|Overall Study|Positive result for hepatitis B|0|||
164515238|NCT01399697|594257377|FG002|Overall Study|Positive result for hepatitis B|0|||
164515239|NCT01399697|594257375|FG000|Overall Study|Clinical RA remission|1|||
164515240|NCT01399697|594257376|FG001|Overall Study|Clinical RA remission|0|||
164515241|NCT01399697|594257377|FG002|Overall Study|Clinical RA remission|0|||
164515242|NCT01399697|594257375|FG000|Overall Study|Sponsor Decision|1|||
164515243|NCT01399697|594257376|FG001|Overall Study|Sponsor Decision|0|||
164515244|NCT01399697|594257377|FG002|Overall Study|Sponsor Decision|0|||
164515245|NCT01401153|594257378|FG000|First Test Day|Learning disabilities; illness|1|||
164515246|NCT01401153|594257379|FG001|First Test Day|Learning disabilities; illness|10|||
164515247|NCT01401153|594257378|FG000|Second Test Day|illness|0|||
164515248|NCT01401153|594257379|FG001|Second Test Day|illness|5|||
164515249|NCT01677767|594257383|FG000|Overall Study|Adverse Event|1|||
164515250|NCT01677767|594257383|FG000|Overall Study|Death|4|||
164515251|NCT01677767|594257383|FG000|Overall Study|Protocol Violation|4|||
164515252|NCT01677767|594257383|FG000|Overall Study|Withdrawal by Subject|10|||
164515253|NCT01677767|594257383|FG000|Overall Study|Non-compliance by the participants|3|||
164515254|NCT00842244|594257384|FG000|Overall Study|Death|3|||
164515255|NCT00842244|594257384|FG000|Overall Study|Withdrawal by Subject|1|||
164515256|NCT00842244|594257384|FG000|Overall Study|Other|17|||
164515257|NCT02807272|594257389|FG000|Overall Study|Death|9|||
164515258|NCT02807272|594257390|FG001|Overall Study|Death|5|||
164515259|NCT02807272|594257391|FG002|Overall Study|Death|2|||
164515260|NCT02807272|594257392|FG003|Overall Study|Death|0|||
164515261|NCT02807272|594257393|FG004|Overall Study|Death|1|||
164515262|NCT02807272|594257389|FG000|Overall Study|Lost to Follow-up|1|||
164515263|NCT02807272|594257390|FG001|Overall Study|Lost to Follow-up|0|||
164515264|NCT02807272|594257391|FG002|Overall Study|Lost to Follow-up|0|||
164515265|NCT02807272|594257392|FG003|Overall Study|Lost to Follow-up|0|||
164515266|NCT02807272|594257393|FG004|Overall Study|Lost to Follow-up|0|||
164515267|NCT02807272|594257389|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
164515268|NCT02807272|594257390|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
164515269|NCT02807272|594257391|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
164515270|NCT02807272|594257392|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
164515271|NCT02807272|594257393|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
164515272|NCT02807272|594257389|FG000|Overall Study|Protocol-defined Disease Progression|0|||
164515273|NCT02807272|594257390|FG001|Overall Study|Protocol-defined Disease Progression|1|||
164515274|NCT02807272|594257391|FG002|Overall Study|Protocol-defined Disease Progression|0|||
164515275|NCT02807272|594257392|FG003|Overall Study|Protocol-defined Disease Progression|0|||
164515276|NCT02807272|594257393|FG004|Overall Study|Protocol-defined Disease Progression|1|||
164515277|NCT02807272|594257389|FG000|Overall Study|Study Terminated by Sponsor|1|||
164515278|NCT02807272|594257390|FG001|Overall Study|Study Terminated by Sponsor|0|||
164515279|NCT02807272|594257391|FG002|Overall Study|Study Terminated by Sponsor|0|||
164515280|NCT02807272|594257392|FG003|Overall Study|Study Terminated by Sponsor|1|||
164515281|NCT02807272|594257393|FG004|Overall Study|Study Terminated by Sponsor|0|||
164515282|NCT02807272|594257389|FG000|Overall Study|Other|1|||
164515283|NCT02807272|594257390|FG001|Overall Study|Other|0|||
164515284|NCT02807272|594257391|FG002|Overall Study|Other|0|||
164515285|NCT02807272|594257392|FG003|Overall Study|Other|0|||
164515286|NCT02807272|594257393|FG004|Overall Study|Other|1|||
164515287|NCT01162863|594257397|FG000|Overall Study|Lack of Efficacy|1|||
164515288|NCT01162863|594257398|FG001|Overall Study|Lack of Efficacy|0|||
164515289|NCT01162863|594257399|FG002|Overall Study|Lack of Efficacy|0|||
164515290|NCT01162863|594257397|FG000|Overall Study|Adverse Event|0|||
164515291|NCT01162863|594257398|FG001|Overall Study|Adverse Event|1|||
164515292|NCT01162863|594257399|FG002|Overall Study|Adverse Event|0|||
164515293|NCT00392925|594257400|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
164515294|NCT00392925|594257401|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
164515295|NCT00392925|594257402|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
164611238|NCT00391807|594598166|FG000|Overall Study|Lost to Follow-up|227|||
164611239|NCT00391807|594598166|FG000|Overall Study|Withdrawal by Subject|147|||
164611240|NCT00391807|594598166|FG000|Overall Study|Protocol Violation|20|||
164611241|NCT00391807|594598166|FG000|Overall Study|Various|96|||
164611242|NCT01369225|594598169|FG000|Overall Study|Withdrawal by Subject|1|||
164611243|NCT01369225|594598170|FG001|Overall Study|Withdrawal by Subject|0|||
164611244|NCT01369225|594598171|FG002|Overall Study|Withdrawal by Subject|2|||
164611245|NCT01369225|594598172|FG003|Overall Study|Withdrawal by Subject|1|||
164611246|NCT01369225|594598173|FG004|Overall Study|Withdrawal by Subject|0|||
164611247|NCT01369225|594598174|FG005|Overall Study|Withdrawal by Subject|0|||
164611248|NCT01369225|594598169|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
164611249|NCT01369225|594598170|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
164611250|NCT01369225|594598171|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
164611251|NCT01369225|594598172|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
164611252|NCT01369225|594598173|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
164611253|NCT01369225|594598174|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
164611254|NCT01369225|594598169|FG000|Overall Study|Other|1|||
164611255|NCT01369225|594598170|FG001|Overall Study|Other|0|||
164611256|NCT01369225|594598171|FG002|Overall Study|Other|0|||
164611257|NCT01369225|594598172|FG003|Overall Study|Other|0|||
164611258|NCT01369225|594598173|FG004|Overall Study|Other|1|||
164611259|NCT01369225|594598174|FG005|Overall Study|Other|0|||
164611260|NCT01369225|594598169|FG000|Overall Study|Adverse Event|0|||
164611261|NCT01369225|594598170|FG001|Overall Study|Adverse Event|0|||
164611262|NCT01369225|594598171|FG002|Overall Study|Adverse Event|0|||
164611263|NCT01369225|594598172|FG003|Overall Study|Adverse Event|1|||
164611264|NCT01369225|594598173|FG004|Overall Study|Adverse Event|1|||
164611265|NCT01369225|594598174|FG005|Overall Study|Adverse Event|0|||
164611266|NCT04539262|594598178|FG000|Overall Study|Adverse Event|0|||
164611267|NCT04539262|594598179|FG001|Overall Study|Adverse Event|0|||
164611268|NCT04539262|594598180|FG002|Overall Study|Adverse Event|1|||
164611269|NCT04539262|594598181|FG003|Overall Study|Adverse Event|0|||
164611270|NCT04539262|594598182|FG004|Overall Study|Adverse Event|0|||
164611271|NCT04539262|594598183|FG005|Overall Study|Adverse Event|0|||
164611272|NCT04539262|594598184|FG006|Overall Study|Adverse Event|0|||
164611273|NCT04539262|594598185|FG007|Overall Study|Adverse Event|0|||
164611274|NCT04539262|594598178|FG000|Overall Study|Withdrew Consent|0|||
164611275|NCT04539262|594598179|FG001|Overall Study|Withdrew Consent|0|||
164611276|NCT04539262|594598180|FG002|Overall Study|Withdrew Consent|0|||
164611277|NCT04539262|594598181|FG003|Overall Study|Withdrew Consent|1|||
164611278|NCT04539262|594598182|FG004|Overall Study|Withdrew Consent|0|||
164611279|NCT04539262|594598183|FG005|Overall Study|Withdrew Consent|0|||
164611280|NCT04539262|594598184|FG006|Overall Study|Withdrew Consent|0|||
164611281|NCT04539262|594598185|FG007|Overall Study|Withdrew Consent|0|||
164611282|NCT04539262|594598178|FG000|Overall Study|Randomized, Not treated|0|||
164611283|NCT04539262|594598179|FG001|Overall Study|Randomized, Not treated|1|||
164611284|NCT04539262|594598180|FG002|Overall Study|Randomized, Not treated|0|||
164611285|NCT04539262|594598181|FG003|Overall Study|Randomized, Not treated|0|||
164611286|NCT04539262|594598182|FG004|Overall Study|Randomized, Not treated|0|||
164611287|NCT04539262|594598183|FG005|Overall Study|Randomized, Not treated|0|||
164611288|NCT04539262|594598184|FG006|Overall Study|Randomized, Not treated|1|||
164611289|NCT04539262|594598185|FG007|Overall Study|Randomized, Not treated|0|||
164611290|NCT00792701|594598188|FG000|Overall Study|Adverse Event|0|||
164611291|NCT00792701|594598189|FG001|Overall Study|Adverse Event|22|||
164515296|NCT00392925|594257403|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
164515297|NCT00392925|594257400|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
164515298|NCT00392925|594257401|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
164515299|NCT00392925|594257402|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
164515300|NCT00392925|594257403|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
164515301|NCT00392925|594257400|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
164515302|NCT00392925|594257401|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
164515303|NCT00392925|594257402|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
164515304|NCT00392925|594257403|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
164515305|NCT00392925|594257400|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
164515306|NCT00392925|594257401|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
164515307|NCT00392925|594257402|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
164515308|NCT00392925|594257403|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
164515309|NCT00392925|594257400|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
164515310|NCT00392925|594257401|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
164515311|NCT00392925|594257402|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
164515312|NCT00392925|594257403|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
164515313|NCT00392925|594257400|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
164515314|NCT00392925|594257401|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
164515315|NCT00392925|594257402|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
164515316|NCT00392925|594257403|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
164515317|NCT00392925|594257400|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
164515318|NCT00392925|594257401|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
164515319|NCT00392925|594257402|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
164515320|NCT00392925|594257403|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
164515321|NCT00392925|594257400|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
164515322|NCT00392925|594257401|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
164515323|NCT00392925|594257402|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
164515324|NCT00392925|594257403|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
164515325|NCT00392925|594257400|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
164515326|NCT00392925|594257401|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
164515327|NCT00392925|594257402|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
164515328|NCT00392925|594257403|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
164515329|NCT03552523|594257404|FG000|Overall Study|Withdrawal by Subject|1|||
164515330|NCT03552523|594257405|FG001|Overall Study|Withdrawal by Subject|1|||
164515331|NCT04145700|594257406|FG000|Overall Study|Withdrawal by Subject|8|||
164515332|NCT04145700|594257407|FG001|Overall Study|Withdrawal by Subject|3|||
164515333|NCT00780559|594257408|FG000|Overall Study|Lost to Follow-up|2|||
164515334|NCT00780559|594257409|FG001|Overall Study|Lost to Follow-up|7|||
164515335|NCT00780559|594257408|FG000|Overall Study|Death|1|||
164515336|NCT00780559|594257409|FG001|Overall Study|Death|0|||
164515337|NCT01840410|594257413|FG000|Overall Study|Physician Decision|1|||
164515338|NCT01840410|594257414|FG001|Overall Study|Physician Decision|2|||
164515339|NCT01840410|594257413|FG000|Overall Study|Pregnancy|1|||
164515340|NCT01840410|594257414|FG001|Overall Study|Pregnancy|0|||
164515341|NCT01840410|594257413|FG000|Overall Study|Protocol deviation|1|||
164515342|NCT01840410|594257414|FG001|Overall Study|Protocol deviation|0|||
164515343|NCT01840410|594257413|FG000|Overall Study|Lost to Follow-up|1|||
164515344|NCT01840410|594257414|FG001|Overall Study|Lost to Follow-up|0|||
164515345|NCT01840410|594257413|FG000|Overall Study|Withdrawal by Subject|2|||
164515346|NCT01840410|594257414|FG001|Overall Study|Withdrawal by Subject|1|||
164515347|NCT01840410|594257413|FG000|Overall Study|Adverse Event|1|||
164515348|NCT01840410|594257414|FG001|Overall Study|Adverse Event|1|||
164515349|NCT00839956|594257415|FG000|Overall Study|Adverse Event|2|||
164515350|NCT00839956|594257415|FG000|Overall Study|Lack of Efficacy|6|||
164515351|NCT00839956|594257415|FG000|Overall Study|Physician Decision|1|||
164515352|NCT00839956|594257415|FG000|Overall Study|Withdrawal by Subject|3|||
164515353|NCT00594880|594257416|FG000|Overall Study|Withdrawal by Subject|1|||
164515354|NCT00594880|594257417|FG001|Overall Study|Withdrawal by Subject|1|||
164515355|NCT00594880|594257416|FG000|Overall Study|Lost to Follow-up|1|||
164515356|NCT00594880|594257417|FG001|Overall Study|Lost to Follow-up|0|||
164515357|NCT02206061|594257418|FG000|Overall Study|Withdrawal by Subject|4|||
164515358|NCT02206061|594257419|FG001|Overall Study|Withdrawal by Subject|7|||
164611292|NCT00792701|594598188|FG000|Overall Study|Ineligible|1|||
164611293|NCT00792701|594598189|FG001|Overall Study|Ineligible|3|||
164611294|NCT00792701|594598188|FG000|Overall Study|Withdrawal by Subject|1|||
164611295|NCT00792701|594598189|FG001|Overall Study|Withdrawal by Subject|19|||
164611296|NCT00792701|594598188|FG000|Overall Study|Not protocol specified|17|||
164611297|NCT00792701|594598189|FG001|Overall Study|Not protocol specified|0|||
164611298|NCT02980692|594598190|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
164611299|NCT02980692|594598191|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
164611300|NCT02980692|594598192|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
164611301|NCT02980692|594598193|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
164611302|NCT02980692|594598194|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
164611303|NCT02980692|594598190|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
164611304|NCT02980692|594598191|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
164611305|NCT02980692|594598192|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
164611306|NCT02980692|594598193|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
164611307|NCT02980692|594598194|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
164611308|NCT02980692|594598190|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
164611309|NCT02980692|594598191|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
164611310|NCT02980692|594598192|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
164611311|NCT02980692|594598193|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
164611312|NCT02980692|594598194|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
164611313|NCT02980692|594598190|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
164611314|NCT02980692|594598191|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
164611315|NCT02980692|594598192|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
164611316|NCT02980692|594598193|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
164611317|NCT02980692|594598194|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
164611318|NCT02980692|594598190|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
164611319|NCT02980692|594598191|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
164611320|NCT02980692|594598192|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
164611321|NCT02980692|594598193|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
164611322|NCT02980692|594598194|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
164611323|NCT02980692|594598190|FG000|Double Blind Placebo Controlled Period|Other|1|||
164611324|NCT02980692|594598191|FG001|Double Blind Placebo Controlled Period|Other|0|||
164611325|NCT02980692|594598192|FG002|Double Blind Placebo Controlled Period|Other|0|||
164611326|NCT02980692|594598193|FG003|Double Blind Placebo Controlled Period|Other|0|||
164611327|NCT02980692|594598194|FG004|Double Blind Placebo Controlled Period|Other|1|||
164611328|NCT02980692|594598190|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
164611329|NCT02980692|594598191|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
164611330|NCT02980692|594598192|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
164611331|NCT02980692|594598193|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
164611332|NCT02980692|594598194|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
164611333|NCT02980692|594598190|FG000|Double-blind Follow-up Period|Adverse Event|0|||
164611334|NCT02980692|594598191|FG001|Double-blind Follow-up Period|Adverse Event|0|||
164611335|NCT02980692|594598192|FG002|Double-blind Follow-up Period|Adverse Event|0|||
164611336|NCT02980692|594598193|FG003|Double-blind Follow-up Period|Adverse Event|1|||
164611337|NCT02980692|594598194|FG004|Double-blind Follow-up Period|Adverse Event|1|||
164611338|NCT02980692|594598190|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
164611339|NCT02980692|594598191|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
164611340|NCT02980692|594598192|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
164611341|NCT02980692|594598193|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
164611342|NCT02980692|594598194|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
164611343|NCT02980692|594598190|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
164611344|NCT02980692|594598191|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
164611345|NCT02980692|594598192|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
164611346|NCT02980692|594598193|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
164611347|NCT02980692|594598194|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
164611348|NCT02980692|594598190|FG000|Double-blind Follow-up Period|Pregnancy|0|||
164611349|NCT02980692|594598191|FG001|Double-blind Follow-up Period|Pregnancy|0|||
164611350|NCT02980692|594598192|FG002|Double-blind Follow-up Period|Pregnancy|1|||
164611351|NCT02980692|594598193|FG003|Double-blind Follow-up Period|Pregnancy|1|||
164611352|NCT02980692|594598194|FG004|Double-blind Follow-up Period|Pregnancy|0|||
164611353|NCT02980692|594598190|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
164611354|NCT02980692|594598191|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
164611355|NCT02980692|594598192|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
164611356|NCT02980692|594598193|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
164611357|NCT02980692|594598194|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
164611358|NCT02980692|594598190|FG000|Double-blind Follow-up Period|Other|0|||
164611359|NCT02980692|594598191|FG001|Double-blind Follow-up Period|Other|0|||
164611360|NCT02980692|594598192|FG002|Double-blind Follow-up Period|Other|1|||
164611361|NCT02980692|594598193|FG003|Double-blind Follow-up Period|Other|1|||
164611362|NCT02980692|594598194|FG004|Double-blind Follow-up Period|Other|3|||
164611363|NCT05507580|594598197|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
164515359|NCT02206061|594257420|FG002|Overall Study|Withdrawal by Subject|1|||
164515360|NCT02206061|594257418|FG000|Overall Study|Lost to Follow-up|14|||
164515361|NCT02206061|594257419|FG001|Overall Study|Lost to Follow-up|7|||
164515362|NCT02206061|594257420|FG002|Overall Study|Lost to Follow-up|20|||
164515363|NCT00694109|594257421|FG000|Overall Study|Physician Decision|3|||
164515364|NCT00694109|594257421|FG000|Overall Study|Adverse Event|74|||
164515365|NCT00694109|594257421|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
164515366|NCT00694109|594257421|FG000|Overall Study|Lack of Efficacy|2|||
164515367|NCT00694109|594257421|FG000|Overall Study|Withdrawal by Subject|13|||
164515368|NCT00694109|594257421|FG000|Overall Study|Pregnancy|1|||
164515369|NCT00694109|594257421|FG000|Overall Study|Enrolled but not treated|1|||
164515370|NCT00694109|594257421|FG000|Overall Study|Other|2|||
164515371|NCT00694109|594257421|FG000|Overall Study|Consented but no additional treatment|3|||
164515372|NCT00846807|594257424|FG000|Overall Study|Adverse Event|270|||
164515373|NCT00846807|594257424|FG000|Overall Study|Lost to Follow-up|94|||
164515374|NCT00846807|594257424|FG000|Overall Study|Withdrawal by Subject|56|||
164515375|NCT00846807|594257424|FG000|Overall Study|Non compliant with European label|7|||
164515376|NCT00846807|594257424|FG000|Overall Study|Switch to other anticoagulants|89|||
164515377|NCT00846807|594257424|FG000|Overall Study|No prescription after hospital discharge|56|||
164515378|NCT00846807|594257424|FG000|Overall Study|Other|60|||
164515379|NCT01067846|594257425|FG000|Overall Study|Lost to Follow-up|17|||
164515380|NCT01067846|594257426|FG001|Overall Study|Lost to Follow-up|19|||
164515381|NCT01067846|594257425|FG000|Overall Study|Withdrawal by Subject|1|||
164515382|NCT01067846|594257426|FG001|Overall Study|Withdrawal by Subject|0|||
164515383|NCT01067846|594257425|FG000|Overall Study|participation in other tx study|1|||
164515384|NCT01067846|594257426|FG001|Overall Study|participation in other tx study|0|||
164515385|NCT02817906|594257427|FG000|Overall Study|Adverse Event|3|||
164515386|NCT02817906|594257428|FG001|Overall Study|Adverse Event|0|||
164515387|NCT02817906|594257427|FG000|Overall Study|Lack of Efficacy|1|||
164515388|NCT02817906|594257428|FG001|Overall Study|Lack of Efficacy|0|||
164515389|NCT02817906|594257427|FG000|Overall Study|Protocol Violation|1|||
164515390|NCT02817906|594257428|FG001|Overall Study|Protocol Violation|1|||
164515391|NCT02817906|594257427|FG000|Overall Study|Study Terminated by Sponsor|2|||
164515392|NCT02817906|594257428|FG001|Overall Study|Study Terminated by Sponsor|2|||
164515393|NCT02817906|594257427|FG000|Overall Study|Withdrawal by Subject|7|||
164515394|NCT02817906|594257428|FG001|Overall Study|Withdrawal by Subject|0|||
164515395|NCT02817906|594257427|FG000|Overall Study|Other|2|||
164515396|NCT02817906|594257428|FG001|Overall Study|Other|2|||
164515397|NCT01077518|594257437|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
164515398|NCT01077518|594257438|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
164515399|NCT01077518|594257439|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
164515400|NCT01077518|594257437|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
164515401|NCT01077518|594257438|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
164515402|NCT01077518|594257439|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
164515403|NCT01077518|594257437|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
164515404|NCT01077518|594257438|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
164515405|NCT01077518|594257439|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
164515406|NCT01077518|594257437|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
164515407|NCT01077518|594257438|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
164515408|NCT01077518|594257439|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
164515409|NCT01077518|594257437|FG000|Optional Ofa Phase|Physician Decision|0|||
164515410|NCT01077518|594257438|FG001|Optional Ofa Phase|Physician Decision|0|||
164515411|NCT01077518|594257439|FG002|Optional Ofa Phase|Physician Decision|1|||
164515412|NCT01077518|594257437|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
164611364|NCT05507580|594598198|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
164515413|NCT01077518|594257438|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
164515414|NCT01077518|594257439|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
164611365|NCT05507580|594598199|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
164611366|NCT05507580|594598200|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
164611367|NCT05507580|594598201|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
164611368|NCT05507580|594598202|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
164611369|NCT05507580|594598197|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
164611370|NCT05507580|594598198|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
164611371|NCT05507580|594598199|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164611372|NCT05507580|594598200|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164611373|NCT05507580|594598201|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164611374|NCT05507580|594598202|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164611375|NCT05507580|594598197|FG000|Double-Blind Treatment Period|Other, not specified|5|||
164611376|NCT05507580|594598198|FG001|Double-Blind Treatment Period|Other, not specified|4|||
164611377|NCT05507580|594598199|FG002|Double-Blind Treatment Period|Other, not specified|0|||
164611378|NCT05507580|594598200|FG003|Double-Blind Treatment Period|Other, not specified|0|||
164611379|NCT05507580|594598201|FG004|Double-Blind Treatment Period|Other, not specified|0|||
164611380|NCT05507580|594598202|FG005|Double-Blind Treatment Period|Other, not specified|0|||
164611381|NCT05507580|594598197|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
164611382|NCT05507580|594598198|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
164611383|NCT05507580|594598199|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
164611384|NCT05507580|594598200|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
164611385|NCT05507580|594598201|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
164611386|NCT05507580|594598202|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
164611387|NCT05507580|594598197|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
164611388|NCT05507580|594598198|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
164611389|NCT05507580|594598199|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
164611390|NCT05507580|594598200|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
164611391|NCT05507580|594598201|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
164611392|NCT05507580|594598202|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
164611393|NCT05507580|594598197|FG000|Single-Blind Treatment Period|Other, not specified|0|||
164611394|NCT05507580|594598198|FG001|Single-Blind Treatment Period|Other, not specified|0|||
164611395|NCT05507580|594598199|FG002|Single-Blind Treatment Period|Other, not specified|2|||
164611396|NCT05507580|594598200|FG003|Single-Blind Treatment Period|Other, not specified|7|||
164611397|NCT05507580|594598201|FG004|Single-Blind Treatment Period|Other, not specified|3|||
164611398|NCT05507580|594598202|FG005|Single-Blind Treatment Period|Other, not specified|5|||
164611399|NCT04702984|594598203|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
164611400|NCT00064077|594598206|FG000|Overall Study|Improper prior treatment|1|||
164611401|NCT00064077|594598207|FG001|Overall Study|Improper prior treatment|0|||
164611402|NCT00064077|594598208|FG002|Overall Study|Improper prior treatment|0|||
164611403|NCT00064077|594598209|FG003|Overall Study|Improper prior treatment|0|||
164611404|NCT00064077|594598206|FG000|Overall Study|Poor risk|2|||
164611405|NCT00064077|594598207|FG001|Overall Study|Poor risk|0|||
164611406|NCT00064077|594598208|FG002|Overall Study|Poor risk|1|||
164611407|NCT00064077|594598209|FG003|Overall Study|Poor risk|1|||
164611408|NCT00064077|594598206|FG000|Overall Study|Pathology|10|||
164611409|NCT00064077|594598207|FG001|Overall Study|Pathology|7|||
164611410|NCT00064077|594598208|FG002|Overall Study|Pathology|3|||
164611411|NCT00064077|594598209|FG003|Overall Study|Pathology|4|||
164611412|NCT00064077|594598206|FG000|Overall Study|No surgery|0|||
164611413|NCT00064077|594598207|FG001|Overall Study|No surgery|0|||
164611414|NCT00064077|594598208|FG002|Overall Study|No surgery|1|||
164611415|NCT00064077|594598209|FG003|Overall Study|No surgery|0|||
164611416|NCT00064077|594598206|FG000|Overall Study|No tumor|0|||
164611417|NCT00064077|594598207|FG001|Overall Study|No tumor|0|||
164611418|NCT00064077|594598208|FG002|Overall Study|No tumor|1|||
164611419|NCT00064077|594598209|FG003|Overall Study|No tumor|0|||
164611420|NCT00064077|594598206|FG000|Overall Study|Other reasons|2|||
164611421|NCT00064077|594598207|FG001|Overall Study|Other reasons|2|||
164611422|NCT00064077|594598208|FG002|Overall Study|Other reasons|1|||
164611423|NCT00064077|594598209|FG003|Overall Study|Other reasons|2|||
164611424|NCT03037307|594598210|FG000|Period 1|Did Not Meet Study Criteria|0|||
164611425|NCT03037307|594598211|FG001|Period 1|Did Not Meet Study Criteria|0|||
164611426|NCT03037307|594598212|FG002|Period 1|Did Not Meet Study Criteria|0|||
164611427|NCT03037307|594598213|FG003|Period 1|Did Not Meet Study Criteria|1|||
164611428|NCT03037307|594598214|FG004|Period 1|Did Not Meet Study Criteria|0|||
164611429|NCT03037307|594598215|FG005|Period 1|Did Not Meet Study Criteria|0|||
164611430|NCT04397796|594598216|FG000|Overall Study|Death|3|||
164611431|NCT04397796|594598217|FG001|Overall Study|Death|1|||
164611432|NCT02156804|594598218|FG000|Overall Study|Withdrawal by Subject|1|||
164611433|NCT03000686|594598219|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
164611434|NCT03000686|594598220|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
164611435|NCT03000686|594598221|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
164611436|NCT03000686|594598222|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
164611437|NCT01484561|594598223|FG000|Overall Study|Lack of Efficacy|3|||
164611438|NCT01484561|594598224|FG001|Overall Study|Lack of Efficacy|1|||
164611439|NCT01484561|594598223|FG000|Overall Study|Lost to Follow-up|1|||
164611440|NCT01484561|594598224|FG001|Overall Study|Lost to Follow-up|0|||
164611441|NCT01484561|594598223|FG000|Overall Study|Withdrawal by Subject|3|||
164611442|NCT01484561|594598224|FG001|Overall Study|Withdrawal by Subject|0|||
164611443|NCT01484561|594598223|FG000|Overall Study|Other|1|||
164611444|NCT01484561|594598224|FG001|Overall Study|Other|1|||
164611445|NCT01484561|594598223|FG000|Overall Study|Adverse Event|1|||
164611446|NCT01484561|594598224|FG001|Overall Study|Adverse Event|4|||
164611447|NCT01112982|594598225|FG000|Overall Study|Withdrawal by Subject|1|||
164611448|NCT01112982|594598225|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
164611449|NCT03371251|594598226|FG000|Overall Study|Withdrawal by Subject|1|||
164611450|NCT03371251|594598227|FG001|Overall Study|Withdrawal by Subject|0|||
164611451|NCT03371251|594598228|FG002|Overall Study|Withdrawal by Subject|1|||
164611452|NCT03371251|594598229|FG003|Overall Study|Withdrawal by Subject|0|||
164611453|NCT03371251|594598230|FG004|Overall Study|Withdrawal by Subject|2|||
164611454|NCT03371251|594598231|FG005|Overall Study|Withdrawal by Subject|2|||
164611455|NCT03371251|594598226|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
164611456|NCT03371251|594598227|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
164611457|NCT03371251|594598228|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
164611458|NCT03371251|594598229|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
164611459|NCT03371251|594598230|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
164611460|NCT03371251|594598231|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
164611461|NCT03371251|594598226|FG000|Overall Study|Adverse Event|0|||
164611462|NCT03371251|594598227|FG001|Overall Study|Adverse Event|0|||
164611463|NCT03371251|594598228|FG002|Overall Study|Adverse Event|0|||
164611464|NCT03371251|594598229|FG003|Overall Study|Adverse Event|0|||
164611465|NCT03371251|594598230|FG004|Overall Study|Adverse Event|1|||
164611466|NCT03371251|594598231|FG005|Overall Study|Adverse Event|0|||
164611467|NCT03371251|594598226|FG000|Overall Study|Decision by Sponsor|0|||
164611468|NCT03371251|594598227|FG001|Overall Study|Decision by Sponsor|0|||
164611469|NCT03371251|594598228|FG002|Overall Study|Decision by Sponsor|0|||
164611470|NCT03371251|594598229|FG003|Overall Study|Decision by Sponsor|0|||
164611471|NCT03371251|594598230|FG004|Overall Study|Decision by Sponsor|2|||
164611472|NCT03371251|594598231|FG005|Overall Study|Decision by Sponsor|0|||
164611473|NCT01851863|594598232|FG000|Overall Study|Did not receive study medication|2|||
164611474|NCT01851863|594598233|FG001|Overall Study|Did not receive study medication|5|||
164611475|NCT01851863|594598234|FG002|Overall Study|Did not receive study medication|3|||
164611476|NCT01851863|594598235|FG003|Overall Study|Did not receive study medication|0|||
164611477|NCT01851863|594598232|FG000|Overall Study|Lost to Follow-up|3|||
164611478|NCT01851863|594598233|FG001|Overall Study|Lost to Follow-up|4|||
164611479|NCT01851863|594598234|FG002|Overall Study|Lost to Follow-up|2|||
164611480|NCT01851863|594598235|FG003|Overall Study|Lost to Follow-up|3|||
164611481|NCT05425719|594598236|FG000|Overall Study|Lost to Follow-up|4|||
164611482|NCT05425719|594598237|FG001|Overall Study|Lost to Follow-up|0|||
164611483|NCT05425719|594598236|FG000|Overall Study|Withdrew consent|1|||
164611484|NCT05425719|594598237|FG001|Overall Study|Withdrew consent|1|||
164611485|NCT00889681|594598238|FG000|Overall Study|Not meeting qualification Criteria|2|||
164611486|NCT00889681|594598238|FG000|Overall Study|Insurance disapproval|1|||
164611487|NCT01185704|594598239|FG000|Overall Study|Randomized but not treated|3|||
164611488|NCT01185704|594598240|FG001|Overall Study|Randomized but not treated|3|||
164611489|NCT01185704|594598239|FG000|Overall Study|Lack of ovarian response|5|||
164611490|NCT01185704|594598240|FG001|Overall Study|Lack of ovarian response|1|||
164611491|NCT01185704|594598239|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
164611492|NCT01185704|594598240|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
164611493|NCT01185704|594598239|FG000|Overall Study|Ectopic pregnancy|0|||
164611494|NCT01185704|594598240|FG001|Overall Study|Ectopic pregnancy|1|||
164611495|NCT00871572|594598241|FG000|Overall Study|Adverse Event|0|||
164611496|NCT00871572|594598242|FG001|Overall Study|Adverse Event|2|||
164611497|NCT00871572|594598243|FG002|Overall Study|Adverse Event|0|||
164611498|NCT00871572|594598244|FG003|Overall Study|Adverse Event|3|||
164611499|NCT00871572|594598241|FG000|Overall Study|Investigator Decision|0|||
164611500|NCT00871572|594598242|FG001|Overall Study|Investigator Decision|1|||
164611501|NCT00871572|594598243|FG002|Overall Study|Investigator Decision|0|||
164611502|NCT00871572|594598244|FG003|Overall Study|Investigator Decision|1|||
164611503|NCT00871572|594598241|FG000|Overall Study|Lost to Follow-up|0|||
164611504|NCT00871572|594598242|FG001|Overall Study|Lost to Follow-up|1|||
164611505|NCT00871572|594598243|FG002|Overall Study|Lost to Follow-up|0|||
164611506|NCT00871572|594598244|FG003|Overall Study|Lost to Follow-up|1|||
164611507|NCT00871572|594598241|FG000|Overall Study|Protocol Violation|0|||
164611508|NCT00871572|594598242|FG001|Overall Study|Protocol Violation|0|||
164611509|NCT00871572|594598243|FG002|Overall Study|Protocol Violation|1|||
164611510|NCT00871572|594598244|FG003|Overall Study|Protocol Violation|1|||
164611511|NCT00871572|594598241|FG000|Overall Study|Sponsor Decision|1|||
164611512|NCT00871572|594598242|FG001|Overall Study|Sponsor Decision|0|||
164611513|NCT00871572|594598243|FG002|Overall Study|Sponsor Decision|0|||
164611514|NCT00871572|594598244|FG003|Overall Study|Sponsor Decision|0|||
164611515|NCT00871572|594598241|FG000|Overall Study|Withdrawal by Subject|1|||
164611516|NCT00871572|594598242|FG001|Overall Study|Withdrawal by Subject|2|||
164611517|NCT00871572|594598243|FG002|Overall Study|Withdrawal by Subject|3|||
164611518|NCT00871572|594598244|FG003|Overall Study|Withdrawal by Subject|1|||
164611519|NCT04176445|594598245|FG000|Overall Study|Adverse Event|0|||
164611520|NCT04176445|594598246|FG001|Overall Study|Adverse Event|1|||
164611521|NCT04176445|594598245|FG000|Overall Study|change plans weaning after first intervention|0|||
164611522|NCT04176445|594598246|FG001|Overall Study|change plans weaning after first intervention|1|||
164611523|NCT00187889|594598247|FG000|Overall Study|Withdrawal by Subject|6|||
164611524|NCT00187889|594598248|FG001|Overall Study|Withdrawal by Subject|4|||
164611525|NCT03954444|594598249|FG000|Overall Study|Withdrawal by Subject|5|||
164611526|NCT03954444|594598250|FG001|Overall Study|Withdrawal by Subject|5|||
164611527|NCT03954444|594598251|FG002|Overall Study|Withdrawal by Subject|5|||
164611528|NCT03954444|594598249|FG000|Overall Study|Adverse Event|1|||
164611529|NCT03954444|594598250|FG001|Overall Study|Adverse Event|3|||
164611530|NCT03954444|594598251|FG002|Overall Study|Adverse Event|2|||
164611531|NCT03954444|594598249|FG000|Overall Study|Protocol Violation|0|||
164611532|NCT03954444|594598250|FG001|Overall Study|Protocol Violation|3|||
164611533|NCT03954444|594598251|FG002|Overall Study|Protocol Violation|5|||
164611534|NCT03954444|594598249|FG000|Overall Study|Use of prohibited therapy|1|||
164611535|NCT03954444|594598250|FG001|Overall Study|Use of prohibited therapy|1|||
164611536|NCT03954444|594598251|FG002|Overall Study|Use of prohibited therapy|2|||
164611537|NCT03954444|594598249|FG000|Overall Study|Lost to Follow-up|1|||
164611538|NCT03954444|594598250|FG001|Overall Study|Lost to Follow-up|0|||
164611539|NCT03954444|594598251|FG002|Overall Study|Lost to Follow-up|1|||
164611540|NCT03954444|594598249|FG000|Overall Study|Non-compliant with study drug application|2|||
164611541|NCT03954444|594598250|FG001|Overall Study|Non-compliant with study drug application|2|||
164611542|NCT03954444|594598251|FG002|Overall Study|Non-compliant with study drug application|0|||
164611543|NCT03954444|594598249|FG000|Overall Study|Administrative reasons|0|||
164611544|NCT03954444|594598250|FG001|Overall Study|Administrative reasons|0|||
164611545|NCT03954444|594598251|FG002|Overall Study|Administrative reasons|1|||
164611546|NCT03954444|594598249|FG000|Overall Study|Miscellaneous|3|||
164611547|NCT03954444|594598250|FG001|Overall Study|Miscellaneous|2|||
164611548|NCT03954444|594598251|FG002|Overall Study|Miscellaneous|1|||
164611549|NCT03094832|594598257|FG000|Overall Study|Lost to Follow-up|0|||
164611550|NCT03094832|594598258|FG001|Overall Study|Lost to Follow-up|0|||
164611551|NCT03094832|594598259|FG002|Overall Study|Lost to Follow-up|0|||
164611552|NCT03094832|594598260|FG003|Overall Study|Lost to Follow-up|1|||
164611553|NCT03094832|594598261|FG004|Overall Study|Lost to Follow-up|1|||
164611554|NCT03094832|594598257|FG000|Overall Study|Death|1|||
164611555|NCT03094832|594598258|FG001|Overall Study|Death|0|||
164611556|NCT03094832|594598259|FG002|Overall Study|Death|0|||
164611557|NCT03094832|594598260|FG003|Overall Study|Death|0|||
164611558|NCT03094832|594598261|FG004|Overall Study|Death|0|||
164611559|NCT03094832|594598257|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
164611560|NCT03094832|594598258|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164611561|NCT03094832|594598259|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
164611562|NCT03094832|594598260|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
164611563|NCT03094832|594598261|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
164611564|NCT03094832|594598257|FG000|Overall Study|Other|13|||
164611565|NCT03094832|594598258|FG001|Overall Study|Other|20|||
164611566|NCT03094832|594598259|FG002|Overall Study|Other|1|||
164611567|NCT03094832|594598260|FG003|Overall Study|Other|7|||
164611568|NCT03094832|594598261|FG004|Overall Study|Other|1|||
164611569|NCT02322411|594598264|FG000|Overall Study|Lost to Follow-up|4|||
164611570|NCT02322411|594598265|FG001|Overall Study|Lost to Follow-up|7|||
164611571|NCT02322411|594598264|FG000|Overall Study|Withdrawal by Subject|1|||
164611572|NCT02322411|594598265|FG001|Overall Study|Withdrawal by Subject|0|||
164611573|NCT01392378|594598266|FG000|Infant Series|Adverse Event|0|||
164611574|NCT01392378|594598267|FG001|Infant Series|Adverse Event|0|||
164611575|NCT01392378|594598268|FG002|Infant Series|Adverse Event|0|||
164611576|NCT01392378|594598269|FG003|Infant Series|Adverse Event|1|||
164611577|NCT01392378|594598270|FG004|Infant Series|Adverse Event|0|||
164611578|NCT01392378|594598266|FG000|Infant Series|Lost to Follow-up|0|||
164611579|NCT01392378|594598267|FG001|Infant Series|Lost to Follow-up|0|||
164611580|NCT01392378|594598268|FG002|Infant Series|Lost to Follow-up|0|||
164611581|NCT01392378|594598269|FG003|Infant Series|Lost to Follow-up|1|||
164611582|NCT01392378|594598270|FG004|Infant Series|Lost to Follow-up|0|||
164611583|NCT01392378|594598266|FG000|Infant Series|Protocol Violation|0|||
164611584|NCT01392378|594598267|FG001|Infant Series|Protocol Violation|1|||
164611585|NCT01392378|594598268|FG002|Infant Series|Protocol Violation|0|||
164611586|NCT01392378|594598269|FG003|Infant Series|Protocol Violation|0|||
164611587|NCT01392378|594598270|FG004|Infant Series|Protocol Violation|0|||
164611588|NCT01392378|594598266|FG000|Infant Series|Withdrawal by Parent|4|||
164611589|NCT01392378|594598267|FG001|Infant Series|Withdrawal by Parent|1|||
164611590|NCT01392378|594598268|FG002|Infant Series|Withdrawal by Parent|0|||
164611591|NCT01392378|594598269|FG003|Infant Series|Withdrawal by Parent|0|||
164611592|NCT01392378|594598270|FG004|Infant Series|Withdrawal by Parent|0|||
164611593|NCT01392378|594598266|FG000|After Infant Series|Lost to Follow-up|0|||
164611594|NCT01392378|594598267|FG001|After Infant Series|Lost to Follow-up|0|||
164611595|NCT01392378|594598268|FG002|After Infant Series|Lost to Follow-up|1|||
164611596|NCT01392378|594598269|FG003|After Infant Series|Lost to Follow-up|0|||
164611597|NCT01392378|594598270|FG004|After Infant Series|Lost to Follow-up|0|||
164611598|NCT01392378|594598266|FG000|After Infant Series|Withdrawal by Parent|0|||
164611599|NCT01392378|594598267|FG001|After Infant Series|Withdrawal by Parent|1|||
164611600|NCT01392378|594598268|FG002|After Infant Series|Withdrawal by Parent|1|||
164611601|NCT01392378|594598269|FG003|After Infant Series|Withdrawal by Parent|0|||
164611602|NCT01392378|594598270|FG004|After Infant Series|Withdrawal by Parent|1|||
164611603|NCT01392378|594598266|FG000|Toddler Dose|Lost to Follow-up|0|||
164611604|NCT01392378|594598267|FG001|Toddler Dose|Lost to Follow-up|0|||
164611605|NCT01392378|594598268|FG002|Toddler Dose|Lost to Follow-up|0|||
164611606|NCT01392378|594598269|FG003|Toddler Dose|Lost to Follow-up|1|||
164611607|NCT01392378|594598270|FG004|Toddler Dose|Lost to Follow-up|0|||
164611608|NCT01392378|594598266|FG000|Toddler Dose|Withdrawal by Parent|0|||
164611609|NCT01392378|594598267|FG001|Toddler Dose|Withdrawal by Parent|1|||
164611610|NCT01392378|594598268|FG002|Toddler Dose|Withdrawal by Parent|0|||
164611611|NCT01392378|594598269|FG003|Toddler Dose|Withdrawal by Parent|1|||
164611612|NCT01392378|594598270|FG004|Toddler Dose|Withdrawal by Parent|1|||
164611613|NCT01998880|594598273|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
164611614|NCT01998880|594598274|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
164611615|NCT01998880|594598273|FG000|Overall Study|Disease Progression|1|||
164611616|NCT01998880|594598274|FG001|Overall Study|Disease Progression|8|||
164611617|NCT01998880|594598273|FG000|Overall Study|Withdrew Consent|2|||
164611618|NCT01998880|594598274|FG001|Overall Study|Withdrew Consent|1|||
164611619|NCT01998880|594598273|FG000|Overall Study|Death|3|||
164611620|NCT01998880|594598274|FG001|Overall Study|Death|6|||
164611621|NCT01998880|594598273|FG000|Overall Study|Insufficient Therapeutic Response|1|||
164611622|NCT01998880|594598274|FG001|Overall Study|Insufficient Therapeutic Response|5|||
164611623|NCT01998880|594598273|FG000|Overall Study|Administrative/Other|1|||
164611624|NCT01998880|594598274|FG001|Overall Study|Administrative/Other|1|||
164611625|NCT01998880|594598273|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
164611626|NCT01998880|594598274|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
164611627|NCT01998880|594598273|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
164611628|NCT01998880|594598274|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
164611629|NCT01998880|594598273|FG000|Overall Study|Did Not Receive Treatment|3|||
164611630|NCT01998880|594598274|FG001|Overall Study|Did Not Receive Treatment|2|||
164611631|NCT02248857|594598275|FG000|3 Month|Withdrawal by Subject|9|||
164611632|NCT02248857|594598276|FG001|3 Month|Withdrawal by Subject|3|||
164611633|NCT02248857|594598277|FG002|3 Month|Withdrawal by Subject|4|||
164611634|NCT02248857|594598275|FG000|3 Month|Unable to reach for 3 month|35|||
164611635|NCT02248857|594598276|FG001|3 Month|Unable to reach for 3 month|29|||
164611636|NCT02248857|594598277|FG002|3 Month|Unable to reach for 3 month|26|||
164611637|NCT02248857|594598275|FG000|3 Month|Partially completed, unable to finish|2|||
164611638|NCT02248857|594598276|FG001|3 Month|Partially completed, unable to finish|2|||
164611639|NCT02248857|594598277|FG002|3 Month|Partially completed, unable to finish|1|||
164611640|NCT02248857|594598275|FG000|6 Month|Lost to Follow-up|27|||
164611641|NCT02248857|594598276|FG001|6 Month|Lost to Follow-up|26|||
164611642|NCT02248857|594598277|FG002|6 Month|Lost to Follow-up|15|||
164611643|NCT02248857|594598275|FG000|6 Month|Partially completed, unable to finish|0|||
164611644|NCT02248857|594598276|FG001|6 Month|Partially completed, unable to finish|1|||
164611645|NCT02248857|594598277|FG002|6 Month|Partially completed, unable to finish|0|||
164611646|NCT02248857|594598275|FG000|6 Month|Withdrawal by Subject|0|||
164611647|NCT02248857|594598276|FG001|6 Month|Withdrawal by Subject|2|||
164611648|NCT02248857|594598277|FG002|6 Month|Withdrawal by Subject|2|||
164611649|NCT02248857|594598275|FG000|6 Month|Death|1|||
164611650|NCT02248857|594598276|FG001|6 Month|Death|0|||
164611651|NCT02248857|594598277|FG002|6 Month|Death|0|||
164611652|NCT02671461|594598278|FG000|Treatment|Adverse Event|0|||
164611653|NCT02671461|594598279|FG001|Treatment|Adverse Event|0|||
164611654|NCT02671461|594598280|FG002|Treatment|Adverse Event|1|||
164611655|NCT02671461|594598278|FG000|Treatment|Administrative Reason by Sponsor|1|||
164611656|NCT02671461|594598279|FG001|Treatment|Administrative Reason by Sponsor|3|||
164611657|NCT02671461|594598280|FG002|Treatment|Administrative Reason by Sponsor|4|||
164611658|NCT02671461|594598278|FG000|Treatment|Randomized, not treated|1|||
164611659|NCT02671461|594598279|FG001|Treatment|Randomized, not treated|0|||
164611660|NCT02671461|594598280|FG002|Treatment|Randomized, not treated|0|||
164611661|NCT02671461|594598278|FG000|Follow-up|Withdrawal by Subject|1|||
164611662|NCT02671461|594598279|FG001|Follow-up|Withdrawal by Subject|0|||
164611663|NCT02671461|594598280|FG002|Follow-up|Withdrawal by Subject|0|||
164611664|NCT02671461|594598278|FG000|Follow-up|Lost to Follow-up|0|||
164611665|NCT02671461|594598279|FG001|Follow-up|Lost to Follow-up|0|||
164611666|NCT02671461|594598280|FG002|Follow-up|Lost to Follow-up|1|||
164611667|NCT02671461|594598278|FG000|Follow-up|Administrative Reason by Sponsor|0|||
164611668|NCT02671461|594598279|FG001|Follow-up|Administrative Reason by Sponsor|1|||
164611669|NCT02671461|594598280|FG002|Follow-up|Administrative Reason by Sponsor|0|||
164611670|NCT00345540|594598281|FG000|Overall Study|Withdrawal by Subject|1|||
164611671|NCT04179786|594598282|FG000|Overall Study|Withdrawal by Subject|8|||
164611672|NCT01938001|594598283|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
164611673|NCT01938001|594598284|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
164611674|NCT01938001|594598283|FG000|Pre-Treatment|Death|1|||
164611675|NCT01938001|594598284|FG001|Pre-Treatment|Death|0|||
164611676|NCT01938001|594598283|FG000|Treatment|Death|2|||
164611677|NCT01938001|594598284|FG001|Treatment|Death|0|||
164611678|NCT01938001|594598283|FG000|Treatment|Adverse Event|14|||
164611679|NCT01938001|594598284|FG001|Treatment|Adverse Event|8|||
164611680|NCT01938001|594598283|FG000|Treatment|Progressive Disease|21|||
164611681|NCT01938001|594598284|FG001|Treatment|Progressive Disease|54|||
164611682|NCT01938001|594598283|FG000|Treatment|Withdrawal by Subject|13|||
164611683|NCT01938001|594598284|FG001|Treatment|Withdrawal by Subject|7|||
164611684|NCT01938001|594598283|FG000|Treatment|Other reasons|2|||
164611685|NCT01938001|594598284|FG001|Treatment|Other reasons|1|||
164611686|NCT03310580|594598285|FG000|Overall Study|Adverse Event|0|||
164611687|NCT03310580|594598286|FG001|Overall Study|Adverse Event|1|||
164611688|NCT03310580|594598287|FG002|Overall Study|Adverse Event|0|||
164611689|NCT03205982|594598288|FG000|Overall Study|Lost to Follow-up|20|||
164611690|NCT03205982|594598289|FG001|Overall Study|Lost to Follow-up|19|||
164611691|NCT03205982|594598288|FG000|Overall Study|Withdrawal by Subject|4|||
164611692|NCT03205982|594598289|FG001|Overall Study|Withdrawal by Subject|3|||
164611693|NCT03205982|594598288|FG000|Overall Study|Withdrawal by PI|0|||
164611694|NCT03205982|594598289|FG001|Overall Study|Withdrawal by PI|1|||
164611695|NCT01468701|594598292|FG000|Overall Study|Not eligible|91|||
164611696|NCT01468701|594598293|FG001|Overall Study|Not eligible|140|||
164611697|NCT01468701|594598294|FG002|Overall Study|Not eligible|29|||
164611698|NCT01468701|594598295|FG003|Overall Study|Not eligible|12|||
164611699|NCT01468701|594598296|FG004|Overall Study|Not eligible|22|||
164611700|NCT01468701|594598297|FG005|Overall Study|Not eligible|2|||
164611701|NCT01468701|594598298|FG006|Overall Study|Not eligible|39|||
164611702|NCT01468701|594598299|FG007|Overall Study|Not eligible|1|||
164611703|NCT01468701|594598300|FG008|Overall Study|Not eligible|40|||
164611704|NCT01468701|594598301|FG009|Overall Study|Not eligible|126|||
164611705|NCT01468701|594598302|FG010|Overall Study|Not eligible|39|||
164611706|NCT01468701|594598303|FG011|Overall Study|Not eligible|33|||
164611707|NCT01468701|594598304|FG012|Overall Study|Not eligible|1|||
164611708|NCT01468701|594598305|FG013|Overall Study|Not eligible|19|||
164611709|NCT01468701|594598306|FG014|Overall Study|Not eligible|1|||
164611710|NCT01468701|594598307|FG015|Overall Study|Not eligible|32|||
164515415|NCT01077518|594257437|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
164515416|NCT01077518|594257438|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
164515417|NCT01077518|594257439|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
164515418|NCT04958200|594257440|FG000|Overall Study|Withdrawal by Subject|0|||
164515419|NCT04958200|594257441|FG001|Overall Study|Withdrawal by Subject|2|||
164515420|NCT04958200|594257440|FG000|Overall Study|Lost to Follow-up|3|||
164515421|NCT04958200|594257441|FG001|Overall Study|Lost to Follow-up|2|||
164515422|NCT04954326|594257442|FG000|Overall Study|Protocol Violation|0|||
164515423|NCT04954326|594257443|FG001|Overall Study|Protocol Violation|1|||
164515424|NCT04954326|594257442|FG000|Overall Study|Death|0|||
164515425|NCT04954326|594257443|FG001|Overall Study|Death|2|||
164515426|NCT04954326|594257442|FG000|Overall Study|Physician Decision|0|||
164515427|NCT04954326|594257443|FG001|Overall Study|Physician Decision|1|||
164515428|NCT01495598|594257448|FG000|Overall Study|Death during follow up period|2|||
164515429|NCT01495598|594257448|FG000|Overall Study|Death on study|1|||
164515430|NCT01495598|594257448|FG000|Overall Study|Lost to Follow-up|3|||
164515431|NCT01495598|594257448|FG000|Overall Study|Physician Decision|8|||
164515432|NCT04157400|594257449|FG000|Overall Study|Withdrawal by Subject|1|||
164515433|NCT04157400|594257449|FG000|Overall Study|Lost to Follow-up|3|||
164515434|NCT00669877|594257454|FG000|Overall Study|Disease Progression/Death|4|||
164515435|NCT04520659|594257455|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
164515436|NCT04520659|594257456|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
164515437|NCT04520659|594257457|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
164515438|NCT04520659|594257458|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
164515439|NCT04485611|594257463|FG000|Prehabilitation|Physician Decision|1|||
164515440|NCT04879849|594257464|FG000|Overall Study|Lost to Follow-up|0|||
164515441|NCT04879849|594257465|FG001|Overall Study|Lost to Follow-up|0|||
164515442|NCT04879849|594257466|FG002|Overall Study|Lost to Follow-up|0|||
164515443|NCT04879849|594257467|FG003|Overall Study|Lost to Follow-up|1|||
164515444|NCT04879849|594257468|FG004|Overall Study|Lost to Follow-up|0|||
164515445|NCT04879849|594257469|FG005|Overall Study|Lost to Follow-up|0|||
164515446|NCT04879849|594257470|FG006|Overall Study|Lost to Follow-up|0|||
164515447|NCT04879849|594257471|FG007|Overall Study|Lost to Follow-up|0|||
164515448|NCT04879849|594257464|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
164515449|NCT04879849|594257465|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
164515450|NCT04879849|594257466|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
164515451|NCT04879849|594257467|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
164515452|NCT04879849|594257468|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
164515453|NCT04879849|594257469|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
164611711|NCT01468701|594598308|FG016|Overall Study|Not eligible|0|||
164611712|NCT01468701|594598292|FG000|Overall Study|Lost to Follow-up|306|||
164611713|NCT01468701|594598293|FG001|Overall Study|Lost to Follow-up|0|||
164611714|NCT01468701|594598294|FG002|Overall Study|Lost to Follow-up|0|||
164611715|NCT01468701|594598295|FG003|Overall Study|Lost to Follow-up|0|||
164611716|NCT01468701|594598296|FG004|Overall Study|Lost to Follow-up|0|||
164611717|NCT01468701|594598297|FG005|Overall Study|Lost to Follow-up|0|||
164611718|NCT01468701|594598298|FG006|Overall Study|Lost to Follow-up|0|||
164611719|NCT01468701|594598299|FG007|Overall Study|Lost to Follow-up|0|||
164611720|NCT01468701|594598300|FG008|Overall Study|Lost to Follow-up|215|||
164611721|NCT01468701|594598301|FG009|Overall Study|Lost to Follow-up|309|||
164611722|NCT01468701|594598302|FG010|Overall Study|Lost to Follow-up|224|||
164611723|NCT01468701|594598303|FG011|Overall Study|Lost to Follow-up|212|||
164611724|NCT01468701|594598304|FG012|Overall Study|Lost to Follow-up|11|||
164611725|NCT01468701|594598305|FG013|Overall Study|Lost to Follow-up|164|||
164611726|NCT01468701|594598306|FG014|Overall Study|Lost to Follow-up|17|||
164611727|NCT01468701|594598307|FG015|Overall Study|Lost to Follow-up|127|||
164611728|NCT01468701|594598308|FG016|Overall Study|Lost to Follow-up|1|||
164611729|NCT01468701|594598292|FG000|Overall Study|Withdrawal by Subject|165|||
164611730|NCT01468701|594598293|FG001|Overall Study|Withdrawal by Subject|0|||
164611731|NCT01468701|594598294|FG002|Overall Study|Withdrawal by Subject|0|||
164611732|NCT01468701|594598295|FG003|Overall Study|Withdrawal by Subject|0|||
164611733|NCT01468701|594598296|FG004|Overall Study|Withdrawal by Subject|0|||
164611734|NCT01468701|594598297|FG005|Overall Study|Withdrawal by Subject|0|||
164611735|NCT01468701|594598298|FG006|Overall Study|Withdrawal by Subject|0|||
164611736|NCT01468701|594598299|FG007|Overall Study|Withdrawal by Subject|0|||
164611737|NCT01468701|594598300|FG008|Overall Study|Withdrawal by Subject|83|||
164611738|NCT01468701|594598301|FG009|Overall Study|Withdrawal by Subject|88|||
164611739|NCT01468701|594598302|FG010|Overall Study|Withdrawal by Subject|100|||
164611740|NCT01468701|594598303|FG011|Overall Study|Withdrawal by Subject|114|||
164611741|NCT01468701|594598304|FG012|Overall Study|Withdrawal by Subject|9|||
164611742|NCT01468701|594598305|FG013|Overall Study|Withdrawal by Subject|47|||
164611743|NCT01468701|594598306|FG014|Overall Study|Withdrawal by Subject|6|||
164611744|NCT01468701|594598307|FG015|Overall Study|Withdrawal by Subject|31|||
164611745|NCT01468701|594598308|FG016|Overall Study|Withdrawal by Subject|0|||
164611746|NCT01468701|594598292|FG000|Overall Study|Other reasons than listed|437|||
164611747|NCT01468701|594598293|FG001|Overall Study|Other reasons than listed|0|||
164611748|NCT01468701|594598294|FG002|Overall Study|Other reasons than listed|0|||
164515454|NCT04879849|594257470|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
164515455|NCT04879849|594257471|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
164515456|NCT04879849|594257464|FG000|Overall Study|Withdrawal by Subject|0|||
164515457|NCT04879849|594257465|FG001|Overall Study|Withdrawal by Subject|0|||
164515458|NCT04879849|594257466|FG002|Overall Study|Withdrawal by Subject|0|||
164515459|NCT04879849|594257467|FG003|Overall Study|Withdrawal by Subject|0|||
164515460|NCT04879849|594257468|FG004|Overall Study|Withdrawal by Subject|2|||
164515461|NCT04879849|594257469|FG005|Overall Study|Withdrawal by Subject|0|||
164515462|NCT04879849|594257470|FG006|Overall Study|Withdrawal by Subject|1|||
164515463|NCT04879849|594257471|FG007|Overall Study|Withdrawal by Subject|0|||
164515464|NCT04879849|594257464|FG000|Overall Study|Progressive Disease|0|||
164515465|NCT04879849|594257465|FG001|Overall Study|Progressive Disease|0|||
164515466|NCT04879849|594257466|FG002|Overall Study|Progressive Disease|1|||
164515467|NCT04879849|594257467|FG003|Overall Study|Progressive Disease|0|||
164515468|NCT04879849|594257468|FG004|Overall Study|Progressive Disease|0|||
164515469|NCT04879849|594257469|FG005|Overall Study|Progressive Disease|0|||
164515470|NCT04879849|594257470|FG006|Overall Study|Progressive Disease|0|||
164515471|NCT04879849|594257471|FG007|Overall Study|Progressive Disease|0|||
164515472|NCT04879849|594257464|FG000|Overall Study|Death|0|||
164515473|NCT04879849|594257465|FG001|Overall Study|Death|0|||
164515474|NCT04879849|594257466|FG002|Overall Study|Death|1|||
164515475|NCT04879849|594257467|FG003|Overall Study|Death|1|||
164515476|NCT04879849|594257468|FG004|Overall Study|Death|1|||
164515477|NCT04879849|594257469|FG005|Overall Study|Death|2|||
164515478|NCT04879849|594257470|FG006|Overall Study|Death|1|||
164515479|NCT04879849|594257471|FG007|Overall Study|Death|2|||
164515480|NCT04879849|594257464|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
164515481|NCT04879849|594257465|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
164515482|NCT04879849|594257466|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
164515483|NCT04879849|594257467|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
164515484|NCT04879849|594257468|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
164515485|NCT04879849|594257469|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
164515486|NCT04879849|594257470|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
164515487|NCT04879849|594257471|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
164515488|NCT04879849|594257464|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
164515489|NCT04879849|594257465|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
164515490|NCT04879849|594257466|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
164515491|NCT04879849|594257467|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
164515492|NCT04879849|594257468|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
164515493|NCT04879849|594257469|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
164515494|NCT04879849|594257470|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
164515495|NCT04879849|594257471|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
164515496|NCT04879849|594257464|FG000|Overall Study|Reason Not Specified|1|||
164515497|NCT04879849|594257465|FG001|Overall Study|Reason Not Specified|0|||
164515498|NCT04879849|594257466|FG002|Overall Study|Reason Not Specified|0|||
164515499|NCT04879849|594257467|FG003|Overall Study|Reason Not Specified|0|||
164515500|NCT04879849|594257468|FG004|Overall Study|Reason Not Specified|0|||
164515501|NCT04879849|594257469|FG005|Overall Study|Reason Not Specified|0|||
164515502|NCT04879849|594257470|FG006|Overall Study|Reason Not Specified|0|||
164515503|NCT04879849|594257471|FG007|Overall Study|Reason Not Specified|0|||
164515504|NCT04201262|594257472|FG000|Primary Treatment Period|Adverse Event|1|||
164515505|NCT04201262|594257473|FG001|Primary Treatment Period|Adverse Event|2|||
164515506|NCT04201262|594257472|FG000|Primary Treatment Period|Physician Decision|1|||
164515507|NCT04201262|594257473|FG001|Primary Treatment Period|Physician Decision|1|||
164515508|NCT04201262|594257472|FG000|Long-term Extension Period|Death|1|||
164515509|NCT04201262|594257473|FG001|Long-term Extension Period|Death|0|||
164515510|NCT02819024|594257474|FG000|Overall Study|Withdrawal by Subject|1|||
164515511|NCT05217641|594257478|FG000|Overall Study|Lost to Follow-up|1|||
164515512|NCT05217641|594257479|FG001|Overall Study|Lost to Follow-up|1|||
164515513|NCT05217641|594257480|FG002|Overall Study|Lost to Follow-up|0|||
164515514|NCT05217641|594257481|FG003|Overall Study|Lost to Follow-up|1|||
164515515|NCT05217641|594257482|FG004|Overall Study|Lost to Follow-up|1|||
164611749|NCT01468701|594598295|FG003|Overall Study|Other reasons than listed|0|||
164515516|NCT05217641|594257483|FG005|Overall Study|Lost to Follow-up|0|||
164515517|NCT05217641|594257478|FG000|Overall Study|Withdrawal by Subject|0|||
164611750|NCT01468701|594598296|FG004|Overall Study|Other reasons than listed|0|||
164611751|NCT01468701|594598297|FG005|Overall Study|Other reasons than listed|0|||
164611752|NCT01468701|594598298|FG006|Overall Study|Other reasons than listed|0|||
164515518|NCT05217641|594257479|FG001|Overall Study|Withdrawal by Subject|0|||
164611753|NCT01468701|594598299|FG007|Overall Study|Other reasons than listed|0|||
164611754|NCT01468701|594598300|FG008|Overall Study|Other reasons than listed|318|||
164147139|NCT02466685|592899987|FG000|Overall Study|Lost to Follow-up|1|||
164515519|NCT05217641|594257480|FG002|Overall Study|Withdrawal by Subject|0|||
164515520|NCT05217641|594257481|FG003|Overall Study|Withdrawal by Subject|3|||
164515521|NCT05217641|594257482|FG004|Overall Study|Withdrawal by Subject|1|||
164515522|NCT05217641|594257483|FG005|Overall Study|Withdrawal by Subject|0|||
164515523|NCT05217641|594257478|FG000|Overall Study|Other: participant did not specify reason|0|||
164515524|NCT05217641|594257479|FG001|Overall Study|Other: participant did not specify reason|0|||
164515525|NCT05217641|594257480|FG002|Overall Study|Other: participant did not specify reason|0|||
164515526|NCT05217641|594257481|FG003|Overall Study|Other: participant did not specify reason|0|||
164515527|NCT05217641|594257482|FG004|Overall Study|Other: participant did not specify reason|1|||
164515528|NCT05217641|594257483|FG005|Overall Study|Other: participant did not specify reason|0|||
164515529|NCT05217641|594257478|FG000|Overall Study|Extended Follow up|1|||
164515530|NCT05217641|594257479|FG001|Overall Study|Extended Follow up|1|||
164515531|NCT05217641|594257480|FG002|Overall Study|Extended Follow up|0|||
164515532|NCT05217641|594257481|FG003|Overall Study|Extended Follow up|0|||
164515533|NCT05217641|594257482|FG004|Overall Study|Extended Follow up|1|||
164515534|NCT05217641|594257483|FG005|Overall Study|Extended Follow up|0|||
164515535|NCT03682185|594257486|FG000|Overall Study|Lost to Follow-up|4|||
164515536|NCT03682185|594257487|FG001|Overall Study|Lost to Follow-up|7|||
164515537|NCT03682185|594257488|FG002|Overall Study|Lost to Follow-up|4|||
164515538|NCT03682185|594257489|FG003|Overall Study|Lost to Follow-up|7|||
164515539|NCT03682185|594257490|FG004|Overall Study|Lost to Follow-up|1|||
164515540|NCT03682185|594257486|FG000|Overall Study|Withdrawal by Subject|7|||
164515541|NCT03682185|594257487|FG001|Overall Study|Withdrawal by Subject|3|||
164515542|NCT03682185|594257488|FG002|Overall Study|Withdrawal by Subject|7|||
164515543|NCT03682185|594257489|FG003|Overall Study|Withdrawal by Subject|3|||
164515544|NCT03682185|594257490|FG004|Overall Study|Withdrawal by Subject|0|||
164515545|NCT03548220|594257493|FG000|Overall Study|Lost to Follow-up|1|||
164515546|NCT03548220|594257494|FG001|Overall Study|Lost to Follow-up|0|||
164515547|NCT03548220|594257495|FG002|Overall Study|Lost to Follow-up|0|||
164515548|NCT03548220|594257496|FG003|Overall Study|Lost to Follow-up|0|||
164515549|NCT03007420|594257497|FG000|Overall Study|Withdrawal by Subject|0|||
164515550|NCT03007420|594257498|FG001|Overall Study|Withdrawal by Subject|2|||
164515551|NCT03007420|594257497|FG000|Overall Study|Physician Decision|0|||
164515552|NCT03007420|594257498|FG001|Overall Study|Physician Decision|1|||
164515553|NCT02284009|594257502|FG000|Overall Study|Adverse Event|3|||
164515554|NCT02284009|594257503|FG001|Overall Study|Adverse Event|0|||
164515555|NCT02284009|594257502|FG000|Overall Study|Lost to Follow-up|1|||
164515556|NCT02284009|594257503|FG001|Overall Study|Lost to Follow-up|3|||
164515557|NCT02284009|594257502|FG000|Overall Study|Physician Decision|0|||
164515558|NCT02284009|594257503|FG001|Overall Study|Physician Decision|2|||
164515559|NCT02284009|594257502|FG000|Overall Study|Withdrawal by Subject|2|||
164515560|NCT02284009|594257503|FG001|Overall Study|Withdrawal by Subject|5|||
164515561|NCT04147195|594257504|FG000|Overall Study|Adverse Event|0|||
164515562|NCT04147195|594257505|FG001|Overall Study|Adverse Event|3|||
164515563|NCT04147195|594257504|FG000|Overall Study|Study Terminated by Sponsor|4|||
164515564|NCT04147195|594257505|FG001|Overall Study|Study Terminated by Sponsor|2|||
164515565|NCT04147195|594257504|FG000|Overall Study|Withdrawal by Subject|0|||
164515566|NCT04147195|594257505|FG001|Overall Study|Withdrawal by Subject|1|||
164515567|NCT03841526|594257506|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
164515568|NCT03841526|594257507|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
164515569|NCT03841526|594257508|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
164515570|NCT03841526|594257509|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
164515571|NCT03841526|594257510|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
164515572|NCT03841526|594257511|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
164515573|NCT03841526|594257506|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
164515574|NCT03841526|594257507|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
164515575|NCT03841526|594257508|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
164515576|NCT03841526|594257509|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
164515577|NCT03841526|594257510|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
164611755|NCT01468701|594598301|FG009|Overall Study|Other reasons than listed|658|||
164611756|NCT01468701|594598302|FG010|Overall Study|Other reasons than listed|433|||
164611757|NCT01468701|594598303|FG011|Overall Study|Other reasons than listed|504|||
164611758|NCT01468701|594598304|FG012|Overall Study|Other reasons than listed|28|||
164611759|NCT01468701|594598305|FG013|Overall Study|Other reasons than listed|239|||
164611760|NCT01468701|594598306|FG014|Overall Study|Other reasons than listed|39|||
164611761|NCT01468701|594598307|FG015|Overall Study|Other reasons than listed|172|||
164611762|NCT01468701|594598308|FG016|Overall Study|Other reasons than listed|0|||
164611763|NCT01468701|594598292|FG000|Overall Study|No end of study case report form|0|||
164611764|NCT01468701|594598293|FG001|Overall Study|No end of study case report form|0|||
164611765|NCT01468701|594598294|FG002|Overall Study|No end of study case report form|0|||
164611766|NCT01468701|594598295|FG003|Overall Study|No end of study case report form|0|||
164611767|NCT01468701|594598296|FG004|Overall Study|No end of study case report form|0|||
164611768|NCT01468701|594598297|FG005|Overall Study|No end of study case report form|0|||
164611769|NCT01468701|594598298|FG006|Overall Study|No end of study case report form|0|||
164611770|NCT01468701|594598299|FG007|Overall Study|No end of study case report form|0|||
164611771|NCT01468701|594598300|FG008|Overall Study|No end of study case report form|4|||
164611772|NCT01468701|594598301|FG009|Overall Study|No end of study case report form|1|||
164611773|NCT01468701|594598302|FG010|Overall Study|No end of study case report form|2|||
164611774|NCT01468701|594598303|FG011|Overall Study|No end of study case report form|3|||
164611775|NCT01468701|594598304|FG012|Overall Study|No end of study case report form|0|||
164611776|NCT01468701|594598305|FG013|Overall Study|No end of study case report form|1|||
164611777|NCT01468701|594598306|FG014|Overall Study|No end of study case report form|0|||
164611778|NCT01468701|594598307|FG015|Overall Study|No end of study case report form|0|||
164611779|NCT01468701|594598308|FG016|Overall Study|No end of study case report form|0|||
164611780|NCT01468701|594598292|FG000|Overall Study|Not being followed up|0|||
164611781|NCT01468701|594598293|FG001|Overall Study|Not being followed up|4963|||
164611782|NCT01468701|594598294|FG002|Overall Study|Not being followed up|1755|||
164611783|NCT01468701|594598295|FG003|Overall Study|Not being followed up|703|||
164611784|NCT01468701|594598296|FG004|Overall Study|Not being followed up|1714|||
164611785|NCT01468701|594598297|FG005|Overall Study|Not being followed up|126|||
164611786|NCT01468701|594598298|FG006|Overall Study|Not being followed up|1170|||
164611787|NCT01468701|594598299|FG007|Overall Study|Not being followed up|4|||
164611788|NCT01468701|594598300|FG008|Overall Study|Not being followed up|0|||
164611789|NCT01468701|594598301|FG009|Overall Study|Not being followed up|0|||
164611790|NCT01468701|594598302|FG010|Overall Study|Not being followed up|0|||
164611791|NCT01468701|594598303|FG011|Overall Study|Not being followed up|0|||
164611792|NCT01468701|594598304|FG012|Overall Study|Not being followed up|0|||
164611793|NCT01468701|594598305|FG013|Overall Study|Not being followed up|0|||
164611794|NCT01468701|594598306|FG014|Overall Study|Not being followed up|0|||
164611795|NCT01468701|594598307|FG015|Overall Study|Not being followed up|0|||
164611796|NCT01468701|594598308|FG016|Overall Study|Not being followed up|0|||
164611797|NCT01079195|594598316|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
164611798|NCT01079195|594598316|FG000|Overall Study|No Documentation Available|437|||
164611799|NCT01079195|594598316|FG000|Overall Study|Adverse Event|157|||
164611800|NCT01079195|594598316|FG000|Overall Study|Reason Unknown|39|||
164611801|NCT01079195|594598316|FG000|Overall Study|Withdrawal by Subject|18|||
164611802|NCT01079195|594598316|FG000|Overall Study|Financial Reasons|15|||
164611803|NCT01079195|594598316|FG000|Overall Study|Lack of Effectiveness|12|||
164611804|NCT01079195|594598316|FG000|Overall Study|Physician Decision|4|||
164611805|NCT01079195|594598316|FG000|Overall Study|Improved Status of Participant|4|||
164611806|NCT01079195|594598316|FG000|Overall Study|No Follow-up Documentation Available|4|||
164611807|NCT01079195|594598316|FG000|Overall Study|Non-compliance|2|||
164611808|NCT03170258|594599590|FG000|Overall Study|Physician Decision|4|||
164611809|NCT03170258|594599591|FG001|Overall Study|Physician Decision|0|||
164611810|NCT03170258|594599590|FG000|Overall Study|Equipment issues|1|||
164611811|NCT03170258|594599591|FG001|Overall Study|Equipment issues|0|||
164611812|NCT03170258|594599590|FG000|Overall Study|Medication|1|||
164611813|NCT03170258|594599591|FG001|Overall Study|Medication|0|||
164611814|NCT03170258|594599590|FG000|Overall Study|Sleep issues|1|||
164611815|NCT03170258|594599591|FG001|Overall Study|Sleep issues|0|||
164611816|NCT00666536|594599592|FG000|Overall Study|Adverse Event|9|||
164611817|NCT00666536|594599593|FG001|Overall Study|Adverse Event|19|||
164611818|NCT00666536|594599592|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164611819|NCT00666536|594599593|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164611820|NCT00666536|594599592|FG000|Overall Study|Protocol deviation(s)|8|||
164611821|NCT00666536|594599593|FG001|Overall Study|Protocol deviation(s)|6|||
164611822|NCT00666536|594599592|FG000|Overall Study|Withdrawal by Subject|10|||
164611823|NCT00666536|594599593|FG001|Overall Study|Withdrawal by Subject|9|||
164611824|NCT00666536|594599592|FG000|Overall Study|Lost to Follow-up|4|||
164611825|NCT00666536|594599593|FG001|Overall Study|Lost to Follow-up|3|||
164611826|NCT02853123|594599597|FG000|Treatment Period 1|Adverse Event|0|||
164611827|NCT02853123|594599598|FG001|Treatment Period 1|Adverse Event|3|||
164611828|NCT02853123|594599597|FG000|Washout Period|Worsening of COPD|0|||
164611829|NCT02853123|594599598|FG001|Washout Period|Worsening of COPD|3|||
164611830|NCT02853123|594599597|FG000|Washout Period|Adverse Event|1|||
164611831|NCT02853123|594599598|FG001|Washout Period|Adverse Event|0|||
164611832|NCT04839393|594599611|FG000|Overall Study|Adverse Event|0|||
164611833|NCT04839393|594599612|FG001|Overall Study|Adverse Event|0|||
164611834|NCT04839393|594599613|FG002|Overall Study|Adverse Event|2|||
164611835|NCT04839393|594599611|FG000|Overall Study|Withdrawal by participant|0|||
164611836|NCT04839393|594599612|FG001|Overall Study|Withdrawal by participant|0|||
164611837|NCT04839393|594599613|FG002|Overall Study|Withdrawal by participant|1|||
164515578|NCT03841526|594257511|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
164515579|NCT03841526|594257506|FG000|Outpatient Phase Treatment|Physician Decision|0|||
164611838|NCT00633893|594599614|FG000|Overall Study|Death|1|||
164611839|NCT00633893|594599615|FG001|Overall Study|Death|3|||
164611840|NCT00633893|594599616|FG002|Overall Study|Death|9|||
164611841|NCT00633893|594599614|FG000|Overall Study|Adverse Event|65|||
164611842|NCT00633893|594599615|FG001|Overall Study|Adverse Event|58|||
164611843|NCT00633893|594599616|FG002|Overall Study|Adverse Event|126|||
164611844|NCT00633893|594599614|FG000|Overall Study|Withdrawal by Subject|7|||
164611845|NCT00633893|594599615|FG001|Overall Study|Withdrawal by Subject|12|||
164611846|NCT00633893|594599616|FG002|Overall Study|Withdrawal by Subject|6|||
164515580|NCT03841526|594257507|FG001|Outpatient Phase Treatment|Physician Decision|1|||
164515581|NCT03841526|594257508|FG002|Outpatient Phase Treatment|Physician Decision|0|||
164515582|NCT03841526|594257509|FG003|Outpatient Phase Treatment|Physician Decision|0|||
164515583|NCT03841526|594257510|FG004|Outpatient Phase Treatment|Physician Decision|0|||
164515584|NCT03841526|594257511|FG005|Outpatient Phase Treatment|Physician Decision|0|||
164515585|NCT03841526|594257506|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
164515586|NCT03841526|594257507|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
164515587|NCT03841526|594257508|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
164515588|NCT03841526|594257509|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
164515589|NCT03841526|594257510|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
164515590|NCT03841526|594257511|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
164515591|NCT02397447|594257512|FG000|Overall Study|Lost to Follow-up|2|||
164515592|NCT02397447|594257513|FG001|Overall Study|Lost to Follow-up|2|||
164515593|NCT02994069|594257516|FG000|Overall Study|Death|7|||
164515594|NCT02994069|594257517|FG001|Overall Study|Death|13|||
164515595|NCT02994069|594257516|FG000|Overall Study|Adverse Event|1|||
164515596|NCT02994069|594257517|FG001|Overall Study|Adverse Event|0|||
164515597|NCT02994069|594257516|FG000|Overall Study|Other|2|||
164515598|NCT02994069|594257517|FG001|Overall Study|Other|0|||
164515599|NCT02994069|594257516|FG000|Overall Study|still on follow up/treatment|5|||
164515600|NCT02994069|594257517|FG001|Overall Study|still on follow up/treatment|6|||
164515601|NCT06926673|594257518|FG000|Overall Study|Lost to Follow-up|0|||
164515602|NCT06926673|594257519|FG001|Overall Study|Lost to Follow-up|0|||
164515603|NCT06926673|594257520|FG002|Overall Study|Lost to Follow-up|0|||
164515604|NCT06926673|594257521|FG003|Overall Study|Lost to Follow-up|1|||
164515605|NCT06926673|594257522|FG004|Overall Study|Lost to Follow-up|0|||
164515606|NCT06926673|594257523|FG005|Overall Study|Lost to Follow-up|0|||
164515607|NCT06926673|594257524|FG006|Overall Study|Lost to Follow-up|0|||
164515608|NCT06926673|594257518|FG000|Overall Study|Physician Decision|0|||
164515609|NCT06926673|594257519|FG001|Overall Study|Physician Decision|0|||
164515610|NCT06926673|594257520|FG002|Overall Study|Physician Decision|0|||
164515611|NCT06926673|594257521|FG003|Overall Study|Physician Decision|0|||
164515612|NCT06926673|594257522|FG004|Overall Study|Physician Decision|0|||
164515613|NCT06926673|594257523|FG005|Overall Study|Physician Decision|0|||
164515614|NCT06926673|594257524|FG006|Overall Study|Physician Decision|1|||
164515615|NCT06926673|594257518|FG000|Overall Study|Withdrawal by Subject|0|||
164611847|NCT00633893|594599614|FG000|Overall Study|Lost to Follow-up|2|||
164611848|NCT00633893|594599615|FG001|Overall Study|Lost to Follow-up|4|||
164611849|NCT00633893|594599616|FG002|Overall Study|Lost to Follow-up|8|||
164611850|NCT00633893|594599614|FG000|Overall Study|Poor/non-compliance|5|||
164611851|NCT00633893|594599615|FG001|Overall Study|Poor/non-compliance|12|||
164611852|NCT00633893|594599616|FG002|Overall Study|Poor/non-compliance|3|||
164611853|NCT00633893|594599614|FG000|Overall Study|Pregnancy|2|||
164611854|NCT00633893|594599615|FG001|Overall Study|Pregnancy|1|||
164611855|NCT00633893|594599616|FG002|Overall Study|Pregnancy|1|||
164611856|NCT00633893|594599614|FG000|Overall Study|Not meet/no longer meets criteria|4|||
164611857|NCT00633893|594599615|FG001|Overall Study|Not meet/no longer meets criteria|6|||
164611858|NCT00633893|594599616|FG002|Overall Study|Not meet/no longer meets criteria|4|||
164611859|NCT00633893|594599614|FG000|Overall Study|Other|28|||
164611860|NCT00633893|594599615|FG001|Overall Study|Other|33|||
164611861|NCT00633893|594599616|FG002|Overall Study|Other|31|||
164611862|NCT01784211|594599617|FG000|Part A (Days 1-15)|Adverse Event|1|||
164611863|NCT01784211|594599618|FG001|Part A (Days 1-15)|Adverse Event|1|||
164611864|NCT01784211|594599619|FG002|Part A (Days 1-15)|Adverse Event|0|||
164611865|NCT01784211|594599620|FG003|Part A (Days 1-15)|Adverse Event|0|||
164611866|NCT01784211|594599621|FG004|Part A (Days 1-15)|Adverse Event|0|||
164611867|NCT01784211|594599622|FG005|Part A (Days 1-15)|Adverse Event|0|||
164611868|NCT01784211|594599617|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
164611869|NCT01784211|594599618|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
164611870|NCT01784211|594599619|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
164611871|NCT01784211|594599620|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
164611872|NCT01784211|594599621|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
164611873|NCT01784211|594599622|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
164611874|NCT00369278|594599623|FG000|Overall Study|Adverse Event|14|||
164611875|NCT00369278|594599624|FG001|Overall Study|Adverse Event|11|||
164611876|NCT00369278|594599623|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
164611877|NCT00369278|594599624|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
164611878|NCT00369278|594599623|FG000|Overall Study|Protocol Violation|2|||
164611879|NCT00369278|594599624|FG001|Overall Study|Protocol Violation|1|||
164611880|NCT00369278|594599623|FG000|Overall Study|Withdrawal by Subject|2|||
164611881|NCT00369278|594599624|FG001|Overall Study|Withdrawal by Subject|2|||
164611882|NCT00369278|594599623|FG000|Overall Study|Lost to Follow-up|1|||
164611883|NCT00369278|594599624|FG001|Overall Study|Lost to Follow-up|0|||
164611884|NCT00369278|594599623|FG000|Overall Study|Graft loss|1|||
164611885|NCT00369278|594599624|FG001|Overall Study|Graft loss|2|||
164611886|NCT01017549|594599625|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
164611887|NCT01017549|594599625|FG000|One-year Follow-up|Lost to Follow-up|2|||
164611888|NCT01017549|594599625|FG000|One-year Follow-up|Withdrawal by Subject|5|||
164611889|NCT01017549|594599625|FG000|5 Year Follow-up|Lost to Follow-up|9|||
164611890|NCT01017549|594599625|FG000|5 Year Follow-up|Mastectomy|3|||
164611891|NCT02143141|594599635|FG000|Overall Study|pain scores at 24 hours not collected|1|||
164611892|NCT02143141|594599636|FG001|Overall Study|pain scores at 24 hours not collected|0|||
164611893|NCT03862495|594599637|FG000|Overall Study|Lost to Follow-up|37|||
164611894|NCT03862495|594599638|FG001|Overall Study|Lost to Follow-up|35|||
164611895|NCT01057862|594599641|FG000|Overall Study|Withdrawal by Subject|1|||
164611896|NCT01057862|594599642|FG001|Overall Study|Withdrawal by Subject|2|||
164611897|NCT00802867|594599643|FG000|Overall Study|Lost to Follow-up|6|||
164611898|NCT00802867|594599643|FG000|Overall Study|Protocol Violation|6|||
164611899|NCT00802867|594599643|FG000|Overall Study|Withdrawal by Subject|1|||
164611900|NCT03363165|594599646|FG000|3-month Follow-up|Death|0|||
164611901|NCT03363165|594599647|FG001|3-month Follow-up|Death|1|||
164611902|NCT03363165|594599646|FG000|6-month Follow-up|Death|0|||
164611903|NCT03363165|594599647|FG001|6-month Follow-up|Death|1|||
164611904|NCT03363165|594599646|FG000|6-month Follow-up|Withdrawal by Subject|1|||
164611905|NCT03363165|594599647|FG001|6-month Follow-up|Withdrawal by Subject|1|||
164611906|NCT03363165|594599646|FG000|12-month Follow-up|Death|1|||
164611907|NCT03363165|594599647|FG001|12-month Follow-up|Death|1|||
164611908|NCT03363165|594599646|FG000|12-month Follow-up|Withdrawal by Subject|1|||
164611909|NCT03363165|594599647|FG001|12-month Follow-up|Withdrawal by Subject|1|||
164611910|NCT02255760|594599648|FG000|Overall Study|Lost to Follow-up|0|||
164611911|NCT02255760|594599649|FG001|Overall Study|Lost to Follow-up|1|||
164611912|NCT02255760|594599650|FG002|Overall Study|Lost to Follow-up|0|||
164611913|NCT02255760|594599651|FG003|Overall Study|Lost to Follow-up|0|||
164611914|NCT02255760|594599652|FG004|Overall Study|Lost to Follow-up|0|||
164611915|NCT00618813|594599653|FG000|Overall Study|Lack of Efficacy|1|||
164611916|NCT00618813|594599653|FG000|Overall Study|Physician Decision|2|||
164611917|NCT00618813|594599653|FG000|Overall Study|Withdrawal by Subject|1|||
164611918|NCT01809197|594599654|FG000|Overall Study|Lost to Follow-up|4|||
164611919|NCT01809197|594599655|FG001|Overall Study|Lost to Follow-up|2|||
164611920|NCT01809197|594599654|FG000|Overall Study|Adverse Event|2|||
164611921|NCT01809197|594599655|FG001|Overall Study|Adverse Event|3|||
164611922|NCT01809197|594599654|FG000|Overall Study|Failed slit lamp exam|1|||
164611923|NCT01809197|594599655|FG001|Overall Study|Failed slit lamp exam|0|||
164611924|NCT01809197|594599654|FG000|Overall Study|Non-Compliance|1|||
164611925|NCT01809197|594599655|FG001|Overall Study|Non-Compliance|1|||
164611926|NCT01809197|594599654|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
164611927|NCT01809197|594599655|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
164611928|NCT01809197|594599654|FG000|Overall Study|Withdrawal by Subject|1|||
164611929|NCT01809197|594599655|FG001|Overall Study|Withdrawal by Subject|1|||
164611930|NCT01809197|594599654|FG000|Overall Study|Product not available|0|||
164611931|NCT01809197|594599655|FG001|Overall Study|Product not available|1|||
164611932|NCT01855945|594599656|FG000|Overall Study|Adverse Event|0|||
164611933|NCT01855945|594599657|FG001|Overall Study|Adverse Event|0|||
164611934|NCT01855945|594599658|FG002|Overall Study|Adverse Event|0|||
164611935|NCT01855945|594599659|FG003|Overall Study|Adverse Event|0|||
164611936|NCT01855945|594599660|FG004|Overall Study|Adverse Event|0|||
164611937|NCT01855945|594599661|FG005|Overall Study|Adverse Event|0|||
164611938|NCT01855945|594599662|FG006|Overall Study|Adverse Event|1|||
164611939|NCT01855945|594599663|FG007|Overall Study|Adverse Event|0|||
164611940|NCT01855945|594599664|FG008|Overall Study|Adverse Event|0|||
164611941|NCT01855945|594599665|FG009|Overall Study|Adverse Event|0|||
164611942|NCT01855945|594599666|FG010|Overall Study|Adverse Event|0|||
164611943|NCT01855945|594599667|FG011|Overall Study|Adverse Event|0|||
164611944|NCT01855945|594599656|FG000|Overall Study|Death|0|||
164611945|NCT01855945|594599657|FG001|Overall Study|Death|0|||
164611946|NCT01855945|594599658|FG002|Overall Study|Death|0|||
164611947|NCT01855945|594599659|FG003|Overall Study|Death|0|||
164611948|NCT01855945|594599660|FG004|Overall Study|Death|0|||
164611949|NCT01855945|594599661|FG005|Overall Study|Death|0|||
164611950|NCT01855945|594599662|FG006|Overall Study|Death|2|||
164611951|NCT01855945|594599663|FG007|Overall Study|Death|0|||
164611952|NCT01855945|594599664|FG008|Overall Study|Death|0|||
164611953|NCT01855945|594599665|FG009|Overall Study|Death|0|||
164611954|NCT01855945|594599666|FG010|Overall Study|Death|0|||
164611955|NCT01855945|594599667|FG011|Overall Study|Death|0|||
164611956|NCT01855945|594599656|FG000|Overall Study|Lost to Follow-up|11|||
164611957|NCT01855945|594599657|FG001|Overall Study|Lost to Follow-up|10|||
164611958|NCT01855945|594599658|FG002|Overall Study|Lost to Follow-up|7|||
164611959|NCT01855945|594599659|FG003|Overall Study|Lost to Follow-up|3|||
164611960|NCT01855945|594599660|FG004|Overall Study|Lost to Follow-up|0|||
164611961|NCT01855945|594599661|FG005|Overall Study|Lost to Follow-up|3|||
164611962|NCT01855945|594599662|FG006|Overall Study|Lost to Follow-up|4|||
164611963|NCT01855945|594599663|FG007|Overall Study|Lost to Follow-up|7|||
164611964|NCT01855945|594599664|FG008|Overall Study|Lost to Follow-up|2|||
164611965|NCT01855945|594599665|FG009|Overall Study|Lost to Follow-up|0|||
164611966|NCT01855945|594599666|FG010|Overall Study|Lost to Follow-up|0|||
164611967|NCT01855945|594599667|FG011|Overall Study|Lost to Follow-up|2|||
164611968|NCT01855945|594599656|FG000|Overall Study|Other - Unclassified|1|||
164611969|NCT01855945|594599657|FG001|Overall Study|Other - Unclassified|1|||
164611970|NCT01855945|594599658|FG002|Overall Study|Other - Unclassified|1|||
164611971|NCT01855945|594599659|FG003|Overall Study|Other - Unclassified|0|||
164611972|NCT01855945|594599660|FG004|Overall Study|Other - Unclassified|0|||
164611973|NCT01855945|594599661|FG005|Overall Study|Other - Unclassified|0|||
164611974|NCT01855945|594599662|FG006|Overall Study|Other - Unclassified|2|||
164611975|NCT01855945|594599663|FG007|Overall Study|Other - Unclassified|1|||
164611976|NCT01855945|594599664|FG008|Overall Study|Other - Unclassified|0|||
164611977|NCT01855945|594599665|FG009|Overall Study|Other - Unclassified|0|||
164611978|NCT01855945|594599666|FG010|Overall Study|Other - Unclassified|1|||
164611979|NCT01855945|594599667|FG011|Overall Study|Other - Unclassified|0|||
164611980|NCT01855945|594599656|FG000|Overall Study|Withdrawal by Subject|4|||
164611981|NCT01855945|594599657|FG001|Overall Study|Withdrawal by Subject|0|||
164611982|NCT01855945|594599658|FG002|Overall Study|Withdrawal by Subject|4|||
164611983|NCT01855945|594599659|FG003|Overall Study|Withdrawal by Subject|1|||
164611984|NCT01855945|594599660|FG004|Overall Study|Withdrawal by Subject|1|||
164611985|NCT01855945|594599661|FG005|Overall Study|Withdrawal by Subject|0|||
164611986|NCT01855945|594599662|FG006|Overall Study|Withdrawal by Subject|1|||
164611987|NCT01855945|594599663|FG007|Overall Study|Withdrawal by Subject|0|||
164611988|NCT01855945|594599664|FG008|Overall Study|Withdrawal by Subject|0|||
164611989|NCT01855945|594599665|FG009|Overall Study|Withdrawal by Subject|2|||
164611990|NCT01855945|594599666|FG010|Overall Study|Withdrawal by Subject|4|||
164611991|NCT01855945|594599667|FG011|Overall Study|Withdrawal by Subject|1|||
164611992|NCT00770224|594599675|FG000|Step 1: Induction|Adverse Event|3|||
164611993|NCT00770224|594599676|FG001|Step 1: Induction|Adverse Event|0|||
164611994|NCT00770224|594599675|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
164611995|NCT00770224|594599676|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
164611996|NCT00770224|594599675|FG000|Step 1: Induction|Other reason not protocol specified|2|||
164611997|NCT00770224|594599676|FG001|Step 1: Induction|Other reason not protocol specified|0|||
164611998|NCT00770224|594599675|FG000|Step 1: Induction|Ineligible|2|||
164611999|NCT00770224|594599676|FG001|Step 1: Induction|Ineligible|0|||
164612000|NCT00770224|594599675|FG000|Step 1: Induction|No protocol treatment given|1|||
164612001|NCT00770224|594599676|FG001|Step 1: Induction|No protocol treatment given|0|||
164612002|NCT00770224|594599675|FG000|Step 2: Maintenance|Adverse Event|0|||
164612003|NCT00770224|594599676|FG001|Step 2: Maintenance|Adverse Event|10|||
164612004|NCT00770224|594599675|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
164612005|NCT00770224|594599676|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
164612006|NCT00770224|594599675|FG000|Step 2: Maintenance|Progression/relapse|0|||
164612007|NCT00770224|594599676|FG001|Step 2: Maintenance|Progression/relapse|1|||
164612008|NCT00770224|594599675|FG000|Step 2: Maintenance|Death|0|||
164612009|NCT00770224|594599676|FG001|Step 2: Maintenance|Death|2|||
164612010|NCT00770224|594599675|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
164612011|NCT00770224|594599676|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
164612012|NCT00770224|594599675|FG000|Step 2: Maintenance|Ineligible|0|||
164612013|NCT00770224|594599676|FG001|Step 2: Maintenance|Ineligible|2|||
164612014|NCT02260388|594599679|FG000|Overall Study|Lost to Follow-up|2|||
164612015|NCT02260388|594599680|FG001|Overall Study|Lost to Follow-up|8|||
164612016|NCT02260388|594599681|FG002|Overall Study|Lost to Follow-up|3|||
164612017|NCT02260388|594599682|FG003|Overall Study|Lost to Follow-up|4|||
164612018|NCT00126672|594599683|FG000|Overall Study|Adverse Event|4|||
164612019|NCT00126672|594599683|FG000|Overall Study|Lost to Follow-up|4|||
164612020|NCT00753623|594599685|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
164612021|NCT00753623|594599686|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
164612022|NCT00753623|594599685|FG000|Phase I (14 Days)|Physician Decision|1|||
164612023|NCT00753623|594599686|FG001|Phase I (14 Days)|Physician Decision|2|||
164612024|NCT00753623|594599685|FG000|Phase I (14 Days)|Adverse Event|0|||
164612025|NCT00753623|594599686|FG001|Phase I (14 Days)|Adverse Event|1|||
164612026|NCT00753623|594599685|FG000|Washout (7 Days)|Physician Decision|1|||
164612027|NCT00753623|594599686|FG001|Washout (7 Days)|Physician Decision|0|||
164612028|NCT00753623|594599685|FG000|Phase II (14 Days)|Physician Decision|0|||
164612029|NCT00753623|594599686|FG001|Phase II (14 Days)|Physician Decision|1|||
164612030|NCT03332303|594599687|FG000|Overall Study|Participant did not dose|1|||
164612031|NCT03332303|594599688|FG001|Overall Study|Participant did not dose|2|||
164612032|NCT03332303|594599689|FG002|Overall Study|Participant did not dose|0|||
164612033|NCT03332303|594599687|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
164612034|NCT03332303|594599688|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
164612035|NCT03332303|594599689|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
164612036|NCT03332303|594599687|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
164612037|NCT03332303|594599688|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
164612038|NCT03332303|594599689|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
164612039|NCT03332303|594599687|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
164612040|NCT03332303|594599688|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
164612041|NCT03332303|594599689|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
164612042|NCT03332303|594599687|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
164612043|NCT03332303|594599688|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
164612044|NCT03332303|594599689|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
164612045|NCT03332303|594599687|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
164612046|NCT03332303|594599688|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
164612047|NCT03332303|594599689|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
164612048|NCT03332303|594599687|FG000|Overall Study|Participant had a significant protocol deviation|0|||
164612049|NCT03332303|594599688|FG001|Overall Study|Participant had a significant protocol deviation|1|||
164612050|NCT03332303|594599689|FG002|Overall Study|Participant had a significant protocol deviation|0|||
164612051|NCT01296698|594599690|FG000|Overall Study|Adverse Event|1|||
164612052|NCT01296698|594599691|FG001|Overall Study|Adverse Event|0|||
164612053|NCT01296698|594599690|FG000|Overall Study|Death|1|||
164612054|NCT01296698|594599691|FG001|Overall Study|Death|0|||
164612055|NCT01296698|594599690|FG000|Overall Study|Lost to Follow-up|19|||
164612056|NCT01296698|594599691|FG001|Overall Study|Lost to Follow-up|1|||
164612057|NCT01296698|594599690|FG000|Overall Study|Withdrawal by Subject|12|||
164612058|NCT01296698|594599691|FG001|Overall Study|Withdrawal by Subject|0|||
164612059|NCT01296698|594599690|FG000|Overall Study|Difficulty Contacting Subject|2|||
164612060|NCT01296698|594599691|FG001|Overall Study|Difficulty Contacting Subject|0|||
164612061|NCT01296698|594599690|FG000|Overall Study|Study Terminated by Sponsor|209|||
164612062|NCT01296698|594599691|FG001|Overall Study|Study Terminated by Sponsor|12|||
164612063|NCT03495817|594599693|FG000|26 Week Open Label|Adverse Event|3|||
164612064|NCT03495817|594599693|FG000|26 Week Open Label|Withdrawal by Subject|4|||
164612065|NCT03495817|594599693|FG000|26 Week Open Label|Lost to Follow-up|1|||
164612066|NCT03495817|594599693|FG000|26 Week Extension|Lost to Follow-up|2|||
164612067|NCT01957787|594599694|FG000|Overall Study|Death|18|||
164612068|NCT01957787|594599694|FG000|Overall Study|Lost to Follow-up|3|||
164612069|NCT01957787|594599694|FG000|Overall Study|Withdrawal by Subject|3|||
164612070|NCT01957787|594599694|FG000|Overall Study|Entered Hospice or Similar Program|2|||
164147140|NCT02466685|592899988|FG001|Overall Study|Lost to Follow-up|1|||
164515616|NCT06926673|594257519|FG001|Overall Study|Withdrawal by Subject|3|||
164515617|NCT06926673|594257520|FG002|Overall Study|Withdrawal by Subject|2|||
164515618|NCT06926673|594257521|FG003|Overall Study|Withdrawal by Subject|1|||
164515619|NCT06926673|594257522|FG004|Overall Study|Withdrawal by Subject|0|||
164515620|NCT06926673|594257523|FG005|Overall Study|Withdrawal by Subject|2|||
164515621|NCT06926673|594257524|FG006|Overall Study|Withdrawal by Subject|0|||
164515622|NCT03345576|594257527|FG000|Overall Study|Withdrawal by Subject|2|||
164515623|NCT03345576|594257528|FG001|Overall Study|Withdrawal by Subject|2|||
164515624|NCT03345576|594257527|FG000|Overall Study|Adverse Event|1|||
164515625|NCT03345576|594257528|FG001|Overall Study|Adverse Event|0|||
164515626|NCT05718466|594259061|FG000|Overall Study|Withdrawal by Subject|1|||
164515627|NCT05718466|594259062|FG001|Overall Study|Withdrawal by Subject|2|||
164515628|NCT05718466|594259061|FG000|Overall Study|Death|0|||
164515629|NCT05718466|594259062|FG001|Overall Study|Death|1|||
164515630|NCT01967147|594259063|FG000|Overall Study|Adverse Event|5|||
164515631|NCT01967147|594259064|FG001|Overall Study|Adverse Event|2|||
164515632|NCT01967147|594259063|FG000|Overall Study|Lack of Efficacy|1|||
164515633|NCT01967147|594259064|FG001|Overall Study|Lack of Efficacy|4|||
164515634|NCT01967147|594259063|FG000|Overall Study|Lost to Follow-up|1|||
164515635|NCT01967147|594259064|FG001|Overall Study|Lost to Follow-up|2|||
164515636|NCT01967147|594259063|FG000|Overall Study|Withdrawal by Subject|2|||
164515637|NCT01967147|594259064|FG001|Overall Study|Withdrawal by Subject|4|||
164515638|NCT01967147|594259063|FG000|Overall Study|Non-compliance with Study Drug|0|||
164515639|NCT01967147|594259064|FG001|Overall Study|Non-compliance with Study Drug|3|||
164515640|NCT01967147|594259063|FG000|Overall Study|Other|4|||
164515641|NCT01967147|594259064|FG001|Overall Study|Other|5|||
164515642|NCT01253135|594259067|FG000|Original Protocol|Protocol Amendment|15|||
164515643|NCT01253135|594259067|FG000|Amended Protocol|Non-compliance|1|||
164515644|NCT00833261|594259068|FG000|Overall Study|Withdrawal by Subject|4|||
164515645|NCT00264303|594259078|FG000|Overall Study|Adverse Event|4|||
164515646|NCT00264303|594259079|FG001|Overall Study|Adverse Event|3|||
164515647|NCT00264303|594259078|FG000|Overall Study|Lack of Efficacy|10|||
164515648|NCT00264303|594259079|FG001|Overall Study|Lack of Efficacy|13|||
164515649|NCT00264303|594259078|FG000|Overall Study|Lost to Follow-up|3|||
164515650|NCT00264303|594259079|FG001|Overall Study|Lost to Follow-up|3|||
164515651|NCT00264303|594259078|FG000|Overall Study|Withdrawal by Subject|2|||
164515652|NCT00264303|594259079|FG001|Overall Study|Withdrawal by Subject|3|||
164515653|NCT00264303|594259078|FG000|Overall Study|Various reasons listed in study report|6|||
164515654|NCT00264303|594259079|FG001|Overall Study|Various reasons listed in study report|7|||
164515655|NCT02815579|594259080|FG000|Overall Study|Non-payment of loan down-payment|16|||
164515656|NCT02815579|594259081|FG001|Overall Study|Non-payment of loan down-payment|0|||
164515657|NCT02815579|594259080|FG000|Overall Study|Withdrawal by Subject|7|||
164515658|NCT02815579|594259081|FG001|Overall Study|Withdrawal by Subject|1|||
164515659|NCT02815579|594259080|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
164515660|NCT02815579|594259081|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
164515661|NCT02815579|594259080|FG000|Overall Study|Lost to Follow-up|7|||
164515662|NCT02815579|594259081|FG001|Overall Study|Lost to Follow-up|4|||
164515663|NCT02815579|594259080|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
164515664|NCT02815579|594259081|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
164515665|NCT02815579|594259080|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
164515666|NCT02815579|594259081|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
164515667|NCT02815579|594259080|FG000|Overall Study|Death|5|||
164515668|NCT02815579|594259081|FG001|Overall Study|Death|4|||
164515669|NCT02815579|594259080|FG000|Overall Study|Imprisoned|0|||
164515670|NCT02815579|594259081|FG001|Overall Study|Imprisoned|2|||
164515671|NCT02815579|594259080|FG000|Overall Study|Did not meet enrollment criteria|0|||
164515672|NCT02815579|594259081|FG001|Overall Study|Did not meet enrollment criteria|1|||
164515673|NCT02389452|594259082|FG000|Overall Study|Lost to Follow-up|13|||
164515674|NCT02389452|594259082|FG000|Overall Study|Adverse Event|1|||
164515675|NCT02389452|594259082|FG000|Overall Study|Withdrawal by Subject|5|||
164515676|NCT02389452|594259082|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
164515677|NCT02311673|594259083|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
164515678|NCT02311673|594259084|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
164515679|NCT02311673|594259085|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
164515680|NCT02311673|594259086|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
164515681|NCT00414908|594259089|FG000|Overall Study|Protocol Violation|1|||
164515682|NCT00414908|594259090|FG001|Overall Study|Protocol Violation|1|||
164515683|NCT01076153|594259091|FG000|Overall Study|Symptoms improved/resolved|10|||
164515684|NCT01076153|594259091|FG000|Overall Study|Adverse Event|1|||
164515685|NCT04165031|594259092|FG000|Overall Study|Adverse Event|1|||
164515686|NCT04165031|594259093|FG001|Overall Study|Adverse Event|1|||
164515687|NCT04165031|594259094|FG002|Overall Study|Adverse Event|0|||
164515688|NCT04165031|594259095|FG003|Overall Study|Adverse Event|0|||
164515689|NCT04165031|594259096|FG004|Overall Study|Adverse Event|0|||
164515690|NCT04165031|594259097|FG005|Overall Study|Adverse Event|0|||
164515691|NCT04165031|594259092|FG000|Overall Study|Withdrawal by Subject|0|||
164515692|NCT04165031|594259093|FG001|Overall Study|Withdrawal by Subject|0|||
164515693|NCT04165031|594259094|FG002|Overall Study|Withdrawal by Subject|1|||
164515694|NCT04165031|594259095|FG003|Overall Study|Withdrawal by Subject|0|||
164515695|NCT04165031|594259096|FG004|Overall Study|Withdrawal by Subject|0|||
164515696|NCT04165031|594259097|FG005|Overall Study|Withdrawal by Subject|0|||
164515697|NCT01977677|594259098|FG000|Overall Study|Unrelated Adverse Event|0|||
164515698|NCT01977677|594259099|FG001|Overall Study|Unrelated Adverse Event|0|||
164515699|NCT01977677|594259100|FG002|Overall Study|Unrelated Adverse Event|1|||
164515700|NCT01498887|594259101|FG000|Overall Study|Administrative problems|1|||
164515701|NCT01498887|594259102|FG001|Overall Study|Administrative problems|0|||
164515702|NCT01498887|594259101|FG000|Overall Study|Lost to Follow-up|1|||
164515703|NCT01498887|594259102|FG001|Overall Study|Lost to Follow-up|1|||
164515704|NCT01498887|594259101|FG000|Overall Study|Withdrawal by Subject|1|||
164515705|NCT01498887|594259102|FG001|Overall Study|Withdrawal by Subject|0|||
164515706|NCT01498887|594259101|FG000|Overall Study|Protocol Violation|1|||
164515707|NCT01498887|594259102|FG001|Overall Study|Protocol Violation|3|||
164515708|NCT01498887|594259101|FG000|Overall Study|Lack of Efficacy|5|||
164515709|NCT01498887|594259102|FG001|Overall Study|Lack of Efficacy|3|||
164515710|NCT01498887|594259101|FG000|Overall Study|Abnormal result from test procedure|1|||
164515711|NCT01498887|594259102|FG001|Overall Study|Abnormal result from test procedure|1|||
164515712|NCT01498887|594259101|FG000|Overall Study|Abnormal laboratory value|2|||
164515713|NCT01498887|594259102|FG001|Overall Study|Abnormal laboratory value|2|||
164515714|NCT01498887|594259101|FG000|Overall Study|Adverse Event|4|||
164515715|NCT01498887|594259102|FG001|Overall Study|Adverse Event|1|||
164515716|NCT00667225|594259107|FG000|Overall Study|Subject had no more lesions to treat.|1|||
164515717|NCT00667225|594259108|FG001|Overall Study|Subject had no more lesions to treat.|0|||
164515718|NCT00667225|594259107|FG000|Overall Study|Lost to Follow-up|0|||
164515719|NCT00667225|594259108|FG001|Overall Study|Lost to Follow-up|1|||
164515720|NCT02993406|594259113|FG000|Overall Study|Withdrawal by Subject|170|||
164515721|NCT02993406|594259114|FG001|Overall Study|Withdrawal by Subject|196|||
164515722|NCT02993406|594259113|FG000|Overall Study|Physician Decision|3|||
164515723|NCT02993406|594259114|FG001|Overall Study|Physician Decision|5|||
164515724|NCT02993406|594259113|FG000|Overall Study|Lost to Follow-up|12|||
164515725|NCT02993406|594259114|FG001|Overall Study|Lost to Follow-up|13|||
164515726|NCT02993406|594259113|FG000|Overall Study|Unclassifiable Response|105|||
164515727|NCT02993406|594259114|FG001|Overall Study|Unclassifiable Response|139|||
164515728|NCT02993406|594259113|FG000|Overall Study|Administrative decision|1|||
164515729|NCT02993406|594259114|FG001|Overall Study|Administrative decision|0|||
164515730|NCT02993406|594259113|FG000|Overall Study|Sponsor decision|4|||
164515731|NCT02993406|594259114|FG001|Overall Study|Sponsor decision|5|||
164515732|NCT03563157|594259115|FG000|Overall Study|Progressive Disease|2|||
164515733|NCT02248818|594259116|FG000|Screening|Protocol Violation|0|||
164515734|NCT02248818|594259117|FG001|Screening|Protocol Violation|0|||
164515735|NCT02248818|594259118|FG002|Screening|Protocol Violation|0|||
164515736|NCT02248818|594259119|FG003|Screening|Protocol Violation|0|||
164515737|NCT02248818|594259120|FG004|Screening|Protocol Violation|0|||
164515738|NCT02248818|594259121|FG005|Screening|Protocol Violation|0|||
164515739|NCT02248818|594259122|FG006|Screening|Protocol Violation|0|||
164515740|NCT02248818|594259123|FG007|Screening|Protocol Violation|0|||
164515741|NCT02248818|594259124|FG008|Screening|Protocol Violation|7|||
164515742|NCT02248818|594259116|FG000|Screening|Study fully enrolled|0|||
164515743|NCT02248818|594259117|FG001|Screening|Study fully enrolled|0|||
164515744|NCT02248818|594259118|FG002|Screening|Study fully enrolled|0|||
164515745|NCT02248818|594259119|FG003|Screening|Study fully enrolled|0|||
164515746|NCT02248818|594259120|FG004|Screening|Study fully enrolled|0|||
164515747|NCT02248818|594259121|FG005|Screening|Study fully enrolled|0|||
164515748|NCT02248818|594259122|FG006|Screening|Study fully enrolled|0|||
164515749|NCT02248818|594259123|FG007|Screening|Study fully enrolled|0|||
164515750|NCT02248818|594259124|FG008|Screening|Study fully enrolled|14|||
164515751|NCT02248818|594259116|FG000|Screening|Physician Decision|0|||
164515752|NCT02248818|594259117|FG001|Screening|Physician Decision|0|||
164515753|NCT02248818|594259118|FG002|Screening|Physician Decision|0|||
164515754|NCT02248818|594259119|FG003|Screening|Physician Decision|0|||
164515755|NCT02248818|594259120|FG004|Screening|Physician Decision|0|||
164515756|NCT02248818|594259121|FG005|Screening|Physician Decision|0|||
164515757|NCT02248818|594259122|FG006|Screening|Physician Decision|0|||
164515758|NCT02248818|594259123|FG007|Screening|Physician Decision|0|||
164515759|NCT02248818|594259124|FG008|Screening|Physician Decision|73|||
164515760|NCT02248818|594259116|FG000|Screening|Withdrawal by Subject|0|||
164515761|NCT02248818|594259117|FG001|Screening|Withdrawal by Subject|0|||
164515762|NCT02248818|594259118|FG002|Screening|Withdrawal by Subject|0|||
164515763|NCT02248818|594259119|FG003|Screening|Withdrawal by Subject|0|||
164515764|NCT02248818|594259120|FG004|Screening|Withdrawal by Subject|0|||
164515765|NCT02248818|594259121|FG005|Screening|Withdrawal by Subject|0|||
164515766|NCT02248818|594259122|FG006|Screening|Withdrawal by Subject|0|||
164515767|NCT02248818|594259123|FG007|Screening|Withdrawal by Subject|0|||
164515768|NCT02248818|594259124|FG008|Screening|Withdrawal by Subject|6|||
164515769|NCT02248818|594259116|FG000|Screening|Lost to Follow-up|0|||
164515770|NCT02248818|594259117|FG001|Screening|Lost to Follow-up|0|||
164515771|NCT02248818|594259118|FG002|Screening|Lost to Follow-up|0|||
164515772|NCT02248818|594259119|FG003|Screening|Lost to Follow-up|0|||
164515773|NCT02248818|594259120|FG004|Screening|Lost to Follow-up|0|||
164515774|NCT02248818|594259121|FG005|Screening|Lost to Follow-up|0|||
164515775|NCT02248818|594259122|FG006|Screening|Lost to Follow-up|0|||
164515776|NCT02248818|594259123|FG007|Screening|Lost to Follow-up|0|||
164515777|NCT02248818|594259124|FG008|Screening|Lost to Follow-up|7|||
164515778|NCT02248818|594259116|FG000|Randomised Study|Administrative - randomization error|0|||
164612071|NCT01957787|594599694|FG000|Overall Study|Index Tumor(s) Resected|2|||
164612072|NCT01957787|594599694|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
164612073|NCT01957787|594599694|FG000|Overall Study|Local therapy, not cryoablation|6|||
164612074|NCT04294095|594599701|FG000|Overall Study|Adverse Event|1|||
164612075|NCT04294095|594599702|FG001|Overall Study|Adverse Event|0|||
164612076|NCT00260429|594599707|FG000|Overall Study|failure to follow appointments|1|||
164612077|NCT00260429|594599708|FG001|Overall Study|failure to follow appointments|0|||
164612078|NCT00260429|594599707|FG000|Overall Study|scheduled hand surgery|1|||
164612079|NCT00260429|594599708|FG001|Overall Study|scheduled hand surgery|0|||
164612080|NCT00659126|594599709|FG000|Overall Study|Adverse Event|2|||
164612081|NCT00659126|594599710|FG001|Overall Study|Adverse Event|2|||
164612082|NCT00659126|594599709|FG000|Overall Study|Screen failure|1|||
164612083|NCT00659126|594599710|FG001|Overall Study|Screen failure|1|||
164612084|NCT00659126|594599709|FG000|Overall Study|Technical problems with MRI|0|||
164515779|NCT02248818|594259117|FG001|Randomised Study|Administrative - randomization error|0|||
164515780|NCT02248818|594259118|FG002|Randomised Study|Administrative - randomization error|0|||
164515781|NCT02248818|594259119|FG003|Randomised Study|Administrative - randomization error|0|||
164515782|NCT02248818|594259120|FG004|Randomised Study|Administrative - randomization error|0|||
164612085|NCT00659126|594599710|FG001|Overall Study|Technical problems with MRI|1|||
164612086|NCT02762708|594599714|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
164612087|NCT02762708|594599715|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
164612088|NCT02762708|594599716|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
164612089|NCT02762708|594599717|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
164612090|NCT00631540|594599718|FG000|Overall Study|Withdrawal by Subject|5|||
164612091|NCT00631540|594599718|FG000|Overall Study|Death|4|||
164515783|NCT02248818|594259121|FG005|Randomised Study|Administrative - randomization error|8|||
164515784|NCT02248818|594259122|FG006|Randomised Study|Administrative - randomization error|0|||
164515785|NCT02248818|594259123|FG007|Randomised Study|Administrative - randomization error|0|||
164515786|NCT02248818|594259124|FG008|Randomised Study|Administrative - randomization error|0|||
164515787|NCT04079868|594259125|FG000|Overall Study|Lost to Follow-up|100|||
164515788|NCT04079868|594259126|FG001|Overall Study|Lost to Follow-up|200|||
164515789|NCT04079868|594259125|FG000|Overall Study|Physician Decision|100|||
164515790|NCT04079868|594259126|FG001|Overall Study|Physician Decision|0|||
164515791|NCT02942277|594259129|FG000|Year 1|Withdrawal by Subject|0|||
164515792|NCT02942277|594259130|FG001|Year 1|Withdrawal by Subject|0|||
164515793|NCT02942277|594259131|FG002|Year 1|Withdrawal by Subject|0|||
164515794|NCT02942277|594259132|FG003|Year 1|Withdrawal by Subject|0|||
164515795|NCT02942277|594259133|FG004|Year 1|Withdrawal by Subject|1|||
164515796|NCT02942277|594259134|FG005|Year 1|Withdrawal by Subject|3|||
164515797|NCT02942277|594259135|FG006|Year 1|Withdrawal by Subject|0|||
164515798|NCT02942277|594259136|FG007|Year 1|Withdrawal by Subject|1|||
164515799|NCT02942277|594259137|FG008|Year 1|Withdrawal by Subject|0|||
164515800|NCT02942277|594259138|FG009|Year 1|Withdrawal by Subject|0|||
164515801|NCT02942277|594259139|FG010|Year 1|Withdrawal by Subject|3|||
164515802|NCT02942277|594259129|FG000|Year 1|Travel|0|||
164515803|NCT02942277|594259130|FG001|Year 1|Travel|1|||
164515804|NCT02942277|594259131|FG002|Year 1|Travel|0|||
164515805|NCT02942277|594259132|FG003|Year 1|Travel|0|||
164612092|NCT00631540|594599718|FG000|Overall Study|Lost to Follow-up|2|||
164612093|NCT00631540|594599718|FG000|Overall Study|Core Lab Data Unavailable|3|||
164515806|NCT02942277|594259133|FG004|Year 1|Travel|4|||
164515807|NCT02942277|594259134|FG005|Year 1|Travel|5|||
164515808|NCT02942277|594259135|FG006|Year 1|Travel|0|||
164515809|NCT02942277|594259136|FG007|Year 1|Travel|0|||
164515810|NCT02942277|594259137|FG008|Year 1|Travel|0|||
164515811|NCT02942277|594259138|FG009|Year 1|Travel|0|||
164612094|NCT00970268|594599719|FG000|Overall Study|Withdrawal by Subject|12|||
164612095|NCT00970268|594599720|FG001|Overall Study|Withdrawal by Subject|19|||
164612096|NCT00970268|594599719|FG000|Overall Study|Adverse Event|15|||
164612097|NCT00970268|594599720|FG001|Overall Study|Adverse Event|12|||
164612098|NCT00970268|594599719|FG000|Overall Study|Lack of Efficacy|3|||
164612099|NCT00970268|594599720|FG001|Overall Study|Lack of Efficacy|6|||
164612100|NCT00970268|594599719|FG000|Overall Study|Protocol Violation|4|||
164612101|NCT00970268|594599720|FG001|Overall Study|Protocol Violation|7|||
164612102|NCT00970268|594599719|FG000|Overall Study|Other Reason|3|||
164612103|NCT00970268|594599720|FG001|Overall Study|Other Reason|1|||
164612104|NCT00970268|594599719|FG000|Overall Study|COPD Exacerbation|4|||
164612105|NCT00970268|594599720|FG001|Overall Study|COPD Exacerbation|2|||
164612106|NCT00970268|594599719|FG000|Overall Study|Lost to Follow-up|1|||
164612107|NCT00970268|594599720|FG001|Overall Study|Lost to Follow-up|2|||
164612108|NCT00970268|594599719|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
164612109|NCT00970268|594599720|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
164612110|NCT01999946|594599721|FG000|Overall Study|Participant not released from jail|2|||
164612111|NCT01999946|594599722|FG001|Overall Study|Participant not released from jail|2|||
164612112|NCT01999946|594599723|FG002|Overall Study|Participant not released from jail|0|||
164612113|NCT01999946|594599721|FG000|Overall Study|Not included in primary outcome analysis|0|||
164612114|NCT01999946|594599722|FG001|Overall Study|Not included in primary outcome analysis|0|||
164612115|NCT01999946|594599723|FG002|Overall Study|Not included in primary outcome analysis|79|||
164612116|NCT00719953|594599724|FG000|Overall Study|Adverse Event|4|||
164612117|NCT03726333|594599730|FG000|Overall Study|Progressive Disease|0|||
164612118|NCT03726333|594599731|FG001|Overall Study|Progressive Disease|0|||
164612119|NCT03726333|594599732|FG002|Overall Study|Progressive Disease|1|||
164612120|NCT03726333|594599733|FG003|Overall Study|Progressive Disease|0|||
164612121|NCT03726333|594599734|FG004|Overall Study|Progressive Disease|0|||
164612122|NCT03906136|594602265|FG000|Overall Study|Adverse Event|1|||
164612123|NCT03906136|594602266|FG001|Overall Study|Adverse Event|0|||
164612124|NCT03906136|594602265|FG000|Overall Study|Lost to Follow-up|7|||
164612125|NCT03906136|594602266|FG001|Overall Study|Lost to Follow-up|4|||
164612126|NCT03906136|594602265|FG000|Overall Study|Physician Decision|1|||
164612127|NCT03906136|594602266|FG001|Overall Study|Physician Decision|0|||
164612128|NCT03906136|594602265|FG000|Overall Study|Withdrawal by Subject|3|||
164612129|NCT03906136|594602266|FG001|Overall Study|Withdrawal by Subject|7|||
164612130|NCT01696396|594602269|FG000|Overall Study|Withdrawal by Subject|19|||
164612131|NCT01696396|594602270|FG001|Overall Study|Withdrawal by Subject|5|||
164612132|NCT01696396|594602271|FG002|Overall Study|Withdrawal by Subject|19|||
164612133|NCT01696396|594602272|FG003|Overall Study|Withdrawal by Subject|11|||
164612134|NCT01696396|594602269|FG000|Overall Study|Decision by Sponsor|3|||
164612135|NCT01696396|594602270|FG001|Overall Study|Decision by Sponsor|1|||
164612136|NCT01696396|594602271|FG002|Overall Study|Decision by Sponsor|2|||
164612137|NCT01696396|594602272|FG003|Overall Study|Decision by Sponsor|2|||
164612138|NCT01696396|594602269|FG000|Overall Study|Lost to Follow-up|9|||
164612139|NCT01696396|594602270|FG001|Overall Study|Lost to Follow-up|1|||
164612140|NCT01696396|594602271|FG002|Overall Study|Lost to Follow-up|4|||
164612141|NCT01696396|594602272|FG003|Overall Study|Lost to Follow-up|1|||
164612142|NCT01696396|594602269|FG000|Overall Study|Death|0|||
164612143|NCT01696396|594602270|FG001|Overall Study|Death|0|||
164612144|NCT01696396|594602271|FG002|Overall Study|Death|1|||
164612145|NCT01696396|594602272|FG003|Overall Study|Death|0|||
164612146|NCT02371980|594602278|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
164612147|NCT02371980|594602279|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
164612148|NCT02371980|594602280|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
164612149|NCT02371980|594602281|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
164612150|NCT02371980|594602282|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
164612151|NCT02371980|594602278|FG000|Open-label Period|Significant Protocol Deviation|19|||
164612152|NCT02371980|594602279|FG001|Open-label Period|Significant Protocol Deviation|0|||
164612153|NCT02371980|594602280|FG002|Open-label Period|Significant Protocol Deviation|0|||
164612154|NCT02371980|594602281|FG003|Open-label Period|Significant Protocol Deviation|0|||
164612155|NCT02371980|594602282|FG004|Open-label Period|Significant Protocol Deviation|0|||
164612156|NCT02371980|594602278|FG000|Open-label Period|Noncompliance with Study Drug|10|||
164612157|NCT02371980|594602279|FG001|Open-label Period|Noncompliance with Study Drug|0|||
164612158|NCT02371980|594602280|FG002|Open-label Period|Noncompliance with Study Drug|0|||
164612159|NCT02371980|594602281|FG003|Open-label Period|Noncompliance with Study Drug|0|||
164612160|NCT02371980|594602282|FG004|Open-label Period|Noncompliance with Study Drug|0|||
164612161|NCT02371980|594602278|FG000|Open-label Period|Lost to Follow-up|55|||
164612162|NCT02371980|594602279|FG001|Open-label Period|Lost to Follow-up|0|||
164612163|NCT02371980|594602280|FG002|Open-label Period|Lost to Follow-up|0|||
164612164|NCT02371980|594602281|FG003|Open-label Period|Lost to Follow-up|0|||
164612165|NCT02371980|594602282|FG004|Open-label Period|Lost to Follow-up|0|||
164612166|NCT02371980|594602278|FG000|Open-label Period|Voluntary Withdrawal|91|||
164612167|NCT02371980|594602279|FG001|Open-label Period|Voluntary Withdrawal|0|||
164612168|NCT02371980|594602280|FG002|Open-label Period|Voluntary Withdrawal|0|||
164612169|NCT02371980|594602281|FG003|Open-label Period|Voluntary Withdrawal|0|||
164612170|NCT02371980|594602282|FG004|Open-label Period|Voluntary Withdrawal|0|||
164612171|NCT02371980|594602278|FG000|Open-label Period|Pregnancy|1|||
164612172|NCT02371980|594602279|FG001|Open-label Period|Pregnancy|0|||
164612173|NCT02371980|594602280|FG002|Open-label Period|Pregnancy|0|||
164612174|NCT02371980|594602281|FG003|Open-label Period|Pregnancy|0|||
164612175|NCT02371980|594602282|FG004|Open-label Period|Pregnancy|0|||
164612176|NCT02371980|594602278|FG000|Open-label Period|Lack of Efficacy|116|||
164612177|NCT02371980|594602279|FG001|Open-label Period|Lack of Efficacy|0|||
164612178|NCT02371980|594602280|FG002|Open-label Period|Lack of Efficacy|0|||
164612179|NCT02371980|594602281|FG003|Open-label Period|Lack of Efficacy|0|||
164612180|NCT02371980|594602282|FG004|Open-label Period|Lack of Efficacy|0|||
164612181|NCT02371980|594602278|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
164612182|NCT02371980|594602279|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
164612183|NCT02371980|594602280|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
164612184|NCT02371980|594602281|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
164612185|NCT02371980|594602282|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
164612186|NCT02371980|594602278|FG000|Open-label Period|Reason not Specified|9|||
164147371|NCT05168202|592902026|FG002|Overall Study|Adverse Event|4|||
164612187|NCT02371980|594602279|FG001|Open-label Period|Reason not Specified|0|||
164612188|NCT02371980|594602280|FG002|Open-label Period|Reason not Specified|0|||
164612189|NCT02371980|594602281|FG003|Open-label Period|Reason not Specified|0|||
164612190|NCT02371980|594602282|FG004|Open-label Period|Reason not Specified|0|||
164612191|NCT02371980|594602278|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
164612192|NCT02371980|594602279|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
164612193|NCT02371980|594602280|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
164612194|NCT02371980|594602281|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
164612195|NCT02371980|594602282|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
164612196|NCT02371980|594602278|FG000|Double-blind Period|Significant Protocol Deviation|0|||
164612197|NCT02371980|594602279|FG001|Double-blind Period|Significant Protocol Deviation|2|||
164612198|NCT02371980|594602280|FG002|Double-blind Period|Significant Protocol Deviation|7|||
164612199|NCT02371980|594602281|FG003|Double-blind Period|Significant Protocol Deviation|3|||
164612200|NCT02371980|594602282|FG004|Double-blind Period|Significant Protocol Deviation|3|||
164612201|NCT02371980|594602278|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
164612202|NCT02371980|594602279|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
164612203|NCT02371980|594602280|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
164612204|NCT02371980|594602281|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
164612205|NCT02371980|594602282|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
164612206|NCT02371980|594602278|FG000|Double-blind Period|Lost to Follow-up|0|||
164612207|NCT02371980|594602279|FG001|Double-blind Period|Lost to Follow-up|8|||
164612208|NCT02371980|594602280|FG002|Double-blind Period|Lost to Follow-up|8|||
164612209|NCT02371980|594602281|FG003|Double-blind Period|Lost to Follow-up|6|||
164612210|NCT02371980|594602282|FG004|Double-blind Period|Lost to Follow-up|5|||
164612211|NCT02371980|594602278|FG000|Double-blind Period|Voluntary Withdrawal|0|||
164612212|NCT02371980|594602279|FG001|Double-blind Period|Voluntary Withdrawal|12|||
164612213|NCT02371980|594602280|FG002|Double-blind Period|Voluntary Withdrawal|8|||
164612214|NCT02371980|594602281|FG003|Double-blind Period|Voluntary Withdrawal|9|||
164612215|NCT02371980|594602282|FG004|Double-blind Period|Voluntary Withdrawal|11|||
164612216|NCT02371980|594602278|FG000|Double-blind Period|Relapse|0|||
164612217|NCT02371980|594602279|FG001|Double-blind Period|Relapse|50|||
164612218|NCT02371980|594602280|FG002|Double-blind Period|Relapse|25|||
164612219|NCT02371980|594602281|FG003|Double-blind Period|Relapse|25|||
164612220|NCT02371980|594602282|FG004|Double-blind Period|Relapse|26|||
164612221|NCT02371980|594602278|FG000|Double-blind Period|Reason not Specified|0|||
164612222|NCT02371980|594602279|FG001|Double-blind Period|Reason not Specified|3|||
164612223|NCT02371980|594602280|FG002|Double-blind Period|Reason not Specified|3|||
164612224|NCT02371980|594602281|FG003|Double-blind Period|Reason not Specified|2|||
164612225|NCT02371980|594602282|FG004|Double-blind Period|Reason not Specified|1|||
164612226|NCT02371980|594602278|FG000|Double-blind Period|Missing|0|||
164612227|NCT02371980|594602279|FG001|Double-blind Period|Missing|1|||
164612228|NCT02371980|594602280|FG002|Double-blind Period|Missing|0|||
164612229|NCT02371980|594602281|FG003|Double-blind Period|Missing|0|||
164612230|NCT02371980|594602282|FG004|Double-blind Period|Missing|0|||
164612231|NCT01280812|594602284|FG000|Overall Study|Withdrawal by Subject|2|||
164612232|NCT01280812|594602285|FG001|Overall Study|Withdrawal by Subject|1|||
164612233|NCT01280812|594602286|FG002|Overall Study|Withdrawal by Subject|0|||
164612234|NCT01280812|594602284|FG000|Overall Study|Lost to Follow-up|1|||
164612235|NCT01280812|594602285|FG001|Overall Study|Lost to Follow-up|1|||
164612236|NCT01280812|594602286|FG002|Overall Study|Lost to Follow-up|1|||
164612237|NCT01594749|594602292|FG000|Overall Study|Adverse Event|2|||
164612238|NCT01594749|594602293|FG001|Overall Study|Adverse Event|1|||
164612239|NCT01594749|594602292|FG000|Overall Study|Withdrawal by Subject|2|||
164612240|NCT01594749|594602293|FG001|Overall Study|Withdrawal by Subject|2|||
164612241|NCT01594749|594602292|FG000|Overall Study|Protocol Violation|2|||
164612242|NCT01594749|594602293|FG001|Overall Study|Protocol Violation|0|||
164612243|NCT01594749|594602292|FG000|Overall Study|Physician Decision|1|||
164612244|NCT01594749|594602293|FG001|Overall Study|Physician Decision|1|||
164612245|NCT01594749|594602292|FG000|Overall Study|Non-compliance with Protocol|0|||
164612246|NCT01594749|594602293|FG001|Overall Study|Non-compliance with Protocol|1|||
164612247|NCT01594749|594602292|FG000|Overall Study|Lost to Follow-up|1|||
164612248|NCT01594749|594602293|FG001|Overall Study|Lost to Follow-up|0|||
164612249|NCT01594749|594602292|FG000|Overall Study|Death|9|||
164612250|NCT01594749|594602293|FG001|Overall Study|Death|3|||
164612251|NCT01594749|594602292|FG000|Overall Study|Not Treated|4|||
164612252|NCT01594749|594602293|FG001|Overall Study|Not Treated|10|||
164612253|NCT01594749|594602292|FG000|Overall Study|Lost Source Documentation|1|||
164612254|NCT01594749|594602293|FG001|Overall Study|Lost Source Documentation|0|||
164612255|NCT00959894|594602294|FG000|Overall Study|Lost to Follow-up|10|||
164612256|NCT00959894|594602294|FG000|Overall Study|Adverse Event|3|||
164612257|NCT00959894|594602294|FG000|Overall Study|Withdrawal by Subject|1|||
164612258|NCT00959894|594602294|FG000|Overall Study|Need for contraindicated medication|1|||
164612259|NCT00959894|594602294|FG000|Overall Study|Subject moved out of town|1|||
164612260|NCT00922974|594602295|FG000|Phase II Component|Protocol Violation|2|||
164612261|NCT00922974|594602296|FG001|Phase II Component|Protocol Violation|0|||
164612262|NCT00922974|594602295|FG000|Phase II Component|Not evaluable for treatment review|5|||
164612263|NCT00922974|594602296|FG001|Phase II Component|Not evaluable for treatment review|0|||
164612264|NCT00922974|594602295|FG000|Phase III Component|Protocol Violation|8|||
164612265|NCT00922974|594602296|FG001|Phase III Component|Protocol Violation|6|||
164612266|NCT01826448|594602297|FG000|Overall Study|Adverse Event|1|||
164612267|NCT01826448|594602298|FG001|Overall Study|Adverse Event|3|||
164612268|NCT01826448|594602297|FG000|Overall Study|Disease progression|2|||
164612269|NCT01826448|594602298|FG001|Overall Study|Disease progression|4|||
164612270|NCT01826448|594602297|FG000|Overall Study|Withdrawal by Subject|1|||
164612271|NCT01826448|594602298|FG001|Overall Study|Withdrawal by Subject|0|||
164612272|NCT01826448|594602297|FG000|Overall Study|Physician Decision|0|||
164612273|NCT01826448|594602298|FG001|Overall Study|Physician Decision|1|||
164612274|NCT01826448|594602297|FG000|Overall Study|2 active cancers|0|||
164612275|NCT01826448|594602298|FG001|Overall Study|2 active cancers|1|||
164612276|NCT02578992|594602300|FG000|Overall Study|equipment not available or malfunction|3|||
164612277|NCT02578992|594602301|FG001|Overall Study|equipment not available or malfunction|3|||
164612278|NCT00880100|594602303|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
164612279|NCT00880100|594602303|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
164612280|NCT00880100|594602303|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
164612281|NCT02038790|594602306|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
164612282|NCT02038790|594602307|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
164612283|NCT02431702|594602309|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
164612284|NCT02431702|594602310|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
164612285|NCT02431702|594602311|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
164612286|NCT02431702|594602312|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
164612287|NCT02431702|594602313|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
164612288|NCT02431702|594602314|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
164612289|NCT02431702|594602315|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
164612290|NCT02431702|594602309|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
164612291|NCT02431702|594602310|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
164612292|NCT02431702|594602311|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
164612293|NCT02431702|594602312|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
164612294|NCT02431702|594602313|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
164612295|NCT02431702|594602314|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
164612296|NCT02431702|594602315|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
164612297|NCT02431702|594602309|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
164612298|NCT02431702|594602310|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
164612299|NCT02431702|594602311|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
164612300|NCT02431702|594602312|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
164612301|NCT02431702|594602313|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
164612302|NCT02431702|594602314|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
164612303|NCT02431702|594602315|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
164612304|NCT02431702|594602309|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
164612305|NCT02431702|594602310|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
164612306|NCT02431702|594602311|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
164612307|NCT02431702|594602312|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
164612308|NCT02431702|594602313|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
164612309|NCT02431702|594602314|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
164612310|NCT02431702|594602315|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
164612311|NCT02431702|594602309|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
164612312|NCT02431702|594602310|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
164612313|NCT02431702|594602311|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
164612314|NCT02431702|594602312|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
164612315|NCT02431702|594602313|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
164612316|NCT02431702|594602314|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
164612317|NCT02431702|594602315|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
164612318|NCT02431702|594602309|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
164612319|NCT02431702|594602310|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
164612320|NCT02431702|594602311|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
164612321|NCT02431702|594602312|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
164612322|NCT02431702|594602313|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
164612323|NCT02431702|594602314|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
164612324|NCT02431702|594602315|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
164612325|NCT02431702|594602309|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
164612326|NCT02431702|594602310|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
164612327|NCT02431702|594602311|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
164612328|NCT02431702|594602312|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
164612329|NCT02431702|594602313|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
164612330|NCT02431702|594602314|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
164612331|NCT02431702|594602315|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
164612332|NCT02431702|594602309|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
164612333|NCT02431702|594602310|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
164612334|NCT02431702|594602311|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
164612335|NCT02431702|594602312|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
164612336|NCT02431702|594602313|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
164612337|NCT02431702|594602314|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
164612338|NCT02431702|594602315|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
164612339|NCT02431702|594602309|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
164612340|NCT02431702|594602310|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
164612341|NCT02431702|594602311|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
164612342|NCT02431702|594602312|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
164612343|NCT02431702|594602313|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
164612344|NCT02431702|594602314|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
164612345|NCT02431702|594602315|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
164612346|NCT02431702|594602309|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
164612347|NCT02431702|594602310|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
164612348|NCT02431702|594602311|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
164612349|NCT02431702|594602312|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
164612350|NCT02431702|594602313|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
164612351|NCT02431702|594602314|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
164612352|NCT02431702|594602315|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
164612353|NCT02431702|594602309|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
164612354|NCT02431702|594602310|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
164612355|NCT02431702|594602311|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
164612356|NCT02431702|594602312|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
164612357|NCT02431702|594602313|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
164612358|NCT02431702|594602314|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
164612359|NCT02431702|594602315|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
164612360|NCT02431702|594602309|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
164612361|NCT02431702|594602310|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
164612362|NCT02431702|594602311|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
164612363|NCT02431702|594602312|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
164612364|NCT02431702|594602313|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
164612365|NCT02431702|594602314|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
164612366|NCT02431702|594602315|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
164612367|NCT02431702|594602309|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
164612368|NCT02431702|594602310|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
164612369|NCT02431702|594602311|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
164612370|NCT02431702|594602312|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
164612371|NCT02431702|594602313|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
164612372|NCT02431702|594602314|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
164612373|NCT02431702|594602315|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
164612374|NCT02431702|594602309|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
164612375|NCT02431702|594602310|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
164612376|NCT02431702|594602311|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
164612377|NCT02431702|594602312|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
164612378|NCT02431702|594602313|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
164612379|NCT02431702|594602314|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
164612380|NCT02431702|594602315|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
164612381|NCT02431702|594602309|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
164612382|NCT02431702|594602310|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
164612383|NCT02431702|594602311|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
164612384|NCT02431702|594602312|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
164612385|NCT02431702|594602313|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
164612386|NCT02431702|594602314|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
164612387|NCT02431702|594602315|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
164612388|NCT01376388|594602325|FG000|Overall Study|Adverse Event|13|||
164612389|NCT01376388|594602325|FG000|Overall Study|Lack of Efficacy|2|||
164612390|NCT01376388|594602325|FG000|Overall Study|Withdrawal by Subject|3|||
164612391|NCT02009930|594602326|FG000|Overall Study|withdrawn|5|||
164612392|NCT03907969|594602330|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
164612393|NCT03907969|594602331|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
164612394|NCT03907969|594602332|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
164612395|NCT03907969|594602333|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
164612396|NCT03907969|594602334|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
164612397|NCT03907969|594602335|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
164612398|NCT03907969|594602336|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
164612399|NCT03907969|594602337|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
164612400|NCT03907969|594602338|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
164612401|NCT03907969|594602339|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
164612402|NCT03907969|594602340|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
164612403|NCT03907969|594602330|FG000|Monotherapy Part A|Progressive Disease|0|||
164612404|NCT03907969|594602331|FG001|Monotherapy Part A|Progressive Disease|1|||
164612405|NCT03907969|594602332|FG002|Monotherapy Part A|Progressive Disease|0|||
164612406|NCT03907969|594602333|FG003|Monotherapy Part A|Progressive Disease|0|||
164612407|NCT03907969|594602334|FG004|Monotherapy Part A|Progressive Disease|0|||
164612408|NCT03907969|594602335|FG005|Monotherapy Part A|Progressive Disease|1|||
164612409|NCT03907969|594602336|FG006|Monotherapy Part A|Progressive Disease|2|||
164612410|NCT03907969|594602337|FG007|Monotherapy Part A|Progressive Disease|0|||
164612411|NCT03907969|594602338|FG008|Monotherapy Part A|Progressive Disease|0|||
164612412|NCT03907969|594602339|FG009|Monotherapy Part A|Progressive Disease|0|||
164612413|NCT03907969|594602340|FG010|Monotherapy Part A|Progressive Disease|0|||
164612414|NCT03907969|594602330|FG000|Monotherapy Part A|Death|0|||
164612415|NCT03907969|594602331|FG001|Monotherapy Part A|Death|0|||
164612416|NCT03907969|594602332|FG002|Monotherapy Part A|Death|1|||
164612417|NCT03907969|594602333|FG003|Monotherapy Part A|Death|1|||
164612418|NCT03907969|594602334|FG004|Monotherapy Part A|Death|0|||
164612419|NCT03907969|594602335|FG005|Monotherapy Part A|Death|1|||
164612420|NCT03907969|594602336|FG006|Monotherapy Part A|Death|0|||
164612421|NCT03907969|594602337|FG007|Monotherapy Part A|Death|0|||
164612422|NCT03907969|594602338|FG008|Monotherapy Part A|Death|0|||
164612423|NCT03907969|594602339|FG009|Monotherapy Part A|Death|0|||
164612424|NCT03907969|594602340|FG010|Monotherapy Part A|Death|0|||
164612425|NCT03907969|594602330|FG000|Combination Therapy Part A|Adverse Event|0|||
164612426|NCT03907969|594602331|FG001|Combination Therapy Part A|Adverse Event|0|||
164612427|NCT03907969|594602332|FG002|Combination Therapy Part A|Adverse Event|0|||
164612428|NCT03907969|594602333|FG003|Combination Therapy Part A|Adverse Event|0|||
164612429|NCT03907969|594602334|FG004|Combination Therapy Part A|Adverse Event|0|||
164612430|NCT03907969|594602335|FG005|Combination Therapy Part A|Adverse Event|0|||
164612431|NCT03907969|594602336|FG006|Combination Therapy Part A|Adverse Event|0|||
164612432|NCT03907969|594602337|FG007|Combination Therapy Part A|Adverse Event|0|||
164612433|NCT03907969|594602338|FG008|Combination Therapy Part A|Adverse Event|0|||
164612434|NCT03907969|594602339|FG009|Combination Therapy Part A|Adverse Event|1|||
164612435|NCT03907969|594602340|FG010|Combination Therapy Part A|Adverse Event|1|||
164612436|NCT03907969|594602330|FG000|Combination Therapy Part A|Progressive disease|0|||
164612437|NCT03907969|594602331|FG001|Combination Therapy Part A|Progressive disease|0|||
164612438|NCT03907969|594602332|FG002|Combination Therapy Part A|Progressive disease|0|||
164612439|NCT03907969|594602333|FG003|Combination Therapy Part A|Progressive disease|0|||
164612440|NCT03907969|594602334|FG004|Combination Therapy Part A|Progressive disease|0|||
164612441|NCT03907969|594602335|FG005|Combination Therapy Part A|Progressive disease|0|||
164612442|NCT03907969|594602336|FG006|Combination Therapy Part A|Progressive disease|0|||
164612443|NCT03907969|594602337|FG007|Combination Therapy Part A|Progressive disease|1|||
164612444|NCT03907969|594602338|FG008|Combination Therapy Part A|Progressive disease|0|||
164612445|NCT03907969|594602339|FG009|Combination Therapy Part A|Progressive disease|2|||
164612446|NCT03907969|594602340|FG010|Combination Therapy Part A|Progressive disease|3|||
164612447|NCT03907969|594602330|FG000|Combination Therapy Part A|Death|0|||
164612448|NCT03907969|594602331|FG001|Combination Therapy Part A|Death|0|||
164612449|NCT03907969|594602332|FG002|Combination Therapy Part A|Death|0|||
164612450|NCT03907969|594602333|FG003|Combination Therapy Part A|Death|0|||
164612451|NCT03907969|594602334|FG004|Combination Therapy Part A|Death|0|||
164515812|NCT02942277|594259139|FG010|Year 1|Travel|8|||
164515813|NCT02942277|594259129|FG000|Year 1|Joined Army|0|||
164515814|NCT02942277|594259130|FG001|Year 1|Joined Army|1|||
164515815|NCT02942277|594259131|FG002|Year 1|Joined Army|0|||
164515816|NCT02942277|594259132|FG003|Year 1|Joined Army|0|||
164515817|NCT02942277|594259133|FG004|Year 1|Joined Army|0|||
164515818|NCT02942277|594259134|FG005|Year 1|Joined Army|0|||
164515819|NCT02942277|594259135|FG006|Year 1|Joined Army|0|||
164515820|NCT02942277|594259136|FG007|Year 1|Joined Army|0|||
164515821|NCT02942277|594259137|FG008|Year 1|Joined Army|0|||
164515822|NCT02942277|594259138|FG009|Year 1|Joined Army|0|||
164515823|NCT02942277|594259139|FG010|Year 1|Joined Army|0|||
164515824|NCT02942277|594259129|FG000|Year 1|Subject met withdrawal criteria|0|||
164515825|NCT02942277|594259130|FG001|Year 1|Subject met withdrawal criteria|0|||
164515826|NCT02942277|594259131|FG002|Year 1|Subject met withdrawal criteria|0|||
164515827|NCT02942277|594259132|FG003|Year 1|Subject met withdrawal criteria|1|||
164515828|NCT02942277|594259133|FG004|Year 1|Subject met withdrawal criteria|0|||
164515829|NCT02942277|594259134|FG005|Year 1|Subject met withdrawal criteria|0|||
164515830|NCT02942277|594259135|FG006|Year 1|Subject met withdrawal criteria|0|||
164515831|NCT02942277|594259136|FG007|Year 1|Subject met withdrawal criteria|0|||
164515832|NCT02942277|594259137|FG008|Year 1|Subject met withdrawal criteria|0|||
164515833|NCT02942277|594259138|FG009|Year 1|Subject met withdrawal criteria|0|||
164515834|NCT02942277|594259139|FG010|Year 1|Subject met withdrawal criteria|0|||
164515835|NCT02942277|594259129|FG000|Year 1|Lost to Follow-up|0|||
164515836|NCT02942277|594259130|FG001|Year 1|Lost to Follow-up|0|||
164515837|NCT02942277|594259131|FG002|Year 1|Lost to Follow-up|0|||
164515838|NCT02942277|594259132|FG003|Year 1|Lost to Follow-up|0|||
164515839|NCT02942277|594259133|FG004|Year 1|Lost to Follow-up|1|||
164515840|NCT02942277|594259134|FG005|Year 1|Lost to Follow-up|0|||
164515841|NCT02942277|594259135|FG006|Year 1|Lost to Follow-up|0|||
164515842|NCT02942277|594259136|FG007|Year 1|Lost to Follow-up|0|||
164515843|NCT02942277|594259137|FG008|Year 1|Lost to Follow-up|0|||
164515844|NCT02942277|594259138|FG009|Year 1|Lost to Follow-up|0|||
164515845|NCT02942277|594259139|FG010|Year 1|Lost to Follow-up|2|||
164515846|NCT02942277|594259129|FG000|Year 1|Protocol Violation|0|||
164515847|NCT02942277|594259130|FG001|Year 1|Protocol Violation|0|||
164515848|NCT02942277|594259131|FG002|Year 1|Protocol Violation|0|||
164515849|NCT02942277|594259132|FG003|Year 1|Protocol Violation|0|||
164515850|NCT02942277|594259133|FG004|Year 1|Protocol Violation|1|||
164515851|NCT02942277|594259134|FG005|Year 1|Protocol Violation|1|||
164515852|NCT02942277|594259135|FG006|Year 1|Protocol Violation|0|||
164515853|NCT02942277|594259136|FG007|Year 1|Protocol Violation|0|||
164515854|NCT02942277|594259137|FG008|Year 1|Protocol Violation|0|||
164515855|NCT02942277|594259138|FG009|Year 1|Protocol Violation|0|||
164515856|NCT02942277|594259139|FG010|Year 1|Protocol Violation|2|||
164515857|NCT02942277|594259129|FG000|Year 1|Pregnancy|0|||
164515858|NCT02942277|594259130|FG001|Year 1|Pregnancy|0|||
164515859|NCT02942277|594259131|FG002|Year 1|Pregnancy|0|||
164515860|NCT02942277|594259132|FG003|Year 1|Pregnancy|0|||
164515861|NCT02942277|594259133|FG004|Year 1|Pregnancy|0|||
164515862|NCT02942277|594259134|FG005|Year 1|Pregnancy|1|||
164515863|NCT02942277|594259135|FG006|Year 1|Pregnancy|0|||
164515864|NCT02942277|594259136|FG007|Year 1|Pregnancy|0|||
164515865|NCT02942277|594259137|FG008|Year 1|Pregnancy|0|||
164515866|NCT02942277|594259138|FG009|Year 1|Pregnancy|0|||
164515867|NCT02942277|594259139|FG010|Year 1|Pregnancy|0|||
164515868|NCT02942277|594259129|FG000|Year 2|Lost to Follow-up|0|||
164515869|NCT02942277|594259130|FG001|Year 2|Lost to Follow-up|0|||
164515870|NCT02942277|594259131|FG002|Year 2|Lost to Follow-up|0|||
164515871|NCT02942277|594259132|FG003|Year 2|Lost to Follow-up|0|||
164515872|NCT02942277|594259133|FG004|Year 2|Lost to Follow-up|2|||
164515873|NCT02942277|594259134|FG005|Year 2|Lost to Follow-up|1|||
164515874|NCT02942277|594259135|FG006|Year 2|Lost to Follow-up|0|||
164515875|NCT02942277|594259136|FG007|Year 2|Lost to Follow-up|0|||
164515876|NCT02942277|594259137|FG008|Year 2|Lost to Follow-up|0|||
164515877|NCT02942277|594259138|FG009|Year 2|Lost to Follow-up|0|||
164515878|NCT02942277|594259139|FG010|Year 2|Lost to Follow-up|0|||
164515879|NCT02942277|594259129|FG000|Year 2|Did not rescreen|0|||
164515880|NCT02942277|594259130|FG001|Year 2|Did not rescreen|0|||
164515881|NCT02942277|594259131|FG002|Year 2|Did not rescreen|1|||
164515882|NCT02942277|594259132|FG003|Year 2|Did not rescreen|1|||
164515883|NCT02942277|594259133|FG004|Year 2|Did not rescreen|9|||
164515884|NCT02942277|594259134|FG005|Year 2|Did not rescreen|6|||
164515885|NCT02942277|594259135|FG006|Year 2|Did not rescreen|0|||
164515886|NCT02942277|594259136|FG007|Year 2|Did not rescreen|1|||
164515887|NCT02942277|594259137|FG008|Year 2|Did not rescreen|0|||
164515888|NCT02942277|594259138|FG009|Year 2|Did not rescreen|0|||
164515889|NCT02942277|594259139|FG010|Year 2|Did not rescreen|21|||
164515890|NCT02942277|594259129|FG000|Year 2|Met withdrawal criteria|0|||
164515891|NCT02942277|594259130|FG001|Year 2|Met withdrawal criteria|0|||
164515892|NCT02942277|594259131|FG002|Year 2|Met withdrawal criteria|0|||
164515893|NCT02942277|594259132|FG003|Year 2|Met withdrawal criteria|0|||
164515894|NCT02942277|594259133|FG004|Year 2|Met withdrawal criteria|1|||
164515895|NCT02942277|594259134|FG005|Year 2|Met withdrawal criteria|2|||
164515896|NCT02942277|594259135|FG006|Year 2|Met withdrawal criteria|0|||
164515897|NCT02942277|594259136|FG007|Year 2|Met withdrawal criteria|0|||
164515898|NCT02942277|594259137|FG008|Year 2|Met withdrawal criteria|0|||
164515899|NCT02942277|594259138|FG009|Year 2|Met withdrawal criteria|0|||
164515900|NCT02942277|594259139|FG010|Year 2|Met withdrawal criteria|1|||
164515901|NCT02942277|594259129|FG000|Year 2|Travel|0|||
164515902|NCT02942277|594259130|FG001|Year 2|Travel|1|||
164515903|NCT02942277|594259131|FG002|Year 2|Travel|0|||
164515904|NCT02942277|594259132|FG003|Year 2|Travel|0|||
164515905|NCT02942277|594259133|FG004|Year 2|Travel|0|||
164515906|NCT02942277|594259134|FG005|Year 2|Travel|1|||
164515907|NCT02942277|594259135|FG006|Year 2|Travel|0|||
164515908|NCT02942277|594259136|FG007|Year 2|Travel|0|||
164515909|NCT02942277|594259137|FG008|Year 2|Travel|0|||
164515910|NCT02942277|594259138|FG009|Year 2|Travel|1|||
164515911|NCT02942277|594259139|FG010|Year 2|Travel|3|||
164515912|NCT02942277|594259129|FG000|Year 2|Non-compliant|0|||
164515913|NCT02942277|594259130|FG001|Year 2|Non-compliant|0|||
164515914|NCT02942277|594259131|FG002|Year 2|Non-compliant|0|||
164515915|NCT02942277|594259132|FG003|Year 2|Non-compliant|0|||
164515916|NCT02942277|594259133|FG004|Year 2|Non-compliant|1|||
164515917|NCT02942277|594259134|FG005|Year 2|Non-compliant|1|||
164515918|NCT02942277|594259135|FG006|Year 2|Non-compliant|0|||
164515919|NCT02942277|594259136|FG007|Year 2|Non-compliant|0|||
164515920|NCT02942277|594259137|FG008|Year 2|Non-compliant|0|||
164515921|NCT02942277|594259138|FG009|Year 2|Non-compliant|0|||
164515922|NCT02942277|594259139|FG010|Year 2|Non-compliant|0|||
164515923|NCT02942277|594259129|FG000|Year 2|Withdrawal by Subject|0|||
164515924|NCT02942277|594259130|FG001|Year 2|Withdrawal by Subject|0|||
164515925|NCT02942277|594259131|FG002|Year 2|Withdrawal by Subject|0|||
164515926|NCT02942277|594259132|FG003|Year 2|Withdrawal by Subject|0|||
164515927|NCT02942277|594259133|FG004|Year 2|Withdrawal by Subject|0|||
164515928|NCT02942277|594259134|FG005|Year 2|Withdrawal by Subject|0|||
164515929|NCT02942277|594259135|FG006|Year 2|Withdrawal by Subject|1|||
164515930|NCT02942277|594259136|FG007|Year 2|Withdrawal by Subject|0|||
164515931|NCT02942277|594259137|FG008|Year 2|Withdrawal by Subject|0|||
164515932|NCT02942277|594259138|FG009|Year 2|Withdrawal by Subject|0|||
164515933|NCT02942277|594259139|FG010|Year 2|Withdrawal by Subject|0|||
164515934|NCT04325282|594259140|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
164515935|NCT04325282|594259141|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
164515936|NCT04325282|594259140|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
164515937|NCT04325282|594259141|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
164515938|NCT00565773|594259144|FG000|Overall Study|Withdrawal by Subject|1|||
164515939|NCT00565773|594259144|FG000|Overall Study|Physician Decision|1|||
164515940|NCT03031496|594259145|FG000|Period 1|Adverse Event|2|||
164515941|NCT03031496|594259146|FG001|Period 1|Adverse Event|0|||
164515942|NCT03031496|594259145|FG000|Period 1|Withdrawal by Subject|0|||
164515943|NCT03031496|594259146|FG001|Period 1|Withdrawal by Subject|2|||
164515944|NCT01240915|594259147|FG000|Overall Study|Adverse Event|0|||
164515945|NCT01240915|594259148|FG001|Overall Study|Adverse Event|0|||
164515946|NCT01240915|594259149|FG002|Overall Study|Adverse Event|0|||
164515947|NCT01240915|594259150|FG003|Overall Study|Adverse Event|1|||
164515948|NCT01240915|594259151|FG004|Overall Study|Adverse Event|0|||
164515949|NCT01240915|594259152|FG005|Overall Study|Adverse Event|2|||
164515950|NCT01240915|594259153|FG006|Overall Study|Adverse Event|0|||
164515951|NCT01240915|594259154|FG007|Overall Study|Adverse Event|0|||
164515952|NCT01240915|594259155|FG008|Overall Study|Adverse Event|1|||
164515953|NCT01240915|594259147|FG000|Overall Study|Lost to Follow-up|0|||
164515954|NCT01240915|594259148|FG001|Overall Study|Lost to Follow-up|0|||
164515955|NCT01240915|594259149|FG002|Overall Study|Lost to Follow-up|0|||
164515956|NCT01240915|594259150|FG003|Overall Study|Lost to Follow-up|0|||
164515957|NCT01240915|594259151|FG004|Overall Study|Lost to Follow-up|1|||
164515958|NCT01240915|594259152|FG005|Overall Study|Lost to Follow-up|1|||
164515959|NCT01240915|594259153|FG006|Overall Study|Lost to Follow-up|0|||
164515960|NCT01240915|594259154|FG007|Overall Study|Lost to Follow-up|1|||
164515961|NCT01240915|594259155|FG008|Overall Study|Lost to Follow-up|1|||
164515962|NCT01240915|594259147|FG000|Overall Study|Withdrawal by Subject|2|||
164515963|NCT01240915|594259148|FG001|Overall Study|Withdrawal by Subject|1|||
164515964|NCT01240915|594259149|FG002|Overall Study|Withdrawal by Subject|0|||
164515965|NCT01240915|594259150|FG003|Overall Study|Withdrawal by Subject|2|||
164515966|NCT01240915|594259151|FG004|Overall Study|Withdrawal by Subject|0|||
164515967|NCT01240915|594259152|FG005|Overall Study|Withdrawal by Subject|4|||
164515968|NCT01240915|594259153|FG006|Overall Study|Withdrawal by Subject|2|||
164515969|NCT01240915|594259154|FG007|Overall Study|Withdrawal by Subject|3|||
164515970|NCT01240915|594259155|FG008|Overall Study|Withdrawal by Subject|3|||
164515971|NCT01240915|594259147|FG000|Overall Study|Other|0|||
164515972|NCT01240915|594259148|FG001|Overall Study|Other|0|||
164515973|NCT01240915|594259149|FG002|Overall Study|Other|0|||
164515974|NCT01240915|594259150|FG003|Overall Study|Other|0|||
164515975|NCT01240915|594259151|FG004|Overall Study|Other|2|||
164515976|NCT01240915|594259152|FG005|Overall Study|Other|0|||
164515977|NCT01240915|594259153|FG006|Overall Study|Other|0|||
164515978|NCT01240915|594259154|FG007|Overall Study|Other|0|||
164515979|NCT01240915|594259155|FG008|Overall Study|Other|0|||
164515980|NCT01240915|594259147|FG000|Overall Study|Insufficient Clinical Response|0|||
164612452|NCT03907969|594602335|FG005|Combination Therapy Part A|Death|0|||
164612453|NCT03907969|594602336|FG006|Combination Therapy Part A|Death|0|||
164612454|NCT03907969|594602337|FG007|Combination Therapy Part A|Death|0|||
164612455|NCT03907969|594602338|FG008|Combination Therapy Part A|Death|1|||
164612456|NCT03907969|594602339|FG009|Combination Therapy Part A|Death|0|||
164612457|NCT03907969|594602340|FG010|Combination Therapy Part A|Death|1|||
164612458|NCT03907969|594602330|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
164612459|NCT03907969|594602331|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
164612460|NCT03907969|594602332|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
164612461|NCT03907969|594602333|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
164612462|NCT03907969|594602334|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
164612463|NCT03907969|594602335|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
164612464|NCT03907969|594602336|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
164612465|NCT03907969|594602337|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
164612466|NCT03907969|594602338|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
164612467|NCT03907969|594602339|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
164612468|NCT03907969|594602340|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
164612469|NCT03907969|594602330|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
164612470|NCT03907969|594602331|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
164612471|NCT03907969|594602332|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
164612472|NCT03907969|594602333|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
164612473|NCT03907969|594602334|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
164612474|NCT03907969|594602335|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
164612475|NCT03907969|594602336|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
164612476|NCT03907969|594602337|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
164612477|NCT03907969|594602338|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
164612478|NCT03907969|594602339|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
164612479|NCT03907969|594602340|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
164612480|NCT03907969|594602330|FG000|Combination Therapy Part A|Physician Decision|0|||
164612481|NCT03907969|594602331|FG001|Combination Therapy Part A|Physician Decision|0|||
164612482|NCT03907969|594602332|FG002|Combination Therapy Part A|Physician Decision|0|||
164612483|NCT03907969|594602333|FG003|Combination Therapy Part A|Physician Decision|0|||
164612484|NCT03907969|594602334|FG004|Combination Therapy Part A|Physician Decision|0|||
164612485|NCT03907969|594602335|FG005|Combination Therapy Part A|Physician Decision|0|||
164612486|NCT03907969|594602336|FG006|Combination Therapy Part A|Physician Decision|0|||
164612487|NCT03907969|594602337|FG007|Combination Therapy Part A|Physician Decision|1|||
164612488|NCT03907969|594602338|FG008|Combination Therapy Part A|Physician Decision|0|||
164612489|NCT03907969|594602339|FG009|Combination Therapy Part A|Physician Decision|0|||
164612490|NCT03907969|594602340|FG010|Combination Therapy Part A|Physician Decision|1|||
164612491|NCT01419015|594602341|FG000|Overall Study|Death|2|||
164612492|NCT01510028|594602344|FG000|Overall Study|Lack of Efficacy|1|||
164612493|NCT01510028|594602345|FG001|Overall Study|Lack of Efficacy|0|||
164612494|NCT01510028|594602346|FG002|Overall Study|Lack of Efficacy|0|||
164612495|NCT01510028|594602347|FG003|Overall Study|Lack of Efficacy|0|||
164612496|NCT02741310|594602348|FG000|Overall Study|Sponsor Decision|2|||
164612497|NCT02741310|594602349|FG001|Overall Study|Sponsor Decision|2|||
164612498|NCT05091918|594602350|FG000|Overall Study|Adverse Event|1|||
164612499|NCT05091918|594602350|FG000|Overall Study|Withdrawal by Subject|81|||
164612500|NCT03725293|594602358|FG000|Overall Study|Physician Decision|9|||
164612501|NCT03725293|594602359|FG001|Overall Study|Physician Decision|6|||
164612502|NCT03725293|594602358|FG000|Overall Study|alternative vascular access needs|1|||
164612503|NCT03725293|594602359|FG001|Overall Study|alternative vascular access needs|2|||
164612504|NCT03725293|594602358|FG000|Overall Study|venous anatomy screen failures|2|||
164612505|NCT03725293|594602359|FG001|Overall Study|venous anatomy screen failures|1|||
164612506|NCT03673956|594602360|FG000|Overall Study|Lost to Follow-up|1|||
164612507|NCT03673956|594602361|FG001|Overall Study|Lost to Follow-up|0|||
164612508|NCT03673956|594602362|FG002|Overall Study|Lost to Follow-up|0|||
164612509|NCT03673956|594602363|FG003|Overall Study|Lost to Follow-up|0|||
164612510|NCT03673956|594602360|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
164612511|NCT03673956|594602361|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
164612512|NCT03673956|594602362|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
164612513|NCT03673956|594602363|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
164612514|NCT00003838|594602364|FG000|Overall Study|Death|0|||
164612515|NCT00003838|594602365|FG001|Overall Study|Death|12|||
164612516|NCT00003838|594602366|FG002|Overall Study|Death|7|||
164612517|NCT00003838|594602364|FG000|Overall Study|Lost to Follow-up|0|||
164612518|NCT00003838|594602365|FG001|Overall Study|Lost to Follow-up|1|||
164612519|NCT00003838|594602366|FG002|Overall Study|Lost to Follow-up|1|||
164612520|NCT00003838|594602364|FG000|Overall Study|Disease Progression|0|||
164612521|NCT00003838|594602365|FG001|Overall Study|Disease Progression|12|||
164612522|NCT00003838|594602366|FG002|Overall Study|Disease Progression|0|||
164612523|NCT03228394|594602367|FG000|Overall Study|Lost to Follow-up|0|||
164515981|NCT01240915|594259148|FG001|Overall Study|Insufficient Clinical Response|0|||
164515982|NCT01240915|594259149|FG002|Overall Study|Insufficient Clinical Response|0|||
164515983|NCT01240915|594259150|FG003|Overall Study|Insufficient Clinical Response|0|||
164515984|NCT01240915|594259151|FG004|Overall Study|Insufficient Clinical Response|1|||
164515985|NCT01240915|594259152|FG005|Overall Study|Insufficient Clinical Response|3|||
164515986|NCT01240915|594259153|FG006|Overall Study|Insufficient Clinical Response|6|||
164515987|NCT01240915|594259154|FG007|Overall Study|Insufficient Clinical Response|0|||
164515988|NCT01240915|594259155|FG008|Overall Study|Insufficient Clinical Response|3|||
164515989|NCT03868787|594259158|FG000|Overall Study|Withdrawal by Subject|2|||
164515990|NCT03868787|594259159|FG001|Overall Study|Withdrawal by Subject|1|||
164515991|NCT02574845|594259160|FG000|Overall Study|Consent withdrawn further participation|0|||
164515992|NCT02574845|594259161|FG001|Overall Study|Consent withdrawn further participation|0|||
164515993|NCT02574845|594259162|FG002|Overall Study|Consent withdrawn further participation|0|||
164515994|NCT02574845|594259163|FG003|Overall Study|Consent withdrawn further participation|0|||
164515995|NCT02574845|594259164|FG004|Overall Study|Consent withdrawn further participation|1|||
164515996|NCT02574845|594259165|FG005|Overall Study|Consent withdrawn further participation|0|||
164515997|NCT02574845|594259160|FG000|Overall Study|Adverse Event|0|||
164515998|NCT02574845|594259161|FG001|Overall Study|Adverse Event|1|||
164515999|NCT02574845|594259162|FG002|Overall Study|Adverse Event|0|||
164516000|NCT02574845|594259163|FG003|Overall Study|Adverse Event|0|||
164516001|NCT02574845|594259164|FG004|Overall Study|Adverse Event|0|||
164516002|NCT02574845|594259165|FG005|Overall Study|Adverse Event|1|||
164516003|NCT04313608|594259170|FG000|Overall Study|Death|12|||
164516004|NCT04313608|594259171|FG001|Overall Study|Death|3|||
164516005|NCT01867333|594259172|FG000|Overall Study|Withdrawal by Subject|1|||
164516006|NCT01867333|594259173|FG001|Overall Study|Withdrawal by Subject|0|||
164516007|NCT01867333|594259172|FG000|Overall Study|Adverse Event|1|||
164516008|NCT01867333|594259173|FG001|Overall Study|Adverse Event|0|||
164516009|NCT01867333|594259172|FG000|Overall Study|Participant choice|1|||
164516010|NCT01867333|594259173|FG001|Overall Study|Participant choice|2|||
164516011|NCT01867333|594259172|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
164516012|NCT01867333|594259173|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
164516013|NCT01867333|594259172|FG000|Overall Study|Death|0|||
164516014|NCT01867333|594259173|FG001|Overall Study|Death|1|||
164516015|NCT01867333|594259172|FG000|Overall Study|Physician Decision|3|||
164516016|NCT01867333|594259173|FG001|Overall Study|Physician Decision|2|||
164516017|NCT01867333|594259172|FG000|Overall Study|Switched to alternative treatment|1|||
164516018|NCT01867333|594259173|FG001|Overall Study|Switched to alternative treatment|0|||
164516019|NCT01145898|594259174|FG000|3-year Treatment|medication change by treating physician|3|||
164516020|NCT01145898|594259175|FG001|3-year Treatment|medication change by treating physician|16|||
164516021|NCT00879775|594259176|FG000|Overall Study|Lost to Follow-up|2|||
164516022|NCT00879775|594259177|FG001|Overall Study|Lost to Follow-up|1|||
164516023|NCT02440425|594259178|FG000|Overall Study|Death likely due to disease progression|1|||
164516024|NCT02440425|594259178|FG000|Overall Study|Withdrawal by Subject|2|||
164516025|NCT02440425|594259178|FG000|Overall Study|Adverse Event|1|||
164516026|NCT02440425|594259178|FG000|Overall Study|Adverse Event/Ineligible|1|||
164516027|NCT03101462|594259179|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
164516028|NCT03101462|594259180|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
164516029|NCT01669577|594259183|FG000|Overall Study|Death|22|||
164516030|NCT01669577|594259183|FG000|Overall Study|Lost to Follow-up|78|||
164516031|NCT01669577|594259183|FG000|Overall Study|Physician Decision|34|||
164516032|NCT03309813|594259184|FG000|Main Randomized Study|Withdrawal by Subject|1|||
164516033|NCT03309813|594259185|FG001|Main Randomized Study|Withdrawal by Subject|0|||
164516034|NCT00208325|594259186|FG000|Overall Study|Death|18|||
164516035|NCT00208325|594259187|FG001|Overall Study|Death|19|||
164516036|NCT00208325|594259188|FG002|Overall Study|Death|7|||
164516037|NCT00208325|594259189|FG003|Overall Study|Death|5|||
164516038|NCT00208325|594259186|FG000|Overall Study|Withdrawal by Subject|0|||
164516039|NCT00208325|594259187|FG001|Overall Study|Withdrawal by Subject|1|||
164516040|NCT00208325|594259188|FG002|Overall Study|Withdrawal by Subject|0|||
164516041|NCT00208325|594259189|FG003|Overall Study|Withdrawal by Subject|0|||
164516042|NCT00208325|594259186|FG000|Overall Study|Revision|4|||
164516043|NCT00208325|594259187|FG001|Overall Study|Revision|1|||
164516044|NCT00208325|594259188|FG002|Overall Study|Revision|0|||
164516045|NCT00208325|594259189|FG003|Overall Study|Revision|4|||
164516046|NCT00208325|594259186|FG000|Overall Study|Lost to Follow-up|1|||
164516047|NCT00208325|594259187|FG001|Overall Study|Lost to Follow-up|0|||
164516048|NCT00208325|594259188|FG002|Overall Study|Lost to Follow-up|2|||
164516049|NCT00208325|594259189|FG003|Overall Study|Lost to Follow-up|0|||
164516050|NCT00208325|594259186|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
164612524|NCT03228394|594602368|FG001|Overall Study|Lost to Follow-up|0|||
164612525|NCT03228394|594602369|FG002|Overall Study|Lost to Follow-up|1|||
164612526|NCT03228394|594602370|FG003|Overall Study|Lost to Follow-up|1|||
164612527|NCT03228394|594602371|FG004|Overall Study|Lost to Follow-up|0|||
164612528|NCT03228394|594602372|FG005|Overall Study|Lost to Follow-up|0|||
164612529|NCT03228394|594602373|FG006|Overall Study|Lost to Follow-up|2|||
164612530|NCT03228394|594602374|FG007|Overall Study|Lost to Follow-up|0|||
164612531|NCT03228394|594602367|FG000|Overall Study|Withdrawal by Subject|0|||
164612532|NCT03228394|594602368|FG001|Overall Study|Withdrawal by Subject|0|||
164612533|NCT03228394|594602369|FG002|Overall Study|Withdrawal by Subject|1|||
164612534|NCT03228394|594602370|FG003|Overall Study|Withdrawal by Subject|0|||
164612535|NCT03228394|594602371|FG004|Overall Study|Withdrawal by Subject|0|||
164612536|NCT03228394|594602372|FG005|Overall Study|Withdrawal by Subject|0|||
164612537|NCT03228394|594602373|FG006|Overall Study|Withdrawal by Subject|1|||
164612538|NCT03228394|594602374|FG007|Overall Study|Withdrawal by Subject|3|||
164612539|NCT03228394|594602367|FG000|Overall Study|Protocol Violation|0|||
164612540|NCT03228394|594602368|FG001|Overall Study|Protocol Violation|0|||
164612541|NCT03228394|594602369|FG002|Overall Study|Protocol Violation|0|||
164612542|NCT03228394|594602370|FG003|Overall Study|Protocol Violation|1|||
164612543|NCT03228394|594602371|FG004|Overall Study|Protocol Violation|0|||
164612544|NCT03228394|594602372|FG005|Overall Study|Protocol Violation|0|||
164612545|NCT03228394|594602373|FG006|Overall Study|Protocol Violation|0|||
164612546|NCT03228394|594602374|FG007|Overall Study|Protocol Violation|0|||
164612547|NCT03228394|594602367|FG000|Overall Study|Physician Decision|0|||
164612548|NCT03228394|594602368|FG001|Overall Study|Physician Decision|0|||
164612549|NCT03228394|594602369|FG002|Overall Study|Physician Decision|0|||
164612550|NCT03228394|594602370|FG003|Overall Study|Physician Decision|0|||
164612551|NCT03228394|594602371|FG004|Overall Study|Physician Decision|0|||
164612552|NCT03228394|594602372|FG005|Overall Study|Physician Decision|0|||
164612553|NCT03228394|594602373|FG006|Overall Study|Physician Decision|1|||
164612554|NCT03228394|594602374|FG007|Overall Study|Physician Decision|0|||
164612555|NCT03228394|594602367|FG000|Overall Study|Noncompliance|0|||
164612556|NCT03228394|594602368|FG001|Overall Study|Noncompliance|0|||
164612557|NCT03228394|594602369|FG002|Overall Study|Noncompliance|0|||
164612558|NCT03228394|594602370|FG003|Overall Study|Noncompliance|0|||
164612559|NCT03228394|594602371|FG004|Overall Study|Noncompliance|0|||
164612560|NCT03228394|594602372|FG005|Overall Study|Noncompliance|0|||
164612561|NCT03228394|594602373|FG006|Overall Study|Noncompliance|1|||
164612562|NCT03228394|594602374|FG007|Overall Study|Noncompliance|0|||
164612563|NCT00291187|594602378|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
164612564|NCT00291187|594602379|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
164612565|NCT00291187|594602380|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
164612566|NCT00291187|594602381|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
164612567|NCT02023268|594602382|FG000|Overall Study|Lack of Efficacy|0|||
164612568|NCT02023268|594602383|FG001|Overall Study|Lack of Efficacy|1|||
164612569|NCT02023268|594602382|FG000|Overall Study|Adverse Event|0|||
164612570|NCT02023268|594602383|FG001|Overall Study|Adverse Event|2|||
164612571|NCT02023268|594602382|FG000|Overall Study|Withdrawal by Subject|0|||
164612572|NCT02023268|594602383|FG001|Overall Study|Withdrawal by Subject|1|||
164612573|NCT01001234|594602386|FG000|Overall Study|Withdrawal by Subject|2|||
164612574|NCT01001234|594602387|FG001|Overall Study|Withdrawal by Subject|0|||
164612575|NCT01001234|594602388|FG002|Overall Study|Withdrawal by Subject|3|||
164612576|NCT01001234|594602389|FG003|Overall Study|Withdrawal by Subject|0|||
164612577|NCT01001234|594602390|FG004|Overall Study|Withdrawal by Subject|0|||
164612578|NCT01001234|594602386|FG000|Overall Study|Protocol Violation|34|||
164612579|NCT01001234|594602387|FG001|Overall Study|Protocol Violation|3|||
164612580|NCT01001234|594602388|FG002|Overall Study|Protocol Violation|19|||
164612581|NCT01001234|594602389|FG003|Overall Study|Protocol Violation|18|||
164612582|NCT01001234|594602390|FG004|Overall Study|Protocol Violation|0|||
164612583|NCT01001234|594602386|FG000|Overall Study|Lost to Follow-up|0|||
164612584|NCT01001234|594602387|FG001|Overall Study|Lost to Follow-up|0|||
164612585|NCT01001234|594602388|FG002|Overall Study|Lost to Follow-up|1|||
164612586|NCT01001234|594602389|FG003|Overall Study|Lost to Follow-up|2|||
164612587|NCT01001234|594602390|FG004|Overall Study|Lost to Follow-up|0|||
164612588|NCT01001234|594602386|FG000|Overall Study|Physician Decision|1|||
164612589|NCT01001234|594602387|FG001|Overall Study|Physician Decision|0|||
164612590|NCT01001234|594602388|FG002|Overall Study|Physician Decision|0|||
164612591|NCT01001234|594602389|FG003|Overall Study|Physician Decision|0|||
164612592|NCT01001234|594602390|FG004|Overall Study|Physician Decision|0|||
164612593|NCT01001234|594602386|FG000|Overall Study|Not Treated: Adverse Event|1|||
164612594|NCT01001234|594602387|FG001|Overall Study|Not Treated: Adverse Event|0|||
164612595|NCT01001234|594602388|FG002|Overall Study|Not Treated: Adverse Event|0|||
164612596|NCT01001234|594602389|FG003|Overall Study|Not Treated: Adverse Event|0|||
164612597|NCT01001234|594602390|FG004|Overall Study|Not Treated: Adverse Event|0|||
164612598|NCT01001234|594602386|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
164612599|NCT01001234|594602387|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
164612600|NCT01001234|594602388|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
164612601|NCT01001234|594602389|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
164612602|NCT01001234|594602390|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
164612603|NCT01001234|594602386|FG000|Overall Study|Not Treated: Protocol Violation|3|||
164612604|NCT01001234|594602387|FG001|Overall Study|Not Treated: Protocol Violation|0|||
164612605|NCT01001234|594602388|FG002|Overall Study|Not Treated: Protocol Violation|0|||
164612606|NCT01001234|594602389|FG003|Overall Study|Not Treated: Protocol Violation|0|||
164612607|NCT01001234|594602390|FG004|Overall Study|Not Treated: Protocol Violation|0|||
164612608|NCT01001234|594602386|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
164612609|NCT01001234|594602387|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
164612610|NCT01001234|594602388|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
164612611|NCT01001234|594602389|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
164612612|NCT01001234|594602390|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
164612613|NCT01001234|594602386|FG000|Overall Study|Not Treated: Pregnancy|3|||
164612614|NCT01001234|594602387|FG001|Overall Study|Not Treated: Pregnancy|0|||
164612615|NCT01001234|594602388|FG002|Overall Study|Not Treated: Pregnancy|0|||
164612616|NCT01001234|594602389|FG003|Overall Study|Not Treated: Pregnancy|0|||
164612617|NCT01001234|594602390|FG004|Overall Study|Not Treated: Pregnancy|0|||
164612618|NCT01001234|594602386|FG000|Overall Study|Not Treated: Physician Decision|37|||
164612619|NCT01001234|594602387|FG001|Overall Study|Not Treated: Physician Decision|4|||
164612620|NCT01001234|594602388|FG002|Overall Study|Not Treated: Physician Decision|0|||
164612621|NCT01001234|594602389|FG003|Overall Study|Not Treated: Physician Decision|0|||
164612622|NCT01001234|594602390|FG004|Overall Study|Not Treated: Physician Decision|0|||
164612623|NCT01001234|594602386|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
164612624|NCT01001234|594602387|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
164612625|NCT01001234|594602388|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
164612626|NCT01001234|594602389|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
164612627|NCT01001234|594602390|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
164612628|NCT01611298|594602393|FG000|Overall Study|Relapsed|2|||
164612629|NCT03238352|594602394|FG000|Overall Study|Lost to Follow-up|0|||
164612630|NCT03238352|594602395|FG001|Overall Study|Lost to Follow-up|2|||
164612631|NCT03238352|594602396|FG002|Overall Study|Lost to Follow-up|1|||
164612632|NCT03238352|594602394|FG000|Overall Study|Withdrawal by Subject|0|||
164612633|NCT03238352|594602395|FG001|Overall Study|Withdrawal by Subject|1|||
164612634|NCT03238352|594602396|FG002|Overall Study|Withdrawal by Subject|0|||
164612635|NCT00928512|594602397|FG000|Overall Study|Adverse Event|4|||
164612636|NCT00928512|594602398|FG001|Overall Study|Adverse Event|3|||
164612637|NCT00928512|594602399|FG002|Overall Study|Adverse Event|2|||
164612638|NCT00928512|594602400|FG003|Overall Study|Adverse Event|8|||
164612639|NCT00928512|594602401|FG004|Overall Study|Adverse Event|6|||
164612640|NCT00928512|594602397|FG000|Overall Study|Lack of Efficacy|2|||
164612641|NCT00928512|594602398|FG001|Overall Study|Lack of Efficacy|0|||
164612642|NCT00928512|594602399|FG002|Overall Study|Lack of Efficacy|4|||
164612643|NCT00928512|594602400|FG003|Overall Study|Lack of Efficacy|7|||
164612644|NCT00928512|594602401|FG004|Overall Study|Lack of Efficacy|3|||
164612645|NCT00928512|594602397|FG000|Overall Study|Protocol Violation|0|||
164612646|NCT00928512|594602398|FG001|Overall Study|Protocol Violation|1|||
164612647|NCT00928512|594602399|FG002|Overall Study|Protocol Violation|0|||
164612648|NCT00928512|594602400|FG003|Overall Study|Protocol Violation|1|||
164612649|NCT00928512|594602401|FG004|Overall Study|Protocol Violation|3|||
164612650|NCT00928512|594602397|FG000|Overall Study|Withdrawal by Subject|3|||
164612651|NCT00928512|594602398|FG001|Overall Study|Withdrawal by Subject|0|||
164612652|NCT00928512|594602399|FG002|Overall Study|Withdrawal by Subject|3|||
164612653|NCT00928512|594602400|FG003|Overall Study|Withdrawal by Subject|4|||
164612654|NCT00928512|594602401|FG004|Overall Study|Withdrawal by Subject|0|||
164612655|NCT00928512|594602397|FG000|Overall Study|Lost to Follow-up|1|||
164612656|NCT00928512|594602398|FG001|Overall Study|Lost to Follow-up|1|||
164612657|NCT00928512|594602399|FG002|Overall Study|Lost to Follow-up|2|||
164612658|NCT00928512|594602400|FG003|Overall Study|Lost to Follow-up|1|||
164612659|NCT00928512|594602401|FG004|Overall Study|Lost to Follow-up|3|||
164612660|NCT00928512|594602397|FG000|Overall Study|Administrative Problems|0|||
164612661|NCT00928512|594602398|FG001|Overall Study|Administrative Problems|1|||
164612662|NCT00928512|594602399|FG002|Overall Study|Administrative Problems|0|||
164612663|NCT00928512|594602400|FG003|Overall Study|Administrative Problems|0|||
164612664|NCT00928512|594602401|FG004|Overall Study|Administrative Problems|0|||
164612665|NCT04153929|594602402|FG000|Overall Study|Other than listed|2|||
164612666|NCT04153929|594602403|FG001|Overall Study|Other than listed|2|||
164612667|NCT04153929|594602404|FG002|Overall Study|Other than listed|0|||
164612668|NCT04153929|594602405|FG003|Overall Study|Other than listed|1|||
164612669|NCT04153929|594602406|FG004|Overall Study|Other than listed|0|||
164612670|NCT04153929|594602407|FG005|Overall Study|Other than listed|2|||
164612671|NCT04153929|594602408|FG006|Overall Study|Other than listed|2|||
164612672|NCT04153929|594602409|FG007|Overall Study|Other than listed|1|||
164612673|NCT04153929|594602402|FG000|Overall Study|Lost to Follow-up|2|||
164612674|NCT04153929|594602403|FG001|Overall Study|Lost to Follow-up|1|||
164612675|NCT04153929|594602404|FG002|Overall Study|Lost to Follow-up|0|||
164612676|NCT04153929|594602405|FG003|Overall Study|Lost to Follow-up|1|||
164612677|NCT04153929|594602406|FG004|Overall Study|Lost to Follow-up|1|||
164612678|NCT04153929|594602407|FG005|Overall Study|Lost to Follow-up|0|||
164612679|NCT04153929|594602408|FG006|Overall Study|Lost to Follow-up|0|||
164612680|NCT04153929|594602409|FG007|Overall Study|Lost to Follow-up|0|||
164612681|NCT04153929|594602402|FG000|Overall Study|Withdrawal by Subject|3|||
164612682|NCT04153929|594602403|FG001|Overall Study|Withdrawal by Subject|1|||
164612683|NCT04153929|594602404|FG002|Overall Study|Withdrawal by Subject|0|||
164612684|NCT04153929|594602405|FG003|Overall Study|Withdrawal by Subject|3|||
164612685|NCT04153929|594602406|FG004|Overall Study|Withdrawal by Subject|1|||
164612686|NCT04153929|594602407|FG005|Overall Study|Withdrawal by Subject|0|||
164612687|NCT04153929|594602408|FG006|Overall Study|Withdrawal by Subject|1|||
164612688|NCT04153929|594602409|FG007|Overall Study|Withdrawal by Subject|0|||
164612689|NCT04153929|594602402|FG000|Overall Study|Protocol Violation|0|||
164612690|NCT04153929|594602403|FG001|Overall Study|Protocol Violation|0|||
164612691|NCT04153929|594602404|FG002|Overall Study|Protocol Violation|0|||
164612692|NCT04153929|594602405|FG003|Overall Study|Protocol Violation|0|||
164612693|NCT04153929|594602406|FG004|Overall Study|Protocol Violation|0|||
164612694|NCT04153929|594602407|FG005|Overall Study|Protocol Violation|0|||
164612695|NCT04153929|594602408|FG006|Overall Study|Protocol Violation|1|||
164612696|NCT04153929|594602409|FG007|Overall Study|Protocol Violation|2|||
164612697|NCT04153929|594602402|FG000|Overall Study|Adverse Event|3|||
164612698|NCT04153929|594602403|FG001|Overall Study|Adverse Event|5|||
164612699|NCT04153929|594602404|FG002|Overall Study|Adverse Event|5|||
164612700|NCT04153929|594602405|FG003|Overall Study|Adverse Event|11|||
164612701|NCT04153929|594602406|FG004|Overall Study|Adverse Event|15|||
164612702|NCT04153929|594602407|FG005|Overall Study|Adverse Event|4|||
164612703|NCT04153929|594602408|FG006|Overall Study|Adverse Event|8|||
164612704|NCT04153929|594602409|FG007|Overall Study|Adverse Event|2|||
164612705|NCT04153929|594602402|FG000|Overall Study|Not treated|1|||
164612706|NCT04153929|594602403|FG001|Overall Study|Not treated|0|||
164612707|NCT04153929|594602404|FG002|Overall Study|Not treated|0|||
164612708|NCT04153929|594602405|FG003|Overall Study|Not treated|0|||
164612709|NCT04153929|594602406|FG004|Overall Study|Not treated|0|||
164612710|NCT04153929|594602407|FG005|Overall Study|Not treated|0|||
164612711|NCT04153929|594602408|FG006|Overall Study|Not treated|1|||
164612712|NCT04153929|594602409|FG007|Overall Study|Not treated|0|||
164612713|NCT03383614|594602410|FG000|Overall Study|Withdrawal by Subject|0|||
164612714|NCT03383614|594602411|FG001|Overall Study|Withdrawal by Subject|1|||
164612715|NCT03383614|594602412|FG002|Overall Study|Withdrawal by Subject|0|||
164612716|NCT03383614|594602413|FG003|Overall Study|Withdrawal by Subject|0|||
164612717|NCT01686958|594602416|FG000|Overall Study|Withdrawal by Subject|1|||
164612718|NCT03199638|594602421|FG000|Overall Study|inability to drink glutamine during regularly|0|||
164612719|NCT03199638|594602422|FG001|Overall Study|inability to drink glutamine during regularly|2|||
164612720|NCT02807844|594602423|FG000|Overall Study|Physician Decision|0|||
164612721|NCT02807844|594602424|FG001|Overall Study|Physician Decision|0|||
164612722|NCT02807844|594602425|FG002|Overall Study|Physician Decision|0|||
164612723|NCT02807844|594602426|FG003|Overall Study|Physician Decision|0|||
164612724|NCT02807844|594602427|FG004|Overall Study|Physician Decision|0|||
164612725|NCT02807844|594602428|FG005|Overall Study|Physician Decision|0|||
164612726|NCT02807844|594602429|FG006|Overall Study|Physician Decision|3|||
164612727|NCT02807844|594602430|FG007|Overall Study|Physician Decision|0|||
164612728|NCT02807844|594602431|FG008|Overall Study|Physician Decision|1|||
164612729|NCT02807844|594602432|FG009|Overall Study|Physician Decision|2|||
164612730|NCT02807844|594602423|FG000|Overall Study|Death|0|||
164612731|NCT02807844|594602424|FG001|Overall Study|Death|0|||
164612732|NCT02807844|594602425|FG002|Overall Study|Death|2|||
164612733|NCT02807844|594602426|FG003|Overall Study|Death|4|||
164612734|NCT02807844|594602427|FG004|Overall Study|Death|1|||
164612735|NCT02807844|594602428|FG005|Overall Study|Death|2|||
164612736|NCT02807844|594602429|FG006|Overall Study|Death|1|||
164612737|NCT02807844|594602430|FG007|Overall Study|Death|2|||
164612738|NCT02807844|594602431|FG008|Overall Study|Death|0|||
164612739|NCT02807844|594602432|FG009|Overall Study|Death|1|||
164612740|NCT02807844|594602423|FG000|Overall Study|Withdrawal by Subject|0|||
164612741|NCT02807844|594602424|FG001|Overall Study|Withdrawal by Subject|0|||
164612742|NCT02807844|594602425|FG002|Overall Study|Withdrawal by Subject|2|||
164612743|NCT02807844|594602426|FG003|Overall Study|Withdrawal by Subject|1|||
164612744|NCT02807844|594602427|FG004|Overall Study|Withdrawal by Subject|1|||
164612745|NCT02807844|594602428|FG005|Overall Study|Withdrawal by Subject|0|||
164612746|NCT02807844|594602429|FG006|Overall Study|Withdrawal by Subject|1|||
164612747|NCT02807844|594602430|FG007|Overall Study|Withdrawal by Subject|0|||
164612748|NCT02807844|594602431|FG008|Overall Study|Withdrawal by Subject|0|||
164612749|NCT02807844|594602432|FG009|Overall Study|Withdrawal by Subject|0|||
164612750|NCT02807844|594602423|FG000|Overall Study|Progressive disease|5|||
164612751|NCT02807844|594602424|FG001|Overall Study|Progressive disease|12|||
164612752|NCT02807844|594602425|FG002|Overall Study|Progressive disease|8|||
164612753|NCT02807844|594602426|FG003|Overall Study|Progressive disease|8|||
164612754|NCT02807844|594602427|FG004|Overall Study|Progressive disease|3|||
164612755|NCT02807844|594602428|FG005|Overall Study|Progressive disease|8|||
164612756|NCT02807844|594602429|FG006|Overall Study|Progressive disease|14|||
164612757|NCT02807844|594602430|FG007|Overall Study|Progressive disease|17|||
164612758|NCT02807844|594602431|FG008|Overall Study|Progressive disease|19|||
164612759|NCT02807844|594602432|FG009|Overall Study|Progressive disease|15|||
164612760|NCT02807844|594602423|FG000|Overall Study|Adverse Event|1|||
164612761|NCT02807844|594602424|FG001|Overall Study|Adverse Event|0|||
164612762|NCT02807844|594602425|FG002|Overall Study|Adverse Event|0|||
164612763|NCT02807844|594602426|FG003|Overall Study|Adverse Event|0|||
164612764|NCT02807844|594602427|FG004|Overall Study|Adverse Event|1|||
164612765|NCT02807844|594602428|FG005|Overall Study|Adverse Event|1|||
164612766|NCT02807844|594602429|FG006|Overall Study|Adverse Event|1|||
164612767|NCT02807844|594602430|FG007|Overall Study|Adverse Event|1|||
164612768|NCT02807844|594602431|FG008|Overall Study|Adverse Event|1|||
164612769|NCT02807844|594602432|FG009|Overall Study|Adverse Event|2|||
164612770|NCT00108953|594602439|FG000|Follow-up|Death|18|||
164612771|NCT00108953|594602440|FG001|Follow-up|Death|26|||
164612772|NCT00108953|594602439|FG000|Follow-up|Lost to Follow-up|1|||
164612773|NCT00108953|594602440|FG001|Follow-up|Lost to Follow-up|1|||
164612774|NCT00108953|594602439|FG000|Follow-up|Study terminated by sponsor|10|||
164612775|NCT00108953|594602440|FG001|Follow-up|Study terminated by sponsor|6|||
164612776|NCT03595384|594602442|FG000|Overall Study|Other time commitments|8|||
164612777|NCT03595384|594602442|FG000|Overall Study|Changes to session time|7|||
164612778|NCT03595384|594602442|FG000|Overall Study|Relocation out of country|1|||
164612779|NCT03803202|594602443|FG000|Overall Study|Other|0|||
164612780|NCT03803202|594602444|FG001|Overall Study|Other|1|||
164612781|NCT03803202|594602445|FG002|Overall Study|Other|0|||
164612782|NCT03803202|594602446|FG003|Overall Study|Other|0|||
164612783|NCT03803202|594602447|FG004|Overall Study|Other|0|||
164612784|NCT03803202|594602448|FG005|Overall Study|Other|0|||
164612785|NCT03803202|594602449|FG006|Overall Study|Other|0|||
164612786|NCT03803202|594602450|FG007|Overall Study|Other|0|||
164612787|NCT03803202|594602451|FG008|Overall Study|Other|0|||
164612788|NCT03803202|594602443|FG000|Overall Study|Death|0|||
164612789|NCT03803202|594602444|FG001|Overall Study|Death|0|||
164612790|NCT03803202|594602445|FG002|Overall Study|Death|0|||
164612791|NCT03803202|594602446|FG003|Overall Study|Death|0|||
164612792|NCT03803202|594602447|FG004|Overall Study|Death|0|||
164612793|NCT03803202|594602448|FG005|Overall Study|Death|1|||
164612794|NCT03803202|594602449|FG006|Overall Study|Death|0|||
164612795|NCT03803202|594602450|FG007|Overall Study|Death|0|||
164612796|NCT03803202|594602451|FG008|Overall Study|Death|0|||
164612797|NCT03803202|594602443|FG000|Overall Study|Withdrawal by Subject|0|||
164612798|NCT03803202|594602444|FG001|Overall Study|Withdrawal by Subject|0|||
164612799|NCT03803202|594602445|FG002|Overall Study|Withdrawal by Subject|1|||
164612800|NCT03803202|594602446|FG003|Overall Study|Withdrawal by Subject|0|||
164612801|NCT03803202|594602447|FG004|Overall Study|Withdrawal by Subject|0|||
164612802|NCT03803202|594602448|FG005|Overall Study|Withdrawal by Subject|0|||
164612803|NCT03803202|594602449|FG006|Overall Study|Withdrawal by Subject|0|||
164612804|NCT03803202|594602450|FG007|Overall Study|Withdrawal by Subject|1|||
164612805|NCT03803202|594602451|FG008|Overall Study|Withdrawal by Subject|0|||
164612806|NCT03803202|594602443|FG000|Overall Study|Lost to Follow-up|0|||
164612807|NCT03803202|594602444|FG001|Overall Study|Lost to Follow-up|0|||
164612808|NCT03803202|594602445|FG002|Overall Study|Lost to Follow-up|0|||
164612809|NCT03803202|594602446|FG003|Overall Study|Lost to Follow-up|1|||
164612810|NCT03803202|594602447|FG004|Overall Study|Lost to Follow-up|1|||
164612811|NCT03803202|594602448|FG005|Overall Study|Lost to Follow-up|0|||
164612812|NCT03803202|594602449|FG006|Overall Study|Lost to Follow-up|1|||
164612813|NCT03803202|594602450|FG007|Overall Study|Lost to Follow-up|0|||
164612814|NCT03803202|594602451|FG008|Overall Study|Lost to Follow-up|0|||
164612815|NCT00293241|594602452|FG000|Overall Study|Lost to Follow-up|9|||
164612816|NCT00293241|594602453|FG001|Overall Study|Lost to Follow-up|16|||
164612817|NCT00293241|594602452|FG000|Overall Study|Physician Decision|23|||
164612818|NCT00293241|594602453|FG001|Overall Study|Physician Decision|17|||
164612819|NCT00293241|594602452|FG000|Overall Study|Withdrawal by Subject|4|||
164612820|NCT00293241|594602453|FG001|Overall Study|Withdrawal by Subject|8|||
164612821|NCT01125293|594602454|FG000|Overall Study|Disease Progression|1|||
164612822|NCT01125293|594602455|FG001|Overall Study|Disease Progression|3|||
164612823|NCT01125293|594602456|FG002|Overall Study|Disease Progression|4|||
164612824|NCT01125293|594602457|FG003|Overall Study|Disease Progression|3|||
164612825|NCT01125293|594602458|FG004|Overall Study|Disease Progression|5|||
164612826|NCT01125293|594602459|FG005|Overall Study|Disease Progression|12|||
164612827|NCT01125293|594602454|FG000|Overall Study|Adverse Event|1|||
164612828|NCT01125293|594602455|FG001|Overall Study|Adverse Event|0|||
164612829|NCT01125293|594602456|FG002|Overall Study|Adverse Event|0|||
164612830|NCT01125293|594602457|FG003|Overall Study|Adverse Event|0|||
164612831|NCT01125293|594602458|FG004|Overall Study|Adverse Event|2|||
164612832|NCT01125293|594602459|FG005|Overall Study|Adverse Event|8|||
164612833|NCT01125293|594602454|FG000|Overall Study|Symptomatic Deterioration|1|||
164612834|NCT01125293|594602455|FG001|Overall Study|Symptomatic Deterioration|0|||
164612835|NCT01125293|594602456|FG002|Overall Study|Symptomatic Deterioration|0|||
164612836|NCT01125293|594602457|FG003|Overall Study|Symptomatic Deterioration|0|||
164612837|NCT01125293|594602458|FG004|Overall Study|Symptomatic Deterioration|0|||
164612838|NCT01125293|594602459|FG005|Overall Study|Symptomatic Deterioration|0|||
164612839|NCT01125293|594602454|FG000|Overall Study|Death|0|||
164612840|NCT01125293|594602455|FG001|Overall Study|Death|0|||
164612841|NCT01125293|594602456|FG002|Overall Study|Death|0|||
164612842|NCT01125293|594602457|FG003|Overall Study|Death|0|||
164612843|NCT01125293|594602458|FG004|Overall Study|Death|1|||
164612844|NCT01125293|594602459|FG005|Overall Study|Death|0|||
164612845|NCT01125293|594602454|FG000|Overall Study|Withdrawal by Subject|0|||
164612846|NCT01125293|594602455|FG001|Overall Study|Withdrawal by Subject|0|||
164612847|NCT01125293|594602456|FG002|Overall Study|Withdrawal by Subject|0|||
164612848|NCT01125293|594602457|FG003|Overall Study|Withdrawal by Subject|0|||
164612849|NCT01125293|594602458|FG004|Overall Study|Withdrawal by Subject|2|||
164612850|NCT01125293|594602459|FG005|Overall Study|Withdrawal by Subject|1|||
164612851|NCT01125293|594602454|FG000|Overall Study|Physician Decision|0|||
164612852|NCT01125293|594602455|FG001|Overall Study|Physician Decision|0|||
164612853|NCT01125293|594602456|FG002|Overall Study|Physician Decision|0|||
164612854|NCT01125293|594602457|FG003|Overall Study|Physician Decision|0|||
164612855|NCT01125293|594602458|FG004|Overall Study|Physician Decision|0|||
164612856|NCT01125293|594602459|FG005|Overall Study|Physician Decision|2|||
164612857|NCT02224638|594602460|FG000|Overall Study|Adverse Event|1|||
164612858|NCT02224638|594602461|FG001|Overall Study|Adverse Event|1|||
164612859|NCT01270958|594602462|FG000|Overall Study|Lost to Follow-up|2|||
164612860|NCT01270958|594602462|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
164612861|NCT01406652|594602463|FG000|Overall Study|Lost-to-follow-up|3|||
164612862|NCT01406652|594602464|FG001|Overall Study|Lost-to-follow-up|4|||
164612863|NCT01406652|594602463|FG000|Overall Study|Withdrawal by Subject|2|||
164612864|NCT01406652|594602464|FG001|Overall Study|Withdrawal by Subject|2|||
164612865|NCT01406652|594602463|FG000|Overall Study|Insufficient follow-up|5|||
164612866|NCT01406652|594602464|FG001|Overall Study|Insufficient follow-up|4|||
164612867|NCT01406652|594602463|FG000|Overall Study|Infection not sure|10|||
164612868|NCT01406652|594602464|FG001|Overall Study|Infection not sure|10|||
164612869|NCT02228564|594602467|FG000|Overall Study|Withdrawal by Subject|10|||
164612870|NCT02228564|594602467|FG000|Overall Study|Death|11|||
164612871|NCT02228564|594602467|FG000|Overall Study|Physician Decision|5|||
164612872|NCT02228564|594602467|FG000|Overall Study|Lost to Follow-up|17|||
164612873|NCT02228564|594602467|FG000|Overall Study|Other|6|||
164612874|NCT02633046|594602469|FG000|Overall Study|Adverse Event|8|||
164612875|NCT02633046|594602469|FG000|Overall Study|Physician Decision|7|||
164612876|NCT02633046|594602469|FG000|Overall Study|Withdrawal by Subject|8|||
164612877|NCT02633046|594602469|FG000|Overall Study|Increased proteinuria|2|||
164612878|NCT02633046|594602469|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
164612879|NCT02633046|594602469|FG000|Overall Study|Mutual decision patient and physician|1|||
164612880|NCT02142504|594602470|FG000|Overall Study|Protocol Violation|2|||
164612881|NCT02142504|594602471|FG001|Overall Study|Protocol Violation|1|||
164612882|NCT02142504|594602472|FG002|Overall Study|Protocol Violation|2|||
164612883|NCT02142504|594602470|FG000|Overall Study|Adverse Event|2|||
164612884|NCT02142504|594602471|FG001|Overall Study|Adverse Event|3|||
164612885|NCT02142504|594602472|FG002|Overall Study|Adverse Event|4|||
164612886|NCT02142504|594602470|FG000|Overall Study|Lost to Follow-up|12|||
164612887|NCT02142504|594602471|FG001|Overall Study|Lost to Follow-up|19|||
164612888|NCT02142504|594602472|FG002|Overall Study|Lost to Follow-up|17|||
164612889|NCT02142504|594602470|FG000|Overall Study|Withdrawal by Subject|7|||
164612890|NCT02142504|594602471|FG001|Overall Study|Withdrawal by Subject|9|||
164612891|NCT02142504|594602472|FG002|Overall Study|Withdrawal by Subject|11|||
164612892|NCT02142504|594602470|FG000|Overall Study|Pregnancy|4|||
164612893|NCT02142504|594602471|FG001|Overall Study|Pregnancy|4|||
164612894|NCT02142504|594602472|FG002|Overall Study|Pregnancy|2|||
164612895|NCT02142504|594602470|FG000|Overall Study|Physician Decision|0|||
164612896|NCT02142504|594602471|FG001|Overall Study|Physician Decision|1|||
164612897|NCT02142504|594602472|FG002|Overall Study|Physician Decision|3|||
164612898|NCT02142504|594602470|FG000|Overall Study|Reason Not Specified|4|||
164612899|NCT02142504|594602471|FG001|Overall Study|Reason Not Specified|5|||
164612900|NCT02142504|594602472|FG002|Overall Study|Reason Not Specified|4|||
164612901|NCT02925312|594602473|FG000|Overall Study|Lost to Follow-up|25|||
164612902|NCT02925312|594602474|FG001|Overall Study|Lost to Follow-up|0|||
164612903|NCT02925312|594602473|FG000|Overall Study|Adverse Event|2|||
164612904|NCT02925312|594602474|FG001|Overall Study|Adverse Event|0|||
164612905|NCT04114539|594602483|FG000|Overall Study|Adverse Event|14|||
164612906|NCT04114539|594602483|FG000|Overall Study|Lost to Follow-up|2|||
164612907|NCT04114539|594602483|FG000|Overall Study|Non-compliance with Protocol|2|||
164612908|NCT04114539|594602483|FG000|Overall Study|Non-compliance with Study Drug|1|||
164612909|NCT04114539|594602483|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
164612910|NCT04114539|594602483|FG000|Overall Study|Withdrew consent|10|||
164612911|NCT04114539|594602483|FG000|Overall Study|Others not specified|5|||
164612912|NCT04114539|594602483|FG000|Overall Study|Investigator Decision|2|||
164612913|NCT03682055|594604501|FG000|Overall Study|Lack of Efficacy|1|||
164612914|NCT03682055|594604502|FG001|Overall Study|Lack of Efficacy|2|||
164612915|NCT03682055|594604503|FG002|Overall Study|Lack of Efficacy|1|||
164612916|NCT03682055|594604504|FG003|Overall Study|Lack of Efficacy|2|||
164612917|NCT03682055|594604505|FG004|Overall Study|Lack of Efficacy|1|||
164612918|NCT03682055|594604506|FG005|Overall Study|Lack of Efficacy|3|||
164612919|NCT03682055|594604501|FG000|Overall Study|Withdrawal by Subject|0|||
164612920|NCT03682055|594604502|FG001|Overall Study|Withdrawal by Subject|0|||
164612921|NCT03682055|594604503|FG002|Overall Study|Withdrawal by Subject|0|||
164612922|NCT03682055|594604504|FG003|Overall Study|Withdrawal by Subject|0|||
164612923|NCT03682055|594604505|FG004|Overall Study|Withdrawal by Subject|0|||
164612924|NCT03682055|594604506|FG005|Overall Study|Withdrawal by Subject|1|||
164612925|NCT03682055|594604501|FG000|Overall Study|Termination of Study by Sponsor|0|||
164612926|NCT03682055|594604502|FG001|Overall Study|Termination of Study by Sponsor|0|||
164612927|NCT03682055|594604503|FG002|Overall Study|Termination of Study by Sponsor|0|||
164612928|NCT03682055|594604504|FG003|Overall Study|Termination of Study by Sponsor|0|||
164612929|NCT03682055|594604505|FG004|Overall Study|Termination of Study by Sponsor|0|||
164612930|NCT03682055|594604506|FG005|Overall Study|Termination of Study by Sponsor|3|||
164612931|NCT00191386|594604507|FG000|Overall Study|Adverse Event|16|||
164612932|NCT00191386|594604507|FG000|Overall Study|Lost to Follow-up|1|||
164612933|NCT00191386|594604507|FG000|Overall Study|Entry Criteria Exclusion|3|||
164612934|NCT00191386|594604507|FG000|Overall Study|Protocol Violation|18|||
164612935|NCT00191386|594604507|FG000|Overall Study|Withdrawal by Subject|96|||
164612936|NCT00191386|594604507|FG000|Overall Study|Physician Decision|11|||
164612937|NCT00191386|594604507|FG000|Overall Study|Lack of Efficacy|15|||
164612938|NCT03077243|594604509|FG000|Overall Study|Death|1|||
164612939|NCT03077243|594604510|FG001|Overall Study|Death|2|||
164612940|NCT03077243|594604511|FG002|Overall Study|Death|0|||
164612941|NCT03077243|594604512|FG003|Overall Study|Death|0|||
164612942|NCT03077243|594604509|FG000|Overall Study|Withdrawal by Subject|1|||
164612943|NCT03077243|594604510|FG001|Overall Study|Withdrawal by Subject|3|||
164612944|NCT03077243|594604511|FG002|Overall Study|Withdrawal by Subject|0|||
164612945|NCT03077243|594604512|FG003|Overall Study|Withdrawal by Subject|0|||
164612946|NCT03077243|594604509|FG000|Overall Study|Physician Decision|1|||
164612947|NCT03077243|594604510|FG001|Overall Study|Physician Decision|0|||
164612948|NCT03077243|594604511|FG002|Overall Study|Physician Decision|0|||
164612949|NCT03077243|594604512|FG003|Overall Study|Physician Decision|0|||
164612950|NCT03077243|594604509|FG000|Overall Study|Research at two study sites terminated early|0|||
164612951|NCT03077243|594604510|FG001|Overall Study|Research at two study sites terminated early|0|||
164612952|NCT03077243|594604511|FG002|Overall Study|Research at two study sites terminated early|0|||
164612953|NCT03077243|594604512|FG003|Overall Study|Research at two study sites terminated early|69|||
164612954|NCT01544478|594604513|FG000|Overall Study|Adverse Event|1|||
164612955|NCT01544478|594604513|FG000|Overall Study|Death|1|||
164612956|NCT01544478|594604513|FG000|Overall Study|Lost to Follow-up|48|||
164612957|NCT01544478|594604513|FG000|Overall Study|Physician Decision|15|||
164612958|NCT01544478|594604513|FG000|Overall Study|Pregnancy|1|||
164612959|NCT01544478|594604513|FG000|Overall Study|Withdrawal by Subject|52|||
164612960|NCT00212758|594604514|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
164612961|NCT00212758|594604515|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
164612962|NCT00212758|594604514|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
164612963|NCT00212758|594604515|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
164612964|NCT02574481|594604516|FG000|Overall Study|Withdrawal by Subject|29|||
164612965|NCT02574481|594604517|FG001|Overall Study|Withdrawal by Subject|15|||
164612966|NCT02574481|594604518|FG002|Overall Study|Withdrawal by Subject|4|||
164612967|NCT02574481|594604519|FG003|Overall Study|Withdrawal by Subject|1|||
164612968|NCT02574481|594604516|FG000|Overall Study|Adverse Event|5|||
164612969|NCT02574481|594604517|FG001|Overall Study|Adverse Event|1|||
164612970|NCT02574481|594604518|FG002|Overall Study|Adverse Event|1|||
164612971|NCT02574481|594604519|FG003|Overall Study|Adverse Event|0|||
164612972|NCT02574481|594604516|FG000|Overall Study|Visit Missed|15|||
164612973|NCT02574481|594604517|FG001|Overall Study|Visit Missed|7|||
164612974|NCT02574481|594604518|FG002|Overall Study|Visit Missed|5|||
164612975|NCT02574481|594604519|FG003|Overall Study|Visit Missed|0|||
164612976|NCT02574481|594604516|FG000|Overall Study|Other|7|||
164612977|NCT02574481|594604517|FG001|Overall Study|Other|2|||
164612978|NCT02574481|594604518|FG002|Overall Study|Other|0|||
164612979|NCT02574481|594604519|FG003|Overall Study|Other|0|||
164612980|NCT02574481|594604516|FG000|Overall Study|Death|48|||
164612981|NCT02574481|594604517|FG001|Overall Study|Death|26|||
164612982|NCT02574481|594604518|FG002|Overall Study|Death|12|||
164612983|NCT02574481|594604519|FG003|Overall Study|Death|4|||
164612984|NCT02574481|594604516|FG000|Overall Study|Physician Decision|5|||
164612985|NCT02574481|594604517|FG001|Overall Study|Physician Decision|2|||
164612986|NCT02574481|594604518|FG002|Overall Study|Physician Decision|0|||
164612987|NCT02574481|594604519|FG003|Overall Study|Physician Decision|0|||
164612988|NCT02574481|594604516|FG000|Overall Study|Lost to Follow-up|5|||
164612989|NCT02574481|594604517|FG001|Overall Study|Lost to Follow-up|1|||
164612990|NCT02574481|594604518|FG002|Overall Study|Lost to Follow-up|3|||
164612991|NCT02574481|594604519|FG003|Overall Study|Lost to Follow-up|0|||
164612992|NCT01105936|594604523|FG000|Period 1|Adverse Event|0|||
164612993|NCT01105936|594604524|FG001|Period 1|Adverse Event|0|||
164612994|NCT01105936|594604525|FG002|Period 1|Adverse Event|0|||
164612995|NCT01105936|594604526|FG003|Period 1|Adverse Event|1|||
164612996|NCT01105936|594604523|FG000|Period 2|Adverse Event|1|||
164612997|NCT01105936|594604524|FG001|Period 2|Adverse Event|0|||
164612998|NCT01105936|594604525|FG002|Period 2|Adverse Event|0|||
164612999|NCT01105936|594604526|FG003|Period 2|Adverse Event|0|||
164613000|NCT01105936|594604523|FG000|Period 3|Protocol Violation|0|||
164613001|NCT01105936|594604524|FG001|Period 3|Protocol Violation|2|||
164613002|NCT01105936|594604525|FG002|Period 3|Protocol Violation|0|||
164613003|NCT01105936|594604526|FG003|Period 3|Protocol Violation|0|||
164613004|NCT00446641|594604527|FG000|Overall Study|Withdrawal by Subject|8|||
164613005|NCT00446641|594604528|FG001|Overall Study|Withdrawal by Subject|3|||
164613006|NCT00446641|594604527|FG000|Overall Study|poor compliance|8|||
164613007|NCT00446641|594604528|FG001|Overall Study|poor compliance|6|||
164613008|NCT00446641|594604527|FG000|Overall Study|Lost to Follow-up|1|||
164613009|NCT00446641|594604528|FG001|Overall Study|Lost to Follow-up|1|||
164613010|NCT00086385|594604532|FG000|Overall Study|Death|2|||
164613011|NCT00086385|594604533|FG001|Overall Study|Death|2|||
164613012|NCT00086385|594604534|FG002|Overall Study|Death|1|||
164613013|NCT00086385|594604535|FG003|Overall Study|Death|1|||
164613014|NCT04038385|594604536|FG000|Overall Study|Completed baseline assessment only|7|||
164613015|NCT04038385|594604537|FG001|Overall Study|Completed baseline assessment only|4|||
164613016|NCT04038385|594604536|FG000|Overall Study|Moved out of area|4|||
164613017|NCT04038385|594604537|FG001|Overall Study|Moved out of area|2|||
164613018|NCT04038385|594604536|FG000|Overall Study|Discontinued study involvement|6|||
164613019|NCT04038385|594604537|FG001|Overall Study|Discontinued study involvement|1|||
164613020|NCT00402285|594604544|FG000|Overall Study|insufficient RNA quality|7|||
164613021|NCT00402285|594604545|FG001|Overall Study|insufficient RNA quality|6|||
164613022|NCT00402285|594604546|FG002|Overall Study|insufficient RNA quality|2|||
164613023|NCT00784459|594604549|FG000|Overall Study|Adverse Event|0|||
164613024|NCT00784459|594604550|FG001|Overall Study|Adverse Event|2|||
164613025|NCT00405275|594604551|FG000|Overall Study|Death|1|||
164613026|NCT00405275|594604552|FG001|Overall Study|Death|0|||
164613027|NCT00405275|594604551|FG000|Overall Study|Lost to Follow-up|5|||
164613028|NCT00405275|594604552|FG001|Overall Study|Lost to Follow-up|1|||
164613029|NCT00405275|594604551|FG000|Overall Study|Withdrawal by Subject|7|||
164613030|NCT00405275|594604552|FG001|Overall Study|Withdrawal by Subject|9|||
164613031|NCT00405275|594604551|FG000|Overall Study|Unwilling to continue|10|||
164613032|NCT00405275|594604552|FG001|Overall Study|Unwilling to continue|9|||
164613033|NCT00088595|594604553|FG000|Overall Study|Adverse Event|11|||
164613034|NCT00088595|594604553|FG000|Overall Study|Withdrawal by Subject|8|||
164613035|NCT00088595|594604553|FG000|Overall Study|Ongoing (After Core)|7|||
164613036|NCT00088595|594604553|FG000|Overall Study|New Cancer Therapy|2|||
164613037|NCT02959970|594604568|FG000|Overall Study|Adverse Event|1|||
164613038|NCT02959970|594604569|FG001|Overall Study|Adverse Event|0|||
164613039|NCT02959970|594604568|FG000|Overall Study|Withdrawal by Subject|0|||
164613040|NCT02959970|594604569|FG001|Overall Study|Withdrawal by Subject|2|||
164613041|NCT02959970|594604568|FG000|Overall Study|Lost to Follow-up|1|||
164613042|NCT02959970|594604569|FG001|Overall Study|Lost to Follow-up|5|||
164613043|NCT01473355|594604574|FG000|Overall Study|Protocol Violation|2|||
164613044|NCT01473355|594604574|FG000|Overall Study|Adverse Event|2|||
164613045|NCT01473355|594604574|FG000|Overall Study|Lost to Follow-up|2|||
164613046|NCT02603172|594604583|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
164613047|NCT02603172|594604584|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
164613048|NCT02603172|594604585|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
164613049|NCT02603172|594604586|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
164613050|NCT02603172|594604587|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
164613051|NCT02603172|594604588|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
164613052|NCT02603172|594604589|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
164613053|NCT02603172|594604590|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
164613054|NCT00863317|594604591|FG000|Overall Study|Lost to Follow-up|8|||
164613055|NCT00863317|594604592|FG001|Overall Study|Lost to Follow-up|9|||
164613056|NCT00441727|594604593|FG000|Overall Study|Protocol Violation|19|||
164613057|NCT00441727|594604594|FG001|Overall Study|Protocol Violation|28|||
164613058|NCT00441727|594604595|FG002|Overall Study|Protocol Violation|32|||
164613059|NCT00441727|594604593|FG000|Overall Study|Adverse Event|26|||
164613060|NCT00441727|594604594|FG001|Overall Study|Adverse Event|33|||
164613061|NCT00441727|594604595|FG002|Overall Study|Adverse Event|28|||
164613062|NCT00441727|594604593|FG000|Overall Study|Lack of Efficacy|7|||
164613063|NCT00441727|594604594|FG001|Overall Study|Lack of Efficacy|8|||
164613064|NCT00441727|594604595|FG002|Overall Study|Lack of Efficacy|48|||
164613065|NCT00441727|594604593|FG000|Overall Study|Withdrawal by Subject|40|||
164613066|NCT00441727|594604594|FG001|Overall Study|Withdrawal by Subject|34|||
164613067|NCT00441727|594604595|FG002|Overall Study|Withdrawal by Subject|47|||
164613068|NCT00441727|594604593|FG000|Overall Study|Lost to Follow-up|5|||
164613069|NCT00441727|594604594|FG001|Overall Study|Lost to Follow-up|6|||
164613070|NCT00441727|594604595|FG002|Overall Study|Lost to Follow-up|5|||
164613071|NCT00441727|594604593|FG000|Overall Study|Safety Reasons|3|||
164613072|NCT00441727|594604594|FG001|Overall Study|Safety Reasons|1|||
164613073|NCT00441727|594604595|FG002|Overall Study|Safety Reasons|3|||
164613074|NCT00441727|594604593|FG000|Overall Study|Various reason specified|6|||
164613075|NCT00441727|594604594|FG001|Overall Study|Various reason specified|8|||
164613076|NCT00441727|594604595|FG002|Overall Study|Various reason specified|5|||
164613077|NCT03417505|594604598|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
164613078|NCT03417505|594604599|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
164613079|NCT02133001|594604600|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
164613080|NCT02133001|594604601|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
164613081|NCT02133001|594604600|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
164613082|NCT02133001|594604601|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
164613083|NCT02133001|594604600|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
164613084|NCT02133001|594604601|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
164613085|NCT02133001|594604600|FG000|Double Blind (Day 1-25)|Other|2|||
164613086|NCT02133001|594604601|FG001|Double Blind (Day 1-25)|Other|2|||
164613087|NCT02133001|594604600|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
164613088|NCT02133001|594604601|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
164613089|NCT02133001|594604600|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
164613090|NCT02133001|594604601|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
164613091|NCT02133001|594604600|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
164613092|NCT02133001|594604601|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
164613093|NCT02133001|594604600|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
164613094|NCT02133001|594604601|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
164613095|NCT04211961|594604602|FG000|Overall Study|Death|0|||
164613096|NCT04211961|594604603|FG001|Overall Study|Death|1|||
164613097|NCT04211961|594604602|FG000|Overall Study|Lost to Follow-up|0|||
164613098|NCT04211961|594604603|FG001|Overall Study|Lost to Follow-up|1|||
164516051|NCT00208325|594259187|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
164516052|NCT00208325|594259188|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
164516053|NCT00208325|594259189|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
164516054|NCT00208325|594259186|FG000|Overall Study|Does not wish to Continue in Study|5|||
164516055|NCT00208325|594259187|FG001|Overall Study|Does not wish to Continue in Study|8|||
164516056|NCT00208325|594259188|FG002|Overall Study|Does not wish to Continue in Study|3|||
164516057|NCT00208325|594259189|FG003|Overall Study|Does not wish to Continue in Study|2|||
164516058|NCT00208325|594259186|FG000|Overall Study|Other|2|||
164516059|NCT00208325|594259187|FG001|Overall Study|Other|1|||
164516060|NCT00208325|594259188|FG002|Overall Study|Other|1|||
164516061|NCT00208325|594259189|FG003|Overall Study|Other|0|||
164516062|NCT00208325|594259186|FG000|Overall Study|Mis-Randomized|17|||
164516063|NCT00208325|594259187|FG001|Overall Study|Mis-Randomized|20|||
164516064|NCT00208325|594259188|FG002|Overall Study|Mis-Randomized|0|||
164516065|NCT00208325|594259189|FG003|Overall Study|Mis-Randomized|0|||
164516066|NCT01327846|594259190|FG000|Core Phase|Subject decision (vital status: missing)|1|||
164516067|NCT01327846|594259191|FG001|Core Phase|Subject decision (vital status: missing)|2|||
164516068|NCT01327846|594259192|FG002|Core Phase|Subject decision (vital status: missing)|2|||
164516069|NCT01327846|594259193|FG003|Core Phase|Subject decision (vital status: missing)|1|||
164516070|NCT01327846|594259190|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
164516071|NCT01327846|594259191|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
164516072|NCT01327846|594259192|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
164516073|NCT01327846|594259193|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
164516074|NCT01327846|594259190|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
164516075|NCT01327846|594259191|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
164516076|NCT01327846|594259192|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
164516077|NCT01327846|594259193|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
164516078|NCT01327846|594259190|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
164516079|NCT01327846|594259191|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
164516080|NCT01327846|594259192|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
164516081|NCT01327846|594259193|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
164516082|NCT01327846|594259190|FG000|Core Phase|Lost to Follow-up|3|||
164516083|NCT01327846|594259191|FG001|Core Phase|Lost to Follow-up|3|||
164516084|NCT01327846|594259192|FG002|Core Phase|Lost to Follow-up|4|||
164516085|NCT01327846|594259193|FG003|Core Phase|Lost to Follow-up|5|||
164516086|NCT01327846|594259190|FG000|Extension Phase|Study terminated by sponsor|1073|||
164516087|NCT01327846|594259191|FG001|Extension Phase|Study terminated by sponsor|1124|||
164516088|NCT01327846|594259192|FG002|Extension Phase|Study terminated by sponsor|1067|||
164516089|NCT01327846|594259193|FG003|Extension Phase|Study terminated by sponsor|1660|||
164516090|NCT01327846|594259190|FG000|Extension Phase|Withdrawal by Subject|20|||
164516091|NCT01327846|594259191|FG001|Extension Phase|Withdrawal by Subject|13|||
164516092|NCT01327846|594259192|FG002|Extension Phase|Withdrawal by Subject|19|||
164516093|NCT01327846|594259193|FG003|Extension Phase|Withdrawal by Subject|37|||
164516094|NCT01327846|594259190|FG000|Extension Phase|Lost to Follow-up|4|||
164516095|NCT01327846|594259191|FG001|Extension Phase|Lost to Follow-up|3|||
164516096|NCT01327846|594259192|FG002|Extension Phase|Lost to Follow-up|4|||
164516097|NCT01327846|594259193|FG003|Extension Phase|Lost to Follow-up|7|||
164516098|NCT01327846|594259190|FG000|Extension Phase|Technical Problems|2|||
164516099|NCT01327846|594259191|FG001|Extension Phase|Technical Problems|4|||
164516100|NCT01327846|594259192|FG002|Extension Phase|Technical Problems|2|||
164516101|NCT01327846|594259193|FG003|Extension Phase|Technical Problems|2|||
164516102|NCT04662931|594259196|FG000|Overall Study|Withdrawal by Subject|17|||
164516103|NCT04662931|594259196|FG000|Overall Study|Death|3|||
164516104|NCT04662931|594259196|FG000|Overall Study|Lost to Follow-up|3|||
164516105|NCT04662931|594259196|FG000|Overall Study|Guardian Decision|1|||
164516106|NCT04343976|594259198|FG000|Overall Study|Withdrawal by Subject|0|||
164516107|NCT04343976|594259199|FG001|Overall Study|Withdrawal by Subject|1|||
164516108|NCT02807883|594259200|FG000|Overall Study|Withdrawal by Subject|2|||
164516109|NCT03852719|594259201|FG000|Overall Study|Withdrawal of consent|8|||
164516110|NCT03852719|594259202|FG001|Overall Study|Withdrawal of consent|8|||
164516111|NCT03852719|594259203|FG002|Overall Study|Withdrawal of consent|9|||
164516112|NCT03852719|594259201|FG000|Overall Study|Physician Decision|5|||
164516113|NCT03852719|594259202|FG001|Overall Study|Physician Decision|4|||
164516114|NCT03852719|594259203|FG002|Overall Study|Physician Decision|1|||
164516115|NCT03852719|594259201|FG000|Overall Study|Pregnancy|2|||
164516116|NCT03852719|594259202|FG001|Overall Study|Pregnancy|1|||
164516117|NCT03852719|594259203|FG002|Overall Study|Pregnancy|0|||
164516118|NCT03852719|594259201|FG000|Overall Study|Death|1|||
164516119|NCT03852719|594259202|FG001|Overall Study|Death|0|||
164516120|NCT03852719|594259203|FG002|Overall Study|Death|0|||
164516121|NCT03852719|594259201|FG000|Overall Study|Reason not Specified|3|||
164516122|NCT03852719|594259202|FG001|Overall Study|Reason not Specified|3|||
164516123|NCT03852719|594259203|FG002|Overall Study|Reason not Specified|5|||
164516124|NCT03852719|594259201|FG000|Overall Study|Adverse Event|2|||
164516125|NCT03852719|594259202|FG001|Overall Study|Adverse Event|1|||
164516126|NCT03852719|594259203|FG002|Overall Study|Adverse Event|4|||
164516127|NCT03852719|594259201|FG000|Overall Study|Progressive disease|1|||
164516128|NCT03852719|594259202|FG001|Overall Study|Progressive disease|4|||
164516129|NCT03852719|594259203|FG002|Overall Study|Progressive disease|1|||
164516130|NCT03852719|594259201|FG000|Overall Study|Lost to Follow-up|1|||
164516131|NCT03852719|594259202|FG001|Overall Study|Lost to Follow-up|0|||
164516132|NCT03852719|594259203|FG002|Overall Study|Lost to Follow-up|0|||
164516133|NCT03843554|594260783|FG000|Overall Study|Physician Decision|0|||
164516134|NCT03843554|594260784|FG001|Overall Study|Physician Decision|2|||
164516135|NCT02218606|594260786|FG000|Overall Study|Adverse Event|1|||
164516136|NCT02218606|594260787|FG001|Overall Study|Adverse Event|1|||
164516137|NCT02218606|594260786|FG000|Overall Study|Death|15|||
164516138|NCT02218606|594260787|FG001|Overall Study|Death|28|||
164516139|NCT02218606|594260786|FG000|Overall Study|Physician Decision|0|||
164516140|NCT02218606|594260787|FG001|Overall Study|Physician Decision|1|||
164516141|NCT02218606|594260786|FG000|Overall Study|Withdrawal by Subject|4|||
164516142|NCT02218606|594260787|FG001|Overall Study|Withdrawal by Subject|0|||
164516143|NCT02218606|594260786|FG000|Overall Study|Noncompliance|1|||
164516144|NCT02218606|594260787|FG001|Overall Study|Noncompliance|0|||
164516145|NCT02218606|594260786|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
164516146|NCT02218606|594260787|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
164516147|NCT02218606|594260786|FG000|Overall Study|Other|2|||
164516148|NCT02218606|594260787|FG001|Overall Study|Other|1|||
164516149|NCT02218606|594260786|FG000|Overall Study|Never started treatment|0|||
164516150|NCT02218606|594260787|FG001|Overall Study|Never started treatment|1|||
164516151|NCT00890695|594260788|FG000|Overall Study|Protocol Violation|1|||
164516152|NCT00890695|594260789|FG001|Overall Study|Protocol Violation|0|||
164516153|NCT04396366|594260792|FG000|Overall Study|Adverse Event|1|||
164516154|NCT04396366|594260793|FG001|Overall Study|Adverse Event|0|||
164516155|NCT01127893|594260799|FG000|Overall Study|Study Termination by the Sponsor|1|||
164516156|NCT01262677|594260800|FG000|Overall Study|Does not meet entrance criteria|0|||
164516157|NCT01262677|594260801|FG001|Overall Study|Does not meet entrance criteria|2|||
164516158|NCT01262677|594260802|FG002|Overall Study|Does not meet entrance criteria|0|||
164516159|NCT01262677|594260800|FG000|Overall Study|Insufficient clinical response|0|||
164516160|NCT01262677|594260801|FG001|Overall Study|Insufficient clinical response|0|||
164516161|NCT01262677|594260802|FG002|Overall Study|Insufficient clinical response|1|||
164516162|NCT01262677|594260800|FG000|Overall Study|Lost to Follow-up|1|||
164516163|NCT01262677|594260801|FG001|Overall Study|Lost to Follow-up|0|||
164516164|NCT01262677|594260802|FG002|Overall Study|Lost to Follow-up|2|||
164516165|NCT01262677|594260800|FG000|Overall Study|No longer willing to participate|3|||
164516166|NCT01262677|594260801|FG001|Overall Study|No longer willing to participate|3|||
164516167|NCT01262677|594260802|FG002|Overall Study|No longer willing to participate|2|||
164516168|NCT01262677|594260800|FG000|Overall Study|Reason not provided|2|||
164516169|NCT01262677|594260801|FG001|Overall Study|Reason not provided|1|||
164516170|NCT01262677|594260802|FG002|Overall Study|Reason not provided|3|||
164516171|NCT01262677|594260800|FG000|Overall Study|Protocol Violation|0|||
164516172|NCT01262677|594260801|FG001|Overall Study|Protocol Violation|1|||
164516173|NCT01262677|594260802|FG002|Overall Study|Protocol Violation|1|||
164516174|NCT01262677|594260800|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
164613099|NCT04211961|594604602|FG000|Overall Study|Withdrawal by Subject|0|||
164613100|NCT04211961|594604603|FG001|Overall Study|Withdrawal by Subject|1|||
164613101|NCT03235726|594604608|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
164613102|NCT03235726|594604609|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
164613103|NCT03235726|594604610|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
164613104|NCT03235726|594604611|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
164613105|NCT03235726|594604612|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
164613106|NCT03235726|594604613|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
164613107|NCT03235726|594604614|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
164613108|NCT03235726|594604615|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
164613109|NCT03235726|594604616|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
164613110|NCT03235726|594604617|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
164613111|NCT03235726|594604608|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
164613112|NCT03235726|594604609|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
164613113|NCT03235726|594604610|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
164613114|NCT03235726|594604611|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
164613115|NCT03235726|594604612|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
164613116|NCT03235726|594604613|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
164613117|NCT03235726|594604614|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
164613118|NCT03235726|594604615|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
164613119|NCT03235726|594604616|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
164613120|NCT03235726|594604617|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
164613121|NCT00425113|594604618|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
164613122|NCT00425113|594604619|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
164613123|NCT00425113|594604618|FG000|Overall Study|diagnosis of abdominal TB|0|||
164613124|NCT00425113|594604619|FG001|Overall Study|diagnosis of abdominal TB|1|||
164613125|NCT00425113|594604618|FG000|Overall Study|missing study drug more than 14 days|0|||
164613126|NCT00425113|594604619|FG001|Overall Study|missing study drug more than 14 days|1|||
164613127|NCT00425113|594604618|FG000|Overall Study|Withdrawal by Subject|1|||
164613128|NCT00425113|594604619|FG001|Overall Study|Withdrawal by Subject|0|||
164613129|NCT00879437|594604620|FG000|Overall Study|Protocol Violation|0|||
164613130|NCT00879437|594604621|FG001|Overall Study|Protocol Violation|1|||
164613131|NCT00879437|594604620|FG000|Overall Study|Death|1|||
164613132|NCT00879437|594604621|FG001|Overall Study|Death|0|||
164613133|NCT00268463|594604622|FG000|Overall Study|study terminated due to low accrual|10|||
164613134|NCT00268463|594604623|FG001|Overall Study|study terminated due to low accrual|12|||
164613135|NCT04685538|594604624|FG000|Overall Study|Adverse Event|0|||
164613136|NCT04685538|594604625|FG001|Overall Study|Adverse Event|1|||
164613137|NCT04685538|594604624|FG000|Overall Study|Lost to Follow-up|0|||
164613138|NCT04685538|594604625|FG001|Overall Study|Lost to Follow-up|2|||
164613139|NCT02920450|594604626|FG000|Overall Study|Death|1|||
164613140|NCT02920450|594604627|FG001|Overall Study|Death|0|||
164613141|NCT02920450|594604628|FG002|Overall Study|Death|0|||
164613142|NCT02920450|594604629|FG003|Overall Study|Death|0|||
164613143|NCT02920450|594604626|FG000|Overall Study|Withdrawal by Subject|1|||
164613144|NCT02920450|594604627|FG001|Overall Study|Withdrawal by Subject|0|||
164613145|NCT02920450|594604628|FG002|Overall Study|Withdrawal by Subject|0|||
164613146|NCT02920450|594604629|FG003|Overall Study|Withdrawal by Subject|0|||
164613147|NCT01040845|594604630|FG000|Overall Study|Withdrawal by Subject|1|||
164613148|NCT01040845|594604631|FG001|Overall Study|Withdrawal by Subject|1|||
164613149|NCT01040845|594604630|FG000|Overall Study|Physician Decision|1|||
164613150|NCT01040845|594604631|FG001|Overall Study|Physician Decision|0|||
164613151|NCT04362813|594604632|FG000|Overall Study|Death|12|||
164613152|NCT04362813|594604633|FG001|Overall Study|Death|16|||
164613153|NCT04362813|594604632|FG000|Overall Study|Withdrawal by Subject|3|||
164613154|NCT04362813|594604633|FG001|Overall Study|Withdrawal by Subject|1|||
164613155|NCT04362813|594604632|FG000|Overall Study|Protocol Violation|0|||
164613156|NCT04362813|594604633|FG001|Overall Study|Protocol Violation|3|||
164613157|NCT04362813|594604632|FG000|Overall Study|Lost to Follow-up|1|||
164613158|NCT04362813|594604633|FG001|Overall Study|Lost to Follow-up|1|||
164613159|NCT04362813|594604632|FG000|Overall Study|Enrolled but did not receive treatment|2|||
164613160|NCT04362813|594604633|FG001|Overall Study|Enrolled but did not receive treatment|4|||
164613161|NCT01732107|594604638|FG000|Overall Study|Adverse Event|2|||
164613162|NCT01732107|594604638|FG000|Overall Study|Disease Progression|8|||
164613163|NCT01732107|594604638|FG000|Overall Study|Physician Decision|1|||
164613164|NCT01732107|594604638|FG000|Overall Study|Withdrawal by Subject|2|||
164613165|NCT04445688|594604639|FG000|Washout (One Week)|Adverse Event|2|||
164613166|NCT04445688|594604639|FG000|Washout (One Week)|Withdrawal by Subject|1|||
164613167|NCT00918346|594604643|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
164613168|NCT00918346|594604644|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
164613169|NCT03379376|594604645|FG000|Overall Study|Lost to Follow-up|2|||
164613170|NCT03379376|594604645|FG000|Overall Study|Did not wish to complete follow up|1|||
164613171|NCT03379376|594604645|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
164613172|NCT03379376|594604645|FG000|Overall Study|Death|1|||
164613173|NCT02475629|594604646|FG000|Overall Study|Adverse Event|1|||
164613174|NCT02475629|594604646|FG000|Overall Study|Death|4|||
164613175|NCT02475629|594604646|FG000|Overall Study|Physician Decision|1|||
164613176|NCT02475629|594604646|FG000|Overall Study|Withdrawal by Subject|1|||
164613177|NCT02475629|594604646|FG000|Overall Study|Lost to Follow-up|1|||
164613178|NCT02475629|594604646|FG000|Overall Study|Subject non-compliance|1|||
164613179|NCT04083794|594604647|FG000|Overall Study|Lost to Follow-up|9|||
164613180|NCT00224003|594604654|FG000|Overall Study|Adverse Event|1|||
164613181|NCT00224003|594604654|FG000|Overall Study|Protocol Violation|2|||
164613182|NCT00224003|594604654|FG000|Overall Study|Withdrawal by Subject|1|||
164613183|NCT00224003|594604654|FG000|Overall Study|unk|3|||
164613184|NCT03549429|594604655|FG000|Overall Study|Protocol Violation|5|||
164613185|NCT03549429|594604656|FG001|Overall Study|Protocol Violation|3|||
164613186|NCT00729326|594604666|FG000|Overall Study|Lost to Follow-up|2|||
164613187|NCT00729326|594604667|FG001|Overall Study|Lost to Follow-up|0|||
164613188|NCT00729326|594604666|FG000|Overall Study|Physician Decision|0|||
164613189|NCT00729326|594604667|FG001|Overall Study|Physician Decision|1|||
164613190|NCT00729326|594604666|FG000|Overall Study|Protocol Violation|3|||
164613191|NCT00729326|594604667|FG001|Overall Study|Protocol Violation|2|||
164613192|NCT00729326|594604666|FG000|Overall Study|Subject Decision|4|||
164613193|NCT00729326|594604667|FG001|Overall Study|Subject Decision|4|||
164613194|NCT00729326|594604666|FG000|Overall Study|Sponsor Decision|1|||
164613195|NCT00729326|594604667|FG001|Overall Study|Sponsor Decision|2|||
164613196|NCT01235728|594604668|FG000|Overall Study|Protocol Violation|0|||
164613197|NCT01235728|594604669|FG001|Overall Study|Protocol Violation|0|||
164613198|NCT01235728|594604670|FG002|Overall Study|Protocol Violation|0|||
164613199|NCT01235728|594604671|FG003|Overall Study|Protocol Violation|1|||
164613200|NCT01235728|594604672|FG004|Overall Study|Protocol Violation|0|||
164613201|NCT01235728|594604673|FG005|Overall Study|Protocol Violation|0|||
164613202|NCT01235728|594604674|FG006|Overall Study|Protocol Violation|0|||
164613203|NCT01235728|594604675|FG007|Overall Study|Protocol Violation|0|||
164613204|NCT01000025|594604676|FG000|Overall Study|Adverse Event|43|||
164613205|NCT01000025|594604677|FG001|Overall Study|Adverse Event|2|||
164613206|NCT01000025|594604676|FG000|Overall Study|Withdrawal by Subject|13|||
164613207|NCT01000025|594604677|FG001|Overall Study|Withdrawal by Subject|8|||
164613208|NCT01000025|594604676|FG000|Overall Study|Death|23|||
164613209|NCT01000025|594604677|FG001|Overall Study|Death|13|||
164613210|NCT01000025|594604676|FG000|Overall Study|Lack of Efficacy|363|||
164613211|NCT01000025|594604677|FG001|Overall Study|Lack of Efficacy|208|||
164613212|NCT01000025|594604676|FG000|Overall Study|Intercurrent Illness|26|||
164613213|NCT01000025|594604677|FG001|Overall Study|Intercurrent Illness|7|||
164613214|NCT04423757|594604678|FG000|Overall Study|Adverse Event|2|||
164613215|NCT04423757|594604679|FG001|Overall Study|Adverse Event|0|||
164613216|NCT04423757|594604678|FG000|Overall Study|Not treated|1|||
164613217|NCT04423757|594604679|FG001|Overall Study|Not treated|1|||
164613218|NCT01202760|594604680|FG000|Overall Study|Entry Criteria Not Met|0|||
164613219|NCT01202760|594604681|FG001|Overall Study|Entry Criteria Not Met|3|||
164613220|NCT01202760|594604682|FG002|Overall Study|Entry Criteria Not Met|1|||
164613221|NCT01202760|594604680|FG000|Overall Study|Adverse Event|11|||
164613222|NCT01202760|594604681|FG001|Overall Study|Adverse Event|9|||
164613223|NCT01202760|594604682|FG002|Overall Study|Adverse Event|10|||
164613224|NCT01202760|594604680|FG000|Overall Study|Death|2|||
164613225|NCT01202760|594604681|FG001|Overall Study|Death|1|||
164613226|NCT01202760|594604682|FG002|Overall Study|Death|0|||
164613227|NCT01202760|594604680|FG000|Overall Study|Lack of Efficacy|6|||
164613228|NCT01202760|594604681|FG001|Overall Study|Lack of Efficacy|8|||
164613229|NCT01202760|594604682|FG002|Overall Study|Lack of Efficacy|7|||
164613230|NCT01202760|594604680|FG000|Overall Study|Lost to Follow-up|0|||
164613231|NCT01202760|594604681|FG001|Overall Study|Lost to Follow-up|2|||
164613232|NCT01202760|594604682|FG002|Overall Study|Lost to Follow-up|1|||
164613233|NCT01202760|594604680|FG000|Overall Study|Parent / Caregiver Decision|0|||
164613234|NCT01202760|594604681|FG001|Overall Study|Parent / Caregiver Decision|1|||
164613235|NCT01202760|594604682|FG002|Overall Study|Parent / Caregiver Decision|0|||
164613236|NCT01202760|594604680|FG000|Overall Study|Withdrawal by Subject|17|||
164613237|NCT01202760|594604681|FG001|Overall Study|Withdrawal by Subject|18|||
164613238|NCT01202760|594604682|FG002|Overall Study|Withdrawal by Subject|14|||
164613239|NCT01202760|594604680|FG000|Overall Study|Physician Decision|0|||
164613240|NCT01202760|594604681|FG001|Overall Study|Physician Decision|1|||
164613241|NCT01202760|594604682|FG002|Overall Study|Physician Decision|0|||
164613242|NCT01202760|594604680|FG000|Overall Study|Protocol Violation|7|||
164613243|NCT01202760|594604681|FG001|Overall Study|Protocol Violation|5|||
164613244|NCT01202760|594604682|FG002|Overall Study|Protocol Violation|2|||
164613245|NCT01202760|594604680|FG000|Overall Study|Sponsor Decision|4|||
164613246|NCT01202760|594604681|FG001|Overall Study|Sponsor Decision|4|||
164613247|NCT01202760|594604682|FG002|Overall Study|Sponsor Decision|0|||
164613248|NCT01654523|594604683|FG000|Overall Study|Withdrawal by Subject|1|||
164613249|NCT00418717|594604686|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
164613250|NCT00418717|594604686|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
164613251|NCT01400139|594604687|FG000|HYD Core Study|Adverse Event|210|||
164613252|NCT01400139|594604687|FG000|HYD Core Study|Lack of Efficacy|59|||
164516175|NCT01262677|594260801|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
164516176|NCT01262677|594260802|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
164516177|NCT00574873|594260803|FG000|Overall Study|Withdrawal by Subject|18|||
164516178|NCT00574873|594260804|FG001|Overall Study|Withdrawal by Subject|19|||
164516179|NCT00574873|594260803|FG000|Overall Study|Investigator request|18|||
164516180|NCT00574873|594260804|FG001|Overall Study|Investigator request|8|||
164516181|NCT00574873|594260803|FG000|Overall Study|Death|15|||
164516182|NCT00574873|594260804|FG001|Overall Study|Death|14|||
164516183|NCT00574873|594260803|FG000|Overall Study|Lost to Follow-up|14|||
164516184|NCT00574873|594260804|FG001|Overall Study|Lost to Follow-up|5|||
164516185|NCT00574873|594260803|FG000|Overall Study|Other|40|||
164516186|NCT00574873|594260804|FG001|Overall Study|Other|4|||
164516187|NCT00574873|594260803|FG000|Overall Study|Discontinuation of study by sponsor|5|||
164516188|NCT00574873|594260804|FG001|Overall Study|Discontinuation of study by sponsor|199|||
164516189|NCT00574873|594260803|FG000|Overall Study|Blank, site closed per local regulations|2|||
164516190|NCT00574873|594260804|FG001|Overall Study|Blank, site closed per local regulations|2|||
164516191|NCT00574873|594260803|FG000|Overall Study|Extension Study|126|||
164516192|NCT00574873|594260804|FG001|Overall Study|Extension Study|0|||
164516193|NCT02187159|594260807|FG000|Overall Study|Protocol Violation|4|||
164516194|NCT02187159|594260808|FG001|Overall Study|Protocol Violation|6|||
164516195|NCT02187159|594260809|FG002|Overall Study|Protocol Violation|3|||
164516196|NCT02187159|594260810|FG003|Overall Study|Protocol Violation|4|||
164516197|NCT02187159|594260807|FG000|Overall Study|Lack of Efficacy|10|||
164516198|NCT02187159|594260808|FG001|Overall Study|Lack of Efficacy|5|||
164516199|NCT02187159|594260809|FG002|Overall Study|Lack of Efficacy|4|||
164516200|NCT02187159|594260810|FG003|Overall Study|Lack of Efficacy|7|||
164516201|NCT02187159|594260807|FG000|Overall Study|Adverse Event|28|||
164516202|NCT02187159|594260808|FG001|Overall Study|Adverse Event|33|||
164516203|NCT02187159|594260809|FG002|Overall Study|Adverse Event|42|||
164516204|NCT02187159|594260810|FG003|Overall Study|Adverse Event|50|||
164516205|NCT02187159|594260807|FG000|Overall Study|Withdrawal by Subject|24|||
164516206|NCT02187159|594260808|FG001|Overall Study|Withdrawal by Subject|28|||
164516207|NCT02187159|594260809|FG002|Overall Study|Withdrawal by Subject|25|||
164516208|NCT02187159|594260810|FG003|Overall Study|Withdrawal by Subject|26|||
164516209|NCT02187159|594260807|FG000|Overall Study|Other|3|||
164516210|NCT02187159|594260808|FG001|Overall Study|Other|7|||
164516211|NCT02187159|594260809|FG002|Overall Study|Other|3|||
164516212|NCT02187159|594260810|FG003|Overall Study|Other|9|||
164516213|NCT01283152|594260811|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
164516214|NCT01283152|594260812|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
164516215|NCT01283152|594260811|FG000|Overall Study|Refused HESA|1|||
164516216|NCT01283152|594260812|FG001|Overall Study|Refused HESA|0|||
164516217|NCT00567567|594260813|FG000|Overall Study|Adverse Event|0|||
164516218|NCT00567567|594260814|FG001|Overall Study|Adverse Event|2|||
164516219|NCT00567567|594260815|FG002|Overall Study|Adverse Event|5|||
164516220|NCT00567567|594260813|FG000|Overall Study|Death|8|||
164516221|NCT00567567|594260814|FG001|Overall Study|Death|1|||
164516222|NCT00567567|594260815|FG002|Overall Study|Death|5|||
164516223|NCT00567567|594260813|FG000|Overall Study|Lack of Efficacy|16|||
164516224|NCT00567567|594260814|FG001|Overall Study|Lack of Efficacy|17|||
164516225|NCT00567567|594260815|FG002|Overall Study|Lack of Efficacy|48|||
164516226|NCT00567567|594260813|FG000|Overall Study|Lost to Follow-up|0|||
164516227|NCT00567567|594260814|FG001|Overall Study|Lost to Follow-up|0|||
164516228|NCT00567567|594260815|FG002|Overall Study|Lost to Follow-up|1|||
164516229|NCT00567567|594260813|FG000|Overall Study|Physician Decision|16|||
164516230|NCT00567567|594260814|FG001|Overall Study|Physician Decision|18|||
164516231|NCT00567567|594260815|FG002|Overall Study|Physician Decision|84|||
164516232|NCT00567567|594260813|FG000|Overall Study|Withdrawal by Subject|0|||
164516233|NCT00567567|594260814|FG001|Overall Study|Withdrawal by Subject|0|||
164516234|NCT00567567|594260815|FG002|Overall Study|Withdrawal by Subject|2|||
164516235|NCT00567567|594260813|FG000|Overall Study|Ineligible|4|||
164516236|NCT00567567|594260814|FG001|Overall Study|Ineligible|0|||
164516237|NCT00567567|594260815|FG002|Overall Study|Ineligible|9|||
164516238|NCT00567567|594260813|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
164516239|NCT00567567|594260814|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
164516240|NCT00567567|594260815|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
164516241|NCT00567567|594260813|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
164516242|NCT00567567|594260814|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
164516243|NCT00567567|594260815|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
164516244|NCT00567567|594260813|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
164516245|NCT00567567|594260814|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
164516246|NCT00567567|594260815|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
164516247|NCT03433677|594260816|FG000|Period 1|Protocol Violation|1|||
164516248|NCT03433677|594260817|FG001|Period 1|Protocol Violation|0|||
164516249|NCT03433677|594260816|FG000|Period 2|Withdrawal by Subject|1|||
164516250|NCT03433677|594260817|FG001|Period 2|Withdrawal by Subject|1|||
164516251|NCT03330405|594260818|FG000|Overall Study|Other|1|||
164516252|NCT03330405|594260819|FG001|Overall Study|Other|3|||
164516253|NCT03330405|594260820|FG002|Overall Study|Other|1|||
164516254|NCT03330405|594260821|FG003|Overall Study|Other|0|||
164516255|NCT03330405|594260822|FG004|Overall Study|Other|2|||
164516256|NCT03330405|594260823|FG005|Overall Study|Other|0|||
164516257|NCT03330405|594260824|FG006|Overall Study|Other|1|||
164516258|NCT03330405|594260825|FG007|Overall Study|Other|0|||
164516259|NCT03330405|594260826|FG008|Overall Study|Other|0|||
164516260|NCT03330405|594260827|FG009|Overall Study|Other|0|||
164516261|NCT03330405|594260828|FG010|Overall Study|Other|0|||
164516262|NCT03330405|594260818|FG000|Overall Study|Progressive disease|8|||
164516263|NCT03330405|594260819|FG001|Overall Study|Progressive disease|27|||
164516264|NCT03330405|594260820|FG002|Overall Study|Progressive disease|4|||
164516265|NCT03330405|594260821|FG003|Overall Study|Progressive disease|18|||
164516266|NCT03330405|594260822|FG004|Overall Study|Progressive disease|16|||
164516267|NCT03330405|594260823|FG005|Overall Study|Progressive disease|14|||
164516268|NCT03330405|594260824|FG006|Overall Study|Progressive disease|7|||
164516269|NCT03330405|594260825|FG007|Overall Study|Progressive disease|29|||
164516270|NCT03330405|594260826|FG008|Overall Study|Progressive disease|9|||
164516271|NCT03330405|594260827|FG009|Overall Study|Progressive disease|11|||
164516272|NCT03330405|594260828|FG010|Overall Study|Progressive disease|5|||
164516273|NCT03330405|594260818|FG000|Overall Study|Withdrawal by Subject|1|||
164516274|NCT03330405|594260819|FG001|Overall Study|Withdrawal by Subject|4|||
164516275|NCT03330405|594260820|FG002|Overall Study|Withdrawal by Subject|0|||
164516276|NCT03330405|594260821|FG003|Overall Study|Withdrawal by Subject|1|||
164516277|NCT03330405|594260822|FG004|Overall Study|Withdrawal by Subject|1|||
164516278|NCT03330405|594260823|FG005|Overall Study|Withdrawal by Subject|1|||
164516279|NCT03330405|594260824|FG006|Overall Study|Withdrawal by Subject|0|||
164516280|NCT03330405|594260825|FG007|Overall Study|Withdrawal by Subject|2|||
164516281|NCT03330405|594260826|FG008|Overall Study|Withdrawal by Subject|2|||
164516282|NCT03330405|594260827|FG009|Overall Study|Withdrawal by Subject|1|||
164516283|NCT03330405|594260828|FG010|Overall Study|Withdrawal by Subject|1|||
164516284|NCT03330405|594260818|FG000|Overall Study|Global deterioration of health status|2|||
164516285|NCT03330405|594260819|FG001|Overall Study|Global deterioration of health status|3|||
164516286|NCT03330405|594260820|FG002|Overall Study|Global deterioration of health status|0|||
164516287|NCT03330405|594260821|FG003|Overall Study|Global deterioration of health status|2|||
164516288|NCT03330405|594260822|FG004|Overall Study|Global deterioration of health status|3|||
164516289|NCT03330405|594260823|FG005|Overall Study|Global deterioration of health status|3|||
164516290|NCT03330405|594260824|FG006|Overall Study|Global deterioration of health status|0|||
164516291|NCT03330405|594260825|FG007|Overall Study|Global deterioration of health status|2|||
164516292|NCT03330405|594260826|FG008|Overall Study|Global deterioration of health status|8|||
164516293|NCT03330405|594260827|FG009|Overall Study|Global deterioration of health status|4|||
164516294|NCT03330405|594260828|FG010|Overall Study|Global deterioration of health status|1|||
164516295|NCT03330405|594260818|FG000|Overall Study|Adverse Event|0|||
164516296|NCT03330405|594260819|FG001|Overall Study|Adverse Event|1|||
164516297|NCT03330405|594260820|FG002|Overall Study|Adverse Event|0|||
164516298|NCT03330405|594260821|FG003|Overall Study|Adverse Event|1|||
164516299|NCT03330405|594260822|FG004|Overall Study|Adverse Event|1|||
164516300|NCT03330405|594260823|FG005|Overall Study|Adverse Event|1|||
164516301|NCT03330405|594260824|FG006|Overall Study|Adverse Event|3|||
164516302|NCT03330405|594260825|FG007|Overall Study|Adverse Event|4|||
164516303|NCT03330405|594260826|FG008|Overall Study|Adverse Event|2|||
164516304|NCT03330405|594260827|FG009|Overall Study|Adverse Event|2|||
164516305|NCT03330405|594260828|FG010|Overall Study|Adverse Event|2|||
164516306|NCT03330405|594260818|FG000|Overall Study|Death|0|||
164516307|NCT03330405|594260819|FG001|Overall Study|Death|4|||
164516308|NCT03330405|594260820|FG002|Overall Study|Death|0|||
164516309|NCT03330405|594260821|FG003|Overall Study|Death|0|||
164516310|NCT03330405|594260822|FG004|Overall Study|Death|0|||
164516311|NCT03330405|594260823|FG005|Overall Study|Death|1|||
164516312|NCT03330405|594260824|FG006|Overall Study|Death|0|||
164516313|NCT03330405|594260825|FG007|Overall Study|Death|2|||
164516314|NCT03330405|594260826|FG008|Overall Study|Death|0|||
164516315|NCT03330405|594260827|FG009|Overall Study|Death|0|||
164516316|NCT03330405|594260828|FG010|Overall Study|Death|0|||
164516317|NCT03330405|594260818|FG000|Overall Study|Physician Decision|0|||
164516318|NCT03330405|594260819|FG001|Overall Study|Physician Decision|0|||
164613253|NCT01400139|594604687|FG000|HYD Core Study|Withdrawal by Subject|114|||
164613254|NCT01400139|594604687|FG000|HYD Core Study|Lost to Follow-up|39|||
164613255|NCT01400139|594604687|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
164613256|NCT01400139|594604687|FG000|HYD Core Study|Administrative|56|||
164613257|NCT01400139|594604687|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
164613258|NCT01400139|594604687|FG000|HYD Extension Period|Adverse Event|8|||
164613259|NCT01400139|594604687|FG000|HYD Extension Period|Withdrawal by Subject|5|||
164613260|NCT01400139|594604687|FG000|HYD Extension Period|Administrative|10|||
164613261|NCT00795509|594604695|FG000|Overall Study|Protocol Violation|31|||
164613262|NCT03136367|594604697|FG000|T1 Consultation|discontinued mistakenly included|2|||
164613263|NCT03136367|594604698|FG001|T1 Consultation|discontinued mistakenly included|6|||
164613264|NCT03136367|594604699|FG002|T1 Consultation|discontinued mistakenly included|1|||
164613265|NCT03136367|594604697|FG000|T1 Consultation|Discontinued other|0|||
164613266|NCT03136367|594604698|FG001|T1 Consultation|Discontinued other|1|||
164613267|NCT03136367|594604699|FG002|T1 Consultation|Discontinued other|0|||
164613268|NCT03136367|594604697|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
164613269|NCT03136367|594604698|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
164613270|NCT03136367|594604699|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
164613271|NCT03136367|594604697|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
164613272|NCT03136367|594604698|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
164613273|NCT03136367|594604699|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
164613274|NCT03136367|594604697|FG000|T2 Post-consultation|Discontinued other|0|||
164613275|NCT03136367|594604698|FG001|T2 Post-consultation|Discontinued other|2|||
164613276|NCT03136367|594604699|FG002|T2 Post-consultation|Discontinued other|6|||
164613277|NCT03136367|594604697|FG000|T2 Post-consultation|Discontinued transferred care|0|||
164613278|NCT03136367|594604698|FG001|T2 Post-consultation|Discontinued transferred care|0|||
164613279|NCT03136367|594604699|FG002|T2 Post-consultation|Discontinued transferred care|3|||
164613280|NCT03136367|594604697|FG000|T2 Post-consultation|Discontinued lost contact|0|||
164613281|NCT03136367|594604698|FG001|T2 Post-consultation|Discontinued lost contact|1|||
164613282|NCT03136367|594604699|FG002|T2 Post-consultation|Discontinued lost contact|0|||
164613283|NCT03136367|594604697|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
164613284|NCT03136367|594604698|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
164613285|NCT03136367|594604699|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
164613286|NCT03136367|594604697|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
164613287|NCT03136367|594604698|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
164613288|NCT03136367|594604699|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
164613289|NCT03136367|594604697|FG000|T3 1 Week After Surgery|other discontinued|2|||
164613290|NCT03136367|594604698|FG001|T3 1 Week After Surgery|other discontinued|4|||
164613291|NCT03136367|594604699|FG002|T3 1 Week After Surgery|other discontinued|3|||
164613292|NCT03136367|594604697|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
164516319|NCT03330405|594260820|FG002|Overall Study|Physician Decision|0|||
164516320|NCT03330405|594260821|FG003|Overall Study|Physician Decision|0|||
164516321|NCT03330405|594260822|FG004|Overall Study|Physician Decision|0|||
164516322|NCT03330405|594260823|FG005|Overall Study|Physician Decision|0|||
164516323|NCT03330405|594260824|FG006|Overall Study|Physician Decision|0|||
164516324|NCT03330405|594260825|FG007|Overall Study|Physician Decision|1|||
164516325|NCT03330405|594260826|FG008|Overall Study|Physician Decision|0|||
164516326|NCT03330405|594260827|FG009|Overall Study|Physician Decision|0|||
164516327|NCT03330405|594260828|FG010|Overall Study|Physician Decision|0|||
164516328|NCT03482466|594260829|FG000|Overall Study|Protocol Violation|2|||
164516329|NCT04833127|594260830|FG000|Overall Study|Lost to Follow-up|1|||
164516330|NCT04833127|594260831|FG001|Overall Study|Lost to Follow-up|1|||
164516331|NCT01736189|594260832|FG000|Overall Study|Violation of registration criteria|41|||
164516332|NCT01736189|594260832|FG000|Overall Study|Protocol Violation|4|||
164516333|NCT01736189|594260832|FG000|Overall Study|Criteria and protocol violations|1|||
164516334|NCT01499303|594260833|FG000|Overall Study|Ongoing|2|||
164516335|NCT01499303|594260834|FG001|Overall Study|Ongoing|1|||
164516336|NCT01499303|594260833|FG000|Overall Study|Withdrawal by Subject|0|||
164516337|NCT01499303|594260834|FG001|Overall Study|Withdrawal by Subject|1|||
164516338|NCT01499303|594260833|FG000|Overall Study|Adverse Event|1|||
164516339|NCT01499303|594260834|FG001|Overall Study|Adverse Event|4|||
164516340|NCT01499303|594260833|FG000|Overall Study|Other|0|||
164516341|NCT01499303|594260834|FG001|Overall Study|Other|1|||
164613293|NCT03136367|594604698|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
164613294|NCT03136367|594604699|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
164516342|NCT01896557|594260835|FG000|Clopidogrel Alone|Adverse Event|1|||
164516343|NCT01896557|594260836|FG001|Clopidogrel Alone|Adverse Event|0|||
164516344|NCT01896557|594260835|FG000|Clopidogrel + GI Protector|low adherence|1|||
164516345|NCT01896557|594260836|FG001|Clopidogrel + GI Protector|low adherence|1|||
164516346|NCT01896557|594260835|FG000|Clopidogrel + GI Protector|Reading error|1|||
164516347|NCT01896557|594260836|FG001|Clopidogrel + GI Protector|Reading error|3|||
164516348|NCT02383940|594260837|FG000|Overall Study|Adverse Event|1|||
164516349|NCT02383940|594260838|FG001|Overall Study|Adverse Event|0|||
164516350|NCT02383940|594260837|FG000|Overall Study|Lost to Follow-up|2|||
164516351|NCT02383940|594260838|FG001|Overall Study|Lost to Follow-up|2|||
164516352|NCT02383940|594260837|FG000|Overall Study|Physician Decision|2|||
164516353|NCT02383940|594260838|FG001|Overall Study|Physician Decision|0|||
164516354|NCT02383940|594260837|FG000|Overall Study|Withdrawal by Subject|1|||
164516355|NCT02383940|594260838|FG001|Overall Study|Withdrawal by Subject|1|||
164516356|NCT02383940|594260837|FG000|Overall Study|Randomized but not treated|2|||
164516357|NCT02383940|594260838|FG001|Overall Study|Randomized but not treated|0|||
164516358|NCT02383940|594260837|FG000|Overall Study|Other than specified above|1|||
164516359|NCT02383940|594260838|FG001|Overall Study|Other than specified above|0|||
164516360|NCT01517295|594260839|FG000|Overall Study|Physician Decision|1|||
164516361|NCT01517295|594260840|FG001|Overall Study|Physician Decision|0|||
164516362|NCT01353859|594260841|FG000|Overall Study|Adverse Event|3|||
164516363|NCT01353859|594260841|FG000|Overall Study|Lack of Efficacy|1|||
164516364|NCT02672852|594260842|FG000|Part A1|Disease Worsening|1|||
164516365|NCT02672852|594260843|FG001|Part A1|Disease Worsening|0|||
164516366|NCT02672852|594260844|FG002|Part A1|Disease Worsening|0|||
164516367|NCT02672852|594260845|FG003|Part A1|Disease Worsening|0|||
164516368|NCT02672852|594260846|FG004|Part A1|Disease Worsening|0|||
164516369|NCT02672852|594260847|FG005|Part A1|Disease Worsening|0|||
164516370|NCT02672852|594260848|FG006|Part A1|Disease Worsening|0|||
164516371|NCT02672852|594260842|FG000|Part A1|Adverse Event|0|||
164516372|NCT02672852|594260843|FG001|Part A1|Adverse Event|1|||
164516373|NCT02672852|594260844|FG002|Part A1|Adverse Event|0|||
164516374|NCT02672852|594260845|FG003|Part A1|Adverse Event|0|||
164516375|NCT02672852|594260846|FG004|Part A1|Adverse Event|0|||
164516376|NCT02672852|594260847|FG005|Part A1|Adverse Event|0|||
164516377|NCT02672852|594260848|FG006|Part A1|Adverse Event|0|||
164516378|NCT02672852|594260842|FG000|Part A1|Lost to Follow-up|1|||
164516379|NCT02672852|594260843|FG001|Part A1|Lost to Follow-up|2|||
164516380|NCT02672852|594260844|FG002|Part A1|Lost to Follow-up|0|||
164516381|NCT02672852|594260845|FG003|Part A1|Lost to Follow-up|0|||
164516382|NCT02672852|594260846|FG004|Part A1|Lost to Follow-up|0|||
164516383|NCT02672852|594260847|FG005|Part A1|Lost to Follow-up|0|||
164516384|NCT02672852|594260848|FG006|Part A1|Lost to Follow-up|0|||
164516385|NCT02672852|594260842|FG000|Part A1|Withdrawal by Subject|1|||
164516386|NCT02672852|594260843|FG001|Part A1|Withdrawal by Subject|1|||
164516387|NCT02672852|594260844|FG002|Part A1|Withdrawal by Subject|0|||
164516388|NCT02672852|594260845|FG003|Part A1|Withdrawal by Subject|0|||
164516389|NCT02672852|594260846|FG004|Part A1|Withdrawal by Subject|0|||
164516390|NCT02672852|594260847|FG005|Part A1|Withdrawal by Subject|0|||
164516391|NCT02672852|594260848|FG006|Part A1|Withdrawal by Subject|0|||
164516392|NCT02672852|594260842|FG000|Part A2|Disease worsening|0|||
164516393|NCT02672852|594260843|FG001|Part A2|Disease worsening|0|||
164516394|NCT02672852|594260844|FG002|Part A2|Disease worsening|1|||
164516395|NCT02672852|594260845|FG003|Part A2|Disease worsening|0|||
164516396|NCT02672852|594260846|FG004|Part A2|Disease worsening|0|||
164516397|NCT02672852|594260847|FG005|Part A2|Disease worsening|0|||
164516398|NCT02672852|594260848|FG006|Part A2|Disease worsening|0|||
164516399|NCT02672852|594260842|FG000|Part A2|Adverse Event|0|||
164516400|NCT02672852|594260843|FG001|Part A2|Adverse Event|0|||
164516401|NCT02672852|594260844|FG002|Part A2|Adverse Event|3|||
164516402|NCT02672852|594260845|FG003|Part A2|Adverse Event|0|||
164516403|NCT02672852|594260846|FG004|Part A2|Adverse Event|0|||
164516404|NCT02672852|594260847|FG005|Part A2|Adverse Event|0|||
164516405|NCT02672852|594260848|FG006|Part A2|Adverse Event|0|||
164516406|NCT02672852|594260842|FG000|Part A2|Lost to Follow-up|0|||
164516407|NCT02672852|594260843|FG001|Part A2|Lost to Follow-up|0|||
164516408|NCT02672852|594260844|FG002|Part A2|Lost to Follow-up|2|||
164516409|NCT02672852|594260845|FG003|Part A2|Lost to Follow-up|0|||
164516410|NCT02672852|594260846|FG004|Part A2|Lost to Follow-up|0|||
164516411|NCT02672852|594260847|FG005|Part A2|Lost to Follow-up|0|||
164516412|NCT02672852|594260848|FG006|Part A2|Lost to Follow-up|0|||
164516413|NCT02672852|594260842|FG000|Part A2|Withdrawal by Subject|0|||
164516414|NCT02672852|594260843|FG001|Part A2|Withdrawal by Subject|0|||
164516415|NCT02672852|594260844|FG002|Part A2|Withdrawal by Subject|1|||
164516416|NCT02672852|594260845|FG003|Part A2|Withdrawal by Subject|0|||
164516417|NCT02672852|594260846|FG004|Part A2|Withdrawal by Subject|0|||
164516418|NCT02672852|594260847|FG005|Part A2|Withdrawal by Subject|0|||
164516419|NCT02672852|594260848|FG006|Part A2|Withdrawal by Subject|0|||
164516420|NCT02672852|594260842|FG000|Part A2|Other|0|||
164516421|NCT02672852|594260843|FG001|Part A2|Other|0|||
164516422|NCT02672852|594260844|FG002|Part A2|Other|3|||
164516423|NCT02672852|594260845|FG003|Part A2|Other|0|||
164516424|NCT02672852|594260846|FG004|Part A2|Other|0|||
164516425|NCT02672852|594260847|FG005|Part A2|Other|0|||
164516426|NCT02672852|594260848|FG006|Part A2|Other|0|||
164516427|NCT02672852|594260842|FG000|Part A2|Not entered in Part B|0|||
164516428|NCT02672852|594260843|FG001|Part A2|Not entered in Part B|0|||
164516429|NCT02672852|594260844|FG002|Part A2|Not entered in Part B|0|||
164516430|NCT02672852|594260845|FG003|Part A2|Not entered in Part B|4|||
164613295|NCT03136367|594604697|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
164613296|NCT03136367|594604698|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
164613297|NCT03136367|594604699|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
164613298|NCT03136367|594604697|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
164613299|NCT03136367|594604698|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
164613300|NCT03136367|594604699|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
164613301|NCT03136367|594604697|FG000|T4 12 Weeks After Surgery|Death|0|||
164613302|NCT03136367|594604698|FG001|T4 12 Weeks After Surgery|Death|1|||
164613303|NCT03136367|594604699|FG002|T4 12 Weeks After Surgery|Death|3|||
164613304|NCT03136367|594604697|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
164613305|NCT03136367|594604698|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
164613306|NCT03136367|594604699|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
164613307|NCT03136367|594604697|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
164613308|NCT03136367|594604698|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
164613309|NCT03136367|594604699|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
164613310|NCT03136367|594604697|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
164613311|NCT03136367|594604698|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
164613312|NCT03136367|594604699|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
164613313|NCT03136367|594604697|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
164613314|NCT03136367|594604698|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
164613315|NCT03136367|594604699|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
164613316|NCT03136367|594604697|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
164613317|NCT03136367|594604698|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
164613318|NCT03136367|594604699|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
164613319|NCT03136367|594604697|FG000|T5 1 Year After Surgery|Death|0|||
164613320|NCT03136367|594604698|FG001|T5 1 Year After Surgery|Death|0|||
164613321|NCT03136367|594604699|FG002|T5 1 Year After Surgery|Death|1|||
164613322|NCT03136367|594604697|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
164613323|NCT03136367|594604698|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
164613324|NCT03136367|594604699|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
164613325|NCT03136367|594604697|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
164613326|NCT03136367|594604698|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
164613327|NCT03136367|594604699|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
164613328|NCT03136367|594604697|FG000|T5 1 Year After Surgery|study ended before due|31|||
164613329|NCT03136367|594604698|FG001|T5 1 Year After Surgery|study ended before due|103|||
164613330|NCT03136367|594604699|FG002|T5 1 Year After Surgery|study ended before due|110|||
164613331|NCT03136367|594604697|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
164613332|NCT03136367|594604698|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
164613333|NCT03136367|594604699|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
164613334|NCT02947022|594604702|FG000|Overall Study|Study Stopped|1|||
164613335|NCT01230749|594604703|FG000|Overall Study|Adverse Event|0|||
164613336|NCT01230749|594604704|FG001|Overall Study|Adverse Event|0|||
164613337|NCT01230749|594604705|FG002|Overall Study|Adverse Event|0|||
164613338|NCT01230749|594604706|FG003|Overall Study|Adverse Event|1|||
164613339|NCT01230749|594604703|FG000|Overall Study|Physician Decision|0|||
164613340|NCT01230749|594604704|FG001|Overall Study|Physician Decision|0|||
164613341|NCT01230749|594604705|FG002|Overall Study|Physician Decision|1|||
164613342|NCT01230749|594604706|FG003|Overall Study|Physician Decision|0|||
164613343|NCT01230749|594604703|FG000|Overall Study|Withdrawal by Subject|0|||
164613344|NCT01230749|594604704|FG001|Overall Study|Withdrawal by Subject|1|||
164613345|NCT01230749|594604705|FG002|Overall Study|Withdrawal by Subject|0|||
164613346|NCT01230749|594604706|FG003|Overall Study|Withdrawal by Subject|0|||
164613347|NCT01230749|594604703|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
164613348|NCT01230749|594604704|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
164613349|NCT01230749|594604705|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
164613350|NCT01230749|594604706|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
164613351|NCT01731990|594606412|FG000|Overall Study|Adverse Event|1|||
164613352|NCT01731990|594606413|FG001|Overall Study|Adverse Event|5|||
164613353|NCT01731990|594606412|FG000|Overall Study|Withdrawal by Subject|1|||
164613354|NCT01731990|594606413|FG001|Overall Study|Withdrawal by Subject|1|||
164613355|NCT01731990|594606412|FG000|Overall Study|Protocol deviation|1|||
164613356|NCT01731990|594606413|FG001|Overall Study|Protocol deviation|2|||
164613357|NCT01731990|594606412|FG000|Overall Study|Death|1|||
164613358|NCT01731990|594606413|FG001|Overall Study|Death|0|||
164613359|NCT01183104|594606414|FG000|Overall Study|Adverse Event|8|||
164613360|NCT01183104|594606415|FG001|Overall Study|Adverse Event|6|||
164613361|NCT01183104|594606414|FG000|Overall Study|Death|0|||
164613362|NCT01183104|594606415|FG001|Overall Study|Death|1|||
164613363|NCT01183104|594606414|FG000|Overall Study|Lost to Follow-up|14|||
164613364|NCT01183104|594606415|FG001|Overall Study|Lost to Follow-up|7|||
164613365|NCT01183104|594606414|FG000|Overall Study|Physician Decision|5|||
164613366|NCT01183104|594606415|FG001|Overall Study|Physician Decision|8|||
164613367|NCT01183104|594606414|FG000|Overall Study|Withdrawal by Subject|6|||
164516431|NCT02672852|594260846|FG004|Part A2|Not entered in Part B|0|||
164516432|NCT02672852|594260847|FG005|Part A2|Not entered in Part B|0|||
164516433|NCT02672852|594260848|FG006|Part A2|Not entered in Part B|0|||
164516434|NCT02672852|594260842|FG000|Part B|Disease worsening|0|||
164516435|NCT02672852|594260843|FG001|Part B|Disease worsening|0|||
164516436|NCT02672852|594260844|FG002|Part B|Disease worsening|0|||
164516437|NCT02672852|594260845|FG003|Part B|Disease worsening|0|||
164516438|NCT02672852|594260846|FG004|Part B|Disease worsening|1|||
164516439|NCT02672852|594260847|FG005|Part B|Disease worsening|0|||
164516440|NCT02672852|594260848|FG006|Part B|Disease worsening|1|||
164516441|NCT02672852|594260842|FG000|Part B|Worsening pre-existing condition|0|||
164516442|NCT02672852|594260843|FG001|Part B|Worsening pre-existing condition|0|||
164516443|NCT02672852|594260844|FG002|Part B|Worsening pre-existing condition|0|||
164516444|NCT02672852|594260845|FG003|Part B|Worsening pre-existing condition|0|||
164516445|NCT02672852|594260846|FG004|Part B|Worsening pre-existing condition|0|||
164516446|NCT02672852|594260847|FG005|Part B|Worsening pre-existing condition|1|||
164516447|NCT02672852|594260848|FG006|Part B|Worsening pre-existing condition|0|||
164516448|NCT02672852|594260842|FG000|Part B|Other adverse event|0|||
164516449|NCT02672852|594260843|FG001|Part B|Other adverse event|0|||
164516450|NCT02672852|594260844|FG002|Part B|Other adverse event|0|||
164516451|NCT02672852|594260845|FG003|Part B|Other adverse event|0|||
164516452|NCT02672852|594260846|FG004|Part B|Other adverse event|3|||
164516453|NCT02672852|594260847|FG005|Part B|Other adverse event|5|||
164516454|NCT02672852|594260848|FG006|Part B|Other adverse event|1|||
164516455|NCT02672852|594260842|FG000|Part B|Lost to Follow-up|0|||
164516456|NCT02672852|594260843|FG001|Part B|Lost to Follow-up|0|||
164516457|NCT02672852|594260844|FG002|Part B|Lost to Follow-up|0|||
164516458|NCT02672852|594260845|FG003|Part B|Lost to Follow-up|0|||
164516459|NCT02672852|594260846|FG004|Part B|Lost to Follow-up|3|||
164516460|NCT02672852|594260847|FG005|Part B|Lost to Follow-up|4|||
164516461|NCT02672852|594260848|FG006|Part B|Lost to Follow-up|1|||
164516462|NCT02672852|594260842|FG000|Part B|Withdrawal by Subject|0|||
164516463|NCT02672852|594260843|FG001|Part B|Withdrawal by Subject|0|||
164516464|NCT02672852|594260844|FG002|Part B|Withdrawal by Subject|0|||
164516465|NCT02672852|594260845|FG003|Part B|Withdrawal by Subject|0|||
164516466|NCT02672852|594260846|FG004|Part B|Withdrawal by Subject|5|||
164516467|NCT02672852|594260847|FG005|Part B|Withdrawal by Subject|0|||
164516468|NCT02672852|594260848|FG006|Part B|Withdrawal by Subject|7|||
164516469|NCT02672852|594260842|FG000|Part B|Other|0|||
164516470|NCT02672852|594260843|FG001|Part B|Other|0|||
164516471|NCT02672852|594260844|FG002|Part B|Other|0|||
164516472|NCT02672852|594260845|FG003|Part B|Other|0|||
164516473|NCT02672852|594260846|FG004|Part B|Other|4|||
164516474|NCT02672852|594260847|FG005|Part B|Other|1|||
164516475|NCT02672852|594260848|FG006|Part B|Other|2|||
164516476|NCT03853551|594260851|FG000|Overall Study|Death|2|||
164516477|NCT03853551|594260851|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
164516478|NCT01923467|594260854|FG000|Overall Study|Lost to Follow-up|62|||
164516479|NCT01923467|594260854|FG000|Overall Study|Subject non-interest|479|||
164516480|NCT01075958|594260855|FG000|Overall Study|Blood sample could not be obtained|44|||
164516481|NCT02636725|594260859|FG000|Overall Study|Adverse Event|1|||
164516482|NCT01696045|594260862|FG000|Overall Study|Study drug toxicity|1|||
164516483|NCT01696045|594260863|FG001|Overall Study|Study drug toxicity|5|||
164516484|NCT01696045|594260862|FG000|Overall Study|Disease progression|2|||
164516485|NCT01696045|594260863|FG001|Overall Study|Disease progression|2|||
164516486|NCT01559129|594260864|FG000|Treatment Phase|Adverse Event|0|||
164516487|NCT01559129|594260865|FG001|Treatment Phase|Adverse Event|2|||
164516488|NCT01559129|594260864|FG000|Treatment Phase|Progressive Disease|1|||
164516489|NCT01559129|594260865|FG001|Treatment Phase|Progressive Disease|1|||
164516490|NCT01559129|594260864|FG000|Treatment Phase|Lack of Efficacy|0|||
164516491|NCT01559129|594260865|FG001|Treatment Phase|Lack of Efficacy|1|||
164516492|NCT01559129|594260864|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
164516493|NCT01559129|594260865|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
164516494|NCT01559129|594260864|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
164516495|NCT01559129|594260865|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
164516496|NCT01559129|594260864|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
164516497|NCT01559129|594260865|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
164516498|NCT01559129|594260864|FG000|Open-label Extension Period|Adverse Event|1|||
164516499|NCT01559129|594260865|FG001|Open-label Extension Period|Adverse Event|0|||
164516500|NCT01559129|594260864|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
164516501|NCT01559129|594260865|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
164516502|NCT03525392|594260866|FG000|Overall Study|Adverse Event|1|||
164516503|NCT03525392|594260867|FG001|Overall Study|Adverse Event|0|||
164516504|NCT03525392|594260868|FG002|Overall Study|Adverse Event|2|||
164516505|NCT03525392|594260869|FG003|Overall Study|Adverse Event|0|||
164516506|NCT03525392|594260870|FG004|Overall Study|Adverse Event|0|||
164516507|NCT03525392|594260866|FG000|Overall Study|Progressive disease|0|||
164516508|NCT03525392|594260867|FG001|Overall Study|Progressive disease|1|||
164516509|NCT03525392|594260868|FG002|Overall Study|Progressive disease|1|||
164516510|NCT03525392|594260869|FG003|Overall Study|Progressive disease|3|||
164613368|NCT01183104|594606415|FG001|Overall Study|Withdrawal by Subject|11|||
164613369|NCT01183104|594606414|FG000|Overall Study|Nonparticipation in Extension Study|39|||
164613370|NCT01183104|594606415|FG001|Overall Study|Nonparticipation in Extension Study|50|||
164613371|NCT01183104|594606414|FG000|Overall Study|Did not receive study drug|5|||
164613372|NCT01183104|594606415|FG001|Overall Study|Did not receive study drug|9|||
164613373|NCT00323310|594606416|FG000|Overall Study|Withdrawal by Subject|1|||
164613374|NCT00323310|594606416|FG000|Overall Study|a parent refused blood draw|1|||
164613375|NCT00323310|594606416|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
164613376|NCT02944513|594606417|FG000|Overall Study|Withdrawal by Subject|4|||
164613377|NCT02944513|594606418|FG001|Overall Study|Withdrawal by Subject|1|||
164613378|NCT00937326|594606419|FG000|Overall Study|Adverse Event|0|||
164613379|NCT00937326|594606420|FG001|Overall Study|Adverse Event|3|||
164613380|NCT00937326|594606421|FG002|Overall Study|Adverse Event|1|||
164613381|NCT00937326|594606422|FG003|Overall Study|Adverse Event|1|||
164613382|NCT00937326|594606423|FG004|Overall Study|Adverse Event|2|||
164613383|NCT00937326|594606419|FG000|Overall Study|Death|0|||
164613384|NCT00937326|594606420|FG001|Overall Study|Death|0|||
164613385|NCT00937326|594606421|FG002|Overall Study|Death|1|||
164613386|NCT00937326|594606422|FG003|Overall Study|Death|0|||
164613387|NCT00937326|594606423|FG004|Overall Study|Death|0|||
164613388|NCT00937326|594606419|FG000|Overall Study|Withdrawal by Subject|3|||
164613389|NCT00937326|594606420|FG001|Overall Study|Withdrawal by Subject|4|||
164613390|NCT00937326|594606421|FG002|Overall Study|Withdrawal by Subject|1|||
164613391|NCT00937326|594606422|FG003|Overall Study|Withdrawal by Subject|4|||
164613392|NCT00937326|594606423|FG004|Overall Study|Withdrawal by Subject|3|||
164613393|NCT00937326|594606419|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
164613394|NCT00937326|594606420|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
164613395|NCT00937326|594606421|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
164613396|NCT00937326|594606422|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
164613397|NCT00937326|594606423|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
164613398|NCT00790218|594606424|FG000|Overall Study|Death|1|||
164613399|NCT00790218|594606425|FG001|Overall Study|Death|0|||
164613400|NCT00790218|594606426|FG002|Overall Study|Death|0|||
164613401|NCT03424044|594606432|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
164613402|NCT03424044|594606433|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
164613403|NCT03424044|594606434|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
164613404|NCT03424044|594606435|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
164613405|NCT03424044|594606436|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
164613406|NCT03424044|594606437|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
164613407|NCT03424044|594606438|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
164613408|NCT03424044|594606439|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
164613409|NCT03424044|594606440|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
164613410|NCT03424044|594606432|FG000|First Intervention (76 Hours)|Adverse Event|0|||
164613411|NCT03424044|594606433|FG001|First Intervention (76 Hours)|Adverse Event|0|||
164613412|NCT03424044|594606434|FG002|First Intervention (76 Hours)|Adverse Event|0|||
164613413|NCT03424044|594606435|FG003|First Intervention (76 Hours)|Adverse Event|0|||
164613414|NCT03424044|594606436|FG004|First Intervention (76 Hours)|Adverse Event|1|||
164613415|NCT03424044|594606437|FG005|First Intervention (76 Hours)|Adverse Event|0|||
164613416|NCT03424044|594606438|FG006|First Intervention (76 Hours)|Adverse Event|0|||
164613417|NCT03424044|594606439|FG007|First Intervention (76 Hours)|Adverse Event|0|||
164613418|NCT03424044|594606440|FG008|First Intervention (76 Hours)|Adverse Event|0|||
164613419|NCT03424044|594606432|FG000|First Intervention (76 Hours)|device issues|0|||
164613420|NCT03424044|594606433|FG001|First Intervention (76 Hours)|device issues|0|||
164613421|NCT03424044|594606434|FG002|First Intervention (76 Hours)|device issues|0|||
164613422|NCT03424044|594606435|FG003|First Intervention (76 Hours)|device issues|0|||
164613423|NCT03424044|594606436|FG004|First Intervention (76 Hours)|device issues|0|||
164613424|NCT03424044|594606437|FG005|First Intervention (76 Hours)|device issues|0|||
164613425|NCT03424044|594606438|FG006|First Intervention (76 Hours)|device issues|1|||
164613426|NCT03424044|594606439|FG007|First Intervention (76 Hours)|device issues|1|||
164613427|NCT03424044|594606440|FG008|First Intervention (76 Hours)|device issues|1|||
164613428|NCT03424044|594606432|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
164613429|NCT03424044|594606433|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
164613430|NCT03424044|594606434|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
164613431|NCT03424044|594606435|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
164613432|NCT03424044|594606436|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
164613433|NCT03424044|594606437|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
164613434|NCT03424044|594606438|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
164613435|NCT03424044|594606439|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
164613436|NCT03424044|594606440|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
164613437|NCT03424044|594606432|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
164613438|NCT03424044|594606433|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
164613439|NCT03424044|594606434|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
164613440|NCT03424044|594606435|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
164613441|NCT03424044|594606436|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
164613442|NCT03424044|594606437|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
164613443|NCT03424044|594606438|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
164613444|NCT03424044|594606439|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
164613445|NCT03424044|594606440|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
164613446|NCT04402385|594606442|FG000|Overall Study|Withdrawal by Subject|4|||
164613447|NCT04402385|594606443|FG001|Overall Study|Withdrawal by Subject|4|||
164613448|NCT04402385|594606442|FG000|Overall Study|Lost to Follow-up|1|||
164613449|NCT04402385|594606443|FG001|Overall Study|Lost to Follow-up|1|||
164516511|NCT03525392|594260870|FG004|Overall Study|Progressive disease|1|||
164516512|NCT00831129|594260873|FG000|Overall Study|Adverse Event|0|||
164516513|NCT00831129|594260874|FG001|Overall Study|Adverse Event|1|||
164516514|NCT00831129|594260873|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
164516515|NCT00831129|594260874|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
164516516|NCT04462289|594260878|FG000|Overall Study|Lost to Follow-up|4|||
164516517|NCT04462289|594260879|FG001|Overall Study|Lost to Follow-up|5|||
164516518|NCT04462289|594260878|FG000|Overall Study|Death|0|||
164516519|NCT04462289|594260879|FG001|Overall Study|Death|3|||
164516520|NCT04462289|594260878|FG000|Overall Study|Withdrawal by Subject|1|||
164516521|NCT04462289|594260879|FG001|Overall Study|Withdrawal by Subject|3|||
164516522|NCT00818779|594260880|FG000|Overall Study|Protocol Violation|1|||
164516523|NCT00818779|594260881|FG001|Overall Study|Protocol Violation|0|||
164516524|NCT00818779|594260880|FG000|Overall Study|Lost to Follow-up|1|||
164516525|NCT00818779|594260881|FG001|Overall Study|Lost to Follow-up|0|||
164516526|NCT00818779|594260880|FG000|Overall Study|Adverse Event|4|||
164516527|NCT00818779|594260881|FG001|Overall Study|Adverse Event|1|||
164516528|NCT00132873|594260882|FG000|Overall Study|Adverse Event|3|||
164516529|NCT00132873|594260882|FG000|Overall Study|Lost to Follow-up|1|||
164516530|NCT00132873|594260882|FG000|Overall Study|Lack of Efficacy|1|||
164516531|NCT00132873|594260882|FG000|Overall Study|Withdrawal by Subject|3|||
164516532|NCT00132873|594260882|FG000|Overall Study|Planned Pregnancy|1|||
164516533|NCT04276415|594260883|FG000|Overall Study|Adverse Event|0|||
164516534|NCT04276415|594260884|FG001|Overall Study|Adverse Event|0|||
164516535|NCT04276415|594260885|FG002|Overall Study|Adverse Event|0|||
164516536|NCT04276415|594260886|FG003|Overall Study|Adverse Event|3|||
164516537|NCT04276415|594260887|FG004|Overall Study|Adverse Event|0|||
164516538|NCT04276415|594260888|FG005|Overall Study|Adverse Event|0|||
164516539|NCT04276415|594260883|FG000|Overall Study|Clinical progression|1|||
164516540|NCT04276415|594260884|FG001|Overall Study|Clinical progression|1|||
164516541|NCT04276415|594260885|FG002|Overall Study|Clinical progression|0|||
164516542|NCT04276415|594260886|FG003|Overall Study|Clinical progression|0|||
164516543|NCT04276415|594260887|FG004|Overall Study|Clinical progression|1|||
164516544|NCT04276415|594260888|FG005|Overall Study|Clinical progression|0|||
164516545|NCT04276415|594260883|FG000|Overall Study|Other|0|||
164516546|NCT04276415|594260884|FG001|Overall Study|Other|0|||
164516547|NCT04276415|594260885|FG002|Overall Study|Other|0|||
164516548|NCT04276415|594260886|FG003|Overall Study|Other|1|||
164516549|NCT04276415|594260887|FG004|Overall Study|Other|0|||
164516550|NCT04276415|594260888|FG005|Overall Study|Other|0|||
164516551|NCT04276415|594260883|FG000|Overall Study|Physician Decision|0|||
164516552|NCT04276415|594260884|FG001|Overall Study|Physician Decision|0|||
164516553|NCT04276415|594260885|FG002|Overall Study|Physician Decision|1|||
164516554|NCT04276415|594260886|FG003|Overall Study|Physician Decision|3|||
164516555|NCT04276415|594260887|FG004|Overall Study|Physician Decision|2|||
164516556|NCT04276415|594260888|FG005|Overall Study|Physician Decision|0|||
164516557|NCT04276415|594260883|FG000|Overall Study|Progressive disease|3|||
164516558|NCT04276415|594260884|FG001|Overall Study|Progressive disease|3|||
164516559|NCT04276415|594260885|FG002|Overall Study|Progressive disease|4|||
164516560|NCT04276415|594260886|FG003|Overall Study|Progressive disease|5|||
164516561|NCT04276415|594260887|FG004|Overall Study|Progressive disease|1|||
164516562|NCT04276415|594260888|FG005|Overall Study|Progressive disease|2|||
164516563|NCT04276415|594260883|FG000|Overall Study|Withdrawal by patient|0|||
164516564|NCT04276415|594260884|FG001|Overall Study|Withdrawal by patient|0|||
164516565|NCT04276415|594260885|FG002|Overall Study|Withdrawal by patient|0|||
164516566|NCT04276415|594260886|FG003|Overall Study|Withdrawal by patient|1|||
164516567|NCT04276415|594260887|FG004|Overall Study|Withdrawal by patient|2|||
164516568|NCT04276415|594260888|FG005|Overall Study|Withdrawal by patient|0|||
164516569|NCT01254747|594260889|FG000|Overall Study|Unacceptable subjective vision|0|||
164516570|NCT01254747|594260890|FG001|Overall Study|Unacceptable subjective vision|0|||
164516571|NCT01254747|594260891|FG002|Overall Study|Unacceptable subjective vision|0|||
164516572|NCT01254747|594260892|FG003|Overall Study|Unacceptable subjective vision|2|||
164516573|NCT01254747|594260889|FG000|Overall Study|Difficult removal handling|0|||
164516574|NCT01254747|594260890|FG001|Overall Study|Difficult removal handling|0|||
164516575|NCT01254747|594260891|FG002|Overall Study|Difficult removal handling|1|||
164613450|NCT04402385|594606442|FG000|Overall Study|Physician Decision|0|||
164613451|NCT04402385|594606443|FG001|Overall Study|Physician Decision|1|||
164613452|NCT00731666|594606444|FG000|Overall Study|Adverse Event|2|||
164613453|NCT00731666|594606444|FG000|Overall Study|Lost to Follow-up|8|||
164613454|NCT00731666|594606444|FG000|Overall Study|Withdrawal by Subject|2|||
164613455|NCT01308853|594606445|FG000|Overall Study|Adverse Event|1|||
164613456|NCT01308853|594606445|FG000|Overall Study|Lost to Follow-up|2|||
164613457|NCT01308853|594606445|FG000|Overall Study|Insertion of permanent implants|1|||
164613458|NCT03250624|594606447|FG000|Overall Study|Lack of Efficacy|1|||
164613459|NCT03250624|594606448|FG001|Overall Study|Lack of Efficacy|4|||
164613460|NCT03250624|594606447|FG000|Overall Study|Adverse Event|0|||
164613461|NCT03250624|594606448|FG001|Overall Study|Adverse Event|1|||
164613462|NCT03250624|594606447|FG000|Overall Study|Other|1|||
164613463|NCT03250624|594606448|FG001|Overall Study|Other|2|||
164613464|NCT00606177|594606449|FG000|Overall Study|Adverse Event|9|||
164613465|NCT00606177|594606450|FG001|Overall Study|Adverse Event|5|||
164613466|NCT00606177|594606449|FG000|Overall Study|Lack of Efficacy|3|||
164613467|NCT00606177|594606450|FG001|Overall Study|Lack of Efficacy|7|||
164613468|NCT00606177|594606449|FG000|Overall Study|Physician Decision|1|||
164613469|NCT00606177|594606450|FG001|Overall Study|Physician Decision|0|||
164613470|NCT00606177|594606449|FG000|Overall Study|Protocol Violation|1|||
164613471|NCT00606177|594606450|FG001|Overall Study|Protocol Violation|4|||
164613472|NCT00606177|594606449|FG000|Overall Study|Withdrawal by Subject|5|||
164613473|NCT00606177|594606450|FG001|Overall Study|Withdrawal by Subject|6|||
164613474|NCT00606177|594606449|FG000|Overall Study|Progression to depressive phase|6|||
164613475|NCT00606177|594606450|FG001|Overall Study|Progression to depressive phase|1|||
164613476|NCT00606177|594606449|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
164613477|NCT00606177|594606450|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
164613478|NCT00606177|594606449|FG000|Overall Study|Change of residence or other commitments|1|||
164613479|NCT00606177|594606450|FG001|Overall Study|Change of residence or other commitments|1|||
164613480|NCT00136357|594606451|FG000|Overall Study|Withdrawal by Subject|3|||
164613481|NCT00136357|594606452|FG001|Overall Study|Withdrawal by Subject|2|||
164613482|NCT01819506|594606455|FG000|Overall Study|Physician Decision|5|||
164613483|NCT01819506|594606456|FG001|Overall Study|Physician Decision|2|||
164613484|NCT01819506|594606455|FG000|Overall Study|Withdrawal by Subject|3|||
164613485|NCT01819506|594606456|FG001|Overall Study|Withdrawal by Subject|3|||
164613486|NCT01505114|594606457|FG000|Overall Study|Withdrawal by Subject|5|||
164613487|NCT01505114|594606458|FG001|Overall Study|Withdrawal by Subject|4|||
164613488|NCT01505114|594606459|FG002|Overall Study|Withdrawal by Subject|4|||
164613489|NCT01505114|594606460|FG003|Overall Study|Withdrawal by Subject|7|||
164613490|NCT01505114|594606457|FG000|Overall Study|Death|1|||
164613491|NCT01505114|594606458|FG001|Overall Study|Death|0|||
164613492|NCT01505114|594606459|FG002|Overall Study|Death|0|||
164613493|NCT01505114|594606460|FG003|Overall Study|Death|1|||
164613494|NCT01505114|594606457|FG000|Overall Study|unable to adhere to visit schedule|3|||
164613495|NCT01505114|594606458|FG001|Overall Study|unable to adhere to visit schedule|2|||
164613496|NCT01505114|594606459|FG002|Overall Study|unable to adhere to visit schedule|3|||
164613497|NCT01505114|594606460|FG003|Overall Study|unable to adhere to visit schedule|3|||
164613498|NCT01505114|594606457|FG000|Overall Study|Lost to Follow-up|11|||
164613499|NCT01505114|594606458|FG001|Overall Study|Lost to Follow-up|5|||
164613500|NCT01505114|594606459|FG002|Overall Study|Lost to Follow-up|8|||
164613501|NCT01505114|594606460|FG003|Overall Study|Lost to Follow-up|7|||
164613502|NCT01505114|594606457|FG000|Overall Study|relocated|4|||
164613503|NCT01505114|594606458|FG001|Overall Study|relocated|2|||
164613504|NCT01505114|594606459|FG002|Overall Study|relocated|2|||
164613505|NCT01505114|594606460|FG003|Overall Study|relocated|3|||
164613506|NCT01505114|594606457|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
164613507|NCT01505114|594606458|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
164613508|NCT01505114|594606459|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
164613509|NCT01505114|594606460|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
164613510|NCT01505114|594606457|FG000|Overall Study|staff safety concerns|0|||
164613511|NCT01505114|594606458|FG001|Overall Study|staff safety concerns|0|||
164613512|NCT01505114|594606459|FG002|Overall Study|staff safety concerns|0|||
164613513|NCT01505114|594606460|FG003|Overall Study|staff safety concerns|1|||
164613514|NCT01505114|594606457|FG000|Overall Study|investigator decision|1|||
164613515|NCT01505114|594606458|FG001|Overall Study|investigator decision|0|||
164613516|NCT01505114|594606459|FG002|Overall Study|investigator decision|1|||
164613517|NCT01505114|594606460|FG003|Overall Study|investigator decision|0|||
164613518|NCT02017704|594606467|FG000|Overall Study|Withdrawal by Subject|2|||
164613519|NCT02017704|594606468|FG001|Overall Study|Withdrawal by Subject|0|||
164613520|NCT02076334|594606469|FG000|Overall Study|Protocol Violation|1|||
164613521|NCT02076334|594606470|FG001|Overall Study|Protocol Violation|0|||
164613522|NCT02076334|594606471|FG002|Overall Study|Protocol Violation|0|||
164147372|NCT05168202|592902027|FG003|Overall Study|Adverse Event|4|||
164613523|NCT02076334|594606472|FG003|Overall Study|Protocol Violation|0|||
164613524|NCT02076334|594606469|FG000|Overall Study|Lost to Follow-up|0|||
164613525|NCT02076334|594606470|FG001|Overall Study|Lost to Follow-up|1|||
164613526|NCT02076334|594606471|FG002|Overall Study|Lost to Follow-up|1|||
164613527|NCT02076334|594606472|FG003|Overall Study|Lost to Follow-up|0|||
164613528|NCT02076334|594606469|FG000|Overall Study|muscle soreness|0|||
164613529|NCT02076334|594606470|FG001|Overall Study|muscle soreness|0|||
164613530|NCT02076334|594606471|FG002|Overall Study|muscle soreness|0|||
164613531|NCT02076334|594606472|FG003|Overall Study|muscle soreness|1|||
164613532|NCT01963780|594606473|FG000|Overall Study|Death|7|||
164613533|NCT01749800|594606474|FG000|Overall Study|not meeting inclusion criteria|3|||
164613534|NCT01749800|594606475|FG001|Overall Study|not meeting inclusion criteria|0|||
164613535|NCT01749800|594606476|FG002|Overall Study|not meeting inclusion criteria|0|||
164613536|NCT01749800|594606474|FG000|Overall Study|Withdrawal by Subject|0|||
164613537|NCT01749800|594606475|FG001|Overall Study|Withdrawal by Subject|1|||
164613538|NCT01749800|594606476|FG002|Overall Study|Withdrawal by Subject|0|||
164613539|NCT01975675|594606477|FG000|Overall Study|Death|0|||
164613540|NCT01975675|594606478|FG001|Overall Study|Death|1|||
164613541|NCT01975675|594606479|FG002|Overall Study|Death|0|||
164613542|NCT01975675|594606480|FG003|Overall Study|Death|0|||
164613543|NCT03639987|594606481|FG000|Overall Study|Study terminated by sponsor|26|||
164613544|NCT03639987|594606482|FG001|Overall Study|Study terminated by sponsor|25|||
164613545|NCT03639987|594606481|FG000|Overall Study|Lost to Follow-up|0|||
164613546|NCT03639987|594606482|FG001|Overall Study|Lost to Follow-up|1|||
164613547|NCT04354155|594606483|FG000|Overall Study|Withdrawal by Subject|1|||
164613548|NCT04354155|594606483|FG000|Overall Study|Did not meet criteria for study intervention|1|||
164613549|NCT02810951|594606486|FG000|Overall Study|Adverse Event|1|||
164613550|NCT01575899|594606487|FG000|Overall Study|Lost to Follow-up|3|||
164613551|NCT01575899|594606488|FG001|Overall Study|Lost to Follow-up|4|||
164613552|NCT01575899|594606489|FG002|Overall Study|Lost to Follow-up|2|||
164613553|NCT01575899|594606487|FG000|Overall Study|Protocol Violation|2|||
164613554|NCT01575899|594606488|FG001|Overall Study|Protocol Violation|1|||
164613555|NCT01575899|594606489|FG002|Overall Study|Protocol Violation|0|||
164613556|NCT01015820|594606490|FG000|Overall Study|Suboptimal measurements|1|||
164613557|NCT01015820|594606491|FG001|Overall Study|Suboptimal measurements|0|||
164613558|NCT03097029|594606492|FG000|Overall Study|Withdrawal by Subject|1|||
164613559|NCT00709124|594606493|FG000|Overall Study|Death|3|||
164613560|NCT00709124|594606494|FG001|Overall Study|Death|1|||
164613561|NCT00709124|594606493|FG000|Overall Study|encephalopathy; can't do assessment|1|||
164613562|NCT00709124|594606494|FG001|Overall Study|encephalopathy; can't do assessment|0|||
164613563|NCT00373490|594606495|FG000|Overall Study|Adverse Event|0|||
164613564|NCT00373490|594606496|FG001|Overall Study|Adverse Event|1|||
164613565|NCT00373490|594606495|FG000|Overall Study|Lack of Efficacy|9|||
164613566|NCT00373490|594606496|FG001|Overall Study|Lack of Efficacy|4|||
164613567|NCT00373490|594606495|FG000|Overall Study|Withdrawal by Subject|0|||
164613568|NCT00373490|594606496|FG001|Overall Study|Withdrawal by Subject|1|||
164613569|NCT00753688|594606497|FG000|Overall Study|Death|102|||
164613570|NCT00753688|594606498|FG001|Overall Study|Death|203|||
164613571|NCT00753688|594606497|FG000|Overall Study|Missing|4|||
164613572|NCT00753688|594606498|FG001|Overall Study|Missing|9|||
164613573|NCT00753688|594606497|FG000|Overall Study|Participant Withdrew Consent|2|||
164613574|NCT00753688|594606498|FG001|Overall Study|Participant Withdrew Consent|2|||
164613575|NCT00753688|594606497|FG000|Overall Study|Ongoing - in Follow-up|15|||
164613576|NCT00753688|594606498|FG001|Overall Study|Ongoing - in Follow-up|31|||
164613577|NCT00753688|594606497|FG000|Overall Study|Adverse Event|0|||
164613578|NCT00753688|594606498|FG001|Overall Study|Adverse Event|1|||
164613579|NCT01250756|594606499|FG000|Infant Series|Withdrawal by Subject|4|||
164613580|NCT01250756|594606500|FG001|Infant Series|Withdrawal by Subject|5|||
164613581|NCT01250756|594606499|FG000|Infant Series|Randomized, Not Vaccinated|2|||
164613582|NCT01250756|594606500|FG001|Infant Series|Randomized, Not Vaccinated|2|||
164613583|NCT01250756|594606499|FG000|Infant Series|Other|22|||
164613584|NCT01250756|594606500|FG001|Infant Series|Other|0|||
164613585|NCT01250756|594606499|FG000|After Infant Series|Adverse Event|5|||
164613586|NCT01250756|594606500|FG001|After Infant Series|Adverse Event|2|||
164613587|NCT01250756|594606499|FG000|After Infant Series|Withdrawal by Subject|4|||
164613588|NCT01250756|594606500|FG001|After Infant Series|Withdrawal by Subject|1|||
164613589|NCT01250756|594606499|FG000|After Infant Series|Other|2|||
164613590|NCT01250756|594606500|FG001|After Infant Series|Other|1|||
164613591|NCT01250756|594606499|FG000|Toddler Dose|Adverse Event|0|||
164613592|NCT01250756|594606500|FG001|Toddler Dose|Adverse Event|1|||
164613593|NCT01250756|594606499|FG000|After Toddler Dose|Adverse Event|0|||
164613594|NCT01250756|594606500|FG001|After Toddler Dose|Adverse Event|1|||
164613595|NCT02999100|594606503|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
164613596|NCT02999100|594606504|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
164613597|NCT02999100|594606505|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
164613598|NCT02999100|594606506|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
164613599|NCT02999100|594606507|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
164613600|NCT02999100|594606508|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
164613601|NCT02999100|594606503|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
164613602|NCT02999100|594606504|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
164613603|NCT02999100|594606505|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
164613604|NCT02999100|594606506|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
164613605|NCT02999100|594606507|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
164613606|NCT02999100|594606508|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
164613607|NCT02999100|594606503|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
164613608|NCT02999100|594606504|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
164613609|NCT02999100|594606505|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
164613610|NCT02999100|594606506|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
164613611|NCT02999100|594606507|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
164613612|NCT02999100|594606508|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
164613613|NCT01998399|594606511|FG000|Overall Study|Lost to Follow-up|1|||
164613614|NCT01998399|594606512|FG001|Overall Study|Lost to Follow-up|3|||
164613615|NCT01998399|594606511|FG000|Overall Study|Death|4|||
164613616|NCT01998399|594606512|FG001|Overall Study|Death|2|||
164613617|NCT01998399|594606511|FG000|Overall Study|Study stopped before dosing completed|3|||
164613618|NCT01998399|594606512|FG001|Overall Study|Study stopped before dosing completed|3|||
164613619|NCT01998399|594606511|FG000|Overall Study|Withdrawal by Subject|0|||
164613620|NCT01998399|594606512|FG001|Overall Study|Withdrawal by Subject|1|||
164613621|NCT00376246|594606513|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
164613622|NCT00376246|594606514|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
164613623|NCT00376246|594606513|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
164613624|NCT00376246|594606514|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
164613625|NCT00376246|594606513|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
164613626|NCT00376246|594606514|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
164613627|NCT01455415|594606517|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
164613628|NCT01455415|594606518|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
164613629|NCT01455415|594606517|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
164613630|NCT01455415|594606518|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
164613631|NCT01455415|594606517|FG000|Period 1|Drug Error not Associated to AE|0|||
164613632|NCT01455415|594606518|FG001|Period 1|Drug Error not Associated to AE|1|||
164613633|NCT01455415|594606517|FG000|Period 1|AE Not Related to Study Drug|2|||
164613634|NCT01455415|594606518|FG001|Period 1|AE Not Related to Study Drug|6|||
164613635|NCT01455415|594606517|FG000|Period 1|Withdrawal by Subject|4|||
164613636|NCT01455415|594606518|FG001|Period 1|Withdrawal by Subject|5|||
164613637|NCT01455415|594606517|FG000|Period 1|Unspecified Reason|1|||
164613638|NCT01455415|594606518|FG001|Period 1|Unspecified Reason|1|||
164613639|NCT01455415|594606517|FG000|Period 1|Protocol Violation|0|||
164613640|NCT01455415|594606518|FG001|Period 1|Protocol Violation|2|||
164613641|NCT01455415|594606517|FG000|Washout|AE Related to Study Drug|2|||
164613642|NCT01455415|594606518|FG001|Washout|AE Related to Study Drug|0|||
164613643|NCT01455415|594606517|FG000|Washout|Lost to Follow-up|1|||
164613644|NCT01455415|594606518|FG001|Washout|Lost to Follow-up|0|||
164613645|NCT01455415|594606517|FG000|Washout|Drug Error not Associated to AE|2|||
164613646|NCT01455415|594606518|FG001|Washout|Drug Error not Associated to AE|1|||
164613647|NCT01455415|594606517|FG000|Washout|AE Not Related to Study Drug|2|||
164613648|NCT01455415|594606518|FG001|Washout|AE Not Related to Study Drug|3|||
164613649|NCT01455415|594606517|FG000|Washout|Unspecified Reason|1|||
164613650|NCT01455415|594606518|FG001|Washout|Unspecified Reason|2|||
164613651|NCT01455415|594606517|FG000|Washout|Protocol Violation|0|||
164613652|NCT01455415|594606518|FG001|Washout|Protocol Violation|1|||
164613653|NCT01455415|594606517|FG000|Period 2|AE Related to Study Drug|1|||
164613654|NCT01455415|594606518|FG001|Period 2|AE Related to Study Drug|2|||
164613655|NCT01455415|594606517|FG000|Period 2|Lost to Follow-up|2|||
164613656|NCT01455415|594606518|FG001|Period 2|Lost to Follow-up|1|||
164613657|NCT01455415|594606517|FG000|Period 2|AE Not Related to Study Drug|2|||
164613658|NCT01455415|594606518|FG001|Period 2|AE Not Related to Study Drug|1|||
164613659|NCT01455415|594606517|FG000|Period 2|Lack of Efficacy|2|||
164613660|NCT01455415|594606518|FG001|Period 2|Lack of Efficacy|0|||
164516576|NCT01254747|594260892|FG003|Overall Study|Difficult removal handling|0|||
164516577|NCT01254747|594260889|FG000|Overall Study|Symptoms and problems|0|||
164516578|NCT01254747|594260890|FG001|Overall Study|Symptoms and problems|2|||
164516579|NCT01254747|594260891|FG002|Overall Study|Symptoms and problems|1|||
164516580|NCT01254747|594260892|FG003|Overall Study|Symptoms and problems|0|||
164516581|NCT01254747|594260889|FG000|Overall Study|Lost to Follow-up|0|||
164516582|NCT01254747|594260890|FG001|Overall Study|Lost to Follow-up|0|||
164516583|NCT01254747|594260891|FG002|Overall Study|Lost to Follow-up|1|||
164516584|NCT01254747|594260892|FG003|Overall Study|Lost to Follow-up|0|||
164516585|NCT01254747|594260889|FG000|Overall Study|Biomicroscopy|0|||
164516586|NCT01254747|594260890|FG001|Overall Study|Biomicroscopy|0|||
164516587|NCT01254747|594260891|FG002|Overall Study|Biomicroscopy|1|||
164516588|NCT01254747|594260892|FG003|Overall Study|Biomicroscopy|0|||
164516589|NCT01254747|594260889|FG000|Overall Study|Discomfort|0|||
164516590|NCT01254747|594260890|FG001|Overall Study|Discomfort|4|||
164516591|NCT01254747|594260891|FG002|Overall Study|Discomfort|0|||
164516592|NCT01254747|594260892|FG003|Overall Study|Discomfort|0|||
164516593|NCT02406677|594260893|FG000|Overall Study|Death|16|||
164516594|NCT02406677|594260894|FG001|Overall Study|Death|8|||
164516595|NCT02406677|594260893|FG000|Overall Study|Discharged without P2Y12|1|||
164516596|NCT02406677|594260894|FG001|Overall Study|Discharged without P2Y12|3|||
164516597|NCT02406677|594260893|FG000|Overall Study|Discharged on prasugrel|283|||
164516598|NCT02406677|594260894|FG001|Overall Study|Discharged on prasugrel|587|||
164516599|NCT02406677|594260893|FG000|Overall Study|Withdrawal by Subject|1|||
164516600|NCT02406677|594260894|FG001|Overall Study|Withdrawal by Subject|0|||
164516601|NCT02833077|594260897|FG000|Overall Study|Adverse Event|1|||
164516602|NCT02833077|594260898|FG001|Overall Study|Adverse Event|2|||
164516603|NCT02833077|594260897|FG000|Overall Study|Lost to Follow-up|10|||
164516604|NCT02833077|594260898|FG001|Overall Study|Lost to Follow-up|1|||
164516605|NCT02833077|594260897|FG000|Overall Study|Personal Reasons|6|||
164516606|NCT02833077|594260898|FG001|Overall Study|Personal Reasons|4|||
164516607|NCT02833077|594260897|FG000|Overall Study|Protocol Deviation|0|||
164516608|NCT02833077|594260898|FG001|Overall Study|Protocol Deviation|1|||
164516609|NCT04608773|594260899|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
164516610|NCT04608773|594260900|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
164516611|NCT04608773|594260899|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
164516612|NCT04608773|594260900|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
164516613|NCT04608773|594260899|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
164516614|NCT04608773|594260900|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
164516615|NCT04608773|594260899|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
164516616|NCT04608773|594260900|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
164516617|NCT04608773|594260899|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
164516618|NCT04608773|594260900|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
164516619|NCT00972322|594260901|FG000|Overall Study|Adverse Event|2|||
164516620|NCT00972322|594260902|FG001|Overall Study|Adverse Event|1|||
164516621|NCT00972322|594260901|FG000|Overall Study|Positive drug screen|0|||
164516622|NCT00972322|594260902|FG001|Overall Study|Positive drug screen|1|||
164516623|NCT00972322|594260901|FG000|Overall Study|Lost to Follow-up|0|||
164516624|NCT00972322|594260902|FG001|Overall Study|Lost to Follow-up|1|||
164516625|NCT00972322|594260901|FG000|Overall Study|Consistently high glucose values|1|||
164516626|NCT00972322|594260902|FG001|Overall Study|Consistently high glucose values|0|||
164516627|NCT04531098|594260905|FG000|Stage I|Adverse Event|0|||
164516628|NCT04531098|594260906|FG001|Stage I|Adverse Event|0|||
164516629|NCT04531098|594260907|FG002|Stage I|Adverse Event|3|||
164516630|NCT04531098|594260905|FG000|Stage I|Protocol Violation|0|||
164516631|NCT04531098|594260906|FG001|Stage I|Protocol Violation|0|||
164516632|NCT04531098|594260907|FG002|Stage I|Protocol Violation|5|||
164516633|NCT04531098|594260905|FG000|Stage I|Withdrawal by Subject|0|||
164516634|NCT04531098|594260906|FG001|Stage I|Withdrawal by Subject|5|||
164516635|NCT04531098|594260907|FG002|Stage I|Withdrawal by Subject|10|||
164516636|NCT04531098|594260905|FG000|Stage II|Adverse Event|1|||
164516637|NCT04531098|594260906|FG001|Stage II|Adverse Event|2|||
164516638|NCT04531098|594260907|FG002|Stage II|Adverse Event|0|||
164516639|NCT04531098|594260905|FG000|Stage II|Protocol Violation|1|||
164516640|NCT04531098|594260906|FG001|Stage II|Protocol Violation|2|||
164516641|NCT04531098|594260907|FG002|Stage II|Protocol Violation|0|||
164516642|NCT04531098|594260905|FG000|Stage II|Withdrawal by Subject|3|||
164516643|NCT04531098|594260906|FG001|Stage II|Withdrawal by Subject|1|||
164516644|NCT04531098|594260907|FG002|Stage II|Withdrawal by Subject|0|||
164516645|NCT04531098|594260905|FG000|Stage II|Moved from study area|8|||
164516646|NCT04531098|594260906|FG001|Stage II|Moved from study area|5|||
164516647|NCT04531098|594260907|FG002|Stage II|Moved from study area|0|||
164516648|NCT00316017|594260908|FG000|Overall Study|Protocol Violation|11|||
164516649|NCT00316017|594260909|FG001|Overall Study|Protocol Violation|13|||
164516650|NCT00316017|594260910|FG002|Overall Study|Protocol Violation|19|||
164516651|NCT00623805|594260916|FG000|Overall Study|Adverse Event|9|||
164516652|NCT00623805|594260917|FG001|Overall Study|Adverse Event|6|||
164516653|NCT00623805|594260916|FG000|Overall Study|Death|2|||
164516654|NCT00623805|594260917|FG001|Overall Study|Death|0|||
164516655|NCT00623805|594260916|FG000|Overall Study|Lack of Efficacy|3|||
164516656|NCT00623805|594260917|FG001|Overall Study|Lack of Efficacy|7|||
164516657|NCT00623805|594260916|FG000|Overall Study|Lost to Follow-up|2|||
164516658|NCT00623805|594260917|FG001|Overall Study|Lost to Follow-up|2|||
164516659|NCT00623805|594260916|FG000|Overall Study|Protocol Violation|1|||
164516660|NCT00623805|594260917|FG001|Overall Study|Protocol Violation|1|||
164516661|NCT00623805|594260916|FG000|Overall Study|Reason not Specified|3|||
164516662|NCT00623805|594260917|FG001|Overall Study|Reason not Specified|6|||
164516663|NCT02671500|594260919|FG000|Overall Study|Lack of Efficacy|12|||
164516664|NCT02671500|594260919|FG000|Overall Study|Lost to Follow-up|2|||
164516665|NCT05235269|594260921|FG000|Overall Study|Adverse Event|1|||
164516666|NCT05235269|594260921|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
164516667|NCT05235269|594260921|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
164516668|NCT03361865|594260922|FG000|Overall Study|Death|17|||
164516669|NCT03361865|594260923|FG001|Overall Study|Death|18|||
164516670|NCT03361865|594260922|FG000|Overall Study|Physician Decision|1|||
164516671|NCT03361865|594260923|FG001|Overall Study|Physician Decision|9|||
164516672|NCT03361865|594260922|FG000|Overall Study|Withdrawal by Subject|1|||
164516673|NCT03361865|594260923|FG001|Overall Study|Withdrawal by Subject|0|||
164516674|NCT03810235|594260927|FG000|Overall Study|Withdrawal by Subject|2|||
164516675|NCT03810235|594260928|FG001|Overall Study|Withdrawal by Subject|0|||
164516676|NCT01647542|594260929|FG000|Overall Study|Major Protocol Deviation|1|||
164516677|NCT01647542|594260930|FG001|Overall Study|Major Protocol Deviation|0|||
164516678|NCT01647542|594260931|FG002|Overall Study|Major Protocol Deviation|0|||
164516679|NCT01647542|594260929|FG000|Overall Study|Adverse Event|4|||
164516680|NCT01647542|594260930|FG001|Overall Study|Adverse Event|5|||
164516681|NCT01647542|594260931|FG002|Overall Study|Adverse Event|4|||
164516682|NCT01647542|594260929|FG000|Overall Study|Lost to Follow-up|0|||
164516683|NCT01647542|594260930|FG001|Overall Study|Lost to Follow-up|2|||
164516684|NCT01647542|594260931|FG002|Overall Study|Lost to Follow-up|2|||
164516685|NCT01647542|594260929|FG000|Overall Study|Withdrawal by Subject|6|||
164516686|NCT01647542|594260930|FG001|Overall Study|Withdrawal by Subject|4|||
164516687|NCT01647542|594260931|FG002|Overall Study|Withdrawal by Subject|0|||
164516688|NCT01647542|594260929|FG000|Overall Study|Study Termination|64|||
164516689|NCT01647542|594260930|FG001|Overall Study|Study Termination|61|||
164516690|NCT01647542|594260931|FG002|Overall Study|Study Termination|65|||
164516691|NCT01647542|594260929|FG000|Overall Study|Lack of Efficacy|1|||
164516692|NCT01647542|594260930|FG001|Overall Study|Lack of Efficacy|1|||
164516693|NCT01647542|594260931|FG002|Overall Study|Lack of Efficacy|0|||
164516694|NCT01647542|594260929|FG000|Overall Study|Death|0|||
164516695|NCT01647542|594260930|FG001|Overall Study|Death|0|||
164516696|NCT01647542|594260931|FG002|Overall Study|Death|1|||
164516697|NCT00215137|594262823|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
164516698|NCT00215137|594262824|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
164516699|NCT00215137|594262825|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
164516700|NCT00215137|594262823|FG000|Randomization Period|Lost to Follow-up|0|||
164516701|NCT00215137|594262824|FG001|Randomization Period|Lost to Follow-up|1|||
164516702|NCT00215137|594262825|FG002|Randomization Period|Lost to Follow-up|0|||
164516703|NCT00215137|594262823|FG000|Randomization Period|Withdrawal by Subject|0|||
164516704|NCT00215137|594262824|FG001|Randomization Period|Withdrawal by Subject|1|||
164516705|NCT00215137|594262825|FG002|Randomization Period|Withdrawal by Subject|0|||
164516706|NCT03333876|594262826|FG000|Screening Period|Screen Failure|4|||
164516707|NCT03333876|594262826|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
164516708|NCT03333876|594262826|FG000|Mandibular Advancement|Adverse Event|2|||
164516709|NCT03333876|594262826|FG000|Mandibular Advancement|Product Damage|2|||
164516710|NCT00095498|594262830|FG000|Overall Study|Physician Decision|9|||
164516711|NCT00095498|594262831|FG001|Overall Study|Physician Decision|10|||
164516712|NCT00095498|594262832|FG002|Overall Study|Physician Decision|8|||
164516713|NCT00095498|594262830|FG000|Overall Study|Adverse Event|1|||
164516714|NCT00095498|594262831|FG001|Overall Study|Adverse Event|0|||
164516715|NCT00095498|594262832|FG002|Overall Study|Adverse Event|1|||
164516716|NCT00095498|594262830|FG000|Overall Study|Withdrawal by Subject|15|||
164516717|NCT00095498|594262831|FG001|Overall Study|Withdrawal by Subject|16|||
164516718|NCT00095498|594262832|FG002|Overall Study|Withdrawal by Subject|15|||
164516719|NCT00095498|594262830|FG000|Overall Study|Disease progression|0|||
164516720|NCT00095498|594262831|FG001|Overall Study|Disease progression|1|||
164516721|NCT00095498|594262832|FG002|Overall Study|Disease progression|1|||
164516722|NCT00095498|594262830|FG000|Overall Study|Ineligibility determined|3|||
164516723|NCT00095498|594262831|FG001|Overall Study|Ineligibility determined|0|||
164516724|NCT00095498|594262832|FG002|Overall Study|Ineligibility determined|2|||
164516725|NCT00095498|594262830|FG000|Overall Study|Lost to Follow-up|1|||
164516726|NCT00095498|594262831|FG001|Overall Study|Lost to Follow-up|1|||
164516727|NCT00095498|594262832|FG002|Overall Study|Lost to Follow-up|2|||
164516728|NCT00095498|594262830|FG000|Overall Study|Noncompliance|1|||
164516729|NCT00095498|594262831|FG001|Overall Study|Noncompliance|0|||
164516730|NCT00095498|594262832|FG002|Overall Study|Noncompliance|1|||
164516731|NCT00095498|594262830|FG000|Overall Study|Other|6|||
164516732|NCT00095498|594262831|FG001|Overall Study|Other|7|||
164613661|NCT01455415|594606517|FG000|Period 2|Withdrawal by Subject|2|||
164613662|NCT01455415|594606518|FG001|Period 2|Withdrawal by Subject|3|||
164613663|NCT01455415|594606517|FG000|Period 2|Unspecified Reason|2|||
164613664|NCT01455415|594606518|FG001|Period 2|Unspecified Reason|3|||
164613665|NCT01455415|594606517|FG000|Period 2|Protocol Violation|2|||
164613666|NCT01455415|594606518|FG001|Period 2|Protocol Violation|0|||
164613667|NCT01455415|594606517|FG000|Follow-up|AE Related to Study Drug|0|||
164613668|NCT01455415|594606518|FG001|Follow-up|AE Related to Study Drug|1|||
164613669|NCT01455415|594606517|FG000|Follow-up|Lack of Efficacy|0|||
164613670|NCT01455415|594606518|FG001|Follow-up|Lack of Efficacy|1|||
164613671|NCT01455415|594606517|FG000|Follow-up|Withdrawal by Subject|2|||
164613672|NCT01455415|594606518|FG001|Follow-up|Withdrawal by Subject|0|||
164613673|NCT01455415|594606517|FG000|Follow-up|Unspecified Reason|1|||
164613674|NCT01455415|594606518|FG001|Follow-up|Unspecified Reason|0|||
164613675|NCT00587301|594606519|FG000|Overall Study|Screen Failure|9|||
164613676|NCT00587301|594606519|FG000|Overall Study|Lost to Follow-up|22|||
164613677|NCT00587301|594606519|FG000|Overall Study|Withdrawal by Subject|7|||
164613678|NCT00587301|594606519|FG000|Overall Study|Protocol Violation|7|||
164613679|NCT00351819|594606520|FG000|Overall Study|Lost to Follow-up|4|||
164613680|NCT00351819|594606521|FG001|Overall Study|Lost to Follow-up|4|||
164613681|NCT00351819|594606520|FG000|Overall Study|Withdrawal by Subject|0|||
164613682|NCT00351819|594606521|FG001|Overall Study|Withdrawal by Subject|4|||
164613683|NCT00351819|594606520|FG000|Overall Study|Elevated PSA|1|||
164613684|NCT00351819|594606521|FG001|Overall Study|Elevated PSA|1|||
164613685|NCT00351819|594606520|FG000|Overall Study|Traumatic ankle fracture|1|||
164613686|NCT00351819|594606521|FG001|Overall Study|Traumatic ankle fracture|0|||
164613687|NCT00351819|594606520|FG000|Overall Study|Unprofessional behavior|1|||
164613688|NCT00351819|594606521|FG001|Overall Study|Unprofessional behavior|0|||
164613689|NCT00351819|594606520|FG000|Overall Study|Non-compliance|0|||
164613690|NCT00351819|594606521|FG001|Overall Study|Non-compliance|1|||
164613691|NCT00351819|594606520|FG000|Overall Study|Incarcerated|0|||
164613692|NCT00351819|594606521|FG001|Overall Study|Incarcerated|1|||
164613693|NCT00351819|594606520|FG000|Overall Study|Enrolled in another trial|0|||
164613694|NCT00351819|594606521|FG001|Overall Study|Enrolled in another trial|1|||
164613695|NCT00719537|594606524|FG000|Overall Study|Withdrawal by Subject|1|||
164613696|NCT00719537|594606525|FG001|Overall Study|Withdrawal by Subject|0|||
164613697|NCT00719537|594606524|FG000|Overall Study|Lost to Follow-up|0|||
164613698|NCT00719537|594606525|FG001|Overall Study|Lost to Follow-up|1|||
164613699|NCT02460978|594606526|FG000|Overall Study|Adverse Event|17|||
164613700|NCT02460978|594606527|FG001|Overall Study|Adverse Event|11|||
164613701|NCT02460978|594606528|FG002|Overall Study|Adverse Event|11|||
164613702|NCT02460978|594606526|FG000|Overall Study|Withdrawal by Subject|5|||
164613703|NCT02460978|594606527|FG001|Overall Study|Withdrawal by Subject|5|||
164613704|NCT02460978|594606528|FG002|Overall Study|Withdrawal by Subject|14|||
164613705|NCT02460978|594606526|FG000|Overall Study|Lost to Follow-up|2|||
164613706|NCT02460978|594606527|FG001|Overall Study|Lost to Follow-up|3|||
164613707|NCT02460978|594606528|FG002|Overall Study|Lost to Follow-up|1|||
164613708|NCT02460978|594606526|FG000|Overall Study|Protocol Violation|1|||
164613709|NCT02460978|594606527|FG001|Overall Study|Protocol Violation|1|||
164613710|NCT02460978|594606528|FG002|Overall Study|Protocol Violation|1|||
164613711|NCT02460978|594606526|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
164613712|NCT02460978|594606527|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
164613713|NCT02460978|594606528|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
164613714|NCT02460978|594606526|FG000|Overall Study|Pregnancy|0|||
164613715|NCT02460978|594606527|FG001|Overall Study|Pregnancy|0|||
164613716|NCT02460978|594606528|FG002|Overall Study|Pregnancy|2|||
164613717|NCT01142193|594606529|FG000|Overall Study|Adverse Event|12|||
164613718|NCT01142193|594606530|FG001|Overall Study|Adverse Event|4|||
164613719|NCT01142193|594606529|FG000|Overall Study|Lack of Efficacy|2|||
164613720|NCT01142193|594606530|FG001|Overall Study|Lack of Efficacy|1|||
164613721|NCT01142193|594606529|FG000|Overall Study|Physician Decision|1|||
164613722|NCT01142193|594606530|FG001|Overall Study|Physician Decision|1|||
164613723|NCT01142193|594606529|FG000|Overall Study|Withdrawal by Subject|4|||
164613724|NCT01142193|594606530|FG001|Overall Study|Withdrawal by Subject|3|||
164613725|NCT01142193|594606529|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
164613726|NCT01142193|594606530|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
164613727|NCT01142193|594606529|FG000|Overall Study|Other|1|||
164613728|NCT01142193|594606530|FG001|Overall Study|Other|2|||
164613729|NCT00994162|594606531|FG000|Overall Study|Withdrawal by Subject|1|||
164613730|NCT00994162|594606531|FG000|Overall Study|Lost to Follow-up|2|||
164613731|NCT00994162|594606531|FG000|Overall Study|Product Complaint|1|||
164613732|NCT00994162|594606531|FG000|Overall Study|Poor Compliance|5|||
164613733|NCT00994162|594606531|FG000|Overall Study|Lack of Response|3|||
164613734|NCT00994162|594606531|FG000|Overall Study|Discharged from Hospital|4|||
164613735|NCT00994162|594606531|FG000|Overall Study|Death|2|||
164613736|NCT00994162|594606531|FG000|Overall Study|Care Transferred to Another Physician|2|||
164613737|NCT00994162|594606531|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
164613738|NCT00994162|594606531|FG000|Overall Study|Physician Decision|2|||
164613739|NCT00994162|594606531|FG000|Overall Study|Surrounding Wound Erythematous|1|||
164613740|NCT00994162|594606531|FG000|Overall Study|Machine Losing Vaccum|1|||
164613741|NCT00994162|594606531|FG000|Overall Study|Patient Lived Too Far Away|1|||
164613742|NCT00994162|594606531|FG000|Overall Study|Above Knee Amputation|1|||
164613743|NCT00994162|594606531|FG000|Overall Study|Reason Not Reported By Site|1|||
164613744|NCT01459068|594606534|FG000|Overall Study|Withdrawal by Subject|8|||
164613745|NCT01459068|594606535|FG001|Overall Study|Withdrawal by Subject|18|||
164613746|NCT01459068|594606534|FG000|Overall Study|Lost to Follow-up|31|||
164613747|NCT01459068|594606535|FG001|Overall Study|Lost to Follow-up|15|||
164613748|NCT01459068|594606534|FG000|Overall Study|Death|0|||
164613749|NCT01459068|594606535|FG001|Overall Study|Death|1|||
164613750|NCT02023112|594606536|FG000|Overall Study|Withdrawal by Subject|2|||
164613751|NCT02023112|594606537|FG001|Overall Study|Withdrawal by Subject|1|||
164613752|NCT00910728|594606538|FG000|Overall Study|Lack of Efficacy|2|||
164613753|NCT00910728|594606539|FG001|Overall Study|Lack of Efficacy|3|||
164613754|NCT00910728|594606540|FG002|Overall Study|Lack of Efficacy|1|||
164613755|NCT00910728|594606541|FG003|Overall Study|Lack of Efficacy|2|||
164613756|NCT00910728|594606542|FG004|Overall Study|Lack of Efficacy|1|||
164613757|NCT00910728|594606543|FG005|Overall Study|Lack of Efficacy|0|||
164613758|NCT00910728|594606544|FG006|Overall Study|Lack of Efficacy|2|||
164613759|NCT00910728|594606545|FG007|Overall Study|Lack of Efficacy|2|||
164613760|NCT00910728|594606546|FG008|Overall Study|Lack of Efficacy|2|||
164613761|NCT00910728|594606538|FG000|Overall Study|Withdrawal by Subject|0|||
164613762|NCT00910728|594606539|FG001|Overall Study|Withdrawal by Subject|0|||
164613763|NCT00910728|594606540|FG002|Overall Study|Withdrawal by Subject|0|||
164613764|NCT00910728|594606541|FG003|Overall Study|Withdrawal by Subject|0|||
164613765|NCT00910728|594606542|FG004|Overall Study|Withdrawal by Subject|3|||
164613766|NCT00910728|594606543|FG005|Overall Study|Withdrawal by Subject|1|||
164613767|NCT00910728|594606544|FG006|Overall Study|Withdrawal by Subject|2|||
164613768|NCT00910728|594606545|FG007|Overall Study|Withdrawal by Subject|0|||
164613769|NCT00910728|594606546|FG008|Overall Study|Withdrawal by Subject|0|||
164613770|NCT00910728|594606538|FG000|Overall Study|(not specified)|2|||
164613771|NCT00910728|594606539|FG001|Overall Study|(not specified)|0|||
164613772|NCT00910728|594606540|FG002|Overall Study|(not specified)|1|||
164613773|NCT00910728|594606541|FG003|Overall Study|(not specified)|0|||
164613774|NCT00910728|594606542|FG004|Overall Study|(not specified)|1|||
164613775|NCT00910728|594606543|FG005|Overall Study|(not specified)|0|||
164613776|NCT00910728|594606544|FG006|Overall Study|(not specified)|0|||
164613777|NCT00910728|594606545|FG007|Overall Study|(not specified)|0|||
164613778|NCT00910728|594606546|FG008|Overall Study|(not specified)|0|||
164613779|NCT00910728|594606538|FG000|Overall Study|Adverse Event|2|||
164613780|NCT00910728|594606539|FG001|Overall Study|Adverse Event|0|||
164613781|NCT00910728|594606540|FG002|Overall Study|Adverse Event|1|||
164613782|NCT00910728|594606541|FG003|Overall Study|Adverse Event|1|||
164613783|NCT00910728|594606542|FG004|Overall Study|Adverse Event|0|||
164613784|NCT00910728|594606543|FG005|Overall Study|Adverse Event|0|||
164613785|NCT00910728|594606544|FG006|Overall Study|Adverse Event|2|||
164613786|NCT00910728|594606545|FG007|Overall Study|Adverse Event|1|||
164613787|NCT00910728|594606546|FG008|Overall Study|Adverse Event|1|||
164613788|NCT01225172|594606548|FG000|Overall Study|Subject decision to stop|1|||
164613789|NCT01225172|594606549|FG001|Overall Study|Subject decision to stop|0|||
164613790|NCT01225172|594606548|FG000|Overall Study|Subject request to discontinue treatment|3|||
164613791|NCT01225172|594606549|FG001|Overall Study|Subject request to discontinue treatment|1|||
164613792|NCT01225172|594606548|FG000|Overall Study|Subject no longer meets study criteria|1|||
164613793|NCT01225172|594606549|FG001|Overall Study|Subject no longer meets study criteria|0|||
164613794|NCT01225172|594606548|FG000|Overall Study|Withdrawal by Subject|1|||
164613795|NCT01225172|594606549|FG001|Overall Study|Withdrawal by Subject|0|||
164613796|NCT03404518|594606561|FG000|Overall Study|Lost to Follow-up|28|||
164613797|NCT03404518|594606562|FG001|Overall Study|Lost to Follow-up|30|||
164613798|NCT03404518|594606561|FG000|Overall Study|Protocol Violation|13|||
164613799|NCT03404518|594606562|FG001|Overall Study|Protocol Violation|6|||
164613800|NCT03565991|594608418|FG000|Overall Study|Other|11|||
164613801|NCT03565991|594608419|FG001|Overall Study|Other|0|||
164613802|NCT03565991|594608418|FG000|Overall Study|Global deterioration of health status|14|||
164613803|NCT03565991|594608419|FG001|Overall Study|Global deterioration of health status|4|||
164613804|NCT03565991|594608418|FG000|Overall Study|Withdrawal by Subject|2|||
164613805|NCT03565991|594608419|FG001|Overall Study|Withdrawal by Subject|6|||
164613806|NCT03565991|594608418|FG000|Overall Study|Progressive disease|121|||
164613807|NCT03565991|594608419|FG001|Overall Study|Progressive disease|29|||
164613808|NCT03565991|594608418|FG000|Overall Study|Death|3|||
164613809|NCT03565991|594608419|FG001|Overall Study|Death|0|||
164613810|NCT03565991|594608418|FG000|Overall Study|Adverse Event|7|||
164613811|NCT03565991|594608419|FG001|Overall Study|Adverse Event|2|||
164613812|NCT00106249|594608422|FG000|Overall Study|Lost to Follow-up|3|||
164613813|NCT00106249|594608423|FG001|Overall Study|Lost to Follow-up|2|||
164613814|NCT00948428|594608424|FG000|Overall Study|Withdrawal by Subject|6|||
164613815|NCT00948428|594608425|FG001|Overall Study|Withdrawal by Subject|12|||
164613816|NCT00948428|594608426|FG002|Overall Study|Withdrawal by Subject|7|||
164613817|NCT00948428|594608424|FG000|Overall Study|Adverse Event|6|||
164613818|NCT00948428|594608425|FG001|Overall Study|Adverse Event|3|||
164613819|NCT00948428|594608426|FG002|Overall Study|Adverse Event|0|||
164613820|NCT00948428|594608424|FG000|Overall Study|Lost to Follow-up|2|||
164613821|NCT00948428|594608425|FG001|Overall Study|Lost to Follow-up|1|||
164613822|NCT00948428|594608426|FG002|Overall Study|Lost to Follow-up|1|||
164613823|NCT00948428|594608424|FG000|Overall Study|Death|2|||
164613824|NCT00948428|594608425|FG001|Overall Study|Death|0|||
164613825|NCT00948428|594608426|FG002|Overall Study|Death|0|||
164613826|NCT00948428|594608424|FG000|Overall Study|Intercurrent Illness|1|||
164613827|NCT00948428|594608425|FG001|Overall Study|Intercurrent Illness|0|||
164613828|NCT00948428|594608426|FG002|Overall Study|Intercurrent Illness|0|||
164613829|NCT00948428|594608424|FG000|Overall Study|Non-compliance|1|||
164613830|NCT00948428|594608425|FG001|Overall Study|Non-compliance|2|||
164613831|NCT00948428|594608426|FG002|Overall Study|Non-compliance|0|||
164613832|NCT01495689|594608430|FG000|Overall Study|Death|0|||
164613833|NCT01495689|594608431|FG001|Overall Study|Death|1|||
164613834|NCT01495689|594608430|FG000|Overall Study|Withdrawal by Subject|3|||
164613835|NCT01495689|594608431|FG001|Overall Study|Withdrawal by Subject|0|||
164613836|NCT01495689|594608430|FG000|Overall Study|Lost to Follow-up|7|||
164613837|NCT01495689|594608431|FG001|Overall Study|Lost to Follow-up|6|||
164613838|NCT05516134|594608438|FG000|Overall Study|Lost to Follow-up|1|||
164613839|NCT05516134|594608439|FG001|Overall Study|Lost to Follow-up|0|||
164613840|NCT05516134|594608440|FG002|Overall Study|Lost to Follow-up|0|||
164613841|NCT01599806|594608447|FG000|Overall Study|Lost to Follow-up|20|||
164613842|NCT01599806|594608448|FG001|Overall Study|Lost to Follow-up|20|||
164613843|NCT01599806|594608447|FG000|Overall Study|Withdrawal by Subject|12|||
164613844|NCT01599806|594608448|FG001|Overall Study|Withdrawal by Subject|12|||
164613845|NCT01599806|594608447|FG000|Overall Study|Other Eligibility criteria|11|||
164613846|NCT01599806|594608448|FG001|Overall Study|Other Eligibility criteria|9|||
164613847|NCT02873208|594608449|FG000|Overall Study|Withdrawal by Subject|36|||
164613848|NCT02873208|594608449|FG000|Overall Study|Lost to Follow-up|22|||
164613849|NCT02873208|594608449|FG000|Overall Study|Adverse Event|15|||
164613850|NCT02873208|594608449|FG000|Overall Study|Non-compliance with study drug|12|||
164613851|NCT02873208|594608449|FG000|Overall Study|Protocol Violation|8|||
164613852|NCT02873208|594608449|FG000|Overall Study|Pregnancy|2|||
164613853|NCT02873208|594608449|FG000|Overall Study|Incarceration|1|||
164613854|NCT02873208|594608449|FG000|Overall Study|Lack of Efficacy|1|||
164613855|NCT02873208|594608449|FG000|Overall Study|Physician Decision|1|||
164613856|NCT00415584|594608450|FG000|Overall Study|Withdrawal by Subject|1|||
164613857|NCT00563368|594608451|FG000|Overall Study|Lost to Follow-up|14|||
164613858|NCT00563368|594608452|FG001|Overall Study|Lost to Follow-up|14|||
164613859|NCT00563368|594608453|FG002|Overall Study|Lost to Follow-up|12|||
164613860|NCT00563368|594608454|FG003|Overall Study|Lost to Follow-up|6|||
164613861|NCT00563368|594608455|FG004|Overall Study|Lost to Follow-up|9|||
164613862|NCT00563368|594608456|FG005|Overall Study|Lost to Follow-up|8|||
164613863|NCT00563368|594608457|FG006|Overall Study|Lost to Follow-up|9|||
164613864|NCT00563368|594608451|FG000|Overall Study|Adverse Event|3|||
164613865|NCT00563368|594608452|FG001|Overall Study|Adverse Event|4|||
164613866|NCT00563368|594608453|FG002|Overall Study|Adverse Event|5|||
164613867|NCT00563368|594608454|FG003|Overall Study|Adverse Event|9|||
164613868|NCT00563368|594608455|FG004|Overall Study|Adverse Event|6|||
164613869|NCT00563368|594608456|FG005|Overall Study|Adverse Event|10|||
164613870|NCT00563368|594608457|FG006|Overall Study|Adverse Event|17|||
164613871|NCT00563368|594608451|FG000|Overall Study|Withdrawal by Subject|11|||
164613872|NCT00563368|594608452|FG001|Overall Study|Withdrawal by Subject|6|||
164613873|NCT00563368|594608453|FG002|Overall Study|Withdrawal by Subject|5|||
164613874|NCT00563368|594608454|FG003|Overall Study|Withdrawal by Subject|7|||
164613875|NCT00563368|594608455|FG004|Overall Study|Withdrawal by Subject|8|||
164613876|NCT00563368|594608456|FG005|Overall Study|Withdrawal by Subject|5|||
164613877|NCT00563368|594608457|FG006|Overall Study|Withdrawal by Subject|4|||
164613878|NCT00563368|594608451|FG000|Overall Study|protocol non-compliance|1|||
164613879|NCT00563368|594608452|FG001|Overall Study|protocol non-compliance|1|||
164613880|NCT00563368|594608453|FG002|Overall Study|protocol non-compliance|2|||
164613881|NCT00563368|594608454|FG003|Overall Study|protocol non-compliance|1|||
164613882|NCT00563368|594608455|FG004|Overall Study|protocol non-compliance|0|||
164613883|NCT00563368|594608456|FG005|Overall Study|protocol non-compliance|1|||
164613884|NCT00563368|594608457|FG006|Overall Study|protocol non-compliance|3|||
164613885|NCT00563368|594608451|FG000|Overall Study|Pregnancy|1|||
164613886|NCT00563368|594608452|FG001|Overall Study|Pregnancy|0|||
164613887|NCT00563368|594608453|FG002|Overall Study|Pregnancy|1|||
164613888|NCT00563368|594608454|FG003|Overall Study|Pregnancy|2|||
164613889|NCT00563368|594608455|FG004|Overall Study|Pregnancy|1|||
164613890|NCT00563368|594608456|FG005|Overall Study|Pregnancy|2|||
164613891|NCT00563368|594608457|FG006|Overall Study|Pregnancy|0|||
164613892|NCT00563368|594608451|FG000|Overall Study|requirement for restricted medication|0|||
164613893|NCT00563368|594608452|FG001|Overall Study|requirement for restricted medication|0|||
164613894|NCT00563368|594608453|FG002|Overall Study|requirement for restricted medication|2|||
164613895|NCT00563368|594608454|FG003|Overall Study|requirement for restricted medication|0|||
164613896|NCT00563368|594608455|FG004|Overall Study|requirement for restricted medication|0|||
164613897|NCT00563368|594608456|FG005|Overall Study|requirement for restricted medication|0|||
164613898|NCT00563368|594608457|FG006|Overall Study|requirement for restricted medication|0|||
164613899|NCT00563368|594608451|FG000|Overall Study|Other|5|||
164613900|NCT00563368|594608452|FG001|Overall Study|Other|5|||
164613901|NCT00563368|594608453|FG002|Overall Study|Other|3|||
164613902|NCT00563368|594608454|FG003|Overall Study|Other|4|||
164613903|NCT00563368|594608455|FG004|Overall Study|Other|4|||
164613904|NCT00563368|594608456|FG005|Overall Study|Other|4|||
164613905|NCT00563368|594608457|FG006|Overall Study|Other|0|||
164613906|NCT01061567|594608458|FG000|Overall Study|Adverse Event|32|||
164613907|NCT01061567|594608458|FG000|Overall Study|Death|2|||
164613908|NCT01061567|594608458|FG000|Overall Study|Lack of Efficacy|3|||
164613909|NCT01061567|594608458|FG000|Overall Study|Lost to Follow-up|24|||
164613910|NCT01061567|594608458|FG000|Overall Study|Protocol Violation|1|||
164613911|NCT01061567|594608458|FG000|Overall Study|Withdrawal by Subject|11|||
164613912|NCT01061567|594608458|FG000|Overall Study|Other reason than stated above|3|||
164613913|NCT01831804|594608459|FG000|Overall Study|Adverse Event|0|||
164613914|NCT01831804|594608460|FG001|Overall Study|Adverse Event|0|||
164613915|NCT01831804|594608461|FG002|Overall Study|Adverse Event|0|||
164613916|NCT01831804|594608462|FG003|Overall Study|Adverse Event|0|||
164613917|NCT01831804|594608463|FG004|Overall Study|Adverse Event|0|||
164613918|NCT01831804|594608464|FG005|Overall Study|Adverse Event|0|||
164613919|NCT01831804|594608465|FG006|Overall Study|Adverse Event|1|||
164613920|NCT01831804|594608466|FG007|Overall Study|Adverse Event|0|||
164613921|NCT01831804|594608467|FG008|Overall Study|Adverse Event|1|||
164613922|NCT01831804|594608459|FG000|Overall Study|Protocol Violation|0|||
164613923|NCT01831804|594608460|FG001|Overall Study|Protocol Violation|0|||
164613924|NCT01831804|594608461|FG002|Overall Study|Protocol Violation|2|||
164613925|NCT01831804|594608462|FG003|Overall Study|Protocol Violation|0|||
164613926|NCT01831804|594608463|FG004|Overall Study|Protocol Violation|0|||
164613927|NCT01831804|594608464|FG005|Overall Study|Protocol Violation|0|||
164613928|NCT01831804|594608465|FG006|Overall Study|Protocol Violation|0|||
164613929|NCT01831804|594608466|FG007|Overall Study|Protocol Violation|0|||
164613930|NCT01831804|594608467|FG008|Overall Study|Protocol Violation|0|||
164613931|NCT01831804|594608459|FG000|Overall Study|Protocol defined stopping criteria|1|||
164613932|NCT01831804|594608460|FG001|Overall Study|Protocol defined stopping criteria|1|||
164613933|NCT01831804|594608461|FG002|Overall Study|Protocol defined stopping criteria|3|||
164613934|NCT01831804|594608462|FG003|Overall Study|Protocol defined stopping criteria|0|||
164613935|NCT01831804|594608463|FG004|Overall Study|Protocol defined stopping criteria|1|||
164613936|NCT01831804|594608464|FG005|Overall Study|Protocol defined stopping criteria|0|||
164516733|NCT00095498|594262832|FG002|Overall Study|Other|6|||
164516734|NCT00095498|594262830|FG000|Overall Study|Protocol Violation|0|||
164516735|NCT00095498|594262831|FG001|Overall Study|Protocol Violation|0|||
164516736|NCT00095498|594262832|FG002|Overall Study|Protocol Violation|1|||
164516737|NCT00095498|594262830|FG000|Overall Study|Requirement for alternative therapy|1|||
164516738|NCT00095498|594262831|FG001|Overall Study|Requirement for alternative therapy|0|||
164516739|NCT00095498|594262832|FG002|Overall Study|Requirement for alternative therapy|2|||
164516740|NCT05020327|594262834|FG000|Overall Study|Physician Decision|3|||
164516741|NCT05020327|594262835|FG001|Overall Study|Physician Decision|0|||
164516742|NCT05020327|594262836|FG002|Overall Study|Physician Decision|0|||
164516743|NCT05020327|594262834|FG000|Overall Study|Withdrawal by Subject|1|||
164516744|NCT05020327|594262835|FG001|Overall Study|Withdrawal by Subject|1|||
164516745|NCT05020327|594262836|FG002|Overall Study|Withdrawal by Subject|0|||
164516746|NCT05020327|594262834|FG000|Overall Study|personal/cultural, ineligible|12|||
164516747|NCT05020327|594262835|FG001|Overall Study|personal/cultural, ineligible|0|||
164516748|NCT05020327|594262836|FG002|Overall Study|personal/cultural, ineligible|0|||
164516749|NCT03002220|594262838|FG000|Overall Study|Lack of Efficacy|2|||
164516750|NCT03002220|594262838|FG000|Overall Study|Withdrawal by Subject|3|||
164516751|NCT03002220|594262838|FG000|Overall Study|Adverse Event|2|||
164516752|NCT03002220|594262838|FG000|Overall Study|Disease progression|13|||
164516753|NCT03002220|594262838|FG000|Overall Study|Physician Decision|1|||
164516754|NCT01015560|594262841|FG000|Overall Study|Adverse Event|1|||
164516755|NCT01015560|594262841|FG000|Overall Study|Not protocol specified|1|||
164516756|NCT01015560|594262841|FG000|Overall Study|Withdrawal by Subject|1|||
164516757|NCT03439254|594262842|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
164516758|NCT03439254|594262843|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
164516759|NCT03439254|594262844|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
164516760|NCT03439254|594262845|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
164516761|NCT03439254|594262846|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
164516762|NCT03439254|594262847|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
164516763|NCT03439254|594262842|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
164516764|NCT03439254|594262843|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
164516765|NCT03439254|594262844|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
164516766|NCT03439254|594262845|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
164516767|NCT03439254|594262846|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
164516768|NCT03439254|594262847|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
164516769|NCT03439254|594262842|FG000|Double-blind Phase (18 Months)|Death|1|||
164516770|NCT03439254|594262843|FG001|Double-blind Phase (18 Months)|Death|2|||
164516771|NCT03439254|594262844|FG002|Double-blind Phase (18 Months)|Death|2|||
164516772|NCT03439254|594262845|FG003|Double-blind Phase (18 Months)|Death|0|||
164516773|NCT03439254|594262846|FG004|Double-blind Phase (18 Months)|Death|0|||
164516774|NCT03439254|594262847|FG005|Double-blind Phase (18 Months)|Death|0|||
164516775|NCT03439254|594262842|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
164516776|NCT03439254|594262843|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
164516777|NCT03439254|594262844|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
164516778|NCT03439254|594262845|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
164516779|NCT03439254|594262846|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
164516780|NCT03439254|594262847|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
164516781|NCT03439254|594262842|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
164516782|NCT03439254|594262843|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
164516783|NCT03439254|594262844|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
164516784|NCT03439254|594262845|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
164516785|NCT03439254|594262846|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
164516786|NCT03439254|594262847|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
164516787|NCT03439254|594262842|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
164516788|NCT03439254|594262843|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
164516789|NCT03439254|594262844|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
164516790|NCT03439254|594262845|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
164516791|NCT03439254|594262846|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
164516792|NCT03439254|594262847|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
164516793|NCT03439254|594262842|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
164516794|NCT03439254|594262843|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
164516795|NCT03439254|594262844|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
164516796|NCT03439254|594262845|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
164516797|NCT03439254|594262846|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
164532317|NCT00394953|594320530|FG000|First Treatment Period|Not defined|4|||
164613937|NCT01831804|594608465|FG006|Overall Study|Protocol defined stopping criteria|0|||
164613938|NCT01831804|594608466|FG007|Overall Study|Protocol defined stopping criteria|0|||
164613939|NCT01831804|594608467|FG008|Overall Study|Protocol defined stopping criteria|0|||
164613940|NCT01831804|594608459|FG000|Overall Study|Lost to Follow-up|0|||
164613941|NCT01831804|594608460|FG001|Overall Study|Lost to Follow-up|0|||
164613942|NCT01831804|594608461|FG002|Overall Study|Lost to Follow-up|1|||
164613943|NCT01831804|594608462|FG003|Overall Study|Lost to Follow-up|0|||
164613944|NCT01831804|594608463|FG004|Overall Study|Lost to Follow-up|0|||
164613945|NCT01831804|594608464|FG005|Overall Study|Lost to Follow-up|0|||
164613946|NCT01831804|594608465|FG006|Overall Study|Lost to Follow-up|0|||
164613947|NCT01831804|594608466|FG007|Overall Study|Lost to Follow-up|0|||
164613948|NCT01831804|594608467|FG008|Overall Study|Lost to Follow-up|1|||
164613949|NCT01831804|594608459|FG000|Overall Study|Investigator discretion|0|||
164613950|NCT01831804|594608460|FG001|Overall Study|Investigator discretion|0|||
164613951|NCT01831804|594608461|FG002|Overall Study|Investigator discretion|0|||
164613952|NCT01831804|594608462|FG003|Overall Study|Investigator discretion|0|||
164613953|NCT01831804|594608463|FG004|Overall Study|Investigator discretion|1|||
164613954|NCT01831804|594608464|FG005|Overall Study|Investigator discretion|0|||
164613955|NCT01831804|594608465|FG006|Overall Study|Investigator discretion|0|||
164613956|NCT01831804|594608466|FG007|Overall Study|Investigator discretion|1|||
164613957|NCT01831804|594608467|FG008|Overall Study|Investigator discretion|0|||
164613958|NCT01831804|594608459|FG000|Overall Study|Withdrew Consent|0|||
164613959|NCT01831804|594608460|FG001|Overall Study|Withdrew Consent|1|||
164613960|NCT01831804|594608461|FG002|Overall Study|Withdrew Consent|0|||
164613961|NCT01831804|594608462|FG003|Overall Study|Withdrew Consent|0|||
164613962|NCT01831804|594608463|FG004|Overall Study|Withdrew Consent|0|||
164613963|NCT01831804|594608464|FG005|Overall Study|Withdrew Consent|0|||
164613964|NCT01831804|594608465|FG006|Overall Study|Withdrew Consent|0|||
164613965|NCT01831804|594608466|FG007|Overall Study|Withdrew Consent|2|||
164613966|NCT01831804|594608467|FG008|Overall Study|Withdrew Consent|0|||
164613967|NCT00114218|594608481|FG000|Overall Study|Wrong Cell Type|2|||
164613968|NCT00114218|594608481|FG000|Overall Study|Wrong Primary|1|||
164613969|NCT00114218|594608481|FG000|Overall Study|Never Treated|1|||
164613970|NCT03168555|594608482|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
164613971|NCT03168555|594608482|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
164613972|NCT03168555|594608482|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
164613973|NCT03168555|594608482|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
164613974|NCT02959190|594608484|FG000|Open Label|Adverse Event|5|||
164613975|NCT02959190|594608485|FG001|Open Label|Adverse Event|7|||
164613976|NCT02959190|594608486|FG002|Open Label|Adverse Event|3|||
164613977|NCT02959190|594608487|FG003|Open Label|Adverse Event|4|||
164613978|NCT02959190|594608484|FG000|Open Label|Pregnancy|0|||
164613979|NCT02959190|594608485|FG001|Open Label|Pregnancy|1|||
164613980|NCT02959190|594608486|FG002|Open Label|Pregnancy|0|||
164613981|NCT02959190|594608487|FG003|Open Label|Pregnancy|0|||
164613982|NCT02959190|594608484|FG000|Open Label|Withdrawal by Subject|2|||
164613983|NCT02959190|594608485|FG001|Open Label|Withdrawal by Subject|8|||
164613984|NCT02959190|594608486|FG002|Open Label|Withdrawal by Subject|0|||
164613985|NCT02959190|594608487|FG003|Open Label|Withdrawal by Subject|0|||
164613986|NCT02959190|594608484|FG000|Open Label|Physician Decision|0|||
164613987|NCT02959190|594608485|FG001|Open Label|Physician Decision|0|||
164613988|NCT02959190|594608486|FG002|Open Label|Physician Decision|1|||
164613989|NCT02959190|594608487|FG003|Open Label|Physician Decision|0|||
164613990|NCT02959190|594608484|FG000|Open Label|Protocol Violation|0|||
164613991|NCT02959190|594608485|FG001|Open Label|Protocol Violation|0|||
164613992|NCT02959190|594608486|FG002|Open Label|Protocol Violation|0|||
164613993|NCT02959190|594608487|FG003|Open Label|Protocol Violation|2|||
164613994|NCT02959190|594608484|FG000|Post Treatment Follow Up|Adverse Event|1|||
164613995|NCT02959190|594608485|FG001|Post Treatment Follow Up|Adverse Event|1|||
164613996|NCT02959190|594608486|FG002|Post Treatment Follow Up|Adverse Event|0|||
164613997|NCT02959190|594608487|FG003|Post Treatment Follow Up|Adverse Event|0|||
164613998|NCT02959190|594608484|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
164613999|NCT02959190|594608485|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
164614000|NCT02959190|594608486|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
164614001|NCT02959190|594608487|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
164614002|NCT00615459|594608489|FG000|Period I|Adverse Event|2|||
164614003|NCT00615459|594608490|FG001|Period I|Adverse Event|0|||
164614004|NCT00615459|594608491|FG002|Period I|Adverse Event|1|||
164614005|NCT00615459|594608492|FG003|Period I|Adverse Event|0|||
164614006|NCT00615459|594608489|FG000|Period I|Subject withdrew consent|1|||
164614007|NCT00615459|594608490|FG001|Period I|Subject withdrew consent|0|||
164614008|NCT00615459|594608491|FG002|Period I|Subject withdrew consent|0|||
164614009|NCT00615459|594608492|FG003|Period I|Subject withdrew consent|1|||
164614010|NCT00615459|594608489|FG000|Period I|Abnormal test procedure results|1|||
164614011|NCT00615459|594608490|FG001|Period I|Abnormal test procedure results|1|||
164614012|NCT00615459|594608491|FG002|Period I|Abnormal test procedure results|1|||
164614013|NCT00615459|594608492|FG003|Period I|Abnormal test procedure results|0|||
164614014|NCT00615459|594608489|FG000|Period II|Adverse Event|1|||
164614015|NCT00615459|594608490|FG001|Period II|Adverse Event|0|||
164614016|NCT00615459|594608491|FG002|Period II|Adverse Event|0|||
164614017|NCT00615459|594608492|FG003|Period II|Adverse Event|0|||
164614018|NCT00615459|594608489|FG000|Period II|Lost to Follow-up|0|||
164614019|NCT00615459|594608490|FG001|Period II|Lost to Follow-up|0|||
164614020|NCT00615459|594608491|FG002|Period II|Lost to Follow-up|0|||
164614021|NCT00615459|594608492|FG003|Period II|Lost to Follow-up|1|||
164614022|NCT00615459|594608489|FG000|Period III|Adverse Event|0|||
164614023|NCT00615459|594608490|FG001|Period III|Adverse Event|1|||
164614024|NCT00615459|594608491|FG002|Period III|Adverse Event|0|||
164614025|NCT00615459|594608492|FG003|Period III|Adverse Event|0|||
164614026|NCT00615459|594608489|FG000|Period III|Administrative problems|0|||
164614027|NCT00615459|594608490|FG001|Period III|Administrative problems|1|||
164614028|NCT00615459|594608491|FG002|Period III|Administrative problems|1|||
164614029|NCT00615459|594608492|FG003|Period III|Administrative problems|0|||
164614030|NCT00615459|594608489|FG000|Period III|Unsatisfactory therapeutic effect|0|||
164614031|NCT00615459|594608490|FG001|Period III|Unsatisfactory therapeutic effect|1|||
164614032|NCT00615459|594608491|FG002|Period III|Unsatisfactory therapeutic effect|0|||
164614033|NCT00615459|594608492|FG003|Period III|Unsatisfactory therapeutic effect|0|||
164614034|NCT01235507|594608493|FG000|Overall Study|Adverse Event|1|||
164614035|NCT01235507|594608493|FG000|Overall Study|Withdrawal by Subject|1|||
164614036|NCT02738580|594608496|FG000|Overall Study|Adverse Event|1|||
164614037|NCT02738580|594608497|FG001|Overall Study|Adverse Event|0|||
164614038|NCT02738580|594608496|FG000|Overall Study|Lack of Efficacy|3|||
164614039|NCT02738580|594608497|FG001|Overall Study|Lack of Efficacy|2|||
164614040|NCT02738580|594608496|FG000|Overall Study|Withdrawal by Subject|0|||
164614041|NCT02738580|594608497|FG001|Overall Study|Withdrawal by Subject|1|||
164614042|NCT02738580|594608496|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
164614043|NCT02738580|594608497|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
164614044|NCT00617591|594608501|FG000|Overall Study|Withdrew consent during Induction|4|||
164614045|NCT00617591|594608501|FG000|Overall Study|Withdrew consent during Maintenance|6|||
164614046|NCT00588523|594608504|FG000|Overall Study|Not treated|3|||
164614047|NCT02096042|594608507|FG000|Overall Study|Disease Progression|1|||
164614048|NCT02096042|594608508|FG001|Overall Study|Disease Progression|0|||
164614049|NCT02096042|594608509|FG002|Overall Study|Disease Progression|0|||
164614050|NCT00701441|594608513|FG000|Overall Study|failure in cpap compliance|0|||
164614051|NCT00701441|594608514|FG001|Overall Study|failure in cpap compliance|4|||
164614052|NCT03034057|594608515|FG000|Overall Study|Withdrawal by Subject|10|||
164614053|NCT03034057|594608515|FG000|Overall Study|Protocol Violation|1|||
164614054|NCT03034057|594608515|FG000|Overall Study|Not defined|2|||
164614055|NCT03034057|594608515|FG000|Overall Study|Lost to Follow-up|19|||
164614056|NCT03034057|594608515|FG000|Overall Study|Adverse Event|22|||
164614057|NCT03034057|594608515|FG000|Overall Study|Medication error without associated AE|1|||
164614058|NCT03339401|594608516|FG000|Overall Study|Death|2|||
164614059|NCT03339401|594608517|FG001|Overall Study|Death|1|||
164614060|NCT03339401|594608516|FG000|Overall Study|Withdrawal by Subject|2|||
164614061|NCT03339401|594608517|FG001|Overall Study|Withdrawal by Subject|0|||
164614062|NCT03339401|594608516|FG000|Overall Study|Study terminated|4|||
164614063|NCT03339401|594608517|FG001|Overall Study|Study terminated|3|||
164614064|NCT03339401|594608516|FG000|Overall Study|Investigator Decision|1|||
164614065|NCT03339401|594608517|FG001|Overall Study|Investigator Decision|0|||
164614066|NCT00718523|594608518|FG000|Overall Study|Withdrawal by Subject|5|||
164614067|NCT00718523|594608519|FG001|Overall Study|Withdrawal by Subject|7|||
164614068|NCT00718523|594608518|FG000|Overall Study|Death|13|||
164614069|NCT00718523|594608519|FG001|Overall Study|Death|17|||
164614070|NCT01313078|594608520|FG000|Overall Study|Death|1|||
164614071|NCT01313078|594608520|FG000|Overall Study|Discontinued study drug|1|||
164614072|NCT01313078|594608520|FG000|Overall Study|Withdrawal by Subject|1|||
164614073|NCT01068717|594608524|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
164614074|NCT01068717|594608525|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
164614075|NCT01068717|594608526|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
164614076|NCT01068717|594608527|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
164614077|NCT01822223|594608528|FG000|Overall Study|Death|0|||
164614078|NCT01822223|594608529|FG001|Overall Study|Death|1|||
164614079|NCT04209400|594608532|FG000|Overall Study|Withdrawal by Subject|0|||
164614080|NCT04209400|594608533|FG001|Overall Study|Withdrawal by Subject|1|||
164614081|NCT01449955|594608537|FG000|Overall Study|Withdrawal by Subject|1|||
164614082|NCT01449955|594608538|FG001|Overall Study|Withdrawal by Subject|2|||
164614083|NCT05041062|594608540|FG000|Overall Study|Adverse Event|2|||
164614084|NCT03693404|594608541|FG000|Overall Study|Withdrawal by Subject|1|||
164614085|NCT03693404|594608542|FG001|Overall Study|Withdrawal by Subject|0|||
164614086|NCT03693404|594608541|FG000|Overall Study|Lost to Follow-up|0|||
164614087|NCT03693404|594608542|FG001|Overall Study|Lost to Follow-up|5|||
164614088|NCT03693404|594608541|FG000|Overall Study|Excluded from Analysis|0|||
164614089|NCT03693404|594608542|FG001|Overall Study|Excluded from Analysis|1|||
164614090|NCT01176240|594608543|FG000|Study 306A|Lack of Efficacy|2|||
164614091|NCT01176240|594608544|FG001|Study 306A|Lack of Efficacy|1|||
164614092|NCT01176240|594608543|FG000|Study 306A|Protocol Violation|0|||
164614093|NCT01176240|594608544|FG001|Study 306A|Protocol Violation|1|||
164614094|NCT01176240|594608543|FG000|Study 306A|Withdrawal by Subject|0|||
164614095|NCT01176240|594608544|FG001|Study 306A|Withdrawal by Subject|1|||
164614096|NCT01176240|594608543|FG000|Study 306A|Stop due to diverse problems|1|||
164614097|NCT01176240|594608544|FG001|Study 306A|Stop due to diverse problems|0|||
164614098|NCT01176240|594608543|FG000|Study 306B|Lack of Efficacy|5|||
164614099|NCT01176240|594608544|FG001|Study 306B|Lack of Efficacy|3|||
164614100|NCT01176240|594608543|FG000|Study 306B|Adverse Event|10|||
164614101|NCT01176240|594608544|FG001|Study 306B|Adverse Event|5|||
164614102|NCT01176240|594608543|FG000|Study 306B|Protocol Violation|2|||
164614103|NCT01176240|594608544|FG001|Study 306B|Protocol Violation|3|||
164614104|NCT01176240|594608543|FG000|Study 306B|Withdrawal by Subject|4|||
164614105|NCT01176240|594608544|FG001|Study 306B|Withdrawal by Subject|1|||
164614106|NCT01176240|594608543|FG000|Study 306B|Physician Decision|2|||
164614107|NCT01176240|594608544|FG001|Study 306B|Physician Decision|1|||
164614108|NCT01176240|594608543|FG000|Study 306B|Supine Hypertension|1|||
164614109|NCT01176240|594608544|FG001|Study 306B|Supine Hypertension|2|||
164614110|NCT01176240|594608543|FG000|Study 306B|Lost to Follow-up|0|||
164614111|NCT01176240|594608544|FG001|Study 306B|Lost to Follow-up|1|||
164614112|NCT01176240|594608543|FG000|Study 306B|withdrew prior to dosing|2|||
164614113|NCT01176240|594608544|FG001|Study 306B|withdrew prior to dosing|1|||
164614114|NCT04968353|594608545|FG000|Overall Study|Non-compliance|1|||
164614115|NCT04968353|594608546|FG001|Overall Study|Non-compliance|0|||
164614116|NCT04968353|594608547|FG002|Overall Study|Non-compliance|2|||
164614117|NCT04968353|594608548|FG003|Overall Study|Non-compliance|0|||
164614118|NCT00318370|594608549|FG000|Period 1|Lack of Efficacy|5|||
164614119|NCT00318370|594608550|FG001|Period 1|Lack of Efficacy|0|||
164614120|NCT00318370|594608551|FG002|Period 1|Lack of Efficacy|0|||
164614121|NCT00318370|594608549|FG000|Period 1|Physician Decision|1|||
164614122|NCT00318370|594608550|FG001|Period 1|Physician Decision|0|||
164614123|NCT00318370|594608551|FG002|Period 1|Physician Decision|0|||
164614124|NCT00318370|594608549|FG000|Period 1|Withdrawal by Subject|1|||
164614125|NCT00318370|594608550|FG001|Period 1|Withdrawal by Subject|0|||
164614126|NCT00318370|594608551|FG002|Period 1|Withdrawal by Subject|0|||
164614127|NCT00318370|594608549|FG000|Period 2|Adverse Event|0|||
164614128|NCT00318370|594608550|FG001|Period 2|Adverse Event|3|||
164614129|NCT00318370|594608551|FG002|Period 2|Adverse Event|0|||
164614130|NCT00318370|594608549|FG000|Period 2|Lack of Efficacy|0|||
164614131|NCT00318370|594608550|FG001|Period 2|Lack of Efficacy|5|||
164614132|NCT00318370|594608551|FG002|Period 2|Lack of Efficacy|0|||
164614133|NCT00318370|594608549|FG000|Period 2|Physician Decision|0|||
164614134|NCT00318370|594608550|FG001|Period 2|Physician Decision|1|||
164614135|NCT00318370|594608551|FG002|Period 2|Physician Decision|0|||
164614136|NCT00318370|594608549|FG000|Period 2|Withdrawal by Subject|0|||
164614137|NCT00318370|594608550|FG001|Period 2|Withdrawal by Subject|1|||
164614138|NCT00318370|594608551|FG002|Period 2|Withdrawal by Subject|0|||
164614139|NCT00318370|594608549|FG000|Period 2|Other|0|||
164614140|NCT00318370|594608550|FG001|Period 2|Other|1|||
164614141|NCT00318370|594608551|FG002|Period 2|Other|0|||
164614142|NCT00318370|594608549|FG000|Period 3|Adverse Event|0|||
164614143|NCT00318370|594608550|FG001|Period 3|Adverse Event|0|||
164614144|NCT00318370|594608551|FG002|Period 3|Adverse Event|1|||
164614145|NCT00318370|594608549|FG000|Period 3|Lack of Efficacy|0|||
164614146|NCT00318370|594608550|FG001|Period 3|Lack of Efficacy|0|||
164614147|NCT00318370|594608551|FG002|Period 3|Lack of Efficacy|24|||
164614148|NCT00318370|594608549|FG000|Period 3|Death|0|||
164614149|NCT00318370|594608550|FG001|Period 3|Death|0|||
164614150|NCT00318370|594608551|FG002|Period 3|Death|1|||
164614151|NCT00318370|594608549|FG000|Period 3|Physician Decision|0|||
164614152|NCT00318370|594608550|FG001|Period 3|Physician Decision|0|||
164614153|NCT00318370|594608551|FG002|Period 3|Physician Decision|1|||
164614154|NCT00318370|594608549|FG000|Period 3|Withdrawal by Subject|0|||
164614155|NCT00318370|594608550|FG001|Period 3|Withdrawal by Subject|0|||
164614156|NCT00318370|594608551|FG002|Period 3|Withdrawal by Subject|3|||
164614157|NCT00318370|594608549|FG000|Period 3|Other|0|||
164614158|NCT00318370|594608550|FG001|Period 3|Other|0|||
164614159|NCT00318370|594608551|FG002|Period 3|Other|3|||
164614160|NCT00807014|594608554|FG000|Overall Study|Participant Considered Disease Cured|13|||
164614161|NCT00807014|594608555|FG001|Overall Study|Participant Considered Disease Cured|2|||
164614162|NCT00807014|594608554|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
164614163|NCT00807014|594608555|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
164614164|NCT00807014|594608554|FG000|Overall Study|Protocol Violation|2|||
164614165|NCT00807014|594608555|FG001|Overall Study|Protocol Violation|8|||
164614166|NCT00807014|594608554|FG000|Overall Study|Adverse Event|0|||
164614167|NCT00807014|594608555|FG001|Overall Study|Adverse Event|2|||
164614168|NCT00807014|594608554|FG000|Overall Study|Lost to Follow-up|9|||
164614169|NCT00807014|594608555|FG001|Overall Study|Lost to Follow-up|7|||
164614170|NCT00807014|594608554|FG000|Overall Study|Recovery|1|||
164614171|NCT00807014|594608555|FG001|Overall Study|Recovery|0|||
164614172|NCT00807014|594608554|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
164614173|NCT00807014|594608555|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
164614174|NCT00651313|594608556|FG000|Overall Study|Adverse Event|0|||
164614175|NCT00651313|594608557|FG001|Overall Study|Adverse Event|1|||
164614176|NCT00651313|594608556|FG000|Overall Study|Withdrawal by Subject|3|||
164614177|NCT00651313|594608557|FG001|Overall Study|Withdrawal by Subject|1|||
164614178|NCT00651313|594608556|FG000|Overall Study|Lost to Follow-up|1|||
164614179|NCT00651313|594608557|FG001|Overall Study|Lost to Follow-up|1|||
164614180|NCT00651313|594608556|FG000|Overall Study|Adminstrative Discontinuation|2|||
164614181|NCT00651313|594608557|FG001|Overall Study|Adminstrative Discontinuation|3|||
164614182|NCT03307629|594608564|FG000|Overall Study|Withdrawal by Subject|0|||
164614183|NCT03307629|594608565|FG001|Overall Study|Withdrawal by Subject|0|||
164614184|NCT03307629|594608566|FG002|Overall Study|Withdrawal by Subject|0|||
164614185|NCT03307629|594608567|FG003|Overall Study|Withdrawal by Subject|2|||
164614186|NCT03307629|594608564|FG000|Overall Study|Disease Progression|0|||
164614187|NCT03307629|594608565|FG001|Overall Study|Disease Progression|0|||
164614188|NCT03307629|594608566|FG002|Overall Study|Disease Progression|0|||
164614189|NCT03307629|594608567|FG003|Overall Study|Disease Progression|3|||
164614190|NCT03307629|594608564|FG000|Overall Study|Death|0|||
164614191|NCT03307629|594608565|FG001|Overall Study|Death|3|||
164614192|NCT03307629|594608566|FG002|Overall Study|Death|0|||
164614193|NCT03307629|594608567|FG003|Overall Study|Death|1|||
164614194|NCT02853032|594608572|FG000|Overall Study|Adverse Event|4|||
164614195|NCT02853032|594608573|FG001|Overall Study|Adverse Event|0|||
164614196|NCT02853032|594608572|FG000|Overall Study|Withdrawal by Subject|3|||
164614197|NCT02853032|594608573|FG001|Overall Study|Withdrawal by Subject|1|||
164614198|NCT02853032|594608572|FG000|Overall Study|Requested to withdraw from all treatment|2|||
164614199|NCT02853032|594608573|FG001|Overall Study|Requested to withdraw from all treatment|2|||
164614200|NCT03175562|594608574|FG000|Overall Study|Adverse Event|1|||
164614201|NCT03175562|594608574|FG000|Overall Study|Lost to Follow-up|3|||
164614202|NCT03175562|594608574|FG000|Overall Study|Withdrawal by Subject|7|||
164614203|NCT03175562|594608574|FG000|Overall Study|Other (Not Specified)|5|||
164614204|NCT02146833|594608575|FG000|Overall Study|Death|10|||
164614205|NCT02146833|594608575|FG000|Overall Study|No longer consented to study treatment|1|||
164614206|NCT00676208|594608578|FG000|Overall Study|Lost to Follow-up|0|||
164614207|NCT00676208|594608579|FG001|Overall Study|Lost to Follow-up|2|||
164614208|NCT00676208|594608578|FG000|Overall Study|Incomplete data|2|||
164614209|NCT00676208|594608579|FG001|Overall Study|Incomplete data|4|||
164614210|NCT03700736|594608582|FG000|Overall Study|Pregnancy|1|||
164614211|NCT03700736|594608583|FG001|Overall Study|Pregnancy|1|||
164614212|NCT03700736|594608582|FG000|Overall Study|Withdrawal by Subject|2|||
164614213|NCT03700736|594608583|FG001|Overall Study|Withdrawal by Subject|6|||
164614214|NCT00642018|594608584|FG000|Overall Study|Adverse Event|11|||
164614215|NCT00642018|594608585|FG001|Overall Study|Adverse Event|36|||
164614216|NCT00642018|594608584|FG000|Overall Study|Withdrawal by Subject|4|||
164614217|NCT00642018|594608585|FG001|Overall Study|Withdrawal by Subject|10|||
164614218|NCT00642018|594608584|FG000|Overall Study|Progressive Disease|13|||
164614219|NCT00642018|594608585|FG001|Overall Study|Progressive Disease|18|||
164614220|NCT00642018|594608584|FG000|Overall Study|Physician Decision|0|||
164614221|NCT00642018|594608585|FG001|Overall Study|Physician Decision|10|||
164614222|NCT00642018|594608584|FG000|Overall Study|Protocol Violation|0|||
164614223|NCT00642018|594608585|FG001|Overall Study|Protocol Violation|1|||
164614224|NCT00642018|594608584|FG000|Overall Study|Death|0|||
164614225|NCT00642018|594608585|FG001|Overall Study|Death|3|||
164614226|NCT00642018|594608584|FG000|Overall Study|Entry Criteria Not Met|0|||
164614227|NCT00642018|594608585|FG001|Overall Study|Entry Criteria Not Met|1|||
164614228|NCT01410799|594608586|FG000|Overall Study|PI decision|13|||
164614229|NCT01946412|594608587|FG000|Overall Study|Adverse Event|1|||
164614230|NCT01946412|594608587|FG000|Overall Study|Non-Compliance|1|||
164614231|NCT01946412|594608587|FG000|Overall Study|Continued with commercial Kalydeco|2|||
164614232|NCT01946412|594608587|FG000|Overall Study|Difficulty in swallowing|1|||
164614233|NCT00617656|594608588|FG000|Overall Study|Inclusion error|4|||
164614234|NCT00617656|594608589|FG001|Overall Study|Inclusion error|4|||
164614235|NCT00617656|594608590|FG002|Overall Study|Inclusion error|0|||
164614236|NCT00617656|594608591|FG003|Overall Study|Inclusion error|0|||
164614237|NCT00617656|594608588|FG000|Overall Study|Missing data|44|||
164614238|NCT00617656|594608589|FG001|Overall Study|Missing data|30|||
164614239|NCT00617656|594608590|FG002|Overall Study|Missing data|13|||
164614240|NCT00617656|594608591|FG003|Overall Study|Missing data|6|||
164614241|NCT00617656|594608588|FG000|Overall Study|Withdrawal by Subject|0|||
164614242|NCT00617656|594608589|FG001|Overall Study|Withdrawal by Subject|2|||
164614243|NCT00617656|594608590|FG002|Overall Study|Withdrawal by Subject|0|||
164516798|NCT03439254|594262847|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
164516799|NCT03439254|594262842|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
164516800|NCT03439254|594262843|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
164614244|NCT00617656|594608591|FG003|Overall Study|Withdrawal by Subject|0|||
164614245|NCT00254163|594609984|FG000|Overall Study|Adverse Event|29|||
164614246|NCT00254163|594609985|FG001|Overall Study|Adverse Event|26|||
164614247|NCT00254163|594609984|FG000|Overall Study|Patient request/withdrew consent|6|||
164614248|NCT00254163|594609985|FG001|Overall Study|Patient request/withdrew consent|4|||
164614249|NCT00254163|594609984|FG000|Overall Study|Investigator request|1|||
164614250|NCT00254163|594609985|FG001|Overall Study|Investigator request|3|||
164614251|NCT00254163|594609984|FG000|Overall Study|Failed entry|1|||
164614252|NCT00254163|594609985|FG001|Overall Study|Failed entry|3|||
164614253|NCT00254163|594609984|FG000|Overall Study|Progressive disease|0|||
164614254|NCT00254163|594609985|FG001|Overall Study|Progressive disease|1|||
164614255|NCT00254163|594609984|FG000|Overall Study|Death|0|||
164614256|NCT00254163|594609985|FG001|Overall Study|Death|1|||
164614257|NCT00254163|594609984|FG000|Overall Study|Other|8|||
164614258|NCT00254163|594609985|FG001|Overall Study|Other|8|||
164516801|NCT03439254|594262844|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
164516802|NCT03439254|594262845|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
164516803|NCT03439254|594262846|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
164516804|NCT03439254|594262847|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
164516805|NCT03439254|594262842|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
164516806|NCT03439254|594262843|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
164516807|NCT03439254|594262844|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
164516808|NCT03439254|594262845|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
164516809|NCT03439254|594262846|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
164516810|NCT03439254|594262847|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
164516811|NCT03439254|594262842|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
164516812|NCT03439254|594262843|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
164516813|NCT03439254|594262844|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
164516814|NCT03439254|594262845|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
164516815|NCT03439254|594262846|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
164516816|NCT03439254|594262847|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
164516817|NCT03439254|594262842|FG000|Double-blind Phase (18 Months)|Site closure|0|||
164516818|NCT03439254|594262843|FG001|Double-blind Phase (18 Months)|Site closure|0|||
164516819|NCT03439254|594262844|FG002|Double-blind Phase (18 Months)|Site closure|1|||
164516820|NCT03439254|594262845|FG003|Double-blind Phase (18 Months)|Site closure|0|||
164516821|NCT03439254|594262846|FG004|Double-blind Phase (18 Months)|Site closure|0|||
164516822|NCT03439254|594262847|FG005|Double-blind Phase (18 Months)|Site closure|0|||
164516823|NCT03439254|594262842|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
164516824|NCT03439254|594262843|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
164516825|NCT03439254|594262844|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
164516826|NCT03439254|594262845|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
164516827|NCT03439254|594262846|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
164516828|NCT03439254|594262847|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
164516829|NCT03439254|594262842|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
164516830|NCT03439254|594262843|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
164516831|NCT03439254|594262844|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
164516832|NCT03439254|594262845|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
164516833|NCT03439254|594262846|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
164516834|NCT03439254|594262847|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
164516835|NCT03439254|594262842|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
164516836|NCT03439254|594262843|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
164516837|NCT03439254|594262844|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
164516838|NCT03439254|594262845|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
164516839|NCT03439254|594262846|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
164516840|NCT03439254|594262847|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
164516841|NCT03439254|594262842|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
164516842|NCT03439254|594262843|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
164516843|NCT03439254|594262844|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
164516844|NCT03439254|594262845|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
164516845|NCT03439254|594262846|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
164516846|NCT03439254|594262847|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
164516847|NCT03439254|594262842|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
164516848|NCT03439254|594262843|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
164516849|NCT03439254|594262844|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
164516850|NCT03439254|594262845|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
164516851|NCT03439254|594262846|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
164516852|NCT03439254|594262847|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
164516853|NCT03439254|594262842|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
164516854|NCT03439254|594262843|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
164516855|NCT03439254|594262844|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
164516856|NCT03439254|594262845|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
164516857|NCT03439254|594262846|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
164516858|NCT03439254|594262847|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
164516859|NCT03439254|594262842|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
164516860|NCT03439254|594262843|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
164516861|NCT03439254|594262844|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
164516862|NCT03439254|594262845|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
164516863|NCT03439254|594262846|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
164516864|NCT03439254|594262847|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
164516865|NCT03439254|594262842|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
164516866|NCT03439254|594262843|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
164516867|NCT03439254|594262844|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
164516868|NCT03439254|594262845|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
164516869|NCT03439254|594262846|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
164516870|NCT03439254|594262847|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
164516871|NCT03439254|594262842|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
164516872|NCT03439254|594262843|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
164516873|NCT03439254|594262844|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
164516874|NCT03439254|594262845|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
164516875|NCT03439254|594262846|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
164516876|NCT03439254|594262847|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
164516877|NCT03439254|594262842|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
164516878|NCT03439254|594262843|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
164516879|NCT03439254|594262844|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
164516880|NCT03439254|594262845|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
164516881|NCT03439254|594262846|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
164516882|NCT03439254|594262847|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
164516883|NCT03439254|594262842|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
164516884|NCT03439254|594262843|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
164516885|NCT03439254|594262844|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
164516886|NCT03439254|594262845|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
164516887|NCT03439254|594262846|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
164614259|NCT01119963|594609986|FG000|Overall Study|Lost to Follow-up|1|||
164614260|NCT01119963|594609987|FG001|Overall Study|Lost to Follow-up|1|||
164614261|NCT01843205|594609992|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
164614262|NCT01843205|594609993|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
164614263|NCT01355497|594609994|FG000|Overall Study|Death|19|||
164147373|NCT05168202|592902028|FG004|Overall Study|Adverse Event|3|||
164516888|NCT03439254|594262847|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
164516889|NCT03439254|594262842|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
164516890|NCT03439254|594262843|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
164516891|NCT03439254|594262844|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
164516892|NCT03439254|594262845|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
164516893|NCT03439254|594262846|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
164516894|NCT03439254|594262847|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
164516895|NCT00128102|594262850|FG000|Overall Study|Site Discontinued|3|||
164516896|NCT00128102|594262851|FG001|Overall Study|Site Discontinued|6|||
164516897|NCT00128102|594262850|FG000|Overall Study|Other|0|||
164516898|NCT00128102|594262851|FG001|Overall Study|Other|1|||
164516899|NCT00128102|594262850|FG000|Overall Study|Progressive Disease|255|||
164516900|NCT00128102|594262851|FG001|Overall Study|Progressive Disease|285|||
164516901|NCT00128102|594262850|FG000|Overall Study|Adverse Event|34|||
164516902|NCT00128102|594262851|FG001|Overall Study|Adverse Event|11|||
164516903|NCT00128102|594262850|FG000|Overall Study|Death|12|||
164516904|NCT00128102|594262851|FG001|Overall Study|Death|13|||
164516905|NCT00128102|594262850|FG000|Overall Study|Physician Decision|3|||
164516906|NCT00128102|594262851|FG001|Overall Study|Physician Decision|3|||
164516907|NCT00128102|594262850|FG000|Overall Study|Withdrawal by Subject|19|||
164516908|NCT00128102|594262851|FG001|Overall Study|Withdrawal by Subject|11|||
164516909|NCT00128102|594262850|FG000|Overall Study|Protocol Violation|2|||
164516910|NCT00128102|594262851|FG001|Overall Study|Protocol Violation|2|||
164516911|NCT01014208|594262855|FG000|Overall Study|Lost to Follow-up|2|||
164516912|NCT01014208|594262856|FG001|Overall Study|Lost to Follow-up|5|||
164516913|NCT01014208|594262855|FG000|Overall Study|Participant Withdrew Consent|12|||
164516914|NCT01014208|594262856|FG001|Overall Study|Participant Withdrew Consent|12|||
164516915|NCT01014208|594262855|FG000|Overall Study|Did Not Receive Study Drug|2|||
164516916|NCT01014208|594262856|FG001|Overall Study|Did Not Receive Study Drug|0|||
164516917|NCT01014208|594262855|FG000|Overall Study|Study Closed/terminated|78|||
164516918|NCT01014208|594262856|FG001|Overall Study|Study Closed/terminated|83|||
164516919|NCT01008410|594262858|FG000|Overall Study|Adverse Event|13|||
164516920|NCT01008410|594262859|FG001|Overall Study|Adverse Event|7|||
164516921|NCT01008410|594262858|FG000|Overall Study|Withdrawal by Subject|6|||
164516922|NCT01008410|594262859|FG001|Overall Study|Withdrawal by Subject|2|||
164516923|NCT01008410|594262858|FG000|Overall Study|Lost to Follow-up|1|||
164516924|NCT01008410|594262859|FG001|Overall Study|Lost to Follow-up|0|||
164516925|NCT01008410|594262858|FG000|Overall Study|Noncompliance|1|||
164516926|NCT01008410|594262859|FG001|Overall Study|Noncompliance|0|||
164516927|NCT01008410|594262858|FG000|Overall Study|Low Cortisol|2|||
164516928|NCT01008410|594262859|FG001|Overall Study|Low Cortisol|0|||
164516929|NCT01008410|594262858|FG000|Overall Study|Lack of Efficacy|2|||
164516930|NCT01008410|594262859|FG001|Overall Study|Lack of Efficacy|6|||
164516931|NCT01008410|594262858|FG000|Overall Study|Met Exclusion Criterion|0|||
164516932|NCT01008410|594262859|FG001|Overall Study|Met Exclusion Criterion|1|||
164516933|NCT00297427|594262860|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
164516934|NCT00297427|594262861|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
164516935|NCT00297427|594262860|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
164516936|NCT00297427|594262861|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
164516937|NCT00297427|594262860|FG000|Phase 1: Initial Intervention|Death|0|||
164516938|NCT00297427|594262861|FG001|Phase 1: Initial Intervention|Death|1|||
164516939|NCT00297427|594262860|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
164516940|NCT00297427|594262861|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
164516941|NCT00297427|594262860|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
164516942|NCT00297427|594262861|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
164516943|NCT00297427|594262860|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
164516944|NCT00297427|594262861|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
164516945|NCT00297427|594262860|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
164516946|NCT00297427|594262861|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
164516947|NCT00297427|594262860|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
164516948|NCT00297427|594262861|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
164516949|NCT03889704|594262863|FG000|Overall Study|Study terminated due to pandemic|1|||
164614264|NCT01355497|594609995|FG001|Overall Study|Death|18|||
164516950|NCT04552899|594262866|FG000|Overall Study|Adverse Event|4|||
164516951|NCT04552899|594262867|FG001|Overall Study|Adverse Event|3|||
164516952|NCT04552899|594262866|FG000|Overall Study|Death|4|||
164516953|NCT04552899|594262867|FG001|Overall Study|Death|4|||
164516954|NCT04552899|594262866|FG000|Overall Study|Lost to Follow-up|8|||
164516955|NCT04552899|594262867|FG001|Overall Study|Lost to Follow-up|13|||
164614265|NCT01355497|594609994|FG000|Overall Study|Lost to Follow-up|3|||
164614266|NCT01355497|594609995|FG001|Overall Study|Lost to Follow-up|0|||
164516956|NCT04552899|594262866|FG000|Overall Study|Lung Transplant|4|||
164516957|NCT04552899|594262867|FG001|Overall Study|Lung Transplant|3|||
164516958|NCT04552899|594262866|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
164516959|NCT04552899|594262867|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
164516960|NCT04552899|594262866|FG000|Overall Study|Physician Decision|3|||
164516961|NCT04552899|594262867|FG001|Overall Study|Physician Decision|4|||
164516962|NCT04552899|594262866|FG000|Overall Study|Study Terminated By Sponsor|237|||
164516963|NCT04552899|594262867|FG001|Overall Study|Study Terminated By Sponsor|239|||
164516964|NCT04552899|594262866|FG000|Overall Study|Withdrawal by Subject|15|||
164516965|NCT04552899|594262867|FG001|Overall Study|Withdrawal by Subject|17|||
164516966|NCT02591953|594262870|FG000|Overall Study|Lost to Follow-up|6|||
164516967|NCT02591953|594262871|FG001|Overall Study|Lost to Follow-up|6|||
164516968|NCT00461981|594262872|FG000|Overall Study|Lost to Follow-up|9|||
164516969|NCT00461981|594262873|FG001|Overall Study|Lost to Follow-up|6|||
164516970|NCT00461981|594262872|FG000|Overall Study|Withdrawal by Subject|2|||
164516971|NCT00461981|594262873|FG001|Overall Study|Withdrawal by Subject|3|||
164516972|NCT02060370|594262876|FG000|Overall Study|Physician Decision|1|||
164516973|NCT00731133|594262877|FG000|Overall Study|Withdrawal by Subject|10|||
164516974|NCT00943852|594262878|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
164516975|NCT00943852|594262879|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
164516976|NCT00943852|594262880|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
164516977|NCT00943852|594262881|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
164516978|NCT00943852|594262882|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
164516979|NCT00943852|594262883|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
164516980|NCT00943852|594262884|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
164516981|NCT00943852|594262885|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
164516982|NCT00943852|594262886|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
164516983|NCT00943852|594262887|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
164516984|NCT00943852|594262878|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
164516985|NCT00943852|594262879|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
164516986|NCT00943852|594262880|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
164516987|NCT00943852|594262881|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
164516988|NCT00943852|594262882|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
164516989|NCT00943852|594262883|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
164516990|NCT00943852|594262884|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
164516991|NCT00943852|594262885|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
164516992|NCT00943852|594262886|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
164516993|NCT00943852|594262887|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
164516994|NCT00943852|594262878|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
164516995|NCT00943852|594262879|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
164516996|NCT00943852|594262880|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
164516997|NCT00943852|594262881|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
164516998|NCT00943852|594262882|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
164516999|NCT00943852|594262883|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
164517000|NCT00943852|594262884|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
164517001|NCT00943852|594262885|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
164517002|NCT00943852|594262886|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
164517003|NCT00943852|594262887|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
164517004|NCT00943852|594262878|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
164517005|NCT00943852|594262879|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
164517006|NCT00943852|594262880|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
164517007|NCT00943852|594262881|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
164517008|NCT00943852|594262882|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
164517009|NCT00943852|594262883|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
164517010|NCT00943852|594262884|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
164517011|NCT00943852|594262885|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
164517012|NCT00943852|594262886|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
164614267|NCT01355497|594609994|FG000|Overall Study|Protocol Violation|0|||
164614268|NCT01355497|594609995|FG001|Overall Study|Protocol Violation|1|||
164614269|NCT01355497|594609994|FG000|Overall Study|other-not provided|9|||
164614270|NCT01355497|594609995|FG001|Overall Study|other-not provided|4|||
164614271|NCT01355497|594609994|FG000|Overall Study|Withdrawal by Subject|12|||
164614272|NCT01355497|594609995|FG001|Overall Study|Withdrawal by Subject|20|||
164614273|NCT01355497|594609994|FG000|Overall Study|noncompliance|1|||
164614274|NCT01355497|594609995|FG001|Overall Study|noncompliance|2|||
164614275|NCT01355497|594609994|FG000|Overall Study|progressive disease|11|||
164614276|NCT01355497|594609995|FG001|Overall Study|progressive disease|8|||
164614277|NCT01355497|594609994|FG000|Overall Study|Adverse Event|11|||
164614278|NCT01355497|594609995|FG001|Overall Study|Adverse Event|10|||
164614279|NCT01518309|594609996|FG000|Overall Study|Adverse Event|6|||
164614280|NCT01518309|594609996|FG000|Overall Study|Death|6|||
164614281|NCT01518309|594609996|FG000|Overall Study|Lack of Efficacy|7|||
164614282|NCT01518309|594609996|FG000|Overall Study|Withdrawal by Subject|6|||
164614283|NCT01518309|594609996|FG000|Overall Study|Physician Decision|3|||
164614284|NCT01518309|594609996|FG000|Overall Study|Sponsor Decision|2|||
164614285|NCT01518309|594609996|FG000|Overall Study|Not in Predefined Categories|9|||
164614286|NCT02579863|594609998|FG000|Overall Study|Final Disposition Unknown|2|||
164614287|NCT02579863|594609999|FG001|Overall Study|Final Disposition Unknown|1|||
164614288|NCT02579863|594609998|FG000|Overall Study|Adverse Event|18|||
164614289|NCT02579863|594609999|FG001|Overall Study|Adverse Event|11|||
164614290|NCT02579863|594609998|FG000|Overall Study|Death|31|||
164614291|NCT02579863|594609999|FG001|Overall Study|Death|29|||
164614292|NCT02579863|594609998|FG000|Overall Study|Lost to Follow-up|2|||
164614293|NCT02579863|594609999|FG001|Overall Study|Lost to Follow-up|1|||
164614294|NCT02579863|594609998|FG000|Overall Study|Physician Decision|1|||
164614295|NCT02579863|594609999|FG001|Overall Study|Physician Decision|2|||
164614296|NCT02579863|594609998|FG000|Overall Study|Screen Failure|0|||
164614297|NCT02579863|594609999|FG001|Overall Study|Screen Failure|2|||
164614298|NCT02579863|594609998|FG000|Overall Study|Study Terminated at Selected Sites|82|||
164614299|NCT02579863|594609999|FG001|Overall Study|Study Terminated at Selected Sites|88|||
164614300|NCT02579863|594609998|FG000|Overall Study|Withdrawal by Subject|20|||
164614301|NCT02579863|594609999|FG001|Overall Study|Withdrawal by Subject|20|||
164614302|NCT00038142|594610004|FG000|Overall Study|Ineligible|1|||
164614303|NCT00038142|594610005|FG001|Overall Study|Ineligible|0|||
164614304|NCT00038142|594610004|FG000|Overall Study|Progressive Disease|11|||
164614305|NCT00038142|594610005|FG001|Overall Study|Progressive Disease|7|||
164614306|NCT00038142|594610004|FG000|Overall Study|Death|1|||
164614307|NCT00038142|594610005|FG001|Overall Study|Death|0|||
164614308|NCT00038142|594610004|FG000|Overall Study|Adverse Event|1|||
164614309|NCT00038142|594610005|FG001|Overall Study|Adverse Event|0|||
164614310|NCT00038142|594610004|FG000|Overall Study|Unknown Reason|8|||
164614311|NCT00038142|594610005|FG001|Overall Study|Unknown Reason|0|||
164614312|NCT00809614|594610006|FG000|Overall Study|Lack of Efficacy|2|||
164614313|NCT00809614|594610007|FG001|Overall Study|Lack of Efficacy|3|||
164614314|NCT00809614|594610006|FG000|Overall Study|Withdrawal by Subject|1|||
164614315|NCT00809614|594610007|FG001|Overall Study|Withdrawal by Subject|1|||
164614316|NCT01224106|594610008|FG000|Double-Blind Treatment Phase|Death|3|||
164614317|NCT01224106|594610009|FG001|Double-Blind Treatment Phase|Death|0|||
164614318|NCT01224106|594610010|FG002|Double-Blind Treatment Phase|Death|0|||
164614319|NCT01224106|594610011|FG003|Double-Blind Treatment Phase|Death|0|||
164614320|NCT01224106|594610012|FG004|Double-Blind Treatment Phase|Death|0|||
164614321|NCT01224106|594610008|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
164614322|NCT01224106|594610009|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
164614323|NCT01224106|594610010|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
164614324|NCT01224106|594610011|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
164614325|NCT01224106|594610012|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
164614326|NCT01224106|594610008|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
164614327|NCT01224106|594610009|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
164614328|NCT01224106|594610010|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
164614329|NCT01224106|594610011|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
164614330|NCT01224106|594610012|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
164614331|NCT01224106|594610008|FG000|Double-Blind Treatment Phase|Other|0|||
164614332|NCT01224106|594610009|FG001|Double-Blind Treatment Phase|Other|0|||
164614333|NCT01224106|594610010|FG002|Double-Blind Treatment Phase|Other|1|||
164614334|NCT01224106|594610011|FG003|Double-Blind Treatment Phase|Other|0|||
164614335|NCT01224106|594610012|FG004|Double-Blind Treatment Phase|Other|0|||
164614336|NCT01224106|594610008|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
164614337|NCT01224106|594610009|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
164614338|NCT01224106|594610010|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
164614339|NCT01224106|594610011|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
164614340|NCT01224106|594610012|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
164614341|NCT01224106|594610008|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
164614342|NCT01224106|594610009|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
164614343|NCT01224106|594610010|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
164614344|NCT01224106|594610011|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
164614345|NCT01224106|594610012|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
164614346|NCT01224106|594610008|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
164614347|NCT01224106|594610009|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164614348|NCT01224106|594610010|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
164614349|NCT01224106|594610011|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164614350|NCT01224106|594610012|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164614351|NCT01224106|594610008|FG000|Open-Label Extension (OLE) Phase|Death|0|||
164614352|NCT01224106|594610009|FG001|Open-Label Extension (OLE) Phase|Death|0|||
164614353|NCT01224106|594610010|FG002|Open-Label Extension (OLE) Phase|Death|0|||
164614354|NCT01224106|594610011|FG003|Open-Label Extension (OLE) Phase|Death|1|||
164614355|NCT01224106|594610012|FG004|Open-Label Extension (OLE) Phase|Death|3|||
164614356|NCT01224106|594610008|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
164614357|NCT01224106|594610009|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
164614358|NCT01224106|594610010|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
164614359|NCT01224106|594610011|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
164614360|NCT01224106|594610012|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
164614361|NCT01224106|594610008|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
164614362|NCT01224106|594610009|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
164614363|NCT01224106|594610010|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
164614364|NCT01224106|594610011|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
164614365|NCT01224106|594610012|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
164614366|NCT01224106|594610008|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
164614367|NCT01224106|594610009|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
164614368|NCT01224106|594610010|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
164614369|NCT01224106|594610011|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
164614370|NCT01224106|594610012|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
164614371|NCT01224106|594610008|FG000|Open-Label Extension (OLE) Phase|Other|0|||
164614372|NCT01224106|594610009|FG001|Open-Label Extension (OLE) Phase|Other|0|||
164614373|NCT01224106|594610010|FG002|Open-Label Extension (OLE) Phase|Other|0|||
164614374|NCT01224106|594610011|FG003|Open-Label Extension (OLE) Phase|Other|5|||
164614375|NCT01224106|594610012|FG004|Open-Label Extension (OLE) Phase|Other|3|||
164614376|NCT00446797|594610013|FG000|Overall Study|Lack of Efficacy|0|||
164614377|NCT00446797|594610014|FG001|Overall Study|Lack of Efficacy|2|||
164614378|NCT00446797|594610013|FG000|Overall Study|Lost to Follow-up|5|||
164614379|NCT00446797|594610014|FG001|Overall Study|Lost to Follow-up|3|||
164614380|NCT00446797|594610013|FG000|Overall Study|Withdrawal by Subject|2|||
164614381|NCT00446797|594610014|FG001|Overall Study|Withdrawal by Subject|2|||
164614382|NCT00446797|594610013|FG000|Overall Study|Protocol Violation|1|||
164614383|NCT00446797|594610014|FG001|Overall Study|Protocol Violation|3|||
164614384|NCT00446797|594610013|FG000|Overall Study|subject entered at another site|0|||
164614385|NCT00446797|594610014|FG001|Overall Study|subject entered at another site|1|||
164614386|NCT00446797|594610013|FG000|Overall Study|did not meet entrance criteria|0|||
164614387|NCT00446797|594610014|FG001|Overall Study|did not meet entrance criteria|1|||
164614388|NCT03210220|594610017|FG000|Overall Study|Physician Decision|1|||
164614389|NCT03210220|594610018|FG001|Overall Study|Physician Decision|0|||
164614390|NCT00420342|594610019|FG000|Overall Study|Lost to Follow-up|1|||
164614391|NCT00420342|594610020|FG001|Overall Study|Lost to Follow-up|0|||
164614392|NCT00420342|594610021|FG002|Overall Study|Lost to Follow-up|1|||
164614393|NCT00420342|594610019|FG000|Overall Study|Withdrawal by Subject|0|||
164614394|NCT00420342|594610020|FG001|Overall Study|Withdrawal by Subject|2|||
164614395|NCT00420342|594610021|FG002|Overall Study|Withdrawal by Subject|0|||
164614396|NCT00839436|594610026|FG000|Overall Study|Developed exclusionary condition|1|||
164614397|NCT00839436|594610027|FG001|Overall Study|Developed exclusionary condition|0|||
164614398|NCT00839436|594610028|FG002|Overall Study|Developed exclusionary condition|0|||
164614399|NCT00839436|594610026|FG000|Overall Study|Withdrawal by Subject|0|||
164614400|NCT00839436|594610027|FG001|Overall Study|Withdrawal by Subject|1|||
164614401|NCT00839436|594610028|FG002|Overall Study|Withdrawal by Subject|0|||
164614402|NCT00839436|594610026|FG000|Overall Study|Study drug no longer available|0|||
164614403|NCT00839436|594610027|FG001|Overall Study|Study drug no longer available|0|||
164614404|NCT00839436|594610028|FG002|Overall Study|Study drug no longer available|1|||
164614405|NCT01440972|594610029|FG000|Overall Study|Withdrawal by Subject|3|||
164614406|NCT01440972|594610030|FG001|Overall Study|Withdrawal by Subject|2|||
164614407|NCT03933215|594610031|FG000|Overall Study|Other|6|||
164614408|NCT03933215|594610031|FG000|Overall Study|Sponsor decision|5|||
164614409|NCT03933215|594610031|FG000|Overall Study|Protocol Violation|5|||
164614410|NCT03933215|594610031|FG000|Overall Study|Withdrawal by Subject|6|||
164614411|NCT03933215|594610031|FG000|Overall Study|Lost to Follow-up|6|||
164614412|NCT03933215|594610031|FG000|Overall Study|Enrolled but not treated|38|||
164614413|NCT04072575|594610034|FG000|Overall Study|Physician Decision|1|||
164614414|NCT04072575|594610034|FG000|Overall Study|Adverse Event|7|||
164614415|NCT04072575|594610034|FG000|Overall Study|Withdrawal by Subject|14|||
164614416|NCT04072575|594610034|FG000|Overall Study|Other|2|||
164614417|NCT05784129|594610035|FG000|Overall Study|Study terminated by sponsor|2|||
164614418|NCT05784129|594610036|FG001|Overall Study|Study terminated by sponsor|2|||
164614419|NCT00407550|594610037|FG000|Overall Study|Adverse Event|0|||
164614420|NCT00407550|594610038|FG001|Overall Study|Adverse Event|1|||
164614421|NCT00407550|594610037|FG000|Overall Study|Withdrawal by Subject|0|||
164614422|NCT00407550|594610038|FG001|Overall Study|Withdrawal by Subject|2|||
164614423|NCT00407550|594610037|FG000|Overall Study|Death|1|||
164614424|NCT00407550|594610038|FG001|Overall Study|Death|0|||
164614425|NCT00407550|594610037|FG000|Overall Study|Insurance or Other medical condition|2|||
164614426|NCT00407550|594610038|FG001|Overall Study|Insurance or Other medical condition|1|||
164614427|NCT01444898|594610039|FG000|Overall Study|Withdrawal by Subject|1|||
164614428|NCT02580591|594610041|FG000|Overall Study|Adverse Event|0|||
164614429|NCT02580591|594610042|FG001|Overall Study|Adverse Event|1|||
164614430|NCT02580591|594610043|FG002|Overall Study|Adverse Event|2|||
164614431|NCT02580591|594610044|FG003|Overall Study|Adverse Event|5|||
164614432|NCT02580591|594610041|FG000|Overall Study|Protocol Violation|3|||
164614433|NCT02580591|594610042|FG001|Overall Study|Protocol Violation|2|||
164614434|NCT02580591|594610043|FG002|Overall Study|Protocol Violation|1|||
164614435|NCT02580591|594610044|FG003|Overall Study|Protocol Violation|1|||
164614436|NCT02580591|594610041|FG000|Overall Study|Lost to Follow-up|5|||
164614437|NCT02580591|594610042|FG001|Overall Study|Lost to Follow-up|3|||
164614438|NCT02580591|594610043|FG002|Overall Study|Lost to Follow-up|3|||
164614439|NCT02580591|594610044|FG003|Overall Study|Lost to Follow-up|1|||
164614440|NCT02580591|594610041|FG000|Overall Study|Withdrawal by Subject|6|||
164614441|NCT02580591|594610042|FG001|Overall Study|Withdrawal by Subject|1|||
164614442|NCT02580591|594610043|FG002|Overall Study|Withdrawal by Subject|2|||
164614443|NCT02580591|594610044|FG003|Overall Study|Withdrawal by Subject|3|||
164614444|NCT02580591|594610041|FG000|Overall Study|Not treated|1|||
164614445|NCT02580591|594610042|FG001|Overall Study|Not treated|1|||
164614446|NCT02580591|594610043|FG002|Overall Study|Not treated|0|||
164614447|NCT02580591|594610044|FG003|Overall Study|Not treated|0|||
164614448|NCT02580591|594610041|FG000|Overall Study|Other than specified|3|||
164614449|NCT02580591|594610042|FG001|Overall Study|Other than specified|2|||
164614450|NCT02580591|594610043|FG002|Overall Study|Other than specified|5|||
164614451|NCT02580591|594610044|FG003|Overall Study|Other than specified|2|||
164614452|NCT01366534|594610049|FG000|Overall Study|Lost to Follow-up|1|||
164614453|NCT01366534|594610050|FG001|Overall Study|Lost to Follow-up|0|||
164614454|NCT01366534|594610051|FG002|Overall Study|Lost to Follow-up|0|||
164614455|NCT01366534|594610049|FG000|Overall Study|Migrated|1|||
164614456|NCT01366534|594610050|FG001|Overall Study|Migrated|1|||
164614457|NCT01366534|594610051|FG002|Overall Study|Migrated|0|||
164614458|NCT01366534|594610049|FG000|Overall Study|Declined challenged|0|||
164614459|NCT01366534|594610050|FG001|Overall Study|Declined challenged|1|||
164614460|NCT01366534|594610051|FG002|Overall Study|Declined challenged|0|||
164614461|NCT03006926|594610052|FG000|Overall Study|Adverse Event|0|||
164614462|NCT03006926|594610053|FG001|Overall Study|Adverse Event|27|||
164614463|NCT03006926|594610052|FG000|Overall Study|Withdrawal by Subject|0|||
164614464|NCT03006926|594610053|FG001|Overall Study|Withdrawal by Subject|1|||
164614465|NCT03006926|594610052|FG000|Overall Study|Radiological Disease Progression|0|||
164614466|NCT03006926|594610053|FG001|Overall Study|Radiological Disease Progression|52|||
164614467|NCT03006926|594610052|FG000|Overall Study|Clinical Disease Progression|0|||
164614468|NCT03006926|594610053|FG001|Overall Study|Clinical Disease Progression|10|||
164614469|NCT03006926|594610052|FG000|Overall Study|Other|0|||
164614470|NCT03006926|594610053|FG001|Overall Study|Other|8|||
164614471|NCT02918318|594610058|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
164614472|NCT02918318|594610059|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
164614473|NCT02918318|594610060|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
164614474|NCT02918318|594610061|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
164614475|NCT02918318|594610062|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
164614476|NCT02918318|594610058|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
164614477|NCT02918318|594610059|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
164614478|NCT02918318|594610060|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
164614479|NCT02918318|594610061|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
164614480|NCT02918318|594610062|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
164614481|NCT02918318|594610058|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
164614482|NCT02918318|594610059|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
164614483|NCT02918318|594610060|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
164614484|NCT02918318|594610061|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
164614485|NCT02918318|594610062|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
164614486|NCT02918318|594610058|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
164614487|NCT02918318|594610059|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
164614488|NCT02918318|594610060|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
164614489|NCT02918318|594610061|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
164614490|NCT02918318|594610062|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
164614491|NCT02918318|594610058|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
164614492|NCT02918318|594610059|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
164614493|NCT02918318|594610060|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
164614494|NCT02918318|594610061|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
164614495|NCT02918318|594610062|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
164614496|NCT02918318|594610058|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
164614497|NCT02918318|594610059|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
164614498|NCT02918318|594610060|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
164614499|NCT02918318|594610061|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
164614500|NCT02918318|594610062|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
164614501|NCT02918318|594610058|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
164614502|NCT02918318|594610059|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
164614503|NCT02918318|594610060|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
164614504|NCT02918318|594610061|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
164614505|NCT02918318|594610062|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
164614506|NCT02918318|594610058|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
164614507|NCT02918318|594610059|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
164614508|NCT02918318|594610060|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
164614509|NCT02918318|594610061|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
164614510|NCT02918318|594610062|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
164614511|NCT02918318|594610058|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
164614512|NCT02918318|594610059|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
164614513|NCT02918318|594610060|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
164614514|NCT02918318|594610061|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
164614515|NCT02918318|594610062|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
164614516|NCT02918318|594610058|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
164614517|NCT02918318|594610059|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
164614518|NCT02918318|594610060|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
164614519|NCT02918318|594610061|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
164614520|NCT02918318|594610062|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
164614521|NCT02918318|594610058|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
164614522|NCT02918318|594610059|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
164614523|NCT02918318|594610060|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
164614524|NCT02918318|594610061|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
164614525|NCT02918318|594610062|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
164614526|NCT02918318|594610058|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
164614527|NCT02918318|594610059|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
164614528|NCT02918318|594610060|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
164614529|NCT02918318|594610061|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
164614530|NCT02918318|594610062|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
164614531|NCT00990249|594610063|FG000|Overall Study|Disease Progression|8|||
164614532|NCT00990249|594610063|FG000|Overall Study|Non-Compliance|1|||
164614533|NCT00990249|594610063|FG000|Overall Study|Death|2|||
164614534|NCT00990249|594610063|FG000|Overall Study|Not treated|2|||
164614535|NCT04080752|594610064|FG000|Overall Study|Adverse Event|2|||
164614536|NCT04080752|594610065|FG001|Overall Study|Adverse Event|3|||
164614537|NCT04080752|594610064|FG000|Overall Study|Lack of Efficacy|1|||
164614538|NCT04080752|594610065|FG001|Overall Study|Lack of Efficacy|0|||
164614539|NCT04080752|594610064|FG000|Overall Study|Lost to Follow-up|1|||
164614540|NCT04080752|594610065|FG001|Overall Study|Lost to Follow-up|0|||
164614541|NCT04080752|594610064|FG000|Overall Study|Pregnancy|0|||
164614542|NCT04080752|594610065|FG001|Overall Study|Pregnancy|1|||
164614543|NCT04080752|594610064|FG000|Overall Study|Withdrawal by Subject|7|||
164614544|NCT04080752|594610065|FG001|Overall Study|Withdrawal by Subject|0|||
164614545|NCT04080752|594610064|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164614546|NCT04080752|594610065|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164614547|NCT04080752|594610064|FG000|Overall Study|Other|2|||
164614548|NCT04080752|594610065|FG001|Overall Study|Other|1|||
164614549|NCT01641081|594610068|FG000|Period 1|Sponsor request (potential unblinding)|0|||
164614550|NCT01641081|594610069|FG001|Period 1|Sponsor request (potential unblinding)|0|||
164614551|NCT01641081|594610070|FG002|Period 1|Sponsor request (potential unblinding)|0|||
164614552|NCT01641081|594610071|FG003|Period 1|Sponsor request (potential unblinding)|0|||
164614553|NCT01641081|594610072|FG004|Period 1|Sponsor request (potential unblinding)|0|||
164614554|NCT01641081|594610073|FG005|Period 1|Sponsor request (potential unblinding)|0|||
164614555|NCT01641081|594610074|FG006|Period 1|Sponsor request (potential unblinding)|1|||
164614556|NCT01641081|594610075|FG007|Period 1|Sponsor request (potential unblinding)|0|||
164614557|NCT01641081|594610076|FG008|Period 1|Sponsor request (potential unblinding)|0|||
164614558|NCT01641081|594610077|FG009|Period 1|Sponsor request (potential unblinding)|0|||
164614559|NCT01641081|594610068|FG000|Period 1|Protocol Violation|0|||
164614560|NCT01641081|594610069|FG001|Period 1|Protocol Violation|0|||
164614561|NCT01641081|594610070|FG002|Period 1|Protocol Violation|0|||
164614562|NCT01641081|594610071|FG003|Period 1|Protocol Violation|0|||
164614563|NCT01641081|594610072|FG004|Period 1|Protocol Violation|1|||
164614564|NCT01641081|594610073|FG005|Period 1|Protocol Violation|0|||
164517013|NCT00943852|594262887|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
164517014|NCT00943852|594262878|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
164517015|NCT00943852|594262879|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
164517016|NCT00943852|594262880|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
164517017|NCT00943852|594262881|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
164517018|NCT00943852|594262882|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
164517019|NCT00943852|594262883|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
164517020|NCT00943852|594262884|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
164517021|NCT00943852|594262885|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
164517022|NCT00943852|594262886|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
164517023|NCT00943852|594262887|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
164517024|NCT01725126|594262892|FG000|Overall Study|Protocol Violation|0|||
164517025|NCT01725126|594262893|FG001|Overall Study|Protocol Violation|1|||
164517026|NCT01725126|594262894|FG002|Overall Study|Protocol Violation|0|||
164517027|NCT01725126|594262895|FG003|Overall Study|Protocol Violation|0|||
164517028|NCT01725126|594262896|FG004|Overall Study|Protocol Violation|0|||
164517029|NCT01725126|594262897|FG005|Overall Study|Protocol Violation|0|||
164517030|NCT01725126|594262892|FG000|Overall Study|Withdrawal by Subject|0|||
164517031|NCT01725126|594262893|FG001|Overall Study|Withdrawal by Subject|0|||
164517032|NCT01725126|594262894|FG002|Overall Study|Withdrawal by Subject|0|||
164517033|NCT01725126|594262895|FG003|Overall Study|Withdrawal by Subject|1|||
164517034|NCT01725126|594262896|FG004|Overall Study|Withdrawal by Subject|0|||
164517035|NCT01725126|594262897|FG005|Overall Study|Withdrawal by Subject|0|||
164517036|NCT01518153|594262900|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
164517037|NCT01518153|594262901|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
164517038|NCT01518153|594262902|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
164517039|NCT01518153|594262900|FG000|Stem Cell Transplant|Death|2|||
164517040|NCT01518153|594262901|FG001|Stem Cell Transplant|Death|0|||
164517041|NCT01518153|594262902|FG002|Stem Cell Transplant|Death|0|||
164517042|NCT01518153|594262900|FG000|Stem Cell Transplant|Secondary graft failure|1|||
164517043|NCT01518153|594262901|FG001|Stem Cell Transplant|Secondary graft failure|0|||
164517044|NCT01518153|594262902|FG002|Stem Cell Transplant|Secondary graft failure|0|||
164517045|NCT01518153|594262900|FG000|Stem Cell Transplant|Adverse Event|1|||
164517046|NCT01518153|594262901|FG001|Stem Cell Transplant|Adverse Event|0|||
164517047|NCT01518153|594262902|FG002|Stem Cell Transplant|Adverse Event|0|||
164517048|NCT01518153|594262900|FG000|Donor Lymphocyte Infusion|Death|0|||
164517049|NCT01518153|594262901|FG001|Donor Lymphocyte Infusion|Death|2|||
164517050|NCT01518153|594262902|FG002|Donor Lymphocyte Infusion|Death|1|||
164517051|NCT02145468|594262909|FG000|Overall Study|Withdrawal by Subject|5|||
164517052|NCT02145468|594262910|FG001|Overall Study|Withdrawal by Subject|8|||
164517053|NCT01803282|594262914|FG000|Overall Study|Progressive Disease|4|||
164517054|NCT01803282|594262915|FG001|Overall Study|Progressive Disease|3|||
164517055|NCT01803282|594262916|FG002|Overall Study|Progressive Disease|6|||
164517056|NCT01803282|594262917|FG003|Overall Study|Progressive Disease|22|||
164517057|NCT01803282|594262918|FG004|Overall Study|Progressive Disease|5|||
164517058|NCT01803282|594262919|FG005|Overall Study|Progressive Disease|8|||
164517059|NCT01803282|594262920|FG006|Overall Study|Progressive Disease|23|||
164517060|NCT01803282|594262921|FG007|Overall Study|Progressive Disease|24|||
164517061|NCT01803282|594262922|FG008|Overall Study|Progressive Disease|3|||
164517062|NCT01803282|594262923|FG009|Overall Study|Progressive Disease|29|||
164517063|NCT01803282|594262924|FG010|Overall Study|Progressive Disease|6|||
164517064|NCT01803282|594262925|FG011|Overall Study|Progressive Disease|11|||
164517065|NCT01803282|594262914|FG000|Overall Study|Death|0|||
164517066|NCT01803282|594262915|FG001|Overall Study|Death|0|||
164517067|NCT01803282|594262916|FG002|Overall Study|Death|0|||
164517068|NCT01803282|594262917|FG003|Overall Study|Death|0|||
164517069|NCT01803282|594262918|FG004|Overall Study|Death|2|||
164517070|NCT01803282|594262919|FG005|Overall Study|Death|1|||
164517071|NCT01803282|594262920|FG006|Overall Study|Death|1|||
164517072|NCT01803282|594262921|FG007|Overall Study|Death|5|||
164517073|NCT01803282|594262922|FG008|Overall Study|Death|1|||
164517074|NCT01803282|594262923|FG009|Overall Study|Death|1|||
164517075|NCT01803282|594262924|FG010|Overall Study|Death|0|||
164517076|NCT01803282|594262925|FG011|Overall Study|Death|0|||
164517077|NCT01803282|594262914|FG000|Overall Study|Withdrew Consent|0|||
164517078|NCT01803282|594262915|FG001|Overall Study|Withdrew Consent|0|||
164517079|NCT01803282|594262916|FG002|Overall Study|Withdrew Consent|0|||
164517080|NCT01803282|594262917|FG003|Overall Study|Withdrew Consent|6|||
164517081|NCT01803282|594262918|FG004|Overall Study|Withdrew Consent|1|||
164517082|NCT01803282|594262919|FG005|Overall Study|Withdrew Consent|0|||
164517083|NCT01803282|594262920|FG006|Overall Study|Withdrew Consent|8|||
164517084|NCT01803282|594262921|FG007|Overall Study|Withdrew Consent|3|||
164517085|NCT01803282|594262922|FG008|Overall Study|Withdrew Consent|1|||
164614565|NCT01641081|594610074|FG006|Period 1|Protocol Violation|0|||
164614566|NCT01641081|594610075|FG007|Period 1|Protocol Violation|1|||
164614567|NCT01641081|594610076|FG008|Period 1|Protocol Violation|0|||
164614568|NCT01641081|594610077|FG009|Period 1|Protocol Violation|0|||
164614569|NCT01641081|594610068|FG000|Period 1|Adverse Event|1|||
164614570|NCT01641081|594610069|FG001|Period 1|Adverse Event|0|||
164614571|NCT01641081|594610070|FG002|Period 1|Adverse Event|0|||
164614572|NCT01641081|594610071|FG003|Period 1|Adverse Event|0|||
164614573|NCT01641081|594610072|FG004|Period 1|Adverse Event|0|||
164614574|NCT01641081|594610073|FG005|Period 1|Adverse Event|0|||
164614575|NCT01641081|594610074|FG006|Period 1|Adverse Event|0|||
164614576|NCT01641081|594610075|FG007|Period 1|Adverse Event|2|||
164614577|NCT01641081|594610076|FG008|Period 1|Adverse Event|0|||
164614578|NCT01641081|594610077|FG009|Period 1|Adverse Event|0|||
164614579|NCT01641081|594610068|FG000|Period 2|Adverse Event|0|||
164614580|NCT01641081|594610069|FG001|Period 2|Adverse Event|0|||
164614581|NCT01641081|594610070|FG002|Period 2|Adverse Event|0|||
164614582|NCT01641081|594610071|FG003|Period 2|Adverse Event|0|||
164614583|NCT01641081|594610072|FG004|Period 2|Adverse Event|0|||
164614584|NCT01641081|594610073|FG005|Period 2|Adverse Event|1|||
164614585|NCT01641081|594610074|FG006|Period 2|Adverse Event|0|||
164614586|NCT01641081|594610075|FG007|Period 2|Adverse Event|0|||
164614587|NCT01641081|594610076|FG008|Period 2|Adverse Event|0|||
164614588|NCT01641081|594610077|FG009|Period 2|Adverse Event|0|||
164517086|NCT01803282|594262923|FG009|Overall Study|Withdrew Consent|5|||
164517087|NCT01803282|594262924|FG010|Overall Study|Withdrew Consent|0|||
164517088|NCT01803282|594262925|FG011|Overall Study|Withdrew Consent|1|||
164517089|NCT01803282|594262914|FG000|Overall Study|Investigator's Discretion|0|||
164517090|NCT01803282|594262915|FG001|Overall Study|Investigator's Discretion|0|||
164517091|NCT01803282|594262916|FG002|Overall Study|Investigator's Discretion|0|||
164517092|NCT01803282|594262917|FG003|Overall Study|Investigator's Discretion|7|||
164517093|NCT01803282|594262918|FG004|Overall Study|Investigator's Discretion|2|||
164517094|NCT01803282|594262919|FG005|Overall Study|Investigator's Discretion|1|||
164517095|NCT01803282|594262920|FG006|Overall Study|Investigator's Discretion|7|||
164517096|NCT01803282|594262921|FG007|Overall Study|Investigator's Discretion|10|||
164517097|NCT01803282|594262922|FG008|Overall Study|Investigator's Discretion|6|||
164517098|NCT01803282|594262923|FG009|Overall Study|Investigator's Discretion|7|||
164517099|NCT01803282|594262924|FG010|Overall Study|Investigator's Discretion|1|||
164517100|NCT01803282|594262925|FG011|Overall Study|Investigator's Discretion|0|||
164517101|NCT01803282|594262914|FG000|Overall Study|Adverse Event|0|||
164517102|NCT01803282|594262915|FG001|Overall Study|Adverse Event|0|||
164517103|NCT01803282|594262916|FG002|Overall Study|Adverse Event|0|||
164517104|NCT01803282|594262917|FG003|Overall Study|Adverse Event|0|||
164517105|NCT01803282|594262918|FG004|Overall Study|Adverse Event|0|||
164517106|NCT01803282|594262919|FG005|Overall Study|Adverse Event|0|||
164517107|NCT01803282|594262920|FG006|Overall Study|Adverse Event|1|||
164517108|NCT01803282|594262921|FG007|Overall Study|Adverse Event|2|||
164517109|NCT01803282|594262922|FG008|Overall Study|Adverse Event|0|||
164517110|NCT01803282|594262923|FG009|Overall Study|Adverse Event|1|||
164517111|NCT01803282|594262924|FG010|Overall Study|Adverse Event|0|||
164517112|NCT01803282|594262925|FG011|Overall Study|Adverse Event|3|||
164517113|NCT01803282|594262914|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164517114|NCT01803282|594262915|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164517115|NCT01803282|594262916|FG002|Overall Study|Non-Compliance with Study Drug|0|||
164517116|NCT01803282|594262917|FG003|Overall Study|Non-Compliance with Study Drug|1|||
164517117|NCT01803282|594262918|FG004|Overall Study|Non-Compliance with Study Drug|0|||
164517118|NCT01803282|594262919|FG005|Overall Study|Non-Compliance with Study Drug|0|||
164517119|NCT01803282|594262920|FG006|Overall Study|Non-Compliance with Study Drug|0|||
164517120|NCT01803282|594262921|FG007|Overall Study|Non-Compliance with Study Drug|0|||
164517121|NCT01803282|594262922|FG008|Overall Study|Non-Compliance with Study Drug|0|||
164517122|NCT01803282|594262923|FG009|Overall Study|Non-Compliance with Study Drug|0|||
164517123|NCT01803282|594262924|FG010|Overall Study|Non-Compliance with Study Drug|0|||
164517124|NCT01803282|594262925|FG011|Overall Study|Non-Compliance with Study Drug|0|||
164517125|NCT01803282|594262914|FG000|Overall Study|Unknown Reason|0|||
164517126|NCT01803282|594262915|FG001|Overall Study|Unknown Reason|0|||
164614589|NCT01641081|594610068|FG000|Period 2|Withdrawal by Subject|0|||
164614590|NCT01641081|594610069|FG001|Period 2|Withdrawal by Subject|0|||
164614591|NCT01641081|594610070|FG002|Period 2|Withdrawal by Subject|0|||
164614592|NCT01641081|594610071|FG003|Period 2|Withdrawal by Subject|1|||
164614593|NCT01641081|594610072|FG004|Period 2|Withdrawal by Subject|0|||
164517127|NCT01803282|594262916|FG002|Overall Study|Unknown Reason|0|||
164517128|NCT01803282|594262917|FG003|Overall Study|Unknown Reason|0|||
164614594|NCT01641081|594610073|FG005|Period 2|Withdrawal by Subject|0|||
164614595|NCT01641081|594610074|FG006|Period 2|Withdrawal by Subject|2|||
164614596|NCT01641081|594610075|FG007|Period 2|Withdrawal by Subject|0|||
164517129|NCT01803282|594262918|FG004|Overall Study|Unknown Reason|0|||
164517130|NCT01803282|594262919|FG005|Overall Study|Unknown Reason|0|||
164147374|NCT05168202|592902029|FG005|Overall Study|Adverse Event|2|||
164517131|NCT01803282|594262920|FG006|Overall Study|Unknown Reason|0|||
164517132|NCT01803282|594262921|FG007|Overall Study|Unknown Reason|1|||
164517133|NCT01803282|594262922|FG008|Overall Study|Unknown Reason|0|||
164517134|NCT01803282|594262923|FG009|Overall Study|Unknown Reason|0|||
164517135|NCT01803282|594262924|FG010|Overall Study|Unknown Reason|0|||
164517136|NCT01803282|594262925|FG011|Overall Study|Unknown Reason|0|||
164517137|NCT01803282|594262914|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
164517138|NCT01803282|594262915|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
164517139|NCT01803282|594262916|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
164517140|NCT01803282|594262917|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
164517141|NCT01803282|594262918|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
164517142|NCT01803282|594262919|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
164517143|NCT01803282|594262920|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
164517144|NCT01803282|594262921|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
164517145|NCT01803282|594262922|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
164517146|NCT01803282|594262923|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
164517147|NCT01803282|594262924|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
164517148|NCT01803282|594262925|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
164517149|NCT01803282|594262914|FG000|Overall Study|Enrolled but Never Treated|0|||
164517150|NCT01803282|594262915|FG001|Overall Study|Enrolled but Never Treated|0|||
164517151|NCT01803282|594262916|FG002|Overall Study|Enrolled but Never Treated|0|||
164517152|NCT01803282|594262917|FG003|Overall Study|Enrolled but Never Treated|0|||
164517153|NCT01803282|594262918|FG004|Overall Study|Enrolled but Never Treated|1|||
164517154|NCT01803282|594262919|FG005|Overall Study|Enrolled but Never Treated|0|||
164517155|NCT01803282|594262920|FG006|Overall Study|Enrolled but Never Treated|1|||
164517156|NCT01803282|594262921|FG007|Overall Study|Enrolled but Never Treated|1|||
164517157|NCT01803282|594262922|FG008|Overall Study|Enrolled but Never Treated|0|||
164517158|NCT01803282|594262923|FG009|Overall Study|Enrolled but Never Treated|1|||
164517159|NCT01803282|594262924|FG010|Overall Study|Enrolled but Never Treated|0|||
164517160|NCT01803282|594262925|FG011|Overall Study|Enrolled but Never Treated|0|||
164517161|NCT00798434|594262930|FG000|Double-Blind|Adverse Event|22|||
164517162|NCT00798434|594262931|FG001|Double-Blind|Adverse Event|46|||
164517163|NCT00798434|594262930|FG000|Double-Blind|Death|0|||
164614597|NCT01641081|594610076|FG008|Period 2|Withdrawal by Subject|0|||
164614598|NCT01641081|594610077|FG009|Period 2|Withdrawal by Subject|0|||
164614599|NCT01641081|594610068|FG000|Period 2|Protocol Violation|1|||
164614600|NCT01641081|594610069|FG001|Period 2|Protocol Violation|0|||
164614601|NCT01641081|594610070|FG002|Period 2|Protocol Violation|0|||
164614602|NCT01641081|594610071|FG003|Period 2|Protocol Violation|0|||
164614603|NCT01641081|594610072|FG004|Period 2|Protocol Violation|0|||
164614604|NCT01641081|594610073|FG005|Period 2|Protocol Violation|0|||
164614605|NCT01641081|594610074|FG006|Period 2|Protocol Violation|0|||
164614606|NCT01641081|594610075|FG007|Period 2|Protocol Violation|0|||
164614607|NCT01641081|594610076|FG008|Period 2|Protocol Violation|0|||
164614608|NCT01641081|594610077|FG009|Period 2|Protocol Violation|0|||
164614609|NCT01641081|594610068|FG000|Period 3|Adverse Event|0|||
164614610|NCT01641081|594610069|FG001|Period 3|Adverse Event|0|||
164614611|NCT01641081|594610070|FG002|Period 3|Adverse Event|1|||
164614612|NCT01641081|594610071|FG003|Period 3|Adverse Event|0|||
164614613|NCT01641081|594610072|FG004|Period 3|Adverse Event|0|||
164614614|NCT01641081|594610073|FG005|Period 3|Adverse Event|0|||
164614615|NCT01641081|594610074|FG006|Period 3|Adverse Event|0|||
164614616|NCT01641081|594610075|FG007|Period 3|Adverse Event|0|||
164614617|NCT01641081|594610076|FG008|Period 3|Adverse Event|0|||
164614618|NCT01641081|594610077|FG009|Period 3|Adverse Event|0|||
164614619|NCT01641081|594610068|FG000|Period 3|Withdrawal by Subject|0|||
164614620|NCT01641081|594610069|FG001|Period 3|Withdrawal by Subject|0|||
164614621|NCT01641081|594610070|FG002|Period 3|Withdrawal by Subject|0|||
164614622|NCT01641081|594610071|FG003|Period 3|Withdrawal by Subject|0|||
164614623|NCT01641081|594610072|FG004|Period 3|Withdrawal by Subject|0|||
164614624|NCT01641081|594610073|FG005|Period 3|Withdrawal by Subject|0|||
164614625|NCT01641081|594610074|FG006|Period 3|Withdrawal by Subject|0|||
164614626|NCT01641081|594610075|FG007|Period 3|Withdrawal by Subject|0|||
164614627|NCT01641081|594610076|FG008|Period 3|Withdrawal by Subject|1|||
164614628|NCT01641081|594610077|FG009|Period 3|Withdrawal by Subject|0|||
164614629|NCT01641081|594610068|FG000|Period 4|Adverse Event|0|||
164614630|NCT01641081|594610069|FG001|Period 4|Adverse Event|1|||
164614631|NCT01641081|594610070|FG002|Period 4|Adverse Event|0|||
164614632|NCT01641081|594610071|FG003|Period 4|Adverse Event|1|||
164614633|NCT01641081|594610072|FG004|Period 4|Adverse Event|0|||
164614634|NCT01641081|594610073|FG005|Period 4|Adverse Event|0|||
164614635|NCT01641081|594610074|FG006|Period 4|Adverse Event|0|||
164614636|NCT01641081|594610075|FG007|Period 4|Adverse Event|0|||
164614637|NCT01641081|594610076|FG008|Period 4|Adverse Event|0|||
164614638|NCT01641081|594610077|FG009|Period 4|Adverse Event|0|||
164614639|NCT01641081|594610068|FG000|Period 5|Adverse Event|0|||
164614640|NCT01641081|594610069|FG001|Period 5|Adverse Event|0|||
164614641|NCT01641081|594610070|FG002|Period 5|Adverse Event|2|||
164614642|NCT01641081|594610071|FG003|Period 5|Adverse Event|0|||
164614643|NCT01641081|594610072|FG004|Period 5|Adverse Event|0|||
164614644|NCT01641081|594610073|FG005|Period 5|Adverse Event|0|||
164614645|NCT01641081|594610074|FG006|Period 5|Adverse Event|0|||
164517164|NCT00798434|594262931|FG001|Double-Blind|Death|1|||
164517165|NCT00798434|594262930|FG000|Double-Blind|Lost to Follow-up|1|||
164517166|NCT00798434|594262931|FG001|Double-Blind|Lost to Follow-up|0|||
164517167|NCT00798434|594262930|FG000|Double-Blind|Lack of Efficacy|8|||
164517168|NCT00798434|594262931|FG001|Double-Blind|Lack of Efficacy|12|||
164517169|NCT00798434|594262930|FG000|Double-Blind|Withdrawal by Subject|17|||
164517170|NCT00798434|594262931|FG001|Double-Blind|Withdrawal by Subject|14|||
164517171|NCT00798434|594262930|FG000|Double-Blind|Protocol Violation|1|||
164517172|NCT00798434|594262931|FG001|Double-Blind|Protocol Violation|4|||
164517173|NCT00798434|594262930|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
164517174|NCT00798434|594262931|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
164517175|NCT00798434|594262930|FG000|Double-Blind|Other|1|||
164517176|NCT00798434|594262931|FG001|Double-Blind|Other|0|||
164517177|NCT00798434|594262930|FG000|Double-Blind|Not Treated|3|||
164517178|NCT00798434|594262931|FG001|Double-Blind|Not Treated|6|||
164517179|NCT00798434|594262930|FG000|Open-Label|Adverse Event|33|||
164517180|NCT00798434|594262931|FG001|Open-Label|Adverse Event|11|||
164517181|NCT00798434|594262930|FG000|Open-Label|Lack of Efficacy|5|||
164517182|NCT00798434|594262931|FG001|Open-Label|Lack of Efficacy|11|||
164517183|NCT00798434|594262930|FG000|Open-Label|Withdrawal by Subject|2|||
164517184|NCT00798434|594262931|FG001|Open-Label|Withdrawal by Subject|7|||
164517185|NCT00798434|594262930|FG000|Open-Label|Protocol Violation|1|||
164517186|NCT00798434|594262931|FG001|Open-Label|Protocol Violation|0|||
164517187|NCT00798434|594262930|FG000|Open-Label|Other|1|||
164517188|NCT00798434|594262931|FG001|Open-Label|Other|2|||
164517189|NCT00798434|594262930|FG000|Open-Label|Not Treated|0|||
164517190|NCT00798434|594262931|FG001|Open-Label|Not Treated|1|||
164517191|NCT01217437|594262935|FG000|Overall Study|Adverse Event|0|||
164517192|NCT01217437|594262936|FG001|Overall Study|Adverse Event|8|||
164517193|NCT01217437|594262935|FG000|Overall Study|Death|5|||
164517194|NCT01217437|594262936|FG001|Overall Study|Death|0|||
164517195|NCT01217437|594262935|FG000|Overall Study|Lack of Efficacy|29|||
164517196|NCT01217437|594262936|FG001|Overall Study|Lack of Efficacy|25|||
164517197|NCT01217437|594262935|FG000|Overall Study|Physician Decision|8|||
164517198|NCT01217437|594262936|FG001|Overall Study|Physician Decision|5|||
164517199|NCT01217437|594262935|FG000|Overall Study|Withdrawal by Subject|0|||
164517200|NCT01217437|594262936|FG001|Overall Study|Withdrawal by Subject|2|||
164517201|NCT01217437|594262935|FG000|Overall Study|Ineligible|1|||
164517202|NCT01217437|594262936|FG001|Overall Study|Ineligible|1|||
164517203|NCT02336451|594262940|FG000|Overall Study|Adverse Event|1|||
164517204|NCT02336451|594262941|FG001|Overall Study|Adverse Event|2|||
164517205|NCT02336451|594262942|FG002|Overall Study|Adverse Event|0|||
164517206|NCT02336451|594262943|FG003|Overall Study|Adverse Event|6|||
164517207|NCT02336451|594262944|FG004|Overall Study|Adverse Event|4|||
164517208|NCT02336451|594262940|FG000|Overall Study|Death|6|||
164517209|NCT02336451|594262941|FG001|Overall Study|Death|2|||
164517210|NCT02336451|594262942|FG002|Overall Study|Death|3|||
164517211|NCT02336451|594262943|FG003|Overall Study|Death|6|||
164517212|NCT02336451|594262944|FG004|Overall Study|Death|6|||
164614646|NCT01641081|594610075|FG007|Period 5|Adverse Event|0|||
164614647|NCT01641081|594610076|FG008|Period 5|Adverse Event|0|||
164614648|NCT01641081|594610077|FG009|Period 5|Adverse Event|0|||
164614649|NCT01095666|594610078|FG000|Overall Study|Lack of Efficacy|0|||
164614650|NCT01095666|594610079|FG001|Overall Study|Lack of Efficacy|0|||
164614651|NCT01095666|594610080|FG002|Overall Study|Lack of Efficacy|1|||
164614652|NCT01095666|594610078|FG000|Overall Study|Adverse Event|2|||
164614653|NCT01095666|594610079|FG001|Overall Study|Adverse Event|1|||
164614654|NCT01095666|594610080|FG002|Overall Study|Adverse Event|3|||
164614655|NCT01095666|594610078|FG000|Overall Study|Lost to Follow-up|2|||
164614656|NCT01095666|594610079|FG001|Overall Study|Lost to Follow-up|2|||
164614657|NCT01095666|594610080|FG002|Overall Study|Lost to Follow-up|0|||
164614658|NCT01095666|594610078|FG000|Overall Study|Withdrawal by Subject|6|||
164614659|NCT01095666|594610079|FG001|Overall Study|Withdrawal by Subject|6|||
164614660|NCT01095666|594610080|FG002|Overall Study|Withdrawal by Subject|1|||
164614661|NCT01095666|594610078|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
164614662|NCT01095666|594610079|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
164614663|NCT01095666|594610080|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
164614664|NCT02758613|594610085|FG000|Treatment|Physician and Sponsor Decision|1|||
164614665|NCT02758613|594610086|FG001|Treatment|Physician and Sponsor Decision|0|||
164614666|NCT02758613|594610087|FG002|Treatment|Physician and Sponsor Decision|0|||
164614667|NCT02758613|594610088|FG003|Treatment|Physician and Sponsor Decision|0|||
164614668|NCT02758613|594610085|FG000|Treatment|Withdrawal by Subject|1|||
164614669|NCT02758613|594610086|FG001|Treatment|Withdrawal by Subject|0|||
164614670|NCT02758613|594610087|FG002|Treatment|Withdrawal by Subject|1|||
164614671|NCT02758613|594610088|FG003|Treatment|Withdrawal by Subject|0|||
164614672|NCT01425749|594610094|FG000|Overall Study|progression of melanoma|0|||
164614673|NCT01425749|594610095|FG001|Overall Study|progression of melanoma|1|||
164614674|NCT02910219|594610096|FG000|Overall Study|Withdrawal by Subject|1|||
164614675|NCT02910219|594610097|FG001|Overall Study|Withdrawal by Subject|1|||
164614676|NCT02679781|594610099|FG000|Overall Study|Lost to Follow-up|1|||
164614677|NCT02679781|594610100|FG001|Overall Study|Lost to Follow-up|2|||
164614678|NCT02679781|594610099|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
164614679|NCT02679781|594610100|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
164614680|NCT01496274|594610101|FG000|Overall Study|Protocol Violation|0|||
164614681|NCT01496274|594610102|FG001|Overall Study|Protocol Violation|1|||
164614682|NCT01496274|594610101|FG000|Overall Study|Adverse Event|1|||
164614683|NCT01496274|594610102|FG001|Overall Study|Adverse Event|1|||
164614684|NCT01496274|594610101|FG000|Overall Study|Withdrawal by Subject|2|||
164614685|NCT01496274|594610102|FG001|Overall Study|Withdrawal by Subject|0|||
164614686|NCT01496274|594610101|FG000|Overall Study|Lost to Follow-up|0|||
164614687|NCT01496274|594610102|FG001|Overall Study|Lost to Follow-up|3|||
164614688|NCT04018612|594610103|FG000|Overall Study|Withdrawal by Subject|1|||
164614689|NCT04018612|594610104|FG001|Overall Study|Withdrawal by Subject|0|||
164614690|NCT04018612|594610105|FG002|Overall Study|Withdrawal by Subject|1|||
164614691|NCT00361218|594610106|FG000|Overall Study|Lost to Follow-up|11|||
164614692|NCT00361218|594610106|FG000|Overall Study|Personal Reasons|7|||
164614693|NCT00361218|594610106|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
164614694|NCT01041404|594610110|FG000|Overall Study|Adverse Event|45|||
164614695|NCT01041404|594610111|FG001|Overall Study|Adverse Event|35|||
164614696|NCT01041404|594610110|FG000|Overall Study|Lack of Efficacy|200|||
164614697|NCT01041404|594610111|FG001|Overall Study|Lack of Efficacy|210|||
164614698|NCT01041404|594610110|FG000|Overall Study|Violation of Selection Criteria|0|||
164614699|NCT01041404|594610111|FG001|Overall Study|Violation of Selection Criteria|1|||
164614700|NCT01041404|594610110|FG000|Overall Study|Protocol Violation|4|||
164614701|NCT01041404|594610111|FG001|Overall Study|Protocol Violation|0|||
164614702|NCT01041404|594610110|FG000|Overall Study|Withdrawal by Subject|29|||
164614703|NCT01041404|594610111|FG001|Overall Study|Withdrawal by Subject|23|||
164614704|NCT01041404|594610110|FG000|Overall Study|Failure to Return|1|||
164614705|NCT01041404|594610111|FG001|Overall Study|Failure to Return|2|||
164614706|NCT01041404|594610110|FG000|Overall Study|Other|11|||
164614707|NCT01041404|594610111|FG001|Overall Study|Other|23|||
164614708|NCT01750840|594610116|FG000|Overall Study|Lost to Follow-up|4|||
164614709|NCT01432756|594611817|FG000|Overall Study|Lost to Follow-up|1|||
164614710|NCT01432756|594611818|FG001|Overall Study|Lost to Follow-up|0|||
164614711|NCT01432756|594611819|FG002|Overall Study|Lost to Follow-up|2|||
164614712|NCT01432756|594611820|FG003|Overall Study|Lost to Follow-up|1|||
164614713|NCT02712008|594611821|FG000|Baseline (Day 1) up to Week 12|Death|3|||
164614714|NCT02712008|594611822|FG001|Baseline (Day 1) up to Week 12|Death|0|||
164614715|NCT02712008|594611823|FG002|Baseline (Day 1) up to Week 12|Death|0|||
164614716|NCT02712008|594611824|FG003|Baseline (Day 1) up to Week 12|Death|0|||
164614717|NCT02712008|594611825|FG004|Baseline (Day 1) up to Week 12|Death|0|||
164614718|NCT02712008|594611826|FG005|Baseline (Day 1) up to Week 12|Death|0|||
164614719|NCT02712008|594611827|FG006|Baseline (Day 1) up to Week 12|Death|0|||
164614720|NCT02712008|594611828|FG007|Baseline (Day 1) up to Week 12|Death|0|||
164614721|NCT02712008|594611821|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164614722|NCT02712008|594611822|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
164614723|NCT02712008|594611823|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
164614724|NCT02712008|594611824|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164614725|NCT02712008|594611825|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164614726|NCT02712008|594611826|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164614727|NCT02712008|594611827|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164614728|NCT02712008|594611828|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164614729|NCT02712008|594611821|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
164614730|NCT02712008|594611822|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164614731|NCT02712008|594611823|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
164614732|NCT02712008|594611824|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164614733|NCT02712008|594611825|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164614734|NCT02712008|594611826|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164614735|NCT02712008|594611827|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164614736|NCT02712008|594611828|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164614737|NCT02712008|594611821|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
164614738|NCT02712008|594611822|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
164614739|NCT02712008|594611823|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
164614740|NCT02712008|594611824|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
164614741|NCT02712008|594611825|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
164614742|NCT02712008|594611826|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
164614743|NCT02712008|594611827|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
164614744|NCT02712008|594611828|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
164614745|NCT02712008|594611821|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
164614746|NCT02712008|594611822|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
164614747|NCT02712008|594611823|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
164614748|NCT02712008|594611824|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
164614749|NCT02712008|594611825|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
164614750|NCT02712008|594611826|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
164614751|NCT02712008|594611827|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
164614752|NCT02712008|594611828|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
164614753|NCT02712008|594611821|FG000|From Week 12 up to Week 36|Adverse Event|0|||
164614754|NCT02712008|594611822|FG001|From Week 12 up to Week 36|Adverse Event|0|||
164614755|NCT02712008|594611823|FG002|From Week 12 up to Week 36|Adverse Event|0|||
164614756|NCT02712008|594611824|FG003|From Week 12 up to Week 36|Adverse Event|0|||
164614757|NCT02712008|594611825|FG004|From Week 12 up to Week 36|Adverse Event|1|||
164614758|NCT02712008|594611826|FG005|From Week 12 up to Week 36|Adverse Event|0|||
164614759|NCT02712008|594611827|FG006|From Week 12 up to Week 36|Adverse Event|0|||
164614760|NCT02712008|594611828|FG007|From Week 12 up to Week 36|Adverse Event|2|||
164614761|NCT02712008|594611821|FG000|From Week 12 up to Week 36|Death|1|||
164614762|NCT02712008|594611822|FG001|From Week 12 up to Week 36|Death|0|||
164614763|NCT02712008|594611823|FG002|From Week 12 up to Week 36|Death|0|||
164614764|NCT02712008|594611824|FG003|From Week 12 up to Week 36|Death|0|||
164614765|NCT02712008|594611825|FG004|From Week 12 up to Week 36|Death|0|||
164614766|NCT02712008|594611826|FG005|From Week 12 up to Week 36|Death|0|||
164614767|NCT02712008|594611827|FG006|From Week 12 up to Week 36|Death|1|||
164614768|NCT02712008|594611828|FG007|From Week 12 up to Week 36|Death|0|||
164614769|NCT02712008|594611821|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
164614770|NCT02712008|594611822|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
164614771|NCT02712008|594611823|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
164614772|NCT02712008|594611824|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
164614773|NCT02712008|594611825|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
164614774|NCT02712008|594611826|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
164614775|NCT02712008|594611827|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
164614776|NCT02712008|594611828|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
164614777|NCT02712008|594611821|FG000|From Week 12 up to Week 36|Physician Decision|0|||
164614778|NCT02712008|594611822|FG001|From Week 12 up to Week 36|Physician Decision|0|||
164614779|NCT02712008|594611823|FG002|From Week 12 up to Week 36|Physician Decision|0|||
164614780|NCT02712008|594611824|FG003|From Week 12 up to Week 36|Physician Decision|1|||
164614781|NCT02712008|594611825|FG004|From Week 12 up to Week 36|Physician Decision|1|||
164614782|NCT02712008|594611826|FG005|From Week 12 up to Week 36|Physician Decision|0|||
164614783|NCT02712008|594611827|FG006|From Week 12 up to Week 36|Physician Decision|0|||
164614784|NCT02712008|594611828|FG007|From Week 12 up to Week 36|Physician Decision|0|||
164614785|NCT02712008|594611821|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
164614786|NCT02712008|594611822|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
164614787|NCT02712008|594611823|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
164614788|NCT02712008|594611824|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
164614789|NCT02712008|594611825|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
164614790|NCT02712008|594611826|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
164614791|NCT02712008|594611827|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
164614792|NCT02712008|594611828|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
164614793|NCT00364351|594611829|FG000|Overall Study|Adverse Event|90|||
164614794|NCT00364351|594611830|FG001|Overall Study|Adverse Event|44|||
164614795|NCT00364351|594611829|FG000|Overall Study|Condition under investigation worsened|469|||
164614796|NCT00364351|594611830|FG001|Overall Study|Condition under investigation worsened|497|||
164614797|NCT00364351|594611829|FG000|Overall Study|Prohibited concomitant medication|0|||
164614798|NCT00364351|594611830|FG001|Overall Study|Prohibited concomitant medication|2|||
164614799|NCT00364351|594611829|FG000|Overall Study|Lost to Follow-up|1|||
164614800|NCT00364351|594611830|FG001|Overall Study|Lost to Follow-up|1|||
164614801|NCT00364351|594611829|FG000|Overall Study|Withdrawal by Subject|30|||
164614802|NCT00364351|594611830|FG001|Overall Study|Withdrawal by Subject|29|||
164614803|NCT00364351|594611829|FG000|Overall Study|Incorrect enrollment|1|||
164614804|NCT00364351|594611830|FG001|Overall Study|Incorrect enrollment|1|||
164614805|NCT00364351|594611829|FG000|Overall Study|Sponsor decision|1|||
164614806|NCT00364351|594611830|FG001|Overall Study|Sponsor decision|0|||
164614807|NCT00364351|594611829|FG000|Overall Study|Poor treatment compliance|0|||
164614808|NCT00364351|594611830|FG001|Overall Study|Poor treatment compliance|3|||
164614809|NCT00364351|594611829|FG000|Overall Study|Investigator error|0|||
164614810|NCT00364351|594611830|FG001|Overall Study|Investigator error|2|||
164614811|NCT00364351|594611829|FG000|Overall Study|Patient could not travel to site|0|||
164614812|NCT00364351|594611830|FG001|Overall Study|Patient could not travel to site|1|||
164614813|NCT00364351|594611829|FG000|Overall Study|Randomised treatment not started|0|||
164614814|NCT00364351|594611830|FG001|Overall Study|Randomised treatment not started|3|||
164614815|NCT00509028|594611839|FG000|Overall Study|Adverse Event|2|||
164614816|NCT00509028|594611840|FG001|Overall Study|Adverse Event|0|||
164614817|NCT00509028|594611839|FG000|Overall Study|Withdrawal by Subject|4|||
164614818|NCT00509028|594611840|FG001|Overall Study|Withdrawal by Subject|3|||
164614819|NCT00509028|594611839|FG000|Overall Study|Lost to Follow-up|0|||
164614820|NCT00509028|594611840|FG001|Overall Study|Lost to Follow-up|1|||
164614821|NCT00509028|594611839|FG000|Overall Study|Protocol Violation|4|||
164614822|NCT00509028|594611840|FG001|Overall Study|Protocol Violation|2|||
164614823|NCT00509028|594611839|FG000|Overall Study|Non-compliance|2|||
164614824|NCT00509028|594611840|FG001|Overall Study|Non-compliance|1|||
164614825|NCT02996110|594611841|FG000|Pre-Treatment|Other Reasons|0|||
164614826|NCT02996110|594611842|FG001|Pre-Treatment|Other Reasons|1|||
164614827|NCT02996110|594611843|FG002|Pre-Treatment|Other Reasons|0|||
164614828|NCT02996110|594611844|FG003|Pre-Treatment|Other Reasons|0|||
164614829|NCT02996110|594611845|FG004|Pre-Treatment|Other Reasons|1|||
164517213|NCT02336451|594262940|FG000|Overall Study|Physician Decision|9|||
164517214|NCT02336451|594262941|FG001|Overall Study|Physician Decision|6|||
164517215|NCT02336451|594262942|FG002|Overall Study|Physician Decision|7|||
164517216|NCT02336451|594262943|FG003|Overall Study|Physician Decision|16|||
164517217|NCT02336451|594262944|FG004|Overall Study|Physician Decision|3|||
164517218|NCT02336451|594262940|FG000|Overall Study|Progressive disease|23|||
164517219|NCT02336451|594262941|FG001|Overall Study|Progressive disease|26|||
164517220|NCT02336451|594262942|FG002|Overall Study|Progressive disease|2|||
164517221|NCT02336451|594262943|FG003|Overall Study|Progressive disease|14|||
164517222|NCT02336451|594262944|FG004|Overall Study|Progressive disease|4|||
164517223|NCT02336451|594262940|FG000|Overall Study|Protocol Violation|1|||
164517224|NCT02336451|594262941|FG001|Overall Study|Protocol Violation|0|||
164517225|NCT02336451|594262942|FG002|Overall Study|Protocol Violation|0|||
164517226|NCT02336451|594262943|FG003|Overall Study|Protocol Violation|0|||
164517227|NCT02336451|594262944|FG004|Overall Study|Protocol Violation|0|||
164517228|NCT02336451|594262940|FG000|Overall Study|Patient/guardian decision|2|||
164517229|NCT02336451|594262941|FG001|Overall Study|Patient/guardian decision|4|||
164517230|NCT02336451|594262942|FG002|Overall Study|Patient/guardian decision|0|||
164517231|NCT02336451|594262943|FG003|Overall Study|Patient/guardian decision|2|||
164517232|NCT02336451|594262944|FG004|Overall Study|Patient/guardian decision|1|||
164517233|NCT04893460|594262951|FG000|Overall Study|Lost to Follow-up|18|||
164517234|NCT00387426|594264131|FG000|Overall Study|Lack of Response|7|||
164517235|NCT00387426|594264131|FG000|Overall Study|Toxicities|4|||
164517236|NCT00387426|594264131|FG000|Overall Study|Disease Progression|3|||
164517237|NCT03203473|594264132|FG000|Induction Phase|Never started primary treatment|2|||
164517238|NCT03203473|594264133|FG001|Induction Phase|Never started primary treatment|0|||
164517239|NCT03203473|594264134|FG002|Induction Phase|Never started primary treatment|0|||
164517240|NCT03203473|594264132|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
164614830|NCT02996110|594611841|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
164614831|NCT02996110|594611842|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
164614832|NCT02996110|594611843|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
164614833|NCT02996110|594611844|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
164614834|NCT02996110|594611845|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
164614835|NCT02996110|594611841|FG000|Track 1|Disease Progression|15|||
164614836|NCT02996110|594611842|FG001|Track 1|Disease Progression|17|||
164614837|NCT02996110|594611843|FG002|Track 1|Disease Progression|0|||
164614838|NCT02996110|594611844|FG003|Track 1|Disease Progression|0|||
164614839|NCT02996110|594611845|FG004|Track 1|Disease Progression|0|||
164614840|NCT02996110|594611841|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
164614841|NCT02996110|594611842|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
164614842|NCT02996110|594611843|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
164614843|NCT02996110|594611844|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
164614844|NCT02996110|594611845|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
164614845|NCT02996110|594611841|FG000|Track 1|Study Drug Toxicity|5|||
164614846|NCT02996110|594611842|FG001|Track 1|Study Drug Toxicity|3|||
164614847|NCT02996110|594611843|FG002|Track 1|Study Drug Toxicity|0|||
164614848|NCT02996110|594611844|FG003|Track 1|Study Drug Toxicity|0|||
164614849|NCT02996110|594611845|FG004|Track 1|Study Drug Toxicity|0|||
164614850|NCT02996110|594611841|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
164614851|NCT02996110|594611842|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
164614852|NCT02996110|594611843|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
164614853|NCT02996110|594611844|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
164614854|NCT02996110|594611845|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
164614855|NCT02996110|594611841|FG000|Track 1|Administrative Reason by Sponsor|0|||
164614856|NCT02996110|594611842|FG001|Track 1|Administrative Reason by Sponsor|1|||
164614857|NCT02996110|594611843|FG002|Track 1|Administrative Reason by Sponsor|0|||
164614858|NCT02996110|594611844|FG003|Track 1|Administrative Reason by Sponsor|0|||
164614859|NCT02996110|594611845|FG004|Track 1|Administrative Reason by Sponsor|0|||
164614860|NCT02996110|594611841|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
164614861|NCT02996110|594611842|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
164614862|NCT02996110|594611843|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
164614863|NCT02996110|594611844|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
164614864|NCT02996110|594611845|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
164614865|NCT02996110|594611841|FG000|Track 2|Disease Progression|33|||
164614866|NCT02996110|594611842|FG001|Track 2|Disease Progression|26|||
164614867|NCT02996110|594611843|FG002|Track 2|Disease Progression|19|||
164614868|NCT02996110|594611844|FG003|Track 2|Disease Progression|16|||
164614869|NCT02996110|594611845|FG004|Track 2|Disease Progression|15|||
164614870|NCT02996110|594611841|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
164614871|NCT02996110|594611842|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
164614872|NCT02996110|594611843|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
164614873|NCT02996110|594611844|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
164614874|NCT02996110|594611845|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
164614875|NCT02996110|594611841|FG000|Track 2|Death|0|||
164614876|NCT02996110|594611842|FG001|Track 2|Death|0|||
164614877|NCT02996110|594611843|FG002|Track 2|Death|1|||
164517241|NCT03203473|594264133|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
164517242|NCT03203473|594264134|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
164517243|NCT03203473|594264132|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
164517244|NCT03203473|594264133|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
164517245|NCT03203473|594264134|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
164517246|NCT03203473|594264132|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
164517247|NCT03203473|594264133|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
164517248|NCT03203473|594264134|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
164517249|NCT03203473|594264132|FG000|Arm Allocation Phase|started salvage therapy|0|||
164517250|NCT03203473|594264133|FG001|Arm Allocation Phase|started salvage therapy|5|||
164517251|NCT03203473|594264134|FG002|Arm Allocation Phase|started salvage therapy|0|||
164517252|NCT03203473|594264132|FG000|Arm Allocation Phase|Disease progression|0|||
164517253|NCT03203473|594264133|FG001|Arm Allocation Phase|Disease progression|0|||
164517254|NCT03203473|594264134|FG002|Arm Allocation Phase|Disease progression|37|||
164517255|NCT03203473|594264132|FG000|Arm Allocation Phase|Adverse Event|0|||
164517256|NCT03203473|594264133|FG001|Arm Allocation Phase|Adverse Event|0|||
164517257|NCT03203473|594264134|FG002|Arm Allocation Phase|Adverse Event|11|||
164614878|NCT02996110|594611844|FG003|Track 2|Death|0|||
164614879|NCT02996110|594611845|FG004|Track 2|Death|1|||
164614880|NCT02996110|594611841|FG000|Track 2|Study Drug Toxicity|4|||
164614881|NCT02996110|594611842|FG001|Track 2|Study Drug Toxicity|1|||
164614882|NCT02996110|594611843|FG002|Track 2|Study Drug Toxicity|4|||
164614883|NCT02996110|594611844|FG003|Track 2|Study Drug Toxicity|1|||
164517258|NCT03203473|594264132|FG000|Arm Allocation Phase|Physician Decision|0|||
164614884|NCT02996110|594611845|FG004|Track 2|Study Drug Toxicity|0|||
164614885|NCT02996110|594611841|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
164614886|NCT02996110|594611842|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
164614887|NCT02996110|594611843|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
164614888|NCT02996110|594611844|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
164614889|NCT02996110|594611845|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
164614890|NCT02996110|594611841|FG000|Track 2|Participant Withdrew Consent|1|||
164614891|NCT02996110|594611842|FG001|Track 2|Participant Withdrew Consent|2|||
164614892|NCT02996110|594611843|FG002|Track 2|Participant Withdrew Consent|3|||
164614893|NCT02996110|594611844|FG003|Track 2|Participant Withdrew Consent|1|||
164614894|NCT02996110|594611845|FG004|Track 2|Participant Withdrew Consent|1|||
164614895|NCT02996110|594611841|FG000|Track 2|Other Reasons|0|||
164614896|NCT02996110|594611842|FG001|Track 2|Other Reasons|0|||
164614897|NCT02996110|594611843|FG002|Track 2|Other Reasons|1|||
164614898|NCT02996110|594611844|FG003|Track 2|Other Reasons|0|||
164614899|NCT02996110|594611845|FG004|Track 2|Other Reasons|1|||
164614900|NCT02436915|594611846|FG000|Overall Study|Withdrawal by Subject|0|||
164614901|NCT02436915|594611847|FG001|Overall Study|Withdrawal by Subject|1|||
164614902|NCT03805971|594611848|FG000|Overall Study|Withdrawal by Subject|1|||
164614903|NCT03805971|594611848|FG000|Overall Study|Protocol Violation|2|||
164614904|NCT00364832|594611853|FG000|Core Period|Early Withdrawals|2|||
164614905|NCT00364832|594611854|FG001|Core Period|Early Withdrawals|2|||
164614906|NCT00364832|594611855|FG002|Core Period|Early Withdrawals|1|||
164614907|NCT00364832|594611856|FG003|Core Period|Early Withdrawals|1|||
164614908|NCT00364832|594611857|FG004|Core Period|Early Withdrawals|0|||
164614909|NCT00364832|594611858|FG005|Core Period|Early Withdrawals|0|||
164614910|NCT00364832|594611859|FG006|Core Period|Early Withdrawals|4|||
164614911|NCT00364832|594611860|FG007|Core Period|Early Withdrawals|1|||
164614912|NCT00364832|594611861|FG008|Core Period|Early Withdrawals|0|||
164614913|NCT00364832|594611862|FG009|Core Period|Early Withdrawals|0|||
164614914|NCT00364832|594611863|FG010|Core Period|Early Withdrawals|0|||
164614915|NCT00364832|594611864|FG011|Core Period|Early Withdrawals|0|||
164614916|NCT00364832|594611853|FG000|Extension Year 1|Early Withdrawals|0|||
164614917|NCT00364832|594611854|FG001|Extension Year 1|Early Withdrawals|0|||
164614918|NCT00364832|594611855|FG002|Extension Year 1|Early Withdrawals|0|||
164614919|NCT00364832|594611856|FG003|Extension Year 1|Early Withdrawals|0|||
164614920|NCT00364832|594611857|FG004|Extension Year 1|Early Withdrawals|0|||
164614921|NCT00364832|594611858|FG005|Extension Year 1|Early Withdrawals|0|||
164614922|NCT00364832|594611859|FG006|Extension Year 1|Early Withdrawals|0|||
164614923|NCT00364832|594611860|FG007|Extension Year 1|Early Withdrawals|0|||
164614924|NCT00364832|594611861|FG008|Extension Year 1|Early Withdrawals|0|||
164614925|NCT00364832|594611862|FG009|Extension Year 1|Early Withdrawals|4|||
164614926|NCT00364832|594611863|FG010|Extension Year 1|Early Withdrawals|2|||
164614927|NCT00364832|594611864|FG011|Extension Year 1|Early Withdrawals|10|||
164614928|NCT00364832|594611853|FG000|Extension Year 2|Early Withdrawals|0|||
164614929|NCT00364832|594611854|FG001|Extension Year 2|Early Withdrawals|0|||
164614930|NCT00364832|594611855|FG002|Extension Year 2|Early Withdrawals|0|||
164614931|NCT00364832|594611856|FG003|Extension Year 2|Early Withdrawals|0|||
164614932|NCT00364832|594611857|FG004|Extension Year 2|Early Withdrawals|0|||
164614933|NCT00364832|594611858|FG005|Extension Year 2|Early Withdrawals|0|||
164614934|NCT00364832|594611859|FG006|Extension Year 2|Early Withdrawals|0|||
164614935|NCT00364832|594611860|FG007|Extension Year 2|Early Withdrawals|0|||
164614936|NCT00364832|594611861|FG008|Extension Year 2|Early Withdrawals|0|||
164614937|NCT00364832|594611862|FG009|Extension Year 2|Early Withdrawals|5|||
164614938|NCT00364832|594611863|FG010|Extension Year 2|Early Withdrawals|5|||
164614939|NCT00364832|594611864|FG011|Extension Year 2|Early Withdrawals|3|||
164614940|NCT01838213|594611868|FG000|Overall Study|Ineligible|166|||
164614941|NCT01838213|594611869|FG001|Overall Study|Ineligible|191|||
164614942|NCT04882072|594611870|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
164614943|NCT04882072|594611871|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
164614944|NCT04882072|594611870|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
164614945|NCT04882072|594611871|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
164614946|NCT04882072|594611870|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
164614947|NCT04882072|594611871|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
164614948|NCT01548417|594611872|FG000|Overall Study|Withdrawal by Subject|0|||
164614949|NCT01548417|594611873|FG001|Overall Study|Withdrawal by Subject|2|||
164614950|NCT04583969|594611876|FG000|Overall Study|Death|31|||
164614951|NCT04583969|594611877|FG001|Overall Study|Death|38|||
164614952|NCT04583969|594611876|FG000|Overall Study|Lost to Follow-up|16|||
164614953|NCT04583969|594611877|FG001|Overall Study|Lost to Follow-up|13|||
164614954|NCT04583969|594611876|FG000|Overall Study|Protocol Violation|1|||
164614955|NCT04583969|594611877|FG001|Overall Study|Protocol Violation|0|||
164614956|NCT04583969|594611876|FG000|Overall Study|Withdrawal by Subject|3|||
164614957|NCT04583969|594611877|FG001|Overall Study|Withdrawal by Subject|3|||
164614958|NCT04583969|594611876|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
164614959|NCT04583969|594611877|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
164614960|NCT04583969|594611876|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
164614961|NCT04583969|594611877|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
164614962|NCT04583969|594611876|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
164614963|NCT04583969|594611877|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
164614964|NCT04583969|594611876|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
164614965|NCT04583969|594611877|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
164614966|NCT04583969|594611876|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
164614967|NCT04583969|594611877|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
164614968|NCT02939976|594611878|FG000|Overall Study|Lost to Follow-up|7|||
164614969|NCT02939976|594611879|FG001|Overall Study|Lost to Follow-up|1|||
164614970|NCT02939976|594611880|FG002|Overall Study|Lost to Follow-up|1|||
164614971|NCT02939976|594611881|FG003|Overall Study|Lost to Follow-up|2|||
164614972|NCT02939976|594611878|FG000|Overall Study|Withdrawal by Subject|4|||
164614973|NCT02939976|594611879|FG001|Overall Study|Withdrawal by Subject|0|||
164614974|NCT02939976|594611880|FG002|Overall Study|Withdrawal by Subject|2|||
164147375|NCT05168202|592902030|FG006|Overall Study|Adverse Event|0|||
164614975|NCT02939976|594611881|FG003|Overall Study|Withdrawal by Subject|4|||
164614976|NCT02939976|594611878|FG000|Overall Study|Due to early study closure|4|||
164614977|NCT02939976|594611879|FG001|Overall Study|Due to early study closure|3|||
164614978|NCT02939976|594611880|FG002|Overall Study|Due to early study closure|2|||
164614979|NCT02939976|594611881|FG003|Overall Study|Due to early study closure|3|||
164614980|NCT01585168|594611886|FG000|Overall Study|Lost to Follow-up|3|||
164614981|NCT01585168|594611887|FG001|Overall Study|Lost to Follow-up|1|||
164614982|NCT01585168|594611888|FG002|Overall Study|Lost to Follow-up|1|||
164614983|NCT01585168|594611889|FG003|Overall Study|Lost to Follow-up|1|||
164614984|NCT01194414|594611890|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
164614985|NCT01194414|594611891|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
164614986|NCT01194414|594611892|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
164614987|NCT01194414|594611893|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
164614988|NCT01194414|594611890|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
164614989|NCT01194414|594611891|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
164614990|NCT01194414|594611892|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
164614991|NCT01194414|594611893|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
164614992|NCT01194414|594611890|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
164614993|NCT01194414|594611891|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
164614994|NCT01194414|594611892|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
164614995|NCT01194414|594611893|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
164614996|NCT01194414|594611890|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
164614997|NCT01194414|594611891|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
164614998|NCT01194414|594611892|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
164614999|NCT01194414|594611893|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
164615000|NCT01194414|594611890|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
164615001|NCT01194414|594611891|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
164615002|NCT01194414|594611892|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
164615003|NCT01194414|594611893|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
164615004|NCT01194414|594611890|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
164615005|NCT01194414|594611891|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
164615006|NCT01194414|594611892|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
164615007|NCT01194414|594611893|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
164615008|NCT01194414|594611890|FG000|24 Weeks Double Blind Period|Other|0|||
164615009|NCT01194414|594611891|FG001|24 Weeks Double Blind Period|Other|1|||
164615010|NCT01194414|594611892|FG002|24 Weeks Double Blind Period|Other|0|||
164615011|NCT01194414|594611893|FG003|24 Weeks Double Blind Period|Other|0|||
164615012|NCT01194414|594611890|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
164615013|NCT01194414|594611891|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
164615014|NCT01194414|594611892|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
164615015|NCT01194414|594611893|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
164615016|NCT01194414|594611890|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
164615017|NCT01194414|594611891|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
164615018|NCT01194414|594611892|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
164615019|NCT01194414|594611893|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
164615020|NCT01194414|594611890|FG000|24 Weeks Double Blind Period|Death|0|||
164615021|NCT01194414|594611891|FG001|24 Weeks Double Blind Period|Death|1|||
164615022|NCT01194414|594611892|FG002|24 Weeks Double Blind Period|Death|0|||
164615023|NCT01194414|594611893|FG003|24 Weeks Double Blind Period|Death|0|||
164615024|NCT01194414|594611890|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
164615025|NCT01194414|594611891|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
164615026|NCT01194414|594611892|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
164615027|NCT01194414|594611893|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
164615028|NCT01194414|594611890|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
164615029|NCT01194414|594611891|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
164615030|NCT01194414|594611892|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
164615031|NCT01194414|594611893|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
164615032|NCT01194414|594611890|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
164615033|NCT01194414|594611891|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
164615034|NCT01194414|594611892|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
164615035|NCT01194414|594611893|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
164615036|NCT01194414|594611890|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
164615037|NCT01194414|594611891|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
164615038|NCT01194414|594611892|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
164615039|NCT01194414|594611893|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
164615040|NCT01194414|594611890|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
164615041|NCT01194414|594611891|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
164615042|NCT01194414|594611892|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
164615043|NCT01194414|594611893|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
164615044|NCT01194414|594611890|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
164615045|NCT01194414|594611891|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
164615046|NCT01194414|594611892|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
164615047|NCT01194414|594611893|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
164615048|NCT01194414|594611890|FG000|72 Weeks Open Label Extension|Other|2|||
164615049|NCT01194414|594611891|FG001|72 Weeks Open Label Extension|Other|1|||
164615050|NCT01194414|594611892|FG002|72 Weeks Open Label Extension|Other|0|||
164615051|NCT01194414|594611893|FG003|72 Weeks Open Label Extension|Other|0|||
164615052|NCT01194414|594611890|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
164615053|NCT01194414|594611891|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
164615054|NCT01194414|594611892|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
164615055|NCT01194414|594611893|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
164615056|NCT01194414|594611890|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
164615057|NCT01194414|594611891|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
164615058|NCT01194414|594611892|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
164615059|NCT01194414|594611893|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
164615060|NCT01194414|594611890|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
164615061|NCT01194414|594611891|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
164615062|NCT01194414|594611892|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
164517259|NCT03203473|594264133|FG001|Arm Allocation Phase|Physician Decision|0|||
164517260|NCT03203473|594264134|FG002|Arm Allocation Phase|Physician Decision|3|||
164517261|NCT03203473|594264132|FG000|Arm Allocation Phase|Death|0|||
164517262|NCT03203473|594264133|FG001|Arm Allocation Phase|Death|0|||
164517263|NCT03203473|594264134|FG002|Arm Allocation Phase|Death|1|||
164517264|NCT03203473|594264132|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
164517265|NCT03203473|594264133|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
164517266|NCT03203473|594264134|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
164517267|NCT03203473|594264132|FG000|Arm Allocation Phase|Intercurrent illness|0|||
164517268|NCT03203473|594264133|FG001|Arm Allocation Phase|Intercurrent illness|0|||
164517269|NCT03203473|594264134|FG002|Arm Allocation Phase|Intercurrent illness|1|||
164517270|NCT03203473|594264132|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
164517271|NCT03203473|594264133|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
164517272|NCT03203473|594264134|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
164517273|NCT01732822|594264137|FG000|Overall Study|Withdrawal by Subject|123|||
164517274|NCT01732822|594264138|FG001|Overall Study|Withdrawal by Subject|113|||
164517275|NCT02314780|594264139|FG000|Overall Study|organizational reasons|0|||
164517276|NCT02314780|594264140|FG001|Overall Study|organizational reasons|2|||
164517277|NCT02314780|594264141|FG002|Overall Study|organizational reasons|0|||
164517278|NCT02314780|594264139|FG000|Overall Study|Adverse Event|0|||
164517279|NCT02314780|594264140|FG001|Overall Study|Adverse Event|1|||
164517280|NCT02314780|594264141|FG002|Overall Study|Adverse Event|0|||
164517281|NCT01901432|594264142|FG000|Overall Study|Adverse Event|0|||
164517282|NCT01901432|594264143|FG001|Overall Study|Adverse Event|1|||
164517283|NCT01901432|594264144|FG002|Overall Study|Adverse Event|1|||
164517284|NCT01901432|594264145|FG003|Overall Study|Adverse Event|0|||
164517285|NCT01901432|594264146|FG004|Overall Study|Adverse Event|1|||
164517286|NCT01901432|594264142|FG000|Overall Study|Withdrawal by Subject|0|||
164517287|NCT01901432|594264143|FG001|Overall Study|Withdrawal by Subject|0|||
164517288|NCT01901432|594264144|FG002|Overall Study|Withdrawal by Subject|1|||
164517289|NCT01901432|594264145|FG003|Overall Study|Withdrawal by Subject|0|||
164517290|NCT01901432|594264146|FG004|Overall Study|Withdrawal by Subject|5|||
164517291|NCT01901432|594264142|FG000|Overall Study|Physician Decision|0|||
164517292|NCT01901432|594264143|FG001|Overall Study|Physician Decision|0|||
164517293|NCT01901432|594264144|FG002|Overall Study|Physician Decision|0|||
164517294|NCT01901432|594264145|FG003|Overall Study|Physician Decision|0|||
164517295|NCT01901432|594264146|FG004|Overall Study|Physician Decision|2|||
164517296|NCT01901432|594264142|FG000|Overall Study|Patient decision to stop study drug|0|||
164517297|NCT01901432|594264143|FG001|Overall Study|Patient decision to stop study drug|0|||
164517298|NCT01901432|594264144|FG002|Overall Study|Patient decision to stop study drug|0|||
164517299|NCT01901432|594264145|FG003|Overall Study|Patient decision to stop study drug|0|||
164517300|NCT01901432|594264146|FG004|Overall Study|Patient decision to stop study drug|1|||
164517301|NCT01077271|594264152|FG000|Overall Study|Parental desire|8|||
164517302|NCT01077271|594264152|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
164517303|NCT01077271|594264152|FG000|Overall Study|Noncompliance|2|||
164517304|NCT01077271|594264152|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
164517305|NCT01077271|594264152|FG000|Overall Study|Changed doctors|2|||
164517306|NCT01077271|594264152|FG000|Overall Study|Parents thought too many injections|2|||
164517307|NCT01077271|594264152|FG000|Overall Study|End of RSV season nearly reached|1|||
164517308|NCT01077271|594264152|FG000|Overall Study|Mother unconvinced of the necessity|1|||
164517309|NCT00166712|594264153|FG000|Overall Study|Death|0|||
164517310|NCT00166712|594264154|FG001|Overall Study|Death|1|||
164517311|NCT00166712|594264153|FG000|Overall Study|Adverse Event|1|||
164517312|NCT00166712|594264154|FG001|Overall Study|Adverse Event|0|||
164517313|NCT00166712|594264153|FG000|Overall Study|Withdrawal by Subject|1|||
164517314|NCT00166712|594264154|FG001|Overall Study|Withdrawal by Subject|2|||
164517315|NCT00166712|594264153|FG000|Overall Study|Physician Decision|0|||
164517316|NCT00166712|594264154|FG001|Overall Study|Physician Decision|2|||
164517317|NCT04684394|594264155|FG000|Overall Study|Death|1|||
164517318|NCT04684394|594264156|FG001|Overall Study|Death|2|||
164517319|NCT04684394|594264155|FG000|Overall Study|Lost to Follow-up|1|||
164517320|NCT04684394|594264156|FG001|Overall Study|Lost to Follow-up|0|||
164517321|NCT04684394|594264155|FG000|Overall Study|Withdrawal by Subject|2|||
164517322|NCT04684394|594264156|FG001|Overall Study|Withdrawal by Subject|0|||
164517323|NCT04684394|594264155|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
164517324|NCT04684394|594264156|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
164517325|NCT03986944|594264157|FG000|Overall Study|Adverse Event|1|||
164517326|NCT03986944|594264158|FG001|Overall Study|Adverse Event|2|||
164615063|NCT01194414|594611893|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
164615064|NCT01194414|594611890|FG000|72 Weeks Open Label Extension|Death|1|||
164615065|NCT01194414|594611891|FG001|72 Weeks Open Label Extension|Death|2|||
164615066|NCT01194414|594611892|FG002|72 Weeks Open Label Extension|Death|0|||
164615067|NCT01194414|594611893|FG003|72 Weeks Open Label Extension|Death|2|||
164615068|NCT01192100|594611894|FG000|Overall Study|Withdrawal by Subject|0|||
164615069|NCT01192100|594611895|FG001|Overall Study|Withdrawal by Subject|0|||
164615070|NCT01192100|594611896|FG002|Overall Study|Withdrawal by Subject|0|||
164615071|NCT01192100|594611897|FG003|Overall Study|Withdrawal by Subject|0|||
164615072|NCT01192100|594611898|FG004|Overall Study|Withdrawal by Subject|1|||
164615073|NCT01192100|594611899|FG005|Overall Study|Withdrawal by Subject|0|||
164615074|NCT01192100|594611894|FG000|Overall Study|Protocol Violation|0|||
164615075|NCT01192100|594611895|FG001|Overall Study|Protocol Violation|0|||
164615076|NCT01192100|594611896|FG002|Overall Study|Protocol Violation|0|||
164615077|NCT01192100|594611897|FG003|Overall Study|Protocol Violation|1|||
164615078|NCT01192100|594611898|FG004|Overall Study|Protocol Violation|0|||
164615079|NCT01192100|594611899|FG005|Overall Study|Protocol Violation|0|||
164615080|NCT02057068|594611900|FG000|Overall Study|Withdrawal by Subject|2|||
164615081|NCT02057068|594611901|FG001|Overall Study|Withdrawal by Subject|2|||
164615082|NCT02057068|594611900|FG000|Overall Study|Caregiver (CG) Health|0|||
164615083|NCT02057068|594611901|FG001|Overall Study|Caregiver (CG) Health|2|||
164615084|NCT02057068|594611900|FG000|Overall Study|Carepartner (CP) Health|4|||
164615085|NCT02057068|594611901|FG001|Overall Study|Carepartner (CP) Health|2|||
164615086|NCT02057068|594611900|FG000|Overall Study|Lost to Follow-up|2|||
164615087|NCT02057068|594611901|FG001|Overall Study|Lost to Follow-up|2|||
164615088|NCT01098032|594611904|FG000|Overall Study|Withdrawal by Subject|1|||
164615089|NCT01098032|594611905|FG001|Overall Study|Withdrawal by Subject|1|||
164615090|NCT00841672|594611911|FG000|Overall Study|Adverse Event|7|||
164615091|NCT00841672|594611912|FG001|Overall Study|Adverse Event|16|||
164615092|NCT00841672|594611911|FG000|Overall Study|Abnormal test procedure result(s)|0|||
164615093|NCT00841672|594611912|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164615094|NCT00841672|594611911|FG000|Overall Study|Subject withdrew consent|2|||
164615095|NCT00841672|594611912|FG001|Overall Study|Subject withdrew consent|4|||
164615096|NCT00841672|594611911|FG000|Overall Study|Lost to Follow-up|1|||
164615097|NCT00841672|594611912|FG001|Overall Study|Lost to Follow-up|1|||
164615098|NCT00841672|594611911|FG000|Overall Study|Administrative problems|9|||
164615099|NCT00841672|594611912|FG001|Overall Study|Administrative problems|9|||
164615100|NCT00841672|594611911|FG000|Overall Study|Misrandomized|1|||
164615101|NCT00841672|594611912|FG001|Overall Study|Misrandomized|0|||
164615102|NCT00841672|594611911|FG000|Overall Study|Protocol Deviation|0|||
164615103|NCT00841672|594611912|FG001|Overall Study|Protocol Deviation|1|||
164615104|NCT05563714|594611913|FG000|Overall Study|Death|2|||
164615105|NCT05563714|594611914|FG001|Overall Study|Death|2|||
164615106|NCT05563714|594611915|FG002|Overall Study|Death|0|||
164615107|NCT05563714|594611916|FG003|Overall Study|Death|0|||
164615108|NCT05563714|594611913|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
164615109|NCT05563714|594611914|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
164615110|NCT05563714|594611915|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
164615111|NCT05563714|594611916|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
164615112|NCT05563714|594611913|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
164615113|NCT05563714|594611914|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
164615114|NCT05563714|594611915|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
164615115|NCT05563714|594611916|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
164615116|NCT05563714|594611913|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
164615117|NCT05563714|594611914|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
164615118|NCT05563714|594611915|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
164615119|NCT05563714|594611916|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
164615120|NCT05563714|594611913|FG000|Overall Study|Lost to Follow-up|22|||
164615121|NCT05563714|594611914|FG001|Overall Study|Lost to Follow-up|19|||
164615122|NCT05563714|594611915|FG002|Overall Study|Lost to Follow-up|0|||
164615123|NCT05563714|594611916|FG003|Overall Study|Lost to Follow-up|0|||
164615124|NCT00166517|594611920|FG000|Overall Study|Lost to Follow-up|1|||
164615125|NCT00166517|594611921|FG001|Overall Study|Lost to Follow-up|0|||
164615126|NCT00166517|594611920|FG000|Overall Study|Protocol Violation|4|||
164615127|NCT00166517|594611921|FG001|Overall Study|Protocol Violation|1|||
164615128|NCT00166517|594611920|FG000|Overall Study|Withdrawal by Subject|0|||
164615129|NCT00166517|594611921|FG001|Overall Study|Withdrawal by Subject|1|||
164615130|NCT03094611|594611925|FG000|Overall Study|Lack of Efficacy|1|||
164615131|NCT03094611|594611925|FG000|Overall Study|Stem Cell Transplant|1|||
164615132|NCT04285853|594611926|FG000|Overall Study|Withdrawal by Subject|1|||
164615133|NCT04285853|594611927|FG001|Overall Study|Withdrawal by Subject|0|||
164517327|NCT03986944|594264159|FG002|Overall Study|Adverse Event|3|||
164517328|NCT03986944|594264157|FG000|Overall Study|Protocol Violation|0|||
164517329|NCT03986944|594264158|FG001|Overall Study|Protocol Violation|1|||
164517330|NCT03986944|594264159|FG002|Overall Study|Protocol Violation|1|||
164517331|NCT03986944|594264157|FG000|Overall Study|Withdrawal by Subject|3|||
164517332|NCT03986944|594264158|FG001|Overall Study|Withdrawal by Subject|5|||
164517333|NCT03986944|594264159|FG002|Overall Study|Withdrawal by Subject|5|||
164517334|NCT03986944|594264157|FG000|Overall Study|Study termination|10|||
164517335|NCT03986944|594264158|FG001|Overall Study|Study termination|10|||
164517336|NCT03986944|594264159|FG002|Overall Study|Study termination|10|||
164517337|NCT03986944|594264157|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
164517338|NCT03986944|594264158|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
164517339|NCT03986944|594264159|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
164517340|NCT03986944|594264157|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
164517341|NCT03986944|594264158|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
164517342|NCT03986944|594264159|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
164517343|NCT01332630|594264160|FG000|Overall Study|Withdrawal by Subject|3|||
164517344|NCT01008553|594264161|FG000|Period 1 (Titration Period)|Physician Decision|2|||
164517345|NCT01008553|594264162|FG001|Period 1 (Titration Period)|Physician Decision|0|||
164517346|NCT01008553|594264163|FG002|Period 1 (Titration Period)|Physician Decision|0|||
164517347|NCT01008553|594264161|FG000|Period 1 (Titration Period)|Adverse Event|33|||
164517348|NCT01008553|594264162|FG001|Period 1 (Titration Period)|Adverse Event|0|||
164517349|NCT01008553|594264163|FG002|Period 1 (Titration Period)|Adverse Event|0|||
164517350|NCT01008553|594264161|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
164517351|NCT01008553|594264162|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
164517352|NCT01008553|594264163|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
164517353|NCT01008553|594264161|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
164517354|NCT01008553|594264162|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
164517355|NCT01008553|594264163|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
164517356|NCT01008553|594264161|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
164517357|NCT01008553|594264162|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
164517358|NCT01008553|594264163|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
164517359|NCT01008553|594264161|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
164517360|NCT01008553|594264162|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
164517361|NCT01008553|594264163|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
164517362|NCT01008553|594264161|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
164517363|NCT01008553|594264162|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
164517364|NCT01008553|594264163|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
164517365|NCT01008553|594264161|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
164517366|NCT01008553|594264162|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
164517367|NCT01008553|594264163|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
164517368|NCT01008553|594264161|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
164517369|NCT01008553|594264162|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
164517370|NCT01008553|594264163|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
164517371|NCT01008553|594264161|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
164517372|NCT01008553|594264162|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
164517373|NCT01008553|594264163|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
164517374|NCT01008553|594264161|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
164615134|NCT04285853|594611926|FG000|Overall Study|Lost to Follow-up|9|||
164517375|NCT01008553|594264162|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
164517376|NCT01008553|594264163|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
164517377|NCT01008553|594264161|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
164517378|NCT01008553|594264162|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
164517379|NCT01008553|594264163|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
164517380|NCT01008553|594264161|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
164517381|NCT01008553|594264162|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
164517382|NCT01008553|594264163|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
164517383|NCT01008553|594264161|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
164517384|NCT01008553|594264162|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
164517385|NCT01008553|594264163|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
164517386|NCT00581555|594264164|FG000|Overall Study|Adverse Event|4|||
164517387|NCT00581555|594264165|FG001|Overall Study|Adverse Event|3|||
164517388|NCT00581555|594264164|FG000|Overall Study|Physician Decision|3|||
164517389|NCT00581555|594264165|FG001|Overall Study|Physician Decision|2|||
164517390|NCT00581555|594264164|FG000|Overall Study|Withdrawal by Subject|18|||
164517391|NCT00581555|594264165|FG001|Overall Study|Withdrawal by Subject|9|||
164517392|NCT00581555|594264164|FG000|Overall Study|Lost to Follow-up|2|||
164517393|NCT00581555|594264165|FG001|Overall Study|Lost to Follow-up|2|||
164517394|NCT00581555|594264164|FG000|Overall Study|Other reasons|16|||
164517395|NCT00581555|594264165|FG001|Overall Study|Other reasons|4|||
164517396|NCT02530970|594264170|FG000|Overall Study|Adverse Event|8|||
164517397|NCT02530970|594264170|FG000|Overall Study|Lost to Follow-up|88|||
164517398|NCT02530970|594264170|FG000|Overall Study|Physician Decision|5|||
164517399|NCT02530970|594264170|FG000|Overall Study|Withdrawal by Subject|14|||
164517400|NCT02530970|594264170|FG000|Overall Study|Death|6|||
164517401|NCT02530970|594264170|FG000|Overall Study|Hospitalization|1|||
164517402|NCT02530970|594264170|FG000|Overall Study|Insurance|2|||
164517403|NCT02530970|594264170|FG000|Overall Study|Explant|2|||
164517404|NCT02530970|594264170|FG000|Overall Study|Change in Provider|5|||
164517405|NCT02530970|594264170|FG000|Overall Study|Relocation|3|||
164517406|NCT00743431|594264172|FG000|Overall Study|Toxicity|6|||
164517407|NCT00743431|594264172|FG000|Overall Study|Tumor progression|56|||
164517408|NCT00743431|594264172|FG000|Overall Study|Withdrawal by Subject|13|||
164517409|NCT00743431|594264172|FG000|Overall Study|Death|9|||
164517410|NCT00743431|594264172|FG000|Overall Study|Reason for discontinuation not specified|29|||
164517411|NCT00743431|594264172|FG000|Overall Study|No documentation available|13|||
164517412|NCT03291288|594264173|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
164517413|NCT03291288|594264174|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
164517414|NCT03291288|594264173|FG000|Drug-drug Interaction Phase|Disease progression|1|||
164517415|NCT03291288|594264174|FG001|Drug-drug Interaction Phase|Disease progression|0|||
164517416|NCT03291288|594264173|FG000|Drug-drug Interaction Phase|Other|3|||
164517417|NCT03291288|594264174|FG001|Drug-drug Interaction Phase|Other|0|||
164517418|NCT03291288|594264173|FG000|Pexidartinib Only|Ongoing|0|||
164517419|NCT03291288|594264174|FG001|Pexidartinib Only|Ongoing|2|||
164517420|NCT04978493|594264175|FG000|Overall Study|No reason available|0|||
164517421|NCT04978493|594264176|FG001|Overall Study|No reason available|1|||
164517422|NCT04978493|594264175|FG000|Overall Study|Adverse Event|1|||
164517423|NCT04978493|594264176|FG001|Overall Study|Adverse Event|0|||
164517424|NCT01896726|594264177|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
164517425|NCT01896726|594264177|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
164517426|NCT01128114|594264178|FG000|Overall Study|Treatment Withdrawn|6|||
164517427|NCT01128114|594264178|FG000|Overall Study|Screening Failed|2|||
164517428|NCT02387970|594264179|FG000|Overall Study|Did not complete 1-year follow up|1|||
164517429|NCT02387970|594264180|FG001|Overall Study|Did not complete 1-year follow up|2|||
164517430|NCT02628028|594264181|FG000|Dosing Period|Withdrawal by Subject|0|||
164517431|NCT02628028|594264182|FG001|Dosing Period|Withdrawal by Subject|0|||
164517432|NCT02628028|594264183|FG002|Dosing Period|Withdrawal by Subject|1|||
164517433|NCT02628028|594264184|FG003|Dosing Period|Withdrawal by Subject|0|||
164517434|NCT02628028|594264185|FG004|Dosing Period|Withdrawal by Subject|2|||
164517435|NCT02628028|594264186|FG005|Dosing Period|Withdrawal by Subject|4|||
164517436|NCT02628028|594264187|FG006|Dosing Period|Withdrawal by Subject|1|||
164517437|NCT02628028|594264188|FG007|Dosing Period|Withdrawal by Subject|1|||
164517438|NCT02628028|594264181|FG000|Dosing Period|Adverse Event|0|||
164517439|NCT02628028|594264182|FG001|Dosing Period|Adverse Event|0|||
164517440|NCT02628028|594264183|FG002|Dosing Period|Adverse Event|0|||
164517441|NCT02628028|594264184|FG003|Dosing Period|Adverse Event|0|||
164517442|NCT02628028|594264185|FG004|Dosing Period|Adverse Event|2|||
164517443|NCT02628028|594264186|FG005|Dosing Period|Adverse Event|1|||
164517444|NCT02628028|594264187|FG006|Dosing Period|Adverse Event|3|||
164517445|NCT02628028|594264188|FG007|Dosing Period|Adverse Event|2|||
164517446|NCT02628028|594264181|FG000|Dosing Period|Death|0|||
164517447|NCT02628028|594264182|FG001|Dosing Period|Death|0|||
164517448|NCT02628028|594264183|FG002|Dosing Period|Death|0|||
164517449|NCT02628028|594264184|FG003|Dosing Period|Death|0|||
164517450|NCT02628028|594264185|FG004|Dosing Period|Death|0|||
164517451|NCT02628028|594264186|FG005|Dosing Period|Death|0|||
164517452|NCT02628028|594264187|FG006|Dosing Period|Death|0|||
164517453|NCT02628028|594264188|FG007|Dosing Period|Death|1|||
164517454|NCT02628028|594264181|FG000|Dosing Period|Lack of Efficacy|0|||
164517455|NCT02628028|594264182|FG001|Dosing Period|Lack of Efficacy|0|||
164517456|NCT02628028|594264183|FG002|Dosing Period|Lack of Efficacy|0|||
164517457|NCT02628028|594264184|FG003|Dosing Period|Lack of Efficacy|0|||
164517458|NCT02628028|594264185|FG004|Dosing Period|Lack of Efficacy|3|||
164517459|NCT02628028|594264186|FG005|Dosing Period|Lack of Efficacy|0|||
164517460|NCT02628028|594264187|FG006|Dosing Period|Lack of Efficacy|1|||
164517461|NCT02628028|594264188|FG007|Dosing Period|Lack of Efficacy|0|||
164517462|NCT02628028|594264181|FG000|Dosing Period|Study Terminated by Sponsor|0|||
164517463|NCT02628028|594264182|FG001|Dosing Period|Study Terminated by Sponsor|0|||
164517464|NCT02628028|594264183|FG002|Dosing Period|Study Terminated by Sponsor|0|||
164517465|NCT02628028|594264184|FG003|Dosing Period|Study Terminated by Sponsor|0|||
164517466|NCT02628028|594264185|FG004|Dosing Period|Study Terminated by Sponsor|7|||
164517467|NCT02628028|594264186|FG005|Dosing Period|Study Terminated by Sponsor|6|||
164517468|NCT02628028|594264187|FG006|Dosing Period|Study Terminated by Sponsor|7|||
164517469|NCT02628028|594264188|FG007|Dosing Period|Study Terminated by Sponsor|7|||
164517470|NCT02628028|594264181|FG000|Dosing Period|Physician Decision|0|||
164517471|NCT02628028|594264182|FG001|Dosing Period|Physician Decision|0|||
164517472|NCT02628028|594264183|FG002|Dosing Period|Physician Decision|0|||
164517473|NCT02628028|594264184|FG003|Dosing Period|Physician Decision|0|||
164517474|NCT02628028|594264185|FG004|Dosing Period|Physician Decision|0|||
164517475|NCT02628028|594264186|FG005|Dosing Period|Physician Decision|1|||
164517476|NCT02628028|594264187|FG006|Dosing Period|Physician Decision|0|||
164517477|NCT02628028|594264188|FG007|Dosing Period|Physician Decision|0|||
164517478|NCT02628028|594264181|FG000|Dosing Period|Site Terminated by Sponsor|0|||
164517479|NCT02628028|594264182|FG001|Dosing Period|Site Terminated by Sponsor|0|||
164517480|NCT02628028|594264183|FG002|Dosing Period|Site Terminated by Sponsor|0|||
164517481|NCT02628028|594264184|FG003|Dosing Period|Site Terminated by Sponsor|0|||
164517482|NCT02628028|594264185|FG004|Dosing Period|Site Terminated by Sponsor|0|||
164517483|NCT02628028|594264186|FG005|Dosing Period|Site Terminated by Sponsor|1|||
164517484|NCT02628028|594264187|FG006|Dosing Period|Site Terminated by Sponsor|1|||
164517485|NCT02628028|594264188|FG007|Dosing Period|Site Terminated by Sponsor|0|||
164517486|NCT02628028|594264181|FG000|Dosing Period|Lost to Follow-up|0|||
164517487|NCT02628028|594264182|FG001|Dosing Period|Lost to Follow-up|0|||
164517488|NCT02628028|594264183|FG002|Dosing Period|Lost to Follow-up|0|||
164517489|NCT02628028|594264184|FG003|Dosing Period|Lost to Follow-up|0|||
164517490|NCT02628028|594264185|FG004|Dosing Period|Lost to Follow-up|0|||
164517491|NCT02628028|594264186|FG005|Dosing Period|Lost to Follow-up|0|||
164517492|NCT02628028|594264187|FG006|Dosing Period|Lost to Follow-up|1|||
164517493|NCT02628028|594264188|FG007|Dosing Period|Lost to Follow-up|0|||
164517494|NCT02628028|594264181|FG000|Dosing Period|Other|0|||
164517495|NCT02628028|594264182|FG001|Dosing Period|Other|0|||
164517496|NCT02628028|594264183|FG002|Dosing Period|Other|0|||
164517497|NCT02628028|594264184|FG003|Dosing Period|Other|0|||
164517498|NCT02628028|594264185|FG004|Dosing Period|Other|2|||
164517499|NCT02628028|594264186|FG005|Dosing Period|Other|1|||
164517500|NCT02628028|594264187|FG006|Dosing Period|Other|2|||
164517501|NCT02628028|594264188|FG007|Dosing Period|Other|4|||
164517502|NCT02628028|594264181|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
164517503|NCT02628028|594264182|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
164517504|NCT02628028|594264183|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
164517505|NCT02628028|594264184|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
164517506|NCT02628028|594264185|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
164517507|NCT02628028|594264186|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
164517508|NCT02628028|594264187|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
164517509|NCT02628028|594264188|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
164517510|NCT02628028|594264181|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
164517511|NCT02628028|594264182|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
164517512|NCT02628028|594264183|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
164517513|NCT02628028|594264184|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
164517514|NCT02628028|594264185|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
164517515|NCT02628028|594264186|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
164517516|NCT02628028|594264187|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
164517517|NCT02628028|594264188|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
164517518|NCT02628028|594264181|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
164517519|NCT02628028|594264182|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
164517520|NCT02628028|594264183|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
164517521|NCT02628028|594264184|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
164517522|NCT02628028|594264185|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
164517523|NCT02628028|594264186|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
164517524|NCT02628028|594264187|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
164517525|NCT02628028|594264188|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
164517526|NCT02628028|594264181|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
164517527|NCT02628028|594264182|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
164517528|NCT02628028|594264183|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
164517529|NCT02628028|594264184|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
164517530|NCT02628028|594264185|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
164517531|NCT02628028|594264186|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
164517532|NCT02628028|594264187|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
164517533|NCT02628028|594264188|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
164517534|NCT02628028|594264181|FG000|Long-term Extension (LTE) Period|Other|0|||
164517535|NCT02628028|594264182|FG001|Long-term Extension (LTE) Period|Other|0|||
164517536|NCT02628028|594264183|FG002|Long-term Extension (LTE) Period|Other|0|||
164517537|NCT02628028|594264184|FG003|Long-term Extension (LTE) Period|Other|0|||
164517538|NCT02628028|594264185|FG004|Long-term Extension (LTE) Period|Other|0|||
164517539|NCT02628028|594264186|FG005|Long-term Extension (LTE) Period|Other|3|||
164517540|NCT02628028|594264187|FG006|Long-term Extension (LTE) Period|Other|4|||
164517541|NCT02628028|594264188|FG007|Long-term Extension (LTE) Period|Other|3|||
164517542|NCT00586612|594264189|FG000|Primary Phase|Protocol Violation|1|||
164517543|NCT00586612|594264190|FG001|Primary Phase|Protocol Violation|0|||
164517544|NCT00586612|594264189|FG000|Primary Phase|Lost to Follow-up|0|||
164517545|NCT00586612|594264190|FG001|Primary Phase|Lost to Follow-up|1|||
164517546|NCT00586612|594264189|FG000|Primary Phase|Withdrawal by Subject|0|||
164517547|NCT00586612|594264190|FG001|Primary Phase|Withdrawal by Subject|2|||
164517548|NCT00586612|594264189|FG000|Booster Phase|Lost to Follow-up|3|||
164517549|NCT00586612|594264190|FG001|Booster Phase|Lost to Follow-up|1|||
164517550|NCT00186888|594264195|FG000|Overall Study|Toxicity|0|||
164517551|NCT00186888|594264196|FG001|Overall Study|Toxicity|1|||
164517552|NCT00186888|594264197|FG002|Overall Study|Toxicity|0|||
164517553|NCT00186888|594264195|FG000|Overall Study|Relapse or progression of disease|4|||
164517554|NCT00186888|594264196|FG001|Overall Study|Relapse or progression of disease|2|||
164517555|NCT00186888|594264197|FG002|Overall Study|Relapse or progression of disease|0|||
164517556|NCT05511038|594264198|FG000|Overall|Withdrawal by Subject|5|||
164517557|NCT05511038|594264199|FG001|Overall|Withdrawal by Subject|3|||
164517558|NCT05511038|594264198|FG000|Overall|Screen Failure|20|||
164517559|NCT05511038|594264199|FG001|Overall|Screen Failure|1|||
164517560|NCT05511038|594264198|FG000|Overall|Physician Decision|3|||
164517561|NCT05511038|594264199|FG001|Overall|Physician Decision|0|||
164517562|NCT05511038|594264198|FG000|Overall|Lost to Follow-up|3|||
164517563|NCT05511038|594264199|FG001|Overall|Lost to Follow-up|0|||
164517564|NCT05511038|594264198|FG000|Overall|Death|1|||
164517565|NCT05511038|594264199|FG001|Overall|Death|0|||
164517566|NCT05511038|594264198|FG000|Screening|Withdrawal by Subject|1|||
164517567|NCT05511038|594264199|FG001|Screening|Withdrawal by Subject|0|||
164517568|NCT05511038|594264198|FG000|Screening|Lost to Follow Up (1 participant)|1|||
164517569|NCT05511038|594264199|FG001|Screening|Lost to Follow Up (1 participant)|0|||
164517570|NCT05511038|594264198|FG000|Screening|Screen Failure|3|||
164517571|NCT05511038|594264199|FG001|Screening|Screen Failure|0|||
164517572|NCT05511038|594264198|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
164517573|NCT05511038|594264199|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
164517574|NCT05511038|594264198|FG000|Treatment|Withdrawal by Subject|5|||
164517575|NCT05511038|594264199|FG001|Treatment|Withdrawal by Subject|3|||
164517576|NCT05511038|594264198|FG000|Treatment|Physician Decision|4|||
164517577|NCT05511038|594264199|FG001|Treatment|Physician Decision|0|||
164517578|NCT05511038|594264198|FG000|Treatment|Lost to Follow-up|2|||
164517579|NCT05511038|594264199|FG001|Treatment|Lost to Follow-up|0|||
164517580|NCT05511038|594264198|FG000|Treatment|Death|1|||
164517581|NCT05511038|594264199|FG001|Treatment|Death|0|||
164517582|NCT05511038|594264198|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
164517583|NCT05511038|594264199|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
164517584|NCT05511038|594264198|FG000|Treatment|Refuse by subject|1|||
164517585|NCT05511038|594264199|FG001|Treatment|Refuse by subject|0|||
164517586|NCT05511038|594264198|FG000|Treatment|Subject did not go to the site for visit|1|||
164517587|NCT05511038|594264199|FG001|Treatment|Subject did not go to the site for visit|0|||
164517588|NCT02108964|594264200|FG000|Overall Study|Progressive disease|15|||
164517589|NCT02108964|594264201|FG001|Overall Study|Progressive disease|31|||
164517590|NCT02108964|594264202|FG002|Overall Study|Progressive disease|54|||
164517591|NCT02108964|594264203|FG003|Overall Study|Progressive disease|7|||
164517592|NCT02108964|594264204|FG004|Overall Study|Progressive disease|20|||
164517593|NCT02108964|594264205|FG005|Overall Study|Progressive disease|4|||
164517594|NCT02108964|594264206|FG006|Overall Study|Progressive disease|6|||
164517595|NCT02108964|594264207|FG007|Overall Study|Progressive disease|33|||
164517596|NCT02108964|594264200|FG000|Overall Study|Physician Decision|1|||
164517597|NCT02108964|594264201|FG001|Overall Study|Physician Decision|5|||
164517598|NCT02108964|594264202|FG002|Overall Study|Physician Decision|7|||
164517599|NCT02108964|594264203|FG003|Overall Study|Physician Decision|1|||
164517600|NCT02108964|594264204|FG004|Overall Study|Physician Decision|2|||
164517601|NCT02108964|594264205|FG005|Overall Study|Physician Decision|1|||
164517602|NCT02108964|594264206|FG006|Overall Study|Physician Decision|1|||
164517603|NCT02108964|594264207|FG007|Overall Study|Physician Decision|3|||
164517604|NCT02108964|594264200|FG000|Overall Study|Adverse Event|0|||
164517605|NCT02108964|594264201|FG001|Overall Study|Adverse Event|0|||
164517606|NCT02108964|594264202|FG002|Overall Study|Adverse Event|4|||
164517607|NCT02108964|594264203|FG003|Overall Study|Adverse Event|0|||
164517608|NCT02108964|594264204|FG004|Overall Study|Adverse Event|1|||
164517609|NCT02108964|594264205|FG005|Overall Study|Adverse Event|0|||
164517610|NCT02108964|594264206|FG006|Overall Study|Adverse Event|3|||
164517611|NCT02108964|594264207|FG007|Overall Study|Adverse Event|2|||
164517612|NCT02108964|594264200|FG000|Overall Study|Death|1|||
164517613|NCT02108964|594264201|FG001|Overall Study|Death|1|||
164517614|NCT02108964|594264202|FG002|Overall Study|Death|4|||
164517615|NCT02108964|594264203|FG003|Overall Study|Death|0|||
164517616|NCT02108964|594264204|FG004|Overall Study|Death|3|||
164517617|NCT02108964|594264205|FG005|Overall Study|Death|0|||
164517618|NCT02108964|594264206|FG006|Overall Study|Death|0|||
164517619|NCT02108964|594264207|FG007|Overall Study|Death|2|||
164517620|NCT02108964|594264200|FG000|Overall Study|Subject/Guardian decision|0|||
164517621|NCT02108964|594264201|FG001|Overall Study|Subject/Guardian decision|1|||
164517622|NCT02108964|594264202|FG002|Overall Study|Subject/Guardian decision|4|||
164517623|NCT02108964|594264203|FG003|Overall Study|Subject/Guardian decision|0|||
164517624|NCT02108964|594264204|FG004|Overall Study|Subject/Guardian decision|2|||
164517625|NCT02108964|594264205|FG005|Overall Study|Subject/Guardian decision|0|||
164517626|NCT02108964|594264206|FG006|Overall Study|Subject/Guardian decision|1|||
164147376|NCT05168202|592902024|FG000|Overall Study|Lack of Efficacy|0|||
164517627|NCT02108964|594264207|FG007|Overall Study|Subject/Guardian decision|2|||
164517628|NCT02108964|594264200|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
164517629|NCT02108964|594264201|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
164517630|NCT02108964|594264202|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
164517631|NCT02108964|594264203|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
164517632|NCT02108964|594264204|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
164517633|NCT02108964|594264205|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
164517634|NCT02108964|594264206|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
164517635|NCT02108964|594264207|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
164517636|NCT03086655|594264210|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
164517637|NCT03086655|594264211|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
164517638|NCT03086655|594264210|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
164517639|NCT03086655|594264211|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
164517640|NCT03086655|594264210|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
164517641|NCT03086655|594264211|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
164517642|NCT03086655|594264210|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
164517643|NCT03086655|594264211|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
164517644|NCT03086655|594264210|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
164517645|NCT03086655|594264211|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
164517646|NCT03086655|594264210|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
164517647|NCT03086655|594264211|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
164517648|NCT03086655|594264210|FG000|12 Month Follow-up = Final Assessment|Death|0|||
164517649|NCT03086655|594264211|FG001|12 Month Follow-up = Final Assessment|Death|1|||
164517650|NCT04908631|594264212|FG000|Overall Study|Lost to Follow-up|1|||
164517651|NCT04908631|594264212|FG000|Overall Study|Physician Decision|1|||
164517652|NCT04908631|594264212|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
164517653|NCT00384397|594264213|FG000|Overall Study|Adverse Event|0|||
164517654|NCT00384397|594264214|FG001|Overall Study|Adverse Event|1|||
164517655|NCT00384397|594264215|FG002|Overall Study|Adverse Event|2|||
164517656|NCT00384397|594264213|FG000|Overall Study|Protocol Violation|7|||
164517657|NCT00384397|594264214|FG001|Overall Study|Protocol Violation|15|||
164517658|NCT00384397|594264215|FG002|Overall Study|Protocol Violation|13|||
164517659|NCT00384397|594264213|FG000|Overall Study|Lost to Follow-up|11|||
164517660|NCT00384397|594264214|FG001|Overall Study|Lost to Follow-up|13|||
164517661|NCT00384397|594264215|FG002|Overall Study|Lost to Follow-up|3|||
164517662|NCT00384397|594264213|FG000|Overall Study|Withdrawal by Subject|14|||
164517663|NCT00384397|594264214|FG001|Overall Study|Withdrawal by Subject|17|||
164517664|NCT00384397|594264215|FG002|Overall Study|Withdrawal by Subject|15|||
164517665|NCT04531982|594264216|FG000|Overall Study|Withdrawal by Subject|10|||
164517666|NCT04531982|594264217|FG001|Overall Study|Withdrawal by Subject|11|||
164517667|NCT04531982|594264216|FG000|Overall Study|Adverse Event|6|||
164517668|NCT04531982|594264217|FG001|Overall Study|Adverse Event|14|||
164517669|NCT04531982|594264216|FG000|Overall Study|Protocol Violation|6|||
164517670|NCT04531982|594264217|FG001|Overall Study|Protocol Violation|9|||
164517671|NCT04531982|594264216|FG000|Overall Study|Non-compliance with study drug|3|||
164517672|NCT04531982|594264217|FG001|Overall Study|Non-compliance with study drug|2|||
164615135|NCT04285853|594611927|FG001|Overall Study|Lost to Follow-up|5|||
164517673|NCT04531982|594264216|FG000|Overall Study|Use of prohibited medication|2|||
164517674|NCT04531982|594264217|FG001|Overall Study|Use of prohibited medication|0|||
164517675|NCT04531982|594264216|FG000|Overall Study|Lost to Follow-up|0|||
164517676|NCT04531982|594264217|FG001|Overall Study|Lost to Follow-up|1|||
164517677|NCT04531982|594264216|FG000|Overall Study|Geopolitical conflict|2|||
164517678|NCT04531982|594264217|FG001|Overall Study|Geopolitical conflict|0|||
164517679|NCT04531982|594264216|FG000|Overall Study|Lack of Efficacy|3|||
164615136|NCT01072448|594611928|FG000|Overall Study|Adverse Event|9|||
164615137|NCT01072448|594611929|FG001|Overall Study|Adverse Event|10|||
164615138|NCT01072448|594611928|FG000|Overall Study|Subject withdrew consent|4|||
164615139|NCT01072448|594611929|FG001|Overall Study|Subject withdrew consent|9|||
164615140|NCT01072448|594611928|FG000|Overall Study|Protocol deviation|3|||
164615141|NCT01072448|594611929|FG001|Overall Study|Protocol deviation|4|||
164615142|NCT01072448|594611928|FG000|Overall Study|Abnormal test procedure result(s)|1|||
164615143|NCT01072448|594611929|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164615144|NCT01072448|594611928|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164615145|NCT01072448|594611929|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
164615146|NCT01072448|594611928|FG000|Overall Study|Lost to Follow-up|1|||
164615147|NCT01072448|594611929|FG001|Overall Study|Lost to Follow-up|1|||
164615148|NCT01072448|594611928|FG000|Overall Study|Abnormal laboratory value(s)|0|||
164615149|NCT01072448|594611929|FG001|Overall Study|Abnormal laboratory value(s)|1|||
164615150|NCT01072448|594611928|FG000|Overall Study|Death|0|||
164615151|NCT01072448|594611929|FG001|Overall Study|Death|2|||
164615152|NCT00249795|594611931|FG000|Overall Study|Not treated|16|||
164615153|NCT00249795|594611932|FG001|Overall Study|Not treated|14|||
164615154|NCT00249795|594611931|FG000|Overall Study|Symptomatic hypotension|127|||
164615155|NCT00249795|594611932|FG001|Overall Study|Symptomatic hypotension|64|||
164615156|NCT00249795|594611931|FG000|Overall Study|Other Serious Adverse Event|84|||
164615157|NCT00249795|594611932|FG001|Overall Study|Other Serious Adverse Event|93|||
164615158|NCT00249795|594611931|FG000|Overall Study|Qualifying condition not present|26|||
164615159|NCT00249795|594611932|FG001|Overall Study|Qualifying condition not present|29|||
164615160|NCT00249795|594611931|FG000|Overall Study|Withdrawal by Subject|678|||
164615161|NCT00249795|594611932|FG001|Overall Study|Withdrawal by Subject|742|||
164615162|NCT00249795|594611931|FG000|Overall Study|Thromboembolic / outcome event|39|||
164615163|NCT00249795|594611932|FG001|Overall Study|Thromboembolic / outcome event|45|||
164615164|NCT00249795|594611931|FG000|Overall Study|Oral anticoagulant required|2|||
164615165|NCT00249795|594611932|FG001|Overall Study|Oral anticoagulant required|0|||
164615166|NCT00249795|594611931|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
164615167|NCT00249795|594611932|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
164615168|NCT00249795|594611931|FG000|Overall Study|Non-compliance|71|||
164615169|NCT00249795|594611932|FG001|Overall Study|Non-compliance|69|||
164615170|NCT00249795|594611931|FG000|Overall Study|Study drug intolerance|3|||
164615171|NCT00249795|594611932|FG001|Overall Study|Study drug intolerance|3|||
164615172|NCT00249795|594611931|FG000|Overall Study|Other adverse events (non-serious)|188|||
164615173|NCT00249795|594611932|FG001|Overall Study|Other adverse events (non-serious)|159|||
164615174|NCT00249795|594611931|FG000|Overall Study|Physician withdrew consent|71|||
164615175|NCT00249795|594611932|FG001|Overall Study|Physician withdrew consent|63|||
164615176|NCT00249795|594611931|FG000|Overall Study|Surgery / procedure|4|||
164615177|NCT00249795|594611932|FG001|Overall Study|Surgery / procedure|5|||
164615178|NCT00249795|594611931|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
164615179|NCT00249795|594611932|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
164615180|NCT00249795|594611931|FG000|Overall Study|Lightheadedness / dizziness|15|||
164615181|NCT00249795|594611932|FG001|Overall Study|Lightheadedness / dizziness|11|||
164615182|NCT00249795|594611931|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
164615183|NCT00249795|594611932|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
164615184|NCT00249795|594611931|FG000|Overall Study|Other contraindicated medication|1|||
164615185|NCT00249795|594611932|FG001|Overall Study|Other contraindicated medication|1|||
164517680|NCT04531982|594264217|FG001|Overall Study|Lack of Efficacy|1|||
164615186|NCT00249795|594611931|FG000|Overall Study|Event related to cardiac condition|17|||
164615187|NCT00249795|594611932|FG001|Overall Study|Event related to cardiac condition|16|||
164615188|NCT00249795|594611931|FG000|Overall Study|Patient not wish to continue after May08|4|||
164615189|NCT00249795|594611932|FG001|Overall Study|Patient not wish to continue after May08|6|||
164615190|NCT00249795|594611931|FG000|Overall Study|Site not agree to continue after May08|1|||
164615191|NCT00249795|594611932|FG001|Overall Study|Site not agree to continue after May08|1|||
164615192|NCT00249795|594611931|FG000|Overall Study|Lost to Follow-up|0|||
164615193|NCT00249795|594611932|FG001|Overall Study|Lost to Follow-up|2|||
164615194|NCT00249795|594611931|FG000|Overall Study|Missing|0|||
164615195|NCT00249795|594611932|FG001|Overall Study|Missing|1|||
164615196|NCT00196196|594611936|FG000|Overall Study|Withdrawal by Subject|2|||
164615197|NCT00196196|594611936|FG000|Overall Study|Did not have required condition (hydroce|5|||
164615198|NCT01814826|594611939|FG000|Overall Study|Other|3|||
164615199|NCT01814826|594611940|FG001|Overall Study|Other|5|||
164615200|NCT01814826|594611941|FG002|Overall Study|Other|0|||
164615201|NCT01814826|594611939|FG000|Overall Study|Death|29|||
164615202|NCT01814826|594611940|FG001|Overall Study|Death|24|||
164615203|NCT01814826|594611941|FG002|Overall Study|Death|3|||
164615204|NCT02917629|594611942|FG000|Overall Study|Withdrawal by Subject|0|||
164615205|NCT02917629|594611943|FG001|Overall Study|Withdrawal by Subject|1|||
164615206|NCT03271307|594611944|FG000|Overall Study|Lost to Follow-up|0|||
164615207|NCT03271307|594611945|FG001|Overall Study|Lost to Follow-up|0|||
164615208|NCT03271307|594611946|FG002|Overall Study|Lost to Follow-up|0|||
164615209|NCT03271307|594611947|FG003|Overall Study|Lost to Follow-up|28|||
164615210|NCT03271307|594611948|FG004|Overall Study|Lost to Follow-up|91|||
164147377|NCT05168202|592902025|FG001|Overall Study|Lack of Efficacy|1|||
164615211|NCT01042938|594611949|FG000|Overall Study|Withdrawal by Subject|1|||
164615212|NCT01042938|594611950|FG001|Overall Study|Withdrawal by Subject|1|||
164615213|NCT01042938|594611949|FG000|Overall Study|Protocol Violation|1|||
164615214|NCT01042938|594611950|FG001|Overall Study|Protocol Violation|1|||
164615215|NCT01042938|594611949|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
164615216|NCT01042938|594611950|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
164615217|NCT03136484|594611951|FG000|Overall Study|Withdrawal by Subject|19|||
164615218|NCT03136484|594611952|FG001|Overall Study|Withdrawal by Subject|14|||
164615219|NCT03136484|594611951|FG000|Overall Study|Lost to Follow-up|7|||
164615220|NCT03136484|594611952|FG001|Overall Study|Lost to Follow-up|8|||
164615221|NCT03136484|594611951|FG000|Overall Study|Death|1|||
164615222|NCT03136484|594611952|FG001|Overall Study|Death|0|||
164615223|NCT03032510|594611955|FG000|Overall Study|Adverse Event|5|||
164615224|NCT03032510|594611956|FG001|Overall Study|Adverse Event|2|||
164615225|NCT03032510|594611955|FG000|Overall Study|Lost to Follow-up|8|||
164615226|NCT03032510|594611956|FG001|Overall Study|Lost to Follow-up|7|||
164615227|NCT03032510|594611955|FG000|Overall Study|Withdrawal by Subject|8|||
164615228|NCT03032510|594611956|FG001|Overall Study|Withdrawal by Subject|7|||
164615229|NCT03032510|594611955|FG000|Overall Study|Subject noncompliance|4|||
164615230|NCT03032510|594611956|FG001|Overall Study|Subject noncompliance|2|||
164615231|NCT03032510|594611955|FG000|Overall Study|Physician Decision|2|||
164615232|NCT03032510|594611956|FG001|Overall Study|Physician Decision|0|||
164615233|NCT01570309|594611961|FG000|Overall Study|Withdrawal by Subject|3|||
164615234|NCT01570309|594611962|FG001|Overall Study|Withdrawal by Subject|3|||
164615235|NCT05200455|594611963|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
164615236|NCT00892957|594611965|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
164615237|NCT00892957|594611966|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
164615238|NCT00892957|594611965|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
164615239|NCT00892957|594611966|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
164615240|NCT02091921|594611967|FG000|Overall Study|Adverse Event|3|||
164615241|NCT02483078|594611968|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
164615242|NCT02483078|594611969|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
164615243|NCT02483078|594611968|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
164615244|NCT02483078|594611969|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
164615245|NCT02483078|594611968|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
164615246|NCT02483078|594611969|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
164615247|NCT02483078|594611968|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
164615248|NCT02483078|594611969|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
164615249|NCT02483078|594611968|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
164615250|NCT02483078|594611969|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
164615251|NCT02483078|594611968|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
164615252|NCT02483078|594611969|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
164615253|NCT04876599|594611970|FG000|Overall Study|Missed|2|||
164615254|NCT04876599|594611971|FG001|Overall Study|Missed|0|||
164615255|NCT04876599|594611970|FG000|Overall Study|Declined|2|||
164615256|NCT04876599|594611971|FG001|Overall Study|Declined|3|||
164615257|NCT00669032|594611976|FG000|Overall Study|Lost to Follow-up|6|||
164615258|NCT00669032|594611977|FG001|Overall Study|Lost to Follow-up|5|||
164615259|NCT00669032|594611976|FG000|Overall Study|Lack of Efficacy|8|||
164615260|NCT00669032|594611977|FG001|Overall Study|Lack of Efficacy|19|||
164615261|NCT00669032|594611976|FG000|Overall Study|Withdrawal by Subject|12|||
164615262|NCT00669032|594611977|FG001|Overall Study|Withdrawal by Subject|13|||
164615263|NCT00669032|594611976|FG000|Overall Study|Adverse Event|12|||
164615264|NCT00669032|594611977|FG001|Overall Study|Adverse Event|16|||
164615265|NCT00669032|594611976|FG000|Overall Study|Physician Decision|1|||
164615266|NCT00669032|594611977|FG001|Overall Study|Physician Decision|1|||
164615267|NCT00669032|594611976|FG000|Overall Study|No fulfilment of the selection criteria|5|||
164615268|NCT00669032|594611977|FG001|Overall Study|No fulfilment of the selection criteria|5|||
164615269|NCT01607073|594611978|FG000|Overall Study|Adverse Event|1|||
164615270|NCT04126031|594611980|FG000|Part A|Withdrawal by Subject|0|||
164615271|NCT04126031|594611981|FG001|Part A|Withdrawal by Subject|0|||
164615272|NCT04126031|594611982|FG002|Part A|Withdrawal by Subject|1|||
164615273|NCT04126031|594611983|FG003|Part A|Withdrawal by Subject|0|||
164615274|NCT04126031|594611984|FG004|Part A|Withdrawal by Subject|0|||
164615275|NCT04126031|594611985|FG005|Part A|Withdrawal by Subject|0|||
164615276|NCT04126031|594611980|FG000|Part A|Other|1|||
164615277|NCT04126031|594611981|FG001|Part A|Other|0|||
164615278|NCT04126031|594611982|FG002|Part A|Other|0|||
164615279|NCT04126031|594611983|FG003|Part A|Other|0|||
164615280|NCT04126031|594611984|FG004|Part A|Other|0|||
164615281|NCT04126031|594611985|FG005|Part A|Other|0|||
164615282|NCT04126031|594611980|FG000|Part B|Adverse Event|0|||
164615283|NCT04126031|594611981|FG001|Part B|Adverse Event|0|||
164615284|NCT04126031|594611982|FG002|Part B|Adverse Event|0|||
164615285|NCT04126031|594611983|FG003|Part B|Adverse Event|0|||
164615286|NCT04126031|594611984|FG004|Part B|Adverse Event|0|||
164615287|NCT04126031|594611985|FG005|Part B|Adverse Event|2|||
164615288|NCT04126031|594611980|FG000|Part B|Pre-existing hypertransaminasemia|0|||
164615289|NCT04126031|594611981|FG001|Part B|Pre-existing hypertransaminasemia|0|||
164615290|NCT04126031|594611982|FG002|Part B|Pre-existing hypertransaminasemia|0|||
164615291|NCT04126031|594611983|FG003|Part B|Pre-existing hypertransaminasemia|0|||
164615292|NCT04126031|594611984|FG004|Part B|Pre-existing hypertransaminasemia|1|||
164615293|NCT04126031|594611985|FG005|Part B|Pre-existing hypertransaminasemia|0|||
164615294|NCT00131664|594611986|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
164615295|NCT00131664|594611987|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
164615296|NCT00131664|594611988|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
164615297|NCT00131664|594611989|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
164615298|NCT00131664|594611990|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
164615299|NCT00131664|594611991|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
164615300|NCT00131664|594611986|FG000|First Period (First 6 Months)|Death|0|||
164615301|NCT00131664|594611987|FG001|First Period (First 6 Months)|Death|1|||
164615302|NCT00131664|594611988|FG002|First Period (First 6 Months)|Death|0|||
164615303|NCT00131664|594611989|FG003|First Period (First 6 Months)|Death|0|||
164615304|NCT00131664|594611990|FG004|First Period (First 6 Months)|Death|0|||
164615305|NCT00131664|594611991|FG005|First Period (First 6 Months)|Death|0|||
164615306|NCT00131664|594611986|FG000|First Period (First 6 Months)|Protocol Violation|2|||
164615307|NCT00131664|594611987|FG001|First Period (First 6 Months)|Protocol Violation|2|||
164615308|NCT00131664|594611988|FG002|First Period (First 6 Months)|Protocol Violation|1|||
164615309|NCT00131664|594611989|FG003|First Period (First 6 Months)|Protocol Violation|0|||
164615310|NCT00131664|594611990|FG004|First Period (First 6 Months)|Protocol Violation|0|||
164615311|NCT00131664|594611991|FG005|First Period (First 6 Months)|Protocol Violation|0|||
164615312|NCT00131664|594611986|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
164615313|NCT00131664|594611987|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
164615314|NCT00131664|594611988|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
164615315|NCT00131664|594611989|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
164615316|NCT00131664|594611990|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
164615317|NCT00131664|594611991|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
164615318|NCT00131664|594611986|FG000|First Period (First 6 Months)|Adverse Event|9|||
164615319|NCT00131664|594611987|FG001|First Period (First 6 Months)|Adverse Event|4|||
164615320|NCT00131664|594611988|FG002|First Period (First 6 Months)|Adverse Event|5|||
164615321|NCT00131664|594611989|FG003|First Period (First 6 Months)|Adverse Event|0|||
164615322|NCT00131664|594611990|FG004|First Period (First 6 Months)|Adverse Event|0|||
164615323|NCT00131664|594611991|FG005|First Period (First 6 Months)|Adverse Event|0|||
164615324|NCT00131664|594611986|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
164615325|NCT00131664|594611987|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
164615326|NCT00131664|594611988|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
164615327|NCT00131664|594611989|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
164615328|NCT00131664|594611990|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
164615329|NCT00131664|594611991|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
164615330|NCT00131664|594611986|FG000|First Period (First 6 Months)|Administrative reasons|2|||
164615331|NCT00131664|594611987|FG001|First Period (First 6 Months)|Administrative reasons|0|||
164615332|NCT00131664|594611988|FG002|First Period (First 6 Months)|Administrative reasons|5|||
164615333|NCT00131664|594611989|FG003|First Period (First 6 Months)|Administrative reasons|0|||
164615334|NCT00131664|594611990|FG004|First Period (First 6 Months)|Administrative reasons|0|||
164615335|NCT00131664|594611991|FG005|First Period (First 6 Months)|Administrative reasons|0|||
164615336|NCT00131664|594611986|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
164615337|NCT00131664|594611987|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
164615338|NCT00131664|594611988|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
164517681|NCT06655558|594264218|FG000|Overall Study|Protocol Violation|1|||
164517682|NCT04998812|594264221|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
164517683|NCT04998812|594264222|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
164517684|NCT04998812|594264221|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
164517685|NCT04998812|594264222|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
164517686|NCT04998812|594264221|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
164517687|NCT04998812|594264222|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
164615339|NCT00131664|594611989|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
164615340|NCT00131664|594611990|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
164615341|NCT00131664|594611991|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
164615342|NCT00131664|594611986|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
164615343|NCT00131664|594611987|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
164615344|NCT00131664|594611988|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
164615345|NCT00131664|594611989|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
164517688|NCT04998812|594264221|FG000|Vaccination Period|Ongoing in study|23|||
164517689|NCT04998812|594264222|FG001|Vaccination Period|Ongoing in study|23|||
164517690|NCT03524092|594264228|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
164517691|NCT03524092|594264229|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
164517692|NCT03524092|594264230|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
164517693|NCT03524092|594264231|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
164517694|NCT03524092|594264232|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
164517695|NCT03524092|594264233|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
164517696|NCT03524092|594264228|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
164517697|NCT03524092|594264229|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
164517698|NCT03524092|594264230|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
164517699|NCT03524092|594264231|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
164517700|NCT03524092|594264232|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
164517701|NCT03524092|594264233|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
164517702|NCT03524092|594264228|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
164517703|NCT03524092|594264229|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
164517704|NCT03524092|594264230|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
164517705|NCT03524092|594264231|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
164517706|NCT03524092|594264232|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
164517707|NCT03524092|594264233|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
164517708|NCT03524092|594264228|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
164517709|NCT03524092|594264229|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
164517710|NCT03524092|594264230|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
164517711|NCT03524092|594264231|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
164517712|NCT03524092|594264232|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
164517713|NCT03524092|594264233|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
164517714|NCT03524092|594264228|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
164517715|NCT03524092|594264229|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
164517716|NCT03524092|594264230|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
164517717|NCT03524092|594264231|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
164517718|NCT03524092|594264232|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
164517719|NCT03524092|594264233|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
164517720|NCT03524092|594264228|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
164517721|NCT03524092|594264229|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
164517722|NCT03524092|594264230|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
164517723|NCT03524092|594264231|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
164517724|NCT03524092|594264232|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
164517725|NCT03524092|594264233|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
164517726|NCT03524092|594264228|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
164517727|NCT03524092|594264229|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
164517728|NCT03524092|594264230|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
164517729|NCT03524092|594264231|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
164517730|NCT03524092|594264232|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
164517731|NCT03524092|594264233|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
164517732|NCT03524092|594264228|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
164517733|NCT03524092|594264229|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
164517734|NCT03524092|594264230|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
164517735|NCT03524092|594264231|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
164615346|NCT00131664|594611990|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
164615347|NCT00131664|594611991|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
164615348|NCT00131664|594611986|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
164615349|NCT00131664|594611987|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
164615350|NCT00131664|594611988|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
164615351|NCT00131664|594611989|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
164615352|NCT00131664|594611990|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
164615353|NCT00131664|594611991|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
164615354|NCT00131664|594611986|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
164615355|NCT00131664|594611987|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
164615356|NCT00131664|594611988|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
164615357|NCT00131664|594611989|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
164615358|NCT00131664|594611990|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
164615359|NCT00131664|594611991|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
164615360|NCT00131664|594611986|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
164615361|NCT00131664|594611987|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
164615362|NCT00131664|594611988|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
164615363|NCT00131664|594611989|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
164615364|NCT00131664|594611990|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
164615365|NCT00131664|594611991|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
164615366|NCT00131664|594611986|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
164615367|NCT00131664|594611987|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
164615368|NCT00131664|594611988|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
164615369|NCT00131664|594611989|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
164615370|NCT00131664|594611990|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
164615371|NCT00131664|594611991|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
164615372|NCT04483544|594613637|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
164615373|NCT04483544|594613637|FG000|Post-Treatment|Admitted to hospice|2|||
164615374|NCT04483544|594613637|FG000|Post-Treatment|Study terminated|3|||
164615375|NCT01131078|594613638|FG000|Overall Study|Adverse Event|22|||
164615376|NCT01131078|594613639|FG001|Overall Study|Adverse Event|12|||
164615377|NCT01131078|594613640|FG002|Overall Study|Adverse Event|17|||
164615378|NCT01131078|594613638|FG000|Overall Study|Progressive Disease|58|||
164615379|NCT01131078|594613639|FG001|Overall Study|Progressive Disease|77|||
164615380|NCT01131078|594613640|FG002|Overall Study|Progressive Disease|71|||
164615381|NCT01131078|594613638|FG000|Overall Study|Protocol Violation|1|||
164615382|NCT01131078|594613639|FG001|Overall Study|Protocol Violation|0|||
164615383|NCT01131078|594613640|FG002|Overall Study|Protocol Violation|0|||
164615384|NCT01131078|594613638|FG000|Overall Study|Lost to Follow-up|1|||
164615385|NCT01131078|594613639|FG001|Overall Study|Lost to Follow-up|1|||
164615386|NCT01131078|594613640|FG002|Overall Study|Lost to Follow-up|1|||
164615387|NCT01131078|594613638|FG000|Overall Study|Withdrawal by Subject|2|||
164615388|NCT01131078|594613639|FG001|Overall Study|Withdrawal by Subject|4|||
164615389|NCT01131078|594613640|FG002|Overall Study|Withdrawal by Subject|3|||
164615390|NCT01131078|594613638|FG000|Overall Study|Non-compliance|3|||
164615391|NCT01131078|594613639|FG001|Overall Study|Non-compliance|0|||
164615392|NCT01131078|594613640|FG002|Overall Study|Non-compliance|0|||
164615393|NCT01131078|594613638|FG000|Overall Study|Physician Decision|10|||
164615394|NCT01131078|594613639|FG001|Overall Study|Physician Decision|6|||
164615395|NCT01131078|594613640|FG002|Overall Study|Physician Decision|8|||
164615396|NCT01131078|594613638|FG000|Overall Study|Death|4|||
164615397|NCT01131078|594613639|FG001|Overall Study|Death|0|||
164615398|NCT01131078|594613640|FG002|Overall Study|Death|2|||
164615399|NCT01131078|594613638|FG000|Overall Study|Other|0|||
164615400|NCT01131078|594613639|FG001|Overall Study|Other|1|||
164615401|NCT01131078|594613640|FG002|Overall Study|Other|0|||
164615402|NCT02177786|594613641|FG000|Overall Study|Withdrew Consent|2|||
164615403|NCT02177786|594613642|FG001|Overall Study|Withdrew Consent|6|||
164615404|NCT02177786|594613643|FG002|Overall Study|Withdrew Consent|9|||
164615405|NCT02177786|594613644|FG003|Overall Study|Withdrew Consent|5|||
164615406|NCT02177786|594613641|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
164615407|NCT02177786|594613642|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
164615408|NCT02177786|594613643|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
164615409|NCT02177786|594613644|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
164615410|NCT02177786|594613641|FG000|Overall Study|Adverse Event|1|||
164615411|NCT02177786|594613642|FG001|Overall Study|Adverse Event|1|||
164615412|NCT02177786|594613643|FG002|Overall Study|Adverse Event|2|||
164615413|NCT02177786|594613644|FG003|Overall Study|Adverse Event|3|||
164615414|NCT02177786|594613641|FG000|Overall Study|Death|1|||
164615415|NCT02177786|594613642|FG001|Overall Study|Death|1|||
164615416|NCT02177786|594613643|FG002|Overall Study|Death|1|||
164615417|NCT02177786|594613644|FG003|Overall Study|Death|1|||
164615418|NCT02177786|594613641|FG000|Overall Study|Lost to Follow-up|0|||
164615419|NCT02177786|594613642|FG001|Overall Study|Lost to Follow-up|0|||
164615420|NCT02177786|594613643|FG002|Overall Study|Lost to Follow-up|2|||
164615421|NCT02177786|594613644|FG003|Overall Study|Lost to Follow-up|2|||
164615422|NCT02177786|594613641|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164517736|NCT03524092|594264232|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
164517737|NCT03524092|594264233|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
164517738|NCT03524092|594264228|FG000|Loss of Response Rescue Period|Adverse Event|0|||
164517739|NCT03524092|594264229|FG001|Loss of Response Rescue Period|Adverse Event|0|||
164517740|NCT03524092|594264230|FG002|Loss of Response Rescue Period|Adverse Event|0|||
164517741|NCT03524092|594264231|FG003|Loss of Response Rescue Period|Adverse Event|2|||
164517742|NCT03524092|594264232|FG004|Loss of Response Rescue Period|Adverse Event|0|||
164517743|NCT03524092|594264233|FG005|Loss of Response Rescue Period|Adverse Event|0|||
164517744|NCT03524092|594264228|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
164517745|NCT03524092|594264229|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
164517746|NCT03524092|594264230|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
164517747|NCT03524092|594264231|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
164517748|NCT03524092|594264232|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
164517749|NCT03524092|594264233|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
164517750|NCT03524092|594264228|FG000|Loss of Response Rescue Period|Pregnancy|0|||
164517751|NCT03524092|594264229|FG001|Loss of Response Rescue Period|Pregnancy|0|||
164517752|NCT03524092|594264230|FG002|Loss of Response Rescue Period|Pregnancy|0|||
164517753|NCT03524092|594264231|FG003|Loss of Response Rescue Period|Pregnancy|1|||
164517754|NCT03524092|594264232|FG004|Loss of Response Rescue Period|Pregnancy|0|||
164517755|NCT03524092|594264233|FG005|Loss of Response Rescue Period|Pregnancy|0|||
164517756|NCT03524092|594264228|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
164517757|NCT03524092|594264229|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
164517758|NCT03524092|594264230|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
164517759|NCT03524092|594264231|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
164517760|NCT03524092|594264232|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
164517761|NCT03524092|594264233|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
164517762|NCT03524092|594264228|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
164517763|NCT03524092|594264229|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
164517764|NCT03524092|594264230|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
164517765|NCT03524092|594264231|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
164517766|NCT03524092|594264232|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
164517767|NCT03524092|594264233|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
164517768|NCT03524092|594264228|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
164517769|NCT03524092|594264229|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
164517770|NCT03524092|594264230|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
164517771|NCT03524092|594264231|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
164517772|NCT03524092|594264232|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
164517773|NCT03524092|594264233|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
164517774|NCT03524092|594264228|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
164517775|NCT03524092|594264229|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
164517776|NCT03524092|594264230|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
164517777|NCT03524092|594264231|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
164517778|NCT03524092|594264232|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
164517779|NCT03524092|594264233|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
164517780|NCT03524092|594264228|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
164517781|NCT03524092|594264229|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
164517782|NCT03524092|594264230|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
164517783|NCT03524092|594264231|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
164517784|NCT03524092|594264232|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
164517785|NCT03524092|594264233|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
164517786|NCT03524092|594264228|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
164517787|NCT03524092|594264229|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
164517788|NCT03524092|594264230|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
164615423|NCT02177786|594613642|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164615424|NCT02177786|594613643|FG002|Overall Study|Non-Compliance with Study Drug|0|||
164615425|NCT02177786|594613644|FG003|Overall Study|Non-Compliance with Study Drug|1|||
164615426|NCT02177786|594613641|FG000|Overall Study|Protocol Violation|0|||
164615427|NCT02177786|594613642|FG001|Overall Study|Protocol Violation|0|||
164615428|NCT02177786|594613643|FG002|Overall Study|Protocol Violation|2|||
164615429|NCT02177786|594613644|FG003|Overall Study|Protocol Violation|0|||
164615430|NCT02177786|594613641|FG000|Overall Study|Progressive Disease|0|||
164615431|NCT02177786|594613642|FG001|Overall Study|Progressive Disease|1|||
164615432|NCT02177786|594613643|FG002|Overall Study|Progressive Disease|0|||
164615433|NCT02177786|594613644|FG003|Overall Study|Progressive Disease|0|||
164615434|NCT02177786|594613641|FG000|Overall Study|Missing study completion status|0|||
164615435|NCT02177786|594613642|FG001|Overall Study|Missing study completion status|1|||
164615436|NCT02177786|594613643|FG002|Overall Study|Missing study completion status|0|||
164615437|NCT02177786|594613644|FG003|Overall Study|Missing study completion status|0|||
164615438|NCT01305941|594613645|FG000|Overall Study|Adverse Event|6|||
164615439|NCT01305941|594613645|FG000|Overall Study|Clinical decline|2|||
164615440|NCT01305941|594613645|FG000|Overall Study|Withdrawal by Subject|1|||
164615441|NCT01305941|594613645|FG000|Overall Study|Death|1|||
164615442|NCT00430027|594613647|FG000|Overall Study|Study terminated|8|||
164615443|NCT01957215|594613648|FG000|Overall Study|Adverse Event|2|||
164615444|NCT01957215|594613649|FG001|Overall Study|Adverse Event|2|||
164615445|NCT01957215|594613648|FG000|Overall Study|Lost to Follow-up|3|||
164615446|NCT01957215|594613649|FG001|Overall Study|Lost to Follow-up|3|||
164615447|NCT01957215|594613648|FG000|Overall Study|Protocol Violation|1|||
164615448|NCT01957215|594613649|FG001|Overall Study|Protocol Violation|2|||
164615449|NCT01957215|594613648|FG000|Overall Study|Withdrawal by Subject|7|||
164615450|NCT01957215|594613649|FG001|Overall Study|Withdrawal by Subject|5|||
164615451|NCT01977040|594613652|FG000|Overall Study|Vasa previa not confirmed|2|||
164615452|NCT03597503|594613656|FG000|Overall Study|Withdrawal by Subject|0|||
164615453|NCT03597503|594613657|FG001|Overall Study|Withdrawal by Subject|2|||
164615454|NCT03597503|594613656|FG000|Overall Study|Lost to Follow-up|1|||
164615455|NCT03597503|594613657|FG001|Overall Study|Lost to Follow-up|2|||
164615456|NCT03597503|594613656|FG000|Overall Study|Protocol Violation|1|||
164615457|NCT03597503|594613657|FG001|Overall Study|Protocol Violation|0|||
164615458|NCT02667236|594613660|FG000|Overall Study|Adverse Event|1|||
164615459|NCT02667236|594613661|FG001|Overall Study|Adverse Event|1|||
164615460|NCT02667236|594613660|FG000|Overall Study|Withdrawal by Subject|2|||
164615461|NCT02667236|594613661|FG001|Overall Study|Withdrawal by Subject|0|||
164615462|NCT00634751|594613662|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
164615463|NCT00634751|594613663|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
164615464|NCT00634751|594613664|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
164615465|NCT00634751|594613665|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
164615466|NCT00634751|594613662|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
164615467|NCT00634751|594613663|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
164615468|NCT00634751|594613664|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
164615469|NCT00634751|594613665|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
164615470|NCT00634751|594613662|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
164615471|NCT00634751|594613663|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
164615472|NCT00634751|594613664|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
164615473|NCT00634751|594613665|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
164615474|NCT00608894|594613666|FG000|Overall Study|Withdrawal by Subject|0|||
164615475|NCT00608894|594613667|FG001|Overall Study|Withdrawal by Subject|2|||
164615476|NCT03654560|594613668|FG000|Overall Study|Death|3|||
164615477|NCT03654560|594613669|FG001|Overall Study|Death|1|||
164615478|NCT03654560|594613668|FG000|Overall Study|Lost to Follow-up|1|||
164615479|NCT03654560|594613669|FG001|Overall Study|Lost to Follow-up|0|||
164615480|NCT01235338|594613671|FG000|Overall Study|Adverse Event|3|||
164615481|NCT01235338|594613672|FG001|Overall Study|Adverse Event|2|||
164615482|NCT01235338|594613671|FG000|Overall Study|Protocol Violation|1|||
164615483|NCT01235338|594613672|FG001|Overall Study|Protocol Violation|1|||
164615484|NCT01235338|594613671|FG000|Overall Study|Withdrawal by Subject|5|||
164615485|NCT01235338|594613672|FG001|Overall Study|Withdrawal by Subject|0|||
164615486|NCT01235338|594613671|FG000|Overall Study|Exclusion criteria violations|1|||
164615487|NCT01235338|594613672|FG001|Overall Study|Exclusion criteria violations|1|||
164615488|NCT01235338|594613671|FG000|Overall Study|Positive drug screen|0|||
164615489|NCT01235338|594613672|FG001|Overall Study|Positive drug screen|1|||
164615490|NCT01235338|594613671|FG000|Overall Study|Prohibited meds|1|||
164615491|NCT01235338|594613672|FG001|Overall Study|Prohibited meds|0|||
164615492|NCT05283499|594613674|FG000|Overall Study|Did not receive intervention|1|||
164615493|NCT05283499|594613675|FG001|Overall Study|Did not receive intervention|2|||
164615494|NCT02828644|594613676|FG000|Overall Study|Lost to Follow-up|23|||
164615495|NCT02828644|594613677|FG001|Overall Study|Lost to Follow-up|22|||
164615496|NCT02408484|594613678|FG000|Overall Study|Withdrawal by Subject|3|||
164615497|NCT02408484|594613678|FG000|Overall Study|Not treated during study period|1|||
164615498|NCT01117181|594613682|FG000|Overall Study|Lost to Follow-up|1|||
164615499|NCT01117181|594613683|FG001|Overall Study|Lost to Follow-up|0|||
164615500|NCT01117181|594613682|FG000|Overall Study|Withdrawal by Subject|0|||
164615501|NCT01117181|594613683|FG001|Overall Study|Withdrawal by Subject|2|||
164615502|NCT00524043|594613689|FG000|Overall Study|Lack of Efficacy|15|||
164615503|NCT00524043|594613690|FG001|Overall Study|Lack of Efficacy|13|||
164517789|NCT03524092|594264231|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
164517790|NCT03524092|594264232|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
164517791|NCT03524092|594264233|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
164517792|NCT03524092|594264228|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
164517793|NCT03524092|594264229|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
164517794|NCT03524092|594264230|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
164517795|NCT03524092|594264231|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
164517796|NCT03524092|594264232|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
164517797|NCT03524092|594264233|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
164517798|NCT03524092|594264228|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
164517799|NCT03524092|594264229|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
164517800|NCT03524092|594264230|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
164517801|NCT03524092|594264231|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
164517802|NCT03524092|594264232|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
164517803|NCT03524092|594264233|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
164517804|NCT03524092|594264228|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
164517805|NCT03524092|594264229|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
164517806|NCT03524092|594264230|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
164517807|NCT03524092|594264231|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
164517808|NCT03524092|594264232|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
164517809|NCT03524092|594264233|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
164517810|NCT03524092|594264228|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
164517811|NCT03524092|594264229|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
164517812|NCT03524092|594264230|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
164517813|NCT03524092|594264231|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
164517814|NCT03524092|594264232|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
164517815|NCT03524092|594264233|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
164517816|NCT03524092|594264228|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
164517817|NCT03524092|594264229|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
164517818|NCT03524092|594264230|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
164517819|NCT03524092|594264231|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
164517820|NCT03524092|594264232|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
164517821|NCT03524092|594264233|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
164517822|NCT03524092|594264228|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
164517823|NCT03524092|594264229|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
164517824|NCT03524092|594264230|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
164517825|NCT03524092|594264231|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
164517826|NCT03524092|594264232|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
164517827|NCT03524092|594264233|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
164517828|NCT04303780|594264234|FG000|Overall Study|Death|104|||
164517829|NCT04303780|594264235|FG001|Overall Study|Death|85|||
164517830|NCT04303780|594264234|FG000|Overall Study|Lost to Follow-up|5|||
164517831|NCT04303780|594264235|FG001|Overall Study|Lost to Follow-up|2|||
164517832|NCT04303780|594264234|FG000|Overall Study|Withdrawal by Subject|12|||
164517833|NCT04303780|594264235|FG001|Overall Study|Withdrawal by Subject|39|||
164517834|NCT04303780|594264234|FG000|Overall Study|Ongoing in study|50|||
164517835|NCT04303780|594264235|FG001|Overall Study|Ongoing in study|45|||
164517836|NCT03826030|594264236|FG000|Overall Study|Withdrawal by Subject|2|||
164517837|NCT03826030|594264237|FG001|Overall Study|Withdrawal by Subject|0|||
164517838|NCT03826030|594264238|FG002|Overall Study|Withdrawal by Subject|1|||
164517839|NCT03826030|594264236|FG000|Overall Study|Lost to Follow-up|1|||
164517840|NCT03826030|594264237|FG001|Overall Study|Lost to Follow-up|1|||
164517841|NCT03826030|594264238|FG002|Overall Study|Lost to Follow-up|1|||
164517842|NCT03826030|594264236|FG000|Overall Study|Too busy to return for visits|1|||
164517843|NCT03826030|594264237|FG001|Overall Study|Too busy to return for visits|0|||
164517844|NCT03826030|594264238|FG002|Overall Study|Too busy to return for visits|0|||
164517845|NCT03578887|594264239|FG000|Overall Study|Withdrawal by Subject|7|||
164517846|NCT03578887|594264240|FG001|Overall Study|Withdrawal by Subject|2|||
164517847|NCT03578887|594264241|FG002|Overall Study|Withdrawal by Subject|1|||
164517848|NCT03578887|594264239|FG000|Overall Study|Lost to Follow-up|13|||
164517849|NCT03578887|594264240|FG001|Overall Study|Lost to Follow-up|1|||
164517850|NCT03578887|594264241|FG002|Overall Study|Lost to Follow-up|4|||
164517851|NCT03578887|594264239|FG000|Overall Study|Physician Decision|0|||
164517852|NCT03578887|594264240|FG001|Overall Study|Physician Decision|1|||
164517853|NCT03578887|594264241|FG002|Overall Study|Physician Decision|1|||
164517854|NCT01099215|594266178|FG000|Overall Study|Withdrawal by Subject|1|||
164517855|NCT01099215|594266179|FG001|Overall Study|Withdrawal by Subject|0|||
164517856|NCT01099215|594266178|FG000|Overall Study|Adverse Event|0|||
164517857|NCT01099215|594266179|FG001|Overall Study|Adverse Event|1|||
164517858|NCT00379288|594266180|FG000|Overall Study|Adverse Event|5|||
164517859|NCT00379288|594266181|FG001|Overall Study|Adverse Event|6|||
164517860|NCT00379288|594266182|FG002|Overall Study|Adverse Event|2|||
164517861|NCT00379288|594266183|FG003|Overall Study|Adverse Event|0|||
164517862|NCT00379288|594266180|FG000|Overall Study|Treatment Failure|0|||
164517863|NCT00379288|594266181|FG001|Overall Study|Treatment Failure|1|||
164517864|NCT00379288|594266182|FG002|Overall Study|Treatment Failure|0|||
164517865|NCT00379288|594266183|FG003|Overall Study|Treatment Failure|1|||
164517866|NCT00379288|594266180|FG000|Overall Study|Lost to Follow-up|3|||
164517867|NCT00379288|594266181|FG001|Overall Study|Lost to Follow-up|3|||
164517868|NCT00379288|594266182|FG002|Overall Study|Lost to Follow-up|2|||
164517869|NCT00379288|594266183|FG003|Overall Study|Lost to Follow-up|0|||
164517870|NCT00379288|594266180|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
164517871|NCT00379288|594266181|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
164517872|NCT00379288|594266182|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
164517873|NCT00379288|594266183|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
164517874|NCT00379288|594266180|FG000|Overall Study|Subject withdrew-related to study drug|1|||
164517875|NCT00379288|594266181|FG001|Overall Study|Subject withdrew-related to study drug|0|||
164517876|NCT00379288|594266182|FG002|Overall Study|Subject withdrew-related to study drug|0|||
164517877|NCT00379288|594266183|FG003|Overall Study|Subject withdrew-related to study drug|1|||
164517878|NCT00379288|594266180|FG000|Overall Study|Noncompliance with protocol|8|||
164517879|NCT00379288|594266181|FG001|Overall Study|Noncompliance with protocol|6|||
164517880|NCT00379288|594266182|FG002|Overall Study|Noncompliance with protocol|2|||
164517881|NCT00379288|594266183|FG003|Overall Study|Noncompliance with protocol|1|||
164517882|NCT00379288|594266180|FG000|Overall Study|Did not meet protocol eligibility|0|||
164517883|NCT00379288|594266181|FG001|Overall Study|Did not meet protocol eligibility|1|||
164517884|NCT00379288|594266182|FG002|Overall Study|Did not meet protocol eligibility|0|||
164517885|NCT00379288|594266183|FG003|Overall Study|Did not meet protocol eligibility|2|||
164517886|NCT00379288|594266180|FG000|Overall Study|Administrative|2|||
164517887|NCT00379288|594266181|FG001|Overall Study|Administrative|2|||
164517888|NCT00379288|594266182|FG002|Overall Study|Administrative|0|||
164517889|NCT00379288|594266183|FG003|Overall Study|Administrative|1|||
164517890|NCT01302080|594266185|FG000|Overall Study|Withdrew Consent|92|||
164517891|NCT01302080|594266186|FG001|Overall Study|Withdrew Consent|39|||
164517892|NCT01302080|594266185|FG000|Overall Study|Patient/Family Moved|28|||
164517893|NCT01302080|594266186|FG001|Overall Study|Patient/Family Moved|3|||
164517894|NCT01302080|594266185|FG000|Overall Study|Lost to Follow-up|192|||
164517895|NCT01302080|594266186|FG001|Overall Study|Lost to Follow-up|93|||
164517896|NCT01302080|594266185|FG000|Overall Study|Death|1|||
164517897|NCT01302080|594266186|FG001|Overall Study|Death|0|||
164517898|NCT01302080|594266185|FG000|Overall Study|Other|52|||
164517899|NCT01302080|594266186|FG001|Overall Study|Other|8|||
164517900|NCT01302080|594266185|FG000|Overall Study|Reason Missing For Discontinuation|1|||
164517901|NCT01302080|594266186|FG001|Overall Study|Reason Missing For Discontinuation|0|||
164517902|NCT01531673|594266187|FG000|Overall Study|Non-Compliance|0|||
164517903|NCT01531673|594266188|FG001|Overall Study|Non-Compliance|0|||
164517904|NCT01531673|594266189|FG002|Overall Study|Non-Compliance|0|||
164517905|NCT01531673|594266190|FG003|Overall Study|Non-Compliance|0|||
164517906|NCT01531673|594266191|FG004|Overall Study|Non-Compliance|0|||
164517907|NCT01531673|594266192|FG005|Overall Study|Non-Compliance|1|||
164517908|NCT01531673|594266193|FG006|Overall Study|Non-Compliance|0|||
164517909|NCT01531673|594266194|FG007|Overall Study|Non-Compliance|0|||
164517910|NCT01531673|594266195|FG008|Overall Study|Non-Compliance|0|||
164517911|NCT01531673|594266196|FG009|Overall Study|Non-Compliance|0|||
164517912|NCT01531673|594266197|FG010|Overall Study|Non-Compliance|0|||
164517913|NCT01531673|594266198|FG011|Overall Study|Non-Compliance|0|||
164517914|NCT01531673|594266199|FG012|Overall Study|Non-Compliance|0|||
164517915|NCT01531673|594266187|FG000|Overall Study|Adverse Event|0|||
164517916|NCT01531673|594266188|FG001|Overall Study|Adverse Event|1|||
164517917|NCT01531673|594266189|FG002|Overall Study|Adverse Event|0|||
164517918|NCT01531673|594266190|FG003|Overall Study|Adverse Event|0|||
164517919|NCT01531673|594266191|FG004|Overall Study|Adverse Event|0|||
164517920|NCT01531673|594266192|FG005|Overall Study|Adverse Event|0|||
164517921|NCT01531673|594266193|FG006|Overall Study|Adverse Event|0|||
164517922|NCT01531673|594266194|FG007|Overall Study|Adverse Event|0|||
164517923|NCT01531673|594266195|FG008|Overall Study|Adverse Event|0|||
164517924|NCT01531673|594266196|FG009|Overall Study|Adverse Event|0|||
164517925|NCT01531673|594266197|FG010|Overall Study|Adverse Event|0|||
164517926|NCT01531673|594266198|FG011|Overall Study|Adverse Event|0|||
164517927|NCT01531673|594266199|FG012|Overall Study|Adverse Event|0|||
164517928|NCT01531673|594266187|FG000|Overall Study|Lost to Follow-up|0|||
164517929|NCT01531673|594266188|FG001|Overall Study|Lost to Follow-up|0|||
164517930|NCT01531673|594266189|FG002|Overall Study|Lost to Follow-up|0|||
164517931|NCT01531673|594266190|FG003|Overall Study|Lost to Follow-up|0|||
164517932|NCT01531673|594266191|FG004|Overall Study|Lost to Follow-up|1|||
164517933|NCT01531673|594266192|FG005|Overall Study|Lost to Follow-up|0|||
164517934|NCT01531673|594266193|FG006|Overall Study|Lost to Follow-up|0|||
164517935|NCT01531673|594266194|FG007|Overall Study|Lost to Follow-up|0|||
164517936|NCT01531673|594266195|FG008|Overall Study|Lost to Follow-up|0|||
164517937|NCT01531673|594266196|FG009|Overall Study|Lost to Follow-up|0|||
164517938|NCT01531673|594266197|FG010|Overall Study|Lost to Follow-up|0|||
164517939|NCT01531673|594266198|FG011|Overall Study|Lost to Follow-up|0|||
164517940|NCT01531673|594266199|FG012|Overall Study|Lost to Follow-up|0|||
164517941|NCT01531673|594266187|FG000|Overall Study|Other|0|||
164517942|NCT01531673|594266188|FG001|Overall Study|Other|0|||
164517943|NCT01531673|594266189|FG002|Overall Study|Other|0|||
164517944|NCT01531673|594266190|FG003|Overall Study|Other|1|||
164517945|NCT01531673|594266191|FG004|Overall Study|Other|0|||
164517946|NCT01531673|594266192|FG005|Overall Study|Other|0|||
164517947|NCT01531673|594266193|FG006|Overall Study|Other|0|||
164517948|NCT01531673|594266194|FG007|Overall Study|Other|0|||
164517949|NCT01531673|594266195|FG008|Overall Study|Other|0|||
164517950|NCT01531673|594266196|FG009|Overall Study|Other|1|||
164517951|NCT01531673|594266197|FG010|Overall Study|Other|0|||
164517952|NCT01531673|594266198|FG011|Overall Study|Other|0|||
164517953|NCT01531673|594266199|FG012|Overall Study|Other|0|||
164517954|NCT00568178|594266200|FG000|Double Blind Base Study|Adverse Event|0|||
164517955|NCT00568178|594266201|FG001|Double Blind Base Study|Adverse Event|2|||
164517956|NCT00568178|594266202|FG002|Double Blind Base Study|Adverse Event|1|||
164517957|NCT00568178|594266203|FG003|Double Blind Base Study|Adverse Event|2|||
164517958|NCT00568178|594266204|FG004|Double Blind Base Study|Adverse Event|0|||
164517959|NCT00568178|594266205|FG005|Double Blind Base Study|Adverse Event|0|||
164517960|NCT00568178|594266200|FG000|Double Blind Base Study|Lost to Follow-up|1|||
164517961|NCT00568178|594266201|FG001|Double Blind Base Study|Lost to Follow-up|0|||
164517962|NCT00568178|594266202|FG002|Double Blind Base Study|Lost to Follow-up|0|||
164517963|NCT00568178|594266203|FG003|Double Blind Base Study|Lost to Follow-up|1|||
164517964|NCT00568178|594266204|FG004|Double Blind Base Study|Lost to Follow-up|0|||
164517965|NCT00568178|594266205|FG005|Double Blind Base Study|Lost to Follow-up|0|||
164517966|NCT00568178|594266200|FG000|Double Blind Base Study|Physician Decision|1|||
164517967|NCT00568178|594266201|FG001|Double Blind Base Study|Physician Decision|1|||
164517968|NCT00568178|594266202|FG002|Double Blind Base Study|Physician Decision|0|||
164517969|NCT00568178|594266203|FG003|Double Blind Base Study|Physician Decision|1|||
164517970|NCT00568178|594266204|FG004|Double Blind Base Study|Physician Decision|0|||
164517971|NCT00568178|594266205|FG005|Double Blind Base Study|Physician Decision|0|||
164517972|NCT00568178|594266200|FG000|Double Blind Base Study|Protocol Violation|3|||
164517973|NCT00568178|594266201|FG001|Double Blind Base Study|Protocol Violation|2|||
164517974|NCT00568178|594266202|FG002|Double Blind Base Study|Protocol Violation|0|||
164517975|NCT00568178|594266203|FG003|Double Blind Base Study|Protocol Violation|0|||
164517976|NCT00568178|594266204|FG004|Double Blind Base Study|Protocol Violation|0|||
164517977|NCT00568178|594266205|FG005|Double Blind Base Study|Protocol Violation|0|||
164517978|NCT00568178|594266200|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
164517979|NCT00568178|594266201|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
164517980|NCT00568178|594266202|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
164517981|NCT00568178|594266203|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
164517982|NCT00568178|594266204|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
164517983|NCT00568178|594266205|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
164517984|NCT00568178|594266200|FG000|Double Blind Base Study|Progressive Disease|0|||
164517985|NCT00568178|594266201|FG001|Double Blind Base Study|Progressive Disease|0|||
164517986|NCT00568178|594266202|FG002|Double Blind Base Study|Progressive Disease|0|||
164517987|NCT00568178|594266203|FG003|Double Blind Base Study|Progressive Disease|1|||
164517988|NCT00568178|594266204|FG004|Double Blind Base Study|Progressive Disease|0|||
164517989|NCT00568178|594266205|FG005|Double Blind Base Study|Progressive Disease|0|||
164517990|NCT00568178|594266200|FG000|Open Label Extension|Adverse Event|0|||
164517991|NCT00568178|594266201|FG001|Open Label Extension|Adverse Event|0|||
164517992|NCT00568178|594266202|FG002|Open Label Extension|Adverse Event|0|||
164517993|NCT00568178|594266203|FG003|Open Label Extension|Adverse Event|0|||
164517994|NCT00568178|594266204|FG004|Open Label Extension|Adverse Event|11|||
164517995|NCT00568178|594266205|FG005|Open Label Extension|Adverse Event|8|||
164517996|NCT00568178|594266200|FG000|Open Label Extension|Protocol Violation|0|||
164517997|NCT00568178|594266201|FG001|Open Label Extension|Protocol Violation|0|||
164517998|NCT00568178|594266202|FG002|Open Label Extension|Protocol Violation|0|||
164517999|NCT00568178|594266203|FG003|Open Label Extension|Protocol Violation|0|||
164518000|NCT00568178|594266204|FG004|Open Label Extension|Protocol Violation|1|||
164518001|NCT00568178|594266205|FG005|Open Label Extension|Protocol Violation|0|||
164518002|NCT00568178|594266200|FG000|Open Label Extension|Lost to Follow-up|0|||
164518003|NCT00568178|594266201|FG001|Open Label Extension|Lost to Follow-up|0|||
164518004|NCT00568178|594266202|FG002|Open Label Extension|Lost to Follow-up|0|||
164518005|NCT00568178|594266203|FG003|Open Label Extension|Lost to Follow-up|0|||
164518006|NCT00568178|594266204|FG004|Open Label Extension|Lost to Follow-up|6|||
164518007|NCT00568178|594266205|FG005|Open Label Extension|Lost to Follow-up|11|||
164518008|NCT00568178|594266200|FG000|Open Label Extension|Physician Decision|0|||
164518009|NCT00568178|594266201|FG001|Open Label Extension|Physician Decision|0|||
164518010|NCT00568178|594266202|FG002|Open Label Extension|Physician Decision|0|||
164518011|NCT00568178|594266203|FG003|Open Label Extension|Physician Decision|0|||
164518012|NCT00568178|594266204|FG004|Open Label Extension|Physician Decision|9|||
164518013|NCT00568178|594266205|FG005|Open Label Extension|Physician Decision|8|||
164518014|NCT00568178|594266200|FG000|Open Label Extension|Pregnancy|0|||
164518015|NCT00568178|594266201|FG001|Open Label Extension|Pregnancy|0|||
164518016|NCT00568178|594266202|FG002|Open Label Extension|Pregnancy|0|||
164518017|NCT00568178|594266203|FG003|Open Label Extension|Pregnancy|0|||
164518018|NCT00568178|594266204|FG004|Open Label Extension|Pregnancy|0|||
164518019|NCT00568178|594266205|FG005|Open Label Extension|Pregnancy|1|||
164518020|NCT00568178|594266200|FG000|Open Label Extension|Progressive Disease|0|||
164518021|NCT00568178|594266201|FG001|Open Label Extension|Progressive Disease|0|||
164518022|NCT00568178|594266202|FG002|Open Label Extension|Progressive Disease|0|||
164518023|NCT00568178|594266203|FG003|Open Label Extension|Progressive Disease|0|||
164518024|NCT00568178|594266204|FG004|Open Label Extension|Progressive Disease|3|||
164518025|NCT00568178|594266205|FG005|Open Label Extension|Progressive Disease|1|||
164518026|NCT00568178|594266200|FG000|Open Label Extension|Termination of Trial|0|||
164518027|NCT00568178|594266201|FG001|Open Label Extension|Termination of Trial|0|||
164518028|NCT00568178|594266202|FG002|Open Label Extension|Termination of Trial|0|||
164518029|NCT00568178|594266203|FG003|Open Label Extension|Termination of Trial|0|||
164518030|NCT00568178|594266204|FG004|Open Label Extension|Termination of Trial|45|||
164518031|NCT00568178|594266205|FG005|Open Label Extension|Termination of Trial|47|||
164518032|NCT00568178|594266200|FG000|Open Label Extension|Withdrawal by Subject|0|||
164518033|NCT00568178|594266201|FG001|Open Label Extension|Withdrawal by Subject|0|||
164518034|NCT00568178|594266202|FG002|Open Label Extension|Withdrawal by Subject|0|||
164518035|NCT00568178|594266203|FG003|Open Label Extension|Withdrawal by Subject|0|||
164518036|NCT00568178|594266204|FG004|Open Label Extension|Withdrawal by Subject|4|||
164518037|NCT00568178|594266205|FG005|Open Label Extension|Withdrawal by Subject|4|||
164518038|NCT00095056|594266208|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
164518039|NCT00095056|594266209|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
164518040|NCT00095056|594266208|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
164518041|NCT00095056|594266209|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
164518042|NCT00095056|594266208|FG000|Phase A (Weeks 0-12)|Death|1|||
164518043|NCT00095056|594266209|FG001|Phase A (Weeks 0-12)|Death|0|||
164518044|NCT00095056|594266208|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
164518045|NCT00095056|594266209|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
164518046|NCT00095056|594266208|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
164518047|NCT00095056|594266209|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
164518048|NCT00095056|594266208|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
164518049|NCT00095056|594266209|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
164518050|NCT00095056|594266208|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
164518051|NCT00095056|594266209|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
164518052|NCT00095056|594266208|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
164518053|NCT00095056|594266209|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
164518054|NCT00095056|594266208|FG000|Phase B (Weeks 12-54)|Death|3|||
164518055|NCT00095056|594266209|FG001|Phase B (Weeks 12-54)|Death|1|||
164518056|NCT00095056|594266208|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
164518057|NCT00095056|594266209|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
164518058|NCT00095056|594266208|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
164518059|NCT00095056|594266209|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
164518060|NCT04476251|594266212|FG000|Overall Study|Not treated|1|||
164518061|NCT05816330|594266216|FG000|Overall Study|Withdrawal by Subject|4|||
164518062|NCT05816330|594266217|FG001|Overall Study|Withdrawal by Subject|1|||
164518063|NCT00201643|594266218|FG000|Overall Study|Withdrawal by Subject|5|||
164518064|NCT00201643|594266219|FG001|Overall Study|Withdrawal by Subject|4|||
164518065|NCT03446781|594266220|FG000|Overall Study|Lost to Follow-up|11|||
164518066|NCT03446781|594266221|FG001|Overall Study|Lost to Follow-up|5|||
164518067|NCT03446781|594266220|FG000|Overall Study|Withdrawal by Subject|9|||
164518068|NCT03446781|594266221|FG001|Overall Study|Withdrawal by Subject|7|||
164518069|NCT03446781|594266220|FG000|Overall Study|Adverse Event|8|||
164518070|NCT03446781|594266221|FG001|Overall Study|Adverse Event|2|||
164518071|NCT03446781|594266220|FG000|Overall Study|Protocol Violation|0|||
164518072|NCT03446781|594266221|FG001|Overall Study|Protocol Violation|3|||
164518073|NCT02787044|594266223|FG000|Overall Study|Lost to Follow-up|15|||
164518074|NCT02787044|594266224|FG001|Overall Study|Lost to Follow-up|19|||
164518075|NCT02898077|594266230|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
164518076|NCT02898077|594266231|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
164518077|NCT02898077|594266230|FG000|Overall Study|Lost to Follow-up|4|||
164518078|NCT02898077|594266231|FG001|Overall Study|Lost to Follow-up|3|||
164518079|NCT02898077|594266230|FG000|Overall Study|Physician Decision|0|||
164518080|NCT02898077|594266231|FG001|Overall Study|Physician Decision|2|||
164518081|NCT02898077|594266230|FG000|Overall Study|Sponsor Decision|32|||
164518082|NCT02898077|594266231|FG001|Overall Study|Sponsor Decision|13|||
164518083|NCT02898077|594266230|FG000|Overall Study|Withdrawal by Subject|6|||
164518084|NCT02898077|594266231|FG001|Overall Study|Withdrawal by Subject|3|||
164615504|NCT00524043|594613691|FG002|Overall Study|Lack of Efficacy|14|||
164615505|NCT00524043|594613689|FG000|Overall Study|Withdrawal by Subject|5|||
164615506|NCT00524043|594613690|FG001|Overall Study|Withdrawal by Subject|7|||
164615507|NCT00524043|594613691|FG002|Overall Study|Withdrawal by Subject|7|||
164615508|NCT00524043|594613689|FG000|Overall Study|Adverse Event|5|||
164615509|NCT00524043|594613690|FG001|Overall Study|Adverse Event|2|||
164615510|NCT00524043|594613691|FG002|Overall Study|Adverse Event|7|||
164615511|NCT00524043|594613689|FG000|Overall Study|Lost to Follow-up|3|||
164615512|NCT00524043|594613690|FG001|Overall Study|Lost to Follow-up|5|||
164615513|NCT00524043|594613691|FG002|Overall Study|Lost to Follow-up|3|||
164615514|NCT00524043|594613689|FG000|Overall Study|Various (eg, incarceration)|2|||
164615515|NCT00524043|594613690|FG001|Overall Study|Various (eg, incarceration)|1|||
164615516|NCT00524043|594613691|FG002|Overall Study|Various (eg, incarceration)|0|||
164615517|NCT00517413|594613693|FG000|Overall Study|Adverse Event|7|||
164615518|NCT00517413|594613693|FG000|Overall Study|Death|13|||
164615519|NCT00517413|594613693|FG000|Overall Study|Protocol Violation|15|||
164615520|NCT00517413|594613693|FG000|Overall Study|Withdrawal by Subject|2|||
164615521|NCT00517413|594613693|FG000|Overall Study|Failure to return|1|||
164615522|NCT00517413|594613693|FG000|Overall Study|Other-Reasons|23|||
164615523|NCT03938636|594613694|FG000|Overall Study|Protocol Violation|0|||
164615524|NCT03938636|594613695|FG001|Overall Study|Protocol Violation|1|||
164615525|NCT03938636|594613696|FG002|Overall Study|Protocol Violation|1|||
164615526|NCT03938636|594613694|FG000|Overall Study|Subject withdrew due to death in family|0|||
164615527|NCT03938636|594613695|FG001|Overall Study|Subject withdrew due to death in family|1|||
164615528|NCT03938636|594613696|FG002|Overall Study|Subject withdrew due to death in family|0|||
164615529|NCT03938636|594613694|FG000|Overall Study|Missed visit|0|||
164615530|NCT03938636|594613695|FG001|Overall Study|Missed visit|1|||
164615531|NCT03938636|594613696|FG002|Overall Study|Missed visit|0|||
164615532|NCT03938636|594613694|FG000|Overall Study|Adverse Event|0|||
164615533|NCT03938636|594613695|FG001|Overall Study|Adverse Event|0|||
164615534|NCT03938636|594613696|FG002|Overall Study|Adverse Event|1|||
164615535|NCT03938636|594613694|FG000|Overall Study|Lost to Follow-up|0|||
164615536|NCT03938636|594613695|FG001|Overall Study|Lost to Follow-up|0|||
164615537|NCT03938636|594613696|FG002|Overall Study|Lost to Follow-up|1|||
164615538|NCT00216086|594613697|FG000|Overall Study|Protocol Violation|1|||
164615539|NCT00216086|594613697|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
164615540|NCT00216086|594613697|FG000|Overall Study|Social Reasons|2|||
164615541|NCT01080625|594613704|FG000|Overall Study|Physician Decision|0|||
164615542|NCT01080625|594613705|FG001|Overall Study|Physician Decision|2|||
164615543|NCT01080625|594613706|FG002|Overall Study|Physician Decision|1|||
164615544|NCT00735072|594613709|FG000|Overall Study|interrupted study med during ARV change|1|||
164615545|NCT00735072|594613710|FG001|Overall Study|interrupted study med during ARV change|0|||
164615546|NCT00735072|594613709|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
164615547|NCT00735072|594613710|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
164615548|NCT02640755|594613720|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
164615549|NCT02640755|594613721|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
164615550|NCT02640755|594613720|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
164615551|NCT02640755|594613721|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
164615552|NCT02640755|594613720|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
164615553|NCT02640755|594613721|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
164615554|NCT00329784|594613726|FG000|Overall Study|Lost to Follow-up|0|||
164615555|NCT00329784|594613727|FG001|Overall Study|Lost to Follow-up|1|||
164615556|NCT00329784|594613728|FG002|Overall Study|Lost to Follow-up|0|||
164615557|NCT00329784|594613729|FG003|Overall Study|Lost to Follow-up|0|||
164615558|NCT00329784|594613726|FG000|Overall Study|Withdrawal by Subject|4|||
164615559|NCT00329784|594613727|FG001|Overall Study|Withdrawal by Subject|2|||
164615560|NCT00329784|594613728|FG002|Overall Study|Withdrawal by Subject|0|||
164615561|NCT00329784|594613729|FG003|Overall Study|Withdrawal by Subject|0|||
164615562|NCT00329784|594613726|FG000|Overall Study|Other|1|||
164615563|NCT00329784|594613727|FG001|Overall Study|Other|2|||
164615564|NCT00329784|594613728|FG002|Overall Study|Other|0|||
164615565|NCT00329784|594613729|FG003|Overall Study|Other|0|||
164615566|NCT00654420|594613730|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
164615567|NCT00654420|594613731|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
164615568|NCT00654420|594613732|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
164615569|NCT00654420|594613733|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
164615570|NCT00654420|594613730|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
164615571|NCT00654420|594613731|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
164615572|NCT00654420|594613732|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
164615573|NCT00654420|594613733|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
164518085|NCT02898077|594266230|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
164518086|NCT02898077|594266231|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
164518087|NCT02898077|594266230|FG000|Overall Study|Ended extension period|3|||
164518088|NCT02898077|594266231|FG001|Overall Study|Ended extension period|0|||
164518089|NCT01638429|594266232|FG000|Overall Study|Withdrawal by Subject|1|||
164518090|NCT02040584|594266234|FG000|Overall Study|Adverse Event|13|||
164518091|NCT02040584|594266235|FG001|Overall Study|Adverse Event|6|||
164518092|NCT02040584|594266234|FG000|Overall Study|Protocol Violation|9|||
164518093|NCT02040584|594266235|FG001|Overall Study|Protocol Violation|11|||
164518094|NCT02040584|594266234|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164518095|NCT02040584|594266235|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
164518096|NCT02040584|594266234|FG000|Overall Study|Death|6|||
164518097|NCT02040584|594266235|FG001|Overall Study|Death|3|||
164518098|NCT02040584|594266234|FG000|Overall Study|Transplant rejection/retransplant|0|||
164518099|NCT02040584|594266235|FG001|Overall Study|Transplant rejection/retransplant|1|||
164518100|NCT02040584|594266234|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
164518101|NCT02040584|594266235|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
164518102|NCT00996476|594266236|FG000|Overall Study|Withdrawal by Subject|1|||
164518103|NCT00996476|594266237|FG001|Overall Study|Withdrawal by Subject|2|||
164518104|NCT00996476|594266238|FG002|Overall Study|Withdrawal by Subject|1|||
164615574|NCT00654420|594613730|FG000|Phase II|Adverse Event|0|||
164615575|NCT00654420|594613731|FG001|Phase II|Adverse Event|0|||
164615576|NCT00654420|594613732|FG002|Phase II|Adverse Event|3|||
164615577|NCT00654420|594613733|FG003|Phase II|Adverse Event|3|||
164615578|NCT00654420|594613730|FG000|Phase II|Lost to Follow-up|0|||
164615579|NCT00654420|594613731|FG001|Phase II|Lost to Follow-up|0|||
164615580|NCT00654420|594613732|FG002|Phase II|Lost to Follow-up|0|||
164615581|NCT00654420|594613733|FG003|Phase II|Lost to Follow-up|1|||
164615582|NCT00654420|594613730|FG000|Phase II|Physician Decision|0|||
164615583|NCT00654420|594613731|FG001|Phase II|Physician Decision|0|||
164615584|NCT00654420|594613732|FG002|Phase II|Physician Decision|0|||
164615585|NCT00654420|594613733|FG003|Phase II|Physician Decision|4|||
164615586|NCT00654420|594613730|FG000|Phase II|Progressive Disease|0|||
164615587|NCT00654420|594613731|FG001|Phase II|Progressive Disease|0|||
164615588|NCT00654420|594613732|FG002|Phase II|Progressive Disease|29|||
164615589|NCT00654420|594613733|FG003|Phase II|Progressive Disease|29|||
164615590|NCT00654420|594613730|FG000|Phase II|Withdrawal by Subject|0|||
164615591|NCT00654420|594613731|FG001|Phase II|Withdrawal by Subject|0|||
164615592|NCT00654420|594613732|FG002|Phase II|Withdrawal by Subject|4|||
164615593|NCT00654420|594613733|FG003|Phase II|Withdrawal by Subject|1|||
164615594|NCT00654420|594613730|FG000|Phase II|Missing Disposition Record|0|||
164615595|NCT00654420|594613731|FG001|Phase II|Missing Disposition Record|0|||
164615596|NCT00654420|594613732|FG002|Phase II|Missing Disposition Record|1|||
164615597|NCT00654420|594613733|FG003|Phase II|Missing Disposition Record|0|||
164615598|NCT01421069|594613736|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
164615599|NCT01421069|594613736|FG000|Parent Study|Failed to return|3|||
164615600|NCT01421069|594613736|FG000|Parent Study|Withdrawal by Subject|1|||
164615601|NCT01421069|594613736|FG000|Parent Study|Lost to Follow-up|2|||
164615602|NCT01421069|594613736|FG000|Parent Study|Lack of Efficacy|1|||
164615603|NCT01421069|594613736|FG000|Overall Period for Extension Study|Other|2|||
164615604|NCT01421069|594613736|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
164615605|NCT01421069|594613736|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
164615606|NCT01421069|594613736|FG000|Overall Period for Extension Study|Pregnancy|1|||
164615607|NCT01421069|594613736|FG000|Overall Period for Extension Study|Adverse Event|1|||
164615608|NCT01421069|594613736|FG000|Overall Period for Extension Study|Protocol Violation|1|||
164615609|NCT01421069|594613736|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
164615610|NCT01421069|594613736|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
164615611|NCT01421069|594613736|FG000|Active Treatment Period|Other|1|||
164615612|NCT01421069|594613736|FG000|Active Treatment Period|No longer willing to participate in study|8|||
164615613|NCT01421069|594613736|FG000|Active Treatment Period|Insufficient clinical response|1|||
164615614|NCT01421069|594613736|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
164518105|NCT00996476|594266239|FG003|Overall Study|Withdrawal by Subject|0|||
164518106|NCT00996476|594266240|FG004|Overall Study|Withdrawal by Subject|1|||
164518107|NCT00996476|594266236|FG000|Overall Study|Adverse Event|0|||
164518108|NCT00996476|594266237|FG001|Overall Study|Adverse Event|1|||
164518109|NCT00996476|594266238|FG002|Overall Study|Adverse Event|0|||
164518110|NCT00996476|594266239|FG003|Overall Study|Adverse Event|0|||
164518111|NCT00996476|594266240|FG004|Overall Study|Adverse Event|1|||
164518112|NCT01802567|594266241|FG000|Overall Study|Withdrawal by Subject|2|||
164518113|NCT01802567|594266241|FG000|Overall Study|Physician Decision|1|||
164518114|NCT01802567|594266241|FG000|Overall Study|Lack of Efficacy|7|||
164518115|NCT01802567|594266241|FG000|Overall Study|Consented but did not start therapy|7|||
164518116|NCT01802567|594266241|FG000|Overall Study|Protocol Violation|1|||
164518117|NCT01940939|594266242|FG000|Overall Study|Withdrawal by Subject|2|||
164518118|NCT01940939|594266243|FG001|Overall Study|Withdrawal by Subject|8|||
164518119|NCT01470001|594266244|FG000|Overall Study|Lost to Follow-up|1|||
164518120|NCT01470001|594266245|FG001|Overall Study|Lost to Follow-up|1|||
164518121|NCT01470001|594266244|FG000|Overall Study|Physician Decision|2|||
164518122|NCT01470001|594266245|FG001|Overall Study|Physician Decision|0|||
164518123|NCT01470001|594266244|FG000|Overall Study|Withdrawal by Subject|2|||
164518124|NCT01470001|594266245|FG001|Overall Study|Withdrawal by Subject|1|||
164518125|NCT01895101|594266246|FG000|Overall Study|OPCAB procedure|1|||
164518126|NCT01895101|594266247|FG001|Overall Study|OPCAB procedure|1|||
164518127|NCT01895101|594266248|FG002|Overall Study|OPCAB procedure|3|||
164518128|NCT01895101|594266246|FG000|Overall Study|Withdrawal by Subject|0|||
164518129|NCT01895101|594266247|FG001|Overall Study|Withdrawal by Subject|1|||
164518130|NCT01895101|594266248|FG002|Overall Study|Withdrawal by Subject|2|||
164518131|NCT01895101|594266246|FG000|Overall Study|another study, enrolled in other study|0|||
164518132|NCT01895101|594266247|FG001|Overall Study|another study, enrolled in other study|1|||
164518133|NCT01895101|594266248|FG002|Overall Study|another study, enrolled in other study|0|||
164518134|NCT01895101|594266246|FG000|Overall Study|Death|0|||
164518135|NCT01895101|594266247|FG001|Overall Study|Death|1|||
164518136|NCT01895101|594266248|FG002|Overall Study|Death|0|||
164518137|NCT01895101|594266246|FG000|Overall Study|coagulation disorder|0|||
164518138|NCT01895101|594266247|FG001|Overall Study|coagulation disorder|1|||
164518139|NCT01895101|594266248|FG002|Overall Study|coagulation disorder|0|||
164518140|NCT02182947|594266253|FG000|Overall Study|Withdrawal by Subject|7|||
164518141|NCT02182947|594266253|FG000|Overall Study|Lost to Follow-up|3|||
164518142|NCT02182947|594266253|FG000|Overall Study|Failed screening activities|8|||
164518143|NCT02236988|594266254|FG000|Overall Study|Lost to Follow-up|0|||
164518144|NCT02236988|594266255|FG001|Overall Study|Lost to Follow-up|0|||
164518145|NCT02236988|594266256|FG002|Overall Study|Lost to Follow-up|0|||
164518146|NCT02236988|594266257|FG003|Overall Study|Lost to Follow-up|1|||
164518147|NCT02236988|594266254|FG000|Overall Study|Unable to Comply with Study Visits|0|||
164518148|NCT02236988|594266255|FG001|Overall Study|Unable to Comply with Study Visits|0|||
164615615|NCT01421069|594613736|FG000|Active Treatment Period|Pregnancy|1|||
164518149|NCT02236988|594266256|FG002|Overall Study|Unable to Comply with Study Visits|0|||
164518150|NCT02236988|594266257|FG003|Overall Study|Unable to Comply with Study Visits|2|||
164615616|NCT01421069|594613736|FG000|Active Treatment Period|Adverse Event|1|||
164518151|NCT04308590|594266258|FG000|Overall Study|Adverse Event|12|||
164518152|NCT04308590|594266259|FG001|Overall Study|Adverse Event|2|||
164518153|NCT04308590|594266258|FG000|Overall Study|Withdrawal by Subject|10|||
164615617|NCT01421069|594613736|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
164615618|NCT01421069|594613736|FG000|Active Treatment Period|Enrolled in observational period|29|||
164615619|NCT01421069|594613736|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
164615620|NCT01421069|594613736|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
164615621|NCT01421069|594613736|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
164615622|NCT01421069|594613736|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
164615623|NCT01421069|594613736|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
164615624|NCT01421069|594613736|FG000|2b. Retreatment Period|Protocol Violation|1|||
164615625|NCT01421069|594613736|FG000|Observational Period|Other|1|||
164615626|NCT01421069|594613736|FG000|Observational Period|No longer willing to participate in study|4|||
164615627|NCT01421069|594613736|FG000|Observational Period|Lost to Follow-up|3|||
164615628|NCT00741260|594613741|FG000|Overall Study|Disease Progression|3|||
164615629|NCT00741260|594613742|FG001|Overall Study|Disease Progression|5|||
164615630|NCT00741260|594613743|FG002|Overall Study|Disease Progression|3|||
164615631|NCT00741260|594613744|FG003|Overall Study|Disease Progression|3|||
164615632|NCT00741260|594613745|FG004|Overall Study|Disease Progression|5|||
164615633|NCT00741260|594613746|FG005|Overall Study|Disease Progression|37|||
164615634|NCT00741260|594613747|FG006|Overall Study|Disease Progression|4|||
164615635|NCT00741260|594613741|FG000|Overall Study|Death|0|||
164615636|NCT00741260|594613742|FG001|Overall Study|Death|1|||
164615637|NCT00741260|594613743|FG002|Overall Study|Death|0|||
164615638|NCT00741260|594613744|FG003|Overall Study|Death|1|||
164615639|NCT00741260|594613745|FG004|Overall Study|Death|2|||
164615640|NCT00741260|594613746|FG005|Overall Study|Death|2|||
164615641|NCT00741260|594613747|FG006|Overall Study|Death|1|||
164615642|NCT00741260|594613741|FG000|Overall Study|Withdrawal by Subject|0|||
164615643|NCT00741260|594613742|FG001|Overall Study|Withdrawal by Subject|0|||
164615644|NCT00741260|594613743|FG002|Overall Study|Withdrawal by Subject|0|||
164615645|NCT00741260|594613744|FG003|Overall Study|Withdrawal by Subject|0|||
164615646|NCT00741260|594613745|FG004|Overall Study|Withdrawal by Subject|1|||
164615647|NCT00741260|594613746|FG005|Overall Study|Withdrawal by Subject|3|||
164615648|NCT00741260|594613747|FG006|Overall Study|Withdrawal by Subject|1|||
164615649|NCT00741260|594613741|FG000|Overall Study|Physician Decision|1|||
164615650|NCT00741260|594613742|FG001|Overall Study|Physician Decision|1|||
164615651|NCT00741260|594613743|FG002|Overall Study|Physician Decision|0|||
164615652|NCT00741260|594613744|FG003|Overall Study|Physician Decision|0|||
164615653|NCT00741260|594613745|FG004|Overall Study|Physician Decision|0|||
164615654|NCT00741260|594613746|FG005|Overall Study|Physician Decision|0|||
164615655|NCT00741260|594613747|FG006|Overall Study|Physician Decision|0|||
164615656|NCT00741260|594613741|FG000|Overall Study|Other|2|||
164615657|NCT00741260|594613742|FG001|Overall Study|Other|1|||
164615658|NCT00741260|594613743|FG002|Overall Study|Other|1|||
164615659|NCT00741260|594613744|FG003|Overall Study|Other|2|||
164615660|NCT00741260|594613745|FG004|Overall Study|Other|1|||
164615661|NCT00741260|594613746|FG005|Overall Study|Other|3|||
164615662|NCT00741260|594613747|FG006|Overall Study|Other|1|||
164615663|NCT02565615|594613748|FG000|Overall Study|Death|0|||
164615664|NCT02565615|594613749|FG001|Overall Study|Death|1|||
164615665|NCT02565615|594613750|FG002|Overall Study|Death|0|||
164615666|NCT02565615|594613751|FG003|Overall Study|Death|0|||
164615667|NCT02565615|594613752|FG004|Overall Study|Death|4|||
164615668|NCT02565615|594613748|FG000|Overall Study|Not willing to participate in study|2|||
164615669|NCT02565615|594613749|FG001|Overall Study|Not willing to participate in study|21|||
164615670|NCT02565615|594613750|FG002|Overall Study|Not willing to participate in study|0|||
164615671|NCT02565615|594613751|FG003|Overall Study|Not willing to participate in study|1|||
164615672|NCT02565615|594613752|FG004|Overall Study|Not willing to participate in study|169|||
164615673|NCT02565615|594613748|FG000|Overall Study|Lost to Follow-up|0|||
164615674|NCT02565615|594613749|FG001|Overall Study|Lost to Follow-up|4|||
164615675|NCT02565615|594613750|FG002|Overall Study|Lost to Follow-up|0|||
164615676|NCT02565615|594613751|FG003|Overall Study|Lost to Follow-up|1|||
164615677|NCT02565615|594613752|FG004|Overall Study|Lost to Follow-up|765|||
164615678|NCT02565615|594613748|FG000|Overall Study|Not meeting eligibility criteria|0|||
164615679|NCT02565615|594613749|FG001|Overall Study|Not meeting eligibility criteria|7|||
164615680|NCT02565615|594613750|FG002|Overall Study|Not meeting eligibility criteria|0|||
164615681|NCT02565615|594613751|FG003|Overall Study|Not meeting eligibility criteria|0|||
164615682|NCT02565615|594613752|FG004|Overall Study|Not meeting eligibility criteria|25|||
164615683|NCT02565615|594613748|FG000|Overall Study|Reason not defined|0|||
164615684|NCT02565615|594613749|FG001|Overall Study|Reason not defined|2|||
164615685|NCT02565615|594613750|FG002|Overall Study|Reason not defined|0|||
164615686|NCT02565615|594613751|FG003|Overall Study|Reason not defined|1|||
164615687|NCT02565615|594613752|FG004|Overall Study|Reason not defined|62|||
164615688|NCT02565615|594613748|FG000|Overall Study|Adverse Event|1|||
164615689|NCT02565615|594613749|FG001|Overall Study|Adverse Event|1|||
164615690|NCT02565615|594613750|FG002|Overall Study|Adverse Event|0|||
164615691|NCT02565615|594613751|FG003|Overall Study|Adverse Event|0|||
164615692|NCT02565615|594613752|FG004|Overall Study|Adverse Event|9|||
164615693|NCT02565615|594613748|FG000|Overall Study|Untreated|0|||
164615694|NCT02565615|594613749|FG001|Overall Study|Untreated|0|||
164615695|NCT02565615|594613750|FG002|Overall Study|Untreated|0|||
164615696|NCT02565615|594613751|FG003|Overall Study|Untreated|0|||
164615697|NCT02565615|594613752|FG004|Overall Study|Untreated|567|||
164615698|NCT01928082|594613754|FG000|Overall Study|Study terminated.|1|||
164615699|NCT01815580|594613755|FG000|Overall Study|Lost to Follow-up|4|||
164615700|NCT01815580|594613756|FG001|Overall Study|Lost to Follow-up|7|||
164615701|NCT01815580|594613755|FG000|Overall Study|Withdrawal by Subject|3|||
164615702|NCT01815580|594613756|FG001|Overall Study|Withdrawal by Subject|4|||
164615703|NCT01815580|594613755|FG000|Overall Study|Excluded from analysis|5|||
164615704|NCT01815580|594613756|FG001|Overall Study|Excluded from analysis|4|||
164615705|NCT02120352|594613759|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
164615706|NCT02120352|594613760|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
164615707|NCT02120352|594613761|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
164615708|NCT02120352|594613762|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
164615709|NCT02120352|594613763|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
164615710|NCT02120352|594613764|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
164615711|NCT02120352|594613765|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
164615712|NCT02120352|594613759|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
164615713|NCT02120352|594613760|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
164615714|NCT02120352|594613761|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
164615715|NCT02120352|594613762|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
164615716|NCT02120352|594613763|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
164615717|NCT02120352|594613764|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
164615718|NCT02120352|594613765|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
164615719|NCT02120352|594613759|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
164615720|NCT02120352|594613760|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
164615721|NCT02120352|594613761|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
164615722|NCT02120352|594613762|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
164615723|NCT02120352|594613763|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
164615724|NCT02120352|594613764|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
164615725|NCT02120352|594613765|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
164615726|NCT02120352|594613759|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
164615727|NCT02120352|594613760|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
164615728|NCT02120352|594613761|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
164615729|NCT02120352|594613762|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
164615730|NCT02120352|594613763|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
164615731|NCT02120352|594613764|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
164615732|NCT02120352|594613765|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
164615733|NCT02120352|594613759|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
164615734|NCT02120352|594613760|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
164615735|NCT02120352|594613761|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
164615736|NCT02120352|594613762|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
164615737|NCT02120352|594613763|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
164615738|NCT02120352|594613764|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
164615739|NCT02120352|594613765|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
164615740|NCT02120352|594613759|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
164615741|NCT02120352|594613760|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
164615742|NCT02120352|594613761|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
164615743|NCT02120352|594613762|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
164615744|NCT02120352|594613763|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
164615745|NCT02120352|594613764|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
164615746|NCT02120352|594613765|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
164615747|NCT02120352|594613759|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
164615748|NCT02120352|594613760|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
164615749|NCT02120352|594613761|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
164615750|NCT02120352|594613762|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
164615751|NCT02120352|594613763|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
164615752|NCT02120352|594613764|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
164615753|NCT02120352|594613765|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
164615754|NCT02120352|594613759|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
164615755|NCT02120352|594613760|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
164615756|NCT02120352|594613761|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
164615757|NCT02120352|594613762|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
164615758|NCT02120352|594613763|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
164615759|NCT02120352|594613764|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
164615760|NCT02120352|594613765|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
164615761|NCT02120352|594613759|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
164615762|NCT02120352|594613760|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
164615763|NCT02120352|594613761|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
164615764|NCT02120352|594613762|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
164615765|NCT02120352|594613763|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
164615766|NCT02120352|594613764|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
164615767|NCT02120352|594613765|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
164615768|NCT02120352|594613759|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
164615769|NCT02120352|594613760|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
164615770|NCT02120352|594613761|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
164615771|NCT02120352|594613762|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
164615772|NCT02120352|594613763|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
164615773|NCT02120352|594613764|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
164615774|NCT02120352|594613765|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
164615775|NCT02120352|594613759|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
164615776|NCT02120352|594613760|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
164615777|NCT02120352|594613761|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
164615778|NCT02120352|594613762|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
164615779|NCT02120352|594613763|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
164615780|NCT02120352|594613764|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
164615781|NCT02120352|594613765|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
164615782|NCT02120352|594613759|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
164615783|NCT02120352|594613760|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
164615784|NCT02120352|594613761|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
164615785|NCT02120352|594613762|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
164615786|NCT02120352|594613763|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
164615787|NCT02120352|594613764|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
164615788|NCT02120352|594613765|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
164615789|NCT02120352|594613759|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
164615790|NCT02120352|594613760|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
164615791|NCT02120352|594613761|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
164615792|NCT02120352|594613762|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
164615793|NCT02120352|594613763|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
164615794|NCT02120352|594613764|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
164615795|NCT02120352|594613765|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
164615796|NCT02120352|594613759|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
164615797|NCT02120352|594613760|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
164615798|NCT02120352|594613761|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
164615799|NCT02120352|594613762|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
164615800|NCT02120352|594613763|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
164615801|NCT02120352|594613764|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
164615802|NCT02120352|594613765|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
164615803|NCT02120352|594613759|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
164615804|NCT02120352|594613760|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
164615805|NCT02120352|594613761|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
164615806|NCT02120352|594613762|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
164615807|NCT02120352|594613763|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
164615808|NCT02120352|594613764|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
164615809|NCT02120352|594613765|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
164615810|NCT02120352|594613759|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
164615811|NCT02120352|594613760|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
164518154|NCT04308590|594266259|FG001|Overall Study|Withdrawal by Subject|4|||
164518155|NCT04308590|594266258|FG000|Overall Study|Death|1|||
164518156|NCT04308590|594266259|FG001|Overall Study|Death|0|||
164518157|NCT04308590|594266258|FG000|Overall Study|Lost to Follow-up|1|||
164518158|NCT04308590|594266259|FG001|Overall Study|Lost to Follow-up|1|||
164518159|NCT04308590|594266258|FG000|Overall Study|Physician Decision|1|||
164518160|NCT04308590|594266259|FG001|Overall Study|Physician Decision|0|||
164518161|NCT04308590|594266258|FG000|Overall Study|Subject does not want to continue with Pi|0|||
164518162|NCT04308590|594266259|FG001|Overall Study|Subject does not want to continue with Pi|1|||
164518163|NCT00939822|594266260|FG000|Overall Study|Lost to Follow-up|1|||
164518164|NCT00939822|594266261|FG001|Overall Study|Lost to Follow-up|0|||
164518165|NCT00939822|594266260|FG000|Overall Study|withdrew from study due to busy schedule|1|||
164518166|NCT00939822|594266261|FG001|Overall Study|withdrew from study due to busy schedule|1|||
164518167|NCT00939822|594266260|FG000|Overall Study|Mental health issues|0|||
164518168|NCT00939822|594266261|FG001|Overall Study|Mental health issues|2|||
164518169|NCT01072630|594266266|FG000|Overall Study|Adverse Event|11|||
164518170|NCT01072630|594266267|FG001|Overall Study|Adverse Event|19|||
164518171|NCT01072630|594266268|FG002|Overall Study|Adverse Event|2|||
164518172|NCT01072630|594266266|FG000|Overall Study|Lack of Efficacy|10|||
164518173|NCT01072630|594266267|FG001|Overall Study|Lack of Efficacy|10|||
164518174|NCT01072630|594266268|FG002|Overall Study|Lack of Efficacy|1|||
164518175|NCT01072630|594266266|FG000|Overall Study|Withdrawal by Subject|8|||
164518176|NCT01072630|594266267|FG001|Overall Study|Withdrawal by Subject|7|||
164518177|NCT01072630|594266268|FG002|Overall Study|Withdrawal by Subject|2|||
164518178|NCT01072630|594266266|FG000|Overall Study|Protocol Violation|10|||
164518179|NCT01072630|594266267|FG001|Overall Study|Protocol Violation|8|||
164518180|NCT01072630|594266268|FG002|Overall Study|Protocol Violation|4|||
164518181|NCT01072630|594266266|FG000|Overall Study|Lost to Follow-up|11|||
164518182|NCT01072630|594266267|FG001|Overall Study|Lost to Follow-up|11|||
164518183|NCT01072630|594266268|FG002|Overall Study|Lost to Follow-up|1|||
164518184|NCT01072630|594266266|FG000|Overall Study|Noncompliance with study medication|1|||
164518185|NCT01072630|594266267|FG001|Overall Study|Noncompliance with study medication|1|||
164518186|NCT01072630|594266268|FG002|Overall Study|Noncompliance with study medication|1|||
164518187|NCT01072630|594266266|FG000|Overall Study|Noncompliance with study procedures|1|||
164518188|NCT01072630|594266267|FG001|Overall Study|Noncompliance with study procedures|2|||
164518189|NCT01072630|594266268|FG002|Overall Study|Noncompliance with study procedures|1|||
164518190|NCT01072630|594266266|FG000|Overall Study|Other|3|||
164518191|NCT01072630|594266267|FG001|Overall Study|Other|2|||
164518192|NCT01072630|594266268|FG002|Overall Study|Other|1|||
164518193|NCT02683785|594266284|FG000|Overall Study|Withdrawal by Subject|1|||
164518194|NCT02683785|594266285|FG001|Overall Study|Withdrawal by Subject|1|||
164518195|NCT02683785|594266284|FG000|Overall Study|Lost to Follow-up|0|||
164518196|NCT02683785|594266285|FG001|Overall Study|Lost to Follow-up|1|||
164518197|NCT02683785|594266284|FG000|Overall Study|Adverse Event|0|||
164518198|NCT02683785|594266285|FG001|Overall Study|Adverse Event|2|||
164518199|NCT00416195|594266286|FG000|Overall Study|Adverse Event|1|||
164518200|NCT00416195|594266287|FG001|Overall Study|Adverse Event|2|||
164518201|NCT00416195|594266286|FG000|Overall Study|Protocol Violation|1|||
164518202|NCT00416195|594266287|FG001|Overall Study|Protocol Violation|1|||
164518203|NCT00416195|594266286|FG000|Overall Study|Other|0|||
164518204|NCT00416195|594266287|FG001|Overall Study|Other|1|||
164518205|NCT01305408|594266288|FG000|Overall Study|Adverse Event|10|||
164518206|NCT01305408|594266289|FG001|Overall Study|Adverse Event|7|||
164518207|NCT01305408|594266288|FG000|Overall Study|Lack of Efficacy|3|||
164518208|NCT01305408|594266289|FG001|Overall Study|Lack of Efficacy|4|||
164518209|NCT01305408|594266288|FG000|Overall Study|Withdrawal by Subject|9|||
164518210|NCT01305408|594266289|FG001|Overall Study|Withdrawal by Subject|9|||
164518211|NCT01305408|594266288|FG000|Overall Study|Protocol Violation|4|||
164518212|NCT01305408|594266289|FG001|Overall Study|Protocol Violation|6|||
164518213|NCT01305408|594266288|FG000|Overall Study|Lost to Follow-up|5|||
164518214|NCT01305408|594266289|FG001|Overall Study|Lost to Follow-up|3|||
164518215|NCT01305408|594266288|FG000|Overall Study|Noncompliance with study medication|0|||
164518216|NCT01305408|594266289|FG001|Overall Study|Noncompliance with study medication|1|||
164518217|NCT01305408|594266288|FG000|Overall Study|Noncompliance with study procedures|0|||
164518218|NCT01305408|594266289|FG001|Overall Study|Noncompliance with study procedures|1|||
164518219|NCT01305408|594266288|FG000|Overall Study|Other|1|||
164518220|NCT01305408|594266289|FG001|Overall Study|Other|0|||
164518221|NCT01877239|594266290|FG000|Overall Study|Adverse Event|4|||
164518222|NCT01877239|594266290|FG000|Overall Study|Disease Remission|1|||
164518223|NCT01877239|594266290|FG000|Overall Study|Withdrawal by Subject|4|||
164518224|NCT01877239|594266290|FG000|Overall Study|Other|2|||
164518225|NCT01877239|594266290|FG000|Overall Study|Lack of Efficacy|4|||
164518226|NCT01877239|594266290|FG000|Overall Study|Data not available|35|||
164518227|NCT01283516|594266294|FG000|Overall Study|Adverse Event|0|||
164518228|NCT01283516|594266295|FG001|Overall Study|Adverse Event|0|||
164518229|NCT01283516|594266296|FG002|Overall Study|Adverse Event|0|||
164518230|NCT01283516|594266297|FG003|Overall Study|Adverse Event|0|||
164518231|NCT01283516|594266298|FG004|Overall Study|Adverse Event|0|||
164518232|NCT01283516|594266299|FG005|Overall Study|Adverse Event|0|||
164518233|NCT01283516|594266300|FG006|Overall Study|Adverse Event|2|||
164518234|NCT01283516|594266301|FG007|Overall Study|Adverse Event|0|||
164518235|NCT01283516|594266302|FG008|Overall Study|Adverse Event|28|||
164518236|NCT01283516|594266294|FG000|Overall Study|Death|0|||
164518237|NCT01283516|594266295|FG001|Overall Study|Death|0|||
164518238|NCT01283516|594266296|FG002|Overall Study|Death|0|||
164518239|NCT01283516|594266297|FG003|Overall Study|Death|0|||
164518240|NCT01283516|594266298|FG004|Overall Study|Death|0|||
164518241|NCT01283516|594266299|FG005|Overall Study|Death|1|||
164518242|NCT01283516|594266300|FG006|Overall Study|Death|0|||
164518243|NCT01283516|594266301|FG007|Overall Study|Death|1|||
164518244|NCT01283516|594266302|FG008|Overall Study|Death|12|||
164518245|NCT01283516|594266294|FG000|Overall Study|Disease Progression|2|||
164518246|NCT01283516|594266295|FG001|Overall Study|Disease Progression|2|||
164518247|NCT01283516|594266296|FG002|Overall Study|Disease Progression|3|||
164518248|NCT01283516|594266297|FG003|Overall Study|Disease Progression|3|||
164518249|NCT01283516|594266298|FG004|Overall Study|Disease Progression|13|||
164615812|NCT02120352|594613761|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
164615813|NCT02120352|594613762|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
164615814|NCT02120352|594613763|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
164615815|NCT02120352|594613764|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
164615816|NCT02120352|594613765|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
164615817|NCT02120352|594613759|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
164615818|NCT02120352|594613760|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
164615819|NCT02120352|594613761|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
164615820|NCT02120352|594613762|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
164615821|NCT02120352|594613763|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
164615822|NCT02120352|594613764|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
164615823|NCT02120352|594613765|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
164615824|NCT02120352|594613759|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
164615825|NCT02120352|594613760|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
164615826|NCT02120352|594613761|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
164615827|NCT02120352|594613762|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
164615828|NCT02120352|594613763|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
164615829|NCT02120352|594613764|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
164615830|NCT02120352|594613765|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
164615831|NCT02120352|594613759|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
164615832|NCT02120352|594613760|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
164615833|NCT02120352|594613761|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
164615834|NCT02120352|594613762|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
164615835|NCT02120352|594613763|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
164615836|NCT02120352|594613764|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
164615837|NCT02120352|594613765|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
164615838|NCT02120352|594613759|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
164615839|NCT02120352|594613760|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
164615840|NCT02120352|594613761|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
164615841|NCT02120352|594613762|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
164615842|NCT02120352|594613763|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
164615843|NCT02120352|594613764|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
164615844|NCT02120352|594613765|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
164615845|NCT02120352|594613759|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
164615846|NCT02120352|594613760|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
164615847|NCT02120352|594613761|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
164615848|NCT02120352|594613762|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
164615849|NCT02120352|594613763|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
164615850|NCT02120352|594613764|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
164615851|NCT02120352|594613765|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
164615852|NCT02120352|594613759|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
164615853|NCT02120352|594613760|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
164615854|NCT02120352|594613761|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
164615855|NCT02120352|594613762|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
164615856|NCT02120352|594613763|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
164615857|NCT02120352|594613764|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
164615858|NCT02120352|594613765|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
164615859|NCT02427100|594613766|FG000|Overall Study|Lost to Follow-up|0|||
164615860|NCT02427100|594613767|FG001|Overall Study|Lost to Follow-up|2|||
164615861|NCT01610206|594613770|FG000|Overall Study|Adverse Event|10|||
164615862|NCT01610206|594613771|FG001|Overall Study|Adverse Event|30|||
164615863|NCT02186561|594613772|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
164615864|NCT02186561|594613772|FG000|Enrollment|Enrollment Cap Reached|5|||
164615865|NCT02186561|594613772|FG000|Enrollment|Insurance Denial|2|||
164615866|NCT02186561|594613772|FG000|Enrollment|Withdrawal by Subject|2|||
164615867|NCT02186561|594613772|FG000|Enrollment|Investigator Withdrew Consent|1|||
164615868|NCT02186561|594613772|FG000|30-Day Post Index Procedure Visit|Death|1|||
164615869|NCT02186561|594613772|FG000|1- Year Post Index Procedure Visit|Death|1|||
164615870|NCT02186561|594613772|FG000|1- Year Post Index Procedure Visit|Missed|1|||
164615871|NCT00023712|594613773|FG000|Overall Study|Not platinum sensitive|1|||
164615872|NCT00023712|594613774|FG001|Overall Study|Not platinum sensitive|0|||
164615873|NCT00023712|594613773|FG000|Overall Study|Never treated|1|||
164615874|NCT00023712|594613774|FG001|Overall Study|Never treated|1|||
164615875|NCT01601470|594613775|FG000|Period 2 - LCZ696|Physician Decision|1|||
164615876|NCT01203787|594613776|FG000|Overall Study|Death|12|||
164615877|NCT01203787|594613777|FG001|Overall Study|Death|10|||
164615878|NCT01203787|594613776|FG000|Overall Study|Withdrawal by Subject|6|||
164615879|NCT01203787|594613777|FG001|Overall Study|Withdrawal by Subject|2|||
164615880|NCT01203787|594613776|FG000|Overall Study|Lost to Follow-up|2|||
164615881|NCT01203787|594613777|FG001|Overall Study|Lost to Follow-up|0|||
164615882|NCT01203787|594613776|FG000|Overall Study|Adverse Event|11|||
164615883|NCT01203787|594613777|FG001|Overall Study|Adverse Event|15|||
164615884|NCT00431496|594613780|FG000|Overall Study|Adverse Event|3|||
164615885|NCT00431496|594613780|FG000|Overall Study|Lost to Follow-up|1|||
164615886|NCT00431496|594613780|FG000|Overall Study|Withdrawal by Subject|2|||
164615887|NCT00431496|594613780|FG000|Overall Study|Protocol-specified criteria|5|||
164615888|NCT02343952|594613781|FG000|Study Treatment|Disease Progression|23|||
164615889|NCT02343952|594613781|FG000|Study Treatment|Death|3|||
164615890|NCT02343952|594613781|FG000|Study Treatment|Adverse Event|19|||
164615891|NCT02343952|594613781|FG000|Study Treatment|Withdrawal by Subject|7|||
164615892|NCT02343952|594613781|FG000|Study Treatment|other complicating Diseases|1|||
164615893|NCT02343952|594613781|FG000|Follow up|Withdrawal by Subject|3|||
164147378|NCT05168202|592902026|FG002|Overall Study|Lack of Efficacy|1|||
164518250|NCT01283516|594266299|FG005|Overall Study|Disease Progression|8|||
164518251|NCT01283516|594266300|FG006|Overall Study|Disease Progression|6|||
164518252|NCT01283516|594266301|FG007|Overall Study|Disease Progression|3|||
164518253|NCT01283516|594266302|FG008|Overall Study|Disease Progression|139|||
164518254|NCT01283516|594266294|FG000|Overall Study|Withdrawal by Subject|0|||
164518255|NCT01283516|594266295|FG001|Overall Study|Withdrawal by Subject|0|||
164518256|NCT01283516|594266296|FG002|Overall Study|Withdrawal by Subject|0|||
164518257|NCT01283516|594266297|FG003|Overall Study|Withdrawal by Subject|0|||
164518258|NCT01283516|594266298|FG004|Overall Study|Withdrawal by Subject|1|||
164518259|NCT01283516|594266299|FG005|Overall Study|Withdrawal by Subject|0|||
164518260|NCT01283516|594266300|FG006|Overall Study|Withdrawal by Subject|1|||
164518261|NCT01283516|594266301|FG007|Overall Study|Withdrawal by Subject|0|||
164518262|NCT01283516|594266302|FG008|Overall Study|Withdrawal by Subject|36|||
164518263|NCT01283516|594266294|FG000|Overall Study|Administrative problems|0|||
164518264|NCT01283516|594266295|FG001|Overall Study|Administrative problems|0|||
164518265|NCT01283516|594266296|FG002|Overall Study|Administrative problems|0|||
164518266|NCT01283516|594266297|FG003|Overall Study|Administrative problems|0|||
164518267|NCT01283516|594266298|FG004|Overall Study|Administrative problems|0|||
164518268|NCT01283516|594266299|FG005|Overall Study|Administrative problems|1|||
164518269|NCT01283516|594266300|FG006|Overall Study|Administrative problems|1|||
164518270|NCT01283516|594266301|FG007|Overall Study|Administrative problems|1|||
164615894|NCT02343952|594613781|FG000|Follow up|Death|33|||
164615895|NCT02343952|594613781|FG000|Follow up|Patient does not meet eligibility for study.|1|||
164615896|NCT02343952|594613781|FG000|Follow up|Research department closed by the practice.|5|||
164518271|NCT01283516|594266302|FG008|Overall Study|Administrative problems|39|||
164615897|NCT02343952|594613781|FG000|Follow up|Patient went home to Russia|1|||
164615898|NCT02343952|594613781|FG000|Follow up|Disease Progression|1|||
164615899|NCT02343952|594613781|FG000|Follow up|study terminated|1|||
164615900|NCT02671760|594613782|FG000|Overall Study|Lost to Follow-up|0|||
164615901|NCT02671760|594613783|FG001|Overall Study|Lost to Follow-up|1|||
164615902|NCT02671760|594613784|FG002|Overall Study|Lost to Follow-up|0|||
164615903|NCT02079519|594613789|FG000|Overall Study|Disease Progression|9|||
164615904|NCT02079519|594613789|FG000|Overall Study|Adverse Event|1|||
164615905|NCT01802515|594613790|FG000|Overall Study|Withdrawal by Subject|3|||
164615906|NCT01802515|594613791|FG001|Overall Study|Withdrawal by Subject|0|||
164615907|NCT01802515|594613792|FG002|Overall Study|Withdrawal by Subject|0|||
164615908|NCT01931150|594613795|FG000|Overall Study|Withdrawal by Subject|1|||
164615909|NCT01931150|594613796|FG001|Overall Study|Withdrawal by Subject|2|||
164615910|NCT00845845|594613797|FG000|Overall Study|Lost to Follow-up|0|||
164615911|NCT00845845|594613798|FG001|Overall Study|Lost to Follow-up|4|||
164615912|NCT01685203|594613799|FG000|Overall Study|Lost to Follow-up|3|||
164615913|NCT01685203|594613800|FG001|Overall Study|Lost to Follow-up|3|||
164615914|NCT01685203|594613801|FG002|Overall Study|Lost to Follow-up|0|||
164615915|NCT01685203|594613802|FG003|Overall Study|Lost to Follow-up|1|||
164615916|NCT01685203|594613803|FG004|Overall Study|Lost to Follow-up|0|||
164615917|NCT01685203|594613804|FG005|Overall Study|Lost to Follow-up|0|||
164615918|NCT01685203|594613805|FG006|Overall Study|Lost to Follow-up|0|||
164615919|NCT01685203|594613799|FG000|Overall Study|Adverse Event|0|||
164615920|NCT01685203|594613800|FG001|Overall Study|Adverse Event|0|||
164615921|NCT01685203|594613801|FG002|Overall Study|Adverse Event|0|||
164615922|NCT01685203|594613802|FG003|Overall Study|Adverse Event|0|||
164615923|NCT01685203|594613803|FG004|Overall Study|Adverse Event|0|||
164615924|NCT01685203|594613804|FG005|Overall Study|Adverse Event|2|||
164615925|NCT01685203|594613805|FG006|Overall Study|Adverse Event|0|||
164615926|NCT01685203|594613799|FG000|Overall Study|Adverse event and withdrew consent|1|||
164615927|NCT01685203|594613800|FG001|Overall Study|Adverse event and withdrew consent|0|||
164615928|NCT01685203|594613801|FG002|Overall Study|Adverse event and withdrew consent|0|||
164615929|NCT01685203|594613802|FG003|Overall Study|Adverse event and withdrew consent|0|||
164615930|NCT01685203|594613803|FG004|Overall Study|Adverse event and withdrew consent|0|||
164615931|NCT01685203|594613804|FG005|Overall Study|Adverse event and withdrew consent|0|||
164615932|NCT01685203|594613805|FG006|Overall Study|Adverse event and withdrew consent|0|||
164615933|NCT01685203|594613799|FG000|Overall Study|Patient's decision|0|||
164615934|NCT01685203|594613800|FG001|Overall Study|Patient's decision|0|||
164615935|NCT01685203|594613801|FG002|Overall Study|Patient's decision|0|||
164615936|NCT01685203|594613802|FG003|Overall Study|Patient's decision|0|||
164615937|NCT01685203|594613803|FG004|Overall Study|Patient's decision|0|||
164615938|NCT01685203|594613804|FG005|Overall Study|Patient's decision|1|||
164615939|NCT01685203|594613805|FG006|Overall Study|Patient's decision|0|||
164615940|NCT04095793|594613806|FG000|Overall Study|Adverse Event|3|||
164615941|NCT04095793|594613806|FG000|Overall Study|Study Terminated by Sponsor|103|||
164615942|NCT04095793|594613806|FG000|Overall Study|Withdrawal by Subject|4|||
164615943|NCT03619837|594613807|FG000|Screening|received organs from HCV-negative donors|47|||
164615944|NCT03619837|594613807|FG000|Screening|died on the wait-list|2|||
164615945|NCT03619837|594613807|FG000|Screening|remained on the wait list|40|||
164615946|NCT03619837|594613807|FG000|Screening|didn't meet eligibility criteria|3|||
164615947|NCT03619837|594613807|FG000|Screening|withdrew consent|2|||
164615948|NCT03619837|594613807|FG000|Screening|never listed for HCV-viremic donor|1|||
164615949|NCT03619837|594613807|FG000|Screening|developed exclusion criteria|2|||
164615950|NCT03619837|594613807|FG000|Screening|excluded by the investigator due to non-compliance|1|||
164615951|NCT01602549|594613808|FG000|Overall Study|Protocol Violation|0|||
164615952|NCT01602549|594613809|FG001|Overall Study|Protocol Violation|1|||
164615953|NCT01602549|594613808|FG000|Overall Study|Withdrawal by Subject|1|||
164615954|NCT01602549|594613809|FG001|Overall Study|Withdrawal by Subject|0|||
164615955|NCT03695471|594616054|FG000|Overall Study|Cancellation|1|||
164615956|NCT02859558|594616055|FG000|Step 1|Not Eligible|0|||
164615957|NCT02859558|594616056|FG001|Step 1|Not Eligible|0|||
164615958|NCT02859558|594616057|FG002|Step 1|Not Eligible|0|||
164615959|NCT02859558|594616058|FG003|Step 1|Not Eligible|0|||
164615960|NCT02859558|594616059|FG004|Step 1|Not Eligible|3|||
164615961|NCT02859558|594616055|FG000|Step 1|Lost to Follow-up|1|||
164615962|NCT02859558|594616056|FG001|Step 1|Lost to Follow-up|3|||
164615963|NCT02859558|594616057|FG002|Step 1|Lost to Follow-up|3|||
164615964|NCT02859558|594616058|FG003|Step 1|Lost to Follow-up|0|||
164615965|NCT02859558|594616059|FG004|Step 1|Lost to Follow-up|0|||
164615966|NCT02859558|594616055|FG000|Step 1|Did Not Return to Clinic|2|||
164615967|NCT02859558|594616056|FG001|Step 1|Did Not Return to Clinic|3|||
164615968|NCT02859558|594616057|FG002|Step 1|Did Not Return to Clinic|4|||
164615969|NCT02859558|594616058|FG003|Step 1|Did Not Return to Clinic|0|||
164615970|NCT02859558|594616059|FG004|Step 1|Did Not Return to Clinic|0|||
164615971|NCT02859558|594616055|FG000|Step 1|Moved|0|||
164615972|NCT02859558|594616056|FG001|Step 1|Moved|1|||
164615973|NCT02859558|594616057|FG002|Step 1|Moved|1|||
164615974|NCT02859558|594616058|FG003|Step 1|Moved|0|||
164615975|NCT02859558|594616059|FG004|Step 1|Moved|0|||
164615976|NCT02859558|594616055|FG000|Step 1|Withdrawal By Participant|1|||
164518272|NCT01283516|594266294|FG000|Overall Study|Lost to Follow-up|0|||
164518273|NCT01283516|594266295|FG001|Overall Study|Lost to Follow-up|0|||
164518274|NCT01283516|594266296|FG002|Overall Study|Lost to Follow-up|0|||
164518275|NCT01283516|594266297|FG003|Overall Study|Lost to Follow-up|0|||
164518276|NCT01283516|594266298|FG004|Overall Study|Lost to Follow-up|0|||
164518277|NCT01283516|594266299|FG005|Overall Study|Lost to Follow-up|0|||
164518278|NCT01283516|594266300|FG006|Overall Study|Lost to Follow-up|0|||
164518279|NCT01283516|594266301|FG007|Overall Study|Lost to Follow-up|0|||
164518280|NCT01283516|594266302|FG008|Overall Study|Lost to Follow-up|1|||
164518281|NCT00444275|594266305|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
164518282|NCT00444275|594266306|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
164518283|NCT00444275|594266307|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
164518284|NCT00444275|594266308|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
164518285|NCT00444275|594266309|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
164518286|NCT00444275|594266305|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
164518287|NCT00444275|594266306|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
164518288|NCT00444275|594266307|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
164518289|NCT00444275|594266308|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
164518290|NCT00444275|594266309|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
164518291|NCT00444275|594266305|FG000|Maintenance Treatment Phase|Adverse Event|0|||
164518292|NCT00444275|594266306|FG001|Maintenance Treatment Phase|Adverse Event|0|||
164518293|NCT00444275|594266307|FG002|Maintenance Treatment Phase|Adverse Event|3|||
164518294|NCT00444275|594266308|FG003|Maintenance Treatment Phase|Adverse Event|2|||
164518295|NCT00444275|594266309|FG004|Maintenance Treatment Phase|Adverse Event|13|||
164518296|NCT00444275|594266305|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
164518297|NCT00444275|594266306|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
164518298|NCT00444275|594266307|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
164518299|NCT00444275|594266308|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
164518300|NCT00444275|594266309|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
164518301|NCT00444275|594266305|FG000|Maintenance Treatment Phase|Patient's wish|0|||
164518302|NCT00444275|594266306|FG001|Maintenance Treatment Phase|Patient's wish|0|||
164518303|NCT00444275|594266307|FG002|Maintenance Treatment Phase|Patient's wish|19|||
164518304|NCT00444275|594266308|FG003|Maintenance Treatment Phase|Patient's wish|9|||
164518305|NCT00444275|594266309|FG004|Maintenance Treatment Phase|Patient's wish|20|||
164518306|NCT00444275|594266305|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
164518307|NCT00444275|594266306|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
164518308|NCT00444275|594266307|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
164518309|NCT00444275|594266308|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
164518310|NCT00444275|594266309|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
164518311|NCT00444275|594266305|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
164518312|NCT00444275|594266306|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
164518313|NCT00444275|594266307|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
164518314|NCT00444275|594266308|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
164518315|NCT00444275|594266309|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
164518316|NCT01743989|594266310|FG000|Treatment Phase|Unstable MR4.0|0|||
164518317|NCT01743989|594266311|FG001|Treatment Phase|Unstable MR4.0|6|||
164518318|NCT01743989|594266312|FG002|Treatment Phase|Unstable MR4.0|263|||
164518319|NCT01743989|594266310|FG000|Treatment Phase|Adverse Event|0|||
164518320|NCT01743989|594266311|FG001|Treatment Phase|Adverse Event|4|||
164518321|NCT01743989|594266312|FG002|Treatment Phase|Adverse Event|67|||
164518322|NCT01743989|594266310|FG000|Treatment Phase|Withdrawal by Subject|1|||
164518323|NCT01743989|594266311|FG001|Treatment Phase|Withdrawal by Subject|3|||
164518324|NCT01743989|594266312|FG002|Treatment Phase|Withdrawal by Subject|28|||
164518325|NCT01743989|594266310|FG000|Treatment Phase|Death|0|||
164518326|NCT01743989|594266311|FG001|Treatment Phase|Death|1|||
164518327|NCT01743989|594266312|FG002|Treatment Phase|Death|3|||
164518328|NCT01743989|594266310|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
164518329|NCT01743989|594266311|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
164518330|NCT01743989|594266312|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
164518331|NCT01743989|594266310|FG000|Treatment Phase|Protocol deviation|0|||
164518332|NCT01743989|594266311|FG001|Treatment Phase|Protocol deviation|0|||
164518333|NCT01743989|594266312|FG002|Treatment Phase|Protocol deviation|3|||
164518334|NCT01743989|594266310|FG000|Treatment Phase|Pregnancy|0|||
164518335|NCT01743989|594266311|FG001|Treatment Phase|Pregnancy|0|||
164518336|NCT01743989|594266312|FG002|Treatment Phase|Pregnancy|2|||
164518337|NCT01743989|594266310|FG000|Treatment Phase|Lost to Follow-up|0|||
164518338|NCT01743989|594266311|FG001|Treatment Phase|Lost to Follow-up|0|||
164518339|NCT01743989|594266312|FG002|Treatment Phase|Lost to Follow-up|2|||
164518340|NCT01743989|594266310|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
164518341|NCT01743989|594266311|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
164518342|NCT01743989|594266312|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
164518343|NCT01743989|594266310|FG000|Treatment Phase|Administrative problems|0|||
164518344|NCT01743989|594266311|FG001|Treatment Phase|Administrative problems|0|||
164518345|NCT01743989|594266312|FG002|Treatment Phase|Administrative problems|1|||
164518346|NCT01743989|594266310|FG000|Treatment Phase|New cancer (CML) therapy|0|||
164518347|NCT01743989|594266311|FG001|Treatment Phase|New cancer (CML) therapy|1|||
164518348|NCT01743989|594266312|FG002|Treatment Phase|New cancer (CML) therapy|0|||
164518349|NCT01743989|594266310|FG000|Treatment Phase|Physician Decision|0|||
164518350|NCT01743989|594266311|FG001|Treatment Phase|Physician Decision|0|||
164518351|NCT01743989|594266312|FG002|Treatment Phase|Physician Decision|3|||
164518352|NCT01743989|594266310|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
164518353|NCT01743989|594266311|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
164518354|NCT01743989|594266312|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
164518355|NCT01743989|594266310|FG000|Treatment Phase|Not randomized by mistake|0|||
164518356|NCT01743989|594266311|FG001|Treatment Phase|Not randomized by mistake|0|||
164518357|NCT01743989|594266312|FG002|Treatment Phase|Not randomized by mistake|1|||
164518358|NCT01743989|594266310|FG000|Treatment Phase|Included by mistake|0|||
164518359|NCT01743989|594266311|FG001|Treatment Phase|Included by mistake|0|||
164518360|NCT01743989|594266312|FG002|Treatment Phase|Included by mistake|1|||
164518361|NCT01743989|594266310|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
164518362|NCT01743989|594266311|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
164518363|NCT01743989|594266312|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
164518364|NCT01743989|594266310|FG000|TFR Phase|Adverse Event|0|||
164518365|NCT01743989|594266311|FG001|TFR Phase|Adverse Event|1|||
164518366|NCT01743989|594266312|FG002|TFR Phase|Adverse Event|0|||
164518367|NCT01743989|594266310|FG000|TFR Phase|Lost to Follow-up|0|||
164518368|NCT01743989|594266311|FG001|TFR Phase|Lost to Follow-up|2|||
164518369|NCT01743989|594266312|FG002|TFR Phase|Lost to Follow-up|0|||
164518370|NCT01743989|594266310|FG000|TFR Phase|Physician Decision|0|||
164518371|NCT01743989|594266311|FG001|TFR Phase|Physician Decision|1|||
164518372|NCT01743989|594266312|FG002|TFR Phase|Physician Decision|0|||
164518373|NCT01743989|594266310|FG000|TFR Phase|Logistical problems|0|||
164518374|NCT01743989|594266311|FG001|TFR Phase|Logistical problems|2|||
164518375|NCT01743989|594266312|FG002|TFR Phase|Logistical problems|0|||
164518376|NCT01743989|594266310|FG000|TFR Phase|Protocol deviation|0|||
164518377|NCT01743989|594266311|FG001|TFR Phase|Protocol deviation|1|||
164518378|NCT01743989|594266312|FG002|TFR Phase|Protocol deviation|0|||
164518379|NCT01743989|594266310|FG000|TFR Phase|Withdrawal by Subject|0|||
164518380|NCT01743989|594266311|FG001|TFR Phase|Withdrawal by Subject|2|||
164518381|NCT01743989|594266312|FG002|TFR Phase|Withdrawal by Subject|0|||
164518382|NCT01743989|594266310|FG000|Re-treatment Phase|Adverse Event|8|||
164518383|NCT01743989|594266311|FG001|Re-treatment Phase|Adverse Event|4|||
164518384|NCT01743989|594266312|FG002|Re-treatment Phase|Adverse Event|0|||
164518385|NCT01743989|594266310|FG000|Re-treatment Phase|Death|1|||
164518386|NCT01743989|594266311|FG001|Re-treatment Phase|Death|1|||
164518387|NCT01743989|594266312|FG002|Re-treatment Phase|Death|0|||
164518388|NCT01743989|594266310|FG000|Re-treatment Phase|Administrative problems|1|||
164518389|NCT01743989|594266311|FG001|Re-treatment Phase|Administrative problems|1|||
164518390|NCT01743989|594266312|FG002|Re-treatment Phase|Administrative problems|0|||
164518391|NCT01743989|594266310|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
164518392|NCT01743989|594266311|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
164518393|NCT01743989|594266312|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
164518394|NCT01743989|594266310|FG000|Re-treatment Phase|Unstable MR|1|||
164518395|NCT01743989|594266311|FG001|Re-treatment Phase|Unstable MR|0|||
164518396|NCT01743989|594266312|FG002|Re-treatment Phase|Unstable MR|0|||
164518397|NCT01743989|594266310|FG000|Re-treatment Phase|Physician Decision|0|||
164518398|NCT01743989|594266311|FG001|Re-treatment Phase|Physician Decision|1|||
164518399|NCT01743989|594266312|FG002|Re-treatment Phase|Physician Decision|0|||
164518400|NCT01743989|594266310|FG000|Re-treatment Phase|Lost to Follow-up|0|||
164518401|NCT01743989|594266311|FG001|Re-treatment Phase|Lost to Follow-up|1|||
164518402|NCT01743989|594266312|FG002|Re-treatment Phase|Lost to Follow-up|0|||
164518403|NCT02235311|594266315|FG000|Overall Study|Lost to Follow-up|0|||
164518404|NCT02235311|594266316|FG001|Overall Study|Lost to Follow-up|1|||
164518405|NCT02235311|594266315|FG000|Overall Study|Protocol Violation|0|||
164518406|NCT02235311|594266316|FG001|Overall Study|Protocol Violation|1|||
164518407|NCT04655027|594266317|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
164518408|NCT04655027|594266318|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
164518409|NCT00658788|594266319|FG000|Overall Study|Adverse Event|11|||
164518410|NCT00658788|594266319|FG000|Overall Study|Withdrawal by Subject|13|||
164518411|NCT00658788|594266319|FG000|Overall Study|Lost to Follow-up|18|||
164518412|NCT00658788|594266319|FG000|Overall Study|Treatment Discontinuation|32|||
164518413|NCT00653523|594266320|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
164518414|NCT00653523|594266320|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
164518415|NCT00653523|594266320|FG000|Overall Study|Adverse Event|7|||
164518416|NCT00653523|594266320|FG000|Overall Study|Withdrawal by Subject|6|||
164518417|NCT00653523|594266320|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
164518418|NCT00653523|594266320|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
164518419|NCT05543707|594266321|FG000|Overall Study|Study drug non-compliance/|5|||
164518420|NCT05543707|594266322|FG001|Overall Study|Study drug non-compliance/|0|||
164518421|NCT05543707|594266321|FG000|Overall Study|Withdrawal by Subject|1|||
164518422|NCT05543707|594266322|FG001|Overall Study|Withdrawal by Subject|1|||
164518423|NCT05543707|594266321|FG000|Overall Study|Adverse Event|1|||
164518424|NCT05543707|594266322|FG001|Overall Study|Adverse Event|0|||
164518425|NCT05543707|594266321|FG000|Overall Study|concurrent illness|0|||
164518426|NCT05543707|594266322|FG001|Overall Study|concurrent illness|1|||
164518427|NCT05543707|594266321|FG000|Overall Study|Pregnancy|1|||
164518428|NCT05543707|594266322|FG001|Overall Study|Pregnancy|1|||
164518429|NCT03006848|594266323|FG000|Overall Study|Adverse Event|1|||
164518430|NCT03006848|594266323|FG000|Overall Study|Physician Decision|1|||
164518431|NCT03006848|594266323|FG000|Overall Study|Lack of Efficacy|16|||
164518432|NCT04777864|594266324|FG000|Overall Study|Lost to Follow-up|8|||
164518433|NCT04777864|594266325|FG001|Overall Study|Lost to Follow-up|19|||
164518434|NCT06748729|594266330|FG000|Overall Study|Withdrawal by Subject|1|||
164518435|NCT00591370|594268328|FG000|Overall Study|Not Treated|2|||
164615977|NCT02859558|594616056|FG001|Step 1|Withdrawal By Participant|2|||
164518436|NCT01183260|594268329|FG000|Overall Study|Intraop screen failure|2|||
164518437|NCT01183260|594268330|FG001|Overall Study|Intraop screen failure|0|||
164518438|NCT01183260|594268329|FG000|Overall Study|Withdrawal by Subject|1|||
164518439|NCT01183260|594268330|FG001|Overall Study|Withdrawal by Subject|1|||
164518440|NCT01183260|594268329|FG000|Overall Study|Revised within 30 days|0|||
164518441|NCT01183260|594268330|FG001|Overall Study|Revised within 30 days|1|||
164615978|NCT02859558|594616057|FG002|Step 1|Withdrawal By Participant|1|||
164518442|NCT01183260|594268329|FG000|Overall Study|Death|1|||
164518443|NCT01183260|594268330|FG001|Overall Study|Death|0|||
164518444|NCT01202903|594268332|FG000|Overall Study|Administrative Probelms|1|||
164518445|NCT01202903|594268333|FG001|Overall Study|Administrative Probelms|4|||
164518446|NCT01202903|594268332|FG000|Overall Study|Protocol Violation|0|||
164518447|NCT01202903|594268333|FG001|Overall Study|Protocol Violation|1|||
164518448|NCT01202903|594268332|FG000|Overall Study|Death|1|||
164518449|NCT01202903|594268333|FG001|Overall Study|Death|0|||
164518450|NCT01202903|594268332|FG000|Overall Study|Lost to Follow-up|1|||
164518451|NCT01202903|594268333|FG001|Overall Study|Lost to Follow-up|1|||
164518452|NCT01202903|594268332|FG000|Overall Study|Lack of Efficacy|1|||
164518453|NCT01202903|594268333|FG001|Overall Study|Lack of Efficacy|3|||
164518454|NCT01202903|594268332|FG000|Overall Study|Adverse Event|3|||
164518455|NCT01202903|594268333|FG001|Overall Study|Adverse Event|3|||
164518456|NCT01202903|594268332|FG000|Overall Study|Withdrawal by Subject|4|||
164518457|NCT01202903|594268333|FG001|Overall Study|Withdrawal by Subject|4|||
164518458|NCT00837694|594268334|FG000|Overall Study|Lost to Follow-up|2|||
164518459|NCT00837694|594268335|FG001|Overall Study|Lost to Follow-up|0|||
164518460|NCT00837694|594268336|FG002|Overall Study|Lost to Follow-up|2|||
164518461|NCT00837694|594268337|FG003|Overall Study|Lost to Follow-up|1|||
164518462|NCT00837694|594268338|FG004|Overall Study|Lost to Follow-up|1|||
164518463|NCT00837694|594268339|FG005|Overall Study|Lost to Follow-up|1|||
164518464|NCT00306670|594268340|FG000|Overall Study|patients recruited; Genentech, the st|0|||
164518465|NCT00306670|594268341|FG001|Overall Study|patients recruited; Genentech, the st|2|||
164518466|NCT00503139|594268345|FG000|Overall Study|Case Report Forms were not collected|4|||
164518467|NCT00503139|594268345|FG000|Overall Study|Protocol Violation|4|||
164518468|NCT00091169|594268349|FG000|Overall Study|Disease progression|3|||
164518469|NCT00091169|594268350|FG001|Overall Study|Disease progression|1|||
164518470|NCT00091169|594268349|FG000|Overall Study|Adverse Event|11|||
164518471|NCT00091169|594268350|FG001|Overall Study|Adverse Event|17|||
164518472|NCT00091169|594268349|FG000|Overall Study|Death|4|||
164518473|NCT00091169|594268350|FG001|Overall Study|Death|1|||
164518474|NCT00091169|594268349|FG000|Overall Study|Withdrawal by Subject|10|||
164518475|NCT00091169|594268350|FG001|Overall Study|Withdrawal by Subject|13|||
164518476|NCT00091169|594268349|FG000|Overall Study|Other|3|||
164518477|NCT00091169|594268350|FG001|Overall Study|Other|4|||
164518478|NCT00091169|594268349|FG000|Overall Study|Not start protocol therapy|26|||
164518479|NCT00091169|594268350|FG001|Overall Study|Not start protocol therapy|17|||
164518480|NCT02735577|594268351|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
164518481|NCT02735577|594268351|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
164518482|NCT00833833|594268352|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
164518483|NCT00833833|594268353|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
164518484|NCT00833833|594268354|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
164518485|NCT00833833|594268355|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
164518486|NCT00833833|594268356|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
164518487|NCT00833833|594268357|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
164518488|NCT00833833|594268352|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
164518489|NCT00833833|594268353|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
164518490|NCT00833833|594268354|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
164518491|NCT00833833|594268355|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
164518492|NCT00833833|594268356|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
164518493|NCT00833833|594268357|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
164518494|NCT00833833|594268352|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
164518495|NCT00833833|594268353|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
164518496|NCT00833833|594268354|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
164518497|NCT00833833|594268355|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
164518498|NCT00833833|594268356|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
164518499|NCT00833833|594268357|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
164518500|NCT00833833|594268352|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
164518501|NCT00833833|594268353|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
164518502|NCT00833833|594268354|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
164518503|NCT00833833|594268355|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
164518504|NCT00833833|594268356|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
164518505|NCT00833833|594268357|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
164518506|NCT00833833|594268352|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
164615979|NCT02859558|594616058|FG003|Step 1|Withdrawal By Participant|0|||
164615980|NCT02859558|594616059|FG004|Step 1|Withdrawal By Participant|0|||
164615981|NCT02859558|594616055|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
164615982|NCT02859558|594616056|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
164615983|NCT02859558|594616057|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
164615984|NCT02859558|594616058|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
164615985|NCT02859558|594616059|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
164615986|NCT02859558|594616055|FG000|Step 1|Incarceration|0|||
164615987|NCT02859558|594616056|FG001|Step 1|Incarceration|1|||
164615988|NCT02859558|594616057|FG002|Step 1|Incarceration|0|||
164615989|NCT02859558|594616058|FG003|Step 1|Incarceration|0|||
164615990|NCT02859558|594616059|FG004|Step 1|Incarceration|0|||
164615991|NCT02859558|594616055|FG000|Step 1|Non-Adherence to Study Drug|2|||
164615992|NCT02859558|594616056|FG001|Step 1|Non-Adherence to Study Drug|0|||
164615993|NCT02859558|594616057|FG002|Step 1|Non-Adherence to Study Drug|1|||
164615994|NCT02859558|594616058|FG003|Step 1|Non-Adherence to Study Drug|0|||
164615995|NCT02859558|594616059|FG004|Step 1|Non-Adherence to Study Drug|0|||
164615996|NCT02859558|594616055|FG000|Step 1|Non-Adherence to Study Requirements|3|||
164615997|NCT02859558|594616056|FG001|Step 1|Non-Adherence to Study Requirements|1|||
164615998|NCT02859558|594616057|FG002|Step 1|Non-Adherence to Study Requirements|0|||
164615999|NCT02859558|594616058|FG003|Step 1|Non-Adherence to Study Requirements|0|||
164616000|NCT02859558|594616059|FG004|Step 1|Non-Adherence to Study Requirements|0|||
164616001|NCT02859558|594616055|FG000|Step 1|Virologic Failure|2|||
164616002|NCT02859558|594616056|FG001|Step 1|Virologic Failure|1|||
164616003|NCT02859558|594616057|FG002|Step 1|Virologic Failure|1|||
164616004|NCT02859558|594616058|FG003|Step 1|Virologic Failure|0|||
164616005|NCT02859558|594616059|FG004|Step 1|Virologic Failure|0|||
164616006|NCT02859558|594616055|FG000|Step 2|Lost to Follow-up|3|||
164616007|NCT02859558|594616056|FG001|Step 2|Lost to Follow-up|3|||
164616008|NCT02859558|594616057|FG002|Step 2|Lost to Follow-up|1|||
164616009|NCT02859558|594616058|FG003|Step 2|Lost to Follow-up|0|||
164616010|NCT02859558|594616059|FG004|Step 2|Lost to Follow-up|0|||
164616011|NCT02859558|594616055|FG000|Step 2|Withdrawal by Subject|0|||
164616012|NCT02859558|594616056|FG001|Step 2|Withdrawal by Subject|1|||
164616013|NCT02859558|594616057|FG002|Step 2|Withdrawal by Subject|1|||
164616014|NCT02859558|594616058|FG003|Step 2|Withdrawal by Subject|0|||
164616015|NCT02859558|594616059|FG004|Step 2|Withdrawal by Subject|0|||
164616016|NCT02859558|594616055|FG000|Step 2|Unexpected Closure of Site|0|||
164616017|NCT02859558|594616056|FG001|Step 2|Unexpected Closure of Site|1|||
164616018|NCT02859558|594616057|FG002|Step 2|Unexpected Closure of Site|1|||
164616019|NCT02859558|594616058|FG003|Step 2|Unexpected Closure of Site|0|||
164616020|NCT02859558|594616059|FG004|Step 2|Unexpected Closure of Site|0|||
164616021|NCT02859558|594616055|FG000|Step 2|Death|1|||
164616022|NCT02859558|594616056|FG001|Step 2|Death|0|||
164616023|NCT02859558|594616057|FG002|Step 2|Death|0|||
164616024|NCT02859558|594616058|FG003|Step 2|Death|0|||
164616025|NCT02859558|594616059|FG004|Step 2|Death|0|||
164616026|NCT02859558|594616055|FG000|Step 2|Incarceration|0|||
164616027|NCT02859558|594616056|FG001|Step 2|Incarceration|0|||
164616028|NCT02859558|594616057|FG002|Step 2|Incarceration|1|||
164616029|NCT02859558|594616058|FG003|Step 2|Incarceration|0|||
164616030|NCT02859558|594616059|FG004|Step 2|Incarceration|0|||
164616031|NCT04507360|594616060|FG000|Week 1|Lost to Follow-up|0|||
164616032|NCT04507360|594616061|FG001|Week 1|Lost to Follow-up|0|||
164616033|NCT04507360|594616062|FG002|Week 1|Lost to Follow-up|0|||
164616034|NCT04507360|594616063|FG003|Week 1|Lost to Follow-up|0|||
164616035|NCT04507360|594616064|FG004|Week 1|Lost to Follow-up|0|||
164616036|NCT04507360|594616065|FG005|Week 1|Lost to Follow-up|0|||
164616037|NCT04507360|594616066|FG006|Week 1|Lost to Follow-up|0|||
164616038|NCT04507360|594616067|FG007|Week 1|Lost to Follow-up|0|||
164616039|NCT04507360|594616068|FG008|Week 1|Lost to Follow-up|72|||
164616040|NCT04507360|594616069|FG009|Week 1|Lost to Follow-up|22|||
164616041|NCT04507360|594616070|FG010|Week 1|Lost to Follow-up|10|||
164616042|NCT04507360|594616060|FG000|Week 2|Lost to Follow-up|0|||
164616043|NCT04507360|594616061|FG001|Week 2|Lost to Follow-up|0|||
164616044|NCT04507360|594616062|FG002|Week 2|Lost to Follow-up|0|||
164616045|NCT04507360|594616063|FG003|Week 2|Lost to Follow-up|0|||
164616046|NCT04507360|594616064|FG004|Week 2|Lost to Follow-up|0|||
164616047|NCT04507360|594616065|FG005|Week 2|Lost to Follow-up|0|||
164616048|NCT04507360|594616066|FG006|Week 2|Lost to Follow-up|0|||
164616049|NCT04507360|594616067|FG007|Week 2|Lost to Follow-up|0|||
164616050|NCT04507360|594616068|FG008|Week 2|Lost to Follow-up|121|||
164616051|NCT04507360|594616069|FG009|Week 2|Lost to Follow-up|85|||
164616052|NCT04507360|594616070|FG010|Week 2|Lost to Follow-up|82|||
164616053|NCT04507360|594616060|FG000|Week 3|Lost to Follow-up|0|||
164616054|NCT04507360|594616061|FG001|Week 3|Lost to Follow-up|0|||
164616055|NCT04507360|594616062|FG002|Week 3|Lost to Follow-up|0|||
164616056|NCT04507360|594616063|FG003|Week 3|Lost to Follow-up|0|||
164616057|NCT04507360|594616064|FG004|Week 3|Lost to Follow-up|0|||
164616058|NCT04507360|594616065|FG005|Week 3|Lost to Follow-up|0|||
164616059|NCT04507360|594616066|FG006|Week 3|Lost to Follow-up|0|||
164616060|NCT04507360|594616067|FG007|Week 3|Lost to Follow-up|0|||
164616061|NCT04507360|594616068|FG008|Week 3|Lost to Follow-up|123|||
164616062|NCT04507360|594616069|FG009|Week 3|Lost to Follow-up|92|||
164616063|NCT04507360|594616070|FG010|Week 3|Lost to Follow-up|84|||
164616064|NCT04507360|594616060|FG000|Week 4|Lost to Follow-up|0|||
164616065|NCT04507360|594616061|FG001|Week 4|Lost to Follow-up|0|||
164616066|NCT04507360|594616062|FG002|Week 4|Lost to Follow-up|0|||
164616067|NCT04507360|594616063|FG003|Week 4|Lost to Follow-up|0|||
164616068|NCT04507360|594616064|FG004|Week 4|Lost to Follow-up|0|||
164616069|NCT04507360|594616065|FG005|Week 4|Lost to Follow-up|0|||
164616070|NCT04507360|594616066|FG006|Week 4|Lost to Follow-up|0|||
164616071|NCT04507360|594616067|FG007|Week 4|Lost to Follow-up|0|||
164616072|NCT04507360|594616068|FG008|Week 4|Lost to Follow-up|131|||
164616073|NCT04507360|594616069|FG009|Week 4|Lost to Follow-up|115|||
164616074|NCT04507360|594616070|FG010|Week 4|Lost to Follow-up|102|||
164616075|NCT04507360|594616060|FG000|Week 5|Lost to Follow-up|0|||
164616076|NCT04507360|594616061|FG001|Week 5|Lost to Follow-up|0|||
164518507|NCT00833833|594268353|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
164518508|NCT00833833|594268354|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
164518509|NCT00833833|594268355|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
164518510|NCT00833833|594268356|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
164518511|NCT00833833|594268357|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
164518512|NCT00833833|594268352|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
164518513|NCT00833833|594268353|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
164518514|NCT00833833|594268354|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
164518515|NCT00833833|594268355|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
164518516|NCT00833833|594268356|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
164518517|NCT00833833|594268357|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
164518518|NCT00833833|594268352|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
164518519|NCT00833833|594268353|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
164518520|NCT00833833|594268354|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
164518521|NCT00833833|594268355|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
164518522|NCT00833833|594268356|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
164518523|NCT00833833|594268357|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
164518524|NCT00833833|594268352|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
164518525|NCT00833833|594268353|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
164518526|NCT00833833|594268354|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
164518527|NCT00833833|594268355|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
164518528|NCT00833833|594268356|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
164518529|NCT00833833|594268357|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
164518530|NCT00833833|594268352|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
164518531|NCT00833833|594268353|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
164518532|NCT00833833|594268354|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
164518533|NCT00833833|594268355|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
164518534|NCT00833833|594268356|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
164518535|NCT00833833|594268357|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
164518536|NCT00833833|594268352|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
164518537|NCT00833833|594268353|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
164518538|NCT00833833|594268354|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
164518539|NCT00833833|594268355|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
164518540|NCT00833833|594268356|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
164518541|NCT00833833|594268357|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
164518542|NCT00833833|594268352|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
164518543|NCT00833833|594268353|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
164518544|NCT00833833|594268354|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
164518545|NCT00833833|594268355|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
164518546|NCT00833833|594268356|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
164518547|NCT00833833|594268357|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
164518548|NCT00833833|594268352|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
164518549|NCT00833833|594268353|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
164518550|NCT00833833|594268354|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
164518551|NCT00833833|594268355|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
164518552|NCT00833833|594268356|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
164518553|NCT00833833|594268357|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
164518554|NCT00833833|594268352|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
164518555|NCT00833833|594268353|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
164518556|NCT00833833|594268354|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
164518557|NCT00833833|594268355|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
164518558|NCT00833833|594268356|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
164518559|NCT00833833|594268357|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
164518560|NCT02040259|594268358|FG000|Overall Study|Death|280|||
164518561|NCT02040259|594268358|FG000|Overall Study|Lost to Follow-up|76|||
164518562|NCT02040259|594268358|FG000|Overall Study|Assessment not completed|3|||
164518563|NCT02040259|594268358|FG000|Overall Study|Withdrawal by Subject|4|||
164518564|NCT00316602|594268368|FG000|Overall Study|Withdrawal by Subject|3|||
164518565|NCT00316602|594268369|FG001|Overall Study|Withdrawal by Subject|2|||
164518566|NCT00316602|594268368|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
164518567|NCT00316602|594268369|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
164518568|NCT00316602|594268368|FG000|Overall Study|Adverse Event|1|||
164518569|NCT00316602|594268369|FG001|Overall Study|Adverse Event|0|||
164518570|NCT00316602|594268368|FG000|Overall Study|Other|3|||
164616077|NCT04507360|594616062|FG002|Week 5|Lost to Follow-up|0|||
164616078|NCT04507360|594616063|FG003|Week 5|Lost to Follow-up|0|||
164518571|NCT00316602|594268369|FG001|Overall Study|Other|6|||
164518572|NCT01142232|594268370|FG000|Overall Study|Adverse Event|1|||
164518573|NCT01142232|594268371|FG001|Overall Study|Adverse Event|2|||
164518574|NCT01142232|594268372|FG002|Overall Study|Adverse Event|1|||
164518575|NCT01142232|594268373|FG003|Overall Study|Adverse Event|0|||
164616079|NCT04507360|594616064|FG004|Week 5|Lost to Follow-up|0|||
164616080|NCT04507360|594616065|FG005|Week 5|Lost to Follow-up|0|||
164616081|NCT04507360|594616066|FG006|Week 5|Lost to Follow-up|0|||
164616082|NCT04507360|594616067|FG007|Week 5|Lost to Follow-up|0|||
164616083|NCT04507360|594616068|FG008|Week 5|Lost to Follow-up|103|||
164616084|NCT04507360|594616069|FG009|Week 5|Lost to Follow-up|135|||
164616085|NCT04507360|594616070|FG010|Week 5|Lost to Follow-up|143|||
164616086|NCT04507360|594616060|FG000|Week 8|Lost to Follow-up|0|||
164616087|NCT04507360|594616061|FG001|Week 8|Lost to Follow-up|0|||
164616088|NCT04507360|594616062|FG002|Week 8|Lost to Follow-up|0|||
164616089|NCT04507360|594616063|FG003|Week 8|Lost to Follow-up|0|||
164616090|NCT04507360|594616064|FG004|Week 8|Lost to Follow-up|0|||
164616091|NCT04507360|594616065|FG005|Week 8|Lost to Follow-up|0|||
164616092|NCT04507360|594616066|FG006|Week 8|Lost to Follow-up|0|||
164616093|NCT04507360|594616067|FG007|Week 8|Lost to Follow-up|0|||
164616094|NCT04507360|594616068|FG008|Week 8|Lost to Follow-up|139|||
164616095|NCT04507360|594616069|FG009|Week 8|Lost to Follow-up|145|||
164616096|NCT04507360|594616070|FG010|Week 8|Lost to Follow-up|152|||
164616097|NCT00400946|594616071|FG000|Overall Study|Ineligible|0|||
164616098|NCT00400946|594616072|FG001|Overall Study|Ineligible|0|||
164616099|NCT00400946|594616073|FG002|Overall Study|Ineligible|0|||
164616100|NCT00400946|594616074|FG003|Overall Study|Ineligible|5|||
164616101|NCT00400946|594616075|FG004|Overall Study|Ineligible|1|||
164616102|NCT00400946|594616071|FG000|Overall Study|Induction Failure|0|||
164616103|NCT00400946|594616072|FG001|Overall Study|Induction Failure|0|||
164616104|NCT00400946|594616073|FG002|Overall Study|Induction Failure|0|||
164616105|NCT00400946|594616074|FG003|Overall Study|Induction Failure|11|||
164616106|NCT00400946|594616075|FG004|Overall Study|Induction Failure|8|||
164616107|NCT00400946|594616071|FG000|Overall Study|Induction Death|0|||
164616108|NCT00400946|594616072|FG001|Overall Study|Induction Death|0|||
164616109|NCT00400946|594616073|FG002|Overall Study|Induction Death|0|||
164616110|NCT00400946|594616074|FG003|Overall Study|Induction Death|13|||
164616111|NCT00400946|594616075|FG004|Overall Study|Induction Death|3|||
164616112|NCT00400946|594616071|FG000|Overall Study|Lost to Follow-up|1|||
164616113|NCT00400946|594616072|FG001|Overall Study|Lost to Follow-up|1|||
164616114|NCT00400946|594616073|FG002|Overall Study|Lost to Follow-up|0|||
164616115|NCT00400946|594616074|FG003|Overall Study|Lost to Follow-up|0|||
164616116|NCT00400946|594616075|FG004|Overall Study|Lost to Follow-up|1|||
164616117|NCT00400946|594616071|FG000|Overall Study|Remission Death|1|||
164616118|NCT00400946|594616072|FG001|Overall Study|Remission Death|1|||
164616119|NCT00400946|594616073|FG002|Overall Study|Remission Death|0|||
164616120|NCT00400946|594616074|FG003|Overall Study|Remission Death|0|||
164616121|NCT00400946|594616075|FG004|Overall Study|Remission Death|1|||
164616122|NCT00400946|594616071|FG000|Overall Study|Relapse|9|||
164616123|NCT00400946|594616072|FG001|Overall Study|Relapse|2|||
164616124|NCT00400946|594616073|FG002|Overall Study|Relapse|1|||
164616125|NCT00400946|594616074|FG003|Overall Study|Relapse|1|||
164616126|NCT00400946|594616075|FG004|Overall Study|Relapse|5|||
164616127|NCT00400946|594616071|FG000|Overall Study|Transplant in CR1|0|||
164616128|NCT00400946|594616072|FG001|Overall Study|Transplant in CR1|0|||
164616129|NCT00400946|594616073|FG002|Overall Study|Transplant in CR1|0|||
164616130|NCT00400946|594616074|FG003|Overall Study|Transplant in CR1|10|||
164616131|NCT00400946|594616075|FG004|Overall Study|Transplant in CR1|1|||
164616132|NCT00400946|594616071|FG000|Overall Study|Withdrawal by Subject|2|||
164616133|NCT00400946|594616072|FG001|Overall Study|Withdrawal by Subject|5|||
164616134|NCT00400946|594616073|FG002|Overall Study|Withdrawal by Subject|1|||
164616135|NCT00400946|594616074|FG003|Overall Study|Withdrawal by Subject|5|||
164616136|NCT00400946|594616075|FG004|Overall Study|Withdrawal by Subject|8|||
164616137|NCT00400946|594616071|FG000|Overall Study|Clinical|1|||
164616138|NCT00400946|594616072|FG001|Overall Study|Clinical|2|||
164616139|NCT00400946|594616073|FG002|Overall Study|Clinical|0|||
164616140|NCT00400946|594616074|FG003|Overall Study|Clinical|2|||
164616141|NCT00400946|594616075|FG004|Overall Study|Clinical|9|||
164616142|NCT00400946|594616071|FG000|Overall Study|Other|0|||
164616143|NCT00400946|594616072|FG001|Overall Study|Other|0|||
164616144|NCT00400946|594616073|FG002|Overall Study|Other|0|||
164616145|NCT00400946|594616074|FG003|Overall Study|Other|0|||
164616146|NCT00400946|594616075|FG004|Overall Study|Other|1|||
164616147|NCT02892734|594616078|FG000|Treatment on Study|Progressive Disease|2|||
164616148|NCT02892734|594616078|FG000|Follow up for 2 Years|Death|2|||
164616149|NCT02892734|594616078|FG000|Follow up for 2 Years|Study closed early|1|||
164616150|NCT00688623|594616079|FG000|Overall Study|Adverse Event|22|||
164616151|NCT00688623|594616079|FG000|Overall Study|abnormal lab value|1|||
164616152|NCT00688623|594616079|FG000|Overall Study|Withdrawal by Subject|4|||
164616153|NCT00688623|594616079|FG000|Overall Study|Death|3|||
164616154|NCT00688623|594616079|FG000|Overall Study|disease progression|23|||
164616155|NCT00688623|594616079|FG000|Overall Study|Protocol Violation|2|||
164616156|NCT01998906|594616080|FG000|Overall Study|Participants ongoing in follow-up|77|||
164616157|NCT01998906|594616081|FG001|Overall Study|Participants ongoing in follow-up|60|||
164616158|NCT01998906|594616082|FG002|Overall Study|Participants ongoing in follow-up|58|||
164616159|NCT01998906|594616080|FG000|Overall Study|Death|21|||
164616160|NCT01998906|594616081|FG001|Overall Study|Death|30|||
164616161|NCT01998906|594616082|FG002|Overall Study|Death|17|||
164616162|NCT01998906|594616080|FG000|Overall Study|Lack of Efficacy|10|||
164616163|NCT01998906|594616081|FG001|Overall Study|Lack of Efficacy|9|||
164616164|NCT01998906|594616082|FG002|Overall Study|Lack of Efficacy|8|||
164616165|NCT01998906|594616080|FG000|Overall Study|Failure to return|0|||
164616166|NCT01998906|594616081|FG001|Overall Study|Failure to return|2|||
164616167|NCT01998906|594616082|FG002|Overall Study|Failure to return|4|||
164616168|NCT01998906|594616080|FG000|Overall Study|Violation of Selection Criteria|0|||
164616169|NCT01998906|594616081|FG001|Overall Study|Violation of Selection Criteria|0|||
164616170|NCT01998906|594616082|FG002|Overall Study|Violation of Selection Criteria|1|||
164616171|NCT01998906|594616080|FG000|Overall Study|Withdrawal by Subject|1|||
164616172|NCT01998906|594616081|FG001|Overall Study|Withdrawal by Subject|4|||
164616173|NCT01998906|594616082|FG002|Overall Study|Withdrawal by Subject|3|||
164616174|NCT01998906|594616080|FG000|Overall Study|Administrative/Other|2|||
164616175|NCT01998906|594616081|FG001|Overall Study|Administrative/Other|1|||
164616176|NCT01998906|594616082|FG002|Overall Study|Administrative/Other|3|||
164616177|NCT01998906|594616080|FG000|Overall Study|Other|3|||
164616178|NCT01998906|594616081|FG001|Overall Study|Other|8|||
164616179|NCT01998906|594616082|FG002|Overall Study|Other|4|||
164616180|NCT01572844|594616083|FG000|Overall Study|Physician Decision|1|||
164616181|NCT01572844|594616084|FG001|Overall Study|Physician Decision|1|||
164616182|NCT00693420|594616087|FG000|Overall Study|Adverse Event|4|||
164616183|NCT00693420|594616088|FG001|Overall Study|Adverse Event|4|||
164616184|NCT00693420|594616087|FG000|Overall Study|Lost to Follow-up|0|||
164616185|NCT00693420|594616088|FG001|Overall Study|Lost to Follow-up|3|||
164616186|NCT00693420|594616087|FG000|Overall Study|Withdrawal by Subject|1|||
164616187|NCT00693420|594616088|FG001|Overall Study|Withdrawal by Subject|0|||
164616188|NCT00693420|594616087|FG000|Overall Study|Protocol Violation|0|||
164616189|NCT00693420|594616088|FG001|Overall Study|Protocol Violation|2|||
164616190|NCT00693420|594616087|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
164616191|NCT00693420|594616088|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
164616192|NCT00693420|594616087|FG000|Overall Study|Personal Reasons|1|||
164616193|NCT00693420|594616088|FG001|Overall Study|Personal Reasons|4|||
164616194|NCT03135262|594616097|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
164616195|NCT03135262|594616098|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
164616196|NCT03135262|594616099|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
164616197|NCT03135262|594616100|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
164616198|NCT03135262|594616101|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
164616199|NCT03135262|594616097|FG000|Overall Study|Progression of disease|0|||
164616200|NCT03135262|594616098|FG001|Overall Study|Progression of disease|0|||
164616201|NCT03135262|594616099|FG002|Overall Study|Progression of disease|0|||
164616202|NCT03135262|594616100|FG003|Overall Study|Progression of disease|1|||
164616203|NCT03135262|594616101|FG004|Overall Study|Progression of disease|0|||
164616204|NCT03135262|594616097|FG000|Overall Study|Death|6|||
164616205|NCT03135262|594616098|FG001|Overall Study|Death|2|||
164616206|NCT03135262|594616099|FG002|Overall Study|Death|2|||
164616207|NCT03135262|594616100|FG003|Overall Study|Death|2|||
164616208|NCT03135262|594616101|FG004|Overall Study|Death|0|||
164616209|NCT03135262|594616097|FG000|Overall Study|Withdrawal by Subject|0|||
164616210|NCT03135262|594616098|FG001|Overall Study|Withdrawal by Subject|0|||
164616211|NCT03135262|594616099|FG002|Overall Study|Withdrawal by Subject|1|||
164616212|NCT03135262|594616100|FG003|Overall Study|Withdrawal by Subject|0|||
164616213|NCT03135262|594616101|FG004|Overall Study|Withdrawal by Subject|1|||
164616214|NCT03135262|594616097|FG000|Overall Study|Study terminated by sponsor|2|||
164616215|NCT03135262|594616098|FG001|Overall Study|Study terminated by sponsor|4|||
164616216|NCT03135262|594616099|FG002|Overall Study|Study terminated by sponsor|4|||
164616217|NCT03135262|594616100|FG003|Overall Study|Study terminated by sponsor|3|||
164616218|NCT03135262|594616101|FG004|Overall Study|Study terminated by sponsor|0|||
164616219|NCT03745989|594616102|FG000|Overall Study|Death|3|||
164616220|NCT03745989|594616103|FG001|Overall Study|Death|7|||
164616221|NCT03745989|594616104|FG002|Overall Study|Death|4|||
164616222|NCT03745989|594616102|FG000|Overall Study|Lost to Follow-up|0|||
164616223|NCT03745989|594616103|FG001|Overall Study|Lost to Follow-up|2|||
164616224|NCT03745989|594616104|FG002|Overall Study|Lost to Follow-up|0|||
164616225|NCT03745989|594616102|FG000|Overall Study|Sponsor Decision|0|||
164616226|NCT03745989|594616103|FG001|Overall Study|Sponsor Decision|2|||
164616227|NCT03745989|594616104|FG002|Overall Study|Sponsor Decision|8|||
164616228|NCT03745989|594616102|FG000|Overall Study|Withdrawal by Subject|0|||
164616229|NCT03745989|594616103|FG001|Overall Study|Withdrawal by Subject|1|||
164616230|NCT03745989|594616104|FG002|Overall Study|Withdrawal by Subject|3|||
164616231|NCT00911144|594616105|FG000|Overall Study|Withdrawal by Subject|16|||
164616232|NCT00911144|594616106|FG001|Overall Study|Withdrawal by Subject|5|||
164616233|NCT01291511|594616107|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
164616234|NCT01291511|594616108|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
164616235|NCT01291511|594616107|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
164616236|NCT01291511|594616108|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
164616237|NCT01291511|594616107|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
164616238|NCT01291511|594616108|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
164616239|NCT01291511|594616107|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
164616240|NCT01291511|594616108|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
164616241|NCT01291511|594616107|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
164616242|NCT01291511|594616108|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
164616243|NCT01291511|594616107|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
164616244|NCT01291511|594616108|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
164616245|NCT01291511|594616107|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
164616246|NCT01291511|594616108|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
164616247|NCT01291511|594616107|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
164616248|NCT01291511|594616108|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
164616249|NCT01291511|594616107|FG000|Cross-Titration and Stabilization Phase|Death|1|||
164616250|NCT01291511|594616108|FG001|Cross-Titration and Stabilization Phase|Death|0|||
164616251|NCT01291511|594616107|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
164616252|NCT01291511|594616108|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
164616253|NCT01291511|594616107|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
164616254|NCT01291511|594616108|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
164616255|NCT01291511|594616107|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
164616256|NCT01291511|594616108|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
164616257|NCT01291511|594616107|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
164616258|NCT01291511|594616108|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
164616259|NCT01291511|594616107|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
164616260|NCT01291511|594616108|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
164616261|NCT01291511|594616107|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
164616262|NCT01291511|594616108|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
164616263|NCT01291511|594616107|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
164616264|NCT01291511|594616108|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
164616265|NCT01291511|594616107|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
164616266|NCT01291511|594616108|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
164616267|NCT01291511|594616107|FG000|Double-blind Relapse Prevention Phase|Death|1|||
164616268|NCT01291511|594616108|FG001|Double-blind Relapse Prevention Phase|Death|0|||
164616269|NCT00047008|594616110|FG000|Overall Study|Withdrawn consent|2|||
164616270|NCT00047008|594616111|FG001|Overall Study|Withdrawn consent|3|||
164616271|NCT00047008|594616110|FG000|Overall Study|Ineligible|9|||
164616272|NCT00047008|594616111|FG001|Overall Study|Ineligible|8|||
164616273|NCT00429572|594616112|FG000|Overall Study|Disease progression|1|||
164616274|NCT02773368|594616115|FG000|Overall Study|Lost to Follow-up|4|||
164616275|NCT02773368|594616116|FG001|Overall Study|Lost to Follow-up|1|||
164616276|NCT02773368|594616115|FG000|Overall Study|Withdrawal by Subject|5|||
164616277|NCT02773368|594616116|FG001|Overall Study|Withdrawal by Subject|1|||
164616278|NCT02773368|594616115|FG000|Overall Study|Unclassified|1|||
164616279|NCT02773368|594616116|FG001|Overall Study|Unclassified|1|||
164616280|NCT02773368|594616115|FG000|Overall Study|Missing|0|||
164616281|NCT02773368|594616116|FG001|Overall Study|Missing|1|||
164616282|NCT01929018|594616119|FG000|Overall Study|Lost to Follow-up|1|||
164616283|NCT01929018|594616120|FG001|Overall Study|Lost to Follow-up|0|||
164616284|NCT01929018|594616119|FG000|Overall Study|Hospitalization|0|||
164616285|NCT01929018|594616120|FG001|Overall Study|Hospitalization|1|||
164616286|NCT01047436|594616124|FG000|Overall Study|Protocol Violation|1|||
164616287|NCT01047436|594616125|FG001|Overall Study|Protocol Violation|0|||
164616288|NCT02635867|594616128|FG000|Overall Study|Lost to Follow-up|4|||
164616289|NCT02635867|594616129|FG001|Overall Study|Lost to Follow-up|3|||
164616290|NCT02635867|594616130|FG002|Overall Study|Lost to Follow-up|3|||
164616291|NCT02635867|594616131|FG003|Overall Study|Lost to Follow-up|4|||
164616292|NCT02635867|594616132|FG004|Overall Study|Lost to Follow-up|1|||
164616293|NCT02565576|594616135|FG000|Overall Study|abnormal lab value|2|||
164616294|NCT02565576|594616136|FG001|Overall Study|abnormal lab value|0|||
164616295|NCT02565576|594616135|FG000|Overall Study|subject / guardian decision|1|||
164616296|NCT02565576|594616136|FG001|Overall Study|subject / guardian decision|3|||
164616297|NCT02565576|594616135|FG000|Overall Study|Lost to Follow-up|1|||
164616298|NCT02565576|594616136|FG001|Overall Study|Lost to Follow-up|0|||
164616299|NCT02565576|594616135|FG000|Overall Study|Death|0|||
164616300|NCT02565576|594616136|FG001|Overall Study|Death|2|||
164616301|NCT02565576|594616135|FG000|Overall Study|Adverse Event|1|||
164616302|NCT02565576|594616136|FG001|Overall Study|Adverse Event|0|||
164616303|NCT00282568|594616137|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
164616304|NCT00282568|594616137|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
164616305|NCT00282568|594616137|FG000|Extended Treatment Period|Adverse Event|17|||
164616306|NCT00282568|594616137|FG000|Extended Treatment Period|Non-compliance|4|||
164616307|NCT00282568|594616137|FG000|Extended Treatment Period|Physician Decision|1|||
164616308|NCT00282568|594616137|FG000|Extended Treatment Period|Lost to Follow-up|2|||
164616309|NCT01266070|594616138|FG000|Overall Study|Adverse Event|3|||
164616310|NCT01266070|594616138|FG000|Overall Study|Protocol Violation|1|||
164616311|NCT00939341|594616139|FG000|Overall Study|Adverse Event|15|||
164616312|NCT00939341|594616139|FG000|Overall Study|Pregnancy|1|||
164616313|NCT00939341|594616139|FG000|Overall Study|Lost to Follow-up|23|||
164616314|NCT00939341|594616139|FG000|Overall Study|Withdrawal by Subject|13|||
164616315|NCT00939341|594616139|FG000|Overall Study|Protocol Violation|6|||
164616316|NCT00939341|594616139|FG000|Overall Study|Incorrect enrolment|8|||
164616317|NCT01408732|594616140|FG000|Overall Study|Withdrawal by Subject|2|||
164616318|NCT01408732|594616141|FG001|Overall Study|Withdrawal by Subject|2|||
164616319|NCT03185819|594616143|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
164616320|NCT03185819|594616144|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
164616321|NCT03185819|594616145|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
164616322|NCT03185819|594616146|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
164616323|NCT03185819|594616143|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
164616324|NCT03185819|594616144|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
164616325|NCT03185819|594616145|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
164616326|NCT03185819|594616146|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
164616327|NCT03185819|594616143|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
164616328|NCT03185819|594616144|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
164616329|NCT03185819|594616145|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
164616330|NCT03185819|594616146|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
164616331|NCT03185819|594616143|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
164616332|NCT03185819|594616144|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
164616333|NCT03185819|594616145|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
164616334|NCT03185819|594616146|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
164616335|NCT03185819|594616143|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
164616336|NCT03185819|594616144|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
164616337|NCT03185819|594616145|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
164616338|NCT03185819|594616146|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
164616339|NCT03185819|594616143|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
164616340|NCT03185819|594616144|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
164616341|NCT03185819|594616145|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
164616342|NCT03185819|594616146|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
164616343|NCT03185819|594616143|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
164616344|NCT03185819|594616144|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
164616345|NCT03185819|594616145|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
164616346|NCT03185819|594616146|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
164616347|NCT03185819|594616143|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
164616348|NCT03185819|594616144|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
164616349|NCT03185819|594616145|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
164616350|NCT03185819|594616146|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
164616351|NCT03185819|594616143|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
164616352|NCT03185819|594616144|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
164616353|NCT03185819|594616145|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
164616354|NCT03185819|594616146|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
164616355|NCT03185819|594616143|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
164616356|NCT03185819|594616144|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
164616357|NCT03185819|594616145|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
164616358|NCT03185819|594616146|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
164616359|NCT03185819|594616143|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
164616360|NCT03185819|594616144|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
164616361|NCT03185819|594616145|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
164518576|NCT01142232|594268374|FG004|Overall Study|Adverse Event|4|||
164518577|NCT01142232|594268370|FG000|Overall Study|Death|0|||
164518578|NCT01142232|594268371|FG001|Overall Study|Death|0|||
164616362|NCT03185819|594616146|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
164616363|NCT03185819|594616143|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
164616364|NCT03185819|594616144|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
164616365|NCT03185819|594616145|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
164616366|NCT03185819|594616146|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
164616367|NCT03185819|594616143|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
164616368|NCT03185819|594616144|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
164616369|NCT03185819|594616145|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
164616370|NCT03185819|594616146|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
164616371|NCT00732641|594616147|FG000|Overall Study|Relapse or Progressive Disease|65|||
164616372|NCT00732641|594616148|FG001|Overall Study|Relapse or Progressive Disease|101|||
164616373|NCT00732641|594616147|FG000|Overall Study|Serious Adverse Events|12|||
164616374|NCT00732641|594616148|FG001|Overall Study|Serious Adverse Events|3|||
164616375|NCT00732641|594616147|FG000|Overall Study|Physician Decision|6|||
164616376|NCT00732641|594616148|FG001|Overall Study|Physician Decision|0|||
164616377|NCT00732641|594616147|FG000|Overall Study|Withdrawal by Subject|4|||
164616378|NCT00732641|594616148|FG001|Overall Study|Withdrawal by Subject|2|||
164616379|NCT00732641|594616147|FG000|Overall Study|Unable to Complete|1|||
164616380|NCT00732641|594616148|FG001|Overall Study|Unable to Complete|1|||
164616381|NCT00732641|594616147|FG000|Overall Study|Other|18|||
164616382|NCT00732641|594616148|FG001|Overall Study|Other|5|||
164616383|NCT02910089|594616149|FG000|Overall Study|Lost insurance eligibility|22|||
164616384|NCT02910089|594616150|FG001|Overall Study|Lost insurance eligibility|16|||
164616385|NCT03434041|594616153|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
164616386|NCT03434041|594616154|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
164616387|NCT03434041|594616153|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
164616388|NCT03434041|594616154|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
164616389|NCT03434041|594616153|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
164616390|NCT03434041|594616154|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
164616391|NCT03434041|594616153|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
164616392|NCT03434041|594616154|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
164616393|NCT03434041|594616153|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
164616394|NCT03434041|594616154|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
164616395|NCT03434041|594616153|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
164616396|NCT03434041|594616154|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
164616397|NCT03434041|594616153|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
164616398|NCT03434041|594616154|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
164616399|NCT03434041|594616153|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
164616400|NCT03434041|594616154|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
164616401|NCT03434041|594616153|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
164616402|NCT03434041|594616154|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
164616403|NCT03434041|594616153|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
164616404|NCT03434041|594616154|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
164616405|NCT03434041|594616153|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
164616406|NCT03434041|594616154|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
164616407|NCT00865046|594616155|FG000|Overall Study|Lost to Follow-up|1|||
164616408|NCT00865046|594616156|FG001|Overall Study|Lost to Follow-up|4|||
164616409|NCT00865046|594616157|FG002|Overall Study|Lost to Follow-up|0|||
164616410|NCT00865046|594616155|FG000|Overall Study|Death|0|||
164616411|NCT00865046|594616156|FG001|Overall Study|Death|1|||
164616412|NCT00865046|594616157|FG002|Overall Study|Death|1|||
164616413|NCT00865046|594616155|FG000|Overall Study|Withdrawal by Subject|5|||
164616414|NCT00865046|594616156|FG001|Overall Study|Withdrawal by Subject|0|||
164616415|NCT00865046|594616157|FG002|Overall Study|Withdrawal by Subject|0|||
164616416|NCT03447821|594616158|FG000|Overall Study|Withdrawal by Subject|1|||
164616417|NCT03447821|594616159|FG001|Overall Study|Withdrawal by Subject|1|||
164616418|NCT03447821|594616160|FG002|Overall Study|Withdrawal by Subject|0|||
164616419|NCT03447821|594616158|FG000|Overall Study|Lost to Follow-up|0|||
164616420|NCT03447821|594616159|FG001|Overall Study|Lost to Follow-up|0|||
164616421|NCT03447821|594616160|FG002|Overall Study|Lost to Follow-up|1|||
164616422|NCT02977507|594616161|FG000|Overall Study|Protocol Deviation|1|||
164616423|NCT02977507|594616162|FG001|Overall Study|Protocol Deviation|0|||
164616424|NCT02977507|594616161|FG000|Overall Study|Lost to Follow-up|1|||
164616425|NCT02977507|594616162|FG001|Overall Study|Lost to Follow-up|0|||
164616426|NCT01587274|594616165|FG000|Overall Study|Lost to Follow-up|4|||
164616427|NCT01587274|594616166|FG001|Overall Study|Lost to Follow-up|5|||
164616428|NCT01587274|594616167|FG002|Overall Study|Lost to Follow-up|3|||
164616429|NCT03236506|594616173|FG000|Overall Study|Death|1|||
164616430|NCT03236506|594616174|FG001|Overall Study|Death|1|||
164616431|NCT03236506|594616175|FG002|Overall Study|Death|1|||
164616432|NCT03236506|594616173|FG000|Overall Study|Withdrawal by Subject|3|||
164616433|NCT03236506|594616174|FG001|Overall Study|Withdrawal by Subject|3|||
164616434|NCT03236506|594616175|FG002|Overall Study|Withdrawal by Subject|4|||
164616435|NCT03236506|594616173|FG000|Overall Study|Did not initiate treatment|2|||
164616436|NCT03236506|594616174|FG001|Overall Study|Did not initiate treatment|1|||
164616437|NCT03236506|594616175|FG002|Overall Study|Did not initiate treatment|2|||
164616438|NCT00422669|594616186|FG000|Overall Study|The study was terminated early.|98|||
164616439|NCT00422669|594616187|FG001|Overall Study|The study was terminated early.|100|||
164616440|NCT00422669|594616188|FG002|Overall Study|The study was terminated early.|7|||
164616441|NCT02709109|594616189|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
164616442|NCT02709109|594616190|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
164616443|NCT02709109|594616191|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
164616444|NCT02709109|594616192|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
164616445|NCT02709109|594616189|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
164616446|NCT02709109|594616190|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
164616447|NCT02709109|594616191|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
164616448|NCT02709109|594616192|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
164616449|NCT02709109|594616189|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
164616450|NCT02709109|594616190|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
164616451|NCT02709109|594616191|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
164616452|NCT02709109|594616192|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
164616453|NCT02709109|594616189|FG000|Washout Period (28 Days)|Other|2|||
164616454|NCT02709109|594616190|FG001|Washout Period (28 Days)|Other|2|||
164616455|NCT02709109|594616191|FG002|Washout Period (28 Days)|Other|3|||
164518579|NCT01142232|594268372|FG002|Overall Study|Death|0|||
164518580|NCT01142232|594268373|FG003|Overall Study|Death|0|||
164518581|NCT01142232|594268374|FG004|Overall Study|Death|1|||
164518582|NCT01142232|594268370|FG000|Overall Study|Disease Progression|2|||
164518583|NCT01142232|594268371|FG001|Overall Study|Disease Progression|0|||
164518584|NCT01142232|594268372|FG002|Overall Study|Disease Progression|1|||
164518585|NCT01142232|594268373|FG003|Overall Study|Disease Progression|2|||
164518586|NCT01142232|594268374|FG004|Overall Study|Disease Progression|12|||
164518587|NCT01142232|594268370|FG000|Overall Study|Withdrawal by Subject|0|||
164518588|NCT01142232|594268371|FG001|Overall Study|Withdrawal by Subject|0|||
164518589|NCT01142232|594268372|FG002|Overall Study|Withdrawal by Subject|0|||
164518590|NCT01142232|594268373|FG003|Overall Study|Withdrawal by Subject|1|||
164518591|NCT01142232|594268374|FG004|Overall Study|Withdrawal by Subject|3|||
164518592|NCT01142232|594268370|FG000|Overall Study|Physician Decision|0|||
164518593|NCT01142232|594268371|FG001|Overall Study|Physician Decision|1|||
164518594|NCT01142232|594268372|FG002|Overall Study|Physician Decision|0|||
164518595|NCT01142232|594268373|FG003|Overall Study|Physician Decision|2|||
164518596|NCT01142232|594268374|FG004|Overall Study|Physician Decision|10|||
164518597|NCT01142232|594268370|FG000|Overall Study|Alternative Therapy|0|||
164518598|NCT01142232|594268371|FG001|Overall Study|Alternative Therapy|1|||
164518599|NCT01142232|594268372|FG002|Overall Study|Alternative Therapy|1|||
164518600|NCT01142232|594268373|FG003|Overall Study|Alternative Therapy|0|||
164518601|NCT01142232|594268374|FG004|Overall Study|Alternative Therapy|1|||
164518602|NCT01142232|594268370|FG000|Overall Study|Off Trt for other complicating disease|0|||
164518603|NCT01142232|594268371|FG001|Overall Study|Off Trt for other complicating disease|0|||
164518604|NCT01142232|594268372|FG002|Overall Study|Off Trt for other complicating disease|0|||
164518605|NCT01142232|594268373|FG003|Overall Study|Off Trt for other complicating disease|0|||
164518606|NCT01142232|594268374|FG004|Overall Study|Off Trt for other complicating disease|1|||
164518607|NCT01142232|594268370|FG000|Overall Study|Noncompliance|0|||
164518608|NCT01142232|594268371|FG001|Overall Study|Noncompliance|0|||
164616456|NCT02709109|594616192|FG003|Washout Period (28 Days)|Other|0|||
164616457|NCT02709109|594616189|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
164616458|NCT02709109|594616190|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
164616459|NCT02709109|594616191|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
164518609|NCT01142232|594268372|FG002|Overall Study|Noncompliance|0|||
164518610|NCT01142232|594268373|FG003|Overall Study|Noncompliance|0|||
164518611|NCT01142232|594268374|FG004|Overall Study|Noncompliance|2|||
164518612|NCT00626990|594268375|FG000|Overall Study|Lack of Efficacy|6|||
164518613|NCT00626990|594268376|FG001|Overall Study|Lack of Efficacy|7|||
164518614|NCT00626990|594268377|FG002|Overall Study|Lack of Efficacy|49|||
164518615|NCT00626990|594268378|FG003|Overall Study|Lack of Efficacy|40|||
164518616|NCT00626990|594268375|FG000|Overall Study|Adverse Event|1|||
164518617|NCT00626990|594268376|FG001|Overall Study|Adverse Event|7|||
164518618|NCT00626990|594268377|FG002|Overall Study|Adverse Event|14|||
164518619|NCT00626990|594268378|FG003|Overall Study|Adverse Event|28|||
164518620|NCT00626990|594268375|FG000|Overall Study|Death|0|||
164518621|NCT00626990|594268376|FG001|Overall Study|Death|1|||
164518622|NCT00626990|594268377|FG002|Overall Study|Death|0|||
164518623|NCT00626990|594268378|FG003|Overall Study|Death|0|||
164518624|NCT00626990|594268375|FG000|Overall Study|Withdrawal by Subject|3|||
164518625|NCT00626990|594268376|FG001|Overall Study|Withdrawal by Subject|1|||
164518626|NCT00626990|594268377|FG002|Overall Study|Withdrawal by Subject|5|||
164518627|NCT00626990|594268378|FG003|Overall Study|Withdrawal by Subject|11|||
164518628|NCT00626990|594268375|FG000|Overall Study|Protocol Violation|0|||
164518629|NCT00626990|594268376|FG001|Overall Study|Protocol Violation|1|||
164518630|NCT00626990|594268377|FG002|Overall Study|Protocol Violation|1|||
164518631|NCT00626990|594268378|FG003|Overall Study|Protocol Violation|0|||
164518632|NCT00626990|594268375|FG000|Overall Study|Various different reasons/missing|4|||
164518633|NCT00626990|594268376|FG001|Overall Study|Various different reasons/missing|8|||
164518634|NCT00626990|594268377|FG002|Overall Study|Various different reasons/missing|8|||
164518635|NCT00626990|594268378|FG003|Overall Study|Various different reasons/missing|16|||
164518636|NCT04138576|594268383|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
164518637|NCT04410523|594268388|FG000|Overall Study|Study terminated by sponsor|1|||
164518638|NCT04410523|594268389|FG001|Overall Study|Study terminated by sponsor|3|||
164518639|NCT04410523|594268390|FG002|Overall Study|Study terminated by sponsor|2|||
164518640|NCT04410523|594268391|FG003|Overall Study|Study terminated by sponsor|6|||
164518641|NCT04410523|594268392|FG004|Overall Study|Study terminated by sponsor|3|||
164518642|NCT04410523|594268393|FG005|Overall Study|Study terminated by sponsor|4|||
164518643|NCT04410523|594268388|FG000|Overall Study|Adverse Event|1|||
164518644|NCT04410523|594268389|FG001|Overall Study|Adverse Event|0|||
164518645|NCT04410523|594268390|FG002|Overall Study|Adverse Event|0|||
164518646|NCT04410523|594268391|FG003|Overall Study|Adverse Event|0|||
164518647|NCT04410523|594268392|FG004|Overall Study|Adverse Event|0|||
164518648|NCT04410523|594268393|FG005|Overall Study|Adverse Event|2|||
164518649|NCT04410523|594268388|FG000|Overall Study|Lost to Follow-up|0|||
164518650|NCT04410523|594268389|FG001|Overall Study|Lost to Follow-up|1|||
164518651|NCT04410523|594268390|FG002|Overall Study|Lost to Follow-up|0|||
164518652|NCT04410523|594268391|FG003|Overall Study|Lost to Follow-up|0|||
164518653|NCT04410523|594268392|FG004|Overall Study|Lost to Follow-up|0|||
164518654|NCT04410523|594268393|FG005|Overall Study|Lost to Follow-up|0|||
164518655|NCT04410523|594268388|FG000|Overall Study|Physician Decision|0|||
164518656|NCT04410523|594268389|FG001|Overall Study|Physician Decision|1|||
164518657|NCT04410523|594268390|FG002|Overall Study|Physician Decision|0|||
164518658|NCT04410523|594268391|FG003|Overall Study|Physician Decision|0|||
164518659|NCT04410523|594268392|FG004|Overall Study|Physician Decision|0|||
164518660|NCT04410523|594268393|FG005|Overall Study|Physician Decision|0|||
164518661|NCT04410523|594268388|FG000|Overall Study|Pregnancy|0|||
164518662|NCT04410523|594268389|FG001|Overall Study|Pregnancy|0|||
164518663|NCT04410523|594268390|FG002|Overall Study|Pregnancy|0|||
164518664|NCT04410523|594268391|FG003|Overall Study|Pregnancy|0|||
164518665|NCT04410523|594268392|FG004|Overall Study|Pregnancy|0|||
164518666|NCT04410523|594268393|FG005|Overall Study|Pregnancy|1|||
164518667|NCT04410523|594268388|FG000|Overall Study|Protocol deviation|0|||
164518668|NCT04410523|594268389|FG001|Overall Study|Protocol deviation|0|||
164518669|NCT04410523|594268390|FG002|Overall Study|Protocol deviation|0|||
164616460|NCT02709109|594616192|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
164616461|NCT02709109|594616189|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
164616462|NCT02709109|594616190|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
164616463|NCT02709109|594616191|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
164518670|NCT04410523|594268391|FG003|Overall Study|Protocol deviation|0|||
164518671|NCT04410523|594268392|FG004|Overall Study|Protocol deviation|0|||
164518672|NCT04410523|594268393|FG005|Overall Study|Protocol deviation|2|||
164518673|NCT04410523|594268388|FG000|Overall Study|Subject decision|2|||
164518674|NCT04410523|594268389|FG001|Overall Study|Subject decision|0|||
164518675|NCT04410523|594268390|FG002|Overall Study|Subject decision|0|||
164518676|NCT04410523|594268391|FG003|Overall Study|Subject decision|1|||
164616464|NCT02709109|594616192|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
164616465|NCT02709109|594616189|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
164616466|NCT02709109|594616190|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
164616467|NCT02709109|594616191|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
164616468|NCT02709109|594616192|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
164518677|NCT04410523|594268392|FG004|Overall Study|Subject decision|0|||
164518678|NCT04410523|594268393|FG005|Overall Study|Subject decision|1|||
164518679|NCT00490490|594268394|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
164518680|NCT00490490|594268394|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
164518681|NCT03268603|594268395|FG000|Overall Study|Withdrawal by Subject|6|||
164518682|NCT03268603|594268395|FG000|Overall Study|Physician Decision|1|||
164518683|NCT03268603|594268395|FG000|Overall Study|Withdrawn due to disease progression|2|||
164518684|NCT04939701|594268396|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
164518685|NCT04939701|594268397|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
164518686|NCT04939701|594268398|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
164518687|NCT04939701|594268396|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
164518688|NCT04939701|594268397|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
164518689|NCT04939701|594268398|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
164518690|NCT04939701|594268396|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
164518691|NCT04939701|594268397|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
164518692|NCT04939701|594268398|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
164518693|NCT04939701|594268396|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
164518694|NCT04939701|594268397|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
164518695|NCT04939701|594268398|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
164518696|NCT04939701|594268396|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
164518697|NCT04939701|594268397|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
164518698|NCT04939701|594268398|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
164518699|NCT04939701|594268396|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
164518700|NCT04939701|594268397|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
164518701|NCT04939701|594268398|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
164518702|NCT04939701|594268396|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
164518703|NCT04939701|594268397|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
164518704|NCT04939701|594268398|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
164616469|NCT02709109|594616189|FG000|Treatment Period 2 (28 Days)|Other|0|||
164616470|NCT02709109|594616190|FG001|Treatment Period 2 (28 Days)|Other|0|||
164616471|NCT02709109|594616191|FG002|Treatment Period 2 (28 Days)|Other|1|||
164616472|NCT02709109|594616192|FG003|Treatment Period 2 (28 Days)|Other|0|||
164616473|NCT00842361|594616203|FG000|Overall Study|Protocol Violation|1|||
164616474|NCT00842361|594616204|FG001|Overall Study|Protocol Violation|0|||
164616475|NCT00842361|594616203|FG000|Overall Study|Unclassified|0|||
164616476|NCT00842361|594616204|FG001|Overall Study|Unclassified|2|||
164616477|NCT00437203|594616207|FG000|Overall Study|Death|0|||
164616478|NCT00437203|594616208|FG001|Overall Study|Death|0|||
164616479|NCT00437203|594616209|FG002|Overall Study|Death|1|||
164616480|NCT00437203|594616210|FG003|Overall Study|Death|0|||
164616481|NCT00437203|594616211|FG004|Overall Study|Death|0|||
164616482|NCT00437203|594616212|FG005|Overall Study|Death|0|||
164616483|NCT00437203|594616213|FG006|Overall Study|Death|0|||
164616484|NCT00437203|594616214|FG007|Overall Study|Death|1|||
164616485|NCT00437203|594616215|FG008|Overall Study|Death|0|||
164616486|NCT00437203|594616216|FG009|Overall Study|Death|1|||
164616487|NCT00437203|594616207|FG000|Overall Study|Adverse Event|1|||
164616488|NCT00437203|594616208|FG001|Overall Study|Adverse Event|1|||
164616489|NCT00437203|594616209|FG002|Overall Study|Adverse Event|0|||
164616490|NCT00437203|594616210|FG003|Overall Study|Adverse Event|0|||
164616491|NCT00437203|594616211|FG004|Overall Study|Adverse Event|0|||
164616492|NCT00437203|594616212|FG005|Overall Study|Adverse Event|0|||
164616493|NCT00437203|594616213|FG006|Overall Study|Adverse Event|0|||
164616494|NCT00437203|594616214|FG007|Overall Study|Adverse Event|1|||
164616495|NCT00437203|594616215|FG008|Overall Study|Adverse Event|0|||
164616496|NCT00437203|594616216|FG009|Overall Study|Adverse Event|1|||
164616497|NCT00437203|594616207|FG000|Overall Study|Study terminated by sponsor|0|||
164616498|NCT00437203|594616208|FG001|Overall Study|Study terminated by sponsor|0|||
164616499|NCT00437203|594616209|FG002|Overall Study|Study terminated by sponsor|0|||
164616500|NCT00437203|594616210|FG003|Overall Study|Study terminated by sponsor|0|||
164616501|NCT00437203|594616211|FG004|Overall Study|Study terminated by sponsor|0|||
164616502|NCT00437203|594616212|FG005|Overall Study|Study terminated by sponsor|0|||
164616503|NCT00437203|594616213|FG006|Overall Study|Study terminated by sponsor|0|||
164616504|NCT00437203|594616214|FG007|Overall Study|Study terminated by sponsor|0|||
164616505|NCT00437203|594616215|FG008|Overall Study|Study terminated by sponsor|1|||
164616506|NCT00437203|594616216|FG009|Overall Study|Study terminated by sponsor|0|||
164616507|NCT00437203|594616207|FG000|Overall Study|Objective progression or relapse|5|||
164616508|NCT00437203|594616208|FG001|Overall Study|Objective progression or relapse|6|||
164616509|NCT00437203|594616209|FG002|Overall Study|Objective progression or relapse|2|||
164616510|NCT00437203|594616210|FG003|Overall Study|Objective progression or relapse|3|||
164616511|NCT00437203|594616211|FG004|Overall Study|Objective progression or relapse|3|||
164616512|NCT00437203|594616212|FG005|Overall Study|Objective progression or relapse|3|||
164616513|NCT00437203|594616213|FG006|Overall Study|Objective progression or relapse|6|||
164616514|NCT00437203|594616214|FG007|Overall Study|Objective progression or relapse|1|||
164616515|NCT00437203|594616215|FG008|Overall Study|Objective progression or relapse|2|||
164616516|NCT00437203|594616216|FG009|Overall Study|Objective progression or relapse|2|||
164616517|NCT00437203|594616207|FG000|Overall Study|Other|0|||
164616518|NCT00437203|594616208|FG001|Overall Study|Other|1|||
164616519|NCT00437203|594616209|FG002|Overall Study|Other|0|||
164616520|NCT00437203|594616210|FG003|Overall Study|Other|0|||
164616521|NCT00437203|594616211|FG004|Overall Study|Other|0|||
164616522|NCT00437203|594616212|FG005|Overall Study|Other|0|||
164616523|NCT00437203|594616213|FG006|Overall Study|Other|1|||
164616524|NCT00437203|594616214|FG007|Overall Study|Other|0|||
164616525|NCT00437203|594616215|FG008|Overall Study|Other|0|||
164616526|NCT00437203|594616216|FG009|Overall Study|Other|0|||
164616527|NCT03997760|594616217|FG000|Overall Study|Protocol Deviation|0|||
164616528|NCT03997760|594616218|FG001|Overall Study|Protocol Deviation|1|||
164616529|NCT03997760|594616219|FG002|Overall Study|Protocol Deviation|0|||
164616530|NCT03997760|594616220|FG003|Overall Study|Protocol Deviation|0|||
164616531|NCT02999191|594616222|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
164616532|NCT02999191|594616223|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
164616533|NCT02999191|594616224|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
164616534|NCT02566109|594616226|FG000|Overall Study|Withdrawal by Subject|1|||
164616535|NCT01906476|594616227|FG000|Overall Study|Lost to Follow-up|17|||
164616536|NCT01906476|594616228|FG001|Overall Study|Lost to Follow-up|16|||
164616537|NCT01993667|594616229|FG000|Overall Study|Insufficient data to analyze|16|||
164616538|NCT01993667|594616230|FG001|Overall Study|Insufficient data to analyze|16|||
164616539|NCT01993667|594616229|FG000|Overall Study|Insufficient altitude reached|3|||
164616540|NCT01993667|594616230|FG001|Overall Study|Insufficient altitude reached|1|||
164616541|NCT01993667|594616229|FG000|Overall Study|Lost to Follow-up|2|||
164616542|NCT01993667|594616230|FG001|Overall Study|Lost to Follow-up|2|||
164616543|NCT00479167|594616233|FG000|Overall Study|Withdrawal by Subject|1|||
164616544|NCT01576406|594616235|FG000|Overall Study|Lost to Follow-up|1|||
164616545|NCT01576406|594616236|FG001|Overall Study|Lost to Follow-up|2|||
164616546|NCT01576406|594616237|FG002|Overall Study|Lost to Follow-up|0|||
164616547|NCT01576406|594616238|FG003|Overall Study|Lost to Follow-up|0|||
164518705|NCT00772330|594268399|FG000|Overall Study|Lost to Follow-up|3|||
164518706|NCT00734591|594268400|FG000|Screening for Prospective Period|Site did not participate|1604|||
164518707|NCT00734591|594268401|FG001|Screening for Prospective Period|Site did not participate|1488|||
164518708|NCT00734591|594268400|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
164518709|NCT00734591|594268401|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
164518710|NCT00734591|594268400|FG000|Prospective Period|Withdrawal by Subject|11|||
164518711|NCT00734591|594268401|FG001|Prospective Period|Withdrawal by Subject|9|||
164518712|NCT00734591|594268400|FG000|Prospective Period|Lost to Follow-up|37|||
164518713|NCT00734591|594268401|FG001|Prospective Period|Lost to Follow-up|33|||
164518714|NCT00734591|594268400|FG000|Prospective Period|Study Terminated|1|||
164518715|NCT00734591|594268401|FG001|Prospective Period|Study Terminated|0|||
164518716|NCT00734591|594268400|FG000|Prospective Period|Other|2|||
164518717|NCT00734591|594268401|FG001|Prospective Period|Other|2|||
164518718|NCT03248882|594268404|FG000|Overall Study|Adverse Event|3|||
164518719|NCT03248882|594268405|FG001|Overall Study|Adverse Event|3|||
164518720|NCT03248882|594268406|FG002|Overall Study|Adverse Event|2|||
164518721|NCT03248882|594268407|FG003|Overall Study|Adverse Event|6|||
164518722|NCT03248882|594268408|FG004|Overall Study|Adverse Event|9|||
164518723|NCT03248882|594268404|FG000|Overall Study|Lost to Follow-up|0|||
164518724|NCT03248882|594268405|FG001|Overall Study|Lost to Follow-up|0|||
164518725|NCT03248882|594268406|FG002|Overall Study|Lost to Follow-up|0|||
164518726|NCT03248882|594268407|FG003|Overall Study|Lost to Follow-up|0|||
164518727|NCT03248882|594268408|FG004|Overall Study|Lost to Follow-up|1|||
164518728|NCT03248882|594268404|FG000|Overall Study|Protocol Violation|2|||
164518729|NCT03248882|594268405|FG001|Overall Study|Protocol Violation|0|||
164518730|NCT03248882|594268406|FG002|Overall Study|Protocol Violation|2|||
164518731|NCT03248882|594268407|FG003|Overall Study|Protocol Violation|0|||
164518732|NCT03248882|594268408|FG004|Overall Study|Protocol Violation|1|||
164518733|NCT03248882|594268404|FG000|Overall Study|Withdrawal by Subject|2|||
164518734|NCT03248882|594268405|FG001|Overall Study|Withdrawal by Subject|2|||
164518735|NCT03248882|594268406|FG002|Overall Study|Withdrawal by Subject|3|||
164518736|NCT03248882|594268407|FG003|Overall Study|Withdrawal by Subject|4|||
164518737|NCT03248882|594268408|FG004|Overall Study|Withdrawal by Subject|2|||
164518738|NCT01656200|594268409|FG000|Overall Study|Withdrawal by Subject|1|||
164518739|NCT01156376|594268411|FG000|Overall Study|Adverse Event|1|||
164518740|NCT01156376|594268412|FG001|Overall Study|Adverse Event|0|||
164518741|NCT01156376|594268413|FG002|Overall Study|Adverse Event|1|||
164518742|NCT01156376|594268411|FG000|Overall Study|Withdrawal by Subject|0|||
164518743|NCT01156376|594268412|FG001|Overall Study|Withdrawal by Subject|0|||
164518744|NCT01156376|594268413|FG002|Overall Study|Withdrawal by Subject|3|||
164518745|NCT01493427|594268414|FG000|Overall Study|Adverse Event|10|||
164518746|NCT01493427|594268414|FG000|Overall Study|Personal Reasons|4|||
164518747|NCT01493427|594268414|FG000|Overall Study|Lost to Follow-up|2|||
164518748|NCT01493427|594268414|FG000|Overall Study|Inability to Follow Instructions|2|||
164518749|NCT01493427|594268414|FG000|Overall Study|Other|2|||
164518750|NCT05775991|594268415|FG000|Overall Study|Withdrawal by Subject|0|||
164518751|NCT05775991|594268416|FG001|Overall Study|Withdrawal by Subject|0|||
164518752|NCT05775991|594268417|FG002|Overall Study|Withdrawal by Subject|2|||
164518753|NCT01461811|594268420|FG000|Overall Study|Adverse Event|2|||
164518754|NCT01461811|594268421|FG001|Overall Study|Adverse Event|1|||
164518755|NCT01461811|594268420|FG000|Overall Study|Subject decision unrelated to an AE|1|||
164518756|NCT01461811|594268421|FG001|Overall Study|Subject decision unrelated to an AE|1|||
164518757|NCT01461811|594268420|FG000|Overall Study|Noncompliance|1|||
164518758|NCT01461811|594268421|FG001|Overall Study|Noncompliance|1|||
164518759|NCT03015129|594268422|FG000|Overall Study|Death|2|||
164518760|NCT03015129|594268423|FG001|Overall Study|Death|2|||
164518761|NCT03015129|594268422|FG000|Overall Study|Lost to Follow-up|0|||
164518762|NCT03015129|594268423|FG001|Overall Study|Lost to Follow-up|1|||
164518763|NCT03015129|594268422|FG000|Overall Study|Progression of disease|38|||
164518764|NCT03015129|594268423|FG001|Overall Study|Progression of disease|33|||
164518765|NCT03015129|594268422|FG000|Overall Study|Adverse Event|0|||
164518766|NCT03015129|594268423|FG001|Overall Study|Adverse Event|4|||
164518767|NCT05032872|594268424|FG000|Overall Study|Adverse Event|1|||
164518768|NCT05032872|594268425|FG001|Overall Study|Adverse Event|0|||
164518769|NCT05032872|594268424|FG000|Overall Study|Lost to Follow-up|2|||
164518770|NCT05032872|594268425|FG001|Overall Study|Lost to Follow-up|4|||
164518771|NCT05032872|594268424|FG000|Overall Study|Withdrawal by Subject|4|||
164518772|NCT05032872|594268425|FG001|Overall Study|Withdrawal by Subject|3|||
164518773|NCT00338962|594268426|FG000|Overall Study|Lost to Follow-up|3|||
164518774|NCT00338962|594268427|FG001|Overall Study|Lost to Follow-up|3|||
164518775|NCT00338962|594268428|FG002|Overall Study|Lost to Follow-up|2|||
164518776|NCT00338962|594268429|FG003|Overall Study|Lost to Follow-up|3|||
164518777|NCT00338962|594268426|FG000|Overall Study|Withdrawal by Subject|1|||
164518778|NCT00338962|594268427|FG001|Overall Study|Withdrawal by Subject|0|||
164518779|NCT00338962|594268428|FG002|Overall Study|Withdrawal by Subject|0|||
164518780|NCT00338962|594268429|FG003|Overall Study|Withdrawal by Subject|0|||
164518781|NCT00338962|594268426|FG000|Overall Study|No Transportation|2|||
164518782|NCT00338962|594268427|FG001|Overall Study|No Transportation|0|||
164518783|NCT00338962|594268428|FG002|Overall Study|No Transportation|0|||
164518784|NCT00338962|594268429|FG003|Overall Study|No Transportation|0|||
164518785|NCT00338962|594268426|FG000|Overall Study|Time Constraint|2|||
164518786|NCT00338962|594268427|FG001|Overall Study|Time Constraint|0|||
164518787|NCT00338962|594268428|FG002|Overall Study|Time Constraint|0|||
164518788|NCT00338962|594268429|FG003|Overall Study|Time Constraint|0|||
164518789|NCT00338962|594268426|FG000|Overall Study|Moved|0|||
164518790|NCT00338962|594268427|FG001|Overall Study|Moved|1|||
164518791|NCT00338962|594268428|FG002|Overall Study|Moved|0|||
164518792|NCT00338962|594268429|FG003|Overall Study|Moved|0|||
164518793|NCT00338962|594268426|FG000|Overall Study|Adverse Event|0|||
164518794|NCT00338962|594268427|FG001|Overall Study|Adverse Event|0|||
164518795|NCT00338962|594268428|FG002|Overall Study|Adverse Event|2|||
164518796|NCT00338962|594268429|FG003|Overall Study|Adverse Event|0|||
164518797|NCT00338962|594268426|FG000|Overall Study|Poor Compliance|0|||
164518798|NCT00338962|594268427|FG001|Overall Study|Poor Compliance|0|||
164518799|NCT00338962|594268428|FG002|Overall Study|Poor Compliance|2|||
164518800|NCT00338962|594268429|FG003|Overall Study|Poor Compliance|0|||
164518801|NCT03733314|594268430|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
164518802|NCT03733314|594268431|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
164518803|NCT03733314|594268430|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
164518804|NCT03733314|594268431|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
164518805|NCT03733314|594268430|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
164518806|NCT03733314|594268431|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
164518807|NCT03733314|594268430|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
164518808|NCT03733314|594268431|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
164518809|NCT03733314|594268430|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
164518810|NCT03733314|594268431|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
164518811|NCT03733314|594268430|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
164518812|NCT03733314|594268431|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
164518813|NCT01598662|594268432|FG000|Overall Study|Lost to Follow-up|10|||
164518814|NCT01598662|594268433|FG001|Overall Study|Lost to Follow-up|17|||
164518815|NCT01598662|594268432|FG000|Overall Study|Physician Decision|1|||
164518816|NCT01598662|594268433|FG001|Overall Study|Physician Decision|2|||
164518817|NCT01598662|594268432|FG000|Overall Study|IUD expelled before month 6|0|||
164518818|NCT01598662|594268433|FG001|Overall Study|IUD expelled before month 6|2|||
164518819|NCT00910039|594268434|FG000|Overall Study|Physician Decision|1|||
164518820|NCT04155047|594268439|FG000|Overall Study|Adverse Event|1|||
164518821|NCT04155047|594268440|FG001|Overall Study|Adverse Event|0|||
164518822|NCT04155047|594268439|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
164518823|NCT04155047|594268440|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
164518824|NCT04514510|594268441|FG000|Overall Study|Lost to Follow-up|0|||
164518825|NCT04514510|594268442|FG001|Overall Study|Lost to Follow-up|1|||
164518826|NCT04514510|594268441|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
164518827|NCT04514510|594268442|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
164518828|NCT00821587|594268443|FG000|Overall Study|Physician Decision|0|||
164518829|NCT00821587|594268444|FG001|Overall Study|Physician Decision|1|||
164518830|NCT02781090|594268447|FG000|3-Month Follow-Up|Missed Visit|20|||
164518831|NCT02781090|594268448|FG001|3-Month Follow-Up|Missed Visit|20|||
164518832|NCT02781090|594268447|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
164518833|NCT02781090|594268448|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
164518834|NCT02781090|594268447|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
164518835|NCT02781090|594268448|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
164518836|NCT02781090|594268447|FG000|3-Month Follow-Up|Death|1|||
164518837|NCT02781090|594268448|FG001|3-Month Follow-Up|Death|0|||
164518838|NCT02781090|594268447|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
164518839|NCT02781090|594268448|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
164518840|NCT02781090|594268447|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
164518841|NCT02781090|594268448|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
164518842|NCT02781090|594268447|FG000|6-Month Follow-Up|Death|0|||
164518843|NCT02781090|594268448|FG001|6-Month Follow-Up|Death|1|||
164518844|NCT00643617|594268449|FG000|Overall Study|Death|6|||
164518845|NCT00643617|594268450|FG001|Overall Study|Death|9|||
164518846|NCT00643617|594268449|FG000|Overall Study|Lost to Follow-up|42|||
164518847|NCT00643617|594268450|FG001|Overall Study|Lost to Follow-up|51|||
164518848|NCT02075073|594268451|FG000|Overall Study|Withdrawal by Subject|0|||
164518849|NCT02075073|594268452|FG001|Overall Study|Withdrawal by Subject|1|||
164518850|NCT02075073|594268453|FG002|Overall Study|Withdrawal by Subject|0|||
164518851|NCT01208103|594268460|FG000|Overall Study|Adverse Event|1|||
164518852|NCT01208103|594268460|FG000|Overall Study|Withdrawal by Subject|1|||
164518853|NCT02233803|594268463|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
164518854|NCT02233803|594268464|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
164518855|NCT02233803|594268463|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
164518856|NCT02233803|594268464|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
164518857|NCT02233803|594268463|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
164518858|NCT02233803|594268464|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
164518859|NCT02233803|594268463|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
164518860|NCT02233803|594268464|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
164518861|NCT02233803|594268463|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
164518862|NCT02233803|594268464|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
164518863|NCT02233803|594268463|FG000|Washout Period (4-Wks)|Physician Decision|1|||
164518864|NCT02233803|594268464|FG001|Washout Period (4-Wks)|Physician Decision|0|||
164518865|NCT02233803|594268463|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
164518866|NCT02233803|594268464|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
164518867|NCT02233803|594268463|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
164518868|NCT02233803|594268464|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
164518869|NCT02233803|594268463|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
164518870|NCT02233803|594268464|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
164518871|NCT01696955|594268465|FG000|Main Study|Protocol Violation|1|||
164518872|NCT01696955|594268466|FG001|Main Study|Protocol Violation|0|||
164518873|NCT01696955|594268465|FG000|Main Study|Withdrawal by Subject|1|||
164518874|NCT01696955|594268466|FG001|Main Study|Withdrawal by Subject|1|||
164518875|NCT05330676|594268467|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
164518876|NCT05330676|594268468|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
164518877|NCT03653208|594268469|FG000|Overall Study|Withdrawal by Subject|0|||
164518878|NCT03653208|594268470|FG001|Overall Study|Withdrawal by Subject|0|||
164518879|NCT03653208|594268471|FG002|Overall Study|Withdrawal by Subject|0|||
164518880|NCT03653208|594268472|FG003|Overall Study|Withdrawal by Subject|0|||
164518881|NCT03653208|594268473|FG004|Overall Study|Withdrawal by Subject|1|||
164518882|NCT03653208|594268474|FG005|Overall Study|Withdrawal by Subject|0|||
164518883|NCT03653208|594268475|FG006|Overall Study|Withdrawal by Subject|0|||
164518884|NCT03653208|594268476|FG007|Overall Study|Withdrawal by Subject|1|||
164518885|NCT03653208|594268477|FG008|Overall Study|Withdrawal by Subject|1|||
164518886|NCT00436605|594268478|FG000|Overall Study|Protocol Violation|3|||
164518887|NCT00573859|594268481|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
164518888|NCT00573859|594268481|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
164518889|NCT02416453|594268482|FG000|Overall Study|Adverse Event|0|||
164518890|NCT02416453|594268483|FG001|Overall Study|Adverse Event|0|||
164518891|NCT02416453|594268484|FG002|Overall Study|Adverse Event|0|||
164518892|NCT02416453|594268485|FG003|Overall Study|Adverse Event|2|||
164518893|NCT02416453|594268486|FG004|Overall Study|Adverse Event|0|||
164518894|NCT02416453|594268487|FG005|Overall Study|Adverse Event|1|||
164518895|NCT02416453|594268488|FG006|Overall Study|Adverse Event|0|||
164518896|NCT02416453|594268489|FG007|Overall Study|Adverse Event|0|||
164518897|NCT02416453|594268490|FG008|Overall Study|Adverse Event|0|||
164518898|NCT02416453|594268491|FG009|Overall Study|Adverse Event|0|||
164518899|NCT02416453|594268492|FG010|Overall Study|Adverse Event|0|||
164518900|NCT02416453|594268482|FG000|Overall Study|Lost to Follow-up|1|||
164518901|NCT02416453|594268483|FG001|Overall Study|Lost to Follow-up|3|||
164518902|NCT02416453|594268484|FG002|Overall Study|Lost to Follow-up|0|||
164518903|NCT02416453|594268485|FG003|Overall Study|Lost to Follow-up|8|||
164518904|NCT02416453|594268486|FG004|Overall Study|Lost to Follow-up|0|||
164518905|NCT02416453|594268487|FG005|Overall Study|Lost to Follow-up|5|||
164518906|NCT02416453|594268488|FG006|Overall Study|Lost to Follow-up|1|||
164518907|NCT02416453|594268489|FG007|Overall Study|Lost to Follow-up|3|||
164518908|NCT02416453|594268490|FG008|Overall Study|Lost to Follow-up|1|||
164518909|NCT02416453|594268491|FG009|Overall Study|Lost to Follow-up|0|||
164518910|NCT02416453|594268492|FG010|Overall Study|Lost to Follow-up|0|||
164518911|NCT02416453|594268482|FG000|Overall Study|Physician Decision|0|||
164518912|NCT02416453|594268483|FG001|Overall Study|Physician Decision|0|||
164518913|NCT02416453|594268484|FG002|Overall Study|Physician Decision|0|||
164518914|NCT02416453|594268485|FG003|Overall Study|Physician Decision|0|||
164518915|NCT02416453|594268486|FG004|Overall Study|Physician Decision|0|||
164518916|NCT02416453|594268487|FG005|Overall Study|Physician Decision|1|||
164518917|NCT02416453|594268488|FG006|Overall Study|Physician Decision|1|||
164518918|NCT02416453|594268489|FG007|Overall Study|Physician Decision|1|||
164518919|NCT02416453|594268490|FG008|Overall Study|Physician Decision|0|||
164518920|NCT02416453|594268491|FG009|Overall Study|Physician Decision|0|||
164518921|NCT02416453|594268492|FG010|Overall Study|Physician Decision|0|||
164518922|NCT02416453|594268482|FG000|Overall Study|Withdrawal by Subject|2|||
164518923|NCT02416453|594268483|FG001|Overall Study|Withdrawal by Subject|0|||
164518924|NCT02416453|594268484|FG002|Overall Study|Withdrawal by Subject|0|||
164518925|NCT02416453|594268485|FG003|Overall Study|Withdrawal by Subject|5|||
164518926|NCT02416453|594268486|FG004|Overall Study|Withdrawal by Subject|1|||
164518927|NCT02416453|594268487|FG005|Overall Study|Withdrawal by Subject|8|||
164518928|NCT02416453|594268488|FG006|Overall Study|Withdrawal by Subject|0|||
164518929|NCT02416453|594268489|FG007|Overall Study|Withdrawal by Subject|8|||
164518930|NCT02416453|594268490|FG008|Overall Study|Withdrawal by Subject|4|||
164518931|NCT02416453|594268491|FG009|Overall Study|Withdrawal by Subject|0|||
164518932|NCT02416453|594268492|FG010|Overall Study|Withdrawal by Subject|0|||
164518933|NCT02416453|594268482|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
164518934|NCT02416453|594268483|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
164518935|NCT02416453|594268484|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
164518936|NCT02416453|594268485|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
164518937|NCT02416453|594268486|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
164518938|NCT02416453|594268487|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
164518939|NCT02416453|594268488|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
164518940|NCT02416453|594268489|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
164518941|NCT02416453|594268490|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
164518942|NCT02416453|594268491|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
164518943|NCT02416453|594268492|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
164518944|NCT02416453|594268482|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
164518945|NCT02416453|594268483|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
164518946|NCT02416453|594268484|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
164518947|NCT02416453|594268485|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
164518948|NCT02416453|594268486|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
164518949|NCT02416453|594268487|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
164518950|NCT02416453|594268488|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
164518951|NCT02416453|594268489|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
164518952|NCT02416453|594268490|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
164518953|NCT02416453|594268491|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
164518954|NCT02416453|594268492|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
164518955|NCT01989169|594268495|FG000|Period 2|Adverse Event|0|||
164518956|NCT01989169|594268496|FG001|Period 2|Adverse Event|1|||
164518957|NCT04187326|594268497|FG000|Overall Study|Lost to Follow-up|2|||
164518958|NCT04187326|594268498|FG001|Overall Study|Lost to Follow-up|1|||
164518959|NCT04187326|594268497|FG000|Overall Study|Computer error- task was only partially completed.|0|||
164518960|NCT04187326|594268498|FG001|Overall Study|Computer error- task was only partially completed.|1|||
164518961|NCT01114880|594268499|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
164518962|NCT01114880|594268500|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
164518963|NCT01114880|594268499|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
164518964|NCT01114880|594268500|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
164518965|NCT01114880|594268499|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
164518966|NCT01114880|594268500|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
164518967|NCT01114880|594268499|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
164518968|NCT01114880|594268500|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
164518969|NCT01114880|594268499|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
164518970|NCT01114880|594268500|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
164518971|NCT01114880|594268499|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
164518972|NCT01114880|594268500|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
164518973|NCT04531904|594268502|FG000|Overall Study|Lost to Follow-up|1|||
164518974|NCT04531904|594268502|FG000|Overall Study|Death|14|||
164518975|NCT00283244|594268503|FG000|Overall Study|Adverse Event|0|||
164616548|NCT01576406|594616239|FG004|Overall Study|Lost to Follow-up|0|||
164616549|NCT01576406|594616240|FG005|Overall Study|Lost to Follow-up|0|||
164616550|NCT01576406|594616235|FG000|Overall Study|Death|3|||
164518976|NCT00283244|594268504|FG001|Overall Study|Adverse Event|8|||
164518977|NCT00283244|594268505|FG002|Overall Study|Adverse Event|11|||
164518978|NCT00283244|594268503|FG000|Overall Study|Death|4|||
164518979|NCT00283244|594268504|FG001|Overall Study|Death|3|||
164518980|NCT00283244|594268505|FG002|Overall Study|Death|2|||
164518981|NCT00283244|594268503|FG000|Overall Study|Lack of Efficacy|8|||
164518982|NCT00283244|594268504|FG001|Overall Study|Lack of Efficacy|32|||
164518983|NCT00283244|594268505|FG002|Overall Study|Lack of Efficacy|26|||
164518984|NCT00283244|594268503|FG000|Overall Study|Withdrawal by Subject|1|||
164518985|NCT00283244|594268504|FG001|Overall Study|Withdrawal by Subject|2|||
164518986|NCT00283244|594268505|FG002|Overall Study|Withdrawal by Subject|2|||
164518987|NCT00283244|594268503|FG000|Overall Study|Physician Decision|0|||
164518988|NCT00283244|594268504|FG001|Overall Study|Physician Decision|0|||
164518989|NCT00283244|594268505|FG002|Overall Study|Physician Decision|1|||
164518990|NCT00283244|594268503|FG000|Overall Study|Medical illness (other complicating dz)|4|||
164518991|NCT00283244|594268504|FG001|Overall Study|Medical illness (other complicating dz)|3|||
164518992|NCT00283244|594268505|FG002|Overall Study|Medical illness (other complicating dz)|6|||
164518993|NCT00283244|594268503|FG000|Overall Study|Clinical deterioration|1|||
164518994|NCT00283244|594268504|FG001|Overall Study|Clinical deterioration|3|||
164518995|NCT00283244|594268505|FG002|Overall Study|Clinical deterioration|3|||
164518996|NCT03519997|594268508|FG000|Overall Study|Adverse Event|4|||
164518997|NCT03519997|594268508|FG000|Overall Study|Withdrawal by Subject|2|||
164518998|NCT03519997|594268508|FG000|Overall Study|Protocol Violation|1|||
164518999|NCT03361605|594268509|FG000|Overall Study|Analyzable data not available|3|||
164519000|NCT05543187|594268512|FG000|Overall Study|Ongoing|3|||
164519001|NCT05543187|594268513|FG001|Overall Study|Ongoing|2|||
164519002|NCT02344290|594268514|FG000|Overall Study|Withdrawal by Subject|315|||
164519003|NCT02344290|594268515|FG001|Overall Study|Withdrawal by Subject|324|||
164519004|NCT02344290|594268514|FG000|Overall Study|Lost to Follow-up|258|||
164519005|NCT02344290|594268515|FG001|Overall Study|Lost to Follow-up|249|||
164519006|NCT02344290|594268514|FG000|Overall Study|Unable to get to clinic|69|||
164519007|NCT02344290|594268515|FG001|Overall Study|Unable to get to clinic|60|||
164519008|NCT02344290|594268514|FG000|Overall Study|Physician Decision|25|||
164616551|NCT01576406|594616236|FG001|Overall Study|Death|4|||
164616552|NCT01576406|594616237|FG002|Overall Study|Death|8|||
164616553|NCT01576406|594616238|FG003|Overall Study|Death|5|||
164616554|NCT01576406|594616239|FG004|Overall Study|Death|7|||
164616555|NCT01576406|594616240|FG005|Overall Study|Death|9|||
164616556|NCT01576406|594616235|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
164616557|NCT01576406|594616236|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
164616558|NCT01576406|594616237|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
164616559|NCT01576406|594616238|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
164616560|NCT01576406|594616239|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
164616561|NCT01576406|594616240|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
164616562|NCT01576406|594616235|FG000|Overall Study|Withdrawal the consent|2|||
164616563|NCT01576406|594616236|FG001|Overall Study|Withdrawal the consent|2|||
164616564|NCT01576406|594616237|FG002|Overall Study|Withdrawal the consent|5|||
164616565|NCT01576406|594616238|FG003|Overall Study|Withdrawal the consent|1|||
164616566|NCT01576406|594616239|FG004|Overall Study|Withdrawal the consent|1|||
164616567|NCT01576406|594616240|FG005|Overall Study|Withdrawal the consent|3|||
164616568|NCT01576406|594616235|FG000|Overall Study|Other|0|||
164616569|NCT01576406|594616236|FG001|Overall Study|Other|0|||
164616570|NCT01576406|594616237|FG002|Overall Study|Other|2|||
164616571|NCT01576406|594616238|FG003|Overall Study|Other|2|||
164616572|NCT01576406|594616239|FG004|Overall Study|Other|0|||
164616573|NCT01576406|594616240|FG005|Overall Study|Other|0|||
164616574|NCT01627782|594616241|FG000|Overall Study|Adverse Event|1|||
164616575|NCT01627782|594616242|FG001|Overall Study|Adverse Event|2|||
164616576|NCT01627782|594616243|FG002|Overall Study|Adverse Event|0|||
164616577|NCT01627782|594616244|FG003|Overall Study|Adverse Event|1|||
164616578|NCT01627782|594616241|FG000|Overall Study|Lack of Efficacy|11|||
164616579|NCT01627782|594616242|FG001|Overall Study|Lack of Efficacy|1|||
164616580|NCT01627782|594616243|FG002|Overall Study|Lack of Efficacy|15|||
164616581|NCT01627782|594616244|FG003|Overall Study|Lack of Efficacy|2|||
164616582|NCT01627782|594616241|FG000|Overall Study|Protocol Violation|1|||
164616583|NCT01627782|594616242|FG001|Overall Study|Protocol Violation|0|||
164616584|NCT01627782|594616243|FG002|Overall Study|Protocol Violation|0|||
164616585|NCT01627782|594616244|FG003|Overall Study|Protocol Violation|0|||
164616586|NCT01627782|594616241|FG000|Overall Study|Withdrawal by Subject|2|||
164616587|NCT01627782|594616242|FG001|Overall Study|Withdrawal by Subject|1|||
164616588|NCT01627782|594616243|FG002|Overall Study|Withdrawal by Subject|0|||
164616589|NCT01627782|594616244|FG003|Overall Study|Withdrawal by Subject|0|||
164616590|NCT01627782|594616241|FG000|Overall Study|Other|0|||
164616591|NCT01627782|594616242|FG001|Overall Study|Other|2|||
164616592|NCT01627782|594616243|FG002|Overall Study|Other|0|||
164616593|NCT01627782|594616244|FG003|Overall Study|Other|3|||
164616594|NCT01627782|594616241|FG000|Overall Study|Randomized But Not Treated|1|||
164616595|NCT01627782|594616242|FG001|Overall Study|Randomized But Not Treated|0|||
164616596|NCT01627782|594616243|FG002|Overall Study|Randomized But Not Treated|0|||
164616597|NCT01627782|594616244|FG003|Overall Study|Randomized But Not Treated|0|||
164616598|NCT03627494|594616245|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
164616599|NCT03627494|594616246|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
164616600|NCT03627494|594616247|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
164616601|NCT03627494|594616248|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
164616602|NCT03627494|594616249|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
164616603|NCT03627494|594616250|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
164616604|NCT03627494|594616251|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
164616605|NCT03627494|594616252|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
164616606|NCT03627494|594616253|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
164616607|NCT03627494|594616254|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
164616608|NCT03627494|594616255|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
164616609|NCT03627494|594616256|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
164616610|NCT03627494|594616245|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
164616611|NCT03627494|594616246|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
164616612|NCT03627494|594616247|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
164616613|NCT03627494|594616248|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
164616614|NCT03627494|594616249|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
164616615|NCT03627494|594616250|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
164616616|NCT03627494|594616251|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
164616617|NCT03627494|594616252|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
164616618|NCT03627494|594616253|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
164616619|NCT03627494|594616254|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
164616620|NCT03627494|594616255|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
164616621|NCT03627494|594616256|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
164616622|NCT03627494|594616245|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
164616623|NCT03627494|594616246|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
164616624|NCT03627494|594616247|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
164616625|NCT03627494|594616248|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
164616626|NCT03627494|594616249|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
164616627|NCT03627494|594616250|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
164616628|NCT03627494|594616251|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
164616629|NCT03627494|594616252|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
164616630|NCT03627494|594616253|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
164616631|NCT03627494|594616254|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
164616632|NCT03627494|594616255|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
164616633|NCT03627494|594616256|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
164616634|NCT01004159|594618827|FG000|Overall Study|Adverse Event|2|||
164616635|NCT01004159|594618827|FG000|Overall Study|Disease Progression|18|||
164616636|NCT04315298|594618833|FG000|Overall Study|Withdrawal by Subject|0|||
164616637|NCT04315298|594618834|FG001|Overall Study|Withdrawal by Subject|0|||
164616638|NCT04315298|594618835|FG002|Overall Study|Withdrawal by Subject|0|||
164616639|NCT04315298|594618836|FG003|Overall Study|Withdrawal by Subject|2|||
164616640|NCT04315298|594618837|FG004|Overall Study|Withdrawal by Subject|2|||
164616641|NCT04315298|594618838|FG005|Overall Study|Withdrawal by Subject|2|||
164616642|NCT04315298|594618839|FG006|Overall Study|Withdrawal by Subject|0|||
164616643|NCT04315298|594618840|FG007|Overall Study|Withdrawal by Subject|1|||
164616644|NCT04315298|594618841|FG008|Overall Study|Withdrawal by Subject|1|||
164616645|NCT04315298|594618842|FG009|Overall Study|Withdrawal by Subject|1|||
164616646|NCT04315298|594618843|FG010|Overall Study|Withdrawal by Subject|0|||
164616647|NCT04315298|594618844|FG011|Overall Study|Withdrawal by Subject|0|||
164519009|NCT02344290|594268515|FG001|Overall Study|Physician Decision|25|||
164519010|NCT02344290|594268514|FG000|Overall Study|Site Closure|15|||
164519011|NCT02344290|594268515|FG001|Overall Study|Site Closure|19|||
164519012|NCT02344290|594268514|FG000|Overall Study|Other|5|||
164519013|NCT02344290|594268515|FG001|Overall Study|Other|3|||
164519014|NCT03896152|594270640|FG000|Overall Study|Patient/guardian decision|1|||
164519015|NCT03896152|594270641|FG001|Overall Study|Patient/guardian decision|1|||
164519016|NCT03896152|594270640|FG000|Overall Study|Adverse Event|0|||
164519017|NCT03896152|594270641|FG001|Overall Study|Adverse Event|1|||
164519018|NCT03896152|594270640|FG000|Overall Study|Physician Decision|1|||
164519019|NCT03896152|594270641|FG001|Overall Study|Physician Decision|0|||
164519020|NCT03896152|594270640|FG000|Overall Study|Technical problems|1|||
164519021|NCT03896152|594270641|FG001|Overall Study|Technical problems|0|||
164519022|NCT00224887|594270642|FG000|Overall Study|Pregnancy|6|||
164519023|NCT00224887|594270643|FG001|Overall Study|Pregnancy|6|||
164519024|NCT01659853|594270644|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
164519025|NCT01659853|594270645|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
164519026|NCT01659853|594270644|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
164519027|NCT01659853|594270645|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
164519028|NCT03921723|594270646|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
164519029|NCT03921723|594270646|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
164519030|NCT03046121|594270648|FG000|Overall Study|Death|32|||
164519031|NCT03046121|594270649|FG001|Overall Study|Death|60|||
164519032|NCT03046121|594270648|FG000|Overall Study|Withdrawal by Subject|14|||
164519033|NCT03046121|594270649|FG001|Overall Study|Withdrawal by Subject|12|||
164519034|NCT03214640|594270650|FG000|Overall Study|Protocol Violation|1|||
164519035|NCT03214640|594270651|FG001|Overall Study|Protocol Violation|2|||
164519036|NCT03214640|594270652|FG002|Overall Study|Protocol Violation|1|||
164519037|NCT03214640|594270653|FG003|Overall Study|Protocol Violation|4|||
164519038|NCT00406692|594270661|FG000|Overall Study|Withdrawal by Subject|4|||
164519039|NCT00406692|594270661|FG000|Overall Study|Physician Decision|1|||
164519040|NCT00406692|594270661|FG000|Overall Study|Adverse Event|1|||
164519041|NCT00406692|594270661|FG000|Overall Study|Lack of Efficacy|1|||
164519042|NCT04488770|594270662|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
164519043|NCT04488770|594270663|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
164519044|NCT04488770|594270664|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
164519045|NCT04488770|594270665|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
164519046|NCT04488770|594270666|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
164519047|NCT04488770|594270667|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
164519048|NCT04488770|594270668|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
164519049|NCT04488770|594270669|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
164519050|NCT04488770|594270670|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
164519051|NCT04488770|594270671|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
164519052|NCT04488770|594270672|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
164519053|NCT04488770|594270673|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
164519054|NCT04488770|594270674|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
164519055|NCT04488770|594270662|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
164519056|NCT04488770|594270663|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
164519057|NCT04488770|594270664|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
164519058|NCT04488770|594270665|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
164519059|NCT04488770|594270666|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
164519060|NCT04488770|594270667|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
164519061|NCT04488770|594270668|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
164519062|NCT04488770|594270669|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
164519063|NCT04488770|594270670|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
164519064|NCT04488770|594270671|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
164519065|NCT04488770|594270672|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
164519066|NCT04488770|594270673|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
164519067|NCT04488770|594270674|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
164519068|NCT04488770|594270662|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
164519069|NCT04488770|594270663|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
164519070|NCT04488770|594270664|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
164519071|NCT04488770|594270665|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
164519072|NCT04488770|594270666|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
164519073|NCT04488770|594270667|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
164519074|NCT04488770|594270668|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
164519075|NCT04488770|594270669|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
164519076|NCT04488770|594270670|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
164519077|NCT04488770|594270671|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
164519078|NCT04488770|594270672|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
164519079|NCT04488770|594270673|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
164616648|NCT04315298|594618845|FG012|Overall Study|Withdrawal by Subject|0|||
164616649|NCT04315298|594618846|FG013|Overall Study|Withdrawal by Subject|0|||
164616650|NCT04315298|594618847|FG014|Overall Study|Withdrawal by Subject|0|||
164616651|NCT04315298|594618848|FG015|Overall Study|Withdrawal by Subject|0|||
164616652|NCT04315298|594618849|FG016|Overall Study|Withdrawal by Subject|0|||
164616653|NCT04315298|594618850|FG017|Overall Study|Withdrawal by Subject|0|||
164616654|NCT04315298|594618851|FG018|Overall Study|Withdrawal by Subject|0|||
164616655|NCT04315298|594618833|FG000|Overall Study|Physician Decision|0|||
164616656|NCT04315298|594618834|FG001|Overall Study|Physician Decision|0|||
164616657|NCT04315298|594618835|FG002|Overall Study|Physician Decision|0|||
164616658|NCT04315298|594618836|FG003|Overall Study|Physician Decision|0|||
164616659|NCT04315298|594618837|FG004|Overall Study|Physician Decision|1|||
164616660|NCT04315298|594618838|FG005|Overall Study|Physician Decision|0|||
164616661|NCT04315298|594618839|FG006|Overall Study|Physician Decision|0|||
164616662|NCT04315298|594618840|FG007|Overall Study|Physician Decision|0|||
164616663|NCT04315298|594618841|FG008|Overall Study|Physician Decision|0|||
164616664|NCT04315298|594618842|FG009|Overall Study|Physician Decision|0|||
164616665|NCT04315298|594618843|FG010|Overall Study|Physician Decision|0|||
164616666|NCT04315298|594618844|FG011|Overall Study|Physician Decision|0|||
164616667|NCT04315298|594618845|FG012|Overall Study|Physician Decision|0|||
164616668|NCT04315298|594618846|FG013|Overall Study|Physician Decision|0|||
164616669|NCT04315298|594618847|FG014|Overall Study|Physician Decision|0|||
164616670|NCT04315298|594618848|FG015|Overall Study|Physician Decision|0|||
164616671|NCT04315298|594618849|FG016|Overall Study|Physician Decision|0|||
164616672|NCT04315298|594618850|FG017|Overall Study|Physician Decision|0|||
164616673|NCT04315298|594618851|FG018|Overall Study|Physician Decision|0|||
164616674|NCT04315298|594618833|FG000|Overall Study|Lost to Follow-up|5|||
164616675|NCT04315298|594618834|FG001|Overall Study|Lost to Follow-up|10|||
164616676|NCT04315298|594618835|FG002|Overall Study|Lost to Follow-up|6|||
164616677|NCT04315298|594618836|FG003|Overall Study|Lost to Follow-up|8|||
164616678|NCT04315298|594618837|FG004|Overall Study|Lost to Follow-up|12|||
164616679|NCT04315298|594618838|FG005|Overall Study|Lost to Follow-up|13|||
164616680|NCT04315298|594618839|FG006|Overall Study|Lost to Follow-up|9|||
164616681|NCT04315298|594618840|FG007|Overall Study|Lost to Follow-up|16|||
164616682|NCT04315298|594618841|FG008|Overall Study|Lost to Follow-up|14|||
164616683|NCT04315298|594618842|FG009|Overall Study|Lost to Follow-up|0|||
164616684|NCT04315298|594618843|FG010|Overall Study|Lost to Follow-up|2|||
164616685|NCT04315298|594618844|FG011|Overall Study|Lost to Follow-up|1|||
164616686|NCT04315298|594618845|FG012|Overall Study|Lost to Follow-up|0|||
164616687|NCT04315298|594618846|FG013|Overall Study|Lost to Follow-up|0|||
164616688|NCT04315298|594618847|FG014|Overall Study|Lost to Follow-up|0|||
164616689|NCT04315298|594618848|FG015|Overall Study|Lost to Follow-up|2|||
164616690|NCT04315298|594618849|FG016|Overall Study|Lost to Follow-up|0|||
164616691|NCT04315298|594618850|FG017|Overall Study|Lost to Follow-up|0|||
164616692|NCT04315298|594618851|FG018|Overall Study|Lost to Follow-up|0|||
164616693|NCT04315298|594618833|FG000|Overall Study|Death|24|||
164616694|NCT04315298|594618834|FG001|Overall Study|Death|60|||
164616695|NCT04315298|594618835|FG002|Overall Study|Death|49|||
164616696|NCT04315298|594618836|FG003|Overall Study|Death|59|||
164616697|NCT04315298|594618837|FG004|Overall Study|Death|70|||
164616698|NCT04315298|594618838|FG005|Overall Study|Death|114|||
164616699|NCT04315298|594618839|FG006|Overall Study|Death|9|||
164616700|NCT04315298|594618840|FG007|Overall Study|Death|12|||
164616701|NCT04315298|594618841|FG008|Overall Study|Death|21|||
164616702|NCT04315298|594618842|FG009|Overall Study|Death|16|||
164616703|NCT04315298|594618843|FG010|Overall Study|Death|40|||
164616704|NCT04315298|594618844|FG011|Overall Study|Death|40|||
164616705|NCT04315298|594618845|FG012|Overall Study|Death|3|||
164616706|NCT04315298|594618846|FG013|Overall Study|Death|4|||
164616707|NCT04315298|594618847|FG014|Overall Study|Death|6|||
164616708|NCT04315298|594618848|FG015|Overall Study|Death|4|||
164616709|NCT04315298|594618849|FG016|Overall Study|Death|3|||
164616710|NCT04315298|594618850|FG017|Overall Study|Death|1|||
164616711|NCT04315298|594618851|FG018|Overall Study|Death|0|||
164616712|NCT01199198|594618852|FG000|Overall Study|Adverse Event|3|||
164616713|NCT01199198|594618853|FG001|Overall Study|Adverse Event|0|||
164616714|NCT01199198|594618852|FG000|Overall Study|Lost to Follow-up|1|||
164616715|NCT01199198|594618853|FG001|Overall Study|Lost to Follow-up|5|||
164616716|NCT01199198|594618852|FG000|Overall Study|Withdrawal by Subject|1|||
164616717|NCT01199198|594618853|FG001|Overall Study|Withdrawal by Subject|2|||
164616718|NCT01199198|594618852|FG000|Overall Study|ICU Transfer|1|||
164616719|NCT01199198|594618853|FG001|Overall Study|ICU Transfer|2|||
164616720|NCT01199198|594618852|FG000|Overall Study|Hospice-care transfer|1|||
164616721|NCT01199198|594618853|FG001|Overall Study|Hospice-care transfer|2|||
164616722|NCT00736385|594618854|FG000|Overall Study|Withdrawal by Subject|2|||
164616723|NCT00736385|594618855|FG001|Overall Study|Withdrawal by Subject|2|||
164616724|NCT00736385|594618854|FG000|Overall Study|Adverse Event|0|||
164616725|NCT00736385|594618855|FG001|Overall Study|Adverse Event|1|||
164616726|NCT03267511|594618856|FG000|Overall Study|Lost to Follow-up|0|||
164616727|NCT03267511|594618857|FG001|Overall Study|Lost to Follow-up|0|||
164616728|NCT03267511|594618858|FG002|Overall Study|Lost to Follow-up|0|||
164616729|NCT03267511|594618859|FG003|Overall Study|Lost to Follow-up|1|||
164616730|NCT03050307|594618860|FG000|Overall Study|Adverse Event|4|||
164616731|NCT03050307|594618861|FG001|Overall Study|Adverse Event|2|||
164616732|NCT03050307|594618860|FG000|Overall Study|Significant Protocol Deviation|0|||
164616733|NCT03050307|594618861|FG001|Overall Study|Significant Protocol Deviation|1|||
164616734|NCT03050307|594618860|FG000|Overall Study|Lost to Follow-up|0|||
164616735|NCT03050307|594618861|FG001|Overall Study|Lost to Follow-up|1|||
164616736|NCT03050307|594618860|FG000|Overall Study|Voluntary Withdrawal|3|||
164616737|NCT03050307|594618861|FG001|Overall Study|Voluntary Withdrawal|4|||
164616738|NCT03050307|594618860|FG000|Overall Study|Reason not Specified|1|||
164616739|NCT03050307|594618861|FG001|Overall Study|Reason not Specified|1|||
164616740|NCT03950440|594618862|FG000|Overall Study|Death|8|||
164616741|NCT03950440|594618863|FG001|Overall Study|Death|2|||
164616742|NCT03950440|594618864|FG002|Overall Study|Death|1|||
164616743|NCT00439309|594618865|FG000|Follow-Up|Death|1|||
164616744|NCT00439309|594618866|FG001|Follow-Up|Death|0|||
164616745|NCT00439309|594618865|FG000|Follow-Up|Lost to Follow-up|2|||
164616746|NCT00439309|594618866|FG001|Follow-Up|Lost to Follow-up|0|||
164616747|NCT00439309|594618865|FG000|Follow-Up|Withdrawal by Subject|0|||
164616748|NCT00439309|594618866|FG001|Follow-Up|Withdrawal by Subject|1|||
164616749|NCT00439309|594618865|FG000|Follow-Up|Late response by subject|0|||
164616750|NCT00439309|594618866|FG001|Follow-Up|Late response by subject|1|||
164616751|NCT02043509|594618867|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
164616752|NCT02043509|594618868|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
164616753|NCT02043509|594618867|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
164616754|NCT02043509|594618868|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
164616755|NCT02043509|594618867|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
164616756|NCT02043509|594618868|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
164519080|NCT04488770|594270674|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
164519081|NCT04488770|594270662|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
164519082|NCT04488770|594270663|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
164519083|NCT04488770|594270664|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
164519084|NCT04488770|594270665|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
164519085|NCT04488770|594270666|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
164519086|NCT04488770|594270667|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
164519087|NCT04488770|594270668|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
164519088|NCT04488770|594270669|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
164519089|NCT04488770|594270670|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
164519090|NCT04488770|594270671|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
164519091|NCT04488770|594270672|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
164519092|NCT04488770|594270673|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
164519093|NCT04488770|594270674|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
164519094|NCT03547739|594270675|FG000|Overall Study|Death|0|||
164519095|NCT03547739|594270676|FG001|Overall Study|Death|1|||
164519096|NCT03547739|594270677|FG002|Overall Study|Death|5|||
164519097|NCT03547739|594270675|FG000|Overall Study|Adverse Event|24|||
164519098|NCT03547739|594270676|FG001|Overall Study|Adverse Event|11|||
164519099|NCT03547739|594270677|FG002|Overall Study|Adverse Event|13|||
164519100|NCT03547739|594270675|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
164519101|NCT03547739|594270676|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
164519102|NCT03547739|594270677|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
164519103|NCT03547739|594270675|FG000|Overall Study|Lost to Follow-up|80|||
164519104|NCT03547739|594270676|FG001|Overall Study|Lost to Follow-up|84|||
164519105|NCT03547739|594270677|FG002|Overall Study|Lost to Follow-up|116|||
164519106|NCT02770612|594270684|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
164519107|NCT01365481|594270690|FG000|Overall Study|Adverse Event|6|||
164616757|NCT02043509|594618867|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
164616758|NCT02043509|594618868|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
164519108|NCT01365481|594270691|FG001|Overall Study|Adverse Event|9|||
164616759|NCT00608244|594618873|FG000|Overall Study|Adverse Event|1|||
164616760|NCT00608244|594618873|FG000|Overall Study|Low trough levels|1|||
164616761|NCT01685060|594618876|FG000|Overall Study|Rollover patients|16|||
164519109|NCT01365481|594270692|FG002|Overall Study|Adverse Event|0|||
164519110|NCT01365481|594270693|FG003|Overall Study|Adverse Event|2|||
164519111|NCT01365481|594270690|FG000|Overall Study|Withdrawal by Subject|0|||
164519112|NCT01365481|594270691|FG001|Overall Study|Withdrawal by Subject|2|||
164519113|NCT01365481|594270692|FG002|Overall Study|Withdrawal by Subject|1|||
164519114|NCT01365481|594270693|FG003|Overall Study|Withdrawal by Subject|1|||
164519115|NCT01365481|594270690|FG000|Overall Study|Lost to Follow-up|1|||
164519116|NCT01365481|594270691|FG001|Overall Study|Lost to Follow-up|1|||
164519117|NCT01365481|594270692|FG002|Overall Study|Lost to Follow-up|2|||
164519118|NCT01365481|594270693|FG003|Overall Study|Lost to Follow-up|3|||
164519119|NCT01365481|594270690|FG000|Overall Study|Abnormal laboratory value(s)|0|||
164519120|NCT01365481|594270691|FG001|Overall Study|Abnormal laboratory value(s)|1|||
164519121|NCT01365481|594270692|FG002|Overall Study|Abnormal laboratory value(s)|0|||
164519122|NCT01365481|594270693|FG003|Overall Study|Abnormal laboratory value(s)|0|||
164519123|NCT01365481|594270690|FG000|Overall Study|Administrative problems|0|||
164519124|NCT01365481|594270691|FG001|Overall Study|Administrative problems|1|||
164519125|NCT01365481|594270692|FG002|Overall Study|Administrative problems|0|||
164519126|NCT01365481|594270693|FG003|Overall Study|Administrative problems|0|||
164519127|NCT01365481|594270690|FG000|Overall Study|Protocol deviation|0|||
164519128|NCT01365481|594270691|FG001|Overall Study|Protocol deviation|1|||
164519129|NCT01365481|594270692|FG002|Overall Study|Protocol deviation|0|||
164519130|NCT01365481|594270693|FG003|Overall Study|Protocol deviation|1|||
164519131|NCT01365481|594270690|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164519132|NCT01365481|594270691|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164519133|NCT01365481|594270692|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
164616762|NCT01685060|594618876|FG000|Overall Study|Adverse Event|12|||
164616763|NCT01685060|594618876|FG000|Overall Study|Progressive disease|69|||
164616764|NCT01685060|594618876|FG000|Overall Study|Physician Decision|14|||
164616765|NCT01685060|594618876|FG000|Overall Study|Subject/guardian decision|20|||
164616766|NCT01685060|594618876|FG000|Overall Study|Lost to Follow-up|1|||
164616767|NCT01685060|594618876|FG000|Overall Study|Death|8|||
164616768|NCT02443155|594618879|FG000|Overall Study|Adverse Event|3|||
164616769|NCT02443155|594618880|FG001|Overall Study|Adverse Event|4|||
164616770|NCT02443155|594618881|FG002|Overall Study|Adverse Event|1|||
164616771|NCT02443155|594618882|FG003|Overall Study|Adverse Event|2|||
164616772|NCT02443155|594618879|FG000|Overall Study|Unclassified|0|||
164519134|NCT01365481|594270693|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
164519135|NCT00757627|594270694|FG000|Overall Study|Adverse Event|15|||
164519136|NCT00757627|594270694|FG000|Overall Study|Lack of Efficacy|10|||
164519137|NCT00757627|594270694|FG000|Overall Study|Lost to Follow-up|28|||
164519138|NCT00757627|594270694|FG000|Overall Study|Withdrawal by Subject|27|||
164519139|NCT00757627|594270694|FG000|Overall Study|Other|1|||
164616773|NCT02443155|594618880|FG001|Overall Study|Unclassified|0|||
164616774|NCT02443155|594618881|FG002|Overall Study|Unclassified|2|||
164616775|NCT02443155|594618882|FG003|Overall Study|Unclassified|1|||
164616776|NCT02443155|594618879|FG000|Overall Study|Withdrawal by Subject|4|||
164616777|NCT02443155|594618880|FG001|Overall Study|Withdrawal by Subject|7|||
164616778|NCT02443155|594618881|FG002|Overall Study|Withdrawal by Subject|3|||
164616779|NCT02443155|594618882|FG003|Overall Study|Withdrawal by Subject|9|||
164616780|NCT02443155|594618879|FG000|Overall Study|Pregnancy|3|||
164616781|NCT02443155|594618880|FG001|Overall Study|Pregnancy|1|||
164616782|NCT02443155|594618881|FG002|Overall Study|Pregnancy|1|||
164616783|NCT02443155|594618882|FG003|Overall Study|Pregnancy|2|||
164616784|NCT02443155|594618879|FG000|Overall Study|Lost to Follow-up|1|||
164616785|NCT02443155|594618880|FG001|Overall Study|Lost to Follow-up|2|||
164616786|NCT02443155|594618881|FG002|Overall Study|Lost to Follow-up|0|||
164616787|NCT02443155|594618882|FG003|Overall Study|Lost to Follow-up|1|||
164616788|NCT02443155|594618879|FG000|Overall Study|Protocol Violation|1|||
164616789|NCT02443155|594618880|FG001|Overall Study|Protocol Violation|0|||
164519140|NCT03846453|594270695|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
164616790|NCT02443155|594618881|FG002|Overall Study|Protocol Violation|1|||
164616791|NCT02443155|594618882|FG003|Overall Study|Protocol Violation|1|||
164616792|NCT02443155|594618879|FG000|Overall Study|Death|0|||
164616793|NCT02443155|594618880|FG001|Overall Study|Death|0|||
164519141|NCT03846453|594270696|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
164519142|NCT03846453|594270697|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
164519143|NCT03846453|594270695|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
164519144|NCT03846453|594270696|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
164519145|NCT03846453|594270697|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
164616794|NCT02443155|594618881|FG002|Overall Study|Death|1|||
164616795|NCT02443155|594618882|FG003|Overall Study|Death|0|||
164616796|NCT02000219|594618883|FG000|14-Week Study Period|Physician Decision|1|||
164616797|NCT02000219|594618883|FG000|14-Week Study Period|Adverse Event|1|||
164616798|NCT02000219|594618883|FG000|14-Week Study Period|Underwent transplantation|1|||
164616799|NCT02000219|594618883|FG000|Continuation Period|Withdrawal by Subject|1|||
164616800|NCT02000219|594618883|FG000|Continuation Period|Had liver transplant|2|||
164616801|NCT02000219|594618883|FG000|Continuation Period|Non-compliance with study drug|2|||
164616802|NCT00464620|594618884|FG000|Overall Study|Physician Decision|1|||
164616803|NCT00464620|594618885|FG001|Overall Study|Physician Decision|0|||
164616804|NCT00464620|594618886|FG002|Overall Study|Physician Decision|0|||
164616805|NCT00464620|594618884|FG000|Overall Study|Withdrawal by Subject|1|||
164616806|NCT00464620|594618885|FG001|Overall Study|Withdrawal by Subject|0|||
164616807|NCT00464620|594618886|FG002|Overall Study|Withdrawal by Subject|3|||
164616808|NCT00464620|594618884|FG000|Overall Study|Ineligible sarcoma subtype|0|||
164616809|NCT00464620|594618885|FG001|Overall Study|Ineligible sarcoma subtype|2|||
164616810|NCT00464620|594618886|FG002|Overall Study|Ineligible sarcoma subtype|2|||
164616811|NCT00464620|594618884|FG000|Overall Study|Use of prohibited concomitant medication|0|||
164616812|NCT00464620|594618885|FG001|Overall Study|Use of prohibited concomitant medication|0|||
164616813|NCT00464620|594618886|FG002|Overall Study|Use of prohibited concomitant medication|2|||
164616814|NCT00209092|594618893|FG000|Overall Study|Progression of disease|7|||
164616815|NCT00209092|594618894|FG001|Overall Study|Progression of disease|1|||
164616816|NCT00209092|594618893|FG000|Overall Study|Adverse Event|0|||
164616817|NCT00209092|594618894|FG001|Overall Study|Adverse Event|1|||
164616818|NCT00209092|594618893|FG000|Overall Study|Withdrawal by Subject|1|||
164616819|NCT00209092|594618894|FG001|Overall Study|Withdrawal by Subject|0|||
164616820|NCT02809118|594618895|FG000|Overall Study|Withdrawal by Subject|0|||
164616821|NCT02809118|594618896|FG001|Overall Study|Withdrawal by Subject|1|||
164616822|NCT02809118|594618897|FG002|Overall Study|Withdrawal by Subject|1|||
164616823|NCT06048809|594618906|FG000|Overall Study|Adverse Event|2|||
164616824|NCT06048809|594618907|FG001|Overall Study|Adverse Event|0|||
164616825|NCT06048809|594618906|FG000|Overall Study|Withdrawal by Subject|1|||
164616826|NCT06048809|594618907|FG001|Overall Study|Withdrawal by Subject|1|||
164616827|NCT02158728|594618908|FG000|Overall Study|no procedure according to CIP done|3|||
164616828|NCT02158728|594618908|FG000|Overall Study|no qualified dataset|24|||
164616829|NCT01536418|594618924|FG000|Overall Study|Protocol Violation|2|||
164616830|NCT01536418|594618925|FG001|Overall Study|Protocol Violation|3|||
164616831|NCT01536418|594618924|FG000|Overall Study|Physician Decision|1|||
164616832|NCT01536418|594618925|FG001|Overall Study|Physician Decision|3|||
164616833|NCT01536418|594618924|FG000|Overall Study|Study closed/terminated|41|||
164616834|NCT01536418|594618925|FG001|Overall Study|Study closed/terminated|37|||
164616835|NCT01536418|594618924|FG000|Overall Study|Lack of Efficacy|10|||
164616836|NCT01536418|594618925|FG001|Overall Study|Lack of Efficacy|16|||
164616837|NCT01536418|594618924|FG000|Overall Study|Adverse Event|9|||
164616838|NCT01536418|594618925|FG001|Overall Study|Adverse Event|4|||
164616839|NCT01536418|594618924|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
164616840|NCT01536418|594618925|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
164616841|NCT01536418|594618924|FG000|Overall Study|Withdrawal by Subject|5|||
164616842|NCT01536418|594618925|FG001|Overall Study|Withdrawal by Subject|3|||
164519146|NCT03846453|594270695|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
164519147|NCT03846453|594270696|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
164519148|NCT03846453|594270697|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
164519149|NCT03846453|594270695|FG000|Placebo Run-in (14 Days)|Other|2|||
164519150|NCT03846453|594270696|FG001|Placebo Run-in (14 Days)|Other|0|||
164519151|NCT03846453|594270697|FG002|Placebo Run-in (14 Days)|Other|0|||
164519152|NCT03846453|594270695|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
164519153|NCT03846453|594270696|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
164519154|NCT03846453|594270697|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
164519155|NCT03846453|594270695|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
164616843|NCT02658149|594618927|FG000|Overall Study|Physician Decision|1|||
164616844|NCT02658149|594618928|FG001|Overall Study|Physician Decision|0|||
164616845|NCT00711412|594618931|FG000|Induction Treatment|Death|2|||
164519156|NCT03846453|594270696|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
164519157|NCT03846453|594270697|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
164519158|NCT03846453|594270695|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
164519159|NCT03846453|594270696|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
164519160|NCT03846453|594270697|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
164519161|NCT03846453|594270695|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
164519162|NCT03846453|594270696|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
164616846|NCT00711412|594618931|FG000|Induction Treatment|Adverse Event|1|||
164616847|NCT00711412|594618931|FG000|Induction Treatment|Other|1|||
164616848|NCT00711412|594618931|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
164519163|NCT03846453|594270697|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
164616849|NCT00711412|594618931|FG000|Evaluated for Combination Treatment|Death|1|||
164616850|NCT00711412|594618931|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
164616851|NCT00711412|594618931|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
164616852|NCT00711412|594618931|FG000|Combination Treatment|Progressive Disease|1|||
164616853|NCT00711412|594618931|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
164616854|NCT00711412|594618931|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
164616855|NCT00711412|594618931|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
164616856|NCT00711412|594618931|FG000|Evaluation for Response and Surgery|Death|1|||
164616857|NCT00711412|594618931|FG000|Survival Follow up Until Death|Other|12|||
164519164|NCT03846453|594270695|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
164519165|NCT03846453|594270696|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
164519166|NCT03846453|594270697|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
164519167|NCT00635661|594270702|FG000|Overall Study|Withdrawal by Subject|4|||
164519168|NCT00468143|594270707|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
164519169|NCT00468143|594270708|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
164519170|NCT00468143|594270707|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
164519171|NCT00468143|594270708|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
164519172|NCT01606670|594270709|FG000|Overall Study|Adverse Event|6|||
164519173|NCT01606670|594270709|FG000|Overall Study|Lack of Efficacy|2|||
164519174|NCT01606670|594270709|FG000|Overall Study|Lost to Follow-up|3|||
164519175|NCT01606670|594270709|FG000|Overall Study|Withdrawal by Subject|3|||
164519176|NCT01606670|594270709|FG000|Overall Study|Other Reason|2|||
164519177|NCT03192475|594270721|FG000|Overall Study|Death|0|||
164519178|NCT03192475|594270722|FG001|Overall Study|Death|1|||
164519179|NCT03192475|594270721|FG000|Overall Study|Lost to Follow-up|13|||
164519180|NCT03192475|594270722|FG001|Overall Study|Lost to Follow-up|8|||
164519181|NCT01641159|594270723|FG000|Overall Study|Lost to Follow-up|2|||
164519182|NCT01641159|594270724|FG001|Overall Study|Lost to Follow-up|1|||
164519183|NCT01641159|594270723|FG000|Overall Study|Withdrawal by Subject|0|||
164519184|NCT01641159|594270724|FG001|Overall Study|Withdrawal by Subject|1|||
164519185|NCT00798590|594270725|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
164519186|NCT00798590|594270726|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
164519187|NCT03980808|594270727|FG000|Overall Study|Lost to Follow-up|2|||
164519188|NCT03980808|594270728|FG001|Overall Study|Lost to Follow-up|2|||
164519189|NCT00368927|594270735|FG000|Overall Study|Lost to Follow-up|2|||
164519190|NCT00368927|594270736|FG001|Overall Study|Lost to Follow-up|0|||
164519191|NCT00368927|594270735|FG000|Overall Study|Adverse Event|1|||
164519192|NCT00368927|594270736|FG001|Overall Study|Adverse Event|1|||
164519193|NCT00368927|594270735|FG000|Overall Study|Withdrawal by Subject|1|||
164519194|NCT00368927|594270736|FG001|Overall Study|Withdrawal by Subject|2|||
164519195|NCT00368927|594270735|FG000|Overall Study|Physician Decision|1|||
164519196|NCT00368927|594270736|FG001|Overall Study|Physician Decision|0|||
164519197|NCT00886795|594270737|FG000|Overall Study|Lack of Efficacy|1|||
164519198|NCT02229851|594270738|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
164519199|NCT02229851|594270739|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
164519200|NCT02229851|594270740|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
164519201|NCT02229851|594270741|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
164519202|NCT02229851|594270742|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
164519203|NCT02229851|594270743|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
164519204|NCT02229851|594270744|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
164519205|NCT02229851|594270738|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
164519206|NCT02229851|594270739|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
164519207|NCT02229851|594270740|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
164519208|NCT02229851|594270741|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
164519209|NCT02229851|594270742|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
164519210|NCT02229851|594270743|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
164519211|NCT02229851|594270744|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
164519212|NCT02229851|594270738|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
164519213|NCT02229851|594270739|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
164519214|NCT02229851|594270740|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
164519215|NCT02229851|594270741|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
164519216|NCT02229851|594270742|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
164519217|NCT02229851|594270743|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
164519218|NCT02229851|594270744|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
164519219|NCT02229851|594270738|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
164519220|NCT02229851|594270739|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
164519221|NCT02229851|594270740|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
164519222|NCT02229851|594270741|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
164519223|NCT02229851|594270742|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
164519224|NCT02229851|594270743|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
164519225|NCT02229851|594270744|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
164519226|NCT02229851|594270738|FG000|Main Phase (Double-blind Phase)|Death|1|||
164519227|NCT02229851|594270739|FG001|Main Phase (Double-blind Phase)|Death|1|||
164519228|NCT02229851|594270740|FG002|Main Phase (Double-blind Phase)|Death|0|||
164519229|NCT02229851|594270741|FG003|Main Phase (Double-blind Phase)|Death|0|||
164519230|NCT02229851|594270742|FG004|Main Phase (Double-blind Phase)|Death|0|||
164519231|NCT02229851|594270743|FG005|Main Phase (Double-blind Phase)|Death|0|||
164519232|NCT02229851|594270744|FG006|Main Phase (Double-blind Phase)|Death|0|||
164519233|NCT02229851|594270738|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
164519234|NCT02229851|594270739|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
164519235|NCT02229851|594270740|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
164519236|NCT02229851|594270741|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
164519237|NCT02229851|594270742|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
164519238|NCT02229851|594270743|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
164519239|NCT02229851|594270744|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
164519240|NCT02229851|594270738|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
164519241|NCT02229851|594270739|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
164519242|NCT02229851|594270740|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
164519243|NCT02229851|594270741|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
164519244|NCT02229851|594270742|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
164519245|NCT02229851|594270743|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
164519246|NCT02229851|594270744|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
164519247|NCT02229851|594270738|FG000|Extension Phase (Open-label Phase)|Death|0|||
164519248|NCT02229851|594270739|FG001|Extension Phase (Open-label Phase)|Death|0|||
164519249|NCT02229851|594270740|FG002|Extension Phase (Open-label Phase)|Death|0|||
164519250|NCT02229851|594270741|FG003|Extension Phase (Open-label Phase)|Death|1|||
164519251|NCT02229851|594270742|FG004|Extension Phase (Open-label Phase)|Death|0|||
164519252|NCT02229851|594270743|FG005|Extension Phase (Open-label Phase)|Death|1|||
164519253|NCT02229851|594270744|FG006|Extension Phase (Open-label Phase)|Death|1|||
164519254|NCT01204710|594270747|FG000|Randomization Treatment|Lost to Follow-up|1|||
164519255|NCT01204710|594270748|FG001|Randomization Treatment|Lost to Follow-up|0|||
164519256|NCT01204710|594270747|FG000|Randomization Treatment|Withdrawal by Subject|6|||
164519257|NCT01204710|594270748|FG001|Randomization Treatment|Withdrawal by Subject|5|||
164519258|NCT01204710|594270747|FG000|Randomization Treatment|Physician Decision|3|||
164519259|NCT01204710|594270748|FG001|Randomization Treatment|Physician Decision|2|||
164519260|NCT01204710|594270747|FG000|Randomization Treatment|Entry criteria not met|0|||
164519261|NCT01204710|594270748|FG001|Randomization Treatment|Entry criteria not met|1|||
164519262|NCT01204710|594270747|FG000|Randomization Treatment|Adverse Event|4|||
164519263|NCT01204710|594270748|FG001|Randomization Treatment|Adverse Event|2|||
164519264|NCT01204710|594270747|FG000|Randomization Treatment|Sponsor Decision|0|||
164519265|NCT01204710|594270748|FG001|Randomization Treatment|Sponsor Decision|1|||
164519266|NCT01204710|594270747|FG000|Randomization Treatment|Worsening of General condition|0|||
164519267|NCT01204710|594270748|FG001|Randomization Treatment|Worsening of General condition|1|||
164519268|NCT01204710|594270747|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
164519269|NCT01204710|594270748|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
164519270|NCT01204710|594270747|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
164519271|NCT01204710|594270748|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
164519272|NCT01204710|594270747|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
164519273|NCT01204710|594270748|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
164519274|NCT01204710|594270747|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
164519275|NCT01204710|594270748|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
164519276|NCT02738853|594270749|FG000|Enrollment|Inclusion/Exclusion not met|21|||
164519277|NCT02738853|594270749|FG000|Enrollment|Withdrawal by Subject|3|||
164519278|NCT02738853|594270749|FG000|Enrollment|Subject treated with commercially available device|6|||
164519279|NCT02738853|594270749|FG000|Enrollment|Study Enrollment Closed|3|||
164519280|NCT02738853|594270749|FG000|Procedure|Death|1|||
164519281|NCT02738853|594270749|FG000|1 Month|Death|2|||
164519282|NCT02738853|594270749|FG000|6 Month|Death|4|||
164519283|NCT02738853|594270749|FG000|6 Month|Withdrawal by Subject|2|||
164519284|NCT02738853|594270749|FG000|1 Year|Death|6|||
164519285|NCT02738853|594270749|FG000|1 Year|Withdrawal by Subject|1|||
164519286|NCT02738853|594270749|FG000|2 Year|Death|2|||
164519287|NCT02738853|594270749|FG000|2 Year|Lost to Follow-up|1|||
164519288|NCT02738853|594270749|FG000|3 Year|Death|2|||
164519289|NCT02738853|594270749|FG000|3 Year|Withdrawal by Subject|1|||
164519290|NCT02738853|594270749|FG000|4 Year|Death|9|||
164519291|NCT02738853|594270749|FG000|5 Year|Lost to Follow-up|4|||
164519292|NCT03898167|594270750|FG000|Overall Study|Terminated phone call early|7|||
164519293|NCT03898167|594270751|FG001|Overall Study|Terminated phone call early|0|||
164519294|NCT03898167|594270752|FG002|Overall Study|Terminated phone call early|0|||
164519295|NCT03898167|594270750|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
164519296|NCT03898167|594270751|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
164519297|NCT03898167|594270752|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
164519298|NCT02906007|594270753|FG000|Overall Study|Physician Decision|0|||
164616858|NCT01680991|594618935|FG000|Overall Study|Adverse Event|1|||
164616859|NCT01680991|594618936|FG001|Overall Study|Adverse Event|0|||
164616860|NCT01680991|594618937|FG002|Overall Study|Adverse Event|0|||
164519299|NCT02906007|594270754|FG001|Overall Study|Physician Decision|0|||
164519300|NCT02906007|594270755|FG002|Overall Study|Physician Decision|1|||
164519301|NCT02906007|594270753|FG000|Overall Study|Died|1|||
164519302|NCT02906007|594270754|FG001|Overall Study|Died|0|||
164519303|NCT02906007|594270755|FG002|Overall Study|Died|0|||
164519304|NCT04696653|594270756|FG000|Overall Study|left organization|18|||
164519305|NCT04696653|594270756|FG000|Overall Study|Lost to Follow-up|3|||
164519306|NCT03520712|594270757|FG000|Overall Study|Early termination of the study by Sponsor|2|||
164519307|NCT04372121|594270758|FG000|Overall Study|Lost to Follow-up|0|||
164519308|NCT04372121|594270759|FG001|Overall Study|Lost to Follow-up|0|||
164519309|NCT04372121|594270760|FG002|Overall Study|Lost to Follow-up|0|||
164519310|NCT04372121|594270761|FG003|Overall Study|Lost to Follow-up|1|||
164519311|NCT04372121|594270758|FG000|Overall Study|Protocol Violation|0|||
164519312|NCT04372121|594270759|FG001|Overall Study|Protocol Violation|0|||
164519313|NCT04372121|594270760|FG002|Overall Study|Protocol Violation|1|||
164519314|NCT04372121|594270761|FG003|Overall Study|Protocol Violation|0|||
164519315|NCT04372121|594270758|FG000|Overall Study|Withdrawal by Subject|3|||
164519316|NCT04372121|594270759|FG001|Overall Study|Withdrawal by Subject|1|||
164519317|NCT04372121|594270760|FG002|Overall Study|Withdrawal by Subject|0|||
164519318|NCT04372121|594270761|FG003|Overall Study|Withdrawal by Subject|0|||
164519319|NCT04372121|594270758|FG000|Overall Study|Study termination|6|||
164519320|NCT04372121|594270759|FG001|Overall Study|Study termination|5|||
164519321|NCT04372121|594270760|FG002|Overall Study|Study termination|1|||
164519322|NCT04372121|594270761|FG003|Overall Study|Study termination|1|||
164519323|NCT04372121|594270758|FG000|Overall Study|Hysterectomy planned|1|||
164519324|NCT04372121|594270759|FG001|Overall Study|Hysterectomy planned|0|||
164519325|NCT04372121|594270760|FG002|Overall Study|Hysterectomy planned|0|||
164519326|NCT04372121|594270761|FG003|Overall Study|Hysterectomy planned|0|||
164519327|NCT04047862|594270766|FG000|Overall Study|Death|0|||
164519328|NCT04047862|594270767|FG001|Overall Study|Death|0|||
164519329|NCT04047862|594270768|FG002|Overall Study|Death|4|||
164519330|NCT04047862|594270769|FG003|Overall Study|Death|7|||
164519331|NCT04047862|594270770|FG004|Overall Study|Death|2|||
164519332|NCT04047862|594270771|FG005|Overall Study|Death|4|||
164519333|NCT04047862|594270772|FG006|Overall Study|Death|3|||
164519334|NCT04047862|594270773|FG007|Overall Study|Death|24|||
164519335|NCT04047862|594270774|FG008|Overall Study|Death|24|||
164519336|NCT04047862|594270775|FG009|Overall Study|Death|22|||
164519337|NCT04047862|594270776|FG010|Overall Study|Death|35|||
164519338|NCT04047862|594270777|FG011|Overall Study|Death|18|||
164519339|NCT04047862|594270778|FG012|Overall Study|Death|14|||
164519340|NCT04047862|594270779|FG013|Overall Study|Death|6|||
164519341|NCT04047862|594270780|FG014|Overall Study|Death|19|||
164519342|NCT04047862|594270781|FG015|Overall Study|Death|42|||
164519343|NCT04047862|594270782|FG016|Overall Study|Death|9|||
164519344|NCT04047862|594270783|FG017|Overall Study|Death|8|||
164519345|NCT04047862|594270784|FG018|Overall Study|Death|10|||
164519346|NCT04047862|594270766|FG000|Overall Study|Withdrawal by Subject|0|||
164519347|NCT04047862|594270767|FG001|Overall Study|Withdrawal by Subject|0|||
164616861|NCT01680991|594618935|FG000|Overall Study|Death|1|||
164616862|NCT01680991|594618936|FG001|Overall Study|Death|0|||
164616863|NCT01680991|594618937|FG002|Overall Study|Death|1|||
164616864|NCT01680991|594618935|FG000|Overall Study|Protocol Violation|0|||
164616865|NCT01680991|594618936|FG001|Overall Study|Protocol Violation|1|||
164616866|NCT01680991|594618937|FG002|Overall Study|Protocol Violation|0|||
164616867|NCT01680991|594618935|FG000|Overall Study|Withdrawal by Subject|5|||
164616868|NCT01680991|594618936|FG001|Overall Study|Withdrawal by Subject|1|||
164616869|NCT01680991|594618937|FG002|Overall Study|Withdrawal by Subject|0|||
164616870|NCT01680991|594618935|FG000|Overall Study|Progressive disease (PD)|0|||
164616871|NCT01680991|594618936|FG001|Overall Study|Progressive disease (PD)|10|||
164616872|NCT01680991|594618937|FG002|Overall Study|Progressive disease (PD)|0|||
164616873|NCT01680991|594618935|FG000|Overall Study|Physician Decision|0|||
164616874|NCT01680991|594618936|FG001|Overall Study|Physician Decision|7|||
164616875|NCT01680991|594618937|FG002|Overall Study|Physician Decision|2|||
164616876|NCT01680991|594618935|FG000|Overall Study|Bad physical condition|0|||
164616877|NCT01680991|594618936|FG001|Overall Study|Bad physical condition|0|||
164616878|NCT01680991|594618937|FG002|Overall Study|Bad physical condition|1|||
164616879|NCT01680991|594618935|FG000|Overall Study|PD confirmed in other hospital|1|||
164616880|NCT01680991|594618936|FG001|Overall Study|PD confirmed in other hospital|0|||
164519348|NCT04047862|594270768|FG002|Overall Study|Withdrawal by Subject|0|||
164519349|NCT04047862|594270769|FG003|Overall Study|Withdrawal by Subject|5|||
164519350|NCT04047862|594270770|FG004|Overall Study|Withdrawal by Subject|2|||
164519351|NCT04047862|594270771|FG005|Overall Study|Withdrawal by Subject|0|||
164519352|NCT04047862|594270772|FG006|Overall Study|Withdrawal by Subject|1|||
164616881|NCT01680991|594618937|FG002|Overall Study|PD confirmed in other hospital|0|||
164519353|NCT04047862|594270773|FG007|Overall Study|Withdrawal by Subject|0|||
164519354|NCT04047862|594270774|FG008|Overall Study|Withdrawal by Subject|4|||
164519355|NCT04047862|594270775|FG009|Overall Study|Withdrawal by Subject|4|||
164519356|NCT04047862|594270776|FG010|Overall Study|Withdrawal by Subject|4|||
164519357|NCT04047862|594270777|FG011|Overall Study|Withdrawal by Subject|2|||
164519358|NCT04047862|594270778|FG012|Overall Study|Withdrawal by Subject|3|||
164519359|NCT04047862|594270779|FG013|Overall Study|Withdrawal by Subject|0|||
164519360|NCT04047862|594270780|FG014|Overall Study|Withdrawal by Subject|9|||
164519361|NCT04047862|594270781|FG015|Overall Study|Withdrawal by Subject|5|||
164519362|NCT04047862|594270782|FG016|Overall Study|Withdrawal by Subject|1|||
164519363|NCT04047862|594270783|FG017|Overall Study|Withdrawal by Subject|3|||
164519364|NCT04047862|594270784|FG018|Overall Study|Withdrawal by Subject|1|||
164519365|NCT04047862|594270766|FG000|Overall Study|Lost to Follow-up|0|||
164519366|NCT04047862|594270767|FG001|Overall Study|Lost to Follow-up|0|||
164519367|NCT04047862|594270768|FG002|Overall Study|Lost to Follow-up|1|||
164519368|NCT04047862|594270769|FG003|Overall Study|Lost to Follow-up|0|||
164519369|NCT04047862|594270770|FG004|Overall Study|Lost to Follow-up|0|||
164519370|NCT04047862|594270771|FG005|Overall Study|Lost to Follow-up|0|||
164519371|NCT04047862|594270772|FG006|Overall Study|Lost to Follow-up|0|||
164519372|NCT04047862|594270773|FG007|Overall Study|Lost to Follow-up|1|||
164519373|NCT04047862|594270774|FG008|Overall Study|Lost to Follow-up|0|||
164519374|NCT04047862|594270775|FG009|Overall Study|Lost to Follow-up|1|||
164519375|NCT04047862|594270776|FG010|Overall Study|Lost to Follow-up|0|||
164519376|NCT04047862|594270777|FG011|Overall Study|Lost to Follow-up|3|||
164519377|NCT04047862|594270778|FG012|Overall Study|Lost to Follow-up|0|||
164519378|NCT04047862|594270779|FG013|Overall Study|Lost to Follow-up|0|||
164519379|NCT04047862|594270780|FG014|Overall Study|Lost to Follow-up|2|||
164519380|NCT04047862|594270781|FG015|Overall Study|Lost to Follow-up|2|||
164519381|NCT04047862|594270782|FG016|Overall Study|Lost to Follow-up|1|||
164519382|NCT04047862|594270783|FG017|Overall Study|Lost to Follow-up|0|||
164519383|NCT04047862|594270784|FG018|Overall Study|Lost to Follow-up|0|||
164519384|NCT04047862|594270766|FG000|Overall Study|Physician Decision|0|||
164519385|NCT04047862|594270767|FG001|Overall Study|Physician Decision|0|||
164519386|NCT04047862|594270768|FG002|Overall Study|Physician Decision|0|||
164519387|NCT04047862|594270769|FG003|Overall Study|Physician Decision|1|||
164519388|NCT04047862|594270770|FG004|Overall Study|Physician Decision|0|||
164519389|NCT04047862|594270771|FG005|Overall Study|Physician Decision|0|||
164519390|NCT04047862|594270772|FG006|Overall Study|Physician Decision|0|||
164519391|NCT04047862|594270773|FG007|Overall Study|Physician Decision|0|||
164519392|NCT04047862|594270774|FG008|Overall Study|Physician Decision|0|||
164519393|NCT04047862|594270775|FG009|Overall Study|Physician Decision|0|||
164519394|NCT04047862|594270776|FG010|Overall Study|Physician Decision|0|||
164519395|NCT04047862|594270777|FG011|Overall Study|Physician Decision|0|||
164519396|NCT04047862|594270778|FG012|Overall Study|Physician Decision|0|||
164519397|NCT04047862|594270779|FG013|Overall Study|Physician Decision|0|||
164519398|NCT04047862|594270780|FG014|Overall Study|Physician Decision|1|||
164519399|NCT04047862|594270781|FG015|Overall Study|Physician Decision|0|||
164519400|NCT04047862|594270782|FG016|Overall Study|Physician Decision|1|||
164519401|NCT04047862|594270783|FG017|Overall Study|Physician Decision|0|||
164519402|NCT04047862|594270784|FG018|Overall Study|Physician Decision|0|||
164519403|NCT04047862|594270766|FG000|Overall Study|Completed all Assessments|1|||
164519404|NCT04047862|594270767|FG001|Overall Study|Completed all Assessments|3|||
164519405|NCT04047862|594270768|FG002|Overall Study|Completed all Assessments|1|||
164519406|NCT04047862|594270769|FG003|Overall Study|Completed all Assessments|3|||
164519407|NCT04047862|594270770|FG004|Overall Study|Completed all Assessments|2|||
164519408|NCT04047862|594270771|FG005|Overall Study|Completed all Assessments|5|||
164519409|NCT04047862|594270772|FG006|Overall Study|Completed all Assessments|7|||
164519410|NCT04047862|594270773|FG007|Overall Study|Completed all Assessments|0|||
164519411|NCT04047862|594270774|FG008|Overall Study|Completed all Assessments|0|||
164519412|NCT04047862|594270775|FG009|Overall Study|Completed all Assessments|0|||
164519413|NCT04047862|594270776|FG010|Overall Study|Completed all Assessments|0|||
164519414|NCT04047862|594270777|FG011|Overall Study|Completed all Assessments|0|||
164519415|NCT04047862|594270778|FG012|Overall Study|Completed all Assessments|0|||
164519416|NCT04047862|594270779|FG013|Overall Study|Completed all Assessments|0|||
164519417|NCT04047862|594270780|FG014|Overall Study|Completed all Assessments|0|||
164519418|NCT04047862|594270781|FG015|Overall Study|Completed all Assessments|0|||
164519419|NCT04047862|594270782|FG016|Overall Study|Completed all Assessments|0|||
164519420|NCT04047862|594270783|FG017|Overall Study|Completed all Assessments|0|||
164519421|NCT04047862|594270784|FG018|Overall Study|Completed all Assessments|0|||
164519422|NCT04047862|594270766|FG000|Overall Study|Sponsor Decision|0|||
164519423|NCT04047862|594270767|FG001|Overall Study|Sponsor Decision|0|||
164519424|NCT04047862|594270768|FG002|Overall Study|Sponsor Decision|0|||
164519425|NCT04047862|594270769|FG003|Overall Study|Sponsor Decision|0|||
164519426|NCT04047862|594270770|FG004|Overall Study|Sponsor Decision|0|||
164519427|NCT04047862|594270771|FG005|Overall Study|Sponsor Decision|0|||
164519428|NCT04047862|594270772|FG006|Overall Study|Sponsor Decision|0|||
164519429|NCT04047862|594270773|FG007|Overall Study|Sponsor Decision|13|||
164519430|NCT04047862|594270774|FG008|Overall Study|Sponsor Decision|10|||
164519431|NCT04047862|594270775|FG009|Overall Study|Sponsor Decision|18|||
164519432|NCT04047862|594270776|FG010|Overall Study|Sponsor Decision|3|||
164519433|NCT04047862|594270777|FG011|Overall Study|Sponsor Decision|3|||
164519434|NCT04047862|594270778|FG012|Overall Study|Sponsor Decision|4|||
164616882|NCT02498392|594618938|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
164616883|NCT02498392|594618939|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
164616884|NCT02498392|594618938|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
164616885|NCT02498392|594618939|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
164616886|NCT02498392|594618938|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
164519435|NCT04047862|594270779|FG013|Overall Study|Sponsor Decision|0|||
164519436|NCT04047862|594270780|FG014|Overall Study|Sponsor Decision|7|||
164519437|NCT04047862|594270781|FG015|Overall Study|Sponsor Decision|8|||
164519438|NCT04047862|594270782|FG016|Overall Study|Sponsor Decision|9|||
164519439|NCT04047862|594270783|FG017|Overall Study|Sponsor Decision|7|||
164519440|NCT04047862|594270784|FG018|Overall Study|Sponsor Decision|8|||
164519441|NCT04047862|594270766|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
164519442|NCT04047862|594270767|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
164519443|NCT04047862|594270768|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
164616887|NCT02498392|594618939|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
164616888|NCT02498392|594618938|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
164616889|NCT02498392|594618939|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
164616890|NCT02498392|594618938|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
164616891|NCT02498392|594618939|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
164616892|NCT02498392|594618938|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
164616893|NCT02498392|594618939|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
164616894|NCT06073054|594618940|FG000|Overall Study|Withdrawal by Subject|2|||
164616895|NCT02244619|594618941|FG000|Overall Study|Did not receive study intervention|8|||
164616896|NCT02244619|594618942|FG001|Overall Study|Did not receive study intervention|21|||
164616897|NCT01156363|594618943|FG000|Overall Study|Adverse Event|6|||
164616898|NCT01156363|594618943|FG000|Overall Study|Insufficient Therapeutic Response|5|||
164616899|NCT01156363|594618943|FG000|Overall Study|Failure to Return|1|||
164616900|NCT01156363|594618943|FG000|Overall Study|Refused Treatment|4|||
164616901|NCT01156363|594618943|FG000|Overall Study|Other|6|||
164616902|NCT00068822|594618945|FG000|First Randomized Intervention|Lost to Follow-up|1|||
164616903|NCT00068822|594618946|FG001|First Randomized Intervention|Lost to Follow-up|2|||
164616904|NCT00424099|594618950|FG000|Overall Study|Adverse Event|0|||
164616905|NCT00424099|594618951|FG001|Overall Study|Adverse Event|1|||
164616906|NCT00424099|594618952|FG002|Overall Study|Adverse Event|1|||
164616907|NCT00424099|594618953|FG003|Overall Study|Adverse Event|0|||
164616908|NCT00424099|594618950|FG000|Overall Study|Death|0|||
164616909|NCT00424099|594618951|FG001|Overall Study|Death|1|||
164616910|NCT00424099|594618952|FG002|Overall Study|Death|0|||
164616911|NCT00424099|594618953|FG003|Overall Study|Death|0|||
164616912|NCT00424099|594618950|FG000|Overall Study|Illness|2|||
164616913|NCT00424099|594618951|FG001|Overall Study|Illness|0|||
164616914|NCT00424099|594618952|FG002|Overall Study|Illness|1|||
164616915|NCT00424099|594618953|FG003|Overall Study|Illness|4|||
164616916|NCT00424099|594618950|FG000|Overall Study|Lost to Follow-up|0|||
164616917|NCT00424099|594618951|FG001|Overall Study|Lost to Follow-up|0|||
164616918|NCT00424099|594618952|FG002|Overall Study|Lost to Follow-up|3|||
164616919|NCT00424099|594618953|FG003|Overall Study|Lost to Follow-up|0|||
164616920|NCT00424099|594618950|FG000|Overall Study|Hospitalized|1|||
164616921|NCT00424099|594618951|FG001|Overall Study|Hospitalized|2|||
164616922|NCT00424099|594618952|FG002|Overall Study|Hospitalized|1|||
164616923|NCT00424099|594618953|FG003|Overall Study|Hospitalized|3|||
164616924|NCT00424099|594618950|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
164616925|NCT00424099|594618951|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
164616926|NCT00424099|594618952|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
164616927|NCT00424099|594618953|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
164616928|NCT00424099|594618950|FG000|Overall Study|Withdrawal by Subject|1|||
164616929|NCT00424099|594618951|FG001|Overall Study|Withdrawal by Subject|9|||
164616930|NCT00424099|594618952|FG002|Overall Study|Withdrawal by Subject|4|||
164616931|NCT00424099|594618953|FG003|Overall Study|Withdrawal by Subject|6|||
164616932|NCT00424099|594618950|FG000|Overall Study|Physician Decision|0|||
164616933|NCT00424099|594618951|FG001|Overall Study|Physician Decision|0|||
164616934|NCT00424099|594618952|FG002|Overall Study|Physician Decision|1|||
164616935|NCT00424099|594618953|FG003|Overall Study|Physician Decision|0|||
164616936|NCT00424099|594618950|FG000|Overall Study|Missing|0|||
164616937|NCT00424099|594618951|FG001|Overall Study|Missing|0|||
164616938|NCT00424099|594618952|FG002|Overall Study|Missing|1|||
164616939|NCT00424099|594618953|FG003|Overall Study|Missing|0|||
164616940|NCT00764322|594618954|FG000|Overall Study|Withdrawal by Subject|11|||
164616941|NCT00764322|594618954|FG000|Overall Study|No CYP2D6 genotyping|9|||
164616942|NCT00796003|594618955|FG000|Overall Study|Disease Progression|2|||
164519444|NCT04047862|594270769|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
164616943|NCT00796003|594618956|FG001|Overall Study|Disease Progression|13|||
164616944|NCT00796003|594618955|FG000|Overall Study|Adverse Event|1|||
164616945|NCT00796003|594618956|FG001|Overall Study|Adverse Event|7|||
164616946|NCT00796003|594618955|FG000|Overall Study|Specified organ function not met|0|||
164616947|NCT00796003|594618956|FG001|Overall Study|Specified organ function not met|1|||
164616948|NCT00796003|594618955|FG000|Overall Study|Physician Decision|0|||
164519445|NCT04047862|594270770|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
164519446|NCT04047862|594270771|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
164519447|NCT04047862|594270772|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
164519448|NCT04047862|594270773|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
164519449|NCT04047862|594270774|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
164519450|NCT04047862|594270775|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
164519451|NCT04047862|594270776|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
164519452|NCT04047862|594270777|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
164519453|NCT04047862|594270778|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
164519454|NCT04047862|594270779|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
164519455|NCT04047862|594270780|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
164519456|NCT04047862|594270781|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
164519457|NCT04047862|594270782|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
164519458|NCT04047862|594270783|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
164519459|NCT04047862|594270784|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
164519460|NCT04047862|594270766|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
164519461|NCT04047862|594270767|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
164519462|NCT04047862|594270768|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
164519463|NCT04047862|594270769|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
164519464|NCT04047862|594270770|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
164519465|NCT04047862|594270771|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
164519466|NCT04047862|594270772|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
164519467|NCT04047862|594270773|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
164519468|NCT04047862|594270774|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
164519469|NCT04047862|594270775|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
164519470|NCT04047862|594270776|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
164519471|NCT04047862|594270777|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
164519472|NCT04047862|594270778|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
164519473|NCT04047862|594270779|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
164519474|NCT04047862|594270780|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
164519475|NCT04047862|594270781|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
164519476|NCT04047862|594270782|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
164519477|NCT04047862|594270783|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
164519478|NCT04047862|594270784|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
164616949|NCT00796003|594618956|FG001|Overall Study|Physician Decision|4|||
164616950|NCT00796003|594618955|FG000|Overall Study|Withdrawal by Subject|0|||
164616951|NCT00796003|594618956|FG001|Overall Study|Withdrawal by Subject|1|||
164616952|NCT00796003|594618955|FG000|Overall Study|Other|0|||
164616953|NCT00796003|594618956|FG001|Overall Study|Other|1|||
164519479|NCT04047862|594270766|FG000|Overall Study|Other|0|||
164519480|NCT04047862|594270767|FG001|Overall Study|Other|0|||
164519481|NCT04047862|594270768|FG002|Overall Study|Other|0|||
164519482|NCT04047862|594270769|FG003|Overall Study|Other|0|||
164519483|NCT04047862|594270770|FG004|Overall Study|Other|0|||
164519484|NCT04047862|594270771|FG005|Overall Study|Other|0|||
164519485|NCT04047862|594270772|FG006|Overall Study|Other|0|||
164519486|NCT04047862|594270773|FG007|Overall Study|Other|0|||
164519487|NCT04047862|594270774|FG008|Overall Study|Other|0|||
164519488|NCT04047862|594270775|FG009|Overall Study|Other|0|||
164519489|NCT04047862|594270776|FG010|Overall Study|Other|0|||
164519490|NCT04047862|594270777|FG011|Overall Study|Other|0|||
164519491|NCT04047862|594270778|FG012|Overall Study|Other|0|||
164519492|NCT04047862|594270779|FG013|Overall Study|Other|0|||
164519493|NCT04047862|594270780|FG014|Overall Study|Other|2|||
164616954|NCT00796003|594618955|FG000|Overall Study|Participants Not treated|0|||
164616955|NCT00796003|594618956|FG001|Overall Study|Participants Not treated|2|||
164616956|NCT02417064|594618960|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
164616957|NCT02417064|594618961|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
164616958|NCT02417064|594618962|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
164519494|NCT04047862|594270781|FG015|Overall Study|Other|1|||
164519495|NCT04047862|594270782|FG016|Overall Study|Other|1|||
164519496|NCT04047862|594270783|FG017|Overall Study|Other|1|||
164519497|NCT04047862|594270784|FG018|Overall Study|Other|0|||
164519498|NCT04032613|594271869|FG000|Overall Study|Did not complete post-program assessment|5|||
164519499|NCT04032613|594271870|FG001|Overall Study|Did not complete post-program assessment|2|||
164519500|NCT01744392|594271876|FG000|Overall Study|Physician Decision|1|||
164519501|NCT00299494|594271877|FG000|Overall Study|Withdrawal by Subject|0|||
164519502|NCT00299494|594271878|FG001|Overall Study|Withdrawal by Subject|0|||
164519503|NCT00299494|594271879|FG002|Overall Study|Withdrawal by Subject|0|||
164519504|NCT00299494|594271880|FG003|Overall Study|Withdrawal by Subject|3|||
164519505|NCT00299494|594271881|FG004|Overall Study|Withdrawal by Subject|1|||
164519506|NCT00299494|594271882|FG005|Overall Study|Withdrawal by Subject|4|||
164519507|NCT00299494|594271877|FG000|Overall Study|Physician Decision|0|||
164519508|NCT00299494|594271878|FG001|Overall Study|Physician Decision|0|||
164519509|NCT00299494|594271879|FG002|Overall Study|Physician Decision|0|||
164519510|NCT00299494|594271880|FG003|Overall Study|Physician Decision|0|||
164519511|NCT00299494|594271881|FG004|Overall Study|Physician Decision|1|||
164519512|NCT00299494|594271882|FG005|Overall Study|Physician Decision|0|||
164519513|NCT00299494|594271877|FG000|Overall Study|Death|3|||
164519514|NCT00299494|594271878|FG001|Overall Study|Death|1|||
164519515|NCT00299494|594271879|FG002|Overall Study|Death|4|||
164519516|NCT00299494|594271880|FG003|Overall Study|Death|6|||
164519517|NCT00299494|594271881|FG004|Overall Study|Death|18|||
164519518|NCT00299494|594271882|FG005|Overall Study|Death|19|||
164519519|NCT00299494|594271877|FG000|Overall Study|Lost to Follow-up|0|||
164519520|NCT00299494|594271878|FG001|Overall Study|Lost to Follow-up|0|||
164519521|NCT00299494|594271879|FG002|Overall Study|Lost to Follow-up|0|||
164519522|NCT00299494|594271880|FG003|Overall Study|Lost to Follow-up|0|||
164519523|NCT00299494|594271881|FG004|Overall Study|Lost to Follow-up|3|||
164519524|NCT00299494|594271882|FG005|Overall Study|Lost to Follow-up|1|||
164519525|NCT00299494|594271877|FG000|Overall Study|Other - Unspecified|0|||
164519526|NCT00299494|594271878|FG001|Overall Study|Other - Unspecified|0|||
164519527|NCT00299494|594271879|FG002|Overall Study|Other - Unspecified|0|||
164519528|NCT00299494|594271880|FG003|Overall Study|Other - Unspecified|0|||
164519529|NCT00299494|594271881|FG004|Overall Study|Other - Unspecified|3|||
164519530|NCT00299494|594271882|FG005|Overall Study|Other - Unspecified|1|||
164519531|NCT00299494|594271877|FG000|Overall Study|Other - site closure|0|||
164519532|NCT00299494|594271878|FG001|Overall Study|Other - site closure|0|||
164519533|NCT00299494|594271879|FG002|Overall Study|Other - site closure|0|||
164519534|NCT00299494|594271880|FG003|Overall Study|Other - site closure|1|||
164519535|NCT00299494|594271881|FG004|Overall Study|Other - site closure|1|||
164519536|NCT00299494|594271882|FG005|Overall Study|Other - site closure|1|||
164519537|NCT00403767|594271888|FG000|Overall Study|Adverse Event|993|||
164519538|NCT00403767|594271889|FG001|Overall Study|Adverse Event|919|||
164519539|NCT00403767|594271888|FG000|Overall Study|Non-compliant with study medication|134|||
164519540|NCT00403767|594271889|FG001|Overall Study|Non-compliant with study medication|164|||
164519541|NCT00403767|594271888|FG000|Overall Study|Consent withdrawn|671|||
164519542|NCT00403767|594271889|FG001|Overall Study|Consent withdrawn|673|||
164519543|NCT00403767|594271888|FG000|Overall Study|Investigator dec./not protocol-related|191|||
164519544|NCT00403767|594271889|FG001|Overall Study|Investigator dec./not protocol-related|178|||
164519545|NCT00403767|594271888|FG000|Overall Study|Lost to Follow-up|6|||
164519546|NCT00403767|594271889|FG001|Overall Study|Lost to Follow-up|8|||
164519547|NCT00403767|594271888|FG000|Overall Study|Protocol Violation|142|||
164519548|NCT00403767|594271889|FG001|Overall Study|Protocol Violation|124|||
164519549|NCT00403767|594271888|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
164519550|NCT00403767|594271889|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
164519551|NCT00403767|594271888|FG000|Overall Study|Study terminated by sponsor|82|||
164519552|NCT00403767|594271889|FG001|Overall Study|Study terminated by sponsor|69|||
164519553|NCT00403767|594271888|FG000|Overall Study|Missing/incomplete data|1|||
164519554|NCT00403767|594271889|FG001|Overall Study|Missing/incomplete data|1|||
164519555|NCT03014011|594271890|FG000|First Intervention|Withdrawal by Subject|1|||
164519556|NCT03014011|594271891|FG001|First Intervention|Withdrawal by Subject|0|||
164519557|NCT03014011|594271890|FG000|Washout|Withdrawal by Subject|1|||
164519558|NCT03014011|594271891|FG001|Washout|Withdrawal by Subject|0|||
164519559|NCT02755818|594271892|FG000|Overall Study|Withdrawal by Subject|0|||
164519560|NCT02755818|594271893|FG001|Overall Study|Withdrawal by Subject|0|||
164519561|NCT02755818|594271894|FG002|Overall Study|Withdrawal by Subject|0|||
164519562|NCT02755818|594271895|FG003|Overall Study|Withdrawal by Subject|2|||
164519563|NCT02755818|594271892|FG000|Overall Study|withdrawal by PI|0|||
164519564|NCT02755818|594271893|FG001|Overall Study|withdrawal by PI|0|||
164519565|NCT02755818|594271894|FG002|Overall Study|withdrawal by PI|1|||
164519566|NCT02755818|594271895|FG003|Overall Study|withdrawal by PI|1|||
164519567|NCT01152814|594271896|FG000|Overall Study|Lost to Follow-up|2|||
164519568|NCT01280357|594271907|FG000|Overall Study|Excluded no internal monitoring|14|||
164519569|NCT01280357|594271907|FG000|Overall Study|IInsufficient data/No data supplied|12|||
164519570|NCT03284203|594271908|FG000|Overall Study|Lost to Follow-up|3|||
164519571|NCT03682302|594271911|FG000|Overall Study|Lost to Follow-up|1|||
164519572|NCT03682302|594271912|FG001|Overall Study|Lost to Follow-up|2|||
164519573|NCT03682302|594271913|FG002|Overall Study|Lost to Follow-up|0|||
164519574|NCT03682302|594271914|FG003|Overall Study|Lost to Follow-up|1|||
164519575|NCT03682302|594271911|FG000|Overall Study|Study drug was not administered|0|||
164519576|NCT03682302|594271912|FG001|Overall Study|Study drug was not administered|0|||
164519577|NCT03682302|594271913|FG002|Overall Study|Study drug was not administered|1|||
164519578|NCT03682302|594271914|FG003|Overall Study|Study drug was not administered|1|||
164519579|NCT01489891|594271916|FG000|Overall Study|Endoscopy failure|1|||
164519580|NCT01489891|594271917|FG001|Overall Study|Endoscopy failure|0|||
164519581|NCT00532493|594271918|FG000|Overall Study|Death|1|||
164519582|NCT00532493|594271919|FG001|Overall Study|Death|1|||
164519583|NCT00532493|594271918|FG000|Overall Study|Lost to Follow-up|10|||
164519584|NCT00532493|594271919|FG001|Overall Study|Lost to Follow-up|7|||
164519585|NCT00532493|594271918|FG000|Overall Study|Withdrawal by Subject|7|||
164519586|NCT00532493|594271919|FG001|Overall Study|Withdrawal by Subject|9|||
164519587|NCT00532493|594271918|FG000|Overall Study|Physician Decision|1|||
164519588|NCT00532493|594271919|FG001|Overall Study|Physician Decision|6|||
164519589|NCT00532493|594271918|FG000|Overall Study|Adverse Event|6|||
164519590|NCT00532493|594271919|FG001|Overall Study|Adverse Event|5|||
164519591|NCT00532493|594271918|FG000|Overall Study|Protocol Deviation|1|||
164519592|NCT00532493|594271919|FG001|Overall Study|Protocol Deviation|0|||
164519593|NCT00532493|594271918|FG000|Overall Study|Subject Moved Away|3|||
164519594|NCT00532493|594271919|FG001|Overall Study|Subject Moved Away|1|||
164519595|NCT00532493|594271918|FG000|Overall Study|Contraindicative Medication|1|||
164519596|NCT00532493|594271919|FG001|Overall Study|Contraindicative Medication|0|||
164519597|NCT00948766|594271920|FG000|Core Study|Adverse Event|73|||
164519598|NCT00948766|594271921|FG001|Core Study|Adverse Event|51|||
164519599|NCT00948766|594271920|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
164519600|NCT00948766|594271921|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
164519601|NCT00948766|594271920|FG000|Core Study|Patient Withdrew Consent|27|||
164519602|NCT00948766|594271921|FG001|Core Study|Patient Withdrew Consent|46|||
164519603|NCT00948766|594271920|FG000|Core Study|Lost to Follow-up|3|||
164519604|NCT00948766|594271921|FG001|Core Study|Lost to Follow-up|2|||
164519605|NCT00948766|594271920|FG000|Core Study|Administrative Problems|2|||
164519606|NCT00948766|594271921|FG001|Core Study|Administrative Problems|2|||
164519607|NCT00948766|594271920|FG000|Core Study|Death|1|||
164519608|NCT00948766|594271921|FG001|Core Study|Death|1|||
164519609|NCT00948766|594271920|FG000|Core Study|Protocol Deviation|8|||
164519610|NCT00948766|594271921|FG001|Core Study|Protocol Deviation|10|||
164519611|NCT00948766|594271920|FG000|Extension Study|Adverse Event|43|||
164519612|NCT00948766|594271921|FG001|Extension Study|Adverse Event|0|||
164519613|NCT00948766|594271920|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
164519614|NCT00948766|594271921|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
164519615|NCT00948766|594271920|FG000|Extension Study|Study Drug No Longer Required|1|||
164519616|NCT00948766|594271921|FG001|Extension Study|Study Drug No Longer Required|0|||
164519617|NCT00948766|594271920|FG000|Extension Study|Patient Withdrew Consent|32|||
164519618|NCT00948766|594271921|FG001|Extension Study|Patient Withdrew Consent|0|||
164519619|NCT00948766|594271920|FG000|Extension Study|Lost to Follow-up|8|||
164519620|NCT00948766|594271921|FG001|Extension Study|Lost to Follow-up|0|||
164519621|NCT00948766|594271920|FG000|Extension Study|Administrative Problems|1|||
164519622|NCT00948766|594271921|FG001|Extension Study|Administrative Problems|0|||
164519623|NCT00948766|594271920|FG000|Extension Study|Death|4|||
164519624|NCT00948766|594271921|FG001|Extension Study|Death|0|||
164616959|NCT02417064|594618960|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
164519625|NCT03459443|594271922|FG000|Overall Study|Lack of Efficacy|3|||
164519626|NCT03459443|594271922|FG000|Overall Study|Adverse Event|1|||
164519627|NCT03459443|594271922|FG000|Overall Study|Sponsor's decision to close the study|18|||
164519628|NCT02153073|594271923|FG000|Overall Study|Case Report Forms Uncollected|230|||
164519629|NCT02153073|594271923|FG000|Overall Study|Protocol Deviation|68|||
164519630|NCT03189745|594271924|FG000|Overall Study|Conflict in work schedule of participant|1|||
164519631|NCT03189745|594271925|FG001|Overall Study|Conflict in work schedule of participant|1|||
164519632|NCT00680992|594271926|FG000|Overall Study|Complete Resection (as per protocol)|25|||
164519633|NCT00680992|594271927|FG001|Overall Study|Complete Resection (as per protocol)|121|||
164519634|NCT00680992|594271928|FG002|Overall Study|Complete Resection (as per protocol)|0|||
164519635|NCT00680992|594271926|FG000|Overall Study|Administrative Decision|83|||
164519636|NCT00680992|594271927|FG001|Overall Study|Administrative Decision|42|||
164519637|NCT00680992|594271928|FG002|Overall Study|Administrative Decision|5|||
164519638|NCT00680992|594271926|FG000|Overall Study|End of Trial|32|||
164519639|NCT00680992|594271927|FG001|Overall Study|End of Trial|12|||
164519640|NCT00680992|594271928|FG002|Overall Study|End of Trial|3|||
164519641|NCT00680992|594271926|FG000|Overall Study|Withdrawal by Subject|33|||
164519642|NCT00680992|594271927|FG001|Overall Study|Withdrawal by Subject|11|||
164519643|NCT00680992|594271928|FG002|Overall Study|Withdrawal by Subject|1|||
164519644|NCT00680992|594271926|FG000|Overall Study|Adverse Event|21|||
164519645|NCT00680992|594271927|FG001|Overall Study|Adverse Event|19|||
164519646|NCT00680992|594271928|FG002|Overall Study|Adverse Event|1|||
164519647|NCT00680992|594271926|FG000|Overall Study|Other|19|||
164519648|NCT00680992|594271927|FG001|Overall Study|Other|14|||
164519649|NCT00680992|594271928|FG002|Overall Study|Other|1|||
164519650|NCT00680992|594271926|FG000|Overall Study|Disease Progression|21|||
164519651|NCT00680992|594271927|FG001|Overall Study|Disease Progression|9|||
164519652|NCT00680992|594271928|FG002|Overall Study|Disease Progression|0|||
164519653|NCT00680992|594271926|FG000|Overall Study|Lost to Follow-up|12|||
164519654|NCT00680992|594271927|FG001|Overall Study|Lost to Follow-up|14|||
164519655|NCT00680992|594271928|FG002|Overall Study|Lost to Follow-up|0|||
164519656|NCT00680992|594271926|FG000|Overall Study|Noncompliance|4|||
164519657|NCT00680992|594271927|FG001|Overall Study|Noncompliance|6|||
164519658|NCT00680992|594271928|FG002|Overall Study|Noncompliance|0|||
164519659|NCT00680992|594271926|FG000|Overall Study|Requirement for Alternative Therapy|8|||
164519660|NCT00680992|594271927|FG001|Overall Study|Requirement for Alternative Therapy|2|||
164519661|NCT00680992|594271928|FG002|Overall Study|Requirement for Alternative Therapy|0|||
164519662|NCT00680992|594271926|FG000|Overall Study|Pregnancy|5|||
164519663|NCT00680992|594271927|FG001|Overall Study|Pregnancy|0|||
164519664|NCT00680992|594271928|FG002|Overall Study|Pregnancy|1|||
164519665|NCT00680992|594271926|FG000|Overall Study|Death|5|||
164519666|NCT00680992|594271927|FG001|Overall Study|Death|1|||
164519667|NCT00680992|594271928|FG002|Overall Study|Death|0|||
164519668|NCT00680992|594271926|FG000|Overall Study|Ineligibility Determined|0|||
164519669|NCT00680992|594271927|FG001|Overall Study|Ineligibility Determined|1|||
164519670|NCT00680992|594271928|FG002|Overall Study|Ineligibility Determined|0|||
164519671|NCT06665919|594271929|FG000|Overall Study|Withdrawal by Subject|4|||
164519672|NCT06665919|594271930|FG001|Overall Study|Withdrawal by Subject|4|||
164519673|NCT06665919|594271931|FG002|Overall Study|Withdrawal by Subject|4|||
164519674|NCT06665919|594271929|FG000|Overall Study|Non-compliance to Treatment|4|||
164519675|NCT06665919|594271930|FG001|Overall Study|Non-compliance to Treatment|1|||
164519676|NCT06665919|594271931|FG002|Overall Study|Non-compliance to Treatment|6|||
164519677|NCT06665919|594271929|FG000|Overall Study|Lost to Follow-up|3|||
164519678|NCT06665919|594271930|FG001|Overall Study|Lost to Follow-up|0|||
164519679|NCT06665919|594271931|FG002|Overall Study|Lost to Follow-up|2|||
164519680|NCT06665919|594271929|FG000|Overall Study|Physician Decision|4|||
164519681|NCT06665919|594271930|FG001|Overall Study|Physician Decision|0|||
164519682|NCT06665919|594271931|FG002|Overall Study|Physician Decision|1|||
164519683|NCT05148962|594271932|FG000|Overall Study|Withdrawal by Subject|1|||
164519684|NCT05148962|594271933|FG001|Overall Study|Withdrawal by Subject|1|||
164519685|NCT05148962|594271934|FG002|Overall Study|Withdrawal by Subject|0|||
164519686|NCT05148962|594271935|FG003|Overall Study|Withdrawal by Subject|1|||
164519687|NCT05148962|594271936|FG004|Overall Study|Withdrawal by Subject|0|||
164519688|NCT05148962|594271932|FG000|Overall Study|Participant was early terminated per protocol|0|||
164519689|NCT05148962|594271933|FG001|Overall Study|Participant was early terminated per protocol|0|||
164519690|NCT05148962|594271934|FG002|Overall Study|Participant was early terminated per protocol|3|||
164519691|NCT05148962|594271935|FG003|Overall Study|Participant was early terminated per protocol|5|||
164519692|NCT05148962|594271936|FG004|Overall Study|Participant was early terminated per protocol|2|||
164519693|NCT05148962|594271932|FG000|Overall Study|Miscellaneous|0|||
164519694|NCT05148962|594271933|FG001|Overall Study|Miscellaneous|0|||
164519695|NCT05148962|594271934|FG002|Overall Study|Miscellaneous|0|||
164519696|NCT05148962|594271935|FG003|Overall Study|Miscellaneous|1|||
164519697|NCT05148962|594271936|FG004|Overall Study|Miscellaneous|0|||
164519698|NCT01200290|594271938|FG000|Treatment Period|Adverse Event|1|||
164519699|NCT01200290|594271938|FG000|Post-Treatment Follow-Up Period|Death|2|||
164519700|NCT01525238|594271939|FG000|Overall Study|Withdrawal by Subject|1|||
164519701|NCT01525238|594271940|FG001|Overall Study|Withdrawal by Subject|0|||
164519702|NCT01525238|594271941|FG002|Overall Study|Withdrawal by Subject|0|||
164519703|NCT00607724|594271942|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
164519704|NCT00607724|594271943|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
164519705|NCT00607724|594271944|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
164519706|NCT00607724|594271945|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
164519707|NCT00607724|594271946|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
164519708|NCT00607724|594271947|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
164519709|NCT00607724|594271948|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
164519710|NCT00607724|594271942|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
164519711|NCT00607724|594271943|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
164519712|NCT00607724|594271944|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
164519713|NCT00607724|594271945|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
164519714|NCT00607724|594271946|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
164519715|NCT00607724|594271947|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
164519716|NCT00607724|594271948|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
164519717|NCT00607724|594271942|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
164519718|NCT00607724|594271943|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
164519719|NCT00607724|594271944|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
164519720|NCT00607724|594271945|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
164519721|NCT00607724|594271946|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
164519722|NCT00607724|594271947|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
164519723|NCT00607724|594271948|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
164519724|NCT00607724|594271942|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
164519725|NCT00607724|594271943|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
164519726|NCT00607724|594271944|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
164519727|NCT00607724|594271945|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
164519728|NCT00607724|594271946|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
164519729|NCT00607724|594271947|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
164519730|NCT00607724|594271948|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
164519731|NCT00607724|594271942|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
164519732|NCT00607724|594271943|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
164519733|NCT00607724|594271944|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
164519734|NCT00607724|594271945|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
164519735|NCT00607724|594271946|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
164519736|NCT00607724|594271947|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
164519737|NCT00607724|594271948|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
164519738|NCT00151281|594271949|FG000|Overall Study|Not evaluable|3|||
164519739|NCT01946529|594271952|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
164519740|NCT01946529|594271953|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
164519741|NCT01946529|594271954|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
164519742|NCT01946529|594271952|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
164519743|NCT01946529|594271953|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
164519744|NCT01946529|594271954|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
164519745|NCT04349631|594271970|FG000|Overall Study|Lost to Follow-up|3|||
164519746|NCT04349631|594271970|FG000|Overall Study|Withdrawal by Subject|7|||
164519747|NCT00640133|594273394|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
164519748|NCT00640133|594273395|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
164519749|NCT00640133|594273394|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
164519750|NCT00640133|594273395|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
164519751|NCT00640133|594273394|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
164519752|NCT00640133|594273395|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
164519753|NCT03037931|594273396|FG000|Overall Study|Death|354|||
164519754|NCT03037931|594273397|FG001|Overall Study|Death|367|||
164519755|NCT03037931|594273396|FG000|Overall Study|Lost to Follow-up|7|||
164519756|NCT03037931|594273397|FG001|Overall Study|Lost to Follow-up|4|||
164519757|NCT03037931|594273396|FG000|Overall Study|Withdrawal by Subject|48|||
164519758|NCT03037931|594273397|FG001|Overall Study|Withdrawal by Subject|41|||
164519759|NCT02075476|594273398|FG000|Overall Study|Death|2|||
164519760|NCT02075476|594273399|FG001|Overall Study|Death|2|||
164519761|NCT02075476|594273398|FG000|Overall Study|Lost to Follow-up|1|||
164519762|NCT02075476|594273399|FG001|Overall Study|Lost to Follow-up|3|||
164519763|NCT01789567|594273400|FG000|Overall Study|Death|6|||
164519764|NCT02731690|594273401|FG000|Overall Study|Adverse Event|1|||
164519765|NCT02731690|594273401|FG000|Overall Study|Withdrawal by Subject|3|||
164519766|NCT02731690|594273401|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
164519767|NCT00872989|594273402|FG000|Overall Study|Adverse Event|7|||
164519768|NCT00872989|594273403|FG001|Overall Study|Adverse Event|15|||
164519769|NCT00872989|594273402|FG000|Overall Study|Withdrawal by Subject|8|||
164519770|NCT00872989|594273403|FG001|Overall Study|Withdrawal by Subject|5|||
164519771|NCT00872989|594273402|FG000|Overall Study|Progression/relapse|47|||
164519772|NCT00872989|594273403|FG001|Overall Study|Progression/relapse|35|||
164519773|NCT00872989|594273402|FG000|Overall Study|Not protocol specified|3|||
164519774|NCT00872989|594273403|FG001|Overall Study|Not protocol specified|8|||
164519775|NCT02407990|594273404|FG000|Overall Study|Death|2|||
164519776|NCT02407990|594273405|FG001|Overall Study|Death|22|||
164519777|NCT02407990|594273406|FG002|Overall Study|Death|23|||
164519778|NCT02407990|594273407|FG003|Overall Study|Death|7|||
164519779|NCT02407990|594273408|FG004|Overall Study|Death|17|||
164519780|NCT02407990|594273409|FG005|Overall Study|Death|16|||
164519781|NCT02407990|594273410|FG006|Overall Study|Death|10|||
164519782|NCT02407990|594273411|FG007|Overall Study|Death|248|||
164519783|NCT02407990|594273404|FG000|Overall Study|Lost to Follow-up|0|||
164519784|NCT02407990|594273405|FG001|Overall Study|Lost to Follow-up|1|||
164519785|NCT02407990|594273406|FG002|Overall Study|Lost to Follow-up|0|||
164519786|NCT02407990|594273407|FG003|Overall Study|Lost to Follow-up|0|||
164519787|NCT02407990|594273408|FG004|Overall Study|Lost to Follow-up|0|||
164519788|NCT02407990|594273409|FG005|Overall Study|Lost to Follow-up|0|||
164519789|NCT02407990|594273410|FG006|Overall Study|Lost to Follow-up|0|||
164519790|NCT02407990|594273411|FG007|Overall Study|Lost to Follow-up|17|||
164519791|NCT02407990|594273404|FG000|Overall Study|Progressive Disease|0|||
164519792|NCT02407990|594273405|FG001|Overall Study|Progressive Disease|0|||
164519793|NCT02407990|594273406|FG002|Overall Study|Progressive Disease|0|||
164519794|NCT02407990|594273407|FG003|Overall Study|Progressive Disease|0|||
164519795|NCT02407990|594273408|FG004|Overall Study|Progressive Disease|0|||
164519796|NCT02407990|594273409|FG005|Overall Study|Progressive Disease|0|||
164519797|NCT02407990|594273410|FG006|Overall Study|Progressive Disease|0|||
164519798|NCT02407990|594273411|FG007|Overall Study|Progressive Disease|1|||
164519799|NCT02407990|594273404|FG000|Overall Study|Withdrawal by Subject|0|||
164519800|NCT02407990|594273405|FG001|Overall Study|Withdrawal by Subject|0|||
164519801|NCT02407990|594273406|FG002|Overall Study|Withdrawal by Subject|0|||
164519802|NCT02407990|594273407|FG003|Overall Study|Withdrawal by Subject|0|||
164519803|NCT02407990|594273408|FG004|Overall Study|Withdrawal by Subject|1|||
164519804|NCT02407990|594273409|FG005|Overall Study|Withdrawal by Subject|0|||
164519805|NCT02407990|594273410|FG006|Overall Study|Withdrawal by Subject|0|||
164519806|NCT02407990|594273411|FG007|Overall Study|Withdrawal by Subject|30|||
164519807|NCT02407990|594273404|FG000|Overall Study|Study Terminated by Sponsor|1|||
164519808|NCT02407990|594273405|FG001|Overall Study|Study Terminated by Sponsor|3|||
164519809|NCT02407990|594273406|FG002|Overall Study|Study Terminated by Sponsor|3|||
164519810|NCT02407990|594273407|FG003|Overall Study|Study Terminated by Sponsor|0|||
164519811|NCT02407990|594273408|FG004|Overall Study|Study Terminated by Sponsor|3|||
164519812|NCT02407990|594273409|FG005|Overall Study|Study Terminated by Sponsor|4|||
164519813|NCT02407990|594273410|FG006|Overall Study|Study Terminated by Sponsor|3|||
164519814|NCT02407990|594273411|FG007|Overall Study|Study Terminated by Sponsor|37|||
164519815|NCT02407990|594273404|FG000|Overall Study|Logistics|0|||
164519816|NCT02407990|594273405|FG001|Overall Study|Logistics|0|||
164519817|NCT02407990|594273406|FG002|Overall Study|Logistics|0|||
164519818|NCT02407990|594273407|FG003|Overall Study|Logistics|0|||
164519819|NCT02407990|594273408|FG004|Overall Study|Logistics|0|||
164519820|NCT02407990|594273409|FG005|Overall Study|Logistics|0|||
164519821|NCT02407990|594273410|FG006|Overall Study|Logistics|0|||
164519822|NCT02407990|594273411|FG007|Overall Study|Logistics|1|||
164519823|NCT02407990|594273404|FG000|Overall Study|Rolled into long-term extension study|0|||
164519824|NCT02407990|594273405|FG001|Overall Study|Rolled into long-term extension study|0|||
164519825|NCT02407990|594273406|FG002|Overall Study|Rolled into long-term extension study|0|||
164519826|NCT02407990|594273407|FG003|Overall Study|Rolled into long-term extension study|0|||
164519827|NCT02407990|594273408|FG004|Overall Study|Rolled into long-term extension study|0|||
164519828|NCT02407990|594273409|FG005|Overall Study|Rolled into long-term extension study|0|||
164519829|NCT02407990|594273410|FG006|Overall Study|Rolled into long-term extension study|0|||
164519830|NCT02407990|594273411|FG007|Overall Study|Rolled into long-term extension study|1|||
164519831|NCT01238900|594273412|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
164519832|NCT01238900|594273412|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
164519833|NCT01994837|594273413|FG000|Overall Study|Progressive disease per protocol|23|||
164519834|NCT01994837|594273413|FG000|Overall Study|Adv event related to progressive disease|3|||
164519835|NCT01994837|594273413|FG000|Overall Study|Fatal progressive disease|2|||
164519836|NCT01994837|594273413|FG000|Overall Study|Adverse event not related to progression|1|||
164519837|NCT01994837|594273413|FG000|Overall Study|Chose palliative care|1|||
164519838|NCT01994837|594273413|FG000|Overall Study|Proceeded to transplant|1|||
164519839|NCT01994837|594273413|FG000|Overall Study|Removed from study due to no response|1|||
164519840|NCT03241927|594273415|FG000|Overall Study|study terminated|1|||
164519841|NCT03241927|594273416|FG001|Overall Study|study terminated|0|||
164519842|NCT03573583|594273417|FG000|Overall Study|Lost to Follow-up|1|||
164519843|NCT03573583|594273418|FG001|Overall Study|Lost to Follow-up|0|||
164519844|NCT03573583|594273417|FG000|Overall Study|Withdrawal by Subject|1|||
164519845|NCT03573583|594273418|FG001|Overall Study|Withdrawal by Subject|1|||
164519846|NCT01198756|594273419|FG000|Overall Study|Adverse Event|0|||
164519847|NCT01198756|594273420|FG001|Overall Study|Adverse Event|0|||
164519848|NCT01198756|594273421|FG002|Overall Study|Adverse Event|0|||
164519849|NCT01198756|594273422|FG003|Overall Study|Adverse Event|1|||
164519850|NCT01198756|594273419|FG000|Overall Study|Protocol Violation|0|||
164519851|NCT01198756|594273420|FG001|Overall Study|Protocol Violation|0|||
164519852|NCT01198756|594273421|FG002|Overall Study|Protocol Violation|0|||
164519853|NCT01198756|594273422|FG003|Overall Study|Protocol Violation|2|||
164519854|NCT01198756|594273419|FG000|Overall Study|Withdrawal by Subject|9|||
164519855|NCT01198756|594273420|FG001|Overall Study|Withdrawal by Subject|4|||
164519856|NCT01198756|594273421|FG002|Overall Study|Withdrawal by Subject|7|||
164519857|NCT01198756|594273422|FG003|Overall Study|Withdrawal by Subject|5|||
164519858|NCT01198756|594273419|FG000|Overall Study|Lost to Follow-up|29|||
164519859|NCT01198756|594273420|FG001|Overall Study|Lost to Follow-up|36|||
164519860|NCT01198756|594273421|FG002|Overall Study|Lost to Follow-up|23|||
164519861|NCT01198756|594273422|FG003|Overall Study|Lost to Follow-up|18|||
164519862|NCT02915302|594273425|FG000|Overall Study|Adverse Event|3|||
164519863|NCT02915302|594273426|FG001|Overall Study|Adverse Event|0|||
164519864|NCT02915302|594273425|FG000|Overall Study|Protocol Violation|20|||
164519865|NCT02915302|594273426|FG001|Overall Study|Protocol Violation|27|||
164519866|NCT02915302|594273425|FG000|Overall Study|Lost to Follow-up|19|||
164519867|NCT02915302|594273426|FG001|Overall Study|Lost to Follow-up|22|||
164519868|NCT02915302|594273425|FG000|Overall Study|Withdrawal by Subject|22|||
164519869|NCT02915302|594273426|FG001|Overall Study|Withdrawal by Subject|29|||
164519870|NCT02915302|594273425|FG000|Overall Study|Other|1|||
164519871|NCT02915302|594273426|FG001|Overall Study|Other|0|||
164519872|NCT04343872|594273429|FG000|Overall Study|Lost to Follow-up|6|||
164519873|NCT04343872|594273430|FG001|Overall Study|Lost to Follow-up|3|||
164519874|NCT01850446|594273431|FG000|Overall Study|Lack of Efficacy|1|||
164519875|NCT01850446|594273432|FG001|Overall Study|Lack of Efficacy|0|||
164519876|NCT01850446|594273431|FG000|Overall Study|Withdrawal by Subject|4|||
164519877|NCT01850446|594273432|FG001|Overall Study|Withdrawal by Subject|0|||
164519878|NCT01850446|594273431|FG000|Overall Study|Protocol Violation|0|||
164519879|NCT01850446|594273432|FG001|Overall Study|Protocol Violation|2|||
164519880|NCT00591721|594273433|FG000|Overall Study|Withdrawal by Subject|10|||
164519881|NCT00591721|594273434|FG001|Overall Study|Withdrawal by Subject|10|||
164519882|NCT00591721|594273433|FG000|Overall Study|Lost to Follow-up|1|||
164519883|NCT00591721|594273434|FG001|Overall Study|Lost to Follow-up|4|||
164519884|NCT00591721|594273433|FG000|Overall Study|Intervention not received|10|||
164519885|NCT00591721|594273434|FG001|Overall Study|Intervention not received|8|||
164519886|NCT01119105|594273435|FG000|Overall Study|Withdrawal by Subject|1|||
164519887|NCT01119105|594273436|FG001|Overall Study|Withdrawal by Subject|1|||
164519888|NCT01119105|594273437|FG002|Overall Study|Withdrawal by Subject|1|||
164519889|NCT01119105|594273435|FG000|Overall Study|Lost to Follow-up|0|||
164519890|NCT01119105|594273436|FG001|Overall Study|Lost to Follow-up|2|||
164519891|NCT01119105|594273437|FG002|Overall Study|Lost to Follow-up|5|||
164519892|NCT01119105|594273435|FG000|Overall Study|Adverse Event|1|||
164519893|NCT01119105|594273436|FG001|Overall Study|Adverse Event|0|||
164519894|NCT01119105|594273437|FG002|Overall Study|Adverse Event|1|||
164519895|NCT01119105|594273435|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
164519896|NCT01119105|594273436|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
164519897|NCT01119105|594273437|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
164519898|NCT01119105|594273435|FG000|Overall Study|Other|1|||
164519899|NCT01119105|594273436|FG001|Overall Study|Other|1|||
164519900|NCT01119105|594273437|FG002|Overall Study|Other|0|||
164519901|NCT03900416|594273438|FG000|Six Week Follow-up|Lost to Follow-up|1|||
164519902|NCT03900416|594273439|FG001|Six Week Follow-up|Lost to Follow-up|0|||
164519903|NCT03900416|594273438|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
164519904|NCT03900416|594273439|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
164519905|NCT03900416|594273438|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
164519906|NCT03900416|594273439|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
164519907|NCT03900416|594273438|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
164519908|NCT03900416|594273439|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
164519909|NCT03900416|594273438|FG000|Twelve Week Follow-up|Adverse Event|1|||
164519910|NCT03900416|594273439|FG001|Twelve Week Follow-up|Adverse Event|1|||
164519911|NCT03900416|594273438|FG000|Six Month Follow-up|Lost to Follow-up|4|||
164519912|NCT03900416|594273439|FG001|Six Month Follow-up|Lost to Follow-up|3|||
164519913|NCT03900416|594273438|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
164519914|NCT03900416|594273439|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
164519915|NCT00730275|594273440|FG000|Overall Study|Withdrawal by Subject|0|||
164519916|NCT00730275|594273441|FG001|Overall Study|Withdrawal by Subject|0|||
164519917|NCT00730275|594273442|FG002|Overall Study|Withdrawal by Subject|0|||
164519918|NCT00730275|594273443|FG003|Overall Study|Withdrawal by Subject|1|||
164519919|NCT05487586|594273444|FG000|Overall Study|Death|22|||
164519920|NCT05487586|594273444|FG000|Overall Study|Physician Decision|1|||
164519921|NCT05487586|594273444|FG000|Overall Study|Transfer to another hospital|4|||
164519922|NCT05487586|594273444|FG000|Overall Study|Other|1|||
164519923|NCT01417104|594273447|FG000|Overall Study|Withdrawal by Subject|5|||
164519924|NCT01417104|594273448|FG001|Overall Study|Withdrawal by Subject|1|||
164519925|NCT01417104|594273447|FG000|Overall Study|Failure to make contact|0|||
164519926|NCT01417104|594273448|FG001|Overall Study|Failure to make contact|1|||
164519927|NCT01417104|594273447|FG000|Overall Study|Adverse Event|1|||
164519928|NCT01417104|594273448|FG001|Overall Study|Adverse Event|0|||
164519929|NCT03223662|594273449|FG000|Overall Study|Physician Decision|1|||
164519930|NCT03223662|594273449|FG000|Overall Study|Study closure|1|||
164519931|NCT00528931|594273450|FG000|Overall Study|Lost to Follow-up|1|||
164519932|NCT00992225|594273451|FG000|Overall Study|Entry Criteria Not Met|8|||
164519933|NCT00992225|594273451|FG000|Overall Study|Adverse Event|2|||
164519934|NCT03122223|594273452|FG000|Overall Study|Withdrawal by Subject|2|||
164519935|NCT03122223|594273453|FG001|Overall Study|Withdrawal by Subject|2|||
164519936|NCT03122223|594273454|FG002|Overall Study|Withdrawal by Subject|1|||
164519937|NCT03122223|594273455|FG003|Overall Study|Withdrawal by Subject|0|||
164519938|NCT03122223|594273452|FG000|Overall Study|Lost to Follow-up|0|||
164519939|NCT03122223|594273453|FG001|Overall Study|Lost to Follow-up|2|||
164519940|NCT03122223|594273454|FG002|Overall Study|Lost to Follow-up|2|||
164519941|NCT03122223|594273455|FG003|Overall Study|Lost to Follow-up|0|||
164519942|NCT03122223|594273452|FG000|Overall Study|Participant unable to adhere|1|||
164519943|NCT03122223|594273453|FG001|Overall Study|Participant unable to adhere|1|||
164519944|NCT03122223|594273454|FG002|Overall Study|Participant unable to adhere|1|||
164519945|NCT03122223|594273455|FG003|Overall Study|Participant unable to adhere|0|||
164616960|NCT02417064|594618961|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
164616961|NCT02417064|594618962|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
164616962|NCT02417064|594618960|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
164616963|NCT02417064|594618961|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
164616964|NCT02417064|594618962|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
164616965|NCT02417064|594618960|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
164616966|NCT02417064|594618961|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
164616967|NCT02417064|594618962|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
164616968|NCT02417064|594618960|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
164616969|NCT02417064|594618961|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
164616970|NCT02417064|594618962|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
164616971|NCT02417064|594618960|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
164616972|NCT02417064|594618961|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
164616973|NCT02417064|594618962|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
164616974|NCT02417064|594618960|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
164616975|NCT02417064|594618961|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
164616976|NCT02417064|594618962|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
164616977|NCT02417064|594618960|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
164616978|NCT02417064|594618961|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
164616979|NCT02417064|594618962|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
164616980|NCT02417064|594618960|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
164616981|NCT02417064|594618961|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
164616982|NCT02417064|594618962|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
164616983|NCT02417064|594618960|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
164616984|NCT02417064|594618961|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
164616985|NCT02417064|594618962|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
164616986|NCT02417064|594618960|FG000|Follow-up Phase (24 Weeks)|Other|2|||
164616987|NCT02417064|594618961|FG001|Follow-up Phase (24 Weeks)|Other|2|||
164616988|NCT02417064|594618962|FG002|Follow-up Phase (24 Weeks)|Other|3|||
164616989|NCT02437162|594618963|FG000|Overall Study|Protocol Violation|0|||
164616990|NCT02437162|594618964|FG001|Overall Study|Protocol Violation|1|||
164616991|NCT02437162|594618965|FG002|Overall Study|Protocol Violation|0|||
164616992|NCT02437162|594618963|FG000|Overall Study|Randomized but not treated|0|||
164616993|NCT02437162|594618964|FG001|Overall Study|Randomized but not treated|0|||
164616994|NCT02437162|594618965|FG002|Overall Study|Randomized but not treated|1|||
164616995|NCT02437162|594618963|FG000|Overall Study|Study discontinued by Sponsor|93|||
164616996|NCT02437162|594618964|FG001|Overall Study|Study discontinued by Sponsor|98|||
164616997|NCT02437162|594618965|FG002|Overall Study|Study discontinued by Sponsor|97|||
164616998|NCT02437162|594618963|FG000|Overall Study|Withdrawal by Subject|13|||
164616999|NCT02437162|594618964|FG001|Overall Study|Withdrawal by Subject|7|||
164617000|NCT02437162|594618965|FG002|Overall Study|Withdrawal by Subject|9|||
164617001|NCT02437162|594618963|FG000|Overall Study|Adverse Event|0|||
164617002|NCT02437162|594618964|FG001|Overall Study|Adverse Event|1|||
164617003|NCT02437162|594618965|FG002|Overall Study|Adverse Event|0|||
164617004|NCT02437162|594618963|FG000|Overall Study|Lost to Follow-up|1|||
164617005|NCT02437162|594618964|FG001|Overall Study|Lost to Follow-up|0|||
164617006|NCT02437162|594618965|FG002|Overall Study|Lost to Follow-up|1|||
164519946|NCT03466073|594273456|FG000|Overall Study|Death|1|||
164617007|NCT02437162|594618963|FG000|Overall Study|Death|0|||
164617008|NCT02437162|594618964|FG001|Overall Study|Death|1|||
164617009|NCT02437162|594618965|FG002|Overall Study|Death|0|||
164617010|NCT02437162|594618963|FG000|Overall Study|Other|0|||
164617011|NCT02437162|594618964|FG001|Overall Study|Other|0|||
164617012|NCT02437162|594618965|FG002|Overall Study|Other|1|||
164617013|NCT03321526|594618970|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
164147379|NCT05168202|592902027|FG003|Overall Study|Lack of Efficacy|0|||
164519947|NCT03466073|594273457|FG001|Overall Study|Death|0|||
164519948|NCT03466073|594273458|FG002|Overall Study|Death|0|||
164519949|NCT03466073|594273459|FG003|Overall Study|Death|0|||
164519950|NCT03466073|594273460|FG004|Overall Study|Death|0|||
164519951|NCT03466073|594273461|FG005|Overall Study|Death|1|||
164519952|NCT02285153|594273462|FG000|Overall Study|Adverse Event|1|||
164519953|NCT02285153|594273463|FG001|Overall Study|Adverse Event|0|||
164519954|NCT02045875|594273468|FG000|Overall Study|Lost to Follow-up|3|||
164519955|NCT02045875|594273469|FG001|Overall Study|Lost to Follow-up|0|||
164519956|NCT02045875|594273468|FG000|Overall Study|Withdrawal by Subject|4|||
164519957|NCT02045875|594273469|FG001|Overall Study|Withdrawal by Subject|3|||
164519958|NCT03702231|594273472|FG000|Overall Study|Withdrawal by Subject|1|||
164519959|NCT03702231|594273473|FG001|Overall Study|Withdrawal by Subject|0|||
164519960|NCT03702231|594273474|FG002|Overall Study|Withdrawal by Subject|0|||
164519961|NCT03702231|594273472|FG000|Overall Study|Protocol Violation|0|||
164519962|NCT03702231|594273473|FG001|Overall Study|Protocol Violation|0|||
164519963|NCT03702231|594273474|FG002|Overall Study|Protocol Violation|1|||
164519964|NCT03702231|594273472|FG000|Overall Study|Change in CLL Treatment|0|||
164519965|NCT03702231|594273473|FG001|Overall Study|Change in CLL Treatment|0|||
164519966|NCT03702231|594273474|FG002|Overall Study|Change in CLL Treatment|1|||
164519967|NCT03702231|594273472|FG000|Overall Study|COVID Pandemic|1|||
164519968|NCT03702231|594273473|FG001|Overall Study|COVID Pandemic|4|||
164519969|NCT03702231|594273474|FG002|Overall Study|COVID Pandemic|1|||
164519970|NCT03702231|594273472|FG000|Overall Study|Non-compliance|0|||
164519971|NCT03702231|594273473|FG001|Overall Study|Non-compliance|0|||
164519972|NCT03702231|594273474|FG002|Overall Study|Non-compliance|1|||
164519973|NCT01276379|594273475|FG000|Overall Study|Screening failure|40|||
164519974|NCT01278173|594273476|FG000|Overall Study|Lack of Efficacy|13|||
164519975|NCT01278173|594273476|FG000|Overall Study|Adverse Event|8|||
164519976|NCT01278173|594273476|FG000|Overall Study|Administrative or other reason|4|||
164519977|NCT01278173|594273476|FG000|Overall Study|Protocol Violation|1|||
164519978|NCT01278173|594273476|FG000|Overall Study|Withdrawal by Subject|1|||
164519979|NCT02270515|594273477|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
164519980|NCT02270515|594273477|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
164519981|NCT02270515|594273477|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
164519982|NCT02270515|594273477|FG000|Intervention Period 1: 0-6 Months|Death|7|||
164519983|NCT02270515|594273477|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
164519984|NCT02270515|594273477|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
164519985|NCT02270515|594273477|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
164519986|NCT02270515|594273477|FG000|Intervention Period 2: 6-12 Months|Death|5|||
164519987|NCT02270515|594273477|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
164519988|NCT02270515|594273477|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
164519989|NCT02270515|594273477|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
164519990|NCT02270515|594273477|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
164519991|NCT02270515|594273477|FG000|Intervention Period 3: 12-18 Months|Death|3|||
164519992|NCT02270515|594273477|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
164519993|NCT02729831|594273479|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
164519994|NCT02729831|594273480|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
164519995|NCT02729831|594273481|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
164519996|NCT02729831|594273482|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
164519997|NCT02729831|594273479|FG000|1 Week Post-visit|Lost to Follow-up|43|||
164519998|NCT02729831|594273480|FG001|1 Week Post-visit|Lost to Follow-up|40|||
164519999|NCT02729831|594273481|FG002|1 Week Post-visit|Lost to Follow-up|38|||
164520000|NCT02729831|594273482|FG003|1 Week Post-visit|Lost to Follow-up|36|||
164520001|NCT02729831|594273479|FG000|6 Month Follow-up|Lost to Follow-up|54|||
164520002|NCT02729831|594273480|FG001|6 Month Follow-up|Lost to Follow-up|51|||
164520003|NCT02729831|594273481|FG002|6 Month Follow-up|Lost to Follow-up|48|||
164520004|NCT02729831|594273482|FG003|6 Month Follow-up|Lost to Follow-up|42|||
164520005|NCT02729831|594273479|FG000|6 Month Follow-up|Death|1|||
164520006|NCT02729831|594273480|FG001|6 Month Follow-up|Death|3|||
164520007|NCT02729831|594273481|FG002|6 Month Follow-up|Death|0|||
164520008|NCT02729831|594273482|FG003|6 Month Follow-up|Death|1|||
164520009|NCT00864253|594273483|FG000|Overall Study|Adverse Event|56|||
164520010|NCT00864253|594273484|FG001|Overall Study|Adverse Event|11|||
164520011|NCT00864253|594273483|FG000|Overall Study|Unrelated Adverse Event|3|||
164520012|NCT00864253|594273484|FG001|Overall Study|Unrelated Adverse Event|1|||
164520013|NCT00864253|594273483|FG000|Overall Study|Physician Decision|11|||
164520014|NCT00864253|594273484|FG001|Overall Study|Physician Decision|15|||
164520015|NCT00864253|594273483|FG000|Overall Study|Protocol Violation|0|||
164520016|NCT00864253|594273484|FG001|Overall Study|Protocol Violation|2|||
164520017|NCT00864253|594273483|FG000|Overall Study|Lost to Follow-up|1|||
164520018|NCT00864253|594273484|FG001|Overall Study|Lost to Follow-up|1|||
164520019|NCT00864253|594273483|FG000|Overall Study|Withdrawal by Subject|18|||
164520020|NCT00864253|594273484|FG001|Overall Study|Withdrawal by Subject|18|||
164520021|NCT00864253|594273483|FG000|Overall Study|Death|1|||
164520022|NCT00864253|594273484|FG001|Overall Study|Death|0|||
164520023|NCT00864253|594273483|FG000|Overall Study|Ongoing|2|||
164520024|NCT00864253|594273484|FG001|Overall Study|Ongoing|3|||
164520025|NCT00864253|594273483|FG000|Overall Study|Untreated|7|||
164520026|NCT00864253|594273484|FG001|Overall Study|Untreated|7|||
164520027|NCT01111240|594273486|FG000|Overall Study|Adverse Event|190|||
164520028|NCT01111240|594273486|FG000|Overall Study|Lack of Efficacy|545|||
164520029|NCT01111240|594273486|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
164520030|NCT01111240|594273486|FG000|Overall Study|Other|312|||
164520031|NCT01747551|594273488|FG000|Overall Study|Progressive Disease|24|||
164520032|NCT01747551|594273489|FG001|Overall Study|Progressive Disease|17|||
164520033|NCT01747551|594273488|FG000|Overall Study|Death|3|||
164520034|NCT01747551|594273489|FG001|Overall Study|Death|1|||
164520035|NCT01747551|594273488|FG000|Overall Study|Adverse Event|7|||
164520036|NCT01747551|594273489|FG001|Overall Study|Adverse Event|1|||
164520037|NCT01747551|594273488|FG000|Overall Study|Prolonged Treatment Delay|2|||
164520038|NCT01747551|594273489|FG001|Overall Study|Prolonged Treatment Delay|0|||
164520039|NCT01747551|594273488|FG000|Overall Study|Withdrawal by Subject|3|||
164520040|NCT01747551|594273489|FG001|Overall Study|Withdrawal by Subject|1|||
164520041|NCT01747551|594273488|FG000|Overall Study|Physician Decision|2|||
164520042|NCT01747551|594273489|FG001|Overall Study|Physician Decision|1|||
164520043|NCT01747551|594273488|FG000|Overall Study|Other|2|||
164520044|NCT01747551|594273489|FG001|Overall Study|Other|0|||
164520045|NCT01607476|594273490|FG000|Overall Study|Withdrawal by Subject|1|||
164520046|NCT01607476|594273491|FG001|Overall Study|Withdrawal by Subject|0|||
164520047|NCT01607476|594273492|FG002|Overall Study|Withdrawal by Subject|1|||
164520048|NCT01607476|594273490|FG000|Overall Study|Lost to Follow-up|0|||
164520049|NCT01607476|594273491|FG001|Overall Study|Lost to Follow-up|0|||
164520050|NCT01607476|594273492|FG002|Overall Study|Lost to Follow-up|2|||
164520051|NCT02091206|594273493|FG000|Treatment Period|Adverse Event|0|||
164520052|NCT02091206|594273494|FG001|Treatment Period|Adverse Event|1|||
164520053|NCT02091206|594273495|FG002|Treatment Period|Adverse Event|0|||
164520054|NCT02091206|594273496|FG003|Treatment Period|Adverse Event|0|||
164520055|NCT02091206|594273493|FG000|Treatment Period|Met withdrawal criteria|0|||
164520056|NCT02091206|594273494|FG001|Treatment Period|Met withdrawal criteria|0|||
164520057|NCT02091206|594273495|FG002|Treatment Period|Met withdrawal criteria|1|||
164520058|NCT02091206|594273496|FG003|Treatment Period|Met withdrawal criteria|0|||
164520059|NCT02091206|594273493|FG000|Taper Period|Participant refused study drug|1|||
164520060|NCT02091206|594273494|FG001|Taper Period|Participant refused study drug|0|||
164520061|NCT02091206|594273495|FG002|Taper Period|Participant refused study drug|0|||
164520062|NCT02091206|594273496|FG003|Taper Period|Participant refused study drug|1|||
164520063|NCT02091206|594273493|FG000|Taper Period|Lost to Follow-up|0|||
164520064|NCT02091206|594273494|FG001|Taper Period|Lost to Follow-up|0|||
164520065|NCT02091206|594273495|FG002|Taper Period|Lost to Follow-up|0|||
164520066|NCT02091206|594273496|FG003|Taper Period|Lost to Follow-up|1|||
164520067|NCT01609062|594273502|FG000|Extension Phase|Terminated by Sponsor|14|||
164520068|NCT01609062|594273503|FG001|Extension Phase|Terminated by Sponsor|9|||
164520069|NCT01609062|594273502|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
164520070|NCT01609062|594273503|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
164520071|NCT01609062|594273502|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
164520072|NCT01609062|594273503|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
164520073|NCT03772587|594273504|FG000|Overall Study|COVID-19|0|||
164520074|NCT03772587|594273505|FG001|Overall Study|COVID-19|0|||
164520075|NCT03772587|594273506|FG002|Overall Study|COVID-19|1|||
164520076|NCT03772587|594273507|FG003|Overall Study|COVID-19|1|||
164520077|NCT03772587|594273508|FG004|Overall Study|COVID-19|0|||
164520078|NCT03772587|594273504|FG000|Overall Study|Withdrawal by Subject|1|||
164520079|NCT03772587|594273505|FG001|Overall Study|Withdrawal by Subject|0|||
164520080|NCT03772587|594273506|FG002|Overall Study|Withdrawal by Subject|0|||
164520081|NCT03772587|594273507|FG003|Overall Study|Withdrawal by Subject|0|||
164520082|NCT03772587|594273508|FG004|Overall Study|Withdrawal by Subject|0|||
164520083|NCT02297139|594273509|FG000|Overall Study|Disease progression|0|||
164520084|NCT02297139|594273510|FG001|Overall Study|Disease progression|1|||
164520085|NCT02297139|594273509|FG000|Overall Study|Study drug toxicity|0|||
164520086|NCT02297139|594273510|FG001|Overall Study|Study drug toxicity|4|||
164520087|NCT02297139|594273509|FG000|Overall Study|Participant request to discontinue study treatment|0|||
164520088|NCT02297139|594273510|FG001|Overall Study|Participant request to discontinue study treatment|1|||
164520089|NCT02297139|594273509|FG000|Overall Study|Maximum clinical benefit|1|||
164520090|NCT02297139|594273510|FG001|Overall Study|Maximum clinical benefit|0|||
164520091|NCT02297139|594273509|FG000|Overall Study|Administrative reason by sponsor|0|||
164520092|NCT02297139|594273510|FG001|Overall Study|Administrative reason by sponsor|2|||
164520093|NCT02297139|594273509|FG000|Overall Study|Other reasons|0|||
164520094|NCT02297139|594273510|FG001|Overall Study|Other reasons|8|||
164520095|NCT05260021|594273520|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
164520096|NCT05260021|594273521|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
164520097|NCT05260021|594273522|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
164520098|NCT05260021|594273520|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
164520099|NCT05260021|594273521|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
164520100|NCT05260021|594273522|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
164520101|NCT05260021|594273520|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
164520102|NCT05260021|594273521|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
164520103|NCT05260021|594273522|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
164520104|NCT05260021|594273520|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
164520105|NCT05260021|594273521|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
164520106|NCT05260021|594273522|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
164520107|NCT05260021|594273520|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
164520108|NCT05260021|594273521|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
164520109|NCT05260021|594273522|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
164520110|NCT03842358|594273523|FG000|Overall Study|Poor DOT probe contact with breast|2|||
164520111|NCT03842358|594273523|FG000|Overall Study|DOT system problem|1|||
164520112|NCT03842358|594273523|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
164520113|NCT03842358|594273523|FG000|Overall Study|No biopsy after physician review|4|||
164520114|NCT03842358|594273523|FG000|Overall Study|Patient withdrew|2|||
164520115|NCT05384938|594273524|FG000|Overall Study|Withdrawal by Subject|8|||
164520116|NCT05384938|594273524|FG000|Overall Study|Lost to Follow-up|6|||
164520117|NCT05384938|594273524|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
164520118|NCT02626455|594273525|FG000|Overall Study|Other|1|||
164520119|NCT02626455|594273526|FG001|Overall Study|Other|1|||
164520120|NCT02626455|594273527|FG002|Overall Study|Other|0|||
164520121|NCT02626455|594273528|FG003|Overall Study|Other|0|||
164520122|NCT02626455|594273529|FG004|Overall Study|Other|0|||
164520123|NCT02626455|594273530|FG005|Overall Study|Other|17|||
164520124|NCT02626455|594273531|FG006|Overall Study|Other|23|||
164520125|NCT02626455|594273525|FG000|Overall Study|Withdrawal by Subject|1|||
164520126|NCT02626455|594273526|FG001|Overall Study|Withdrawal by Subject|0|||
164520127|NCT02626455|594273527|FG002|Overall Study|Withdrawal by Subject|0|||
164520128|NCT02626455|594273528|FG003|Overall Study|Withdrawal by Subject|0|||
164520129|NCT02626455|594273529|FG004|Overall Study|Withdrawal by Subject|0|||
164520130|NCT02626455|594273530|FG005|Overall Study|Withdrawal by Subject|10|||
164520131|NCT02626455|594273531|FG006|Overall Study|Withdrawal by Subject|6|||
164520132|NCT02626455|594273525|FG000|Overall Study|Physician Decision|0|||
164520133|NCT02626455|594273526|FG001|Overall Study|Physician Decision|2|||
164520134|NCT02626455|594273527|FG002|Overall Study|Physician Decision|2|||
164520135|NCT02626455|594273528|FG003|Overall Study|Physician Decision|2|||
164520136|NCT02626455|594273529|FG004|Overall Study|Physician Decision|1|||
164520137|NCT02626455|594273530|FG005|Overall Study|Physician Decision|10|||
164520138|NCT02626455|594273531|FG006|Overall Study|Physician Decision|3|||
164520139|NCT02626455|594273525|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
164520140|NCT02626455|594273526|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
164520141|NCT02626455|594273527|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
164520142|NCT02626455|594273528|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
164520143|NCT02626455|594273529|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
164520144|NCT02626455|594273530|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
164520145|NCT02626455|594273531|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
164520146|NCT02626455|594273525|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
164520147|NCT02626455|594273526|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
164520148|NCT02626455|594273527|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
164520149|NCT02626455|594273528|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
164520150|NCT02626455|594273529|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
164520151|NCT02626455|594273530|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
164520152|NCT02626455|594273531|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
164520153|NCT02626455|594273525|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
164520154|NCT02626455|594273526|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
164520155|NCT02626455|594273527|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
164520156|NCT02626455|594273528|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
164520157|NCT02626455|594273529|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
164520158|NCT02626455|594273530|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
164520159|NCT02626455|594273531|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
164520160|NCT02626455|594273525|FG000|Overall Study|Patient decision|0|||
164520161|NCT02626455|594273526|FG001|Overall Study|Patient decision|1|||
164520162|NCT02626455|594273527|FG002|Overall Study|Patient decision|0|||
164520163|NCT02626455|594273528|FG003|Overall Study|Patient decision|0|||
164520164|NCT02626455|594273529|FG004|Overall Study|Patient decision|1|||
164520165|NCT02626455|594273530|FG005|Overall Study|Patient decision|36|||
164520166|NCT02626455|594273531|FG006|Overall Study|Patient decision|22|||
164520167|NCT02626455|594273525|FG000|Overall Study|Protocol Violation|0|||
164520168|NCT02626455|594273526|FG001|Overall Study|Protocol Violation|0|||
164520169|NCT02626455|594273527|FG002|Overall Study|Protocol Violation|0|||
164520170|NCT02626455|594273528|FG003|Overall Study|Protocol Violation|0|||
164520171|NCT02626455|594273529|FG004|Overall Study|Protocol Violation|0|||
164520172|NCT02626455|594273530|FG005|Overall Study|Protocol Violation|0|||
164520173|NCT02626455|594273531|FG006|Overall Study|Protocol Violation|1|||
164520174|NCT02626455|594273525|FG000|Overall Study|Progressive disease - radiological progression|0|||
164520175|NCT02626455|594273526|FG001|Overall Study|Progressive disease - radiological progression|0|||
164520176|NCT02626455|594273527|FG002|Overall Study|Progressive disease - radiological progression|0|||
164520177|NCT02626455|594273528|FG003|Overall Study|Progressive disease - radiological progression|0|||
164520178|NCT02626455|594273529|FG004|Overall Study|Progressive disease - radiological progression|0|||
164520179|NCT02626455|594273530|FG005|Overall Study|Progressive disease - radiological progression|11|||
164520180|NCT02626455|594273531|FG006|Overall Study|Progressive disease - radiological progression|22|||
164520181|NCT02626455|594273525|FG000|Overall Study|Progressive disease - clinical progression|0|||
164520182|NCT02626455|594273526|FG001|Overall Study|Progressive disease - clinical progression|0|||
164520183|NCT02626455|594273527|FG002|Overall Study|Progressive disease - clinical progression|0|||
164520184|NCT02626455|594273528|FG003|Overall Study|Progressive disease - clinical progression|0|||
164520185|NCT02626455|594273529|FG004|Overall Study|Progressive disease - clinical progression|0|||
164520186|NCT02626455|594273530|FG005|Overall Study|Progressive disease - clinical progression|1|||
164520187|NCT02626455|594273531|FG006|Overall Study|Progressive disease - clinical progression|2|||
164520188|NCT02626455|594273525|FG000|Overall Study|Lost to Follow-up|0|||
164520189|NCT02626455|594273526|FG001|Overall Study|Lost to Follow-up|0|||
164520190|NCT02626455|594273527|FG002|Overall Study|Lost to Follow-up|0|||
164520191|NCT02626455|594273528|FG003|Overall Study|Lost to Follow-up|0|||
164520192|NCT02626455|594273529|FG004|Overall Study|Lost to Follow-up|0|||
164520193|NCT02626455|594273530|FG005|Overall Study|Lost to Follow-up|1|||
164520194|NCT02626455|594273531|FG006|Overall Study|Lost to Follow-up|0|||
164520195|NCT02626455|594273525|FG000|Overall Study|AE not associated with clinical disease progression|1|||
164520196|NCT02626455|594273526|FG001|Overall Study|AE not associated with clinical disease progression|1|||
164520197|NCT02626455|594273527|FG002|Overall Study|AE not associated with clinical disease progression|0|||
164520198|NCT02626455|594273528|FG003|Overall Study|AE not associated with clinical disease progression|2|||
164520199|NCT02626455|594273529|FG004|Overall Study|AE not associated with clinical disease progression|1|||
164520200|NCT02626455|594273530|FG005|Overall Study|AE not associated with clinical disease progression|65|||
164520201|NCT02626455|594273531|FG006|Overall Study|AE not associated with clinical disease progression|21|||
164520202|NCT02626455|594273525|FG000|Overall Study|AE associated with clinical disease progression|0|||
164520203|NCT02626455|594273526|FG001|Overall Study|AE associated with clinical disease progression|0|||
164520204|NCT02626455|594273527|FG002|Overall Study|AE associated with clinical disease progression|0|||
164520205|NCT02626455|594273528|FG003|Overall Study|AE associated with clinical disease progression|0|||
164520206|NCT02626455|594273529|FG004|Overall Study|AE associated with clinical disease progression|0|||
164520207|NCT02626455|594273530|FG005|Overall Study|AE associated with clinical disease progression|1|||
164520208|NCT02626455|594273531|FG006|Overall Study|AE associated with clinical disease progression|2|||
164520209|NCT02626455|594273525|FG000|Overall Study|Study intervention never administered|0|||
164520210|NCT02626455|594273526|FG001|Overall Study|Study intervention never administered|0|||
164520211|NCT02626455|594273527|FG002|Overall Study|Study intervention never administered|0|||
164520212|NCT02626455|594273528|FG003|Overall Study|Study intervention never administered|0|||
164520213|NCT02626455|594273529|FG004|Overall Study|Study intervention never administered|0|||
164520214|NCT02626455|594273530|FG005|Overall Study|Study intervention never administered|1|||
164520215|NCT02626455|594273531|FG006|Overall Study|Study intervention never administered|3|||
164520216|NCT00775463|594275126|FG000|Overall Study|Withdrawal by Subject|0|||
164520217|NCT00775463|594275127|FG001|Overall Study|Withdrawal by Subject|1|||
164520218|NCT00775463|594275126|FG000|Overall Study|Adverse Event|7|||
164617014|NCT03321526|594618971|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
164617015|NCT03321526|594618970|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
164617016|NCT03321526|594618971|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
164520219|NCT00775463|594275127|FG001|Overall Study|Adverse Event|9|||
164520220|NCT00775463|594275126|FG000|Overall Study|Protocol Violation|2|||
164520221|NCT00775463|594275127|FG001|Overall Study|Protocol Violation|2|||
164520222|NCT00775463|594275126|FG000|Overall Study|Lost to Follow-up|1|||
164520223|NCT00775463|594275127|FG001|Overall Study|Lost to Follow-up|0|||
164520224|NCT00775463|594275126|FG000|Overall Study|Lack of Efficacy|1|||
164520225|NCT00775463|594275127|FG001|Overall Study|Lack of Efficacy|1|||
164520226|NCT02980731|594275128|FG000|Overall Study|Death|63|||
164520227|NCT02980731|594275128|FG000|Overall Study|Withdrawal by Subject|6|||
164520228|NCT02980731|594275128|FG000|Overall Study|Lost to Follow-up|5|||
164520229|NCT02980731|594275128|FG000|Overall Study|Study terminated by Sponsor|4|||
164520230|NCT02980731|594275128|FG000|Overall Study|Completed survival follow-up period|65|||
164520231|NCT02980731|594275128|FG000|Overall Study|COVID-19 infection|1|||
164520232|NCT02980731|594275128|FG000|Overall Study|Other, not specified|66|||
164520233|NCT01639495|594275129|FG000|Overall Study|Lost to Follow-up|6|||
164520234|NCT01639495|594275129|FG000|Overall Study|Consented but didn't have study catheter|4|||
164520235|NCT01639495|594275129|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
164520236|NCT01639495|594275129|FG000|Overall Study|No radiofrequency energy applied|2|||
164520237|NCT02366468|594275133|FG000|Overall Study|Adverse Event|2|||
164520238|NCT02366468|594275134|FG001|Overall Study|Adverse Event|0|||
164520239|NCT02366468|594275133|FG000|Overall Study|Withdrawal by Subject|1|||
164520240|NCT02366468|594275134|FG001|Overall Study|Withdrawal by Subject|5|||
164520241|NCT02366468|594275133|FG000|Overall Study|Lost to Follow-up|2|||
164520242|NCT02366468|594275134|FG001|Overall Study|Lost to Follow-up|0|||
164520243|NCT02366468|594275133|FG000|Overall Study|Death|1|||
164520244|NCT02366468|594275134|FG001|Overall Study|Death|2|||
164520245|NCT02366468|594275133|FG000|Overall Study|Other|0|||
164520246|NCT02366468|594275134|FG001|Overall Study|Other|2|||
164520247|NCT03207451|594275137|FG000|Overall Study|scheduling conflict|1|||
164520248|NCT03207451|594275138|FG001|Overall Study|scheduling conflict|0|||
164520249|NCT03207451|594275139|FG002|Overall Study|scheduling conflict|2|||
164520250|NCT03207451|594275140|FG003|Overall Study|scheduling conflict|2|||
164520251|NCT03207451|594275137|FG000|Overall Study|Adverse Event|0|||
164520252|NCT03207451|594275138|FG001|Overall Study|Adverse Event|0|||
164520253|NCT03207451|594275139|FG002|Overall Study|Adverse Event|0|||
164520254|NCT03207451|594275140|FG003|Overall Study|Adverse Event|1|||
164520255|NCT05540717|594275143|FG000|Overall Study|Lost to Follow-up|2|||
164520256|NCT05540717|594275144|FG001|Overall Study|Lost to Follow-up|5|||
164520257|NCT05540717|594275143|FG000|Overall Study|Withdrawal by Subject|6|||
164520258|NCT05540717|594275144|FG001|Overall Study|Withdrawal by Subject|6|||
164520259|NCT05540717|594275143|FG000|Overall Study|Sponsor request|1|||
164520260|NCT05540717|594275144|FG001|Overall Study|Sponsor request|0|||
164520261|NCT05540717|594275143|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
164520262|NCT05540717|594275144|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
164520263|NCT05540717|594275143|FG000|Overall Study|Other|0|||
164520264|NCT05540717|594275144|FG001|Overall Study|Other|1|||
164520265|NCT01144052|594275145|FG000|Overall Study|Withdrawal by Subject|1|||
164520266|NCT01144052|594275146|FG001|Overall Study|Withdrawal by Subject|1|||
164520267|NCT00436852|594275147|FG000|Overall Study|Death|23|||
164520268|NCT00436852|594275148|FG001|Overall Study|Death|34|||
164520269|NCT00436852|594275147|FG000|Overall Study|Lack of Efficacy|9|||
164520270|NCT00436852|594275148|FG001|Overall Study|Lack of Efficacy|7|||
164520271|NCT00436852|594275147|FG000|Overall Study|Withdrawal by Subject|2|||
164520272|NCT00436852|594275148|FG001|Overall Study|Withdrawal by Subject|4|||
164520273|NCT00436852|594275147|FG000|Overall Study|Ineligible|1|||
164520274|NCT00436852|594275148|FG001|Overall Study|Ineligible|0|||
164520275|NCT00370682|594275152|FG000|Overall Study|Moved from area|0|||
164520276|NCT00370682|594275153|FG001|Overall Study|Moved from area|2|||
164520277|NCT00370682|594275154|FG002|Overall Study|Moved from area|0|||
164520278|NCT00370682|594275152|FG000|Overall Study|Lost to Follow-up|0|||
164520279|NCT00370682|594275153|FG001|Overall Study|Lost to Follow-up|1|||
164617017|NCT03321526|594618970|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
164520280|NCT00370682|594275154|FG002|Overall Study|Lost to Follow-up|1|||
164520281|NCT03167359|594275155|FG000|Overall Study|Physician Decision|1|||
164520282|NCT03167359|594275155|FG000|Overall Study|Lost to Follow-up|1|||
164520283|NCT03339583|594275156|FG000|First Intervention (14 Days)|Adverse Event|1|||
164520284|NCT03339583|594275157|FG001|First Intervention (14 Days)|Adverse Event|0|||
164520285|NCT03339583|594275156|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
164520286|NCT03339583|594275157|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
164520287|NCT03339583|594275156|FG000|Second Intervention (14 Days)|Adverse Event|0|||
164617018|NCT03321526|594618971|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
164520288|NCT03339583|594275157|FG001|Second Intervention (14 Days)|Adverse Event|1|||
164520289|NCT03339583|594275156|FG000|Follow-up (14 Days)|Physician Decision|6|||
164617019|NCT03321526|594618970|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
164617020|NCT03321526|594618971|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
164617021|NCT03321526|594618970|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
164617022|NCT03321526|594618971|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
164617023|NCT03321526|594618970|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
164617024|NCT03321526|594618971|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
164617025|NCT03321526|594618970|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
164617026|NCT03321526|594618971|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
164617027|NCT03321526|594618970|FG000|Follow-up Phase (2 Weeks)|Other|24|||
164617028|NCT03321526|594618971|FG001|Follow-up Phase (2 Weeks)|Other|24|||
164617029|NCT03097133|594618972|FG000|Overall Study|Lost to Follow-up|3|||
164617030|NCT03097133|594618973|FG001|Overall Study|Lost to Follow-up|2|||
164617031|NCT03097133|594618972|FG000|Overall Study|Withdrawal by Subject|2|||
164617032|NCT03097133|594618973|FG001|Overall Study|Withdrawal by Subject|5|||
164617033|NCT03097133|594618972|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
164617034|NCT03097133|594618973|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
164617035|NCT03097133|594618972|FG000|Overall Study|Other|3|||
164617036|NCT03097133|594618973|FG001|Overall Study|Other|2|||
164617037|NCT03097133|594618972|FG000|Overall Study|Adverse Event|1|||
164617038|NCT03097133|594618973|FG001|Overall Study|Adverse Event|0|||
164617039|NCT03605836|594618974|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
164617040|NCT03605836|594618975|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
164617041|NCT03605836|594618976|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
164617042|NCT03605836|594618977|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
164617043|NCT03605836|594618974|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
164617044|NCT03605836|594618975|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
164617045|NCT03605836|594618976|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
164617046|NCT03605836|594618977|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
164617047|NCT03605836|594618974|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
164617048|NCT03605836|594618975|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
164617049|NCT03605836|594618976|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
164617050|NCT03605836|594618977|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
164617051|NCT03605836|594618974|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
164520290|NCT03339583|594275157|FG001|Follow-up (14 Days)|Physician Decision|3|||
164520291|NCT03836716|594275158|FG000|Overall Study|Adverse Event|3|||
164520292|NCT03836716|594275158|FG000|Overall Study|Death|22|||
164520293|NCT03836716|594275158|FG000|Overall Study|Withdrawal by Subject|8|||
164520294|NCT03836716|594275158|FG000|Overall Study|Study terminated by sponsor|87|||
164520295|NCT01879722|594275159|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
164520296|NCT01879722|594275160|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
164617052|NCT03605836|594618975|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
164520297|NCT01879722|594275161|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
164520298|NCT01879722|594275162|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
164520299|NCT01879722|594275163|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
164520300|NCT01879722|594275164|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
164520301|NCT01879722|594275165|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
164520302|NCT01879722|594275166|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
164520303|NCT01879722|594275167|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
164520304|NCT01879722|594275168|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
164520305|NCT01879722|594275159|FG000|Overall Study|Voluntary Withdrawal|0|||
164520306|NCT01879722|594275160|FG001|Overall Study|Voluntary Withdrawal|0|||
164520307|NCT01879722|594275161|FG002|Overall Study|Voluntary Withdrawal|0|||
164520308|NCT01879722|594275162|FG003|Overall Study|Voluntary Withdrawal|0|||
164520309|NCT01879722|594275163|FG004|Overall Study|Voluntary Withdrawal|0|||
164520310|NCT01879722|594275164|FG005|Overall Study|Voluntary Withdrawal|0|||
164520311|NCT01879722|594275165|FG006|Overall Study|Voluntary Withdrawal|0|||
164520312|NCT01879722|594275166|FG007|Overall Study|Voluntary Withdrawal|0|||
164520313|NCT01879722|594275167|FG008|Overall Study|Voluntary Withdrawal|1|||
164520314|NCT01879722|594275168|FG009|Overall Study|Voluntary Withdrawal|0|||
164617053|NCT03605836|594618976|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
164617054|NCT03605836|594618977|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
164617055|NCT03605836|594618974|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
164617056|NCT03605836|594618975|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
164520315|NCT01983254|594275169|FG000|Overall Study|Death|6|||
164520316|NCT01983254|594275170|FG001|Overall Study|Death|6|||
164520317|NCT01983254|594275169|FG000|Overall Study|Lost to Follow-up|17|||
164520318|NCT01983254|594275170|FG001|Overall Study|Lost to Follow-up|16|||
164520319|NCT01983254|594275169|FG000|Overall Study|too ill|11|||
164520320|NCT01983254|594275170|FG001|Overall Study|too ill|8|||
164520321|NCT00037830|594275173|FG000|Overall Study|Adverse Event|2|||
164520322|NCT00037830|594275174|FG001|Overall Study|Adverse Event|0|||
164617057|NCT03605836|594618976|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
164617058|NCT03605836|594618977|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
164617059|NCT03605836|594618974|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
164617060|NCT03605836|594618975|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
164617061|NCT03605836|594618976|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
164617062|NCT03605836|594618977|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
164617063|NCT03605836|594618974|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
164617064|NCT03605836|594618975|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
164617065|NCT03605836|594618976|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
164617066|NCT03605836|594618977|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
164617067|NCT03605836|594618974|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
164617068|NCT03605836|594618975|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
164617069|NCT03605836|594618976|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
164617070|NCT03605836|594618977|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
164617071|NCT03605836|594618974|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
164617072|NCT03605836|594618975|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
164617073|NCT03605836|594618976|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
164617074|NCT03605836|594618977|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
164617075|NCT03605836|594618974|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
164617076|NCT03605836|594618975|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
164617077|NCT03605836|594618976|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
164520323|NCT00037830|594275175|FG002|Overall Study|Adverse Event|0|||
164520324|NCT00037830|594275173|FG000|Overall Study|Withdrawal by Subject|4|||
164520325|NCT00037830|594275174|FG001|Overall Study|Withdrawal by Subject|5|||
164520326|NCT00037830|594275175|FG002|Overall Study|Withdrawal by Subject|1|||
164520327|NCT00037830|594275173|FG000|Overall Study|Protocol Violation|2|||
164520328|NCT00037830|594275174|FG001|Overall Study|Protocol Violation|2|||
164520329|NCT00037830|594275175|FG002|Overall Study|Protocol Violation|0|||
164520330|NCT00037830|594275173|FG000|Overall Study|Unrelated Medical Problem|2|||
164617078|NCT03605836|594618977|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
164617079|NCT03605836|594618974|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
164617080|NCT03605836|594618975|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
164617081|NCT03605836|594618976|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
164617082|NCT03605836|594618977|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
164617083|NCT03605836|594618974|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
164617084|NCT03605836|594618975|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
164617085|NCT03605836|594618976|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
164617086|NCT03605836|594618977|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
164617087|NCT03605836|594618974|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
164617088|NCT03605836|594618975|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
164520331|NCT00037830|594275174|FG001|Overall Study|Unrelated Medical Problem|0|||
164520332|NCT00037830|594275175|FG002|Overall Study|Unrelated Medical Problem|0|||
164520333|NCT02141620|594275176|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
164520334|NCT02141620|594275177|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
164520335|NCT03651622|594275178|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
164520336|NCT03651622|594275179|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
164520337|NCT03651622|594275180|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
164520338|NCT03651622|594275178|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
164520339|NCT03651622|594275179|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
164520340|NCT03651622|594275180|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
164520341|NCT03651622|594275178|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
164520342|NCT03651622|594275179|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
164520343|NCT03651622|594275180|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
164520344|NCT03651622|594275178|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
164520345|NCT03651622|594275179|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
164520346|NCT03651622|594275180|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
164520347|NCT03651622|594275178|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
164520348|NCT03651622|594275179|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
164520349|NCT03651622|594275180|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
164520350|NCT01519089|594275181|FG000|Overall Study|Adverse Event|4|||
164617089|NCT03605836|594618976|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
164617090|NCT03605836|594618977|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
164617091|NCT03605836|594618974|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
164617092|NCT03605836|594618975|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
164617093|NCT03605836|594618976|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
164617094|NCT03605836|594618977|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
164617095|NCT03605836|594618974|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
164617096|NCT03605836|594618975|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
164617097|NCT03605836|594618976|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
164617098|NCT03605836|594618977|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
164617099|NCT03605836|594618974|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
164617100|NCT03605836|594618975|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
164617101|NCT03605836|594618976|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
164617102|NCT03605836|594618977|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
164617103|NCT03605836|594618974|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
164617104|NCT03605836|594618975|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
164520351|NCT01519089|594275182|FG001|Overall Study|Adverse Event|4|||
164520352|NCT01519089|594275181|FG000|Overall Study|Lack of Efficacy|0|||
164520353|NCT01519089|594275182|FG001|Overall Study|Lack of Efficacy|2|||
164520354|NCT01519089|594275181|FG000|Overall Study|Lost to Follow-up|1|||
164520355|NCT01519089|594275182|FG001|Overall Study|Lost to Follow-up|0|||
164520356|NCT01519089|594275181|FG000|Overall Study|Withdrawal by Subject|0|||
164520357|NCT01519089|594275182|FG001|Overall Study|Withdrawal by Subject|2|||
164520358|NCT01519089|594275181|FG000|Overall Study|Other|2|||
164520359|NCT01519089|594275182|FG001|Overall Study|Other|6|||
164520360|NCT01519089|594275181|FG000|Overall Study|Not received study drug|0|||
164520361|NCT01519089|594275182|FG001|Overall Study|Not received study drug|1|||
164520362|NCT00307684|594275183|FG000|Open Label Phase|Lack of Efficacy|0|||
164520363|NCT00307684|594275184|FG001|Open Label Phase|Lack of Efficacy|0|||
164520364|NCT00307684|594275185|FG002|Open Label Phase|Lack of Efficacy|3|||
164520365|NCT00307684|594275183|FG000|Open Label Phase|Adverse Event|0|||
164520366|NCT00307684|594275184|FG001|Open Label Phase|Adverse Event|0|||
164520367|NCT00307684|594275185|FG002|Open Label Phase|Adverse Event|16|||
164520368|NCT00307684|594275183|FG000|Open Label Phase|Withdrawal by Subject|0|||
164520369|NCT00307684|594275184|FG001|Open Label Phase|Withdrawal by Subject|0|||
164520370|NCT00307684|594275185|FG002|Open Label Phase|Withdrawal by Subject|15|||
164520371|NCT00307684|594275183|FG000|Open Label Phase|Lost to Follow-up|0|||
164520372|NCT00307684|594275184|FG001|Open Label Phase|Lost to Follow-up|0|||
164520373|NCT00307684|594275185|FG002|Open Label Phase|Lost to Follow-up|11|||
164520374|NCT00307684|594275183|FG000|Open Label Phase|non compliance|0|||
164520375|NCT00307684|594275184|FG001|Open Label Phase|non compliance|0|||
164520376|NCT00307684|594275185|FG002|Open Label Phase|non compliance|5|||
164520377|NCT00307684|594275183|FG000|Open Label Phase|other|0|||
164520378|NCT00307684|594275184|FG001|Open Label Phase|other|0|||
164520379|NCT00307684|594275185|FG002|Open Label Phase|other|6|||
164520380|NCT00307684|594275183|FG000|Double Blind Phase|Lack of Efficacy|2|||
164520381|NCT00307684|594275184|FG001|Double Blind Phase|Lack of Efficacy|5|||
164520382|NCT00307684|594275185|FG002|Double Blind Phase|Lack of Efficacy|0|||
164520383|NCT03582943|594275188|FG000|Allocated to Groups|Withdrawal by Subject|1|||
164520384|NCT03582943|594275189|FG001|Allocated to Groups|Withdrawal by Subject|1|||
164520385|NCT03582943|594275188|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
164520386|NCT03582943|594275189|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
164520387|NCT03582943|594275188|FG000|Analyzed|Protocol Violation|4|||
164520388|NCT03582943|594275189|FG001|Analyzed|Protocol Violation|1|||
164520389|NCT01631227|594275192|FG000|Overall Study|withdrawn consent|27|||
164520390|NCT01631227|594275193|FG001|Overall Study|withdrawn consent|21|||
164520391|NCT01631227|594275192|FG000|Overall Study|Adverse Event|1|||
164520392|NCT01631227|594275193|FG001|Overall Study|Adverse Event|0|||
164520393|NCT01631227|594275192|FG000|Overall Study|administrative|2|||
164520394|NCT01631227|594275193|FG001|Overall Study|administrative|1|||
164520395|NCT01153321|594275194|FG000|Overall Study|Development of study withdrawal criteria|0|||
164520396|NCT01153321|594275195|FG001|Overall Study|Development of study withdrawal criteria|1|||
164520397|NCT01153321|594275194|FG000|Overall Study|Withdrawal by Subject|0|||
164520398|NCT01153321|594275195|FG001|Overall Study|Withdrawal by Subject|1|||
164520399|NCT01153321|594275194|FG000|Overall Study|Adverse Event|1|||
164520400|NCT01153321|594275195|FG001|Overall Study|Adverse Event|1|||
164520401|NCT01177800|594275197|FG000|Overall Study|Adverse Event|9|||
164520402|NCT01177800|594275198|FG001|Overall Study|Adverse Event|3|||
164520403|NCT01177800|594275197|FG000|Overall Study|Protocol Violation|0|||
164520404|NCT01177800|594275198|FG001|Overall Study|Protocol Violation|1|||
164520405|NCT01177800|594275197|FG000|Overall Study|Physician Decision|1|||
164520406|NCT01177800|594275198|FG001|Overall Study|Physician Decision|0|||
164520407|NCT01177800|594275197|FG000|Overall Study|Withdrawal of informed consent|0|||
164520408|NCT01177800|594275198|FG001|Overall Study|Withdrawal of informed consent|1|||
164520409|NCT00356408|594275199|FG000|Overall Study|Adverse Event|9|||
164520410|NCT00356408|594275199|FG000|Overall Study|Lack of Efficacy|36|||
164520411|NCT00356408|594275199|FG000|Overall Study|Lost to Follow-up|2|||
164520412|NCT00356408|594275199|FG000|Overall Study|Withdrawal by Subject|6|||
164520413|NCT00356408|594275199|FG000|Overall Study|Other: Principal investigator discretion|3|||
164520414|NCT00356408|594275199|FG000|Overall Study|Other: Sponsor request|1|||
164520415|NCT00356408|594275199|FG000|Overall Study|Other: Azathioprine stopped|1|||
164520416|NCT00356408|594275199|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
164520417|NCT00356408|594275199|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
164520418|NCT03527550|594275200|FG000|Overall Study|Lost to Follow-up|4|||
164520419|NCT03527550|594275201|FG001|Overall Study|Lost to Follow-up|2|||
164520420|NCT03527550|594275200|FG000|Overall Study|Withdrawal by Subject|4|||
164520421|NCT03527550|594275201|FG001|Overall Study|Withdrawal by Subject|1|||
164520422|NCT03527550|594275200|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
164520423|NCT03527550|594275201|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
164520424|NCT03053518|594275206|FG000|Overall Study|Withdrawal by Subject|3|||
164520425|NCT03053518|594275206|FG000|Overall Study|Lost to Follow-up|2|||
164520426|NCT03053518|594275206|FG000|Overall Study|Ineligible|5|||
164520427|NCT02683876|594275207|FG000|Overall Study|samples damaged during shipping|2|||
164520428|NCT02683876|594275208|FG001|Overall Study|samples damaged during shipping|0|||
164520429|NCT01232738|594275209|FG000|Overall Study|Death|3|||
164520430|NCT01232738|594275209|FG000|Overall Study|Physician Decision|2|||
164520431|NCT01232738|594275209|FG000|Overall Study|Lost to Follow-up|1|||
164520432|NCT01232738|594275209|FG000|Overall Study|Withdrawal by Subject|2|||
164520433|NCT01232738|594275209|FG000|Overall Study|Adverse Event|5|||
164520434|NCT03231800|594275214|FG000|Overall Study|Lost to Follow-up|0|||
164520435|NCT03231800|594275215|FG001|Overall Study|Lost to Follow-up|2|||
164520436|NCT03231800|594275214|FG000|Overall Study|Protocol Violation|1|||
164520437|NCT03231800|594275215|FG001|Overall Study|Protocol Violation|1|||
164520438|NCT03231800|594275214|FG000|Overall Study|reason not provided|2|||
164520439|NCT03231800|594275215|FG001|Overall Study|reason not provided|0|||
164520440|NCT00488475|594275216|FG000|Overall Study|Other|1754|||
164520441|NCT00400725|594275227|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
164520442|NCT00400725|594275228|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
164520443|NCT00400725|594275229|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
164520444|NCT00400725|594275227|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
164520445|NCT00400725|594275228|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
164520446|NCT00400725|594275229|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
164520447|NCT00400725|594275227|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
164520448|NCT00400725|594275228|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
164520449|NCT00400725|594275229|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
164520450|NCT00400725|594275227|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
164617105|NCT03605836|594618976|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
164617106|NCT03605836|594618977|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
164617107|NCT03605836|594618974|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
164617108|NCT03605836|594618975|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
164617109|NCT03605836|594618976|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
164520451|NCT00400725|594275228|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
164520452|NCT00400725|594275229|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
164520453|NCT00400725|594275227|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
164520454|NCT00400725|594275228|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
164520455|NCT00400725|594275229|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
164520456|NCT00400725|594275227|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
164520457|NCT00400725|594275228|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
164520458|NCT00400725|594275229|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
164520459|NCT00400725|594275227|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
164520460|NCT00400725|594275228|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
164520461|NCT00400725|594275229|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
164520462|NCT00400725|594275227|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
164520463|NCT00400725|594275228|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
164617110|NCT03605836|594618977|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
164617111|NCT03605836|594618974|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
164617112|NCT03605836|594618975|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
164617113|NCT03605836|594618976|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
164617114|NCT03605836|594618977|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
164617115|NCT03605836|594618974|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
164617116|NCT03605836|594618975|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
164617117|NCT03605836|594618976|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
164617118|NCT03605836|594618977|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
164617119|NCT03605836|594618974|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
164617120|NCT03605836|594618975|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
164617121|NCT03605836|594618976|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
164617122|NCT03605836|594618977|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
164617123|NCT03605836|594618974|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
164617124|NCT03605836|594618975|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
164617125|NCT03605836|594618976|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
164617126|NCT03605836|594618977|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
164617127|NCT00633360|594618981|FG000|Overall Study|Lost to Follow-up|1|||
164617128|NCT00633360|594618982|FG001|Overall Study|Lost to Follow-up|1|||
164617129|NCT00633360|594618981|FG000|Overall Study|Adverse Event|3|||
164617130|NCT00633360|594618982|FG001|Overall Study|Adverse Event|1|||
164617131|NCT00633360|594618981|FG000|Overall Study|Protocol Violation|0|||
164617132|NCT00633360|594618982|FG001|Overall Study|Protocol Violation|1|||
164617133|NCT00610207|594618983|FG000|Overall Study|Lost to Follow-up|3|||
164617134|NCT02348840|594618987|FG000|Overall Study|Withdrawal by Subject|2|||
164617135|NCT02348840|594618988|FG001|Overall Study|Withdrawal by Subject|1|||
164617136|NCT02348840|594618989|FG002|Overall Study|Withdrawal by Subject|0|||
164617137|NCT02348840|594618990|FG003|Overall Study|Withdrawal by Subject|0|||
164617138|NCT01025232|594618991|FG000|Overall Study|Study drug no longer available|3|||
164617139|NCT01025232|594618992|FG001|Overall Study|Study drug no longer available|6|||
164617140|NCT03748420|594618995|FG000|Overall Study|No 12 month medication adherence data available|0|||
164617141|NCT03748420|594618996|FG001|Overall Study|No 12 month medication adherence data available|1|||
164617142|NCT03748420|594618995|FG000|Overall Study|Death|24|||
164617143|NCT03748420|594618996|FG001|Overall Study|Death|28|||
164617144|NCT03748420|594618995|FG000|Overall Study|Lost to Follow-up|231|||
164617145|NCT03748420|594618996|FG001|Overall Study|Lost to Follow-up|230|||
164617146|NCT00373880|594618997|FG000|Overall Study|Physician Decision|3|||
164617147|NCT00373880|594618997|FG000|Overall Study|Arrested|1|||
164617148|NCT00373880|594618997|FG000|Overall Study|Protocol Violation|14|||
164617149|NCT01347073|594618998|FG000|Overall Study|Adverse Event|1|||
164617150|NCT01347073|594618998|FG000|Overall Study|Liver Transplant|1|||
164617151|NCT00621244|594619000|FG000|Overall Study|Withdrawal by Subject|7|||
164617152|NCT00621244|594619001|FG001|Overall Study|Withdrawal by Subject|3|||
164617153|NCT00621244|594619002|FG002|Overall Study|Withdrawal by Subject|3|||
164520464|NCT00400725|594275229|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
164520465|NCT00400725|594275227|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
164617154|NCT00621244|594619003|FG003|Overall Study|Withdrawal by Subject|3|||
164617155|NCT00621244|594619000|FG000|Overall Study|Disease progression|44|||
164617156|NCT00621244|594619001|FG001|Overall Study|Disease progression|20|||
164617157|NCT00621244|594619002|FG002|Overall Study|Disease progression|20|||
164617158|NCT00621244|594619003|FG003|Overall Study|Disease progression|15|||
164617159|NCT00621244|594619000|FG000|Overall Study|Death|3|||
164617160|NCT00621244|594619001|FG001|Overall Study|Death|3|||
164617161|NCT00621244|594619002|FG002|Overall Study|Death|1|||
164617162|NCT00621244|594619003|FG003|Overall Study|Death|1|||
164617163|NCT00621244|594619000|FG000|Overall Study|Adverse Event|27|||
164617164|NCT00621244|594619001|FG001|Overall Study|Adverse Event|7|||
164617165|NCT00621244|594619002|FG002|Overall Study|Adverse Event|9|||
164520466|NCT00400725|594275228|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
164617166|NCT00621244|594619003|FG003|Overall Study|Adverse Event|2|||
164617167|NCT00621244|594619000|FG000|Overall Study|Administrative problems|5|||
164617168|NCT00621244|594619001|FG001|Overall Study|Administrative problems|1|||
164617169|NCT00621244|594619002|FG002|Overall Study|Administrative problems|0|||
164617170|NCT00621244|594619003|FG003|Overall Study|Administrative problems|2|||
164617171|NCT00312728|594619008|FG000|Overall Study|Progressive disease|53|||
164617172|NCT00312728|594619008|FG000|Overall Study|Adverse Event|32|||
164617173|NCT00312728|594619008|FG000|Overall Study|Withdrawal by Subject|10|||
164617174|NCT00312728|594619008|FG000|Overall Study|Required non-protocol cancer treatment|2|||
164617175|NCT00312728|594619008|FG000|Overall Study|Protocol Violation|2|||
164617176|NCT00312728|594619008|FG000|Overall Study|Other|10|||
164617177|NCT00312728|594619008|FG000|Overall Study|Other|1|||
164617178|NCT01634100|594619009|FG000|Overall Study|Withdrawal by Subject|1|||
164617179|NCT01634100|594619010|FG001|Overall Study|Withdrawal by Subject|0|||
164617180|NCT01634100|594619011|FG002|Overall Study|Withdrawal by Subject|1|||
164617181|NCT01634100|594619012|FG003|Overall Study|Withdrawal by Subject|0|||
164617182|NCT01634100|594619013|FG004|Overall Study|Withdrawal by Subject|0|||
164617183|NCT01634100|594619014|FG005|Overall Study|Withdrawal by Subject|0|||
164617184|NCT00338806|594619015|FG000|Acute Phase|Withdrawal by Subject|0|||
164617185|NCT00338806|594619016|FG001|Acute Phase|Withdrawal by Subject|1|||
164617186|NCT00338806|594619015|FG000|Follow-up|Lost to Follow-up|1|||
164617187|NCT00338806|594619016|FG001|Follow-up|Lost to Follow-up|3|||
164617188|NCT02358863|594621210|FG000|Overall Study|Physician Decision|3|||
164617189|NCT00098865|594621211|FG000|Overall Study|Progressive Disease|6|||
164617190|NCT00098865|594621211|FG000|Overall Study|Adverse Event|2|||
164617191|NCT00098865|594621211|FG000|Overall Study|Alternative Therapy|1|||
164617192|NCT05426460|594621218|FG000|Overall Study|Protocol Violation|1|||
164617193|NCT05426460|594621219|FG001|Overall Study|Protocol Violation|1|||
164617194|NCT05426460|594621220|FG002|Overall Study|Protocol Violation|1|||
164617195|NCT05426460|594621221|FG003|Overall Study|Protocol Violation|0|||
164617196|NCT00653068|594621222|FG000|Overall Study|Death|9|||
164617197|NCT00653068|594621222|FG000|Overall Study|Lack of Efficacy|34|||
164617198|NCT00653068|594621222|FG000|Overall Study|Physician Decision|4|||
164617199|NCT00653068|594621222|FG000|Overall Study|Withdrawal by Subject|1|||
164617200|NCT00653068|594621222|FG000|Overall Study|Ineligible|2|||
164617201|NCT02204410|594621223|FG000|Overall Study|Lost to Follow-up|5|||
164617202|NCT02204410|594621223|FG000|Overall Study|Physician Decision|2|||
164617203|NCT02204410|594621223|FG000|Overall Study|Protocol Violation|1|||
164617204|NCT02204410|594621223|FG000|Overall Study|Withdrawal by Subject|3|||
164617205|NCT01405027|594621226|FG000|Overall Study|Withdrawn consent|3|||
164617206|NCT01405027|594621227|FG001|Overall Study|Withdrawn consent|0|||
164617207|NCT01405027|594621226|FG000|Overall Study|Lost to Follow-up|16|||
164617208|NCT01405027|594621227|FG001|Overall Study|Lost to Follow-up|24|||
164617209|NCT01405027|594621226|FG000|Overall Study|Investigator judgement|0|||
164617210|NCT01405027|594621227|FG001|Overall Study|Investigator judgement|2|||
164617211|NCT01405027|594621226|FG000|Overall Study|Death|1|||
164617212|NCT01405027|594621227|FG001|Overall Study|Death|0|||
164617213|NCT01405027|594621226|FG000|Overall Study|Other or Unknown|12|||
164617214|NCT01405027|594621227|FG001|Overall Study|Other or Unknown|25|||
164617215|NCT02234050|594621236|FG000|Overall Study|Lack of Efficacy|38|||
164617216|NCT02234050|594621237|FG001|Overall Study|Lack of Efficacy|22|||
164617217|NCT02234050|594621236|FG000|Overall Study|Adverse Event|13|||
164617218|NCT02234050|594621237|FG001|Overall Study|Adverse Event|1|||
164617219|NCT02234050|594621236|FG000|Overall Study|Withdrawal by Subject|4|||
164617220|NCT02234050|594621237|FG001|Overall Study|Withdrawal by Subject|2|||
164617221|NCT02234050|594621236|FG000|Overall Study|Sponsor's decision|6|||
164617222|NCT02234050|594621237|FG001|Overall Study|Sponsor's decision|0|||
164617223|NCT04097028|594621239|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
164617224|NCT04097028|594621239|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
164617225|NCT04097028|594621239|FG000|Overall Study|Disease Progression prior to Surgery|2|||
164617226|NCT04097028|594621239|FG000|Overall Study|Adverse Event prior to Surgery|1|||
164617227|NCT02473289|594621240|FG000|Overall Study|Adverse Event|2|||
164617228|NCT02473289|594621241|FG001|Overall Study|Adverse Event|3|||
164617229|NCT02473289|594621240|FG000|Overall Study|Lost to Follow-up|1|||
164617230|NCT02473289|594621241|FG001|Overall Study|Lost to Follow-up|1|||
164617231|NCT02473289|594621240|FG000|Overall Study|Protocol Violation|0|||
164617232|NCT02473289|594621241|FG001|Overall Study|Protocol Violation|1|||
164617233|NCT02473289|594621240|FG000|Overall Study|Withdrawal of consent|6|||
164617234|NCT02473289|594621241|FG001|Overall Study|Withdrawal of consent|7|||
164617235|NCT02473289|594621240|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
164617236|NCT02473289|594621241|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
164617237|NCT02473289|594621240|FG000|Overall Study|Other|2|||
164617238|NCT02473289|594621241|FG001|Overall Study|Other|0|||
164617239|NCT02728206|594621242|FG000|Overall Study|Death|1|||
164617240|NCT03689972|594621244|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
164617241|NCT03689972|594621245|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
164617242|NCT03689972|594621246|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
164617243|NCT03689972|594621247|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
164617244|NCT03689972|594621248|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
164617245|NCT03689972|594621244|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
164617246|NCT03689972|594621245|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
164617247|NCT03689972|594621246|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
164520467|NCT00400725|594275229|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
164520468|NCT00252577|594275231|FG000|Overall Study|Lost to Follow-up|20|||
164520469|NCT00560066|594275232|FG000|Overall Study|Death|2|||
164520470|NCT00560066|594275233|FG001|Overall Study|Death|1|||
164520471|NCT00560066|594275232|FG000|Overall Study|Withdrawal by Subject|0|||
164520472|NCT00560066|594275233|FG001|Overall Study|Withdrawal by Subject|3|||
164520473|NCT00560066|594275232|FG000|Overall Study|Lost to Follow-up|4|||
164617248|NCT03689972|594621247|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
164617249|NCT03689972|594621248|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
164617250|NCT03689972|594621244|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
164617251|NCT03689972|594621245|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
164617252|NCT03689972|594621246|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
164617253|NCT03689972|594621247|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
164617254|NCT03689972|594621248|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
164617255|NCT03689972|594621244|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
164617256|NCT03689972|594621245|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
164617257|NCT03689972|594621246|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
164617258|NCT03689972|594621247|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
164617259|NCT03689972|594621248|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
164617260|NCT03689972|594621244|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
164617261|NCT03689972|594621245|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
164617262|NCT03689972|594621246|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
164617263|NCT03689972|594621247|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
164617264|NCT03689972|594621248|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
164617265|NCT03689972|594621244|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
164617266|NCT03689972|594621245|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
164617267|NCT03689972|594621246|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
164617268|NCT03689972|594621247|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
164617269|NCT03689972|594621248|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
164617270|NCT03689972|594621244|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
164617271|NCT03689972|594621245|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
164617272|NCT03689972|594621246|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
164617273|NCT03689972|594621247|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
164617274|NCT03689972|594621248|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
164617275|NCT03689972|594621244|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
164617276|NCT03689972|594621245|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
164617277|NCT03689972|594621246|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
164617278|NCT03689972|594621247|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
164617279|NCT03689972|594621248|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
164617280|NCT03689972|594621244|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
164617281|NCT03689972|594621245|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
164617282|NCT03689972|594621246|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
164617283|NCT03689972|594621247|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
164617284|NCT03689972|594621248|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
164617285|NCT03689972|594621244|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
164617286|NCT03689972|594621245|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
164617287|NCT03689972|594621246|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
164617288|NCT03689972|594621247|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
164617289|NCT03689972|594621248|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
164617290|NCT03689972|594621244|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
164617291|NCT03689972|594621245|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
164617292|NCT03689972|594621246|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
164617293|NCT03689972|594621247|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
164520474|NCT00560066|594275233|FG001|Overall Study|Lost to Follow-up|10|||
164520475|NCT00560066|594275232|FG000|Overall Study|Protocol Violation|0|||
164520476|NCT00560066|594275233|FG001|Overall Study|Protocol Violation|1|||
164617294|NCT03689972|594621248|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
164617295|NCT03689972|594621244|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
164617296|NCT03689972|594621245|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
164617297|NCT03689972|594621246|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
164617298|NCT03689972|594621247|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
164617299|NCT03689972|594621248|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
164617300|NCT03689972|594621244|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
164617301|NCT03689972|594621245|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
164520477|NCT00560066|594275232|FG000|Overall Study|Administrative reason|0|||
164520478|NCT00560066|594275233|FG001|Overall Study|Administrative reason|5|||
164520479|NCT00560066|594275232|FG000|Overall Study|Missing primary reason|0|||
164520480|NCT00560066|594275233|FG001|Overall Study|Missing primary reason|2|||
164520481|NCT01163292|594275234|FG000|Overall Study|Lack of Efficacy|9|||
164520482|NCT01163292|594275235|FG001|Overall Study|Lack of Efficacy|0|||
164520483|NCT01163292|594275234|FG000|Overall Study|Adverse Event|6|||
164520484|NCT01163292|594275235|FG001|Overall Study|Adverse Event|0|||
164520485|NCT01163292|594275234|FG000|Overall Study|Initiation of biological therapy|0|||
164520486|NCT01163292|594275235|FG001|Overall Study|Initiation of biological therapy|15|||
164520487|NCT01163292|594275234|FG000|Overall Study|Sufficient response to adalimumab|8|||
164520488|NCT01163292|594275235|FG001|Overall Study|Sufficient response to adalimumab|0|||
164520489|NCT01163292|594275234|FG000|Overall Study|Refusal to receive adalimumab|7|||
164520490|NCT01163292|594275235|FG001|Overall Study|Refusal to receive adalimumab|0|||
164520491|NCT01163292|594275234|FG000|Overall Study|Economic reasons|6|||
164520492|NCT01163292|594275235|FG001|Overall Study|Economic reasons|0|||
164520493|NCT01163292|594275234|FG000|Overall Study|No further visits|5|||
164520494|NCT01163292|594275235|FG001|Overall Study|No further visits|7|||
164520495|NCT04445987|594275237|FG000|Overall Study|Adverse Event|0|||
164520496|NCT04445987|594275238|FG001|Overall Study|Adverse Event|0|||
164520497|NCT04445987|594275239|FG002|Overall Study|Adverse Event|1|||
164520498|NCT04445987|594275240|FG003|Overall Study|Adverse Event|0|||
164520499|NCT04445987|594275241|FG004|Overall Study|Adverse Event|4|||
164520500|NCT04445987|594275242|FG005|Overall Study|Adverse Event|0|||
164520501|NCT04445987|594275237|FG000|Overall Study|Lost to Follow-up|4|||
164520502|NCT04445987|594275238|FG001|Overall Study|Lost to Follow-up|3|||
164520503|NCT04445987|594275239|FG002|Overall Study|Lost to Follow-up|1|||
164520504|NCT04445987|594275240|FG003|Overall Study|Lost to Follow-up|1|||
164520505|NCT04445987|594275241|FG004|Overall Study|Lost to Follow-up|29|||
164520506|NCT04445987|594275242|FG005|Overall Study|Lost to Follow-up|0|||
164520507|NCT04445987|594275237|FG000|Overall Study|Physician Decision|0|||
164520508|NCT04445987|594275238|FG001|Overall Study|Physician Decision|0|||
164520509|NCT04445987|594275239|FG002|Overall Study|Physician Decision|0|||
164520510|NCT04445987|594275240|FG003|Overall Study|Physician Decision|0|||
164520511|NCT04445987|594275241|FG004|Overall Study|Physician Decision|1|||
164520512|NCT04445987|594275242|FG005|Overall Study|Physician Decision|0|||
164520513|NCT04445987|594275237|FG000|Overall Study|Protocol Violation|1|||
164520514|NCT04445987|594275238|FG001|Overall Study|Protocol Violation|0|||
164520515|NCT04445987|594275239|FG002|Overall Study|Protocol Violation|0|||
164520516|NCT04445987|594275240|FG003|Overall Study|Protocol Violation|0|||
164520517|NCT04445987|594275241|FG004|Overall Study|Protocol Violation|2|||
164520518|NCT04445987|594275242|FG005|Overall Study|Protocol Violation|0|||
164520519|NCT04445987|594275237|FG000|Overall Study|Withdrawal by Subject|4|||
164520520|NCT04445987|594275238|FG001|Overall Study|Withdrawal by Subject|0|||
164520521|NCT04445987|594275239|FG002|Overall Study|Withdrawal by Subject|1|||
164520522|NCT04445987|594275240|FG003|Overall Study|Withdrawal by Subject|0|||
164520523|NCT04445987|594275241|FG004|Overall Study|Withdrawal by Subject|18|||
164520524|NCT04445987|594275242|FG005|Overall Study|Withdrawal by Subject|1|||
164520525|NCT04445987|594275237|FG000|Overall Study|Other reason|0|||
164520526|NCT04445987|594275238|FG001|Overall Study|Other reason|0|||
164520527|NCT04445987|594275239|FG002|Overall Study|Other reason|1|||
164520528|NCT04445987|594275240|FG003|Overall Study|Other reason|0|||
164520529|NCT04445987|594275241|FG004|Overall Study|Other reason|2|||
164520530|NCT04445987|594275242|FG005|Overall Study|Other reason|0|||
164520531|NCT05051462|594275243|FG000|Overall Study|Lost to Follow-up|1|||
164520532|NCT05051462|594275244|FG001|Overall Study|Lost to Follow-up|8|||
164520533|NCT05051462|594275243|FG000|Overall Study|Withdrawal by Subject|1|||
164520534|NCT05051462|594275244|FG001|Overall Study|Withdrawal by Subject|0|||
164520535|NCT05051462|594275243|FG000|Overall Study|Protocol Violation|0|||
164520536|NCT05051462|594275244|FG001|Overall Study|Protocol Violation|2|||
164520537|NCT02425904|594275245|FG000|Overall Study|Lost to Follow-up|1|||
164520538|NCT02425904|594275246|FG001|Overall Study|Lost to Follow-up|0|||
164520539|NCT02425904|594275245|FG000|Overall Study|Withdrawal by Subject|2|||
164520540|NCT02425904|594275246|FG001|Overall Study|Withdrawal by Subject|0|||
164520541|NCT02425904|594275245|FG000|Overall Study|Death|0|||
164520542|NCT02425904|594275246|FG001|Overall Study|Death|3|||
164520543|NCT05597787|594275247|FG000|Overall Study|Withdrawal by Subject|0|||
164520544|NCT05597787|594275248|FG001|Overall Study|Withdrawal by Subject|0|||
164617302|NCT03689972|594621246|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
164520545|NCT05597787|594275249|FG002|Overall Study|Withdrawal by Subject|1|||
164520546|NCT01144377|594275250|FG000|52 Week Treatment Period|Adverse Event|0|||
164520547|NCT01144377|594275251|FG001|52 Week Treatment Period|Adverse Event|0|||
164520548|NCT01144377|594275252|FG002|52 Week Treatment Period|Adverse Event|3|||
164520549|NCT01144377|594275253|FG003|52 Week Treatment Period|Adverse Event|2|||
164520550|NCT01144377|594275254|FG004|52 Week Treatment Period|Adverse Event|1|||
164520551|NCT01144377|594275250|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
164520552|NCT01144377|594275251|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
164520553|NCT01144377|594275252|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
164520554|NCT01144377|594275253|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
164520555|NCT01144377|594275254|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
164520556|NCT01144377|594275250|FG000|52 Week Treatment Period|Protocol Violation|0|||
164520557|NCT01144377|594275251|FG001|52 Week Treatment Period|Protocol Violation|0|||
164520558|NCT01144377|594275252|FG002|52 Week Treatment Period|Protocol Violation|0|||
164520559|NCT01144377|594275253|FG003|52 Week Treatment Period|Protocol Violation|0|||
164520560|NCT01144377|594275254|FG004|52 Week Treatment Period|Protocol Violation|1|||
164520561|NCT01144377|594275250|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
164520562|NCT01144377|594275251|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
164520563|NCT01144377|594275252|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
164520564|NCT01144377|594275253|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
164520565|NCT01144377|594275254|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
164520566|NCT01144377|594275250|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
164520567|NCT01144377|594275251|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
164520568|NCT01144377|594275252|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
164520569|NCT01144377|594275253|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
164520570|NCT01144377|594275254|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
164520571|NCT01144377|594275250|FG000|52 Week Treatment Period|Sponsor Decision|0|||
164520572|NCT01144377|594275251|FG001|52 Week Treatment Period|Sponsor Decision|0|||
164520573|NCT01144377|594275252|FG002|52 Week Treatment Period|Sponsor Decision|0|||
164520574|NCT01144377|594275253|FG003|52 Week Treatment Period|Sponsor Decision|0|||
164520575|NCT01144377|594275254|FG004|52 Week Treatment Period|Sponsor Decision|1|||
164520576|NCT01144377|594275250|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
164520577|NCT01144377|594275251|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
164520578|NCT01144377|594275252|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
164520579|NCT01144377|594275253|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
164520580|NCT01144377|594275254|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
164520581|NCT01144377|594275250|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
164520582|NCT01144377|594275251|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
164520583|NCT01144377|594275252|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
164520584|NCT01144377|594275253|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
164520585|NCT01144377|594275254|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
164520586|NCT01144377|594275250|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
164520587|NCT01144377|594275251|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
164520588|NCT01144377|594275252|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
164520589|NCT01144377|594275253|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
164520590|NCT01144377|594275254|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
164520591|NCT01241604|594275256|FG000|Screening Period|Screen Failure|3|||
164520592|NCT01241604|594275257|FG001|Screening Period|Screen Failure|0|||
164520593|NCT01241604|594275258|FG002|Screening Period|Screen Failure|0|||
164520594|NCT01214642|594275259|FG000|Overall Study|Progressive Disease|3|||
164520595|NCT01214642|594275260|FG001|Overall Study|Progressive Disease|2|||
164520596|NCT01214642|594275261|FG002|Overall Study|Progressive Disease|3|||
164520597|NCT01214642|594275262|FG003|Overall Study|Progressive Disease|5|||
164520598|NCT01214642|594275263|FG004|Overall Study|Progressive Disease|5|||
164520599|NCT01214642|594275264|FG005|Overall Study|Progressive Disease|3|||
164520600|NCT01214642|594275265|FG006|Overall Study|Progressive Disease|5|||
164520601|NCT01214642|594275266|FG007|Overall Study|Progressive Disease|3|||
164520602|NCT01214642|594275267|FG008|Overall Study|Progressive Disease|10|||
164520603|NCT01214642|594275268|FG009|Overall Study|Progressive Disease|2|||
164520604|NCT01214642|594275269|FG010|Overall Study|Progressive Disease|1|||
164520605|NCT01214642|594275270|FG011|Overall Study|Progressive Disease|4|||
164520606|NCT01214642|594275259|FG000|Overall Study|Adverse Event|0|||
164520607|NCT01214642|594275260|FG001|Overall Study|Adverse Event|1|||
164520608|NCT01214642|594275261|FG002|Overall Study|Adverse Event|0|||
164520609|NCT01214642|594275262|FG003|Overall Study|Adverse Event|0|||
164520610|NCT01214642|594275263|FG004|Overall Study|Adverse Event|0|||
164520611|NCT01214642|594275264|FG005|Overall Study|Adverse Event|0|||
164520612|NCT01214642|594275265|FG006|Overall Study|Adverse Event|1|||
164520613|NCT01214642|594275266|FG007|Overall Study|Adverse Event|0|||
164520614|NCT01214642|594275267|FG008|Overall Study|Adverse Event|0|||
164520615|NCT01214642|594275268|FG009|Overall Study|Adverse Event|1|||
164520616|NCT01214642|594275269|FG010|Overall Study|Adverse Event|1|||
164520617|NCT01214642|594275270|FG011|Overall Study|Adverse Event|0|||
164520618|NCT01214642|594275259|FG000|Overall Study|Death|0|||
164520619|NCT01214642|594275260|FG001|Overall Study|Death|0|||
164520620|NCT01214642|594275261|FG002|Overall Study|Death|1|||
164520621|NCT01214642|594275262|FG003|Overall Study|Death|0|||
164520622|NCT01214642|594275263|FG004|Overall Study|Death|0|||
164520623|NCT01214642|594275264|FG005|Overall Study|Death|0|||
164520624|NCT01214642|594275265|FG006|Overall Study|Death|0|||
164520625|NCT01214642|594275266|FG007|Overall Study|Death|0|||
164520626|NCT01214642|594275267|FG008|Overall Study|Death|0|||
164520627|NCT01214642|594275268|FG009|Overall Study|Death|0|||
164520628|NCT01214642|594275269|FG010|Overall Study|Death|1|||
164520629|NCT01214642|594275270|FG011|Overall Study|Death|0|||
164520630|NCT01214642|594275259|FG000|Overall Study|Withdrawal by Subject|0|||
164520631|NCT01214642|594275260|FG001|Overall Study|Withdrawal by Subject|0|||
164520632|NCT01214642|594275261|FG002|Overall Study|Withdrawal by Subject|1|||
164520633|NCT01214642|594275262|FG003|Overall Study|Withdrawal by Subject|0|||
164520634|NCT01214642|594275263|FG004|Overall Study|Withdrawal by Subject|0|||
164520635|NCT01214642|594275264|FG005|Overall Study|Withdrawal by Subject|0|||
164520636|NCT01214642|594275265|FG006|Overall Study|Withdrawal by Subject|0|||
164520637|NCT01214642|594275266|FG007|Overall Study|Withdrawal by Subject|0|||
164520638|NCT01214642|594275267|FG008|Overall Study|Withdrawal by Subject|3|||
164520639|NCT01214642|594275268|FG009|Overall Study|Withdrawal by Subject|1|||
164520640|NCT01214642|594275269|FG010|Overall Study|Withdrawal by Subject|1|||
164520641|NCT01214642|594275270|FG011|Overall Study|Withdrawal by Subject|0|||
164520642|NCT01214642|594275259|FG000|Overall Study|Physician Decision|0|||
164520643|NCT01214642|594275260|FG001|Overall Study|Physician Decision|0|||
164520644|NCT01214642|594275261|FG002|Overall Study|Physician Decision|1|||
164520645|NCT01214642|594275262|FG003|Overall Study|Physician Decision|1|||
164520646|NCT01214642|594275263|FG004|Overall Study|Physician Decision|1|||
164520647|NCT01214642|594275264|FG005|Overall Study|Physician Decision|0|||
164520648|NCT01214642|594275265|FG006|Overall Study|Physician Decision|0|||
164520649|NCT01214642|594275266|FG007|Overall Study|Physician Decision|0|||
164520650|NCT01214642|594275267|FG008|Overall Study|Physician Decision|0|||
164520651|NCT01214642|594275268|FG009|Overall Study|Physician Decision|0|||
164520652|NCT01214642|594275269|FG010|Overall Study|Physician Decision|0|||
164520653|NCT01214642|594275270|FG011|Overall Study|Physician Decision|2|||
164520654|NCT00969709|594276905|FG000|Overall Study|Adverse Event|3|||
164520655|NCT00969709|594276906|FG001|Overall Study|Adverse Event|13|||
164520656|NCT00969709|594276907|FG002|Overall Study|Adverse Event|26|||
164520657|NCT00969709|594276908|FG003|Overall Study|Adverse Event|12|||
164520658|NCT00969709|594276905|FG000|Overall Study|Lack of Efficacy|7|||
164520659|NCT00969709|594276906|FG001|Overall Study|Lack of Efficacy|4|||
164520660|NCT00969709|594276907|FG002|Overall Study|Lack of Efficacy|1|||
164520661|NCT00969709|594276908|FG003|Overall Study|Lack of Efficacy|3|||
164520662|NCT00969709|594276905|FG000|Overall Study|Protocol Violation|9|||
164520663|NCT00969709|594276906|FG001|Overall Study|Protocol Violation|5|||
164520664|NCT00969709|594276907|FG002|Overall Study|Protocol Violation|9|||
164520665|NCT00969709|594276908|FG003|Overall Study|Protocol Violation|10|||
164520666|NCT00969709|594276905|FG000|Overall Study|Withdrawal by Subject|9|||
164520667|NCT00969709|594276906|FG001|Overall Study|Withdrawal by Subject|12|||
164520668|NCT00969709|594276907|FG002|Overall Study|Withdrawal by Subject|11|||
164520669|NCT00969709|594276908|FG003|Overall Study|Withdrawal by Subject|23|||
164520670|NCT00969709|594276905|FG000|Overall Study|Lost to Follow-up|10|||
164520671|NCT00969709|594276906|FG001|Overall Study|Lost to Follow-up|14|||
164520672|NCT00969709|594276907|FG002|Overall Study|Lost to Follow-up|8|||
164520673|NCT00969709|594276908|FG003|Overall Study|Lost to Follow-up|15|||
164520674|NCT00969709|594276905|FG000|Overall Study|Other reasons|0|||
164520675|NCT00969709|594276906|FG001|Overall Study|Other reasons|0|||
164520676|NCT00969709|594276907|FG002|Overall Study|Other reasons|3|||
164520677|NCT00969709|594276908|FG003|Overall Study|Other reasons|0|||
164520678|NCT03695237|594276909|FG000|Overall Study|Withdrawal by Subject|1|||
164520679|NCT03695237|594276910|FG001|Overall Study|Withdrawal by Subject|3|||
164520680|NCT03695237|594276909|FG000|Overall Study|Lost to Follow-up|1|||
164520681|NCT03695237|594276910|FG001|Overall Study|Lost to Follow-up|2|||
164520682|NCT03695237|594276909|FG000|Overall Study|Other, Not Specified|8|||
164520683|NCT03695237|594276910|FG001|Overall Study|Other, Not Specified|2|||
164520684|NCT02516332|594276911|FG000|Overall Study|Withdrawal by Subject|2|||
164520685|NCT02516332|594276912|FG001|Overall Study|Withdrawal by Subject|1|||
164520686|NCT02516332|594276913|FG002|Overall Study|Withdrawal by Subject|2|||
164520687|NCT00055601|594276914|FG000|Overall Study|Protocol Violation|1|||
164520688|NCT00055601|594276915|FG001|Overall Study|Protocol Violation|1|||
164520689|NCT00055601|594276914|FG000|Overall Study|No protocol treatment received|1|||
164617303|NCT03689972|594621247|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
164617304|NCT03689972|594621248|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
164617305|NCT03689972|594621244|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
164617306|NCT03689972|594621245|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
164520690|NCT00055601|594276915|FG001|Overall Study|No protocol treatment received|1|||
164520691|NCT02217332|594276916|FG000|Overall Study|Adverse Event|3|||
164520692|NCT02217332|594276916|FG000|Overall Study|Dose interruption >1 month|1|||
164520693|NCT02217332|594276916|FG000|Overall Study|Protocol Violation (eligibility)|1|||
164520694|NCT02217332|594276916|FG000|Overall Study|Withdrawal by Subject|1|||
164520695|NCT02217332|594276916|FG000|Overall Study|Lost to Follow-up|1|||
164520696|NCT02134977|594276924|FG000|Overall Study|Protocol Deviation|102|||
164520697|NCT03828747|594276925|FG000|Double-Blind Treatment Period|Adverse Event|6|||
164520698|NCT03828747|594276926|FG001|Double-Blind Treatment Period|Adverse Event|6|||
164520699|NCT03828747|594276925|FG000|Double-Blind Treatment Period|Death|1|||
164520700|NCT03828747|594276926|FG001|Double-Blind Treatment Period|Death|1|||
164520701|NCT03828747|594276925|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
164520702|NCT03828747|594276926|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
164520703|NCT03828747|594276925|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
164520704|NCT03828747|594276926|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
164520705|NCT03828747|594276925|FG000|Double-Blind Treatment Period|Physician Decision|1|||
164520706|NCT03828747|594276926|FG001|Double-Blind Treatment Period|Physician Decision|4|||
164520707|NCT03828747|594276925|FG000|Double-Blind Treatment Period|Various reasons|5|||
164520708|NCT03828747|594276926|FG001|Double-Blind Treatment Period|Various reasons|3|||
164520709|NCT03828747|594276925|FG000|Open-Label Extension|Adverse Event|9|||
164520710|NCT03828747|594276926|FG001|Open-Label Extension|Adverse Event|7|||
164520711|NCT03828747|594276925|FG000|Open-Label Extension|Death|0|||
164520712|NCT03828747|594276926|FG001|Open-Label Extension|Death|2|||
164520713|NCT03828747|594276925|FG000|Open-Label Extension|Lost to Follow-up|4|||
164520714|NCT03828747|594276926|FG001|Open-Label Extension|Lost to Follow-up|0|||
164520715|NCT03828747|594276925|FG000|Open-Label Extension|Withdrawal by Subject|31|||
164520716|NCT03828747|594276926|FG001|Open-Label Extension|Withdrawal by Subject|30|||
164520717|NCT03828747|594276925|FG000|Open-Label Extension|Various reasons|4|||
164520718|NCT03828747|594276926|FG001|Open-Label Extension|Various reasons|4|||
164520719|NCT03828747|594276925|FG000|Open-Label Extension|Physician Decision|6|||
164520720|NCT03828747|594276926|FG001|Open-Label Extension|Physician Decision|2|||
164520721|NCT01658150|594276927|FG000|Overall Study|Withdrawal by Subject|1|||
164617307|NCT03689972|594621246|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
164520722|NCT04187989|594276928|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
164520723|NCT04187989|594276929|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
164520724|NCT04187989|594276928|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
164520725|NCT04187989|594276929|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
164520726|NCT03646656|594276930|FG000|Overall Study|Lost to Follow-up|1|||
164520727|NCT03646656|594276931|FG001|Overall Study|Lost to Follow-up|0|||
164520728|NCT03646656|594276930|FG000|Overall Study|Withdrawal by Subject|2|||
164617308|NCT03689972|594621247|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
164520729|NCT03646656|594276931|FG001|Overall Study|Withdrawal by Subject|0|||
164520730|NCT00127205|594276932|FG000|Overall Study|Adverse Event|228|||
164520731|NCT00127205|594276933|FG001|Overall Study|Adverse Event|387|||
164520732|NCT00127205|594276934|FG002|Overall Study|Adverse Event|273|||
164520733|NCT00127205|594276932|FG000|Overall Study|Death|8|||
164520734|NCT00127205|594276933|FG001|Overall Study|Death|6|||
164520735|NCT00127205|594276934|FG002|Overall Study|Death|5|||
164520736|NCT00127205|594276932|FG000|Overall Study|Withdrawal by Subject|318|||
164520737|NCT00127205|594276933|FG001|Overall Study|Withdrawal by Subject|310|||
164520738|NCT00127205|594276934|FG002|Overall Study|Withdrawal by Subject|172|||
164520739|NCT00127205|594276932|FG000|Overall Study|Other-non protocol specified|142|||
164520740|NCT00127205|594276933|FG001|Overall Study|Other-non protocol specified|129|||
164520741|NCT00127205|594276934|FG002|Overall Study|Other-non protocol specified|77|||
164520742|NCT00127205|594276932|FG000|Overall Study|Data not reported|6|||
164520743|NCT00127205|594276933|FG001|Overall Study|Data not reported|10|||
164520744|NCT00127205|594276934|FG002|Overall Study|Data not reported|1|||
164520745|NCT00127205|594276932|FG000|Overall Study|Progression|127|||
164520746|NCT00127205|594276933|FG001|Overall Study|Progression|131|||
164520747|NCT00127205|594276934|FG002|Overall Study|Progression|84|||
164520748|NCT01327495|594276935|FG000|Overall Study|Adverse Event|2|||
164520749|NCT01327495|594276936|FG001|Overall Study|Adverse Event|1|||
164520750|NCT01327495|594276937|FG002|Overall Study|Adverse Event|1|||
164520751|NCT01327495|594276938|FG003|Overall Study|Adverse Event|0|||
164520752|NCT01327495|594276939|FG004|Overall Study|Adverse Event|0|||
164520753|NCT01327495|594276940|FG005|Overall Study|Adverse Event|2|||
164520754|NCT01327495|594276935|FG000|Overall Study|Withdrawal by Subject|0|||
164520755|NCT01327495|594276936|FG001|Overall Study|Withdrawal by Subject|1|||
164520756|NCT01327495|594276937|FG002|Overall Study|Withdrawal by Subject|1|||
164520757|NCT01327495|594276938|FG003|Overall Study|Withdrawal by Subject|0|||
164520758|NCT01327495|594276939|FG004|Overall Study|Withdrawal by Subject|1|||
164520759|NCT01327495|594276940|FG005|Overall Study|Withdrawal by Subject|0|||
164520760|NCT01327495|594276935|FG000|Overall Study|Physician Decision|0|||
164520761|NCT01327495|594276936|FG001|Overall Study|Physician Decision|0|||
164520762|NCT01327495|594276937|FG002|Overall Study|Physician Decision|0|||
164520763|NCT01327495|594276938|FG003|Overall Study|Physician Decision|0|||
164520764|NCT01327495|594276939|FG004|Overall Study|Physician Decision|2|||
164520765|NCT01327495|594276940|FG005|Overall Study|Physician Decision|0|||
164520766|NCT03377699|594276941|FG000|Overall Study|Withdrawal by Subject|2|||
164520767|NCT03377699|594276942|FG001|Overall Study|Withdrawal by Subject|9|||
164520768|NCT03377699|594276941|FG000|Overall Study|Lost to Follow-up|1|||
164520769|NCT03377699|594276942|FG001|Overall Study|Lost to Follow-up|1|||
164520770|NCT03377699|594276941|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
164520771|NCT03377699|594276942|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
164520772|NCT03377699|594276941|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
164520773|NCT03377699|594276942|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
164520774|NCT03377699|594276941|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
164520775|NCT03377699|594276942|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
164520776|NCT03377699|594276941|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
164520777|NCT03377699|594276942|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
164520778|NCT02580305|594276946|FG000|Overall Study|Adverse Event|15|||
164617309|NCT03689972|594621248|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
164617310|NCT03689972|594621244|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
164617311|NCT03689972|594621245|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
164617312|NCT03689972|594621246|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
164520779|NCT02580305|594276947|FG001|Overall Study|Adverse Event|19|||
164520780|NCT02580305|594276948|FG002|Overall Study|Adverse Event|10|||
164520781|NCT02580305|594276946|FG000|Overall Study|Lack of Efficacy|5|||
164520782|NCT02580305|594276947|FG001|Overall Study|Lack of Efficacy|0|||
164520783|NCT02580305|594276948|FG002|Overall Study|Lack of Efficacy|2|||
164520784|NCT02580305|594276946|FG000|Overall Study|Protocol Violation|4|||
164520785|NCT02580305|594276947|FG001|Overall Study|Protocol Violation|9|||
164617313|NCT03689972|594621247|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
164520786|NCT02580305|594276948|FG002|Overall Study|Protocol Violation|6|||
164520787|NCT02580305|594276946|FG000|Overall Study|Lost to Follow-up|4|||
164520788|NCT02580305|594276947|FG001|Overall Study|Lost to Follow-up|4|||
164520789|NCT02580305|594276948|FG002|Overall Study|Lost to Follow-up|2|||
164520790|NCT02580305|594276946|FG000|Overall Study|Withdrawal by Subject|11|||
164520791|NCT02580305|594276947|FG001|Overall Study|Withdrawal by Subject|9|||
164520792|NCT02580305|594276948|FG002|Overall Study|Withdrawal by Subject|7|||
164617314|NCT03689972|594621248|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
164617315|NCT03689972|594621244|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
164617316|NCT03689972|594621245|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
164617317|NCT03689972|594621246|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
164617318|NCT03689972|594621247|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
164617319|NCT03689972|594621248|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
164617320|NCT03689972|594621244|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
164520793|NCT02580305|594276946|FG000|Overall Study|Randomized in error and never treated|4|||
164520794|NCT02580305|594276947|FG001|Overall Study|Randomized in error and never treated|8|||
164520795|NCT02580305|594276948|FG002|Overall Study|Randomized in error and never treated|5|||
164520796|NCT00700427|594276949|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
164520797|NCT00700427|594276950|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
164520798|NCT00700427|594276951|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
164520799|NCT00700427|594276952|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
164520800|NCT00700427|594276953|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
164520801|NCT00700427|594276949|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
164520802|NCT00700427|594276950|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
164520803|NCT00700427|594276951|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
164520804|NCT00700427|594276952|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
164520805|NCT00700427|594276953|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
164520806|NCT00700427|594276949|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
164520807|NCT00700427|594276950|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
164520808|NCT00700427|594276951|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
164520809|NCT00700427|594276952|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
164520810|NCT00700427|594276953|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
164520811|NCT00700427|594276949|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
164520812|NCT00700427|594276950|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
164520813|NCT00700427|594276951|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
164520814|NCT00700427|594276952|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
164520815|NCT00700427|594276953|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
164520816|NCT00700427|594276949|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
164520817|NCT00700427|594276950|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
164520818|NCT00700427|594276951|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
164520819|NCT00700427|594276952|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
164520820|NCT00700427|594276953|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
164520821|NCT00700427|594276949|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
164520822|NCT00700427|594276950|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
164520823|NCT00700427|594276951|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
164520824|NCT00700427|594276952|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
164520825|NCT00700427|594276953|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
164520826|NCT00700427|594276949|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
164520827|NCT00700427|594276950|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
164520828|NCT00700427|594276951|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
164520829|NCT00700427|594276952|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
164520830|NCT00700427|594276953|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
164520831|NCT00700427|594276949|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
164520832|NCT00700427|594276950|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
164520833|NCT00700427|594276951|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
164520834|NCT00700427|594276952|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
164520835|NCT00700427|594276953|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
164520836|NCT00700427|594276949|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
164520837|NCT00700427|594276950|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
164520838|NCT00700427|594276951|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
164520839|NCT00700427|594276952|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
164520840|NCT00700427|594276953|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
164520841|NCT00700427|594276949|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
164520842|NCT00700427|594276950|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
164520843|NCT00700427|594276951|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
164520844|NCT00700427|594276952|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
164520845|NCT00700427|594276953|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
164520846|NCT00700427|594276949|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
164520847|NCT00700427|594276950|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
164520848|NCT00700427|594276951|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
164520849|NCT00700427|594276952|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
164520850|NCT00700427|594276953|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
164520851|NCT00700427|594276949|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
164520852|NCT00700427|594276950|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
164520853|NCT00700427|594276951|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
164520854|NCT00700427|594276952|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
164520855|NCT00700427|594276953|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
164520856|NCT00700427|594276949|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
164520857|NCT00700427|594276950|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
164520858|NCT00700427|594276951|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
164520859|NCT00700427|594276952|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
164520860|NCT00700427|594276953|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
164520861|NCT00700427|594276949|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
164520862|NCT00700427|594276950|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
164520863|NCT00700427|594276951|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
164520864|NCT00700427|594276952|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
164520865|NCT00700427|594276953|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
164520866|NCT00700427|594276949|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
164520867|NCT00700427|594276950|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
164520868|NCT00700427|594276951|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
164520869|NCT00700427|594276952|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
164520870|NCT00700427|594276953|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
164520871|NCT00700427|594276949|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
164520872|NCT00700427|594276950|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
164520873|NCT00700427|594276951|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
164520874|NCT00700427|594276952|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
164520875|NCT00700427|594276953|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
164520876|NCT00700427|594276949|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
164520877|NCT00700427|594276950|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
164520878|NCT00700427|594276951|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
164520879|NCT00700427|594276952|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
164520880|NCT00700427|594276953|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
164520881|NCT00700427|594276949|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
164520882|NCT00700427|594276950|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
164520883|NCT00700427|594276951|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
164520884|NCT00700427|594276952|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
164520885|NCT00700427|594276953|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
164520886|NCT00700427|594276949|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
164520887|NCT00700427|594276950|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
164520888|NCT00700427|594276951|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
164520889|NCT00700427|594276952|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
164520890|NCT00700427|594276953|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
164520891|NCT00700427|594276949|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
164520892|NCT00700427|594276950|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
164520893|NCT00700427|594276951|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
164520894|NCT00700427|594276952|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
164520895|NCT00700427|594276953|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
164520896|NCT00700427|594276949|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
164520897|NCT00700427|594276950|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
164520898|NCT00700427|594276951|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
164520899|NCT00700427|594276952|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
164520900|NCT00700427|594276953|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
164520901|NCT00700427|594276949|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
164520902|NCT00700427|594276950|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
164520903|NCT00700427|594276951|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
164520904|NCT00700427|594276952|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
164520905|NCT00700427|594276953|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
164520906|NCT00700427|594276949|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
164520907|NCT00700427|594276950|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
164520908|NCT00700427|594276951|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
164520909|NCT00700427|594276952|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
164520910|NCT00700427|594276953|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
164520911|NCT00700427|594276949|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
164520912|NCT00700427|594276950|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
164520913|NCT00700427|594276951|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
164520914|NCT00700427|594276952|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
164520915|NCT00700427|594276953|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
164520916|NCT00700427|594276949|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
164520917|NCT00700427|594276950|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
164520918|NCT00700427|594276951|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
164520919|NCT00700427|594276952|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
164520920|NCT00700427|594276953|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
164520921|NCT00700427|594276949|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
164520922|NCT00700427|594276950|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
164520923|NCT00700427|594276951|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
164520924|NCT00700427|594276952|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
164520925|NCT00700427|594276953|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
164520926|NCT00700427|594276949|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
164520927|NCT00700427|594276950|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
164520928|NCT00700427|594276951|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
164520929|NCT00700427|594276952|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
164520930|NCT00700427|594276953|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
164520931|NCT00700427|594276949|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
164520932|NCT00700427|594276950|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
164520933|NCT00700427|594276951|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
164520934|NCT00700427|594276952|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
164520935|NCT00700427|594276953|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
164520936|NCT00700427|594276949|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
164520937|NCT00700427|594276950|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
164520938|NCT00700427|594276951|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
164520939|NCT00700427|594276952|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
164520940|NCT00700427|594276953|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
164520941|NCT00700427|594276949|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
164520942|NCT00700427|594276950|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
164520943|NCT00700427|594276951|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
164520944|NCT00700427|594276952|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
164520945|NCT00700427|594276953|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
164520946|NCT00700427|594276949|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
164520947|NCT00700427|594276950|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
164520948|NCT00700427|594276951|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
164520949|NCT00700427|594276952|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
164520950|NCT00700427|594276953|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
164520951|NCT00700427|594276949|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
164520952|NCT00700427|594276950|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
164520953|NCT00700427|594276951|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
164520954|NCT00700427|594276952|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
164520955|NCT00700427|594276953|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
164520956|NCT00700427|594276949|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
164520957|NCT00700427|594276950|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
164520958|NCT00700427|594276951|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
164520959|NCT00700427|594276952|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
164520960|NCT00700427|594276953|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
164520961|NCT00700427|594276949|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
164520962|NCT00700427|594276950|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
164520963|NCT00700427|594276951|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
164617321|NCT03689972|594621245|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
164617322|NCT03689972|594621246|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
164617323|NCT03689972|594621247|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
164617324|NCT03689972|594621248|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
164617325|NCT03689972|594621244|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
164617326|NCT03689972|594621245|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
164617327|NCT03689972|594621246|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
164617328|NCT03689972|594621247|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
164617329|NCT03689972|594621248|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
164617330|NCT03689972|594621244|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
164617331|NCT03689972|594621245|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
164617332|NCT03689972|594621246|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
164617333|NCT03689972|594621247|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
164617334|NCT03689972|594621248|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
164617335|NCT01131130|594621249|FG000|Period 1 - Baseline|Pregnancy|1|||
164617336|NCT01131130|594621249|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
164617337|NCT03981744|594621250|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
164617338|NCT03981744|594621251|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
164617339|NCT03981744|594621252|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
164617340|NCT03981744|594621253|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
164617341|NCT03981744|594621250|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
164617342|NCT03981744|594621251|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
164617343|NCT03981744|594621252|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
164617344|NCT03981744|594621253|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
164617345|NCT03981744|594621250|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
164617346|NCT03981744|594621251|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
164617347|NCT03981744|594621252|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
164617348|NCT03981744|594621253|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
164617349|NCT04338321|594621254|FG000|Overall Study|Adverse Event|4|||
164617350|NCT04338321|594621255|FG001|Overall Study|Adverse Event|10|||
164617351|NCT04338321|594621254|FG000|Overall Study|Death|1|||
164617352|NCT04338321|594621255|FG001|Overall Study|Death|1|||
164617353|NCT04338321|594621254|FG000|Overall Study|Lost to Follow-up|4|||
164617354|NCT04338321|594621255|FG001|Overall Study|Lost to Follow-up|9|||
164617355|NCT04338321|594621254|FG000|Overall Study|Withdrawal by Subject|45|||
164617356|NCT04338321|594621255|FG001|Overall Study|Withdrawal by Subject|69|||
164617357|NCT04338321|594621254|FG000|Overall Study|Physician Decision|5|||
164617358|NCT04338321|594621255|FG001|Overall Study|Physician Decision|9|||
164617359|NCT04338321|594621254|FG000|Overall Study|Other|3|||
164617360|NCT04338321|594621255|FG001|Overall Study|Other|10|||
164617361|NCT02438787|594621256|FG000|Overall Study|Adverse Event|1|||
164617362|NCT02438787|594621257|FG001|Overall Study|Adverse Event|0|||
164617363|NCT02438787|594621258|FG002|Overall Study|Adverse Event|2|||
164617364|NCT02438787|594621256|FG000|Overall Study|Lack of Efficacy|1|||
164617365|NCT02438787|594621257|FG001|Overall Study|Lack of Efficacy|2|||
164617366|NCT02438787|594621258|FG002|Overall Study|Lack of Efficacy|0|||
164617367|NCT02438787|594621256|FG000|Overall Study|Lost to Follow-up|0|||
164617368|NCT02438787|594621257|FG001|Overall Study|Lost to Follow-up|1|||
164617369|NCT02438787|594621258|FG002|Overall Study|Lost to Follow-up|0|||
164617370|NCT02438787|594621256|FG000|Overall Study|Protocol Violation|0|||
164617371|NCT02438787|594621257|FG001|Overall Study|Protocol Violation|0|||
164617372|NCT02438787|594621258|FG002|Overall Study|Protocol Violation|1|||
164617373|NCT02438787|594621256|FG000|Overall Study|Withdrawal by Subject|15|||
164617374|NCT02438787|594621257|FG001|Overall Study|Withdrawal by Subject|7|||
164617375|NCT02438787|594621258|FG002|Overall Study|Withdrawal by Subject|10|||
164617376|NCT02438787|594621256|FG000|Overall Study|Study discontinued by sponsor|64|||
164617377|NCT02438787|594621257|FG001|Overall Study|Study discontinued by sponsor|72|||
164617378|NCT02438787|594621258|FG002|Overall Study|Study discontinued by sponsor|69|||
164617379|NCT02438787|594621256|FG000|Overall Study|Other|0|||
164617380|NCT02438787|594621257|FG001|Overall Study|Other|1|||
164617381|NCT02438787|594621258|FG002|Overall Study|Other|0|||
164617382|NCT02438787|594621256|FG000|Overall Study|Site terminated by sponsor|0|||
164617383|NCT02438787|594621257|FG001|Overall Study|Site terminated by sponsor|0|||
164617384|NCT02438787|594621258|FG002|Overall Study|Site terminated by sponsor|1|||
164617385|NCT03412565|594621259|FG000|Overall Study|Lost to Follow-up|0|||
164617386|NCT03412565|594621260|FG001|Overall Study|Lost to Follow-up|0|||
164617387|NCT03412565|594621261|FG002|Overall Study|Lost to Follow-up|1|||
164617388|NCT03412565|594621262|FG003|Overall Study|Lost to Follow-up|0|||
164617389|NCT03412565|594621259|FG000|Overall Study|Physician Decision|0|||
164617390|NCT03412565|594621260|FG001|Overall Study|Physician Decision|0|||
164617391|NCT03412565|594621261|FG002|Overall Study|Physician Decision|0|||
164617392|NCT03412565|594621262|FG003|Overall Study|Physician Decision|1|||
164617393|NCT03412565|594621259|FG000|Overall Study|Withdrawal by Subject|0|||
164617394|NCT03412565|594621260|FG001|Overall Study|Withdrawal by Subject|4|||
164617395|NCT03412565|594621261|FG002|Overall Study|Withdrawal by Subject|5|||
164617396|NCT03412565|594621262|FG003|Overall Study|Withdrawal by Subject|5|||
164617397|NCT03412565|594621259|FG000|Overall Study|Death|1|||
164617398|NCT03412565|594621260|FG001|Overall Study|Death|3|||
164617399|NCT03412565|594621261|FG002|Overall Study|Death|4|||
164617400|NCT03412565|594621262|FG003|Overall Study|Death|5|||
164617401|NCT03412565|594621259|FG000|Overall Study|Data collection ended|0|||
164617402|NCT03412565|594621260|FG001|Overall Study|Data collection ended|41|||
164617403|NCT03412565|594621261|FG002|Overall Study|Data collection ended|41|||
164617404|NCT03412565|594621262|FG003|Overall Study|Data collection ended|40|||
164617405|NCT01989572|594621265|FG000|Overall Study|Lack of Efficacy|35|||
164617406|NCT01989572|594621266|FG001|Overall Study|Lack of Efficacy|48|||
164617407|NCT01989572|594621267|FG002|Overall Study|Lack of Efficacy|48|||
164617408|NCT01989572|594621268|FG003|Overall Study|Lack of Efficacy|43|||
164617409|NCT01989572|594621269|FG004|Overall Study|Lack of Efficacy|71|||
164617410|NCT01989572|594621270|FG005|Overall Study|Lack of Efficacy|79|||
164617411|NCT01989572|594621265|FG000|Overall Study|Adverse Event|2|||
164617412|NCT01989572|594621266|FG001|Overall Study|Adverse Event|1|||
164617413|NCT01989572|594621267|FG002|Overall Study|Adverse Event|3|||
164617414|NCT01989572|594621268|FG003|Overall Study|Adverse Event|0|||
164617415|NCT01989572|594621269|FG004|Overall Study|Adverse Event|3|||
164617416|NCT01989572|594621270|FG005|Overall Study|Adverse Event|0|||
164617417|NCT01989572|594621265|FG000|Overall Study|Death|0|||
164617418|NCT01989572|594621266|FG001|Overall Study|Death|0|||
164617419|NCT01989572|594621267|FG002|Overall Study|Death|0|||
164617420|NCT01989572|594621268|FG003|Overall Study|Death|0|||
164617421|NCT01989572|594621269|FG004|Overall Study|Death|1|||
164617422|NCT01989572|594621270|FG005|Overall Study|Death|0|||
164617423|NCT01989572|594621265|FG000|Overall Study|Withdrawal by Subject|4|||
164617424|NCT01989572|594621266|FG001|Overall Study|Withdrawal by Subject|1|||
164617425|NCT01989572|594621267|FG002|Overall Study|Withdrawal by Subject|5|||
164617426|NCT01989572|594621268|FG003|Overall Study|Withdrawal by Subject|1|||
164617427|NCT01989572|594621269|FG004|Overall Study|Withdrawal by Subject|12|||
164520964|NCT00700427|594276952|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
164520965|NCT00700427|594276953|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
164520966|NCT00700427|594276949|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
164520967|NCT00700427|594276950|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
164520968|NCT00700427|594276951|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
164520969|NCT00700427|594276952|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
164520970|NCT00700427|594276953|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
164520971|NCT00700427|594276949|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
164520972|NCT00700427|594276950|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
164520973|NCT00700427|594276951|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
164520974|NCT00700427|594276952|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
164520975|NCT00700427|594276953|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
164520976|NCT00700427|594276949|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
164520977|NCT00700427|594276950|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
164520978|NCT00700427|594276951|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
164520979|NCT00700427|594276952|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
164520980|NCT00700427|594276953|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
164520981|NCT00700427|594276949|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
164520982|NCT00700427|594276950|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
164520983|NCT00700427|594276951|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
164520984|NCT00700427|594276952|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
164520985|NCT00700427|594276953|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
164520986|NCT05560243|594276954|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
164520987|NCT00859222|594276959|FG000|Overall Study|Adverse Event|2|||
164520988|NCT00859222|594276960|FG001|Overall Study|Adverse Event|3|||
164520989|NCT00859222|594276961|FG002|Overall Study|Adverse Event|6|||
164520990|NCT00859222|594276962|FG003|Overall Study|Adverse Event|24|||
164520991|NCT00859222|594276963|FG004|Overall Study|Adverse Event|15|||
164520992|NCT00859222|594276959|FG000|Overall Study|DLT|1|||
164520993|NCT00859222|594276960|FG001|Overall Study|DLT|0|||
164520994|NCT00859222|594276961|FG002|Overall Study|DLT|0|||
164520995|NCT00859222|594276962|FG003|Overall Study|DLT|0|||
164520996|NCT00859222|594276963|FG004|Overall Study|DLT|0|||
164520997|NCT00941070|594276968|FG000|Overall Study|Patient non-compliant|1|||
164520998|NCT03500159|594276969|FG000|Overall Study|Study Terminated|2|||
164520999|NCT03500159|594276970|FG001|Overall Study|Study Terminated|1|||
164521000|NCT02535091|594276975|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
164521001|NCT02535091|594276976|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
164521002|NCT02535091|594276977|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
164521003|NCT02535091|594276975|FG000|Overall Study|Withdrawal by Subject|14|||
164521004|NCT02535091|594276976|FG001|Overall Study|Withdrawal by Subject|5|||
164521005|NCT02535091|594276977|FG002|Overall Study|Withdrawal by Subject|121|||
164521006|NCT02535091|594276975|FG000|Overall Study|Adverse Event|9|||
164521007|NCT02535091|594276976|FG001|Overall Study|Adverse Event|4|||
164521008|NCT02535091|594276977|FG002|Overall Study|Adverse Event|170|||
164521009|NCT02535091|594276975|FG000|Overall Study|Other|4|||
164521010|NCT02535091|594276976|FG001|Overall Study|Other|3|||
164521011|NCT02535091|594276977|FG002|Overall Study|Other|81|||
164521012|NCT02535091|594276975|FG000|Overall Study|Lost to Follow-up|0|||
164521013|NCT02535091|594276976|FG001|Overall Study|Lost to Follow-up|1|||
164521014|NCT02535091|594276977|FG002|Overall Study|Lost to Follow-up|19|||
164521015|NCT02535091|594276975|FG000|Overall Study|Protocol Violation|0|||
164521016|NCT02535091|594276976|FG001|Overall Study|Protocol Violation|1|||
164521017|NCT02535091|594276977|FG002|Overall Study|Protocol Violation|11|||
164521018|NCT02535091|594276975|FG000|Overall Study|Pregnancy|0|||
164521019|NCT02535091|594276976|FG001|Overall Study|Pregnancy|0|||
164521020|NCT02535091|594276977|FG002|Overall Study|Pregnancy|7|||
164521021|NCT02643472|594276981|FG000|Overall Study|Death|2|||
164521022|NCT02643472|594276982|FG001|Overall Study|Death|5|||
164521023|NCT02643472|594276981|FG000|Overall Study|Withdrawal by Subject|3|||
164521024|NCT02643472|594276982|FG001|Overall Study|Withdrawal by Subject|2|||
164521025|NCT02643472|594276981|FG000|Overall Study|Protocol Violation|0|||
164521026|NCT02643472|594276982|FG001|Overall Study|Protocol Violation|1|||
164521027|NCT02643472|594276981|FG000|Overall Study|Lost to Follow-up|22|||
164521028|NCT02643472|594276982|FG001|Overall Study|Lost to Follow-up|26|||
164521029|NCT01259089|594276987|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
164521030|NCT01259089|594276988|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
164521031|NCT01259089|594276989|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
164521032|NCT01259089|594276990|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
164521033|NCT01259089|594276991|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
164521034|NCT01259089|594276992|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
164521035|NCT01259089|594276987|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
164521036|NCT01259089|594276988|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
164521037|NCT01259089|594276989|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
164521038|NCT01259089|594276990|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
164521039|NCT01259089|594276991|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
164521040|NCT01259089|594276992|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
164521041|NCT01259089|594276987|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
164521042|NCT01259089|594276988|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
164521043|NCT01259089|594276989|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
164521044|NCT01259089|594276990|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
164521045|NCT01259089|594276991|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
164521046|NCT01259089|594276992|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
164521047|NCT01259089|594276987|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
164521048|NCT01259089|594276988|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
164521049|NCT01259089|594276989|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
164521050|NCT01259089|594276990|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
164521051|NCT01259089|594276991|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
164521052|NCT01259089|594276992|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
164521053|NCT01259089|594276987|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
164521054|NCT01259089|594276988|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
164521055|NCT01259089|594276989|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
164521056|NCT01259089|594276990|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
164521057|NCT01259089|594276991|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
164521058|NCT01259089|594276992|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
164521059|NCT01259089|594276987|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
164521060|NCT01259089|594276988|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
164521061|NCT01259089|594276989|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
164521062|NCT01259089|594276990|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
164521063|NCT01259089|594276991|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
164521064|NCT01259089|594276992|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
164521065|NCT01259089|594276987|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
164521066|NCT01259089|594276988|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
164521067|NCT01259089|594276989|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
164521068|NCT01259089|594276990|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
164521069|NCT01259089|594276991|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
164521070|NCT01259089|594276992|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
164521071|NCT01259089|594276987|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
164521072|NCT01259089|594276988|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
164521073|NCT01259089|594276989|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
164521074|NCT01259089|594276990|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
164521075|NCT01259089|594276991|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
164521076|NCT01259089|594276992|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
164521077|NCT01259089|594276987|FG000|Survival Follow up for Two Years|Death|3|||
164521078|NCT01259089|594276988|FG001|Survival Follow up for Two Years|Death|2|||
164521079|NCT01259089|594276989|FG002|Survival Follow up for Two Years|Death|2|||
164521080|NCT01259089|594276990|FG003|Survival Follow up for Two Years|Death|3|||
164521081|NCT01259089|594276991|FG004|Survival Follow up for Two Years|Death|6|||
164521082|NCT01259089|594276992|FG005|Survival Follow up for Two Years|Death|13|||
164521083|NCT01259089|594276987|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
164521084|NCT01259089|594276988|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
164617428|NCT01989572|594621270|FG005|Overall Study|Withdrawal by Subject|4|||
164617429|NCT01989572|594621265|FG000|Overall Study|complicating disease|1|||
164617430|NCT01989572|594621266|FG001|Overall Study|complicating disease|1|||
164617431|NCT01989572|594621267|FG002|Overall Study|complicating disease|2|||
164617432|NCT01989572|594621268|FG003|Overall Study|complicating disease|0|||
164617433|NCT01989572|594621269|FG004|Overall Study|complicating disease|1|||
164617434|NCT01989572|594621270|FG005|Overall Study|complicating disease|0|||
164617435|NCT01989572|594621265|FG000|Overall Study|error|2|||
164617436|NCT01989572|594621266|FG001|Overall Study|error|1|||
164617437|NCT01989572|594621267|FG002|Overall Study|error|1|||
164617438|NCT01989572|594621268|FG003|Overall Study|error|1|||
164617439|NCT01989572|594621269|FG004|Overall Study|error|1|||
164617440|NCT01989572|594621270|FG005|Overall Study|error|1|||
164617441|NCT01989572|594621265|FG000|Overall Study|maximum dose reached|0|||
164617442|NCT01989572|594621266|FG001|Overall Study|maximum dose reached|1|||
164617443|NCT01989572|594621267|FG002|Overall Study|maximum dose reached|0|||
164617444|NCT01989572|594621268|FG003|Overall Study|maximum dose reached|0|||
164617445|NCT01989572|594621269|FG004|Overall Study|maximum dose reached|1|||
164617446|NCT01989572|594621270|FG005|Overall Study|maximum dose reached|0|||
164617447|NCT01989572|594621265|FG000|Overall Study|unknown/not specify|3|||
164617448|NCT01989572|594621266|FG001|Overall Study|unknown/not specify|4|||
164617449|NCT01989572|594621267|FG002|Overall Study|unknown/not specify|1|||
164617450|NCT01989572|594621268|FG003|Overall Study|unknown/not specify|3|||
164617451|NCT01989572|594621269|FG004|Overall Study|unknown/not specify|3|||
164617452|NCT01989572|594621270|FG005|Overall Study|unknown/not specify|5|||
164617453|NCT01989572|594621265|FG000|Overall Study|not start protocol therapy|5|||
164617454|NCT01989572|594621266|FG001|Overall Study|not start protocol therapy|1|||
164617455|NCT01989572|594621267|FG002|Overall Study|not start protocol therapy|2|||
164521085|NCT01259089|594276989|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
164521086|NCT01259089|594276990|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
164521087|NCT01259089|594276991|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
164521088|NCT01259089|594276992|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
164521089|NCT01259089|594276987|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
164521090|NCT01259089|594276988|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
164521091|NCT01259089|594276989|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
164521092|NCT01259089|594276990|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
164521093|NCT01259089|594276991|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
164521094|NCT01259089|594276992|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
164521095|NCT01215188|594276993|FG000|Overall Study|Lost to Follow-up|22|||
164521096|NCT01215188|594276994|FG001|Overall Study|Lost to Follow-up|22|||
164521097|NCT01215188|594276995|FG002|Overall Study|Lost to Follow-up|16|||
164521098|NCT01215188|594276993|FG000|Overall Study|Adverse Event|1|||
164521099|NCT01215188|594276994|FG001|Overall Study|Adverse Event|1|||
164521100|NCT01215188|594276995|FG002|Overall Study|Adverse Event|3|||
164521101|NCT01215188|594276993|FG000|Overall Study|Physician Decision|2|||
164521102|NCT01215188|594276994|FG001|Overall Study|Physician Decision|1|||
164521103|NCT01215188|594276995|FG002|Overall Study|Physician Decision|0|||
164521104|NCT01215188|594276993|FG000|Overall Study|Lack of Efficacy|0|||
164521105|NCT01215188|594276994|FG001|Overall Study|Lack of Efficacy|0|||
164521106|NCT01215188|594276995|FG002|Overall Study|Lack of Efficacy|1|||
164521107|NCT01215188|594276993|FG000|Overall Study|Protocol Violation|1|||
164521108|NCT01215188|594276994|FG001|Overall Study|Protocol Violation|1|||
164521109|NCT01215188|594276995|FG002|Overall Study|Protocol Violation|1|||
164521110|NCT01215188|594276993|FG000|Overall Study|Withdrawal by Subject|32|||
164521111|NCT01215188|594276994|FG001|Overall Study|Withdrawal by Subject|34|||
164521112|NCT01215188|594276995|FG002|Overall Study|Withdrawal by Subject|31|||
164521113|NCT00688870|594276999|FG000|Infant Series|Parent or legal guardian request|4|||
164521114|NCT00688870|594277000|FG001|Infant Series|Parent or legal guardian request|0|||
164521115|NCT01151410|594277003|FG000|Overall Study|Withdrawal by Subject|3|||
164521116|NCT01151410|594277004|FG001|Overall Study|Withdrawal by Subject|5|||
164521117|NCT01151410|594277003|FG000|Overall Study|Lost to Follow-up|3|||
164617456|NCT01989572|594621268|FG003|Overall Study|not start protocol therapy|3|||
164617457|NCT01989572|594621269|FG004|Overall Study|not start protocol therapy|4|||
164617458|NCT01989572|594621270|FG005|Overall Study|not start protocol therapy|18|||
164617459|NCT01989572|594621265|FG000|Overall Study|alternative therapy|3|||
164617460|NCT01989572|594621266|FG001|Overall Study|alternative therapy|0|||
164617461|NCT01989572|594621267|FG002|Overall Study|alternative therapy|0|||
164521118|NCT01151410|594277004|FG001|Overall Study|Lost to Follow-up|4|||
164521119|NCT01151410|594277003|FG000|Overall Study|Adverse Event|1|||
164521120|NCT01151410|594277004|FG001|Overall Study|Adverse Event|2|||
164521121|NCT01151410|594277003|FG000|Overall Study|Protocol deviation|2|||
164617462|NCT01989572|594621268|FG003|Overall Study|alternative therapy|0|||
164617463|NCT01989572|594621269|FG004|Overall Study|alternative therapy|1|||
164617464|NCT01989572|594621270|FG005|Overall Study|alternative therapy|3|||
164617465|NCT00246376|594621273|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
164617466|NCT00246376|594621274|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
164617467|NCT00246376|594621275|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
164617468|NCT00246376|594621276|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
164617469|NCT00246376|594621277|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
164617470|NCT00246376|594621273|FG000|Overall Study|Adverse Event|2|||
164617471|NCT00246376|594621274|FG001|Overall Study|Adverse Event|3|||
164617472|NCT00246376|594621275|FG002|Overall Study|Adverse Event|1|||
164617473|NCT00246376|594621276|FG003|Overall Study|Adverse Event|3|||
164617474|NCT00246376|594621277|FG004|Overall Study|Adverse Event|1|||
164617475|NCT00246376|594621273|FG000|Overall Study|Lost to Follow-up|2|||
164617476|NCT00246376|594621274|FG001|Overall Study|Lost to Follow-up|11|||
164617477|NCT00246376|594621275|FG002|Overall Study|Lost to Follow-up|11|||
164617478|NCT00246376|594621276|FG003|Overall Study|Lost to Follow-up|16|||
164617479|NCT00246376|594621277|FG004|Overall Study|Lost to Follow-up|13|||
164617480|NCT01872897|594621282|FG000|Overall Study|Withdrawal by Subject|1|||
164617481|NCT01872897|594621283|FG001|Overall Study|Withdrawal by Subject|0|||
164617482|NCT04159701|594621286|FG000|Period 1: Treatment Period|Pregnancy|1|||
164617483|NCT04159701|594621287|FG001|Period 1: Treatment Period|Pregnancy|0|||
164617484|NCT04159701|594621286|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
164617485|NCT04159701|594621287|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
164617486|NCT04159701|594621286|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
164617487|NCT04159701|594621287|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
164617488|NCT04159701|594621286|FG000|Washout Period|site terminated by sponsor|0|||
164617489|NCT04159701|594621287|FG001|Washout Period|site terminated by sponsor|1|||
164617490|NCT04159701|594621286|FG000|Washout Period|study terminated by sponsor|10|||
164617491|NCT04159701|594621287|FG001|Washout Period|study terminated by sponsor|3|||
164617492|NCT04159701|594621286|FG000|Washout Period|Withdrawal by Subject|1|||
164617493|NCT04159701|594621287|FG001|Washout Period|Withdrawal by Subject|0|||
164617494|NCT04159701|594621286|FG000|Washout Period|Inadvertent Enrollment|1|||
164617495|NCT04159701|594621287|FG001|Washout Period|Inadvertent Enrollment|0|||
164617496|NCT04159701|594621286|FG000|Washout Period|Miscellaneous|1|||
164617497|NCT04159701|594621287|FG001|Washout Period|Miscellaneous|0|||
164617498|NCT04159701|594621286|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
164617499|NCT04159701|594621287|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
164617500|NCT04159701|594621286|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
164617501|NCT04159701|594621287|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
164617502|NCT04159701|594621286|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
164617503|NCT04159701|594621287|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
164617504|NCT04159701|594621286|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
164617505|NCT04159701|594621287|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
164617506|NCT04159701|594621286|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
164617507|NCT04159701|594621287|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
164617508|NCT01849562|594621295|FG000|Overall Study|Lost to Follow-up|1|||
164617509|NCT01849562|594621296|FG001|Overall Study|Lost to Follow-up|0|||
164617510|NCT01849562|594621297|FG002|Overall Study|Lost to Follow-up|0|||
164617511|NCT01849562|594621295|FG000|Overall Study|Non-compliance with Study Drug|1|||
164617512|NCT01849562|594621296|FG001|Overall Study|Non-compliance with Study Drug|0|||
164617513|NCT01849562|594621297|FG002|Overall Study|Non-compliance with Study Drug|0|||
164617514|NCT01782885|594621298|FG000|Overall Study|Lost to Follow-up|4|||
164617515|NCT01782885|594621299|FG001|Overall Study|Lost to Follow-up|6|||
164617516|NCT04599972|594621305|FG000|Overall Study|Withdrawal by Subject|6|||
164617517|NCT04599972|594621306|FG001|Overall Study|Withdrawal by Subject|1|||
164617518|NCT04599972|594621305|FG000|Overall Study|Adverse Event|1|||
164617519|NCT04599972|594621306|FG001|Overall Study|Adverse Event|1|||
164617520|NCT04599972|594621305|FG000|Overall Study|Lost to Follow-up|1|||
164617521|NCT04599972|594621306|FG001|Overall Study|Lost to Follow-up|6|||
164617522|NCT04599972|594621305|FG000|Overall Study|Protocol Violation|1|||
164617523|NCT04599972|594621306|FG001|Overall Study|Protocol Violation|0|||
164617524|NCT04599972|594621305|FG000|Overall Study|Other reason|1|||
164617525|NCT04599972|594621306|FG001|Overall Study|Other reason|0|||
164617526|NCT01690988|594621314|FG000|Overall Study|Withdrawal by Subject|2|||
164617527|NCT01690988|594621315|FG001|Overall Study|Withdrawal by Subject|2|||
164617528|NCT01690988|594621316|FG002|Overall Study|Withdrawal by Subject|3|||
164617529|NCT01690988|594621314|FG000|Overall Study|Physician Decision|0|||
164617530|NCT01690988|594621315|FG001|Overall Study|Physician Decision|0|||
164617531|NCT01690988|594621316|FG002|Overall Study|Physician Decision|1|||
164617532|NCT01690988|594621314|FG000|Overall Study|Operation Cancelled|1|||
164617533|NCT01690988|594621315|FG001|Overall Study|Operation Cancelled|1|||
164617534|NCT01690988|594621316|FG002|Overall Study|Operation Cancelled|0|||
164617535|NCT01690988|594621314|FG000|Overall Study|Determined ineligible|1|||
164617536|NCT01690988|594621315|FG001|Overall Study|Determined ineligible|0|||
164617537|NCT01690988|594621316|FG002|Overall Study|Determined ineligible|0|||
164617538|NCT01690988|594621314|FG000|Overall Study|Death|1|||
164617539|NCT01690988|594621315|FG001|Overall Study|Death|1|||
164617540|NCT01690988|594621316|FG002|Overall Study|Death|1|||
164617541|NCT01690988|594621314|FG000|Overall Study|Sedated|1|||
164617542|NCT01690988|594621315|FG001|Overall Study|Sedated|1|||
164617543|NCT01690988|594621316|FG002|Overall Study|Sedated|2|||
164617544|NCT03696576|594621317|FG000|Overall Study|Soreness of throat after therapy|1|||
164617545|NCT03696576|594621318|FG001|Overall Study|Soreness of throat after therapy|1|||
164617546|NCT03696576|594621317|FG000|Overall Study|Lost to Follow-up|2|||
164617547|NCT03696576|594621318|FG001|Overall Study|Lost to Follow-up|4|||
164617548|NCT00744991|594621321|FG000|Overall Study|Progressive Disease|11|||
164617549|NCT00744991|594621321|FG000|Overall Study|Withdrawal by Subject|8|||
164617550|NCT00744991|594621321|FG000|Overall Study|Physician Decision|3|||
164617551|NCT00744991|594621321|FG000|Overall Study|Adverse Event|2|||
164617552|NCT00744991|594621321|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
164617553|NCT01662986|594621322|FG000|Overall Study|Adverse Event|5|||
164617554|NCT01662986|594621323|FG001|Overall Study|Adverse Event|4|||
164617555|NCT01662986|594621322|FG000|Overall Study|Protocol Violation|2|||
164617556|NCT01662986|594621323|FG001|Overall Study|Protocol Violation|3|||
164617557|NCT01662986|594621322|FG000|Overall Study|Lost to Follow-up|5|||
164617558|NCT01662986|594621323|FG001|Overall Study|Lost to Follow-up|4|||
164617559|NCT01662986|594621322|FG000|Overall Study|Withdrawal by Subject|2|||
164617560|NCT01662986|594621323|FG001|Overall Study|Withdrawal by Subject|2|||
164617561|NCT01662986|594621322|FG000|Overall Study|Not Treated|1|||
164617562|NCT01662986|594621323|FG001|Overall Study|Not Treated|0|||
164617563|NCT01662986|594621322|FG000|Overall Study|Other than stated above|3|||
164617564|NCT01662986|594621323|FG001|Overall Study|Other than stated above|0|||
164617565|NCT01594411|594621326|FG000|Overall Study|Lost to Follow-up|2|||
164617566|NCT01975376|594621327|FG000|Overall Study|Adverse Event|5|||
164617567|NCT01975376|594621328|FG001|Overall Study|Adverse Event|5|||
164617568|NCT01975376|594621327|FG000|Overall Study|Death|65|||
164617569|NCT01975376|594621328|FG001|Overall Study|Death|72|||
164617570|NCT01975376|594621327|FG000|Overall Study|Lost to Follow-up|70|||
164617571|NCT01975376|594621328|FG001|Overall Study|Lost to Follow-up|66|||
164617572|NCT01975376|594621327|FG000|Overall Study|Withdrew consent|68|||
164617573|NCT01975376|594621328|FG001|Overall Study|Withdrew consent|62|||
164617574|NCT01975376|594621327|FG000|Overall Study|Other|2|||
164617575|NCT01975376|594621328|FG001|Overall Study|Other|4|||
164617576|NCT01975376|594621327|FG000|Overall Study|Randomized, Not Treated|16|||
164617577|NCT01975376|594621328|FG001|Overall Study|Randomized, Not Treated|8|||
164617578|NCT01451398|594621332|FG000|Overall Study|Adverse Event|7|||
164617579|NCT01451398|594621333|FG001|Overall Study|Adverse Event|9|||
164617580|NCT01451398|594621332|FG000|Overall Study|Protocol Violation|1|||
164617581|NCT01451398|594621333|FG001|Overall Study|Protocol Violation|2|||
164617582|NCT01451398|594621332|FG000|Overall Study|Physician Decision|1|||
164617583|NCT01451398|594621333|FG001|Overall Study|Physician Decision|1|||
164617584|NCT01451398|594621332|FG000|Overall Study|Withdrawal by Subject|10|||
164617585|NCT01451398|594621333|FG001|Overall Study|Withdrawal by Subject|14|||
164617586|NCT01451398|594621332|FG000|Overall Study|Lost to Follow-up|6|||
164617587|NCT01451398|594621333|FG001|Overall Study|Lost to Follow-up|4|||
164617588|NCT01451398|594621332|FG000|Overall Study|Non-compliance with study drug|1|||
164617589|NCT01451398|594621333|FG001|Overall Study|Non-compliance with study drug|3|||
164617590|NCT01451398|594621332|FG000|Overall Study|Non-compliance with protocol|1|||
164617591|NCT01451398|594621333|FG001|Overall Study|Non-compliance with protocol|1|||
164617592|NCT01451398|594621332|FG000|Overall Study|Moved out of country|0|||
164617593|NCT01451398|594621333|FG001|Overall Study|Moved out of country|1|||
164617594|NCT01451398|594621332|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
164617595|NCT01451398|594621333|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
164617596|NCT01451398|594621332|FG000|Overall Study|Lack of Efficacy|0|||
164617597|NCT01451398|594621333|FG001|Overall Study|Lack of Efficacy|1|||
164617598|NCT00924729|594621334|FG000|Overall Study|insufficient volume for analysis|1|||
164617599|NCT00924729|594621335|FG001|Overall Study|insufficient volume for analysis|0|||
164617600|NCT00924729|594621334|FG000|Overall Study|Protocol Violation|1|||
164617601|NCT00924729|594621335|FG001|Overall Study|Protocol Violation|0|||
164617602|NCT04449276|594621336|FG000|Overall Study|Adverse Event|1|||
164617603|NCT04449276|594621337|FG001|Overall Study|Adverse Event|2|||
164617604|NCT04449276|594621338|FG002|Overall Study|Adverse Event|0|||
164617605|NCT04449276|594621339|FG003|Overall Study|Adverse Event|0|||
164617606|NCT04449276|594621340|FG004|Overall Study|Adverse Event|2|||
164617607|NCT04449276|594621341|FG005|Overall Study|Adverse Event|0|||
164617608|NCT04449276|594621342|FG006|Overall Study|Adverse Event|0|||
164617609|NCT04449276|594621343|FG007|Overall Study|Adverse Event|1|||
164617610|NCT04449276|594621336|FG000|Overall Study|Withdrawal by Subject|2|||
164617611|NCT04449276|594621337|FG001|Overall Study|Withdrawal by Subject|0|||
164617612|NCT04449276|594621338|FG002|Overall Study|Withdrawal by Subject|0|||
164617613|NCT04449276|594621339|FG003|Overall Study|Withdrawal by Subject|1|||
164617614|NCT04449276|594621340|FG004|Overall Study|Withdrawal by Subject|0|||
164617615|NCT04449276|594621341|FG005|Overall Study|Withdrawal by Subject|0|||
164617616|NCT04449276|594621342|FG006|Overall Study|Withdrawal by Subject|0|||
164617617|NCT04449276|594621343|FG007|Overall Study|Withdrawal by Subject|0|||
164617618|NCT04449276|594621336|FG000|Overall Study|Other|0|||
164617619|NCT04449276|594621337|FG001|Overall Study|Other|2|||
164617620|NCT04449276|594621338|FG002|Overall Study|Other|3|||
164617621|NCT04449276|594621339|FG003|Overall Study|Other|2|||
164617622|NCT04449276|594621340|FG004|Overall Study|Other|0|||
164617623|NCT04449276|594621341|FG005|Overall Study|Other|0|||
164617624|NCT04449276|594621342|FG006|Overall Study|Other|0|||
164617625|NCT04449276|594621343|FG007|Overall Study|Other|1|||
164617626|NCT01614795|594621344|FG000|Overall Study|Adverse Event|0|||
164617627|NCT01614795|594621345|FG001|Overall Study|Adverse Event|0|||
164617628|NCT01614795|594621346|FG002|Overall Study|Adverse Event|1|||
164617629|NCT01614795|594621347|FG003|Overall Study|Adverse Event|1|||
164617630|NCT01614795|594621344|FG000|Overall Study|Lack of Efficacy|10|||
164617631|NCT01614795|594621345|FG001|Overall Study|Lack of Efficacy|10|||
164617632|NCT01614795|594621346|FG002|Overall Study|Lack of Efficacy|9|||
164617633|NCT01614795|594621347|FG003|Overall Study|Lack of Efficacy|8|||
164617634|NCT01614795|594621344|FG000|Overall Study|Physician Decision|1|||
164617635|NCT01614795|594621345|FG001|Overall Study|Physician Decision|0|||
164617636|NCT01614795|594621346|FG002|Overall Study|Physician Decision|1|||
164617637|NCT01614795|594621347|FG003|Overall Study|Physician Decision|1|||
164617638|NCT01614795|594621344|FG000|Overall Study|Withdrawal by Subject|0|||
164617639|NCT01614795|594621345|FG001|Overall Study|Withdrawal by Subject|1|||
164617640|NCT01614795|594621346|FG002|Overall Study|Withdrawal by Subject|0|||
164617641|NCT01614795|594621347|FG003|Overall Study|Withdrawal by Subject|2|||
164617642|NCT01614795|594621344|FG000|Overall Study|Ineligible|0|||
164617643|NCT01614795|594621345|FG001|Overall Study|Ineligible|1|||
164617644|NCT01614795|594621346|FG002|Overall Study|Ineligible|0|||
164617645|NCT01614795|594621347|FG003|Overall Study|Ineligible|0|||
164617646|NCT00701103|594621348|FG000|Overall Study|Adverse Event|0|||
164617647|NCT00701103|594621349|FG001|Overall Study|Adverse Event|0|||
164617648|NCT00701103|594621350|FG002|Overall Study|Adverse Event|1|||
164617649|NCT00701103|594621351|FG003|Overall Study|Adverse Event|1|||
164617650|NCT00701103|594621352|FG004|Overall Study|Adverse Event|0|||
164617651|NCT00701103|594621353|FG005|Overall Study|Adverse Event|1|||
164617652|NCT00701103|594621354|FG006|Overall Study|Adverse Event|1|||
164617653|NCT00701103|594621355|FG007|Overall Study|Adverse Event|0|||
164617654|NCT00701103|594621356|FG008|Overall Study|Adverse Event|0|||
164617655|NCT00701103|594621357|FG009|Overall Study|Adverse Event|2|||
164617656|NCT00701103|594621358|FG010|Overall Study|Adverse Event|0|||
164617657|NCT00701103|594621348|FG000|Overall Study|Progressive Disease|5|||
164617658|NCT00701103|594621349|FG001|Overall Study|Progressive Disease|2|||
164617659|NCT00701103|594621350|FG002|Overall Study|Progressive Disease|6|||
164617660|NCT00701103|594621351|FG003|Overall Study|Progressive Disease|5|||
164617661|NCT00701103|594621352|FG004|Overall Study|Progressive Disease|6|||
164617662|NCT00701103|594621353|FG005|Overall Study|Progressive Disease|5|||
164617663|NCT00701103|594621354|FG006|Overall Study|Progressive Disease|7|||
164617664|NCT00701103|594621355|FG007|Overall Study|Progressive Disease|7|||
164617665|NCT00701103|594621356|FG008|Overall Study|Progressive Disease|8|||
164617666|NCT00701103|594621357|FG009|Overall Study|Progressive Disease|8|||
164617667|NCT00701103|594621358|FG010|Overall Study|Progressive Disease|11|||
164617668|NCT00701103|594621348|FG000|Overall Study|Withdrawal by Subject|0|||
164617669|NCT00701103|594621349|FG001|Overall Study|Withdrawal by Subject|1|||
164617670|NCT00701103|594621350|FG002|Overall Study|Withdrawal by Subject|1|||
164617671|NCT00701103|594621351|FG003|Overall Study|Withdrawal by Subject|0|||
164617672|NCT00701103|594621352|FG004|Overall Study|Withdrawal by Subject|0|||
164617673|NCT00701103|594621353|FG005|Overall Study|Withdrawal by Subject|0|||
164617674|NCT00701103|594621354|FG006|Overall Study|Withdrawal by Subject|0|||
164617675|NCT00701103|594621355|FG007|Overall Study|Withdrawal by Subject|0|||
164617676|NCT00701103|594621356|FG008|Overall Study|Withdrawal by Subject|0|||
164617677|NCT00701103|594621357|FG009|Overall Study|Withdrawal by Subject|0|||
164617678|NCT00701103|594621358|FG010|Overall Study|Withdrawal by Subject|0|||
164617679|NCT00701103|594621348|FG000|Overall Study|Other|0|||
164617680|NCT00701103|594621349|FG001|Overall Study|Other|0|||
164617681|NCT00701103|594621350|FG002|Overall Study|Other|0|||
164617682|NCT00701103|594621351|FG003|Overall Study|Other|0|||
164617683|NCT00701103|594621352|FG004|Overall Study|Other|0|||
164617684|NCT00701103|594621353|FG005|Overall Study|Other|0|||
164617685|NCT00701103|594621354|FG006|Overall Study|Other|0|||
164617686|NCT00701103|594621355|FG007|Overall Study|Other|0|||
164617687|NCT00701103|594621356|FG008|Overall Study|Other|1|||
164617688|NCT00701103|594621357|FG009|Overall Study|Other|1|||
164617689|NCT00701103|594621358|FG010|Overall Study|Other|0|||
164617690|NCT01929707|594621359|FG000|Intervention Period 1|Lost to Follow-up|0|||
164617691|NCT01929707|594621360|FG001|Intervention Period 1|Lost to Follow-up|0|||
164617692|NCT01929707|594621361|FG002|Intervention Period 1|Lost to Follow-up|0|||
164617693|NCT01929707|594621362|FG003|Intervention Period 1|Lost to Follow-up|1|||
164617694|NCT01929707|594621363|FG004|Intervention Period 1|Lost to Follow-up|0|||
164617695|NCT01929707|594621364|FG005|Intervention Period 1|Lost to Follow-up|0|||
164617696|NCT01929707|594621365|FG006|Intervention Period 1|Lost to Follow-up|0|||
164617697|NCT01929707|594621366|FG007|Intervention Period 1|Lost to Follow-up|0|||
164617698|NCT01929707|594621359|FG000|Intervention Period 1|Withdrawal by Subject|0|||
164617699|NCT01929707|594621360|FG001|Intervention Period 1|Withdrawal by Subject|0|||
164617700|NCT01929707|594621361|FG002|Intervention Period 1|Withdrawal by Subject|0|||
164617701|NCT01929707|594621362|FG003|Intervention Period 1|Withdrawal by Subject|2|||
164617702|NCT01929707|594621363|FG004|Intervention Period 1|Withdrawal by Subject|0|||
164617703|NCT01929707|594621364|FG005|Intervention Period 1|Withdrawal by Subject|0|||
164617704|NCT01929707|594621365|FG006|Intervention Period 1|Withdrawal by Subject|0|||
164617705|NCT01929707|594621366|FG007|Intervention Period 1|Withdrawal by Subject|0|||
164617706|NCT01929707|594621359|FG000|Intervention Period 2|Withdrawal by Subject|0|||
164617707|NCT01929707|594621360|FG001|Intervention Period 2|Withdrawal by Subject|0|||
164617708|NCT01929707|594621361|FG002|Intervention Period 2|Withdrawal by Subject|0|||
164617709|NCT01929707|594621362|FG003|Intervention Period 2|Withdrawal by Subject|0|||
164617710|NCT01929707|594621363|FG004|Intervention Period 2|Withdrawal by Subject|0|||
164617711|NCT01929707|594621364|FG005|Intervention Period 2|Withdrawal by Subject|2|||
164617712|NCT01929707|594621365|FG006|Intervention Period 2|Withdrawal by Subject|0|||
164617713|NCT01929707|594621366|FG007|Intervention Period 2|Withdrawal by Subject|0|||
164617714|NCT00179517|594621367|FG000|Overall Study|Withdrawal by Subject|2|||
164617715|NCT00179517|594621368|FG001|Overall Study|Withdrawal by Subject|1|||
164617716|NCT00856986|594621375|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
164617717|NCT00856986|594621376|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
164617718|NCT00856986|594621377|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
164617719|NCT00856986|594621378|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
164617720|NCT00856986|594621379|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
164617721|NCT00856986|594621375|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
164617722|NCT00856986|594621376|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
164617723|NCT00856986|594621377|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
164617724|NCT00856986|594621378|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
164617725|NCT00856986|594621379|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
164617726|NCT00856986|594621375|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
164617727|NCT00856986|594621376|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
164617728|NCT00856986|594621377|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
164617729|NCT00856986|594621378|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
164617730|NCT00856986|594621379|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
164617731|NCT00856986|594621375|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
164617732|NCT00856986|594621376|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
164617733|NCT00856986|594621377|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
164617734|NCT00856986|594621378|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
164617735|NCT00856986|594621379|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
164617736|NCT00856986|594621375|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
164617737|NCT00856986|594621376|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
164617738|NCT00856986|594621377|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
164617739|NCT00856986|594621378|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
164617740|NCT00856986|594621379|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
164617741|NCT00856986|594621375|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
164617742|NCT00856986|594621376|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
164617743|NCT00856986|594621377|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
164617744|NCT00856986|594621378|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
164617745|NCT00856986|594621379|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
164617746|NCT00856986|594621375|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
164617747|NCT00856986|594621376|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
164617748|NCT00856986|594621377|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
164617749|NCT00856986|594621378|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
164617750|NCT00856986|594621379|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
164617751|NCT00856986|594621375|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
164617752|NCT00856986|594621376|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
164617753|NCT00856986|594621377|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
164617754|NCT00856986|594621378|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
164617755|NCT00856986|594621379|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
164617756|NCT00856986|594621375|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
164617757|NCT00856986|594621376|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
164617758|NCT00856986|594621377|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
164617759|NCT00856986|594621378|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
164617760|NCT00856986|594621379|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
164617761|NCT00856986|594621375|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
164617762|NCT00856986|594621376|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
164617763|NCT00856986|594621377|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
164617764|NCT00856986|594621378|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
164617765|NCT00856986|594621379|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
164617766|NCT00856986|594621375|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
164617767|NCT00856986|594621376|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
164617768|NCT00856986|594621377|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
164617769|NCT00856986|594621378|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
164617770|NCT00856986|594621379|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
164617771|NCT00856986|594621375|FG000|Main Period, Weeks 0-26|Unclassified|7|||
164617772|NCT00856986|594621376|FG001|Main Period, Weeks 0-26|Unclassified|6|||
164617773|NCT00856986|594621377|FG002|Main Period, Weeks 0-26|Unclassified|7|||
164617774|NCT00856986|594621378|FG003|Main Period, Weeks 0-26|Unclassified|0|||
164617775|NCT00856986|594621379|FG004|Main Period, Weeks 0-26|Unclassified|0|||
164617776|NCT00856986|594621375|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
164617777|NCT00856986|594621376|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
164617778|NCT00856986|594621377|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
164617779|NCT00856986|594621378|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
164617780|NCT00856986|594621379|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
164617781|NCT00856986|594621375|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
164617782|NCT00856986|594621376|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
164617783|NCT00856986|594621377|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
164617784|NCT00856986|594621378|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
164617785|NCT00856986|594621379|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
164617786|NCT00856986|594621375|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
164617787|NCT00856986|594621376|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
164617788|NCT00856986|594621377|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
164617789|NCT00856986|594621378|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
164617790|NCT00856986|594621379|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
164617791|NCT00856986|594621375|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
164617792|NCT00856986|594621376|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
164617793|NCT00856986|594621377|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
164617794|NCT00856986|594621378|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
164617795|NCT00856986|594621379|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
164617796|NCT00856986|594621375|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
164617797|NCT00856986|594621376|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
164617798|NCT00856986|594621377|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
164617799|NCT00856986|594621378|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
164617800|NCT00856986|594621379|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
164617801|NCT00856986|594621375|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
164617802|NCT00856986|594621376|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
164617803|NCT00856986|594621377|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
164617804|NCT00856986|594621378|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
164617805|NCT00856986|594621379|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
164617806|NCT01915095|594621380|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
164617807|NCT01915095|594621381|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
164617808|NCT01915095|594621382|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
164617809|NCT01915095|594621383|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
164617810|NCT01915095|594621384|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
164617811|NCT02067533|594621385|FG000|Overall Study|Lost to Follow-up|4|||
164617812|NCT02067533|594621386|FG001|Overall Study|Lost to Follow-up|2|||
164617813|NCT04857892|594621390|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
164617814|NCT04857892|594621391|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
164617815|NCT04857892|594621392|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
164617816|NCT04857892|594621393|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
164617817|NCT04857892|594621394|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
164617818|NCT04857892|594621390|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
164617819|NCT04857892|594621391|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
164617820|NCT04857892|594621392|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
164617821|NCT04857892|594621393|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
164617822|NCT04857892|594621394|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
164617823|NCT04857892|594621390|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
164617824|NCT04857892|594621391|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
164617825|NCT04857892|594621392|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
164617826|NCT04857892|594621393|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
164617827|NCT04857892|594621394|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
164617828|NCT02384993|594621396|FG000|Overall Study|Adverse Event|0|||
164617829|NCT02384993|594621397|FG001|Overall Study|Adverse Event|1|||
164617830|NCT03209362|594621398|FG000|Overall Study|Adverse Event|0|||
164617831|NCT03209362|594621399|FG001|Overall Study|Adverse Event|1|||
164617832|NCT03209362|594621398|FG000|Overall Study|Lost to Follow-up|0|||
164617833|NCT03209362|594621399|FG001|Overall Study|Lost to Follow-up|1|||
164617834|NCT03209362|594621398|FG000|Overall Study|Withdrawal by Subject|2|||
164617835|NCT03209362|594621399|FG001|Overall Study|Withdrawal by Subject|0|||
164617836|NCT03209362|594621398|FG000|Overall Study|Other|0|||
164617837|NCT03209362|594621399|FG001|Overall Study|Other|1|||
164617838|NCT00643448|594621404|FG000|Overall Study|Lack of Efficacy|2|||
164617839|NCT00643448|594621405|FG001|Overall Study|Lack of Efficacy|0|||
164617840|NCT00643448|594621406|FG002|Overall Study|Lack of Efficacy|4|||
164617841|NCT00643448|594621404|FG000|Overall Study|Adverse Event|2|||
164617842|NCT00643448|594621405|FG001|Overall Study|Adverse Event|2|||
164617843|NCT00643448|594621406|FG002|Overall Study|Adverse Event|2|||
164617844|NCT00643448|594621404|FG000|Overall Study|QTcF>550 ms|0|||
164617845|NCT00643448|594621405|FG001|Overall Study|QTcF>550 ms|3|||
164617846|NCT00643448|594621406|FG002|Overall Study|QTcF>550 ms|0|||
164617847|NCT00981682|594621407|FG000|Overall Study|Adverse Event|48|||
164617848|NCT00981682|594621407|FG000|Overall Study|Withdrawal by Subject|52|||
164617849|NCT00981682|594621407|FG000|Overall Study|Lost to Follow-up|14|||
164617850|NCT00981682|594621407|FG000|Overall Study|Lack of Efficacy|13|||
164617851|NCT00981682|594621407|FG000|Overall Study|Protocol Violation|6|||
164617852|NCT00981682|594621407|FG000|Overall Study|administrative|9|||
164617853|NCT02632344|594622957|FG000|Overall Study|Adverse Event|3|||
164617854|NCT02632344|594622957|FG000|Overall Study|Lack of Efficacy|3|||
164617855|NCT02632344|594622957|FG000|Overall Study|Withdrawal by Subject|2|||
164617856|NCT04984876|594622958|FG000|Overall Study|Subject decision|2|||
164617857|NCT04984876|594622959|FG001|Overall Study|Subject decision|10|||
164617858|NCT04984876|594622960|FG002|Overall Study|Subject decision|3|||
164617859|NCT04984876|594622961|FG003|Overall Study|Subject decision|3|||
164617860|NCT04984876|594622962|FG004|Overall Study|Subject decision|3|||
164617861|NCT04984876|594622963|FG005|Overall Study|Subject decision|0|||
164617862|NCT04984876|594622958|FG000|Overall Study|Guardian decision|0|||
164617863|NCT04984876|594622959|FG001|Overall Study|Guardian decision|1|||
164617864|NCT04984876|594622960|FG002|Overall Study|Guardian decision|0|||
164617865|NCT04984876|594622961|FG003|Overall Study|Guardian decision|2|||
164617866|NCT04984876|594622962|FG004|Overall Study|Guardian decision|0|||
164617867|NCT04984876|594622963|FG005|Overall Study|Guardian decision|1|||
164617868|NCT04984876|594622958|FG000|Overall Study|Lost to Follow-up|0|||
164617869|NCT04984876|594622959|FG001|Overall Study|Lost to Follow-up|0|||
164617870|NCT04984876|594622960|FG002|Overall Study|Lost to Follow-up|1|||
164617871|NCT04984876|594622961|FG003|Overall Study|Lost to Follow-up|1|||
164617872|NCT04984876|594622962|FG004|Overall Study|Lost to Follow-up|0|||
164617873|NCT04984876|594622963|FG005|Overall Study|Lost to Follow-up|0|||
164617874|NCT04984876|594622958|FG000|Overall Study|Physician Decision|1|||
164617875|NCT04984876|594622959|FG001|Overall Study|Physician Decision|0|||
164617876|NCT04984876|594622960|FG002|Overall Study|Physician Decision|0|||
164617877|NCT04984876|594622961|FG003|Overall Study|Physician Decision|1|||
164617878|NCT04984876|594622962|FG004|Overall Study|Physician Decision|0|||
164617879|NCT04984876|594622963|FG005|Overall Study|Physician Decision|0|||
164617880|NCT04984876|594622958|FG000|Overall Study|Adverse Event|0|||
164617881|NCT04984876|594622959|FG001|Overall Study|Adverse Event|0|||
164617882|NCT04984876|594622960|FG002|Overall Study|Adverse Event|1|||
164617883|NCT04984876|594622961|FG003|Overall Study|Adverse Event|0|||
164617884|NCT04984876|594622962|FG004|Overall Study|Adverse Event|0|||
164617885|NCT04984876|594622963|FG005|Overall Study|Adverse Event|0|||
164617886|NCT04960202|594622964|FG000|Overall Study|Other|5|||
164617887|NCT04960202|594622965|FG001|Overall Study|Other|0|||
164617888|NCT04960202|594622964|FG000|Overall Study|Withdrawal by Subject|37|||
164617889|NCT04960202|594622965|FG001|Overall Study|Withdrawal by Subject|43|||
164617890|NCT04960202|594622964|FG000|Overall Study|Lost to Follow-up|20|||
164617891|NCT04960202|594622965|FG001|Overall Study|Lost to Follow-up|16|||
164617892|NCT04960202|594622964|FG000|Overall Study|Death|0|||
164617893|NCT04960202|594622965|FG001|Overall Study|Death|15|||
164617894|NCT03687827|594622968|FG000|Treatment Period 1|Death|0|||
164617895|NCT03687827|594622969|FG001|Treatment Period 1|Death|1|||
164617896|NCT03687827|594622968|FG000|Treatment Period 1|Lost to Follow-up|2|||
164617897|NCT03687827|594622969|FG001|Treatment Period 1|Lost to Follow-up|2|||
164617898|NCT03687827|594622968|FG000|Treatment Period 1|Physician Decision|5|||
164617899|NCT03687827|594622969|FG001|Treatment Period 1|Physician Decision|2|||
164617900|NCT03687827|594622968|FG000|Treatment Period 1|Withdrawal by Subject|7|||
164617901|NCT03687827|594622969|FG001|Treatment Period 1|Withdrawal by Subject|3|||
164617902|NCT03687827|594622968|FG000|Treatment Period 2|Physician Decision|4|||
164617903|NCT03687827|594622969|FG001|Treatment Period 2|Physician Decision|1|||
164617904|NCT03687827|594622968|FG000|Treatment Period 2|Withdrawal by Subject|1|||
164617905|NCT03687827|594622969|FG001|Treatment Period 2|Withdrawal by Subject|2|||
164617906|NCT03285490|594622970|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
164617907|NCT03285490|594622971|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
164617908|NCT03285490|594622970|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
164617909|NCT03285490|594622971|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
164617910|NCT03377452|594622974|FG000|Overall Study|Refused assessment|0|||
164617911|NCT03377452|594622975|FG001|Overall Study|Refused assessment|2|||
164617912|NCT03377452|594622974|FG000|Overall Study|Lost to Follow-up|5|||
164617913|NCT03377452|594622975|FG001|Overall Study|Lost to Follow-up|4|||
164617914|NCT02782104|594622976|FG000|Overall Study|Other|215|||
164617915|NCT02782104|594622976|FG000|Overall Study|Induction Day 28 Non Responder|9|||
164617916|NCT02782104|594622976|FG000|Overall Study|Non-Compliance with Study Drug|2|||
164617917|NCT02782104|594622976|FG000|Overall Study|Death|8|||
164617918|NCT02782104|594622976|FG000|Overall Study|Pregnancy|6|||
164617919|NCT02782104|594622976|FG000|Overall Study|Withdrawal by Subject|63|||
164617920|NCT02782104|594622976|FG000|Overall Study|Protocol Violation|7|||
164617921|NCT02782104|594622976|FG000|Overall Study|Lack of Efficacy|61|||
164617922|NCT02782104|594622976|FG000|Overall Study|Lost to Follow-up|23|||
164617923|NCT02782104|594622976|FG000|Overall Study|Adverse Event|74|||
164617924|NCT00732238|594622981|FG000|Overall Study|Bacteremia|4|||
164617925|NCT00732238|594622982|FG001|Overall Study|Bacteremia|1|||
164617926|NCT00732238|594622981|FG000|Overall Study|Asymptomatic bacteriuria|1|||
164617927|NCT00732238|594622982|FG001|Overall Study|Asymptomatic bacteriuria|0|||
164617928|NCT02280096|594622983|FG000|Overall Study|Pregnancy|1|||
164617929|NCT02280096|594622984|FG001|Overall Study|Pregnancy|0|||
164617930|NCT02280096|594622983|FG000|Overall Study|Functional neurological disorder|1|||
164617931|NCT02280096|594622984|FG001|Overall Study|Functional neurological disorder|0|||
164617932|NCT02280096|594622983|FG000|Overall Study|Lack of attachment|0|||
164617933|NCT02280096|594622984|FG001|Overall Study|Lack of attachment|1|||
164617934|NCT03146403|594622987|FG000|Overall Study|Withdrawal by Subject|0|||
164617935|NCT03146403|594622988|FG001|Overall Study|Withdrawal by Subject|3|||
164617936|NCT03146403|594622987|FG000|Overall Study|Lost to Follow-up|2|||
164617937|NCT03146403|594622988|FG001|Overall Study|Lost to Follow-up|0|||
164617938|NCT00481988|594622989|FG000|Overall Study|Withdrawal by Subject|1|||
164617939|NCT00481988|594622990|FG001|Overall Study|Withdrawal by Subject|1|||
164617940|NCT02252588|594622991|FG000|Overall Study|Withdrawal by Subject|4|||
164617941|NCT02252588|594622992|FG001|Overall Study|Withdrawal by Subject|0|||
164617942|NCT00693693|594622993|FG000|Overall Study|Lost to Follow-up|1|||
164617943|NCT00693693|594622994|FG001|Overall Study|Lost to Follow-up|1|||
164617944|NCT00693693|594622995|FG002|Overall Study|Lost to Follow-up|2|||
164617945|NCT00638690|594623000|FG000|Overall Study|Death|655|||
164617946|NCT00638690|594623001|FG001|Overall Study|Death|335|||
164617947|NCT00638690|594623000|FG000|Overall Study|Withdrawal by Subject|22|||
164617948|NCT00638690|594623001|FG001|Overall Study|Withdrawal by Subject|5|||
164617949|NCT00638690|594623000|FG000|Overall Study|Lost to Follow-up|4|||
164617950|NCT00638690|594623001|FG001|Overall Study|Lost to Follow-up|2|||
164617951|NCT02203916|594623004|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
164617952|NCT02203916|594623005|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
164617953|NCT02203916|594623006|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
164617954|NCT02203916|594623004|FG000|Overall Study|Major Protocol Deviation|1|||
164617955|NCT02203916|594623005|FG001|Overall Study|Major Protocol Deviation|1|||
164617956|NCT02203916|594623006|FG002|Overall Study|Major Protocol Deviation|0|||
164617957|NCT02203916|594623004|FG000|Overall Study|Lost to Follow-up|0|||
164617958|NCT02203916|594623005|FG001|Overall Study|Lost to Follow-up|1|||
164617959|NCT02203916|594623006|FG002|Overall Study|Lost to Follow-up|0|||
164617960|NCT02203916|594623004|FG000|Overall Study|Voluntary Withdrawal|3|||
164617961|NCT02203916|594623005|FG001|Overall Study|Voluntary Withdrawal|3|||
164617962|NCT02203916|594623006|FG002|Overall Study|Voluntary Withdrawal|8|||
164617963|NCT02203916|594623004|FG000|Overall Study|Lack of Efficacy|3|||
164617964|NCT02203916|594623005|FG001|Overall Study|Lack of Efficacy|0|||
164617965|NCT02203916|594623006|FG002|Overall Study|Lack of Efficacy|0|||
164617966|NCT02203916|594623004|FG000|Overall Study|Reason Not Specified|0|||
164617967|NCT02203916|594623005|FG001|Overall Study|Reason Not Specified|2|||
164617968|NCT02203916|594623006|FG002|Overall Study|Reason Not Specified|1|||
164617969|NCT03152110|594623017|FG000|Overall Study|Withdrawal by Subject|3|||
164617970|NCT00552344|594623027|FG000|Overall Study|Lack of Efficacy|55|||
164617971|NCT00552344|594623027|FG000|Overall Study|Loss of efficacy|75|||
164521122|NCT01151410|594277004|FG001|Overall Study|Protocol deviation|1|||
164521123|NCT01151410|594277003|FG000|Overall Study|Administrative problems|1|||
164521124|NCT01151410|594277004|FG001|Overall Study|Administrative problems|1|||
164521125|NCT01151410|594277003|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164521126|NCT01151410|594277004|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
164521127|NCT01151410|594277003|FG000|Overall Study|Abnormal laboratory value(s)|0|||
164521128|NCT01151410|594277004|FG001|Overall Study|Abnormal laboratory value(s)|1|||
164521129|NCT01253018|594277005|FG000|Overall Study|Lost to Follow-up|1|||
164521130|NCT01253018|594277006|FG001|Overall Study|Lost to Follow-up|1|||
164521131|NCT01253018|594277005|FG000|Overall Study|Robot Repair Issues|2|||
164521132|NCT01253018|594277006|FG001|Overall Study|Robot Repair Issues|0|||
164521133|NCT01253018|594277005|FG000|Overall Study|Withdrawal by Subject|1|||
164521134|NCT01253018|594277006|FG001|Overall Study|Withdrawal by Subject|1|||
164521135|NCT00744757|594277007|FG000|Overall Study|Objective disease progression|7|||
164521136|NCT00744757|594277007|FG000|Overall Study|Physician Decision|5|||
164521137|NCT00744757|594277007|FG000|Overall Study|Withdrawal by Subject|1|||
164521138|NCT00744757|594277007|FG000|Overall Study|Death|6|||
164521139|NCT00744757|594277007|FG000|Overall Study|Adverse Event|2|||
164521140|NCT01820585|594277008|FG000|Overall Study|Adverse Event|9|||
164521141|NCT01820585|594277009|FG001|Overall Study|Adverse Event|13|||
164521142|NCT01820585|594277010|FG002|Overall Study|Adverse Event|23|||
164521143|NCT01820585|594277011|FG003|Overall Study|Adverse Event|34|||
164521144|NCT01820585|594277008|FG000|Overall Study|Lack of Efficacy|9|||
164521145|NCT01820585|594277009|FG001|Overall Study|Lack of Efficacy|7|||
164521146|NCT01820585|594277010|FG002|Overall Study|Lack of Efficacy|5|||
164521147|NCT01820585|594277011|FG003|Overall Study|Lack of Efficacy|1|||
164521148|NCT01820585|594277008|FG000|Overall Study|Withdrawal by Subject|3|||
164521149|NCT01820585|594277009|FG001|Overall Study|Withdrawal by Subject|7|||
164521150|NCT01820585|594277010|FG002|Overall Study|Withdrawal by Subject|3|||
164521151|NCT01820585|594277011|FG003|Overall Study|Withdrawal by Subject|8|||
164521152|NCT01820585|594277008|FG000|Overall Study|Lost to Follow-up|3|||
164521153|NCT01820585|594277009|FG001|Overall Study|Lost to Follow-up|3|||
164521154|NCT01820585|594277010|FG002|Overall Study|Lost to Follow-up|0|||
164521155|NCT01820585|594277011|FG003|Overall Study|Lost to Follow-up|3|||
164521156|NCT01820585|594277008|FG000|Overall Study|Protocol Violation|3|||
164521157|NCT01820585|594277009|FG001|Overall Study|Protocol Violation|1|||
164521158|NCT01820585|594277010|FG002|Overall Study|Protocol Violation|1|||
164521159|NCT01820585|594277011|FG003|Overall Study|Protocol Violation|1|||
164521160|NCT01820585|594277008|FG000|Overall Study|Subject non-compliance|0|||
164521161|NCT01820585|594277009|FG001|Overall Study|Subject non-compliance|0|||
164521162|NCT01820585|594277010|FG002|Overall Study|Subject non-compliance|1|||
164521163|NCT01820585|594277011|FG003|Overall Study|Subject non-compliance|2|||
164521164|NCT01820585|594277008|FG000|Overall Study|at sponsor request|0|||
164521165|NCT01820585|594277009|FG001|Overall Study|at sponsor request|0|||
164521166|NCT01820585|594277010|FG002|Overall Study|at sponsor request|1|||
164521167|NCT01820585|594277011|FG003|Overall Study|at sponsor request|0|||
164521168|NCT01820585|594277008|FG000|Overall Study|Pregnancy|0|||
164521169|NCT01820585|594277009|FG001|Overall Study|Pregnancy|1|||
164521170|NCT01820585|594277010|FG002|Overall Study|Pregnancy|0|||
164521171|NCT01820585|594277011|FG003|Overall Study|Pregnancy|0|||
164521172|NCT01712659|594277012|FG000|Dose Escalation|Physician Decision|0|||
164521173|NCT01712659|594277013|FG001|Dose Escalation|Physician Decision|1|||
164521174|NCT01712659|594277014|FG002|Dose Escalation|Physician Decision|0|||
164521175|NCT01712659|594277015|FG003|Dose Escalation|Physician Decision|0|||
164521176|NCT01712659|594277016|FG004|Dose Escalation|Physician Decision|0|||
164521177|NCT01712659|594277012|FG000|Dose Escalation|Unable to take study drug|0|||
164521178|NCT01712659|594277013|FG001|Dose Escalation|Unable to take study drug|1|||
164521179|NCT01712659|594277014|FG002|Dose Escalation|Unable to take study drug|0|||
164521180|NCT01712659|594277015|FG003|Dose Escalation|Unable to take study drug|0|||
164521181|NCT01712659|594277016|FG004|Dose Escalation|Unable to take study drug|0|||
164521182|NCT01712659|594277012|FG000|Dose Expansion|Early disease progression|1|||
164521183|NCT01712659|594277013|FG001|Dose Expansion|Early disease progression|0|||
164521184|NCT01712659|594277014|FG002|Dose Expansion|Early disease progression|0|||
164521185|NCT01712659|594277015|FG003|Dose Expansion|Early disease progression|0|||
164521186|NCT01712659|594277016|FG004|Dose Expansion|Early disease progression|0|||
164521187|NCT01712659|594277012|FG000|Dose Expansion|Physician Decision|1|||
164521188|NCT01712659|594277013|FG001|Dose Expansion|Physician Decision|0|||
164521189|NCT01712659|594277014|FG002|Dose Expansion|Physician Decision|0|||
164521190|NCT01712659|594277015|FG003|Dose Expansion|Physician Decision|0|||
164521191|NCT01712659|594277016|FG004|Dose Expansion|Physician Decision|0|||
164521192|NCT00548262|594277017|FG000|Overall Study|Death|21|||
164617972|NCT00552344|594623027|FG000|Overall Study|Lost to Follow-up|8|||
164617973|NCT00552344|594623027|FG000|Overall Study|Withdrawal by Subject|48|||
164617974|NCT00552344|594623027|FG000|Overall Study|SAE, non-fatal|6|||
164617975|NCT00552344|594623027|FG000|Overall Study|AE, non-serious non-fatal|38|||
164617976|NCT00552344|594623027|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
164617977|NCT00552344|594623027|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
164617978|NCT00552344|594623027|FG000|Overall Study|Other Reason|22|||
164617979|NCT04247828|594623030|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
164617980|NCT00045630|594623033|FG000|Overall Study|Adverse Event|1|||
164617981|NCT00045630|594623033|FG000|Overall Study|Refusal unrelated to adverse event|1|||
164617982|NCT00045630|594623033|FG000|Overall Study|Progression/relapse|1|||
164617983|NCT00045630|594623033|FG000|Overall Study|Death|1|||
164617984|NCT00045630|594623033|FG000|Overall Study|Ineligible|2|||
164617985|NCT00565812|594623038|FG000|Overall Study|Death|2|||
164617986|NCT00565812|594623039|FG001|Overall Study|Death|1|||
164617987|NCT00565812|594623040|FG002|Overall Study|Death|3|||
164617988|NCT00565812|594623038|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
164617989|NCT00565812|594623039|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
164617990|NCT00565812|594623040|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
164617991|NCT00565812|594623038|FG000|Overall Study|Lost to Follow-up|10|||
164617992|NCT00565812|594623039|FG001|Overall Study|Lost to Follow-up|8|||
164617993|NCT00565812|594623040|FG002|Overall Study|Lost to Follow-up|8|||
164617994|NCT00565812|594623038|FG000|Overall Study|Withdrawal by Subject|58|||
164617995|NCT00565812|594623039|FG001|Overall Study|Withdrawal by Subject|47|||
164617996|NCT00565812|594623040|FG002|Overall Study|Withdrawal by Subject|48|||
164617997|NCT00565812|594623038|FG000|Overall Study|Work Schedule|5|||
164617998|NCT00565812|594623039|FG001|Overall Study|Work Schedule|3|||
164617999|NCT00565812|594623040|FG002|Overall Study|Work Schedule|1|||
164618000|NCT00565812|594623038|FG000|Overall Study|Protocol Violation|2|||
164618001|NCT00565812|594623039|FG001|Overall Study|Protocol Violation|6|||
164618002|NCT00565812|594623040|FG002|Overall Study|Protocol Violation|4|||
164618003|NCT00565812|594623038|FG000|Overall Study|Adverse Event|41|||
164618004|NCT00565812|594623039|FG001|Overall Study|Adverse Event|54|||
164618005|NCT00565812|594623040|FG002|Overall Study|Adverse Event|40|||
164618006|NCT00565812|594623038|FG000|Overall Study|Jury Duty|1|||
164618007|NCT00565812|594623039|FG001|Overall Study|Jury Duty|0|||
164618008|NCT00565812|594623040|FG002|Overall Study|Jury Duty|0|||
164618009|NCT00565812|594623038|FG000|Overall Study|Relocated Out of Area|5|||
164618010|NCT00565812|594623039|FG001|Overall Study|Relocated Out of Area|8|||
164618011|NCT00565812|594623040|FG002|Overall Study|Relocated Out of Area|9|||
164618012|NCT00565812|594623038|FG000|Overall Study|Sponsor Decision|1|||
164618013|NCT00565812|594623039|FG001|Overall Study|Sponsor Decision|5|||
164618014|NCT00565812|594623040|FG002|Overall Study|Sponsor Decision|1|||
164618015|NCT00565812|594623038|FG000|Overall Study|Domestic Reasons|7|||
164618016|NCT00565812|594623039|FG001|Overall Study|Domestic Reasons|1|||
164618017|NCT00565812|594623040|FG002|Overall Study|Domestic Reasons|3|||
164618018|NCT00565812|594623038|FG000|Overall Study|Research Site Closure|6|||
164618019|NCT00565812|594623039|FG001|Overall Study|Research Site Closure|1|||
164618020|NCT00565812|594623040|FG002|Overall Study|Research Site Closure|8|||
164618021|NCT00565812|594623038|FG000|Overall Study|Surgical Intervention|0|||
164618022|NCT00565812|594623039|FG001|Overall Study|Surgical Intervention|1|||
164618023|NCT00565812|594623040|FG002|Overall Study|Surgical Intervention|2|||
164618024|NCT00565812|594623038|FG000|Overall Study|Low Compliance|1|||
164618025|NCT00565812|594623039|FG001|Overall Study|Low Compliance|0|||
164618026|NCT00565812|594623040|FG002|Overall Study|Low Compliance|1|||
164618027|NCT00565812|594623038|FG000|Overall Study|Follow-up Visit Not Completed|2|||
164618028|NCT00565812|594623039|FG001|Overall Study|Follow-up Visit Not Completed|0|||
164618029|NCT00565812|594623040|FG002|Overall Study|Follow-up Visit Not Completed|1|||
164618030|NCT00565812|594623038|FG000|Overall Study|Physician Decision|2|||
164618031|NCT00565812|594623039|FG001|Overall Study|Physician Decision|0|||
164618032|NCT00565812|594623040|FG002|Overall Study|Physician Decision|0|||
164618033|NCT02896192|594623048|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
164618034|NCT02896192|594623048|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
164618035|NCT02896192|594623048|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
164618036|NCT00383708|594623052|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
164618037|NCT00383708|594623052|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
164618038|NCT00383708|594623052|FG000|Run-in Period|Protocol Violation|4|||
164618039|NCT00383708|594623052|FG000|Run-in Period|Adverse Event|2|||
164618040|NCT00383708|594623052|FG000|Run-in Period|Claustrophobia|1|||
164618041|NCT00383708|594623052|FG000|Co-administration Period|Adverse Event|5|||
164618042|NCT02820038|594623057|FG000|Overall Study|Lost to Follow-up|7|||
164618043|NCT02820038|594623058|FG001|Overall Study|Lost to Follow-up|11|||
164618044|NCT02820038|594623059|FG002|Overall Study|Lost to Follow-up|2|||
164618045|NCT02820038|594623060|FG003|Overall Study|Lost to Follow-up|9|||
164618046|NCT02820038|594623057|FG000|Overall Study|Withdrawal by Subject|3|||
164618047|NCT02820038|594623058|FG001|Overall Study|Withdrawal by Subject|14|||
164618048|NCT02820038|594623059|FG002|Overall Study|Withdrawal by Subject|3|||
164618049|NCT02820038|594623060|FG003|Overall Study|Withdrawal by Subject|13|||
164618050|NCT03934203|594623061|FG000|Overall Study|Adverse Event|0|||
164618051|NCT03934203|594623062|FG001|Overall Study|Adverse Event|0|||
164618052|NCT03934203|594623063|FG002|Overall Study|Adverse Event|1|||
164618053|NCT03934203|594623064|FG003|Overall Study|Adverse Event|0|||
164618054|NCT03934203|594623065|FG004|Overall Study|Adverse Event|1|||
164618055|NCT03934203|594623066|FG005|Overall Study|Adverse Event|0|||
164618056|NCT03934203|594623067|FG006|Overall Study|Adverse Event|2|||
164618057|NCT03934203|594623068|FG007|Overall Study|Adverse Event|0|||
164618058|NCT03934203|594623069|FG008|Overall Study|Adverse Event|0|||
164618059|NCT03934203|594623070|FG009|Overall Study|Adverse Event|0|||
164618060|NCT03934203|594623071|FG010|Overall Study|Adverse Event|0|||
164618061|NCT03934203|594623072|FG011|Overall Study|Adverse Event|0|||
164618062|NCT03934203|594623073|FG012|Overall Study|Adverse Event|0|||
164618063|NCT03934203|594623074|FG013|Overall Study|Adverse Event|1|||
164618064|NCT03934203|594623075|FG014|Overall Study|Adverse Event|0|||
164618065|NCT00899678|594623076|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
164618066|NCT00899678|594623077|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
164618067|NCT00899678|594623078|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
164618068|NCT00899678|594623076|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
164618069|NCT00899678|594623077|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
164618070|NCT00899678|594623078|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
164618071|NCT00899678|594623076|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
164618072|NCT00899678|594623077|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
164618073|NCT00899678|594623078|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
164618074|NCT00899678|594623076|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
164618075|NCT00899678|594623077|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
164618076|NCT00899678|594623078|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
164618077|NCT00899678|594623076|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
164618078|NCT00899678|594623077|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
164618079|NCT00899678|594623078|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
164618080|NCT00899678|594623076|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
164618081|NCT00899678|594623077|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
164618082|NCT00899678|594623078|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
164618083|NCT00899678|594623076|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
164618084|NCT00899678|594623077|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
164618085|NCT00899678|594623078|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
164618086|NCT00899678|594623076|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
164618087|NCT00899678|594623077|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
164618088|NCT00899678|594623078|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
164618089|NCT00899678|594623076|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
164618090|NCT00899678|594623077|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
164618091|NCT00899678|594623078|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
164618092|NCT00368472|594623085|FG000|Overall Study|Adverse Event|22|||
164618093|NCT00368472|594623085|FG000|Overall Study|Medication non-compliance|4|||
164618094|NCT00368472|594623085|FG000|Overall Study|Protocol Violation|2|||
164618095|NCT00368472|594623085|FG000|Overall Study|Request of Investigator or Sponsor|3|||
164618096|NCT00368472|594623085|FG000|Overall Study|Withdrawal by Subject|40|||
164618097|NCT00368472|594623085|FG000|Overall Study|Diary non-compliance|1|||
164618098|NCT00368472|594623085|FG000|Overall Study|Other|32|||
164618099|NCT00368472|594623085|FG000|Overall Study|Missing Final Disposition Date|1|||
164618100|NCT00422240|594623090|FG000|Overall Study|Lack of Efficacy|1|||
164618101|NCT00422240|594623091|FG001|Overall Study|Lack of Efficacy|2|||
164618102|NCT00422240|594623092|FG002|Overall Study|Lack of Efficacy|0|||
164618103|NCT00422240|594623093|FG003|Overall Study|Lack of Efficacy|1|||
164618104|NCT00422240|594623090|FG000|Overall Study|Adverse Event|11|||
164618105|NCT00422240|594623091|FG001|Overall Study|Adverse Event|4|||
164618106|NCT00422240|594623092|FG002|Overall Study|Adverse Event|5|||
164618107|NCT00422240|594623093|FG003|Overall Study|Adverse Event|2|||
164618108|NCT00422240|594623090|FG000|Overall Study|Subject request|21|||
164618109|NCT00422240|594623091|FG001|Overall Study|Subject request|17|||
164618110|NCT00422240|594623092|FG002|Overall Study|Subject request|18|||
164618111|NCT00422240|594623093|FG003|Overall Study|Subject request|30|||
164618112|NCT00422240|594623090|FG000|Overall Study|Protocol Violation|0|||
164618113|NCT00422240|594623091|FG001|Overall Study|Protocol Violation|1|||
164618114|NCT00422240|594623092|FG002|Overall Study|Protocol Violation|0|||
164618115|NCT00422240|594623093|FG003|Overall Study|Protocol Violation|1|||
164618116|NCT00422240|594623090|FG000|Overall Study|Lost to Follow-up|31|||
164618117|NCT00422240|594623091|FG001|Overall Study|Lost to Follow-up|32|||
164618118|NCT00422240|594623092|FG002|Overall Study|Lost to Follow-up|19|||
164618119|NCT00422240|594623093|FG003|Overall Study|Lost to Follow-up|34|||
164618120|NCT00422240|594623090|FG000|Overall Study|Other|1|||
164618121|NCT00422240|594623091|FG001|Overall Study|Other|0|||
164618122|NCT00422240|594623092|FG002|Overall Study|Other|0|||
164618123|NCT00422240|594623093|FG003|Overall Study|Other|1|||
164618124|NCT00422240|594623090|FG000|Overall Study|Pregnancy|3|||
164618125|NCT00422240|594623091|FG001|Overall Study|Pregnancy|1|||
164618126|NCT00422240|594623092|FG002|Overall Study|Pregnancy|1|||
164618127|NCT00422240|594623093|FG003|Overall Study|Pregnancy|2|||
164618128|NCT00901394|594623094|FG000|Overall Study|Physician Decision|1|||
164618129|NCT00901394|594623095|FG001|Overall Study|Physician Decision|1|||
164618130|NCT00901394|594623096|FG002|Overall Study|Physician Decision|2|||
164618131|NCT02650895|594623100|FG000|Overall Study|Withdrawal by Subject|0|||
164618132|NCT02650895|594623101|FG001|Overall Study|Withdrawal by Subject|1|||
164618133|NCT02650895|594623102|FG002|Overall Study|Withdrawal by Subject|0|||
164618134|NCT02650895|594623103|FG003|Overall Study|Withdrawal by Subject|0|||
164618135|NCT02650895|594623104|FG004|Overall Study|Withdrawal by Subject|0|||
164618136|NCT02650895|594623105|FG005|Overall Study|Withdrawal by Subject|0|||
164618137|NCT01167153|594623106|FG000|Overall Study|Non-effective therapy|1|||
164618138|NCT01167153|594623107|FG001|Overall Study|Non-effective therapy|4|||
164618139|NCT01167153|594623106|FG000|Overall Study|AE including clinical laboratory AE|2|||
164618140|NCT01167153|594623107|FG001|Overall Study|AE including clinical laboratory AE|8|||
164618141|NCT01167153|594623106|FG000|Overall Study|Hypotension|1|||
164618142|NCT01167153|594623107|FG001|Overall Study|Hypotension|0|||
164618143|NCT01167153|594623106|FG000|Overall Study|Lost to Follow-up|7|||
164618144|NCT01167153|594623107|FG001|Overall Study|Lost to Follow-up|9|||
164618145|NCT01167153|594623106|FG000|Overall Study|Non-compliance to concomitant medication|0|||
164618146|NCT01167153|594623107|FG001|Overall Study|Non-compliance to concomitant medication|2|||
164618147|NCT01167153|594623106|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
164618148|NCT01167153|594623107|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
164618149|NCT01167153|594623106|FG000|Overall Study|Withdrawal consent|1|||
164618150|NCT01167153|594623107|FG001|Overall Study|Withdrawal consent|1|||
164618151|NCT01167153|594623106|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
164618152|NCT01167153|594623107|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
164618153|NCT05643170|594625247|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
164618154|NCT05643170|594625247|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
164618155|NCT00777257|594625256|FG000|Overall Study|Adverse Event|3|||
164618156|NCT00777257|594625257|FG001|Overall Study|Adverse Event|1|||
164618157|NCT00777257|594625258|FG002|Overall Study|Adverse Event|0|||
164618158|NCT00777257|594625256|FG000|Overall Study|Lost to Follow-up|3|||
164618159|NCT00777257|594625257|FG001|Overall Study|Lost to Follow-up|3|||
164618160|NCT00777257|594625258|FG002|Overall Study|Lost to Follow-up|2|||
164618161|NCT00777257|594625256|FG000|Overall Study|Protocol Violation|2|||
164618162|NCT00777257|594625257|FG001|Overall Study|Protocol Violation|2|||
164618163|NCT00777257|594625258|FG002|Overall Study|Protocol Violation|2|||
164618164|NCT00777257|594625256|FG000|Overall Study|Withdrawal by Subject|3|||
164618165|NCT00777257|594625257|FG001|Overall Study|Withdrawal by Subject|6|||
164618166|NCT00777257|594625258|FG002|Overall Study|Withdrawal by Subject|5|||
164618167|NCT00444951|594625262|FG000|Overall Study|Lost to Follow-up|1|||
164618168|NCT00444951|594625263|FG001|Overall Study|Lost to Follow-up|1|||
164618169|NCT00444951|594625264|FG002|Overall Study|Lost to Follow-up|0|||
164618170|NCT00444951|594625262|FG000|Overall Study|Withdrawal by Subject|4|||
164618171|NCT00444951|594625263|FG001|Overall Study|Withdrawal by Subject|5|||
164618172|NCT00444951|594625264|FG002|Overall Study|Withdrawal by Subject|3|||
164618173|NCT02710422|594625265|FG000|Overall Study|Termination of study|9|||
164618174|NCT02710422|594625266|FG001|Overall Study|Termination of study|9|||
164521193|NCT00548262|594277017|FG000|Overall Study|Adverse Event|2|||
164521194|NCT00548262|594277017|FG000|Overall Study|Lack of Efficacy|4|||
164521195|NCT00548262|594277017|FG000|Overall Study|Lost to Follow-up|1|||
164521196|NCT00548262|594277017|FG000|Overall Study|Other|3|||
164521197|NCT00548262|594277017|FG000|Overall Study|Withdrawal by Subject|1|||
164521198|NCT01769326|594277023|FG000|Overall Study|Lost to Follow-up|1|||
164521199|NCT01769326|594277024|FG001|Overall Study|Lost to Follow-up|2|||
164521200|NCT01769326|594277025|FG002|Overall Study|Lost to Follow-up|0|||
164521201|NCT01769326|594277026|FG003|Overall Study|Lost to Follow-up|0|||
164521202|NCT01769326|594277023|FG000|Overall Study|unrelated injry|1|||
164521203|NCT01769326|594277024|FG001|Overall Study|unrelated injry|1|||
164521204|NCT01769326|594277025|FG002|Overall Study|unrelated injry|0|||
164521205|NCT01769326|594277026|FG003|Overall Study|unrelated injry|0|||
164521206|NCT01769326|594277023|FG000|Overall Study|got a job|0|||
164521207|NCT01769326|594277024|FG001|Overall Study|got a job|1|||
164521208|NCT01769326|594277025|FG002|Overall Study|got a job|0|||
164521209|NCT01769326|594277026|FG003|Overall Study|got a job|0|||
164521210|NCT01769326|594277023|FG000|Overall Study|Got sick and could not complete study|0|||
164521211|NCT01769326|594277024|FG001|Overall Study|Got sick and could not complete study|0|||
164521212|NCT01769326|594277025|FG002|Overall Study|Got sick and could not complete study|1|||
164521213|NCT01769326|594277026|FG003|Overall Study|Got sick and could not complete study|0|||
164521214|NCT03592745|594277027|FG000|Overall Study|Adverse Event|0|||
164521215|NCT03592745|594277028|FG001|Overall Study|Adverse Event|2|||
164521216|NCT03592745|594277027|FG000|Overall Study|Lost to Follow-up|2|||
164521217|NCT03592745|594277028|FG001|Overall Study|Lost to Follow-up|0|||
164521218|NCT03592745|594277027|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
164521219|NCT03592745|594277028|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
164521220|NCT00293059|594277029|FG000|Overall Study|Adverse Event|12|||
164521221|NCT00293059|594277030|FG001|Overall Study|Adverse Event|4|||
164521222|NCT00293059|594277029|FG000|Overall Study|Lack of Efficacy|2|||
164521223|NCT00293059|594277030|FG001|Overall Study|Lack of Efficacy|0|||
164521224|NCT00293059|594277029|FG000|Overall Study|Lost to Follow-up|2|||
164521225|NCT00293059|594277030|FG001|Overall Study|Lost to Follow-up|3|||
164521226|NCT00293059|594277029|FG000|Overall Study|Pregnancy|1|||
164521227|NCT00293059|594277030|FG001|Overall Study|Pregnancy|1|||
164521228|NCT00293059|594277029|FG000|Overall Study|Protocol Violation|2|||
164521229|NCT00293059|594277030|FG001|Overall Study|Protocol Violation|0|||
164521230|NCT00293059|594277029|FG000|Overall Study|Withdrawal by Subject|11|||
164521231|NCT00293059|594277030|FG001|Overall Study|Withdrawal by Subject|5|||
164521232|NCT00293059|594277029|FG000|Overall Study|Participant moved out of state|1|||
164521233|NCT00293059|594277030|FG001|Overall Study|Participant moved out of state|0|||
164521234|NCT00293059|594277029|FG000|Overall Study|Participant stopped study drug|1|||
164521235|NCT00293059|594277030|FG001|Overall Study|Participant stopped study drug|0|||
164521236|NCT00293059|594277029|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
164521237|NCT00293059|594277030|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
164521238|NCT00293059|594277029|FG000|Overall Study|missing|3|||
164521239|NCT00293059|594277030|FG001|Overall Study|missing|5|||
164521240|NCT01593787|594277033|FG000|Overall Study|Adverse Event|1|||
164521241|NCT01593787|594277034|FG001|Overall Study|Adverse Event|0|||
164521242|NCT01593787|594277035|FG002|Overall Study|Adverse Event|0|||
164521243|NCT01133418|594277038|FG000|Overall Study|Lost to Follow-up|5|||
164521244|NCT01133418|594277039|FG001|Overall Study|Lost to Follow-up|6|||
164521245|NCT04150068|594277040|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
164521246|NCT04150068|594277041|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
164521247|NCT04150068|594277042|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
164521248|NCT04150068|594277040|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
164521249|NCT04150068|594277041|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
164521250|NCT04150068|594277042|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
164521251|NCT05316701|594277043|FG000|Overall Study|Adverse Event|0|||
164521252|NCT05316701|594277044|FG001|Overall Study|Adverse Event|1|||
164521253|NCT05316701|594277043|FG000|Overall Study|Death|3|||
164521254|NCT05316701|594277044|FG001|Overall Study|Death|9|||
164521255|NCT05316701|594277043|FG000|Overall Study|Lost to Follow-up|1|||
164521256|NCT05316701|594277044|FG001|Overall Study|Lost to Follow-up|0|||
164521257|NCT05316701|594277043|FG000|Overall Study|Physician Decision|1|||
164521258|NCT05316701|594277044|FG001|Overall Study|Physician Decision|4|||
164521259|NCT05316701|594277043|FG000|Overall Study|Withdrawal by Subject|3|||
164521260|NCT05316701|594277044|FG001|Overall Study|Withdrawal by Subject|5|||
164618175|NCT01370499|594625267|FG000|Overall Study|Adverse Event|38|||
164618176|NCT01370499|594625268|FG001|Overall Study|Adverse Event|12|||
164618177|NCT01370499|594625267|FG000|Overall Study|Lack of Efficacy|4|||
164618178|NCT01370499|594625268|FG001|Overall Study|Lack of Efficacy|2|||
164618179|NCT01370499|594625267|FG000|Overall Study|Lost to Follow-up|2|||
164618180|NCT01370499|594625268|FG001|Overall Study|Lost to Follow-up|1|||
164618181|NCT01370499|594625267|FG000|Overall Study|Physician Decision|3|||
164618182|NCT01370499|594625268|FG001|Overall Study|Physician Decision|3|||
164618183|NCT01370499|594625267|FG000|Overall Study|Protocol Violation|5|||
164618184|NCT01370499|594625268|FG001|Overall Study|Protocol Violation|4|||
164618185|NCT01370499|594625267|FG000|Overall Study|Withdrawal by Subject|18|||
164618186|NCT01370499|594625268|FG001|Overall Study|Withdrawal by Subject|7|||
164618187|NCT01370499|594625267|FG000|Overall Study|Sponsor Decision|41|||
164618188|NCT01370499|594625268|FG001|Overall Study|Sponsor Decision|15|||
164618189|NCT00887822|594625269|FG000|Overall Study|Insufficient therapeutic response|53|||
164618190|NCT00887822|594625270|FG001|Overall Study|Insufficient therapeutic response|55|||
164618191|NCT00887822|594625269|FG000|Overall Study|Adverse Event|14|||
164618192|NCT00887822|594625270|FG001|Overall Study|Adverse Event|17|||
164618193|NCT00887822|594625269|FG000|Overall Study|Failure to return|11|||
164618194|NCT00887822|594625270|FG001|Overall Study|Failure to return|11|||
164618195|NCT00887822|594625269|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
164618196|NCT00887822|594625270|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
164618197|NCT00887822|594625269|FG000|Overall Study|Administrative/Other than specified|5|||
164618198|NCT00887822|594625270|FG001|Overall Study|Administrative/Other than specified|4|||
164618199|NCT00887822|594625269|FG000|Overall Study|Death|2|||
164618200|NCT00887822|594625270|FG001|Overall Study|Death|3|||
164618201|NCT00887822|594625269|FG000|Overall Study|Protocol Violation|0|||
164618202|NCT00887822|594625270|FG001|Overall Study|Protocol Violation|1|||
164618203|NCT00887822|594625269|FG000|Overall Study|Randomized but not treated|0|||
164618204|NCT00887822|594625270|FG001|Overall Study|Randomized but not treated|1|||
164618205|NCT02000622|594625271|FG000|Overall Study|Withdrawal by Subject|5|||
164618206|NCT02000622|594625272|FG001|Overall Study|Withdrawal by Subject|7|||
164618207|NCT02000622|594625271|FG000|Overall Study|Lost to Follow-up|4|||
164618208|NCT02000622|594625272|FG001|Overall Study|Lost to Follow-up|0|||
164618209|NCT02000622|594625271|FG000|Overall Study|Death|159|||
164618210|NCT02000622|594625272|FG001|Overall Study|Death|73|||
164618211|NCT02000622|594625271|FG000|Overall Study|Withdrawn due to site closure|1|||
164618212|NCT02000622|594625272|FG001|Overall Study|Withdrawn due to site closure|0|||
164618213|NCT01462045|594625273|FG000|Overall Study|Family matter|0|||
164618214|NCT01462045|594625274|FG001|Overall Study|Family matter|1|||
164618215|NCT01462045|594625275|FG002|Overall Study|Family matter|0|||
164618216|NCT01938391|594625280|FG000|6 Month Follow up|Withdrawal by Subject|1|||
164618217|NCT01938391|594625280|FG000|12 Month Follow up|Physician Decision|1|||
164618218|NCT01938391|594625280|FG000|12 Month Follow up|Withdrawal by Subject|1|||
164618219|NCT01077193|594625281|FG000|Overall Study|Lost to Follow-up|1|||
164618220|NCT01077193|594625281|FG000|Overall Study|Withdrawal by Subject|2|||
164618221|NCT01077193|594625281|FG000|Overall Study|Lack of Efficacy|1|||
164618222|NCT01077193|594625281|FG000|Overall Study|Study Terminated by Sponsor|40|||
164618223|NCT04924114|594625286|FG000|Overall Study|Withdrawal by Subject|0|||
164618224|NCT04924114|594625287|FG001|Overall Study|Withdrawal by Subject|2|||
164618225|NCT04924114|594625288|FG002|Overall Study|Withdrawal by Subject|2|||
164618226|NCT04924114|594625289|FG003|Overall Study|Withdrawal by Subject|0|||
164618227|NCT04924114|594625290|FG004|Overall Study|Withdrawal by Subject|2|||
164618228|NCT03558828|594625294|FG000|Overall Study|Lost to Follow-up|4|||
164618229|NCT03558828|594625295|FG001|Overall Study|Lost to Follow-up|3|||
164618230|NCT03558828|594625296|FG002|Overall Study|Lost to Follow-up|3|||
164618231|NCT03558828|594625297|FG003|Overall Study|Lost to Follow-up|5|||
164618232|NCT03558828|594625298|FG004|Overall Study|Lost to Follow-up|2|||
164618233|NCT03558828|594625299|FG005|Overall Study|Lost to Follow-up|3|||
164618234|NCT03558828|594625294|FG000|Overall Study|dropped before the intervention|1|||
164618235|NCT03558828|594625295|FG001|Overall Study|dropped before the intervention|1|||
164618236|NCT03558828|594625296|FG002|Overall Study|dropped before the intervention|0|||
164618237|NCT03558828|594625297|FG003|Overall Study|dropped before the intervention|0|||
164618238|NCT03558828|594625298|FG004|Overall Study|dropped before the intervention|0|||
164618239|NCT03558828|594625299|FG005|Overall Study|dropped before the intervention|0|||
164618240|NCT00378534|594625300|FG000|Overall Study|Participants did not receive transplant|3|||
164618241|NCT00378534|594625301|FG001|Overall Study|Participants did not receive transplant|0|||
164618242|NCT03671148|594625305|FG000|Overall Study|Adverse Event|3|||
164618243|NCT03671148|594625306|FG001|Overall Study|Adverse Event|2|||
164618244|NCT03671148|594625305|FG000|Overall Study|Withdrawal by Subject|8|||
164618245|NCT03671148|594625306|FG001|Overall Study|Withdrawal by Subject|2|||
164618246|NCT03671148|594625305|FG000|Overall Study|Lost to Follow-up|1|||
164618247|NCT03671148|594625306|FG001|Overall Study|Lost to Follow-up|2|||
164618248|NCT03671148|594625305|FG000|Overall Study|Lack of Efficacy|7|||
164618249|NCT03671148|594625306|FG001|Overall Study|Lack of Efficacy|2|||
164618250|NCT03671148|594625305|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
164618251|NCT03671148|594625306|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
164618252|NCT03671148|594625305|FG000|Overall Study|Other|1|||
164618253|NCT03671148|594625306|FG001|Overall Study|Other|0|||
164618254|NCT03671148|594625305|FG000|Overall Study|Incomplete Randomization Visit|1|||
164147380|NCT05168202|592902028|FG004|Overall Study|Lack of Efficacy|1|||
164618255|NCT03671148|594625306|FG001|Overall Study|Incomplete Randomization Visit|0|||
164521261|NCT05316701|594277043|FG000|Overall Study|Progression/Relapse|14|||
164521262|NCT05316701|594277044|FG001|Overall Study|Progression/Relapse|9|||
164521263|NCT05316701|594277043|FG000|Overall Study|Received Standard of Care|1|||
164521264|NCT05316701|594277044|FG001|Overall Study|Received Standard of Care|0|||
164521265|NCT05316701|594277043|FG000|Overall Study|Ongoing|70|||
164521266|NCT05316701|594277044|FG001|Overall Study|Ongoing|64|||
164521267|NCT04679935|594277045|FG000|Overall Study|Death|0|||
164521268|NCT04679935|594277046|FG001|Overall Study|Death|1|||
164521269|NCT04362189|594277048|FG000|Overall Study|Lost to Follow-up|0|||
164521270|NCT04362189|594277049|FG001|Overall Study|Lost to Follow-up|1|||
164521271|NCT04362189|594277048|FG000|Overall Study|Withdrawal by Subject|1|||
164521272|NCT04362189|594277049|FG001|Overall Study|Withdrawal by Subject|0|||
164521273|NCT04362189|594277048|FG000|Overall Study|FDA Clinical Hold|7|||
164521274|NCT04362189|594277049|FG001|Overall Study|FDA Clinical Hold|2|||
164521275|NCT04362189|594277048|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
164521276|NCT04362189|594277049|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
164521277|NCT04362189|594277048|FG000|Overall Study|Adverse Event|0|||
164521278|NCT04362189|594277049|FG001|Overall Study|Adverse Event|2|||
164521279|NCT04362189|594277048|FG000|Overall Study|Death|4|||
164521280|NCT04362189|594277049|FG001|Overall Study|Death|1|||
164521281|NCT02111681|594277050|FG000|Overall Study|Death|5|||
164521282|NCT02111681|594277050|FG000|Overall Study|Lack of Efficacy|2|||
164521283|NCT02111681|594277050|FG000|Overall Study|Progression of disease|4|||
164521284|NCT03981861|594277051|FG000|Overall Study|Withdrawal by Subject|3|||
164521285|NCT04058366|594278644|FG000|Overall Study|Adverse Event|14|||
164521286|NCT04058366|594278644|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
164521287|NCT04058366|594278644|FG000|Overall Study|Commercial drug is available for participants|6|||
164521288|NCT04058366|594278644|FG000|Overall Study|Death|1|||
164521289|NCT04058366|594278644|FG000|Overall Study|Other non-compliance|2|||
164521290|NCT04058366|594278644|FG000|Overall Study|Other|6|||
164521291|NCT02914275|594278645|FG000|Overall Study|Lost to Follow-up|84|||
164521292|NCT02914275|594278646|FG001|Overall Study|Lost to Follow-up|29|||
164521293|NCT02914275|594278645|FG000|Overall Study|Withdrawal by Subject|26|||
164521294|NCT02914275|594278646|FG001|Overall Study|Withdrawal by Subject|10|||
164521295|NCT02914275|594278645|FG000|Overall Study|Protocol Violation|1|||
164521296|NCT02914275|594278646|FG001|Overall Study|Protocol Violation|1|||
164521297|NCT02914275|594278645|FG000|Overall Study|Physician Decision|3|||
164521298|NCT02914275|594278646|FG001|Overall Study|Physician Decision|1|||
164521299|NCT02914275|594278645|FG000|Overall Study|Other|4|||
164521300|NCT02914275|594278646|FG001|Overall Study|Other|1|||
164521301|NCT02914275|594278645|FG000|Overall Study|Excluded due to invalid informed consent|3|||
164521302|NCT02914275|594278646|FG001|Overall Study|Excluded due to invalid informed consent|0|||
164521303|NCT00923260|594278647|FG000|Overall Study|Lost to Follow-up|1|||
164521304|NCT00923260|594278648|FG001|Overall Study|Lost to Follow-up|1|||
164521305|NCT02738203|594278655|FG000|Overall Study|Failed IUD Insertion|2|||
164521306|NCT02738203|594278656|FG001|Overall Study|Failed IUD Insertion|2|||
164521307|NCT02738203|594278655|FG000|Overall Study|Protocol Violation|0|||
164521308|NCT02738203|594278656|FG001|Overall Study|Protocol Violation|1|||
164521309|NCT05087979|594278657|FG000|Overall Study|Converted to general anesthesia|1|||
164521310|NCT05087979|594278658|FG001|Overall Study|Converted to general anesthesia|0|||
164521311|NCT02071290|594278661|FG000|Overall Study|Death|1|||
164521312|NCT02071290|594278662|FG001|Overall Study|Death|0|||
164521313|NCT02071290|594278661|FG000|Overall Study|Withdrawal by Subject|0|||
164521314|NCT02071290|594278662|FG001|Overall Study|Withdrawal by Subject|1|||
164521315|NCT02071290|594278661|FG000|Overall Study|Protocol Violation|3|||
164521316|NCT02071290|594278662|FG001|Overall Study|Protocol Violation|5|||
164521317|NCT02071290|594278661|FG000|Overall Study|Physician Decision|0|||
164521318|NCT02071290|594278662|FG001|Overall Study|Physician Decision|1|||
164521319|NCT05870228|594278664|FG000|Overall Study|Lost to Follow-up|2|||
164521320|NCT05870228|594278665|FG001|Overall Study|Lost to Follow-up|0|||
164521321|NCT05870228|594278664|FG000|Overall Study|Withdrawal by Subject|1|||
164618256|NCT00425945|594625307|FG000|Overall Study|Concern about Supplement|2|||
164618257|NCT00425945|594625308|FG001|Overall Study|Concern about Supplement|0|||
164618258|NCT00425945|594625307|FG000|Overall Study|Inconvenience|0|||
164618259|NCT00425945|594625308|FG001|Overall Study|Inconvenience|2|||
164618260|NCT00425945|594625307|FG000|Overall Study|Lost to Follow-up|0|||
164618261|NCT00425945|594625308|FG001|Overall Study|Lost to Follow-up|2|||
164618262|NCT00425945|594625307|FG000|Overall Study|Began hypertension medication|1|||
164618263|NCT00425945|594625308|FG001|Overall Study|Began hypertension medication|0|||
164618264|NCT00425945|594625307|FG000|Overall Study|Began cancer treatments|1|||
164618265|NCT00425945|594625308|FG001|Overall Study|Began cancer treatments|0|||
164618266|NCT00425945|594625307|FG000|Overall Study|Moved from area|0|||
164618267|NCT00425945|594625308|FG001|Overall Study|Moved from area|1|||
164618268|NCT03878160|594625312|FG000|Overall Study|Lost to Follow-up|1|||
164618269|NCT03878160|594625313|FG001|Overall Study|Lost to Follow-up|1|||
164618270|NCT03878160|594625314|FG002|Overall Study|Lost to Follow-up|1|||
164618271|NCT03878160|594625312|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
164618272|NCT03878160|594625313|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
164618273|NCT03878160|594625314|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
164618274|NCT00673816|594625315|FG000|Overall Study|Adverse Event|1|||
164618275|NCT00673816|594625315|FG000|Overall Study|Withdrawal by Subject|1|||
164618276|NCT05618808|594625318|FG000|Overall Study|Withdrawal by Subject|3|||
164618277|NCT05618808|594625319|FG001|Overall Study|Withdrawal by Subject|1|||
164618278|NCT05618808|594625320|FG002|Overall Study|Withdrawal by Subject|3|||
164618279|NCT01804842|594625324|FG000|Overall Study|Adverse Event|1|||
164618280|NCT01804842|594625325|FG001|Overall Study|Adverse Event|1|||
164618281|NCT01804842|594625326|FG002|Overall Study|Adverse Event|0|||
164618282|NCT01804842|594625324|FG000|Overall Study|Lost to Follow-up|1|||
164618283|NCT01804842|594625325|FG001|Overall Study|Lost to Follow-up|0|||
164618284|NCT01804842|594625326|FG002|Overall Study|Lost to Follow-up|0|||
164618285|NCT01804842|594625324|FG000|Overall Study|Non-Compliance|1|||
164618286|NCT01804842|594625325|FG001|Overall Study|Non-Compliance|1|||
164618287|NCT01804842|594625326|FG002|Overall Study|Non-Compliance|0|||
164618288|NCT01804842|594625324|FG000|Overall Study|Personal Reason|0|||
164618289|NCT01804842|594625325|FG001|Overall Study|Personal Reason|0|||
164618290|NCT01804842|594625326|FG002|Overall Study|Personal Reason|1|||
164618291|NCT02365506|594625329|FG000|Overall Study|Investigator's Discretion|0|||
164618292|NCT02365506|594625330|FG001|Overall Study|Investigator's Discretion|0|||
164618293|NCT02365506|594625331|FG002|Overall Study|Investigator's Discretion|1|||
164618294|NCT03774875|594625332|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
164618295|NCT03774875|594625333|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
164618296|NCT03774875|594625332|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
164618297|NCT03774875|594625333|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
164618298|NCT03774875|594625332|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
164618299|NCT03774875|594625333|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
164618300|NCT03774875|594625332|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
164618301|NCT03774875|594625333|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
164618302|NCT03774875|594625332|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
164618303|NCT03774875|594625333|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
164618304|NCT03774875|594625332|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
164618305|NCT03774875|594625333|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
164618306|NCT03774875|594625332|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
164618307|NCT03774875|594625333|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
164618308|NCT03774875|594625332|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
164618309|NCT03774875|594625333|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
164618310|NCT03774875|594625332|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
164618311|NCT03774875|594625333|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
164618312|NCT03774875|594625332|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
164618313|NCT03774875|594625333|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
164618314|NCT03774875|594625332|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
164618315|NCT03774875|594625333|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
164618316|NCT03774875|594625332|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
164618317|NCT03774875|594625333|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
164618318|NCT03774875|594625332|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
164618319|NCT03774875|594625333|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
164618320|NCT02352090|594625334|FG000|Overall Study|general malaise|1|||
164618321|NCT02352090|594625335|FG001|Overall Study|general malaise|0|||
164618322|NCT02352090|594625336|FG002|Overall Study|general malaise|0|||
164618323|NCT02352090|594625334|FG000|Overall Study|non-specified mild side-effects|0|||
164618324|NCT02352090|594625335|FG001|Overall Study|non-specified mild side-effects|0|||
164618325|NCT02352090|594625336|FG002|Overall Study|non-specified mild side-effects|2|||
164618326|NCT06048367|594625339|FG000|Overall Study|Withdrawal by Subject|0|||
164521322|NCT05870228|594278665|FG001|Overall Study|Withdrawal by Subject|0|||
164521323|NCT01871805|594278666|FG000|Phase I|Death|7|||
164521324|NCT01871805|594278667|FG001|Phase I|Death|4|||
164521325|NCT01871805|594278668|FG002|Phase I|Death|6|||
164521326|NCT01871805|594278669|FG003|Phase I|Death|2|||
164521327|NCT01871805|594278670|FG004|Phase I|Death|9|||
164521328|NCT01871805|594278671|FG005|Phase I|Death|0|||
164521329|NCT01871805|594278666|FG000|Phase I|Alive in Survival Follow-up|0|||
164521330|NCT01871805|594278667|FG001|Phase I|Alive in Survival Follow-up|2|||
164521331|NCT01871805|594278668|FG002|Phase I|Alive in Survival Follow-up|4|||
164521332|NCT01871805|594278669|FG003|Phase I|Alive in Survival Follow-up|5|||
164521333|NCT01871805|594278670|FG004|Phase I|Alive in Survival Follow-up|4|||
164521334|NCT01871805|594278671|FG005|Phase I|Alive in Survival Follow-up|0|||
164521335|NCT01871805|594278666|FG000|Phase I|Lost to Follow-up|0|||
164521336|NCT01871805|594278667|FG001|Phase I|Lost to Follow-up|1|||
164521337|NCT01871805|594278668|FG002|Phase I|Lost to Follow-up|3|||
164521338|NCT01871805|594278669|FG003|Phase I|Lost to Follow-up|0|||
164521339|NCT01871805|594278670|FG004|Phase I|Lost to Follow-up|0|||
164521340|NCT01871805|594278671|FG005|Phase I|Lost to Follow-up|0|||
164521341|NCT01871805|594278666|FG000|Phase II|Death|0|||
164521342|NCT01871805|594278667|FG001|Phase II|Death|0|||
164521343|NCT01871805|594278668|FG002|Phase II|Death|0|||
164521344|NCT01871805|594278669|FG003|Phase II|Death|0|||
164521345|NCT01871805|594278670|FG004|Phase II|Death|0|||
164521346|NCT01871805|594278671|FG005|Phase II|Death|45|||
164521347|NCT01871805|594278666|FG000|Phase II|Alive in Survival Follow-up|0|||
164521348|NCT01871805|594278667|FG001|Phase II|Alive in Survival Follow-up|0|||
164521349|NCT01871805|594278668|FG002|Phase II|Alive in Survival Follow-up|0|||
164521350|NCT01871805|594278669|FG003|Phase II|Alive in Survival Follow-up|0|||
164521351|NCT01871805|594278670|FG004|Phase II|Alive in Survival Follow-up|0|||
164521352|NCT01871805|594278671|FG005|Phase II|Alive in Survival Follow-up|29|||
164521353|NCT01871805|594278666|FG000|Phase II|Lost to Follow-up|0|||
164521354|NCT01871805|594278667|FG001|Phase II|Lost to Follow-up|0|||
164521355|NCT01871805|594278668|FG002|Phase II|Lost to Follow-up|0|||
164521356|NCT01871805|594278669|FG003|Phase II|Lost to Follow-up|0|||
164521357|NCT01871805|594278670|FG004|Phase II|Lost to Follow-up|0|||
164521358|NCT01871805|594278671|FG005|Phase II|Lost to Follow-up|13|||
164521359|NCT03484273|594278676|FG000|Overall Study|Equipment Malfunction|1|||
164521360|NCT03484273|594278676|FG000|Overall Study|Data excluded from analysis|1|||
164521361|NCT04075994|594278677|FG000|Overall Study|Withdrawal by Subject|8|||
164521362|NCT04075994|594278678|FG001|Overall Study|Withdrawal by Subject|9|||
164521363|NCT04075994|594278677|FG000|Overall Study|Adverse Event|2|||
164521364|NCT04075994|594278678|FG001|Overall Study|Adverse Event|2|||
164521365|NCT04075994|594278677|FG000|Overall Study|Investigator withdrew|3|||
164521366|NCT04075994|594278678|FG001|Overall Study|Investigator withdrew|1|||
164521367|NCT00468104|594278681|FG000|First Intervention|Protocol Violation|2|||
164521368|NCT00468104|594278682|FG001|First Intervention|Protocol Violation|1|||
164521369|NCT00468104|594278681|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
164521370|NCT00468104|594278682|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
164521371|NCT00468104|594278681|FG000|First Intervention|died within 3 weeks|1|||
164521372|NCT00468104|594278682|FG001|First Intervention|died within 3 weeks|0|||
164521373|NCT00468104|594278681|FG000|First Intervention|malposition/blocked chest tube tube|2|||
164521374|NCT00468104|594278682|FG001|First Intervention|malposition/blocked chest tube tube|0|||
164521375|NCT00468104|594278681|FG000|First Intervention|large lung mass with minimal effusion|1|||
164521376|NCT00468104|594278682|FG001|First Intervention|large lung mass with minimal effusion|0|||
164521377|NCT00468104|594278681|FG000|First Intervention|associated prolonged pneumothorax|1|||
164521378|NCT00468104|594278682|FG001|First Intervention|associated prolonged pneumothorax|0|||
164521379|NCT00468104|594278681|FG000|First Intervention|trapped lung|1|||
164521380|NCT00468104|594278682|FG001|First Intervention|trapped lung|0|||
164521381|NCT00468104|594278681|FG000|Second Intervention|Withdrawal by Subject|5|||
164521382|NCT00468104|594278682|FG001|Second Intervention|Withdrawal by Subject|2|||
164521383|NCT00468104|594278681|FG000|Second Intervention|discarded for malposition of chest tube|0|||
164521384|NCT00468104|594278682|FG001|Second Intervention|discarded for malposition of chest tube|2|||
164521385|NCT01263665|594278683|FG000|Overall Study|Withdrew Consent|1|||
164521386|NCT01263665|594278683|FG000|Overall Study|Lost to Follow-up|3|||
164521387|NCT01263665|594278683|FG000|Overall Study|Death|2|||
164521388|NCT01263665|594278683|FG000|Overall Study|Amputation above the ankle|1|||
164521389|NCT01263665|594278683|FG000|Overall Study|Surgical Bypass|2|||
164521390|NCT00324675|594278688|FG000|Overall Study|Adverse Event|1|||
164521391|NCT00324675|594278689|FG001|Overall Study|Adverse Event|0|||
164521392|NCT01941719|594278692|FG000|Overall Study|Lost to Follow-up|20|||
164521393|NCT01941719|594278693|FG001|Overall Study|Lost to Follow-up|19|||
164521394|NCT00381615|594278694|FG000|Overall Study|Withdrawal by Subject|1|||
164521395|NCT00381615|594278695|FG001|Overall Study|Withdrawal by Subject|3|||
164521396|NCT00381615|594278696|FG002|Overall Study|Withdrawal by Subject|0|||
164521397|NCT00381615|594278697|FG003|Overall Study|Withdrawal by Subject|1|||
164521398|NCT00381615|594278694|FG000|Overall Study|Lost to Follow-up|3|||
164521399|NCT00381615|594278695|FG001|Overall Study|Lost to Follow-up|2|||
164521400|NCT00381615|594278696|FG002|Overall Study|Lost to Follow-up|0|||
164521401|NCT00381615|594278697|FG003|Overall Study|Lost to Follow-up|1|||
164521402|NCT00381615|594278694|FG000|Overall Study|Protocol Violation|0|||
164521403|NCT00381615|594278695|FG001|Overall Study|Protocol Violation|0|||
164618327|NCT06048367|594625340|FG001|Overall Study|Withdrawal by Subject|1|||
164618328|NCT06048367|594625341|FG002|Overall Study|Withdrawal by Subject|0|||
164618329|NCT06048367|594625342|FG003|Overall Study|Withdrawal by Subject|0|||
164618330|NCT06048367|594625343|FG004|Overall Study|Withdrawal by Subject|0|||
164618331|NCT06048367|594625339|FG000|Overall Study|Withdrawal by Subject|0|||
164618332|NCT06048367|594625340|FG001|Overall Study|Withdrawal by Subject|0|||
164618333|NCT06048367|594625341|FG002|Overall Study|Withdrawal by Subject|1|||
164618334|NCT06048367|594625342|FG003|Overall Study|Withdrawal by Subject|0|||
164618335|NCT06048367|594625343|FG004|Overall Study|Withdrawal by Subject|0|||
164618336|NCT06048367|594625339|FG000|Overall Study|Withdrawal by Subject|0|||
164618337|NCT06048367|594625340|FG001|Overall Study|Withdrawal by Subject|0|||
164618338|NCT06048367|594625341|FG002|Overall Study|Withdrawal by Subject|0|||
164618339|NCT06048367|594625342|FG003|Overall Study|Withdrawal by Subject|1|||
164618340|NCT06048367|594625343|FG004|Overall Study|Withdrawal by Subject|0|||
164618341|NCT06048367|594625339|FG000|Overall Study|Withdrawal by Subject|0|||
164618342|NCT06048367|594625340|FG001|Overall Study|Withdrawal by Subject|0|||
164618343|NCT06048367|594625341|FG002|Overall Study|Withdrawal by Subject|0|||
164618344|NCT06048367|594625342|FG003|Overall Study|Withdrawal by Subject|1|||
164618345|NCT06048367|594625343|FG004|Overall Study|Withdrawal by Subject|0|||
164618346|NCT00413777|594625347|FG000|Fixed-dose Period|Lost to Follow-up|1|||
164618347|NCT00413777|594625348|FG001|Fixed-dose Period|Lost to Follow-up|1|||
164618348|NCT00413777|594625347|FG000|Fixed-dose Period|Adverse Event|2|||
164618349|NCT00413777|594625348|FG001|Fixed-dose Period|Adverse Event|1|||
164618350|NCT00413777|594625347|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
164618351|NCT00413777|594625348|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
164618352|NCT00413777|594625347|FG000|Fixed-dose Period|Withdrew Consent|0|||
164521404|NCT00381615|594278696|FG002|Overall Study|Protocol Violation|1|||
164521405|NCT00381615|594278697|FG003|Overall Study|Protocol Violation|0|||
164521406|NCT02797080|594278701|FG000|Overall Study|Lost to Follow-up|1|||
164521407|NCT02797080|594278701|FG000|Overall Study|Withdrawal by Subject|1|||
164521408|NCT00951015|594278702|FG000|Randomization Phase 96 Week|Adverse Event|1|||
164521409|NCT00951015|594278703|FG001|Randomization Phase 96 Week|Adverse Event|1|||
164521410|NCT00951015|594278704|FG002|Randomization Phase 96 Week|Adverse Event|2|||
164521411|NCT00951015|594278705|FG003|Randomization Phase 96 Week|Adverse Event|5|||
164521412|NCT00951015|594278706|FG004|Randomization Phase 96 Week|Adverse Event|0|||
164521413|NCT00951015|594278702|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
164521414|NCT00951015|594278703|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
164521415|NCT00951015|594278704|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
164521416|NCT00951015|594278705|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
164521417|NCT00951015|594278706|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
164521418|NCT00951015|594278702|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
164521419|NCT00951015|594278703|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
164618353|NCT00413777|594625348|FG001|Fixed-dose Period|Withdrew Consent|1|||
164618354|NCT01678313|594625349|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
164618355|NCT01678313|594625350|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
164618356|NCT01678313|594625349|FG000|Completed the 3-month Therapy|Physician Decision|3|||
164618357|NCT01678313|594625350|FG001|Completed the 3-month Therapy|Physician Decision|4|||
164618358|NCT01678313|594625349|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
164618359|NCT01678313|594625350|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
164618360|NCT01678313|594625349|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
164618361|NCT01678313|594625350|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
164618362|NCT00981292|594625351|FG000|Day 1|Protocol Violation|1|||
164618363|NCT00981292|594625352|FG001|Day 1|Protocol Violation|0|||
164618364|NCT00981292|594625353|FG002|Day 1|Protocol Violation|0|||
164618365|NCT00981292|594625354|FG003|Day 1|Protocol Violation|0|||
164618366|NCT00981292|594625355|FG004|Day 1|Protocol Violation|0|||
164618367|NCT00981292|594625356|FG005|Day 1|Protocol Violation|2|||
164618368|NCT00981292|594625351|FG000|Day 2|Protocol Violation|2|||
164618369|NCT00981292|594625352|FG001|Day 2|Protocol Violation|0|||
164618370|NCT00981292|594625353|FG002|Day 2|Protocol Violation|0|||
164521420|NCT00951015|594278704|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
164521421|NCT00951015|594278705|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
164521422|NCT00951015|594278706|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
164521423|NCT00951015|594278702|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
164521424|NCT00951015|594278703|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
164521425|NCT00951015|594278704|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
164521426|NCT00951015|594278705|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
164521427|NCT00951015|594278706|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
164521428|NCT00951015|594278702|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
164521429|NCT00951015|594278703|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
164521430|NCT00951015|594278704|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
164521431|NCT00951015|594278705|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
164521432|NCT00951015|594278706|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
164521433|NCT00951015|594278702|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
164521434|NCT00951015|594278703|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
164521435|NCT00951015|594278704|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
164521436|NCT00951015|594278705|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
164521437|NCT00951015|594278706|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
164521438|NCT00951015|594278702|FG000|Open-label Phase|Adverse Event|0|||
164521439|NCT00951015|594278703|FG001|Open-label Phase|Adverse Event|0|||
164521440|NCT00951015|594278704|FG002|Open-label Phase|Adverse Event|0|||
164521441|NCT00951015|594278705|FG003|Open-label Phase|Adverse Event|0|||
164521442|NCT00951015|594278706|FG004|Open-label Phase|Adverse Event|3|||
164521443|NCT00951015|594278702|FG000|Open-label Phase|Lack of Efficacy|0|||
164521444|NCT00951015|594278703|FG001|Open-label Phase|Lack of Efficacy|0|||
164521445|NCT00951015|594278704|FG002|Open-label Phase|Lack of Efficacy|0|||
164521446|NCT00951015|594278705|FG003|Open-label Phase|Lack of Efficacy|0|||
164521447|NCT00951015|594278706|FG004|Open-label Phase|Lack of Efficacy|1|||
164521448|NCT00951015|594278702|FG000|Open-label Phase|Protocol Violation|0|||
164521449|NCT00951015|594278703|FG001|Open-label Phase|Protocol Violation|0|||
164521450|NCT00951015|594278704|FG002|Open-label Phase|Protocol Violation|0|||
164521451|NCT00951015|594278705|FG003|Open-label Phase|Protocol Violation|0|||
164521452|NCT00951015|594278706|FG004|Open-label Phase|Protocol Violation|12|||
164521453|NCT00951015|594278702|FG000|Open-label Phase|Lost to Follow-up|0|||
164521454|NCT00951015|594278703|FG001|Open-label Phase|Lost to Follow-up|0|||
164521455|NCT00951015|594278704|FG002|Open-label Phase|Lost to Follow-up|0|||
164521456|NCT00951015|594278705|FG003|Open-label Phase|Lost to Follow-up|0|||
164521457|NCT00951015|594278706|FG004|Open-label Phase|Lost to Follow-up|12|||
164521458|NCT00951015|594278702|FG000|Open-label Phase|Withdrawal by Subject|0|||
164521459|NCT00951015|594278703|FG001|Open-label Phase|Withdrawal by Subject|0|||
164521460|NCT00951015|594278704|FG002|Open-label Phase|Withdrawal by Subject|0|||
164521461|NCT00951015|594278705|FG003|Open-label Phase|Withdrawal by Subject|0|||
164521462|NCT00951015|594278706|FG004|Open-label Phase|Withdrawal by Subject|14|||
164521463|NCT00951015|594278702|FG000|Open-label Phase|Physician Decision|0|||
164521464|NCT00951015|594278703|FG001|Open-label Phase|Physician Decision|0|||
164521465|NCT00951015|594278704|FG002|Open-label Phase|Physician Decision|0|||
164521466|NCT00951015|594278705|FG003|Open-label Phase|Physician Decision|0|||
164521467|NCT00951015|594278706|FG004|Open-label Phase|Physician Decision|8|||
164521468|NCT03819634|594278708|FG000|Overall Study|Physician Decision|2|||
164521469|NCT01416389|594278709|FG000|Overall Study|Lost to Follow-up|1|||
164521470|NCT01416389|594278710|FG001|Overall Study|Lost to Follow-up|0|||
164521471|NCT01416389|594278709|FG000|Overall Study|Started New Therapy|2|||
164521472|NCT01416389|594278710|FG001|Overall Study|Started New Therapy|0|||
164521473|NCT00958841|594278711|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164521474|NCT00958841|594278711|FG000|Overall Study|Abnormal test procedure result(s)|3|||
164521475|NCT00958841|594278711|FG000|Overall Study|Administrative problems|1|||
164521476|NCT00958841|594278711|FG000|Overall Study|Adverse Event|8|||
164521477|NCT00958841|594278711|FG000|Overall Study|New cancer therapy|5|||
164521478|NCT00958841|594278711|FG000|Overall Study|Withdrawal by Subject|1|||
164521479|NCT00958841|594278711|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
164521480|NCT00958841|594278711|FG000|Overall Study|Completed M6/did not enter extension|27|||
164521481|NCT00958841|594278711|FG000|Overall Study|Discontinued prior to M*|28|||
164521482|NCT01125514|594278719|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
164521483|NCT01125514|594278719|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
164521484|NCT01125514|594278719|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
164521485|NCT01125514|594278719|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
164521486|NCT01125514|594278719|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
164521487|NCT01125514|594278719|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
164521488|NCT00858364|594278720|FG000|Overall Study|Administrative Decision|3|||
164521489|NCT00858364|594278721|FG001|Overall Study|Administrative Decision|2|||
164521490|NCT00858364|594278720|FG000|Overall Study|Adverse Event|5|||
164521491|NCT00858364|594278721|FG001|Overall Study|Adverse Event|2|||
164521492|NCT00858364|594278720|FG000|Overall Study|Withdrawal by Subject|44|||
164521493|NCT00858364|594278721|FG001|Overall Study|Withdrawal by Subject|118|||
164521494|NCT00858364|594278720|FG000|Overall Study|Ineligibility Determined|1|||
164521495|NCT00858364|594278721|FG001|Overall Study|Ineligibility Determined|10|||
164521496|NCT00858364|594278720|FG000|Overall Study|Lost to Follow-up|24|||
164521497|NCT00858364|594278721|FG001|Overall Study|Lost to Follow-up|54|||
164521498|NCT00858364|594278720|FG000|Overall Study|Noncompliance|3|||
164521499|NCT00858364|594278721|FG001|Overall Study|Noncompliance|4|||
164521500|NCT00858364|594278720|FG000|Overall Study|Protocol Deviation|0|||
164521501|NCT00858364|594278721|FG001|Overall Study|Protocol Deviation|2|||
164521502|NCT00858364|594278720|FG000|Overall Study|Other|9|||
164521503|NCT00858364|594278721|FG001|Overall Study|Other|17|||
164521504|NCT00858364|594278720|FG000|Overall Study|Missing|1|||
164521505|NCT00858364|594278721|FG001|Overall Study|Missing|1|||
164521506|NCT00858364|594278720|FG000|Overall Study|Still on-study|114|||
164521507|NCT00858364|594278721|FG001|Overall Study|Still on-study|247|||
164521508|NCT01655693|594278725|FG000|Overall Study|Progression of Disease|92|||
164521509|NCT01655693|594278726|FG001|Overall Study|Progression of Disease|76|||
164521510|NCT01655693|594278727|FG002|Overall Study|Progression of Disease|58|||
164521511|NCT01655693|594278725|FG000|Overall Study|Death|8|||
164521512|NCT01655693|594278726|FG001|Overall Study|Death|9|||
164521513|NCT01655693|594278727|FG002|Overall Study|Death|12|||
164521514|NCT01655693|594278725|FG000|Overall Study|Serious Adverse Event|3|||
164521515|NCT01655693|594278726|FG001|Overall Study|Serious Adverse Event|15|||
164521516|NCT01655693|594278727|FG002|Overall Study|Serious Adverse Event|11|||
164521517|NCT01655693|594278725|FG000|Overall Study|Withdrawal by Subject|3|||
164521518|NCT01655693|594278726|FG001|Overall Study|Withdrawal by Subject|2|||
164521519|NCT01655693|594278727|FG002|Overall Study|Withdrawal by Subject|20|||
164521520|NCT01655693|594278725|FG000|Overall Study|Adverse Event|3|||
164521521|NCT01655693|594278726|FG001|Overall Study|Adverse Event|11|||
164521522|NCT01655693|594278727|FG002|Overall Study|Adverse Event|3|||
164521523|NCT01655693|594278725|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
164521524|NCT01655693|594278726|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
164521525|NCT01655693|594278727|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
164521526|NCT01655693|594278725|FG000|Overall Study|Non-Compliance|0|||
164521527|NCT01655693|594278726|FG001|Overall Study|Non-Compliance|0|||
164521528|NCT01655693|594278727|FG002|Overall Study|Non-Compliance|7|||
164521529|NCT01655693|594278725|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
164521530|NCT01655693|594278726|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
164521531|NCT01655693|594278727|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
164521532|NCT01655693|594278725|FG000|Overall Study|Protocol Violation|1|||
164521533|NCT01655693|594278726|FG001|Overall Study|Protocol Violation|0|||
164521534|NCT01655693|594278727|FG002|Overall Study|Protocol Violation|3|||
164521535|NCT01655693|594278725|FG000|Overall Study|Lost to Follow-up|1|||
164521536|NCT01655693|594278726|FG001|Overall Study|Lost to Follow-up|0|||
164521537|NCT01655693|594278727|FG002|Overall Study|Lost to Follow-up|1|||
164521538|NCT01655693|594278725|FG000|Overall Study|Screening Failure|1|||
164521539|NCT01655693|594278726|FG001|Overall Study|Screening Failure|0|||
164521540|NCT01655693|594278727|FG002|Overall Study|Screening Failure|0|||
164521541|NCT01655693|594278725|FG000|Overall Study|Other|8|||
164521542|NCT01655693|594278726|FG001|Overall Study|Other|6|||
164521543|NCT01655693|594278727|FG002|Overall Study|Other|15|||
164521544|NCT00929110|594278730|FG000|Overall Study|Adverse Event|40|||
164521545|NCT00929110|594278731|FG001|Overall Study|Adverse Event|29|||
164521546|NCT00929110|594278732|FG002|Overall Study|Adverse Event|18|||
164521547|NCT00929110|594278730|FG000|Overall Study|Subject withdrew consent|40|||
164521548|NCT00929110|594278731|FG001|Overall Study|Subject withdrew consent|23|||
164521549|NCT00929110|594278732|FG002|Overall Study|Subject withdrew consent|26|||
164521550|NCT00929110|594278730|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
164521551|NCT00929110|594278731|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
164521552|NCT00929110|594278732|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
164521553|NCT00929110|594278730|FG000|Overall Study|Lost to Follow-up|7|||
164521554|NCT00929110|594278731|FG001|Overall Study|Lost to Follow-up|7|||
164521555|NCT00929110|594278732|FG002|Overall Study|Lost to Follow-up|3|||
164521556|NCT00929110|594278730|FG000|Overall Study|Protocol deviation|5|||
164521557|NCT00929110|594278731|FG001|Overall Study|Protocol deviation|2|||
164521558|NCT00929110|594278732|FG002|Overall Study|Protocol deviation|4|||
164521559|NCT00929110|594278730|FG000|Overall Study|Administrative problems|4|||
164521560|NCT00929110|594278731|FG001|Overall Study|Administrative problems|1|||
164521561|NCT00929110|594278732|FG002|Overall Study|Administrative problems|2|||
164521562|NCT00929110|594278730|FG000|Overall Study|Death|2|||
164521563|NCT00929110|594278731|FG001|Overall Study|Death|2|||
164618371|NCT00981292|594625354|FG003|Day 2|Protocol Violation|0|||
164618372|NCT00981292|594625355|FG004|Day 2|Protocol Violation|0|||
164618373|NCT00981292|594625356|FG005|Day 2|Protocol Violation|0|||
164618374|NCT00981292|594625351|FG000|Day 3|Protocol Violation|0|||
164618375|NCT00981292|594625352|FG001|Day 3|Protocol Violation|0|||
164618376|NCT00981292|594625353|FG002|Day 3|Protocol Violation|0|||
164618377|NCT00981292|594625354|FG003|Day 3|Protocol Violation|0|||
164618378|NCT00981292|594625355|FG004|Day 3|Protocol Violation|0|||
164618379|NCT00981292|594625356|FG005|Day 3|Protocol Violation|1|||
164618380|NCT05179057|594625357|FG000|Overall Study|Adverse Event|3|||
164618381|NCT05179057|594625358|FG001|Overall Study|Adverse Event|2|||
164618382|NCT05179057|594625357|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
164618383|NCT05179057|594625358|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
164618384|NCT05179057|594625357|FG000|Overall Study|Study terminated|13|||
164618385|NCT05179057|594625358|FG001|Overall Study|Study terminated|7|||
164618386|NCT05179057|594625357|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
164618387|NCT05179057|594625358|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
164618388|NCT05179057|594625357|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
164618389|NCT05179057|594625358|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
164618390|NCT03345342|594625359|FG000|Open-Label Phase|Adverse Event|30|||
164618391|NCT03345342|594625360|FG001|Open-Label Phase|Adverse Event|0|||
164618392|NCT03345342|594625361|FG002|Open-Label Phase|Adverse Event|0|||
164618393|NCT03345342|594625362|FG003|Open-Label Phase|Adverse Event|0|||
164618394|NCT03345342|594625363|FG004|Open-Label Phase|Adverse Event|0|||
164618395|NCT03345342|594625359|FG000|Open-Label Phase|Death|1|||
164618396|NCT03345342|594625360|FG001|Open-Label Phase|Death|0|||
164618397|NCT03345342|594625361|FG002|Open-Label Phase|Death|0|||
164618398|NCT03345342|594625362|FG003|Open-Label Phase|Death|0|||
164618399|NCT03345342|594625363|FG004|Open-Label Phase|Death|0|||
164618400|NCT03345342|594625359|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
164618401|NCT03345342|594625360|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
164618402|NCT03345342|594625361|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
164618403|NCT03345342|594625362|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
164618404|NCT03345342|594625363|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
164618405|NCT03345342|594625359|FG000|Open-Label Phase|Lack of Efficacy|6|||
164618406|NCT03345342|594625360|FG001|Open-Label Phase|Lack of Efficacy|0|||
164618407|NCT03345342|594625361|FG002|Open-Label Phase|Lack of Efficacy|0|||
164618408|NCT03345342|594625362|FG003|Open-Label Phase|Lack of Efficacy|0|||
164618409|NCT03345342|594625363|FG004|Open-Label Phase|Lack of Efficacy|0|||
164618410|NCT03345342|594625359|FG000|Open-Label Phase|Lost to Follow-up|9|||
164618411|NCT03345342|594625360|FG001|Open-Label Phase|Lost to Follow-up|0|||
164618412|NCT03345342|594625361|FG002|Open-Label Phase|Lost to Follow-up|0|||
164618413|NCT03345342|594625362|FG003|Open-Label Phase|Lost to Follow-up|0|||
164618414|NCT03345342|594625363|FG004|Open-Label Phase|Lost to Follow-up|0|||
164618415|NCT03345342|594625359|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
164618416|NCT03345342|594625360|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
164618417|NCT03345342|594625361|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
164618418|NCT03345342|594625362|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
164618419|NCT03345342|594625363|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
164618420|NCT03345342|594625359|FG000|Open-Label Phase|Physician Decision|4|||
164618421|NCT03345342|594625360|FG001|Open-Label Phase|Physician Decision|0|||
164618422|NCT03345342|594625361|FG002|Open-Label Phase|Physician Decision|0|||
164618423|NCT03345342|594625362|FG003|Open-Label Phase|Physician Decision|0|||
164618424|NCT03345342|594625363|FG004|Open-Label Phase|Physician Decision|0|||
164618425|NCT03345342|594625359|FG000|Open-Label Phase|Protocol Violation|8|||
164618426|NCT03345342|594625360|FG001|Open-Label Phase|Protocol Violation|0|||
164618427|NCT03345342|594625361|FG002|Open-Label Phase|Protocol Violation|0|||
164618428|NCT03345342|594625362|FG003|Open-Label Phase|Protocol Violation|0|||
164618429|NCT03345342|594625363|FG004|Open-Label Phase|Protocol Violation|0|||
164618430|NCT03345342|594625359|FG000|Open-Label Phase|Withdrawal by Subject|57|||
164618431|NCT03345342|594625360|FG001|Open-Label Phase|Withdrawal by Subject|0|||
164618432|NCT03345342|594625361|FG002|Open-Label Phase|Withdrawal by Subject|0|||
164618433|NCT03345342|594625362|FG003|Open-Label Phase|Withdrawal by Subject|0|||
164618434|NCT03345342|594625363|FG004|Open-Label Phase|Withdrawal by Subject|0|||
164618435|NCT03345342|594625359|FG000|Open-Label Phase|Other|15|||
164618436|NCT03345342|594625360|FG001|Open-Label Phase|Other|0|||
164618437|NCT03345342|594625361|FG002|Open-Label Phase|Other|0|||
164618438|NCT03345342|594625362|FG003|Open-Label Phase|Other|0|||
164618439|NCT03345342|594625363|FG004|Open-Label Phase|Other|0|||
164618440|NCT03345342|594625359|FG000|Double-Blind Phase|Adverse Event|0|||
164618441|NCT03345342|594625360|FG001|Double-Blind Phase|Adverse Event|1|||
164618442|NCT03345342|594625361|FG002|Double-Blind Phase|Adverse Event|6|||
164618443|NCT03345342|594625362|FG003|Double-Blind Phase|Adverse Event|0|||
164618444|NCT03345342|594625363|FG004|Double-Blind Phase|Adverse Event|0|||
164618445|NCT03345342|594625359|FG000|Double-Blind Phase|Death|0|||
164618446|NCT03345342|594625360|FG001|Double-Blind Phase|Death|2|||
164618447|NCT03345342|594625361|FG002|Double-Blind Phase|Death|1|||
164618448|NCT03345342|594625362|FG003|Double-Blind Phase|Death|0|||
164618449|NCT03345342|594625363|FG004|Double-Blind Phase|Death|0|||
164618450|NCT03345342|594625359|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
164618451|NCT03345342|594625360|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
164618452|NCT03345342|594625361|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
164618453|NCT03345342|594625362|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
164618454|NCT03345342|594625363|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
164618455|NCT03345342|594625359|FG000|Double-Blind Phase|Lost to Follow-up|0|||
164618456|NCT03345342|594625360|FG001|Double-Blind Phase|Lost to Follow-up|1|||
164618457|NCT03345342|594625361|FG002|Double-Blind Phase|Lost to Follow-up|7|||
164618458|NCT03345342|594625362|FG003|Double-Blind Phase|Lost to Follow-up|0|||
164618459|NCT03345342|594625363|FG004|Double-Blind Phase|Lost to Follow-up|0|||
164618460|NCT03345342|594625359|FG000|Double-Blind Phase|Physician Decision|0|||
164618461|NCT03345342|594625360|FG001|Double-Blind Phase|Physician Decision|1|||
164618462|NCT03345342|594625361|FG002|Double-Blind Phase|Physician Decision|4|||
164618463|NCT03345342|594625362|FG003|Double-Blind Phase|Physician Decision|0|||
164618464|NCT03345342|594625363|FG004|Double-Blind Phase|Physician Decision|0|||
164618465|NCT03345342|594625359|FG000|Double-Blind Phase|Protocol Violation|0|||
164618466|NCT03345342|594625360|FG001|Double-Blind Phase|Protocol Violation|0|||
164618467|NCT03345342|594625361|FG002|Double-Blind Phase|Protocol Violation|1|||
164618468|NCT03345342|594625362|FG003|Double-Blind Phase|Protocol Violation|0|||
164618469|NCT03345342|594625363|FG004|Double-Blind Phase|Protocol Violation|0|||
164618470|NCT03345342|594625359|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
164618471|NCT03345342|594625360|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
164618472|NCT03345342|594625361|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
164618473|NCT03345342|594625362|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
164618474|NCT03345342|594625363|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
164618475|NCT03345342|594625359|FG000|Double-Blind Phase|Other|0|||
164618476|NCT03345342|594625360|FG001|Double-Blind Phase|Other|1|||
164618477|NCT03345342|594625361|FG002|Double-Blind Phase|Other|3|||
164618478|NCT03345342|594625362|FG003|Double-Blind Phase|Other|0|||
164618479|NCT03345342|594625363|FG004|Double-Blind Phase|Other|0|||
164618480|NCT03345342|594625359|FG000|Follow-Up Phase|Adverse Event|0|||
164618481|NCT03345342|594625360|FG001|Follow-Up Phase|Adverse Event|0|||
164618482|NCT03345342|594625361|FG002|Follow-Up Phase|Adverse Event|0|||
164618483|NCT03345342|594625362|FG003|Follow-Up Phase|Adverse Event|0|||
164618484|NCT03345342|594625363|FG004|Follow-Up Phase|Adverse Event|4|||
164618485|NCT03345342|594625359|FG000|Follow-Up Phase|Lost to Follow-up|0|||
164618486|NCT03345342|594625360|FG001|Follow-Up Phase|Lost to Follow-up|0|||
164618487|NCT03345342|594625361|FG002|Follow-Up Phase|Lost to Follow-up|0|||
164618488|NCT03345342|594625362|FG003|Follow-Up Phase|Lost to Follow-up|0|||
164618489|NCT03345342|594625363|FG004|Follow-Up Phase|Lost to Follow-up|6|||
164618490|NCT03345342|594625359|FG000|Follow-Up Phase|Physician Decision|0|||
164618491|NCT03345342|594625360|FG001|Follow-Up Phase|Physician Decision|0|||
164618492|NCT03345342|594625361|FG002|Follow-Up Phase|Physician Decision|0|||
164618493|NCT03345342|594625362|FG003|Follow-Up Phase|Physician Decision|0|||
164521564|NCT00929110|594278732|FG002|Overall Study|Death|2|||
164521565|NCT00929110|594278730|FG000|Overall Study|Abnormal laboratory value(s)|0|||
164521566|NCT00929110|594278731|FG001|Overall Study|Abnormal laboratory value(s)|1|||
164521567|NCT00929110|594278732|FG002|Overall Study|Abnormal laboratory value(s)|0|||
164521568|NCT00929110|594278730|FG000|Overall Study|Abnormal test procedure result(s)|0|||
164521569|NCT00929110|594278731|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164521570|NCT00929110|594278732|FG002|Overall Study|Abnormal test procedure result(s)|1|||
164521571|NCT00929110|594278730|FG000|Overall Study|Patient inability to use the device|0|||
164521572|NCT00929110|594278731|FG001|Overall Study|Patient inability to use the device|1|||
164521573|NCT00929110|594278732|FG002|Overall Study|Patient inability to use the device|0|||
164521574|NCT01258595|594278736|FG000|Overall Study|Lost to Follow-up|1|||
164521575|NCT01258595|594278737|FG001|Overall Study|Lost to Follow-up|0|||
164521576|NCT01258595|594278736|FG000|Overall Study|Withdrawal by Subject|0|||
164521577|NCT01258595|594278737|FG001|Overall Study|Withdrawal by Subject|1|||
164521578|NCT02310100|594278738|FG000|Overall Study|Physician Decision|3|||
164521579|NCT02310100|594278738|FG000|Overall Study|Withdrawal by Subject|10|||
164521580|NCT02310100|594278738|FG000|Overall Study|Enrollment closure|1|||
164521581|NCT02310100|594278738|FG000|Overall Study|Unapproved ablation operator|1|||
164521582|NCT02310100|594278738|FG000|Overall Study|Visit compliance|1|||
164521583|NCT02310100|594278738|FG000|Overall Study|Lost to Follow-up|2|||
164521584|NCT04602221|594278740|FG000|Overall Study|Discontinuation of trial treatment|0|||
164521585|NCT04602221|594278741|FG001|Overall Study|Discontinuation of trial treatment|0|||
164521586|NCT04602221|594278742|FG002|Overall Study|Discontinuation of trial treatment|1|||
164521587|NCT04602221|594278743|FG003|Overall Study|Discontinuation of trial treatment|0|||
164521588|NCT04602221|594278744|FG004|Overall Study|Discontinuation of trial treatment|0|||
164521589|NCT04602221|594278745|FG005|Overall Study|Discontinuation of trial treatment|0|||
164521590|NCT04602221|594278746|FG006|Overall Study|Discontinuation of trial treatment|0|||
164521591|NCT04602221|594278747|FG007|Overall Study|Discontinuation of trial treatment|0|||
164521592|NCT04602221|594278748|FG008|Overall Study|Discontinuation of trial treatment|0|||
164521593|NCT04602221|594278749|FG009|Overall Study|Discontinuation of trial treatment|0|||
164521594|NCT04602221|594278750|FG010|Overall Study|Discontinuation of trial treatment|0|||
164521595|NCT04602221|594278751|FG011|Overall Study|Discontinuation of trial treatment|0|||
164521596|NCT04602221|594278752|FG012|Overall Study|Discontinuation of trial treatment|0|||
164521597|NCT04602221|594278753|FG013|Overall Study|Discontinuation of trial treatment|0|||
164521598|NCT04602221|594278754|FG014|Overall Study|Discontinuation of trial treatment|0|||
164521599|NCT04602221|594278755|FG015|Overall Study|Discontinuation of trial treatment|0|||
164521600|NCT04602221|594278756|FG016|Overall Study|Discontinuation of trial treatment|0|||
164521601|NCT04602221|594278757|FG017|Overall Study|Discontinuation of trial treatment|0|||
164521602|NCT04602221|594278740|FG000|Overall Study|Other than listed|0|||
164521603|NCT04602221|594278741|FG001|Overall Study|Other than listed|0|||
164521604|NCT04602221|594278742|FG002|Overall Study|Other than listed|0|||
164521605|NCT04602221|594278743|FG003|Overall Study|Other than listed|0|||
164521606|NCT04602221|594278744|FG004|Overall Study|Other than listed|0|||
164521607|NCT04602221|594278745|FG005|Overall Study|Other than listed|0|||
164521608|NCT04602221|594278746|FG006|Overall Study|Other than listed|0|||
164521609|NCT04602221|594278747|FG007|Overall Study|Other than listed|0|||
164521610|NCT04602221|594278748|FG008|Overall Study|Other than listed|0|||
164521611|NCT04602221|594278749|FG009|Overall Study|Other than listed|0|||
164521612|NCT04602221|594278750|FG010|Overall Study|Other than listed|0|||
164521613|NCT04602221|594278751|FG011|Overall Study|Other than listed|0|||
164521614|NCT04602221|594278752|FG012|Overall Study|Other than listed|0|||
164521615|NCT04602221|594278753|FG013|Overall Study|Other than listed|0|||
164521616|NCT04602221|594278754|FG014|Overall Study|Other than listed|0|||
164521617|NCT04602221|594278755|FG015|Overall Study|Other than listed|1|||
164521618|NCT04602221|594278756|FG016|Overall Study|Other than listed|0|||
164521619|NCT04602221|594278757|FG017|Overall Study|Other than listed|1|||
164521620|NCT04602221|594278740|FG000|Overall Study|Withdrawal by Subject|0|||
164521621|NCT04602221|594278741|FG001|Overall Study|Withdrawal by Subject|0|||
164521622|NCT04602221|594278742|FG002|Overall Study|Withdrawal by Subject|0|||
164521623|NCT04602221|594278743|FG003|Overall Study|Withdrawal by Subject|0|||
164521624|NCT04602221|594278744|FG004|Overall Study|Withdrawal by Subject|0|||
164521625|NCT04602221|594278745|FG005|Overall Study|Withdrawal by Subject|0|||
164521626|NCT04602221|594278746|FG006|Overall Study|Withdrawal by Subject|0|||
164521627|NCT04602221|594278747|FG007|Overall Study|Withdrawal by Subject|0|||
164521628|NCT04602221|594278748|FG008|Overall Study|Withdrawal by Subject|0|||
164618494|NCT03345342|594625363|FG004|Follow-Up Phase|Physician Decision|5|||
164618495|NCT03345342|594625359|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
164618496|NCT03345342|594625360|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
164618497|NCT03345342|594625361|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
164618498|NCT03345342|594625362|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
164618499|NCT03345342|594625363|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
164618500|NCT03345342|594625359|FG000|Follow-Up Phase|Other|0|||
164618501|NCT03345342|594625360|FG001|Follow-Up Phase|Other|0|||
164618502|NCT03345342|594625361|FG002|Follow-Up Phase|Other|0|||
164618503|NCT03345342|594625362|FG003|Follow-Up Phase|Other|3|||
164618504|NCT03345342|594625363|FG004|Follow-Up Phase|Other|1|||
164618505|NCT03464136|594625364|FG000|Overall Study|Lost to Follow-up|5|||
164618506|NCT03464136|594625365|FG001|Overall Study|Lost to Follow-up|8|||
164618507|NCT03464136|594625364|FG000|Overall Study|Withdrawal by Subject|16|||
164618508|NCT03464136|594625365|FG001|Overall Study|Withdrawal by Subject|13|||
164618509|NCT03464136|594625364|FG000|Overall Study|Death|1|||
164618510|NCT03464136|594625365|FG001|Overall Study|Death|0|||
164618511|NCT03464136|594625364|FG000|Overall Study|Other|8|||
164618512|NCT03464136|594625365|FG001|Overall Study|Other|4|||
164618513|NCT03375203|594625366|FG000|Overall Study|Protocol Violation|0|||
164618514|NCT03375203|594625367|FG001|Overall Study|Protocol Violation|0|||
164618515|NCT03375203|594625368|FG002|Overall Study|Protocol Violation|1|||
164618516|NCT03375203|594625369|FG003|Overall Study|Protocol Violation|0|||
164618517|NCT03375203|594625370|FG004|Overall Study|Protocol Violation|0|||
164618518|NCT03375203|594625366|FG000|Overall Study|Adverse Event|2|||
164618519|NCT03375203|594625367|FG001|Overall Study|Adverse Event|3|||
164618520|NCT03375203|594625368|FG002|Overall Study|Adverse Event|0|||
164618521|NCT03375203|594625369|FG003|Overall Study|Adverse Event|2|||
164618522|NCT03375203|594625370|FG004|Overall Study|Adverse Event|2|||
164618523|NCT03375203|594625366|FG000|Overall Study|Withdrawal by Subject|3|||
164618524|NCT03375203|594625367|FG001|Overall Study|Withdrawal by Subject|0|||
164618525|NCT03375203|594625368|FG002|Overall Study|Withdrawal by Subject|1|||
164618526|NCT03375203|594625369|FG003|Overall Study|Withdrawal by Subject|0|||
164618527|NCT03375203|594625370|FG004|Overall Study|Withdrawal by Subject|2|||
164618528|NCT03375203|594625366|FG000|Overall Study|Non-compliance with study drug|1|||
164618529|NCT03375203|594625367|FG001|Overall Study|Non-compliance with study drug|0|||
164618530|NCT03375203|594625368|FG002|Overall Study|Non-compliance with study drug|0|||
164618531|NCT03375203|594625369|FG003|Overall Study|Non-compliance with study drug|0|||
164618532|NCT03375203|594625370|FG004|Overall Study|Non-compliance with study drug|0|||
164618533|NCT03375203|594625366|FG000|Overall Study|Randomized, not treated.|0|||
164618534|NCT03375203|594625367|FG001|Overall Study|Randomized, not treated.|1|||
164618535|NCT03375203|594625368|FG002|Overall Study|Randomized, not treated.|0|||
164618536|NCT03375203|594625369|FG003|Overall Study|Randomized, not treated.|0|||
164618537|NCT03375203|594625370|FG004|Overall Study|Randomized, not treated.|0|||
164618538|NCT03107793|594625371|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
164618539|NCT03107793|594625372|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
164618540|NCT03107793|594625373|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
164618541|NCT03107793|594625374|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
164618542|NCT03107793|594625375|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
164618543|NCT03107793|594625371|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
164618544|NCT03107793|594625372|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
164618545|NCT03107793|594625373|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
164618546|NCT03107793|594625374|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
164618547|NCT03107793|594625375|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
164618548|NCT03107793|594625371|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
164618549|NCT03107793|594625372|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
164618550|NCT03107793|594625373|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
164618551|NCT03107793|594625374|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
164618552|NCT03107793|594625375|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
164618553|NCT03107793|594625371|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
164618554|NCT03107793|594625372|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164618555|NCT03107793|594625373|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164618556|NCT03107793|594625374|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164618557|NCT03107793|594625375|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164618558|NCT03107793|594625371|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
164618559|NCT03107793|594625372|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
164618560|NCT03107793|594625373|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
164618561|NCT03107793|594625374|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
164618562|NCT03107793|594625375|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
164618563|NCT03107793|594625371|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
164618564|NCT03107793|594625372|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
164618565|NCT03107793|594625373|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
164618566|NCT03107793|594625374|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
164618567|NCT03107793|594625375|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
164618568|NCT03107793|594625371|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
164618569|NCT03107793|594625372|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
164618570|NCT03107793|594625373|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
164618571|NCT03107793|594625374|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
164618572|NCT03107793|594625375|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
164618573|NCT03107793|594625371|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
164618574|NCT03107793|594625372|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
164618575|NCT03107793|594625373|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
164618576|NCT03107793|594625374|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
164618577|NCT03107793|594625375|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
164618578|NCT03107793|594625371|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
164618579|NCT03107793|594625372|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
164618580|NCT03107793|594625373|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
164618581|NCT03107793|594625374|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
164618582|NCT03107793|594625375|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
164618583|NCT03107793|594625371|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
164618584|NCT03107793|594625372|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
164618585|NCT03107793|594625373|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
164618586|NCT03107793|594625374|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
164618587|NCT03107793|594625375|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
164618588|NCT03107793|594625371|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
164618589|NCT03107793|594625372|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
164618590|NCT03107793|594625373|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
164618591|NCT03107793|594625374|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
164618592|NCT03107793|594625375|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
164618593|NCT03107793|594625371|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
164618594|NCT03107793|594625372|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
164618595|NCT03107793|594625373|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
164618596|NCT03107793|594625374|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
164618597|NCT03107793|594625375|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
164618598|NCT03107793|594625371|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
164618599|NCT03107793|594625372|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
164618600|NCT03107793|594625373|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
164618601|NCT03107793|594625374|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
164618602|NCT03107793|594625375|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
164618603|NCT03107793|594625371|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
164618604|NCT03107793|594625372|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
164618605|NCT03107793|594625373|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
164618606|NCT03107793|594625374|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
164618607|NCT03107793|594625375|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
164618608|NCT03107793|594625371|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
164618609|NCT03107793|594625372|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
164618610|NCT03107793|594625373|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
164618611|NCT03107793|594625374|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
164618612|NCT03107793|594625375|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
164618613|NCT03107793|594625371|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
164618614|NCT03107793|594625372|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
164618615|NCT03107793|594625373|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
164618616|NCT03107793|594625374|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
164618617|NCT03107793|594625375|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
164618618|NCT03107793|594625371|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
164618619|NCT03107793|594625372|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
164618620|NCT03107793|594625373|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
164618621|NCT03107793|594625374|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
164618622|NCT03107793|594625375|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
164618623|NCT03107793|594625371|FG000|Extension Period (Week 48- Week 104)|Death|0|||
164618624|NCT03107793|594625372|FG001|Extension Period (Week 48- Week 104)|Death|0|||
164618625|NCT03107793|594625373|FG002|Extension Period (Week 48- Week 104)|Death|0|||
164618626|NCT03107793|594625374|FG003|Extension Period (Week 48- Week 104)|Death|0|||
164618627|NCT03107793|594625375|FG004|Extension Period (Week 48- Week 104)|Death|1|||
164618628|NCT03107793|594625371|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
164618629|NCT03107793|594625372|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
164618630|NCT03107793|594625373|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
164618631|NCT03107793|594625374|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
164618632|NCT03107793|594625375|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
164618633|NCT03107793|594625371|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
164618634|NCT03107793|594625372|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
164618635|NCT03107793|594625373|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
164618636|NCT03107793|594625374|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
164618637|NCT03107793|594625375|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
164618638|NCT03107793|594625371|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
164618639|NCT03107793|594625372|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
164618640|NCT03107793|594625373|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
164618641|NCT03107793|594625374|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
164618642|NCT03107793|594625375|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
164618643|NCT03107793|594625371|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
164618644|NCT03107793|594625372|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
164618645|NCT03107793|594625373|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
164618646|NCT03107793|594625374|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
164618647|NCT03107793|594625375|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
164618648|NCT03107793|594625371|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
164618649|NCT03107793|594625372|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
164618650|NCT03107793|594625373|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
164618651|NCT03107793|594625374|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
164618652|NCT03107793|594625375|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
164618653|NCT03107793|594625371|FG000|Extension Period (Week 48- Week 104)|Other|0|||
164618654|NCT03107793|594625372|FG001|Extension Period (Week 48- Week 104)|Other|0|||
164618655|NCT03107793|594625373|FG002|Extension Period (Week 48- Week 104)|Other|0|||
164618656|NCT03107793|594625374|FG003|Extension Period (Week 48- Week 104)|Other|1|||
164618657|NCT03107793|594625375|FG004|Extension Period (Week 48- Week 104)|Other|3|||
164618658|NCT03107793|594625371|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
164618659|NCT03107793|594625372|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
164618660|NCT03107793|594625373|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
164618661|NCT03107793|594625374|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
164618662|NCT03107793|594625375|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
164618663|NCT03277105|594625376|FG000|Overall Study|Death|129|||
164618664|NCT03277105|594625377|FG001|Overall Study|Death|124|||
164618665|NCT03277105|594625376|FG000|Overall Study|Lost to Follow-up|2|||
164618666|NCT03277105|594625377|FG001|Overall Study|Lost to Follow-up|4|||
164618667|NCT03277105|594625376|FG000|Overall Study|Withdrawal by Subject|10|||
164618668|NCT03277105|594625377|FG001|Overall Study|Withdrawal by Subject|10|||
164618669|NCT03277105|594625376|FG000|Overall Study|Other|118|||
164618670|NCT03277105|594625377|FG001|Overall Study|Other|125|||
164618671|NCT05180721|594625381|FG000|Overall Study|Lost to Follow-up|4|||
164618672|NCT02040857|594625385|FG000|Overall Study|Adverse Event|14|||
164618673|NCT02040857|594625385|FG000|Overall Study|Physician Decision|5|||
164618674|NCT02040857|594625385|FG000|Overall Study|Withdrawal by Subject|31|||
164618675|NCT02040857|594625385|FG000|Overall Study|patient non-compliance|3|||
164618676|NCT02040857|594625385|FG000|Overall Study|Lost to Follow-up|2|||
164618677|NCT02040857|594625385|FG000|Overall Study|recurrence|4|||
164618678|NCT02040857|594625385|FG000|Overall Study|ineligible|1|||
164618679|NCT00976963|594625386|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
164618680|NCT00976963|594625387|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
164618681|NCT00976963|594625386|FG000|Overall Study|administrative error|1|||
164618682|NCT00976963|594625387|FG001|Overall Study|administrative error|0|||
164618683|NCT00976963|594625386|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
164618684|NCT00976963|594625387|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
164618685|NCT00608842|594625388|FG000|Overall Study|Participant's Request|0|||
164618686|NCT00608842|594625389|FG001|Overall Study|Participant's Request|1|||
164618687|NCT00608842|594625390|FG002|Overall Study|Participant's Request|2|||
164618688|NCT00608842|594625391|FG003|Overall Study|Participant's Request|1|||
164618689|NCT00608842|594625388|FG000|Overall Study|Lost to Follow-up|1|||
164618690|NCT00608842|594625389|FG001|Overall Study|Lost to Follow-up|0|||
164618691|NCT00608842|594625390|FG002|Overall Study|Lost to Follow-up|0|||
164618692|NCT00608842|594625391|FG003|Overall Study|Lost to Follow-up|0|||
164618693|NCT02182999|594625392|FG000|Overall Study|Adverse Event|4|||
164618694|NCT02182999|594625393|FG001|Overall Study|Adverse Event|3|||
164618695|NCT02182999|594625392|FG000|Overall Study|Physician Decision|1|||
164618696|NCT02182999|594625393|FG001|Overall Study|Physician Decision|0|||
164521629|NCT04602221|594278749|FG009|Overall Study|Withdrawal by Subject|0|||
164521630|NCT04602221|594278750|FG010|Overall Study|Withdrawal by Subject|0|||
164521631|NCT04602221|594278751|FG011|Overall Study|Withdrawal by Subject|0|||
164521632|NCT04602221|594278752|FG012|Overall Study|Withdrawal by Subject|1|||
164521633|NCT04602221|594278753|FG013|Overall Study|Withdrawal by Subject|0|||
164521634|NCT04602221|594278754|FG014|Overall Study|Withdrawal by Subject|0|||
164521635|NCT04602221|594278755|FG015|Overall Study|Withdrawal by Subject|0|||
164521636|NCT04602221|594278756|FG016|Overall Study|Withdrawal by Subject|0|||
164521637|NCT04602221|594278757|FG017|Overall Study|Withdrawal by Subject|0|||
164521638|NCT04602221|594278740|FG000|Overall Study|Lost to Follow-up|0|||
164521639|NCT04602221|594278741|FG001|Overall Study|Lost to Follow-up|0|||
164521640|NCT04602221|594278742|FG002|Overall Study|Lost to Follow-up|0|||
164521641|NCT04602221|594278743|FG003|Overall Study|Lost to Follow-up|0|||
164521642|NCT04602221|594278744|FG004|Overall Study|Lost to Follow-up|0|||
164521643|NCT04602221|594278745|FG005|Overall Study|Lost to Follow-up|1|||
164521644|NCT04602221|594278746|FG006|Overall Study|Lost to Follow-up|0|||
164521645|NCT04602221|594278747|FG007|Overall Study|Lost to Follow-up|0|||
164521646|NCT04602221|594278748|FG008|Overall Study|Lost to Follow-up|0|||
164521647|NCT04602221|594278749|FG009|Overall Study|Lost to Follow-up|0|||
164521648|NCT04602221|594278750|FG010|Overall Study|Lost to Follow-up|0|||
164521649|NCT04602221|594278751|FG011|Overall Study|Lost to Follow-up|0|||
164521650|NCT04602221|594278752|FG012|Overall Study|Lost to Follow-up|0|||
164521651|NCT04602221|594278753|FG013|Overall Study|Lost to Follow-up|0|||
164521652|NCT04602221|594278754|FG014|Overall Study|Lost to Follow-up|0|||
164521653|NCT04602221|594278755|FG015|Overall Study|Lost to Follow-up|0|||
164521654|NCT04602221|594278756|FG016|Overall Study|Lost to Follow-up|0|||
164521655|NCT04602221|594278757|FG017|Overall Study|Lost to Follow-up|0|||
164521656|NCT01036438|594278758|FG000|Overall Study|Adverse Event|7|||
164521657|NCT01036438|594278759|FG001|Overall Study|Adverse Event|8|||
164521658|NCT01036438|594278758|FG000|Overall Study|Death|0|||
164521659|NCT01036438|594278759|FG001|Overall Study|Death|1|||
164521660|NCT01036438|594278758|FG000|Overall Study|No effect of study treatment|3|||
164521661|NCT01036438|594278759|FG001|Overall Study|No effect of study treatment|1|||
164521662|NCT00888927|594278760|FG000|Overall Study|Adverse Event|0|||
164521663|NCT00888927|594278761|FG001|Overall Study|Adverse Event|0|||
164521664|NCT00888927|594278762|FG002|Overall Study|Adverse Event|0|||
164521665|NCT00888927|594278763|FG003|Overall Study|Adverse Event|1|||
164521666|NCT00888927|594278760|FG000|Overall Study|Withdrawal of consent|0|||
164521667|NCT00888927|594278761|FG001|Overall Study|Withdrawal of consent|0|||
164521668|NCT00888927|594278762|FG002|Overall Study|Withdrawal of consent|0|||
164521669|NCT00888927|594278763|FG003|Overall Study|Withdrawal of consent|1|||
164521670|NCT01080716|594278764|FG000|Part 1|Physician Decision|1|||
164521671|NCT01080716|594278765|FG001|Part 1|Physician Decision|0|||
164521672|NCT01080716|594278766|FG002|Part 1|Physician Decision|0|||
164521673|NCT01080716|594278767|FG003|Part 1|Physician Decision|0|||
164521674|NCT01056718|594278768|FG000|Overall Study|Withdrawal by Subject|2|||
164521675|NCT01056718|594278768|FG000|Overall Study|Ischemia on baseline stress test|1|||
164521676|NCT00738894|594278769|FG000|Overall Study|Lost to Follow-up|23|||
164521677|NCT00738894|594278770|FG001|Overall Study|Lost to Follow-up|13|||
164521678|NCT00738894|594278769|FG000|Overall Study|Withdrawal by Subject|10|||
164521679|NCT00738894|594278770|FG001|Overall Study|Withdrawal by Subject|15|||
164521680|NCT00738894|594278769|FG000|Overall Study|Physician Decision|4|||
164521681|NCT00738894|594278770|FG001|Overall Study|Physician Decision|5|||
164521682|NCT00738894|594278769|FG000|Overall Study|Death|2|||
164521683|NCT00738894|594278770|FG001|Overall Study|Death|0|||
164521684|NCT05017103|594278771|FG000|Overall Study|Death|2|||
164521685|NCT02656329|594278772|FG000|Overall Study|Lost to Follow-up|2|||
164521686|NCT02656329|594278773|FG001|Overall Study|Lost to Follow-up|3|||
164521687|NCT02656329|594278772|FG000|Overall Study|Withdrawal by Subject|7|||
164521688|NCT02656329|594278773|FG001|Overall Study|Withdrawal by Subject|6|||
164521689|NCT02656329|594278772|FG000|Overall Study|Study termination by Sponsor|150|||
164521690|NCT02656329|594278773|FG001|Overall Study|Study termination by Sponsor|142|||
164521691|NCT02656329|594278772|FG000|Overall Study|Other than specified above|5|||
164521692|NCT02656329|594278773|FG001|Overall Study|Other than specified above|6|||
164521693|NCT01081665|594278775|FG000|Overall Study|Death|41|||
164521694|NCT01081665|594278775|FG000|Overall Study|Lost to Follow-up|18|||
164521695|NCT01081665|594278775|FG000|Overall Study|Withdrawal by Subject|17|||
164521696|NCT01081665|594278775|FG000|Overall Study|Change of dialysis unit|10|||
164521697|NCT01081665|594278775|FG000|Overall Study|Regulation of iPTH|5|||
164521698|NCT01081665|594278775|FG000|Overall Study|Change in renal replacement therapy|2|||
164521699|NCT01081665|594278775|FG000|Overall Study|Adverse Event|1|||
164618697|NCT00285649|594625397|FG000|Overall Study|Lost to Follow-up|6|||
164618698|NCT00285649|594625398|FG001|Overall Study|Lost to Follow-up|4|||
164618699|NCT00285649|594625399|FG002|Overall Study|Lost to Follow-up|4|||
164618700|NCT00285649|594625397|FG000|Overall Study|Withdrawal by Subject|3|||
164618701|NCT00285649|594625398|FG001|Overall Study|Withdrawal by Subject|2|||
164618702|NCT00285649|594625399|FG002|Overall Study|Withdrawal by Subject|2|||
164618703|NCT03077711|594625402|FG000|Overall Study|Lost to Follow-up|2|||
164618704|NCT03077711|594625403|FG001|Overall Study|Lost to Follow-up|2|||
164618705|NCT03077711|594625402|FG000|Overall Study|noncompliant taking medication|2|||
164618706|NCT03077711|594625403|FG001|Overall Study|noncompliant taking medication|0|||
164618707|NCT01819194|594625404|FG000|Overall Study|Loss of study articles|2|||
164618708|NCT01448707|594625407|FG000|Overall Study|Adverse Event|3|||
164618709|NCT01448707|594625408|FG001|Overall Study|Adverse Event|1|||
164618710|NCT01448707|594625407|FG000|Overall Study|Lost to Follow-up|2|||
164618711|NCT01448707|594625408|FG001|Overall Study|Lost to Follow-up|6|||
164618712|NCT01448707|594625407|FG000|Overall Study|Withdrawal by Subject|6|||
164618713|NCT01448707|594625408|FG001|Overall Study|Withdrawal by Subject|7|||
164618714|NCT01448707|594625407|FG000|Overall Study|Other|7|||
164618715|NCT01448707|594625408|FG001|Overall Study|Other|4|||
164618716|NCT02033850|594625409|FG000|Overall Study|Death|1|||
164618717|NCT02033850|594625410|FG001|Overall Study|Death|0|||
164618718|NCT02033850|594625409|FG000|Overall Study|unrelated medical reason|1|||
164618719|NCT02033850|594625410|FG001|Overall Study|unrelated medical reason|1|||
164618720|NCT03215667|594625411|FG000|Overall Study|Physician Decision|4|||
164618721|NCT01997281|594625412|FG000|Overall Study|Withdrawal by Subject|1|||
164618722|NCT01997281|594625413|FG001|Overall Study|Withdrawal by Subject|0|||
164618723|NCT00333970|594625415|FG000|Overall Study|Withdrawal by Subject|13|||
164618724|NCT00333970|594625416|FG001|Overall Study|Withdrawal by Subject|7|||
164618725|NCT00560794|594625417|FG000|Overall Study|Adverse Event|2|||
164618726|NCT00560794|594625417|FG000|Overall Study|Patient was not Compliant|1|||
164521700|NCT01081665|594278775|FG000|Overall Study|Lack of Efficacy|1|||
164521701|NCT03026075|594278788|FG000|Overall Study|Physician Decision|1|||
164521702|NCT03381339|594278789|FG000|Overall Study|Protocol Violation|4|||
164521703|NCT03381339|594278790|FG001|Overall Study|Protocol Violation|3|||
164521704|NCT03381339|594278789|FG000|Overall Study|Lost to Follow-up|0|||
164521705|NCT03381339|594278790|FG001|Overall Study|Lost to Follow-up|1|||
164521706|NCT03117998|594278791|FG000|Overall Study|Adverse Event|1|||
164521707|NCT03117998|594278792|FG001|Overall Study|Adverse Event|0|||
164521708|NCT03117998|594278793|FG002|Overall Study|Adverse Event|0|||
164521709|NCT03117998|594278794|FG003|Overall Study|Adverse Event|0|||
164521710|NCT03117998|594278795|FG004|Overall Study|Adverse Event|0|||
164521711|NCT03117998|594278796|FG005|Overall Study|Adverse Event|0|||
164521712|NCT03117998|594278791|FG000|Overall Study|Withdrawal by Subject|0|||
164521713|NCT03117998|594278792|FG001|Overall Study|Withdrawal by Subject|0|||
164521714|NCT03117998|594278793|FG002|Overall Study|Withdrawal by Subject|2|||
164521715|NCT03117998|594278794|FG003|Overall Study|Withdrawal by Subject|3|||
164521716|NCT03117998|594278795|FG004|Overall Study|Withdrawal by Subject|3|||
164521717|NCT03117998|594278796|FG005|Overall Study|Withdrawal by Subject|0|||
164521718|NCT03117998|594278791|FG000|Overall Study|Physician Decision|0|||
164521719|NCT03117998|594278792|FG001|Overall Study|Physician Decision|1|||
164521720|NCT03117998|594278793|FG002|Overall Study|Physician Decision|1|||
164618727|NCT00560794|594625417|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
164618728|NCT00560794|594625417|FG000|Overall Study|Hematological Relapse|1|||
164618729|NCT00560794|594625417|FG000|Overall Study|Received Bone Marrow Transplant|6|||
164618730|NCT00614991|594625418|FG000|Overall Study|Adverse Event|3|||
164618731|NCT00614991|594625419|FG001|Overall Study|Adverse Event|3|||
164618732|NCT00614991|594625420|FG002|Overall Study|Adverse Event|0|||
164618733|NCT00614991|594625421|FG003|Overall Study|Adverse Event|0|||
164618734|NCT00614991|594625422|FG004|Overall Study|Adverse Event|1|||
164618735|NCT00614991|594625423|FG005|Overall Study|Adverse Event|0|||
164618736|NCT00441480|594625424|FG000|Overall Study|Protocol Violation|1|||
164618737|NCT00441480|594625425|FG001|Overall Study|Protocol Violation|1|||
164618738|NCT00441480|594625424|FG000|Overall Study|Withdrawal by Subject|2|||
164618739|NCT00441480|594625425|FG001|Overall Study|Withdrawal by Subject|3|||
164618740|NCT01922739|594625426|FG000|Titration/Adjustment Period|Adverse Event|3|||
164618741|NCT01922739|594625426|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
164618742|NCT01922739|594625426|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
164147381|NCT05168202|592902029|FG005|Overall Study|Lack of Efficacy|2|||
164618743|NCT01922739|594625426|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
164618744|NCT01922739|594625426|FG000|Open-label Treatment Period|Adverse Event|6|||
164521721|NCT03117998|594278794|FG003|Overall Study|Physician Decision|0|||
164521722|NCT03117998|594278795|FG004|Overall Study|Physician Decision|0|||
164521723|NCT03117998|594278796|FG005|Overall Study|Physician Decision|0|||
164618745|NCT01922739|594625426|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
164618746|NCT01922739|594625426|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
164618747|NCT01922739|594625426|FG000|Open-label Treatment Period|Protocol Violation|5|||
164618748|NCT01922739|594625426|FG000|Open-label Treatment Period|Pregnancy|1|||
164618749|NCT01922739|594625426|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
164618750|NCT01922739|594625426|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
164618751|NCT01922739|594625426|FG000|Open-label Treatment Period|Physician Decision|1|||
164618752|NCT01922739|594625426|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
164618753|NCT00044213|594625427|FG000|Overall Study|Withdrawal by Subject|50|||
164618754|NCT00044213|594625428|FG001|Overall Study|Withdrawal by Subject|65|||
164618755|NCT00044213|594625429|FG002|Overall Study|Withdrawal by Subject|91|||
164618756|NCT00044213|594625430|FG003|Overall Study|Withdrawal by Subject|83|||
164618757|NCT00044213|594625427|FG000|Overall Study|Death|42|||
164618758|NCT00044213|594625428|FG001|Overall Study|Death|42|||
164618759|NCT00044213|594625429|FG002|Overall Study|Death|42|||
164618760|NCT00044213|594625430|FG003|Overall Study|Death|49|||
164618761|NCT00044213|594625427|FG000|Overall Study|Lost to Follow-up|8|||
164618762|NCT00044213|594625428|FG001|Overall Study|Lost to Follow-up|5|||
164618763|NCT00044213|594625429|FG002|Overall Study|Lost to Follow-up|5|||
164618764|NCT00044213|594625430|FG003|Overall Study|Lost to Follow-up|4|||
164618765|NCT00880607|594625431|FG000|Overall Study|Physician Decision|2|||
164618766|NCT00880607|594625432|FG001|Overall Study|Physician Decision|2|||
164618767|NCT00880607|594625431|FG000|Overall Study|Protocol Violation|2|||
164618768|NCT00880607|594625432|FG001|Overall Study|Protocol Violation|1|||
164618769|NCT00880607|594625431|FG000|Overall Study|surgery did not extend past L1 level|3|||
164618770|NCT00880607|594625432|FG001|Overall Study|surgery did not extend past L1 level|0|||
164618771|NCT05104749|594625433|FG000|Overall Study|Lost to Follow-up|2|||
164618772|NCT05104749|594625434|FG001|Overall Study|Lost to Follow-up|3|||
164618773|NCT02963766|594625435|FG000|Double-Blind Period|Adverse Event|1|||
164618774|NCT02963766|594625436|FG001|Double-Blind Period|Adverse Event|0|||
164618775|NCT02963766|594625437|FG002|Double-Blind Period|Adverse Event|1|||
164618776|NCT02963766|594625435|FG000|Double-Blind Period|Physician Decision|1|||
164618777|NCT02963766|594625436|FG001|Double-Blind Period|Physician Decision|0|||
164618778|NCT02963766|594625437|FG002|Double-Blind Period|Physician Decision|0|||
164618779|NCT02963766|594625435|FG000|Double-Blind Period|Withdrawal by Subject|1|||
164618780|NCT02963766|594625436|FG001|Double-Blind Period|Withdrawal by Subject|1|||
164618781|NCT02963766|594625437|FG002|Double-Blind Period|Withdrawal by Subject|0|||
164618782|NCT02963766|594625435|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
164618783|NCT02963766|594625436|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
164618784|NCT02963766|594625437|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
164618785|NCT02963766|594625435|FG000|Double-Blind Period|Protocol Violation|1|||
164618786|NCT02963766|594625436|FG001|Double-Blind Period|Protocol Violation|0|||
164618787|NCT02963766|594625437|FG002|Double-Blind Period|Protocol Violation|0|||
164618788|NCT02963766|594625435|FG000|Double-Blind Period|Lost to Follow-up|0|||
164618789|NCT02963766|594625436|FG001|Double-Blind Period|Lost to Follow-up|1|||
164618790|NCT02963766|594625437|FG002|Double-Blind Period|Lost to Follow-up|0|||
164618791|NCT02963766|594625435|FG000|Open Label Extension (OLE)|Physician Decision|1|||
164618792|NCT02963766|594625436|FG001|Open Label Extension (OLE)|Physician Decision|2|||
164618793|NCT02963766|594625437|FG002|Open Label Extension (OLE)|Physician Decision|2|||
164618794|NCT02963766|594625435|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
164618795|NCT02963766|594625436|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
164618796|NCT02963766|594625437|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
164618797|NCT04888507|594627840|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
164618798|NCT00636155|594627841|FG000|Overall Study|Adverse Event|8|||
164618799|NCT00636155|594627841|FG000|Overall Study|Lack of Efficacy|1|||
164618800|NCT00636155|594627841|FG000|Overall Study|Withdrawal by Subject|3|||
164618801|NCT00636155|594627841|FG000|Overall Study|Stem cell transplant|1|||
164618802|NCT00636155|594627841|FG000|Overall Study|Physician Decision|5|||
164618803|NCT00766142|594627842|FG000|Overall Study|Protocol Violation|4|||
164618804|NCT02973997|594627843|FG000|Overall Study|Withdrawal by Subject|4|||
164618805|NCT02973997|594627844|FG001|Overall Study|Withdrawal by Subject|0|||
164618806|NCT02973997|594627843|FG000|Overall Study|Adverse Event|4|||
164618807|NCT02973997|594627844|FG001|Overall Study|Adverse Event|1|||
164618808|NCT02973997|594627843|FG000|Overall Study|Disease Progression|11|||
164618809|NCT02973997|594627844|FG001|Overall Study|Disease Progression|20|||
164618810|NCT02973997|594627843|FG000|Overall Study|Alternative Therapy|3|||
164618811|NCT02973997|594627844|FG001|Overall Study|Alternative Therapy|0|||
164618812|NCT02973997|594627843|FG000|Overall Study|Other complicating disease|0|||
164618813|NCT02973997|594627844|FG001|Overall Study|Other complicating disease|1|||
164618814|NCT02973997|594627843|FG000|Overall Study|Death|0|||
164618815|NCT02973997|594627844|FG001|Overall Study|Death|1|||
164618816|NCT01431521|594627845|FG000|Overall Study|Withdrawal by Subject|0|||
164618817|NCT01431521|594627846|FG001|Overall Study|Withdrawal by Subject|0|||
164147382|NCT05168202|592902030|FG006|Overall Study|Lack of Efficacy|2|||
164618818|NCT01431521|594627847|FG002|Overall Study|Withdrawal by Subject|1|||
164618819|NCT01431521|594627848|FG003|Overall Study|Withdrawal by Subject|0|||
164618820|NCT02045979|594627852|FG000|Overall Study|Informed Consent Withdrawn|2|||
164618821|NCT02045979|594627853|FG001|Overall Study|Informed Consent Withdrawn|0|||
164618822|NCT02045979|594627854|FG002|Overall Study|Informed Consent Withdrawn|1|||
164618823|NCT02045979|594627852|FG000|Overall Study|not specified above|0|||
164618824|NCT02045979|594627853|FG001|Overall Study|not specified above|1|||
164618825|NCT02045979|594627854|FG002|Overall Study|not specified above|0|||
164618826|NCT03287830|594627859|FG000|Overall Study|Withdrawal by Subject|1|||
164618827|NCT03287830|594627860|FG001|Overall Study|Withdrawal by Subject|1|||
164618828|NCT03287830|594627859|FG000|Overall Study|not meeting inclusion criteria|5|||
164618829|NCT03287830|594627860|FG001|Overall Study|not meeting inclusion criteria|12|||
164618830|NCT02155712|594627864|FG000|Overall Study|Death|12|||
164618831|NCT02155712|594627865|FG001|Overall Study|Death|0|||
164618832|NCT02155712|594627864|FG000|Overall Study|Lost to Follow-up|37|||
164618833|NCT02155712|594627865|FG001|Overall Study|Lost to Follow-up|22|||
164618834|NCT02155712|594627864|FG000|Overall Study|Revision of device|4|||
164618835|NCT02155712|594627865|FG001|Overall Study|Revision of device|3|||
164618836|NCT02155712|594627864|FG000|Overall Study|Withdrawal by Subject|39|||
164618837|NCT02155712|594627865|FG001|Overall Study|Withdrawal by Subject|21|||
164618838|NCT02155712|594627864|FG000|Overall Study|Site termination|77|||
164618839|NCT02155712|594627865|FG001|Overall Study|Site termination|19|||
164618840|NCT02155712|594627864|FG000|Overall Study|Sponsor terminated study early|150|||
164618841|NCT02155712|594627865|FG001|Overall Study|Sponsor terminated study early|0|||
164618842|NCT02155712|594627864|FG000|Overall Study|Missed final 5-year protocol visit|0|||
164618843|NCT02155712|594627865|FG001|Overall Study|Missed final 5-year protocol visit|32|||
164618844|NCT02155712|594627864|FG000|Overall Study|Censored because surgery cancelled|6|||
164618845|NCT02155712|594627865|FG001|Overall Study|Censored because surgery cancelled|10|||
164618846|NCT02155712|594627864|FG000|Overall Study|Censored because study device was not implanted|61|||
164618847|NCT02155712|594627865|FG001|Overall Study|Censored because study device was not implanted|66|||
164618848|NCT02155712|594627864|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
164618849|NCT02155712|594627865|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
164618850|NCT02060903|594627866|FG000|Overall Study|Lost to Follow-up|4|||
164618851|NCT02060903|594627867|FG001|Overall Study|Lost to Follow-up|0|||
164618852|NCT02060903|594627866|FG000|Overall Study|Withdrawal by Subject|0|||
164618853|NCT02060903|594627867|FG001|Overall Study|Withdrawal by Subject|7|||
164618854|NCT02418585|594627868|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
164618855|NCT02418585|594627869|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
164618856|NCT02418585|594627868|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
164618857|NCT02418585|594627869|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
164618858|NCT02418585|594627868|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
164618859|NCT02418585|594627869|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
164618860|NCT02418585|594627868|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
164618861|NCT02418585|594627869|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
164618862|NCT02418585|594627868|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
164618863|NCT02418585|594627869|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
164618864|NCT02418585|594627868|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
164618865|NCT02418585|594627869|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
164618866|NCT02418585|594627868|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
164618867|NCT02418585|594627869|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
164618868|NCT02418585|594627868|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
164618869|NCT02418585|594627869|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
164618870|NCT02418585|594627868|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
164618871|NCT02418585|594627869|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
164618872|NCT02418585|594627868|FG000|Follow-up Phase (24 Weeks)|Other|3|||
164618873|NCT02418585|594627869|FG001|Follow-up Phase (24 Weeks)|Other|2|||
164618874|NCT01024920|594627870|FG000|Overall Study|Progressive disease|47|||
164618875|NCT01024920|594627871|FG001|Overall Study|Progressive disease|25|||
164618876|NCT01024920|594627870|FG000|Overall Study|Adverse Event|8|||
164618877|NCT01024920|594627871|FG001|Overall Study|Adverse Event|4|||
164618878|NCT01024920|594627870|FG000|Overall Study|Lost to Follow-up|0|||
164618879|NCT01024920|594627871|FG001|Overall Study|Lost to Follow-up|1|||
164618880|NCT01024920|594627870|FG000|Overall Study|Patient refusal to continue|4|||
164618881|NCT01024920|594627871|FG001|Overall Study|Patient refusal to continue|0|||
164618882|NCT01024920|594627870|FG000|Overall Study|Other than listed|5|||
164618883|NCT01024920|594627871|FG001|Overall Study|Other than listed|1|||
164618884|NCT01024920|594627870|FG000|Overall Study|Not treated|3|||
164618885|NCT01024920|594627871|FG001|Overall Study|Not treated|0|||
164618886|NCT01024920|594627870|FG000|Overall Study|Protocol Violation|0|||
164618887|NCT01024920|594627871|FG001|Overall Study|Protocol Violation|1|||
164618888|NCT02768103|594627874|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
164147611|NCT03685344|592902084|FG000|Overall Study|Death|1|||
164618889|NCT00498368|594627902|FG000|Overall Study|Withdrawal by Subject|3|||
164618890|NCT00498368|594627903|FG001|Overall Study|Withdrawal by Subject|2|||
164618891|NCT02972593|594627909|FG000|Overall Study|Lost to Follow-up|19|||
164521724|NCT03117998|594278791|FG000|Overall Study|Lost to Follow-up|0|||
164521725|NCT03117998|594278792|FG001|Overall Study|Lost to Follow-up|0|||
164521726|NCT03117998|594278793|FG002|Overall Study|Lost to Follow-up|0|||
164521727|NCT03117998|594278794|FG003|Overall Study|Lost to Follow-up|1|||
164521728|NCT03117998|594278795|FG004|Overall Study|Lost to Follow-up|4|||
164521729|NCT03117998|594278796|FG005|Overall Study|Lost to Follow-up|0|||
164521730|NCT03117998|594278791|FG000|Overall Study|Subject noncompliance|0|||
164521731|NCT03117998|594278792|FG001|Overall Study|Subject noncompliance|0|||
164521732|NCT03117998|594278793|FG002|Overall Study|Subject noncompliance|1|||
164521733|NCT03117998|594278794|FG003|Overall Study|Subject noncompliance|0|||
164521734|NCT03117998|594278795|FG004|Overall Study|Subject noncompliance|0|||
164521735|NCT03117998|594278796|FG005|Overall Study|Subject noncompliance|2|||
164521736|NCT03117998|594278791|FG000|Overall Study|Protocol Violation|0|||
164521737|NCT03117998|594278792|FG001|Overall Study|Protocol Violation|0|||
164521738|NCT03117998|594278793|FG002|Overall Study|Protocol Violation|0|||
164521739|NCT03117998|594278794|FG003|Overall Study|Protocol Violation|0|||
164521740|NCT03117998|594278795|FG004|Overall Study|Protocol Violation|0|||
164521741|NCT03117998|594278796|FG005|Overall Study|Protocol Violation|1|||
164521742|NCT04927247|594278797|FG000|Overall Study|Other|2|||
164521743|NCT04927247|594278798|FG001|Overall Study|Other|1|||
164521744|NCT04927247|594278797|FG000|Overall Study|Physician Decision|0|||
164521745|NCT04927247|594278798|FG001|Overall Study|Physician Decision|1|||
164521746|NCT04927247|594278797|FG000|Overall Study|Adverse Event|1|||
164521747|NCT04927247|594278798|FG001|Overall Study|Adverse Event|0|||
164521748|NCT02001064|594278800|FG000|Overall Study|Withdrawal by Subject|2|||
164521749|NCT02001064|594278801|FG001|Overall Study|Withdrawal by Subject|1|||
164521750|NCT00432666|594281084|FG000|Main Period|Adverse Event|1|||
164521751|NCT00432666|594281085|FG001|Main Period|Adverse Event|1|||
164521752|NCT00432666|594281084|FG000|Main Period|Consent Withdrawn|1|||
164521753|NCT00432666|594281085|FG001|Main Period|Consent Withdrawn|0|||
164521754|NCT00432666|594281084|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
164521755|NCT00432666|594281085|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
164521756|NCT00432666|594281084|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
164521757|NCT00432666|594281085|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
164521758|NCT00432666|594281084|FG000|Open-Label Extension Period|Adverse Event|5|||
164521759|NCT00432666|594281085|FG001|Open-Label Extension Period|Adverse Event|0|||
164521760|NCT00432666|594281084|FG000|Open-Label Extension Period|Consent withdrawn|10|||
164521761|NCT00432666|594281085|FG001|Open-Label Extension Period|Consent withdrawn|0|||
164521762|NCT00432666|594281084|FG000|Open-Label Extension Period|Physician Decision|3|||
164521763|NCT00432666|594281085|FG001|Open-Label Extension Period|Physician Decision|0|||
164521764|NCT00978627|594281086|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
164521765|NCT00978627|594281087|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
164521766|NCT00978627|594281086|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
164521767|NCT00978627|594281087|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
164521768|NCT00978627|594281086|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
164521769|NCT00978627|594281087|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
164521770|NCT00978627|594281086|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
164521771|NCT00978627|594281087|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
164521772|NCT00978627|594281086|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
164521773|NCT00978627|594281087|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
164521774|NCT00978627|594281086|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
164521775|NCT00978627|594281087|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
164521776|NCT00978627|594281086|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
164521777|NCT00978627|594281087|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
164521778|NCT00978627|594281086|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
164521779|NCT00978627|594281087|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
164521780|NCT00978627|594281086|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
164521781|NCT00978627|594281087|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
164521782|NCT00275262|594281094|FG000|Overall Study|Adverse Event|2|||
164521783|NCT00275262|594281095|FG001|Overall Study|Adverse Event|0|||
164521784|NCT00275262|594281094|FG000|Overall Study|Disease progression|2|||
164521785|NCT00275262|594281095|FG001|Overall Study|Disease progression|5|||
164521786|NCT00275262|594281094|FG000|Overall Study|Lost to Follow-up|0|||
164521787|NCT00275262|594281095|FG001|Overall Study|Lost to Follow-up|2|||
164521788|NCT00275262|594281094|FG000|Overall Study|Protocol Violation|0|||
164521789|NCT00275262|594281095|FG001|Overall Study|Protocol Violation|2|||
164521790|NCT00275262|594281094|FG000|Overall Study|Death|1|||
164521791|NCT00275262|594281095|FG001|Overall Study|Death|0|||
164521792|NCT00275262|594281094|FG000|Overall Study|Started Chemotherapy|1|||
164521793|NCT00275262|594281095|FG001|Overall Study|Started Chemotherapy|0|||
164521794|NCT00603304|594281111|FG000|Overall Study|Lost to Follow-up|5|||
164521795|NCT00603304|594281112|FG001|Overall Study|Lost to Follow-up|7|||
164521796|NCT00603304|594281111|FG000|Overall Study|Withdrawal by Subject|8|||
164521797|NCT00603304|594281112|FG001|Overall Study|Withdrawal by Subject|5|||
164521798|NCT00603304|594281111|FG000|Overall Study|Protocol Violation|1|||
164521799|NCT00603304|594281112|FG001|Overall Study|Protocol Violation|0|||
164521800|NCT00603304|594281111|FG000|Overall Study|Adverse Event|4|||
164521801|NCT00603304|594281112|FG001|Overall Study|Adverse Event|2|||
164521802|NCT00603304|594281111|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
164521803|NCT00603304|594281112|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
164521804|NCT00603304|594281111|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
164521805|NCT00603304|594281112|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
164521806|NCT00603304|594281111|FG000|Overall Study|Exclusionary Medication|2|||
164521807|NCT00603304|594281112|FG001|Overall Study|Exclusionary Medication|3|||
164521808|NCT00603304|594281111|FG000|Overall Study|Non-Compliant|0|||
164521809|NCT00603304|594281112|FG001|Overall Study|Non-Compliant|1|||
164521810|NCT00603304|594281111|FG000|Overall Study|Moved Away|0|||
164521811|NCT00603304|594281112|FG001|Overall Study|Moved Away|2|||
164521812|NCT00603304|594281111|FG000|Overall Study|Other|2|||
164521813|NCT00603304|594281112|FG001|Overall Study|Other|0|||
164521814|NCT00603304|594281111|FG000|Overall Study|Patient Decision|2|||
164521815|NCT00603304|594281112|FG001|Overall Study|Patient Decision|0|||
164521816|NCT01076192|594281113|FG000|Overall Study|Other|197|||
164521817|NCT01290315|594281114|FG000|Overall Study|Adverse Event|0|||
164521818|NCT01290315|594281115|FG001|Overall Study|Adverse Event|0|||
164521819|NCT01290315|594281116|FG002|Overall Study|Adverse Event|0|||
164521820|NCT01290315|594281117|FG003|Overall Study|Adverse Event|3|||
164521821|NCT01290315|594281114|FG000|Overall Study|Selection criteria/compliance|2|||
164521822|NCT01290315|594281115|FG001|Overall Study|Selection criteria/compliance|1|||
164521823|NCT01290315|594281116|FG002|Overall Study|Selection criteria/compliance|0|||
164521824|NCT01290315|594281117|FG003|Overall Study|Selection criteria/compliance|2|||
164521825|NCT01290315|594281114|FG000|Overall Study|Lost to Follow-up|0|||
164521826|NCT01290315|594281115|FG001|Overall Study|Lost to Follow-up|1|||
164521827|NCT01290315|594281116|FG002|Overall Study|Lost to Follow-up|0|||
164521828|NCT01290315|594281117|FG003|Overall Study|Lost to Follow-up|0|||
164521829|NCT01290315|594281114|FG000|Overall Study|Withdrawal by Subject|1|||
164521830|NCT01290315|594281115|FG001|Overall Study|Withdrawal by Subject|1|||
164521831|NCT01290315|594281116|FG002|Overall Study|Withdrawal by Subject|0|||
164521832|NCT01290315|594281117|FG003|Overall Study|Withdrawal by Subject|0|||
164521833|NCT03725085|594281118|FG000|Overall Study|Lost to Follow-up|2|||
164521834|NCT00705679|594281119|FG000|Overall Study|Adverse Event|1|||
164521835|NCT00705679|594281120|FG001|Overall Study|Adverse Event|1|||
164521836|NCT00705679|594281121|FG002|Overall Study|Adverse Event|0|||
164521837|NCT00705679|594281122|FG003|Overall Study|Adverse Event|0|||
164521838|NCT00705679|594281123|FG004|Overall Study|Adverse Event|0|||
164521839|NCT00705679|594281119|FG000|Overall Study|Death|0|||
164521840|NCT00705679|594281120|FG001|Overall Study|Death|0|||
164521841|NCT00705679|594281121|FG002|Overall Study|Death|3|||
164521842|NCT00705679|594281122|FG003|Overall Study|Death|2|||
164521843|NCT00705679|594281123|FG004|Overall Study|Death|1|||
164521844|NCT00705679|594281119|FG000|Overall Study|Lost to Follow-up|32|||
164521845|NCT00705679|594281120|FG001|Overall Study|Lost to Follow-up|60|||
164521846|NCT00705679|594281121|FG002|Overall Study|Lost to Follow-up|44|||
164521847|NCT00705679|594281122|FG003|Overall Study|Lost to Follow-up|30|||
164521848|NCT00705679|594281123|FG004|Overall Study|Lost to Follow-up|35|||
164521849|NCT00705679|594281119|FG000|Overall Study|Physician Decision|0|||
164521850|NCT00705679|594281120|FG001|Overall Study|Physician Decision|1|||
164521851|NCT00705679|594281121|FG002|Overall Study|Physician Decision|0|||
164521852|NCT00705679|594281122|FG003|Overall Study|Physician Decision|1|||
164521853|NCT00705679|594281123|FG004|Overall Study|Physician Decision|0|||
164521854|NCT00705679|594281119|FG000|Overall Study|Withdrawal by Subject|32|||
164521855|NCT00705679|594281120|FG001|Overall Study|Withdrawal by Subject|77|||
164521856|NCT00705679|594281121|FG002|Overall Study|Withdrawal by Subject|68|||
164521857|NCT00705679|594281122|FG003|Overall Study|Withdrawal by Subject|47|||
164521858|NCT00705679|594281123|FG004|Overall Study|Withdrawal by Subject|33|||
164521859|NCT03527173|594281124|FG000|Overall Study|Lost to Follow-up|4|||
164521860|NCT03527173|594281125|FG001|Overall Study|Lost to Follow-up|2|||
164521861|NCT03527173|594281124|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
164521862|NCT03527173|594281125|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
164521863|NCT03527173|594281124|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
164521864|NCT03527173|594281125|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
164521865|NCT03527173|594281124|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
164521866|NCT03527173|594281125|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
164521867|NCT01248780|594281126|FG000|Overall Study|Lack of Efficacy|2|||
164521868|NCT01248780|594281127|FG001|Overall Study|Lack of Efficacy|0|||
164521869|NCT01248780|594281126|FG000|Overall Study|Lost to Follow-up|0|||
164521870|NCT01248780|594281127|FG001|Overall Study|Lost to Follow-up|1|||
164521871|NCT01248780|594281126|FG000|Overall Study|Death|0|||
164521872|NCT01248780|594281127|FG001|Overall Study|Death|1|||
164521873|NCT01248780|594281126|FG000|Overall Study|Adverse Event|2|||
164521874|NCT01248780|594281127|FG001|Overall Study|Adverse Event|7|||
164521875|NCT01248780|594281126|FG000|Overall Study|Protocol Violation|1|||
164521876|NCT01248780|594281127|FG001|Overall Study|Protocol Violation|1|||
164521877|NCT01248780|594281126|FG000|Overall Study|Withdrawal by Subject|4|||
164521878|NCT01248780|594281127|FG001|Overall Study|Withdrawal by Subject|4|||
164521879|NCT01248780|594281126|FG000|Overall Study|Not treated|0|||
164521880|NCT01248780|594281127|FG001|Overall Study|Not treated|1|||
164521881|NCT01227577|594281130|FG000|Overall Study|Protocol deviation|3|||
164521882|NCT01227577|594281130|FG000|Overall Study|Death|3|||
164521883|NCT01227577|594281130|FG000|Overall Study|Administrative problems|2|||
164521884|NCT01227577|594281130|FG000|Overall Study|Lost to Follow-up|1|||
164521885|NCT01227577|594281130|FG000|Overall Study|Withdrawal by Subject|4|||
164521886|NCT01227577|594281130|FG000|Overall Study|Lack of Efficacy|5|||
164521887|NCT01227577|594281130|FG000|Overall Study|Adverse Event|17|||
164521888|NCT03809429|594281131|FG000|Overall Study|Withdrawal by Subject|7|||
164521889|NCT03809429|594281132|FG001|Overall Study|Withdrawal by Subject|3|||
164521890|NCT03809429|594281131|FG000|Overall Study|Adverse Event|6|||
164521891|NCT03809429|594281132|FG001|Overall Study|Adverse Event|9|||
164521892|NCT03809429|594281131|FG000|Overall Study|COVID-19|3|||
164521893|NCT03809429|594281132|FG001|Overall Study|COVID-19|1|||
164521894|NCT03809429|594281131|FG000|Overall Study|Participant was discontinued by investigator|12|||
164521895|NCT03809429|594281132|FG001|Overall Study|Participant was discontinued by investigator|7|||
164521896|NCT00194987|594281133|FG000|Overall Study|Withdrawal by Subject|0|||
164521897|NCT00194987|594281134|FG001|Overall Study|Withdrawal by Subject|3|||
164521898|NCT01664598|594281135|FG000|Overall Study|Sponsor Decision|1|||
164521899|NCT01664598|594281135|FG000|Overall Study|Withdrawal of Informed Consent|4|||
164521900|NCT01664598|594281135|FG000|Overall Study|Adverse Event|1|||
164521901|NCT03507777|594281140|FG000|Overall Study|Lost to Follow-up|5|||
164521902|NCT03507777|594281141|FG001|Overall Study|Lost to Follow-up|7|||
164521903|NCT03507777|594281140|FG000|Overall Study|Withdrawal by Subject|6|||
164521904|NCT03507777|594281141|FG001|Overall Study|Withdrawal by Subject|11|||
164521905|NCT03507777|594281140|FG000|Overall Study|Death|30|||
164521906|NCT03507777|594281141|FG001|Overall Study|Death|44|||
164521907|NCT03507777|594281140|FG000|Overall Study|Other Reasons|3|||
164521908|NCT03507777|594281141|FG001|Overall Study|Other Reasons|8|||
164521909|NCT02245737|594281142|FG000|Overall Study|Adverse Event|23|||
164521910|NCT02245737|594281143|FG001|Overall Study|Adverse Event|26|||
164521911|NCT02245737|594281144|FG002|Overall Study|Adverse Event|33|||
164521912|NCT02245737|594281142|FG000|Overall Study|Condition Worsened|9|||
164521913|NCT02245737|594281143|FG001|Overall Study|Condition Worsened|10|||
164521914|NCT02245737|594281144|FG002|Overall Study|Condition Worsened|9|||
164521915|NCT02245737|594281142|FG000|Overall Study|Death|2|||
164521916|NCT02245737|594281143|FG001|Overall Study|Death|4|||
164521917|NCT02245737|594281144|FG002|Overall Study|Death|4|||
164521918|NCT02245737|594281142|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
164521919|NCT02245737|594281143|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
164521920|NCT02245737|594281144|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
164521921|NCT02245737|594281142|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
164521922|NCT02245737|594281143|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
164521923|NCT02245737|594281144|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
164521924|NCT02245737|594281142|FG000|Overall Study|Lost to Follow-up|2|||
164521925|NCT02245737|594281143|FG001|Overall Study|Lost to Follow-up|5|||
164521926|NCT02245737|594281144|FG002|Overall Study|Lost to Follow-up|4|||
164521927|NCT02245737|594281142|FG000|Overall Study|Other-determined by Investigator|9|||
164521928|NCT02245737|594281143|FG001|Overall Study|Other-determined by Investigator|10|||
164521929|NCT02245737|594281144|FG002|Overall Study|Other-determined by Investigator|10|||
164521930|NCT02245737|594281142|FG000|Overall Study|Physician Decision|6|||
164521931|NCT02245737|594281143|FG001|Overall Study|Physician Decision|3|||
164521932|NCT02245737|594281144|FG002|Overall Study|Physician Decision|6|||
164521933|NCT02245737|594281142|FG000|Overall Study|Protocol Violation|3|||
164521934|NCT02245737|594281143|FG001|Overall Study|Protocol Violation|2|||
164521935|NCT02245737|594281144|FG002|Overall Study|Protocol Violation|3|||
164521936|NCT02245737|594281142|FG000|Overall Study|Withdrawal by Subject|40|||
164521937|NCT02245737|594281143|FG001|Overall Study|Withdrawal by Subject|41|||
164521938|NCT02245737|594281144|FG002|Overall Study|Withdrawal by Subject|44|||
164521939|NCT02245737|594281142|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
164521940|NCT02245737|594281143|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
164521941|NCT02245737|594281144|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
164521942|NCT02245737|594281142|FG000|Overall Study|Sponsor Decision|445|||
164521943|NCT02245737|594281143|FG001|Overall Study|Sponsor Decision|430|||
164521944|NCT02245737|594281144|FG002|Overall Study|Sponsor Decision|432|||
164521945|NCT00836745|594281148|FG000|Overall Study|Death|2|||
164521946|NCT00836745|594281148|FG000|Overall Study|Lost to Follow-up|10|||
164521947|NCT00836745|594281148|FG000|Overall Study|Adverse Event|3|||
164521948|NCT00836745|594281148|FG000|Overall Study|Objective progression or relapse|4|||
164521949|NCT00836745|594281148|FG000|Overall Study|Other|2|||
164521950|NCT00446043|594281151|FG000|Overall Study|Adverse Event|9|||
164521951|NCT00446043|594281151|FG000|Overall Study|Withdrawal by Subject|70|||
164521952|NCT00446043|594281151|FG000|Overall Study|Protocol Violation|2|||
164521953|NCT00446043|594281151|FG000|Overall Study|Lost to Follow-up|42|||
164521954|NCT00446043|594281151|FG000|Overall Study|Pregnancy|2|||
164521955|NCT01239043|594281152|FG000|Overall Study|Protocol Violation|2|||
164618892|NCT02972593|594627910|FG001|Overall Study|Lost to Follow-up|15|||
164618893|NCT02972593|594627909|FG000|Overall Study|Protocol Violation|1|||
164618894|NCT02972593|594627910|FG001|Overall Study|Protocol Violation|0|||
164618895|NCT02148952|594627919|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
164618896|NCT02148952|594627920|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
164618897|NCT02148952|594627919|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
164618898|NCT02148952|594627920|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
164618899|NCT02148952|594627919|FG000|Follow-Up|Lost to Follow-up|219|||
164618900|NCT02148952|594627920|FG001|Follow-Up|Lost to Follow-up|231|||
164618901|NCT02148952|594627919|FG000|Follow-Up|Withdrawal by Subject|46|||
164618902|NCT02148952|594627920|FG001|Follow-Up|Withdrawal by Subject|48|||
164618903|NCT01925014|594627921|FG000|Overall Study|Inappropriate enrollment|4|||
164618904|NCT01925014|594627922|FG001|Overall Study|Inappropriate enrollment|6|||
164618905|NCT01925014|594627921|FG000|Overall Study|Withdrawal by Subject|5|||
164618906|NCT01925014|594627922|FG001|Overall Study|Withdrawal by Subject|13|||
164618907|NCT01487863|594627923|FG000|Overall Study|Death|19|||
164618908|NCT01487863|594627924|FG001|Overall Study|Death|19|||
164618909|NCT01437267|594627928|FG000|Overall Study|Withdrawal by Subject|0|||
164618910|NCT01437267|594627929|FG001|Overall Study|Withdrawal by Subject|0|||
164618911|NCT01437267|594627930|FG002|Overall Study|Withdrawal by Subject|0|||
164618912|NCT01437267|594627931|FG003|Overall Study|Withdrawal by Subject|1|||
164618913|NCT01437267|594627932|FG004|Overall Study|Withdrawal by Subject|0|||
164618914|NCT01437267|594627933|FG005|Overall Study|Withdrawal by Subject|0|||
164618915|NCT01437267|594627928|FG000|Overall Study|Protocol Violation|0|||
164618916|NCT01437267|594627929|FG001|Overall Study|Protocol Violation|1|||
164618917|NCT01437267|594627930|FG002|Overall Study|Protocol Violation|0|||
164618918|NCT01437267|594627931|FG003|Overall Study|Protocol Violation|0|||
164618919|NCT01437267|594627932|FG004|Overall Study|Protocol Violation|0|||
164618920|NCT01437267|594627933|FG005|Overall Study|Protocol Violation|0|||
164618921|NCT01810380|594627936|FG000|Overall Study|Randomised not treated|2|||
164618922|NCT01810380|594627937|FG001|Overall Study|Randomised not treated|1|||
164618923|NCT01810380|594627938|FG002|Overall Study|Randomised not treated|1|||
164618924|NCT01810380|594627936|FG000|Overall Study|Adverse Event|11|||
164618925|NCT01810380|594627937|FG001|Overall Study|Adverse Event|14|||
164618926|NCT01810380|594627938|FG002|Overall Study|Adverse Event|4|||
164618927|NCT01810380|594627936|FG000|Overall Study|Lack of Efficacy|24|||
164618928|NCT01810380|594627937|FG001|Overall Study|Lack of Efficacy|10|||
164618929|NCT01810380|594627938|FG002|Overall Study|Lack of Efficacy|11|||
164618930|NCT01810380|594627936|FG000|Overall Study|Protocol Violation|1|||
164618931|NCT01810380|594627937|FG001|Overall Study|Protocol Violation|0|||
164618932|NCT01810380|594627938|FG002|Overall Study|Protocol Violation|1|||
164618933|NCT01810380|594627936|FG000|Overall Study|Withdrawal by Subject|6|||
164618934|NCT01810380|594627937|FG001|Overall Study|Withdrawal by Subject|0|||
164618935|NCT01810380|594627938|FG002|Overall Study|Withdrawal by Subject|6|||
164618936|NCT01810380|594627936|FG000|Overall Study|Administrative or other reasons|11|||
164618937|NCT01810380|594627937|FG001|Overall Study|Administrative or other reasons|13|||
164618938|NCT01810380|594627938|FG002|Overall Study|Administrative or other reasons|9|||
164618939|NCT00033371|594627939|FG000|Overall Study|Adverse Event|1|||
164618940|NCT00033371|594627940|FG001|Overall Study|Adverse Event|5|||
164618941|NCT00033371|594627939|FG000|Overall Study|Lost to Follow-up|2|||
164618942|NCT00033371|594627940|FG001|Overall Study|Lost to Follow-up|1|||
164618943|NCT00033371|594627939|FG000|Overall Study|Withdrawal by Subject|3|||
164618944|NCT00033371|594627940|FG001|Overall Study|Withdrawal by Subject|3|||
164618945|NCT00033371|594627939|FG000|Overall Study|Disease Progression|0|||
164618946|NCT00033371|594627940|FG001|Overall Study|Disease Progression|1|||
164618947|NCT02699125|594627941|FG000|Placebo|Lost to Follow-up|2|||
164618948|NCT02699125|594627942|FG001|Placebo|Lost to Follow-up|0|||
164618949|NCT02699125|594627941|FG000|Placebo|Protocol Violation|1|||
164618950|NCT02699125|594627942|FG001|Placebo|Protocol Violation|0|||
164618951|NCT02699125|594627941|FG000|Placebo|Withdrawal by Subject|0|||
164618952|NCT02699125|594627942|FG001|Placebo|Withdrawal by Subject|4|||
164618953|NCT02699125|594627941|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
164618954|NCT02699125|594627942|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
164618955|NCT01390038|594627945|FG000|Overall Study|Death|1|||
164618956|NCT01390038|594627945|FG000|Overall Study|Lost to Follow-up|1|||
164618957|NCT01390038|594627945|FG000|Overall Study|Withdrawal by Subject|4|||
164618958|NCT01390038|594627945|FG000|Overall Study|Simpliciti System Removal|2|||
164618959|NCT03799627|594627950|FG000|Overall Study|Adverse Event|1|||
164618960|NCT03799627|594627951|FG001|Overall Study|Adverse Event|2|||
164618961|NCT03799627|594627952|FG002|Overall Study|Adverse Event|0|||
164618962|NCT03799627|594627953|FG003|Overall Study|Adverse Event|0|||
164618963|NCT03799627|594627954|FG004|Overall Study|Adverse Event|2|||
164618964|NCT03799627|594627955|FG005|Overall Study|Adverse Event|5|||
164618965|NCT03799627|594627956|FG006|Overall Study|Adverse Event|0|||
164618966|NCT03799627|594627957|FG007|Overall Study|Adverse Event|2|||
164618967|NCT03799627|594627958|FG008|Overall Study|Adverse Event|0|||
164618968|NCT03799627|594627950|FG000|Overall Study|Physician Decision|2|||
164618969|NCT03799627|594627951|FG001|Overall Study|Physician Decision|2|||
164618970|NCT03799627|594627952|FG002|Overall Study|Physician Decision|0|||
164618971|NCT03799627|594627953|FG003|Overall Study|Physician Decision|0|||
164618972|NCT03799627|594627954|FG004|Overall Study|Physician Decision|2|||
164618973|NCT03799627|594627955|FG005|Overall Study|Physician Decision|2|||
164618974|NCT03799627|594627956|FG006|Overall Study|Physician Decision|0|||
164618975|NCT03799627|594627957|FG007|Overall Study|Physician Decision|0|||
164618976|NCT03799627|594627958|FG008|Overall Study|Physician Decision|0|||
164618977|NCT03799627|594627950|FG000|Overall Study|Withdrawal by Subject|1|||
164618978|NCT03799627|594627951|FG001|Overall Study|Withdrawal by Subject|1|||
164618979|NCT03799627|594627952|FG002|Overall Study|Withdrawal by Subject|0|||
164618980|NCT03799627|594627953|FG003|Overall Study|Withdrawal by Subject|2|||
164618981|NCT03799627|594627954|FG004|Overall Study|Withdrawal by Subject|0|||
164618982|NCT03799627|594627955|FG005|Overall Study|Withdrawal by Subject|3|||
164618983|NCT03799627|594627956|FG006|Overall Study|Withdrawal by Subject|0|||
164618984|NCT03799627|594627957|FG007|Overall Study|Withdrawal by Subject|0|||
164618985|NCT03799627|594627958|FG008|Overall Study|Withdrawal by Subject|0|||
164618986|NCT03799627|594627950|FG000|Overall Study|Lack of Efficacy|0|||
164618987|NCT03799627|594627951|FG001|Overall Study|Lack of Efficacy|0|||
164618988|NCT03799627|594627952|FG002|Overall Study|Lack of Efficacy|0|||
164618989|NCT03799627|594627953|FG003|Overall Study|Lack of Efficacy|1|||
164618990|NCT03799627|594627954|FG004|Overall Study|Lack of Efficacy|0|||
164618991|NCT03799627|594627955|FG005|Overall Study|Lack of Efficacy|0|||
164618992|NCT03799627|594627956|FG006|Overall Study|Lack of Efficacy|0|||
164618993|NCT03799627|594627957|FG007|Overall Study|Lack of Efficacy|0|||
164618994|NCT03799627|594627958|FG008|Overall Study|Lack of Efficacy|0|||
164618995|NCT03799627|594627950|FG000|Overall Study|Lost to Follow-up|0|||
164618996|NCT03799627|594627951|FG001|Overall Study|Lost to Follow-up|0|||
164618997|NCT03799627|594627952|FG002|Overall Study|Lost to Follow-up|0|||
164618998|NCT03799627|594627953|FG003|Overall Study|Lost to Follow-up|0|||
164618999|NCT03799627|594627954|FG004|Overall Study|Lost to Follow-up|0|||
164619000|NCT03799627|594627955|FG005|Overall Study|Lost to Follow-up|0|||
164619001|NCT03799627|594627956|FG006|Overall Study|Lost to Follow-up|1|||
164619002|NCT03799627|594627957|FG007|Overall Study|Lost to Follow-up|0|||
164619003|NCT03799627|594627958|FG008|Overall Study|Lost to Follow-up|1|||
164619004|NCT03799627|594627950|FG000|Overall Study|Death|0|||
164619005|NCT03799627|594627951|FG001|Overall Study|Death|0|||
164619006|NCT03799627|594627952|FG002|Overall Study|Death|0|||
164619007|NCT03799627|594627953|FG003|Overall Study|Death|1|||
164619008|NCT03799627|594627954|FG004|Overall Study|Death|0|||
164619009|NCT03799627|594627955|FG005|Overall Study|Death|0|||
164619010|NCT03799627|594627956|FG006|Overall Study|Death|0|||
164619011|NCT03799627|594627957|FG007|Overall Study|Death|0|||
164619012|NCT03799627|594627958|FG008|Overall Study|Death|0|||
164619013|NCT03799627|594627950|FG000|Overall Study|Study Drug Put on Hold|1|||
164619014|NCT03799627|594627951|FG001|Overall Study|Study Drug Put on Hold|0|||
164619015|NCT03799627|594627952|FG002|Overall Study|Study Drug Put on Hold|0|||
164619016|NCT03799627|594627953|FG003|Overall Study|Study Drug Put on Hold|0|||
164619017|NCT03799627|594627954|FG004|Overall Study|Study Drug Put on Hold|0|||
164619018|NCT03799627|594627955|FG005|Overall Study|Study Drug Put on Hold|0|||
164619019|NCT03799627|594627956|FG006|Overall Study|Study Drug Put on Hold|0|||
164619020|NCT03799627|594627957|FG007|Overall Study|Study Drug Put on Hold|0|||
164619021|NCT03799627|594627958|FG008|Overall Study|Study Drug Put on Hold|0|||
164619022|NCT03799627|594627950|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
164619023|NCT03799627|594627951|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
164619024|NCT03799627|594627952|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
164619025|NCT03799627|594627953|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
164619026|NCT03799627|594627954|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
164619027|NCT03799627|594627955|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
164619028|NCT03799627|594627956|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
164619029|NCT03799627|594627957|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
164619030|NCT03799627|594627958|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
164619031|NCT03799627|594627950|FG000|Overall Study|Kidney Transplantation|1|||
164619032|NCT03799627|594627951|FG001|Overall Study|Kidney Transplantation|0|||
164619033|NCT03799627|594627952|FG002|Overall Study|Kidney Transplantation|0|||
164619034|NCT03799627|594627953|FG003|Overall Study|Kidney Transplantation|1|||
164619035|NCT03799627|594627954|FG004|Overall Study|Kidney Transplantation|1|||
164619036|NCT03799627|594627955|FG005|Overall Study|Kidney Transplantation|0|||
164619037|NCT03799627|594627956|FG006|Overall Study|Kidney Transplantation|0|||
164619038|NCT03799627|594627957|FG007|Overall Study|Kidney Transplantation|0|||
164619039|NCT03799627|594627958|FG008|Overall Study|Kidney Transplantation|0|||
164619040|NCT03799627|594627950|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
164619041|NCT03799627|594627951|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
164619042|NCT03799627|594627952|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
164521956|NCT01239043|594281153|FG001|Overall Study|Protocol Violation|1|||
164521957|NCT02929329|594281156|FG000|Overall Study|Withdrawal by Subject|24|||
164521958|NCT02929329|594281157|FG001|Overall Study|Withdrawal by Subject|21|||
164521959|NCT02929329|594281156|FG000|Overall Study|Lost to Follow-up|26|||
164521960|NCT02929329|594281157|FG001|Overall Study|Lost to Follow-up|20|||
164521961|NCT02929329|594281156|FG000|Overall Study|Death|1054|||
164521962|NCT02929329|594281157|FG001|Overall Study|Death|1051|||
164521963|NCT01639560|594281163|FG000|Overall Study|Withdrawal by Subject|9|||
164521964|NCT01639560|594281164|FG001|Overall Study|Withdrawal by Subject|14|||
164521965|NCT01639560|594281163|FG000|Overall Study|Lack of Efficacy|1|||
164521966|NCT01639560|594281164|FG001|Overall Study|Lack of Efficacy|2|||
164521967|NCT01639560|594281163|FG000|Overall Study|Lost to Follow-up|9|||
164521968|NCT01639560|594281164|FG001|Overall Study|Lost to Follow-up|11|||
164521969|NCT01639560|594281163|FG000|Overall Study|Adverse Event|0|||
164521970|NCT01639560|594281164|FG001|Overall Study|Adverse Event|2|||
164521971|NCT00774930|594281166|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
164521972|NCT00774930|594281167|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
164521973|NCT00774930|594281166|FG000|DB Phase|Adverse Event|1|||
164521974|NCT00774930|594281167|FG001|DB Phase|Adverse Event|2|||
164521975|NCT00774930|594281166|FG000|DB Phase|Subject Decision|1|||
164521976|NCT00774930|594281167|FG001|DB Phase|Subject Decision|5|||
164521977|NCT00774930|594281166|FG000|DB Phase|Sponsor Decision|0|||
164521978|NCT00774930|594281167|FG001|DB Phase|Sponsor Decision|1|||
164521979|NCT00774930|594281166|FG000|DB Phase|Disease Progression|1|||
164521980|NCT00774930|594281167|FG001|DB Phase|Disease Progression|1|||
164521981|NCT00774930|594281166|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
164521982|NCT00774930|594281167|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
164521983|NCT00774930|594281166|FG000|IOL Phase|Adverse Event|1|||
164521984|NCT00774930|594281167|FG001|IOL Phase|Adverse Event|1|||
164521985|NCT00774930|594281166|FG000|IOL Phase|Subject Decision|4|||
164521986|NCT00774930|594281167|FG001|IOL Phase|Subject Decision|3|||
164521987|NCT00774930|594281166|FG000|IOL Phase|Physician Decision|3|||
164521988|NCT00774930|594281167|FG001|IOL Phase|Physician Decision|2|||
164521989|NCT00774930|594281166|FG000|IOL Phase|Sponsor Decision|1|||
164521990|NCT00774930|594281167|FG001|IOL Phase|Sponsor Decision|0|||
164521991|NCT00774930|594281166|FG000|IOL Phase|Disease Progression|2|||
164521992|NCT00774930|594281167|FG001|IOL Phase|Disease Progression|1|||
164521993|NCT00774930|594281166|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
164521994|NCT00774930|594281167|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
164521995|NCT00774930|594281166|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
164521996|NCT00774930|594281167|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
164521997|NCT00774930|594281166|FG000|IOL Phase|Other|1|||
164521998|NCT00774930|594281167|FG001|IOL Phase|Other|0|||
164619043|NCT03799627|594627953|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
164619044|NCT03799627|594627954|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
164619045|NCT03799627|594627955|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
164619046|NCT03799627|594627956|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
164619047|NCT03799627|594627957|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
164619048|NCT03799627|594627958|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
164619049|NCT03799627|594627950|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
164619050|NCT03799627|594627951|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
164619051|NCT03799627|594627952|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
164619052|NCT03799627|594627953|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
164619053|NCT03799627|594627954|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
164619054|NCT03799627|594627955|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
164619055|NCT03799627|594627956|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
164619056|NCT03799627|594627957|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
164619057|NCT03799627|594627958|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
164619058|NCT03799627|594627950|FG000|Overall Study|Met Exclusion Criteria|0|||
164619059|NCT03799627|594627951|FG001|Overall Study|Met Exclusion Criteria|0|||
164619060|NCT03799627|594627952|FG002|Overall Study|Met Exclusion Criteria|0|||
164619061|NCT03799627|594627953|FG003|Overall Study|Met Exclusion Criteria|1|||
164619062|NCT03799627|594627954|FG004|Overall Study|Met Exclusion Criteria|0|||
164619063|NCT03799627|594627955|FG005|Overall Study|Met Exclusion Criteria|0|||
164619064|NCT03799627|594627956|FG006|Overall Study|Met Exclusion Criteria|0|||
164619065|NCT03799627|594627957|FG007|Overall Study|Met Exclusion Criteria|0|||
164619066|NCT03799627|594627958|FG008|Overall Study|Met Exclusion Criteria|0|||
164619067|NCT03799627|594627950|FG000|Overall Study|Investigational Product Noncompliance|0|||
164619068|NCT03799627|594627951|FG001|Overall Study|Investigational Product Noncompliance|0|||
164619069|NCT03799627|594627952|FG002|Overall Study|Investigational Product Noncompliance|0|||
164619070|NCT03799627|594627953|FG003|Overall Study|Investigational Product Noncompliance|1|||
164619071|NCT03799627|594627954|FG004|Overall Study|Investigational Product Noncompliance|0|||
164619072|NCT03799627|594627955|FG005|Overall Study|Investigational Product Noncompliance|0|||
164619073|NCT03799627|594627956|FG006|Overall Study|Investigational Product Noncompliance|0|||
164619074|NCT03799627|594627957|FG007|Overall Study|Investigational Product Noncompliance|0|||
164619075|NCT03799627|594627958|FG008|Overall Study|Investigational Product Noncompliance|0|||
164619076|NCT03799627|594627950|FG000|Overall Study|Participant Relocation|0|||
164619077|NCT03799627|594627951|FG001|Overall Study|Participant Relocation|0|||
164619078|NCT03799627|594627952|FG002|Overall Study|Participant Relocation|0|||
164619079|NCT03799627|594627953|FG003|Overall Study|Participant Relocation|1|||
164619080|NCT03799627|594627954|FG004|Overall Study|Participant Relocation|0|||
164619081|NCT03799627|594627955|FG005|Overall Study|Participant Relocation|1|||
164619082|NCT03799627|594627956|FG006|Overall Study|Participant Relocation|0|||
164619083|NCT03799627|594627957|FG007|Overall Study|Participant Relocation|0|||
164619084|NCT03799627|594627958|FG008|Overall Study|Participant Relocation|0|||
164619085|NCT03799627|594627950|FG000|Overall Study|Eurofin Issue|0|||
164619086|NCT03799627|594627951|FG001|Overall Study|Eurofin Issue|0|||
164619087|NCT03799627|594627952|FG002|Overall Study|Eurofin Issue|0|||
164619088|NCT03799627|594627953|FG003|Overall Study|Eurofin Issue|0|||
164619089|NCT03799627|594627954|FG004|Overall Study|Eurofin Issue|1|||
164619090|NCT03799627|594627955|FG005|Overall Study|Eurofin Issue|0|||
164619091|NCT03799627|594627956|FG006|Overall Study|Eurofin Issue|0|||
164619092|NCT03799627|594627957|FG007|Overall Study|Eurofin Issue|0|||
164619093|NCT03799627|594627958|FG008|Overall Study|Eurofin Issue|0|||
164619094|NCT03799627|594627950|FG000|Overall Study|Noncompliance with Site Instructions|0|||
164619095|NCT03799627|594627951|FG001|Overall Study|Noncompliance with Site Instructions|0|||
164619096|NCT03799627|594627952|FG002|Overall Study|Noncompliance with Site Instructions|0|||
164619097|NCT03799627|594627953|FG003|Overall Study|Noncompliance with Site Instructions|0|||
164619098|NCT03799627|594627954|FG004|Overall Study|Noncompliance with Site Instructions|1|||
164619099|NCT03799627|594627955|FG005|Overall Study|Noncompliance with Site Instructions|0|||
164619100|NCT03799627|594627956|FG006|Overall Study|Noncompliance with Site Instructions|0|||
164619101|NCT03799627|594627957|FG007|Overall Study|Noncompliance with Site Instructions|0|||
164619102|NCT03799627|594627958|FG008|Overall Study|Noncompliance with Site Instructions|0|||
164619103|NCT03799627|594627950|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
164619104|NCT03799627|594627951|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
164619105|NCT03799627|594627952|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
164619106|NCT03799627|594627953|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
164619107|NCT03799627|594627954|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
164619108|NCT03799627|594627955|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
164619109|NCT03799627|594627956|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
164619110|NCT03799627|594627957|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
164619111|NCT03799627|594627958|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
164619112|NCT03799627|594627950|FG000|Overall Study|Changes In Hemoglobin Values|1|||
164619113|NCT03799627|594627951|FG001|Overall Study|Changes In Hemoglobin Values|2|||
164619114|NCT03799627|594627952|FG002|Overall Study|Changes In Hemoglobin Values|1|||
164619115|NCT03799627|594627953|FG003|Overall Study|Changes In Hemoglobin Values|0|||
164619116|NCT03799627|594627954|FG004|Overall Study|Changes In Hemoglobin Values|0|||
164619117|NCT03799627|594627955|FG005|Overall Study|Changes In Hemoglobin Values|2|||
164619118|NCT03799627|594627956|FG006|Overall Study|Changes In Hemoglobin Values|1|||
164619119|NCT03799627|594627957|FG007|Overall Study|Changes In Hemoglobin Values|0|||
164619120|NCT03799627|594627958|FG008|Overall Study|Changes In Hemoglobin Values|1|||
164619121|NCT01927068|594627967|FG000|Overall Study|Death|37|||
164619122|NCT01927068|594627968|FG001|Overall Study|Death|3|||
164619123|NCT01927068|594627967|FG000|Overall Study|Withdrawal by Subject|50|||
164619124|NCT01927068|594627968|FG001|Overall Study|Withdrawal by Subject|3|||
164619125|NCT01927068|594627967|FG000|Overall Study|Lost to Follow-up|10|||
164619126|NCT01927068|594627968|FG001|Overall Study|Lost to Follow-up|2|||
164619127|NCT01927068|594627967|FG000|Overall Study|Physician Decision|9|||
164619128|NCT01927068|594627968|FG001|Overall Study|Physician Decision|0|||
164619129|NCT01927068|594627967|FG000|Overall Study|Missed last follow-up visit|2|||
164619130|NCT01927068|594627968|FG001|Overall Study|Missed last follow-up visit|0|||
164619131|NCT01624467|594627969|FG000|Overall Study|Withdrawal by Subject|2|||
164619132|NCT01624467|594627969|FG000|Overall Study|Lost to Follow-up|1|||
164619133|NCT01624467|594627969|FG000|Overall Study|Adverse Event|7|||
164619134|NCT01624467|594627969|FG000|Overall Study|Progressive Disease|19|||
164619135|NCT01624467|594627969|FG000|Overall Study|Per Sponsor Requirement|1|||
164619136|NCT01624467|594627969|FG000|Overall Study|Subject Withdrew from Treatment|1|||
164619137|NCT03964493|594627970|FG000|Overall Study|Withdrawal by Subject|4|||
164619138|NCT03964493|594627971|FG001|Overall Study|Withdrawal by Subject|1|||
164619139|NCT03964493|594627970|FG000|Overall Study|Lost to Follow-up|13|||
164619140|NCT03964493|594627971|FG001|Overall Study|Lost to Follow-up|4|||
164619141|NCT00398138|594627972|FG000|Overall Study|Adverse Event|2|||
164619142|NCT00814307|594627975|FG000|Overall Study|Randomized but not treated|1|||
164619143|NCT00814307|594627976|FG001|Overall Study|Randomized but not treated|0|||
164619144|NCT00814307|594627977|FG002|Overall Study|Randomized but not treated|0|||
164619145|NCT00814307|594627978|FG003|Overall Study|Randomized but not treated|0|||
164619146|NCT00814307|594627975|FG000|Overall Study|Adverse Event|3|||
164619147|NCT00814307|594627976|FG001|Overall Study|Adverse Event|9|||
164619148|NCT00814307|594627977|FG002|Overall Study|Adverse Event|3|||
164521999|NCT00774930|594281166|FG000|IOL Phase|Brain radiation|0|||
164522000|NCT00774930|594281167|FG001|IOL Phase|Brain radiation|1|||
164522001|NCT00774930|594281166|FG000|LTOLE Phase|Adverse Event|7|||
164522002|NCT00774930|594281167|FG001|LTOLE Phase|Adverse Event|3|||
164522003|NCT00774930|594281166|FG000|LTOLE Phase|Subject decision|0|||
164522004|NCT00774930|594281167|FG001|LTOLE Phase|Subject decision|5|||
164522005|NCT00774930|594281166|FG000|LTOLE Phase|Physician Decision|4|||
164522006|NCT00774930|594281167|FG001|LTOLE Phase|Physician Decision|1|||
164522007|NCT00774930|594281166|FG000|LTOLE Phase|Sponsor decision|2|||
164522008|NCT00774930|594281167|FG001|LTOLE Phase|Sponsor decision|1|||
164522009|NCT00774930|594281166|FG000|LTOLE Phase|Disease Progression|2|||
164522010|NCT00774930|594281167|FG001|LTOLE Phase|Disease Progression|5|||
164522011|NCT00774930|594281166|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
164522012|NCT00774930|594281167|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
164522013|NCT00774930|594281166|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
164522014|NCT00774930|594281167|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
164522015|NCT00766363|594281172|FG000|Overall Study|Withdrawal by Subject|1|||
164522016|NCT00766363|594281173|FG001|Overall Study|Withdrawal by Subject|0|||
164522017|NCT00766363|594281174|FG002|Overall Study|Withdrawal by Subject|0|||
164522018|NCT00766363|594281175|FG003|Overall Study|Withdrawal by Subject|0|||
164522019|NCT00766363|594281172|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
164522020|NCT00766363|594281173|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
164522021|NCT00766363|594281174|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
164522022|NCT00766363|594281175|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
164522023|NCT03020576|594281176|FG000|Overall Study|Withdrawal by Subject|1|||
164522024|NCT03020576|594281177|FG001|Overall Study|Withdrawal by Subject|2|||
164522025|NCT03292432|594281178|FG000|Overall Study|Lost to Follow-up|11|||
164522026|NCT03292432|594281179|FG001|Overall Study|Lost to Follow-up|8|||
164522027|NCT03292432|594281178|FG000|Overall Study|Death|2|||
164522028|NCT03292432|594281179|FG001|Overall Study|Death|1|||
164522029|NCT03292432|594281178|FG000|Overall Study|Withdrawal by Subject|1|||
164522030|NCT03292432|594281179|FG001|Overall Study|Withdrawal by Subject|2|||
164522031|NCT03292432|594281178|FG000|Overall Study|Site closed before any data collected|1|||
164522032|NCT03292432|594281179|FG001|Overall Study|Site closed before any data collected|0|||
164522033|NCT00911937|594281180|FG000|Overall Study|Death|1|||
164522034|NCT00911937|594281181|FG001|Overall Study|Death|0|||
164522035|NCT00911937|594281180|FG000|Overall Study|Lost to Follow-up|8|||
164522036|NCT00911937|594281181|FG001|Overall Study|Lost to Follow-up|5|||
164522037|NCT00911937|594281180|FG000|Overall Study|Withdrawal by Subject|10|||
164522038|NCT00911937|594281181|FG001|Overall Study|Withdrawal by Subject|7|||
164522039|NCT00911937|594281180|FG000|Overall Study|Withdrawn due to pregnancy|1|||
164522040|NCT00911937|594281181|FG001|Overall Study|Withdrawn due to pregnancy|0|||
164522041|NCT00911937|594281180|FG000|Overall Study|Adverse Event|11|||
164522042|NCT00911937|594281181|FG001|Overall Study|Adverse Event|25|||
164522043|NCT00911937|594281180|FG000|Overall Study|Lack of Efficacy|11|||
164522044|NCT00911937|594281181|FG001|Overall Study|Lack of Efficacy|6|||
164522045|NCT00911937|594281180|FG000|Overall Study|Did not meet inclusion criteria|9|||
164522046|NCT00911937|594281181|FG001|Overall Study|Did not meet inclusion criteria|11|||
164522047|NCT00911937|594281180|FG000|Overall Study|Protocol Violation|14|||
164522048|NCT00911937|594281181|FG001|Overall Study|Protocol Violation|23|||
164522049|NCT00911937|594281180|FG000|Overall Study|Randomized but not treated|13|||
164522050|NCT00911937|594281181|FG001|Overall Study|Randomized but not treated|13|||
164522051|NCT00911937|594281180|FG000|Overall Study|Other|9|||
164522052|NCT00911937|594281181|FG001|Overall Study|Other|5|||
164522053|NCT01498679|594281182|FG000|Overall Study|Adverse Event|1|||
164522054|NCT01498679|594281183|FG001|Overall Study|Adverse Event|4|||
164522055|NCT01498679|594281182|FG000|Overall Study|Lack of Efficacy|72|||
164522056|NCT01498679|594281183|FG001|Overall Study|Lack of Efficacy|12|||
164522057|NCT01498679|594281182|FG000|Overall Study|Protocol Violation|4|||
164522058|NCT01498679|594281183|FG001|Overall Study|Protocol Violation|0|||
164522059|NCT01498679|594281182|FG000|Overall Study|Physician Decision|0|||
164522060|NCT01498679|594281183|FG001|Overall Study|Physician Decision|2|||
164522061|NCT01498679|594281182|FG000|Overall Study|Withdrawal by Subject|12|||
164522062|NCT01498679|594281183|FG001|Overall Study|Withdrawal by Subject|4|||
164522063|NCT00424385|594281186|FG000|Cohort 0|Withdrawal by Subject|5|||
164522064|NCT00424385|594281186|FG000|Cohort 0|Physician Decision|1|||
164522065|NCT00424385|594281186|FG000|Cohort 1|Withdrawal by Subject|1|||
164522066|NCT02057523|594281187|FG000|Overall Study|Withdrawal by Subject|1|||
164522067|NCT02057523|594281187|FG000|Overall Study|Lack of Efficacy|1|||
164522068|NCT00964886|594281198|FG000|Overall Study|Lost to Follow-up|2|||
164522069|NCT00964886|594281199|FG001|Overall Study|Lost to Follow-up|2|||
164522070|NCT00964886|594281200|FG002|Overall Study|Lost to Follow-up|6|||
164522071|NCT00964886|594281201|FG003|Overall Study|Lost to Follow-up|4|||
164522072|NCT00964886|594281198|FG000|Overall Study|Withdrawal by Subject|6|||
164522073|NCT00964886|594281199|FG001|Overall Study|Withdrawal by Subject|2|||
164522074|NCT00964886|594281200|FG002|Overall Study|Withdrawal by Subject|5|||
164522075|NCT00964886|594281201|FG003|Overall Study|Withdrawal by Subject|3|||
164522076|NCT00964886|594281198|FG000|Overall Study|Adverse Event|3|||
164522077|NCT00964886|594281199|FG001|Overall Study|Adverse Event|1|||
164522078|NCT00964886|594281200|FG002|Overall Study|Adverse Event|5|||
164522079|NCT00964886|594281201|FG003|Overall Study|Adverse Event|2|||
164522080|NCT00964886|594281198|FG000|Overall Study|Protocol Violation|0|||
164522081|NCT00964886|594281199|FG001|Overall Study|Protocol Violation|2|||
164522082|NCT00964886|594281200|FG002|Overall Study|Protocol Violation|0|||
164522083|NCT00964886|594281201|FG003|Overall Study|Protocol Violation|0|||
164522084|NCT03174431|594281204|FG000|Overall Study|Withdrawal by Subject|14|||
164522085|NCT03174431|594281205|FG001|Overall Study|Withdrawal by Subject|11|||
164522086|NCT03174431|594281204|FG000|Overall Study|alternative treatment|2|||
164522087|NCT03174431|594281205|FG001|Overall Study|alternative treatment|0|||
164522088|NCT03174431|594281204|FG000|Overall Study|Lost to Follow-up|1|||
164522089|NCT03174431|594281205|FG001|Overall Study|Lost to Follow-up|5|||
164522090|NCT02706899|594281213|FG000|Overall Study|Withdrawal by Subject|1|||
164522091|NCT02706899|594281214|FG001|Overall Study|Withdrawal by Subject|0|||
164522092|NCT02706899|594281213|FG000|Overall Study|Death|8|||
164522093|NCT02706899|594281214|FG001|Overall Study|Death|0|||
164522094|NCT02706899|594281213|FG000|Overall Study|Study Termination by Sponsor|4|||
164522095|NCT02706899|594281214|FG001|Overall Study|Study Termination by Sponsor|6|||
164522096|NCT01012414|594281215|FG000|Overall Study|Withdrawal by Subject|2|||
164522097|NCT01012414|594281215|FG000|Overall Study|Lost to Follow-up|1|||
164522098|NCT01012414|594281215|FG000|Overall Study|Trial was stopped before completed|7|||
164522099|NCT02601300|594281216|FG000|Induction Phase|Lack of Efficacy|2|||
164522100|NCT02601300|594281216|FG000|Induction Phase|Protocol Violation|1|||
164522101|NCT02601300|594281216|FG000|Extension Phase|Withdrawal by Subject|3|||
164522102|NCT02601300|594281216|FG000|Extension Phase|Adverse Event|4|||
164522103|NCT02601300|594281216|FG000|Extension Phase|Lack of Efficacy|10|||
164522104|NCT00291642|594281221|FG000|Overall Study|Adverse Event|1|||
164522105|NCT00291642|594281222|FG001|Overall Study|Adverse Event|0|||
164522106|NCT00291642|594281223|FG002|Overall Study|Adverse Event|1|||
164522107|NCT00291642|594281224|FG003|Overall Study|Adverse Event|0|||
164522108|NCT00291642|594281225|FG004|Overall Study|Adverse Event|1|||
164522109|NCT00291642|594281221|FG000|Overall Study|Patient missed visit|0|||
164522110|NCT00291642|594281222|FG001|Overall Study|Patient missed visit|0|||
164522111|NCT00291642|594281223|FG002|Overall Study|Patient missed visit|1|||
164522112|NCT00291642|594281224|FG003|Overall Study|Patient missed visit|0|||
164522113|NCT00291642|594281225|FG004|Overall Study|Patient missed visit|0|||
164522114|NCT00291642|594281221|FG000|Overall Study|Intake of prohibited medication|1|||
164522115|NCT00291642|594281222|FG001|Overall Study|Intake of prohibited medication|0|||
164522116|NCT00291642|594281223|FG002|Overall Study|Intake of prohibited medication|0|||
164522117|NCT00291642|594281224|FG003|Overall Study|Intake of prohibited medication|0|||
164522118|NCT00291642|594281225|FG004|Overall Study|Intake of prohibited medication|0|||
164522119|NCT02544451|594281229|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
164522120|NCT02544451|594281230|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
164522121|NCT02544451|594281231|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
164522122|NCT02544451|594281232|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
164522123|NCT02544451|594281229|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
164522124|NCT02544451|594281230|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
164522125|NCT02544451|594281231|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
164522126|NCT02544451|594281232|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
164522127|NCT02544451|594281229|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
164522128|NCT02544451|594281230|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
164522129|NCT02544451|594281231|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
164522130|NCT02544451|594281232|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
164522131|NCT02544451|594281229|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
164522132|NCT02544451|594281230|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
164522133|NCT02544451|594281231|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
164522134|NCT02544451|594281232|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
164522135|NCT02544451|594281229|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
164522136|NCT02544451|594281230|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
164522137|NCT02544451|594281231|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
164522138|NCT02544451|594281232|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
164522139|NCT02544451|594281229|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
164522140|NCT02544451|594281230|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
164522141|NCT02544451|594281231|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
164522142|NCT02544451|594281232|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
164619149|NCT00814307|594627978|FG003|Overall Study|Adverse Event|2|||
164619150|NCT00814307|594627975|FG000|Overall Study|Lack of Efficacy|1|||
164619151|NCT00814307|594627976|FG001|Overall Study|Lack of Efficacy|1|||
164619152|NCT00814307|594627977|FG002|Overall Study|Lack of Efficacy|3|||
164619153|NCT00814307|594627978|FG003|Overall Study|Lack of Efficacy|4|||
164619154|NCT00814307|594627975|FG000|Overall Study|Other|1|||
164619155|NCT00814307|594627976|FG001|Overall Study|Other|2|||
164619156|NCT00814307|594627977|FG002|Overall Study|Other|0|||
164619157|NCT00814307|594627978|FG003|Overall Study|Other|1|||
164619158|NCT00814307|594627975|FG000|Overall Study|Protocol Violation|2|||
164619159|NCT00814307|594627976|FG001|Overall Study|Protocol Violation|8|||
164619160|NCT00814307|594627977|FG002|Overall Study|Protocol Violation|1|||
164619161|NCT00814307|594627978|FG003|Overall Study|Protocol Violation|1|||
164619162|NCT00814307|594627975|FG000|Overall Study|Withdrawal by Subject|4|||
164619163|NCT00814307|594627976|FG001|Overall Study|Withdrawal by Subject|6|||
164619164|NCT00814307|594627977|FG002|Overall Study|Withdrawal by Subject|0|||
164619165|NCT00814307|594627978|FG003|Overall Study|Withdrawal by Subject|2|||
164619166|NCT00814307|594627975|FG000|Overall Study|Death|0|||
164619167|NCT00814307|594627976|FG001|Overall Study|Death|1|||
164619168|NCT00814307|594627977|FG002|Overall Study|Death|0|||
164619169|NCT00814307|594627978|FG003|Overall Study|Death|0|||
164619170|NCT01474889|594627979|FG000|Overall Study|Physician Decision|1|||
164619171|NCT01474889|594627980|FG001|Overall Study|Physician Decision|0|||
164619172|NCT01474889|594627981|FG002|Overall Study|Physician Decision|0|||
164619173|NCT01474889|594627979|FG000|Overall Study|Did not meet inclusion|1|||
164619174|NCT01474889|594627980|FG001|Overall Study|Did not meet inclusion|0|||
164619175|NCT01474889|594627981|FG002|Overall Study|Did not meet inclusion|0|||
164619176|NCT01474889|594627979|FG000|Overall Study|Withdrawal by Subject|0|||
164619177|NCT01474889|594627980|FG001|Overall Study|Withdrawal by Subject|1|||
164619178|NCT01474889|594627981|FG002|Overall Study|Withdrawal by Subject|0|||
164619179|NCT02290340|594627983|FG000|Overall Study|Lost to Follow-up|0|||
164619180|NCT02290340|594627984|FG001|Overall Study|Lost to Follow-up|0|||
164619181|NCT02290340|594627985|FG002|Overall Study|Lost to Follow-up|0|||
164619182|NCT02290340|594627986|FG003|Overall Study|Lost to Follow-up|1|||
164619183|NCT02290340|594627983|FG000|Overall Study|Withdrawal by Subject|1|||
164619184|NCT02290340|594627984|FG001|Overall Study|Withdrawal by Subject|0|||
164619185|NCT02290340|594627985|FG002|Overall Study|Withdrawal by Subject|0|||
164619186|NCT02290340|594627986|FG003|Overall Study|Withdrawal by Subject|0|||
164619187|NCT02290340|594627983|FG000|Overall Study|Other|1|||
164619188|NCT02290340|594627984|FG001|Overall Study|Other|0|||
164619189|NCT02290340|594627985|FG002|Overall Study|Other|0|||
164619190|NCT02290340|594627986|FG003|Overall Study|Other|1|||
164619191|NCT04964557|594627987|FG000|Overall Study|Withdrawal by Subject|3|||
164619192|NCT04964557|594627988|FG001|Overall Study|Withdrawal by Subject|2|||
164619193|NCT04964557|594627987|FG000|Overall Study|Lost to Follow-up|1|||
164619194|NCT04964557|594627988|FG001|Overall Study|Lost to Follow-up|2|||
164619195|NCT04964557|594627987|FG000|Overall Study|Physician Decision|2|||
164619196|NCT04964557|594627988|FG001|Overall Study|Physician Decision|0|||
164619197|NCT04964557|594627987|FG000|Overall Study|Death|3|||
164619198|NCT04964557|594627988|FG001|Overall Study|Death|0|||
164619199|NCT04964557|594627987|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
164619200|NCT04964557|594627988|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
164619201|NCT00251589|594627990|FG000|Overall Study|Adverse Event|5|||
164619202|NCT00251589|594627991|FG001|Overall Study|Adverse Event|1|||
164619203|NCT00251589|594627992|FG002|Overall Study|Adverse Event|2|||
164619204|NCT00251589|594627993|FG003|Overall Study|Adverse Event|1|||
164522143|NCT03001076|594281236|FG000|Overall Study|Withdrawal by patient|2|||
164522144|NCT03001076|594281237|FG001|Overall Study|Withdrawal by patient|0|||
164522145|NCT03001076|594281236|FG000|Overall Study|Other|1|||
164522146|NCT03001076|594281237|FG001|Overall Study|Other|0|||
164522147|NCT03001076|594281236|FG000|Overall Study|Adverse Event|3|||
164522148|NCT03001076|594281237|FG001|Overall Study|Adverse Event|3|||
164522149|NCT03001076|594281236|FG000|Overall Study|Sponsor decision|1|||
164522150|NCT03001076|594281237|FG001|Overall Study|Sponsor decision|0|||
164522151|NCT03001076|594281236|FG000|Overall Study|Lost to Follow-up|0|||
164522152|NCT03001076|594281237|FG001|Overall Study|Lost to Follow-up|2|||
164522153|NCT02576587|594281239|FG000|Baseline|Equipment failure|0|||
164522154|NCT02576587|594281240|FG001|Baseline|Equipment failure|1|||
164619205|NCT00251589|594627990|FG000|Overall Study|Withdrawal by Subject|1|||
164619206|NCT00251589|594627991|FG001|Overall Study|Withdrawal by Subject|1|||
164619207|NCT00251589|594627992|FG002|Overall Study|Withdrawal by Subject|0|||
164147612|NCT03685344|592902085|FG001|Overall Study|Death|1|||
164522155|NCT02576587|594281239|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
164522156|NCT02576587|594281240|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
164619208|NCT00251589|594627993|FG003|Overall Study|Withdrawal by Subject|0|||
164619209|NCT00251589|594627990|FG000|Overall Study|Discontinued due to progressive disease|9|||
164619210|NCT00251589|594627991|FG001|Overall Study|Discontinued due to progressive disease|1|||
164619211|NCT00251589|594627992|FG002|Overall Study|Discontinued due to progressive disease|0|||
164619212|NCT00251589|594627993|FG003|Overall Study|Discontinued due to progressive disease|1|||
164619213|NCT03227224|594627996|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
164619214|NCT03227224|594627997|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
164619215|NCT03227224|594627998|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
164619216|NCT03227224|594627999|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
164619217|NCT03227224|594627996|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
164619218|NCT03227224|594627997|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
164619219|NCT03227224|594627998|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
164619220|NCT03227224|594627999|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
164619221|NCT03227224|594627996|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
164619222|NCT03227224|594627997|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
164619223|NCT03227224|594627998|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
164619224|NCT03227224|594627999|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
164619225|NCT03227224|594627996|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
164619226|NCT03227224|594627997|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
164619227|NCT03227224|594627998|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
164619228|NCT03227224|594627999|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
164619229|NCT03227224|594627996|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
164619230|NCT03227224|594627997|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
164619231|NCT03227224|594627998|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
164619232|NCT03227224|594627999|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
164619233|NCT03227224|594627996|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
164619234|NCT03227224|594627997|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
164619235|NCT03227224|594627998|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
164619236|NCT03227224|594627999|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
164619237|NCT03227224|594627996|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
164619238|NCT03227224|594627997|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
164619239|NCT03227224|594627998|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
164619240|NCT03227224|594627999|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
164619241|NCT03227224|594627996|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
164619242|NCT03227224|594627997|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
164619243|NCT03227224|594627998|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
164619244|NCT03227224|594627999|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
164619245|NCT03227224|594627996|FG000|Follow-up Phase (2 Weeks)|Other|4|||
164619246|NCT03227224|594627997|FG001|Follow-up Phase (2 Weeks)|Other|4|||
164619247|NCT03227224|594627998|FG002|Follow-up Phase (2 Weeks)|Other|6|||
164619248|NCT03227224|594627999|FG003|Follow-up Phase (2 Weeks)|Other|3|||
164619249|NCT03782376|594628002|FG000|Overall Study|Lost to Follow-up|2|||
164619250|NCT03782376|594628003|FG001|Overall Study|Lost to Follow-up|2|||
164619251|NCT03782376|594628002|FG000|Overall Study|Withdrawal by Subject|7|||
164619252|NCT03782376|594628003|FG001|Overall Study|Withdrawal by Subject|11|||
164619253|NCT03782376|594628002|FG000|Overall Study|Death|1|||
164619254|NCT03782376|594628003|FG001|Overall Study|Death|0|||
164619255|NCT03782376|594628002|FG000|Overall Study|Other|16|||
164619256|NCT03782376|594628003|FG001|Overall Study|Other|17|||
164619257|NCT02659098|594628004|FG000|Overall Study|Withdrawal by Subject|7|||
164619258|NCT03039192|594628005|FG000|Overall Study|Lost to Follow-up|4|||
164619259|NCT03039192|594628006|FG001|Overall Study|Lost to Follow-up|4|||
164619260|NCT03039192|594628005|FG000|Overall Study|Adverse event, serious fatal|0|||
164619261|NCT03039192|594628006|FG001|Overall Study|Adverse event, serious fatal|1|||
164619262|NCT03039192|594628005|FG000|Overall Study|Adverse event, non-fatal|0|||
164619263|NCT03039192|594628006|FG001|Overall Study|Adverse event, non-fatal|2|||
164619264|NCT03039192|594628005|FG000|Overall Study|Withdrawal by Subject|6|||
164619265|NCT03039192|594628006|FG001|Overall Study|Withdrawal by Subject|9|||
164619266|NCT03039192|594628005|FG000|Overall Study|Discontinued from treatment phase|19|||
164619267|NCT03039192|594628006|FG001|Overall Study|Discontinued from treatment phase|12|||
164619268|NCT03039192|594628005|FG000|Overall Study|Other|3|||
164619269|NCT03039192|594628006|FG001|Overall Study|Other|2|||
164619270|NCT02493868|594628007|FG000|Induction Phase: DE Participants|Adverse Event|22|||
164619271|NCT02493868|594628008|FG001|Induction Phase: DE Participants|Adverse Event|0|||
164619272|NCT02493868|594628007|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
164619273|NCT02493868|594628008|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
164619274|NCT02493868|594628007|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
164619275|NCT02493868|594628008|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
164619276|NCT02493868|594628007|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
164619277|NCT02493868|594628008|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
164619278|NCT02493868|594628007|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
164619279|NCT02493868|594628008|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
164619280|NCT02493868|594628007|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
164619281|NCT02493868|594628008|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
164619282|NCT02493868|594628007|FG000|Induction Phase: DE Participants|Other|8|||
164619283|NCT02493868|594628008|FG001|Induction Phase: DE Participants|Other|0|||
164619284|NCT02493868|594628007|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
164619285|NCT02493868|594628008|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
164619286|NCT02493868|594628007|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
164619287|NCT02493868|594628008|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
164619288|NCT02493868|594628007|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
164619289|NCT02493868|594628008|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
164619290|NCT02493868|594628007|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
164619291|NCT02493868|594628008|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
164619292|NCT02493868|594628007|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
164619293|NCT02493868|594628008|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
164619294|NCT02493868|594628007|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
164619295|NCT02493868|594628008|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
164619296|NCT02493868|594628007|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
164619297|NCT02493868|594628008|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
164619298|NCT02493868|594628007|FG000|Optimization Phase: DE+TE Participants|Other|10|||
164619299|NCT02493868|594628008|FG001|Optimization Phase: DE+TE Participants|Other|2|||
164619300|NCT02493868|594628007|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
164619301|NCT02493868|594628008|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
164619302|NCT02493868|594628007|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
164619303|NCT02493868|594628008|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
164619304|NCT02493868|594628007|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
164619305|NCT02493868|594628008|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
164619306|NCT02493868|594628007|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
164619307|NCT02493868|594628008|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
164619308|NCT02493868|594628007|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
164619309|NCT02493868|594628008|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
164619310|NCT02493868|594628007|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
164619311|NCT02493868|594628008|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
164619312|NCT02493868|594628007|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
164619313|NCT02493868|594628008|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
164619314|NCT02493868|594628007|FG000|Follow-up Phase|Lost to Follow-up|1|||
164619315|NCT02493868|594628008|FG001|Follow-up Phase|Lost to Follow-up|0|||
164619316|NCT02493868|594628007|FG000|Follow-up Phase|Withdrawal by Subject|3|||
164619317|NCT02493868|594628008|FG001|Follow-up Phase|Withdrawal by Subject|0|||
164619318|NCT02493868|594628007|FG000|Follow-up Phase|Investigator Decision|5|||
164619319|NCT02493868|594628008|FG001|Follow-up Phase|Investigator Decision|1|||
164619320|NCT02493868|594628007|FG000|Follow-up Phase|Other|2|||
164619321|NCT02493868|594628008|FG001|Follow-up Phase|Other|1|||
164619322|NCT02407236|594628009|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
164619323|NCT02407236|594628010|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
164619324|NCT02407236|594628011|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
164619325|NCT02407236|594628012|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
164619326|NCT02407236|594628013|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
164619327|NCT02407236|594628014|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
164619328|NCT02407236|594628015|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
164619329|NCT02407236|594628016|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
164619330|NCT02407236|594628017|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
164619331|NCT02407236|594628018|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
164619332|NCT02407236|594628019|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
164619333|NCT02407236|594628020|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
164619334|NCT02407236|594628021|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
164619335|NCT02407236|594628009|FG000|Induction Study (8 Weeks)|Death|0|||
164619336|NCT02407236|594628010|FG001|Induction Study (8 Weeks)|Death|0|||
164619337|NCT02407236|594628011|FG002|Induction Study (8 Weeks)|Death|1|||
164619338|NCT02407236|594628012|FG003|Induction Study (8 Weeks)|Death|0|||
164619339|NCT02407236|594628013|FG004|Induction Study (8 Weeks)|Death|0|||
164619340|NCT02407236|594628014|FG005|Induction Study (8 Weeks)|Death|0|||
164619341|NCT02407236|594628015|FG006|Induction Study (8 Weeks)|Death|0|||
164619342|NCT02407236|594628016|FG007|Induction Study (8 Weeks)|Death|0|||
164619343|NCT02407236|594628017|FG008|Induction Study (8 Weeks)|Death|0|||
164619344|NCT02407236|594628018|FG009|Induction Study (8 Weeks)|Death|0|||
164619345|NCT02407236|594628019|FG010|Induction Study (8 Weeks)|Death|0|||
164619346|NCT02407236|594628020|FG011|Induction Study (8 Weeks)|Death|0|||
164619347|NCT02407236|594628021|FG012|Induction Study (8 Weeks)|Death|0|||
164619348|NCT02407236|594628009|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
164619349|NCT02407236|594628010|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
164619350|NCT02407236|594628011|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
164619351|NCT02407236|594628012|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
164619352|NCT02407236|594628013|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
164619353|NCT02407236|594628014|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
164619354|NCT02407236|594628015|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
164619355|NCT02407236|594628016|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
164619356|NCT02407236|594628017|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
164619357|NCT02407236|594628018|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
164619358|NCT02407236|594628019|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
164619359|NCT02407236|594628020|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
164619360|NCT02407236|594628021|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
164619361|NCT02407236|594628009|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
164619362|NCT02407236|594628010|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
164619363|NCT02407236|594628011|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
164619364|NCT02407236|594628012|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
164619365|NCT02407236|594628013|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
164619366|NCT02407236|594628014|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
164619367|NCT02407236|594628015|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
164619368|NCT02407236|594628016|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
164619369|NCT02407236|594628017|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
164619370|NCT02407236|594628018|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
164619371|NCT02407236|594628019|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
164619372|NCT02407236|594628020|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
164619373|NCT02407236|594628021|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
164619374|NCT02407236|594628009|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
164619375|NCT02407236|594628010|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
164619376|NCT02407236|594628011|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
164619377|NCT02407236|594628012|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
164619378|NCT02407236|594628013|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
164619379|NCT02407236|594628014|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
164619380|NCT02407236|594628015|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
164619381|NCT02407236|594628016|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
164619382|NCT02407236|594628017|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
164619383|NCT02407236|594628018|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
164619384|NCT02407236|594628019|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
164619385|NCT02407236|594628020|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
164619386|NCT02407236|594628021|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
164619387|NCT02407236|594628009|FG000|Induction Study (8 Weeks)|Other|2|||
164619388|NCT02407236|594628010|FG001|Induction Study (8 Weeks)|Other|1|||
164619389|NCT02407236|594628011|FG002|Induction Study (8 Weeks)|Other|5|||
164619390|NCT02407236|594628012|FG003|Induction Study (8 Weeks)|Other|0|||
164619391|NCT02407236|594628013|FG004|Induction Study (8 Weeks)|Other|0|||
164619392|NCT02407236|594628014|FG005|Induction Study (8 Weeks)|Other|0|||
164619393|NCT02407236|594628015|FG006|Induction Study (8 Weeks)|Other|0|||
164619394|NCT02407236|594628016|FG007|Induction Study (8 Weeks)|Other|0|||
164619395|NCT02407236|594628017|FG008|Induction Study (8 Weeks)|Other|0|||
164619396|NCT02407236|594628018|FG009|Induction Study (8 Weeks)|Other|0|||
164619397|NCT02407236|594628019|FG010|Induction Study (8 Weeks)|Other|0|||
164619398|NCT02407236|594628020|FG011|Induction Study (8 Weeks)|Other|0|||
164619399|NCT02407236|594628021|FG012|Induction Study (8 Weeks)|Other|0|||
164619400|NCT02407236|594628009|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
164619401|NCT02407236|594628010|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
164619402|NCT02407236|594628011|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
164619403|NCT02407236|594628012|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
164619404|NCT02407236|594628013|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
164619405|NCT02407236|594628014|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
164619406|NCT02407236|594628015|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
164619407|NCT02407236|594628016|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
164619408|NCT02407236|594628017|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
164619409|NCT02407236|594628018|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
164619410|NCT02407236|594628019|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
164619411|NCT02407236|594628020|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
164619412|NCT02407236|594628021|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
164619413|NCT02407236|594628009|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
164619414|NCT02407236|594628010|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
164619415|NCT02407236|594628011|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
164619416|NCT02407236|594628012|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
164619417|NCT02407236|594628013|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
164619418|NCT02407236|594628014|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
164619419|NCT02407236|594628015|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
164619420|NCT02407236|594628016|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
164619421|NCT02407236|594628017|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
164619422|NCT02407236|594628018|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
164619423|NCT02407236|594628019|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
164619424|NCT02407236|594628020|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
164619425|NCT02407236|594628021|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
164619426|NCT02407236|594628009|FG000|Maintenance Study (44 Weeks)|Other|0|||
164619427|NCT02407236|594628010|FG001|Maintenance Study (44 Weeks)|Other|0|||
164619428|NCT02407236|594628011|FG002|Maintenance Study (44 Weeks)|Other|0|||
164619429|NCT02407236|594628012|FG003|Maintenance Study (44 Weeks)|Other|5|||
164619430|NCT02407236|594628013|FG004|Maintenance Study (44 Weeks)|Other|7|||
164619431|NCT02407236|594628014|FG005|Maintenance Study (44 Weeks)|Other|8|||
164619432|NCT02407236|594628015|FG006|Maintenance Study (44 Weeks)|Other|4|||
164619433|NCT02407236|594628016|FG007|Maintenance Study (44 Weeks)|Other|6|||
164619434|NCT02407236|594628017|FG008|Maintenance Study (44 Weeks)|Other|0|||
164619435|NCT02407236|594628018|FG009|Maintenance Study (44 Weeks)|Other|0|||
164619436|NCT02407236|594628019|FG010|Maintenance Study (44 Weeks)|Other|0|||
164619437|NCT02407236|594628020|FG011|Maintenance Study (44 Weeks)|Other|0|||
164619438|NCT02407236|594628021|FG012|Maintenance Study (44 Weeks)|Other|0|||
164619439|NCT02407236|594628009|FG000|Maintenance Study (44 Weeks)|Death|0|||
164619440|NCT02407236|594628010|FG001|Maintenance Study (44 Weeks)|Death|0|||
164619441|NCT02407236|594628011|FG002|Maintenance Study (44 Weeks)|Death|0|||
164619442|NCT02407236|594628012|FG003|Maintenance Study (44 Weeks)|Death|0|||
164619443|NCT02407236|594628013|FG004|Maintenance Study (44 Weeks)|Death|0|||
164619444|NCT02407236|594628014|FG005|Maintenance Study (44 Weeks)|Death|0|||
164619445|NCT02407236|594628015|FG006|Maintenance Study (44 Weeks)|Death|0|||
164619446|NCT02407236|594628016|FG007|Maintenance Study (44 Weeks)|Death|1|||
164619447|NCT02407236|594628017|FG008|Maintenance Study (44 Weeks)|Death|0|||
164619448|NCT02407236|594628018|FG009|Maintenance Study (44 Weeks)|Death|0|||
164619449|NCT02407236|594628019|FG010|Maintenance Study (44 Weeks)|Death|0|||
164619450|NCT02407236|594628020|FG011|Maintenance Study (44 Weeks)|Death|0|||
164619451|NCT02407236|594628021|FG012|Maintenance Study (44 Weeks)|Death|0|||
164619452|NCT02407236|594628009|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
164619453|NCT02407236|594628010|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
164619454|NCT02407236|594628011|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
164619455|NCT02407236|594628012|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
164619456|NCT02407236|594628013|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
164619457|NCT02407236|594628014|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
164619458|NCT02407236|594628015|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
164619459|NCT02407236|594628016|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
164619460|NCT02407236|594628017|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
164619461|NCT02407236|594628018|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
164619462|NCT02407236|594628019|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
164619463|NCT02407236|594628020|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
164619464|NCT02407236|594628021|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
164619465|NCT02407236|594628009|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
164619466|NCT02407236|594628010|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
164619467|NCT02407236|594628011|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
164619468|NCT02407236|594628012|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
164619469|NCT02407236|594628013|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
164619470|NCT02407236|594628014|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
164619471|NCT02407236|594628015|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
164619472|NCT02407236|594628016|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
164619473|NCT02407236|594628017|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
164619474|NCT02407236|594628018|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
164619475|NCT02407236|594628019|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
164619476|NCT02407236|594628020|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
164619477|NCT02407236|594628021|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
164619478|NCT02407236|594628009|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
164619479|NCT02407236|594628010|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
164619480|NCT02407236|594628011|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
164619481|NCT02407236|594628012|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
164619482|NCT02407236|594628013|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
164619483|NCT02407236|594628014|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
164619484|NCT02407236|594628015|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
164619485|NCT02407236|594628016|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
164619486|NCT02407236|594628017|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
164619487|NCT02407236|594628018|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
164619488|NCT02407236|594628019|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
164619489|NCT02407236|594628020|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
164619490|NCT02407236|594628021|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
164619491|NCT02407236|594628009|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
164619492|NCT02407236|594628010|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
164619493|NCT02407236|594628011|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
164619494|NCT02407236|594628012|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
164619495|NCT02407236|594628013|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
164619496|NCT02407236|594628014|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
164619497|NCT02407236|594628015|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
164619498|NCT02407236|594628016|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
164619499|NCT02407236|594628017|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
164619500|NCT02407236|594628018|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
164619501|NCT02407236|594628019|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
164619502|NCT02407236|594628020|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
164619503|NCT02407236|594628021|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
164619504|NCT03277794|594628026|FG000|Overall Study|Lost to Follow-up|2|||
164619505|NCT03277794|594628027|FG001|Overall Study|Lost to Follow-up|4|||
164619506|NCT03277794|594628026|FG000|Overall Study|Withdrew due to high acuity|1|||
164619507|NCT03277794|594628027|FG001|Overall Study|Withdrew due to high acuity|0|||
164619508|NCT03039569|594628033|FG000|Overall Study|Lost to Follow-up|5|||
164619509|NCT03039569|594628034|FG001|Overall Study|Lost to Follow-up|4|||
164619510|NCT02254304|594628035|FG000|Overall Study|Adverse Event|2|||
164619511|NCT02254304|594628036|FG001|Overall Study|Adverse Event|1|||
164619512|NCT02254304|594628035|FG000|Overall Study|Lost to Follow-up|2|||
164619513|NCT02254304|594628036|FG001|Overall Study|Lost to Follow-up|2|||
164619514|NCT02254304|594628035|FG000|Overall Study|Protocol Violation|1|||
164619515|NCT02254304|594628036|FG001|Overall Study|Protocol Violation|0|||
164619516|NCT02254304|594628035|FG000|Overall Study|Withdrawal by Subject|3|||
164619517|NCT02254304|594628036|FG001|Overall Study|Withdrawal by Subject|0|||
164619518|NCT02254304|594628035|FG000|Overall Study|Injection site pain and Injection fear|1|||
164619519|NCT02254304|594628036|FG001|Overall Study|Injection site pain and Injection fear|0|||
164619520|NCT02254304|594628035|FG000|Overall Study|Personal causes|4|||
164619521|NCT02254304|594628036|FG001|Overall Study|Personal causes|1|||
164619522|NCT02254304|594628035|FG000|Overall Study|Personal decision|1|||
164619523|NCT02254304|594628036|FG001|Overall Study|Personal decision|0|||
164619524|NCT00952419|594628037|FG000|Overall Study|Adverse Event|2|||
164619525|NCT00952419|594628038|FG001|Overall Study|Adverse Event|0|||
164619526|NCT00952419|594628039|FG002|Overall Study|Adverse Event|0|||
164619527|NCT00952419|594628037|FG000|Overall Study|Protocol Violation|3|||
164619528|NCT00952419|594628038|FG001|Overall Study|Protocol Violation|7|||
164619529|NCT00952419|594628039|FG002|Overall Study|Protocol Violation|0|||
164619530|NCT00952419|594628037|FG000|Overall Study|Withdrawal by Subject|1|||
164619531|NCT00952419|594628038|FG001|Overall Study|Withdrawal by Subject|3|||
164619532|NCT00952419|594628039|FG002|Overall Study|Withdrawal by Subject|0|||
164522157|NCT02576587|594281239|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
164522158|NCT02576587|594281240|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
164522159|NCT02576587|594281239|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
164522160|NCT02576587|594281240|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
164522161|NCT00844532|594281241|FG000|Overall Study|Death|16|||
164522162|NCT00844532|594281241|FG000|Overall Study|Withdrawal by Subject|16|||
164522163|NCT00844532|594281241|FG000|Overall Study|Lost to Follow-up|7|||
164522164|NCT03590366|594281242|FG000|Overall Study|Adverse Event|0|||
164522165|NCT03590366|594281243|FG001|Overall Study|Adverse Event|3|||
164522166|NCT03590366|594281242|FG000|Overall Study|Lost to Follow-up|3|||
164522167|NCT03590366|594281243|FG001|Overall Study|Lost to Follow-up|3|||
164522168|NCT03590366|594281242|FG000|Overall Study|Withdrawal by Subject|0|||
164522169|NCT03590366|594281243|FG001|Overall Study|Withdrawal by Subject|2|||
164522170|NCT00633880|594281246|FG000|Open Label Titration|Lack of Efficacy|1|||
164522171|NCT00633880|594281247|FG001|Open Label Titration|Lack of Efficacy|0|||
164522172|NCT00633880|594281248|FG002|Open Label Titration|Lack of Efficacy|0|||
164522173|NCT00633880|594281246|FG000|Open Label Titration|Adverse Event|13|||
164522174|NCT00633880|594281247|FG001|Open Label Titration|Adverse Event|0|||
164522175|NCT00633880|594281248|FG002|Open Label Titration|Adverse Event|0|||
164522176|NCT00633880|594281246|FG000|Open Label Titration|Treatment Failure|55|||
164522177|NCT00633880|594281247|FG001|Open Label Titration|Treatment Failure|0|||
164522178|NCT00633880|594281248|FG002|Open Label Titration|Treatment Failure|0|||
164522179|NCT00633880|594281246|FG000|Open Label Titration|Protocol Violation|6|||
164522180|NCT00633880|594281247|FG001|Open Label Titration|Protocol Violation|0|||
164522181|NCT00633880|594281248|FG002|Open Label Titration|Protocol Violation|0|||
164522182|NCT00633880|594281246|FG000|Open Label Titration|Physician Decision|1|||
164522183|NCT00633880|594281247|FG001|Open Label Titration|Physician Decision|0|||
164522184|NCT00633880|594281248|FG002|Open Label Titration|Physician Decision|0|||
164522185|NCT00633880|594281246|FG000|Open Label Titration|Withdrawal by Subject|4|||
164522186|NCT00633880|594281247|FG001|Open Label Titration|Withdrawal by Subject|0|||
164522187|NCT00633880|594281248|FG002|Open Label Titration|Withdrawal by Subject|0|||
164522188|NCT01413503|594281250|FG000|Overall Study|Lost to Follow-up|1|||
164522189|NCT02546921|594281251|FG000|Overall Study|Adverse Event|0|||
164522190|NCT02546921|594281252|FG001|Overall Study|Adverse Event|5|||
164522191|NCT02546921|594281253|FG002|Overall Study|Adverse Event|2|||
164522192|NCT02546921|594281254|FG003|Overall Study|Adverse Event|0|||
164522193|NCT02546921|594281255|FG004|Overall Study|Adverse Event|0|||
164522194|NCT02546921|594281256|FG005|Overall Study|Adverse Event|0|||
164522195|NCT02546921|594281257|FG006|Overall Study|Adverse Event|0|||
164522196|NCT02546921|594281251|FG000|Overall Study|Evidence of Disease Progression|1|||
164522197|NCT02546921|594281252|FG001|Overall Study|Evidence of Disease Progression|0|||
164522198|NCT02546921|594281253|FG002|Overall Study|Evidence of Disease Progression|0|||
164522199|NCT02546921|594281254|FG003|Overall Study|Evidence of Disease Progression|0|||
164522200|NCT02546921|594281255|FG004|Overall Study|Evidence of Disease Progression|1|||
164522201|NCT02546921|594281256|FG005|Overall Study|Evidence of Disease Progression|0|||
164522202|NCT02546921|594281257|FG006|Overall Study|Evidence of Disease Progression|0|||
164522203|NCT02546921|594281251|FG000|Overall Study|Patient Choice|0|||
164522204|NCT02546921|594281252|FG001|Overall Study|Patient Choice|1|||
164522205|NCT02546921|594281253|FG002|Overall Study|Patient Choice|0|||
164522206|NCT02546921|594281254|FG003|Overall Study|Patient Choice|0|||
164522207|NCT02546921|594281255|FG004|Overall Study|Patient Choice|0|||
164522208|NCT02546921|594281256|FG005|Overall Study|Patient Choice|1|||
164522209|NCT02546921|594281257|FG006|Overall Study|Patient Choice|0|||
164522210|NCT01373151|594281258|FG000|Period 1|Lack of Efficacy|3|||
164522211|NCT01373151|594281259|FG001|Period 1|Lack of Efficacy|0|||
164522212|NCT01373151|594281260|FG002|Period 1|Lack of Efficacy|0|||
164522213|NCT01373151|594281261|FG003|Period 1|Lack of Efficacy|0|||
164522214|NCT01373151|594281262|FG004|Period 1|Lack of Efficacy|1|||
164522215|NCT01373151|594281263|FG005|Period 1|Lack of Efficacy|0|||
164522216|NCT01373151|594281264|FG006|Period 1|Lack of Efficacy|0|||
164522217|NCT01373151|594281258|FG000|Period 1|Adverse Event|0|||
164522218|NCT01373151|594281259|FG001|Period 1|Adverse Event|0|||
164522219|NCT01373151|594281260|FG002|Period 1|Adverse Event|1|||
164522220|NCT01373151|594281261|FG003|Period 1|Adverse Event|0|||
164522221|NCT01373151|594281262|FG004|Period 1|Adverse Event|4|||
164522222|NCT01373151|594281263|FG005|Period 1|Adverse Event|3|||
164619533|NCT03598140|594629963|FG000|Overall Study|enrolled but didn't start|1|||
164619534|NCT03598140|594629964|FG001|Overall Study|enrolled but didn't start|0|||
164619535|NCT01688999|594629968|FG000|Overall Study|Withdrawal by Subject|5|||
164619536|NCT01688999|594629969|FG001|Overall Study|Withdrawal by Subject|1|||
164619537|NCT01688999|594629970|FG002|Overall Study|Withdrawal by Subject|1|||
164619538|NCT01688999|594629968|FG000|Overall Study|Adverse Event|2|||
164619539|NCT01688999|594629969|FG001|Overall Study|Adverse Event|0|||
164619540|NCT01688999|594629970|FG002|Overall Study|Adverse Event|2|||
164619541|NCT01688999|594629968|FG000|Overall Study|Ineligible/Not treated|1|||
164619542|NCT01688999|594629969|FG001|Overall Study|Ineligible/Not treated|0|||
164619543|NCT01688999|594629970|FG002|Overall Study|Ineligible/Not treated|0|||
164619544|NCT03039790|594629971|FG000|Overall Study|Lost to Follow-up|2|||
164619545|NCT03039790|594629972|FG001|Overall Study|Lost to Follow-up|0|||
164619546|NCT03039790|594629973|FG002|Overall Study|Lost to Follow-up|1|||
164619547|NCT03039790|594629974|FG003|Overall Study|Lost to Follow-up|1|||
164619548|NCT03039790|594629975|FG004|Overall Study|Lost to Follow-up|0|||
164619549|NCT03039790|594629976|FG005|Overall Study|Lost to Follow-up|1|||
164619550|NCT03039790|594629977|FG006|Overall Study|Lost to Follow-up|1|||
164619551|NCT03039790|594629978|FG007|Overall Study|Lost to Follow-up|1|||
164619552|NCT03039790|594629979|FG008|Overall Study|Lost to Follow-up|0|||
164619553|NCT03039790|594629980|FG009|Overall Study|Lost to Follow-up|1|||
164619554|NCT03039790|594629981|FG010|Overall Study|Lost to Follow-up|1|||
164619555|NCT03039790|594629982|FG011|Overall Study|Lost to Follow-up|0|||
164619556|NCT03039790|594629983|FG012|Overall Study|Lost to Follow-up|1|||
164619557|NCT03039790|594629984|FG013|Overall Study|Lost to Follow-up|0|||
164619558|NCT03039790|594629985|FG014|Overall Study|Lost to Follow-up|3|||
164619559|NCT03039790|594629986|FG015|Overall Study|Lost to Follow-up|1|||
164619560|NCT03039790|594629987|FG016|Overall Study|Lost to Follow-up|2|||
164619561|NCT03039790|594629988|FG017|Overall Study|Lost to Follow-up|2|||
164619562|NCT03039790|594629989|FG018|Overall Study|Lost to Follow-up|1|||
164619563|NCT03039790|594629990|FG019|Overall Study|Lost to Follow-up|3|||
164619564|NCT03039790|594629971|FG000|Overall Study|Withdrawal of Consent|1|||
164619565|NCT03039790|594629972|FG001|Overall Study|Withdrawal of Consent|0|||
164619566|NCT03039790|594629973|FG002|Overall Study|Withdrawal of Consent|0|||
164619567|NCT03039790|594629974|FG003|Overall Study|Withdrawal of Consent|1|||
164619568|NCT03039790|594629975|FG004|Overall Study|Withdrawal of Consent|0|||
164619569|NCT03039790|594629976|FG005|Overall Study|Withdrawal of Consent|0|||
164619570|NCT03039790|594629977|FG006|Overall Study|Withdrawal of Consent|0|||
164619571|NCT03039790|594629978|FG007|Overall Study|Withdrawal of Consent|0|||
164619572|NCT03039790|594629979|FG008|Overall Study|Withdrawal of Consent|0|||
164619573|NCT03039790|594629980|FG009|Overall Study|Withdrawal of Consent|1|||
164619574|NCT03039790|594629981|FG010|Overall Study|Withdrawal of Consent|0|||
164619575|NCT03039790|594629982|FG011|Overall Study|Withdrawal of Consent|0|||
164619576|NCT03039790|594629983|FG012|Overall Study|Withdrawal of Consent|2|||
164619577|NCT03039790|594629984|FG013|Overall Study|Withdrawal of Consent|0|||
164619578|NCT03039790|594629985|FG014|Overall Study|Withdrawal of Consent|1|||
164619579|NCT03039790|594629986|FG015|Overall Study|Withdrawal of Consent|5|||
164619580|NCT03039790|594629987|FG016|Overall Study|Withdrawal of Consent|3|||
164619581|NCT03039790|594629988|FG017|Overall Study|Withdrawal of Consent|0|||
164619582|NCT03039790|594629989|FG018|Overall Study|Withdrawal of Consent|2|||
164619583|NCT03039790|594629990|FG019|Overall Study|Withdrawal of Consent|5|||
164619584|NCT03039790|594629971|FG000|Overall Study|Death|0|||
164619585|NCT03039790|594629972|FG001|Overall Study|Death|0|||
164619586|NCT03039790|594629973|FG002|Overall Study|Death|0|||
164619587|NCT03039790|594629974|FG003|Overall Study|Death|0|||
164619588|NCT03039790|594629975|FG004|Overall Study|Death|0|||
164619589|NCT03039790|594629976|FG005|Overall Study|Death|0|||
164619590|NCT03039790|594629977|FG006|Overall Study|Death|0|||
164619591|NCT03039790|594629978|FG007|Overall Study|Death|0|||
164619592|NCT03039790|594629979|FG008|Overall Study|Death|0|||
164619593|NCT03039790|594629980|FG009|Overall Study|Death|0|||
164619594|NCT03039790|594629981|FG010|Overall Study|Death|0|||
164619595|NCT03039790|594629982|FG011|Overall Study|Death|0|||
164619596|NCT03039790|594629983|FG012|Overall Study|Death|0|||
164619597|NCT03039790|594629984|FG013|Overall Study|Death|0|||
164619598|NCT03039790|594629985|FG014|Overall Study|Death|0|||
164619599|NCT03039790|594629986|FG015|Overall Study|Death|1|||
164619600|NCT03039790|594629987|FG016|Overall Study|Death|3|||
164619601|NCT03039790|594629988|FG017|Overall Study|Death|0|||
164619602|NCT03039790|594629989|FG018|Overall Study|Death|2|||
164619603|NCT03039790|594629990|FG019|Overall Study|Death|0|||
164619604|NCT03039790|594629971|FG000|Overall Study|Reason, not Specified|1|||
164619605|NCT03039790|594629972|FG001|Overall Study|Reason, not Specified|0|||
164619606|NCT03039790|594629973|FG002|Overall Study|Reason, not Specified|0|||
164619607|NCT03039790|594629974|FG003|Overall Study|Reason, not Specified|0|||
164619608|NCT03039790|594629975|FG004|Overall Study|Reason, not Specified|0|||
164619609|NCT03039790|594629976|FG005|Overall Study|Reason, not Specified|0|||
164619610|NCT03039790|594629977|FG006|Overall Study|Reason, not Specified|0|||
164619611|NCT03039790|594629978|FG007|Overall Study|Reason, not Specified|0|||
164619612|NCT03039790|594629979|FG008|Overall Study|Reason, not Specified|0|||
164619613|NCT03039790|594629980|FG009|Overall Study|Reason, not Specified|0|||
164619614|NCT03039790|594629981|FG010|Overall Study|Reason, not Specified|0|||
164619615|NCT03039790|594629982|FG011|Overall Study|Reason, not Specified|0|||
164619616|NCT03039790|594629983|FG012|Overall Study|Reason, not Specified|0|||
164619617|NCT03039790|594629984|FG013|Overall Study|Reason, not Specified|0|||
164619618|NCT03039790|594629985|FG014|Overall Study|Reason, not Specified|0|||
164619619|NCT03039790|594629986|FG015|Overall Study|Reason, not Specified|0|||
164619620|NCT03039790|594629987|FG016|Overall Study|Reason, not Specified|2|||
164619621|NCT03039790|594629988|FG017|Overall Study|Reason, not Specified|0|||
164619622|NCT03039790|594629989|FG018|Overall Study|Reason, not Specified|1|||
164619623|NCT03039790|594629990|FG019|Overall Study|Reason, not Specified|0|||
164619624|NCT02266004|594629991|FG000|Overall Study|unrelated adverse event|1|||
164619625|NCT02266004|594629991|FG000|Overall Study|Physician Decision|1|||
164619626|NCT00537771|594629992|FG000|Overall Study|Withdrawal by Subject|6|||
164619627|NCT00537771|594629993|FG001|Overall Study|Withdrawal by Subject|23|||
164619628|NCT00537771|594629992|FG000|Overall Study|Adverse Event|8|||
164619629|NCT00537771|594629993|FG001|Overall Study|Adverse Event|15|||
164619630|NCT00537771|594629992|FG000|Overall Study|Lost to Follow-up|9|||
164619631|NCT00537771|594629993|FG001|Overall Study|Lost to Follow-up|15|||
164619632|NCT00537771|594629992|FG000|Overall Study|Protocol Violation|2|||
164619633|NCT00537771|594629993|FG001|Overall Study|Protocol Violation|6|||
164619634|NCT00537771|594629992|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
164619635|NCT00537771|594629993|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
164619636|NCT02736929|594629994|FG000|Main Study|Lost to Follow-up|7|||
164619637|NCT02736929|594629995|FG001|Main Study|Lost to Follow-up|1|||
164619638|NCT02736929|594629996|FG002|Main Study|Lost to Follow-up|0|||
164619639|NCT02736929|594629994|FG000|Main Study|Withdrawal by Subject|1|||
164619640|NCT02736929|594629995|FG001|Main Study|Withdrawal by Subject|1|||
164619641|NCT02736929|594629996|FG002|Main Study|Withdrawal by Subject|0|||
164619642|NCT02736929|594629994|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
164619643|NCT02736929|594629995|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
164619644|NCT02736929|594629996|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
164619645|NCT02465489|594629999|FG000|Overall Study|Adverse Event|5|||
164619646|NCT01855425|594630000|FG000|Overall Study|Physician Decision|20|||
164619647|NCT01600105|594630003|FG000|Total Participants|Withdrawal by Subject|1|||
164619648|NCT01600105|594630004|FG001|Total Participants|Withdrawal by Subject|0|||
164619649|NCT01600105|594630003|FG000|Total Participants|No images in PACS|10|||
164619650|NCT01600105|594630004|FG001|Total Participants|No images in PACS|0|||
164619651|NCT01600105|594630003|FG000|Total Participants|Insufficient image quality|30|||
164619652|NCT01600105|594630004|FG001|Total Participants|Insufficient image quality|10|||
164619653|NCT01600105|594630003|FG000|Sub Study I|Insufficient image quality|0|||
164619654|NCT01600105|594630004|FG001|Sub Study I|Insufficient image quality|10|||
164619655|NCT01600105|594630003|FG000|Sub Study II|Withdrawal by Subject|1|||
164619656|NCT01600105|594630004|FG001|Sub Study II|Withdrawal by Subject|0|||
164619657|NCT01600105|594630003|FG000|Sub Study II|No images in PACS|1|||
164619658|NCT01600105|594630004|FG001|Sub Study II|No images in PACS|0|||
164619659|NCT01600105|594630003|FG000|Sub Study II|Insufficient image quality|3|||
164619660|NCT01600105|594630004|FG001|Sub Study II|Insufficient image quality|0|||
164619661|NCT01600105|594630003|FG000|Sub Study III|Insufficient image quality|5|||
164619662|NCT01600105|594630004|FG001|Sub Study III|Insufficient image quality|0|||
164619663|NCT01600105|594630003|FG000|Sub Study V|Poor Image Quality|2|||
164619664|NCT01600105|594630004|FG001|Sub Study V|Poor Image Quality|0|||
164619665|NCT01263444|594630005|FG000|Overall Study|Adverse Event|8|||
164619666|NCT01263444|594630005|FG000|Overall Study|Withdrawal by Subject|1|||
164619667|NCT01263444|594630005|FG000|Overall Study|Protocol Violation|1|||
164619668|NCT01764022|594630006|FG000|Overall Study|Death|3|||
164619669|NCT01764022|594630007|FG001|Overall Study|Death|5|||
164619670|NCT01764022|594630006|FG000|Overall Study|Withdrawal by Subject|2|||
164619671|NCT01764022|594630007|FG001|Overall Study|Withdrawal by Subject|6|||
164619672|NCT01764022|594630006|FG000|Overall Study|Lack of Efficacy|0|||
164619673|NCT01764022|594630007|FG001|Overall Study|Lack of Efficacy|1|||
164619674|NCT01764022|594630006|FG000|Overall Study|Physician Decision|0|||
164619675|NCT01764022|594630007|FG001|Overall Study|Physician Decision|2|||
164619676|NCT01764022|594630006|FG000|Overall Study|Lost to Follow-up|2|||
164619677|NCT01764022|594630007|FG001|Overall Study|Lost to Follow-up|0|||
164619678|NCT01764022|594630006|FG000|Overall Study|Protocol Violation|1|||
164619679|NCT01764022|594630007|FG001|Overall Study|Protocol Violation|0|||
164619680|NCT01899768|594630009|FG000|Part A|Adverse Event|2|||
164619681|NCT01899768|594630009|FG000|Part A|Withdrawal by Subject|1|||
164619682|NCT01899768|594630009|FG000|Part B|Adverse Event|1|||
164619683|NCT01899768|594630009|FG000|Part B|Withdrawal by Subject|1|||
164619684|NCT04043416|594630010|FG000|Washout|Change in health condition|0|||
164619685|NCT04043416|594630011|FG001|Washout|Change in health condition|1|||
164619686|NCT00118040|594630012|FG000|Overall Study|Adverse Event|0|||
164619687|NCT00118040|594630013|FG001|Overall Study|Adverse Event|1|||
164619688|NCT00118040|594630014|FG002|Overall Study|Adverse Event|0|||
164619689|NCT00118040|594630012|FG000|Overall Study|Withdrawal by Subject|0|||
164619690|NCT00118040|594630013|FG001|Overall Study|Withdrawal by Subject|0|||
164619691|NCT00118040|594630014|FG002|Overall Study|Withdrawal by Subject|2|||
164619692|NCT00118040|594630012|FG000|Overall Study|Medical Contraindication|0|||
164619693|NCT00118040|594630013|FG001|Overall Study|Medical Contraindication|0|||
164619694|NCT00118040|594630014|FG002|Overall Study|Medical Contraindication|1|||
164619695|NCT00118040|594630012|FG000|Overall Study|Non-Compliant Participant|1|||
164619696|NCT00118040|594630013|FG001|Overall Study|Non-Compliant Participant|1|||
164619697|NCT00118040|594630014|FG002|Overall Study|Non-Compliant Participant|2|||
164619698|NCT00118040|594630012|FG000|Overall Study|Other|0|||
164619699|NCT00118040|594630013|FG001|Overall Study|Other|0|||
164619700|NCT00118040|594630014|FG002|Overall Study|Other|1|||
164619701|NCT02865928|594630015|FG000|Overall Study|Withdrawal by Subject|1|||
164619702|NCT02865928|594630016|FG001|Overall Study|Withdrawal by Subject|0|||
164619703|NCT02865928|594630015|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
164619704|NCT02865928|594630016|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
164619705|NCT02865928|594630015|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
164619706|NCT02865928|594630016|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
164619707|NCT01196091|594630020|FG000|Overall Study|Adverse Event|22|||
164619708|NCT01196091|594630021|FG001|Overall Study|Adverse Event|27|||
164619709|NCT01196091|594630022|FG002|Overall Study|Adverse Event|26|||
164619710|NCT01196091|594630020|FG000|Overall Study|Death|3|||
164619711|NCT01196091|594630021|FG001|Overall Study|Death|2|||
164619712|NCT01196091|594630022|FG002|Overall Study|Death|2|||
164619713|NCT01196091|594630020|FG000|Overall Study|Entry Criteria Not Met|11|||
164619714|NCT01196091|594630021|FG001|Overall Study|Entry Criteria Not Met|11|||
164619715|NCT01196091|594630022|FG002|Overall Study|Entry Criteria Not Met|10|||
164619716|NCT01196091|594630020|FG000|Overall Study|Lack of Efficacy|15|||
164619717|NCT01196091|594630021|FG001|Overall Study|Lack of Efficacy|12|||
164619718|NCT01196091|594630022|FG002|Overall Study|Lack of Efficacy|17|||
164619719|NCT01196091|594630020|FG000|Overall Study|Lost to Follow-up|5|||
164619720|NCT01196091|594630021|FG001|Overall Study|Lost to Follow-up|5|||
164619721|NCT01196091|594630022|FG002|Overall Study|Lost to Follow-up|6|||
164619722|NCT01196091|594630020|FG000|Overall Study|Parent/Caregiver Decision|0|||
164619723|NCT01196091|594630021|FG001|Overall Study|Parent/Caregiver Decision|0|||
164619724|NCT01196091|594630022|FG002|Overall Study|Parent/Caregiver Decision|1|||
164619725|NCT01196091|594630020|FG000|Overall Study|Withdrawal by Subject|16|||
164619726|NCT01196091|594630021|FG001|Overall Study|Withdrawal by Subject|19|||
164619727|NCT01196091|594630022|FG002|Overall Study|Withdrawal by Subject|22|||
164619728|NCT01196091|594630020|FG000|Overall Study|Physician Decision|3|||
164619729|NCT01196091|594630021|FG001|Overall Study|Physician Decision|3|||
164619730|NCT01196091|594630022|FG002|Overall Study|Physician Decision|4|||
164619731|NCT01196091|594630020|FG000|Overall Study|Protocol Violation|1|||
164619732|NCT01196091|594630021|FG001|Overall Study|Protocol Violation|3|||
164619733|NCT01196091|594630022|FG002|Overall Study|Protocol Violation|3|||
164619734|NCT01196091|594630020|FG000|Overall Study|Sponsor Decision|6|||
164619735|NCT01196091|594630021|FG001|Overall Study|Sponsor Decision|5|||
164619736|NCT01196091|594630022|FG002|Overall Study|Sponsor Decision|4|||
164619737|NCT01196091|594630020|FG000|Overall Study|Excluded Site|5|||
164619738|NCT01196091|594630021|FG001|Overall Study|Excluded Site|11|||
164619739|NCT01196091|594630022|FG002|Overall Study|Excluded Site|8|||
164619740|NCT01196091|594630020|FG000|Overall Study|Randomized, No Study Drug Received|1|||
164619741|NCT01196091|594630021|FG001|Overall Study|Randomized, No Study Drug Received|0|||
164619742|NCT01196091|594630022|FG002|Overall Study|Randomized, No Study Drug Received|1|||
164619743|NCT00850135|594630023|FG000|Overall Study|Physician Decision|1|||
164619744|NCT02253992|594630024|FG000|Overall Study|Study drug toxicity|1|||
164619745|NCT02253992|594630025|FG001|Overall Study|Study drug toxicity|0|||
164619746|NCT02253992|594630026|FG002|Overall Study|Study drug toxicity|10|||
164619747|NCT02253992|594630024|FG000|Overall Study|Disease progression|4|||
164619748|NCT02253992|594630025|FG001|Overall Study|Disease progression|3|||
164619749|NCT02253992|594630026|FG002|Overall Study|Disease progression|98|||
164619750|NCT02253992|594630024|FG000|Overall Study|Withdrawal by Subject|0|||
164619751|NCT02253992|594630025|FG001|Overall Study|Withdrawal by Subject|0|||
164619752|NCT02253992|594630026|FG002|Overall Study|Withdrawal by Subject|3|||
164619753|NCT02253992|594630024|FG000|Overall Study|Adverse Event|0|||
164619754|NCT02253992|594630025|FG001|Overall Study|Adverse Event|0|||
164619755|NCT02253992|594630026|FG002|Overall Study|Adverse Event|8|||
164619756|NCT02253992|594630024|FG000|Overall Study|Death|0|||
164619757|NCT02253992|594630025|FG001|Overall Study|Death|0|||
164619758|NCT02253992|594630026|FG002|Overall Study|Death|1|||
164619759|NCT02253992|594630024|FG000|Overall Study|Subject discontinued study drug|1|||
164619760|NCT02253992|594630025|FG001|Overall Study|Subject discontinued study drug|0|||
164619761|NCT02253992|594630026|FG002|Overall Study|Subject discontinued study drug|1|||
164619762|NCT02253992|594630024|FG000|Overall Study|Completed treatment as per protocol|0|||
164619763|NCT02253992|594630025|FG001|Overall Study|Completed treatment as per protocol|1|||
164619764|NCT02253992|594630026|FG002|Overall Study|Completed treatment as per protocol|22|||
164619765|NCT02253992|594630024|FG000|Overall Study|Other|0|||
164619766|NCT02253992|594630025|FG001|Overall Study|Other|0|||
164619767|NCT02253992|594630026|FG002|Overall Study|Other|1|||
164619768|NCT00471276|594630027|FG000|Overall Study|Death|2|||
164619769|NCT00471276|594630027|FG000|Overall Study|Adverse Event|16|||
164619770|NCT00471276|594630027|FG000|Overall Study|Protocol Violation|1|||
164619771|NCT00471276|594630027|FG000|Overall Study|Objective progression or relapse|54|||
164619772|NCT00471276|594630027|FG000|Overall Study|Global deterioration of health status|1|||
164619773|NCT00471276|594630027|FG000|Overall Study|Other|3|||
164619774|NCT00471276|594630027|FG000|Overall Study|Refused treatment|6|||
164619775|NCT02324049|594630034|FG000|Part C|Study terminated|11|||
164619776|NCT02159365|594630035|FG000|Overall Study|Disease Progression|23|||
164619777|NCT02159365|594630035|FG000|Overall Study|Other reasons|11|||
164619778|NCT02159365|594630035|FG000|Overall Study|Administrative reason by Sponsor|9|||
164619779|NCT02159365|594630035|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
164619780|NCT02159365|594630035|FG000|Overall Study|Study drug toxicity|7|||
164619781|NCT02159365|594630035|FG000|Overall Study|Maximum clinical benefit|3|||
164619782|NCT02159365|594630035|FG000|Overall Study|Subject request to discontinue treatment|3|||
164619783|NCT02159365|594630035|FG000|Overall Study|Subject withdrew consent|3|||
164619784|NCT02159365|594630035|FG000|Overall Study|Death|1|||
164619785|NCT02159365|594630035|FG000|Overall Study|Lost to Follow-up|1|||
164619786|NCT03198728|594630036|FG000|Overall Study|Adverse Event|10|||
164619787|NCT03198728|594630037|FG001|Overall Study|Adverse Event|5|||
164619788|NCT03198728|594630036|FG000|Overall Study|Lost to Follow-up|21|||
164619789|NCT03198728|594630037|FG001|Overall Study|Lost to Follow-up|7|||
164619790|NCT03198728|594630036|FG000|Overall Study|Physician Decision|7|||
164619791|NCT03198728|594630037|FG001|Overall Study|Physician Decision|2|||
164619792|NCT03198728|594630036|FG000|Overall Study|Withdrawal by Subject|14|||
164619793|NCT03198728|594630037|FG001|Overall Study|Withdrawal by Subject|10|||
164619794|NCT04051944|594630038|FG000|Overall Study|Study ending|1|||
164619795|NCT04051944|594630039|FG001|Overall Study|Study ending|1|||
164619796|NCT04051944|594630038|FG000|Overall Study|Early study termination by participant|1|||
164619797|NCT04051944|594630039|FG001|Overall Study|Early study termination by participant|0|||
164619798|NCT04051944|594630038|FG000|Overall Study|Withdrawal by Subject|2|||
164619799|NCT04051944|594630039|FG001|Overall Study|Withdrawal by Subject|2|||
164619800|NCT04051944|594630038|FG000|Overall Study|Lack of Efficacy|3|||
164619801|NCT04051944|594630039|FG001|Overall Study|Lack of Efficacy|0|||
164619802|NCT04051944|594630038|FG000|Overall Study|Adverse event, non- fatal|1|||
164619803|NCT04051944|594630039|FG001|Overall Study|Adverse event, non- fatal|1|||
164619804|NCT03083470|594630040|FG000|Overall Study|Lost to Follow-up|0|||
164619805|NCT03083470|594630041|FG001|Overall Study|Lost to Follow-up|0|||
164619806|NCT03083470|594630042|FG002|Overall Study|Lost to Follow-up|0|||
164619807|NCT03083470|594630043|FG003|Overall Study|Lost to Follow-up|0|||
164619808|NCT03083470|594630044|FG004|Overall Study|Lost to Follow-up|1|||
164619809|NCT03083470|594630040|FG000|Overall Study|Withdrawal by Subject|0|||
164619810|NCT03083470|594630041|FG001|Overall Study|Withdrawal by Subject|0|||
164619811|NCT03083470|594630042|FG002|Overall Study|Withdrawal by Subject|0|||
164619812|NCT03083470|594630043|FG003|Overall Study|Withdrawal by Subject|0|||
164619813|NCT03083470|594630044|FG004|Overall Study|Withdrawal by Subject|1|||
164619814|NCT01512693|594630045|FG000|Overall Study|Withdrawal by Subject|0|||
164619815|NCT01512693|594630046|FG001|Overall Study|Withdrawal by Subject|1|||
164619816|NCT02139280|594630047|FG000|Overall Study|No longer eligible|2|||
164619817|NCT02139280|594630048|FG001|Overall Study|No longer eligible|0|||
164619818|NCT00736450|594630055|FG000|Overall Study|Not ABC gene eligible|19|||
164619819|NCT00736450|594630055|FG000|Overall Study|Withdrawal by Subject|5|||
164619820|NCT00736450|594630055|FG000|Overall Study|Physician Decision|1|||
164619821|NCT04157751|594630059|FG000|Overall Study|Withdrawal by Subject|12|||
164619822|NCT04157751|594630060|FG001|Overall Study|Withdrawal by Subject|17|||
164619823|NCT04157751|594630059|FG000|Overall Study|Lost to Follow-up|6|||
164619824|NCT04157751|594630060|FG001|Overall Study|Lost to Follow-up|2|||
164619825|NCT04157751|594630059|FG000|Overall Study|Adverse Event|34|||
164619826|NCT04157751|594630060|FG001|Overall Study|Adverse Event|23|||
164619827|NCT04157751|594630059|FG000|Overall Study|Not treated|1|||
164619828|NCT04157751|594630060|FG001|Overall Study|Not treated|5|||
164619829|NCT04157751|594630059|FG000|Overall Study|Other reason not stated above|10|||
164619830|NCT04157751|594630060|FG001|Overall Study|Other reason not stated above|10|||
164619831|NCT04731922|594630061|FG000|Overall Study|Adverse Event|0|||
164619832|NCT04731922|594630062|FG001|Overall Study|Adverse Event|0|||
164619833|NCT04731922|594630063|FG002|Overall Study|Adverse Event|0|||
164619834|NCT04731922|594630064|FG003|Overall Study|Adverse Event|0|||
164619835|NCT04731922|594630065|FG004|Overall Study|Adverse Event|0|||
164619836|NCT04731922|594630066|FG005|Overall Study|Adverse Event|0|||
164619837|NCT04731922|594630067|FG006|Overall Study|Adverse Event|0|||
164619838|NCT04731922|594630068|FG007|Overall Study|Adverse Event|0|||
164619839|NCT04731922|594630069|FG008|Overall Study|Adverse Event|0|||
164619840|NCT04731922|594630070|FG009|Overall Study|Adverse Event|0|||
164619841|NCT04731922|594630071|FG010|Overall Study|Adverse Event|1|||
164619842|NCT04731922|594630072|FG011|Overall Study|Adverse Event|0|||
164619843|NCT04731922|594630073|FG012|Overall Study|Adverse Event|0|||
164619844|NCT04731922|594630074|FG013|Overall Study|Adverse Event|0|||
164619845|NCT04731922|594630075|FG014|Overall Study|Adverse Event|0|||
164619846|NCT04731922|594630076|FG015|Overall Study|Adverse Event|0|||
164619847|NCT04731922|594630077|FG016|Overall Study|Adverse Event|0|||
164619848|NCT04731922|594630061|FG000|Overall Study|Lost to Follow-up|0|||
164619849|NCT04731922|594630062|FG001|Overall Study|Lost to Follow-up|0|||
164619850|NCT04731922|594630063|FG002|Overall Study|Lost to Follow-up|0|||
164619851|NCT04731922|594630064|FG003|Overall Study|Lost to Follow-up|1|||
164619852|NCT04731922|594630065|FG004|Overall Study|Lost to Follow-up|0|||
164619853|NCT04731922|594630066|FG005|Overall Study|Lost to Follow-up|1|||
164619854|NCT04731922|594630067|FG006|Overall Study|Lost to Follow-up|0|||
164619855|NCT04731922|594630068|FG007|Overall Study|Lost to Follow-up|0|||
164619856|NCT04731922|594630069|FG008|Overall Study|Lost to Follow-up|0|||
164619857|NCT04731922|594630070|FG009|Overall Study|Lost to Follow-up|0|||
164619858|NCT04731922|594630071|FG010|Overall Study|Lost to Follow-up|0|||
164619859|NCT04731922|594630072|FG011|Overall Study|Lost to Follow-up|0|||
164619860|NCT04731922|594630073|FG012|Overall Study|Lost to Follow-up|0|||
164619861|NCT04731922|594630074|FG013|Overall Study|Lost to Follow-up|0|||
164619862|NCT04731922|594630075|FG014|Overall Study|Lost to Follow-up|0|||
164619863|NCT04731922|594630076|FG015|Overall Study|Lost to Follow-up|0|||
164619864|NCT04731922|594630077|FG016|Overall Study|Lost to Follow-up|0|||
164619865|NCT04731922|594630061|FG000|Overall Study|Withdrawal by Subject|1|||
164619866|NCT04731922|594630062|FG001|Overall Study|Withdrawal by Subject|0|||
164619867|NCT04731922|594630063|FG002|Overall Study|Withdrawal by Subject|0|||
164619868|NCT04731922|594630064|FG003|Overall Study|Withdrawal by Subject|0|||
164619869|NCT04731922|594630065|FG004|Overall Study|Withdrawal by Subject|1|||
164619870|NCT04731922|594630066|FG005|Overall Study|Withdrawal by Subject|0|||
164619871|NCT04731922|594630067|FG006|Overall Study|Withdrawal by Subject|1|||
164619872|NCT04731922|594630068|FG007|Overall Study|Withdrawal by Subject|0|||
164619873|NCT04731922|594630069|FG008|Overall Study|Withdrawal by Subject|0|||
164619874|NCT04731922|594630070|FG009|Overall Study|Withdrawal by Subject|0|||
164619875|NCT04731922|594630071|FG010|Overall Study|Withdrawal by Subject|0|||
164619876|NCT04731922|594630072|FG011|Overall Study|Withdrawal by Subject|0|||
164619877|NCT04731922|594630073|FG012|Overall Study|Withdrawal by Subject|0|||
164619878|NCT04731922|594630074|FG013|Overall Study|Withdrawal by Subject|1|||
164619879|NCT04731922|594630075|FG014|Overall Study|Withdrawal by Subject|0|||
164619880|NCT04731922|594630076|FG015|Overall Study|Withdrawal by Subject|0|||
164619881|NCT04731922|594630077|FG016|Overall Study|Withdrawal by Subject|0|||
164619882|NCT04731922|594630061|FG000|Overall Study|Other|0|||
164619883|NCT04731922|594630062|FG001|Overall Study|Other|0|||
164619884|NCT04731922|594630063|FG002|Overall Study|Other|0|||
164619885|NCT04731922|594630064|FG003|Overall Study|Other|0|||
164619886|NCT04731922|594630065|FG004|Overall Study|Other|0|||
164619887|NCT04731922|594630066|FG005|Overall Study|Other|0|||
164619888|NCT04731922|594630067|FG006|Overall Study|Other|1|||
164619889|NCT04731922|594630068|FG007|Overall Study|Other|0|||
164619890|NCT04731922|594630069|FG008|Overall Study|Other|0|||
164619891|NCT04731922|594630070|FG009|Overall Study|Other|0|||
164619892|NCT04731922|594630071|FG010|Overall Study|Other|0|||
164619893|NCT04731922|594630072|FG011|Overall Study|Other|0|||
164619894|NCT04731922|594630073|FG012|Overall Study|Other|0|||
164619895|NCT04731922|594630074|FG013|Overall Study|Other|0|||
164619896|NCT04731922|594630075|FG014|Overall Study|Other|0|||
164619897|NCT04731922|594630076|FG015|Overall Study|Other|0|||
164619898|NCT04731922|594630077|FG016|Overall Study|Other|0|||
164619899|NCT00981747|594630084|FG000|Losartan|Withdrawal by Subject|1|||
164619900|NCT00981747|594630084|FG000|Losartan|Death|1|||
164619901|NCT00981747|594630084|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
164619902|NCT03148795|594630092|FG000|Overall Study|Progressive Disease|1|||
164619903|NCT00441012|594630093|FG000|Overall Study|Adverse Event|0|||
164619904|NCT00441012|594630094|FG001|Overall Study|Adverse Event|1|||
164619905|NCT00441012|594630093|FG000|Overall Study|Lost to Follow-up|3|||
164619906|NCT00441012|594630094|FG001|Overall Study|Lost to Follow-up|3|||
164619907|NCT00441012|594630093|FG000|Overall Study|Protocol Violation|10|||
164619908|NCT00441012|594630094|FG001|Overall Study|Protocol Violation|9|||
164619909|NCT00441012|594630093|FG000|Overall Study|Withdrawal by Subject|4|||
164619910|NCT00441012|594630094|FG001|Overall Study|Withdrawal by Subject|0|||
164619911|NCT00441012|594630093|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
164619912|NCT00441012|594630094|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
164619913|NCT04489940|594630095|FG000|Overall Study|Other|2|||
164619914|NCT04489940|594630095|FG000|Overall Study|Withdrawal by Subject|2|||
164619915|NCT04489940|594630095|FG000|Overall Study|Death|5|||
164619916|NCT04489940|594630095|FG000|Overall Study|Lost to Follow-up|1|||
164619917|NCT04498468|594630096|FG000|Overall Study|Lost to Follow-up|3|||
164619918|NCT02092324|594630097|FG000|Overall Study|Adverse Event|1|||
164619919|NCT02092324|594630097|FG000|Overall Study|Lack of Efficacy|6|||
164619920|NCT02092324|594630097|FG000|Overall Study|Proceed to Transplant|3|||
164619921|NCT02092324|594630097|FG000|Overall Study|Physician Decision|7|||
164619922|NCT02092324|594630097|FG000|Overall Study|Misdiagnosis|2|||
164619923|NCT02224274|594630099|FG000|Overall Study|Death|1|||
164619924|NCT02224274|594630100|FG001|Overall Study|Death|0|||
164619925|NCT00499460|594630101|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
164619926|NCT00499460|594630102|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
164619927|NCT00499460|594630101|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
164619928|NCT00499460|594630102|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
164619929|NCT00499460|594630101|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
164619930|NCT00499460|594630102|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
164619931|NCT00887068|594630103|FG000|Overall Study|Withdrawal by Subject|2|||
164619932|NCT00887068|594630104|FG001|Overall Study|Withdrawal by Subject|0|||
164619933|NCT00887068|594630103|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
164619934|NCT00887068|594630104|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
164619935|NCT00090766|594630112|FG000|Overall Study|Nephrectomy Planned|0|||
164619936|NCT00090766|594630113|FG001|Overall Study|Nephrectomy Planned|0|||
164619937|NCT00090766|594630114|FG002|Overall Study|Nephrectomy Planned|1|||
164619938|NCT00090766|594630112|FG000|Overall Study|Death|1|||
164619939|NCT00090766|594630113|FG001|Overall Study|Death|0|||
164619940|NCT00090766|594630114|FG002|Overall Study|Death|0|||
164619941|NCT00090766|594630112|FG000|Overall Study|Admin|0|||
164619942|NCT00090766|594630113|FG001|Overall Study|Admin|2|||
164619943|NCT00090766|594630114|FG002|Overall Study|Admin|0|||
164619944|NCT00090766|594630112|FG000|Overall Study|Lost to Follow-up|2|||
164619945|NCT00090766|594630113|FG001|Overall Study|Lost to Follow-up|0|||
164619946|NCT00090766|594630114|FG002|Overall Study|Lost to Follow-up|2|||
164619947|NCT00804986|594630115|FG000|Overall Study|Adverse Event|0|||
164619948|NCT00804986|594630116|FG001|Overall Study|Adverse Event|1|||
164619949|NCT00804986|594630117|FG002|Overall Study|Adverse Event|2|||
164619950|NCT00804986|594630118|FG003|Overall Study|Adverse Event|1|||
164619951|NCT00804986|594630119|FG004|Overall Study|Adverse Event|3|||
164619952|NCT00804986|594630120|FG005|Overall Study|Adverse Event|0|||
164619953|NCT00804986|594630115|FG000|Overall Study|Lack of Efficacy|0|||
164619954|NCT00804986|594630116|FG001|Overall Study|Lack of Efficacy|0|||
164619955|NCT00804986|594630117|FG002|Overall Study|Lack of Efficacy|0|||
164619956|NCT00804986|594630118|FG003|Overall Study|Lack of Efficacy|1|||
164619957|NCT00804986|594630119|FG004|Overall Study|Lack of Efficacy|0|||
164619958|NCT00804986|594630120|FG005|Overall Study|Lack of Efficacy|3|||
164619959|NCT00804986|594630115|FG000|Overall Study|Lost to Follow-up|0|||
164619960|NCT00804986|594630116|FG001|Overall Study|Lost to Follow-up|0|||
164619961|NCT00804986|594630117|FG002|Overall Study|Lost to Follow-up|0|||
164619962|NCT00804986|594630118|FG003|Overall Study|Lost to Follow-up|1|||
164619963|NCT00804986|594630119|FG004|Overall Study|Lost to Follow-up|1|||
164619964|NCT00804986|594630120|FG005|Overall Study|Lost to Follow-up|3|||
164619965|NCT00804986|594630115|FG000|Overall Study|Protocol Violation|0|||
164619966|NCT00804986|594630116|FG001|Overall Study|Protocol Violation|1|||
164619967|NCT00804986|594630117|FG002|Overall Study|Protocol Violation|0|||
164619968|NCT00804986|594630118|FG003|Overall Study|Protocol Violation|1|||
164619969|NCT00804986|594630119|FG004|Overall Study|Protocol Violation|0|||
164619970|NCT00804986|594630120|FG005|Overall Study|Protocol Violation|0|||
164619971|NCT00804986|594630115|FG000|Overall Study|Withdrawal by Subject|0|||
164619972|NCT00804986|594630116|FG001|Overall Study|Withdrawal by Subject|3|||
164619973|NCT00804986|594630117|FG002|Overall Study|Withdrawal by Subject|0|||
164619974|NCT00804986|594630118|FG003|Overall Study|Withdrawal by Subject|3|||
164619975|NCT00804986|594630119|FG004|Overall Study|Withdrawal by Subject|5|||
164619976|NCT00804986|594630120|FG005|Overall Study|Withdrawal by Subject|3|||
164619977|NCT00804986|594630115|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
164619978|NCT00804986|594630116|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
164619979|NCT00804986|594630117|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
164619980|NCT00804986|594630118|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
164619981|NCT00804986|594630119|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
164619982|NCT00804986|594630120|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
164619983|NCT00804986|594630115|FG000|Overall Study|Sponsor Decision|0|||
164619984|NCT00804986|594630116|FG001|Overall Study|Sponsor Decision|1|||
164619985|NCT00804986|594630117|FG002|Overall Study|Sponsor Decision|0|||
164619986|NCT00804986|594630118|FG003|Overall Study|Sponsor Decision|0|||
164619987|NCT00804986|594630119|FG004|Overall Study|Sponsor Decision|0|||
164619988|NCT00804986|594630120|FG005|Overall Study|Sponsor Decision|0|||
164619989|NCT00804986|594630115|FG000|Overall Study|Physician Decision|1|||
164619990|NCT00804986|594630116|FG001|Overall Study|Physician Decision|0|||
164619991|NCT00804986|594630117|FG002|Overall Study|Physician Decision|0|||
164619992|NCT00804986|594630118|FG003|Overall Study|Physician Decision|0|||
164619993|NCT00804986|594630119|FG004|Overall Study|Physician Decision|0|||
164619994|NCT00804986|594630120|FG005|Overall Study|Physician Decision|0|||
164619995|NCT03418376|594630122|FG000|Overall Study|Musculoskeletal injury|1|||
164619996|NCT03418376|594630123|FG001|Overall Study|Musculoskeletal injury|2|||
164619997|NCT03418376|594630124|FG002|Overall Study|Musculoskeletal injury|1|||
164619998|NCT03418376|594630125|FG003|Overall Study|Musculoskeletal injury|0|||
164619999|NCT03418376|594630122|FG000|Overall Study|Personal reasons|0|||
164620000|NCT03418376|594630123|FG001|Overall Study|Personal reasons|2|||
164620001|NCT03418376|594630124|FG002|Overall Study|Personal reasons|2|||
164620002|NCT03418376|594630125|FG003|Overall Study|Personal reasons|1|||
164620003|NCT03418376|594630122|FG000|Overall Study|Exacerbation|0|||
164620004|NCT03418376|594630123|FG001|Overall Study|Exacerbation|1|||
164620005|NCT03418376|594630124|FG002|Overall Study|Exacerbation|0|||
164620006|NCT03418376|594630125|FG003|Overall Study|Exacerbation|0|||
164620007|NCT02774291|594630127|FG000|Overall Study|Lost to Follow-up|1|||
164620008|NCT00149890|594630131|FG000|Overall Study|Adverse Event|1|||
164620009|NCT00149890|594630132|FG001|Overall Study|Adverse Event|8|||
164620010|NCT00149890|594630131|FG000|Overall Study|Lack of Efficacy|8|||
164620011|NCT00149890|594630132|FG001|Overall Study|Lack of Efficacy|9|||
164620012|NCT00149890|594630131|FG000|Overall Study|Protocol Violation|1|||
164620013|NCT00149890|594630132|FG001|Overall Study|Protocol Violation|0|||
164620014|NCT00149890|594630131|FG000|Overall Study|Lost to Follow-up|1|||
164620015|NCT00149890|594630132|FG001|Overall Study|Lost to Follow-up|0|||
164620016|NCT00149890|594630131|FG000|Overall Study|Graft Loss|2|||
164620017|NCT00149890|594630132|FG001|Overall Study|Graft Loss|1|||
164620018|NCT01387594|594630133|FG000|Overall Study|Withdrawal by Subject|0|||
164620019|NCT01387594|594630134|FG001|Overall Study|Withdrawal by Subject|2|||
164620020|NCT01387594|594630133|FG000|Overall Study|Lost to Follow-up|0|||
164620021|NCT01387594|594630134|FG001|Overall Study|Lost to Follow-up|1|||
164620022|NCT03073200|594630142|FG000|Double Blind Treatment Period|Protocol Violation|1|||
164620023|NCT03073200|594630143|FG001|Double Blind Treatment Period|Protocol Violation|0|||
164620024|NCT03073200|594630144|FG002|Double Blind Treatment Period|Protocol Violation|0|||
164620025|NCT03073200|594630145|FG003|Double Blind Treatment Period|Protocol Violation|0|||
164620026|NCT03073200|594630146|FG004|Double Blind Treatment Period|Protocol Violation|0|||
164620027|NCT03073200|594630147|FG005|Double Blind Treatment Period|Protocol Violation|0|||
164620028|NCT03073200|594630148|FG006|Double Blind Treatment Period|Protocol Violation|0|||
164620029|NCT03073200|594630149|FG007|Double Blind Treatment Period|Protocol Violation|0|||
164620030|NCT03073200|594630150|FG008|Double Blind Treatment Period|Protocol Violation|0|||
164620031|NCT03073200|594630151|FG009|Double Blind Treatment Period|Protocol Violation|0|||
164620032|NCT03073200|594630152|FG010|Double Blind Treatment Period|Protocol Violation|0|||
164620033|NCT03073200|594630153|FG011|Double Blind Treatment Period|Protocol Violation|0|||
164620034|NCT03073200|594630154|FG012|Double Blind Treatment Period|Protocol Violation|0|||
164620035|NCT03073200|594630155|FG013|Double Blind Treatment Period|Protocol Violation|0|||
164620036|NCT03073200|594630156|FG014|Double Blind Treatment Period|Protocol Violation|0|||
164620037|NCT03073200|594630142|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164620038|NCT03073200|594630143|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
164620039|NCT03073200|594630144|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164620040|NCT03073200|594630145|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164620041|NCT03073200|594630146|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164620042|NCT03073200|594630147|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164620043|NCT03073200|594630148|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164620044|NCT03073200|594630149|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164620045|NCT03073200|594630150|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164620046|NCT03073200|594630151|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164620047|NCT03073200|594630152|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164620048|NCT03073200|594630153|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164620049|NCT03073200|594630154|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164620050|NCT03073200|594630155|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164620051|NCT03073200|594630156|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164620052|NCT03073200|594630142|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
164620053|NCT03073200|594630143|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
164620054|NCT03073200|594630144|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
164620055|NCT03073200|594630145|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
164620056|NCT03073200|594630146|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
164620057|NCT03073200|594630147|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
164620058|NCT03073200|594630148|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
164620059|NCT03073200|594630149|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
164620060|NCT03073200|594630150|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
164620061|NCT03073200|594630151|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
164620062|NCT03073200|594630152|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
164620063|NCT03073200|594630153|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
164620064|NCT03073200|594630154|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
164620065|NCT03073200|594630155|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
164620066|NCT03073200|594630156|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
164620067|NCT03073200|594630142|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
164620068|NCT03073200|594630143|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
164620069|NCT03073200|594630144|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
164620070|NCT03073200|594630145|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
164620071|NCT03073200|594630146|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
164620072|NCT03073200|594630147|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
164620073|NCT03073200|594630148|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
164620074|NCT03073200|594630149|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
164620075|NCT03073200|594630150|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
164620076|NCT03073200|594630151|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
164620077|NCT03073200|594630152|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
164620078|NCT03073200|594630153|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
164620079|NCT03073200|594630154|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
164620080|NCT03073200|594630155|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
164620081|NCT03073200|594630156|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
164620082|NCT03073200|594630142|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
164620083|NCT03073200|594630143|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
164620084|NCT03073200|594630144|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
164620085|NCT03073200|594630145|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
164620086|NCT03073200|594630146|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
164620087|NCT03073200|594630147|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
164620088|NCT03073200|594630148|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
164620089|NCT03073200|594630149|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
164620090|NCT03073200|594630150|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
164620091|NCT03073200|594630151|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
164620092|NCT03073200|594630152|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
164620093|NCT03073200|594630153|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
164620094|NCT03073200|594630154|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
164620095|NCT03073200|594630155|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
164620096|NCT03073200|594630156|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
164620097|NCT03073200|594630142|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
164620098|NCT03073200|594630143|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
164620099|NCT03073200|594630144|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
164620100|NCT03073200|594630145|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
164620101|NCT03073200|594630146|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
164620102|NCT03073200|594630147|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
164620103|NCT03073200|594630148|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
164620104|NCT03073200|594630149|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
164522223|NCT01373151|594281264|FG006|Period 1|Adverse Event|0|||
164522224|NCT01373151|594281258|FG000|Period 1|Withdrawal by Subject|2|||
164522225|NCT01373151|594281259|FG001|Period 1|Withdrawal by Subject|0|||
164522226|NCT01373151|594281260|FG002|Period 1|Withdrawal by Subject|3|||
164522227|NCT01373151|594281261|FG003|Period 1|Withdrawal by Subject|1|||
164522228|NCT01373151|594281262|FG004|Period 1|Withdrawal by Subject|0|||
164522229|NCT01373151|594281263|FG005|Period 1|Withdrawal by Subject|1|||
164522230|NCT01373151|594281264|FG006|Period 1|Withdrawal by Subject|0|||
164522231|NCT01373151|594281258|FG000|Period 2|Lack of Efficacy|9|||
164522232|NCT01373151|594281259|FG001|Period 2|Lack of Efficacy|0|||
164522233|NCT01373151|594281260|FG002|Period 2|Lack of Efficacy|0|||
164522234|NCT01373151|594281261|FG003|Period 2|Lack of Efficacy|1|||
164522235|NCT01373151|594281262|FG004|Period 2|Lack of Efficacy|2|||
164522236|NCT01373151|594281263|FG005|Period 2|Lack of Efficacy|0|||
164522237|NCT01373151|594281264|FG006|Period 2|Lack of Efficacy|3|||
164522238|NCT01373151|594281258|FG000|Period 2|Adverse Event|0|||
164522239|NCT01373151|594281259|FG001|Period 2|Adverse Event|0|||
164620105|NCT03073200|594630150|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
164620106|NCT03073200|594630151|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
164620107|NCT03073200|594630152|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
164620108|NCT03073200|594630153|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
164620109|NCT03073200|594630154|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
164620110|NCT03073200|594630155|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
164620111|NCT03073200|594630156|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
164620112|NCT03073200|594630142|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164620113|NCT03073200|594630143|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164620114|NCT03073200|594630144|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164620115|NCT03073200|594630145|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
164620116|NCT03073200|594630146|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
164620117|NCT03073200|594630147|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164620118|NCT03073200|594630148|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164620119|NCT03073200|594630149|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164620120|NCT03073200|594630150|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164620121|NCT03073200|594630151|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164620122|NCT03073200|594630152|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164620123|NCT03073200|594630153|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164620124|NCT03073200|594630154|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164620125|NCT03073200|594630155|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164620126|NCT03073200|594630156|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164620127|NCT03073200|594630142|FG000|Extension Period|Lost to Follow-up|0|||
164522240|NCT01373151|594281260|FG002|Period 2|Adverse Event|3|||
164522241|NCT01373151|594281261|FG003|Period 2|Adverse Event|3|||
164522242|NCT01373151|594281262|FG004|Period 2|Adverse Event|0|||
164522243|NCT01373151|594281263|FG005|Period 2|Adverse Event|0|||
164522244|NCT01373151|594281264|FG006|Period 2|Adverse Event|1|||
164522245|NCT01373151|594281258|FG000|Period 2|subject request to discontinue|0|||
164522246|NCT01373151|594281259|FG001|Period 2|subject request to discontinue|1|||
164522247|NCT01373151|594281260|FG002|Period 2|subject request to discontinue|0|||
164522248|NCT01373151|594281261|FG003|Period 2|subject request to discontinue|0|||
164522249|NCT01373151|594281262|FG004|Period 2|subject request to discontinue|0|||
164522250|NCT01373151|594281263|FG005|Period 2|subject request to discontinue|0|||
164522251|NCT01373151|594281264|FG006|Period 2|subject request to discontinue|0|||
164522252|NCT01373151|594281258|FG000|Period 2|Withdrawal by Subject|0|||
164522253|NCT01373151|594281259|FG001|Period 2|Withdrawal by Subject|0|||
164522254|NCT01373151|594281260|FG002|Period 2|Withdrawal by Subject|0|||
164522255|NCT01373151|594281261|FG003|Period 2|Withdrawal by Subject|1|||
164522256|NCT01373151|594281262|FG004|Period 2|Withdrawal by Subject|0|||
164522257|NCT01373151|594281263|FG005|Period 2|Withdrawal by Subject|0|||
164522258|NCT01373151|594281264|FG006|Period 2|Withdrawal by Subject|0|||
164522259|NCT01373151|594281258|FG000|Period 2|Other|0|||
164522260|NCT01373151|594281259|FG001|Period 2|Other|0|||
164522261|NCT01373151|594281260|FG002|Period 2|Other|1|||
164522262|NCT01373151|594281261|FG003|Period 2|Other|0|||
164522263|NCT01373151|594281262|FG004|Period 2|Other|0|||
164522264|NCT01373151|594281263|FG005|Period 2|Other|0|||
164522265|NCT01373151|594281264|FG006|Period 2|Other|1|||
164522266|NCT01468181|594281271|FG000|Overall Study|Adverse Event|8|||
164522267|NCT01468181|594281272|FG001|Overall Study|Adverse Event|1|||
164522268|NCT01468181|594281273|FG002|Overall Study|Adverse Event|6|||
164522269|NCT01468181|594281274|FG003|Overall Study|Adverse Event|2|||
164522270|NCT01468181|594281275|FG004|Overall Study|Adverse Event|2|||
164522271|NCT01468181|594281271|FG000|Overall Study|Protocol Violation|2|||
164522272|NCT01468181|594281272|FG001|Overall Study|Protocol Violation|0|||
164522273|NCT01468181|594281273|FG002|Overall Study|Protocol Violation|1|||
164522274|NCT01468181|594281274|FG003|Overall Study|Protocol Violation|0|||
164522275|NCT01468181|594281275|FG004|Overall Study|Protocol Violation|1|||
164522276|NCT01468181|594281271|FG000|Overall Study|Physician Decision|0|||
164522277|NCT01468181|594281272|FG001|Overall Study|Physician Decision|0|||
164522278|NCT01468181|594281273|FG002|Overall Study|Physician Decision|0|||
164522279|NCT01468181|594281274|FG003|Overall Study|Physician Decision|1|||
164522280|NCT01468181|594281275|FG004|Overall Study|Physician Decision|1|||
164522281|NCT01468181|594281271|FG000|Overall Study|Lost to Follow-up|0|||
164522282|NCT01468181|594281272|FG001|Overall Study|Lost to Follow-up|0|||
164522283|NCT01468181|594281273|FG002|Overall Study|Lost to Follow-up|1|||
164522284|NCT01468181|594281274|FG003|Overall Study|Lost to Follow-up|0|||
164522285|NCT01468181|594281275|FG004|Overall Study|Lost to Follow-up|1|||
164522286|NCT01468181|594281271|FG000|Overall Study|Withdrawal by Subject|0|||
164522287|NCT01468181|594281272|FG001|Overall Study|Withdrawal by Subject|1|||
164522288|NCT01468181|594281273|FG002|Overall Study|Withdrawal by Subject|0|||
164522289|NCT01468181|594281274|FG003|Overall Study|Withdrawal by Subject|0|||
164522290|NCT01468181|594281275|FG004|Overall Study|Withdrawal by Subject|0|||
164522291|NCT01506453|594282590|FG000|Overall Study|Withdrawal prior to treatment|0|||
164522292|NCT01506453|594282591|FG001|Overall Study|Withdrawal prior to treatment|2|||
164522293|NCT03541174|594282592|FG000|Part 1 Double-Blind|Adverse Event|6|||
164522294|NCT03541174|594282593|FG001|Part 1 Double-Blind|Adverse Event|5|||
164522295|NCT03541174|594282594|FG002|Part 1 Double-Blind|Adverse Event|2|||
164522296|NCT03541174|594282595|FG003|Part 1 Double-Blind|Adverse Event|0|||
164522297|NCT03541174|594282596|FG004|Part 1 Double-Blind|Adverse Event|0|||
164522298|NCT03541174|594282597|FG005|Part 1 Double-Blind|Adverse Event|0|||
164522299|NCT03541174|594282592|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
164522300|NCT03541174|594282593|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
164522301|NCT03541174|594282594|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
164522302|NCT03541174|594282595|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
164522303|NCT03541174|594282596|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
164522304|NCT03541174|594282597|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
164522305|NCT03541174|594282592|FG000|Part 1 Double-Blind|Other reasons|3|||
164522306|NCT03541174|594282593|FG001|Part 1 Double-Blind|Other reasons|2|||
164522307|NCT03541174|594282594|FG002|Part 1 Double-Blind|Other reasons|3|||
164522308|NCT03541174|594282595|FG003|Part 1 Double-Blind|Other reasons|0|||
164522309|NCT03541174|594282596|FG004|Part 1 Double-Blind|Other reasons|0|||
164522310|NCT03541174|594282597|FG005|Part 1 Double-Blind|Other reasons|0|||
164522311|NCT03541174|594282592|FG000|Part 2 Single-Blind|Adverse Event|0|||
164522312|NCT03541174|594282593|FG001|Part 2 Single-Blind|Adverse Event|0|||
164522313|NCT03541174|594282594|FG002|Part 2 Single-Blind|Adverse Event|0|||
164522314|NCT03541174|594282595|FG003|Part 2 Single-Blind|Adverse Event|25|||
164522315|NCT03541174|594282596|FG004|Part 2 Single-Blind|Adverse Event|0|||
164522316|NCT03541174|594282597|FG005|Part 2 Single-Blind|Adverse Event|0|||
164522317|NCT03541174|594282592|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
164522318|NCT03541174|594282593|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
164522319|NCT03541174|594282594|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
164522320|NCT03541174|594282595|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
164522321|NCT03541174|594282596|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
164522322|NCT03541174|594282597|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
164522323|NCT03541174|594282592|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
164522324|NCT03541174|594282593|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
164522325|NCT03541174|594282594|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
164522326|NCT03541174|594282595|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
164522327|NCT03541174|594282596|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
164522328|NCT03541174|594282597|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
164522329|NCT03541174|594282592|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
164522330|NCT03541174|594282593|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
164522331|NCT03541174|594282594|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
164522332|NCT03541174|594282595|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
164522333|NCT03541174|594282596|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
164522334|NCT03541174|594282597|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
164522335|NCT03541174|594282592|FG000|Part 2 Single-Blind|Death|0|||
164522336|NCT03541174|594282593|FG001|Part 2 Single-Blind|Death|0|||
164522337|NCT03541174|594282594|FG002|Part 2 Single-Blind|Death|0|||
164522338|NCT03541174|594282595|FG003|Part 2 Single-Blind|Death|5|||
164522339|NCT03541174|594282596|FG004|Part 2 Single-Blind|Death|0|||
164522340|NCT03541174|594282597|FG005|Part 2 Single-Blind|Death|0|||
164522341|NCT03541174|594282592|FG000|Part 2 Single-Blind|Pregnancy|0|||
164522342|NCT03541174|594282593|FG001|Part 2 Single-Blind|Pregnancy|0|||
164522343|NCT03541174|594282594|FG002|Part 2 Single-Blind|Pregnancy|0|||
164522344|NCT03541174|594282595|FG003|Part 2 Single-Blind|Pregnancy|1|||
164522345|NCT03541174|594282596|FG004|Part 2 Single-Blind|Pregnancy|0|||
164522346|NCT03541174|594282597|FG005|Part 2 Single-Blind|Pregnancy|0|||
164522347|NCT03541174|594282592|FG000|Part 2 Single-Blind|Other reasons|0|||
164522348|NCT03541174|594282593|FG001|Part 2 Single-Blind|Other reasons|0|||
164522349|NCT03541174|594282594|FG002|Part 2 Single-Blind|Other reasons|0|||
164522350|NCT03541174|594282595|FG003|Part 2 Single-Blind|Other reasons|32|||
164522351|NCT03541174|594282596|FG004|Part 2 Single-Blind|Other reasons|0|||
164522352|NCT03541174|594282597|FG005|Part 2 Single-Blind|Other reasons|0|||
164522353|NCT03541174|594282592|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
164522354|NCT03541174|594282593|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
164522355|NCT03541174|594282594|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
164522356|NCT03541174|594282595|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
164522357|NCT03541174|594282596|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
164522358|NCT03541174|594282597|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
164522359|NCT03541174|594282592|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
164522360|NCT03541174|594282593|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
164522361|NCT03541174|594282594|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
164522362|NCT03541174|594282595|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
164522363|NCT03541174|594282596|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
164522364|NCT03541174|594282597|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
164522365|NCT03541174|594282592|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
164522366|NCT03541174|594282593|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
164522367|NCT03541174|594282594|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
164522368|NCT03541174|594282595|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
164522369|NCT03541174|594282596|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
164522370|NCT03541174|594282597|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
164522371|NCT03541174|594282592|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
164522372|NCT03541174|594282593|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
164522373|NCT03541174|594282594|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
164522374|NCT03541174|594282595|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
164522375|NCT03541174|594282596|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
164522376|NCT03541174|594282597|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
164522377|NCT03541174|594282592|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
164522378|NCT03541174|594282593|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
164522379|NCT03541174|594282594|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
164522380|NCT03541174|594282595|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
164522381|NCT03541174|594282596|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
164522382|NCT03541174|594282597|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
164522383|NCT00605215|594282598|FG000|Overall Study|Death|0|||
164522384|NCT00605215|594282599|FG001|Overall Study|Death|0|||
164522385|NCT00605215|594282600|FG002|Overall Study|Death|1|||
164522386|NCT00605215|594282598|FG000|Overall Study|Adverse Event|19|||
164522387|NCT00605215|594282599|FG001|Overall Study|Adverse Event|21|||
164522388|NCT00605215|594282600|FG002|Overall Study|Adverse Event|26|||
164522389|NCT00605215|594282598|FG000|Overall Study|Refusal to sign the re-consent form|8|||
164522390|NCT00605215|594282599|FG001|Overall Study|Refusal to sign the re-consent form|3|||
164522391|NCT00605215|594282600|FG002|Overall Study|Refusal to sign the re-consent form|3|||
164522392|NCT00605215|594282598|FG000|Overall Study|Withdrawal by Subject|39|||
164522393|NCT00605215|594282599|FG001|Overall Study|Withdrawal by Subject|37|||
164522394|NCT00605215|594282600|FG002|Overall Study|Withdrawal by Subject|27|||
164522395|NCT00605215|594282598|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
164522396|NCT00605215|594282599|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
164522397|NCT00605215|594282600|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
164522398|NCT00605215|594282598|FG000|Overall Study|Protocol Violation|3|||
164522399|NCT00605215|594282599|FG001|Overall Study|Protocol Violation|4|||
164522400|NCT00605215|594282600|FG002|Overall Study|Protocol Violation|1|||
164522401|NCT00605215|594282598|FG000|Overall Study|Pregnancy|8|||
164522402|NCT00605215|594282599|FG001|Overall Study|Pregnancy|5|||
164522403|NCT00605215|594282600|FG002|Overall Study|Pregnancy|4|||
164522404|NCT00605215|594282598|FG000|Overall Study|Lost to Follow-up|8|||
164522405|NCT00605215|594282599|FG001|Overall Study|Lost to Follow-up|5|||
164522406|NCT00605215|594282600|FG002|Overall Study|Lost to Follow-up|2|||
164522407|NCT00605215|594282598|FG000|Overall Study|Other than specified|0|||
164522408|NCT00605215|594282599|FG001|Overall Study|Other than specified|2|||
164522409|NCT00605215|594282600|FG002|Overall Study|Other than specified|1|||
164522410|NCT00896051|594282601|FG000|Overall Study|Adverse Event|2|||
164522411|NCT00896051|594282602|FG001|Overall Study|Adverse Event|1|||
164522412|NCT00896051|594282601|FG000|Overall Study|Lost to Follow-up|3|||
164522413|NCT00896051|594282602|FG001|Overall Study|Lost to Follow-up|2|||
164522414|NCT00896051|594282601|FG000|Overall Study|Withdrawal by Subject|3|||
164522415|NCT00896051|594282602|FG001|Overall Study|Withdrawal by Subject|2|||
164522416|NCT00896051|594282601|FG000|Overall Study|Subject noncompliant|1|||
164522417|NCT00896051|594282602|FG001|Overall Study|Subject noncompliant|3|||
164522418|NCT00896051|594282601|FG000|Overall Study|Other|1|||
164522419|NCT00896051|594282602|FG001|Overall Study|Other|1|||
164522420|NCT00007345|594282603|FG000|Overall Study|Refused further treatment|0|||
164522421|NCT00007345|594282604|FG001|Overall Study|Refused further treatment|7|||
164620128|NCT03073200|594630143|FG001|Extension Period|Lost to Follow-up|0|||
164620129|NCT03073200|594630144|FG002|Extension Period|Lost to Follow-up|0|||
164620130|NCT03073200|594630145|FG003|Extension Period|Lost to Follow-up|0|||
164620131|NCT03073200|594630146|FG004|Extension Period|Lost to Follow-up|0|||
164620132|NCT03073200|594630147|FG005|Extension Period|Lost to Follow-up|0|||
164620133|NCT03073200|594630148|FG006|Extension Period|Lost to Follow-up|1|||
164620134|NCT03073200|594630149|FG007|Extension Period|Lost to Follow-up|1|||
164620135|NCT03073200|594630150|FG008|Extension Period|Lost to Follow-up|0|||
164620136|NCT03073200|594630151|FG009|Extension Period|Lost to Follow-up|0|||
164620137|NCT03073200|594630152|FG010|Extension Period|Lost to Follow-up|0|||
164620138|NCT03073200|594630153|FG011|Extension Period|Lost to Follow-up|0|||
164620139|NCT03073200|594630154|FG012|Extension Period|Lost to Follow-up|0|||
164620140|NCT03073200|594630155|FG013|Extension Period|Lost to Follow-up|0|||
164620141|NCT03073200|594630156|FG014|Extension Period|Lost to Follow-up|0|||
164620142|NCT03073200|594630142|FG000|Extension Period|Sponsor Decision|0|||
164620143|NCT03073200|594630143|FG001|Extension Period|Sponsor Decision|0|||
164620144|NCT03073200|594630144|FG002|Extension Period|Sponsor Decision|0|||
164620145|NCT03073200|594630145|FG003|Extension Period|Sponsor Decision|0|||
164620146|NCT03073200|594630146|FG004|Extension Period|Sponsor Decision|0|||
164620147|NCT03073200|594630147|FG005|Extension Period|Sponsor Decision|0|||
164620148|NCT03073200|594630148|FG006|Extension Period|Sponsor Decision|0|||
164620149|NCT03073200|594630149|FG007|Extension Period|Sponsor Decision|0|||
164620150|NCT03073200|594630150|FG008|Extension Period|Sponsor Decision|1|||
164620151|NCT03073200|594630151|FG009|Extension Period|Sponsor Decision|0|||
164620152|NCT03073200|594630152|FG010|Extension Period|Sponsor Decision|0|||
164620153|NCT03073200|594630153|FG011|Extension Period|Sponsor Decision|0|||
164620154|NCT03073200|594630154|FG012|Extension Period|Sponsor Decision|0|||
164620155|NCT03073200|594630155|FG013|Extension Period|Sponsor Decision|0|||
164620156|NCT03073200|594630156|FG014|Extension Period|Sponsor Decision|0|||
164620157|NCT03073200|594630142|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
164620158|NCT03073200|594630143|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
164620159|NCT03073200|594630144|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
164620160|NCT03073200|594630145|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
164620161|NCT03073200|594630146|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
164620162|NCT03073200|594630147|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
164620163|NCT03073200|594630148|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
164620164|NCT03073200|594630149|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
164620165|NCT03073200|594630150|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
164620166|NCT03073200|594630151|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
164620167|NCT03073200|594630152|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
164620168|NCT03073200|594630153|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
164620169|NCT03073200|594630154|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
164620170|NCT03073200|594630155|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
164620171|NCT03073200|594630156|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
164620172|NCT03073200|594630142|FG000|Extension Period|Withdrawal by Subject|0|||
164620173|NCT03073200|594630143|FG001|Extension Period|Withdrawal by Subject|0|||
164620174|NCT03073200|594630144|FG002|Extension Period|Withdrawal by Subject|0|||
164620175|NCT03073200|594630145|FG003|Extension Period|Withdrawal by Subject|0|||
164620176|NCT03073200|594630146|FG004|Extension Period|Withdrawal by Subject|0|||
164620177|NCT03073200|594630147|FG005|Extension Period|Withdrawal by Subject|0|||
164620178|NCT03073200|594630148|FG006|Extension Period|Withdrawal by Subject|1|||
164620179|NCT03073200|594630149|FG007|Extension Period|Withdrawal by Subject|2|||
164620180|NCT03073200|594630150|FG008|Extension Period|Withdrawal by Subject|0|||
164620181|NCT03073200|594630151|FG009|Extension Period|Withdrawal by Subject|0|||
164620182|NCT03073200|594630152|FG010|Extension Period|Withdrawal by Subject|0|||
164620183|NCT03073200|594630153|FG011|Extension Period|Withdrawal by Subject|0|||
164620184|NCT03073200|594630154|FG012|Extension Period|Withdrawal by Subject|0|||
164620185|NCT03073200|594630155|FG013|Extension Period|Withdrawal by Subject|0|||
164620186|NCT03073200|594630156|FG014|Extension Period|Withdrawal by Subject|0|||
164620187|NCT03073200|594630142|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
164620188|NCT03073200|594630143|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
164620189|NCT03073200|594630144|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
164620190|NCT03073200|594630145|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
164620191|NCT03073200|594630146|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
164620192|NCT03073200|594630147|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
164620193|NCT03073200|594630148|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
164620194|NCT03073200|594630149|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
164620195|NCT03073200|594630150|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
164620196|NCT03073200|594630151|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
164620197|NCT03073200|594630152|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
164620198|NCT03073200|594630153|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
164620199|NCT03073200|594630154|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
164620200|NCT03073200|594630155|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
164620201|NCT03073200|594630156|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
164522422|NCT00007345|594282603|FG000|Overall Study|Switched to alternative treatment|0|||
164522423|NCT00007345|594282604|FG001|Overall Study|Switched to alternative treatment|3|||
164522424|NCT00007345|594282603|FG000|Overall Study|Intercurrent illness|1|||
164522425|NCT00007345|594282604|FG001|Overall Study|Intercurrent illness|0|||
164522426|NCT00007345|594282603|FG000|Overall Study|Death on study|1|||
164522427|NCT00007345|594282604|FG001|Overall Study|Death on study|1|||
164522428|NCT04433585|594282605|FG000|Overall Study|Withdrawal by Subject|15|||
164522429|NCT04433585|594282606|FG001|Overall Study|Withdrawal by Subject|3|||
164522430|NCT04433585|594282607|FG002|Overall Study|Withdrawal by Subject|15|||
164522431|NCT04433585|594282608|FG003|Overall Study|Withdrawal by Subject|6|||
164522432|NCT04433585|594282605|FG000|Overall Study|Adverse Event|10|||
164522433|NCT04433585|594282606|FG001|Overall Study|Adverse Event|4|||
164522434|NCT04433585|594282607|FG002|Overall Study|Adverse Event|1|||
164522435|NCT04433585|594282608|FG003|Overall Study|Adverse Event|0|||
164522436|NCT04433585|594282605|FG000|Overall Study|Due to the conflict in Ukraine|2|||
164522437|NCT04433585|594282606|FG001|Overall Study|Due to the conflict in Ukraine|1|||
164522438|NCT04433585|594282607|FG002|Overall Study|Due to the conflict in Ukraine|1|||
164522439|NCT04433585|594282608|FG003|Overall Study|Due to the conflict in Ukraine|2|||
164522440|NCT04433585|594282605|FG000|Overall Study|Physician Decision|1|||
164522441|NCT04433585|594282606|FG001|Overall Study|Physician Decision|2|||
164522442|NCT04433585|594282607|FG002|Overall Study|Physician Decision|0|||
164522443|NCT04433585|594282608|FG003|Overall Study|Physician Decision|0|||
164522444|NCT04433585|594282605|FG000|Overall Study|Lost to Follow-up|1|||
164522445|NCT04433585|594282606|FG001|Overall Study|Lost to Follow-up|1|||
164522446|NCT04433585|594282607|FG002|Overall Study|Lost to Follow-up|1|||
164522447|NCT04433585|594282608|FG003|Overall Study|Lost to Follow-up|0|||
164522448|NCT04433585|594282605|FG000|Overall Study|Lack of Efficacy|0|||
164522449|NCT04433585|594282606|FG001|Overall Study|Lack of Efficacy|1|||
164522450|NCT04433585|594282607|FG002|Overall Study|Lack of Efficacy|1|||
164522451|NCT04433585|594282608|FG003|Overall Study|Lack of Efficacy|1|||
164522452|NCT04433585|594282605|FG000|Overall Study|Death|0|||
164522453|NCT04433585|594282606|FG001|Overall Study|Death|1|||
164522454|NCT04433585|594282607|FG002|Overall Study|Death|0|||
164522455|NCT04433585|594282608|FG003|Overall Study|Death|0|||
164522456|NCT02121301|594282612|FG000|Overall Study|Protocol Violation|1|||
164522457|NCT02121301|594282613|FG001|Overall Study|Protocol Violation|4|||
164522458|NCT02121301|594282614|FG002|Overall Study|Protocol Violation|1|||
164522459|NCT00434213|594282617|FG000|Overall Study|Adverse Event|12|||
164522460|NCT00434213|594282617|FG000|Overall Study|Lack of Efficacy|9|||
164522461|NCT00434213|594282617|FG000|Overall Study|Lost to Follow-up|14|||
164522462|NCT00434213|594282617|FG000|Overall Study|Withdrawal by Subject|7|||
164522463|NCT00434213|594282617|FG000|Overall Study|Protocol Violation|3|||
164522464|NCT00434213|594282617|FG000|Overall Study|Unable to comply with study visit window|2|||
164522465|NCT00434213|594282617|FG000|Overall Study|Application site reaction|1|||
164522466|NCT00434213|594282617|FG000|Overall Study|Non-compliant to study schedule|1|||
164522467|NCT04988867|594282618|FG000|Overall Study|Study terminated by Sponsor|12|||
164522468|NCT04988867|594282618|FG000|Overall Study|Adverse Event|2|||
164522469|NCT04988867|594282618|FG000|Overall Study|Study drug noncompliance|1|||
164522470|NCT01699503|594282619|FG000|Overall Study|Death|31|||
164522471|NCT01699503|594282620|FG001|Overall Study|Death|40|||
164522472|NCT01699503|594282619|FG000|Overall Study|Withdrawal by Subject|65|||
164522473|NCT01699503|594282620|FG001|Overall Study|Withdrawal by Subject|57|||
164522474|NCT01699503|594282619|FG000|Overall Study|Lost to Follow-up|121|||
164522475|NCT01699503|594282620|FG001|Overall Study|Lost to Follow-up|117|||
164522476|NCT01699503|594282619|FG000|Overall Study|Excluded due to quality|783|||
164522477|NCT01699503|594282620|FG001|Overall Study|Excluded due to quality|791|||
164522478|NCT01097707|594282623|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
164522479|NCT01097707|594282624|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
164522480|NCT01097707|594282625|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
164522481|NCT01097707|594282626|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
164522482|NCT01097707|594282627|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
164522483|NCT01097707|594282623|FG000|Overall Study|Adverse Event|4|||
164522484|NCT01097707|594282624|FG001|Overall Study|Adverse Event|2|||
164522485|NCT01097707|594282625|FG002|Overall Study|Adverse Event|3|||
164522486|NCT01097707|594282626|FG003|Overall Study|Adverse Event|1|||
164522487|NCT01097707|594282627|FG004|Overall Study|Adverse Event|3|||
164522488|NCT01097707|594282623|FG000|Overall Study|Entry Criteria Not Met|2|||
164522489|NCT01097707|594282624|FG001|Overall Study|Entry Criteria Not Met|1|||
164620202|NCT03073200|594630142|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164620203|NCT03073200|594630143|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164620204|NCT03073200|594630144|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164620205|NCT03073200|594630145|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164620206|NCT03073200|594630146|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164620207|NCT03073200|594630147|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164620208|NCT03073200|594630148|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164620209|NCT03073200|594630149|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164620210|NCT03073200|594630150|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164620211|NCT03073200|594630151|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164620212|NCT03073200|594630152|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164620213|NCT03073200|594630153|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
164620214|NCT03073200|594630154|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164620215|NCT03073200|594630155|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164620216|NCT03073200|594630156|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164620217|NCT03073200|594630142|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164620218|NCT03073200|594630143|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164620219|NCT03073200|594630144|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164620220|NCT03073200|594630145|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164620221|NCT03073200|594630146|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164620222|NCT03073200|594630147|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164620223|NCT03073200|594630148|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164620224|NCT03073200|594630149|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164620225|NCT03073200|594630150|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164620226|NCT03073200|594630151|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164620227|NCT03073200|594630152|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
164620228|NCT03073200|594630153|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
164620229|NCT03073200|594630154|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164620230|NCT03073200|594630155|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164620231|NCT03073200|594630156|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164620232|NCT03073200|594630142|FG000|Randomized Withdrawal Period|Adverse Event|0|||
164620233|NCT03073200|594630143|FG001|Randomized Withdrawal Period|Adverse Event|0|||
164620234|NCT03073200|594630144|FG002|Randomized Withdrawal Period|Adverse Event|0|||
164620235|NCT03073200|594630145|FG003|Randomized Withdrawal Period|Adverse Event|0|||
164620236|NCT03073200|594630146|FG004|Randomized Withdrawal Period|Adverse Event|0|||
164620237|NCT03073200|594630147|FG005|Randomized Withdrawal Period|Adverse Event|0|||
164620238|NCT03073200|594630148|FG006|Randomized Withdrawal Period|Adverse Event|0|||
164620239|NCT03073200|594630149|FG007|Randomized Withdrawal Period|Adverse Event|0|||
164620240|NCT03073200|594630150|FG008|Randomized Withdrawal Period|Adverse Event|0|||
164620241|NCT03073200|594630151|FG009|Randomized Withdrawal Period|Adverse Event|0|||
164620242|NCT03073200|594630152|FG010|Randomized Withdrawal Period|Adverse Event|1|||
164620243|NCT03073200|594630153|FG011|Randomized Withdrawal Period|Adverse Event|0|||
164620244|NCT03073200|594630154|FG012|Randomized Withdrawal Period|Adverse Event|0|||
164620245|NCT03073200|594630155|FG013|Randomized Withdrawal Period|Adverse Event|0|||
164620246|NCT03073200|594630156|FG014|Randomized Withdrawal Period|Adverse Event|0|||
164620247|NCT03073200|594630142|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
164620248|NCT03073200|594630143|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
164620249|NCT03073200|594630144|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
164620250|NCT03073200|594630145|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
164620251|NCT03073200|594630146|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
164620252|NCT03073200|594630147|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
164620253|NCT03073200|594630148|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
164620254|NCT03073200|594630149|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
164620255|NCT03073200|594630150|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
164620256|NCT03073200|594630151|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
164620257|NCT03073200|594630152|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
164620258|NCT03073200|594630153|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
164620259|NCT03073200|594630154|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
164620260|NCT03073200|594630155|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
164620261|NCT03073200|594630156|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
164620262|NCT03073200|594630142|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164620263|NCT03073200|594630143|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164620264|NCT03073200|594630144|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164522490|NCT01097707|594282625|FG002|Overall Study|Entry Criteria Not Met|1|||
164522491|NCT01097707|594282626|FG003|Overall Study|Entry Criteria Not Met|0|||
164522492|NCT01097707|594282627|FG004|Overall Study|Entry Criteria Not Met|1|||
164522493|NCT01097707|594282623|FG000|Overall Study|Lack of Efficacy|1|||
164522494|NCT01097707|594282624|FG001|Overall Study|Lack of Efficacy|0|||
164522495|NCT01097707|594282625|FG002|Overall Study|Lack of Efficacy|0|||
164522496|NCT01097707|594282626|FG003|Overall Study|Lack of Efficacy|1|||
164522497|NCT01097707|594282627|FG004|Overall Study|Lack of Efficacy|0|||
164522498|NCT01097707|594282623|FG000|Overall Study|Lost to Follow-up|1|||
164522499|NCT01097707|594282624|FG001|Overall Study|Lost to Follow-up|1|||
164522500|NCT01097707|594282625|FG002|Overall Study|Lost to Follow-up|2|||
164522501|NCT01097707|594282626|FG003|Overall Study|Lost to Follow-up|0|||
164522502|NCT01097707|594282627|FG004|Overall Study|Lost to Follow-up|3|||
164522503|NCT01097707|594282623|FG000|Overall Study|Protocol Violation|2|||
164522504|NCT01097707|594282624|FG001|Overall Study|Protocol Violation|2|||
164522505|NCT01097707|594282625|FG002|Overall Study|Protocol Violation|3|||
164522506|NCT01097707|594282626|FG003|Overall Study|Protocol Violation|2|||
164522507|NCT01097707|594282627|FG004|Overall Study|Protocol Violation|2|||
164522508|NCT01097707|594282623|FG000|Overall Study|Sponsor Decision|31|||
164522509|NCT01097707|594282624|FG001|Overall Study|Sponsor Decision|31|||
164522510|NCT01097707|594282625|FG002|Overall Study|Sponsor Decision|34|||
164522511|NCT01097707|594282626|FG003|Overall Study|Sponsor Decision|35|||
164522512|NCT01097707|594282627|FG004|Overall Study|Sponsor Decision|36|||
164522513|NCT01097707|594282623|FG000|Overall Study|Withdrawal by Subject|3|||
164522514|NCT01097707|594282624|FG001|Overall Study|Withdrawal by Subject|6|||
164522515|NCT01097707|594282625|FG002|Overall Study|Withdrawal by Subject|1|||
164522516|NCT01097707|594282626|FG003|Overall Study|Withdrawal by Subject|4|||
164522517|NCT01097707|594282627|FG004|Overall Study|Withdrawal by Subject|3|||
164522518|NCT01097707|594282623|FG000|Overall Study|Reason unknown|0|||
164522519|NCT01097707|594282624|FG001|Overall Study|Reason unknown|0|||
164522520|NCT01097707|594282625|FG002|Overall Study|Reason unknown|0|||
164522521|NCT01097707|594282626|FG003|Overall Study|Reason unknown|0|||
164522522|NCT01097707|594282627|FG004|Overall Study|Reason unknown|1|||
164522523|NCT03212989|594282628|FG000|Overall Study|Physician Decision|8|||
164522524|NCT03775434|594282629|FG000|Overall Study|Adverse Event|2|||
164522525|NCT03775434|594282629|FG000|Overall Study|Withdrawal by Subject|1|||
164522526|NCT03047395|594282630|FG000|Overall Study|Adverse Event|142|||
164522527|NCT03047395|594282630|FG000|Overall Study|Withdrawal by Subject|155|||
164522528|NCT03047395|594282630|FG000|Overall Study|Lost to Follow-up|144|||
164522529|NCT03047395|594282630|FG000|Overall Study|COVID-19 Infection|2|||
164522530|NCT03047395|594282630|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
164522531|NCT03047395|594282630|FG000|Overall Study|Other, Not Specified|117|||
164522532|NCT04811131|594282637|FG000|Overall Study|Adverse Event|0|||
164522533|NCT04811131|594282638|FG001|Overall Study|Adverse Event|0|||
164522534|NCT04811131|594282639|FG002|Overall Study|Adverse Event|1|||
164522535|NCT04811131|594282640|FG003|Overall Study|Adverse Event|0|||
164522536|NCT04811131|594282637|FG000|Overall Study|Lack of Efficacy|0|||
164522537|NCT04811131|594282638|FG001|Overall Study|Lack of Efficacy|0|||
164522538|NCT04811131|594282639|FG002|Overall Study|Lack of Efficacy|0|||
164522539|NCT04811131|594282640|FG003|Overall Study|Lack of Efficacy|1|||
164522540|NCT04811131|594282637|FG000|Overall Study|Lost to Follow-up|0|||
164522541|NCT04811131|594282638|FG001|Overall Study|Lost to Follow-up|1|||
164522542|NCT04811131|594282639|FG002|Overall Study|Lost to Follow-up|0|||
164522543|NCT04811131|594282640|FG003|Overall Study|Lost to Follow-up|0|||
164522544|NCT04811131|594282637|FG000|Overall Study|Sponsor request|31|||
164522545|NCT04811131|594282638|FG001|Overall Study|Sponsor request|35|||
164522546|NCT04811131|594282639|FG002|Overall Study|Sponsor request|27|||
164522547|NCT04811131|594282640|FG003|Overall Study|Sponsor request|10|||
164522548|NCT04811131|594282637|FG000|Overall Study|Withdrawal by Subject|3|||
164522549|NCT04811131|594282638|FG001|Overall Study|Withdrawal by Subject|1|||
164522550|NCT04811131|594282639|FG002|Overall Study|Withdrawal by Subject|3|||
164522551|NCT04811131|594282640|FG003|Overall Study|Withdrawal by Subject|1|||
164522552|NCT00620282|594282648|FG000|Overall Study|Adverse Event|0|||
164522553|NCT00620282|594282649|FG001|Overall Study|Adverse Event|1|||
164620265|NCT03073200|594630145|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164620266|NCT03073200|594630146|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164620267|NCT03073200|594630147|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164620268|NCT03073200|594630148|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164620269|NCT03073200|594630149|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164620270|NCT03073200|594630150|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164620271|NCT03073200|594630151|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164620272|NCT03073200|594630152|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164620273|NCT03073200|594630153|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164620274|NCT03073200|594630154|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164620275|NCT03073200|594630155|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
164620276|NCT03073200|594630156|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164620277|NCT03073200|594630142|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164620278|NCT03073200|594630143|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164620279|NCT03073200|594630144|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164620280|NCT03073200|594630145|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164620281|NCT03073200|594630146|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164620282|NCT03073200|594630147|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164620283|NCT03073200|594630148|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164620284|NCT03073200|594630149|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164620285|NCT03073200|594630150|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164620286|NCT03073200|594630151|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164620287|NCT03073200|594630152|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164620288|NCT03073200|594630153|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164620289|NCT03073200|594630154|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164620290|NCT03073200|594630155|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
164620291|NCT03073200|594630156|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164620292|NCT03073200|594630142|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164620293|NCT03073200|594630143|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164620294|NCT03073200|594630144|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164620295|NCT03073200|594630145|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164620296|NCT03073200|594630146|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164620297|NCT03073200|594630147|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164620298|NCT03073200|594630148|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164620299|NCT03073200|594630149|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164620300|NCT03073200|594630150|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164620301|NCT03073200|594630151|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164620302|NCT03073200|594630152|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164620303|NCT03073200|594630153|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164620304|NCT03073200|594630154|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164620305|NCT03073200|594630155|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
164620306|NCT03073200|594630156|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164620307|NCT03073200|594630142|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164620308|NCT03073200|594630143|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164620309|NCT03073200|594630144|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164620310|NCT03073200|594630145|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164620311|NCT03073200|594630146|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164620312|NCT03073200|594630147|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164620313|NCT03073200|594630148|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164620314|NCT03073200|594630149|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164620315|NCT03073200|594630150|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164620316|NCT03073200|594630151|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164620317|NCT03073200|594630152|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164620318|NCT03073200|594630153|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164620319|NCT03073200|594630154|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164620320|NCT03073200|594630155|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164620321|NCT03073200|594630156|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
164620322|NCT03073200|594630142|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164522554|NCT00620282|594282650|FG002|Overall Study|Adverse Event|0|||
164522555|NCT00620282|594282648|FG000|Overall Study|Arterial line unable to be placed|0|||
164522556|NCT00620282|594282649|FG001|Overall Study|Arterial line unable to be placed|0|||
164522557|NCT00620282|594282650|FG002|Overall Study|Arterial line unable to be placed|1|||
164522558|NCT00620282|594282648|FG000|Overall Study|Withdrawal by Subject|0|||
164522559|NCT00620282|594282649|FG001|Overall Study|Withdrawal by Subject|1|||
164522560|NCT00620282|594282650|FG002|Overall Study|Withdrawal by Subject|0|||
164522561|NCT02217475|594282651|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
164522562|NCT02217475|594282652|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
164522563|NCT02217475|594282653|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
164522564|NCT02217475|594282651|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
164522565|NCT02217475|594282652|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
164522566|NCT02217475|594282653|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
164522567|NCT02217475|594282651|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
164522568|NCT02217475|594282652|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
164522569|NCT02217475|594282653|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
164522570|NCT02217475|594282651|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
164522571|NCT02217475|594282652|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
164522572|NCT02217475|594282653|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
164522573|NCT02217475|594282651|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
164522574|NCT02217475|594282652|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
164522575|NCT02217475|594282653|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
164522576|NCT02217475|594282651|FG000|Discontinued After Period 1|Adverse Event|1|||
164522577|NCT02217475|594282652|FG001|Discontinued After Period 1|Adverse Event|2|||
164522578|NCT02217475|594282653|FG002|Discontinued After Period 1|Adverse Event|0|||
164522579|NCT02217475|594282651|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
164522580|NCT02217475|594282652|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
164522581|NCT02217475|594282653|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
164522582|NCT02217475|594282651|FG000|Discontinued After Period 1|Physician Decision|0|||
164522583|NCT02217475|594282652|FG001|Discontinued After Period 1|Physician Decision|0|||
164522584|NCT02217475|594282653|FG002|Discontinued After Period 1|Physician Decision|1|||
164522585|NCT02217475|594282651|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
164522586|NCT02217475|594282652|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
164522587|NCT02217475|594282653|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
164522588|NCT02217475|594282651|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
164522589|NCT02217475|594282652|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
164522590|NCT02217475|594282653|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
164522591|NCT02217475|594282651|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
164522592|NCT02217475|594282652|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
164522593|NCT02217475|594282653|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
164522594|NCT02217475|594282651|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
164522595|NCT02217475|594282652|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
164522596|NCT02217475|594282653|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
164522597|NCT02217475|594282651|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
164522598|NCT02217475|594282652|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
164522599|NCT02217475|594282653|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
164522600|NCT01131182|594282654|FG000|Overall Study|Withdrawal by Subject|1|||
164522601|NCT01131182|594282655|FG001|Overall Study|Withdrawal by Subject|1|||
164522602|NCT01131182|594282654|FG000|Overall Study|Lost to Follow-up|14|||
164522603|NCT01131182|594282655|FG001|Overall Study|Lost to Follow-up|15|||
164620323|NCT03073200|594630143|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164620324|NCT03073200|594630144|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164620325|NCT03073200|594630145|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164620326|NCT03073200|594630146|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164620327|NCT03073200|594630147|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164620328|NCT03073200|594630148|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164620329|NCT03073200|594630149|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164620330|NCT03073200|594630150|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164620331|NCT03073200|594630151|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164620332|NCT03073200|594630152|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164620333|NCT03073200|594630153|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164620334|NCT03073200|594630154|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164620335|NCT03073200|594630155|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
164620336|NCT03073200|594630156|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164620337|NCT03073200|594630142|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164620338|NCT03073200|594630143|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164620339|NCT03073200|594630144|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164620340|NCT03073200|594630145|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164620341|NCT03073200|594630146|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164620342|NCT03073200|594630147|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164620343|NCT03073200|594630148|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164620344|NCT03073200|594630149|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164620345|NCT03073200|594630150|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164620346|NCT03073200|594630151|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164620347|NCT03073200|594630152|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164620348|NCT03073200|594630153|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164620349|NCT03073200|594630154|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164620350|NCT03073200|594630155|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
164620351|NCT03073200|594630156|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164620352|NCT03073200|594630142|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164620353|NCT03073200|594630143|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164620354|NCT03073200|594630144|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164620355|NCT03073200|594630145|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164620356|NCT03073200|594630146|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164620357|NCT03073200|594630147|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164620358|NCT03073200|594630148|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164620359|NCT03073200|594630149|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164620360|NCT03073200|594630150|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164620361|NCT03073200|594630151|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164620362|NCT03073200|594630152|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164620363|NCT03073200|594630153|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164620364|NCT03073200|594630154|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164620365|NCT03073200|594630155|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
164620366|NCT03073200|594630156|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164620367|NCT04757376|594630157|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
164620368|NCT04757376|594630158|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
164620369|NCT04757376|594630159|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
164620370|NCT04757376|594630160|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
164620371|NCT04757376|594630161|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
164620372|NCT04757376|594630157|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
164620373|NCT04757376|594630158|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
164620374|NCT04757376|594630159|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
164620375|NCT04757376|594630160|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
164620376|NCT04757376|594630161|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
164620377|NCT04757376|594630157|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
164620378|NCT04757376|594630158|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
164620379|NCT04757376|594630159|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
164620380|NCT04757376|594630160|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
164620381|NCT04757376|594630161|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
164620382|NCT04757376|594630157|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
164620383|NCT04757376|594630158|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
164620384|NCT04757376|594630159|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
164620385|NCT04757376|594630160|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
164620386|NCT04757376|594630161|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
164620387|NCT04757376|594630157|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
164620388|NCT04757376|594630158|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
164620389|NCT04757376|594630159|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
164620390|NCT04757376|594630160|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
164620391|NCT04757376|594630161|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
164620392|NCT04757376|594630157|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
164620393|NCT04757376|594630158|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
164620394|NCT04757376|594630159|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
164620395|NCT04757376|594630160|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
164620396|NCT04757376|594630161|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
164620397|NCT04757376|594630157|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
164620398|NCT04757376|594630158|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
164620399|NCT04757376|594630159|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
164620400|NCT04757376|594630160|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
164620401|NCT04757376|594630161|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
164620402|NCT04757376|594630157|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
164620403|NCT04757376|594630158|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
164620404|NCT04757376|594630159|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
164620405|NCT04757376|594630160|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
164620406|NCT04757376|594630161|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
164620407|NCT03898323|594630162|FG000|Overall Study|Physician Decision|1|||
164620408|NCT02116361|594630169|FG000|Overall Study|Pregnancy|0|||
164620409|NCT02116361|594630170|FG001|Overall Study|Pregnancy|0|||
164620410|NCT02116361|594630171|FG002|Overall Study|Pregnancy|0|||
164620411|NCT02116361|594630172|FG003|Overall Study|Pregnancy|1|||
164620412|NCT02116361|594630169|FG000|Overall Study|Protocol Violation|1|||
164620413|NCT02116361|594630170|FG001|Overall Study|Protocol Violation|0|||
164620414|NCT02116361|594630171|FG002|Overall Study|Protocol Violation|0|||
164620415|NCT02116361|594630172|FG003|Overall Study|Protocol Violation|2|||
164620416|NCT02116361|594630169|FG000|Overall Study|Physician Decision|2|||
164620417|NCT02116361|594630170|FG001|Overall Study|Physician Decision|3|||
164620418|NCT02116361|594630171|FG002|Overall Study|Physician Decision|0|||
164620419|NCT02116361|594630172|FG003|Overall Study|Physician Decision|0|||
164620420|NCT02116361|594630169|FG000|Overall Study|Adverse Event|1|||
164620421|NCT02116361|594630170|FG001|Overall Study|Adverse Event|0|||
164620422|NCT02116361|594630171|FG002|Overall Study|Adverse Event|0|||
164620423|NCT02116361|594630172|FG003|Overall Study|Adverse Event|3|||
164620424|NCT02116361|594630169|FG000|Overall Study|Other Reasons|3|||
164620425|NCT02116361|594630170|FG001|Overall Study|Other Reasons|3|||
164620426|NCT02116361|594630171|FG002|Overall Study|Other Reasons|3|||
164620427|NCT02116361|594630172|FG003|Overall Study|Other Reasons|3|||
164620428|NCT02116361|594630169|FG000|Overall Study|Lack of Efficacy|5|||
164620429|NCT02116361|594630170|FG001|Overall Study|Lack of Efficacy|7|||
164620430|NCT02116361|594630171|FG002|Overall Study|Lack of Efficacy|4|||
164147613|NCT03685344|592902086|FG002|Overall Study|Death|0|||
164522604|NCT01131182|594282654|FG000|Overall Study|Other Reason|1|||
164522605|NCT01131182|594282655|FG001|Overall Study|Other Reason|0|||
164522606|NCT00777088|594282656|FG000|Overall Study|PED Treatment not attempted|1|||
164522607|NCT00350103|594282657|FG000|Overall Study|Adverse Event|12|||
164522608|NCT00350103|594282658|FG001|Overall Study|Adverse Event|29|||
164522609|NCT00350103|594282659|FG002|Overall Study|Adverse Event|17|||
164522610|NCT00350103|594282657|FG000|Overall Study|Lack of Efficacy|5|||
164522611|NCT00350103|594282658|FG001|Overall Study|Lack of Efficacy|1|||
164522612|NCT00350103|594282659|FG002|Overall Study|Lack of Efficacy|3|||
164522613|NCT00350103|594282657|FG000|Overall Study|Withdrawal by Subject|6|||
164522614|NCT00350103|594282658|FG001|Overall Study|Withdrawal by Subject|6|||
164522615|NCT00350103|594282659|FG002|Overall Study|Withdrawal by Subject|8|||
164522616|NCT00350103|594282657|FG000|Overall Study|Protocol Violation|0|||
164522617|NCT00350103|594282658|FG001|Overall Study|Protocol Violation|0|||
164522618|NCT00350103|594282659|FG002|Overall Study|Protocol Violation|1|||
164522619|NCT00350103|594282657|FG000|Overall Study|Unsatisfactory Compliance|2|||
164522620|NCT00350103|594282658|FG001|Overall Study|Unsatisfactory Compliance|2|||
164522621|NCT00350103|594282659|FG002|Overall Study|Unsatisfactory Compliance|1|||
164522622|NCT00350103|594282657|FG000|Overall Study|Investigator´s decision|1|||
164522623|NCT00350103|594282658|FG001|Overall Study|Investigator´s decision|1|||
164522624|NCT00350103|594282659|FG002|Overall Study|Investigator´s decision|0|||
164522625|NCT00350103|594282657|FG000|Overall Study|Exclusion criteria met|0|||
164522626|NCT00350103|594282658|FG001|Overall Study|Exclusion criteria met|0|||
164522627|NCT00350103|594282659|FG002|Overall Study|Exclusion criteria met|1|||
164522628|NCT00350103|594282657|FG000|Overall Study|Patient relocated|0|||
164522629|NCT00350103|594282658|FG001|Overall Study|Patient relocated|0|||
164522630|NCT00350103|594282659|FG002|Overall Study|Patient relocated|1|||
164522631|NCT00350103|594282657|FG000|Overall Study|Need for prohibited medication|1|||
164522632|NCT00350103|594282658|FG001|Overall Study|Need for prohibited medication|0|||
164522633|NCT00350103|594282659|FG002|Overall Study|Need for prohibited medication|0|||
164522634|NCT00350103|594282657|FG000|Overall Study|Personal reasons|0|||
164522635|NCT00350103|594282658|FG001|Overall Study|Personal reasons|0|||
164522636|NCT00350103|594282659|FG002|Overall Study|Personal reasons|1|||
164522637|NCT00350103|594282657|FG000|Overall Study|Patient stopped feeling pain|1|||
164522638|NCT00350103|594282658|FG001|Overall Study|Patient stopped feeling pain|0|||
164522639|NCT00350103|594282659|FG002|Overall Study|Patient stopped feeling pain|0|||
164522640|NCT00350103|594282657|FG000|Overall Study|PR greater than 250ms|0|||
164522641|NCT00350103|594282658|FG001|Overall Study|PR greater than 250ms|0|||
164522642|NCT00350103|594282659|FG002|Overall Study|PR greater than 250ms|1|||
164522643|NCT00350103|594282657|FG000|Overall Study|Wrong calculation of QT interval|0|||
164522644|NCT00350103|594282658|FG001|Overall Study|Wrong calculation of QT interval|0|||
164522645|NCT00350103|594282659|FG002|Overall Study|Wrong calculation of QT interval|1|||
164522646|NCT00350103|594282657|FG000|Overall Study|Sponsor mistake|1|||
164522647|NCT00350103|594282658|FG001|Overall Study|Sponsor mistake|0|||
164522648|NCT00350103|594282659|FG002|Overall Study|Sponsor mistake|0|||
164522649|NCT00350103|594282657|FG000|Overall Study|Randomization mistake|0|||
164522650|NCT00350103|594282658|FG001|Overall Study|Randomization mistake|1|||
164522651|NCT00350103|594282659|FG002|Overall Study|Randomization mistake|1|||
164522652|NCT00350103|594282657|FG000|Overall Study|Sponsor´s decision|0|||
164522653|NCT00350103|594282658|FG001|Overall Study|Sponsor´s decision|1|||
164522654|NCT00350103|594282659|FG002|Overall Study|Sponsor´s decision|0|||
164522655|NCT00350103|594282657|FG000|Overall Study|Lost, Reason unknown|1|||
164522656|NCT00350103|594282658|FG001|Overall Study|Lost, Reason unknown|1|||
164522657|NCT00350103|594282659|FG002|Overall Study|Lost, Reason unknown|0|||
164522658|NCT01879553|594282660|FG000|Overall Study|Withdrawal by Subject|1|||
164522659|NCT01879553|594282661|FG001|Overall Study|Withdrawal by Subject|0|||
164522660|NCT04828837|594282662|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
164522661|NCT04828837|594282663|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
164522662|NCT04828837|594282662|FG000|Overall Study|Lost to Follow-up|2|||
164522663|NCT04828837|594282663|FG001|Overall Study|Lost to Follow-up|6|||
164522664|NCT04828837|594282662|FG000|Overall Study|Lack of Efficacy|1|||
164522665|NCT04828837|594282663|FG001|Overall Study|Lack of Efficacy|0|||
164522666|NCT04828837|594282662|FG000|Overall Study|Admitted due to pneumothorax.|1|||
164522667|NCT04828837|594282663|FG001|Overall Study|Admitted due to pneumothorax.|0|||
164522668|NCT04828837|594282662|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
164522669|NCT04828837|594282663|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
164522670|NCT00545753|594282669|FG000|Overall Study|Withdrawal by Subject|0|||
164522671|NCT00545753|594282670|FG001|Overall Study|Withdrawal by Subject|1|||
164522672|NCT00545753|594282671|FG002|Overall Study|Withdrawal by Subject|10|||
164522673|NCT00545753|594282669|FG000|Overall Study|Lost to Follow-up|13|||
164522674|NCT00545753|594282670|FG001|Overall Study|Lost to Follow-up|3|||
164620431|NCT02116361|594630172|FG003|Overall Study|Lack of Efficacy|3|||
164620432|NCT02116361|594630169|FG000|Overall Study|Lost to Follow-up|4|||
164620433|NCT02116361|594630170|FG001|Overall Study|Lost to Follow-up|5|||
164620434|NCT02116361|594630171|FG002|Overall Study|Lost to Follow-up|7|||
164620435|NCT02116361|594630172|FG003|Overall Study|Lost to Follow-up|5|||
164620436|NCT02116361|594630169|FG000|Overall Study|Personal Reasons|6|||
164620437|NCT02116361|594630170|FG001|Overall Study|Personal Reasons|6|||
164620438|NCT02116361|594630171|FG002|Overall Study|Personal Reasons|4|||
164620439|NCT02116361|594630172|FG003|Overall Study|Personal Reasons|9|||
164620440|NCT02116361|594630169|FG000|Overall Study|Investigator Decision - Relapse|9|||
164620441|NCT02116361|594630170|FG001|Overall Study|Investigator Decision - Relapse|7|||
164620442|NCT02116361|594630171|FG002|Overall Study|Investigator Decision - Relapse|8|||
164620443|NCT02116361|594630172|FG003|Overall Study|Investigator Decision - Relapse|5|||
164620444|NCT04195750|594630173|FG000|Overall Study|Death|245|||
164620445|NCT04195750|594630174|FG001|Overall Study|Death|253|||
164620446|NCT04195750|594630175|FG002|Overall Study|Death|5|||
164620447|NCT04195750|594630173|FG000|Overall Study|Physician Decision|0|||
164620448|NCT04195750|594630174|FG001|Overall Study|Physician Decision|1|||
164620449|NCT04195750|594630175|FG002|Overall Study|Physician Decision|0|||
164620450|NCT04195750|594630173|FG000|Overall Study|Withdrawal by Subject|9|||
164620451|NCT04195750|594630174|FG001|Overall Study|Withdrawal by Subject|8|||
164620452|NCT04195750|594630175|FG002|Overall Study|Withdrawal by Subject|0|||
164620453|NCT04195750|594630173|FG000|Overall Study|Ongoing|120|||
164620454|NCT04195750|594630174|FG001|Overall Study|Ongoing|110|||
164620455|NCT04195750|594630175|FG002|Overall Study|Ongoing|4|||
164620456|NCT02406027|594630176|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
164620457|NCT02406027|594630177|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
164620458|NCT02406027|594630178|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
164620459|NCT02406027|594630179|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
164620460|NCT02406027|594630180|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
164620461|NCT02406027|594630181|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
164620462|NCT02406027|594630182|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
164620463|NCT02406027|594630176|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
164620464|NCT02406027|594630177|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
164620465|NCT02406027|594630178|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
164620466|NCT02406027|594630179|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
164620467|NCT02406027|594630180|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
164620468|NCT02406027|594630181|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
164620469|NCT02406027|594630182|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
164620470|NCT02406027|594630176|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
164620471|NCT02406027|594630177|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
164620472|NCT02406027|594630178|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
164620473|NCT02406027|594630179|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
164620474|NCT02406027|594630180|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
164620475|NCT02406027|594630181|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
164620476|NCT02406027|594630182|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
164620477|NCT02406027|594630176|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
164620478|NCT02406027|594630177|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
164620479|NCT02406027|594630178|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
164620480|NCT02406027|594630179|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
164620481|NCT02406027|594630180|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
164620482|NCT02406027|594630181|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
164620483|NCT02406027|594630182|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
164620484|NCT02406027|594630176|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
164620485|NCT02406027|594630177|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
164620486|NCT02406027|594630178|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
164620487|NCT02406027|594630179|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
164620488|NCT02406027|594630180|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
164620489|NCT02406027|594630181|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
164620490|NCT02406027|594630182|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
164620491|NCT02406027|594630176|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
164620492|NCT02406027|594630177|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
164620493|NCT02406027|594630178|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
164620494|NCT02406027|594630179|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
164620495|NCT02406027|594630180|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
164620496|NCT02406027|594630181|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
164620497|NCT02406027|594630182|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
164620498|NCT02406027|594630176|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
164620499|NCT02406027|594630177|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
164620500|NCT02406027|594630178|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
164620501|NCT02406027|594630179|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
164620502|NCT02406027|594630180|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
164620503|NCT02406027|594630181|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
164620504|NCT02406027|594630182|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
164620505|NCT02406027|594630176|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
164620506|NCT02406027|594630177|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
164620507|NCT02406027|594630178|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
164620508|NCT02406027|594630179|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
164620509|NCT02406027|594630180|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
164620510|NCT02406027|594630181|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
164620511|NCT02406027|594630182|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
164620512|NCT02406027|594630176|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
164620513|NCT02406027|594630177|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
164620514|NCT02406027|594630178|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
164620515|NCT02406027|594630179|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
164620516|NCT02406027|594630180|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
164620517|NCT02406027|594630181|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
164620518|NCT02406027|594630182|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
164620519|NCT02406027|594630176|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
164620520|NCT02406027|594630177|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
164620521|NCT02406027|594630178|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
164620522|NCT02406027|594630179|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
164620523|NCT02406027|594630180|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
164620524|NCT02406027|594630181|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
164620525|NCT02406027|594630182|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
164620526|NCT03559192|594630183|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
164620527|NCT03559192|594630184|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
164620528|NCT03559192|594630185|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
164620529|NCT03559192|594630183|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
164620530|NCT03559192|594630184|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
164620531|NCT03559192|594630185|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
164620532|NCT03559192|594630183|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
164620533|NCT03559192|594630184|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
164620534|NCT03559192|594630185|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
164620535|NCT03559192|594630183|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
164620536|NCT03559192|594630184|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
164620537|NCT03559192|594630185|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
164620538|NCT03559192|594630183|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
164620539|NCT03559192|594630184|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
164620540|NCT03559192|594630185|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
164620541|NCT03559192|594630183|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
164620542|NCT03559192|594630184|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
164620543|NCT03559192|594630185|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
164620544|NCT03559192|594630183|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
164620545|NCT03559192|594630184|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
164620546|NCT03559192|594630185|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
164620547|NCT03559192|594630183|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
164620548|NCT03559192|594630184|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
164620549|NCT03559192|594630185|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
164620550|NCT03559192|594630183|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
164620551|NCT03559192|594630184|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
164620552|NCT03559192|594630185|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
164620553|NCT01673373|594631828|FG000|Overall Study|Death|2|||
164620554|NCT00166504|594631829|FG000|Overall Study|Adverse Event|3|||
164620555|NCT00166504|594631830|FG001|Overall Study|Adverse Event|3|||
164620556|NCT00166504|594631829|FG000|Overall Study|Lost to Follow-up|1|||
164620557|NCT00166504|594631830|FG001|Overall Study|Lost to Follow-up|1|||
164620558|NCT00166504|594631829|FG000|Overall Study|Withdrawal by Subject|1|||
164620559|NCT00166504|594631830|FG001|Overall Study|Withdrawal by Subject|0|||
164620560|NCT03261037|594631833|FG000|Overall Study|Withdrawal by Subject|2|||
164620561|NCT03261037|594631834|FG001|Overall Study|Withdrawal by Subject|13|||
164620562|NCT03261037|594631835|FG002|Overall Study|Withdrawal by Subject|0|||
164620563|NCT03261037|594631836|FG003|Overall Study|Withdrawal by Subject|18|||
164620564|NCT03261037|594631833|FG000|Overall Study|Non-compliance with study procedures|0|||
164620565|NCT03261037|594631834|FG001|Overall Study|Non-compliance with study procedures|2|||
164620566|NCT03261037|594631835|FG002|Overall Study|Non-compliance with study procedures|0|||
164620567|NCT03261037|594631836|FG003|Overall Study|Non-compliance with study procedures|6|||
164620568|NCT03261037|594631833|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
164620569|NCT03261037|594631834|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
164620570|NCT03261037|594631835|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
164620571|NCT03261037|594631836|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
164620572|NCT03261037|594631833|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
164620573|NCT03261037|594631834|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
164620574|NCT03261037|594631835|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
164620575|NCT03261037|594631836|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
164620576|NCT03261037|594631833|FG000|Overall Study|Diagnosed but protocol deviation|1|||
164620577|NCT03261037|594631834|FG001|Overall Study|Diagnosed but protocol deviation|0|||
164620578|NCT03261037|594631835|FG002|Overall Study|Diagnosed but protocol deviation|0|||
164620579|NCT03261037|594631836|FG003|Overall Study|Diagnosed but protocol deviation|0|||
164620580|NCT03261037|594631833|FG000|Overall Study|Participant did not want to continue the study|0|||
164620581|NCT03261037|594631834|FG001|Overall Study|Participant did not want to continue the study|1|||
164620582|NCT03261037|594631835|FG002|Overall Study|Participant did not want to continue the study|0|||
164620583|NCT03261037|594631836|FG003|Overall Study|Participant did not want to continue the study|0|||
164620584|NCT03261037|594631833|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
164620585|NCT03261037|594631834|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
164620586|NCT03261037|594631835|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
164620587|NCT03261037|594631836|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
164620588|NCT03261037|594631833|FG000|Overall Study|Participant presented clinical improvement|0|||
164620589|NCT03261037|594631834|FG001|Overall Study|Participant presented clinical improvement|2|||
164620590|NCT03261037|594631835|FG002|Overall Study|Participant presented clinical improvement|0|||
164620591|NCT03261037|594631836|FG003|Overall Study|Participant presented clinical improvement|0|||
164620592|NCT03261037|594631833|FG000|Overall Study|Technical difficulties|0|||
164620593|NCT03261037|594631834|FG001|Overall Study|Technical difficulties|0|||
164620594|NCT03261037|594631835|FG002|Overall Study|Technical difficulties|0|||
164620595|NCT03261037|594631836|FG003|Overall Study|Technical difficulties|1|||
164620596|NCT03261037|594631833|FG000|Overall Study|Equipment failed to work|0|||
164620597|NCT03261037|594631834|FG001|Overall Study|Equipment failed to work|0|||
164620598|NCT03261037|594631835|FG002|Overall Study|Equipment failed to work|0|||
164620599|NCT03261037|594631836|FG003|Overall Study|Equipment failed to work|1|||
164620600|NCT03261037|594631833|FG000|Overall Study|End of study for participant and no follow up|0|||
164620601|NCT03261037|594631834|FG001|Overall Study|End of study for participant and no follow up|0|||
164620602|NCT03261037|594631835|FG002|Overall Study|End of study for participant and no follow up|0|||
164620603|NCT03261037|594631836|FG003|Overall Study|End of study for participant and no follow up|1|||
164620604|NCT03261037|594631833|FG000|Overall Study|Participant was too weak to continue in study|1|||
164620605|NCT03261037|594631834|FG001|Overall Study|Participant was too weak to continue in study|0|||
164620606|NCT03261037|594631835|FG002|Overall Study|Participant was too weak to continue in study|0|||
164620607|NCT03261037|594631836|FG003|Overall Study|Participant was too weak to continue in study|0|||
164620608|NCT04423718|594631837|FG000|Main Study|Adverse Event|9|||
164620609|NCT04423718|594631838|FG001|Main Study|Adverse Event|5|||
164620610|NCT04423718|594631839|FG002|Main Study|Adverse Event|8|||
164620611|NCT04423718|594631837|FG000|Main Study|Physician Decision|3|||
164620612|NCT04423718|594631838|FG001|Main Study|Physician Decision|3|||
164620613|NCT04423718|594631839|FG002|Main Study|Physician Decision|2|||
164620614|NCT04423718|594631837|FG000|Main Study|Protocol Violation|0|||
164620615|NCT04423718|594631838|FG001|Main Study|Protocol Violation|0|||
164620616|NCT04423718|594631839|FG002|Main Study|Protocol Violation|1|||
164620617|NCT04423718|594631837|FG000|Main Study|Lost to Follow-up|3|||
164620618|NCT04423718|594631838|FG001|Main Study|Lost to Follow-up|3|||
164620619|NCT04423718|594631839|FG002|Main Study|Lost to Follow-up|4|||
164620620|NCT04423718|594631837|FG000|Main Study|Lack of Efficacy|2|||
164620621|NCT04423718|594631838|FG001|Main Study|Lack of Efficacy|1|||
164620622|NCT04423718|594631839|FG002|Main Study|Lack of Efficacy|0|||
164620623|NCT04423718|594631837|FG000|Main Study|Withdrawal by Subject|14|||
164620624|NCT04423718|594631838|FG001|Main Study|Withdrawal by Subject|20|||
164620625|NCT04423718|594631839|FG002|Main Study|Withdrawal by Subject|20|||
164620626|NCT04423718|594631837|FG000|Main Study|Death|10|||
164620627|NCT04423718|594631838|FG001|Main Study|Death|7|||
164620628|NCT04423718|594631839|FG002|Main Study|Death|7|||
164620629|NCT04423718|594631837|FG000|Main Study|COVID-19 pandemic|2|||
164620630|NCT04423718|594631838|FG001|Main Study|COVID-19 pandemic|2|||
164522675|NCT00545753|594282671|FG002|Overall Study|Lost to Follow-up|12|||
164522676|NCT00545753|594282669|FG000|Overall Study|Protocol Violation|3|||
164522677|NCT00545753|594282670|FG001|Overall Study|Protocol Violation|1|||
164522678|NCT00545753|594282671|FG002|Overall Study|Protocol Violation|4|||
164522679|NCT04540887|594282672|FG000|Overall Study|Withdrawal by Subject|2|||
164522680|NCT00513305|594282673|FG000|Overall Study|Adverse Event|6|||
164522681|NCT00513305|594282674|FG001|Overall Study|Adverse Event|2|||
164522682|NCT00513305|594282673|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
164522683|NCT00513305|594282674|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
164522684|NCT00513305|594282673|FG000|Overall Study|Lack of Efficacy|8|||
164522685|NCT00513305|594282674|FG001|Overall Study|Lack of Efficacy|13|||
164522686|NCT00513305|594282673|FG000|Overall Study|Withdrawal by Subject|1|||
164522687|NCT00513305|594282674|FG001|Overall Study|Withdrawal by Subject|2|||
164522688|NCT00513305|594282673|FG000|Overall Study|Disease progression|8|||
164522689|NCT00513305|594282674|FG001|Overall Study|Disease progression|5|||
164522690|NCT00513305|594282673|FG000|Overall Study|Eligible for stem cell transplant|1|||
164522691|NCT00513305|594282674|FG001|Overall Study|Eligible for stem cell transplant|0|||
164522692|NCT00513305|594282673|FG000|Overall Study|Hematologic counts did not recover|1|||
164522693|NCT00513305|594282674|FG001|Overall Study|Hematologic counts did not recover|0|||
164522694|NCT00513305|594282673|FG000|Overall Study|Physician Decision|1|||
164522695|NCT00513305|594282674|FG001|Overall Study|Physician Decision|0|||
164522696|NCT00513305|594282673|FG000|Overall Study|Persistent hypocellularity|0|||
164522697|NCT00513305|594282674|FG001|Overall Study|Persistent hypocellularity|1|||
164522698|NCT00513305|594282673|FG000|Overall Study|Sponsor Decision|0|||
164522699|NCT00513305|594282674|FG001|Overall Study|Sponsor Decision|2|||
164522700|NCT01262027|594282676|FG000|Overall Study|Adverse Event|1|||
164522701|NCT01262027|594282676|FG000|Overall Study|Withdrawal by Subject|3|||
164522702|NCT01262027|594282676|FG000|Overall Study|Protocol Violation|1|||
164522703|NCT01011153|594282680|FG000|Overall Study|Less than 78 cases completed|8|||
164522704|NCT01011153|594282681|FG001|Overall Study|Less than 78 cases completed|11|||
164522705|NCT01011153|594282682|FG002|Overall Study|Less than 78 cases completed|9|||
164522706|NCT03014479|594282683|FG000|Overall Study|Adverse Event|0|||
164522707|NCT03014479|594282684|FG001|Overall Study|Adverse Event|1|||
164522708|NCT03014479|594282683|FG000|Overall Study|Voluntary Withdrawal|0|||
164522709|NCT03014479|594282684|FG001|Overall Study|Voluntary Withdrawal|2|||
164620631|NCT04423718|594631839|FG002|Main Study|COVID-19 pandemic|2|||
164620632|NCT04423718|594631837|FG000|Main Study|Other|7|||
164620633|NCT04423718|594631838|FG001|Main Study|Other|3|||
164620634|NCT04423718|594631839|FG002|Main Study|Other|2|||
164620635|NCT04423718|594631837|FG000|Extension Phase|Other|1|||
164620636|NCT04423718|594631838|FG001|Extension Phase|Other|0|||
164620637|NCT04423718|594631839|FG002|Extension Phase|Other|0|||
164620638|NCT04423718|594631837|FG000|Extension Phase|Logistical problems|0|||
164620639|NCT04423718|594631838|FG001|Extension Phase|Logistical problems|1|||
164620640|NCT04423718|594631839|FG002|Extension Phase|Logistical problems|1|||
164522710|NCT03014479|594282683|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
164522711|NCT03014479|594282684|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
164522712|NCT01081132|594282692|FG000|Overall Study|Lack of Efficacy|25|||
164620641|NCT04423718|594631837|FG000|Extension Phase|Physician Decision|1|||
164620642|NCT04423718|594631838|FG001|Extension Phase|Physician Decision|0|||
164620643|NCT04423718|594631839|FG002|Extension Phase|Physician Decision|1|||
164620644|NCT04423718|594631837|FG000|Extension Phase|Lack of Efficacy|2|||
164620645|NCT04423718|594631838|FG001|Extension Phase|Lack of Efficacy|0|||
164620646|NCT04423718|594631839|FG002|Extension Phase|Lack of Efficacy|1|||
164620647|NCT04423718|594631837|FG000|Extension Phase|Lost to Follow-up|0|||
164620648|NCT04423718|594631838|FG001|Extension Phase|Lost to Follow-up|2|||
164620649|NCT04423718|594631839|FG002|Extension Phase|Lost to Follow-up|3|||
164620650|NCT04423718|594631837|FG000|Extension Phase|Adverse Event|2|||
164620651|NCT04423718|594631838|FG001|Extension Phase|Adverse Event|3|||
164620652|NCT04423718|594631839|FG002|Extension Phase|Adverse Event|1|||
164620653|NCT04423718|594631837|FG000|Extension Phase|Death|4|||
164620654|NCT04423718|594631838|FG001|Extension Phase|Death|7|||
164620655|NCT04423718|594631839|FG002|Extension Phase|Death|2|||
164620656|NCT04423718|594631837|FG000|Extension Phase|Withdrawal by Subject|11|||
164620657|NCT04423718|594631838|FG001|Extension Phase|Withdrawal by Subject|11|||
164620658|NCT04423718|594631839|FG002|Extension Phase|Withdrawal by Subject|7|||
164620659|NCT00589602|594631843|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
164620660|NCT05298774|594631847|FG000|Overall Study|Physician Decision|3|||
164620661|NCT05298774|594631847|FG000|Overall Study|Withdrawal by Subject|2|||
164620662|NCT05298774|594631847|FG000|Overall Study|Lost to Follow-up|3|||
164620663|NCT05298774|594631847|FG000|Overall Study|Screen failure|1|||
164620664|NCT04992507|594631848|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
164620665|NCT04992507|594631849|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
164620666|NCT04992507|594631848|FG000|Overall Study|Death|0|||
164620667|NCT04992507|594631849|FG001|Overall Study|Death|1|||
164620668|NCT01058395|594631850|FG000|Overall Study|Death|2|||
164620669|NCT01058395|594631851|FG001|Overall Study|Death|1|||
164620670|NCT01058395|594631850|FG000|Overall Study|Lost to Follow-up|1|||
164620671|NCT01058395|594631851|FG001|Overall Study|Lost to Follow-up|0|||
164620672|NCT01266876|594631852|FG000|Overall Study|Adverse Event|0|||
164620673|NCT01266876|594631853|FG001|Overall Study|Adverse Event|0|||
164620674|NCT01266876|594631854|FG002|Overall Study|Adverse Event|0|||
164620675|NCT01266876|594631855|FG003|Overall Study|Adverse Event|1|||
164620676|NCT01266876|594631856|FG004|Overall Study|Adverse Event|0|||
164620677|NCT05016037|594631857|FG000|Overall Study|Lost to Follow-up|2|||
164620678|NCT00557323|594631858|FG000|Overall Study|Death|3|||
164620679|NCT00557323|594631858|FG000|Overall Study|Withdrawal by Subject|2|||
164620680|NCT00557323|594631858|FG000|Overall Study|Administrative change|2|||
164620681|NCT04007367|594631859|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
164620682|NCT04007367|594631860|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
164620683|NCT04007367|594631861|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
164620684|NCT04007367|594631859|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
164620685|NCT04007367|594631860|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
164620686|NCT04007367|594631861|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
164620687|NCT04007367|594631859|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
164620688|NCT04007367|594631860|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
164620689|NCT04007367|594631861|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
164620690|NCT04007367|594631859|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
164620691|NCT04007367|594631860|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
164620692|NCT04007367|594631861|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
164620693|NCT04007367|594631859|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
164620694|NCT04007367|594631860|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
164620695|NCT04007367|594631861|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
164620696|NCT02010567|594631864|FG000|Overall Study|Adverse Event|0|||
164620697|NCT02010567|594631865|FG001|Overall Study|Adverse Event|0|||
164620698|NCT02010567|594631866|FG002|Overall Study|Adverse Event|1|||
164620699|NCT02010567|594631867|FG003|Overall Study|Adverse Event|0|||
164620700|NCT02010567|594631868|FG004|Overall Study|Adverse Event|1|||
164620701|NCT00414973|594631869|FG000|Overall Study|Withdrawal by Subject|14|||
164620702|NCT00414973|594631870|FG001|Overall Study|Withdrawal by Subject|4|||
164620703|NCT00414973|594631871|FG002|Overall Study|Withdrawal by Subject|1|||
164620704|NCT00414973|594631872|FG003|Overall Study|Withdrawal by Subject|0|||
164620705|NCT00414973|594631869|FG000|Overall Study|Adverse Event|10|||
164620706|NCT00414973|594631870|FG001|Overall Study|Adverse Event|0|||
164620707|NCT00414973|594631871|FG002|Overall Study|Adverse Event|1|||
164620708|NCT00414973|594631872|FG003|Overall Study|Adverse Event|0|||
164620709|NCT00414973|594631869|FG000|Overall Study|Protocol Violation|3|||
164620710|NCT00414973|594631870|FG001|Overall Study|Protocol Violation|4|||
164620711|NCT00414973|594631871|FG002|Overall Study|Protocol Violation|0|||
164620712|NCT00414973|594631872|FG003|Overall Study|Protocol Violation|0|||
164620713|NCT00414973|594631869|FG000|Overall Study|Lost to Follow-up|0|||
164620714|NCT00414973|594631870|FG001|Overall Study|Lost to Follow-up|2|||
164620715|NCT00414973|594631871|FG002|Overall Study|Lost to Follow-up|0|||
164620716|NCT00414973|594631872|FG003|Overall Study|Lost to Follow-up|0|||
164620717|NCT00414973|594631869|FG000|Overall Study|Sponsor Decision|1|||
164620718|NCT00414973|594631870|FG001|Overall Study|Sponsor Decision|0|||
164522713|NCT01081132|594282693|FG001|Overall Study|Lack of Efficacy|9|||
164522714|NCT01081132|594282692|FG000|Overall Study|Withdrawal by Subject|13|||
164522715|NCT01081132|594282693|FG001|Overall Study|Withdrawal by Subject|16|||
164522716|NCT01081132|594282692|FG000|Overall Study|Lost to Follow-up|4|||
164522717|NCT01081132|594282693|FG001|Overall Study|Lost to Follow-up|11|||
164522718|NCT01081132|594282692|FG000|Overall Study|Adverse Event|3|||
164522719|NCT01081132|594282693|FG001|Overall Study|Adverse Event|9|||
164522720|NCT01081132|594282692|FG000|Overall Study|Non Compliance|4|||
164522721|NCT01081132|594282693|FG001|Overall Study|Non Compliance|2|||
164522722|NCT01081132|594282692|FG000|Overall Study|Lack Of Compliance|0|||
164522723|NCT01081132|594282693|FG001|Overall Study|Lack Of Compliance|1|||
164522724|NCT01081132|594282692|FG000|Overall Study|Missed Visits|1|||
164522725|NCT01081132|594282693|FG001|Overall Study|Missed Visits|1|||
164522726|NCT01081132|594282692|FG000|Overall Study|Stopped Taking Meds|2|||
164522727|NCT01081132|594282693|FG001|Overall Study|Stopped Taking Meds|0|||
164522728|NCT01081132|594282692|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
164522729|NCT01081132|594282693|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
164522730|NCT01081132|594282692|FG000|Overall Study|Declined Taper Phase|0|||
164522731|NCT01081132|594282693|FG001|Overall Study|Declined Taper Phase|1|||
164522732|NCT01081132|594282692|FG000|Overall Study|Protocol Violation|3|||
164522733|NCT01081132|594282693|FG001|Overall Study|Protocol Violation|1|||
164522734|NCT02101385|594282694|FG000|Study Treatment|Disease Progression|9|||
164522735|NCT02101385|594282695|FG001|Study Treatment|Disease Progression|3|||
164522736|NCT02101385|594282694|FG000|Study Treatment|Alternative therapy|0|||
164522737|NCT02101385|594282695|FG001|Study Treatment|Alternative therapy|1|||
164522738|NCT02101385|594282694|FG000|Study Treatment|No treatment, per protocol criteria|0|||
164522739|NCT02101385|594282695|FG001|Study Treatment|No treatment, per protocol criteria|4|||
164522740|NCT02101385|594282694|FG000|Study Treatment|Patient Non compliance|0|||
164522741|NCT02101385|594282695|FG001|Study Treatment|Patient Non compliance|2|||
164522742|NCT02101385|594282694|FG000|Study Treatment|Withdrawal by Subject|5|||
164522743|NCT02101385|594282695|FG001|Study Treatment|Withdrawal by Subject|2|||
164522744|NCT02101385|594282694|FG000|Study Treatment|screen failure|1|||
164522745|NCT02101385|594282695|FG001|Study Treatment|screen failure|0|||
164522746|NCT02101385|594282694|FG000|Study Treatment|AE/Side Effects/Complications|8|||
164522747|NCT02101385|594282695|FG001|Study Treatment|AE/Side Effects/Complications|0|||
164522748|NCT02101385|594282694|FG000|Study Treatment|Lost to Follow-up|1|||
164522749|NCT02101385|594282695|FG001|Study Treatment|Lost to Follow-up|0|||
164522750|NCT02101385|594282694|FG000|Study Treatment|Disease Progression before treatment|1|||
164522751|NCT02101385|594282695|FG001|Study Treatment|Disease Progression before treatment|0|||
164522752|NCT02101385|594282694|FG000|Study Treatment|Death|1|||
164522753|NCT02101385|594282695|FG001|Study Treatment|Death|0|||
164522754|NCT02101385|594282694|FG000|Follow up|Lost to Follow-up|4|||
164522755|NCT02101385|594282695|FG001|Follow up|Lost to Follow-up|9|||
164522756|NCT02101385|594282694|FG000|Follow up|Refused to follow up|5|||
164522757|NCT02101385|594282695|FG001|Follow up|Refused to follow up|4|||
164522758|NCT02101385|594282694|FG000|Follow up|Death|21|||
164522759|NCT02101385|594282695|FG001|Follow up|Death|39|||
164522760|NCT02101385|594282694|FG000|Follow up|study completed|33|||
164522761|NCT02101385|594282695|FG001|Follow up|study completed|52|||
164522762|NCT02101385|594282694|FG000|Follow up|screen failure|2|||
164522763|NCT02101385|594282695|FG001|Follow up|screen failure|0|||
164522764|NCT02101385|594282694|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
164522765|NCT02101385|594282695|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
164522766|NCT02101385|594282694|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
164522767|NCT02101385|594282695|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
164522768|NCT02101385|594282694|FG000|Follow up|Withdrawal by Subject|2|||
164522769|NCT02101385|594282695|FG001|Follow up|Withdrawal by Subject|2|||
164522770|NCT02101385|594282694|FG000|Follow up|PI requested closure of site|0|||
164522771|NCT02101385|594282695|FG001|Follow up|PI requested closure of site|5|||
164522772|NCT02489968|594282698|FG000|Open-label Treatment Period|Adverse Event|14|||
164522773|NCT02489968|594282699|FG001|Open-label Treatment Period|Adverse Event|7|||
164522774|NCT02489968|594282700|FG002|Open-label Treatment Period|Adverse Event|0|||
164522775|NCT02489968|594282701|FG003|Open-label Treatment Period|Adverse Event|0|||
164522776|NCT02489968|594282702|FG004|Open-label Treatment Period|Adverse Event|0|||
164522777|NCT02489968|594282703|FG005|Open-label Treatment Period|Adverse Event|0|||
164522778|NCT02489968|594282698|FG000|Open-label Treatment Period|Protocol Violation|2|||
164522779|NCT02489968|594282699|FG001|Open-label Treatment Period|Protocol Violation|2|||
164522780|NCT02489968|594282700|FG002|Open-label Treatment Period|Protocol Violation|0|||
164522781|NCT02489968|594282701|FG003|Open-label Treatment Period|Protocol Violation|0|||
164522782|NCT02489968|594282702|FG004|Open-label Treatment Period|Protocol Violation|0|||
164522783|NCT02489968|594282703|FG005|Open-label Treatment Period|Protocol Violation|0|||
164522784|NCT02489968|594282698|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
164522785|NCT02489968|594282699|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
164522786|NCT02489968|594282700|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
164620719|NCT00414973|594631871|FG002|Overall Study|Sponsor Decision|0|||
164620720|NCT00414973|594631872|FG003|Overall Study|Sponsor Decision|0|||
164620721|NCT00414973|594631869|FG000|Overall Study|Death|0|||
164620722|NCT00414973|594631870|FG001|Overall Study|Death|0|||
164620723|NCT00414973|594631871|FG002|Overall Study|Death|1|||
164620724|NCT00414973|594631872|FG003|Overall Study|Death|0|||
164620725|NCT01466062|594631873|FG000|Overall Study|Adverse Event|1|||
164620726|NCT01466062|594631873|FG000|Overall Study|Withdrawal by Subject|1|||
164620727|NCT03733249|594631874|FG000|Overall Study|Death|7|||
164620728|NCT03733249|594631874|FG000|Overall Study|Disease relapse|16|||
164620729|NCT03733249|594631874|FG000|Overall Study|Lost to Follow-up|4|||
164620730|NCT03733249|594631874|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
164620731|NCT03733249|594631874|FG000|Overall Study|Withdrawal by Subject|1|||
164620732|NCT04476108|594631875|FG000|Overall Study|Adverse Event|4|||
164620733|NCT04476108|594631876|FG001|Overall Study|Adverse Event|1|||
164620734|NCT04476108|594631875|FG000|Overall Study|Lost to Follow-up|1|||
164620735|NCT04476108|594631876|FG001|Overall Study|Lost to Follow-up|0|||
164620736|NCT04476108|594631875|FG000|Overall Study|Inadvertent Enrollment|1|||
164620737|NCT04476108|594631876|FG001|Overall Study|Inadvertent Enrollment|0|||
164620738|NCT04476108|594631875|FG000|Overall Study|Protocol Violation|1|||
164620739|NCT04476108|594631876|FG001|Overall Study|Protocol Violation|1|||
164620740|NCT04476108|594631875|FG000|Overall Study|Withdrawal by Subject|1|||
164620741|NCT04476108|594631876|FG001|Overall Study|Withdrawal by Subject|1|||
164620742|NCT00606229|594631880|FG000|Overall Study|Adverse Event|11|||
164620743|NCT00606229|594631880|FG000|Overall Study|Lack of Efficacy|1|||
164620744|NCT00606229|594631880|FG000|Overall Study|Withdrawal by Subject|4|||
164620745|NCT00606229|594631880|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
164620746|NCT00606229|594631880|FG000|Overall Study|change of residence or other commitments|2|||
164620747|NCT03523715|594631881|FG000|Overall Study|Lost to Follow-up|11|||
164620748|NCT03523715|594631882|FG001|Overall Study|Lost to Follow-up|14|||
164620749|NCT03523715|594631881|FG000|Overall Study|Did not meet inclusion criteria|1|||
164620750|NCT03523715|594631882|FG001|Overall Study|Did not meet inclusion criteria|0|||
164620751|NCT03523715|594631881|FG000|Overall Study|Internally inconsistent reporting|0|||
164620752|NCT03523715|594631882|FG001|Overall Study|Internally inconsistent reporting|2|||
164620753|NCT01526928|594631883|FG000|Overall Study|Progressive Disease|35|||
164620754|NCT01526928|594631884|FG001|Overall Study|Progressive Disease|17|||
164620755|NCT01526928|594631885|FG002|Overall Study|Progressive Disease|150|||
164620756|NCT01526928|594631886|FG003|Overall Study|Progressive Disease|182|||
164620757|NCT01526928|594631887|FG004|Overall Study|Progressive Disease|76|||
164620758|NCT01526928|594631888|FG005|Overall Study|Progressive Disease|4|||
164620759|NCT01526928|594631883|FG000|Overall Study|Adverse Event|2|||
164620760|NCT01526928|594631884|FG001|Overall Study|Adverse Event|1|||
164620761|NCT01526928|594631885|FG002|Overall Study|Adverse Event|29|||
164620762|NCT01526928|594631886|FG003|Overall Study|Adverse Event|40|||
164620763|NCT01526928|594631887|FG004|Overall Study|Adverse Event|13|||
164620764|NCT01526928|594631888|FG005|Overall Study|Adverse Event|2|||
164620765|NCT01526928|594631883|FG000|Overall Study|Death|0|||
164620766|NCT01526928|594631884|FG001|Overall Study|Death|0|||
164620767|NCT01526928|594631885|FG002|Overall Study|Death|3|||
164620768|NCT01526928|594631886|FG003|Overall Study|Death|0|||
164620769|NCT01526928|594631887|FG004|Overall Study|Death|0|||
164620770|NCT01526928|594631888|FG005|Overall Study|Death|0|||
164620771|NCT01526928|594631883|FG000|Overall Study|Withdrawal by Subject|1|||
164147614|NCT03685344|592902087|FG003|Overall Study|Death|0|||
164620772|NCT01526928|594631884|FG001|Overall Study|Withdrawal by Subject|0|||
164620773|NCT01526928|594631885|FG002|Overall Study|Withdrawal by Subject|13|||
164620774|NCT01526928|594631886|FG003|Overall Study|Withdrawal by Subject|11|||
164620775|NCT01526928|594631887|FG004|Overall Study|Withdrawal by Subject|3|||
164620776|NCT01526928|594631888|FG005|Overall Study|Withdrawal by Subject|0|||
164620777|NCT01526928|594631883|FG000|Overall Study|Physician Decision|0|||
164620778|NCT01526928|594631884|FG001|Overall Study|Physician Decision|0|||
164620779|NCT01526928|594631885|FG002|Overall Study|Physician Decision|2|||
164620780|NCT01526928|594631886|FG003|Overall Study|Physician Decision|5|||
164620781|NCT01526928|594631887|FG004|Overall Study|Physician Decision|0|||
164620782|NCT01526928|594631888|FG005|Overall Study|Physician Decision|0|||
164620783|NCT01526928|594631883|FG000|Overall Study|Other Reason|0|||
164620784|NCT01526928|594631884|FG001|Overall Study|Other Reason|1|||
164620785|NCT01526928|594631885|FG002|Overall Study|Other Reason|11|||
164620786|NCT01526928|594631886|FG003|Overall Study|Other Reason|4|||
164620787|NCT01526928|594631887|FG004|Overall Study|Other Reason|1|||
164620788|NCT01526928|594631888|FG005|Overall Study|Other Reason|0|||
164620789|NCT01526928|594631883|FG000|Overall Study|Lost to Follow-up|0|||
164620790|NCT01526928|594631884|FG001|Overall Study|Lost to Follow-up|0|||
164620791|NCT01526928|594631885|FG002|Overall Study|Lost to Follow-up|0|||
164620792|NCT01526928|594631886|FG003|Overall Study|Lost to Follow-up|1|||
164620793|NCT01526928|594631887|FG004|Overall Study|Lost to Follow-up|0|||
164620794|NCT01526928|594631888|FG005|Overall Study|Lost to Follow-up|0|||
164620795|NCT01526928|594631883|FG000|Overall Study|Protocol Deviation|0|||
164620796|NCT01526928|594631884|FG001|Overall Study|Protocol Deviation|0|||
164620797|NCT01526928|594631885|FG002|Overall Study|Protocol Deviation|0|||
164620798|NCT01526928|594631886|FG003|Overall Study|Protocol Deviation|2|||
164620799|NCT01526928|594631887|FG004|Overall Study|Protocol Deviation|0|||
164620800|NCT01526928|594631888|FG005|Overall Study|Protocol Deviation|0|||
164620801|NCT01526928|594631883|FG000|Overall Study|Missing|0|||
164620802|NCT01526928|594631884|FG001|Overall Study|Missing|0|||
164620803|NCT01526928|594631885|FG002|Overall Study|Missing|1|||
164620804|NCT01526928|594631886|FG003|Overall Study|Missing|0|||
164620805|NCT01526928|594631887|FG004|Overall Study|Missing|2|||
164620806|NCT01526928|594631888|FG005|Overall Study|Missing|0|||
164620807|NCT00942422|594631889|FG000|Overall Study|Withdrawal by Subject|1|||
164620808|NCT00942422|594631889|FG000|Overall Study|Death|1|||
164620809|NCT00942422|594631889|FG000|Overall Study|Progressive diease|1|||
164620810|NCT01947894|594631897|FG000|Overall Study|Other|3|||
164620811|NCT01947894|594631898|FG001|Overall Study|Other|4|||
164620812|NCT01947894|594631899|FG002|Overall Study|Other|3|||
164620813|NCT01947894|594631897|FG000|Overall Study|Withdrawal by Subject|12|||
164620814|NCT01947894|594631898|FG001|Overall Study|Withdrawal by Subject|4|||
164620815|NCT01947894|594631899|FG002|Overall Study|Withdrawal by Subject|1|||
164620816|NCT01947894|594631897|FG000|Overall Study|Death|12|||
164620817|NCT01947894|594631898|FG001|Overall Study|Death|1|||
164620818|NCT01947894|594631899|FG002|Overall Study|Death|0|||
164620819|NCT01947894|594631897|FG000|Overall Study|Physician Decision|2|||
164620820|NCT01947894|594631898|FG001|Overall Study|Physician Decision|0|||
164620821|NCT01947894|594631899|FG002|Overall Study|Physician Decision|0|||
164620822|NCT01947894|594631897|FG000|Overall Study|Adverse Event|5|||
164620823|NCT01947894|594631898|FG001|Overall Study|Adverse Event|1|||
164620824|NCT01947894|594631899|FG002|Overall Study|Adverse Event|0|||
164620825|NCT01947894|594631897|FG000|Overall Study|Switched to other growth hormone brand|53|||
164620826|NCT01947894|594631898|FG001|Overall Study|Switched to other growth hormone brand|8|||
164620827|NCT01947894|594631899|FG002|Overall Study|Switched to other growth hormone brand|23|||
164620828|NCT02829775|594631900|FG000|Overall Study|Death|1|||
164620829|NCT02829775|594631900|FG000|Overall Study|Withdrawal by Subject|3|||
164620830|NCT02829775|594631900|FG000|Overall Study|Disease remission|1|||
164620831|NCT02725268|594631901|FG000|Overall Study|Death|58|||
164620832|NCT02725268|594631902|FG001|Overall Study|Death|59|||
164620833|NCT02725268|594631903|FG002|Overall Study|Death|30|||
164620834|NCT02725268|594631904|FG003|Overall Study|Death|16|||
164620835|NCT02725268|594631901|FG000|Overall Study|Lost to Follow-up|4|||
164620836|NCT02725268|594631902|FG001|Overall Study|Lost to Follow-up|3|||
164620837|NCT02725268|594631903|FG002|Overall Study|Lost to Follow-up|0|||
164620838|NCT02725268|594631904|FG003|Overall Study|Lost to Follow-up|1|||
164620839|NCT02725268|594631901|FG000|Overall Study|Site Terminated by Sponsor|0|||
164620840|NCT02725268|594631902|FG001|Overall Study|Site Terminated by Sponsor|1|||
164620841|NCT02725268|594631903|FG002|Overall Study|Site Terminated by Sponsor|0|||
164620842|NCT02725268|594631904|FG003|Overall Study|Site Terminated by Sponsor|0|||
164620843|NCT02725268|594631901|FG000|Overall Study|Withdrawal by Subject|8|||
164620844|NCT02725268|594631902|FG001|Overall Study|Withdrawal by Subject|6|||
164620845|NCT02725268|594631903|FG002|Overall Study|Withdrawal by Subject|8|||
164620846|NCT02725268|594631904|FG003|Overall Study|Withdrawal by Subject|1|||
164620847|NCT02725268|594631901|FG000|Overall Study|Reason not Specified|2|||
164147693|NCT03910673|592902127|FG003|Overall Study|Adverse Event|2|||
164620848|NCT02725268|594631902|FG001|Overall Study|Reason not Specified|1|||
164620849|NCT02725268|594631903|FG002|Overall Study|Reason not Specified|0|||
164620850|NCT02725268|594631904|FG003|Overall Study|Reason not Specified|0|||
164620851|NCT01188811|594631911|FG000|Overall Study|Withdrawal by Subject|0|||
164620852|NCT01188811|594631912|FG001|Overall Study|Withdrawal by Subject|2|||
164620853|NCT01188811|594631911|FG000|Overall Study|Adverse Event|6|||
164620854|NCT01188811|594631912|FG001|Overall Study|Adverse Event|0|||
164620855|NCT00654368|594631913|FG000|Overall Study|Ineligibility determined|6|||
164620856|NCT00654368|594631914|FG001|Overall Study|Ineligibility determined|0|||
164620857|NCT00654368|594631915|FG002|Overall Study|Ineligibility determined|0|||
164620858|NCT00654368|594631913|FG000|Overall Study|Protocol deviation|3|||
164620859|NCT00654368|594631914|FG001|Overall Study|Protocol deviation|2|||
164620860|NCT00654368|594631915|FG002|Overall Study|Protocol deviation|1|||
164620861|NCT00654368|594631913|FG000|Overall Study|Non-compliance|2|||
164620862|NCT00654368|594631914|FG001|Overall Study|Non-compliance|1|||
164620863|NCT00654368|594631915|FG002|Overall Study|Non-compliance|2|||
164620864|NCT00654368|594631913|FG000|Overall Study|Withdrawal by Subject|5|||
164620865|NCT00654368|594631914|FG001|Overall Study|Withdrawal by Subject|2|||
164620866|NCT00654368|594631915|FG002|Overall Study|Withdrawal by Subject|2|||
164620867|NCT00654368|594631913|FG000|Overall Study|Disease progression|21|||
164620868|NCT00654368|594631914|FG001|Overall Study|Disease progression|31|||
164620869|NCT00654368|594631915|FG002|Overall Study|Disease progression|13|||
164620870|NCT00654368|594631913|FG000|Overall Study|Requirement for alternative therapy|1|||
164620871|NCT00654368|594631914|FG001|Overall Study|Requirement for alternative therapy|1|||
164620872|NCT00654368|594631915|FG002|Overall Study|Requirement for alternative therapy|1|||
164620873|NCT00654368|594631913|FG000|Overall Study|Physician Decision|0|||
164620874|NCT00654368|594631914|FG001|Overall Study|Physician Decision|0|||
164620875|NCT00654368|594631915|FG002|Overall Study|Physician Decision|2|||
164620876|NCT00654368|594631913|FG000|Overall Study|Death|1|||
164620877|NCT00654368|594631914|FG001|Overall Study|Death|0|||
164620878|NCT00654368|594631915|FG002|Overall Study|Death|0|||
164620879|NCT00654368|594631913|FG000|Overall Study|Pregnancy|0|||
164620880|NCT00654368|594631914|FG001|Overall Study|Pregnancy|0|||
164620881|NCT00654368|594631915|FG002|Overall Study|Pregnancy|2|||
164620882|NCT00654368|594631913|FG000|Overall Study|Other|0|||
164620883|NCT00654368|594631914|FG001|Overall Study|Other|2|||
164620884|NCT00654368|594631915|FG002|Overall Study|Other|3|||
164620885|NCT00654368|594631913|FG000|Overall Study|Adverse Event|14|||
164620886|NCT00654368|594631914|FG001|Overall Study|Adverse Event|9|||
164620887|NCT00654368|594631915|FG002|Overall Study|Adverse Event|6|||
164620888|NCT04228445|594631916|FG000|Overall Study|Lost to Follow-up|1|||
164620889|NCT04228445|594631917|FG001|Overall Study|Lost to Follow-up|1|||
164620890|NCT04228445|594631916|FG000|Overall Study|Physician Decision|1|||
164620891|NCT04228445|594631917|FG001|Overall Study|Physician Decision|2|||
164620892|NCT04228445|594631916|FG000|Overall Study|Withdrawal by Subject|0|||
164620893|NCT04228445|594631917|FG001|Overall Study|Withdrawal by Subject|1|||
164620894|NCT04228445|594631916|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
164620895|NCT04228445|594631917|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
164620896|NCT01307046|594631924|FG000|Overall Study|Adverse Event|3|||
164620897|NCT01307046|594631925|FG001|Overall Study|Adverse Event|3|||
164620898|NCT01307046|594631924|FG000|Overall Study|Lack of Efficacy|0|||
164620899|NCT01307046|594631925|FG001|Overall Study|Lack of Efficacy|2|||
164620900|NCT01307046|594631924|FG000|Overall Study|Physician Decision|2|||
164620901|NCT01307046|594631925|FG001|Overall Study|Physician Decision|0|||
164620902|NCT01307046|594631924|FG000|Overall Study|Withdrawal by Subject|1|||
164620903|NCT01307046|594631925|FG001|Overall Study|Withdrawal by Subject|1|||
164620904|NCT01307046|594631924|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
164620905|NCT01307046|594631925|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
164620906|NCT01307046|594631924|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
164620907|NCT01307046|594631925|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
164620908|NCT04035473|594631927|FG000|Screening/Baseline|Death|0|||
164620909|NCT04035473|594631928|FG001|Screening/Baseline|Death|1|||
164620910|NCT04035473|594631927|FG000|Screening/Baseline|Adverse Event|0|||
164620911|NCT04035473|594631928|FG001|Screening/Baseline|Adverse Event|1|||
164620912|NCT04035473|594631927|FG000|Follow-up Period|Adverse Event|2|||
164620913|NCT04035473|594631928|FG001|Follow-up Period|Adverse Event|0|||
164620914|NCT00397891|594631929|FG000|Overall Study|Withdrawal by Subject|1|||
164620915|NCT00397891|594631930|FG001|Overall Study|Withdrawal by Subject|0|||
164620916|NCT00397891|594631931|FG002|Overall Study|Withdrawal by Subject|0|||
164620917|NCT00397891|594631932|FG003|Overall Study|Withdrawal by Subject|0|||
164620918|NCT00397891|594631933|FG004|Overall Study|Withdrawal by Subject|1|||
164620919|NCT00796224|594631936|FG000|Overall Study|Adverse Event|1|||
164620920|NCT00796224|594631937|FG001|Overall Study|Adverse Event|0|||
164620921|NCT00796224|594631936|FG000|Overall Study|Protocol Violation|0|||
164620922|NCT00796224|594631937|FG001|Overall Study|Protocol Violation|1|||
164620923|NCT02569398|594631942|FG000|Overall Study|Adverse Event|0|||
164620924|NCT02569398|594631943|FG001|Overall Study|Adverse Event|1|||
164620925|NCT02569398|594631944|FG002|Overall Study|Adverse Event|6|||
164620926|NCT02569398|594631942|FG000|Overall Study|Withdrawal by Subject|43|||
164620927|NCT02569398|594631943|FG001|Overall Study|Withdrawal by Subject|43|||
164620928|NCT02569398|594631944|FG002|Overall Study|Withdrawal by Subject|30|||
164620929|NCT02569398|594631942|FG000|Overall Study|Study terminated by sponsor|130|||
164620930|NCT02569398|594631943|FG001|Overall Study|Study terminated by sponsor|131|||
164620931|NCT02569398|594631944|FG002|Overall Study|Study terminated by sponsor|134|||
164620932|NCT02569398|594631942|FG000|Overall Study|Other|12|||
164620933|NCT02569398|594631943|FG001|Overall Study|Other|14|||
164620934|NCT02569398|594631944|FG002|Overall Study|Other|13|||
164620935|NCT02571972|594631947|FG000|Overall Study|Protocol Violation|2|||
164620936|NCT02571972|594631947|FG000|Overall Study|Withdrawal by Subject|2|||
164620937|NCT04363944|594631948|FG000|Overall Study|Withdrawal by Subject|2|||
164620938|NCT04363944|594631949|FG001|Overall Study|Withdrawal by Subject|0|||
164620939|NCT03517722|594631950|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
164620940|NCT03517722|594631951|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
164620941|NCT03517722|594631950|FG000|Double Blind Period: Week 0-52|Death|0|||
164620942|NCT03517722|594631951|FG001|Double Blind Period: Week 0-52|Death|4|||
164620943|NCT03517722|594631950|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
164620944|NCT03517722|594631951|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
164620945|NCT03517722|594631950|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
164620946|NCT03517722|594631951|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
164620947|NCT03517722|594631950|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
164620948|NCT03517722|594631951|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
164620949|NCT03517722|594631950|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
164620950|NCT03517722|594631951|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
164620951|NCT03517722|594631950|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
164620952|NCT03517722|594631951|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
164620953|NCT03517722|594631950|FG000|Double Blind Period: Week 0-52|Other|4|||
164620954|NCT03517722|594631951|FG001|Double Blind Period: Week 0-52|Other|3|||
164620955|NCT03517722|594631950|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
164620956|NCT03517722|594631951|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
164620957|NCT03517722|594631950|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
164620958|NCT03517722|594631951|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
164620959|NCT03517722|594631950|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
164620960|NCT03517722|594631951|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
164620961|NCT03517722|594631950|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
164620962|NCT03517722|594631951|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
164620963|NCT03517722|594631950|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
164522787|NCT02489968|594282701|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
164522788|NCT02489968|594282702|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
164522789|NCT02489968|594282703|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
164522790|NCT02489968|594282698|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
164522791|NCT02489968|594282699|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
164522792|NCT02489968|594282700|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
164522793|NCT02489968|594282701|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
164522794|NCT02489968|594282702|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
164522795|NCT02489968|594282703|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
164522796|NCT02489968|594282698|FG000|Open-label Treatment Period|Other than specified above|204|||
164522797|NCT02489968|594282699|FG001|Open-label Treatment Period|Other than specified above|189|||
164522798|NCT02489968|594282700|FG002|Open-label Treatment Period|Other than specified above|0|||
164522799|NCT02489968|594282701|FG003|Open-label Treatment Period|Other than specified above|0|||
164522800|NCT02489968|594282702|FG004|Open-label Treatment Period|Other than specified above|0|||
164522801|NCT02489968|594282703|FG005|Open-label Treatment Period|Other than specified above|0|||
164522802|NCT02489968|594282698|FG000|Double-blind Treatment Period|Adverse Event|0|||
164522803|NCT02489968|594282699|FG001|Double-blind Treatment Period|Adverse Event|0|||
164522804|NCT02489968|594282700|FG002|Double-blind Treatment Period|Adverse Event|2|||
164522805|NCT02489968|594282701|FG003|Double-blind Treatment Period|Adverse Event|6|||
164522806|NCT02489968|594282702|FG004|Double-blind Treatment Period|Adverse Event|4|||
164522807|NCT02489968|594282703|FG005|Double-blind Treatment Period|Adverse Event|5|||
164522808|NCT02489968|594282698|FG000|Double-blind Treatment Period|Protocol Violation|0|||
164522809|NCT02489968|594282699|FG001|Double-blind Treatment Period|Protocol Violation|0|||
164522810|NCT02489968|594282700|FG002|Double-blind Treatment Period|Protocol Violation|0|||
164522811|NCT02489968|594282701|FG003|Double-blind Treatment Period|Protocol Violation|0|||
164522812|NCT02489968|594282702|FG004|Double-blind Treatment Period|Protocol Violation|1|||
164522813|NCT02489968|594282703|FG005|Double-blind Treatment Period|Protocol Violation|1|||
164522814|NCT02489968|594282698|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
164522815|NCT02489968|594282699|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
164522816|NCT02489968|594282700|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
164522817|NCT02489968|594282701|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
164522818|NCT02489968|594282702|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
164522819|NCT02489968|594282703|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
164522820|NCT02489968|594282698|FG000|Double-blind Treatment Period|Other than specified above|0|||
164522821|NCT02489968|594282699|FG001|Double-blind Treatment Period|Other than specified above|0|||
164522822|NCT02489968|594282700|FG002|Double-blind Treatment Period|Other than specified above|0|||
164522823|NCT02489968|594282701|FG003|Double-blind Treatment Period|Other than specified above|0|||
164522824|NCT02489968|594282702|FG004|Double-blind Treatment Period|Other than specified above|1|||
164522825|NCT02489968|594282703|FG005|Double-blind Treatment Period|Other than specified above|0|||
164522826|NCT04664400|594282708|FG000|Overall Study|Withdrawal by Subject|2|||
164522827|NCT03973931|594282709|FG000|Overall Study|Lost to Follow-up|47|||
164522828|NCT03973931|594282710|FG001|Overall Study|Lost to Follow-up|63|||
164522829|NCT03973931|594282711|FG002|Overall Study|Lost to Follow-up|51|||
164522830|NCT03973931|594282712|FG003|Overall Study|Lost to Follow-up|54|||
164522831|NCT03973931|594282709|FG000|Overall Study|opted out|6|||
164522832|NCT03973931|594282710|FG001|Overall Study|opted out|5|||
164522833|NCT03973931|594282711|FG002|Overall Study|opted out|5|||
164522834|NCT03973931|594282712|FG003|Overall Study|opted out|1|||
164522835|NCT01982448|594282713|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
164522836|NCT01982448|594282714|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
164522837|NCT01982448|594282713|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
164522838|NCT01982448|594282714|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
164522839|NCT01982448|594282713|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
164522840|NCT01982448|594282714|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
164522841|NCT01982448|594282713|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
164522842|NCT01982448|594282714|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
164522843|NCT02594163|594283960|FG000|Treatment Period|Progressive disease|2|||
164522844|NCT02594163|594283961|FG001|Treatment Period|Progressive disease|3|||
164522845|NCT02594163|594283960|FG000|Treatment Period|Adverse Event|1|||
164522846|NCT02594163|594283961|FG001|Treatment Period|Adverse Event|5|||
164522847|NCT02594163|594283960|FG000|Treatment Period|Physician Decision|1|||
164522848|NCT02594163|594283961|FG001|Treatment Period|Physician Decision|3|||
164522849|NCT02594163|594283960|FG000|Treatment Period|Study termination by sponsor|2|||
164522850|NCT02594163|594283961|FG001|Treatment Period|Study termination by sponsor|1|||
164522851|NCT02594163|594283960|FG000|Treatment Period|Other, Non-AE|1|||
164522852|NCT02594163|594283961|FG001|Treatment Period|Other, Non-AE|0|||
164522853|NCT02594163|594283960|FG000|Follow-up Period|Withdrawal by Subject|0|||
164522854|NCT02594163|594283961|FG001|Follow-up Period|Withdrawal by Subject|1|||
164522855|NCT02594163|594283960|FG000|Follow-up Period|Study Termination by Sponsor|6|||
164522856|NCT02594163|594283961|FG001|Follow-up Period|Study Termination by Sponsor|4|||
164620964|NCT03517722|594631951|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
164620965|NCT02177812|594631954|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
164620966|NCT02177812|594631955|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
164620967|NCT02177812|594631956|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
164620968|NCT02177812|594631957|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
164620969|NCT02177812|594631958|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
164620970|NCT02177812|594631959|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
164620971|NCT02177812|594631960|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
164620972|NCT02177812|594631961|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
164620973|NCT02177812|594631962|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
164620974|NCT02177812|594631954|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
164620975|NCT02177812|594631955|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
164620976|NCT02177812|594631956|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
164620977|NCT02177812|594631957|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
164620978|NCT02177812|594631958|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
164620979|NCT02177812|594631959|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
164620980|NCT02177812|594631960|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
164620981|NCT02177812|594631961|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
164620982|NCT02177812|594631962|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
164620983|NCT02177812|594631954|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
164620984|NCT02177812|594631955|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
164620985|NCT02177812|594631956|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
164620986|NCT02177812|594631957|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
164620987|NCT02177812|594631958|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
164620988|NCT02177812|594631959|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
164620989|NCT02177812|594631960|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
164620990|NCT02177812|594631961|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
164522857|NCT02594163|594283960|FG000|Follow-up Period|Lost to Follow-up|1|||
164522858|NCT02594163|594283961|FG001|Follow-up Period|Lost to Follow-up|0|||
164522859|NCT02594163|594283960|FG000|Follow-up Period|Death|2|||
164522860|NCT02594163|594283961|FG001|Follow-up Period|Death|5|||
164522861|NCT02594163|594283960|FG000|Follow-up Period|Adverse Event|0|||
164522862|NCT02594163|594283961|FG001|Follow-up Period|Adverse Event|1|||
164522863|NCT02594163|594283960|FG000|Follow-up Period|Progressive Disease|2|||
164522864|NCT02594163|594283961|FG001|Follow-up Period|Progressive Disease|0|||
164522865|NCT02594163|594283960|FG000|Follow-up Period|Physician Decision|0|||
164522866|NCT02594163|594283961|FG001|Follow-up Period|Physician Decision|1|||
164522867|NCT01342341|594283962|FG000|Overall Study|Lost to Follow-up|4|||
164522868|NCT01342341|594283963|FG001|Overall Study|Lost to Follow-up|4|||
164522869|NCT01022268|594283966|FG000|Overall Study|Withdrawal by Subject|1|||
164522870|NCT01022268|594283967|FG001|Overall Study|Withdrawal by Subject|0|||
164522871|NCT01022268|594283966|FG000|Overall Study|Withdrawal by Subject|1|||
164522872|NCT01022268|594283967|FG001|Overall Study|Withdrawal by Subject|0|||
164522873|NCT00734097|594283968|FG000|Screening|Protocol Violation|12|||
164522874|NCT00734097|594283968|FG000|Screening|Withdrawal by Subject|5|||
164522875|NCT00734097|594283968|FG000|Screening|Lost to Follow-up|2|||
164522876|NCT00734097|594283968|FG000|Screening|Unconfirmed pregnancy|1|||
164522877|NCT00734097|594283968|FG000|Open Label|Lost to Follow-up|7|||
164522878|NCT00734097|594283968|FG000|Open Label|Withdrawal by Subject|5|||
164522879|NCT00734097|594283968|FG000|Open Label|Protocol Violation|4|||
164522880|NCT02233543|594283971|FG000|Period 1|Withdrawal by Subject|1|||
164522881|NCT02233543|594283972|FG001|Period 1|Withdrawal by Subject|0|||
164522882|NCT02233543|594283971|FG000|Period 1|Participants required other treatment.|2|||
164522883|NCT02233543|594283972|FG001|Period 1|Participants required other treatment.|3|||
164522884|NCT02233543|594283971|FG000|Period 2|Adverse Event|1|||
164522885|NCT02233543|594283972|FG001|Period 2|Adverse Event|0|||
164522886|NCT02233543|594283971|FG000|Period 2|Participant required other treatment.|0|||
164522887|NCT02233543|594283972|FG001|Period 2|Participant required other treatment.|1|||
164522888|NCT02233543|594283971|FG000|Period 2|COPD exacerbation|1|||
164522889|NCT02233543|594283972|FG001|Period 2|COPD exacerbation|0|||
164522890|NCT01302067|594283973|FG000|Overall Study|Death|0|||
164522891|NCT01302067|594283974|FG001|Overall Study|Death|0|||
164522892|NCT01302067|594283975|FG002|Overall Study|Death|1|||
164522893|NCT01302067|594283973|FG000|Overall Study|Physician Decision|9|||
164522894|NCT01302067|594283974|FG001|Overall Study|Physician Decision|5|||
164522895|NCT01302067|594283975|FG002|Overall Study|Physician Decision|14|||
164522896|NCT01302067|594283973|FG000|Overall Study|Lack of Efficacy|8|||
164522897|NCT01302067|594283974|FG001|Overall Study|Lack of Efficacy|4|||
164522898|NCT01302067|594283975|FG002|Overall Study|Lack of Efficacy|2|||
164522899|NCT01302067|594283973|FG000|Overall Study|Lost to Follow-up|9|||
164522900|NCT01302067|594283974|FG001|Overall Study|Lost to Follow-up|4|||
164522901|NCT01302067|594283975|FG002|Overall Study|Lost to Follow-up|15|||
164522902|NCT01302067|594283973|FG000|Overall Study|Withdrawal by Subject|13|||
164522903|NCT01302067|594283974|FG001|Overall Study|Withdrawal by Subject|6|||
164522904|NCT01302067|594283975|FG002|Overall Study|Withdrawal by Subject|10|||
164522905|NCT01302067|594283973|FG000|Overall Study|Other|1|||
164522906|NCT01302067|594283974|FG001|Overall Study|Other|1|||
164522907|NCT01302067|594283975|FG002|Overall Study|Other|3|||
164522908|NCT01302067|594283973|FG000|Overall Study|Protocol Violation|11|||
164522909|NCT01302067|594283974|FG001|Overall Study|Protocol Violation|0|||
164522910|NCT01302067|594283975|FG002|Overall Study|Protocol Violation|8|||
164522911|NCT01302067|594283973|FG000|Overall Study|Adverse Event|27|||
164522912|NCT01302067|594283974|FG001|Overall Study|Adverse Event|14|||
164522913|NCT01302067|594283975|FG002|Overall Study|Adverse Event|45|||
164522914|NCT01034176|594283976|FG000|Overall Study|Physician Decision|2|||
164522915|NCT01034176|594283977|FG001|Overall Study|Physician Decision|0|||
164522916|NCT01034176|594283976|FG000|Overall Study|Withdrawal by Subject|0|||
164522917|NCT01034176|594283977|FG001|Overall Study|Withdrawal by Subject|1|||
164522918|NCT01034176|594283976|FG000|Overall Study|Lost to Follow-up|0|||
164522919|NCT01034176|594283977|FG001|Overall Study|Lost to Follow-up|1|||
164522920|NCT00266227|594283980|FG000|Initial Treatment|Adverse Event|0|||
164522921|NCT00266227|594283981|FG001|Initial Treatment|Adverse Event|0|||
164522922|NCT00266227|594283982|FG002|Initial Treatment|Adverse Event|13|||
164522923|NCT00266227|594283980|FG000|Initial Treatment|Lost to Follow-up|0|||
164522924|NCT00266227|594283981|FG001|Initial Treatment|Lost to Follow-up|0|||
164522925|NCT00266227|594283982|FG002|Initial Treatment|Lost to Follow-up|6|||
164522926|NCT00266227|594283980|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
164522927|NCT00266227|594283981|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
164620991|NCT02177812|594631962|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
164620992|NCT00089999|594631963|FG000|Overall Study|Adverse Event|4|||
164620993|NCT00089999|594631964|FG001|Overall Study|Adverse Event|7|||
164620994|NCT00089999|594631963|FG000|Overall Study|Withdrawal by Subject|0|||
164620995|NCT00089999|594631964|FG001|Overall Study|Withdrawal by Subject|4|||
164620996|NCT00089999|594631963|FG000|Overall Study|Lost to Follow-up|2|||
164620997|NCT00089999|594631964|FG001|Overall Study|Lost to Follow-up|1|||
164620998|NCT00089999|594631963|FG000|Overall Study|Radiological Progression of Cancer|52|||
164620999|NCT00089999|594631964|FG001|Overall Study|Radiological Progression of Cancer|44|||
164621000|NCT00089999|594631963|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
164621001|NCT00089999|594631964|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
164621002|NCT00089999|594631963|FG000|Overall Study|Death|3|||
164621003|NCT00089999|594631964|FG001|Overall Study|Death|3|||
164621004|NCT00089999|594631963|FG000|Overall Study|Poor General Condition|1|||
164621005|NCT00089999|594631964|FG001|Overall Study|Poor General Condition|0|||
164621006|NCT00089999|594631963|FG000|Overall Study|Clinical Progression|1|||
164621007|NCT00089999|594631964|FG001|Overall Study|Clinical Progression|2|||
164621008|NCT00089999|594631963|FG000|Overall Study|Physician Decision|2|||
164621009|NCT00089999|594631964|FG001|Overall Study|Physician Decision|2|||
164621010|NCT00089999|594631963|FG000|Overall Study|Patient Underwent Surgery|2|||
164621011|NCT00089999|594631964|FG001|Overall Study|Patient Underwent Surgery|0|||
164621012|NCT00089999|594631963|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
164621013|NCT00089999|594631964|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
164621014|NCT03573804|594631968|FG000|Overall Study|claustrophobia or MRI table problems|10|||
164621015|NCT01654224|594634077|FG000|Overall Study|Lost to Follow-up|2|||
164621016|NCT01654224|594634078|FG001|Overall Study|Lost to Follow-up|2|||
164621017|NCT01654224|594634077|FG000|Overall Study|Did not receive allocation|1|||
164621018|NCT01654224|594634078|FG001|Overall Study|Did not receive allocation|8|||
164621019|NCT01654224|594634077|FG000|Overall Study|Insufficient blood sample|3|||
164621020|NCT01654224|594634078|FG001|Overall Study|Insufficient blood sample|2|||
164621021|NCT01874353|594634079|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
164621022|NCT01874353|594634080|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
164621023|NCT01874353|594634081|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
164621024|NCT01874353|594634082|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
164621025|NCT01874353|594634079|FG000|Overall Study|Lost to Follow-up|2|||
164621026|NCT01874353|594634080|FG001|Overall Study|Lost to Follow-up|2|||
164621027|NCT01874353|594634081|FG002|Overall Study|Lost to Follow-up|2|||
164621028|NCT01874353|594634082|FG003|Overall Study|Lost to Follow-up|0|||
164621029|NCT01874353|594634079|FG000|Overall Study|Death|110|||
164621030|NCT01874353|594634080|FG001|Overall Study|Death|60|||
164621031|NCT01874353|594634081|FG002|Overall Study|Death|13|||
164621032|NCT01874353|594634082|FG003|Overall Study|Death|7|||
164621033|NCT01874353|594634079|FG000|Overall Study|Withdrawal by Subject|13|||
164621034|NCT01874353|594634080|FG001|Overall Study|Withdrawal by Subject|11|||
164621035|NCT01874353|594634081|FG002|Overall Study|Withdrawal by Subject|0|||
164621036|NCT01874353|594634082|FG003|Overall Study|Withdrawal by Subject|0|||
164621037|NCT03728881|594634083|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
164621038|NCT03728881|594634084|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
164621039|NCT03728881|594634083|FG000|Enrolled and Received 1st Vaccination|Death|1|||
164621040|NCT03728881|594634084|FG001|Enrolled and Received 1st Vaccination|Death|1|||
164621041|NCT03728881|594634083|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
164621042|NCT03728881|594634084|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
164621043|NCT03728881|594634083|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
164621044|NCT03728881|594634084|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
164621045|NCT03728881|594634083|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
164621046|NCT03728881|594634084|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
164621047|NCT03728881|594634083|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
164621048|NCT03728881|594634084|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
164621049|NCT03728881|594634083|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
164621050|NCT03728881|594634084|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
164621051|NCT03728881|594634083|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
164621052|NCT03728881|594634084|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
164621053|NCT03728881|594634083|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
164621054|NCT03728881|594634084|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
164621055|NCT03728881|594634083|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
164621056|NCT03728881|594634084|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
164621057|NCT03728881|594634083|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
164522928|NCT00266227|594283982|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
164522929|NCT00266227|594283980|FG000|Initial Treatment|Physician decision to withdraw|0|||
164522930|NCT00266227|594283981|FG001|Initial Treatment|Physician decision to withdraw|0|||
164522931|NCT00266227|594283982|FG002|Initial Treatment|Physician decision to withdraw|12|||
164522932|NCT00266227|594283980|FG000|Initial Treatment|Pregnancy|0|||
164522933|NCT00266227|594283981|FG001|Initial Treatment|Pregnancy|0|||
164522934|NCT00266227|594283982|FG002|Initial Treatment|Pregnancy|1|||
164522935|NCT00266227|594283980|FG000|Retreatment: Up to Week 48|Death|1|||
164522936|NCT00266227|594283981|FG001|Retreatment: Up to Week 48|Death|0|||
164522937|NCT00266227|594283982|FG002|Retreatment: Up to Week 48|Death|0|||
164522938|NCT00266227|594283980|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
164522939|NCT00266227|594283981|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
164522940|NCT00266227|594283982|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
164522941|NCT00266227|594283980|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
164522942|NCT00266227|594283981|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
164522943|NCT00266227|594283982|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
164522944|NCT00266227|594283980|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
164522945|NCT00266227|594283981|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
164522946|NCT00266227|594283982|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
164522947|NCT00266227|594283980|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
164522948|NCT00266227|594283981|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
164522949|NCT00266227|594283982|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
164522950|NCT00266227|594283980|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
164522951|NCT00266227|594283981|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
164522952|NCT00266227|594283982|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
164522953|NCT00266227|594283980|FG000|Retreatment: Week 48 to Week 72|Death|1|||
164522954|NCT00266227|594283981|FG001|Retreatment: Week 48 to Week 72|Death|1|||
164522955|NCT00266227|594283982|FG002|Retreatment: Week 48 to Week 72|Death|0|||
164522956|NCT00266227|594283980|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
164522957|NCT00266227|594283981|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
164522958|NCT00266227|594283982|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
164522959|NCT00266227|594283980|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
164522960|NCT00266227|594283981|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
164522961|NCT00266227|594283982|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
164522962|NCT00266227|594283980|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
164522963|NCT00266227|594283981|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
164522964|NCT00266227|594283982|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
164522965|NCT00266227|594283980|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
164522966|NCT00266227|594283981|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
164522967|NCT00266227|594283982|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
164522968|NCT02924428|594283984|FG000|Overall Study|Adverse Event|1|||
164522969|NCT02924428|594283985|FG001|Overall Study|Adverse Event|0|||
164522970|NCT02924428|594283984|FG000|Overall Study|Physician Decision|1|||
164522971|NCT02924428|594283985|FG001|Overall Study|Physician Decision|0|||
164522972|NCT02924428|594283984|FG000|Overall Study|Lost to Follow-up|2|||
164522973|NCT02924428|594283985|FG001|Overall Study|Lost to Follow-up|4|||
164522974|NCT02924428|594283984|FG000|Overall Study|Pregnancy|0|||
164522975|NCT02924428|594283985|FG001|Overall Study|Pregnancy|1|||
164522976|NCT02680002|594283986|FG000|Overall Study|Lost to Follow-up|5|||
164522977|NCT02680002|594283987|FG001|Overall Study|Lost to Follow-up|1|||
164522978|NCT02680002|594283988|FG002|Overall Study|Lost to Follow-up|4|||
164522979|NCT02680002|594283989|FG003|Overall Study|Lost to Follow-up|2|||
164522980|NCT02680002|594283990|FG004|Overall Study|Lost to Follow-up|0|||
164522981|NCT02680002|594283991|FG005|Overall Study|Lost to Follow-up|2|||
164522982|NCT02680002|594283986|FG000|Overall Study|Physician Decision|5|||
164522983|NCT02680002|594283987|FG001|Overall Study|Physician Decision|1|||
164522984|NCT02680002|594283988|FG002|Overall Study|Physician Decision|1|||
164522985|NCT02680002|594283989|FG003|Overall Study|Physician Decision|1|||
164522986|NCT02680002|594283990|FG004|Overall Study|Physician Decision|1|||
164522987|NCT02680002|594283991|FG005|Overall Study|Physician Decision|1|||
164522988|NCT02680002|594283986|FG000|Overall Study|Protocol Violation|1|||
164522989|NCT02680002|594283987|FG001|Overall Study|Protocol Violation|0|||
164522990|NCT02680002|594283988|FG002|Overall Study|Protocol Violation|1|||
164522991|NCT02680002|594283989|FG003|Overall Study|Protocol Violation|0|||
164522992|NCT02680002|594283990|FG004|Overall Study|Protocol Violation|1|||
164522993|NCT02680002|594283991|FG005|Overall Study|Protocol Violation|2|||
164522994|NCT02680002|594283986|FG000|Overall Study|Withdrawal by Subject|0|||
164522995|NCT02680002|594283987|FG001|Overall Study|Withdrawal by Subject|0|||
164522996|NCT02680002|594283988|FG002|Overall Study|Withdrawal by Subject|1|||
164522997|NCT02680002|594283989|FG003|Overall Study|Withdrawal by Subject|0|||
164522998|NCT02680002|594283990|FG004|Overall Study|Withdrawal by Subject|2|||
164522999|NCT02680002|594283991|FG005|Overall Study|Withdrawal by Subject|2|||
164523000|NCT02680002|594283986|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
164523001|NCT02680002|594283987|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
164621058|NCT03728881|594634084|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
164621059|NCT04651777|594634087|FG000|Overall Study|Adverse Event|1|||
164621060|NCT04651777|594634087|FG000|Overall Study|Withdrawal by Subject|2|||
164621061|NCT05505734|594634088|FG000|Overall Study|Withdrawal by Subject|51|||
164621062|NCT05505734|594634089|FG001|Overall Study|Withdrawal by Subject|64|||
164621063|NCT05505734|594634088|FG000|Overall Study|Adverse Event|6|||
164621064|NCT05505734|594634089|FG001|Overall Study|Adverse Event|20|||
164621065|NCT05505734|594634088|FG000|Overall Study|Protocol Violation|8|||
164621066|NCT05505734|594634089|FG001|Overall Study|Protocol Violation|15|||
164621067|NCT05505734|594634088|FG000|Overall Study|Lack of therapeutic response|0|||
164621068|NCT05505734|594634089|FG001|Overall Study|Lack of therapeutic response|1|||
164621069|NCT05505734|594634088|FG000|Overall Study|Lost to Follow-up|247|||
164621070|NCT05505734|594634089|FG001|Overall Study|Lost to Follow-up|237|||
164621071|NCT05505734|594634088|FG000|Overall Study|Physician Decision|22|||
164621072|NCT05505734|594634089|FG001|Overall Study|Physician Decision|13|||
164621073|NCT05505734|594634088|FG000|Overall Study|Death|2|||
164621074|NCT05505734|594634089|FG001|Overall Study|Death|1|||
164621075|NCT05505734|594634088|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164621076|NCT05505734|594634089|FG001|Overall Study|Withdrawal by parent/guardian|1|||
164621077|NCT05505734|594634088|FG000|Overall Study|Pregnancy|1|||
164621078|NCT05505734|594634089|FG001|Overall Study|Pregnancy|0|||
164621079|NCT05505734|594634088|FG000|Overall Study|Other|17|||
164621080|NCT05505734|594634089|FG001|Overall Study|Other|13|||
164621081|NCT00732472|594634090|FG000|Overall Study|Adverse Event|0|||
164621082|NCT00732472|594634091|FG001|Overall Study|Adverse Event|1|||
164621083|NCT00732472|594634092|FG002|Overall Study|Adverse Event|1|||
164621084|NCT00732472|594634093|FG003|Overall Study|Adverse Event|1|||
164621085|NCT00732472|594634090|FG000|Overall Study|Protocol Violation|0|||
164621086|NCT00732472|594634091|FG001|Overall Study|Protocol Violation|0|||
164621087|NCT00732472|594634092|FG002|Overall Study|Protocol Violation|0|||
164621088|NCT00732472|594634093|FG003|Overall Study|Protocol Violation|1|||
164621089|NCT00732472|594634090|FG000|Overall Study|Withdrawal by Subject|0|||
164621090|NCT00732472|594634091|FG001|Overall Study|Withdrawal by Subject|2|||
164621091|NCT00732472|594634092|FG002|Overall Study|Withdrawal by Subject|0|||
164621092|NCT00732472|594634093|FG003|Overall Study|Withdrawal by Subject|1|||
164621093|NCT03575351|594634096|FG000|Overall Study|Adverse Event|1|||
164621094|NCT03575351|594634097|FG001|Overall Study|Adverse Event|0|||
164621095|NCT03575351|594634096|FG000|Overall Study|Death|2|||
164621096|NCT03575351|594634097|FG001|Overall Study|Death|2|||
164621097|NCT03575351|594634096|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
164621098|NCT03575351|594634097|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
164621099|NCT03575351|594634096|FG000|Overall Study|Lack of Efficacy|28|||
164621100|NCT03575351|594634097|FG001|Overall Study|Lack of Efficacy|0|||
164621101|NCT03575351|594634096|FG000|Overall Study|Withdrawal by Subject|1|||
164621102|NCT03575351|594634097|FG001|Overall Study|Withdrawal by Subject|1|||
164621103|NCT03575351|594634096|FG000|Overall Study|Physician Decision|3|||
164621104|NCT03575351|594634097|FG001|Overall Study|Physician Decision|0|||
164621105|NCT03575351|594634096|FG000|Overall Study|Disease relapse|15|||
164621106|NCT03575351|594634097|FG001|Overall Study|Disease relapse|6|||
164621107|NCT03575351|594634096|FG000|Overall Study|Study drug manufacturing failure|0|||
164621108|NCT03575351|594634097|FG001|Overall Study|Study drug manufacturing failure|1|||
164621109|NCT03575351|594634096|FG000|Overall Study|other reasons|5|||
164621110|NCT03575351|594634097|FG001|Overall Study|other reasons|0|||
164621111|NCT02623699|594634098|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
164621112|NCT02623699|594634099|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
164621113|NCT02623699|594634100|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
164621114|NCT02623699|594634101|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
164621115|NCT02623699|594634102|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
164621116|NCT02623699|594634103|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
164621117|NCT02623699|594634104|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
164621118|NCT02623699|594634105|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
164621119|NCT02623699|594634106|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
164621120|NCT02623699|594634107|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
164621121|NCT02623699|594634108|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
164621122|NCT02623699|594634109|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
164621123|NCT02623699|594634098|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
164621124|NCT02623699|594634099|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
164621125|NCT02623699|594634100|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
164621126|NCT02623699|594634101|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
164621127|NCT02623699|594634102|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
164621128|NCT02623699|594634103|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
164621129|NCT02623699|594634104|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
164621130|NCT02623699|594634105|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
164621131|NCT02623699|594634106|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
164621132|NCT02623699|594634107|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
164621133|NCT02623699|594634108|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
164621134|NCT02623699|594634109|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
164621135|NCT02623699|594634098|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
164621136|NCT02623699|594634099|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
164621137|NCT02623699|594634100|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
164621138|NCT02623699|594634101|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
164621139|NCT02623699|594634102|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
164621140|NCT02623699|594634103|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
164621141|NCT02623699|594634104|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
164621142|NCT02623699|594634105|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
164621143|NCT02623699|594634106|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
164621144|NCT02623699|594634107|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
164523002|NCT02680002|594283988|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
164523003|NCT02680002|594283989|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
164523004|NCT02680002|594283990|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
164523005|NCT02680002|594283991|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
164523006|NCT02680002|594283986|FG000|Overall Study|Other|0|||
164523007|NCT02680002|594283987|FG001|Overall Study|Other|1|||
164523008|NCT02680002|594283988|FG002|Overall Study|Other|0|||
164523009|NCT02680002|594283989|FG003|Overall Study|Other|0|||
164523010|NCT02680002|594283990|FG004|Overall Study|Other|1|||
164523011|NCT02680002|594283991|FG005|Overall Study|Other|0|||
164523012|NCT02680002|594283986|FG000|Overall Study|Adverse Event|0|||
164523013|NCT02680002|594283987|FG001|Overall Study|Adverse Event|0|||
164523014|NCT02680002|594283988|FG002|Overall Study|Adverse Event|0|||
164523015|NCT02680002|594283989|FG003|Overall Study|Adverse Event|0|||
164523016|NCT02680002|594283990|FG004|Overall Study|Adverse Event|1|||
164523017|NCT02680002|594283991|FG005|Overall Study|Adverse Event|2|||
164523018|NCT00901186|594283993|FG000|Overall Study|Lack of Efficacy|0|||
164523019|NCT00901186|594283994|FG001|Overall Study|Lack of Efficacy|1|||
164523020|NCT00901186|594283993|FG000|Overall Study|Abnormal laboratory values|0|||
164523021|NCT00901186|594283994|FG001|Overall Study|Abnormal laboratory values|1|||
164523022|NCT00901186|594283993|FG000|Overall Study|Lost to Follow-up|2|||
164523023|NCT00901186|594283994|FG001|Overall Study|Lost to Follow-up|0|||
164523024|NCT00901186|594283993|FG000|Overall Study|Adverse Event|2|||
164523025|NCT00901186|594283994|FG001|Overall Study|Adverse Event|4|||
164523026|NCT00901186|594283993|FG000|Overall Study|Administration problems|0|||
164523027|NCT00901186|594283994|FG001|Overall Study|Administration problems|1|||
164523028|NCT00901186|594283993|FG000|Overall Study|Protocol deviations|5|||
164523029|NCT00901186|594283994|FG001|Overall Study|Protocol deviations|4|||
164523030|NCT04214600|594283996|FG000|Overall Study|Lost to Follow-up|9|||
164523031|NCT04214600|594283997|FG001|Overall Study|Lost to Follow-up|14|||
164523032|NCT02935452|594283998|FG000|Overall Study|work and life commintment|3|||
164523033|NCT02935452|594283999|FG001|Overall Study|work and life commintment|1|||
164523034|NCT01813929|594284001|FG000|Overall Study|Withdrawal by Subject|0|||
164523035|NCT01813929|594284002|FG001|Overall Study|Withdrawal by Subject|1|||
164523036|NCT04638920|594284018|FG000|Overall Study|Withdrawal by Subject|5|||
164523037|NCT01801735|594284019|FG000|Overall Study|Adverse Event|79|||
164523038|NCT01801735|594284019|FG000|Overall Study|Lack of Efficacy|28|||
164523039|NCT01801735|594284019|FG000|Overall Study|Withdrawal by Subject|27|||
164523040|NCT01801735|594284019|FG000|Overall Study|Protocol Violation|25|||
164523041|NCT01801735|594284019|FG000|Overall Study|Lost to Follow-up|15|||
164523042|NCT01801735|594284019|FG000|Overall Study|Non-compliance with Trial Drug|13|||
164523043|NCT01801735|594284019|FG000|Overall Study|Physician Decision|3|||
164523044|NCT01801735|594284019|FG000|Overall Study|Death|1|||
164523045|NCT01801735|594284019|FG000|Overall Study|Other, including site closure|19|||
164523046|NCT01435616|594284020|FG000|Overall Study|Adverse Event|39|||
164523047|NCT01435616|594284021|FG001|Overall Study|Adverse Event|21|||
164523048|NCT01435616|594284020|FG000|Overall Study|Death|7|||
164523049|NCT01435616|594284021|FG001|Overall Study|Death|2|||
164523050|NCT01435616|594284020|FG000|Overall Study|Lost to Follow-up|22|||
164523051|NCT01435616|594284021|FG001|Overall Study|Lost to Follow-up|13|||
164523052|NCT01435616|594284020|FG000|Overall Study|Protocol Violation|16|||
164523053|NCT01435616|594284021|FG001|Overall Study|Protocol Violation|13|||
164523054|NCT01435616|594284020|FG000|Overall Study|Withdrawal by Subject|66|||
164523055|NCT01435616|594284021|FG001|Overall Study|Withdrawal by Subject|24|||
164523056|NCT01435616|594284020|FG000|Overall Study|Physician Decision|20|||
164523057|NCT01435616|594284021|FG001|Overall Study|Physician Decision|7|||
164523058|NCT01435616|594284020|FG000|Overall Study|Sponsor Decision|1|||
164523059|NCT01435616|594284021|FG001|Overall Study|Sponsor Decision|0|||
164523060|NCT01127763|594284023|FG000|Overall Study|Adverse Event|2|||
164523061|NCT01127763|594284023|FG000|Overall Study|Withdrawal by Subject|1|||
164523062|NCT01127763|594284023|FG000|Overall Study|Physician Decision|2|||
164523063|NCT04738292|594284028|FG000|Overall Study|Death|1|||
164523064|NCT00371683|594284029|FG000|DB Treatment Period-Randomized Patients|Death|1|||
164523065|NCT00371683|594284030|FG001|DB Treatment Period-Randomized Patients|Death|1|||
164523066|NCT00371683|594284029|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
164523067|NCT00371683|594284030|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
164523068|NCT00371683|594284029|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
164523069|NCT00371683|594284030|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
164523070|NCT00371683|594284029|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
164523071|NCT00371683|594284030|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
164523072|NCT00371683|594284029|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
164523073|NCT00371683|594284030|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
164523074|NCT00371683|594284029|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
164523075|NCT00371683|594284030|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
164523076|NCT00371683|594284029|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
164523077|NCT00371683|594284030|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
164523078|NCT00371683|594284029|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
164523079|NCT00371683|594284030|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
164523080|NCT00371683|594284029|FG000|Follow-Up Period - Randomized Patients|Death|0|||
164523081|NCT00371683|594284030|FG001|Follow-Up Period - Randomized Patients|Death|2|||
164523082|NCT00371683|594284029|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
164523083|NCT00371683|594284030|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
164523084|NCT00371683|594284029|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
164523085|NCT00371683|594284030|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
164523086|NCT03181789|594284032|FG000|Overall Study|Withdrawal by Subject|0|||
164523087|NCT03181789|594284033|FG001|Overall Study|Withdrawal by Subject|1|||
164523088|NCT03181789|594284034|FG002|Overall Study|Withdrawal by Subject|1|||
164523089|NCT03181789|594284035|FG003|Overall Study|Withdrawal by Subject|0|||
164523090|NCT03181789|594284032|FG000|Overall Study|Lost to Follow-up|7|||
164523091|NCT03181789|594284033|FG001|Overall Study|Lost to Follow-up|1|||
164523092|NCT03181789|594284034|FG002|Overall Study|Lost to Follow-up|0|||
164523093|NCT03181789|594284035|FG003|Overall Study|Lost to Follow-up|0|||
164523094|NCT03181789|594284032|FG000|Overall Study|Participant unable to adhere to visit|0|||
164523095|NCT03181789|594284033|FG001|Overall Study|Participant unable to adhere to visit|1|||
164523096|NCT03181789|594284034|FG002|Overall Study|Participant unable to adhere to visit|0|||
164523097|NCT03181789|594284035|FG003|Overall Study|Participant unable to adhere to visit|0|||
164523098|NCT00735475|594284036|FG000|Overall Study|Adverse Event|0|||
164523099|NCT00735475|594284037|FG001|Overall Study|Adverse Event|1|||
164523100|NCT00735475|594284036|FG000|Overall Study|Death|1|||
164523101|NCT00735475|594284037|FG001|Overall Study|Death|1|||
164523102|NCT00735475|594284036|FG000|Overall Study|Lost to Follow-up|3|||
164523103|NCT00735475|594284037|FG001|Overall Study|Lost to Follow-up|3|||
164523104|NCT00735475|594284036|FG000|Overall Study|Physician Decision|0|||
164523105|NCT00735475|594284037|FG001|Overall Study|Physician Decision|1|||
164523106|NCT00735475|594284036|FG000|Overall Study|Withdrawal by Subject|4|||
164523107|NCT00735475|594284037|FG001|Overall Study|Withdrawal by Subject|5|||
164523108|NCT02442336|594284038|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
164523109|NCT02442336|594284038|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
164621145|NCT02623699|594634108|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
164621146|NCT02623699|594634109|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
164621147|NCT02623699|594634098|FG000|Part B (Up to 289 Days)|Death|0|||
164621148|NCT02623699|594634099|FG001|Part B (Up to 289 Days)|Death|0|||
164621149|NCT02623699|594634100|FG002|Part B (Up to 289 Days)|Death|0|||
164621150|NCT02623699|594634101|FG003|Part B (Up to 289 Days)|Death|0|||
164621151|NCT02623699|594634102|FG004|Part B (Up to 289 Days)|Death|0|||
164621152|NCT02623699|594634103|FG005|Part B (Up to 289 Days)|Death|1|||
164621153|NCT02623699|594634104|FG006|Part B (Up to 289 Days)|Death|1|||
164621154|NCT02623699|594634105|FG007|Part B (Up to 289 Days)|Death|0|||
164621155|NCT02623699|594634106|FG008|Part B (Up to 289 Days)|Death|1|||
164621156|NCT02623699|594634107|FG009|Part B (Up to 289 Days)|Death|0|||
164621157|NCT02623699|594634108|FG010|Part B (Up to 289 Days)|Death|0|||
164621158|NCT02623699|594634109|FG011|Part B (Up to 289 Days)|Death|0|||
164621159|NCT02623699|594634098|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
164621160|NCT02623699|594634099|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
164621161|NCT02623699|594634100|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
164621162|NCT02623699|594634101|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
164621163|NCT02623699|594634102|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
164621164|NCT02623699|594634103|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
164621165|NCT02623699|594634104|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
164621166|NCT02623699|594634105|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
164621167|NCT02623699|594634106|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
164621168|NCT02623699|594634107|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
164621169|NCT02623699|594634108|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
164621170|NCT02623699|594634109|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
164621171|NCT02623699|594634098|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
164621172|NCT02623699|594634099|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
164621173|NCT02623699|594634100|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
164621174|NCT02623699|594634101|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
164621175|NCT02623699|594634102|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
164621176|NCT02623699|594634103|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
164621177|NCT02623699|594634104|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
164621178|NCT02623699|594634105|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
164523110|NCT02442336|594284038|FG000|Overall Study|Lost to Follow-up|11|||
164523111|NCT05086276|594284039|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
164523112|NCT05086276|594284040|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
164523113|NCT01237587|594284041|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
164523114|NCT01237587|594284042|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
164523115|NCT01237587|594284041|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
164523116|NCT01237587|594284042|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
164523117|NCT01237587|594284041|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
164523118|NCT01237587|594284042|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
164523119|NCT01237587|594284041|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
164523120|NCT01237587|594284042|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
164523121|NCT01237587|594284041|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
164523122|NCT01237587|594284042|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
164523123|NCT01237587|594284041|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
164523124|NCT01237587|594284042|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
164523125|NCT01237587|594284041|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
164523126|NCT01237587|594284042|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
164523127|NCT01237587|594284041|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
164523128|NCT01237587|594284042|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
164523129|NCT01237587|594284041|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
164523130|NCT01237587|594284042|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
164523131|NCT01237587|594284041|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
164523132|NCT01237587|594284042|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
164523133|NCT01237587|594284041|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
164523134|NCT01237587|594284042|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
164523135|NCT01237587|594284041|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
164523136|NCT01237587|594284042|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
164523137|NCT01237587|594284041|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
164523138|NCT01237587|594284042|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
164523139|NCT01237587|594284041|FG000|Taper Phase|Adverse Event|0|||
164523140|NCT01237587|594284042|FG001|Taper Phase|Adverse Event|2|||
164523141|NCT01237587|594284041|FG000|Taper Phase|Protocol Violation|2|||
164523142|NCT01237587|594284042|FG001|Taper Phase|Protocol Violation|0|||
164523143|NCT01237587|594284041|FG000|Taper Phase|Lack of Efficacy|2|||
164523144|NCT01237587|594284042|FG001|Taper Phase|Lack of Efficacy|5|||
164523145|NCT01237587|594284041|FG000|Taper Phase|Parent/Guardian Decision|0|||
164523146|NCT01237587|594284042|FG001|Taper Phase|Parent/Guardian Decision|2|||
164523147|NCT01237587|594284041|FG000|Taper Phase|Sponsor Decision|1|||
164523148|NCT01237587|594284042|FG001|Taper Phase|Sponsor Decision|0|||
164523149|NCT01237587|594284041|FG000|Taper Phase|Withdrawal by Subject|0|||
164523150|NCT01237587|594284042|FG001|Taper Phase|Withdrawal by Subject|1|||
164523151|NCT01011387|594284044|FG000|Overall Study|Withdrawal by Subject|3|||
164523152|NCT01011387|594284044|FG000|Overall Study|Adverse Event|2|||
164523153|NCT01011387|594284044|FG000|Overall Study|Protocol Violation|1|||
164523154|NCT01139580|594284045|FG000|Overall Study|Adverse Event|5|||
164523155|NCT01139580|594284046|FG001|Overall Study|Adverse Event|4|||
164523156|NCT01139580|594284045|FG000|Overall Study|Lost to Follow-up|9|||
164523157|NCT01139580|594284046|FG001|Overall Study|Lost to Follow-up|1|||
164523158|NCT01139580|594284045|FG000|Overall Study|Lack of Efficacy|0|||
164523159|NCT01139580|594284046|FG001|Overall Study|Lack of Efficacy|2|||
164523160|NCT01139580|594284045|FG000|Overall Study|Withdrawal by Subject|6|||
164523161|NCT01139580|594284046|FG001|Overall Study|Withdrawal by Subject|9|||
164523162|NCT01139580|594284045|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
164523163|NCT01139580|594284046|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
164523164|NCT01139580|594284045|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
164523165|NCT01139580|594284046|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
164523166|NCT01139580|594284045|FG000|Overall Study|Misrandomized|1|||
164523167|NCT01139580|594284046|FG001|Overall Study|Misrandomized|0|||
164523168|NCT01139580|594284045|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
164523169|NCT01139580|594284046|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
164523170|NCT01139580|594284045|FG000|Overall Study|Participant Randomization in Error|0|||
164523171|NCT01139580|594284046|FG001|Overall Study|Participant Randomization in Error|1|||
164523172|NCT01285609|594284047|FG000|Randomized|Progressive Disease|41|||
164523173|NCT01285609|594284048|FG001|Randomized|Progressive Disease|61|||
164523174|NCT01285609|594284047|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
164523175|NCT01285609|594284048|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
164523176|NCT01285609|594284047|FG000|Randomized|Study Drug Toxicity|13|||
164621179|NCT02623699|594634106|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
164621180|NCT02623699|594634107|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
164621181|NCT02623699|594634108|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
164621182|NCT02623699|594634109|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
164621183|NCT02623699|594634098|FG000|Part C (Up to 236 Days)|Death|0|||
164621184|NCT02623699|594634099|FG001|Part C (Up to 236 Days)|Death|0|||
164621185|NCT02623699|594634100|FG002|Part C (Up to 236 Days)|Death|0|||
164621186|NCT02623699|594634101|FG003|Part C (Up to 236 Days)|Death|0|||
164621187|NCT02623699|594634102|FG004|Part C (Up to 236 Days)|Death|0|||
164523177|NCT01285609|594284048|FG001|Randomized|Study Drug Toxicity|14|||
164523178|NCT01285609|594284047|FG000|Randomized|Death|5|||
164523179|NCT01285609|594284048|FG001|Randomized|Death|7|||
164523180|NCT01285609|594284047|FG000|Randomized|Withdrawal by Subject|8|||
164523181|NCT01285609|594284048|FG001|Randomized|Withdrawal by Subject|11|||
164523182|NCT01285609|594284047|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
164523183|NCT01285609|594284048|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
164523184|NCT01285609|594284047|FG000|Randomized|Undisclosed Reasons|1|||
164523185|NCT01285609|594284048|FG001|Randomized|Undisclosed Reasons|0|||
164523186|NCT01285609|594284047|FG000|Randomized|Randomized but not Treated|4|||
164523187|NCT01285609|594284048|FG001|Randomized|Randomized but not Treated|4|||
164523188|NCT01285609|594284047|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
164523189|NCT01285609|594284048|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
164523190|NCT01285609|594284047|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
164523191|NCT01285609|594284048|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
164523192|NCT01285609|594284047|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
164523193|NCT01285609|594284048|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
164523194|NCT01285609|594284047|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
164523195|NCT01285609|594284048|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
164523196|NCT01285609|594284047|FG000|Treated With Blinded Therapy|Death|11|||
164523197|NCT01285609|594284048|FG001|Treated With Blinded Therapy|Death|3|||
164523198|NCT01285609|594284047|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
164523199|NCT01285609|594284048|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
164523200|NCT01285609|594284047|FG000|Treated With Blinded Therapy|Not Reported|0|||
164523201|NCT01285609|594284048|FG001|Treated With Blinded Therapy|Not Reported|2|||
164523202|NCT01285609|594284047|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
164523203|NCT01285609|594284048|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
164523204|NCT01285609|594284047|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
164523205|NCT01285609|594284048|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
164523206|NCT01285609|594284047|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
164523207|NCT01285609|594284048|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
164523208|NCT01285609|594284047|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
164523209|NCT01285609|594284048|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
164523210|NCT01285609|594284047|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
164523211|NCT01285609|594284048|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
164523212|NCT01285609|594284047|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
164523213|NCT01285609|594284048|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
164523214|NCT01285609|594284047|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
164523215|NCT01285609|594284048|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
164523216|NCT01285609|594284047|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
164523217|NCT01285609|594284048|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
164523218|NCT01285609|594284047|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
164523219|NCT01285609|594284048|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
164523220|NCT01285609|594284047|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
164523221|NCT01285609|594284048|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
164523222|NCT01142115|594284049|FG000|First Intervention|Lack of Efficacy|1|||
164523223|NCT01142115|594284050|FG001|First Intervention|Lack of Efficacy|1|||
164523224|NCT01142115|594284049|FG000|First Intervention|Adverse Event|1|||
164523225|NCT01142115|594284050|FG001|First Intervention|Adverse Event|0|||
164523226|NCT03208036|594284051|FG000|Baseline Assessment|Withdrawal by Subject|1|||
164523227|NCT03208036|594284052|FG001|Baseline Assessment|Withdrawal by Subject|1|||
164523228|NCT03208036|594284051|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
164523229|NCT03208036|594284052|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
164621188|NCT02623699|594634103|FG005|Part C (Up to 236 Days)|Death|0|||
164523230|NCT03208036|594284051|FG000|Intervention|Withdrawal by Subject|3|||
164523231|NCT03208036|594284052|FG001|Intervention|Withdrawal by Subject|2|||
164523232|NCT03208036|594284051|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
164523233|NCT03208036|594284052|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
164523234|NCT00700778|594284053|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
164523235|NCT00320528|594284056|FG000|Study Period II|Adverse Event|3|||
164523236|NCT00320528|594284057|FG001|Study Period II|Adverse Event|4|||
164523237|NCT00320528|594284058|FG002|Study Period II|Adverse Event|8|||
164523238|NCT00320528|594284056|FG000|Study Period II|Parent/Caregiver Decision|8|||
164523239|NCT00320528|594284057|FG001|Study Period II|Parent/Caregiver Decision|3|||
164523240|NCT00320528|594284058|FG002|Study Period II|Parent/Caregiver Decision|11|||
164523241|NCT00320528|594284056|FG000|Study Period II|Withdrawal by Subject|0|||
164523242|NCT00320528|594284057|FG001|Study Period II|Withdrawal by Subject|1|||
164523243|NCT00320528|594284058|FG002|Study Period II|Withdrawal by Subject|1|||
164523244|NCT00320528|594284056|FG000|Study Period II|Entry Criteria Exclusion|0|||
164523245|NCT00320528|594284057|FG001|Study Period II|Entry Criteria Exclusion|2|||
164523246|NCT00320528|594284058|FG002|Study Period II|Entry Criteria Exclusion|2|||
164523247|NCT00320528|594284056|FG000|Study Period III|Adverse Event|1|||
164523248|NCT00320528|594284057|FG001|Study Period III|Adverse Event|0|||
164523249|NCT00320528|594284058|FG002|Study Period III|Adverse Event|0|||
164523250|NCT00320528|594284056|FG000|Study Period III|Lost to Follow-up|1|||
164523251|NCT00320528|594284057|FG001|Study Period III|Lost to Follow-up|0|||
164523252|NCT00320528|594284058|FG002|Study Period III|Lost to Follow-up|0|||
164523253|NCT00320528|594284056|FG000|Study Period III|Withdrawal by Subject|1|||
164523254|NCT00320528|594284057|FG001|Study Period III|Withdrawal by Subject|1|||
164523255|NCT00320528|594284058|FG002|Study Period III|Withdrawal by Subject|2|||
164523256|NCT00320528|594284056|FG000|Study Period III|Lack of Efficacy|2|||
164523257|NCT00320528|594284057|FG001|Study Period III|Lack of Efficacy|0|||
164523258|NCT00320528|594284058|FG002|Study Period III|Lack of Efficacy|0|||
164523259|NCT00320528|594284056|FG000|Study Period III|Parent/Caregiver Decision|14|||
164523260|NCT00320528|594284057|FG001|Study Period III|Parent/Caregiver Decision|3|||
164523261|NCT00320528|594284058|FG002|Study Period III|Parent/Caregiver Decision|11|||
164523262|NCT00320528|594284056|FG000|Study Period III|Protocol Violation|0|||
164523263|NCT00320528|594284057|FG001|Study Period III|Protocol Violation|1|||
164523264|NCT00320528|594284058|FG002|Study Period III|Protocol Violation|0|||
164523265|NCT00320528|594284056|FG000|Study Period III|Physician Decision|0|||
164523266|NCT00320528|594284057|FG001|Study Period III|Physician Decision|1|||
164523267|NCT00320528|594284058|FG002|Study Period III|Physician Decision|2|||
164523268|NCT00320528|594284056|FG000|Study Period III|Sponsor Decision|0|||
164523269|NCT00320528|594284057|FG001|Study Period III|Sponsor Decision|0|||
164523270|NCT00320528|594284058|FG002|Study Period III|Sponsor Decision|1|||
164523271|NCT00320528|594284056|FG000|Study Period III|Atomoxetine Commercially Available|68|||
164523272|NCT00320528|594284057|FG001|Study Period III|Atomoxetine Commercially Available|25|||
164523273|NCT00320528|594284058|FG002|Study Period III|Atomoxetine Commercially Available|90|||
164523274|NCT01397422|594284059|FG000|Overall Study|Adverse Event|0|||
164523275|NCT01397422|594284060|FG001|Overall Study|Adverse Event|3|||
164523276|NCT01397422|594284061|FG002|Overall Study|Adverse Event|3|||
164523277|NCT01397422|594284062|FG003|Overall Study|Adverse Event|8|||
164523278|NCT01397422|594284059|FG000|Overall Study|Withdrawal by Subject|1|||
164523279|NCT01397422|594284060|FG001|Overall Study|Withdrawal by Subject|0|||
164523280|NCT01397422|594284061|FG002|Overall Study|Withdrawal by Subject|0|||
164523281|NCT01397422|594284062|FG003|Overall Study|Withdrawal by Subject|0|||
164523282|NCT01397422|594284059|FG000|Overall Study|Increased bradykinesia related to PD|1|||
164523283|NCT01397422|594284060|FG001|Overall Study|Increased bradykinesia related to PD|0|||
164523284|NCT01397422|594284061|FG002|Overall Study|Increased bradykinesia related to PD|0|||
164523285|NCT01397422|594284062|FG003|Overall Study|Increased bradykinesia related to PD|0|||
164523286|NCT00760474|594284063|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
164523287|NCT00760474|594284064|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
164523288|NCT00760474|594284063|FG000|Placebo Washout Period|Other|0|||
164523289|NCT00760474|594284064|FG001|Placebo Washout Period|Other|1|||
164523290|NCT00760474|594284063|FG000|Period 2 (P2)|Lost to Follow-up|1|||
164523291|NCT00760474|594284064|FG001|Period 2 (P2)|Lost to Follow-up|0|||
164523292|NCT00760474|594284063|FG000|Period 2 (P2)|Adverse Event|0|||
164523293|NCT00760474|594284064|FG001|Period 2 (P2)|Adverse Event|1|||
164523294|NCT01865747|594284065|FG000|Overall Study (ITT)|Adverse Event|32|||
164523295|NCT01865747|594284066|FG001|Overall Study (ITT)|Adverse Event|31|||
164523296|NCT01865747|594284065|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
164523297|NCT01865747|594284066|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
164523298|NCT01865747|594284065|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
164523299|NCT01865747|594284066|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
164523300|NCT01865747|594284065|FG000|Overall Study (ITT)|Protocol Violation|1|||
164523301|NCT01865747|594284066|FG001|Overall Study (ITT)|Protocol Violation|1|||
164523302|NCT01865747|594284065|FG000|Overall Study (ITT)|Physician Decision|5|||
164523303|NCT01865747|594284066|FG001|Overall Study (ITT)|Physician Decision|2|||
164523304|NCT01865747|594284065|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
164523305|NCT01865747|594284066|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
164523306|NCT01865747|594284065|FG000|Overall Study (ITT)|Sponsor Decision|0|||
164523307|NCT01865747|594284066|FG001|Overall Study (ITT)|Sponsor Decision|1|||
164523308|NCT01865747|594284065|FG000|Overall Study (ITT)|Progressive Disease|122|||
164523309|NCT01865747|594284066|FG001|Overall Study (ITT)|Progressive Disease|158|||
164523310|NCT01865747|594284065|FG000|Overall Study (ITT)|Reason Not Provided|0|||
164523311|NCT01865747|594284066|FG001|Overall Study (ITT)|Reason Not Provided|1|||
164523312|NCT01865747|594284065|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
164523313|NCT01865747|594284066|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
164523314|NCT01865747|594284065|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
164523315|NCT01865747|594284066|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
164523316|NCT01865747|594284065|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
164523317|NCT01865747|594284066|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
164523318|NCT01865747|594284065|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
164523319|NCT01865747|594284066|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
164523320|NCT01865747|594284065|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
164523321|NCT01865747|594284066|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
164523322|NCT01865747|594284065|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
164523323|NCT01865747|594284066|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
164523324|NCT01865747|594284065|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
164523325|NCT01865747|594284066|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
164523326|NCT01865747|594284065|FG000|Primary Intent to Treat (PITT)|Other|0|||
164523327|NCT01865747|594284066|FG001|Primary Intent to Treat (PITT)|Other|1|||
164523328|NCT02592876|594284067|FG000|Overall Study|Withdrawal by Subject|3|||
164523329|NCT02592876|594284068|FG001|Overall Study|Withdrawal by Subject|3|||
164523330|NCT02592876|594284067|FG000|Overall Study|Study Termination by Sponsor|32|||
164523331|NCT02592876|594284068|FG001|Overall Study|Study Termination by Sponsor|27|||
164523332|NCT02592876|594284067|FG000|Overall Study|Lost to Follow-up|0|||
164523333|NCT02592876|594284068|FG001|Overall Study|Lost to Follow-up|1|||
164523334|NCT02592876|594284067|FG000|Overall Study|Death|6|||
164523335|NCT02592876|594284068|FG001|Overall Study|Death|9|||
164523336|NCT00867308|594284069|FG000|Overall Study|Death|1|||
164523337|NCT00867308|594284070|FG001|Overall Study|Death|0|||
164523338|NCT00867308|594284069|FG000|Overall Study|Adverse Event|1|||
164523339|NCT00867308|594284070|FG001|Overall Study|Adverse Event|4|||
164523340|NCT00867308|594284069|FG000|Overall Study|Lack of Efficacy|6|||
164523341|NCT00867308|594284070|FG001|Overall Study|Lack of Efficacy|12|||
164523342|NCT00867308|594284069|FG000|Overall Study|Withdrawal by Subject|1|||
164523343|NCT00867308|594284070|FG001|Overall Study|Withdrawal by Subject|2|||
164523344|NCT00611975|594284073|FG000|Overall Study|Withdrawal by Subject|3|||
164523345|NCT00611975|594284074|FG001|Overall Study|Withdrawal by Subject|7|||
164523346|NCT00611975|594284073|FG000|Overall Study|Pregnancy|2|||
164523347|NCT00611975|594284074|FG001|Overall Study|Pregnancy|1|||
164523348|NCT05618912|594284078|FG000|Overall Study|Lost to Follow-up|14|||
164523349|NCT05618912|594284079|FG001|Overall Study|Lost to Follow-up|19|||
164523350|NCT02704754|594286130|FG000|Overall Study|Lost to Follow-up|1|||
164523351|NCT02704754|594286131|FG001|Overall Study|Lost to Follow-up|1|||
164523352|NCT02704754|594286130|FG000|Overall Study|Lack of Efficacy|1|||
164523353|NCT02704754|594286131|FG001|Overall Study|Lack of Efficacy|0|||
164523354|NCT02704754|594286130|FG000|Overall Study|Withdrawal by Subject|1|||
164523355|NCT02704754|594286131|FG001|Overall Study|Withdrawal by Subject|0|||
164523356|NCT00423943|594286134|FG000|Overall Study|Withdrawal by Subject|3|||
164523357|NCT00423943|594286135|FG001|Overall Study|Withdrawal by Subject|1|||
164523358|NCT03730480|594286136|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
164523359|NCT04097301|594286139|FG000|Overall Study|Death|1|||
164523360|NCT04097301|594286139|FG000|Overall Study|Withdrawal by Subject|1|||
164523361|NCT04097301|594286139|FG000|Overall Study|Screening Failure|5|||
164523362|NCT02480153|594286145|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
164523363|NCT02480153|594286146|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
164523364|NCT02480153|594286147|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
164523365|NCT02480153|594286145|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
164523366|NCT02480153|594286146|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
164523367|NCT02480153|594286147|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
164523368|NCT02480153|594286145|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
164523369|NCT02480153|594286146|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
164523370|NCT02480153|594286147|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
164523371|NCT02480153|594286145|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
164523372|NCT02480153|594286146|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
164523373|NCT02480153|594286147|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
164523374|NCT02480153|594286145|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
164523375|NCT02480153|594286146|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
164523376|NCT02480153|594286147|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
164523377|NCT02480153|594286145|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
164523378|NCT02480153|594286146|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
164523379|NCT02480153|594286147|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
164523380|NCT02480153|594286145|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
164523381|NCT02480153|594286146|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
164523382|NCT02480153|594286147|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
164523383|NCT02480153|594286145|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
164523384|NCT02480153|594286146|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
164523385|NCT02480153|594286147|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
164523386|NCT02480153|594286145|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
164523387|NCT02480153|594286146|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
164523388|NCT02480153|594286147|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
164523389|NCT02480153|594286145|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
164523390|NCT02480153|594286146|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
164523391|NCT02480153|594286147|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
164523392|NCT02480153|594286145|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
164523393|NCT02480153|594286146|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
164523394|NCT02480153|594286147|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
164523395|NCT02480153|594286145|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
164523396|NCT02480153|594286146|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
164523397|NCT02480153|594286147|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
164523398|NCT02480153|594286145|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
164523399|NCT02480153|594286146|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
164523400|NCT02480153|594286147|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
164523401|NCT02480153|594286145|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
164523402|NCT02480153|594286146|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
164523403|NCT02480153|594286147|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
164523404|NCT02480153|594286145|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
164523405|NCT02480153|594286146|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
164523406|NCT02480153|594286147|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
164523407|NCT02480153|594286145|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
164523408|NCT02480153|594286146|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
164523409|NCT02480153|594286147|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
164523410|NCT02480153|594286145|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
164523411|NCT02480153|594286146|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
164523412|NCT02480153|594286147|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
164523413|NCT02480153|594286145|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
164523414|NCT02480153|594286146|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
164523415|NCT02480153|594286147|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
164523416|NCT01403610|594286148|FG000|Overall Study|Withdrawal by Subject|2|||
164523417|NCT01403610|594286149|FG001|Overall Study|Withdrawal by Subject|0|||
164523418|NCT01403610|594286150|FG002|Overall Study|Withdrawal by Subject|0|||
164523419|NCT01403610|594286151|FG003|Overall Study|Withdrawal by Subject|0|||
164523420|NCT01403610|594286148|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
164523421|NCT01403610|594286149|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
164523422|NCT01403610|594286150|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
164523423|NCT01403610|594286151|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
164523424|NCT00107120|594286152|FG000|Overall Study|Adverse Event|4|||
164523425|NCT00107120|594286153|FG001|Overall Study|Adverse Event|1|||
164523426|NCT00107120|594286152|FG000|Overall Study|Lack of Efficacy|5|||
164523427|NCT00107120|594286153|FG001|Overall Study|Lack of Efficacy|5|||
164523428|NCT00107120|594286152|FG000|Overall Study|Protocol Violation|3|||
164523429|NCT00107120|594286153|FG001|Overall Study|Protocol Violation|0|||
164523430|NCT00107120|594286152|FG000|Overall Study|Withdrawal by Subject|8|||
164523431|NCT00107120|594286153|FG001|Overall Study|Withdrawal by Subject|9|||
164523432|NCT00107120|594286152|FG000|Overall Study|Lost to Follow-up|8|||
164621189|NCT02623699|594634104|FG006|Part C (Up to 236 Days)|Death|0|||
164621190|NCT02623699|594634105|FG007|Part C (Up to 236 Days)|Death|0|||
164523433|NCT00107120|594286153|FG001|Overall Study|Lost to Follow-up|6|||
164523434|NCT00107120|594286152|FG000|Overall Study|Pregnancy|0|||
164523435|NCT00107120|594286153|FG001|Overall Study|Pregnancy|1|||
164523436|NCT00107120|594286152|FG000|Overall Study|moving away from site|1|||
164523437|NCT00107120|594286153|FG001|Overall Study|moving away from site|1|||
164523438|NCT00107120|594286152|FG000|Overall Study|death of parent|0|||
164523439|NCT00107120|594286153|FG001|Overall Study|death of parent|1|||
164523440|NCT03241225|594286156|FG000|Overall Study|Lost to Follow-up|2|||
164621191|NCT02623699|594634106|FG008|Part C (Up to 236 Days)|Death|0|||
164523441|NCT03241225|594286157|FG001|Overall Study|Lost to Follow-up|1|||
164523442|NCT03241225|594286156|FG000|Overall Study|Protocol Violation|4|||
164523443|NCT03241225|594286157|FG001|Overall Study|Protocol Violation|1|||
164523444|NCT03241225|594286156|FG000|Overall Study|Withdrawal by Subject|1|||
164523445|NCT03241225|594286157|FG001|Overall Study|Withdrawal by Subject|0|||
164523446|NCT00852540|594286158|FG000|Overall Study|Adverse Event|10|||
164621192|NCT02623699|594634107|FG009|Part C (Up to 236 Days)|Death|0|||
164621193|NCT02623699|594634108|FG010|Part C (Up to 236 Days)|Death|0|||
164621194|NCT02623699|594634109|FG011|Part C (Up to 236 Days)|Death|1|||
164621195|NCT02623699|594634098|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
164621196|NCT02623699|594634099|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
164621197|NCT02623699|594634100|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
164621198|NCT02623699|594634101|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
164621199|NCT02623699|594634102|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
164621200|NCT02623699|594634103|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
164621201|NCT02623699|594634104|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
164621202|NCT02623699|594634105|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
164621203|NCT02623699|594634106|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
164621204|NCT02623699|594634107|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
164621205|NCT02623699|594634108|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
164621206|NCT02623699|594634109|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
164621207|NCT01426009|594634110|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
164621208|NCT01426009|594634110|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
164621209|NCT01426009|594634110|FG000|Washout 1|Withdrawal by Subject|1|||
164523447|NCT00852540|594286159|FG001|Overall Study|Adverse Event|3|||
164523448|NCT00852540|594286158|FG000|Overall Study|Lack of Efficacy|15|||
164523449|NCT00852540|594286159|FG001|Overall Study|Lack of Efficacy|3|||
164523450|NCT00852540|594286158|FG000|Overall Study|Protocol Violation|1|||
164621210|NCT01426009|594634110|FG000|Washout 1|Personal Reasons|1|||
164621211|NCT01426009|594634110|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
164621212|NCT01426009|594634110|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
164523451|NCT00852540|594286159|FG001|Overall Study|Protocol Violation|2|||
164523452|NCT00852540|594286158|FG000|Overall Study|Lost to Follow-up|2|||
164523453|NCT00852540|594286159|FG001|Overall Study|Lost to Follow-up|3|||
164523454|NCT00852540|594286158|FG000|Overall Study|Investigator Discretion|2|||
164523455|NCT00852540|594286159|FG001|Overall Study|Investigator Discretion|3|||
164523456|NCT00852540|594286158|FG000|Overall Study|Withdrawal by Subject|3|||
164523457|NCT00852540|594286159|FG001|Overall Study|Withdrawal by Subject|1|||
164523458|NCT00852540|594286158|FG000|Overall Study|Did Not Receive Study Drug|3|||
164523459|NCT00852540|594286159|FG001|Overall Study|Did Not Receive Study Drug|3|||
164523460|NCT02383056|594286164|FG000|Overall Study|Adverse Event|1|||
164523461|NCT02383056|594286165|FG001|Overall Study|Adverse Event|0|||
164523462|NCT02383056|594286164|FG000|Overall Study|Lost to Follow-up|0|||
164523463|NCT02383056|594286165|FG001|Overall Study|Lost to Follow-up|2|||
164523464|NCT01775475|594286169|FG000|Overall Study|Death|3|||
164523465|NCT01775475|594286170|FG001|Overall Study|Death|3|||
164523466|NCT01635920|594286178|FG000|Overall Study|Adverse Event|1|||
164523467|NCT01635920|594286179|FG001|Overall Study|Adverse Event|0|||
164523468|NCT01635920|594286178|FG000|Overall Study|Lost to Follow-up|0|||
164523469|NCT01635920|594286179|FG001|Overall Study|Lost to Follow-up|1|||
164523470|NCT01635920|594286178|FG000|Overall Study|Subject decision|2|||
164621213|NCT01426009|594634110|FG000|Washout 2|electrive surgery|1|||
164621214|NCT01426009|594634110|FG000|Washout 3|personal reasons|1|||
164523471|NCT01635920|594286179|FG001|Overall Study|Subject decision|0|||
164523472|NCT02074553|594286180|FG000|Intervention Period 1|Family Emergency|0|||
164523473|NCT02074553|594286181|FG001|Intervention Period 1|Family Emergency|0|||
164523474|NCT02074553|594286182|FG002|Intervention Period 1|Family Emergency|0|||
164523475|NCT02074553|594286183|FG003|Intervention Period 1|Family Emergency|1|||
164523476|NCT02074553|594286184|FG004|Intervention Period 1|Family Emergency|0|||
164523477|NCT02074553|594286185|FG005|Intervention Period 1|Family Emergency|0|||
164523478|NCT02074553|594286186|FG006|Intervention Period 1|Family Emergency|0|||
164523479|NCT02074553|594286187|FG007|Intervention Period 1|Family Emergency|0|||
164523480|NCT02074553|594286180|FG000|Washout Period 1|Adverse Event|1|||
164523481|NCT02074553|594286181|FG001|Washout Period 1|Adverse Event|0|||
164523482|NCT02074553|594286182|FG002|Washout Period 1|Adverse Event|0|||
164523483|NCT02074553|594286183|FG003|Washout Period 1|Adverse Event|0|||
164523484|NCT02074553|594286184|FG004|Washout Period 1|Adverse Event|0|||
164523485|NCT02074553|594286185|FG005|Washout Period 1|Adverse Event|0|||
164523486|NCT02074553|594286186|FG006|Washout Period 1|Adverse Event|0|||
164523487|NCT02074553|594286187|FG007|Washout Period 1|Adverse Event|0|||
164523488|NCT02074553|594286180|FG000|Washout Period 1|Physician Decision|0|||
164523489|NCT02074553|594286181|FG001|Washout Period 1|Physician Decision|0|||
164523490|NCT02074553|594286182|FG002|Washout Period 1|Physician Decision|0|||
164523491|NCT02074553|594286183|FG003|Washout Period 1|Physician Decision|1|||
164523492|NCT02074553|594286184|FG004|Washout Period 1|Physician Decision|0|||
164523493|NCT02074553|594286185|FG005|Washout Period 1|Physician Decision|0|||
164523494|NCT02074553|594286186|FG006|Washout Period 1|Physician Decision|0|||
164523495|NCT02074553|594286187|FG007|Washout Period 1|Physician Decision|0|||
164523496|NCT02074553|594286180|FG000|Washout Period 1|Other|0|||
164523497|NCT02074553|594286181|FG001|Washout Period 1|Other|0|||
164523498|NCT02074553|594286182|FG002|Washout Period 1|Other|0|||
164523499|NCT02074553|594286183|FG003|Washout Period 1|Other|0|||
164523500|NCT02074553|594286184|FG004|Washout Period 1|Other|0|||
164523501|NCT02074553|594286185|FG005|Washout Period 1|Other|1|||
164523502|NCT02074553|594286186|FG006|Washout Period 1|Other|0|||
164523503|NCT02074553|594286187|FG007|Washout Period 1|Other|0|||
164523504|NCT02074553|594286180|FG000|Washout Period 2|Adverse Event|0|||
164523505|NCT02074553|594286181|FG001|Washout Period 2|Adverse Event|0|||
164523506|NCT02074553|594286182|FG002|Washout Period 2|Adverse Event|0|||
164523507|NCT02074553|594286183|FG003|Washout Period 2|Adverse Event|0|||
164523508|NCT02074553|594286184|FG004|Washout Period 2|Adverse Event|0|||
164523509|NCT02074553|594286185|FG005|Washout Period 2|Adverse Event|0|||
164523510|NCT02074553|594286186|FG006|Washout Period 2|Adverse Event|1|||
164523511|NCT02074553|594286187|FG007|Washout Period 2|Adverse Event|0|||
164523512|NCT02074553|594286180|FG000|Washout Period 2|Physician Decision|0|||
164523513|NCT02074553|594286181|FG001|Washout Period 2|Physician Decision|0|||
164523514|NCT02074553|594286182|FG002|Washout Period 2|Physician Decision|0|||
164523515|NCT02074553|594286183|FG003|Washout Period 2|Physician Decision|0|||
164523516|NCT02074553|594286184|FG004|Washout Period 2|Physician Decision|0|||
164523517|NCT02074553|594286185|FG005|Washout Period 2|Physician Decision|1|||
164523518|NCT02074553|594286186|FG006|Washout Period 2|Physician Decision|0|||
164523519|NCT02074553|594286187|FG007|Washout Period 2|Physician Decision|0|||
164523520|NCT02074553|594286180|FG000|Washout Period 2|Lost to Follow-up|0|||
164523521|NCT02074553|594286181|FG001|Washout Period 2|Lost to Follow-up|0|||
164523522|NCT02074553|594286182|FG002|Washout Period 2|Lost to Follow-up|1|||
164523523|NCT02074553|594286183|FG003|Washout Period 2|Lost to Follow-up|0|||
164523524|NCT02074553|594286184|FG004|Washout Period 2|Lost to Follow-up|0|||
164523525|NCT02074553|594286185|FG005|Washout Period 2|Lost to Follow-up|0|||
164523526|NCT02074553|594286186|FG006|Washout Period 2|Lost to Follow-up|0|||
164523527|NCT02074553|594286187|FG007|Washout Period 2|Lost to Follow-up|0|||
164523528|NCT02074553|594286180|FG000|Washout Period 3|Physician Decision|0|||
164523529|NCT02074553|594286181|FG001|Washout Period 3|Physician Decision|0|||
164523530|NCT02074553|594286182|FG002|Washout Period 3|Physician Decision|0|||
164523531|NCT02074553|594286183|FG003|Washout Period 3|Physician Decision|0|||
164523532|NCT02074553|594286184|FG004|Washout Period 3|Physician Decision|0|||
164523533|NCT02074553|594286185|FG005|Washout Period 3|Physician Decision|0|||
164523534|NCT02074553|594286186|FG006|Washout Period 3|Physician Decision|0|||
164523535|NCT02074553|594286187|FG007|Washout Period 3|Physician Decision|1|||
164523536|NCT02342743|594286188|FG000|Baseline Period|Withdrawal by Subject|3|||
164523537|NCT02342743|594286188|FG000|Baseline Period|Lost to Follow-up|2|||
164523538|NCT02342743|594286188|FG000|Baseline Period|Change in prophylactic medication|3|||
164523539|NCT02342743|594286188|FG000|Baseline Period|Screening failure regarding baseline|7|||
164523540|NCT02342743|594286188|FG000|Treatment Period|Withdrawal by Subject|2|||
164523541|NCT02342743|594286188|FG000|Treatment Period|Lost to Follow-up|8|||
164523542|NCT02342743|594286188|FG000|Treatment Period|Change in prophylactic medication|1|||
164523543|NCT00686725|594286189|FG000|Overall Study|Adverse Event|1|||
164523544|NCT00686725|594286190|FG001|Overall Study|Adverse Event|1|||
164523545|NCT00686725|594286189|FG000|Overall Study|Progressive Disease|17|||
164523546|NCT00686725|594286190|FG001|Overall Study|Progressive Disease|23|||
164523547|NCT00686725|594286189|FG000|Overall Study|Lost to Follow-up|7|||
164523548|NCT00686725|594286190|FG001|Overall Study|Lost to Follow-up|5|||
164523549|NCT00686725|594286189|FG000|Overall Study|Death|6|||
164523550|NCT00686725|594286190|FG001|Overall Study|Death|3|||
164523551|NCT00686725|594286189|FG000|Overall Study|Withdrawal by Subject|13|||
164523552|NCT00686725|594286190|FG001|Overall Study|Withdrawal by Subject|4|||
164523553|NCT00686725|594286189|FG000|Overall Study|Protocol Violation|1|||
164523554|NCT00686725|594286190|FG001|Overall Study|Protocol Violation|3|||
164523555|NCT00686725|594286189|FG000|Overall Study|Other|1|||
164523556|NCT00686725|594286190|FG001|Overall Study|Other|3|||
164523557|NCT04875676|594286191|FG000|Overall Study|Lost to Follow-up|1|||
164523558|NCT04875676|594286192|FG001|Overall Study|Lost to Follow-up|0|||
164523559|NCT04875676|594286193|FG002|Overall Study|Lost to Follow-up|0|||
164523560|NCT03064035|594286194|FG000|Overall Study|Did not receive allocated intervention|4|||
164523561|NCT03064035|594286195|FG001|Overall Study|Did not receive allocated intervention|2|||
164523562|NCT03064035|594286194|FG000|Overall Study|Lost to Follow-up|1|||
164523563|NCT03064035|594286195|FG001|Overall Study|Lost to Follow-up|1|||
164523564|NCT03602066|594286196|FG000|Overall Study|Withdrawal by Subject|2|||
164523565|NCT03602066|594286197|FG001|Overall Study|Withdrawal by Subject|0|||
164523566|NCT03602066|594286196|FG000|Overall Study|Physician Decision|1|||
164523567|NCT03602066|594286197|FG001|Overall Study|Physician Decision|0|||
164523568|NCT00092495|594286198|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
164523569|NCT00092495|594286199|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
164523570|NCT00092495|594286200|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
164523571|NCT00092495|594286201|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
164523572|NCT00092495|594286202|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
164523573|NCT00092495|594286198|FG000|Base Study Vaccination Period|Extended|0|||
164523574|NCT00092495|594286199|FG001|Base Study Vaccination Period|Extended|0|||
164523575|NCT00092495|594286200|FG002|Base Study Vaccination Period|Extended|0|||
164523576|NCT00092495|594286201|FG003|Base Study Vaccination Period|Extended|1|||
164523577|NCT00092495|594286202|FG004|Base Study Vaccination Period|Extended|0|||
164523578|NCT00092495|594286198|FG000|Base Study Vaccination Period|*Clinical AE|1|||
164523579|NCT00092495|594286199|FG001|Base Study Vaccination Period|*Clinical AE|0|||
164523580|NCT00092495|594286200|FG002|Base Study Vaccination Period|*Clinical AE|1|||
164523581|NCT00092495|594286201|FG003|Base Study Vaccination Period|*Clinical AE|2|||
164523582|NCT00092495|594286202|FG004|Base Study Vaccination Period|*Clinical AE|0|||
164523583|NCT00092495|594286198|FG000|Base Study Vaccination Period|*Other reasons|1|||
164523584|NCT00092495|594286199|FG001|Base Study Vaccination Period|*Other reasons|0|||
164523585|NCT00092495|594286200|FG002|Base Study Vaccination Period|*Other reasons|0|||
164523586|NCT00092495|594286201|FG003|Base Study Vaccination Period|*Other reasons|1|||
164523587|NCT00092495|594286202|FG004|Base Study Vaccination Period|*Other reasons|0|||
164523588|NCT00092495|594286198|FG000|Base Study Vaccination Period|*Pregnancy|0|||
164621215|NCT01426009|594634110|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
164621216|NCT01426009|594634110|FG000|Washout 4|Lost to Follow-up|1|||
164621217|NCT00515099|594634116|FG000|Overall Study|Lost to Follow-up|0|||
164621218|NCT00515099|594634117|FG001|Overall Study|Lost to Follow-up|4|||
164621219|NCT00515099|594634116|FG000|Overall Study|Withdrawal by Subject|2|||
164621220|NCT00515099|594634117|FG001|Overall Study|Withdrawal by Subject|0|||
164621221|NCT00515099|594634116|FG000|Overall Study|IRB Recommendation|1|||
164523589|NCT00092495|594286199|FG001|Base Study Vaccination Period|*Pregnancy|2|||
164523590|NCT00092495|594286200|FG002|Base Study Vaccination Period|*Pregnancy|5|||
164523591|NCT00092495|594286201|FG003|Base Study Vaccination Period|*Pregnancy|7|||
164523592|NCT00092495|594286202|FG004|Base Study Vaccination Period|*Pregnancy|0|||
164523593|NCT00092495|594286198|FG000|Base Study Vaccination Period|Adverse Event|1|||
164523594|NCT00092495|594286199|FG001|Base Study Vaccination Period|Adverse Event|0|||
164523595|NCT00092495|594286200|FG002|Base Study Vaccination Period|Adverse Event|0|||
164523596|NCT00092495|594286201|FG003|Base Study Vaccination Period|Adverse Event|3|||
164523597|NCT00092495|594286202|FG004|Base Study Vaccination Period|Adverse Event|0|||
164523598|NCT00092495|594286198|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
164523599|NCT00092495|594286199|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
164523600|NCT00092495|594286200|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
164523601|NCT00092495|594286201|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
164523602|NCT00092495|594286202|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
164523603|NCT00092495|594286198|FG000|Base Study Vaccination Period|Moved|3|||
164523604|NCT00092495|594286199|FG001|Base Study Vaccination Period|Moved|1|||
164523605|NCT00092495|594286200|FG002|Base Study Vaccination Period|Moved|2|||
164523606|NCT00092495|594286201|FG003|Base Study Vaccination Period|Moved|2|||
164523607|NCT00092495|594286202|FG004|Base Study Vaccination Period|Moved|0|||
164523608|NCT00092495|594286198|FG000|Base Study Vaccination Period|Other|1|||
164523609|NCT00092495|594286199|FG001|Base Study Vaccination Period|Other|1|||
164523610|NCT00092495|594286200|FG002|Base Study Vaccination Period|Other|0|||
164523611|NCT00092495|594286201|FG003|Base Study Vaccination Period|Other|2|||
164523612|NCT00092495|594286202|FG004|Base Study Vaccination Period|Other|0|||
164523613|NCT00092495|594286198|FG000|Base Study Vaccination Period|Pregnancy|2|||
164523614|NCT00092495|594286199|FG001|Base Study Vaccination Period|Pregnancy|0|||
164523615|NCT00092495|594286200|FG002|Base Study Vaccination Period|Pregnancy|0|||
164523616|NCT00092495|594286201|FG003|Base Study Vaccination Period|Pregnancy|0|||
164523617|NCT00092495|594286202|FG004|Base Study Vaccination Period|Pregnancy|0|||
164523618|NCT00092495|594286198|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
164523619|NCT00092495|594286199|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
164523620|NCT00092495|594286200|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
164523621|NCT00092495|594286201|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
164523622|NCT00092495|594286202|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
164523623|NCT00092495|594286198|FG000|Base Study Vaccination Period|Protocol Violation|1|||
164523624|NCT00092495|594286199|FG001|Base Study Vaccination Period|Protocol Violation|0|||
164523625|NCT00092495|594286200|FG002|Base Study Vaccination Period|Protocol Violation|0|||
164523626|NCT00092495|594286201|FG003|Base Study Vaccination Period|Protocol Violation|0|||
164523627|NCT00092495|594286202|FG004|Base Study Vaccination Period|Protocol Violation|0|||
164523628|NCT00092495|594286198|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
164621222|NCT00515099|594634117|FG001|Overall Study|IRB Recommendation|0|||
164621223|NCT03342404|594634118|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
164621224|NCT03342404|594634119|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
164621225|NCT03342404|594634118|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
164621226|NCT03342404|594634119|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
164621227|NCT03342404|594634118|FG000|Blinded Treatment Phase|Adverse Event|5|||
164621228|NCT03342404|594634119|FG001|Blinded Treatment Phase|Adverse Event|4|||
164621229|NCT03342404|594634118|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
164621230|NCT03342404|594634119|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
164621231|NCT03342404|594634118|FG000|Blinded Treatment Phase|Other reasons|1|||
164621232|NCT03342404|594634119|FG001|Blinded Treatment Phase|Other reasons|0|||
164621233|NCT03342404|594634118|FG000|Blinded Treatment Phase|Physician Decision|1|||
164621234|NCT03342404|594634119|FG001|Blinded Treatment Phase|Physician Decision|0|||
164621235|NCT03342404|594634118|FG000|Blinded Treatment Phase|Death|1|||
164621236|NCT03342404|594634119|FG001|Blinded Treatment Phase|Death|0|||
164621237|NCT03342404|594634118|FG000|Open-Label Phase|Lost to Follow-up|0|||
164621238|NCT03342404|594634119|FG001|Open-Label Phase|Lost to Follow-up|1|||
164621239|NCT03342404|594634118|FG000|Open-Label Phase|Other reasons|0|||
164621240|NCT03342404|594634119|FG001|Open-Label Phase|Other reasons|1|||
164621241|NCT03342404|594634118|FG000|Open-Label Phase|Adverse Event|0|||
164621242|NCT03342404|594634119|FG001|Open-Label Phase|Adverse Event|3|||
164621243|NCT03342404|594634118|FG000|Open-Label Phase|Withdrawal by Subject|0|||
164621244|NCT03342404|594634119|FG001|Open-Label Phase|Withdrawal by Subject|6|||
164621245|NCT00372489|594634125|FG000|Overall Study|Adverse Event|18|||
164621246|NCT00372489|594634125|FG000|Overall Study|Lack of Efficacy|1|||
164523629|NCT00092495|594286199|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
164523630|NCT00092495|594286200|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
164523631|NCT00092495|594286201|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
164523632|NCT00092495|594286202|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
164523633|NCT00092495|594286198|FG000|Base Study Follow-up Period|Extended|0|||
164523634|NCT00092495|594286199|FG001|Base Study Follow-up Period|Extended|0|||
164523635|NCT00092495|594286200|FG002|Base Study Follow-up Period|Extended|1|||
164523636|NCT00092495|594286201|FG003|Base Study Follow-up Period|Extended|2|||
164523637|NCT00092495|594286202|FG004|Base Study Follow-up Period|Extended|0|||
164523638|NCT00092495|594286198|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
164523639|NCT00092495|594286199|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
164523640|NCT00092495|594286200|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
164523641|NCT00092495|594286201|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
164523642|NCT00092495|594286202|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
164523643|NCT00092495|594286198|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
164523644|NCT00092495|594286199|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
164523645|NCT00092495|594286200|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
164523646|NCT00092495|594286201|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
164523647|NCT00092495|594286202|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
164523648|NCT03103763|594286205|FG000|Overall Study|Death|15|||
164523649|NCT03103763|594286206|FG001|Overall Study|Death|5|||
164523650|NCT03103763|594286207|FG002|Overall Study|Death|5|||
164523651|NCT03103763|594286205|FG000|Overall Study|Withdrawal by Subject|0|||
164621247|NCT00372489|594634125|FG000|Overall Study|Lost to Follow-up|3|||
164621248|NCT00372489|594634125|FG000|Overall Study|Physician Decision|3|||
164621249|NCT00372489|594634125|FG000|Overall Study|Withdrawal by Subject|5|||
164621250|NCT00372489|594634125|FG000|Overall Study|Patient Relocation|2|||
164621251|NCT00372489|594634125|FG000|Overall Study|Renal transplant|6|||
164621252|NCT00372489|594634125|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
164621253|NCT00772889|594634126|FG000|Overall Study|Adverse Event|7|||
164621254|NCT00772889|594634127|FG001|Overall Study|Adverse Event|4|||
164621255|NCT00772889|594634128|FG002|Overall Study|Adverse Event|0|||
164621256|NCT00772889|594634126|FG000|Overall Study|Withdrawal by Subject|9|||
164523652|NCT03103763|594286206|FG001|Overall Study|Withdrawal by Subject|3|||
164523653|NCT03103763|594286207|FG002|Overall Study|Withdrawal by Subject|2|||
164523654|NCT00938470|594286208|FG000|Overall Study|Disease Progression|3|||
164523655|NCT00938470|594286209|FG001|Overall Study|Disease Progression|0|||
164523656|NCT00938470|594286208|FG000|Overall Study|Alternate Treatment|1|||
164523657|NCT00938470|594286209|FG001|Overall Study|Alternate Treatment|0|||
164523658|NCT00938470|594286208|FG000|Overall Study|Death|3|||
164523659|NCT00938470|594286209|FG001|Overall Study|Death|2|||
164523660|NCT00938470|594286208|FG000|Overall Study|Other Reason|0|||
164523661|NCT00938470|594286209|FG001|Overall Study|Other Reason|1|||
164523662|NCT02336178|594286210|FG000|Overall Study|Lost to Follow-up|1|||
164523663|NCT02336178|594286210|FG000|Overall Study|Protocol Violation|1|||
164523664|NCT02336178|594286210|FG000|Overall Study|Withdrawal by Subject|1|||
164523665|NCT02336178|594286210|FG000|Overall Study|Other|1|||
164523666|NCT03245151|594286211|FG000|Overall Study|Withdrawal by Subject|2|||
164523667|NCT03245151|594286212|FG001|Overall Study|Withdrawal by Subject|0|||
164523668|NCT03245151|594286213|FG002|Overall Study|Withdrawal by Subject|0|||
164523669|NCT03245151|594286214|FG003|Overall Study|Withdrawal by Subject|2|||
164523670|NCT03245151|594286215|FG004|Overall Study|Withdrawal by Subject|1|||
164523671|NCT03245151|594286211|FG000|Overall Study|Death|3|||
164523672|NCT03245151|594286212|FG001|Overall Study|Death|14|||
164523673|NCT03245151|594286213|FG002|Overall Study|Death|9|||
164523674|NCT03245151|594286214|FG003|Overall Study|Death|16|||
164523675|NCT03245151|594286215|FG004|Overall Study|Death|7|||
164621257|NCT00772889|594634127|FG001|Overall Study|Withdrawal by Subject|8|||
164621258|NCT00772889|594634128|FG002|Overall Study|Withdrawal by Subject|9|||
164621259|NCT00772889|594634126|FG000|Overall Study|Lost to Follow-up|6|||
164621260|NCT00772889|594634127|FG001|Overall Study|Lost to Follow-up|6|||
164621261|NCT00772889|594634128|FG002|Overall Study|Lost to Follow-up|7|||
164621262|NCT03323086|594634129|FG000|Overall Study|Lost to Follow-up|3|||
164621263|NCT03323086|594634130|FG001|Overall Study|Lost to Follow-up|2|||
164621264|NCT00355615|594634136|FG000|Randomized Double Blind Period|Adverse Event|1|||
164621265|NCT00355615|594634137|FG001|Randomized Double Blind Period|Adverse Event|0|||
164621266|NCT00355615|594634138|FG002|Randomized Double Blind Period|Adverse Event|0|||
164147694|NCT03910673|592902128|FG004|Overall Study|Adverse Event|0|||
164523676|NCT03245151|594286211|FG000|Overall Study|Sponsor's decision|0|||
164523677|NCT03245151|594286212|FG001|Overall Study|Sponsor's decision|1|||
164523678|NCT03245151|594286213|FG002|Overall Study|Sponsor's decision|0|||
164523679|NCT03245151|594286214|FG003|Overall Study|Sponsor's decision|0|||
164523680|NCT03245151|594286215|FG004|Overall Study|Sponsor's decision|0|||
164523681|NCT01970345|594286216|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
164523682|NCT01970345|594286217|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
164523683|NCT01970345|594286216|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
164523684|NCT01970345|594286217|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
164523685|NCT00618618|594286218|FG000|Overall Study|Patient Request|0|||
164523686|NCT00618618|594286219|FG001|Overall Study|Patient Request|0|||
164523687|NCT00618618|594286220|FG002|Overall Study|Patient Request|2|||
164621267|NCT00355615|594634139|FG003|Randomized Double Blind Period|Adverse Event|0|||
164621268|NCT00355615|594634140|FG004|Randomized Double Blind Period|Adverse Event|0|||
164523688|NCT00618618|594286221|FG003|Overall Study|Patient Request|0|||
164523689|NCT00618618|594286218|FG000|Overall Study|Inability to Complete Study Procedures|0|||
164523690|NCT00618618|594286219|FG001|Overall Study|Inability to Complete Study Procedures|1|||
164523691|NCT00618618|594286220|FG002|Overall Study|Inability to Complete Study Procedures|0|||
164523692|NCT00618618|594286221|FG003|Overall Study|Inability to Complete Study Procedures|0|||
164523693|NCT00618618|594286218|FG000|Overall Study|Lost to Follow-up|3|||
164523694|NCT00618618|594286219|FG001|Overall Study|Lost to Follow-up|0|||
164523695|NCT00618618|594286220|FG002|Overall Study|Lost to Follow-up|0|||
164523696|NCT00618618|594286221|FG003|Overall Study|Lost to Follow-up|1|||
164523697|NCT00618618|594286218|FG000|Overall Study|Non-compliance|1|||
164523698|NCT00618618|594286219|FG001|Overall Study|Non-compliance|1|||
164523699|NCT00618618|594286220|FG002|Overall Study|Non-compliance|0|||
164523700|NCT00618618|594286221|FG003|Overall Study|Non-compliance|0|||
164523701|NCT00618618|594286218|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
164523702|NCT00618618|594286219|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
164523703|NCT00618618|594286220|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
164523704|NCT00618618|594286221|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
164523705|NCT00618618|594286218|FG000|Overall Study|Death|0|||
164523706|NCT00618618|594286219|FG001|Overall Study|Death|1|||
164523707|NCT00618618|594286220|FG002|Overall Study|Death|0|||
164523708|NCT00618618|594286221|FG003|Overall Study|Death|0|||
164523709|NCT00621777|594286222|FG000|Open Phase|Adverse Event|20|||
164523710|NCT00621777|594286223|FG001|Open Phase|Adverse Event|0|||
164523711|NCT00621777|594286222|FG000|Open Phase|Did not abstain during open phase|56|||
164523712|NCT00621777|594286223|FG001|Open Phase|Did not abstain during open phase|0|||
164523713|NCT00621777|594286222|FG000|Open Phase|Withdrawal by Subject|17|||
164523714|NCT00621777|594286223|FG001|Open Phase|Withdrawal by Subject|0|||
164523715|NCT00621777|594286222|FG000|Open Phase|administrative|13|||
164523716|NCT00621777|594286223|FG001|Open Phase|administrative|0|||
164523717|NCT00621777|594286222|FG000|Open Phase|Lost to Follow-up|10|||
164523718|NCT00621777|594286223|FG001|Open Phase|Lost to Follow-up|0|||
164523719|NCT00621777|594286222|FG000|Randomized Phase|Adverse Event|3|||
164523720|NCT00621777|594286223|FG001|Randomized Phase|Adverse Event|3|||
164523721|NCT00621777|594286222|FG000|Randomized Phase|Lost to Follow-up|3|||
164523722|NCT00621777|594286223|FG001|Randomized Phase|Lost to Follow-up|3|||
164523723|NCT00621777|594286222|FG000|Randomized Phase|Withdrawal by Subject|1|||
164523724|NCT00621777|594286223|FG001|Randomized Phase|Withdrawal by Subject|9|||
164523725|NCT00621777|594286222|FG000|Randomized Phase|administrative|0|||
164523726|NCT00621777|594286223|FG001|Randomized Phase|administrative|3|||
164523727|NCT00621777|594286222|FG000|Randomized Phase|Death|0|||
164523728|NCT00621777|594286223|FG001|Randomized Phase|Death|1|||
164523729|NCT02663518|594286226|FG000|Part 1: Phase 1a Escalation|Death|0|||
164523730|NCT02663518|594286227|FG001|Part 1: Phase 1a Escalation|Death|0|||
164523731|NCT02663518|594286228|FG002|Part 1: Phase 1a Escalation|Death|1|||
164523732|NCT02663518|594286229|FG003|Part 1: Phase 1a Escalation|Death|0|||
164523733|NCT02663518|594286230|FG004|Part 1: Phase 1a Escalation|Death|0|||
164523734|NCT02663518|594286231|FG005|Part 1: Phase 1a Escalation|Death|0|||
164523735|NCT02663518|594286232|FG006|Part 1: Phase 1a Escalation|Death|0|||
164523736|NCT02663518|594286233|FG007|Part 1: Phase 1a Escalation|Death|0|||
164523737|NCT02663518|594286234|FG008|Part 1: Phase 1a Escalation|Death|0|||
164523738|NCT02663518|594286235|FG009|Part 1: Phase 1a Escalation|Death|0|||
164523739|NCT02663518|594286236|FG010|Part 1: Phase 1a Escalation|Death|0|||
164523740|NCT02663518|594286237|FG011|Part 1: Phase 1a Escalation|Death|0|||
164523741|NCT02663518|594286238|FG012|Part 1: Phase 1a Escalation|Death|0|||
164523742|NCT02663518|594286239|FG013|Part 1: Phase 1a Escalation|Death|0|||
164523743|NCT02663518|594286226|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
164523744|NCT02663518|594286227|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
164523745|NCT02663518|594286228|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
164523746|NCT02663518|594286229|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
164523747|NCT02663518|594286230|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
164523748|NCT02663518|594286231|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
164523749|NCT02663518|594286232|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
164523750|NCT02663518|594286233|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
164621269|NCT00355615|594634136|FG000|Randomized Double Blind Period|Protocol Violation|0|||
164621270|NCT00355615|594634137|FG001|Randomized Double Blind Period|Protocol Violation|0|||
164621271|NCT00355615|594634138|FG002|Randomized Double Blind Period|Protocol Violation|1|||
164621272|NCT00355615|594634139|FG003|Randomized Double Blind Period|Protocol Violation|1|||
164621273|NCT00355615|594634140|FG004|Randomized Double Blind Period|Protocol Violation|0|||
164621274|NCT00355615|594634136|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
164523751|NCT02663518|594286234|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
164523752|NCT02663518|594286235|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
164523753|NCT02663518|594286236|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
164523754|NCT02663518|594286237|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
164523755|NCT02663518|594286238|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
164523756|NCT02663518|594286239|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
164523757|NCT02663518|594286226|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
164523758|NCT02663518|594286227|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
164523759|NCT02663518|594286228|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
164523760|NCT02663518|594286229|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
164523761|NCT02663518|594286230|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
164523762|NCT02663518|594286231|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
164523763|NCT02663518|594286232|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
164523764|NCT02663518|594286233|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
164523765|NCT02663518|594286234|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
164523766|NCT02663518|594286235|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
164523767|NCT02663518|594286236|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
164523768|NCT02663518|594286237|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
164523769|NCT02663518|594286238|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
164523770|NCT02663518|594286239|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
164523771|NCT02663518|594286226|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
164523772|NCT02663518|594286227|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
164523773|NCT02663518|594286228|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
164523774|NCT02663518|594286229|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
164523775|NCT02663518|594286230|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
164523776|NCT02663518|594286231|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
164523777|NCT02663518|594286232|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
164523778|NCT02663518|594286233|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
164523779|NCT02663518|594286234|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
164523780|NCT02663518|594286235|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
164523781|NCT02663518|594286236|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
164523782|NCT02663518|594286237|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
164523783|NCT02663518|594286238|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
164523784|NCT02663518|594286239|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
164523785|NCT02663518|594286226|FG000|Part 1: Phase 1a Escalation|Other|0|||
164523786|NCT02663518|594286227|FG001|Part 1: Phase 1a Escalation|Other|0|||
164523787|NCT02663518|594286228|FG002|Part 1: Phase 1a Escalation|Other|2|||
164523788|NCT02663518|594286229|FG003|Part 1: Phase 1a Escalation|Other|0|||
164523789|NCT02663518|594286230|FG004|Part 1: Phase 1a Escalation|Other|0|||
164523790|NCT02663518|594286231|FG005|Part 1: Phase 1a Escalation|Other|0|||
164523791|NCT02663518|594286232|FG006|Part 1: Phase 1a Escalation|Other|0|||
164523792|NCT02663518|594286233|FG007|Part 1: Phase 1a Escalation|Other|0|||
164523793|NCT02663518|594286234|FG008|Part 1: Phase 1a Escalation|Other|0|||
164523794|NCT02663518|594286235|FG009|Part 1: Phase 1a Escalation|Other|0|||
164523795|NCT02663518|594286236|FG010|Part 1: Phase 1a Escalation|Other|0|||
164523796|NCT02663518|594286237|FG011|Part 1: Phase 1a Escalation|Other|0|||
164523797|NCT02663518|594286238|FG012|Part 1: Phase 1a Escalation|Other|0|||
164523798|NCT02663518|594286239|FG013|Part 1: Phase 1a Escalation|Other|0|||
164523799|NCT02663518|594286226|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
164523800|NCT02663518|594286227|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
164523801|NCT02663518|594286228|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
164523802|NCT02663518|594286229|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
164523803|NCT02663518|594286230|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
164523804|NCT02663518|594286231|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
164523805|NCT02663518|594286232|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
164523806|NCT02663518|594286233|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
164523807|NCT02663518|594286234|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
164523808|NCT02663518|594286235|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
164523809|NCT02663518|594286236|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
164523810|NCT02663518|594286237|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
164523811|NCT02663518|594286238|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
164523812|NCT02663518|594286239|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
164523813|NCT02663518|594286226|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
164523814|NCT02663518|594286227|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
164147695|NCT02006732|592902129|FG000|Overall Study|Adverse Event|10|||
164523815|NCT02663518|594286228|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
164523816|NCT02663518|594286229|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
164523817|NCT02663518|594286230|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
164523818|NCT02663518|594286231|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
164523819|NCT02663518|594286232|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
164523820|NCT02663518|594286233|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
164523821|NCT02663518|594286234|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
164523822|NCT02663518|594286235|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
164523823|NCT02663518|594286236|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
164523824|NCT02663518|594286237|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
164523825|NCT02663518|594286238|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
164523826|NCT02663518|594286239|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
164523827|NCT02663518|594286226|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
164523828|NCT02663518|594286227|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
164523829|NCT02663518|594286228|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
164523830|NCT02663518|594286229|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
164523831|NCT02663518|594286230|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
164523832|NCT02663518|594286231|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
164523833|NCT02663518|594286232|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
164523834|NCT02663518|594286233|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
164523835|NCT02663518|594286234|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
164523836|NCT02663518|594286235|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
164523837|NCT02663518|594286236|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
164523838|NCT02663518|594286237|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
164523839|NCT02663518|594286238|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
164523840|NCT02663518|594286239|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
164523841|NCT02663518|594286226|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
164523842|NCT02663518|594286227|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
164523843|NCT02663518|594286228|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
164523844|NCT02663518|594286229|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
164523845|NCT02663518|594286230|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
164523846|NCT02663518|594286231|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
164523847|NCT02663518|594286232|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
164523848|NCT02663518|594286233|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
164523849|NCT02663518|594286234|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
164523850|NCT02663518|594286235|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
164523851|NCT02663518|594286236|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
164523852|NCT02663518|594286237|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
164523853|NCT02663518|594286238|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
164523854|NCT02663518|594286239|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
164523855|NCT02663518|594286226|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
164523856|NCT02663518|594286227|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
164523857|NCT02663518|594286228|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
164523858|NCT02663518|594286229|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
164523859|NCT02663518|594286230|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
164523860|NCT02663518|594286231|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
164523861|NCT02663518|594286232|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
164523862|NCT02663518|594286233|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
164523863|NCT02663518|594286234|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
164523864|NCT02663518|594286235|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
164523865|NCT02663518|594286236|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
164523866|NCT02663518|594286237|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
164523867|NCT02663518|594286238|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
164523868|NCT02663518|594286239|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
164523869|NCT02663518|594286226|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
164621275|NCT00355615|594634137|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
164621276|NCT00355615|594634138|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
164621277|NCT00355615|594634139|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
164621278|NCT00355615|594634140|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
164621279|NCT00355615|594634136|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
164621280|NCT00355615|594634137|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
164621281|NCT00355615|594634138|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
164621282|NCT00355615|594634139|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
164621283|NCT00355615|594634140|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
164621284|NCT00355615|594634136|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
164621285|NCT00355615|594634137|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
164621286|NCT00355615|594634138|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
164621287|NCT00355615|594634139|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
164621288|NCT00355615|594634140|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
164523870|NCT02663518|594286227|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
164523871|NCT02663518|594286228|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
164523872|NCT02663518|594286229|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
164523873|NCT02663518|594286230|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
164523874|NCT02663518|594286231|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
164523875|NCT02663518|594286232|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
164523876|NCT02663518|594286233|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
164523877|NCT02663518|594286234|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
164523878|NCT02663518|594286235|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
164523879|NCT02663518|594286236|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
164523880|NCT02663518|594286237|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
164523881|NCT02663518|594286238|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
164523882|NCT02663518|594286239|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
164523883|NCT02663518|594286226|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
164523884|NCT02663518|594286227|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
164523885|NCT02663518|594286228|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
164523886|NCT02663518|594286229|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
164523887|NCT02663518|594286230|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
164523888|NCT02663518|594286231|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
164523889|NCT02663518|594286232|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
164523890|NCT02663518|594286233|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
164523891|NCT02663518|594286234|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
164523892|NCT02663518|594286235|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
164523893|NCT02663518|594286236|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
164523894|NCT02663518|594286237|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
164523895|NCT02663518|594286238|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
164523896|NCT02663518|594286239|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
164523897|NCT02663518|594286226|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
164523898|NCT02663518|594286227|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
164523899|NCT02663518|594286228|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
164523900|NCT02663518|594286229|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
164523901|NCT02663518|594286230|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
164523902|NCT02663518|594286231|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
164523903|NCT02663518|594286232|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
164523904|NCT02663518|594286233|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
164523905|NCT02663518|594286234|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
164523906|NCT02663518|594286235|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
164523907|NCT02663518|594286236|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
164523908|NCT02663518|594286237|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
164523909|NCT02663518|594286238|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
164523910|NCT02663518|594286239|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
164523911|NCT02663518|594286226|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
164523912|NCT02663518|594286227|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
164523913|NCT02663518|594286228|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
164523914|NCT02663518|594286229|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
164523915|NCT02663518|594286230|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
164523916|NCT02663518|594286231|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
164523917|NCT02663518|594286232|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
164523918|NCT02663518|594286233|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
164523919|NCT02663518|594286234|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
164523920|NCT02663518|594286235|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
164523921|NCT02663518|594286236|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
164523922|NCT02663518|594286237|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
164523923|NCT02663518|594286238|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
164523924|NCT02663518|594286239|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
164523925|NCT02663518|594286226|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
164523926|NCT02663518|594286227|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
164523927|NCT02663518|594286228|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
164523928|NCT02663518|594286229|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
164523929|NCT02663518|594286230|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
164523930|NCT02663518|594286231|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
164523931|NCT02663518|594286232|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
164523932|NCT02663518|594286233|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
164523933|NCT02663518|594286234|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
164523934|NCT02663518|594286235|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
164147696|NCT02006732|592902130|FG001|Overall Study|Adverse Event|7|||
164523935|NCT02663518|594286236|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
164523936|NCT02663518|594286237|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
164523937|NCT02663518|594286238|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
164523938|NCT02663518|594286239|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
164523939|NCT02663518|594286226|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
164523940|NCT02663518|594286227|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
164523941|NCT02663518|594286228|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
164523942|NCT02663518|594286229|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
164523943|NCT02663518|594286230|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
164523944|NCT02663518|594286231|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
164523945|NCT02663518|594286232|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
164523946|NCT02663518|594286233|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
164523947|NCT02663518|594286234|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
164523948|NCT02663518|594286235|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
164523949|NCT02663518|594286236|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
164523950|NCT02663518|594286237|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
164523951|NCT02663518|594286238|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
164523952|NCT02663518|594286239|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
164523953|NCT02663518|594286226|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
164523954|NCT02663518|594286227|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
164523955|NCT02663518|594286228|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
164523956|NCT02663518|594286229|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
164523957|NCT02663518|594286230|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
164523958|NCT02663518|594286231|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
164523959|NCT02663518|594286232|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
164523960|NCT02663518|594286233|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
164523961|NCT02663518|594286234|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
164523962|NCT02663518|594286235|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
164523963|NCT02663518|594286236|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
164523964|NCT02663518|594286237|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
164523965|NCT02663518|594286238|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
164523966|NCT02663518|594286239|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
164523967|NCT00006011|594286243|FG000|Overall Study|Disease progression|13|||
164523968|NCT00006011|594286244|FG001|Overall Study|Disease progression|6|||
164523969|NCT00006011|594286245|FG002|Overall Study|Disease progression|26|||
164523970|NCT00006011|594286243|FG000|Overall Study|Refused further treatment|15|||
164523971|NCT00006011|594286244|FG001|Overall Study|Refused further treatment|13|||
164523972|NCT00006011|594286245|FG002|Overall Study|Refused further treatment|26|||
164523973|NCT00006011|594286243|FG000|Overall Study|Adverse Event|15|||
164523974|NCT00006011|594286244|FG001|Overall Study|Adverse Event|39|||
164523975|NCT00006011|594286245|FG002|Overall Study|Adverse Event|5|||
164523976|NCT00006011|594286243|FG000|Overall Study|Death|0|||
164523977|NCT00006011|594286244|FG001|Overall Study|Death|1|||
164523978|NCT00006011|594286245|FG002|Overall Study|Death|2|||
164523979|NCT00006011|594286243|FG000|Overall Study|Other|4|||
164523980|NCT00006011|594286244|FG001|Overall Study|Other|2|||
164523981|NCT00006011|594286245|FG002|Overall Study|Other|5|||
164523982|NCT00006011|594286243|FG000|Overall Study|Ineligible|18|||
164523983|NCT00006011|594286244|FG001|Overall Study|Ineligible|16|||
164523984|NCT00006011|594286245|FG002|Overall Study|Ineligible|9|||
164523985|NCT01004848|594286246|FG000|Overall Study|Lost to Follow-up|55|||
164523986|NCT01004848|594286247|FG001|Overall Study|Lost to Follow-up|45|||
164523987|NCT01844687|594286253|FG000|Visit 1|Protocol Violation|3|||
164523988|NCT01844687|594286253|FG000|Visit 1|Lost to Follow-up|5|||
164523989|NCT01844687|594286253|FG000|Visit 2|Withdrawal by Subject|1|||
164523990|NCT01844687|594286253|FG000|Visit 2|Protocol Violation|1|||
164523991|NCT01844687|594286253|FG000|Visit 3|Lost to Follow-up|1|||
164523992|NCT01844687|594286253|FG000|Visit 3|Withdrawal by Subject|3|||
164523993|NCT01844687|594286253|FG000|Visit 3|child care problems|1|||
164523994|NCT01844687|594286253|FG000|Visit 4|Pregnancy|1|||
164523995|NCT01844687|594286253|FG000|Visit 4|Lost to Follow-up|1|||
164523996|NCT01844687|594286253|FG000|Visit 4|Withdrawal by Subject|2|||
164523997|NCT00158860|594286260|FG000|Overall Study|Adverse Event|3|||
164523998|NCT00158860|594286261|FG001|Overall Study|Adverse Event|6|||
164523999|NCT00158860|594286260|FG000|Overall Study|Lost to Follow-up|11|||
164524000|NCT00158860|594286261|FG001|Overall Study|Lost to Follow-up|17|||
164524001|NCT00158860|594286260|FG000|Overall Study|Protocol Violation|8|||
164524002|NCT00158860|594286261|FG001|Overall Study|Protocol Violation|23|||
164524003|NCT00158860|594286260|FG000|Overall Study|Withdrawal by Subject|7|||
164524004|NCT00158860|594286261|FG001|Overall Study|Withdrawal by Subject|17|||
164524005|NCT00158860|594286260|FG000|Overall Study|MOVING OUT OF STATE|1|||
164524006|NCT00158860|594286261|FG001|Overall Study|MOVING OUT OF STATE|0|||
164524007|NCT00158860|594286260|FG000|Overall Study|Pregnancy|3|||
164524008|NCT00158860|594286261|FG001|Overall Study|Pregnancy|3|||
164524009|NCT00158860|594286260|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
164524010|NCT00158860|594286261|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
164524011|NCT00158860|594286260|FG000|Overall Study|SPONSOR REQUEST|0|||
164524012|NCT00158860|594286261|FG001|Overall Study|SPONSOR REQUEST|1|||
164524013|NCT00158860|594286260|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
164524014|NCT00158860|594286261|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
164524015|NCT00158860|594286260|FG000|Overall Study|Closed per sponsor|0|||
164524016|NCT00158860|594286261|FG001|Overall Study|Closed per sponsor|1|||
164524017|NCT02559895|594286265|FG000|Overall Study|Adverse Event|3|||
164524018|NCT02559895|594286266|FG001|Overall Study|Adverse Event|3|||
164524019|NCT02559895|594286267|FG002|Overall Study|Adverse Event|2|||
164524020|NCT02559895|594286268|FG003|Overall Study|Adverse Event|1|||
164524021|NCT02559895|594286265|FG000|Overall Study|Lack of Efficacy|2|||
164524022|NCT02559895|594286266|FG001|Overall Study|Lack of Efficacy|3|||
164524023|NCT02559895|594286267|FG002|Overall Study|Lack of Efficacy|2|||
164524024|NCT02559895|594286268|FG003|Overall Study|Lack of Efficacy|8|||
164524025|NCT02559895|594286265|FG000|Overall Study|Lost to Follow-up|22|||
164524026|NCT02559895|594286266|FG001|Overall Study|Lost to Follow-up|16|||
164524027|NCT02559895|594286267|FG002|Overall Study|Lost to Follow-up|12|||
164524028|NCT02559895|594286268|FG003|Overall Study|Lost to Follow-up|17|||
164524029|NCT02559895|594286265|FG000|Overall Study|Physician Decision|1|||
164524030|NCT02559895|594286266|FG001|Overall Study|Physician Decision|1|||
164524031|NCT02559895|594286267|FG002|Overall Study|Physician Decision|3|||
164524032|NCT02559895|594286268|FG003|Overall Study|Physician Decision|0|||
164524033|NCT02559895|594286265|FG000|Overall Study|Withdrawal by Subject|16|||
164524034|NCT02559895|594286266|FG001|Overall Study|Withdrawal by Subject|9|||
164524035|NCT02559895|594286267|FG002|Overall Study|Withdrawal by Subject|20|||
164524036|NCT02559895|594286268|FG003|Overall Study|Withdrawal by Subject|9|||
164524037|NCT02559895|594286265|FG000|Overall Study|Study Burden|10|||
164524038|NCT02559895|594286266|FG001|Overall Study|Study Burden|16|||
164524039|NCT02559895|594286267|FG002|Overall Study|Study Burden|12|||
164524040|NCT02559895|594286268|FG003|Overall Study|Study Burden|22|||
164524041|NCT02559895|594286265|FG000|Overall Study|Other|1|||
164524042|NCT02559895|594286266|FG001|Overall Study|Other|5|||
164524043|NCT02559895|594286267|FG002|Overall Study|Other|3|||
164524044|NCT02559895|594286268|FG003|Overall Study|Other|3|||
164524045|NCT02019667|594286269|FG000|First Intervention (6 Months)|Adverse Event|0|||
164524046|NCT02019667|594286270|FG001|First Intervention (6 Months)|Adverse Event|1|||
164524047|NCT02019667|594286269|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
164524048|NCT02019667|594286270|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
164524049|NCT02019667|594286269|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
164524050|NCT02019667|594286270|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
164524051|NCT02432196|594286271|FG000|Overall Study|Exit - did not receive study device|1|||
164524052|NCT02432196|594286271|FG000|Overall Study|Death|2|||
164524053|NCT02432196|594286271|FG000|Overall Study|Reoperation|3|||
164524054|NCT01942785|594286276|FG000|Overall Study|Adverse Event|2|||
164524055|NCT01942785|594286276|FG000|Overall Study|Withdrawal by Subject|1|||
164524056|NCT01942785|594286276|FG000|Overall Study|Protocol Violation|1|||
164524057|NCT05453201|594286282|FG000|Overall Study|Withdrawal by Subject|1|||
164524058|NCT01934790|594286283|FG000|Treatment|Adverse Event|3|||
164524059|NCT01934790|594286283|FG000|Treatment|Clinical progression|6|||
164524060|NCT01934790|594286283|FG000|Treatment|Radiological progression|4|||
164524061|NCT01934790|594286283|FG000|Treatment|Withdrawal by Subject|2|||
164524062|NCT01934790|594286283|FG000|Treatment|Study drug never administered|1|||
164524063|NCT01934790|594286283|FG000|Active Follow up|Death|20|||
164524064|NCT01934790|594286283|FG000|Active Follow up|Physician Decision|2|||
164524065|NCT01934790|594286283|FG000|Active Follow up|Progressive disease|1|||
164524066|NCT01934790|594286283|FG000|Active Follow up|Other reason|1|||
164524067|NCT00552929|594286286|FG000|Overall Study|Lost to Follow-up|0|||
164524068|NCT00552929|594286287|FG001|Overall Study|Lost to Follow-up|0|||
164621289|NCT00355615|594634136|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
164621290|NCT00355615|594634137|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
164621291|NCT00355615|594634138|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
164621292|NCT00355615|594634139|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
164621293|NCT00355615|594634140|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
164621294|NCT00085644|594634143|FG000|Double-Blind Period|Adverse Event|5|||
164621295|NCT00085644|594634144|FG001|Double-Blind Period|Adverse Event|2|||
164621296|NCT00085644|594634145|FG002|Double-Blind Period|Adverse Event|0|||
164621297|NCT00085644|594634143|FG000|Double-Blind Period|Withdrawal by Subject|3|||
164524069|NCT00552929|594286288|FG002|Overall Study|Lost to Follow-up|0|||
164524070|NCT00552929|594286289|FG003|Overall Study|Lost to Follow-up|0|||
164524071|NCT00552929|594286290|FG004|Overall Study|Lost to Follow-up|0|||
164524072|NCT00552929|594286291|FG005|Overall Study|Lost to Follow-up|0|||
164524073|NCT00552929|594286292|FG006|Overall Study|Lost to Follow-up|0|||
164524074|NCT00552929|594286293|FG007|Overall Study|Lost to Follow-up|0|||
164524075|NCT00552929|594286294|FG008|Overall Study|Lost to Follow-up|1|||
164524076|NCT00552929|594286295|FG009|Overall Study|Lost to Follow-up|0|||
164524077|NCT00552929|594286286|FG000|Overall Study|Not Eligible|0|||
164524078|NCT00552929|594286287|FG001|Overall Study|Not Eligible|0|||
164524079|NCT00552929|594286288|FG002|Overall Study|Not Eligible|0|||
164524080|NCT00552929|594286289|FG003|Overall Study|Not Eligible|0|||
164524081|NCT00552929|594286290|FG004|Overall Study|Not Eligible|0|||
164524082|NCT00552929|594286291|FG005|Overall Study|Not Eligible|1|||
164524083|NCT00552929|594286292|FG006|Overall Study|Not Eligible|0|||
164524084|NCT00552929|594286293|FG007|Overall Study|Not Eligible|0|||
164524085|NCT00552929|594286294|FG008|Overall Study|Not Eligible|0|||
164524086|NCT00552929|594286295|FG009|Overall Study|Not Eligible|0|||
164524087|NCT01147536|594286298|FG000|Overall Study|Administrative study close|2|||
164524088|NCT01147536|594286298|FG000|Overall Study|Death|1|||
164524089|NCT03762200|594286300|FG000|Overall Study|Death|2|||
164524090|NCT03738423|594286303|FG000|Overall Study|Withdrawal by Subject|9|||
164524091|NCT03738423|594286304|FG001|Overall Study|Withdrawal by Subject|12|||
164524092|NCT03738423|594286305|FG002|Overall Study|Withdrawal by Subject|9|||
164524093|NCT03738423|594286306|FG003|Overall Study|Withdrawal by Subject|12|||
164524094|NCT03738423|594286307|FG004|Overall Study|Withdrawal by Subject|10|||
164524095|NCT03738423|594286303|FG000|Overall Study|Lack of Efficacy|3|||
164524096|NCT03738423|594286304|FG001|Overall Study|Lack of Efficacy|1|||
164524097|NCT03738423|594286305|FG002|Overall Study|Lack of Efficacy|1|||
164524098|NCT03738423|594286306|FG003|Overall Study|Lack of Efficacy|1|||
164524099|NCT03738423|594286307|FG004|Overall Study|Lack of Efficacy|2|||
164524100|NCT03738423|594286303|FG000|Overall Study|Lost to Follow-up|1|||
164524101|NCT03738423|594286304|FG001|Overall Study|Lost to Follow-up|0|||
164524102|NCT03738423|594286305|FG002|Overall Study|Lost to Follow-up|1|||
164524103|NCT03738423|594286306|FG003|Overall Study|Lost to Follow-up|1|||
164524104|NCT03738423|594286307|FG004|Overall Study|Lost to Follow-up|0|||
164524105|NCT03738423|594286303|FG000|Overall Study|Protocol Violation|1|||
164524106|NCT03738423|594286304|FG001|Overall Study|Protocol Violation|0|||
164524107|NCT03738423|594286305|FG002|Overall Study|Protocol Violation|0|||
164524108|NCT03738423|594286306|FG003|Overall Study|Protocol Violation|0|||
164524109|NCT03738423|594286307|FG004|Overall Study|Protocol Violation|1|||
164524110|NCT03738423|594286303|FG000|Overall Study|Physician Decision|0|||
164524111|NCT03738423|594286304|FG001|Overall Study|Physician Decision|0|||
164524112|NCT03738423|594286305|FG002|Overall Study|Physician Decision|1|||
164524113|NCT03738423|594286306|FG003|Overall Study|Physician Decision|0|||
164524114|NCT03738423|594286307|FG004|Overall Study|Physician Decision|1|||
164524115|NCT03738423|594286303|FG000|Overall Study|Death|0|||
164524116|NCT03738423|594286304|FG001|Overall Study|Death|0|||
164524117|NCT03738423|594286305|FG002|Overall Study|Death|0|||
164524118|NCT03738423|594286306|FG003|Overall Study|Death|0|||
164524119|NCT03738423|594286307|FG004|Overall Study|Death|1|||
164524120|NCT03738423|594286303|FG000|Overall Study|Randomized but never treated|0|||
164524121|NCT03738423|594286304|FG001|Overall Study|Randomized but never treated|0|||
164524122|NCT03738423|594286305|FG002|Overall Study|Randomized but never treated|1|||
164524123|NCT03738423|594286306|FG003|Overall Study|Randomized but never treated|1|||
164524124|NCT03738423|594286307|FG004|Overall Study|Randomized but never treated|0|||
164524125|NCT03647488|594287839|FG000|Overall Study|Progressive disease|10|||
164524126|NCT03647488|594287840|FG001|Overall Study|Progressive disease|0|||
164524127|NCT03647488|594287841|FG002|Overall Study|Progressive disease|0|||
164524128|NCT03647488|594287839|FG000|Overall Study|Adverse Event|5|||
164524129|NCT03647488|594287840|FG001|Overall Study|Adverse Event|0|||
164524130|NCT03647488|594287841|FG002|Overall Study|Adverse Event|0|||
164524131|NCT03647488|594287839|FG000|Overall Study|Clinical progression|2|||
164524132|NCT03647488|594287840|FG001|Overall Study|Clinical progression|0|||
164621298|NCT00085644|594634144|FG001|Double-Blind Period|Withdrawal by Subject|0|||
164621299|NCT00085644|594634145|FG002|Double-Blind Period|Withdrawal by Subject|0|||
164621300|NCT00085644|594634143|FG000|Double-Blind Period|Lost to Follow-up|2|||
164621301|NCT00085644|594634144|FG001|Double-Blind Period|Lost to Follow-up|1|||
164621302|NCT00085644|594634145|FG002|Double-Blind Period|Lost to Follow-up|0|||
164621303|NCT00085644|594634143|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
164621304|NCT00085644|594634144|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
164621305|NCT00085644|594634145|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
164621306|NCT00085644|594634143|FG000|Double-Blind Period|Contemplating pregnancy|1|||
164621307|NCT00085644|594634144|FG001|Double-Blind Period|Contemplating pregnancy|0|||
164621308|NCT00085644|594634145|FG002|Double-Blind Period|Contemplating pregnancy|0|||
164621309|NCT00085644|594634143|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
164621310|NCT00085644|594634144|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
164621311|NCT00085644|594634145|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
164621312|NCT00085644|594634143|FG000|Open-Label Period|Adverse Event|0|||
164621313|NCT00085644|594634144|FG001|Open-Label Period|Adverse Event|0|||
164621314|NCT00085644|594634145|FG002|Open-Label Period|Adverse Event|38|||
164621315|NCT00085644|594634143|FG000|Open-Label Period|Withdrawal by Subject|0|||
164621316|NCT00085644|594634144|FG001|Open-Label Period|Withdrawal by Subject|0|||
164621317|NCT00085644|594634145|FG002|Open-Label Period|Withdrawal by Subject|29|||
164621318|NCT00085644|594634143|FG000|Open-Label Period|Lost to Follow-up|0|||
164621319|NCT00085644|594634144|FG001|Open-Label Period|Lost to Follow-up|0|||
164621320|NCT00085644|594634145|FG002|Open-Label Period|Lost to Follow-up|13|||
164621321|NCT00085644|594634143|FG000|Open-Label Period|Lack of Efficacy|0|||
164621322|NCT00085644|594634144|FG001|Open-Label Period|Lack of Efficacy|0|||
164621323|NCT00085644|594634145|FG002|Open-Label Period|Lack of Efficacy|15|||
164621324|NCT00085644|594634143|FG000|Open-Label Period|Pregnancy|0|||
164621325|NCT00085644|594634144|FG001|Open-Label Period|Pregnancy|0|||
164621326|NCT00085644|594634145|FG002|Open-Label Period|Pregnancy|3|||
164621327|NCT00085644|594634143|FG000|Open-Label Period|Contemplating pregnancy|0|||
164621328|NCT00085644|594634144|FG001|Open-Label Period|Contemplating pregnancy|0|||
164621329|NCT00085644|594634145|FG002|Open-Label Period|Contemplating pregnancy|3|||
164621330|NCT00085644|594634143|FG000|Open-Label Period|Protocol Violation|0|||
164621331|NCT00085644|594634144|FG001|Open-Label Period|Protocol Violation|0|||
164621332|NCT00085644|594634145|FG002|Open-Label Period|Protocol Violation|4|||
164621333|NCT00085644|594634143|FG000|Open-Label Period|Personal reason|0|||
164621334|NCT00085644|594634144|FG001|Open-Label Period|Personal reason|0|||
164621335|NCT00085644|594634145|FG002|Open-Label Period|Personal reason|4|||
164621336|NCT04259346|594634153|FG000|Overall Study|Lost to Follow-up|1|||
164524133|NCT03647488|594287841|FG002|Overall Study|Clinical progression|0|||
164524134|NCT03647488|594287839|FG000|Overall Study|Participant refused to take investigational product|1|||
164524135|NCT03647488|594287840|FG001|Overall Study|Participant refused to take investigational product|0|||
164524136|NCT03647488|594287841|FG002|Overall Study|Participant refused to take investigational product|0|||
164524137|NCT00153062|594287842|FG000|Overall Study|Death|360|||
164524138|NCT00153062|594287843|FG001|Overall Study|Death|352|||
164524139|NCT00153062|594287844|FG002|Overall Study|Death|369|||
164524140|NCT00153062|594287845|FG003|Overall Study|Death|365|||
164524141|NCT00153062|594287842|FG000|Overall Study|Withdrawal by Subject|14|||
164524142|NCT00153062|594287843|FG001|Overall Study|Withdrawal by Subject|30|||
164524143|NCT00153062|594287844|FG002|Overall Study|Withdrawal by Subject|27|||
164524144|NCT00153062|594287845|FG003|Overall Study|Withdrawal by Subject|28|||
164524145|NCT00153062|594287842|FG000|Overall Study|Lost to Follow-up|12|||
164524146|NCT00153062|594287843|FG001|Overall Study|Lost to Follow-up|20|||
164524147|NCT00153062|594287844|FG002|Overall Study|Lost to Follow-up|15|||
164524148|NCT00153062|594287845|FG003|Overall Study|Lost to Follow-up|16|||
164524149|NCT00153062|594287842|FG000|Overall Study|Adverse Event|0|||
164524150|NCT00153062|594287843|FG001|Overall Study|Adverse Event|1|||
164524151|NCT00153062|594287844|FG002|Overall Study|Adverse Event|1|||
164524152|NCT00153062|594287845|FG003|Overall Study|Adverse Event|0|||
164524153|NCT00153062|594287842|FG000|Overall Study|Protocol Violation|0|||
164524154|NCT00153062|594287843|FG001|Overall Study|Protocol Violation|2|||
164524155|NCT00153062|594287844|FG002|Overall Study|Protocol Violation|1|||
164524156|NCT00153062|594287845|FG003|Overall Study|Protocol Violation|1|||
164524157|NCT00153062|594287842|FG000|Overall Study|No disposition data available|1|||
164524158|NCT00153062|594287843|FG001|Overall Study|No disposition data available|1|||
164524159|NCT00153062|594287844|FG002|Overall Study|No disposition data available|1|||
164524160|NCT00153062|594287845|FG003|Overall Study|No disposition data available|1|||
164524161|NCT00153062|594287842|FG000|Overall Study|Other|0|||
164524162|NCT00153062|594287843|FG001|Overall Study|Other|0|||
164621337|NCT04259346|594634154|FG001|Overall Study|Lost to Follow-up|3|||
164524163|NCT00153062|594287844|FG002|Overall Study|Other|1|||
164524164|NCT00153062|594287845|FG003|Overall Study|Other|0|||
164524165|NCT01773291|594287846|FG000|Overall Study|Protocol Violation|1|||
164524166|NCT01773291|594287847|FG001|Overall Study|Protocol Violation|0|||
164524167|NCT01773291|594287848|FG002|Overall Study|Protocol Violation|0|||
164524168|NCT01773291|594287846|FG000|Overall Study|Withdrawal by Subject|0|||
164524169|NCT01773291|594287847|FG001|Overall Study|Withdrawal by Subject|0|||
164524170|NCT01773291|594287848|FG002|Overall Study|Withdrawal by Subject|1|||
164524171|NCT01346475|594287849|FG000|First Intervention|Lost to Follow-up|4|||
164524172|NCT01346475|594287850|FG001|First Intervention|Lost to Follow-up|3|||
164524173|NCT01552603|594287851|FG000|Overall Study|Physician Decision|1|||
164524174|NCT01236365|594287855|FG000|Overall Study|Lost to Follow-up|0|||
164524175|NCT01236365|594287856|FG001|Overall Study|Lost to Follow-up|2|||
164524176|NCT01236365|594287855|FG000|Overall Study|Moved Out of State|1|||
164524177|NCT01236365|594287856|FG001|Overall Study|Moved Out of State|0|||
164524178|NCT01236365|594287855|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
164524179|NCT01236365|594287856|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
164524180|NCT00558259|594287859|FG000|Overall Study|Adverse Event|50|||
164524181|NCT00558259|594287860|FG001|Overall Study|Adverse Event|81|||
164524182|NCT00558259|594287859|FG000|Overall Study|Protocol Violation|9|||
164524183|NCT00558259|594287860|FG001|Overall Study|Protocol Violation|5|||
164524184|NCT00558259|594287859|FG000|Overall Study|Withdrawal by Subject|12|||
164524185|NCT00558259|594287860|FG001|Overall Study|Withdrawal by Subject|13|||
164524186|NCT00700258|594287869|FG000|Overall Study|Premature discontinuation of documentation|136|||
164524187|NCT00700258|594287869|FG000|Overall Study|Type of study end not documented|1|||
164524188|NCT00700258|594287869|FG000|Overall Study|Lost to Follow-up|81|||
164524189|NCT00700258|594287869|FG000|Overall Study|Premature discontinuation of therapy|1013|||
164524190|NCT04772898|594287870|FG000|Overall Study|Withdrawal by Subject|0|||
164524191|NCT04772898|594287871|FG001|Overall Study|Withdrawal by Subject|1|||
164524192|NCT00473265|594287872|FG000|Overall Study|Unrelated adverse event|5|||
164524193|NCT00473265|594287872|FG000|Overall Study|Off treatment early|15|||
164524194|NCT00309959|594287874|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
164524195|NCT02937454|594287875|FG000|Overall Study|Adverse Event|0|||
164524196|NCT02937454|594287876|FG001|Overall Study|Adverse Event|1|||
164524197|NCT02937454|594287875|FG000|Overall Study|Death|98|||
164524198|NCT02937454|594287876|FG001|Overall Study|Death|95|||
164524199|NCT02937454|594287875|FG000|Overall Study|Lost to Follow-up|1|||
164524200|NCT02937454|594287876|FG001|Overall Study|Lost to Follow-up|1|||
164524201|NCT02937454|594287875|FG000|Overall Study|Physician Decision|0|||
164524202|NCT02937454|594287876|FG001|Overall Study|Physician Decision|1|||
164524203|NCT02937454|594287875|FG000|Overall Study|Protocol Violation|6|||
164524204|NCT02937454|594287876|FG001|Overall Study|Protocol Violation|10|||
164524205|NCT02937454|594287875|FG000|Overall Study|Withdrawal by Subject|27|||
164524206|NCT02937454|594287876|FG001|Overall Study|Withdrawal by Subject|15|||
164524207|NCT02937454|594287875|FG000|Overall Study|Other|8|||
164524208|NCT02937454|594287876|FG001|Overall Study|Other|5|||
164524209|NCT01253304|594287877|FG000|Overall Study|Adverse Event|0|||
164524210|NCT01253304|594287878|FG001|Overall Study|Adverse Event|0|||
164524211|NCT01253304|594287879|FG002|Overall Study|Adverse Event|0|||
164524212|NCT01253304|594287880|FG003|Overall Study|Adverse Event|1|||
164524213|NCT01888900|594287884|FG000|Overall Study|failed treatment|0|||
164524214|NCT01888900|594287885|FG001|Overall Study|failed treatment|2|||
164524215|NCT03271021|594287890|FG000|Overall Study|Adverse Event|3|||
164524216|NCT03271021|594287891|FG001|Overall Study|Adverse Event|2|||
164524217|NCT03271021|594287890|FG000|Overall Study|Withdrawal by Subject|36|||
164524218|NCT03271021|594287891|FG001|Overall Study|Withdrawal by Subject|53|||
164524219|NCT03271021|594287890|FG000|Overall Study|Lost to Follow-up|34|||
164524220|NCT03271021|594287891|FG001|Overall Study|Lost to Follow-up|39|||
164524221|NCT03271021|594287890|FG000|Overall Study|Protocol Violation|6|||
164524222|NCT03271021|594287891|FG001|Overall Study|Protocol Violation|4|||
164524223|NCT03271021|594287890|FG000|Overall Study|Abnormal Lab Results|1|||
164524224|NCT03271021|594287891|FG001|Overall Study|Abnormal Lab Results|0|||
164524225|NCT03271021|594287890|FG000|Overall Study|Miscellaneous|9|||
164524226|NCT03271021|594287891|FG001|Overall Study|Miscellaneous|8|||
164524227|NCT01474434|594287892|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
164524228|NCT01474434|594287893|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
164524229|NCT01474434|594287894|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
164524230|NCT01474434|594287895|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
164524231|NCT01474434|594287892|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
164524232|NCT01474434|594287893|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
164524233|NCT01474434|594287894|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
164524234|NCT01474434|594287895|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
164524235|NCT01474434|594287892|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
164621338|NCT04259346|594634153|FG000|Overall Study|Protocol Violation|1|||
164621339|NCT04259346|594634154|FG001|Overall Study|Protocol Violation|0|||
164621340|NCT04259346|594634153|FG000|Overall Study|Withdrawal by Subject|1|||
164621341|NCT04259346|594634154|FG001|Overall Study|Withdrawal by Subject|0|||
164621342|NCT04259346|594634153|FG000|Overall Study|Adverse Event|1|||
164621343|NCT04259346|594634154|FG001|Overall Study|Adverse Event|1|||
164621344|NCT03330106|594634155|FG000|Part A|Withdrawal by Subject|1|||
164621345|NCT03330106|594634156|FG001|Part A|Withdrawal by Subject|1|||
164621346|NCT03330106|594634157|FG002|Part A|Withdrawal by Subject|0|||
164621347|NCT03330106|594634158|FG003|Part A|Withdrawal by Subject|0|||
164621348|NCT03330106|594634155|FG000|Part A|Death|2|||
164621349|NCT03330106|594634156|FG001|Part A|Death|1|||
164621350|NCT03330106|594634157|FG002|Part A|Death|0|||
164621351|NCT03330106|594634158|FG003|Part A|Death|0|||
164621352|NCT03330106|594634155|FG000|Part A|Adverse Event|0|||
164621353|NCT03330106|594634156|FG001|Part A|Adverse Event|1|||
164621354|NCT03330106|594634157|FG002|Part A|Adverse Event|0|||
164621355|NCT03330106|594634158|FG003|Part A|Adverse Event|0|||
164621356|NCT03330106|594634155|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
164621357|NCT03330106|594634156|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
164621358|NCT03330106|594634157|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
164621359|NCT03330106|594634158|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
164621360|NCT03330106|594634155|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
164621361|NCT03330106|594634156|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
164621362|NCT03330106|594634157|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
164621363|NCT03330106|594634158|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
164621364|NCT03330106|594634155|FG000|Part A|Progressive Disease|0|||
164621365|NCT03330106|594634156|FG001|Part A|Progressive Disease|1|||
164621366|NCT03330106|594634157|FG002|Part A|Progressive Disease|0|||
164621367|NCT03330106|594634158|FG003|Part A|Progressive Disease|0|||
164621368|NCT03330106|594634155|FG000|Part B|Lost to Follow-up|0|||
164621369|NCT03330106|594634156|FG001|Part B|Lost to Follow-up|0|||
164621370|NCT03330106|594634157|FG002|Part B|Lost to Follow-up|0|||
164621371|NCT03330106|594634158|FG003|Part B|Lost to Follow-up|1|||
164621372|NCT03330106|594634155|FG000|Part B|Withdrawal by Subject|0|||
164621373|NCT03330106|594634156|FG001|Part B|Withdrawal by Subject|0|||
164621374|NCT03330106|594634157|FG002|Part B|Withdrawal by Subject|4|||
164621375|NCT03330106|594634158|FG003|Part B|Withdrawal by Subject|0|||
164621376|NCT03330106|594634155|FG000|Part B|Death|0|||
164621377|NCT03330106|594634156|FG001|Part B|Death|0|||
164621378|NCT03330106|594634157|FG002|Part B|Death|2|||
164621379|NCT03330106|594634158|FG003|Part B|Death|0|||
164621380|NCT03330106|594634155|FG000|Part B|Clinical Progression|0|||
164621381|NCT03330106|594634156|FG001|Part B|Clinical Progression|0|||
164621382|NCT03330106|594634157|FG002|Part B|Clinical Progression|1|||
164621383|NCT03330106|594634158|FG003|Part B|Clinical Progression|1|||
164621384|NCT03330106|594634155|FG000|Part B|Symptomatic Deterioration|0|||
164621385|NCT03330106|594634156|FG001|Part B|Symptomatic Deterioration|0|||
164621386|NCT03330106|594634157|FG002|Part B|Symptomatic Deterioration|0|||
164621387|NCT03330106|594634158|FG003|Part B|Symptomatic Deterioration|1|||
164621388|NCT03330106|594634155|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
164621389|NCT03330106|594634156|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
164621390|NCT03330106|594634157|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
164621391|NCT03330106|594634158|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
164621392|NCT03330106|594634155|FG000|Part B|Progressive Disease|0|||
164621393|NCT03330106|594634156|FG001|Part B|Progressive Disease|0|||
164621394|NCT03330106|594634157|FG002|Part B|Progressive Disease|11|||
164621395|NCT03330106|594634158|FG003|Part B|Progressive Disease|4|||
164621396|NCT00623766|594634160|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
164621397|NCT00623766|594634161|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
164621398|NCT00623766|594634160|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
164621399|NCT00623766|594634161|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
164621400|NCT00623766|594634160|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
164621401|NCT00623766|594634161|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
164621402|NCT00623766|594634160|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
164621403|NCT00623766|594634161|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
164621404|NCT00623766|594634160|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
164621405|NCT00623766|594634161|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
164621406|NCT00486889|594634163|FG000|Overall Study|Death|3|||
164621407|NCT00486889|594634163|FG000|Overall Study|Non-compliant|2|||
164621408|NCT00486889|594634163|FG000|Overall Study|Withdrawal by Subject|6|||
164621409|NCT02750501|594634164|FG000|Overall Study|Adverse Event|4|||
164621410|NCT02750501|594634164|FG000|Overall Study|Physician Decision|1|||
164147697|NCT02006732|592902131|FG002|Overall Study|Adverse Event|4|||
164621411|NCT02750501|594634164|FG000|Overall Study|Protocol Violation|1|||
164524236|NCT01474434|594287893|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
164524237|NCT01474434|594287894|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
164524238|NCT01474434|594287895|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
164524239|NCT01236534|594287900|FG000|Overall Study|Adverse Event|3|||
164524240|NCT01236534|594287901|FG001|Overall Study|Adverse Event|0|||
164524241|NCT02585232|594287902|FG000|Overall Study|Lost to Follow-up|8|||
164524242|NCT02585232|594287903|FG001|Overall Study|Lost to Follow-up|8|||
164524243|NCT02585232|594287902|FG000|Overall Study|Withdrawal by Subject|4|||
164524244|NCT02585232|594287903|FG001|Overall Study|Withdrawal by Subject|8|||
164524245|NCT03215810|594287908|FG000|Overall Study|Still responding to nivolumab|1|||
164524246|NCT03215810|594287908|FG000|Overall Study|Insufficient TIL growth|1|||
164621412|NCT02750501|594634164|FG000|Overall Study|G-tube came out|1|||
164621413|NCT02750501|594634164|FG000|Overall Study|Non-compliant use of PERT|1|||
164621414|NCT00893763|594634165|FG000|Overall Study|extubated|110|||
164621415|NCT00893763|594634166|FG001|Overall Study|extubated|110|||
164621416|NCT01738594|594634167|FG000|Registration and Treatment Start|Adverse Event|0|||
164621417|NCT01738594|594634168|FG001|Registration and Treatment Start|Adverse Event|1|||
164621418|NCT01738594|594634169|FG002|Registration and Treatment Start|Adverse Event|0|||
164621419|NCT01738594|594634170|FG003|Registration and Treatment Start|Adverse Event|0|||
164621420|NCT01738594|594634171|FG004|Registration and Treatment Start|Adverse Event|0|||
164621421|NCT01738594|594634172|FG005|Registration and Treatment Start|Adverse Event|0|||
164621422|NCT01738594|594634173|FG006|Registration and Treatment Start|Adverse Event|0|||
164621423|NCT01738594|594634174|FG007|Registration and Treatment Start|Adverse Event|0|||
164621424|NCT01738594|594634167|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
164621425|NCT01738594|594634168|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
164621426|NCT01738594|594634169|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
164621427|NCT01738594|594634170|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
164621428|NCT01738594|594634171|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
164621429|NCT01738594|594634172|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
164621430|NCT01738594|594634173|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
164621431|NCT01738594|594634174|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
164621432|NCT01738594|594634167|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
164621433|NCT01738594|594634168|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
164621434|NCT01738594|594634169|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
164621435|NCT01738594|594634170|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
164621436|NCT01738594|594634171|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
164621437|NCT01738594|594634172|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
164621438|NCT01738594|594634173|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
164621439|NCT01738594|594634174|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
164621440|NCT01738594|594634167|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
164621441|NCT01738594|594634168|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
164621442|NCT01738594|594634169|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
164621443|NCT01738594|594634170|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
164621444|NCT01738594|594634171|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
164621445|NCT01738594|594634172|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
164621446|NCT01738594|594634173|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
164621447|NCT01738594|594634174|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
164621448|NCT01738594|594634167|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
164621449|NCT01738594|594634168|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
164621450|NCT01738594|594634169|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
164621451|NCT01738594|594634170|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
164621452|NCT01738594|594634171|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
164621453|NCT01738594|594634172|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
164621454|NCT01738594|594634173|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
164621455|NCT01738594|594634174|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
164621456|NCT01738594|594634167|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
164621457|NCT01738594|594634168|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
164621458|NCT01738594|594634169|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
164621459|NCT01738594|594634170|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
164621460|NCT01738594|594634171|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
164621461|NCT01738594|594634172|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
164621462|NCT01738594|594634173|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
164621463|NCT01738594|594634174|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
164621464|NCT01738594|594634167|FG000|Follow up for 1 Year|Death|0|||
164621465|NCT01738594|594634168|FG001|Follow up for 1 Year|Death|0|||
164621466|NCT01738594|594634169|FG002|Follow up for 1 Year|Death|0|||
164621467|NCT01738594|594634170|FG003|Follow up for 1 Year|Death|0|||
164621468|NCT01738594|594634171|FG004|Follow up for 1 Year|Death|0|||
164621469|NCT01738594|594634172|FG005|Follow up for 1 Year|Death|1|||
164621470|NCT01738594|594634173|FG006|Follow up for 1 Year|Death|0|||
164621471|NCT01738594|594634174|FG007|Follow up for 1 Year|Death|0|||
164621472|NCT01738594|594634167|FG000|Follow up for 1 Year|Other|0|||
164621473|NCT01738594|594634168|FG001|Follow up for 1 Year|Other|0|||
164621474|NCT01738594|594634169|FG002|Follow up for 1 Year|Other|0|||
164621475|NCT01738594|594634170|FG003|Follow up for 1 Year|Other|0|||
164621476|NCT01738594|594634171|FG004|Follow up for 1 Year|Other|0|||
164621477|NCT01738594|594634172|FG005|Follow up for 1 Year|Other|2|||
164621478|NCT01738594|594634173|FG006|Follow up for 1 Year|Other|0|||
164621479|NCT01738594|594634174|FG007|Follow up for 1 Year|Other|0|||
164621480|NCT00796549|594634175|FG000|Overall Study|Adverse Event|11|||
164621481|NCT00796549|594634175|FG000|Overall Study|not entered|149|||
164621482|NCT00796549|594634175|FG000|Overall Study|Other|2|||
164621483|NCT00796549|594634175|FG000|Overall Study|Progressive disease|56|||
164621484|NCT04107935|594634177|FG000|Overall Study|Death|1|||
164621485|NCT04107935|594634178|FG001|Overall Study|Death|0|||
164621486|NCT00376675|594634179|FG000|Overall Study|Withdrawal by Subject|9|||
164621487|NCT00376675|594634180|FG001|Overall Study|Withdrawal by Subject|2|||
164621488|NCT00376675|594634179|FG000|Overall Study|Adverse Event|10|||
164621489|NCT00376675|594634180|FG001|Overall Study|Adverse Event|5|||
164621490|NCT00376675|594634179|FG000|Overall Study|Other Reason|1|||
164621491|NCT00376675|594634180|FG001|Overall Study|Other Reason|7|||
164621492|NCT05559203|594634181|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
164621493|NCT00422903|594634186|FG000|Overall Study|Disease Progression|3|||
164524247|NCT03215810|594287908|FG000|Overall Study|Decline in performance status|1|||
164524248|NCT03215810|594287908|FG000|Overall Study|Withdrawal by Subject|1|||
164524249|NCT01157676|594287919|FG000|Randomization|Death|1|||
164524250|NCT01157676|594287920|FG001|Randomization|Death|1|||
164524251|NCT01157676|594287919|FG000|Randomization|unresectable|2|||
164524252|NCT01157676|594287920|FG001|Randomization|unresectable|3|||
164524253|NCT01157676|594287919|FG000|Randomization|Withdrawal by Subject|17|||
164524254|NCT01157676|594287920|FG001|Randomization|Withdrawal by Subject|13|||
164524255|NCT01157676|594287919|FG000|Randomization|Physician Decision|1|||
164524256|NCT01157676|594287920|FG001|Randomization|Physician Decision|0|||
164524257|NCT01157676|594287919|FG000|Surgery|underwent open cystectomy|0|||
164524258|NCT01157676|594287920|FG001|Surgery|underwent open cystectomy|4|||
164524259|NCT01157676|594287919|FG000|Surgery|converted to open procedure|0|||
164524260|NCT01157676|594287920|FG001|Surgery|converted to open procedure|5|||
164524261|NCT01157676|594287919|FG000|Surgery|underwent robotic cystectomy|1|||
164524262|NCT01157676|594287920|FG001|Surgery|underwent robotic cystectomy|0|||
164524263|NCT00141219|594287923|FG000|Overall Study|Protocol violations|5|||
164524264|NCT00141219|594287924|FG001|Overall Study|Protocol violations|4|||
164524265|NCT00141219|594287923|FG000|Overall Study|Adverse Event|8|||
164621494|NCT00422903|594634187|FG001|Overall Study|Disease Progression|1|||
164621495|NCT00422903|594634186|FG000|Overall Study|Adverse Event|0|||
164621496|NCT00422903|594634187|FG001|Overall Study|Adverse Event|2|||
164621497|NCT00422903|594634186|FG000|Overall Study|Informed Consent Withdrawn|1|||
164621498|NCT00422903|594634187|FG001|Overall Study|Informed Consent Withdrawn|2|||
164524266|NCT00141219|594287924|FG001|Overall Study|Adverse Event|6|||
164524267|NCT00141219|594287923|FG000|Overall Study|Lack of Efficacy|5|||
164524268|NCT00141219|594287924|FG001|Overall Study|Lack of Efficacy|4|||
164524269|NCT00141219|594287923|FG000|Overall Study|Withdrawal by Subject|6|||
164524270|NCT00141219|594287924|FG001|Overall Study|Withdrawal by Subject|2|||
164524271|NCT01577745|594287925|FG000|Overall Study|Withdrawal by Subject|0|||
164524272|NCT01577745|594287926|FG001|Overall Study|Withdrawal by Subject|1|||
164524273|NCT01577745|594287927|FG002|Overall Study|Withdrawal by Subject|0|||
164524274|NCT01577745|594287928|FG003|Overall Study|Withdrawal by Subject|3|||
164621499|NCT00262314|594634205|FG000|Overall Study|Changing physicians|38|||
164621500|NCT00262314|594634205|FG000|Overall Study|Death|12|||
164621501|NCT00262314|594634205|FG000|Overall Study|Patient's decision|92|||
164621502|NCT00262314|594634205|FG000|Overall Study|Other|95|||
164621503|NCT00262314|594634205|FG000|Overall Study|Lost to Follow-up|70|||
164621504|NCT00262314|594634205|FG000|Overall Study|Administrative withdrawal|30|||
164621505|NCT00117572|594634210|FG000|Overall Study|Site withdrew before starting treatment|2|||
164621506|NCT00117572|594634211|FG001|Overall Study|Site withdrew before starting treatment|3|||
164621507|NCT00117572|594634210|FG000|Overall Study|Withdrawal by Subject|3|||
164524275|NCT01577745|594287929|FG004|Overall Study|Withdrawal by Subject|2|||
164524276|NCT01577745|594287930|FG005|Overall Study|Withdrawal by Subject|0|||
164524277|NCT01577745|594287925|FG000|Overall Study|Death|3|||
164524278|NCT01577745|594287926|FG001|Overall Study|Death|2|||
164524279|NCT01577745|594287927|FG002|Overall Study|Death|2|||
164524280|NCT01577745|594287928|FG003|Overall Study|Death|1|||
164524281|NCT01577745|594287929|FG004|Overall Study|Death|1|||
164524282|NCT01577745|594287930|FG005|Overall Study|Death|3|||
164524283|NCT01577745|594287925|FG000|Overall Study|Physician Decision|0|||
164524284|NCT01577745|594287926|FG001|Overall Study|Physician Decision|0|||
164524285|NCT01577745|594287927|FG002|Overall Study|Physician Decision|0|||
164524286|NCT01577745|594287928|FG003|Overall Study|Physician Decision|1|||
164524287|NCT01577745|594287929|FG004|Overall Study|Physician Decision|1|||
164524288|NCT01577745|594287930|FG005|Overall Study|Physician Decision|0|||
164524289|NCT01577745|594287925|FG000|Overall Study|Lost to Follow-up|0|||
164524290|NCT01577745|594287926|FG001|Overall Study|Lost to Follow-up|0|||
164524291|NCT01577745|594287927|FG002|Overall Study|Lost to Follow-up|0|||
164524292|NCT01577745|594287928|FG003|Overall Study|Lost to Follow-up|0|||
164524293|NCT01577745|594287929|FG004|Overall Study|Lost to Follow-up|0|||
164524294|NCT01577745|594287930|FG005|Overall Study|Lost to Follow-up|1|||
164524295|NCT01577745|594287925|FG000|Overall Study|Alternative Therapy|0|||
164524296|NCT01577745|594287926|FG001|Overall Study|Alternative Therapy|0|||
164524297|NCT01577745|594287927|FG002|Overall Study|Alternative Therapy|0|||
164524298|NCT01577745|594287928|FG003|Overall Study|Alternative Therapy|1|||
164524299|NCT01577745|594287929|FG004|Overall Study|Alternative Therapy|1|||
164524300|NCT01577745|594287930|FG005|Overall Study|Alternative Therapy|0|||
164524301|NCT02325557|594287931|FG000|Overall Study|Progressive disease|1|||
164524302|NCT02325557|594287932|FG001|Overall Study|Progressive disease|0|||
164524303|NCT02325557|594287933|FG002|Overall Study|Progressive disease|0|||
164524304|NCT02325557|594287934|FG003|Overall Study|Progressive disease|0|||
164621508|NCT00117572|594634211|FG001|Overall Study|Withdrawal by Subject|3|||
164621509|NCT00117572|594634210|FG000|Overall Study|Protocol Violation|1|||
164621510|NCT00117572|594634211|FG001|Overall Study|Protocol Violation|0|||
164621511|NCT04973085|594634212|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
164621512|NCT04973085|594634213|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
164621513|NCT00959699|594634217|FG000|Treatment Period|Adverse Event|3|||
164621514|NCT00959699|594634218|FG001|Treatment Period|Adverse Event|13|||
164621515|NCT00959699|594634217|FG000|Treatment Period|Lack of Efficacy|15|||
164621516|NCT00959699|594634218|FG001|Treatment Period|Lack of Efficacy|6|||
164621517|NCT00959699|594634217|FG000|Treatment Period|Lost to Follow-up|0|||
164621518|NCT00959699|594634218|FG001|Treatment Period|Lost to Follow-up|1|||
164621519|NCT00959699|594634217|FG000|Treatment Period|Withdrawal by Subject|1|||
164621520|NCT00959699|594634218|FG001|Treatment Period|Withdrawal by Subject|3|||
164621521|NCT00959699|594634217|FG000|Treatment Period|Non-Compliance with Protocol|0|||
164621522|NCT00959699|594634218|FG001|Treatment Period|Non-Compliance with Protocol|1|||
164621523|NCT00959699|594634217|FG000|Treatment Period|Did not receive treatment|0|||
164621524|NCT00959699|594634218|FG001|Treatment Period|Did not receive treatment|1|||
164621525|NCT00959699|594634217|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
164621526|NCT00959699|594634218|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
164621527|NCT00959699|594634217|FG000|Follow-up Period|Lost to Follow-up|3|||
164621528|NCT00959699|594634218|FG001|Follow-up Period|Lost to Follow-up|2|||
164621529|NCT00959699|594634217|FG000|Follow-up Period|Withdrawal by Subject|3|||
164621530|NCT00959699|594634218|FG001|Follow-up Period|Withdrawal by Subject|4|||
164621531|NCT03924427|594634219|FG000|Overall Study|Adverse Event|4|||
164621532|NCT03924427|594634219|FG000|Overall Study|Lack of Efficacy|1|||
164621533|NCT03924427|594634219|FG000|Overall Study|Withdrawal by Subject|1|||
164621534|NCT00609167|594634222|FG000|Overall Study|Withdrawal by Subject|1|||
164621535|NCT00609167|594634223|FG001|Overall Study|Withdrawal by Subject|0|||
164621536|NCT00609167|594634222|FG000|Overall Study|Lack of Efficacy|1|||
164621537|NCT00609167|594634223|FG001|Overall Study|Lack of Efficacy|0|||
164621538|NCT00609167|594634222|FG000|Overall Study|Adverse Event|5|||
164621539|NCT00609167|594634223|FG001|Overall Study|Adverse Event|1|||
164621540|NCT00609167|594634222|FG000|Overall Study|Disease Progression|1|||
164621541|NCT00609167|594634223|FG001|Overall Study|Disease Progression|0|||
164621542|NCT00609167|594634222|FG000|Overall Study|Stem Cell Transplant|0|||
164524305|NCT02325557|594287931|FG000|Overall Study|Withdrawal by Subject|4|||
164524306|NCT02325557|594287932|FG001|Overall Study|Withdrawal by Subject|0|||
164524307|NCT02325557|594287933|FG002|Overall Study|Withdrawal by Subject|0|||
164524308|NCT02325557|594287934|FG003|Overall Study|Withdrawal by Subject|15|||
164524309|NCT02325557|594287931|FG000|Overall Study|Death|5|||
164524310|NCT02325557|594287932|FG001|Overall Study|Death|1|||
164524311|NCT02325557|594287933|FG002|Overall Study|Death|1|||
164621543|NCT00609167|594634223|FG001|Overall Study|Stem Cell Transplant|6|||
164621544|NCT00712270|594634224|FG000|Overall Study|Withdrawal by Subject|11|||
164621545|NCT00712270|594634224|FG000|Overall Study|Screen Failure|3|||
164621546|NCT03954704|594634229|FG000|Overall Study|Death|1|||
164621547|NCT03954704|594634230|FG001|Overall Study|Death|1|||
164524312|NCT02325557|594287934|FG003|Overall Study|Death|16|||
164524313|NCT02325557|594287931|FG000|Overall Study|Lost to Follow-up|0|||
164524314|NCT02325557|594287932|FG001|Overall Study|Lost to Follow-up|0|||
164524315|NCT02325557|594287933|FG002|Overall Study|Lost to Follow-up|1|||
164524316|NCT02325557|594287934|FG003|Overall Study|Lost to Follow-up|1|||
164524317|NCT02325557|594287931|FG000|Overall Study|Other|0|||
164524318|NCT02325557|594287932|FG001|Overall Study|Other|0|||
164524319|NCT02325557|594287933|FG002|Overall Study|Other|0|||
164524320|NCT02325557|594287934|FG003|Overall Study|Other|5|||
164524321|NCT00468559|594287939|FG000|Open-label Treatment Phase|Adverse Event|5|||
164524322|NCT00468559|594287940|FG001|Open-label Treatment Phase|Adverse Event|0|||
164524323|NCT00468559|594287941|FG002|Open-label Treatment Phase|Adverse Event|0|||
164524324|NCT00468559|594287939|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
164524325|NCT00468559|594287940|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
164524326|NCT00468559|594287941|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
164524327|NCT00468559|594287939|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
164524328|NCT00468559|594287940|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
164524329|NCT00468559|594287941|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
164524330|NCT00468559|594287939|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
164524331|NCT00468559|594287940|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
164524332|NCT00468559|594287941|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
164524333|NCT00468559|594287939|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
164524334|NCT00468559|594287940|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
164524335|NCT00468559|594287941|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
164524336|NCT01146782|594287943|FG000|Screening Cohort|Screen Failure|187|||
164524337|NCT01146782|594287943|FG000|Screening Cohort|Lost to Follow-up|4|||
164524338|NCT01146782|594287943|FG000|Screening Cohort|Physician Decision|1|||
164524339|NCT01146782|594287943|FG000|Screening Cohort|Withdrawal by Subject|29|||
164524340|NCT01146782|594287943|FG000|Safety Cohort|Screen Failure|61|||
164524341|NCT01146782|594287943|FG000|Safety Cohort|Withdrawal by Subject|4|||
164524342|NCT01146782|594287943|FG000|Safety Cohort|Control AHI <5|4|||
164524343|NCT01146782|594287943|FG000|Safety Cohort|TST <4 hrs|14|||
164524344|NCT01146782|594287943|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
164524345|NCT01146782|594287943|FG000|Primary Endpoint Cohort|Physician Decision|1|||
164524346|NCT01605916|594287944|FG000|Overall Study|Adverse Event|1|||
164524347|NCT01605916|594287945|FG001|Overall Study|Adverse Event|0|||
164524348|NCT01605916|594287946|FG002|Overall Study|Adverse Event|0|||
164524349|NCT01605916|594287947|FG003|Overall Study|Adverse Event|1|||
164524350|NCT01605916|594287948|FG004|Overall Study|Adverse Event|0|||
164524351|NCT01605916|594287944|FG000|Overall Study|Lack of Efficacy|2|||
164524352|NCT01605916|594287945|FG001|Overall Study|Lack of Efficacy|3|||
164524353|NCT01605916|594287946|FG002|Overall Study|Lack of Efficacy|3|||
164524354|NCT01605916|594287947|FG003|Overall Study|Lack of Efficacy|5|||
164524355|NCT01605916|594287948|FG004|Overall Study|Lack of Efficacy|4|||
164524356|NCT01605916|594287944|FG000|Overall Study|Withdrawal by Subject|1|||
164524357|NCT01605916|594287945|FG001|Overall Study|Withdrawal by Subject|1|||
164524358|NCT01605916|594287946|FG002|Overall Study|Withdrawal by Subject|0|||
164524359|NCT01605916|594287947|FG003|Overall Study|Withdrawal by Subject|0|||
164524360|NCT01605916|594287948|FG004|Overall Study|Withdrawal by Subject|2|||
164524361|NCT00470366|594287949|FG000|Overall Study|Adverse Event|3|||
164524362|NCT00470366|594287949|FG000|Overall Study|Poor compliance|1|||
164524363|NCT01021215|594287952|FG000|Overall Study|Lost to Follow-up|3|||
164524364|NCT01021215|594287953|FG001|Overall Study|Lost to Follow-up|0|||
164524365|NCT01103362|594287954|FG000|Overall Study|study terminated|596|||
164524366|NCT02842151|594287955|FG000|Overall Study|Adverse Event|1|||
164524367|NCT02842151|594287955|FG000|Overall Study|Subject moved too far away|1|||
164524368|NCT00438672|594287956|FG000|Overall Study|Lost to Follow-up|7|||
164524369|NCT00438672|594287957|FG001|Overall Study|Lost to Follow-up|9|||
164524370|NCT01394978|594287964|FG000|Overall Study|Withdrawal by Subject|2|||
164524371|NCT01394978|594287965|FG001|Overall Study|Withdrawal by Subject|4|||
164524372|NCT01394978|594287964|FG000|Overall Study|Lost to Follow-up|13|||
164524373|NCT01394978|594287965|FG001|Overall Study|Lost to Follow-up|20|||
164524374|NCT01394978|594287964|FG000|Overall Study|Death|6|||
164524375|NCT01394978|594287965|FG001|Overall Study|Death|7|||
164524376|NCT02217501|594287966|FG000|Overall Study|Death|3|||
164524377|NCT02217501|594287967|FG001|Overall Study|Death|4|||
164524378|NCT03562975|594287972|FG000|Overall Study|Death|1|||
164524379|NCT03562975|594287972|FG000|Overall Study|Lost to Follow-up|1|||
164524380|NCT03562975|594287972|FG000|Overall Study|Withdrawal by Subject|1|||
164524381|NCT04577001|594287977|FG000|Overall Study|Subject became ineligible|0|||
164524382|NCT04577001|594287978|FG001|Overall Study|Subject became ineligible|1|||
164524383|NCT00604825|594287979|FG000|Overall Study|Adverse Event|2|||
164524384|NCT00604825|594287980|FG001|Overall Study|Adverse Event|6|||
164524385|NCT00604825|594287981|FG002|Overall Study|Adverse Event|7|||
164524386|NCT00604825|594287982|FG003|Overall Study|Adverse Event|4|||
164524387|NCT00604825|594287979|FG000|Overall Study|Lost to Follow-up|0|||
164524388|NCT00604825|594287980|FG001|Overall Study|Lost to Follow-up|3|||
164524389|NCT00604825|594287981|FG002|Overall Study|Lost to Follow-up|1|||
164524390|NCT00604825|594287982|FG003|Overall Study|Lost to Follow-up|0|||
164524391|NCT00604825|594287979|FG000|Overall Study|Protocol Violation|0|||
164524392|NCT00604825|594287980|FG001|Overall Study|Protocol Violation|1|||
164524393|NCT00604825|594287981|FG002|Overall Study|Protocol Violation|0|||
164524394|NCT00604825|594287982|FG003|Overall Study|Protocol Violation|0|||
164524395|NCT00604825|594287979|FG000|Overall Study|Withdrawal by Subject|4|||
164524396|NCT00604825|594287980|FG001|Overall Study|Withdrawal by Subject|3|||
164524397|NCT00604825|594287981|FG002|Overall Study|Withdrawal by Subject|5|||
164524398|NCT00604825|594287982|FG003|Overall Study|Withdrawal by Subject|5|||
164524399|NCT00604825|594287979|FG000|Overall Study|Lack of Efficacy|3|||
164524400|NCT00604825|594287980|FG001|Overall Study|Lack of Efficacy|2|||
164524401|NCT00604825|594287981|FG002|Overall Study|Lack of Efficacy|1|||
164524402|NCT00604825|594287982|FG003|Overall Study|Lack of Efficacy|0|||
164524403|NCT00604825|594287979|FG000|Overall Study|Did not meet eligibility criteria|0|||
164524404|NCT00604825|594287980|FG001|Overall Study|Did not meet eligibility criteria|0|||
164524405|NCT00604825|594287981|FG002|Overall Study|Did not meet eligibility criteria|2|||
164524406|NCT00604825|594287982|FG003|Overall Study|Did not meet eligibility criteria|0|||
164621548|NCT03954704|594634231|FG002|Overall Study|Death|1|||
164621549|NCT03954704|594634232|FG003|Overall Study|Death|3|||
164621550|NCT03954704|594634233|FG004|Overall Study|Death|2|||
164621551|NCT03954704|594634234|FG005|Overall Study|Death|2|||
164621552|NCT03954704|594634235|FG006|Overall Study|Death|0|||
164621553|NCT03954704|594634229|FG000|Overall Study|Withdrew Consent|0|||
164621554|NCT03954704|594634230|FG001|Overall Study|Withdrew Consent|0|||
164621555|NCT03954704|594634231|FG002|Overall Study|Withdrew Consent|1|||
164621556|NCT03954704|594634232|FG003|Overall Study|Withdrew Consent|0|||
164621557|NCT03954704|594634233|FG004|Overall Study|Withdrew Consent|0|||
164621558|NCT03954704|594634234|FG005|Overall Study|Withdrew Consent|1|||
164621559|NCT03954704|594634235|FG006|Overall Study|Withdrew Consent|0|||
164621560|NCT03954704|594634229|FG000|Overall Study|Lost to Follow-up|0|||
164621561|NCT03954704|594634230|FG001|Overall Study|Lost to Follow-up|0|||
164621562|NCT03954704|594634231|FG002|Overall Study|Lost to Follow-up|0|||
164621563|NCT03954704|594634232|FG003|Overall Study|Lost to Follow-up|0|||
164621564|NCT03954704|594634233|FG004|Overall Study|Lost to Follow-up|0|||
164621565|NCT03954704|594634234|FG005|Overall Study|Lost to Follow-up|0|||
164621566|NCT03954704|594634235|FG006|Overall Study|Lost to Follow-up|1|||
164621567|NCT03954704|594634229|FG000|Overall Study|Study Terminated by Sponsor|0|||
164524407|NCT00604825|594287979|FG000|Overall Study|Physician Decision|0|||
164524408|NCT00604825|594287980|FG001|Overall Study|Physician Decision|0|||
164524409|NCT00604825|594287981|FG002|Overall Study|Physician Decision|0|||
164524410|NCT00604825|594287982|FG003|Overall Study|Physician Decision|1|||
164524411|NCT00604825|594287979|FG000|Overall Study|Exclusion criterion met|0|||
164524412|NCT00604825|594287980|FG001|Overall Study|Exclusion criterion met|0|||
164524413|NCT00604825|594287981|FG002|Overall Study|Exclusion criterion met|0|||
164524414|NCT00604825|594287982|FG003|Overall Study|Exclusion criterion met|1|||
164524415|NCT00910689|594289704|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
164524416|NCT00910689|594289705|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
164524417|NCT00910689|594289706|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
164524418|NCT00910689|594289707|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
164524419|NCT00910689|594289704|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
164524420|NCT00910689|594289705|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
164524421|NCT00910689|594289706|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
164524422|NCT00910689|594289707|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
164524423|NCT00910689|594289704|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
164524424|NCT00910689|594289705|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
164524425|NCT00910689|594289706|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
164524426|NCT00910689|594289707|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
164524427|NCT00910689|594289704|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
164524428|NCT00910689|594289705|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
164524429|NCT00910689|594289706|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
164524430|NCT00910689|594289707|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
164524431|NCT00910689|594289704|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
164524432|NCT00910689|594289705|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
164524433|NCT00910689|594289706|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
164524434|NCT00910689|594289707|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
164524435|NCT00910689|594289704|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
164524436|NCT00910689|594289705|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
164621568|NCT03954704|594634230|FG001|Overall Study|Study Terminated by Sponsor|0|||
164621569|NCT03954704|594634231|FG002|Overall Study|Study Terminated by Sponsor|1|||
164621570|NCT03954704|594634232|FG003|Overall Study|Study Terminated by Sponsor|0|||
164621571|NCT03954704|594634233|FG004|Overall Study|Study Terminated by Sponsor|1|||
164621572|NCT03954704|594634234|FG005|Overall Study|Study Terminated by Sponsor|4|||
164524437|NCT00910689|594289706|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
164524438|NCT00910689|594289707|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
164524439|NCT00910689|594289704|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
164524440|NCT00910689|594289705|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
164524441|NCT00910689|594289706|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
164524442|NCT00910689|594289707|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
164524443|NCT00910689|594289704|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
164524444|NCT00910689|594289705|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
164524445|NCT00910689|594289706|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
164524446|NCT00910689|594289707|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
164524447|NCT00910689|594289704|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
164524448|NCT00910689|594289705|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
164524449|NCT00910689|594289706|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
164524450|NCT00910689|594289707|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
164524451|NCT00910689|594289704|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
164524452|NCT00910689|594289705|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
164524453|NCT00910689|594289706|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
164524454|NCT00910689|594289707|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
164524455|NCT00910689|594289704|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
164524456|NCT00910689|594289705|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
164524457|NCT00910689|594289706|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
164524458|NCT00910689|594289707|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
164524459|NCT00910689|594289704|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
164524460|NCT00910689|594289705|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
164524461|NCT00910689|594289706|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
164524462|NCT00910689|594289707|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
164524463|NCT00910689|594289704|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
164524464|NCT00910689|594289705|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
164621573|NCT03954704|594634235|FG006|Overall Study|Study Terminated by Sponsor|2|||
164621574|NCT03954704|594634229|FG000|Overall Study|Enrolled but not Treated|0|||
164621575|NCT03954704|594634230|FG001|Overall Study|Enrolled but not Treated|0|||
164621576|NCT03954704|594634231|FG002|Overall Study|Enrolled but not Treated|0|||
164621577|NCT03954704|594634232|FG003|Overall Study|Enrolled but not Treated|0|||
164621578|NCT03954704|594634233|FG004|Overall Study|Enrolled but not Treated|0|||
164621579|NCT03954704|594634234|FG005|Overall Study|Enrolled but not Treated|1|||
164621580|NCT03954704|594634235|FG006|Overall Study|Enrolled but not Treated|0|||
164621581|NCT04412668|594634236|FG000|Overall Study|Death - multiple comorbidities|2|||
164524465|NCT00910689|594289706|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
164524466|NCT00910689|594289707|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
164524467|NCT00910689|594289704|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
164524468|NCT00910689|594289705|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
164524469|NCT00910689|594289706|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
164524470|NCT00910689|594289707|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
164524471|NCT00910689|594289704|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
164524472|NCT00910689|594289705|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
164524473|NCT00910689|594289706|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
164524474|NCT00910689|594289707|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
164524475|NCT00910689|594289704|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
164524476|NCT00910689|594289705|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
164524477|NCT00910689|594289706|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
164524478|NCT00910689|594289707|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
164524479|NCT00910689|594289704|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
164524480|NCT00910689|594289705|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
164524481|NCT00910689|594289706|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
164524482|NCT00910689|594289707|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
164524483|NCT00910689|594289704|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
164524484|NCT00910689|594289705|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
164621582|NCT04412668|594634237|FG001|Overall Study|Death - multiple comorbidities|0|||
164621583|NCT04412668|594634238|FG002|Overall Study|Death - multiple comorbidities|0|||
164621584|NCT04412668|594634236|FG000|Overall Study|Withdrawal by Subject|3|||
164621585|NCT04412668|594634237|FG001|Overall Study|Withdrawal by Subject|0|||
164621586|NCT04412668|594634238|FG002|Overall Study|Withdrawal by Subject|0|||
164621587|NCT04412668|594634236|FG000|Overall Study|Other than Specified|2|||
164621588|NCT04412668|594634237|FG001|Overall Study|Other than Specified|0|||
164621589|NCT04412668|594634238|FG002|Overall Study|Other than Specified|0|||
164621590|NCT05166603|594634240|FG000|Overall Study|Withdrawal by Subject|68|||
164621591|NCT05166603|594634241|FG001|Overall Study|Withdrawal by Subject|0|||
164621592|NCT04418427|594635472|FG000|Overall Study|Death|0|||
164621593|NCT04418427|594635473|FG001|Overall Study|Death|1|||
164621594|NCT04418427|594635474|FG002|Overall Study|Death|0|||
164621595|NCT04418427|594635472|FG000|Overall Study|Lost to Follow-up|0|||
164524485|NCT00910689|594289706|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
164524486|NCT00910689|594289707|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
164524487|NCT00910689|594289704|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
164524488|NCT00910689|594289705|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
164524489|NCT00910689|594289706|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
164524490|NCT00910689|594289707|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
164524491|NCT00910689|594289704|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
164524492|NCT00910689|594289705|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
164524493|NCT00910689|594289706|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
164524494|NCT00910689|594289707|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
164524495|NCT00910689|594289704|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
164524496|NCT00910689|594289705|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
164524497|NCT00910689|594289706|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
164524498|NCT00910689|594289707|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
164524499|NCT01290029|594289708|FG000|Overall Study|Other|2|||
164524500|NCT00189488|594289709|FG000|Overall Study|Ineligibility determined|1|||
164524501|NCT00189488|594289710|FG001|Overall Study|Ineligibility determined|0|||
164524502|NCT00189488|594289709|FG000|Overall Study|Protocol deviation|2|||
164524503|NCT00189488|594289710|FG001|Overall Study|Protocol deviation|1|||
164524504|NCT00189488|594289709|FG000|Overall Study|Adverse Event|2|||
164524505|NCT00189488|594289710|FG001|Overall Study|Adverse Event|1|||
164524506|NCT00189488|594289709|FG000|Overall Study|Withdrawal by Subject|2|||
164524507|NCT00189488|594289710|FG001|Overall Study|Withdrawal by Subject|6|||
164524508|NCT00189488|594289709|FG000|Overall Study|Disease progression|2|||
164524509|NCT00189488|594289710|FG001|Overall Study|Disease progression|4|||
164524510|NCT00189488|594289709|FG000|Overall Study|Administrative Decision|0|||
164524511|NCT00189488|594289710|FG001|Overall Study|Administrative Decision|2|||
164524512|NCT00189488|594289709|FG000|Overall Study|Death|5|||
164524513|NCT00189488|594289710|FG001|Overall Study|Death|8|||
164524514|NCT00189488|594289709|FG000|Overall Study|Other|1|||
164524515|NCT00189488|594289710|FG001|Overall Study|Other|0|||
164524516|NCT02349425|594289713|FG000|Period 1|Adverse Event|1|||
164524517|NCT02349425|594289714|FG001|Period 1|Adverse Event|1|||
164524518|NCT02349425|594289715|FG002|Period 1|Adverse Event|0|||
164524519|NCT02349425|594289716|FG003|Period 1|Adverse Event|0|||
164524520|NCT02349425|594289713|FG000|Period 2|Adverse Event|0|||
164524521|NCT02349425|594289714|FG001|Period 2|Adverse Event|1|||
164524522|NCT02349425|594289715|FG002|Period 2|Adverse Event|1|||
164524523|NCT02349425|594289716|FG003|Period 2|Adverse Event|0|||
164524524|NCT00616902|594289717|FG000|Overall Study|Termination of study|6|||
164524525|NCT00616902|594289718|FG001|Overall Study|Termination of study|6|||
164524526|NCT01877837|594289719|FG000|Overall Study|Lost to Follow-up|1|||
164524527|NCT01877837|594289719|FG000|Overall Study|Ineligible|4|||
164524528|NCT00645801|594289720|FG000|Overall Study|unclear if patient took all the medication.|1|||
164524529|NCT00645801|594289721|FG001|Overall Study|unclear if patient took all the medication.|0|||
164524530|NCT00645801|594289720|FG000|Overall Study|Lost to Follow-up|19|||
164524531|NCT00645801|594289721|FG001|Overall Study|Lost to Follow-up|15|||
164524532|NCT00759915|594289722|FG000|Overall Study|Withdrawal by Subject|1|||
164524533|NCT00759915|594289723|FG001|Overall Study|Withdrawal by Subject|0|||
164524534|NCT00759915|594289722|FG000|Overall Study|Adverse Event|0|||
164524535|NCT00759915|594289723|FG001|Overall Study|Adverse Event|1|||
164524536|NCT00932113|594289726|FG000|Overall Study|Lost to Follow-up|1|||
164524537|NCT00932113|594289727|FG001|Overall Study|Lost to Follow-up|0|||
164524538|NCT00203476|594289728|FG000|Overall Study|Lost to Follow-up|1|||
164524539|NCT00203476|594289729|FG001|Overall Study|Lost to Follow-up|0|||
164524540|NCT00203476|594289730|FG002|Overall Study|Lost to Follow-up|0|||
164524541|NCT00203476|594289728|FG000|Overall Study|Withdrawal by Subject|0|||
164524542|NCT00203476|594289729|FG001|Overall Study|Withdrawal by Subject|1|||
164524543|NCT00203476|594289730|FG002|Overall Study|Withdrawal by Subject|0|||
164524544|NCT01190514|594289731|FG000|First Intervention (Period 1)|Adverse Event|1|||
164524545|NCT01190514|594289732|FG001|First Intervention (Period 1)|Adverse Event|0|||
164524546|NCT01190514|594289733|FG002|First Intervention (Period 1)|Adverse Event|0|||
164524547|NCT01190514|594289734|FG003|First Intervention (Period 1)|Adverse Event|0|||
164524548|NCT01190514|594289731|FG000|Third Intervention (Period 3)|Adverse Event|1|||
164524549|NCT01190514|594289732|FG001|Third Intervention (Period 3)|Adverse Event|0|||
164524550|NCT01190514|594289733|FG002|Third Intervention (Period 3)|Adverse Event|0|||
164621596|NCT04418427|594635473|FG001|Overall Study|Lost to Follow-up|2|||
164621597|NCT04418427|594635474|FG002|Overall Study|Lost to Follow-up|2|||
164621598|NCT04418427|594635472|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
164621599|NCT04418427|594635473|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
164621600|NCT04418427|594635474|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
164621601|NCT04418427|594635472|FG000|Overall Study|Pre-existing medical condition|0|||
164621602|NCT04418427|594635473|FG001|Overall Study|Pre-existing medical condition|1|||
164621603|NCT04418427|594635474|FG002|Overall Study|Pre-existing medical condition|0|||
164621604|NCT00366444|594635476|FG000|Overall Study|Withdrawal by Subject|1|||
164621605|NCT00366444|594635477|FG001|Overall Study|Withdrawal by Subject|1|||
164621606|NCT00366444|594635476|FG000|Overall Study|Lack of Efficacy|0|||
164621607|NCT00366444|594635477|FG001|Overall Study|Lack of Efficacy|1|||
164621608|NCT03763942|594635483|FG000|Overall Study|Lost to Follow-up|114|||
164621609|NCT03763942|594635484|FG001|Overall Study|Lost to Follow-up|54|||
164621610|NCT03763942|594635483|FG000|Overall Study|Protocol Violation|1|||
164621611|NCT03763942|594635484|FG001|Overall Study|Protocol Violation|0|||
164621612|NCT03763942|594635483|FG000|Overall Study|Withdrawal by Subject|2|||
164621613|NCT03763942|594635484|FG001|Overall Study|Withdrawal by Subject|0|||
164621614|NCT03763942|594635483|FG000|Overall Study|Other|2|||
164621615|NCT03763942|594635484|FG001|Overall Study|Other|3|||
164621616|NCT02200510|594635485|FG000|Overall Study|Death|1|||
164621617|NCT02200510|594635486|FG001|Overall Study|Death|1|||
164621618|NCT02200510|594635485|FG000|Overall Study|Protocol Violation|0|||
164621619|NCT02200510|594635486|FG001|Overall Study|Protocol Violation|1|||
164621620|NCT02200510|594635485|FG000|Overall Study|Lost to Follow-up|7|||
164621621|NCT02200510|594635486|FG001|Overall Study|Lost to Follow-up|1|||
164621622|NCT02200510|594635485|FG000|Overall Study|potential COI - joined study team|1|||
164621623|NCT02200510|594635486|FG001|Overall Study|potential COI - joined study team|0|||
164621624|NCT04969900|594635489|FG000|Overall Study|Physician Decision|1|||
164621625|NCT04969900|594635490|FG001|Overall Study|Physician Decision|1|||
164621626|NCT04969900|594635489|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
164621627|NCT04969900|594635490|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
164621628|NCT02881151|594635491|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
164621629|NCT04284787|594635495|FG000|Overall Study|Disease Progression|9|||
164621630|NCT04284787|594635496|FG001|Overall Study|Disease Progression|12|||
164621631|NCT04284787|594635495|FG000|Overall Study|Physician Decision|12|||
164621632|NCT04284787|594635496|FG001|Overall Study|Physician Decision|7|||
164621633|NCT04284787|594635495|FG000|Overall Study|Transplant|5|||
164621634|NCT04284787|594635496|FG001|Overall Study|Transplant|4|||
164621635|NCT04284787|594635495|FG000|Overall Study|Death|1|||
164621636|NCT04284787|594635496|FG001|Overall Study|Death|2|||
164621637|NCT04284787|594635495|FG000|Overall Study|Adverse Event|0|||
164621638|NCT04284787|594635496|FG001|Overall Study|Adverse Event|4|||
164621639|NCT04284787|594635495|FG000|Overall Study|Non-adherence|2|||
164621640|NCT04284787|594635496|FG001|Overall Study|Non-adherence|0|||
164621641|NCT04284787|594635495|FG000|Overall Study|Lack of Efficacy|2|||
164621642|NCT04284787|594635496|FG001|Overall Study|Lack of Efficacy|0|||
164621643|NCT03887052|594635497|FG000|Overall Study|Adverse Event|2|||
164621644|NCT03887052|594635497|FG000|Overall Study|Physician Decision|2|||
164621645|NCT03887052|594635497|FG000|Overall Study|Withdrawal by Subject|3|||
164621646|NCT03887052|594635497|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
164621647|NCT03887052|594635497|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
164621648|NCT04517253|594635498|FG000|Primary Treatment Period|Adverse Event|1|||
164621649|NCT04517253|594635499|FG001|Primary Treatment Period|Adverse Event|0|||
164621650|NCT04517253|594635500|FG002|Primary Treatment Period|Adverse Event|0|||
164621651|NCT04517253|594635498|FG000|Primary Treatment Period|Death|0|||
164621652|NCT04517253|594635499|FG001|Primary Treatment Period|Death|1|||
164621653|NCT04517253|594635500|FG002|Primary Treatment Period|Death|0|||
164621654|NCT04517253|594635498|FG000|Maintenance Period|Withdrawal by Subject|1|||
164621655|NCT04517253|594635499|FG001|Maintenance Period|Withdrawal by Subject|0|||
164621656|NCT04517253|594635500|FG002|Maintenance Period|Withdrawal by Subject|0|||
164621657|NCT04517253|594635498|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
164621658|NCT04517253|594635499|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
164621659|NCT04517253|594635500|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
164621660|NCT00610714|594635502|FG000|Overall Study|Adverse Event|3|||
164621661|NCT00610714|594635503|FG001|Overall Study|Adverse Event|1|||
164621662|NCT00610714|594635502|FG000|Overall Study|Death|12|||
164621663|NCT00610714|594635503|FG001|Overall Study|Death|18|||
164621664|NCT00610714|594635502|FG000|Overall Study|Withdrawal by Subject|9|||
164621665|NCT00610714|594635503|FG001|Overall Study|Withdrawal by Subject|3|||
164621666|NCT00610714|594635502|FG000|Overall Study|Study completion at 120 PFS events|2|||
164621667|NCT00610714|594635503|FG001|Overall Study|Study completion at 120 PFS events|2|||
164621668|NCT01108263|594635504|FG000|Overall Study|Adverse Event|0|||
164621669|NCT01108263|594635505|FG001|Overall Study|Adverse Event|1|||
164621670|NCT02974621|594635507|FG000|Overall Study|Didn't receive study treatment|1|||
164621671|NCT02974621|594635508|FG001|Overall Study|Didn't receive study treatment|10|||
164621672|NCT01023516|594635509|FG000|Overall Study|Voluntary discontinuation|7|||
164621673|NCT01023516|594635510|FG001|Overall Study|Voluntary discontinuation|5|||
164621674|NCT01023516|594635509|FG000|Overall Study|Adverse Event|9|||
164621675|NCT01023516|594635510|FG001|Overall Study|Adverse Event|6|||
164621676|NCT01023516|594635509|FG000|Overall Study|Safety reason|0|||
164621677|NCT01023516|594635510|FG001|Overall Study|Safety reason|3|||
164621678|NCT01023516|594635509|FG000|Overall Study|Study-specific criteria|4|||
164621679|NCT01023516|594635510|FG001|Overall Study|Study-specific criteria|2|||
164621680|NCT01023516|594635509|FG000|Overall Study|Incorrect enrolment|4|||
164621681|NCT01023516|594635510|FG001|Overall Study|Incorrect enrolment|2|||
164621682|NCT02559115|594635512|FG000|Overall Study|Withdrawal by Subject|3|||
164524551|NCT01190514|594289734|FG003|Third Intervention (Period 3)|Adverse Event|0|||
164524552|NCT01143038|594289735|FG000|Overall Study|Withdrawal by Subject|4|||
164524553|NCT01143038|594289735|FG000|Overall Study|Requirement for alternative therapy|5|||
164524554|NCT01143038|594289735|FG000|Overall Study|Adverse Event|3|||
164524555|NCT01143038|594289735|FG000|Overall Study|Lost to Follow-up|2|||
164524556|NCT01143038|594289735|FG000|Overall Study|Protocol Deviation|1|||
164524557|NCT01143038|594289735|FG000|Overall Study|Death|1|||
164524558|NCT03310268|594289736|FG000|Overall Study|(Not specified)|1|||
164524559|NCT03310268|594289737|FG001|Overall Study|(Not specified)|5|||
164524560|NCT03310268|594289738|FG002|Overall Study|(Not specified)|0|||
164524561|NCT04101318|594289739|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
164524562|NCT04101318|594289740|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
164524563|NCT04101318|594289739|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
164524564|NCT04101318|594289740|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
164524565|NCT04101318|594289739|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
164524566|NCT04101318|594289740|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
164524567|NCT04797650|594289741|FG000|Overall Study|Reason Not Specified|5|||
164524568|NCT04797650|594289742|FG001|Overall Study|Reason Not Specified|12|||
164524569|NCT04797650|594289743|FG002|Overall Study|Reason Not Specified|5|||
164524570|NCT04797650|594289741|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
164524571|NCT04797650|594289742|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
164524572|NCT04797650|594289743|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
164524573|NCT04797650|594289741|FG000|Overall Study|Lack of Efficacy|1|||
164524574|NCT04797650|594289742|FG001|Overall Study|Lack of Efficacy|0|||
164524575|NCT04797650|594289743|FG002|Overall Study|Lack of Efficacy|1|||
164524576|NCT04797650|594289741|FG000|Overall Study|Non-compliance with Study Drug|0|||
164524577|NCT04797650|594289742|FG001|Overall Study|Non-compliance with Study Drug|0|||
164524578|NCT04797650|594289743|FG002|Overall Study|Non-compliance with Study Drug|2|||
164524579|NCT04797650|594289741|FG000|Overall Study|Lost to Follow-up|4|||
164524580|NCT04797650|594289742|FG001|Overall Study|Lost to Follow-up|6|||
164524581|NCT04797650|594289743|FG002|Overall Study|Lost to Follow-up|1|||
164524582|NCT00717067|594289744|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
164524583|NCT00717067|594289745|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
164524584|NCT00717067|594289746|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
164524585|NCT00717067|594289747|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
164524586|NCT00717067|594289748|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
164524587|NCT01183234|594289749|FG000|First Intervention|Adverse Event|1|||
164524588|NCT01183234|594289750|FG001|First Intervention|Adverse Event|0|||
164524589|NCT02029846|594289751|FG000|Overall Study|n=1 each arm|1|||
164524590|NCT02029846|594289752|FG001|Overall Study|n=1 each arm|1|||
164524591|NCT02966301|594289753|FG000|Overall Study|Death|2|||
164524592|NCT02966301|594289753|FG000|Overall Study|Withdrawal by Subject|1|||
164524593|NCT00370331|594289755|FG000|Overall Study|Adverse Event|4|||
164524594|NCT00370331|594289756|FG001|Overall Study|Adverse Event|13|||
164524595|NCT00370331|594289755|FG000|Overall Study|Withdrawal by Subject|2|||
164524596|NCT00370331|594289756|FG001|Overall Study|Withdrawal by Subject|4|||
164524597|NCT00370331|594289755|FG000|Overall Study|Lost to Follow-up|0|||
164524598|NCT00370331|594289756|FG001|Overall Study|Lost to Follow-up|3|||
164524599|NCT00370331|594289755|FG000|Overall Study|Lack of Efficacy|0|||
164524600|NCT00370331|594289756|FG001|Overall Study|Lack of Efficacy|1|||
164524601|NCT00370331|594289755|FG000|Overall Study|Non-compliance|0|||
164524602|NCT00370331|594289756|FG001|Overall Study|Non-compliance|1|||
164524603|NCT00370331|594289755|FG000|Overall Study|Protocol Violation|1|||
164524604|NCT00370331|594289756|FG001|Overall Study|Protocol Violation|1|||
164524605|NCT01160289|594289762|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
164524606|NCT01160289|594289763|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
164524607|NCT01160289|594289764|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
164524608|NCT01160289|594289765|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
164524609|NCT01160289|594289766|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
164524610|NCT01160289|594289767|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
164524611|NCT01160289|594289762|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
164524612|NCT01160289|594289763|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
164621683|NCT04288089|594635513|FG000|Overall Study|Ongoing Treatment|2|||
164621684|NCT04288089|594635514|FG001|Overall Study|Ongoing Treatment|1|||
164621685|NCT04288089|594635515|FG002|Overall Study|Ongoing Treatment|1|||
164621686|NCT04288089|594635516|FG003|Overall Study|Ongoing Treatment|4|||
164621687|NCT03715205|594635517|FG000|Overall Study|Death|13|||
164621688|NCT03715205|594635517|FG000|Overall Study|Lost to Follow-up|2|||
164621689|NCT03715205|594635517|FG000|Overall Study|Physician Decision|93|||
164524613|NCT01160289|594289764|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
164524614|NCT01160289|594289765|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
164621690|NCT03715205|594635517|FG000|Overall Study|Withdrawal by Subject|26|||
164621691|NCT02354690|594635518|FG000|Overall Study|Physician Decision|1|||
164524615|NCT01160289|594289766|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
164524616|NCT01160289|594289767|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
164524617|NCT01160289|594289762|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
164524618|NCT01160289|594289763|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
164524619|NCT01160289|594289764|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
164524620|NCT01160289|594289765|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
164524621|NCT01160289|594289766|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
164524622|NCT01160289|594289767|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
164524623|NCT01160289|594289762|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
164524624|NCT01160289|594289763|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
164524625|NCT01160289|594289764|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
164524626|NCT01160289|594289765|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
164524627|NCT01160289|594289766|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
164524628|NCT01160289|594289767|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
164524629|NCT01160289|594289762|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
164524630|NCT01160289|594289763|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
164524631|NCT01160289|594289764|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
164524632|NCT01160289|594289765|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
164524633|NCT01160289|594289766|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
164524634|NCT01160289|594289767|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
164524635|NCT01160289|594289762|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
164524636|NCT01160289|594289763|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
164524637|NCT01160289|594289764|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
164524638|NCT01160289|594289765|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
164524639|NCT01160289|594289766|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
164524640|NCT01160289|594289767|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
164524641|NCT01160289|594289762|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
164524642|NCT01160289|594289763|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
164524643|NCT01160289|594289764|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
164524644|NCT01160289|594289765|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
164524645|NCT01160289|594289766|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
164524646|NCT01160289|594289767|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
164524647|NCT01160289|594289762|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
164524648|NCT01160289|594289763|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
164524649|NCT01160289|594289764|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
164524650|NCT01160289|594289765|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
164524651|NCT01160289|594289766|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
164524652|NCT01160289|594289767|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
164524653|NCT01160289|594289762|FG000|Post-Randomization Period|Adverse Event|0|||
164524654|NCT01160289|594289763|FG001|Post-Randomization Period|Adverse Event|4|||
164524655|NCT01160289|594289764|FG002|Post-Randomization Period|Adverse Event|4|||
164524656|NCT01160289|594289765|FG003|Post-Randomization Period|Adverse Event|2|||
164524657|NCT01160289|594289766|FG004|Post-Randomization Period|Adverse Event|0|||
164524658|NCT01160289|594289767|FG005|Post-Randomization Period|Adverse Event|0|||
164524659|NCT01160289|594289762|FG000|Post-Randomization Period|Death|0|||
164524660|NCT01160289|594289763|FG001|Post-Randomization Period|Death|0|||
164524661|NCT01160289|594289764|FG002|Post-Randomization Period|Death|0|||
164524662|NCT01160289|594289765|FG003|Post-Randomization Period|Death|1|||
164524663|NCT01160289|594289766|FG004|Post-Randomization Period|Death|0|||
164524664|NCT01160289|594289767|FG005|Post-Randomization Period|Death|0|||
164524665|NCT01160289|594289762|FG000|Post-Randomization Period|Lack of Efficacy|0|||
164524666|NCT01160289|594289763|FG001|Post-Randomization Period|Lack of Efficacy|1|||
164524667|NCT01160289|594289764|FG002|Post-Randomization Period|Lack of Efficacy|0|||
164524668|NCT01160289|594289765|FG003|Post-Randomization Period|Lack of Efficacy|3|||
164524669|NCT01160289|594289766|FG004|Post-Randomization Period|Lack of Efficacy|0|||
164524670|NCT01160289|594289767|FG005|Post-Randomization Period|Lack of Efficacy|0|||
164524671|NCT01160289|594289762|FG000|Post-Randomization Period|Lost to Follow-up|0|||
164524672|NCT01160289|594289763|FG001|Post-Randomization Period|Lost to Follow-up|3|||
164524673|NCT01160289|594289764|FG002|Post-Randomization Period|Lost to Follow-up|2|||
164524674|NCT01160289|594289765|FG003|Post-Randomization Period|Lost to Follow-up|5|||
164524675|NCT01160289|594289766|FG004|Post-Randomization Period|Lost to Follow-up|3|||
164524676|NCT01160289|594289767|FG005|Post-Randomization Period|Lost to Follow-up|4|||
164524677|NCT01160289|594289762|FG000|Post-Randomization Period|Physician Decision|0|||
164524678|NCT01160289|594289763|FG001|Post-Randomization Period|Physician Decision|0|||
164524679|NCT01160289|594289764|FG002|Post-Randomization Period|Physician Decision|1|||
164524680|NCT01160289|594289765|FG003|Post-Randomization Period|Physician Decision|0|||
164524681|NCT01160289|594289766|FG004|Post-Randomization Period|Physician Decision|0|||
164524682|NCT01160289|594289767|FG005|Post-Randomization Period|Physician Decision|0|||
164524683|NCT01160289|594289762|FG000|Post-Randomization Period|Protocol Violation|0|||
164524684|NCT01160289|594289763|FG001|Post-Randomization Period|Protocol Violation|4|||
164524685|NCT01160289|594289764|FG002|Post-Randomization Period|Protocol Violation|2|||
164524686|NCT01160289|594289765|FG003|Post-Randomization Period|Protocol Violation|0|||
164524687|NCT01160289|594289766|FG004|Post-Randomization Period|Protocol Violation|1|||
164524688|NCT01160289|594289767|FG005|Post-Randomization Period|Protocol Violation|3|||
164524689|NCT01160289|594289762|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
164524690|NCT01160289|594289763|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
164524691|NCT01160289|594289764|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
164524692|NCT01160289|594289765|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
164524693|NCT01160289|594289766|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
164524694|NCT01160289|594289767|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
164524695|NCT01160289|594289762|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
164524696|NCT01160289|594289763|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
164524697|NCT01160289|594289764|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
164524698|NCT01160289|594289765|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
164524699|NCT01160289|594289766|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
164524700|NCT01160289|594289767|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
164524701|NCT01160289|594289762|FG000|Post-Randomization Period|Sponsor Decision|0|||
164524702|NCT01160289|594289763|FG001|Post-Randomization Period|Sponsor Decision|1|||
164524703|NCT01160289|594289764|FG002|Post-Randomization Period|Sponsor Decision|0|||
164524704|NCT01160289|594289765|FG003|Post-Randomization Period|Sponsor Decision|0|||
164524705|NCT01160289|594289766|FG004|Post-Randomization Period|Sponsor Decision|0|||
164524706|NCT01160289|594289767|FG005|Post-Randomization Period|Sponsor Decision|0|||
164524707|NCT00768079|594289768|FG000|Overall Study|Lost to Follow-up|2|||
164524708|NCT00768079|594289769|FG001|Overall Study|Lost to Follow-up|0|||
164524709|NCT00768079|594289770|FG002|Overall Study|Lost to Follow-up|4|||
164524710|NCT00768079|594289768|FG000|Overall Study|Participant incarcerated|0|||
164524711|NCT00768079|594289769|FG001|Overall Study|Participant incarcerated|1|||
164524712|NCT00768079|594289770|FG002|Overall Study|Participant incarcerated|0|||
164524713|NCT01156792|594289771|FG000|Overall Study|Adverse Event|1|||
164524714|NCT01156792|594289771|FG000|Overall Study|Lack of Efficacy|36|||
164524715|NCT01156792|594289771|FG000|Overall Study|Protocol Violation|6|||
164524716|NCT01156792|594289771|FG000|Overall Study|Lost to Follow-up|3|||
164524717|NCT01156792|594289771|FG000|Overall Study|Physician Decision|3|||
164524718|NCT01156792|594289771|FG000|Overall Study|Withdrawal by Subject|9|||
164524719|NCT01156792|594289771|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
164524720|NCT00993668|594289772|FG000|Single-Blind Period|Adverse Event|1|||
164524721|NCT00993668|594289773|FG001|Single-Blind Period|Adverse Event|1|||
164524722|NCT00993668|594289772|FG000|Single-Blind Period|Lack of Efficacy|0|||
164524723|NCT00993668|594289773|FG001|Single-Blind Period|Lack of Efficacy|1|||
164524724|NCT00993668|594289772|FG000|Single-Blind Period|Lost to Follow-up|3|||
164524725|NCT00993668|594289773|FG001|Single-Blind Period|Lost to Follow-up|1|||
164524726|NCT00993668|594289772|FG000|Open-Label Period|Adverse Event|9|||
164524727|NCT00993668|594289773|FG001|Open-Label Period|Adverse Event|8|||
164524728|NCT00993668|594289772|FG000|Open-Label Period|Lack of Efficacy|4|||
164524729|NCT00993668|594289773|FG001|Open-Label Period|Lack of Efficacy|3|||
164524730|NCT00993668|594289772|FG000|Open-Label Period|Withdrawal by Subject|4|||
164524731|NCT00993668|594289773|FG001|Open-Label Period|Withdrawal by Subject|3|||
164524732|NCT00993668|594289772|FG000|Open-Label Period|Lost to Follow-up|6|||
164524733|NCT00993668|594289773|FG001|Open-Label Period|Lost to Follow-up|1|||
164524734|NCT02207569|594289774|FG000|1-Month|Death|6|||
164524735|NCT02207569|594289774|FG000|1-Month|Withdrawal by Subject|2|||
164524736|NCT02207569|594289774|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
164524737|NCT02207569|594289774|FG000|6-Month|Death|8|||
164524738|NCT02207569|594289774|FG000|6-Month|Withdrawal by Subject|2|||
164524739|NCT02207569|594289774|FG000|12-Month|Death|14|||
164524740|NCT02207569|594289774|FG000|12-Month|Withdrawal by Subject|2|||
164524741|NCT02207569|594289774|FG000|24-Month|Death|23|||
164524742|NCT02207569|594289774|FG000|24-Month|Withdrawal by Subject|3|||
164524743|NCT02207569|594289774|FG000|36-Month|Death|23|||
164524744|NCT02207569|594289774|FG000|36-Month|Withdrawal by Subject|4|||
164524745|NCT02207569|594289774|FG000|48-Month|Death|25|||
164524746|NCT02207569|594289774|FG000|48-Month|Withdrawal by Subject|2|||
164524747|NCT02207569|594289774|FG000|48-Month|Lost to Follow-up|4|||
164524748|NCT02207569|594289774|FG000|60-Month|Death|1|||
164524749|NCT02207569|594289774|FG000|60-Month|Lost to Follow-up|1|||
164524750|NCT02207569|594289774|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
164524751|NCT02207569|594289774|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
164524752|NCT02313233|594289777|FG000|Overall Study|Withdrawal by Subject|1|||
164524753|NCT02313233|594289778|FG001|Overall Study|Withdrawal by Subject|2|||
164524754|NCT02313233|594289777|FG000|Overall Study|Administrative reason|1|||
164524755|NCT02313233|594289778|FG001|Overall Study|Administrative reason|1|||
164524756|NCT03618823|594289779|FG000|Overall Study|Lost to Follow-up|63|||
164524757|NCT03618823|594289780|FG001|Overall Study|Lost to Follow-up|61|||
164524758|NCT05383508|594289781|FG000|Overall Study|Withdrawal by Subject|1|||
164524759|NCT05383508|594289782|FG001|Overall Study|Withdrawal by Subject|0|||
164524760|NCT05383508|594289783|FG002|Overall Study|Withdrawal by Subject|1|||
164524761|NCT05383508|594289784|FG003|Overall Study|Withdrawal by Subject|1|||
164524762|NCT05383508|594289785|FG004|Overall Study|Withdrawal by Subject|2|||
164524763|NCT05383508|594289786|FG005|Overall Study|Withdrawal by Subject|0|||
164524764|NCT01621568|594289788|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
164524765|NCT01621568|594289789|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
164524766|NCT01621568|594289788|FG000|Week 5-6 No Treatment|Death|1|||
164524767|NCT01621568|594289789|FG001|Week 5-6 No Treatment|Death|0|||
164524768|NCT02930226|594289790|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
164524769|NCT02930226|594289791|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
164524770|NCT02930226|594289792|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
164524771|NCT02930226|594289793|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
164524772|NCT02930226|594289794|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
164524773|NCT02930226|594289795|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
164524774|NCT00682890|594289799|FG000|Overall Study|Lost to Follow-up|1|||
164524775|NCT00682890|594289800|FG001|Overall Study|Lost to Follow-up|1|||
164524776|NCT00682890|594289799|FG000|Overall Study|subject moved away|0|||
164524777|NCT00682890|594289800|FG001|Overall Study|subject moved away|1|||
164524778|NCT00682890|594289799|FG000|Overall Study|heavy menstrual bleeding|1|||
164524779|NCT00682890|594289800|FG001|Overall Study|heavy menstrual bleeding|0|||
164524780|NCT02224690|594289802|FG000|Overall Study|Adverse Event|8|||
164524781|NCT02224690|594289803|FG001|Overall Study|Adverse Event|1|||
164524782|NCT02224690|594289802|FG000|Overall Study|Met Withdrawal Criteria|4|||
164524783|NCT02224690|594289803|FG001|Overall Study|Met Withdrawal Criteria|0|||
164524784|NCT02224690|594289802|FG000|Overall Study|Use of G-tube|1|||
164524785|NCT02224690|594289803|FG001|Overall Study|Use of G-tube|0|||
164524786|NCT02224690|594289802|FG000|Overall Study|Did not meet eligibility criteria|1|||
164524787|NCT02224690|594289803|FG001|Overall Study|Did not meet eligibility criteria|0|||
164524788|NCT01506609|594289805|FG000|Overall Study|Adverse Event Related to Progression|0|||
164524789|NCT01506609|594289806|FG001|Overall Study|Adverse Event Related to Progression|0|||
164524790|NCT01506609|594289807|FG002|Overall Study|Adverse Event Related to Progression|0|||
164524791|NCT01506609|594289808|FG003|Overall Study|Adverse Event Related to Progression|3|||
164524792|NCT01506609|594289809|FG004|Overall Study|Adverse Event Related to Progression|7|||
164524793|NCT01506609|594289810|FG005|Overall Study|Adverse Event Related to Progression|3|||
164524794|NCT01506609|594289805|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
164524795|NCT01506609|594289806|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
164524796|NCT01506609|594289807|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
164524797|NCT01506609|594289808|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
164524798|NCT01506609|594289809|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
164524799|NCT01506609|594289810|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
164524800|NCT01506609|594289805|FG000|Overall Study|Withdrawal by Subject|0|||
164524801|NCT01506609|594289806|FG001|Overall Study|Withdrawal by Subject|0|||
164524802|NCT01506609|594289807|FG002|Overall Study|Withdrawal by Subject|0|||
164524803|NCT01506609|594289808|FG003|Overall Study|Withdrawal by Subject|9|||
164524804|NCT01506609|594289809|FG004|Overall Study|Withdrawal by Subject|7|||
164524805|NCT01506609|594289810|FG005|Overall Study|Withdrawal by Subject|7|||
164524806|NCT01506609|594289805|FG000|Overall Study|Lost to Follow-up|0|||
164524807|NCT01506609|594289806|FG001|Overall Study|Lost to Follow-up|0|||
164524808|NCT01506609|594289807|FG002|Overall Study|Lost to Follow-up|0|||
164524809|NCT01506609|594289808|FG003|Overall Study|Lost to Follow-up|1|||
164524810|NCT01506609|594289809|FG004|Overall Study|Lost to Follow-up|2|||
164524811|NCT01506609|594289810|FG005|Overall Study|Lost to Follow-up|0|||
164524812|NCT01506609|594289805|FG000|Overall Study|Sponsor Discontinued Study|0|||
164524813|NCT01506609|594289806|FG001|Overall Study|Sponsor Discontinued Study|0|||
164524814|NCT01506609|594289807|FG002|Overall Study|Sponsor Discontinued Study|0|||
164524815|NCT01506609|594289808|FG003|Overall Study|Sponsor Discontinued Study|2|||
164524816|NCT01506609|594289809|FG004|Overall Study|Sponsor Discontinued Study|2|||
164524817|NCT01506609|594289810|FG005|Overall Study|Sponsor Discontinued Study|0|||
164524818|NCT01506609|594289805|FG000|Overall Study|Progressive Disease per Protocol|1|||
164524819|NCT01506609|594289806|FG001|Overall Study|Progressive Disease per Protocol|0|||
164524820|NCT01506609|594289807|FG002|Overall Study|Progressive Disease per Protocol|0|||
164524821|NCT01506609|594289808|FG003|Overall Study|Progressive Disease per Protocol|64|||
164524822|NCT01506609|594289809|FG004|Overall Study|Progressive Disease per Protocol|57|||
164524823|NCT01506609|594289810|FG005|Overall Study|Progressive Disease per Protocol|74|||
164524824|NCT01506609|594289805|FG000|Overall Study|Other, Not Specified|0|||
164524825|NCT01506609|594289806|FG001|Overall Study|Other, Not Specified|0|||
164524826|NCT01506609|594289807|FG002|Overall Study|Other, Not Specified|0|||
164524827|NCT01506609|594289808|FG003|Overall Study|Other, Not Specified|10|||
164524828|NCT01506609|594289809|FG004|Overall Study|Other, Not Specified|7|||
164524829|NCT01506609|594289810|FG005|Overall Study|Other, Not Specified|3|||
164524830|NCT01506609|594289805|FG000|Overall Study|Missing / Unknown Reason|1|||
164524831|NCT01506609|594289806|FG001|Overall Study|Missing / Unknown Reason|0|||
164524832|NCT01506609|594289807|FG002|Overall Study|Missing / Unknown Reason|1|||
164524833|NCT01506609|594289808|FG003|Overall Study|Missing / Unknown Reason|4|||
164524834|NCT01506609|594289809|FG004|Overall Study|Missing / Unknown Reason|4|||
164524835|NCT01506609|594289810|FG005|Overall Study|Missing / Unknown Reason|2|||
164524836|NCT02703259|594289817|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
164524837|NCT02703259|594289818|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
164524838|NCT02703259|594289817|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
164524839|NCT02703259|594289818|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
164524840|NCT02703259|594289817|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
164524841|NCT02703259|594289818|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
164524842|NCT01153958|594289819|FG000|Overall Study|Study Terminated|36|||
164524843|NCT01153958|594289820|FG001|Overall Study|Study Terminated|32|||
164524844|NCT02971761|594289821|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
164524845|NCT02624791|594289822|FG000|Overall Study|Withdrawal by Subject|2|||
164524846|NCT02624791|594289823|FG001|Overall Study|Withdrawal by Subject|0|||
164524847|NCT02624791|594289824|FG002|Overall Study|Withdrawal by Subject|0|||
164524848|NCT02624791|594289825|FG003|Overall Study|Withdrawal by Subject|0|||
164524849|NCT02624791|594289826|FG004|Overall Study|Withdrawal by Subject|0|||
164524850|NCT02624791|594289827|FG005|Overall Study|Withdrawal by Subject|0|||
164524851|NCT00895154|594289831|FG000|Overall Study|Lost to Follow-up|1|||
164524852|NCT00895154|594289832|FG001|Overall Study|Lost to Follow-up|1|||
164524853|NCT00895154|594289831|FG000|Overall Study|Withdrawal by Subject|0|||
164524854|NCT00895154|594289832|FG001|Overall Study|Withdrawal by Subject|1|||
164524855|NCT01688830|594289836|FG000|Overall Study|Lost to Follow-up|0|||
164524856|NCT01688830|594289837|FG001|Overall Study|Lost to Follow-up|0|||
164524857|NCT01688830|594289838|FG002|Overall Study|Lost to Follow-up|0|||
164524858|NCT01688830|594289839|FG003|Overall Study|Lost to Follow-up|0|||
164524859|NCT01688830|594289840|FG004|Overall Study|Lost to Follow-up|0|||
164524860|NCT01688830|594289841|FG005|Overall Study|Lost to Follow-up|0|||
164524861|NCT01688830|594289842|FG006|Overall Study|Lost to Follow-up|0|||
164524862|NCT01688830|594289843|FG007|Overall Study|Lost to Follow-up|0|||
164524863|NCT01688830|594289844|FG008|Overall Study|Lost to Follow-up|0|||
164524864|NCT01688830|594289845|FG009|Overall Study|Lost to Follow-up|0|||
164524865|NCT01688830|594289846|FG010|Overall Study|Lost to Follow-up|1|||
164524866|NCT01688830|594289847|FG011|Overall Study|Lost to Follow-up|0|||
164524867|NCT01688830|594289848|FG012|Overall Study|Lost to Follow-up|0|||
164524868|NCT01688830|594289849|FG013|Overall Study|Lost to Follow-up|0|||
164524869|NCT01688830|594289850|FG014|Overall Study|Lost to Follow-up|0|||
164524870|NCT01688830|594289851|FG015|Overall Study|Lost to Follow-up|0|||
164524871|NCT01688830|594289852|FG016|Overall Study|Lost to Follow-up|0|||
164524872|NCT01688830|594289853|FG017|Overall Study|Lost to Follow-up|0|||
164524873|NCT01688830|594289854|FG018|Overall Study|Lost to Follow-up|0|||
164524874|NCT01688830|594289855|FG019|Overall Study|Lost to Follow-up|0|||
164524875|NCT01688830|594289856|FG020|Overall Study|Lost to Follow-up|0|||
164524876|NCT03965351|594289859|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
164524877|NCT03965351|594289860|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
164524878|NCT03965351|594289859|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
164524879|NCT03965351|594289860|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
164524880|NCT05038163|594289865|FG000|Stage 1|Did not complete survey|374|||
164524881|NCT05038163|594289866|FG001|Stage 1|Did not complete survey|0|||
164524882|NCT05038163|594289867|FG002|Stage 1|Did not complete survey|0|||
164524883|NCT05038163|594289868|FG003|Stage 1|Did not complete survey|0|||
164524884|NCT05038163|594289869|FG004|Stage 1|Did not complete survey|0|||
164524885|NCT05038163|594289870|FG005|Stage 1|Did not complete survey|0|||
164524886|NCT05038163|594289865|FG000|Stage 2|Did not complete Stage 2 survey|0|||
164524887|NCT05038163|594289866|FG001|Stage 2|Did not complete Stage 2 survey|29|||
164524888|NCT05038163|594289867|FG002|Stage 2|Did not complete Stage 2 survey|30|||
164524889|NCT05038163|594289868|FG003|Stage 2|Did not complete Stage 2 survey|24|||
164524890|NCT05038163|594289869|FG004|Stage 2|Did not complete Stage 2 survey|21|||
164524891|NCT05038163|594289870|FG005|Stage 2|Did not complete Stage 2 survey|100|||
164524892|NCT01905150|594289871|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
164524893|NCT01905150|594289872|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
164524894|NCT01758900|594289873|FG000|Overall Study|difficulty for further intubation|7|||
164524895|NCT01758900|594289874|FG001|Overall Study|difficulty for further intubation|8|||
164524896|NCT00935818|594289875|FG000|Overall Study|Withdrawal by Subject|45|||
164524897|NCT00935818|594289876|FG001|Overall Study|Withdrawal by Subject|50|||
164524898|NCT00935818|594289875|FG000|Overall Study|Lost to Follow-up|40|||
164524899|NCT00935818|594289876|FG001|Overall Study|Lost to Follow-up|42|||
164524900|NCT00935818|594289875|FG000|Overall Study|Adverse Event|6|||
164524901|NCT00935818|594289876|FG001|Overall Study|Adverse Event|7|||
164524902|NCT00935818|594289875|FG000|Overall Study|Physician Decision|0|||
164524903|NCT00935818|594289876|FG001|Overall Study|Physician Decision|1|||
164524904|NCT02631577|594289877|FG000|Overall Study|Death|1|||
164524905|NCT02631577|594289878|FG001|Overall Study|Death|7|||
164524906|NCT02631577|594289877|FG000|Overall Study|Withdrawal by Subject|0|||
164524907|NCT02631577|594289878|FG001|Overall Study|Withdrawal by Subject|3|||
164524908|NCT03465904|594289879|FG000|Overall Study|Withdrawal by Subject|9|||
164524909|NCT03465904|594289880|FG001|Overall Study|Withdrawal by Subject|5|||
164524910|NCT03465904|594289879|FG000|Overall Study|Lost to Follow-up|11|||
164524911|NCT03465904|594289880|FG001|Overall Study|Lost to Follow-up|9|||
164524912|NCT03465904|594289879|FG000|Overall Study|Protocol Violation|20|||
164524913|NCT03465904|594289880|FG001|Overall Study|Protocol Violation|15|||
164524914|NCT01305200|594289881|FG000|Overall Study|Physician Decision|4|||
164524915|NCT01305200|594289882|FG001|Overall Study|Physician Decision|6|||
164524916|NCT01305200|594289883|FG002|Overall Study|Physician Decision|1|||
164524917|NCT01305200|594289881|FG000|Overall Study|Withdrawal by Subject|24|||
164524918|NCT01305200|594289882|FG001|Overall Study|Withdrawal by Subject|21|||
164524919|NCT01305200|594289883|FG002|Overall Study|Withdrawal by Subject|1|||
164524920|NCT01305200|594289881|FG000|Overall Study|Ineligible|1|||
164524921|NCT01305200|594289882|FG001|Overall Study|Ineligible|2|||
164524922|NCT01305200|594289883|FG002|Overall Study|Ineligible|1|||
164524923|NCT01305200|594289881|FG000|Overall Study|Death|0|||
164524924|NCT01305200|594289882|FG001|Overall Study|Death|2|||
164524925|NCT01305200|594289883|FG002|Overall Study|Death|0|||
164524926|NCT05593445|594289884|FG000|12-Week DBVC Period|Adverse Event|1|||
164524927|NCT05593445|594289885|FG001|12-Week DBVC Period|Adverse Event|0|||
164524928|NCT05593445|594289886|FG002|12-Week DBVC Period|Adverse Event|0|||
164524929|NCT05593445|594289887|FG003|12-Week DBVC Period|Adverse Event|0|||
164524930|NCT05593445|594289884|FG000|12-Week DBVC Period|Physician Decision|0|||
164524931|NCT05593445|594289885|FG001|12-Week DBVC Period|Physician Decision|1|||
164524932|NCT05593445|594289886|FG002|12-Week DBVC Period|Physician Decision|0|||
164524933|NCT05593445|594289887|FG003|12-Week DBVC Period|Physician Decision|0|||
164524934|NCT05593445|594289884|FG000|12-Week DBVC Period|Protocol Violation|0|||
164524935|NCT05593445|594289885|FG001|12-Week DBVC Period|Protocol Violation|1|||
164524936|NCT05593445|594289886|FG002|12-Week DBVC Period|Protocol Violation|0|||
164524937|NCT05593445|594289887|FG003|12-Week DBVC Period|Protocol Violation|0|||
164524938|NCT05593445|594289884|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
164524939|NCT05593445|594289885|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
164524940|NCT05593445|594289886|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
164524941|NCT05593445|594289887|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
164524942|NCT05593445|594289884|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
164524943|NCT05593445|594289885|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
164524944|NCT05593445|594289886|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
164524945|NCT05593445|594289887|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
164524946|NCT05593445|594289884|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
164524947|NCT05593445|594289885|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
164524948|NCT05593445|594289886|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
164524949|NCT05593445|594289887|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
164524950|NCT05593445|594289884|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
164524951|NCT05593445|594289885|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
164524952|NCT05593445|594289886|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
164524953|NCT05593445|594289887|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
164524954|NCT05593445|594289884|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
164524955|NCT05593445|594289885|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
164524956|NCT05593445|594289886|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
164524957|NCT05593445|594289887|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
164524958|NCT05559476|594289888|FG000|Overall Study|Adverse Event|2|||
164524959|NCT05559476|594289889|FG001|Overall Study|Adverse Event|0|||
164524960|NCT05559476|594289888|FG000|Overall Study|Lost to Follow-up|13|||
164524961|NCT05559476|594289889|FG001|Overall Study|Lost to Follow-up|12|||
164524962|NCT05559476|594289888|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
164524963|NCT05559476|594289889|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
164524964|NCT05559476|594289888|FG000|Overall Study|Other|0|||
164524965|NCT05559476|594289889|FG001|Overall Study|Other|2|||
164524966|NCT00925353|594289890|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
164524967|NCT00812331|594292097|FG000|Overall Study|Adverse Event|1|||
164524968|NCT00812331|594292098|FG001|Overall Study|Adverse Event|0|||
164524969|NCT00812331|594292099|FG002|Overall Study|Adverse Event|0|||
164524970|NCT00812331|594292100|FG003|Overall Study|Adverse Event|0|||
164524971|NCT00812331|594292101|FG004|Overall Study|Adverse Event|0|||
164524972|NCT03694275|594292102|FG000|Overall Study|Adverse Event|0|||
164524973|NCT03694275|594292103|FG001|Overall Study|Adverse Event|1|||
164621692|NCT04556175|594635522|FG000|Overall Study|Study terminated due to COVID-19|8|||
164621693|NCT04556175|594635523|FG001|Overall Study|Study terminated due to COVID-19|8|||
164524974|NCT03694275|594292102|FG000|Overall Study|Reason not Specified|0|||
164524975|NCT03694275|594292103|FG001|Overall Study|Reason not Specified|1|||
164524976|NCT02502799|594292104|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
164621694|NCT05549505|594635524|FG000|Overall Study|Lost to Follow-up|2|||
164621695|NCT05549505|594635525|FG001|Overall Study|Lost to Follow-up|0|||
164621696|NCT05549505|594635524|FG000|Overall Study|Withdrawal by Subject|3|||
164524977|NCT02502799|594292105|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
164524978|NCT02502799|594292106|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
164524979|NCT02502799|594292107|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
164524980|NCT02502799|594292104|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
164524981|NCT02502799|594292105|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
164524982|NCT02502799|594292106|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
164524983|NCT02502799|594292107|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
164524984|NCT02502799|594292104|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
164524985|NCT02502799|594292105|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
164524986|NCT02502799|594292106|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
164524987|NCT02502799|594292107|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
164524988|NCT02502799|594292104|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
164524989|NCT02502799|594292105|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
164524990|NCT02502799|594292106|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
164524991|NCT02502799|594292107|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
164524992|NCT02502799|594292104|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
164524993|NCT02502799|594292105|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
164524994|NCT02502799|594292106|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
164524995|NCT02502799|594292107|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
164524996|NCT02359877|594292117|FG000|Overall Study|Withdrawal by Subject|1|||
164524997|NCT02359877|594292118|FG001|Overall Study|Withdrawal by Subject|0|||
164524998|NCT02359877|594292119|FG002|Overall Study|Withdrawal by Subject|0|||
164524999|NCT02359877|594292120|FG003|Overall Study|Withdrawal by Subject|2|||
164525000|NCT02359877|594292117|FG000|Overall Study|Adverse Event|0|||
164525001|NCT02359877|594292118|FG001|Overall Study|Adverse Event|0|||
164525002|NCT02359877|594292119|FG002|Overall Study|Adverse Event|0|||
164525003|NCT02359877|594292120|FG003|Overall Study|Adverse Event|1|||
164525004|NCT01589237|594292133|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
164525005|NCT01589237|594292134|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
164525006|NCT01589237|594292135|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
164525007|NCT01589237|594292136|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
164525008|NCT01589237|594292133|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
164525009|NCT01589237|594292134|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
164525010|NCT01589237|594292135|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
164525011|NCT01589237|594292136|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
164525012|NCT01589237|594292133|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
164525013|NCT01589237|594292134|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
164525014|NCT01589237|594292135|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
164525015|NCT01589237|594292136|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
164525016|NCT01589237|594292133|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
164525017|NCT01589237|594292134|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
164525018|NCT01589237|594292135|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
164525019|NCT01589237|594292136|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
164525020|NCT00117845|594292137|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
164525021|NCT03207009|594292139|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
164525022|NCT00512317|594292140|FG000|Overall Study|Insufficient clinical response|36|||
164525023|NCT00512317|594292140|FG000|Overall Study|Withdrawal by Subject|23|||
164525024|NCT00512317|594292140|FG000|Overall Study|Sponsor closure of study|21|||
164525025|NCT00512317|594292140|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
164525026|NCT00512317|594292140|FG000|Overall Study|Adverse Event|13|||
164525027|NCT00512317|594292140|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
164525028|NCT00512317|594292140|FG000|Overall Study|Lost to Follow-up|2|||
164525029|NCT00512317|594292140|FG000|Overall Study|Other|2|||
164525030|NCT01491672|594292141|FG000|Overall Study|Lost to Follow-up|0|||
164525031|NCT01491672|594292142|FG001|Overall Study|Lost to Follow-up|4|||
164525032|NCT01491672|594292143|FG002|Overall Study|Lost to Follow-up|1|||
164525033|NCT01491672|594292141|FG000|Overall Study|Withdrawal by Subject|6|||
164525034|NCT01491672|594292142|FG001|Overall Study|Withdrawal by Subject|7|||
164525035|NCT01491672|594292143|FG002|Overall Study|Withdrawal by Subject|0|||
164525036|NCT01491672|594292141|FG000|Overall Study|Adverse Event|8|||
164525037|NCT01491672|594292142|FG001|Overall Study|Adverse Event|10|||
164621697|NCT05549505|594635525|FG001|Overall Study|Withdrawal by Subject|3|||
164621698|NCT05549505|594635524|FG000|Overall Study|Other: Miscellaneous|3|||
164621699|NCT05549505|594635525|FG001|Overall Study|Other: Miscellaneous|6|||
164525038|NCT01491672|594292143|FG002|Overall Study|Adverse Event|4|||
164525039|NCT01491672|594292141|FG000|Overall Study|Disease progression|42|||
164621700|NCT00592072|594635528|FG000|Wash Out Period|Lost to Follow-up|1|||
164621701|NCT00592072|594635529|FG001|Wash Out Period|Lost to Follow-up|1|||
164621702|NCT00403390|594635530|FG000|Overall Study|Withdrawal by Subject|1|||
164621703|NCT00403390|594635531|FG001|Overall Study|Withdrawal by Subject|0|||
164525040|NCT01491672|594292142|FG001|Overall Study|Disease progression|34|||
164525041|NCT01491672|594292143|FG002|Overall Study|Disease progression|6|||
164525042|NCT01491672|594292141|FG000|Overall Study|Protocol deviation|0|||
164525043|NCT01491672|594292142|FG001|Overall Study|Protocol deviation|1|||
164525044|NCT01491672|594292143|FG002|Overall Study|Protocol deviation|0|||
164525045|NCT01491672|594292141|FG000|Overall Study|Death|0|||
164525046|NCT01491672|594292142|FG001|Overall Study|Death|4|||
164525047|NCT01491672|594292143|FG002|Overall Study|Death|0|||
164525048|NCT00706433|594292149|FG000|Overall Study|Lost to Follow-up|3|||
164525049|NCT00706433|594292150|FG001|Overall Study|Lost to Follow-up|1|||
164525050|NCT00706433|594292151|FG002|Overall Study|Lost to Follow-up|6|||
164525051|NCT00706433|594292152|FG003|Overall Study|Lost to Follow-up|0|||
164525052|NCT00706433|594292149|FG000|Overall Study|Withdrawal by Subject|1|||
164525053|NCT00706433|594292150|FG001|Overall Study|Withdrawal by Subject|2|||
164525054|NCT00706433|594292151|FG002|Overall Study|Withdrawal by Subject|3|||
164525055|NCT00706433|594292152|FG003|Overall Study|Withdrawal by Subject|1|||
164525056|NCT00706433|594292149|FG000|Overall Study|Adverse Event|0|||
164525057|NCT00706433|594292150|FG001|Overall Study|Adverse Event|0|||
164525058|NCT00706433|594292151|FG002|Overall Study|Adverse Event|1|||
164525059|NCT00706433|594292152|FG003|Overall Study|Adverse Event|0|||
164525060|NCT00706433|594292149|FG000|Overall Study|Protocol Violation|1|||
164525061|NCT00706433|594292150|FG001|Overall Study|Protocol Violation|0|||
164525062|NCT00706433|594292151|FG002|Overall Study|Protocol Violation|0|||
164525063|NCT00706433|594292152|FG003|Overall Study|Protocol Violation|0|||
164525064|NCT00706433|594292149|FG000|Overall Study|new job|0|||
164525065|NCT00706433|594292150|FG001|Overall Study|new job|0|||
164525066|NCT00706433|594292151|FG002|Overall Study|new job|0|||
164525067|NCT00706433|594292152|FG003|Overall Study|new job|1|||
164525068|NCT02090959|594292154|FG000|Overall Study|Withdrawal by Subject|10|||
164525069|NCT02090959|594292154|FG000|Overall Study|Adverse Event|1|||
164525070|NCT02090959|594292154|FG000|Overall Study|Investigator decision|2|||
164525071|NCT02090959|594292154|FG000|Overall Study|Study termination|6|||
164525072|NCT02090959|594292154|FG000|Overall Study|Enrolled but not treated|1|||
164525073|NCT02090959|594292154|FG000|Overall Study|Transfer for compassionate use medicine|4|||
164525074|NCT02090959|594292154|FG000|Overall Study|Move to medical need program|3|||
164525075|NCT02090959|594292154|FG000|Overall Study|Entered in to other study|34|||
164525076|NCT02090959|594292154|FG000|Overall Study|Switched to commercial supply|88|||
164525077|NCT02090959|594292154|FG000|Overall Study|Other than specified|2|||
164525078|NCT00522873|594292155|FG000|Overall Study|Adverse Event|41|||
164525079|NCT00522873|594292156|FG001|Overall Study|Adverse Event|26|||
164525080|NCT00522873|594292155|FG000|Overall Study|Withdrawal by Subject|20|||
164525081|NCT00522873|594292156|FG001|Overall Study|Withdrawal by Subject|9|||
164525082|NCT00522873|594292155|FG000|Overall Study|Protocol Violation|14|||
164525083|NCT00522873|594292156|FG001|Overall Study|Protocol Violation|4|||
164525084|NCT00522873|594292155|FG000|Overall Study|Lost to Follow-up|11|||
164525085|NCT00522873|594292156|FG001|Overall Study|Lost to Follow-up|3|||
164525086|NCT00522873|594292155|FG000|Overall Study|Personal Reasons|8|||
164525087|NCT00522873|594292156|FG001|Overall Study|Personal Reasons|1|||
164525088|NCT00522873|594292155|FG000|Overall Study|Medication Errors|1|||
164525089|NCT00522873|594292156|FG001|Overall Study|Medication Errors|1|||
164525090|NCT00522873|594292155|FG000|Overall Study|Never Received Medication|1|||
164525091|NCT00522873|594292156|FG001|Overall Study|Never Received Medication|0|||
164525092|NCT00657020|594292157|FG000|PERIOD 1|Adverse Event|0|||
164525093|NCT00657020|594292158|FG001|PERIOD 1|Adverse Event|1|||
164525094|NCT00822172|594292164|FG000|Overall Study|Adverse Event|10|||
164525095|NCT00822172|594292165|FG001|Overall Study|Adverse Event|12|||
164525096|NCT00822172|594292164|FG000|Overall Study|Death|1|||
164525097|NCT00822172|594292165|FG001|Overall Study|Death|0|||
164525098|NCT00822172|594292164|FG000|Overall Study|Lost to Follow-up|3|||
164525099|NCT00822172|594292165|FG001|Overall Study|Lost to Follow-up|1|||
164525100|NCT00822172|594292164|FG000|Overall Study|Withdrawal by Subject|1|||
164525101|NCT00822172|594292165|FG001|Overall Study|Withdrawal by Subject|4|||
164525102|NCT00822172|594292164|FG000|Overall Study|site closed|0|||
164525103|NCT00822172|594292165|FG001|Overall Study|site closed|1|||
164525104|NCT00822172|594292164|FG000|Overall Study|Other|0|||
164525105|NCT00822172|594292165|FG001|Overall Study|Other|1|||
164525106|NCT00642772|594292167|FG000|Overall Study|Lost to Follow-up|3|||
164525107|NCT00642772|594292167|FG000|Overall Study|Withdrawal by Subject|7|||
164525108|NCT02947087|594292168|FG000|Overall Study|Withdrawal by Subject|3|||
164525109|NCT02947087|594292169|FG001|Overall Study|Withdrawal by Subject|2|||
164525110|NCT00545051|594292171|FG000|Overall Study|Adverse Event|7|||
164525111|NCT00545051|594292172|FG001|Overall Study|Adverse Event|3|||
164525112|NCT00545051|594292171|FG000|Overall Study|Death|1|||
164525113|NCT00545051|594292172|FG001|Overall Study|Death|0|||
164525114|NCT00545051|594292171|FG000|Overall Study|Violation of inclusion/exclusion|0|||
164525115|NCT00545051|594292172|FG001|Overall Study|Violation of inclusion/exclusion|2|||
164525116|NCT00545051|594292171|FG000|Overall Study|Protocol Violation|1|||
164525117|NCT00545051|594292172|FG001|Overall Study|Protocol Violation|0|||
164525118|NCT00545051|594292171|FG000|Overall Study|Withdrawal by Subject|0|||
164525119|NCT00545051|594292172|FG001|Overall Study|Withdrawal by Subject|1|||
164525120|NCT00545051|594292171|FG000|Overall Study|Administrative reasons|0|||
164525121|NCT00545051|594292172|FG001|Overall Study|Administrative reasons|1|||
164525122|NCT01375114|594292173|FG000|Overall Study|Lost to Follow-up|1|||
164525123|NCT01375114|594292174|FG001|Overall Study|Lost to Follow-up|0|||
164525124|NCT01375114|594292175|FG002|Overall Study|Lost to Follow-up|1|||
164525125|NCT01375114|594292173|FG000|Overall Study|Disease Progression|3|||
164525126|NCT01375114|594292174|FG001|Overall Study|Disease Progression|2|||
164525127|NCT01375114|594292175|FG002|Overall Study|Disease Progression|2|||
164525128|NCT01375114|594292173|FG000|Overall Study|Patient Changed Mind|0|||
164525129|NCT01375114|594292174|FG001|Overall Study|Patient Changed Mind|0|||
164525130|NCT01375114|594292175|FG002|Overall Study|Patient Changed Mind|2|||
164525131|NCT01375114|594292173|FG000|Overall Study|Pruritus|0|||
164525132|NCT01375114|594292174|FG001|Overall Study|Pruritus|0|||
164525133|NCT01375114|594292175|FG002|Overall Study|Pruritus|1|||
164525134|NCT01375114|594292173|FG000|Overall Study|Restlessness|0|||
164525135|NCT01375114|594292174|FG001|Overall Study|Restlessness|0|||
164525136|NCT01375114|594292175|FG002|Overall Study|Restlessness|1|||
164525137|NCT01375114|594292173|FG000|Overall Study|Diarrhea|0|||
164525138|NCT01375114|594292174|FG001|Overall Study|Diarrhea|0|||
164525139|NCT01375114|594292175|FG002|Overall Study|Diarrhea|1|||
164525140|NCT01375114|594292173|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
164525141|NCT01375114|594292174|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
164525142|NCT01375114|594292175|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
164525143|NCT01375114|594292173|FG000|Overall Study|Nausea|0|||
164525144|NCT01375114|594292174|FG001|Overall Study|Nausea|1|||
164525145|NCT01375114|594292175|FG002|Overall Study|Nausea|0|||
164525146|NCT01375114|594292173|FG000|Overall Study|Increased AST/ALT|0|||
164525147|NCT01375114|594292174|FG001|Overall Study|Increased AST/ALT|1|||
164525148|NCT01375114|594292175|FG002|Overall Study|Increased AST/ALT|0|||
164525149|NCT01375114|594292173|FG000|Overall Study|Vaginal Hemorrhage|0|||
164525150|NCT01375114|594292174|FG001|Overall Study|Vaginal Hemorrhage|1|||
164525151|NCT01375114|594292175|FG002|Overall Study|Vaginal Hemorrhage|0|||
164525152|NCT01375114|594292173|FG000|Overall Study|Family problem|0|||
164525153|NCT01375114|594292174|FG001|Overall Study|Family problem|1|||
164525154|NCT01375114|594292175|FG002|Overall Study|Family problem|0|||
164525155|NCT01375114|594292173|FG000|Overall Study|Protocol Violation|2|||
164525156|NCT01375114|594292174|FG001|Overall Study|Protocol Violation|0|||
164525157|NCT01375114|594292175|FG002|Overall Study|Protocol Violation|0|||
164525158|NCT04256629|594292182|FG000|Overall Study|Adverse Event|0|||
164525159|NCT04256629|594292183|FG001|Overall Study|Adverse Event|0|||
164525160|NCT04256629|594292184|FG002|Overall Study|Adverse Event|0|||
164525161|NCT04256629|594292185|FG003|Overall Study|Adverse Event|0|||
164525162|NCT04256629|594292186|FG004|Overall Study|Adverse Event|0|||
164525163|NCT04256629|594292187|FG005|Overall Study|Adverse Event|1|||
164525164|NCT04256629|594292182|FG000|Overall Study|Protocol Violation|0|||
164525165|NCT04256629|594292183|FG001|Overall Study|Protocol Violation|1|||
164525166|NCT04256629|594292184|FG002|Overall Study|Protocol Violation|0|||
164525167|NCT04256629|594292185|FG003|Overall Study|Protocol Violation|0|||
164525168|NCT04256629|594292186|FG004|Overall Study|Protocol Violation|0|||
164525169|NCT04256629|594292187|FG005|Overall Study|Protocol Violation|0|||
164525170|NCT02095951|594292188|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
164525171|NCT02095951|594292189|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
164525172|NCT01859988|594292190|FG000|Overall Study|Withdrawal by Subject|6|||
164525173|NCT01859988|594292191|FG001|Overall Study|Withdrawal by Subject|3|||
164525174|NCT01859988|594292192|FG002|Overall Study|Withdrawal by Subject|4|||
164525175|NCT01859988|594292193|FG003|Overall Study|Withdrawal by Subject|3|||
164525176|NCT01859988|594292194|FG004|Overall Study|Withdrawal by Subject|2|||
164525177|NCT01859988|594292195|FG005|Overall Study|Withdrawal by Subject|2|||
164525178|NCT01859988|594292190|FG000|Overall Study|Lack of Efficacy|1|||
164525179|NCT01859988|594292191|FG001|Overall Study|Lack of Efficacy|1|||
164621704|NCT00403390|594635530|FG000|Overall Study|samples lost|1|||
164621705|NCT00403390|594635531|FG001|Overall Study|samples lost|0|||
164621706|NCT00403390|594635530|FG000|Overall Study|non-compliant|1|||
164525180|NCT01859988|594292192|FG002|Overall Study|Lack of Efficacy|5|||
164525181|NCT01859988|594292193|FG003|Overall Study|Lack of Efficacy|0|||
164621707|NCT00403390|594635531|FG001|Overall Study|non-compliant|0|||
164621708|NCT01796106|594635532|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
164525182|NCT01859988|594292194|FG004|Overall Study|Lack of Efficacy|7|||
164525183|NCT01859988|594292195|FG005|Overall Study|Lack of Efficacy|9|||
164525184|NCT01859988|594292190|FG000|Overall Study|Physician Decision|1|||
164525185|NCT01859988|594292191|FG001|Overall Study|Physician Decision|3|||
164525186|NCT01859988|594292192|FG002|Overall Study|Physician Decision|1|||
164525187|NCT01859988|594292193|FG003|Overall Study|Physician Decision|3|||
164525188|NCT01859988|594292194|FG004|Overall Study|Physician Decision|4|||
164525189|NCT01859988|594292195|FG005|Overall Study|Physician Decision|1|||
164525190|NCT01859988|594292190|FG000|Overall Study|Adverse Event|2|||
164525191|NCT01859988|594292191|FG001|Overall Study|Adverse Event|1|||
164525192|NCT01859988|594292192|FG002|Overall Study|Adverse Event|3|||
164525193|NCT01859988|594292193|FG003|Overall Study|Adverse Event|1|||
164525194|NCT01859988|594292194|FG004|Overall Study|Adverse Event|2|||
164525195|NCT01859988|594292195|FG005|Overall Study|Adverse Event|2|||
164525196|NCT01859988|594292190|FG000|Overall Study|Lost to Follow-up|1|||
164525197|NCT01859988|594292191|FG001|Overall Study|Lost to Follow-up|2|||
164525198|NCT01859988|594292192|FG002|Overall Study|Lost to Follow-up|3|||
164525199|NCT01859988|594292193|FG003|Overall Study|Lost to Follow-up|0|||
164525200|NCT01859988|594292194|FG004|Overall Study|Lost to Follow-up|3|||
164525201|NCT01859988|594292195|FG005|Overall Study|Lost to Follow-up|2|||
164525202|NCT01859988|594292190|FG000|Overall Study|Protocol Violation|0|||
164525203|NCT01859988|594292191|FG001|Overall Study|Protocol Violation|0|||
164525204|NCT01859988|594292192|FG002|Overall Study|Protocol Violation|1|||
164525205|NCT01859988|594292193|FG003|Overall Study|Protocol Violation|0|||
164525206|NCT01859988|594292194|FG004|Overall Study|Protocol Violation|0|||
164525207|NCT01859988|594292195|FG005|Overall Study|Protocol Violation|0|||
164525208|NCT01859988|594292190|FG000|Overall Study|Other than specified above|0|||
164525209|NCT01859988|594292191|FG001|Overall Study|Other than specified above|2|||
164525210|NCT01859988|594292192|FG002|Overall Study|Other than specified above|11|||
164525211|NCT01859988|594292193|FG003|Overall Study|Other than specified above|3|||
164525212|NCT01859988|594292194|FG004|Overall Study|Other than specified above|5|||
164525213|NCT01859988|594292195|FG005|Overall Study|Other than specified above|3|||
164525214|NCT00652327|594292196|FG000|Overall Study|Adverse Event|0|||
164525215|NCT00652327|594292197|FG001|Overall Study|Adverse Event|2|||
164525216|NCT00652327|594292196|FG000|Overall Study|Lost to Follow-up|0|||
164525217|NCT00652327|594292197|FG001|Overall Study|Lost to Follow-up|3|||
164525218|NCT00564889|594292198|FG000|Overall Study|Death|7|||
164525219|NCT00564889|594292198|FG000|Overall Study|Adverse Event|12|||
164525220|NCT00564889|594292198|FG000|Overall Study|Alternative treatment|3|||
164525221|NCT00564889|594292198|FG000|Overall Study|Disease progression|3|||
164525222|NCT00564889|594292198|FG000|Overall Study|Other, not specified|4|||
164525223|NCT00635427|594292199|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
164525224|NCT00635427|594292200|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
164525225|NCT00635427|594292201|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
164525226|NCT00635427|594292202|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
164525227|NCT00635427|594292203|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
164525228|NCT00635427|594292199|FG000|Overall Study|Death|0|||
164525229|NCT00635427|594292200|FG001|Overall Study|Death|0|||
164525230|NCT00635427|594292201|FG002|Overall Study|Death|0|||
164525231|NCT00635427|594292202|FG003|Overall Study|Death|1|||
164525232|NCT00635427|594292203|FG004|Overall Study|Death|0|||
164525233|NCT00635427|594292199|FG000|Overall Study|Termination Of Study By Sponsor|12|||
164525234|NCT00635427|594292200|FG001|Overall Study|Termination Of Study By Sponsor|6|||
164525235|NCT00635427|594292201|FG002|Overall Study|Termination Of Study By Sponsor|10|||
164525236|NCT00635427|594292202|FG003|Overall Study|Termination Of Study By Sponsor|6|||
164525237|NCT00635427|594292203|FG004|Overall Study|Termination Of Study By Sponsor|6|||
164525238|NCT00635427|594292199|FG000|Overall Study|Withdrawal Of Consent|0|||
164525239|NCT00635427|594292200|FG001|Overall Study|Withdrawal Of Consent|0|||
164525240|NCT00635427|594292201|FG002|Overall Study|Withdrawal Of Consent|0|||
164525241|NCT00635427|594292202|FG003|Overall Study|Withdrawal Of Consent|2|||
164525242|NCT00635427|594292203|FG004|Overall Study|Withdrawal Of Consent|2|||
164525243|NCT05753670|594292204|FG000|Overall Study|Withdrawal by Subject|6|||
164525244|NCT05753670|594292205|FG001|Overall Study|Withdrawal by Subject|8|||
164525245|NCT05753670|594292204|FG000|Overall Study|Protocol Violation|3|||
164525246|NCT05753670|594292205|FG001|Overall Study|Protocol Violation|1|||
164525247|NCT00577473|594292208|FG000|Overall Study|Protocol Violation|1|||
164525248|NCT00577473|594292209|FG001|Overall Study|Protocol Violation|4|||
164525249|NCT00577473|594292208|FG000|Overall Study|Adverse Event|8|||
164525250|NCT00577473|594292209|FG001|Overall Study|Adverse Event|5|||
164525251|NCT00577473|594292208|FG000|Overall Study|Withdrawal by Subject|2|||
164525252|NCT00577473|594292209|FG001|Overall Study|Withdrawal by Subject|6|||
164525253|NCT00577473|594292208|FG000|Overall Study|Physician Decision|2|||
164525254|NCT00577473|594292209|FG001|Overall Study|Physician Decision|2|||
164525255|NCT00577473|594292208|FG000|Overall Study|Lack of Efficacy|8|||
164525256|NCT00577473|594292209|FG001|Overall Study|Lack of Efficacy|7|||
164525257|NCT02595073|594292210|FG000|Overall Study|Progressive Disease|0|||
164525258|NCT02595073|594292211|FG001|Overall Study|Progressive Disease|1|||
164525259|NCT02595073|594292210|FG000|Overall Study|Protocol Violation|2|||
164525260|NCT02595073|594292211|FG001|Overall Study|Protocol Violation|0|||
164525261|NCT01990560|594292212|FG000|Overall Study|Withdrawal by Subject|1|||
164525262|NCT01324440|594292218|FG000|Overall Study|Subject moved|0|||
164525263|NCT01324440|594292219|FG001|Overall Study|Subject moved|1|||
164525264|NCT02884908|594292220|FG000|Overall Study|Lost to Follow-up|13|||
164525265|NCT02884908|594292221|FG001|Overall Study|Lost to Follow-up|18|||
164525266|NCT01293487|594292225|FG000|Overall Study|Lost to Follow-up|0|||
164525267|NCT01293487|594292226|FG001|Overall Study|Lost to Follow-up|0|||
164525268|NCT01293487|594292227|FG002|Overall Study|Lost to Follow-up|0|||
164525269|NCT01293487|594292228|FG003|Overall Study|Lost to Follow-up|1|||
164525270|NCT01293487|594292229|FG004|Overall Study|Lost to Follow-up|0|||
164525271|NCT01293487|594292230|FG005|Overall Study|Lost to Follow-up|0|||
164525272|NCT01293487|594292231|FG006|Overall Study|Lost to Follow-up|0|||
164525273|NCT01293487|594292232|FG007|Overall Study|Lost to Follow-up|0|||
164525274|NCT01293487|594292225|FG000|Overall Study|Withdrawal by Subject|0|||
164525275|NCT01293487|594292226|FG001|Overall Study|Withdrawal by Subject|0|||
164525276|NCT01293487|594292227|FG002|Overall Study|Withdrawal by Subject|0|||
164525277|NCT01293487|594292228|FG003|Overall Study|Withdrawal by Subject|0|||
164525278|NCT01293487|594292229|FG004|Overall Study|Withdrawal by Subject|0|||
164525279|NCT01293487|594292230|FG005|Overall Study|Withdrawal by Subject|0|||
164525280|NCT01293487|594292231|FG006|Overall Study|Withdrawal by Subject|0|||
164525281|NCT01293487|594292232|FG007|Overall Study|Withdrawal by Subject|2|||
164525282|NCT04860297|594292233|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
164525283|NCT04860297|594292234|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
164525284|NCT04860297|594292235|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
164525285|NCT04860297|594292236|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
164525286|NCT04860297|594292237|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
164525287|NCT04860297|594292238|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
164525288|NCT04860297|594292239|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
164525289|NCT04860297|594292240|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
164525290|NCT04860297|594292233|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
164525291|NCT04860297|594292234|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
164525292|NCT04860297|594292235|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
164525293|NCT04860297|594292236|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
164525294|NCT04860297|594292237|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
164525295|NCT04860297|594292238|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
164525296|NCT04860297|594292239|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
164525297|NCT04860297|594292240|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
164525298|NCT04860297|594292233|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
164525299|NCT04860297|594292234|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
164525300|NCT04860297|594292235|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
164525301|NCT04860297|594292236|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
164525302|NCT04860297|594292237|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
164525303|NCT04860297|594292238|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
164525304|NCT04860297|594292239|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
164525305|NCT04860297|594292240|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
164525306|NCT04860297|594292233|FG000|Part B (Booster Dose)|Other Than Specified|0|||
164525307|NCT04860297|594292234|FG001|Part B (Booster Dose)|Other Than Specified|0|||
164525308|NCT04860297|594292235|FG002|Part B (Booster Dose)|Other Than Specified|0|||
164525309|NCT04860297|594292236|FG003|Part B (Booster Dose)|Other Than Specified|0|||
164525310|NCT04860297|594292237|FG004|Part B (Booster Dose)|Other Than Specified|0|||
164525311|NCT04860297|594292238|FG005|Part B (Booster Dose)|Other Than Specified|1|||
164525312|NCT04860297|594292239|FG006|Part B (Booster Dose)|Other Than Specified|1|||
164525313|NCT04860297|594292240|FG007|Part B (Booster Dose)|Other Than Specified|0|||
164525314|NCT04860297|594292233|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
164525315|NCT04860297|594292234|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
164525316|NCT04860297|594292235|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
164525317|NCT04860297|594292236|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
164525318|NCT04860297|594292237|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
164525319|NCT04860297|594292238|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
164525320|NCT04860297|594292239|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
164525321|NCT04860297|594292240|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
164525322|NCT04860297|594292233|FG000|Part B (Booster Dose)|Death|0|||
164525323|NCT04860297|594292234|FG001|Part B (Booster Dose)|Death|0|||
164525324|NCT04860297|594292235|FG002|Part B (Booster Dose)|Death|0|||
164525325|NCT04860297|594292236|FG003|Part B (Booster Dose)|Death|0|||
164525326|NCT04860297|594292237|FG004|Part B (Booster Dose)|Death|1|||
164525327|NCT04860297|594292238|FG005|Part B (Booster Dose)|Death|2|||
164525328|NCT04860297|594292239|FG006|Part B (Booster Dose)|Death|1|||
164525329|NCT04860297|594292240|FG007|Part B (Booster Dose)|Death|0|||
164525330|NCT04860297|594292233|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
164525331|NCT04860297|594292234|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
164525332|NCT04860297|594292235|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
164525333|NCT04860297|594292236|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
164525334|NCT04860297|594292237|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
164525335|NCT04860297|594292238|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
164525336|NCT04860297|594292239|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
164525337|NCT04860297|594292240|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
164525338|NCT00862719|594292241|FG000|Overall Study|Disease Progression|5|||
164525339|NCT00862719|594292242|FG001|Overall Study|Disease Progression|0|||
164525340|NCT00862719|594292243|FG002|Overall Study|Disease Progression|1|||
164525341|NCT00862719|594292244|FG003|Overall Study|Disease Progression|0|||
164525342|NCT00862719|594292241|FG000|Overall Study|Death|5|||
164525343|NCT00862719|594292242|FG001|Overall Study|Death|6|||
164525344|NCT00862719|594292243|FG002|Overall Study|Death|1|||
164525345|NCT00862719|594292244|FG003|Overall Study|Death|1|||
164525346|NCT00862719|594292241|FG000|Overall Study|Engraftment failure|0|||
164525347|NCT00862719|594292242|FG001|Overall Study|Engraftment failure|0|||
164525348|NCT00862719|594292243|FG002|Overall Study|Engraftment failure|1|||
164525349|NCT00862719|594292244|FG003|Overall Study|Engraftment failure|0|||
164525350|NCT00862719|594292241|FG000|Overall Study|Veno-Occlusive Disease|0|||
164525351|NCT00862719|594292242|FG001|Overall Study|Veno-Occlusive Disease|0|||
164525352|NCT00862719|594292243|FG002|Overall Study|Veno-Occlusive Disease|1|||
164525353|NCT00862719|594292244|FG003|Overall Study|Veno-Occlusive Disease|0|||
164525354|NCT01642251|594292245|FG000|Overall Study|Progressive disease|0|||
164525355|NCT01642251|594292246|FG001|Overall Study|Progressive disease|0|||
164525356|NCT01642251|594292247|FG002|Overall Study|Progressive disease|3|||
164525357|NCT01642251|594292248|FG003|Overall Study|Progressive disease|3|||
164525358|NCT01642251|594292245|FG000|Overall Study|Adverse Event|0|||
164525359|NCT01642251|594292246|FG001|Overall Study|Adverse Event|0|||
164525360|NCT01642251|594292247|FG002|Overall Study|Adverse Event|5|||
164525361|NCT01642251|594292248|FG003|Overall Study|Adverse Event|4|||
164525362|NCT01642251|594292245|FG000|Overall Study|Death|0|||
164525363|NCT01642251|594292246|FG001|Overall Study|Death|0|||
164525364|NCT01642251|594292247|FG002|Overall Study|Death|1|||
164525365|NCT01642251|594292248|FG003|Overall Study|Death|3|||
164525366|NCT01642251|594292245|FG000|Overall Study|Withdrawal by Subject|0|||
164525367|NCT01642251|594292246|FG001|Overall Study|Withdrawal by Subject|0|||
164525368|NCT01642251|594292247|FG002|Overall Study|Withdrawal by Subject|1|||
164525369|NCT01642251|594292248|FG003|Overall Study|Withdrawal by Subject|3|||
164525370|NCT01642251|594292245|FG000|Overall Study|Alternative therapy|0|||
164525371|NCT01642251|594292246|FG001|Overall Study|Alternative therapy|0|||
164525372|NCT01642251|594292247|FG002|Overall Study|Alternative therapy|0|||
164525373|NCT01642251|594292248|FG003|Overall Study|Alternative therapy|2|||
164525374|NCT01642251|594292245|FG000|Overall Study|Other complicating disease|0|||
164525375|NCT01642251|594292246|FG001|Overall Study|Other complicating disease|0|||
164525376|NCT01642251|594292247|FG002|Overall Study|Other complicating disease|1|||
164525377|NCT01642251|594292248|FG003|Overall Study|Other complicating disease|0|||
164525378|NCT01642251|594292245|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
164525379|NCT01642251|594292246|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
164525380|NCT01642251|594292247|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
164525381|NCT01642251|594292248|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
164621709|NCT01796106|594635533|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
164621710|NCT04430036|594635534|FG000|Safety Run in Phase|Progression of disease|2|||
164621711|NCT01842334|594635535|FG000|Overall Study|Withdrawal by Subject|3|||
164525382|NCT00998790|594292249|FG000|Overall Study|Withdrawal by Subject|21|||
164525383|NCT01993927|594292250|FG000|Overall Study|Case Report Forms Uncollected|18|||
164525384|NCT01993927|594292250|FG000|Overall Study|Protocol Violation|11|||
164525385|NCT00287690|594292253|FG000|Overall Study|Protocol Violation|20|||
164525386|NCT00287690|594292254|FG001|Overall Study|Protocol Violation|26|||
164525387|NCT02414932|594292255|FG000|Overall Study|Withdrawal by Subject|2|||
164525388|NCT02414932|594292256|FG001|Overall Study|Withdrawal by Subject|3|||
164525389|NCT02414932|594292255|FG000|Overall Study|Adverse Event|1|||
164621712|NCT01842334|594635536|FG001|Overall Study|Withdrawal by Subject|3|||
164525390|NCT02414932|594292256|FG001|Overall Study|Adverse Event|0|||
164525391|NCT00540046|594292257|FG000|Overall Study|Lost to Follow-up|33|||
164525392|NCT00540046|594292258|FG001|Overall Study|Lost to Follow-up|23|||
164525393|NCT00185965|594292266|FG000|Overall Study|Adverse Event|0|||
164525394|NCT00185965|594292267|FG001|Overall Study|Adverse Event|1|||
164525395|NCT02533531|594292270|FG000|Overall Study|Device did not turn on|1|||
164525396|NCT03814187|594292271|FG000|Overall Study|Sponsor's Administrative Decision|0|||
164525397|NCT03814187|594292272|FG001|Overall Study|Sponsor's Administrative Decision|0|||
164525398|NCT03814187|594292273|FG002|Overall Study|Sponsor's Administrative Decision|272|||
164525399|NCT03814187|594292271|FG000|Overall Study|Death|80|||
164525400|NCT03814187|594292272|FG001|Overall Study|Death|81|||
164525401|NCT03814187|594292273|FG002|Overall Study|Death|4|||
164525402|NCT03814187|594292271|FG000|Overall Study|Withdrew Consent|77|||
164525403|NCT03814187|594292272|FG001|Overall Study|Withdrew Consent|78|||
164525404|NCT03814187|594292273|FG002|Overall Study|Withdrew Consent|2|||
164525405|NCT03814187|594292271|FG000|Overall Study|Lost to Follow-up|47|||
164525406|NCT03814187|594292272|FG001|Overall Study|Lost to Follow-up|52|||
164525407|NCT03814187|594292273|FG002|Overall Study|Lost to Follow-up|1|||
164525408|NCT03814187|594292271|FG000|Overall Study|Adverse Event|22|||
164525409|NCT03814187|594292272|FG001|Overall Study|Adverse Event|23|||
164525410|NCT03814187|594292273|FG002|Overall Study|Adverse Event|0|||
164525411|NCT03814187|594292271|FG000|Overall Study|Physician Decision|7|||
164525412|NCT03814187|594292272|FG001|Overall Study|Physician Decision|4|||
164525413|NCT03814187|594292273|FG002|Overall Study|Physician Decision|2|||
164525414|NCT03814187|594292271|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
164525415|NCT03814187|594292272|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
164621713|NCT01842334|594635535|FG000|Overall Study|Moved away mid-study|0|||
164621714|NCT01842334|594635536|FG001|Overall Study|Moved away mid-study|1|||
164621715|NCT01332851|594635541|FG000|Overall Study|Withdrawal by Subject|4|||
164621716|NCT01332851|594635542|FG001|Overall Study|Withdrawal by Subject|2|||
164621717|NCT01332851|594635541|FG000|Overall Study|Lost to Follow-up|7|||
164621718|NCT01332851|594635542|FG001|Overall Study|Lost to Follow-up|11|||
164621719|NCT01302691|594635543|FG000|Overall Study|Adverse Event|2|||
164621720|NCT01302691|594635544|FG001|Overall Study|Adverse Event|0|||
164621721|NCT01302691|594635543|FG000|Overall Study|Death|0|||
164621722|NCT01302691|594635544|FG001|Overall Study|Death|1|||
164621723|NCT01302691|594635543|FG000|Overall Study|Lost to Follow-up|1|||
164621724|NCT01302691|594635544|FG001|Overall Study|Lost to Follow-up|0|||
164621725|NCT01302691|594635543|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
164621726|NCT01302691|594635544|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
164621727|NCT01302691|594635543|FG000|Overall Study|Physician Decision|0|||
164621728|NCT01302691|594635544|FG001|Overall Study|Physician Decision|1|||
164621729|NCT01302691|594635543|FG000|Overall Study|Protocol Violation|1|||
164621730|NCT01302691|594635544|FG001|Overall Study|Protocol Violation|0|||
164621731|NCT03446612|594635545|FG000|Overall Study|Protocol defined stopping criteria|0|||
164621732|NCT03446612|594635546|FG001|Overall Study|Protocol defined stopping criteria|1|||
164621733|NCT01249157|594635548|FG000|Overall Study|Withdrawal by Subject|1|||
164621734|NCT03796195|594635549|FG000|Overall Study|Study closed early|1|||
164621735|NCT04445051|594635550|FG000|Overall Study|Adverse Event|0|||
164621736|NCT04445051|594635551|FG001|Overall Study|Adverse Event|0|||
164621737|NCT04445051|594635552|FG002|Overall Study|Adverse Event|1|||
164621738|NCT04445051|594635553|FG003|Overall Study|Adverse Event|0|||
164621739|NCT04445051|594635554|FG004|Overall Study|Adverse Event|0|||
164621740|NCT04445051|594635555|FG005|Overall Study|Adverse Event|0|||
164621741|NCT02392468|594635558|FG000|Overall Study|Adverse Event|0|||
164621742|NCT02392468|594635559|FG001|Overall Study|Adverse Event|1|||
164621743|NCT02392468|594635560|FG002|Overall Study|Adverse Event|0|||
164621744|NCT02392468|594635561|FG003|Overall Study|Adverse Event|0|||
164621745|NCT02392468|594635562|FG004|Overall Study|Adverse Event|0|||
164621746|NCT02392468|594635563|FG005|Overall Study|Adverse Event|1|||
164621747|NCT01039428|594635564|FG000|Overall Study|Protocol Violation|1|||
164621748|NCT01039428|594635565|FG001|Overall Study|Protocol Violation|0|||
164621749|NCT01039428|594635564|FG000|Overall Study|Withdrawal by Subject|1|||
164621750|NCT01039428|594635565|FG001|Overall Study|Withdrawal by Subject|0|||
164621751|NCT01313039|594635566|FG000|Overall Study|Physician Decision|1|||
164621752|NCT01313039|594635566|FG000|Overall Study|Adverse Event|1|||
164621753|NCT03630016|594635567|FG000|Overall Study|Poor Sensor Placement|1|||
164525416|NCT03814187|594292273|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
164525417|NCT03814187|594292271|FG000|Overall Study|Other reasons|34|||
164525418|NCT03814187|594292272|FG001|Overall Study|Other reasons|40|||
164621754|NCT05083949|594635568|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
164621755|NCT05083949|594635569|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
164621756|NCT05083949|594635568|FG000|Period 1|Adverse Event|1|||
164621757|NCT05083949|594635569|FG001|Period 1|Adverse Event|1|||
164621758|NCT05083949|594635568|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
164525419|NCT03814187|594292273|FG002|Overall Study|Other reasons|2|||
164525420|NCT02047903|594292274|FG000|Overall Study|Adverse Event|14|||
164621759|NCT05083949|594635569|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
164621760|NCT05083949|594635568|FG000|Period 2|Adverse Event|0|||
164621761|NCT05083949|594635569|FG001|Period 2|Adverse Event|2|||
164621762|NCT01678560|594635570|FG000|Overall Study|Physician Decision|4|||
164621763|NCT01678560|594635571|FG001|Overall Study|Physician Decision|4|||
164621764|NCT01678560|594635570|FG000|Overall Study|Death|0|||
164621765|NCT01678560|594635571|FG001|Overall Study|Death|1|||
164621766|NCT01678560|594635570|FG000|Overall Study|Withdrawal by Subject|0|||
164621767|NCT01678560|594635571|FG001|Overall Study|Withdrawal by Subject|1|||
164525421|NCT02047903|594292274|FG000|Overall Study|Serious adverse event|10|||
164525422|NCT02047903|594292274|FG000|Overall Study|Withdrawal by Subject|16|||
164525423|NCT02047903|594292274|FG000|Overall Study|Lost to Follow-up|4|||
164525424|NCT02047903|594292274|FG000|Overall Study|Reason not listed|6|||
164525425|NCT02047903|594292274|FG000|Overall Study|Not Treated|9|||
164525426|NCT00513604|594292275|FG000|Overall Study|Not treated|2|||
164525427|NCT00513604|594292276|FG001|Overall Study|Not treated|0|||
164525428|NCT00513604|594292277|FG002|Overall Study|Not treated|1|||
164525429|NCT00513604|594292278|FG003|Overall Study|Not treated|0|||
164525430|NCT00513604|594292279|FG004|Overall Study|Not treated|0|||
164525431|NCT00513604|594292275|FG000|Overall Study|Death during treatment|0|||
164525432|NCT00513604|594292276|FG001|Overall Study|Death during treatment|3|||
164525433|NCT00513604|594292277|FG002|Overall Study|Death during treatment|2|||
164525434|NCT00513604|594292278|FG003|Overall Study|Death during treatment|0|||
164525435|NCT00513604|594292279|FG004|Overall Study|Death during treatment|0|||
164525436|NCT01014533|594292280|FG000|Overall Study|Protocol Violation|3|||
164525437|NCT01014533|594292281|FG001|Overall Study|Protocol Violation|2|||
164525438|NCT01014533|594292280|FG000|Overall Study|Withdrawal by Subject|2|||
164525439|NCT01014533|594292281|FG001|Overall Study|Withdrawal by Subject|0|||
164525440|NCT01014533|594292280|FG000|Overall Study|unable to come to appointment|0|||
164525441|NCT01014533|594292281|FG001|Overall Study|unable to come to appointment|3|||
164525442|NCT00412061|594292285|FG000|Double Blind Phase|Disease Progression|101|||
164525443|NCT00412061|594292286|FG001|Double Blind Phase|Disease Progression|154|||
164525444|NCT00412061|594292285|FG000|Double Blind Phase|Adverse Event|61|||
164525445|NCT00412061|594292286|FG001|Double Blind Phase|Adverse Event|16|||
164525446|NCT00412061|594292285|FG000|Double Blind Phase|Final Primary Analysis|26|||
164525447|NCT00412061|594292286|FG001|Double Blind Phase|Final Primary Analysis|14|||
164525448|NCT00412061|594292285|FG000|Double Blind Phase|Withdrawal by Subject|18|||
164525449|NCT00412061|594292286|FG001|Double Blind Phase|Withdrawal by Subject|20|||
164525450|NCT00412061|594292285|FG000|Double Blind Phase|Death|6|||
164525451|NCT00412061|594292286|FG001|Double Blind Phase|Death|3|||
164525452|NCT00412061|594292285|FG000|Double Blind Phase|Protocol Violation|3|||
164525453|NCT00412061|594292286|FG001|Double Blind Phase|Protocol Violation|4|||
164525454|NCT00412061|594292285|FG000|Double Blind Phase|New Cander Therapy|1|||
164525455|NCT00412061|594292286|FG001|Double Blind Phase|New Cander Therapy|1|||
164525456|NCT00412061|594292285|FG000|Double Blind Phase|Lost to Follow-up|0|||
164525457|NCT00412061|594292286|FG001|Double Blind Phase|Lost to Follow-up|1|||
164525458|NCT00412061|594292285|FG000|Open Label Phase|Disease Progression|0|||
164525459|NCT00412061|594292286|FG001|Open Label Phase|Disease Progression|86|||
164525460|NCT00412061|594292285|FG000|Open Label Phase|Adverse Event|0|||
164525461|NCT00412061|594292286|FG001|Open Label Phase|Adverse Event|46|||
164525462|NCT00412061|594292285|FG000|Open Label Phase|Withdrawal by Subject|0|||
164525463|NCT00412061|594292286|FG001|Open Label Phase|Withdrawal by Subject|15|||
164525464|NCT00412061|594292285|FG000|Open Label Phase|Administrative Problems|0|||
164525465|NCT00412061|594292286|FG001|Open Label Phase|Administrative Problems|13|||
164525466|NCT00412061|594292285|FG000|Open Label Phase|Death|0|||
164525467|NCT00412061|594292286|FG001|Open Label Phase|Death|7|||
164525468|NCT00412061|594292285|FG000|Open Label Phase|Lost to Follow-up|0|||
164525469|NCT00412061|594292286|FG001|Open Label Phase|Lost to Follow-up|2|||
164525470|NCT00412061|594292285|FG000|Open Label Phase|New Cancer Therapy|0|||
164525471|NCT00412061|594292286|FG001|Open Label Phase|New Cancer Therapy|1|||
164525472|NCT02689518|594292287|FG000|Overall Study|Withdrawal by Subject|3|||
164525473|NCT01942590|594292290|FG000|Overall Study|Withdrawal by Subject|0|||
164525474|NCT01942590|594292291|FG001|Overall Study|Withdrawal by Subject|1|||
164525475|NCT01942590|594292290|FG000|Overall Study|Adverse Event|1|||
164525476|NCT01942590|594292291|FG001|Overall Study|Adverse Event|0|||
164525477|NCT01586910|594294883|FG000|Overall Study|Death|4|||
164525478|NCT01586910|594294884|FG001|Overall Study|Death|4|||
164525479|NCT01586910|594294883|FG000|Overall Study|Withdrawal by Subject|6|||
164525480|NCT01586910|594294884|FG001|Overall Study|Withdrawal by Subject|43|||
164525481|NCT01586910|594294883|FG000|Overall Study|Physician withdrew Subject|5|||
164525482|NCT01586910|594294884|FG001|Overall Study|Physician withdrew Subject|24|||
164525483|NCT00953407|594294885|FG000|Overall Study|Failed inclusion criteria|1|||
164525484|NCT00953407|594294886|FG001|Overall Study|Failed inclusion criteria|1|||
164525485|NCT00953407|594294887|FG002|Overall Study|Failed inclusion criteria|1|||
164525486|NCT00953407|594294888|FG003|Overall Study|Failed inclusion criteria|1|||
164525487|NCT00953407|594294889|FG004|Overall Study|Failed inclusion criteria|1|||
164621768|NCT02201472|594635572|FG000|Overall Study|Lack of Efficacy|2|||
164621769|NCT02470429|594635573|FG000|Overall Study|Adverse Event|1|||
164525488|NCT00953407|594294885|FG000|Overall Study|Lost to Follow-up|0|||
164621770|NCT02470429|594635574|FG001|Overall Study|Adverse Event|0|||
164621771|NCT02470429|594635573|FG000|Overall Study|Withdrawal by Subject|1|||
164621772|NCT02470429|594635574|FG001|Overall Study|Withdrawal by Subject|0|||
164621773|NCT01300767|594635575|FG000|Overall Study|Discomfort|2|||
164621774|NCT01300767|594635575|FG000|Overall Study|Biomicroscopy|1|||
164621775|NCT01300767|594635575|FG000|Overall Study|Unacceptable fit|1|||
164621776|NCT01602744|594635576|FG000|Overall Study|Death|17|||
164621777|NCT01602744|594635577|FG001|Overall Study|Death|15|||
164621778|NCT01602744|594635576|FG000|Overall Study|Lost to Follow-up|13|||
164621779|NCT01602744|594635577|FG001|Overall Study|Lost to Follow-up|8|||
164621780|NCT00606294|594635578|FG000|Overall Study|Withdrawal by Subject|36|||
164621781|NCT00606294|594635579|FG001|Overall Study|Withdrawal by Subject|0|||
164621782|NCT01976624|594635580|FG000|Overall Study|Participants contraindicated|2|||
164621783|NCT01976624|594635580|FG000|Overall Study|Participants age less than 19 years|12|||
164621784|NCT01885104|594635581|FG000|Overall Study|Withdrawal of Consent|1|||
164621785|NCT01885104|594635582|FG001|Overall Study|Withdrawal of Consent|0|||
164621786|NCT01885104|594635581|FG000|Overall Study|Lost to Follow-up|0|||
164621787|NCT01885104|594635582|FG001|Overall Study|Lost to Follow-up|1|||
164621788|NCT01885104|594635581|FG000|Overall Study|Physician Decision|1|||
164621789|NCT01885104|594635582|FG001|Overall Study|Physician Decision|0|||
164621790|NCT00126425|594635584|FG000|Overall Study|Withdrawal by Subject|17|||
164621791|NCT00126425|594635585|FG001|Overall Study|Withdrawal by Subject|1|||
164621792|NCT00126425|594635584|FG000|Overall Study|Lost to Follow-up|8|||
164621793|NCT00126425|594635585|FG001|Overall Study|Lost to Follow-up|4|||
164621794|NCT00126425|594635584|FG000|Overall Study|Protocol Violation|9|||
164621795|NCT00126425|594635585|FG001|Overall Study|Protocol Violation|6|||
164621796|NCT00126425|594635584|FG000|Overall Study|Adverse Event|1|||
164621797|NCT00126425|594635585|FG001|Overall Study|Adverse Event|0|||
164621798|NCT00126425|594635584|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
164621799|NCT00126425|594635585|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
164621800|NCT00126425|594635584|FG000|Overall Study|Other|5|||
164621801|NCT00126425|594635585|FG001|Overall Study|Other|0|||
164621802|NCT01316380|594635586|FG000|Overall Study|Adverse Event|0|||
164621803|NCT01316380|594635587|FG001|Overall Study|Adverse Event|2|||
164621804|NCT01316380|594635588|FG002|Overall Study|Adverse Event|1|||
164621805|NCT01316380|594635586|FG000|Overall Study|Protocol Violation|0|||
164621806|NCT01316380|594635587|FG001|Overall Study|Protocol Violation|0|||
164621807|NCT01316380|594635588|FG002|Overall Study|Protocol Violation|1|||
164621808|NCT01316380|594635586|FG000|Overall Study|Withdrawal by Subject|1|||
164621809|NCT01316380|594635587|FG001|Overall Study|Withdrawal by Subject|2|||
164621810|NCT01316380|594635588|FG002|Overall Study|Withdrawal by Subject|0|||
164621811|NCT01316380|594635586|FG000|Overall Study|Other|0|||
164621812|NCT01316380|594635587|FG001|Overall Study|Other|1|||
164621813|NCT01316380|594635588|FG002|Overall Study|Other|1|||
164621814|NCT01316380|594635586|FG000|Overall Study|Not treated|1|||
164621815|NCT01316380|594635587|FG001|Overall Study|Not treated|0|||
164621816|NCT01316380|594635588|FG002|Overall Study|Not treated|0|||
164621817|NCT01894776|594635589|FG000|Overall Study|Withdrawal by Subject|1|||
164621818|NCT00471315|594635591|FG000|Overall Study|Adverse Event|7|||
164621819|NCT00471315|594635591|FG000|Overall Study|Withdrawal by Subject|1|||
164621820|NCT02574520|594635595|FG000|Overall Study|Not dosed|2|||
164621821|NCT02574520|594635596|FG001|Overall Study|Not dosed|0|||
164621822|NCT02574520|594635597|FG002|Overall Study|Not dosed|5|||
164621823|NCT02574520|594635598|FG003|Overall Study|Not dosed|4|||
164621824|NCT02574520|594635595|FG000|Overall Study|Adverse Event|0|||
164621825|NCT02574520|594635596|FG001|Overall Study|Adverse Event|0|||
164621826|NCT02574520|594635597|FG002|Overall Study|Adverse Event|0|||
164621827|NCT02574520|594635598|FG003|Overall Study|Adverse Event|1|||
164621828|NCT02574520|594635595|FG000|Overall Study|Withdrawal by Subject|0|||
164621829|NCT02574520|594635596|FG001|Overall Study|Withdrawal by Subject|0|||
164621830|NCT02574520|594635597|FG002|Overall Study|Withdrawal by Subject|0|||
164621831|NCT02574520|594635598|FG003|Overall Study|Withdrawal by Subject|1|||
164621832|NCT02574520|594635595|FG000|Overall Study|Other|0|||
164621833|NCT02574520|594635596|FG001|Overall Study|Other|0|||
164621834|NCT02574520|594635597|FG002|Overall Study|Other|0|||
164621835|NCT02574520|594635598|FG003|Overall Study|Other|2|||
164621836|NCT01365091|594635601|FG000|Period 1|Adverse Event|1|||
164621837|NCT01365091|594635602|FG001|Period 1|Adverse Event|0|||
164621838|NCT01365091|594635603|FG002|Period 1|Adverse Event|2|||
164621839|NCT01365091|594635604|FG003|Period 1|Adverse Event|3|||
164621840|NCT01365091|594635601|FG000|Period 1|Positive test result for drugs of abuse|1|||
164621841|NCT01365091|594635602|FG001|Period 1|Positive test result for drugs of abuse|0|||
164621842|NCT01365091|594635603|FG002|Period 1|Positive test result for drugs of abuse|0|||
164621843|NCT01365091|594635604|FG003|Period 1|Positive test result for drugs of abuse|0|||
164621844|NCT01365091|594635601|FG000|Period 1|No longer met study criteria|0|||
164621845|NCT01365091|594635602|FG001|Period 1|No longer met study criteria|1|||
164621846|NCT01365091|594635603|FG002|Period 1|No longer met study criteria|0|||
164525489|NCT00953407|594294886|FG001|Overall Study|Lost to Follow-up|0|||
164525490|NCT00953407|594294887|FG002|Overall Study|Lost to Follow-up|0|||
164525491|NCT00953407|594294888|FG003|Overall Study|Lost to Follow-up|1|||
164525492|NCT00953407|594294889|FG004|Overall Study|Lost to Follow-up|0|||
164525493|NCT02186223|594294890|FG000|Overall Study|Not eligible for device placement|6|||
164525494|NCT02186223|594294890|FG000|Overall Study|Unable to obtain femoral access|3|||
164525495|NCT02186223|594294890|FG000|Overall Study|Death|3|||
164525496|NCT02186223|594294890|FG000|Overall Study|Device in place less than 48 hours|9|||
164525497|NCT00252733|594294891|FG000|Overall Study|Withdrawal by Subject|73|||
164525498|NCT00252733|594294892|FG001|Overall Study|Withdrawal by Subject|67|||
164525499|NCT00252733|594294891|FG000|Overall Study|Death|7|||
164525500|NCT00252733|594294892|FG001|Overall Study|Death|5|||
164525501|NCT00252733|594294891|FG000|Overall Study|Lost to Follow-up|12|||
164525502|NCT00252733|594294892|FG001|Overall Study|Lost to Follow-up|6|||
164525503|NCT00252733|594294891|FG000|Overall Study|Multiple Reasons|14|||
164525504|NCT00252733|594294892|FG001|Overall Study|Multiple Reasons|14|||
164525505|NCT01111474|594294893|FG000|Overall Study|Lost to Follow-up|12|||
164525506|NCT00618982|594294894|FG000|Overall Study|Adverse Event|23|||
164525507|NCT00618982|594294894|FG000|Overall Study|Withdrawal by Subject|1|||
164525508|NCT00618982|594294894|FG000|Overall Study|Protocol Violation|1|||
164525509|NCT00618982|594294894|FG000|Overall Study|ongoing, still treated with study med.|25|||
164525510|NCT04289051|594294895|FG000|Overall Study|Lost to Follow-up|0|||
164525511|NCT04289051|594294896|FG001|Overall Study|Lost to Follow-up|0|||
164525512|NCT04289051|594294897|FG002|Overall Study|Lost to Follow-up|2|||
164525513|NCT00156819|594294898|FG000|Overall Study|Lost to Follow-up|1|||
164525514|NCT00156819|594294899|FG001|Overall Study|Lost to Follow-up|1|||
164525515|NCT00156819|594294900|FG002|Overall Study|Lost to Follow-up|3|||
164525516|NCT01689337|594294901|FG000|Overall Study|Study Discontinuation|1|||
164525517|NCT05398237|594294906|FG000|Overall Study|Withdrawal by Subject|1|||
164525518|NCT01312857|594294909|FG000|Overall Study|Adverse Event|1|||
164525519|NCT01312857|594294910|FG001|Overall Study|Adverse Event|1|||
164525520|NCT01312857|594294909|FG000|Overall Study|Lost to Follow-up|2|||
164525521|NCT01312857|594294910|FG001|Overall Study|Lost to Follow-up|0|||
164525522|NCT01312857|594294909|FG000|Overall Study|Physician Decision|3|||
164525523|NCT01312857|594294910|FG001|Overall Study|Physician Decision|0|||
164525524|NCT01312857|594294909|FG000|Overall Study|Withdrawal by Subject|2|||
164525525|NCT01312857|594294910|FG001|Overall Study|Withdrawal by Subject|0|||
164525526|NCT01248065|594294911|FG000|Overall Study|Lost to Follow-up|3|||
164525527|NCT01248065|594294912|FG001|Overall Study|Lost to Follow-up|5|||
164525528|NCT01248065|594294911|FG000|Overall Study|Withdrawal by Subject|14|||
164525529|NCT01248065|594294912|FG001|Overall Study|Withdrawal by Subject|11|||
164525530|NCT01248065|594294911|FG000|Overall Study|Adverse Event|3|||
164525531|NCT01248065|594294912|FG001|Overall Study|Adverse Event|0|||
164525532|NCT01248065|594294911|FG000|Overall Study|Third treatment failure event|3|||
164525533|NCT01248065|594294912|FG001|Overall Study|Third treatment failure event|1|||
164525534|NCT01248065|594294911|FG000|Overall Study|Other|3|||
164525535|NCT01248065|594294912|FG001|Overall Study|Other|5|||
164525536|NCT02781844|594294918|FG000|Treatment Period 1|Adverse Event|0|||
164525537|NCT02781844|594294919|FG001|Treatment Period 1|Adverse Event|0|||
164525538|NCT02781844|594294920|FG002|Treatment Period 1|Adverse Event|0|||
164525539|NCT02781844|594294921|FG003|Treatment Period 1|Adverse Event|0|||
164525540|NCT02781844|594294922|FG004|Treatment Period 1|Adverse Event|0|||
164525541|NCT02781844|594294923|FG005|Treatment Period 1|Adverse Event|1|||
164525542|NCT02781844|594294924|FG006|Treatment Period 1|Adverse Event|0|||
164525543|NCT02781844|594294925|FG007|Treatment Period 1|Adverse Event|0|||
164525544|NCT00321373|594294926|FG000|Overall Study|Adverse Event|0|||
164525545|NCT00321373|594294927|FG001|Overall Study|Adverse Event|0|||
164525546|NCT00321373|594294928|FG002|Overall Study|Adverse Event|1|||
164525547|NCT00321373|594294926|FG000|Overall Study|Lost to Follow-up|1|||
164525548|NCT00321373|594294927|FG001|Overall Study|Lost to Follow-up|0|||
164525549|NCT00321373|594294928|FG002|Overall Study|Lost to Follow-up|1|||
164525550|NCT00321373|594294926|FG000|Overall Study|Withdrawal by Subject|1|||
164525551|NCT00321373|594294927|FG001|Overall Study|Withdrawal by Subject|0|||
164525552|NCT00321373|594294928|FG002|Overall Study|Withdrawal by Subject|0|||
164525553|NCT00321373|594294926|FG000|Overall Study|Other|0|||
164525554|NCT00321373|594294927|FG001|Overall Study|Other|0|||
164525555|NCT00321373|594294928|FG002|Overall Study|Other|1|||
164525556|NCT01383499|594294929|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
164525557|NCT01383499|594294930|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
164525558|NCT01383499|594294931|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
164525559|NCT01383499|594294932|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
164525560|NCT01774487|594294933|FG000|Overall Study|Did not tolerate taste|4|||
164525561|NCT01774487|594294934|FG001|Overall Study|Did not tolerate taste|4|||
164525562|NCT00477334|594294939|FG000|Overall Study|Discontinued prior to taking study drug|106|||
164525563|NCT00477334|594294940|FG001|Overall Study|Discontinued prior to taking study drug|53|||
164525564|NCT00477334|594294939|FG000|Overall Study|Adverse Event|1|||
164525565|NCT00477334|594294940|FG001|Overall Study|Adverse Event|2|||
164621847|NCT01365091|594635604|FG003|Period 1|No longer met study criteria|0|||
164621848|NCT01365091|594635601|FG000|Period 1|Withdrawal by Subject|0|||
164621849|NCT01365091|594635602|FG001|Period 1|Withdrawal by Subject|1|||
164621850|NCT01365091|594635603|FG002|Period 1|Withdrawal by Subject|0|||
164621851|NCT01365091|594635604|FG003|Period 1|Withdrawal by Subject|0|||
164621852|NCT01365091|594635601|FG000|Period 1|Personal reasons|0|||
164621853|NCT01365091|594635602|FG001|Period 1|Personal reasons|0|||
164621854|NCT01365091|594635603|FG002|Period 1|Personal reasons|1|||
164621855|NCT01365091|594635604|FG003|Period 1|Personal reasons|0|||
164621856|NCT01365091|594635601|FG000|Period 2|Withdrawal by Subject|1|||
164621857|NCT01365091|594635602|FG001|Period 2|Withdrawal by Subject|0|||
164621858|NCT01365091|594635603|FG002|Period 2|Withdrawal by Subject|0|||
164621859|NCT01365091|594635604|FG003|Period 2|Withdrawal by Subject|0|||
164621860|NCT01365091|594635601|FG000|Period 2|Adverse Event|0|||
164621861|NCT01365091|594635602|FG001|Period 2|Adverse Event|0|||
164621862|NCT01365091|594635603|FG002|Period 2|Adverse Event|1|||
164621863|NCT01365091|594635604|FG003|Period 2|Adverse Event|0|||
164621864|NCT05307523|594635606|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
164621865|NCT05307523|594635607|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
164621866|NCT05307523|594635606|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
164621867|NCT05307523|594635607|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
164621868|NCT05116683|594635609|FG000|Overall Study|Physician Decision|4|||
164621869|NCT03935594|594635613|FG000|Overall Study|Physician Decision|3|||
164621870|NCT01435122|594635614|FG000|Overall Study|Early withdrawal due to toxicity|8|||
164621871|NCT01592773|594637469|FG000|Overall Study|Study Terminated by Sponsor|582|||
164621872|NCT01592773|594637469|FG000|Overall Study|Withdrawal by Subject|35|||
164621873|NCT01592773|594637469|FG000|Overall Study|Lost to Follow-up|19|||
164621874|NCT01592773|594637469|FG000|Overall Study|Adverse Event|17|||
164621875|NCT01592773|594637469|FG000|Overall Study|Lack of Efficacy|9|||
164621876|NCT01592773|594637469|FG000|Overall Study|Protocol Violation|2|||
164621877|NCT01592773|594637469|FG000|Overall Study|Inclusion/exclusion not meet|1|||
164621878|NCT01592773|594637469|FG000|Overall Study|Other Reason|1|||
164621879|NCT00740116|594637470|FG000|Overall Study|Withdrawal by Subject|1|||
164621880|NCT00740116|594637471|FG001|Overall Study|Withdrawal by Subject|1|||
164621881|NCT00740116|594637470|FG000|Overall Study|Protocol Violation|1|||
164621882|NCT00740116|594637471|FG001|Overall Study|Protocol Violation|4|||
164621883|NCT00621764|594637472|FG000|Overall Study|Protocol Violation|0|||
164621884|NCT00621764|594637473|FG001|Overall Study|Protocol Violation|0|||
164621885|NCT00621764|594637474|FG002|Overall Study|Protocol Violation|0|||
164621886|NCT00621764|594637475|FG003|Overall Study|Protocol Violation|1|||
164621887|NCT02499172|594637476|FG000|Overall Study|Financial reason|0|||
164621888|NCT02499172|594637477|FG001|Overall Study|Financial reason|0|||
164621889|NCT02499172|594637478|FG002|Overall Study|Financial reason|523|||
164621890|NCT02499172|594637479|FG003|Overall Study|Financial reason|436|||
164621891|NCT02499172|594637476|FG000|Overall Study|Lost to Follow-up|65|||
164621892|NCT02499172|594637477|FG001|Overall Study|Lost to Follow-up|64|||
164621893|NCT02499172|594637478|FG002|Overall Study|Lost to Follow-up|0|||
164621894|NCT02499172|594637479|FG003|Overall Study|Lost to Follow-up|0|||
164621895|NCT01293123|594637480|FG000|Overall Study|Lost to Follow-up|0|||
164621896|NCT01293123|594637481|FG001|Overall Study|Lost to Follow-up|1|||
164621897|NCT00121485|594637482|FG000|Overall Study|Not implanted|1|||
164621898|NCT00121485|594637483|FG001|Overall Study|Not implanted|5|||
164621899|NCT00121485|594637482|FG000|Overall Study|Crossover|0|||
164621900|NCT00121485|594637483|FG001|Overall Study|Crossover|2|||
164621901|NCT01888965|594637493|FG000|Overall Study|Adverse Event|5|||
164621902|NCT01888965|594637493|FG000|Overall Study|Lack of Efficacy|4|||
164621903|NCT04076579|594637494|FG000|Overall Study|Adverse Event|2|||
164621904|NCT04076579|594637495|FG001|Overall Study|Adverse Event|0|||
164621905|NCT04076579|594637494|FG000|Overall Study|discontinued due to toxicity|1|||
164621906|NCT04076579|594637495|FG001|Overall Study|discontinued due to toxicity|0|||
164621907|NCT04076579|594637494|FG000|Overall Study|Physician Decision|1|||
164621908|NCT04076579|594637495|FG001|Overall Study|Physician Decision|0|||
164621909|NCT04076579|594637494|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
164621910|NCT04076579|594637495|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
164621911|NCT04076579|594637494|FG000|Overall Study|Noncompliance|0|||
164621912|NCT04076579|594637495|FG001|Overall Study|Noncompliance|1|||
164621913|NCT04076579|594637494|FG000|Overall Study|Withdrawal by Subject|0|||
164621914|NCT04076579|594637495|FG001|Overall Study|Withdrawal by Subject|2|||
164621915|NCT00186121|594637496|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
164621916|NCT00186121|594637496|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
164621917|NCT00186121|594637496|FG000|Overall Study|Not eligible (no treatment)|1|||
164621918|NCT03650387|594637497|FG000|Overall Study|Withdrawal by Subject|13|||
164621919|NCT03650387|594637497|FG000|Overall Study|Lost to Follow-up|12|||
164621920|NCT03650387|594637497|FG000|Overall Study|Adverse Event (Not related)|1|||
164621921|NCT03650387|594637497|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
164621922|NCT00417248|594637498|FG000|Overall Study|Study Terminated|6|||
164621923|NCT00417248|594637498|FG000|Overall Study|Death|1|||
164621924|NCT00417248|594637498|FG000|Overall Study|Lack of Efficacy|1|||
164621925|NCT05815758|594637499|FG000|Overall Study|Adverse Event|6|||
164525566|NCT00477334|594294939|FG000|Overall Study|Withdrawal by Subject|2|||
164525567|NCT00477334|594294940|FG001|Overall Study|Withdrawal by Subject|1|||
164525568|NCT00477334|594294939|FG000|Overall Study|Lost to Follow-up|15|||
164525569|NCT00477334|594294940|FG001|Overall Study|Lost to Follow-up|4|||
164525570|NCT00477334|594294939|FG000|Overall Study|Administrative Problems|39|||
164525571|NCT00477334|594294940|FG001|Overall Study|Administrative Problems|15|||
164525572|NCT00477334|594294939|FG000|Overall Study|Protocol Violation|7|||
164525573|NCT00477334|594294940|FG001|Overall Study|Protocol Violation|1|||
164525574|NCT02572882|594294941|FG000|Overall Study|Withdrawal by Subject|1|||
164525575|NCT02572882|594294941|FG000|Overall Study|Participant received kidney transplant|1|||
164525576|NCT04745026|594294945|FG000|Overall Study|Physician Decision|1|||
164525577|NCT04745026|594294946|FG001|Overall Study|Physician Decision|0|||
164525578|NCT04745026|594294945|FG000|Overall Study|Adverse Event|2|||
164525579|NCT04745026|594294946|FG001|Overall Study|Adverse Event|2|||
164525580|NCT04745026|594294945|FG000|Overall Study|Protocol Violation|1|||
164525581|NCT04745026|594294946|FG001|Overall Study|Protocol Violation|3|||
164525582|NCT04745026|594294945|FG000|Overall Study|Lost to Follow-up|4|||
164525583|NCT04745026|594294946|FG001|Overall Study|Lost to Follow-up|3|||
164525584|NCT04745026|594294945|FG000|Overall Study|Withdrawal by Subject|5|||
164525585|NCT04745026|594294946|FG001|Overall Study|Withdrawal by Subject|5|||
164525586|NCT02292927|594294949|FG000|Overall Study|Protocol Violation|13|||
164525587|NCT02292927|594294950|FG001|Overall Study|Protocol Violation|7|||
164525588|NCT01656733|594294951|FG000|Overall Study|No permission to collect birth outcomes|0|||
164525589|NCT01656733|594294952|FG001|Overall Study|No permission to collect birth outcomes|1|||
164525590|NCT01656733|594294951|FG000|Overall Study|Delivery at another hospital|0|||
164525591|NCT01656733|594294952|FG001|Overall Study|Delivery at another hospital|2|||
164525592|NCT01656733|594294951|FG000|Overall Study|Spontaneous abortion|0|||
164525593|NCT01656733|594294952|FG001|Overall Study|Spontaneous abortion|1|||
164525594|NCT01415531|594294954|FG000|Overall Study|Adverse Event|7|||
164525595|NCT01415531|594294955|FG001|Overall Study|Adverse Event|10|||
164525596|NCT01415531|594294954|FG000|Overall Study|Lack of Efficacy|3|||
164525597|NCT01415531|594294955|FG001|Overall Study|Lack of Efficacy|2|||
164525598|NCT01415531|594294954|FG000|Overall Study|Protocol Violation|0|||
164525599|NCT01415531|594294955|FG001|Overall Study|Protocol Violation|1|||
164525600|NCT01415531|594294954|FG000|Overall Study|Withdrawal by Subject|5|||
164525601|NCT01415531|594294955|FG001|Overall Study|Withdrawal by Subject|4|||
164525602|NCT01415531|594294954|FG000|Overall Study|Lost to Follow-up|6|||
164525603|NCT01415531|594294955|FG001|Overall Study|Lost to Follow-up|14|||
164525604|NCT01415531|594294954|FG000|Overall Study|Lack of Compliance|1|||
164525605|NCT01415531|594294955|FG001|Overall Study|Lack of Compliance|4|||
164525606|NCT01415531|594294954|FG000|Overall Study|Other Reasons|3|||
164525607|NCT01415531|594294955|FG001|Overall Study|Other Reasons|2|||
164525608|NCT00122460|594294956|FG000|Overall Study|investigational study phase ongoing|7|||
164525609|NCT00122460|594294957|FG001|Overall Study|investigational study phase ongoing|1|||
164525610|NCT02962960|594294958|FG000|Overall Study|Withdrawal by Subject|1|||
164525611|NCT02962960|594294959|FG001|Overall Study|Withdrawal by Subject|1|||
164525612|NCT02962960|594294960|FG002|Overall Study|Withdrawal by Subject|0|||
164525613|NCT02962960|594294958|FG000|Overall Study|Adverse Event|1|||
164525614|NCT02962960|594294959|FG001|Overall Study|Adverse Event|1|||
164525615|NCT02962960|594294960|FG002|Overall Study|Adverse Event|0|||
164525616|NCT02962960|594294958|FG000|Overall Study|Protocol Violation|1|||
164525617|NCT02962960|594294959|FG001|Overall Study|Protocol Violation|0|||
164525618|NCT02962960|594294960|FG002|Overall Study|Protocol Violation|0|||
164525619|NCT01236339|594294961|FG000|Overall Study|Termination of study by sponsor|11|||
164525620|NCT01236339|594294962|FG001|Overall Study|Termination of study by sponsor|13|||
164525621|NCT02054741|594294963|FG000|Overall Study|Protocol Violation|13|||
164525622|NCT02054741|594294964|FG001|Overall Study|Protocol Violation|2|||
164525623|NCT02054741|594294963|FG000|Overall Study|Withdrawal by Subject|10|||
164525624|NCT02054741|594294964|FG001|Overall Study|Withdrawal by Subject|5|||
164525625|NCT02054741|594294963|FG000|Overall Study|Death|94|||
164525626|NCT02054741|594294964|FG001|Overall Study|Death|90|||
164525627|NCT02054741|594294963|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
164525628|NCT02054741|594294964|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
164525629|NCT00394082|594294965|FG000|Overall Study|Unacceptable toxicity|15|||
164525630|NCT00394082|594294965|FG000|Overall Study|Adverse Event|4|||
164525631|NCT00394082|594294965|FG000|Overall Study|Physician Decision|4|||
164525632|NCT00394082|594294965|FG000|Overall Study|Withdrawal by Subject|2|||
164525633|NCT00394082|594294965|FG000|Overall Study|Other|1|||
164525634|NCT01945060|594294967|FG000|Overall Study|Lost to follow up|1|||
164525635|NCT01945060|594294968|FG001|Overall Study|Lost to follow up|0|||
164525636|NCT01945060|594294967|FG000|Overall Study|Distress related to IV access|0|||
164525637|NCT01945060|594294968|FG001|Overall Study|Distress related to IV access|1|||
164525638|NCT00138671|594294969|FG000|Overall Study|Death|0|||
164621926|NCT05815758|594637500|FG001|Overall Study|Adverse Event|2|||
164621927|NCT05815758|594637499|FG000|Overall Study|Lost to Follow-up|14|||
164621928|NCT05815758|594637500|FG001|Overall Study|Lost to Follow-up|1|||
164621929|NCT05815758|594637499|FG000|Overall Study|Withdrawal by Subject|6|||
164621930|NCT05815758|594637500|FG001|Overall Study|Withdrawal by Subject|6|||
164621931|NCT05815758|594637499|FG000|Overall Study|Protocol Violation|1|||
164621932|NCT05815758|594637500|FG001|Overall Study|Protocol Violation|1|||
164621933|NCT05815758|594637499|FG000|Overall Study|Discontinued|4|||
164621934|NCT05815758|594637500|FG001|Overall Study|Discontinued|4|||
164621935|NCT03661983|594637501|FG000|Open Label Stabilization Phase|Adverse Event|5|||
164621936|NCT03661983|594637502|FG001|Open Label Stabilization Phase|Adverse Event|0|||
164621937|NCT03661983|594637503|FG002|Open Label Stabilization Phase|Adverse Event|0|||
164621938|NCT03661983|594637504|FG003|Open Label Stabilization Phase|Adverse Event|0|||
164621939|NCT03661983|594637501|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
164621940|NCT03661983|594637502|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
164621941|NCT03661983|594637503|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
164621942|NCT03661983|594637504|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
164621943|NCT03661983|594637501|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
164621944|NCT03661983|594637502|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
164621945|NCT03661983|594637503|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
164621946|NCT03661983|594637504|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
164621947|NCT03661983|594637501|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
164621948|NCT03661983|594637502|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
164621949|NCT03661983|594637503|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
164621950|NCT03661983|594637504|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
164621951|NCT03661983|594637501|FG000|Double-blind Randomized Phase|Adverse Event|0|||
164621952|NCT03661983|594637502|FG001|Double-blind Randomized Phase|Adverse Event|1|||
164621953|NCT03661983|594637503|FG002|Double-blind Randomized Phase|Adverse Event|0|||
164621954|NCT03661983|594637504|FG003|Double-blind Randomized Phase|Adverse Event|0|||
164525639|NCT00138671|594294970|FG001|Overall Study|Death|3|||
164525640|NCT00138671|594294969|FG000|Overall Study|Adverse Event|6|||
164525641|NCT00138671|594294970|FG001|Overall Study|Adverse Event|3|||
164525642|NCT00138671|594294969|FG000|Overall Study|Lost to Follow-up|1|||
164525643|NCT00138671|594294970|FG001|Overall Study|Lost to Follow-up|2|||
164525644|NCT00138671|594294969|FG000|Overall Study|Withdrawal by Subject|3|||
164525645|NCT00138671|594294970|FG001|Overall Study|Withdrawal by Subject|5|||
164525646|NCT00138671|594294969|FG000|Overall Study|Other|3|||
164525647|NCT00138671|594294970|FG001|Overall Study|Other|3|||
164525648|NCT00938860|594294977|FG000|Overall Study|Adverse Event|2|||
164525649|NCT00938860|594294978|FG001|Overall Study|Adverse Event|1|||
164525650|NCT00938860|594294977|FG000|Overall Study|Abnormal laboratory values|2|||
164525651|NCT00938860|594294978|FG001|Overall Study|Abnormal laboratory values|2|||
164525652|NCT00938860|594294977|FG000|Overall Study|Withdrawal by Subject|11|||
164525653|NCT00938860|594294978|FG001|Overall Study|Withdrawal by Subject|8|||
164525654|NCT00938860|594294977|FG000|Overall Study|Lost to Follow-up|4|||
164525655|NCT00938860|594294978|FG001|Overall Study|Lost to Follow-up|4|||
164525656|NCT00938860|594294977|FG000|Overall Study|Administration problems|2|||
164525657|NCT00938860|594294978|FG001|Overall Study|Administration problems|0|||
164525658|NCT00938860|594294977|FG000|Overall Study|Death|1|||
164525659|NCT00938860|594294978|FG001|Overall Study|Death|1|||
164525660|NCT00938860|594294977|FG000|Overall Study|Protocol Violation|3|||
164525661|NCT00938860|594294978|FG001|Overall Study|Protocol Violation|1|||
164525662|NCT04223830|594294979|FG000|Overall Study|Lost to Follow-up|9|||
164525663|NCT04223830|594294979|FG000|Overall Study|Adverse Event|1|||
164525664|NCT01806623|594294980|FG000|Overall Study|Withdrawal by Subject|1|||
164525665|NCT01806623|594294980|FG000|Overall Study|Adverse Event|1|||
164525666|NCT01806623|594294980|FG000|Overall Study|Did not meet the inclusion criteria|56|||
164525667|NCT01737827|594294981|FG000|Overall Study|Adverse Event|3|||
164525668|NCT01737827|594294982|FG001|Overall Study|Adverse Event|6|||
164525669|NCT01737827|594294983|FG002|Overall Study|Adverse Event|0|||
164525670|NCT01737827|594294981|FG000|Overall Study|Lost to Follow-up|0|||
164525671|NCT01737827|594294982|FG001|Overall Study|Lost to Follow-up|1|||
164525672|NCT01737827|594294983|FG002|Overall Study|Lost to Follow-up|0|||
164525673|NCT01737827|594294981|FG000|Overall Study|Physician Decision|0|||
164525674|NCT01737827|594294982|FG001|Overall Study|Physician Decision|2|||
164525675|NCT01737827|594294983|FG002|Overall Study|Physician Decision|0|||
164525676|NCT01737827|594294981|FG000|Overall Study|Progressive Disease|5|||
164525677|NCT01737827|594294982|FG001|Overall Study|Progressive Disease|16|||
164525678|NCT01737827|594294983|FG002|Overall Study|Progressive Disease|2|||
164525679|NCT01737827|594294981|FG000|Overall Study|Study Terminated by Sponsor|0|||
164525680|NCT01737827|594294982|FG001|Overall Study|Study Terminated by Sponsor|1|||
164525681|NCT01737827|594294983|FG002|Overall Study|Study Terminated by Sponsor|0|||
164525682|NCT01737827|594294981|FG000|Overall Study|Subject/Guardian Decision|0|||
164525683|NCT01737827|594294982|FG001|Overall Study|Subject/Guardian Decision|2|||
164525684|NCT01737827|594294983|FG002|Overall Study|Subject/Guardian Decision|0|||
164621955|NCT03661983|594637501|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
164621956|NCT03661983|594637502|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
164621957|NCT03661983|594637503|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
164621958|NCT03661983|594637504|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
164621959|NCT03661983|594637501|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
164621960|NCT03661983|594637502|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
164621961|NCT03661983|594637503|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
164621962|NCT03661983|594637504|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
164621963|NCT03661983|594637501|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
164621964|NCT03661983|594637502|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
164621965|NCT03661983|594637503|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
164621966|NCT03661983|594637504|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
164621967|NCT02903966|594637505|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
164621968|NCT02903966|594637506|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
164621969|NCT02903966|594637505|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
164621970|NCT02903966|594637506|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
164621971|NCT02903966|594637505|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
164621972|NCT02903966|594637506|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
164621973|NCT00934791|594637507|FG000|Overall Study|Withdrawal by Subject|1|||
164621974|NCT00934791|594637508|FG001|Overall Study|Withdrawal by Subject|0|||
164621975|NCT01320033|594637510|FG000|Overall Study|Lack of Efficacy|0|||
164621976|NCT01320033|594637511|FG001|Overall Study|Lack of Efficacy|0|||
164621977|NCT01320033|594637512|FG002|Overall Study|Lack of Efficacy|1|||
164621978|NCT01320033|594637510|FG000|Overall Study|Adverse Event|9|||
164621979|NCT01320033|594637511|FG001|Overall Study|Adverse Event|7|||
164621980|NCT01320033|594637512|FG002|Overall Study|Adverse Event|8|||
164621981|NCT01320033|594637510|FG000|Overall Study|Withdrawal by Subject|22|||
164621982|NCT01320033|594637511|FG001|Overall Study|Withdrawal by Subject|23|||
164621983|NCT01320033|594637512|FG002|Overall Study|Withdrawal by Subject|23|||
164621984|NCT01320033|594637510|FG000|Overall Study|Protocol Violation|3|||
164621985|NCT01320033|594637511|FG001|Overall Study|Protocol Violation|5|||
164621986|NCT01320033|594637512|FG002|Overall Study|Protocol Violation|3|||
164621987|NCT01320033|594637510|FG000|Overall Study|Lost to Follow-up|22|||
164621988|NCT01320033|594637511|FG001|Overall Study|Lost to Follow-up|26|||
164621989|NCT01320033|594637512|FG002|Overall Study|Lost to Follow-up|17|||
164621990|NCT01320033|594637510|FG000|Overall Study|Other|2|||
164621991|NCT01320033|594637511|FG001|Overall Study|Other|3|||
164621992|NCT01320033|594637512|FG002|Overall Study|Other|1|||
164621993|NCT02425891|594637513|FG000|Overall Study|Death|333|||
164621994|NCT02425891|594637514|FG001|Overall Study|Death|314|||
164621995|NCT02425891|594637513|FG000|Overall Study|Lost to Follow-up|4|||
164621996|NCT02425891|594637514|FG001|Overall Study|Lost to Follow-up|6|||
164621997|NCT02425891|594637513|FG000|Overall Study|Non-Compliance|1|||
164621998|NCT02425891|594637514|FG001|Overall Study|Non-Compliance|1|||
164621999|NCT02425891|594637513|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
164622000|NCT02425891|594637514|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
164622001|NCT02425891|594637513|FG000|Overall Study|Physician Decision|0|||
164622002|NCT02425891|594637514|FG001|Overall Study|Physician Decision|1|||
164622003|NCT02425891|594637513|FG000|Overall Study|Protocol Violation|1|||
164622004|NCT02425891|594637514|FG001|Overall Study|Protocol Violation|1|||
164622005|NCT02425891|594637513|FG000|Overall Study|Study Terminated By Sponsor|85|||
164622006|NCT02425891|594637514|FG001|Overall Study|Study Terminated By Sponsor|95|||
164622007|NCT02425891|594637513|FG000|Overall Study|Withdrawal by Subject|27|||
164622008|NCT02425891|594637514|FG001|Overall Study|Withdrawal by Subject|32|||
164622009|NCT00963469|594637515|FG000|Overall Study|Adverse Event|15|||
164622010|NCT00963469|594637516|FG001|Overall Study|Adverse Event|11|||
164622011|NCT00963469|594637517|FG002|Overall Study|Adverse Event|1|||
164622012|NCT00963469|594637515|FG000|Overall Study|Lack of Efficacy|10|||
164622013|NCT00963469|594637516|FG001|Overall Study|Lack of Efficacy|7|||
164622014|NCT00963469|594637517|FG002|Overall Study|Lack of Efficacy|2|||
164622015|NCT00963469|594637515|FG000|Overall Study|Lost to Follow-up|1|||
164622016|NCT00963469|594637516|FG001|Overall Study|Lost to Follow-up|1|||
164622017|NCT00963469|594637517|FG002|Overall Study|Lost to Follow-up|0|||
164622018|NCT00963469|594637515|FG000|Overall Study|Protocol Violation|5|||
164622019|NCT00963469|594637516|FG001|Overall Study|Protocol Violation|5|||
164622020|NCT00963469|594637517|FG002|Overall Study|Protocol Violation|3|||
164622021|NCT00963469|594637515|FG000|Overall Study|Withdrawal by Subject|4|||
164622022|NCT00963469|594637516|FG001|Overall Study|Withdrawal by Subject|1|||
164622023|NCT00963469|594637517|FG002|Overall Study|Withdrawal by Subject|1|||
164622024|NCT00963469|594637515|FG000|Overall Study|Pre-randomization Adverse Event|1|||
164622025|NCT00963469|594637516|FG001|Overall Study|Pre-randomization Adverse Event|2|||
164622026|NCT00963469|594637517|FG002|Overall Study|Pre-randomization Adverse Event|0|||
164622027|NCT00963469|594637515|FG000|Overall Study|Moved|1|||
164622028|NCT00963469|594637516|FG001|Overall Study|Moved|0|||
164622029|NCT00963469|594637517|FG002|Overall Study|Moved|0|||
164622030|NCT00963469|594637515|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
164622031|NCT00963469|594637516|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
164622032|NCT00963469|594637517|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
164622033|NCT04124952|594637520|FG000|Overall Study|Lost to Follow-up|1|||
164622034|NCT02145429|594637521|FG000|Overall Study|Death|4|||
164622035|NCT02145429|594637522|FG001|Overall Study|Death|5|||
164622036|NCT02145429|594637521|FG000|Overall Study|Lost to Follow-up|4|||
164622037|NCT02145429|594637522|FG001|Overall Study|Lost to Follow-up|3|||
164622038|NCT02145429|594637521|FG000|Overall Study|Withdrawal by Subject|8|||
164622039|NCT02145429|594637522|FG001|Overall Study|Withdrawal by Subject|3|||
164622040|NCT02943577|594637523|FG000|Overall Study|Protocol Violation|0|||
164622041|NCT02943577|594637524|FG001|Overall Study|Protocol Violation|1|||
164622042|NCT02943577|594637523|FG000|Overall Study|Adverse Event|3|||
164622043|NCT02943577|594637524|FG001|Overall Study|Adverse Event|2|||
164622044|NCT02943577|594637523|FG000|Overall Study|Lost to Follow-up|0|||
164622045|NCT02943577|594637524|FG001|Overall Study|Lost to Follow-up|1|||
164622046|NCT02943577|594637523|FG000|Overall Study|Withdrawal by Subject|1|||
164622047|NCT02943577|594637524|FG001|Overall Study|Withdrawal by Subject|1|||
164622048|NCT02943577|594637523|FG000|Overall Study|Pregnancy|1|||
164622049|NCT02943577|594637524|FG001|Overall Study|Pregnancy|0|||
164622050|NCT03991936|594637529|FG000|Overall Study|Lost to Follow-up|1|||
164622051|NCT03991936|594637530|FG001|Overall Study|Lost to Follow-up|1|||
164622052|NCT03991936|594637531|FG002|Overall Study|Lost to Follow-up|1|||
164622053|NCT03991936|594637532|FG003|Overall Study|Lost to Follow-up|1|||
164622054|NCT03991936|594637533|FG004|Overall Study|Lost to Follow-up|1|||
164622055|NCT00939055|594637534|FG000|Overall Study|Discontinuation prior to procedure|4|||
164622056|NCT00939055|594637535|FG001|Overall Study|Discontinuation prior to procedure|0|||
164622057|NCT00584987|594637538|FG000|Overall Study|Protocol Violation|1|||
164622058|NCT00584987|594637539|FG001|Overall Study|Protocol Violation|1|||
164622059|NCT00584987|594637540|FG002|Overall Study|Protocol Violation|1|||
164622060|NCT00584987|594637541|FG003|Overall Study|Protocol Violation|0|||
164622061|NCT00584987|594637538|FG000|Overall Study|Adverse Event|0|||
164622062|NCT00584987|594637539|FG001|Overall Study|Adverse Event|0|||
164622063|NCT00584987|594637540|FG002|Overall Study|Adverse Event|0|||
164622064|NCT00584987|594637541|FG003|Overall Study|Adverse Event|1|||
164622065|NCT01944462|594637545|FG000|PPPP Educational Program|Lost to Follow-up|60|||
164622066|NCT00808028|594637546|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
164622067|NCT00808028|594637547|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
164622068|NCT00808028|594637548|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
164622069|NCT00808028|594637549|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
164622070|NCT00808028|594637546|FG000|Stage 1 (6 Months)|Other|1|||
164622071|NCT00808028|594637547|FG001|Stage 1 (6 Months)|Other|0|||
164622072|NCT00808028|594637548|FG002|Stage 1 (6 Months)|Other|2|||
164622073|NCT00808028|594637549|FG003|Stage 1 (6 Months)|Other|4|||
164622074|NCT00808028|594637546|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
164622075|NCT00808028|594637547|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
164622076|NCT00808028|594637548|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
164622077|NCT00808028|594637549|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
164622078|NCT00808028|594637546|FG000|Stage 1 (6 Months)|Adverse Event|0|||
164622079|NCT00808028|594637547|FG001|Stage 1 (6 Months)|Adverse Event|0|||
164622080|NCT00808028|594637548|FG002|Stage 1 (6 Months)|Adverse Event|1|||
164622081|NCT00808028|594637549|FG003|Stage 1 (6 Months)|Adverse Event|2|||
164622082|NCT00808028|594637546|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
164622083|NCT00808028|594637547|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
164622084|NCT00808028|594637548|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
164622085|NCT00808028|594637549|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
164622086|NCT00808028|594637546|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
164622087|NCT00808028|594637547|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
164622088|NCT00808028|594637548|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
164622089|NCT00808028|594637549|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
164622090|NCT00808028|594637546|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
164622091|NCT00808028|594637547|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
164622092|NCT00808028|594637548|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
164622093|NCT00808028|594637549|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
164622094|NCT00808028|594637546|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
164622095|NCT00808028|594637547|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
164622096|NCT00808028|594637548|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
164622097|NCT00808028|594637549|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
164622098|NCT00808028|594637546|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
164622099|NCT00808028|594637547|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
164622100|NCT00808028|594637548|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
164622101|NCT00808028|594637549|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
164622102|NCT00808028|594637546|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
164622103|NCT00808028|594637547|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
164622104|NCT00808028|594637548|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
164622105|NCT00808028|594637549|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
164622106|NCT00808028|594637546|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
164622107|NCT00808028|594637547|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
164622108|NCT00808028|594637548|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
164622109|NCT00808028|594637549|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
164622110|NCT00808028|594637546|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
164622111|NCT00808028|594637547|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
164622112|NCT00808028|594637548|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
164622113|NCT00808028|594637549|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
164622114|NCT00808028|594637546|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
164622115|NCT00808028|594637547|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
164622116|NCT00808028|594637548|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
164622117|NCT00808028|594637549|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
164622118|NCT00808028|594637546|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
164622119|NCT00808028|594637547|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
164622120|NCT00808028|594637548|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
164622121|NCT00808028|594637549|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
164622122|NCT00808028|594637546|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
164622123|NCT00808028|594637547|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
164622124|NCT00808028|594637548|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
164622125|NCT00808028|594637549|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
164622126|NCT01599585|594637551|FG000|Overall Study|Withdrawal by Subject|16|||
164622127|NCT01599585|594637552|FG001|Overall Study|Withdrawal by Subject|9|||
164622128|NCT01599585|594637551|FG000|Overall Study|Lost to Follow-up|3|||
164622129|NCT01599585|594637552|FG001|Overall Study|Lost to Follow-up|5|||
164622130|NCT01599585|594637551|FG000|Overall Study|randomized did not start treatment|3|||
164622131|NCT01599585|594637552|FG001|Overall Study|randomized did not start treatment|3|||
164622132|NCT00081263|594637553|FG000|Overall Study|clerical error|1|||
164622133|NCT00081263|594637554|FG001|Overall Study|clerical error|0|||
164622134|NCT00081263|594637553|FG000|Overall Study|wrong cell type|7|||
164622135|NCT00081263|594637554|FG001|Overall Study|wrong cell type|5|||
164622136|NCT00081263|594637553|FG000|Overall Study|improper pre-protocol therapy|0|||
164622137|NCT00081263|594637554|FG001|Overall Study|improper pre-protocol therapy|1|||
164622138|NCT00081263|594637553|FG000|Overall Study|Inadequate pathology|0|||
164622139|NCT00081263|594637554|FG001|Overall Study|Inadequate pathology|1|||
164622140|NCT00081263|594637553|FG000|Overall Study|Never treated|4|||
164622141|NCT00081263|594637554|FG001|Overall Study|Never treated|5|||
164622142|NCT00081263|594637553|FG000|Overall Study|Inadequate data|5|||
164622143|NCT00081263|594637554|FG001|Overall Study|Inadequate data|10|||
164622144|NCT01852591|594637555|FG000|Overall Study|Withdrawal by Subject|2|||
164622145|NCT01852591|594637555|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
164622146|NCT01267955|594637562|FG000|Stage 1 (6 Months)|Death|3|||
164622147|NCT01267955|594637562|FG000|Stage 2 (6 Months)|Death|5|||
164622148|NCT01267955|594637562|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
164622149|NCT03070119|594637563|FG000|Overall Study|Adverse Event|0|||
164622150|NCT03070119|594637564|FG001|Overall Study|Adverse Event|0|||
164622151|NCT03070119|594637565|FG002|Overall Study|Adverse Event|1|||
164622152|NCT03070119|594637563|FG000|Overall Study|Lost to Follow-up|0|||
164622153|NCT03070119|594637564|FG001|Overall Study|Lost to Follow-up|1|||
164622154|NCT03070119|594637565|FG002|Overall Study|Lost to Follow-up|0|||
164622155|NCT03070119|594637563|FG000|Overall Study|Consent Withdrawn|6|||
164622156|NCT03070119|594637564|FG001|Overall Study|Consent Withdrawn|5|||
164622157|NCT03070119|594637565|FG002|Overall Study|Consent Withdrawn|3|||
164622158|NCT03070119|594637563|FG000|Overall Study|Investigator Decision|0|||
164622159|NCT03070119|594637564|FG001|Overall Study|Investigator Decision|0|||
164622160|NCT03070119|594637565|FG002|Overall Study|Investigator Decision|1|||
164622161|NCT03070119|594637563|FG000|Overall Study|Death|7|||
164622162|NCT03070119|594637564|FG001|Overall Study|Death|14|||
164622163|NCT03070119|594637565|FG002|Overall Study|Death|5|||
164622164|NCT03070119|594637563|FG000|Overall Study|Disease Progression|5|||
164622165|NCT03070119|594637564|FG001|Overall Study|Disease Progression|7|||
164622166|NCT03070119|594637565|FG002|Overall Study|Disease Progression|7|||
164622167|NCT03070119|594637563|FG000|Overall Study|Reason not Specified|2|||
164622168|NCT03070119|594637564|FG001|Overall Study|Reason not Specified|2|||
164622169|NCT03070119|594637565|FG002|Overall Study|Reason not Specified|1|||
164622170|NCT01996865|594637566|FG000|Induction Period|Protocol Violation|1|||
164622171|NCT01996865|594637567|FG001|Induction Period|Protocol Violation|0|||
164622172|NCT01996865|594637568|FG002|Induction Period|Protocol Violation|0|||
164622173|NCT01996865|594637566|FG000|Induction Period|Progressive Disease|4|||
164525685|NCT01034163|594294984|FG000|Overall Study|Treatment completed as per protocol|8|||
164525686|NCT01034163|594294985|FG001|Overall Study|Treatment completed as per protocol|7|||
164525687|NCT01034163|594294984|FG000|Overall Study|Withdrawal by Subject|8|||
164525688|NCT01034163|594294985|FG001|Overall Study|Withdrawal by Subject|2|||
164525689|NCT01034163|594294984|FG000|Overall Study|Protocol deviation|1|||
164525690|NCT01034163|594294985|FG001|Overall Study|Protocol deviation|0|||
164525691|NCT01034163|594294984|FG000|Overall Study|Disease progression|3|||
164525692|NCT01034163|594294985|FG001|Overall Study|Disease progression|4|||
164525693|NCT01034163|594294984|FG000|Overall Study|Adverse Event|6|||
164525694|NCT01034163|594294985|FG001|Overall Study|Adverse Event|0|||
164525695|NCT01034163|594294984|FG000|Overall Study|Administrative problems|0|||
164525696|NCT01034163|594294985|FG001|Overall Study|Administrative problems|1|||
164525697|NCT01034163|594294984|FG000|Overall Study|Abnormal laboratory value|1|||
164525698|NCT01034163|594294985|FG001|Overall Study|Abnormal laboratory value|0|||
164525699|NCT00296400|594294986|FG000|Overall Study|Adverse Event|7|||
164525700|NCT00296400|594294987|FG001|Overall Study|Adverse Event|7|||
164525701|NCT00296400|594294988|FG002|Overall Study|Adverse Event|7|||
164525702|NCT00296400|594294986|FG000|Overall Study|Withdrawal by Subject|5|||
164525703|NCT00296400|594294987|FG001|Overall Study|Withdrawal by Subject|6|||
164525704|NCT00296400|594294988|FG002|Overall Study|Withdrawal by Subject|2|||
164525705|NCT00296400|594294986|FG000|Overall Study|Incorrect enrollment|2|||
164525706|NCT00296400|594294987|FG001|Overall Study|Incorrect enrollment|0|||
164525707|NCT00296400|594294988|FG002|Overall Study|Incorrect enrollment|0|||
164525708|NCT00296400|594294986|FG000|Overall Study|Protocol Violation|1|||
164525709|NCT00296400|594294987|FG001|Overall Study|Protocol Violation|1|||
164525710|NCT00296400|594294988|FG002|Overall Study|Protocol Violation|1|||
164525711|NCT00296400|594294986|FG000|Overall Study|Lost to Follow-up|1|||
164525712|NCT00296400|594294987|FG001|Overall Study|Lost to Follow-up|1|||
164525713|NCT00296400|594294988|FG002|Overall Study|Lost to Follow-up|2|||
164525714|NCT00296400|594294986|FG000|Overall Study|Study specific discontinuation criteria|0|||
164525715|NCT00296400|594294987|FG001|Overall Study|Study specific discontinuation criteria|0|||
164525716|NCT00296400|594294988|FG002|Overall Study|Study specific discontinuation criteria|1|||
164525717|NCT00296400|594294986|FG000|Overall Study|Visit 10 was performed earlier|0|||
164525718|NCT00296400|594294987|FG001|Overall Study|Visit 10 was performed earlier|1|||
164525719|NCT00296400|594294988|FG002|Overall Study|Visit 10 was performed earlier|0|||
164525720|NCT00296400|594294986|FG000|Overall Study|Pregnancy|1|||
164525721|NCT00296400|594294987|FG001|Overall Study|Pregnancy|2|||
164525722|NCT00296400|594294988|FG002|Overall Study|Pregnancy|0|||
164525723|NCT02433340|594294989|FG000|Overall Study|Adverse Event|0|||
164525724|NCT02433340|594294990|FG001|Overall Study|Adverse Event|0|||
164525725|NCT02433340|594294991|FG002|Overall Study|Adverse Event|1|||
164525726|NCT02433340|594294992|FG003|Overall Study|Adverse Event|0|||
164525727|NCT02433340|594294989|FG000|Overall Study|Withdrawal by Subject|1|||
164525728|NCT02433340|594294990|FG001|Overall Study|Withdrawal by Subject|0|||
164525729|NCT02433340|594294991|FG002|Overall Study|Withdrawal by Subject|1|||
164525730|NCT02433340|594294992|FG003|Overall Study|Withdrawal by Subject|2|||
164525731|NCT02433340|594294989|FG000|Overall Study|Lost to Follow-up|0|||
164525732|NCT02433340|594294990|FG001|Overall Study|Lost to Follow-up|1|||
164525733|NCT02433340|594294991|FG002|Overall Study|Lost to Follow-up|0|||
164525734|NCT02433340|594294992|FG003|Overall Study|Lost to Follow-up|0|||
164525735|NCT02433340|594294989|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
164525736|NCT02433340|594294990|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
164525737|NCT02433340|594294991|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
164525738|NCT02433340|594294992|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
164525739|NCT02433340|594294989|FG000|Overall Study|Other|0|||
164525740|NCT02433340|594294990|FG001|Overall Study|Other|1|||
164525741|NCT02433340|594294991|FG002|Overall Study|Other|0|||
164525742|NCT02433340|594294992|FG003|Overall Study|Other|0|||
164525743|NCT01226095|594294993|FG000|Overall Study|Poor compliance|1|||
164525744|NCT04822597|594294998|FG000|Overall Study|Withdrawal by Subject|0|||
164525745|NCT04822597|594294999|FG001|Overall Study|Withdrawal by Subject|1|||
164525746|NCT04822597|594295000|FG002|Overall Study|Withdrawal by Subject|1|||
164525747|NCT04822597|594295001|FG003|Overall Study|Withdrawal by Subject|0|||
164525748|NCT04822597|594294998|FG000|Overall Study|Physician Decision|0|||
164525749|NCT04822597|594294999|FG001|Overall Study|Physician Decision|0|||
164525750|NCT04822597|594295000|FG002|Overall Study|Physician Decision|1|||
164525751|NCT04822597|594295001|FG003|Overall Study|Physician Decision|1|||
164525752|NCT04822597|594294998|FG000|Overall Study|Subject withdrawn after enrollment|0|||
164525753|NCT04822597|594294999|FG001|Overall Study|Subject withdrawn after enrollment|1|||
164525754|NCT04822597|594295000|FG002|Overall Study|Subject withdrawn after enrollment|0|||
164525755|NCT04822597|594295001|FG003|Overall Study|Subject withdrawn after enrollment|1|||
164525756|NCT04822597|594294998|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
164525757|NCT04822597|594294999|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
164525758|NCT04822597|594295000|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
164525759|NCT04822597|594295001|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
164525760|NCT00911768|594295008|FG000|Overall Study|Protocol Violation|5|||
164622174|NCT01996865|594637567|FG001|Induction Period|Progressive Disease|0|||
164622175|NCT01996865|594637568|FG002|Induction Period|Progressive Disease|0|||
164622176|NCT01996865|594637566|FG000|Induction Period|Lost to Follow-up|10|||
164622177|NCT01996865|594637567|FG001|Induction Period|Lost to Follow-up|0|||
164622178|NCT01996865|594637568|FG002|Induction Period|Lost to Follow-up|0|||
164622179|NCT01996865|594637566|FG000|Induction Period|Other Reasons|13|||
164622180|NCT01996865|594637567|FG001|Induction Period|Other Reasons|0|||
164622181|NCT01996865|594637568|FG002|Induction Period|Other Reasons|0|||
164622182|NCT01996865|594637566|FG000|Induction Period|Adverse Event|20|||
164622183|NCT01996865|594637567|FG001|Induction Period|Adverse Event|0|||
164622184|NCT01996865|594637568|FG002|Induction Period|Adverse Event|0|||
164622185|NCT01996865|594637566|FG000|Induction Period|Withdrawal by Subject|60|||
164622186|NCT01996865|594637567|FG001|Induction Period|Withdrawal by Subject|0|||
164622187|NCT01996865|594637568|FG002|Induction Period|Withdrawal by Subject|0|||
164622188|NCT01996865|594637566|FG000|Induction Period|Death|111|||
164622189|NCT01996865|594637567|FG001|Induction Period|Death|0|||
164622190|NCT01996865|594637568|FG002|Induction Period|Death|0|||
164622191|NCT01996865|594637566|FG000|Maintenance Period|Protocol Violation|0|||
164622192|NCT01996865|594637567|FG001|Maintenance Period|Protocol Violation|1|||
164622193|NCT01996865|594637568|FG002|Maintenance Period|Protocol Violation|1|||
164622194|NCT01996865|594637566|FG000|Maintenance Period|Other reasons|0|||
164622195|NCT01996865|594637567|FG001|Maintenance Period|Other reasons|8|||
164622196|NCT01996865|594637568|FG002|Maintenance Period|Other reasons|5|||
164622197|NCT01996865|594637566|FG000|Maintenance Period|Progressive Disease|0|||
164622198|NCT01996865|594637567|FG001|Maintenance Period|Progressive Disease|6|||
164622199|NCT01996865|594637568|FG002|Maintenance Period|Progressive Disease|23|||
164622200|NCT01996865|594637566|FG000|Maintenance Period|Withdrawal by Subject|0|||
164525761|NCT00911768|594295009|FG001|Overall Study|Protocol Violation|4|||
164525762|NCT00911768|594295008|FG000|Overall Study|Withdrawal by Subject|1|||
164525763|NCT00911768|594295009|FG001|Overall Study|Withdrawal by Subject|0|||
164525764|NCT02859324|594295011|FG000|Overall Study|Death|4|||
164525765|NCT02859324|594295012|FG001|Overall Study|Death|6|||
164525766|NCT02859324|594295013|FG002|Overall Study|Death|5|||
164525767|NCT02859324|594295011|FG000|Overall Study|Other reasons|3|||
164525768|NCT02859324|594295012|FG001|Overall Study|Other reasons|3|||
164525769|NCT02859324|594295013|FG002|Overall Study|Other reasons|0|||
164525770|NCT02665338|594295015|FG000|Overall Study|Withdrawal by Subject|0|||
164525771|NCT02665338|594295016|FG001|Overall Study|Withdrawal by Subject|1|||
164525772|NCT00998335|594295017|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
164525773|NCT00998335|594295018|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
164525774|NCT05110690|594295021|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
164525775|NCT05110690|594295021|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
164525776|NCT05110690|594295021|FG000|Completion of Intervention|Lost to Follow-up|1|||
164525777|NCT05110690|594295021|FG000|Completion of Intervention|Death|1|||
164525778|NCT05110690|594295021|FG000|Completion of Intervention|Withdrawal by Subject|2|||
164525779|NCT02808143|594296700|FG000|Maintenance Phase|Disease recurrence|1|||
164525780|NCT02808143|594296701|FG001|Maintenance Phase|Disease recurrence|3|||
164525781|NCT02808143|594296700|FG000|Maintenance Phase|Disease progression|1|||
164525782|NCT02808143|594296701|FG001|Maintenance Phase|Disease progression|2|||
164525783|NCT02808143|594296700|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
164525784|NCT02808143|594296701|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
164525785|NCT02808143|594296700|FG000|Survival Follow-Up|Disease recurrence|0|||
164525786|NCT02808143|594296701|FG001|Survival Follow-Up|Disease recurrence|2|||
164525787|NCT02808143|594296700|FG000|Survival Follow-Up|Adverse Event|0|||
164525788|NCT02808143|594296701|FG001|Survival Follow-Up|Adverse Event|1|||
164525789|NCT02808143|594296700|FG000|Survival Follow-Up|Death|1|||
164525790|NCT02808143|594296701|FG001|Survival Follow-Up|Death|0|||
164622201|NCT01996865|594637567|FG001|Maintenance Period|Withdrawal by Subject|18|||
164622202|NCT01996865|594637568|FG002|Maintenance Period|Withdrawal by Subject|4|||
164622203|NCT01996865|594637566|FG000|Maintenance Period|Adverse Event|0|||
164622204|NCT01996865|594637567|FG001|Maintenance Period|Adverse Event|7|||
164622205|NCT01996865|594637568|FG002|Maintenance Period|Adverse Event|7|||
164622206|NCT01996865|594637566|FG000|Maintenance Period|Death|0|||
164622207|NCT01996865|594637567|FG001|Maintenance Period|Death|15|||
164622208|NCT01996865|594637568|FG002|Maintenance Period|Death|3|||
164622209|NCT01996865|594637566|FG000|Maintenance Period|Lost to Follow-up|0|||
164525791|NCT01874431|594296702|FG000|Overall Study|Physician Decision|0|||
164525792|NCT01874431|594296703|FG001|Overall Study|Physician Decision|0|||
164525793|NCT01874431|594296704|FG002|Overall Study|Physician Decision|1|||
164525794|NCT01874431|594296705|FG003|Overall Study|Physician Decision|0|||
164525795|NCT01874431|594296706|FG004|Overall Study|Physician Decision|0|||
164525796|NCT01874431|594296707|FG005|Overall Study|Physician Decision|0|||
164525797|NCT01874431|594296708|FG006|Overall Study|Physician Decision|0|||
164622210|NCT01996865|594637567|FG001|Maintenance Period|Lost to Follow-up|2|||
164622211|NCT01996865|594637568|FG002|Maintenance Period|Lost to Follow-up|0|||
164622212|NCT05304611|594637571|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
164622213|NCT05304611|594637572|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
164525798|NCT01874431|594296709|FG007|Overall Study|Physician Decision|0|||
164525799|NCT01874431|594296702|FG000|Overall Study|Adverse Event|5|||
164525800|NCT01874431|594296703|FG001|Overall Study|Adverse Event|4|||
164525801|NCT01874431|594296704|FG002|Overall Study|Adverse Event|6|||
164525802|NCT01874431|594296705|FG003|Overall Study|Adverse Event|5|||
164525803|NCT01874431|594296706|FG004|Overall Study|Adverse Event|2|||
164525804|NCT01874431|594296707|FG005|Overall Study|Adverse Event|8|||
164525805|NCT01874431|594296708|FG006|Overall Study|Adverse Event|2|||
164525806|NCT01874431|594296709|FG007|Overall Study|Adverse Event|3|||
164525807|NCT01874431|594296702|FG000|Overall Study|Protocol Violation|1|||
164525808|NCT01874431|594296703|FG001|Overall Study|Protocol Violation|1|||
164525809|NCT01874431|594296704|FG002|Overall Study|Protocol Violation|1|||
164525810|NCT01874431|594296705|FG003|Overall Study|Protocol Violation|0|||
164525811|NCT01874431|594296706|FG004|Overall Study|Protocol Violation|3|||
164525812|NCT01874431|594296707|FG005|Overall Study|Protocol Violation|2|||
164525813|NCT01874431|594296708|FG006|Overall Study|Protocol Violation|1|||
164525814|NCT01874431|594296709|FG007|Overall Study|Protocol Violation|1|||
164525815|NCT01874431|594296702|FG000|Overall Study|Non-compliance|0|||
164525816|NCT01874431|594296703|FG001|Overall Study|Non-compliance|0|||
164525817|NCT01874431|594296704|FG002|Overall Study|Non-compliance|0|||
164525818|NCT01874431|594296705|FG003|Overall Study|Non-compliance|0|||
164525819|NCT01874431|594296706|FG004|Overall Study|Non-compliance|1|||
164525820|NCT01874431|594296707|FG005|Overall Study|Non-compliance|0|||
164525821|NCT01874431|594296708|FG006|Overall Study|Non-compliance|1|||
164525822|NCT01874431|594296709|FG007|Overall Study|Non-compliance|0|||
164525823|NCT01874431|594296702|FG000|Overall Study|Logistical difficulties|0|||
164525824|NCT01874431|594296703|FG001|Overall Study|Logistical difficulties|0|||
164525825|NCT01874431|594296704|FG002|Overall Study|Logistical difficulties|0|||
164525826|NCT01874431|594296705|FG003|Overall Study|Logistical difficulties|0|||
164525827|NCT01874431|594296706|FG004|Overall Study|Logistical difficulties|0|||
164525828|NCT01874431|594296707|FG005|Overall Study|Logistical difficulties|0|||
164525829|NCT01874431|594296708|FG006|Overall Study|Logistical difficulties|1|||
164525830|NCT01874431|594296709|FG007|Overall Study|Logistical difficulties|0|||
164525831|NCT01874431|594296702|FG000|Overall Study|Withdrawal by Subject|0|||
164525832|NCT01874431|594296703|FG001|Overall Study|Withdrawal by Subject|0|||
164525833|NCT01874431|594296704|FG002|Overall Study|Withdrawal by Subject|1|||
164525834|NCT01874431|594296705|FG003|Overall Study|Withdrawal by Subject|2|||
164525835|NCT01874431|594296706|FG004|Overall Study|Withdrawal by Subject|1|||
164525836|NCT01874431|594296707|FG005|Overall Study|Withdrawal by Subject|1|||
164525837|NCT01874431|594296708|FG006|Overall Study|Withdrawal by Subject|3|||
164525838|NCT01874431|594296709|FG007|Overall Study|Withdrawal by Subject|0|||
164525839|NCT01874431|594296702|FG000|Overall Study|Sponsor decision|0|||
164525840|NCT01874431|594296703|FG001|Overall Study|Sponsor decision|0|||
164525841|NCT01874431|594296704|FG002|Overall Study|Sponsor decision|0|||
164525842|NCT01874431|594296705|FG003|Overall Study|Sponsor decision|0|||
164525843|NCT01874431|594296706|FG004|Overall Study|Sponsor decision|1|||
164525844|NCT01874431|594296707|FG005|Overall Study|Sponsor decision|0|||
164525845|NCT01874431|594296708|FG006|Overall Study|Sponsor decision|0|||
164525846|NCT01874431|594296709|FG007|Overall Study|Sponsor decision|0|||
164525847|NCT01874431|594296702|FG000|Overall Study|Lost to Follow-up|0|||
164525848|NCT01874431|594296703|FG001|Overall Study|Lost to Follow-up|0|||
164525849|NCT01874431|594296704|FG002|Overall Study|Lost to Follow-up|1|||
164525850|NCT01874431|594296705|FG003|Overall Study|Lost to Follow-up|0|||
164525851|NCT01874431|594296706|FG004|Overall Study|Lost to Follow-up|0|||
164525852|NCT01874431|594296707|FG005|Overall Study|Lost to Follow-up|0|||
164525853|NCT01874431|594296708|FG006|Overall Study|Lost to Follow-up|0|||
164525854|NCT01874431|594296709|FG007|Overall Study|Lost to Follow-up|0|||
164525855|NCT04275089|594296713|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
164525856|NCT01014143|594296714|FG000|Second Intervention|Lost to Follow-up|2|||
164525857|NCT01014143|594296715|FG001|Second Intervention|Lost to Follow-up|0|||
164525858|NCT01014143|594296716|FG002|Second Intervention|Lost to Follow-up|0|||
164525859|NCT02354508|594296718|FG000|Period 1: Core Phase|Adverse Event|1|||
164525860|NCT02354508|594296719|FG001|Period 1: Core Phase|Adverse Event|1|||
164525861|NCT02354508|594296720|FG002|Period 1: Core Phase|Adverse Event|2|||
164525862|NCT02354508|594296718|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
164525863|NCT02354508|594296719|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
164525864|NCT02354508|594296720|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
164525865|NCT02354508|594296718|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
164525866|NCT02354508|594296719|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
164525867|NCT02354508|594296720|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
164525868|NCT02354508|594296718|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
164525869|NCT02354508|594296719|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
164525870|NCT02354508|594296720|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
164525871|NCT02354508|594296718|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
164525872|NCT02354508|594296719|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
164525873|NCT02354508|594296720|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
164622214|NCT05304611|594637573|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
164622215|NCT05304611|594637574|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
164622216|NCT05304611|594637575|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
164622217|NCT05304611|594637576|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
164622218|NCT05304611|594637577|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
164622219|NCT05304611|594637578|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
164622220|NCT05304611|594637579|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
164622221|NCT05304611|594637580|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
164622222|NCT05304611|594637581|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
164622223|NCT05304611|594637582|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
164622224|NCT05304611|594637571|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
164622225|NCT05304611|594637572|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
164622226|NCT05304611|594637573|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
164622227|NCT05304611|594637574|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
164622228|NCT05304611|594637575|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
164622229|NCT05304611|594637576|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
164622230|NCT05304611|594637577|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
164622231|NCT05304611|594637578|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
164622232|NCT05304611|594637579|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
164622233|NCT05304611|594637580|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
164622234|NCT05304611|594637581|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
164622235|NCT05304611|594637582|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
164622236|NCT05304611|594637571|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
164622237|NCT05304611|594637572|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
164622238|NCT05304611|594637573|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
164622239|NCT05304611|594637574|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
164622240|NCT05304611|594637575|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
164622241|NCT05304611|594637576|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
164622242|NCT05304611|594637577|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
164622243|NCT05304611|594637578|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
164622244|NCT05304611|594637579|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
164622245|NCT05304611|594637580|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
164622246|NCT05304611|594637581|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
164622247|NCT05304611|594637582|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
164622248|NCT00963820|594637583|FG000|Dose Escalation Phase|Progressive Disease|3|||
164622249|NCT00963820|594637584|FG001|Dose Escalation Phase|Progressive Disease|3|||
164622250|NCT00963820|594637585|FG002|Dose Escalation Phase|Progressive Disease|3|||
164622251|NCT00963820|594637586|FG003|Dose Escalation Phase|Progressive Disease|3|||
164622252|NCT00963820|594637587|FG004|Dose Escalation Phase|Progressive Disease|4|||
164622253|NCT00963820|594637588|FG005|Dose Escalation Phase|Progressive Disease|3|||
164622254|NCT00963820|594637589|FG006|Dose Escalation Phase|Progressive Disease|3|||
164622255|NCT00963820|594637590|FG007|Dose Escalation Phase|Progressive Disease|2|||
164622256|NCT00963820|594637591|FG008|Dose Escalation Phase|Progressive Disease|0|||
164622257|NCT00963820|594637592|FG009|Dose Escalation Phase|Progressive Disease|0|||
164622258|NCT00963820|594637593|FG010|Dose Escalation Phase|Progressive Disease|0|||
164622259|NCT00963820|594637594|FG011|Dose Escalation Phase|Progressive Disease|0|||
164622260|NCT00963820|594637583|FG000|Dose Escalation Phase|Adverse Event|0|||
164622261|NCT00963820|594637584|FG001|Dose Escalation Phase|Adverse Event|0|||
164622262|NCT00963820|594637585|FG002|Dose Escalation Phase|Adverse Event|0|||
164622263|NCT00963820|594637586|FG003|Dose Escalation Phase|Adverse Event|0|||
164622264|NCT00963820|594637587|FG004|Dose Escalation Phase|Adverse Event|0|||
164622265|NCT00963820|594637588|FG005|Dose Escalation Phase|Adverse Event|0|||
164622266|NCT00963820|594637589|FG006|Dose Escalation Phase|Adverse Event|3|||
164622267|NCT00963820|594637590|FG007|Dose Escalation Phase|Adverse Event|1|||
164622268|NCT00963820|594637591|FG008|Dose Escalation Phase|Adverse Event|0|||
164622269|NCT00963820|594637592|FG009|Dose Escalation Phase|Adverse Event|0|||
164622270|NCT00963820|594637593|FG010|Dose Escalation Phase|Adverse Event|0|||
164622271|NCT00963820|594637594|FG011|Dose Escalation Phase|Adverse Event|0|||
164622272|NCT00963820|594637583|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
164622273|NCT00963820|594637584|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
164622274|NCT00963820|594637585|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
164622275|NCT00963820|594637586|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
164622276|NCT00963820|594637587|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
164622277|NCT00963820|594637588|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
164622278|NCT00963820|594637589|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
164622279|NCT00963820|594637590|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
164622280|NCT00963820|594637591|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
164622281|NCT00963820|594637592|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
164622282|NCT00963820|594637593|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
164622283|NCT00963820|594637594|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
164622284|NCT00963820|594637583|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164622285|NCT00963820|594637584|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164622286|NCT00963820|594637585|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164622287|NCT00963820|594637586|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164622288|NCT00963820|594637587|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164622289|NCT00963820|594637588|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164622290|NCT00963820|594637589|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
164622291|NCT00963820|594637590|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164622292|NCT00963820|594637591|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164622293|NCT00963820|594637592|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164622294|NCT00963820|594637593|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164622295|NCT00963820|594637594|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164622296|NCT00963820|594637583|FG000|Expansion Phase|Progressive Disease|0|||
164622297|NCT00963820|594637584|FG001|Expansion Phase|Progressive Disease|0|||
164622298|NCT00963820|594637585|FG002|Expansion Phase|Progressive Disease|0|||
164622299|NCT00963820|594637586|FG003|Expansion Phase|Progressive Disease|0|||
164622300|NCT00963820|594637587|FG004|Expansion Phase|Progressive Disease|0|||
164622301|NCT00963820|594637588|FG005|Expansion Phase|Progressive Disease|0|||
164622302|NCT00963820|594637589|FG006|Expansion Phase|Progressive Disease|0|||
164622303|NCT00963820|594637590|FG007|Expansion Phase|Progressive Disease|0|||
164622304|NCT00963820|594637591|FG008|Expansion Phase|Progressive Disease|8|||
164622305|NCT00963820|594637592|FG009|Expansion Phase|Progressive Disease|6|||
164622306|NCT00963820|594637593|FG010|Expansion Phase|Progressive Disease|4|||
164622307|NCT00963820|594637594|FG011|Expansion Phase|Progressive Disease|2|||
164622308|NCT00963820|594637583|FG000|Expansion Phase|Adverse Event|0|||
164622309|NCT00963820|594637584|FG001|Expansion Phase|Adverse Event|0|||
164622310|NCT00963820|594637585|FG002|Expansion Phase|Adverse Event|0|||
164622311|NCT00963820|594637586|FG003|Expansion Phase|Adverse Event|0|||
164622312|NCT00963820|594637587|FG004|Expansion Phase|Adverse Event|0|||
164622313|NCT00963820|594637588|FG005|Expansion Phase|Adverse Event|0|||
164622314|NCT00963820|594637589|FG006|Expansion Phase|Adverse Event|0|||
164622315|NCT00963820|594637590|FG007|Expansion Phase|Adverse Event|0|||
164622316|NCT00963820|594637591|FG008|Expansion Phase|Adverse Event|1|||
164622317|NCT00963820|594637592|FG009|Expansion Phase|Adverse Event|3|||
164622318|NCT00963820|594637593|FG010|Expansion Phase|Adverse Event|0|||
164622319|NCT00963820|594637594|FG011|Expansion Phase|Adverse Event|0|||
164622320|NCT00963820|594637583|FG000|Expansion Phase|Withdrawal by Subject|0|||
164622321|NCT00963820|594637584|FG001|Expansion Phase|Withdrawal by Subject|0|||
164622322|NCT00963820|594637585|FG002|Expansion Phase|Withdrawal by Subject|0|||
164622323|NCT00963820|594637586|FG003|Expansion Phase|Withdrawal by Subject|0|||
164622324|NCT00963820|594637587|FG004|Expansion Phase|Withdrawal by Subject|0|||
164622325|NCT00963820|594637588|FG005|Expansion Phase|Withdrawal by Subject|0|||
164622326|NCT00963820|594637589|FG006|Expansion Phase|Withdrawal by Subject|0|||
164622327|NCT00963820|594637590|FG007|Expansion Phase|Withdrawal by Subject|0|||
164622328|NCT00963820|594637591|FG008|Expansion Phase|Withdrawal by Subject|1|||
164622329|NCT00963820|594637592|FG009|Expansion Phase|Withdrawal by Subject|0|||
164622330|NCT00963820|594637593|FG010|Expansion Phase|Withdrawal by Subject|1|||
164622331|NCT00963820|594637594|FG011|Expansion Phase|Withdrawal by Subject|1|||
164622332|NCT00963820|594637583|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164622333|NCT00963820|594637584|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164622334|NCT00963820|594637585|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164622335|NCT00963820|594637586|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164622336|NCT00963820|594637587|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164622337|NCT00963820|594637588|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164622338|NCT00963820|594637589|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164622339|NCT00963820|594637590|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164622340|NCT00963820|594637591|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164622341|NCT00963820|594637592|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164622342|NCT00963820|594637593|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164622343|NCT00963820|594637594|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
164622344|NCT02756845|594637600|FG000|Overall Study|Death|12|||
164622345|NCT02756845|594637601|FG001|Overall Study|Death|2|||
164622346|NCT02756845|594637600|FG000|Overall Study|Withdrawal by Subject|1|||
164622347|NCT02756845|594637601|FG001|Overall Study|Withdrawal by Subject|0|||
164622348|NCT05333289|594637602|FG000|Overall Study|Other|1|||
164622349|NCT05333289|594637603|FG001|Overall Study|Other|0|||
164622350|NCT05333289|594637604|FG002|Overall Study|Other|0|||
164622351|NCT05333289|594637605|FG003|Overall Study|Other|1|||
164622352|NCT05333289|594637606|FG004|Overall Study|Other|1|||
164622353|NCT05333289|594637607|FG005|Overall Study|Other|2|||
164622354|NCT05333289|594637608|FG006|Overall Study|Other|2|||
164622355|NCT05333289|594637609|FG007|Overall Study|Other|0|||
164622356|NCT05333289|594637602|FG000|Overall Study|Withdrawal by Subject|1|||
164622357|NCT05333289|594637603|FG001|Overall Study|Withdrawal by Subject|2|||
164622358|NCT05333289|594637604|FG002|Overall Study|Withdrawal by Subject|2|||
164622359|NCT05333289|594637605|FG003|Overall Study|Withdrawal by Subject|1|||
164622360|NCT05333289|594637606|FG004|Overall Study|Withdrawal by Subject|1|||
164622361|NCT05333289|594637607|FG005|Overall Study|Withdrawal by Subject|2|||
164622362|NCT05333289|594637608|FG006|Overall Study|Withdrawal by Subject|1|||
164622363|NCT05333289|594637609|FG007|Overall Study|Withdrawal by Subject|3|||
164622364|NCT05333289|594637602|FG000|Overall Study|Protocol Violation|1|||
164622365|NCT05333289|594637603|FG001|Overall Study|Protocol Violation|0|||
164622366|NCT05333289|594637604|FG002|Overall Study|Protocol Violation|0|||
164622367|NCT05333289|594637605|FG003|Overall Study|Protocol Violation|0|||
164622368|NCT05333289|594637606|FG004|Overall Study|Protocol Violation|0|||
164622369|NCT05333289|594637607|FG005|Overall Study|Protocol Violation|0|||
164622370|NCT05333289|594637608|FG006|Overall Study|Protocol Violation|0|||
164622371|NCT05333289|594637609|FG007|Overall Study|Protocol Violation|0|||
164622372|NCT05333289|594637602|FG000|Overall Study|Physician Decision|0|||
164622373|NCT05333289|594637603|FG001|Overall Study|Physician Decision|0|||
164622374|NCT05333289|594637604|FG002|Overall Study|Physician Decision|1|||
164622375|NCT05333289|594637605|FG003|Overall Study|Physician Decision|0|||
164622376|NCT05333289|594637606|FG004|Overall Study|Physician Decision|0|||
164622377|NCT05333289|594637607|FG005|Overall Study|Physician Decision|2|||
164622378|NCT05333289|594637608|FG006|Overall Study|Physician Decision|0|||
164622379|NCT05333289|594637609|FG007|Overall Study|Physician Decision|0|||
164622380|NCT05333289|594637602|FG000|Overall Study|Lost to Follow-up|6|||
164622381|NCT05333289|594637603|FG001|Overall Study|Lost to Follow-up|0|||
164622382|NCT05333289|594637604|FG002|Overall Study|Lost to Follow-up|1|||
164622383|NCT05333289|594637605|FG003|Overall Study|Lost to Follow-up|6|||
164622384|NCT05333289|594637606|FG004|Overall Study|Lost to Follow-up|3|||
164622385|NCT05333289|594637607|FG005|Overall Study|Lost to Follow-up|3|||
164622386|NCT05333289|594637608|FG006|Overall Study|Lost to Follow-up|2|||
164622387|NCT05333289|594637609|FG007|Overall Study|Lost to Follow-up|1|||
164622388|NCT05333289|594637602|FG000|Overall Study|Death|1|||
164622389|NCT05333289|594637603|FG001|Overall Study|Death|0|||
164622390|NCT05333289|594637604|FG002|Overall Study|Death|0|||
164622391|NCT05333289|594637605|FG003|Overall Study|Death|0|||
164622392|NCT05333289|594637606|FG004|Overall Study|Death|0|||
164622393|NCT05333289|594637607|FG005|Overall Study|Death|0|||
164622394|NCT05333289|594637608|FG006|Overall Study|Death|0|||
164622395|NCT05333289|594637609|FG007|Overall Study|Death|0|||
164622396|NCT02005211|594637610|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
164622397|NCT02005211|594637611|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
164622398|NCT02005211|594637612|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
164622399|NCT02005211|594637613|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
164622400|NCT02005211|594637614|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
164622401|NCT02005211|594637615|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
164622402|NCT02005211|594637616|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
164622403|NCT00397631|594637618|FG000|Overall Study|Adverse Event|5|||
164622404|NCT00397631|594637619|FG001|Overall Study|Adverse Event|6|||
164622405|NCT00397631|594637618|FG000|Overall Study|Lack of Efficacy|7|||
164622406|NCT00397631|594637619|FG001|Overall Study|Lack of Efficacy|10|||
164622407|NCT00397631|594637618|FG000|Overall Study|Lost to Follow-up|8|||
164622408|NCT00397631|594637619|FG001|Overall Study|Lost to Follow-up|9|||
164622409|NCT00397631|594637618|FG000|Overall Study|Physician Decision|2|||
164622410|NCT00397631|594637619|FG001|Overall Study|Physician Decision|0|||
164622411|NCT00397631|594637618|FG000|Overall Study|Protocol Violation|0|||
164622412|NCT00397631|594637619|FG001|Overall Study|Protocol Violation|1|||
164622413|NCT00397631|594637618|FG000|Overall Study|Withdrawal by Subject|7|||
164622414|NCT00397631|594637619|FG001|Overall Study|Withdrawal by Subject|14|||
164622415|NCT00397631|594637618|FG000|Overall Study|protocol discontinuation criteria|1|||
164622416|NCT00397631|594637619|FG001|Overall Study|protocol discontinuation criteria|4|||
164622417|NCT02202161|594637620|FG000|Overall Study|Adverse Event|1|||
164622418|NCT02202161|594637621|FG001|Overall Study|Adverse Event|1|||
164622419|NCT02202161|594637622|FG002|Overall Study|Adverse Event|0|||
164622420|NCT02202161|594637623|FG003|Overall Study|Adverse Event|0|||
164622421|NCT02202161|594637624|FG004|Overall Study|Adverse Event|0|||
164622422|NCT02202161|594637625|FG005|Overall Study|Adverse Event|1|||
164622423|NCT02202161|594637626|FG006|Overall Study|Adverse Event|0|||
164622424|NCT02202161|594637627|FG007|Overall Study|Adverse Event|0|||
164622425|NCT02202161|594637620|FG000|Overall Study|Did not meet continuation criteria|0|||
164622426|NCT02202161|594637621|FG001|Overall Study|Did not meet continuation criteria|0|||
164622427|NCT02202161|594637622|FG002|Overall Study|Did not meet continuation criteria|0|||
164622428|NCT02202161|594637623|FG003|Overall Study|Did not meet continuation criteria|0|||
164622429|NCT02202161|594637624|FG004|Overall Study|Did not meet continuation criteria|0|||
164622430|NCT02202161|594637625|FG005|Overall Study|Did not meet continuation criteria|0|||
164622431|NCT02202161|594637626|FG006|Overall Study|Did not meet continuation criteria|0|||
164622432|NCT02202161|594637627|FG007|Overall Study|Did not meet continuation criteria|3|||
164622433|NCT02202161|594637620|FG000|Overall Study|Physician Decision|0|||
164622434|NCT02202161|594637621|FG001|Overall Study|Physician Decision|0|||
164622435|NCT02202161|594637622|FG002|Overall Study|Physician Decision|0|||
164622436|NCT02202161|594637623|FG003|Overall Study|Physician Decision|0|||
164622437|NCT02202161|594637624|FG004|Overall Study|Physician Decision|0|||
164622438|NCT02202161|594637625|FG005|Overall Study|Physician Decision|0|||
164622439|NCT02202161|594637626|FG006|Overall Study|Physician Decision|0|||
164622440|NCT02202161|594637627|FG007|Overall Study|Physician Decision|3|||
164622441|NCT02202161|594637620|FG000|Overall Study|Withdrawal by Subject|0|||
164622442|NCT02202161|594637621|FG001|Overall Study|Withdrawal by Subject|0|||
164622443|NCT02202161|594637622|FG002|Overall Study|Withdrawal by Subject|0|||
164622444|NCT02202161|594637623|FG003|Overall Study|Withdrawal by Subject|0|||
164622445|NCT02202161|594637624|FG004|Overall Study|Withdrawal by Subject|1|||
164622446|NCT02202161|594637625|FG005|Overall Study|Withdrawal by Subject|0|||
164622447|NCT02202161|594637626|FG006|Overall Study|Withdrawal by Subject|0|||
164622448|NCT02202161|594637627|FG007|Overall Study|Withdrawal by Subject|0|||
164622449|NCT03797144|594637629|FG000|Enrollment|Protocol Violation|4|||
164622450|NCT03797144|594637630|FG001|Enrollment|Protocol Violation|1|||
164622451|NCT03797144|594637629|FG000|Surgery|Protocol Violation|1|||
164622452|NCT03797144|594637630|FG001|Surgery|Protocol Violation|0|||
164622453|NCT03797144|594637629|FG000|3 Month|Early termination cut-off date|2|||
164622454|NCT03797144|594637630|FG001|3 Month|Early termination cut-off date|0|||
164622455|NCT03797144|594637629|FG000|12 Month|Early termination cut-off date|8|||
164622456|NCT03797144|594637630|FG001|12 Month|Early termination cut-off date|9|||
164622457|NCT03797144|594637629|FG000|24 Month|Early termination cut-off date|1|||
164622458|NCT03797144|594637630|FG001|24 Month|Early termination cut-off date|1|||
164622459|NCT01878175|594637632|FG000|Overall Study|Developed contraindicated health problem|2|||
164622460|NCT03864627|594637633|FG000|Overall Study|Adverse Event|0|||
164622461|NCT03864627|594637634|FG001|Overall Study|Adverse Event|1|||
164622462|NCT03864627|594637633|FG000|Overall Study|Lack of Efficacy|0|||
164622463|NCT03864627|594637634|FG001|Overall Study|Lack of Efficacy|1|||
164622464|NCT03864627|594637633|FG000|Overall Study|Lost to Follow-up|0|||
164622465|NCT03864627|594637634|FG001|Overall Study|Lost to Follow-up|1|||
164622466|NCT03864627|594637633|FG000|Overall Study|Withdrawal by Subject|4|||
164622467|NCT03864627|594637634|FG001|Overall Study|Withdrawal by Subject|8|||
164622468|NCT03864627|594637633|FG000|Overall Study|Study terminated by sponsor|0|||
164622469|NCT03864627|594637634|FG001|Overall Study|Study terminated by sponsor|1|||
164622470|NCT01388491|594637635|FG000|Overall Study|Adverse Event|10|||
164622471|NCT01388491|594637636|FG001|Overall Study|Adverse Event|9|||
164622472|NCT01388491|594637635|FG000|Overall Study|Sponsor Request|9|||
164622473|NCT01388491|594637636|FG001|Overall Study|Sponsor Request|7|||
164622474|NCT01388491|594637635|FG000|Overall Study|Withdrawal by Subject|6|||
164622475|NCT01388491|594637636|FG001|Overall Study|Withdrawal by Subject|10|||
164622476|NCT01388491|594637635|FG000|Overall Study|Lost to Follow-up|4|||
164622477|NCT01388491|594637636|FG001|Overall Study|Lost to Follow-up|3|||
164622478|NCT01388491|594637635|FG000|Overall Study|Protocol Violation|2|||
164622479|NCT01388491|594637636|FG001|Overall Study|Protocol Violation|0|||
164622480|NCT01388491|594637635|FG000|Overall Study|Noncompliance|2|||
164622481|NCT01388491|594637636|FG001|Overall Study|Noncompliance|0|||
164622482|NCT01388491|594637635|FG000|Overall Study|Pregnancy|1|||
164622483|NCT01388491|594637636|FG001|Overall Study|Pregnancy|0|||
164622484|NCT00112840|594637637|FG000|Overall Study|Physician Decision|1|||
164622485|NCT00112840|594637638|FG001|Overall Study|Physician Decision|0|||
164622486|NCT00112840|594637639|FG002|Overall Study|Physician Decision|0|||
164622487|NCT00112840|594637637|FG000|Overall Study|Withdrawal by Subject|1|||
164622488|NCT00112840|594637638|FG001|Overall Study|Withdrawal by Subject|0|||
164622489|NCT00112840|594637639|FG002|Overall Study|Withdrawal by Subject|1|||
164622490|NCT00112840|594637637|FG000|Overall Study|Protocol Violation|0|||
164622491|NCT00112840|594637638|FG001|Overall Study|Protocol Violation|0|||
164622492|NCT00112840|594637639|FG002|Overall Study|Protocol Violation|5|||
164622493|NCT02875366|594637640|FG000|Overall Study|Adverse Event|0|||
164622494|NCT02875366|594637641|FG001|Overall Study|Adverse Event|2|||
164622495|NCT02875366|594637640|FG000|Overall Study|Noncompliance|0|||
164622496|NCT02875366|594637641|FG001|Overall Study|Noncompliance|1|||
164622497|NCT00683774|594637642|FG000|Overall Study|Withdrawal by Subject|0|||
164622498|NCT00683774|594637643|FG001|Overall Study|Withdrawal by Subject|1|||
164622499|NCT00683774|594637642|FG000|Overall Study|Physician Decision|3|||
164622500|NCT00683774|594637643|FG001|Overall Study|Physician Decision|0|||
164622501|NCT03595176|594637644|FG000|Overall Study|Death|0|||
164622502|NCT03595176|594637645|FG001|Overall Study|Death|2|||
164622503|NCT03595176|594637644|FG000|Overall Study|Lost to Follow-up|0|||
164622504|NCT03595176|594637645|FG001|Overall Study|Lost to Follow-up|1|||
164622505|NCT02735044|594637647|FG000|Overall Study|Adverse Event|3|||
164622506|NCT02735044|594637648|FG001|Overall Study|Adverse Event|3|||
164622507|NCT02735044|594637647|FG000|Overall Study|Lack of Efficacy|1|||
164622508|NCT02735044|594637648|FG001|Overall Study|Lack of Efficacy|0|||
164622509|NCT02735044|594637647|FG000|Overall Study|Poor compliance to protocol|7|||
164622510|NCT02735044|594637648|FG001|Overall Study|Poor compliance to protocol|7|||
164622511|NCT02735044|594637647|FG000|Overall Study|Randomized and not treated|0|||
164622512|NCT02735044|594637648|FG001|Overall Study|Randomized and not treated|2|||
164622513|NCT02735044|594637647|FG000|Overall Study|Other, not specified above|5|||
164622514|NCT02735044|594637648|FG001|Overall Study|Other, not specified above|11|||
164622515|NCT00412113|594637650|FG000|Overall Study|Adverse Event|11|||
164622516|NCT00412113|594637651|FG001|Overall Study|Adverse Event|15|||
164622517|NCT00412113|594637650|FG000|Overall Study|did not receive treatment|1|||
164622518|NCT00412113|594637651|FG001|Overall Study|did not receive treatment|0|||
164622519|NCT02972658|594639380|FG000|Overall Study|Adverse Event|0|||
164622520|NCT02972658|594639381|FG001|Overall Study|Adverse Event|3|||
164622521|NCT02972658|594639382|FG002|Overall Study|Adverse Event|0|||
164622522|NCT02972658|594639383|FG003|Overall Study|Adverse Event|2|||
164622523|NCT02972658|594639380|FG000|Overall Study|Other-determined by Investigator|1|||
164622524|NCT02972658|594639381|FG001|Overall Study|Other-determined by Investigator|1|||
164622525|NCT02972658|594639382|FG002|Overall Study|Other-determined by Investigator|0|||
164622526|NCT02972658|594639383|FG003|Overall Study|Other-determined by Investigator|0|||
164622527|NCT02972658|594639380|FG000|Overall Study|Death|0|||
164622528|NCT02972658|594639381|FG001|Overall Study|Death|0|||
164622529|NCT02972658|594639382|FG002|Overall Study|Death|0|||
164622530|NCT02972658|594639383|FG003|Overall Study|Death|1|||
164622531|NCT02972658|594639380|FG000|Overall Study|Lost to Follow-up|0|||
164622532|NCT02972658|594639381|FG001|Overall Study|Lost to Follow-up|1|||
164622533|NCT02972658|594639382|FG002|Overall Study|Lost to Follow-up|1|||
164622534|NCT02972658|594639383|FG003|Overall Study|Lost to Follow-up|2|||
164622535|NCT02972658|594639380|FG000|Overall Study|Progressive Disease|0|||
164622536|NCT02972658|594639381|FG001|Overall Study|Progressive Disease|1|||
164622537|NCT02972658|594639382|FG002|Overall Study|Progressive Disease|0|||
164622538|NCT02972658|594639383|FG003|Overall Study|Progressive Disease|1|||
164622539|NCT02972658|594639380|FG000|Overall Study|Withdrawal by Subject|4|||
164622540|NCT02972658|594639381|FG001|Overall Study|Withdrawal by Subject|4|||
164622541|NCT02972658|594639382|FG002|Overall Study|Withdrawal by Subject|1|||
164622542|NCT02972658|594639383|FG003|Overall Study|Withdrawal by Subject|6|||
164622543|NCT02972658|594639380|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
164622544|NCT02972658|594639381|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
164622545|NCT02972658|594639382|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
164622546|NCT02972658|594639383|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
164622547|NCT02972658|594639380|FG000|Overall Study|Sponsor Decision|70|||
164622548|NCT02972658|594639381|FG001|Overall Study|Sponsor Decision|127|||
164622549|NCT02972658|594639382|FG002|Overall Study|Sponsor Decision|72|||
164622550|NCT02972658|594639383|FG003|Overall Study|Sponsor Decision|119|||
164622551|NCT02785588|594639387|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
164622552|NCT02785588|594639387|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
164622553|NCT03037489|594639388|FG000|Overall Study|Adverse Event|4|||
164622554|NCT03037489|594639389|FG001|Overall Study|Adverse Event|0|||
164622555|NCT03037489|594639388|FG000|Overall Study|Withdrawal by Subject|3|||
164622556|NCT03037489|594639389|FG001|Overall Study|Withdrawal by Subject|0|||
164622557|NCT03031327|594639390|FG000|Overall Study|Withdrawal by Subject|0|||
164622558|NCT03031327|594639391|FG001|Overall Study|Withdrawal by Subject|1|||
164622559|NCT03031327|594639392|FG002|Overall Study|Withdrawal by Subject|1|||
164622560|NCT00669240|594639393|FG000|Overall Study|Lack of Efficacy|33|||
164622561|NCT00669240|594639393|FG000|Overall Study|Withdrawal by Subject|42|||
164622562|NCT00669240|594639393|FG000|Overall Study|Lost to Follow-up|34|||
164622563|NCT00669240|594639393|FG000|Overall Study|Adverse Event|21|||
164622564|NCT00669240|594639393|FG000|Overall Study|Other|19|||
164622565|NCT00669240|594639393|FG000|Overall Study|Enrolled but not treated|15|||
164622566|NCT00669240|594639393|FG000|Overall Study|Enrolled but no dosing record|1|||
164622567|NCT01997892|594639398|FG000|Overall Study|Physician Decision|2|||
164622568|NCT01997892|594639398|FG000|Overall Study|Lost to Follow-up|6|||
164622569|NCT01997892|594639398|FG000|Overall Study|Death|14|||
164622570|NCT01997892|594639398|FG000|Overall Study|Renal transplant|8|||
164622571|NCT01997892|594639398|FG000|Overall Study|Other|3|||
164622572|NCT01997892|594639398|FG000|Overall Study|Study completion data not recorded|35|||
164622573|NCT00364611|594639399|FG000|Overall Study|Did not receive study medication|0|||
164622574|NCT00364611|594639400|FG001|Overall Study|Did not receive study medication|1|||
164622575|NCT00364611|594639399|FG000|Overall Study|Adverse Event|7|||
164622576|NCT00364611|594639400|FG001|Overall Study|Adverse Event|4|||
164622577|NCT00364611|594639399|FG000|Overall Study|Participant's Request|3|||
164622578|NCT00364611|594639400|FG001|Overall Study|Participant's Request|4|||
164622579|NCT00364611|594639399|FG000|Overall Study|Disease Progression|38|||
164622580|NCT00364611|594639400|FG001|Overall Study|Disease Progression|8|||
164622581|NCT00364611|594639399|FG000|Overall Study|Investigator decision|2|||
164622582|NCT00364611|594639400|FG001|Overall Study|Investigator decision|2|||
164622583|NCT00364611|594639399|FG000|Overall Study|Found Ineligible|1|||
164622584|NCT00364611|594639400|FG001|Overall Study|Found Ineligible|0|||
164622585|NCT00364611|594639399|FG000|Overall Study|Presumed CR on Study|0|||
164622586|NCT00364611|594639400|FG001|Overall Study|Presumed CR on Study|1|||
164622587|NCT00364611|594639399|FG000|Overall Study|Receiving Liver Ablation|0|||
164622588|NCT00364611|594639400|FG001|Overall Study|Receiving Liver Ablation|1|||
164622589|NCT02531633|594639401|FG000|Part A (52 Weeks)|Sponsor request|24|||
164622590|NCT02531633|594639402|FG001|Part A (52 Weeks)|Sponsor request|24|||
164622591|NCT02531633|594639403|FG002|Part A (52 Weeks)|Sponsor request|18|||
164622592|NCT02531633|594639404|FG003|Part A (52 Weeks)|Sponsor request|18|||
164622593|NCT02531633|594639405|FG004|Part A (52 Weeks)|Sponsor request|19|||
164622594|NCT02531633|594639406|FG005|Part A (52 Weeks)|Sponsor request|0|||
164622595|NCT02531633|594639407|FG006|Part A (52 Weeks)|Sponsor request|0|||
164622596|NCT02531633|594639408|FG007|Part A (52 Weeks)|Sponsor request|0|||
164622597|NCT02531633|594639409|FG008|Part A (52 Weeks)|Sponsor request|0|||
164622598|NCT02531633|594639410|FG009|Part A (52 Weeks)|Sponsor request|0|||
164622599|NCT02531633|594639401|FG000|Part A (52 Weeks)|Protocol Violation|1|||
164622600|NCT02531633|594639402|FG001|Part A (52 Weeks)|Protocol Violation|0|||
164622601|NCT02531633|594639403|FG002|Part A (52 Weeks)|Protocol Violation|0|||
164622602|NCT02531633|594639404|FG003|Part A (52 Weeks)|Protocol Violation|0|||
164622603|NCT02531633|594639405|FG004|Part A (52 Weeks)|Protocol Violation|0|||
164622604|NCT02531633|594639406|FG005|Part A (52 Weeks)|Protocol Violation|0|||
164622605|NCT02531633|594639407|FG006|Part A (52 Weeks)|Protocol Violation|0|||
164622606|NCT02531633|594639408|FG007|Part A (52 Weeks)|Protocol Violation|0|||
164622607|NCT02531633|594639409|FG008|Part A (52 Weeks)|Protocol Violation|0|||
164622608|NCT02531633|594639410|FG009|Part A (52 Weeks)|Protocol Violation|0|||
164622609|NCT02531633|594639401|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
164622610|NCT02531633|594639402|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
164622611|NCT02531633|594639403|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
164622612|NCT02531633|594639404|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
164622613|NCT02531633|594639405|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
164622614|NCT02531633|594639406|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
164622615|NCT02531633|594639407|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
164622616|NCT02531633|594639408|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
164622617|NCT02531633|594639409|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
164622618|NCT02531633|594639410|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
164622619|NCT02531633|594639401|FG000|Part A (52 Weeks)|Physician Decision|1|||
164622620|NCT02531633|594639402|FG001|Part A (52 Weeks)|Physician Decision|4|||
164622621|NCT02531633|594639403|FG002|Part A (52 Weeks)|Physician Decision|3|||
164622622|NCT02531633|594639404|FG003|Part A (52 Weeks)|Physician Decision|1|||
164622623|NCT02531633|594639405|FG004|Part A (52 Weeks)|Physician Decision|0|||
164622624|NCT02531633|594639406|FG005|Part A (52 Weeks)|Physician Decision|0|||
164622625|NCT02531633|594639407|FG006|Part A (52 Weeks)|Physician Decision|0|||
164622626|NCT02531633|594639408|FG007|Part A (52 Weeks)|Physician Decision|0|||
164622627|NCT02531633|594639409|FG008|Part A (52 Weeks)|Physician Decision|0|||
164622628|NCT02531633|594639410|FG009|Part A (52 Weeks)|Physician Decision|0|||
164622629|NCT02531633|594639401|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
164622630|NCT02531633|594639402|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
164622631|NCT02531633|594639403|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
164622632|NCT02531633|594639404|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
164622633|NCT02531633|594639405|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
164622634|NCT02531633|594639406|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
164622635|NCT02531633|594639407|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
164622636|NCT02531633|594639408|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
164622637|NCT02531633|594639409|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
164622638|NCT02531633|594639410|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
164622639|NCT02531633|594639401|FG000|Part A (52 Weeks)|Other|2|||
164622640|NCT02531633|594639402|FG001|Part A (52 Weeks)|Other|0|||
164622641|NCT02531633|594639403|FG002|Part A (52 Weeks)|Other|0|||
164622642|NCT02531633|594639404|FG003|Part A (52 Weeks)|Other|0|||
164622643|NCT02531633|594639405|FG004|Part A (52 Weeks)|Other|0|||
164622644|NCT02531633|594639406|FG005|Part A (52 Weeks)|Other|0|||
164622645|NCT02531633|594639407|FG006|Part A (52 Weeks)|Other|0|||
164622646|NCT02531633|594639408|FG007|Part A (52 Weeks)|Other|0|||
164622647|NCT02531633|594639409|FG008|Part A (52 Weeks)|Other|0|||
164622648|NCT02531633|594639410|FG009|Part A (52 Weeks)|Other|0|||
164622649|NCT02531633|594639401|FG000|Part B (104 Weeks)|Sponsor request|0|||
164622650|NCT02531633|594639402|FG001|Part B (104 Weeks)|Sponsor request|0|||
164622651|NCT02531633|594639403|FG002|Part B (104 Weeks)|Sponsor request|0|||
164622652|NCT02531633|594639404|FG003|Part B (104 Weeks)|Sponsor request|0|||
164622653|NCT02531633|594639405|FG004|Part B (104 Weeks)|Sponsor request|0|||
164622654|NCT02531633|594639406|FG005|Part B (104 Weeks)|Sponsor request|8|||
164622655|NCT02531633|594639407|FG006|Part B (104 Weeks)|Sponsor request|5|||
164622656|NCT02531633|594639408|FG007|Part B (104 Weeks)|Sponsor request|3|||
164622657|NCT02531633|594639409|FG008|Part B (104 Weeks)|Sponsor request|5|||
164622658|NCT02531633|594639410|FG009|Part B (104 Weeks)|Sponsor request|4|||
164622659|NCT02531633|594639401|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
164622660|NCT02531633|594639402|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
164622661|NCT02531633|594639403|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
164622662|NCT02531633|594639404|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
164622663|NCT02531633|594639405|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
164622664|NCT02531633|594639406|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
164622665|NCT02531633|594639407|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
164622666|NCT02531633|594639408|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
164622667|NCT02531633|594639409|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
164622668|NCT02531633|594639410|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
164622669|NCT02608099|594639417|FG000|Overall Study|Ablation procedure not initiated|3|||
164622670|NCT02608099|594639418|FG001|Overall Study|Ablation procedure not initiated|2|||
164622671|NCT00087594|594639423|FG000|Overall Study|Adverse Event|2|||
164622672|NCT00087594|594639424|FG001|Overall Study|Adverse Event|3|||
164622673|NCT00087594|594639423|FG000|Overall Study|Lost to Follow-up|0|||
164622674|NCT00087594|594639424|FG001|Overall Study|Lost to Follow-up|2|||
164622675|NCT00087594|594639423|FG000|Overall Study|Withdrawal by Subject|4|||
164622676|NCT00087594|594639424|FG001|Overall Study|Withdrawal by Subject|2|||
164622677|NCT00087594|594639423|FG000|Overall Study|Lack of Efficacy|2|||
164622678|NCT00087594|594639424|FG001|Overall Study|Lack of Efficacy|5|||
164622679|NCT01952041|594639425|FG000|Overall Study|Lost to Follow-up|9|||
164622680|NCT01952041|594639426|FG001|Overall Study|Lost to Follow-up|16|||
164622681|NCT01952041|594639425|FG000|Overall Study|Withdrawal by Subject|7|||
164622682|NCT01952041|594639426|FG001|Overall Study|Withdrawal by Subject|5|||
164622683|NCT01952041|594639425|FG000|Overall Study|Death|1|||
164622684|NCT01952041|594639426|FG001|Overall Study|Death|0|||
164622685|NCT01736176|594639427|FG000|Overall Study|Adverse Event|3|||
164622686|NCT01736176|594639427|FG000|Overall Study|Withdrawal by Subject|4|||
164622687|NCT01736176|594639427|FG000|Overall Study|Lack of Efficacy|3|||
164622688|NCT01736176|594639427|FG000|Overall Study|Unable to Complete PEG Placement|1|||
164622689|NCT01569568|594639428|FG000|Overall Study|Physician Decision|0|||
164622690|NCT01569568|594639429|FG001|Overall Study|Physician Decision|2|||
164622691|NCT03657576|594639430|FG000|Overall Study|Death|0|||
164622692|NCT03657576|594639431|FG001|Overall Study|Death|1|||
164622693|NCT03657576|594639432|FG002|Overall Study|Death|1|||
164622694|NCT03657576|594639433|FG003|Overall Study|Death|0|||
164622695|NCT03657576|594639434|FG004|Overall Study|Death|0|||
164622696|NCT03657576|594639435|FG005|Overall Study|Death|0|||
164622697|NCT03657576|594639430|FG000|Overall Study|Withdrawal by Subject|0|||
164622698|NCT03657576|594639431|FG001|Overall Study|Withdrawal by Subject|0|||
164525874|NCT02354508|594296718|FG000|Period 2: Extension Phase|Physician Decision|5|||
164525875|NCT02354508|594296719|FG001|Period 2: Extension Phase|Physician Decision|0|||
164525876|NCT02354508|594296720|FG002|Period 2: Extension Phase|Physician Decision|1|||
164525877|NCT02354508|594296718|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
164525878|NCT02354508|594296719|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
164525879|NCT02354508|594296720|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
164525880|NCT02354508|594296718|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
164525881|NCT02354508|594296719|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
164525882|NCT02354508|594296720|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
164525883|NCT02354508|594296718|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
164525884|NCT02354508|594296719|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
164525885|NCT02354508|594296720|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
164525886|NCT04447846|594296721|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
164525887|NCT00461032|594296722|FG000|Overall Study|Adverse Event|5|||
164525888|NCT00461032|594296723|FG001|Overall Study|Adverse Event|6|||
164525889|NCT00461032|594296722|FG000|Overall Study|Lack of Efficacy|5|||
164525890|NCT00461032|594296723|FG001|Overall Study|Lack of Efficacy|1|||
164525891|NCT00461032|594296722|FG000|Overall Study|Lost to Follow-up|7|||
164525892|NCT00461032|594296723|FG001|Overall Study|Lost to Follow-up|12|||
164525893|NCT00461032|594296722|FG000|Overall Study|Protocol Violation|4|||
164525894|NCT00461032|594296723|FG001|Overall Study|Protocol Violation|4|||
164525895|NCT00461032|594296722|FG000|Overall Study|Withdrawal by Subject|7|||
164525896|NCT00461032|594296723|FG001|Overall Study|Withdrawal by Subject|15|||
164525897|NCT00461032|594296722|FG000|Overall Study|Patient Moved or Relocated|2|||
164525898|NCT00461032|594296723|FG001|Overall Study|Patient Moved or Relocated|1|||
164525899|NCT00461032|594296722|FG000|Overall Study|Other|7|||
164525900|NCT00461032|594296723|FG001|Overall Study|Other|5|||
164525901|NCT00297232|594296724|FG000|Overall Study|Lack of Efficacy|7|||
164525902|NCT00297232|594296724|FG000|Overall Study|Lost to Follow-up|10|||
164525903|NCT00297232|594296724|FG000|Overall Study|Adverse Event|63|||
164525904|NCT00297232|594296724|FG000|Overall Study|Voluntary Withdrawal|120|||
164525905|NCT00297232|594296724|FG000|Overall Study|Subject was Noncompliant|9|||
164525906|NCT00297232|594296724|FG000|Overall Study|Death|9|||
164525907|NCT00297232|594296724|FG000|Overall Study|Anti-natalizumab Positive|8|||
164525908|NCT00297232|594296724|FG000|Overall Study|Switched to Commercial Tysabri|22|||
164525909|NCT00297232|594296724|FG000|Overall Study|Disease Progression|8|||
164525910|NCT00297232|594296724|FG000|Overall Study|Fear of PML|10|||
164525911|NCT00297232|594296724|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
164525912|NCT00297232|594296724|FG000|Overall Study|Miscellaneous|5|||
164525913|NCT00297232|594296724|FG000|Overall Study|Sponsor Decision|34|||
164525914|NCT00297232|594296724|FG000|Overall Study|Subject Relocated|7|||
164525915|NCT00297232|594296724|FG000|Overall Study|Subject Withdrew Consent|37|||
164525916|NCT00297232|594296724|FG000|Overall Study|Persistently Positive Antibodies|11|||
164525917|NCT00297232|594296724|FG000|Overall Study|Investigator Withdrew From Program|19|||
164525918|NCT00297232|594296724|FG000|Overall Study|Did Not Enroll to Week 264|34|||
164525919|NCT00297232|594296724|FG000|Overall Study|Did Not Enroll to Week 480|17|||
164525920|NCT00297232|594296724|FG000|Overall Study|No data available after Week 264|161|||
164525921|NCT00297232|594296724|FG000|Overall Study|Other|1|||
164525922|NCT03038438|594296728|FG000|Overall Study|Death|3|||
164525923|NCT03038438|594296728|FG000|Overall Study|Lost to Follow-up|8|||
164525924|NCT03038438|594296728|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
164525925|NCT03038438|594296728|FG000|Overall Study|Withdrawal by Subject|5|||
164525926|NCT03038438|594296728|FG000|Overall Study|No 36-Month Follow-Up|18|||
164525927|NCT01174160|594296729|FG000|Overall Study|Adverse Event|1|||
164525928|NCT01174160|594296730|FG001|Overall Study|Adverse Event|0|||
164525929|NCT01174160|594296729|FG000|Overall Study|Lost to Follow-up|1|||
164525930|NCT01174160|594296730|FG001|Overall Study|Lost to Follow-up|0|||
164525931|NCT01174160|594296729|FG000|Overall Study|Physician Decision|1|||
164525932|NCT01174160|594296730|FG001|Overall Study|Physician Decision|0|||
164525933|NCT01174160|594296729|FG000|Overall Study|Protocol Violation|4|||
164525934|NCT01174160|594296730|FG001|Overall Study|Protocol Violation|6|||
164525935|NCT01174160|594296729|FG000|Overall Study|Withdrawal by Subject|1|||
164525936|NCT01174160|594296730|FG001|Overall Study|Withdrawal by Subject|0|||
164525937|NCT00093808|594296731|FG000|Overall Study|Cancel participation before receiving tx|1|||
164525938|NCT00093808|594296731|FG000|Overall Study|Protocol Violation|1|||
164525939|NCT05767021|594296732|FG000|Overall Study|Adverse Event|2|||
164525940|NCT05767021|594296732|FG000|Overall Study|Protocol Deviation|1|||
164525941|NCT05767021|594296732|FG000|Overall Study|Withdrawal by Subject|1|||
164525942|NCT05767021|594296732|FG000|Overall Study|Physician Decision|1|||
164525943|NCT05767021|594296732|FG000|Overall Study|Lack of Efficacy|11|||
164622699|NCT03657576|594639432|FG002|Overall Study|Withdrawal by Subject|0|||
164622700|NCT03657576|594639433|FG003|Overall Study|Withdrawal by Subject|1|||
164525944|NCT05767021|594296732|FG000|Overall Study|Assigned Treatment by Mistake|1|||
164525945|NCT06377488|594296737|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
164525946|NCT06377488|594296737|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
164525947|NCT06377488|594296737|FG000|Overall Study|Protocol Violation|1|||
164525948|NCT06377488|594296737|FG000|Overall Study|Lost to Follow-up|1|||
164525949|NCT06377488|594296737|FG000|Overall Study|Incorrect Lens Dispensed|2|||
164525950|NCT02399254|594296740|FG000|Overall Study|Physician Decision|2|||
164525951|NCT04494256|594296745|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
164525952|NCT04494256|594296746|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
164525953|NCT04494256|594296747|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
164525954|NCT04494256|594296748|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
164525955|NCT04494256|594296749|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
164525956|NCT04494256|594296750|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
164525957|NCT04494256|594296751|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
164525958|NCT04494256|594296745|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
164525959|NCT04494256|594296746|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
164525960|NCT04494256|594296747|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
164525961|NCT04494256|594296748|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
164525962|NCT04494256|594296749|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
164525963|NCT04494256|594296750|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
164525964|NCT04494256|594296751|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
164525965|NCT04494256|594296745|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
164525966|NCT04494256|594296746|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
164525967|NCT04494256|594296747|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
164525968|NCT04494256|594296748|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
164525969|NCT04494256|594296749|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
164525970|NCT04494256|594296750|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
164525971|NCT04494256|594296751|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
164525972|NCT04494256|594296745|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
164525973|NCT04494256|594296746|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
164525974|NCT04494256|594296747|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
164525975|NCT04494256|594296748|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
164525976|NCT04494256|594296749|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
164525977|NCT04494256|594296750|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
164525978|NCT04494256|594296751|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
164525979|NCT04494256|594296745|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
164525980|NCT04494256|594296746|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
164525981|NCT04494256|594296747|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
164525982|NCT04494256|594296748|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
164525983|NCT04494256|594296749|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
164525984|NCT04494256|594296750|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
164525985|NCT04494256|594296751|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
164525986|NCT04494256|594296745|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
164525987|NCT04494256|594296746|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
164525988|NCT04494256|594296747|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
164525989|NCT04494256|594296748|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
164525990|NCT04494256|594296749|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
164525991|NCT04494256|594296750|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
164525992|NCT04494256|594296751|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
164525993|NCT04494256|594296745|FG000|Part 2: Open Label Period|Death|0|||
164525994|NCT04494256|594296746|FG001|Part 2: Open Label Period|Death|0|||
164525995|NCT04494256|594296747|FG002|Part 2: Open Label Period|Death|0|||
164525996|NCT04494256|594296748|FG003|Part 2: Open Label Period|Death|0|||
164525997|NCT04494256|594296749|FG004|Part 2: Open Label Period|Death|0|||
164525998|NCT04494256|594296750|FG005|Part 2: Open Label Period|Death|4|||
164525999|NCT04494256|594296751|FG006|Part 2: Open Label Period|Death|2|||
164526000|NCT04494256|594296745|FG000|Part 2: Open Label Period|Adverse Event|0|||
164526001|NCT04494256|594296746|FG001|Part 2: Open Label Period|Adverse Event|0|||
164526002|NCT04494256|594296747|FG002|Part 2: Open Label Period|Adverse Event|0|||
164526003|NCT04494256|594296748|FG003|Part 2: Open Label Period|Adverse Event|0|||
164526004|NCT04494256|594296749|FG004|Part 2: Open Label Period|Adverse Event|0|||
164526005|NCT04494256|594296750|FG005|Part 2: Open Label Period|Adverse Event|0|||
164622701|NCT03657576|594639434|FG004|Overall Study|Withdrawal by Subject|0|||
164622702|NCT03657576|594639435|FG005|Overall Study|Withdrawal by Subject|0|||
164622703|NCT03657576|594639430|FG000|Overall Study|Screen Fail|0|||
164622704|NCT03657576|594639431|FG001|Overall Study|Screen Fail|0|||
164622705|NCT03657576|594639432|FG002|Overall Study|Screen Fail|0|||
164622706|NCT03657576|594639433|FG003|Overall Study|Screen Fail|0|||
164622707|NCT03657576|594639434|FG004|Overall Study|Screen Fail|0|||
164622708|NCT03657576|594639435|FG005|Overall Study|Screen Fail|5|||
164622709|NCT03657576|594639430|FG000|Overall Study|Disease Progression|1|||
164622710|NCT03657576|594639431|FG001|Overall Study|Disease Progression|1|||
164622711|NCT03657576|594639432|FG002|Overall Study|Disease Progression|0|||
164622712|NCT03657576|594639433|FG003|Overall Study|Disease Progression|5|||
164622713|NCT03657576|594639434|FG004|Overall Study|Disease Progression|0|||
164622714|NCT03657576|594639435|FG005|Overall Study|Disease Progression|0|||
164622715|NCT03657576|594639430|FG000|Overall Study|Insurance Coverage|0|||
164622716|NCT03657576|594639431|FG001|Overall Study|Insurance Coverage|0|||
164622717|NCT03657576|594639432|FG002|Overall Study|Insurance Coverage|0|||
164622718|NCT03657576|594639433|FG003|Overall Study|Insurance Coverage|1|||
164622719|NCT03657576|594639434|FG004|Overall Study|Insurance Coverage|0|||
164622720|NCT03657576|594639435|FG005|Overall Study|Insurance Coverage|0|||
164622721|NCT04437511|594639436|FG000|Overall Study|Adverse Event|50|||
164622722|NCT04437511|594639437|FG001|Overall Study|Adverse Event|21|||
164622723|NCT04437511|594639436|FG000|Overall Study|Death|15|||
164622724|NCT04437511|594639437|FG001|Overall Study|Death|10|||
164622725|NCT04437511|594639436|FG000|Overall Study|Lost to Follow-up|11|||
164622726|NCT04437511|594639437|FG001|Overall Study|Lost to Follow-up|11|||
164622727|NCT04437511|594639436|FG000|Overall Study|Physician Decision|19|||
164622728|NCT04437511|594639437|FG001|Overall Study|Physician Decision|10|||
164622729|NCT04437511|594639436|FG000|Overall Study|Progressive Disease|4|||
164622730|NCT04437511|594639437|FG001|Overall Study|Progressive Disease|7|||
164622731|NCT04437511|594639436|FG000|Overall Study|Withdrawal by Subject|111|||
164622732|NCT04437511|594639437|FG001|Overall Study|Withdrawal by Subject|94|||
164622733|NCT04437511|594639436|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
164622734|NCT04437511|594639437|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
164622735|NCT04437511|594639436|FG000|Overall Study|Continuing Study|7|||
164622736|NCT04437511|594639437|FG001|Overall Study|Continuing Study|5|||
164622737|NCT03093350|594639446|FG000|Overall Study|Death|1|||
164622738|NCT03093350|594639446|FG000|Overall Study|Signed consent, never began treartment|1|||
164622739|NCT00777036|594639450|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
164622740|NCT00777036|594639451|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
164622741|NCT00777036|594639452|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
164622742|NCT00777036|594639453|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
164622743|NCT00777036|594639450|FG000|On Treatment|Administrative Reason By Sponsor|1|||
164622744|NCT00777036|594639451|FG001|On Treatment|Administrative Reason By Sponsor|0|||
164622745|NCT00777036|594639452|FG002|On Treatment|Administrative Reason By Sponsor|9|||
164622746|NCT00777036|594639453|FG003|On Treatment|Administrative Reason By Sponsor|0|||
164622747|NCT00777036|594639450|FG000|On Treatment|Failure to Meet Study Criteria|0|||
164622748|NCT00777036|594639451|FG001|On Treatment|Failure to Meet Study Criteria|1|||
164622749|NCT00777036|594639452|FG002|On Treatment|Failure to Meet Study Criteria|4|||
164622750|NCT00777036|594639453|FG003|On Treatment|Failure to Meet Study Criteria|0|||
164622751|NCT00777036|594639450|FG000|On Treatment|Pregnancy|1|||
164622752|NCT00777036|594639451|FG001|On Treatment|Pregnancy|0|||
164622753|NCT00777036|594639452|FG002|On Treatment|Pregnancy|1|||
164622754|NCT00777036|594639453|FG003|On Treatment|Pregnancy|0|||
164622755|NCT00777036|594639450|FG000|On Treatment|Non-compliance with Study Drug|1|||
164622756|NCT00777036|594639451|FG001|On Treatment|Non-compliance with Study Drug|0|||
164622757|NCT00777036|594639452|FG002|On Treatment|Non-compliance with Study Drug|1|||
164622758|NCT00777036|594639453|FG003|On Treatment|Non-compliance with Study Drug|0|||
164622759|NCT00777036|594639450|FG000|On Treatment|Maximum Clinical Benefit|2|||
164622760|NCT00777036|594639451|FG001|On Treatment|Maximum Clinical Benefit|0|||
164622761|NCT00777036|594639452|FG002|On Treatment|Maximum Clinical Benefit|5|||
164622762|NCT00777036|594639453|FG003|On Treatment|Maximum Clinical Benefit|0|||
164622763|NCT00777036|594639450|FG000|On Treatment|Withdrawal by Subject|0|||
164622764|NCT00777036|594639451|FG001|On Treatment|Withdrawal by Subject|2|||
164622765|NCT00777036|594639452|FG002|On Treatment|Withdrawal by Subject|2|||
164622766|NCT00777036|594639453|FG003|On Treatment|Withdrawal by Subject|0|||
164622767|NCT00777036|594639450|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
164622768|NCT00777036|594639451|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
164622769|NCT00777036|594639452|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
164622770|NCT00777036|594639453|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
164622771|NCT00777036|594639450|FG000|On Treatment|Death|0|||
164622772|NCT00777036|594639451|FG001|On Treatment|Death|2|||
164622773|NCT00777036|594639452|FG002|On Treatment|Death|0|||
164622774|NCT00777036|594639453|FG003|On Treatment|Death|0|||
164622775|NCT00777036|594639450|FG000|On Treatment|Study Drug Toxicity|1|||
164622776|NCT00777036|594639451|FG001|On Treatment|Study Drug Toxicity|0|||
164622777|NCT00777036|594639452|FG002|On Treatment|Study Drug Toxicity|4|||
164622778|NCT00777036|594639453|FG003|On Treatment|Study Drug Toxicity|0|||
164622779|NCT00777036|594639450|FG000|On Treatment|Progressive Disease|6|||
164526006|NCT04494256|594296751|FG006|Part 2: Open Label Period|Adverse Event|2|||
164526007|NCT04494256|594296745|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
164526008|NCT04494256|594296746|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
164526009|NCT04494256|594296747|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
164526010|NCT04494256|594296748|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
164526011|NCT04494256|594296749|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
164526012|NCT04494256|594296750|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
164526013|NCT04494256|594296751|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
164526014|NCT04494256|594296745|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
164526015|NCT04494256|594296746|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
164526016|NCT04494256|594296747|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
164526017|NCT04494256|594296748|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
164526018|NCT04494256|594296749|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
164526019|NCT04494256|594296750|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
164526020|NCT04494256|594296751|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
164526021|NCT04494256|594296745|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
164526022|NCT04494256|594296746|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
164526023|NCT04494256|594296747|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
164622780|NCT00777036|594639451|FG001|On Treatment|Progressive Disease|4|||
164622781|NCT00777036|594639452|FG002|On Treatment|Progressive Disease|7|||
164622782|NCT00777036|594639453|FG003|On Treatment|Progressive Disease|0|||
164622783|NCT00777036|594639450|FG000|On Treatment|Not Reported|0|||
164622784|NCT00777036|594639451|FG001|On Treatment|Not Reported|0|||
164622785|NCT00777036|594639452|FG002|On Treatment|Not Reported|2|||
164622786|NCT00777036|594639453|FG003|On Treatment|Not Reported|0|||
164622787|NCT00777036|594639450|FG000|On Treatment|Site Closed|0|||
164622788|NCT00777036|594639451|FG001|On Treatment|Site Closed|1|||
164622789|NCT00777036|594639452|FG002|On Treatment|Site Closed|1|||
164622790|NCT00777036|594639453|FG003|On Treatment|Site Closed|0|||
164622791|NCT00777036|594639450|FG000|Follow-Up|Withdrawal by Subject|0|||
164622792|NCT00777036|594639451|FG001|Follow-Up|Withdrawal by Subject|0|||
164622793|NCT00777036|594639452|FG002|Follow-Up|Withdrawal by Subject|5|||
164622794|NCT00777036|594639453|FG003|Follow-Up|Withdrawal by Subject|0|||
164622795|NCT00777036|594639450|FG000|Follow-Up|Death|1|||
164622796|NCT00777036|594639451|FG001|Follow-Up|Death|9|||
164622797|NCT00777036|594639452|FG002|Follow-Up|Death|0|||
164622798|NCT00777036|594639453|FG003|Follow-Up|Death|0|||
164622799|NCT00777036|594639450|FG000|Follow-Up|Lost to Follow-up|3|||
164622800|NCT00777036|594639451|FG001|Follow-Up|Lost to Follow-up|0|||
164622801|NCT00777036|594639452|FG002|Follow-Up|Lost to Follow-up|0|||
164622802|NCT00777036|594639453|FG003|Follow-Up|Lost to Follow-up|0|||
164622803|NCT00777036|594639450|FG000|Follow-Up|Reason Not Specified|4|||
164622804|NCT00777036|594639451|FG001|Follow-Up|Reason Not Specified|0|||
164622805|NCT00777036|594639452|FG002|Follow-Up|Reason Not Specified|13|||
164622806|NCT00777036|594639453|FG003|Follow-Up|Reason Not Specified|0|||
164622807|NCT00777036|594639450|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
164622808|NCT00777036|594639451|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
164622809|NCT00777036|594639452|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
164622810|NCT00777036|594639453|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
164622811|NCT05564039|594639454|FG000|Overall Study|Adverse Event|1|||
164622812|NCT05564039|594639455|FG001|Overall Study|Adverse Event|0|||
164622813|NCT05564039|594639454|FG000|Overall Study|Death|1|||
164622814|NCT05564039|594639455|FG001|Overall Study|Death|1|||
164622815|NCT05564039|594639454|FG000|Overall Study|Lost to Follow-up|3|||
164622816|NCT05564039|594639455|FG001|Overall Study|Lost to Follow-up|2|||
164622817|NCT05564039|594639454|FG000|Overall Study|Withdrawal by Subject|2|||
164622818|NCT05564039|594639455|FG001|Overall Study|Withdrawal by Subject|0|||
164622819|NCT05564039|594639454|FG000|Overall Study|Inadvertent enrollment|3|||
164622820|NCT05564039|594639455|FG001|Overall Study|Inadvertent enrollment|6|||
164622821|NCT01263470|594639456|FG000|Overall Study|Adverse Event|2|||
164622822|NCT01263470|594639457|FG001|Overall Study|Adverse Event|2|||
164622823|NCT01263470|594639458|FG002|Overall Study|Adverse Event|1|||
164526024|NCT04494256|594296748|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
164526025|NCT04494256|594296749|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
164526026|NCT04494256|594296750|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
164526027|NCT04494256|594296751|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
164526028|NCT04494256|594296745|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
164526029|NCT04494256|594296746|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
164526030|NCT04494256|594296747|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
164526031|NCT04494256|594296748|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
164526032|NCT04494256|594296749|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
164526033|NCT04494256|594296750|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
164526034|NCT04494256|594296751|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
164526035|NCT04494256|594296745|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
164526036|NCT04494256|594296746|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
164526037|NCT04494256|594296747|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
164526038|NCT04494256|594296748|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
164526039|NCT04494256|594296749|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
164526040|NCT04494256|594296750|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
164526041|NCT04494256|594296751|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
164526042|NCT00262951|594296752|FG000|Overall Study|Progressive disease/relapse|3|||
164526043|NCT00262951|594296752|FG000|Overall Study|Adverse Event|7|||
164526044|NCT00262951|594296752|FG000|Overall Study|Death|1|||
164526045|NCT00262951|594296752|FG000|Overall Study|Withdrawal by Subject|1|||
164526046|NCT00262951|594296752|FG000|Overall Study|Alternative treatment|3|||
164526047|NCT00262951|594296752|FG000|Overall Study|Off treatment for other disease|1|||
164526048|NCT00825916|594296755|FG000|Overall Study|Lost to Follow-up|4|||
164526049|NCT00825916|594296756|FG001|Overall Study|Lost to Follow-up|2|||
164526050|NCT00825916|594296757|FG002|Overall Study|Lost to Follow-up|1|||
164526051|NCT02344004|594296758|FG000|Overall Study|Adverse Event|11|||
164526052|NCT02344004|594296759|FG001|Overall Study|Adverse Event|1|||
164526053|NCT02344004|594296758|FG000|Overall Study|Death|9|||
164526054|NCT02344004|594296759|FG001|Overall Study|Death|7|||
164526055|NCT02344004|594296758|FG000|Overall Study|Physician Decision|4|||
164526056|NCT02344004|594296759|FG001|Overall Study|Physician Decision|1|||
164526057|NCT02344004|594296758|FG000|Overall Study|Withdrawal by Subject|22|||
164526058|NCT02344004|594296759|FG001|Overall Study|Withdrawal by Subject|5|||
164526059|NCT02344004|594296758|FG000|Overall Study|Rescue Medication|2|||
164526060|NCT02344004|594296759|FG001|Overall Study|Rescue Medication|0|||
164526061|NCT02344004|594296758|FG000|Overall Study|Other Not Specified|12|||
164526062|NCT02344004|594296759|FG001|Overall Study|Other Not Specified|0|||
164526063|NCT02344004|594296758|FG000|Overall Study|Protocol Violation|1|||
164526064|NCT02344004|594296759|FG001|Overall Study|Protocol Violation|0|||
164526065|NCT01768117|594296760|FG000|Overall Study|Lost to Follow-up|1|||
164526066|NCT01768117|594296760|FG000|Overall Study|Withdrawal by Subject|2|||
164526067|NCT01768117|594296760|FG000|Overall Study|Protocol Violation|3|||
164526068|NCT02084056|594296761|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
164526069|NCT02084056|594296762|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
164526070|NCT02084056|594296763|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
164526071|NCT02084056|594296764|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
164526072|NCT02084056|594296761|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
164526073|NCT02084056|594296762|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
164526074|NCT02084056|594296763|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
164526075|NCT02084056|594296764|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
164526076|NCT01488487|594296765|FG000|Overall Study|Adverse Event|6|||
164526077|NCT01488487|594296765|FG000|Overall Study|Death|1|||
164526078|NCT01488487|594296765|FG000|Overall Study|Withdrawal by Subject|2|||
164526079|NCT00395460|594296766|FG000|Overall Study|Withdrawal by Subject|1|||
164526080|NCT00395460|594296767|FG001|Overall Study|Withdrawal by Subject|0|||
164526081|NCT01605019|594296772|FG000|Overall Study|pt did not meet transplant endpoint|3|||
164526082|NCT01605019|594296773|FG001|Overall Study|pt did not meet transplant endpoint|0|||
164526083|NCT00324116|594296777|FG000|Overall Study|Adverse Event|5|||
164526084|NCT00324116|594296777|FG000|Overall Study|Lack of Efficacy|17|||
164526085|NCT00324116|594296777|FG000|Overall Study|Withdrawal by Subject|5|||
164526086|NCT00324116|594296777|FG000|Overall Study|Other|5|||
164526087|NCT01451827|594296778|FG000|Overall Study|Adverse Event|2|||
164526088|NCT01451827|594296779|FG001|Overall Study|Adverse Event|0|||
164526089|NCT01451827|594296780|FG002|Overall Study|Adverse Event|1|||
164526090|NCT01451827|594296781|FG003|Overall Study|Adverse Event|1|||
164526091|NCT01451827|594296778|FG000|Overall Study|Protocol deviation|1|||
164526092|NCT01451827|594296779|FG001|Overall Study|Protocol deviation|0|||
164526093|NCT01451827|594296780|FG002|Overall Study|Protocol deviation|0|||
164526094|NCT01451827|594296781|FG003|Overall Study|Protocol deviation|0|||
164526095|NCT01451827|594296778|FG000|Overall Study|Lost to Follow-up|0|||
164526096|NCT01451827|594296779|FG001|Overall Study|Lost to Follow-up|3|||
164622824|NCT01263470|594639459|FG003|Overall Study|Adverse Event|1|||
164622825|NCT01263470|594639460|FG004|Overall Study|Adverse Event|2|||
164622826|NCT01263470|594639461|FG005|Overall Study|Adverse Event|2|||
164622827|NCT01263470|594639456|FG000|Overall Study|Protocol Violation|0|||
164622828|NCT01263470|594639457|FG001|Overall Study|Protocol Violation|1|||
164622829|NCT01263470|594639458|FG002|Overall Study|Protocol Violation|0|||
164622830|NCT01263470|594639459|FG003|Overall Study|Protocol Violation|0|||
164622831|NCT01263470|594639460|FG004|Overall Study|Protocol Violation|0|||
164622832|NCT01263470|594639461|FG005|Overall Study|Protocol Violation|1|||
164622833|NCT01263470|594639456|FG000|Overall Study|Withdrawal by Subject|0|||
164622834|NCT01263470|594639457|FG001|Overall Study|Withdrawal by Subject|1|||
164622835|NCT01263470|594639458|FG002|Overall Study|Withdrawal by Subject|1|||
164622836|NCT01263470|594639459|FG003|Overall Study|Withdrawal by Subject|2|||
164622837|NCT01263470|594639460|FG004|Overall Study|Withdrawal by Subject|0|||
164622838|NCT01263470|594639461|FG005|Overall Study|Withdrawal by Subject|2|||
164622839|NCT01263470|594639456|FG000|Overall Study|Lack of Efficacy|0|||
164622840|NCT01263470|594639457|FG001|Overall Study|Lack of Efficacy|0|||
164622841|NCT01263470|594639458|FG002|Overall Study|Lack of Efficacy|2|||
164622842|NCT01263470|594639459|FG003|Overall Study|Lack of Efficacy|0|||
164622843|NCT01263470|594639460|FG004|Overall Study|Lack of Efficacy|0|||
164622844|NCT01263470|594639461|FG005|Overall Study|Lack of Efficacy|0|||
164622845|NCT01263470|594639456|FG000|Overall Study|Participant Unavailability|0|||
164622846|NCT01263470|594639457|FG001|Overall Study|Participant Unavailability|1|||
164622847|NCT01263470|594639458|FG002|Overall Study|Participant Unavailability|0|||
164622848|NCT01263470|594639459|FG003|Overall Study|Participant Unavailability|0|||
164622849|NCT01263470|594639460|FG004|Overall Study|Participant Unavailability|0|||
164622850|NCT01263470|594639461|FG005|Overall Study|Participant Unavailability|0|||
164622851|NCT01263470|594639456|FG000|Overall Study|Study Drug Non-compliance|0|||
164622852|NCT01263470|594639457|FG001|Overall Study|Study Drug Non-compliance|0|||
164622853|NCT01263470|594639458|FG002|Overall Study|Study Drug Non-compliance|0|||
164622854|NCT01263470|594639459|FG003|Overall Study|Study Drug Non-compliance|0|||
164622855|NCT01263470|594639460|FG004|Overall Study|Study Drug Non-compliance|1|||
164622856|NCT01263470|594639461|FG005|Overall Study|Study Drug Non-compliance|0|||
164622857|NCT01327573|594639462|FG000|Overall Study|Physician Decision|3|||
164622858|NCT01327573|594639463|FG001|Overall Study|Physician Decision|1|||
164622859|NCT00729560|594639464|FG000|Overall Study|Withdrawal by Subject|3|||
164622860|NCT03662789|594639465|FG000|Overall Study|Lost to Follow-up|1|||
164622861|NCT03662789|594639466|FG001|Overall Study|Lost to Follow-up|2|||
164622862|NCT03662789|594639465|FG000|Overall Study|Could not perform treadmill test|4|||
164622863|NCT03662789|594639466|FG001|Overall Study|Could not perform treadmill test|4|||
164622864|NCT03662789|594639465|FG000|Overall Study|Death|0|||
164622865|NCT03662789|594639466|FG001|Overall Study|Death|1|||
164622866|NCT02136134|594639467|FG000|Overall Study|Death|170|||
164622867|NCT02136134|594639468|FG001|Overall Study|Death|148|||
164622868|NCT02136134|594639467|FG000|Overall Study|Withdrawal by Subject|19|||
164622869|NCT02136134|594639468|FG001|Overall Study|Withdrawal by Subject|10|||
164622870|NCT02136134|594639467|FG000|Overall Study|Lost to Follow-up|3|||
164622871|NCT02136134|594639468|FG001|Overall Study|Lost to Follow-up|3|||
164622872|NCT02136134|594639467|FG000|Overall Study|Uspecified|55|||
164622873|NCT02136134|594639468|FG001|Overall Study|Uspecified|90|||
164622874|NCT05245071|594639469|FG000|Overall Study|Progressive disease|18|||
164622875|NCT05245071|594639469|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
164622876|NCT05245071|594639469|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
164622877|NCT01602822|594639470|FG000|Overall Study|Adverse Event|11|||
164622878|NCT03685643|594639474|FG000|Overall Study|Lost to Follow-up|14|||
164622879|NCT03685643|594639475|FG001|Overall Study|Lost to Follow-up|22|||
164622880|NCT00423592|594639478|FG000|Overall Study|Adverse Event (through Week 12)|2|||
164622881|NCT00423592|594639478|FG000|Overall Study|Adverse Event (post Week 12)|5|||
164622882|NCT00062647|594639479|FG000|Overall Study|Death|2|||
164622883|NCT00062647|594639480|FG001|Overall Study|Death|2|||
164622884|NCT00062647|594639479|FG000|Overall Study|Adverse Event|1|||
164622885|NCT00062647|594639480|FG001|Overall Study|Adverse Event|1|||
164622886|NCT00062647|594639479|FG000|Overall Study|Withdrawal by Subject|2|||
164622887|NCT00062647|594639480|FG001|Overall Study|Withdrawal by Subject|1|||
164622888|NCT00062647|594639479|FG000|Overall Study|Protocol Violation|1|||
164622889|NCT00062647|594639480|FG001|Overall Study|Protocol Violation|0|||
164622890|NCT00062647|594639479|FG000|Overall Study|Lost to Follow-up|1|||
164622891|NCT00062647|594639480|FG001|Overall Study|Lost to Follow-up|2|||
164622892|NCT00062647|594639479|FG000|Overall Study|Failed continuation criteria|4|||
164622893|NCT00062647|594639480|FG001|Overall Study|Failed continuation criteria|2|||
164622894|NCT00062647|594639479|FG000|Overall Study|Other|4|||
164622895|NCT00062647|594639480|FG001|Overall Study|Other|4|||
164622896|NCT00062647|594639479|FG000|Overall Study|Never received study treatment|1|||
164622897|NCT00062647|594639480|FG001|Overall Study|Never received study treatment|1|||
164622898|NCT00002981|594639483|FG000|Overall Study|Inevaluable|6|||
164622899|NCT00255008|594639484|FG000|Overall Study|Adverse Event|1|||
164622900|NCT00255008|594639485|FG001|Overall Study|Adverse Event|1|||
164622901|NCT00255008|594639486|FG002|Overall Study|Adverse Event|2|||
164622902|NCT00255008|594639487|FG003|Overall Study|Adverse Event|0|||
164622903|NCT00255008|594639484|FG000|Overall Study|Lost to Follow-up|1|||
164622904|NCT00255008|594639485|FG001|Overall Study|Lost to Follow-up|0|||
164622905|NCT00255008|594639486|FG002|Overall Study|Lost to Follow-up|1|||
164622906|NCT00255008|594639487|FG003|Overall Study|Lost to Follow-up|2|||
164622907|NCT00255008|594639484|FG000|Overall Study|Did not meet viral reduction criteria|4|||
164622908|NCT00255008|594639485|FG001|Overall Study|Did not meet viral reduction criteria|5|||
164622909|NCT00255008|594639486|FG002|Overall Study|Did not meet viral reduction criteria|0|||
164622910|NCT00255008|594639487|FG003|Overall Study|Did not meet viral reduction criteria|1|||
164622911|NCT00255008|594639484|FG000|Overall Study|Withdrew consent|0|||
164622912|NCT00255008|594639485|FG001|Overall Study|Withdrew consent|0|||
164622913|NCT00255008|594639486|FG002|Overall Study|Withdrew consent|2|||
164622914|NCT00255008|594639487|FG003|Overall Study|Withdrew consent|0|||
164622915|NCT00255008|594639484|FG000|Overall Study|Sponsor request|18|||
164622916|NCT00255008|594639485|FG001|Overall Study|Sponsor request|3|||
164622917|NCT00255008|594639486|FG002|Overall Study|Sponsor request|8|||
164622918|NCT00255008|594639487|FG003|Overall Study|Sponsor request|17|||
164622919|NCT00255008|594639484|FG000|Overall Study|Adverse lab experience|1|||
164622920|NCT00255008|594639485|FG001|Overall Study|Adverse lab experience|0|||
164622921|NCT00255008|594639486|FG002|Overall Study|Adverse lab experience|0|||
164622922|NCT00255008|594639487|FG003|Overall Study|Adverse lab experience|0|||
164622923|NCT00255008|594639484|FG000|Overall Study|Other|7|||
164622924|NCT00255008|594639485|FG001|Overall Study|Other|0|||
164622925|NCT00255008|594639486|FG002|Overall Study|Other|3|||
164622926|NCT00255008|594639487|FG003|Overall Study|Other|2|||
164622927|NCT02415595|594639497|FG000|Overall Study|Administrative reason by sponsor|39|||
164622928|NCT02415595|594639498|FG001|Overall Study|Administrative reason by sponsor|40|||
164622929|NCT02415595|594639499|FG002|Overall Study|Administrative reason by sponsor|41|||
164622930|NCT02415595|594639500|FG003|Overall Study|Administrative reason by sponsor|39|||
164622931|NCT02415595|594639497|FG000|Overall Study|Adverse Event|1|||
164622932|NCT02415595|594639498|FG001|Overall Study|Adverse Event|3|||
164622933|NCT02415595|594639499|FG002|Overall Study|Adverse Event|5|||
164622934|NCT02415595|594639500|FG003|Overall Study|Adverse Event|10|||
164622935|NCT02415595|594639497|FG000|Overall Study|Lack of Efficacy|4|||
164622936|NCT02415595|594639498|FG001|Overall Study|Lack of Efficacy|4|||
164622937|NCT02415595|594639499|FG002|Overall Study|Lack of Efficacy|0|||
164622938|NCT02415595|594639500|FG003|Overall Study|Lack of Efficacy|0|||
164622939|NCT02415595|594639497|FG000|Overall Study|Lost to Follow-up|1|||
164622940|NCT02415595|594639498|FG001|Overall Study|Lost to Follow-up|3|||
164622941|NCT02415595|594639499|FG002|Overall Study|Lost to Follow-up|1|||
164622942|NCT02415595|594639500|FG003|Overall Study|Lost to Follow-up|1|||
164622943|NCT02415595|594639497|FG000|Overall Study|Poor/Non-compliance|1|||
164622944|NCT02415595|594639498|FG001|Overall Study|Poor/Non-compliance|0|||
164622945|NCT02415595|594639499|FG002|Overall Study|Poor/Non-compliance|1|||
164622946|NCT02415595|594639500|FG003|Overall Study|Poor/Non-compliance|0|||
164622947|NCT02415595|594639497|FG000|Overall Study|Reached stopping criteria|0|||
164622948|NCT02415595|594639498|FG001|Overall Study|Reached stopping criteria|1|||
164622949|NCT02415595|594639499|FG002|Overall Study|Reached stopping criteria|1|||
164622950|NCT02415595|594639500|FG003|Overall Study|Reached stopping criteria|0|||
164622951|NCT02415595|594639497|FG000|Overall Study|Withdrawal by Subject|4|||
164622952|NCT02415595|594639498|FG001|Overall Study|Withdrawal by Subject|0|||
164622953|NCT02415595|594639499|FG002|Overall Study|Withdrawal by Subject|1|||
164622954|NCT02415595|594639500|FG003|Overall Study|Withdrawal by Subject|3|||
164622955|NCT02415595|594639497|FG000|Overall Study|Other|0|||
164622956|NCT02415595|594639498|FG001|Overall Study|Other|1|||
164622957|NCT02415595|594639499|FG002|Overall Study|Other|1|||
164622958|NCT02415595|594639500|FG003|Overall Study|Other|0|||
164622959|NCT01682759|594639508|FG000|Overall Study|Death|2|||
164622960|NCT01682759|594639509|FG001|Overall Study|Death|1|||
164622961|NCT01682759|594639508|FG000|Overall Study|Lost to Follow-up|10|||
164622962|NCT01682759|594639509|FG001|Overall Study|Lost to Follow-up|13|||
164622963|NCT01682759|594639508|FG000|Overall Study|Physician Decision|1|||
164622964|NCT01682759|594639509|FG001|Overall Study|Physician Decision|1|||
164622965|NCT01682759|594639508|FG000|Overall Study|Withdrawal by Subject|56|||
164622966|NCT01682759|594639509|FG001|Overall Study|Withdrawal by Subject|55|||
164622967|NCT01201967|594639510|FG000|Overall Study|Lost to Follow-up|6|||
164622968|NCT01201967|594639511|FG001|Overall Study|Lost to Follow-up|5|||
164622969|NCT02497287|594639512|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
164622970|NCT02497287|594639512|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
164622971|NCT02497287|594639512|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
164622972|NCT02497287|594639512|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
164622973|NCT02497287|594639512|FG000|Induction Phase (4 Weeks)|Other|13|||
164622974|NCT02497287|594639512|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
164622975|NCT02497287|594639512|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
164622976|NCT02497287|594639512|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
164622977|NCT02497287|594639512|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
164622978|NCT02497287|594639512|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
164622979|NCT02497287|594639512|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
164622980|NCT02497287|594639512|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
164622981|NCT02497287|594639512|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
164622982|NCT02497287|594639512|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
164622983|NCT02497287|594639512|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
164622984|NCT02497287|594639512|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
164622985|NCT02497287|594639512|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
164622986|NCT02497287|594639512|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
164622987|NCT02497287|594639512|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
164622988|NCT02497287|594639512|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
164622989|NCT02497287|594639512|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
164622990|NCT02497287|594639512|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
164622991|NCT02497287|594639512|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
164622992|NCT02497287|594639512|FG000|Follow-up Phase (4 Week)|Other|1|||
164622993|NCT01226472|594639514|FG000|Overall Study|Progressive Disease|1|||
164622994|NCT03128307|594639517|FG000|Overall Study|Lost to Follow-up|29|||
164622995|NCT03128307|594639517|FG000|Overall Study|Withdrawal by Subject|5|||
164622996|NCT01855919|594641206|FG000|Overall Study|Adverse Event|16|||
164622997|NCT01855919|594641207|FG001|Overall Study|Adverse Event|8|||
164622998|NCT01855919|594641206|FG000|Overall Study|Lack of Efficacy|1|||
164622999|NCT01855919|594641207|FG001|Overall Study|Lack of Efficacy|3|||
164623000|NCT01855919|594641206|FG000|Overall Study|Withdrawal by Subject|4|||
164623001|NCT01855919|594641207|FG001|Overall Study|Withdrawal by Subject|10|||
164623002|NCT01855919|594641206|FG000|Overall Study|Entry Criteria Not Met|1|||
164623003|NCT01855919|594641207|FG001|Overall Study|Entry Criteria Not Met|1|||
164623004|NCT01855919|594641206|FG000|Overall Study|Protocol Violation|1|||
164623005|NCT01855919|594641207|FG001|Overall Study|Protocol Violation|4|||
164623006|NCT03958149|594641211|FG000|Overall Study|Withdrawal by Subject|0|||
164623007|NCT03958149|594641212|FG001|Overall Study|Withdrawal by Subject|1|||
164623008|NCT00724243|594641214|FG000|Overall Study|Lack of Efficacy|10|||
164623009|NCT00724243|594641214|FG000|Overall Study|Adverse Event|5|||
164623010|NCT03793010|594641215|FG000|Overall Study|Withdrawal by Subject|5|||
164623011|NCT03793010|594641216|FG001|Overall Study|Withdrawal by Subject|7|||
164623012|NCT03793010|594641215|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
164623013|NCT03793010|594641216|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
164623014|NCT03793010|594641215|FG000|Overall Study|Lost to Follow-up|1|||
164623015|NCT03793010|594641216|FG001|Overall Study|Lost to Follow-up|2|||
164623016|NCT03793010|594641215|FG000|Overall Study|Patient couldn't sit still for injection|1|||
164623017|NCT03793010|594641216|FG001|Overall Study|Patient couldn't sit still for injection|0|||
164623018|NCT03793010|594641215|FG000|Overall Study|Withdrew to pursue other treatment|1|||
164623019|NCT03793010|594641216|FG001|Overall Study|Withdrew to pursue other treatment|0|||
164623020|NCT03793010|594641215|FG000|Overall Study|Did not meet eligibility criteria|1|||
164623021|NCT03793010|594641216|FG001|Overall Study|Did not meet eligibility criteria|0|||
164623022|NCT04097925|594641217|FG000|Overall Study|Withdrawal by Subject|1|||
164623023|NCT02059174|594641239|FG000|Period 1|Withdrawal by Subject|0|||
164623024|NCT02059174|594641240|FG001|Period 1|Withdrawal by Subject|2|||
164623025|NCT02059174|594641239|FG000|Period 2|Withdrawal by Subject|0|||
164623026|NCT02059174|594641240|FG001|Period 2|Withdrawal by Subject|2|||
164623027|NCT02059174|594641239|FG000|Period 2|Protocol Violation|1|||
164623028|NCT02059174|594641240|FG001|Period 2|Protocol Violation|0|||
164623029|NCT02059174|594641239|FG000|Period 3|Physician Decision|1|||
164623030|NCT02059174|594641240|FG001|Period 3|Physician Decision|0|||
164623031|NCT00768040|594641244|FG000|Overall Study|Adverse Event|3|||
164623032|NCT00768040|594641245|FG001|Overall Study|Adverse Event|2|||
164623033|NCT00768040|594641244|FG000|Overall Study|Abnormal laboratory value|1|||
164623034|NCT00768040|594641245|FG001|Overall Study|Abnormal laboratory value|1|||
164623035|NCT00290355|594641254|FG000|Overall Study|Serious adverse event|7|||
164623036|NCT00290355|594641255|FG001|Overall Study|Serious adverse event|4|||
164623037|NCT00290355|594641254|FG000|Overall Study|Study product reactogenicity|1|||
164623038|NCT00290355|594641255|FG001|Overall Study|Study product reactogenicity|0|||
164623039|NCT00290355|594641254|FG000|Overall Study|Protocol Violation|1|||
164623040|NCT00290355|594641255|FG001|Overall Study|Protocol Violation|0|||
164623041|NCT00290355|594641254|FG000|Overall Study|Withdrawal by Subject|2|||
164623042|NCT00290355|594641255|FG001|Overall Study|Withdrawal by Subject|0|||
164623043|NCT00290355|594641254|FG000|Overall Study|Migrated / moved from the study area|1|||
164623044|NCT00290355|594641255|FG001|Overall Study|Migrated / moved from the study area|0|||
164623045|NCT00290355|594641254|FG000|Overall Study|Lost to Follow-up|3|||
164623046|NCT00290355|594641255|FG001|Overall Study|Lost to Follow-up|1|||
164623047|NCT00290355|594641254|FG000|Overall Study|Other|2|||
164623048|NCT00290355|594641255|FG001|Overall Study|Other|0|||
164623049|NCT03345849|594641256|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
164623050|NCT03345849|594641257|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
164623051|NCT03345849|594641258|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
164623052|NCT03345849|594641259|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
164623053|NCT03345849|594641256|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
164623054|NCT03345849|594641257|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
164623055|NCT03345849|594641258|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
164623056|NCT03345849|594641259|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
164623057|NCT03345849|594641256|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
164623058|NCT03345849|594641257|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
164623059|NCT03345849|594641258|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
164623060|NCT03345849|594641259|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
164623061|NCT03345849|594641256|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
164623062|NCT03345849|594641257|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
164623063|NCT03345849|594641258|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
164623064|NCT03345849|594641259|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
164623065|NCT03345849|594641256|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
164623066|NCT03345849|594641257|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
164623067|NCT03345849|594641258|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
164623068|NCT03345849|594641259|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
164623069|NCT03345849|594641256|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
164623070|NCT03345849|594641257|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
164623071|NCT03345849|594641258|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
164623072|NCT03345849|594641259|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
164623073|NCT03345849|594641256|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
164623074|NCT03345849|594641257|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
164623075|NCT03345849|594641258|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
164623076|NCT03345849|594641259|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
164623077|NCT03345849|594641256|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
164623078|NCT03345849|594641257|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
164623079|NCT03345849|594641258|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
164623080|NCT03345849|594641259|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
164623081|NCT03345849|594641256|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
164623082|NCT03345849|594641257|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
164623083|NCT03345849|594641258|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
164623084|NCT03345849|594641259|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
164623085|NCT03345849|594641256|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
164623086|NCT03345849|594641257|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
164623087|NCT03345849|594641258|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
164623088|NCT03345849|594641259|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
164623089|NCT03345849|594641256|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
164623090|NCT03345849|594641257|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
164623091|NCT03345849|594641258|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
164623092|NCT03345849|594641259|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
164623093|NCT02274311|594641260|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
164623094|NCT01685372|594641265|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
164623095|NCT01685372|594641266|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
164623096|NCT03233308|594641267|FG000|Overall Study|Adverse Event|1|||
164623097|NCT03233308|594641267|FG000|Overall Study|Protocol Violation|1|||
164623098|NCT01626859|594641268|FG000|Overall Study|Adverse Event|1|||
164623099|NCT01626859|594641269|FG001|Overall Study|Adverse Event|3|||
164623100|NCT01626859|594641270|FG002|Overall Study|Adverse Event|2|||
164623101|NCT01626859|594641268|FG000|Overall Study|Physician Decision|0|||
164623102|NCT01626859|594641269|FG001|Overall Study|Physician Decision|1|||
164623103|NCT01626859|594641270|FG002|Overall Study|Physician Decision|0|||
164623104|NCT01626859|594641268|FG000|Overall Study|Withdrawal by Subject|1|||
164623105|NCT01626859|594641269|FG001|Overall Study|Withdrawal by Subject|4|||
164623106|NCT01626859|594641270|FG002|Overall Study|Withdrawal by Subject|2|||
164623107|NCT00638989|594641276|FG000|Overall Study|Lost to Follow-up|0|||
164623108|NCT00638989|594641277|FG001|Overall Study|Lost to Follow-up|0|||
164623109|NCT00638989|594641278|FG002|Overall Study|Lost to Follow-up|1|||
164623110|NCT00853112|594641291|FG000|Overall Study|Randomized but not treated|0|||
164623111|NCT00853112|594641292|FG001|Overall Study|Randomized but not treated|1|||
164623112|NCT00853112|594641293|FG002|Overall Study|Randomized but not treated|0|||
164623113|NCT00853112|594641294|FG003|Overall Study|Randomized but not treated|2|||
164623114|NCT00853112|594641295|FG004|Overall Study|Randomized but not treated|0|||
164623115|NCT00853112|594641296|FG005|Overall Study|Randomized but not treated|0|||
164623116|NCT00853112|594641297|FG006|Overall Study|Randomized but not treated|1|||
164623117|NCT01553591|594641298|FG000|Overall Study|Voluntarily withdrew|94|||
164623118|NCT01553591|594641299|FG001|Overall Study|Voluntarily withdrew|79|||
164623119|NCT01553591|594641300|FG002|Overall Study|Voluntarily withdrew|96|||
164623120|NCT01553591|594641298|FG000|Overall Study|Adverse Event|36|||
164623121|NCT01553591|594641299|FG001|Overall Study|Adverse Event|45|||
164623122|NCT01553591|594641300|FG002|Overall Study|Adverse Event|16|||
164623123|NCT01553591|594641298|FG000|Overall Study|Lost to Follow-up|25|||
164623124|NCT01553591|594641299|FG001|Overall Study|Lost to Follow-up|23|||
164623125|NCT01553591|594641300|FG002|Overall Study|Lost to Follow-up|16|||
164623126|NCT01553591|594641298|FG000|Overall Study|Physician decision: other|11|||
164623127|NCT01553591|594641299|FG001|Overall Study|Physician decision: other|14|||
164623128|NCT01553591|594641300|FG002|Overall Study|Physician decision: other|16|||
164623129|NCT01553591|594641298|FG000|Overall Study|Physician decision: lack of efficacy|2|||
164623130|NCT01553591|594641299|FG001|Overall Study|Physician decision: lack of efficacy|3|||
164623131|NCT01553591|594641300|FG002|Overall Study|Physician decision: lack of efficacy|7|||
164623132|NCT01553591|594641298|FG000|Overall Study|Protocol Violation|3|||
164623133|NCT01553591|594641299|FG001|Overall Study|Protocol Violation|4|||
164623134|NCT01553591|594641300|FG002|Overall Study|Protocol Violation|4|||
164623135|NCT01553591|594641298|FG000|Overall Study|Sponsor decision|1|||
164623136|NCT01553591|594641299|FG001|Overall Study|Sponsor decision|0|||
164623137|NCT01553591|594641300|FG002|Overall Study|Sponsor decision|3|||
164623138|NCT01553591|594641298|FG000|Overall Study|Randomized and never dispensed drug|0|||
164623139|NCT01553591|594641299|FG001|Overall Study|Randomized and never dispensed drug|1|||
164623140|NCT01553591|594641300|FG002|Overall Study|Randomized and never dispensed drug|0|||
164623141|NCT02477800|594641301|FG000|Placebo-Controlled Period|Adverse Event|16|||
164623142|NCT02477800|594641302|FG001|Placebo-Controlled Period|Adverse Event|25|||
164623143|NCT02477800|594641303|FG002|Placebo-Controlled Period|Adverse Event|28|||
164623144|NCT02477800|594641304|FG003|Placebo-Controlled Period|Adverse Event|0|||
164623145|NCT02477800|594641305|FG004|Placebo-Controlled Period|Adverse Event|0|||
164623146|NCT02477800|594641306|FG005|Placebo-Controlled Period|Adverse Event|0|||
164623147|NCT02477800|594641307|FG006|Placebo-Controlled Period|Adverse Event|0|||
164623148|NCT02477800|594641301|FG000|Placebo-Controlled Period|Change of Treatment|1|||
164623149|NCT02477800|594641302|FG001|Placebo-Controlled Period|Change of Treatment|2|||
164623150|NCT02477800|594641303|FG002|Placebo-Controlled Period|Change of Treatment|1|||
164623151|NCT02477800|594641304|FG003|Placebo-Controlled Period|Change of Treatment|0|||
164623152|NCT02477800|594641305|FG004|Placebo-Controlled Period|Change of Treatment|0|||
164623153|NCT02477800|594641306|FG005|Placebo-Controlled Period|Change of Treatment|0|||
164623154|NCT02477800|594641307|FG006|Placebo-Controlled Period|Change of Treatment|0|||
164623155|NCT02477800|594641301|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
164623156|NCT02477800|594641302|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
164623157|NCT02477800|594641303|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
164623158|NCT02477800|594641304|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
164623159|NCT02477800|594641305|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
164623160|NCT02477800|594641306|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
164623161|NCT02477800|594641307|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
164623162|NCT02477800|594641301|FG000|Placebo-Controlled Period|Death|0|||
164623163|NCT02477800|594641302|FG001|Placebo-Controlled Period|Death|3|||
164623164|NCT02477800|594641303|FG002|Placebo-Controlled Period|Death|2|||
164623165|NCT02477800|594641304|FG003|Placebo-Controlled Period|Death|0|||
164623166|NCT02477800|594641305|FG004|Placebo-Controlled Period|Death|0|||
164623167|NCT02477800|594641306|FG005|Placebo-Controlled Period|Death|0|||
164623168|NCT02477800|594641307|FG006|Placebo-Controlled Period|Death|0|||
164623169|NCT02477800|594641301|FG000|Placebo-Controlled Period|Disease Progression|1|||
164623170|NCT02477800|594641302|FG001|Placebo-Controlled Period|Disease Progression|0|||
164623171|NCT02477800|594641303|FG002|Placebo-Controlled Period|Disease Progression|1|||
164623172|NCT02477800|594641304|FG003|Placebo-Controlled Period|Disease Progression|0|||
164623173|NCT02477800|594641305|FG004|Placebo-Controlled Period|Disease Progression|0|||
164623174|NCT02477800|594641306|FG005|Placebo-Controlled Period|Disease Progression|0|||
164623175|NCT02477800|594641307|FG006|Placebo-Controlled Period|Disease Progression|0|||
164526097|NCT01451827|594296780|FG002|Overall Study|Lost to Follow-up|0|||
164526098|NCT01451827|594296781|FG003|Overall Study|Lost to Follow-up|2|||
164526099|NCT01451827|594296778|FG000|Overall Study|Participant met withdrawal criteria|0|||
164526100|NCT01451827|594296779|FG001|Overall Study|Participant met withdrawal criteria|2|||
164526101|NCT01451827|594296780|FG002|Overall Study|Participant met withdrawal criteria|0|||
164526102|NCT01451827|594296781|FG003|Overall Study|Participant met withdrawal criteria|0|||
164526103|NCT01451827|594296778|FG000|Overall Study|Withdrawal by Subject|0|||
164526104|NCT01451827|594296779|FG001|Overall Study|Withdrawal by Subject|0|||
164526105|NCT01451827|594296780|FG002|Overall Study|Withdrawal by Subject|1|||
164526106|NCT01451827|594296781|FG003|Overall Study|Withdrawal by Subject|1|||
164526107|NCT01964924|594296782|FG000|Trametinib Monotherapy|Progression|19|||
164526108|NCT01964924|594296783|FG001|Trametinib Monotherapy|Progression|0|||
164526109|NCT00577577|594296784|FG000|Overall Study|Adverse Event|3|||
164526110|NCT00577577|594296785|FG001|Overall Study|Adverse Event|2|||
164526111|NCT00577577|594296784|FG000|Overall Study|Lost to Follow-up|1|||
164526112|NCT00577577|594296785|FG001|Overall Study|Lost to Follow-up|0|||
164526113|NCT00577577|594296784|FG000|Overall Study|Protocol Violation|0|||
164526114|NCT00577577|594296785|FG001|Overall Study|Protocol Violation|3|||
164526115|NCT00577577|594296784|FG000|Overall Study|Transportation|1|||
164526116|NCT00577577|594296785|FG001|Overall Study|Transportation|0|||
164526117|NCT01528345|594296786|FG000|Overall Study|Adverse Event|10|||
164526118|NCT01528345|594296787|FG001|Overall Study|Adverse Event|1|||
164526119|NCT01528345|594296786|FG000|Overall Study|Death|1|||
164526120|NCT01528345|594296787|FG001|Overall Study|Death|1|||
164526121|NCT01528345|594296786|FG000|Overall Study|Non-compliance with study treatment|1|||
164526122|NCT01528345|594296787|FG001|Overall Study|Non-compliance with study treatment|0|||
164526123|NCT01528345|594296786|FG000|Overall Study|Progressive Disease|26|||
164526124|NCT01528345|594296787|FG001|Overall Study|Progressive Disease|40|||
164526125|NCT01528345|594296786|FG000|Overall Study|Study Terminated by Sponsor|4|||
164526126|NCT01528345|594296787|FG001|Overall Study|Study Terminated by Sponsor|8|||
164526127|NCT01528345|594296786|FG000|Overall Study|Subject/Guardian Decision|5|||
164526128|NCT01528345|594296787|FG001|Overall Study|Subject/Guardian Decision|0|||
164526129|NCT00528645|594296788|FG000|Overall Study|Adverse Event|3|||
164526130|NCT01090427|594296789|FG000|After Controlled Period|Death|0|||
164526131|NCT01090427|594296790|FG001|After Controlled Period|Death|0|||
164526132|NCT01090427|594296791|FG002|After Controlled Period|Death|0|||
164526133|NCT01090427|594296792|FG003|After Controlled Period|Death|0|||
164526134|NCT01090427|594296793|FG004|After Controlled Period|Death|0|||
164526135|NCT01090427|594296794|FG005|After Controlled Period|Death|1|||
164526136|NCT01090427|594296795|FG006|After Controlled Period|Death|0|||
164526137|NCT01090427|594296789|FG000|After Controlled Period|Lack of Efficacy|0|||
164526138|NCT01090427|594296790|FG001|After Controlled Period|Lack of Efficacy|0|||
164526139|NCT01090427|594296791|FG002|After Controlled Period|Lack of Efficacy|0|||
164526140|NCT01090427|594296792|FG003|After Controlled Period|Lack of Efficacy|0|||
164526141|NCT01090427|594296793|FG004|After Controlled Period|Lack of Efficacy|0|||
164526142|NCT01090427|594296794|FG005|After Controlled Period|Lack of Efficacy|3|||
164526143|NCT01090427|594296795|FG006|After Controlled Period|Lack of Efficacy|2|||
164526144|NCT01090427|594296789|FG000|After Controlled Period|Adverse Event|0|||
164526145|NCT01090427|594296790|FG001|After Controlled Period|Adverse Event|0|||
164526146|NCT01090427|594296791|FG002|After Controlled Period|Adverse Event|0|||
164526147|NCT01090427|594296792|FG003|After Controlled Period|Adverse Event|2|||
164526148|NCT01090427|594296793|FG004|After Controlled Period|Adverse Event|0|||
164526149|NCT01090427|594296794|FG005|After Controlled Period|Adverse Event|1|||
164526150|NCT01090427|594296795|FG006|After Controlled Period|Adverse Event|0|||
164526151|NCT01154010|594296796|FG000|Overall Study|Lost to Follow-up|0|||
164526152|NCT01154010|594296797|FG001|Overall Study|Lost to Follow-up|1|||
164526153|NCT01465347|594296803|FG000|Overall Study|Withdrawal by Subject|1|||
164526154|NCT01465347|594296804|FG001|Overall Study|Withdrawal by Subject|1|||
164526155|NCT01465347|594296803|FG000|Overall Study|Physician Decision|0|||
164526156|NCT01465347|594296804|FG001|Overall Study|Physician Decision|1|||
164526157|NCT01465347|594296803|FG000|Overall Study|Admitted to hospice|0|||
164526158|NCT01465347|594296804|FG001|Overall Study|Admitted to hospice|1|||
164526159|NCT02413333|594296805|FG000|Period 1|Adverse Event|1|||
164526160|NCT02413333|594296806|FG001|Period 1|Adverse Event|0|||
164526161|NCT02413333|594296805|FG000|Period 1|Reason Not Specified|0|||
164526162|NCT02413333|594296806|FG001|Period 1|Reason Not Specified|1|||
164526163|NCT02413333|594296805|FG000|Period 2|Protocol Deviation|1|||
164526164|NCT02413333|594296806|FG001|Period 2|Protocol Deviation|0|||
164526165|NCT00906945|594296807|FG000|Overall Study|Found to be not eligible|0|||
164526166|NCT00906945|594296808|FG001|Overall Study|Found to be not eligible|0|||
164526167|NCT00906945|594296809|FG002|Overall Study|Found to be not eligible|0|||
164526168|NCT00906945|594296810|FG003|Overall Study|Found to be not eligible|1|||
164526169|NCT00906945|594296811|FG004|Overall Study|Found to be not eligible|1|||
164526170|NCT00906945|594296812|FG005|Overall Study|Found to be not eligible|1|||
164526171|NCT00906945|594296807|FG000|Overall Study|Physician Decision|0|||
164526172|NCT00906945|594296808|FG001|Overall Study|Physician Decision|0|||
164526173|NCT00906945|594296809|FG002|Overall Study|Physician Decision|0|||
164623176|NCT02477800|594641301|FG000|Placebo-Controlled Period|Investigator Decision|3|||
164623177|NCT02477800|594641302|FG001|Placebo-Controlled Period|Investigator Decision|2|||
164623178|NCT02477800|594641303|FG002|Placebo-Controlled Period|Investigator Decision|1|||
164623179|NCT02477800|594641304|FG003|Placebo-Controlled Period|Investigator Decision|0|||
164623180|NCT02477800|594641305|FG004|Placebo-Controlled Period|Investigator Decision|0|||
164623181|NCT02477800|594641306|FG005|Placebo-Controlled Period|Investigator Decision|0|||
164623182|NCT02477800|594641307|FG006|Placebo-Controlled Period|Investigator Decision|0|||
164623183|NCT02477800|594641301|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
164526174|NCT00906945|594296810|FG003|Overall Study|Physician Decision|0|||
164526175|NCT00906945|594296811|FG004|Overall Study|Physician Decision|0|||
164526176|NCT00906945|594296812|FG005|Overall Study|Physician Decision|1|||
164526177|NCT02996474|594296813|FG000|Overall Study|Physician Decision|5|||
164526178|NCT01210664|594296815|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
164526179|NCT01210664|594296816|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
164526180|NCT01210664|594296817|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
164526181|NCT01210664|594296818|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
164526182|NCT01210664|594296815|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
164526183|NCT01210664|594296816|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
164526184|NCT01210664|594296817|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
164526185|NCT01210664|594296818|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
164526186|NCT01210664|594296815|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
164526187|NCT01210664|594296816|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
164526188|NCT01210664|594296817|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
164526189|NCT01210664|594296818|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
164526190|NCT01853644|594296819|FG000|Registration and Treatment Start|Did not start treatment|1|||
164526191|NCT01853644|594296819|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
164526192|NCT01853644|594296819|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
164526193|NCT01853644|594296819|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
164526194|NCT01853644|594296819|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
164526195|NCT01853644|594296819|FG000|Continued Treatment After First Response|Adverse Event|2|||
164526196|NCT01853644|594296819|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
164526197|NCT02891837|594296820|FG000|Overall Study|Lost to Follow-up|2|||
164526198|NCT02891837|594296821|FG001|Overall Study|Lost to Follow-up|0|||
164526199|NCT02891837|594296820|FG000|Overall Study|Withdrawal by Subject|1|||
164526200|NCT02891837|594296821|FG001|Overall Study|Withdrawal by Subject|0|||
164526201|NCT05924945|594296823|FG000|Overall Study|Withdrawal by Subject|3|||
164526202|NCT05924945|594296824|FG001|Overall Study|Withdrawal by Subject|4|||
164526203|NCT03406078|594296826|FG000|Overall Study|Death|1|||
164526204|NCT03406078|594296827|FG001|Overall Study|Death|0|||
164526205|NCT03406078|594296826|FG000|Overall Study|Lost to Follow-up|0|||
164526206|NCT03406078|594296827|FG001|Overall Study|Lost to Follow-up|1|||
164526207|NCT03406078|594296826|FG000|Overall Study|Withdrawal by Subject|5|||
164526208|NCT03406078|594296827|FG001|Overall Study|Withdrawal by Subject|2|||
164526209|NCT03538301|594296830|FG000|Overall Study|Adverse Event|1|||
164526210|NCT03538301|594296831|FG001|Overall Study|Adverse Event|4|||
164526211|NCT03538301|594296832|FG002|Overall Study|Adverse Event|4|||
164526212|NCT03538301|594296830|FG000|Overall Study|Death|1|||
164526213|NCT03538301|594296831|FG001|Overall Study|Death|1|||
164526214|NCT03538301|594296832|FG002|Overall Study|Death|0|||
164526215|NCT03538301|594296830|FG000|Overall Study|Physician Decision|0|||
164526216|NCT03538301|594296831|FG001|Overall Study|Physician Decision|1|||
164526217|NCT03538301|594296832|FG002|Overall Study|Physician Decision|0|||
164526218|NCT03538301|594296830|FG000|Overall Study|Protocol Violation|0|||
164526219|NCT03538301|594296831|FG001|Overall Study|Protocol Violation|0|||
164526220|NCT03538301|594296832|FG002|Overall Study|Protocol Violation|1|||
164526221|NCT03538301|594296830|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
164526222|NCT03538301|594296831|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
164526223|NCT03538301|594296832|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
164526224|NCT03616977|594296833|FG000|Period 1|Physician Decision|0|||
164526225|NCT03616977|594296834|FG001|Period 1|Physician Decision|1|||
164526226|NCT03616977|594296833|FG000|Period 3|Adverse Event|1|||
164526227|NCT03616977|594296834|FG001|Period 3|Adverse Event|1|||
164526228|NCT00591851|594296835|FG000|Overall Study|Withdrawal by Subject|3|||
164526229|NCT00591851|594296835|FG000|Overall Study|Adverse Event|2|||
164526230|NCT00591851|594296835|FG000|Overall Study|Progressive Disease|1|||
164526231|NCT00515853|594296836|FG000|Overall Study|Lost to Follow-up|9|||
164526232|NCT00515853|594296837|FG001|Overall Study|Lost to Follow-up|13|||
164526233|NCT00515853|594296836|FG000|Overall Study|Withdrawal by Subject|6|||
164526234|NCT00515853|594296837|FG001|Overall Study|Withdrawal by Subject|4|||
164526235|NCT00928018|594296842|FG000|Overall Study|Withdrawal by Subject|1|||
164526236|NCT00928018|594296843|FG001|Overall Study|Withdrawal by Subject|0|||
164526237|NCT00943111|594296844|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
164623184|NCT02477800|594641302|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
164623185|NCT02477800|594641303|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
164623186|NCT02477800|594641304|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
164623187|NCT02477800|594641305|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
164623188|NCT02477800|594641306|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
164623189|NCT02477800|594641307|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
164623190|NCT02477800|594641301|FG000|Placebo-Controlled Period|Relocation|2|||
164623191|NCT02477800|594641302|FG001|Placebo-Controlled Period|Relocation|0|||
164623192|NCT02477800|594641303|FG002|Placebo-Controlled Period|Relocation|0|||
164623193|NCT02477800|594641304|FG003|Placebo-Controlled Period|Relocation|0|||
164623194|NCT02477800|594641305|FG004|Placebo-Controlled Period|Relocation|0|||
164623195|NCT02477800|594641306|FG005|Placebo-Controlled Period|Relocation|0|||
164623196|NCT02477800|594641307|FG006|Placebo-Controlled Period|Relocation|0|||
164623197|NCT02477800|594641301|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
164623198|NCT02477800|594641302|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
164623199|NCT02477800|594641303|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
164623200|NCT02477800|594641304|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
164623201|NCT02477800|594641305|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
164623202|NCT02477800|594641306|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
164623203|NCT02477800|594641307|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
164623204|NCT02477800|594641301|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
164623205|NCT02477800|594641302|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
164623206|NCT02477800|594641303|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
164623207|NCT02477800|594641304|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
164623208|NCT02477800|594641305|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
164623209|NCT02477800|594641306|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
164623210|NCT02477800|594641307|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
164623211|NCT02477800|594641301|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
164623212|NCT02477800|594641302|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
164623213|NCT02477800|594641303|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
164623214|NCT02477800|594641304|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
164623215|NCT02477800|594641305|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
164623216|NCT02477800|594641306|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
164623217|NCT02477800|594641307|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
164623218|NCT02477800|594641301|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
164623219|NCT02477800|594641302|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
164623220|NCT02477800|594641303|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
164623221|NCT02477800|594641304|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
164623222|NCT02477800|594641305|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
164623223|NCT02477800|594641306|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
164623224|NCT02477800|594641307|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
164623225|NCT02477800|594641301|FG000|Placebo-Controlled Period|Reason not Specified|161|||
164623226|NCT02477800|594641302|FG001|Placebo-Controlled Period|Reason not Specified|161|||
164623227|NCT02477800|594641303|FG002|Placebo-Controlled Period|Reason not Specified|189|||
164623228|NCT02477800|594641304|FG003|Placebo-Controlled Period|Reason not Specified|0|||
164623229|NCT02477800|594641305|FG004|Placebo-Controlled Period|Reason not Specified|0|||
164623230|NCT02477800|594641306|FG005|Placebo-Controlled Period|Reason not Specified|0|||
164623231|NCT02477800|594641307|FG006|Placebo-Controlled Period|Reason not Specified|0|||
164623232|NCT02477800|594641301|FG000|Long Term Extension Period|Adverse Event|0|||
164623233|NCT02477800|594641302|FG001|Long Term Extension Period|Adverse Event|0|||
164623234|NCT02477800|594641303|FG002|Long Term Extension Period|Adverse Event|0|||
164623235|NCT02477800|594641304|FG003|Long Term Extension Period|Adverse Event|6|||
164623236|NCT02477800|594641305|FG004|Long Term Extension Period|Adverse Event|2|||
164623237|NCT02477800|594641306|FG005|Long Term Extension Period|Adverse Event|4|||
164623238|NCT02477800|594641307|FG006|Long Term Extension Period|Adverse Event|3|||
164623239|NCT02477800|594641301|FG000|Long Term Extension Period|Death|0|||
164623240|NCT02477800|594641302|FG001|Long Term Extension Period|Death|0|||
164623241|NCT02477800|594641303|FG002|Long Term Extension Period|Death|0|||
164623242|NCT02477800|594641304|FG003|Long Term Extension Period|Death|1|||
164623243|NCT02477800|594641305|FG004|Long Term Extension Period|Death|1|||
164623244|NCT02477800|594641306|FG005|Long Term Extension Period|Death|1|||
164623245|NCT02477800|594641307|FG006|Long Term Extension Period|Death|2|||
164623246|NCT02477800|594641301|FG000|Long Term Extension Period|Consent Withdrawn|0|||
164623247|NCT02477800|594641302|FG001|Long Term Extension Period|Consent Withdrawn|0|||
164623248|NCT02477800|594641303|FG002|Long Term Extension Period|Consent Withdrawn|0|||
164623249|NCT02477800|594641304|FG003|Long Term Extension Period|Consent Withdrawn|10|||
164623250|NCT02477800|594641305|FG004|Long Term Extension Period|Consent Withdrawn|4|||
164623251|NCT02477800|594641306|FG005|Long Term Extension Period|Consent Withdrawn|13|||
164623252|NCT02477800|594641307|FG006|Long Term Extension Period|Consent Withdrawn|16|||
164623253|NCT02477800|594641301|FG000|Long Term Extension Period|Disease Progression|0|||
164623254|NCT02477800|594641302|FG001|Long Term Extension Period|Disease Progression|0|||
164623255|NCT02477800|594641303|FG002|Long Term Extension Period|Disease Progression|0|||
164623256|NCT02477800|594641304|FG003|Long Term Extension Period|Disease Progression|3|||
164623257|NCT02477800|594641305|FG004|Long Term Extension Period|Disease Progression|1|||
164623258|NCT02477800|594641306|FG005|Long Term Extension Period|Disease Progression|1|||
164623259|NCT02477800|594641307|FG006|Long Term Extension Period|Disease Progression|0|||
164623260|NCT02477800|594641301|FG000|Long Term Extension Period|Investigator Decision|0|||
164623261|NCT02477800|594641302|FG001|Long Term Extension Period|Investigator Decision|0|||
164623262|NCT02477800|594641303|FG002|Long Term Extension Period|Investigator Decision|0|||
164623263|NCT02477800|594641304|FG003|Long Term Extension Period|Investigator Decision|0|||
164623264|NCT02477800|594641305|FG004|Long Term Extension Period|Investigator Decision|0|||
164623265|NCT02477800|594641306|FG005|Long Term Extension Period|Investigator Decision|0|||
164623266|NCT02477800|594641307|FG006|Long Term Extension Period|Investigator Decision|2|||
164623267|NCT02477800|594641301|FG000|Long Term Extension Period|Lost to Follow-up|0|||
164623268|NCT02477800|594641302|FG001|Long Term Extension Period|Lost to Follow-up|0|||
164623269|NCT02477800|594641303|FG002|Long Term Extension Period|Lost to Follow-up|0|||
164623270|NCT02477800|594641304|FG003|Long Term Extension Period|Lost to Follow-up|0|||
164623271|NCT02477800|594641305|FG004|Long Term Extension Period|Lost to Follow-up|1|||
164623272|NCT02477800|594641306|FG005|Long Term Extension Period|Lost to Follow-up|3|||
164623273|NCT02477800|594641307|FG006|Long Term Extension Period|Lost to Follow-up|0|||
164623274|NCT02477800|594641301|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
164623275|NCT02477800|594641302|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
164623276|NCT02477800|594641303|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
164623277|NCT02477800|594641304|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
164623278|NCT02477800|594641305|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
164623279|NCT02477800|594641306|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
164623280|NCT02477800|594641307|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
164623281|NCT02477800|594641301|FG000|Long Term Extension Period|Study Visit Burden|0|||
164623282|NCT02477800|594641302|FG001|Long Term Extension Period|Study Visit Burden|0|||
164623283|NCT02477800|594641303|FG002|Long Term Extension Period|Study Visit Burden|0|||
164623284|NCT02477800|594641304|FG003|Long Term Extension Period|Study Visit Burden|3|||
164623285|NCT02477800|594641305|FG004|Long Term Extension Period|Study Visit Burden|0|||
164623286|NCT02477800|594641306|FG005|Long Term Extension Period|Study Visit Burden|2|||
164623287|NCT02477800|594641307|FG006|Long Term Extension Period|Study Visit Burden|2|||
164623288|NCT02477800|594641301|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
164623289|NCT02477800|594641302|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
164623290|NCT02477800|594641303|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
164623291|NCT02477800|594641304|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
164623292|NCT02477800|594641305|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
164623293|NCT02477800|594641306|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
164623294|NCT02477800|594641307|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
164623295|NCT02477800|594641301|FG000|Long Term Extension Period|Reason not Specified|0|||
164623296|NCT02477800|594641302|FG001|Long Term Extension Period|Reason not Specified|0|||
164623297|NCT02477800|594641303|FG002|Long Term Extension Period|Reason not Specified|0|||
164623298|NCT02477800|594641304|FG003|Long Term Extension Period|Reason not Specified|126|||
164623299|NCT02477800|594641305|FG004|Long Term Extension Period|Reason not Specified|140|||
164623300|NCT02477800|594641306|FG005|Long Term Extension Period|Reason not Specified|270|||
164623301|NCT02477800|594641307|FG006|Long Term Extension Period|Reason not Specified|224|||
164623302|NCT01969565|594641312|FG000|Overall Study|Withdrawal by Subject|1|||
164623303|NCT00832091|594641313|FG000|Overall Study|Adverse Event|1|||
164623304|NCT00832091|594641314|FG001|Overall Study|Adverse Event|1|||
164623305|NCT00832091|594641313|FG000|Overall Study|Protocol Violation|1|||
164623306|NCT00832091|594641314|FG001|Overall Study|Protocol Violation|0|||
164623307|NCT00832091|594641313|FG000|Overall Study|Withdrawal by Subject|2|||
164623308|NCT00832091|594641314|FG001|Overall Study|Withdrawal by Subject|1|||
164623309|NCT00832091|594641313|FG000|Overall Study|Prohibited Medication|1|||
164623310|NCT00832091|594641314|FG001|Overall Study|Prohibited Medication|0|||
164623311|NCT01955005|594641316|FG000|Overall Study|Withdrawal by Subject|3|||
164623312|NCT01955005|594641317|FG001|Overall Study|Withdrawal by Subject|5|||
164623313|NCT00322387|594641319|FG000|Treatment Period|Adverse Event|0|||
164623314|NCT00322387|594641320|FG001|Treatment Period|Adverse Event|1|||
164623315|NCT00322387|594641319|FG000|Follow-up Period|Final assessment not done|1|||
164623316|NCT00322387|594641320|FG001|Follow-up Period|Final assessment not done|3|||
164623317|NCT00322387|594641319|FG000|Follow-up Period|Death|1|||
164623318|NCT00322387|594641320|FG001|Follow-up Period|Death|0|||
164623319|NCT01828567|594641321|FG000|Overall Study|Lost to Follow-up|27|||
164623320|NCT01828567|594641322|FG001|Overall Study|Lost to Follow-up|9|||
164623321|NCT01828567|594641321|FG000|Overall Study|Excluded - did not meet criteria|4|||
164623322|NCT01828567|594641322|FG001|Overall Study|Excluded - did not meet criteria|1|||
164623323|NCT00707486|594641323|FG000|Overall Study|Withdrawal by Subject|1|||
164623324|NCT03325010|594641338|FG000|Overall Study|Adverse Event|3|||
164623325|NCT03325010|594641339|FG001|Overall Study|Adverse Event|8|||
164623326|NCT03325010|594641338|FG000|Overall Study|Protocol Violation|1|||
164623327|NCT03325010|594641339|FG001|Overall Study|Protocol Violation|8|||
164623328|NCT03325010|594641338|FG000|Overall Study|Withdrawal by Subject|1|||
164623329|NCT03325010|594641339|FG001|Overall Study|Withdrawal by Subject|3|||
164623330|NCT03325010|594641338|FG000|Overall Study|Lost to Follow-up|1|||
164623331|NCT03325010|594641339|FG001|Overall Study|Lost to Follow-up|0|||
164623332|NCT03325010|594641338|FG000|Overall Study|Physician Decision|1|||
164623333|NCT03325010|594641339|FG001|Overall Study|Physician Decision|1|||
164623334|NCT03325010|594641338|FG000|Overall Study|Lack of Efficacy|2|||
164623335|NCT03325010|594641339|FG001|Overall Study|Lack of Efficacy|0|||
164623336|NCT02614261|594641340|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
164623337|NCT02614261|594641341|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
164623338|NCT02614261|594641342|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
164623339|NCT02614261|594641343|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
164623340|NCT02614261|594641340|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
164623341|NCT02614261|594641341|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
164623342|NCT02614261|594641342|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
164623343|NCT02614261|594641343|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
164623344|NCT02614261|594641340|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
164623345|NCT02614261|594641341|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
164623346|NCT02614261|594641342|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
164623347|NCT02614261|594641343|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164623348|NCT02614261|594641340|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
164623349|NCT02614261|594641341|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
164623350|NCT02614261|594641342|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
164623351|NCT02614261|594641343|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
164623352|NCT02614261|594641340|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
164623353|NCT02614261|594641341|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
164623354|NCT02614261|594641342|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
164623355|NCT02614261|594641343|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
164623356|NCT02614261|594641340|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
164623357|NCT02614261|594641341|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
164623358|NCT02614261|594641342|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
164623359|NCT02614261|594641343|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
164623360|NCT02614261|594641340|FG000|Double-Blind Treatment Phase|Screen failure|0|||
164623361|NCT02614261|594641341|FG001|Double-Blind Treatment Phase|Screen failure|1|||
164623362|NCT02614261|594641342|FG002|Double-Blind Treatment Phase|Screen failure|2|||
164623363|NCT02614261|594641343|FG003|Double-Blind Treatment Phase|Screen failure|0|||
164526238|NCT00943111|594296845|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
164526239|NCT00943111|594296846|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
164526240|NCT00943111|594296844|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
164526241|NCT00943111|594296845|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
164526242|NCT00943111|594296846|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
164526243|NCT00943111|594296844|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
164526244|NCT00943111|594296845|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
164526245|NCT00943111|594296846|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
164526246|NCT00943111|594296844|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
164526247|NCT00943111|594296845|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
164526248|NCT00943111|594296846|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
164526249|NCT00943111|594296844|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
164526250|NCT00943111|594296845|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
164526251|NCT00943111|594296846|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
164526252|NCT00943111|594296844|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
164623364|NCT02614261|594641340|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
164623365|NCT02614261|594641341|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
164623366|NCT02614261|594641342|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
164623367|NCT02614261|594641343|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
164623368|NCT02614261|594641340|FG000|Open-Label Extension Phase|Adverse Event|23|||
164623369|NCT02614261|594641341|FG001|Open-Label Extension Phase|Adverse Event|12|||
164623370|NCT02614261|594641342|FG002|Open-Label Extension Phase|Adverse Event|11|||
164623371|NCT02614261|594641343|FG003|Open-Label Extension Phase|Adverse Event|0|||
164623372|NCT02614261|594641340|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
164623373|NCT02614261|594641341|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
164623374|NCT02614261|594641342|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
164623375|NCT02614261|594641343|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
164623376|NCT02614261|594641340|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
164623377|NCT02614261|594641341|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
164623378|NCT02614261|594641342|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
164623379|NCT02614261|594641343|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
164623380|NCT02614261|594641340|FG000|Open-Label Extension Phase|Physician Decision|2|||
164623381|NCT02614261|594641341|FG001|Open-Label Extension Phase|Physician Decision|0|||
164623382|NCT02614261|594641342|FG002|Open-Label Extension Phase|Physician Decision|0|||
164623383|NCT02614261|594641343|FG003|Open-Label Extension Phase|Physician Decision|0|||
164623384|NCT02614261|594641340|FG000|Open-Label Extension Phase|Pregnancy|1|||
164623385|NCT02614261|594641341|FG001|Open-Label Extension Phase|Pregnancy|2|||
164623386|NCT02614261|594641342|FG002|Open-Label Extension Phase|Pregnancy|1|||
164623387|NCT02614261|594641343|FG003|Open-Label Extension Phase|Pregnancy|0|||
164623388|NCT02614261|594641340|FG000|Open-Label Extension Phase|Protocol Violation|3|||
164623389|NCT02614261|594641341|FG001|Open-Label Extension Phase|Protocol Violation|4|||
164623390|NCT02614261|594641342|FG002|Open-Label Extension Phase|Protocol Violation|1|||
164623391|NCT02614261|594641343|FG003|Open-Label Extension Phase|Protocol Violation|0|||
164623392|NCT02614261|594641340|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
164623393|NCT02614261|594641341|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
164623394|NCT02614261|594641342|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
164623395|NCT02614261|594641343|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
164623396|NCT02614261|594641340|FG000|Follow-up Phase|Adverse Event|2|||
164623397|NCT02614261|594641341|FG001|Follow-up Phase|Adverse Event|0|||
164623398|NCT02614261|594641342|FG002|Follow-up Phase|Adverse Event|1|||
164623399|NCT02614261|594641343|FG003|Follow-up Phase|Adverse Event|0|||
164623400|NCT02614261|594641340|FG000|Follow-up Phase|Lost to Follow-up|12|||
164623401|NCT02614261|594641341|FG001|Follow-up Phase|Lost to Follow-up|5|||
164623402|NCT02614261|594641342|FG002|Follow-up Phase|Lost to Follow-up|2|||
164623403|NCT02614261|594641343|FG003|Follow-up Phase|Lost to Follow-up|0|||
164623404|NCT02614261|594641340|FG000|Follow-up Phase|Physician Decision|5|||
164623405|NCT02614261|594641341|FG001|Follow-up Phase|Physician Decision|1|||
164623406|NCT02614261|594641342|FG002|Follow-up Phase|Physician Decision|0|||
164623407|NCT02614261|594641343|FG003|Follow-up Phase|Physician Decision|0|||
164623408|NCT02614261|594641340|FG000|Follow-up Phase|Pregnancy|0|||
164623409|NCT02614261|594641341|FG001|Follow-up Phase|Pregnancy|1|||
164623410|NCT02614261|594641342|FG002|Follow-up Phase|Pregnancy|0|||
164623411|NCT02614261|594641343|FG003|Follow-up Phase|Pregnancy|0|||
164623412|NCT02614261|594641340|FG000|Follow-up Phase|Protocol Violation|1|||
164623413|NCT02614261|594641341|FG001|Follow-up Phase|Protocol Violation|0|||
164623414|NCT02614261|594641342|FG002|Follow-up Phase|Protocol Violation|0|||
164623415|NCT02614261|594641343|FG003|Follow-up Phase|Protocol Violation|0|||
164623416|NCT02614261|594641340|FG000|Follow-up Phase|Withdrawal by Subject|12|||
164623417|NCT02614261|594641341|FG001|Follow-up Phase|Withdrawal by Subject|4|||
164623418|NCT02614261|594641342|FG002|Follow-up Phase|Withdrawal by Subject|11|||
164623419|NCT02614261|594641343|FG003|Follow-up Phase|Withdrawal by Subject|0|||
164623420|NCT02614261|594641340|FG000|Israel Addendum|Withdrawal by Subject|0|||
164623421|NCT02614261|594641341|FG001|Israel Addendum|Withdrawal by Subject|0|||
164623422|NCT02614261|594641342|FG002|Israel Addendum|Withdrawal by Subject|0|||
164623423|NCT02614261|594641343|FG003|Israel Addendum|Withdrawal by Subject|4|||
164623424|NCT03512275|594641345|FG000|Overall Study|Withdrawal by Subject|1|||
164623425|NCT03512275|594641346|FG001|Overall Study|Withdrawal by Subject|3|||
164623426|NCT03512275|594641345|FG000|Overall Study|Physician Decision|0|||
164623427|NCT03512275|594641346|FG001|Overall Study|Physician Decision|1|||
164623428|NCT03512275|594641345|FG000|Overall Study|Lost to Follow-up|0|||
164623429|NCT03512275|594641346|FG001|Overall Study|Lost to Follow-up|3|||
164623430|NCT03512275|594641345|FG000|Overall Study|Other|1|||
164623431|NCT03512275|594641346|FG001|Overall Study|Other|0|||
164623432|NCT00113555|594641347|FG000|Overall Study|Baseline Failure|59|||
164623433|NCT00113555|594641347|FG000|Overall Study|Permanently Explanted|7|||
164623434|NCT00113555|594641347|FG000|Overall Study|Death|1|||
164623435|NCT00113555|594641347|FG000|Overall Study|Missed Followup|4|||
164623436|NCT00113555|594641347|FG000|Overall Study|Lost to Follow-up|8|||
164623437|NCT04474366|594641348|FG000|Overall Study|Lost to Follow-up|2|||
164623438|NCT04474366|594641349|FG001|Overall Study|Lost to Follow-up|5|||
164623439|NCT04063865|594641350|FG000|Overall Study|Physician Decision|1|||
164623440|NCT04063865|594641351|FG001|Overall Study|Physician Decision|3|||
164623441|NCT04063865|594641350|FG000|Overall Study|Study Closed Prior to Completion|4|||
164623442|NCT04063865|594641351|FG001|Overall Study|Study Closed Prior to Completion|4|||
164623443|NCT04063865|594641350|FG000|Overall Study|Withdrawal by Subject|1|||
164623444|NCT04063865|594641351|FG001|Overall Study|Withdrawal by Subject|1|||
164623445|NCT00320190|594641352|FG000|First 12 Months|Completed but did not enter extension|5|||
164623446|NCT00320190|594641353|FG001|First 12 Months|Completed but did not enter extension|3|||
164623447|NCT00320190|594641352|FG000|First 12 Months|Sponsor terminated study|2|||
164623448|NCT00320190|594641353|FG001|First 12 Months|Sponsor terminated study|2|||
164623449|NCT00320190|594641352|FG000|First 12 Months|Lost to Follow-up|0|||
164623450|NCT00320190|594641353|FG001|First 12 Months|Lost to Follow-up|1|||
164623451|NCT00320190|594641352|FG000|First 12 Months|Enrollment failure|0|||
164623452|NCT00320190|594641353|FG001|First 12 Months|Enrollment failure|1|||
164623453|NCT00320190|594641352|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
164623454|NCT00320190|594641353|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
164623455|NCT00320190|594641352|FG000|First 12 Months|Investigator request|0|||
164623456|NCT00320190|594641353|FG001|First 12 Months|Investigator request|1|||
164623457|NCT00320190|594641352|FG000|First 12 Months|Study drug toxicity|0|||
164623458|NCT00320190|594641353|FG001|First 12 Months|Study drug toxicity|1|||
164623459|NCT00320190|594641352|FG000|First 12 Months|Withdrawal by Subject|0|||
164623460|NCT00320190|594641353|FG001|First 12 Months|Withdrawal by Subject|1|||
164623461|NCT00320190|594641352|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
164623462|NCT00320190|594641353|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
164623463|NCT00320190|594641352|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
164623464|NCT00320190|594641353|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
164623465|NCT00320190|594641352|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
164623466|NCT00320190|594641353|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
164623467|NCT01700140|594641354|FG000|Overall Study|Use of rescue drugs|3|||
164623468|NCT01700140|594641355|FG001|Overall Study|Use of rescue drugs|3|||
164623469|NCT01700140|594641356|FG002|Overall Study|Use of rescue drugs|1|||
164623470|NCT01700140|594641354|FG000|Overall Study|Discontinuation of radiotherapy|1|||
164623471|NCT01700140|594641355|FG001|Overall Study|Discontinuation of radiotherapy|0|||
164623472|NCT01700140|594641356|FG002|Overall Study|Discontinuation of radiotherapy|0|||
164623473|NCT01700140|594641354|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
164623474|NCT01700140|594641355|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
164623475|NCT01700140|594641356|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
164623476|NCT01700140|594641354|FG000|Overall Study|Aggravation of symptoms|1|||
164623477|NCT01700140|594641355|FG001|Overall Study|Aggravation of symptoms|0|||
164623478|NCT01700140|594641356|FG002|Overall Study|Aggravation of symptoms|0|||
164623479|NCT01700140|594641354|FG000|Overall Study|Adverse Event|0|||
164623480|NCT01700140|594641355|FG001|Overall Study|Adverse Event|1|||
164623481|NCT01700140|594641356|FG002|Overall Study|Adverse Event|0|||
164623482|NCT01700140|594641354|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
164623483|NCT01700140|594641355|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
164623484|NCT01700140|594641356|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
164623485|NCT01060124|594641357|FG000|Overall Study|Other|16|||
164623486|NCT01060124|594641357|FG000|Overall Study|Adverse Event|14|||
164623487|NCT01060124|594641357|FG000|Overall Study|Withdrawal by Subject|7|||
164623488|NCT00102804|594641360|FG000|Overall Study|Progressive Disease (PD)|307|||
164623489|NCT00102804|594641361|FG001|Overall Study|Progressive Disease (PD)|196|||
164623490|NCT00102804|594641360|FG000|Overall Study|Withdrawal by Subject|46|||
164623491|NCT00102804|594641361|FG001|Overall Study|Withdrawal by Subject|7|||
164623492|NCT00102804|594641360|FG000|Overall Study|Adverse Event|37|||
164623493|NCT00102804|594641361|FG001|Overall Study|Adverse Event|3|||
164623494|NCT00102804|594641360|FG000|Overall Study|Physician Decision|24|||
164623495|NCT00102804|594641361|FG001|Overall Study|Physician Decision|6|||
164623496|NCT00102804|594641360|FG000|Overall Study|Death|5|||
164623497|NCT00102804|594641361|FG001|Overall Study|Death|6|||
164623498|NCT00102804|594641360|FG000|Overall Study|Enrollment Criteria Not Met|6|||
164623499|NCT00102804|594641361|FG001|Overall Study|Enrollment Criteria Not Met|0|||
164623500|NCT00102804|594641360|FG000|Overall Study|Lost to Follow-up|4|||
164623501|NCT00102804|594641361|FG001|Overall Study|Lost to Follow-up|1|||
164623502|NCT00102804|594641360|FG000|Overall Study|Protocol Violation|2|||
164623503|NCT00102804|594641361|FG001|Overall Study|Protocol Violation|1|||
164623504|NCT00102804|594641360|FG000|Overall Study|Satisfactory Response|2|||
164623505|NCT00102804|594641361|FG001|Overall Study|Satisfactory Response|0|||
164623506|NCT00102804|594641360|FG000|Overall Study|Sponsor Decision|1|||
164623507|NCT00102804|594641361|FG001|Overall Study|Sponsor Decision|0|||
164623508|NCT00102804|594641360|FG000|Overall Study|Alive, Receiving Treatment|7|||
164623509|NCT00102804|594641361|FG001|Overall Study|Alive, Receiving Treatment|2|||
164623510|NCT02299206|594641368|FG000|Overall Study|Lost to Follow-up|1|||
164623511|NCT02299206|594641368|FG000|Overall Study|Withdrawal by Subject|1|||
164623512|NCT00691054|594641369|FG000|Overall Study|Withdrawal by Subject|1|||
164623513|NCT00518336|594641370|FG000|Year 7|Lost to Follow-up|2|||
164623514|NCT00518336|594641371|FG001|Year 7|Lost to Follow-up|0|||
164623515|NCT00518336|594641370|FG000|Year 7|Could not attend in time|0|||
164623516|NCT00518336|594641371|FG001|Year 7|Could not attend in time|3|||
164623517|NCT00518336|594641370|FG000|Year 8|Lost to Follow-up|1|||
164623518|NCT00518336|594641371|FG001|Year 8|Lost to Follow-up|1|||
164623519|NCT00518336|594641370|FG000|Year 8|Could not attend in time|0|||
164623520|NCT00518336|594641371|FG001|Year 8|Could not attend in time|1|||
164623521|NCT00518336|594641370|FG000|Year 9|Migrated/moved from study area|1|||
164623522|NCT00518336|594641371|FG001|Year 9|Migrated/moved from study area|1|||
164623523|NCT00518336|594641370|FG000|Year 9|Lost to Follow-up|3|||
164623524|NCT00518336|594641371|FG001|Year 9|Lost to Follow-up|0|||
164623525|NCT00518336|594641370|FG000|Year 9|Personal reasons|1|||
164623526|NCT00518336|594641371|FG001|Year 9|Personal reasons|0|||
164623527|NCT03074318|594641374|FG000|Overall Study|Adverse Event|0|||
164623528|NCT03074318|594641375|FG001|Overall Study|Adverse Event|1|||
164623529|NCT03074318|594641376|FG002|Overall Study|Adverse Event|1|||
164623530|NCT03074318|594641377|FG003|Overall Study|Adverse Event|1|||
164623531|NCT03074318|594641374|FG000|Overall Study|Death|1|||
164623532|NCT03074318|594641375|FG001|Overall Study|Death|0|||
164623533|NCT03074318|594641376|FG002|Overall Study|Death|0|||
164623534|NCT03074318|594641377|FG003|Overall Study|Death|0|||
164623535|NCT03074318|594641374|FG000|Overall Study|Withdrawal by Subject|1|||
164623536|NCT03074318|594641375|FG001|Overall Study|Withdrawal by Subject|2|||
164623537|NCT03074318|594641376|FG002|Overall Study|Withdrawal by Subject|2|||
164623538|NCT03074318|594641377|FG003|Overall Study|Withdrawal by Subject|4|||
164623539|NCT03074318|594641374|FG000|Overall Study|Trial Closure|2|||
164623540|NCT03074318|594641375|FG001|Overall Study|Trial Closure|2|||
164623541|NCT03074318|594641376|FG002|Overall Study|Trial Closure|3|||
164623542|NCT03074318|594641377|FG003|Overall Study|Trial Closure|11|||
164623543|NCT01625897|594642623|FG000|Overall Study|Adverse Event|27|||
164623544|NCT01625897|594642624|FG001|Overall Study|Adverse Event|10|||
164623545|NCT01625897|594642623|FG000|Overall Study|Physician Decision|0|||
164623546|NCT01625897|594642624|FG001|Overall Study|Physician Decision|1|||
164623547|NCT01625897|594642623|FG000|Overall Study|Withdrawal by Subject|25|||
164623548|NCT01625897|594642624|FG001|Overall Study|Withdrawal by Subject|3|||
164623549|NCT03455530|594642625|FG000|Overall Study|Withdrawal by Subject|9|||
164623550|NCT03455530|594642626|FG001|Overall Study|Withdrawal by Subject|1|||
164623551|NCT03455530|594642627|FG002|Overall Study|Withdrawal by Subject|3|||
164623552|NCT03455530|594642628|FG003|Overall Study|Withdrawal by Subject|3|||
164623553|NCT02314637|594642631|FG000|Overall Study|Adverse Event|4|||
164623554|NCT02314637|594642632|FG001|Overall Study|Adverse Event|8|||
164623555|NCT02314637|594642631|FG000|Overall Study|Lack of Efficacy|1|||
164623556|NCT02314637|594642632|FG001|Overall Study|Lack of Efficacy|0|||
164623557|NCT02314637|594642631|FG000|Overall Study|Physician Decision|5|||
164623558|NCT02314637|594642632|FG001|Overall Study|Physician Decision|2|||
164623559|NCT02314637|594642631|FG000|Overall Study|Withdrawal by Subject|5|||
164623560|NCT02314637|594642632|FG001|Overall Study|Withdrawal by Subject|4|||
164623561|NCT02314637|594642631|FG000|Overall Study|Other Reason|1|||
164623562|NCT02314637|594642632|FG001|Overall Study|Other Reason|0|||
164623563|NCT00686699|594642634|FG000|Treatment Period 1|Adverse Event|0|||
164623564|NCT00686699|594642635|FG001|Treatment Period 1|Adverse Event|2|||
164623565|NCT00908895|594642636|FG000|Overall Study|Lost to Follow-up|1|||
164623566|NCT00908895|594642637|FG001|Overall Study|Lost to Follow-up|3|||
164623567|NCT00908895|594642636|FG000|Overall Study|algodystrophy|2|||
164623568|NCT00908895|594642637|FG001|Overall Study|algodystrophy|2|||
164623569|NCT00908895|594642636|FG000|Overall Study|Adverse Event|1|||
164623570|NCT00908895|594642637|FG001|Overall Study|Adverse Event|1|||
164623571|NCT02511106|594642643|FG000|Overall Study|Lost to Follow-up|6|||
164623572|NCT02511106|594642644|FG001|Overall Study|Lost to Follow-up|4|||
164623573|NCT02511106|594642643|FG000|Overall Study|Withdrawal by Subject|24|||
164623574|NCT02511106|594642644|FG001|Overall Study|Withdrawal by Subject|21|||
164623575|NCT02511106|594642643|FG000|Overall Study|Death|42|||
164623576|NCT02511106|594642644|FG001|Overall Study|Death|82|||
164623577|NCT02511106|594642643|FG000|Overall Study|Ongoing study at data cut-off|3|||
164623578|NCT02511106|594642644|FG001|Overall Study|Ongoing study at data cut-off|2|||
164623579|NCT02511106|594642643|FG000|Overall Study|Without specified reason|3|||
164623580|NCT02511106|594642644|FG001|Overall Study|Without specified reason|0|||
164623581|NCT00033514|594642645|FG000|Overall Study|Lost to Follow-up|1|||
164623582|NCT00033514|594642646|FG001|Overall Study|Lost to Follow-up|1|||
164623583|NCT00033514|594642645|FG000|Overall Study|Withdrawal by Subject|0|||
164623584|NCT00033514|594642646|FG001|Overall Study|Withdrawal by Subject|3|||
164623585|NCT01222767|594642651|FG000|Overall Study|Progressive disease|13|||
164623586|NCT01222767|594642651|FG000|Overall Study|Adverse Event|2|||
164623587|NCT01222767|594642651|FG000|Overall Study|Surgical resection|1|||
164623588|NCT01222767|594642651|FG000|Overall Study|Never treated|1|||
164623589|NCT02773849|594642652|FG000|Overall Study|Lost to Follow-up|11|||
164623590|NCT02773849|594642652|FG000|Overall Study|Death|26|||
164623591|NCT02773849|594642652|FG000|Overall Study|Withdrawal by Subject|5|||
164623592|NCT02773849|594642652|FG000|Overall Study|Withdrawal of Consent|9|||
164623593|NCT02773849|594642652|FG000|Overall Study|Other: not due to lack of tolerability|11|||
164623594|NCT00723489|594642653|FG000|Overall Study|Physician Decision|0|||
164623595|NCT00723489|594642654|FG001|Overall Study|Physician Decision|1|||
164623596|NCT00723489|594642655|FG002|Overall Study|Physician Decision|0|||
164623597|NCT00723489|594642656|FG003|Overall Study|Physician Decision|0|||
164623598|NCT00723489|594642653|FG000|Overall Study|Pregnancy|0|||
164623599|NCT00723489|594642654|FG001|Overall Study|Pregnancy|0|||
164623600|NCT00723489|594642655|FG002|Overall Study|Pregnancy|0|||
164623601|NCT00723489|594642656|FG003|Overall Study|Pregnancy|1|||
164623602|NCT00723489|594642653|FG000|Overall Study|Withdrawal by Subject|0|||
164623603|NCT00723489|594642654|FG001|Overall Study|Withdrawal by Subject|0|||
164623604|NCT00723489|594642655|FG002|Overall Study|Withdrawal by Subject|0|||
164526253|NCT00943111|594296845|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
164526254|NCT00943111|594296846|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
164526255|NCT00943111|594296844|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
164526256|NCT00943111|594296845|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
164526257|NCT00943111|594296846|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
164526258|NCT00943111|594296844|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
164526259|NCT00943111|594296845|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
164526260|NCT00943111|594296846|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
164526261|NCT00847808|594296847|FG000|Overall Study|Adverse Event|7|||
164526262|NCT00847808|594296847|FG000|Overall Study|Protocol Violation|1|||
164526263|NCT00847808|594296847|FG000|Overall Study|Lost to Follow-up|1|||
164526264|NCT00847808|594296847|FG000|Overall Study|Withdrawal by Subject|4|||
164526265|NCT00847808|594296847|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
164526266|NCT00847808|594296847|FG000|Overall Study|Participant Took Excluded Medication|1|||
164526267|NCT05326815|594296849|FG000|Overall Study|Withdrawal by Subject|3|||
164526268|NCT05326815|594296849|FG000|Overall Study|Did not complete required labs|6|||
164526269|NCT05326815|594296849|FG000|Overall Study|Screen fail- abnormal labs|5|||
164526270|NCT03798691|594296850|FG000|Overall Study|Lost to Follow-up|2|||
164526271|NCT03798691|594296851|FG001|Overall Study|Lost to Follow-up|2|||
164526272|NCT00979134|594296862|FG000|Overall Study|Disease progression|18|||
164526273|NCT00979134|594296863|FG001|Overall Study|Disease progression|2|||
164526274|NCT00979134|594296864|FG002|Overall Study|Disease progression|5|||
164526275|NCT00979134|594296862|FG000|Overall Study|Adverse Event|0|||
164526276|NCT00979134|594296863|FG001|Overall Study|Adverse Event|0|||
164526277|NCT00979134|594296864|FG002|Overall Study|Adverse Event|2|||
164526278|NCT00979134|594296862|FG000|Overall Study|Withdrawal by Subject|1|||
164526279|NCT00979134|594296863|FG001|Overall Study|Withdrawal by Subject|1|||
164526280|NCT00979134|594296864|FG002|Overall Study|Withdrawal by Subject|2|||
164623605|NCT00723489|594642656|FG003|Overall Study|Withdrawal by Subject|1|||
164623606|NCT00723489|594642653|FG000|Overall Study|Seropositive at baseline|1|||
164623607|NCT00723489|594642654|FG001|Overall Study|Seropositive at baseline|0|||
164526281|NCT00979134|594296862|FG000|Overall Study|Lost to Follow-up|2|||
164526282|NCT00979134|594296863|FG001|Overall Study|Lost to Follow-up|2|||
164526283|NCT00979134|594296864|FG002|Overall Study|Lost to Follow-up|0|||
164526284|NCT00979134|594296862|FG000|Overall Study|Death|4|||
164526285|NCT00979134|594296863|FG001|Overall Study|Death|0|||
164526286|NCT00979134|594296864|FG002|Overall Study|Death|26|||
164623608|NCT00723489|594642655|FG002|Overall Study|Seropositive at baseline|0|||
164623609|NCT00723489|594642656|FG003|Overall Study|Seropositive at baseline|0|||
164623610|NCT00723489|594642653|FG000|Overall Study|Prohibited Medication|0|||
164623611|NCT00723489|594642654|FG001|Overall Study|Prohibited Medication|0|||
164623612|NCT00723489|594642655|FG002|Overall Study|Prohibited Medication|0|||
164623613|NCT00723489|594642656|FG003|Overall Study|Prohibited Medication|1|||
164623614|NCT00723489|594642653|FG000|Overall Study|Samples Collected Out of Window|0|||
164623615|NCT00723489|594642654|FG001|Overall Study|Samples Collected Out of Window|3|||
164623616|NCT00723489|594642655|FG002|Overall Study|Samples Collected Out of Window|0|||
164623617|NCT00723489|594642656|FG003|Overall Study|Samples Collected Out of Window|0|||
164623618|NCT00508001|594642663|FG000|Overall Study|Adverse Event|2|||
164623619|NCT00508001|594642664|FG001|Overall Study|Adverse Event|0|||
164623620|NCT00508001|594642665|FG002|Overall Study|Adverse Event|4|||
164623621|NCT00508001|594642663|FG000|Overall Study|condition under investigation worsened|13|||
164623622|NCT00508001|594642664|FG001|Overall Study|condition under investigation worsened|7|||
164623623|NCT00508001|594642665|FG002|Overall Study|condition under investigation worsened|1|||
164623624|NCT00508001|594642663|FG000|Overall Study|Death|0|||
164623625|NCT00508001|594642664|FG001|Overall Study|Death|1|||
164623626|NCT00508001|594642665|FG002|Overall Study|Death|1|||
164623627|NCT00508001|594642663|FG000|Overall Study|Withdrawal by Subject|4|||
164623628|NCT00508001|594642664|FG001|Overall Study|Withdrawal by Subject|4|||
164623629|NCT00508001|594642665|FG002|Overall Study|Withdrawal by Subject|1|||
164623630|NCT04221945|594642666|FG000|Overall Study|Death|103|||
164623631|NCT04221945|594642667|FG001|Overall Study|Death|140|||
164623632|NCT04221945|594642666|FG000|Overall Study|Lost to Follow-up|5|||
164623633|NCT04221945|594642667|FG001|Overall Study|Lost to Follow-up|8|||
164623634|NCT04221945|594642666|FG000|Overall Study|Withdrawal by Subject|21|||
164623635|NCT04221945|594642667|FG001|Overall Study|Withdrawal by Subject|11|||
164623636|NCT04221945|594642666|FG000|Overall Study|Participants Ongoing|400|||
164623637|NCT04221945|594642667|FG001|Overall Study|Participants Ongoing|372|||
164623638|NCT00974090|594642669|FG000|Period 1: Double Blind Period|Adverse Event|2|||
164623639|NCT00974090|594642670|FG001|Period 1: Double Blind Period|Adverse Event|1|||
164623640|NCT00974090|594642669|FG000|Period 1: Double Blind Period|Physician Decision|1|||
164623641|NCT00974090|594642670|FG001|Period 1: Double Blind Period|Physician Decision|0|||
164623642|NCT00974090|594642669|FG000|Period 2: Open-label Period|Adverse Event|4|||
164623643|NCT00974090|594642670|FG001|Period 2: Open-label Period|Adverse Event|6|||
164623644|NCT00974090|594642669|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
164623645|NCT00974090|594642670|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
164623646|NCT00974090|594642669|FG000|Period 2: Open-label Period|Physician Decision|0|||
164623647|NCT00974090|594642670|FG001|Period 2: Open-label Period|Physician Decision|3|||
164623648|NCT00974090|594642669|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
164623649|NCT00974090|594642670|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
164623650|NCT01626872|594642671|FG000|Overall Study|Physician Decision|13|||
164623651|NCT01626872|594642672|FG001|Overall Study|Physician Decision|9|||
164623652|NCT01626872|594642673|FG002|Overall Study|Physician Decision|6|||
164623653|NCT01626872|594642671|FG000|Overall Study|Withdrawal by Subject|19|||
164623654|NCT01626872|594642672|FG001|Overall Study|Withdrawal by Subject|27|||
164623655|NCT01626872|594642673|FG002|Overall Study|Withdrawal by Subject|8|||
164623656|NCT01626872|594642671|FG000|Overall Study|Adverse Event (including Death)|20|||
164623657|NCT01626872|594642672|FG001|Overall Study|Adverse Event (including Death)|28|||
164623658|NCT01626872|594642673|FG002|Overall Study|Adverse Event (including Death)|8|||
164623659|NCT01626872|594642671|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
164623660|NCT01626872|594642672|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
164623661|NCT01626872|594642673|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
164623662|NCT05626751|594642674|FG000|Overall Study|Lost to Follow-up|1|||
164623663|NCT05626751|594642675|FG001|Overall Study|Lost to Follow-up|2|||
164623664|NCT05626751|594642676|FG002|Overall Study|Lost to Follow-up|1|||
164623665|NCT05626751|594642674|FG000|Overall Study|Trial Terminated by Sponsor|39|||
164623666|NCT05626751|594642675|FG001|Overall Study|Trial Terminated by Sponsor|30|||
164623667|NCT05626751|594642676|FG002|Overall Study|Trial Terminated by Sponsor|37|||
164623668|NCT05626751|594642674|FG000|Overall Study|Withdrawal by Subject|7|||
164623669|NCT05626751|594642675|FG001|Overall Study|Withdrawal by Subject|5|||
164623670|NCT05626751|594642676|FG002|Overall Study|Withdrawal by Subject|5|||
164623671|NCT01625000|594642677|FG000|Overall Study|Physician Decision|15|||
164623672|NCT01625000|594642678|FG001|Overall Study|Physician Decision|7|||
164623673|NCT01625000|594642679|FG002|Overall Study|Physician Decision|7|||
164623674|NCT01625000|594642680|FG003|Overall Study|Physician Decision|2|||
164623675|NCT01625000|594642681|FG004|Overall Study|Physician Decision|15|||
164623676|NCT01625000|594642677|FG000|Overall Study|Protocol Violation|3|||
164623677|NCT01625000|594642678|FG001|Overall Study|Protocol Violation|10|||
164623678|NCT01625000|594642679|FG002|Overall Study|Protocol Violation|4|||
164623679|NCT01625000|594642680|FG003|Overall Study|Protocol Violation|1|||
164623680|NCT01625000|594642681|FG004|Overall Study|Protocol Violation|2|||
164623681|NCT01625000|594642677|FG000|Overall Study|Withdrawal by Subject|19|||
164623682|NCT01625000|594642678|FG001|Overall Study|Withdrawal by Subject|16|||
164526287|NCT00979134|594296862|FG000|Overall Study|Other|8|||
164526288|NCT00979134|594296863|FG001|Overall Study|Other|1|||
164526289|NCT00979134|594296864|FG002|Overall Study|Other|5|||
164526290|NCT00484289|594299195|FG000|Long Term Phase|Adverse Event|1|||
164526291|NCT00484289|594299196|FG001|Long Term Phase|Adverse Event|17|||
164526292|NCT00484289|594299197|FG002|Long Term Phase|Adverse Event|5|||
164526293|NCT00484289|594299195|FG000|Long Term Phase|Withdrawal by Subject|0|||
164526294|NCT00484289|594299196|FG001|Long Term Phase|Withdrawal by Subject|7|||
164526295|NCT00484289|594299197|FG002|Long Term Phase|Withdrawal by Subject|6|||
164526296|NCT00484289|594299195|FG000|Long Term Phase|Inadequate response|2|||
164526297|NCT00484289|594299196|FG001|Long Term Phase|Inadequate response|7|||
164526298|NCT00484289|594299197|FG002|Long Term Phase|Inadequate response|4|||
164526299|NCT00484289|594299195|FG000|Long Term Phase|Other Reason|0|||
164526300|NCT00484289|594299196|FG001|Long Term Phase|Other Reason|5|||
164526301|NCT00484289|594299197|FG002|Long Term Phase|Other Reason|1|||
164526302|NCT00484289|594299195|FG000|Post Marketing Phase|Adverse Event|0|||
164526303|NCT00484289|594299196|FG001|Post Marketing Phase|Adverse Event|1|||
164526304|NCT00484289|594299197|FG002|Post Marketing Phase|Adverse Event|0|||
164526305|NCT00690443|594299198|FG000|Overall Study|Adverse Event|1|||
164526306|NCT00690443|594299199|FG001|Overall Study|Adverse Event|2|||
164526307|NCT02502097|594299200|FG000|Period 1|Adverse Event|0|||
164526308|NCT02502097|594299201|FG001|Period 1|Adverse Event|0|||
164526309|NCT02502097|594299202|FG002|Period 1|Adverse Event|1|||
164526310|NCT02502097|594299203|FG003|Period 1|Adverse Event|0|||
164526311|NCT02502097|594299200|FG000|Wash Out Period|Adverse Event|0|||
164526312|NCT02502097|594299201|FG001|Wash Out Period|Adverse Event|1|||
164526313|NCT02502097|594299202|FG002|Wash Out Period|Adverse Event|1|||
164526314|NCT02502097|594299203|FG003|Wash Out Period|Adverse Event|1|||
164526315|NCT02502097|594299200|FG000|Period 2|Adverse Event|0|||
164526316|NCT02502097|594299201|FG001|Period 2|Adverse Event|0|||
164526317|NCT02502097|594299202|FG002|Period 2|Adverse Event|1|||
164526318|NCT02502097|594299203|FG003|Period 2|Adverse Event|0|||
164526319|NCT03718533|594299204|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
164526320|NCT03718533|594299204|FG000|Overall Study|Protocol deviation|1|||
164526321|NCT03718533|594299204|FG000|Overall Study|Disease progression|1|||
164526322|NCT03718533|594299204|FG000|Overall Study|Relapse|1|||
164526323|NCT03718533|594299204|FG000|Overall Study|Physician Decision|2|||
164526324|NCT03718533|594299204|FG000|Overall Study|Physician Decision and Adverse Event|1|||
164526325|NCT01079663|594299207|FG000|Overall Study|Adverse Event|0|||
164526326|NCT01079663|594299208|FG001|Overall Study|Adverse Event|2|||
164526327|NCT01079663|594299207|FG000|Overall Study|Protocol Violation|0|||
164526328|NCT01079663|594299208|FG001|Overall Study|Protocol Violation|2|||
164526329|NCT03606668|594299209|FG000|Overall Study|Screen Failure|1|||
164526330|NCT03606668|594299209|FG000|Overall Study|Lost to Follow-up|1|||
164526331|NCT02257567|594299215|FG000|Overall Study|Adverse Event|0|||
164526332|NCT02257567|594299216|FG001|Overall Study|Adverse Event|0|||
164526333|NCT02257567|594299217|FG002|Overall Study|Adverse Event|0|||
164526334|NCT02257567|594299218|FG003|Overall Study|Adverse Event|1|||
164526335|NCT02257567|594299219|FG004|Overall Study|Adverse Event|1|||
164526336|NCT02257567|594299220|FG005|Overall Study|Adverse Event|0|||
164526337|NCT02257567|594299221|FG006|Overall Study|Adverse Event|0|||
164526338|NCT02257567|594299222|FG007|Overall Study|Adverse Event|0|||
164526339|NCT02257567|594299223|FG008|Overall Study|Adverse Event|1|||
164526340|NCT02257567|594299224|FG009|Overall Study|Adverse Event|0|||
164526341|NCT02257567|594299225|FG010|Overall Study|Adverse Event|0|||
164526342|NCT02257567|594299215|FG000|Overall Study|Death|2|||
164526343|NCT02257567|594299216|FG001|Overall Study|Death|2|||
164526344|NCT02257567|594299217|FG002|Overall Study|Death|2|||
164526345|NCT02257567|594299218|FG003|Overall Study|Death|4|||
164526346|NCT02257567|594299219|FG004|Overall Study|Death|15|||
164526347|NCT02257567|594299220|FG005|Overall Study|Death|11|||
164526348|NCT02257567|594299221|FG006|Overall Study|Death|26|||
164526349|NCT02257567|594299222|FG007|Overall Study|Death|30|||
164526350|NCT02257567|594299223|FG008|Overall Study|Death|2|||
164526351|NCT02257567|594299224|FG009|Overall Study|Death|18|||
164526352|NCT02257567|594299225|FG010|Overall Study|Death|65|||
164526353|NCT02257567|594299215|FG000|Overall Study|Lost to Follow-up|0|||
164526354|NCT02257567|594299216|FG001|Overall Study|Lost to Follow-up|0|||
164526355|NCT02257567|594299217|FG002|Overall Study|Lost to Follow-up|0|||
164526356|NCT02257567|594299218|FG003|Overall Study|Lost to Follow-up|0|||
164526357|NCT02257567|594299219|FG004|Overall Study|Lost to Follow-up|2|||
164526358|NCT02257567|594299220|FG005|Overall Study|Lost to Follow-up|2|||
164526359|NCT02257567|594299221|FG006|Overall Study|Lost to Follow-up|0|||
164526360|NCT02257567|594299222|FG007|Overall Study|Lost to Follow-up|0|||
164526361|NCT02257567|594299223|FG008|Overall Study|Lost to Follow-up|0|||
164526362|NCT02257567|594299224|FG009|Overall Study|Lost to Follow-up|1|||
164526363|NCT02257567|594299225|FG010|Overall Study|Lost to Follow-up|1|||
164526364|NCT02257567|594299215|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
164526365|NCT02257567|594299216|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
164526366|NCT02257567|594299217|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
164526367|NCT02257567|594299218|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
164526368|NCT02257567|594299219|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
164526369|NCT02257567|594299220|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
164526370|NCT02257567|594299221|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
164526371|NCT02257567|594299222|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
164526372|NCT02257567|594299223|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
164526373|NCT02257567|594299224|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
164526374|NCT02257567|594299225|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
164526375|NCT02257567|594299215|FG000|Overall Study|Physician Decision|0|||
164526376|NCT02257567|594299216|FG001|Overall Study|Physician Decision|0|||
164526377|NCT02257567|594299217|FG002|Overall Study|Physician Decision|0|||
164526378|NCT02257567|594299218|FG003|Overall Study|Physician Decision|0|||
164526379|NCT02257567|594299219|FG004|Overall Study|Physician Decision|0|||
164526380|NCT02257567|594299220|FG005|Overall Study|Physician Decision|0|||
164526381|NCT02257567|594299221|FG006|Overall Study|Physician Decision|0|||
164526382|NCT02257567|594299222|FG007|Overall Study|Physician Decision|2|||
164526383|NCT02257567|594299223|FG008|Overall Study|Physician Decision|0|||
164526384|NCT02257567|594299224|FG009|Overall Study|Physician Decision|1|||
164526385|NCT02257567|594299225|FG010|Overall Study|Physician Decision|0|||
164526386|NCT02257567|594299215|FG000|Overall Study|Withdrawal by Subject|0|||
164526387|NCT02257567|594299216|FG001|Overall Study|Withdrawal by Subject|0|||
164526388|NCT02257567|594299217|FG002|Overall Study|Withdrawal by Subject|2|||
164526389|NCT02257567|594299218|FG003|Overall Study|Withdrawal by Subject|0|||
164526390|NCT02257567|594299219|FG004|Overall Study|Withdrawal by Subject|0|||
164526391|NCT02257567|594299220|FG005|Overall Study|Withdrawal by Subject|6|||
164526392|NCT02257567|594299221|FG006|Overall Study|Withdrawal by Subject|6|||
164526393|NCT02257567|594299222|FG007|Overall Study|Withdrawal by Subject|6|||
164526394|NCT02257567|594299223|FG008|Overall Study|Withdrawal by Subject|1|||
164526395|NCT02257567|594299224|FG009|Overall Study|Withdrawal by Subject|1|||
164526396|NCT02257567|594299225|FG010|Overall Study|Withdrawal by Subject|10|||
164526397|NCT03536143|594299226|FG000|Overall Study|Early termination, Sponsor decision|1|||
164526398|NCT01878214|594299227|FG000|Overall Study|Withdrawal by Subject|18|||
164526399|NCT01878214|594299228|FG001|Overall Study|Withdrawal by Subject|7|||
164526400|NCT01878214|594299227|FG000|Overall Study|Death|0|||
164526401|NCT01878214|594299228|FG001|Overall Study|Death|1|||
164526402|NCT01878214|594299227|FG000|Overall Study|Lost to Follow-up|35|||
164526403|NCT01878214|594299228|FG001|Overall Study|Lost to Follow-up|36|||
164526404|NCT00946101|594299229|FG000|Overall Study|Lost to Follow-up|2|||
164526405|NCT00946101|594299230|FG001|Overall Study|Lost to Follow-up|1|||
164526406|NCT00946101|594299229|FG000|Overall Study|Withdrawal of consent|2|||
164526407|NCT00946101|594299230|FG001|Overall Study|Withdrawal of consent|0|||
164526408|NCT00946101|594299229|FG000|Overall Study|Physician Decision|0|||
164526409|NCT00946101|594299230|FG001|Overall Study|Physician Decision|1|||
164526410|NCT00495586|594299231|FG000|Overall Study|Withdrawal by Subject|4|||
164526411|NCT00495586|594299232|FG001|Overall Study|Withdrawal by Subject|4|||
164526412|NCT01590017|594299235|FG000|Overall Study|Adverse Event|1|||
164526413|NCT01590017|594299235|FG000|Overall Study|Withdrawal by Subject|1|||
164526414|NCT01590017|594299235|FG000|Overall Study|Lack of Efficacy|1|||
164526415|NCT01590017|594299235|FG000|Overall Study|Physician Decision|1|||
164526416|NCT01347762|594299236|FG000|Overall Study|Lost to Follow-up|0|||
164526417|NCT01347762|594299237|FG001|Overall Study|Lost to Follow-up|1|||
164526418|NCT01347762|594299238|FG002|Overall Study|Lost to Follow-up|6|||
164526419|NCT01347762|594299239|FG003|Overall Study|Lost to Follow-up|5|||
164526420|NCT01347762|594299236|FG000|Overall Study|Withdrawal by Subject|4|||
164526421|NCT01347762|594299237|FG001|Overall Study|Withdrawal by Subject|1|||
164526422|NCT01347762|594299238|FG002|Overall Study|Withdrawal by Subject|3|||
164526423|NCT01347762|594299239|FG003|Overall Study|Withdrawal by Subject|3|||
164526424|NCT02038543|594299240|FG000|Overall Study|Screen Failure|0|||
164526425|NCT02038543|594299241|FG001|Overall Study|Screen Failure|0|||
164526426|NCT02038543|594299242|FG002|Overall Study|Screen Failure|0|||
164526427|NCT02038543|594299243|FG003|Overall Study|Screen Failure|1|||
164623683|NCT01625000|594642679|FG002|Overall Study|Withdrawal by Subject|11|||
164623684|NCT01625000|594642680|FG003|Overall Study|Withdrawal by Subject|9|||
164623685|NCT01625000|594642681|FG004|Overall Study|Withdrawal by Subject|17|||
164623686|NCT01625000|594642677|FG000|Overall Study|Adverse Event (including Death)|15|||
164623687|NCT01625000|594642678|FG001|Overall Study|Adverse Event (including Death)|19|||
164623688|NCT01625000|594642679|FG002|Overall Study|Adverse Event (including Death)|11|||
164623689|NCT01625000|594642680|FG003|Overall Study|Adverse Event (including Death)|7|||
164623690|NCT01625000|594642681|FG004|Overall Study|Adverse Event (including Death)|21|||
164623691|NCT03912064|594642682|FG000|Overall Study|Withdrawal by Subject|2|||
164623692|NCT03912064|594642683|FG001|Overall Study|Withdrawal by Subject|0|||
164623693|NCT03912064|594642684|FG002|Overall Study|Withdrawal by Subject|0|||
164623694|NCT03912064|594642682|FG000|Overall Study|Adverse reaction to Ipilimumab|2|||
164623695|NCT03912064|594642683|FG001|Overall Study|Adverse reaction to Ipilimumab|0|||
164623696|NCT03912064|594642684|FG002|Overall Study|Adverse reaction to Ipilimumab|1|||
164623697|NCT03912064|594642682|FG000|Overall Study|Progression/Relapse|7|||
164623698|NCT03912064|594642683|FG001|Overall Study|Progression/Relapse|3|||
164623699|NCT03912064|594642684|FG002|Overall Study|Progression/Relapse|0|||
164623700|NCT03912064|594642682|FG000|Overall Study|Prolonged treatment delays|3|||
164623701|NCT03912064|594642683|FG001|Overall Study|Prolonged treatment delays|2|||
164623702|NCT03912064|594642684|FG002|Overall Study|Prolonged treatment delays|0|||
164623703|NCT03912064|594642682|FG000|Overall Study|Prohibited concomitant treatments|3|||
164623704|NCT03912064|594642683|FG001|Overall Study|Prohibited concomitant treatments|1|||
164623705|NCT03912064|594642684|FG002|Overall Study|Prohibited concomitant treatments|0|||
164623706|NCT01026194|594642685|FG000|Period 1：Double Blind Period|Adverse Event|2|||
164623707|NCT01026194|594642686|FG001|Period 1：Double Blind Period|Adverse Event|1|||
164623708|NCT01026194|594642685|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
164623709|NCT01026194|594642686|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
164623710|NCT01026194|594642685|FG000|Period 1：Double Blind Period|Physician Decision|0|||
164623711|NCT01026194|594642686|FG001|Period 1：Double Blind Period|Physician Decision|4|||
164623712|NCT01026194|594642685|FG000|Period 2：Open-label Period|Adverse Event|4|||
164623713|NCT01026194|594642686|FG001|Period 2：Open-label Period|Adverse Event|5|||
164623714|NCT01026194|594642685|FG000|Period 2：Open-label Period|Physician Decision|3|||
164623715|NCT01026194|594642686|FG001|Period 2：Open-label Period|Physician Decision|1|||
164623716|NCT01026194|594642685|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
164623717|NCT01026194|594642686|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
164623718|NCT04295759|594642687|FG000|Overall Study|Lack of Efficacy|9|||
164623719|NCT04295759|594642687|FG000|Overall Study|Death|1|||
164623720|NCT04295759|594642687|FG000|Overall Study|Withdrawal by Subject|2|||
164623721|NCT04295759|594642687|FG000|Overall Study|Deemed ineligible|1|||
164623722|NCT05740566|594642688|FG000|Overall Study|Death|151|||
164623723|NCT05740566|594642689|FG001|Overall Study|Death|111|||
164623724|NCT05740566|594642688|FG000|Overall Study|Withdrawal by Subject|2|||
164623725|NCT05740566|594642689|FG001|Overall Study|Withdrawal by Subject|0|||
164623726|NCT05740566|594642688|FG000|Overall Study|Ongoing in study|102|||
164623727|NCT05740566|594642689|FG001|Overall Study|Ongoing in study|143|||
164623728|NCT00829010|594642692|FG000|Overall Study|Adverse Event|1|||
164623729|NCT00829010|594642693|FG001|Overall Study|Adverse Event|0|||
164623730|NCT00829010|594642694|FG002|Overall Study|Adverse Event|0|||
164623731|NCT00829010|594642695|FG003|Overall Study|Adverse Event|0|||
164623732|NCT00829010|594642696|FG004|Overall Study|Adverse Event|0|||
164623733|NCT00829010|594642692|FG000|Overall Study|Withdrawal by Subject|0|||
164623734|NCT00829010|594642693|FG001|Overall Study|Withdrawal by Subject|1|||
164623735|NCT00829010|594642694|FG002|Overall Study|Withdrawal by Subject|1|||
164623736|NCT00829010|594642695|FG003|Overall Study|Withdrawal by Subject|0|||
164623737|NCT00829010|594642696|FG004|Overall Study|Withdrawal by Subject|2|||
164623738|NCT00829010|594642692|FG000|Overall Study|Lost to Follow-up|1|||
164623739|NCT00829010|594642693|FG001|Overall Study|Lost to Follow-up|0|||
164623740|NCT00829010|594642694|FG002|Overall Study|Lost to Follow-up|2|||
164623741|NCT00829010|594642695|FG003|Overall Study|Lost to Follow-up|0|||
164623742|NCT00829010|594642696|FG004|Overall Study|Lost to Follow-up|0|||
164623743|NCT00829010|594642692|FG000|Overall Study|Fatality|5|||
164623744|NCT00829010|594642693|FG001|Overall Study|Fatality|4|||
164623745|NCT00829010|594642694|FG002|Overall Study|Fatality|0|||
164623746|NCT00829010|594642695|FG003|Overall Study|Fatality|3|||
164623747|NCT00829010|594642696|FG004|Overall Study|Fatality|0|||
164623748|NCT00829010|594642692|FG000|Overall Study|Migrated/Moved from study area|3|||
164623749|NCT00829010|594642693|FG001|Overall Study|Migrated/Moved from study area|4|||
164623750|NCT00829010|594642694|FG002|Overall Study|Migrated/Moved from study area|0|||
164623751|NCT00829010|594642695|FG003|Overall Study|Migrated/Moved from study area|5|||
164623752|NCT00829010|594642696|FG004|Overall Study|Migrated/Moved from study area|0|||
164623753|NCT06210035|594642697|FG000|Overall Study|Withdrawal by Subject|3|||
164623754|NCT06210035|594642698|FG001|Overall Study|Withdrawal by Subject|0|||
164623755|NCT06210035|594642699|FG002|Overall Study|Withdrawal by Subject|0|||
164623756|NCT01029691|594642700|FG000|Continued APAP to Delivery|Death|0|||
164623757|NCT01029691|594642701|FG001|Continued APAP to Delivery|Death|0|||
164623758|NCT01029691|594642702|FG002|Continued APAP to Delivery|Death|1|||
164623759|NCT05616221|594642707|FG000|Overall Study|Withdrawal by Subject|0|||
164623760|NCT05616221|594642708|FG001|Overall Study|Withdrawal by Subject|1|||
164526428|NCT02038543|594299240|FG000|Overall Study|Withdrawal by Subject|0|||
164526429|NCT02038543|594299241|FG001|Overall Study|Withdrawal by Subject|0|||
164526430|NCT02038543|594299242|FG002|Overall Study|Withdrawal by Subject|0|||
164526431|NCT02038543|594299243|FG003|Overall Study|Withdrawal by Subject|1|||
164526432|NCT00871780|594299244|FG000|Overall Study|Enrolled But Not Treated|6|||
164526433|NCT00871780|594299244|FG000|Overall Study|Withdrawal by Subject|9|||
164526434|NCT00871780|594299244|FG000|Overall Study|Adverse Event|6|||
164526435|NCT00871780|594299244|FG000|Overall Study|Voluntary Discontinuation|4|||
164526436|NCT00871780|594299244|FG000|Overall Study|Death|1|||
164526437|NCT00871780|594299244|FG000|Overall Study|Physician Decision|1|||
164526438|NCT02647866|594299245|FG000|Overall Study|Adverse Event|0|||
164526439|NCT02647866|594299246|FG001|Overall Study|Adverse Event|0|||
164526440|NCT02647866|594299247|FG002|Overall Study|Adverse Event|2|||
164526441|NCT02647866|594299248|FG003|Overall Study|Adverse Event|2|||
164526442|NCT02647866|594299249|FG004|Overall Study|Adverse Event|1|||
164526443|NCT02647866|594299245|FG000|Overall Study|Disease Worsening|3|||
164526444|NCT02647866|594299246|FG001|Overall Study|Disease Worsening|1|||
164526445|NCT02647866|594299247|FG002|Overall Study|Disease Worsening|0|||
164526446|NCT02647866|594299248|FG003|Overall Study|Disease Worsening|0|||
164526447|NCT02647866|594299249|FG004|Overall Study|Disease Worsening|1|||
164526448|NCT02647866|594299245|FG000|Overall Study|Withdrawal by Subject|1|||
164526449|NCT02647866|594299246|FG001|Overall Study|Withdrawal by Subject|1|||
164526450|NCT02647866|594299247|FG002|Overall Study|Withdrawal by Subject|2|||
164526451|NCT02647866|594299248|FG003|Overall Study|Withdrawal by Subject|4|||
164526452|NCT02647866|594299249|FG004|Overall Study|Withdrawal by Subject|4|||
164526453|NCT02647866|594299245|FG000|Overall Study|Physician Decision|0|||
164526454|NCT02647866|594299246|FG001|Overall Study|Physician Decision|1|||
164526455|NCT02647866|594299247|FG002|Overall Study|Physician Decision|1|||
164526456|NCT02647866|594299248|FG003|Overall Study|Physician Decision|0|||
164526457|NCT02647866|594299249|FG004|Overall Study|Physician Decision|2|||
164526458|NCT02647866|594299245|FG000|Overall Study|Death|0|||
164526459|NCT02647866|594299246|FG001|Overall Study|Death|1|||
164526460|NCT02647866|594299247|FG002|Overall Study|Death|0|||
164526461|NCT02647866|594299248|FG003|Overall Study|Death|0|||
164526462|NCT02647866|594299249|FG004|Overall Study|Death|0|||
164526463|NCT02647866|594299245|FG000|Overall Study|Subject moved to different country|1|||
164526464|NCT02647866|594299246|FG001|Overall Study|Subject moved to different country|0|||
164526465|NCT02647866|594299247|FG002|Overall Study|Subject moved to different country|0|||
164526466|NCT02647866|594299248|FG003|Overall Study|Subject moved to different country|0|||
164526467|NCT02647866|594299249|FG004|Overall Study|Subject moved to different country|0|||
164526468|NCT03406260|594299250|FG000|Period 1|Adverse Event|0|||
164526469|NCT03406260|594299251|FG001|Period 1|Adverse Event|0|||
164526470|NCT03406260|594299252|FG002|Period 1|Adverse Event|0|||
164526471|NCT03406260|594299253|FG003|Period 1|Adverse Event|0|||
164526472|NCT03406260|594299254|FG004|Period 1|Adverse Event|1|||
164526473|NCT03406260|594299255|FG005|Period 1|Adverse Event|0|||
164526474|NCT02527343|594299259|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
164526475|NCT02527343|594299260|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
164526476|NCT02527343|594299261|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
164526477|NCT02527343|594299262|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
164526478|NCT02527343|594299263|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
164526479|NCT02527343|594299264|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
164526480|NCT02527343|594299259|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
164526481|NCT02527343|594299260|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
164526482|NCT02527343|594299261|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
164526483|NCT02527343|594299262|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
164526484|NCT02527343|594299263|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
164526485|NCT02527343|594299264|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
164526486|NCT02527343|594299259|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
164526487|NCT02527343|594299260|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
164526488|NCT02527343|594299261|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
164526489|NCT02527343|594299262|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
164526490|NCT02527343|594299263|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
164526491|NCT02527343|594299264|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
164526492|NCT02527343|594299259|FG000|RT Period: Weeks 1 to 52|Other|4|||
164526493|NCT02527343|594299260|FG001|RT Period: Weeks 1 to 52|Other|3|||
164526494|NCT02527343|594299261|FG002|RT Period: Weeks 1 to 52|Other|0|||
164526495|NCT02527343|594299262|FG003|RT Period: Weeks 1 to 52|Other|0|||
164526496|NCT02527343|594299263|FG004|RT Period: Weeks 1 to 52|Other|0|||
164526497|NCT02527343|594299264|FG005|RT Period: Weeks 1 to 52|Other|0|||
164526498|NCT02527343|594299259|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
164526499|NCT02527343|594299260|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
164623761|NCT05616221|594642709|FG002|Overall Study|Withdrawal by Subject|0|||
164623762|NCT05616221|594642710|FG003|Overall Study|Withdrawal by Subject|0|||
164623763|NCT05616221|594642711|FG004|Overall Study|Withdrawal by Subject|0|||
164623764|NCT05616221|594642712|FG005|Overall Study|Withdrawal by Subject|0|||
164623765|NCT05616221|594642707|FG000|Overall Study|Adverse Event|0|||
164623766|NCT05616221|594642708|FG001|Overall Study|Adverse Event|2|||
164623767|NCT05616221|594642709|FG002|Overall Study|Adverse Event|0|||
164623768|NCT05616221|594642710|FG003|Overall Study|Adverse Event|0|||
164623769|NCT05616221|594642711|FG004|Overall Study|Adverse Event|2|||
164623770|NCT05616221|594642712|FG005|Overall Study|Adverse Event|0|||
164623771|NCT04880733|594642713|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
164623772|NCT04880733|594642714|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
164623773|NCT04880733|594642715|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
164623774|NCT04880733|594642713|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
164623775|NCT04880733|594642714|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
164623776|NCT04880733|594642715|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
164623777|NCT04880733|594642713|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
164623778|NCT04880733|594642714|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
164623779|NCT04880733|594642715|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
164623780|NCT04880733|594642713|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
164623781|NCT04880733|594642714|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
164623782|NCT04880733|594642715|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
164623783|NCT04880733|594642713|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
164623784|NCT04880733|594642714|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
164623785|NCT04880733|594642715|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
164623786|NCT00862992|594642716|FG000|Overall Study|Adverse Event|2|||
164623787|NCT00862992|594642717|FG001|Overall Study|Adverse Event|1|||
164623788|NCT00862992|594642718|FG002|Overall Study|Adverse Event|1|||
164623789|NCT00862992|594642716|FG000|Overall Study|Physician Decision|1|||
164623790|NCT00862992|594642717|FG001|Overall Study|Physician Decision|0|||
164623791|NCT00862992|594642718|FG002|Overall Study|Physician Decision|0|||
164623792|NCT00862992|594642716|FG000|Overall Study|Withdrawal by Subject|0|||
164623793|NCT00862992|594642717|FG001|Overall Study|Withdrawal by Subject|0|||
164623794|NCT00862992|594642718|FG002|Overall Study|Withdrawal by Subject|2|||
164623795|NCT05492877|594642719|FG000|Overall Study|Adverse Event|11|||
164623796|NCT05492877|594642720|FG001|Overall Study|Adverse Event|7|||
164623797|NCT05492877|594642719|FG000|Overall Study|Death|1|||
164623798|NCT05492877|594642720|FG001|Overall Study|Death|0|||
164623799|NCT05492877|594642719|FG000|Overall Study|Lost to Follow-up|1|||
164623800|NCT05492877|594642720|FG001|Overall Study|Lost to Follow-up|1|||
164623801|NCT05492877|594642719|FG000|Overall Study|Physician Decision|1|||
164623802|NCT05492877|594642720|FG001|Overall Study|Physician Decision|2|||
164623803|NCT05492877|594642719|FG000|Overall Study|Protocol Violation|1|||
164623804|NCT05492877|594642720|FG001|Overall Study|Protocol Violation|1|||
164623805|NCT05492877|594642719|FG000|Overall Study|Withdrawal by Subject|3|||
164623806|NCT05492877|594642720|FG001|Overall Study|Withdrawal by Subject|7|||
164623807|NCT05492877|594642719|FG000|Overall Study|Reason not specified|6|||
164623808|NCT05492877|594642720|FG001|Overall Study|Reason not specified|4|||
164623809|NCT02871791|594642721|FG000|Phase 1b|Death|0|||
164623810|NCT02871791|594642722|FG001|Phase 1b|Death|1|||
164623811|NCT02871791|594642721|FG000|Phase 1b|progressive disease|6|||
164623812|NCT02871791|594642722|FG001|Phase 1b|progressive disease|2|||
164623813|NCT02871791|594642721|FG000|Phase 2|Death|1|||
164623814|NCT02871791|594642722|FG001|Phase 2|Death|0|||
164623815|NCT02871791|594642721|FG000|Phase 2|Lost to Follow-up|2|||
164623816|NCT02871791|594642722|FG001|Phase 2|Lost to Follow-up|0|||
164623817|NCT03737318|594642732|FG000|Phase 2 (Generalization)|Withdrawal by Subject|4|||
164623818|NCT03737318|594642733|FG001|Phase 2 (Generalization)|Withdrawal by Subject|1|||
164623819|NCT03737318|594642734|FG002|Phase 2 (Generalization)|Withdrawal by Subject|1|||
164623820|NCT00528840|594642738|FG000|Overall Study|Lost to Follow-up|10|||
164623821|NCT00528840|594642738|FG000|Overall Study|Adverse Event|1|||
164623822|NCT00528840|594642738|FG000|Overall Study|Withdrawal by Subject|17|||
164623823|NCT00528840|594642738|FG000|Overall Study|Death|2|||
164623824|NCT00528840|594642738|FG000|Overall Study|Administrative Reasons|1|||
164623825|NCT00528840|594642738|FG000|Overall Study|Other|2|||
164623826|NCT01603628|594642739|FG000|Overall Study|Personal Reasons|1|||
164623827|NCT01603628|594642740|FG001|Overall Study|Personal Reasons|1|||
164623828|NCT01603628|594642741|FG002|Overall Study|Personal Reasons|2|||
164623829|NCT01603628|594642739|FG000|Overall Study|Protocol Violation|1|||
164623830|NCT01603628|594642740|FG001|Overall Study|Protocol Violation|1|||
164623831|NCT01603628|594642741|FG002|Overall Study|Protocol Violation|0|||
164623832|NCT01603628|594642739|FG000|Overall Study|Lost to Follow-up|0|||
164623833|NCT01603628|594642740|FG001|Overall Study|Lost to Follow-up|1|||
164623834|NCT01603628|594642741|FG002|Overall Study|Lost to Follow-up|0|||
164623835|NCT01603628|594642739|FG000|Overall Study|Other Miscellaneous Reason|1|||
164623836|NCT01603628|594642740|FG001|Overall Study|Other Miscellaneous Reason|0|||
164623837|NCT01603628|594642741|FG002|Overall Study|Other Miscellaneous Reason|0|||
164623838|NCT02087241|594642742|FG000|Overall Study|Death|2|||
164623839|NCT02087241|594642743|FG001|Overall Study|Death|1|||
164623840|NCT02087241|594642744|FG002|Overall Study|Death|1|||
164623841|NCT02087241|594642745|FG003|Overall Study|Death|1|||
164623842|NCT02087241|594642742|FG000|Overall Study|Withdrawal by Subject|1|||
164623843|NCT02087241|594642743|FG001|Overall Study|Withdrawal by Subject|0|||
164623844|NCT02087241|594642744|FG002|Overall Study|Withdrawal by Subject|0|||
164623845|NCT02087241|594642745|FG003|Overall Study|Withdrawal by Subject|1|||
164623846|NCT02087241|594642742|FG000|Overall Study|Progressive Disease|0|||
164623847|NCT02087241|594642743|FG001|Overall Study|Progressive Disease|0|||
164623848|NCT02087241|594642744|FG002|Overall Study|Progressive Disease|0|||
164623849|NCT02087241|594642745|FG003|Overall Study|Progressive Disease|1|||
164623850|NCT02087241|594642742|FG000|Overall Study|Study Terminated by Sponsor|0|||
164623851|NCT02087241|594642743|FG001|Overall Study|Study Terminated by Sponsor|2|||
164623852|NCT02087241|594642744|FG002|Overall Study|Study Terminated by Sponsor|0|||
164623853|NCT02087241|594642745|FG003|Overall Study|Study Terminated by Sponsor|4|||
164623854|NCT00836953|594642746|FG000|Overall Study|Withdrawal by Subject|1|||
164623855|NCT00836953|594642746|FG000|Overall Study|Lost to Follow-up|1|||
164623856|NCT02943668|594642747|FG000|Overall Study|Disease Progression|1|||
164623857|NCT01200758|594642748|FG000|Stage I|Death|0|||
164623858|NCT01200758|594642749|FG001|Stage I|Death|1|||
164623859|NCT01200758|594642750|FG002|Stage I|Death|0|||
164623860|NCT01200758|594642751|FG003|Stage I|Death|0|||
164623861|NCT01200758|594642748|FG000|Stage I|Physician Decision|1|||
164623862|NCT01200758|594642749|FG001|Stage I|Physician Decision|1|||
164623863|NCT01200758|594642750|FG002|Stage I|Physician Decision|0|||
164623864|NCT01200758|594642751|FG003|Stage I|Physician Decision|0|||
164623865|NCT01200758|594642748|FG000|Stage I|Lack of Efficacy|2|||
164623866|NCT01200758|594642749|FG001|Stage I|Lack of Efficacy|1|||
164623867|NCT01200758|594642750|FG002|Stage I|Lack of Efficacy|0|||
164623868|NCT01200758|594642751|FG003|Stage I|Lack of Efficacy|0|||
164623869|NCT01200758|594642748|FG000|Stage I|Adverse Event|5|||
164623870|NCT01200758|594642749|FG001|Stage I|Adverse Event|5|||
164623871|NCT01200758|594642750|FG002|Stage I|Adverse Event|0|||
164623872|NCT01200758|594642751|FG003|Stage I|Adverse Event|0|||
164623873|NCT01200758|594642748|FG000|Stage I|Withdrawal by Subject|1|||
164623874|NCT01200758|594642749|FG001|Stage I|Withdrawal by Subject|2|||
164623875|NCT01200758|594642750|FG002|Stage I|Withdrawal by Subject|0|||
164623876|NCT01200758|594642751|FG003|Stage I|Withdrawal by Subject|0|||
164623877|NCT01200758|594642748|FG000|Stage I|Disease Progression|9|||
164623878|NCT01200758|594642749|FG001|Stage I|Disease Progression|7|||
164623879|NCT01200758|594642750|FG002|Stage I|Disease Progression|0|||
164623880|NCT01200758|594642751|FG003|Stage I|Disease Progression|0|||
164623881|NCT01200758|594642748|FG000|Stage 2|Disease Progression|0|||
164623882|NCT01200758|594642749|FG001|Stage 2|Disease Progression|0|||
164623883|NCT01200758|594642750|FG002|Stage 2|Disease Progression|16|||
164623884|NCT01200758|594642751|FG003|Stage 2|Disease Progression|21|||
164623885|NCT01200758|594642748|FG000|Stage 2|Lack of Efficacy|0|||
164623886|NCT01200758|594642749|FG001|Stage 2|Lack of Efficacy|0|||
164623887|NCT01200758|594642750|FG002|Stage 2|Lack of Efficacy|4|||
164623888|NCT01200758|594642751|FG003|Stage 2|Lack of Efficacy|2|||
164623889|NCT01200758|594642748|FG000|Stage 2|Physician Decision|0|||
164623890|NCT01200758|594642749|FG001|Stage 2|Physician Decision|0|||
164623891|NCT01200758|594642750|FG002|Stage 2|Physician Decision|5|||
164623892|NCT01200758|594642751|FG003|Stage 2|Physician Decision|7|||
164623893|NCT01200758|594642748|FG000|Stage 2|Adverse Event|0|||
164623894|NCT01200758|594642749|FG001|Stage 2|Adverse Event|0|||
164623895|NCT01200758|594642750|FG002|Stage 2|Adverse Event|5|||
164623896|NCT01200758|594642751|FG003|Stage 2|Adverse Event|9|||
164623897|NCT01200758|594642748|FG000|Stage 2|Withdrawal by Subject|0|||
164623898|NCT01200758|594642749|FG001|Stage 2|Withdrawal by Subject|0|||
164623899|NCT01200758|594642750|FG002|Stage 2|Withdrawal by Subject|4|||
164623900|NCT01200758|594642751|FG003|Stage 2|Withdrawal by Subject|1|||
164623901|NCT01200758|594642748|FG000|Stage 2|Lost to Follow-up|0|||
164623902|NCT01200758|594642749|FG001|Stage 2|Lost to Follow-up|0|||
164623903|NCT01200758|594642750|FG002|Stage 2|Lost to Follow-up|3|||
164623904|NCT01200758|594642751|FG003|Stage 2|Lost to Follow-up|1|||
164623905|NCT01200758|594642748|FG000|Stage 2|Protocol Violation|0|||
164623906|NCT01200758|594642749|FG001|Stage 2|Protocol Violation|0|||
164623907|NCT01200758|594642750|FG002|Stage 2|Protocol Violation|1|||
164623908|NCT01200758|594642751|FG003|Stage 2|Protocol Violation|4|||
164623909|NCT01200758|594642748|FG000|Stage 2|Death|0|||
164623910|NCT01200758|594642749|FG001|Stage 2|Death|0|||
164623911|NCT01200758|594642750|FG002|Stage 2|Death|3|||
164623912|NCT01200758|594642751|FG003|Stage 2|Death|5|||
164623913|NCT03053180|594644576|FG000|Overall Study|Failure to Return|1|||
164623914|NCT01465958|594644581|FG000|Run-in Phase|Protocol Violation|1|||
164623915|NCT01465958|594644582|FG001|Run-in Phase|Protocol Violation|0|||
164623916|NCT01465958|594644581|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
164623917|NCT01465958|594644582|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
164623918|NCT00211536|594644590|FG000|Overall Study|Withdrawal by Subject|2|||
164623919|NCT00211536|594644591|FG001|Overall Study|Withdrawal by Subject|2|||
164526500|NCT02527343|594299261|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
164526501|NCT02527343|594299262|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
164526502|NCT02527343|594299263|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
164526503|NCT02527343|594299264|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
164526504|NCT02527343|594299259|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
164526505|NCT02527343|594299260|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
164526506|NCT02527343|594299261|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
164526507|NCT02527343|594299262|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
164526508|NCT02527343|594299263|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
164526509|NCT02527343|594299264|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
164526510|NCT02527343|594299259|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
164526511|NCT02527343|594299260|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
164526512|NCT02527343|594299261|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
164526513|NCT02527343|594299262|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
164526514|NCT02527343|594299263|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
164526515|NCT02527343|594299264|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
164526516|NCT02527343|594299259|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
164526517|NCT02527343|594299260|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
164526518|NCT02527343|594299261|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
164526519|NCT02527343|594299262|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
164526520|NCT02527343|594299263|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
164526521|NCT02527343|594299264|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
164526522|NCT02527343|594299259|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
164526523|NCT02527343|594299260|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
164526524|NCT02527343|594299261|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
164526525|NCT02527343|594299262|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
164526526|NCT02527343|594299263|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
164526527|NCT02527343|594299264|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
164526528|NCT02527343|594299259|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
164526529|NCT02527343|594299260|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
164526530|NCT02527343|594299261|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
164526531|NCT02527343|594299262|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
164526532|NCT02527343|594299263|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
164526533|NCT02527343|594299264|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
164526534|NCT02527343|594299259|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
164526535|NCT02527343|594299260|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
164526536|NCT02527343|594299261|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
164526537|NCT02527343|594299262|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
164526538|NCT02527343|594299263|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
164526539|NCT02527343|594299264|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
164526540|NCT02527343|594299259|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
164526541|NCT02527343|594299260|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
164526542|NCT02527343|594299261|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
164526543|NCT02527343|594299262|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
164526544|NCT02527343|594299263|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
164526545|NCT02527343|594299264|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
164526546|NCT02527343|594299259|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
164526547|NCT02527343|594299260|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
164526548|NCT02527343|594299261|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
164526549|NCT02527343|594299262|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
164526550|NCT02527343|594299263|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
164526551|NCT02527343|594299264|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
164526552|NCT01029652|594299265|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
164526553|NCT01029652|594299266|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
164526554|NCT01029652|594299265|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
164526555|NCT01029652|594299266|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
164526556|NCT01029652|594299265|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
164526557|NCT01029652|594299266|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
164526558|NCT01029652|594299265|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
164526559|NCT01029652|594299266|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
164526560|NCT01029652|594299265|FG000|Core Study (0-12 Weeks)|Death|0|||
164526561|NCT01029652|594299266|FG001|Core Study (0-12 Weeks)|Death|1|||
164526562|NCT01029652|594299265|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
164526563|NCT01029652|594299266|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
164526564|NCT01029652|594299265|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
164526565|NCT01029652|594299266|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
164526566|NCT01029652|594299265|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
164526567|NCT01029652|594299266|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
164526568|NCT01029652|594299265|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
164623920|NCT00211536|594644590|FG000|Overall Study|Physician Decision|0|||
164623921|NCT00211536|594644591|FG001|Overall Study|Physician Decision|5|||
164623922|NCT00211536|594644590|FG000|Overall Study|Adverse Event|2|||
164623923|NCT00211536|594644591|FG001|Overall Study|Adverse Event|0|||
164623924|NCT02583399|594644592|FG000|Overall Study|Able to be discharged|3|||
164623925|NCT02583399|594644592|FG000|Overall Study|Wanted to use a restricted medication|3|||
164623926|NCT01004861|594644593|FG000|Overall Study|Disease progression|3|||
164623927|NCT01004861|594644594|FG001|Overall Study|Disease progression|4|||
164623928|NCT01004861|594644595|FG002|Overall Study|Disease progression|5|||
164623929|NCT01004861|594644596|FG003|Overall Study|Disease progression|4|||
164623930|NCT01004861|594644597|FG004|Overall Study|Disease progression|4|||
164623931|NCT01004861|594644598|FG005|Overall Study|Disease progression|4|||
164623932|NCT01004861|594644599|FG006|Overall Study|Disease progression|5|||
164623933|NCT01004861|594644600|FG007|Overall Study|Disease progression|1|||
164623934|NCT01004861|594644601|FG008|Overall Study|Disease progression|4|||
164623935|NCT01004861|594644602|FG009|Overall Study|Disease progression|7|||
164623936|NCT01004861|594644603|FG010|Overall Study|Disease progression|6|||
164623937|NCT01004861|594644604|FG011|Overall Study|Disease progression|3|||
164623938|NCT01004861|594644605|FG012|Overall Study|Disease progression|8|||
164623939|NCT01004861|594644593|FG000|Overall Study|Physician Decision|0|||
164526569|NCT01029652|594299266|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
164526570|NCT01029652|594299265|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
164526571|NCT01029652|594299266|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
164526572|NCT01029652|594299265|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
164526573|NCT01029652|594299266|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
164526574|NCT01029652|594299265|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
164526575|NCT01029652|594299266|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
164526576|NCT00523640|594299267|FG000|Overall Study|Death|1|||
164526577|NCT02334423|594299268|FG000|Overall Study|Protocol Violation|10|||
164526578|NCT02334423|594299269|FG001|Overall Study|Protocol Violation|3|||
164526579|NCT01076647|594299270|FG000|Overall Study|Adverse Event|4|||
164526580|NCT01076647|594299271|FG001|Overall Study|Adverse Event|1|||
164526581|NCT01076647|594299270|FG000|Overall Study|Lack of Efficacy|0|||
164526582|NCT01076647|594299271|FG001|Overall Study|Lack of Efficacy|1|||
164526583|NCT01076647|594299270|FG000|Overall Study|Protocol Violation|7|||
164526584|NCT01076647|594299271|FG001|Overall Study|Protocol Violation|9|||
164526585|NCT01076647|594299270|FG000|Overall Study|Withdrawal criteria|2|||
164526586|NCT01076647|594299271|FG001|Overall Study|Withdrawal criteria|2|||
164526587|NCT01076647|594299270|FG000|Overall Study|Unclassified|12|||
164526588|NCT01076647|594299271|FG001|Overall Study|Unclassified|12|||
164526589|NCT04426851|594299272|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
164526590|NCT04426851|594299273|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
164526591|NCT04426851|594299272|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
164526592|NCT04426851|594299273|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
164526593|NCT03256851|594299275|FG000|Overall Study|Withdrawal by Subject|1|||
164526594|NCT03256851|594299276|FG001|Overall Study|Withdrawal by Subject|0|||
164526595|NCT03625895|594299277|FG000|Overall Study|Protocol Violation|585|||
164526596|NCT02081417|594299278|FG000|Overall Study|Lost to Follow-up|26|||
164526597|NCT02081417|594299279|FG001|Overall Study|Lost to Follow-up|23|||
164526598|NCT02081417|594299278|FG000|Overall Study|Moved Away|1|||
164526599|NCT02081417|594299279|FG001|Overall Study|Moved Away|2|||
164526600|NCT02081417|594299278|FG000|Overall Study|Incarcerated|2|||
164526601|NCT02081417|594299279|FG001|Overall Study|Incarcerated|2|||
164526602|NCT02081417|594299278|FG000|Overall Study|Death|4|||
164526603|NCT02081417|594299279|FG001|Overall Study|Death|3|||
164526604|NCT02081417|594299278|FG000|Overall Study|Withdrawal by Subject|4|||
164526605|NCT02081417|594299279|FG001|Overall Study|Withdrawal by Subject|0|||
164526606|NCT02081417|594299278|FG000|Overall Study|Admitted to Residential Treatment|2|||
164623940|NCT01004861|594644594|FG001|Overall Study|Physician Decision|2|||
164526607|NCT02081417|594299279|FG001|Overall Study|Admitted to Residential Treatment|0|||
164623941|NCT01004861|594644595|FG002|Overall Study|Physician Decision|1|||
164623942|NCT01004861|594644596|FG003|Overall Study|Physician Decision|1|||
164623943|NCT01004861|594644597|FG004|Overall Study|Physician Decision|1|||
164623944|NCT01004861|594644598|FG005|Overall Study|Physician Decision|0|||
164623945|NCT01004861|594644599|FG006|Overall Study|Physician Decision|0|||
164526608|NCT02081417|594299278|FG000|Overall Study|Did not start treatment|17|||
164526609|NCT02081417|594299279|FG001|Overall Study|Did not start treatment|21|||
164526610|NCT01065844|594299282|FG000|Overall Study|Adverse Event|5|||
164526611|NCT03545503|594299284|FG000|Overall Study|Protocol Violation|14|||
164526612|NCT03545503|594299285|FG001|Overall Study|Protocol Violation|16|||
164526613|NCT02483585|594299286|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
164526614|NCT02483585|594299287|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
164526615|NCT02483585|594299286|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
164526616|NCT02483585|594299287|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
164526617|NCT02483585|594299286|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
164526618|NCT02483585|594299287|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
164526619|NCT02483585|594299286|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
164526620|NCT02483585|594299287|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
164526621|NCT02483585|594299286|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
164526622|NCT02483585|594299287|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
164526623|NCT02483585|594299286|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
164526624|NCT02483585|594299287|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
164526625|NCT02483585|594299286|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
164526626|NCT02483585|594299287|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
164526627|NCT01778023|594299289|FG000|Overall Study|Withdrawal by Subject|0|||
164526628|NCT01778023|594299290|FG001|Overall Study|Withdrawal by Subject|3|||
164526629|NCT01098097|594299291|FG000|Overall Study|Adverse Event|17|||
164526630|NCT01098097|594299291|FG000|Overall Study|Lost to Follow-up|18|||
164526631|NCT01098097|594299291|FG000|Overall Study|Status unknown|16|||
164526632|NCT01098097|594299291|FG000|Overall Study|No reason reported|31|||
164526633|NCT01502631|594299296|FG000|Overall Study|Adverse Event|5|||
164526634|NCT01502631|594299297|FG001|Overall Study|Adverse Event|8|||
164526635|NCT01502631|594299296|FG000|Overall Study|Lost to Follow-up|2|||
164526636|NCT01502631|594299297|FG001|Overall Study|Lost to Follow-up|2|||
164526637|NCT01502631|594299296|FG000|Overall Study|Participant withdrew consent|2|||
164526638|NCT01502631|594299297|FG001|Overall Study|Participant withdrew consent|4|||
164526639|NCT01502631|594299296|FG000|Overall Study|Participant non-compliant|1|||
164526640|NCT01502631|594299297|FG001|Overall Study|Participant non-compliant|0|||
164526641|NCT01502631|594299296|FG000|Overall Study|Investigator's decision|0|||
164526642|NCT01502631|594299297|FG001|Overall Study|Investigator's decision|1|||
164526643|NCT01502631|594299296|FG000|Overall Study|Other|10|||
164526644|NCT01502631|594299297|FG001|Overall Study|Other|5|||
164526645|NCT01000636|594299300|FG000|Overall Study|Withdrawal by Subject|1|||
164526646|NCT01000636|594299300|FG000|Overall Study|Adverse Event|1|||
164526647|NCT02424734|594299302|FG000|Overall Study|Treatment stopped to be discharged home|2|||
164526648|NCT02424734|594299303|FG001|Overall Study|Treatment stopped to be discharged home|2|||
164526649|NCT02424734|594299304|FG002|Overall Study|Treatment stopped to be discharged home|0|||
164526650|NCT01445301|594299305|FG000|Overall Study|Adverse Event|15|||
164526651|NCT01445301|594299306|FG001|Overall Study|Adverse Event|25|||
164526652|NCT01445301|594299307|FG002|Overall Study|Adverse Event|4|||
164526653|NCT01445301|594299305|FG000|Overall Study|Lack of Efficacy|0|||
164526654|NCT01445301|594299306|FG001|Overall Study|Lack of Efficacy|1|||
164526655|NCT01445301|594299307|FG002|Overall Study|Lack of Efficacy|0|||
164526656|NCT01445301|594299305|FG000|Overall Study|Protocol Violation|1|||
164526657|NCT01445301|594299306|FG001|Overall Study|Protocol Violation|0|||
164526658|NCT01445301|594299307|FG002|Overall Study|Protocol Violation|0|||
164526659|NCT01445301|594299305|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
164526660|NCT01445301|594299306|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
164526661|NCT01445301|594299307|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
164526662|NCT01445301|594299305|FG000|Overall Study|Physician Decision|0|||
164526663|NCT01445301|594299306|FG001|Overall Study|Physician Decision|2|||
164526664|NCT01445301|594299307|FG002|Overall Study|Physician Decision|0|||
164526665|NCT01445301|594299305|FG000|Overall Study|Withdrawal by Subject|5|||
164526666|NCT01445301|594299306|FG001|Overall Study|Withdrawal by Subject|6|||
164526667|NCT01445301|594299307|FG002|Overall Study|Withdrawal by Subject|4|||
164526668|NCT00752557|594299308|FG000|Overall Study|Withdrawal by Subject|4|||
164526669|NCT00752557|594299309|FG001|Overall Study|Withdrawal by Subject|3|||
164526670|NCT00752557|594299310|FG002|Overall Study|Withdrawal by Subject|3|||
164526671|NCT00752557|594299308|FG000|Overall Study|Unspecified resaons|0|||
164526672|NCT00752557|594299309|FG001|Overall Study|Unspecified resaons|2|||
164623946|NCT01004861|594644600|FG007|Overall Study|Physician Decision|1|||
164623947|NCT01004861|594644601|FG008|Overall Study|Physician Decision|0|||
164623948|NCT01004861|594644602|FG009|Overall Study|Physician Decision|0|||
164623949|NCT01004861|594644603|FG010|Overall Study|Physician Decision|0|||
164623950|NCT01004861|594644604|FG011|Overall Study|Physician Decision|0|||
164623951|NCT01004861|594644605|FG012|Overall Study|Physician Decision|3|||
164623952|NCT01004861|594644593|FG000|Overall Study|Adverse Event|0|||
164623953|NCT01004861|594644594|FG001|Overall Study|Adverse Event|0|||
164623954|NCT01004861|594644595|FG002|Overall Study|Adverse Event|0|||
164623955|NCT01004861|594644596|FG003|Overall Study|Adverse Event|1|||
164623956|NCT01004861|594644597|FG004|Overall Study|Adverse Event|0|||
164623957|NCT01004861|594644598|FG005|Overall Study|Adverse Event|2|||
164623958|NCT01004861|594644599|FG006|Overall Study|Adverse Event|1|||
164623959|NCT01004861|594644600|FG007|Overall Study|Adverse Event|1|||
164623960|NCT01004861|594644601|FG008|Overall Study|Adverse Event|13|||
164623961|NCT01004861|594644602|FG009|Overall Study|Adverse Event|1|||
164623962|NCT01004861|594644603|FG010|Overall Study|Adverse Event|1|||
164623963|NCT01004861|594644604|FG011|Overall Study|Adverse Event|0|||
164623964|NCT01004861|594644605|FG012|Overall Study|Adverse Event|2|||
164623965|NCT01004861|594644593|FG000|Overall Study|Protocol Violation|0|||
164623966|NCT01004861|594644594|FG001|Overall Study|Protocol Violation|0|||
164623967|NCT01004861|594644595|FG002|Overall Study|Protocol Violation|0|||
164623968|NCT01004861|594644596|FG003|Overall Study|Protocol Violation|0|||
164623969|NCT01004861|594644597|FG004|Overall Study|Protocol Violation|1|||
164623970|NCT01004861|594644598|FG005|Overall Study|Protocol Violation|0|||
164623971|NCT01004861|594644599|FG006|Overall Study|Protocol Violation|0|||
164623972|NCT01004861|594644600|FG007|Overall Study|Protocol Violation|0|||
164623973|NCT01004861|594644601|FG008|Overall Study|Protocol Violation|0|||
164623974|NCT01004861|594644602|FG009|Overall Study|Protocol Violation|0|||
164623975|NCT01004861|594644603|FG010|Overall Study|Protocol Violation|0|||
164623976|NCT01004861|594644604|FG011|Overall Study|Protocol Violation|0|||
164623977|NCT01004861|594644605|FG012|Overall Study|Protocol Violation|0|||
164623978|NCT01004861|594644593|FG000|Overall Study|Lost to Follow-up|0|||
164623979|NCT01004861|594644594|FG001|Overall Study|Lost to Follow-up|0|||
164526673|NCT00752557|594299310|FG002|Overall Study|Unspecified resaons|2|||
164623980|NCT01004861|594644595|FG002|Overall Study|Lost to Follow-up|0|||
164623981|NCT01004861|594644596|FG003|Overall Study|Lost to Follow-up|0|||
164623982|NCT01004861|594644597|FG004|Overall Study|Lost to Follow-up|0|||
164623983|NCT01004861|594644598|FG005|Overall Study|Lost to Follow-up|0|||
164623984|NCT01004861|594644599|FG006|Overall Study|Lost to Follow-up|0|||
164623985|NCT01004861|594644600|FG007|Overall Study|Lost to Follow-up|1|||
164623986|NCT01004861|594644601|FG008|Overall Study|Lost to Follow-up|3|||
164623987|NCT01004861|594644602|FG009|Overall Study|Lost to Follow-up|0|||
164623988|NCT01004861|594644603|FG010|Overall Study|Lost to Follow-up|0|||
164623989|NCT01004861|594644604|FG011|Overall Study|Lost to Follow-up|1|||
164623990|NCT01004861|594644605|FG012|Overall Study|Lost to Follow-up|0|||
164623991|NCT01004861|594644593|FG000|Overall Study|Non-compliance|0|||
164623992|NCT01004861|594644594|FG001|Overall Study|Non-compliance|0|||
164623993|NCT01004861|594644595|FG002|Overall Study|Non-compliance|0|||
164623994|NCT01004861|594644596|FG003|Overall Study|Non-compliance|0|||
164623995|NCT01004861|594644597|FG004|Overall Study|Non-compliance|0|||
164623996|NCT01004861|594644598|FG005|Overall Study|Non-compliance|0|||
164623997|NCT01004861|594644599|FG006|Overall Study|Non-compliance|0|||
164623998|NCT01004861|594644600|FG007|Overall Study|Non-compliance|0|||
164623999|NCT01004861|594644601|FG008|Overall Study|Non-compliance|5|||
164624000|NCT01004861|594644602|FG009|Overall Study|Non-compliance|0|||
164624001|NCT01004861|594644603|FG010|Overall Study|Non-compliance|0|||
164624002|NCT01004861|594644604|FG011|Overall Study|Non-compliance|0|||
164624003|NCT01004861|594644605|FG012|Overall Study|Non-compliance|1|||
164624004|NCT01004861|594644593|FG000|Overall Study|Other|0|||
164624005|NCT01004861|594644594|FG001|Overall Study|Other|0|||
164624006|NCT01004861|594644595|FG002|Overall Study|Other|0|||
164624007|NCT01004861|594644596|FG003|Overall Study|Other|0|||
164624008|NCT01004861|594644597|FG004|Overall Study|Other|0|||
164624009|NCT01004861|594644598|FG005|Overall Study|Other|0|||
164624010|NCT01004861|594644599|FG006|Overall Study|Other|0|||
164624011|NCT01004861|594644600|FG007|Overall Study|Other|0|||
164624012|NCT01004861|594644601|FG008|Overall Study|Other|0|||
164624013|NCT01004861|594644602|FG009|Overall Study|Other|2|||
164624014|NCT01004861|594644603|FG010|Overall Study|Other|1|||
164624015|NCT01004861|594644604|FG011|Overall Study|Other|2|||
164624016|NCT01004861|594644605|FG012|Overall Study|Other|3|||
164624017|NCT01004861|594644593|FG000|Overall Study|Patient decision|0|||
164624018|NCT01004861|594644594|FG001|Overall Study|Patient decision|0|||
164624019|NCT01004861|594644595|FG002|Overall Study|Patient decision|0|||
164624020|NCT01004861|594644596|FG003|Overall Study|Patient decision|0|||
164624021|NCT01004861|594644597|FG004|Overall Study|Patient decision|1|||
164624022|NCT01004861|594644598|FG005|Overall Study|Patient decision|0|||
164624023|NCT01004861|594644599|FG006|Overall Study|Patient decision|1|||
164624024|NCT01004861|594644600|FG007|Overall Study|Patient decision|0|||
164624025|NCT01004861|594644601|FG008|Overall Study|Patient decision|7|||
164624026|NCT01004861|594644602|FG009|Overall Study|Patient decision|1|||
164624027|NCT01004861|594644603|FG010|Overall Study|Patient decision|1|||
164624028|NCT01004861|594644604|FG011|Overall Study|Patient decision|2|||
164624029|NCT01004861|594644605|FG012|Overall Study|Patient decision|3|||
164624030|NCT01004861|594644593|FG000|Overall Study|Transitioned to Phase 4 study|0|||
164624031|NCT01004861|594644594|FG001|Overall Study|Transitioned to Phase 4 study|0|||
164624032|NCT01004861|594644595|FG002|Overall Study|Transitioned to Phase 4 study|0|||
164624033|NCT01004861|594644596|FG003|Overall Study|Transitioned to Phase 4 study|0|||
164624034|NCT01004861|594644597|FG004|Overall Study|Transitioned to Phase 4 study|0|||
164624035|NCT01004861|594644598|FG005|Overall Study|Transitioned to Phase 4 study|0|||
164624036|NCT01004861|594644599|FG006|Overall Study|Transitioned to Phase 4 study|0|||
164624037|NCT01004861|594644600|FG007|Overall Study|Transitioned to Phase 4 study|0|||
164624038|NCT01004861|594644601|FG008|Overall Study|Transitioned to Phase 4 study|2|||
164624039|NCT01004861|594644602|FG009|Overall Study|Transitioned to Phase 4 study|0|||
164624040|NCT01004861|594644603|FG010|Overall Study|Transitioned to Phase 4 study|0|||
164624041|NCT01004861|594644604|FG011|Overall Study|Transitioned to Phase 4 study|0|||
164624042|NCT01004861|594644605|FG012|Overall Study|Transitioned to Phase 4 study|0|||
164624043|NCT01004861|594644593|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
164624044|NCT01004861|594644594|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
164624045|NCT01004861|594644595|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
164624046|NCT01004861|594644596|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
164624047|NCT01004861|594644597|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
164624048|NCT01004861|594644598|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
164624049|NCT01004861|594644599|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
164624050|NCT01004861|594644600|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
164624051|NCT01004861|594644601|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
164624052|NCT01004861|594644602|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
164624053|NCT01004861|594644603|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
164624054|NCT01004861|594644604|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
164624055|NCT01004861|594644605|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
164624056|NCT01004861|594644593|FG000|Overall Study|Patient withdrew|0|||
164624057|NCT01004861|594644594|FG001|Overall Study|Patient withdrew|0|||
164624058|NCT01004861|594644595|FG002|Overall Study|Patient withdrew|0|||
164624059|NCT01004861|594644596|FG003|Overall Study|Patient withdrew|0|||
164624060|NCT01004861|594644597|FG004|Overall Study|Patient withdrew|0|||
164624061|NCT01004861|594644598|FG005|Overall Study|Patient withdrew|0|||
164624062|NCT01004861|594644599|FG006|Overall Study|Patient withdrew|0|||
164624063|NCT01004861|594644600|FG007|Overall Study|Patient withdrew|0|||
164624064|NCT01004861|594644601|FG008|Overall Study|Patient withdrew|1|||
164624065|NCT01004861|594644602|FG009|Overall Study|Patient withdrew|0|||
164624066|NCT01004861|594644603|FG010|Overall Study|Patient withdrew|0|||
164624067|NCT01004861|594644604|FG011|Overall Study|Patient withdrew|0|||
164624068|NCT01004861|594644605|FG012|Overall Study|Patient withdrew|0|||
164624069|NCT01004861|594644593|FG000|Overall Study|Surgical resection|0|||
164624070|NCT01004861|594644594|FG001|Overall Study|Surgical resection|0|||
164624071|NCT01004861|594644595|FG002|Overall Study|Surgical resection|0|||
164624072|NCT01004861|594644596|FG003|Overall Study|Surgical resection|0|||
164624073|NCT01004861|594644597|FG004|Overall Study|Surgical resection|0|||
164624074|NCT01004861|594644598|FG005|Overall Study|Surgical resection|0|||
164624075|NCT01004861|594644599|FG006|Overall Study|Surgical resection|0|||
164624076|NCT01004861|594644600|FG007|Overall Study|Surgical resection|0|||
164624077|NCT01004861|594644601|FG008|Overall Study|Surgical resection|1|||
164624078|NCT01004861|594644602|FG009|Overall Study|Surgical resection|0|||
164624079|NCT01004861|594644603|FG010|Overall Study|Surgical resection|0|||
164624080|NCT01004861|594644604|FG011|Overall Study|Surgical resection|0|||
164624081|NCT01004861|594644605|FG012|Overall Study|Surgical resection|0|||
164624082|NCT01004861|594644593|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
164624083|NCT01004861|594644594|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
164624084|NCT01004861|594644595|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
164624085|NCT01004861|594644596|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
164624086|NCT01004861|594644597|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
164624087|NCT01004861|594644598|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
164624088|NCT01004861|594644599|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
164624089|NCT01004861|594644600|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
164624090|NCT01004861|594644601|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
164624091|NCT01004861|594644602|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
164624092|NCT01004861|594644603|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
164624093|NCT01004861|594644604|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
164624094|NCT01004861|594644605|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
164624095|NCT01004861|594644593|FG000|Overall Study|Study termination by Sponsor|0|||
164624096|NCT01004861|594644594|FG001|Overall Study|Study termination by Sponsor|0|||
164624097|NCT01004861|594644595|FG002|Overall Study|Study termination by Sponsor|0|||
164624098|NCT01004861|594644596|FG003|Overall Study|Study termination by Sponsor|0|||
164624099|NCT01004861|594644597|FG004|Overall Study|Study termination by Sponsor|0|||
164624100|NCT01004861|594644598|FG005|Overall Study|Study termination by Sponsor|0|||
164624101|NCT01004861|594644599|FG006|Overall Study|Study termination by Sponsor|0|||
164624102|NCT01004861|594644600|FG007|Overall Study|Study termination by Sponsor|0|||
164624103|NCT01004861|594644601|FG008|Overall Study|Study termination by Sponsor|1|||
164624104|NCT01004861|594644602|FG009|Overall Study|Study termination by Sponsor|0|||
164624105|NCT01004861|594644603|FG010|Overall Study|Study termination by Sponsor|0|||
164624106|NCT01004861|594644604|FG011|Overall Study|Study termination by Sponsor|0|||
164624107|NCT01004861|594644605|FG012|Overall Study|Study termination by Sponsor|0|||
164624108|NCT04610827|594644607|FG000|Overall Study|Withdrawal by Subject|1|||
164624109|NCT04610827|594644608|FG001|Overall Study|Withdrawal by Subject|1|||
164624110|NCT04610827|594644609|FG002|Overall Study|Withdrawal by Subject|0|||
164624111|NCT01823991|594644610|FG000|Overall Study|Withdrawal by Subject|8|||
164624112|NCT01823991|594644611|FG001|Overall Study|Withdrawal by Subject|5|||
164624113|NCT00805194|594644612|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
164624114|NCT00805194|594644613|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
164624115|NCT00805194|594644612|FG000|Overall Study|Worsening or AE of underlying disease|64|||
164624116|NCT00805194|594644613|FG001|Overall Study|Worsening or AE of underlying disease|70|||
164624117|NCT00805194|594644612|FG000|Overall Study|Other AE|84|||
164624118|NCT00805194|594644613|FG001|Overall Study|Other AE|73|||
164624119|NCT00805194|594644612|FG000|Overall Study|Protocol Violation|9|||
164624120|NCT00805194|594644613|FG001|Overall Study|Protocol Violation|9|||
164624121|NCT00805194|594644612|FG000|Overall Study|Lost to Follow-up|5|||
164624122|NCT00805194|594644613|FG001|Overall Study|Lost to Follow-up|5|||
164624123|NCT00805194|594644612|FG000|Overall Study|Withdrawal by Subject|60|||
164624124|NCT00805194|594644613|FG001|Overall Study|Withdrawal by Subject|42|||
164624125|NCT00805194|594644612|FG000|Overall Study|Not treated|3|||
164624126|NCT00805194|594644613|FG001|Overall Study|Not treated|4|||
164624127|NCT00805194|594644612|FG000|Overall Study|Reasons other than stated above|20|||
164624128|NCT00805194|594644613|FG001|Overall Study|Reasons other than stated above|16|||
164624129|NCT02185040|594644617|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
164624130|NCT02185040|594644618|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
164624131|NCT02185040|594644619|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
164624132|NCT02185040|594644620|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
164624133|NCT02185040|594644621|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
164624134|NCT02185040|594644622|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
164624135|NCT02185040|594644623|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
164624136|NCT02185040|594644617|FG000|Part 1 Treatment Phase|Adverse Event|1|||
164624137|NCT02185040|594644618|FG001|Part 1 Treatment Phase|Adverse Event|0|||
164624138|NCT02185040|594644619|FG002|Part 1 Treatment Phase|Adverse Event|0|||
164624139|NCT02185040|594644620|FG003|Part 1 Treatment Phase|Adverse Event|2|||
164624140|NCT02185040|594644621|FG004|Part 1 Treatment Phase|Adverse Event|3|||
164624141|NCT02185040|594644622|FG005|Part 1 Treatment Phase|Adverse Event|0|||
164624142|NCT02185040|594644623|FG006|Part 1 Treatment Phase|Adverse Event|0|||
164624143|NCT02185040|594644617|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
164624144|NCT02185040|594644618|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
164624145|NCT02185040|594644619|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
164624146|NCT02185040|594644620|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
164624147|NCT02185040|594644621|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
164624148|NCT02185040|594644622|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
164624149|NCT02185040|594644623|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
164624150|NCT02185040|594644617|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
164624151|NCT02185040|594644618|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
164624152|NCT02185040|594644619|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
164624153|NCT02185040|594644620|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
164624154|NCT02185040|594644621|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
164624155|NCT02185040|594644622|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
164624156|NCT02185040|594644623|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
164624157|NCT02185040|594644617|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
164624158|NCT02185040|594644618|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
164624159|NCT02185040|594644619|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
164624160|NCT02185040|594644620|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
164624161|NCT02185040|594644621|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
164624162|NCT02185040|594644622|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
164624163|NCT02185040|594644623|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
164624164|NCT02185040|594644617|FG000|Active Treatment Extension Phase|Adverse Event|0|||
164624165|NCT02185040|594644618|FG001|Active Treatment Extension Phase|Adverse Event|0|||
164624166|NCT02185040|594644619|FG002|Active Treatment Extension Phase|Adverse Event|0|||
164526674|NCT00752557|594299308|FG000|Overall Study|Lost to Follow-up|1|||
164526675|NCT00752557|594299309|FG001|Overall Study|Lost to Follow-up|0|||
164526676|NCT00752557|594299310|FG002|Overall Study|Lost to Follow-up|1|||
164526677|NCT02150343|594299311|FG000|Overall Study|Adverse Event|2|||
164526678|NCT02150343|594299312|FG001|Overall Study|Adverse Event|0|||
164526679|NCT02150343|594299313|FG002|Overall Study|Adverse Event|1|||
164526680|NCT02150343|594299314|FG003|Overall Study|Adverse Event|1|||
164526681|NCT02150343|594299311|FG000|Overall Study|Withdrawal by Subject|13|||
164526682|NCT02150343|594299312|FG001|Overall Study|Withdrawal by Subject|10|||
164526683|NCT02150343|594299313|FG002|Overall Study|Withdrawal by Subject|9|||
164526684|NCT02150343|594299314|FG003|Overall Study|Withdrawal by Subject|4|||
164526685|NCT02150343|594299311|FG000|Overall Study|Lost to Follow-up|4|||
164526686|NCT02150343|594299312|FG001|Overall Study|Lost to Follow-up|4|||
164526687|NCT02150343|594299313|FG002|Overall Study|Lost to Follow-up|2|||
164526688|NCT02150343|594299314|FG003|Overall Study|Lost to Follow-up|3|||
164526689|NCT02150343|594299311|FG000|Overall Study|Other|2|||
164526690|NCT02150343|594299312|FG001|Overall Study|Other|6|||
164526691|NCT02150343|594299313|FG002|Overall Study|Other|0|||
164526692|NCT02150343|594299314|FG003|Overall Study|Other|2|||
164526693|NCT00190749|594299315|FG000|Overall Study|Lost to Follow-up|8|||
164526694|NCT00190749|594299316|FG001|Overall Study|Lost to Follow-up|11|||
164526695|NCT00190749|594299315|FG000|Overall Study|Withdrawal by Subject|10|||
164624167|NCT02185040|594644620|FG003|Active Treatment Extension Phase|Adverse Event|0|||
164624168|NCT02185040|594644621|FG004|Active Treatment Extension Phase|Adverse Event|0|||
164526696|NCT00190749|594299316|FG001|Overall Study|Withdrawal by Subject|6|||
164526697|NCT00190749|594299315|FG000|Overall Study|Protocol Violation|5|||
164624169|NCT02185040|594644622|FG005|Active Treatment Extension Phase|Adverse Event|1|||
164526698|NCT00190749|594299316|FG001|Overall Study|Protocol Violation|4|||
164526699|NCT00190749|594299315|FG000|Overall Study|Adverse Event|0|||
164526700|NCT00190749|594299316|FG001|Overall Study|Adverse Event|5|||
164526701|NCT00190749|594299315|FG000|Overall Study|Lack of Efficacy|2|||
164526702|NCT00190749|594299316|FG001|Overall Study|Lack of Efficacy|3|||
164526703|NCT00190749|594299315|FG000|Overall Study|Reason Not Specified|0|||
164526704|NCT00190749|594299316|FG001|Overall Study|Reason Not Specified|2|||
164526705|NCT00190749|594299315|FG000|Overall Study|Sponsor Decision|1|||
164526706|NCT00190749|594299316|FG001|Overall Study|Sponsor Decision|0|||
164526707|NCT00439231|594299317|FG000|Overall Study|Lack of Efficacy|28|||
164526708|NCT04493502|594299318|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
164526709|NCT04493502|594299319|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
164526710|NCT04493502|594299318|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
164526711|NCT04493502|594299319|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
164526712|NCT04493502|594299318|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
164526713|NCT04493502|594299319|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
164526714|NCT04493502|594299318|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
164526715|NCT04493502|594299319|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
164526716|NCT04493502|594299318|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
164526717|NCT04493502|594299319|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
164526718|NCT04493502|594299318|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
164526719|NCT04493502|594299319|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
164526720|NCT04493502|594299318|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
164526721|NCT04493502|594299319|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
164526722|NCT04493502|594299318|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
164526723|NCT04493502|594299319|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
164526724|NCT04493502|594299318|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
164526725|NCT04493502|594299319|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
164624170|NCT02185040|594644623|FG006|Active Treatment Extension Phase|Adverse Event|4|||
164624171|NCT02185040|594644617|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
164624172|NCT02185040|594644618|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
164624173|NCT02185040|594644619|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
164624174|NCT02185040|594644620|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
164624175|NCT02185040|594644621|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
164624176|NCT02185040|594644622|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
164624177|NCT02185040|594644623|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
164624178|NCT02185040|594644617|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
164624179|NCT02185040|594644618|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
164624180|NCT02185040|594644619|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
164624181|NCT02185040|594644620|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
164624182|NCT02185040|594644621|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
164624183|NCT02185040|594644622|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
164624184|NCT02185040|594644623|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
164624185|NCT00718887|594644627|FG000|Overall Study|Withdrawal by Subject|3|||
164624186|NCT00718887|594644628|FG001|Overall Study|Withdrawal by Subject|2|||
164624187|NCT00718887|594644627|FG000|Overall Study|Not identified|2|||
164624188|NCT00718887|594644628|FG001|Overall Study|Not identified|7|||
164624189|NCT03557801|594644631|FG000|Overall Study|Protocol Violation|1|||
164624190|NCT03557801|594644632|FG001|Overall Study|Protocol Violation|0|||
164624191|NCT03557801|594644633|FG002|Overall Study|Protocol Violation|0|||
164624192|NCT03557801|594644631|FG000|Overall Study|Withdrawal by Subject|1|||
164624193|NCT03557801|594644632|FG001|Overall Study|Withdrawal by Subject|0|||
164624194|NCT03557801|594644633|FG002|Overall Study|Withdrawal by Subject|3|||
164624195|NCT03557801|594644631|FG000|Overall Study|Lost to Follow-up|0|||
164624196|NCT03557801|594644632|FG001|Overall Study|Lost to Follow-up|1|||
164624197|NCT03557801|594644633|FG002|Overall Study|Lost to Follow-up|0|||
164624198|NCT00535236|594644634|FG000|Overall Study|Adverse Event|1|||
164624199|NCT00535236|594644635|FG001|Overall Study|Adverse Event|0|||
164624200|NCT00535236|594644636|FG002|Overall Study|Adverse Event|9|||
164624201|NCT00535236|594644637|FG003|Overall Study|Adverse Event|3|||
164624202|NCT00535236|594644638|FG004|Overall Study|Adverse Event|3|||
164624203|NCT00535236|594644639|FG005|Overall Study|Adverse Event|0|||
164624204|NCT00535236|594644640|FG006|Overall Study|Adverse Event|5|||
164624205|NCT00535236|594644641|FG007|Overall Study|Adverse Event|1|||
164624206|NCT00535236|594644642|FG008|Overall Study|Adverse Event|2|||
164624207|NCT00535236|594644643|FG009|Overall Study|Adverse Event|1|||
164624208|NCT00535236|594644634|FG000|Overall Study|Lost to Follow-up|1|||
164624209|NCT00535236|594644635|FG001|Overall Study|Lost to Follow-up|2|||
164624210|NCT00535236|594644636|FG002|Overall Study|Lost to Follow-up|0|||
164624211|NCT00535236|594644637|FG003|Overall Study|Lost to Follow-up|0|||
164624212|NCT00535236|594644638|FG004|Overall Study|Lost to Follow-up|2|||
164624213|NCT00535236|594644639|FG005|Overall Study|Lost to Follow-up|0|||
164624214|NCT00535236|594644640|FG006|Overall Study|Lost to Follow-up|0|||
164624215|NCT00535236|594644641|FG007|Overall Study|Lost to Follow-up|0|||
164624216|NCT00535236|594644642|FG008|Overall Study|Lost to Follow-up|6|||
164624217|NCT00535236|594644643|FG009|Overall Study|Lost to Follow-up|1|||
164624218|NCT00535236|594644634|FG000|Overall Study|Physician Decision|0|||
164624219|NCT00535236|594644635|FG001|Overall Study|Physician Decision|0|||
164624220|NCT00535236|594644636|FG002|Overall Study|Physician Decision|0|||
164624221|NCT00535236|594644637|FG003|Overall Study|Physician Decision|0|||
164624222|NCT00535236|594644638|FG004|Overall Study|Physician Decision|1|||
164624223|NCT00535236|594644639|FG005|Overall Study|Physician Decision|0|||
164624224|NCT00535236|594644640|FG006|Overall Study|Physician Decision|1|||
164624225|NCT00535236|594644641|FG007|Overall Study|Physician Decision|0|||
164624226|NCT00535236|594644642|FG008|Overall Study|Physician Decision|0|||
164624227|NCT00535236|594644643|FG009|Overall Study|Physician Decision|0|||
164624228|NCT00535236|594644634|FG000|Overall Study|Protocol Violation|2|||
164624229|NCT00535236|594644635|FG001|Overall Study|Protocol Violation|0|||
164624230|NCT00535236|594644636|FG002|Overall Study|Protocol Violation|1|||
164624231|NCT00535236|594644637|FG003|Overall Study|Protocol Violation|0|||
164624232|NCT00535236|594644638|FG004|Overall Study|Protocol Violation|0|||
164624233|NCT00535236|594644639|FG005|Overall Study|Protocol Violation|0|||
164624234|NCT00535236|594644640|FG006|Overall Study|Protocol Violation|0|||
164624235|NCT00535236|594644641|FG007|Overall Study|Protocol Violation|0|||
164624236|NCT00535236|594644642|FG008|Overall Study|Protocol Violation|1|||
164624237|NCT00535236|594644643|FG009|Overall Study|Protocol Violation|0|||
164624238|NCT00535236|594644634|FG000|Overall Study|Withdrawal by Subject|3|||
164624239|NCT00535236|594644635|FG001|Overall Study|Withdrawal by Subject|0|||
164526726|NCT04493502|594299318|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
164624240|NCT00535236|594644636|FG002|Overall Study|Withdrawal by Subject|2|||
164624241|NCT00535236|594644637|FG003|Overall Study|Withdrawal by Subject|1|||
164624242|NCT00535236|594644638|FG004|Overall Study|Withdrawal by Subject|6|||
164624243|NCT00535236|594644639|FG005|Overall Study|Withdrawal by Subject|1|||
164624244|NCT00535236|594644640|FG006|Overall Study|Withdrawal by Subject|5|||
164624245|NCT00535236|594644641|FG007|Overall Study|Withdrawal by Subject|0|||
164624246|NCT00535236|594644642|FG008|Overall Study|Withdrawal by Subject|4|||
164624247|NCT00535236|594644643|FG009|Overall Study|Withdrawal by Subject|2|||
164624248|NCT03558503|594644645|FG000|Overall Study|Adverse Event|1|||
164624249|NCT03558503|594644645|FG000|Overall Study|Death|1|||
164624250|NCT03558503|594644645|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
164624251|NCT00561795|594644646|FG000|Overall Study|Adverse Event|3|||
164624252|NCT00561795|594644647|FG001|Overall Study|Adverse Event|3|||
164624253|NCT00561795|594644648|FG002|Overall Study|Adverse Event|0|||
164624254|NCT00561795|594644649|FG003|Overall Study|Adverse Event|0|||
164624255|NCT00561795|594644646|FG000|Overall Study|Study Closed/Terminated|0|||
164624256|NCT00561795|594644647|FG001|Overall Study|Study Closed/Terminated|3|||
164624257|NCT00561795|594644648|FG002|Overall Study|Study Closed/Terminated|0|||
164624258|NCT00561795|594644649|FG003|Overall Study|Study Closed/Terminated|0|||
164624259|NCT00561795|594644646|FG000|Overall Study|Physician Decision|1|||
164624260|NCT00561795|594644647|FG001|Overall Study|Physician Decision|0|||
164624261|NCT00561795|594644648|FG002|Overall Study|Physician Decision|0|||
164624262|NCT00561795|594644649|FG003|Overall Study|Physician Decision|0|||
164624263|NCT02094612|594644650|FG000|Overall Study|Lost to Follow-up|47|||
164624264|NCT02094612|594644651|FG001|Overall Study|Lost to Follow-up|47|||
164624265|NCT02094612|594644650|FG000|Overall Study|Never started ADHD medication|32|||
164624266|NCT02094612|594644651|FG001|Overall Study|Never started ADHD medication|23|||
164624267|NCT04167514|594644652|FG000|Overall Study|Adverse event, not serious|0|||
164624268|NCT04167514|594644653|FG001|Overall Study|Adverse event, not serious|1|||
164624269|NCT04167514|594644652|FG000|Overall Study|Lost to Follow-up|1|||
164624270|NCT04167514|594644653|FG001|Overall Study|Lost to Follow-up|0|||
164624271|NCT04167514|594644652|FG000|Overall Study|Participant Decision|2|||
164624272|NCT04167514|594644653|FG001|Overall Study|Participant Decision|4|||
164624273|NCT04167514|594644652|FG000|Overall Study|Physician Decision|3|||
164624274|NCT04167514|594644653|FG001|Overall Study|Physician Decision|2|||
164624275|NCT04167514|594644652|FG000|Overall Study|Death|14|||
164624276|NCT04167514|594644653|FG001|Overall Study|Death|18|||
164624277|NCT04167514|594644652|FG000|Overall Study|Enrolled but treatment not administered|2|||
164624278|NCT04167514|594644653|FG001|Overall Study|Enrolled but treatment not administered|0|||
164624279|NCT04167514|594644652|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
164624280|NCT04167514|594644653|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
164624281|NCT04167514|594644652|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
164624282|NCT04167514|594644653|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
164624283|NCT02646891|594644654|FG000|Overall Study|Adverse Event|0|||
164624284|NCT02646891|594644655|FG001|Overall Study|Adverse Event|1|||
164624285|NCT02646891|594644656|FG002|Overall Study|Adverse Event|0|||
164624286|NCT02646891|594644657|FG003|Overall Study|Adverse Event|0|||
164624287|NCT02646891|594644658|FG004|Overall Study|Adverse Event|0|||
164624288|NCT02646891|594644659|FG005|Overall Study|Adverse Event|0|||
164624289|NCT02646891|594644660|FG006|Overall Study|Adverse Event|0|||
164624290|NCT02646891|594644661|FG007|Overall Study|Adverse Event|0|||
164624291|NCT02646891|594644662|FG008|Overall Study|Adverse Event|0|||
164624292|NCT02646891|594644663|FG009|Overall Study|Adverse Event|0|||
164624293|NCT02646891|594644654|FG000|Overall Study|Lost to Follow-up|0|||
164624294|NCT02646891|594644655|FG001|Overall Study|Lost to Follow-up|0|||
164624295|NCT02646891|594644656|FG002|Overall Study|Lost to Follow-up|0|||
164624296|NCT02646891|594644657|FG003|Overall Study|Lost to Follow-up|0|||
164624297|NCT02646891|594644658|FG004|Overall Study|Lost to Follow-up|0|||
164624298|NCT02646891|594644659|FG005|Overall Study|Lost to Follow-up|0|||
164624299|NCT02646891|594644660|FG006|Overall Study|Lost to Follow-up|2|||
164624300|NCT02646891|594644661|FG007|Overall Study|Lost to Follow-up|2|||
164624301|NCT02646891|594644662|FG008|Overall Study|Lost to Follow-up|2|||
164624302|NCT02646891|594644663|FG009|Overall Study|Lost to Follow-up|2|||
164624303|NCT02646891|594644654|FG000|Overall Study|Protocol Violation|0|||
164624304|NCT02646891|594644655|FG001|Overall Study|Protocol Violation|0|||
164624305|NCT02646891|594644656|FG002|Overall Study|Protocol Violation|0|||
164624306|NCT02646891|594644657|FG003|Overall Study|Protocol Violation|0|||
164624307|NCT02646891|594644658|FG004|Overall Study|Protocol Violation|0|||
164526727|NCT04493502|594299319|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
164526728|NCT04493502|594299318|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
164526729|NCT04493502|594299319|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
164526730|NCT04493502|594299318|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
164526731|NCT04493502|594299319|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
164526732|NCT04493502|594299318|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
164526733|NCT04493502|594299319|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
164526734|NCT02891408|594299320|FG000|Overall Study|Lost to Follow-up|0|||
164526735|NCT02891408|594299321|FG001|Overall Study|Lost to Follow-up|0|||
164526736|NCT02891408|594299322|FG002|Overall Study|Lost to Follow-up|1|||
164526737|NCT02891408|594299323|FG003|Overall Study|Lost to Follow-up|0|||
164526738|NCT02891408|594299324|FG004|Overall Study|Lost to Follow-up|0|||
164526739|NCT02891408|594299325|FG005|Overall Study|Lost to Follow-up|0|||
164526740|NCT02891408|594299326|FG006|Overall Study|Lost to Follow-up|0|||
164526741|NCT00709852|594299327|FG000|Period 1|Adverse Event|2|||
164526742|NCT00709852|594299328|FG001|Period 1|Adverse Event|0|||
164526743|NCT00709852|594299327|FG000|Period 1|Withdrawal by Subject|4|||
164526744|NCT00709852|594299328|FG001|Period 1|Withdrawal by Subject|2|||
164526745|NCT00709852|594299327|FG000|Period 1|Protocol Violation|1|||
164526746|NCT00709852|594299328|FG001|Period 1|Protocol Violation|0|||
164526747|NCT00709852|594299327|FG000|Period 1|Defective scanner|0|||
164526748|NCT00709852|594299328|FG001|Period 1|Defective scanner|1|||
164526749|NCT00709852|594299327|FG000|Period 1|Lost to Follow-up|1|||
164526750|NCT00709852|594299328|FG001|Period 1|Lost to Follow-up|0|||
164526751|NCT00709852|594299327|FG000|Period 2|Protocol Violation|4|||
164526752|NCT00709852|594299328|FG001|Period 2|Protocol Violation|1|||
164526753|NCT00709852|594299327|FG000|Period 2|Adverse Event|1|||
164526754|NCT00709852|594299328|FG001|Period 2|Adverse Event|1|||
164526755|NCT00709852|594299327|FG000|Period 2|Lost to Follow-up|1|||
164526756|NCT00709852|594299328|FG001|Period 2|Lost to Follow-up|0|||
164526757|NCT00709852|594299327|FG000|Period 2|No 72-hour follow-up|3|||
164526758|NCT00709852|594299328|FG001|Period 2|No 72-hour follow-up|0|||
164526759|NCT01048671|594299329|FG000|Overall Study|Protocol Violation|0|||
164526760|NCT01048671|594299330|FG001|Overall Study|Protocol Violation|1|||
164526761|NCT01048671|594299331|FG002|Overall Study|Protocol Violation|1|||
164624308|NCT02646891|594644659|FG005|Overall Study|Protocol Violation|0|||
164624309|NCT02646891|594644660|FG006|Overall Study|Protocol Violation|1|||
164624310|NCT02646891|594644661|FG007|Overall Study|Protocol Violation|1|||
164624311|NCT02646891|594644662|FG008|Overall Study|Protocol Violation|0|||
164624312|NCT02646891|594644663|FG009|Overall Study|Protocol Violation|0|||
164624313|NCT02646891|594644654|FG000|Overall Study|Withdrawal by Subject|2|||
164624314|NCT02646891|594644655|FG001|Overall Study|Withdrawal by Subject|0|||
164624315|NCT02646891|594644656|FG002|Overall Study|Withdrawal by Subject|1|||
164624316|NCT02646891|594644657|FG003|Overall Study|Withdrawal by Subject|0|||
164624317|NCT02646891|594644658|FG004|Overall Study|Withdrawal by Subject|0|||
164624318|NCT02646891|594644659|FG005|Overall Study|Withdrawal by Subject|0|||
164624319|NCT02646891|594644660|FG006|Overall Study|Withdrawal by Subject|5|||
164624320|NCT02646891|594644661|FG007|Overall Study|Withdrawal by Subject|9|||
164624321|NCT02646891|594644662|FG008|Overall Study|Withdrawal by Subject|7|||
164624322|NCT02646891|594644663|FG009|Overall Study|Withdrawal by Subject|3|||
164624323|NCT02646891|594644654|FG000|Overall Study|Death|0|||
164624324|NCT02646891|594644655|FG001|Overall Study|Death|0|||
164624325|NCT02646891|594644656|FG002|Overall Study|Death|0|||
164624326|NCT02646891|594644657|FG003|Overall Study|Death|0|||
164624327|NCT02646891|594644658|FG004|Overall Study|Death|0|||
164624328|NCT02646891|594644659|FG005|Overall Study|Death|0|||
164624329|NCT02646891|594644660|FG006|Overall Study|Death|1|||
164624330|NCT02646891|594644661|FG007|Overall Study|Death|1|||
164624331|NCT02646891|594644662|FG008|Overall Study|Death|1|||
164624332|NCT02646891|594644663|FG009|Overall Study|Death|0|||
164624333|NCT06029127|594644665|FG000|Overall Study|Withdrawal by Subject|2|||
164624334|NCT06029127|594644666|FG001|Overall Study|Withdrawal by Subject|0|||
164624335|NCT06029127|594644665|FG000|Overall Study|Lost to Follow-up|1|||
164624336|NCT06029127|594644666|FG001|Overall Study|Lost to Follow-up|0|||
164624337|NCT06029127|594644665|FG000|Overall Study|Study Closed by Sponsor|6|||
164624338|NCT06029127|594644666|FG001|Overall Study|Study Closed by Sponsor|6|||
164624339|NCT06029127|594644665|FG000|Overall Study|Death|12|||
164624340|NCT06029127|594644666|FG001|Overall Study|Death|7|||
164624341|NCT06029127|594644665|FG000|Overall Study|Declined Follow-Up Contact|0|||
164624342|NCT06029127|594644666|FG001|Overall Study|Declined Follow-Up Contact|1|||
164624343|NCT04785144|594644667|FG000|Overall Study|Withdrawal by Subject|4|||
164624344|NCT04785144|594644668|FG001|Overall Study|Withdrawal by Subject|1|||
164624345|NCT04785144|594644669|FG002|Overall Study|Withdrawal by Subject|0|||
164624346|NCT04785144|594644670|FG003|Overall Study|Withdrawal by Subject|0|||
164624347|NCT04785144|594644671|FG004|Overall Study|Withdrawal by Subject|0|||
164624348|NCT04785144|594644672|FG005|Overall Study|Withdrawal by Subject|2|||
164624349|NCT04785144|594644673|FG006|Overall Study|Withdrawal by Subject|2|||
164624350|NCT04785144|594644674|FG007|Overall Study|Withdrawal by Subject|0|||
164624351|NCT04785144|594644675|FG008|Overall Study|Withdrawal by Subject|1|||
164624352|NCT04785144|594644676|FG009|Overall Study|Withdrawal by Subject|0|||
164624353|NCT04785144|594644667|FG000|Overall Study|Lost to Follow-up|1|||
164624354|NCT04785144|594644668|FG001|Overall Study|Lost to Follow-up|0|||
164624355|NCT04785144|594644669|FG002|Overall Study|Lost to Follow-up|0|||
164624356|NCT04785144|594644670|FG003|Overall Study|Lost to Follow-up|0|||
164624357|NCT04785144|594644671|FG004|Overall Study|Lost to Follow-up|1|||
164624358|NCT04785144|594644672|FG005|Overall Study|Lost to Follow-up|2|||
164624359|NCT04785144|594644673|FG006|Overall Study|Lost to Follow-up|1|||
164624360|NCT04785144|594644674|FG007|Overall Study|Lost to Follow-up|2|||
164624361|NCT04785144|594644675|FG008|Overall Study|Lost to Follow-up|4|||
164624362|NCT04785144|594644676|FG009|Overall Study|Lost to Follow-up|1|||
164624363|NCT04785144|594644667|FG000|Overall Study|Protocol Violation|0|||
164624364|NCT04785144|594644668|FG001|Overall Study|Protocol Violation|0|||
164624365|NCT04785144|594644669|FG002|Overall Study|Protocol Violation|0|||
164624366|NCT04785144|594644670|FG003|Overall Study|Protocol Violation|0|||
164624367|NCT04785144|594644671|FG004|Overall Study|Protocol Violation|0|||
164624368|NCT04785144|594644672|FG005|Overall Study|Protocol Violation|0|||
164624369|NCT04785144|594644673|FG006|Overall Study|Protocol Violation|1|||
164624370|NCT04785144|594644674|FG007|Overall Study|Protocol Violation|0|||
164624371|NCT04785144|594644675|FG008|Overall Study|Protocol Violation|0|||
164624372|NCT04785144|594644676|FG009|Overall Study|Protocol Violation|0|||
164624373|NCT04785144|594644667|FG000|Overall Study|Physician Decision|0|||
164624374|NCT04785144|594644668|FG001|Overall Study|Physician Decision|0|||
164624375|NCT04785144|594644669|FG002|Overall Study|Physician Decision|0|||
164624376|NCT04785144|594644670|FG003|Overall Study|Physician Decision|0|||
164624377|NCT04785144|594644671|FG004|Overall Study|Physician Decision|0|||
164624378|NCT04785144|594644672|FG005|Overall Study|Physician Decision|0|||
164624379|NCT04785144|594644673|FG006|Overall Study|Physician Decision|0|||
164624380|NCT04785144|594644674|FG007|Overall Study|Physician Decision|0|||
164624381|NCT04785144|594644675|FG008|Overall Study|Physician Decision|0|||
164624382|NCT04785144|594644676|FG009|Overall Study|Physician Decision|1|||
164624383|NCT04785144|594644667|FG000|Overall Study|Unable to continue due to work schedule|0|||
164624384|NCT04785144|594644668|FG001|Overall Study|Unable to continue due to work schedule|0|||
164624385|NCT04785144|594644669|FG002|Overall Study|Unable to continue due to work schedule|0|||
164624386|NCT04785144|594644670|FG003|Overall Study|Unable to continue due to work schedule|0|||
164526762|NCT05249829|594299332|FG000|Overall Study|Participant Relocation|0|||
164526763|NCT05249829|594299333|FG001|Overall Study|Participant Relocation|1|||
164526764|NCT05249829|594299334|FG002|Overall Study|Participant Relocation|2|||
164526765|NCT05249829|594299335|FG003|Overall Study|Participant Relocation|2|||
164526766|NCT05249829|594299332|FG000|Overall Study|Withdrawal by Subject|9|||
164526767|NCT05249829|594299333|FG001|Overall Study|Withdrawal by Subject|17|||
164526768|NCT05249829|594299334|FG002|Overall Study|Withdrawal by Subject|40|||
164526769|NCT05249829|594299335|FG003|Overall Study|Withdrawal by Subject|35|||
164526770|NCT05249829|594299332|FG000|Overall Study|Physician Decision|1|||
164526771|NCT05249829|594299333|FG001|Overall Study|Physician Decision|0|||
164526772|NCT05249829|594299334|FG002|Overall Study|Physician Decision|0|||
164526773|NCT05249829|594299335|FG003|Overall Study|Physician Decision|0|||
164526774|NCT05249829|594299332|FG000|Overall Study|Lost to Follow-up|16|||
164526775|NCT05249829|594299333|FG001|Overall Study|Lost to Follow-up|16|||
164526776|NCT05249829|594299334|FG002|Overall Study|Lost to Follow-up|57|||
164526777|NCT05249829|594299335|FG003|Overall Study|Lost to Follow-up|60|||
164526778|NCT05249829|594299332|FG000|Overall Study|Adverse Event|2|||
164526779|NCT05249829|594299333|FG001|Overall Study|Adverse Event|2|||
164526780|NCT05249829|594299334|FG002|Overall Study|Adverse Event|2|||
164526781|NCT05249829|594299335|FG003|Overall Study|Adverse Event|2|||
164526782|NCT05249829|594299332|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
164526783|NCT05249829|594299333|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
164526784|NCT05249829|594299334|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
164526785|NCT05249829|594299335|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
164526786|NCT05249829|594299332|FG000|Overall Study|Protocol Violation|2|||
164526787|NCT05249829|594299333|FG001|Overall Study|Protocol Violation|0|||
164526788|NCT05249829|594299334|FG002|Overall Study|Protocol Violation|5|||
164526789|NCT05249829|594299335|FG003|Overall Study|Protocol Violation|3|||
164526790|NCT05249829|594299332|FG000|Overall Study|Death|0|||
164526791|NCT05249829|594299333|FG001|Overall Study|Death|1|||
164526792|NCT05249829|594299334|FG002|Overall Study|Death|2|||
164526793|NCT05249829|594299335|FG003|Overall Study|Death|4|||
164526794|NCT00196976|594299337|FG000|Primary Study|Migrated from study area|0|||
164526795|NCT00196976|594299338|FG001|Primary Study|Migrated from study area|0|||
164526796|NCT00196976|594299339|FG002|Primary Study|Migrated from study area|0|||
164526797|NCT00196976|594299340|FG003|Primary Study|Migrated from study area|0|||
164526798|NCT00196976|594299341|FG004|Primary Study|Migrated from study area|0|||
164526799|NCT00196976|594299342|FG005|Primary Study|Migrated from study area|0|||
164526800|NCT00196976|594299343|FG006|Primary Study|Migrated from study area|0|||
164526801|NCT00196976|594299344|FG007|Primary Study|Migrated from study area|1|||
164526802|NCT00196976|594299345|FG008|Primary Study|Migrated from study area|0|||
164526803|NCT00196976|594299346|FG009|Primary Study|Migrated from study area|0|||
164526804|NCT00196976|594299347|FG010|Primary Study|Migrated from study area|0|||
164526805|NCT00196976|594299348|FG011|Primary Study|Migrated from study area|0|||
164526806|NCT00196976|594299349|FG012|Primary Study|Migrated from study area|0|||
164526807|NCT00196976|594299350|FG013|Primary Study|Migrated from study area|0|||
164526808|NCT00196976|594299337|FG000|Primary Study|Protocol Violation|0|||
164526809|NCT00196976|594299338|FG001|Primary Study|Protocol Violation|1|||
164526810|NCT00196976|594299339|FG002|Primary Study|Protocol Violation|1|||
164526811|NCT00196976|594299340|FG003|Primary Study|Protocol Violation|0|||
164526812|NCT00196976|594299341|FG004|Primary Study|Protocol Violation|0|||
164526813|NCT00196976|594299342|FG005|Primary Study|Protocol Violation|0|||
164526814|NCT00196976|594299343|FG006|Primary Study|Protocol Violation|0|||
164526815|NCT00196976|594299344|FG007|Primary Study|Protocol Violation|0|||
164526816|NCT00196976|594299345|FG008|Primary Study|Protocol Violation|0|||
164526817|NCT00196976|594299346|FG009|Primary Study|Protocol Violation|0|||
164526818|NCT00196976|594299347|FG010|Primary Study|Protocol Violation|0|||
164526819|NCT00196976|594299348|FG011|Primary Study|Protocol Violation|0|||
164526820|NCT00196976|594299349|FG012|Primary Study|Protocol Violation|0|||
164526821|NCT00196976|594299350|FG013|Primary Study|Protocol Violation|0|||
164526822|NCT00196976|594299337|FG000|Primary Study|Withdrawal by Subject|1|||
164526823|NCT00196976|594299338|FG001|Primary Study|Withdrawal by Subject|0|||
164526824|NCT00196976|594299339|FG002|Primary Study|Withdrawal by Subject|1|||
164526825|NCT00196976|594299340|FG003|Primary Study|Withdrawal by Subject|1|||
164526826|NCT00196976|594299341|FG004|Primary Study|Withdrawal by Subject|2|||
164526827|NCT00196976|594299342|FG005|Primary Study|Withdrawal by Subject|1|||
164526828|NCT00196976|594299343|FG006|Primary Study|Withdrawal by Subject|0|||
164526829|NCT00196976|594299344|FG007|Primary Study|Withdrawal by Subject|0|||
164624387|NCT04785144|594644671|FG004|Overall Study|Unable to continue due to work schedule|0|||
164624388|NCT04785144|594644672|FG005|Overall Study|Unable to continue due to work schedule|0|||
164147698|NCT02006732|592902132|FG003|Overall Study|Adverse Event|2|||
164526830|NCT00196976|594299345|FG008|Primary Study|Withdrawal by Subject|0|||
164526831|NCT00196976|594299346|FG009|Primary Study|Withdrawal by Subject|1|||
164526832|NCT00196976|594299347|FG010|Primary Study|Withdrawal by Subject|0|||
164624389|NCT04785144|594644673|FG006|Overall Study|Unable to continue due to work schedule|0|||
164624390|NCT04785144|594644674|FG007|Overall Study|Unable to continue due to work schedule|0|||
164624391|NCT04785144|594644675|FG008|Overall Study|Unable to continue due to work schedule|0|||
164624392|NCT04785144|594644676|FG009|Overall Study|Unable to continue due to work schedule|1|||
164624393|NCT01766401|594644678|FG000|Overall Study|Adverse Event|7|||
164624394|NCT01766401|594644679|FG001|Overall Study|Adverse Event|22|||
164624395|NCT01766401|594644678|FG000|Overall Study|Lack of Efficacy|1|||
164624396|NCT01766401|594644679|FG001|Overall Study|Lack of Efficacy|2|||
164624397|NCT01766401|594644678|FG000|Overall Study|Protocol Violation|3|||
164624398|NCT01766401|594644679|FG001|Overall Study|Protocol Violation|8|||
164624399|NCT01766401|594644678|FG000|Overall Study|Withdrawal by Subject|15|||
164624400|NCT01766401|594644679|FG001|Overall Study|Withdrawal by Subject|12|||
164624401|NCT01766401|594644678|FG000|Overall Study|Lost to Follow-up|10|||
164624402|NCT01766401|594644679|FG001|Overall Study|Lost to Follow-up|11|||
164624403|NCT01766401|594644678|FG000|Overall Study|Pregnancy|1|||
164624404|NCT01766401|594644679|FG001|Overall Study|Pregnancy|1|||
164624405|NCT00886587|594644680|FG000|Overall Study|Adverse Event|2|||
164624406|NCT00886587|594644681|FG001|Overall Study|Adverse Event|1|||
164624407|NCT00886587|594644680|FG000|Overall Study|Protocol Violation|2|||
164624408|NCT00886587|594644681|FG001|Overall Study|Protocol Violation|0|||
164624409|NCT00886587|594644680|FG000|Overall Study|Withdrawal by Subject|0|||
164624410|NCT00886587|594644681|FG001|Overall Study|Withdrawal by Subject|1|||
164624411|NCT01108068|594644685|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
164624412|NCT01108068|594644686|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
164624413|NCT00398086|594644687|FG000|Overall Study|Unacceptable Toxicity|2|||
164624414|NCT00398086|594644688|FG001|Overall Study|Unacceptable Toxicity|8|||
164624415|NCT00398086|594644689|FG002|Overall Study|Unacceptable Toxicity|2|||
164624416|NCT00398086|594644687|FG000|Overall Study|Adverse Event|1|||
164624417|NCT00398086|594644688|FG001|Overall Study|Adverse Event|4|||
164624418|NCT00398086|594644689|FG002|Overall Study|Adverse Event|0|||
164624419|NCT00398086|594644687|FG000|Overall Study|Physician Decision|1|||
164624420|NCT00398086|594644688|FG001|Overall Study|Physician Decision|4|||
164624421|NCT00398086|594644689|FG002|Overall Study|Physician Decision|0|||
164624422|NCT00398086|594644687|FG000|Overall Study|Withdrawal by Subject|5|||
164624423|NCT00398086|594644688|FG001|Overall Study|Withdrawal by Subject|7|||
164624424|NCT00398086|594644689|FG002|Overall Study|Withdrawal by Subject|0|||
164624425|NCT00696774|594644690|FG000|Period II|Adverse Event|0|||
164624426|NCT00696774|594644691|FG001|Period II|Adverse Event|0|||
164624427|NCT00696774|594644692|FG002|Period II|Adverse Event|15|||
164624428|NCT00696774|594644690|FG000|Period II|Lost to Follow-up|0|||
164624429|NCT00696774|594644691|FG001|Period II|Lost to Follow-up|0|||
164624430|NCT00696774|594644692|FG002|Period II|Lost to Follow-up|4|||
164624431|NCT00696774|594644690|FG000|Period II|Protocol Violation|0|||
164624432|NCT00696774|594644691|FG001|Period II|Protocol Violation|0|||
164624433|NCT00696774|594644692|FG002|Period II|Protocol Violation|11|||
164624434|NCT00696774|594644690|FG000|Period II|Withdrawal by Subject|0|||
164624435|NCT00696774|594644691|FG001|Period II|Withdrawal by Subject|0|||
164624436|NCT00696774|594644692|FG002|Period II|Withdrawal by Subject|4|||
164624437|NCT00696774|594644690|FG000|Period II|Sponsor Decision|0|||
164624438|NCT00696774|594644691|FG001|Period II|Sponsor Decision|0|||
164624439|NCT00696774|594644692|FG002|Period II|Sponsor Decision|0|||
164624440|NCT00696774|594644690|FG000|Period II|Lack of Efficacy|0|||
164624441|NCT00696774|594644691|FG001|Period II|Lack of Efficacy|0|||
164624442|NCT00696774|594644692|FG002|Period II|Lack of Efficacy|2|||
164624443|NCT00696774|594644690|FG000|Period III|Adverse Event|1|||
164624444|NCT00696774|594644691|FG001|Period III|Adverse Event|1|||
164624445|NCT00696774|594644692|FG002|Period III|Adverse Event|0|||
164624446|NCT00696774|594644690|FG000|Period III|Lost to Follow-up|2|||
164624447|NCT00696774|594644691|FG001|Period III|Lost to Follow-up|1|||
164624448|NCT00696774|594644692|FG002|Period III|Lost to Follow-up|0|||
164624449|NCT00696774|594644690|FG000|Period III|Protocol Violation|1|||
164624450|NCT00696774|594644691|FG001|Period III|Protocol Violation|1|||
164624451|NCT00696774|594644692|FG002|Period III|Protocol Violation|0|||
164624452|NCT00696774|594644690|FG000|Period III|Withdrawal by Subject|1|||
164624453|NCT00696774|594644691|FG001|Period III|Withdrawal by Subject|2|||
164624454|NCT00696774|594644692|FG002|Period III|Withdrawal by Subject|0|||
164624455|NCT00696774|594644690|FG000|Period III|Sponsor Decision|2|||
164624456|NCT00696774|594644691|FG001|Period III|Sponsor Decision|0|||
164624457|NCT00696774|594644692|FG002|Period III|Sponsor Decision|0|||
164624458|NCT00696774|594644690|FG000|Period III|Lack of Efficacy|0|||
164624459|NCT00696774|594644691|FG001|Period III|Lack of Efficacy|2|||
164624460|NCT00696774|594644692|FG002|Period III|Lack of Efficacy|0|||
164624461|NCT00033293|594644699|FG000|Overall Study|Death|0|||
164624462|NCT00033293|594644700|FG001|Overall Study|Death|1|||
164624463|NCT00033293|594644699|FG000|Overall Study|Lack of Efficacy|5|||
164624464|NCT00033293|594644700|FG001|Overall Study|Lack of Efficacy|8|||
164624465|NCT00033293|594644699|FG000|Overall Study|Lost to Follow-up|0|||
164624466|NCT00033293|594644700|FG001|Overall Study|Lost to Follow-up|1|||
164624467|NCT00033293|594644699|FG000|Overall Study|Physician Decision|3|||
164624468|NCT00033293|594644700|FG001|Overall Study|Physician Decision|1|||
164624469|NCT00033293|594644699|FG000|Overall Study|Withdrawal by Subject|1|||
164624470|NCT00033293|594644700|FG001|Overall Study|Withdrawal by Subject|0|||
164624471|NCT00033293|594644699|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
164624472|NCT00033293|594644700|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
164624473|NCT00033293|594644699|FG000|Overall Study|Treatment refused|0|||
164624474|NCT00033293|594644700|FG001|Overall Study|Treatment refused|6|||
164624475|NCT00935701|594644701|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
164624476|NCT02201251|594644702|FG000|Overall Study|Adverse Event|1|||
164624477|NCT02201251|594644703|FG001|Overall Study|Adverse Event|1|||
164624478|NCT02201251|594644702|FG000|Overall Study|Protocol Violation|1|||
164624479|NCT02201251|594644703|FG001|Overall Study|Protocol Violation|0|||
164624480|NCT02201251|594644702|FG000|Overall Study|Noncompliance with Study Drug|0|||
164624481|NCT02201251|594644703|FG001|Overall Study|Noncompliance with Study Drug|1|||
164624482|NCT02201251|594644702|FG000|Overall Study|Withdrawal by Subject|2|||
164624483|NCT02201251|594644703|FG001|Overall Study|Withdrawal by Subject|1|||
164624484|NCT02711553|594644706|FG000|Overall Study|Withdrawal by Subject|2|||
164624485|NCT02711553|594644707|FG001|Overall Study|Withdrawal by Subject|1|||
164624486|NCT02711553|594644708|FG002|Overall Study|Withdrawal by Subject|1|||
164624487|NCT02711553|594644709|FG003|Overall Study|Withdrawal by Subject|0|||
164624488|NCT02711553|594644706|FG000|Overall Study|Lost to Follow-up|3|||
164624489|NCT02711553|594644707|FG001|Overall Study|Lost to Follow-up|3|||
164624490|NCT02711553|594644708|FG002|Overall Study|Lost to Follow-up|6|||
164624491|NCT02711553|594644709|FG003|Overall Study|Lost to Follow-up|3|||
164624492|NCT02711553|594644706|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
164526833|NCT00196976|594299348|FG011|Primary Study|Withdrawal by Subject|0|||
164526834|NCT00196976|594299349|FG012|Primary Study|Withdrawal by Subject|0|||
164526835|NCT00196976|594299350|FG013|Primary Study|Withdrawal by Subject|0|||
164526836|NCT00196976|594299337|FG000|Primary Study|Lost to Follow-up|0|||
164526837|NCT00196976|594299338|FG001|Primary Study|Lost to Follow-up|0|||
164526838|NCT00196976|594299339|FG002|Primary Study|Lost to Follow-up|0|||
164526839|NCT00196976|594299340|FG003|Primary Study|Lost to Follow-up|0|||
164526840|NCT00196976|594299341|FG004|Primary Study|Lost to Follow-up|1|||
164526841|NCT00196976|594299342|FG005|Primary Study|Lost to Follow-up|1|||
164526842|NCT00196976|594299343|FG006|Primary Study|Lost to Follow-up|0|||
164526843|NCT00196976|594299344|FG007|Primary Study|Lost to Follow-up|2|||
164526844|NCT00196976|594299345|FG008|Primary Study|Lost to Follow-up|0|||
164526845|NCT00196976|594299346|FG009|Primary Study|Lost to Follow-up|0|||
164526846|NCT00196976|594299347|FG010|Primary Study|Lost to Follow-up|0|||
164526847|NCT00196976|594299348|FG011|Primary Study|Lost to Follow-up|0|||
164526848|NCT00196976|594299349|FG012|Primary Study|Lost to Follow-up|0|||
164526849|NCT00196976|594299350|FG013|Primary Study|Lost to Follow-up|0|||
164526850|NCT00196976|594299337|FG000|Primary Study|Other|0|||
164526851|NCT00196976|594299338|FG001|Primary Study|Other|0|||
164526852|NCT00196976|594299339|FG002|Primary Study|Other|2|||
164526853|NCT00196976|594299340|FG003|Primary Study|Other|0|||
164526854|NCT00196976|594299341|FG004|Primary Study|Other|0|||
164526855|NCT00196976|594299342|FG005|Primary Study|Other|0|||
164526856|NCT00196976|594299343|FG006|Primary Study|Other|0|||
164526857|NCT00196976|594299344|FG007|Primary Study|Other|0|||
164526858|NCT00196976|594299345|FG008|Primary Study|Other|0|||
164526859|NCT00196976|594299346|FG009|Primary Study|Other|0|||
164526860|NCT00196976|594299347|FG010|Primary Study|Other|0|||
164526861|NCT00196976|594299348|FG011|Primary Study|Other|0|||
164526862|NCT00196976|594299349|FG012|Primary Study|Other|0|||
164526863|NCT00196976|594299350|FG013|Primary Study|Other|0|||
164526864|NCT00196976|594299337|FG000|Booster Study|Withdrawal by Subject|0|||
164526865|NCT00196976|594299338|FG001|Booster Study|Withdrawal by Subject|0|||
164526866|NCT00196976|594299339|FG002|Booster Study|Withdrawal by Subject|0|||
164526867|NCT00196976|594299340|FG003|Booster Study|Withdrawal by Subject|0|||
164526868|NCT00196976|594299341|FG004|Booster Study|Withdrawal by Subject|0|||
164526869|NCT00196976|594299342|FG005|Booster Study|Withdrawal by Subject|0|||
164526870|NCT00196976|594299343|FG006|Booster Study|Withdrawal by Subject|0|||
164526871|NCT00196976|594299344|FG007|Booster Study|Withdrawal by Subject|0|||
164526872|NCT00196976|594299345|FG008|Booster Study|Withdrawal by Subject|0|||
164526873|NCT00196976|594299346|FG009|Booster Study|Withdrawal by Subject|0|||
164526874|NCT00196976|594299347|FG010|Booster Study|Withdrawal by Subject|1|||
164526875|NCT00196976|594299348|FG011|Booster Study|Withdrawal by Subject|0|||
164526876|NCT00196976|594299349|FG012|Booster Study|Withdrawal by Subject|0|||
164526877|NCT00196976|594299350|FG013|Booster Study|Withdrawal by Subject|0|||
164526878|NCT00196976|594299337|FG000|Booster Study|Lost to Follow-up|0|||
164526879|NCT00196976|594299338|FG001|Booster Study|Lost to Follow-up|0|||
164526880|NCT00196976|594299339|FG002|Booster Study|Lost to Follow-up|0|||
164526881|NCT00196976|594299340|FG003|Booster Study|Lost to Follow-up|0|||
164526882|NCT00196976|594299341|FG004|Booster Study|Lost to Follow-up|0|||
164526883|NCT00196976|594299342|FG005|Booster Study|Lost to Follow-up|0|||
164526884|NCT00196976|594299343|FG006|Booster Study|Lost to Follow-up|0|||
164526885|NCT00196976|594299344|FG007|Booster Study|Lost to Follow-up|0|||
164526886|NCT00196976|594299345|FG008|Booster Study|Lost to Follow-up|0|||
164526887|NCT00196976|594299346|FG009|Booster Study|Lost to Follow-up|0|||
164526888|NCT00196976|594299347|FG010|Booster Study|Lost to Follow-up|1|||
164526889|NCT00196976|594299348|FG011|Booster Study|Lost to Follow-up|2|||
164526890|NCT00196976|594299349|FG012|Booster Study|Lost to Follow-up|0|||
164526891|NCT00196976|594299350|FG013|Booster Study|Lost to Follow-up|0|||
164526892|NCT01535560|594299351|FG000|Overall Study|Adverse Event|12|||
164526893|NCT01535560|594299352|FG001|Overall Study|Adverse Event|7|||
164526894|NCT01535560|594299351|FG000|Overall Study|Lost to Follow-up|1|||
164526895|NCT01535560|594299352|FG001|Overall Study|Lost to Follow-up|3|||
164526896|NCT01535560|594299351|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
164526897|NCT01535560|594299352|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
164526898|NCT01535560|594299351|FG000|Overall Study|Treatment Failure|21|||
164526899|NCT01535560|594299352|FG001|Overall Study|Treatment Failure|83|||
164526900|NCT01535560|594299351|FG000|Overall Study|Other|0|||
164526901|NCT01535560|594299352|FG001|Overall Study|Other|1|||
164526902|NCT01535560|594299351|FG000|Overall Study|Randomized in Error|0|||
164526903|NCT01535560|594299352|FG001|Overall Study|Randomized in Error|1|||
164526904|NCT02009761|594299353|FG000|Overall Study|Adverse Event|4|||
164526905|NCT00825825|594299356|FG000|First Medication Period (14 Days)|Adverse Event|1|||
164526906|NCT00825825|594299357|FG001|First Medication Period (14 Days)|Adverse Event|0|||
164526907|NCT00825825|594299358|FG002|First Medication Period (14 Days)|Adverse Event|0|||
164526908|NCT00825825|594299359|FG003|First Medication Period (14 Days)|Adverse Event|0|||
164526909|NCT00825825|594299360|FG004|First Medication Period (14 Days)|Adverse Event|0|||
164526910|NCT00825825|594299361|FG005|First Medication Period (14 Days)|Adverse Event|1|||
164526911|NCT00825825|594299356|FG000|First Medication Period (14 Days)|Physician Decision|2|||
164526912|NCT00825825|594299357|FG001|First Medication Period (14 Days)|Physician Decision|0|||
164526913|NCT00825825|594299358|FG002|First Medication Period (14 Days)|Physician Decision|1|||
164526914|NCT00825825|594299359|FG003|First Medication Period (14 Days)|Physician Decision|0|||
164526915|NCT00825825|594299360|FG004|First Medication Period (14 Days)|Physician Decision|0|||
164526916|NCT00825825|594299361|FG005|First Medication Period (14 Days)|Physician Decision|1|||
164526917|NCT00825825|594299356|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
164526918|NCT00825825|594299357|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
164526919|NCT00825825|594299358|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
164526920|NCT00825825|594299359|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
164526921|NCT00825825|594299360|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
164526922|NCT00825825|594299361|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
164526923|NCT00825825|594299356|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
164526924|NCT00825825|594299357|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
164526925|NCT00825825|594299358|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
164526926|NCT00825825|594299359|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
164526927|NCT00825825|594299360|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
164526928|NCT00825825|594299361|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
164526929|NCT00825825|594299356|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
164526930|NCT00825825|594299357|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
164526931|NCT00825825|594299358|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
164526932|NCT00825825|594299359|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
164526933|NCT00825825|594299360|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
164526934|NCT00825825|594299361|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
164526935|NCT00825825|594299356|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
164526936|NCT00825825|594299357|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
164526937|NCT00825825|594299358|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
164526938|NCT00825825|594299359|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
164526939|NCT00825825|594299360|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
164526940|NCT00825825|594299361|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
164526941|NCT00825825|594299356|FG000|Third Medication Period (14 Days)|poor data quality|0|||
164526942|NCT00825825|594299357|FG001|Third Medication Period (14 Days)|poor data quality|1|||
164526943|NCT00825825|594299358|FG002|Third Medication Period (14 Days)|poor data quality|0|||
164526944|NCT00825825|594299359|FG003|Third Medication Period (14 Days)|poor data quality|0|||
164526945|NCT00825825|594299360|FG004|Third Medication Period (14 Days)|poor data quality|0|||
164526946|NCT00825825|594299361|FG005|Third Medication Period (14 Days)|poor data quality|0|||
164526947|NCT02649946|594299367|FG000|Overall Study|Withdrawal by Subject|1|||
164526948|NCT02649946|594299368|FG001|Overall Study|Withdrawal by Subject|1|||
164526949|NCT02649946|594299367|FG000|Overall Study|Death|7|||
164526950|NCT02649946|594299368|FG001|Overall Study|Death|9|||
164526951|NCT02649946|594299367|FG000|Overall Study|Physician Decision|1|||
164526952|NCT02649946|594299368|FG001|Overall Study|Physician Decision|0|||
164526953|NCT02649946|594299367|FG000|Overall Study|Lost to Follow-up|2|||
164526954|NCT02649946|594299368|FG001|Overall Study|Lost to Follow-up|1|||
164526955|NCT02649946|594299367|FG000|Overall Study|Erroneously enrolled|1|||
164526956|NCT02649946|594299368|FG001|Overall Study|Erroneously enrolled|0|||
164526957|NCT02649946|594299367|FG000|Overall Study|Missed 6-month follow-up visit|0|||
164526958|NCT02649946|594299368|FG001|Overall Study|Missed 6-month follow-up visit|4|||
164526959|NCT01178385|594299369|FG000|Overall Study|Withdrawal by Subject|2|||
164624493|NCT02711553|594644707|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
164624494|NCT02711553|594644708|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
164624495|NCT02711553|594644709|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
164624496|NCT04048876|594644714|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
164624497|NCT04048876|594644715|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
164624498|NCT04048876|594644716|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
164624499|NCT04048876|594644717|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
164624500|NCT04048876|594644714|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
164624501|NCT04048876|594644715|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
164624502|NCT04048876|594644716|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
164624503|NCT04048876|594644717|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
164624504|NCT04048876|594644714|FG000|Placebo Controlled Phase|Adverse Event|0|||
164624505|NCT04048876|594644715|FG001|Placebo Controlled Phase|Adverse Event|1|||
164624506|NCT04048876|594644716|FG002|Placebo Controlled Phase|Adverse Event|0|||
164624507|NCT04048876|594644717|FG003|Placebo Controlled Phase|Adverse Event|0|||
164624508|NCT04048876|594644714|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
164624509|NCT04048876|594644715|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
164624510|NCT04048876|594644716|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
164624511|NCT04048876|594644717|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
164624512|NCT04055844|594644718|FG000|Overall Study|Adverse Event|12|||
164624513|NCT04055844|594644718|FG000|Overall Study|Poor Performance|1|||
164624514|NCT04055844|594644718|FG000|Overall Study|Death|1|||
164624515|NCT03457636|594644723|FG000|Overall Study|Lost to Follow-up|2|||
164624516|NCT04350372|594644728|FG000|Overall Study|Death|1|||
164624517|NCT03858686|594644734|FG000|Period 1|Adverse Event|1|||
164624518|NCT03858686|594644735|FG001|Period 1|Adverse Event|1|||
164624519|NCT03858686|594644734|FG000|Period 1|Lack of compliance|0|||
164624520|NCT03858686|594644735|FG001|Period 1|Lack of compliance|1|||
164624521|NCT03858686|594644734|FG000|Period 1|Adverse Event|0|||
164624522|NCT03858686|594644735|FG001|Period 1|Adverse Event|1|||
164624523|NCT03858686|594644734|FG000|Period 2|Adverse Event|0|||
164624524|NCT03858686|594644735|FG001|Period 2|Adverse Event|1|||
164624525|NCT03231228|594644736|FG000|Overall Study|Lost to Follow-up|2|||
164624526|NCT03231228|594644737|FG001|Overall Study|Lost to Follow-up|0|||
164624527|NCT03231228|594644736|FG000|Overall Study|Physician Decision|1|||
164624528|NCT03231228|594644737|FG001|Overall Study|Physician Decision|0|||
164624529|NCT03049852|594644748|FG000|Overall Study|Lost to Follow-up|0|||
164624530|NCT03049852|594644749|FG001|Overall Study|Lost to Follow-up|1|||
164624531|NCT03049852|594644750|FG002|Overall Study|Lost to Follow-up|0|||
164624532|NCT02141854|594644751|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
164624533|NCT02141854|594644752|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164624534|NCT02141854|594644753|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164624535|NCT02141854|594644754|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164624536|NCT02141854|594644755|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164624537|NCT02141854|594644756|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164624538|NCT02141854|594644751|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
164624539|NCT02141854|594644752|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164624540|NCT02141854|594644753|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164624541|NCT02141854|594644754|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164624542|NCT02141854|594644755|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164624543|NCT02141854|594644756|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164624544|NCT02141854|594644751|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
164624545|NCT02141854|594644752|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164624546|NCT02141854|594644753|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164624547|NCT02141854|594644754|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164624548|NCT02141854|594644755|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164624549|NCT02141854|594644756|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164624550|NCT02141854|594644751|FG000|Run-In Period (Pre-assignment)|Other|14|||
164624551|NCT02141854|594644752|FG001|Run-In Period (Pre-assignment)|Other|0|||
164624552|NCT02141854|594644753|FG002|Run-In Period (Pre-assignment)|Other|0|||
164624553|NCT02141854|594644754|FG003|Run-In Period (Pre-assignment)|Other|0|||
164624554|NCT02141854|594644755|FG004|Run-In Period (Pre-assignment)|Other|0|||
164624555|NCT02141854|594644756|FG005|Run-In Period (Pre-assignment)|Other|0|||
164624556|NCT02141854|594644751|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
164624557|NCT02141854|594644752|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
164624558|NCT02141854|594644753|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
164624559|NCT02141854|594644754|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
164624560|NCT02141854|594644755|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
164624561|NCT02141854|594644756|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
164624562|NCT02141854|594644751|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
164624563|NCT02141854|594644752|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164624564|NCT02141854|594644753|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164624565|NCT02141854|594644754|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164624566|NCT02141854|594644755|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164624567|NCT02141854|594644756|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164624568|NCT02141854|594644751|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
164624569|NCT02141854|594644752|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164624570|NCT02141854|594644753|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164624571|NCT02141854|594644754|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164624572|NCT02141854|594644755|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164624573|NCT02141854|594644756|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164624574|NCT02141854|594644751|FG000|Treatment Period|Protocol Violation|0|||
164624575|NCT02141854|594644752|FG001|Treatment Period|Protocol Violation|1|||
164624576|NCT02141854|594644753|FG002|Treatment Period|Protocol Violation|0|||
164624577|NCT02141854|594644754|FG003|Treatment Period|Protocol Violation|2|||
164624578|NCT02141854|594644755|FG004|Treatment Period|Protocol Violation|2|||
164526960|NCT01178385|594299370|FG001|Overall Study|Withdrawal by Subject|0|||
164526961|NCT05172050|594299386|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
164624579|NCT02141854|594644756|FG005|Treatment Period|Protocol Violation|1|||
164624580|NCT02141854|594644751|FG000|Treatment Period|Noncompliance|0|||
164624581|NCT02141854|594644752|FG001|Treatment Period|Noncompliance|0|||
164624582|NCT02141854|594644753|FG002|Treatment Period|Noncompliance|0|||
164624583|NCT02141854|594644754|FG003|Treatment Period|Noncompliance|1|||
164624584|NCT02141854|594644755|FG004|Treatment Period|Noncompliance|0|||
164624585|NCT02141854|594644756|FG005|Treatment Period|Noncompliance|0|||
164624586|NCT02141854|594644751|FG000|Treatment Period|Lack of Efficacy|0|||
164624587|NCT02141854|594644752|FG001|Treatment Period|Lack of Efficacy|0|||
164624588|NCT02141854|594644753|FG002|Treatment Period|Lack of Efficacy|0|||
164624589|NCT02141854|594644754|FG003|Treatment Period|Lack of Efficacy|1|||
164624590|NCT02141854|594644755|FG004|Treatment Period|Lack of Efficacy|1|||
164624591|NCT02141854|594644756|FG005|Treatment Period|Lack of Efficacy|7|||
164624592|NCT02141854|594644751|FG000|Treatment Period|Pregnancy|0|||
164624593|NCT02141854|594644752|FG001|Treatment Period|Pregnancy|1|||
164624594|NCT02141854|594644753|FG002|Treatment Period|Pregnancy|0|||
164624595|NCT02141854|594644754|FG003|Treatment Period|Pregnancy|0|||
164624596|NCT02141854|594644755|FG004|Treatment Period|Pregnancy|0|||
164624597|NCT02141854|594644756|FG005|Treatment Period|Pregnancy|0|||
164624598|NCT02141854|594644751|FG000|Treatment Period|Other|0|||
164624599|NCT02141854|594644752|FG001|Treatment Period|Other|1|||
164624600|NCT02141854|594644753|FG002|Treatment Period|Other|2|||
164526962|NCT05172050|594299387|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
164526963|NCT05172050|594299388|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
164526964|NCT05172050|594299386|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
164526965|NCT05172050|594299387|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
164526966|NCT05172050|594299388|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
164526967|NCT05172050|594299386|FG000|Overall Study|Other|2|||
164526968|NCT05172050|594299387|FG001|Overall Study|Other|2|||
164526969|NCT05172050|594299388|FG002|Overall Study|Other|1|||
164526970|NCT04227704|594299391|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
164526971|NCT04227704|594299392|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
164526972|NCT04227704|594299393|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
164526973|NCT04227704|594299391|FG000|Overall Study|due to C/S being cancelled|1|||
164526974|NCT04227704|594299392|FG001|Overall Study|due to C/S being cancelled|0|||
164526975|NCT04227704|594299393|FG002|Overall Study|due to C/S being cancelled|0|||
164526976|NCT00729378|594302058|FG000|Baseline|Did not complete study measurements|72|||
164526977|NCT00729378|594302059|FG001|Baseline|Did not complete study measurements|33|||
164526978|NCT00729378|594302058|FG000|Baseline|Withdrawal by Subject|66|||
164526979|NCT00729378|594302059|FG001|Baseline|Withdrawal by Subject|59|||
164526980|NCT00729378|594302058|FG000|12-months|Lost to Follow-up|100|||
164526981|NCT00729378|594302059|FG001|12-months|Lost to Follow-up|65|||
164526982|NCT00729378|594302058|FG000|24-months|Lost to Follow-up|72|||
164526983|NCT00729378|594302059|FG001|24-months|Lost to Follow-up|51|||
164526984|NCT00729378|594302058|FG000|36-months|Lost to Follow-up|15|||
164526985|NCT00729378|594302059|FG001|36-months|Lost to Follow-up|6|||
164526986|NCT03184870|594302069|FG000|Initial Treatment|Death|6|||
164526987|NCT03184870|594302070|FG001|Initial Treatment|Death|6|||
164526988|NCT03184870|594302071|FG002|Initial Treatment|Death|8|||
164526989|NCT03184870|594302072|FG003|Initial Treatment|Death|8|||
164526990|NCT03184870|594302073|FG004|Initial Treatment|Death|6|||
164526991|NCT03184870|594302074|FG005|Initial Treatment|Death|6|||
164526992|NCT03184870|594302075|FG006|Initial Treatment|Death|6|||
164526993|NCT03184870|594302076|FG007|Initial Treatment|Death|7|||
164526994|NCT03184870|594302077|FG008|Initial Treatment|Death|1|||
164526995|NCT03184870|594302078|FG009|Initial Treatment|Death|2|||
164526996|NCT03184870|594302079|FG010|Initial Treatment|Death|26|||
164526997|NCT03184870|594302080|FG011|Initial Treatment|Death|28|||
164526998|NCT03184870|594302081|FG012|Initial Treatment|Death|10|||
164526999|NCT03184870|594302082|FG013|Initial Treatment|Death|33|||
164527000|NCT03184870|594302083|FG014|Initial Treatment|Death|34|||
164527001|NCT03184870|594302084|FG015|Initial Treatment|Death|26|||
164527002|NCT03184870|594302085|FG016|Initial Treatment|Death|20|||
164527003|NCT03184870|594302086|FG017|Initial Treatment|Death|18|||
164527004|NCT03184870|594302069|FG000|Initial Treatment|Other Reasons|2|||
164527005|NCT03184870|594302070|FG001|Initial Treatment|Other Reasons|2|||
164527006|NCT03184870|594302071|FG002|Initial Treatment|Other Reasons|0|||
164527007|NCT03184870|594302072|FG003|Initial Treatment|Other Reasons|1|||
164527008|NCT03184870|594302073|FG004|Initial Treatment|Other Reasons|0|||
164527009|NCT03184870|594302074|FG005|Initial Treatment|Other Reasons|0|||
164527010|NCT03184870|594302075|FG006|Initial Treatment|Other Reasons|0|||
164527011|NCT03184870|594302076|FG007|Initial Treatment|Other Reasons|2|||
164527012|NCT03184870|594302077|FG008|Initial Treatment|Other Reasons|0|||
164527013|NCT03184870|594302078|FG009|Initial Treatment|Other Reasons|0|||
164527014|NCT03184870|594302079|FG010|Initial Treatment|Other Reasons|4|||
164527015|NCT03184870|594302080|FG011|Initial Treatment|Other Reasons|2|||
164527016|NCT03184870|594302081|FG012|Initial Treatment|Other Reasons|2|||
164527017|NCT03184870|594302082|FG013|Initial Treatment|Other Reasons|0|||
164527018|NCT03184870|594302083|FG014|Initial Treatment|Other Reasons|0|||
164527019|NCT03184870|594302084|FG015|Initial Treatment|Other Reasons|1|||
164527020|NCT03184870|594302085|FG016|Initial Treatment|Other Reasons|0|||
164527021|NCT03184870|594302086|FG017|Initial Treatment|Other Reasons|2|||
164527022|NCT03184870|594302069|FG000|Initial Treatment|Lost to Follow-up|2|||
164527023|NCT03184870|594302070|FG001|Initial Treatment|Lost to Follow-up|0|||
164527024|NCT03184870|594302071|FG002|Initial Treatment|Lost to Follow-up|0|||
164527025|NCT03184870|594302072|FG003|Initial Treatment|Lost to Follow-up|1|||
164527026|NCT03184870|594302073|FG004|Initial Treatment|Lost to Follow-up|1|||
164527027|NCT03184870|594302074|FG005|Initial Treatment|Lost to Follow-up|1|||
164527028|NCT03184870|594302075|FG006|Initial Treatment|Lost to Follow-up|0|||
164527029|NCT03184870|594302076|FG007|Initial Treatment|Lost to Follow-up|2|||
164527030|NCT03184870|594302077|FG008|Initial Treatment|Lost to Follow-up|0|||
164527031|NCT03184870|594302078|FG009|Initial Treatment|Lost to Follow-up|0|||
164527032|NCT03184870|594302079|FG010|Initial Treatment|Lost to Follow-up|2|||
164527033|NCT03184870|594302080|FG011|Initial Treatment|Lost to Follow-up|0|||
164527034|NCT03184870|594302081|FG012|Initial Treatment|Lost to Follow-up|2|||
164527035|NCT03184870|594302082|FG013|Initial Treatment|Lost to Follow-up|2|||
164527036|NCT03184870|594302083|FG014|Initial Treatment|Lost to Follow-up|0|||
164527037|NCT03184870|594302084|FG015|Initial Treatment|Lost to Follow-up|0|||
164527038|NCT03184870|594302085|FG016|Initial Treatment|Lost to Follow-up|2|||
164527039|NCT03184870|594302086|FG017|Initial Treatment|Lost to Follow-up|2|||
164527040|NCT03184870|594302069|FG000|Initial Treatment|Withdrawal by Subject|0|||
164624601|NCT02141854|594644754|FG003|Treatment Period|Other|0|||
164624602|NCT02141854|594644755|FG004|Treatment Period|Other|1|||
164624603|NCT02141854|594644756|FG005|Treatment Period|Other|2|||
164624604|NCT02141854|594644751|FG000|Treatment Period|Adverse Event|0|||
164624605|NCT02141854|594644752|FG001|Treatment Period|Adverse Event|2|||
164624606|NCT02141854|594644753|FG002|Treatment Period|Adverse Event|2|||
164624607|NCT02141854|594644754|FG003|Treatment Period|Adverse Event|0|||
164624608|NCT02141854|594644755|FG004|Treatment Period|Adverse Event|2|||
164624609|NCT02141854|594644756|FG005|Treatment Period|Adverse Event|2|||
164624610|NCT02141854|594644751|FG000|Treatment Period|Withdrawal by Subject|0|||
164624611|NCT02141854|594644752|FG001|Treatment Period|Withdrawal by Subject|2|||
164624612|NCT02141854|594644753|FG002|Treatment Period|Withdrawal by Subject|3|||
164624613|NCT02141854|594644754|FG003|Treatment Period|Withdrawal by Subject|3|||
164624614|NCT02141854|594644755|FG004|Treatment Period|Withdrawal by Subject|4|||
164624615|NCT02141854|594644756|FG005|Treatment Period|Withdrawal by Subject|7|||
164624616|NCT02141854|594644751|FG000|Treatment Period|Disease progression|0|||
164624617|NCT02141854|594644752|FG001|Treatment Period|Disease progression|2|||
164624618|NCT02141854|594644753|FG002|Treatment Period|Disease progression|1|||
164624619|NCT02141854|594644754|FG003|Treatment Period|Disease progression|3|||
164624620|NCT02141854|594644755|FG004|Treatment Period|Disease progression|0|||
164624621|NCT02141854|594644756|FG005|Treatment Period|Disease progression|18|||
164624622|NCT02141854|594644751|FG000|Treatment Period|Lost to Follow-up|0|||
164624623|NCT02141854|594644752|FG001|Treatment Period|Lost to Follow-up|1|||
164624624|NCT02141854|594644753|FG002|Treatment Period|Lost to Follow-up|1|||
164624625|NCT02141854|594644754|FG003|Treatment Period|Lost to Follow-up|1|||
164624626|NCT02141854|594644755|FG004|Treatment Period|Lost to Follow-up|0|||
164624627|NCT02141854|594644756|FG005|Treatment Period|Lost to Follow-up|1|||
164624628|NCT01868594|594644757|FG000|Overall Study|Do not meet inclusion criteria|4|||
164624629|NCT01868594|594644758|FG001|Overall Study|Do not meet inclusion criteria|3|||
164624630|NCT03399786|594644761|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
164624631|NCT03399786|594644762|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
164624632|NCT03399786|594644763|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
164624633|NCT03399786|594644764|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
164624634|NCT03399786|594644761|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
164624635|NCT03399786|594644762|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
164624636|NCT03399786|594644763|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
164624637|NCT03399786|594644764|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
164624638|NCT03399786|594644761|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
164624639|NCT03399786|594644762|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
164624640|NCT03399786|594644763|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
164624641|NCT03399786|594644764|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
164624642|NCT01542632|594646524|FG000|Overall Study|Withdrawal of Consent|0|||
164624643|NCT01542632|594646525|FG001|Overall Study|Withdrawal of Consent|0|||
164624644|NCT01542632|594646526|FG002|Overall Study|Withdrawal of Consent|0|||
164624645|NCT01542632|594646527|FG003|Overall Study|Withdrawal of Consent|2|||
164624646|NCT01542632|594646528|FG004|Overall Study|Withdrawal of Consent|3|||
164624647|NCT01542632|594646529|FG005|Overall Study|Withdrawal of Consent|0|||
164624648|NCT01542632|594646524|FG000|Overall Study|Adverse Event|0|||
164624649|NCT01542632|594646525|FG001|Overall Study|Adverse Event|0|||
164624650|NCT01542632|594646526|FG002|Overall Study|Adverse Event|1|||
164624651|NCT01542632|594646527|FG003|Overall Study|Adverse Event|0|||
164624652|NCT01542632|594646528|FG004|Overall Study|Adverse Event|0|||
164624653|NCT01542632|594646529|FG005|Overall Study|Adverse Event|0|||
164624654|NCT01542632|594646524|FG000|Overall Study|Lost to Follow-up|0|||
164624655|NCT01542632|594646525|FG001|Overall Study|Lost to Follow-up|1|||
164624656|NCT01542632|594646526|FG002|Overall Study|Lost to Follow-up|0|||
164624657|NCT01542632|594646527|FG003|Overall Study|Lost to Follow-up|0|||
164624658|NCT01542632|594646528|FG004|Overall Study|Lost to Follow-up|0|||
164624659|NCT01542632|594646529|FG005|Overall Study|Lost to Follow-up|0|||
164624660|NCT01542632|594646524|FG000|Overall Study|Sponsor/Investigator Decision|0|||
164624661|NCT01542632|594646525|FG001|Overall Study|Sponsor/Investigator Decision|0|||
164624662|NCT01542632|594646526|FG002|Overall Study|Sponsor/Investigator Decision|0|||
164624663|NCT01542632|594646527|FG003|Overall Study|Sponsor/Investigator Decision|0|||
164624664|NCT01542632|594646528|FG004|Overall Study|Sponsor/Investigator Decision|1|||
164624665|NCT01542632|594646529|FG005|Overall Study|Sponsor/Investigator Decision|0|||
164624666|NCT03225833|594646530|FG000|Overall Study|Adverse Event|0|||
164624667|NCT03225833|594646531|FG001|Overall Study|Adverse Event|1|||
164624668|NCT03225833|594646532|FG002|Overall Study|Adverse Event|2|||
164624669|NCT03225833|594646533|FG003|Overall Study|Adverse Event|0|||
164624670|NCT03225833|594646534|FG004|Overall Study|Adverse Event|0|||
164624671|NCT03225833|594646535|FG005|Overall Study|Adverse Event|2|||
164624672|NCT03225833|594646530|FG000|Overall Study|Withdrawal by Subject|1|||
164624673|NCT03225833|594646531|FG001|Overall Study|Withdrawal by Subject|0|||
164624674|NCT03225833|594646532|FG002|Overall Study|Withdrawal by Subject|0|||
164624675|NCT03225833|594646533|FG003|Overall Study|Withdrawal by Subject|0|||
164624676|NCT03225833|594646534|FG004|Overall Study|Withdrawal by Subject|1|||
164624677|NCT03225833|594646535|FG005|Overall Study|Withdrawal by Subject|0|||
164624678|NCT03225833|594646530|FG000|Overall Study|Termination of Study by Sponsor|4|||
164624679|NCT03225833|594646531|FG001|Overall Study|Termination of Study by Sponsor|0|||
164624680|NCT03225833|594646532|FG002|Overall Study|Termination of Study by Sponsor|0|||
164624681|NCT03225833|594646533|FG003|Overall Study|Termination of Study by Sponsor|0|||
164624682|NCT03225833|594646534|FG004|Overall Study|Termination of Study by Sponsor|0|||
164624683|NCT03225833|594646535|FG005|Overall Study|Termination of Study by Sponsor|7|||
164624684|NCT03225833|594646530|FG000|Overall Study|Sponsor Decision|0|||
164624685|NCT03225833|594646531|FG001|Overall Study|Sponsor Decision|0|||
164624686|NCT03225833|594646532|FG002|Overall Study|Sponsor Decision|0|||
164624687|NCT03225833|594646533|FG003|Overall Study|Sponsor Decision|0|||
164624688|NCT03225833|594646534|FG004|Overall Study|Sponsor Decision|0|||
164624689|NCT03225833|594646535|FG005|Overall Study|Sponsor Decision|1|||
164624690|NCT04564027|594646536|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
164624691|NCT04564027|594646537|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
164624692|NCT04564027|594646538|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
164624693|NCT04564027|594646539|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
164624694|NCT05827978|594646540|FG000|Overall Study|Adverse Event|1|||
164624695|NCT05827978|594646541|FG001|Overall Study|Adverse Event|0|||
164624696|NCT05827978|594646542|FG002|Overall Study|Adverse Event|0|||
164624697|NCT05827978|594646543|FG003|Overall Study|Adverse Event|1|||
164624698|NCT05827978|594646544|FG004|Overall Study|Adverse Event|0|||
164624699|NCT05827978|594646545|FG005|Overall Study|Adverse Event|0|||
164624700|NCT05827978|594646540|FG000|Overall Study|Death|1|||
164624701|NCT05827978|594646541|FG001|Overall Study|Death|5|||
164624702|NCT05827978|594646542|FG002|Overall Study|Death|2|||
164624703|NCT05827978|594646543|FG003|Overall Study|Death|3|||
164624704|NCT05827978|594646544|FG004|Overall Study|Death|1|||
164624705|NCT05827978|594646545|FG005|Overall Study|Death|3|||
164624706|NCT05827978|594646540|FG000|Overall Study|Lost to Follow-up|57|||
164624707|NCT05827978|594646541|FG001|Overall Study|Lost to Follow-up|88|||
164624708|NCT05827978|594646542|FG002|Overall Study|Lost to Follow-up|54|||
164624709|NCT05827978|594646543|FG003|Overall Study|Lost to Follow-up|47|||
164624710|NCT05827978|594646544|FG004|Overall Study|Lost to Follow-up|25|||
164624711|NCT05827978|594646545|FG005|Overall Study|Lost to Follow-up|10|||
164624712|NCT05827978|594646540|FG000|Overall Study|Noncompliance with Study Procedures|0|||
164624713|NCT05827978|594646541|FG001|Overall Study|Noncompliance with Study Procedures|1|||
164624714|NCT05827978|594646542|FG002|Overall Study|Noncompliance with Study Procedures|1|||
164624715|NCT05827978|594646543|FG003|Overall Study|Noncompliance with Study Procedures|1|||
164624716|NCT05827978|594646544|FG004|Overall Study|Noncompliance with Study Procedures|1|||
164624717|NCT05827978|594646545|FG005|Overall Study|Noncompliance with Study Procedures|0|||
164624718|NCT05827978|594646540|FG000|Overall Study|Physician Decision|2|||
164624719|NCT05827978|594646541|FG001|Overall Study|Physician Decision|0|||
164624720|NCT05827978|594646542|FG002|Overall Study|Physician Decision|1|||
164624721|NCT05827978|594646543|FG003|Overall Study|Physician Decision|2|||
164624722|NCT05827978|594646544|FG004|Overall Study|Physician Decision|1|||
164624723|NCT05827978|594646545|FG005|Overall Study|Physician Decision|1|||
164624724|NCT05827978|594646540|FG000|Overall Study|Protocol Violation|5|||
164624725|NCT05827978|594646541|FG001|Overall Study|Protocol Violation|2|||
164624726|NCT05827978|594646542|FG002|Overall Study|Protocol Violation|0|||
164624727|NCT05827978|594646543|FG003|Overall Study|Protocol Violation|0|||
164624728|NCT05827978|594646544|FG004|Overall Study|Protocol Violation|0|||
164624729|NCT05827978|594646545|FG005|Overall Study|Protocol Violation|0|||
164624730|NCT05827978|594646540|FG000|Overall Study|Withdrawal by Subject|17|||
164624731|NCT05827978|594646541|FG001|Overall Study|Withdrawal by Subject|16|||
164624732|NCT05827978|594646542|FG002|Overall Study|Withdrawal by Subject|10|||
164624733|NCT05827978|594646543|FG003|Overall Study|Withdrawal by Subject|12|||
164624734|NCT05827978|594646544|FG004|Overall Study|Withdrawal by Subject|10|||
164624735|NCT05827978|594646545|FG005|Overall Study|Withdrawal by Subject|9|||
164624736|NCT05827978|594646540|FG000|Overall Study|Other Than Specified|0|||
164624737|NCT05827978|594646541|FG001|Overall Study|Other Than Specified|0|||
164624738|NCT05827978|594646542|FG002|Overall Study|Other Than Specified|1|||
164624739|NCT05827978|594646543|FG003|Overall Study|Other Than Specified|0|||
164624740|NCT05827978|594646544|FG004|Overall Study|Other Than Specified|2|||
164624741|NCT05827978|594646545|FG005|Overall Study|Other Than Specified|0|||
164624742|NCT04566445|594646546|FG000|Overall Study|Death|4|||
164624743|NCT04566445|594646547|FG001|Overall Study|Death|1|||
164624744|NCT04566445|594646548|FG002|Overall Study|Death|1|||
164624745|NCT04566445|594646546|FG000|Overall Study|Lost to Follow-up|3|||
164624746|NCT04566445|594646547|FG001|Overall Study|Lost to Follow-up|1|||
164624747|NCT04566445|594646548|FG002|Overall Study|Lost to Follow-up|1|||
164624748|NCT04566445|594646546|FG000|Overall Study|Study terminated by sponsor|11|||
164624749|NCT04566445|594646547|FG001|Overall Study|Study terminated by sponsor|17|||
164624750|NCT04566445|594646548|FG002|Overall Study|Study terminated by sponsor|32|||
164624751|NCT04566445|594646546|FG000|Overall Study|Withdrawal by Subject|12|||
164624752|NCT04566445|594646547|FG001|Overall Study|Withdrawal by Subject|14|||
164624753|NCT04566445|594646548|FG002|Overall Study|Withdrawal by Subject|13|||
164624754|NCT04566445|594646546|FG000|Overall Study|Randomized but not treated due to AE|2|||
164624755|NCT04566445|594646547|FG001|Overall Study|Randomized but not treated due to AE|1|||
164624756|NCT04566445|594646548|FG002|Overall Study|Randomized but not treated due to AE|0|||
164624757|NCT04566445|594646546|FG000|Overall Study|Adverse Event|1|||
164624758|NCT04566445|594646547|FG001|Overall Study|Adverse Event|1|||
164624759|NCT04566445|594646548|FG002|Overall Study|Adverse Event|0|||
164624760|NCT00137267|594646551|FG000|Overall Study|Lost to Follow-up|15|||
164624761|NCT00137267|594646552|FG001|Overall Study|Lost to Follow-up|21|||
164624762|NCT00129376|594646557|FG000|Overall Study|Adverse Event|1|||
164624763|NCT00129376|594646557|FG000|Overall Study|Lack of Efficacy|1|||
164624764|NCT02061540|594646559|FG000|Overall Study|Adverse Event|2|||
164624765|NCT02061540|594646559|FG000|Overall Study|Withdrawal by Subject|2|||
164624766|NCT04005755|594646561|FG000|Overall Study|Adverse Event|6|||
164624767|NCT04005755|594646561|FG000|Overall Study|Physician Decision|3|||
164624768|NCT04005755|594646561|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
164624769|NCT04005755|594646561|FG000|Overall Study|Withdrawal by Subject|3|||
164624770|NCT04005755|594646561|FG000|Overall Study|Lost to Follow-up|1|||
164624771|NCT02289833|594646562|FG000|Overall Study|Study discontinuation|0|||
164624772|NCT02289833|594646563|FG001|Overall Study|Study discontinuation|1|||
164624773|NCT02289833|594646562|FG000|Overall Study|Lost to Follow-up|4|||
164624774|NCT02289833|594646563|FG001|Overall Study|Lost to Follow-up|0|||
164624775|NCT02289833|594646562|FG000|Overall Study|Death|23|||
164624776|NCT02289833|594646563|FG001|Overall Study|Death|16|||
164624777|NCT02561273|594646570|FG000|Overall Study|Protocol Violation|1|||
164624778|NCT02561273|594646571|FG001|Overall Study|Protocol Violation|0|||
164624779|NCT00958191|594646572|FG000|Overall Study|Death|4|||
164624780|NCT00958191|594646572|FG000|Overall Study|Lost to Follow-up|5|||
164624781|NCT00958191|594646572|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
164624782|NCT00958191|594646572|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
164624783|NCT00958191|594646572|FG000|Overall Study|Revision of study device|4|||
164624784|NCT00958191|594646572|FG000|Overall Study|Site termination|11|||
164624785|NCT00958191|594646572|FG000|Overall Study|No 5 yr x-rays|56|||
164624786|NCT01642004|594646573|FG000|Randomization|Adverse Event unrelated to study drug|1|||
164624787|NCT01642004|594646574|FG001|Randomization|Adverse Event unrelated to study drug|0|||
164624788|NCT01642004|594646573|FG000|Randomization|Participant withdrew consent|1|||
164624789|NCT01642004|594646574|FG001|Randomization|Participant withdrew consent|6|||
164624790|NCT01642004|594646573|FG000|Randomization|No longer meets study criteria|2|||
164624791|NCT01642004|594646574|FG001|Randomization|No longer meets study criteria|2|||
164624792|NCT01642004|594646573|FG000|Treatment|Disease progression|95|||
164624793|NCT01642004|594646574|FG001|Treatment|Disease progression|79|||
164624794|NCT01642004|594646573|FG000|Treatment|Study drug toxicity|10|||
164624795|NCT01642004|594646574|FG001|Treatment|Study drug toxicity|13|||
164624796|NCT01642004|594646573|FG000|Treatment|Death|1|||
164624797|NCT01642004|594646574|FG001|Treatment|Death|1|||
164624798|NCT01642004|594646573|FG000|Treatment|Adverse event unrelated to study drug|9|||
164624799|NCT01642004|594646574|FG001|Treatment|Adverse event unrelated to study drug|13|||
164624800|NCT01642004|594646573|FG000|Treatment|Maximum clinical benefit|1|||
164624801|NCT01642004|594646574|FG001|Treatment|Maximum clinical benefit|9|||
164624802|NCT01642004|594646573|FG000|Treatment|Poor/non-compliance|1|||
164624803|NCT01642004|594646574|FG001|Treatment|Poor/non-compliance|0|||
164624804|NCT01642004|594646573|FG000|Treatment|No longer meets study criteria|1|||
164624805|NCT01642004|594646574|FG001|Treatment|No longer meets study criteria|2|||
164624806|NCT01642004|594646573|FG000|Treatment|Other reasons|2|||
164624807|NCT01642004|594646574|FG001|Treatment|Other reasons|0|||
164624808|NCT01642004|594646573|FG000|Treatment|Not reported|0|||
164624809|NCT01642004|594646574|FG001|Treatment|Not reported|3|||
164624810|NCT01642004|594646573|FG000|Treatment|Participant request to discontinue study treatment|6|||
164624811|NCT01642004|594646574|FG001|Treatment|Participant request to discontinue study treatment|4|||
164527041|NCT03184870|594302070|FG001|Initial Treatment|Withdrawal by Subject|0|||
164527042|NCT03184870|594302071|FG002|Initial Treatment|Withdrawal by Subject|2|||
164527043|NCT03184870|594302072|FG003|Initial Treatment|Withdrawal by Subject|1|||
164527044|NCT03184870|594302073|FG004|Initial Treatment|Withdrawal by Subject|1|||
164527045|NCT03184870|594302074|FG005|Initial Treatment|Withdrawal by Subject|0|||
164527046|NCT03184870|594302075|FG006|Initial Treatment|Withdrawal by Subject|1|||
164527047|NCT03184870|594302076|FG007|Initial Treatment|Withdrawal by Subject|0|||
164527048|NCT03184870|594302077|FG008|Initial Treatment|Withdrawal by Subject|0|||
164527049|NCT03184870|594302078|FG009|Initial Treatment|Withdrawal by Subject|0|||
164527050|NCT03184870|594302079|FG010|Initial Treatment|Withdrawal by Subject|0|||
164527051|NCT03184870|594302080|FG011|Initial Treatment|Withdrawal by Subject|2|||
164527052|NCT03184870|594302081|FG012|Initial Treatment|Withdrawal by Subject|3|||
164527053|NCT03184870|594302082|FG013|Initial Treatment|Withdrawal by Subject|0|||
164527054|NCT03184870|594302083|FG014|Initial Treatment|Withdrawal by Subject|1|||
164527055|NCT03184870|594302084|FG015|Initial Treatment|Withdrawal by Subject|5|||
164527056|NCT03184870|594302085|FG016|Initial Treatment|Withdrawal by Subject|2|||
164527057|NCT03184870|594302086|FG017|Initial Treatment|Withdrawal by Subject|2|||
164527058|NCT03184870|594302069|FG000|Initial Treatment|Moved to crossover treatment|0|||
164527059|NCT03184870|594302070|FG001|Initial Treatment|Moved to crossover treatment|0|||
164527060|NCT03184870|594302071|FG002|Initial Treatment|Moved to crossover treatment|0|||
164527061|NCT03184870|594302072|FG003|Initial Treatment|Moved to crossover treatment|0|||
164527062|NCT03184870|594302073|FG004|Initial Treatment|Moved to crossover treatment|0|||
164527063|NCT03184870|594302074|FG005|Initial Treatment|Moved to crossover treatment|0|||
164527064|NCT03184870|594302075|FG006|Initial Treatment|Moved to crossover treatment|0|||
164527065|NCT03184870|594302076|FG007|Initial Treatment|Moved to crossover treatment|0|||
164527066|NCT03184870|594302077|FG008|Initial Treatment|Moved to crossover treatment|0|||
164527067|NCT03184870|594302078|FG009|Initial Treatment|Moved to crossover treatment|0|||
164527068|NCT03184870|594302079|FG010|Initial Treatment|Moved to crossover treatment|0|||
164527069|NCT03184870|594302080|FG011|Initial Treatment|Moved to crossover treatment|0|||
164527070|NCT03184870|594302081|FG012|Initial Treatment|Moved to crossover treatment|9|||
164527071|NCT03184870|594302082|FG013|Initial Treatment|Moved to crossover treatment|0|||
164527072|NCT03184870|594302083|FG014|Initial Treatment|Moved to crossover treatment|0|||
164527073|NCT03184870|594302084|FG015|Initial Treatment|Moved to crossover treatment|0|||
164527074|NCT03184870|594302085|FG016|Initial Treatment|Moved to crossover treatment|0|||
164527075|NCT03184870|594302086|FG017|Initial Treatment|Moved to crossover treatment|0|||
164527076|NCT03184870|594302069|FG000|Crossover Treatment|Other reasons|0|||
164527077|NCT03184870|594302070|FG001|Crossover Treatment|Other reasons|0|||
164527078|NCT03184870|594302071|FG002|Crossover Treatment|Other reasons|0|||
164527079|NCT03184870|594302072|FG003|Crossover Treatment|Other reasons|0|||
164527080|NCT03184870|594302073|FG004|Crossover Treatment|Other reasons|0|||
164527081|NCT03184870|594302074|FG005|Crossover Treatment|Other reasons|0|||
164527082|NCT03184870|594302075|FG006|Crossover Treatment|Other reasons|0|||
164527083|NCT03184870|594302076|FG007|Crossover Treatment|Other reasons|0|||
164527084|NCT03184870|594302077|FG008|Crossover Treatment|Other reasons|0|||
164527085|NCT03184870|594302078|FG009|Crossover Treatment|Other reasons|0|||
164527086|NCT03184870|594302079|FG010|Crossover Treatment|Other reasons|0|||
164527087|NCT03184870|594302080|FG011|Crossover Treatment|Other reasons|0|||
164527088|NCT03184870|594302081|FG012|Crossover Treatment|Other reasons|0|||
164527089|NCT03184870|594302082|FG013|Crossover Treatment|Other reasons|0|||
164527090|NCT03184870|594302083|FG014|Crossover Treatment|Other reasons|0|||
164527091|NCT03184870|594302084|FG015|Crossover Treatment|Other reasons|0|||
164527092|NCT03184870|594302085|FG016|Crossover Treatment|Other reasons|0|||
164527093|NCT03184870|594302086|FG017|Crossover Treatment|Other reasons|2|||
164527094|NCT03184870|594302069|FG000|Crossover Treatment|Death|0|||
164527095|NCT03184870|594302070|FG001|Crossover Treatment|Death|0|||
164527096|NCT03184870|594302071|FG002|Crossover Treatment|Death|0|||
164527097|NCT03184870|594302072|FG003|Crossover Treatment|Death|0|||
164527098|NCT03184870|594302073|FG004|Crossover Treatment|Death|0|||
164527099|NCT03184870|594302074|FG005|Crossover Treatment|Death|0|||
164527100|NCT03184870|594302075|FG006|Crossover Treatment|Death|0|||
164527101|NCT03184870|594302076|FG007|Crossover Treatment|Death|0|||
164527102|NCT03184870|594302077|FG008|Crossover Treatment|Death|0|||
164527103|NCT03184870|594302078|FG009|Crossover Treatment|Death|0|||
164527104|NCT03184870|594302079|FG010|Crossover Treatment|Death|0|||
164527105|NCT03184870|594302080|FG011|Crossover Treatment|Death|0|||
164527106|NCT03184870|594302081|FG012|Crossover Treatment|Death|0|||
164527107|NCT03184870|594302082|FG013|Crossover Treatment|Death|0|||
164527108|NCT03184870|594302083|FG014|Crossover Treatment|Death|0|||
164527109|NCT03184870|594302084|FG015|Crossover Treatment|Death|0|||
164527110|NCT03184870|594302085|FG016|Crossover Treatment|Death|0|||
164527111|NCT03184870|594302086|FG017|Crossover Treatment|Death|7|||
164527112|NCT05081388|594302087|FG000|Overall Study|Adverse Event|1|||
164527113|NCT05081388|594302088|FG001|Overall Study|Adverse Event|0|||
164527114|NCT05081388|594302089|FG002|Overall Study|Adverse Event|0|||
164527115|NCT05081388|594302090|FG003|Overall Study|Adverse Event|0|||
164527116|NCT05081388|594302091|FG004|Overall Study|Adverse Event|0|||
164527117|NCT05081388|594302087|FG000|Overall Study|Lost to Follow-up|0|||
164527118|NCT05081388|594302088|FG001|Overall Study|Lost to Follow-up|1|||
164624812|NCT01642004|594646573|FG000|Treatment|Participant withdrew consent|5|||
164624813|NCT01642004|594646574|FG001|Treatment|Participant withdrew consent|5|||
164624814|NCT01818765|594646577|FG000|Overall Study|Death|2|||
164624815|NCT01562327|594646578|FG000|Overall Study|Adverse Event|2|||
164624816|NCT01562327|594646578|FG000|Overall Study|Lack of Efficacy|1|||
164527119|NCT05081388|594302089|FG002|Overall Study|Lost to Follow-up|0|||
164527120|NCT05081388|594302090|FG003|Overall Study|Lost to Follow-up|0|||
164527121|NCT05081388|594302091|FG004|Overall Study|Lost to Follow-up|0|||
164527122|NCT05081388|594302087|FG000|Overall Study|Subject decision|0|||
164527123|NCT05081388|594302088|FG001|Overall Study|Subject decision|0|||
164527124|NCT05081388|594302089|FG002|Overall Study|Subject decision|0|||
164527125|NCT05081388|594302090|FG003|Overall Study|Subject decision|1|||
164527126|NCT05081388|594302091|FG004|Overall Study|Subject decision|0|||
164527127|NCT01776541|594302092|FG000|Overall Study|Administrative Reason|6|||
164527128|NCT01776541|594302093|FG001|Overall Study|Administrative Reason|2|||
164527129|NCT01776541|594302092|FG000|Overall Study|Death|4|||
164527130|NCT01776541|594302093|FG001|Overall Study|Death|0|||
164527131|NCT01776541|594302092|FG000|Overall Study|Lost to Follow-up|27|||
164527132|NCT01776541|594302093|FG001|Overall Study|Lost to Follow-up|48|||
164527133|NCT01776541|594302092|FG000|Overall Study|Unclassified|5|||
164527134|NCT01776541|594302093|FG001|Overall Study|Unclassified|4|||
164527135|NCT01776541|594302092|FG000|Overall Study|Protocol Violation|2|||
164527136|NCT01776541|594302093|FG001|Overall Study|Protocol Violation|1|||
164527137|NCT01776541|594302092|FG000|Overall Study|Withdrawal by Subject|12|||
164527138|NCT01776541|594302093|FG001|Overall Study|Withdrawal by Subject|20|||
164527139|NCT02874924|594302094|FG000|Overall Study|Adverse Event|2|||
164527140|NCT02874924|594302095|FG001|Overall Study|Adverse Event|0|||
164527141|NCT02874924|594302096|FG002|Overall Study|Adverse Event|0|||
164527142|NCT02874924|594302094|FG000|Overall Study|Withdrawal by Subject|1|||
164527143|NCT02874924|594302095|FG001|Overall Study|Withdrawal by Subject|0|||
164527144|NCT02874924|594302096|FG002|Overall Study|Withdrawal by Subject|0|||
164527145|NCT00903006|594302100|FG000|Overall Study|Withdrawal by Subject|2|||
164527146|NCT00903006|594302101|FG001|Overall Study|Withdrawal by Subject|0|||
164527147|NCT00903006|594302102|FG002|Overall Study|Withdrawal by Subject|0|||
164527148|NCT00903006|594302103|FG003|Overall Study|Withdrawal by Subject|0|||
164527149|NCT00903006|594302100|FG000|Overall Study|Progressive Disease|0|||
164527150|NCT00903006|594302101|FG001|Overall Study|Progressive Disease|3|||
164527151|NCT00903006|594302102|FG002|Overall Study|Progressive Disease|1|||
164527152|NCT00903006|594302103|FG003|Overall Study|Progressive Disease|0|||
164527153|NCT03405792|594302104|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
164527154|NCT03405792|594302105|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
164527155|NCT03405792|594302104|FG000|Overall Study|o Did not receive pembrolizumab|1|||
164527156|NCT03405792|594302105|FG001|Overall Study|o Did not receive pembrolizumab|0|||
164527157|NCT00346632|594302108|FG000|Overall Study|Progressive Disease|2|||
164527158|NCT00346632|594302109|FG001|Overall Study|Progressive Disease|2|||
164527159|NCT00346632|594302110|FG002|Overall Study|Progressive Disease|4|||
164527160|NCT00346632|594302111|FG003|Overall Study|Progressive Disease|3|||
164527161|NCT00346632|594302112|FG004|Overall Study|Progressive Disease|3|||
164527162|NCT00346632|594302113|FG005|Overall Study|Progressive Disease|1|||
164527163|NCT00346632|594302114|FG006|Overall Study|Progressive Disease|2|||
164527164|NCT00346632|594302115|FG007|Overall Study|Progressive Disease|2|||
164527165|NCT00346632|594302116|FG008|Overall Study|Progressive Disease|2|||
164527166|NCT00346632|594302117|FG009|Overall Study|Progressive Disease|2|||
164527167|NCT00346632|594302108|FG000|Overall Study|Adverse Event|0|||
164527168|NCT00346632|594302109|FG001|Overall Study|Adverse Event|0|||
164527169|NCT00346632|594302110|FG002|Overall Study|Adverse Event|0|||
164527170|NCT00346632|594302111|FG003|Overall Study|Adverse Event|0|||
164527171|NCT00346632|594302112|FG004|Overall Study|Adverse Event|1|||
164527172|NCT00346632|594302113|FG005|Overall Study|Adverse Event|1|||
164527173|NCT00346632|594302114|FG006|Overall Study|Adverse Event|1|||
164527174|NCT00346632|594302115|FG007|Overall Study|Adverse Event|0|||
164527175|NCT00346632|594302116|FG008|Overall Study|Adverse Event|0|||
164527176|NCT00346632|594302117|FG009|Overall Study|Adverse Event|0|||
164527177|NCT00346632|594302108|FG000|Overall Study|Death|0|||
164527178|NCT00346632|594302109|FG001|Overall Study|Death|0|||
164527179|NCT00346632|594302110|FG002|Overall Study|Death|1|||
164527180|NCT00346632|594302111|FG003|Overall Study|Death|0|||
164527181|NCT00346632|594302112|FG004|Overall Study|Death|0|||
164527182|NCT00346632|594302113|FG005|Overall Study|Death|0|||
164527183|NCT00346632|594302114|FG006|Overall Study|Death|0|||
164527184|NCT00346632|594302115|FG007|Overall Study|Death|0|||
164527185|NCT00346632|594302116|FG008|Overall Study|Death|0|||
164527186|NCT00346632|594302117|FG009|Overall Study|Death|0|||
164527187|NCT00346632|594302108|FG000|Overall Study|Protocol Violation|0|||
164527188|NCT00346632|594302109|FG001|Overall Study|Protocol Violation|0|||
164527189|NCT00346632|594302110|FG002|Overall Study|Protocol Violation|0|||
164527190|NCT00346632|594302111|FG003|Overall Study|Protocol Violation|0|||
164527191|NCT00346632|594302112|FG004|Overall Study|Protocol Violation|0|||
164527192|NCT00346632|594302113|FG005|Overall Study|Protocol Violation|0|||
164527193|NCT00346632|594302114|FG006|Overall Study|Protocol Violation|1|||
164527194|NCT00346632|594302115|FG007|Overall Study|Protocol Violation|0|||
164527195|NCT00346632|594302116|FG008|Overall Study|Protocol Violation|0|||
164527196|NCT00346632|594302117|FG009|Overall Study|Protocol Violation|0|||
164147699|NCT02006732|592902129|FG000|Overall Study|Lack of Efficacy|6|||
164527197|NCT00346632|594302108|FG000|Overall Study|Withdrawal by Subject|0|||
164527198|NCT00346632|594302109|FG001|Overall Study|Withdrawal by Subject|0|||
164527199|NCT00346632|594302110|FG002|Overall Study|Withdrawal by Subject|0|||
164527200|NCT00346632|594302111|FG003|Overall Study|Withdrawal by Subject|0|||
164527201|NCT00346632|594302112|FG004|Overall Study|Withdrawal by Subject|0|||
164527202|NCT00346632|594302113|FG005|Overall Study|Withdrawal by Subject|0|||
164527203|NCT00346632|594302114|FG006|Overall Study|Withdrawal by Subject|1|||
164527204|NCT00346632|594302115|FG007|Overall Study|Withdrawal by Subject|0|||
164527205|NCT00346632|594302116|FG008|Overall Study|Withdrawal by Subject|0|||
164527206|NCT00346632|594302117|FG009|Overall Study|Withdrawal by Subject|0|||
164527207|NCT00346632|594302108|FG000|Overall Study|Switched to alternative treatment|0|||
164527208|NCT00346632|594302109|FG001|Overall Study|Switched to alternative treatment|0|||
164527209|NCT00346632|594302110|FG002|Overall Study|Switched to alternative treatment|1|||
164527210|NCT00346632|594302111|FG003|Overall Study|Switched to alternative treatment|0|||
164527211|NCT00346632|594302112|FG004|Overall Study|Switched to alternative treatment|0|||
164527212|NCT00346632|594302113|FG005|Overall Study|Switched to alternative treatment|0|||
164624817|NCT01562327|594646578|FG000|Overall Study|Participant drop-out|1|||
164624818|NCT01562327|594646578|FG000|Overall Study|Infusion not received at 6 month window|4|||
164624819|NCT02795182|594646579|FG000|Overall Study|Death|5|||
164624820|NCT02795182|594646580|FG001|Overall Study|Death|4|||
164624821|NCT02795182|594646581|FG002|Overall Study|Death|4|||
164624822|NCT02795182|594646582|FG003|Overall Study|Death|18|||
164624823|NCT02795182|594646579|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
164624824|NCT02795182|594646580|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
164624825|NCT02795182|594646581|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
164624826|NCT02795182|594646582|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
164624827|NCT02795182|594646579|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
164624828|NCT02795182|594646580|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
164624829|NCT02795182|594646581|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
164624830|NCT02795182|594646582|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
164624831|NCT02795182|594646579|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
164624832|NCT02795182|594646580|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
164624833|NCT02795182|594646581|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
164624834|NCT02795182|594646582|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
164624835|NCT02795182|594646579|FG000|Overall Study|Withdrawal by Subject|4|||
164624836|NCT02795182|594646580|FG001|Overall Study|Withdrawal by Subject|0|||
164624837|NCT02795182|594646581|FG002|Overall Study|Withdrawal by Subject|0|||
164624838|NCT02795182|594646582|FG003|Overall Study|Withdrawal by Subject|3|||
164624839|NCT02795182|594646579|FG000|Overall Study|Lost to Follow-up|0|||
164624840|NCT02795182|594646580|FG001|Overall Study|Lost to Follow-up|0|||
164624841|NCT02795182|594646581|FG002|Overall Study|Lost to Follow-up|1|||
164624842|NCT02795182|594646582|FG003|Overall Study|Lost to Follow-up|1|||
164624843|NCT02795182|594646579|FG000|Overall Study|Roll Over to Long Term Extension|3|||
164624844|NCT02795182|594646580|FG001|Overall Study|Roll Over to Long Term Extension|3|||
164624845|NCT02795182|594646581|FG002|Overall Study|Roll Over to Long Term Extension|2|||
164624846|NCT02795182|594646582|FG003|Overall Study|Roll Over to Long Term Extension|5|||
164624847|NCT02795182|594646579|FG000|Overall Study|Progressive Disease|0|||
164624848|NCT02795182|594646580|FG001|Overall Study|Progressive Disease|1|||
164624849|NCT02795182|594646581|FG002|Overall Study|Progressive Disease|0|||
164624850|NCT02795182|594646582|FG003|Overall Study|Progressive Disease|4|||
164624851|NCT02795182|594646579|FG000|Overall Study|Physician Decision|0|||
164624852|NCT02795182|594646580|FG001|Overall Study|Physician Decision|0|||
164624853|NCT02795182|594646581|FG002|Overall Study|Physician Decision|0|||
164624854|NCT02795182|594646582|FG003|Overall Study|Physician Decision|1|||
164624855|NCT01197794|594646587|FG000|Overall Study|Adverse Event|3|||
164624856|NCT01197794|594646588|FG001|Overall Study|Adverse Event|2|||
164624857|NCT01197794|594646589|FG002|Overall Study|Adverse Event|4|||
164527213|NCT00346632|594302114|FG006|Overall Study|Switched to alternative treatment|0|||
164527214|NCT00346632|594302115|FG007|Overall Study|Switched to alternative treatment|0|||
164527215|NCT00346632|594302116|FG008|Overall Study|Switched to alternative treatment|0|||
164527216|NCT00346632|594302117|FG009|Overall Study|Switched to alternative treatment|0|||
164527217|NCT00346632|594302108|FG000|Overall Study|Not Stated|1|||
164527218|NCT00346632|594302109|FG001|Overall Study|Not Stated|1|||
164527219|NCT00346632|594302110|FG002|Overall Study|Not Stated|0|||
164527220|NCT00346632|594302111|FG003|Overall Study|Not Stated|0|||
164527221|NCT00346632|594302112|FG004|Overall Study|Not Stated|0|||
164527222|NCT00346632|594302113|FG005|Overall Study|Not Stated|0|||
164527223|NCT00346632|594302114|FG006|Overall Study|Not Stated|0|||
164527224|NCT00346632|594302115|FG007|Overall Study|Not Stated|2|||
164527225|NCT00346632|594302116|FG008|Overall Study|Not Stated|2|||
164527226|NCT00346632|594302117|FG009|Overall Study|Not Stated|1|||
164527227|NCT00918580|594302118|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
164527228|NCT00918580|594302118|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
164527229|NCT00918580|594302118|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
164527230|NCT00918580|594302118|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
164527231|NCT00918580|594302118|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
164527232|NCT00918580|594302118|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
164527233|NCT00918580|594302118|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
164527234|NCT04882995|594302119|FG000|Overall Study|Withdrawal by Subject|1|||
164527235|NCT04882995|594302120|FG001|Overall Study|Withdrawal by Subject|2|||
164527236|NCT04882995|594302119|FG000|Overall Study|Protocol Violation|4|||
164527237|NCT04882995|594302120|FG001|Overall Study|Protocol Violation|4|||
164527238|NCT04882995|594302119|FG000|Overall Study|Surgery postponed due to COVID|1|||
164527239|NCT04882995|594302120|FG001|Overall Study|Surgery postponed due to COVID|1|||
164527240|NCT03587974|594302121|FG000|Overall Study|caregiver demented, care recipient died|3|||
164527241|NCT03587974|594302122|FG001|Overall Study|caregiver demented, care recipient died|3|||
164527242|NCT03587974|594302121|FG000|Overall Study|Withdrawal by Subject|2|||
164527243|NCT03587974|594302122|FG001|Overall Study|Withdrawal by Subject|1|||
164624858|NCT01197794|594646590|FG003|Overall Study|Adverse Event|4|||
164624859|NCT01197794|594646591|FG004|Overall Study|Adverse Event|4|||
164624860|NCT01197794|594646592|FG005|Overall Study|Adverse Event|2|||
164624861|NCT01197794|594646593|FG006|Overall Study|Adverse Event|3|||
164624862|NCT01197794|594646587|FG000|Overall Study|Protocol Violation|0|||
164624863|NCT01197794|594646588|FG001|Overall Study|Protocol Violation|0|||
164624864|NCT01197794|594646589|FG002|Overall Study|Protocol Violation|0|||
164624865|NCT01197794|594646590|FG003|Overall Study|Protocol Violation|0|||
164624866|NCT01197794|594646591|FG004|Overall Study|Protocol Violation|2|||
164624867|NCT01197794|594646592|FG005|Overall Study|Protocol Violation|0|||
164624868|NCT01197794|594646593|FG006|Overall Study|Protocol Violation|1|||
164624869|NCT01197794|594646587|FG000|Overall Study|Development of study withdrawal criteria|3|||
164624870|NCT01197794|594646588|FG001|Overall Study|Development of study withdrawal criteria|0|||
164624871|NCT01197794|594646589|FG002|Overall Study|Development of study withdrawal criteria|0|||
164624872|NCT01197794|594646590|FG003|Overall Study|Development of study withdrawal criteria|1|||
164624873|NCT01197794|594646591|FG004|Overall Study|Development of study withdrawal criteria|0|||
164624874|NCT01197794|594646592|FG005|Overall Study|Development of study withdrawal criteria|0|||
164624875|NCT01197794|594646593|FG006|Overall Study|Development of study withdrawal criteria|1|||
164624876|NCT01197794|594646587|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
164624877|NCT01197794|594646588|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
164624878|NCT01197794|594646589|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
164624879|NCT01197794|594646590|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
164624880|NCT01197794|594646591|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
164624881|NCT01197794|594646592|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
164624882|NCT01197794|594646593|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
164624883|NCT01197794|594646587|FG000|Overall Study|Withdrawal by Subject|3|||
164624884|NCT01197794|594646588|FG001|Overall Study|Withdrawal by Subject|3|||
164624885|NCT01197794|594646589|FG002|Overall Study|Withdrawal by Subject|4|||
164624886|NCT01197794|594646590|FG003|Overall Study|Withdrawal by Subject|1|||
164624887|NCT01197794|594646591|FG004|Overall Study|Withdrawal by Subject|1|||
164624888|NCT01197794|594646592|FG005|Overall Study|Withdrawal by Subject|5|||
164624889|NCT01197794|594646593|FG006|Overall Study|Withdrawal by Subject|6|||
164624890|NCT01197794|594646587|FG000|Overall Study|Lost to Follow-up|1|||
164624891|NCT01197794|594646588|FG001|Overall Study|Lost to Follow-up|1|||
164624892|NCT01197794|594646589|FG002|Overall Study|Lost to Follow-up|0|||
164624893|NCT01197794|594646590|FG003|Overall Study|Lost to Follow-up|1|||
164624894|NCT01197794|594646591|FG004|Overall Study|Lost to Follow-up|0|||
164624895|NCT01197794|594646592|FG005|Overall Study|Lost to Follow-up|1|||
164527244|NCT03486457|594302123|FG000|Up to Month 3|Adverse Event|2|||
164527245|NCT03486457|594302124|FG001|Up to Month 3|Adverse Event|5|||
164527246|NCT03486457|594302123|FG000|Up to Month 3|Lack of Efficacy|1|||
164527247|NCT03486457|594302124|FG001|Up to Month 3|Lack of Efficacy|0|||
164527248|NCT03486457|594302123|FG000|Up to Month 3|Withdrawal by Subject|1|||
164527249|NCT03486457|594302124|FG001|Up to Month 3|Withdrawal by Subject|0|||
164527250|NCT03486457|594302123|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
164527251|NCT03486457|594302124|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
164527252|NCT03486457|594302123|FG000|Up to Month 3|Other|1|||
164527253|NCT03486457|594302124|FG001|Up to Month 3|Other|0|||
164527254|NCT03486457|594302123|FG000|Month 3 to Month 6|Adverse Event|2|||
164624896|NCT01197794|594646593|FG006|Overall Study|Lost to Follow-up|0|||
164624897|NCT01197794|594646587|FG000|Overall Study|Other|1|||
164624898|NCT01197794|594646588|FG001|Overall Study|Other|1|||
164527255|NCT03486457|594302124|FG001|Month 3 to Month 6|Adverse Event|0|||
164527256|NCT03486457|594302123|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
164527257|NCT03486457|594302124|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
164527258|NCT03486457|594302123|FG000|Month 3 to Month 6|Pregnancy|0|||
164527259|NCT03486457|594302124|FG001|Month 3 to Month 6|Pregnancy|1|||
164527260|NCT03486457|594302123|FG000|Month 3 to Month 6|Other|1|||
164527261|NCT03486457|594302124|FG001|Month 3 to Month 6|Other|0|||
164527262|NCT00372229|594302125|FG000|Study Phase|Graft loss|0|||
164527263|NCT00372229|594302126|FG001|Study Phase|Graft loss|3|||
164527264|NCT00372229|594302125|FG000|Study Phase|Protocol Violation|3|||
164527265|NCT00372229|594302126|FG001|Study Phase|Protocol Violation|4|||
164527266|NCT00372229|594302125|FG000|Study Phase|Consent withdrawn|16|||
164527267|NCT00372229|594302126|FG001|Study Phase|Consent withdrawn|14|||
164527268|NCT00372229|594302125|FG000|Study Phase|Refused treatment/did not cooperate|3|||
164527269|NCT00372229|594302126|FG001|Study Phase|Refused treatment/did not cooperate|1|||
164527270|NCT00372229|594302125|FG000|Study Phase|Death|3|||
164527271|NCT00372229|594302126|FG001|Study Phase|Death|2|||
164527272|NCT00372229|594302125|FG000|Study Phase|Reason not specified|3|||
164527273|NCT00372229|594302126|FG001|Study Phase|Reason not specified|2|||
164527274|NCT00372229|594302125|FG000|Study Phase|Lost to Follow-up|3|||
164527275|NCT00372229|594302126|FG001|Study Phase|Lost to Follow-up|3|||
164527276|NCT00372229|594302125|FG000|Follow-Up Phase|Graft loss|8|||
164527277|NCT00372229|594302126|FG001|Follow-Up Phase|Graft loss|7|||
164527278|NCT00372229|594302125|FG000|Follow-Up Phase|Consent withdrawn|13|||
164527279|NCT00372229|594302126|FG001|Follow-Up Phase|Consent withdrawn|19|||
164527280|NCT00372229|594302125|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
164527281|NCT00372229|594302126|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
164527282|NCT00372229|594302125|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
164527283|NCT00372229|594302126|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
164624899|NCT01197794|594646589|FG002|Overall Study|Other|3|||
164624900|NCT01197794|594646590|FG003|Overall Study|Other|0|||
164624901|NCT01197794|594646591|FG004|Overall Study|Other|2|||
164624902|NCT01197794|594646592|FG005|Overall Study|Other|2|||
164624903|NCT01197794|594646593|FG006|Overall Study|Other|4|||
164624904|NCT01055457|594646594|FG000|Overall Study|Lost to Follow-up|0|||
164624905|NCT01055457|594646595|FG001|Overall Study|Lost to Follow-up|1|||
164624906|NCT01055457|594646596|FG002|Overall Study|Lost to Follow-up|0|||
164624907|NCT01055457|594646597|FG003|Overall Study|Lost to Follow-up|0|||
164624908|NCT01055457|594646598|FG004|Overall Study|Lost to Follow-up|0|||
164624909|NCT01055457|594646599|FG005|Overall Study|Lost to Follow-up|1|||
164624910|NCT01055457|594646600|FG006|Overall Study|Lost to Follow-up|0|||
164624911|NCT01055457|594646601|FG007|Overall Study|Lost to Follow-up|0|||
164624912|NCT01055457|594646602|FG008|Overall Study|Lost to Follow-up|0|||
164624913|NCT01055457|594646603|FG009|Overall Study|Lost to Follow-up|0|||
164624914|NCT01055457|594646594|FG000|Overall Study|Protocol Violation|0|||
164624915|NCT01055457|594646595|FG001|Overall Study|Protocol Violation|0|||
164624916|NCT01055457|594646596|FG002|Overall Study|Protocol Violation|1|||
164624917|NCT01055457|594646597|FG003|Overall Study|Protocol Violation|1|||
164624918|NCT01055457|594646598|FG004|Overall Study|Protocol Violation|1|||
164624919|NCT01055457|594646599|FG005|Overall Study|Protocol Violation|2|||
164624920|NCT01055457|594646600|FG006|Overall Study|Protocol Violation|1|||
164624921|NCT01055457|594646601|FG007|Overall Study|Protocol Violation|0|||
164624922|NCT01055457|594646602|FG008|Overall Study|Protocol Violation|0|||
164624923|NCT01055457|594646603|FG009|Overall Study|Protocol Violation|1|||
164624924|NCT01055457|594646594|FG000|Overall Study|Subject Disinterest|0|||
164624925|NCT01055457|594646595|FG001|Overall Study|Subject Disinterest|0|||
164624926|NCT01055457|594646596|FG002|Overall Study|Subject Disinterest|0|||
164624927|NCT01055457|594646597|FG003|Overall Study|Subject Disinterest|0|||
164624928|NCT01055457|594646598|FG004|Overall Study|Subject Disinterest|0|||
164624929|NCT01055457|594646599|FG005|Overall Study|Subject Disinterest|0|||
164624930|NCT01055457|594646600|FG006|Overall Study|Subject Disinterest|0|||
164624931|NCT01055457|594646601|FG007|Overall Study|Subject Disinterest|1|||
164624932|NCT01055457|594646602|FG008|Overall Study|Subject Disinterest|0|||
164624933|NCT01055457|594646603|FG009|Overall Study|Subject Disinterest|0|||
164624934|NCT01055457|594646594|FG000|Overall Study|Subject Ineligible|1|||
164624935|NCT01055457|594646595|FG001|Overall Study|Subject Ineligible|0|||
164624936|NCT01055457|594646596|FG002|Overall Study|Subject Ineligible|1|||
164624937|NCT01055457|594646597|FG003|Overall Study|Subject Ineligible|0|||
164624938|NCT01055457|594646598|FG004|Overall Study|Subject Ineligible|1|||
164624939|NCT01055457|594646599|FG005|Overall Study|Subject Ineligible|0|||
164624940|NCT01055457|594646600|FG006|Overall Study|Subject Ineligible|0|||
164624941|NCT01055457|594646601|FG007|Overall Study|Subject Ineligible|0|||
164624942|NCT01055457|594646602|FG008|Overall Study|Subject Ineligible|0|||
164624943|NCT01055457|594646603|FG009|Overall Study|Subject Ineligible|0|||
164624944|NCT01055457|594646594|FG000|Overall Study|Discomfort|0|||
164624945|NCT01055457|594646595|FG001|Overall Study|Discomfort|0|||
164624946|NCT01055457|594646596|FG002|Overall Study|Discomfort|0|||
164527284|NCT00372229|594302125|FG000|Follow-Up Phase|Death|9|||
164624947|NCT01055457|594646597|FG003|Overall Study|Discomfort|0|||
164624948|NCT01055457|594646598|FG004|Overall Study|Discomfort|1|||
164624949|NCT01055457|594646599|FG005|Overall Study|Discomfort|0|||
164527285|NCT00372229|594302126|FG001|Follow-Up Phase|Death|12|||
164527286|NCT00372229|594302125|FG000|Follow-Up Phase|Administrative|1|||
164527287|NCT00372229|594302126|FG001|Follow-Up Phase|Administrative|0|||
164527288|NCT00372229|594302125|FG000|Follow-Up Phase|Reason not specified|2|||
164527289|NCT00372229|594302126|FG001|Follow-Up Phase|Reason not specified|3|||
164527290|NCT00372229|594302125|FG000|Follow-Up Phase|Lost to Follow-up|12|||
164527291|NCT00372229|594302126|FG001|Follow-Up Phase|Lost to Follow-up|10|||
164527292|NCT01382706|594302127|FG000|Overall Study|Adverse Event|1|||
164527293|NCT01382706|594302127|FG000|Overall Study|Withdrawal by Subject|1|||
164527294|NCT04055090|594302128|FG000|Overall Study|screen failure|1|||
164527295|NCT04055090|594302129|FG001|Overall Study|screen failure|0|||
164527296|NCT04055090|594302128|FG000|Overall Study|Withdrawal by Subject|1|||
164527297|NCT04055090|594302129|FG001|Overall Study|Withdrawal by Subject|0|||
164527298|NCT05478499|594302132|FG000|Placebo Controlled: Week 0 - 16|Adverse Event|4|||
164527299|NCT05478499|594302133|FG001|Placebo Controlled: Week 0 - 16|Adverse Event|2|||
164527300|NCT05478499|594302132|FG000|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|3|||
164527301|NCT05478499|594302133|FG001|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|2|||
164527302|NCT05478499|594302132|FG000|Placebo Controlled: Week 0 - 16|Lack of Efficacy|1|||
164527303|NCT05478499|594302133|FG001|Placebo Controlled: Week 0 - 16|Lack of Efficacy|0|||
164527304|NCT05478499|594302132|FG000|Placebo Controlled: Week 0 - 16|Lost to Follow-up|1|||
164527305|NCT05478499|594302133|FG001|Placebo Controlled: Week 0 - 16|Lost to Follow-up|0|||
164527306|NCT05478499|594302132|FG000|Placebo Controlled: Week 0 - 16|Other reasons|0|||
164527307|NCT05478499|594302133|FG001|Placebo Controlled: Week 0 - 16|Other reasons|2|||
164527308|NCT05478499|594302132|FG000|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|4|||
164527309|NCT05478499|594302133|FG001|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|2|||
164527310|NCT05478499|594302132|FG000|Active Treatment: Week 16 - Week 52|Lack of Efficacy|4|||
164527311|NCT05478499|594302133|FG001|Active Treatment: Week 16 - Week 52|Lack of Efficacy|1|||
164527312|NCT05478499|594302132|FG000|Active Treatment: Week 16 - Week 52|Adverse Event|4|||
164527313|NCT05478499|594302133|FG001|Active Treatment: Week 16 - Week 52|Adverse Event|0|||
164527314|NCT05478499|594302132|FG000|Active Treatment: Week 16 - Week 52|Lost to Follow-up|1|||
164527315|NCT05478499|594302133|FG001|Active Treatment: Week 16 - Week 52|Lost to Follow-up|2|||
164527316|NCT05478499|594302132|FG000|Active Treatment: Week 16 - Week 52|Death|1|||
164527317|NCT05478499|594302133|FG001|Active Treatment: Week 16 - Week 52|Death|0|||
164527318|NCT05478499|594302132|FG000|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|0|||
164527319|NCT05478499|594302133|FG001|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|1|||
164527320|NCT00249002|594302137|FG000|Overall Study|Adverse Event|2|||
164527321|NCT00249002|594302137|FG000|Overall Study|Study cancellation|3|||
164527322|NCT00249002|594302137|FG000|Overall Study|Other|2|||
164527323|NCT02319525|594302138|FG000|Overall Study|Withdrawal by Subject|2|||
164527324|NCT02319525|594302139|FG001|Overall Study|Withdrawal by Subject|1|||
164527325|NCT02729753|594302146|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
164527326|NCT02729753|594302147|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
164527327|NCT02842827|594302148|FG000|Overall Study|Adverse Event|0|||
164527328|NCT02842827|594302149|FG001|Overall Study|Adverse Event|1|||
164527329|NCT02842827|594302150|FG002|Overall Study|Adverse Event|0|||
164527330|NCT02842827|594302151|FG003|Overall Study|Adverse Event|1|||
164527331|NCT02842827|594302152|FG004|Overall Study|Adverse Event|0|||
164527332|NCT02842827|594302153|FG005|Overall Study|Adverse Event|1|||
164527333|NCT02842827|594302154|FG006|Overall Study|Adverse Event|0|||
164527334|NCT02842827|594302155|FG007|Overall Study|Adverse Event|0|||
164527335|NCT02842827|594302148|FG000|Overall Study|Death|1|||
164527336|NCT02842827|594302149|FG001|Overall Study|Death|0|||
164527337|NCT02842827|594302150|FG002|Overall Study|Death|2|||
164527338|NCT02842827|594302151|FG003|Overall Study|Death|3|||
164527339|NCT02842827|594302152|FG004|Overall Study|Death|2|||
164527340|NCT02842827|594302153|FG005|Overall Study|Death|1|||
164527341|NCT02842827|594302154|FG006|Overall Study|Death|0|||
164527342|NCT02842827|594302155|FG007|Overall Study|Death|4|||
164527343|NCT02842827|594302148|FG000|Overall Study|Physician Decision|1|||
164527344|NCT02842827|594302149|FG001|Overall Study|Physician Decision|3|||
164527345|NCT02842827|594302150|FG002|Overall Study|Physician Decision|0|||
164527346|NCT02842827|594302151|FG003|Overall Study|Physician Decision|0|||
164527347|NCT02842827|594302152|FG004|Overall Study|Physician Decision|1|||
164527348|NCT02842827|594302153|FG005|Overall Study|Physician Decision|4|||
164527349|NCT02842827|594302154|FG006|Overall Study|Physician Decision|2|||
164527350|NCT02842827|594302155|FG007|Overall Study|Physician Decision|1|||
164624950|NCT01055457|594646600|FG006|Overall Study|Discomfort|0|||
164624951|NCT01055457|594646601|FG007|Overall Study|Discomfort|0|||
164624952|NCT01055457|594646602|FG008|Overall Study|Discomfort|0|||
164624953|NCT01055457|594646603|FG009|Overall Study|Discomfort|0|||
164624954|NCT01055457|594646594|FG000|Overall Study|Pregnancy|0|||
164624955|NCT01055457|594646595|FG001|Overall Study|Pregnancy|0|||
164624956|NCT01055457|594646596|FG002|Overall Study|Pregnancy|0|||
164624957|NCT01055457|594646597|FG003|Overall Study|Pregnancy|1|||
164624958|NCT01055457|594646598|FG004|Overall Study|Pregnancy|0|||
164624959|NCT01055457|594646599|FG005|Overall Study|Pregnancy|0|||
164624960|NCT01055457|594646600|FG006|Overall Study|Pregnancy|0|||
164624961|NCT01055457|594646601|FG007|Overall Study|Pregnancy|0|||
164624962|NCT01055457|594646602|FG008|Overall Study|Pregnancy|0|||
164624963|NCT01055457|594646603|FG009|Overall Study|Pregnancy|0|||
164624964|NCT01055457|594646594|FG000|Overall Study|Adverse Event|0|||
164624965|NCT01055457|594646595|FG001|Overall Study|Adverse Event|0|||
164624966|NCT01055457|594646596|FG002|Overall Study|Adverse Event|0|||
164624967|NCT01055457|594646597|FG003|Overall Study|Adverse Event|1|||
164624968|NCT01055457|594646598|FG004|Overall Study|Adverse Event|0|||
164624969|NCT01055457|594646599|FG005|Overall Study|Adverse Event|0|||
164624970|NCT01055457|594646600|FG006|Overall Study|Adverse Event|0|||
164624971|NCT01055457|594646601|FG007|Overall Study|Adverse Event|0|||
164624972|NCT01055457|594646602|FG008|Overall Study|Adverse Event|0|||
164624973|NCT01055457|594646603|FG009|Overall Study|Adverse Event|0|||
164624974|NCT02724111|594646604|FG000|Overall Study|Protocol Violation|2|||
164624975|NCT02724111|594646605|FG001|Overall Study|Protocol Violation|5|||
164624976|NCT02996500|594646606|FG000|Overall Study|Adverse Event|1|||
164624977|NCT02996500|594646607|FG001|Overall Study|Adverse Event|1|||
164624978|NCT02996500|594646608|FG002|Overall Study|Adverse Event|4|||
164624979|NCT02996500|594646609|FG003|Overall Study|Adverse Event|3|||
164624980|NCT02996500|594646610|FG004|Overall Study|Adverse Event|1|||
164624981|NCT02996500|594646611|FG005|Overall Study|Adverse Event|2|||
164624982|NCT02996500|594646606|FG000|Overall Study|Lack of Efficacy|0|||
164624983|NCT02996500|594646607|FG001|Overall Study|Lack of Efficacy|0|||
164624984|NCT02996500|594646608|FG002|Overall Study|Lack of Efficacy|0|||
164624985|NCT02996500|594646609|FG003|Overall Study|Lack of Efficacy|0|||
164624986|NCT02996500|594646610|FG004|Overall Study|Lack of Efficacy|2|||
164624987|NCT02996500|594646611|FG005|Overall Study|Lack of Efficacy|0|||
164624988|NCT02996500|594646606|FG000|Overall Study|Lost to Follow-up|1|||
164624989|NCT02996500|594646607|FG001|Overall Study|Lost to Follow-up|0|||
164624990|NCT02996500|594646608|FG002|Overall Study|Lost to Follow-up|0|||
164624991|NCT02996500|594646609|FG003|Overall Study|Lost to Follow-up|0|||
164624992|NCT02996500|594646610|FG004|Overall Study|Lost to Follow-up|0|||
164624993|NCT02996500|594646611|FG005|Overall Study|Lost to Follow-up|1|||
164624994|NCT02996500|594646606|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
164624995|NCT02996500|594646607|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
164624996|NCT02996500|594646608|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
164624997|NCT02996500|594646609|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
164624998|NCT02996500|594646610|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
164624999|NCT02996500|594646611|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
164625000|NCT02996500|594646606|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164625001|NCT02996500|594646607|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164625002|NCT02996500|594646608|FG002|Overall Study|Non-Compliance With Study Drug|0|||
164625003|NCT02996500|594646609|FG003|Overall Study|Non-Compliance With Study Drug|0|||
164625004|NCT02996500|594646610|FG004|Overall Study|Non-Compliance With Study Drug|0|||
164625005|NCT02996500|594646611|FG005|Overall Study|Non-Compliance With Study Drug|1|||
164625006|NCT02996500|594646606|FG000|Overall Study|Progressive Disease|1|||
164625007|NCT02996500|594646607|FG001|Overall Study|Progressive Disease|0|||
164625008|NCT02996500|594646608|FG002|Overall Study|Progressive Disease|0|||
164625009|NCT02996500|594646609|FG003|Overall Study|Progressive Disease|0|||
164625010|NCT02996500|594646610|FG004|Overall Study|Progressive Disease|0|||
164625011|NCT02996500|594646611|FG005|Overall Study|Progressive Disease|0|||
164625012|NCT02996500|594646606|FG000|Overall Study|Other|2|||
164625013|NCT02996500|594646607|FG001|Overall Study|Other|0|||
164625014|NCT02996500|594646608|FG002|Overall Study|Other|2|||
164625015|NCT02996500|594646609|FG003|Overall Study|Other|0|||
164625016|NCT02996500|594646610|FG004|Overall Study|Other|0|||
164625017|NCT02996500|594646611|FG005|Overall Study|Other|0|||
164625018|NCT02996500|594646606|FG000|Overall Study|Protocol Violation|0|||
164625019|NCT02996500|594646607|FG001|Overall Study|Protocol Violation|0|||
164625020|NCT02996500|594646608|FG002|Overall Study|Protocol Violation|0|||
164625021|NCT02996500|594646609|FG003|Overall Study|Protocol Violation|1|||
164625022|NCT02996500|594646610|FG004|Overall Study|Protocol Violation|0|||
164625023|NCT02996500|594646611|FG005|Overall Study|Protocol Violation|0|||
164625024|NCT02996500|594646606|FG000|Overall Study|Withdrawal by Subject|3|||
164625025|NCT02996500|594646607|FG001|Overall Study|Withdrawal by Subject|0|||
164625026|NCT02996500|594646608|FG002|Overall Study|Withdrawal by Subject|3|||
164625027|NCT02996500|594646609|FG003|Overall Study|Withdrawal by Subject|0|||
164625028|NCT02996500|594646610|FG004|Overall Study|Withdrawal by Subject|2|||
164625029|NCT02996500|594646611|FG005|Overall Study|Withdrawal by Subject|0|||
164625030|NCT02187224|594646612|FG000|Overall Study|Did not show up for test day|1|||
164625031|NCT02187224|594646613|FG001|Overall Study|Did not show up for test day|0|||
164625032|NCT01010776|594646618|FG000|Main Phase|Withdrawal by Subject|14|||
164625033|NCT01010776|594646618|FG000|Main Phase|Lack of Efficacy|8|||
164625034|NCT01010776|594646618|FG000|Main Phase|Adverse Event|7|||
164625035|NCT01010776|594646618|FG000|Main Phase|Lost to Follow-up|6|||
164625036|NCT01010776|594646618|FG000|Main Phase|Non-compliance to study medication|5|||
164625037|NCT01010776|594646618|FG000|Main Phase|Selection failure|2|||
164625038|NCT01010776|594646618|FG000|Main Phase|Inform consent withdrawal|1|||
164625039|NCT01010776|594646618|FG000|Main Phase|Other|1|||
164625040|NCT01010776|594646618|FG000|Main Phase|Did not received study medication|5|||
164625041|NCT01010776|594646618|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
164625042|NCT01010776|594646618|FG000|Extension Phase|Other|3|||
164625043|NCT02332876|594646619|FG000|Overall Study|Lost to Follow-up|1|||
164625044|NCT02332876|594646620|FG001|Overall Study|Lost to Follow-up|1|||
164625045|NCT01369069|594646624|FG000|Overall Study|Lost to Follow-up|8|||
164625046|NCT01369069|594646625|FG001|Overall Study|Lost to Follow-up|9|||
164625047|NCT01369069|594646624|FG000|Overall Study|Withdrawal by Subject|9|||
164625048|NCT01369069|594646625|FG001|Overall Study|Withdrawal by Subject|7|||
164625049|NCT02573012|594646626|FG000|Overall Study|Adverse Event|5|||
164625050|NCT02573012|594646627|FG001|Overall Study|Adverse Event|5|||
164625051|NCT02573012|594646626|FG000|Overall Study|Lack of Efficacy|5|||
164625052|NCT02573012|594646627|FG001|Overall Study|Lack of Efficacy|4|||
164625053|NCT02573012|594646626|FG000|Overall Study|Non-compliance|1|||
164625054|NCT02573012|594646627|FG001|Overall Study|Non-compliance|2|||
164625055|NCT02573012|594646626|FG000|Overall Study|Withdrawal by Subject|2|||
164625056|NCT02573012|594646627|FG001|Overall Study|Withdrawal by Subject|2|||
164625057|NCT02573012|594646626|FG000|Overall Study|Study Ended per Protocol|1|||
164625058|NCT02573012|594646627|FG001|Overall Study|Study Ended per Protocol|0|||
164625059|NCT02573012|594646626|FG000|Overall Study|Physician Decision|1|||
164625060|NCT02573012|594646627|FG001|Overall Study|Physician Decision|2|||
164625061|NCT00882362|594646628|FG000|Overall Study|Adverse Event|13|||
164625062|NCT00882362|594646629|FG001|Overall Study|Adverse Event|10|||
164625063|NCT00882362|594646628|FG000|Overall Study|Withdrawal by Subject|13|||
164625064|NCT00882362|594646629|FG001|Overall Study|Withdrawal by Subject|10|||
164625065|NCT00882362|594646628|FG000|Overall Study|Lack of Efficacy|3|||
164625066|NCT00882362|594646629|FG001|Overall Study|Lack of Efficacy|0|||
164625067|NCT00882362|594646628|FG000|Overall Study|Protocol Violation|7|||
164625068|NCT00882362|594646629|FG001|Overall Study|Protocol Violation|2|||
164625069|NCT00882362|594646628|FG000|Overall Study|Pregnancy|1|||
164625070|NCT00882362|594646629|FG001|Overall Study|Pregnancy|0|||
164625071|NCT00882362|594646628|FG000|Overall Study|Physician Decision|5|||
164625072|NCT00882362|594646629|FG001|Overall Study|Physician Decision|1|||
164625073|NCT00882362|594646628|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
164625074|NCT00882362|594646629|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
164625075|NCT00882362|594646628|FG000|Overall Study|change of residence or other commitments|5|||
164625076|NCT00882362|594646629|FG001|Overall Study|change of residence or other commitments|0|||
164625077|NCT01268514|594646630|FG000|Overall Study|Adverse Event|20|||
164625078|NCT01268514|594646630|FG000|Overall Study|Death|8|||
164625079|NCT01268514|594646630|FG000|Overall Study|Lost to Follow-up|5|||
164625080|NCT01268514|594646630|FG000|Overall Study|Withdrawal by Subject|3|||
164625081|NCT01268514|594646630|FG000|Overall Study|Withdrawal by Surgeon|5|||
164625082|NCT01222416|594646631|FG000|Overall Study|ineligible;metastasis|3|||
164625083|NCT01222416|594646632|FG001|Overall Study|ineligible;metastasis|0|||
164625084|NCT01222416|594646631|FG000|Overall Study|Adverse Event|4|||
164625085|NCT01222416|594646632|FG001|Overall Study|Adverse Event|0|||
164625086|NCT01222416|594646631|FG000|Overall Study|Withdrawal by Subject|5|||
164625087|NCT01222416|594646632|FG001|Overall Study|Withdrawal by Subject|0|||
164625088|NCT01222416|594646631|FG000|Overall Study|scheduling|6|||
164625089|NCT01222416|594646632|FG001|Overall Study|scheduling|0|||
164625090|NCT01222416|594646631|FG000|Overall Study|missed view/scan|1|||
164625091|NCT01222416|594646632|FG001|Overall Study|missed view/scan|0|||
164625092|NCT01222416|594646631|FG000|Overall Study|Death|1|||
164625093|NCT01222416|594646632|FG001|Overall Study|Death|0|||
164625094|NCT03258762|594646639|FG000|Overall Study|Lost to Follow-up|0|||
164625095|NCT03258762|594646640|FG001|Overall Study|Lost to Follow-up|1|||
164625096|NCT02545049|594646647|FG000|Overall Study|Withdrawal by Subject|1|||
164625097|NCT02545049|594646648|FG001|Overall Study|Withdrawal by Subject|7|||
164625098|NCT02545049|594646647|FG000|Overall Study|Lost to Follow-up|4|||
164625099|NCT02545049|594646648|FG001|Overall Study|Lost to Follow-up|6|||
164625100|NCT02545049|594646647|FG000|Overall Study|GCP violations|37|||
164625101|NCT02545049|594646648|FG001|Overall Study|GCP violations|48|||
164625102|NCT04490057|594646650|FG000|Stage 1|Death|1|||
164625103|NCT04490057|594646651|FG001|Stage 1|Death|2|||
164625104|NCT04490057|594646652|FG002|Stage 1|Death|0|||
164625105|NCT04490057|594646653|FG003|Stage 1|Death|0|||
164625106|NCT04490057|594646654|FG004|Stage 1|Death|0|||
164625107|NCT04490057|594646655|FG005|Stage 1|Death|0|||
164625108|NCT04490057|594646656|FG006|Stage 1|Death|0|||
164625109|NCT04490057|594646657|FG007|Stage 1|Death|0|||
164625110|NCT04490057|594646650|FG000|Stage 1|Withdrawal by Subject|2|||
164625111|NCT04490057|594646651|FG001|Stage 1|Withdrawal by Subject|0|||
164625112|NCT04490057|594646652|FG002|Stage 1|Withdrawal by Subject|0|||
164625113|NCT04490057|594646653|FG003|Stage 1|Withdrawal by Subject|0|||
164625114|NCT04490057|594646654|FG004|Stage 1|Withdrawal by Subject|0|||
164625115|NCT04490057|594646655|FG005|Stage 1|Withdrawal by Subject|0|||
164625116|NCT04490057|594646656|FG006|Stage 1|Withdrawal by Subject|0|||
164625117|NCT04490057|594646657|FG007|Stage 1|Withdrawal by Subject|0|||
164625118|NCT04490057|594646650|FG000|Stage 2|Death|0|||
164625119|NCT04490057|594646651|FG001|Stage 2|Death|0|||
164625120|NCT04490057|594646652|FG002|Stage 2|Death|0|||
164625121|NCT04490057|594646653|FG003|Stage 2|Death|0|||
164625122|NCT04490057|594646654|FG004|Stage 2|Death|1|||
164625123|NCT04490057|594646655|FG005|Stage 2|Death|0|||
164625124|NCT04490057|594646656|FG006|Stage 2|Death|0|||
164625125|NCT04490057|594646657|FG007|Stage 2|Death|0|||
164625126|NCT04490057|594646650|FG000|Stage 2|Lost to Follow-up|0|||
164625127|NCT04490057|594646651|FG001|Stage 2|Lost to Follow-up|0|||
164625128|NCT04490057|594646652|FG002|Stage 2|Lost to Follow-up|0|||
164625129|NCT04490057|594646653|FG003|Stage 2|Lost to Follow-up|11|||
164625130|NCT04490057|594646654|FG004|Stage 2|Lost to Follow-up|17|||
164625131|NCT04490057|594646655|FG005|Stage 2|Lost to Follow-up|4|||
164625132|NCT04490057|594646656|FG006|Stage 2|Lost to Follow-up|21|||
164625133|NCT04490057|594646657|FG007|Stage 2|Lost to Follow-up|14|||
164625134|NCT04191096|594646658|FG000|Overall Study|Death|102|||
164625135|NCT04191096|594646659|FG001|Overall Study|Death|89|||
164625136|NCT04191096|594646658|FG000|Overall Study|Lost to Follow-up|1|||
164625137|NCT04191096|594646659|FG001|Overall Study|Lost to Follow-up|1|||
164625138|NCT04191096|594646658|FG000|Overall Study|Withdrawal by Subject|5|||
164625139|NCT04191096|594646659|FG001|Overall Study|Withdrawal by Subject|5|||
164625140|NCT04191096|594646658|FG000|Overall Study|Participants Ongoing|518|||
164625141|NCT04191096|594646659|FG001|Overall Study|Participants Ongoing|530|||
164625142|NCT02598661|594646663|FG000|Overall Study|Death|27|||
164625143|NCT02598661|594646664|FG001|Overall Study|Death|34|||
164625144|NCT02598661|594646665|FG002|Overall Study|Death|14|||
164625145|NCT02598661|594646666|FG003|Overall Study|Death|1|||
164625146|NCT02598661|594646667|FG004|Overall Study|Death|0|||
164625147|NCT02598661|594646663|FG000|Overall Study|Lost to Follow-up|2|||
164625148|NCT02598661|594646664|FG001|Overall Study|Lost to Follow-up|3|||
164625149|NCT02598661|594646665|FG002|Overall Study|Lost to Follow-up|2|||
164625150|NCT02598661|594646666|FG003|Overall Study|Lost to Follow-up|0|||
164625151|NCT02598661|594646667|FG004|Overall Study|Lost to Follow-up|0|||
164625152|NCT02598661|594646663|FG000|Overall Study|Withdrawal by Subject|13|||
164625153|NCT02598661|594646664|FG001|Overall Study|Withdrawal by Subject|24|||
164625154|NCT02598661|594646665|FG002|Overall Study|Withdrawal by Subject|14|||
164625155|NCT02598661|594646666|FG003|Overall Study|Withdrawal by Subject|1|||
164625156|NCT02598661|594646667|FG004|Overall Study|Withdrawal by Subject|1|||
164625157|NCT02598661|594646663|FG000|Overall Study|Adverse Event|0|||
164625158|NCT02598661|594646664|FG001|Overall Study|Adverse Event|0|||
164625159|NCT02598661|594646665|FG002|Overall Study|Adverse Event|1|||
164625160|NCT02598661|594646666|FG003|Overall Study|Adverse Event|0|||
164625161|NCT02598661|594646667|FG004|Overall Study|Adverse Event|0|||
164625162|NCT02598661|594646663|FG000|Overall Study|Randomized, Never Treated|0|||
164625163|NCT02598661|594646664|FG001|Overall Study|Randomized, Never Treated|0|||
164625164|NCT02598661|594646665|FG002|Overall Study|Randomized, Never Treated|0|||
164625165|NCT02598661|594646666|FG003|Overall Study|Randomized, Never Treated|0|||
164625166|NCT02598661|594646667|FG004|Overall Study|Randomized, Never Treated|1|||
164625167|NCT00027027|594648243|FG000|Overall Study|Adverse Event|0|||
164625168|NCT00027027|594648244|FG001|Overall Study|Adverse Event|0|||
164625169|NCT00027027|594648245|FG002|Overall Study|Adverse Event|1|||
164625170|NCT00027027|594648246|FG003|Overall Study|Adverse Event|0|||
164625171|NCT00027027|594648247|FG004|Overall Study|Adverse Event|1|||
164625172|NCT00027027|594648243|FG000|Overall Study|Admitted for Signs of PD|0|||
164625173|NCT00027027|594648244|FG001|Overall Study|Admitted for Signs of PD|0|||
164625174|NCT00027027|594648245|FG002|Overall Study|Admitted for Signs of PD|0|||
164625175|NCT00027027|594648246|FG003|Overall Study|Admitted for Signs of PD|0|||
164625176|NCT00027027|594648247|FG004|Overall Study|Admitted for Signs of PD|1|||
164625177|NCT00027027|594648243|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
164625178|NCT00027027|594648244|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
164625179|NCT00027027|594648245|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
164625180|NCT00027027|594648246|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
164625181|NCT00027027|594648247|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
164625182|NCT00027027|594648243|FG000|Overall Study|PD Requiring Surgery|0|||
164625183|NCT00027027|594648244|FG001|Overall Study|PD Requiring Surgery|0|||
164625184|NCT00027027|594648245|FG002|Overall Study|PD Requiring Surgery|1|||
164625185|NCT00027027|594648246|FG003|Overall Study|PD Requiring Surgery|0|||
164625186|NCT00027027|594648247|FG004|Overall Study|PD Requiring Surgery|0|||
164625187|NCT00027027|594648243|FG000|Overall Study|Physician Decision Due To PD|2|||
164625188|NCT00027027|594648244|FG001|Overall Study|Physician Decision Due To PD|3|||
164625189|NCT00027027|594648245|FG002|Overall Study|Physician Decision Due To PD|2|||
164625190|NCT00027027|594648246|FG003|Overall Study|Physician Decision Due To PD|3|||
164625191|NCT00027027|594648247|FG004|Overall Study|Physician Decision Due To PD|5|||
164625192|NCT00027027|594648243|FG000|Overall Study|Withdrawal by Subject|0|||
164625193|NCT00027027|594648244|FG001|Overall Study|Withdrawal by Subject|0|||
164625194|NCT00027027|594648245|FG002|Overall Study|Withdrawal by Subject|0|||
164625195|NCT00027027|594648246|FG003|Overall Study|Withdrawal by Subject|0|||
164625196|NCT00027027|594648247|FG004|Overall Study|Withdrawal by Subject|1|||
164625197|NCT00003389|594648251|FG000|Overall Study|Disease progression|6|||
164625198|NCT00003389|594648252|FG001|Overall Study|Disease progression|1|||
164625199|NCT00003389|594648251|FG000|Overall Study|Adverse Event|13|||
164625200|NCT00003389|594648252|FG001|Overall Study|Adverse Event|2|||
164625201|NCT00003389|594648251|FG000|Overall Study|Death|0|||
164625202|NCT00003389|594648252|FG001|Overall Study|Death|3|||
164625203|NCT00003389|594648251|FG000|Overall Study|Withdrawal by Subject|12|||
164625204|NCT00003389|594648252|FG001|Overall Study|Withdrawal by Subject|5|||
164625205|NCT00003389|594648251|FG000|Overall Study|Alternative therapy|2|||
164625206|NCT00003389|594648252|FG001|Overall Study|Alternative therapy|1|||
164625207|NCT00003389|594648251|FG000|Overall Study|Complicating disease|1|||
164625208|NCT00003389|594648252|FG001|Overall Study|Complicating disease|0|||
164625209|NCT00003389|594648251|FG000|Overall Study|Off-treatment reason missing|31|||
164625210|NCT00003389|594648252|FG001|Overall Study|Off-treatment reason missing|21|||
164625211|NCT00003389|594648251|FG000|Overall Study|Ineligible|33|||
164625212|NCT00003389|594648252|FG001|Overall Study|Ineligible|27|||
164625213|NCT05158244|594648261|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
164625214|NCT05158244|594648262|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
164625215|NCT05158244|594648263|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
164625216|NCT05158244|594648264|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
164625217|NCT05158244|594648265|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
164625218|NCT05158244|594648261|FG000|Overall Study|Withdrawal by Subject|0|||
164625219|NCT05158244|594648262|FG001|Overall Study|Withdrawal by Subject|0|||
164625220|NCT05158244|594648263|FG002|Overall Study|Withdrawal by Subject|1|||
164625221|NCT05158244|594648264|FG003|Overall Study|Withdrawal by Subject|0|||
164625222|NCT05158244|594648265|FG004|Overall Study|Withdrawal by Subject|0|||
164625223|NCT00775138|594648266|FG000|Overall Study|Withdrawal by Subject|0|||
164625224|NCT00775138|594648267|FG001|Overall Study|Withdrawal by Subject|0|||
164625225|NCT00775138|594648268|FG002|Overall Study|Withdrawal by Subject|2|||
164625226|NCT00775138|594648269|FG003|Overall Study|Withdrawal by Subject|2|||
164625227|NCT00775138|594648266|FG000|Overall Study|Adverse Event|0|||
164625228|NCT00775138|594648267|FG001|Overall Study|Adverse Event|0|||
164625229|NCT00775138|594648268|FG002|Overall Study|Adverse Event|1|||
164625230|NCT00775138|594648269|FG003|Overall Study|Adverse Event|0|||
164625231|NCT00712712|594648272|FG000|Overall Study|Protocol Violation|11|||
164625232|NCT00712712|594648272|FG000|Overall Study|Radiofrequency not done|3|||
164625233|NCT00712712|594648272|FG000|Overall Study|Death|8|||
164625234|NCT00712712|594648272|FG000|Overall Study|Withdrawal by Subject|1|||
164625235|NCT02723019|594648274|FG000|Overall Study|Death|17|||
164625236|NCT02723019|594648275|FG001|Overall Study|Death|13|||
164625237|NCT02723019|594648274|FG000|Overall Study|Withdrawal by Subject|11|||
164625238|NCT02723019|594648275|FG001|Overall Study|Withdrawal by Subject|7|||
164625239|NCT02723019|594648274|FG000|Overall Study|Lost to Follow-up|57|||
164625240|NCT02723019|594648275|FG001|Overall Study|Lost to Follow-up|70|||
164625241|NCT00611767|594648277|FG000|Overall Study|Withdrawal by Subject|4|||
164625242|NCT00611767|594648278|FG001|Overall Study|Withdrawal by Subject|1|||
164625243|NCT00611767|594648277|FG000|Overall Study|Thiopental not available|3|||
164625244|NCT00611767|594648278|FG001|Overall Study|Thiopental not available|0|||
164625245|NCT00611767|594648277|FG000|Overall Study|didn't like the medication|1|||
164625246|NCT00611767|594648278|FG001|Overall Study|didn't like the medication|1|||
164625247|NCT00611767|594648277|FG000|Overall Study|Physician Decision|1|||
164625248|NCT00611767|594648278|FG001|Overall Study|Physician Decision|0|||
164625249|NCT02718625|594648279|FG000|Overall Study|Adverse Event|0|||
164625250|NCT02718625|594648280|FG001|Overall Study|Adverse Event|1|||
164625251|NCT02718625|594648279|FG000|Overall Study|Termination of Study by Sponsor|0|||
164625252|NCT02718625|594648280|FG001|Overall Study|Termination of Study by Sponsor|1|||
164625253|NCT00811395|594648281|FG000|Extension Treatment|Adverse Event|1|||
164625254|NCT00811395|594648282|FG001|Extension Treatment|Adverse Event|2|||
164625255|NCT00811395|594648283|FG002|Extension Treatment|Adverse Event|2|||
164625256|NCT00811395|594648284|FG003|Extension Treatment|Adverse Event|2|||
164625257|NCT00811395|594648285|FG004|Extension Treatment|Adverse Event|0|||
164625258|NCT00811395|594648286|FG005|Extension Treatment|Adverse Event|1|||
164625259|NCT00811395|594648281|FG000|Extension Treatment|Progressive disease|1|||
164625260|NCT00811395|594648282|FG001|Extension Treatment|Progressive disease|1|||
164625261|NCT00811395|594648283|FG002|Extension Treatment|Progressive disease|0|||
164625262|NCT00811395|594648284|FG003|Extension Treatment|Progressive disease|0|||
164625263|NCT00811395|594648285|FG004|Extension Treatment|Progressive disease|0|||
164625264|NCT00811395|594648286|FG005|Extension Treatment|Progressive disease|0|||
164625265|NCT00811395|594648281|FG000|Extension Treatment|Participant did not wish to continue|0|||
164625266|NCT00811395|594648282|FG001|Extension Treatment|Participant did not wish to continue|3|||
164625267|NCT00811395|594648283|FG002|Extension Treatment|Participant did not wish to continue|0|||
164625268|NCT00811395|594648284|FG003|Extension Treatment|Participant did not wish to continue|1|||
164625269|NCT00811395|594648285|FG004|Extension Treatment|Participant did not wish to continue|0|||
164625270|NCT00811395|594648286|FG005|Extension Treatment|Participant did not wish to continue|1|||
164625271|NCT00811395|594648281|FG000|Extension Treatment|Other than above|0|||
164625272|NCT00811395|594648282|FG001|Extension Treatment|Other than above|0|||
164527351|NCT02842827|594302148|FG000|Overall Study|Protocol Defined Disease Progression|0|||
164527352|NCT02842827|594302149|FG001|Overall Study|Protocol Defined Disease Progression|0|||
164527353|NCT02842827|594302150|FG002|Overall Study|Protocol Defined Disease Progression|0|||
164527354|NCT02842827|594302151|FG003|Overall Study|Protocol Defined Disease Progression|0|||
164527355|NCT02842827|594302152|FG004|Overall Study|Protocol Defined Disease Progression|0|||
164527356|NCT02842827|594302153|FG005|Overall Study|Protocol Defined Disease Progression|1|||
164527357|NCT02842827|594302154|FG006|Overall Study|Protocol Defined Disease Progression|0|||
164625273|NCT00811395|594648283|FG002|Extension Treatment|Other than above|1|||
164625274|NCT00811395|594648284|FG003|Extension Treatment|Other than above|0|||
164625275|NCT00811395|594648285|FG004|Extension Treatment|Other than above|0|||
164625276|NCT00811395|594648286|FG005|Extension Treatment|Other than above|0|||
164625277|NCT01947127|594648291|FG000|Overall Study|Protocol Violation|18|||
164625278|NCT01947127|594648292|FG001|Overall Study|Protocol Violation|38|||
164625279|NCT01947127|594648291|FG000|Overall Study|Withdrawal by Subject|1|||
164625280|NCT01947127|594648292|FG001|Overall Study|Withdrawal by Subject|1|||
164625281|NCT01947127|594648291|FG000|Overall Study|Data loss|4|||
164625282|NCT01947127|594648292|FG001|Overall Study|Data loss|4|||
164625283|NCT00170846|594648293|FG000|Overall Study|Subject withdrew Informed Consent|5|||
164625284|NCT00170846|594648294|FG001|Overall Study|Subject withdrew Informed Consent|12|||
164625285|NCT00170846|594648295|FG002|Overall Study|Subject withdrew Informed Consent|8|||
164625286|NCT00170846|594648293|FG000|Overall Study|Lost to Follow-up|6|||
164625287|NCT00170846|594648294|FG001|Overall Study|Lost to Follow-up|3|||
164625288|NCT00170846|594648295|FG002|Overall Study|Lost to Follow-up|2|||
164625289|NCT00170846|594648293|FG000|Overall Study|Death|0|||
164625290|NCT00170846|594648294|FG001|Overall Study|Death|3|||
164625291|NCT00170846|594648295|FG002|Overall Study|Death|3|||
164625292|NCT00170846|594648293|FG000|Overall Study|Reason Missing|0|||
164625293|NCT00170846|594648294|FG001|Overall Study|Reason Missing|1|||
164625294|NCT00170846|594648295|FG002|Overall Study|Reason Missing|0|||
164625295|NCT04554394|594648304|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
164625296|NCT04554394|594648305|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
164625297|NCT04554394|594648304|FG000|Overall Study|Withdrawal by Subject|2|||
164625298|NCT04554394|594648305|FG001|Overall Study|Withdrawal by Subject|2|||
164625299|NCT04554394|594648304|FG000|Overall Study|Lost to Follow-up|2|||
164625300|NCT04554394|594648305|FG001|Overall Study|Lost to Follow-up|2|||
164625301|NCT04554394|594648304|FG000|Overall Study|Physician Decision|1|||
164625302|NCT04554394|594648305|FG001|Overall Study|Physician Decision|1|||
164625303|NCT01021553|594648306|FG000|Overall Study|Adverse Event|1|||
164625304|NCT01021553|594648307|FG001|Overall Study|Adverse Event|0|||
164625305|NCT01021553|594648308|FG002|Overall Study|Adverse Event|0|||
164625306|NCT01021553|594648306|FG000|Overall Study|Lack of Efficacy|2|||
164625307|NCT01021553|594648307|FG001|Overall Study|Lack of Efficacy|2|||
164625308|NCT01021553|594648308|FG002|Overall Study|Lack of Efficacy|0|||
164625309|NCT01021553|594648306|FG000|Overall Study|Protocol Violation|0|||
164625310|NCT01021553|594648307|FG001|Overall Study|Protocol Violation|2|||
164625311|NCT01021553|594648308|FG002|Overall Study|Protocol Violation|2|||
164625312|NCT01021553|594648306|FG000|Overall Study|Lost to Follow-up|0|||
164625313|NCT01021553|594648307|FG001|Overall Study|Lost to Follow-up|0|||
164625314|NCT01021553|594648308|FG002|Overall Study|Lost to Follow-up|1|||
164625315|NCT01021553|594648306|FG000|Overall Study|Withdrawal by Subject|1|||
164625316|NCT01021553|594648307|FG001|Overall Study|Withdrawal by Subject|1|||
164625317|NCT01021553|594648308|FG002|Overall Study|Withdrawal by Subject|0|||
164625318|NCT01950364|594648309|FG000|Overall Study|Adverse Event|3|||
164625319|NCT01950364|594648310|FG001|Overall Study|Adverse Event|0|||
164625320|NCT01950364|594648309|FG000|Overall Study|Stem Cell Transplant|2|||
164625321|NCT01950364|594648310|FG001|Overall Study|Stem Cell Transplant|6|||
164625322|NCT01950364|594648309|FG000|Overall Study|Disease Progression|5|||
164625323|NCT01950364|594648310|FG001|Overall Study|Disease Progression|2|||
164625324|NCT01950364|594648309|FG000|Overall Study|Withdrawal by Subject|0|||
164625325|NCT01950364|594648310|FG001|Overall Study|Withdrawal by Subject|1|||
164625326|NCT01950364|594648309|FG000|Overall Study|Protocol Violation|0|||
164625327|NCT01950364|594648310|FG001|Overall Study|Protocol Violation|1|||
164625328|NCT01469637|594648311|FG000|First Intervention|Unacceptable behavior|0|||
164625329|NCT01469637|594648312|FG001|First Intervention|Unacceptable behavior|1|||
164625330|NCT01469637|594648311|FG000|Second Intervention|Incarcerated|1|||
164625331|NCT01469637|594648312|FG001|Second Intervention|Incarcerated|0|||
164625332|NCT00887913|594648313|FG000|Overall Study|Withdrawal by Subject|6|||
164625333|NCT00572728|594648322|FG000|Overall Study|Withdrawal by Subject|10|||
164625334|NCT00572728|594648322|FG000|Overall Study|Ineligible|3|||
164625335|NCT00572728|594648322|FG000|Overall Study|Enrolled under Amendment 4|5|||
164527358|NCT02842827|594302155|FG007|Overall Study|Protocol Defined Disease Progression|0|||
164527359|NCT02842827|594302148|FG000|Overall Study|Participant Withdrawal of Consent|1|||
164527360|NCT02842827|594302149|FG001|Overall Study|Participant Withdrawal of Consent|2|||
164527361|NCT02842827|594302150|FG002|Overall Study|Participant Withdrawal of Consent|2|||
164527362|NCT02842827|594302151|FG003|Overall Study|Participant Withdrawal of Consent|2|||
164527363|NCT02842827|594302152|FG004|Overall Study|Participant Withdrawal of Consent|2|||
164527364|NCT02842827|594302153|FG005|Overall Study|Participant Withdrawal of Consent|1|||
164527365|NCT02842827|594302154|FG006|Overall Study|Participant Withdrawal of Consent|2|||
164527366|NCT02842827|594302155|FG007|Overall Study|Participant Withdrawal of Consent|1|||
164527367|NCT01815138|594302156|FG000|Overall Study|Withdrawal by Subject|0|||
164527368|NCT01815138|594302157|FG001|Overall Study|Withdrawal by Subject|1|||
164527369|NCT01815138|594302156|FG000|Overall Study|Physician Decision|8|||
164527370|NCT01815138|594302157|FG001|Overall Study|Physician Decision|5|||
164527371|NCT00950950|594302159|FG000|Overall Study|Adverse Event|1|||
164527372|NCT00950950|594302160|FG001|Overall Study|Adverse Event|0|||
164527373|NCT00950950|594302159|FG000|Overall Study|Withdrawal by Subject|0|||
164527374|NCT00950950|594302160|FG001|Overall Study|Withdrawal by Subject|1|||
164527375|NCT01047293|594302161|FG000|Overall Study|DLT criteria not fulfilled|1|||
164527376|NCT01047293|594302162|FG001|Overall Study|DLT criteria not fulfilled|1|||
164527377|NCT01047293|594302163|FG002|Overall Study|DLT criteria not fulfilled|0|||
164527378|NCT01047293|594302164|FG003|Overall Study|DLT criteria not fulfilled|0|||
164527379|NCT00757783|594302165|FG000|Overall Study|Adverse Event|0|||
164527380|NCT00757783|594302166|FG001|Overall Study|Adverse Event|2|||
164147700|NCT02006732|592902130|FG001|Overall Study|Lack of Efficacy|3|||
164527381|NCT00757783|594302165|FG000|Overall Study|Lost to Follow-up|1|||
164527382|NCT00757783|594302166|FG001|Overall Study|Lost to Follow-up|1|||
164527383|NCT00757783|594302165|FG000|Overall Study|Protocol Violation|1|||
164527384|NCT00757783|594302166|FG001|Overall Study|Protocol Violation|0|||
164527385|NCT00757783|594302165|FG000|Overall Study|Withdrawal by Subject|2|||
164527386|NCT00757783|594302166|FG001|Overall Study|Withdrawal by Subject|1|||
164527387|NCT00757783|594302165|FG000|Overall Study|Other|1|||
164527388|NCT00757783|594302166|FG001|Overall Study|Other|2|||
164527389|NCT02372136|594302167|FG000|Overall Study|Death|3|||
164527390|NCT02372136|594302168|FG001|Overall Study|Death|1|||
164527391|NCT00985946|594302169|FG000|Overall Study|Lost to Follow-up|6|||
164527392|NCT00985946|594302169|FG000|Overall Study|Withdrawal by Subject|1|||
164527393|NCT02679508|594302170|FG000|Healing Phase|Protocol Violation|1|||
164527394|NCT02679508|594302171|FG001|Healing Phase|Protocol Violation|1|||
164527395|NCT02679508|594302170|FG000|Healing Phase|Lost to Follow-up|1|||
164527396|NCT02679508|594302171|FG001|Healing Phase|Lost to Follow-up|0|||
164527397|NCT02679508|594302170|FG000|Maintenance Phase|Adverse Event|12|||
164527398|NCT02679508|594302171|FG001|Maintenance Phase|Adverse Event|2|||
164527399|NCT02679508|594302170|FG000|Maintenance Phase|Lost to Follow-up|0|||
164527400|NCT02679508|594302171|FG001|Maintenance Phase|Lost to Follow-up|1|||
164527401|NCT02679508|594302170|FG000|Maintenance Phase|Withdrawal by Subject|15|||
164527402|NCT02679508|594302171|FG001|Maintenance Phase|Withdrawal by Subject|8|||
164527403|NCT02679508|594302170|FG000|Maintenance Phase|Other|5|||
164527404|NCT02679508|594302171|FG001|Maintenance Phase|Other|4|||
164527405|NCT01588496|594302172|FG000|Overall Study|Withdrawal by Subject|0|||
164527406|NCT01588496|594302173|FG001|Overall Study|Withdrawal by Subject|1|||
164527407|NCT01588496|594302174|FG002|Overall Study|Withdrawal by Subject|0|||
164527408|NCT03143166|594302175|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
164527409|NCT02003573|594302179|FG000|Overall Study|Progressive disease|2|||
164527410|NCT02003573|594302180|FG001|Overall Study|Progressive disease|0|||
164527411|NCT02003573|594302181|FG002|Overall Study|Progressive disease|1|||
164527412|NCT02003573|594302179|FG000|Overall Study|Other Adverse event|0|||
164527413|NCT02003573|594302180|FG001|Overall Study|Other Adverse event|1|||
164527414|NCT02003573|594302181|FG002|Overall Study|Other Adverse event|1|||
164527415|NCT02003573|594302179|FG000|Overall Study|Refuse to take trial medication|0|||
164527416|NCT02003573|594302180|FG001|Overall Study|Refuse to take trial medication|1|||
164527417|NCT02003573|594302181|FG002|Overall Study|Refuse to take trial medication|1|||
164527418|NCT02003573|594302179|FG000|Overall Study|Other than specified|1|||
164527419|NCT02003573|594302180|FG001|Overall Study|Other than specified|2|||
164527420|NCT02003573|594302181|FG002|Overall Study|Other than specified|3|||
164527421|NCT03683823|594302188|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
164527422|NCT03683823|594302189|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
164527423|NCT03683823|594302188|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
164527424|NCT03683823|594302189|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
164527425|NCT03683823|594302188|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
164527426|NCT03683823|594302189|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
164527427|NCT05026710|594302191|FG000|Overall Study|No longer met eligibility criteria|3|||
164527428|NCT05026710|594302192|FG001|Overall Study|No longer met eligibility criteria|1|||
164527429|NCT01323972|594302193|FG000|Overall Study|Withdrawal by Subject|1|||
164527430|NCT01323972|594302194|FG001|Overall Study|Withdrawal by Subject|0|||
164527431|NCT01323972|594302195|FG002|Overall Study|Withdrawal by Subject|1|||
164527432|NCT01323972|594302196|FG003|Overall Study|Withdrawal by Subject|0|||
164527433|NCT01323972|594302193|FG000|Overall Study|Migrated/moved from study area|1|||
164527434|NCT01323972|594302194|FG001|Overall Study|Migrated/moved from study area|2|||
164527435|NCT01323972|594302195|FG002|Overall Study|Migrated/moved from study area|0|||
164527436|NCT01323972|594302196|FG003|Overall Study|Migrated/moved from study area|0|||
164527437|NCT01323972|594302193|FG000|Overall Study|Lost to Follow-up|0|||
164527438|NCT01323972|594302194|FG001|Overall Study|Lost to Follow-up|1|||
164527439|NCT01323972|594302195|FG002|Overall Study|Lost to Follow-up|1|||
164527440|NCT01323972|594302196|FG003|Overall Study|Lost to Follow-up|1|||
164527441|NCT00994682|594302197|FG000|Double Bilnd|Withdrawal by Subject|5|||
164527442|NCT00994682|594302198|FG001|Double Bilnd|Withdrawal by Subject|6|||
164625336|NCT00572728|594648322|FG000|Overall Study|Offstudy due to complicating disease|1|||
164625337|NCT00572728|594648322|FG000|Overall Study|FLT1 not completed|4|||
164527443|NCT00994682|594302197|FG000|Double Bilnd|Lost to Follow-up|3|||
164527444|NCT00994682|594302198|FG001|Double Bilnd|Lost to Follow-up|3|||
164527445|NCT00994682|594302197|FG000|Double Bilnd|Adverse Event|1|||
164527446|NCT00994682|594302198|FG001|Double Bilnd|Adverse Event|0|||
164625338|NCT00572728|594648322|FG000|Overall Study|First Chemotherapy not initiated|2|||
164625339|NCT00572728|594648322|FG000|Overall Study|FLT2 not completed|5|||
164625340|NCT00572728|594648322|FG000|Overall Study|Second chemotherapy not initiated|1|||
164625341|NCT00572728|594648322|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
164625342|NCT00572728|594648322|FG000|Overall Study|Pathology missing|1|||
164625343|NCT01833806|594648325|FG000|Overall Study|Alternative treatment|2|||
164625344|NCT01833806|594648325|FG000|Overall Study|Death|5|||
164625345|NCT01833806|594648325|FG000|Overall Study|Physician Decision|1|||
164625346|NCT01833806|594648325|FG000|Overall Study|Lost to Follow-up|1|||
164625347|NCT00415623|594648329|FG000|Overall Study|Adverse Event|3|||
164625348|NCT00415623|594648330|FG001|Overall Study|Adverse Event|4|||
164625349|NCT00415623|594648329|FG000|Overall Study|Death|1|||
164625350|NCT00415623|594648330|FG001|Overall Study|Death|0|||
164625351|NCT00415623|594648329|FG000|Overall Study|Withdrawal by Subject|1|||
164625352|NCT00415623|594648330|FG001|Overall Study|Withdrawal by Subject|1|||
164625353|NCT01708915|594648333|FG000|Overall Study|Adverse Event|1|||
164625354|NCT01708915|594648334|FG001|Overall Study|Adverse Event|0|||
164625355|NCT01708915|594648335|FG002|Overall Study|Adverse Event|9|||
164625356|NCT01708915|594648336|FG003|Overall Study|Adverse Event|13|||
164625357|NCT01708915|594648333|FG000|Overall Study|Lack of Efficacy|84|||
164625358|NCT01708915|594648334|FG001|Overall Study|Lack of Efficacy|60|||
164625359|NCT01708915|594648335|FG002|Overall Study|Lack of Efficacy|35|||
164625360|NCT01708915|594648336|FG003|Overall Study|Lack of Efficacy|15|||
164625361|NCT01708915|594648333|FG000|Overall Study|Protocol Violation|0|||
164625362|NCT01708915|594648334|FG001|Overall Study|Protocol Violation|0|||
164625363|NCT01708915|594648335|FG002|Overall Study|Protocol Violation|0|||
164625364|NCT01708915|594648336|FG003|Overall Study|Protocol Violation|1|||
164625365|NCT01708915|594648333|FG000|Overall Study|Withdrawal by Subject|0|||
164625366|NCT01708915|594648334|FG001|Overall Study|Withdrawal by Subject|1|||
164625367|NCT01708915|594648335|FG002|Overall Study|Withdrawal by Subject|2|||
164625368|NCT01708915|594648336|FG003|Overall Study|Withdrawal by Subject|2|||
164625369|NCT01708915|594648333|FG000|Overall Study|Other reasons than stated above|1|||
164625370|NCT01708915|594648334|FG001|Overall Study|Other reasons than stated above|1|||
164625371|NCT01708915|594648335|FG002|Overall Study|Other reasons than stated above|0|||
164625372|NCT01708915|594648336|FG003|Overall Study|Other reasons than stated above|2|||
164625373|NCT03267576|594648337|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
164625374|NCT03267576|594648338|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
164625375|NCT03267576|594648337|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
164625376|NCT03267576|594648338|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
164625377|NCT02382276|594648343|FG000|Overall Study|Withdrawal by Subject|4|||
164625378|NCT02382276|594648344|FG001|Overall Study|Withdrawal by Subject|8|||
164625379|NCT02382276|594648345|FG002|Overall Study|Withdrawal by Subject|5|||
164625380|NCT02382276|594648343|FG000|Overall Study|Adverse Event|7|||
164625381|NCT02382276|594648344|FG001|Overall Study|Adverse Event|2|||
164625382|NCT02382276|594648345|FG002|Overall Study|Adverse Event|32|||
164625383|NCT02382276|594648343|FG000|Overall Study|Physician Decision|0|||
164625384|NCT02382276|594648344|FG001|Overall Study|Physician Decision|0|||
164625385|NCT02382276|594648345|FG002|Overall Study|Physician Decision|2|||
164625386|NCT01987609|594648350|FG000|Overall Study|Adverse Event|1|||
164625387|NCT01066546|594648351|FG000|Overall Study|Study terminated by sponsor|5|||
164625388|NCT03452397|594648356|FG000|Overall Study|Adverse Event|1|||
164625389|NCT03452397|594648357|FG001|Overall Study|Adverse Event|0|||
164625390|NCT03452397|594648358|FG002|Overall Study|Adverse Event|0|||
164625391|NCT03452397|594648359|FG003|Overall Study|Adverse Event|0|||
164625392|NCT03452397|594648356|FG000|Overall Study|Administrative reason|0|||
164625393|NCT03452397|594648357|FG001|Overall Study|Administrative reason|0|||
164625394|NCT03452397|594648358|FG002|Overall Study|Administrative reason|1|||
164625395|NCT03452397|594648359|FG003|Overall Study|Administrative reason|1|||
164625396|NCT03452397|594648356|FG000|Overall Study|Withdrawal by Subject|0|||
164625397|NCT03452397|594648357|FG001|Overall Study|Withdrawal by Subject|0|||
164625398|NCT03452397|594648358|FG002|Overall Study|Withdrawal by Subject|1|||
164625399|NCT03452397|594648359|FG003|Overall Study|Withdrawal by Subject|0|||
164625400|NCT00125268|594648360|FG000|Overall Study|Withdrawal by Subject|1|||
164625401|NCT00125268|594648361|FG001|Overall Study|Withdrawal by Subject|1|||
164625402|NCT00925522|594648362|FG000|Overall Study|study closed -- business decision|20|||
164625403|NCT02561572|594648363|FG000|Overall Study|Inadequate time before surgery|2|||
164625404|NCT02561572|594648364|FG001|Overall Study|Inadequate time before surgery|1|||
164625405|NCT02561572|594648363|FG000|Overall Study|Protocol Violation|0|||
164625406|NCT02561572|594648364|FG001|Overall Study|Protocol Violation|1|||
164625407|NCT02691468|594648365|FG000|Overall Study|Bronchial blocker use|2|||
164625408|NCT02691468|594648366|FG001|Overall Study|Bronchial blocker use|1|||
164625409|NCT02691468|594648365|FG000|Overall Study|Lost to Follow-up|2|||
164625410|NCT02691468|594648366|FG001|Overall Study|Lost to Follow-up|1|||
164625411|NCT02691468|594648365|FG000|Overall Study|Failure to advance FOB|2|||
164625412|NCT02691468|594648366|FG001|Overall Study|Failure to advance FOB|0|||
164625413|NCT01190020|594648369|FG000|Overall Study|Adverse Event|2|||
164625414|NCT01190020|594648370|FG001|Overall Study|Adverse Event|0|||
164625415|NCT01190020|594648369|FG000|Overall Study|Lost to Follow-up|2|||
164625416|NCT01190020|594648370|FG001|Overall Study|Lost to Follow-up|0|||
164625417|NCT01190020|594648369|FG000|Overall Study|Withdrawal by Subject|3|||
164625418|NCT01190020|594648370|FG001|Overall Study|Withdrawal by Subject|0|||
164625419|NCT00656799|594648373|FG000|Overall Study|Death|2|||
164625420|NCT02422186|594648374|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
164625421|NCT02422186|594648375|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
164625422|NCT02422186|594648374|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
164625423|NCT02422186|594648375|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
164625424|NCT02422186|594648374|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
164625425|NCT02422186|594648375|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
164625426|NCT02422186|594648374|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
164625427|NCT02422186|594648375|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
164625428|NCT02422186|594648374|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
164625429|NCT02422186|594648375|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
164625430|NCT02422186|594648374|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
164625431|NCT02422186|594648375|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
164625432|NCT02422186|594648374|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
164625433|NCT02422186|594648375|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
164625434|NCT02422186|594648374|FG000|Follow-up Phase (2 Weeks)|Other|3|||
164625435|NCT02422186|594648375|FG001|Follow-up Phase (2 Weeks)|Other|0|||
164625436|NCT05281094|594648376|FG000|Overall Study|Adverse Event|1|||
164625437|NCT05281094|594648377|FG001|Overall Study|Adverse Event|0|||
164625438|NCT05281094|594648376|FG000|Overall Study|Lost to Follow-up|29|||
164625439|NCT05281094|594648377|FG001|Overall Study|Lost to Follow-up|22|||
164625440|NCT05281094|594648376|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
164625441|NCT05281094|594648377|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
164625442|NCT05281094|594648376|FG000|Overall Study|Death|1|||
164625443|NCT05281094|594648377|FG001|Overall Study|Death|2|||
164625444|NCT05281094|594648376|FG000|Overall Study|Not pre-specified reason|8|||
164625445|NCT05281094|594648377|FG001|Overall Study|Not pre-specified reason|5|||
164625446|NCT02390167|594650147|FG000|Overall Study|Lost to Follow-up|1|||
164625447|NCT01265719|594650149|FG000|Overall Study|Does not meet entrance criteria|0|||
164625448|NCT01265719|594650150|FG001|Overall Study|Does not meet entrance criteria|3|||
164625449|NCT01265719|594650149|FG000|Overall Study|Other reasons|2|||
164625450|NCT01265719|594650150|FG001|Overall Study|Other reasons|0|||
164625451|NCT01265719|594650149|FG000|Overall Study|Withdrawal by Subject|8|||
164625452|NCT01265719|594650150|FG001|Overall Study|Withdrawal by Subject|3|||
164625453|NCT01265719|594650149|FG000|Overall Study|Lost to Follow-up|2|||
164625454|NCT01265719|594650150|FG001|Overall Study|Lost to Follow-up|7|||
164625455|NCT01265719|594650149|FG000|Overall Study|Adverse Event|2|||
164625456|NCT01265719|594650150|FG001|Overall Study|Adverse Event|0|||
164625457|NCT02442765|594650151|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
164625458|NCT02442765|594650152|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
164625459|NCT02442765|594650153|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
164625460|NCT02442765|594650154|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
164625461|NCT02442765|594650155|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
164625462|NCT02442765|594650156|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
164625463|NCT02442765|594650157|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
164625464|NCT02442765|594650158|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
164625465|NCT02442765|594650151|FG000|Stage 2- (Days 43 to 85)|Death|0|||
164625466|NCT02442765|594650152|FG001|Stage 2- (Days 43 to 85)|Death|0|||
164625467|NCT02442765|594650153|FG002|Stage 2- (Days 43 to 85)|Death|0|||
164625468|NCT02442765|594650154|FG003|Stage 2- (Days 43 to 85)|Death|1|||
164625469|NCT02442765|594650155|FG004|Stage 2- (Days 43 to 85)|Death|1|||
164625470|NCT02442765|594650156|FG005|Stage 2- (Days 43 to 85)|Death|0|||
164625471|NCT02442765|594650157|FG006|Stage 2- (Days 43 to 85)|Death|2|||
164625472|NCT02442765|594650158|FG007|Stage 2- (Days 43 to 85)|Death|0|||
164625473|NCT02442765|594650151|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
164625474|NCT02442765|594650152|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
164625475|NCT02442765|594650153|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
164625476|NCT02442765|594650154|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
164625477|NCT02442765|594650155|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
164625478|NCT02442765|594650156|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
164625479|NCT02442765|594650157|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
164625480|NCT02442765|594650158|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
164625481|NCT02442765|594650151|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
164625482|NCT02442765|594650152|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
164625483|NCT02442765|594650153|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
164625484|NCT02442765|594650154|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
164625485|NCT02442765|594650155|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
164625486|NCT02442765|594650156|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
164625487|NCT02442765|594650157|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
164625488|NCT02442765|594650158|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
164625489|NCT02442765|594650151|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
164625490|NCT02442765|594650152|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
164625491|NCT02442765|594650153|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
164625492|NCT02442765|594650154|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
164625493|NCT02442765|594650155|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
164625494|NCT02442765|594650156|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
164625495|NCT02442765|594650157|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
164625496|NCT02442765|594650158|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
164625497|NCT02442765|594650151|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
164625498|NCT02442765|594650152|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
164625499|NCT02442765|594650153|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
164625500|NCT02442765|594650154|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
164625501|NCT02442765|594650155|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
164625502|NCT02442765|594650156|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
164625503|NCT02442765|594650157|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
164625504|NCT02442765|594650158|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
164625505|NCT02442765|594650151|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
164625506|NCT02442765|594650152|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
164625507|NCT02442765|594650153|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
164625508|NCT02442765|594650154|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
164625509|NCT02442765|594650155|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
164625510|NCT02442765|594650156|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
164625511|NCT02442765|594650157|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
164625512|NCT02442765|594650158|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
164625513|NCT02442765|594650151|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
164625514|NCT02442765|594650152|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
164625515|NCT02442765|594650153|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
164625516|NCT02442765|594650154|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
164625517|NCT02442765|594650155|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
164625518|NCT02442765|594650156|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
164625519|NCT02442765|594650157|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
164625520|NCT02442765|594650158|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
164625521|NCT01693562|594650162|FG000|Escalation Phase|Withdrawal by Subject|0|||
164625522|NCT01693562|594650163|FG001|Escalation Phase|Withdrawal by Subject|1|||
164625523|NCT01693562|594650164|FG002|Escalation Phase|Withdrawal by Subject|0|||
164625524|NCT01693562|594650165|FG003|Escalation Phase|Withdrawal by Subject|0|||
164625525|NCT01693562|594650166|FG004|Escalation Phase|Withdrawal by Subject|0|||
164625526|NCT01693562|594650167|FG005|Escalation Phase|Withdrawal by Subject|2|||
164625527|NCT01693562|594650168|FG006|Escalation Phase|Withdrawal by Subject|0|||
164625528|NCT01693562|594650169|FG007|Escalation Phase|Withdrawal by Subject|0|||
164625529|NCT01693562|594650170|FG008|Escalation Phase|Withdrawal by Subject|0|||
164625530|NCT01693562|594650171|FG009|Escalation Phase|Withdrawal by Subject|0|||
164625531|NCT01693562|594650172|FG010|Escalation Phase|Withdrawal by Subject|0|||
164625532|NCT01693562|594650173|FG011|Escalation Phase|Withdrawal by Subject|0|||
164625533|NCT01693562|594650174|FG012|Escalation Phase|Withdrawal by Subject|0|||
164625534|NCT01693562|594650175|FG013|Escalation Phase|Withdrawal by Subject|0|||
164625535|NCT01693562|594650176|FG014|Escalation Phase|Withdrawal by Subject|0|||
164625536|NCT01693562|594650177|FG015|Escalation Phase|Withdrawal by Subject|0|||
164625537|NCT01693562|594650178|FG016|Escalation Phase|Withdrawal by Subject|0|||
164625538|NCT01693562|594650179|FG017|Escalation Phase|Withdrawal by Subject|0|||
164625539|NCT01693562|594650180|FG018|Escalation Phase|Withdrawal by Subject|0|||
164625540|NCT01693562|594650181|FG019|Escalation Phase|Withdrawal by Subject|0|||
164625541|NCT01693562|594650182|FG020|Escalation Phase|Withdrawal by Subject|0|||
164625542|NCT01693562|594650183|FG021|Escalation Phase|Withdrawal by Subject|0|||
164625543|NCT01693562|594650184|FG022|Escalation Phase|Withdrawal by Subject|0|||
164625544|NCT01693562|594650162|FG000|Escalation Phase|Death|4|||
164625545|NCT01693562|594650163|FG001|Escalation Phase|Death|2|||
164625546|NCT01693562|594650164|FG002|Escalation Phase|Death|0|||
164625547|NCT01693562|594650165|FG003|Escalation Phase|Death|3|||
164625548|NCT01693562|594650166|FG004|Escalation Phase|Death|6|||
164625549|NCT01693562|594650167|FG005|Escalation Phase|Death|4|||
164625550|NCT01693562|594650168|FG006|Escalation Phase|Death|0|||
164625551|NCT01693562|594650169|FG007|Escalation Phase|Death|0|||
164625552|NCT01693562|594650170|FG008|Escalation Phase|Death|0|||
164625553|NCT01693562|594650171|FG009|Escalation Phase|Death|0|||
164625554|NCT01693562|594650172|FG010|Escalation Phase|Death|0|||
164625555|NCT01693562|594650173|FG011|Escalation Phase|Death|0|||
164625556|NCT01693562|594650174|FG012|Escalation Phase|Death|0|||
164625557|NCT01693562|594650175|FG013|Escalation Phase|Death|0|||
164625558|NCT01693562|594650176|FG014|Escalation Phase|Death|0|||
164625559|NCT01693562|594650177|FG015|Escalation Phase|Death|0|||
164625560|NCT01693562|594650178|FG016|Escalation Phase|Death|0|||
164625561|NCT01693562|594650179|FG017|Escalation Phase|Death|0|||
164625562|NCT01693562|594650180|FG018|Escalation Phase|Death|0|||
164625563|NCT01693562|594650181|FG019|Escalation Phase|Death|0|||
164625564|NCT01693562|594650182|FG020|Escalation Phase|Death|0|||
164625565|NCT01693562|594650183|FG021|Escalation Phase|Death|0|||
164625566|NCT01693562|594650184|FG022|Escalation Phase|Death|0|||
164625567|NCT01693562|594650162|FG000|Escalation Phase|Lost to Follow-up|0|||
164625568|NCT01693562|594650163|FG001|Escalation Phase|Lost to Follow-up|1|||
164625569|NCT01693562|594650164|FG002|Escalation Phase|Lost to Follow-up|1|||
164625570|NCT01693562|594650165|FG003|Escalation Phase|Lost to Follow-up|0|||
164625571|NCT01693562|594650166|FG004|Escalation Phase|Lost to Follow-up|0|||
164625572|NCT01693562|594650167|FG005|Escalation Phase|Lost to Follow-up|0|||
164625573|NCT01693562|594650168|FG006|Escalation Phase|Lost to Follow-up|0|||
164625574|NCT01693562|594650169|FG007|Escalation Phase|Lost to Follow-up|0|||
164625575|NCT01693562|594650170|FG008|Escalation Phase|Lost to Follow-up|0|||
164625576|NCT01693562|594650171|FG009|Escalation Phase|Lost to Follow-up|0|||
164625577|NCT01693562|594650172|FG010|Escalation Phase|Lost to Follow-up|0|||
164625578|NCT01693562|594650173|FG011|Escalation Phase|Lost to Follow-up|0|||
164625579|NCT01693562|594650174|FG012|Escalation Phase|Lost to Follow-up|0|||
164625580|NCT01693562|594650175|FG013|Escalation Phase|Lost to Follow-up|0|||
164625581|NCT01693562|594650176|FG014|Escalation Phase|Lost to Follow-up|0|||
164625582|NCT01693562|594650177|FG015|Escalation Phase|Lost to Follow-up|0|||
164625583|NCT01693562|594650178|FG016|Escalation Phase|Lost to Follow-up|0|||
164625584|NCT01693562|594650179|FG017|Escalation Phase|Lost to Follow-up|0|||
164625585|NCT01693562|594650180|FG018|Escalation Phase|Lost to Follow-up|0|||
164625586|NCT01693562|594650181|FG019|Escalation Phase|Lost to Follow-up|0|||
164625587|NCT01693562|594650182|FG020|Escalation Phase|Lost to Follow-up|0|||
164625588|NCT01693562|594650183|FG021|Escalation Phase|Lost to Follow-up|0|||
164625589|NCT01693562|594650184|FG022|Escalation Phase|Lost to Follow-up|0|||
164625590|NCT01693562|594650162|FG000|Escalation Phase|Other|0|||
164625591|NCT01693562|594650163|FG001|Escalation Phase|Other|0|||
164625592|NCT01693562|594650164|FG002|Escalation Phase|Other|2|||
164625593|NCT01693562|594650165|FG003|Escalation Phase|Other|0|||
164625594|NCT01693562|594650166|FG004|Escalation Phase|Other|0|||
164625595|NCT01693562|594650167|FG005|Escalation Phase|Other|1|||
164625596|NCT01693562|594650168|FG006|Escalation Phase|Other|0|||
164625597|NCT01693562|594650169|FG007|Escalation Phase|Other|0|||
164527447|NCT00994682|594302197|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
164625598|NCT01693562|594650170|FG008|Escalation Phase|Other|0|||
164625599|NCT01693562|594650171|FG009|Escalation Phase|Other|0|||
164625600|NCT01693562|594650172|FG010|Escalation Phase|Other|0|||
164625601|NCT01693562|594650173|FG011|Escalation Phase|Other|0|||
164625602|NCT01693562|594650174|FG012|Escalation Phase|Other|0|||
164625603|NCT01693562|594650175|FG013|Escalation Phase|Other|0|||
164625604|NCT01693562|594650176|FG014|Escalation Phase|Other|0|||
164625605|NCT01693562|594650177|FG015|Escalation Phase|Other|0|||
164625606|NCT01693562|594650178|FG016|Escalation Phase|Other|0|||
164625607|NCT01693562|594650179|FG017|Escalation Phase|Other|0|||
164625608|NCT01693562|594650180|FG018|Escalation Phase|Other|0|||
164625609|NCT01693562|594650181|FG019|Escalation Phase|Other|0|||
164625610|NCT01693562|594650182|FG020|Escalation Phase|Other|0|||
164625611|NCT01693562|594650183|FG021|Escalation Phase|Other|0|||
164625612|NCT01693562|594650184|FG022|Escalation Phase|Other|0|||
164625613|NCT01693562|594650162|FG000|Exploration Phase|Withdrawal by Subject|0|||
164625614|NCT01693562|594650163|FG001|Exploration Phase|Withdrawal by Subject|0|||
164625615|NCT01693562|594650164|FG002|Exploration Phase|Withdrawal by Subject|0|||
164625616|NCT01693562|594650165|FG003|Exploration Phase|Withdrawal by Subject|0|||
164625617|NCT01693562|594650166|FG004|Exploration Phase|Withdrawal by Subject|0|||
164625618|NCT01693562|594650167|FG005|Exploration Phase|Withdrawal by Subject|0|||
164625619|NCT01693562|594650168|FG006|Exploration Phase|Withdrawal by Subject|2|||
164625620|NCT01693562|594650169|FG007|Exploration Phase|Withdrawal by Subject|0|||
164625621|NCT01693562|594650170|FG008|Exploration Phase|Withdrawal by Subject|0|||
164625622|NCT01693562|594650171|FG009|Exploration Phase|Withdrawal by Subject|0|||
164625623|NCT01693562|594650172|FG010|Exploration Phase|Withdrawal by Subject|0|||
164625624|NCT01693562|594650173|FG011|Exploration Phase|Withdrawal by Subject|0|||
164625625|NCT01693562|594650174|FG012|Exploration Phase|Withdrawal by Subject|0|||
164625626|NCT01693562|594650175|FG013|Exploration Phase|Withdrawal by Subject|0|||
164625627|NCT01693562|594650176|FG014|Exploration Phase|Withdrawal by Subject|0|||
164625628|NCT01693562|594650177|FG015|Exploration Phase|Withdrawal by Subject|0|||
164625629|NCT01693562|594650178|FG016|Exploration Phase|Withdrawal by Subject|0|||
164625630|NCT01693562|594650179|FG017|Exploration Phase|Withdrawal by Subject|0|||
164625631|NCT01693562|594650180|FG018|Exploration Phase|Withdrawal by Subject|0|||
164625632|NCT01693562|594650181|FG019|Exploration Phase|Withdrawal by Subject|0|||
164625633|NCT01693562|594650182|FG020|Exploration Phase|Withdrawal by Subject|0|||
164625634|NCT01693562|594650183|FG021|Exploration Phase|Withdrawal by Subject|0|||
164625635|NCT01693562|594650184|FG022|Exploration Phase|Withdrawal by Subject|0|||
164625636|NCT01693562|594650162|FG000|Exploration Phase|Death|0|||
164625637|NCT01693562|594650163|FG001|Exploration Phase|Death|0|||
164625638|NCT01693562|594650164|FG002|Exploration Phase|Death|0|||
164625639|NCT01693562|594650165|FG003|Exploration Phase|Death|0|||
164625640|NCT01693562|594650166|FG004|Exploration Phase|Death|0|||
164625641|NCT01693562|594650167|FG005|Exploration Phase|Death|0|||
164625642|NCT01693562|594650168|FG006|Exploration Phase|Death|17|||
164625643|NCT01693562|594650169|FG007|Exploration Phase|Death|0|||
164625644|NCT01693562|594650170|FG008|Exploration Phase|Death|0|||
164625645|NCT01693562|594650171|FG009|Exploration Phase|Death|0|||
164625646|NCT01693562|594650172|FG010|Exploration Phase|Death|0|||
164625647|NCT01693562|594650173|FG011|Exploration Phase|Death|0|||
164625648|NCT01693562|594650174|FG012|Exploration Phase|Death|0|||
164625649|NCT01693562|594650175|FG013|Exploration Phase|Death|0|||
164625650|NCT01693562|594650176|FG014|Exploration Phase|Death|0|||
164625651|NCT01693562|594650177|FG015|Exploration Phase|Death|0|||
164625652|NCT01693562|594650178|FG016|Exploration Phase|Death|0|||
164625653|NCT01693562|594650179|FG017|Exploration Phase|Death|0|||
164625654|NCT01693562|594650180|FG018|Exploration Phase|Death|0|||
164625655|NCT01693562|594650181|FG019|Exploration Phase|Death|0|||
164625656|NCT01693562|594650182|FG020|Exploration Phase|Death|0|||
164625657|NCT01693562|594650183|FG021|Exploration Phase|Death|0|||
164625658|NCT01693562|594650184|FG022|Exploration Phase|Death|0|||
164625659|NCT01693562|594650162|FG000|Exploration Phase|Other|0|||
164625660|NCT01693562|594650163|FG001|Exploration Phase|Other|0|||
164625661|NCT01693562|594650164|FG002|Exploration Phase|Other|0|||
164625662|NCT01693562|594650165|FG003|Exploration Phase|Other|0|||
164625663|NCT01693562|594650166|FG004|Exploration Phase|Other|0|||
164625664|NCT01693562|594650167|FG005|Exploration Phase|Other|0|||
164625665|NCT01693562|594650168|FG006|Exploration Phase|Other|2|||
164625666|NCT01693562|594650169|FG007|Exploration Phase|Other|0|||
164625667|NCT01693562|594650170|FG008|Exploration Phase|Other|0|||
164625668|NCT01693562|594650171|FG009|Exploration Phase|Other|0|||
164625669|NCT01693562|594650172|FG010|Exploration Phase|Other|0|||
164625670|NCT01693562|594650173|FG011|Exploration Phase|Other|0|||
164625671|NCT01693562|594650174|FG012|Exploration Phase|Other|0|||
164625672|NCT01693562|594650175|FG013|Exploration Phase|Other|0|||
164625673|NCT01693562|594650176|FG014|Exploration Phase|Other|0|||
164625674|NCT01693562|594650177|FG015|Exploration Phase|Other|0|||
164625675|NCT01693562|594650178|FG016|Exploration Phase|Other|0|||
164625676|NCT01693562|594650179|FG017|Exploration Phase|Other|0|||
164625677|NCT01693562|594650180|FG018|Exploration Phase|Other|0|||
164625678|NCT01693562|594650181|FG019|Exploration Phase|Other|0|||
164625679|NCT01693562|594650182|FG020|Exploration Phase|Other|0|||
164625680|NCT01693562|594650183|FG021|Exploration Phase|Other|0|||
164625681|NCT01693562|594650184|FG022|Exploration Phase|Other|0|||
164625682|NCT01693562|594650162|FG000|Expansion Phase|Withdrawal by Subject|0|||
164625683|NCT01693562|594650163|FG001|Expansion Phase|Withdrawal by Subject|0|||
164625684|NCT01693562|594650164|FG002|Expansion Phase|Withdrawal by Subject|0|||
164625685|NCT01693562|594650165|FG003|Expansion Phase|Withdrawal by Subject|0|||
164625686|NCT01693562|594650166|FG004|Expansion Phase|Withdrawal by Subject|0|||
164625687|NCT01693562|594650167|FG005|Expansion Phase|Withdrawal by Subject|0|||
164625688|NCT01693562|594650168|FG006|Expansion Phase|Withdrawal by Subject|0|||
164625689|NCT01693562|594650169|FG007|Expansion Phase|Withdrawal by Subject|16|||
164625690|NCT01693562|594650170|FG008|Expansion Phase|Withdrawal by Subject|2|||
164625691|NCT01693562|594650171|FG009|Expansion Phase|Withdrawal by Subject|54|||
164625692|NCT01693562|594650172|FG010|Expansion Phase|Withdrawal by Subject|2|||
164625693|NCT01693562|594650173|FG011|Expansion Phase|Withdrawal by Subject|2|||
164625694|NCT01693562|594650174|FG012|Expansion Phase|Withdrawal by Subject|3|||
164625695|NCT01693562|594650175|FG013|Expansion Phase|Withdrawal by Subject|5|||
164625696|NCT01693562|594650176|FG014|Expansion Phase|Withdrawal by Subject|16|||
164625697|NCT01693562|594650177|FG015|Expansion Phase|Withdrawal by Subject|7|||
164527448|NCT00994682|594302198|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
164527449|NCT00994682|594302197|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
164527450|NCT00994682|594302198|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
164527451|NCT00994682|594302197|FG000|Pioglitazone Open Label|Physician Decision|6|||
164527452|NCT00994682|594302198|FG001|Pioglitazone Open Label|Physician Decision|1|||
164527453|NCT01796548|594302201|FG000|Overall Study|Lost to Follow-up|1|||
164527454|NCT01796548|594302201|FG000|Overall Study|Other|2|||
164527455|NCT02008877|594302202|FG000|Overall Study|Inevaluable|0|||
164527456|NCT02008877|594302203|FG001|Overall Study|Inevaluable|1|||
164527457|NCT02008877|594302204|FG002|Overall Study|Inevaluable|0|||
164527458|NCT01049217|594302205|FG000|Overall Study|Adverse Event|2|||
164527459|NCT01049217|594302206|FG001|Overall Study|Adverse Event|1|||
164527460|NCT01049217|594302205|FG000|Overall Study|Lack of Efficacy|1|||
164527461|NCT01049217|594302206|FG001|Overall Study|Lack of Efficacy|1|||
164527462|NCT01049217|594302205|FG000|Overall Study|Lost to Follow-up|3|||
164527463|NCT01049217|594302206|FG001|Overall Study|Lost to Follow-up|8|||
164527464|NCT01049217|594302205|FG000|Overall Study|Withdrawal by Subject|4|||
164527465|NCT01049217|594302206|FG001|Overall Study|Withdrawal by Subject|3|||
164527466|NCT01049217|594302205|FG000|Overall Study|Protocol Violation|1|||
164527467|NCT01049217|594302206|FG001|Overall Study|Protocol Violation|3|||
164527468|NCT01049217|594302205|FG000|Overall Study|Pregnancy|1|||
164527469|NCT01049217|594302206|FG001|Overall Study|Pregnancy|0|||
164527470|NCT01049217|594302205|FG000|Overall Study|Study Terminated by Sponsor|43|||
164527471|NCT01049217|594302206|FG001|Overall Study|Study Terminated by Sponsor|43|||
164527472|NCT01049217|594302205|FG000|Overall Study|Other|1|||
164527473|NCT01049217|594302206|FG001|Overall Study|Other|2|||
164527474|NCT01049217|594302205|FG000|Overall Study|Randomized but not Treated|0|||
164527475|NCT01049217|594302206|FG001|Overall Study|Randomized but not Treated|2|||
164527476|NCT00589121|594302207|FG000|Overall Study|Protocol Violation|2|||
164527477|NCT00589121|594302208|FG001|Overall Study|Protocol Violation|6|||
164527478|NCT00589121|594302207|FG000|Overall Study|No protocol treatment received|0|||
164527479|NCT00589121|594302208|FG001|Overall Study|No protocol treatment received|1|||
164527480|NCT03519971|594302217|FG000|Overall Study|Death|142|||
164527481|NCT03519971|594302218|FG001|Overall Study|Death|69|||
164527482|NCT03519971|594302217|FG000|Overall Study|Lost to Follow-up|0|||
164527483|NCT03519971|594302218|FG001|Overall Study|Lost to Follow-up|1|||
164527484|NCT03519971|594302217|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
164527485|NCT03519971|594302218|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
164527486|NCT03519971|594302217|FG000|Overall Study|Withdrawal by Subject|3|||
164527487|NCT03519971|594302218|FG001|Overall Study|Withdrawal by Subject|2|||
164527488|NCT03519971|594302217|FG000|Overall Study|Other|1|||
164527489|NCT03519971|594302218|FG001|Overall Study|Other|0|||
164527490|NCT05000931|594302219|FG000|Overall Study|Lost to Follow-up|1|||
164527491|NCT02545933|594302220|FG000|Overall Study|Adverse Event|3|||
164527492|NCT02545933|594302221|FG001|Overall Study|Adverse Event|0|||
164527493|NCT02545933|594302222|FG002|Overall Study|Adverse Event|0|||
164527494|NCT02545933|594302220|FG000|Overall Study|Withdrawal by Subject|2|||
164527495|NCT02545933|594302221|FG001|Overall Study|Withdrawal by Subject|3|||
164527496|NCT02545933|594302222|FG002|Overall Study|Withdrawal by Subject|3|||
164527497|NCT02545933|594302220|FG000|Overall Study|Protocol Violation|1|||
164527498|NCT02545933|594302221|FG001|Overall Study|Protocol Violation|0|||
164527499|NCT02545933|594302222|FG002|Overall Study|Protocol Violation|1|||
164527500|NCT03141905|594302225|FG000|Overall Study|Death|3|||
164527501|NCT03141905|594302226|FG001|Overall Study|Death|2|||
164527502|NCT03141905|594302225|FG000|Overall Study|Withdrawal by Subject|1|||
164527503|NCT03141905|594302226|FG001|Overall Study|Withdrawal by Subject|0|||
164527504|NCT03141905|594302225|FG000|Overall Study|Lost to Follow-up|3|||
164527505|NCT03141905|594302226|FG001|Overall Study|Lost to Follow-up|7|||
164527506|NCT03141905|594302225|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
164527507|NCT03141905|594302226|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
164527508|NCT04617275|594302227|FG000|Treatment Period|Adverse Event|1|||
164527509|NCT04617275|594302228|FG001|Treatment Period|Adverse Event|6|||
164527510|NCT04617275|594302229|FG002|Treatment Period|Adverse Event|4|||
164527511|NCT04617275|594302230|FG003|Treatment Period|Adverse Event|6|||
164527512|NCT04617275|594302231|FG004|Treatment Period|Adverse Event|7|||
164527513|NCT04617275|594302232|FG005|Treatment Period|Adverse Event|8|||
164527514|NCT04617275|594302233|FG006|Treatment Period|Adverse Event|0|||
164527515|NCT04617275|594302234|FG007|Treatment Period|Adverse Event|12|||
164527516|NCT04617275|594302227|FG000|Treatment Period|Lost to Follow-up|0|||
164527517|NCT04617275|594302228|FG001|Treatment Period|Lost to Follow-up|0|||
164527518|NCT04617275|594302229|FG002|Treatment Period|Lost to Follow-up|2|||
164527519|NCT04617275|594302230|FG003|Treatment Period|Lost to Follow-up|0|||
164527520|NCT04617275|594302231|FG004|Treatment Period|Lost to Follow-up|0|||
164527521|NCT04617275|594302232|FG005|Treatment Period|Lost to Follow-up|3|||
164527522|NCT04617275|594302233|FG006|Treatment Period|Lost to Follow-up|0|||
164527523|NCT04617275|594302234|FG007|Treatment Period|Lost to Follow-up|2|||
164527524|NCT04617275|594302227|FG000|Treatment Period|No longer meets eligibility criteria|0|||
164527525|NCT04617275|594302228|FG001|Treatment Period|No longer meets eligibility criteria|0|||
164527526|NCT04617275|594302229|FG002|Treatment Period|No longer meets eligibility criteria|0|||
164527527|NCT04617275|594302230|FG003|Treatment Period|No longer meets eligibility criteria|1|||
164527528|NCT04617275|594302231|FG004|Treatment Period|No longer meets eligibility criteria|0|||
164527529|NCT04617275|594302232|FG005|Treatment Period|No longer meets eligibility criteria|0|||
164527530|NCT04617275|594302233|FG006|Treatment Period|No longer meets eligibility criteria|0|||
164527531|NCT04617275|594302234|FG007|Treatment Period|No longer meets eligibility criteria|0|||
164527532|NCT04617275|594302227|FG000|Treatment Period|Other|0|||
164527533|NCT04617275|594302228|FG001|Treatment Period|Other|1|||
164527534|NCT04617275|594302229|FG002|Treatment Period|Other|0|||
164527535|NCT04617275|594302230|FG003|Treatment Period|Other|0|||
164527536|NCT04617275|594302231|FG004|Treatment Period|Other|0|||
164527537|NCT04617275|594302232|FG005|Treatment Period|Other|0|||
164527538|NCT04617275|594302233|FG006|Treatment Period|Other|0|||
164527539|NCT04617275|594302234|FG007|Treatment Period|Other|0|||
164527540|NCT04617275|594302227|FG000|Treatment Period|Withdrawal by Subject|2|||
164527541|NCT04617275|594302228|FG001|Treatment Period|Withdrawal by Subject|0|||
164527542|NCT04617275|594302229|FG002|Treatment Period|Withdrawal by Subject|0|||
164527543|NCT04617275|594302230|FG003|Treatment Period|Withdrawal by Subject|2|||
164527544|NCT04617275|594302231|FG004|Treatment Period|Withdrawal by Subject|2|||
164527545|NCT04617275|594302232|FG005|Treatment Period|Withdrawal by Subject|0|||
164527546|NCT04617275|594302233|FG006|Treatment Period|Withdrawal by Subject|1|||
164527547|NCT04617275|594302234|FG007|Treatment Period|Withdrawal by Subject|2|||
164527548|NCT04617275|594302227|FG000|Follow-up Period|Adverse Event|1|||
164527549|NCT04617275|594302228|FG001|Follow-up Period|Adverse Event|1|||
164527550|NCT04617275|594302229|FG002|Follow-up Period|Adverse Event|2|||
164527551|NCT04617275|594302230|FG003|Follow-up Period|Adverse Event|3|||
164527552|NCT04617275|594302231|FG004|Follow-up Period|Adverse Event|4|||
164527553|NCT04617275|594302232|FG005|Follow-up Period|Adverse Event|3|||
164527554|NCT04617275|594302233|FG006|Follow-up Period|Adverse Event|0|||
164527555|NCT04617275|594302234|FG007|Follow-up Period|Adverse Event|3|||
164527556|NCT04617275|594302227|FG000|Follow-up Period|Lost to Follow-up|0|||
164527557|NCT04617275|594302228|FG001|Follow-up Period|Lost to Follow-up|1|||
164527558|NCT04617275|594302229|FG002|Follow-up Period|Lost to Follow-up|2|||
164527559|NCT04617275|594302230|FG003|Follow-up Period|Lost to Follow-up|0|||
164527560|NCT04617275|594302231|FG004|Follow-up Period|Lost to Follow-up|0|||
164527561|NCT04617275|594302232|FG005|Follow-up Period|Lost to Follow-up|4|||
164527562|NCT04617275|594302233|FG006|Follow-up Period|Lost to Follow-up|0|||
164527563|NCT04617275|594302234|FG007|Follow-up Period|Lost to Follow-up|3|||
164527564|NCT04617275|594302227|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
164527565|NCT04617275|594302228|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
164527566|NCT04617275|594302229|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
164527567|NCT04617275|594302230|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
164527568|NCT04617275|594302231|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
164527569|NCT04617275|594302232|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
164527570|NCT04617275|594302233|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
164527571|NCT04617275|594302234|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
164527572|NCT04617275|594302227|FG000|Follow-up Period|Other|0|||
164527573|NCT04617275|594302228|FG001|Follow-up Period|Other|1|||
164527574|NCT04617275|594302229|FG002|Follow-up Period|Other|0|||
164527575|NCT04617275|594302230|FG003|Follow-up Period|Other|0|||
164527576|NCT04617275|594302231|FG004|Follow-up Period|Other|0|||
164527577|NCT04617275|594302232|FG005|Follow-up Period|Other|0|||
164527578|NCT04617275|594302233|FG006|Follow-up Period|Other|0|||
164527579|NCT04617275|594302234|FG007|Follow-up Period|Other|0|||
164527580|NCT04617275|594302227|FG000|Follow-up Period|Withdrawal by Subject|2|||
164527581|NCT04617275|594302228|FG001|Follow-up Period|Withdrawal by Subject|0|||
164527582|NCT04617275|594302229|FG002|Follow-up Period|Withdrawal by Subject|0|||
164625698|NCT01693562|594650178|FG016|Expansion Phase|Withdrawal by Subject|40|||
164625699|NCT01693562|594650179|FG017|Expansion Phase|Withdrawal by Subject|4|||
164625700|NCT01693562|594650180|FG018|Expansion Phase|Withdrawal by Subject|8|||
164625701|NCT01693562|594650181|FG019|Expansion Phase|Withdrawal by Subject|3|||
164625702|NCT01693562|594650182|FG020|Expansion Phase|Withdrawal by Subject|1|||
164625703|NCT01693562|594650183|FG021|Expansion Phase|Withdrawal by Subject|8|||
164625704|NCT01693562|594650184|FG022|Expansion Phase|Withdrawal by Subject|1|||
164625705|NCT01693562|594650162|FG000|Expansion Phase|Death|0|||
164625706|NCT01693562|594650163|FG001|Expansion Phase|Death|0|||
164625707|NCT01693562|594650164|FG002|Expansion Phase|Death|0|||
164625708|NCT01693562|594650165|FG003|Expansion Phase|Death|0|||
164625709|NCT01693562|594650166|FG004|Expansion Phase|Death|0|||
164625710|NCT01693562|594650167|FG005|Expansion Phase|Death|0|||
164527583|NCT04617275|594302230|FG003|Follow-up Period|Withdrawal by Subject|2|||
164527584|NCT04617275|594302231|FG004|Follow-up Period|Withdrawal by Subject|2|||
164527585|NCT04617275|594302232|FG005|Follow-up Period|Withdrawal by Subject|0|||
164527586|NCT04617275|594302233|FG006|Follow-up Period|Withdrawal by Subject|1|||
164527587|NCT04617275|594302234|FG007|Follow-up Period|Withdrawal by Subject|2|||
164527588|NCT04927884|594302239|FG000|Overall Study|Progressive Disease|2|||
164527589|NCT01775124|594302240|FG000|Core Period|Disease Progression|0|||
164527590|NCT01775124|594302241|FG001|Core Period|Disease Progression|1|||
164527591|NCT01775124|594302240|FG000|Core Period|Physician Decision|1|||
164527592|NCT01775124|594302241|FG001|Core Period|Physician Decision|1|||
164527593|NCT01775124|594302240|FG000|Core Period|Death|0|||
164527594|NCT01775124|594302241|FG001|Core Period|Death|1|||
164527595|NCT01775124|594302240|FG000|Core Period|Administrative problems|1|||
164527596|NCT01775124|594302241|FG001|Core Period|Administrative problems|0|||
164527597|NCT01775124|594302240|FG000|Core Period|Withdrawal by Subject|4|||
164527598|NCT01775124|594302241|FG001|Core Period|Withdrawal by Subject|2|||
164527599|NCT01775124|594302240|FG000|Core Period|Adverse Event|5|||
164527600|NCT01775124|594302241|FG001|Core Period|Adverse Event|5|||
164527601|NCT01775124|594302240|FG000|Extension Period|Adverse Event|3|||
164527602|NCT01775124|594302241|FG001|Extension Period|Adverse Event|2|||
164527603|NCT01775124|594302240|FG000|Extension Period|Physician Decision|0|||
164527604|NCT01775124|594302241|FG001|Extension Period|Physician Decision|2|||
164527605|NCT01775124|594302240|FG000|Extension Period|Administrative problems|0|||
164527606|NCT01775124|594302241|FG001|Extension Period|Administrative problems|1|||
164527607|NCT01775124|594302240|FG000|Extension Period|Lost to Follow-up|0|||
164527608|NCT01775124|594302241|FG001|Extension Period|Lost to Follow-up|1|||
164527609|NCT01775124|594302240|FG000|Extension Period|Withdrawal by Subject|9|||
164527610|NCT01775124|594302241|FG001|Extension Period|Withdrawal by Subject|12|||
164527611|NCT02317432|594302242|FG000|Overall Study|Death|4|||
164527612|NCT02317432|594302243|FG001|Overall Study|Death|1|||
164527613|NCT02317432|594302242|FG000|Overall Study|Lost to Follow-up|0|||
164527614|NCT02317432|594302243|FG001|Overall Study|Lost to Follow-up|5|||
164527615|NCT02317432|594302242|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
164527616|NCT02317432|594302243|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
164527617|NCT01328717|594303614|FG000|Overall Study|Adverse Event|1|||
164527618|NCT01177722|594303615|FG000|Overall Study|Serious Adverse Event|0|||
164527619|NCT01177722|594303616|FG001|Overall Study|Serious Adverse Event|0|||
164527620|NCT01177722|594303617|FG002|Overall Study|Serious Adverse Event|1|||
164527621|NCT01177722|594303618|FG003|Overall Study|Serious Adverse Event|0|||
164527622|NCT01177722|594303615|FG000|Overall Study|Protocol Violation|0|||
164527623|NCT01177722|594303616|FG001|Overall Study|Protocol Violation|0|||
164527624|NCT01177722|594303617|FG002|Overall Study|Protocol Violation|1|||
164527625|NCT01177722|594303618|FG003|Overall Study|Protocol Violation|0|||
164527626|NCT01177722|594303615|FG000|Overall Study|Lost to Follow-up|3|||
164527627|NCT01177722|594303616|FG001|Overall Study|Lost to Follow-up|4|||
164527628|NCT01177722|594303617|FG002|Overall Study|Lost to Follow-up|3|||
164527629|NCT01177722|594303618|FG003|Overall Study|Lost to Follow-up|1|||
164527630|NCT01177722|594303615|FG000|Overall Study|Withdrawal by Subject|10|||
164527631|NCT01177722|594303616|FG001|Overall Study|Withdrawal by Subject|6|||
164527632|NCT01177722|594303617|FG002|Overall Study|Withdrawal by Subject|4|||
164527633|NCT01177722|594303618|FG003|Overall Study|Withdrawal by Subject|6|||
164527634|NCT00192647|594303619|FG000|Overall Study|Death|1|||
164527635|NCT00192647|594303620|FG001|Overall Study|Death|1|||
164527636|NCT00192647|594303619|FG000|Overall Study|Adverse Event|35|||
164527637|NCT00192647|594303620|FG001|Overall Study|Adverse Event|29|||
164527638|NCT00192647|594303619|FG000|Overall Study|Laboratory Test Abnormality|4|||
164527639|NCT00192647|594303620|FG001|Overall Study|Laboratory Test Abnormality|2|||
164527640|NCT00192647|594303619|FG000|Overall Study|Insufficient Therapeutic Response|53|||
164527641|NCT00192647|594303620|FG001|Overall Study|Insufficient Therapeutic Response|83|||
164527642|NCT00192647|594303619|FG000|Overall Study|Entry Criteria Violation|6|||
164527643|NCT00192647|594303620|FG001|Overall Study|Entry Criteria Violation|6|||
164527644|NCT00192647|594303619|FG000|Overall Study|Protocol Violation|3|||
164527645|NCT00192647|594303620|FG001|Overall Study|Protocol Violation|1|||
164527646|NCT00192647|594303619|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
164527647|NCT00192647|594303620|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
164527648|NCT00192647|594303619|FG000|Overall Study|Failure to Return|11|||
164527649|NCT00192647|594303620|FG001|Overall Study|Failure to Return|13|||
164527650|NCT00192647|594303619|FG000|Overall Study|Other/Administrative|5|||
164527651|NCT00192647|594303620|FG001|Overall Study|Other/Administrative|3|||
164527652|NCT02079610|594303626|FG000|Overall Study|Withdrawal by Subject|1|||
164527653|NCT02079610|594303627|FG001|Overall Study|Withdrawal by Subject|1|||
164527654|NCT05220254|594303628|FG000|Overall Study|Withdrawal by Subject|4|||
164625711|NCT01693562|594650168|FG006|Expansion Phase|Death|0|||
164527655|NCT05220254|594303628|FG000|Overall Study|Removed due to ineligibility|1|||
164527656|NCT05220254|594303628|FG000|Overall Study|Lost to Follow-up|7|||
164527657|NCT01557283|594303631|FG000|Overall Study|Lost to Follow-up|7|||
164527658|NCT01557283|594303631|FG000|Overall Study|Non-responder|19|||
164625712|NCT01693562|594650169|FG007|Expansion Phase|Death|42|||
164527659|NCT01557283|594303631|FG000|Overall Study|Adverse Event|7|||
164527660|NCT01557283|594303631|FG000|Overall Study|Lack of Efficacy|1|||
164527661|NCT01557283|594303631|FG000|Overall Study|Non-compliance|1|||
164527662|NCT01557283|594303631|FG000|Overall Study|Withdrawal by Subject|1|||
164527663|NCT01557283|594303631|FG000|Overall Study|Participant's weight too high for dose|1|||
164527664|NCT01557283|594303631|FG000|Overall Study|Worsening of psoriasis|1|||
164527665|NCT01557283|594303631|FG000|Overall Study|Other|6|||
164527666|NCT01765192|594303632|FG000|Treatment Period 1|Adverse Event|0|||
164527667|NCT01765192|594303633|FG001|Treatment Period 1|Adverse Event|1|||
164527668|NCT01765192|594303632|FG000|Washout Period|Voluntary Withdrawal|1|||
164527669|NCT01765192|594303633|FG001|Washout Period|Voluntary Withdrawal|1|||
164527670|NCT01765192|594303632|FG000|Washout Period|Reason not specified|1|||
164527671|NCT01765192|594303633|FG001|Washout Period|Reason not specified|0|||
164527672|NCT01765192|594303632|FG000|Treatment Period 2|Reason not specified|0|||
164527673|NCT01765192|594303633|FG001|Treatment Period 2|Reason not specified|2|||
164527674|NCT01765192|594303632|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
164527675|NCT01765192|594303633|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
164527676|NCT01016977|594303636|FG000|Overall Study|Lost to Follow-up|1|||
164527677|NCT01016977|594303637|FG001|Overall Study|Lost to Follow-up|0|||
164527678|NCT01016977|594303636|FG000|Overall Study|Withdrawal by Subject|2|||
164527679|NCT01016977|594303637|FG001|Overall Study|Withdrawal by Subject|2|||
164527680|NCT02080221|594303638|FG000|Overall Study|Withdrawal by Subject|1|||
164527681|NCT02080221|594303638|FG000|Overall Study|Clinical Progression of Disease|1|||
164527682|NCT03786783|594303644|FG000|Overall Study|Death|1|||
164527683|NCT03786783|594303644|FG000|Overall Study|Physician Decision|6|||
164527684|NCT03786783|594303644|FG000|Overall Study|Withdrawal by Subject|2|||
164527685|NCT03786783|594303644|FG000|Overall Study|Disease Progression|7|||
164527686|NCT03786783|594303644|FG000|Overall Study|Patient/Parent Refusal|4|||
164527687|NCT04279392|594303647|FG000|Overall Study|Physician Decision|1|||
164527688|NCT04279392|594303648|FG001|Overall Study|Physician Decision|0|||
164527689|NCT00738582|594303649|FG000|Combination Therapy|Completed Combination Therapy|1|||
164527690|NCT00738582|594303650|FG001|Combination Therapy|Completed Combination Therapy|0|||
164527691|NCT00738582|594303649|FG000|Combination Therapy|Physician Decision|1|||
164527692|NCT00738582|594303650|FG001|Combination Therapy|Physician Decision|0|||
164527693|NCT00738582|594303649|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
164527694|NCT00738582|594303650|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
164527695|NCT00738582|594303649|FG000|Combination Therapy|Other|5|||
164527696|NCT00738582|594303650|FG001|Combination Therapy|Other|0|||
164527697|NCT00738582|594303649|FG000|Combination Therapy|Adverse Event|16|||
164625713|NCT01693562|594650170|FG008|Expansion Phase|Death|17|||
164625714|NCT01693562|594650171|FG009|Expansion Phase|Death|208|||
164625715|NCT01693562|594650172|FG010|Expansion Phase|Death|30|||
164625716|NCT01693562|594650173|FG011|Expansion Phase|Death|8|||
164625717|NCT01693562|594650174|FG012|Expansion Phase|Death|19|||
164625718|NCT01693562|594650175|FG013|Expansion Phase|Death|42|||
164625719|NCT01693562|594650176|FG014|Expansion Phase|Death|23|||
164625720|NCT01693562|594650177|FG015|Expansion Phase|Death|23|||
164625721|NCT01693562|594650178|FG016|Expansion Phase|Death|128|||
164625722|NCT01693562|594650179|FG017|Expansion Phase|Death|16|||
164625723|NCT01693562|594650180|FG018|Expansion Phase|Death|36|||
164625724|NCT01693562|594650181|FG019|Expansion Phase|Death|16|||
164625725|NCT01693562|594650182|FG020|Expansion Phase|Death|17|||
164625726|NCT01693562|594650183|FG021|Expansion Phase|Death|35|||
164625727|NCT01693562|594650184|FG022|Expansion Phase|Death|7|||
164625728|NCT01693562|594650162|FG000|Expansion Phase|Lost to Follow-up|0|||
164625729|NCT01693562|594650163|FG001|Expansion Phase|Lost to Follow-up|0|||
164625730|NCT01693562|594650164|FG002|Expansion Phase|Lost to Follow-up|0|||
164625731|NCT01693562|594650165|FG003|Expansion Phase|Lost to Follow-up|0|||
164625732|NCT01693562|594650166|FG004|Expansion Phase|Lost to Follow-up|0|||
164625733|NCT01693562|594650167|FG005|Expansion Phase|Lost to Follow-up|0|||
164625734|NCT01693562|594650168|FG006|Expansion Phase|Lost to Follow-up|0|||
164625735|NCT01693562|594650169|FG007|Expansion Phase|Lost to Follow-up|1|||
164625736|NCT01693562|594650170|FG008|Expansion Phase|Lost to Follow-up|2|||
164625737|NCT01693562|594650171|FG009|Expansion Phase|Lost to Follow-up|10|||
164625738|NCT01693562|594650172|FG010|Expansion Phase|Lost to Follow-up|4|||
164527698|NCT00738582|594303650|FG001|Combination Therapy|Adverse Event|0|||
164527699|NCT00738582|594303649|FG000|Combination Therapy|Progressive Disease|9|||
164527700|NCT00738582|594303650|FG001|Combination Therapy|Progressive Disease|0|||
164527701|NCT00738582|594303649|FG000|Maintenance Therapy|Other|0|||
164527702|NCT00738582|594303650|FG001|Maintenance Therapy|Other|2|||
164527703|NCT00738582|594303649|FG000|Maintenance Therapy|Adverse Event|0|||
164527704|NCT00738582|594303650|FG001|Maintenance Therapy|Adverse Event|6|||
164527705|NCT00738582|594303649|FG000|Maintenance Therapy|Progressive Disease|0|||
164527706|NCT00738582|594303650|FG001|Maintenance Therapy|Progressive Disease|47|||
164527707|NCT00738582|594303649|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
164527708|NCT00738582|594303650|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
164527709|NCT01052103|594303651|FG000|Overall Study|Adverse Event|10|||
164527710|NCT01052103|594303652|FG001|Overall Study|Adverse Event|6|||
164527711|NCT01052103|594303651|FG000|Overall Study|Entry Criteria Not Met|3|||
164527712|NCT01052103|594303652|FG001|Overall Study|Entry Criteria Not Met|1|||
164527713|NCT01052103|594303651|FG000|Overall Study|Lost to Follow-up|3|||
164527714|NCT01052103|594303652|FG001|Overall Study|Lost to Follow-up|5|||
164527715|NCT01052103|594303651|FG000|Overall Study|Protocol Violation|10|||
164527716|NCT01052103|594303652|FG001|Overall Study|Protocol Violation|4|||
164527717|NCT01052103|594303651|FG000|Overall Study|Scheduling conflict|2|||
164527718|NCT01052103|594303652|FG001|Overall Study|Scheduling conflict|1|||
164527719|NCT01052103|594303651|FG000|Overall Study|Sponsor Decision|2|||
164527720|NCT01052103|594303652|FG001|Overall Study|Sponsor Decision|0|||
164527721|NCT01052103|594303651|FG000|Overall Study|Withdrawal by Subject|3|||
164527722|NCT01052103|594303652|FG001|Overall Study|Withdrawal by Subject|6|||
164527723|NCT01052103|594303651|FG000|Overall Study|Perceived Lack of Efficacy|1|||
164527724|NCT01052103|594303652|FG001|Overall Study|Perceived Lack of Efficacy|0|||
164527725|NCT00666679|594303655|FG000|First Intervention|Lost to Follow-up|1|||
164527726|NCT00666679|594303656|FG001|First Intervention|Lost to Follow-up|0|||
164527727|NCT00666679|594303655|FG000|First Intervention|Protocol Violation|1|||
164527728|NCT00666679|594303656|FG001|First Intervention|Protocol Violation|0|||
164527729|NCT00666679|594303655|FG000|First Intervention|Withdrawal by Subject|1|||
164625739|NCT01693562|594650173|FG011|Expansion Phase|Lost to Follow-up|4|||
164625740|NCT01693562|594650174|FG012|Expansion Phase|Lost to Follow-up|1|||
164625741|NCT01693562|594650175|FG013|Expansion Phase|Lost to Follow-up|3|||
164625742|NCT01693562|594650176|FG014|Expansion Phase|Lost to Follow-up|0|||
164625743|NCT01693562|594650177|FG015|Expansion Phase|Lost to Follow-up|1|||
164625744|NCT01693562|594650178|FG016|Expansion Phase|Lost to Follow-up|1|||
164625745|NCT01693562|594650179|FG017|Expansion Phase|Lost to Follow-up|0|||
164625746|NCT01693562|594650180|FG018|Expansion Phase|Lost to Follow-up|2|||
164625747|NCT01693562|594650181|FG019|Expansion Phase|Lost to Follow-up|1|||
164625748|NCT01693562|594650182|FG020|Expansion Phase|Lost to Follow-up|2|||
164625749|NCT01693562|594650183|FG021|Expansion Phase|Lost to Follow-up|2|||
164625750|NCT01693562|594650184|FG022|Expansion Phase|Lost to Follow-up|1|||
164625751|NCT01693562|594650162|FG000|Expansion Phase|Other|0|||
164625752|NCT01693562|594650163|FG001|Expansion Phase|Other|0|||
164625753|NCT01693562|594650164|FG002|Expansion Phase|Other|0|||
164625754|NCT01693562|594650165|FG003|Expansion Phase|Other|0|||
164625755|NCT01693562|594650166|FG004|Expansion Phase|Other|0|||
164625756|NCT01693562|594650167|FG005|Expansion Phase|Other|0|||
164625757|NCT01693562|594650168|FG006|Expansion Phase|Other|0|||
164625758|NCT01693562|594650169|FG007|Expansion Phase|Other|3|||
164625759|NCT01693562|594650170|FG008|Expansion Phase|Other|1|||
164625760|NCT01693562|594650171|FG009|Expansion Phase|Other|28|||
164625761|NCT01693562|594650172|FG010|Expansion Phase|Other|4|||
164625762|NCT01693562|594650173|FG011|Expansion Phase|Other|7|||
164625763|NCT01693562|594650174|FG012|Expansion Phase|Other|0|||
164625764|NCT01693562|594650175|FG013|Expansion Phase|Other|1|||
164625765|NCT01693562|594650176|FG014|Expansion Phase|Other|1|||
164625766|NCT01693562|594650177|FG015|Expansion Phase|Other|0|||
164625767|NCT01693562|594650178|FG016|Expansion Phase|Other|28|||
164625768|NCT01693562|594650179|FG017|Expansion Phase|Other|0|||
164625769|NCT01693562|594650180|FG018|Expansion Phase|Other|1|||
164625770|NCT01693562|594650181|FG019|Expansion Phase|Other|0|||
164625771|NCT01693562|594650182|FG020|Expansion Phase|Other|1|||
164625772|NCT01693562|594650183|FG021|Expansion Phase|Other|17|||
164625773|NCT01693562|594650184|FG022|Expansion Phase|Other|1|||
164625774|NCT05466240|594650185|FG000|Overall Study|Adverse Event|1|||
164625775|NCT05466240|594650186|FG001|Overall Study|Adverse Event|0|||
164625776|NCT05466240|594650185|FG000|Overall Study|Withdrawal by Subject|1|||
164625777|NCT05466240|594650186|FG001|Overall Study|Withdrawal by Subject|0|||
164625778|NCT02759939|594650187|FG000|Overall Study|Missing data on first outcome assessed|11|||
164625779|NCT02759939|594650188|FG001|Overall Study|Missing data on first outcome assessed|2|||
164625780|NCT02759939|594650189|FG002|Overall Study|Missing data on first outcome assessed|5|||
164625781|NCT02759939|594650190|FG003|Overall Study|Missing data on first outcome assessed|2|||
164625782|NCT02759939|594650187|FG000|Overall Study|Ineligible for T2 and T3|310|||
164625783|NCT02759939|594650188|FG001|Overall Study|Ineligible for T2 and T3|179|||
164625784|NCT02759939|594650189|FG002|Overall Study|Ineligible for T2 and T3|366|||
164625785|NCT02759939|594650190|FG003|Overall Study|Ineligible for T2 and T3|391|||
164625786|NCT02759939|594650187|FG000|Overall Study|Lost to Follow-up|735|||
164625787|NCT02759939|594650188|FG001|Overall Study|Lost to Follow-up|791|||
164625788|NCT02759939|594650189|FG002|Overall Study|Lost to Follow-up|783|||
164625789|NCT02759939|594650190|FG003|Overall Study|Lost to Follow-up|650|||
164625790|NCT04735432|594650191|FG000|Overall Study|Other - due to personal reason|1|||
164625791|NCT04735432|594650192|FG001|Overall Study|Other - due to personal reason|0|||
164625792|NCT04735432|594650191|FG000|Overall Study|Adverse Event|2|||
164625793|NCT04735432|594650192|FG001|Overall Study|Adverse Event|0|||
164625794|NCT02306148|594650193|FG000|Overall Study|Adverse Event|12|||
164625795|NCT02306148|594650194|FG001|Overall Study|Adverse Event|6|||
164625796|NCT02306148|594650193|FG000|Overall Study|Lost to Follow-up|1|||
164625797|NCT02306148|594650194|FG001|Overall Study|Lost to Follow-up|4|||
164625798|NCT04397757|594650195|FG000|Overall Study|Death|3|||
164625799|NCT04397757|594650196|FG001|Overall Study|Death|11|||
164625800|NCT04397757|594650195|FG000|Overall Study|Withdrawal by Subject|2|||
164625801|NCT04397757|594650196|FG001|Overall Study|Withdrawal by Subject|0|||
164625802|NCT04397757|594650195|FG000|Overall Study|Lost to Follow-up|4|||
164625803|NCT04397757|594650196|FG001|Overall Study|Lost to Follow-up|3|||
164625804|NCT04657003|594650197|FG000|Overall Study|Adverse Event|5|||
164625805|NCT04657003|594650198|FG001|Overall Study|Adverse Event|1|||
164625806|NCT04657003|594650199|FG002|Overall Study|Adverse Event|5|||
164625807|NCT04657003|594650197|FG000|Overall Study|Death|0|||
164625808|NCT04657003|594650198|FG001|Overall Study|Death|2|||
164625809|NCT04657003|594650199|FG002|Overall Study|Death|0|||
164625810|NCT04657003|594650197|FG000|Overall Study|Lost to Follow-up|8|||
164625811|NCT04657003|594650198|FG001|Overall Study|Lost to Follow-up|4|||
164625812|NCT04657003|594650199|FG002|Overall Study|Lost to Follow-up|10|||
164625813|NCT04657003|594650197|FG000|Overall Study|Other - As Reported by Investigator|3|||
164625814|NCT04657003|594650198|FG001|Overall Study|Other - As Reported by Investigator|2|||
164625815|NCT04657003|594650199|FG002|Overall Study|Other - As Reported by Investigator|2|||
164625816|NCT04657003|594650197|FG000|Overall Study|Pregnancy|2|||
164625817|NCT04657003|594650198|FG001|Overall Study|Pregnancy|0|||
164625818|NCT04657003|594650199|FG002|Overall Study|Pregnancy|2|||
164625819|NCT04657003|594650197|FG000|Overall Study|Withdrawal by Subject|16|||
164625820|NCT04657003|594650198|FG001|Overall Study|Withdrawal by Subject|7|||
164625821|NCT04657003|594650199|FG002|Overall Study|Withdrawal by Subject|10|||
164625822|NCT02408016|594650201|FG000|Overall Study|Death|6|||
164625823|NCT02408016|594650202|FG001|Overall Study|Death|1|||
164625824|NCT02408016|594650203|FG002|Overall Study|Death|0|||
164625825|NCT02408016|594650201|FG000|Overall Study|Physician Decision|0|||
164625826|NCT02408016|594650202|FG001|Overall Study|Physician Decision|2|||
164625827|NCT02408016|594650203|FG002|Overall Study|Physician Decision|0|||
164625828|NCT03818399|594650204|FG000|Overall Study|Lost to Follow-up|11|||
164625829|NCT03818399|594650204|FG000|Overall Study|Withdrawal by Subject|1|||
164625830|NCT03818399|594650204|FG000|Overall Study|Protocol Violation|2|||
164625831|NCT02987205|594650206|FG000|Overall Study|Adverse Event|1|||
164625832|NCT02987205|594650206|FG000|Overall Study|Withdrawal by Subject|3|||
164625833|NCT02807376|594650208|FG000|Overall Study|Intra-operative exclusion criteria|3|||
164625834|NCT02807376|594650209|FG001|Overall Study|Intra-operative exclusion criteria|0|||
164625835|NCT02807376|594650208|FG000|Overall Study|Lost to Follow-up|0|||
164625836|NCT02807376|594650209|FG001|Overall Study|Lost to Follow-up|1|||
164625837|NCT04652102|594650212|FG000|Overall Study|Adverse Event|14|||
164625838|NCT04652102|594650213|FG001|Overall Study|Adverse Event|13|||
164625839|NCT04652102|594650212|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
164625840|NCT04652102|594650213|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
164625841|NCT04652102|594650212|FG000|Overall Study|Physician Decision|78|||
164625842|NCT04652102|594650213|FG001|Overall Study|Physician Decision|40|||
164625843|NCT04652102|594650212|FG000|Overall Study|Study Ended by Sponsor|64|||
164625844|NCT04652102|594650213|FG001|Overall Study|Study Ended by Sponsor|17|||
164625845|NCT04652102|594650212|FG000|Overall Study|Withdrawal by Subject|4625|||
164625846|NCT04652102|594650213|FG001|Overall Study|Withdrawal by Subject|5594|||
164625847|NCT04652102|594650212|FG000|Overall Study|Lost to Follow-up|2019|||
164625848|NCT04652102|594650213|FG001|Overall Study|Lost to Follow-up|1082|||
164625849|NCT04652102|594650212|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
164625850|NCT04652102|594650213|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
164625851|NCT04652102|594650212|FG000|Overall Study|Miscellaneous|80|||
164625852|NCT04652102|594650213|FG001|Overall Study|Miscellaneous|64|||
164625853|NCT01756833|594650214|FG000|Overall Study|Withdrawal by Subject|4|||
164625854|NCT01756833|594650215|FG001|Overall Study|Withdrawal by Subject|3|||
164625855|NCT00952588|594650216|FG000|Overall Study|Death|28|||
164625856|NCT00952588|594650217|FG001|Overall Study|Death|13|||
164625857|NCT00952588|594650216|FG000|Overall Study|Withdrawal by Subject|2|||
164625858|NCT00952588|594650217|FG001|Overall Study|Withdrawal by Subject|5|||
164625859|NCT00952588|594650216|FG000|Overall Study|Adverse Event|2|||
164625860|NCT00952588|594650217|FG001|Overall Study|Adverse Event|3|||
164625861|NCT00952588|594650216|FG000|Overall Study|Lost to Follow-up|2|||
164625862|NCT00952588|594650217|FG001|Overall Study|Lost to Follow-up|0|||
164625863|NCT00952588|594650216|FG000|Overall Study|Physician Decision|0|||
164625864|NCT00952588|594650217|FG001|Overall Study|Physician Decision|1|||
164625865|NCT00952588|594650216|FG000|Overall Study|Lack of Efficacy|2|||
164625866|NCT00952588|594650217|FG001|Overall Study|Lack of Efficacy|2|||
164625867|NCT00808132|594650218|FG000|Overall Study|Adverse Event|34|||
164625868|NCT00808132|594650219|FG001|Overall Study|Adverse Event|33|||
164625869|NCT00808132|594650220|FG002|Overall Study|Adverse Event|16|||
164625870|NCT00808132|594650221|FG003|Overall Study|Adverse Event|31|||
164625871|NCT00808132|594650222|FG004|Overall Study|Adverse Event|33|||
164625872|NCT00808132|594650218|FG000|Overall Study|Death|0|||
164527730|NCT00666679|594303656|FG001|First Intervention|Withdrawal by Subject|0|||
164527731|NCT00666679|594303655|FG000|First Intervention|Randomized did not start treatment|1|||
164527732|NCT00666679|594303656|FG001|First Intervention|Randomized did not start treatment|1|||
164527733|NCT00666679|594303655|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
164625873|NCT00808132|594650219|FG001|Overall Study|Death|0|||
164625874|NCT00808132|594650220|FG002|Overall Study|Death|0|||
164527734|NCT00666679|594303656|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
164527735|NCT00666679|594303655|FG000|Washout Period of 1 Week|Protocol Violation|0|||
164527736|NCT00666679|594303656|FG001|Washout Period of 1 Week|Protocol Violation|1|||
164527737|NCT00666679|594303655|FG000|Second Intervention|Adverse Event|1|||
164527738|NCT00666679|594303656|FG001|Second Intervention|Adverse Event|0|||
164527739|NCT00666679|594303655|FG000|Second Intervention|Death|0|||
164527740|NCT00666679|594303656|FG001|Second Intervention|Death|1|||
164527741|NCT02518490|594303658|FG000|Overall Study|Withdrawal by Subject|1|||
164527742|NCT02518490|594303659|FG001|Overall Study|Withdrawal by Subject|1|||
164527743|NCT03235284|594303660|FG000|Overall Study|Adverse Event|1|||
164527744|NCT03235284|594303661|FG001|Overall Study|Adverse Event|2|||
164527745|NCT03235284|594303662|FG002|Overall Study|Adverse Event|1|||
164625875|NCT00808132|594650221|FG003|Overall Study|Death|0|||
164625876|NCT00808132|594650222|FG004|Overall Study|Death|1|||
164625877|NCT00808132|594650218|FG000|Overall Study|Physician Decision|0|||
164625878|NCT00808132|594650219|FG001|Overall Study|Physician Decision|1|||
164625879|NCT00808132|594650220|FG002|Overall Study|Physician Decision|0|||
164625880|NCT00808132|594650221|FG003|Overall Study|Physician Decision|0|||
164625881|NCT00808132|594650222|FG004|Overall Study|Physician Decision|0|||
164625882|NCT00808132|594650218|FG000|Overall Study|Lost to Follow-up|8|||
164625883|NCT00808132|594650219|FG001|Overall Study|Lost to Follow-up|10|||
164625884|NCT00808132|594650220|FG002|Overall Study|Lost to Follow-up|11|||
164625885|NCT00808132|594650221|FG003|Overall Study|Lost to Follow-up|8|||
164625886|NCT00808132|594650222|FG004|Overall Study|Lost to Follow-up|9|||
164625887|NCT00808132|594650218|FG000|Overall Study|Protocol Violation|8|||
164625888|NCT00808132|594650219|FG001|Overall Study|Protocol Violation|9|||
164625889|NCT00808132|594650220|FG002|Overall Study|Protocol Violation|4|||
164625890|NCT00808132|594650221|FG003|Overall Study|Protocol Violation|9|||
164625891|NCT00808132|594650222|FG004|Overall Study|Protocol Violation|5|||
164625892|NCT00808132|594650218|FG000|Overall Study|Withdrawal by Subject|27|||
164625893|NCT00808132|594650219|FG001|Overall Study|Withdrawal by Subject|18|||
164625894|NCT00808132|594650220|FG002|Overall Study|Withdrawal by Subject|2|||
164625895|NCT00808132|594650221|FG003|Overall Study|Withdrawal by Subject|7|||
164625896|NCT00808132|594650222|FG004|Overall Study|Withdrawal by Subject|16|||
164625897|NCT00808132|594650218|FG000|Overall Study|Other|6|||
164625898|NCT00808132|594650219|FG001|Overall Study|Other|4|||
164625899|NCT00808132|594650220|FG002|Overall Study|Other|6|||
164625900|NCT00808132|594650221|FG003|Overall Study|Other|2|||
164625901|NCT00808132|594650222|FG004|Overall Study|Other|15|||
164625902|NCT00808132|594650218|FG000|Overall Study|Randomized, but not treated|10|||
164625903|NCT00808132|594650219|FG001|Overall Study|Randomized, but not treated|7|||
164625904|NCT00808132|594650220|FG002|Overall Study|Randomized, but not treated|9|||
164625905|NCT00808132|594650221|FG003|Overall Study|Randomized, but not treated|8|||
164625906|NCT00808132|594650222|FG004|Overall Study|Randomized, but not treated|9|||
164625907|NCT00808132|594650218|FG000|Overall Study|Unsatisfactory response|5|||
164625908|NCT00808132|594650219|FG001|Overall Study|Unsatisfactory response|6|||
164625909|NCT00808132|594650220|FG002|Overall Study|Unsatisfactory response|6|||
164625910|NCT00808132|594650221|FG003|Overall Study|Unsatisfactory response|4|||
164625911|NCT00808132|594650222|FG004|Overall Study|Unsatisfactory response|12|||
164625912|NCT00890201|594650225|FG000|Overall Study|Protocol Violation|5|||
164625913|NCT00890201|594650226|FG001|Overall Study|Protocol Violation|56|||
164625914|NCT01371721|594650227|FG000|Overall Study|Adverse Event|5|||
164625915|NCT01371721|594650228|FG001|Overall Study|Adverse Event|4|||
164625916|NCT01371721|594650229|FG002|Overall Study|Adverse Event|5|||
164625917|NCT01371721|594650227|FG000|Overall Study|Protocol Violation|6|||
164625918|NCT01371721|594650228|FG001|Overall Study|Protocol Violation|4|||
164625919|NCT01371721|594650229|FG002|Overall Study|Protocol Violation|5|||
164625920|NCT01371721|594650227|FG000|Overall Study|Lost to Follow-up|8|||
164625921|NCT01371721|594650228|FG001|Overall Study|Lost to Follow-up|2|||
164625922|NCT01371721|594650229|FG002|Overall Study|Lost to Follow-up|6|||
164625923|NCT01371721|594650227|FG000|Overall Study|Withdrawal by Subject|5|||
164625924|NCT01371721|594650228|FG001|Overall Study|Withdrawal by Subject|7|||
164625925|NCT01371721|594650229|FG002|Overall Study|Withdrawal by Subject|11|||
164625926|NCT01371721|594650227|FG000|Overall Study|Other|2|||
164625927|NCT01371721|594650228|FG001|Overall Study|Other|3|||
164625928|NCT01371721|594650229|FG002|Overall Study|Other|0|||
164625929|NCT01371721|594650227|FG000|Overall Study|Lack of Efficacy|2|||
164625930|NCT01371721|594650228|FG001|Overall Study|Lack of Efficacy|4|||
164625931|NCT01371721|594650229|FG002|Overall Study|Lack of Efficacy|3|||
164625932|NCT01371721|594650227|FG000|Overall Study|Randomized but not treated|1|||
164625933|NCT01371721|594650228|FG001|Overall Study|Randomized but not treated|0|||
164527746|NCT00211185|594303663|FG000|Overall Study|Death|2|||
164527747|NCT00211185|594303663|FG000|Overall Study|Disease progression|7|||
164527748|NCT00211185|594303663|FG000|Overall Study|Withdrawal by Subject|6|||
164527749|NCT00211185|594303663|FG000|Overall Study|Physician Decision|5|||
164527750|NCT00552240|594303664|FG000|Overall Study|Adverse Event|9|||
164527751|NCT00552240|594303665|FG001|Overall Study|Adverse Event|9|||
164527752|NCT00552240|594303664|FG000|Overall Study|Protocol Violation|1|||
164527753|NCT00552240|594303665|FG001|Overall Study|Protocol Violation|1|||
164527754|NCT00552240|594303664|FG000|Overall Study|Lost to Follow-up|5|||
164625934|NCT01371721|594650229|FG002|Overall Study|Randomized but not treated|0|||
164625935|NCT01347840|594650230|FG000|Overall Study|Withdrawal by Subject|1|||
164625936|NCT01846208|594650234|FG000|Overall Study|Withdrew prior to treatment|1|||
164625937|NCT01846208|594650235|FG001|Overall Study|Withdrew prior to treatment|1|||
164625938|NCT01846208|594650236|FG002|Overall Study|Withdrew prior to treatment|1|||
164625939|NCT01846208|594650234|FG000|Overall Study|Dosing Symptoms|1|||
164625940|NCT01846208|594650235|FG001|Overall Study|Dosing Symptoms|2|||
164625941|NCT01846208|594650236|FG002|Overall Study|Dosing Symptoms|6|||
164625942|NCT01846208|594650234|FG000|Overall Study|Withdrawal by Subject|5|||
164625943|NCT01846208|594650235|FG001|Overall Study|Withdrawal by Subject|0|||
164625944|NCT01846208|594650236|FG002|Overall Study|Withdrawal by Subject|0|||
164625945|NCT01846208|594650234|FG000|Overall Study|Non-compliance|1|||
164625946|NCT01846208|594650235|FG001|Overall Study|Non-compliance|1|||
164625947|NCT01846208|594650236|FG002|Overall Study|Non-compliance|0|||
164625948|NCT01846208|594650234|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
164625949|NCT01846208|594650235|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
164625950|NCT01846208|594650236|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
164625951|NCT01846208|594650234|FG000|Overall Study|Refused SU OFC|0|||
164625952|NCT01846208|594650235|FG001|Overall Study|Refused SU OFC|0|||
164625953|NCT01846208|594650236|FG002|Overall Study|Refused SU OFC|1|||
164625954|NCT01432938|594650237|FG000|First Intervention|Protocol Violation|1|||
164625955|NCT01432938|594650238|FG001|First Intervention|Protocol Violation|0|||
164625956|NCT01432938|594650237|FG000|First Intervention|Physician Decision|1|||
164625957|NCT01432938|594650238|FG001|First Intervention|Physician Decision|0|||
164625958|NCT01432938|594650237|FG000|Second Intervention|Adverse Event|1|||
164625959|NCT01432938|594650238|FG001|Second Intervention|Adverse Event|0|||
164625960|NCT01875874|594650242|FG000|Overall Study|Death|3|||
164625961|NCT00374127|594650243|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
164625962|NCT00374127|594650243|FG000|Overall Study|Blood could not be drawn.|2|||
164625963|NCT00374127|594650243|FG000|Overall Study|Protocol Violation|5|||
164625964|NCT00374127|594650243|FG000|Overall Study|Pregnancy|1|||
164625965|NCT00281528|594650247|FG000|Overall Study|Progressive Disease|28|||
164625966|NCT00281528|594650248|FG001|Overall Study|Progressive Disease|18|||
164625967|NCT00281528|594650249|FG002|Overall Study|Progressive Disease|27|||
164625968|NCT00281528|594650247|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
164625969|NCT00281528|594650248|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
164625970|NCT00281528|594650249|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
164625971|NCT00281528|594650247|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
164625972|NCT00281528|594650248|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
164625973|NCT00281528|594650249|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
164625974|NCT00281528|594650247|FG000|Overall Study|Physician Decision|11|||
164625975|NCT00281528|594650248|FG001|Overall Study|Physician Decision|4|||
164625976|NCT00281528|594650249|FG002|Overall Study|Physician Decision|5|||
164625977|NCT00281528|594650247|FG000|Overall Study|Protocol Violation|1|||
164625978|NCT00281528|594650248|FG001|Overall Study|Protocol Violation|0|||
164625979|NCT00281528|594650249|FG002|Overall Study|Protocol Violation|1|||
164625980|NCT00281528|594650247|FG000|Overall Study|Withdrawal by Subject|5|||
164625981|NCT00281528|594650248|FG001|Overall Study|Withdrawal by Subject|5|||
164625982|NCT00281528|594650249|FG002|Overall Study|Withdrawal by Subject|7|||
164625983|NCT00281528|594650247|FG000|Overall Study|Other|6|||
164625984|NCT00281528|594650248|FG001|Overall Study|Other|3|||
164625985|NCT00281528|594650249|FG002|Overall Study|Other|5|||
164625986|NCT02520141|594650252|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
164625987|NCT00703781|594650253|FG000|Overall Study|Withdrawal by Subject|1|||
164625988|NCT00703781|594650254|FG001|Overall Study|Withdrawal by Subject|2|||
164625989|NCT00703781|594650253|FG000|Overall Study|Cancelled surgery|1|||
164625990|NCT00703781|594650254|FG001|Overall Study|Cancelled surgery|0|||
164625991|NCT02168816|594650255|FG000|Overall Study|Lost to Follow-up|2|||
164625992|NCT02168816|594650256|FG001|Overall Study|Lost to Follow-up|2|||
164625993|NCT01225211|594650257|FG000|Overall Study|Adverse Event|0|||
164625994|NCT01225211|594650258|FG001|Overall Study|Adverse Event|0|||
164625995|NCT01225211|594650259|FG002|Overall Study|Adverse Event|1|||
164625996|NCT01225211|594650260|FG003|Overall Study|Adverse Event|0|||
164625997|NCT01225211|594650261|FG004|Overall Study|Adverse Event|0|||
164625998|NCT01225211|594650262|FG005|Overall Study|Adverse Event|0|||
164625999|NCT01225211|594650263|FG006|Overall Study|Adverse Event|0|||
164626000|NCT01225211|594650264|FG007|Overall Study|Adverse Event|0|||
164626001|NCT01225211|594650265|FG008|Overall Study|Adverse Event|0|||
164626002|NCT01225211|594650266|FG009|Overall Study|Adverse Event|1|||
164626003|NCT01225211|594650257|FG000|Overall Study|Withdrawal by Subject|0|||
164626004|NCT01225211|594650258|FG001|Overall Study|Withdrawal by Subject|0|||
164626005|NCT01225211|594650259|FG002|Overall Study|Withdrawal by Subject|0|||
164626006|NCT01225211|594650260|FG003|Overall Study|Withdrawal by Subject|0|||
164626007|NCT01225211|594650261|FG004|Overall Study|Withdrawal by Subject|0|||
164626008|NCT01225211|594650262|FG005|Overall Study|Withdrawal by Subject|0|||
164626009|NCT01225211|594650263|FG006|Overall Study|Withdrawal by Subject|1|||
164626010|NCT01225211|594650264|FG007|Overall Study|Withdrawal by Subject|0|||
164626011|NCT01225211|594650265|FG008|Overall Study|Withdrawal by Subject|1|||
164626012|NCT01225211|594650266|FG009|Overall Study|Withdrawal by Subject|3|||
164626013|NCT01225211|594650257|FG000|Overall Study|Other|0|||
164626014|NCT01225211|594650258|FG001|Overall Study|Other|0|||
164626015|NCT01225211|594650259|FG002|Overall Study|Other|0|||
164626016|NCT01225211|594650260|FG003|Overall Study|Other|0|||
164626017|NCT01225211|594650261|FG004|Overall Study|Other|0|||
164626018|NCT01225211|594650262|FG005|Overall Study|Other|0|||
164626019|NCT01225211|594650263|FG006|Overall Study|Other|0|||
164626020|NCT01225211|594650264|FG007|Overall Study|Other|0|||
164626021|NCT01225211|594650265|FG008|Overall Study|Other|0|||
164626022|NCT01225211|594650266|FG009|Overall Study|Other|1|||
164626023|NCT01984294|594650271|FG000|Overall Study|Randomized but Never Treated|0|||
164626024|NCT01984294|594650272|FG001|Overall Study|Randomized but Never Treated|0|||
164626025|NCT01984294|594650273|FG002|Overall Study|Randomized but Never Treated|1|||
164626026|NCT01984294|594650271|FG000|Overall Study|Lack of Efficacy|4|||
164626027|NCT01984294|594650272|FG001|Overall Study|Lack of Efficacy|2|||
164626028|NCT01984294|594650273|FG002|Overall Study|Lack of Efficacy|6|||
164626029|NCT01984294|594650271|FG000|Overall Study|Adverse Event|0|||
164626030|NCT01984294|594650272|FG001|Overall Study|Adverse Event|1|||
164626031|NCT01984294|594650273|FG002|Overall Study|Adverse Event|0|||
164626032|NCT02709889|594650278|FG000|Overall Study|Withdrawal by Subject|11|||
164626033|NCT02709889|594650279|FG001|Overall Study|Withdrawal by Subject|10|||
164626034|NCT02709889|594650280|FG002|Overall Study|Withdrawal by Subject|2|||
164626035|NCT02709889|594650281|FG003|Overall Study|Withdrawal by Subject|12|||
164626036|NCT02709889|594650278|FG000|Overall Study|Death|25|||
164626037|NCT02709889|594650279|FG001|Overall Study|Death|38|||
164626038|NCT02709889|594650280|FG002|Overall Study|Death|4|||
164626039|NCT02709889|594650281|FG003|Overall Study|Death|44|||
164626040|NCT02709889|594650278|FG000|Overall Study|Physician Decision|1|||
164626041|NCT02709889|594650279|FG001|Overall Study|Physician Decision|2|||
164626042|NCT02709889|594650280|FG002|Overall Study|Physician Decision|3|||
164626043|NCT02709889|594650281|FG003|Overall Study|Physician Decision|5|||
164626044|NCT02709889|594650278|FG000|Overall Study|Lost to Follow-up|2|||
164626045|NCT02709889|594650279|FG001|Overall Study|Lost to Follow-up|0|||
164626046|NCT02709889|594650280|FG002|Overall Study|Lost to Follow-up|0|||
164626047|NCT02709889|594650281|FG003|Overall Study|Lost to Follow-up|4|||
164626048|NCT02709889|594650278|FG000|Overall Study|Study Terminated by Sponsor|4|||
164626049|NCT02709889|594650279|FG001|Overall Study|Study Terminated by Sponsor|6|||
164626050|NCT02709889|594650280|FG002|Overall Study|Study Terminated by Sponsor|2|||
164626051|NCT02709889|594650281|FG003|Overall Study|Study Terminated by Sponsor|17|||
164626052|NCT02709889|594650278|FG000|Overall Study|Other, Not Specified|0|||
164626053|NCT02709889|594650279|FG001|Overall Study|Other, Not Specified|1|||
164626054|NCT02709889|594650280|FG002|Overall Study|Other, Not Specified|1|||
164626055|NCT02709889|594650281|FG003|Overall Study|Other, Not Specified|6|||
164626056|NCT00537810|594650282|FG000|Overall Study|Withdrawal by Subject|4|||
164626057|NCT00537810|594650283|FG001|Overall Study|Withdrawal by Subject|11|||
164626058|NCT00537810|594650284|FG002|Overall Study|Withdrawal by Subject|4|||
164626059|NCT00537810|594650285|FG003|Overall Study|Withdrawal by Subject|3|||
164626060|NCT00537810|594650282|FG000|Overall Study|Medically withdrawn|2|||
164626061|NCT00537810|594650283|FG001|Overall Study|Medically withdrawn|2|||
164626062|NCT00537810|594650284|FG002|Overall Study|Medically withdrawn|0|||
164626063|NCT00537810|594650285|FG003|Overall Study|Medically withdrawn|1|||
164626064|NCT00410514|594650286|FG000|Overall Study|Adverse Event|2|||
164626065|NCT00410514|594650287|FG001|Overall Study|Adverse Event|2|||
164626066|NCT00410514|594650288|FG002|Overall Study|Adverse Event|2|||
164626067|NCT00410514|594650286|FG000|Overall Study|Protocol Violation|0|||
164626068|NCT00410514|594650287|FG001|Overall Study|Protocol Violation|1|||
164626069|NCT00410514|594650288|FG002|Overall Study|Protocol Violation|1|||
164626070|NCT00410514|594650286|FG000|Overall Study|Lost to Follow-up|0|||
164626071|NCT00410514|594650287|FG001|Overall Study|Lost to Follow-up|0|||
164626072|NCT00410514|594650288|FG002|Overall Study|Lost to Follow-up|2|||
164626073|NCT00410514|594650286|FG000|Overall Study|Non-compliant with study procedures|0|||
164626074|NCT00410514|594650287|FG001|Overall Study|Non-compliant with study procedures|0|||
164626075|NCT00410514|594650288|FG002|Overall Study|Non-compliant with study procedures|2|||
164626076|NCT02449915|594650290|FG000|Overall Study|Exclusion criteria - drug use|1|||
164626077|NCT02449915|594650291|FG001|Overall Study|Exclusion criteria - drug use|0|||
164626078|NCT02449915|594650290|FG000|Overall Study|Withdrawal by Subject|0|||
164626079|NCT02449915|594650291|FG001|Overall Study|Withdrawal by Subject|2|||
164626080|NCT02449915|594650290|FG000|Overall Study|Intraoperative surgical findings|1|||
164626081|NCT02449915|594650291|FG001|Overall Study|Intraoperative surgical findings|1|||
164626082|NCT02449915|594650290|FG000|Overall Study|Abnormal preop lab|0|||
164626083|NCT02449915|594650291|FG001|Overall Study|Abnormal preop lab|1|||
164626084|NCT01436357|594650292|FG000|Overall Study|Death|5|||
164626085|NCT01436357|594650293|FG001|Overall Study|Death|1|||
164626086|NCT01436357|594650292|FG000|Overall Study|Enrolled but not vaccinated|1|||
164626087|NCT01436357|594650293|FG001|Overall Study|Enrolled but not vaccinated|1|||
164626088|NCT01436357|594650292|FG000|Overall Study|Incarceration|18|||
164626089|NCT01436357|594650293|FG001|Overall Study|Incarceration|20|||
164626090|NCT01436357|594650292|FG000|Overall Study|Lost to Follow-up|67|||
164626091|NCT01436357|594650293|FG001|Overall Study|Lost to Follow-up|61|||
164626092|NCT01436357|594650292|FG000|Overall Study|Protocol Violation|1|||
164626093|NCT01436357|594650293|FG001|Overall Study|Protocol Violation|0|||
164626094|NCT01436357|594650292|FG000|Overall Study|Withdrawal by Subject|26|||
164626095|NCT01436357|594650293|FG001|Overall Study|Withdrawal by Subject|38|||
164626096|NCT01436357|594650292|FG000|Overall Study|Physician Decision|3|||
164626097|NCT01436357|594650293|FG001|Overall Study|Physician Decision|4|||
164626098|NCT01436357|594650292|FG000|Overall Study|Moved out of area|1|||
164626099|NCT01436357|594650293|FG001|Overall Study|Moved out of area|2|||
164626100|NCT01436357|594650292|FG000|Overall Study|Subject in rehab|0|||
164626101|NCT01436357|594650293|FG001|Overall Study|Subject in rehab|1|||
164626102|NCT01021293|594650298|FG000|Overall Study|Serious Adverse Event|2|||
164626103|NCT01021293|594650299|FG001|Overall Study|Serious Adverse Event|1|||
164626104|NCT01021293|594650298|FG000|Overall Study|Adverse Event|2|||
164626105|NCT01021293|594650299|FG001|Overall Study|Adverse Event|1|||
164626106|NCT01021293|594650298|FG000|Overall Study|Withdrawal by Subject|1|||
164626107|NCT01021293|594650299|FG001|Overall Study|Withdrawal by Subject|3|||
164626108|NCT01021293|594650298|FG000|Overall Study|Migrated/moved from study area|6|||
164626109|NCT01021293|594650299|FG001|Overall Study|Migrated/moved from study area|18|||
164626110|NCT01021293|594650298|FG000|Overall Study|Lost to Follow-up|1|||
164626111|NCT01021293|594650299|FG001|Overall Study|Lost to Follow-up|1|||
164626112|NCT02683668|594650302|FG000|Period 2|Withdrawal by Subject|0|||
164626113|NCT02683668|594650303|FG001|Period 2|Withdrawal by Subject|1|||
164626114|NCT02683668|594650304|FG002|Period 2|Withdrawal by Subject|0|||
164626115|NCT04223778|594650305|FG000|Overall Study|Death|1|||
164626116|NCT04223778|594650306|FG001|Overall Study|Death|1|||
164626117|NCT04223778|594650305|FG000|Overall Study|Lost to Follow-up|4|||
164626118|NCT04223778|594650306|FG001|Overall Study|Lost to Follow-up|5|||
164626119|NCT04223778|594650305|FG000|Overall Study|Physician Decision|10|||
164626120|NCT04223778|594650306|FG001|Overall Study|Physician Decision|6|||
164626121|NCT04223778|594650305|FG000|Overall Study|Withdrawal by Subject|35|||
164626122|NCT04223778|594650306|FG001|Overall Study|Withdrawal by Subject|17|||
164626123|NCT04223778|594650305|FG000|Overall Study|Not Reported|7|||
164626124|NCT04223778|594650306|FG001|Overall Study|Not Reported|8|||
164626125|NCT03893630|594650309|FG000|Overall Study|Lost to Follow-up|5|||
164626126|NCT03893630|594650310|FG001|Overall Study|Lost to Follow-up|4|||
164626127|NCT03893630|594650311|FG002|Overall Study|Lost to Follow-up|2|||
164626128|NCT03893630|594650309|FG000|Overall Study|Withdrawal by Subject|3|||
164626129|NCT03893630|594650310|FG001|Overall Study|Withdrawal by Subject|6|||
164626130|NCT03893630|594650311|FG002|Overall Study|Withdrawal by Subject|3|||
164626131|NCT03893630|594650309|FG000|Overall Study|Discontinued Intervention|0|||
164626132|NCT03893630|594650310|FG001|Overall Study|Discontinued Intervention|4|||
164626133|NCT03893630|594650311|FG002|Overall Study|Discontinued Intervention|2|||
164626134|NCT04335929|594652266|FG000|Overall Study|Lost to Follow-up|10|||
164626135|NCT00303602|594652268|FG000|Overall Study|Adverse Event|2|||
164626136|NCT00303602|594652269|FG001|Overall Study|Adverse Event|2|||
164626137|NCT00303602|594652268|FG000|Overall Study|Withdrawal by Subject|5|||
164626138|NCT00303602|594652269|FG001|Overall Study|Withdrawal by Subject|6|||
164626139|NCT00303602|594652268|FG000|Overall Study|Lost to Follow-up|5|||
164626140|NCT00303602|594652269|FG001|Overall Study|Lost to Follow-up|2|||
164626141|NCT00303602|594652268|FG000|Overall Study|Protocol entry criteria not met|2|||
164626142|NCT00303602|594652269|FG001|Overall Study|Protocol entry criteria not met|2|||
164626143|NCT00303602|594652268|FG000|Overall Study|Physician Decision|2|||
164626144|NCT00303602|594652269|FG001|Overall Study|Physician Decision|1|||
164626145|NCT00303602|594652268|FG000|Overall Study|Noncompliance|2|||
164626146|NCT00303602|594652269|FG001|Overall Study|Noncompliance|2|||
164626147|NCT00303602|594652268|FG000|Overall Study|Protocol Violation|1|||
164626148|NCT00303602|594652269|FG001|Overall Study|Protocol Violation|0|||
164626149|NCT02491463|594652270|FG000|Overall Study|Withdrawal by Subject|1|||
164626150|NCT02491463|594652271|FG001|Overall Study|Withdrawal by Subject|2|||
164626151|NCT02491463|594652272|FG002|Overall Study|Withdrawal by Subject|0|||
164626152|NCT02491463|594652273|FG003|Overall Study|Withdrawal by Subject|0|||
164626153|NCT02491463|594652270|FG000|Overall Study|Migrated/moved from study area|1|||
164626154|NCT02491463|594652271|FG001|Overall Study|Migrated/moved from study area|5|||
164626155|NCT02491463|594652272|FG002|Overall Study|Migrated/moved from study area|1|||
164626156|NCT02491463|594652273|FG003|Overall Study|Migrated/moved from study area|1|||
164626157|NCT02491463|594652270|FG000|Overall Study|Lost to Follow-up|0|||
164626158|NCT02491463|594652271|FG001|Overall Study|Lost to Follow-up|3|||
164626159|NCT02491463|594652272|FG002|Overall Study|Lost to Follow-up|3|||
164626160|NCT02491463|594652273|FG003|Overall Study|Lost to Follow-up|0|||
164626161|NCT01491802|594652274|FG000|Overall Study|Adverse Event|1|||
164626162|NCT01491802|594652275|FG001|Overall Study|Adverse Event|1|||
164626163|NCT01491802|594652274|FG000|Overall Study|Withdrawal by Subject|0|||
164626164|NCT01491802|594652275|FG001|Overall Study|Withdrawal by Subject|1|||
164626165|NCT01864746|594652278|FG000|Overall Study|Disease recurrence|25|||
164626166|NCT01864746|594652279|FG001|Overall Study|Disease recurrence|40|||
164626167|NCT01864746|594652278|FG000|Overall Study|Second primary invasive nonbreast|2|||
164626168|NCT01864746|594652279|FG001|Overall Study|Second primary invasive nonbreast|3|||
164626169|NCT01864746|594652278|FG000|Overall Study|Death|2|||
164626170|NCT01864746|594652279|FG001|Overall Study|Death|1|||
164626171|NCT01864746|594652278|FG000|Overall Study|Adverse Event|33|||
164626172|NCT01864746|594652279|FG001|Overall Study|Adverse Event|5|||
164626173|NCT01864746|594652278|FG000|Overall Study|Withdrawal by Subject|56|||
164626174|NCT01864746|594652279|FG001|Overall Study|Withdrawal by Subject|41|||
164626175|NCT01864746|594652278|FG000|Overall Study|Physician Decision|5|||
164626176|NCT01864746|594652279|FG001|Overall Study|Physician Decision|6|||
164626177|NCT01005966|594652280|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
164626178|NCT01005966|594652281|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
164626179|NCT01005966|594652282|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
164626180|NCT01005966|594652283|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
164626181|NCT01005966|594652284|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
164626182|NCT01005966|594652280|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
164626183|NCT01005966|594652281|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
164626184|NCT01005966|594652282|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
164626185|NCT01005966|594652283|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
164626186|NCT01005966|594652284|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
164626187|NCT01005966|594652280|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
164626188|NCT01005966|594652281|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
164626189|NCT01005966|594652282|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
164626190|NCT01005966|594652283|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
164626191|NCT01005966|594652284|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
164626192|NCT01005966|594652280|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
164626193|NCT01005966|594652281|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
164626194|NCT01005966|594652282|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
164626195|NCT01005966|594652283|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
164626196|NCT01005966|594652284|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
164626197|NCT01005966|594652280|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
164626198|NCT01005966|594652281|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
164626199|NCT01005966|594652282|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
164626200|NCT01005966|594652283|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
164626201|NCT01005966|594652284|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
164626202|NCT01005966|594652280|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
164626203|NCT01005966|594652281|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
164626204|NCT01005966|594652282|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
164626205|NCT01005966|594652283|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
164626206|NCT01005966|594652284|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
164626207|NCT01005966|594652280|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
164626208|NCT01005966|594652281|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
164626209|NCT01005966|594652282|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
164626210|NCT01005966|594652283|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
164626211|NCT01005966|594652284|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
164626212|NCT01005966|594652280|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
164626213|NCT01005966|594652281|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
164626214|NCT01005966|594652282|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
164626215|NCT01005966|594652283|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
164626216|NCT01005966|594652284|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
164626217|NCT01005966|594652280|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
164626218|NCT01005966|594652281|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
164626219|NCT01005966|594652282|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
164626220|NCT01005966|594652283|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
164626221|NCT01005966|594652284|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
164626222|NCT01347931|594652285|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
164626223|NCT02554721|594652286|FG000|Overall Study|Adverse Event|1|||
164626224|NCT02554721|594652287|FG001|Overall Study|Adverse Event|0|||
164626225|NCT02554721|594652288|FG002|Overall Study|Adverse Event|0|||
164626226|NCT02554721|594652289|FG003|Overall Study|Adverse Event|0|||
164626227|NCT02554721|594652290|FG004|Overall Study|Adverse Event|1|||
164626228|NCT02554721|594652286|FG000|Overall Study|Noncompliance|0|||
164626229|NCT02554721|594652287|FG001|Overall Study|Noncompliance|0|||
164626230|NCT02554721|594652288|FG002|Overall Study|Noncompliance|0|||
164626231|NCT02554721|594652289|FG003|Overall Study|Noncompliance|0|||
164626232|NCT02554721|594652290|FG004|Overall Study|Noncompliance|1|||
164626233|NCT00626327|594652292|FG000|Overall Study|Withdrawal by Subject|21|||
164626234|NCT00626327|594652293|FG001|Overall Study|Withdrawal by Subject|29|||
164626235|NCT00626327|594652294|FG002|Overall Study|Withdrawal by Subject|30|||
164626236|NCT00626327|594652292|FG000|Overall Study|Adverse Event|1|||
164626237|NCT00626327|594652293|FG001|Overall Study|Adverse Event|0|||
164626238|NCT00626327|594652294|FG002|Overall Study|Adverse Event|0|||
164626239|NCT00626327|594652292|FG000|Overall Study|Lost to Follow-up|24|||
164626240|NCT00626327|594652293|FG001|Overall Study|Lost to Follow-up|21|||
164626241|NCT00626327|594652294|FG002|Overall Study|Lost to Follow-up|23|||
164626242|NCT00626327|594652292|FG000|Overall Study|Inappropriate enrollment|4|||
164626243|NCT00626327|594652293|FG001|Overall Study|Inappropriate enrollment|5|||
164626244|NCT00626327|594652294|FG002|Overall Study|Inappropriate enrollment|3|||
164626245|NCT00626327|594652292|FG000|Overall Study|Administrative Reason|2|||
164626246|NCT00626327|594652293|FG001|Overall Study|Administrative Reason|0|||
164626247|NCT00626327|594652294|FG002|Overall Study|Administrative Reason|6|||
164626248|NCT00626327|594652292|FG000|Overall Study|Protocol Violation|26|||
164626249|NCT00626327|594652293|FG001|Overall Study|Protocol Violation|4|||
164626250|NCT00626327|594652294|FG002|Overall Study|Protocol Violation|26|||
164626251|NCT03347279|594652297|FG000|Overall Study|Withdrawal by Subject|8|||
164626252|NCT03347279|594652298|FG001|Overall Study|Withdrawal by Subject|15|||
164626253|NCT03347279|594652297|FG000|Overall Study|Death|0|||
164626254|NCT03347279|594652298|FG001|Overall Study|Death|2|||
164626255|NCT03347279|594652297|FG000|Overall Study|Lost to Follow-up|5|||
164626256|NCT03347279|594652298|FG001|Overall Study|Lost to Follow-up|2|||
164626257|NCT03347279|594652297|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
164626258|NCT03347279|594652298|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
164626259|NCT04880642|594652299|FG000|Randomization|Withdrawal by Subject|2|||
164626260|NCT04880642|594652300|FG001|Randomization|Withdrawal by Subject|3|||
164626261|NCT04880642|594652299|FG000|Treatment Period|Adverse Event|0|||
164626262|NCT04880642|594652300|FG001|Treatment Period|Adverse Event|1|||
164626263|NCT04880642|594652299|FG000|Treatment Period|Death|6|||
164626264|NCT04880642|594652300|FG001|Treatment Period|Death|6|||
164626265|NCT04880642|594652299|FG000|Treatment Period|Lost to Follow-up|1|||
164626266|NCT04880642|594652300|FG001|Treatment Period|Lost to Follow-up|0|||
164626267|NCT04880642|594652299|FG000|Treatment Period|Protocol Violation|0|||
164626268|NCT04880642|594652300|FG001|Treatment Period|Protocol Violation|1|||
164626269|NCT04880642|594652299|FG000|Treatment Period|Withdrawal by Subject|5|||
164626270|NCT04880642|594652300|FG001|Treatment Period|Withdrawal by Subject|3|||
164626271|NCT04880642|594652299|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
164626272|NCT04880642|594652300|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
164626273|NCT04880642|594652299|FG000|Follow-up|Death|4|||
164626274|NCT04880642|594652300|FG001|Follow-up|Death|3|||
164626275|NCT04880642|594652299|FG000|Follow-up|Withdrawal by Subject|1|||
164626276|NCT04880642|594652300|FG001|Follow-up|Withdrawal by Subject|0|||
164626277|NCT00141297|594652301|FG000|Overall Study|Adverse Event|0|||
164626278|NCT00141297|594652302|FG001|Overall Study|Adverse Event|0|||
164626279|NCT00141297|594652303|FG002|Overall Study|Adverse Event|1|||
164626280|NCT00141297|594652304|FG003|Overall Study|Adverse Event|0|||
164626281|NCT00141297|594652305|FG004|Overall Study|Adverse Event|1|||
164626282|NCT00141297|594652306|FG005|Overall Study|Adverse Event|1|||
164626283|NCT00141297|594652307|FG006|Overall Study|Adverse Event|0|||
164626284|NCT00141297|594652308|FG007|Overall Study|Adverse Event|1|||
164626285|NCT00141297|594652309|FG008|Overall Study|Adverse Event|1|||
164626286|NCT00141297|594652310|FG009|Overall Study|Adverse Event|0|||
164626287|NCT00141297|594652301|FG000|Overall Study|Death|1|||
164626288|NCT00141297|594652302|FG001|Overall Study|Death|0|||
164626289|NCT00141297|594652303|FG002|Overall Study|Death|0|||
164626290|NCT00141297|594652304|FG003|Overall Study|Death|0|||
164626291|NCT00141297|594652305|FG004|Overall Study|Death|0|||
164626292|NCT00141297|594652306|FG005|Overall Study|Death|0|||
164626293|NCT00141297|594652307|FG006|Overall Study|Death|0|||
164626294|NCT00141297|594652308|FG007|Overall Study|Death|0|||
164626295|NCT00141297|594652309|FG008|Overall Study|Death|1|||
164626296|NCT00141297|594652310|FG009|Overall Study|Death|0|||
164626297|NCT00141297|594652301|FG000|Overall Study|Withdrawal by Subject|0|||
164626298|NCT00141297|594652302|FG001|Overall Study|Withdrawal by Subject|0|||
164626299|NCT00141297|594652303|FG002|Overall Study|Withdrawal by Subject|0|||
164626300|NCT00141297|594652304|FG003|Overall Study|Withdrawal by Subject|0|||
164626301|NCT00141297|594652305|FG004|Overall Study|Withdrawal by Subject|0|||
164626302|NCT00141297|594652306|FG005|Overall Study|Withdrawal by Subject|0|||
164626303|NCT00141297|594652307|FG006|Overall Study|Withdrawal by Subject|0|||
164626304|NCT00141297|594652308|FG007|Overall Study|Withdrawal by Subject|0|||
164626305|NCT00141297|594652309|FG008|Overall Study|Withdrawal by Subject|1|||
164626306|NCT00141297|594652310|FG009|Overall Study|Withdrawal by Subject|0|||
164626307|NCT00141297|594652301|FG000|Overall Study|Other|0|||
164626308|NCT00141297|594652302|FG001|Overall Study|Other|0|||
164626309|NCT00141297|594652303|FG002|Overall Study|Other|0|||
164626310|NCT00141297|594652304|FG003|Overall Study|Other|1|||
164626311|NCT00141297|594652305|FG004|Overall Study|Other|5|||
164626312|NCT00141297|594652306|FG005|Overall Study|Other|0|||
164626313|NCT00141297|594652307|FG006|Overall Study|Other|0|||
164626314|NCT00141297|594652308|FG007|Overall Study|Other|0|||
164626315|NCT00141297|594652309|FG008|Overall Study|Other|2|||
164626316|NCT00141297|594652310|FG009|Overall Study|Other|0|||
164626317|NCT00141297|594652301|FG000|Overall Study|Progressive Disease|2|||
164626318|NCT00141297|594652302|FG001|Overall Study|Progressive Disease|3|||
164626319|NCT00141297|594652303|FG002|Overall Study|Progressive Disease|6|||
164626320|NCT00141297|594652304|FG003|Overall Study|Progressive Disease|2|||
164626321|NCT00141297|594652305|FG004|Overall Study|Progressive Disease|15|||
164626322|NCT00141297|594652306|FG005|Overall Study|Progressive Disease|2|||
164626323|NCT00141297|594652307|FG006|Overall Study|Progressive Disease|3|||
164626324|NCT00141297|594652308|FG007|Overall Study|Progressive Disease|3|||
164626325|NCT00141297|594652309|FG008|Overall Study|Progressive Disease|15|||
164626326|NCT00141297|594652310|FG009|Overall Study|Progressive Disease|6|||
164626327|NCT00141297|594652301|FG000|Overall Study|Transitioned|0|||
164626328|NCT00141297|594652302|FG001|Overall Study|Transitioned|0|||
164626329|NCT00141297|594652303|FG002|Overall Study|Transitioned|0|||
164626330|NCT00141297|594652304|FG003|Overall Study|Transitioned|0|||
164626331|NCT00141297|594652305|FG004|Overall Study|Transitioned|1|||
164626332|NCT00141297|594652306|FG005|Overall Study|Transitioned|0|||
164626333|NCT00141297|594652307|FG006|Overall Study|Transitioned|0|||
164626334|NCT00141297|594652308|FG007|Overall Study|Transitioned|0|||
164626335|NCT00141297|594652309|FG008|Overall Study|Transitioned|0|||
164626336|NCT00141297|594652310|FG009|Overall Study|Transitioned|0|||
164626337|NCT03228836|594652311|FG000|Overall Study|Adverse Event|3|||
164626338|NCT03228836|594652311|FG000|Overall Study|Withdrawal by Subject|1|||
164626339|NCT03228836|594652311|FG000|Overall Study|Death|1|||
164626340|NCT03228836|594652311|FG000|Overall Study|Physician Decision|1|||
164626341|NCT03228836|594652311|FG000|Overall Study|Disease Progression|7|||
164626342|NCT03228836|594652311|FG000|Overall Study|Other|4|||
164626343|NCT00948389|594652312|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
164626344|NCT00948389|594652313|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
164147701|NCT02006732|592902131|FG002|Overall Study|Lack of Efficacy|1|||
164626345|NCT00948389|594652314|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
164626346|NCT00948389|594652315|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
164626347|NCT00948389|594652316|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
164626348|NCT00948389|594652312|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
164626349|NCT00948389|594652313|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
164626350|NCT00948389|594652314|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
164626351|NCT00948389|594652315|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
164626352|NCT00948389|594652316|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
164626353|NCT00948389|594652312|FG000|Overall Study|Both Progression and Toxicity|1|||
164626354|NCT00948389|594652313|FG001|Overall Study|Both Progression and Toxicity|0|||
164626355|NCT00948389|594652314|FG002|Overall Study|Both Progression and Toxicity|0|||
164626356|NCT00948389|594652315|FG003|Overall Study|Both Progression and Toxicity|0|||
164626357|NCT00948389|594652316|FG004|Overall Study|Both Progression and Toxicity|0|||
164626358|NCT00750867|594652337|FG000|Overall Study|Adverse Event|2|||
164626359|NCT00394654|594652338|FG000|Overall Study|Lost to Follow-up|1|||
164626360|NCT00394654|594652339|FG001|Overall Study|Lost to Follow-up|0|||
164626361|NCT00394654|594652338|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
164626362|NCT00394654|594652339|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
164626363|NCT03442595|594652340|FG000|Overall Study|Lost to Follow-up|94|||
164626364|NCT03442595|594652341|FG001|Overall Study|Lost to Follow-up|0|||
164626365|NCT01060150|594652344|FG000|Overall Study|Adverse Event|6|||
164626366|NCT01060150|594652344|FG000|Overall Study|Lost to Follow-up|1|||
164626367|NCT01060150|594652344|FG000|Overall Study|Protocol Violation|6|||
164626368|NCT01060150|594652344|FG000|Overall Study|Withdrawal by Subject|8|||
164626369|NCT01060150|594652344|FG000|Overall Study|Enrolled, but not treated|2|||
164626370|NCT03018340|594652345|FG000|Overall Study|Adverse Event|1|||
164626371|NCT03018340|594652346|FG001|Overall Study|Adverse Event|2|||
164626372|NCT03018340|594652345|FG000|Overall Study|Withdrawal by Subject|0|||
164626373|NCT03018340|594652346|FG001|Overall Study|Withdrawal by Subject|8|||
164626374|NCT03018340|594652345|FG000|Overall Study|Lack of Efficacy|0|||
164626375|NCT03018340|594652346|FG001|Overall Study|Lack of Efficacy|1|||
164626376|NCT03018340|594652345|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
164626377|NCT03018340|594652346|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
164626378|NCT03018340|594652345|FG000|Overall Study|Lost to Follow-up|1|||
164626379|NCT03018340|594652346|FG001|Overall Study|Lost to Follow-up|7|||
164626380|NCT03018340|594652345|FG000|Overall Study|Protocol Violation|3|||
164626381|NCT03018340|594652346|FG001|Overall Study|Protocol Violation|7|||
164626382|NCT03018340|594652345|FG000|Overall Study|Not further specified|0|||
164626383|NCT03018340|594652346|FG001|Overall Study|Not further specified|1|||
164626384|NCT01836549|594652347|FG000|Overall Study|Did not receive study drug|0|||
164626385|NCT01836549|594652348|FG001|Overall Study|Did not receive study drug|0|||
164626386|NCT01836549|594652349|FG002|Overall Study|Did not receive study drug|1|||
164626387|NCT01836549|594652350|FG003|Overall Study|Did not receive study drug|0|||
164626388|NCT01836549|594652351|FG004|Overall Study|Did not receive study drug|0|||
164626389|NCT01836549|594652352|FG005|Overall Study|Did not receive study drug|0|||
164626390|NCT01836549|594652353|FG006|Overall Study|Did not receive study drug|0|||
164626391|NCT01836549|594652347|FG000|Overall Study|Patient declared ineligible|0|||
164626392|NCT01836549|594652348|FG001|Overall Study|Patient declared ineligible|0|||
164626393|NCT01836549|594652349|FG002|Overall Study|Patient declared ineligible|0|||
164626394|NCT01836549|594652350|FG003|Overall Study|Patient declared ineligible|1|||
164626395|NCT01836549|594652351|FG004|Overall Study|Patient declared ineligible|0|||
164626396|NCT01836549|594652352|FG005|Overall Study|Patient declared ineligible|0|||
164626397|NCT01836549|594652353|FG006|Overall Study|Patient declared ineligible|0|||
164626398|NCT01836549|594652347|FG000|Overall Study|Patient inevaluable to start therapy|0|||
164626399|NCT01836549|594652348|FG001|Overall Study|Patient inevaluable to start therapy|0|||
164626400|NCT01836549|594652349|FG002|Overall Study|Patient inevaluable to start therapy|0|||
164626401|NCT01836549|594652350|FG003|Overall Study|Patient inevaluable to start therapy|0|||
164626402|NCT01836549|594652351|FG004|Overall Study|Patient inevaluable to start therapy|0|||
164626403|NCT01836549|594652352|FG005|Overall Study|Patient inevaluable to start therapy|0|||
164626404|NCT01836549|594652353|FG006|Overall Study|Patient inevaluable to start therapy|1|||
164626405|NCT02192190|594652356|FG000|Overall Study|Adverse Event|1|||
164626406|NCT02192190|594652357|FG001|Overall Study|Adverse Event|1|||
164626407|NCT02192190|594652358|FG002|Overall Study|Adverse Event|0|||
164626408|NCT02192190|594652359|FG003|Overall Study|Adverse Event|0|||
164626409|NCT02192190|594652360|FG004|Overall Study|Adverse Event|0|||
164626410|NCT02192190|594652361|FG005|Overall Study|Adverse Event|0|||
164626411|NCT02192190|594652356|FG000|Overall Study|Lost to Follow-up|3|||
164626412|NCT02192190|594652357|FG001|Overall Study|Lost to Follow-up|3|||
164626413|NCT02192190|594652358|FG002|Overall Study|Lost to Follow-up|2|||
164626414|NCT02192190|594652359|FG003|Overall Study|Lost to Follow-up|1|||
164626415|NCT02192190|594652360|FG004|Overall Study|Lost to Follow-up|4|||
164626416|NCT02192190|594652361|FG005|Overall Study|Lost to Follow-up|3|||
164626417|NCT02192190|594652356|FG000|Overall Study|Physician Decision|2|||
164626418|NCT02192190|594652357|FG001|Overall Study|Physician Decision|0|||
164626419|NCT02192190|594652358|FG002|Overall Study|Physician Decision|0|||
164626420|NCT02192190|594652359|FG003|Overall Study|Physician Decision|0|||
164626421|NCT02192190|594652360|FG004|Overall Study|Physician Decision|0|||
164626422|NCT02192190|594652361|FG005|Overall Study|Physician Decision|0|||
164626423|NCT02192190|594652356|FG000|Overall Study|Terminated by Sponsor|43|||
164626424|NCT02192190|594652357|FG001|Overall Study|Terminated by Sponsor|23|||
164626425|NCT02192190|594652358|FG002|Overall Study|Terminated by Sponsor|20|||
164626426|NCT02192190|594652359|FG003|Overall Study|Terminated by Sponsor|23|||
164626427|NCT02192190|594652360|FG004|Overall Study|Terminated by Sponsor|21|||
164626428|NCT02192190|594652361|FG005|Overall Study|Terminated by Sponsor|23|||
164626429|NCT02192190|594652356|FG000|Overall Study|Withdrawal by Subject|4|||
164626430|NCT02192190|594652357|FG001|Overall Study|Withdrawal by Subject|1|||
164626431|NCT02192190|594652358|FG002|Overall Study|Withdrawal by Subject|2|||
164626432|NCT02192190|594652359|FG003|Overall Study|Withdrawal by Subject|1|||
164626433|NCT02192190|594652360|FG004|Overall Study|Withdrawal by Subject|5|||
164626434|NCT02192190|594652361|FG005|Overall Study|Withdrawal by Subject|3|||
164626435|NCT02192190|594652356|FG000|Overall Study|Could not Keep Visit Schedule|1|||
164626436|NCT02192190|594652357|FG001|Overall Study|Could not Keep Visit Schedule|0|||
164626437|NCT02192190|594652358|FG002|Overall Study|Could not Keep Visit Schedule|0|||
164626438|NCT02192190|594652359|FG003|Overall Study|Could not Keep Visit Schedule|0|||
164626439|NCT02192190|594652360|FG004|Overall Study|Could not Keep Visit Schedule|0|||
164626440|NCT02192190|594652361|FG005|Overall Study|Could not Keep Visit Schedule|0|||
164626441|NCT02192190|594652356|FG000|Overall Study|Positive Drug Screen|0|||
164626442|NCT02192190|594652357|FG001|Overall Study|Positive Drug Screen|0|||
164626443|NCT02192190|594652358|FG002|Overall Study|Positive Drug Screen|0|||
164626444|NCT02192190|594652359|FG003|Overall Study|Positive Drug Screen|1|||
164626445|NCT02192190|594652360|FG004|Overall Study|Positive Drug Screen|0|||
164626446|NCT02192190|594652361|FG005|Overall Study|Positive Drug Screen|0|||
164626447|NCT02192190|594652356|FG000|Overall Study|Inadequate Pain Relief|0|||
164626448|NCT02192190|594652357|FG001|Overall Study|Inadequate Pain Relief|1|||
164626449|NCT02192190|594652358|FG002|Overall Study|Inadequate Pain Relief|1|||
164626450|NCT02192190|594652359|FG003|Overall Study|Inadequate Pain Relief|0|||
164626451|NCT02192190|594652360|FG004|Overall Study|Inadequate Pain Relief|0|||
164626452|NCT02192190|594652361|FG005|Overall Study|Inadequate Pain Relief|0|||
164626453|NCT00381706|594652362|FG000|Overall Study|Never treated|7|||
164626454|NCT00381706|594652363|FG001|Overall Study|Never treated|2|||
164626455|NCT00381706|594652364|FG002|Overall Study|Never treated|1|||
164626456|NCT02364999|594652365|FG000|Overall Study|Death|136|||
164626457|NCT02364999|594652366|FG001|Overall Study|Death|138|||
164626458|NCT02364999|594652365|FG000|Overall Study|Lost to Follow-up|10|||
164626459|NCT02364999|594652366|FG001|Overall Study|Lost to Follow-up|15|||
164626460|NCT02364999|594652365|FG000|Overall Study|Protocol Violation|3|||
164626461|NCT02364999|594652366|FG001|Overall Study|Protocol Violation|2|||
164626462|NCT02364999|594652365|FG000|Overall Study|Withdrawal by Subject|14|||
164626463|NCT02364999|594652366|FG001|Overall Study|Withdrawal by Subject|14|||
164626464|NCT02364999|594652365|FG000|Overall Study|Other|0|||
164626465|NCT02364999|594652366|FG001|Overall Study|Other|1|||
164626466|NCT02364999|594652365|FG000|Overall Study|Randomized but did not receive treatment|2|||
164626467|NCT02364999|594652366|FG001|Overall Study|Randomized but did not receive treatment|3|||
164626468|NCT00550615|594652367|FG000|Overall Study|Withdrawal by Subject|0|||
164626469|NCT00550615|594652368|FG001|Overall Study|Withdrawal by Subject|0|||
164626470|NCT00550615|594652369|FG002|Overall Study|Withdrawal by Subject|2|||
164626471|NCT00550615|594652370|FG003|Overall Study|Withdrawal by Subject|3|||
164626472|NCT00550615|594652367|FG000|Overall Study|Not evaluable|0|||
164626473|NCT00550615|594652368|FG001|Overall Study|Not evaluable|0|||
164626474|NCT00550615|594652369|FG002|Overall Study|Not evaluable|2|||
164626475|NCT00550615|594652370|FG003|Overall Study|Not evaluable|7|||
164626476|NCT01234337|594652371|FG000|Overall Study|Adverse Event|58|||
164626477|NCT01234337|594652372|FG001|Overall Study|Adverse Event|21|||
164626478|NCT01234337|594652371|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
164626479|NCT01234337|594652372|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
164626480|NCT01234337|594652371|FG000|Overall Study|Investi. decision not protocol driven|5|||
164626481|NCT01234337|594652372|FG001|Overall Study|Investi. decision not protocol driven|6|||
164626482|NCT01234337|594652371|FG000|Overall Study|Non-compliant with study medication|3|||
164626483|NCT01234337|594652372|FG001|Overall Study|Non-compliant with study medication|2|||
164626484|NCT01234337|594652371|FG000|Overall Study|Randomized but not treated|6|||
164626485|NCT01234337|594652372|FG001|Overall Study|Randomized but not treated|4|||
164626486|NCT01234337|594652371|FG000|Overall Study|Lost to Follow-up|0|||
164626487|NCT01234337|594652372|FG001|Overall Study|Lost to Follow-up|1|||
164626488|NCT01234337|594652371|FG000|Overall Study|Protocol Violation|2|||
164626489|NCT01234337|594652372|FG001|Overall Study|Protocol Violation|3|||
164626490|NCT01234337|594652371|FG000|Overall Study|Withdrawal by Subject|11|||
164626491|NCT01234337|594652372|FG001|Overall Study|Withdrawal by Subject|9|||
164626492|NCT01234337|594652371|FG000|Overall Study|Death|0|||
164626493|NCT01234337|594652372|FG001|Overall Study|Death|1|||
164626494|NCT01234337|594652371|FG000|Overall Study|Switch to commercial drug|0|||
164626495|NCT01234337|594652372|FG001|Overall Study|Switch to commercial drug|1|||
164626496|NCT02181504|594652375|FG000|Overall Study|Adverse Event|1|||
164626497|NCT02181504|594652376|FG001|Overall Study|Adverse Event|1|||
164626498|NCT02181504|594652377|FG002|Overall Study|Adverse Event|1|||
164626499|NCT02555722|594652378|FG000|Week 2|Adverse Event|0|||
164626500|NCT02555722|594652379|FG001|Week 2|Adverse Event|1|||
164626501|NCT02555722|594652378|FG000|Week 2|Withdrawal by Subject|1|||
164626502|NCT02555722|594652379|FG001|Week 2|Withdrawal by Subject|0|||
164626503|NCT02555722|594652378|FG000|Month 1|Lens Discomfort|1|||
164626504|NCT02555722|594652379|FG001|Month 1|Lens Discomfort|0|||
164626505|NCT02555722|594652378|FG000|Month 2|Withdrawal by Subject|3|||
164626506|NCT02555722|594652379|FG001|Month 2|Withdrawal by Subject|0|||
164626507|NCT02555722|594652378|FG000|Month 2|Lost to Follow-up|1|||
164626508|NCT02555722|594652379|FG001|Month 2|Lost to Follow-up|0|||
164626509|NCT02584660|594652389|FG000|Overall Study|Adverse Event|4|||
164626510|NCT02584660|594652390|FG001|Overall Study|Adverse Event|0|||
164626511|NCT02584660|594652389|FG000|Overall Study|Lost to Follow-up|3|||
164626512|NCT02584660|594652390|FG001|Overall Study|Lost to Follow-up|4|||
164626513|NCT02584660|594652389|FG000|Overall Study|Protocol Violation|0|||
164626514|NCT02584660|594652390|FG001|Overall Study|Protocol Violation|1|||
164626515|NCT02584660|594652389|FG000|Overall Study|Withdrawal by Subject|0|||
164626516|NCT02584660|594652390|FG001|Overall Study|Withdrawal by Subject|2|||
164626517|NCT02584660|594652389|FG000|Overall Study|Other|0|||
164626518|NCT02584660|594652390|FG001|Overall Study|Other|1|||
164626519|NCT00461552|594652391|FG000|Overall Study|Drug Dispensing error|0|||
164626520|NCT00461552|594652392|FG001|Overall Study|Drug Dispensing error|2|||
164626521|NCT00374452|594652393|FG000|Overall Study|Left clinic before intervention started|4|||
164626522|NCT00374452|594652394|FG001|Overall Study|Left clinic before intervention started|1|||
164626523|NCT00374452|594652393|FG000|Overall Study|Change in job role before intervention|0|||
164626524|NCT00374452|594652394|FG001|Overall Study|Change in job role before intervention|1|||
164626525|NCT00374452|594652393|FG000|Overall Study|Left clinic after intervention started|1|||
164626526|NCT00374452|594652394|FG001|Overall Study|Left clinic after intervention started|1|||
164626527|NCT00374452|594652393|FG000|Overall Study|Withdrawal by Subject|0|||
164626528|NCT00374452|594652394|FG001|Overall Study|Withdrawal by Subject|2|||
164626529|NCT02877134|594652395|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
164626530|NCT02877134|594652396|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
164626531|NCT02877134|594652397|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
164626532|NCT02877134|594652398|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
164626533|NCT02877134|594652399|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
164626534|NCT02877134|594652400|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
164626535|NCT02877134|594652401|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
164626536|NCT02877134|594652402|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
164626537|NCT02877134|594652403|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
164626538|NCT02877134|594652404|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
164626539|NCT02877134|594652405|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
164626540|NCT02877134|594652406|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
164626541|NCT02877134|594652395|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
164626542|NCT02877134|594652396|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
164626543|NCT02877134|594652397|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
164626544|NCT02877134|594652398|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
164626545|NCT02877134|594652399|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
164527755|NCT00552240|594303665|FG001|Overall Study|Lost to Follow-up|6|||
164527756|NCT00552240|594303664|FG000|Overall Study|Withdrawal by Subject|2|||
164527757|NCT00552240|594303665|FG001|Overall Study|Withdrawal by Subject|2|||
164527758|NCT00552240|594303664|FG000|Overall Study|Lack of Efficacy|6|||
164527759|NCT00552240|594303665|FG001|Overall Study|Lack of Efficacy|0|||
164527760|NCT00552240|594303664|FG000|Overall Study|Other|1|||
164527761|NCT00552240|594303665|FG001|Overall Study|Other|0|||
164527762|NCT02679573|594303666|FG000|Overall Study|Adverse Event|13|||
164527763|NCT02679573|594303667|FG001|Overall Study|Adverse Event|6|||
164527764|NCT02679573|594303666|FG000|Overall Study|Lack of Efficacy|12|||
164527765|NCT02679573|594303667|FG001|Overall Study|Lack of Efficacy|15|||
164527766|NCT02679573|594303666|FG000|Overall Study|Could not complete required study visits|6|||
164527767|NCT02679573|594303667|FG001|Overall Study|Could not complete required study visits|2|||
164527768|NCT02679573|594303666|FG000|Overall Study|Withdrawal by Subject|2|||
164527769|NCT02679573|594303667|FG001|Overall Study|Withdrawal by Subject|9|||
164527770|NCT02679573|594303666|FG000|Overall Study|Death|2|||
164527771|NCT02679573|594303667|FG001|Overall Study|Death|0|||
164527772|NCT02679573|594303666|FG000|Overall Study|Physician Decision|2|||
164527773|NCT02679573|594303667|FG001|Overall Study|Physician Decision|4|||
164527774|NCT02679573|594303666|FG000|Overall Study|Lost to Follow-up|0|||
164527775|NCT02679573|594303667|FG001|Overall Study|Lost to Follow-up|3|||
164527776|NCT02476279|594303668|FG000|Overall Study|Lost to Follow-up|1|||
164527777|NCT02476279|594303669|FG001|Overall Study|Lost to Follow-up|1|||
164527778|NCT02128542|594303670|FG000|Overall Study|Lost to Follow-up|3|||
164527779|NCT02128542|594303671|FG001|Overall Study|Lost to Follow-up|0|||
164527780|NCT02128542|594303670|FG000|Overall Study|Withdrew Consent|1|||
164527781|NCT02128542|594303671|FG001|Overall Study|Withdrew Consent|0|||
164527782|NCT01411215|594303675|FG000|Overall Study|Adverse Event|1|||
164527783|NCT01411215|594303676|FG001|Overall Study|Adverse Event|2|||
164527784|NCT01411215|594303675|FG000|Overall Study|Lack of Efficacy|2|||
164527785|NCT01411215|594303676|FG001|Overall Study|Lack of Efficacy|4|||
164527786|NCT01411215|594303675|FG000|Overall Study|Lost to Follow-up|12|||
164527787|NCT01411215|594303676|FG001|Overall Study|Lost to Follow-up|18|||
164527788|NCT01411215|594303675|FG000|Overall Study|Did not meet entrance criteria|0|||
164527789|NCT01411215|594303676|FG001|Overall Study|Did not meet entrance criteria|1|||
164527790|NCT01411215|594303675|FG000|Overall Study|Study terminated by sponsor|2|||
164527791|NCT01411215|594303676|FG001|Overall Study|Study terminated by sponsor|15|||
164527792|NCT01411215|594303675|FG000|Overall Study|Protocol Violation|3|||
164527793|NCT01411215|594303676|FG001|Overall Study|Protocol Violation|5|||
164527794|NCT01411215|594303675|FG000|Overall Study|Withdrawal by Subject|34|||
164527795|NCT01411215|594303676|FG001|Overall Study|Withdrawal by Subject|21|||
164527796|NCT01411215|594303675|FG000|Overall Study|Other|12|||
164527797|NCT01411215|594303676|FG001|Overall Study|Other|17|||
164527798|NCT01411215|594303675|FG000|Overall Study|Screen failure|0|||
164527799|NCT01411215|594303676|FG001|Overall Study|Screen failure|1|||
164527800|NCT03451162|594303681|FG000|Overall Study|Lost to Follow-up|1|||
164527801|NCT03451162|594303682|FG001|Overall Study|Lost to Follow-up|0|||
164527802|NCT03451162|594303683|FG002|Overall Study|Lost to Follow-up|0|||
164527803|NCT03451162|594303684|FG003|Overall Study|Lost to Follow-up|0|||
164527804|NCT03451162|594303685|FG004|Overall Study|Lost to Follow-up|0|||
164527805|NCT03451162|594303681|FG000|Overall Study|Physician Decision|0|||
164527806|NCT03451162|594303682|FG001|Overall Study|Physician Decision|1|||
164527807|NCT03451162|594303683|FG002|Overall Study|Physician Decision|0|||
164527808|NCT03451162|594303684|FG003|Overall Study|Physician Decision|0|||
164527809|NCT03451162|594303685|FG004|Overall Study|Physician Decision|0|||
164527810|NCT03451162|594303681|FG000|Overall Study|Withdrawal by Subject|1|||
164527811|NCT03451162|594303682|FG001|Overall Study|Withdrawal by Subject|1|||
164527812|NCT03451162|594303683|FG002|Overall Study|Withdrawal by Subject|0|||
164147702|NCT02006732|592902132|FG003|Overall Study|Lack of Efficacy|1|||
164527813|NCT03451162|594303684|FG003|Overall Study|Withdrawal by Subject|0|||
164527814|NCT03451162|594303685|FG004|Overall Study|Withdrawal by Subject|0|||
164527815|NCT03305731|594303686|FG000|Overall Study|Protocol Violation|1|||
164527816|NCT04634825|594303687|FG000|Overall Study|Death|10|||
164527817|NCT04634825|594303688|FG001|Overall Study|Death|3|||
164527818|NCT04634825|594303687|FG000|Overall Study|Lost to Follow-up|1|||
164527819|NCT04634825|594303688|FG001|Overall Study|Lost to Follow-up|0|||
164527820|NCT04634825|594303687|FG000|Overall Study|Study terminated by sponsor|35|||
164527821|NCT04634825|594303688|FG001|Overall Study|Study terminated by sponsor|11|||
164527822|NCT04634825|594303687|FG000|Overall Study|Withdrawal by Subject|2|||
164527823|NCT04634825|594303688|FG001|Overall Study|Withdrawal by Subject|0|||
164527824|NCT01952054|594303689|FG000|Overall Study|Physician Decision|1|||
164527825|NCT00402597|594303690|FG000|Overall Study|Death|15|||
164527826|NCT00402597|594303691|FG001|Overall Study|Death|7|||
164527827|NCT00402597|594303692|FG002|Overall Study|Death|6|||
164527828|NCT00402597|594303693|FG003|Overall Study|Death|4|||
164527829|NCT00402597|594303694|FG004|Overall Study|Death|6|||
164527830|NCT00402597|594303690|FG000|Overall Study|Adverse Event|81|||
164527831|NCT00402597|594303691|FG001|Overall Study|Adverse Event|18|||
164527832|NCT00402597|594303692|FG002|Overall Study|Adverse Event|106|||
164527833|NCT00402597|594303693|FG003|Overall Study|Adverse Event|39|||
164527834|NCT00402597|594303694|FG004|Overall Study|Adverse Event|71|||
164527835|NCT00402597|594303690|FG000|Overall Study|Lost to Follow-up|8|||
164527836|NCT00402597|594303691|FG001|Overall Study|Lost to Follow-up|1|||
164527837|NCT00402597|594303692|FG002|Overall Study|Lost to Follow-up|8|||
164527838|NCT00402597|594303693|FG003|Overall Study|Lost to Follow-up|2|||
164527839|NCT00402597|594303694|FG004|Overall Study|Lost to Follow-up|3|||
164527840|NCT00402597|594303690|FG000|Overall Study|Withdrawal by Subject|57|||
164527841|NCT00402597|594303691|FG001|Overall Study|Withdrawal by Subject|16|||
164527842|NCT00402597|594303692|FG002|Overall Study|Withdrawal by Subject|65|||
164527843|NCT00402597|594303693|FG003|Overall Study|Withdrawal by Subject|15|||
164527844|NCT00402597|594303694|FG004|Overall Study|Withdrawal by Subject|24|||
164527845|NCT00402597|594303690|FG000|Overall Study|reason not specified|30|||
164527846|NCT00402597|594303691|FG001|Overall Study|reason not specified|4|||
164527847|NCT00402597|594303692|FG002|Overall Study|reason not specified|27|||
164527848|NCT00402597|594303693|FG003|Overall Study|reason not specified|14|||
164527849|NCT00402597|594303694|FG004|Overall Study|reason not specified|20|||
164527850|NCT01831856|594303695|FG000|Overall Study|Adverse Event|5|||
164527851|NCT01831856|594303696|FG001|Overall Study|Adverse Event|8|||
164527852|NCT01831856|594303695|FG000|Overall Study|Lack of Efficacy|13|||
164527853|NCT01831856|594303696|FG001|Overall Study|Lack of Efficacy|11|||
164527854|NCT01831856|594303695|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
164527855|NCT01831856|594303696|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
164527856|NCT04964414|594303699|FG000|Overall Study|Lost to Follow-up|10|||
164527857|NCT04964414|594303700|FG001|Overall Study|Lost to Follow-up|8|||
164527858|NCT04964414|594303699|FG000|Overall Study|Withdrawal by Subject|1|||
164527859|NCT04964414|594303700|FG001|Overall Study|Withdrawal by Subject|1|||
164527860|NCT00232544|594303707|FG000|Overall Study|Lost to Follow-up|20|||
164626546|NCT02877134|594652400|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
164626547|NCT02877134|594652401|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
164626548|NCT02877134|594652402|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
164626549|NCT02877134|594652403|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
164626550|NCT02877134|594652404|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
164626551|NCT02877134|594652405|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
164626552|NCT02877134|594652406|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
164626553|NCT02877134|594652395|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
164626554|NCT02877134|594652396|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
164626555|NCT02877134|594652397|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
164626556|NCT02877134|594652398|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
164626557|NCT02877134|594652399|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
164626558|NCT02877134|594652400|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
164626559|NCT02877134|594652401|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
164626560|NCT02877134|594652402|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
164626561|NCT02877134|594652403|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
164626562|NCT02877134|594652404|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
164626563|NCT02877134|594652405|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
164626564|NCT02877134|594652406|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
164626565|NCT02877134|594652395|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
164626566|NCT02877134|594652396|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
164626567|NCT02877134|594652397|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
164626568|NCT02877134|594652398|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
164626569|NCT02877134|594652399|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
164626570|NCT02877134|594652400|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
164626571|NCT02877134|594652401|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
164626572|NCT02877134|594652402|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
164626573|NCT02877134|594652403|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
164626574|NCT02877134|594652404|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
164626575|NCT02877134|594652405|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
164626576|NCT02877134|594652406|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
164626577|NCT02877134|594652395|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
164626578|NCT02877134|594652396|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
164626579|NCT02877134|594652397|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
164626580|NCT02877134|594652398|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
164626581|NCT02877134|594652399|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
164626582|NCT02877134|594652400|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
164626583|NCT02877134|594652401|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
164527861|NCT00232544|594303708|FG001|Overall Study|Lost to Follow-up|15|||
164626584|NCT02877134|594652402|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
164626585|NCT02877134|594652403|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
164626586|NCT02877134|594652404|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
164626587|NCT02877134|594652405|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
164626588|NCT02877134|594652406|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
164626589|NCT02877134|594652395|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
164626590|NCT02877134|594652396|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
164626591|NCT02877134|594652397|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
164626592|NCT02877134|594652398|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
164626593|NCT02877134|594652399|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
164626594|NCT02877134|594652400|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
164626595|NCT02877134|594652401|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
164626596|NCT02877134|594652402|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
164626597|NCT02877134|594652403|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
164626598|NCT02877134|594652404|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
164626599|NCT02877134|594652405|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
164626600|NCT02877134|594652406|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
164626601|NCT02877134|594652395|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
164626602|NCT02877134|594652396|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
164626603|NCT02877134|594652397|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
164626604|NCT02877134|594652398|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
164626605|NCT02877134|594652399|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
164626606|NCT02877134|594652400|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
164626607|NCT02877134|594652401|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
164626608|NCT02877134|594652402|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
164626609|NCT02877134|594652403|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
164626610|NCT02877134|594652404|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
164626611|NCT02877134|594652405|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
164626612|NCT02877134|594652406|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
164626613|NCT02877134|594652395|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
164626614|NCT02877134|594652396|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
164626615|NCT02877134|594652397|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
164626616|NCT02877134|594652398|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
164626617|NCT02877134|594652399|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
164626618|NCT02877134|594652400|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
164626619|NCT02877134|594652401|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
164626620|NCT02877134|594652402|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
164626621|NCT02877134|594652403|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
164626622|NCT02877134|594652404|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
164626623|NCT02877134|594652405|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
164626624|NCT02877134|594652406|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
164527862|NCT02581631|594303709|FG000|Overall Study|Disease progression|29|||
164527863|NCT02581631|594303710|FG001|Overall Study|Disease progression|19|||
164527864|NCT02581631|594303711|FG002|Overall Study|Disease progression|13|||
164527865|NCT02581631|594303712|FG003|Overall Study|Disease progression|5|||
164527866|NCT02581631|594303713|FG004|Overall Study|Disease progression|8|||
164527867|NCT02581631|594303709|FG000|Overall Study|Study drug toxicity|4|||
164626625|NCT00523744|594652407|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
164626626|NCT00523744|594652407|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
164626627|NCT00523744|594652407|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
164626628|NCT00523744|594652407|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
164626629|NCT00523744|594652407|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
164626630|NCT00523744|594652407|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
164626631|NCT01289028|594652408|FG000|Overall Study|Progressive Disease|49|||
164626632|NCT01289028|594652408|FG000|Overall Study|Adverse Event|14|||
164626633|NCT01289028|594652408|FG000|Overall Study|Withdrawal by Subject|6|||
164626634|NCT01289028|594652408|FG000|Overall Study|Death|4|||
164626635|NCT01289028|594652408|FG000|Overall Study|Lack of Efficacy|2|||
164626636|NCT01289028|594652408|FG000|Overall Study|No longer required|2|||
164626637|NCT01289028|594652408|FG000|Overall Study|Lost to Follow-up|2|||
164626638|NCT01289028|594652408|FG000|Overall Study|New Cancer Therapy|2|||
164626639|NCT01289028|594652408|FG000|Overall Study|Abnormal Lab Value|1|||
164626640|NCT01289028|594652408|FG000|Overall Study|Missing reason for discon|1|||
164626641|NCT01040728|594652416|FG000|Overall Study|Adverse Event|4|||
164626642|NCT01040728|594652417|FG001|Overall Study|Adverse Event|8|||
164626643|NCT01040728|594652418|FG002|Overall Study|Adverse Event|0|||
164626644|NCT01040728|594652419|FG003|Overall Study|Adverse Event|4|||
164626645|NCT01040728|594652416|FG000|Overall Study|Withdrawal by Subject|0|||
164626646|NCT01040728|594652417|FG001|Overall Study|Withdrawal by Subject|1|||
164626647|NCT01040728|594652418|FG002|Overall Study|Withdrawal by Subject|1|||
164626648|NCT01040728|594652419|FG003|Overall Study|Withdrawal by Subject|0|||
164626649|NCT01040728|594652416|FG000|Overall Study|Protocol Violation|0|||
164626650|NCT01040728|594652417|FG001|Overall Study|Protocol Violation|0|||
164626651|NCT01040728|594652418|FG002|Overall Study|Protocol Violation|0|||
164626652|NCT01040728|594652419|FG003|Overall Study|Protocol Violation|1|||
164626653|NCT01040728|594652416|FG000|Overall Study|Lack of Efficacy|0|||
164626654|NCT01040728|594652417|FG001|Overall Study|Lack of Efficacy|1|||
164626655|NCT01040728|594652418|FG002|Overall Study|Lack of Efficacy|0|||
164626656|NCT01040728|594652419|FG003|Overall Study|Lack of Efficacy|1|||
164626657|NCT01040728|594652416|FG000|Overall Study|Other reasons not listed above|0|||
164626658|NCT01040728|594652417|FG001|Overall Study|Other reasons not listed above|1|||
164626659|NCT01040728|594652418|FG002|Overall Study|Other reasons not listed above|0|||
164626660|NCT01040728|594652419|FG003|Overall Study|Other reasons not listed above|0|||
164626661|NCT00542425|594652426|FG000|Initial 24 Weeks|Administrative reasons|0|||
164626662|NCT00542425|594652427|FG001|Initial 24 Weeks|Administrative reasons|0|||
164626663|NCT00542425|594652428|FG002|Initial 24 Weeks|Administrative reasons|1|||
164626664|NCT00542425|594652429|FG003|Initial 24 Weeks|Administrative reasons|1|||
164626665|NCT00542425|594652430|FG004|Initial 24 Weeks|Administrative reasons|0|||
164626666|NCT00542425|594652426|FG000|Initial 24 Weeks|Adverse Event|0|||
164626667|NCT00542425|594652427|FG001|Initial 24 Weeks|Adverse Event|1|||
164626668|NCT00542425|594652428|FG002|Initial 24 Weeks|Adverse Event|1|||
164626669|NCT00542425|594652429|FG003|Initial 24 Weeks|Adverse Event|3|||
164626670|NCT00542425|594652430|FG004|Initial 24 Weeks|Adverse Event|2|||
164626671|NCT00542425|594652426|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
164626672|NCT00542425|594652427|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
164626673|NCT00542425|594652428|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
164626674|NCT00542425|594652429|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
164626675|NCT00542425|594652430|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
164626676|NCT00542425|594652426|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
164626677|NCT00542425|594652427|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
164626678|NCT00542425|594652428|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
164626679|NCT00542425|594652429|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
164626680|NCT00542425|594652430|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
164626681|NCT00542425|594652426|FG000|Initial 24 Weeks|Non-compliance|0|||
164626682|NCT00542425|594652427|FG001|Initial 24 Weeks|Non-compliance|0|||
164626683|NCT00542425|594652428|FG002|Initial 24 Weeks|Non-compliance|0|||
164626684|NCT00542425|594652429|FG003|Initial 24 Weeks|Non-compliance|1|||
164626685|NCT00542425|594652430|FG004|Initial 24 Weeks|Non-compliance|1|||
164626686|NCT00542425|594652426|FG000|Initial 24 Weeks|Protocol Violation|0|||
164626687|NCT00542425|594652427|FG001|Initial 24 Weeks|Protocol Violation|0|||
164626688|NCT00542425|594652428|FG002|Initial 24 Weeks|Protocol Violation|0|||
164626689|NCT00542425|594652429|FG003|Initial 24 Weeks|Protocol Violation|1|||
164626690|NCT00542425|594652430|FG004|Initial 24 Weeks|Protocol Violation|0|||
164626691|NCT00542425|594652426|FG000|Initial 24 Weeks|Refusal of treatment|2|||
164626692|NCT00542425|594652427|FG001|Initial 24 Weeks|Refusal of treatment|2|||
164626693|NCT00542425|594652428|FG002|Initial 24 Weeks|Refusal of treatment|1|||
164626694|NCT00542425|594652429|FG003|Initial 24 Weeks|Refusal of treatment|4|||
164626695|NCT00542425|594652430|FG004|Initial 24 Weeks|Refusal of treatment|1|||
164626696|NCT00542425|594652426|FG000|Initial 24 Weeks|Other|0|||
164626697|NCT00542425|594652427|FG001|Initial 24 Weeks|Other|2|||
164626698|NCT00542425|594652428|FG002|Initial 24 Weeks|Other|1|||
164527868|NCT02581631|594303710|FG001|Overall Study|Study drug toxicity|6|||
164527869|NCT02581631|594303711|FG002|Overall Study|Study drug toxicity|7|||
164527870|NCT02581631|594303712|FG003|Overall Study|Study drug toxicity|0|||
164527871|NCT02581631|594303713|FG004|Overall Study|Study drug toxicity|3|||
164527872|NCT02581631|594303709|FG000|Overall Study|AE unrelated to study drug|3|||
164527873|NCT02581631|594303710|FG001|Overall Study|AE unrelated to study drug|1|||
164527874|NCT02581631|594303711|FG002|Overall Study|AE unrelated to study drug|1|||
164527875|NCT02581631|594303712|FG003|Overall Study|AE unrelated to study drug|0|||
164527876|NCT02581631|594303713|FG004|Overall Study|AE unrelated to study drug|2|||
164626699|NCT00542425|594652429|FG003|Initial 24 Weeks|Other|0|||
164626700|NCT00542425|594652430|FG004|Initial 24 Weeks|Other|0|||
164626701|NCT00542425|594652426|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
164626702|NCT00542425|594652427|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
164626703|NCT00542425|594652428|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
164626704|NCT00542425|594652429|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
164626705|NCT00542425|594652430|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
164626706|NCT00542425|594652426|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
164626707|NCT00542425|594652427|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
164626708|NCT00542425|594652428|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
164626709|NCT00542425|594652429|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
164626710|NCT00542425|594652430|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
164626711|NCT00542425|594652426|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
164626712|NCT00542425|594652427|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
164626713|NCT00542425|594652428|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
164626714|NCT00542425|594652429|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
164626715|NCT00542425|594652430|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
164626716|NCT00542425|594652426|FG000|Extended 24 Weeks of Treatment|Other|1|||
164626717|NCT00542425|594652427|FG001|Extended 24 Weeks of Treatment|Other|1|||
164626718|NCT00542425|594652428|FG002|Extended 24 Weeks of Treatment|Other|0|||
164626719|NCT00542425|594652429|FG003|Extended 24 Weeks of Treatment|Other|0|||
164626720|NCT00542425|594652430|FG004|Extended 24 Weeks of Treatment|Other|1|||
164626721|NCT01424306|594652431|FG000|Overall Study|Protocol Violation|0|||
164626722|NCT01424306|594652432|FG001|Overall Study|Protocol Violation|0|||
164626723|NCT01424306|594652433|FG002|Overall Study|Protocol Violation|0|||
164626724|NCT01424306|594652434|FG003|Overall Study|Protocol Violation|0|||
164626725|NCT01424306|594652435|FG004|Overall Study|Protocol Violation|1|||
164626726|NCT01424306|594652436|FG005|Overall Study|Protocol Violation|0|||
164626727|NCT02096471|594652439|FG000|Overall Study|Adverse Event|1|||
164626728|NCT02096471|594652439|FG000|Overall Study|Lack of Efficacy|7|||
164626729|NCT02096471|594652439|FG000|Overall Study|Withdrawal by Subject|3|||
164626730|NCT02096471|594652439|FG000|Overall Study|Non-Compliant|2|||
164626731|NCT03344562|594652440|FG000|Overall Study|Withdrawal by Subject|2|||
164626732|NCT03344562|594652441|FG001|Overall Study|Withdrawal by Subject|0|||
164626733|NCT02463331|594652442|FG000|Overall Study|Adverse Event|4|||
164626734|NCT02463331|594652443|FG001|Overall Study|Adverse Event|2|||
164626735|NCT02463331|594652442|FG000|Overall Study|Lost to Follow-up|1|||
164626736|NCT02463331|594652443|FG001|Overall Study|Lost to Follow-up|1|||
164626737|NCT02463331|594652442|FG000|Overall Study|Pregnancy|2|||
164626738|NCT02463331|594652443|FG001|Overall Study|Pregnancy|3|||
164626739|NCT02463331|594652442|FG000|Overall Study|Lack of Efficacy|6|||
164626740|NCT02463331|594652443|FG001|Overall Study|Lack of Efficacy|0|||
164626741|NCT02463331|594652442|FG000|Overall Study|Physician Decision|3|||
164626742|NCT02463331|594652443|FG001|Overall Study|Physician Decision|0|||
164626743|NCT01084096|594654031|FG000|Overall Study|Lost to Follow-up|1501|||
164626744|NCT01084096|594654032|FG001|Overall Study|Lost to Follow-up|1833|||
164626745|NCT01084096|594654031|FG000|Overall Study|Withdrawal by Subject|3|||
164626746|NCT01084096|594654032|FG001|Overall Study|Withdrawal by Subject|0|||
164626747|NCT01084096|594654031|FG000|Overall Study|Woman had a miscarriage|21|||
164626748|NCT01084096|594654032|FG001|Overall Study|Woman had a miscarriage|17|||
164626749|NCT00027846|594654033|FG000|Overall Study|Lost to Follow-up|0|||
164626750|NCT00027846|594654034|FG001|Overall Study|Lost to Follow-up|41|||
164626751|NCT00027846|594654035|FG002|Overall Study|Lost to Follow-up|9|||
164626752|NCT00027846|594654033|FG000|Overall Study|Withdrawal by Subject|0|||
164626753|NCT00027846|594654034|FG001|Overall Study|Withdrawal by Subject|14|||
164626754|NCT00027846|594654035|FG002|Overall Study|Withdrawal by Subject|7|||
164626755|NCT00027846|594654033|FG000|Overall Study|Ineligible for study|2|||
164626756|NCT00027846|594654034|FG001|Overall Study|Ineligible for study|6|||
164626757|NCT00027846|594654035|FG002|Overall Study|Ineligible for study|14|||
164626758|NCT00027846|594654033|FG000|Overall Study|Entry into another COG therapeutic study|0|||
164626759|NCT00027846|594654034|FG001|Overall Study|Entry into another COG therapeutic study|5|||
164626760|NCT00027846|594654035|FG002|Overall Study|Entry into another COG therapeutic study|2|||
164626761|NCT00027846|594654033|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
164626762|NCT00027846|594654034|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
164626763|NCT00027846|594654035|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
164626764|NCT02033369|594654036|FG000|Overall Study|Physician Decision|1|||
164626765|NCT02033369|594654037|FG001|Overall Study|Physician Decision|2|||
164626766|NCT02033369|594654036|FG000|Overall Study|Not a good demographic match|0|||
164626767|NCT02033369|594654037|FG001|Overall Study|Not a good demographic match|2|||
164626768|NCT02033369|594654036|FG000|Overall Study|Withdrawal by Subject|1|||
164626769|NCT02033369|594654037|FG001|Overall Study|Withdrawal by Subject|1|||
164626770|NCT02033369|594654036|FG000|Overall Study|Lost to Follow-up|1|||
164626771|NCT02033369|594654037|FG001|Overall Study|Lost to Follow-up|0|||
164626772|NCT02033369|594654036|FG000|Overall Study|Protocol Violation|2|||
164626773|NCT02033369|594654037|FG001|Overall Study|Protocol Violation|0|||
164626774|NCT00663208|594654040|FG000|Treatment Period|Lost to Follow-up|0|||
164626775|NCT00663208|594654041|FG001|Treatment Period|Lost to Follow-up|1|||
164626776|NCT00663208|594654042|FG002|Treatment Period|Lost to Follow-up|0|||
164626777|NCT00663208|594654043|FG003|Treatment Period|Lost to Follow-up|0|||
164626778|NCT00663208|594654044|FG004|Treatment Period|Lost to Follow-up|0|||
164626779|NCT00663208|594654045|FG005|Treatment Period|Lost to Follow-up|0|||
164626780|NCT00663208|594654046|FG006|Treatment Period|Lost to Follow-up|0|||
164626781|NCT00663208|594654040|FG000|Follow-up Period|Lost to Follow-up|2|||
164626782|NCT00663208|594654041|FG001|Follow-up Period|Lost to Follow-up|0|||
164626783|NCT00663208|594654042|FG002|Follow-up Period|Lost to Follow-up|3|||
164626784|NCT00663208|594654043|FG003|Follow-up Period|Lost to Follow-up|2|||
164626785|NCT00663208|594654044|FG004|Follow-up Period|Lost to Follow-up|0|||
164626786|NCT00663208|594654045|FG005|Follow-up Period|Lost to Follow-up|0|||
164626787|NCT00663208|594654046|FG006|Follow-up Period|Lost to Follow-up|0|||
164626788|NCT00663208|594654040|FG000|Follow-up Period|Other reason|1|||
164626789|NCT00663208|594654041|FG001|Follow-up Period|Other reason|0|||
164626790|NCT00663208|594654042|FG002|Follow-up Period|Other reason|0|||
164626791|NCT00663208|594654043|FG003|Follow-up Period|Other reason|0|||
164626792|NCT00663208|594654044|FG004|Follow-up Period|Other reason|0|||
164626793|NCT00663208|594654045|FG005|Follow-up Period|Other reason|0|||
164626794|NCT00663208|594654046|FG006|Follow-up Period|Other reason|1|||
164626795|NCT01451203|594654047|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
164626796|NCT01451203|594654048|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
164626797|NCT01451203|594654047|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
164626798|NCT01451203|594654048|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
164626799|NCT01451203|594654047|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
164626800|NCT01451203|594654048|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
164626801|NCT01451203|594654047|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
164626802|NCT01451203|594654048|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
164626803|NCT01451203|594654047|FG000|Double-blind Treatment Period|Adverse Event|6|||
164626804|NCT01451203|594654048|FG001|Double-blind Treatment Period|Adverse Event|9|||
164626805|NCT01451203|594654047|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
164626806|NCT01451203|594654048|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
164626807|NCT01451203|594654047|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
164626808|NCT01451203|594654048|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
164626809|NCT01451203|594654047|FG000|Double-blind Treatment Period|Investigator decision|2|||
164626810|NCT01451203|594654048|FG001|Double-blind Treatment Period|Investigator decision|0|||
164626811|NCT01451203|594654047|FG000|Post-treatment Period|Consent withdrawn|2|||
164626812|NCT01451203|594654048|FG001|Post-treatment Period|Consent withdrawn|4|||
164626813|NCT01451203|594654047|FG000|Post-treatment Period|Lack of Efficacy|12|||
164626814|NCT01451203|594654048|FG001|Post-treatment Period|Lack of Efficacy|28|||
164626815|NCT01451203|594654047|FG000|Post-treatment Period|Adverse Event|0|||
164626816|NCT01451203|594654048|FG001|Post-treatment Period|Adverse Event|1|||
164626817|NCT01451203|594654047|FG000|Post-treatment Period|Investigator decision|0|||
164626818|NCT01451203|594654048|FG001|Post-treatment Period|Investigator decision|1|||
164626819|NCT00039377|594654049|FG000|Initial Registration|Adverse Event|2|||
164626820|NCT00039377|594654050|FG001|Initial Registration|Adverse Event|0|||
164626821|NCT00039377|594654051|FG002|Initial Registration|Adverse Event|0|||
164626822|NCT00039377|594654052|FG003|Initial Registration|Adverse Event|0|||
164626823|NCT00039377|594654049|FG000|Initial Registration|Relapsed|6|||
164626824|NCT00039377|594654050|FG001|Initial Registration|Relapsed|0|||
164626825|NCT00039377|594654051|FG002|Initial Registration|Relapsed|0|||
164626826|NCT00039377|594654052|FG003|Initial Registration|Relapsed|0|||
164626827|NCT00039377|594654049|FG000|Initial Registration|Received non-protocol therapy|11|||
164626828|NCT00039377|594654050|FG001|Initial Registration|Received non-protocol therapy|0|||
164626829|NCT00039377|594654051|FG002|Initial Registration|Received non-protocol therapy|0|||
164626830|NCT00039377|594654052|FG003|Initial Registration|Received non-protocol therapy|0|||
164626831|NCT00039377|594654049|FG000|Initial Registration|Withdrawal by Subject|3|||
164626832|NCT00039377|594654050|FG001|Initial Registration|Withdrawal by Subject|0|||
164626833|NCT00039377|594654051|FG002|Initial Registration|Withdrawal by Subject|0|||
164626834|NCT00039377|594654052|FG003|Initial Registration|Withdrawal by Subject|0|||
164626835|NCT01249404|594654053|FG000|Overall Study|Study treatment not received|0|||
164626836|NCT01249404|594654054|FG001|Overall Study|Study treatment not received|1|||
164626837|NCT01249404|594654055|FG002|Overall Study|Study treatment not received|2|||
164626838|NCT01249404|594654053|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
164626839|NCT01249404|594654054|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
164626840|NCT01249404|594654055|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
164626841|NCT01249404|594654053|FG000|Overall Study|Adverse Event|2|||
164626842|NCT01249404|594654054|FG001|Overall Study|Adverse Event|2|||
164626843|NCT01249404|594654055|FG002|Overall Study|Adverse Event|2|||
164626844|NCT01249404|594654053|FG000|Overall Study|Withdrawal by Subject|2|||
164626845|NCT01249404|594654054|FG001|Overall Study|Withdrawal by Subject|2|||
164626846|NCT01249404|594654055|FG002|Overall Study|Withdrawal by Subject|0|||
164626847|NCT01249404|594654053|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
164626848|NCT01249404|594654054|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
164626849|NCT01249404|594654055|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
164626850|NCT01249404|594654053|FG000|Overall Study|Non compliance to visit schedule|0|||
164626851|NCT01249404|594654054|FG001|Overall Study|Non compliance to visit schedule|1|||
164626852|NCT01249404|594654055|FG002|Overall Study|Non compliance to visit schedule|0|||
164626853|NCT03890731|594654056|FG000|Overall Study|Progressive disease|1|||
164626854|NCT03890731|594654056|FG000|Overall Study|Patient's decision|1|||
164626855|NCT03890731|594654056|FG000|Overall Study|Adverse Event|4|||
164626856|NCT03758612|594654057|FG000|Washout Period|Withdrawal by Subject|0|||
164626857|NCT03758612|594654058|FG001|Washout Period|Withdrawal by Subject|0|||
164626858|NCT03758612|594654059|FG002|Washout Period|Withdrawal by Subject|2|||
164626859|NCT03758612|594654060|FG003|Washout Period|Withdrawal by Subject|0|||
164626860|NCT03758612|594654061|FG004|Washout Period|Withdrawal by Subject|0|||
164626861|NCT03758612|594654062|FG005|Washout Period|Withdrawal by Subject|0|||
164626862|NCT03758612|594654063|FG006|Washout Period|Withdrawal by Subject|0|||
164626863|NCT03758612|594654064|FG007|Washout Period|Withdrawal by Subject|0|||
164626864|NCT03758612|594654065|FG008|Washout Period|Withdrawal by Subject|0|||
164626865|NCT03758612|594654066|FG009|Washout Period|Withdrawal by Subject|0|||
164626866|NCT03758612|594654067|FG010|Washout Period|Withdrawal by Subject|0|||
164626867|NCT03758612|594654068|FG011|Washout Period|Withdrawal by Subject|0|||
164626868|NCT03758612|594654057|FG000|Period 2|Protocol Violation|0|||
164626869|NCT03758612|594654058|FG001|Period 2|Protocol Violation|0|||
164626870|NCT03758612|594654059|FG002|Period 2|Protocol Violation|0|||
164626871|NCT03758612|594654060|FG003|Period 2|Protocol Violation|0|||
164626872|NCT03758612|594654061|FG004|Period 2|Protocol Violation|1|||
164626873|NCT03758612|594654062|FG005|Period 2|Protocol Violation|0|||
164626874|NCT03758612|594654063|FG006|Period 2|Protocol Violation|0|||
164626875|NCT03758612|594654064|FG007|Period 2|Protocol Violation|0|||
164626876|NCT03758612|594654065|FG008|Period 2|Protocol Violation|0|||
164626877|NCT03758612|594654066|FG009|Period 2|Protocol Violation|0|||
164626878|NCT03758612|594654067|FG010|Period 2|Protocol Violation|0|||
164626879|NCT03758612|594654068|FG011|Period 2|Protocol Violation|0|||
164626880|NCT00945945|594654071|FG000|Overall Study|Adverse Event|15|||
164626881|NCT00945945|594654072|FG001|Overall Study|Adverse Event|35|||
164626882|NCT00945945|594654071|FG000|Overall Study|Withdrawal by Subject|7|||
164626883|NCT00945945|594654072|FG001|Overall Study|Withdrawal by Subject|10|||
164626884|NCT00945945|594654071|FG000|Overall Study|Lost to Follow-up|4|||
164626885|NCT00945945|594654072|FG001|Overall Study|Lost to Follow-up|5|||
164626886|NCT00945945|594654071|FG000|Overall Study|Lack of Efficacy|6|||
164626887|NCT00945945|594654072|FG001|Overall Study|Lack of Efficacy|2|||
164626888|NCT00945945|594654071|FG000|Overall Study|Protocol Violation|4|||
164626889|NCT00945945|594654072|FG001|Overall Study|Protocol Violation|2|||
164626890|NCT00945945|594654071|FG000|Overall Study|Entry Criteria Not Met|0|||
164626891|NCT00945945|594654072|FG001|Overall Study|Entry Criteria Not Met|1|||
164626892|NCT02500901|594654073|FG000|Overall Study|Disease ProgressionDD|2|||
164626893|NCT01191190|594654074|FG000|Overall Study|Withdrawal by Subject|1|||
164626894|NCT01716585|594654075|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
164626895|NCT01716585|594654076|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
164626896|NCT01716585|594654075|FG000|Double-blind Treatment|Adverse Event|2|||
164626897|NCT01716585|594654076|FG001|Double-blind Treatment|Adverse Event|1|||
164626898|NCT01716585|594654075|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
164626899|NCT01716585|594654076|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
164626900|NCT01716585|594654075|FG000|Double-blind Treatment|Lost to Follow-up|2|||
164626901|NCT01716585|594654076|FG001|Double-blind Treatment|Lost to Follow-up|0|||
164626902|NCT01716585|594654075|FG000|Double-blind Treatment|Subject Noncompliant|1|||
164626903|NCT01716585|594654076|FG001|Double-blind Treatment|Subject Noncompliant|0|||
164626904|NCT01716585|594654075|FG000|Double-blind Treatment|Other|1|||
164626905|NCT01716585|594654076|FG001|Double-blind Treatment|Other|0|||
164626906|NCT01716585|594654075|FG000|Open-label Treatment|Adverse Event|0|||
164626907|NCT01716585|594654076|FG001|Open-label Treatment|Adverse Event|2|||
164626908|NCT01716585|594654075|FG000|Open-label Treatment|Virologic Failure|0|||
164626909|NCT01716585|594654076|FG001|Open-label Treatment|Virologic Failure|2|||
164626910|NCT01716585|594654075|FG000|Open-label Treatment|Withdrawal by Subject|0|||
164626911|NCT01716585|594654076|FG001|Open-label Treatment|Withdrawal by Subject|3|||
164626912|NCT04235959|594654077|FG000|Overall Study|Protocol Violation|0|||
164626913|NCT04235959|594654078|FG001|Overall Study|Protocol Violation|1|||
164626914|NCT04235959|594654079|FG002|Overall Study|Protocol Violation|0|||
164626915|NCT04235959|594654077|FG000|Overall Study|Adverse Event|1|||
164626916|NCT04235959|594654078|FG001|Overall Study|Adverse Event|0|||
164626917|NCT04235959|594654079|FG002|Overall Study|Adverse Event|0|||
164626918|NCT00125138|594654080|FG000|Overall Study|Adverse Event|1|||
164626919|NCT00125138|594654081|FG001|Overall Study|Adverse Event|0|||
164626920|NCT00125138|594654082|FG002|Overall Study|Adverse Event|3|||
164626921|NCT00125138|594654083|FG003|Overall Study|Adverse Event|2|||
164626922|NCT00125138|594654080|FG000|Overall Study|Withdrawal by Subject|2|||
164626923|NCT00125138|594654081|FG001|Overall Study|Withdrawal by Subject|3|||
164626924|NCT00125138|594654082|FG002|Overall Study|Withdrawal by Subject|1|||
164626925|NCT00125138|594654083|FG003|Overall Study|Withdrawal by Subject|1|||
164626926|NCT00125138|594654080|FG000|Overall Study|Lack of Efficacy|0|||
164626927|NCT00125138|594654081|FG001|Overall Study|Lack of Efficacy|0|||
164626928|NCT00125138|594654082|FG002|Overall Study|Lack of Efficacy|0|||
164626929|NCT00125138|594654083|FG003|Overall Study|Lack of Efficacy|1|||
164626930|NCT00125138|594654080|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
164626931|NCT00125138|594654081|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
164626932|NCT00125138|594654082|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
164626933|NCT00125138|594654083|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
164626934|NCT00348686|594654084|FG000|Overall Study|Withdrawal by Subject|45|||
164626935|NCT00348686|594654084|FG000|Overall Study|Adverse Event|5|||
164626936|NCT00348686|594654084|FG000|Overall Study|Protocol Violation|6|||
164626937|NCT00348686|594654084|FG000|Overall Study|Lost to Follow-up|2|||
164626938|NCT00348686|594654084|FG000|Overall Study|Multiple Reasons|8|||
164626939|NCT02381795|594654087|FG000|Overall Study|Withdrawal by Subject|1|||
164626940|NCT02381795|594654087|FG000|Overall Study|Study Terminated|2|||
164626941|NCT03798366|594654088|FG000|Overall Study|Lost to Follow-up|0|||
164626942|NCT03798366|594654089|FG001|Overall Study|Lost to Follow-up|1|||
164626943|NCT00474539|594654090|FG000|Infant Series|Withdrawal by Subject|3|||
164626944|NCT00474539|594654091|FG001|Infant Series|Withdrawal by Subject|4|||
164626945|NCT00474539|594654090|FG000|Infant Series|Randomization error|5|||
164626946|NCT00474539|594654091|FG001|Infant Series|Randomization error|0|||
164626947|NCT00474539|594654090|FG000|Infant Series|Lost to Follow-up|2|||
164626948|NCT00474539|594654091|FG001|Infant Series|Lost to Follow-up|1|||
164626949|NCT00474539|594654090|FG000|Infant Series|Protocol Violation|0|||
164626950|NCT00474539|594654091|FG001|Infant Series|Protocol Violation|1|||
164626951|NCT00474539|594654090|FG000|After Infant Series|Lost to Follow-up|3|||
164626952|NCT00474539|594654091|FG001|After Infant Series|Lost to Follow-up|0|||
164626953|NCT00474539|594654090|FG000|After Infant Series|Withdrawal by Subject|1|||
164626954|NCT00474539|594654091|FG001|After Infant Series|Withdrawal by Subject|0|||
164626955|NCT00474539|594654090|FG000|Toddler Dose|Protocol Violation|1|||
164626956|NCT00474539|594654091|FG001|Toddler Dose|Protocol Violation|0|||
164626957|NCT01117428|594654092|FG000|Overall Study|Lack of Efficacy|1|||
164626958|NCT01117428|594654093|FG001|Overall Study|Lack of Efficacy|0|||
164626959|NCT01117428|594654094|FG002|Overall Study|Lack of Efficacy|0|||
164626960|NCT01117428|594654095|FG003|Overall Study|Lack of Efficacy|0|||
164626961|NCT01117428|594654096|FG004|Overall Study|Lack of Efficacy|0|||
164626962|NCT01117428|594654097|FG005|Overall Study|Lack of Efficacy|0|||
164626963|NCT01117428|594654092|FG000|Overall Study|Adverse Event|4|||
164626964|NCT01117428|594654093|FG001|Overall Study|Adverse Event|0|||
164626965|NCT01117428|594654094|FG002|Overall Study|Adverse Event|0|||
164626966|NCT01117428|594654095|FG003|Overall Study|Adverse Event|0|||
164626967|NCT01117428|594654096|FG004|Overall Study|Adverse Event|1|||
164626968|NCT01117428|594654097|FG005|Overall Study|Adverse Event|2|||
164626969|NCT01117428|594654092|FG000|Overall Study|Death|0|||
164626970|NCT01117428|594654093|FG001|Overall Study|Death|1|||
164626971|NCT01117428|594654094|FG002|Overall Study|Death|2|||
164626972|NCT01117428|594654095|FG003|Overall Study|Death|0|||
164626973|NCT01117428|594654096|FG004|Overall Study|Death|0|||
164626974|NCT01117428|594654097|FG005|Overall Study|Death|1|||
164626975|NCT01117428|594654092|FG000|Overall Study|Physician Decision|0|||
164626976|NCT01117428|594654093|FG001|Overall Study|Physician Decision|1|||
164626977|NCT01117428|594654094|FG002|Overall Study|Physician Decision|0|||
164626978|NCT01117428|594654095|FG003|Overall Study|Physician Decision|0|||
164626979|NCT01117428|594654096|FG004|Overall Study|Physician Decision|0|||
164626980|NCT01117428|594654097|FG005|Overall Study|Physician Decision|0|||
164626981|NCT01117428|594654092|FG000|Overall Study|Withdrawal by Subject|0|||
164626982|NCT01117428|594654093|FG001|Overall Study|Withdrawal by Subject|0|||
164626983|NCT01117428|594654094|FG002|Overall Study|Withdrawal by Subject|1|||
164626984|NCT01117428|594654095|FG003|Overall Study|Withdrawal by Subject|0|||
164626985|NCT01117428|594654096|FG004|Overall Study|Withdrawal by Subject|0|||
164626986|NCT01117428|594654097|FG005|Overall Study|Withdrawal by Subject|0|||
164626987|NCT01117428|594654092|FG000|Overall Study|Progressive disease|15|||
164626988|NCT01117428|594654093|FG001|Overall Study|Progressive disease|27|||
164626989|NCT01117428|594654094|FG002|Overall Study|Progressive disease|10|||
164626990|NCT01117428|594654095|FG003|Overall Study|Progressive disease|12|||
164626991|NCT01117428|594654096|FG004|Overall Study|Progressive disease|16|||
164626992|NCT01117428|594654097|FG005|Overall Study|Progressive disease|17|||
164626993|NCT02195531|594654098|FG000|Overall Study|Withdrawal by Subject|1|||
164626994|NCT02195531|594654099|FG001|Overall Study|Withdrawal by Subject|1|||
164626995|NCT02195531|594654100|FG002|Overall Study|Withdrawal by Subject|1|||
164626996|NCT01657253|594654107|FG000|Overall Study|Lost to Follow-up|6|||
164626997|NCT01657253|594654108|FG001|Overall Study|Lost to Follow-up|5|||
164626998|NCT01657253|594654107|FG000|Overall Study|Withdrawal by Subject|11|||
164626999|NCT01657253|594654108|FG001|Overall Study|Withdrawal by Subject|12|||
164627000|NCT01657253|594654107|FG000|Overall Study|Adverse Event|0|||
164627001|NCT01657253|594654108|FG001|Overall Study|Adverse Event|1|||
164627002|NCT01970540|594654109|FG000|Overall Study|Non-treatment-related AE|0|||
164627003|NCT01970540|594654110|FG001|Overall Study|Non-treatment-related AE|0|||
164627004|NCT01970540|594654111|FG002|Overall Study|Non-treatment-related AE|1|||
164627005|NCT01970540|594654109|FG000|Overall Study|Progressive disease|55|||
164627006|NCT01970540|594654110|FG001|Overall Study|Progressive disease|23|||
164627007|NCT01970540|594654111|FG002|Overall Study|Progressive disease|10|||
164627008|NCT01970540|594654109|FG000|Overall Study|Treatment delay over protocol|0|||
164627009|NCT01970540|594654110|FG001|Overall Study|Treatment delay over protocol|0|||
164627010|NCT01970540|594654111|FG002|Overall Study|Treatment delay over protocol|1|||
164627011|NCT01970540|594654109|FG000|Overall Study|Physician Decision|7|||
164627012|NCT01970540|594654110|FG001|Overall Study|Physician Decision|2|||
164627013|NCT01970540|594654111|FG002|Overall Study|Physician Decision|0|||
164627014|NCT01970540|594654109|FG000|Overall Study|Clinical progression|0|||
164627015|NCT01970540|594654110|FG001|Overall Study|Clinical progression|1|||
164627016|NCT01970540|594654111|FG002|Overall Study|Clinical progression|1|||
164627017|NCT01970540|594654109|FG000|Overall Study|End of study|2|||
164627018|NCT01970540|594654110|FG001|Overall Study|End of study|0|||
164627019|NCT01970540|594654111|FG002|Overall Study|End of study|2|||
164627020|NCT01970540|594654109|FG000|Overall Study|Adverse Event|0|||
164627021|NCT01970540|594654110|FG001|Overall Study|Adverse Event|2|||
164627022|NCT01970540|594654111|FG002|Overall Study|Adverse Event|1|||
164627023|NCT01970540|594654109|FG000|Overall Study|Treatment-related AE|4|||
164627024|NCT01970540|594654110|FG001|Overall Study|Treatment-related AE|0|||
164627025|NCT01970540|594654111|FG002|Overall Study|Treatment-related AE|2|||
164627026|NCT01970540|594654109|FG000|Overall Study|Withdrawal by Subject|4|||
164627027|NCT01970540|594654110|FG001|Overall Study|Withdrawal by Subject|0|||
164627028|NCT01970540|594654111|FG002|Overall Study|Withdrawal by Subject|1|||
164627029|NCT01970540|594654109|FG000|Overall Study|Clinical deterioration|1|||
164627030|NCT01970540|594654110|FG001|Overall Study|Clinical deterioration|0|||
164627031|NCT01970540|594654111|FG002|Overall Study|Clinical deterioration|0|||
164627032|NCT00242710|594654112|FG000|Core Study (up to Year 1)|Adverse Event|30|||
164627033|NCT00242710|594654113|FG001|Core Study (up to Year 1)|Adverse Event|25|||
164627034|NCT00242710|594654114|FG002|Core Study (up to Year 1)|Adverse Event|23|||
164627035|NCT00242710|594654115|FG003|Core Study (up to Year 1)|Adverse Event|14|||
164627036|NCT00242710|594654112|FG000|Core Study (up to Year 1)|Death|0|||
164627037|NCT00242710|594654113|FG001|Core Study (up to Year 1)|Death|0|||
164627038|NCT00242710|594654114|FG002|Core Study (up to Year 1)|Death|1|||
164627039|NCT00242710|594654115|FG003|Core Study (up to Year 1)|Death|0|||
164627040|NCT00242710|594654112|FG000|Core Study (up to Year 1)|Physician Decision|0|||
164627041|NCT00242710|594654113|FG001|Core Study (up to Year 1)|Physician Decision|1|||
164627042|NCT00242710|594654114|FG002|Core Study (up to Year 1)|Physician Decision|0|||
164627043|NCT00242710|594654115|FG003|Core Study (up to Year 1)|Physician Decision|1|||
164627044|NCT00242710|594654112|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
164627045|NCT00242710|594654113|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
164627046|NCT00242710|594654114|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
164627047|NCT00242710|594654115|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
164627048|NCT00242710|594654112|FG000|Core Study (up to Year 1)|Other|6|||
164627049|NCT00242710|594654113|FG001|Core Study (up to Year 1)|Other|1|||
164627050|NCT00242710|594654114|FG002|Core Study (up to Year 1)|Other|0|||
164627051|NCT00242710|594654115|FG003|Core Study (up to Year 1)|Other|2|||
164627052|NCT00242710|594654112|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
164627053|NCT00242710|594654113|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
164627054|NCT00242710|594654114|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
164627055|NCT00242710|594654115|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
164627056|NCT00242710|594654112|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
164627057|NCT00242710|594654113|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
164627058|NCT00242710|594654114|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
164627059|NCT00242710|594654115|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
164627060|NCT00242710|594654112|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
164627061|NCT00242710|594654113|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
164627062|NCT00242710|594654114|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
164627063|NCT00242710|594654115|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
164627064|NCT00242710|594654112|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
164627065|NCT00242710|594654113|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
164627066|NCT00242710|594654114|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
164627067|NCT00242710|594654115|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
164627068|NCT00242710|594654112|FG000|Period Between Core Study and Extension|Adverse Event|2|||
164627069|NCT00242710|594654113|FG001|Period Between Core Study and Extension|Adverse Event|3|||
164627070|NCT00242710|594654114|FG002|Period Between Core Study and Extension|Adverse Event|5|||
164627071|NCT00242710|594654115|FG003|Period Between Core Study and Extension|Adverse Event|2|||
164627072|NCT00242710|594654112|FG000|Period Between Core Study and Extension|Physician Decision|1|||
164627073|NCT00242710|594654113|FG001|Period Between Core Study and Extension|Physician Decision|1|||
164627074|NCT00242710|594654114|FG002|Period Between Core Study and Extension|Physician Decision|0|||
164627075|NCT00242710|594654115|FG003|Period Between Core Study and Extension|Physician Decision|0|||
164627076|NCT00242710|594654112|FG000|Period Between Core Study and Extension|Other|24|||
164627077|NCT00242710|594654113|FG001|Period Between Core Study and Extension|Other|24|||
164627078|NCT00242710|594654114|FG002|Period Between Core Study and Extension|Other|9|||
164627079|NCT00242710|594654115|FG003|Period Between Core Study and Extension|Other|11|||
164627080|NCT00242710|594654112|FG000|Period Between Core Study and Extension|Extension not Available|17|||
164627081|NCT00242710|594654113|FG001|Period Between Core Study and Extension|Extension not Available|21|||
164627082|NCT00242710|594654114|FG002|Period Between Core Study and Extension|Extension not Available|8|||
164627083|NCT00242710|594654115|FG003|Period Between Core Study and Extension|Extension not Available|7|||
164627084|NCT00242710|594654112|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
164627085|NCT00242710|594654113|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
164627086|NCT00242710|594654114|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
164627087|NCT00242710|594654115|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
164627088|NCT00242710|594654112|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
164627089|NCT00242710|594654113|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
164627090|NCT00242710|594654114|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
164627091|NCT00242710|594654115|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
164627092|NCT00242710|594654112|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
164627093|NCT00242710|594654113|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
164627094|NCT00242710|594654114|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
164627095|NCT00242710|594654115|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
164627096|NCT00242710|594654112|FG000|Study Extension (up to Year 2)|Death|0|||
164627097|NCT00242710|594654113|FG001|Study Extension (up to Year 2)|Death|0|||
164627098|NCT00242710|594654114|FG002|Study Extension (up to Year 2)|Death|0|||
164627099|NCT00242710|594654115|FG003|Study Extension (up to Year 2)|Death|1|||
164627100|NCT00242710|594654112|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
164627101|NCT00242710|594654113|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
164627102|NCT00242710|594654114|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
164627103|NCT00242710|594654115|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
164627104|NCT00242710|594654112|FG000|Study Extension (up to Year 2)|Other|3|||
164627105|NCT00242710|594654113|FG001|Study Extension (up to Year 2)|Other|5|||
164627106|NCT00242710|594654114|FG002|Study Extension (up to Year 2)|Other|4|||
164627107|NCT00242710|594654115|FG003|Study Extension (up to Year 2)|Other|3|||
164627108|NCT00242710|594654112|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
164627109|NCT00242710|594654113|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
164627110|NCT00242710|594654114|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
164627111|NCT00242710|594654115|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
164627112|NCT00242710|594654112|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
164627113|NCT00242710|594654113|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
164627114|NCT00242710|594654114|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
164627115|NCT00242710|594654115|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
164627116|NCT01057394|594654116|FG000|Overall Study|Not eligible|0|||
164627117|NCT01057394|594654117|FG001|Overall Study|Not eligible|2|||
164627118|NCT00579527|594654118|FG000|Overall Study|Death|4|||
164627119|NCT02177942|594654128|FG000|Overall Study|Adverse Event|1|||
164627120|NCT02177942|594654129|FG001|Overall Study|Adverse Event|0|||
164627121|NCT02177942|594654128|FG000|Overall Study|Lost to Follow-up|1|||
164627122|NCT02177942|594654129|FG001|Overall Study|Lost to Follow-up|1|||
164627123|NCT02177942|594654128|FG000|Overall Study|Protocol Violation|4|||
164627124|NCT02177942|594654129|FG001|Overall Study|Protocol Violation|6|||
164627125|NCT02177942|594654128|FG000|Overall Study|Withdrawal by Subject|71|||
164627126|NCT02177942|594654129|FG001|Overall Study|Withdrawal by Subject|81|||
164627127|NCT00702949|594654135|FG000|Overall Study|Refusal|3|||
164627128|NCT00702949|594654136|FG001|Overall Study|Refusal|2|||
164627129|NCT00702949|594654137|FG002|Overall Study|Refusal|2|||
164627130|NCT00702949|594654135|FG000|Overall Study|Adverse Event|1|||
164627131|NCT00702949|594654136|FG001|Overall Study|Adverse Event|6|||
164627132|NCT00702949|594654137|FG002|Overall Study|Adverse Event|3|||
164627133|NCT00702949|594654135|FG000|Overall Study|Other Medical Reason/unknown|1|||
164627134|NCT00702949|594654136|FG001|Overall Study|Other Medical Reason/unknown|1|||
164627135|NCT00702949|594654137|FG002|Overall Study|Other Medical Reason/unknown|3|||
164627136|NCT00598585|594654138|FG000|Overall Study|Lost to Follow-up|1|||
164627137|NCT00598585|594654139|FG001|Overall Study|Lost to Follow-up|0|||
164627138|NCT00545584|594654140|FG000|Overall Study|Only one reason for discontinuation|62|||
164627139|NCT00545584|594654141|FG001|Overall Study|Only one reason for discontinuation|61|||
164627140|NCT00545584|594654142|FG002|Overall Study|Only one reason for discontinuation|48|||
164627141|NCT00545584|594654140|FG000|Overall Study|Two or more reasons for discontinuation|17|||
164627142|NCT00545584|594654141|FG001|Overall Study|Two or more reasons for discontinuation|19|||
164627143|NCT00545584|594654142|FG002|Overall Study|Two or more reasons for discontinuation|8|||
164627144|NCT00135694|594654145|FG000|Overall Study|Adverse Event|17|||
164627145|NCT00135694|594654146|FG001|Overall Study|Adverse Event|4|||
164627146|NCT00135694|594654147|FG002|Overall Study|Adverse Event|0|||
164627147|NCT00135694|594654145|FG000|Overall Study|Death|14|||
164627148|NCT00135694|594654146|FG001|Overall Study|Death|1|||
164627149|NCT00135694|594654147|FG002|Overall Study|Death|2|||
164627150|NCT00135694|594654145|FG000|Overall Study|Lost to Follow-up|8|||
164627151|NCT00135694|594654146|FG001|Overall Study|Lost to Follow-up|7|||
164627152|NCT00135694|594654147|FG002|Overall Study|Lost to Follow-up|1|||
164627153|NCT00135694|594654145|FG000|Overall Study|Withdrawal by Subject|41|||
164627154|NCT00135694|594654146|FG001|Overall Study|Withdrawal by Subject|7|||
164627155|NCT00135694|594654147|FG002|Overall Study|Withdrawal by Subject|4|||
164627156|NCT00135694|594654145|FG000|Overall Study|Protocol Violation|19|||
164627157|NCT00135694|594654146|FG001|Overall Study|Protocol Violation|1|||
164627158|NCT00135694|594654147|FG002|Overall Study|Protocol Violation|0|||
164627159|NCT00135694|594654145|FG000|Overall Study|Hepatitis C related reasons|39|||
164627160|NCT00135694|594654146|FG001|Overall Study|Hepatitis C related reasons|1|||
164627161|NCT00135694|594654147|FG002|Overall Study|Hepatitis C related reasons|0|||
164627162|NCT00135694|594654145|FG000|Overall Study|Ineligible for Random assignment|42|||
164627163|NCT00135694|594654146|FG001|Overall Study|Ineligible for Random assignment|0|||
164627164|NCT00135694|594654147|FG002|Overall Study|Ineligible for Random assignment|0|||
164627165|NCT00660816|594654148|FG000|Overall Study|Adverse Event|1|||
164627166|NCT00660816|594654149|FG001|Overall Study|Adverse Event|2|||
164627167|NCT00660816|594654148|FG000|Overall Study|Withdrawal by Subject|1|||
164627168|NCT00660816|594654149|FG001|Overall Study|Withdrawal by Subject|0|||
164627169|NCT00660816|594654148|FG000|Overall Study|Death|0|||
164627170|NCT00660816|594654149|FG001|Overall Study|Death|2|||
164627171|NCT00660816|594654148|FG000|Overall Study|Lack of Efficacy|1|||
164627172|NCT00660816|594654149|FG001|Overall Study|Lack of Efficacy|0|||
164627173|NCT00660816|594654148|FG000|Overall Study|Physician Decision|0|||
164627174|NCT00660816|594654149|FG001|Overall Study|Physician Decision|2|||
164627175|NCT00660816|594654148|FG000|Overall Study|Protocol Violation|1|||
164627176|NCT00660816|594654149|FG001|Overall Study|Protocol Violation|0|||
164627177|NCT00660816|594654148|FG000|Overall Study|Disease Progression|16|||
164627178|NCT00660816|594654149|FG001|Overall Study|Disease Progression|12|||
164627179|NCT00660816|594654148|FG000|Overall Study|Complicating Disease|0|||
164627180|NCT00660816|594654149|FG001|Overall Study|Complicating Disease|1|||
164627181|NCT00998985|594654150|FG000|Overall Study|Withdrawal by Subject|0|||
164627182|NCT00998985|594654151|FG001|Overall Study|Withdrawal by Subject|0|||
164627183|NCT00998985|594654152|FG002|Overall Study|Withdrawal by Subject|0|||
164627184|NCT00998985|594654153|FG003|Overall Study|Withdrawal by Subject|0|||
164627185|NCT00998985|594654154|FG004|Overall Study|Withdrawal by Subject|0|||
164627186|NCT00998985|594654155|FG005|Overall Study|Withdrawal by Subject|0|||
164627187|NCT00998985|594654156|FG006|Overall Study|Withdrawal by Subject|0|||
164627188|NCT00998985|594654157|FG007|Overall Study|Withdrawal by Subject|0|||
164627189|NCT00998985|594654158|FG008|Overall Study|Withdrawal by Subject|1|||
164627190|NCT00998985|594654159|FG009|Overall Study|Withdrawal by Subject|0|||
164627191|NCT00998985|594654160|FG010|Overall Study|Withdrawal by Subject|0|||
164627192|NCT00998985|594654161|FG011|Overall Study|Withdrawal by Subject|0|||
164627193|NCT00998985|594654162|FG012|Overall Study|Withdrawal by Subject|0|||
164627194|NCT00998985|594654163|FG013|Overall Study|Withdrawal by Subject|0|||
164627195|NCT00998985|594654150|FG000|Overall Study|Protocol Violation|0|||
164627196|NCT00998985|594654151|FG001|Overall Study|Protocol Violation|0|||
164627197|NCT00998985|594654152|FG002|Overall Study|Protocol Violation|0|||
164627198|NCT00998985|594654153|FG003|Overall Study|Protocol Violation|0|||
164627199|NCT00998985|594654154|FG004|Overall Study|Protocol Violation|0|||
164627200|NCT00998985|594654155|FG005|Overall Study|Protocol Violation|1|||
164627201|NCT00998985|594654156|FG006|Overall Study|Protocol Violation|0|||
164627202|NCT00998985|594654157|FG007|Overall Study|Protocol Violation|0|||
164627203|NCT00998985|594654158|FG008|Overall Study|Protocol Violation|0|||
164627204|NCT00998985|594654159|FG009|Overall Study|Protocol Violation|0|||
164627205|NCT00998985|594654160|FG010|Overall Study|Protocol Violation|0|||
164627206|NCT00998985|594654161|FG011|Overall Study|Protocol Violation|0|||
164627207|NCT00998985|594654162|FG012|Overall Study|Protocol Violation|0|||
164627208|NCT00998985|594654163|FG013|Overall Study|Protocol Violation|0|||
164627209|NCT01601873|594654164|FG000|Overall Study|Lost to Follow-up|2|||
164627210|NCT01601873|594654165|FG001|Overall Study|Lost to Follow-up|3|||
164627211|NCT03196973|594654166|FG000|Overall Study|Adverse Event|1|||
164627212|NCT03196973|594654167|FG001|Overall Study|Adverse Event|1|||
164627213|NCT03196973|594654168|FG002|Overall Study|Adverse Event|2|||
164627214|NCT03196973|594654166|FG000|Overall Study|Lack of Efficacy|2|||
164627215|NCT03196973|594654167|FG001|Overall Study|Lack of Efficacy|6|||
164627216|NCT03196973|594654168|FG002|Overall Study|Lack of Efficacy|1|||
164627217|NCT03196973|594654166|FG000|Overall Study|Lost to Follow-up|4|||
164627218|NCT03196973|594654167|FG001|Overall Study|Lost to Follow-up|3|||
164627219|NCT03196973|594654168|FG002|Overall Study|Lost to Follow-up|2|||
164627220|NCT03196973|594654166|FG000|Overall Study|Consent withdrawn|2|||
164627221|NCT03196973|594654167|FG001|Overall Study|Consent withdrawn|1|||
164627222|NCT03196973|594654168|FG002|Overall Study|Consent withdrawn|0|||
164627223|NCT03196973|594654166|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
164627224|NCT03196973|594654167|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
164627225|NCT03196973|594654168|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
164627226|NCT01610414|594654171|FG000|Study Start - Month 13|Serious Adverse Event|65|||
164627227|NCT01610414|594654172|FG001|Study Start - Month 13|Serious Adverse Event|67|||
164627228|NCT01610414|594654171|FG000|Study Start - Month 13|Adverse Event|14|||
164627229|NCT01610414|594654172|FG001|Study Start - Month 13|Adverse Event|14|||
164627230|NCT01610414|594654171|FG000|Study Start - Month 13|Protocol Violation|3|||
164627231|NCT01610414|594654172|FG001|Study Start - Month 13|Protocol Violation|1|||
164627232|NCT01610414|594654171|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
164627233|NCT01610414|594654172|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
164627234|NCT01610414|594654171|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
164627235|NCT01610414|594654172|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
164627236|NCT01610414|594654171|FG000|Study Start - Month 13|Lost to Follow-up|4|||
164627237|NCT01610414|594654172|FG001|Study Start - Month 13|Lost to Follow-up|6|||
164627238|NCT01610414|594654171|FG000|Study Start - Month 13|Suspected HZ episode|1|||
164627239|NCT01610414|594654172|FG001|Study Start - Month 13|Suspected HZ episode|3|||
164627240|NCT01610414|594654171|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
164627241|NCT01610414|594654172|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
164627242|NCT01610414|594654171|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
164627243|NCT01610414|594654172|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
164627244|NCT01610414|594654171|FG000|Month 13 - Month 25|Adverse Event|8|||
164627245|NCT01610414|594654172|FG001|Month 13 - Month 25|Adverse Event|4|||
164627246|NCT01610414|594654171|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
164627247|NCT01610414|594654172|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
164627248|NCT01610414|594654171|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
164627249|NCT01610414|594654172|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
164627250|NCT01610414|594654171|FG000|Month 13 - Month 25|Protocol Violation|0|||
164627251|NCT01610414|594654172|FG001|Month 13 - Month 25|Protocol Violation|2|||
164627252|NCT01610414|594654171|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
164627253|NCT01610414|594654172|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
164627254|NCT01610414|594654171|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
164627255|NCT01610414|594654172|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
164627256|NCT01610414|594654171|FG000|After Month 25|Study end not reached|48|||
164627257|NCT01610414|594654172|FG001|After Month 25|Study end not reached|53|||
164627258|NCT02736474|594654174|FG000|Overall Study|Lost to Follow-up|0|||
164627259|NCT02736474|594654175|FG001|Overall Study|Lost to Follow-up|1|||
164627260|NCT00472043|594654177|FG000|Overall Study|Withdrawal by Subject|1|||
164627261|NCT00472043|594654178|FG001|Overall Study|Withdrawal by Subject|0|||
164627262|NCT00472043|594654177|FG000|Overall Study|Death|1|||
164627263|NCT00472043|594654178|FG001|Overall Study|Death|0|||
164627264|NCT04009824|594654180|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
164627265|NCT04009824|594654181|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
164627266|NCT04009824|594654182|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
164627267|NCT04009824|594654183|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
164627268|NCT04009824|594654184|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
164627269|NCT03147495|594654185|FG000|Overall Study|Physician Decision|0|||
164627270|NCT03147495|594654186|FG001|Overall Study|Physician Decision|6|||
164627271|NCT01024946|594654187|FG000|Overall Study|Screen Failure|3|||
164627272|NCT01024946|594654187|FG000|Overall Study|Withdrawal by Subject|1|||
164627273|NCT01024946|594654187|FG000|Overall Study|Adverse Event|1|||
164627274|NCT02483611|594654188|FG000|Overall Study|Protocol Violation|0|||
164627275|NCT02483611|594654189|FG001|Overall Study|Protocol Violation|0|||
164627276|NCT02483611|594654190|FG002|Overall Study|Protocol Violation|1|||
164627277|NCT02608892|594654191|FG000|Overall Study|Lost to Follow-up|1|||
164627278|NCT02608892|594654192|FG001|Overall Study|Lost to Follow-up|0|||
164627279|NCT02590406|594654193|FG000|Overall Study|Adverse Event|1|||
164627280|NCT02590406|594654194|FG001|Overall Study|Adverse Event|0|||
164627281|NCT02590406|594654193|FG000|Overall Study|Saturometer malfunction|0|||
164627282|NCT02590406|594654194|FG001|Overall Study|Saturometer malfunction|1|||
164627283|NCT03032523|594654195|FG000|Overall Study|Withdrawal by Subject|2|||
164627284|NCT03032523|594654196|FG001|Overall Study|Withdrawal by Subject|2|||
164627285|NCT03032523|594654195|FG000|Overall Study|Physician Decision|1|||
164627286|NCT03032523|594654196|FG001|Overall Study|Physician Decision|0|||
164627287|NCT05375838|594654197|FG000|Overall Study|Other|0|||
164627288|NCT05375838|594654198|FG001|Overall Study|Other|0|||
164627289|NCT05375838|594654199|FG002|Overall Study|Other|0|||
164627290|NCT05375838|594654200|FG003|Overall Study|Other|1|||
164627291|NCT05375838|594654201|FG004|Overall Study|Other|1|||
164627292|NCT05375838|594654202|FG005|Overall Study|Other|0|||
164627293|NCT05375838|594654197|FG000|Overall Study|Withdrawal by Subject|2|||
164627294|NCT05375838|594654198|FG001|Overall Study|Withdrawal by Subject|1|||
164627295|NCT05375838|594654199|FG002|Overall Study|Withdrawal by Subject|3|||
164627296|NCT05375838|594654200|FG003|Overall Study|Withdrawal by Subject|2|||
164627297|NCT05375838|594654201|FG004|Overall Study|Withdrawal by Subject|2|||
164627298|NCT05375838|594654202|FG005|Overall Study|Withdrawal by Subject|0|||
164627299|NCT05375838|594654197|FG000|Overall Study|Protocol Violation|0|||
164627300|NCT05375838|594654198|FG001|Overall Study|Protocol Violation|0|||
164627301|NCT05375838|594654199|FG002|Overall Study|Protocol Violation|0|||
164627302|NCT05375838|594654200|FG003|Overall Study|Protocol Violation|0|||
164627303|NCT05375838|594654201|FG004|Overall Study|Protocol Violation|1|||
164627304|NCT05375838|594654202|FG005|Overall Study|Protocol Violation|0|||
164627305|NCT05375838|594654197|FG000|Overall Study|Physician Decision|0|||
164627306|NCT05375838|594654198|FG001|Overall Study|Physician Decision|1|||
164627307|NCT05375838|594654199|FG002|Overall Study|Physician Decision|0|||
164627308|NCT05375838|594654200|FG003|Overall Study|Physician Decision|0|||
164627309|NCT05375838|594654201|FG004|Overall Study|Physician Decision|0|||
164627310|NCT05375838|594654202|FG005|Overall Study|Physician Decision|1|||
164627311|NCT05375838|594654197|FG000|Overall Study|Lost to Follow-up|2|||
164627312|NCT05375838|594654198|FG001|Overall Study|Lost to Follow-up|7|||
164627313|NCT05375838|594654199|FG002|Overall Study|Lost to Follow-up|0|||
164627314|NCT05375838|594654200|FG003|Overall Study|Lost to Follow-up|4|||
164627315|NCT05375838|594654201|FG004|Overall Study|Lost to Follow-up|2|||
164627316|NCT05375838|594654202|FG005|Overall Study|Lost to Follow-up|3|||
164627317|NCT00957723|594654203|FG000|Overall Study|Death|3|||
164627318|NCT00957723|594654203|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
164627319|NCT00957723|594654203|FG000|Overall Study|Lost to Follow-up|8|||
164627320|NCT00957723|594654203|FG000|Overall Study|Withdrawal by Subject|24|||
164627321|NCT00957723|594654203|FG000|Overall Study|Investigative Site Terminated|61|||
164627322|NCT00957723|594654203|FG000|Overall Study|Intercurrent Illness|2|||
164627323|NCT00957723|594654203|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
164627324|NCT00877890|594654204|FG000|Overall Study|Adverse Event|6|||
164627325|NCT00877890|594654205|FG001|Overall Study|Adverse Event|6|||
164627326|NCT00877890|594654204|FG000|Overall Study|Lost to Follow-up|5|||
164627327|NCT00877890|594654205|FG001|Overall Study|Lost to Follow-up|5|||
164627328|NCT00877890|594654204|FG000|Overall Study|Protocol Violation|0|||
164627329|NCT00877890|594654205|FG001|Overall Study|Protocol Violation|1|||
164627330|NCT00877890|594654204|FG000|Overall Study|Withdrawal of Consent|6|||
164627331|NCT00877890|594654205|FG001|Overall Study|Withdrawal of Consent|12|||
164627332|NCT00877890|594654204|FG000|Overall Study|Investigator Decision|0|||
164627333|NCT00877890|594654205|FG001|Overall Study|Investigator Decision|2|||
164627334|NCT00877890|594654204|FG000|Overall Study|Loss of Glucose Control|3|||
164627335|NCT00877890|594654205|FG001|Overall Study|Loss of Glucose Control|4|||
164627336|NCT00984009|594654206|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
164627337|NCT00631969|594654207|FG000|Overall Study|Adverse Event|3|||
164627338|NCT00631969|594654208|FG001|Overall Study|Adverse Event|1|||
164627339|NCT00631969|594654207|FG000|Overall Study|Lack of Efficacy|2|||
164627340|NCT00631969|594654208|FG001|Overall Study|Lack of Efficacy|8|||
164627341|NCT00631969|594654207|FG000|Overall Study|Lost to Follow-up|2|||
164627342|NCT00631969|594654208|FG001|Overall Study|Lost to Follow-up|1|||
164627343|NCT00631969|594654207|FG000|Overall Study|Protocol Violation|1|||
164627344|NCT00631969|594654208|FG001|Overall Study|Protocol Violation|1|||
164627345|NCT00631969|594654207|FG000|Overall Study|Consent Withdrawn|5|||
164627346|NCT00631969|594654208|FG001|Overall Study|Consent Withdrawn|7|||
164627347|NCT00631969|594654207|FG000|Overall Study|Noncompliant With Study Medication|0|||
164527877|NCT02581631|594303709|FG000|Overall Study|Request to discontinue|1|||
164527878|NCT02581631|594303710|FG001|Overall Study|Request to discontinue|0|||
164527879|NCT02581631|594303711|FG002|Overall Study|Request to discontinue|3|||
164527880|NCT02581631|594303712|FG003|Overall Study|Request to discontinue|0|||
164527881|NCT02581631|594303713|FG004|Overall Study|Request to discontinue|1|||
164527882|NCT02581631|594303709|FG000|Overall Study|participant withdrew consent|3|||
164527883|NCT02581631|594303710|FG001|Overall Study|participant withdrew consent|0|||
164527884|NCT02581631|594303711|FG002|Overall Study|participant withdrew consent|1|||
164527885|NCT02581631|594303712|FG003|Overall Study|participant withdrew consent|0|||
164527886|NCT02581631|594303713|FG004|Overall Study|participant withdrew consent|0|||
164527887|NCT02581631|594303709|FG000|Overall Study|Maximum clinical benefit|1|||
164527888|NCT02581631|594303710|FG001|Overall Study|Maximum clinical benefit|7|||
164527889|NCT02581631|594303711|FG002|Overall Study|Maximum clinical benefit|1|||
164527890|NCT02581631|594303712|FG003|Overall Study|Maximum clinical benefit|3|||
164527891|NCT02581631|594303713|FG004|Overall Study|Maximum clinical benefit|13|||
164527892|NCT02581631|594303709|FG000|Overall Study|Other Reasons|1|||
164527893|NCT02581631|594303710|FG001|Overall Study|Other Reasons|0|||
164527894|NCT02581631|594303711|FG002|Overall Study|Other Reasons|2|||
164527895|NCT02581631|594303712|FG003|Overall Study|Other Reasons|2|||
164527896|NCT02581631|594303713|FG004|Overall Study|Other Reasons|3|||
164527897|NCT02581631|594303709|FG000|Overall Study|Poor/Non-Compliance|0|||
164527898|NCT02581631|594303710|FG001|Overall Study|Poor/Non-Compliance|0|||
164527899|NCT02581631|594303711|FG002|Overall Study|Poor/Non-Compliance|1|||
164527900|NCT02581631|594303712|FG003|Overall Study|Poor/Non-Compliance|0|||
164527901|NCT02581631|594303713|FG004|Overall Study|Poor/Non-Compliance|0|||
164527902|NCT00116753|594303714|FG000|Overall Study|Adverse Event|16|||
164527903|NCT00116753|594303715|FG001|Overall Study|Adverse Event|10|||
164527904|NCT00116753|594303716|FG002|Overall Study|Adverse Event|7|||
164527905|NCT00116753|594303714|FG000|Overall Study|Withdrawal by Subject|11|||
164527906|NCT00116753|594303715|FG001|Overall Study|Withdrawal by Subject|12|||
164527907|NCT00116753|594303716|FG002|Overall Study|Withdrawal by Subject|8|||
164527908|NCT00116753|594303714|FG000|Overall Study|Lost to Follow-up|0|||
164527909|NCT00116753|594303715|FG001|Overall Study|Lost to Follow-up|2|||
164527910|NCT00116753|594303716|FG002|Overall Study|Lost to Follow-up|1|||
164527911|NCT00116753|594303714|FG000|Overall Study|Protocol Violation|0|||
164527912|NCT00116753|594303715|FG001|Overall Study|Protocol Violation|0|||
164527913|NCT00116753|594303716|FG002|Overall Study|Protocol Violation|1|||
164527914|NCT00116753|594303714|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
164527915|NCT00116753|594303715|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
164527916|NCT00116753|594303716|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
164527917|NCT00116753|594303714|FG000|Overall Study|Disease Progression|3|||
164527918|NCT00116753|594303715|FG001|Overall Study|Disease Progression|4|||
164527919|NCT00116753|594303716|FG002|Overall Study|Disease Progression|3|||
164527920|NCT00116753|594303714|FG000|Overall Study|Abnormal Echocardiogram|0|||
164527921|NCT00116753|594303715|FG001|Overall Study|Abnormal Echocardiogram|0|||
164527922|NCT00116753|594303716|FG002|Overall Study|Abnormal Echocardiogram|1|||
164527923|NCT00116753|594303714|FG000|Overall Study|Progressive Parkinson's Disease|1|||
164527924|NCT00116753|594303715|FG001|Overall Study|Progressive Parkinson's Disease|0|||
164527925|NCT00116753|594303716|FG002|Overall Study|Progressive Parkinson's Disease|0|||
164527926|NCT00116753|594303714|FG000|Overall Study|Dosing Error|0|||
164527927|NCT00116753|594303715|FG001|Overall Study|Dosing Error|1|||
164527928|NCT00116753|594303716|FG002|Overall Study|Dosing Error|0|||
164527929|NCT00598273|594303717|FG000|Overall Study|Adverse Event|4|||
164527930|NCT00598273|594303718|FG001|Overall Study|Adverse Event|5|||
164527931|NCT00598273|594303719|FG002|Overall Study|Adverse Event|2|||
164527932|NCT00598273|594303717|FG000|Overall Study|Death|6|||
164527933|NCT00598273|594303718|FG001|Overall Study|Death|12|||
164527934|NCT00598273|594303719|FG002|Overall Study|Death|8|||
164527935|NCT00598273|594303717|FG000|Overall Study|Lost to Follow-up|8|||
164527936|NCT00598273|594303718|FG001|Overall Study|Lost to Follow-up|3|||
164527937|NCT00598273|594303719|FG002|Overall Study|Lost to Follow-up|5|||
164527938|NCT00598273|594303717|FG000|Overall Study|Physician Decision|0|||
164527939|NCT00598273|594303718|FG001|Overall Study|Physician Decision|0|||
164527940|NCT00598273|594303719|FG002|Overall Study|Physician Decision|1|||
164527941|NCT00598273|594303717|FG000|Overall Study|Withdrawal by Subject|12|||
164527942|NCT00598273|594303718|FG001|Overall Study|Withdrawal by Subject|10|||
164527943|NCT00598273|594303719|FG002|Overall Study|Withdrawal by Subject|10|||
164527944|NCT00598273|594303717|FG000|Overall Study|Noncompliance|3|||
164527945|NCT00598273|594303718|FG001|Overall Study|Noncompliance|2|||
164527946|NCT00598273|594303719|FG002|Overall Study|Noncompliance|3|||
164527947|NCT00598273|594303717|FG000|Overall Study|Relocation|0|||
164527948|NCT00598273|594303718|FG001|Overall Study|Relocation|2|||
164527949|NCT00598273|594303719|FG002|Overall Study|Relocation|4|||
164527950|NCT00598273|594303717|FG000|Overall Study|Renal transplant|1|||
164527951|NCT00598273|594303718|FG001|Overall Study|Renal transplant|0|||
164527952|NCT00598273|594303719|FG002|Overall Study|Renal transplant|1|||
164527953|NCT00598273|594303717|FG000|Overall Study|Site elected to close|1|||
164527954|NCT00598273|594303718|FG001|Overall Study|Site elected to close|0|||
164627348|NCT00631969|594654208|FG001|Overall Study|Noncompliant With Study Medication|1|||
164627349|NCT00631969|594654207|FG000|Overall Study|No Drug Exposure|2|||
164627350|NCT00631969|594654208|FG001|Overall Study|No Drug Exposure|2|||
164627351|NCT01640353|594655717|FG000|Overall Study|Withdrew prior to treatment|10|||
164627352|NCT01640353|594655717|FG000|Overall Study|Withdrawn from analysis at term site|12|||
164627353|NCT01640353|594655717|FG000|Overall Study|Withdrawal by Subject|5|||
164627354|NCT01640353|594655717|FG000|Overall Study|Death|2|||
164627355|NCT01640353|594655717|FG000|Overall Study|Early site termination|3|||
164627356|NCT01640353|594655717|FG000|Overall Study|Lost to Follow-up|12|||
164627357|NCT01640353|594655717|FG000|Overall Study|Physician Decision|1|||
164627358|NCT01967134|594655718|FG000|Overall Study|Lost to Follow-up|0|||
164627359|NCT01967134|594655719|FG001|Overall Study|Lost to Follow-up|1|||
164627360|NCT01967134|594655720|FG002|Overall Study|Lost to Follow-up|0|||
164627361|NCT00443534|594655721|FG000|Overall Study|Lack of Efficacy|67|||
164627362|NCT00443534|594655721|FG000|Overall Study|Adverse Event|16|||
164627363|NCT00443534|594655721|FG000|Overall Study|Death|9|||
164627364|NCT00443534|594655721|FG000|Overall Study|Withdrawal by Subject|8|||
164627365|NCT00443534|594655721|FG000|Overall Study|Study Terminated by Sponsor|12|||
164627366|NCT00443534|594655721|FG000|Overall Study|Other|10|||
164627367|NCT00443534|594655721|FG000|Overall Study|Enrolled, Not Treated|1|||
164627368|NCT02679222|594655723|FG000|Overall Study|No time for project|1|||
164627369|NCT03419741|594655724|FG000|Overall Study|Adverse Event|1|||
164627370|NCT03419741|594655725|FG001|Overall Study|Adverse Event|0|||
164627371|NCT03419741|594655724|FG000|Overall Study|Withdrawal by Subject|1|||
164627372|NCT03419741|594655725|FG001|Overall Study|Withdrawal by Subject|2|||
164627373|NCT02719028|594655733|FG000|Overall Study|Adverse Event|2|||
164627374|NCT02719028|594655734|FG001|Overall Study|Adverse Event|1|||
164627375|NCT02719028|594655735|FG002|Overall Study|Adverse Event|4|||
164627376|NCT02719028|594655736|FG003|Overall Study|Adverse Event|8|||
164627377|NCT02719028|594655733|FG000|Overall Study|Physician Decision|0|||
164627378|NCT02719028|594655734|FG001|Overall Study|Physician Decision|1|||
164627379|NCT02719028|594655735|FG002|Overall Study|Physician Decision|1|||
164627380|NCT02719028|594655736|FG003|Overall Study|Physician Decision|1|||
164627381|NCT02719028|594655733|FG000|Overall Study|Use of prohibited medication|0|||
164627382|NCT02719028|594655734|FG001|Overall Study|Use of prohibited medication|0|||
164627383|NCT02719028|594655735|FG002|Overall Study|Use of prohibited medication|1|||
164627384|NCT02719028|594655736|FG003|Overall Study|Use of prohibited medication|0|||
164627385|NCT02719028|594655733|FG000|Overall Study|Protocol Violation|0|||
164627386|NCT02719028|594655734|FG001|Overall Study|Protocol Violation|0|||
164627387|NCT02719028|594655735|FG002|Overall Study|Protocol Violation|0|||
164627388|NCT02719028|594655736|FG003|Overall Study|Protocol Violation|1|||
164627389|NCT00298766|594655737|FG000|Overall Study|Adverse Event|18|||
164627390|NCT00298766|594655737|FG000|Overall Study|Death|2|||
164627391|NCT00298766|594655737|FG000|Overall Study|Withdrawal by Subject|9|||
164627392|NCT00298766|594655737|FG000|Overall Study|Treatment ongoing|4|||
164627393|NCT00298766|594655737|FG000|Overall Study|Progression of amyloid markers|4|||
164627394|NCT00298766|594655737|FG000|Overall Study|Deterioration in KPS and organ function|1|||
164627395|NCT00298766|594655737|FG000|Overall Study|Subjects overall condition deterioration|4|||
164627396|NCT00298766|594655737|FG000|Overall Study|Other|4|||
164627397|NCT00303719|594655738|FG000|Overall Study|Not evaluable, prior therapies|0|||
164627398|NCT00303719|594655739|FG001|Overall Study|Not evaluable, prior therapies|30|||
164627399|NCT00303719|594655738|FG000|Overall Study|Lost to Follow-up|0|||
164627400|NCT00303719|594655739|FG001|Overall Study|Lost to Follow-up|7|||
164627401|NCT03633461|594655746|FG000|Overall Study|Lost to Follow-up|0|||
164627402|NCT03633461|594655747|FG001|Overall Study|Lost to Follow-up|1|||
164627403|NCT01258738|594655757|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
164627404|NCT01258738|594655758|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
164627405|NCT01258738|594655757|FG000|Double-blind Period|Withdrawal by Subject|2|||
164627406|NCT01258738|594655758|FG001|Double-blind Period|Withdrawal by Subject|2|||
164627407|NCT01258738|594655757|FG000|Double-blind Period|Protocol Violation|1|||
164627408|NCT01258738|594655758|FG001|Double-blind Period|Protocol Violation|1|||
164627409|NCT01258738|594655757|FG000|Double-blind Period|Adverse Event|3|||
164627410|NCT01258738|594655758|FG001|Double-blind Period|Adverse Event|1|||
164627411|NCT01258738|594655757|FG000|Open-label Period|Did not meet inclusion criteria|0|||
164627412|NCT01258738|594655758|FG001|Open-label Period|Did not meet inclusion criteria|1|||
164627413|NCT01258738|594655757|FG000|Open-label Period|Insufficient clinical response|5|||
164627414|NCT01258738|594655758|FG001|Open-label Period|Insufficient clinical response|3|||
164627415|NCT01258738|594655757|FG000|Open-label Period|Lost to Follow-up|0|||
164627416|NCT01258738|594655758|FG001|Open-label Period|Lost to Follow-up|2|||
164627417|NCT01258738|594655757|FG000|Open-label Period|Withdrawal by Subject|5|||
164627418|NCT01258738|594655758|FG001|Open-label Period|Withdrawal by Subject|6|||
164627419|NCT01258738|594655757|FG000|Open-label Period|Protocol Violation|2|||
164627420|NCT01258738|594655758|FG001|Open-label Period|Protocol Violation|2|||
164627421|NCT01258738|594655757|FG000|Open-label Period|Adverse Event|4|||
164627422|NCT01258738|594655758|FG001|Open-label Period|Adverse Event|5|||
164627423|NCT01258738|594655757|FG000|Open-label Period|Other Reasons|0|||
164627424|NCT01258738|594655758|FG001|Open-label Period|Other Reasons|1|||
164627425|NCT01258738|594655757|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
164627426|NCT01258738|594655758|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
164627427|NCT00689611|594655759|FG000|Overall Study|Death|6|||
164627428|NCT00689611|594655760|FG001|Overall Study|Death|9|||
164627429|NCT00689611|594655759|FG000|Overall Study|Withdrawal by Subject|8|||
164627430|NCT00689611|594655760|FG001|Overall Study|Withdrawal by Subject|9|||
164627431|NCT00689611|594655759|FG000|Overall Study|Lost to Follow-up|27|||
164627432|NCT00689611|594655760|FG001|Overall Study|Lost to Follow-up|28|||
164627433|NCT00568399|594655762|FG000|Overall Study|Death|2|||
164627434|NCT00568399|594655762|FG000|Overall Study|Adverse Event|5|||
164627435|NCT00568399|594655762|FG000|Overall Study|Withdrawal by Subject|8|||
164627436|NCT02967562|594655767|FG000|Overall Study|Consent not obtained|1|||
164627437|NCT02967562|594655768|FG001|Overall Study|Consent not obtained|0|||
164627438|NCT02967562|594655767|FG000|Overall Study|High leak precluding analysis|1|||
164627439|NCT02967562|594655768|FG001|Overall Study|High leak precluding analysis|1|||
164627440|NCT00405756|594655769|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
164627441|NCT00405756|594655770|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
164627442|NCT00405756|594655771|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
164627443|NCT00405756|594655769|FG000|Double-blind Treatment|Adverse Event|31|||
164627444|NCT00405756|594655770|FG001|Double-blind Treatment|Adverse Event|27|||
164627445|NCT00405756|594655771|FG002|Double-blind Treatment|Adverse Event|12|||
164627446|NCT00405756|594655769|FG000|Double-blind Treatment|Disease Progression|47|||
164627447|NCT00405756|594655770|FG001|Double-blind Treatment|Disease Progression|81|||
164627448|NCT00405756|594655771|FG002|Double-blind Treatment|Disease Progression|102|||
164627449|NCT00405756|594655769|FG000|Double-blind Treatment|Lack of Efficacy|1|||
164627450|NCT00405756|594655770|FG001|Double-blind Treatment|Lack of Efficacy|4|||
164627451|NCT00405756|594655771|FG002|Double-blind Treatment|Lack of Efficacy|2|||
164627452|NCT00405756|594655769|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
164627453|NCT00405756|594655770|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
164627454|NCT00405756|594655771|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
164627455|NCT00405756|594655769|FG000|Double-blind Treatment|Lost to Follow-up|1|||
164627456|NCT00405756|594655770|FG001|Double-blind Treatment|Lost to Follow-up|0|||
164627457|NCT00405756|594655771|FG002|Double-blind Treatment|Lost to Follow-up|0|||
164627458|NCT00405756|594655769|FG000|Double-blind Treatment|Death|4|||
164627459|NCT00405756|594655770|FG001|Double-blind Treatment|Death|4|||
164627460|NCT00405756|594655771|FG002|Double-blind Treatment|Death|4|||
164627461|NCT00405756|594655769|FG000|Double-blind Treatment|Protocol Violation|1|||
164627462|NCT00405756|594655770|FG001|Double-blind Treatment|Protocol Violation|0|||
164627463|NCT00405756|594655771|FG002|Double-blind Treatment|Protocol Violation|2|||
164627464|NCT00405756|594655769|FG000|Double-blind Treatment|Other|7|||
164627465|NCT00405756|594655770|FG001|Double-blind Treatment|Other|4|||
164627466|NCT00405756|594655771|FG002|Double-blind Treatment|Other|4|||
164627467|NCT00405756|594655769|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
164627468|NCT00405756|594655770|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
164627469|NCT00405756|594655771|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
164627470|NCT00405756|594655769|FG000|Open-label Extension|Adverse Event|1|||
164627471|NCT00405756|594655770|FG001|Open-label Extension|Adverse Event|3|||
164627472|NCT00405756|594655771|FG002|Open-label Extension|Adverse Event|7|||
164627473|NCT00405756|594655769|FG000|Open-label Extension|Disease Progression|8|||
164627474|NCT00405756|594655770|FG001|Open-label Extension|Disease Progression|23|||
164627475|NCT00405756|594655771|FG002|Open-label Extension|Disease Progression|26|||
164627476|NCT00405756|594655769|FG000|Open-label Extension|Withdrawal by Subject|2|||
164627477|NCT00405756|594655770|FG001|Open-label Extension|Withdrawal by Subject|3|||
164627478|NCT00405756|594655771|FG002|Open-label Extension|Withdrawal by Subject|3|||
164627479|NCT00405756|594655769|FG000|Open-label Extension|Death|1|||
164627480|NCT00405756|594655770|FG001|Open-label Extension|Death|2|||
164627481|NCT00405756|594655771|FG002|Open-label Extension|Death|4|||
164627482|NCT00405756|594655769|FG000|Open-label Extension|Other|0|||
164627483|NCT00405756|594655770|FG001|Open-label Extension|Other|1|||
164627484|NCT00405756|594655771|FG002|Open-label Extension|Other|7|||
164627485|NCT00405756|594655769|FG000|Follow-up|Ongoing in Follow-up Period|52|||
164627486|NCT00405756|594655770|FG001|Follow-up|Ongoing in Follow-up Period|51|||
164627487|NCT00405756|594655771|FG002|Follow-up|Ongoing in Follow-up Period|60|||
164627488|NCT00405756|594655769|FG000|Follow-up|Death|21|||
164627489|NCT00405756|594655770|FG001|Follow-up|Death|31|||
164627490|NCT00405756|594655771|FG002|Follow-up|Death|24|||
164627491|NCT00405756|594655769|FG000|Follow-up|Lost to Follow-up|2|||
164627492|NCT00405756|594655770|FG001|Follow-up|Lost to Follow-up|8|||
164627493|NCT00405756|594655771|FG002|Follow-up|Lost to Follow-up|4|||
164627494|NCT00286156|594655777|FG000|Overall Study|Missed 12 month visit|0|||
164627495|NCT00286156|594655778|FG001|Overall Study|Missed 12 month visit|0|||
164627496|NCT00286156|594655779|FG002|Overall Study|Missed 12 month visit|1|||
164627497|NCT00286156|594655777|FG000|Overall Study|AE: pulmonary embolus|0|||
164627498|NCT00286156|594655778|FG001|Overall Study|AE: pulmonary embolus|1|||
164627499|NCT00286156|594655779|FG002|Overall Study|AE: pulmonary embolus|0|||
164627500|NCT00286156|594655777|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
164627501|NCT00286156|594655778|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
164627502|NCT00286156|594655779|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
164627503|NCT00286156|594655777|FG000|Overall Study|AE: pneumonia|1|||
164627504|NCT00286156|594655778|FG001|Overall Study|AE: pneumonia|0|||
164627505|NCT00286156|594655779|FG002|Overall Study|AE: pneumonia|0|||
164627506|NCT02870348|594655781|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
164627507|NCT00672139|594655782|FG000|Overall Study|Death|14|||
164627508|NCT00672139|594655783|FG001|Overall Study|Death|23|||
164627509|NCT00672139|594655782|FG000|Overall Study|Withdrawal by Subject|2|||
164627510|NCT00672139|594655783|FG001|Overall Study|Withdrawal by Subject|11|||
164627511|NCT00672139|594655782|FG000|Overall Study|Adverse Event|4|||
164627512|NCT00672139|594655783|FG001|Overall Study|Adverse Event|7|||
164627513|NCT00672139|594655782|FG000|Overall Study|Physician Decision|2|||
164627514|NCT00672139|594655783|FG001|Overall Study|Physician Decision|0|||
164627515|NCT00672139|594655782|FG000|Overall Study|Lack of Efficacy|4|||
164627516|NCT00672139|594655783|FG001|Overall Study|Lack of Efficacy|1|||
164627517|NCT00672139|594655782|FG000|Overall Study|Protocol Violation|1|||
164627518|NCT00672139|594655783|FG001|Overall Study|Protocol Violation|1|||
164627519|NCT00672139|594655782|FG000|Overall Study|hospice discharge, caregiver requests|3|||
164627520|NCT00672139|594655783|FG001|Overall Study|hospice discharge, caregiver requests|2|||
164627521|NCT01051856|594655784|FG000|Overall Study|Withdrawal by Subject|1|||
164627522|NCT01051856|594655785|FG001|Overall Study|Withdrawal by Subject|0|||
164627523|NCT02176226|594655786|FG000|Overall Study|Lost to Follow-up|3|||
164627524|NCT02176226|594655786|FG000|Overall Study|Withdrew prior to treatment|6|||
164627525|NCT01488994|594655793|FG000|Overall Study|Withdrawal by Subject|0|||
164627526|NCT01488994|594655794|FG001|Overall Study|Withdrawal by Subject|1|||
164627527|NCT01072500|594655795|FG000|Overall Study|Death|2|||
164627528|NCT01072500|594655796|FG001|Overall Study|Death|2|||
164627529|NCT01072500|594655795|FG000|Overall Study|Lost to Follow-up|5|||
164627530|NCT01072500|594655796|FG001|Overall Study|Lost to Follow-up|2|||
164627531|NCT01072500|594655795|FG000|Overall Study|Withdrawal by Subject|17|||
164627532|NCT01072500|594655796|FG001|Overall Study|Withdrawal by Subject|10|||
164627533|NCT02908841|594655797|FG000|Overall Study|Physician Decision|4|||
164627534|NCT02908841|594655798|FG001|Overall Study|Physician Decision|0|||
164627535|NCT00103207|594655799|FG000|Overall Study|Adverse Event|3|||
164627536|NCT00103207|594655799|FG000|Overall Study|Death|1|||
164627537|NCT00103207|594655799|FG000|Overall Study|Withdrawal by Subject|2|||
164627538|NCT00103207|594655799|FG000|Overall Study|Other complicating disease|1|||
164627539|NCT00103207|594655799|FG000|Overall Study|Ineligible|4|||
164627540|NCT00103207|594655799|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
164627541|NCT01611558|594655800|FG000|Induction Phase|Study drug toxicity|15|||
164627542|NCT01611558|594655800|FG000|Induction Phase|Disease progression|18|||
164627543|NCT01611558|594655800|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
164627544|NCT01611558|594655800|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
164627545|NCT01611558|594655800|FG000|Induction Phase|Death|1|||
164627546|NCT01611558|594655800|FG000|Maintenance Phase|Withdrawal by Subject|1|||
164627547|NCT01611558|594655800|FG000|Maintenance Phase|Elevated Uric acid|1|||
164627548|NCT01412333|594655815|FG000|Overall Study|Adverse Event|40|||
164627549|NCT01412333|594655816|FG001|Overall Study|Adverse Event|42|||
164627550|NCT01412333|594655815|FG000|Overall Study|Death|5|||
164627551|NCT01412333|594655816|FG001|Overall Study|Death|6|||
164627552|NCT01412333|594655815|FG000|Overall Study|Lack of Efficacy|22|||
164627553|NCT01412333|594655816|FG001|Overall Study|Lack of Efficacy|10|||
164627554|NCT01412333|594655815|FG000|Overall Study|Lost to Follow-up|15|||
164627555|NCT01412333|594655816|FG001|Overall Study|Lost to Follow-up|12|||
164627556|NCT01412333|594655815|FG000|Overall Study|Non-Compliance|3|||
164627557|NCT01412333|594655816|FG001|Overall Study|Non-Compliance|7|||
164627558|NCT01412333|594655815|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164627559|NCT01412333|594655816|FG001|Overall Study|Non-Compliance With Study Drug|1|||
164627560|NCT01412333|594655815|FG000|Overall Study|Other|30|||
164627561|NCT01412333|594655816|FG001|Overall Study|Other|33|||
164627562|NCT01412333|594655815|FG000|Overall Study|Physician Decision|11|||
164627563|NCT01412333|594655816|FG001|Overall Study|Physician Decision|16|||
164627564|NCT01412333|594655815|FG000|Overall Study|Pregnancy|6|||
164627565|NCT01412333|594655816|FG001|Overall Study|Pregnancy|4|||
164627566|NCT01412333|594655815|FG000|Overall Study|Protocol Violation|1|||
164627567|NCT01412333|594655816|FG001|Overall Study|Protocol Violation|2|||
164627568|NCT01412333|594655815|FG000|Overall Study|Study Terminated By Sponsor|3|||
164627569|NCT01412333|594655816|FG001|Overall Study|Study Terminated By Sponsor|2|||
164627570|NCT01412333|594655815|FG000|Overall Study|Withdrawal by Subject|51|||
164627571|NCT01412333|594655816|FG001|Overall Study|Withdrawal by Subject|54|||
164627572|NCT01412333|594655815|FG000|Overall Study|Missing|1|||
164627573|NCT01412333|594655816|FG001|Overall Study|Missing|3|||
164627574|NCT04005885|594655817|FG000|First Intervention|Withdrawal by Subject|1|||
164627575|NCT04005885|594655818|FG001|First Intervention|Withdrawal by Subject|1|||
164627576|NCT04005885|594655817|FG000|Second Intervention|Withdrawal by Subject|0|||
164627577|NCT04005885|594655818|FG001|Second Intervention|Withdrawal by Subject|2|||
164627578|NCT01038635|594655819|FG000|Overall Study|Disease Progression|2|||
164627579|NCT01038635|594655820|FG001|Overall Study|Disease Progression|0|||
164627580|NCT01038635|594655821|FG002|Overall Study|Disease Progression|0|||
164627581|NCT01038635|594655822|FG003|Overall Study|Disease Progression|0|||
164627582|NCT01038635|594655823|FG004|Overall Study|Disease Progression|0|||
164627583|NCT01038635|594655824|FG005|Overall Study|Disease Progression|0|||
164627584|NCT01038635|594655825|FG006|Overall Study|Disease Progression|1|||
164627585|NCT01038635|594655826|FG007|Overall Study|Disease Progression|4|||
164627586|NCT01038635|594655827|FG008|Overall Study|Disease Progression|0|||
164627587|NCT01038635|594655819|FG000|Overall Study|Death|0|||
164627588|NCT01038635|594655820|FG001|Overall Study|Death|0|||
164627589|NCT01038635|594655821|FG002|Overall Study|Death|0|||
164627590|NCT01038635|594655822|FG003|Overall Study|Death|0|||
164627591|NCT01038635|594655823|FG004|Overall Study|Death|1|||
164627592|NCT01038635|594655824|FG005|Overall Study|Death|0|||
164627593|NCT01038635|594655825|FG006|Overall Study|Death|1|||
164627594|NCT01038635|594655826|FG007|Overall Study|Death|1|||
164627595|NCT01038635|594655827|FG008|Overall Study|Death|2|||
164627596|NCT01227252|594655828|FG000|Overall Study|Sponsor Decision|0|||
164627597|NCT01227252|594655829|FG001|Overall Study|Sponsor Decision|1|||
164627598|NCT01227252|594655830|FG002|Overall Study|Sponsor Decision|0|||
164627599|NCT01227252|594655831|FG003|Overall Study|Sponsor Decision|0|||
164627600|NCT01227252|594655828|FG000|Overall Study|Lost to Follow-up|0|||
164627601|NCT01227252|594655829|FG001|Overall Study|Lost to Follow-up|1|||
164627602|NCT01227252|594655830|FG002|Overall Study|Lost to Follow-up|0|||
164627603|NCT01227252|594655831|FG003|Overall Study|Lost to Follow-up|0|||
164627604|NCT01227252|594655828|FG000|Overall Study|Withdrawal by Subject|0|||
164627605|NCT01227252|594655829|FG001|Overall Study|Withdrawal by Subject|1|||
164627606|NCT01227252|594655830|FG002|Overall Study|Withdrawal by Subject|0|||
164627607|NCT01227252|594655831|FG003|Overall Study|Withdrawal by Subject|0|||
164627608|NCT01034709|594655833|FG000|Overall Study|Protocol Violation|9|||
164627609|NCT01034709|594655834|FG001|Overall Study|Protocol Violation|16|||
164627610|NCT03227692|594655835|FG000|Overall Study|Protocol Violation|1|||
164627611|NCT03227692|594655836|FG001|Overall Study|Protocol Violation|1|||
164627612|NCT03227692|594655835|FG000|Overall Study|Lost to Follow-up|4|||
164627613|NCT03227692|594655836|FG001|Overall Study|Lost to Follow-up|2|||
164627614|NCT03227692|594655835|FG000|Overall Study|Adverse Event|0|||
164627615|NCT03227692|594655836|FG001|Overall Study|Adverse Event|2|||
164627616|NCT02447952|594655837|FG000|Overall Study|Adverse Event|2|||
164627617|NCT02447952|594655837|FG000|Overall Study|Physician Decision|1|||
164627618|NCT02447952|594655837|FG000|Overall Study|Withdrawal by Subject|4|||
164627619|NCT01683058|594655839|FG000|Overall Study|Lost to Follow-up|9|||
164627620|NCT01683058|594655839|FG000|Overall Study|Adverse Event|6|||
164627621|NCT01683058|594655839|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
164627622|NCT01683058|594655839|FG000|Overall Study|Withdrawal by Subject|7|||
164627623|NCT01683058|594655839|FG000|Overall Study|Lack of Efficacy|2|||
164627624|NCT01195636|594655840|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
164627625|NCT01195636|594655841|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
164627626|NCT01195636|594655840|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
164627627|NCT01195636|594655841|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
164627628|NCT01195636|594655840|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
164627629|NCT01195636|594655841|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
164627630|NCT01195636|594655840|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
164627631|NCT01195636|594655841|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
164627632|NCT01195636|594655840|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
164627633|NCT01195636|594655841|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
164627634|NCT01195636|594655840|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
164627635|NCT01195636|594655841|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
164627636|NCT01195636|594655840|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
164627637|NCT01195636|594655841|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
164627638|NCT01195636|594655840|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
164627639|NCT01195636|594655841|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
164627640|NCT00203294|594655842|FG000|Overall Study|Withdrawal by Subject|8|||
164627641|NCT00203294|594655843|FG001|Overall Study|Withdrawal by Subject|13|||
164627642|NCT01566981|594655844|FG000|Overall Study|Lost to Follow-up|5|||
164627643|NCT01566981|594655845|FG001|Overall Study|Lost to Follow-up|8|||
164627644|NCT02405091|594655848|FG000|Overall Study|Adverse Event|16|||
164627645|NCT02405091|594655849|FG001|Overall Study|Adverse Event|10|||
164627646|NCT02405091|594655850|FG002|Overall Study|Adverse Event|0|||
164627647|NCT02405091|594655848|FG000|Overall Study|Protocol Violation|1|||
164627648|NCT02405091|594655849|FG001|Overall Study|Protocol Violation|0|||
164627649|NCT02405091|594655850|FG002|Overall Study|Protocol Violation|0|||
164627650|NCT02405091|594655848|FG000|Overall Study|Noncompliance|1|||
164627651|NCT02405091|594655849|FG001|Overall Study|Noncompliance|6|||
164627652|NCT02405091|594655850|FG002|Overall Study|Noncompliance|2|||
164627653|NCT02405091|594655848|FG000|Overall Study|Withdrawal by Subject|4|||
164627654|NCT02405091|594655849|FG001|Overall Study|Withdrawal by Subject|8|||
164627655|NCT02405091|594655850|FG002|Overall Study|Withdrawal by Subject|0|||
164627656|NCT02405091|594655848|FG000|Overall Study|Death|0|||
164627657|NCT02405091|594655849|FG001|Overall Study|Death|1|||
164627658|NCT02405091|594655850|FG002|Overall Study|Death|0|||
164627659|NCT02405091|594655848|FG000|Overall Study|Lost to Follow-up|5|||
164627660|NCT02405091|594655849|FG001|Overall Study|Lost to Follow-up|6|||
164627661|NCT02405091|594655850|FG002|Overall Study|Lost to Follow-up|0|||
164627662|NCT02405091|594655848|FG000|Overall Study|Physician Decision|2|||
164627663|NCT02405091|594655849|FG001|Overall Study|Physician Decision|2|||
164627664|NCT02405091|594655850|FG002|Overall Study|Physician Decision|0|||
164627665|NCT01948791|594655857|FG000|Overall Study|Adverse Event|12|||
164627666|NCT01948791|594655857|FG000|Overall Study|Lack of Efficacy|3|||
164627667|NCT01948791|594655857|FG000|Overall Study|Protocol Violation|2|||
164627668|NCT01948791|594655857|FG000|Overall Study|Withdrawal by Subject|5|||
164627669|NCT01948791|594655857|FG000|Overall Study|Lost to Follow-up|6|||
164627670|NCT01948791|594655857|FG000|Overall Study|Management issues|1|||
164627671|NCT01948791|594655857|FG000|Overall Study|Others|7|||
164627672|NCT01948791|594655857|FG000|Overall Study|Screening failure|35|||
164627673|NCT00590031|594655866|FG000|Overall Study|Adverse Event|3|||
164627674|NCT00590031|594655866|FG000|Overall Study|Withdrawal by Subject|1|||
164627675|NCT00590031|594655866|FG000|Overall Study|Metastatic Disease|1|||
164627676|NCT00590031|594655866|FG000|Overall Study|Admin Hold|1|||
164627677|NCT02036476|594655873|FG000|Overall Study|Withdrawal by Subject|2|||
164627678|NCT02036476|594655873|FG000|Overall Study|Progressive Disease|4|||
164627679|NCT02036476|594655873|FG000|Overall Study|Unacceptable Toxicity|2|||
164627680|NCT02698176|594655874|FG000|Overall Study|Progressive disease|4|||
164627681|NCT02698176|594655875|FG001|Overall Study|Progressive disease|3|||
164627682|NCT02698176|594655876|FG002|Overall Study|Progressive disease|1|||
164627683|NCT02698176|594655877|FG003|Overall Study|Progressive disease|0|||
164627684|NCT02698176|594655874|FG000|Overall Study|Adverse Event|2|||
164627685|NCT02698176|594655875|FG001|Overall Study|Adverse Event|0|||
164627686|NCT02698176|594655876|FG002|Overall Study|Adverse Event|0|||
164627687|NCT02698176|594655877|FG003|Overall Study|Adverse Event|0|||
164627688|NCT02698176|594655874|FG000|Overall Study|Clinical progression|3|||
164627689|NCT02698176|594655875|FG001|Overall Study|Clinical progression|0|||
164627690|NCT02698176|594655876|FG002|Overall Study|Clinical progression|0|||
164627691|NCT02698176|594655877|FG003|Overall Study|Clinical progression|0|||
164627692|NCT02985684|594655879|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
164627693|NCT02985684|594655879|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
164627694|NCT02985684|594655879|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
164627695|NCT02551874|594657273|FG000|Overall Study|Lost to Follow-up|0|||
164627696|NCT02551874|594657274|FG001|Overall Study|Lost to Follow-up|2|||
164627697|NCT02551874|594657273|FG000|Overall Study|Pregnancy|0|||
164627698|NCT02551874|594657274|FG001|Overall Study|Pregnancy|1|||
164627699|NCT02551874|594657273|FG000|Overall Study|Reason not reported|10|||
164627700|NCT02551874|594657274|FG001|Overall Study|Reason not reported|4|||
164627701|NCT02551874|594657273|FG000|Overall Study|Did not receive randomized treatment|0|||
164627702|NCT02551874|594657274|FG001|Overall Study|Did not receive randomized treatment|7|||
164627703|NCT02551874|594657273|FG000|Overall Study|Did not enter long-term study|18|||
164627704|NCT02551874|594657274|FG001|Overall Study|Did not enter long-term study|25|||
164627705|NCT04067310|594657276|FG000|Overall Study|Physician Decision|2|||
164627706|NCT04067310|594657277|FG001|Overall Study|Physician Decision|6|||
164627707|NCT04067310|594657276|FG000|Overall Study|Lost to Follow-up|0|||
164627708|NCT04067310|594657277|FG001|Overall Study|Lost to Follow-up|1|||
164627709|NCT04067310|594657276|FG000|Overall Study|Withdrawal by Subject|3|||
164627710|NCT04067310|594657277|FG001|Overall Study|Withdrawal by Subject|0|||
164627711|NCT01041027|594657278|FG000|Overall Study|Withdrawal by Subject|2|||
164627712|NCT01041027|594657278|FG000|Overall Study|Protocol Violation|1|||
164627713|NCT01041027|594657278|FG000|Overall Study|Delayed Radiation Therapy|1|||
164627714|NCT01041027|594657278|FG000|Overall Study|Adverse Event|4|||
164627715|NCT02493712|594657279|FG000|Overall Study|Withdrawal by Subject|1|||
164627716|NCT02493712|594657280|FG001|Overall Study|Withdrawal by Subject|0|||
164627717|NCT02493712|594657281|FG002|Overall Study|Withdrawal by Subject|2|||
164627718|NCT02493712|594657279|FG000|Overall Study|Protocol Violation|0|||
164627719|NCT02493712|594657280|FG001|Overall Study|Protocol Violation|0|||
164627720|NCT02493712|594657281|FG002|Overall Study|Protocol Violation|1|||
164627721|NCT02493712|594657279|FG000|Overall Study|Lost to Follow-up|1|||
164627722|NCT02493712|594657280|FG001|Overall Study|Lost to Follow-up|0|||
164527955|NCT00598273|594303719|FG002|Overall Study|Site elected to close|0|||
164527956|NCT00598273|594303717|FG000|Overall Study|Started dialysis|6|||
164527957|NCT00598273|594303718|FG001|Overall Study|Started dialysis|4|||
164527958|NCT00598273|594303719|FG002|Overall Study|Started dialysis|5|||
164527959|NCT02549196|594303720|FG000|Overall Study|Protocol Violation|0|||
164527960|NCT02549196|594303721|FG001|Overall Study|Protocol Violation|0|||
164527961|NCT02549196|594303722|FG002|Overall Study|Protocol Violation|0|||
164527962|NCT02549196|594303723|FG003|Overall Study|Protocol Violation|1|||
164527963|NCT02549196|594303720|FG000|Overall Study|Withdrawal by Subject|1|||
164527964|NCT02549196|594303721|FG001|Overall Study|Withdrawal by Subject|0|||
164527965|NCT02549196|594303722|FG002|Overall Study|Withdrawal by Subject|1|||
164527966|NCT02549196|594303723|FG003|Overall Study|Withdrawal by Subject|0|||
164527967|NCT03218397|594303726|FG000|Overall Study|Prior positive blood culture|8|||
164527968|NCT03218397|594303727|FG001|Overall Study|Prior positive blood culture|13|||
164527969|NCT03218397|594303726|FG000|Overall Study|Comfort care|8|||
164527970|NCT03218397|594303727|FG001|Overall Study|Comfort care|5|||
164527971|NCT03218397|594303726|FG000|Overall Study|Comfort care and positive blood culture|1|||
164527972|NCT03218397|594303727|FG001|Overall Study|Comfort care and positive blood culture|0|||
164527973|NCT03218397|594303726|FG000|Overall Study|Comfort care and mixed culture|0|||
164527974|NCT03218397|594303727|FG001|Overall Study|Comfort care and mixed culture|1|||
164527975|NCT03218397|594303726|FG000|Overall Study|Mixed culture|2|||
164527976|NCT03218397|594303727|FG001|Overall Study|Mixed culture|2|||
164527977|NCT03218397|594303726|FG000|Overall Study|Inaccessible hospital records|2|||
164527978|NCT03218397|594303727|FG001|Overall Study|Inaccessible hospital records|5|||
164527979|NCT03218397|594303726|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
164527980|NCT03218397|594303727|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
164527981|NCT03218397|594303726|FG000|Overall Study|Randomized during laboratory off hours|2|||
164527982|NCT03218397|594303727|FG001|Overall Study|Randomized during laboratory off hours|1|||
164527983|NCT00126503|594303730|FG000|Overall Study|disease progression|23|||
164527984|NCT00126503|594303731|FG001|Overall Study|disease progression|14|||
164527985|NCT00126503|594303730|FG000|Overall Study|Withdrawal by Subject|0|||
164527986|NCT00126503|594303731|FG001|Overall Study|Withdrawal by Subject|1|||
164527987|NCT00126503|594303730|FG000|Overall Study|alternative therapy|1|||
164527988|NCT00126503|594303731|FG001|Overall Study|alternative therapy|1|||
164527989|NCT00126503|594303730|FG000|Overall Study|other complicating disease|4|||
164527990|NCT00126503|594303731|FG001|Overall Study|other complicating disease|1|||
164527991|NCT00126503|594303730|FG000|Overall Study|Death|3|||
164527992|NCT00126503|594303731|FG001|Overall Study|Death|0|||
164527993|NCT00126503|594303730|FG000|Overall Study|Adverse Event|13|||
164527994|NCT00126503|594303731|FG001|Overall Study|Adverse Event|3|||
164527995|NCT00126503|594303730|FG000|Overall Study|non-compliant|1|||
164527996|NCT00126503|594303731|FG001|Overall Study|non-compliant|0|||
164527997|NCT00126503|594303730|FG000|Overall Study|Physician Decision|2|||
164527998|NCT00126503|594303731|FG001|Overall Study|Physician Decision|1|||
164527999|NCT02495792|594303732|FG000|Overall Study|Lost to Follow-up|5|||
164528000|NCT02495792|594303733|FG001|Overall Study|Lost to Follow-up|9|||
164528001|NCT02495792|594303732|FG000|Overall Study|Protocol Violation|32|||
164528002|NCT02495792|594303733|FG001|Overall Study|Protocol Violation|31|||
164528003|NCT00925132|594303734|FG000|Overall Study|Withdrawal by Subject|2|||
164528004|NCT00925132|594303735|FG001|Overall Study|Withdrawal by Subject|0|||
164528005|NCT00925132|594303736|FG002|Overall Study|Withdrawal by Subject|0|||
164528006|NCT00925132|594303737|FG003|Overall Study|Withdrawal by Subject|0|||
164528007|NCT00925132|594303738|FG004|Overall Study|Withdrawal by Subject|1|||
164528008|NCT00925132|594303734|FG000|Overall Study|Removed due to disease progression|0|||
164528009|NCT00925132|594303735|FG001|Overall Study|Removed due to disease progression|0|||
164528010|NCT00925132|594303736|FG002|Overall Study|Removed due to disease progression|0|||
164528011|NCT00925132|594303737|FG003|Overall Study|Removed due to disease progression|0|||
164528012|NCT00925132|594303738|FG004|Overall Study|Removed due to disease progression|4|||
164528013|NCT03149549|594303739|FG000|Study Discontinuation--Treatment Period|Death|0|||
164528014|NCT03149549|594303740|FG001|Study Discontinuation--Treatment Period|Death|0|||
164528015|NCT03149549|594303741|FG002|Study Discontinuation--Treatment Period|Death|0|||
164528016|NCT03149549|594303742|FG003|Study Discontinuation--Treatment Period|Death|1|||
164528017|NCT03149549|594303743|FG004|Study Discontinuation--Treatment Period|Death|2|||
164528018|NCT03149549|594303744|FG005|Study Discontinuation--Treatment Period|Death|1|||
164528019|NCT03149549|594303745|FG006|Study Discontinuation--Treatment Period|Death|1|||
164528020|NCT03149549|594303746|FG007|Study Discontinuation--Treatment Period|Death|2|||
164627723|NCT02493712|594657281|FG002|Overall Study|Lost to Follow-up|0|||
164627724|NCT02493712|594657279|FG000|Overall Study|Physician Decision|0|||
164528021|NCT03149549|594303747|FG008|Study Discontinuation--Treatment Period|Death|4|||
164528022|NCT03149549|594303748|FG009|Study Discontinuation--Treatment Period|Death|1|||
164528023|NCT03149549|594303749|FG010|Study Discontinuation--Treatment Period|Death|0|||
164528024|NCT03149549|594303750|FG011|Study Discontinuation--Treatment Period|Death|0|||
164528025|NCT03149549|594303751|FG012|Study Discontinuation--Treatment Period|Death|1|||
164528026|NCT03149549|594303739|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
164627725|NCT02493712|594657280|FG001|Overall Study|Physician Decision|1|||
164627726|NCT02493712|594657281|FG002|Overall Study|Physician Decision|0|||
164627727|NCT02493712|594657279|FG000|Overall Study|Lack of Efficacy|0|||
164627728|NCT02493712|594657280|FG001|Overall Study|Lack of Efficacy|5|||
164627729|NCT02493712|594657281|FG002|Overall Study|Lack of Efficacy|3|||
164627730|NCT02528643|594657282|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
164627731|NCT02528643|594657283|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
164627732|NCT02528643|594657282|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
164627733|NCT02528643|594657283|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
164627734|NCT02528643|594657282|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
164627735|NCT02528643|594657283|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
164627736|NCT02528643|594657282|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
164627737|NCT02528643|594657283|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
164627738|NCT02528643|594657282|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
164627739|NCT02528643|594657283|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
164627740|NCT02528643|594657282|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
164627741|NCT02528643|594657283|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
164627742|NCT02528643|594657282|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
164627743|NCT02528643|594657283|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
164627744|NCT02058940|594657284|FG000|Overall Study|Discharged from Critical Care Unit|1|||
164627745|NCT04144140|594657285|FG000|Overall Study|Other|0|||
164627746|NCT04144140|594657286|FG001|Overall Study|Other|0|||
164627747|NCT04144140|594657287|FG002|Overall Study|Other|0|||
164627748|NCT04144140|594657288|FG003|Overall Study|Other|0|||
164627749|NCT04144140|594657289|FG004|Overall Study|Other|0|||
164627750|NCT04144140|594657290|FG005|Overall Study|Other|1|||
164627751|NCT04144140|594657291|FG006|Overall Study|Other|0|||
164627752|NCT02146274|594657292|FG000|Overall Study|Protocol Violation|73|||
164627753|NCT03384316|594657295|FG000|Overall Study|Screen failure|0|||
164627754|NCT03384316|594657296|FG001|Overall Study|Screen failure|1|||
164627755|NCT00413231|594657297|FG000|0 to 30-day Post Treatment|Death|5|||
164627756|NCT00413231|594657297|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
164627757|NCT00413231|594657297|FG000|30-day to 365-day Post Treatment|Death|13|||
164627758|NCT00413231|594657297|FG000|365-day to 60-month Post Treatment|Death|36|||
164627759|NCT00413231|594657297|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
164627760|NCT00413231|594657297|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
164627761|NCT00413231|594657297|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
164627762|NCT03287960|594657300|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
164627763|NCT03287960|594657300|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
164627764|NCT01641952|594657301|FG000|Overall Study|Lost to Follow-up|28|||
164627765|NCT01641952|594657301|FG000|Overall Study|Adverse Event|6|||
164627766|NCT00656136|594657302|FG000|Overall Study|Progressive disease|177|||
164627767|NCT00656136|594657303|FG001|Overall Study|Progressive disease|322|||
164627768|NCT00656136|594657302|FG000|Overall Study|Other Adverse Event|5|||
164627769|NCT00656136|594657303|FG001|Overall Study|Other Adverse Event|51|||
164627770|NCT00656136|594657302|FG000|Overall Study|Protocol Violation|2|||
164627771|NCT00656136|594657303|FG001|Overall Study|Protocol Violation|3|||
164627772|NCT00656136|594657302|FG000|Overall Study|Patient refused to take study medication|7|||
164627773|NCT00656136|594657303|FG001|Overall Study|Patient refused to take study medication|10|||
164627774|NCT00656136|594657302|FG000|Overall Study|Unknown and others|4|||
164627775|NCT00656136|594657303|FG001|Overall Study|Unknown and others|4|||
164627776|NCT02516306|594657311|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
164627777|NCT02516306|594657312|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
164627778|NCT00247962|594657315|FG000|Overall Study|Adverse Event|15|||
164627779|NCT00247962|594657316|FG001|Overall Study|Adverse Event|12|||
164627780|NCT00247962|594657315|FG000|Overall Study|Lost to Follow-up|3|||
164627781|NCT00247962|594657316|FG001|Overall Study|Lost to Follow-up|1|||
164627782|NCT00247962|594657315|FG000|Overall Study|Physician Decision|0|||
164627783|NCT00247962|594657316|FG001|Overall Study|Physician Decision|1|||
164627784|NCT00247962|594657315|FG000|Overall Study|Protocol Violation|1|||
164627785|NCT00247962|594657316|FG001|Overall Study|Protocol Violation|1|||
164627786|NCT00247962|594657315|FG000|Overall Study|Withdrawal by Subject|3|||
164627787|NCT00247962|594657316|FG001|Overall Study|Withdrawal by Subject|2|||
164627788|NCT00247962|594657315|FG000|Overall Study|Lack of Efficacy|4|||
164627789|NCT00247962|594657316|FG001|Overall Study|Lack of Efficacy|2|||
164627790|NCT03525613|594657318|FG000|Overall Study|Adverse Event|11|||
164627791|NCT03525613|594657319|FG001|Overall Study|Adverse Event|8|||
164627792|NCT03525613|594657320|FG002|Overall Study|Adverse Event|3|||
164627793|NCT03525613|594657321|FG003|Overall Study|Adverse Event|3|||
164627794|NCT03525613|594657318|FG000|Overall Study|Lost to Follow-up|4|||
164627795|NCT03525613|594657319|FG001|Overall Study|Lost to Follow-up|5|||
164627796|NCT03525613|594657320|FG002|Overall Study|Lost to Follow-up|3|||
164627797|NCT03525613|594657321|FG003|Overall Study|Lost to Follow-up|2|||
164627798|NCT03525613|594657318|FG000|Overall Study|Physician Decision|0|||
164627799|NCT03525613|594657319|FG001|Overall Study|Physician Decision|1|||
164627800|NCT03525613|594657320|FG002|Overall Study|Physician Decision|0|||
164627801|NCT03525613|594657321|FG003|Overall Study|Physician Decision|1|||
164627802|NCT03525613|594657318|FG000|Overall Study|Consent Withdrawal|25|||
164627803|NCT03525613|594657319|FG001|Overall Study|Consent Withdrawal|16|||
164627804|NCT03525613|594657320|FG002|Overall Study|Consent Withdrawal|12|||
164627805|NCT03525613|594657321|FG003|Overall Study|Consent Withdrawal|9|||
164627806|NCT03525613|594657318|FG000|Overall Study|Death|20|||
164627807|NCT03525613|594657319|FG001|Overall Study|Death|9|||
164627808|NCT03525613|594657320|FG002|Overall Study|Death|7|||
164627809|NCT03525613|594657321|FG003|Overall Study|Death|1|||
164627810|NCT03525613|594657318|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
164627811|NCT03525613|594657319|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
164627812|NCT03525613|594657320|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
164627813|NCT03525613|594657321|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
164627814|NCT02120469|594657324|FG000|Overall Study|HER-2/neu-amplified|1|||
164627815|NCT02120469|594657325|FG001|Overall Study|HER-2/neu-amplified|0|||
164627816|NCT02120469|594657326|FG002|Overall Study|HER-2/neu-amplified|1|||
164627817|NCT01012037|594657327|FG000|Overall Study|Adverse Event|0|||
164627818|NCT01012037|594657328|FG001|Overall Study|Adverse Event|8|||
164627819|NCT01012037|594657329|FG002|Overall Study|Adverse Event|3|||
164627820|NCT01012037|594657327|FG000|Overall Study|Protocol Violation|0|||
164627821|NCT01012037|594657328|FG001|Overall Study|Protocol Violation|3|||
164627822|NCT01012037|594657329|FG002|Overall Study|Protocol Violation|5|||
164627823|NCT01012037|594657327|FG000|Overall Study|Withdrawal by Subject|0|||
164627824|NCT01012037|594657328|FG001|Overall Study|Withdrawal by Subject|4|||
164627825|NCT01012037|594657329|FG002|Overall Study|Withdrawal by Subject|1|||
164627826|NCT01012037|594657327|FG000|Overall Study|Other reason (not specified)|1|||
164627827|NCT01012037|594657328|FG001|Overall Study|Other reason (not specified)|1|||
164627828|NCT01012037|594657329|FG002|Overall Study|Other reason (not specified)|1|||
164627829|NCT01809327|594657332|FG000|Overall Study|Lost to Follow-up|5|||
164627830|NCT01809327|594657333|FG001|Overall Study|Lost to Follow-up|2|||
164627831|NCT01809327|594657334|FG002|Overall Study|Lost to Follow-up|4|||
164627832|NCT01809327|594657335|FG003|Overall Study|Lost to Follow-up|2|||
164627833|NCT01809327|594657336|FG004|Overall Study|Lost to Follow-up|3|||
164627834|NCT01809327|594657332|FG000|Overall Study|Withdrawal by Subject|6|||
164627835|NCT01809327|594657333|FG001|Overall Study|Withdrawal by Subject|4|||
164627836|NCT01809327|594657334|FG002|Overall Study|Withdrawal by Subject|4|||
164627837|NCT01809327|594657335|FG003|Overall Study|Withdrawal by Subject|2|||
164627838|NCT01809327|594657336|FG004|Overall Study|Withdrawal by Subject|5|||
164627839|NCT01809327|594657332|FG000|Overall Study|Adverse Event|4|||
164627840|NCT01809327|594657333|FG001|Overall Study|Adverse Event|3|||
164627841|NCT01809327|594657334|FG002|Overall Study|Adverse Event|7|||
164627842|NCT01809327|594657335|FG003|Overall Study|Adverse Event|4|||
164627843|NCT01809327|594657336|FG004|Overall Study|Adverse Event|8|||
164627844|NCT01809327|594657332|FG000|Overall Study|Death|1|||
164627845|NCT01809327|594657333|FG001|Overall Study|Death|0|||
164627846|NCT01809327|594657334|FG002|Overall Study|Death|0|||
164627847|NCT01809327|594657335|FG003|Overall Study|Death|0|||
164627848|NCT01809327|594657336|FG004|Overall Study|Death|0|||
164627849|NCT01809327|594657332|FG000|Overall Study|Protocol Violation|0|||
164627850|NCT01809327|594657333|FG001|Overall Study|Protocol Violation|1|||
164627851|NCT01809327|594657334|FG002|Overall Study|Protocol Violation|0|||
164627852|NCT01809327|594657335|FG003|Overall Study|Protocol Violation|0|||
164627853|NCT01809327|594657336|FG004|Overall Study|Protocol Violation|0|||
164627854|NCT01809327|594657332|FG000|Overall Study|Physician Decision|1|||
164627855|NCT01809327|594657333|FG001|Overall Study|Physician Decision|1|||
164627856|NCT01809327|594657334|FG002|Overall Study|Physician Decision|0|||
164627857|NCT01809327|594657335|FG003|Overall Study|Physician Decision|0|||
164627858|NCT01809327|594657336|FG004|Overall Study|Physician Decision|0|||
164627859|NCT01809327|594657332|FG000|Overall Study|Pregnancy|1|||
164627860|NCT01809327|594657333|FG001|Overall Study|Pregnancy|0|||
164627861|NCT01809327|594657334|FG002|Overall Study|Pregnancy|0|||
164627862|NCT01809327|594657335|FG003|Overall Study|Pregnancy|0|||
164627863|NCT01809327|594657336|FG004|Overall Study|Pregnancy|0|||
164627864|NCT01809327|594657332|FG000|Overall Study|Other|14|||
164627865|NCT01809327|594657333|FG001|Overall Study|Other|15|||
164627866|NCT01809327|594657334|FG002|Overall Study|Other|7|||
164627867|NCT01809327|594657335|FG003|Overall Study|Other|4|||
164627868|NCT01809327|594657336|FG004|Overall Study|Other|9|||
164627869|NCT02802735|594657348|FG000|Overall Study|Withdrawal by Subject|0|||
164627870|NCT02802735|594657349|FG001|Overall Study|Withdrawal by Subject|1|||
164627871|NCT02802735|594657350|FG002|Overall Study|Withdrawal by Subject|0|||
164627872|NCT02802735|594657351|FG003|Overall Study|Withdrawal by Subject|0|||
164627873|NCT02802735|594657352|FG004|Overall Study|Withdrawal by Subject|0|||
164627874|NCT01166386|594657353|FG000|Overall Study|Withdrawal by Subject|3|||
164627875|NCT01166386|594657354|FG001|Overall Study|Withdrawal by Subject|5|||
164627876|NCT03922711|594657359|FG000|Overall Study|Adverse Event|3|||
164627877|NCT03922711|594657360|FG001|Overall Study|Adverse Event|2|||
164627878|NCT03922711|594657361|FG002|Overall Study|Adverse Event|2|||
164627879|NCT03922711|594657359|FG000|Overall Study|Protocol Violation|1|||
164627880|NCT03922711|594657360|FG001|Overall Study|Protocol Violation|0|||
164627881|NCT03922711|594657361|FG002|Overall Study|Protocol Violation|0|||
164627882|NCT03922711|594657359|FG000|Overall Study|Withdrawal by Subject|0|||
164627883|NCT03922711|594657360|FG001|Overall Study|Withdrawal by Subject|3|||
164627884|NCT03922711|594657361|FG002|Overall Study|Withdrawal by Subject|1|||
164627885|NCT03922711|594657359|FG000|Overall Study|Not further specified|0|||
164627886|NCT03922711|594657360|FG001|Overall Study|Not further specified|0|||
164627887|NCT03922711|594657361|FG002|Overall Study|Not further specified|1|||
164627888|NCT00420212|594657362|FG000|Overall Study|Adverse Event|22|||
164627889|NCT00420212|594657363|FG001|Overall Study|Adverse Event|40|||
164627890|NCT00420212|594657364|FG002|Overall Study|Adverse Event|36|||
164627891|NCT00420212|594657362|FG000|Overall Study|Lost to Follow-up|9|||
164627892|NCT00420212|594657363|FG001|Overall Study|Lost to Follow-up|11|||
164627893|NCT00420212|594657364|FG002|Overall Study|Lost to Follow-up|11|||
164627894|NCT00420212|594657362|FG000|Overall Study|Withdrawal by Subject|31|||
164627895|NCT00420212|594657363|FG001|Overall Study|Withdrawal by Subject|22|||
164627896|NCT00420212|594657364|FG002|Overall Study|Withdrawal by Subject|19|||
164627897|NCT00420212|594657362|FG000|Overall Study|Physician Decision|4|||
164627898|NCT00420212|594657363|FG001|Overall Study|Physician Decision|4|||
164627899|NCT00420212|594657364|FG002|Overall Study|Physician Decision|3|||
164627900|NCT00420212|594657362|FG000|Overall Study|Protocol Violation|4|||
164627901|NCT00420212|594657363|FG001|Overall Study|Protocol Violation|4|||
164627902|NCT00420212|594657364|FG002|Overall Study|Protocol Violation|8|||
164627903|NCT00420212|594657362|FG000|Overall Study|Death|0|||
164627904|NCT00420212|594657363|FG001|Overall Study|Death|0|||
164627905|NCT00420212|594657364|FG002|Overall Study|Death|1|||
164627906|NCT00420212|594657362|FG000|Overall Study|Other-Unspecified|21|||
164627907|NCT00420212|594657363|FG001|Overall Study|Other-Unspecified|14|||
164627908|NCT00420212|594657364|FG002|Overall Study|Other-Unspecified|18|||
164627909|NCT02390362|594657365|FG000|Overall Study|Withdrawal by Subject|0|||
164627910|NCT02390362|594657366|FG001|Overall Study|Withdrawal by Subject|1|||
164627911|NCT01142791|594657367|FG000|Overall Study|Alternative Treatment|1|||
164627912|NCT01142791|594657368|FG001|Overall Study|Alternative Treatment|0|||
164627913|NCT01142791|594657367|FG000|Overall Study|Lost to Follow-up|1|||
164627914|NCT01142791|594657368|FG001|Overall Study|Lost to Follow-up|0|||
164627915|NCT01142791|594657367|FG000|Overall Study|Withdrawal by Subject|5|||
164627916|NCT01142791|594657368|FG001|Overall Study|Withdrawal by Subject|0|||
164627917|NCT01142791|594657367|FG000|Overall Study|Received only 1 sonication|0|||
164627918|NCT01142791|594657368|FG001|Overall Study|Received only 1 sonication|6|||
164627919|NCT02178592|594657369|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
164627920|NCT02178592|594657370|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
164627921|NCT02178592|594657369|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
164627922|NCT02178592|594657370|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
164627923|NCT02178592|594657369|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
164627924|NCT02178592|594657370|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
164627925|NCT02178592|594657369|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
164627926|NCT02178592|594657370|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
164627927|NCT02178592|594657369|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
164627928|NCT02178592|594657370|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
164627929|NCT02178592|594657369|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
164627930|NCT02178592|594657370|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
164627931|NCT02178592|594657369|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
164627932|NCT02178592|594657370|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
164627933|NCT02178592|594657369|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
164627934|NCT02178592|594657370|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
164627935|NCT02178592|594657369|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
164627936|NCT02178592|594657370|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
164627937|NCT02178592|594657369|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
164627938|NCT02178592|594657370|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
164627939|NCT02178592|594657369|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
164627940|NCT02178592|594657370|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
164627941|NCT02178592|594657369|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
164627942|NCT02178592|594657370|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
164627943|NCT02975206|594657374|FG000|Overall Study|Withdrawal by Subject|14|||
164627944|NCT02975206|594657375|FG001|Overall Study|Withdrawal by Subject|11|||
164627945|NCT02975206|594657376|FG002|Overall Study|Withdrawal by Subject|11|||
164627946|NCT02975206|594657374|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
164627947|NCT02975206|594657375|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
164627948|NCT02975206|594657376|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
164627949|NCT00392210|594657383|FG000|First Voiding Trial|Physician Decision|2|||
164627950|NCT00392210|594657384|FG001|First Voiding Trial|Physician Decision|2|||
164627951|NCT02067104|594657385|FG000|Overall Study|Study termination due to low accrual|4|||
164627952|NCT02067104|594657386|FG001|Overall Study|Study termination due to low accrual|5|||
164627953|NCT02610231|594657387|FG000|Overall Study|Withdrawal by Subject|27|||
164627954|NCT02610231|594657387|FG000|Overall Study|Adverse Event|20|||
164627955|NCT02610231|594657387|FG000|Overall Study|Death|5|||
164627956|NCT02610231|594657387|FG000|Overall Study|Surgery|2|||
164627957|NCT02610231|594657387|FG000|Overall Study|Physician Decision|1|||
164627958|NCT02610231|594657387|FG000|Overall Study|Non Compliance|2|||
164627959|NCT02610231|594657387|FG000|Overall Study|Other|3|||
164627960|NCT01279954|594657395|FG000|Overall Study|Lack of Efficacy|3|||
164627961|NCT01279954|594657396|FG001|Overall Study|Lack of Efficacy|4|||
164627962|NCT02140762|594657397|FG000|Overall Study|Adverse Event|1|||
164627963|NCT02140762|594657398|FG001|Overall Study|Adverse Event|1|||
164627964|NCT02140762|594657397|FG000|Overall Study|Lost to Follow-up|9|||
164627965|NCT02140762|594657398|FG001|Overall Study|Lost to Follow-up|5|||
164627966|NCT02140762|594657397|FG000|Overall Study|Protocol Violation|1|||
164627967|NCT02140762|594657398|FG001|Overall Study|Protocol Violation|1|||
164627968|NCT02140762|594657397|FG000|Overall Study|Withdrawal by Subject|6|||
164627969|NCT02140762|594657398|FG001|Overall Study|Withdrawal by Subject|4|||
164627970|NCT02140762|594657397|FG000|Overall Study|Other|0|||
164627971|NCT02140762|594657398|FG001|Overall Study|Other|1|||
164627972|NCT01385098|594657399|FG000|Overall Study|Adverse Event|10|||
164627973|NCT01385098|594657399|FG000|Overall Study|Lost to Follow-up|4|||
164627974|NCT00795717|594657400|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
164627975|NCT00795717|594657401|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
164627976|NCT00795717|594657400|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
164627977|NCT00795717|594657401|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
164627978|NCT00795717|594657400|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
164627979|NCT00795717|594657401|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
164627980|NCT00795717|594657400|FG000|Phase II|too busy|0|||
164627981|NCT00795717|594657401|FG001|Phase II|too busy|1|||
164627982|NCT01021423|594657404|FG000|Overall Study|Study terminated|4|||
164627983|NCT01021423|594657405|FG001|Overall Study|Study terminated|5|||
164627984|NCT00122317|594657406|FG000|Overall Study|Death|3|||
164627985|NCT00122317|594657406|FG000|Overall Study|Adverse Event|4|||
164627986|NCT00122317|594657406|FG000|Overall Study|Physician Decision|2|||
164627987|NCT00122317|594657406|FG000|Overall Study|patient non-compliance|1|||
164627988|NCT00122317|594657406|FG000|Overall Study|Withdrawal by Subject|1|||
164627989|NCT03756285|594657407|FG000|Overall Study|Lost to Follow-up|0|||
164627990|NCT03756285|594657408|FG001|Overall Study|Lost to Follow-up|1|||
164627991|NCT03756285|594657407|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
164627992|NCT03756285|594657408|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
164627993|NCT03756285|594657407|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
164627994|NCT03756285|594657408|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
164627995|NCT06334055|594657409|FG000|Overall Study|Adverse Event|4|||
164627996|NCT06334055|594657409|FG000|Overall Study|Disqualified|72|||
164627997|NCT04728815|594657412|FG000|Overall Study|Lost to Follow-up|3|||
164627998|NCT04728815|594657413|FG001|Overall Study|Lost to Follow-up|0|||
164627999|NCT04728815|594657414|FG002|Overall Study|Lost to Follow-up|0|||
164628000|NCT04728815|594657415|FG003|Overall Study|Lost to Follow-up|1|||
164628001|NCT04728815|594657416|FG004|Overall Study|Lost to Follow-up|1|||
164628002|NCT04728815|594657417|FG005|Overall Study|Lost to Follow-up|0|||
164628003|NCT04728815|594657418|FG006|Overall Study|Lost to Follow-up|2|||
164628004|NCT04728815|594657419|FG007|Overall Study|Lost to Follow-up|0|||
164628005|NCT04728815|594657412|FG000|Overall Study|Physician Decision|0|||
164628006|NCT04728815|594657413|FG001|Overall Study|Physician Decision|0|||
164628007|NCT04728815|594657414|FG002|Overall Study|Physician Decision|1|||
164628008|NCT04728815|594657415|FG003|Overall Study|Physician Decision|0|||
164628009|NCT04728815|594657416|FG004|Overall Study|Physician Decision|0|||
164628010|NCT04728815|594657417|FG005|Overall Study|Physician Decision|0|||
164628011|NCT04728815|594657418|FG006|Overall Study|Physician Decision|0|||
164628012|NCT04728815|594657419|FG007|Overall Study|Physician Decision|0|||
164628013|NCT04728815|594657412|FG000|Overall Study|Treatment drop|0|||
164628014|NCT04728815|594657413|FG001|Overall Study|Treatment drop|2|||
164628015|NCT04728815|594657414|FG002|Overall Study|Treatment drop|1|||
164628016|NCT04728815|594657415|FG003|Overall Study|Treatment drop|0|||
164628017|NCT04728815|594657416|FG004|Overall Study|Treatment drop|3|||
164628018|NCT04728815|594657417|FG005|Overall Study|Treatment drop|1|||
164628019|NCT04728815|594657418|FG006|Overall Study|Treatment drop|3|||
164628020|NCT04728815|594657419|FG007|Overall Study|Treatment drop|0|||
164628021|NCT04728815|594657412|FG000|Overall Study|Study drop|0|||
164628022|NCT04728815|594657413|FG001|Overall Study|Study drop|3|||
164628023|NCT04728815|594657414|FG002|Overall Study|Study drop|3|||
164628024|NCT04728815|594657415|FG003|Overall Study|Study drop|0|||
164628025|NCT04728815|594657416|FG004|Overall Study|Study drop|0|||
164628026|NCT04728815|594657417|FG005|Overall Study|Study drop|0|||
164628027|NCT04728815|594657418|FG006|Overall Study|Study drop|7|||
164628028|NCT04728815|594657419|FG007|Overall Study|Study drop|0|||
164628029|NCT00957034|594657420|FG000|Overall Study|Adverse Event|0|||
164628030|NCT00957034|594657421|FG001|Overall Study|Adverse Event|1|||
164628031|NCT00957034|594657422|FG002|Overall Study|Adverse Event|1|||
164628032|NCT00957034|594657420|FG000|Overall Study|Sponsor Terminated Study|6|||
164628033|NCT00957034|594657421|FG001|Overall Study|Sponsor Terminated Study|1|||
164628034|NCT00957034|594657422|FG002|Overall Study|Sponsor Terminated Study|5|||
164628035|NCT00957034|594657420|FG000|Overall Study|Withdrawal by Subject|0|||
164628036|NCT00957034|594657421|FG001|Overall Study|Withdrawal by Subject|2|||
164628037|NCT00957034|594657422|FG002|Overall Study|Withdrawal by Subject|0|||
164628038|NCT05315297|594657423|FG000|Overall Study|Lost to Follow-up|6|||
164628039|NCT05315297|594657424|FG001|Overall Study|Lost to Follow-up|4|||
164628040|NCT05315297|594657423|FG000|Overall Study|Withdrawal by Subject|0|||
164628041|NCT05315297|594657424|FG001|Overall Study|Withdrawal by Subject|1|||
164628042|NCT00711009|594660314|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
164628043|NCT00711009|594660315|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
164628044|NCT00711009|594660314|FG000|Overall Study|Withdrawal by Subject|4|||
164628045|NCT00711009|594660315|FG001|Overall Study|Withdrawal by Subject|2|||
164628046|NCT00711009|594660314|FG000|Overall Study|Lost to Follow-up|3|||
164628047|NCT00711009|594660315|FG001|Overall Study|Lost to Follow-up|9|||
164628048|NCT00711009|594660314|FG000|Overall Study|Participant Noncompliant|0|||
164628049|NCT00711009|594660315|FG001|Overall Study|Participant Noncompliant|1|||
164628050|NCT00711009|594660314|FG000|Overall Study|Virologic Failure|2|||
164628051|NCT00711009|594660315|FG001|Overall Study|Virologic Failure|1|||
164628052|NCT00711009|594660314|FG000|Overall Study|Pregnancy|1|||
164628053|NCT00711009|594660315|FG001|Overall Study|Pregnancy|0|||
164628054|NCT00711009|594660314|FG000|Overall Study|Site closing|0|||
164628055|NCT00711009|594660315|FG001|Overall Study|Site closing|1|||
164628056|NCT00711009|594660314|FG000|Overall Study|Dose adjustment|1|||
164628057|NCT00711009|594660315|FG001|Overall Study|Dose adjustment|0|||
164628058|NCT02534324|594660316|FG000|Overall Study|Protocol Violation|4|||
164628059|NCT02534324|594660317|FG001|Overall Study|Protocol Violation|1|||
164628060|NCT02534324|594660316|FG000|Overall Study|Lost to Follow-up|20|||
164628061|NCT02534324|594660317|FG001|Overall Study|Lost to Follow-up|7|||
164628062|NCT02534324|594660316|FG000|Overall Study|Adverse Event|1|||
164628063|NCT02534324|594660317|FG001|Overall Study|Adverse Event|0|||
164628064|NCT01459016|594660320|FG000|Overall Study|Withdrawal by Subject|11|||
164628065|NCT01459016|594660320|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
164628066|NCT02039687|594660321|FG000|Overall Study|Adverse Event|0|||
164628067|NCT02039687|594660322|FG001|Overall Study|Adverse Event|0|||
164628068|NCT02039687|594660323|FG002|Overall Study|Adverse Event|1|||
164628069|NCT02039687|594660324|FG003|Overall Study|Adverse Event|0|||
164628070|NCT02039687|594660321|FG000|Overall Study|Withdrawal by Subject|0|||
164628071|NCT02039687|594660322|FG001|Overall Study|Withdrawal by Subject|1|||
164628072|NCT02039687|594660323|FG002|Overall Study|Withdrawal by Subject|0|||
164628073|NCT02039687|594660324|FG003|Overall Study|Withdrawal by Subject|0|||
164628074|NCT02039687|594660321|FG000|Overall Study|treatment assignment could not be confir|0|||
164628075|NCT02039687|594660322|FG001|Overall Study|treatment assignment could not be confir|0|||
164628076|NCT02039687|594660323|FG002|Overall Study|treatment assignment could not be confir|2|||
164628077|NCT02039687|594660324|FG003|Overall Study|treatment assignment could not be confir|0|||
164628078|NCT04450394|594660332|FG000|Overall Study|Adverse Event|2|||
164628079|NCT04450394|594660333|FG001|Overall Study|Adverse Event|0|||
164628080|NCT04450394|594660334|FG002|Overall Study|Adverse Event|0|||
164628081|NCT04450394|594660332|FG000|Overall Study|Death|0|||
164628082|NCT04450394|594660333|FG001|Overall Study|Death|1|||
164628083|NCT04450394|594660334|FG002|Overall Study|Death|0|||
164628084|NCT04450394|594660332|FG000|Overall Study|Lost to Follow-up|0|||
164628085|NCT04450394|594660333|FG001|Overall Study|Lost to Follow-up|3|||
164628086|NCT04450394|594660334|FG002|Overall Study|Lost to Follow-up|0|||
164628087|NCT04450394|594660332|FG000|Overall Study|Physician Decision|0|||
164628088|NCT04450394|594660333|FG001|Overall Study|Physician Decision|1|||
164628089|NCT04450394|594660334|FG002|Overall Study|Physician Decision|0|||
164628090|NCT04450394|594660332|FG000|Overall Study|Protocol Violation|2|||
164628091|NCT04450394|594660333|FG001|Overall Study|Protocol Violation|0|||
164628092|NCT04450394|594660334|FG002|Overall Study|Protocol Violation|0|||
164628093|NCT04450394|594660332|FG000|Overall Study|Withdrawal by Subject|6|||
164628094|NCT04450394|594660333|FG001|Overall Study|Withdrawal by Subject|9|||
164628095|NCT04450394|594660334|FG002|Overall Study|Withdrawal by Subject|0|||
164628096|NCT01066819|594660335|FG000|Overall Study|Adverse Event|18|||
164628097|NCT01066819|594660336|FG001|Overall Study|Adverse Event|1|||
164628098|NCT01066819|594660337|FG002|Overall Study|Adverse Event|6|||
164628099|NCT01066819|594660338|FG003|Overall Study|Adverse Event|0|||
164628100|NCT01066819|594660339|FG004|Overall Study|Adverse Event|0|||
164628101|NCT01066819|594660340|FG005|Overall Study|Adverse Event|0|||
164628102|NCT01066819|594660335|FG000|Overall Study|Death|5|||
164628103|NCT01066819|594660336|FG001|Overall Study|Death|0|||
164628104|NCT01066819|594660337|FG002|Overall Study|Death|1|||
164628105|NCT01066819|594660338|FG003|Overall Study|Death|0|||
164628106|NCT01066819|594660339|FG004|Overall Study|Death|0|||
164628107|NCT01066819|594660340|FG005|Overall Study|Death|0|||
164628108|NCT01066819|594660335|FG000|Overall Study|Lack of Efficacy|22|||
164628109|NCT01066819|594660336|FG001|Overall Study|Lack of Efficacy|1|||
164628110|NCT01066819|594660337|FG002|Overall Study|Lack of Efficacy|2|||
164628111|NCT01066819|594660338|FG003|Overall Study|Lack of Efficacy|1|||
164628112|NCT01066819|594660339|FG004|Overall Study|Lack of Efficacy|0|||
164628113|NCT01066819|594660340|FG005|Overall Study|Lack of Efficacy|0|||
164628114|NCT01066819|594660335|FG000|Overall Study|Physician Decision|6|||
164628115|NCT01066819|594660336|FG001|Overall Study|Physician Decision|2|||
164628116|NCT01066819|594660337|FG002|Overall Study|Physician Decision|3|||
164628117|NCT01066819|594660338|FG003|Overall Study|Physician Decision|0|||
164628118|NCT01066819|594660339|FG004|Overall Study|Physician Decision|0|||
164628119|NCT01066819|594660340|FG005|Overall Study|Physician Decision|0|||
164628120|NCT01066819|594660335|FG000|Overall Study|Protocol Violation|12|||
164628121|NCT01066819|594660336|FG001|Overall Study|Protocol Violation|6|||
164628122|NCT01066819|594660337|FG002|Overall Study|Protocol Violation|0|||
164628123|NCT01066819|594660338|FG003|Overall Study|Protocol Violation|0|||
164628124|NCT01066819|594660339|FG004|Overall Study|Protocol Violation|0|||
164628125|NCT01066819|594660340|FG005|Overall Study|Protocol Violation|0|||
164628126|NCT01066819|594660335|FG000|Overall Study|Withdrawal by Subject|29|||
164628127|NCT01066819|594660336|FG001|Overall Study|Withdrawal by Subject|11|||
164628128|NCT01066819|594660337|FG002|Overall Study|Withdrawal by Subject|6|||
164628129|NCT01066819|594660338|FG003|Overall Study|Withdrawal by Subject|0|||
164628130|NCT01066819|594660339|FG004|Overall Study|Withdrawal by Subject|0|||
164628131|NCT01066819|594660340|FG005|Overall Study|Withdrawal by Subject|0|||
164628132|NCT01066819|594660335|FG000|Overall Study|Administrative|6|||
164628133|NCT01066819|594660336|FG001|Overall Study|Administrative|4|||
164628134|NCT01066819|594660337|FG002|Overall Study|Administrative|2|||
164628135|NCT01066819|594660338|FG003|Overall Study|Administrative|0|||
164628136|NCT01066819|594660339|FG004|Overall Study|Administrative|0|||
164628137|NCT01066819|594660340|FG005|Overall Study|Administrative|0|||
164628138|NCT01066819|594660335|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
164628139|NCT01066819|594660336|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
164628140|NCT01066819|594660337|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
164628141|NCT01066819|594660338|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
164628142|NCT01066819|594660339|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
164628143|NCT01066819|594660340|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
164628144|NCT01066819|594660335|FG000|Overall Study|Early termination|2|||
164628145|NCT01066819|594660336|FG001|Overall Study|Early termination|0|||
164628146|NCT01066819|594660337|FG002|Overall Study|Early termination|0|||
164628147|NCT01066819|594660338|FG003|Overall Study|Early termination|0|||
164628148|NCT01066819|594660339|FG004|Overall Study|Early termination|0|||
164628149|NCT01066819|594660340|FG005|Overall Study|Early termination|0|||
164628150|NCT01066819|594660335|FG000|Overall Study|Failed to return|298|||
164628151|NCT01066819|594660336|FG001|Overall Study|Failed to return|107|||
164628152|NCT01066819|594660337|FG002|Overall Study|Failed to return|68|||
164628153|NCT01066819|594660338|FG003|Overall Study|Failed to return|7|||
164628154|NCT01066819|594660339|FG004|Overall Study|Failed to return|2|||
164628155|NCT01066819|594660340|FG005|Overall Study|Failed to return|3|||
164628156|NCT01066819|594660335|FG000|Overall Study|Lab test not done|9|||
164628157|NCT01066819|594660336|FG001|Overall Study|Lab test not done|0|||
164628158|NCT01066819|594660337|FG002|Overall Study|Lab test not done|2|||
164628159|NCT01066819|594660338|FG003|Overall Study|Lab test not done|1|||
164628160|NCT01066819|594660339|FG004|Overall Study|Lab test not done|0|||
164628161|NCT01066819|594660340|FG005|Overall Study|Lab test not done|0|||
164628162|NCT01066819|594660335|FG000|Overall Study|Miscellaneous|28|||
164628163|NCT01066819|594660336|FG001|Overall Study|Miscellaneous|10|||
164628164|NCT01066819|594660337|FG002|Overall Study|Miscellaneous|18|||
164628165|NCT01066819|594660338|FG003|Overall Study|Miscellaneous|1|||
164628166|NCT01066819|594660339|FG004|Overall Study|Miscellaneous|0|||
164628167|NCT01066819|594660340|FG005|Overall Study|Miscellaneous|0|||
164628168|NCT01066819|594660335|FG000|Overall Study|Non responders|123|||
164628169|NCT01066819|594660336|FG001|Overall Study|Non responders|2|||
164628170|NCT01066819|594660337|FG002|Overall Study|Non responders|7|||
164628171|NCT01066819|594660338|FG003|Overall Study|Non responders|2|||
164628172|NCT01066819|594660339|FG004|Overall Study|Non responders|0|||
164628173|NCT01066819|594660340|FG005|Overall Study|Non responders|1|||
164628174|NCT01066819|594660335|FG000|Overall Study|Not categorised|9|||
164628175|NCT01066819|594660336|FG001|Overall Study|Not categorised|2|||
164628176|NCT01066819|594660337|FG002|Overall Study|Not categorised|6|||
164628177|NCT01066819|594660338|FG003|Overall Study|Not categorised|1|||
164628178|NCT01066819|594660339|FG004|Overall Study|Not categorised|0|||
164628179|NCT01066819|594660340|FG005|Overall Study|Not categorised|0|||
164628180|NCT01066819|594660335|FG000|Overall Study|Relapse|16|||
164628181|NCT01066819|594660336|FG001|Overall Study|Relapse|4|||
164628182|NCT01066819|594660337|FG002|Overall Study|Relapse|3|||
164628183|NCT01066819|594660338|FG003|Overall Study|Relapse|0|||
164628184|NCT01066819|594660339|FG004|Overall Study|Relapse|0|||
164628185|NCT01066819|594660340|FG005|Overall Study|Relapse|0|||
164628186|NCT01066819|594660335|FG000|Overall Study|Results not available|1|||
164628187|NCT01066819|594660336|FG001|Overall Study|Results not available|0|||
164628188|NCT01066819|594660337|FG002|Overall Study|Results not available|0|||
164628189|NCT01066819|594660338|FG003|Overall Study|Results not available|0|||
164628190|NCT01066819|594660339|FG004|Overall Study|Results not available|0|||
164628191|NCT01066819|594660340|FG005|Overall Study|Results not available|0|||
164628192|NCT01066819|594660335|FG000|Overall Study|Screen failure|1|||
164628193|NCT01066819|594660336|FG001|Overall Study|Screen failure|0|||
164628194|NCT01066819|594660337|FG002|Overall Study|Screen failure|0|||
164628195|NCT01066819|594660338|FG003|Overall Study|Screen failure|0|||
164628196|NCT01066819|594660339|FG004|Overall Study|Screen failure|0|||
164628197|NCT01066819|594660340|FG005|Overall Study|Screen failure|0|||
164628198|NCT01066819|594660335|FG000|Overall Study|Spontaneous cure|1|||
164628199|NCT01066819|594660336|FG001|Overall Study|Spontaneous cure|0|||
164628200|NCT01066819|594660337|FG002|Overall Study|Spontaneous cure|0|||
164628201|NCT01066819|594660338|FG003|Overall Study|Spontaneous cure|0|||
164628202|NCT01066819|594660339|FG004|Overall Study|Spontaneous cure|0|||
164628203|NCT01066819|594660340|FG005|Overall Study|Spontaneous cure|0|||
164628204|NCT01066819|594660335|FG000|Overall Study|Treatment never started|85|||
164628205|NCT01066819|594660336|FG001|Overall Study|Treatment never started|19|||
164628206|NCT01066819|594660337|FG002|Overall Study|Treatment never started|19|||
164628207|NCT01066819|594660338|FG003|Overall Study|Treatment never started|3|||
164628208|NCT01066819|594660339|FG004|Overall Study|Treatment never started|2|||
164628209|NCT01066819|594660340|FG005|Overall Study|Treatment never started|2|||
164628210|NCT01066819|594660335|FG000|Overall Study|Treatment stopped|12|||
164628211|NCT01066819|594660336|FG001|Overall Study|Treatment stopped|1|||
164628212|NCT01066819|594660337|FG002|Overall Study|Treatment stopped|2|||
164628213|NCT01066819|594660338|FG003|Overall Study|Treatment stopped|1|||
164628214|NCT01066819|594660339|FG004|Overall Study|Treatment stopped|0|||
164628215|NCT01066819|594660340|FG005|Overall Study|Treatment stopped|0|||
164628216|NCT01066819|594660335|FG000|Overall Study|Other|5|||
164628217|NCT01066819|594660336|FG001|Overall Study|Other|1|||
164628218|NCT01066819|594660337|FG002|Overall Study|Other|1|||
164628219|NCT01066819|594660338|FG003|Overall Study|Other|0|||
164628220|NCT01066819|594660339|FG004|Overall Study|Other|0|||
164628221|NCT01066819|594660340|FG005|Overall Study|Other|0|||
164628222|NCT02194699|594660341|FG000|Randomised|Did not receive treatment|1|||
164628223|NCT02194699|594660342|FG001|Randomised|Did not receive treatment|5|||
164528027|NCT03149549|594303740|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
164528028|NCT03149549|594303741|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
164528029|NCT03149549|594303742|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
164528030|NCT03149549|594303743|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
164528031|NCT03149549|594303744|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
164528032|NCT03149549|594303745|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
164528033|NCT03149549|594303746|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
164528034|NCT03149549|594303747|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
164528035|NCT03149549|594303748|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
164528036|NCT03149549|594303749|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
164528037|NCT03149549|594303750|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
164528038|NCT03149549|594303751|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
164528039|NCT03149549|594303739|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
164528040|NCT03149549|594303740|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
164528041|NCT03149549|594303741|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
164528042|NCT03149549|594303742|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
164528043|NCT03149549|594303743|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
164528044|NCT03149549|594303744|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
164528045|NCT03149549|594303745|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
164528046|NCT03149549|594303746|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
164528047|NCT03149549|594303747|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
164528048|NCT03149549|594303748|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
164528049|NCT03149549|594303749|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
164528050|NCT03149549|594303750|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
164528051|NCT03149549|594303751|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
164528052|NCT03149549|594303739|FG000|Study Discontinuation--Treatment Period|Other|0|||
164528053|NCT03149549|594303740|FG001|Study Discontinuation--Treatment Period|Other|0|||
164528054|NCT03149549|594303741|FG002|Study Discontinuation--Treatment Period|Other|0|||
164528055|NCT03149549|594303742|FG003|Study Discontinuation--Treatment Period|Other|0|||
164528056|NCT03149549|594303743|FG004|Study Discontinuation--Treatment Period|Other|0|||
164528057|NCT03149549|594303744|FG005|Study Discontinuation--Treatment Period|Other|0|||
164528058|NCT03149549|594303745|FG006|Study Discontinuation--Treatment Period|Other|0|||
164528059|NCT03149549|594303746|FG007|Study Discontinuation--Treatment Period|Other|1|||
164528060|NCT03149549|594303747|FG008|Study Discontinuation--Treatment Period|Other|0|||
164528061|NCT03149549|594303748|FG009|Study Discontinuation--Treatment Period|Other|1|||
164528062|NCT03149549|594303749|FG010|Study Discontinuation--Treatment Period|Other|0|||
164528063|NCT03149549|594303750|FG011|Study Discontinuation--Treatment Period|Other|0|||
164528064|NCT03149549|594303751|FG012|Study Discontinuation--Treatment Period|Other|0|||
164528065|NCT03149549|594303739|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
164528066|NCT03149549|594303740|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
164528067|NCT03149549|594303741|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
164528068|NCT03149549|594303742|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
164528069|NCT03149549|594303743|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
164528070|NCT03149549|594303744|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
164528071|NCT03149549|594303745|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
164528072|NCT03149549|594303746|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
164528073|NCT03149549|594303747|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
164528074|NCT03149549|594303748|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
164528075|NCT03149549|594303749|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
164528076|NCT03149549|594303750|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
164528077|NCT03149549|594303751|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
164528078|NCT03149549|594303739|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
164528079|NCT03149549|594303740|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
164528080|NCT03149549|594303741|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
164528081|NCT03149549|594303742|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
164528082|NCT03149549|594303743|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
164528083|NCT03149549|594303744|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
164528084|NCT03149549|594303745|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
164528085|NCT03149549|594303746|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
164528086|NCT03149549|594303747|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
164528087|NCT03149549|594303748|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
164528088|NCT03149549|594303749|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
164628224|NCT02194699|594660341|FG000|Randomised|Without potential for 52 weeks of IP|5|||
164628225|NCT02194699|594660342|FG001|Randomised|Without potential for 52 weeks of IP|5|||
164628226|NCT02194699|594660341|FG000|Randomised|Duplicate patient|2|||
164628227|NCT02194699|594660342|FG001|Randomised|Duplicate patient|1|||
164628228|NCT02194699|594660341|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
164628229|NCT02194699|594660342|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
164628230|NCT02194699|594660341|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
164628231|NCT02194699|594660342|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
164628232|NCT02194699|594660341|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
164628233|NCT02194699|594660342|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
164628234|NCT02194699|594660341|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
164628235|NCT02194699|594660342|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
164628236|NCT02194699|594660341|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
164628237|NCT02194699|594660342|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
164628238|NCT02194699|594660341|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
164628239|NCT02194699|594660342|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
164628240|NCT01539720|594660344|FG000|Overall Study|Screen Fail|15|||
164628241|NCT01539720|594660345|FG001|Overall Study|Screen Fail|3|||
164628242|NCT01539720|594660344|FG000|Overall Study|Lost to Follow-up|14|||
164628243|NCT01539720|594660345|FG001|Overall Study|Lost to Follow-up|7|||
164628244|NCT03812224|594660352|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
164628245|NCT03812224|594660353|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
164628246|NCT03812224|594660352|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
164628247|NCT03812224|594660353|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
164628248|NCT03812224|594660352|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
164628249|NCT03812224|594660353|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
164628250|NCT03812224|594660352|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
164628251|NCT03812224|594660353|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
164628252|NCT01667731|594660357|FG000|Overall Study|Enrolled but not treated|0|||
164628253|NCT01667731|594660358|FG001|Overall Study|Enrolled but not treated|0|||
164628254|NCT01667731|594660359|FG002|Overall Study|Enrolled but not treated|0|||
164628255|NCT01667731|594660360|FG003|Overall Study|Enrolled but not treated|0|||
164628256|NCT01667731|594660361|FG004|Overall Study|Enrolled but not treated|1|||
164628257|NCT01667731|594660357|FG000|Overall Study|Efficacy Failure|1|||
164628258|NCT01667731|594660358|FG001|Overall Study|Efficacy Failure|12|||
164628259|NCT01667731|594660359|FG002|Overall Study|Efficacy Failure|0|||
164628260|NCT01667731|594660360|FG003|Overall Study|Efficacy Failure|1|||
164628261|NCT01667731|594660361|FG004|Overall Study|Efficacy Failure|24|||
164628262|NCT01667731|594660357|FG000|Overall Study|Lost to Follow-up|2|||
164628263|NCT01667731|594660358|FG001|Overall Study|Lost to Follow-up|3|||
164628264|NCT01667731|594660359|FG002|Overall Study|Lost to Follow-up|1|||
164628265|NCT01667731|594660360|FG003|Overall Study|Lost to Follow-up|1|||
164628266|NCT01667731|594660361|FG004|Overall Study|Lost to Follow-up|2|||
164628267|NCT01667731|594660357|FG000|Overall Study|Subject Withdrew Consent|2|||
164628268|NCT01667731|594660358|FG001|Overall Study|Subject Withdrew Consent|0|||
164628269|NCT01667731|594660359|FG002|Overall Study|Subject Withdrew Consent|1|||
164628270|NCT01667731|594660360|FG003|Overall Study|Subject Withdrew Consent|0|||
164628271|NCT01667731|594660361|FG004|Overall Study|Subject Withdrew Consent|1|||
164628272|NCT01667731|594660357|FG000|Overall Study|Death|0|||
164628273|NCT01667731|594660358|FG001|Overall Study|Death|1|||
164628274|NCT01667731|594660359|FG002|Overall Study|Death|0|||
164628275|NCT01667731|594660360|FG003|Overall Study|Death|0|||
164628276|NCT01667731|594660361|FG004|Overall Study|Death|0|||
164628277|NCT02516605|594660370|FG000|Overall Study|Protocol Violation|0|||
164628278|NCT02516605|594660371|FG001|Overall Study|Protocol Violation|0|||
164628279|NCT02516605|594660372|FG002|Overall Study|Protocol Violation|0|||
164628280|NCT02516605|594660373|FG003|Overall Study|Protocol Violation|0|||
164628281|NCT02516605|594660374|FG004|Overall Study|Protocol Violation|1|||
164628282|NCT02516605|594660370|FG000|Overall Study|Withdrawal by Subject|0|||
164628283|NCT02516605|594660371|FG001|Overall Study|Withdrawal by Subject|0|||
164628284|NCT02516605|594660372|FG002|Overall Study|Withdrawal by Subject|0|||
164628285|NCT02516605|594660373|FG003|Overall Study|Withdrawal by Subject|1|||
164628286|NCT02516605|594660374|FG004|Overall Study|Withdrawal by Subject|0|||
164628287|NCT02127970|594660375|FG000|Overall Study|Adverse Event|2|||
164628288|NCT02127970|594660376|FG001|Overall Study|Adverse Event|1|||
164628289|NCT02127970|594660375|FG000|Overall Study|Death|1|||
164628290|NCT02127970|594660376|FG001|Overall Study|Death|1|||
164628291|NCT02127970|594660375|FG000|Overall Study|Lost to Follow-up|14|||
164628292|NCT02127970|594660376|FG001|Overall Study|Lost to Follow-up|14|||
164628293|NCT02127970|594660375|FG000|Overall Study|Reason not Specified|4|||
164628294|NCT02127970|594660376|FG001|Overall Study|Reason not Specified|7|||
164628295|NCT02127970|594660375|FG000|Overall Study|Pregnancy|0|||
164628296|NCT02127970|594660376|FG001|Overall Study|Pregnancy|1|||
164628297|NCT02127970|594660375|FG000|Overall Study|Subject Withdrew Consent|5|||
164628298|NCT02127970|594660376|FG001|Overall Study|Subject Withdrew Consent|3|||
164628299|NCT01398176|594660378|FG000|Overall Study|Lost to Follow-up|1|||
164628300|NCT01398176|594660379|FG001|Overall Study|Lost to Follow-up|3|||
164628301|NCT01398176|594660378|FG000|Overall Study|Physician Decision|2|||
164628302|NCT01398176|594660379|FG001|Overall Study|Physician Decision|3|||
164628303|NCT01871870|594660383|FG000|Overall Study|Hardware issues|7|||
164628304|NCT01871870|594660383|FG000|Overall Study|hyperglycemia|2|||
164628305|NCT05102734|594660384|FG000|Overall Study|Did not require vasopressors|1|||
164628306|NCT05102734|594660385|FG001|Overall Study|Did not require vasopressors|0|||
164628307|NCT05102734|594660384|FG000|Overall Study|Did not have functioning PA catheter|1|||
164628308|NCT05102734|594660385|FG001|Overall Study|Did not have functioning PA catheter|0|||
164628309|NCT05102734|594660384|FG000|Overall Study|Inadequate video quality|2|||
164628310|NCT05102734|594660385|FG001|Overall Study|Inadequate video quality|0|||
164628311|NCT03055806|594660386|FG000|Overall Study|Adverse Event|0|||
164628312|NCT03055806|594660387|FG001|Overall Study|Adverse Event|0|||
164628313|NCT03055806|594660388|FG002|Overall Study|Adverse Event|1|||
164628314|NCT03055806|594660389|FG003|Overall Study|Adverse Event|1|||
164628315|NCT03055806|594660386|FG000|Overall Study|Lost to Follow-up|0|||
164628316|NCT03055806|594660387|FG001|Overall Study|Lost to Follow-up|3|||
164628317|NCT03055806|594660388|FG002|Overall Study|Lost to Follow-up|6|||
164628318|NCT03055806|594660389|FG003|Overall Study|Lost to Follow-up|7|||
164628319|NCT03055806|594660386|FG000|Overall Study|Physician Decision|1|||
164628320|NCT03055806|594660387|FG001|Overall Study|Physician Decision|0|||
164628321|NCT03055806|594660388|FG002|Overall Study|Physician Decision|0|||
164628322|NCT03055806|594660389|FG003|Overall Study|Physician Decision|1|||
164628323|NCT03055806|594660386|FG000|Overall Study|Protocol Violation|1|||
164628324|NCT03055806|594660387|FG001|Overall Study|Protocol Violation|0|||
164628325|NCT03055806|594660388|FG002|Overall Study|Protocol Violation|0|||
164628326|NCT03055806|594660389|FG003|Overall Study|Protocol Violation|0|||
164628327|NCT03055806|594660386|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
164628328|NCT03055806|594660387|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
164628329|NCT03055806|594660388|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
164628330|NCT03055806|594660389|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
164628331|NCT03055806|594660386|FG000|Overall Study|Withdrawal of consent to continue study|2|||
164628332|NCT03055806|594660387|FG001|Overall Study|Withdrawal of consent to continue study|3|||
164628333|NCT03055806|594660388|FG002|Overall Study|Withdrawal of consent to continue study|4|||
164628334|NCT03055806|594660389|FG003|Overall Study|Withdrawal of consent to continue study|6|||
164628335|NCT03055806|594660386|FG000|Overall Study|Partner not willing to try intercourse|1|||
164628336|NCT03055806|594660387|FG001|Overall Study|Partner not willing to try intercourse|0|||
164628337|NCT03055806|594660388|FG002|Overall Study|Partner not willing to try intercourse|0|||
164628338|NCT03055806|594660389|FG003|Overall Study|Partner not willing to try intercourse|0|||
164628339|NCT00846027|594660390|FG000|Overall Study|Death|3|||
164628340|NCT00846027|594660390|FG000|Overall Study|Disease Progression|30|||
164628341|NCT00846027|594660390|FG000|Overall Study|Toxicity|12|||
164628342|NCT00846027|594660390|FG000|Overall Study|Patient Decision|7|||
164628343|NCT00846027|594660390|FG000|Overall Study|Investigator Discretion|29|||
164628344|NCT00846027|594660390|FG000|Overall Study|Protocol Violation|2|||
164628345|NCT00846027|594660390|FG000|Overall Study|Subject Not Treated|7|||
164628346|NCT04905563|594660393|FG000|Overall Study|Withdrawal by Subject|1|||
164628347|NCT04905563|594660394|FG001|Overall Study|Withdrawal by Subject|0|||
164628348|NCT04905563|594660393|FG000|Overall Study|Standard of care orders entered by resident|1|||
164628349|NCT04905563|594660394|FG001|Overall Study|Standard of care orders entered by resident|0|||
164628350|NCT04905563|594660393|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
164628351|NCT04905563|594660394|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
164628352|NCT04905563|594660393|FG000|Overall Study|Withdrawal by Subject|0|||
164628353|NCT04905563|594660394|FG001|Overall Study|Withdrawal by Subject|1|||
164628354|NCT02418000|594660395|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
164628355|NCT02418000|594660396|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
164628356|NCT02418000|594660397|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
164628357|NCT02418000|594660398|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
164628358|NCT02418000|594660399|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
164628359|NCT02418000|594660395|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
164628360|NCT02418000|594660396|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
164628361|NCT02418000|594660397|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
164628362|NCT02418000|594660398|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
164628363|NCT02418000|594660399|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
164628364|NCT02418000|594660395|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
164628365|NCT02418000|594660396|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
164628366|NCT02418000|594660397|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
164628367|NCT02418000|594660398|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
164628368|NCT02418000|594660399|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
164628369|NCT02418000|594660395|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
164628370|NCT02418000|594660396|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
164628371|NCT02418000|594660397|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
164628372|NCT02418000|594660398|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
164628373|NCT02418000|594660399|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
164628374|NCT02418000|594660395|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
164628375|NCT02418000|594660396|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
164628376|NCT02418000|594660397|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
164628377|NCT02418000|594660398|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
164628378|NCT02418000|594660399|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
164628379|NCT02418000|594660395|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
164628380|NCT02418000|594660396|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
164628381|NCT02418000|594660397|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
164628382|NCT02418000|594660398|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
164628383|NCT02418000|594660399|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
164628384|NCT02418000|594660395|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
164628385|NCT02418000|594660396|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
164628386|NCT02418000|594660397|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
164628387|NCT02418000|594660398|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
164628388|NCT02418000|594660399|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
164628389|NCT02418000|594660395|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
164628390|NCT02418000|594660396|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
164628391|NCT02418000|594660397|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
164628392|NCT02418000|594660398|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
164628393|NCT02418000|594660399|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
164628394|NCT02418000|594660395|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
164628395|NCT02418000|594660396|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
164628396|NCT02418000|594660397|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
164628397|NCT02418000|594660398|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
164628398|NCT02418000|594660399|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
164628399|NCT00490815|594660400|FG000|Overall Study|Adverse Event|2|||
164628400|NCT00490815|594660401|FG001|Overall Study|Adverse Event|3|||
164628401|NCT00490815|594660400|FG000|Overall Study|Withdrawal by Subject|4|||
164628402|NCT00490815|594660401|FG001|Overall Study|Withdrawal by Subject|0|||
164628403|NCT00490815|594660400|FG000|Overall Study|Lost to Follow-up|1|||
164628404|NCT00490815|594660401|FG001|Overall Study|Lost to Follow-up|3|||
164628405|NCT00490815|594660400|FG000|Overall Study|Death|1|||
164628406|NCT00490815|594660401|FG001|Overall Study|Death|3|||
164628407|NCT01904760|594660402|FG000|Overall Study|Protocol Violation|1|||
164628408|NCT01904760|594660403|FG001|Overall Study|Protocol Violation|0|||
164628409|NCT04249076|594660405|FG000|Overall Study|Adverse Event|1|||
164628410|NCT04249076|594660406|FG001|Overall Study|Adverse Event|1|||
164628411|NCT04249076|594660405|FG000|Overall Study|Protocol Violation|1|||
164628412|NCT04249076|594660406|FG001|Overall Study|Protocol Violation|2|||
164628413|NCT04249076|594660405|FG000|Overall Study|Lack of Efficacy|0|||
164628414|NCT04249076|594660406|FG001|Overall Study|Lack of Efficacy|1|||
164628415|NCT04249076|594660405|FG000|Overall Study|Withdrawal by Subject|0|||
164628416|NCT04249076|594660406|FG001|Overall Study|Withdrawal by Subject|1|||
164628417|NCT00732199|594660411|FG000|Overall Study|Withdrawal by Subject|25|||
164628418|NCT00732199|594660412|FG001|Overall Study|Withdrawal by Subject|18|||
164628419|NCT00732199|594660411|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
164628420|NCT00732199|594660412|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
164628421|NCT01284127|594660427|FG000|Overall Study|Adverse Event|2|||
164628422|NCT01284127|594660427|FG000|Overall Study|Withdrawal by Subject|4|||
164628423|NCT01284127|594660427|FG000|Overall Study|Physician Decision|1|||
164628424|NCT02607865|594660429|FG000|Overall Study|Lost to Follow-up|9|||
164628425|NCT02607865|594660430|FG001|Overall Study|Lost to Follow-up|7|||
164628426|NCT02607865|594660431|FG002|Overall Study|Lost to Follow-up|7|||
164628427|NCT02607865|594660432|FG003|Overall Study|Lost to Follow-up|5|||
164628428|NCT02607865|594660429|FG000|Overall Study|Withdrawal by Subject|18|||
164628429|NCT02607865|594660430|FG001|Overall Study|Withdrawal by Subject|18|||
164628430|NCT02607865|594660431|FG002|Overall Study|Withdrawal by Subject|17|||
164628431|NCT02607865|594660432|FG003|Overall Study|Withdrawal by Subject|8|||
164628432|NCT02607865|594660429|FG000|Overall Study|Death|5|||
164628433|NCT02607865|594660430|FG001|Overall Study|Death|4|||
164628434|NCT02607865|594660431|FG002|Overall Study|Death|1|||
164628435|NCT02607865|594660432|FG003|Overall Study|Death|3|||
164628436|NCT02607865|594660429|FG000|Overall Study|Unclassified|1|||
164628437|NCT02607865|594660430|FG001|Overall Study|Unclassified|1|||
164628438|NCT02607865|594660431|FG002|Overall Study|Unclassified|2|||
164628439|NCT02607865|594660432|FG003|Overall Study|Unclassified|0|||
164628440|NCT01351415|594660436|FG000|Overall Study|Withdrawal by Subject|15|||
164628441|NCT01351415|594660437|FG001|Overall Study|Withdrawal by Subject|17|||
164628442|NCT01351415|594660436|FG000|Overall Study|Trial termination by the Sponsor|28|||
164628443|NCT01351415|594660437|FG001|Overall Study|Trial termination by the Sponsor|19|||
164628444|NCT01351415|594660436|FG000|Overall Study|Lost to Follow-up|5|||
164628445|NCT01351415|594660437|FG001|Overall Study|Lost to Follow-up|7|||
164628446|NCT01351415|594660436|FG000|Overall Study|Death|190|||
164628447|NCT01351415|594660437|FG001|Overall Study|Death|187|||
164628448|NCT01351415|594660436|FG000|Overall Study|Physician Decision|2|||
164628449|NCT01351415|594660437|FG001|Overall Study|Physician Decision|3|||
164628450|NCT01351415|594660436|FG000|Overall Study|Reason unknown|0|||
164628451|NCT01351415|594660437|FG001|Overall Study|Reason unknown|2|||
164628452|NCT01351415|594660436|FG000|Overall Study|Never Started|5|||
164628453|NCT01351415|594660437|FG001|Overall Study|Never Started|5|||
164628454|NCT00994890|594660438|FG000|Overall Study|Adverse Event|13|||
164628455|NCT00994890|594660439|FG001|Overall Study|Adverse Event|9|||
164628456|NCT00994890|594660440|FG002|Overall Study|Adverse Event|11|||
164628457|NCT00994890|594660438|FG000|Overall Study|Lack of Efficacy|0|||
164628458|NCT00994890|594660439|FG001|Overall Study|Lack of Efficacy|0|||
164628459|NCT00994890|594660440|FG002|Overall Study|Lack of Efficacy|1|||
164628460|NCT00994890|594660438|FG000|Overall Study|Lost to Follow-up|6|||
164628461|NCT00994890|594660439|FG001|Overall Study|Lost to Follow-up|1|||
164628462|NCT00994890|594660440|FG002|Overall Study|Lost to Follow-up|3|||
164628463|NCT00994890|594660438|FG000|Overall Study|No longer willing to participate|8|||
164628464|NCT00994890|594660439|FG001|Overall Study|No longer willing to participate|5|||
164628465|NCT00994890|594660440|FG002|Overall Study|No longer willing to participate|13|||
164628466|NCT00994890|594660438|FG000|Overall Study|Protocol Violation|2|||
164628467|NCT00994890|594660439|FG001|Overall Study|Protocol Violation|4|||
164628468|NCT00994890|594660440|FG002|Overall Study|Protocol Violation|0|||
164628469|NCT00994890|594660438|FG000|Overall Study|Study terminated by sponsor|199|||
164628470|NCT00994890|594660439|FG001|Overall Study|Study terminated by sponsor|201|||
164628471|NCT00994890|594660440|FG002|Overall Study|Study terminated by sponsor|197|||
164628472|NCT00994890|594660438|FG000|Overall Study|Randomized, but not treated|1|||
164628473|NCT00994890|594660439|FG001|Overall Study|Randomized, but not treated|0|||
164628474|NCT00994890|594660440|FG002|Overall Study|Randomized, but not treated|0|||
164628475|NCT00994890|594660438|FG000|Overall Study|Other|2|||
164628476|NCT00994890|594660439|FG001|Overall Study|Other|2|||
164628477|NCT00994890|594660440|FG002|Overall Study|Other|1|||
164628478|NCT00699582|594660441|FG000|Overall Study|Adverse Event|4|||
164628479|NCT00699582|594660442|FG001|Overall Study|Adverse Event|11|||
164628480|NCT00699582|594660443|FG002|Overall Study|Adverse Event|23|||
164628481|NCT00699582|594660441|FG000|Overall Study|Withdrawal by Subject|6|||
164628482|NCT00699582|594660442|FG001|Overall Study|Withdrawal by Subject|7|||
164628483|NCT00699582|594660443|FG002|Overall Study|Withdrawal by Subject|4|||
164628484|NCT00699582|594660441|FG000|Overall Study|Lack of Efficacy|1|||
164628485|NCT00699582|594660442|FG001|Overall Study|Lack of Efficacy|0|||
164628486|NCT00699582|594660443|FG002|Overall Study|Lack of Efficacy|1|||
164628487|NCT00699582|594660441|FG000|Overall Study|Progressive Disease|1|||
164628488|NCT00699582|594660442|FG001|Overall Study|Progressive Disease|0|||
164628489|NCT00699582|594660443|FG002|Overall Study|Progressive Disease|0|||
164628490|NCT00699582|594660441|FG000|Overall Study|Administrative/Other|4|||
164628491|NCT00699582|594660442|FG001|Overall Study|Administrative/Other|3|||
164628492|NCT00699582|594660443|FG002|Overall Study|Administrative/Other|0|||
164628493|NCT00699582|594660441|FG000|Overall Study|Randomized, Not Treated|2|||
164628494|NCT00699582|594660442|FG001|Overall Study|Randomized, Not Treated|1|||
164628495|NCT00699582|594660443|FG002|Overall Study|Randomized, Not Treated|0|||
164628496|NCT01849289|594660444|FG000|Overall Study|Adverse Event|3|||
164628497|NCT01849289|594660445|FG001|Overall Study|Adverse Event|3|||
164628498|NCT01849289|594660444|FG000|Overall Study|Protocol Violation|3|||
164628499|NCT01849289|594660445|FG001|Overall Study|Protocol Violation|3|||
164628500|NCT01849289|594660444|FG000|Overall Study|Withdrawal criteria|1|||
164628501|NCT01849289|594660445|FG001|Overall Study|Withdrawal criteria|0|||
164628502|NCT01849289|594660444|FG000|Overall Study|Unclassified|25|||
164628503|NCT01849289|594660445|FG001|Overall Study|Unclassified|18|||
164628504|NCT03480360|594660446|FG000|Overall Study|Death|2|||
164628505|NCT03117309|594660453|FG000|Overall Study|Not meeting inclusion criteria|0|||
164628506|NCT03117309|594660454|FG001|Overall Study|Not meeting inclusion criteria|1|||
164628507|NCT02583711|594660455|FG000|Overall Study|Withdrawal by Subject|0|||
164628508|NCT02583711|594660456|FG001|Overall Study|Withdrawal by Subject|10|||
164628509|NCT02583711|594660457|FG002|Overall Study|Withdrawal by Subject|0|||
164628510|NCT01326910|594660460|FG000|Overall Study|Withdrawal by Subject|3|||
164628511|NCT01326910|594660461|FG001|Overall Study|Withdrawal by Subject|2|||
164628512|NCT01326910|594660460|FG000|Overall Study|Protocol Violation|1|||
164628513|NCT01326910|594660461|FG001|Overall Study|Protocol Violation|1|||
164628514|NCT02274766|594660464|FG000|Overall Study|Withdrawal by Subject|3|||
164628515|NCT02274766|594660465|FG001|Overall Study|Withdrawal by Subject|6|||
164628516|NCT02274766|594660464|FG000|Overall Study|Did Not Receive Study Drug|1|||
164628517|NCT02274766|594660465|FG001|Overall Study|Did Not Receive Study Drug|1|||
164628518|NCT02274766|594660464|FG000|Overall Study|Subject Unwilling to Proceed|0|||
164628519|NCT02274766|594660465|FG001|Overall Study|Subject Unwilling to Proceed|1|||
164628520|NCT02274766|594660464|FG000|Overall Study|Adverse Event|0|||
164628521|NCT02274766|594660465|FG001|Overall Study|Adverse Event|1|||
164628522|NCT01981096|594660475|FG000|Overall Study|Parent illness|1|||
164628523|NCT01981096|594660476|FG001|Overall Study|Parent illness|0|||
164628524|NCT01981096|594660475|FG000|Overall Study|Withdrawal by Subject|0|||
164628525|NCT01981096|594660476|FG001|Overall Study|Withdrawal by Subject|1|||
164628526|NCT01981096|594660475|FG000|Overall Study|Lost to Follow-up|2|||
164628527|NCT01981096|594660476|FG001|Overall Study|Lost to Follow-up|0|||
164628528|NCT04129242|594660478|FG000|Overall Study|Physician Decision|1|||
164628529|NCT04129242|594660479|FG001|Overall Study|Physician Decision|1|||
164628530|NCT04129242|594660478|FG000|Overall Study|Protocol Violation|0|||
164628531|NCT04129242|594660479|FG001|Overall Study|Protocol Violation|1|||
164628532|NCT01899729|594660484|FG000|Overall Study|Adverse Event|1|||
164628533|NCT01899729|594660485|FG001|Overall Study|Adverse Event|0|||
164628534|NCT01899729|594660486|FG002|Overall Study|Adverse Event|0|||
164628535|NCT01899729|594660487|FG003|Overall Study|Adverse Event|0|||
164628536|NCT01899729|594660488|FG004|Overall Study|Adverse Event|1|||
164628537|NCT01899729|594660484|FG000|Overall Study|Withdrawal by Subject|1|||
164628538|NCT01899729|594660485|FG001|Overall Study|Withdrawal by Subject|2|||
164628539|NCT01899729|594660486|FG002|Overall Study|Withdrawal by Subject|0|||
164628540|NCT01899729|594660487|FG003|Overall Study|Withdrawal by Subject|0|||
164628541|NCT01899729|594660488|FG004|Overall Study|Withdrawal by Subject|0|||
164628542|NCT01899729|594660484|FG000|Overall Study|Lack of Efficacy|0|||
164628543|NCT01899729|594660485|FG001|Overall Study|Lack of Efficacy|0|||
164628544|NCT01899729|594660486|FG002|Overall Study|Lack of Efficacy|2|||
164628545|NCT01899729|594660487|FG003|Overall Study|Lack of Efficacy|0|||
164628546|NCT01899729|594660488|FG004|Overall Study|Lack of Efficacy|1|||
164628547|NCT01454531|594660489|FG000|Overall Study|Adverse Event|14|||
164628548|NCT01454531|594660489|FG000|Overall Study|Withdrawal by Subject|5|||
164628549|NCT01454531|594660489|FG000|Overall Study|Lost to Follow-up|1|||
164628550|NCT01454531|594660489|FG000|Overall Study|Physician Decision|1|||
164628551|NCT01454531|594660489|FG000|Overall Study|Delay in IMP administration|1|||
164628552|NCT01454531|594660489|FG000|Overall Study|Other|1|||
164628553|NCT00962780|594660492|FG000|Overall Study|Death|0|||
164628554|NCT00962780|594660493|FG001|Overall Study|Death|1|||
164628555|NCT00962780|594660492|FG000|Overall Study|Protocol Violation|9|||
164628556|NCT00962780|594660493|FG001|Overall Study|Protocol Violation|4|||
164628557|NCT00962780|594660492|FG000|Overall Study|Withdrawal by Subject|1|||
164628558|NCT00962780|594660493|FG001|Overall Study|Withdrawal by Subject|8|||
164628559|NCT00962780|594660492|FG000|Overall Study|Other|0|||
164628560|NCT00962780|594660493|FG001|Overall Study|Other|1|||
164628561|NCT02055976|594660494|FG000|Overall Study|Other|0|||
164628562|NCT02055976|594660495|FG001|Overall Study|Other|0|||
164628563|NCT02055976|594660496|FG002|Overall Study|Other|1|||
164628564|NCT02055976|594660497|FG003|Overall Study|Other|0|||
164628565|NCT02055976|594660498|FG004|Overall Study|Other|0|||
164628566|NCT02055976|594660499|FG005|Overall Study|Other|0|||
164628567|NCT02055976|594660500|FG006|Overall Study|Other|0|||
164628568|NCT02055976|594660501|FG007|Overall Study|Other|0|||
164628569|NCT02055976|594660502|FG008|Overall Study|Other|0|||
164628570|NCT02055976|594660494|FG000|Overall Study|Adverse Event|0|||
164628571|NCT02055976|594660495|FG001|Overall Study|Adverse Event|0|||
164628572|NCT02055976|594660496|FG002|Overall Study|Adverse Event|0|||
164628573|NCT02055976|594660497|FG003|Overall Study|Adverse Event|0|||
164628574|NCT02055976|594660498|FG004|Overall Study|Adverse Event|0|||
164628575|NCT02055976|594660499|FG005|Overall Study|Adverse Event|1|||
164628576|NCT02055976|594660500|FG006|Overall Study|Adverse Event|1|||
164628577|NCT02055976|594660501|FG007|Overall Study|Adverse Event|0|||
164628578|NCT02055976|594660502|FG008|Overall Study|Adverse Event|0|||
164628579|NCT02055976|594660494|FG000|Overall Study|Does not meet entrance criteria|0|||
164628580|NCT02055976|594660495|FG001|Overall Study|Does not meet entrance criteria|0|||
164628581|NCT02055976|594660496|FG002|Overall Study|Does not meet entrance criteria|0|||
164628582|NCT02055976|594660497|FG003|Overall Study|Does not meet entrance criteria|0|||
164628583|NCT02055976|594660498|FG004|Overall Study|Does not meet entrance criteria|0|||
164628584|NCT02055976|594660499|FG005|Overall Study|Does not meet entrance criteria|0|||
164628585|NCT02055976|594660500|FG006|Overall Study|Does not meet entrance criteria|1|||
164628586|NCT02055976|594660501|FG007|Overall Study|Does not meet entrance criteria|0|||
164628587|NCT02055976|594660502|FG008|Overall Study|Does not meet entrance criteria|0|||
164628588|NCT02055976|594660494|FG000|Overall Study|Lost to Follow-up|0|||
164628589|NCT02055976|594660495|FG001|Overall Study|Lost to Follow-up|0|||
164628590|NCT02055976|594660496|FG002|Overall Study|Lost to Follow-up|0|||
164628591|NCT02055976|594660497|FG003|Overall Study|Lost to Follow-up|1|||
164628592|NCT02055976|594660498|FG004|Overall Study|Lost to Follow-up|0|||
164628593|NCT02055976|594660499|FG005|Overall Study|Lost to Follow-up|0|||
164628594|NCT02055976|594660500|FG006|Overall Study|Lost to Follow-up|0|||
164628595|NCT02055976|594660501|FG007|Overall Study|Lost to Follow-up|0|||
164628596|NCT02055976|594660502|FG008|Overall Study|Lost to Follow-up|0|||
164628597|NCT02504424|594660503|FG000|Overall Study|Withdrawal by Subject|2|||
164628598|NCT01711359|594660504|FG000|Treatment Period|Withdrawal by Subject|18|||
164628599|NCT01711359|594660505|FG001|Treatment Period|Withdrawal by Subject|7|||
164628600|NCT01711359|594660506|FG002|Treatment Period|Withdrawal by Subject|13|||
164628601|NCT01711359|594660504|FG000|Treatment Period|Lack of Efficacy|13|||
164628602|NCT01711359|594660505|FG001|Treatment Period|Lack of Efficacy|2|||
164628603|NCT01711359|594660506|FG002|Treatment Period|Lack of Efficacy|2|||
164628604|NCT01711359|594660504|FG000|Treatment Period|Adverse Event|8|||
164628605|NCT01711359|594660505|FG001|Treatment Period|Adverse Event|10|||
164628606|NCT01711359|594660506|FG002|Treatment Period|Adverse Event|24|||
164628607|NCT01711359|594660504|FG000|Treatment Period|Physician Decision|4|||
164628608|NCT01711359|594660505|FG001|Treatment Period|Physician Decision|3|||
164628609|NCT01711359|594660506|FG002|Treatment Period|Physician Decision|2|||
164628610|NCT01711359|594660504|FG000|Treatment Period|Death|3|||
164628611|NCT01711359|594660505|FG001|Treatment Period|Death|0|||
164628612|NCT01711359|594660506|FG002|Treatment Period|Death|0|||
164628613|NCT01711359|594660504|FG000|Treatment Period|Entry Criteria Not Met|1|||
164628614|NCT01711359|594660505|FG001|Treatment Period|Entry Criteria Not Met|0|||
164628615|NCT01711359|594660506|FG002|Treatment Period|Entry Criteria Not Met|0|||
164628616|NCT01711359|594660504|FG000|Treatment Period|Sponsor Decision|1|||
164628617|NCT01711359|594660505|FG001|Treatment Period|Sponsor Decision|0|||
164628618|NCT01711359|594660506|FG002|Treatment Period|Sponsor Decision|0|||
164628619|NCT01711359|594660504|FG000|Treatment Period|Lost to Follow-up|1|||
164628620|NCT01711359|594660505|FG001|Treatment Period|Lost to Follow-up|1|||
164628621|NCT01711359|594660506|FG002|Treatment Period|Lost to Follow-up|1|||
164628622|NCT01711359|594660504|FG000|Treatment Period|Randomized, Not Treated|3|||
164628623|NCT01711359|594660505|FG001|Treatment Period|Randomized, Not Treated|1|||
164628624|NCT01711359|594660506|FG002|Treatment Period|Randomized, Not Treated|0|||
164628625|NCT01503229|594662267|FG000|Overall Study|Withdrew consent|1|||
164628626|NCT01354964|594662268|FG000|Overall Study|Lost to Follow-up|2|||
164628627|NCT01354964|594662269|FG001|Overall Study|Lost to Follow-up|0|||
164628628|NCT01354964|594662268|FG000|Overall Study|IV access issues|1|||
164628629|NCT01354964|594662269|FG001|Overall Study|IV access issues|1|||
164628630|NCT01354964|594662268|FG000|Overall Study|Physician Decision|1|||
164628631|NCT01354964|594662269|FG001|Overall Study|Physician Decision|0|||
164628632|NCT05604781|594662271|FG000|Overall Study|Lost to Follow-up|3|||
164628633|NCT05604781|594662271|FG000|Overall Study|Adverse Event|1|||
164628634|NCT03922945|594662285|FG000|Overall Study|Adverse Event|1|||
164628635|NCT03922945|594662286|FG001|Overall Study|Adverse Event|1|||
164628636|NCT03922945|594662287|FG002|Overall Study|Adverse Event|2|||
164628637|NCT03922945|594662285|FG000|Overall Study|Lost to Follow-up|13|||
164628638|NCT03922945|594662286|FG001|Overall Study|Lost to Follow-up|9|||
164628639|NCT03922945|594662287|FG002|Overall Study|Lost to Follow-up|20|||
164628640|NCT03922945|594662285|FG000|Overall Study|Lack of Efficacy|2|||
164628641|NCT03922945|594662286|FG001|Overall Study|Lack of Efficacy|0|||
164628642|NCT03922945|594662287|FG002|Overall Study|Lack of Efficacy|1|||
164628643|NCT03922945|594662285|FG000|Overall Study|Protocol Non-Compliance|0|||
164628644|NCT03922945|594662286|FG001|Overall Study|Protocol Non-Compliance|0|||
164628645|NCT03922945|594662287|FG002|Overall Study|Protocol Non-Compliance|1|||
164628646|NCT03922945|594662285|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
164628647|NCT03922945|594662286|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
164628648|NCT03922945|594662287|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
164628649|NCT03922945|594662285|FG000|Overall Study|All Other Personal Reasons|1|||
164628650|NCT03922945|594662286|FG001|Overall Study|All Other Personal Reasons|1|||
164628651|NCT03922945|594662287|FG002|Overall Study|All Other Personal Reasons|2|||
164628652|NCT02889861|594662288|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
164628653|NCT00313716|594662289|FG000|Overall Study|Death|3|||
164628654|NCT00313716|594662290|FG001|Overall Study|Death|2|||
164628655|NCT00313716|594662291|FG002|Overall Study|Death|9|||
164628656|NCT00313716|594662292|FG003|Overall Study|Death|3|||
164628657|NCT00313716|594662293|FG004|Overall Study|Death|5|||
164628658|NCT00313716|594662294|FG005|Overall Study|Death|9|||
164628659|NCT00313716|594662289|FG000|Overall Study|Lost to Follow-up|2|||
164628660|NCT00313716|594662290|FG001|Overall Study|Lost to Follow-up|5|||
164628661|NCT00313716|594662291|FG002|Overall Study|Lost to Follow-up|2|||
164628662|NCT00313716|594662292|FG003|Overall Study|Lost to Follow-up|1|||
164628663|NCT00313716|594662293|FG004|Overall Study|Lost to Follow-up|0|||
164628664|NCT00313716|594662294|FG005|Overall Study|Lost to Follow-up|4|||
164628665|NCT00313716|594662289|FG000|Overall Study|Withdrawal by Subject|0|||
164628666|NCT00313716|594662290|FG001|Overall Study|Withdrawal by Subject|1|||
164628667|NCT00313716|594662291|FG002|Overall Study|Withdrawal by Subject|1|||
164628668|NCT00313716|594662292|FG003|Overall Study|Withdrawal by Subject|0|||
164628669|NCT00313716|594662293|FG004|Overall Study|Withdrawal by Subject|1|||
164628670|NCT00313716|594662294|FG005|Overall Study|Withdrawal by Subject|0|||
164628671|NCT02927990|594662303|FG000|Overall Study|Protocol Violation|4|||
164628672|NCT02927990|594662303|FG000|Overall Study|Physician Decision|9|||
164628673|NCT02927990|594662303|FG000|Overall Study|Room switched and therefore no study device available|15|||
164628674|NCT02927990|594662303|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
164628675|NCT00960323|594662304|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
164628676|NCT01524900|594662324|FG000|Overall Study|Lost to Follow-up|3|||
164628677|NCT01524900|594662325|FG001|Overall Study|Lost to Follow-up|12|||
164628678|NCT01524900|594662326|FG002|Overall Study|Lost to Follow-up|1|||
164628679|NCT01524900|594662327|FG003|Overall Study|Lost to Follow-up|0|||
164628680|NCT01524900|594662328|FG004|Overall Study|Lost to Follow-up|0|||
164628681|NCT01524900|594662324|FG000|Overall Study|Other reason than stated above|1|||
164628682|NCT01524900|594662325|FG001|Overall Study|Other reason than stated above|1|||
164628683|NCT01524900|594662326|FG002|Overall Study|Other reason than stated above|0|||
164628684|NCT01524900|594662327|FG003|Overall Study|Other reason than stated above|0|||
164628685|NCT01524900|594662328|FG004|Overall Study|Other reason than stated above|0|||
164628686|NCT01524900|594662324|FG000|Overall Study|No reason documented|2|||
164628687|NCT01524900|594662325|FG001|Overall Study|No reason documented|1|||
164628688|NCT01524900|594662326|FG002|Overall Study|No reason documented|0|||
164628689|NCT01524900|594662327|FG003|Overall Study|No reason documented|1|||
164628690|NCT01524900|594662328|FG004|Overall Study|No reason documented|0|||
164628691|NCT00959192|594662329|FG000|Overall Study|Adverse Event|1|||
164628692|NCT00959192|594662330|FG001|Overall Study|Adverse Event|1|||
164628693|NCT00959192|594662331|FG002|Overall Study|Adverse Event|1|||
164628694|NCT00959192|594662332|FG003|Overall Study|Adverse Event|0|||
164628695|NCT00959192|594662329|FG000|Overall Study|Investigator Request|1|||
164628696|NCT00959192|594662330|FG001|Overall Study|Investigator Request|0|||
164628697|NCT00959192|594662331|FG002|Overall Study|Investigator Request|0|||
164628698|NCT00959192|594662332|FG003|Overall Study|Investigator Request|0|||
164628699|NCT00959192|594662329|FG000|Overall Study|Caregiver Request|0|||
164628700|NCT00959192|594662330|FG001|Overall Study|Caregiver Request|0|||
164628701|NCT00959192|594662331|FG002|Overall Study|Caregiver Request|2|||
164628702|NCT00959192|594662332|FG003|Overall Study|Caregiver Request|1|||
164628703|NCT00772031|594662333|FG000|Overall Study|Early termination of trial|12|||
164628704|NCT00772031|594662334|FG001|Overall Study|Early termination of trial|10|||
164628705|NCT00772031|594662333|FG000|Overall Study|Lost to Follow-up|20|||
164628706|NCT00772031|594662334|FG001|Overall Study|Lost to Follow-up|33|||
164628707|NCT00532441|594662335|FG000|Overall Study|Death|1|||
164628708|NCT00532441|594662336|FG001|Overall Study|Death|0|||
164628709|NCT01603615|594662337|FG000|Overall Study|Did not Receive Treatment|7|||
164628710|NCT01603615|594662337|FG000|Overall Study|Lost to Follow-up|9|||
164628711|NCT01603615|594662337|FG000|Overall Study|Personal Reasons|17|||
164628712|NCT01603615|594662337|FG000|Overall Study|Other Miscellaneous|1|||
164628713|NCT00305773|594662338|FG000|Overall Study|Death|3|||
164628714|NCT00305773|594662339|FG001|Overall Study|Death|2|||
164628715|NCT00305773|594662338|FG000|Overall Study|Adverse Event|1|||
164628716|NCT00305773|594662339|FG001|Overall Study|Adverse Event|2|||
164628717|NCT00305773|594662338|FG000|Overall Study|Alternative Treatment|4|||
164628718|NCT00305773|594662339|FG001|Overall Study|Alternative Treatment|4|||
164628719|NCT00305773|594662338|FG000|Overall Study|Physician Decision|1|||
164628720|NCT00305773|594662339|FG001|Overall Study|Physician Decision|1|||
164628721|NCT00305773|594662338|FG000|Overall Study|Withdrawal by Subject|1|||
164628722|NCT00305773|594662339|FG001|Overall Study|Withdrawal by Subject|4|||
164628723|NCT00305773|594662338|FG000|Overall Study|Disease Progression|1|||
164628724|NCT00305773|594662339|FG001|Overall Study|Disease Progression|3|||
164628725|NCT00305773|594662338|FG000|Overall Study|All other reasons|3|||
164628726|NCT00305773|594662339|FG001|Overall Study|All other reasons|2|||
164628727|NCT00303329|594662340|FG000|Overall Study|Adverse Event|7|||
164628728|NCT00303329|594662341|FG001|Overall Study|Adverse Event|14|||
164628729|NCT00303329|594662340|FG000|Overall Study|Abnormal Laboratory Values|0|||
164628730|NCT00303329|594662341|FG001|Overall Study|Abnormal Laboratory Values|1|||
164628731|NCT00303329|594662340|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
164628732|NCT00303329|594662341|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164628733|NCT00303329|594662340|FG000|Overall Study|Condition no longer requires study drug|0|||
164628734|NCT00303329|594662341|FG001|Overall Study|Condition no longer requires study drug|8|||
164628735|NCT00303329|594662340|FG000|Overall Study|Protocol Violation|3|||
164628736|NCT00303329|594662341|FG001|Overall Study|Protocol Violation|0|||
164628737|NCT00303329|594662340|FG000|Overall Study|Withdrawal by Subject|9|||
164628738|NCT00303329|594662341|FG001|Overall Study|Withdrawal by Subject|15|||
164628739|NCT00303329|594662340|FG000|Overall Study|Lost to Follow-up|0|||
164628740|NCT00303329|594662341|FG001|Overall Study|Lost to Follow-up|1|||
164628741|NCT00303329|594662340|FG000|Overall Study|Administrative problems|1|||
164628742|NCT00303329|594662341|FG001|Overall Study|Administrative problems|0|||
164628743|NCT00303329|594662340|FG000|Overall Study|Death|2|||
164628744|NCT00303329|594662341|FG001|Overall Study|Death|12|||
164628745|NCT00303329|594662340|FG000|Overall Study|Stopped at end of core|3|||
164628746|NCT00303329|594662341|FG001|Overall Study|Stopped at end of core|9|||
164628747|NCT00303329|594662340|FG000|Overall Study|Stopped at end of extension 1|1|||
164628748|NCT00303329|594662341|FG001|Overall Study|Stopped at end of extension 1|0|||
164628749|NCT04354870|594662344|FG000|Overall Study|Lost to Follow-up|32|||
164628750|NCT04354870|594662345|FG001|Overall Study|Lost to Follow-up|12|||
164628751|NCT04354870|594662344|FG000|Overall Study|Withdrawal by Subject|10|||
164628752|NCT04354870|594662345|FG001|Overall Study|Withdrawal by Subject|16|||
164628753|NCT04354870|594662344|FG000|Overall Study|Did not complete all study visits|6|||
164628754|NCT04354870|594662345|FG001|Overall Study|Did not complete all study visits|5|||
164628755|NCT01101321|594662352|FG000|Period 1|Withdrawal by Subject|1|||
164628756|NCT01101321|594662353|FG001|Period 1|Withdrawal by Subject|1|||
164628757|NCT01101321|594662352|FG000|Period 1|Adverse Event|3|||
164628758|NCT01101321|594662353|FG001|Period 1|Adverse Event|3|||
164628759|NCT02643420|594662354|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
164628760|NCT02643420|594662355|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
164628761|NCT02643420|594662354|FG000|Overall Study|Withdrawal by Subject|25|||
164628762|NCT02643420|594662355|FG001|Overall Study|Withdrawal by Subject|19|||
164628763|NCT02643420|594662354|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
164628764|NCT02643420|594662355|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
164628765|NCT02643420|594662354|FG000|Overall Study|Lost to Follow-up|6|||
164628766|NCT02643420|594662355|FG001|Overall Study|Lost to Follow-up|10|||
164628767|NCT02643420|594662354|FG000|Overall Study|Investigator Decision|2|||
164628768|NCT02643420|594662355|FG001|Overall Study|Investigator Decision|4|||
164628769|NCT02643420|594662354|FG000|Overall Study|Sponsor decision|1|||
164628770|NCT02643420|594662355|FG001|Overall Study|Sponsor decision|1|||
164628771|NCT02643420|594662354|FG000|Overall Study|Death|0|||
164628772|NCT02643420|594662355|FG001|Overall Study|Death|2|||
164628773|NCT02643420|594662354|FG000|Overall Study|Reason not Specified|8|||
164628774|NCT02643420|594662355|FG001|Overall Study|Reason not Specified|7|||
164628775|NCT01710709|594662356|FG000|Overall Study|Lost to Follow-up|29|||
164628776|NCT01710709|594662356|FG000|Overall Study|Adverse Event|48|||
164628777|NCT01710709|594662356|FG000|Overall Study|Participant met withdrawal criteria|33|||
164628778|NCT01710709|594662356|FG000|Overall Study|Participant withdrawn by investigator|2|||
164628779|NCT01710709|594662356|FG000|Overall Study|Withdrawal by Subject|53|||
164628780|NCT01710709|594662356|FG000|Overall Study|Protocol Violation|5|||
164628781|NCT01710709|594662356|FG000|Overall Study|Lack of Efficacy|3|||
164628782|NCT00542321|594662357|FG000|Overall Study|Death|0|||
164628783|NCT00542321|594662358|FG001|Overall Study|Death|1|||
164628784|NCT03339999|594662364|FG000|Overall Study|Adverse Event|1|||
164628785|NCT03339999|594662365|FG001|Overall Study|Adverse Event|2|||
164628786|NCT03339999|594662366|FG002|Overall Study|Adverse Event|2|||
164628787|NCT03339999|594662367|FG003|Overall Study|Adverse Event|1|||
164628788|NCT03339999|594662364|FG000|Overall Study|Lack of Efficacy|0|||
164628789|NCT03339999|594662365|FG001|Overall Study|Lack of Efficacy|1|||
164628790|NCT03339999|594662366|FG002|Overall Study|Lack of Efficacy|0|||
164628791|NCT03339999|594662367|FG003|Overall Study|Lack of Efficacy|0|||
164628792|NCT03339999|594662364|FG000|Overall Study|Lost to Follow-up|0|||
164628793|NCT03339999|594662365|FG001|Overall Study|Lost to Follow-up|0|||
164628794|NCT03339999|594662366|FG002|Overall Study|Lost to Follow-up|0|||
164628795|NCT03339999|594662367|FG003|Overall Study|Lost to Follow-up|1|||
164628796|NCT03339999|594662364|FG000|Overall Study|Study Terminated by Sponsor|6|||
164628797|NCT03339999|594662365|FG001|Overall Study|Study Terminated by Sponsor|3|||
164628798|NCT03339999|594662366|FG002|Overall Study|Study Terminated by Sponsor|4|||
164628799|NCT03339999|594662367|FG003|Overall Study|Study Terminated by Sponsor|3|||
164628800|NCT00525499|594662368|FG000|Overall Study|Lost to Follow-up|2|||
164628801|NCT00525499|594662369|FG001|Overall Study|Lost to Follow-up|4|||
164628802|NCT00525499|594662370|FG002|Overall Study|Lost to Follow-up|1|||
164628803|NCT00525499|594662371|FG003|Overall Study|Lost to Follow-up|4|||
164628804|NCT00525499|594662368|FG000|Overall Study|Adverse Event|0|||
164628805|NCT00525499|594662369|FG001|Overall Study|Adverse Event|1|||
164628806|NCT00525499|594662370|FG002|Overall Study|Adverse Event|0|||
164628807|NCT00525499|594662371|FG003|Overall Study|Adverse Event|1|||
164628808|NCT00525499|594662368|FG000|Overall Study|Withdrawal by Subject|5|||
164628809|NCT00525499|594662369|FG001|Overall Study|Withdrawal by Subject|1|||
164628810|NCT00525499|594662370|FG002|Overall Study|Withdrawal by Subject|5|||
164628811|NCT00525499|594662371|FG003|Overall Study|Withdrawal by Subject|2|||
164628812|NCT00525499|594662368|FG000|Overall Study|Protocol Violation|0|||
164628813|NCT00525499|594662369|FG001|Overall Study|Protocol Violation|1|||
164628814|NCT00525499|594662370|FG002|Overall Study|Protocol Violation|1|||
164628815|NCT00525499|594662371|FG003|Overall Study|Protocol Violation|0|||
164628816|NCT00253747|594662372|FG000|Overall Study|Lost to Follow-up|13|||
164628817|NCT00253747|594662373|FG001|Overall Study|Lost to Follow-up|14|||
164628818|NCT00253747|594662372|FG000|Overall Study|Withdrawal by Subject|10|||
164628819|NCT00253747|594662373|FG001|Overall Study|Withdrawal by Subject|11|||
164628820|NCT00253747|594662372|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
164628821|NCT00253747|594662373|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
164628822|NCT01856920|594662376|FG000|Overall Study|Disease Progression On Study|3|||
164628823|NCT01856920|594662377|FG001|Overall Study|Disease Progression On Study|4|||
164628824|NCT01856920|594662376|FG000|Overall Study|Disease Progression before Treatment|1|||
164628825|NCT01856920|594662377|FG001|Overall Study|Disease Progression before Treatment|0|||
164628826|NCT01856920|594662376|FG000|Overall Study|Ineligible|0|||
164628827|NCT01856920|594662377|FG001|Overall Study|Ineligible|1|||
164628828|NCT01856920|594662376|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
164628829|NCT01856920|594662377|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
164628830|NCT01856920|594662376|FG000|Overall Study|Refused further Treatment|5|||
164628831|NCT01856920|594662377|FG001|Overall Study|Refused further Treatment|1|||
164628832|NCT01856920|594662376|FG000|Overall Study|Other Reasons|0|||
164628833|NCT01856920|594662377|FG001|Overall Study|Other Reasons|1|||
164628834|NCT01856920|594662376|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
164628835|NCT01856920|594662377|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
164628836|NCT03287089|594662381|FG000|Overall Study|Lost to Follow-up|0|||
164628837|NCT03287089|594662382|FG001|Overall Study|Lost to Follow-up|2|||
164628838|NCT03287089|594662381|FG000|Overall Study|Physician Decision|0|||
164628839|NCT03287089|594662382|FG001|Overall Study|Physician Decision|2|||
164628840|NCT03287089|594662381|FG000|Overall Study|Withdrawal by Subject|0|||
164628841|NCT03287089|594662382|FG001|Overall Study|Withdrawal by Subject|2|||
164628842|NCT02275052|594662387|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164628843|NCT02275052|594662388|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
164628844|NCT02275052|594662389|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164628845|NCT02275052|594662390|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164628846|NCT02275052|594662387|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
164628847|NCT02275052|594662388|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
164628848|NCT02275052|594662389|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
164628849|NCT02275052|594662390|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
164628850|NCT02275052|594662387|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
164628851|NCT02275052|594662388|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
164628852|NCT02275052|594662389|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
164628853|NCT02275052|594662390|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
164628854|NCT02275052|594662387|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
164628855|NCT02275052|594662388|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
164628856|NCT02275052|594662389|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
164628857|NCT02275052|594662390|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
164628858|NCT02275052|594662387|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
164628859|NCT02275052|594662388|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
164628860|NCT02275052|594662389|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
164628861|NCT02275052|594662390|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
164628862|NCT02275052|594662387|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
164628863|NCT02275052|594662388|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
164628864|NCT02275052|594662389|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
164628865|NCT02275052|594662390|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
164628866|NCT02275052|594662387|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
164628867|NCT02275052|594662388|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
164628868|NCT02275052|594662389|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
164628869|NCT02275052|594662390|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
164628870|NCT02275052|594662387|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
164628871|NCT02275052|594662388|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
164628872|NCT02275052|594662389|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
164628873|NCT02275052|594662390|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
164628874|NCT02275052|594662387|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
164628875|NCT02275052|594662388|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
164628876|NCT02275052|594662389|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
164628877|NCT02275052|594662390|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
164628878|NCT02275052|594662387|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
164628879|NCT02275052|594662388|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
164628880|NCT02275052|594662389|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
164628881|NCT02275052|594662390|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
164628882|NCT02275052|594662387|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
164628883|NCT02275052|594662388|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
164628884|NCT02275052|594662389|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
164628885|NCT02275052|594662390|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
164628886|NCT04601194|594662396|FG000|Overall Study|Lost to Follow-up|7|||
164628887|NCT02630459|594662397|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
164628888|NCT02630459|594662398|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
164628889|NCT02630459|594662399|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
164628890|NCT02630459|594662400|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
164628891|NCT02630459|594662401|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
164628892|NCT02630459|594662402|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
164628893|NCT02630459|594662403|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
164628894|NCT02630459|594662404|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
164628895|NCT02630459|594662397|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
164628896|NCT02630459|594662398|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
164628897|NCT02630459|594662399|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
164628898|NCT02630459|594662400|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
164628899|NCT02630459|594662401|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
164628900|NCT02630459|594662402|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
164628901|NCT02630459|594662403|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
164628902|NCT02630459|594662404|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
164628903|NCT02630459|594662397|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
164628904|NCT02630459|594662398|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
164628905|NCT02630459|594662399|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
164628906|NCT02630459|594662400|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
164628907|NCT02630459|594662401|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
164628908|NCT02630459|594662402|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
164628909|NCT02630459|594662403|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
164628910|NCT02630459|594662404|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
164628911|NCT02630459|594662397|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
164628912|NCT02630459|594662398|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
164628913|NCT02630459|594662399|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
164628914|NCT02630459|594662400|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
164628915|NCT02630459|594662401|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
164628916|NCT02630459|594662402|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
164628917|NCT02630459|594662403|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
164628918|NCT02630459|594662404|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
164628919|NCT02630459|594662397|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
164628920|NCT02630459|594662398|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
164628921|NCT02630459|594662399|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
164628922|NCT02630459|594662400|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
164628923|NCT02630459|594662401|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
164628924|NCT02630459|594662402|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
164628925|NCT02630459|594662403|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
164628926|NCT02630459|594662404|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
164628927|NCT02630459|594662397|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
164628928|NCT02630459|594662398|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
164628929|NCT02630459|594662399|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
164628930|NCT02630459|594662400|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
164628931|NCT02630459|594662401|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
164628932|NCT02630459|594662402|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
164628933|NCT02630459|594662403|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
164628934|NCT02630459|594662404|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
164628935|NCT02630459|594662397|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
164628936|NCT02630459|594662398|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
164628937|NCT02630459|594662399|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
164628938|NCT02630459|594662400|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
164628939|NCT02630459|594662401|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
164628940|NCT02630459|594662402|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
164628941|NCT02630459|594662403|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
164628942|NCT02630459|594662404|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
164628943|NCT01797302|594662405|FG000|Overall Study|Lost to Follow-up|16|||
164628944|NCT01797302|594662406|FG001|Overall Study|Lost to Follow-up|23|||
164628945|NCT01797302|594662407|FG002|Overall Study|Lost to Follow-up|22|||
164628946|NCT01797302|594662405|FG000|Overall Study|Withdrawal by Subject|1|||
164628947|NCT01797302|594662406|FG001|Overall Study|Withdrawal by Subject|3|||
164628948|NCT01797302|594662407|FG002|Overall Study|Withdrawal by Subject|4|||
164628949|NCT00783263|594662408|FG000|Overall Study|Adverse Event|3|||
164628950|NCT00783263|594662409|FG001|Overall Study|Adverse Event|0|||
164628951|NCT00783263|594662410|FG002|Overall Study|Adverse Event|2|||
164628952|NCT00783263|594662411|FG003|Overall Study|Adverse Event|1|||
164628953|NCT00783263|594662408|FG000|Overall Study|Lost to Follow-up|1|||
164628954|NCT00783263|594662409|FG001|Overall Study|Lost to Follow-up|1|||
164628955|NCT00783263|594662410|FG002|Overall Study|Lost to Follow-up|0|||
164628956|NCT00783263|594662411|FG003|Overall Study|Lost to Follow-up|0|||
164628957|NCT00783263|594662408|FG000|Overall Study|Withdrawal by Subject|0|||
164628958|NCT00783263|594662409|FG001|Overall Study|Withdrawal by Subject|1|||
164628959|NCT00783263|594662410|FG002|Overall Study|Withdrawal by Subject|1|||
164628960|NCT00783263|594662411|FG003|Overall Study|Withdrawal by Subject|2|||
164628961|NCT00106626|594662412|FG000|Overall Study|Adverse Event|5|||
164628962|NCT00106626|594662413|FG001|Overall Study|Adverse Event|4|||
164628963|NCT00106626|594662414|FG002|Overall Study|Adverse Event|3|||
164628964|NCT00106626|594662415|FG003|Overall Study|Adverse Event|3|||
164628965|NCT00106626|594662412|FG000|Overall Study|Progressive Disease|4|||
164628966|NCT00106626|594662413|FG001|Overall Study|Progressive Disease|1|||
164628967|NCT00106626|594662414|FG002|Overall Study|Progressive Disease|9|||
164628968|NCT00106626|594662415|FG003|Overall Study|Progressive Disease|10|||
164628969|NCT00106626|594662412|FG000|Overall Study|Received radiation on new therapy|1|||
164628970|NCT00106626|594662413|FG001|Overall Study|Received radiation on new therapy|0|||
164628971|NCT00106626|594662414|FG002|Overall Study|Received radiation on new therapy|0|||
164628972|NCT00106626|594662415|FG003|Overall Study|Received radiation on new therapy|0|||
164628973|NCT00106626|594662412|FG000|Overall Study|> 14 day delay in therapy start|0|||
164628974|NCT00106626|594662413|FG001|Overall Study|> 14 day delay in therapy start|1|||
164628975|NCT00106626|594662414|FG002|Overall Study|> 14 day delay in therapy start|0|||
164628976|NCT00106626|594662415|FG003|Overall Study|> 14 day delay in therapy start|0|||
164628977|NCT03018028|594662416|FG000|Overall Study|Withdrawal by Subject|3|||
164628978|NCT03018028|594662417|FG001|Overall Study|Withdrawal by Subject|0|||
164628979|NCT03018028|594662418|FG002|Overall Study|Withdrawal by Subject|1|||
164628980|NCT03018028|594662419|FG003|Overall Study|Withdrawal by Subject|2|||
164628981|NCT03018028|594662420|FG004|Overall Study|Withdrawal by Subject|0|||
164628982|NCT02519777|594662421|FG000|Overall Study|Death|1|||
164628983|NCT02519777|594662422|FG001|Overall Study|Death|0|||
164628984|NCT02519777|594662423|FG002|Overall Study|Death|0|||
164628985|NCT02519777|594662421|FG000|Overall Study|Lost to Follow-up|0|||
164628986|NCT02519777|594662422|FG001|Overall Study|Lost to Follow-up|4|||
164628987|NCT02519777|594662423|FG002|Overall Study|Lost to Follow-up|2|||
164628988|NCT02519777|594662421|FG000|Overall Study|Withdrawal by Subject|3|||
164628989|NCT02519777|594662422|FG001|Overall Study|Withdrawal by Subject|1|||
164628990|NCT02519777|594662423|FG002|Overall Study|Withdrawal by Subject|0|||
164628991|NCT02519777|594662421|FG000|Overall Study|Severe Debilitation|1|||
164628992|NCT02519777|594662422|FG001|Overall Study|Severe Debilitation|1|||
164628993|NCT02519777|594662423|FG002|Overall Study|Severe Debilitation|1|||
164628994|NCT02519777|594662421|FG000|Overall Study|Not able to get to clinic|1|||
164628995|NCT02519777|594662422|FG001|Overall Study|Not able to get to clinic|2|||
164628996|NCT02519777|594662423|FG002|Overall Study|Not able to get to clinic|1|||
164628997|NCT00256204|594662427|FG000|Overall Study|Adverse Event|10|||
164628998|NCT00256204|594662428|FG001|Overall Study|Adverse Event|14|||
164628999|NCT00256204|594662429|FG002|Overall Study|Adverse Event|16|||
164629000|NCT00256204|594662430|FG003|Overall Study|Adverse Event|14|||
164629001|NCT00256204|594662427|FG000|Overall Study|Death|0|||
164629002|NCT00256204|594662428|FG001|Overall Study|Death|1|||
164629003|NCT00256204|594662429|FG002|Overall Study|Death|0|||
164629004|NCT00256204|594662430|FG003|Overall Study|Death|0|||
164629005|NCT00256204|594662427|FG000|Overall Study|Lost to Follow-up|1|||
164629006|NCT00256204|594662428|FG001|Overall Study|Lost to Follow-up|1|||
164629007|NCT00256204|594662429|FG002|Overall Study|Lost to Follow-up|1|||
164629008|NCT00256204|594662430|FG003|Overall Study|Lost to Follow-up|2|||
164629009|NCT00256204|594662427|FG000|Overall Study|Protocol Violation|1|||
164629010|NCT00256204|594662428|FG001|Overall Study|Protocol Violation|0|||
164629011|NCT00256204|594662429|FG002|Overall Study|Protocol Violation|2|||
164629012|NCT00256204|594662430|FG003|Overall Study|Protocol Violation|1|||
164629013|NCT00256204|594662427|FG000|Overall Study|Physician Decision|0|||
164629014|NCT00256204|594662428|FG001|Overall Study|Physician Decision|0|||
164629015|NCT00256204|594662429|FG002|Overall Study|Physician Decision|1|||
164629016|NCT00256204|594662430|FG003|Overall Study|Physician Decision|2|||
164629017|NCT00256204|594662427|FG000|Overall Study|Withdrawal by Subject|17|||
164629018|NCT00256204|594662428|FG001|Overall Study|Withdrawal by Subject|6|||
164629019|NCT00256204|594662429|FG002|Overall Study|Withdrawal by Subject|7|||
164629020|NCT00256204|594662430|FG003|Overall Study|Withdrawal by Subject|5|||
164629021|NCT00256204|594662427|FG000|Overall Study|Need for additional prohibited treatment|38|||
164629022|NCT00256204|594662428|FG001|Overall Study|Need for additional prohibited treatment|28|||
164629023|NCT00256204|594662429|FG002|Overall Study|Need for additional prohibited treatment|27|||
164629024|NCT00256204|594662430|FG003|Overall Study|Need for additional prohibited treatment|25|||
164629025|NCT03490734|594662443|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
164629026|NCT03490734|594662444|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
164629027|NCT03490734|594662445|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
164629028|NCT03490734|594662446|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
164629029|NCT03490734|594662443|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
164629030|NCT03490734|594662444|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
164629031|NCT03490734|594662445|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
164629032|NCT03490734|594662446|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
164629033|NCT03490734|594662443|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
164629034|NCT03490734|594662444|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
164629035|NCT03490734|594662445|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
164629036|NCT03490734|594662446|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
164629037|NCT03490734|594662443|FG000|Post-intervention Scan Visit|Adverse Event|2|||
164629038|NCT03490734|594662444|FG001|Post-intervention Scan Visit|Adverse Event|0|||
164629039|NCT03490734|594662445|FG002|Post-intervention Scan Visit|Adverse Event|0|||
164629040|NCT03490734|594662446|FG003|Post-intervention Scan Visit|Adverse Event|0|||
164629041|NCT03490734|594662443|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
164629042|NCT03490734|594662444|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
164629043|NCT03490734|594662445|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
164629044|NCT03490734|594662446|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
164629045|NCT03490734|594662443|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
164629046|NCT03490734|594662444|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
164629047|NCT03490734|594662445|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
164629048|NCT03490734|594662446|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
164629049|NCT04212221|594662454|FG000|Overall Study|Remained on Treatment|0|||
164629050|NCT04212221|594662455|FG001|Overall Study|Remained on Treatment|0|||
164629051|NCT04212221|594662456|FG002|Overall Study|Remained on Treatment|0|||
164629052|NCT04212221|594662457|FG003|Overall Study|Remained on Treatment|1|||
164629053|NCT04212221|594662458|FG004|Overall Study|Remained on Treatment|0|||
164629054|NCT04212221|594662459|FG005|Overall Study|Remained on Treatment|0|||
164629055|NCT04212221|594662460|FG006|Overall Study|Remained on Treatment|3|||
164629056|NCT04212221|594662461|FG007|Overall Study|Remained on Treatment|9|||
164629057|NCT04212221|594662454|FG000|Overall Study|Adverse Event|0|||
164629058|NCT04212221|594662455|FG001|Overall Study|Adverse Event|0|||
164629059|NCT04212221|594662456|FG002|Overall Study|Adverse Event|0|||
164629060|NCT04212221|594662457|FG003|Overall Study|Adverse Event|0|||
164629061|NCT04212221|594662458|FG004|Overall Study|Adverse Event|0|||
164629062|NCT04212221|594662459|FG005|Overall Study|Adverse Event|0|||
164629063|NCT04212221|594662460|FG006|Overall Study|Adverse Event|2|||
164629064|NCT04212221|594662461|FG007|Overall Study|Adverse Event|3|||
164629065|NCT04212221|594662454|FG000|Overall Study|Death|0|||
164629066|NCT04212221|594662455|FG001|Overall Study|Death|0|||
164629067|NCT04212221|594662456|FG002|Overall Study|Death|0|||
164629068|NCT04212221|594662457|FG003|Overall Study|Death|0|||
164629069|NCT04212221|594662458|FG004|Overall Study|Death|0|||
164629070|NCT04212221|594662459|FG005|Overall Study|Death|0|||
164629071|NCT04212221|594662460|FG006|Overall Study|Death|0|||
164629072|NCT04212221|594662461|FG007|Overall Study|Death|2|||
164629073|NCT04212221|594662454|FG000|Overall Study|Disease progression according to irRECIST|1|||
164629074|NCT04212221|594662455|FG001|Overall Study|Disease progression according to irRECIST|2|||
164629075|NCT04212221|594662456|FG002|Overall Study|Disease progression according to irRECIST|3|||
164629076|NCT04212221|594662457|FG003|Overall Study|Disease progression according to irRECIST|3|||
164629077|NCT04212221|594662458|FG004|Overall Study|Disease progression according to irRECIST|2|||
164629078|NCT04212221|594662459|FG005|Overall Study|Disease progression according to irRECIST|2|||
164629079|NCT04212221|594662460|FG006|Overall Study|Disease progression according to irRECIST|21|||
164629080|NCT04212221|594662461|FG007|Overall Study|Disease progression according to irRECIST|17|||
164629081|NCT04212221|594662454|FG000|Overall Study|Global Deterioration of Health Status|0|||
164629082|NCT04212221|594662455|FG001|Overall Study|Global Deterioration of Health Status|0|||
164629083|NCT04212221|594662456|FG002|Overall Study|Global Deterioration of Health Status|0|||
164629084|NCT04212221|594662457|FG003|Overall Study|Global Deterioration of Health Status|0|||
164629085|NCT04212221|594662458|FG004|Overall Study|Global Deterioration of Health Status|0|||
164629086|NCT04212221|594662459|FG005|Overall Study|Global Deterioration of Health Status|0|||
164629087|NCT04212221|594662460|FG006|Overall Study|Global Deterioration of Health Status|0|||
164629088|NCT04212221|594662461|FG007|Overall Study|Global Deterioration of Health Status|2|||
164629089|NCT04212221|594662454|FG000|Overall Study|Investigator's Decision|0|||
164629090|NCT04212221|594662455|FG001|Overall Study|Investigator's Decision|0|||
164629091|NCT04212221|594662456|FG002|Overall Study|Investigator's Decision|0|||
164629092|NCT04212221|594662457|FG003|Overall Study|Investigator's Decision|1|||
164629093|NCT04212221|594662458|FG004|Overall Study|Investigator's Decision|0|||
164629094|NCT04212221|594662459|FG005|Overall Study|Investigator's Decision|0|||
164629095|NCT04212221|594662460|FG006|Overall Study|Investigator's Decision|3|||
164629096|NCT04212221|594662461|FG007|Overall Study|Investigator's Decision|0|||
164629097|NCT04212221|594662454|FG000|Overall Study|Participant refused to continue treatment|0|||
164629098|NCT04212221|594662455|FG001|Overall Study|Participant refused to continue treatment|1|||
164629099|NCT04212221|594662456|FG002|Overall Study|Participant refused to continue treatment|0|||
164629100|NCT04212221|594662457|FG003|Overall Study|Participant refused to continue treatment|1|||
164629101|NCT04212221|594662458|FG004|Overall Study|Participant refused to continue treatment|1|||
164629102|NCT04212221|594662459|FG005|Overall Study|Participant refused to continue treatment|2|||
164629103|NCT04212221|594662460|FG006|Overall Study|Participant refused to continue treatment|4|||
164629104|NCT04212221|594662461|FG007|Overall Study|Participant refused to continue treatment|2|||
164629105|NCT04212221|594662454|FG000|Overall Study|Protocol Violation|0|||
164629106|NCT04212221|594662455|FG001|Overall Study|Protocol Violation|0|||
164528089|NCT03149549|594303750|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
164528090|NCT03149549|594303751|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
164528091|NCT03149549|594303739|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
164528092|NCT03149549|594303740|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
164528093|NCT03149549|594303741|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
164528094|NCT03149549|594303742|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
164528095|NCT03149549|594303743|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
164528096|NCT03149549|594303744|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
164528097|NCT03149549|594303745|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
164528098|NCT03149549|594303746|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
164528099|NCT03149549|594303747|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
164528100|NCT03149549|594303748|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
164528101|NCT03149549|594303749|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
164528102|NCT03149549|594303750|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
164528103|NCT03149549|594303751|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
164528104|NCT03149549|594303739|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
164528105|NCT03149549|594303740|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
164528106|NCT03149549|594303741|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
164528107|NCT03149549|594303742|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
164528108|NCT03149549|594303743|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
164528109|NCT03149549|594303744|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
164528110|NCT03149549|594303745|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
164528111|NCT03149549|594303746|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
164528112|NCT03149549|594303747|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
164528113|NCT03149549|594303748|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
164528114|NCT03149549|594303749|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
164528115|NCT03149549|594303750|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
164528116|NCT03149549|594303751|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
164528117|NCT03149549|594303739|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
164528118|NCT03149549|594303740|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
164528119|NCT03149549|594303741|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
164528120|NCT03149549|594303742|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
164528121|NCT03149549|594303743|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
164528122|NCT03149549|594303744|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
164629107|NCT04212221|594662456|FG002|Overall Study|Protocol Violation|0|||
164629108|NCT04212221|594662457|FG003|Overall Study|Protocol Violation|0|||
164629109|NCT04212221|594662458|FG004|Overall Study|Protocol Violation|0|||
164629110|NCT04212221|594662459|FG005|Overall Study|Protocol Violation|0|||
164629111|NCT04212221|594662460|FG006|Overall Study|Protocol Violation|0|||
164629112|NCT04212221|594662461|FG007|Overall Study|Protocol Violation|1|||
164629113|NCT02692560|594662464|FG000|Overall Study|Withdrawal by Subject|0|||
164629114|NCT02692560|594662465|FG001|Overall Study|Withdrawal by Subject|6|||
164629115|NCT02363322|594662468|FG000|Overall Study|Lost to Follow-up|1|||
164629116|NCT02363322|594662469|FG001|Overall Study|Lost to Follow-up|0|||
164629117|NCT04524663|594664355|FG000|Overall Study|Withdrawal by Subject|0|||
164629118|NCT04524663|594664356|FG001|Overall Study|Withdrawal by Subject|2|||
164629119|NCT00911508|594664357|FG000|Overall Study|Lost to Follow-up|27|||
164629120|NCT00911508|594664358|FG001|Overall Study|Lost to Follow-up|18|||
164629121|NCT00911508|594664357|FG000|Overall Study|Withdrawal by Subject|79|||
164629122|NCT00911508|594664358|FG001|Overall Study|Withdrawal by Subject|112|||
164629123|NCT04308668|594664359|FG000|Overall Study|Lost to Follow-up|32|||
164629124|NCT04308668|594664360|FG001|Overall Study|Lost to Follow-up|38|||
164629125|NCT04308668|594664359|FG000|Overall Study|Withdrawal by Subject|4|||
164629126|NCT04308668|594664360|FG001|Overall Study|Withdrawal by Subject|4|||
164629127|NCT01266967|594664361|FG000|Overall Study|Death|69|||
164629128|NCT01266967|594664362|FG001|Overall Study|Death|61|||
164629129|NCT01266967|594664361|FG000|Overall Study|Study Closed/Terminated|15|||
164629130|NCT01266967|594664362|FG001|Overall Study|Study Closed/Terminated|17|||
164629131|NCT01266967|594664361|FG000|Overall Study|Lost to Follow-up|2|||
164629132|NCT01266967|594664362|FG001|Overall Study|Lost to Follow-up|1|||
164629133|NCT01266967|594664361|FG000|Overall Study|Physician Decision|0|||
164629134|NCT01266967|594664362|FG001|Overall Study|Physician Decision|1|||
164629135|NCT01266967|594664361|FG000|Overall Study|Withdrawal by Subject|3|||
164629136|NCT01266967|594664362|FG001|Overall Study|Withdrawal by Subject|3|||
164629137|NCT01519700|594664363|FG000|Overall Study|Death|1|||
164629138|NCT01519700|594664364|FG001|Overall Study|Death|0|||
164629139|NCT01519700|594664365|FG002|Overall Study|Death|0|||
164629140|NCT01519700|594664366|FG003|Overall Study|Death|0|||
164629141|NCT01519700|594664363|FG000|Overall Study|Lost to Follow-up|0|||
164629142|NCT01519700|594664364|FG001|Overall Study|Lost to Follow-up|0|||
164629143|NCT01519700|594664365|FG002|Overall Study|Lost to Follow-up|1|||
164629144|NCT01519700|594664366|FG003|Overall Study|Lost to Follow-up|1|||
164629145|NCT01519700|594664363|FG000|Overall Study|Physician Decision|1|||
164629146|NCT01519700|594664364|FG001|Overall Study|Physician Decision|1|||
164629147|NCT01519700|594664365|FG002|Overall Study|Physician Decision|3|||
164629148|NCT01519700|594664366|FG003|Overall Study|Physician Decision|0|||
164629149|NCT01519700|594664363|FG000|Overall Study|Withdrawal by Subject|5|||
164629150|NCT01519700|594664364|FG001|Overall Study|Withdrawal by Subject|3|||
164629151|NCT01519700|594664365|FG002|Overall Study|Withdrawal by Subject|3|||
164629152|NCT01519700|594664366|FG003|Overall Study|Withdrawal by Subject|2|||
164629153|NCT01519700|594664363|FG000|Overall Study|Other Reason|2|||
164629154|NCT01519700|594664364|FG001|Overall Study|Other Reason|2|||
164629155|NCT01519700|594664365|FG002|Overall Study|Other Reason|0|||
164629156|NCT01519700|594664366|FG003|Overall Study|Other Reason|4|||
164629157|NCT05111548|594664367|FG000|Overall Study|Withdrawal by Subject|2|||
164629158|NCT05111548|594664368|FG001|Overall Study|Withdrawal by Subject|1|||
164629159|NCT05111548|594664367|FG000|Overall Study|Adverse Event|1|||
164629160|NCT05111548|594664368|FG001|Overall Study|Adverse Event|0|||
164629161|NCT00561912|594664375|FG000|Overall Study|ineligible|1|||
164629162|NCT03938857|594664376|FG000|Overall Study|Physician Decision|1|||
164629163|NCT03938857|594664377|FG001|Overall Study|Physician Decision|0|||
164629164|NCT03938857|594664378|FG002|Overall Study|Physician Decision|0|||
164629165|NCT03938857|594664379|FG003|Overall Study|Physician Decision|0|||
164629166|NCT01729559|594664380|FG000|Overall Study|Protocol Violation|31|||
164629167|NCT01729559|594664381|FG001|Overall Study|Protocol Violation|28|||
164629168|NCT02452034|594664386|FG000|Overall Study|Adverse Event|0|||
164629169|NCT02452034|594664387|FG001|Overall Study|Adverse Event|0|||
164629170|NCT02452034|594664388|FG002|Overall Study|Adverse Event|0|||
164629171|NCT02452034|594664389|FG003|Overall Study|Adverse Event|0|||
164629172|NCT02452034|594664390|FG004|Overall Study|Adverse Event|0|||
164629173|NCT02452034|594664391|FG005|Overall Study|Adverse Event|1|||
164629174|NCT02452034|594664386|FG000|Overall Study|Death|0|||
164629175|NCT02452034|594664387|FG001|Overall Study|Death|0|||
164629176|NCT02452034|594664388|FG002|Overall Study|Death|0|||
164629177|NCT02452034|594664389|FG003|Overall Study|Death|0|||
164629178|NCT02452034|594664390|FG004|Overall Study|Death|1|||
164629179|NCT02452034|594664391|FG005|Overall Study|Death|1|||
164629180|NCT02452034|594664386|FG000|Overall Study|Physician Decision|0|||
164629181|NCT02452034|594664387|FG001|Overall Study|Physician Decision|1|||
164629182|NCT02452034|594664388|FG002|Overall Study|Physician Decision|1|||
164629183|NCT02452034|594664389|FG003|Overall Study|Physician Decision|0|||
164629184|NCT02452034|594664390|FG004|Overall Study|Physician Decision|0|||
164629185|NCT02452034|594664391|FG005|Overall Study|Physician Decision|0|||
164629186|NCT02452034|594664386|FG000|Overall Study|Protocol Violation|0|||
164629187|NCT02452034|594664387|FG001|Overall Study|Protocol Violation|0|||
164629188|NCT02452034|594664388|FG002|Overall Study|Protocol Violation|0|||
164629189|NCT02452034|594664389|FG003|Overall Study|Protocol Violation|0|||
164629190|NCT02452034|594664390|FG004|Overall Study|Protocol Violation|0|||
164629191|NCT02452034|594664391|FG005|Overall Study|Protocol Violation|1|||
164629192|NCT02452034|594664386|FG000|Overall Study|Screen Failure|1|||
164629193|NCT02452034|594664387|FG001|Overall Study|Screen Failure|0|||
164629194|NCT02452034|594664388|FG002|Overall Study|Screen Failure|0|||
164629195|NCT02452034|594664389|FG003|Overall Study|Screen Failure|1|||
164629196|NCT02452034|594664390|FG004|Overall Study|Screen Failure|0|||
164629197|NCT02452034|594664391|FG005|Overall Study|Screen Failure|0|||
164629198|NCT02452034|594664386|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
164629199|NCT02452034|594664387|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
164629200|NCT02452034|594664388|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
164629201|NCT02452034|594664389|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
164629202|NCT02452034|594664390|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
164629203|NCT02452034|594664391|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
164629204|NCT01453439|594664396|FG000|Treatment Phase|Withdrawal by Subject|13|||
164629205|NCT01453439|594664397|FG001|Treatment Phase|Withdrawal by Subject|10|||
164629206|NCT01453439|594664396|FG000|Treatment Phase|Suicidal Ideation|2|||
164629207|NCT01453439|594664397|FG001|Treatment Phase|Suicidal Ideation|0|||
164629208|NCT01453439|594664396|FG000|Treatment Phase|Need for higher level of care|1|||
164629209|NCT01453439|594664397|FG001|Treatment Phase|Need for higher level of care|1|||
164629210|NCT01453439|594664396|FG000|Treatment Phase|Therapist conflict of interest|1|||
164629211|NCT01453439|594664397|FG001|Treatment Phase|Therapist conflict of interest|0|||
164629212|NCT01453439|594664396|FG000|Follow-up|Withdrawal by Subject|0|||
164629213|NCT01453439|594664397|FG001|Follow-up|Withdrawal by Subject|1|||
164629214|NCT01453439|594664396|FG000|Follow-up|Lost to Follow-up|5|||
164629215|NCT01453439|594664397|FG001|Follow-up|Lost to Follow-up|10|||
164629216|NCT01014442|594664398|FG000|Overall Study|Adverse Event|0|||
164629217|NCT01014442|594664399|FG001|Overall Study|Adverse Event|8|||
164629218|NCT01014442|594664398|FG000|Overall Study|Withdrawal by Subject|4|||
164629219|NCT01014442|594664399|FG001|Overall Study|Withdrawal by Subject|4|||
164629220|NCT01014442|594664398|FG000|Overall Study|Protocol Violation|2|||
164629221|NCT01014442|594664399|FG001|Overall Study|Protocol Violation|5|||
164629222|NCT01014442|594664398|FG000|Overall Study|Lack of Compliance|0|||
164629223|NCT01014442|594664399|FG001|Overall Study|Lack of Compliance|1|||
164629224|NCT01014442|594664398|FG000|Overall Study|Unspecified Reason|1|||
164629225|NCT01014442|594664399|FG001|Overall Study|Unspecified Reason|1|||
164629226|NCT02074059|594664400|FG000|Overall Study|Death|0|||
164629227|NCT02074059|594664401|FG001|Overall Study|Death|0|||
164629228|NCT02074059|594664402|FG002|Overall Study|Death|0|||
164629229|NCT02074059|594664403|FG003|Overall Study|Death|0|||
164629230|NCT02074059|594664404|FG004|Overall Study|Death|1|||
164629231|NCT02074059|594664405|FG005|Overall Study|Death|1|||
164629232|NCT02242305|594664419|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
164629233|NCT02242305|594664420|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
164629234|NCT02242305|594664419|FG000|Overall Study|Adverse Event|1|||
164629235|NCT02242305|594664420|FG001|Overall Study|Adverse Event|0|||
164629236|NCT02242305|594664419|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
164629237|NCT02242305|594664420|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
164629238|NCT02242305|594664419|FG000|Overall Study|Subject withdraws inform consent|0|||
164629239|NCT02242305|594664420|FG001|Overall Study|Subject withdraws inform consent|4|||
164629240|NCT02242305|594664419|FG000|Overall Study|Lost to Follow-up|2|||
164629241|NCT02242305|594664420|FG001|Overall Study|Lost to Follow-up|0|||
164629242|NCT02543801|594664423|FG000|Overall Study|Protocol Violation|1|||
164629243|NCT02543801|594664424|FG001|Overall Study|Protocol Violation|2|||
164629244|NCT02543801|594664425|FG002|Overall Study|Protocol Violation|0|||
164629245|NCT02543801|594664426|FG003|Overall Study|Protocol Violation|0|||
164629246|NCT01756846|594664427|FG000|Overall Study|Lost to Follow-up|5|||
164629247|NCT01756846|594664428|FG001|Overall Study|Lost to Follow-up|10|||
164629248|NCT01756846|594664427|FG000|Overall Study|Withdrawal by Subject|1|||
164528123|NCT03149549|594303745|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
164528124|NCT03149549|594303746|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
164528125|NCT03149549|594303747|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
164528126|NCT03149549|594303748|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
164528127|NCT03149549|594303749|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
164528128|NCT03149549|594303750|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
164528129|NCT03149549|594303751|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
164528130|NCT05180500|594303752|FG000|Overall Study|Adverse Event|1|||
164528131|NCT05180500|594303753|FG001|Overall Study|Adverse Event|0|||
164528132|NCT05180500|594303752|FG000|Overall Study|Withdrawal by Subject|2|||
164528133|NCT05180500|594303753|FG001|Overall Study|Withdrawal by Subject|0|||
164528134|NCT05917470|594303754|FG000|Overall Study|Progressive Disease|1|||
164528135|NCT05917470|594303755|FG001|Overall Study|Progressive Disease|1|||
164528136|NCT05917470|594303756|FG002|Overall Study|Progressive Disease|2|||
164528137|NCT05917470|594303757|FG003|Overall Study|Progressive Disease|3|||
164528138|NCT05917470|594303758|FG004|Overall Study|Progressive Disease|1|||
164528139|NCT05917470|594303759|FG005|Overall Study|Progressive Disease|1|||
164528140|NCT05917470|594303760|FG006|Overall Study|Progressive Disease|0|||
164528141|NCT05917470|594303761|FG007|Overall Study|Progressive Disease|0|||
164528142|NCT05917470|594303754|FG000|Overall Study|Withdrawal by Subject|0|||
164528143|NCT05917470|594303755|FG001|Overall Study|Withdrawal by Subject|0|||
164528144|NCT05917470|594303756|FG002|Overall Study|Withdrawal by Subject|1|||
164528145|NCT05917470|594303757|FG003|Overall Study|Withdrawal by Subject|0|||
164528146|NCT05917470|594303758|FG004|Overall Study|Withdrawal by Subject|0|||
164528147|NCT05917470|594303759|FG005|Overall Study|Withdrawal by Subject|0|||
164528148|NCT05917470|594303760|FG006|Overall Study|Withdrawal by Subject|0|||
164528149|NCT05917470|594303761|FG007|Overall Study|Withdrawal by Subject|0|||
164528150|NCT05917470|594303754|FG000|Overall Study|Sponsor Decision|0|||
164528151|NCT05917470|594303755|FG001|Overall Study|Sponsor Decision|0|||
164528152|NCT05917470|594303756|FG002|Overall Study|Sponsor Decision|1|||
164528153|NCT05917470|594303757|FG003|Overall Study|Sponsor Decision|0|||
164528154|NCT05917470|594303758|FG004|Overall Study|Sponsor Decision|2|||
164528155|NCT05917470|594303759|FG005|Overall Study|Sponsor Decision|1|||
164528156|NCT05917470|594303760|FG006|Overall Study|Sponsor Decision|3|||
164528157|NCT05917470|594303761|FG007|Overall Study|Sponsor Decision|3|||
164528158|NCT05917470|594303754|FG000|Overall Study|Adverse Event|0|||
164528159|NCT05917470|594303755|FG001|Overall Study|Adverse Event|0|||
164528160|NCT05917470|594303756|FG002|Overall Study|Adverse Event|0|||
164528161|NCT05917470|594303757|FG003|Overall Study|Adverse Event|0|||
164528162|NCT05917470|594303758|FG004|Overall Study|Adverse Event|0|||
164528163|NCT05917470|594303759|FG005|Overall Study|Adverse Event|1|||
164528164|NCT05917470|594303760|FG006|Overall Study|Adverse Event|0|||
164528165|NCT05917470|594303761|FG007|Overall Study|Adverse Event|0|||
164528166|NCT05195489|594305677|FG000|Overall Study|Lost to Follow-up|1|||
164528167|NCT05195489|594305678|FG001|Overall Study|Lost to Follow-up|0|||
164528168|NCT05195489|594305677|FG000|Overall Study|Protocol Violation|0|||
164528169|NCT05195489|594305678|FG001|Overall Study|Protocol Violation|2|||
164528170|NCT05195489|594305677|FG000|Overall Study|Withdrawal by Subject|1|||
164528171|NCT05195489|594305678|FG001|Overall Study|Withdrawal by Subject|1|||
164528172|NCT05195489|594305677|FG000|Overall Study|Removed|0|||
164528173|NCT05195489|594305678|FG001|Overall Study|Removed|1|||
164528174|NCT00346268|594305688|FG000|Overall Study|Adverse Event|1|||
164528175|NCT00346268|594305689|FG001|Overall Study|Adverse Event|0|||
164528176|NCT00346268|594305688|FG000|Overall Study|Protocol Violation|1|||
164528177|NCT00346268|594305689|FG001|Overall Study|Protocol Violation|0|||
164528178|NCT00346268|594305688|FG000|Overall Study|Participant refused|0|||
164528179|NCT00346268|594305689|FG001|Overall Study|Participant refused|3|||
164528180|NCT00409773|594305690|FG000|Overall Study|Adverse Event|3|||
164528181|NCT00409773|594305691|FG001|Overall Study|Adverse Event|4|||
164528182|NCT00409773|594305692|FG002|Overall Study|Adverse Event|4|||
164528183|NCT00409773|594305693|FG003|Overall Study|Adverse Event|2|||
164528184|NCT00409773|594305694|FG004|Overall Study|Adverse Event|6|||
164528185|NCT00409773|594305690|FG000|Overall Study|Lost to Follow-up|6|||
164528186|NCT00409773|594305691|FG001|Overall Study|Lost to Follow-up|1|||
164528187|NCT00409773|594305692|FG002|Overall Study|Lost to Follow-up|2|||
164528188|NCT00409773|594305693|FG003|Overall Study|Lost to Follow-up|3|||
164528189|NCT00409773|594305694|FG004|Overall Study|Lost to Follow-up|1|||
164528190|NCT00409773|594305690|FG000|Overall Study|Physician Decision|0|||
164528191|NCT00409773|594305691|FG001|Overall Study|Physician Decision|0|||
164528192|NCT00409773|594305692|FG002|Overall Study|Physician Decision|0|||
164528193|NCT00409773|594305693|FG003|Overall Study|Physician Decision|2|||
164528194|NCT00409773|594305694|FG004|Overall Study|Physician Decision|0|||
164528195|NCT00409773|594305690|FG000|Overall Study|Protocol Violation|0|||
164528196|NCT00409773|594305691|FG001|Overall Study|Protocol Violation|2|||
164528197|NCT00409773|594305692|FG002|Overall Study|Protocol Violation|3|||
164528198|NCT00409773|594305693|FG003|Overall Study|Protocol Violation|3|||
164528199|NCT00409773|594305694|FG004|Overall Study|Protocol Violation|1|||
164528200|NCT00409773|594305690|FG000|Overall Study|Withdrawal by Subject|0|||
164629249|NCT01756846|594664428|FG001|Overall Study|Withdrawal by Subject|2|||
164629250|NCT04118127|594664439|FG000|Overall Study|Trial terminated by sponsor|0|||
164629251|NCT04118127|594664440|FG001|Overall Study|Trial terminated by sponsor|12|||
164629252|NCT04118127|594664439|FG000|Overall Study|Adverse Event|1|||
164629253|NCT04118127|594664440|FG001|Overall Study|Adverse Event|2|||
164629254|NCT04118127|594664439|FG000|Overall Study|Physician Decision|0|||
164629255|NCT04118127|594664440|FG001|Overall Study|Physician Decision|1|||
164629256|NCT04118127|594664439|FG000|Overall Study|Withdrawal by Subject|2|||
164629257|NCT04118127|594664440|FG001|Overall Study|Withdrawal by Subject|1|||
164629258|NCT04491591|594664441|FG000|Overall Study|Accidently randomized|3|||
164629259|NCT04491591|594664442|FG001|Overall Study|Accidently randomized|1|||
164629260|NCT04491591|594664443|FG002|Overall Study|Accidently randomized|0|||
164629261|NCT04491591|594664441|FG000|Overall Study|Did not complete survey|28|||
164629262|NCT04491591|594664442|FG001|Overall Study|Did not complete survey|20|||
164629263|NCT04491591|594664443|FG002|Overall Study|Did not complete survey|3|||
164629264|NCT00636506|594664444|FG000|Overall Study|Lost to Follow-up|8|||
164629265|NCT00636506|594664444|FG000|Overall Study|Explanted|1|||
164629266|NCT00636506|594664444|FG000|Overall Study|Withdrawal by Subject|6|||
164629267|NCT00636506|594664444|FG000|Overall Study|Procedure aborted|1|||
164629268|NCT00715949|594664445|FG000|Overall Study|could not finish first test|4|||
164629269|NCT02607735|594664446|FG000|Primary Study|Randomized but Never Treated|1|||
164629270|NCT02607735|594664447|FG001|Primary Study|Randomized but Never Treated|0|||
164629271|NCT02607735|594664448|FG002|Primary Study|Randomized but Never Treated|0|||
164629272|NCT02607735|594664446|FG000|Primary Study|Lost to Follow-up|4|||
164629273|NCT02607735|594664447|FG001|Primary Study|Lost to Follow-up|0|||
164629274|NCT02607735|594664448|FG002|Primary Study|Lost to Follow-up|0|||
164629275|NCT02607735|594664446|FG000|Primary Study|Withdrew Consent|2|||
164629276|NCT02607735|594664447|FG001|Primary Study|Withdrew Consent|0|||
164629277|NCT02607735|594664448|FG002|Primary Study|Withdrew Consent|0|||
164629278|NCT02607735|594664446|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
164629279|NCT02607735|594664447|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
164629280|NCT02607735|594664448|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
164629281|NCT02607735|594664446|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
164629282|NCT02607735|594664447|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
164629283|NCT02607735|594664448|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
164629284|NCT01376908|594664449|FG000|Overall Study|Protocol Violation|1|||
164629285|NCT01376908|594664450|FG001|Overall Study|Protocol Violation|1|||
164629286|NCT01376908|594664449|FG000|Overall Study|Withdrawal by Subject|1|||
164629287|NCT01376908|594664450|FG001|Overall Study|Withdrawal by Subject|2|||
164629288|NCT01681836|594664459|FG000|Second Intervention|Withdrawal by Subject|0|||
164629289|NCT01681836|594664460|FG001|Second Intervention|Withdrawal by Subject|1|||
164629290|NCT02394028|594664461|FG000|Induction Phase|Adverse Event|2|||
164629291|NCT02394028|594664462|FG001|Induction Phase|Adverse Event|4|||
164629292|NCT02394028|594664463|FG002|Induction Phase|Adverse Event|1|||
164629293|NCT02394028|594664464|FG003|Induction Phase|Adverse Event|2|||
164629294|NCT02394028|594664465|FG004|Induction Phase|Adverse Event|5|||
164629295|NCT02394028|594664466|FG005|Induction Phase|Adverse Event|2|||
164629296|NCT02394028|594664467|FG006|Induction Phase|Adverse Event|0|||
164629297|NCT02394028|594664468|FG007|Induction Phase|Adverse Event|0|||
164629298|NCT02394028|594664469|FG008|Induction Phase|Adverse Event|0|||
164629299|NCT02394028|594664470|FG009|Induction Phase|Adverse Event|0|||
164629300|NCT02394028|594664471|FG010|Induction Phase|Adverse Event|0|||
164629301|NCT02394028|594664461|FG000|Induction Phase|Lack of Efficacy|3|||
164629302|NCT02394028|594664462|FG001|Induction Phase|Lack of Efficacy|6|||
164629303|NCT02394028|594664463|FG002|Induction Phase|Lack of Efficacy|2|||
164629304|NCT02394028|594664464|FG003|Induction Phase|Lack of Efficacy|17|||
164629305|NCT02394028|594664465|FG004|Induction Phase|Lack of Efficacy|14|||
164629306|NCT02394028|594664466|FG005|Induction Phase|Lack of Efficacy|8|||
164629307|NCT02394028|594664467|FG006|Induction Phase|Lack of Efficacy|17|||
164629308|NCT02394028|594664468|FG007|Induction Phase|Lack of Efficacy|23|||
164629309|NCT02394028|594664469|FG008|Induction Phase|Lack of Efficacy|0|||
164629310|NCT02394028|594664470|FG009|Induction Phase|Lack of Efficacy|0|||
164629311|NCT02394028|594664471|FG010|Induction Phase|Lack of Efficacy|0|||
164629312|NCT02394028|594664461|FG000|Induction Phase|Lost to Follow-up|1|||
164629313|NCT02394028|594664462|FG001|Induction Phase|Lost to Follow-up|0|||
164629314|NCT02394028|594664463|FG002|Induction Phase|Lost to Follow-up|0|||
164629315|NCT02394028|594664464|FG003|Induction Phase|Lost to Follow-up|1|||
164629316|NCT02394028|594664465|FG004|Induction Phase|Lost to Follow-up|0|||
164629317|NCT02394028|594664466|FG005|Induction Phase|Lost to Follow-up|0|||
164629318|NCT02394028|594664467|FG006|Induction Phase|Lost to Follow-up|1|||
164629319|NCT02394028|594664468|FG007|Induction Phase|Lost to Follow-up|0|||
164629320|NCT02394028|594664469|FG008|Induction Phase|Lost to Follow-up|0|||
164629321|NCT02394028|594664470|FG009|Induction Phase|Lost to Follow-up|0|||
164629322|NCT02394028|594664471|FG010|Induction Phase|Lost to Follow-up|0|||
164629323|NCT02394028|594664461|FG000|Induction Phase|Non-compliance|0|||
164629324|NCT02394028|594664462|FG001|Induction Phase|Non-compliance|1|||
164629325|NCT02394028|594664463|FG002|Induction Phase|Non-compliance|3|||
164629326|NCT02394028|594664464|FG003|Induction Phase|Non-compliance|1|||
164629327|NCT02394028|594664465|FG004|Induction Phase|Non-compliance|3|||
164629328|NCT02394028|594664466|FG005|Induction Phase|Non-compliance|0|||
164629329|NCT02394028|594664467|FG006|Induction Phase|Non-compliance|1|||
164629330|NCT02394028|594664468|FG007|Induction Phase|Non-compliance|1|||
164629331|NCT02394028|594664469|FG008|Induction Phase|Non-compliance|0|||
164629332|NCT02394028|594664470|FG009|Induction Phase|Non-compliance|0|||
164629333|NCT02394028|594664471|FG010|Induction Phase|Non-compliance|0|||
164629334|NCT02394028|594664461|FG000|Induction Phase|Physician Decision|0|||
164629335|NCT02394028|594664462|FG001|Induction Phase|Physician Decision|0|||
164629336|NCT02394028|594664463|FG002|Induction Phase|Physician Decision|1|||
164629337|NCT02394028|594664464|FG003|Induction Phase|Physician Decision|4|||
164629338|NCT02394028|594664465|FG004|Induction Phase|Physician Decision|0|||
164629339|NCT02394028|594664466|FG005|Induction Phase|Physician Decision|2|||
164629340|NCT02394028|594664467|FG006|Induction Phase|Physician Decision|1|||
164629341|NCT02394028|594664468|FG007|Induction Phase|Physician Decision|0|||
164629342|NCT02394028|594664469|FG008|Induction Phase|Physician Decision|0|||
164629343|NCT02394028|594664470|FG009|Induction Phase|Physician Decision|0|||
164629344|NCT02394028|594664471|FG010|Induction Phase|Physician Decision|0|||
164629345|NCT02394028|594664461|FG000|Induction Phase|Protocol Violation|0|||
164629346|NCT02394028|594664462|FG001|Induction Phase|Protocol Violation|2|||
164629347|NCT02394028|594664463|FG002|Induction Phase|Protocol Violation|0|||
164629348|NCT02394028|594664464|FG003|Induction Phase|Protocol Violation|3|||
164629349|NCT02394028|594664465|FG004|Induction Phase|Protocol Violation|0|||
164629350|NCT02394028|594664466|FG005|Induction Phase|Protocol Violation|1|||
164629351|NCT02394028|594664467|FG006|Induction Phase|Protocol Violation|1|||
164629352|NCT02394028|594664468|FG007|Induction Phase|Protocol Violation|0|||
164629353|NCT02394028|594664469|FG008|Induction Phase|Protocol Violation|0|||
164629354|NCT02394028|594664470|FG009|Induction Phase|Protocol Violation|0|||
164629355|NCT02394028|594664471|FG010|Induction Phase|Protocol Violation|0|||
164629356|NCT02394028|594664461|FG000|Induction Phase|Withdrawal by Subject|1|||
164629357|NCT02394028|594664462|FG001|Induction Phase|Withdrawal by Subject|2|||
164629358|NCT02394028|594664463|FG002|Induction Phase|Withdrawal by Subject|4|||
164629359|NCT02394028|594664464|FG003|Induction Phase|Withdrawal by Subject|6|||
164629360|NCT02394028|594664465|FG004|Induction Phase|Withdrawal by Subject|7|||
164629361|NCT02394028|594664466|FG005|Induction Phase|Withdrawal by Subject|4|||
164629362|NCT02394028|594664467|FG006|Induction Phase|Withdrawal by Subject|3|||
164629363|NCT02394028|594664468|FG007|Induction Phase|Withdrawal by Subject|6|||
164629364|NCT02394028|594664469|FG008|Induction Phase|Withdrawal by Subject|0|||
164629365|NCT02394028|594664470|FG009|Induction Phase|Withdrawal by Subject|0|||
164629366|NCT02394028|594664471|FG010|Induction Phase|Withdrawal by Subject|0|||
164629367|NCT02394028|594664461|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
164629368|NCT02394028|594664462|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
164629369|NCT02394028|594664463|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
164629370|NCT02394028|594664464|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
164629371|NCT02394028|594664465|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
164629372|NCT02394028|594664466|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
164629373|NCT02394028|594664467|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
164629374|NCT02394028|594664468|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
164629375|NCT02394028|594664469|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
164629376|NCT02394028|594664470|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
164629377|NCT02394028|594664471|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
164629378|NCT02394028|594664461|FG000|Induction Phase|Sponsor decision|0|||
164629379|NCT02394028|594664462|FG001|Induction Phase|Sponsor decision|1|||
164629380|NCT02394028|594664463|FG002|Induction Phase|Sponsor decision|2|||
164629381|NCT02394028|594664464|FG003|Induction Phase|Sponsor decision|0|||
164629382|NCT02394028|594664465|FG004|Induction Phase|Sponsor decision|0|||
164629383|NCT02394028|594664466|FG005|Induction Phase|Sponsor decision|0|||
164629384|NCT02394028|594664467|FG006|Induction Phase|Sponsor decision|0|||
164629385|NCT02394028|594664468|FG007|Induction Phase|Sponsor decision|0|||
164629386|NCT02394028|594664469|FG008|Induction Phase|Sponsor decision|0|||
164629387|NCT02394028|594664470|FG009|Induction Phase|Sponsor decision|0|||
164629388|NCT02394028|594664471|FG010|Induction Phase|Sponsor decision|0|||
164629389|NCT02394028|594664461|FG000|Induction Phase|Technical reason|0|||
164629390|NCT02394028|594664462|FG001|Induction Phase|Technical reason|0|||
164629391|NCT02394028|594664463|FG002|Induction Phase|Technical reason|0|||
164629392|NCT02394028|594664464|FG003|Induction Phase|Technical reason|1|||
164629393|NCT02394028|594664465|FG004|Induction Phase|Technical reason|0|||
164629394|NCT02394028|594664466|FG005|Induction Phase|Technical reason|0|||
164629395|NCT02394028|594664467|FG006|Induction Phase|Technical reason|0|||
164629396|NCT02394028|594664468|FG007|Induction Phase|Technical reason|0|||
164629397|NCT02394028|594664469|FG008|Induction Phase|Technical reason|0|||
164629398|NCT02394028|594664470|FG009|Induction Phase|Technical reason|0|||
164629399|NCT02394028|594664471|FG010|Induction Phase|Technical reason|0|||
164629400|NCT02394028|594664461|FG000|Induction Phase|:ack of calculation|0|||
164629401|NCT02394028|594664462|FG001|Induction Phase|:ack of calculation|0|||
164629402|NCT02394028|594664463|FG002|Induction Phase|:ack of calculation|0|||
164629403|NCT02394028|594664464|FG003|Induction Phase|:ack of calculation|0|||
164629404|NCT02394028|594664465|FG004|Induction Phase|:ack of calculation|0|||
164629405|NCT02394028|594664466|FG005|Induction Phase|:ack of calculation|0|||
164629406|NCT02394028|594664467|FG006|Induction Phase|:ack of calculation|0|||
164629407|NCT02394028|594664468|FG007|Induction Phase|:ack of calculation|1|||
164629408|NCT02394028|594664469|FG008|Induction Phase|:ack of calculation|0|||
164629409|NCT02394028|594664470|FG009|Induction Phase|:ack of calculation|0|||
164629410|NCT02394028|594664471|FG010|Induction Phase|:ack of calculation|0|||
164629411|NCT02394028|594664461|FG000|Maintenance Phase|Protocol Violation|0|||
164629412|NCT02394028|594664462|FG001|Maintenance Phase|Protocol Violation|0|||
164629413|NCT02394028|594664463|FG002|Maintenance Phase|Protocol Violation|0|||
164629414|NCT02394028|594664464|FG003|Maintenance Phase|Protocol Violation|0|||
164629415|NCT02394028|594664465|FG004|Maintenance Phase|Protocol Violation|0|||
164629416|NCT02394028|594664466|FG005|Maintenance Phase|Protocol Violation|0|||
164629417|NCT02394028|594664467|FG006|Maintenance Phase|Protocol Violation|0|||
164629418|NCT02394028|594664468|FG007|Maintenance Phase|Protocol Violation|0|||
164629419|NCT02394028|594664469|FG008|Maintenance Phase|Protocol Violation|0|||
164629420|NCT02394028|594664470|FG009|Maintenance Phase|Protocol Violation|0|||
164629421|NCT02394028|594664471|FG010|Maintenance Phase|Protocol Violation|1|||
164629422|NCT02394028|594664461|FG000|Maintenance Phase|Physician Decision|0|||
164629423|NCT02394028|594664462|FG001|Maintenance Phase|Physician Decision|0|||
164629424|NCT02394028|594664463|FG002|Maintenance Phase|Physician Decision|0|||
164629425|NCT02394028|594664464|FG003|Maintenance Phase|Physician Decision|0|||
164629426|NCT02394028|594664465|FG004|Maintenance Phase|Physician Decision|0|||
164629427|NCT02394028|594664466|FG005|Maintenance Phase|Physician Decision|0|||
164629428|NCT02394028|594664467|FG006|Maintenance Phase|Physician Decision|0|||
164629429|NCT02394028|594664468|FG007|Maintenance Phase|Physician Decision|0|||
164629430|NCT02394028|594664469|FG008|Maintenance Phase|Physician Decision|1|||
164629431|NCT02394028|594664470|FG009|Maintenance Phase|Physician Decision|3|||
164629432|NCT02394028|594664471|FG010|Maintenance Phase|Physician Decision|2|||
164629433|NCT02394028|594664461|FG000|Maintenance Phase|Lack of Efficacy|0|||
164629434|NCT02394028|594664462|FG001|Maintenance Phase|Lack of Efficacy|0|||
164629435|NCT02394028|594664463|FG002|Maintenance Phase|Lack of Efficacy|0|||
164528201|NCT00409773|594305691|FG001|Overall Study|Withdrawal by Subject|0|||
164528202|NCT00409773|594305692|FG002|Overall Study|Withdrawal by Subject|0|||
164528203|NCT00409773|594305693|FG003|Overall Study|Withdrawal by Subject|2|||
164528204|NCT00409773|594305694|FG004|Overall Study|Withdrawal by Subject|1|||
164528205|NCT00409773|594305690|FG000|Overall Study|Lack of Eligibility|0|||
164528206|NCT00409773|594305691|FG001|Overall Study|Lack of Eligibility|0|||
164528207|NCT00409773|594305692|FG002|Overall Study|Lack of Eligibility|0|||
164528208|NCT00409773|594305693|FG003|Overall Study|Lack of Eligibility|0|||
164528209|NCT00409773|594305694|FG004|Overall Study|Lack of Eligibility|1|||
164528210|NCT01201343|594305695|FG000|Overall Study|Adverse Event|6|||
164528211|NCT01201343|594305695|FG000|Overall Study|Withdrawal by Subject|5|||
164528212|NCT01201343|594305695|FG000|Overall Study|Lost to Follow-up|2|||
164528213|NCT01201343|594305695|FG000|Overall Study|Lack of Efficacy|2|||
164528214|NCT01201343|594305695|FG000|Overall Study|Participant wrongly included in trial|1|||
164528215|NCT01201343|594305695|FG000|Overall Study|Randomized, not treated|3|||
164528216|NCT01919814|594305696|FG000|Overall Study|Adverse Event|1|||
164528217|NCT01919814|594305697|FG001|Overall Study|Adverse Event|0|||
164528218|NCT01919814|594305696|FG000|Overall Study|Protocol Violation|1|||
164528219|NCT01919814|594305697|FG001|Overall Study|Protocol Violation|0|||
164528220|NCT01919814|594305696|FG000|Overall Study|Withdrawal by Subject|1|||
164528221|NCT01919814|594305697|FG001|Overall Study|Withdrawal by Subject|0|||
164528222|NCT02164383|594305698|FG000|Overall Study|Lost to Follow-up|1|||
164528223|NCT02164383|594305699|FG001|Overall Study|Lost to Follow-up|0|||
164528224|NCT01036763|594305700|FG000|Overall Study|Adverse Event|25|||
164528225|NCT01036763|594305700|FG000|Overall Study|Lost to Follow-up|28|||
164528226|NCT01036763|594305700|FG000|Overall Study|Other reason (not specified)|40|||
164528227|NCT01672723|594305701|FG000|First Intervention|Adverse Event|3|||
164528228|NCT01672723|594305702|FG001|First Intervention|Adverse Event|0|||
164528229|NCT00743275|594305703|FG000|Overall Study|Protocol Violation|0|||
164528230|NCT00743275|594305704|FG001|Overall Study|Protocol Violation|1|||
164528231|NCT02831387|594305709|FG000|Overall Study|Withdrawal by Subject|1|||
164528232|NCT02831387|594305710|FG001|Overall Study|Withdrawal by Subject|1|||
164528233|NCT02831387|594305709|FG000|Overall Study|Discontinued due to stock recovery|0|||
164528234|NCT02831387|594305710|FG001|Overall Study|Discontinued due to stock recovery|1|||
164528235|NCT01828073|594305711|FG000|Overall Study|Lost to Follow-up|1|||
164528236|NCT01828073|594305712|FG001|Overall Study|Lost to Follow-up|2|||
164528237|NCT03057977|594305714|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
164528238|NCT03057977|594305715|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
164528239|NCT03057977|594305714|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
164528240|NCT03057977|594305715|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
164528241|NCT03057977|594305714|FG000|Discontinuation From Treatment|Protocol Violation|6|||
164528242|NCT03057977|594305715|FG001|Discontinuation From Treatment|Protocol Violation|5|||
164528243|NCT03057977|594305714|FG000|Discontinuation From Treatment|Not treated|4|||
164528244|NCT03057977|594305715|FG001|Discontinuation From Treatment|Not treated|0|||
164528245|NCT03057977|594305714|FG000|Discontinuation From Treatment|Adverse Event|343|||
164528246|NCT03057977|594305715|FG001|Discontinuation From Treatment|Adverse Event|337|||
164528247|NCT03057977|594305714|FG000|Discontinuation From Treatment|Reason Unknown|0|||
164528248|NCT03057977|594305715|FG001|Discontinuation From Treatment|Reason Unknown|1|||
164528249|NCT03057977|594305714|FG000|Discontinuation From Treatment|Personal Reasons|1|||
164528250|NCT03057977|594305715|FG001|Discontinuation From Treatment|Personal Reasons|1|||
164528251|NCT03057977|594305714|FG000|Discontinuation From Treatment|Unblinded medication|1|||
164528252|NCT03057977|594305715|FG001|Discontinuation From Treatment|Unblinded medication|0|||
164528253|NCT03057977|594305714|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
164528254|NCT03057977|594305715|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
164528255|NCT03057977|594305714|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
164528256|NCT03057977|594305715|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
164528257|NCT03057977|594305714|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
164528258|NCT03057977|594305715|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
164528259|NCT03057977|594305714|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
164528260|NCT03057977|594305715|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
164528261|NCT03057977|594305714|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
164528262|NCT03057977|594305715|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
164528263|NCT03057977|594305714|FG000|Discontinuation From Treatment|Not attending study visit|3|||
164528264|NCT03057977|594305715|FG001|Discontinuation From Treatment|Not attending study visit|10|||
164528265|NCT03057977|594305714|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
164528266|NCT03057977|594305715|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
164528267|NCT03057977|594305714|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
164528268|NCT03057977|594305715|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
164528269|NCT03057977|594305714|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
164528270|NCT03057977|594305715|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
164629436|NCT02394028|594664464|FG003|Maintenance Phase|Lack of Efficacy|0|||
164629437|NCT02394028|594664465|FG004|Maintenance Phase|Lack of Efficacy|0|||
164629438|NCT02394028|594664466|FG005|Maintenance Phase|Lack of Efficacy|0|||
164629439|NCT02394028|594664467|FG006|Maintenance Phase|Lack of Efficacy|0|||
164629440|NCT02394028|594664468|FG007|Maintenance Phase|Lack of Efficacy|0|||
164629441|NCT02394028|594664469|FG008|Maintenance Phase|Lack of Efficacy|7|||
164629442|NCT02394028|594664470|FG009|Maintenance Phase|Lack of Efficacy|25|||
164629443|NCT02394028|594664471|FG010|Maintenance Phase|Lack of Efficacy|33|||
164629444|NCT02394028|594664461|FG000|Maintenance Phase|Death|0|||
164629445|NCT02394028|594664462|FG001|Maintenance Phase|Death|0|||
164629446|NCT02394028|594664463|FG002|Maintenance Phase|Death|0|||
164629447|NCT02394028|594664464|FG003|Maintenance Phase|Death|0|||
164629448|NCT02394028|594664465|FG004|Maintenance Phase|Death|0|||
164629449|NCT02394028|594664466|FG005|Maintenance Phase|Death|0|||
164629450|NCT02394028|594664467|FG006|Maintenance Phase|Death|0|||
164629451|NCT02394028|594664468|FG007|Maintenance Phase|Death|0|||
164629452|NCT02394028|594664469|FG008|Maintenance Phase|Death|0|||
164629453|NCT02394028|594664470|FG009|Maintenance Phase|Death|0|||
164629454|NCT02394028|594664471|FG010|Maintenance Phase|Death|1|||
164629455|NCT02394028|594664461|FG000|Maintenance Phase|Adverse Event|0|||
164629456|NCT02394028|594664462|FG001|Maintenance Phase|Adverse Event|0|||
164629457|NCT02394028|594664463|FG002|Maintenance Phase|Adverse Event|0|||
164629458|NCT02394028|594664464|FG003|Maintenance Phase|Adverse Event|0|||
164629459|NCT02394028|594664465|FG004|Maintenance Phase|Adverse Event|0|||
164629460|NCT02394028|594664466|FG005|Maintenance Phase|Adverse Event|0|||
164629461|NCT02394028|594664467|FG006|Maintenance Phase|Adverse Event|0|||
164629462|NCT02394028|594664468|FG007|Maintenance Phase|Adverse Event|0|||
164629463|NCT02394028|594664469|FG008|Maintenance Phase|Adverse Event|1|||
164629464|NCT02394028|594664470|FG009|Maintenance Phase|Adverse Event|1|||
164629465|NCT02394028|594664471|FG010|Maintenance Phase|Adverse Event|3|||
164629466|NCT02394028|594664461|FG000|Maintenance Phase|Site closure|0|||
164629467|NCT02394028|594664462|FG001|Maintenance Phase|Site closure|0|||
164629468|NCT02394028|594664463|FG002|Maintenance Phase|Site closure|0|||
164629469|NCT02394028|594664464|FG003|Maintenance Phase|Site closure|0|||
164629470|NCT02394028|594664465|FG004|Maintenance Phase|Site closure|0|||
164629471|NCT02394028|594664466|FG005|Maintenance Phase|Site closure|0|||
164629472|NCT02394028|594664467|FG006|Maintenance Phase|Site closure|0|||
164629473|NCT02394028|594664468|FG007|Maintenance Phase|Site closure|0|||
164629474|NCT02394028|594664469|FG008|Maintenance Phase|Site closure|0|||
164629475|NCT02394028|594664470|FG009|Maintenance Phase|Site closure|1|||
164629476|NCT02394028|594664471|FG010|Maintenance Phase|Site closure|0|||
164629477|NCT02394028|594664461|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164629478|NCT02394028|594664462|FG001|Maintenance Phase|Withdrawal by Subject|0|||
164629479|NCT02394028|594664463|FG002|Maintenance Phase|Withdrawal by Subject|0|||
164629480|NCT02394028|594664464|FG003|Maintenance Phase|Withdrawal by Subject|0|||
164629481|NCT02394028|594664465|FG004|Maintenance Phase|Withdrawal by Subject|0|||
164629482|NCT02394028|594664466|FG005|Maintenance Phase|Withdrawal by Subject|0|||
164629483|NCT02394028|594664467|FG006|Maintenance Phase|Withdrawal by Subject|0|||
164629484|NCT02394028|594664468|FG007|Maintenance Phase|Withdrawal by Subject|0|||
164629485|NCT02394028|594664469|FG008|Maintenance Phase|Withdrawal by Subject|3|||
164629486|NCT02394028|594664470|FG009|Maintenance Phase|Withdrawal by Subject|12|||
164629487|NCT02394028|594664471|FG010|Maintenance Phase|Withdrawal by Subject|12|||
164629488|NCT00742391|594664472|FG000|Overall Study|Adverse Event|2|||
164629489|NCT00742391|594664473|FG001|Overall Study|Adverse Event|1|||
164629490|NCT00742391|594664472|FG000|Overall Study|Lost to Follow-up|1|||
164629491|NCT00742391|594664473|FG001|Overall Study|Lost to Follow-up|0|||
164629492|NCT00742391|594664472|FG000|Overall Study|Protocol Violation|1|||
164629493|NCT00742391|594664473|FG001|Overall Study|Protocol Violation|0|||
164629494|NCT00866606|594664476|FG000|Overall Study|Lost to Follow-up|3|||
164629495|NCT00866606|594664476|FG000|Overall Study|Adverse Event|1|||
164629496|NCT01058356|594664488|FG000|Overall Study|Adverse Event|5|||
164629497|NCT01058356|594664488|FG000|Overall Study|Administration of contraindicated drugs|12|||
164629498|NCT01058356|594664488|FG000|Overall Study|Withdrawal by Subject|21|||
164629499|NCT01058356|594664488|FG000|Overall Study|Lost to Follow-up|4|||
164629500|NCT00806494|594664489|FG000|Overall Study|Adverse Event|29|||
164629501|NCT00806494|594664489|FG000|Overall Study|Lack of Efficacy|6|||
164629502|NCT00806494|594664489|FG000|Overall Study|Lost to Follow-up|10|||
164629503|NCT00806494|594664489|FG000|Overall Study|Other|30|||
164629504|NCT00806494|594664489|FG000|Overall Study|Withdrawal by Subject|5|||
164629505|NCT02417935|594664490|FG000|Treatment Period|Adverse Event|12|||
164629506|NCT02417935|594664491|FG001|Treatment Period|Adverse Event|10|||
164629507|NCT02417935|594664490|FG000|Treatment Period|Lost to Follow-up|1|||
164629508|NCT02417935|594664491|FG001|Treatment Period|Lost to Follow-up|0|||
164629509|NCT02417935|594664490|FG000|Treatment Period|Entry Criteria not met|0|||
164629510|NCT02417935|594664491|FG001|Treatment Period|Entry Criteria not met|1|||
164629511|NCT02417935|594664490|FG000|Treatment Period|Protocol Violation|2|||
164629512|NCT02417935|594664491|FG001|Treatment Period|Protocol Violation|1|||
164629513|NCT02417935|594664490|FG000|Treatment Period|Withdrawal by Subject|3|||
164629514|NCT02417935|594664491|FG001|Treatment Period|Withdrawal by Subject|3|||
164629515|NCT02417935|594664490|FG000|Treatment Period|Physician Decision|3|||
164629516|NCT02417935|594664491|FG001|Treatment Period|Physician Decision|1|||
164629517|NCT02850276|594664492|FG000|Overall Study|screen failure|43|||
164629518|NCT02850276|594664492|FG000|Overall Study|Withdrawal by Subject|14|||
164629519|NCT02850276|594664492|FG000|Overall Study|Physician Decision|2|||
164629520|NCT02850276|594664492|FG000|Overall Study|Lost to Follow-up|2|||
164629521|NCT04815291|594664493|FG000|Overall Study|Lost to Follow-up|1|||
164629522|NCT04815291|594664493|FG000|Overall Study|Physician Decision|4|||
164629523|NCT04815291|594664493|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
164629524|NCT02646332|594664497|FG000|Overall Study|Lost to Follow-up|0|||
164629525|NCT02646332|594664498|FG001|Overall Study|Lost to Follow-up|3|||
164629526|NCT01775995|594664499|FG000|Overall Study|Lost to Follow-up|1|||
164629527|NCT01775995|594664500|FG001|Overall Study|Lost to Follow-up|1|||
164629528|NCT02909504|594664501|FG000|Overall Study|Adverse Event|2|||
164629529|NCT02909504|594664501|FG000|Overall Study|Lack of Efficacy|3|||
164629530|NCT02909504|594664501|FG000|Overall Study|Withdrawal by Subject|4|||
164629531|NCT02909504|594664501|FG000|Overall Study|Pregnancy|1|||
164629532|NCT02909504|594664501|FG000|Overall Study|Subject moved|1|||
164629533|NCT02909504|594664501|FG000|Overall Study|Lost to Follow-up|1|||
164629534|NCT01277666|594664507|FG000|Overall Study|Adverse Event|26|||
164629535|NCT01277666|594664508|FG001|Overall Study|Adverse Event|25|||
164629536|NCT01277666|594664509|FG002|Overall Study|Adverse Event|20|||
164629537|NCT01277666|594664507|FG000|Overall Study|Lack of Efficacy|8|||
164629538|NCT01277666|594664508|FG001|Overall Study|Lack of Efficacy|20|||
164629539|NCT01277666|594664509|FG002|Overall Study|Lack of Efficacy|12|||
164629540|NCT01277666|594664507|FG000|Overall Study|Protocol Violation|2|||
164629541|NCT01277666|594664508|FG001|Overall Study|Protocol Violation|3|||
164629542|NCT01277666|594664509|FG002|Overall Study|Protocol Violation|2|||
164629543|NCT01277666|594664507|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
164629544|NCT01277666|594664508|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
164629545|NCT01277666|594664509|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
164629546|NCT01277666|594664507|FG000|Overall Study|Lost to Follow-up|1|||
164629547|NCT01277666|594664508|FG001|Overall Study|Lost to Follow-up|1|||
164629548|NCT01277666|594664509|FG002|Overall Study|Lost to Follow-up|2|||
164629549|NCT01277666|594664507|FG000|Overall Study|Withdrawal by Subject|7|||
164629550|NCT01277666|594664508|FG001|Overall Study|Withdrawal by Subject|8|||
164629551|NCT01277666|594664509|FG002|Overall Study|Withdrawal by Subject|6|||
164629552|NCT01277666|594664507|FG000|Overall Study|Death|0|||
164629553|NCT01277666|594664508|FG001|Overall Study|Death|0|||
164629554|NCT01277666|594664509|FG002|Overall Study|Death|1|||
164629555|NCT01657903|594664511|FG000|Overall Study|Lost to Follow-up|1|||
164629556|NCT01657903|594664511|FG000|Overall Study|Withdrawal by Subject|1|||
164629557|NCT00554840|594664512|FG000|Overall Study|Physician Decision|0|||
164629558|NCT00554840|594664513|FG001|Overall Study|Physician Decision|1|||
164629559|NCT02312934|594664516|FG000|Overall Study|Lost to Follow-up|1|||
164629560|NCT02312934|594664517|FG001|Overall Study|Lost to Follow-up|0|||
164629561|NCT02312934|594664516|FG000|Overall Study|Physician Decision|1|||
164629562|NCT02312934|594664517|FG001|Overall Study|Physician Decision|0|||
164629563|NCT03395704|594664519|FG000|Overall Study|Adverse Event|2|||
164629564|NCT03395704|594664520|FG001|Overall Study|Adverse Event|1|||
164629565|NCT03395704|594664519|FG000|Overall Study|Withdrawal by Subject|2|||
164629566|NCT03395704|594664520|FG001|Overall Study|Withdrawal by Subject|1|||
164629567|NCT03395704|594664519|FG000|Overall Study|Physician Decision|0|||
164629568|NCT03395704|594664520|FG001|Overall Study|Physician Decision|1|||
164629569|NCT03359811|594666511|FG000|Overall Study|Protocol Violation|2|||
164629570|NCT03359811|594666512|FG001|Overall Study|Protocol Violation|0|||
164629571|NCT02528331|594666525|FG000|Overall Study|Withdrawal by Subject|2|||
164629572|NCT00386152|594666526|FG000|Overall Study|Adverse Event|6|||
164629573|NCT00386152|594666527|FG001|Overall Study|Adverse Event|5|||
164629574|NCT00386152|594666528|FG002|Overall Study|Adverse Event|4|||
164629575|NCT00386152|594666526|FG000|Overall Study|Chang from original chemo stratification|4|||
164629576|NCT00386152|594666527|FG001|Overall Study|Chang from original chemo stratification|5|||
164629577|NCT00386152|594666528|FG002|Overall Study|Chang from original chemo stratification|6|||
164629578|NCT00386152|594666526|FG000|Overall Study|Death|3|||
164629579|NCT00386152|594666527|FG001|Overall Study|Death|0|||
164629580|NCT00386152|594666528|FG002|Overall Study|Death|1|||
164629581|NCT00386152|594666526|FG000|Overall Study|Disease progression|7|||
164629582|NCT00386152|594666527|FG001|Overall Study|Disease progression|4|||
164629583|NCT00386152|594666528|FG002|Overall Study|Disease progression|5|||
164629584|NCT00386152|594666526|FG000|Overall Study|Physician Decision|13|||
164629585|NCT00386152|594666527|FG001|Overall Study|Physician Decision|10|||
164629586|NCT00386152|594666528|FG002|Overall Study|Physician Decision|4|||
164629587|NCT00386152|594666526|FG000|Overall Study|Lost to Follow-up|1|||
164629588|NCT00386152|594666527|FG001|Overall Study|Lost to Follow-up|0|||
164629589|NCT00386152|594666528|FG002|Overall Study|Lost to Follow-up|0|||
164629590|NCT00386152|594666526|FG000|Overall Study|Completed chemotherapy|4|||
164629591|NCT00386152|594666527|FG001|Overall Study|Completed chemotherapy|5|||
164629592|NCT00386152|594666528|FG002|Overall Study|Completed chemotherapy|1|||
164629593|NCT00386152|594666526|FG000|Overall Study|Protocol Violation|3|||
164629594|NCT00386152|594666527|FG001|Overall Study|Protocol Violation|5|||
164629595|NCT00386152|594666528|FG002|Overall Study|Protocol Violation|2|||
164629596|NCT00386152|594666526|FG000|Overall Study|Withdrawal by Subject|3|||
164629597|NCT00386152|594666527|FG001|Overall Study|Withdrawal by Subject|6|||
164629598|NCT00386152|594666528|FG002|Overall Study|Withdrawal by Subject|10|||
164629599|NCT02577107|594666529|FG000|Overall Study|Protocol deviation|0|||
164629600|NCT02577107|594666530|FG001|Overall Study|Protocol deviation|1|||
164629601|NCT00577382|594666531|FG000|Overall Study|Adverse Event|0|||
164629602|NCT00577382|594666532|FG001|Overall Study|Adverse Event|6|||
164629603|NCT00577382|594666531|FG000|Overall Study|Withdrawal by Subject|0|||
164629604|NCT00577382|594666532|FG001|Overall Study|Withdrawal by Subject|1|||
164629605|NCT00577382|594666531|FG000|Overall Study|Progressive Disease|17|||
164629606|NCT00577382|594666532|FG001|Overall Study|Progressive Disease|19|||
164629607|NCT00577382|594666531|FG000|Overall Study|Intercurrent Illness|1|||
164629608|NCT00577382|594666532|FG001|Overall Study|Intercurrent Illness|2|||
164629609|NCT00577382|594666531|FG000|Overall Study|Death|1|||
164629610|NCT00577382|594666532|FG001|Overall Study|Death|1|||
164629611|NCT00577382|594666531|FG000|Overall Study|Lost to Follow-up|2|||
164629612|NCT00577382|594666532|FG001|Overall Study|Lost to Follow-up|2|||
164629613|NCT01345162|594666533|FG000|Overall Study|Protocol Violation|2|||
164629614|NCT01345162|594666534|FG001|Overall Study|Protocol Violation|4|||
164629615|NCT03007472|594666536|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
164629616|NCT03007472|594666536|FG000|Overall Study|Death|2|||
164629617|NCT03007472|594666536|FG000|Overall Study|Loss to Follow Up|1|||
164629618|NCT02988115|594666537|FG000|Overall Study|Adverse Event|6|||
164629619|NCT02988115|594666538|FG001|Overall Study|Adverse Event|1|||
164629620|NCT02988115|594666537|FG000|Overall Study|Sponsor Decision|5|||
164629621|NCT02988115|594666538|FG001|Overall Study|Sponsor Decision|2|||
164629622|NCT02988115|594666537|FG000|Overall Study|Withdrawal by Subject|1|||
164629623|NCT02988115|594666538|FG001|Overall Study|Withdrawal by Subject|1|||
164629624|NCT02988115|594666537|FG000|Overall Study|Withdrawn by Mistake|1|||
164629625|NCT02988115|594666538|FG001|Overall Study|Withdrawn by Mistake|0|||
164629626|NCT02988115|594666537|FG000|Overall Study|Lost to Follow-up|1|||
164629627|NCT02988115|594666538|FG001|Overall Study|Lost to Follow-up|0|||
164629628|NCT01731951|594666539|FG000|Overall Study|Documented Disease Progression|1|||
164629629|NCT01731951|594666540|FG001|Overall Study|Documented Disease Progression|0|||
164629630|NCT01731951|594666541|FG002|Overall Study|Documented Disease Progression|0|||
164629631|NCT01731951|594666542|FG003|Overall Study|Documented Disease Progression|0|||
164629632|NCT01731951|594666543|FG004|Overall Study|Documented Disease Progression|0|||
164629633|NCT01731951|594666544|FG005|Overall Study|Documented Disease Progression|0|||
164629634|NCT01731951|594666539|FG000|Overall Study|Lost to Follow-up|2|||
164629635|NCT01731951|594666540|FG001|Overall Study|Lost to Follow-up|0|||
164629636|NCT01731951|594666541|FG002|Overall Study|Lost to Follow-up|0|||
164629637|NCT01731951|594666542|FG003|Overall Study|Lost to Follow-up|1|||
164629638|NCT01731951|594666543|FG004|Overall Study|Lost to Follow-up|3|||
164629639|NCT01731951|594666544|FG005|Overall Study|Lost to Follow-up|1|||
164629640|NCT01731951|594666539|FG000|Overall Study|Withdrawal of Consent|1|||
164629641|NCT01731951|594666540|FG001|Overall Study|Withdrawal of Consent|0|||
164629642|NCT01731951|594666541|FG002|Overall Study|Withdrawal of Consent|0|||
164629643|NCT01731951|594666542|FG003|Overall Study|Withdrawal of Consent|0|||
164629644|NCT01731951|594666543|FG004|Overall Study|Withdrawal of Consent|0|||
164629645|NCT01731951|594666544|FG005|Overall Study|Withdrawal of Consent|2|||
164629646|NCT01731951|594666539|FG000|Overall Study|Death|13|||
164629647|NCT01731951|594666540|FG001|Overall Study|Death|15|||
164629648|NCT01731951|594666541|FG002|Overall Study|Death|9|||
164629649|NCT01731951|594666542|FG003|Overall Study|Death|8|||
164629650|NCT01731951|594666543|FG004|Overall Study|Death|9|||
164629651|NCT01731951|594666544|FG005|Overall Study|Death|6|||
164629652|NCT00649220|594666551|FG000|Overall Study|Adverse Event|2|||
164629653|NCT00649220|594666551|FG000|Overall Study|Withdrawal by Subject|1|||
164629654|NCT01977651|594666552|FG000|4 Month Treatment Period|Adverse Event|34|||
164629655|NCT01977651|594666552|FG000|4 Month Treatment Period|Death|3|||
164629656|NCT01977651|594666552|FG000|4 Month Treatment Period|Progressive Disease|43|||
164629657|NCT01977651|594666552|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
164629658|NCT01977651|594666552|FG000|4 Month Treatment Period|Physician Decision|4|||
164629659|NCT01977651|594666552|FG000|1 Year Extension Period|Adverse Event|14|||
164629660|NCT01977651|594666552|FG000|1 Year Extension Period|Death|10|||
164629661|NCT01977651|594666552|FG000|1 Year Extension Period|Lost to Follow-up|2|||
164629662|NCT01977651|594666552|FG000|1 Year Extension Period|Progressive Disease|86|||
164629663|NCT01977651|594666552|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
164629664|NCT01977651|594666552|FG000|1 Year Extension Period|Physician Decision|6|||
164629665|NCT01977651|594666552|FG000|1 Year Extension Period|Miscellaneous|1|||
164629666|NCT01977651|594666552|FG000|Post 1 Year Extension Period|Adverse Event|5|||
164629667|NCT01977651|594666552|FG000|Post 1 Year Extension Period|Death|13|||
164629668|NCT01977651|594666552|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
164629669|NCT01977651|594666552|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
164629670|NCT01977651|594666552|FG000|Post 1 Year Extension Period|Physician Decision|4|||
164629671|NCT01977651|594666552|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
164629672|NCT03380091|594666554|FG000|Overall Study|Withdrawal by Subject|2|||
164629673|NCT03380091|594666555|FG001|Overall Study|Withdrawal by Subject|1|||
164629674|NCT04594213|594666561|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
164629675|NCT04594213|594666562|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
164629676|NCT04594213|594666563|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
164629677|NCT04594213|594666564|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
164629678|NCT04594213|594666565|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
164629679|NCT04594213|594666566|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
164629680|NCT04594213|594666561|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
164629681|NCT04594213|594666562|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
164629682|NCT04594213|594666563|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
164629683|NCT04594213|594666564|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
164629684|NCT04594213|594666565|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
164629685|NCT04594213|594666566|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
164629686|NCT04594213|594666561|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
164629687|NCT04594213|594666562|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
164629688|NCT04594213|594666563|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
164629689|NCT04594213|594666564|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
164147703|NCT02006732|592902129|FG000|Overall Study|Protocol Violation|1|||
164629690|NCT04594213|594666565|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
164629691|NCT04594213|594666566|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
164629692|NCT04594213|594666561|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
164629693|NCT04594213|594666562|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
164528271|NCT03057977|594305714|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
164528272|NCT03057977|594305715|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
164528273|NCT03057977|594305714|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
164528274|NCT03057977|594305715|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
164528275|NCT01201317|594305716|FG000|Overall Study|Withdrawal by Subject|5|||
164528276|NCT01201317|594305717|FG001|Overall Study|Withdrawal by Subject|0|||
164528277|NCT01201317|594305718|FG002|Overall Study|Withdrawal by Subject|3|||
164528278|NCT01201317|594305716|FG000|Overall Study|Adverse Event|2|||
164528279|NCT01201317|594305717|FG001|Overall Study|Adverse Event|2|||
164528280|NCT01201317|594305718|FG002|Overall Study|Adverse Event|2|||
164528281|NCT01201317|594305716|FG000|Overall Study|Screen failure|1|||
164528282|NCT01201317|594305717|FG001|Overall Study|Screen failure|1|||
164528283|NCT01201317|594305718|FG002|Overall Study|Screen failure|0|||
164528284|NCT01201317|594305716|FG000|Overall Study|Protocol Violation|0|||
164528285|NCT01201317|594305717|FG001|Overall Study|Protocol Violation|1|||
164528286|NCT01201317|594305718|FG002|Overall Study|Protocol Violation|1|||
164528287|NCT01201317|594305716|FG000|Overall Study|Death|0|||
164528288|NCT01201317|594305717|FG001|Overall Study|Death|1|||
164528289|NCT01201317|594305718|FG002|Overall Study|Death|0|||
164528290|NCT01201317|594305716|FG000|Overall Study|Study-specific withdrawal criteria|0|||
164528291|NCT01201317|594305717|FG001|Overall Study|Study-specific withdrawal criteria|0|||
164528292|NCT01201317|594305718|FG002|Overall Study|Study-specific withdrawal criteria|1|||
164528293|NCT01201317|594305716|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
164528294|NCT01201317|594305717|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
164528295|NCT01201317|594305718|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
164528296|NCT01201317|594305716|FG000|Overall Study|Decrease in renal function|0|||
164528297|NCT01201317|594305717|FG001|Overall Study|Decrease in renal function|1|||
164528298|NCT01201317|594305718|FG002|Overall Study|Decrease in renal function|0|||
164528299|NCT01201317|594305716|FG000|Overall Study|Lack of Efficacy|1|||
164528300|NCT01201317|594305717|FG001|Overall Study|Lack of Efficacy|0|||
164528301|NCT01201317|594305718|FG002|Overall Study|Lack of Efficacy|0|||
164528302|NCT01201317|594305716|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
164528303|NCT01201317|594305717|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
164528304|NCT01201317|594305718|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
164528305|NCT01350336|594305719|FG000|Overall Study|Lost to Follow-up|31|||
164528306|NCT01350336|594305719|FG000|Overall Study|Withdrawal by Subject|14|||
164528307|NCT01350336|594305719|FG000|Overall Study|Physician Decision|8|||
164528308|NCT01350336|594305719|FG000|Overall Study|Death|4|||
164528309|NCT02795429|594305720|FG000|Overall Study|Adverse Event|1|||
164528310|NCT02795429|594305721|FG001|Overall Study|Adverse Event|2|||
164528311|NCT02795429|594305722|FG002|Overall Study|Adverse Event|1|||
164528312|NCT02795429|594305723|FG003|Overall Study|Adverse Event|2|||
164528313|NCT02795429|594305724|FG004|Overall Study|Adverse Event|1|||
164528314|NCT02795429|594305720|FG000|Overall Study|Death|1|||
164528315|NCT02795429|594305721|FG001|Overall Study|Death|0|||
164528316|NCT02795429|594305722|FG002|Overall Study|Death|1|||
164528317|NCT02795429|594305723|FG003|Overall Study|Death|2|||
164528318|NCT02795429|594305724|FG004|Overall Study|Death|1|||
164528319|NCT02795429|594305720|FG000|Overall Study|Physician Decision|0|||
164528320|NCT02795429|594305721|FG001|Overall Study|Physician Decision|0|||
164528321|NCT02795429|594305722|FG002|Overall Study|Physician Decision|2|||
164528322|NCT02795429|594305723|FG003|Overall Study|Physician Decision|1|||
164528323|NCT02795429|594305724|FG004|Overall Study|Physician Decision|5|||
164528324|NCT02795429|594305720|FG000|Overall Study|Progressive disease|3|||
164528325|NCT02795429|594305721|FG001|Overall Study|Progressive disease|7|||
164528326|NCT02795429|594305722|FG002|Overall Study|Progressive disease|6|||
164528327|NCT02795429|594305723|FG003|Overall Study|Progressive disease|26|||
164528328|NCT02795429|594305724|FG004|Overall Study|Progressive disease|20|||
164528329|NCT02795429|594305720|FG000|Overall Study|Subject/guardian decision|1|||
164528330|NCT02795429|594305721|FG001|Overall Study|Subject/guardian decision|1|||
164629694|NCT04594213|594666563|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
164629695|NCT04594213|594666564|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
164629696|NCT04594213|594666565|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
164629697|NCT04594213|594666566|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
164629698|NCT04594213|594666561|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
164629699|NCT04594213|594666562|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
164629700|NCT04594213|594666563|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
164629701|NCT04594213|594666564|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
164629702|NCT04594213|594666565|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
164629703|NCT04594213|594666566|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
164629704|NCT04594213|594666561|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
164629705|NCT04594213|594666562|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
164629706|NCT04594213|594666563|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
164629707|NCT04594213|594666564|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
164629708|NCT04594213|594666565|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
164629709|NCT04594213|594666566|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
164629710|NCT04594213|594666561|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
164629711|NCT04594213|594666562|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
164629712|NCT04594213|594666563|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
164629713|NCT04594213|594666564|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
164629714|NCT04594213|594666565|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
164629715|NCT04594213|594666566|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
164629716|NCT04594213|594666561|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
164629717|NCT04594213|594666562|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
164629718|NCT04594213|594666563|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
164629719|NCT04594213|594666564|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
164629720|NCT04594213|594666565|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
164629721|NCT04594213|594666566|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
164629722|NCT04594213|594666561|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
164629723|NCT04594213|594666562|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
164629724|NCT04594213|594666563|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
164629725|NCT04594213|594666564|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
164629726|NCT04594213|594666565|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
164629727|NCT04594213|594666566|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
164629728|NCT04594213|594666561|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
164629729|NCT04594213|594666562|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
164629730|NCT04594213|594666563|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
164629731|NCT04594213|594666564|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
164629732|NCT04594213|594666565|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
164629733|NCT04594213|594666566|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
164629734|NCT04594213|594666561|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
164629735|NCT04594213|594666562|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
164629736|NCT04594213|594666563|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
164629737|NCT04594213|594666564|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
164629738|NCT04594213|594666565|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
164629739|NCT04594213|594666566|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
164629740|NCT01980056|594666568|FG000|Overall Study|Death|1|||
164629741|NCT01980056|594666569|FG001|Overall Study|Death|1|||
164629742|NCT01980056|594666570|FG002|Overall Study|Death|0|||
164629743|NCT00104299|594666571|FG000|Overall Study|Adverse Event|3|||
164629744|NCT00104299|594666572|FG001|Overall Study|Adverse Event|1|||
164629745|NCT00104299|594666571|FG000|Overall Study|Death|2|||
164629746|NCT00104299|594666572|FG001|Overall Study|Death|2|||
164629747|NCT00104299|594666571|FG000|Overall Study|Withdrawal by Subject|2|||
164629748|NCT00104299|594666572|FG001|Overall Study|Withdrawal by Subject|6|||
164629749|NCT00104299|594666571|FG000|Overall Study|Physician Decision|1|||
164629750|NCT00104299|594666572|FG001|Overall Study|Physician Decision|1|||
164629751|NCT00104299|594666571|FG000|Overall Study|To have renal transplant|1|||
164629752|NCT00104299|594666572|FG001|Overall Study|To have renal transplant|0|||
164629753|NCT02906644|594666573|FG000|First 2 Weeks|Withdrawal by Subject|0|||
164629754|NCT02906644|594666574|FG001|First 2 Weeks|Withdrawal by Subject|2|||
164629755|NCT02906644|594666573|FG000|First 2 Weeks|Physician Decision|1|||
164629756|NCT02906644|594666574|FG001|First 2 Weeks|Physician Decision|1|||
164629757|NCT02906644|594666573|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
164629758|NCT02906644|594666574|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
164629759|NCT02906644|594666573|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
164629760|NCT02906644|594666574|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
164629761|NCT03672006|594666577|FG000|Overall Study|exclusion criteria met|0|||
164629762|NCT03672006|594666578|FG001|Overall Study|exclusion criteria met|1|||
164629763|NCT03288987|594666579|FG000|Overall Study|Protocol Violation|10|||
164629764|NCT03288987|594666580|FG001|Overall Study|Protocol Violation|4|||
164629765|NCT00608426|594666581|FG000|Overall Study|Death|32|||
164629766|NCT00608426|594666582|FG001|Overall Study|Death|36|||
164629767|NCT00608426|594666581|FG000|Overall Study|Lost to Follow-up|485|||
164629768|NCT00608426|594666582|FG001|Overall Study|Lost to Follow-up|521|||
164629769|NCT00608426|594666581|FG000|Overall Study|refused, health issues, wrong address|319|||
164629770|NCT00608426|594666582|FG001|Overall Study|refused, health issues, wrong address|348|||
164629771|NCT00761891|594666583|FG000|Overall Study|Withdrawal by Subject|10|||
164629772|NCT00368069|594666584|FG000|Overall Study|Adverse Event|5|||
164629773|NCT00368069|594666585|FG001|Overall Study|Adverse Event|2|||
164629774|NCT00368069|594666584|FG000|Overall Study|Lack of Efficacy|0|||
164629775|NCT00368069|594666585|FG001|Overall Study|Lack of Efficacy|1|||
164629776|NCT00368069|594666584|FG000|Overall Study|Lost to Follow-up|1|||
164629777|NCT00368069|594666585|FG001|Overall Study|Lost to Follow-up|0|||
164629778|NCT00368069|594666584|FG000|Overall Study|Protocol Violation|0|||
164629779|NCT00368069|594666585|FG001|Overall Study|Protocol Violation|2|||
164629780|NCT00368069|594666584|FG000|Overall Study|Withdrawal of Consent|2|||
164629781|NCT00368069|594666585|FG001|Overall Study|Withdrawal of Consent|1|||
164629782|NCT00368069|594666584|FG000|Overall Study|no blood sampling possible|0|||
164629783|NCT00368069|594666585|FG001|Overall Study|no blood sampling possible|1|||
164629784|NCT02764229|594666587|FG000|Overall Study|Withdrawal by Subject|15|||
164629785|NCT02764229|594666587|FG000|Overall Study|Adverse Event|9|||
164629786|NCT02764229|594666587|FG000|Overall Study|Physician Decision|5|||
164629787|NCT02764229|594666587|FG000|Overall Study|Lost to Follow-up|3|||
164629788|NCT02764229|594666587|FG000|Overall Study|Lack of Efficacy|1|||
164629789|NCT02764229|594666587|FG000|Overall Study|Study Stopped by Sponsor|69|||
164629790|NCT00672490|594666588|FG000|Overall Study|Withdrawal by Subject|8|||
164629791|NCT00672490|594666589|FG001|Overall Study|Withdrawal by Subject|8|||
164629792|NCT00672490|594666588|FG000|Overall Study|Lack of Compliance|2|||
164629793|NCT00672490|594666589|FG001|Overall Study|Lack of Compliance|7|||
164629794|NCT00672490|594666588|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
164629795|NCT00672490|594666589|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
164629796|NCT00672490|594666588|FG000|Overall Study|Adverse Event|5|||
164629797|NCT00672490|594666589|FG001|Overall Study|Adverse Event|8|||
164629798|NCT00672490|594666588|FG000|Overall Study|Violation of Concomitant Medicine|1|||
164629799|NCT00672490|594666589|FG001|Overall Study|Violation of Concomitant Medicine|0|||
164629800|NCT00672490|594666588|FG000|Overall Study|Intolerance|0|||
164629801|NCT00672490|594666589|FG001|Overall Study|Intolerance|2|||
164629802|NCT00672490|594666588|FG000|Overall Study|Lost to Follow-up|1|||
164629803|NCT00672490|594666589|FG001|Overall Study|Lost to Follow-up|5|||
164629804|NCT00672490|594666588|FG000|Overall Study|No reason was provided|6|||
164629805|NCT00672490|594666589|FG001|Overall Study|No reason was provided|2|||
164629806|NCT02030067|594666602|FG000|Overall Study|Disease Progression|1|||
164629807|NCT02030067|594666603|FG001|Overall Study|Disease Progression|1|||
164629808|NCT02030067|594666604|FG002|Overall Study|Disease Progression|2|||
164629809|NCT02030067|594666605|FG003|Overall Study|Disease Progression|2|||
164629810|NCT02030067|594666606|FG004|Overall Study|Disease Progression|3|||
164629811|NCT02030067|594666607|FG005|Overall Study|Disease Progression|2|||
164629812|NCT02030067|594666608|FG006|Overall Study|Disease Progression|3|||
164629813|NCT02030067|594666609|FG007|Overall Study|Disease Progression|3|||
164629814|NCT02030067|594666610|FG008|Overall Study|Disease Progression|4|||
164629815|NCT02030067|594666611|FG009|Overall Study|Disease Progression|3|||
164629816|NCT02030067|594666612|FG010|Overall Study|Disease Progression|7|||
164629817|NCT02030067|594666613|FG011|Overall Study|Disease Progression|2|||
164629818|NCT02030067|594666614|FG012|Overall Study|Disease Progression|59|||
164629819|NCT02030067|594666602|FG000|Overall Study|Withdrawal by Subject|0|||
164629820|NCT02030067|594666603|FG001|Overall Study|Withdrawal by Subject|0|||
164629821|NCT02030067|594666604|FG002|Overall Study|Withdrawal by Subject|0|||
164629822|NCT02030067|594666605|FG003|Overall Study|Withdrawal by Subject|1|||
164629823|NCT02030067|594666606|FG004|Overall Study|Withdrawal by Subject|0|||
164629824|NCT02030067|594666607|FG005|Overall Study|Withdrawal by Subject|0|||
164629825|NCT02030067|594666608|FG006|Overall Study|Withdrawal by Subject|0|||
164629826|NCT02030067|594666609|FG007|Overall Study|Withdrawal by Subject|1|||
164629827|NCT02030067|594666610|FG008|Overall Study|Withdrawal by Subject|0|||
164629828|NCT02030067|594666611|FG009|Overall Study|Withdrawal by Subject|0|||
164629829|NCT02030067|594666612|FG010|Overall Study|Withdrawal by Subject|3|||
164629830|NCT02030067|594666613|FG011|Overall Study|Withdrawal by Subject|0|||
164629831|NCT02030067|594666614|FG012|Overall Study|Withdrawal by Subject|6|||
164629832|NCT02030067|594666602|FG000|Overall Study|Physician Decision|0|||
164629833|NCT02030067|594666603|FG001|Overall Study|Physician Decision|0|||
164629834|NCT02030067|594666604|FG002|Overall Study|Physician Decision|0|||
164629835|NCT02030067|594666605|FG003|Overall Study|Physician Decision|0|||
164629836|NCT02030067|594666606|FG004|Overall Study|Physician Decision|0|||
164629837|NCT02030067|594666607|FG005|Overall Study|Physician Decision|0|||
164629838|NCT02030067|594666608|FG006|Overall Study|Physician Decision|0|||
164629839|NCT02030067|594666609|FG007|Overall Study|Physician Decision|0|||
164629840|NCT02030067|594666610|FG008|Overall Study|Physician Decision|0|||
164528331|NCT02795429|594305722|FG002|Overall Study|Subject/guardian decision|1|||
164528332|NCT02795429|594305723|FG003|Overall Study|Subject/guardian decision|1|||
164528333|NCT02795429|594305724|FG004|Overall Study|Subject/guardian decision|3|||
164528334|NCT04964388|594305725|FG000|Overall Study|Lost to Follow-up|3|||
164528335|NCT04964388|594305726|FG001|Overall Study|Lost to Follow-up|2|||
164528336|NCT00250679|594305727|FG000|Overall Study|Adverse Event|12|||
164528337|NCT00250679|594305728|FG001|Overall Study|Adverse Event|15|||
164528338|NCT00250679|594305729|FG002|Overall Study|Adverse Event|16|||
164528339|NCT00250679|594305727|FG000|Overall Study|Protocol Violation|2|||
164528340|NCT00250679|594305728|FG001|Overall Study|Protocol Violation|4|||
164528341|NCT00250679|594305729|FG002|Overall Study|Protocol Violation|3|||
164528342|NCT00250679|594305727|FG000|Overall Study|Withdrawal by Subject|15|||
164528343|NCT00250679|594305728|FG001|Overall Study|Withdrawal by Subject|18|||
164528344|NCT00250679|594305729|FG002|Overall Study|Withdrawal by Subject|15|||
164528345|NCT00250679|594305727|FG000|Overall Study|Lost to Follow-up|3|||
164528346|NCT00250679|594305728|FG001|Overall Study|Lost to Follow-up|4|||
164528347|NCT00250679|594305729|FG002|Overall Study|Lost to Follow-up|2|||
164528348|NCT00250679|594305727|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
164528349|NCT00250679|594305728|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
164528350|NCT00250679|594305729|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
164528351|NCT00250679|594305727|FG000|Overall Study|Lack of Efficacy|0|||
164528352|NCT00250679|594305728|FG001|Overall Study|Lack of Efficacy|1|||
164528353|NCT00250679|594305729|FG002|Overall Study|Lack of Efficacy|3|||
164528354|NCT00250679|594305727|FG000|Overall Study|Technical Holter issues|1|||
164528355|NCT00250679|594305728|FG001|Overall Study|Technical Holter issues|0|||
164528356|NCT00250679|594305729|FG002|Overall Study|Technical Holter issues|2|||
164528357|NCT00250679|594305727|FG000|Overall Study|Moved|1|||
164528358|NCT00250679|594305728|FG001|Overall Study|Moved|1|||
164528359|NCT00250679|594305729|FG002|Overall Study|Moved|0|||
164528360|NCT00250679|594305727|FG000|Overall Study|Non-compliance|1|||
164528361|NCT00250679|594305728|FG001|Overall Study|Non-compliance|1|||
164528362|NCT00250679|594305729|FG002|Overall Study|Non-compliance|0|||
164528363|NCT00250679|594305727|FG000|Overall Study|various single events: hip surgery,diary|3|||
164528364|NCT00250679|594305728|FG001|Overall Study|various single events: hip surgery,diary|1|||
164528365|NCT00250679|594305729|FG002|Overall Study|various single events: hip surgery,diary|1|||
164528366|NCT00448279|594305730|FG000|Overall Study|Lost to Follow-up|2|||
164528367|NCT00448279|594305731|FG001|Overall Study|Lost to Follow-up|2|||
164528368|NCT00448279|594305730|FG000|Overall Study|Adverse Event|1|||
164528369|NCT00448279|594305731|FG001|Overall Study|Adverse Event|1|||
164528370|NCT00448279|594305730|FG000|Overall Study|Disease progression|16|||
164528371|NCT00448279|594305731|FG001|Overall Study|Disease progression|18|||
164528372|NCT00448279|594305730|FG000|Overall Study|Withdrawal by Subject|4|||
164528373|NCT00448279|594305731|FG001|Overall Study|Withdrawal by Subject|3|||
164528374|NCT00448279|594305730|FG000|Overall Study|Other|6|||
164528375|NCT00448279|594305731|FG001|Overall Study|Other|4|||
164528376|NCT00448279|594305730|FG000|Overall Study|Protocol Violation|0|||
164528377|NCT00448279|594305731|FG001|Overall Study|Protocol Violation|1|||
164528378|NCT03907410|594305732|FG000|Overall Study|Lost to Follow-up|4|||
164528379|NCT03907410|594305733|FG001|Overall Study|Lost to Follow-up|1|||
164528380|NCT03907410|594305734|FG002|Overall Study|Lost to Follow-up|1|||
164528381|NCT03907410|594305732|FG000|Overall Study|Lost to follow-up and research burden|0|||
164528382|NCT03907410|594305733|FG001|Overall Study|Lost to follow-up and research burden|0|||
164528383|NCT03907410|594305734|FG002|Overall Study|Lost to follow-up and research burden|1|||
164528384|NCT01981473|594305735|FG000|Overall Study|Incorrect diagnosis of RA|0|||
164528385|NCT01981473|594305736|FG001|Overall Study|Incorrect diagnosis of RA|0|||
164528386|NCT01981473|594305737|FG002|Overall Study|Incorrect diagnosis of RA|1|||
164528387|NCT01981473|594305735|FG000|Overall Study|Received treatment for < 6 months|0|||
164528388|NCT01981473|594305736|FG001|Overall Study|Received treatment for < 6 months|0|||
164528389|NCT01981473|594305737|FG002|Overall Study|Received treatment for < 6 months|1|||
164528390|NCT01981473|594305735|FG000|Overall Study|Received treatment for >24 months|2|||
164528391|NCT01981473|594305736|FG001|Overall Study|Received treatment for >24 months|0|||
164528392|NCT01981473|594305737|FG002|Overall Study|Received treatment for >24 months|6|||
164528393|NCT04776148|594305738|FG000|Overall Study|Death|249|||
164528394|NCT04776148|594305739|FG001|Overall Study|Death|260|||
164528395|NCT04776148|594305738|FG000|Overall Study|Lost to Follow-up|0|||
164528396|NCT04776148|594305739|FG001|Overall Study|Lost to Follow-up|1|||
164528397|NCT04776148|594305738|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164528398|NCT04776148|594305739|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
164528399|NCT04776148|594305738|FG000|Overall Study|Withdrawal by Subject|3|||
164528400|NCT04776148|594305739|FG001|Overall Study|Withdrawal by Subject|4|||
164528401|NCT04776148|594305738|FG000|Overall Study|Sponsor Decision|30|||
164528402|NCT04776148|594305739|FG001|Overall Study|Sponsor Decision|15|||
164528403|NCT01155375|594305740|FG000|Overall Study|Adverse Event|1|||
164528404|NCT01155375|594305741|FG001|Overall Study|Adverse Event|0|||
164528405|NCT00757588|594305742|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
164528406|NCT00757588|594305743|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
164629841|NCT02030067|594666611|FG009|Overall Study|Physician Decision|0|||
164629842|NCT02030067|594666612|FG010|Overall Study|Physician Decision|1|||
164629843|NCT02030067|594666613|FG011|Overall Study|Physician Decision|0|||
164629844|NCT02030067|594666614|FG012|Overall Study|Physician Decision|3|||
164629845|NCT02030067|594666602|FG000|Overall Study|other reasons|0|||
164629846|NCT02030067|594666603|FG001|Overall Study|other reasons|0|||
164629847|NCT02030067|594666604|FG002|Overall Study|other reasons|0|||
164629848|NCT02030067|594666605|FG003|Overall Study|other reasons|0|||
164629849|NCT02030067|594666606|FG004|Overall Study|other reasons|0|||
164629850|NCT02030067|594666607|FG005|Overall Study|other reasons|1|||
164629851|NCT02030067|594666608|FG006|Overall Study|other reasons|0|||
164629852|NCT02030067|594666609|FG007|Overall Study|other reasons|0|||
164629853|NCT02030067|594666610|FG008|Overall Study|other reasons|2|||
164629854|NCT02030067|594666611|FG009|Overall Study|other reasons|0|||
164629855|NCT02030067|594666612|FG010|Overall Study|other reasons|0|||
164629856|NCT02030067|594666613|FG011|Overall Study|other reasons|0|||
164629857|NCT02030067|594666614|FG012|Overall Study|other reasons|4|||
164629858|NCT02030067|594666602|FG000|Overall Study|Adverse Event|0|||
164629859|NCT02030067|594666603|FG001|Overall Study|Adverse Event|0|||
164629860|NCT02030067|594666604|FG002|Overall Study|Adverse Event|0|||
164629861|NCT02030067|594666605|FG003|Overall Study|Adverse Event|0|||
164629862|NCT02030067|594666606|FG004|Overall Study|Adverse Event|0|||
164629863|NCT02030067|594666607|FG005|Overall Study|Adverse Event|0|||
164629864|NCT02030067|594666608|FG006|Overall Study|Adverse Event|0|||
164629865|NCT02030067|594666609|FG007|Overall Study|Adverse Event|0|||
164629866|NCT02030067|594666610|FG008|Overall Study|Adverse Event|0|||
164629867|NCT02030067|594666611|FG009|Overall Study|Adverse Event|0|||
164629868|NCT02030067|594666612|FG010|Overall Study|Adverse Event|0|||
164629869|NCT02030067|594666613|FG011|Overall Study|Adverse Event|1|||
164629870|NCT02030067|594666614|FG012|Overall Study|Adverse Event|8|||
164629871|NCT00565721|594666616|FG000|Overall Study|Screen Failure|2|||
164629872|NCT00565721|594666616|FG000|Overall Study|Lost to Follow-up|6|||
164629873|NCT00565721|594666616|FG000|Overall Study|Technical Problems|1|||
164629874|NCT00565721|594666616|FG000|Overall Study|Physician Decision|2|||
164629875|NCT00565721|594666616|FG000|Overall Study|Other reasons|6|||
164629876|NCT02813681|594666619|FG000|Overall Study|Physician Decision|5|||
164629877|NCT02813681|594666620|FG001|Overall Study|Physician Decision|5|||
164629878|NCT02813681|594666621|FG002|Overall Study|Physician Decision|0|||
164629879|NCT02813681|594666619|FG000|Overall Study|Lost to Follow-up|0|||
164629880|NCT02813681|594666620|FG001|Overall Study|Lost to Follow-up|1|||
164629881|NCT02813681|594666621|FG002|Overall Study|Lost to Follow-up|0|||
164629882|NCT00529152|594666622|FG000|Overall Study|Adverse Event|2|||
164629883|NCT00529152|594666622|FG000|Overall Study|Withdrawal by Subject|2|||
164629884|NCT00529152|594666622|FG000|Overall Study|Lost to Follow-up|1|||
164629885|NCT04062240|594666626|FG000|Overall Study|equipment malfunction|1|||
164629886|NCT03961529|594666627|FG000|Overall Study|Adverse Event|13|||
164629887|NCT03961529|594666628|FG001|Overall Study|Adverse Event|5|||
164629888|NCT03961529|594666629|FG002|Overall Study|Adverse Event|2|||
164629889|NCT03961529|594666627|FG000|Overall Study|Withdrawal by Subject|17|||
164629890|NCT03961529|594666628|FG001|Overall Study|Withdrawal by Subject|2|||
164629891|NCT03961529|594666629|FG002|Overall Study|Withdrawal by Subject|1|||
164528407|NCT00757588|594305742|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
164528408|NCT00757588|594305743|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
164528409|NCT00757588|594305742|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
164528410|NCT00757588|594305743|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
164528411|NCT00757588|594305742|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
164528412|NCT00757588|594305743|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
164528413|NCT00757588|594305742|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
164528414|NCT00757588|594305743|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
164528415|NCT00757588|594305742|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
164528416|NCT00757588|594305743|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
164528417|NCT00757588|594305742|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
164528418|NCT00757588|594305743|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
164528419|NCT00757588|594305742|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
164528420|NCT00757588|594305743|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
164528421|NCT00757588|594305742|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
164528422|NCT00757588|594305743|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
164528423|NCT00757588|594305742|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
164528424|NCT00757588|594305743|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
164528425|NCT00757588|594305742|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
164528426|NCT00757588|594305743|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
164528427|NCT00757588|594305742|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
164528428|NCT00757588|594305743|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
164528429|NCT00757588|594305742|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
164528430|NCT00757588|594305743|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
164528431|NCT00757588|594305742|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
164528432|NCT00757588|594305743|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
164528433|NCT00757588|594305742|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
164528434|NCT00757588|594305743|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
164528435|NCT00757588|594305742|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
164528436|NCT00757588|594305743|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
164528437|NCT00881608|594305745|FG000|Overall Study|Study prematurely terminated|11|||
164528438|NCT00701220|594305746|FG000|Overall Study|Withdrawal by Subject|0|||
164528439|NCT00701220|594305747|FG001|Overall Study|Withdrawal by Subject|2|||
164528440|NCT00701220|594305746|FG000|Overall Study|Protocol Violation|2|||
164528441|NCT00701220|594305747|FG001|Overall Study|Protocol Violation|0|||
164528442|NCT04018092|594305750|FG000|Overall Study|Withdrawal by Subject|1|||
164528443|NCT04018092|594305751|FG001|Overall Study|Withdrawal by Subject|1|||
164528444|NCT04018092|594305750|FG000|Overall Study|Withdrawal by Subject|1|||
164528445|NCT04018092|594305751|FG001|Overall Study|Withdrawal by Subject|1|||
164528446|NCT06469242|594305752|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
164528447|NCT06469242|594305753|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
164528448|NCT06469242|594305752|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
164528449|NCT06469242|594305753|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
164528450|NCT01205152|594305754|FG000|Overall Study|Death|1|||
164528451|NCT00069108|594305755|FG000|Overall Study|Withdrawal by Subject|5|||
164528452|NCT00069108|594305756|FG001|Overall Study|Withdrawal by Subject|9|||
164528453|NCT00069108|594305755|FG000|Overall Study|Adverse Event|64|||
164528454|NCT00069108|594305756|FG001|Overall Study|Adverse Event|42|||
164528455|NCT00069108|594305755|FG000|Overall Study|Death|6|||
164528456|NCT00069108|594305756|FG001|Overall Study|Death|6|||
164528457|NCT00069108|594305755|FG000|Overall Study|Administration|15|||
164528458|NCT00069108|594305756|FG001|Overall Study|Administration|4|||
164528459|NCT00069108|594305755|FG000|Overall Study|Insufficient therapy|117|||
164528460|NCT00069108|594305756|FG001|Overall Study|Insufficient therapy|144|||
164528461|NCT00069108|594305755|FG000|Overall Study|Violation criteria|1|||
164528462|NCT00069108|594305756|FG001|Overall Study|Violation criteria|4|||
164528463|NCT00069108|594305755|FG000|Overall Study|Refused treatment|5|||
164528464|NCT00069108|594305756|FG001|Overall Study|Refused treatment|10|||
164528465|NCT02783768|594305757|FG000|Overall Study|Lost to Follow-up|1|||
164528466|NCT02783768|594305758|FG001|Overall Study|Lost to Follow-up|0|||
164528467|NCT02208999|594305759|FG000|Overall Study|Lost to Follow-up|1|||
164528468|NCT00319839|594305760|FG000|Overall Study|Adverse Event|5|||
164528469|NCT00319839|594305760|FG000|Overall Study|Withdrawal by Subject|1|||
164528470|NCT00986674|594305761|FG000|Overall Study|Lack of Efficacy|28|||
164528471|NCT00986674|594305762|FG001|Overall Study|Lack of Efficacy|25|||
164528472|NCT00986674|594305763|FG002|Overall Study|Lack of Efficacy|23|||
164629892|NCT03961529|594666627|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164629893|NCT03961529|594666628|FG001|Overall Study|Withdrawal by parent/guardian|7|||
164528473|NCT00986674|594305761|FG000|Overall Study|Adverse Event|4|||
164528474|NCT00986674|594305762|FG001|Overall Study|Adverse Event|8|||
164528475|NCT00986674|594305763|FG002|Overall Study|Adverse Event|9|||
164528476|NCT00986674|594305761|FG000|Overall Study|Death|5|||
164629894|NCT03961529|594666629|FG002|Overall Study|Withdrawal by parent/guardian|0|||
164629895|NCT03961529|594666627|FG000|Overall Study|Physician Decision|2|||
164629896|NCT03961529|594666628|FG001|Overall Study|Physician Decision|1|||
164629897|NCT03961529|594666629|FG002|Overall Study|Physician Decision|1|||
164629898|NCT03961529|594666627|FG000|Overall Study|Lost to Follow-up|2|||
164629899|NCT03961529|594666628|FG001|Overall Study|Lost to Follow-up|1|||
164629900|NCT03961529|594666629|FG002|Overall Study|Lost to Follow-up|0|||
164629901|NCT03961529|594666627|FG000|Overall Study|Lack of Efficacy|2|||
164629902|NCT03961529|594666628|FG001|Overall Study|Lack of Efficacy|0|||
164629903|NCT03961529|594666629|FG002|Overall Study|Lack of Efficacy|1|||
164629904|NCT03961529|594666627|FG000|Overall Study|Other|6|||
164629905|NCT03961529|594666628|FG001|Overall Study|Other|1|||
164629906|NCT03961529|594666629|FG002|Overall Study|Other|0|||
164629907|NCT03500419|594666630|FG000|Overall Study|Withdrawal by Subject|2|||
164629908|NCT03500419|594666631|FG001|Overall Study|Withdrawal by Subject|25|||
164629909|NCT01497899|594666632|FG000|Double-Blind Phase|Randomized but not Treated|1|||
164629910|NCT01497899|594666633|FG001|Double-Blind Phase|Randomized but not Treated|0|||
164629911|NCT01497899|594666634|FG002|Double-Blind Phase|Randomized but not Treated|0|||
164629912|NCT01497899|594666635|FG003|Double-Blind Phase|Randomized but not Treated|0|||
164629913|NCT01497899|594666632|FG000|Double-Blind Phase|Adverse Event|1|||
164629914|NCT01497899|594666633|FG001|Double-Blind Phase|Adverse Event|0|||
164629915|NCT01497899|594666634|FG002|Double-Blind Phase|Adverse Event|0|||
164629916|NCT01497899|594666635|FG003|Double-Blind Phase|Adverse Event|0|||
164629917|NCT01497899|594666632|FG000|Double-Blind Phase|Lack of Efficacy|0|||
164629918|NCT01497899|594666633|FG001|Double-Blind Phase|Lack of Efficacy|1|||
164629919|NCT01497899|594666634|FG002|Double-Blind Phase|Lack of Efficacy|0|||
164629920|NCT01497899|594666635|FG003|Double-Blind Phase|Lack of Efficacy|0|||
164629921|NCT01497899|594666632|FG000|Double-Blind Phase|Investigator's Discretion|1|||
164629922|NCT01497899|594666633|FG001|Double-Blind Phase|Investigator's Discretion|0|||
164629923|NCT01497899|594666634|FG002|Double-Blind Phase|Investigator's Discretion|0|||
164629924|NCT01497899|594666635|FG003|Double-Blind Phase|Investigator's Discretion|0|||
164629925|NCT01497899|594666632|FG000|Double-Blind Phase|Withdrew Consent|0|||
164629926|NCT01497899|594666633|FG001|Double-Blind Phase|Withdrew Consent|1|||
164629927|NCT01497899|594666634|FG002|Double-Blind Phase|Withdrew Consent|0|||
164629928|NCT01497899|594666635|FG003|Double-Blind Phase|Withdrew Consent|0|||
164629929|NCT01497899|594666632|FG000|Double-Blind Phase|Lost to Follow-up|3|||
164629930|NCT01497899|594666633|FG001|Double-Blind Phase|Lost to Follow-up|2|||
164629931|NCT01497899|594666634|FG002|Double-Blind Phase|Lost to Follow-up|0|||
164629932|NCT01497899|594666635|FG003|Double-Blind Phase|Lost to Follow-up|0|||
164629933|NCT01497899|594666632|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
164629934|NCT01497899|594666633|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
164629935|NCT01497899|594666634|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
164629936|NCT01497899|594666635|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
164629937|NCT01497899|594666632|FG000|Open-Label Extension Phase|Adverse Event|1|||
164629938|NCT01497899|594666633|FG001|Open-Label Extension Phase|Adverse Event|0|||
164629939|NCT01497899|594666634|FG002|Open-Label Extension Phase|Adverse Event|0|||
164629940|NCT01497899|594666635|FG003|Open-Label Extension Phase|Adverse Event|0|||
164629941|NCT01497899|594666632|FG000|Open-Label Extension Phase|Death|1|||
164629942|NCT01497899|594666633|FG001|Open-Label Extension Phase|Death|0|||
164629943|NCT01497899|594666634|FG002|Open-Label Extension Phase|Death|0|||
164629944|NCT01497899|594666635|FG003|Open-Label Extension Phase|Death|0|||
164629945|NCT01497899|594666632|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
164629946|NCT01497899|594666633|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
164629947|NCT01497899|594666634|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
164629948|NCT01497899|594666635|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
164629949|NCT01497899|594666632|FG000|Open-Label Extension Phase|Pregnancy|0|||
164629950|NCT01497899|594666633|FG001|Open-Label Extension Phase|Pregnancy|1|||
164629951|NCT01497899|594666634|FG002|Open-Label Extension Phase|Pregnancy|1|||
164629952|NCT01497899|594666635|FG003|Open-Label Extension Phase|Pregnancy|0|||
164629953|NCT01497899|594666632|FG000|Open-Label Extension Phase|Protocol Violation|0|||
164629954|NCT01497899|594666633|FG001|Open-Label Extension Phase|Protocol Violation|0|||
164629955|NCT01497899|594666634|FG002|Open-Label Extension Phase|Protocol Violation|1|||
164629956|NCT01497899|594666635|FG003|Open-Label Extension Phase|Protocol Violation|0|||
164629957|NCT01497899|594666632|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
164629958|NCT01497899|594666633|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
164629959|NCT01497899|594666634|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
164629960|NCT01497899|594666635|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
164629961|NCT00082628|594666638|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
164629962|NCT00082628|594666639|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
164629963|NCT00082628|594666640|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
164629964|NCT00082628|594666641|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
164629965|NCT00082628|594666642|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
164629966|NCT00082628|594666638|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
164629967|NCT00082628|594666639|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
164629968|NCT00082628|594666640|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
164629969|NCT00082628|594666641|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
164629970|NCT00082628|594666642|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
164629971|NCT00082628|594666638|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
164629972|NCT00082628|594666639|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
164629973|NCT00082628|594666640|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
164629974|NCT00082628|594666641|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
164629975|NCT00082628|594666642|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
164629976|NCT00082628|594666638|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
164629977|NCT00082628|594666639|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
164629978|NCT00082628|594666640|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
164629979|NCT00082628|594666641|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
164629980|NCT00082628|594666642|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
164629981|NCT00082628|594666638|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
164629982|NCT00082628|594666639|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
164629983|NCT00082628|594666640|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
164629984|NCT00082628|594666641|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
164629985|NCT00082628|594666642|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
164629986|NCT00082628|594666638|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
164629987|NCT00082628|594666639|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
164629988|NCT00082628|594666640|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
164629989|NCT00082628|594666641|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
164629990|NCT00082628|594666642|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
164629991|NCT00082628|594666638|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
164629992|NCT00082628|594666639|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
164629993|NCT00082628|594666640|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
164629994|NCT00082628|594666641|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
164629995|NCT00082628|594666642|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
164629996|NCT03481634|594666643|FG000|Overall Study|Withdrawal by Subject|16|||
164629997|NCT03481634|594666644|FG001|Overall Study|Withdrawal by Subject|19|||
164629998|NCT03481634|594666645|FG002|Overall Study|Withdrawal by Subject|14|||
164629999|NCT03481634|594666643|FG000|Overall Study|Protocol Violation|1|||
164630000|NCT03481634|594666644|FG001|Overall Study|Protocol Violation|0|||
164630001|NCT03481634|594666645|FG002|Overall Study|Protocol Violation|1|||
164630002|NCT03481634|594666643|FG000|Overall Study|Progressive disease|0|||
164630003|NCT03481634|594666644|FG001|Overall Study|Progressive disease|1|||
164630004|NCT03481634|594666645|FG002|Overall Study|Progressive disease|0|||
164630005|NCT03481634|594666643|FG000|Overall Study|Physician Decision|3|||
164630006|NCT03481634|594666644|FG001|Overall Study|Physician Decision|0|||
164630007|NCT03481634|594666645|FG002|Overall Study|Physician Decision|1|||
164630008|NCT03481634|594666643|FG000|Overall Study|Lost to Follow-up|3|||
164630009|NCT03481634|594666644|FG001|Overall Study|Lost to Follow-up|4|||
164630010|NCT03481634|594666645|FG002|Overall Study|Lost to Follow-up|4|||
164630011|NCT03481634|594666643|FG000|Overall Study|Death|4|||
164630012|NCT03481634|594666644|FG001|Overall Study|Death|8|||
164630013|NCT03481634|594666645|FG002|Overall Study|Death|7|||
164630014|NCT03481634|594666643|FG000|Overall Study|Adverse Event|6|||
164630015|NCT03481634|594666644|FG001|Overall Study|Adverse Event|3|||
164630016|NCT03481634|594666645|FG002|Overall Study|Adverse Event|7|||
164630017|NCT00352027|594666646|FG000|Overall Study|Progressive disease|3|||
164630018|NCT01874288|594666647|FG000|Overall Study|Withdrawal by Subject|1|||
164630019|NCT01874288|594666648|FG001|Overall Study|Withdrawal by Subject|0|||
164630020|NCT01874288|594666649|FG002|Overall Study|Withdrawal by Subject|2|||
164630021|NCT01874288|594666650|FG003|Overall Study|Withdrawal by Subject|1|||
164630022|NCT01874288|594666651|FG004|Overall Study|Withdrawal by Subject|1|||
164630023|NCT01874288|594666647|FG000|Overall Study|Physician Decision|0|||
164630024|NCT01874288|594666648|FG001|Overall Study|Physician Decision|0|||
164630025|NCT01874288|594666649|FG002|Overall Study|Physician Decision|0|||
164630026|NCT01874288|594666650|FG003|Overall Study|Physician Decision|1|||
164630027|NCT01874288|594666651|FG004|Overall Study|Physician Decision|0|||
164630028|NCT01874288|594666647|FG000|Overall Study|Progressive disease|2|||
164630029|NCT01874288|594666648|FG001|Overall Study|Progressive disease|0|||
164630030|NCT01874288|594666649|FG002|Overall Study|Progressive disease|3|||
164630031|NCT01874288|594666650|FG003|Overall Study|Progressive disease|5|||
164630032|NCT01874288|594666651|FG004|Overall Study|Progressive disease|1|||
164630033|NCT03099304|594666652|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
164630034|NCT03099304|594666653|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
164630035|NCT03099304|594666654|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
164630036|NCT03099304|594666655|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
164630037|NCT03099304|594666656|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
164630038|NCT03099304|594666657|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
164630039|NCT03099304|594666652|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
164630040|NCT03099304|594666653|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
164630041|NCT03099304|594666654|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
164630042|NCT03099304|594666655|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
164630043|NCT03099304|594666656|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
164630044|NCT03099304|594666657|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
164630045|NCT03099304|594666652|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
164630046|NCT03099304|594666653|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
164630047|NCT03099304|594666654|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
164630048|NCT03099304|594666655|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
164630049|NCT03099304|594666656|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
164630050|NCT03099304|594666657|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
164630051|NCT03099304|594666652|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
164630052|NCT03099304|594666653|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
164630053|NCT03099304|594666654|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
164630054|NCT03099304|594666655|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
164630055|NCT03099304|594666656|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
164630056|NCT03099304|594666657|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
164630057|NCT03099304|594666652|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
164630058|NCT03099304|594666653|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
164630059|NCT03099304|594666654|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
164630060|NCT03099304|594666655|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
164630061|NCT03099304|594666656|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
164630062|NCT03099304|594666657|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
164630063|NCT03099304|594666652|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
164630064|NCT03099304|594666653|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
164630065|NCT03099304|594666654|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
164630066|NCT03099304|594666655|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
164630067|NCT03099304|594666656|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
164630068|NCT03099304|594666657|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
164630069|NCT03099304|594666652|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
164630070|NCT03099304|594666653|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
164630071|NCT03099304|594666654|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
164630072|NCT03099304|594666655|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
164630073|NCT03099304|594666656|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
164630074|NCT03099304|594666657|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
164630075|NCT03099304|594666652|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
164630076|NCT03099304|594666653|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
164630077|NCT03099304|594666654|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
164630078|NCT03099304|594666655|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
164630079|NCT03099304|594666656|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
164630080|NCT03099304|594666657|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
164630081|NCT03099304|594666652|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
164630082|NCT03099304|594666653|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
164630083|NCT03099304|594666654|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
164630084|NCT03099304|594666655|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
164630085|NCT03099304|594666656|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
164630086|NCT03099304|594666657|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
164630087|NCT03099304|594666652|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
164630088|NCT03099304|594666653|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
164630089|NCT03099304|594666654|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
164630090|NCT03099304|594666655|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
164630091|NCT03099304|594666656|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
164630092|NCT03099304|594666657|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
164630093|NCT03099304|594666652|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
164630094|NCT03099304|594666653|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
164630095|NCT03099304|594666654|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
164630096|NCT03099304|594666655|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
164630097|NCT03099304|594666656|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
164630098|NCT03099304|594666657|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
164630099|NCT03099304|594666652|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
164630100|NCT03099304|594666653|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
164630101|NCT03099304|594666654|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
164630102|NCT03099304|594666655|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
164630103|NCT03099304|594666656|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
164630104|NCT03099304|594666657|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
164630105|NCT03099304|594666652|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
164630106|NCT03099304|594666653|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
164630107|NCT03099304|594666654|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
164630108|NCT03099304|594666655|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
164630109|NCT03099304|594666656|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
164630110|NCT03099304|594666657|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
164630111|NCT03099304|594666652|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
164630112|NCT03099304|594666653|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
164630113|NCT03099304|594666654|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
164630114|NCT03099304|594666655|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
164630115|NCT03099304|594666656|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
164630116|NCT03099304|594666657|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
164630117|NCT03099304|594666652|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
164630118|NCT03099304|594666653|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
164630119|NCT03099304|594666654|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
164630120|NCT03099304|594666655|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
164630121|NCT03099304|594666656|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
164630122|NCT03099304|594666657|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
164630123|NCT03099304|594666652|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
164630124|NCT03099304|594666653|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
164630125|NCT03099304|594666654|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
164630126|NCT03099304|594666655|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
164630127|NCT03099304|594666656|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
164630128|NCT03099304|594666657|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
164630129|NCT03099304|594666652|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
164630130|NCT03099304|594666653|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
164630131|NCT03099304|594666654|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
164630132|NCT03099304|594666655|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
164630133|NCT03099304|594666656|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
164630134|NCT03099304|594666657|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
164630135|NCT01624974|594666658|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
164630136|NCT01624974|594666659|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
164630137|NCT01624974|594666658|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
164630138|NCT01624974|594666659|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
164630139|NCT01624974|594666658|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
164630140|NCT01624974|594666659|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
164630141|NCT01624974|594666658|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
164630142|NCT01624974|594666659|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
164630143|NCT01624974|594666658|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
164630144|NCT01624974|594666659|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
164630145|NCT01624974|594666658|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
164630146|NCT01624974|594666659|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
164630147|NCT01624974|594666658|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
164630148|NCT01624974|594666659|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
164630149|NCT01624974|594666658|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
164630150|NCT01624974|594666659|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
164630151|NCT01624974|594666658|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
164630152|NCT01624974|594666659|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
164630153|NCT01624974|594666658|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
164630154|NCT01624974|594666659|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
164630155|NCT01624974|594666658|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
164630156|NCT01624974|594666659|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
164630157|NCT01624974|594666658|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
164630158|NCT01624974|594666659|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
164630159|NCT02142712|594666660|FG000|Overall Study|Lost to Follow-up|1|||
164630160|NCT02142712|594666661|FG001|Overall Study|Lost to Follow-up|1|||
164630161|NCT02142712|594666662|FG002|Overall Study|Lost to Follow-up|1|||
164630162|NCT02142712|594666663|FG003|Overall Study|Lost to Follow-up|0|||
164630163|NCT00266695|594666664|FG000|Overall Study|Adverse Event|1|||
164630164|NCT00266695|594666664|FG000|Overall Study|Death|9|||
164630165|NCT00266695|594666664|FG000|Overall Study|Physician Decision|1|||
164630166|NCT00266695|594666664|FG000|Overall Study|Lost to Follow-up|3|||
164630167|NCT00266695|594666664|FG000|Overall Study|Withdrawal by Subject|15|||
164630168|NCT03480841|594666665|FG000|Overall Study|Lost to Follow-up|2|||
164630169|NCT00606021|594666666|FG000|Induction Phase|Death|73|||
164630170|NCT00606021|594666667|FG001|Induction Phase|Death|0|||
164630171|NCT00606021|594666668|FG002|Induction Phase|Death|0|||
164630172|NCT00606021|594666666|FG000|Induction Phase|Physician Decision|2|||
164630173|NCT00606021|594666667|FG001|Induction Phase|Physician Decision|0|||
164630174|NCT00606021|594666668|FG002|Induction Phase|Physician Decision|0|||
164630175|NCT00606021|594666666|FG000|Induction Phase|Withdrawal by Subject|2|||
164630176|NCT00606021|594666667|FG001|Induction Phase|Withdrawal by Subject|0|||
164630177|NCT00606021|594666668|FG002|Induction Phase|Withdrawal by Subject|0|||
164630178|NCT00606021|594666666|FG000|Induction Phase|Lost to Follow-up|10|||
164630179|NCT00606021|594666667|FG001|Induction Phase|Lost to Follow-up|0|||
164630180|NCT00606021|594666668|FG002|Induction Phase|Lost to Follow-up|0|||
164630181|NCT00606021|594666666|FG000|Maintenance Phase|Death|0|||
164630182|NCT00606021|594666667|FG001|Maintenance Phase|Death|17|||
164630183|NCT00606021|594666668|FG002|Maintenance Phase|Death|15|||
164630184|NCT00606021|594666666|FG000|Maintenance Phase|Physician Decision|0|||
164630185|NCT00606021|594666667|FG001|Maintenance Phase|Physician Decision|1|||
164630186|NCT00606021|594666668|FG002|Maintenance Phase|Physician Decision|0|||
164630187|NCT00606021|594666666|FG000|Maintenance Phase|Lost to Follow-up|0|||
164630188|NCT00606021|594666667|FG001|Maintenance Phase|Lost to Follow-up|5|||
164630189|NCT00606021|594666668|FG002|Maintenance Phase|Lost to Follow-up|2|||
164630190|NCT01362049|594666669|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
164630191|NCT01362049|594666670|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
164630192|NCT01362049|594666671|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
164630193|NCT01362049|594666672|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
164630194|NCT01362049|594666669|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
164630195|NCT01362049|594666670|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
164630196|NCT01362049|594666671|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
164630197|NCT01362049|594666672|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
164630198|NCT00989664|594666677|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
164630199|NCT00989664|594666677|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
164630200|NCT00989664|594666677|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
164630201|NCT00989664|594666677|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
164630202|NCT00989664|594666677|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
164630203|NCT00989664|594666677|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
164630204|NCT00989664|594666677|FG000|Long-Term Follow-Up|Death|3|||
164630205|NCT00095836|594666678|FG000|Overall Study|Lost to Follow-up|1|||
164630206|NCT00095836|594666678|FG000|Overall Study|Adverse Event|1|||
164630207|NCT00095836|594666678|FG000|Overall Study|Death|2|||
164630208|NCT02993783|594666679|FG000|Overall Study|Reason not Specified|6|||
164630209|NCT02993783|594666680|FG001|Overall Study|Reason not Specified|9|||
164630210|NCT02886338|594666681|FG000|Overall Study|Withdrawal by Subject|1|||
164630211|NCT01156012|594666682|FG000|Overall Study|Adverse Event|3|||
164630212|NCT01156012|594666683|FG001|Overall Study|Adverse Event|1|||
164630213|NCT01156012|594666682|FG000|Overall Study|Lost to Follow-up|1|||
164630214|NCT01156012|594666683|FG001|Overall Study|Lost to Follow-up|0|||
164630215|NCT01156012|594666682|FG000|Overall Study|Withdrawal by Subject|1|||
164630216|NCT01156012|594666683|FG001|Overall Study|Withdrawal by Subject|0|||
164630217|NCT01156012|594666682|FG000|Overall Study|use of commercial drug instead of study|0|||
164630218|NCT01156012|594666683|FG001|Overall Study|use of commercial drug instead of study|1|||
164630219|NCT01156012|594666682|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
164630220|NCT01156012|594666683|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
164630221|NCT01707667|594668808|FG000|Period 1|expulsion of colonic sensor catheter|1|||
164630222|NCT01707667|594668809|FG001|Period 1|expulsion of colonic sensor catheter|0|||
164630223|NCT03802331|594668810|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
164630224|NCT03802331|594668811|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
164630225|NCT03432819|594668815|FG000|Overall Study|Lost to Follow-up|2|||
164630226|NCT03432819|594668816|FG001|Overall Study|Lost to Follow-up|2|||
164630227|NCT03432819|594668815|FG000|Overall Study|Withdrawal by Subject|5|||
164630228|NCT03432819|594668816|FG001|Overall Study|Withdrawal by Subject|3|||
164630229|NCT02135848|594668817|FG000|Overall Study|Adverse Event|2|||
164630230|NCT02135848|594668818|FG001|Overall Study|Adverse Event|0|||
164630231|NCT02135848|594668817|FG000|Overall Study|Withdrawal by Subject|1|||
164630232|NCT02135848|594668818|FG001|Overall Study|Withdrawal by Subject|1|||
164630233|NCT00265382|594668819|FG000|Overall Study|Adverse Event|21|||
164630234|NCT00265382|594668819|FG000|Overall Study|Laboratory Abnormality|1|||
164630235|NCT00265382|594668819|FG000|Overall Study|Lost to Follow-up|3|||
164630236|NCT00265382|594668819|FG000|Overall Study|Lack of Efficacy|6|||
164630237|NCT00265382|594668819|FG000|Overall Study|Miscellaneous|6|||
164630238|NCT00265382|594668819|FG000|Overall Study|Withdrawal by Subject|13|||
164630239|NCT00265382|594668819|FG000|Overall Study|Study terminated by sponsor|94|||
164630240|NCT00265382|594668819|FG000|Overall Study|Death|1|||
164630241|NCT01474993|594668824|FG000|Overall Study|Lost to Follow-up|1|||
164630242|NCT01474993|594668825|FG001|Overall Study|Lost to Follow-up|2|||
164630243|NCT01474993|594668824|FG000|Overall Study|Adverse Event|0|||
164630244|NCT01474993|594668825|FG001|Overall Study|Adverse Event|1|||
164630245|NCT00760994|594668828|FG000|Overall Study|Lost to Follow-up|4|||
164630246|NCT00760994|594668829|FG001|Overall Study|Lost to Follow-up|4|||
164630247|NCT00760994|594668830|FG002|Overall Study|Lost to Follow-up|3|||
164630248|NCT03258710|594668831|FG000|Overall Study|Adverse Event|1|||
164630249|NCT03258710|594668831|FG000|Overall Study|Protocol-defined stopping criteria|1|||
164630250|NCT03258710|594668831|FG000|Overall Study|Physician Decision|1|||
164630251|NCT03451630|594668832|FG000|Overall Study|Death|15|||
164630252|NCT03451630|594668833|FG001|Overall Study|Death|16|||
164630253|NCT03451630|594668834|FG002|Overall Study|Death|11|||
164630254|NCT03451630|594668832|FG000|Overall Study|Lost to Follow-up|9|||
164630255|NCT03451630|594668833|FG001|Overall Study|Lost to Follow-up|0|||
164630256|NCT03451630|594668834|FG002|Overall Study|Lost to Follow-up|4|||
164630257|NCT03451630|594668832|FG000|Overall Study|Withdrawal by Subject|0|||
164630258|NCT03451630|594668833|FG001|Overall Study|Withdrawal by Subject|3|||
164630259|NCT03451630|594668834|FG002|Overall Study|Withdrawal by Subject|0|||
164630260|NCT03451630|594668832|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
164630261|NCT03451630|594668833|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
164630262|NCT03451630|594668834|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
164630263|NCT02041533|594668836|FG000|Pre-Treatment Period|Disease Progression|1|||
164630264|NCT02041533|594668837|FG001|Pre-Treatment Period|Disease Progression|1|||
164630265|NCT02041533|594668836|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
164630266|NCT02041533|594668837|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
164630267|NCT02041533|594668836|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
164630268|NCT02041533|594668837|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
164630269|NCT02041533|594668836|FG000|Treatment Period|Disease progression|189|||
164630270|NCT02041533|594668837|FG001|Treatment Period|Disease progression|146|||
164630271|NCT02041533|594668836|FG000|Treatment Period|Study drug toxicity|30|||
164630272|NCT02041533|594668837|FG001|Treatment Period|Study drug toxicity|34|||
164630273|NCT02041533|594668836|FG000|Treatment Period|Death|1|||
164630274|NCT02041533|594668837|FG001|Treatment Period|Death|0|||
164630275|NCT02041533|594668836|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
164630276|NCT02041533|594668837|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
164630277|NCT02041533|594668836|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
164630278|NCT02041533|594668837|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
164630279|NCT02041533|594668836|FG000|Treatment Period|Participant withdrew consent|2|||
164630280|NCT02041533|594668837|FG001|Treatment Period|Participant withdrew consent|2|||
164630281|NCT02041533|594668836|FG000|Treatment Period|Maximum clinical benefit|0|||
164630282|NCT02041533|594668837|FG001|Treatment Period|Maximum clinical benefit|18|||
164630283|NCT02041533|594668836|FG000|Treatment Period|Poor/Non-compliance|1|||
164630284|NCT02041533|594668837|FG001|Treatment Period|Poor/Non-compliance|0|||
164630285|NCT02041533|594668836|FG000|Treatment Period|Administrative reason by sponsor|1|||
164630286|NCT02041533|594668837|FG001|Treatment Period|Administrative reason by sponsor|0|||
164630287|NCT02041533|594668836|FG000|Treatment Period|Other reasons|9|||
164630288|NCT02041533|594668837|FG001|Treatment Period|Other reasons|2|||
164630289|NCT02041533|594668836|FG000|Treatment Period|Not Reported|0|||
164630290|NCT02041533|594668837|FG001|Treatment Period|Not Reported|1|||
164630291|NCT00545740|594668838|FG000|Overall Study|Lack of Efficacy|34|||
164630292|NCT00545740|594668839|FG001|Overall Study|Lack of Efficacy|35|||
164630293|NCT00545740|594668840|FG002|Overall Study|Lack of Efficacy|47|||
164630294|NCT00545740|594668841|FG003|Overall Study|Lack of Efficacy|36|||
164630295|NCT00545740|594668838|FG000|Overall Study|Withdrawal by Subject|17|||
164630296|NCT00545740|594668839|FG001|Overall Study|Withdrawal by Subject|15|||
164630297|NCT00545740|594668840|FG002|Overall Study|Withdrawal by Subject|16|||
164630298|NCT00545740|594668841|FG003|Overall Study|Withdrawal by Subject|18|||
164630299|NCT00545740|594668838|FG000|Overall Study|Adverse Event|10|||
164630300|NCT00545740|594668839|FG001|Overall Study|Adverse Event|18|||
164630301|NCT00545740|594668840|FG002|Overall Study|Adverse Event|19|||
164630302|NCT00545740|594668841|FG003|Overall Study|Adverse Event|9|||
164630303|NCT00545740|594668838|FG000|Overall Study|Lost to Follow-up|7|||
164630304|NCT00545740|594668839|FG001|Overall Study|Lost to Follow-up|5|||
164630305|NCT00545740|594668840|FG002|Overall Study|Lost to Follow-up|5|||
164630306|NCT00545740|594668841|FG003|Overall Study|Lost to Follow-up|6|||
164630307|NCT00545740|594668838|FG000|Overall Study|Protocol Violation|1|||
164630308|NCT00545740|594668839|FG001|Overall Study|Protocol Violation|3|||
164630309|NCT00545740|594668840|FG002|Overall Study|Protocol Violation|1|||
164630310|NCT00545740|594668841|FG003|Overall Study|Protocol Violation|0|||
164630311|NCT00545740|594668838|FG000|Overall Study|Non-compliance|0|||
164630312|NCT00545740|594668839|FG001|Overall Study|Non-compliance|2|||
164630313|NCT00545740|594668840|FG002|Overall Study|Non-compliance|1|||
164630314|NCT00545740|594668841|FG003|Overall Study|Non-compliance|0|||
164630315|NCT00545740|594668838|FG000|Overall Study|Moved|2|||
164630316|NCT00545740|594668839|FG001|Overall Study|Moved|0|||
164630317|NCT00545740|594668840|FG002|Overall Study|Moved|1|||
164630318|NCT00545740|594668841|FG003|Overall Study|Moved|0|||
164630319|NCT00545740|594668838|FG000|Overall Study|Diverticulitis attack|0|||
164630320|NCT00545740|594668839|FG001|Overall Study|Diverticulitis attack|0|||
164630321|NCT00545740|594668840|FG002|Overall Study|Diverticulitis attack|1|||
164630322|NCT00545740|594668841|FG003|Overall Study|Diverticulitis attack|1|||
164630323|NCT00545740|594668838|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
164630324|NCT00545740|594668839|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
164630325|NCT00545740|594668840|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
164630326|NCT00545740|594668841|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
164630327|NCT00545740|594668838|FG000|Overall Study|Site closure|1|||
164630328|NCT00545740|594668839|FG001|Overall Study|Site closure|0|||
164630329|NCT00545740|594668840|FG002|Overall Study|Site closure|0|||
164630330|NCT00545740|594668841|FG003|Overall Study|Site closure|0|||
164630331|NCT00545740|594668838|FG000|Overall Study|Missed visit|1|||
164630332|NCT00545740|594668839|FG001|Overall Study|Missed visit|0|||
164630333|NCT00545740|594668840|FG002|Overall Study|Missed visit|0|||
164630334|NCT00545740|594668841|FG003|Overall Study|Missed visit|0|||
164630335|NCT00545740|594668838|FG000|Overall Study|Physician Decision|0|||
164630336|NCT00545740|594668839|FG001|Overall Study|Physician Decision|0|||
164630337|NCT00545740|594668840|FG002|Overall Study|Physician Decision|3|||
164630338|NCT00545740|594668841|FG003|Overall Study|Physician Decision|0|||
164630339|NCT00545740|594668838|FG000|Overall Study|Accepted only monthly telephone calls|1|||
164630340|NCT00545740|594668839|FG001|Overall Study|Accepted only monthly telephone calls|0|||
164630341|NCT00545740|594668840|FG002|Overall Study|Accepted only monthly telephone calls|0|||
164630342|NCT00545740|594668841|FG003|Overall Study|Accepted only monthly telephone calls|0|||
164630343|NCT00545740|594668838|FG000|Overall Study|Sponsor decision|0|||
164630344|NCT00545740|594668839|FG001|Overall Study|Sponsor decision|1|||
164630345|NCT00545740|594668840|FG002|Overall Study|Sponsor decision|0|||
164630346|NCT00545740|594668841|FG003|Overall Study|Sponsor decision|0|||
164630347|NCT00545740|594668838|FG000|Overall Study|Lack of time|0|||
164630348|NCT00545740|594668839|FG001|Overall Study|Lack of time|1|||
164630349|NCT00545740|594668840|FG002|Overall Study|Lack of time|0|||
164630350|NCT00545740|594668841|FG003|Overall Study|Lack of time|0|||
164630351|NCT00545740|594668838|FG000|Overall Study|Non-adherence to visits|0|||
164630352|NCT00545740|594668839|FG001|Overall Study|Non-adherence to visits|1|||
164630353|NCT00545740|594668840|FG002|Overall Study|Non-adherence to visits|0|||
164630354|NCT00545740|594668841|FG003|Overall Study|Non-adherence to visits|0|||
164630355|NCT00545740|594668838|FG000|Overall Study|Patient difficulties|0|||
164630356|NCT00545740|594668839|FG001|Overall Study|Patient difficulties|1|||
164630357|NCT00545740|594668840|FG002|Overall Study|Patient difficulties|0|||
164630358|NCT00545740|594668841|FG003|Overall Study|Patient difficulties|0|||
164630359|NCT00545740|594668838|FG000|Overall Study|Husband against study|0|||
164630360|NCT00545740|594668839|FG001|Overall Study|Husband against study|0|||
164630361|NCT00545740|594668840|FG002|Overall Study|Husband against study|1|||
164630362|NCT00545740|594668841|FG003|Overall Study|Husband against study|0|||
164630363|NCT02117024|594668842|FG000|Overall Study|Progressive Disease|26|||
164630364|NCT02117024|594668843|FG001|Overall Study|Progressive Disease|9|||
164630365|NCT02117024|594668842|FG000|Overall Study|Significant Clinical Progression|7|||
164630366|NCT02117024|594668843|FG001|Overall Study|Significant Clinical Progression|4|||
164630367|NCT02117024|594668842|FG000|Overall Study|Death|5|||
164630368|NCT02117024|594668843|FG001|Overall Study|Death|0|||
164630369|NCT02117024|594668842|FG000|Overall Study|Withdrawal by Subject|3|||
164630370|NCT02117024|594668843|FG001|Overall Study|Withdrawal by Subject|1|||
164630371|NCT02117024|594668842|FG000|Overall Study|Protocol Violation|1|||
164630372|NCT02117024|594668843|FG001|Overall Study|Protocol Violation|0|||
164630373|NCT02117024|594668842|FG000|Overall Study|Adverse Event|1|||
164630374|NCT02117024|594668843|FG001|Overall Study|Adverse Event|2|||
164630375|NCT02117024|594668842|FG000|Overall Study|Randomized in Error|1|||
164630376|NCT02117024|594668843|FG001|Overall Study|Randomized in Error|0|||
164630377|NCT02117024|594668842|FG000|Overall Study|Patient returned to primary oncologist|0|||
164630378|NCT02117024|594668843|FG001|Overall Study|Patient returned to primary oncologist|1|||
164630379|NCT02117024|594668842|FG000|Overall Study|Patient took treatment break|0|||
164630380|NCT02117024|594668843|FG001|Overall Study|Patient took treatment break|1|||
164630381|NCT02117024|594668842|FG000|Overall Study|Physician Decision|0|||
164630382|NCT02117024|594668843|FG001|Overall Study|Physician Decision|2|||
164630383|NCT01957111|594668844|FG000|Overall Study|Withdrawal by Subject|1|||
164630384|NCT01957111|594668845|FG001|Overall Study|Withdrawal by Subject|1|||
164630385|NCT01646255|594668846|FG000|Overall Study|Adverse Event|7|||
164630386|NCT01646255|594668847|FG001|Overall Study|Adverse Event|8|||
164630387|NCT01646255|594668846|FG000|Overall Study|Lack of Efficacy|2|||
164630388|NCT01646255|594668847|FG001|Overall Study|Lack of Efficacy|0|||
164630389|NCT01646255|594668846|FG000|Overall Study|Withdrawal by Subject|10|||
164630390|NCT01646255|594668847|FG001|Overall Study|Withdrawal by Subject|6|||
164630391|NCT01646255|594668846|FG000|Overall Study|Compliance is not well|1|||
164630392|NCT01646255|594668847|FG001|Overall Study|Compliance is not well|0|||
164630393|NCT01646255|594668846|FG000|Overall Study|Inclusion Criteria Deviation|1|||
164630394|NCT01646255|594668847|FG001|Overall Study|Inclusion Criteria Deviation|0|||
164630395|NCT01468844|594668848|FG000|Overall Study|Adverse Event|1|||
164630396|NCT01468844|594668849|FG001|Overall Study|Adverse Event|0|||
164630397|NCT01468844|594668848|FG000|Overall Study|Withdrawal by Subject|1|||
164630398|NCT01468844|594668849|FG001|Overall Study|Withdrawal by Subject|0|||
164630399|NCT01241318|594668856|FG000|Overall Study|Woman: false pregnancies|27|||
164630400|NCT01241318|594668857|FG001|Overall Study|Woman: false pregnancies|15|||
164630401|NCT01241318|594668856|FG000|Overall Study|Woman: miscarriage/abortion|46|||
164630402|NCT01241318|594668857|FG001|Overall Study|Woman: miscarriage/abortion|38|||
164630403|NCT01241318|594668856|FG000|Overall Study|Withdrawal by Subject|175|||
164630404|NCT01241318|594668857|FG001|Overall Study|Withdrawal by Subject|46|||
164630405|NCT01241318|594668856|FG000|Overall Study|Lost to Follow-up|740|||
164630406|NCT01241318|594668857|FG001|Overall Study|Lost to Follow-up|455|||
164630407|NCT01241318|594668856|FG000|Overall Study|Death|2|||
164630408|NCT01241318|594668857|FG001|Overall Study|Death|4|||
164630409|NCT01241318|594668856|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
164630410|NCT01241318|594668857|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
164630411|NCT01241318|594668856|FG000|Overall Study|Woman: Stillborn infant|129|||
164630412|NCT01241318|594668857|FG001|Overall Study|Woman: Stillborn infant|146|||
164630413|NCT02355665|594668858|FG000|Overall Study|Adverse Event|16|||
164630414|NCT02355665|594668859|FG001|Overall Study|Adverse Event|24|||
164630415|NCT02355665|594668858|FG000|Overall Study|Protocol Violation|2|||
164630416|NCT02355665|594668859|FG001|Overall Study|Protocol Violation|0|||
164630417|NCT02355665|594668858|FG000|Overall Study|Withdrawal by Subject|90|||
164630418|NCT02355665|594668859|FG001|Overall Study|Withdrawal by Subject|100|||
164630419|NCT02355665|594668858|FG000|Overall Study|Lost to Follow-up|131|||
164630420|NCT02355665|594668859|FG001|Overall Study|Lost to Follow-up|103|||
164630421|NCT02355665|594668858|FG000|Overall Study|Death|4|||
164630422|NCT02355665|594668859|FG001|Overall Study|Death|2|||
164630423|NCT02355665|594668858|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
164630424|NCT02355665|594668859|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
164630425|NCT02380703|594668862|FG000|Overall Study|Withdrawal by Subject|12|||
164630426|NCT02380703|594668863|FG001|Overall Study|Withdrawal by Subject|9|||
164630427|NCT02380703|594668862|FG000|Overall Study|Lost to Follow-up|12|||
164630428|NCT02380703|594668863|FG001|Overall Study|Lost to Follow-up|12|||
164630429|NCT02380703|594668862|FG000|Overall Study|Caregiver death|1|||
164630430|NCT02380703|594668863|FG001|Overall Study|Caregiver death|0|||
164630431|NCT02380703|594668862|FG000|Overall Study|Person with dementia (PWD) death|7|||
164630432|NCT02380703|594668863|FG001|Overall Study|Person with dementia (PWD) death|8|||
164630433|NCT02380703|594668862|FG000|Overall Study|Entered Long-term Care|4|||
164630434|NCT02380703|594668863|FG001|Overall Study|Entered Long-term Care|7|||
164630435|NCT03607994|594668866|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
164630436|NCT03607994|594668867|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
164630437|NCT02853318|594668871|FG000|Overall Study|Withdrawal by Subject|1|||
164630438|NCT03125902|594668881|FG000|Overall Study|Adverse Event|0|||
164630439|NCT03125902|594668882|FG001|Overall Study|Adverse Event|1|||
164630440|NCT03125902|594668881|FG000|Overall Study|Death|119|||
164630441|NCT03125902|594668882|FG001|Overall Study|Death|229|||
164630442|NCT03125902|594668881|FG000|Overall Study|Lost to Follow-up|4|||
164630443|NCT03125902|594668882|FG001|Overall Study|Lost to Follow-up|13|||
164630444|NCT03125902|594668881|FG000|Overall Study|Other|0|||
164630445|NCT03125902|594668882|FG001|Overall Study|Other|4|||
164630446|NCT03125902|594668881|FG000|Overall Study|Physician Decision|2|||
164630447|NCT03125902|594668882|FG001|Overall Study|Physician Decision|1|||
164630448|NCT03125902|594668881|FG000|Overall Study|Progressive Disease|0|||
164630449|NCT03125902|594668882|FG001|Overall Study|Progressive Disease|3|||
164630450|NCT03125902|594668881|FG000|Overall Study|Study Terminated By Sponsor|74|||
164630451|NCT03125902|594668882|FG001|Overall Study|Study Terminated By Sponsor|143|||
164630452|NCT03125902|594668881|FG000|Overall Study|Withdrawal by Subject|21|||
164630453|NCT03125902|594668882|FG001|Overall Study|Withdrawal by Subject|37|||
164630454|NCT01997333|594668883|FG000|Randomization and Treatment|Disease Progression|70|||
164630455|NCT01997333|594668884|FG001|Randomization and Treatment|Disease Progression|159|||
164630456|NCT01997333|594668883|FG000|Randomization and Treatment|Adverse Event|10|||
164630457|NCT01997333|594668884|FG001|Randomization and Treatment|Adverse Event|32|||
164630458|NCT01997333|594668883|FG000|Randomization and Treatment|Physician Decision|0|||
164630459|NCT01997333|594668884|FG001|Randomization and Treatment|Physician Decision|4|||
164630460|NCT01997333|594668883|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
164630461|NCT01997333|594668884|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
164630462|NCT01997333|594668883|FG000|Randomization and Treatment|Did not receive treatment|17|||
164630463|NCT01997333|594668884|FG001|Randomization and Treatment|Did not receive treatment|5|||
164630464|NCT01997333|594668883|FG000|Survival Follow up|Withdrawal by Subject|15|||
164630465|NCT01997333|594668884|FG001|Survival Follow up|Withdrawal by Subject|6|||
164630466|NCT01997333|594668883|FG000|Survival Follow up|Lost to Follow-up|0|||
164630467|NCT01997333|594668884|FG001|Survival Follow up|Lost to Follow-up|6|||
164630468|NCT01997333|594668883|FG000|Survival Follow up|Various|1|||
164630469|NCT01997333|594668884|FG001|Survival Follow up|Various|2|||
164630470|NCT02269709|594668885|FG000|Time of Enrollment|Withdrawal by Subject|3|||
164630471|NCT02269709|594668885|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
164630472|NCT02269709|594668885|FG000|Six Month Follow-up|Lost to Follow-up|12|||
164630473|NCT00426842|594668886|FG000|Overall Study|Lost to Follow-up|1|||
164630474|NCT01747655|594668887|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
164630475|NCT01747655|594668888|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
164630476|NCT01747655|594668887|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
164630477|NCT01747655|594668888|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
164630478|NCT01747655|594668887|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
164630479|NCT01747655|594668888|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
164630480|NCT01070381|594668889|FG000|Period 2, 1 Week of Wear|Handling|0|||
164630481|NCT01070381|594668890|FG001|Period 2, 1 Week of Wear|Handling|1|||
164630482|NCT01070381|594668889|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
164630483|NCT01070381|594668890|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
164630484|NCT00684073|594668891|FG000|Selection|Selection/non-selection criteria|3|||
164630485|NCT00684073|594668891|FG000|Selection|Death|1|||
164630486|NCT00684073|594668891|FG000|Selection|noncompliance|1|||
164630487|NCT00684073|594668891|FG000|Selection|Lost to Follow-up|1|||
164630488|NCT00684073|594668891|FG000|Selection|request of the sponsor|1|||
164630489|NCT00684073|594668891|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
164630490|NCT01259388|594668893|FG000|Overall Study|Adverse Event|3|||
164147704|NCT02006732|592902130|FG001|Overall Study|Protocol Violation|1|||
164630491|NCT01259388|594668894|FG001|Overall Study|Adverse Event|0|||
164630492|NCT01259388|594668893|FG000|Overall Study|Withdrawal by Subject|1|||
164630493|NCT01259388|594668894|FG001|Overall Study|Withdrawal by Subject|1|||
164630494|NCT01259388|594668893|FG000|Overall Study|Physician Decision|1|||
164630495|NCT01259388|594668894|FG001|Overall Study|Physician Decision|0|||
164630496|NCT00620815|594668895|FG000|Overall Study|Adverse Event|1|||
164630497|NCT00620815|594668896|FG001|Overall Study|Adverse Event|1|||
164630498|NCT00620815|594668897|FG002|Overall Study|Adverse Event|2|||
164630499|NCT00620815|594668895|FG000|Overall Study|Withdrawal by Subject|1|||
164630500|NCT00620815|594668896|FG001|Overall Study|Withdrawal by Subject|2|||
164630501|NCT00620815|594668897|FG002|Overall Study|Withdrawal by Subject|0|||
164630502|NCT00620815|594668895|FG000|Overall Study|Lost to Follow-up|1|||
164630503|NCT00620815|594668896|FG001|Overall Study|Lost to Follow-up|6|||
164630504|NCT00620815|594668897|FG002|Overall Study|Lost to Follow-up|3|||
164630505|NCT00620815|594668895|FG000|Overall Study|Inappropriate enrolment|0|||
164630506|NCT00620815|594668896|FG001|Overall Study|Inappropriate enrolment|0|||
164630507|NCT00620815|594668897|FG002|Overall Study|Inappropriate enrolment|1|||
164630508|NCT00620815|594668895|FG000|Overall Study|Protocol Violation|1|||
164630509|NCT00620815|594668896|FG001|Overall Study|Protocol Violation|2|||
164630510|NCT00620815|594668897|FG002|Overall Study|Protocol Violation|1|||
164630511|NCT01230827|594668898|FG000|Overall Study|Lost to Follow-up|0|||
164630512|NCT01230827|594668899|FG001|Overall Study|Lost to Follow-up|0|||
164630513|NCT01230827|594668900|FG002|Overall Study|Lost to Follow-up|1|||
164630514|NCT01230827|594668901|FG003|Overall Study|Lost to Follow-up|3|||
164630515|NCT01230827|594668898|FG000|Overall Study|Withdrawal by Subject|1|||
164630516|NCT01230827|594668899|FG001|Overall Study|Withdrawal by Subject|0|||
164630517|NCT01230827|594668900|FG002|Overall Study|Withdrawal by Subject|3|||
164630518|NCT01230827|594668901|FG003|Overall Study|Withdrawal by Subject|2|||
164630519|NCT01230827|594668898|FG000|Overall Study|Lack of Efficacy|14|||
164630520|NCT01230827|594668899|FG001|Overall Study|Lack of Efficacy|1|||
164630521|NCT01230827|594668900|FG002|Overall Study|Lack of Efficacy|2|||
164630522|NCT01230827|594668901|FG003|Overall Study|Lack of Efficacy|3|||
164630523|NCT01230827|594668898|FG000|Overall Study|Adverse Event|4|||
164630524|NCT01230827|594668899|FG001|Overall Study|Adverse Event|2|||
164630525|NCT01230827|594668900|FG002|Overall Study|Adverse Event|3|||
164630526|NCT01230827|594668901|FG003|Overall Study|Adverse Event|7|||
164630527|NCT01230827|594668898|FG000|Overall Study|Recovery|0|||
164630528|NCT01230827|594668899|FG001|Overall Study|Recovery|6|||
164630529|NCT01230827|594668900|FG002|Overall Study|Recovery|0|||
164630530|NCT01230827|594668901|FG003|Overall Study|Recovery|0|||
164630531|NCT01230827|594668898|FG000|Overall Study|Study terminated by Sponsor|0|||
164630532|NCT01230827|594668899|FG001|Overall Study|Study terminated by Sponsor|2|||
164630533|NCT01230827|594668900|FG002|Overall Study|Study terminated by Sponsor|56|||
164630534|NCT01230827|594668901|FG003|Overall Study|Study terminated by Sponsor|63|||
164630535|NCT00983827|594668902|FG000|Overall Study|Withdrawal by Subject|1|||
164630536|NCT01888367|594668908|FG000|Overall Study|Physician Decision|3|||
164630537|NCT01888367|594668909|FG001|Overall Study|Physician Decision|4|||
164630538|NCT01888367|594668910|FG002|Overall Study|Physician Decision|2|||
164630539|NCT01888367|594668908|FG000|Overall Study|Death|2|||
164630540|NCT01888367|594668909|FG001|Overall Study|Death|0|||
164630541|NCT01888367|594668910|FG002|Overall Study|Death|1|||
164630542|NCT01888367|594668908|FG000|Overall Study|Withdrawal by Subject|1|||
164630543|NCT01888367|594668909|FG001|Overall Study|Withdrawal by Subject|0|||
164630544|NCT01888367|594668910|FG002|Overall Study|Withdrawal by Subject|1|||
164630545|NCT01888367|594668908|FG000|Overall Study|Lost to Follow-up|1|||
164630546|NCT01888367|594668909|FG001|Overall Study|Lost to Follow-up|1|||
164630547|NCT01888367|594668910|FG002|Overall Study|Lost to Follow-up|0|||
164630548|NCT01888367|594668908|FG000|Overall Study|Protocol Violation|0|||
164630549|NCT01888367|594668909|FG001|Overall Study|Protocol Violation|0|||
164630550|NCT01888367|594668910|FG002|Overall Study|Protocol Violation|1|||
164630551|NCT01888367|594668908|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
164630552|NCT01888367|594668909|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
164630553|NCT01888367|594668910|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
164630554|NCT02728804|594668911|FG000|Overall Study|Ineligible|3|||
164630555|NCT02728804|594668911|FG000|Overall Study|Did not complete baseline questionnaire|9|||
164630556|NCT02728804|594668911|FG000|Overall Study|Death|99|||
164630557|NCT00591786|594668912|FG000|Overall Study|Withdrawal of Informed Consent|0|||
164630558|NCT00591786|594668913|FG001|Overall Study|Withdrawal of Informed Consent|0|||
164630559|NCT00591786|594668914|FG002|Overall Study|Withdrawal of Informed Consent|1|||
164630560|NCT00591786|594668915|FG003|Overall Study|Withdrawal of Informed Consent|0|||
164630561|NCT00591786|594668916|FG004|Overall Study|Withdrawal of Informed Consent|0|||
164630562|NCT00591786|594668917|FG005|Overall Study|Withdrawal of Informed Consent|0|||
164630563|NCT00591786|594668918|FG006|Overall Study|Withdrawal of Informed Consent|0|||
164630564|NCT00591786|594668919|FG007|Overall Study|Withdrawal of Informed Consent|0|||
164630565|NCT00591786|594668920|FG008|Overall Study|Withdrawal of Informed Consent|0|||
164630566|NCT00591786|594668921|FG009|Overall Study|Withdrawal of Informed Consent|0|||
164630567|NCT01854918|594668922|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
164630568|NCT01854918|594668923|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
164630569|NCT01854918|594668922|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
164630570|NCT01854918|594668923|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
164630571|NCT01854918|594668922|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
164630572|NCT01854918|594668923|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
164630573|NCT01854918|594668922|FG000|SOC-controlled Period (Year 1)|Death|5|||
164630574|NCT01854918|594668923|FG001|SOC-controlled Period (Year 1)|Death|5|||
164630575|NCT01854918|594668922|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
164630576|NCT01854918|594668923|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
164630577|NCT01854918|594668922|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
164630578|NCT01854918|594668923|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
164630579|NCT01854918|594668922|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
164630580|NCT01854918|594668923|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
164630581|NCT01854918|594668922|FG000|All-IP Period (Years 2 and 3)|Death|5|||
164630582|NCT01854918|594668923|FG001|All-IP Period (Years 2 and 3)|Death|16|||
164630583|NCT01920061|594668927|FG000|Overall Study|Death|1|||
164630584|NCT01920061|594668928|FG001|Overall Study|Death|1|||
164630585|NCT01920061|594668929|FG002|Overall Study|Death|0|||
164630586|NCT01920061|594668930|FG003|Overall Study|Death|1|||
164630587|NCT01920061|594668931|FG004|Overall Study|Death|1|||
164630588|NCT01920061|594668932|FG005|Overall Study|Death|0|||
164630589|NCT01920061|594668933|FG006|Overall Study|Death|0|||
164630590|NCT01920061|594668934|FG007|Overall Study|Death|1|||
164630591|NCT01920061|594668935|FG008|Overall Study|Death|0|||
164630592|NCT01920061|594668936|FG009|Overall Study|Death|1|||
164630593|NCT01920061|594668937|FG010|Overall Study|Death|0|||
164630594|NCT01920061|594668938|FG011|Overall Study|Death|1|||
164630595|NCT01920061|594668939|FG012|Overall Study|Death|0|||
164630596|NCT01920061|594668940|FG013|Overall Study|Death|2|||
164630597|NCT01920061|594668941|FG014|Overall Study|Death|0|||
164630598|NCT01920061|594668942|FG015|Overall Study|Death|0|||
164630599|NCT01920061|594668943|FG016|Overall Study|Death|0|||
164630600|NCT01920061|594668944|FG017|Overall Study|Death|0|||
164630601|NCT01920061|594668945|FG018|Overall Study|Death|1|||
164630602|NCT01920061|594668946|FG019|Overall Study|Death|0|||
164630603|NCT01920061|594668927|FG000|Overall Study|Lost to Follow-up|0|||
164630604|NCT01920061|594668928|FG001|Overall Study|Lost to Follow-up|2|||
164630605|NCT01920061|594668929|FG002|Overall Study|Lost to Follow-up|0|||
164630606|NCT01920061|594668930|FG003|Overall Study|Lost to Follow-up|0|||
164630607|NCT01920061|594668931|FG004|Overall Study|Lost to Follow-up|0|||
164630608|NCT01920061|594668932|FG005|Overall Study|Lost to Follow-up|0|||
164630609|NCT01920061|594668933|FG006|Overall Study|Lost to Follow-up|1|||
164630610|NCT01920061|594668934|FG007|Overall Study|Lost to Follow-up|0|||
164630611|NCT01920061|594668935|FG008|Overall Study|Lost to Follow-up|0|||
164630612|NCT01920061|594668936|FG009|Overall Study|Lost to Follow-up|0|||
164630613|NCT01920061|594668937|FG010|Overall Study|Lost to Follow-up|3|||
164630614|NCT01920061|594668938|FG011|Overall Study|Lost to Follow-up|0|||
164630615|NCT01920061|594668939|FG012|Overall Study|Lost to Follow-up|0|||
164630616|NCT01920061|594668940|FG013|Overall Study|Lost to Follow-up|0|||
164630617|NCT01920061|594668941|FG014|Overall Study|Lost to Follow-up|0|||
164630618|NCT01920061|594668942|FG015|Overall Study|Lost to Follow-up|0|||
164630619|NCT01920061|594668943|FG016|Overall Study|Lost to Follow-up|0|||
164630620|NCT01920061|594668944|FG017|Overall Study|Lost to Follow-up|1|||
164630621|NCT01920061|594668945|FG018|Overall Study|Lost to Follow-up|4|||
164630622|NCT01920061|594668946|FG019|Overall Study|Lost to Follow-up|3|||
164630623|NCT01920061|594668927|FG000|Overall Study|Other|1|||
164630624|NCT01920061|594668928|FG001|Overall Study|Other|1|||
164630625|NCT01920061|594668929|FG002|Overall Study|Other|2|||
164630626|NCT01920061|594668930|FG003|Overall Study|Other|1|||
164630627|NCT01920061|594668931|FG004|Overall Study|Other|0|||
164630628|NCT01920061|594668932|FG005|Overall Study|Other|1|||
164630629|NCT01920061|594668933|FG006|Overall Study|Other|0|||
164630630|NCT01920061|594668934|FG007|Overall Study|Other|0|||
164630631|NCT01920061|594668935|FG008|Overall Study|Other|0|||
164630632|NCT01920061|594668936|FG009|Overall Study|Other|1|||
164630633|NCT01920061|594668937|FG010|Overall Study|Other|1|||
164630634|NCT01920061|594668938|FG011|Overall Study|Other|2|||
164630635|NCT01920061|594668939|FG012|Overall Study|Other|1|||
164630636|NCT01920061|594668940|FG013|Overall Study|Other|4|||
164630637|NCT01920061|594668941|FG014|Overall Study|Other|0|||
164630638|NCT01920061|594668942|FG015|Overall Study|Other|1|||
164630639|NCT01920061|594668943|FG016|Overall Study|Other|1|||
164630640|NCT01920061|594668944|FG017|Overall Study|Other|0|||
164630641|NCT01920061|594668945|FG018|Overall Study|Other|1|||
164630642|NCT01920061|594668946|FG019|Overall Study|Other|1|||
164528477|NCT00986674|594305762|FG001|Overall Study|Death|0|||
164528478|NCT00986674|594305763|FG002|Overall Study|Death|4|||
164528479|NCT00986674|594305761|FG000|Overall Study|Withdrawal by Subject|6|||
164528480|NCT00986674|594305762|FG001|Overall Study|Withdrawal by Subject|2|||
164528481|NCT00986674|594305763|FG002|Overall Study|Withdrawal by Subject|1|||
164528482|NCT00986674|594305761|FG000|Overall Study|alternative therapy|0|||
164528483|NCT00986674|594305762|FG001|Overall Study|alternative therapy|0|||
164528484|NCT00986674|594305763|FG002|Overall Study|alternative therapy|1|||
164528485|NCT00986674|594305761|FG000|Overall Study|not start protocol therapy|4|||
164528486|NCT00986674|594305762|FG001|Overall Study|not start protocol therapy|3|||
164528487|NCT00986674|594305763|FG002|Overall Study|not start protocol therapy|1|||
164528488|NCT00986674|594305761|FG000|Overall Study|unknown/not specify|0|||
164528489|NCT00986674|594305762|FG001|Overall Study|unknown/not specify|7|||
164528490|NCT00986674|594305763|FG002|Overall Study|unknown/not specify|9|||
164528491|NCT01853137|594305764|FG000|Overall Study|Lost to Follow-up|4|||
164528492|NCT01853137|594305765|FG001|Overall Study|Lost to Follow-up|1|||
164528493|NCT03658668|594305766|FG000|Overall Study|Time Commitment|1|||
164528494|NCT03658668|594305767|FG001|Overall Study|Time Commitment|1|||
164528495|NCT01127139|594305770|FG000|Overall Study|Adverse Event|40|||
164528496|NCT01127139|594305770|FG000|Overall Study|Incompliance|12|||
164528497|NCT01127139|594305770|FG000|Overall Study|Lack of Efficacy|4|||
164528498|NCT01127139|594305770|FG000|Overall Study|Reason not specified|1|||
164528499|NCT01136772|594305771|FG000|Overall Study|Adverse Event|15|||
164528500|NCT01136772|594305772|FG001|Overall Study|Adverse Event|14|||
164528501|NCT01136772|594305771|FG000|Overall Study|Lack of Efficacy|42|||
164528502|NCT01136772|594305772|FG001|Overall Study|Lack of Efficacy|39|||
164528503|NCT01136772|594305771|FG000|Overall Study|Administrative|14|||
164528504|NCT01136772|594305772|FG001|Overall Study|Administrative|12|||
164528505|NCT01136772|594305771|FG000|Overall Study|Withdrawal by Subject|33|||
164528506|NCT01136772|594305772|FG001|Overall Study|Withdrawal by Subject|36|||
164528507|NCT01136772|594305771|FG000|Overall Study|Did not receive injection|10|||
164528508|NCT01136772|594305772|FG001|Overall Study|Did not receive injection|7|||
164630643|NCT01920061|594668927|FG000|Overall Study|Participant refused further follow-up|0|||
164630644|NCT01920061|594668928|FG001|Overall Study|Participant refused further follow-up|0|||
164630645|NCT01920061|594668929|FG002|Overall Study|Participant refused further follow-up|0|||
164630646|NCT01920061|594668930|FG003|Overall Study|Participant refused further follow-up|0|||
164630647|NCT01920061|594668931|FG004|Overall Study|Participant refused further follow-up|1|||
164630648|NCT01920061|594668932|FG005|Overall Study|Participant refused further follow-up|1|||
164630649|NCT01920061|594668933|FG006|Overall Study|Participant refused further follow-up|0|||
164630650|NCT01920061|594668934|FG007|Overall Study|Participant refused further follow-up|0|||
164630651|NCT01920061|594668935|FG008|Overall Study|Participant refused further follow-up|1|||
164630652|NCT01920061|594668936|FG009|Overall Study|Participant refused further follow-up|0|||
164630653|NCT01920061|594668937|FG010|Overall Study|Participant refused further follow-up|1|||
164630654|NCT01920061|594668938|FG011|Overall Study|Participant refused further follow-up|0|||
164630655|NCT01920061|594668939|FG012|Overall Study|Participant refused further follow-up|1|||
164630656|NCT01920061|594668940|FG013|Overall Study|Participant refused further follow-up|0|||
164630657|NCT01920061|594668941|FG014|Overall Study|Participant refused further follow-up|1|||
164630658|NCT01920061|594668942|FG015|Overall Study|Participant refused further follow-up|2|||
164630659|NCT01920061|594668943|FG016|Overall Study|Participant refused further follow-up|1|||
164630660|NCT01920061|594668944|FG017|Overall Study|Participant refused further follow-up|1|||
164630661|NCT01920061|594668945|FG018|Overall Study|Participant refused further follow-up|0|||
164630662|NCT01920061|594668946|FG019|Overall Study|Participant refused further follow-up|0|||
164630663|NCT02828982|594668951|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
164630664|NCT02828982|594668952|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
164630665|NCT02475564|594668953|FG000|Overall Study|Withdrawal by Subject|1|||
164630666|NCT02475564|594668954|FG001|Overall Study|Withdrawal by Subject|0|||
164630667|NCT02475564|594668953|FG000|Overall Study|Lost to Follow-up|2|||
164630668|NCT02475564|594668954|FG001|Overall Study|Lost to Follow-up|1|||
164630669|NCT02475564|594668953|FG000|Overall Study|Intense Menstrual bleeding|1|||
164630670|NCT02475564|594668954|FG001|Overall Study|Intense Menstrual bleeding|0|||
164630671|NCT02705755|594668955|FG000|Part A (6 Days)|Adverse Event|1|||
164630672|NCT02705755|594668956|FG001|Part A (6 Days)|Adverse Event|0|||
164630673|NCT02705755|594668957|FG002|Part A (6 Days)|Adverse Event|0|||
164630674|NCT02705755|594668958|FG003|Part A (6 Days)|Adverse Event|0|||
164630675|NCT02705755|594668955|FG000|Part A (6 Days)|Physician Decision|3|||
164630676|NCT02705755|594668956|FG001|Part A (6 Days)|Physician Decision|0|||
164630677|NCT02705755|594668957|FG002|Part A (6 Days)|Physician Decision|0|||
164630678|NCT02705755|594668958|FG003|Part A (6 Days)|Physician Decision|0|||
164630679|NCT02705755|594668955|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
164630680|NCT02705755|594668956|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
164630681|NCT02705755|594668957|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
164630682|NCT02705755|594668958|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
164630683|NCT02705755|594668955|FG000|Part C (20 Weeks)|Physician Decision|0|||
164630684|NCT02705755|594668956|FG001|Part C (20 Weeks)|Physician Decision|0|||
164630685|NCT02705755|594668957|FG002|Part C (20 Weeks)|Physician Decision|0|||
164630686|NCT02705755|594668958|FG003|Part C (20 Weeks)|Physician Decision|2|||
164630687|NCT02705755|594668955|FG000|Part C (20 Weeks)|Adverse Event|0|||
164630688|NCT02705755|594668956|FG001|Part C (20 Weeks)|Adverse Event|0|||
164630689|NCT02705755|594668957|FG002|Part C (20 Weeks)|Adverse Event|0|||
164630690|NCT02705755|594668958|FG003|Part C (20 Weeks)|Adverse Event|6|||
164630691|NCT02705755|594668955|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
164630692|NCT02705755|594668956|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
164630693|NCT02705755|594668957|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
164630694|NCT02705755|594668958|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
164630695|NCT01906489|594668959|FG000|Overall Study|Adverse Event|10|||
164630696|NCT01906489|594668960|FG001|Overall Study|Adverse Event|3|||
164630697|NCT01906489|594668959|FG000|Overall Study|Worsening of CKD|6|||
164630698|NCT01906489|594668960|FG001|Overall Study|Worsening of CKD|4|||
164630699|NCT01906489|594668959|FG000|Overall Study|Withdrawal by Subject|5|||
164630700|NCT01906489|594668960|FG001|Overall Study|Withdrawal by Subject|0|||
164630701|NCT01906489|594668959|FG000|Overall Study|Worsening of Anemia|1|||
164630702|NCT01906489|594668960|FG001|Overall Study|Worsening of Anemia|0|||
164630703|NCT01906489|594668959|FG000|Overall Study|Protocol Violation|0|||
164630704|NCT01906489|594668960|FG001|Overall Study|Protocol Violation|1|||
164630705|NCT01906489|594668959|FG000|Overall Study|Non- Compliance|1|||
164630706|NCT01906489|594668960|FG001|Overall Study|Non- Compliance|0|||
164630707|NCT01906489|594668959|FG000|Overall Study|Sponsor Decision|1|||
164630708|NCT01906489|594668960|FG001|Overall Study|Sponsor Decision|0|||
164630709|NCT01906489|594668959|FG000|Overall Study|Lost to Follow-up|1|||
164630710|NCT01906489|594668960|FG001|Overall Study|Lost to Follow-up|1|||
164630711|NCT01906489|594668959|FG000|Overall Study|Other|1|||
164630712|NCT01906489|594668960|FG001|Overall Study|Other|0|||
164630713|NCT03458234|594668961|FG000|Overall Study|Withdrawal by Subject|1|||
164630714|NCT01078389|594671001|FG000|Overall Study|Adverse Event|10|||
164630715|NCT01078389|594671002|FG001|Overall Study|Adverse Event|6|||
164630716|NCT01078389|594671001|FG000|Overall Study|Major Protocol Deviation|2|||
164528509|NCT01136772|594305771|FG000|Overall Study|Did not follow up after first injection|2|||
164528510|NCT01136772|594305772|FG001|Overall Study|Did not follow up after first injection|2|||
164528511|NCT01100034|594305773|FG000|Overall Study|Lost to Follow-up|11|||
164528512|NCT01100034|594305773|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
164528513|NCT01100034|594305773|FG000|Overall Study|Withdrawal by Subject|4|||
164528514|NCT01100034|594305773|FG000|Overall Study|Sponsor decision|21|||
164528515|NCT01100034|594305773|FG000|Overall Study|Participated in another clinical trial|1|||
164528516|NCT01100034|594305773|FG000|Overall Study|Participants moved to another hospital|4|||
164528517|NCT01100034|594305773|FG000|Overall Study|Site closed due to non-responsiveness|1|||
164528518|NCT05208866|594305775|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
164528519|NCT00836095|594305781|FG000|Overall Study|Physician Decision|0|||
164528520|NCT00836095|594305782|FG001|Overall Study|Physician Decision|3|||
164528521|NCT01602562|594305783|FG000|Overall Study|Adverse Event|3|||
164528522|NCT01602562|594305784|FG001|Overall Study|Adverse Event|1|||
164528523|NCT01602562|594305783|FG000|Overall Study|Physician Decision|1|||
164528524|NCT01602562|594305784|FG001|Overall Study|Physician Decision|1|||
164528525|NCT01602562|594305783|FG000|Overall Study|Withdrawal by Subject|1|||
164528526|NCT01602562|594305784|FG001|Overall Study|Withdrawal by Subject|1|||
164528527|NCT03881553|594305786|FG000|Overall Study|Discharged prior to participation|1|||
164528528|NCT03881553|594305787|FG001|Overall Study|Discharged prior to participation|1|||
164528529|NCT03881553|594305788|FG002|Overall Study|Discharged prior to participation|0|||
164528530|NCT03881553|594305786|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
164528531|NCT03881553|594305787|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
164528532|NCT03881553|594305788|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
164528533|NCT01718353|594305789|FG000|Overall Study|Lost to Follow-up|0|||
164528534|NCT01718353|594305790|FG001|Overall Study|Lost to Follow-up|1|||
164528535|NCT01718353|594305789|FG000|Overall Study|Principal Investigator's Decision|10|||
164528536|NCT01718353|594305790|FG001|Overall Study|Principal Investigator's Decision|4|||
164528537|NCT01718353|594305789|FG000|Overall Study|Randomized but not treated|2|||
164528538|NCT01718353|594305790|FG001|Overall Study|Randomized but not treated|0|||
164528539|NCT01959516|594305791|FG000|Epoch 1|Adverse Event|4|||
164528540|NCT01959516|594305792|FG001|Epoch 1|Adverse Event|1|||
164528541|NCT01959516|594305791|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
164528542|NCT01959516|594305792|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
164528543|NCT01959516|594305791|FG000|Epoch 1|Subject withdrew consent|3|||
164528544|NCT01959516|594305792|FG001|Epoch 1|Subject withdrew consent|2|||
164528545|NCT01959516|594305791|FG000|Epoch 1|Administrative problems|1|||
164528546|NCT01959516|594305792|FG001|Epoch 1|Administrative problems|0|||
164528547|NCT01959516|594305791|FG000|Epoch 1|Use of prohibited treatment|1|||
164528548|NCT01959516|594305792|FG001|Epoch 1|Use of prohibited treatment|0|||
164528549|NCT01959516|594305791|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
164528550|NCT01959516|594305792|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
164528551|NCT01959516|594305791|FG000|Epoch 1|Protocol deviation|0|||
164528552|NCT01959516|594305792|FG001|Epoch 1|Protocol deviation|1|||
164528553|NCT01959516|594305791|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
164528554|NCT01959516|594305792|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
164528555|NCT01959516|594305791|FG000|Epoch 2|Subject withdrew consent|1|||
164528556|NCT01959516|594305792|FG001|Epoch 2|Subject withdrew consent|0|||
164528557|NCT01959516|594305791|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
164528558|NCT01959516|594305792|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
164528559|NCT01759368|594305797|FG000|Overall Study|Lost to Follow-up|1|||
164528560|NCT01759368|594305798|FG001|Overall Study|Lost to Follow-up|0|||
164528561|NCT01200589|594305799|FG000|Overall Study|Withdrawal by Subject|13|||
164528562|NCT01200589|594305800|FG001|Overall Study|Withdrawal by Subject|11|||
164528563|NCT01200589|594305799|FG000|Overall Study|Physician Decision|2|||
164630717|NCT01078389|594671002|FG001|Overall Study|Major Protocol Deviation|0|||
164630718|NCT01078389|594671001|FG000|Overall Study|Lost to Follow-up|23|||
164630719|NCT01078389|594671002|FG001|Overall Study|Lost to Follow-up|23|||
164630720|NCT01078389|594671001|FG000|Overall Study|Voluntary Withdrawal|20|||
164630721|NCT01078389|594671002|FG001|Overall Study|Voluntary Withdrawal|36|||
164630722|NCT01078389|594671001|FG000|Overall Study|Other|9|||
164630723|NCT01078389|594671002|FG001|Overall Study|Other|2|||
164630724|NCT04823494|594671003|FG000|Overall Study|Programming software malfunction.|1|||
164630725|NCT04823494|594671004|FG001|Overall Study|Programming software malfunction.|0|||
164630726|NCT04823494|594671003|FG000|Overall Study|Withdrawal by Subject|1|||
164630727|NCT04823494|594671004|FG001|Overall Study|Withdrawal by Subject|0|||
164630728|NCT04823494|594671003|FG000|Overall Study|Devices lost|0|||
164630729|NCT04823494|594671004|FG001|Overall Study|Devices lost|1|||
164630730|NCT03726320|594671005|FG000|Overall Study|Lost to Follow-up|2|||
164630731|NCT03726320|594671006|FG001|Overall Study|Lost to Follow-up|4|||
164630732|NCT03726320|594671007|FG002|Overall Study|Lost to Follow-up|0|||
164630733|NCT03726320|594671005|FG000|Overall Study|Time Constraints|4|||
164630734|NCT03726320|594671006|FG001|Overall Study|Time Constraints|1|||
164630735|NCT03726320|594671007|FG002|Overall Study|Time Constraints|0|||
164630736|NCT03726320|594671005|FG000|Overall Study|Ineligible after enrollment|3|||
164630737|NCT03726320|594671006|FG001|Overall Study|Ineligible after enrollment|3|||
164630738|NCT03726320|594671007|FG002|Overall Study|Ineligible after enrollment|0|||
164630739|NCT03726320|594671005|FG000|Overall Study|Clinic / insurance issue|2|||
164630740|NCT03726320|594671006|FG001|Overall Study|Clinic / insurance issue|0|||
164630741|NCT03726320|594671007|FG002|Overall Study|Clinic / insurance issue|0|||
164630742|NCT03726320|594671005|FG000|Overall Study|Language barrier|1|||
164630743|NCT03726320|594671006|FG001|Overall Study|Language barrier|0|||
164630744|NCT03726320|594671007|FG002|Overall Study|Language barrier|0|||
164630745|NCT03726320|594671005|FG000|Overall Study|Provider left the clinic|0|||
164630746|NCT03726320|594671006|FG001|Overall Study|Provider left the clinic|0|||
164528564|NCT01200589|594305800|FG001|Overall Study|Physician Decision|2|||
164528565|NCT01200589|594305799|FG000|Overall Study|Lost to Follow-up|5|||
164528566|NCT01200589|594305800|FG001|Overall Study|Lost to Follow-up|4|||
164528567|NCT01200589|594305799|FG000|Overall Study|Study terminated|170|||
164528568|NCT01200589|594305800|FG001|Overall Study|Study terminated|172|||
164528569|NCT01191268|594305801|FG000|Overall Study|Withdrawal by Subject|19|||
164528570|NCT01191268|594305802|FG001|Overall Study|Withdrawal by Subject|25|||
164528571|NCT01191268|594305803|FG002|Overall Study|Withdrawal by Subject|21|||
164528572|NCT01191268|594305801|FG000|Overall Study|Adverse Event|21|||
164528573|NCT01191268|594305802|FG001|Overall Study|Adverse Event|13|||
164528574|NCT01191268|594305803|FG002|Overall Study|Adverse Event|8|||
164528575|NCT01191268|594305801|FG000|Overall Study|Physician Decision|6|||
164528576|NCT01191268|594305802|FG001|Overall Study|Physician Decision|8|||
164528577|NCT01191268|594305803|FG002|Overall Study|Physician Decision|9|||
164528578|NCT01191268|594305801|FG000|Overall Study|Lost to Follow-up|8|||
164528579|NCT01191268|594305802|FG001|Overall Study|Lost to Follow-up|5|||
164528580|NCT01191268|594305803|FG002|Overall Study|Lost to Follow-up|9|||
164528581|NCT01191268|594305801|FG000|Overall Study|Entry Criteria Not Met|3|||
164528582|NCT01191268|594305802|FG001|Overall Study|Entry Criteria Not Met|1|||
164528583|NCT01191268|594305803|FG002|Overall Study|Entry Criteria Not Met|1|||
164528584|NCT01191268|594305801|FG000|Overall Study|Death|0|||
164528585|NCT01191268|594305802|FG001|Overall Study|Death|1|||
164528586|NCT01191268|594305803|FG002|Overall Study|Death|3|||
164147705|NCT02006732|592902131|FG002|Overall Study|Protocol Violation|0|||
164528587|NCT01191268|594305801|FG000|Overall Study|Protocol Violation|1|||
164528588|NCT01191268|594305802|FG001|Overall Study|Protocol Violation|0|||
164528589|NCT01191268|594305803|FG002|Overall Study|Protocol Violation|1|||
164528590|NCT01191268|594305801|FG000|Overall Study|Sponsor Decision|0|||
164528591|NCT01191268|594305802|FG001|Overall Study|Sponsor Decision|2|||
164528592|NCT01191268|594305803|FG002|Overall Study|Sponsor Decision|0|||
164528593|NCT00336895|594305804|FG000|Overall Study|diarrhea|1|||
164528594|NCT00336895|594305804|FG000|Overall Study|nausea and upset stomach|1|||
164528595|NCT00336895|594305804|FG000|Overall Study|Physician Decision|1|||
164528596|NCT00336895|594305804|FG000|Overall Study|screen failed|1|||
164528597|NCT01959334|594305805|FG000|Second Dose|Adverse Event|1|||
164528598|NCT01959334|594305806|FG001|Second Dose|Adverse Event|0|||
164528599|NCT01959334|594305805|FG000|Third Dose|Adverse Event|0|||
164528600|NCT01959334|594305806|FG001|Third Dose|Adverse Event|1|||
164528601|NCT00986973|594305807|FG000|Overall Study|Withdrawn by study team|1|||
164528602|NCT01313689|594305808|FG000|24-Week Randomization 1|Adverse Event|10|||
164528603|NCT01313689|594305809|FG001|24-Week Randomization 1|Adverse Event|5|||
164528604|NCT01313689|594305810|FG002|24-Week Randomization 1|Adverse Event|0|||
164528605|NCT01313689|594305811|FG003|24-Week Randomization 1|Adverse Event|0|||
164528606|NCT01313689|594305812|FG004|24-Week Randomization 1|Adverse Event|0|||
164528607|NCT01313689|594305808|FG000|24-Week Randomization 1|Physician Decision|4|||
164528608|NCT01313689|594305809|FG001|24-Week Randomization 1|Physician Decision|5|||
164528609|NCT01313689|594305810|FG002|24-Week Randomization 1|Physician Decision|0|||
164528610|NCT01313689|594305811|FG003|24-Week Randomization 1|Physician Decision|0|||
164528611|NCT01313689|594305812|FG004|24-Week Randomization 1|Physician Decision|0|||
164528612|NCT01313689|594305808|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
164528613|NCT01313689|594305809|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
164528614|NCT01313689|594305810|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
164528615|NCT01313689|594305811|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
164528616|NCT01313689|594305812|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
164528617|NCT01313689|594305808|FG000|24-Week Randomization 2|Adverse Event|0|||
164528618|NCT01313689|594305809|FG001|24-Week Randomization 2|Adverse Event|0|||
164528619|NCT01313689|594305810|FG002|24-Week Randomization 2|Adverse Event|2|||
164528620|NCT01313689|594305811|FG003|24-Week Randomization 2|Adverse Event|0|||
164528621|NCT01313689|594305812|FG004|24-Week Randomization 2|Adverse Event|8|||
164528622|NCT01313689|594305808|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
164528623|NCT01313689|594305809|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
164528624|NCT01313689|594305810|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
164528625|NCT01313689|594305811|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
164528626|NCT01313689|594305812|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
164528627|NCT01313689|594305808|FG000|24-Week Randomization 2|Physician Decision|0|||
164528628|NCT01313689|594305809|FG001|24-Week Randomization 2|Physician Decision|0|||
164528629|NCT01313689|594305810|FG002|24-Week Randomization 2|Physician Decision|0|||
164528630|NCT01313689|594305811|FG003|24-Week Randomization 2|Physician Decision|0|||
164528631|NCT01313689|594305812|FG004|24-Week Randomization 2|Physician Decision|4|||
164528632|NCT01590082|594305813|FG000|Overall Study|Withdrawal by Subject|1|||
164528633|NCT01590082|594305814|FG001|Overall Study|Withdrawal by Subject|0|||
164528634|NCT01590082|594305813|FG000|Overall Study|Ineligible|1|||
164528635|NCT01590082|594305814|FG001|Overall Study|Ineligible|0|||
164528636|NCT01768637|594305815|FG000|Overall Study|Lost to Follow-up|2|||
164528637|NCT01768637|594305816|FG001|Overall Study|Lost to Follow-up|7|||
164528638|NCT01768637|594305815|FG000|Overall Study|Difficult blood draw|1|||
164528639|NCT01768637|594305816|FG001|Overall Study|Difficult blood draw|0|||
164528640|NCT01054170|594305817|FG000|Overall Study|Protocol Violation|1|||
164528641|NCT01054170|594305818|FG001|Overall Study|Protocol Violation|0|||
164147706|NCT02006732|592902132|FG003|Overall Study|Protocol Violation|0|||
164528642|NCT01054170|594305817|FG000|Overall Study|Withdrawal by Subject|3|||
164528643|NCT01054170|594305818|FG001|Overall Study|Withdrawal by Subject|2|||
164528644|NCT01054170|594305817|FG000|Overall Study|Adverse Event|0|||
164528645|NCT01054170|594305818|FG001|Overall Study|Adverse Event|4|||
164528646|NCT02951767|594305819|FG000|Overall Study|Study Terminated By Sponsor|9|||
164630747|NCT03726320|594671007|FG002|Overall Study|Provider left the clinic|1|||
164630748|NCT03691831|594671010|FG000|Overall Study|Lost to Follow-up|16|||
164630749|NCT03691831|594671011|FG001|Overall Study|Lost to Follow-up|12|||
164630750|NCT03691831|594671010|FG000|Overall Study|Withdrawal by Subject|9|||
164630751|NCT03691831|594671011|FG001|Overall Study|Withdrawal by Subject|17|||
164630752|NCT03691831|594671010|FG000|Overall Study|Investigator Decision|2|||
164630753|NCT03691831|594671011|FG001|Overall Study|Investigator Decision|2|||
164630754|NCT02198040|594671012|FG000|Overall Study|Work reasons|0|||
164630755|NCT02198040|594671013|FG001|Overall Study|Work reasons|1|||
164630756|NCT02198040|594671014|FG002|Overall Study|Work reasons|0|||
164630757|NCT02198040|594671012|FG000|Overall Study|Withdrawal by Subject|0|||
164630758|NCT02198040|594671013|FG001|Overall Study|Withdrawal by Subject|0|||
164630759|NCT02198040|594671014|FG002|Overall Study|Withdrawal by Subject|1|||
164630760|NCT00337935|594671015|FG000|Overall Study|Adverse Event|2|||
164630761|NCT00337935|594671016|FG001|Overall Study|Adverse Event|5|||
164630762|NCT00337935|594671015|FG000|Overall Study|Death|2|||
164630763|NCT00337935|594671016|FG001|Overall Study|Death|8|||
164630764|NCT00337935|594671015|FG000|Overall Study|Physician Decision|1|||
164630765|NCT00337935|594671016|FG001|Overall Study|Physician Decision|1|||
164630766|NCT00337935|594671015|FG000|Overall Study|Lost to Follow-up|0|||
164630767|NCT00337935|594671016|FG001|Overall Study|Lost to Follow-up|1|||
164630768|NCT00337935|594671015|FG000|Overall Study|Protocol Violation|4|||
164630769|NCT00337935|594671016|FG001|Overall Study|Protocol Violation|3|||
164630770|NCT00337935|594671015|FG000|Overall Study|Withdrawal by Subject|1|||
164630771|NCT00337935|594671016|FG001|Overall Study|Withdrawal by Subject|7|||
164630772|NCT00337935|594671015|FG000|Overall Study|Other|0|||
164630773|NCT00337935|594671016|FG001|Overall Study|Other|1|||
164630774|NCT00337935|594671015|FG000|Overall Study|Lack of Efficacy|0|||
164630775|NCT00337935|594671016|FG001|Overall Study|Lack of Efficacy|1|||
164630776|NCT01884675|594671017|FG000|Overall Study|Study closed/terminated|3|||
164630777|NCT01884675|594671018|FG001|Overall Study|Study closed/terminated|2|||
164630778|NCT02361307|594671019|FG000|Overall Study|Unstable medical condition.|0|||
164630779|NCT02361307|594671020|FG001|Overall Study|Unstable medical condition.|1|||
164630780|NCT01189201|594671027|FG000|Overall Study|Adverse Event|1|||
164630781|NCT01277757|594671028|FG000|Overall Study|Disease Progression|1|||
164630782|NCT01277757|594671028|FG000|Overall Study|Withdrawal by Subject|1|||
164630783|NCT00240331|594671032|FG000|Overall Study|Withdrawal by Subject|125|||
164630784|NCT00240331|594671033|FG001|Overall Study|Withdrawal by Subject|132|||
164630785|NCT00240331|594671032|FG000|Overall Study|Option selected by investigator|1|||
164630786|NCT00240331|594671033|FG001|Overall Study|Option selected by investigator|2|||
164630787|NCT01409382|594671034|FG000|Overall Study|Lost to Follow-up|1|||
164630788|NCT01409382|594671035|FG001|Overall Study|Lost to Follow-up|1|||
164630789|NCT01409382|594671034|FG000|Overall Study|Protocol Violation|0|||
164630790|NCT01409382|594671035|FG001|Overall Study|Protocol Violation|3|||
164630791|NCT01409382|594671034|FG000|Overall Study|Multiple pregnancy|2|||
164630792|NCT01409382|594671035|FG001|Overall Study|Multiple pregnancy|4|||
164630793|NCT01409382|594671034|FG000|Overall Study|Still pregnant when study ended|13|||
164630794|NCT01409382|594671035|FG001|Overall Study|Still pregnant when study ended|2|||
164630795|NCT01409382|594671034|FG000|Overall Study|Did not manage to get pregnant|64|||
164630796|NCT01409382|594671035|FG001|Overall Study|Did not manage to get pregnant|70|||
164630797|NCT01409382|594671034|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
164630798|NCT01409382|594671035|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
164630799|NCT01233076|594671036|FG000|Period 2, One Week|Lost to Follow-up|1|||
164630800|NCT01233076|594671037|FG001|Period 2, One Week|Lost to Follow-up|0|||
164630801|NCT04563845|594671038|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164630802|NCT04563845|594671039|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164630803|NCT04563845|594671040|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164630804|NCT04563845|594671041|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164630805|NCT04563845|594671042|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164630806|NCT04563845|594671043|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164630807|NCT04563845|594671044|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164630808|NCT04563845|594671045|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
164630809|NCT04563845|594671046|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164630810|NCT04563845|594671047|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164630811|NCT04563845|594671048|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164630812|NCT04563845|594671049|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164630813|NCT04563845|594671050|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164630814|NCT04563845|594671051|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164630815|NCT04563845|594671038|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164630816|NCT04563845|594671039|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164630817|NCT04563845|594671040|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164630818|NCT04563845|594671041|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164630819|NCT04563845|594671042|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
164630820|NCT04563845|594671043|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164630821|NCT04563845|594671044|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164630822|NCT04563845|594671045|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164630823|NCT04563845|594671046|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164630824|NCT04563845|594671047|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164630825|NCT04563845|594671048|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164630826|NCT04563845|594671049|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164630827|NCT04563845|594671050|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164630828|NCT04563845|594671051|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164630829|NCT04120116|594671052|FG000|Overall Study|Lost to Follow-up|0|||
164630830|NCT04120116|594671053|FG001|Overall Study|Lost to Follow-up|1|||
164630831|NCT04120116|594671054|FG002|Overall Study|Lost to Follow-up|0|||
164630832|NCT04120116|594671055|FG003|Overall Study|Lost to Follow-up|2|||
164630833|NCT04120116|594671052|FG000|Overall Study|Withdrawal by Subject|1|||
164630834|NCT04120116|594671053|FG001|Overall Study|Withdrawal by Subject|0|||
164630835|NCT04120116|594671054|FG002|Overall Study|Withdrawal by Subject|1|||
164630836|NCT04120116|594671055|FG003|Overall Study|Withdrawal by Subject|1|||
164630837|NCT04120116|594671052|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
164630838|NCT04120116|594671053|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
164630839|NCT04120116|594671054|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
164630840|NCT04120116|594671055|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
164630841|NCT02210559|594671060|FG000|Overall Study|Progressive Disease|3|||
164630842|NCT02210559|594671061|FG001|Overall Study|Progressive Disease|2|||
164630843|NCT02210559|594671060|FG000|Overall Study|Adverse Event|2|||
164630844|NCT02210559|594671061|FG001|Overall Study|Adverse Event|2|||
164630845|NCT02210559|594671060|FG000|Overall Study|Physician Decision|1|||
164630846|NCT02210559|594671061|FG001|Overall Study|Physician Decision|0|||
164630847|NCT02210559|594671060|FG000|Overall Study|Withdrawal by Subject|0|||
164630848|NCT02210559|594671061|FG001|Overall Study|Withdrawal by Subject|1|||
164630849|NCT02210559|594671060|FG000|Overall Study|Other than specified|0|||
164630850|NCT02210559|594671061|FG001|Overall Study|Other than specified|1|||
164630851|NCT01287403|594671065|FG000|1st Intervention (1 Day)|Adverse Event|1|||
164630852|NCT01098266|594671066|FG000|Overall Study|Physician Decision|1|||
164630853|NCT01098266|594671067|FG001|Overall Study|Physician Decision|0|||
164630854|NCT01098266|594671066|FG000|Overall Study|Death|3|||
164528647|NCT02951767|594305819|FG000|Overall Study|Withdrawal by Subject|11|||
164528648|NCT02951767|594305819|FG000|Overall Study|Death|96|||
164528649|NCT02951767|594305819|FG000|Overall Study|Lost to Follow-up|2|||
164528650|NCT02951767|594305819|FG000|Overall Study|Physician Decision|1|||
164528651|NCT01442779|594305820|FG000|Overall Study|Withdrawal by Subject|3|||
164528652|NCT01442779|594305820|FG000|Overall Study|Death|3|||
164528653|NCT01442779|594305820|FG000|Overall Study|Non-compliance|1|||
164528654|NCT01337115|594305824|FG000|Overall Study|Protocol Violation|2|||
164528655|NCT01337115|594305825|FG001|Overall Study|Protocol Violation|0|||
164528656|NCT03426267|594305830|FG000|Overall Study|Physician Decision|1|||
164528657|NCT03426267|594305831|FG001|Overall Study|Physician Decision|4|||
164528658|NCT03426267|594305830|FG000|Overall Study|Lost to Follow-up|1|||
164528659|NCT03426267|594305831|FG001|Overall Study|Lost to Follow-up|0|||
164528660|NCT03426267|594305830|FG000|Overall Study|Withdrawal by Subject|4|||
164528661|NCT03426267|594305831|FG001|Overall Study|Withdrawal by Subject|10|||
164528662|NCT03426267|594305830|FG000|Overall Study|Protocol Violation|1|||
164528663|NCT03426267|594305831|FG001|Overall Study|Protocol Violation|3|||
164528664|NCT03426267|594305830|FG000|Overall Study|Adverse Event|9|||
164528665|NCT03426267|594305831|FG001|Overall Study|Adverse Event|27|||
164528666|NCT03426267|594305830|FG000|Overall Study|Prohibited Treatment Intake|2|||
164528667|NCT03426267|594305831|FG001|Overall Study|Prohibited Treatment Intake|3|||
164528668|NCT03426267|594305830|FG000|Overall Study|Lack of Efficacy|0|||
164528669|NCT03426267|594305831|FG001|Overall Study|Lack of Efficacy|25|||
164528670|NCT03426267|594305830|FG000|Overall Study|other|3|||
164528671|NCT03426267|594305831|FG001|Overall Study|other|0|||
164528672|NCT00609765|594305834|FG000|Overall Study|Study ended prior to 12 months|1|||
164528673|NCT02054520|594305841|FG000|Overall Study|Adverse Event|1|||
164528674|NCT02054520|594305842|FG001|Overall Study|Adverse Event|4|||
164630855|NCT01098266|594671067|FG001|Overall Study|Death|2|||
164630856|NCT01098266|594671066|FG000|Overall Study|Withdrawal by Subject|3|||
164630857|NCT01098266|594671067|FG001|Overall Study|Withdrawal by Subject|5|||
164630858|NCT01733758|594671068|FG000|Overall Study|Adverse Event|5|||
164630859|NCT01733758|594671069|FG001|Overall Study|Adverse Event|7|||
164630860|NCT01733758|594671070|FG002|Overall Study|Adverse Event|8|||
164630861|NCT01733758|594671071|FG003|Overall Study|Adverse Event|1|||
164630862|NCT01733758|594671068|FG000|Overall Study|Withdrawal by Subject|1|||
164630863|NCT01733758|594671069|FG001|Overall Study|Withdrawal by Subject|1|||
164630864|NCT01733758|594671070|FG002|Overall Study|Withdrawal by Subject|5|||
164630865|NCT01733758|594671071|FG003|Overall Study|Withdrawal by Subject|3|||
164630866|NCT01733758|594671068|FG000|Overall Study|Persistent Hyperglycemia|3|||
164630867|NCT01733758|594671069|FG001|Overall Study|Persistent Hyperglycemia|2|||
164630868|NCT01733758|594671070|FG002|Overall Study|Persistent Hyperglycemia|0|||
164630869|NCT01733758|594671071|FG003|Overall Study|Persistent Hyperglycemia|0|||
164630870|NCT01733758|594671068|FG000|Overall Study|Protocol Violation|0|||
164630871|NCT01733758|594671069|FG001|Overall Study|Protocol Violation|1|||
164630872|NCT01733758|594671070|FG002|Overall Study|Protocol Violation|2|||
164630873|NCT01733758|594671071|FG003|Overall Study|Protocol Violation|2|||
164630874|NCT01733758|594671068|FG000|Overall Study|Non-compliance|1|||
164630875|NCT01733758|594671069|FG001|Overall Study|Non-compliance|0|||
164630876|NCT01733758|594671070|FG002|Overall Study|Non-compliance|0|||
164630877|NCT01733758|594671071|FG003|Overall Study|Non-compliance|0|||
164630878|NCT01733758|594671068|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
164630879|NCT01733758|594671069|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
164630880|NCT01733758|594671070|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
164630881|NCT01733758|594671071|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
164630882|NCT01733758|594671068|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
164630883|NCT01733758|594671069|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
164630884|NCT01733758|594671070|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
164630885|NCT01733758|594671071|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
164630886|NCT02545270|594671076|FG000|Overall Study|technical difficulties|0|||
164630887|NCT02545270|594671077|FG001|Overall Study|technical difficulties|1|||
164630888|NCT02545270|594671078|FG002|Overall Study|technical difficulties|0|||
164630889|NCT02545270|594671076|FG000|Overall Study|Videos being too similar to other|0|||
164630890|NCT02545270|594671077|FG001|Overall Study|Videos being too similar to other|0|||
164630891|NCT02545270|594671078|FG002|Overall Study|Videos being too similar to other|2|||
164630892|NCT00727246|594671079|FG000|Overall Study|could not complete MRI|0|||
164630893|NCT00727246|594671080|FG001|Overall Study|could not complete MRI|1|||
164630894|NCT00727246|594671081|FG002|Overall Study|could not complete MRI|0|||
164630895|NCT00727246|594671082|FG003|Overall Study|could not complete MRI|1|||
164630896|NCT00727246|594671079|FG000|Overall Study|incidental finding|0|||
164630897|NCT00727246|594671080|FG001|Overall Study|incidental finding|0|||
164630898|NCT00727246|594671081|FG002|Overall Study|incidental finding|0|||
164630899|NCT00727246|594671082|FG003|Overall Study|incidental finding|1|||
164630900|NCT00727246|594671079|FG000|Overall Study|withdrawn|0|||
164630901|NCT00727246|594671080|FG001|Overall Study|withdrawn|0|||
164630902|NCT00727246|594671081|FG002|Overall Study|withdrawn|1|||
164630903|NCT00727246|594671082|FG003|Overall Study|withdrawn|0|||
164630904|NCT00661362|594671083|FG000|Overall Study|Adverse Event|5|||
164630905|NCT00661362|594671084|FG001|Overall Study|Adverse Event|4|||
164630906|NCT00661362|594671083|FG000|Overall Study|Incorrect enrollment|2|||
164630907|NCT00661362|594671084|FG001|Overall Study|Incorrect enrollment|0|||
164630908|NCT00661362|594671083|FG000|Overall Study|Study specific discontinuation criteria|4|||
164630909|NCT00661362|594671084|FG001|Overall Study|Study specific discontinuation criteria|11|||
164630910|NCT00661362|594671083|FG000|Overall Study|Withdrawal by Subject|13|||
164630911|NCT00661362|594671084|FG001|Overall Study|Withdrawal by Subject|23|||
164630912|NCT00661362|594671083|FG000|Overall Study|Lost to Follow-up|3|||
164630913|NCT00661362|594671084|FG001|Overall Study|Lost to Follow-up|1|||
164630914|NCT00661362|594671083|FG000|Overall Study|Severe non-compliance to protocol|0|||
164630915|NCT00661362|594671084|FG001|Overall Study|Severe non-compliance to protocol|1|||
164630916|NCT00661362|594671083|FG000|Overall Study|Safety reasons|1|||
164630917|NCT00661362|594671084|FG001|Overall Study|Safety reasons|0|||
164630918|NCT00661362|594671083|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
164630919|NCT00661362|594671084|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
164630920|NCT00535262|594671087|FG000|Overall Study|No funding|3|||
164630921|NCT04382066|594671090|FG000|Overall Study|Adverse Event|1|||
164630922|NCT04382066|594671091|FG001|Overall Study|Adverse Event|0|||
164630923|NCT04382066|594671092|FG002|Overall Study|Adverse Event|0|||
164630924|NCT04382066|594671090|FG000|Overall Study|Death|1|||
164630925|NCT04382066|594671091|FG001|Overall Study|Death|0|||
164630926|NCT04382066|594671092|FG002|Overall Study|Death|1|||
164630927|NCT04738123|594671093|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
164630928|NCT04738123|594671094|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
164630929|NCT04738123|594671093|FG000|Overall Study|Progressive Disease|0|||
164630930|NCT04738123|594671094|FG001|Overall Study|Progressive Disease|4|||
164630931|NCT04738123|594671093|FG000|Overall Study|Adverse Event|8|||
164630932|NCT04738123|594671094|FG001|Overall Study|Adverse Event|7|||
164630933|NCT04738123|594671093|FG000|Overall Study|Other Reasons|0|||
164630934|NCT04738123|594671094|FG001|Overall Study|Other Reasons|1|||
164630935|NCT04738123|594671093|FG000|Overall Study|Suicidal or assaultive behavior|0|||
164630936|NCT04738123|594671094|FG001|Overall Study|Suicidal or assaultive behavior|2|||
164630937|NCT04738123|594671093|FG000|Overall Study|Protocol Violation|2|||
164630938|NCT04738123|594671094|FG001|Overall Study|Protocol Violation|2|||
164630939|NCT04738123|594671093|FG000|Overall Study|Consent Withdrawn|35|||
164630940|NCT04738123|594671094|FG001|Overall Study|Consent Withdrawn|22|||
164630941|NCT00787527|594671095|FG000|Overall Study|Toxicity|3|||
164630942|NCT00083616|594671098|FG000|Overall Study|Disease Progression|16|||
164630943|NCT00083616|594671098|FG000|Overall Study|Lost to Follow-up|1|||
164630944|NCT00083616|594671098|FG000|Overall Study|Physician Decision|2|||
164630945|NCT00083616|594671098|FG000|Overall Study|Withdrawal by Subject|3|||
164630946|NCT00083616|594671098|FG000|Overall Study|Ineligibility determined|2|||
164630947|NCT00083616|594671098|FG000|Overall Study|Non-compliance|1|||
164630948|NCT00083616|594671098|FG000|Overall Study|Other|6|||
164630949|NCT01724021|594671099|FG000|Overall Study|Adverse Event|11|||
164630950|NCT01724021|594671100|FG001|Overall Study|Adverse Event|6|||
164630951|NCT01724021|594671099|FG000|Overall Study|Death|46|||
164630952|NCT01724021|594671100|FG001|Overall Study|Death|58|||
164630953|NCT01724021|594671099|FG000|Overall Study|Participant request/ Withdrew consent|18|||
164630954|NCT01724021|594671100|FG001|Overall Study|Participant request/ Withdrew consent|14|||
164630955|NCT01724021|594671099|FG000|Overall Study|Lost to Follow-up|15|||
164630956|NCT01724021|594671100|FG001|Overall Study|Lost to Follow-up|15|||
164630957|NCT01724021|594671099|FG000|Overall Study|Reason Not Specified|36|||
164630958|NCT01724021|594671100|FG001|Overall Study|Reason Not Specified|39|||
164630959|NCT01724021|594671099|FG000|Overall Study|Missing|1|||
164630960|NCT01724021|594671100|FG001|Overall Study|Missing|1|||
164630961|NCT02500706|594671103|FG000|Overall Study|Adverse Event|0|||
164630962|NCT02500706|594671104|FG001|Overall Study|Adverse Event|0|||
164630963|NCT02500706|594671105|FG002|Overall Study|Adverse Event|1|||
164630964|NCT02500706|594671103|FG000|Overall Study|Lost to Follow-up|0|||
164630965|NCT02500706|594671104|FG001|Overall Study|Lost to Follow-up|1|||
164630966|NCT02500706|594671105|FG002|Overall Study|Lost to Follow-up|1|||
164630967|NCT02500706|594671103|FG000|Overall Study|Withdrawal by Subject|4|||
164630968|NCT02500706|594671104|FG001|Overall Study|Withdrawal by Subject|6|||
164630969|NCT02500706|594671105|FG002|Overall Study|Withdrawal by Subject|4|||
164630970|NCT02500706|594671103|FG000|Overall Study|Unclassified|0|||
164630971|NCT02500706|594671104|FG001|Overall Study|Unclassified|0|||
164630972|NCT02500706|594671105|FG002|Overall Study|Unclassified|1|||
164630973|NCT03644173|594671108|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
164630974|NCT03644173|594671108|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
164630975|NCT03644173|594671108|FG000|Participants at the 1-month Follow up|Death|2|||
164630976|NCT03644173|594671108|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
164630977|NCT03323385|594671109|FG000|Overall Study|Withdrawal by Subject|1|||
164630978|NCT03323385|594671110|FG001|Overall Study|Withdrawal by Subject|2|||
164630979|NCT03323385|594671109|FG000|Overall Study|Noncompliance|0|||
164630980|NCT03323385|594671110|FG001|Overall Study|Noncompliance|1|||
164630981|NCT04490499|594671119|FG000|Overall Study|Withdrawal by Subject|2|||
164630982|NCT01882439|594671120|FG000|Overall Study|Adverse event related to study drug|3|||
164630983|NCT01882439|594671121|FG001|Overall Study|Adverse event related to study drug|8|||
164630984|NCT01882439|594671122|FG002|Overall Study|Adverse event related to study drug|1|||
164630985|NCT01882439|594671123|FG003|Overall Study|Adverse event related to study drug|2|||
164630986|NCT01882439|594671120|FG000|Overall Study|Pregnancy|0|||
164630987|NCT01882439|594671121|FG001|Overall Study|Pregnancy|1|||
164630988|NCT01882439|594671122|FG002|Overall Study|Pregnancy|0|||
164630989|NCT01882439|594671123|FG003|Overall Study|Pregnancy|0|||
164630990|NCT01882439|594671120|FG000|Overall Study|Protocol Violation|2|||
164630991|NCT01882439|594671121|FG001|Overall Study|Protocol Violation|2|||
164630992|NCT01882439|594671122|FG002|Overall Study|Protocol Violation|0|||
164630993|NCT01882439|594671123|FG003|Overall Study|Protocol Violation|1|||
164630994|NCT01882439|594671120|FG000|Overall Study|No longer willing to participate|1|||
164630995|NCT01882439|594671121|FG001|Overall Study|No longer willing to participate|4|||
164630996|NCT01882439|594671122|FG002|Overall Study|No longer willing to participate|2|||
164630997|NCT01882439|594671123|FG003|Overall Study|No longer willing to participate|3|||
164630998|NCT01882439|594671120|FG000|Overall Study|Medication error with no associated AE|0|||
164630999|NCT01882439|594671121|FG001|Overall Study|Medication error with no associated AE|0|||
164631000|NCT01882439|594671122|FG002|Overall Study|Medication error with no associated AE|2|||
164631001|NCT01882439|594671123|FG003|Overall Study|Medication error with no associated AE|0|||
164631002|NCT01882439|594671120|FG000|Overall Study|Insufficient clinical response|1|||
164631003|NCT01882439|594671121|FG001|Overall Study|Insufficient clinical response|4|||
164631004|NCT01882439|594671122|FG002|Overall Study|Insufficient clinical response|4|||
164631005|NCT01882439|594671123|FG003|Overall Study|Insufficient clinical response|2|||
164631006|NCT01882439|594671120|FG000|Overall Study|Adverse event unrelated to study drug|2|||
164631007|NCT01882439|594671121|FG001|Overall Study|Adverse event unrelated to study drug|2|||
164631008|NCT01882439|594671122|FG002|Overall Study|Adverse event unrelated to study drug|1|||
164631009|NCT01882439|594671123|FG003|Overall Study|Adverse event unrelated to study drug|1|||
164631010|NCT04411472|594671126|FG000|Overall Study|Adverse Event|5|||
164631011|NCT04411472|594671127|FG001|Overall Study|Adverse Event|10|||
164631012|NCT04411472|594671128|FG002|Overall Study|Adverse Event|1|||
164631013|NCT04411472|594671129|FG003|Overall Study|Adverse Event|0|||
164631014|NCT04411472|594671130|FG004|Overall Study|Adverse Event|0|||
164631015|NCT04411472|594671131|FG005|Overall Study|Adverse Event|0|||
164631016|NCT04411472|594671126|FG000|Overall Study|Protocol Violation|1|||
164631017|NCT04411472|594671127|FG001|Overall Study|Protocol Violation|0|||
164631018|NCT04411472|594671128|FG002|Overall Study|Protocol Violation|0|||
164631019|NCT04411472|594671129|FG003|Overall Study|Protocol Violation|0|||
164631020|NCT04411472|594671130|FG004|Overall Study|Protocol Violation|0|||
164631021|NCT04411472|594671131|FG005|Overall Study|Protocol Violation|0|||
164631022|NCT04411472|594671126|FG000|Overall Study|Withdrawal by Subject|0|||
164631023|NCT04411472|594671127|FG001|Overall Study|Withdrawal by Subject|1|||
164631024|NCT04411472|594671128|FG002|Overall Study|Withdrawal by Subject|0|||
164631025|NCT04411472|594671129|FG003|Overall Study|Withdrawal by Subject|1|||
164631026|NCT04411472|594671130|FG004|Overall Study|Withdrawal by Subject|0|||
164631027|NCT04411472|594671131|FG005|Overall Study|Withdrawal by Subject|0|||
164631028|NCT04411472|594671126|FG000|Overall Study|Physician Decision|1|||
164631029|NCT04411472|594671127|FG001|Overall Study|Physician Decision|0|||
164631030|NCT04411472|594671128|FG002|Overall Study|Physician Decision|0|||
164631031|NCT04411472|594671129|FG003|Overall Study|Physician Decision|0|||
164631032|NCT04411472|594671130|FG004|Overall Study|Physician Decision|0|||
164631033|NCT04411472|594671131|FG005|Overall Study|Physician Decision|0|||
164631034|NCT04411472|594671126|FG000|Overall Study|Study terminated by sponsor|17|||
164631035|NCT04411472|594671127|FG001|Overall Study|Study terminated by sponsor|20|||
164631036|NCT04411472|594671128|FG002|Overall Study|Study terminated by sponsor|3|||
164631037|NCT04411472|594671129|FG003|Overall Study|Study terminated by sponsor|0|||
164631038|NCT04411472|594671130|FG004|Overall Study|Study terminated by sponsor|0|||
164631039|NCT04411472|594671131|FG005|Overall Study|Study terminated by sponsor|0|||
164631040|NCT00440232|594671132|FG000|Overall Study|Lost to Follow-up|1|||
164631041|NCT00440232|594671133|FG001|Overall Study|Lost to Follow-up|1|||
164631042|NCT00440232|594671132|FG000|Overall Study|Unable to treat within allowed time|0|||
164631043|NCT00440232|594671133|FG001|Overall Study|Unable to treat within allowed time|1|||
164631044|NCT00440232|594671132|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
164631045|NCT00440232|594671133|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
164631046|NCT00362297|594671134|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
164631047|NCT00362297|594671135|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
164631048|NCT00819052|594671136|FG000|Overall Study|Adverse Event|0|||
164631049|NCT00819052|594671137|FG001|Overall Study|Adverse Event|5|||
164631050|NCT00819052|594671136|FG000|Overall Study|Protocol Violation|1|||
164631051|NCT00819052|594671137|FG001|Overall Study|Protocol Violation|2|||
164631052|NCT00819052|594671136|FG000|Overall Study|Lost to Follow-up|1|||
164631053|NCT00819052|594671137|FG001|Overall Study|Lost to Follow-up|2|||
164631054|NCT00819052|594671136|FG000|Overall Study|Withdrawal by Subject|1|||
164631055|NCT00819052|594671137|FG001|Overall Study|Withdrawal by Subject|2|||
164631056|NCT00819052|594671136|FG000|Overall Study|Lack of Efficacy|1|||
164631057|NCT00819052|594671137|FG001|Overall Study|Lack of Efficacy|1|||
164631058|NCT00819052|594671136|FG000|Overall Study|Pregnancy|1|||
164631059|NCT00819052|594671137|FG001|Overall Study|Pregnancy|2|||
164631060|NCT00819052|594671136|FG000|Overall Study|Death or events leading to death|1|||
164631061|NCT00819052|594671137|FG001|Overall Study|Death or events leading to death|0|||
164631062|NCT00982111|594671142|FG000|Overall Study|Adverse Event|1|||
164631063|NCT00982111|594671143|FG001|Overall Study|Adverse Event|1|||
164631064|NCT00982111|594671142|FG000|Overall Study|Progressive Disease|46|||
164631065|NCT00982111|594671143|FG001|Overall Study|Progressive Disease|39|||
164631066|NCT00982111|594671142|FG000|Overall Study|Lost to Follow-up|9|||
164631067|NCT00982111|594671143|FG001|Overall Study|Lost to Follow-up|6|||
164631068|NCT00982111|594671142|FG000|Overall Study|New Anti-Cancer Therapy|5|||
164631069|NCT00982111|594671143|FG001|Overall Study|New Anti-Cancer Therapy|5|||
164631070|NCT00982111|594671142|FG000|Overall Study|Medical Decision|1|||
164631071|NCT00982111|594671143|FG001|Overall Study|Medical Decision|0|||
164631072|NCT00982111|594671142|FG000|Overall Study|Withdrawal by Subject|17|||
164631073|NCT00982111|594671143|FG001|Overall Study|Withdrawal by Subject|19|||
164631074|NCT00982111|594671142|FG000|Overall Study|Global Study End|0|||
164631075|NCT00982111|594671143|FG001|Overall Study|Global Study End|1|||
164631076|NCT00982111|594671142|FG000|Overall Study|Sponsor's Decision|0|||
164631077|NCT00982111|594671143|FG001|Overall Study|Sponsor's Decision|1|||
164631078|NCT03769753|594671144|FG000|Overall Study|Not Treated|6|||
164631079|NCT03769753|594671144|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
164631080|NCT00489216|594671149|FG000|Overall Study|Adverse Event|1|||
164631081|NCT00422942|594671152|FG000|Overall Study|Study terminated by Sponsor|3|||
164631082|NCT01513460|594671159|FG000|Overall Study|Death|0|||
164631083|NCT01513460|594671160|FG001|Overall Study|Death|0|||
164631084|NCT01513460|594671161|FG002|Overall Study|Death|1|||
164631085|NCT01513460|594671159|FG000|Overall Study|Lost to Follow-up|0|||
164631086|NCT01513460|594671160|FG001|Overall Study|Lost to Follow-up|0|||
164631087|NCT01513460|594671161|FG002|Overall Study|Lost to Follow-up|2|||
164631088|NCT01513460|594671159|FG000|Overall Study|Abnormal laboratory value|1|||
164631089|NCT01513460|594671160|FG001|Overall Study|Abnormal laboratory value|0|||
164631090|NCT01513460|594671161|FG002|Overall Study|Abnormal laboratory value|1|||
164631091|NCT01513460|594671159|FG000|Overall Study|Lack of Efficacy|1|||
164631092|NCT01513460|594671160|FG001|Overall Study|Lack of Efficacy|2|||
164631093|NCT01513460|594671161|FG002|Overall Study|Lack of Efficacy|5|||
164631094|NCT01513460|594671159|FG000|Overall Study|Protocol deviations|3|||
164631095|NCT01513460|594671160|FG001|Overall Study|Protocol deviations|4|||
164631096|NCT01513460|594671161|FG002|Overall Study|Protocol deviations|3|||
164631097|NCT01513460|594671159|FG000|Overall Study|Withdrawal by Subject|7|||
164631098|NCT01513460|594671160|FG001|Overall Study|Withdrawal by Subject|8|||
164631099|NCT01513460|594671161|FG002|Overall Study|Withdrawal by Subject|21|||
164631100|NCT01513460|594671159|FG000|Overall Study|Adverse Event|16|||
164631101|NCT01513460|594671160|FG001|Overall Study|Adverse Event|18|||
164631102|NCT01513460|594671161|FG002|Overall Study|Adverse Event|23|||
164631103|NCT01513460|594671159|FG000|Overall Study|Abnormal test procedure|1|||
164631104|NCT01513460|594671160|FG001|Overall Study|Abnormal test procedure|0|||
164631105|NCT01513460|594671161|FG002|Overall Study|Abnormal test procedure|0|||
164631106|NCT00965458|594673452|FG000|Overall Study|Adverse Event|1|||
164631107|NCT00965458|594673453|FG001|Overall Study|Adverse Event|0|||
164631108|NCT00965458|594673452|FG000|Overall Study|Lost to Follow-up|1|||
164631109|NCT00965458|594673453|FG001|Overall Study|Lost to Follow-up|3|||
164631110|NCT00965458|594673452|FG000|Overall Study|Withdrawal by Subject|0|||
164631111|NCT00965458|594673453|FG001|Overall Study|Withdrawal by Subject|1|||
164631112|NCT01545375|594673455|FG000|Overall Study|Adverse Event|2|||
164631113|NCT01545375|594673456|FG001|Overall Study|Adverse Event|1|||
164631114|NCT01545375|594673455|FG000|Overall Study|Lost to Follow-up|34|||
164631115|NCT01545375|594673456|FG001|Overall Study|Lost to Follow-up|31|||
164631116|NCT01545375|594673455|FG000|Overall Study|Protocol Violation|3|||
164631117|NCT01545375|594673456|FG001|Overall Study|Protocol Violation|3|||
164631118|NCT01545375|594673455|FG000|Overall Study|Withdrawal by Subject|58|||
164631119|NCT01545375|594673456|FG001|Overall Study|Withdrawal by Subject|55|||
164631120|NCT04177862|594673458|FG000|Overall Study|Protocol Violation|2|||
164631121|NCT04177862|594673459|FG001|Overall Study|Protocol Violation|7|||
164631122|NCT01846039|594673460|FG000|Overall Study|Protocol Violation|1|||
164631123|NCT01846039|594673460|FG000|Overall Study|Subject Withdrew Consent|1|||
164631124|NCT00594958|594673461|FG000|Overall Study|Withdrawal by Subject|1|||
164631125|NCT00594958|594673462|FG001|Overall Study|Withdrawal by Subject|0|||
164631126|NCT00594958|594673463|FG002|Overall Study|Withdrawal by Subject|1|||
164631127|NCT00594958|594673461|FG000|Overall Study|Adverse Event|4|||
164631128|NCT00594958|594673462|FG001|Overall Study|Adverse Event|1|||
164631129|NCT00594958|594673463|FG002|Overall Study|Adverse Event|2|||
164631130|NCT00594958|594673461|FG000|Overall Study|Pregnancy|0|||
164631131|NCT00594958|594673462|FG001|Overall Study|Pregnancy|2|||
164631132|NCT00594958|594673463|FG002|Overall Study|Pregnancy|0|||
164631133|NCT00594958|594673461|FG000|Overall Study|Protocol Violation|1|||
164631134|NCT00594958|594673462|FG001|Overall Study|Protocol Violation|0|||
164631135|NCT00594958|594673463|FG002|Overall Study|Protocol Violation|2|||
164631136|NCT00594958|594673461|FG000|Overall Study|Lost to Follow-up|5|||
164631137|NCT00594958|594673462|FG001|Overall Study|Lost to Follow-up|0|||
164631138|NCT00594958|594673463|FG002|Overall Study|Lost to Follow-up|3|||
164631139|NCT00594958|594673461|FG000|Overall Study|administrative|3|||
164631140|NCT00594958|594673462|FG001|Overall Study|administrative|0|||
164631141|NCT00594958|594673463|FG002|Overall Study|administrative|2|||
164631142|NCT05637515|594673464|FG000|Overall Study|Withdrawal by Subject|17|||
164631143|NCT05637515|594673465|FG001|Overall Study|Withdrawal by Subject|17|||
164631144|NCT03233009|594673466|FG000|Overall Study|Lost to Follow-up|1|||
164631145|NCT04516291|594673468|FG000|Treatment Period (24 Weeks)|Other|1|||
164631146|NCT04516291|594673469|FG001|Treatment Period (24 Weeks)|Other|0|||
164631147|NCT04516291|594673470|FG002|Treatment Period (24 Weeks)|Other|0|||
164631148|NCT04516291|594673471|FG003|Treatment Period (24 Weeks)|Other|2|||
164631149|NCT04516291|594673472|FG004|Treatment Period (24 Weeks)|Other|2|||
164631150|NCT04516291|594673473|FG005|Treatment Period (24 Weeks)|Other|4|||
164631151|NCT04516291|594673474|FG006|Treatment Period (24 Weeks)|Other|2|||
164631152|NCT04516291|594673475|FG007|Treatment Period (24 Weeks)|Other|0|||
164631153|NCT04516291|594673468|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164631154|NCT04516291|594673469|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
164631155|NCT04516291|594673470|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
164631156|NCT04516291|594673471|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164631157|NCT04516291|594673472|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
164631158|NCT04516291|594673473|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164631159|NCT04516291|594673474|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164631160|NCT04516291|594673475|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164631161|NCT04516291|594673468|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
164631162|NCT04516291|594673469|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
164631163|NCT04516291|594673470|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
164631164|NCT04516291|594673471|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
164631165|NCT04516291|594673472|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
164631166|NCT04516291|594673473|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
164631167|NCT04516291|594673474|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
164631168|NCT04516291|594673475|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
164528675|NCT02054520|594305843|FG002|Overall Study|Adverse Event|2|||
164528676|NCT02054520|594305844|FG003|Overall Study|Adverse Event|1|||
164528677|NCT02054520|594305845|FG004|Overall Study|Adverse Event|1|||
164528678|NCT02054520|594305846|FG005|Overall Study|Adverse Event|0|||
164528679|NCT02054520|594305841|FG000|Overall Study|Lack of Efficacy|7|||
164528680|NCT02054520|594305842|FG001|Overall Study|Lack of Efficacy|0|||
164528681|NCT02054520|594305843|FG002|Overall Study|Lack of Efficacy|2|||
164528682|NCT02054520|594305844|FG003|Overall Study|Lack of Efficacy|1|||
164528683|NCT02054520|594305845|FG004|Overall Study|Lack of Efficacy|3|||
164528684|NCT02054520|594305846|FG005|Overall Study|Lack of Efficacy|2|||
164528685|NCT02054520|594305841|FG000|Overall Study|Withdrawal by Subject|1|||
164528686|NCT02054520|594305842|FG001|Overall Study|Withdrawal by Subject|0|||
164528687|NCT02054520|594305843|FG002|Overall Study|Withdrawal by Subject|0|||
164528688|NCT02054520|594305844|FG003|Overall Study|Withdrawal by Subject|2|||
164528689|NCT02054520|594305845|FG004|Overall Study|Withdrawal by Subject|1|||
164528690|NCT02054520|594305846|FG005|Overall Study|Withdrawal by Subject|0|||
164528691|NCT02054520|594305841|FG000|Overall Study|Physician Decision|0|||
164528692|NCT02054520|594305842|FG001|Overall Study|Physician Decision|1|||
164528693|NCT02054520|594305843|FG002|Overall Study|Physician Decision|0|||
164528694|NCT02054520|594305844|FG003|Overall Study|Physician Decision|1|||
164528695|NCT02054520|594305845|FG004|Overall Study|Physician Decision|0|||
164528696|NCT02054520|594305846|FG005|Overall Study|Physician Decision|1|||
164528697|NCT02054520|594305841|FG000|Overall Study|Study terminated by Sponsor|0|||
164528698|NCT02054520|594305842|FG001|Overall Study|Study terminated by Sponsor|0|||
164528699|NCT02054520|594305843|FG002|Overall Study|Study terminated by Sponsor|2|||
164528700|NCT02054520|594305844|FG003|Overall Study|Study terminated by Sponsor|1|||
164528701|NCT02054520|594305845|FG004|Overall Study|Study terminated by Sponsor|0|||
164528702|NCT02054520|594305846|FG005|Overall Study|Study terminated by Sponsor|0|||
164528703|NCT02027623|594305847|FG000|Overall Study|Lost to Follow-up|3|||
164528704|NCT02027623|594305848|FG001|Overall Study|Lost to Follow-up|3|||
164528705|NCT02027623|594305847|FG000|Overall Study|Withdrawal by Subject|6|||
164528706|NCT02027623|594305848|FG001|Overall Study|Withdrawal by Subject|9|||
164528707|NCT00031551|594307696|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
164528708|NCT00031551|594307697|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
164528709|NCT00876928|594307702|FG000|Overall Study|Lost to Follow-up|2|||
164528710|NCT00876928|594307703|FG001|Overall Study|Lost to Follow-up|5|||
164528711|NCT00876928|594307702|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
164528712|NCT00876928|594307703|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
164528713|NCT01171807|594307704|FG000|Overall Study|Treatment failure|2|||
164528714|NCT01171807|594307705|FG001|Overall Study|Treatment failure|4|||
164528715|NCT01171807|594307704|FG000|Overall Study|Non compliance|1|||
164528716|NCT01171807|594307705|FG001|Overall Study|Non compliance|0|||
164528717|NCT01171807|594307704|FG000|Overall Study|Lost to Follow-up|3|||
164528718|NCT01171807|594307705|FG001|Overall Study|Lost to Follow-up|0|||
164528719|NCT02563522|594307707|FG000|Overall Study|Adverse Event|2|||
164631169|NCT04516291|594673468|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164631170|NCT04516291|594673469|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
164631171|NCT04516291|594673470|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164631172|NCT04516291|594673471|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164631173|NCT04516291|594673472|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164631174|NCT04516291|594673473|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164631175|NCT04516291|594673474|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164631176|NCT04516291|594673475|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164631177|NCT04516291|594673468|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
164631178|NCT04516291|594673469|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
164631179|NCT04516291|594673470|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
164631180|NCT04516291|594673471|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
164631181|NCT04516291|594673472|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
164631182|NCT04516291|594673473|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
164631183|NCT04516291|594673474|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
164631184|NCT04516291|594673475|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
164631185|NCT04516291|594673468|FG000|Follow-up Period (12 Weeks)|Other|0|||
164631186|NCT04516291|594673469|FG001|Follow-up Period (12 Weeks)|Other|1|||
164631187|NCT04516291|594673470|FG002|Follow-up Period (12 Weeks)|Other|0|||
164631188|NCT04516291|594673471|FG003|Follow-up Period (12 Weeks)|Other|2|||
164631189|NCT04516291|594673472|FG004|Follow-up Period (12 Weeks)|Other|0|||
164631190|NCT04516291|594673473|FG005|Follow-up Period (12 Weeks)|Other|0|||
164631191|NCT04516291|594673474|FG006|Follow-up Period (12 Weeks)|Other|0|||
164631192|NCT04516291|594673475|FG007|Follow-up Period (12 Weeks)|Other|0|||
164631193|NCT04516291|594673468|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
164631194|NCT04516291|594673469|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
164631195|NCT04516291|594673470|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
164631196|NCT04516291|594673471|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
164631197|NCT04516291|594673472|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
164631198|NCT04516291|594673473|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
164631199|NCT04516291|594673474|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
164631200|NCT04516291|594673475|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
164631201|NCT04516291|594673468|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
164631202|NCT04516291|594673469|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
164631203|NCT04516291|594673470|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
164631204|NCT04516291|594673471|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
164631205|NCT04516291|594673472|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
164631206|NCT04516291|594673473|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
164631207|NCT04516291|594673474|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
164631208|NCT04516291|594673475|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
164631209|NCT01855607|594673476|FG000|Overall Study|Withdrawal by Subject|1|||
164631210|NCT01855607|594673476|FG000|Overall Study|Study was terminated|11|||
164631211|NCT02181634|594673477|FG000|Overall Study|Lack of Efficacy|33|||
164631212|NCT02181634|594673477|FG000|Overall Study|Adverse Event|17|||
164631213|NCT02181634|594673477|FG000|Overall Study|Physician Decision|8|||
164631214|NCT02181634|594673477|FG000|Overall Study|Withdrawal by Subject|5|||
164631215|NCT02181634|594673477|FG000|Overall Study|Death|2|||
164631216|NCT02181634|594673477|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
164631217|NCT02181634|594673477|FG000|Overall Study|Ineligible|1|||
164631218|NCT02181634|594673477|FG000|Overall Study|Max number of dose reduction|1|||
164631219|NCT02181634|594673477|FG000|Overall Study|Symptomatic progression|1|||
164631220|NCT02181634|594673477|FG000|Overall Study|Patient opted to proceed to surgery|1|||
164631221|NCT03824704|594673483|FG000|Overall Study|Study Terminated by Sponsor|1|||
164631222|NCT02155660|594673491|FG000|Overall Study|Other Reason|8|||
164631223|NCT02155660|594673492|FG001|Overall Study|Other Reason|6|||
164631224|NCT02155660|594673493|FG002|Overall Study|Other Reason|10|||
164631225|NCT02155660|594673494|FG003|Overall Study|Other Reason|10|||
164631226|NCT02155660|594673491|FG000|Overall Study|Study-specific withdrawal criteria|0|||
164631227|NCT02155660|594673492|FG001|Overall Study|Study-specific withdrawal criteria|1|||
164631228|NCT02155660|594673493|FG002|Overall Study|Study-specific withdrawal criteria|1|||
164631229|NCT02155660|594673494|FG003|Overall Study|Study-specific withdrawal criteria|1|||
164631230|NCT02155660|594673491|FG000|Overall Study|Severe non-compliance|0|||
164631231|NCT02155660|594673492|FG001|Overall Study|Severe non-compliance|4|||
164631232|NCT02155660|594673493|FG002|Overall Study|Severe non-compliance|0|||
164631233|NCT02155660|594673494|FG003|Overall Study|Severe non-compliance|1|||
164631234|NCT02155660|594673491|FG000|Overall Study|Adverse Event|2|||
164631235|NCT02155660|594673492|FG001|Overall Study|Adverse Event|6|||
164631236|NCT02155660|594673493|FG002|Overall Study|Adverse Event|3|||
164631237|NCT02155660|594673494|FG003|Overall Study|Adverse Event|1|||
164631238|NCT02155660|594673491|FG000|Overall Study|Lost to Follow-up|3|||
164631239|NCT02155660|594673492|FG001|Overall Study|Lost to Follow-up|6|||
164631240|NCT02155660|594673493|FG002|Overall Study|Lost to Follow-up|5|||
164631241|NCT02155660|594673494|FG003|Overall Study|Lost to Follow-up|8|||
164631242|NCT02155660|594673491|FG000|Overall Study|Death|17|||
164631243|NCT02155660|594673492|FG001|Overall Study|Death|19|||
164631244|NCT02155660|594673493|FG002|Overall Study|Death|17|||
164631245|NCT02155660|594673494|FG003|Overall Study|Death|19|||
164631246|NCT02155660|594673491|FG000|Overall Study|Withdrawal by Subject|28|||
164631247|NCT02155660|594673492|FG001|Overall Study|Withdrawal by Subject|31|||
164631248|NCT02155660|594673493|FG002|Overall Study|Withdrawal by Subject|24|||
164631249|NCT02155660|594673494|FG003|Overall Study|Withdrawal by Subject|21|||
164631250|NCT03730987|594673495|FG000|Overall Study|Lost to Follow-up|2|||
164631251|NCT03730987|594673496|FG001|Overall Study|Lost to Follow-up|0|||
164631252|NCT03730987|594673497|FG002|Overall Study|Lost to Follow-up|2|||
164631253|NCT03730987|594673498|FG003|Overall Study|Lost to Follow-up|0|||
164631254|NCT02087085|594673499|FG000|Overall Study|Adverse Event|10|||
164631255|NCT02087085|594673500|FG001|Overall Study|Adverse Event|14|||
164631256|NCT02087085|594673499|FG000|Overall Study|Lack of Efficacy|4|||
164631257|NCT02087085|594673500|FG001|Overall Study|Lack of Efficacy|3|||
164631258|NCT02087085|594673499|FG000|Overall Study|Lost to Follow-up|6|||
164631259|NCT02087085|594673500|FG001|Overall Study|Lost to Follow-up|4|||
164631260|NCT02087085|594673499|FG000|Overall Study|Withdrawal by Subject|9|||
164631261|NCT02087085|594673500|FG001|Overall Study|Withdrawal by Subject|11|||
164631262|NCT02087085|594673499|FG000|Overall Study|Protocol Violation|1|||
164631263|NCT02087085|594673500|FG001|Overall Study|Protocol Violation|0|||
164631264|NCT02087085|594673499|FG000|Overall Study|Study Terminated by Sponsor|87|||
164631265|NCT02087085|594673500|FG001|Overall Study|Study Terminated by Sponsor|80|||
164631266|NCT02087085|594673499|FG000|Overall Study|Other Miscellaneous Reasons|3|||
164631267|NCT02087085|594673500|FG001|Overall Study|Other Miscellaneous Reasons|4|||
164631268|NCT02505945|594673501|FG000|Overall Study|Withdrawal by Subject|13|||
164631269|NCT02505945|594673502|FG001|Overall Study|Withdrawal by Subject|2|||
164631270|NCT02505945|594673501|FG000|Overall Study|Adverse Event|1|||
164631271|NCT02505945|594673502|FG001|Overall Study|Adverse Event|0|||
164631272|NCT02505945|594673501|FG000|Overall Study|Physician Decision|2|||
164631273|NCT02505945|594673502|FG001|Overall Study|Physician Decision|1|||
164631274|NCT02505945|594673501|FG000|Overall Study|Lost to Follow-up|6|||
164631275|NCT02505945|594673502|FG001|Overall Study|Lost to Follow-up|1|||
164631276|NCT00635804|594673503|FG000|Overall Study|Adverse Event|0|||
164631277|NCT00635804|594673504|FG001|Overall Study|Adverse Event|0|||
164631278|NCT00635804|594673505|FG002|Overall Study|Adverse Event|0|||
164631279|NCT00635804|594673506|FG003|Overall Study|Adverse Event|0|||
164631280|NCT00635804|594673507|FG004|Overall Study|Adverse Event|0|||
164631281|NCT00635804|594673508|FG005|Overall Study|Adverse Event|1|||
164631282|NCT00635804|594673509|FG006|Overall Study|Adverse Event|0|||
164631283|NCT00635804|594673510|FG007|Overall Study|Adverse Event|0|||
164631284|NCT00635804|594673503|FG000|Overall Study|Withdrawal by Subject|1|||
164631285|NCT00635804|594673504|FG001|Overall Study|Withdrawal by Subject|0|||
164631286|NCT00635804|594673505|FG002|Overall Study|Withdrawal by Subject|0|||
164631287|NCT00635804|594673506|FG003|Overall Study|Withdrawal by Subject|0|||
164631288|NCT00635804|594673507|FG004|Overall Study|Withdrawal by Subject|0|||
164631289|NCT00635804|594673508|FG005|Overall Study|Withdrawal by Subject|0|||
164631290|NCT00635804|594673509|FG006|Overall Study|Withdrawal by Subject|0|||
164631291|NCT00635804|594673510|FG007|Overall Study|Withdrawal by Subject|0|||
164631292|NCT01425268|594673518|FG000|Overall Study|Withdrawal by Subject|2|||
164631293|NCT01425268|594673519|FG001|Overall Study|Withdrawal by Subject|0|||
164631294|NCT01425268|594673518|FG000|Overall Study|Sponsor Decision|5|||
164631295|NCT01425268|594673519|FG001|Overall Study|Sponsor Decision|0|||
164631296|NCT01425268|594673518|FG000|Overall Study|Physician Decision|1|||
164631297|NCT01425268|594673519|FG001|Overall Study|Physician Decision|0|||
164631298|NCT00719706|594673520|FG000|Overall Study|Adverse Event|5|||
164631299|NCT00719706|594673521|FG001|Overall Study|Adverse Event|4|||
164631300|NCT00719706|594673520|FG000|Overall Study|Withdrawal by Subject|1|||
164631301|NCT00719706|594673521|FG001|Overall Study|Withdrawal by Subject|2|||
164631302|NCT00719706|594673520|FG000|Overall Study|Protocol Violation|3|||
164631303|NCT00719706|594673521|FG001|Overall Study|Protocol Violation|0|||
164631304|NCT02681094|594673522|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
164631305|NCT02681094|594673523|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
164631306|NCT02681094|594673524|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
164631307|NCT02681094|594673522|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
164631308|NCT02681094|594673523|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
164631309|NCT02681094|594673524|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
164631310|NCT02681094|594673522|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
164631311|NCT02681094|594673523|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
164631312|NCT02681094|594673524|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
164631313|NCT02681094|594673522|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
164631314|NCT02681094|594673523|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
164631315|NCT02681094|594673524|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
164631316|NCT02681094|594673522|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
164631317|NCT02681094|594673523|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
164631318|NCT02681094|594673524|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
164631319|NCT02681094|594673522|FG000|1 -Modified Enrolled Participants Set|Other|6|||
164631320|NCT02681094|594673523|FG001|1 -Modified Enrolled Participants Set|Other|6|||
164631321|NCT02681094|594673524|FG002|1 -Modified Enrolled Participants Set|Other|7|||
164631322|NCT02681094|594673522|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
164631323|NCT02681094|594673523|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
164631324|NCT02681094|594673524|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
164631325|NCT02681094|594673522|FG000|2 - Enrolled Participants Set|Participant decision|7|||
164631326|NCT02681094|594673523|FG001|2 - Enrolled Participants Set|Participant decision|10|||
164631327|NCT02681094|594673524|FG002|2 - Enrolled Participants Set|Participant decision|9|||
164631328|NCT02681094|594673522|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
164631329|NCT02681094|594673523|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
164631330|NCT02681094|594673524|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
164631331|NCT02681094|594673522|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
164631332|NCT02681094|594673523|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
164631333|NCT02681094|594673524|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
164631334|NCT02681094|594673522|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
164631335|NCT02681094|594673523|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
164631336|NCT02681094|594673524|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
164631337|NCT02681094|594673522|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
164631338|NCT02681094|594673523|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
164631339|NCT02681094|594673524|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
164631340|NCT02681094|594673522|FG000|2 - Enrolled Participants Set|Other|6|||
164631341|NCT02681094|594673523|FG001|2 - Enrolled Participants Set|Other|6|||
164631342|NCT02681094|594673524|FG002|2 - Enrolled Participants Set|Other|7|||
164631343|NCT02681094|594673522|FG000|2 - Enrolled Participants Set|No treatment given|0|||
164631344|NCT02681094|594673523|FG001|2 - Enrolled Participants Set|No treatment given|1|||
164631345|NCT02681094|594673524|FG002|2 - Enrolled Participants Set|No treatment given|1|||
164631346|NCT01072175|594673525|FG000|Part A (Drug-Drug Interaction)|Death|1|||
164631347|NCT01072175|594673526|FG001|Part A (Drug-Drug Interaction)|Death|0|||
164631348|NCT01072175|594673527|FG002|Part A (Drug-Drug Interaction)|Death|0|||
164631349|NCT01072175|594673528|FG003|Part A (Drug-Drug Interaction)|Death|0|||
164631350|NCT01072175|594673529|FG004|Part A (Drug-Drug Interaction)|Death|0|||
164631351|NCT01072175|594673530|FG005|Part A (Drug-Drug Interaction)|Death|0|||
164631352|NCT01072175|594673531|FG006|Part A (Drug-Drug Interaction)|Death|0|||
164631353|NCT01072175|594673532|FG007|Part A (Drug-Drug Interaction)|Death|0|||
164631354|NCT01072175|594673533|FG008|Part A (Drug-Drug Interaction)|Death|0|||
164631355|NCT01072175|594673534|FG009|Part A (Drug-Drug Interaction)|Death|0|||
164631356|NCT01072175|594673535|FG010|Part A (Drug-Drug Interaction)|Death|0|||
164631357|NCT01072175|594673536|FG011|Part A (Drug-Drug Interaction)|Death|0|||
164631358|NCT01072175|594673537|FG012|Part A (Drug-Drug Interaction)|Death|0|||
164631359|NCT01072175|594673525|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
164631360|NCT01072175|594673526|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
164631361|NCT01072175|594673527|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
164631362|NCT01072175|594673528|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
164631363|NCT01072175|594673529|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
164631364|NCT01072175|594673530|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
164631365|NCT01072175|594673531|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
164631366|NCT01072175|594673532|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
164631367|NCT01072175|594673533|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
164631368|NCT01072175|594673534|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
164631369|NCT01072175|594673535|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
164631370|NCT01072175|594673536|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
164631371|NCT01072175|594673537|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
164631372|NCT01072175|594673525|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
164631373|NCT01072175|594673526|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
164631374|NCT01072175|594673527|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
164631375|NCT01072175|594673528|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
164631376|NCT01072175|594673529|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
164631377|NCT01072175|594673530|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
164631378|NCT01072175|594673531|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
164631379|NCT01072175|594673532|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
164631380|NCT01072175|594673533|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
164631381|NCT01072175|594673534|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
164631382|NCT01072175|594673535|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
164631383|NCT01072175|594673536|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
164631384|NCT01072175|594673537|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
164631385|NCT01072175|594673525|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
164631386|NCT01072175|594673526|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
164631387|NCT01072175|594673527|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
164631388|NCT01072175|594673528|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
164631389|NCT01072175|594673529|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
164631390|NCT01072175|594673530|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
164631391|NCT01072175|594673531|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
164631392|NCT01072175|594673532|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
164631393|NCT01072175|594673533|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
164631394|NCT01072175|594673534|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
164631395|NCT01072175|594673535|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
164631396|NCT01072175|594673536|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
164631397|NCT01072175|594673537|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
164631398|NCT01072175|594673525|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
164631399|NCT01072175|594673526|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
164631400|NCT01072175|594673527|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
164631401|NCT01072175|594673528|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
164631402|NCT01072175|594673529|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
164631403|NCT01072175|594673530|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
164631404|NCT01072175|594673531|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
164631405|NCT01072175|594673532|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
164631406|NCT01072175|594673533|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
164631407|NCT01072175|594673534|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
164631408|NCT01072175|594673535|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
164631409|NCT01072175|594673536|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
164631410|NCT01072175|594673537|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
164631411|NCT01072175|594673525|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
164631412|NCT01072175|594673526|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
164631413|NCT01072175|594673527|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
164631414|NCT01072175|594673528|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
164631415|NCT01072175|594673529|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
164631416|NCT01072175|594673530|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
164631417|NCT01072175|594673531|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
164631418|NCT01072175|594673532|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
164631419|NCT01072175|594673533|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
164631420|NCT01072175|594673534|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
164631421|NCT01072175|594673535|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
164631422|NCT01072175|594673536|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
164631423|NCT01072175|594673537|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
164631424|NCT01072175|594673525|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
164631425|NCT01072175|594673526|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
164631426|NCT01072175|594673527|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
164631427|NCT01072175|594673528|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
164631428|NCT01072175|594673529|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
164631429|NCT01072175|594673530|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
164631430|NCT01072175|594673531|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
164631431|NCT01072175|594673532|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
164631432|NCT01072175|594673533|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
164631433|NCT01072175|594673534|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
164631434|NCT01072175|594673535|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
164631435|NCT01072175|594673536|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
164631436|NCT01072175|594673537|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
164631437|NCT01072175|594673525|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
164631438|NCT01072175|594673526|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
164631439|NCT01072175|594673527|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
164631440|NCT01072175|594673528|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
164631441|NCT01072175|594673529|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
164631442|NCT01072175|594673530|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
164631443|NCT01072175|594673531|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
164631444|NCT01072175|594673532|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
164631445|NCT01072175|594673533|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
164631446|NCT01072175|594673534|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
164631447|NCT01072175|594673535|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
164631448|NCT01072175|594673536|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
164631449|NCT01072175|594673537|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
164528720|NCT02563522|594307708|FG001|Overall Study|Adverse Event|3|||
164528721|NCT02563522|594307707|FG000|Overall Study|Lost to Follow-up|1|||
164528722|NCT02563522|594307708|FG001|Overall Study|Lost to Follow-up|0|||
164528723|NCT02563522|594307707|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
164528724|NCT02563522|594307708|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
164528725|NCT04874415|594307711|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
164528726|NCT04874415|594307712|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
164528727|NCT04874415|594307713|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
164528728|NCT04874415|594307714|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
164528729|NCT04874415|594307715|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
164528730|NCT04874415|594307716|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
164528731|NCT04874415|594307717|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
164528732|NCT04874415|594307718|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
164528733|NCT04874415|594307719|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
164528734|NCT04874415|594307720|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
164528735|NCT04874415|594307721|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
164528736|NCT04874415|594307722|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
164528737|NCT04874415|594307723|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
164528738|NCT04874415|594307724|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
164528739|NCT04874415|594307725|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
164528740|NCT04874415|594307726|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
164528741|NCT04874415|594307711|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
164528742|NCT04874415|594307712|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
164528743|NCT04874415|594307713|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
164528744|NCT04874415|594307714|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
164528745|NCT04874415|594307715|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
164528746|NCT04874415|594307716|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
164528747|NCT04874415|594307717|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
164528748|NCT04874415|594307718|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
164528749|NCT04874415|594307719|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
164631450|NCT01072175|594673525|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
164631451|NCT01072175|594673526|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
164631452|NCT01072175|594673527|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
164631453|NCT01072175|594673528|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
164631454|NCT01072175|594673529|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
164631455|NCT01072175|594673530|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
164631456|NCT01072175|594673531|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
164631457|NCT01072175|594673532|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
164631458|NCT01072175|594673533|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
164631459|NCT01072175|594673534|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
164631460|NCT01072175|594673535|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
164631461|NCT01072175|594673536|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
164631462|NCT01072175|594673537|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
164631463|NCT01072175|594673525|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
164631464|NCT01072175|594673526|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
164631465|NCT01072175|594673527|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
164631466|NCT01072175|594673528|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
164631467|NCT01072175|594673529|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
164631468|NCT01072175|594673530|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
164631469|NCT01072175|594673531|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
164631470|NCT01072175|594673532|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
164631471|NCT01072175|594673533|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
164631472|NCT01072175|594673534|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
164631473|NCT01072175|594673535|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
164631474|NCT01072175|594673536|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
164631475|NCT01072175|594673537|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
164631476|NCT01072175|594673525|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
164631477|NCT01072175|594673526|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
164631478|NCT01072175|594673527|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
164631479|NCT01072175|594673528|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
164631480|NCT01072175|594673529|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
164631481|NCT01072175|594673530|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
164631482|NCT01072175|594673531|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
164631483|NCT01072175|594673532|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
164631484|NCT01072175|594673533|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
164631485|NCT01072175|594673534|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
164631486|NCT01072175|594673535|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
164631487|NCT01072175|594673536|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
164631488|NCT01072175|594673537|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
164631489|NCT01072175|594673525|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
164631490|NCT01072175|594673526|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
164631491|NCT01072175|594673527|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
164631492|NCT01072175|594673528|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
164631493|NCT01072175|594673529|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
164631494|NCT01072175|594673530|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
164631495|NCT01072175|594673531|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
164631496|NCT01072175|594673532|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
164631497|NCT01072175|594673533|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
164631498|NCT01072175|594673534|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
164631499|NCT01072175|594673535|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
164631500|NCT01072175|594673536|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
164631501|NCT01072175|594673537|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
164631502|NCT01072175|594673525|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
164631503|NCT01072175|594673526|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
164147707|NCT02006732|592902129|FG000|Overall Study|Lost to Follow-up|0|||
164631504|NCT01072175|594673527|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
164631505|NCT01072175|594673528|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
164631506|NCT01072175|594673529|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
164631507|NCT01072175|594673530|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
164631508|NCT01072175|594673531|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
164631509|NCT01072175|594673532|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
164631510|NCT01072175|594673533|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
164631511|NCT01072175|594673534|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
164631512|NCT01072175|594673535|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
164631513|NCT01072175|594673536|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
164631514|NCT01072175|594673537|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
164631515|NCT01072175|594673525|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
164631516|NCT01072175|594673526|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
164631517|NCT01072175|594673527|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
164631518|NCT01072175|594673528|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
164631519|NCT01072175|594673529|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
164631520|NCT01072175|594673530|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
164631521|NCT01072175|594673531|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
164631522|NCT01072175|594673532|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
164631523|NCT01072175|594673533|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
164631524|NCT01072175|594673534|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
164631525|NCT01072175|594673535|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
164631526|NCT01072175|594673536|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
164631527|NCT01072175|594673537|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
164631528|NCT01072175|594673525|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
164631529|NCT01072175|594673526|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
164631530|NCT01072175|594673527|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
164631531|NCT01072175|594673528|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
164631532|NCT01072175|594673529|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
164631533|NCT01072175|594673530|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
164631534|NCT01072175|594673531|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
164631535|NCT01072175|594673532|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
164631536|NCT01072175|594673533|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
164631537|NCT01072175|594673534|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
164631538|NCT01072175|594673535|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
164631539|NCT01072175|594673536|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
164631540|NCT01072175|594673537|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
164631541|NCT01072175|594673525|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
164631542|NCT01072175|594673526|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
164631543|NCT01072175|594673527|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
164631544|NCT01072175|594673528|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
164631545|NCT01072175|594673529|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
164631546|NCT01072175|594673530|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
164631547|NCT01072175|594673531|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
164631548|NCT01072175|594673532|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
164631549|NCT01072175|594673533|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
164631550|NCT01072175|594673534|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
164631551|NCT01072175|594673535|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
164631552|NCT01072175|594673536|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
164631553|NCT01072175|594673537|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
164631554|NCT01072175|594673525|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
164631555|NCT01072175|594673526|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
164631556|NCT01072175|594673527|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
164631557|NCT01072175|594673528|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
164631558|NCT01072175|594673529|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
164631559|NCT01072175|594673530|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
164631560|NCT01072175|594673531|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
164631561|NCT01072175|594673532|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
164631562|NCT01072175|594673533|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
164631563|NCT01072175|594673534|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
164631564|NCT01072175|594673535|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
164631565|NCT01072175|594673536|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
164528750|NCT04874415|594307720|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
164528751|NCT04874415|594307721|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
164528752|NCT04874415|594307722|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
164528753|NCT04874415|594307723|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
164528754|NCT04874415|594307724|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
164528755|NCT04874415|594307725|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
164528756|NCT04874415|594307726|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
164528757|NCT04874415|594307711|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
164528758|NCT04874415|594307712|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
164528759|NCT04874415|594307713|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
164528760|NCT04874415|594307714|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
164528761|NCT04874415|594307715|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
164528762|NCT04874415|594307716|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
164528763|NCT04874415|594307717|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
164528764|NCT04874415|594307718|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
164528765|NCT04874415|594307719|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
164528766|NCT04874415|594307720|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
164528767|NCT04874415|594307721|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
164528768|NCT04874415|594307722|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
164528769|NCT04874415|594307723|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
164528770|NCT04874415|594307724|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
164528771|NCT04874415|594307725|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
164528772|NCT04874415|594307726|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
164528773|NCT00848926|594307727|FG000|Treatment Period|Progressive disease|45|||
164528774|NCT00848926|594307727|FG000|Treatment Period|Adverse Event|20|||
164528775|NCT00848926|594307727|FG000|Treatment Period|Physician Decision|12|||
164528776|NCT00848926|594307727|FG000|Treatment Period|Withdrawal by Subject|7|||
164528777|NCT00848926|594307727|FG000|Follow-up Period|Lost to Follow-up|7|||
164528778|NCT00848926|594307727|FG000|Follow-up Period|Withdrawal by Subject|3|||
164528779|NCT00848926|594307727|FG000|Follow-up Period|Other|2|||
164528780|NCT04025580|594307728|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
164528781|NCT04025580|594307729|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
164528782|NCT04025580|594307730|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
164528783|NCT02216357|594307731|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
164528784|NCT02216357|594307732|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
164528785|NCT00235326|594307737|FG000|Overall Study|Lost to Follow-up|746|||
164528786|NCT00235326|594307738|FG001|Overall Study|Lost to Follow-up|1400|||
164528787|NCT01790126|594307741|FG000|Overall Study|PSA Progression|12|||
164528788|NCT01790126|594307742|FG001|Overall Study|PSA Progression|16|||
164528789|NCT01790126|594307743|FG002|Overall Study|PSA Progression|16|||
164528790|NCT01790126|594307741|FG000|Overall Study|Other|5|||
164528791|NCT01790126|594307742|FG001|Overall Study|Other|4|||
164528792|NCT01790126|594307743|FG002|Overall Study|Other|8|||
164528793|NCT01790126|594307741|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
164528794|NCT01790126|594307742|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
164528795|NCT01790126|594307743|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
164528796|NCT01790126|594307741|FG000|Overall Study|Withdrawal by Physician|1|||
164528797|NCT01790126|594307742|FG001|Overall Study|Withdrawal by Physician|1|||
164528798|NCT01790126|594307743|FG002|Overall Study|Withdrawal by Physician|2|||
164528799|NCT01790126|594307741|FG000|Overall Study|Withdrawal by Subject|3|||
164528800|NCT01790126|594307742|FG001|Overall Study|Withdrawal by Subject|1|||
164528801|NCT01790126|594307743|FG002|Overall Study|Withdrawal by Subject|2|||
164528802|NCT01790126|594307741|FG000|Overall Study|Lost to Follow-up|1|||
164528803|NCT01790126|594307742|FG001|Overall Study|Lost to Follow-up|0|||
164528804|NCT01790126|594307743|FG002|Overall Study|Lost to Follow-up|1|||
164528805|NCT01790126|594307741|FG000|Overall Study|Adverse Event|0|||
164528806|NCT01790126|594307742|FG001|Overall Study|Adverse Event|2|||
164528807|NCT01790126|594307743|FG002|Overall Study|Adverse Event|0|||
164528808|NCT01790126|594307741|FG000|Overall Study|Death|2|||
164528809|NCT01790126|594307742|FG001|Overall Study|Death|0|||
164528810|NCT01790126|594307743|FG002|Overall Study|Death|0|||
164528811|NCT01790126|594307741|FG000|Overall Study|Radiographic Progression|3|||
164528812|NCT01790126|594307742|FG001|Overall Study|Radiographic Progression|1|||
164528813|NCT01790126|594307743|FG002|Overall Study|Radiographic Progression|0|||
164528814|NCT01477333|594307744|FG000|Overall Study|Adverse Event|1|||
164528815|NCT01477333|594307744|FG000|Overall Study|Withdrawal by Subject|1|||
164528816|NCT01477333|594307744|FG000|Overall Study|Clinical Deterioration|1|||
164528817|NCT00455325|594307745|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
164528818|NCT00455325|594307746|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
164528819|NCT00455325|594307747|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
164528820|NCT00455325|594307748|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
164528821|NCT00455325|594307745|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
164528822|NCT00455325|594307746|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
164528823|NCT00455325|594307747|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
164528824|NCT00455325|594307748|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
164528825|NCT00455325|594307745|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
164528826|NCT00455325|594307746|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
164528827|NCT00455325|594307747|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
164528828|NCT00455325|594307748|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
164528829|NCT00455325|594307745|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
164528830|NCT00455325|594307746|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
164528831|NCT00455325|594307747|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
164528832|NCT00455325|594307748|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
164528833|NCT00455325|594307745|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
164528834|NCT00455325|594307746|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
164528835|NCT00455325|594307747|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
164528836|NCT00455325|594307748|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
164528837|NCT00455325|594307745|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
164528838|NCT00455325|594307746|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
164528839|NCT00455325|594307747|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
164528840|NCT00455325|594307748|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
164528841|NCT00455325|594307745|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
164528842|NCT00455325|594307746|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
164528843|NCT00455325|594307747|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
164528844|NCT00455325|594307748|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
164528845|NCT01178671|594307749|FG000|Overall Study|Adverse Event|4|||
164528846|NCT01178671|594307750|FG001|Overall Study|Adverse Event|6|||
164528847|NCT01178671|594307749|FG000|Overall Study|Protocol Violation|1|||
164528848|NCT01178671|594307750|FG001|Overall Study|Protocol Violation|1|||
164528849|NCT01178671|594307749|FG000|Overall Study|Lack of Efficacy|0|||
164528850|NCT01178671|594307750|FG001|Overall Study|Lack of Efficacy|1|||
164528851|NCT01178671|594307749|FG000|Overall Study|Lost to Follow-up|3|||
164528852|NCT01178671|594307750|FG001|Overall Study|Lost to Follow-up|1|||
164528853|NCT01178671|594307749|FG000|Overall Study|Physician Decision|4|||
164528854|NCT01178671|594307750|FG001|Overall Study|Physician Decision|6|||
164528855|NCT02435966|594307751|FG000|Overall Study|Withdrawal by Subject|0|||
164528856|NCT02435966|594307752|FG001|Overall Study|Withdrawal by Subject|1|||
164528857|NCT02435966|594307753|FG002|Overall Study|Withdrawal by Subject|0|||
164528858|NCT04620811|594307754|FG000|Overall Study|Withdrawal by Subject|18|||
164528859|NCT04620811|594307755|FG001|Overall Study|Withdrawal by Subject|15|||
164528860|NCT04620811|594307754|FG000|Overall Study|Adverse Event|6|||
164528861|NCT04620811|594307755|FG001|Overall Study|Adverse Event|11|||
164528862|NCT04620811|594307754|FG000|Overall Study|Lost to Follow-up|4|||
164528863|NCT04620811|594307755|FG001|Overall Study|Lost to Follow-up|8|||
164528864|NCT04620811|594307754|FG000|Overall Study|Physician Decision|1|||
164528865|NCT04620811|594307755|FG001|Overall Study|Physician Decision|4|||
164528866|NCT04620811|594307754|FG000|Overall Study|Sponsor Decision|0|||
164528867|NCT04620811|594307755|FG001|Overall Study|Sponsor Decision|1|||
164528868|NCT04620811|594307754|FG000|Overall Study|Elevation of ALT or AST|1|||
164528869|NCT04620811|594307755|FG001|Overall Study|Elevation of ALT or AST|0|||
164528870|NCT04620811|594307754|FG000|Overall Study|Other|3|||
164528871|NCT04620811|594307755|FG001|Overall Study|Other|5|||
164528872|NCT01078675|594307757|FG000|Overall Study|Withdrawal by Subject|7|||
164528873|NCT01078675|594307758|FG001|Overall Study|Withdrawal by Subject|3|||
164528874|NCT01078675|594307757|FG000|Overall Study|Protocol Violation|56|||
164528875|NCT01078675|594307758|FG001|Overall Study|Protocol Violation|0|||
164528876|NCT01078675|594307757|FG000|Overall Study|Provided in CRF for specific reasons|2|||
164528877|NCT01078675|594307758|FG001|Overall Study|Provided in CRF for specific reasons|3|||
164528878|NCT01078675|594307757|FG000|Overall Study|Adverse Event|3|||
164528879|NCT01078675|594307758|FG001|Overall Study|Adverse Event|0|||
164631566|NCT01072175|594673537|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
164631567|NCT01072175|594673525|FG000|Part D (HPMC Capsules)|Death|0|||
164631568|NCT01072175|594673526|FG001|Part D (HPMC Capsules)|Death|0|||
164631569|NCT01072175|594673527|FG002|Part D (HPMC Capsules)|Death|0|||
164631570|NCT01072175|594673528|FG003|Part D (HPMC Capsules)|Death|0|||
164631571|NCT01072175|594673529|FG004|Part D (HPMC Capsules)|Death|0|||
164631572|NCT01072175|594673530|FG005|Part D (HPMC Capsules)|Death|0|||
164631573|NCT01072175|594673531|FG006|Part D (HPMC Capsules)|Death|0|||
164631574|NCT01072175|594673532|FG007|Part D (HPMC Capsules)|Death|0|||
164631575|NCT01072175|594673533|FG008|Part D (HPMC Capsules)|Death|0|||
164631576|NCT01072175|594673534|FG009|Part D (HPMC Capsules)|Death|10|||
164631577|NCT01072175|594673535|FG010|Part D (HPMC Capsules)|Death|12|||
164631578|NCT01072175|594673536|FG011|Part D (HPMC Capsules)|Death|28|||
164631579|NCT01072175|594673537|FG012|Part D (HPMC Capsules)|Death|26|||
164631580|NCT01072175|594673525|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
164631581|NCT01072175|594673526|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
164631582|NCT01072175|594673527|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
164631583|NCT01072175|594673528|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
164631584|NCT01072175|594673529|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
164631585|NCT01072175|594673530|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
164631586|NCT01072175|594673531|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
164631587|NCT01072175|594673532|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
164631588|NCT01072175|594673533|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
164631589|NCT01072175|594673534|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
164631590|NCT01072175|594673535|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
164631591|NCT01072175|594673536|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
164631592|NCT01072175|594673537|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
164631593|NCT01072175|594673525|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
164631594|NCT01072175|594673526|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
164631595|NCT01072175|594673527|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
164631596|NCT01072175|594673528|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
164631597|NCT01072175|594673529|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
164631598|NCT01072175|594673530|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
164631599|NCT01072175|594673531|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
164631600|NCT01072175|594673532|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
164631601|NCT01072175|594673533|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
164631602|NCT01072175|594673534|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
164631603|NCT01072175|594673535|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
164631604|NCT01072175|594673536|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
164631605|NCT01072175|594673537|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
164631606|NCT01072175|594673525|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
164631607|NCT01072175|594673526|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
164631608|NCT01072175|594673527|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
164631609|NCT01072175|594673528|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
164631610|NCT01072175|594673529|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
164631611|NCT01072175|594673530|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
164631612|NCT01072175|594673531|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
164631613|NCT01072175|594673532|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
164631614|NCT01072175|594673533|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
164631615|NCT01072175|594673534|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
164631616|NCT01072175|594673535|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
164631617|NCT01072175|594673536|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
164631618|NCT01072175|594673537|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
164631619|NCT01072175|594673525|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
164631620|NCT01072175|594673526|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
164631621|NCT01072175|594673527|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
164631622|NCT01072175|594673528|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
164631623|NCT01072175|594673529|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
164631624|NCT01072175|594673530|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
164631625|NCT01072175|594673531|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
164631626|NCT01072175|594673532|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
164631627|NCT01072175|594673533|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
164631628|NCT01072175|594673534|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
164631629|NCT01072175|594673535|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
164631630|NCT01072175|594673536|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
164631631|NCT01072175|594673537|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
164631632|NCT02839330|594673538|FG000|Overall Study|Adverse Event|0|||
164631633|NCT02839330|594673539|FG001|Overall Study|Adverse Event|1|||
164631634|NCT02839330|594673540|FG002|Overall Study|Adverse Event|2|||
164631635|NCT02839330|594673541|FG003|Overall Study|Adverse Event|2|||
164631636|NCT02839330|594673538|FG000|Overall Study|Death|4|||
164631637|NCT02839330|594673539|FG001|Overall Study|Death|6|||
164631638|NCT02839330|594673540|FG002|Overall Study|Death|1|||
164631639|NCT02839330|594673541|FG003|Overall Study|Death|1|||
164631640|NCT02839330|594673538|FG000|Overall Study|Withdrawal by Subject|27|||
164631641|NCT02839330|594673539|FG001|Overall Study|Withdrawal by Subject|19|||
164631642|NCT02839330|594673540|FG002|Overall Study|Withdrawal by Subject|11|||
164631643|NCT02839330|594673541|FG003|Overall Study|Withdrawal by Subject|13|||
164631644|NCT02839330|594673538|FG000|Overall Study|Lost to Follow-up|22|||
164631645|NCT02839330|594673539|FG001|Overall Study|Lost to Follow-up|27|||
164631646|NCT02839330|594673540|FG002|Overall Study|Lost to Follow-up|29|||
164631647|NCT02839330|594673541|FG003|Overall Study|Lost to Follow-up|25|||
164631648|NCT02839330|594673538|FG000|Overall Study|Administrative Reason|0|||
164631649|NCT02839330|594673539|FG001|Overall Study|Administrative Reason|0|||
164631650|NCT02839330|594673540|FG002|Overall Study|Administrative Reason|0|||
164631651|NCT02839330|594673541|FG003|Overall Study|Administrative Reason|1|||
164631652|NCT02839330|594673538|FG000|Overall Study|Protocol Violation|1|||
164631653|NCT02839330|594673539|FG001|Overall Study|Protocol Violation|2|||
164631654|NCT02839330|594673540|FG002|Overall Study|Protocol Violation|2|||
164631655|NCT02839330|594673541|FG003|Overall Study|Protocol Violation|3|||
164631656|NCT02839330|594673538|FG000|Overall Study|Other reason, not specified|4|||
164631657|NCT02839330|594673539|FG001|Overall Study|Other reason, not specified|3|||
164631658|NCT02839330|594673540|FG002|Overall Study|Other reason, not specified|3|||
164631659|NCT02839330|594673541|FG003|Overall Study|Other reason, not specified|6|||
164631660|NCT00508872|594673551|FG000|Overall Study|Lost to Follow-up|1|||
164631661|NCT00508872|594673551|FG000|Overall Study|Physician Decision|1|||
164631662|NCT00883896|594673552|FG000|Overall Study|Lost to Follow-up|0|||
164631663|NCT00883896|594673553|FG001|Overall Study|Lost to Follow-up|0|||
164631664|NCT00883896|594673554|FG002|Overall Study|Lost to Follow-up|0|||
164631665|NCT00883896|594673555|FG003|Overall Study|Lost to Follow-up|2|||
164631666|NCT00883896|594673552|FG000|Overall Study|Withdrawal by Subject|5|||
164631667|NCT00883896|594673553|FG001|Overall Study|Withdrawal by Subject|0|||
164631668|NCT00883896|594673554|FG002|Overall Study|Withdrawal by Subject|1|||
164631669|NCT00883896|594673555|FG003|Overall Study|Withdrawal by Subject|3|||
164631670|NCT00883896|594673552|FG000|Overall Study|Lack of Efficacy|0|||
164631671|NCT00883896|594673553|FG001|Overall Study|Lack of Efficacy|0|||
164631672|NCT00883896|594673554|FG002|Overall Study|Lack of Efficacy|0|||
164631673|NCT00883896|594673555|FG003|Overall Study|Lack of Efficacy|2|||
164631674|NCT00883896|594673552|FG000|Overall Study|Other|1|||
164631675|NCT00883896|594673553|FG001|Overall Study|Other|0|||
164631676|NCT00883896|594673554|FG002|Overall Study|Other|0|||
164631677|NCT00883896|594673555|FG003|Overall Study|Other|0|||
164631678|NCT02546193|594673556|FG000|Overall Study|Withdrawal by Subject|2|||
164631679|NCT02546193|594673557|FG001|Overall Study|Withdrawal by Subject|0|||
164631680|NCT02546193|594673558|FG002|Overall Study|Withdrawal by Subject|1|||
164631681|NCT02546193|594673559|FG003|Overall Study|Withdrawal by Subject|0|||
164631682|NCT02546193|594673556|FG000|Overall Study|Not eligible at time of induction|4|||
164631683|NCT02546193|594673557|FG001|Overall Study|Not eligible at time of induction|6|||
164631684|NCT02546193|594673558|FG002|Overall Study|Not eligible at time of induction|1|||
164631685|NCT02546193|594673559|FG003|Overall Study|Not eligible at time of induction|0|||
164631686|NCT00792467|594673560|FG000|Overall Study|progression of disease|17|||
164631687|NCT00792467|594673560|FG000|Overall Study|Adverse Event|1|||
164631688|NCT00792467|594673560|FG000|Overall Study|patient request|1|||
164631689|NCT00792467|594673560|FG000|Overall Study|Lost to Follow-up|1|||
164631690|NCT00792467|594673560|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
164631691|NCT00792467|594673560|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
164631692|NCT00438815|594673568|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
164631693|NCT00438815|594673568|FG000|Overall Study|3-month follow-up no longer required|12|||
164631694|NCT00438815|594673568|FG000|Overall Study|Noncompliance with protocol requirements|9|||
164631695|NCT00438815|594673568|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
164631696|NCT00438815|594673568|FG000|Overall Study|Lost to Follow-up|6|||
164631697|NCT00438815|594673568|FG000|Overall Study|Withdrawal by Subject|6|||
164631698|NCT00438815|594673568|FG000|Overall Study|Death|1|||
164631699|NCT01654666|594673569|FG000|Overall Study|Protocol Violation|7|||
164631700|NCT01654666|594673570|FG001|Overall Study|Protocol Violation|4|||
164631701|NCT01654666|594673571|FG002|Overall Study|Protocol Violation|8|||
164631702|NCT01654666|594673569|FG000|Overall Study|Lost to Follow-up|4|||
164631703|NCT01654666|594673570|FG001|Overall Study|Lost to Follow-up|5|||
164631704|NCT01654666|594673571|FG002|Overall Study|Lost to Follow-up|5|||
164631705|NCT01654666|594673569|FG000|Overall Study|Withdrawal by Subject|4|||
164631706|NCT01654666|594673570|FG001|Overall Study|Withdrawal by Subject|4|||
164631707|NCT01654666|594673571|FG002|Overall Study|Withdrawal by Subject|1|||
164631708|NCT01177943|594673573|FG000|First Intervention|Withdrawal by Subject|2|||
164631709|NCT01177943|594673574|FG001|First Intervention|Withdrawal by Subject|0|||
164631710|NCT04225026|594673580|FG000|Overall Study|Withdrawal by Subject|4|||
164631711|NCT04225026|594673580|FG000|Overall Study|Adverse Event|1|||
164631712|NCT04225026|594673580|FG000|Overall Study|Other|1|||
164631713|NCT04225026|594673580|FG000|Overall Study|Death|11|||
164631714|NCT04225026|594673580|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
164631715|NCT00779506|594673583|FG000|Overall Study|Screening Failed|2|||
164631716|NCT00779506|594673583|FG000|Overall Study|Adverse Event|4|||
164631717|NCT00779506|594673583|FG000|Overall Study|Lack of Efficacy|11|||
164631718|NCT00779506|594673583|FG000|Overall Study|Protocol Violation|5|||
164631719|NCT00779506|594673583|FG000|Overall Study|Withdrawal by Subject|6|||
164631720|NCT00779506|594673583|FG000|Overall Study|Lost to Follow-up|1|||
164631721|NCT03982069|594673585|FG000|Overall Study|Lost to Follow-up|5|||
164631722|NCT03982069|594673586|FG001|Overall Study|Lost to Follow-up|5|||
164631723|NCT03982069|594673587|FG002|Overall Study|Lost to Follow-up|3|||
164631724|NCT03982069|594673588|FG003|Overall Study|Lost to Follow-up|5|||
164631725|NCT03982069|594673585|FG000|Overall Study|Physician Decision|0|||
164631726|NCT03982069|594673586|FG001|Overall Study|Physician Decision|1|||
164631727|NCT03982069|594673587|FG002|Overall Study|Physician Decision|0|||
164631728|NCT03982069|594673588|FG003|Overall Study|Physician Decision|0|||
164631729|NCT03982069|594673585|FG000|Overall Study|Withdrawal by Subject|2|||
164631730|NCT03982069|594673586|FG001|Overall Study|Withdrawal by Subject|1|||
164631731|NCT03982069|594673587|FG002|Overall Study|Withdrawal by Subject|5|||
164631732|NCT03982069|594673588|FG003|Overall Study|Withdrawal by Subject|2|||
164631733|NCT03982069|594673585|FG000|Overall Study|Specimen loss|3|||
164631734|NCT03982069|594673586|FG001|Overall Study|Specimen loss|3|||
164631735|NCT03982069|594673587|FG002|Overall Study|Specimen loss|1|||
164631736|NCT03982069|594673588|FG003|Overall Study|Specimen loss|1|||
164631737|NCT00914940|594673589|FG000|D0 to D100 Post-transplant|Death|2|||
164631738|NCT00914940|594673589|FG000|D101 to 2 Years Post-transplant|Death|8|||
164631739|NCT00914940|594673589|FG000|2 Years to 5 Years Post-transplant|Death|3|||
164631740|NCT01000311|594673591|FG000|Overall Study|Adverse Event|2|||
164631741|NCT01000311|594673592|FG001|Overall Study|Adverse Event|5|||
164631742|NCT01000311|594673591|FG000|Overall Study|Withdrawal by Subject|16|||
164631743|NCT01000311|594673592|FG001|Overall Study|Withdrawal by Subject|24|||
164631744|NCT01000311|594673591|FG000|Overall Study|Lost to Follow-up|15|||
164631745|NCT01000311|594673592|FG001|Overall Study|Lost to Follow-up|24|||
164631746|NCT01000311|594673591|FG000|Overall Study|Protocol Violation|1|||
164631747|NCT01000311|594673592|FG001|Overall Study|Protocol Violation|2|||
164631748|NCT01000311|594673591|FG000|Overall Study|Inappropriate enrollment|2|||
164631749|NCT01000311|594673592|FG001|Overall Study|Inappropriate enrollment|0|||
164631750|NCT01000311|594673591|FG000|Overall Study|Administrative reason|9|||
164631751|NCT01000311|594673592|FG001|Overall Study|Administrative reason|15|||
164631752|NCT02146352|594673593|FG000|Overall Study|Death|1|||
164631753|NCT02146352|594673593|FG000|Overall Study|Patient entered hospice care|1|||
164631754|NCT02918006|594673594|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
164631755|NCT02918006|594673595|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
164631756|NCT02918006|594673596|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
164631757|NCT02918006|594673594|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
164631758|NCT02918006|594673595|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
164631759|NCT02918006|594673596|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
164631760|NCT02918006|594673594|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
164631761|NCT02918006|594673595|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
164631762|NCT02918006|594673596|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
164631763|NCT02918006|594673594|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
164631764|NCT02918006|594673595|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
164631765|NCT02918006|594673596|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
164631766|NCT02918006|594673594|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
164631767|NCT02918006|594673595|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
164631768|NCT02918006|594673596|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
164631769|NCT02918006|594673594|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
164631770|NCT02918006|594673595|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
164631771|NCT02918006|594673596|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
164631772|NCT02918006|594673594|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
164631773|NCT02918006|594673595|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
164631774|NCT02918006|594673596|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
164631775|NCT02918006|594673594|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
164631776|NCT02918006|594673595|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
164631777|NCT02918006|594673596|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
164631778|NCT02918006|594673594|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
164631779|NCT02918006|594673595|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
164631780|NCT02918006|594673596|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
164631781|NCT03969589|594673597|FG000|Overall Study|Lost to Follow-up|3|||
164631782|NCT03969589|594673598|FG001|Overall Study|Lost to Follow-up|2|||
164631783|NCT03969589|594673597|FG000|Overall Study|Declined Follow-Up|0|||
164631784|NCT03969589|594673598|FG001|Overall Study|Declined Follow-Up|1|||
164631785|NCT03091920|594673599|FG000|Overall Study|Adverse Event|0|||
164631786|NCT03091920|594673600|FG001|Overall Study|Adverse Event|1|||
164631787|NCT03091920|594673601|FG002|Overall Study|Adverse Event|0|||
164631788|NCT00453349|594673602|FG000|Randomized|Adverse Event|12|||
164631789|NCT00453349|594673603|FG001|Randomized|Adverse Event|11|||
164631790|NCT00453349|594673602|FG000|Randomized|Lack of Efficacy|2|||
164631791|NCT00453349|594673603|FG001|Randomized|Lack of Efficacy|1|||
164631792|NCT00453349|594673602|FG000|Randomized|Lost to Follow-up|7|||
164631793|NCT00453349|594673603|FG001|Randomized|Lost to Follow-up|5|||
164631794|NCT00453349|594673602|FG000|Randomized|Protocol Violation|1|||
164631795|NCT00453349|594673603|FG001|Randomized|Protocol Violation|1|||
164631796|NCT00453349|594673602|FG000|Randomized|Withdrawal by Subject|3|||
164631797|NCT00453349|594673603|FG001|Randomized|Withdrawal by Subject|5|||
164631798|NCT00453349|594673602|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
164631799|NCT00453349|594673603|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
164631800|NCT00453349|594673602|FG000|Completed Study|Adverse Event|12|||
164631801|NCT00453349|594673603|FG001|Completed Study|Adverse Event|11|||
164631802|NCT00453349|594673602|FG000|Completed Study|Lack of Efficacy|2|||
164631803|NCT00453349|594673603|FG001|Completed Study|Lack of Efficacy|1|||
164631804|NCT00453349|594673602|FG000|Completed Study|Lost to Follow-up|7|||
164631805|NCT00453349|594673603|FG001|Completed Study|Lost to Follow-up|5|||
164631806|NCT00453349|594673602|FG000|Completed Study|Protocol Violation|1|||
164631807|NCT00453349|594673603|FG001|Completed Study|Protocol Violation|1|||
164631808|NCT00453349|594673602|FG000|Completed Study|Withdrawal by Subject|3|||
164631809|NCT00453349|594673603|FG001|Completed Study|Withdrawal by Subject|5|||
164631810|NCT00453349|594673602|FG000|Completed Study|Lost to follow up after study treatment|2|||
164631811|NCT00453349|594673603|FG001|Completed Study|Lost to follow up after study treatment|11|||
164631812|NCT00805142|594673604|FG000|Titration Period|Adverse Event|3|||
164631813|NCT00805142|594673605|FG001|Titration Period|Adverse Event|3|||
164631814|NCT00805142|594673604|FG000|Titration Period|Lack of Efficacy|1|||
164631815|NCT00805142|594673605|FG001|Titration Period|Lack of Efficacy|1|||
164631816|NCT00805142|594673604|FG000|Titration Period|Lost to Follow-up|0|||
164631817|NCT00805142|594673605|FG001|Titration Period|Lost to Follow-up|1|||
164631818|NCT00805142|594673604|FG000|Titration Period|Disease Progression|2|||
164631819|NCT00805142|594673605|FG001|Titration Period|Disease Progression|1|||
164631820|NCT00805142|594673604|FG000|Titration Period|Withdrawal of consent|0|||
164631821|NCT00805142|594673605|FG001|Titration Period|Withdrawal of consent|1|||
164631822|NCT00805142|594673604|FG000|Titration Period|Other|0|||
164631823|NCT00805142|594673605|FG001|Titration Period|Other|3|||
164631824|NCT00805142|594673604|FG000|Maintenance Period|Adverse Event|0|||
164631825|NCT00805142|594673605|FG001|Maintenance Period|Adverse Event|1|||
164631826|NCT00805142|594673604|FG000|Maintenance Period|Other|0|||
164631827|NCT00805142|594673605|FG001|Maintenance Period|Other|1|||
164631828|NCT01682876|594674835|FG000|Overall Study|Administrative reason|4|||
164631829|NCT01682876|594674836|FG001|Overall Study|Administrative reason|4|||
164631830|NCT01682876|594674837|FG002|Overall Study|Administrative reason|0|||
164631831|NCT01682876|594674838|FG003|Overall Study|Administrative reason|3|||
164631832|NCT01682876|594674835|FG000|Overall Study|Adverse Event|0|||
164631833|NCT01682876|594674836|FG001|Overall Study|Adverse Event|0|||
164631834|NCT01682876|594674837|FG002|Overall Study|Adverse Event|0|||
164631835|NCT01682876|594674838|FG003|Overall Study|Adverse Event|1|||
164631836|NCT01682876|594674835|FG000|Overall Study|Lost to Follow-up|11|||
164631837|NCT01682876|594674836|FG001|Overall Study|Lost to Follow-up|15|||
164631838|NCT01682876|594674837|FG002|Overall Study|Lost to Follow-up|9|||
164631839|NCT01682876|594674838|FG003|Overall Study|Lost to Follow-up|11|||
164631840|NCT01682876|594674835|FG000|Overall Study|Protocol Violation|1|||
164631841|NCT01682876|594674836|FG001|Overall Study|Protocol Violation|1|||
164631842|NCT01682876|594674837|FG002|Overall Study|Protocol Violation|1|||
164631843|NCT01682876|594674838|FG003|Overall Study|Protocol Violation|1|||
164631844|NCT01682876|594674835|FG000|Overall Study|Withdrawal by Subject|4|||
164631845|NCT01682876|594674836|FG001|Overall Study|Withdrawal by Subject|0|||
164631846|NCT01682876|594674837|FG002|Overall Study|Withdrawal by Subject|0|||
164631847|NCT01682876|594674838|FG003|Overall Study|Withdrawal by Subject|2|||
164631848|NCT01682876|594674835|FG000|Overall Study|Other|1|||
164631849|NCT01682876|594674836|FG001|Overall Study|Other|0|||
164631850|NCT01682876|594674837|FG002|Overall Study|Other|1|||
164631851|NCT01682876|594674838|FG003|Overall Study|Other|1|||
164631852|NCT01674010|594674843|FG000|Open Treatment Phase 1|Adverse Event|10|||
164631853|NCT01674010|594674844|FG001|Open Treatment Phase 1|Adverse Event|0|||
164631854|NCT01674010|594674845|FG002|Open Treatment Phase 1|Adverse Event|0|||
164631855|NCT01674010|594674843|FG000|Open Treatment Phase 1|Death|1|||
164631856|NCT01674010|594674844|FG001|Open Treatment Phase 1|Death|0|||
164631857|NCT01674010|594674845|FG002|Open Treatment Phase 1|Death|0|||
164147708|NCT02006732|592902130|FG001|Overall Study|Lost to Follow-up|1|||
164528880|NCT00928746|594307759|FG000|Overall Study|Adverse Event|2|||
164528881|NCT00928746|594307759|FG000|Overall Study|Protocol Violation|1|||
164528882|NCT00928746|594307759|FG000|Overall Study|Withdrawal by Subject|1|||
164528883|NCT00928746|594307759|FG000|Overall Study|Other|2|||
164528884|NCT02745392|594307764|FG000|Overall Study|Lost to Follow-up|0|||
164528885|NCT02745392|594307765|FG001|Overall Study|Lost to Follow-up|1|||
164528886|NCT02745392|594307766|FG002|Overall Study|Lost to Follow-up|0|||
164528887|NCT02745392|594307767|FG003|Overall Study|Lost to Follow-up|0|||
164528888|NCT02004353|594307772|FG000|Overall Study|Voluntary participation|1334|||
164528889|NCT01007448|594307782|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
164528890|NCT01007448|594307783|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
164528891|NCT01007448|594307782|FG000|Overall Study|Staph Skin Infection Flare|1|||
164528892|NCT01007448|594307783|FG001|Overall Study|Staph Skin Infection Flare|0|||
164528893|NCT01007448|594307782|FG000|Overall Study|Participant Leaving the Country|1|||
164528894|NCT01007448|594307783|FG001|Overall Study|Participant Leaving the Country|0|||
164528895|NCT01007448|594307782|FG000|Overall Study|Participant Given Prohibited Medication|1|||
164528896|NCT01007448|594307783|FG001|Overall Study|Participant Given Prohibited Medication|0|||
164528897|NCT01007448|594307782|FG000|Overall Study|Progressive Disease|1|||
164528898|NCT01007448|594307783|FG001|Overall Study|Progressive Disease|2|||
164528899|NCT01007448|594307782|FG000|Overall Study|Lack of Efficacy|2|||
164528900|NCT01007448|594307783|FG001|Overall Study|Lack of Efficacy|0|||
164528901|NCT01007448|594307782|FG000|Overall Study|Withdrawal by Subject|2|||
164528902|NCT01007448|594307783|FG001|Overall Study|Withdrawal by Subject|3|||
164528903|NCT01007448|594307782|FG000|Overall Study|Adverse Event|1|||
164528904|NCT01007448|594307783|FG001|Overall Study|Adverse Event|4|||
164528905|NCT02481947|594307784|FG000|Overall Study|Withdrawal by Subject|24|||
164528906|NCT02481947|594307785|FG001|Overall Study|Withdrawal by Subject|10|||
164528907|NCT02481947|594307784|FG000|Overall Study|Lost to Follow-up|11|||
164528908|NCT02481947|594307785|FG001|Overall Study|Lost to Follow-up|5|||
164528909|NCT02481947|594307784|FG000|Overall Study|Adverse Event|6|||
164528910|NCT02481947|594307785|FG001|Overall Study|Adverse Event|11|||
164528911|NCT02481947|594307784|FG000|Overall Study|Physician Decision|4|||
164528912|NCT02481947|594307785|FG001|Overall Study|Physician Decision|5|||
164528913|NCT02481947|594307784|FG000|Overall Study|Protocol Violation|1|||
164528914|NCT02481947|594307785|FG001|Overall Study|Protocol Violation|5|||
164528915|NCT02751320|594307786|FG000|Overall Study|Adverse Event|2|||
164528916|NCT02751320|594307786|FG000|Overall Study|Withdrawal by Subject|1|||
164528917|NCT03426605|594307787|FG000|Overall Study|AML relapse or progression|2|||
164528918|NCT03426605|594307788|FG001|Overall Study|AML relapse or progression|1|||
164528919|NCT03426605|594307789|FG002|Overall Study|AML relapse or progression|2|||
164528920|NCT03426605|594307790|FG003|Overall Study|AML relapse or progression|2|||
164528921|NCT03426605|594307787|FG000|Overall Study|Treatment failure|3|||
164528922|NCT03426605|594307788|FG001|Overall Study|Treatment failure|2|||
164528923|NCT03426605|594307789|FG002|Overall Study|Treatment failure|0|||
164528924|NCT03426605|594307790|FG003|Overall Study|Treatment failure|0|||
164528925|NCT03426605|594307787|FG000|Overall Study|Adverse Event|1|||
164528926|NCT03426605|594307788|FG001|Overall Study|Adverse Event|0|||
164528927|NCT03426605|594307789|FG002|Overall Study|Adverse Event|1|||
164528928|NCT03426605|594307790|FG003|Overall Study|Adverse Event|1|||
164528929|NCT03426605|594307787|FG000|Overall Study|Withdrawal by Subject|0|||
164528930|NCT03426605|594307788|FG001|Overall Study|Withdrawal by Subject|0|||
164528931|NCT03426605|594307789|FG002|Overall Study|Withdrawal by Subject|1|||
164528932|NCT03426605|594307790|FG003|Overall Study|Withdrawal by Subject|1|||
164528933|NCT01272804|594307791|FG000|Overall Study|Adverse Event|1|||
164528934|NCT01272804|594307792|FG001|Overall Study|Adverse Event|0|||
164528935|NCT01272804|594307793|FG002|Overall Study|Adverse Event|0|||
164528936|NCT01272804|594307794|FG003|Overall Study|Adverse Event|0|||
164528937|NCT01272804|594307795|FG004|Overall Study|Adverse Event|2|||
164528938|NCT01272804|594307796|FG005|Overall Study|Adverse Event|1|||
164528939|NCT01886378|594307797|FG000|Overall Study|Adverse Event|1|||
164631858|NCT01674010|594674843|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
164631859|NCT01674010|594674844|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
164631860|NCT01674010|594674845|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
164631861|NCT01674010|594674843|FG000|Open Treatment Phase 1|Physician Decision|9|||
164631862|NCT01674010|594674844|FG001|Open Treatment Phase 1|Physician Decision|0|||
164631863|NCT01674010|594674845|FG002|Open Treatment Phase 1|Physician Decision|0|||
164631864|NCT01674010|594674843|FG000|Open Treatment Phase 1|Protocol Violation|7|||
164631865|NCT01674010|594674844|FG001|Open Treatment Phase 1|Protocol Violation|0|||
164631866|NCT01674010|594674845|FG002|Open Treatment Phase 1|Protocol Violation|0|||
164631867|NCT01674010|594674843|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
164631868|NCT01674010|594674844|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
164631869|NCT01674010|594674845|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
164631870|NCT01674010|594674843|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
164631871|NCT01674010|594674844|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
164631872|NCT01674010|594674845|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
164631873|NCT01674010|594674843|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
164528940|NCT01886378|594307797|FG000|Overall Study|Withdrawal by Subject|4|||
164528941|NCT03801915|594307798|FG000|Overall Study|Screen failure|0|||
164528942|NCT03801915|594307799|FG001|Overall Study|Screen failure|0|||
164528943|NCT03801915|594307800|FG002|Overall Study|Screen failure|1|||
164528944|NCT03801915|594307798|FG000|Overall Study|Ineligible|1|||
164528945|NCT03801915|594307799|FG001|Overall Study|Ineligible|0|||
164528946|NCT03801915|594307800|FG002|Overall Study|Ineligible|0|||
164528947|NCT03801915|594307798|FG000|Overall Study|Physician Decision|2|||
164528948|NCT03801915|594307799|FG001|Overall Study|Physician Decision|1|||
164528949|NCT03801915|594307800|FG002|Overall Study|Physician Decision|0|||
164528950|NCT02308020|594307803|FG000|Overall Study|Lost to Follow-up|1|||
164528951|NCT02308020|594307804|FG001|Overall Study|Lost to Follow-up|7|||
164528952|NCT02308020|594307805|FG002|Overall Study|Lost to Follow-up|0|||
164528953|NCT02308020|594307806|FG003|Overall Study|Lost to Follow-up|0|||
164528954|NCT02308020|594307807|FG004|Overall Study|Lost to Follow-up|1|||
164528955|NCT02308020|594307808|FG005|Overall Study|Lost to Follow-up|2|||
164528956|NCT02308020|594307803|FG000|Overall Study|Sponsor Decision|0|||
164528957|NCT02308020|594307804|FG001|Overall Study|Sponsor Decision|8|||
164528958|NCT02308020|594307805|FG002|Overall Study|Sponsor Decision|0|||
164528959|NCT02308020|594307806|FG003|Overall Study|Sponsor Decision|2|||
164528960|NCT02308020|594307807|FG004|Overall Study|Sponsor Decision|2|||
164528961|NCT02308020|594307808|FG005|Overall Study|Sponsor Decision|1|||
164528962|NCT02308020|594307803|FG000|Overall Study|Withdrawal by Subject|3|||
164528963|NCT02308020|594307804|FG001|Overall Study|Withdrawal by Subject|5|||
164528964|NCT02308020|594307805|FG002|Overall Study|Withdrawal by Subject|3|||
164528965|NCT02308020|594307806|FG003|Overall Study|Withdrawal by Subject|2|||
164528966|NCT02308020|594307807|FG004|Overall Study|Withdrawal by Subject|1|||
164528967|NCT02308020|594307808|FG005|Overall Study|Withdrawal by Subject|2|||
164528968|NCT03513588|594307809|FG000|Overall Study|Lost to Follow-up|0|||
164528969|NCT03513588|594307810|FG001|Overall Study|Lost to Follow-up|1|||
164528970|NCT03513588|594307811|FG002|Overall Study|Lost to Follow-up|1|||
164528971|NCT03513588|594307809|FG000|Overall Study|Study dosing paused by sponsor|1|||
164528972|NCT03513588|594307810|FG001|Overall Study|Study dosing paused by sponsor|1|||
164528973|NCT03513588|594307811|FG002|Overall Study|Study dosing paused by sponsor|0|||
164528974|NCT03513588|594307809|FG000|Overall Study|Death|0|||
164528975|NCT03513588|594307810|FG001|Overall Study|Death|0|||
164528976|NCT03513588|594307811|FG002|Overall Study|Death|1|||
164528977|NCT03265938|594307812|FG000|Overall Study|Withdrawal by Subject|1|||
164528978|NCT03265938|594307812|FG000|Overall Study|Physician Decision|1|||
164528979|NCT03265938|594307812|FG000|Overall Study|friable mass|6|||
164528980|NCT01211288|594307813|FG000|Overall Study|Lost to Follow-up|1|||
164528981|NCT01211288|594307814|FG001|Overall Study|Lost to Follow-up|1|||
164528982|NCT01270971|594307815|FG000|Overall Study|Withdrawal by Subject|24|||
164528983|NCT01270971|594307816|FG001|Overall Study|Withdrawal by Subject|11|||
164528984|NCT01270971|594307815|FG000|Overall Study|Lost to Follow-up|18|||
164528985|NCT01270971|594307816|FG001|Overall Study|Lost to Follow-up|5|||
164528986|NCT01270971|594307815|FG000|Overall Study|Adverse Event|1|||
164528987|NCT01270971|594307816|FG001|Overall Study|Adverse Event|2|||
164528988|NCT01270971|594307815|FG000|Overall Study|Non compliance|2|||
164528989|NCT01270971|594307816|FG001|Overall Study|Non compliance|2|||
164528990|NCT01270971|594307815|FG000|Overall Study|Non-specific|7|||
164528991|NCT01270971|594307816|FG001|Overall Study|Non-specific|3|||
164528992|NCT03333837|594307824|FG000|Overall Study|Adverse Event|2|||
164528993|NCT03333837|594307825|FG001|Overall Study|Adverse Event|1|||
164528994|NCT03333837|594307826|FG002|Overall Study|Adverse Event|1|||
164528995|NCT03333837|594307827|FG003|Overall Study|Adverse Event|1|||
164528996|NCT03333837|594307828|FG004|Overall Study|Adverse Event|0|||
164528997|NCT03333837|594307824|FG000|Overall Study|Caregiver withdrew|0|||
164528998|NCT03333837|594307825|FG001|Overall Study|Caregiver withdrew|2|||
164528999|NCT03333837|594307826|FG002|Overall Study|Caregiver withdrew|1|||
164529000|NCT03333837|594307827|FG003|Overall Study|Caregiver withdrew|0|||
164529001|NCT03333837|594307828|FG004|Overall Study|Caregiver withdrew|0|||
164529002|NCT03333837|594307824|FG000|Overall Study|Withdrawal by Subject|0|||
164529003|NCT03333837|594307825|FG001|Overall Study|Withdrawal by Subject|0|||
164529004|NCT03333837|594307826|FG002|Overall Study|Withdrawal by Subject|1|||
164529005|NCT03333837|594307827|FG003|Overall Study|Withdrawal by Subject|1|||
164529006|NCT03333837|594307828|FG004|Overall Study|Withdrawal by Subject|3|||
164529007|NCT03333837|594307824|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
164529008|NCT03333837|594307825|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
164529009|NCT03333837|594307826|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
164529010|NCT03333837|594307827|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
164529011|NCT03333837|594307828|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
164529012|NCT01551212|594307829|FG000|Overall Study|Graft loss/Retransplantation|0|||
164529013|NCT01551212|594307830|FG001|Overall Study|Graft loss/Retransplantation|1|||
164529014|NCT01551212|594307829|FG000|Overall Study|Administrative problems|1|||
164529015|NCT01551212|594307830|FG001|Overall Study|Administrative problems|2|||
164631874|NCT01674010|594674844|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
164631875|NCT01674010|594674845|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
164631876|NCT01674010|594674843|FG000|Randomization Phase 2|Adverse Event|0|||
164631877|NCT01674010|594674844|FG001|Randomization Phase 2|Adverse Event|1|||
164631878|NCT01674010|594674845|FG002|Randomization Phase 2|Adverse Event|1|||
164631879|NCT01674010|594674843|FG000|Randomization Phase 2|Lost to Follow-up|0|||
164631880|NCT01674010|594674844|FG001|Randomization Phase 2|Lost to Follow-up|1|||
164631881|NCT01674010|594674845|FG002|Randomization Phase 2|Lost to Follow-up|2|||
164631882|NCT01674010|594674843|FG000|Randomization Phase 2|Mood episode recurrence|0|||
164631883|NCT01674010|594674844|FG001|Randomization Phase 2|Mood episode recurrence|8|||
164631884|NCT01674010|594674845|FG002|Randomization Phase 2|Mood episode recurrence|2|||
164631885|NCT01674010|594674843|FG000|Randomization Phase 2|Physician Decision|0|||
164631886|NCT01674010|594674844|FG001|Randomization Phase 2|Physician Decision|0|||
164631887|NCT01674010|594674845|FG002|Randomization Phase 2|Physician Decision|2|||
164631888|NCT01674010|594674843|FG000|Randomization Phase 2|Pregnancy|0|||
164631889|NCT01674010|594674844|FG001|Randomization Phase 2|Pregnancy|1|||
164631890|NCT01674010|594674845|FG002|Randomization Phase 2|Pregnancy|1|||
164631891|NCT01674010|594674843|FG000|Randomization Phase 2|Protocol Violation|0|||
164631892|NCT01674010|594674844|FG001|Randomization Phase 2|Protocol Violation|1|||
164631893|NCT01674010|594674845|FG002|Randomization Phase 2|Protocol Violation|1|||
164631894|NCT01674010|594674843|FG000|Randomization Phase 2|Sponsor Decision|0|||
164631895|NCT01674010|594674844|FG001|Randomization Phase 2|Sponsor Decision|42|||
164631896|NCT01674010|594674845|FG002|Randomization Phase 2|Sponsor Decision|45|||
164631897|NCT01674010|594674843|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
164631898|NCT01674010|594674844|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
164631899|NCT01674010|594674845|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
164631900|NCT01020812|594674846|FG000|Overall Study|Physician Decision|1|||
164631901|NCT01020812|594674846|FG000|Overall Study|Withdrawal by Subject|1|||
164631902|NCT01020812|594674846|FG000|Overall Study|Protocol Violation|1|||
164631903|NCT01801475|594674849|FG000|Overall Study|Withdrawal by Subject|0|||
164631904|NCT01801475|594674850|FG001|Overall Study|Withdrawal by Subject|0|||
164631905|NCT01801475|594674851|FG002|Overall Study|Withdrawal by Subject|0|||
164631906|NCT01801475|594674852|FG003|Overall Study|Withdrawal by Subject|0|||
164631907|NCT01801475|594674853|FG004|Overall Study|Withdrawal by Subject|1|||
164631908|NCT01786707|594674854|FG000|Overall Study|Lost to Follow-up|1|||
164631909|NCT01786707|594674855|FG001|Overall Study|Lost to Follow-up|1|||
164631910|NCT00421928|594674856|FG000|Overall Study|Adverse Event|61|||
164631911|NCT00421928|594674857|FG001|Overall Study|Adverse Event|140|||
164631912|NCT00421928|594674858|FG002|Overall Study|Adverse Event|22|||
164631913|NCT00421928|594674856|FG000|Overall Study|Lost to Follow-up|5|||
164631914|NCT00421928|594674857|FG001|Overall Study|Lost to Follow-up|0|||
164631915|NCT00421928|594674858|FG002|Overall Study|Lost to Follow-up|3|||
164631916|NCT00421928|594674856|FG000|Overall Study|Withdrawal by Subject|50|||
164631917|NCT00421928|594674857|FG001|Overall Study|Withdrawal by Subject|48|||
164631918|NCT00421928|594674858|FG002|Overall Study|Withdrawal by Subject|43|||
164631919|NCT00421928|594674856|FG000|Overall Study|Lack of Efficacy|15|||
164631920|NCT00421928|594674857|FG001|Overall Study|Lack of Efficacy|7|||
164631921|NCT00421928|594674858|FG002|Overall Study|Lack of Efficacy|35|||
164631922|NCT00421928|594674856|FG000|Overall Study|Study drug non-compliant|6|||
164631923|NCT00421928|594674857|FG001|Overall Study|Study drug non-compliant|7|||
164631924|NCT00421928|594674858|FG002|Overall Study|Study drug non-compliant|4|||
164631925|NCT00421928|594674856|FG000|Overall Study|All other|26|||
164631926|NCT00421928|594674857|FG001|Overall Study|All other|21|||
164631927|NCT00421928|594674858|FG002|Overall Study|All other|27|||
164631928|NCT00421928|594674856|FG000|Overall Study|Death|0|||
164631929|NCT00421928|594674857|FG001|Overall Study|Death|1|||
164631930|NCT00421928|594674858|FG002|Overall Study|Death|0|||
164631931|NCT02946515|594674859|FG000|Overall Study|Lost to Follow-up|2|||
164631932|NCT02946515|594674860|FG001|Overall Study|Lost to Follow-up|1|||
164631933|NCT02158949|594674868|FG000|Overall Study|Withdrawal by Subject|1|||
164631934|NCT02158949|594674869|FG001|Overall Study|Withdrawal by Subject|0|||
164631935|NCT02158949|594674868|FG000|Overall Study|Lost to Follow-up|5|||
164631936|NCT02158949|594674869|FG001|Overall Study|Lost to Follow-up|11|||
164631937|NCT00682539|594674870|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
164631938|NCT00682539|594674871|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
164631939|NCT00682539|594674872|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
164631940|NCT00682539|594674870|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
164631941|NCT00682539|594674871|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
164147709|NCT02006732|592902131|FG002|Overall Study|Lost to Follow-up|0|||
164631942|NCT00682539|594674872|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
164631943|NCT02477215|594674873|FG000|Dose Escalation Phase|Physician Decision|1|||
164631944|NCT02477215|594674874|FG001|Dose Escalation Phase|Physician Decision|2|||
164631945|NCT02477215|594674875|FG002|Dose Escalation Phase|Physician Decision|0|||
164631946|NCT02477215|594674873|FG000|Fixed Dose Phase|Physician Decision|0|||
164631947|NCT02477215|594674874|FG001|Fixed Dose Phase|Physician Decision|7|||
164631948|NCT02477215|594674875|FG002|Fixed Dose Phase|Physician Decision|0|||
164631949|NCT00310440|594674876|FG000|Overall Study|Lost to Follow-up|17|||
164631950|NCT00310440|594674877|FG001|Overall Study|Lost to Follow-up|8|||
164631951|NCT00310440|594674876|FG000|Overall Study|Withdrawal by Subject|2|||
164631952|NCT00310440|594674877|FG001|Overall Study|Withdrawal by Subject|1|||
164631953|NCT00310440|594674876|FG000|Overall Study|Missed 12 Month Visit|7|||
164631954|NCT00310440|594674877|FG001|Overall Study|Missed 12 Month Visit|4|||
164631955|NCT00475657|594674879|FG000|Overall Study|Death|1|||
164631956|NCT00475657|594674879|FG000|Overall Study|Sponsor's Decision|3|||
164631957|NCT00408408|594674880|FG000|Overall Study|No follow up data|2|||
164631958|NCT00408408|594674881|FG001|Overall Study|No follow up data|3|||
164631959|NCT00408408|594674882|FG002|Overall Study|No follow up data|0|||
164631960|NCT00408408|594674883|FG003|Overall Study|No follow up data|7|||
164631961|NCT00408408|594674884|FG004|Overall Study|No follow up data|5|||
164631962|NCT00408408|594674885|FG005|Overall Study|No follow up data|3|||
164631963|NCT02898662|594674892|FG000|Overall Study|Adverse Event|1|||
164631964|NCT02898662|594674893|FG001|Overall Study|Adverse Event|0|||
164631965|NCT02898662|594674892|FG000|Overall Study|Loss of asthma control|23|||
164631966|NCT02898662|594674893|FG001|Overall Study|Loss of asthma control|24|||
164631967|NCT02898662|594674892|FG000|Overall Study|Withdrawal by Subject|4|||
164631968|NCT02898662|594674893|FG001|Overall Study|Withdrawal by Subject|1|||
164631969|NCT02898662|594674892|FG000|Overall Study|Technical issue|0|||
164631970|NCT02898662|594674893|FG001|Overall Study|Technical issue|1|||
164631971|NCT02898662|594674892|FG000|Overall Study|Randomized in error|0|||
164631972|NCT02898662|594674893|FG001|Overall Study|Randomized in error|1|||
164631973|NCT02898662|594674892|FG000|Overall Study|Subject decision|1|||
164631974|NCT02898662|594674893|FG001|Overall Study|Subject decision|0|||
164631975|NCT02898662|594674892|FG000|Overall Study|Other|0|||
164631976|NCT02898662|594674893|FG001|Overall Study|Other|1|||
164631977|NCT00399542|594674894|FG000|Overall Study|Adverse Event|18|||
164631978|NCT00399542|594674895|FG001|Overall Study|Adverse Event|15|||
164631979|NCT00399542|594674894|FG000|Overall Study|Protocol Violation|13|||
164631980|NCT00399542|594674895|FG001|Overall Study|Protocol Violation|3|||
164631981|NCT00399542|594674894|FG000|Overall Study|Withdrawal by Subject|28|||
164631982|NCT00399542|594674895|FG001|Overall Study|Withdrawal by Subject|10|||
164631983|NCT00399542|594674894|FG000|Overall Study|Lack of Efficacy|18|||
164631984|NCT00399542|594674895|FG001|Overall Study|Lack of Efficacy|8|||
164631985|NCT00399542|594674894|FG000|Overall Study|Lost to Follow-up|6|||
164631986|NCT00399542|594674895|FG001|Overall Study|Lost to Follow-up|6|||
164631987|NCT00399542|594674894|FG000|Overall Study|Other|1|||
164631988|NCT00399542|594674895|FG001|Overall Study|Other|0|||
164631989|NCT00399542|594674894|FG000|Overall Study|Physician Decision|0|||
164631990|NCT00399542|594674895|FG001|Overall Study|Physician Decision|1|||
164631991|NCT00917553|594674896|FG000|Overall Study|Lost to Follow-up|2|||
164631992|NCT00917553|594674897|FG001|Overall Study|Lost to Follow-up|1|||
164631993|NCT01616173|594674898|FG000|Overall Study|Lost to Follow-up|0|||
164631994|NCT01616173|594674899|FG001|Overall Study|Lost to Follow-up|2|||
164631995|NCT01616173|594674900|FG002|Overall Study|Lost to Follow-up|0|||
164631996|NCT03172026|594674907|FG000|Overall Study|Withdrawal by Subject|1|||
164631997|NCT03172026|594674908|FG001|Overall Study|Withdrawal by Subject|0|||
164631998|NCT03172026|594674907|FG000|Overall Study|COVID restrictions|1|||
164631999|NCT03172026|594674908|FG001|Overall Study|COVID restrictions|0|||
164632000|NCT01430559|594674909|FG000|Overall Study|Adverse Event|7|||
164632001|NCT01430559|594674910|FG001|Overall Study|Adverse Event|3|||
164632002|NCT01430559|594674909|FG000|Overall Study|Entry criteria not met|1|||
164632003|NCT01430559|594674910|FG001|Overall Study|Entry criteria not met|1|||
164632004|NCT01430559|594674909|FG000|Overall Study|Lost to Follow-up|1|||
164632005|NCT01430559|594674910|FG001|Overall Study|Lost to Follow-up|0|||
164632006|NCT01430559|594674909|FG000|Overall Study|Medication error|1|||
164632007|NCT01430559|594674910|FG001|Overall Study|Medication error|0|||
164632008|NCT01430559|594674909|FG000|Overall Study|Withdrawal by Subject|3|||
164632009|NCT01430559|594674910|FG001|Overall Study|Withdrawal by Subject|2|||
164632010|NCT01430559|594674909|FG000|Overall Study|Protocol Violation|1|||
164632011|NCT01430559|594674910|FG001|Overall Study|Protocol Violation|0|||
164632012|NCT01430559|594674909|FG000|Overall Study|Other|3|||
164632013|NCT01430559|594674910|FG001|Overall Study|Other|3|||
164632014|NCT01430559|594674909|FG000|Overall Study|Randomized, Not Treated|3|||
164632015|NCT01430559|594674910|FG001|Overall Study|Randomized, Not Treated|3|||
164632016|NCT00504595|594674911|FG000|Overall Study|Lack of Efficacy|1|||
164632017|NCT00504595|594674912|FG001|Overall Study|Lack of Efficacy|0|||
164632018|NCT00504595|594674913|FG002|Overall Study|Lack of Efficacy|0|||
164632019|NCT00504595|594674914|FG003|Overall Study|Lack of Efficacy|0|||
164632020|NCT00504595|594674911|FG000|Overall Study|Other|0|||
164632021|NCT00504595|594674912|FG001|Overall Study|Other|0|||
164632022|NCT00504595|594674913|FG002|Overall Study|Other|2|||
164632023|NCT00504595|594674914|FG003|Overall Study|Other|0|||
164632024|NCT01220024|594674915|FG000|Overall Study|Lost to Follow-up|1|||
164632025|NCT01220024|594674916|FG001|Overall Study|Lost to Follow-up|1|||
164632026|NCT00174460|594674918|FG000|Overall Study|Withdrawal by Subject|0|||
164632027|NCT00174460|594674919|FG001|Overall Study|Withdrawal by Subject|1|||
164632028|NCT00579059|594674920|FG000|Overall Study|Study Canceled at 1 Year|21|||
164632029|NCT00579059|594674921|FG001|Overall Study|Study Canceled at 1 Year|10|||
164632030|NCT00779142|594674922|FG000|Overall Study|Screen Failures|3|||
164632031|NCT04652245|594674923|FG000|Wash-Out Period|Adverse Event|0|||
164632032|NCT04652245|594674924|FG001|Wash-Out Period|Adverse Event|2|||
164632033|NCT04652245|594674923|FG000|Wash-Out Period|Withdrawal by Subject|0|||
164632034|NCT04652245|594674924|FG001|Wash-Out Period|Withdrawal by Subject|2|||
164632035|NCT03137433|594674929|FG000|Overall Study|Withdrawal by Subject|11|||
164632036|NCT03137433|594674930|FG001|Overall Study|Withdrawal by Subject|11|||
164632037|NCT03137433|594674929|FG000|Overall Study|Lost to Follow-up|5|||
164632038|NCT03137433|594674930|FG001|Overall Study|Lost to Follow-up|6|||
164632039|NCT03137433|594674929|FG000|Overall Study|Physician Decision|2|||
164632040|NCT03137433|594674930|FG001|Overall Study|Physician Decision|0|||
164632041|NCT03137433|594674929|FG000|Overall Study|Moved out of study area|1|||
164632042|NCT03137433|594674930|FG001|Overall Study|Moved out of study area|0|||
164632043|NCT03137433|594674929|FG000|Overall Study|Too far out of window due to COVID|0|||
164632044|NCT03137433|594674930|FG001|Overall Study|Too far out of window due to COVID|1|||
164632045|NCT01288911|594674931|FG000|Double-blind Period|Death|11|||
164632046|NCT01288911|594674932|FG001|Double-blind Period|Death|7|||
164632047|NCT01288911|594674931|FG000|Double-blind Period|Lost to Follow-up|0|||
164632048|NCT01288911|594674932|FG001|Double-blind Period|Lost to Follow-up|2|||
164632049|NCT01288911|594674931|FG000|Double-blind Period|Progressive Disease|75|||
164632050|NCT01288911|594674932|FG001|Double-blind Period|Progressive Disease|103|||
164632051|NCT01288911|594674931|FG000|Double-blind Period|Protocol Violation|1|||
164632052|NCT01288911|594674932|FG001|Double-blind Period|Protocol Violation|0|||
164632053|NCT01288911|594674931|FG000|Double-blind Period|Withdrawal by Subject|25|||
164632054|NCT01288911|594674932|FG001|Double-blind Period|Withdrawal by Subject|26|||
164632055|NCT01288911|594674931|FG000|Double-blind Period|Miscellaneous Reason|29|||
164632056|NCT01288911|594674932|FG001|Double-blind Period|Miscellaneous Reason|42|||
164632057|NCT01288911|594674931|FG000|Double-blind Period|Randomized but never received study drug|1|||
164632058|NCT01288911|594674932|FG001|Double-blind Period|Randomized but never received study drug|2|||
164632059|NCT01288911|594674931|FG000|Open-label Period (All Enzalutamide)|Death|0|||
164632060|NCT01288911|594674932|FG001|Open-label Period (All Enzalutamide)|Death|1|||
164632061|NCT01288911|594674931|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
164632062|NCT01288911|594674932|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
164632063|NCT01288911|594674931|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
164632064|NCT01288911|594674932|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
164632065|NCT01288911|594674931|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
164632066|NCT01288911|594674932|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
164632067|NCT01288911|594674931|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
164632068|NCT01288911|594674932|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
164632069|NCT01288911|594674931|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
164632070|NCT01288911|594674932|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
164632071|NCT02452892|594674933|FG000|Week 1 Initial Randommization|Adverse Event|1|||
164632072|NCT02452892|594674934|FG001|Week 1 Initial Randommization|Adverse Event|0|||
164632073|NCT02452892|594674935|FG002|Week 1 Initial Randommization|Adverse Event|0|||
164632074|NCT02452892|594674936|FG003|Week 1 Initial Randommization|Adverse Event|0|||
164632075|NCT02452892|594674933|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
164632076|NCT02452892|594674934|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
164632077|NCT02452892|594674935|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
164632078|NCT02452892|594674936|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
164632079|NCT02452892|594674933|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
164632080|NCT02452892|594674934|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
164632081|NCT02452892|594674935|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
164632082|NCT02452892|594674936|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
164632083|NCT02452892|594674933|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
164632084|NCT02452892|594674934|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
164632085|NCT02452892|594674935|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
164632086|NCT02452892|594674936|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
164632087|NCT02452892|594674933|FG000|Follow-up|Withdrawal by Subject|0|||
164632088|NCT02452892|594674934|FG001|Follow-up|Withdrawal by Subject|0|||
164632089|NCT02452892|594674935|FG002|Follow-up|Withdrawal by Subject|0|||
164632090|NCT02452892|594674936|FG003|Follow-up|Withdrawal by Subject|1|||
164632091|NCT02452892|594674933|FG000|Follow-up|Subject left town on Day 42|1|||
164632092|NCT02452892|594674934|FG001|Follow-up|Subject left town on Day 42|0|||
164632093|NCT02452892|594674935|FG002|Follow-up|Subject left town on Day 42|0|||
164632094|NCT02452892|594674936|FG003|Follow-up|Subject left town on Day 42|0|||
164632095|NCT03742271|594674941|FG000|Overall Study|Unsatisfactory Visual Response|1|||
164632096|NCT03742271|594674941|FG000|Overall Study|Withdrawal by Subject|3|||
164632097|NCT03742271|594674941|FG000|Overall Study|Lost to Follow-up|4|||
164632098|NCT03742271|594674941|FG000|Overall Study|Failed Insertion & removal|3|||
164632099|NCT03742271|594674941|FG000|Overall Study|Protocol Violation|1|||
164632100|NCT02694562|594674942|FG000|Overall Study|Death|8|||
164632101|NCT02694562|594674942|FG000|Overall Study|Protocol Violation|4|||
164632102|NCT02694562|594674942|FG000|Overall Study|Lost to Follow-up|3|||
164632103|NCT02694562|594674942|FG000|Overall Study|Screen Failure|2|||
164632104|NCT02694562|594674942|FG000|Overall Study|Physician Decision|1|||
164632105|NCT03529162|594674945|FG000|Overall Study|Lost to Follow-up|2|||
164632106|NCT03529162|594674946|FG001|Overall Study|Lost to Follow-up|2|||
164632107|NCT00554229|594674951|FG000|Overall Study|Lost to Follow-up|3|||
164632108|NCT00554229|594674952|FG001|Overall Study|Lost to Follow-up|6|||
164632109|NCT00554229|594674951|FG000|Overall Study|Withdrawal by Subject|29|||
164632110|NCT00554229|594674952|FG001|Overall Study|Withdrawal by Subject|37|||
164632111|NCT00554229|594674951|FG000|Overall Study|Adverse Event|71|||
164632112|NCT00554229|594674952|FG001|Overall Study|Adverse Event|39|||
164632113|NCT00554229|594674951|FG000|Overall Study|Protocol Violation|3|||
164632114|NCT00554229|594674952|FG001|Overall Study|Protocol Violation|3|||
164632115|NCT00554229|594674951|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
164632116|NCT00554229|594674952|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
164632117|NCT00554229|594674951|FG000|Overall Study|Randomised but no treatment received|1|||
164632118|NCT00554229|594674952|FG001|Overall Study|Randomised but no treatment received|0|||
164632119|NCT00784836|594674953|FG000|Overall Study|Early Study Termination|3|||
164632120|NCT00517634|594674954|FG000|Second Treatment Period|Withdrawal by Subject|0|||
164632121|NCT00517634|594674955|FG001|Second Treatment Period|Withdrawal by Subject|0|||
164632122|NCT00517634|594674956|FG002|Second Treatment Period|Withdrawal by Subject|0|||
164632123|NCT00517634|594674957|FG003|Second Treatment Period|Withdrawal by Subject|0|||
164632124|NCT00517634|594674958|FG004|Second Treatment Period|Withdrawal by Subject|1|||
164632125|NCT00517634|594674959|FG005|Second Treatment Period|Withdrawal by Subject|0|||
164632126|NCT03143855|594674960|FG000|Overall Study|Withdrawal by Subject|4|||
164632127|NCT03143855|594674961|FG001|Overall Study|Withdrawal by Subject|3|||
164632128|NCT03143855|594674960|FG000|Overall Study|Protocol Violation|1|||
164632129|NCT03143855|594674961|FG001|Overall Study|Protocol Violation|0|||
164632130|NCT03143855|594674960|FG000|Overall Study|Participant experienced withdrawal|0|||
164632131|NCT03143855|594674961|FG001|Overall Study|Participant experienced withdrawal|1|||
164632132|NCT00701064|594674964|FG000|Overall Study|Protocol Violation|1|||
164632133|NCT00701064|594674965|FG001|Overall Study|Protocol Violation|1|||
164632134|NCT00701064|594674964|FG000|Overall Study|Withdrawal by Subject|1|||
164632135|NCT00701064|594674965|FG001|Overall Study|Withdrawal by Subject|1|||
164632136|NCT00701064|594674964|FG000|Overall Study|initiated other PTSD treatment|2|||
164632137|NCT00701064|594674965|FG001|Overall Study|initiated other PTSD treatment|2|||
164632138|NCT02613910|594674966|FG000|Overall Study|Termination of study|1|||
164632139|NCT02098733|594674967|FG000|Overall Study|Data Not Available|5|||
164632140|NCT02098733|594674967|FG000|Overall Study|Lost to Follow-up|5|||
164632141|NCT03077646|594674968|FG000|Overall Study|Lost to Follow-up|29|||
164632142|NCT03077646|594674969|FG001|Overall Study|Lost to Follow-up|30|||
164632143|NCT03077646|594674970|FG002|Overall Study|Lost to Follow-up|31|||
164632144|NCT00765726|594674971|FG000|Overall Study|Withdrawal by Subject|1|||
164632145|NCT00765726|594674971|FG000|Overall Study|Discontinuation of study by sponsor|8|||
164632146|NCT02993731|594674972|FG000|Overall Study|Study Termination|101|||
164632147|NCT02993731|594674973|FG001|Overall Study|Study Termination|105|||
164632148|NCT01002573|594676692|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
164632149|NCT01002573|594676693|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
164632150|NCT00690612|594676696|FG000|Overall Study|Adverse Event|1|||
164632151|NCT00690612|594676696|FG000|Overall Study|Withdrawal by Subject|2|||
164632152|NCT03808298|594676698|FG000|Overall Study|Adverse Event|3|||
164632153|NCT03808298|594676698|FG000|Overall Study|Physician Decision|1|||
164632154|NCT03808298|594676698|FG000|Overall Study|Withdrawal by Subject|1|||
164632155|NCT03808298|594676698|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
164632156|NCT01858701|594676699|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
164632157|NCT01858701|594676700|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
164632158|NCT01858701|594676699|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
164632159|NCT01858701|594676700|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
164632160|NCT01858701|594676699|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
164632161|NCT01858701|594676700|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
164632162|NCT01858701|594676699|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
164632163|NCT01858701|594676700|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
164632164|NCT02713490|594676715|FG000|Overall Study|Withdrawal by Subject|2|||
164632165|NCT02713490|594676716|FG001|Overall Study|Withdrawal by Subject|1|||
164632166|NCT02713490|594676715|FG000|Overall Study|Did not receive study drug|1|||
164632167|NCT02713490|594676716|FG001|Overall Study|Did not receive study drug|0|||
164632168|NCT02713490|594676715|FG000|Overall Study|Met exclusion criteria|0|||
164632169|NCT02713490|594676716|FG001|Overall Study|Met exclusion criteria|1|||
164632170|NCT00346775|594676717|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
164632171|NCT00346775|594676718|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
164632172|NCT00346775|594676717|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
164632173|NCT00346775|594676718|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
164632174|NCT00346775|594676717|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
164632175|NCT00346775|594676718|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
164632176|NCT01096017|594676721|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
164632177|NCT01096017|594676722|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
164632178|NCT03868410|594676723|FG000|Overall Study|Physician Decision|0|||
164632179|NCT03868410|594676724|FG001|Overall Study|Physician Decision|1|||
164632180|NCT02624713|594676728|FG000|Overall Study|Lost to Follow-up|14|||
164632181|NCT02624713|594676729|FG001|Overall Study|Lost to Follow-up|0|||
164632182|NCT00148109|594676730|FG000|Overall Study|Lack of Efficacy|10|||
164632183|NCT00148109|594676731|FG001|Overall Study|Lack of Efficacy|18|||
164632184|NCT00148109|594676730|FG000|Overall Study|Adverse Event|0|||
164632185|NCT00148109|594676731|FG001|Overall Study|Adverse Event|2|||
164632186|NCT00148109|594676730|FG000|Overall Study|Withdrawal by Subject|2|||
164632187|NCT00148109|594676731|FG001|Overall Study|Withdrawal by Subject|0|||
164632188|NCT06104423|594676732|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
164632189|NCT06104423|594676733|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
164632190|NCT06104423|594676734|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
164632191|NCT06104423|594676732|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
164632192|NCT06104423|594676733|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
164632193|NCT06104423|594676734|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
164632194|NCT00351611|594676739|FG000|Overall Study|Adverse Event|11|||
164632195|NCT00351611|594676740|FG001|Overall Study|Adverse Event|3|||
164632196|NCT00351611|594676739|FG000|Overall Study|Death|1|||
164632197|NCT00351611|594676740|FG001|Overall Study|Death|0|||
164632198|NCT00351611|594676739|FG000|Overall Study|Lost to Follow-up|1|||
164632199|NCT00351611|594676740|FG001|Overall Study|Lost to Follow-up|0|||
164632200|NCT00351611|594676739|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
164632201|NCT00351611|594676740|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
164632202|NCT00351611|594676739|FG000|Overall Study|Other|1|||
164632203|NCT00351611|594676740|FG001|Overall Study|Other|0|||
164632204|NCT00351611|594676739|FG000|Overall Study|Protocol Violation|0|||
164632205|NCT00351611|594676740|FG001|Overall Study|Protocol Violation|2|||
164632206|NCT01589185|594676741|FG000|Overall Study|Death|1|||
164632207|NCT01589185|594676742|FG001|Overall Study|Death|2|||
164632208|NCT01589185|594676743|FG002|Overall Study|Death|2|||
164632209|NCT01589185|594676744|FG003|Overall Study|Death|0|||
164632210|NCT01589185|594676745|FG004|Overall Study|Death|1|||
164632211|NCT01589185|594676741|FG000|Overall Study|Lost to Follow-up|1|||
164632212|NCT01589185|594676742|FG001|Overall Study|Lost to Follow-up|0|||
164632213|NCT01589185|594676743|FG002|Overall Study|Lost to Follow-up|2|||
164632214|NCT01589185|594676744|FG003|Overall Study|Lost to Follow-up|3|||
164632215|NCT01589185|594676745|FG004|Overall Study|Lost to Follow-up|0|||
164632216|NCT02708524|594676746|FG000|Overall Study|Adverse Event|0|||
164632217|NCT02708524|594676747|FG001|Overall Study|Adverse Event|1|||
164632218|NCT02708524|594676748|FG002|Overall Study|Adverse Event|0|||
164632219|NCT02708524|594676749|FG003|Overall Study|Adverse Event|0|||
164632220|NCT02708524|594676746|FG000|Overall Study|Lens Discomfort|1|||
164632221|NCT02708524|594676747|FG001|Overall Study|Lens Discomfort|0|||
164632222|NCT02708524|594676748|FG002|Overall Study|Lens Discomfort|1|||
164632223|NCT02708524|594676749|FG003|Overall Study|Lens Discomfort|0|||
164632224|NCT02708524|594676746|FG000|Overall Study|Lost to Follow-up|1|||
164632225|NCT02708524|594676747|FG001|Overall Study|Lost to Follow-up|1|||
164632226|NCT02708524|594676748|FG002|Overall Study|Lost to Follow-up|1|||
164632227|NCT02708524|594676749|FG003|Overall Study|Lost to Follow-up|0|||
164632228|NCT02708524|594676746|FG000|Overall Study|Protocol Violation|0|||
164632229|NCT02708524|594676747|FG001|Overall Study|Protocol Violation|1|||
164632230|NCT02708524|594676748|FG002|Overall Study|Protocol Violation|0|||
164632231|NCT02708524|594676749|FG003|Overall Study|Protocol Violation|0|||
164632232|NCT02708524|594676746|FG000|Overall Study|Withdrawal by Subject|1|||
164632233|NCT02708524|594676747|FG001|Overall Study|Withdrawal by Subject|1|||
164632234|NCT02708524|594676748|FG002|Overall Study|Withdrawal by Subject|0|||
164632235|NCT02708524|594676749|FG003|Overall Study|Withdrawal by Subject|0|||
164632236|NCT02708524|594676746|FG000|Overall Study|Dispensed incorrect study lens|0|||
164632237|NCT02708524|594676747|FG001|Overall Study|Dispensed incorrect study lens|1|||
164632238|NCT02708524|594676748|FG002|Overall Study|Dispensed incorrect study lens|1|||
164632239|NCT02708524|594676749|FG003|Overall Study|Dispensed incorrect study lens|0|||
164632240|NCT02708524|594676746|FG000|Overall Study|Did not wear lens at final visit|0|||
164632241|NCT02708524|594676747|FG001|Overall Study|Did not wear lens at final visit|1|||
164632242|NCT02708524|594676748|FG002|Overall Study|Did not wear lens at final visit|0|||
164632243|NCT02708524|594676749|FG003|Overall Study|Did not wear lens at final visit|0|||
164632244|NCT02708524|594676746|FG000|Overall Study|Subject lost study lens|1|||
164632245|NCT02708524|594676747|FG001|Overall Study|Subject lost study lens|0|||
164632246|NCT02708524|594676748|FG002|Overall Study|Subject lost study lens|0|||
164632247|NCT02708524|594676749|FG003|Overall Study|Subject lost study lens|0|||
164632248|NCT03781167|594676755|FG000|Overall Study|Adverse Event|23|||
164632249|NCT03781167|594676756|FG001|Overall Study|Adverse Event|25|||
164632250|NCT03781167|594676755|FG000|Overall Study|Withdrew consent|16|||
164632251|NCT03781167|594676756|FG001|Overall Study|Withdrew consent|12|||
164632252|NCT03781167|594676755|FG000|Overall Study|Lost to Follow-up|0|||
164632253|NCT03781167|594676756|FG001|Overall Study|Lost to Follow-up|1|||
164632254|NCT03781167|594676755|FG000|Overall Study|Lack of Efficacy|4|||
164632255|NCT03781167|594676756|FG001|Overall Study|Lack of Efficacy|5|||
164632256|NCT03781167|594676755|FG000|Overall Study|Difficulty with drug delivery system|2|||
164632257|NCT03781167|594676756|FG001|Overall Study|Difficulty with drug delivery system|3|||
164632258|NCT03781167|594676755|FG000|Overall Study|Other, not specified|2|||
164632259|NCT03781167|594676756|FG001|Overall Study|Other, not specified|2|||
164632260|NCT00462501|594676757|FG000|Overall Study|Not treated|3|||
164632261|NCT00462501|594676757|FG000|Overall Study|Adverse Event|2|||
164632262|NCT00679354|594676762|FG000|Overall Study|Death|3|||
164632263|NCT00679354|594676762|FG000|Overall Study|Lack of Efficacy|22|||
164632264|NCT00679354|594676762|FG000|Overall Study|Physician Decision|4|||
164632265|NCT00679354|594676762|FG000|Overall Study|Ineligible|1|||
164632266|NCT01258803|594676772|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
164632267|NCT01258803|594676773|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
164632268|NCT01258803|594676774|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
164632269|NCT01258803|594676775|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
164632270|NCT01258803|594676776|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
164632271|NCT01258803|594676777|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
164632272|NCT01258803|594676772|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
164632273|NCT01258803|594676773|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
164632274|NCT01258803|594676774|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
164632275|NCT01258803|594676775|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
164632276|NCT01258803|594676776|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
164632277|NCT01258803|594676777|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
164632278|NCT01258803|594676772|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
164632279|NCT01258803|594676773|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
164632280|NCT01258803|594676774|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
164632281|NCT01258803|594676775|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
164632282|NCT01258803|594676776|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
164632283|NCT01258803|594676777|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
164632284|NCT01552408|594676778|FG000|Overall Study|Lost to Follow-up|2|||
164632285|NCT01552408|594676779|FG001|Overall Study|Lost to Follow-up|0|||
164632286|NCT01552408|594676778|FG000|Overall Study|Relocation|0|||
164632287|NCT01552408|594676779|FG001|Overall Study|Relocation|1|||
164632288|NCT01552408|594676778|FG000|Overall Study|Withdrawal by Subject|2|||
164632289|NCT01552408|594676779|FG001|Overall Study|Withdrawal by Subject|1|||
164632290|NCT01016912|594676782|FG000|End of Treatment Period|Lack of Efficacy|0|||
164632291|NCT01016912|594676783|FG001|End of Treatment Period|Lack of Efficacy|1|||
164632292|NCT01016912|594676784|FG002|End of Treatment Period|Lack of Efficacy|0|||
164632293|NCT01016912|594676785|FG003|End of Treatment Period|Lack of Efficacy|4|||
164632294|NCT01016912|594676786|FG004|End of Treatment Period|Lack of Efficacy|4|||
164632295|NCT01016912|594676782|FG000|End of Treatment Period|Adverse Event|0|||
164632296|NCT01016912|594676783|FG001|End of Treatment Period|Adverse Event|1|||
164632297|NCT01016912|594676784|FG002|End of Treatment Period|Adverse Event|1|||
164632298|NCT01016912|594676785|FG003|End of Treatment Period|Adverse Event|0|||
164632299|NCT01016912|594676786|FG004|End of Treatment Period|Adverse Event|0|||
164632300|NCT01016912|594676782|FG000|End of Treatment Period|Completed double-blind period only|0|||
164632301|NCT01016912|594676783|FG001|End of Treatment Period|Completed double-blind period only|1|||
164632302|NCT01016912|594676784|FG002|End of Treatment Period|Completed double-blind period only|0|||
164632303|NCT01016912|594676785|FG003|End of Treatment Period|Completed double-blind period only|0|||
164632304|NCT01016912|594676786|FG004|End of Treatment Period|Completed double-blind period only|0|||
164632305|NCT01016912|594676782|FG000|Follow-up Period|Other reason|0|||
164632306|NCT01016912|594676783|FG001|Follow-up Period|Other reason|0|||
164632307|NCT01016912|594676784|FG002|Follow-up Period|Other reason|1|||
164632308|NCT01016912|594676785|FG003|Follow-up Period|Other reason|1|||
164632309|NCT01016912|594676786|FG004|Follow-up Period|Other reason|0|||
164632310|NCT01853397|594676789|FG000|Overall Study|Withdrawal by Subject|0|||
164632311|NCT01853397|594676790|FG001|Overall Study|Withdrawal by Subject|0|||
164632312|NCT01853397|594676791|FG002|Overall Study|Withdrawal by Subject|0|||
164632313|NCT01853397|594676792|FG003|Overall Study|Withdrawal by Subject|1|||
164632314|NCT01853397|594676789|FG000|Overall Study|Subject Noncompliance|0|||
164632315|NCT01853397|594676790|FG001|Overall Study|Subject Noncompliance|0|||
164632316|NCT01853397|594676791|FG002|Overall Study|Subject Noncompliance|0|||
164632317|NCT01853397|594676792|FG003|Overall Study|Subject Noncompliance|1|||
164632318|NCT01632345|594676793|FG000|Treatment: Part I|Adverse Event|1|||
164632319|NCT01632345|594676794|FG001|Treatment: Part I|Adverse Event|4|||
164632320|NCT01632345|594676795|FG002|Treatment: Part I|Adverse Event|2|||
164632321|NCT01632345|594676796|FG003|Treatment: Part I|Adverse Event|1|||
164632322|NCT01632345|594676797|FG004|Treatment: Part I|Adverse Event|3|||
164632323|NCT01632345|594676798|FG005|Treatment: Part I|Adverse Event|0|||
164632324|NCT01632345|594676799|FG006|Treatment: Part I|Adverse Event|0|||
164632325|NCT01632345|594676793|FG000|Treatment: Part I|Lack of Efficacy|0|||
164632326|NCT01632345|594676794|FG001|Treatment: Part I|Lack of Efficacy|1|||
164632327|NCT01632345|594676795|FG002|Treatment: Part I|Lack of Efficacy|0|||
164632328|NCT01632345|594676796|FG003|Treatment: Part I|Lack of Efficacy|1|||
164632329|NCT01632345|594676797|FG004|Treatment: Part I|Lack of Efficacy|1|||
164632330|NCT01632345|594676798|FG005|Treatment: Part I|Lack of Efficacy|0|||
164632331|NCT01632345|594676799|FG006|Treatment: Part I|Lack of Efficacy|0|||
164632332|NCT01632345|594676793|FG000|Treatment: Part I|Lost to Follow-up|3|||
164632333|NCT01632345|594676794|FG001|Treatment: Part I|Lost to Follow-up|2|||
164632334|NCT01632345|594676795|FG002|Treatment: Part I|Lost to Follow-up|1|||
164632335|NCT01632345|594676796|FG003|Treatment: Part I|Lost to Follow-up|3|||
164632336|NCT01632345|594676797|FG004|Treatment: Part I|Lost to Follow-up|4|||
164632337|NCT01632345|594676798|FG005|Treatment: Part I|Lost to Follow-up|0|||
164632338|NCT01632345|594676799|FG006|Treatment: Part I|Lost to Follow-up|0|||
164632339|NCT01632345|594676793|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
164632340|NCT01632345|594676794|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
164632341|NCT01632345|594676795|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
164147710|NCT02006732|592902132|FG003|Overall Study|Lost to Follow-up|0|||
164632342|NCT01632345|594676796|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
164632343|NCT01632345|594676797|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
164632344|NCT01632345|594676798|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
164632345|NCT01632345|594676799|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
164632346|NCT01632345|594676793|FG000|Treatment: Part I|Physician Decision|2|||
164632347|NCT01632345|594676794|FG001|Treatment: Part I|Physician Decision|1|||
164632348|NCT01632345|594676795|FG002|Treatment: Part I|Physician Decision|0|||
164632349|NCT01632345|594676796|FG003|Treatment: Part I|Physician Decision|0|||
164632350|NCT01632345|594676797|FG004|Treatment: Part I|Physician Decision|1|||
164632351|NCT01632345|594676798|FG005|Treatment: Part I|Physician Decision|0|||
164632352|NCT01632345|594676799|FG006|Treatment: Part I|Physician Decision|0|||
164632353|NCT01632345|594676793|FG000|Treatment: Part I|Pregnancy|0|||
164632354|NCT01632345|594676794|FG001|Treatment: Part I|Pregnancy|1|||
164632355|NCT01632345|594676795|FG002|Treatment: Part I|Pregnancy|0|||
164632356|NCT01632345|594676796|FG003|Treatment: Part I|Pregnancy|0|||
164632357|NCT01632345|594676797|FG004|Treatment: Part I|Pregnancy|0|||
164632358|NCT01632345|594676798|FG005|Treatment: Part I|Pregnancy|0|||
164632359|NCT01632345|594676799|FG006|Treatment: Part I|Pregnancy|0|||
164632360|NCT01632345|594676793|FG000|Treatment: Part I|Protocol Deviation|0|||
164632361|NCT01632345|594676794|FG001|Treatment: Part I|Protocol Deviation|0|||
164632362|NCT01632345|594676795|FG002|Treatment: Part I|Protocol Deviation|1|||
164632363|NCT01632345|594676796|FG003|Treatment: Part I|Protocol Deviation|1|||
164632364|NCT01632345|594676797|FG004|Treatment: Part I|Protocol Deviation|0|||
164632365|NCT01632345|594676798|FG005|Treatment: Part I|Protocol Deviation|0|||
164632366|NCT01632345|594676799|FG006|Treatment: Part I|Protocol Deviation|0|||
164632367|NCT01632345|594676793|FG000|Treatment: Part I|Withdrawal by Subject|3|||
164632368|NCT01632345|594676794|FG001|Treatment: Part I|Withdrawal by Subject|4|||
164632369|NCT01632345|594676795|FG002|Treatment: Part I|Withdrawal by Subject|4|||
164632370|NCT01632345|594676796|FG003|Treatment: Part I|Withdrawal by Subject|1|||
164632371|NCT01632345|594676797|FG004|Treatment: Part I|Withdrawal by Subject|4|||
164632372|NCT01632345|594676798|FG005|Treatment: Part I|Withdrawal by Subject|0|||
164632373|NCT01632345|594676799|FG006|Treatment: Part I|Withdrawal by Subject|0|||
164632374|NCT01632345|594676793|FG000|Treatment: Part II|Adverse Event|0|||
164632375|NCT01632345|594676794|FG001|Treatment: Part II|Adverse Event|0|||
164632376|NCT01632345|594676795|FG002|Treatment: Part II|Adverse Event|0|||
164632377|NCT01632345|594676796|FG003|Treatment: Part II|Adverse Event|0|||
164632378|NCT01632345|594676797|FG004|Treatment: Part II|Adverse Event|0|||
164632379|NCT01632345|594676798|FG005|Treatment: Part II|Adverse Event|3|||
164632380|NCT01632345|594676799|FG006|Treatment: Part II|Adverse Event|8|||
164632381|NCT01632345|594676793|FG000|Treatment: Part II|Lost to Follow-up|0|||
164632382|NCT01632345|594676794|FG001|Treatment: Part II|Lost to Follow-up|0|||
164632383|NCT01632345|594676795|FG002|Treatment: Part II|Lost to Follow-up|0|||
164632384|NCT01632345|594676796|FG003|Treatment: Part II|Lost to Follow-up|0|||
164632385|NCT01632345|594676797|FG004|Treatment: Part II|Lost to Follow-up|0|||
164632386|NCT01632345|594676798|FG005|Treatment: Part II|Lost to Follow-up|3|||
164632387|NCT01632345|594676799|FG006|Treatment: Part II|Lost to Follow-up|1|||
164632388|NCT01632345|594676793|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
164632389|NCT01632345|594676794|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
164632390|NCT01632345|594676795|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
164632391|NCT01632345|594676796|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
164632392|NCT01632345|594676797|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
164632393|NCT01632345|594676798|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
164632394|NCT01632345|594676799|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
164632395|NCT01632345|594676793|FG000|Treatment: Part II|Withdrawal by Subject|0|||
164632396|NCT01632345|594676794|FG001|Treatment: Part II|Withdrawal by Subject|0|||
164632397|NCT01632345|594676795|FG002|Treatment: Part II|Withdrawal by Subject|0|||
164632398|NCT01632345|594676796|FG003|Treatment: Part II|Withdrawal by Subject|0|||
164632399|NCT01632345|594676797|FG004|Treatment: Part II|Withdrawal by Subject|0|||
164632400|NCT01632345|594676798|FG005|Treatment: Part II|Withdrawal by Subject|2|||
164632401|NCT01632345|594676799|FG006|Treatment: Part II|Withdrawal by Subject|2|||
164632402|NCT00089505|594676800|FG000|Overall Study|Death|4|||
164632403|NCT00089505|594676801|FG001|Overall Study|Death|1|||
164632404|NCT00089505|594676802|FG002|Overall Study|Death|5|||
164632405|NCT00089505|594676803|FG003|Overall Study|Death|8|||
164632406|NCT00089505|594676800|FG000|Overall Study|Withdrawal by Subject|3|||
164632407|NCT00089505|594676801|FG001|Overall Study|Withdrawal by Subject|0|||
164632408|NCT00089505|594676802|FG002|Overall Study|Withdrawal by Subject|6|||
164632409|NCT00089505|594676803|FG003|Overall Study|Withdrawal by Subject|6|||
164632410|NCT00089505|594676800|FG000|Overall Study|Lost to Follow-up|1|||
164632411|NCT00089505|594676801|FG001|Overall Study|Lost to Follow-up|1|||
164632412|NCT00089505|594676802|FG002|Overall Study|Lost to Follow-up|9|||
164632413|NCT00089505|594676803|FG003|Overall Study|Lost to Follow-up|7|||
164632414|NCT00089505|594676800|FG000|Overall Study|Physician Decision|1|||
164632415|NCT00089505|594676801|FG001|Overall Study|Physician Decision|0|||
164632416|NCT00089505|594676802|FG002|Overall Study|Physician Decision|0|||
164632417|NCT00089505|594676803|FG003|Overall Study|Physician Decision|0|||
164632418|NCT00089505|594676800|FG000|Overall Study|Protocol Violation|0|||
164632419|NCT00089505|594676801|FG001|Overall Study|Protocol Violation|0|||
164632420|NCT00089505|594676802|FG002|Overall Study|Protocol Violation|1|||
164632421|NCT00089505|594676803|FG003|Overall Study|Protocol Violation|0|||
164632422|NCT02431559|594676804|FG000|Overall Study|Adverse Event|0|||
164632423|NCT02431559|594676805|FG001|Overall Study|Adverse Event|1|||
164632424|NCT02431559|594676806|FG002|Overall Study|Adverse Event|0|||
164632425|NCT02431559|594676807|FG003|Overall Study|Adverse Event|4|||
164632426|NCT02431559|594676804|FG000|Overall Study|Progressive disease|2|||
164632427|NCT02431559|594676805|FG001|Overall Study|Progressive disease|1|||
164632428|NCT02431559|594676806|FG002|Overall Study|Progressive disease|4|||
164632429|NCT02431559|594676807|FG003|Overall Study|Progressive disease|22|||
164632430|NCT02431559|594676804|FG000|Overall Study|Withdrawal by Subject|0|||
164632431|NCT02431559|594676805|FG001|Overall Study|Withdrawal by Subject|1|||
164632432|NCT02431559|594676806|FG002|Overall Study|Withdrawal by Subject|0|||
164632433|NCT02431559|594676807|FG003|Overall Study|Withdrawal by Subject|4|||
164632434|NCT02431559|594676804|FG000|Overall Study|Physician Decision|0|||
164632435|NCT02431559|594676805|FG001|Overall Study|Physician Decision|0|||
164632436|NCT02431559|594676806|FG002|Overall Study|Physician Decision|0|||
164632437|NCT02431559|594676807|FG003|Overall Study|Physician Decision|1|||
164632438|NCT02543918|594676808|FG000|Overall Study|Never treated|0|||
164632439|NCT02543918|594676809|FG001|Overall Study|Never treated|1|||
164632440|NCT02543918|594676808|FG000|Overall Study|Lost to Follow-up|1|||
164632441|NCT02543918|594676809|FG001|Overall Study|Lost to Follow-up|1|||
164632442|NCT02543918|594676808|FG000|Overall Study|Withdrawal by Subject|1|||
164632443|NCT02543918|594676809|FG001|Overall Study|Withdrawal by Subject|1|||
164632444|NCT02543918|594676808|FG000|Overall Study|Adverse Event|1|||
164632445|NCT02543918|594676809|FG001|Overall Study|Adverse Event|1|||
164632446|NCT00486720|594676812|FG000|Overall Study|Adverse Event|1|||
164632447|NCT00486720|594676813|FG001|Overall Study|Adverse Event|2|||
164632448|NCT00486720|594676812|FG000|Overall Study|Lack of Efficacy|4|||
164632449|NCT00486720|594676813|FG001|Overall Study|Lack of Efficacy|6|||
164632450|NCT00486720|594676812|FG000|Overall Study|Physician Decision|1|||
164632451|NCT00486720|594676813|FG001|Overall Study|Physician Decision|2|||
164632452|NCT00486720|594676812|FG000|Overall Study|Protocol Violation|1|||
164632453|NCT00486720|594676813|FG001|Overall Study|Protocol Violation|0|||
164632454|NCT00486720|594676812|FG000|Overall Study|Withdrawal by Subject|3|||
164632455|NCT00486720|594676813|FG001|Overall Study|Withdrawal by Subject|1|||
164632456|NCT00486720|594676812|FG000|Overall Study|Progressive Disease|0|||
164632457|NCT00486720|594676813|FG001|Overall Study|Progressive Disease|1|||
164632458|NCT05047601|594676821|FG000|Overall Study|Lost to Follow-up|9|||
164632459|NCT05047601|594676822|FG001|Overall Study|Lost to Follow-up|11|||
164632460|NCT05047601|594676823|FG002|Overall Study|Lost to Follow-up|7|||
164632461|NCT05047601|594676821|FG000|Overall Study|Withdrawal by Subject|25|||
164632462|NCT05047601|594676822|FG001|Overall Study|Withdrawal by Subject|36|||
164632463|NCT05047601|594676823|FG002|Overall Study|Withdrawal by Subject|23|||
164632464|NCT05047601|594676821|FG000|Overall Study|Other|10|||
164632465|NCT05047601|594676822|FG001|Overall Study|Other|6|||
164632466|NCT05047601|594676823|FG002|Overall Study|Other|5|||
164632467|NCT00286234|594676824|FG000|Overall Study|Protocol Violation|1|||
164632468|NCT00286234|594676825|FG001|Overall Study|Protocol Violation|2|||
164632469|NCT00286234|594676826|FG002|Overall Study|Protocol Violation|0|||
164632470|NCT00286234|594676827|FG003|Overall Study|Protocol Violation|1|||
164632471|NCT00286234|594676824|FG000|Overall Study|Physician Decision|1|||
164632472|NCT00286234|594676825|FG001|Overall Study|Physician Decision|0|||
164632473|NCT00286234|594676826|FG002|Overall Study|Physician Decision|0|||
164632474|NCT00286234|594676827|FG003|Overall Study|Physician Decision|1|||
164632475|NCT00286234|594676824|FG000|Overall Study|Adverse Event|0|||
164632476|NCT00286234|594676825|FG001|Overall Study|Adverse Event|0|||
164632477|NCT00286234|594676826|FG002|Overall Study|Adverse Event|0|||
164632478|NCT00286234|594676827|FG003|Overall Study|Adverse Event|1|||
164632479|NCT00286234|594676824|FG000|Overall Study|Adverse Event|0|||
164632480|NCT00286234|594676825|FG001|Overall Study|Adverse Event|0|||
164632481|NCT00286234|594676826|FG002|Overall Study|Adverse Event|0|||
164632482|NCT00286234|594676827|FG003|Overall Study|Adverse Event|1|||
164632483|NCT02924129|594676830|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
164632484|NCT02924129|594676831|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
164632485|NCT02924129|594676830|FG000|Overall Study|Withdrawal by Subject|2|||
164632486|NCT02924129|594676831|FG001|Overall Study|Withdrawal by Subject|2|||
164632487|NCT02924129|594676830|FG000|Overall Study|Physician Decision|1|||
164632488|NCT02924129|594676831|FG001|Overall Study|Physician Decision|0|||
164632489|NCT02924129|594676830|FG000|Overall Study|Missed Visit|0|||
164632490|NCT02924129|594676831|FG001|Overall Study|Missed Visit|1|||
164632491|NCT00302731|594676839|FG000|Overall Study|Lost to Follow-up|1|||
164632492|NCT00302731|594676840|FG001|Overall Study|Lost to Follow-up|2|||
164632493|NCT00302731|594676841|FG002|Overall Study|Lost to Follow-up|0|||
164529016|NCT01551212|594307829|FG000|Overall Study|Lost to Follow-up|0|||
164529017|NCT01551212|594307830|FG001|Overall Study|Lost to Follow-up|1|||
164529018|NCT01551212|594307829|FG000|Overall Study|Protocol Violation|0|||
164529019|NCT01551212|594307830|FG001|Overall Study|Protocol Violation|1|||
164529020|NCT01551212|594307829|FG000|Overall Study|Withdrawal by Subject|0|||
164529021|NCT01551212|594307830|FG001|Overall Study|Withdrawal by Subject|7|||
164529022|NCT01551212|594307829|FG000|Overall Study|Death|2|||
164529023|NCT01551212|594307830|FG001|Overall Study|Death|4|||
164529024|NCT01551212|594307829|FG000|Overall Study|Never Received Study Treatment|2|||
164529025|NCT01551212|594307830|FG001|Overall Study|Never Received Study Treatment|4|||
164529026|NCT00705523|594307831|FG000|Overall Study|Lost to Follow-up|2|||
164529027|NCT00705523|594307832|FG001|Overall Study|Lost to Follow-up|3|||
164529028|NCT02471833|594307834|FG000|Overall Study|Lost to Follow-up|1|||
164529029|NCT02471833|594307835|FG001|Overall Study|Lost to Follow-up|0|||
164529030|NCT02471833|594307836|FG002|Overall Study|Lost to Follow-up|0|||
164529031|NCT02471833|594307834|FG000|Overall Study|Withdrawal by Subject|2|||
164529032|NCT02471833|594307835|FG001|Overall Study|Withdrawal by Subject|1|||
164529033|NCT02471833|594307836|FG002|Overall Study|Withdrawal by Subject|5|||
164529034|NCT04217590|594307837|FG000|Overall Study|Other|1|||
164529035|NCT04217590|594307838|FG001|Overall Study|Other|1|||
164529036|NCT04217590|594307837|FG000|Overall Study|Withdrawal by Subject|3|||
164529037|NCT04217590|594307838|FG001|Overall Study|Withdrawal by Subject|1|||
164529038|NCT04217590|594307837|FG000|Overall Study|Death|0|||
164529039|NCT04217590|594307838|FG001|Overall Study|Death|1|||
164529040|NCT02673515|594307839|FG000|Overall Study|Lack of motivation|2|||
164529041|NCT02673515|594307840|FG001|Overall Study|Lack of motivation|1|||
164529042|NCT02232243|594307841|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
164529043|NCT02232243|594307842|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
164529044|NCT02232243|594307843|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
164529045|NCT01946438|594307844|FG000|Overall Study|Adverse Event|0|||
164529046|NCT01946438|594307845|FG001|Overall Study|Adverse Event|0|||
164529047|NCT01946438|594307846|FG002|Overall Study|Adverse Event|0|||
164529048|NCT01946438|594307847|FG003|Overall Study|Adverse Event|1|||
164529049|NCT01946438|594307844|FG000|Overall Study|Serious Adverse event|1|||
164529050|NCT01946438|594307845|FG001|Overall Study|Serious Adverse event|0|||
164529051|NCT01946438|594307846|FG002|Overall Study|Serious Adverse event|0|||
164529052|NCT01946438|594307847|FG003|Overall Study|Serious Adverse event|0|||
164529053|NCT01946438|594307844|FG000|Overall Study|Protocol Violation|0|||
164529054|NCT01946438|594307845|FG001|Overall Study|Protocol Violation|0|||
164529055|NCT01946438|594307846|FG002|Overall Study|Protocol Violation|1|||
164529056|NCT01946438|594307847|FG003|Overall Study|Protocol Violation|0|||
164529057|NCT01946438|594307844|FG000|Overall Study|Withdrawal by Subject|1|||
164529058|NCT01946438|594307845|FG001|Overall Study|Withdrawal by Subject|0|||
164529059|NCT01946438|594307846|FG002|Overall Study|Withdrawal by Subject|0|||
164529060|NCT01946438|594307847|FG003|Overall Study|Withdrawal by Subject|0|||
164529061|NCT02457559|594307848|FG000|Overall Study|Progressive Disease|1|||
164529062|NCT02457559|594307849|FG001|Overall Study|Progressive Disease|2|||
164529063|NCT02457559|594307850|FG002|Overall Study|Progressive Disease|3|||
164529064|NCT02457559|594307851|FG003|Overall Study|Progressive Disease|0|||
164529065|NCT02457559|594307852|FG004|Overall Study|Progressive Disease|0|||
164529066|NCT02457559|594307853|FG005|Overall Study|Progressive Disease|2|||
164529067|NCT02457559|594307854|FG006|Overall Study|Progressive Disease|1|||
164529068|NCT02457559|594307855|FG007|Overall Study|Progressive Disease|0|||
164529069|NCT02457559|594307856|FG008|Overall Study|Progressive Disease|1|||
164529070|NCT02457559|594307857|FG009|Overall Study|Progressive Disease|1|||
164529071|NCT02457559|594307858|FG010|Overall Study|Progressive Disease|1|||
164529072|NCT02457559|594307848|FG000|Overall Study|Investigator's Discretion|0|||
164529073|NCT02457559|594307849|FG001|Overall Study|Investigator's Discretion|0|||
164529074|NCT02457559|594307850|FG002|Overall Study|Investigator's Discretion|2|||
164529075|NCT02457559|594307851|FG003|Overall Study|Investigator's Discretion|0|||
164529076|NCT02457559|594307852|FG004|Overall Study|Investigator's Discretion|1|||
164529077|NCT02457559|594307853|FG005|Overall Study|Investigator's Discretion|0|||
164529078|NCT02457559|594307854|FG006|Overall Study|Investigator's Discretion|1|||
164529079|NCT02457559|594307855|FG007|Overall Study|Investigator's Discretion|0|||
164529080|NCT02457559|594307856|FG008|Overall Study|Investigator's Discretion|1|||
164529081|NCT02457559|594307857|FG009|Overall Study|Investigator's Discretion|0|||
164529082|NCT02457559|594307858|FG010|Overall Study|Investigator's Discretion|1|||
164529083|NCT02457559|594307848|FG000|Overall Study|Adverse Event|0|||
164529084|NCT02457559|594307849|FG001|Overall Study|Adverse Event|1|||
164529085|NCT02457559|594307850|FG002|Overall Study|Adverse Event|2|||
164632494|NCT00302731|594676842|FG003|Overall Study|Lost to Follow-up|0|||
164632495|NCT00302731|594676839|FG000|Overall Study|Adverse Event|0|||
164632496|NCT00302731|594676840|FG001|Overall Study|Adverse Event|2|||
164632497|NCT00302731|594676841|FG002|Overall Study|Adverse Event|2|||
164632498|NCT00302731|594676842|FG003|Overall Study|Adverse Event|0|||
164632499|NCT00302731|594676839|FG000|Overall Study|Withdrawal by Subject|1|||
164632500|NCT00302731|594676840|FG001|Overall Study|Withdrawal by Subject|1|||
164632501|NCT00302731|594676841|FG002|Overall Study|Withdrawal by Subject|0|||
164632502|NCT00302731|594676842|FG003|Overall Study|Withdrawal by Subject|0|||
164632503|NCT00302731|594676839|FG000|Overall Study|Protocol Violation|1|||
164632504|NCT00302731|594676840|FG001|Overall Study|Protocol Violation|0|||
164632505|NCT00302731|594676841|FG002|Overall Study|Protocol Violation|0|||
164632506|NCT00302731|594676842|FG003|Overall Study|Protocol Violation|0|||
164632507|NCT00302731|594676839|FG000|Overall Study|cancer unrelated to study discovered|1|||
164632508|NCT00302731|594676840|FG001|Overall Study|cancer unrelated to study discovered|0|||
164632509|NCT00302731|594676841|FG002|Overall Study|cancer unrelated to study discovered|1|||
164632510|NCT00302731|594676842|FG003|Overall Study|cancer unrelated to study discovered|0|||
164632511|NCT01610752|594676845|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
164632512|NCT01610752|594676846|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
164632513|NCT01610752|594676847|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
164632514|NCT00283062|594676848|FG000|Overall Study|Did not receive any study medication|5|||
164632515|NCT00283062|594676849|FG001|Overall Study|Did not receive any study medication|4|||
164632516|NCT00283062|594676850|FG002|Overall Study|Did not receive any study medication|36|||
164632517|NCT00283062|594676851|FG003|Overall Study|Did not receive any study medication|45|||
164632518|NCT00283062|594676848|FG000|Overall Study|Adverse Event|2|||
164632519|NCT00283062|594676849|FG001|Overall Study|Adverse Event|0|||
164632520|NCT00283062|594676850|FG002|Overall Study|Adverse Event|1|||
164632521|NCT00283062|594676851|FG003|Overall Study|Adverse Event|0|||
164632522|NCT00283062|594676848|FG000|Overall Study|Lost to Follow-up|1|||
164632523|NCT00283062|594676849|FG001|Overall Study|Lost to Follow-up|0|||
164632524|NCT00283062|594676850|FG002|Overall Study|Lost to Follow-up|1|||
164632525|NCT00283062|594676851|FG003|Overall Study|Lost to Follow-up|0|||
164632526|NCT00283062|594676848|FG000|Overall Study|Progressive disease|0|||
164632527|NCT00283062|594676849|FG001|Overall Study|Progressive disease|0|||
164632528|NCT00283062|594676850|FG002|Overall Study|Progressive disease|1|||
164632529|NCT00283062|594676851|FG003|Overall Study|Progressive disease|0|||
164632530|NCT00283062|594676848|FG000|Overall Study|Participant did not wish to continue|3|||
164632531|NCT00283062|594676849|FG001|Overall Study|Participant did not wish to continue|2|||
164632532|NCT00283062|594676850|FG002|Overall Study|Participant did not wish to continue|1|||
164632533|NCT00283062|594676851|FG003|Overall Study|Participant did not wish to continue|0|||
164632534|NCT00283062|594676848|FG000|Overall Study|Undefined|0|||
164632535|NCT00283062|594676849|FG001|Overall Study|Undefined|1|||
164632536|NCT00283062|594676850|FG002|Overall Study|Undefined|1|||
164632537|NCT00283062|594676851|FG003|Overall Study|Undefined|4|||
164632538|NCT00283062|594676848|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
164632539|NCT00283062|594676849|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
164632540|NCT00283062|594676850|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
164632541|NCT00283062|594676851|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
164632542|NCT01843933|594676852|FG000|Overall Study|Data lost|6|||
164632543|NCT01843933|594676853|FG001|Overall Study|Data lost|4|||
164632544|NCT03137173|594676854|FG000|Overall Study|Withdrawal by Subject|8|||
164632545|NCT03137173|594676855|FG001|Overall Study|Withdrawal by Subject|13|||
164632546|NCT03137173|594676854|FG000|Overall Study|Death|1|||
164632547|NCT03137173|594676855|FG001|Overall Study|Death|3|||
164632548|NCT03137173|594676854|FG000|Overall Study|Physician Decision|1|||
164632549|NCT03137173|594676855|FG001|Overall Study|Physician Decision|0|||
164632550|NCT03137173|594676854|FG000|Overall Study|Lost to Follow-up|13|||
164632551|NCT03137173|594676855|FG001|Overall Study|Lost to Follow-up|18|||
164632552|NCT03137173|594676854|FG000|Overall Study|Other reasons|3|||
164632553|NCT03137173|594676855|FG001|Overall Study|Other reasons|2|||
164632554|NCT01535638|594676856|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
164632555|NCT01535638|594676857|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
164632556|NCT01535638|594676858|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
164632557|NCT01535638|594676859|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
164632558|NCT01535638|594676860|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
164632559|NCT01535638|594676861|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
164632560|NCT01535638|594676856|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
164632561|NCT01535638|594676857|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
164632562|NCT01535638|594676858|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
164632563|NCT01535638|594676859|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
164632564|NCT01535638|594676860|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
164632565|NCT01535638|594676861|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
164632566|NCT05060003|594676862|FG000|Overall Study|ctDNA negative|7|||
164632567|NCT03524664|594676863|FG000|Overall Study|Withdrawal by Subject|1|||
164632568|NCT03524664|594676864|FG001|Overall Study|Withdrawal by Subject|2|||
164632569|NCT03524664|594676863|FG000|Overall Study|Lost to Follow-up|4|||
164632570|NCT03524664|594676864|FG001|Overall Study|Lost to Follow-up|13|||
164632571|NCT01482598|594676865|FG000|Overall Study|Death|7|||
164632572|NCT01482598|594676866|FG001|Overall Study|Death|10|||
164632573|NCT01482598|594676865|FG000|Overall Study|Physician Decision|0|||
164632574|NCT01482598|594676866|FG001|Overall Study|Physician Decision|3|||
164632575|NCT01482598|594676865|FG000|Overall Study|Withdrawal by Subject|4|||
164632576|NCT01482598|594676866|FG001|Overall Study|Withdrawal by Subject|5|||
164632577|NCT01482598|594676865|FG000|Overall Study|Lost to Follow-up|5|||
164632578|NCT01482598|594676866|FG001|Overall Study|Lost to Follow-up|4|||
164632579|NCT01373294|594676867|FG000|Overall Study|Adverse Event|1|||
164632580|NCT01373294|594676868|FG001|Overall Study|Adverse Event|0|||
164632581|NCT00423267|594676869|FG000|Period A|Withdrawal by Subject|0|||
164632582|NCT00423267|594676870|FG001|Period A|Withdrawal by Subject|1|||
164632583|NCT00423267|594676869|FG000|Period A|Non-compliance with protocol|1|||
164632584|NCT00423267|594676870|FG001|Period A|Non-compliance with protocol|0|||
164632585|NCT00423267|594676869|FG000|Period A|Administrative|1|||
164632586|NCT00423267|594676870|FG001|Period A|Administrative|0|||
164632587|NCT03702166|594676871|FG000|Overall Study|Lost to Follow-up|1|||
164632588|NCT03702166|594676871|FG000|Overall Study|Withdrawal by Subject|1|||
164632589|NCT00827112|594676872|FG000|Overall Study|Adverse Event|2|||
164632590|NCT00827112|594676873|FG001|Overall Study|Adverse Event|0|||
164632591|NCT00827112|594676872|FG000|Overall Study|Lack of Efficacy|2|||
164632592|NCT00827112|594676873|FG001|Overall Study|Lack of Efficacy|0|||
164632593|NCT00827112|594676872|FG000|Overall Study|Lost to Follow-up|3|||
164632594|NCT00827112|594676873|FG001|Overall Study|Lost to Follow-up|2|||
164632595|NCT00827112|594676872|FG000|Overall Study|Pregnancy|0|||
164632596|NCT00827112|594676873|FG001|Overall Study|Pregnancy|1|||
164632597|NCT00827112|594676872|FG000|Overall Study|Protocol Violation|0|||
164632598|NCT00827112|594676873|FG001|Overall Study|Protocol Violation|2|||
164632599|NCT00827112|594676872|FG000|Overall Study|Withdrawal by Subject|2|||
164632600|NCT00827112|594676873|FG001|Overall Study|Withdrawal by Subject|1|||
164632601|NCT00827112|594676872|FG000|Overall Study|Randomized but not treated|5|||
164632602|NCT00827112|594676873|FG001|Overall Study|Randomized but not treated|3|||
164632603|NCT00827112|594676872|FG000|Overall Study|Other|1|||
164632604|NCT00827112|594676873|FG001|Overall Study|Other|3|||
164632605|NCT01333865|594676874|FG000|Overall Study|Adverse Event|2|||
164632606|NCT03512028|594676877|FG000|Overall Study|Withdrawal by Subject|2|||
164632607|NCT03512028|594676878|FG001|Overall Study|Withdrawal by Subject|0|||
164632608|NCT03512028|594676877|FG000|Overall Study|Protocol Violation|2|||
164632609|NCT03512028|594676878|FG001|Overall Study|Protocol Violation|0|||
164632610|NCT02127931|594676881|FG000|Overall Study|Glitch in Game|1|||
164632611|NCT00939094|594676882|FG000|Overall Study|Adverse Event|9|||
164632612|NCT00939094|594676883|FG001|Overall Study|Adverse Event|0|||
164632613|NCT00939094|594676882|FG000|Overall Study|Withdrawal by Subject|1|||
164632614|NCT00939094|594676883|FG001|Overall Study|Withdrawal by Subject|6|||
164632615|NCT00939094|594676882|FG000|Overall Study|Lost to Follow-up|1|||
164632616|NCT00939094|594676883|FG001|Overall Study|Lost to Follow-up|1|||
164632617|NCT00939094|594676882|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
164632618|NCT00939094|594676883|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164632619|NCT00939094|594676882|FG000|Overall Study|Severe non-compliance to protocol|0|||
164632620|NCT00939094|594676883|FG001|Overall Study|Severe non-compliance to protocol|1|||
164632621|NCT00939094|594676882|FG000|Overall Study|Study stopped by sponsor|0|||
164632622|NCT00939094|594676883|FG001|Overall Study|Study stopped by sponsor|2|||
164632623|NCT00939094|594676882|FG000|Overall Study|Abnormal ECG findings|1|||
164632624|NCT00939094|594676883|FG001|Overall Study|Abnormal ECG findings|0|||
164632625|NCT02028182|594678421|FG000|Overall Study|Protocol Violation|2|||
164632626|NCT01684930|594678422|FG000|Overall Study|Withdrawal by Subject|3|||
164632627|NCT01684930|594678423|FG001|Overall Study|Withdrawal by Subject|1|||
164632628|NCT01945866|594678424|FG000|Overall Study|Eyes did not complete or were dropped|2|||
164632629|NCT01945866|594678425|FG001|Overall Study|Eyes did not complete or were dropped|0|||
164632630|NCT01336647|594678426|FG000|Overall Study|Lost to Follow-up|4|||
164632631|NCT01336647|594678427|FG001|Overall Study|Lost to Follow-up|1|||
164632632|NCT01336647|594678428|FG002|Overall Study|Lost to Follow-up|3|||
164529086|NCT02457559|594307851|FG003|Overall Study|Adverse Event|0|||
164529087|NCT02457559|594307852|FG004|Overall Study|Adverse Event|0|||
164529088|NCT02457559|594307853|FG005|Overall Study|Adverse Event|0|||
164529089|NCT02457559|594307854|FG006|Overall Study|Adverse Event|0|||
164529090|NCT02457559|594307855|FG007|Overall Study|Adverse Event|0|||
164529091|NCT02457559|594307856|FG008|Overall Study|Adverse Event|0|||
164529092|NCT02457559|594307857|FG009|Overall Study|Adverse Event|0|||
164529093|NCT02457559|594307858|FG010|Overall Study|Adverse Event|0|||
164529094|NCT02457559|594307848|FG000|Overall Study|Reason not Specified|1|||
164529095|NCT02457559|594307849|FG001|Overall Study|Reason not Specified|0|||
164529096|NCT02457559|594307850|FG002|Overall Study|Reason not Specified|0|||
164529097|NCT02457559|594307851|FG003|Overall Study|Reason not Specified|0|||
164529098|NCT02457559|594307852|FG004|Overall Study|Reason not Specified|0|||
164529099|NCT02457559|594307853|FG005|Overall Study|Reason not Specified|0|||
164529100|NCT02457559|594307854|FG006|Overall Study|Reason not Specified|0|||
164529101|NCT02457559|594307855|FG007|Overall Study|Reason not Specified|0|||
164529102|NCT02457559|594307856|FG008|Overall Study|Reason not Specified|0|||
164529103|NCT02457559|594307857|FG009|Overall Study|Reason not Specified|2|||
164529104|NCT02457559|594307858|FG010|Overall Study|Reason not Specified|0|||
164529105|NCT02457559|594307848|FG000|Overall Study|Death|0|||
164529106|NCT02457559|594307849|FG001|Overall Study|Death|0|||
164529107|NCT02457559|594307850|FG002|Overall Study|Death|0|||
164529108|NCT02457559|594307851|FG003|Overall Study|Death|0|||
164529109|NCT02457559|594307852|FG004|Overall Study|Death|0|||
164529110|NCT02457559|594307853|FG005|Overall Study|Death|0|||
164529111|NCT02457559|594307854|FG006|Overall Study|Death|0|||
164529112|NCT02457559|594307855|FG007|Overall Study|Death|0|||
164529113|NCT02457559|594307856|FG008|Overall Study|Death|1|||
164529114|NCT02457559|594307857|FG009|Overall Study|Death|1|||
164529115|NCT02457559|594307858|FG010|Overall Study|Death|0|||
164529116|NCT02412371|594307861|FG000|Overall Study|Withdrawal by Subject|0|||
164529117|NCT02412371|594307862|FG001|Overall Study|Withdrawal by Subject|2|||
164529118|NCT02412371|594307863|FG002|Overall Study|Withdrawal by Subject|0|||
164529119|NCT02412371|594307864|FG003|Overall Study|Withdrawal by Subject|1|||
164529120|NCT02412371|594307865|FG004|Overall Study|Withdrawal by Subject|1|||
164529121|NCT02412371|594307866|FG005|Overall Study|Withdrawal by Subject|0|||
164529122|NCT02412371|594307861|FG000|Overall Study|Sponsor Discontinued Study|1|||
164529123|NCT02412371|594307862|FG001|Overall Study|Sponsor Discontinued Study|4|||
164529124|NCT02412371|594307863|FG002|Overall Study|Sponsor Discontinued Study|6|||
164529125|NCT02412371|594307864|FG003|Overall Study|Sponsor Discontinued Study|4|||
164529126|NCT02412371|594307865|FG004|Overall Study|Sponsor Discontinued Study|5|||
164529127|NCT02412371|594307866|FG005|Overall Study|Sponsor Discontinued Study|0|||
164529128|NCT02412371|594307861|FG000|Overall Study|Death|4|||
164529129|NCT02412371|594307862|FG001|Overall Study|Death|2|||
164529130|NCT02412371|594307863|FG002|Overall Study|Death|1|||
164632633|NCT01018680|594678429|FG000|Overall Study|Adverse Event|23|||
164632634|NCT01018680|594678430|FG001|Overall Study|Adverse Event|40|||
164632635|NCT01018680|594678429|FG000|Overall Study|Withdrawal by Subject|10|||
164632636|NCT01018680|594678430|FG001|Overall Study|Withdrawal by Subject|10|||
164632637|NCT01018680|594678429|FG000|Overall Study|Protocol Violation|5|||
164632638|NCT01018680|594678430|FG001|Overall Study|Protocol Violation|8|||
164632639|NCT01018680|594678429|FG000|Overall Study|Sponsor Decision|6|||
164632640|NCT01018680|594678430|FG001|Overall Study|Sponsor Decision|7|||
164632641|NCT01018680|594678429|FG000|Overall Study|Lack of Efficacy|8|||
164632642|NCT01018680|594678430|FG001|Overall Study|Lack of Efficacy|2|||
164632643|NCT01018680|594678429|FG000|Overall Study|Lost to Follow-up|5|||
164632644|NCT01018680|594678430|FG001|Overall Study|Lost to Follow-up|3|||
164632645|NCT01018680|594678429|FG000|Overall Study|Entry Criteria Not Met|1|||
164632646|NCT01018680|594678430|FG001|Overall Study|Entry Criteria Not Met|4|||
164632647|NCT01018680|594678429|FG000|Overall Study|Physician Decision|3|||
164632648|NCT01018680|594678430|FG001|Overall Study|Physician Decision|1|||
164632649|NCT05056311|594678431|FG000|Overall Study|Lost to Follow-up|14|||
164632650|NCT05056311|594678431|FG000|Overall Study|Withdrawal by Subject|1|||
164632651|NCT05056311|594678431|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
164632652|NCT02600559|594678433|FG000|Overall Study|Withdrawal by Subject|3|||
164632653|NCT02600559|594678433|FG000|Overall Study|Lost to Follow-up|20|||
164632654|NCT00665366|594678438|FG000|Overall Study|Lack of Efficacy|11|||
164632655|NCT00665366|594678439|FG001|Overall Study|Lack of Efficacy|10|||
164632656|NCT00665366|594678438|FG000|Overall Study|Adverse Event|25|||
164632657|NCT00665366|594678439|FG001|Overall Study|Adverse Event|23|||
164632658|NCT00665366|594678438|FG000|Overall Study|Withdrawal by Subject|11|||
164632659|NCT00665366|594678439|FG001|Overall Study|Withdrawal by Subject|14|||
164632660|NCT00665366|594678438|FG000|Overall Study|Lost to Follow-up|3|||
164632661|NCT00665366|594678439|FG001|Overall Study|Lost to Follow-up|5|||
164632662|NCT00665366|594678438|FG000|Overall Study|Poor compliance/noncompliance|3|||
164632663|NCT00665366|594678439|FG001|Overall Study|Poor compliance/noncompliance|5|||
164632664|NCT00665366|594678438|FG000|Overall Study|Pregnancy|1|||
164632665|NCT00665366|594678439|FG001|Overall Study|Pregnancy|0|||
164632666|NCT00665366|594678438|FG000|Overall Study|No longer meets study criteria|0|||
164632667|NCT00665366|594678439|FG001|Overall Study|No longer meets study criteria|1|||
164632668|NCT00665366|594678438|FG000|Overall Study|Other reasons|4|||
164632669|NCT00665366|594678439|FG001|Overall Study|Other reasons|1|||
164632670|NCT03628781|594678441|FG000|Overall Study|Lost to Follow-up|16|||
164632671|NCT03628781|594678442|FG001|Overall Study|Lost to Follow-up|8|||
164632672|NCT03628781|594678441|FG000|Overall Study|Withdrawal by Subject|16|||
164632673|NCT03628781|594678442|FG001|Overall Study|Withdrawal by Subject|1|||
164632674|NCT03039686|594678446|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
164632675|NCT03039686|594678447|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
164632676|NCT03039686|594678448|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
164632677|NCT03039686|594678446|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
164632678|NCT03039686|594678447|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
164632679|NCT03039686|594678448|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
164632680|NCT03039686|594678446|FG000|Double-blind Period|Withdrawal by Subject|2|||
164632681|NCT03039686|594678447|FG001|Double-blind Period|Withdrawal by Subject|2|||
164632682|NCT03039686|594678448|FG002|Double-blind Period|Withdrawal by Subject|1|||
164632683|NCT03039686|594678446|FG000|Double-blind Period|Death|0|||
164632684|NCT03039686|594678447|FG001|Double-blind Period|Death|0|||
164632685|NCT03039686|594678448|FG002|Double-blind Period|Death|1|||
164632686|NCT03039686|594678446|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
164632687|NCT03039686|594678447|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
164632688|NCT03039686|594678448|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
164632689|NCT03039686|594678446|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
164632690|NCT03039686|594678447|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
164632691|NCT03039686|594678448|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
164632692|NCT03039686|594678446|FG000|Open Label Period|Withdrawal by Subject|0|||
164632693|NCT03039686|594678447|FG001|Open Label Period|Withdrawal by Subject|3|||
164632694|NCT03039686|594678448|FG002|Open Label Period|Withdrawal by Subject|1|||
164632695|NCT02718131|594678454|FG000|Overall Study|Withdrawal by Subject|1|||
164632696|NCT02718131|594678455|FG001|Overall Study|Withdrawal by Subject|0|||
164632697|NCT02718131|594678454|FG000|Overall Study|Adverse Event|1|||
164632698|NCT02718131|594678455|FG001|Overall Study|Adverse Event|0|||
164632699|NCT02718131|594678454|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
164632700|NCT02718131|594678455|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
164632701|NCT00134563|594678456|FG000|Overall Study|Not treated due to protocol violation|0|||
164632702|NCT00134563|594678457|FG001|Overall Study|Not treated due to protocol violation|1|||
164632703|NCT00134563|594678458|FG002|Overall Study|Not treated due to protocol violation|1|||
164632704|NCT00134563|594678456|FG000|Overall Study|Adverse Event|29|||
164632705|NCT00134563|594678457|FG001|Overall Study|Adverse Event|37|||
164632706|NCT00134563|594678458|FG002|Overall Study|Adverse Event|38|||
164632707|NCT00134563|594678456|FG000|Overall Study|Lack of Efficacy|24|||
164632708|NCT00134563|594678457|FG001|Overall Study|Lack of Efficacy|14|||
164632709|NCT00134563|594678458|FG002|Overall Study|Lack of Efficacy|17|||
164632710|NCT00134563|594678456|FG000|Overall Study|Protocol Violation|3|||
164632711|NCT00134563|594678457|FG001|Overall Study|Protocol Violation|2|||
164632712|NCT00134563|594678458|FG002|Overall Study|Protocol Violation|5|||
164632713|NCT00134563|594678456|FG000|Overall Study|Lost to Follow-up|4|||
164632714|NCT00134563|594678457|FG001|Overall Study|Lost to Follow-up|0|||
164632715|NCT00134563|594678458|FG002|Overall Study|Lost to Follow-up|2|||
164632716|NCT00134563|594678456|FG000|Overall Study|progressive disease|11|||
164632717|NCT00134563|594678457|FG001|Overall Study|progressive disease|4|||
164632718|NCT00134563|594678458|FG002|Overall Study|progressive disease|2|||
164632719|NCT00134563|594678456|FG000|Overall Study|did not wish to continue|33|||
164632720|NCT00134563|594678457|FG001|Overall Study|did not wish to continue|32|||
164632721|NCT00134563|594678458|FG002|Overall Study|did not wish to continue|26|||
164632722|NCT00134563|594678456|FG000|Overall Study|Reason other than above|0|||
164632723|NCT00134563|594678457|FG001|Overall Study|Reason other than above|2|||
164632724|NCT00134563|594678458|FG002|Overall Study|Reason other than above|5|||
164632725|NCT02406586|594678462|FG000|Overall Study|Lost to Follow-up|0|||
164632726|NCT02406586|594678463|FG001|Overall Study|Lost to Follow-up|4|||
164632727|NCT02406586|594678464|FG002|Overall Study|Lost to Follow-up|2|||
164632728|NCT02406586|594678462|FG000|Overall Study|Withdrawal by Subject|1|||
164632729|NCT02406586|594678463|FG001|Overall Study|Withdrawal by Subject|0|||
164632730|NCT02406586|594678464|FG002|Overall Study|Withdrawal by Subject|0|||
164632731|NCT03382639|594678465|FG000|Overall Study|Adverse Event|2|||
164632732|NCT03382639|594678466|FG001|Overall Study|Adverse Event|0|||
164632733|NCT03382639|594678467|FG002|Overall Study|Adverse Event|1|||
164632734|NCT03382639|594678468|FG003|Overall Study|Adverse Event|1|||
164632735|NCT03382639|594678465|FG000|Overall Study|Lost to Follow-up|1|||
164632736|NCT03382639|594678466|FG001|Overall Study|Lost to Follow-up|0|||
164632737|NCT03382639|594678467|FG002|Overall Study|Lost to Follow-up|0|||
164632738|NCT03382639|594678468|FG003|Overall Study|Lost to Follow-up|0|||
164632739|NCT03382639|594678465|FG000|Overall Study|Withdrawal by Subject|4|||
164632740|NCT03382639|594678466|FG001|Overall Study|Withdrawal by Subject|3|||
164632741|NCT03382639|594678467|FG002|Overall Study|Withdrawal by Subject|2|||
164632742|NCT03382639|594678468|FG003|Overall Study|Withdrawal by Subject|3|||
164632743|NCT03382639|594678465|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
164632744|NCT03382639|594678466|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
164632745|NCT03382639|594678467|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
164632746|NCT03382639|594678468|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
164632747|NCT03382639|594678465|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
164632748|NCT03382639|594678466|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
164632749|NCT03382639|594678467|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
164632750|NCT03382639|594678468|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
164632751|NCT03382639|594678465|FG000|Overall Study|Other|2|||
164632752|NCT03382639|594678466|FG001|Overall Study|Other|0|||
164632753|NCT03382639|594678467|FG002|Overall Study|Other|0|||
164632754|NCT03382639|594678468|FG003|Overall Study|Other|3|||
164632755|NCT00285857|594678471|FG000|Overall Study|Withdrawal by Subject|2|||
164632756|NCT00285857|594678471|FG000|Overall Study|Inadequate initial breast cytology|1|||
164632757|NCT00285857|594678471|FG000|Overall Study|Adverse Event|1|||
164632758|NCT01005875|594678483|FG000|Overall Study|Death|3|||
164632759|NCT00606931|594678484|FG000|Overall Study|Withdrawal by Subject|3|||
164632760|NCT01348828|594678498|FG000|Overall Study|Death|20|||
164632761|NCT01348828|594678498|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
164632762|NCT01348828|594678498|FG000|Overall Study|Conversion|2|||
164632763|NCT01348828|594678498|FG000|Overall Study|missed visit|1|||
164632764|NCT04246996|594678500|FG000|Overall Study|Physician Decision|1|||
164632765|NCT04246996|594678501|FG001|Overall Study|Physician Decision|1|||
164632766|NCT04246996|594678500|FG000|Overall Study|Did not meet eligibility criteria|1|||
164632767|NCT04246996|594678501|FG001|Overall Study|Did not meet eligibility criteria|4|||
164632768|NCT02442284|594678502|FG000|Overall Study|Adverse Event|1|||
164632769|NCT02442284|594678502|FG000|Overall Study|Withdrew Consent|2|||
164632770|NCT02442284|594678502|FG000|Overall Study|Lost to Follow-up|3|||
164632771|NCT02442284|594678502|FG000|Overall Study|Other|1|||
164632772|NCT00252499|594678508|FG000|Overall Study|Lost to Follow-up|1|||
164632773|NCT00252499|594678509|FG001|Overall Study|Lost to Follow-up|0|||
164632774|NCT00252499|594678510|FG002|Overall Study|Lost to Follow-up|0|||
164632775|NCT01365468|594678511|FG000|Overall Study|Physician Decision|1|||
164632776|NCT01365468|594678512|FG001|Overall Study|Physician Decision|0|||
164632777|NCT01365468|594678511|FG000|Overall Study|Disease progression|1|||
164632778|NCT01365468|594678512|FG001|Overall Study|Disease progression|0|||
164632779|NCT01365468|594678511|FG000|Overall Study|Lost to Follow-up|2|||
164632780|NCT01365468|594678512|FG001|Overall Study|Lost to Follow-up|0|||
164632781|NCT01521494|594678515|FG000|Overall Study|Adverse Event|1|||
164632782|NCT01521494|594678516|FG001|Overall Study|Adverse Event|2|||
164529131|NCT02412371|594307864|FG003|Overall Study|Death|3|||
164529132|NCT02412371|594307865|FG004|Overall Study|Death|5|||
164529133|NCT02412371|594307866|FG005|Overall Study|Death|2|||
164529134|NCT02412371|594307861|FG000|Overall Study|Other|2|||
164529135|NCT02412371|594307862|FG001|Overall Study|Other|1|||
164529136|NCT02412371|594307863|FG002|Overall Study|Other|0|||
164529137|NCT02412371|594307864|FG003|Overall Study|Other|0|||
164529138|NCT02412371|594307865|FG004|Overall Study|Other|1|||
164529139|NCT02412371|594307866|FG005|Overall Study|Other|3|||
164529140|NCT02374671|594307867|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
164529141|NCT02374671|594307868|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
164529142|NCT02374671|594307869|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
164529143|NCT02374671|594307867|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
164529144|NCT02374671|594307868|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
164529145|NCT02374671|594307869|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
164529146|NCT02374671|594307867|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
164529147|NCT02374671|594307868|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
164529148|NCT02374671|594307869|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
164529149|NCT02374671|594307867|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
164529150|NCT02374671|594307868|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
164529151|NCT02374671|594307869|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
164529152|NCT02374671|594307867|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
164529153|NCT02374671|594307868|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
164529154|NCT02374671|594307869|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
164529155|NCT03169101|594307870|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
164529156|NCT03169101|594307871|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
164529157|NCT03169101|594307872|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
164529158|NCT03169101|594307873|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
164529159|NCT02641496|594307874|FG000|Overall Study|Lost to Follow-up|13|||
164529160|NCT02641496|594307875|FG001|Overall Study|Lost to Follow-up|12|||
164529161|NCT02641496|594307874|FG000|Overall Study|Withdrawal by Subject|1|||
164529162|NCT02641496|594307875|FG001|Overall Study|Withdrawal by Subject|0|||
164529163|NCT02523599|594307876|FG000|Overall Study|Adverse Event|1|||
164529164|NCT02523599|594307877|FG001|Overall Study|Adverse Event|0|||
164529165|NCT02523599|594307876|FG000|Overall Study|Physician Decision|1|||
164529166|NCT02523599|594307877|FG001|Overall Study|Physician Decision|0|||
164529167|NCT02523599|594307876|FG000|Overall Study|Lost to Follow-up|4|||
164529168|NCT02523599|594307877|FG001|Overall Study|Lost to Follow-up|1|||
164529169|NCT02523599|594307876|FG000|Overall Study|Did not return for Day 30 visit|2|||
164529170|NCT02523599|594307877|FG001|Overall Study|Did not return for Day 30 visit|0|||
164529171|NCT05590884|594307878|FG000|Overall Study|Withdrawal by Subject|1|||
164529172|NCT05590884|594307879|FG001|Overall Study|Withdrawal by Subject|0|||
164529173|NCT05590884|594307880|FG002|Overall Study|Withdrawal by Subject|0|||
164529174|NCT01892540|594307885|FG000|Overall Study|Did not complete PET/MRI|0|||
164529175|NCT01892540|594307886|FG001|Overall Study|Did not complete PET/MRI|0|||
164529176|NCT01892540|594307887|FG002|Overall Study|Did not complete PET/MRI|2|||
164529177|NCT01892540|594307885|FG000|Overall Study|Did not fit in scanner|0|||
164529178|NCT01892540|594307886|FG001|Overall Study|Did not fit in scanner|0|||
164529179|NCT01892540|594307887|FG002|Overall Study|Did not fit in scanner|1|||
164529180|NCT01370590|594307888|FG000|Period 1|Adverse Event|8|||
164529181|NCT01370590|594307889|FG001|Period 1|Adverse Event|4|||
164529182|NCT01370590|594307888|FG000|Period 1|Lost to Follow-up|2|||
164529183|NCT01370590|594307889|FG001|Period 1|Lost to Follow-up|2|||
164529184|NCT01370590|594307888|FG000|Period 1|Protocol Violation|2|||
164529185|NCT01370590|594307889|FG001|Period 1|Protocol Violation|2|||
164529186|NCT01370590|594307888|FG000|Period 1|Withdrawal by Subject|4|||
164529187|NCT01370590|594307889|FG001|Period 1|Withdrawal by Subject|2|||
164529188|NCT01370590|594307888|FG000|Period 1|Could not access randomization system|0|||
164529189|NCT01370590|594307889|FG001|Period 1|Could not access randomization system|1|||
164529190|NCT01370590|594307888|FG000|Crossover Washout Period|Adverse Event|1|||
164529191|NCT01370590|594307889|FG001|Crossover Washout Period|Adverse Event|4|||
164529192|NCT01370590|594307888|FG000|Crossover Washout Period|Lost to Follow-up|2|||
164529193|NCT01370590|594307889|FG001|Crossover Washout Period|Lost to Follow-up|0|||
164529194|NCT01370590|594307888|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
164632783|NCT01521494|594678517|FG002|Overall Study|Adverse Event|9|||
164529195|NCT01370590|594307889|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
164529196|NCT01370590|594307888|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
164529197|NCT01370590|594307889|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
164529198|NCT01370590|594307888|FG000|Period 2|Adverse Event|0|||
164529199|NCT01370590|594307889|FG001|Period 2|Adverse Event|1|||
164529200|NCT01370590|594307888|FG000|Period 2|Withdrawal by Subject|1|||
164529201|NCT01370590|594307889|FG001|Period 2|Withdrawal by Subject|1|||
164632784|NCT01521494|594678518|FG003|Overall Study|Adverse Event|6|||
164529202|NCT03110224|594307890|FG000|Overall Study|Death|3|||
164529203|NCT03110224|594307890|FG000|Overall Study|Lost to Follow-up|132|||
164529204|NCT03110224|594307890|FG000|Overall Study|Physician Decision|2|||
164529205|NCT03110224|594307890|FG000|Overall Study|Site Closed by Physician|35|||
164529206|NCT03110224|594307890|FG000|Overall Study|Site Closed by Sponsor|202|||
164529207|NCT03110224|594307890|FG000|Overall Study|Withdrawal by Subject|9|||
164529208|NCT00727311|594307891|FG000|Overall Study|Did not receive drug|316|||
164529209|NCT00727311|594307891|FG000|Overall Study|Missing end of therapy data|205|||
164529210|NCT00727311|594307891|FG000|Overall Study|Adverse Event|58|||
164529211|NCT00727311|594307891|FG000|Overall Study|Lack of Efficacy|242|||
164529212|NCT00727311|594307891|FG000|Overall Study|Lost to Follow-up|73|||
164529213|NCT00727311|594307891|FG000|Overall Study|Withdrawal by Subject|77|||
164529214|NCT00727311|594307891|FG000|Overall Study|Other|97|||
164529215|NCT00727311|594307891|FG000|Overall Study|Multiple reasons|39|||
164529216|NCT03992846|594307892|FG000|Overall Study|Adverse Event|8|||
164529217|NCT03992846|594307893|FG001|Overall Study|Adverse Event|6|||
164529218|NCT03992846|594307894|FG002|Overall Study|Adverse Event|3|||
164529219|NCT03992846|594307892|FG000|Overall Study|Lost to Follow-up|0|||
164529220|NCT03992846|594307893|FG001|Overall Study|Lost to Follow-up|1|||
164529221|NCT03992846|594307894|FG002|Overall Study|Lost to Follow-up|1|||
164529222|NCT03992846|594307892|FG000|Overall Study|Pregnancy|2|||
164529223|NCT03992846|594307893|FG001|Overall Study|Pregnancy|0|||
164529224|NCT03992846|594307894|FG002|Overall Study|Pregnancy|1|||
164529225|NCT03992846|594307892|FG000|Overall Study|Protocol Violation|1|||
164529226|NCT03992846|594307893|FG001|Overall Study|Protocol Violation|2|||
164529227|NCT03992846|594307894|FG002|Overall Study|Protocol Violation|0|||
164529228|NCT03992846|594307892|FG000|Overall Study|Withdrawal by Subject|8|||
164529229|NCT03992846|594307893|FG001|Overall Study|Withdrawal by Subject|10|||
164529230|NCT03992846|594307894|FG002|Overall Study|Withdrawal by Subject|20|||
164529231|NCT03992846|594307892|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
164529232|NCT03992846|594307893|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
164529233|NCT03992846|594307894|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
164529234|NCT03440320|594309408|FG000|Overall Study|Withdrawal by Subject|0|||
164529235|NCT03440320|594309409|FG001|Overall Study|Withdrawal by Subject|1|||
164529236|NCT01912456|594309410|FG000|Period 1|Physician Decision|0|||
164529237|NCT01912456|594309411|FG001|Period 1|Physician Decision|0|||
164529238|NCT01912456|594309412|FG002|Period 1|Physician Decision|1|||
164529239|NCT01912456|594309413|FG003|Period 1|Physician Decision|0|||
164529240|NCT01912456|594309410|FG000|Period 1|non-compliance|1|||
164529241|NCT01912456|594309411|FG001|Period 1|non-compliance|0|||
164529242|NCT01912456|594309412|FG002|Period 1|non-compliance|0|||
164529243|NCT01912456|594309413|FG003|Period 1|non-compliance|1|||
164529244|NCT01912456|594309410|FG000|Period 1|Adverse Event|1|||
164529245|NCT01912456|594309411|FG001|Period 1|Adverse Event|0|||
164529246|NCT01912456|594309412|FG002|Period 1|Adverse Event|0|||
164529247|NCT01912456|594309413|FG003|Period 1|Adverse Event|1|||
164529248|NCT01912456|594309410|FG000|Period 1|Withdrawal by Subject|0|||
164529249|NCT01912456|594309411|FG001|Period 1|Withdrawal by Subject|1|||
164529250|NCT01912456|594309412|FG002|Period 1|Withdrawal by Subject|1|||
164529251|NCT01912456|594309413|FG003|Period 1|Withdrawal by Subject|1|||
164529252|NCT01912456|594309410|FG000|Period 2|Lack of Efficacy|0|||
164529253|NCT01912456|594309411|FG001|Period 2|Lack of Efficacy|2|||
164529254|NCT01912456|594309412|FG002|Period 2|Lack of Efficacy|0|||
164529255|NCT01912456|594309413|FG003|Period 2|Lack of Efficacy|0|||
164529256|NCT01912456|594309410|FG000|Period 2|Adverse Event|0|||
164529257|NCT01912456|594309411|FG001|Period 2|Adverse Event|0|||
164529258|NCT01912456|594309412|FG002|Period 2|Adverse Event|0|||
164529259|NCT01912456|594309413|FG003|Period 2|Adverse Event|1|||
164529260|NCT01340196|594309414|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
164529261|NCT01440374|594309420|FG000|Part 1: Open-label Phase|Adverse Event|5|||
164529262|NCT01440374|594309421|FG001|Part 1: Open-label Phase|Adverse Event|0|||
164529263|NCT01440374|594309422|FG002|Part 1: Open-label Phase|Adverse Event|0|||
164529264|NCT01440374|594309423|FG003|Part 1: Open-label Phase|Adverse Event|0|||
164529265|NCT01440374|594309420|FG000|Part 1: Open-label Phase|Physician Decision|1|||
164529266|NCT01440374|594309421|FG001|Part 1: Open-label Phase|Physician Decision|0|||
164529267|NCT01440374|594309422|FG002|Part 1: Open-label Phase|Physician Decision|0|||
164529268|NCT01440374|594309423|FG003|Part 1: Open-label Phase|Physician Decision|0|||
164632785|NCT01521494|594678519|FG004|Overall Study|Adverse Event|2|||
164529269|NCT01440374|594309420|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
164529270|NCT01440374|594309421|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
164529271|NCT01440374|594309422|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
164529272|NCT01440374|594309423|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
164529273|NCT01440374|594309420|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
164529274|NCT01440374|594309421|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
164529275|NCT01440374|594309422|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
164529276|NCT01440374|594309423|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
164529277|NCT01440374|594309420|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
164529278|NCT01440374|594309421|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
164529279|NCT01440374|594309422|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
164529280|NCT01440374|594309423|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
164529281|NCT01440374|594309420|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
164529282|NCT01440374|594309421|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
164529283|NCT01440374|594309422|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
164529284|NCT01440374|594309423|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
164529285|NCT01440374|594309420|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
164529286|NCT01440374|594309421|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
164529287|NCT01440374|594309422|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
164529288|NCT01440374|594309423|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
164529289|NCT01440374|594309420|FG000|Part 2; Double-blind Phase|Not treated|0|||
164529290|NCT01440374|594309421|FG001|Part 2; Double-blind Phase|Not treated|0|||
164529291|NCT01440374|594309422|FG002|Part 2; Double-blind Phase|Not treated|1|||
164529292|NCT01440374|594309423|FG003|Part 2; Double-blind Phase|Not treated|0|||
164529293|NCT01440374|594309420|FG000|Part 3: Extension|Withdrawal by Subject|0|||
164529294|NCT01440374|594309421|FG001|Part 3: Extension|Withdrawal by Subject|0|||
164529295|NCT01440374|594309422|FG002|Part 3: Extension|Withdrawal by Subject|0|||
164529296|NCT01440374|594309423|FG003|Part 3: Extension|Withdrawal by Subject|5|||
164529297|NCT01440374|594309420|FG000|Part 3: Extension|Adverse Event|0|||
164529298|NCT01440374|594309421|FG001|Part 3: Extension|Adverse Event|0|||
164529299|NCT01440374|594309422|FG002|Part 3: Extension|Adverse Event|0|||
164529300|NCT01440374|594309423|FG003|Part 3: Extension|Adverse Event|13|||
164529301|NCT01440374|594309420|FG000|Part 3: Extension|Physician Decision|0|||
164529302|NCT01440374|594309421|FG001|Part 3: Extension|Physician Decision|0|||
164529303|NCT01440374|594309422|FG002|Part 3: Extension|Physician Decision|0|||
164529304|NCT01440374|594309423|FG003|Part 3: Extension|Physician Decision|14|||
164529305|NCT00171704|594309424|FG000|Overall Study|Adverse Event|24|||
164529306|NCT00171704|594309425|FG001|Overall Study|Adverse Event|33|||
164529307|NCT00171704|594309424|FG000|Overall Study|Disease Progression|14|||
164529308|NCT00171704|594309425|FG001|Overall Study|Disease Progression|9|||
164529309|NCT00171704|594309424|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
164529310|NCT00171704|594309425|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
164529311|NCT00171704|594309424|FG000|Overall Study|Administrative Problems|2|||
164529312|NCT00171704|594309425|FG001|Overall Study|Administrative Problems|1|||
164529313|NCT00171704|594309424|FG000|Overall Study|Death|2|||
164529314|NCT00171704|594309425|FG001|Overall Study|Death|2|||
164529315|NCT00171704|594309424|FG000|Overall Study|Withdrawal by Subject|1|||
164529316|NCT00171704|594309425|FG001|Overall Study|Withdrawal by Subject|3|||
164529317|NCT00171704|594309424|FG000|Overall Study|Protocol Violation|0|||
164529318|NCT00171704|594309425|FG001|Overall Study|Protocol Violation|1|||
164529319|NCT04812548|594309426|FG000|Overall Study|Adverse Event|2|||
164529320|NCT04812548|594309427|FG001|Overall Study|Adverse Event|7|||
164529321|NCT04812548|594309426|FG000|Overall Study|HSCT Planned|2|||
164529322|NCT04812548|594309427|FG001|Overall Study|HSCT Planned|3|||
164529323|NCT04812548|594309426|FG000|Overall Study|Progressive Disease|0|||
164529324|NCT04812548|594309427|FG001|Overall Study|Progressive Disease|2|||
164529325|NCT04812548|594309426|FG000|Overall Study|Death|0|||
164529326|NCT04812548|594309427|FG001|Overall Study|Death|1|||
164529327|NCT04812548|594309426|FG000|Overall Study|Post Study Access to Treatment|0|||
164529328|NCT04812548|594309427|FG001|Overall Study|Post Study Access to Treatment|1|||
164529329|NCT04812548|594309426|FG000|Overall Study|Withdrawal by Subject|0|||
164529330|NCT04812548|594309427|FG001|Overall Study|Withdrawal by Subject|1|||
164529331|NCT04812548|594309426|FG000|Overall Study|Physician Decision|1|||
164529332|NCT04812548|594309427|FG001|Overall Study|Physician Decision|0|||
164529333|NCT02141984|594309429|FG000|Overall Study|Lack of Efficacy|2|||
164529334|NCT00816400|594309433|FG000|Overall Study|Death|2|||
164529335|NCT00816400|594309434|FG001|Overall Study|Death|3|||
164529336|NCT00816400|594309435|FG002|Overall Study|Death|3|||
164529337|NCT00816400|594309436|FG003|Overall Study|Death|3|||
164529338|NCT00816400|594309437|FG004|Overall Study|Death|2|||
164529339|NCT00816400|594309438|FG005|Overall Study|Death|3|||
164529340|NCT00816400|594309439|FG006|Overall Study|Death|2|||
164529341|NCT00816400|594309440|FG007|Overall Study|Death|5|||
164529342|NCT00816400|594309441|FG008|Overall Study|Death|6|||
164529343|NCT00816400|594309433|FG000|Overall Study|In hospice care at the end of the study|0|||
164529344|NCT00816400|594309434|FG001|Overall Study|In hospice care at the end of the study|0|||
164529345|NCT00816400|594309435|FG002|Overall Study|In hospice care at the end of the study|2|||
164529346|NCT00816400|594309436|FG003|Overall Study|In hospice care at the end of the study|0|||
164632786|NCT01521494|594678515|FG000|Overall Study|Lack of Efficacy|0|||
164529347|NCT00816400|594309437|FG004|Overall Study|In hospice care at the end of the study|0|||
164632787|NCT01521494|594678516|FG001|Overall Study|Lack of Efficacy|0|||
164632788|NCT01521494|594678517|FG002|Overall Study|Lack of Efficacy|0|||
164632789|NCT01521494|594678518|FG003|Overall Study|Lack of Efficacy|0|||
164632790|NCT01521494|594678519|FG004|Overall Study|Lack of Efficacy|2|||
164632791|NCT01521494|594678515|FG000|Overall Study|Withdrawal by Subject|1|||
164632792|NCT01521494|594678516|FG001|Overall Study|Withdrawal by Subject|1|||
164632793|NCT01521494|594678517|FG002|Overall Study|Withdrawal by Subject|0|||
164632794|NCT01521494|594678518|FG003|Overall Study|Withdrawal by Subject|2|||
164632795|NCT01521494|594678519|FG004|Overall Study|Withdrawal by Subject|0|||
164632796|NCT01521494|594678515|FG000|Overall Study|Decrease in serum phosphate|0|||
164632797|NCT01521494|594678516|FG001|Overall Study|Decrease in serum phosphate|2|||
164632798|NCT01521494|594678517|FG002|Overall Study|Decrease in serum phosphate|3|||
164632799|NCT01521494|594678518|FG003|Overall Study|Decrease in serum phosphate|12|||
164632800|NCT01521494|594678519|FG004|Overall Study|Decrease in serum phosphate|0|||
164632801|NCT01521494|594678515|FG000|Overall Study|Decrease in serum calcium|0|||
164632802|NCT01521494|594678516|FG001|Overall Study|Decrease in serum calcium|0|||
164632803|NCT01521494|594678517|FG002|Overall Study|Decrease in serum calcium|0|||
164632804|NCT01521494|594678518|FG003|Overall Study|Decrease in serum calcium|1|||
164632805|NCT01521494|594678519|FG004|Overall Study|Decrease in serum calcium|1|||
164632806|NCT01521494|594678515|FG000|Overall Study|Physician Decision|0|||
164632807|NCT01521494|594678516|FG001|Overall Study|Physician Decision|0|||
164632808|NCT01521494|594678517|FG002|Overall Study|Physician Decision|0|||
164632809|NCT01521494|594678518|FG003|Overall Study|Physician Decision|0|||
164632810|NCT01521494|594678519|FG004|Overall Study|Physician Decision|2|||
164632811|NCT01140646|594678520|FG000|Overall Study|Adverse Event|4|||
164632812|NCT01140646|594678520|FG000|Overall Study|Refused Further Treatment|5|||
164632813|NCT00689728|594678524|FG000|Double-Blind Treatment|Adverse Event|1|||
164632814|NCT00689728|594678525|FG001|Double-Blind Treatment|Adverse Event|0|||
164632815|NCT00689728|594678526|FG002|Double-Blind Treatment|Adverse Event|0|||
164632816|NCT00689728|594678524|FG000|Double-Blind Treatment|Protocol Violation|0|||
164632817|NCT00689728|594678525|FG001|Double-Blind Treatment|Protocol Violation|0|||
164632818|NCT00689728|594678526|FG002|Double-Blind Treatment|Protocol Violation|1|||
164632819|NCT00689728|594678524|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
164632820|NCT00689728|594678525|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
164632821|NCT00689728|594678526|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
164632822|NCT00689728|594678524|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
164632823|NCT00689728|594678525|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
164632824|NCT00689728|594678526|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
164632825|NCT00689728|594678524|FG000|Rescue|Adverse Event|0|||
164632826|NCT00689728|594678525|FG001|Rescue|Adverse Event|1|||
164632827|NCT00689728|594678526|FG002|Rescue|Adverse Event|0|||
164632828|NCT00689728|594678524|FG000|Rescue|Withdrawal by Subject|1|||
164632829|NCT00689728|594678525|FG001|Rescue|Withdrawal by Subject|1|||
164632830|NCT00689728|594678526|FG002|Rescue|Withdrawal by Subject|1|||
164632831|NCT00689728|594678524|FG000|Optional Follow-Up|Adverse Event|1|||
164632832|NCT00689728|594678525|FG001|Optional Follow-Up|Adverse Event|0|||
164632833|NCT00689728|594678526|FG002|Optional Follow-Up|Adverse Event|0|||
164632834|NCT00689728|594678524|FG000|Optional Follow-Up|Lack of Efficacy|0|||
164632835|NCT00689728|594678525|FG001|Optional Follow-Up|Lack of Efficacy|1|||
164632836|NCT00689728|594678526|FG002|Optional Follow-Up|Lack of Efficacy|1|||
164632837|NCT00689728|594678524|FG000|Optional Follow-Up|Lost to Follow-up|0|||
164632838|NCT00689728|594678525|FG001|Optional Follow-Up|Lost to Follow-up|1|||
164632839|NCT00689728|594678526|FG002|Optional Follow-Up|Lost to Follow-up|1|||
164632840|NCT00689728|594678524|FG000|Optional Follow-Up|Protocol Violation|0|||
164632841|NCT00689728|594678525|FG001|Optional Follow-Up|Protocol Violation|0|||
164632842|NCT00689728|594678526|FG002|Optional Follow-Up|Protocol Violation|1|||
164632843|NCT00689728|594678524|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
164632844|NCT00689728|594678525|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
164632845|NCT00689728|594678526|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
164632846|NCT00660829|594678532|FG000|Overall Study|Adverse Event|3|||
164632847|NCT00660829|594678533|FG001|Overall Study|Adverse Event|4|||
164632848|NCT00660829|594678532|FG000|Overall Study|Lack of Efficacy|2|||
164632849|NCT00660829|594678533|FG001|Overall Study|Lack of Efficacy|3|||
164632850|NCT00660829|594678532|FG000|Overall Study|Non-Compliance|0|||
164632851|NCT00660829|594678533|FG001|Overall Study|Non-Compliance|4|||
164632852|NCT00660829|594678532|FG000|Overall Study|Withdrawal by Subject|1|||
164632853|NCT00660829|594678533|FG001|Overall Study|Withdrawal by Subject|2|||
164632854|NCT00660829|594678532|FG000|Overall Study|Lost to Follow-up|3|||
164632855|NCT00660829|594678533|FG001|Overall Study|Lost to Follow-up|2|||
164632856|NCT00660829|594678532|FG000|Overall Study|Other|9|||
164632857|NCT00660829|594678533|FG001|Overall Study|Other|4|||
164632858|NCT03417999|594678534|FG000|Overall Study|Withdrawal by Subject|1|||
164632859|NCT03417999|594678535|FG001|Overall Study|Withdrawal by Subject|0|||
164632860|NCT03417999|594678536|FG002|Overall Study|Withdrawal by Subject|0|||
164632861|NCT03417999|594678534|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
164632862|NCT03417999|594678535|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
164632863|NCT03417999|594678536|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
164632864|NCT03417999|594678534|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
164632865|NCT03417999|594678535|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
164632866|NCT03417999|594678536|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
164632867|NCT03417999|594678534|FG000|Overall Study|Inadequate study staff available to process samples|0|||
164632868|NCT03417999|594678535|FG001|Overall Study|Inadequate study staff available to process samples|0|||
164632869|NCT03417999|594678536|FG002|Overall Study|Inadequate study staff available to process samples|1|||
164632870|NCT02539160|594678541|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
164632871|NCT02539160|594678542|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
164632872|NCT02539160|594678543|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
164632873|NCT02539160|594678544|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
164632874|NCT02539160|594678541|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
164632875|NCT02539160|594678542|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
164632876|NCT02539160|594678543|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
164632877|NCT02539160|594678544|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
164632878|NCT02539160|594678541|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
164632879|NCT02539160|594678542|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
164632880|NCT02539160|594678543|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
164632881|NCT02539160|594678544|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
164632882|NCT01681004|594678545|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
164632883|NCT01681004|594678546|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
164632884|NCT01681004|594678545|FG000|Study Completion|Lost to Follow-up|8|||
164632885|NCT01681004|594678546|FG001|Study Completion|Lost to Follow-up|3|||
164632886|NCT01681004|594678545|FG000|Study Completion|Physician Decision|1|||
164632887|NCT01681004|594678546|FG001|Study Completion|Physician Decision|3|||
164632888|NCT01681004|594678545|FG000|Study Completion|Site Termination|2|||
164632889|NCT01681004|594678546|FG001|Study Completion|Site Termination|1|||
164632890|NCT01681004|594678545|FG000|Study Completion|Death|1|||
164632891|NCT01681004|594678546|FG001|Study Completion|Death|1|||
164632892|NCT00372905|594678547|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
164632893|NCT00372905|594678548|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
164632894|NCT00372905|594678549|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
164632895|NCT00372905|594678550|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
164632896|NCT00372905|594678547|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
164632897|NCT00372905|594678548|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
164632898|NCT00372905|594678549|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
164632899|NCT00372905|594678550|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
164632900|NCT00372905|594678547|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
164632901|NCT00372905|594678548|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
164632902|NCT00372905|594678549|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
164632903|NCT00372905|594678550|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
164632904|NCT00372905|594678547|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
164632905|NCT00372905|594678548|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
164632906|NCT00372905|594678549|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
164632907|NCT00372905|594678550|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
164632908|NCT00372905|594678547|FG000|Follow up Until Relapse or Progression|Study closed|0|||
164632909|NCT00372905|594678548|FG001|Follow up Until Relapse or Progression|Study closed|0|||
164632910|NCT00372905|594678549|FG002|Follow up Until Relapse or Progression|Study closed|0|||
164632911|NCT00372905|594678550|FG003|Follow up Until Relapse or Progression|Study closed|3|||
164632912|NCT00372905|594678547|FG000|Follow up Until Relapse or Progression|Other|0|||
164632913|NCT00372905|594678548|FG001|Follow up Until Relapse or Progression|Other|1|||
164632914|NCT00372905|594678549|FG002|Follow up Until Relapse or Progression|Other|0|||
164632915|NCT00372905|594678550|FG003|Follow up Until Relapse or Progression|Other|0|||
164632916|NCT01728454|594678551|FG000|Stage 1 and 2|Pregnancy|1|||
164632917|NCT01728454|594678552|FG001|Stage 1 and 2|Pregnancy|0|||
164632918|NCT01728454|594678553|FG002|Stage 1 and 2|Pregnancy|0|||
164632919|NCT01728454|594678551|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
164632920|NCT01728454|594678552|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
164632921|NCT01728454|594678553|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
164632922|NCT01728454|594678551|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
164632923|NCT01728454|594678552|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
164632924|NCT01728454|594678553|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
164632925|NCT01728454|594678551|FG000|Stage 1 and 2|Lost to Follow-up|1|||
164632926|NCT01728454|594678552|FG001|Stage 1 and 2|Lost to Follow-up|1|||
164632927|NCT01728454|594678553|FG002|Stage 1 and 2|Lost to Follow-up|0|||
164632928|NCT01728454|594678551|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
164632929|NCT01728454|594678552|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
164632930|NCT01728454|594678553|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
164632931|NCT01728454|594678551|FG000|Stage 3|Reason Missing|0|||
164632932|NCT01728454|594678552|FG001|Stage 3|Reason Missing|0|||
164632933|NCT01728454|594678553|FG002|Stage 3|Reason Missing|1|||
164632934|NCT01728454|594678551|FG000|Stage 3|Subject Required Other Treatment|0|||
164632935|NCT01728454|594678552|FG001|Stage 3|Subject Required Other Treatment|1|||
164632936|NCT01728454|594678553|FG002|Stage 3|Subject Required Other Treatment|0|||
164632937|NCT01728454|594678551|FG000|Stage 3|Pregnancy|1|||
164632938|NCT01728454|594678552|FG001|Stage 3|Pregnancy|0|||
164632939|NCT01728454|594678553|FG002|Stage 3|Pregnancy|0|||
164632940|NCT01728454|594678551|FG000|Stage 3|Withdrew Consent|1|||
164632941|NCT01728454|594678552|FG001|Stage 3|Withdrew Consent|0|||
164632942|NCT01728454|594678553|FG002|Stage 3|Withdrew Consent|1|||
164632943|NCT01728454|594678551|FG000|Stage 3|Non-compliance with Protocol|0|||
164632944|NCT01728454|594678552|FG001|Stage 3|Non-compliance with Protocol|0|||
164632945|NCT01728454|594678553|FG002|Stage 3|Non-compliance with Protocol|1|||
164632946|NCT01728454|594678551|FG000|Stage 3|Lost to Follow-up|0|||
164632947|NCT01728454|594678552|FG001|Stage 3|Lost to Follow-up|3|||
164632948|NCT01728454|594678553|FG002|Stage 3|Lost to Follow-up|1|||
164632949|NCT01728454|594678551|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
164632950|NCT01728454|594678552|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
164632951|NCT01728454|594678553|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
164632952|NCT00695318|594678556|FG000|Overall Study|Lost to Follow-up|1|||
164632953|NCT00695318|594678557|FG001|Overall Study|Lost to Follow-up|0|||
164632954|NCT00695318|594678556|FG000|Overall Study|Withdrawal by Subject|2|||
164632955|NCT00695318|594678557|FG001|Overall Study|Withdrawal by Subject|0|||
164632956|NCT00695318|594678556|FG000|Overall Study|Death|1|||
164632957|NCT00695318|594678557|FG001|Overall Study|Death|1|||
164632958|NCT00695318|594678556|FG000|Overall Study|Study Terminated|1|||
164632959|NCT00695318|594678557|FG001|Overall Study|Study Terminated|0|||
164632960|NCT02926833|594680327|FG000|Overall Study|Death|1|||
164632961|NCT02926833|594680328|FG001|Overall Study|Death|1|||
164632962|NCT02926833|594680329|FG002|Overall Study|Death|2|||
164632963|NCT02926833|594680330|FG003|Overall Study|Death|13|||
164632964|NCT02926833|594680327|FG000|Overall Study|Lost to Follow-up|1|||
164632965|NCT02926833|594680328|FG001|Overall Study|Lost to Follow-up|2|||
164632966|NCT02926833|594680329|FG002|Overall Study|Lost to Follow-up|0|||
164632967|NCT02926833|594680330|FG003|Overall Study|Lost to Follow-up|3|||
164632968|NCT02926833|594680327|FG000|Overall Study|Full Consent Withdrawal|0|||
164632969|NCT02926833|594680328|FG001|Overall Study|Full Consent Withdrawal|0|||
164632970|NCT02926833|594680329|FG002|Overall Study|Full Consent Withdrawal|0|||
164632971|NCT02926833|594680330|FG003|Overall Study|Full Consent Withdrawal|2|||
164632972|NCT02926833|594680327|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
164632973|NCT02926833|594680328|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
164632974|NCT02926833|594680329|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
164632975|NCT02926833|594680330|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
164632976|NCT02926833|594680327|FG000|Overall Study|Investigator Decision|0|||
164632977|NCT02926833|594680328|FG001|Overall Study|Investigator Decision|1|||
164632978|NCT02926833|594680329|FG002|Overall Study|Investigator Decision|0|||
164632979|NCT02926833|594680330|FG003|Overall Study|Investigator Decision|0|||
164632980|NCT02926833|594680327|FG000|Overall Study|Adverse Event|0|||
164632981|NCT02926833|594680328|FG001|Overall Study|Adverse Event|0|||
164632982|NCT02926833|594680329|FG002|Overall Study|Adverse Event|1|||
164632983|NCT02926833|594680330|FG003|Overall Study|Adverse Event|0|||
164632984|NCT02926833|594680327|FG000|Overall Study|Partial Withdrawal of Consent|0|||
164632985|NCT02926833|594680328|FG001|Overall Study|Partial Withdrawal of Consent|0|||
164632986|NCT02926833|594680329|FG002|Overall Study|Partial Withdrawal of Consent|0|||
164632987|NCT02926833|594680330|FG003|Overall Study|Partial Withdrawal of Consent|1|||
164632988|NCT02930889|594680331|FG000|Overall Study|Lost to Follow-up|2|||
164632989|NCT02930889|594680331|FG000|Overall Study|Withdrawal by Subject|6|||
164632990|NCT02930889|594680331|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
164632991|NCT04398030|594680332|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
164632992|NCT04398030|594680333|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
164632993|NCT04398030|594680332|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
164632994|NCT04398030|594680333|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
164632995|NCT01004822|594680334|FG000|Overall Study|Objective progression or relapse|3|||
164632996|NCT01004822|594680335|FG001|Overall Study|Objective progression or relapse|3|||
164632997|NCT01004822|594680336|FG002|Overall Study|Objective progression or relapse|0|||
164632998|NCT01004822|594680337|FG003|Overall Study|Objective progression or relapse|1|||
164632999|NCT01004822|594680338|FG004|Overall Study|Objective progression or relapse|2|||
164633000|NCT01004822|594680339|FG005|Overall Study|Objective progression or relapse|2|||
164633001|NCT01004822|594680340|FG006|Overall Study|Objective progression or relapse|1|||
164633002|NCT01004822|594680341|FG007|Overall Study|Objective progression or relapse|4|||
164633003|NCT01004822|594680334|FG000|Overall Study|Global deterioration of health status|0|||
164633004|NCT01004822|594680335|FG001|Overall Study|Global deterioration of health status|0|||
164633005|NCT01004822|594680336|FG002|Overall Study|Global deterioration of health status|0|||
164633006|NCT01004822|594680337|FG003|Overall Study|Global deterioration of health status|1|||
164633007|NCT01004822|594680338|FG004|Overall Study|Global deterioration of health status|0|||
164633008|NCT01004822|594680339|FG005|Overall Study|Global deterioration of health status|0|||
164633009|NCT01004822|594680340|FG006|Overall Study|Global deterioration of health status|1|||
164633010|NCT01004822|594680341|FG007|Overall Study|Global deterioration of health status|0|||
164633011|NCT01004822|594680334|FG000|Overall Study|No longer willing to continue|0|||
164633012|NCT01004822|594680335|FG001|Overall Study|No longer willing to continue|0|||
164633013|NCT01004822|594680336|FG002|Overall Study|No longer willing to continue|0|||
164633014|NCT01004822|594680337|FG003|Overall Study|No longer willing to continue|1|||
164633015|NCT01004822|594680338|FG004|Overall Study|No longer willing to continue|2|||
164633016|NCT01004822|594680339|FG005|Overall Study|No longer willing to continue|1|||
164633017|NCT01004822|594680340|FG006|Overall Study|No longer willing to continue|1|||
164633018|NCT01004822|594680341|FG007|Overall Study|No longer willing to continue|0|||
164633019|NCT01004822|594680334|FG000|Overall Study|Adverse Event|0|||
164633020|NCT01004822|594680335|FG001|Overall Study|Adverse Event|0|||
164633021|NCT01004822|594680336|FG002|Overall Study|Adverse Event|0|||
164633022|NCT01004822|594680337|FG003|Overall Study|Adverse Event|0|||
164633023|NCT01004822|594680338|FG004|Overall Study|Adverse Event|0|||
164633024|NCT01004822|594680339|FG005|Overall Study|Adverse Event|0|||
164633025|NCT01004822|594680340|FG006|Overall Study|Adverse Event|1|||
164633026|NCT01004822|594680341|FG007|Overall Study|Adverse Event|1|||
164633027|NCT01004822|594680334|FG000|Overall Study|Other|0|||
164633028|NCT01004822|594680335|FG001|Overall Study|Other|0|||
164633029|NCT01004822|594680336|FG002|Overall Study|Other|4|||
164633030|NCT01004822|594680337|FG003|Overall Study|Other|1|||
164633031|NCT01004822|594680338|FG004|Overall Study|Other|0|||
164633032|NCT01004822|594680339|FG005|Overall Study|Other|1|||
164633033|NCT01004822|594680340|FG006|Overall Study|Other|0|||
164633034|NCT01004822|594680341|FG007|Overall Study|Other|0|||
164633035|NCT03159455|594680344|FG000|Overall Study|Adverse Event|0|||
164633036|NCT03159455|594680345|FG001|Overall Study|Adverse Event|0|||
164633037|NCT03159455|594680346|FG002|Overall Study|Adverse Event|0|||
164633038|NCT03159455|594680347|FG003|Overall Study|Adverse Event|0|||
164633039|NCT03159455|594680348|FG004|Overall Study|Adverse Event|0|||
164633040|NCT03159455|594680349|FG005|Overall Study|Adverse Event|1|||
164633041|NCT01714726|594680355|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
164633042|NCT01714726|594680356|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
164633043|NCT01714726|594680357|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
164633044|NCT01714726|594680358|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
164633045|NCT01714726|594680355|FG000|Double-Blinded Induction Period|Adverse Event|0|||
164633046|NCT01714726|594680356|FG001|Double-Blinded Induction Period|Adverse Event|1|||
164633047|NCT01714726|594680357|FG002|Double-Blinded Induction Period|Adverse Event|0|||
164633048|NCT01714726|594680358|FG003|Double-Blinded Induction Period|Adverse Event|0|||
164633049|NCT01714726|594680355|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
164633050|NCT01714726|594680356|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
164633051|NCT01714726|594680357|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
164633052|NCT01714726|594680358|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
164633053|NCT01714726|594680355|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
164633054|NCT01714726|594680356|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
164633055|NCT01714726|594680357|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
164633056|NCT01714726|594680358|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
164633057|NCT01714726|594680355|FG000|Open-Label Period|Other|0|||
164633058|NCT01714726|594680356|FG001|Open-Label Period|Other|0|||
164633059|NCT01714726|594680357|FG002|Open-Label Period|Other|1|||
164633060|NCT01714726|594680358|FG003|Open-Label Period|Other|3|||
164633061|NCT01714726|594680355|FG000|Open-Label Period|Adverse Event|0|||
164633062|NCT01714726|594680356|FG001|Open-Label Period|Adverse Event|0|||
164633063|NCT01714726|594680357|FG002|Open-Label Period|Adverse Event|1|||
164633064|NCT01714726|594680358|FG003|Open-Label Period|Adverse Event|0|||
164633065|NCT01714726|594680355|FG000|Open-Label Period|Withdrawal by Subject|0|||
164633066|NCT01714726|594680356|FG001|Open-Label Period|Withdrawal by Subject|0|||
164633067|NCT01714726|594680357|FG002|Open-Label Period|Withdrawal by Subject|9|||
164633068|NCT01714726|594680358|FG003|Open-Label Period|Withdrawal by Subject|19|||
164633069|NCT01714726|594680355|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
164633070|NCT01714726|594680356|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
164633071|NCT01714726|594680357|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
164633072|NCT01714726|594680358|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
164633073|NCT01714726|594680355|FG000|Open-Label Period|Lost to Follow-up|0|||
164633074|NCT01714726|594680356|FG001|Open-Label Period|Lost to Follow-up|0|||
164633075|NCT01714726|594680357|FG002|Open-Label Period|Lost to Follow-up|3|||
164633076|NCT01714726|594680358|FG003|Open-Label Period|Lost to Follow-up|4|||
164633077|NCT00548340|594680359|FG000|Overall Study|Protocol Violation|2|||
164633078|NCT00548340|594680360|FG001|Overall Study|Protocol Violation|3|||
164633079|NCT00548340|594680361|FG002|Overall Study|Protocol Violation|3|||
164633080|NCT00548340|594680359|FG000|Overall Study|Adverse Event|2|||
164633081|NCT00548340|594680360|FG001|Overall Study|Adverse Event|2|||
164633082|NCT00548340|594680361|FG002|Overall Study|Adverse Event|2|||
164633083|NCT00548340|594680359|FG000|Overall Study|Lost to Follow-up|1|||
164633084|NCT00548340|594680360|FG001|Overall Study|Lost to Follow-up|1|||
164633085|NCT00548340|594680361|FG002|Overall Study|Lost to Follow-up|0|||
164633086|NCT00548340|594680359|FG000|Overall Study|Withdrawal by Subject|2|||
164633087|NCT00548340|594680360|FG001|Overall Study|Withdrawal by Subject|4|||
164633088|NCT00548340|594680361|FG002|Overall Study|Withdrawal by Subject|3|||
164148070|NCT00247676|592904819|FG000|Overall Study|Death|5|||
164633089|NCT00548340|594680359|FG000|Overall Study|Other|1|||
164633090|NCT00548340|594680360|FG001|Overall Study|Other|1|||
164633091|NCT00548340|594680361|FG002|Overall Study|Other|1|||
164633092|NCT03778021|594680362|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
164633093|NCT03778021|594680363|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
164633094|NCT00679042|594680364|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
164633095|NCT00679042|594680364|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
164633096|NCT00679042|594680364|FG000|5-Year Follow Up|Death|1|||
164633097|NCT00679042|594680364|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
164633098|NCT00679042|594680364|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
164529348|NCT00816400|594309438|FG005|Overall Study|In hospice care at the end of the study|0|||
164529349|NCT00816400|594309439|FG006|Overall Study|In hospice care at the end of the study|0|||
164529350|NCT00816400|594309440|FG007|Overall Study|In hospice care at the end of the study|0|||
164529351|NCT00816400|594309441|FG008|Overall Study|In hospice care at the end of the study|0|||
164529352|NCT00320541|594309442|FG000|Overall Study|Adverse Event|21|||
164529353|NCT00320541|594309443|FG001|Overall Study|Adverse Event|19|||
164529354|NCT00320541|594309442|FG000|Overall Study|Protocol Violation|0|||
164529355|NCT00320541|594309443|FG001|Overall Study|Protocol Violation|1|||
164529356|NCT00320541|594309442|FG000|Overall Study|Withdrawal by Subject|12|||
164529357|NCT00320541|594309443|FG001|Overall Study|Withdrawal by Subject|16|||
164529358|NCT00320541|594309442|FG000|Overall Study|Physician Decision|9|||
164529359|NCT00320541|594309443|FG001|Overall Study|Physician Decision|13|||
164529360|NCT00320541|594309442|FG000|Overall Study|Other|3|||
164529361|NCT00320541|594309443|FG001|Overall Study|Other|4|||
164529362|NCT00320541|594309442|FG000|Overall Study|Sponsor Decision|2|||
164529363|NCT00320541|594309443|FG001|Overall Study|Sponsor Decision|1|||
164529364|NCT00320541|594309442|FG000|Overall Study|Death due to Study Disease|1|||
164529365|NCT00320541|594309443|FG001|Overall Study|Death due to Study Disease|3|||
164529366|NCT00320541|594309442|FG000|Overall Study|Death due to Adverse Event(s)|1|||
164529367|NCT00320541|594309443|FG001|Overall Study|Death due to Adverse Event(s)|0|||
164529368|NCT00320541|594309442|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
164529369|NCT00320541|594309443|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
164529370|NCT01620255|594309449|FG000|Overall Study|Withdrawal by Subject|4|||
164529371|NCT01620255|594309450|FG001|Overall Study|Withdrawal by Subject|1|||
164529372|NCT01620255|594309451|FG002|Overall Study|Withdrawal by Subject|1|||
164529373|NCT01620255|594309452|FG003|Overall Study|Withdrawal by Subject|2|||
164633099|NCT02687815|594680365|FG000|Overall Study|Lost to Follow-up|2|||
164633100|NCT02687815|594680366|FG001|Overall Study|Lost to Follow-up|4|||
164633101|NCT02687815|594680365|FG000|Overall Study|Withdrawal by Subject|2|||
164633102|NCT02687815|594680366|FG001|Overall Study|Withdrawal by Subject|4|||
164633103|NCT00379639|594680367|FG000|Overall Study|Disease Progression|3|||
164633104|NCT00379639|594680368|FG001|Overall Study|Disease Progression|3|||
164633105|NCT00379639|594680369|FG002|Overall Study|Disease Progression|3|||
164633106|NCT00379639|594680370|FG003|Overall Study|Disease Progression|4|||
164633107|NCT00379639|594680371|FG004|Overall Study|Disease Progression|4|||
164633108|NCT00379639|594680367|FG000|Overall Study|Physician Decision|0|||
164633109|NCT00379639|594680368|FG001|Overall Study|Physician Decision|2|||
164633110|NCT00379639|594680369|FG002|Overall Study|Physician Decision|1|||
164633111|NCT00379639|594680370|FG003|Overall Study|Physician Decision|1|||
164633112|NCT00379639|594680371|FG004|Overall Study|Physician Decision|0|||
164633113|NCT00379639|594680367|FG000|Overall Study|Symptomatic Deterioration|0|||
164633114|NCT00379639|594680368|FG001|Overall Study|Symptomatic Deterioration|0|||
164633115|NCT00379639|594680369|FG002|Overall Study|Symptomatic Deterioration|1|||
164633116|NCT00379639|594680370|FG003|Overall Study|Symptomatic Deterioration|0|||
164633117|NCT00379639|594680371|FG004|Overall Study|Symptomatic Deterioration|1|||
164633118|NCT00379639|594680367|FG000|Overall Study|Adverse Event|0|||
164633119|NCT00379639|594680368|FG001|Overall Study|Adverse Event|0|||
164633120|NCT00379639|594680369|FG002|Overall Study|Adverse Event|1|||
164633121|NCT00379639|594680370|FG003|Overall Study|Adverse Event|0|||
164633122|NCT00379639|594680371|FG004|Overall Study|Adverse Event|1|||
164633123|NCT00379639|594680367|FG000|Overall Study|Lost to Follow-up|0|||
164633124|NCT00379639|594680368|FG001|Overall Study|Lost to Follow-up|0|||
164633125|NCT00379639|594680369|FG002|Overall Study|Lost to Follow-up|0|||
164633126|NCT00379639|594680370|FG003|Overall Study|Lost to Follow-up|1|||
164633127|NCT00379639|594680371|FG004|Overall Study|Lost to Follow-up|0|||
164633128|NCT00379639|594680367|FG000|Overall Study|Other|0|||
164633129|NCT00379639|594680368|FG001|Overall Study|Other|0|||
164633130|NCT00379639|594680369|FG002|Overall Study|Other|3|||
164633131|NCT00379639|594680370|FG003|Overall Study|Other|0|||
164633132|NCT00379639|594680371|FG004|Overall Study|Other|0|||
164633133|NCT03053102|594680376|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
164633134|NCT03053102|594680376|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
164633135|NCT03735680|594680379|FG000|Overall Study|Withdrawal by Subject|0|||
164633136|NCT03735680|594680380|FG001|Overall Study|Withdrawal by Subject|1|||
164633137|NCT03735680|594680381|FG002|Overall Study|Withdrawal by Subject|0|||
164633138|NCT03735680|594680382|FG003|Overall Study|Withdrawal by Subject|0|||
164633139|NCT03735680|594680383|FG004|Overall Study|Withdrawal by Subject|0|||
164633140|NCT03735680|594680384|FG005|Overall Study|Withdrawal by Subject|1|||
164633141|NCT03735680|594680379|FG000|Overall Study|Patient unable or unwilling to continue|0|||
164633142|NCT03735680|594680380|FG001|Overall Study|Patient unable or unwilling to continue|0|||
164633143|NCT03735680|594680381|FG002|Overall Study|Patient unable or unwilling to continue|1|||
164633144|NCT03735680|594680382|FG003|Overall Study|Patient unable or unwilling to continue|0|||
164633145|NCT03735680|594680383|FG004|Overall Study|Patient unable or unwilling to continue|0|||
164633146|NCT03735680|594680384|FG005|Overall Study|Patient unable or unwilling to continue|0|||
164633147|NCT02392078|594680388|FG000|Overall Study|Did not have procedure|32|||
164633148|NCT02392078|594680389|FG001|Overall Study|Did not have procedure|43|||
164633149|NCT02392078|594680390|FG002|Overall Study|Did not have procedure|20|||
164633150|NCT02392078|594680391|FG003|Overall Study|Did not have procedure|1|||
164633151|NCT02079077|594680393|FG000|Overall Study|Lost to Follow-up|5|||
164633152|NCT02079077|594680394|FG001|Overall Study|Lost to Follow-up|7|||
164633153|NCT02079077|594680393|FG000|Overall Study|Became STIs Positive|1|||
164633154|NCT02079077|594680394|FG001|Overall Study|Became STIs Positive|2|||
164633155|NCT01928758|594680395|FG000|Overall Study|Lost to Follow-up|14|||
164633156|NCT01928758|594680396|FG001|Overall Study|Lost to Follow-up|9|||
164633157|NCT01928758|594680395|FG000|Overall Study|Withdrawal by Subject|5|||
164633158|NCT01928758|594680396|FG001|Overall Study|Withdrawal by Subject|2|||
164633159|NCT01928758|594680395|FG000|Overall Study|Adverse Event|3|||
164633160|NCT01928758|594680396|FG001|Overall Study|Adverse Event|5|||
164633161|NCT01928758|594680395|FG000|Overall Study|Protocol Violation|3|||
164633162|NCT01928758|594680396|FG001|Overall Study|Protocol Violation|4|||
164633163|NCT03198559|594680397|FG000|Overall Study|Adverse Event|2|||
164633164|NCT03737812|594680398|FG000|Overall Study|Withdrawal by Subject|1|||
164633165|NCT03737812|594680399|FG001|Overall Study|Withdrawal by Subject|2|||
164633166|NCT03737812|594680400|FG002|Overall Study|Withdrawal by Subject|1|||
164633167|NCT03737812|594680398|FG000|Overall Study|Sponsor Discontinued the Study|4|||
164633168|NCT03737812|594680399|FG001|Overall Study|Sponsor Discontinued the Study|3|||
164633169|NCT03737812|594680400|FG002|Overall Study|Sponsor Discontinued the Study|2|||
164633170|NCT03737812|594680398|FG000|Overall Study|Adverse Event|0|||
164633171|NCT03737812|594680399|FG001|Overall Study|Adverse Event|1|||
164633172|NCT03737812|594680400|FG002|Overall Study|Adverse Event|0|||
164633173|NCT03737812|594680398|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
164633174|NCT03737812|594680399|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
164633175|NCT03737812|594680400|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
164633176|NCT01474291|594680404|FG000|Overall Study|Not Evaluable for Efficacy|26|||
164633177|NCT01474291|594680404|FG000|Overall Study|Lack of Treatment Efficacy|88|||
164633178|NCT01474291|594680404|FG000|Overall Study|Adverse Event|53|||
164633179|NCT01474291|594680404|FG000|Overall Study|Lost to Follow-up|29|||
164633180|NCT01474291|594680404|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
164633181|NCT01474291|594680404|FG000|Overall Study|No Reason Reported|10|||
164633182|NCT01474291|594680404|FG000|Overall Study|Death|2|||
164633183|NCT03471507|594680405|FG000|Overall Study|Lost to Follow-up|1|||
164633184|NCT03471507|594680406|FG001|Overall Study|Lost to Follow-up|3|||
164633185|NCT03471507|594680405|FG000|Overall Study|Physician Decision|0|||
164633186|NCT03471507|594680406|FG001|Overall Study|Physician Decision|1|||
164633187|NCT03471507|594680405|FG000|Overall Study|Withdrawal by Subject|2|||
164633188|NCT03471507|594680406|FG001|Overall Study|Withdrawal by Subject|1|||
164148071|NCT00247676|592904819|FG000|Overall Study|Adverse Event|11|||
164529374|NCT01620255|594309453|FG004|Overall Study|Withdrawal by Subject|4|||
164529375|NCT01620255|594309449|FG000|Overall Study|Participant underwent fecal transplant|0|||
164529376|NCT01620255|594309450|FG001|Overall Study|Participant underwent fecal transplant|0|||
164529377|NCT01620255|594309451|FG002|Overall Study|Participant underwent fecal transplant|1|||
164529378|NCT01620255|594309452|FG003|Overall Study|Participant underwent fecal transplant|0|||
164529379|NCT01620255|594309453|FG004|Overall Study|Participant underwent fecal transplant|0|||
164529380|NCT01620255|594309449|FG000|Overall Study|Non-compliance|0|||
164529381|NCT01620255|594309450|FG001|Overall Study|Non-compliance|1|||
164529382|NCT01620255|594309451|FG002|Overall Study|Non-compliance|0|||
164529383|NCT01620255|594309452|FG003|Overall Study|Non-compliance|0|||
164529384|NCT01620255|594309453|FG004|Overall Study|Non-compliance|0|||
164529385|NCT01620255|594309449|FG000|Overall Study|Adverse Event|0|||
164529386|NCT01620255|594309450|FG001|Overall Study|Adverse Event|4|||
164529387|NCT01620255|594309451|FG002|Overall Study|Adverse Event|0|||
164529388|NCT01620255|594309452|FG003|Overall Study|Adverse Event|1|||
164529389|NCT01620255|594309453|FG004|Overall Study|Adverse Event|1|||
164529390|NCT01620255|594309449|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
164529391|NCT01620255|594309450|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
164529392|NCT01620255|594309451|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
164529393|NCT01620255|594309452|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
164529394|NCT01620255|594309453|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
164529395|NCT01716117|594309457|FG000|Overall Study|Death|5|||
164529396|NCT01716117|594309458|FG001|Overall Study|Death|2|||
164529397|NCT01716117|594309457|FG000|Overall Study|Withdrawal by Subject|2|||
164529398|NCT01716117|594309458|FG001|Overall Study|Withdrawal by Subject|0|||
164529399|NCT03645057|594309464|FG000|Randomization to Baseline|Lost to Follow-up|1|||
164529400|NCT03645057|594309465|FG001|Randomization to Baseline|Lost to Follow-up|0|||
164529401|NCT03645057|594309466|FG002|Randomization to Baseline|Lost to Follow-up|1|||
164529402|NCT03645057|594309467|FG003|Randomization to Baseline|Lost to Follow-up|0|||
164529403|NCT03645057|594309464|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
164529404|NCT03645057|594309465|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
164529405|NCT03645057|594309466|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
164529406|NCT03645057|594309467|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
164529407|NCT03645057|594309464|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
164529408|NCT03645057|594309465|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
164529409|NCT03645057|594309466|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
164529410|NCT03645057|594309467|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
164529411|NCT03645057|594309464|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
164529412|NCT03645057|594309465|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
164529413|NCT03645057|594309466|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
164529414|NCT03645057|594309467|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
164529415|NCT01873495|594309470|FG000|Overall Study|Withdrawal by Subject|1|||
164529416|NCT01873495|594309470|FG000|Overall Study|Physician Decision|3|||
164529417|NCT01873495|594309470|FG000|Overall Study|Adverse Event|1|||
164529418|NCT01873495|594309470|FG000|Overall Study|Removed for Transplantation|1|||
164529419|NCT01873495|594309470|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
164529420|NCT01901341|594309476|FG000|Overall Study|Adverse Event|4|||
164529421|NCT01901341|594309477|FG001|Overall Study|Adverse Event|2|||
164529422|NCT01901341|594309476|FG000|Overall Study|Lack of Efficacy|0|||
164529423|NCT01901341|594309477|FG001|Overall Study|Lack of Efficacy|2|||
164529424|NCT01901341|594309476|FG000|Overall Study|Lost to Follow-up|0|||
164529425|NCT01901341|594309477|FG001|Overall Study|Lost to Follow-up|1|||
164529426|NCT01901341|594309476|FG000|Overall Study|Protocol Violation|2|||
164529427|NCT01901341|594309477|FG001|Overall Study|Protocol Violation|0|||
164529428|NCT01901341|594309476|FG000|Overall Study|Study Terminated by Sponsor|13|||
164529429|NCT01901341|594309477|FG001|Overall Study|Study Terminated by Sponsor|15|||
164529430|NCT01901341|594309476|FG000|Overall Study|Withdrawal by Subject|1|||
164529431|NCT01901341|594309477|FG001|Overall Study|Withdrawal by Subject|1|||
164529432|NCT04335812|594309478|FG000|Overall Study|Withdrawal by Subject|1|||
164529433|NCT04335812|594309479|FG001|Overall Study|Withdrawal by Subject|3|||
164529434|NCT04335812|594309478|FG000|Overall Study|Lost to Follow-up|12|||
164529435|NCT04335812|594309479|FG001|Overall Study|Lost to Follow-up|12|||
164529436|NCT04335812|594309478|FG000|Overall Study|Did not engage in the intervention|22|||
164529437|NCT04335812|594309479|FG001|Overall Study|Did not engage in the intervention|18|||
164529438|NCT03864146|594309483|FG000|Overall Study|Lost to Follow-up|14|||
164529439|NCT03864146|594309484|FG001|Overall Study|Lost to Follow-up|23|||
164529440|NCT03864146|594309483|FG000|Overall Study|Withdrawal by Subject|3|||
164529441|NCT03864146|594309484|FG001|Overall Study|Withdrawal by Subject|2|||
164633189|NCT02557308|594680408|FG000|Overall Study|Withdrawal by Subject|11|||
164633190|NCT02557308|594680409|FG001|Overall Study|Withdrawal by Subject|3|||
164633191|NCT02557308|594680410|FG002|Overall Study|Withdrawal by Subject|2|||
164633192|NCT02557308|594680411|FG003|Overall Study|Withdrawal by Subject|0|||
164633193|NCT02557308|594680412|FG004|Overall Study|Withdrawal by Subject|1|||
164633194|NCT02557308|594680413|FG005|Overall Study|Withdrawal by Subject|0|||
164633195|NCT02557308|594680414|FG006|Overall Study|Withdrawal by Subject|10|||
164633196|NCT02557308|594680415|FG007|Overall Study|Withdrawal by Subject|1|||
164633197|NCT02557308|594680408|FG000|Overall Study|Disease Progression|0|||
164633198|NCT02557308|594680409|FG001|Overall Study|Disease Progression|1|||
164633199|NCT02557308|594680410|FG002|Overall Study|Disease Progression|0|||
164633200|NCT02557308|594680411|FG003|Overall Study|Disease Progression|0|||
164633201|NCT02557308|594680412|FG004|Overall Study|Disease Progression|0|||
164633202|NCT02557308|594680413|FG005|Overall Study|Disease Progression|0|||
164633203|NCT02557308|594680414|FG006|Overall Study|Disease Progression|0|||
164633204|NCT02557308|594680415|FG007|Overall Study|Disease Progression|0|||
164633205|NCT02557308|594680408|FG000|Overall Study|Lack of Efficacy|3|||
164633206|NCT02557308|594680409|FG001|Overall Study|Lack of Efficacy|0|||
164633207|NCT02557308|594680410|FG002|Overall Study|Lack of Efficacy|0|||
164633208|NCT02557308|594680411|FG003|Overall Study|Lack of Efficacy|0|||
164633209|NCT02557308|594680412|FG004|Overall Study|Lack of Efficacy|0|||
164633210|NCT02557308|594680413|FG005|Overall Study|Lack of Efficacy|0|||
164633211|NCT02557308|594680414|FG006|Overall Study|Lack of Efficacy|1|||
164633212|NCT02557308|594680415|FG007|Overall Study|Lack of Efficacy|0|||
164633213|NCT02557308|594680408|FG000|Overall Study|Adverse Event|4|||
164633214|NCT02557308|594680409|FG001|Overall Study|Adverse Event|1|||
164633215|NCT02557308|594680410|FG002|Overall Study|Adverse Event|2|||
164633216|NCT02557308|594680411|FG003|Overall Study|Adverse Event|0|||
164633217|NCT02557308|594680412|FG004|Overall Study|Adverse Event|0|||
164633218|NCT02557308|594680413|FG005|Overall Study|Adverse Event|0|||
164633219|NCT02557308|594680414|FG006|Overall Study|Adverse Event|4|||
164633220|NCT02557308|594680415|FG007|Overall Study|Adverse Event|1|||
164633221|NCT02557308|594680408|FG000|Overall Study|Lost to Follow-up|2|||
164633222|NCT02557308|594680409|FG001|Overall Study|Lost to Follow-up|0|||
164633223|NCT02557308|594680410|FG002|Overall Study|Lost to Follow-up|1|||
164633224|NCT02557308|594680411|FG003|Overall Study|Lost to Follow-up|0|||
164633225|NCT02557308|594680412|FG004|Overall Study|Lost to Follow-up|0|||
164633226|NCT02557308|594680413|FG005|Overall Study|Lost to Follow-up|0|||
164633227|NCT02557308|594680414|FG006|Overall Study|Lost to Follow-up|2|||
164633228|NCT02557308|594680415|FG007|Overall Study|Lost to Follow-up|0|||
164633229|NCT02557308|594680408|FG000|Overall Study|Death|1|||
164633230|NCT02557308|594680409|FG001|Overall Study|Death|0|||
164633231|NCT02557308|594680410|FG002|Overall Study|Death|0|||
164633232|NCT02557308|594680411|FG003|Overall Study|Death|0|||
164633233|NCT02557308|594680412|FG004|Overall Study|Death|0|||
164633234|NCT02557308|594680413|FG005|Overall Study|Death|0|||
164633235|NCT02557308|594680414|FG006|Overall Study|Death|0|||
164633236|NCT02557308|594680415|FG007|Overall Study|Death|0|||
164633237|NCT02557308|594680408|FG000|Overall Study|Study Close|98|||
164633238|NCT02557308|594680409|FG001|Overall Study|Study Close|18|||
164633239|NCT02557308|594680410|FG002|Overall Study|Study Close|5|||
164633240|NCT02557308|594680411|FG003|Overall Study|Study Close|3|||
164633241|NCT02557308|594680412|FG004|Overall Study|Study Close|1|||
164633242|NCT02557308|594680413|FG005|Overall Study|Study Close|0|||
164633243|NCT02557308|594680414|FG006|Overall Study|Study Close|123|||
164633244|NCT02557308|594680415|FG007|Overall Study|Study Close|5|||
164633245|NCT02557308|594680408|FG000|Overall Study|Except for study close|5|||
164633246|NCT02557308|594680409|FG001|Overall Study|Except for study close|0|||
164633247|NCT02557308|594680410|FG002|Overall Study|Except for study close|0|||
164633248|NCT02557308|594680411|FG003|Overall Study|Except for study close|0|||
164633249|NCT02557308|594680412|FG004|Overall Study|Except for study close|3|||
164633250|NCT02557308|594680413|FG005|Overall Study|Except for study close|0|||
164633251|NCT02557308|594680414|FG006|Overall Study|Except for study close|6|||
164633252|NCT02557308|594680415|FG007|Overall Study|Except for study close|10|||
164633253|NCT02046993|594680419|FG000|Overall Study|Withdrawal by Subject|2|||
164633254|NCT02046993|594680420|FG001|Overall Study|Withdrawal by Subject|10|||
164633255|NCT02046993|594680419|FG000|Overall Study|Lost to Follow-up|1|||
164633256|NCT02046993|594680420|FG001|Overall Study|Lost to Follow-up|1|||
164633257|NCT00761735|594680428|FG000|Overall Study|Lost to Follow-up|6|||
164633258|NCT00761735|594680428|FG000|Overall Study|Withdrawal by Subject|6|||
164633259|NCT00761735|594680428|FG000|Overall Study|Non-compliance with protocol|1|||
164633260|NCT00761735|594680428|FG000|Overall Study|Administrative|1|||
164633261|NCT03326323|594680429|FG000|Overall Study|Unable to receive ANH protocol|3|||
164633262|NCT00851721|594680434|FG000|Overall Study|planned surgery|1|||
164633263|NCT00851721|594680435|FG001|Overall Study|planned surgery|0|||
164633264|NCT00851721|594680434|FG000|Overall Study|Death|1|||
164633265|NCT00851721|594680435|FG001|Overall Study|Death|0|||
164633266|NCT00851721|594680434|FG000|Overall Study|Adverse Event|0|||
164633267|NCT00851721|594680435|FG001|Overall Study|Adverse Event|1|||
164633268|NCT04047472|594680436|FG000|Overall Study|Adverse Event|3|||
164633269|NCT04047472|594680437|FG001|Overall Study|Adverse Event|3|||
164633270|NCT04047472|594680436|FG000|Overall Study|Death|0|||
164633271|NCT04047472|594680437|FG001|Overall Study|Death|1|||
164633272|NCT04047472|594680436|FG000|Overall Study|Lost to Follow-up|1|||
164633273|NCT04047472|594680437|FG001|Overall Study|Lost to Follow-up|0|||
164633274|NCT04047472|594680436|FG000|Overall Study|Physician Decision|1|||
164633275|NCT04047472|594680437|FG001|Overall Study|Physician Decision|2|||
164633276|NCT04047472|594680436|FG000|Overall Study|Protocol Violation|1|||
164633277|NCT04047472|594680437|FG001|Overall Study|Protocol Violation|0|||
164633278|NCT04047472|594680436|FG000|Overall Study|Withdrawal by Subject|10|||
164633279|NCT04047472|594680437|FG001|Overall Study|Withdrawal by Subject|10|||
164633280|NCT01218477|594680438|FG000|Overall Study|Disease progression|2|||
164633281|NCT01218477|594680439|FG001|Overall Study|Disease progression|3|||
164633282|NCT01218477|594680440|FG002|Overall Study|Disease progression|6|||
164633283|NCT01218477|594680441|FG003|Overall Study|Disease progression|2|||
164633284|NCT01218477|594680438|FG000|Overall Study|Study drug toxicity|0|||
164633285|NCT01218477|594680439|FG001|Overall Study|Study drug toxicity|2|||
164633286|NCT01218477|594680440|FG002|Overall Study|Study drug toxicity|5|||
164633287|NCT01218477|594680441|FG003|Overall Study|Study drug toxicity|0|||
164633288|NCT01218477|594680438|FG000|Overall Study|No longer meets study criteria|1|||
164633289|NCT01218477|594680439|FG001|Overall Study|No longer meets study criteria|0|||
164633290|NCT01218477|594680440|FG002|Overall Study|No longer meets study criteria|0|||
164633291|NCT01218477|594680441|FG003|Overall Study|No longer meets study criteria|0|||
164633292|NCT01218477|594680438|FG000|Overall Study|Withdrawal by Subject|0|||
164633293|NCT01218477|594680439|FG001|Overall Study|Withdrawal by Subject|0|||
164633294|NCT01218477|594680440|FG002|Overall Study|Withdrawal by Subject|1|||
164633295|NCT01218477|594680441|FG003|Overall Study|Withdrawal by Subject|0|||
164633296|NCT01218477|594680438|FG000|Overall Study|Prepared for cell transplantation|0|||
164633297|NCT01218477|594680439|FG001|Overall Study|Prepared for cell transplantation|1|||
164633298|NCT01218477|594680440|FG002|Overall Study|Prepared for cell transplantation|1|||
164633299|NCT01218477|594680441|FG003|Overall Study|Prepared for cell transplantation|0|||
164633300|NCT01218477|594680438|FG000|Overall Study|Administrative reason by sponsor|0|||
164633301|NCT01218477|594680439|FG001|Overall Study|Administrative reason by sponsor|0|||
164633302|NCT01218477|594680440|FG002|Overall Study|Administrative reason by sponsor|1|||
164633303|NCT01218477|594680441|FG003|Overall Study|Administrative reason by sponsor|0|||
164633304|NCT01218477|594680438|FG000|Overall Study|Maximum clinical benefit|0|||
164633305|NCT01218477|594680439|FG001|Overall Study|Maximum clinical benefit|2|||
164633306|NCT01218477|594680440|FG002|Overall Study|Maximum clinical benefit|0|||
164633307|NCT01218477|594680441|FG003|Overall Study|Maximum clinical benefit|0|||
164633308|NCT01333501|594680445|FG000|Overall Study|Adverse Event|3|||
164633309|NCT01333501|594680446|FG001|Overall Study|Adverse Event|1|||
164633310|NCT01333501|594680445|FG000|Overall Study|Abnormal laboratory value|2|||
164633311|NCT01333501|594680446|FG001|Overall Study|Abnormal laboratory value|1|||
164633312|NCT01333501|594680445|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164633313|NCT01333501|594680446|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
164633314|NCT01333501|594680445|FG000|Overall Study|Withdrawn consent|3|||
164633315|NCT01333501|594680446|FG001|Overall Study|Withdrawn consent|12|||
164633316|NCT01303159|594680447|FG000|Overall Study|Death|16|||
164633317|NCT01303159|594680447|FG000|Overall Study|Study Termination|7|||
164633318|NCT00496782|594680448|FG000|Overall Study|Protocol Violation|1|||
164633319|NCT00496782|594680449|FG001|Overall Study|Protocol Violation|2|||
164633320|NCT02132312|594680451|FG000|Overall Study|Adverse Event|2|||
164633321|NCT02132312|594680452|FG001|Overall Study|Adverse Event|0|||
164633322|NCT02132312|594680451|FG000|Overall Study|Physician Decision|1|||
164633323|NCT02132312|594680452|FG001|Overall Study|Physician Decision|1|||
164633324|NCT02132312|594680451|FG000|Overall Study|Protocol Violation|0|||
164633325|NCT02132312|594680452|FG001|Overall Study|Protocol Violation|1|||
164633326|NCT02132312|594680451|FG000|Overall Study|Withdrawal by Subject|1|||
164633327|NCT02132312|594680452|FG001|Overall Study|Withdrawal by Subject|0|||
164633328|NCT02132312|594680451|FG000|Overall Study|Lost to Follow-up|2|||
164633329|NCT02132312|594680452|FG001|Overall Study|Lost to Follow-up|1|||
164633330|NCT04034225|594680453|FG000|Overall Study|Death|3|||
164633331|NCT04034225|594680453|FG000|Overall Study|Withdrawal by Subject|2|||
164633332|NCT04034225|594680453|FG000|Overall Study|Study termination by Sponsor|18|||
164633333|NCT04034225|594680453|FG000|Overall Study|Physician Decision|1|||
164633334|NCT04034225|594680453|FG000|Overall Study|Lack of Efficacy|1|||
164633335|NCT00955682|594680454|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
164633336|NCT00955682|594680455|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
164633337|NCT00877929|594680461|FG000|Overall Study|Adverse Event|11|||
164633338|NCT00877929|594680462|FG001|Overall Study|Adverse Event|20|||
164633339|NCT00877929|594680461|FG000|Overall Study|Protocol Violation|3|||
164633340|NCT00877929|594680462|FG001|Overall Study|Protocol Violation|3|||
164633341|NCT00877929|594680461|FG000|Overall Study|Lost to Follow-up|0|||
164633342|NCT00877929|594680462|FG001|Overall Study|Lost to Follow-up|1|||
164633343|NCT00877929|594680461|FG000|Overall Study|Withdrawal by Subject|4|||
164633344|NCT00877929|594680462|FG001|Overall Study|Withdrawal by Subject|4|||
164633345|NCT00877929|594680461|FG000|Overall Study|Lack of Efficacy|0|||
164633346|NCT00877929|594680462|FG001|Overall Study|Lack of Efficacy|1|||
164633347|NCT00877929|594680461|FG000|Overall Study|Other reason (not specified)|2|||
164633348|NCT00877929|594680462|FG001|Overall Study|Other reason (not specified)|6|||
164633349|NCT00842829|594680463|FG000|Dose Titration Period|Adverse Event|11|||
164633350|NCT00842829|594680464|FG001|Dose Titration Period|Adverse Event|10|||
164633351|NCT00842829|594680465|FG002|Dose Titration Period|Adverse Event|0|||
164529442|NCT00799513|594309490|FG000|Overall Study|Physician Decision|1|||
164529443|NCT00799513|594309490|FG000|Overall Study|Adverse Event|1|||
164529444|NCT05062759|594309493|FG000|Overall Study|Death|0|||
164529445|NCT05062759|594309494|FG001|Overall Study|Death|1|||
164529446|NCT05062759|594309493|FG000|Overall Study|Lost to Follow-up|1|||
164529447|NCT05062759|594309494|FG001|Overall Study|Lost to Follow-up|0|||
164529448|NCT04981366|594309495|FG000|Overall Study|Withdrawal by Subject|5|||
164529449|NCT04981366|594309496|FG001|Overall Study|Withdrawal by Subject|4|||
164529450|NCT04981366|594309497|FG002|Overall Study|Withdrawal by Subject|8|||
164529451|NCT04981366|594309495|FG000|Overall Study|Health issues unrelated to the trial|1|||
164529452|NCT04981366|594309496|FG001|Overall Study|Health issues unrelated to the trial|2|||
164529453|NCT04981366|594309497|FG002|Overall Study|Health issues unrelated to the trial|0|||
164529454|NCT04371198|594309498|FG000|Overall Study|inadequate sample|4|||
164529455|NCT01112306|594309499|FG000|Overall Study|Death|175|||
164529456|NCT01112306|594309499|FG000|Overall Study|Lost to Follow-up|9|||
164529457|NCT01112306|594309499|FG000|Overall Study|Withdrawal by Subject|31|||
164529458|NCT01112306|594309499|FG000|Overall Study|Other|70|||
164529459|NCT03214094|594309500|FG000|Overall Study|Case Report Forms Uncollected|14|||
164529460|NCT03214094|594309500|FG000|Overall Study|Protocol Deviation|46|||
164529461|NCT00655486|594309506|FG000|Overall Study|Adverse Event|10|||
164529462|NCT00655486|594309506|FG000|Overall Study|Lack of Efficacy|8|||
164529463|NCT00655486|594309506|FG000|Overall Study|Withdrawal by Subject|4|||
164529464|NCT00655486|594309506|FG000|Overall Study|Protocol Violation|1|||
164529465|NCT00655486|594309506|FG000|Overall Study|Unsatisfactory compliance|2|||
164529466|NCT00655486|594309506|FG000|Overall Study|Other: Pregnancy|1|||
164529467|NCT00655486|594309506|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
164529468|NCT00655486|594309506|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
164529469|NCT00310037|594309507|FG000|Overall Study|Adverse Event|7|||
164529470|NCT00310037|594309508|FG001|Overall Study|Adverse Event|14|||
164529471|NCT00310037|594309507|FG000|Overall Study|Withdrawal by Subject|4|||
164529472|NCT00310037|594309508|FG001|Overall Study|Withdrawal by Subject|3|||
164529473|NCT00310037|594309507|FG000|Overall Study|Progression|6|||
164529474|NCT00310037|594309508|FG001|Overall Study|Progression|0|||
164529475|NCT00310037|594309507|FG000|Overall Study|Non-protocol treatment|1|||
164529476|NCT00310037|594309508|FG001|Overall Study|Non-protocol treatment|0|||
164529477|NCT00440999|594309519|FG000|Overall Study|Adverse Event|0|||
164633352|NCT00842829|594680463|FG000|Dose Titration Period|Lack of Efficacy|4|||
164633353|NCT00842829|594680464|FG001|Dose Titration Period|Lack of Efficacy|1|||
164633354|NCT00842829|594680465|FG002|Dose Titration Period|Lack of Efficacy|0|||
164633355|NCT00842829|594680463|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
164633356|NCT00842829|594680464|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
164633357|NCT00842829|594680465|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
164633358|NCT00842829|594680463|FG000|Dose Titration Period|Withdrawal by Subject|2|||
164529478|NCT00440999|594309520|FG001|Overall Study|Adverse Event|2|||
164529479|NCT00440999|594309519|FG000|Overall Study|Lack of Efficacy|6|||
164529480|NCT00440999|594309520|FG001|Overall Study|Lack of Efficacy|7|||
164529481|NCT00440999|594309519|FG000|Overall Study|Lost to Follow-up|19|||
164529482|NCT00440999|594309520|FG001|Overall Study|Lost to Follow-up|12|||
164633359|NCT00842829|594680464|FG001|Dose Titration Period|Withdrawal by Subject|6|||
164633360|NCT00842829|594680465|FG002|Dose Titration Period|Withdrawal by Subject|0|||
164633361|NCT00842829|594680463|FG000|Dose Titration Period|Other|5|||
164633362|NCT00842829|594680464|FG001|Dose Titration Period|Other|4|||
164633363|NCT00842829|594680465|FG002|Dose Titration Period|Other|0|||
164633364|NCT00842829|594680463|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
164633365|NCT00842829|594680464|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
164633366|NCT00842829|594680465|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
164633367|NCT00842829|594680463|FG000|Dose Titration Period|Non-compliance to study drug|2|||
164633368|NCT00842829|594680464|FG001|Dose Titration Period|Non-compliance to study drug|1|||
164633369|NCT00842829|594680465|FG002|Dose Titration Period|Non-compliance to study drug|0|||
164633370|NCT00842829|594680463|FG000|Treatment Period|Adverse Event|0|||
164633371|NCT00842829|594680464|FG001|Treatment Period|Adverse Event|0|||
164633372|NCT00842829|594680465|FG002|Treatment Period|Adverse Event|15|||
164633373|NCT00842829|594680463|FG000|Treatment Period|Lack of Efficacy|0|||
164633374|NCT00842829|594680464|FG001|Treatment Period|Lack of Efficacy|0|||
164633375|NCT00842829|594680465|FG002|Treatment Period|Lack of Efficacy|6|||
164633376|NCT00842829|594680463|FG000|Treatment Period|Unstable persistent cancer pain|0|||
164633377|NCT00842829|594680464|FG001|Treatment Period|Unstable persistent cancer pain|0|||
164633378|NCT00842829|594680465|FG002|Treatment Period|Unstable persistent cancer pain|5|||
164633379|NCT00842829|594680463|FG000|Treatment Period|Withdrawal by Subject|0|||
164633380|NCT00842829|594680464|FG001|Treatment Period|Withdrawal by Subject|0|||
164633381|NCT00842829|594680465|FG002|Treatment Period|Withdrawal by Subject|11|||
164633382|NCT00842829|594680463|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
164633383|NCT00842829|594680464|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
164633384|NCT00842829|594680465|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
164633385|NCT00842829|594680463|FG000|Treatment Period|Protocol Violation|0|||
164633386|NCT00842829|594680464|FG001|Treatment Period|Protocol Violation|0|||
164633387|NCT00842829|594680465|FG002|Treatment Period|Protocol Violation|2|||
164633388|NCT00842829|594680463|FG000|Treatment Period|Other|0|||
164633389|NCT00842829|594680464|FG001|Treatment Period|Other|0|||
164633390|NCT00842829|594680465|FG002|Treatment Period|Other|18|||
164633391|NCT00842829|594680463|FG000|Treatment Period|Non-compliance to study procedures|0|||
164633392|NCT00842829|594680464|FG001|Treatment Period|Non-compliance to study procedures|0|||
164633393|NCT00842829|594680465|FG002|Treatment Period|Non-compliance to study procedures|4|||
164633394|NCT00842829|594680463|FG000|Treatment Period|Unclear completion status|0|||
164633395|NCT00842829|594680464|FG001|Treatment Period|Unclear completion status|0|||
164633396|NCT00842829|594680465|FG002|Treatment Period|Unclear completion status|1|||
164633397|NCT00842829|594680463|FG000|Continuation Period|Adverse Event|0|||
164633398|NCT00842829|594680464|FG001|Continuation Period|Adverse Event|0|||
164633399|NCT00842829|594680465|FG002|Continuation Period|Adverse Event|32|||
164633400|NCT00842829|594680463|FG000|Continuation Period|Lack of Efficacy|0|||
164633401|NCT00842829|594680464|FG001|Continuation Period|Lack of Efficacy|0|||
164633402|NCT00842829|594680465|FG002|Continuation Period|Lack of Efficacy|6|||
164633403|NCT00842829|594680463|FG000|Continuation Period|Unstable persistent cancer pain|0|||
164633404|NCT00842829|594680464|FG001|Continuation Period|Unstable persistent cancer pain|0|||
164633405|NCT00842829|594680465|FG002|Continuation Period|Unstable persistent cancer pain|3|||
164633406|NCT00842829|594680463|FG000|Continuation Period|Withdrawal by Subject|0|||
164633407|NCT00842829|594680464|FG001|Continuation Period|Withdrawal by Subject|0|||
164633408|NCT00842829|594680465|FG002|Continuation Period|Withdrawal by Subject|10|||
164633409|NCT00842829|594680463|FG000|Continuation Period|Other|0|||
164633410|NCT00842829|594680464|FG001|Continuation Period|Other|0|||
164633411|NCT00842829|594680465|FG002|Continuation Period|Other|7|||
164633412|NCT00842829|594680463|FG000|Continuation Period|Non-compliance to study procedures|0|||
164633413|NCT00842829|594680464|FG001|Continuation Period|Non-compliance to study procedures|0|||
164633414|NCT00842829|594680465|FG002|Continuation Period|Non-compliance to study procedures|2|||
164633415|NCT00842829|594680463|FG000|Continuation Period|Non-compliance to study drug|0|||
164633416|NCT00842829|594680464|FG001|Continuation Period|Non-compliance to study drug|0|||
164633417|NCT00842829|594680465|FG002|Continuation Period|Non-compliance to study drug|1|||
164633418|NCT02058966|594680468|FG000|Open-Label Methamphetamine|Adverse Event|1|||
164633419|NCT02058966|594680468|FG000|First Intervention|Withdrawal by Subject|1|||
164633420|NCT01362062|594680471|FG000|Overall Study|Adverse Event|1|||
164633421|NCT01362062|594680472|FG001|Overall Study|Adverse Event|0|||
164633422|NCT01362062|594680471|FG000|Overall Study|Lost to Follow-up|11|||
164633423|NCT01362062|594680472|FG001|Overall Study|Lost to Follow-up|0|||
164633424|NCT01362062|594680471|FG000|Overall Study|Withdrawal by Subject|2|||
164633425|NCT01362062|594680472|FG001|Overall Study|Withdrawal by Subject|0|||
164633426|NCT01362062|594680471|FG000|Overall Study|Non-compliant participant|2|||
164633427|NCT01362062|594680472|FG001|Overall Study|Non-compliant participant|0|||
164633428|NCT01362062|594680471|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
164633429|NCT01362062|594680472|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
164633430|NCT01362062|594680471|FG000|Overall Study|Had significant improvement|9|||
164633431|NCT01362062|594680472|FG001|Overall Study|Had significant improvement|0|||
164633432|NCT02545504|594680476|FG000|Overall Study|Death|174|||
164633433|NCT02545504|594680477|FG001|Overall Study|Death|168|||
164633434|NCT02545504|594680476|FG000|Overall Study|Unknown reason|30|||
164633435|NCT02545504|594680477|FG001|Overall Study|Unknown reason|32|||
164633436|NCT02545504|594680476|FG000|Overall Study|Withdrew consent|9|||
164633437|NCT02545504|594680477|FG001|Overall Study|Withdrew consent|11|||
164633438|NCT02545504|594680476|FG000|Overall Study|Investigator's discretion|3|||
164633439|NCT02545504|594680477|FG001|Overall Study|Investigator's discretion|1|||
164633440|NCT02545504|594680476|FG000|Overall Study|Lost to Follow-up|2|||
164633441|NCT02545504|594680477|FG001|Overall Study|Lost to Follow-up|2|||
164633442|NCT00434876|594680478|FG000|Overall Study|Lost to Follow-up|1|||
164633443|NCT00434876|594680479|FG001|Overall Study|Lost to Follow-up|1|||
164633444|NCT00758394|594680480|FG000|2nd Intervention Order|Lost to Follow-up|0|||
164633445|NCT00758394|594680481|FG001|2nd Intervention Order|Lost to Follow-up|1|||
164633446|NCT00758394|594680482|FG002|2nd Intervention Order|Lost to Follow-up|0|||
164633447|NCT00758394|594680483|FG003|2nd Intervention Order|Lost to Follow-up|0|||
164633448|NCT00758394|594680480|FG000|3rd Intervention|Lost to Follow-up|1|||
164633449|NCT00758394|594680481|FG001|3rd Intervention|Lost to Follow-up|0|||
164633450|NCT00758394|594680482|FG002|3rd Intervention|Lost to Follow-up|0|||
164633451|NCT00758394|594680483|FG003|3rd Intervention|Lost to Follow-up|1|||
164633452|NCT00508820|594680484|FG000|Overall Study|Adverse Event|6|||
164529483|NCT00440999|594309519|FG000|Overall Study|Protocol Violation|1|||
164529484|NCT00440999|594309520|FG001|Overall Study|Protocol Violation|0|||
164529485|NCT00440999|594309519|FG000|Overall Study|Withdrawal by Subject|2|||
164529486|NCT00440999|594309520|FG001|Overall Study|Withdrawal by Subject|5|||
164529487|NCT00440999|594309519|FG000|Overall Study|Subjets missed the visit|1|||
164633453|NCT00508820|594680485|FG001|Overall Study|Adverse Event|10|||
164633454|NCT00508820|594680484|FG000|Overall Study|Death|6|||
164633455|NCT00508820|594680485|FG001|Overall Study|Death|8|||
164633456|NCT00508820|594680484|FG000|Overall Study|Lost to Follow-up|1|||
164633457|NCT00508820|594680485|FG001|Overall Study|Lost to Follow-up|1|||
164633458|NCT00508820|594680484|FG000|Overall Study|Physician Decision|8|||
164633459|NCT00508820|594680485|FG001|Overall Study|Physician Decision|2|||
164633460|NCT00508820|594680484|FG000|Overall Study|Pregnancy|0|||
164633461|NCT00508820|594680485|FG001|Overall Study|Pregnancy|2|||
164633462|NCT00508820|594680484|FG000|Overall Study|Protocol Violation|2|||
164633463|NCT00508820|594680485|FG001|Overall Study|Protocol Violation|0|||
164633464|NCT00508820|594680484|FG000|Overall Study|Withdrawal by Subject|10|||
164633465|NCT00508820|594680485|FG001|Overall Study|Withdrawal by Subject|12|||
164633466|NCT00508820|594680484|FG000|Overall Study|Other|11|||
164633467|NCT00508820|594680485|FG001|Overall Study|Other|2|||
164633468|NCT00508820|594680484|FG000|Overall Study|Noncompliance|1|||
164633469|NCT00508820|594680485|FG001|Overall Study|Noncompliance|0|||
164633470|NCT00508820|594680484|FG000|Overall Study|Requirement for alternative therapy|7|||
164633471|NCT00508820|594680485|FG001|Overall Study|Requirement for alternative therapy|15|||
164633472|NCT00508820|594680484|FG000|Overall Study|Protocol-specified Criteria|3|||
164633473|NCT00508820|594680485|FG001|Overall Study|Protocol-specified Criteria|12|||
164633474|NCT03799198|594682116|FG000|Overall Study|Lost to Follow-up|4|||
164633475|NCT03799198|594682117|FG001|Overall Study|Lost to Follow-up|8|||
164633476|NCT03799198|594682116|FG000|Overall Study|Death|0|||
164633477|NCT03799198|594682117|FG001|Overall Study|Death|1|||
164633478|NCT00960869|594682119|FG000|Overall Study|Adverse Event|17|||
164633479|NCT00960869|594682120|FG001|Overall Study|Adverse Event|26|||
164633480|NCT00960869|594682119|FG000|Overall Study|Withdrawal by Subject|16|||
164633481|NCT00960869|594682120|FG001|Overall Study|Withdrawal by Subject|14|||
164633482|NCT00960869|594682119|FG000|Overall Study|Lost to Follow-up|1|||
164633483|NCT00960869|594682120|FG001|Overall Study|Lost to Follow-up|4|||
164633484|NCT00960869|594682119|FG000|Overall Study|Misc|19|||
164633485|NCT00960869|594682120|FG001|Overall Study|Misc|18|||
164633486|NCT02501642|594682121|FG000|Overall Study|Lost to Follow-up|7|||
164633487|NCT02501642|594682122|FG001|Overall Study|Lost to Follow-up|11|||
164633488|NCT01153971|594682126|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
164633489|NCT01153971|594682126|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
164633490|NCT01153971|594682126|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
164633491|NCT01153971|594682126|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
164633492|NCT01153971|594682126|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
164633493|NCT01153971|594682126|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
164633494|NCT01153971|594682126|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
164633495|NCT03410693|594682127|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
164633496|NCT03410693|594682128|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
164633497|NCT03410693|594682127|FG000|Overall Study|Disc trt: Lost to follow up|0|||
164633498|NCT03410693|594682128|FG001|Overall Study|Disc trt: Lost to follow up|1|||
164633499|NCT03410693|594682127|FG000|Overall Study|Disc trt: radiological progression|58|||
164633500|NCT03410693|594682128|FG001|Overall Study|Disc trt: radiological progression|50|||
164633501|NCT03410693|594682127|FG000|Overall Study|Disc trt: Other|1|||
164633502|NCT03410693|594682128|FG001|Overall Study|Disc trt: Other|0|||
164633503|NCT03410693|594682127|FG000|Overall Study|Study drug never administered|1|||
164633504|NCT03410693|594682128|FG001|Overall Study|Study drug never administered|6|||
164633505|NCT03410693|594682127|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
164633506|NCT03410693|594682128|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
164633507|NCT03410693|594682127|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
164633508|NCT03410693|594682128|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
164633509|NCT03410693|594682127|FG000|Overall Study|Disc trt: Physician decision|0|||
164633510|NCT03410693|594682128|FG001|Overall Study|Disc trt: Physician decision|5|||
164633511|NCT03410693|594682127|FG000|Overall Study|Disc trt: clinical progression|1|||
164633512|NCT03410693|594682128|FG001|Overall Study|Disc trt: clinical progression|5|||
164633513|NCT03410693|594682127|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
164148072|NCT00247676|592904819|FG000|Overall Study|Lack of Efficacy|15|||
164633514|NCT03410693|594682128|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
164633515|NCT01789476|594682129|FG000|Overall Study|Lack of Efficacy|6|||
164633516|NCT01789476|594682130|FG001|Overall Study|Lack of Efficacy|2|||
164633517|NCT01789476|594682129|FG000|Overall Study|Adverse Event|1|||
164633518|NCT01789476|594682130|FG001|Overall Study|Adverse Event|0|||
164633519|NCT01789476|594682129|FG000|Overall Study|Unable to get IV access|1|||
164633520|NCT01789476|594682130|FG001|Overall Study|Unable to get IV access|0|||
164633521|NCT00953576|594682131|FG000|Overall Study|Adverse Event|0|||
164633522|NCT00953576|594682132|FG001|Overall Study|Adverse Event|1|||
164633523|NCT00953576|594682131|FG000|Overall Study|Ineligible after Consent|2|||
164633524|NCT00953576|594682132|FG001|Overall Study|Ineligible after Consent|0|||
164633525|NCT00501969|594682133|FG000|Overall Study|Major Protocol Violation|4|||
164633526|NCT00501969|594682133|FG000|Overall Study|Lack of Efficacy|29|||
164633527|NCT00501969|594682133|FG000|Overall Study|Adverse Event|76|||
164633528|NCT00501969|594682133|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
164633529|NCT00501969|594682133|FG000|Overall Study|Subject withdrew consent|51|||
164633530|NCT00501969|594682133|FG000|Overall Study|Lost to Follow-up|4|||
164633531|NCT00501969|594682133|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
164633532|NCT00501969|594682133|FG000|Overall Study|Other: Sponsors Request|10|||
164633533|NCT00501969|594682133|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
164633534|NCT00501969|594682133|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
164633535|NCT00501969|594682133|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
164633536|NCT00501969|594682133|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
164633537|NCT00501969|594682133|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
164633538|NCT00501969|594682133|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
164633539|NCT00501969|594682133|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
164633540|NCT00501969|594682133|FG000|Overall Study|Other: As Required by Local EC|2|||
164633541|NCT00501969|594682133|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
164633542|NCT00501969|594682133|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
164633543|NCT01798056|594682134|FG000|Overall Study|Serious Adverse Event|13|||
164633544|NCT01798056|594682135|FG001|Overall Study|Serious Adverse Event|12|||
164633545|NCT01798056|594682134|FG000|Overall Study|Withdrawal by Subject|12|||
164633546|NCT01798056|594682135|FG001|Overall Study|Withdrawal by Subject|9|||
164633547|NCT01798056|594682134|FG000|Overall Study|Migrated/moved from study area|1|||
164633548|NCT01798056|594682135|FG001|Overall Study|Migrated/moved from study area|1|||
164633549|NCT01798056|594682134|FG000|Overall Study|Lost to Follow-up|1|||
164633550|NCT01798056|594682135|FG001|Overall Study|Lost to Follow-up|1|||
164633551|NCT01798056|594682134|FG000|Overall Study|Other|0|||
164633552|NCT01798056|594682135|FG001|Overall Study|Other|2|||
164633553|NCT01238861|594682136|FG000|Overall Study|Lost to Follow-up|4|||
164633554|NCT01238861|594682137|FG001|Overall Study|Lost to Follow-up|2|||
164633555|NCT01238861|594682138|FG002|Overall Study|Lost to Follow-up|3|||
164633556|NCT01238861|594682139|FG003|Overall Study|Lost to Follow-up|1|||
164633557|NCT01238861|594682140|FG004|Overall Study|Lost to Follow-up|1|||
164633558|NCT01238861|594682141|FG005|Overall Study|Lost to Follow-up|2|||
164633559|NCT01238861|594682136|FG000|Overall Study|Unplanned surgery|1|||
164633560|NCT01238861|594682137|FG001|Overall Study|Unplanned surgery|0|||
164633561|NCT01238861|594682138|FG002|Overall Study|Unplanned surgery|0|||
164633562|NCT01238861|594682139|FG003|Overall Study|Unplanned surgery|0|||
164633563|NCT01238861|594682140|FG004|Overall Study|Unplanned surgery|0|||
164633564|NCT01238861|594682141|FG005|Overall Study|Unplanned surgery|0|||
164633565|NCT01238861|594682136|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
164633566|NCT01238861|594682137|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
164633567|NCT01238861|594682138|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
164633568|NCT01238861|594682139|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
164633569|NCT01238861|594682140|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
164633570|NCT01238861|594682141|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
164633571|NCT01238861|594682136|FG000|Overall Study|Incorrect enrollment/randomization|0|||
164633572|NCT01238861|594682137|FG001|Overall Study|Incorrect enrollment/randomization|0|||
164633573|NCT01238861|594682138|FG002|Overall Study|Incorrect enrollment/randomization|1|||
164633574|NCT01238861|594682139|FG003|Overall Study|Incorrect enrollment/randomization|0|||
164633575|NCT01238861|594682140|FG004|Overall Study|Incorrect enrollment/randomization|1|||
164633576|NCT01238861|594682141|FG005|Overall Study|Incorrect enrollment/randomization|0|||
164633577|NCT01238861|594682136|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
164633578|NCT01238861|594682137|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
164633579|NCT01238861|594682138|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
164633580|NCT01238861|594682139|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
164633581|NCT01238861|594682140|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
164633582|NCT01238861|594682141|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
164633583|NCT01238861|594682136|FG000|Overall Study|Subject moved out of state/area|0|||
164633584|NCT01238861|594682137|FG001|Overall Study|Subject moved out of state/area|0|||
164633585|NCT01238861|594682138|FG002|Overall Study|Subject moved out of state/area|1|||
164633586|NCT01238861|594682139|FG003|Overall Study|Subject moved out of state/area|1|||
164633587|NCT01238861|594682140|FG004|Overall Study|Subject moved out of state/area|0|||
164633588|NCT01238861|594682141|FG005|Overall Study|Subject moved out of state/area|0|||
164633589|NCT01238861|594682136|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
164633590|NCT01238861|594682137|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
164633591|NCT01238861|594682138|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
164633592|NCT01238861|594682139|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
164633593|NCT01238861|594682140|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
164633594|NCT01238861|594682141|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
164633595|NCT01238861|594682136|FG000|Overall Study|Personal problems|0|||
164633596|NCT01238861|594682137|FG001|Overall Study|Personal problems|0|||
164633597|NCT01238861|594682138|FG002|Overall Study|Personal problems|0|||
164633598|NCT01238861|594682139|FG003|Overall Study|Personal problems|1|||
164633599|NCT01238861|594682140|FG004|Overall Study|Personal problems|0|||
164633600|NCT01238861|594682141|FG005|Overall Study|Personal problems|0|||
164633601|NCT01238861|594682136|FG000|Overall Study|Unable to continue visits|0|||
164633602|NCT01238861|594682137|FG001|Overall Study|Unable to continue visits|0|||
164633603|NCT01238861|594682138|FG002|Overall Study|Unable to continue visits|0|||
164633604|NCT01238861|594682139|FG003|Overall Study|Unable to continue visits|1|||
164633605|NCT01238861|594682140|FG004|Overall Study|Unable to continue visits|0|||
164633606|NCT01238861|594682141|FG005|Overall Study|Unable to continue visits|1|||
164633607|NCT01238861|594682136|FG000|Overall Study|Serious adverse event|0|||
164633608|NCT01238861|594682137|FG001|Overall Study|Serious adverse event|0|||
164633609|NCT01238861|594682138|FG002|Overall Study|Serious adverse event|0|||
164633610|NCT01238861|594682139|FG003|Overall Study|Serious adverse event|0|||
164633611|NCT01238861|594682140|FG004|Overall Study|Serious adverse event|0|||
164633612|NCT01238861|594682141|FG005|Overall Study|Serious adverse event|1|||
164633613|NCT01238861|594682136|FG000|Overall Study|Lack of compliance|0|||
164633614|NCT01238861|594682137|FG001|Overall Study|Lack of compliance|0|||
164633615|NCT01238861|594682138|FG002|Overall Study|Lack of compliance|0|||
164633616|NCT01238861|594682139|FG003|Overall Study|Lack of compliance|0|||
164633617|NCT01238861|594682140|FG004|Overall Study|Lack of compliance|0|||
164633618|NCT01238861|594682141|FG005|Overall Study|Lack of compliance|1|||
164633619|NCT01238861|594682136|FG000|Overall Study|Adverse Event|0|||
164633620|NCT01238861|594682137|FG001|Overall Study|Adverse Event|1|||
164633621|NCT01238861|594682138|FG002|Overall Study|Adverse Event|0|||
164633622|NCT01238861|594682139|FG003|Overall Study|Adverse Event|0|||
164633623|NCT01238861|594682140|FG004|Overall Study|Adverse Event|0|||
164633624|NCT01238861|594682141|FG005|Overall Study|Adverse Event|0|||
164633625|NCT01238861|594682136|FG000|Overall Study|Withdrawal by Subject|6|||
164633626|NCT01238861|594682137|FG001|Overall Study|Withdrawal by Subject|5|||
164633627|NCT01238861|594682138|FG002|Overall Study|Withdrawal by Subject|4|||
164633628|NCT01238861|594682139|FG003|Overall Study|Withdrawal by Subject|8|||
164633629|NCT01238861|594682140|FG004|Overall Study|Withdrawal by Subject|10|||
164633630|NCT01238861|594682141|FG005|Overall Study|Withdrawal by Subject|9|||
164633631|NCT01269346|594682142|FG000|Treatment Phase|Disease progression|3|||
164633632|NCT01269346|594682142|FG000|Treatment Phase|Adverse Event|3|||
164633633|NCT01269346|594682142|FG000|Treatment Phase|Withdrawal by Subject|1|||
164633634|NCT01269346|594682142|FG000|Treatment Phase|Other|2|||
164633635|NCT01269346|594682142|FG000|Extension Phase|Adverse Event|6|||
164633636|NCT01269346|594682142|FG000|Extension Phase|Withdrawal by Subject|4|||
164633637|NCT01269346|594682142|FG000|Extension Phase|Disease progression|22|||
164633638|NCT01269346|594682142|FG000|Extension Phase|Physician decision or participant choice|9|||
164633639|NCT01269346|594682142|FG000|Extension Phase|Clinical progression|1|||
164633640|NCT01269346|594682142|FG000|Extension Phase|Started a prohibited con med|1|||
164633641|NCT00247416|594682143|FG000|Overall Study|3 patients were found to be ineligible|1|||
164633642|NCT00247416|594682144|FG001|Overall Study|3 patients were found to be ineligible|2|||
164633643|NCT02660489|594682153|FG000|Overall Study|Lost to Follow-up|1|||
164633644|NCT02660489|594682154|FG001|Overall Study|Lost to Follow-up|1|||
164633645|NCT02660489|594682153|FG000|Overall Study|Adverse Event|1|||
164633646|NCT02660489|594682154|FG001|Overall Study|Adverse Event|3|||
164633647|NCT02660489|594682153|FG000|Overall Study|no rhinovirus infection|4|||
164633648|NCT02660489|594682154|FG001|Overall Study|no rhinovirus infection|4|||
164633649|NCT00278473|594682155|FG000|Overall Study|drop out|4|||
164633650|NCT00278473|594682156|FG001|Overall Study|drop out|3|||
164633651|NCT02322866|594682157|FG000|Overall Study|Adverse Event|6|||
164633652|NCT02322866|594682158|FG001|Overall Study|Adverse Event|11|||
164633653|NCT02322866|594682157|FG000|Overall Study|Withdrawal of Consent|16|||
164633654|NCT02322866|594682158|FG001|Overall Study|Withdrawal of Consent|25|||
164633655|NCT02322866|594682157|FG000|Overall Study|Lost to Follow-up|36|||
164633656|NCT02322866|594682158|FG001|Overall Study|Lost to Follow-up|39|||
164633657|NCT02322866|594682157|FG000|Overall Study|Protocol Violation|1|||
164633658|NCT02322866|594682158|FG001|Overall Study|Protocol Violation|0|||
164633659|NCT02322866|594682157|FG000|Overall Study|Noncompliance with Treatment|3|||
164633660|NCT02322866|594682158|FG001|Overall Study|Noncompliance with Treatment|4|||
164633661|NCT02322866|594682157|FG000|Overall Study|Lack of Efficacy|3|||
164633662|NCT02322866|594682158|FG001|Overall Study|Lack of Efficacy|1|||
164633663|NCT02322866|594682157|FG000|Overall Study|Other Miscellaneous Reasons|6|||
164633664|NCT02322866|594682158|FG001|Overall Study|Other Miscellaneous Reasons|6|||
164633665|NCT00761761|594682168|FG000|Overall Study|Lost to Follow-up|3|||
164633666|NCT00761761|594682169|FG001|Overall Study|Lost to Follow-up|1|||
164633667|NCT00761761|594682168|FG000|Overall Study|Withdrawal by Subject|3|||
164633668|NCT00761761|594682169|FG001|Overall Study|Withdrawal by Subject|0|||
164633669|NCT04001790|594682174|FG000|Overall Study|Withdrawal by Subject|1|||
164148073|NCT00247676|592904819|FG000|Overall Study|Other|3|||
164633670|NCT04001790|594682175|FG001|Overall Study|Withdrawal by Subject|2|||
164633671|NCT03472586|594682176|FG000|Overall Study|Physician Decision|6|||
164633672|NCT03472586|594682176|FG000|Overall Study|Death|6|||
164633673|NCT03472586|594682176|FG000|Overall Study|Adverse Event|1|||
164633674|NCT04963231|594682179|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
164633675|NCT04963231|594682180|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
164633676|NCT04963231|594682181|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
164633677|NCT04963231|594682179|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
164633678|NCT04963231|594682180|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
164633679|NCT04963231|594682181|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
164633680|NCT04963231|594682179|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
164633681|NCT04963231|594682180|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
164633682|NCT04963231|594682181|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
164633683|NCT04963231|594682179|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
164633684|NCT04963231|594682180|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
164633685|NCT04963231|594682181|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
164633686|NCT04963231|594682179|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
164633687|NCT04963231|594682180|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
164633688|NCT04963231|594682181|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
164633689|NCT04963231|594682179|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
164633690|NCT04963231|594682180|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
164633691|NCT04963231|594682181|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
164633692|NCT04963231|594682179|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
164633693|NCT04963231|594682180|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
164633694|NCT04963231|594682181|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
164633695|NCT01059175|594682184|FG000|Overall Study|Death|17|||
164633696|NCT01059175|594682185|FG001|Overall Study|Death|17|||
164633697|NCT01059175|594682184|FG000|Overall Study|Adverse Event|4|||
164633698|NCT01059175|594682185|FG001|Overall Study|Adverse Event|2|||
164633699|NCT01059175|594682184|FG000|Overall Study|Lost to Follow-up|0|||
164633700|NCT01059175|594682185|FG001|Overall Study|Lost to Follow-up|1|||
164633701|NCT02957149|594682186|FG000|Overall Study|Withdrawal by Subject|5|||
164633702|NCT06045026|594682187|FG000|Overall Study|Lost to Follow-up|60|||
164633703|NCT06045026|594682187|FG000|Overall Study|Adverse Event|12|||
164633704|NCT06045026|594682187|FG000|Overall Study|Withdrawal by Subject|3|||
164633705|NCT06045026|594682187|FG000|Overall Study|Enrollment closed|1|||
164633706|NCT02452320|594682193|FG000|Overall Study|Adverse Event|0|||
164633707|NCT02452320|594682194|FG001|Overall Study|Adverse Event|1|||
164633708|NCT03911401|594682195|FG000|Overall Study|Adverse Event|1|||
164633709|NCT03911401|594682196|FG001|Overall Study|Adverse Event|2|||
164633710|NCT03911401|594682197|FG002|Overall Study|Adverse Event|5|||
164633711|NCT03911401|594682195|FG000|Overall Study|Lack of Efficacy|1|||
164633712|NCT03911401|594682196|FG001|Overall Study|Lack of Efficacy|1|||
164633713|NCT03911401|594682197|FG002|Overall Study|Lack of Efficacy|8|||
164633714|NCT03911401|594682195|FG000|Overall Study|Physician Decision|0|||
164633715|NCT03911401|594682196|FG001|Overall Study|Physician Decision|0|||
164633716|NCT03911401|594682197|FG002|Overall Study|Physician Decision|1|||
164633717|NCT03911401|594682195|FG000|Overall Study|Withdrawal by Subject|1|||
164633718|NCT03911401|594682196|FG001|Overall Study|Withdrawal by Subject|2|||
164633719|NCT03911401|594682197|FG002|Overall Study|Withdrawal by Subject|0|||
164633720|NCT03911401|594682195|FG000|Overall Study|Withdrawal by parent/guardian|4|||
164633721|NCT03911401|594682196|FG001|Overall Study|Withdrawal by parent/guardian|4|||
164633722|NCT03911401|594682197|FG002|Overall Study|Withdrawal by parent/guardian|11|||
164633723|NCT03290131|594682198|FG000|Overall Study|Adverse Event|22|||
164633724|NCT03290131|594682199|FG001|Overall Study|Adverse Event|57|||
164633725|NCT03290131|594682200|FG002|Overall Study|Adverse Event|11|||
164633726|NCT03290131|594682198|FG000|Overall Study|Withdrawal by Subject|18|||
164148524|NCT01823835|592904895|FG003|Overall Study|Study Termination|0|||
164633727|NCT03290131|594682199|FG001|Overall Study|Withdrawal by Subject|13|||
164633728|NCT03290131|594682200|FG002|Overall Study|Withdrawal by Subject|8|||
164633729|NCT03290131|594682198|FG000|Overall Study|MS Relapse|2|||
164633730|NCT03290131|594682199|FG001|Overall Study|MS Relapse|1|||
164633731|NCT03290131|594682200|FG002|Overall Study|MS Relapse|0|||
164633732|NCT03290131|594682198|FG000|Overall Study|Unknown reason|0|||
164633733|NCT03290131|594682199|FG001|Overall Study|Unknown reason|1|||
164633734|NCT03290131|594682200|FG002|Overall Study|Unknown reason|0|||
164633735|NCT00381680|594682203|FG000|Overall Study|Adverse Event|9|||
164633736|NCT00381680|594682204|FG001|Overall Study|Adverse Event|3|||
164633737|NCT00381680|594682203|FG000|Overall Study|Death|10|||
164633738|NCT00381680|594682204|FG001|Overall Study|Death|7|||
164633739|NCT00381680|594682203|FG000|Overall Study|Lost to Follow-up|3|||
164633740|NCT00381680|594682204|FG001|Overall Study|Lost to Follow-up|2|||
164633741|NCT00381680|594682203|FG000|Overall Study|Physician Decision|25|||
164633742|NCT00381680|594682204|FG001|Overall Study|Physician Decision|6|||
164633743|NCT00381680|594682203|FG000|Overall Study|Withdrawal by Subject|3|||
164633744|NCT00381680|594682204|FG001|Overall Study|Withdrawal by Subject|1|||
164633745|NCT00381680|594682203|FG000|Overall Study|Entry onto another COG Trial|1|||
164633746|NCT00381680|594682204|FG001|Overall Study|Entry onto another COG Trial|2|||
164633747|NCT00381680|594682203|FG000|Overall Study|Alternative Therapy|11|||
164633748|NCT00381680|594682204|FG001|Overall Study|Alternative Therapy|5|||
164633749|NCT00381680|594682203|FG000|Overall Study|Secondary Malignancy|3|||
164633750|NCT00381680|594682204|FG001|Overall Study|Secondary Malignancy|0|||
164633751|NCT00381680|594682203|FG000|Overall Study|Delay initiation|1|||
164633752|NCT00381680|594682204|FG001|Overall Study|Delay initiation|0|||
164633753|NCT00381680|594682203|FG000|Overall Study|Stem Cell Transplant|26|||
164633754|NCT00381680|594682204|FG001|Overall Study|Stem Cell Transplant|10|||
164633755|NCT00381680|594682203|FG000|Overall Study|Relapse|18|||
164633756|NCT00381680|594682204|FG001|Overall Study|Relapse|9|||
164633757|NCT00381680|594682203|FG000|Overall Study|Induction Failure|4|||
164633758|NCT00381680|594682204|FG001|Overall Study|Induction Failure|1|||
164633759|NCT00381680|594682203|FG000|Overall Study|Progression|1|||
164633760|NCT00381680|594682204|FG001|Overall Study|Progression|1|||
164633761|NCT00381680|594682203|FG000|Overall Study|Other not otherwise specified|7|||
164633762|NCT00381680|594682204|FG001|Overall Study|Other not otherwise specified|2|||
164633763|NCT00381680|594682203|FG000|Overall Study|Ineligible|3|||
164633764|NCT00381680|594682204|FG001|Overall Study|Ineligible|1|||
164633765|NCT03099096|594682205|FG000|Overall Study|Adverse Event|1|||
164633766|NCT03099096|594682205|FG000|Overall Study|Physician Decision|1|||
164633767|NCT00361504|594682208|FG000|Overall Study|Withdrawal by Subject|94|||
164633768|NCT00361504|594682209|FG001|Overall Study|Withdrawal by Subject|31|||
164633769|NCT00361504|594682208|FG000|Overall Study|Lost to Follow-up|40|||
164633770|NCT00361504|594682209|FG001|Overall Study|Lost to Follow-up|7|||
164633771|NCT00361504|594682208|FG000|Overall Study|Adverse Event|203|||
164633772|NCT00361504|594682209|FG001|Overall Study|Adverse Event|82|||
164633773|NCT00361504|594682208|FG000|Overall Study|Lack of Efficacy|72|||
164633774|NCT00361504|594682209|FG001|Overall Study|Lack of Efficacy|7|||
164633775|NCT00361504|594682208|FG000|Overall Study|Resolution of Pain|2|||
164633776|NCT00361504|594682209|FG001|Overall Study|Resolution of Pain|0|||
164633777|NCT00361504|594682208|FG000|Overall Study|Study medication non compliant|42|||
164633778|NCT00361504|594682209|FG001|Overall Study|Study medication non compliant|15|||
164633779|NCT00361504|594682208|FG000|Overall Study|All other|28|||
164633780|NCT00361504|594682209|FG001|Overall Study|All other|3|||
164633781|NCT03764813|594682212|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
164633782|NCT03764813|594682213|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
164633783|NCT03764813|594682214|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
164633784|NCT03764813|594682215|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
164633785|NCT04837807|594682227|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
164633786|NCT04837807|594682228|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
164633787|NCT00334893|594682231|FG000|Overall Study|Not Treated|1|||
164633788|NCT00334893|594682232|FG001|Overall Study|Not Treated|0|||
164633789|NCT00920582|594682233|FG000|Overall Study|Lost to Follow-up|5|||
164633790|NCT00920582|594682234|FG001|Overall Study|Lost to Follow-up|1|||
164633791|NCT00920582|594682235|FG002|Overall Study|Lost to Follow-up|2|||
164633792|NCT00920582|594682236|FG003|Overall Study|Lost to Follow-up|0|||
164633793|NCT00920582|594682233|FG000|Overall Study|Withdrawal by Subject|5|||
164633794|NCT00920582|594682234|FG001|Overall Study|Withdrawal by Subject|4|||
164633795|NCT00920582|594682235|FG002|Overall Study|Withdrawal by Subject|6|||
164633796|NCT00920582|594682236|FG003|Overall Study|Withdrawal by Subject|3|||
164633797|NCT00920582|594682233|FG000|Overall Study|Protocol Violation|1|||
164633798|NCT00920582|594682234|FG001|Overall Study|Protocol Violation|0|||
164633799|NCT00920582|594682235|FG002|Overall Study|Protocol Violation|0|||
164633800|NCT00920582|594682236|FG003|Overall Study|Protocol Violation|0|||
164633801|NCT00920582|594682233|FG000|Overall Study|Other|2|||
164633802|NCT00920582|594682234|FG001|Overall Study|Other|1|||
164633803|NCT00920582|594682235|FG002|Overall Study|Other|3|||
164633804|NCT00920582|594682236|FG003|Overall Study|Other|2|||
164633805|NCT00665002|594682237|FG000|Overall Study|Progression/relapse during treatment|11|||
164633806|NCT00665002|594682237|FG000|Overall Study|Cytogenetic resistance|1|||
164633807|NCT03604159|594682238|FG000|Overall Study|Lost to Follow-up|6|||
164633808|NCT03604159|594682239|FG001|Overall Study|Lost to Follow-up|7|||
164633809|NCT04533204|594682240|FG000|Overall Study|Unable to understand training instructions|1|||
164633810|NCT04533204|594682241|FG001|Overall Study|Unable to understand training instructions|1|||
164633811|NCT02354599|594682245|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
164633812|NCT02354599|594682246|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
164633813|NCT02354599|594682247|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
164633814|NCT02354599|594682248|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
164633815|NCT02354599|594682249|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
164633816|NCT02354599|594682250|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
164633817|NCT02354599|594682245|FG000|Overall Study|Withdrawal by Subject|1|||
164633818|NCT02354599|594682246|FG001|Overall Study|Withdrawal by Subject|1|||
164633819|NCT02354599|594682247|FG002|Overall Study|Withdrawal by Subject|0|||
164633820|NCT02354599|594682248|FG003|Overall Study|Withdrawal by Subject|0|||
164633821|NCT02354599|594682249|FG004|Overall Study|Withdrawal by Subject|0|||
164633822|NCT02354599|594682250|FG005|Overall Study|Withdrawal by Subject|0|||
164633823|NCT00280059|594682251|FG000|Efficacy Assessment Phase|Death|2|||
164633824|NCT00280059|594682252|FG001|Efficacy Assessment Phase|Death|0|||
164633825|NCT00280059|594682251|FG000|Efficacy Assessment Phase|Adverse Event|33|||
164633826|NCT00280059|594682252|FG001|Efficacy Assessment Phase|Adverse Event|31|||
164633827|NCT00280059|594682251|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
164633828|NCT00280059|594682252|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
164633829|NCT00280059|594682251|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
164633830|NCT00280059|594682252|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
164633831|NCT00280059|594682251|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
164633832|NCT00280059|594682252|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
164633833|NCT00280059|594682251|FG000|Efficacy Assessment Phase|Other|7|||
164633834|NCT00280059|594682252|FG001|Efficacy Assessment Phase|Other|8|||
164633835|NCT00280059|594682251|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
164633836|NCT00280059|594682252|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
164633837|NCT00495794|594682255|FG000|Overall Study|Pharmacist did not activate patient|522|||
164633838|NCT00495794|594682256|FG001|Overall Study|Pharmacist did not activate patient|0|||
164633839|NCT02612194|594682257|FG000|Overall Study|Death|5|||
164633840|NCT02612194|594682258|FG001|Overall Study|Death|0|||
164633841|NCT02612194|594682259|FG002|Overall Study|Death|2|||
164633842|NCT02612194|594682257|FG000|Overall Study|Early Study Termination|1|||
164633843|NCT02612194|594682258|FG001|Overall Study|Early Study Termination|0|||
164633844|NCT02612194|594682259|FG002|Overall Study|Early Study Termination|0|||
164633845|NCT00689299|594682262|FG000|Overall Study|Adverse Event|2|||
164633846|NCT00689299|594682263|FG001|Overall Study|Adverse Event|1|||
164633847|NCT00689299|594682264|FG002|Overall Study|Adverse Event|1|||
164633848|NCT00689299|594682262|FG000|Overall Study|Lost to Follow-up|0|||
164633849|NCT00689299|594682263|FG001|Overall Study|Lost to Follow-up|1|||
164633850|NCT00689299|594682264|FG002|Overall Study|Lost to Follow-up|1|||
164633851|NCT00689299|594682262|FG000|Overall Study|Withdrawal by Subject|4|||
164633852|NCT00689299|594682263|FG001|Overall Study|Withdrawal by Subject|1|||
164633853|NCT00689299|594682264|FG002|Overall Study|Withdrawal by Subject|3|||
164633854|NCT00689299|594682262|FG000|Overall Study|Protocol Violation|1|||
164633855|NCT00689299|594682263|FG001|Overall Study|Protocol Violation|0|||
164633856|NCT00689299|594682264|FG002|Overall Study|Protocol Violation|0|||
164633857|NCT01190839|594682265|FG000|Overall Study|Adverse Event|32|||
164633858|NCT01190839|594682266|FG001|Overall Study|Adverse Event|41|||
164633859|NCT01190839|594682265|FG000|Overall Study|Protocol Violation|2|||
164633860|NCT01190839|594682266|FG001|Overall Study|Protocol Violation|2|||
164633861|NCT01190839|594682265|FG000|Overall Study|Lost to Follow-up|7|||
164633862|NCT01190839|594682266|FG001|Overall Study|Lost to Follow-up|1|||
164633863|NCT01190839|594682265|FG000|Overall Study|Death|1|||
164529488|NCT00440999|594309520|FG001|Overall Study|Subjets missed the visit|0|||
164529489|NCT00440999|594309519|FG000|Overall Study|Mixed infection at entry|1|||
164529490|NCT00440999|594309520|FG001|Overall Study|Mixed infection at entry|0|||
164529491|NCT00440999|594309519|FG000|Overall Study|P. falciparum malaria|5|||
164529492|NCT00440999|594309520|FG001|Overall Study|P. falciparum malaria|14|||
164529493|NCT00440999|594309519|FG000|Overall Study|Subj left hosp without inform staff|0|||
164529494|NCT00440999|594309520|FG001|Overall Study|Subj left hosp without inform staff|1|||
164529495|NCT05559099|594309521|FG000|Overall Study|Death|5|||
164529496|NCT05559099|594309522|FG001|Overall Study|Death|4|||
164529497|NCT05559099|594309521|FG000|Overall Study|Lost to Follow-up|0|||
164529498|NCT05559099|594309522|FG001|Overall Study|Lost to Follow-up|2|||
164529499|NCT05559099|594309521|FG000|Overall Study|Adverse Event|1|||
164529500|NCT05559099|594309522|FG001|Overall Study|Adverse Event|1|||
164529501|NCT04218084|594309523|FG000|Overall Study|Adverse Event|7|||
164529502|NCT04218084|594309524|FG001|Overall Study|Adverse Event|2|||
164529503|NCT04218084|594309523|FG000|Overall Study|Withdrawal of Consent|4|||
164529504|NCT04218084|594309524|FG001|Overall Study|Withdrawal of Consent|5|||
164529505|NCT04218084|594309523|FG000|Overall Study|Physician Decision|1|||
164529506|NCT04218084|594309524|FG001|Overall Study|Physician Decision|1|||
164529507|NCT04218084|594309523|FG000|Overall Study|Lost to Follow-up|1|||
164529508|NCT04218084|594309524|FG001|Overall Study|Lost to Follow-up|1|||
164529509|NCT04218084|594309523|FG000|Overall Study|Non-compliance with study drug|1|||
164529510|NCT04218084|594309524|FG001|Overall Study|Non-compliance with study drug|1|||
164529511|NCT04218084|594309523|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
164529512|NCT04218084|594309524|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
164529513|NCT04218084|594309523|FG000|Overall Study|Other|0|||
164529514|NCT04218084|594309524|FG001|Overall Study|Other|1|||
164529515|NCT04218084|594309523|FG000|Overall Study|Ongoing at data cut-off date|62|||
164529516|NCT04218084|594309524|FG001|Overall Study|Ongoing at data cut-off date|58|||
164529517|NCT05041101|594309525|FG000|Overall Study|Adverse Event|1|||
164529518|NCT05041101|594309526|FG001|Overall Study|Adverse Event|0|||
164529519|NCT05041101|594309527|FG002|Overall Study|Adverse Event|0|||
164529520|NCT05041101|594309525|FG000|Overall Study|Diease Progression|5|||
164529521|NCT05041101|594309526|FG001|Overall Study|Diease Progression|0|||
164529522|NCT05041101|594309527|FG002|Overall Study|Diease Progression|0|||
164529523|NCT00842985|594309528|FG000|Screening|Did not meet entrance requirements|27|||
164529524|NCT00842985|594309528|FG000|First Intervention|Withdrawal by Subject|3|||
164529525|NCT00842985|594309528|FG000|First Intervention|Protocol Violation|3|||
164529526|NCT00842985|594309528|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
164529527|NCT00842985|594309528|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
164529528|NCT01037244|594309529|FG000|Overall Study|Adverse Event|3|||
164529529|NCT01037244|594309530|FG001|Overall Study|Adverse Event|2|||
164529530|NCT01037244|594309531|FG002|Overall Study|Adverse Event|6|||
164529531|NCT01037244|594309532|FG003|Overall Study|Adverse Event|3|||
164529532|NCT01037244|594309529|FG000|Overall Study|Lack of Efficacy|1|||
164529533|NCT01037244|594309530|FG001|Overall Study|Lack of Efficacy|1|||
164529534|NCT01037244|594309531|FG002|Overall Study|Lack of Efficacy|0|||
164529535|NCT01037244|594309532|FG003|Overall Study|Lack of Efficacy|1|||
164529536|NCT01037244|594309529|FG000|Overall Study|Lost to Follow-up|3|||
164529537|NCT01037244|594309530|FG001|Overall Study|Lost to Follow-up|3|||
164529538|NCT01037244|594309531|FG002|Overall Study|Lost to Follow-up|4|||
164529539|NCT01037244|594309532|FG003|Overall Study|Lost to Follow-up|4|||
164529540|NCT01037244|594309529|FG000|Overall Study|Withdrawal by Subject|1|||
164529541|NCT01037244|594309530|FG001|Overall Study|Withdrawal by Subject|5|||
164529542|NCT01037244|594309531|FG002|Overall Study|Withdrawal by Subject|3|||
164529543|NCT01037244|594309532|FG003|Overall Study|Withdrawal by Subject|5|||
164529544|NCT01037244|594309529|FG000|Overall Study|Partner Withdrew Consent|2|||
164529545|NCT01037244|594309530|FG001|Overall Study|Partner Withdrew Consent|1|||
164529546|NCT01037244|594309531|FG002|Overall Study|Partner Withdrew Consent|0|||
164529547|NCT01037244|594309532|FG003|Overall Study|Partner Withdrew Consent|0|||
164529548|NCT01037244|594309529|FG000|Overall Study|Various|3|||
164633864|NCT01190839|594682266|FG001|Overall Study|Death|0|||
164633865|NCT01190839|594682265|FG000|Overall Study|Trial stopped by Sponsor|71|||
164633866|NCT01190839|594682266|FG001|Overall Study|Trial stopped by Sponsor|68|||
164633867|NCT01190839|594682265|FG000|Overall Study|Undefined|35|||
164633868|NCT01190839|594682266|FG001|Overall Study|Undefined|31|||
164633869|NCT01190839|594682265|FG000|Overall Study|Randomized but not treated|2|||
164633870|NCT01190839|594682266|FG001|Overall Study|Randomized but not treated|4|||
164633871|NCT01265511|594682271|FG000|Overall Study|Lack of Efficacy|2|||
164633872|NCT01265511|594682272|FG001|Overall Study|Lack of Efficacy|1|||
164529549|NCT01037244|594309530|FG001|Overall Study|Various|2|||
164529550|NCT01037244|594309531|FG002|Overall Study|Various|1|||
164529551|NCT01037244|594309532|FG003|Overall Study|Various|1|||
164529552|NCT00690820|594309533|FG000|Period 1|Withdrawal by Subject|0|||
164529553|NCT00690820|594309534|FG001|Period 1|Withdrawal by Subject|1|||
164529554|NCT00903630|594309536|FG000|Phase 2|Adverse Event|0|||
164633873|NCT01265511|594682271|FG000|Overall Study|Met stopping rules|0|||
164633874|NCT01265511|594682272|FG001|Overall Study|Met stopping rules|2|||
164633875|NCT00323479|594682273|FG000|Overall Study|Adverse Event|2|||
164633876|NCT00323479|594682273|FG000|Overall Study|Withdrawal by Subject|2|||
164633877|NCT00323479|594682273|FG000|Overall Study|Protocol Violation|3|||
164633878|NCT00323479|594682273|FG000|Overall Study|house moving|1|||
164633879|NCT03044730|594682276|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
164633880|NCT03044730|594682276|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
164633881|NCT03044730|594682276|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
164633882|NCT03044730|594682276|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
164633883|NCT03044730|594682276|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
164633884|NCT03044730|594682276|FG000|Cycles 4 and Beyond|Adverse Event|1|||
164529555|NCT00903630|594309537|FG001|Phase 2|Adverse Event|0|||
164529556|NCT00903630|594309538|FG002|Phase 2|Adverse Event|1|||
164529557|NCT01498653|594309540|FG000|Overall Study|Adverse Event|2|||
164529558|NCT01498653|594309541|FG001|Overall Study|Adverse Event|2|||
164529559|NCT01498653|594309540|FG000|Overall Study|Lack of Efficacy|12|||
164529560|NCT01498653|594309541|FG001|Overall Study|Lack of Efficacy|26|||
164529561|NCT01498653|594309540|FG000|Overall Study|Protocol Violation|0|||
164529562|NCT01498653|594309541|FG001|Overall Study|Protocol Violation|4|||
164529563|NCT01498653|594309540|FG000|Overall Study|Lost to Follow-up|1|||
164529564|NCT01498653|594309541|FG001|Overall Study|Lost to Follow-up|0|||
164529565|NCT01498653|594309540|FG000|Overall Study|Physician Decision|2|||
164529566|NCT01498653|594309541|FG001|Overall Study|Physician Decision|0|||
164529567|NCT01498653|594309540|FG000|Overall Study|Withdrawal by Subject|2|||
164529568|NCT01498653|594309541|FG001|Overall Study|Withdrawal by Subject|3|||
164529569|NCT00679627|594309543|FG000|Overall Study|Death|41|||
164529570|NCT00679627|594309544|FG001|Overall Study|Death|29|||
164529571|NCT00679627|594309543|FG000|Overall Study|Adverse Event|43|||
164529572|NCT00679627|594309544|FG001|Overall Study|Adverse Event|53|||
164529573|NCT00679627|594309543|FG000|Overall Study|Withdrawal by Subject|168|||
164529574|NCT00679627|594309544|FG001|Overall Study|Withdrawal by Subject|172|||
164529575|NCT00679627|594309543|FG000|Overall Study|Lost to Follow-up|22|||
164529576|NCT00679627|594309544|FG001|Overall Study|Lost to Follow-up|26|||
164529577|NCT00679627|594309543|FG000|Overall Study|Early Study Closure|425|||
164529578|NCT00679627|594309544|FG001|Overall Study|Early Study Closure|405|||
164529579|NCT01013285|594309545|FG000|Overall Study|Death|48|||
164529580|NCT01013285|594309546|FG001|Overall Study|Death|89|||
164529581|NCT00704405|594309549|FG000|Overall Study (NC Population)|Adverse Event|1|||
164529582|NCT00704405|594309550|FG001|Overall Study (NC Population)|Adverse Event|0|||
164529583|NCT00704405|594309551|FG002|Overall Study (NC Population)|Adverse Event|0|||
164529584|NCT00704405|594309552|FG003|Overall Study (NC Population)|Adverse Event|0|||
164529585|NCT00704405|594309553|FG004|Overall Study (NC Population)|Adverse Event|0|||
164529586|NCT00704405|594309549|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
164529587|NCT00704405|594309550|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
164529588|NCT00704405|594309551|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
164529589|NCT00704405|594309552|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
164529590|NCT00704405|594309553|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
164529591|NCT00704405|594309549|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
164529592|NCT00704405|594309550|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
164529593|NCT00704405|594309551|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
164529594|NCT00704405|594309552|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
164529595|NCT00704405|594309553|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
164529596|NCT00704405|594309549|FG000|Overall Study (NC Population)|Other|0|||
164529597|NCT00704405|594309550|FG001|Overall Study (NC Population)|Other|0|||
164529598|NCT00704405|594309551|FG002|Overall Study (NC Population)|Other|0|||
164529599|NCT00704405|594309552|FG003|Overall Study (NC Population)|Other|0|||
164529600|NCT00704405|594309553|FG004|Overall Study (NC Population)|Other|1|||
164529601|NCT00704405|594309549|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
164529602|NCT00704405|594309550|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
164529603|NCT00704405|594309551|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
164529604|NCT00704405|594309552|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
164529605|NCT00704405|594309553|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
164529606|NCT00704405|594309549|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
164529607|NCT00704405|594309550|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
164529608|NCT00704405|594309551|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
164529609|NCT00704405|594309552|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
164529610|NCT00704405|594309553|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
164529611|NCT01395888|594309554|FG000|2-week Run-in Period|Adverse Event|2|||
164529612|NCT01395888|594309555|FG001|2-week Run-in Period|Adverse Event|0|||
164529613|NCT01395888|594309556|FG002|2-week Run-in Period|Adverse Event|0|||
164529614|NCT01395888|594309554|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
164529615|NCT01395888|594309555|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
164529616|NCT01395888|594309556|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
164529617|NCT01395888|594309554|FG000|2-week Run-in Period|Lost to Follow-up|1|||
164529618|NCT01395888|594309555|FG001|2-week Run-in Period|Lost to Follow-up|0|||
164633885|NCT03044730|594682276|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
164633886|NCT03044730|594682276|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
164633887|NCT03044730|594682276|FG000|On Follow-up for 2 Years|Death|17|||
164633888|NCT00950755|594682280|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
164633889|NCT00950755|594682280|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
164633890|NCT00950755|594682280|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
164633891|NCT00950755|594682280|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
164633892|NCT00950755|594682280|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
164633893|NCT00950755|594682280|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
164633894|NCT00950755|594682280|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
164529619|NCT01395888|594309556|FG002|2-week Run-in Period|Lost to Follow-up|0|||
164529620|NCT01395888|594309554|FG000|2-week Run-in Period|Protocol Violation|2|||
164529621|NCT01395888|594309555|FG001|2-week Run-in Period|Protocol Violation|0|||
164529622|NCT01395888|594309556|FG002|2-week Run-in Period|Protocol Violation|0|||
164529623|NCT01395888|594309554|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
164529624|NCT01395888|594309555|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
164529625|NCT01395888|594309556|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
164529626|NCT01395888|594309554|FG000|Treatment Period (TP)|Adverse Event|0|||
164529627|NCT01395888|594309555|FG001|Treatment Period (TP)|Adverse Event|7|||
164529628|NCT01395888|594309556|FG002|Treatment Period (TP)|Adverse Event|6|||
164529629|NCT01395888|594309554|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
164529630|NCT01395888|594309555|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
164529631|NCT01395888|594309556|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
164529632|NCT01395888|594309554|FG000|Treatment Period (TP)|Protocol Violation|0|||
164529633|NCT01395888|594309555|FG001|Treatment Period (TP)|Protocol Violation|1|||
164529634|NCT01395888|594309556|FG002|Treatment Period (TP)|Protocol Violation|5|||
164529635|NCT01395888|594309554|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
164529636|NCT01395888|594309555|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
164529637|NCT01395888|594309556|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
164529638|NCT01395888|594309554|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
164529639|NCT01395888|594309555|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
164529640|NCT01395888|594309556|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
164529641|NCT04134845|594309563|FG000|Overall Study|withdrawl by PI|12|||
164529642|NCT04134845|594309564|FG001|Overall Study|withdrawl by PI|5|||
164529643|NCT02382016|594311778|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
164529644|NCT02382016|594311779|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
164529645|NCT02382016|594311778|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
164529646|NCT02382016|594311779|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
164529647|NCT02382016|594311778|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
164529648|NCT02382016|594311779|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
164529649|NCT02382016|594311778|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
164529650|NCT02382016|594311779|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
164529651|NCT02382016|594311778|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
164529652|NCT02382016|594311779|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
164529653|NCT02382016|594311778|FG000|Open-label (OL) Treatment Period|Death|4|||
164529654|NCT02382016|594311779|FG001|Open-label (OL) Treatment Period|Death|0|||
164529655|NCT02382016|594311778|FG000|OL Extension Period|Physician Decision|3|||
164529656|NCT02382016|594311779|FG001|OL Extension Period|Physician Decision|0|||
164529657|NCT02382016|594311778|FG000|OL Extension Period|Death|2|||
164529658|NCT02382016|594311779|FG001|OL Extension Period|Death|0|||
164529659|NCT02382016|594311778|FG000|OL Extension Period|Withdrawal by Subject|1|||
164529660|NCT02382016|594311779|FG001|OL Extension Period|Withdrawal by Subject|0|||
164633895|NCT00950755|594682280|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
164633896|NCT00950755|594682280|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
164633897|NCT00950755|594682280|FG000|Long-Term Follow-Up|Death|8|||
164633898|NCT01302366|594684054|FG000|Overall Study|patient choice or noncompliance|5|||
164633899|NCT00198107|594684057|FG000|Double-Blind Period|Adverse Event|1|||
164633900|NCT00198107|594684058|FG001|Double-Blind Period|Adverse Event|1|||
164633901|NCT00198107|594684059|FG002|Double-Blind Period|Adverse Event|0|||
164633902|NCT00198107|594684057|FG000|Double-Blind Period|Lack of Efficacy|2|||
164633903|NCT00198107|594684058|FG001|Double-Blind Period|Lack of Efficacy|0|||
164633904|NCT00198107|594684059|FG002|Double-Blind Period|Lack of Efficacy|0|||
164633905|NCT00198107|594684057|FG000|Double-Blind Period|Lost to Follow-up|2|||
164633906|NCT00198107|594684058|FG001|Double-Blind Period|Lost to Follow-up|1|||
164633907|NCT00198107|594684059|FG002|Double-Blind Period|Lost to Follow-up|0|||
164633908|NCT00198107|594684057|FG000|Double-Blind Period|Physician Decision|1|||
164633909|NCT00198107|594684058|FG001|Double-Blind Period|Physician Decision|0|||
164633910|NCT00198107|594684059|FG002|Double-Blind Period|Physician Decision|0|||
164633911|NCT00198107|594684057|FG000|Double-Blind Period|Withdrawal by Subject|0|||
164633912|NCT00198107|594684058|FG001|Double-Blind Period|Withdrawal by Subject|1|||
164633913|NCT00198107|594684059|FG002|Double-Blind Period|Withdrawal by Subject|0|||
164633914|NCT00198107|594684057|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
164633915|NCT00198107|594684058|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
164633916|NCT00198107|594684059|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
164633917|NCT01013207|594684060|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
164633918|NCT01541644|594684061|FG000|Overall Study|Withdrawal by Subject|3|||
164633919|NCT01342445|594684063|FG000|Overall Study|Experienced side effects|0|||
164633920|NCT01342445|594684064|FG001|Overall Study|Experienced side effects|2|||
164633921|NCT02652793|594684065|FG000|Overall Study|Adverse Event|1|||
164633922|NCT02652793|594684065|FG000|Overall Study|Lost to Follow-up|2|||
164633923|NCT02652793|594684065|FG000|Overall Study|Withdrawal by Subject|1|||
164633924|NCT01982942|594684066|FG000|Overall Study|Adverse Event|10|||
164633925|NCT01982942|594684067|FG001|Overall Study|Adverse Event|5|||
164633926|NCT01982942|594684066|FG000|Overall Study|Lost to Follow-up|4|||
164529661|NCT01729156|594311780|FG000|Overall Study|Withdrawal by Subject|1|||
164529662|NCT01729156|594311781|FG001|Overall Study|Withdrawal by Subject|0|||
164529663|NCT01729156|594311782|FG002|Overall Study|Withdrawal by Subject|0|||
164529664|NCT04363801|594311785|FG000|Overall Study|Death|18|||
164529665|NCT04363801|594311786|FG001|Overall Study|Death|14|||
164529666|NCT04363801|594311787|FG002|Overall Study|Death|16|||
164529667|NCT04363801|594311788|FG003|Overall Study|Death|48|||
164529668|NCT04363801|594311789|FG004|Overall Study|Death|38|||
164529669|NCT04363801|594311785|FG000|Overall Study|Withdrawal by Subject|1|||
164529670|NCT04363801|594311786|FG001|Overall Study|Withdrawal by Subject|6|||
164529671|NCT04363801|594311787|FG002|Overall Study|Withdrawal by Subject|1|||
164529672|NCT04363801|594311788|FG003|Overall Study|Withdrawal by Subject|4|||
164529673|NCT04363801|594311789|FG004|Overall Study|Withdrawal by Subject|14|||
164529674|NCT04363801|594311785|FG000|Overall Study|Sponsor Decision|6|||
164529675|NCT04363801|594311786|FG001|Overall Study|Sponsor Decision|4|||
164529676|NCT04363801|594311787|FG002|Overall Study|Sponsor Decision|10|||
164529677|NCT04363801|594311788|FG003|Overall Study|Sponsor Decision|33|||
164529678|NCT04363801|594311789|FG004|Overall Study|Sponsor Decision|32|||
164633927|NCT01982942|594684067|FG001|Overall Study|Lost to Follow-up|3|||
164633928|NCT01982942|594684066|FG000|Overall Study|Multiple sclerosis progression|3|||
164633929|NCT01982942|594684067|FG001|Overall Study|Multiple sclerosis progression|2|||
164633930|NCT01982942|594684066|FG000|Overall Study|Wanted to try therapy not permitted|1|||
164633931|NCT01982942|594684067|FG001|Overall Study|Wanted to try therapy not permitted|0|||
164633932|NCT01982942|594684066|FG000|Overall Study|Subject declined future visits|0|||
164633933|NCT01982942|594684067|FG001|Overall Study|Subject declined future visits|1|||
164633934|NCT01982942|594684066|FG000|Overall Study|Left geographical area|2|||
164633935|NCT01982942|594684067|FG001|Overall Study|Left geographical area|0|||
164633936|NCT01982942|594684066|FG000|Overall Study|Too many pills|1|||
164633937|NCT01982942|594684067|FG001|Overall Study|Too many pills|0|||
164633938|NCT01982942|594684066|FG000|Overall Study|MS Relapse|0|||
164633939|NCT01982942|594684067|FG001|Overall Study|MS Relapse|1|||
164633940|NCT01982942|594684066|FG000|Overall Study|Chose to join a stem cell trial|0|||
164633941|NCT01982942|594684067|FG001|Overall Study|Chose to join a stem cell trial|1|||
164633942|NCT01982942|594684066|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
164633943|NCT01982942|594684067|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
164633944|NCT04511533|594684068|FG000|Treatment|Other|2|||
164633945|NCT04511533|594684068|FG000|Treatment|Withdrawal by Subject|11|||
164633946|NCT04511533|594684068|FG000|Treatment|Death|5|||
164633947|NCT04511533|594684068|FG000|Treatment|Physician Decision|1|||
164633948|NCT04511533|594684068|FG000|Treatment|Progressive Disease|61|||
164633949|NCT04511533|594684068|FG000|Follow-Up|Other|7|||
164633950|NCT04511533|594684068|FG000|Follow-Up|Withdrawal by Subject|5|||
164633951|NCT04511533|594684068|FG000|Follow-Up|Lost to Follow-up|2|||
164633952|NCT04511533|594684068|FG000|Follow-Up|Death|4|||
164633953|NCT01270139|594684069|FG000|Overall Study|Adverse Event|8|||
164633954|NCT01270139|594684070|FG001|Overall Study|Adverse Event|17|||
164633955|NCT01270139|594684071|FG002|Overall Study|Adverse Event|18|||
164633956|NCT01270139|594684069|FG000|Overall Study|Lost to Follow-up|10|||
164633957|NCT01270139|594684070|FG001|Overall Study|Lost to Follow-up|9|||
164633958|NCT01270139|594684071|FG002|Overall Study|Lost to Follow-up|2|||
164633959|NCT01161173|594684078|FG000|Overall Study|Protocol Violation|13|||
164633960|NCT01161173|594684078|FG000|Overall Study|Lost to Follow-up|7|||
164633961|NCT01161173|594684078|FG000|Overall Study|Progressive Disease|82|||
164633962|NCT01161173|594684078|FG000|Overall Study|Withdrawal of Consent|5|||
164633963|NCT01161173|594684078|FG000|Overall Study|Unacceptable Toxicity|21|||
164633964|NCT01161173|594684078|FG000|Overall Study|Death|194|||
164633965|NCT01161173|594684078|FG000|Overall Study|End of Study|2|||
164633966|NCT01161173|594684078|FG000|Overall Study|Reasons Not Specified|23|||
164633967|NCT01911546|594684079|FG000|Overall Study|Lost to Follow-up|1|||
164633968|NCT01911546|594684079|FG000|Overall Study|Everolimus was discontinued|5|||
164633969|NCT02213666|594684081|FG000|Overall Study|Withdrawal by Subject|1|||
164633970|NCT01319422|594684082|FG000|Overall Study|Withdrawal by Subject|1|||
164633971|NCT01319422|594684083|FG001|Overall Study|Withdrawal by Subject|0|||
164633972|NCT01399619|594684084|FG000|Overall Study|Adverse Event|10|||
164633973|NCT01399619|594684085|FG001|Overall Study|Adverse Event|0|||
164633974|NCT01399619|594684086|FG002|Overall Study|Adverse Event|4|||
164633975|NCT01399619|594684087|FG003|Overall Study|Adverse Event|10|||
164633976|NCT01399619|594684084|FG000|Overall Study|Lack of Efficacy|9|||
164633977|NCT01399619|594684085|FG001|Overall Study|Lack of Efficacy|0|||
164633978|NCT01399619|594684086|FG002|Overall Study|Lack of Efficacy|5|||
164633979|NCT01399619|594684087|FG003|Overall Study|Lack of Efficacy|0|||
164633980|NCT01399619|594684084|FG000|Overall Study|Withdrawal by Subject|6|||
164633981|NCT01399619|594684085|FG001|Overall Study|Withdrawal by Subject|0|||
164633982|NCT01399619|594684086|FG002|Overall Study|Withdrawal by Subject|3|||
164633983|NCT01399619|594684087|FG003|Overall Study|Withdrawal by Subject|4|||
164633984|NCT01399619|594684084|FG000|Overall Study|Protocol Violation|0|||
164633985|NCT01399619|594684085|FG001|Overall Study|Protocol Violation|0|||
164633986|NCT01399619|594684086|FG002|Overall Study|Protocol Violation|0|||
164633987|NCT01399619|594684087|FG003|Overall Study|Protocol Violation|1|||
164633988|NCT01399619|594684084|FG000|Overall Study|Not treated|0|||
164633989|NCT01399619|594684085|FG001|Overall Study|Not treated|0|||
164633990|NCT01399619|594684086|FG002|Overall Study|Not treated|0|||
164633991|NCT01399619|594684087|FG003|Overall Study|Not treated|2|||
164633992|NCT02918968|594684090|FG000|1st Line AAT|Progressive disease|9|||
164633993|NCT02918968|594684091|FG001|1st Line AAT|Progressive disease|4|||
164633994|NCT02918968|594684090|FG000|1st Line AAT|Adverse Event|12|||
164633995|NCT02918968|594684091|FG001|1st Line AAT|Adverse Event|3|||
164633996|NCT02918968|594684090|FG000|1st Line AAT|Physician Decision|4|||
164633997|NCT02918968|594684091|FG001|1st Line AAT|Physician Decision|2|||
164633998|NCT02918968|594684090|FG000|1st Line AAT|Withdrawal by Subject|2|||
164633999|NCT02918968|594684091|FG001|1st Line AAT|Withdrawal by Subject|1|||
164634000|NCT02918968|594684090|FG000|1st Line AAT|Lost to Follow-up|0|||
164634001|NCT02918968|594684091|FG001|1st Line AAT|Lost to Follow-up|1|||
164634002|NCT02918968|594684090|FG000|1st Line AAT|Death|1|||
164634003|NCT02918968|594684091|FG001|1st Line AAT|Death|0|||
164634004|NCT02918968|594684090|FG000|1st Line AAT|Miscellaneous|1|||
164634005|NCT02918968|594684091|FG001|1st Line AAT|Miscellaneous|0|||
164634006|NCT02918968|594684090|FG000|2nd Line AAT|Progressive disease|21|||
164529679|NCT04363801|594311785|FG000|Overall Study|Lost to Follow-up|0|||
164529680|NCT04363801|594311786|FG001|Overall Study|Lost to Follow-up|0|||
164529681|NCT04363801|594311787|FG002|Overall Study|Lost to Follow-up|1|||
164529682|NCT04363801|594311788|FG003|Overall Study|Lost to Follow-up|0|||
164529683|NCT04363801|594311789|FG004|Overall Study|Lost to Follow-up|1|||
164529684|NCT01146054|594311790|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
164529685|NCT01146054|594311790|FG000|Overall Study|Rapid tumor progression|2|||
164529686|NCT01146054|594311790|FG000|Overall Study|Other illness precluded treatment|2|||
164529687|NCT01146054|594311790|FG000|Overall Study|Lost to Follow-up|1|||
164529688|NCT03401229|594311791|FG000|Overall Study|Lost to Follow-up|2|||
164529689|NCT03401229|594311792|FG001|Overall Study|Lost to Follow-up|1|||
164529690|NCT03401229|594311791|FG000|Overall Study|Other|1|||
164529691|NCT03401229|594311792|FG001|Overall Study|Other|3|||
164529692|NCT03401229|594311791|FG000|Overall Study|Adverse Event|8|||
164529693|NCT03401229|594311792|FG001|Overall Study|Adverse Event|6|||
164529694|NCT03401229|594311791|FG000|Overall Study|Withdrawal by Subject|29|||
164529695|NCT03401229|594311792|FG001|Overall Study|Withdrawal by Subject|26|||
164529696|NCT03401229|594311791|FG000|Overall Study|COVID-19|0|||
164529697|NCT03401229|594311792|FG001|Overall Study|COVID-19|1|||
164529698|NCT05333224|594311793|FG000|Overall Study - Infants|Lost to Follow-up|1|||
164529699|NCT05333224|594311794|FG001|Overall Study - Infants|Lost to Follow-up|1|||
164529700|NCT01122862|594311795|FG000|Period 1|Protocol Violation|0|||
164529701|NCT01122862|594311796|FG001|Period 1|Protocol Violation|1|||
164529702|NCT01122862|594311797|FG002|Period 1|Protocol Violation|0|||
164529703|NCT01122862|594311795|FG000|Period 2|Adverse Event|0|||
164529704|NCT01122862|594311796|FG001|Period 2|Adverse Event|0|||
164529705|NCT01122862|594311797|FG002|Period 2|Adverse Event|1|||
164529706|NCT00966277|594311799|FG000|Overall Study|Withdrawal by Subject|3|||
164529707|NCT00966277|594311800|FG001|Overall Study|Withdrawal by Subject|0|||
164529708|NCT00966277|594311799|FG000|Overall Study|Ineligible|1|||
164529709|NCT00966277|594311800|FG001|Overall Study|Ineligible|3|||
164529710|NCT00966277|594311799|FG000|Overall Study|Treatment Plan Changed|0|||
164529711|NCT00966277|594311800|FG001|Overall Study|Treatment Plan Changed|1|||
164529712|NCT01249274|594311801|FG000|Overall Study|Lost to Follow-up|3|||
164529713|NCT01249274|594311802|FG001|Overall Study|Lost to Follow-up|4|||
164529714|NCT01249274|594311801|FG000|Overall Study|Received inpatient substance treatment|1|||
164529715|NCT01249274|594311802|FG001|Overall Study|Received inpatient substance treatment|2|||
164529716|NCT02070588|594311808|FG000|Overall Study|Withdrawal by Subject|29|||
164529717|NCT02070588|594311809|FG001|Overall Study|Withdrawal by Subject|1|||
164529718|NCT02070588|594311810|FG002|Overall Study|Withdrawal by Subject|0|||
164529719|NCT02070588|594311808|FG000|Overall Study|Writhdrawal due to early termination|9|||
164529720|NCT02070588|594311809|FG001|Overall Study|Writhdrawal due to early termination|0|||
164529721|NCT02070588|594311810|FG002|Overall Study|Writhdrawal due to early termination|0|||
164529722|NCT02070588|594311808|FG000|Overall Study|Adverse Event|1|||
164529723|NCT02070588|594311809|FG001|Overall Study|Adverse Event|0|||
164529724|NCT02070588|594311810|FG002|Overall Study|Adverse Event|0|||
164529725|NCT03421431|594311811|FG000|Overall Study|Adverse Event|2|||
164529726|NCT03421431|594311812|FG001|Overall Study|Adverse Event|1|||
164529727|NCT03421431|594311813|FG002|Overall Study|Adverse Event|12|||
164529728|NCT03421431|594311811|FG000|Overall Study|Lost to Follow-up|1|||
164529729|NCT03421431|594311812|FG001|Overall Study|Lost to Follow-up|1|||
164529730|NCT03421431|594311813|FG002|Overall Study|Lost to Follow-up|1|||
164529731|NCT03421431|594311811|FG000|Overall Study|Withdrawal by Subject|3|||
164529732|NCT03421431|594311812|FG001|Overall Study|Withdrawal by Subject|2|||
164529733|NCT03421431|594311813|FG002|Overall Study|Withdrawal by Subject|1|||
164529734|NCT03421431|594311811|FG000|Overall Study|Protocol Violation|0|||
164529735|NCT03421431|594311812|FG001|Overall Study|Protocol Violation|1|||
164529736|NCT03421431|594311813|FG002|Overall Study|Protocol Violation|0|||
164529737|NCT03421431|594311811|FG000|Overall Study|Participant met Stopping Rules|0|||
164529738|NCT03421431|594311812|FG001|Overall Study|Participant met Stopping Rules|1|||
164529739|NCT03421431|594311813|FG002|Overall Study|Participant met Stopping Rules|0|||
164529740|NCT00141726|594311814|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
164529741|NCT01776424|594311821|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
164529742|NCT01776424|594311822|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
164529743|NCT01776424|594311823|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
164529744|NCT01776424|594311821|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
164529745|NCT01776424|594311822|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
164529746|NCT01776424|594311823|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
164529747|NCT01776424|594311821|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
164529748|NCT01776424|594311822|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
164529749|NCT01776424|594311823|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
164529750|NCT01776424|594311821|FG000|LTOLE Part (Open Label)|Refused|5|||
164529751|NCT01776424|594311822|FG001|LTOLE Part (Open Label)|Refused|2|||
164529752|NCT01776424|594311823|FG002|LTOLE Part (Open Label)|Refused|11|||
164529753|NCT01776424|594311821|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
164529754|NCT01776424|594311822|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
164529755|NCT01776424|594311823|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
164529756|NCT02513303|594311825|FG000|Overall Study|Withdrawal by Subject|9|||
164529757|NCT02513303|594311826|FG001|Overall Study|Withdrawal by Subject|7|||
164529758|NCT02513303|594311827|FG002|Overall Study|Withdrawal by Subject|2|||
164634007|NCT02918968|594684091|FG001|2nd Line AAT|Progressive disease|3|||
164634008|NCT02918968|594684090|FG000|2nd Line AAT|Adverse Event|2|||
164634009|NCT02918968|594684091|FG001|2nd Line AAT|Adverse Event|5|||
164634010|NCT02918968|594684090|FG000|2nd Line AAT|Physician Decision|0|||
164634011|NCT02918968|594684091|FG001|2nd Line AAT|Physician Decision|1|||
164634012|NCT02918968|594684090|FG000|2nd Line AAT|Withdrawal by Subject|2|||
164634013|NCT02918968|594684091|FG001|2nd Line AAT|Withdrawal by Subject|2|||
164634014|NCT02918968|594684090|FG000|2nd Line AAT|Death|0|||
164634015|NCT02918968|594684091|FG001|2nd Line AAT|Death|1|||
164634016|NCT05602818|594684092|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
164634017|NCT05602818|594684093|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
164634018|NCT05602818|594684094|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
164634019|NCT05602818|594684095|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
164634020|NCT05602818|594684096|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
164634021|NCT05602818|594684097|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
164634022|NCT05602818|594684098|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
164634023|NCT05602818|594684099|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
164634024|NCT05602818|594684100|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
164634025|NCT05602818|594684101|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
164634026|NCT05602818|594684102|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
164634027|NCT05602818|594684103|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
164634028|NCT05602818|594684092|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
164634029|NCT05602818|594684093|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
164634030|NCT05602818|594684094|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
164634031|NCT05602818|594684095|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
164634032|NCT05602818|594684096|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
164634033|NCT05602818|594684097|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
164634034|NCT05602818|594684098|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
164634035|NCT05602818|594684099|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
164634036|NCT05602818|594684100|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
164634037|NCT05602818|594684101|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
164634038|NCT05602818|594684102|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
164634039|NCT05602818|594684103|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
164634040|NCT05602818|594684092|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
164634041|NCT05602818|594684093|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
164634042|NCT05602818|594684094|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
164634043|NCT05602818|594684095|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
164634044|NCT05602818|594684096|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
164634045|NCT05602818|594684097|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
164634046|NCT05602818|594684098|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
164634047|NCT05602818|594684099|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
164634048|NCT05602818|594684100|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
164634049|NCT05602818|594684101|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
164634050|NCT05602818|594684102|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
164634051|NCT05602818|594684103|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
164634052|NCT05602818|594684092|FG000|Qualification Phase (3 Days)|Other|1|||
164634053|NCT05602818|594684093|FG001|Qualification Phase (3 Days)|Other|0|||
164634054|NCT05602818|594684094|FG002|Qualification Phase (3 Days)|Other|0|||
164634055|NCT05602818|594684095|FG003|Qualification Phase (3 Days)|Other|0|||
164634056|NCT05602818|594684096|FG004|Qualification Phase (3 Days)|Other|0|||
164634057|NCT05602818|594684097|FG005|Qualification Phase (3 Days)|Other|0|||
164634058|NCT05602818|594684098|FG006|Qualification Phase (3 Days)|Other|0|||
164634059|NCT05602818|594684099|FG007|Qualification Phase (3 Days)|Other|0|||
164634060|NCT05602818|594684100|FG008|Qualification Phase (3 Days)|Other|0|||
164634061|NCT05602818|594684101|FG009|Qualification Phase (3 Days)|Other|0|||
164634062|NCT05602818|594684102|FG010|Qualification Phase (3 Days)|Other|0|||
164634063|NCT05602818|594684103|FG011|Qualification Phase (3 Days)|Other|0|||
164634064|NCT05602818|594684092|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
164634065|NCT05602818|594684093|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
164634066|NCT05602818|594684094|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
164634067|NCT05602818|594684095|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
164634068|NCT05602818|594684096|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
164634069|NCT05602818|594684097|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
164634070|NCT05602818|594684098|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
164634071|NCT05602818|594684099|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
164634072|NCT05602818|594684100|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
164634073|NCT05602818|594684101|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
164634074|NCT05602818|594684102|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
164634075|NCT05602818|594684103|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
164634076|NCT05602818|594684092|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
164634077|NCT05602818|594684093|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
164634078|NCT05602818|594684094|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
164634079|NCT05602818|594684095|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
164634080|NCT05602818|594684096|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
164634081|NCT05602818|594684097|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
164634082|NCT05602818|594684098|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
164634083|NCT05602818|594684099|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
164634084|NCT05602818|594684100|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
164634085|NCT05602818|594684101|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
164634086|NCT05602818|594684102|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
164634087|NCT05602818|594684103|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
164634088|NCT05602818|594684092|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
164634089|NCT05602818|594684093|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
164634090|NCT05602818|594684094|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
164634091|NCT05602818|594684095|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
164634092|NCT05602818|594684096|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
164634093|NCT05602818|594684097|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
164634094|NCT05602818|594684098|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
164634095|NCT05602818|594684099|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
164634096|NCT05602818|594684100|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
164634097|NCT05602818|594684101|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
164634098|NCT05602818|594684102|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
164634099|NCT05602818|594684103|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
164634100|NCT05602818|594684092|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
164634101|NCT05602818|594684093|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
164634102|NCT05602818|594684094|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
164634103|NCT05602818|594684095|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
164634104|NCT05602818|594684096|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
164634105|NCT05602818|594684097|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
164634106|NCT05602818|594684098|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
164634107|NCT05602818|594684099|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
164634108|NCT05602818|594684100|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
164634109|NCT05602818|594684101|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
164634110|NCT05602818|594684102|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
164634111|NCT05602818|594684103|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
164634112|NCT00750061|594684104|FG000|Overall Study|Adverse Event|2|||
164634113|NCT00750061|594684105|FG001|Overall Study|Adverse Event|0|||
164634114|NCT00750061|594684104|FG000|Overall Study|Withdrawal by Subject|0|||
164634115|NCT00750061|594684105|FG001|Overall Study|Withdrawal by Subject|1|||
164634116|NCT00750061|594684104|FG000|Overall Study|Physician Decision|0|||
164634117|NCT00750061|594684105|FG001|Overall Study|Physician Decision|1|||
164634118|NCT03814499|594684108|FG000|Overall Study|Lost to Follow-up|3|||
164634119|NCT03417245|594684109|FG000|Overall Study|Adverse Event|1|||
164634120|NCT03417245|594684110|FG001|Overall Study|Adverse Event|0|||
164634121|NCT03417245|594684109|FG000|Overall Study|Protocol Violation|1|||
164634122|NCT03417245|594684110|FG001|Overall Study|Protocol Violation|0|||
164634123|NCT03417245|594684109|FG000|Overall Study|Withdrawal by Subject|1|||
164634124|NCT03417245|594684110|FG001|Overall Study|Withdrawal by Subject|1|||
164634125|NCT00598442|594684114|FG000|Overall Study|Adverse Event|3|||
164634126|NCT00598442|594684115|FG001|Overall Study|Adverse Event|0|||
164634127|NCT00598442|594684116|FG002|Overall Study|Adverse Event|0|||
164634128|NCT00598442|594684114|FG000|Overall Study|Death|19|||
164634129|NCT00598442|594684115|FG001|Overall Study|Death|11|||
164634130|NCT00598442|594684116|FG002|Overall Study|Death|11|||
164634131|NCT00598442|594684114|FG000|Overall Study|Lost to Follow-up|4|||
164634132|NCT00598442|594684115|FG001|Overall Study|Lost to Follow-up|3|||
164634133|NCT00598442|594684116|FG002|Overall Study|Lost to Follow-up|3|||
164634134|NCT00598442|594684114|FG000|Overall Study|Physician Decision|2|||
164634135|NCT00598442|594684115|FG001|Overall Study|Physician Decision|1|||
164634136|NCT00598442|594684116|FG002|Overall Study|Physician Decision|1|||
164529759|NCT02513303|594311825|FG000|Overall Study|Lost to Follow-up|2|||
164529760|NCT02513303|594311826|FG001|Overall Study|Lost to Follow-up|4|||
164529761|NCT02513303|594311827|FG002|Overall Study|Lost to Follow-up|0|||
164529762|NCT02513303|594311825|FG000|Overall Study|Adverse Event|0|||
164529763|NCT02513303|594311826|FG001|Overall Study|Adverse Event|1|||
164529764|NCT02513303|594311827|FG002|Overall Study|Adverse Event|0|||
164529765|NCT02513303|594311825|FG000|Overall Study|Physician Decision|1|||
164529766|NCT02513303|594311826|FG001|Overall Study|Physician Decision|1|||
164529767|NCT02513303|594311827|FG002|Overall Study|Physician Decision|0|||
164529768|NCT02513303|594311825|FG000|Overall Study|Death|8|||
164529769|NCT02513303|594311826|FG001|Overall Study|Death|4|||
164529770|NCT02513303|594311827|FG002|Overall Study|Death|2|||
164529771|NCT01691768|594311828|FG000|Overall Study|Death|0|||
164529772|NCT01691768|594311829|FG001|Overall Study|Death|2|||
164529773|NCT01691768|594311828|FG000|Overall Study|Lost to Follow-up|4|||
164529774|NCT01691768|594311829|FG001|Overall Study|Lost to Follow-up|3|||
164529775|NCT01691768|594311828|FG000|Overall Study|Withdrawal by Subject|10|||
164634137|NCT00598442|594684114|FG000|Overall Study|Withdrawal by Subject|8|||
164634138|NCT00598442|594684115|FG001|Overall Study|Withdrawal by Subject|16|||
164634139|NCT00598442|594684116|FG002|Overall Study|Withdrawal by Subject|6|||
164634140|NCT00598442|594684114|FG000|Overall Study|Noncompliance|0|||
164634141|NCT00598442|594684115|FG001|Overall Study|Noncompliance|2|||
164634142|NCT00598442|594684116|FG002|Overall Study|Noncompliance|1|||
164634143|NCT00598442|594684114|FG000|Overall Study|Relocation|1|||
164634144|NCT00598442|594684115|FG001|Overall Study|Relocation|4|||
164634145|NCT00598442|594684116|FG002|Overall Study|Relocation|0|||
164634146|NCT00598442|594684114|FG000|Overall Study|Renal transplant|0|||
164634147|NCT00598442|594684115|FG001|Overall Study|Renal transplant|0|||
164634148|NCT00598442|594684116|FG002|Overall Study|Renal transplant|1|||
164634149|NCT00598442|594684114|FG000|Overall Study|Site closed by sponsor|5|||
164634150|NCT00598442|594684115|FG001|Overall Study|Site closed by sponsor|2|||
164634151|NCT00598442|594684116|FG002|Overall Study|Site closed by sponsor|1|||
164634152|NCT00598442|594684114|FG000|Overall Study|Started dialysis|1|||
164634153|NCT00598442|594684115|FG001|Overall Study|Started dialysis|0|||
164634154|NCT00598442|594684116|FG002|Overall Study|Started dialysis|0|||
164634155|NCT01243762|594684123|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
164634156|NCT01243762|594684124|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
164634157|NCT01243762|594684125|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
164634158|NCT01243762|594684126|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
164634159|NCT01243762|594684127|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
164634160|NCT01243762|594684128|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
164634161|NCT01243762|594684129|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
164634162|NCT01243762|594684123|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
164634163|NCT01243762|594684124|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
164634164|NCT01243762|594684125|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
164634165|NCT01243762|594684126|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
164634166|NCT01243762|594684127|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
164634167|NCT01243762|594684128|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
164634168|NCT01243762|594684129|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
164634169|NCT01243762|594684123|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
164634170|NCT01243762|594684124|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
164634171|NCT01243762|594684125|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
164634172|NCT01243762|594684126|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
164634173|NCT01243762|594684127|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
164634174|NCT01243762|594684128|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
164634175|NCT01243762|594684129|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
164634176|NCT01243762|594684123|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
164634177|NCT01243762|594684124|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
164634178|NCT01243762|594684125|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
164634179|NCT01243762|594684126|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
164634180|NCT01243762|594684127|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
164634181|NCT01243762|594684128|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
164634182|NCT01243762|594684129|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
164634183|NCT01243762|594684123|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
164634184|NCT01243762|594684124|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
164634185|NCT01243762|594684125|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
164634186|NCT01243762|594684126|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
164634187|NCT01243762|594684127|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
164634188|NCT01243762|594684128|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
164634189|NCT01243762|594684129|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
164634190|NCT01243762|594684123|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
164634191|NCT01243762|594684124|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
164634192|NCT01243762|594684125|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
164634193|NCT01243762|594684126|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
164634194|NCT01243762|594684127|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
164634195|NCT01243762|594684128|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
164634196|NCT01243762|594684129|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
164634197|NCT01243762|594684123|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
164634198|NCT01243762|594684124|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
164634199|NCT01243762|594684125|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
164634200|NCT01243762|594684126|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
164634201|NCT01243762|594684127|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
164634202|NCT01243762|594684128|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
164634203|NCT01243762|594684129|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
164634204|NCT01243762|594684123|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
164634205|NCT01243762|594684124|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
164634206|NCT01243762|594684125|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
164634207|NCT01243762|594684126|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
164634208|NCT01243762|594684127|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
164634209|NCT01243762|594684128|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
164634210|NCT01243762|594684129|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
164634211|NCT01590628|594684136|FG000|Overall Study|Death|2|||
164634212|NCT01590628|594684137|FG001|Overall Study|Death|0|||
164634213|NCT00229931|594684138|FG000|Overall Study|Death|1|||
164634214|NCT00229931|594684139|FG001|Overall Study|Death|0|||
164634215|NCT00229931|594684138|FG000|Overall Study|Lost to Follow-up|3|||
164634216|NCT00229931|594684139|FG001|Overall Study|Lost to Follow-up|2|||
164634217|NCT02992743|594684140|FG000|Overall Study|Withdrawal by Subject|1|||
164634218|NCT02992743|594684141|FG001|Overall Study|Withdrawal by Subject|1|||
164634219|NCT02992743|594684140|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
164634220|NCT02992743|594684141|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
164634221|NCT02992743|594684140|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
164634222|NCT02992743|594684141|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
164634223|NCT02992743|594684140|FG000|Overall Study|No measurable disease|1|||
164634224|NCT02992743|594684141|FG001|Overall Study|No measurable disease|0|||
164634225|NCT02992743|594684140|FG000|Overall Study|Lost to Follow-up|0|||
164634226|NCT02992743|594684141|FG001|Overall Study|Lost to Follow-up|1|||
164634227|NCT01374516|594684142|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
164634228|NCT01374516|594684143|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
164634229|NCT01374516|594684142|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
164634230|NCT01374516|594684143|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
164634231|NCT01374516|594684142|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
164634232|NCT01374516|594684143|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
164634233|NCT01374516|594684142|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
164634234|NCT01374516|594684143|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
164634235|NCT01374516|594684142|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
164634236|NCT01374516|594684143|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
164634237|NCT01374516|594684142|FG000|Surveillance Expansion Period|Protocol Violation|386|||
164634238|NCT01374516|594684143|FG001|Surveillance Expansion Period|Protocol Violation|217|||
164634239|NCT01374516|594684142|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
164634240|NCT01374516|594684143|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
164634241|NCT01374516|594684142|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
164634242|NCT01374516|594684143|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
164634243|NCT01374516|594684142|FG000|Surveillance Expansion Period|Serious adverse event|20|||
164634244|NCT01374516|594684143|FG001|Surveillance Expansion Period|Serious adverse event|5|||
164634245|NCT00450814|594684144|FG000|Overall Study|Failed to complete the initial therapy|0|||
164634246|NCT00450814|594684145|FG001|Overall Study|Failed to complete the initial therapy|0|||
164634247|NCT00450814|594684146|FG002|Overall Study|Failed to complete the initial therapy|0|||
164634248|NCT00450814|594684147|FG003|Overall Study|Failed to complete the initial therapy|1|||
164634249|NCT00450814|594684148|FG004|Overall Study|Failed to complete the initial therapy|1|||
164634250|NCT00450814|594684149|FG005|Overall Study|Failed to complete the initial therapy|1|||
164634251|NCT00450814|594684150|FG006|Overall Study|Failed to complete the initial therapy|0|||
164634252|NCT00450814|594684151|FG007|Overall Study|Failed to complete the initial therapy|0|||
164634253|NCT00450814|594684152|FG008|Overall Study|Failed to complete the initial therapy|0|||
164634254|NCT00450814|594684153|FG009|Overall Study|Failed to complete the initial therapy|0|||
164634255|NCT00450814|594684154|FG010|Overall Study|Failed to complete the initial therapy|0|||
164634256|NCT00450814|594684144|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
164634257|NCT00450814|594684145|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
164634258|NCT00450814|594684146|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
164634259|NCT00450814|594684147|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
164634260|NCT00450814|594684148|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
164634261|NCT00450814|594684149|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
164634262|NCT00450814|594684150|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
164634263|NCT00450814|594684151|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
164634264|NCT00450814|594684152|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
164634265|NCT00450814|594684153|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
164634266|NCT00450814|594684154|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
164634267|NCT03602976|594684155|FG000|Overall Study|Withdrawal by Subject|1|||
164634268|NCT04629534|594684156|FG000|Overall Study|Physician Decision|1|||
164634269|NCT04629534|594684157|FG001|Overall Study|Physician Decision|0|||
164634270|NCT04629534|594684156|FG000|Overall Study|Protocol Violation|0|||
164634271|NCT04629534|594684157|FG001|Overall Study|Protocol Violation|2|||
164634272|NCT03732534|594684158|FG000|Overall Study|Study terminated by Sponsor|6|||
164634273|NCT02190604|594684159|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164634274|NCT02190604|594684160|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164634275|NCT02190604|594684161|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164634276|NCT02190604|594684162|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164634277|NCT02190604|594684163|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164634278|NCT02190604|594684164|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164634279|NCT02190604|594684165|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164634280|NCT02190604|594684166|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164634281|NCT02190604|594684167|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164634282|NCT02190604|594684168|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164634283|NCT02190604|594684169|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164634284|NCT02190604|594684170|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164634285|NCT02190604|594684171|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164634286|NCT02190604|594684172|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164634287|NCT02190604|594684173|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
164634288|NCT02190604|594684174|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164634289|NCT02190604|594684175|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164634290|NCT02190604|594684176|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164634291|NCT02190604|594684177|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164634292|NCT02190604|594684159|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164634293|NCT02190604|594684160|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164634294|NCT02190604|594684161|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164634295|NCT02190604|594684162|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164634296|NCT02190604|594684163|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164634297|NCT02190604|594684164|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164634298|NCT02190604|594684165|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164634299|NCT02190604|594684166|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164634300|NCT02190604|594684167|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164634301|NCT02190604|594684168|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164634302|NCT02190604|594684169|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164634303|NCT02190604|594684170|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164634304|NCT02190604|594684171|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164634305|NCT02190604|594684172|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
164634306|NCT02190604|594684173|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164634307|NCT02190604|594684174|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164634308|NCT02190604|594684175|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164634309|NCT02190604|594684176|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164634310|NCT02190604|594684177|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164634311|NCT02797951|594684178|FG000|Overall Study|Adverse Event|4|||
164634312|NCT02797951|594684178|FG000|Overall Study|Death|1|||
164634313|NCT02797951|594684178|FG000|Overall Study|Lack of Efficacy|19|||
164634314|NCT02797951|594684178|FG000|Overall Study|Lost to Follow-up|4|||
164634315|NCT02797951|594684178|FG000|Overall Study|Physician Decision|6|||
164634316|NCT02797951|594684178|FG000|Overall Study|Withdrawal by Subject|15|||
164634317|NCT01901393|594684179|FG000|Overall Study|Adverse Event|1|||
164634318|NCT01901393|594684180|FG001|Overall Study|Adverse Event|0|||
164634319|NCT04585906|594684181|FG000|Overall Study|Lost to Follow-up|8|||
164634320|NCT04585906|594684182|FG001|Overall Study|Lost to Follow-up|5|||
164634321|NCT03125382|594684183|FG000|Randomization|screening failure|1|||
164634322|NCT03125382|594684184|FG001|Randomization|screening failure|4|||
164634323|NCT03125382|594684185|FG002|Randomization|screening failure|2|||
164634324|NCT03125382|594684186|FG003|Randomization|screening failure|0|||
164634325|NCT03125382|594684183|FG000|Follow-up|Death|1|||
164634326|NCT03125382|594684184|FG001|Follow-up|Death|2|||
164634327|NCT03125382|594684185|FG002|Follow-up|Death|1|||
164634328|NCT03125382|594684186|FG003|Follow-up|Death|2|||
164634329|NCT03125382|594684183|FG000|Follow-up|Lost to Follow-up|1|||
164634330|NCT03125382|594684184|FG001|Follow-up|Lost to Follow-up|4|||
164634331|NCT03125382|594684185|FG002|Follow-up|Lost to Follow-up|3|||
164634332|NCT03125382|594684186|FG003|Follow-up|Lost to Follow-up|1|||
164634333|NCT04626947|594684187|FG000|Overall Study|Study terminated|14|||
164634334|NCT00267202|594684188|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
164634335|NCT00267202|594684189|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
164634336|NCT00267202|594684188|FG000|Overall Study|Withdrawal by Subject|12|||
164634337|NCT00267202|594684189|FG001|Overall Study|Withdrawal by Subject|15|||
164634338|NCT00267202|594684188|FG000|Overall Study|Adverse Event|13|||
164634339|NCT00267202|594684189|FG001|Overall Study|Adverse Event|7|||
164634340|NCT00267202|594684188|FG000|Overall Study|Protocol Violation|2|||
164634341|NCT00267202|594684189|FG001|Overall Study|Protocol Violation|3|||
164634342|NCT00267202|594684188|FG000|Overall Study|Administrative problems|2|||
164634343|NCT00267202|594684189|FG001|Overall Study|Administrative problems|1|||
164634344|NCT00267202|594684188|FG000|Overall Study|Lost to Follow-up|3|||
164634345|NCT00267202|594684189|FG001|Overall Study|Lost to Follow-up|0|||
164634346|NCT01428882|594684198|FG000|Overall Study|Lack of Efficacy|2|||
164634347|NCT01428882|594684199|FG001|Overall Study|Lack of Efficacy|7|||
164634348|NCT01428882|594684198|FG000|Overall Study|Protocol Violation|4|||
164634349|NCT01428882|594684199|FG001|Overall Study|Protocol Violation|3|||
164634350|NCT03907072|594684200|FG000|Overall Study|Study Terminated by Sponsor|2|||
164634351|NCT03907072|594684201|FG001|Overall Study|Study Terminated by Sponsor|2|||
164634352|NCT03907072|594684202|FG002|Overall Study|Study Terminated by Sponsor|2|||
164634353|NCT00612456|594684203|FG000|Overall Study|Adverse Event|1|||
164634354|NCT00612456|594684204|FG001|Overall Study|Adverse Event|0|||
164634355|NCT00612456|594684205|FG002|Overall Study|Adverse Event|0|||
164634356|NCT00612456|594684203|FG000|Overall Study|Lack of Efficacy|1|||
164634357|NCT00612456|594684204|FG001|Overall Study|Lack of Efficacy|1|||
164634358|NCT00612456|594684205|FG002|Overall Study|Lack of Efficacy|0|||
164634359|NCT00612456|594684203|FG000|Overall Study|Withdrawal by Subject|0|||
164634360|NCT00612456|594684204|FG001|Overall Study|Withdrawal by Subject|1|||
164634361|NCT00612456|594684205|FG002|Overall Study|Withdrawal by Subject|0|||
164634362|NCT00265109|594684206|FG000|Overall Study|Withdrawal by Subject|5|||
164634363|NCT00265109|594684206|FG000|Overall Study|Adverse Event|1|||
164634364|NCT02463097|594684207|FG000|Overall Study|Withdrawal by Subject|1|||
164634365|NCT01757821|594684208|FG000|Overall Study|Adverse Event|1|||
164634366|NCT03831282|594684209|FG000|Overall Study|Could not place sensor|1|||
164634367|NCT03556202|594684213|FG000|Extension Treatment Period|Adverse Event|18|||
164634368|NCT03556202|594684214|FG001|Extension Treatment Period|Adverse Event|14|||
164634369|NCT03556202|594684215|FG002|Extension Treatment Period|Adverse Event|9|||
164634370|NCT03556202|594684213|FG000|Extension Treatment Period|Death|2|||
164634371|NCT03556202|594684214|FG001|Extension Treatment Period|Death|6|||
164634372|NCT03556202|594684215|FG002|Extension Treatment Period|Death|0|||
164634373|NCT03556202|594684213|FG000|Extension Treatment Period|Lack of Efficacy|5|||
164634374|NCT03556202|594684214|FG001|Extension Treatment Period|Lack of Efficacy|12|||
164634375|NCT03556202|594684215|FG002|Extension Treatment Period|Lack of Efficacy|18|||
164634376|NCT03556202|594684213|FG000|Extension Treatment Period|Lost to Follow-up|9|||
164634377|NCT03556202|594684214|FG001|Extension Treatment Period|Lost to Follow-up|20|||
164634378|NCT03556202|594684215|FG002|Extension Treatment Period|Lost to Follow-up|2|||
164634379|NCT03556202|594684213|FG000|Extension Treatment Period|Pregnancy|2|||
164634380|NCT03556202|594684214|FG001|Extension Treatment Period|Pregnancy|4|||
164634381|NCT03556202|594684215|FG002|Extension Treatment Period|Pregnancy|3|||
164634382|NCT03556202|594684213|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
164634383|NCT03556202|594684214|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
164634384|NCT03556202|594684215|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
164634385|NCT03556202|594684213|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
164634386|NCT03556202|594684214|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
164634387|NCT03556202|594684215|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
164634388|NCT03556202|594684213|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
164634389|NCT03556202|594684214|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
164634390|NCT03556202|594684215|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
164634391|NCT03556202|594684213|FG000|Extension Treatment Period|Physician Decision|0|||
164634392|NCT03556202|594684214|FG001|Extension Treatment Period|Physician Decision|8|||
164634393|NCT03556202|594684215|FG002|Extension Treatment Period|Physician Decision|2|||
164634394|NCT03556202|594684213|FG000|Extension Treatment Period|Protocol Violation|0|||
164634395|NCT03556202|594684214|FG001|Extension Treatment Period|Protocol Violation|1|||
164634396|NCT03556202|594684215|FG002|Extension Treatment Period|Protocol Violation|1|||
164634397|NCT03556202|594684213|FG000|Extension Treatment Period|Sponsor Decision|0|||
164634398|NCT03556202|594684214|FG001|Extension Treatment Period|Sponsor Decision|1|||
164634399|NCT03556202|594684215|FG002|Extension Treatment Period|Sponsor Decision|0|||
164634400|NCT03556202|594684213|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
164634401|NCT03556202|594684214|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
164634402|NCT03556202|594684215|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
164634403|NCT03556202|594684213|FG000|Follow-Up Period (12 Weeks)|Death|1|||
164634404|NCT03556202|594684214|FG001|Follow-Up Period (12 Weeks)|Death|0|||
164634405|NCT03556202|594684215|FG002|Follow-Up Period (12 Weeks)|Death|0|||
164634406|NCT03556202|594684213|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
164634407|NCT03556202|594684214|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
164634408|NCT03556202|594684215|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
164529776|NCT01691768|594311829|FG001|Overall Study|Withdrawal by Subject|9|||
164529777|NCT01691768|594311828|FG000|Overall Study|Relocated|0|||
164529778|NCT01691768|594311829|FG001|Overall Study|Relocated|1|||
164529779|NCT01691768|594311828|FG000|Overall Study|Investigator decision|1|||
164529780|NCT01691768|594311829|FG001|Overall Study|Investigator decision|1|||
164529781|NCT00819390|594311830|FG000|Overall Study|Lost to Follow-up|1|||
164529782|NCT00819390|594311831|FG001|Overall Study|Lost to Follow-up|1|||
164529783|NCT00819390|594311832|FG002|Overall Study|Lost to Follow-up|0|||
164529784|NCT00819390|594311833|FG003|Overall Study|Lost to Follow-up|0|||
164529785|NCT00819390|594311830|FG000|Overall Study|Withdrawal by Subject|2|||
164529786|NCT00819390|594311831|FG001|Overall Study|Withdrawal by Subject|0|||
164529787|NCT00819390|594311832|FG002|Overall Study|Withdrawal by Subject|0|||
164529788|NCT00819390|594311833|FG003|Overall Study|Withdrawal by Subject|0|||
164529789|NCT00819390|594311830|FG000|Overall Study|Adverse Event|0|||
164529790|NCT00819390|594311831|FG001|Overall Study|Adverse Event|0|||
164529791|NCT00819390|594311832|FG002|Overall Study|Adverse Event|1|||
164529792|NCT00819390|594311833|FG003|Overall Study|Adverse Event|0|||
164529793|NCT02294227|594311834|FG000|Overall Study|Death|0|||
164529794|NCT02294227|594311835|FG001|Overall Study|Death|0|||
164529795|NCT02294227|594311836|FG002|Overall Study|Death|1|||
164634409|NCT03556202|594684213|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
164634410|NCT03556202|594684214|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
164634411|NCT03556202|594684215|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
164634412|NCT03556202|594684213|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
164634413|NCT03556202|594684214|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
164634414|NCT03556202|594684215|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
164634415|NCT03556202|594684213|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
164634416|NCT03556202|594684214|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
164634417|NCT03556202|594684215|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
164634418|NCT03556202|594684213|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
164634419|NCT03556202|594684214|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
164634420|NCT03556202|594684215|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
164634421|NCT03556202|594684213|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
164634422|NCT03556202|594684214|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
164634423|NCT03556202|594684215|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
164634424|NCT03556202|594684213|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
164634425|NCT03556202|594684214|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
164634426|NCT03556202|594684215|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
164634427|NCT03556202|594684213|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
164634428|NCT03556202|594684214|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
164634429|NCT03556202|594684215|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
164634430|NCT03556202|594684213|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
164634431|NCT03556202|594684214|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
164634432|NCT03556202|594684215|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
164634433|NCT03556202|594684213|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
164634434|NCT03556202|594684214|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
164634435|NCT03556202|594684215|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
164634436|NCT03556202|594684213|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
164634437|NCT03556202|594684214|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
164634438|NCT03556202|594684215|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
164634439|NCT03556202|594684213|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
164634440|NCT03556202|594684214|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
164634441|NCT03556202|594684215|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
164634442|NCT03319160|594684216|FG000|Overall Study|Data not available.|7|||
164634443|NCT00697255|594684219|FG000|Stage 1a|Insufficient ovarian response|1|||
164634444|NCT00697255|594684220|FG001|Stage 1a|Insufficient ovarian response|0|||
164634445|NCT00697255|594684219|FG000|Stage 1a|Multifollicular growth|1|||
164634446|NCT00697255|594684220|FG001|Stage 1a|Multifollicular growth|0|||
164634447|NCT00697255|594684219|FG000|Stage 1a|Not growing of dominant follicle|1|||
164634448|NCT00697255|594684220|FG001|Stage 1a|Not growing of dominant follicle|0|||
164634449|NCT00697255|594684219|FG000|Stage 1b|Not growing of dominant follicle|0|||
164634450|NCT00697255|594684220|FG001|Stage 1b|Not growing of dominant follicle|1|||
164634451|NCT00697255|594684219|FG000|Stage 1b|Insufficient ovarian response|0|||
164634452|NCT00697255|594684220|FG001|Stage 1b|Insufficient ovarian response|1|||
164634453|NCT05664672|594684221|FG000|Overall Study|Adverse Event|0|||
164634454|NCT05664672|594684222|FG001|Overall Study|Adverse Event|0|||
164634455|NCT05664672|594684223|FG002|Overall Study|Adverse Event|0|||
164634456|NCT05664672|594684224|FG003|Overall Study|Adverse Event|0|||
164634457|NCT05664672|594684225|FG004|Overall Study|Adverse Event|0|||
164634458|NCT05664672|594684226|FG005|Overall Study|Adverse Event|1|||
164634459|NCT05664672|594684221|FG000|Overall Study|Withdrawal by Subject|0|||
164634460|NCT05664672|594684222|FG001|Overall Study|Withdrawal by Subject|1|||
164634461|NCT05664672|594684223|FG002|Overall Study|Withdrawal by Subject|3|||
164634462|NCT05664672|594684224|FG003|Overall Study|Withdrawal by Subject|0|||
164634463|NCT05664672|594684225|FG004|Overall Study|Withdrawal by Subject|5|||
164634464|NCT05664672|594684226|FG005|Overall Study|Withdrawal by Subject|6|||
164634465|NCT05664672|594684221|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
164634466|NCT05664672|594684222|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
164634467|NCT05664672|594684223|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
164634468|NCT05664672|594684224|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
164634469|NCT05664672|594684225|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
164634470|NCT05664672|594684226|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
164634471|NCT05664672|594684221|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
164634472|NCT05664672|594684222|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
164634473|NCT05664672|594684223|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
164634474|NCT05664672|594684224|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
164634475|NCT05664672|594684225|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
164634476|NCT05664672|594684226|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
164634477|NCT02260791|594684229|FG000|Overall Study|Lost to Follow-up|4|||
164634478|NCT02260791|594684230|FG001|Overall Study|Lost to Follow-up|4|||
164634479|NCT02260791|594684229|FG000|Overall Study|Lack of Efficacy|2|||
164634480|NCT02260791|594684230|FG001|Overall Study|Lack of Efficacy|1|||
164634481|NCT02260791|594684229|FG000|Overall Study|Adverse Event|13|||
164634482|NCT02260791|594684230|FG001|Overall Study|Adverse Event|9|||
164634483|NCT02260791|594684229|FG000|Overall Study|Death|1|||
164634484|NCT02260791|594684230|FG001|Overall Study|Death|0|||
164634485|NCT02260791|594684229|FG000|Overall Study|Withdrawal by Subject|11|||
164634486|NCT02260791|594684230|FG001|Overall Study|Withdrawal by Subject|16|||
164634487|NCT02260791|594684229|FG000|Overall Study|Screen failure|0|||
164634488|NCT02260791|594684230|FG001|Overall Study|Screen failure|1|||
164634489|NCT02260791|594684229|FG000|Overall Study|Protocol deviation|2|||
164634490|NCT02260791|594684230|FG001|Overall Study|Protocol deviation|3|||
164634491|NCT02815670|594684231|FG000|Overall Study|Prematurely discontinued of the trial|1|||
164634492|NCT01411917|594684232|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
164634493|NCT01411917|594684233|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
164634494|NCT01815099|594684236|FG000|Overall Study|Lack of Efficacy|1|||
164634495|NCT01815099|594684236|FG000|Overall Study|unable to attend study visits|1|||
164634496|NCT01977573|594684237|FG000|Overall Study|Adverse Event|7|||
164634497|NCT01977573|594684238|FG001|Overall Study|Adverse Event|0|||
164634498|NCT01977573|594684239|FG002|Overall Study|Adverse Event|2|||
164634499|NCT01977573|594684240|FG003|Overall Study|Adverse Event|1|||
164634500|NCT01977573|594684237|FG000|Overall Study|Lost to Follow-up|1|||
164634501|NCT01977573|594684238|FG001|Overall Study|Lost to Follow-up|0|||
164634502|NCT01977573|594684239|FG002|Overall Study|Lost to Follow-up|0|||
164634503|NCT01977573|594684240|FG003|Overall Study|Lost to Follow-up|1|||
164634504|NCT01977573|594684237|FG000|Overall Study|Physician Decision|1|||
164634505|NCT01977573|594684238|FG001|Overall Study|Physician Decision|0|||
164634506|NCT01977573|594684239|FG002|Overall Study|Physician Decision|0|||
164634507|NCT01977573|594684240|FG003|Overall Study|Physician Decision|0|||
164634508|NCT01977573|594684237|FG000|Overall Study|Protocol Violation|3|||
164634509|NCT01977573|594684238|FG001|Overall Study|Protocol Violation|1|||
164634510|NCT01977573|594684239|FG002|Overall Study|Protocol Violation|0|||
164634511|NCT01977573|594684240|FG003|Overall Study|Protocol Violation|0|||
164634512|NCT01977573|594684237|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
164634513|NCT01977573|594684238|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
164634514|NCT01977573|594684239|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
164634515|NCT01977573|594684240|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
164634516|NCT01977573|594684237|FG000|Overall Study|Withdrawal by Subject|6|||
164634517|NCT01977573|594684238|FG001|Overall Study|Withdrawal by Subject|1|||
164634518|NCT01977573|594684239|FG002|Overall Study|Withdrawal by Subject|1|||
164634519|NCT01977573|594684240|FG003|Overall Study|Withdrawal by Subject|1|||
164634520|NCT02513732|594686196|FG000|Overall Study|Lost to Follow-up|11|||
164634521|NCT02513732|594686196|FG000|Overall Study|Death|9|||
164634522|NCT02513732|594686196|FG000|Overall Study|Changing hospital|2|||
164634523|NCT00934661|594686197|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
164634524|NCT00934661|594686198|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
164634525|NCT00467051|594686199|FG000|Overall Study|Adverse Event|2|||
164634526|NCT01846442|594686204|FG000|Overall Study|Adverse Event|2|||
164634527|NCT01846442|594686205|FG001|Overall Study|Adverse Event|4|||
164634528|NCT01846442|594686206|FG002|Overall Study|Adverse Event|2|||
164634529|NCT01846442|594686207|FG003|Overall Study|Adverse Event|1|||
164634530|NCT01846442|594686204|FG000|Overall Study|Lost to Follow-up|0|||
164634531|NCT01846442|594686205|FG001|Overall Study|Lost to Follow-up|0|||
164634532|NCT01846442|594686206|FG002|Overall Study|Lost to Follow-up|1|||
164634533|NCT01846442|594686207|FG003|Overall Study|Lost to Follow-up|0|||
164634534|NCT01846442|594686204|FG000|Overall Study|Withdrawal by Subject|3|||
164634535|NCT01846442|594686205|FG001|Overall Study|Withdrawal by Subject|2|||
164634536|NCT01846442|594686206|FG002|Overall Study|Withdrawal by Subject|0|||
164634537|NCT01846442|594686207|FG003|Overall Study|Withdrawal by Subject|1|||
164634538|NCT01846442|594686204|FG000|Overall Study|Left the city/Lost medication|1|||
164634539|NCT01846442|594686205|FG001|Overall Study|Left the city/Lost medication|0|||
164634540|NCT01846442|594686206|FG002|Overall Study|Left the city/Lost medication|1|||
164634541|NCT01846442|594686207|FG003|Overall Study|Left the city/Lost medication|1|||
164634542|NCT03996694|594686208|FG000|First Washout (7 Days)|positive urine drug screen|0|||
164634543|NCT03996694|594686209|FG001|First Washout (7 Days)|positive urine drug screen|0|||
164634544|NCT03996694|594686210|FG002|First Washout (7 Days)|positive urine drug screen|1|||
164634545|NCT03996694|594686211|FG003|First Washout (7 Days)|positive urine drug screen|0|||
164634546|NCT03996694|594686212|FG004|First Washout (7 Days)|positive urine drug screen|0|||
164634547|NCT03996694|594686213|FG005|First Washout (7 Days)|positive urine drug screen|0|||
164634548|NCT03996694|594686208|FG000|First Washout (7 Days)|Adverse Event|0|||
164634549|NCT03996694|594686209|FG001|First Washout (7 Days)|Adverse Event|1|||
164634550|NCT03996694|594686210|FG002|First Washout (7 Days)|Adverse Event|0|||
164634551|NCT03996694|594686211|FG003|First Washout (7 Days)|Adverse Event|0|||
164634552|NCT03996694|594686212|FG004|First Washout (7 Days)|Adverse Event|0|||
164634553|NCT03996694|594686213|FG005|First Washout (7 Days)|Adverse Event|0|||
164634554|NCT03996694|594686208|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
164634555|NCT03996694|594686209|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
164634556|NCT03996694|594686210|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
164634557|NCT03996694|594686211|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
164634558|NCT03996694|594686212|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
164634559|NCT03996694|594686213|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
164634560|NCT03996694|594686208|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
164634561|NCT03996694|594686209|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
164634562|NCT03996694|594686210|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
164634563|NCT03996694|594686211|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
164634564|NCT03996694|594686212|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
164634565|NCT03996694|594686213|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
164634566|NCT02777554|594686220|FG000|Overall Study|Adverse Event|4|||
164634567|NCT02777554|594686221|FG001|Overall Study|Adverse Event|4|||
164634568|NCT02777554|594686222|FG002|Overall Study|Adverse Event|0|||
164634569|NCT02777554|594686223|FG003|Overall Study|Adverse Event|1|||
164634570|NCT02777554|594686224|FG004|Overall Study|Adverse Event|0|||
164634571|NCT02777554|594686225|FG005|Overall Study|Adverse Event|0|||
164634572|NCT02777554|594686220|FG000|Overall Study|Withdrawal by Subject|3|||
164634573|NCT02777554|594686221|FG001|Overall Study|Withdrawal by Subject|1|||
164634574|NCT02777554|594686222|FG002|Overall Study|Withdrawal by Subject|1|||
164634575|NCT02777554|594686223|FG003|Overall Study|Withdrawal by Subject|0|||
164634576|NCT02777554|594686224|FG004|Overall Study|Withdrawal by Subject|0|||
164634577|NCT02777554|594686225|FG005|Overall Study|Withdrawal by Subject|0|||
164634578|NCT02777554|594686220|FG000|Overall Study|Discharged early due to hurricane|22|||
164634579|NCT02777554|594686221|FG001|Overall Study|Discharged early due to hurricane|20|||
164634580|NCT02777554|594686222|FG002|Overall Study|Discharged early due to hurricane|0|||
164634581|NCT02777554|594686223|FG003|Overall Study|Discharged early due to hurricane|0|||
164634582|NCT02777554|594686224|FG004|Overall Study|Discharged early due to hurricane|0|||
164634583|NCT02777554|594686225|FG005|Overall Study|Discharged early due to hurricane|0|||
164634584|NCT02777554|594686220|FG000|Overall Study|Other - Miscellaneous|1|||
164634585|NCT02777554|594686221|FG001|Overall Study|Other - Miscellaneous|0|||
164634586|NCT02777554|594686222|FG002|Overall Study|Other - Miscellaneous|0|||
164634587|NCT02777554|594686223|FG003|Overall Study|Other - Miscellaneous|0|||
164634588|NCT02777554|594686224|FG004|Overall Study|Other - Miscellaneous|0|||
164634589|NCT02777554|594686225|FG005|Overall Study|Other - Miscellaneous|0|||
164634590|NCT02147132|594686226|FG000|Overall Study|Lost to Follow-up|1|||
164634591|NCT02147132|594686227|FG001|Overall Study|Lost to Follow-up|0|||
164634592|NCT02147132|594686228|FG002|Overall Study|Lost to Follow-up|0|||
164634593|NCT02147132|594686229|FG003|Overall Study|Lost to Follow-up|0|||
164634594|NCT01458535|594686236|FG000|Overall Study|Other|0|||
164634595|NCT01458535|594686237|FG001|Overall Study|Other|0|||
164634596|NCT01458535|594686238|FG002|Overall Study|Other|0|||
164634597|NCT01458535|594686239|FG003|Overall Study|Other|0|||
164634598|NCT01458535|594686240|FG004|Overall Study|Other|1|||
164634599|NCT01458535|594686241|FG005|Overall Study|Other|1|||
164634600|NCT01458535|594686236|FG000|Overall Study|Withdrawal by Subject|0|||
164634601|NCT01458535|594686237|FG001|Overall Study|Withdrawal by Subject|0|||
164634602|NCT01458535|594686238|FG002|Overall Study|Withdrawal by Subject|2|||
164634603|NCT01458535|594686239|FG003|Overall Study|Withdrawal by Subject|0|||
164634604|NCT01458535|594686240|FG004|Overall Study|Withdrawal by Subject|1|||
164634605|NCT01458535|594686241|FG005|Overall Study|Withdrawal by Subject|1|||
164634606|NCT01458535|594686236|FG000|Overall Study|Lost to Follow-up|0|||
164634607|NCT01458535|594686237|FG001|Overall Study|Lost to Follow-up|2|||
164634608|NCT01458535|594686238|FG002|Overall Study|Lost to Follow-up|0|||
164634609|NCT01458535|594686239|FG003|Overall Study|Lost to Follow-up|3|||
164634610|NCT01458535|594686240|FG004|Overall Study|Lost to Follow-up|2|||
164634611|NCT01458535|594686241|FG005|Overall Study|Lost to Follow-up|2|||
164634612|NCT01458535|594686236|FG000|Overall Study|Adverse Event|0|||
164634613|NCT01458535|594686237|FG001|Overall Study|Adverse Event|0|||
164634614|NCT01458535|594686238|FG002|Overall Study|Adverse Event|0|||
164634615|NCT01458535|594686239|FG003|Overall Study|Adverse Event|1|||
164634616|NCT01458535|594686240|FG004|Overall Study|Adverse Event|0|||
164634617|NCT01458535|594686241|FG005|Overall Study|Adverse Event|0|||
164634618|NCT00151775|594686242|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
164634619|NCT00151775|594686243|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
164634620|NCT00151775|594686244|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
164634621|NCT00151775|594686245|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
164634622|NCT00151775|594686246|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
164634623|NCT00151775|594686247|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
164634624|NCT00151775|594686248|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
164634625|NCT00151775|594686249|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
164634626|NCT00151775|594686250|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
164634627|NCT00151775|594686251|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
164634628|NCT00151775|594686252|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
164634629|NCT00151775|594686253|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
164634630|NCT00151775|594686242|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
164634631|NCT00151775|594686243|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
164634632|NCT00151775|594686244|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
164634633|NCT00151775|594686245|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
164634634|NCT00151775|594686246|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
164634635|NCT00151775|594686247|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
164634636|NCT00151775|594686248|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
164634637|NCT00151775|594686249|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
164634638|NCT00151775|594686250|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
164634639|NCT00151775|594686251|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
164634640|NCT00151775|594686252|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
164634641|NCT00151775|594686253|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
164634642|NCT00151775|594686242|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
164634643|NCT00151775|594686243|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
164634644|NCT00151775|594686244|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
164634645|NCT00151775|594686245|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
164634646|NCT00151775|594686246|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
164634647|NCT00151775|594686247|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
164634648|NCT00151775|594686248|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
164634649|NCT00151775|594686249|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
164634650|NCT00151775|594686250|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
164634651|NCT00151775|594686251|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
164634652|NCT00151775|594686252|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
164634653|NCT00151775|594686253|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
164634654|NCT00151775|594686242|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
164634655|NCT00151775|594686243|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
164634656|NCT00151775|594686244|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
164634657|NCT00151775|594686245|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
164634658|NCT00151775|594686246|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
164634659|NCT00151775|594686247|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
164634660|NCT00151775|594686248|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
164634661|NCT00151775|594686249|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
164634662|NCT00151775|594686250|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
164634663|NCT00151775|594686251|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
164634664|NCT00151775|594686252|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
164634665|NCT00151775|594686253|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
164634666|NCT00151775|594686242|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
164634667|NCT00151775|594686243|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
164634668|NCT00151775|594686244|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
164634669|NCT00151775|594686245|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
164634670|NCT00151775|594686246|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
164634671|NCT00151775|594686247|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
164634672|NCT00151775|594686248|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
164634673|NCT00151775|594686249|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
164634674|NCT00151775|594686250|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
164634675|NCT00151775|594686251|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
164634676|NCT00151775|594686252|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
164529796|NCT02294227|594311834|FG000|Overall Study|Subject/Guardian Decision|6|||
164529797|NCT02294227|594311835|FG001|Overall Study|Subject/Guardian Decision|3|||
164529798|NCT02294227|594311836|FG002|Overall Study|Subject/Guardian Decision|7|||
164634677|NCT00151775|594686253|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
164634678|NCT00151775|594686242|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
164634679|NCT00151775|594686243|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
164634680|NCT00151775|594686244|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
164529799|NCT02294227|594311834|FG000|Overall Study|Physician Decision|1|||
164529800|NCT02294227|594311835|FG001|Overall Study|Physician Decision|2|||
164529801|NCT02294227|594311836|FG002|Overall Study|Physician Decision|1|||
164529802|NCT02294227|594311834|FG000|Overall Study|Lost to Follow-up|1|||
164529803|NCT02294227|594311835|FG001|Overall Study|Lost to Follow-up|0|||
164529804|NCT02294227|594311836|FG002|Overall Study|Lost to Follow-up|0|||
164529805|NCT02294227|594311834|FG000|Overall Study|Lack of Efficacy|11|||
164529806|NCT02294227|594311835|FG001|Overall Study|Lack of Efficacy|12|||
164529807|NCT02294227|594311836|FG002|Overall Study|Lack of Efficacy|8|||
164529808|NCT02294227|594311834|FG000|Overall Study|Adverse Event|6|||
164529809|NCT02294227|594311835|FG001|Overall Study|Adverse Event|8|||
164529810|NCT02294227|594311836|FG002|Overall Study|Adverse Event|2|||
164529811|NCT00887432|594311837|FG000|Overall Study|Start Excluded Therapy|3|||
164529812|NCT00887432|594311838|FG001|Overall Study|Start Excluded Therapy|0|||
164529813|NCT00887432|594311837|FG000|Overall Study|Did not complete treatment|6|||
164529814|NCT00887432|594311838|FG001|Overall Study|Did not complete treatment|8|||
164529815|NCT00887432|594311837|FG000|Overall Study|Protocol Violation|2|||
164529816|NCT00887432|594311838|FG001|Overall Study|Protocol Violation|3|||
164529817|NCT00887432|594311837|FG000|Overall Study|Withdrawal by Subject|3|||
164529818|NCT00887432|594311838|FG001|Overall Study|Withdrawal by Subject|2|||
164529819|NCT00887432|594311837|FG000|Overall Study|Lost to Follow-up|1|||
164529820|NCT00887432|594311838|FG001|Overall Study|Lost to Follow-up|0|||
164529821|NCT00887432|594311837|FG000|Overall Study|No reason provided|0|||
164529822|NCT00887432|594311838|FG001|Overall Study|No reason provided|1|||
164529823|NCT00899548|594311839|FG000|Overall Study|Physician Decision|3|||
164529824|NCT00551460|594311840|FG000|Overall Study|Adverse Event|1|||
164529825|NCT00551460|594311840|FG000|Overall Study|Withdrawal by Subject|1|||
164529826|NCT00551460|594311840|FG000|Overall Study|Physician Decision|1|||
164529827|NCT00551460|594311840|FG000|Overall Study|Death|7|||
164529828|NCT00551460|594311840|FG000|Overall Study|Ineligible|4|||
164529829|NCT00551460|594311840|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
164529830|NCT01920854|594311843|FG000|Overall Study|Withdrawal by Subject|1|||
164529831|NCT01920854|594311844|FG001|Overall Study|Withdrawal by Subject|0|||
164529832|NCT01920854|594311845|FG002|Overall Study|Withdrawal by Subject|0|||
164529833|NCT01920854|594311846|FG003|Overall Study|Withdrawal by Subject|0|||
164529834|NCT01920854|594311847|FG004|Overall Study|Withdrawal by Subject|1|||
164529835|NCT01920854|594311848|FG005|Overall Study|Withdrawal by Subject|0|||
164529836|NCT01920854|594311849|FG006|Overall Study|Withdrawal by Subject|1|||
164529837|NCT00448123|594311850|FG000|Overall Study|Lost to Follow-up|9|||
164529838|NCT00448123|594311851|FG001|Overall Study|Lost to Follow-up|6|||
164529839|NCT00448123|594311850|FG000|Overall Study|Physician Decision|6|||
164529840|NCT00448123|594311851|FG001|Overall Study|Physician Decision|6|||
164634681|NCT00151775|594686245|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
164529841|NCT00818649|594311853|FG000|Overall Study|Declining performance status|2|||
164634682|NCT00151775|594686246|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
164634683|NCT00151775|594686247|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
164634684|NCT00151775|594686248|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
164634685|NCT00151775|594686249|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
164634686|NCT00151775|594686250|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
164634687|NCT00151775|594686251|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
164634688|NCT00151775|594686252|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
164634689|NCT00151775|594686253|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
164634690|NCT00151775|594686242|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
164634691|NCT00151775|594686243|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
164634692|NCT00151775|594686244|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
164634693|NCT00151775|594686245|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
164634694|NCT00151775|594686246|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
164634695|NCT00151775|594686247|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
164634696|NCT00151775|594686248|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
164634697|NCT00151775|594686249|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
164634698|NCT00151775|594686250|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
164634699|NCT00151775|594686251|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
164634700|NCT00151775|594686252|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
164634701|NCT00151775|594686253|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
164634702|NCT00151775|594686242|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
164634703|NCT00151775|594686243|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
164634704|NCT00151775|594686244|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
164634705|NCT00151775|594686245|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
164634706|NCT00151775|594686246|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
164634707|NCT00151775|594686247|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
164634708|NCT00151775|594686248|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
164634709|NCT00151775|594686249|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
164634710|NCT00151775|594686250|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
164634711|NCT00151775|594686251|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
164634712|NCT00151775|594686252|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
164634713|NCT00151775|594686253|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
164634714|NCT00151775|594686242|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
164634715|NCT00151775|594686243|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
164634716|NCT00151775|594686244|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
164634717|NCT00151775|594686245|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
164634718|NCT00151775|594686246|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
164634719|NCT00151775|594686247|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
164634720|NCT00151775|594686248|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
164634721|NCT00151775|594686249|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
164634722|NCT00151775|594686250|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
164634723|NCT00151775|594686251|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
164634724|NCT00151775|594686252|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
164634725|NCT00151775|594686253|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
164634726|NCT00151775|594686242|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
164634727|NCT00151775|594686243|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
164634728|NCT00151775|594686244|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
164634729|NCT00151775|594686245|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
164634730|NCT00151775|594686246|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
164634731|NCT00151775|594686247|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
164634732|NCT00151775|594686248|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
164634733|NCT00151775|594686249|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
164634734|NCT00151775|594686250|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
164634735|NCT00151775|594686251|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
164634736|NCT00151775|594686252|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
164634737|NCT00151775|594686253|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
164634738|NCT00151775|594686242|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
164634739|NCT00151775|594686243|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
164634740|NCT00151775|594686244|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
164634741|NCT00151775|594686245|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
164634742|NCT00151775|594686246|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
164634743|NCT00151775|594686247|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
164634744|NCT00151775|594686248|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
164634745|NCT00151775|594686249|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
164634746|NCT00151775|594686250|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
164634747|NCT00151775|594686251|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
164634748|NCT00151775|594686252|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
164634749|NCT00151775|594686253|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
164634750|NCT00151775|594686242|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
164634751|NCT00151775|594686243|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
164634752|NCT00151775|594686244|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
164634753|NCT00151775|594686245|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
164634754|NCT00151775|594686246|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
164634755|NCT00151775|594686247|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
164634756|NCT00151775|594686248|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
164634757|NCT00151775|594686249|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
164634758|NCT00151775|594686250|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
164634759|NCT00151775|594686251|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
164634760|NCT00151775|594686252|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
164634761|NCT00151775|594686253|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
164634762|NCT00151775|594686242|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
164634763|NCT00151775|594686243|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
164634764|NCT00151775|594686244|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
164634765|NCT00151775|594686245|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
164634766|NCT00151775|594686246|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
164634767|NCT00151775|594686247|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
164634768|NCT00151775|594686248|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
164634769|NCT00151775|594686249|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
164634770|NCT00151775|594686250|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
164634771|NCT00151775|594686251|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
164634772|NCT00151775|594686252|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
164634773|NCT00151775|594686253|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
164634774|NCT00151775|594686242|FG000|Period 4: Open Label|Increased blood pressure|0|||
164634775|NCT00151775|594686243|FG001|Period 4: Open Label|Increased blood pressure|0|||
164634776|NCT00151775|594686244|FG002|Period 4: Open Label|Increased blood pressure|0|||
164634777|NCT00151775|594686245|FG003|Period 4: Open Label|Increased blood pressure|0|||
164634778|NCT00151775|594686246|FG004|Period 4: Open Label|Increased blood pressure|1|||
164634779|NCT00151775|594686247|FG005|Period 4: Open Label|Increased blood pressure|0|||
164634780|NCT00151775|594686248|FG006|Period 4: Open Label|Increased blood pressure|0|||
164634781|NCT00151775|594686249|FG007|Period 4: Open Label|Increased blood pressure|0|||
164634782|NCT00151775|594686250|FG008|Period 4: Open Label|Increased blood pressure|0|||
164634783|NCT00151775|594686251|FG009|Period 4: Open Label|Increased blood pressure|1|||
164634784|NCT00151775|594686252|FG010|Period 4: Open Label|Increased blood pressure|0|||
164634785|NCT00151775|594686253|FG011|Period 4: Open Label|Increased blood pressure|0|||
164634786|NCT00151775|594686242|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
164634787|NCT00151775|594686243|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
164634788|NCT00151775|594686244|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
164634789|NCT00151775|594686245|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
164634790|NCT00151775|594686246|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
164634791|NCT00151775|594686247|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
164634792|NCT00151775|594686248|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
164634793|NCT00151775|594686249|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
164634794|NCT00151775|594686250|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
164634795|NCT00151775|594686251|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
164634796|NCT00151775|594686252|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
164634797|NCT00151775|594686253|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
164634798|NCT00151775|594686242|FG000|Period 4: Open Label|Adverse Event|0|||
164634799|NCT00151775|594686243|FG001|Period 4: Open Label|Adverse Event|0|||
164634800|NCT00151775|594686244|FG002|Period 4: Open Label|Adverse Event|0|||
164634801|NCT00151775|594686245|FG003|Period 4: Open Label|Adverse Event|0|||
164634802|NCT00151775|594686246|FG004|Period 4: Open Label|Adverse Event|1|||
164634803|NCT00151775|594686247|FG005|Period 4: Open Label|Adverse Event|0|||
164634804|NCT00151775|594686248|FG006|Period 4: Open Label|Adverse Event|0|||
164634805|NCT00151775|594686249|FG007|Period 4: Open Label|Adverse Event|0|||
164634806|NCT00151775|594686250|FG008|Period 4: Open Label|Adverse Event|0|||
164634807|NCT00151775|594686251|FG009|Period 4: Open Label|Adverse Event|2|||
164634808|NCT00151775|594686252|FG010|Period 4: Open Label|Adverse Event|0|||
164634809|NCT00151775|594686253|FG011|Period 4: Open Label|Adverse Event|0|||
164634810|NCT00151775|594686242|FG000|Period 4: Open Label|Lost to Follow-up|0|||
164634811|NCT00151775|594686243|FG001|Period 4: Open Label|Lost to Follow-up|0|||
164634812|NCT00151775|594686244|FG002|Period 4: Open Label|Lost to Follow-up|0|||
164634813|NCT00151775|594686245|FG003|Period 4: Open Label|Lost to Follow-up|0|||
164634814|NCT00151775|594686246|FG004|Period 4: Open Label|Lost to Follow-up|17|||
164634815|NCT00151775|594686247|FG005|Period 4: Open Label|Lost to Follow-up|0|||
164634816|NCT00151775|594686248|FG006|Period 4: Open Label|Lost to Follow-up|0|||
164634817|NCT00151775|594686249|FG007|Period 4: Open Label|Lost to Follow-up|0|||
164634818|NCT00151775|594686250|FG008|Period 4: Open Label|Lost to Follow-up|0|||
164634819|NCT00151775|594686251|FG009|Period 4: Open Label|Lost to Follow-up|7|||
164634820|NCT00151775|594686252|FG010|Period 4: Open Label|Lost to Follow-up|0|||
164634821|NCT00151775|594686253|FG011|Period 4: Open Label|Lost to Follow-up|0|||
164634822|NCT00151775|594686242|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
164634823|NCT00151775|594686243|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
164634824|NCT00151775|594686244|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
164634825|NCT00151775|594686245|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
164634826|NCT00151775|594686246|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
164634827|NCT00151775|594686247|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
164634828|NCT00151775|594686248|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
164634829|NCT00151775|594686249|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
164634830|NCT00151775|594686250|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
164634831|NCT00151775|594686251|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
164634832|NCT00151775|594686252|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
164634833|NCT00151775|594686253|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
164634834|NCT00151775|594686242|FG000|Period 4: Open Label|Other|0|||
164634835|NCT00151775|594686243|FG001|Period 4: Open Label|Other|0|||
164634836|NCT00151775|594686244|FG002|Period 4: Open Label|Other|0|||
164634837|NCT00151775|594686245|FG003|Period 4: Open Label|Other|0|||
164634838|NCT00151775|594686246|FG004|Period 4: Open Label|Other|1|||
164634839|NCT00151775|594686247|FG005|Period 4: Open Label|Other|0|||
164634840|NCT00151775|594686248|FG006|Period 4: Open Label|Other|0|||
164634841|NCT00151775|594686249|FG007|Period 4: Open Label|Other|0|||
164634842|NCT00151775|594686250|FG008|Period 4: Open Label|Other|0|||
164634843|NCT00151775|594686251|FG009|Period 4: Open Label|Other|3|||
164634844|NCT00151775|594686252|FG010|Period 4: Open Label|Other|0|||
164634845|NCT00151775|594686253|FG011|Period 4: Open Label|Other|0|||
164634846|NCT00151775|594686242|FG000|Period 4: Open Label|Physician Decision|0|||
164634847|NCT00151775|594686243|FG001|Period 4: Open Label|Physician Decision|0|||
164634848|NCT00151775|594686244|FG002|Period 4: Open Label|Physician Decision|0|||
164634849|NCT00151775|594686245|FG003|Period 4: Open Label|Physician Decision|0|||
164634850|NCT00151775|594686246|FG004|Period 4: Open Label|Physician Decision|0|||
164634851|NCT00151775|594686247|FG005|Period 4: Open Label|Physician Decision|0|||
164634852|NCT00151775|594686248|FG006|Period 4: Open Label|Physician Decision|0|||
164634853|NCT00151775|594686249|FG007|Period 4: Open Label|Physician Decision|0|||
164634854|NCT00151775|594686250|FG008|Period 4: Open Label|Physician Decision|0|||
164634855|NCT00151775|594686251|FG009|Period 4: Open Label|Physician Decision|2|||
164634856|NCT00151775|594686252|FG010|Period 4: Open Label|Physician Decision|0|||
164634857|NCT00151775|594686253|FG011|Period 4: Open Label|Physician Decision|0|||
164634858|NCT00151775|594686242|FG000|Period 4: Open Label|Protocol Violation|0|||
164634859|NCT00151775|594686243|FG001|Period 4: Open Label|Protocol Violation|0|||
164634860|NCT00151775|594686244|FG002|Period 4: Open Label|Protocol Violation|0|||
164634861|NCT00151775|594686245|FG003|Period 4: Open Label|Protocol Violation|0|||
164634862|NCT00151775|594686246|FG004|Period 4: Open Label|Protocol Violation|1|||
164634863|NCT00151775|594686247|FG005|Period 4: Open Label|Protocol Violation|0|||
164634864|NCT00151775|594686248|FG006|Period 4: Open Label|Protocol Violation|0|||
164634865|NCT00151775|594686249|FG007|Period 4: Open Label|Protocol Violation|0|||
164634866|NCT00151775|594686250|FG008|Period 4: Open Label|Protocol Violation|0|||
164634867|NCT00151775|594686251|FG009|Period 4: Open Label|Protocol Violation|0|||
164634868|NCT00151775|594686252|FG010|Period 4: Open Label|Protocol Violation|0|||
164634869|NCT00151775|594686253|FG011|Period 4: Open Label|Protocol Violation|0|||
164634870|NCT00474994|594686254|FG000|Overall Study|Patient Not treated|1|||
164634871|NCT00474994|594686254|FG000|Overall Study|Patient evaluable for toxicity only|3|||
164634872|NCT00474994|594686254|FG000|Overall Study|Patient found to be ineligible|1|||
164634873|NCT05064436|594686257|FG000|Overall Study|Other Reasons|1|||
164634874|NCT05064436|594686258|FG001|Overall Study|Other Reasons|0|||
164634875|NCT01711736|594686259|FG000|Overall Study|Lost to Follow-up|4|||
164634876|NCT01711736|594686260|FG001|Overall Study|Lost to Follow-up|1|||
164634877|NCT01711736|594686259|FG000|Overall Study|Withdrawal by Subject|6|||
164634878|NCT01711736|594686260|FG001|Overall Study|Withdrawal by Subject|6|||
164634879|NCT01711736|594686259|FG000|Overall Study|Migrated/moved from study area|2|||
164634880|NCT01711736|594686260|FG001|Overall Study|Migrated/moved from study area|1|||
164634881|NCT02706327|594686261|FG000|Overall Study|Lost to Follow-up|1|||
164634882|NCT02706327|594686262|FG001|Overall Study|Lost to Follow-up|1|||
164634883|NCT02706327|594686263|FG002|Overall Study|Lost to Follow-up|2|||
164634884|NCT04579666|594686264|FG000|RTP (Up to Week 52)|Adverse Event|4|||
164634885|NCT04579666|594686265|FG001|RTP (Up to Week 52)|Adverse Event|3|||
164634886|NCT04579666|594686266|FG002|RTP (Up to Week 52)|Adverse Event|0|||
164634887|NCT04579666|594686267|FG003|RTP (Up to Week 52)|Adverse Event|0|||
164634888|NCT04579666|594686264|FG000|RTP (Up to Week 52)|Death|24|||
164634889|NCT04579666|594686265|FG001|RTP (Up to Week 52)|Death|9|||
164634890|NCT04579666|594686266|FG002|RTP (Up to Week 52)|Death|0|||
164634891|NCT04579666|594686267|FG003|RTP (Up to Week 52)|Death|0|||
164634892|NCT04579666|594686264|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
164634893|NCT04579666|594686265|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
164634894|NCT04579666|594686266|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
164634895|NCT04579666|594686267|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
164634896|NCT04579666|594686264|FG000|RTP (Up to Week 52)|Physician Decision|4|||
164634897|NCT04579666|594686265|FG001|RTP (Up to Week 52)|Physician Decision|1|||
164634898|NCT04579666|594686266|FG002|RTP (Up to Week 52)|Physician Decision|0|||
164634899|NCT04579666|594686267|FG003|RTP (Up to Week 52)|Physician Decision|0|||
164634900|NCT04579666|594686264|FG000|RTP (Up to Week 52)|Progressive disease|1|||
164634901|NCT04579666|594686265|FG001|RTP (Up to Week 52)|Progressive disease|0|||
164634902|NCT04579666|594686266|FG002|RTP (Up to Week 52)|Progressive disease|0|||
164634903|NCT04579666|594686267|FG003|RTP (Up to Week 52)|Progressive disease|0|||
164634904|NCT04579666|594686264|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
164634905|NCT04579666|594686265|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
164634906|NCT04579666|594686266|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
164634907|NCT04579666|594686267|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
164634908|NCT04579666|594686264|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
164634909|NCT04579666|594686265|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
164634910|NCT04579666|594686266|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
164634911|NCT04579666|594686267|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
164634912|NCT04579666|594686264|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
164634913|NCT04579666|594686265|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
164634914|NCT04579666|594686266|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
164634915|NCT04579666|594686267|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
164634916|NCT04579666|594686264|FG000|RTP (Up to Week 52)|Other|2|||
164634917|NCT04579666|594686265|FG001|RTP (Up to Week 52)|Other|0|||
164634918|NCT04579666|594686266|FG002|RTP (Up to Week 52)|Other|0|||
164634919|NCT04579666|594686267|FG003|RTP (Up to Week 52)|Other|0|||
164634920|NCT04579666|594686264|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
164634921|NCT04579666|594686265|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
164634922|NCT04579666|594686266|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
164634923|NCT04579666|594686267|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
164634924|NCT04579666|594686264|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
164634925|NCT04579666|594686265|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
164529842|NCT00818649|594311853|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
164529843|NCT00818649|594311853|FG000|Overall Study|Adverse Event|1|||
164529844|NCT01275131|594311854|FG000|Period 1|Withdrawal by Subject|1|||
164529845|NCT01275131|594311855|FG001|Period 1|Withdrawal by Subject|0|||
164529846|NCT01275131|594311856|FG002|Period 1|Withdrawal by Subject|3|||
164529847|NCT01275131|594311857|FG003|Period 1|Withdrawal by Subject|2|||
164529848|NCT01275131|594311854|FG000|Period 1|Physician Decision|1|||
164529849|NCT01275131|594311855|FG001|Period 1|Physician Decision|0|||
164529850|NCT01275131|594311856|FG002|Period 1|Physician Decision|0|||
164529851|NCT01275131|594311857|FG003|Period 1|Physician Decision|0|||
164529852|NCT01275131|594311854|FG000|Period 2 (Crossover)|Adverse Event|0|||
164529853|NCT01275131|594311855|FG001|Period 2 (Crossover)|Adverse Event|1|||
164529854|NCT01275131|594311856|FG002|Period 2 (Crossover)|Adverse Event|0|||
164529855|NCT01275131|594311857|FG003|Period 2 (Crossover)|Adverse Event|0|||
164529856|NCT01275131|594311854|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
164529857|NCT01275131|594311855|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
164634926|NCT04579666|594686266|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
164634927|NCT04579666|594686267|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
164634928|NCT04579666|594686264|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
164634929|NCT04579666|594686265|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
164634930|NCT04579666|594686266|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
164634931|NCT04579666|594686267|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
164634932|NCT04579666|594686264|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
164634933|NCT04579666|594686265|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
164529858|NCT01275131|594311856|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
164634934|NCT04579666|594686266|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
164634935|NCT04579666|594686267|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
164529859|NCT01275131|594311857|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
164529860|NCT02112708|594311864|FG000|Baseline|Physician Decision|16|||
164529861|NCT02112708|594311865|FG001|Baseline|Physician Decision|11|||
164529862|NCT02112708|594311864|FG000|Baseline|Lost to Follow-up|12|||
164529863|NCT02112708|594311865|FG001|Baseline|Lost to Follow-up|0|||
164529864|NCT02112708|594311864|FG000|4 Month|Death|0|||
164529865|NCT02112708|594311865|FG001|4 Month|Death|1|||
164529866|NCT02112708|594311864|FG000|4 Month|Withdrawal by Subject|12|||
164529867|NCT02112708|594311865|FG001|4 Month|Withdrawal by Subject|0|||
164529868|NCT00953745|594311866|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
164529869|NCT00953745|594311867|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
164529870|NCT00953745|594311866|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
164634936|NCT04579666|594686264|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
164634937|NCT04579666|594686265|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
164634938|NCT04579666|594686266|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
164634939|NCT04579666|594686267|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
164529871|NCT00953745|594311867|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
164634940|NCT01224171|594686268|FG000|Overall Study|Adverse Event|8|||
164634941|NCT01224171|594686269|FG001|Overall Study|Adverse Event|4|||
164634942|NCT01224171|594686268|FG000|Overall Study|Protocol Violation|0|||
164634943|NCT01224171|594686269|FG001|Overall Study|Protocol Violation|1|||
164634944|NCT01224171|594686268|FG000|Overall Study|Lack of Efficacy|5|||
164634945|NCT01224171|594686269|FG001|Overall Study|Lack of Efficacy|1|||
164634946|NCT01224171|594686268|FG000|Overall Study|Withdrawal of Consent|2|||
164634947|NCT01224171|594686269|FG001|Overall Study|Withdrawal of Consent|4|||
164634948|NCT01224171|594686268|FG000|Overall Study|Lost to Follow-up|0|||
164634949|NCT01224171|594686269|FG001|Overall Study|Lost to Follow-up|3|||
164634950|NCT01097057|594686270|FG000|Overall Study|Physician Decision|3|||
164634951|NCT00808665|594686281|FG000|Overall Study|Withdrawal by Subject|1|||
164634952|NCT00808665|594686282|FG001|Overall Study|Withdrawal by Subject|0|||
164634953|NCT00808665|594686281|FG000|Overall Study|only required minimally invasive surgery|1|||
164634954|NCT00808665|594686282|FG001|Overall Study|only required minimally invasive surgery|0|||
164634955|NCT00808665|594686281|FG000|Overall Study|surgery cancelled|1|||
164634956|NCT00808665|594686282|FG001|Overall Study|surgery cancelled|0|||
164634957|NCT00808665|594686281|FG000|Overall Study|required an additional procedure|0|||
164634958|NCT00808665|594686282|FG001|Overall Study|required an additional procedure|1|||
164634959|NCT00808665|594686281|FG000|Overall Study|Physician Decision|3|||
164634960|NCT00808665|594686282|FG001|Overall Study|Physician Decision|1|||
164634961|NCT00808665|594686281|FG000|Overall Study|Medication stopped by resident|0|||
164634962|NCT00808665|594686282|FG001|Overall Study|Medication stopped by resident|1|||
164634963|NCT01694849|594686285|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
164634964|NCT01694849|594686286|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
164634965|NCT01694849|594686287|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
164634966|NCT01694849|594686285|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
164634967|NCT01694849|594686286|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
164634968|NCT01694849|594686287|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
164634969|NCT01694849|594686285|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
164634970|NCT01694849|594686286|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
164634971|NCT01694849|594686287|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
164634972|NCT01694849|594686285|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
164634973|NCT01694849|594686286|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
164634974|NCT01694849|594686287|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
164634975|NCT01694849|594686285|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
164634976|NCT01694849|594686286|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
164634977|NCT01694849|594686287|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
164634978|NCT01694849|594686285|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
164634979|NCT01694849|594686286|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
164634980|NCT01694849|594686287|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
164634981|NCT01694849|594686285|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
164634982|NCT01694849|594686286|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
164634983|NCT01694849|594686287|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
164634984|NCT01694849|594686285|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
164634985|NCT01694849|594686286|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
164634986|NCT01694849|594686287|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
164634987|NCT00678652|594686291|FG000|Overall Study|Protocol Violation|2|||
164634988|NCT00678652|594686292|FG001|Overall Study|Protocol Violation|0|||
164634989|NCT00678652|594686293|FG002|Overall Study|Protocol Violation|0|||
164634990|NCT00678652|594686294|FG003|Overall Study|Protocol Violation|0|||
164634991|NCT00678652|594686291|FG000|Overall Study|Pregnancy|0|||
164634992|NCT00678652|594686292|FG001|Overall Study|Pregnancy|0|||
164634993|NCT00678652|594686293|FG002|Overall Study|Pregnancy|1|||
164634994|NCT00678652|594686294|FG003|Overall Study|Pregnancy|0|||
164634995|NCT00678652|594686291|FG000|Overall Study|Relocation|1|||
164634996|NCT00678652|594686292|FG001|Overall Study|Relocation|0|||
164634997|NCT00678652|594686293|FG002|Overall Study|Relocation|0|||
164634998|NCT00678652|594686294|FG003|Overall Study|Relocation|0|||
164634999|NCT05146999|594686295|FG000|Overall Study|Withdrew consent|6|||
164635000|NCT05146999|594686296|FG001|Overall Study|Withdrew consent|1|||
164635001|NCT05146999|594686295|FG000|Overall Study|Lost to Follow-up|3|||
164635002|NCT05146999|594686296|FG001|Overall Study|Lost to Follow-up|2|||
164635003|NCT05146999|594686295|FG000|Overall Study|Other|1|||
164635004|NCT05146999|594686296|FG001|Overall Study|Other|3|||
164635005|NCT03457701|594686306|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
164635006|NCT03457701|594686307|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
164635007|NCT03457701|594686306|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
164635008|NCT03457701|594686307|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
164635009|NCT03329404|594686308|FG000|Overall Study|The study was suspended.|1|||
164635010|NCT03329404|594686309|FG001|Overall Study|The study was suspended.|4|||
164635011|NCT04095039|594686310|FG000|Overall Study|Withdrawal by Subject|2|||
164635012|NCT04095039|594686311|FG001|Overall Study|Withdrawal by Subject|16|||
164635013|NCT04095039|594686310|FG000|Overall Study|Transplanted|21|||
164635014|NCT04095039|594686311|FG001|Overall Study|Transplanted|24|||
164635015|NCT04095039|594686310|FG000|Overall Study|Transferred to Non-study Facility|47|||
164635016|NCT04095039|594686311|FG001|Overall Study|Transferred to Non-study Facility|44|||
164635017|NCT04095039|594686310|FG000|Overall Study|Withdrawal from internvention target|0|||
164635018|NCT04095039|594686311|FG001|Overall Study|Withdrawal from internvention target|2|||
164635019|NCT04095039|594686310|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
164635020|NCT04095039|594686311|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
164635021|NCT04095039|594686310|FG000|Overall Study|Cacliphylaxis|0|||
164635022|NCT04095039|594686311|FG001|Overall Study|Cacliphylaxis|1|||
164635023|NCT04095039|594686310|FG000|Overall Study|Pregnancy|1|||
164635024|NCT04095039|594686311|FG001|Overall Study|Pregnancy|0|||
164635025|NCT04768881|594686312|FG000|Overall Study|Completed Study Follow-up|0|||
164635026|NCT04768881|594686313|FG001|Overall Study|Completed Study Follow-up|2|||
164635027|NCT04768881|594686312|FG000|Overall Study|Death|3|||
164635028|NCT04768881|594686313|FG001|Overall Study|Death|2|||
164635029|NCT04768881|594686312|FG000|Overall Study|Study Terminated by Sponsor|2|||
164635030|NCT04768881|594686313|FG001|Overall Study|Study Terminated by Sponsor|2|||
164635031|NCT04768881|594686312|FG000|Overall Study|Withdrawal by Subject|2|||
164635032|NCT04768881|594686313|FG001|Overall Study|Withdrawal by Subject|0|||
164635033|NCT04768881|594686312|FG000|Overall Study|Other|2|||
164635034|NCT04768881|594686313|FG001|Overall Study|Other|0|||
164635035|NCT04236986|594686316|FG000|Overall Study|Withdrawal by Subject|3|||
164635036|NCT04236986|594686317|FG001|Overall Study|Withdrawal by Subject|1|||
164635037|NCT01365182|594686320|FG000|Overall Study|Withdrawal by Subject|10|||
164635038|NCT01365182|594686321|FG001|Overall Study|Withdrawal by Subject|13|||
164635039|NCT01365182|594686322|FG002|Overall Study|Withdrawal by Subject|12|||
164635040|NCT00736840|594686323|FG000|Overall Study|Lost to Follow-up|13|||
164635041|NCT01728194|594686328|FG000|Overall Study|Lost to Follow-up|4|||
164635042|NCT01728194|594686329|FG001|Overall Study|Lost to Follow-up|3|||
164635043|NCT01728194|594686328|FG000|Overall Study|Physician Decision|4|||
164635044|NCT01728194|594686329|FG001|Overall Study|Physician Decision|0|||
164635045|NCT01728194|594686328|FG000|Overall Study|Withdrawal by Subject|7|||
164635046|NCT01728194|594686329|FG001|Overall Study|Withdrawal by Subject|3|||
164635047|NCT01728194|594686328|FG000|Overall Study|Perceived Medication Side Effects|4|||
164635048|NCT01728194|594686329|FG001|Overall Study|Perceived Medication Side Effects|0|||
164635049|NCT01728194|594686328|FG000|Overall Study|Family Member Request|1|||
164635050|NCT01728194|594686329|FG001|Overall Study|Family Member Request|0|||
164635051|NCT02309372|594686330|FG000|Overall Study|Lost to Follow-up|3|||
164635052|NCT02309372|594686331|FG001|Overall Study|Lost to Follow-up|2|||
164635053|NCT01475214|594686334|FG000|Overall Study|Lost to Follow-up|1|||
164635054|NCT01475214|594686335|FG001|Overall Study|Lost to Follow-up|0|||
164635055|NCT01475214|594686336|FG002|Overall Study|Lost to Follow-up|1|||
164635056|NCT01475214|594686334|FG000|Overall Study|Physician Decision|2|||
164635057|NCT01475214|594686335|FG001|Overall Study|Physician Decision|0|||
164635058|NCT01475214|594686336|FG002|Overall Study|Physician Decision|0|||
164635059|NCT01475214|594686334|FG000|Overall Study|Withdrawal by Subject|2|||
164635060|NCT01475214|594686335|FG001|Overall Study|Withdrawal by Subject|4|||
164635061|NCT01475214|594686336|FG002|Overall Study|Withdrawal by Subject|1|||
164635062|NCT00643851|594686337|FG000|Overall Study|Death|0|||
164635063|NCT00643851|594686338|FG001|Overall Study|Death|1|||
164635064|NCT00643851|594686339|FG002|Overall Study|Death|0|||
164635065|NCT00643851|594686337|FG000|Overall Study|Lack of Efficacy|0|||
164635066|NCT00643851|594686338|FG001|Overall Study|Lack of Efficacy|1|||
164635067|NCT00643851|594686339|FG002|Overall Study|Lack of Efficacy|0|||
164635068|NCT00643851|594686337|FG000|Overall Study|Adverse Event|2|||
164635069|NCT00643851|594686338|FG001|Overall Study|Adverse Event|6|||
164635070|NCT00643851|594686339|FG002|Overall Study|Adverse Event|6|||
164635071|NCT00643851|594686337|FG000|Overall Study|Lost to Follow-up|4|||
164635072|NCT00643851|594686338|FG001|Overall Study|Lost to Follow-up|6|||
164635073|NCT00643851|594686339|FG002|Overall Study|Lost to Follow-up|9|||
164635074|NCT00643851|594686337|FG000|Overall Study|Withdrawal by Subject|8|||
164635075|NCT00643851|594686338|FG001|Overall Study|Withdrawal by Subject|15|||
164635076|NCT00643851|594686339|FG002|Overall Study|Withdrawal by Subject|9|||
164635077|NCT00643851|594686337|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
164635078|NCT00643851|594686338|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
164635079|NCT00643851|594686339|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
164635080|NCT03289676|594686340|FG000|Overall Study|Withdrawal by Subject|2|||
164635081|NCT03289676|594686341|FG001|Overall Study|Withdrawal by Subject|0|||
164635082|NCT03289676|594686340|FG000|Overall Study|Protocol Violation|2|||
164635083|NCT03289676|594686341|FG001|Overall Study|Protocol Violation|0|||
164635084|NCT03289676|594686340|FG000|Overall Study|Lost to Follow-up|0|||
164635085|NCT03289676|594686341|FG001|Overall Study|Lost to Follow-up|1|||
164635086|NCT01314261|594686344|FG000|Overall Study|Adverse Event|1|||
164635087|NCT01314261|594686345|FG001|Overall Study|Adverse Event|0|||
164635088|NCT01314261|594686346|FG002|Overall Study|Adverse Event|0|||
164635089|NCT01314261|594686347|FG003|Overall Study|Adverse Event|0|||
164635090|NCT01314261|594686344|FG000|Overall Study|Withdrawal by Subject|0|||
164635091|NCT01314261|594686345|FG001|Overall Study|Withdrawal by Subject|3|||
164635092|NCT01314261|594686346|FG002|Overall Study|Withdrawal by Subject|1|||
164635093|NCT01314261|594686347|FG003|Overall Study|Withdrawal by Subject|0|||
164635094|NCT01314261|594686344|FG000|Overall Study|Lost to Follow-up|1|||
164635095|NCT01314261|594686345|FG001|Overall Study|Lost to Follow-up|0|||
164635096|NCT01314261|594686346|FG002|Overall Study|Lost to Follow-up|2|||
164635097|NCT01314261|594686347|FG003|Overall Study|Lost to Follow-up|2|||
164635098|NCT01314261|594686344|FG000|Overall Study|Virologic Failure|0|||
164635099|NCT01314261|594686345|FG001|Overall Study|Virologic Failure|1|||
164635100|NCT01314261|594686346|FG002|Overall Study|Virologic Failure|0|||
164635101|NCT01314261|594686347|FG003|Overall Study|Virologic Failure|1|||
164635102|NCT01231620|594686348|FG000|Overall Study|Physician Decision|3|||
164635103|NCT01231620|594686349|FG001|Overall Study|Physician Decision|5|||
164635104|NCT01231620|594686350|FG002|Overall Study|Physician Decision|10|||
164635105|NCT01231620|594686348|FG000|Overall Study|Death|12|||
164635106|NCT01231620|594686349|FG001|Overall Study|Death|14|||
164635107|NCT01231620|594686350|FG002|Overall Study|Death|11|||
164635108|NCT01231620|594686348|FG000|Overall Study|Adverse Event|2|||
164635109|NCT01231620|594686349|FG001|Overall Study|Adverse Event|2|||
164635110|NCT01231620|594686350|FG002|Overall Study|Adverse Event|1|||
164635111|NCT01231620|594686348|FG000|Overall Study|Withdrawal by Subject|6|||
164635112|NCT01231620|594686349|FG001|Overall Study|Withdrawal by Subject|6|||
164635113|NCT01231620|594686350|FG002|Overall Study|Withdrawal by Subject|8|||
164635114|NCT01231620|594686348|FG000|Overall Study|Lost to Follow-up|3|||
164635115|NCT01231620|594686349|FG001|Overall Study|Lost to Follow-up|4|||
164635116|NCT01231620|594686350|FG002|Overall Study|Lost to Follow-up|9|||
164635117|NCT02576652|594686354|FG000|Overall Study|Withdrawal by Subject|2|||
164635118|NCT04806334|594686359|FG000|Overall Study|Withdrawal by Subject|1|||
164635119|NCT02811640|594686360|FG000|Overall Study|Technology malfunction|2|||
164635120|NCT03590613|594686371|FG000|Period 2, 4 Days|Physician Decision|0|||
164635121|NCT03590613|594686372|FG001|Period 2, 4 Days|Physician Decision|0|||
164635122|NCT03590613|594686373|FG002|Period 2, 4 Days|Physician Decision|0|||
164635123|NCT03590613|594686374|FG003|Period 2, 4 Days|Physician Decision|1|||
164635124|NCT00951912|594686375|FG000|Overall Study|Lack of Efficacy|1|||
164635125|NCT00951912|594686376|FG001|Overall Study|Lack of Efficacy|0|||
164635126|NCT00951912|594686377|FG002|Overall Study|Lack of Efficacy|0|||
164635127|NCT00951912|594686375|FG000|Overall Study|Adverse Event|0|||
164635128|NCT00951912|594686376|FG001|Overall Study|Adverse Event|1|||
164635129|NCT00951912|594686377|FG002|Overall Study|Adverse Event|1|||
164635130|NCT00951912|594686375|FG000|Overall Study|Lost to Follow-up|2|||
164635131|NCT00951912|594686376|FG001|Overall Study|Lost to Follow-up|2|||
164635132|NCT00951912|594686377|FG002|Overall Study|Lost to Follow-up|0|||
164635133|NCT00951912|594686375|FG000|Overall Study|Physician Decision|1|||
164635134|NCT00951912|594686376|FG001|Overall Study|Physician Decision|0|||
164635135|NCT00951912|594686377|FG002|Overall Study|Physician Decision|1|||
164635136|NCT00951912|594686375|FG000|Overall Study|Withdrawal by Subject|1|||
164635137|NCT00951912|594686376|FG001|Overall Study|Withdrawal by Subject|1|||
164635138|NCT00951912|594686377|FG002|Overall Study|Withdrawal by Subject|0|||
164635139|NCT00951912|594686375|FG000|Overall Study|Other:Depression|1|||
164635140|NCT00951912|594686376|FG001|Overall Study|Other:Depression|0|||
164635141|NCT00951912|594686377|FG002|Overall Study|Other:Depression|0|||
164635142|NCT00951912|594686375|FG000|Overall Study|Other: Colon cancer|1|||
164635143|NCT00951912|594686376|FG001|Overall Study|Other: Colon cancer|0|||
164635144|NCT00951912|594686377|FG002|Overall Study|Other: Colon cancer|0|||
164635145|NCT00951912|594686375|FG000|Overall Study|Other: Stroke|0|||
164635146|NCT00951912|594686376|FG001|Overall Study|Other: Stroke|1|||
164635147|NCT00951912|594686377|FG002|Overall Study|Other: Stroke|0|||
164635148|NCT01377194|594686378|FG000|Overall Study|Adverse Event|3|||
164635149|NCT01377194|594686379|FG001|Overall Study|Adverse Event|12|||
164635150|NCT01377194|594686380|FG002|Overall Study|Adverse Event|19|||
164635151|NCT01377194|594686378|FG000|Overall Study|Lack of Efficacy|3|||
164635152|NCT01377194|594686379|FG001|Overall Study|Lack of Efficacy|3|||
164635153|NCT01377194|594686380|FG002|Overall Study|Lack of Efficacy|3|||
164635154|NCT01377194|594686378|FG000|Overall Study|Protocol Violation|4|||
164635155|NCT01377194|594686379|FG001|Overall Study|Protocol Violation|10|||
164635156|NCT01377194|594686380|FG002|Overall Study|Protocol Violation|6|||
164635157|NCT01377194|594686378|FG000|Overall Study|Withdrawal by Subject|8|||
164635158|NCT01377194|594686379|FG001|Overall Study|Withdrawal by Subject|10|||
164635159|NCT01377194|594686380|FG002|Overall Study|Withdrawal by Subject|7|||
164635160|NCT01377194|594686378|FG000|Overall Study|Lost to Follow-up|14|||
164635161|NCT01377194|594686379|FG001|Overall Study|Lost to Follow-up|8|||
164635162|NCT01377194|594686380|FG002|Overall Study|Lost to Follow-up|11|||
164635163|NCT00422227|594686381|FG000|Overall Study|Adverse Event|3|||
164635164|NCT00422227|594686382|FG001|Overall Study|Adverse Event|8|||
164635165|NCT00422227|594686381|FG000|Overall Study|Lost to Follow-up|1|||
164635166|NCT00422227|594686382|FG001|Overall Study|Lost to Follow-up|3|||
164635167|NCT00422227|594686381|FG000|Overall Study|Withdrawal by Subject|0|||
164635168|NCT00422227|594686382|FG001|Overall Study|Withdrawal by Subject|4|||
164635169|NCT01207427|594686383|FG000|Double-blind Treatment Period|Adverse Event|0|||
164635170|NCT01207427|594686384|FG001|Double-blind Treatment Period|Adverse Event|1|||
164635171|NCT01207427|594686385|FG002|Double-blind Treatment Period|Adverse Event|0|||
164635172|NCT01207427|594686383|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
164635173|NCT01207427|594686384|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
164635174|NCT01207427|594686385|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
164635175|NCT01207427|594686383|FG000|Double-blind Treatment Period|Protocol Violation|2|||
164635176|NCT01207427|594686384|FG001|Double-blind Treatment Period|Protocol Violation|1|||
164635177|NCT01207427|594686385|FG002|Double-blind Treatment Period|Protocol Violation|1|||
164635178|NCT01207427|594686383|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
164635179|NCT01207427|594686384|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
164635180|NCT01207427|594686385|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
164635181|NCT03323034|594688323|FG000|Overall Study|Lack of Efficacy|5|||
164635182|NCT03323034|594688324|FG001|Overall Study|Lack of Efficacy|5|||
164635183|NCT03323034|594688325|FG002|Overall Study|Lack of Efficacy|6|||
164635184|NCT03323034|594688326|FG003|Overall Study|Lack of Efficacy|5|||
164635185|NCT03323034|594688327|FG004|Overall Study|Lack of Efficacy|5|||
164635186|NCT03323034|594688323|FG000|Overall Study|Physician Decision|0|||
164635187|NCT03323034|594688324|FG001|Overall Study|Physician Decision|0|||
164635188|NCT03323034|594688325|FG002|Overall Study|Physician Decision|0|||
164635189|NCT03323034|594688326|FG003|Overall Study|Physician Decision|0|||
164635190|NCT03323034|594688327|FG004|Overall Study|Physician Decision|1|||
164635191|NCT03323034|594688323|FG000|Overall Study|Withdrawal by Subject|1|||
164635192|NCT03323034|594688324|FG001|Overall Study|Withdrawal by Subject|1|||
164635193|NCT03323034|594688325|FG002|Overall Study|Withdrawal by Subject|0|||
164635194|NCT03323034|594688326|FG003|Overall Study|Withdrawal by Subject|1|||
164635195|NCT03323034|594688327|FG004|Overall Study|Withdrawal by Subject|0|||
164635196|NCT02646566|594688329|FG000|Overall Study|Lost to Follow-up|5|||
164635197|NCT02646566|594688330|FG001|Overall Study|Lost to Follow-up|4|||
164635198|NCT02646566|594688331|FG002|Overall Study|Lost to Follow-up|5|||
164635199|NCT02646566|594688329|FG000|Overall Study|Treatment failure|1|||
164635200|NCT02646566|594688330|FG001|Overall Study|Treatment failure|0|||
164635201|NCT02646566|594688331|FG002|Overall Study|Treatment failure|0|||
164635202|NCT04341727|594688339|FG000|Overall Study|Withdrawal by Subject|0|||
164635203|NCT04341727|594688340|FG001|Overall Study|Withdrawal by Subject|0|||
164635204|NCT04341727|594688341|FG002|Overall Study|Withdrawal by Subject|1|||
164635205|NCT04341727|594688342|FG003|Overall Study|Withdrawal by Subject|0|||
164635206|NCT04341727|594688339|FG000|Overall Study|Lost to Follow-up|0|||
164635207|NCT04341727|594688340|FG001|Overall Study|Lost to Follow-up|0|||
164635208|NCT04341727|594688341|FG002|Overall Study|Lost to Follow-up|0|||
164635209|NCT04341727|594688342|FG003|Overall Study|Lost to Follow-up|1|||
164635210|NCT00503035|594688343|FG000|Overall Study|Lost to Follow-up|2|||
164635211|NCT00503035|594688343|FG000|Overall Study|Physician Decision|3|||
164635212|NCT00503035|594688343|FG000|Overall Study|Ineligible|15|||
164635213|NCT05028816|594688346|FG000|Overall Study|Lost to Follow-up|5|||
164635214|NCT05028816|594688347|FG001|Overall Study|Lost to Follow-up|3|||
164635215|NCT05028816|594688346|FG000|Overall Study|Withdrawal by Subject|4|||
164635216|NCT05028816|594688347|FG001|Overall Study|Withdrawal by Subject|1|||
164635217|NCT05028816|594688346|FG000|Overall Study|Physician Decision|1|||
164635218|NCT05028816|594688347|FG001|Overall Study|Physician Decision|0|||
164635219|NCT05450198|594688354|FG000|Overall Study|Withdrawal by Subject|1|||
164635220|NCT05450198|594688355|FG001|Overall Study|Withdrawal by Subject|1|||
164635221|NCT05450198|594688356|FG002|Overall Study|Withdrawal by Subject|2|||
164635222|NCT05450198|594688357|FG003|Overall Study|Withdrawal by Subject|0|||
164635223|NCT05450198|594688354|FG000|Overall Study|Lost to Follow-up|1|||
164635224|NCT05450198|594688355|FG001|Overall Study|Lost to Follow-up|0|||
164635225|NCT05450198|594688356|FG002|Overall Study|Lost to Follow-up|2|||
164635226|NCT05450198|594688357|FG003|Overall Study|Lost to Follow-up|1|||
164635227|NCT04576702|594688358|FG000|Overall Study|Death|1|||
164635228|NCT04576702|594688359|FG001|Overall Study|Death|0|||
164635229|NCT04576702|594688360|FG002|Overall Study|Death|0|||
164635230|NCT04576702|594688361|FG003|Overall Study|Death|0|||
164635231|NCT04576702|594688358|FG000|Overall Study|Withdrawal by Subject|0|||
164635232|NCT04576702|594688359|FG001|Overall Study|Withdrawal by Subject|2|||
164635233|NCT04576702|594688360|FG002|Overall Study|Withdrawal by Subject|1|||
164635234|NCT04576702|594688361|FG003|Overall Study|Withdrawal by Subject|0|||
164635235|NCT04576702|594688358|FG000|Overall Study|Lost to Follow-up|3|||
164635236|NCT04576702|594688359|FG001|Overall Study|Lost to Follow-up|3|||
164635237|NCT04576702|594688360|FG002|Overall Study|Lost to Follow-up|3|||
164635238|NCT04576702|594688361|FG003|Overall Study|Lost to Follow-up|4|||
164635239|NCT01151085|594688362|FG000|Overall Study|Lost to Follow-up|31|||
164635240|NCT01151085|594688362|FG000|Overall Study|Protocol Violation|25|||
164635241|NCT00003526|594688363|FG000|Overall Study|Not evaluable|6|||
164635242|NCT02059265|594688364|FG000|Overall Study|Ineligible|4|||
164635243|NCT02985996|594688368|FG000|Overall Study|Withdrawal by Subject|0|||
164635244|NCT02985996|594688369|FG001|Overall Study|Withdrawal by Subject|0|||
164635245|NCT02985996|594688370|FG002|Overall Study|Withdrawal by Subject|1|||
164635246|NCT02985996|594688371|FG003|Overall Study|Withdrawal by Subject|0|||
164635247|NCT02985996|594688372|FG004|Overall Study|Withdrawal by Subject|0|||
164635248|NCT02985996|594688368|FG000|Overall Study|Protocol Violation|0|||
164635249|NCT02985996|594688369|FG001|Overall Study|Protocol Violation|1|||
164635250|NCT02985996|594688370|FG002|Overall Study|Protocol Violation|0|||
164635251|NCT02985996|594688371|FG003|Overall Study|Protocol Violation|0|||
164635252|NCT02985996|594688372|FG004|Overall Study|Protocol Violation|0|||
164635253|NCT00401726|594688373|FG000|Overall Study|Adverse Event|34|||
164635254|NCT00401726|594688374|FG001|Overall Study|Adverse Event|45|||
164635255|NCT00401726|594688373|FG000|Overall Study|Death|0|||
164635256|NCT00401726|594688374|FG001|Overall Study|Death|3|||
164635257|NCT00401726|594688373|FG000|Overall Study|Sponsor Request|0|||
164635258|NCT00401726|594688374|FG001|Overall Study|Sponsor Request|1|||
164635259|NCT00401726|594688373|FG000|Overall Study|Physician Decision|3|||
164635260|NCT00401726|594688374|FG001|Overall Study|Physician Decision|6|||
164635261|NCT00401726|594688373|FG000|Overall Study|Lost to Follow-up|23|||
164635262|NCT00401726|594688374|FG001|Overall Study|Lost to Follow-up|20|||
164635263|NCT00401726|594688373|FG000|Overall Study|Protocol Violation|6|||
164635264|NCT00401726|594688374|FG001|Overall Study|Protocol Violation|3|||
164635265|NCT00401726|594688373|FG000|Overall Study|Withdrawal by Subject|18|||
164635266|NCT00401726|594688374|FG001|Overall Study|Withdrawal by Subject|24|||
164635267|NCT00401726|594688373|FG000|Overall Study|Lack of Efficacy|4|||
164635268|NCT00401726|594688374|FG001|Overall Study|Lack of Efficacy|6|||
164635269|NCT00401726|594688373|FG000|Overall Study|Protocol Deviation|9|||
164635270|NCT00401726|594688374|FG001|Overall Study|Protocol Deviation|4|||
164635271|NCT00814502|594688377|FG000|Overall Study|Adverse Event|1|||
164635272|NCT00814502|594688378|FG001|Overall Study|Adverse Event|0|||
164635273|NCT00814502|594688377|FG000|Overall Study|Withdrawal by Subject|0|||
164635274|NCT00814502|594688378|FG001|Overall Study|Withdrawal by Subject|2|||
164635275|NCT03735849|594688380|FG000|Overall Study|Lost to Follow-up|1|||
164635276|NCT03735849|594688381|FG001|Overall Study|Lost to Follow-up|0|||
164635277|NCT03735849|594688382|FG002|Overall Study|Lost to Follow-up|0|||
164635278|NCT03735849|594688380|FG000|Overall Study|Participant unable to adhere to visit|1|||
164635279|NCT03735849|594688381|FG001|Overall Study|Participant unable to adhere to visit|0|||
164635280|NCT03735849|594688382|FG002|Overall Study|Participant unable to adhere to visit|0|||
164635281|NCT03735849|594688380|FG000|Overall Study|Not Randomized|0|||
164635282|NCT03735849|594688381|FG001|Overall Study|Not Randomized|0|||
164635283|NCT03735849|594688382|FG002|Overall Study|Not Randomized|4|||
164635284|NCT01050998|594688385|FG000|Overall Study|Adverse Event|1|||
164635285|NCT01050998|594688386|FG001|Overall Study|Adverse Event|0|||
164635286|NCT01050998|594688387|FG002|Overall Study|Adverse Event|1|||
164635287|NCT01050998|594688388|FG003|Overall Study|Adverse Event|0|||
164635288|NCT01050998|594688389|FG004|Overall Study|Adverse Event|2|||
164635289|NCT01050998|594688385|FG000|Overall Study|Withdrawal by Subject|0|||
164635290|NCT01050998|594688386|FG001|Overall Study|Withdrawal by Subject|0|||
164635291|NCT01050998|594688387|FG002|Overall Study|Withdrawal by Subject|0|||
164635292|NCT01050998|594688388|FG003|Overall Study|Withdrawal by Subject|1|||
164635293|NCT01050998|594688389|FG004|Overall Study|Withdrawal by Subject|3|||
164635294|NCT01050998|594688385|FG000|Overall Study|Other|3|||
164635295|NCT01050998|594688386|FG001|Overall Study|Other|2|||
164635296|NCT01050998|594688387|FG002|Overall Study|Other|1|||
164635297|NCT01050998|594688388|FG003|Overall Study|Other|1|||
164635298|NCT01050998|594688389|FG004|Overall Study|Other|5|||
164635299|NCT01050998|594688385|FG000|Overall Study|Data integrity issues|0|||
164635300|NCT01050998|594688386|FG001|Overall Study|Data integrity issues|0|||
164635301|NCT01050998|594688387|FG002|Overall Study|Data integrity issues|1|||
164635302|NCT01050998|594688388|FG003|Overall Study|Data integrity issues|1|||
164635303|NCT01050998|594688389|FG004|Overall Study|Data integrity issues|4|||
164635304|NCT01012765|594688396|FG000|Treatment Period 1|Adverse Event|1|||
164635305|NCT01012765|594688397|FG001|Treatment Period 1|Adverse Event|0|||
164635306|NCT01012765|594688398|FG002|Treatment Period 1|Adverse Event|1|||
164635307|NCT01012765|594688399|FG003|Treatment Period 1|Adverse Event|0|||
164635308|NCT01012765|594688400|FG004|Treatment Period 1|Adverse Event|0|||
164635309|NCT01012765|594688401|FG005|Treatment Period 1|Adverse Event|0|||
164635310|NCT01012765|594688396|FG000|Treatment Period 1|Withdrawal by Subject|2|||
164635311|NCT01012765|594688397|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164635312|NCT01012765|594688398|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164635313|NCT01012765|594688399|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164635314|NCT01012765|594688400|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164635315|NCT01012765|594688401|FG005|Treatment Period 1|Withdrawal by Subject|0|||
164635316|NCT01012765|594688396|FG000|Treatment Period 1|Administrative problems|0|||
164635317|NCT01012765|594688397|FG001|Treatment Period 1|Administrative problems|0|||
164635318|NCT01012765|594688398|FG002|Treatment Period 1|Administrative problems|1|||
164635319|NCT01012765|594688399|FG003|Treatment Period 1|Administrative problems|1|||
164635320|NCT01012765|594688400|FG004|Treatment Period 1|Administrative problems|1|||
164635321|NCT01012765|594688401|FG005|Treatment Period 1|Administrative problems|0|||
164635322|NCT01012765|594688396|FG000|Treatment Period 1|Protocol Violation|0|||
164635323|NCT01012765|594688397|FG001|Treatment Period 1|Protocol Violation|0|||
164635324|NCT01012765|594688398|FG002|Treatment Period 1|Protocol Violation|0|||
164635325|NCT01012765|594688399|FG003|Treatment Period 1|Protocol Violation|2|||
164635326|NCT01012765|594688400|FG004|Treatment Period 1|Protocol Violation|1|||
164635327|NCT01012765|594688401|FG005|Treatment Period 1|Protocol Violation|0|||
164635328|NCT01012765|594688396|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
164635329|NCT01012765|594688397|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
164635330|NCT01012765|594688398|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
164635331|NCT01012765|594688399|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
164635332|NCT01012765|594688400|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
164635333|NCT01012765|594688401|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
164635334|NCT01012765|594688396|FG000|Treatment Period 2|Withdrawal by Subject|1|||
164635335|NCT01012765|594688397|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164635336|NCT01012765|594688398|FG002|Treatment Period 2|Withdrawal by Subject|1|||
164635337|NCT01012765|594688399|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164635338|NCT01012765|594688400|FG004|Treatment Period 2|Withdrawal by Subject|1|||
164635339|NCT01012765|594688401|FG005|Treatment Period 2|Withdrawal by Subject|0|||
164635340|NCT01012765|594688396|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
164635341|NCT01012765|594688397|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
164635342|NCT01012765|594688398|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
164635343|NCT01012765|594688399|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
164635344|NCT01012765|594688400|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
164635345|NCT01012765|594688401|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
164635346|NCT01012765|594688396|FG000|Treatment Period 2|Adverse Event|0|||
164635347|NCT01012765|594688397|FG001|Treatment Period 2|Adverse Event|1|||
164635348|NCT01012765|594688398|FG002|Treatment Period 2|Adverse Event|1|||
164635349|NCT01012765|594688399|FG003|Treatment Period 2|Adverse Event|0|||
164635350|NCT01012765|594688400|FG004|Treatment Period 2|Adverse Event|0|||
164635351|NCT01012765|594688401|FG005|Treatment Period 2|Adverse Event|0|||
164635352|NCT01012765|594688396|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
164635353|NCT01012765|594688397|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
164635354|NCT01012765|594688398|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
164635355|NCT01012765|594688399|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
164635356|NCT01012765|594688400|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
164635357|NCT01012765|594688401|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
164635358|NCT01326312|594688402|FG000|Overall Study|Adverse Event|11|||
164635359|NCT01326312|594688403|FG001|Overall Study|Adverse Event|11|||
164635360|NCT01326312|594688404|FG002|Overall Study|Adverse Event|1|||
164635361|NCT01326312|594688402|FG000|Overall Study|Withdrawal by Subject|1|||
164635362|NCT01326312|594688403|FG001|Overall Study|Withdrawal by Subject|2|||
164635363|NCT01326312|594688404|FG002|Overall Study|Withdrawal by Subject|1|||
164635364|NCT01326312|594688402|FG000|Overall Study|Protocol Violation|0|||
164635365|NCT01326312|594688403|FG001|Overall Study|Protocol Violation|1|||
164635366|NCT01326312|594688404|FG002|Overall Study|Protocol Violation|0|||
164635367|NCT01326312|594688402|FG000|Overall Study|Lack of Efficacy|13|||
164635368|NCT01326312|594688403|FG001|Overall Study|Lack of Efficacy|7|||
164635369|NCT01326312|594688404|FG002|Overall Study|Lack of Efficacy|1|||
164635370|NCT01326312|594688402|FG000|Overall Study|Death|1|||
164635371|NCT01326312|594688403|FG001|Overall Study|Death|0|||
164635372|NCT01326312|594688404|FG002|Overall Study|Death|1|||
164635373|NCT01326312|594688402|FG000|Overall Study|progressive disease|0|||
164635374|NCT01326312|594688403|FG001|Overall Study|progressive disease|1|||
164635375|NCT01326312|594688404|FG002|Overall Study|progressive disease|1|||
164635376|NCT01326312|594688402|FG000|Overall Study|Study terminated by Sponsor|8|||
164635377|NCT01326312|594688403|FG001|Overall Study|Study terminated by Sponsor|32|||
164635378|NCT01326312|594688404|FG002|Overall Study|Study terminated by Sponsor|46|||
164635379|NCT01326312|594688402|FG000|Overall Study|Treatment arm terminated|19|||
164635380|NCT01326312|594688403|FG001|Overall Study|Treatment arm terminated|0|||
164635381|NCT01326312|594688404|FG002|Overall Study|Treatment arm terminated|0|||
164635382|NCT01326312|594688402|FG000|Overall Study|QTc > 500|0|||
164635383|NCT01326312|594688403|FG001|Overall Study|QTc > 500|1|||
164635384|NCT01326312|594688404|FG002|Overall Study|QTc > 500|0|||
164635385|NCT04668157|594688414|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
164635386|NCT04668157|594688415|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
164635387|NCT04668157|594688414|FG000|Treatment Period (52 Weeks)|Other|0|||
164635388|NCT04668157|594688415|FG001|Treatment Period (52 Weeks)|Other|2|||
164635389|NCT02283411|594688416|FG000|Overall Study|Withdrawal by Subject|3|||
164635390|NCT02283411|594688416|FG000|Overall Study|Screen Failed|28|||
164635391|NCT00383292|594688417|FG000|Overall Study|Adverse Event|4|||
164148525|NCT01823835|592904896|FG004|Overall Study|Study Termination|1|||
164635392|NCT00383292|594688418|FG001|Overall Study|Adverse Event|1|||
164635393|NCT00383292|594688419|FG002|Overall Study|Adverse Event|2|||
164635394|NCT00383292|594688417|FG000|Overall Study|Death|3|||
164635395|NCT00383292|594688418|FG001|Overall Study|Death|3|||
164635396|NCT00383292|594688419|FG002|Overall Study|Death|3|||
164635397|NCT00383292|594688417|FG000|Overall Study|Physician Decision|4|||
164635398|NCT00383292|594688418|FG001|Overall Study|Physician Decision|0|||
164635399|NCT00383292|594688419|FG002|Overall Study|Physician Decision|1|||
164635400|NCT00383292|594688417|FG000|Overall Study|Withdrawal by Subject|3|||
164635401|NCT00383292|594688418|FG001|Overall Study|Withdrawal by Subject|2|||
164635402|NCT00383292|594688419|FG002|Overall Study|Withdrawal by Subject|2|||
164635403|NCT00383292|594688417|FG000|Overall Study|Other|1|||
164635404|NCT00383292|594688418|FG001|Overall Study|Other|0|||
164635405|NCT00383292|594688419|FG002|Overall Study|Other|0|||
164635406|NCT05437211|594688420|FG000|Overall Study|Patient's decision|1|||
164635407|NCT05437211|594688421|FG001|Overall Study|Patient's decision|1|||
164635408|NCT03282123|594688423|FG000|Overall Study|Withdrawal by Subject|5|||
164635409|NCT02243306|594688424|FG000|Overall Study|Adverse Event|0|||
164635410|NCT02243306|594688425|FG001|Overall Study|Adverse Event|1|||
164635411|NCT02243306|594688424|FG000|Overall Study|Other: Reached stopping criteria|0|||
164635412|NCT02243306|594688425|FG001|Overall Study|Other: Reached stopping criteria|1|||
164635413|NCT02243306|594688424|FG000|Overall Study|Physician Decision|0|||
164635414|NCT02243306|594688425|FG001|Overall Study|Physician Decision|1|||
164635415|NCT02221882|594688429|FG000|Overall Study|Withdrawal by Subject|0|||
164635416|NCT02221882|594688430|FG001|Overall Study|Withdrawal by Subject|0|||
164635417|NCT02221882|594688431|FG002|Overall Study|Withdrawal by Subject|4|||
164635418|NCT02221882|594688432|FG003|Overall Study|Withdrawal by Subject|2|||
164635419|NCT02221882|594688433|FG004|Overall Study|Withdrawal by Subject|2|||
164635420|NCT02221882|594688434|FG005|Overall Study|Withdrawal by Subject|2|||
164635421|NCT02221882|594688429|FG000|Overall Study|Death|0|||
164635422|NCT02221882|594688430|FG001|Overall Study|Death|1|||
164635423|NCT02221882|594688431|FG002|Overall Study|Death|0|||
164635424|NCT02221882|594688432|FG003|Overall Study|Death|0|||
164635425|NCT02221882|594688433|FG004|Overall Study|Death|0|||
164635426|NCT02221882|594688434|FG005|Overall Study|Death|0|||
164635427|NCT00796367|594688435|FG000|Overall Study|Adverse Event|6|||
164635428|NCT00796367|594688436|FG001|Overall Study|Adverse Event|4|||
164635429|NCT00796367|594688437|FG002|Overall Study|Adverse Event|7|||
164635430|NCT00796367|594688435|FG000|Overall Study|Lost to Follow-up|5|||
164635431|NCT00796367|594688436|FG001|Overall Study|Lost to Follow-up|4|||
164635432|NCT00796367|594688437|FG002|Overall Study|Lost to Follow-up|21|||
164635433|NCT00796367|594688435|FG000|Overall Study|Withdrawal by Subject|9|||
164635434|NCT00796367|594688436|FG001|Overall Study|Withdrawal by Subject|11|||
164635435|NCT00796367|594688437|FG002|Overall Study|Withdrawal by Subject|12|||
164635436|NCT00796367|594688435|FG000|Overall Study|Lack of Efficacy|2|||
164635437|NCT00796367|594688436|FG001|Overall Study|Lack of Efficacy|1|||
164635438|NCT00796367|594688437|FG002|Overall Study|Lack of Efficacy|0|||
164635439|NCT00796367|594688435|FG000|Overall Study|non compliance|3|||
164635440|NCT00796367|594688436|FG001|Overall Study|non compliance|1|||
164635441|NCT00796367|594688437|FG002|Overall Study|non compliance|1|||
164635442|NCT00796367|594688435|FG000|Overall Study|Pregnancy|1|||
164635443|NCT00796367|594688436|FG001|Overall Study|Pregnancy|0|||
164635444|NCT00796367|594688437|FG002|Overall Study|Pregnancy|1|||
164635445|NCT00796367|594688435|FG000|Overall Study|Requirement for restricted medication|2|||
164635446|NCT00796367|594688436|FG001|Overall Study|Requirement for restricted medication|0|||
164635447|NCT00796367|594688437|FG002|Overall Study|Requirement for restricted medication|2|||
164635448|NCT00796367|594688435|FG000|Overall Study|other|2|||
164635449|NCT00796367|594688436|FG001|Overall Study|other|4|||
164635450|NCT00796367|594688437|FG002|Overall Study|other|3|||
164635451|NCT02370173|594688445|FG000|Overall Study|Protocol Violation|1|||
164635452|NCT02370173|594688446|FG001|Overall Study|Protocol Violation|1|||
164635453|NCT02370173|594688445|FG000|Overall Study|Withdrawal by Subject|2|||
164635454|NCT02370173|594688446|FG001|Overall Study|Withdrawal by Subject|2|||
164635455|NCT00307736|594688451|FG000|Overall Study|Adverse Event|0|||
164635456|NCT00307736|594688452|FG001|Overall Study|Adverse Event|0|||
164635457|NCT00307736|594688453|FG002|Overall Study|Adverse Event|1|||
164635458|NCT00307736|594688454|FG003|Overall Study|Adverse Event|3|||
164635459|NCT00307736|594688451|FG000|Overall Study|Withdrawal by Subject|0|||
164635460|NCT00307736|594688452|FG001|Overall Study|Withdrawal by Subject|0|||
164635461|NCT00307736|594688453|FG002|Overall Study|Withdrawal by Subject|2|||
164635462|NCT00307736|594688454|FG003|Overall Study|Withdrawal by Subject|0|||
164635463|NCT04604015|594688459|FG000|Overall Study|Incomplete Data Collection|33|||
164635464|NCT02129192|594688462|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
164635465|NCT02129192|594688463|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
164635466|NCT04557189|594688464|FG000|Overall Study|Adverse Event|0|||
164635467|NCT04557189|594688465|FG001|Overall Study|Adverse Event|1|||
164635468|NCT04557189|594688464|FG000|Overall Study|Lost to Follow-up|1|||
164635469|NCT04557189|594688465|FG001|Overall Study|Lost to Follow-up|1|||
164635470|NCT04557189|594688464|FG000|Overall Study|Withdrawal by Subject|2|||
164635471|NCT04557189|594688465|FG001|Overall Study|Withdrawal by Subject|1|||
164635472|NCT04557189|594688464|FG000|Overall Study|Reason not Specified|3|||
164635473|NCT04557189|594688465|FG001|Overall Study|Reason not Specified|6|||
164635474|NCT04369742|594688473|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
164635475|NCT04369742|594688474|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
164635476|NCT04369742|594688473|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
164635477|NCT04369742|594688474|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
164635478|NCT03575975|594688475|FG000|Overall Study|Lost to Follow-up|1|||
164635479|NCT03575975|594688476|FG001|Overall Study|Lost to Follow-up|0|||
164635480|NCT03575975|594688477|FG002|Overall Study|Lost to Follow-up|0|||
164635481|NCT01636076|594688478|FG000|Overall Study|Terminated by sponsor|1|||
164635482|NCT01636076|594688479|FG001|Overall Study|Terminated by sponsor|1|||
164635483|NCT01636076|594688478|FG000|Overall Study|Lack of Efficacy|0|||
164635484|NCT01636076|594688479|FG001|Overall Study|Lack of Efficacy|1|||
164635485|NCT01636076|594688478|FG000|Overall Study|Lost to Follow-up|1|||
164635486|NCT01636076|594688479|FG001|Overall Study|Lost to Follow-up|0|||
164635487|NCT01636076|594688478|FG000|Overall Study|Physician Decision|1|||
164635488|NCT01636076|594688479|FG001|Overall Study|Physician Decision|1|||
164635489|NCT01636076|594688478|FG000|Overall Study|Non-compliance with study treatment|1|||
164635490|NCT01636076|594688479|FG001|Overall Study|Non-compliance with study treatment|1|||
164635491|NCT01636076|594688478|FG000|Overall Study|Adverse Event|6|||
164635492|NCT01636076|594688479|FG001|Overall Study|Adverse Event|11|||
164635493|NCT01636076|594688478|FG000|Overall Study|Withdrawal by Subject|7|||
164635494|NCT01636076|594688479|FG001|Overall Study|Withdrawal by Subject|10|||
164635495|NCT00129220|594688480|FG000|Study Period II|Adverse Event|9|||
164635496|NCT00129220|594688481|FG001|Study Period II|Adverse Event|5|||
164635497|NCT00129220|594688482|FG002|Study Period II|Adverse Event|7|||
164635498|NCT00129220|594688480|FG000|Study Period II|Lack of Efficacy|15|||
164635499|NCT00129220|594688481|FG001|Study Period II|Lack of Efficacy|1|||
164635500|NCT00129220|594688482|FG002|Study Period II|Lack of Efficacy|28|||
164635501|NCT00129220|594688480|FG000|Study Period II|Entry Criteria Not Met|2|||
164635502|NCT00129220|594688481|FG001|Study Period II|Entry Criteria Not Met|0|||
164635503|NCT00129220|594688482|FG002|Study Period II|Entry Criteria Not Met|2|||
164635504|NCT00129220|594688480|FG000|Study Period II|Protocol Violation|4|||
164635505|NCT00129220|594688481|FG001|Study Period II|Protocol Violation|2|||
164635506|NCT00129220|594688482|FG002|Study Period II|Protocol Violation|1|||
164635507|NCT00129220|594688480|FG000|Study Period II|Physician Decision|0|||
164635508|NCT00129220|594688481|FG001|Study Period II|Physician Decision|1|||
164635509|NCT00129220|594688482|FG002|Study Period II|Physician Decision|0|||
164635510|NCT00129220|594688480|FG000|Study Period II|Withdrawal by Subject|1|||
164635511|NCT00129220|594688481|FG001|Study Period II|Withdrawal by Subject|3|||
164635512|NCT00129220|594688482|FG002|Study Period II|Withdrawal by Subject|4|||
164635513|NCT00129220|594688480|FG000|Study Period II|Reason Not Specified|2|||
164635514|NCT00129220|594688481|FG001|Study Period II|Reason Not Specified|0|||
164635515|NCT00129220|594688482|FG002|Study Period II|Reason Not Specified|5|||
164635516|NCT00129220|594688480|FG000|Study Period III|Adverse Event|1|||
164635517|NCT00129220|594688481|FG001|Study Period III|Adverse Event|0|||
164635518|NCT00129220|594688482|FG002|Study Period III|Adverse Event|3|||
164635519|NCT00129220|594688480|FG000|Study Period III|Protocol Violation|1|||
164635520|NCT00129220|594688481|FG001|Study Period III|Protocol Violation|1|||
164635521|NCT00129220|594688482|FG002|Study Period III|Protocol Violation|2|||
164635522|NCT00129220|594688480|FG000|Study Period III|Withdrawal by Subject|1|||
164635523|NCT00129220|594688481|FG001|Study Period III|Withdrawal by Subject|0|||
164635524|NCT00129220|594688482|FG002|Study Period III|Withdrawal by Subject|3|||
164635525|NCT00129220|594688480|FG000|Study Period III|Sponsor Decision|1|||
164635526|NCT00129220|594688481|FG001|Study Period III|Sponsor Decision|0|||
164635527|NCT00129220|594688482|FG002|Study Period III|Sponsor Decision|0|||
164635528|NCT00129220|594688480|FG000|Study Period III|Reason Not Specified|9|||
164635529|NCT00129220|594688481|FG001|Study Period III|Reason Not Specified|0|||
164635530|NCT00129220|594688482|FG002|Study Period III|Reason Not Specified|2|||
164635531|NCT02173158|594688483|FG000|Efficacy Phase|Adverse Event|1|||
164635532|NCT00869362|594690085|FG000|Overall Study|Death|0|||
164635533|NCT00869362|594690086|FG001|Overall Study|Death|2|||
164635534|NCT00869362|594690085|FG000|Overall Study|Lost to Follow-up|1|||
164635535|NCT00869362|594690086|FG001|Overall Study|Lost to Follow-up|3|||
164635536|NCT04887922|594690096|FG000|1st Randomization|Decided not to have surgery|0|||
164635537|NCT04887922|594690097|FG001|1st Randomization|Decided not to have surgery|1|||
164635538|NCT04887922|594690098|FG002|1st Randomization|Decided not to have surgery|0|||
164635539|NCT04887922|594690099|FG003|1st Randomization|Decided not to have surgery|0|||
164635540|NCT04887922|594690100|FG004|1st Randomization|Decided not to have surgery|0|||
164635541|NCT00953017|594690101|FG000|Overall Study|DId not show up for colonoscopy|4|||
164635542|NCT00953017|594690102|FG001|Overall Study|DId not show up for colonoscopy|4|||
164635543|NCT00953017|594690103|FG002|Overall Study|DId not show up for colonoscopy|5|||
164635544|NCT00953017|594690104|FG003|Overall Study|DId not show up for colonoscopy|4|||
164635545|NCT00953017|594690101|FG000|Overall Study|Incomplete data|1|||
164635546|NCT00953017|594690102|FG001|Overall Study|Incomplete data|1|||
164635547|NCT00953017|594690103|FG002|Overall Study|Incomplete data|0|||
164635548|NCT00953017|594690104|FG003|Overall Study|Incomplete data|0|||
164635549|NCT00953017|594690101|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
164635550|NCT00953017|594690102|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
164635551|NCT00953017|594690103|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
164635552|NCT00953017|594690104|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
164635553|NCT00953017|594690101|FG000|Overall Study|Brown stool prior to procedure|0|||
164635554|NCT00953017|594690102|FG001|Overall Study|Brown stool prior to procedure|0|||
164635555|NCT00953017|594690103|FG002|Overall Study|Brown stool prior to procedure|1|||
164635556|NCT00953017|594690104|FG003|Overall Study|Brown stool prior to procedure|0|||
164635557|NCT01548573|594690107|FG000|Overall Study|Death|3|||
164635558|NCT01548573|594690107|FG000|Overall Study|Withdrawal by Subject|2|||
164635559|NCT01366846|594690108|FG000|Overall Study|Withdrawal by Subject|2|||
164635560|NCT01366846|594690109|FG001|Overall Study|Withdrawal by Subject|0|||
164635561|NCT01366846|594690110|FG002|Overall Study|Withdrawal by Subject|0|||
164635562|NCT01366846|594690111|FG003|Overall Study|Withdrawal by Subject|0|||
164635563|NCT01366846|594690108|FG000|Overall Study|Communication Difficulties|1|||
164635564|NCT01366846|594690109|FG001|Overall Study|Communication Difficulties|4|||
164635565|NCT01366846|594690110|FG002|Overall Study|Communication Difficulties|0|||
164635566|NCT01366846|594690111|FG003|Overall Study|Communication Difficulties|1|||
164635567|NCT01366846|594690108|FG000|Overall Study|Scheduling Conflicts|0|||
164635568|NCT01366846|594690109|FG001|Overall Study|Scheduling Conflicts|0|||
164635569|NCT01366846|594690110|FG002|Overall Study|Scheduling Conflicts|1|||
164635570|NCT01366846|594690111|FG003|Overall Study|Scheduling Conflicts|0|||
164635571|NCT00290511|594690112|FG000|Overall Study|Adverse Event|1|||
164635572|NCT00290511|594690112|FG000|Overall Study|Death|1|||
164635573|NCT00290511|594690112|FG000|Overall Study|Physician Decision|1|||
164635574|NCT00290511|594690112|FG000|Overall Study|Withdrawal by Subject|1|||
164635575|NCT00447265|594690115|FG000|Overall Study|Physician Decision|1|||
164635576|NCT00447265|594690116|FG001|Overall Study|Physician Decision|0|||
164635577|NCT04311411|594690117|FG000|Overall Study|Adverse Event|2|||
164635578|NCT04311411|594690118|FG001|Overall Study|Adverse Event|3|||
164635579|NCT04311411|594690119|FG002|Overall Study|Adverse Event|2|||
164635580|NCT04311411|594690117|FG000|Overall Study|Withdrawal by Subject|3|||
164635581|NCT04311411|594690118|FG001|Overall Study|Withdrawal by Subject|3|||
164635582|NCT04311411|594690119|FG002|Overall Study|Withdrawal by Subject|0|||
164635583|NCT01976663|594690123|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
164635584|NCT01976663|594690123|FG000|Overall Study|Personal Reasons|6|||
164635585|NCT01976663|594690123|FG000|Overall Study|Withdrawal by Subject|4|||
164635586|NCT01976663|594690123|FG000|Overall Study|Screen Failure|3|||
164635587|NCT01976663|594690123|FG000|Overall Study|Adverse Event|2|||
164635588|NCT01976663|594690123|FG000|Overall Study|Lost to Follow-up|3|||
164635589|NCT04780776|594690127|FG000|Titration Week 1-5|Lost to Follow-up|2|||
164635590|NCT04780776|594690128|FG001|Titration Week 1-5|Lost to Follow-up|8|||
164635591|NCT04780776|594690127|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
164635592|NCT04780776|594690128|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
164635593|NCT04780776|594690127|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
164635594|NCT04780776|594690128|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
164635595|NCT03113760|594690130|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
164635596|NCT03113760|594690131|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
164635597|NCT03113760|594690132|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
164635598|NCT03113760|594690133|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
164635599|NCT03113760|594690130|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
164635600|NCT03113760|594690131|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
164635601|NCT03113760|594690132|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
164635602|NCT03113760|594690133|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
164635603|NCT03113760|594690130|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
164635604|NCT03113760|594690131|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
164635605|NCT03113760|594690132|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
164635606|NCT03113760|594690133|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
164635607|NCT00465101|594690134|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
164635608|NCT00465101|594690134|FG000|Overall Study|Change in health precluded follow up|4|||
164635609|NCT00465101|594690134|FG000|Overall Study|Did not meet study criteria|4|||
164635610|NCT00465101|594690134|FG000|Overall Study|Lost to Follow-up|5|||
164635611|NCT00465101|594690134|FG000|Overall Study|Other|6|||
164635612|NCT00465101|594690134|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
164635613|NCT00465101|594690134|FG000|Overall Study|Patient postponed procedure|1|||
164635614|NCT00465101|594690134|FG000|Overall Study|Site closed due to IRB expiration|1|||
164635615|NCT00465101|594690134|FG000|Overall Study|Unable to obtain IRB approval|1|||
164529872|NCT00953745|594311866|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
164529873|NCT00953745|594311867|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
164529874|NCT00953745|594311866|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
164529875|NCT00953745|594311867|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
164529876|NCT00953745|594311866|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
164529877|NCT00953745|594311867|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
164529878|NCT00953745|594311866|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
164529879|NCT00953745|594311867|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
164529880|NCT00490724|594311868|FG000|Period I|Physician Decision|0|||
164529881|NCT00490724|594311869|FG001|Period I|Physician Decision|0|||
164529882|NCT00490724|594311870|FG002|Period I|Physician Decision|1|||
164529883|NCT00490724|594311868|FG000|Period II|Treatment Discontinuation|3|||
164529884|NCT00490724|594311869|FG001|Period II|Treatment Discontinuation|1|||
164529885|NCT00490724|594311870|FG002|Period II|Treatment Discontinuation|3|||
164529886|NCT00903682|594311873|FG000|Overall Study|Adverse Event|6|||
164529887|NCT00903682|594311874|FG001|Overall Study|Adverse Event|13|||
164529888|NCT00903682|594311873|FG000|Overall Study|Lost to Follow-up|1|||
164529889|NCT00903682|594311874|FG001|Overall Study|Lost to Follow-up|0|||
164529890|NCT00903682|594311873|FG000|Overall Study|Withdrawal by Subject|5|||
164529891|NCT00903682|594311874|FG001|Overall Study|Withdrawal by Subject|0|||
164529892|NCT00903682|594311873|FG000|Overall Study|Pregnancy|0|||
164529893|NCT00903682|594311874|FG001|Overall Study|Pregnancy|1|||
164529894|NCT00903682|594311873|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
164529895|NCT00903682|594311874|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
164529896|NCT00903682|594311873|FG000|Overall Study|Subject Non-Compliant|1|||
164529897|NCT00903682|594311874|FG001|Overall Study|Subject Non-Compliant|0|||
164529898|NCT00903682|594311873|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
164529899|NCT00903682|594311874|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
164529900|NCT00903682|594311873|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
164529901|NCT00903682|594311874|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
164529902|NCT03866473|594311877|FG000|Phase 1|Death|1|||
164529903|NCT03866473|594311878|FG001|Phase 1|Death|0|||
164529904|NCT03866473|594311877|FG000|Phase 2|Death|0|||
164529905|NCT03866473|594311878|FG001|Phase 2|Death|2|||
164529906|NCT03866473|594311877|FG000|Phase 2|Dropped|1|||
164529907|NCT03866473|594311878|FG001|Phase 2|Dropped|1|||
164529908|NCT03866473|594311877|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
164529909|NCT03866473|594311878|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
164529910|NCT03110185|594311879|FG000|Overall Study|Death|0|||
164529911|NCT03110185|594311880|FG001|Overall Study|Death|1|||
164529912|NCT03110185|594311879|FG000|Overall Study|Withdrawal by Subject|2|||
164529913|NCT03110185|594311880|FG001|Overall Study|Withdrawal by Subject|7|||
164529914|NCT03110185|594311879|FG000|Overall Study|Time Constraints|0|||
164529915|NCT03110185|594311880|FG001|Overall Study|Time Constraints|6|||
164529916|NCT03110185|594311879|FG000|Overall Study|Conflict with care|5|||
164529917|NCT03110185|594311880|FG001|Overall Study|Conflict with care|12|||
164529918|NCT03110185|594311879|FG000|Overall Study|Protocol Violation|1|||
164529919|NCT03110185|594311880|FG001|Overall Study|Protocol Violation|4|||
164529920|NCT03110185|594311879|FG000|Overall Study|MRI Incompatible|2|||
164529921|NCT03110185|594311880|FG001|Overall Study|MRI Incompatible|0|||
164529922|NCT03110185|594311879|FG000|Overall Study|Patient Refusal|0|||
164529923|NCT03110185|594311880|FG001|Overall Study|Patient Refusal|1|||
164529924|NCT00600886|594311881|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
164529925|NCT00600886|594311882|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
164529926|NCT00600886|594311881|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
164529927|NCT00600886|594311882|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
164529928|NCT00600886|594311881|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
164529929|NCT00600886|594311882|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
164529930|NCT00600886|594311881|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
164529931|NCT00600886|594311882|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
164529932|NCT00600886|594311881|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
164529933|NCT00600886|594311882|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
164529934|NCT00600886|594311881|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
164529935|NCT00600886|594311882|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
164529936|NCT00600886|594311881|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
164529937|NCT00600886|594311882|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
164529938|NCT00600886|594311881|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
164529939|NCT00600886|594311882|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
164529940|NCT00600886|594311881|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
164529941|NCT00600886|594311882|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
164635616|NCT00465101|594690134|FG000|Overall Study|Death|3|||
164529942|NCT00600886|594311881|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
164529943|NCT00600886|594311882|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
164529944|NCT00600886|594311881|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
164529945|NCT00600886|594311882|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
164529946|NCT00600886|594311881|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
164529947|NCT00600886|594311882|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
164529948|NCT00600886|594311881|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
164529949|NCT00600886|594311882|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
164529950|NCT00600886|594311881|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
164529951|NCT00600886|594311882|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
164529952|NCT00600886|594311881|FG000|Extension - Same Treatment (FAS)|Death|1|||
164529953|NCT00600886|594311882|FG001|Extension - Same Treatment (FAS)|Death|1|||
164529954|NCT00600886|594311881|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
164529955|NCT00600886|594311882|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
164529956|NCT00600886|594311881|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
164529957|NCT00600886|594311882|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
164529958|NCT00600886|594311881|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
164529959|NCT00600886|594311882|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
164529960|NCT00600886|594311881|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
164529961|NCT00600886|594311882|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
164529962|NCT00600886|594311881|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
164529963|NCT00600886|594311882|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
164529964|NCT00600886|594311881|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
164529965|NCT00600886|594311882|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
164529966|NCT00600886|594311881|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
164529967|NCT00600886|594311882|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
164529968|NCT00600886|594311881|FG000|Extension - After Crossover (CAS)|Death|1|||
164529969|NCT00600886|594311882|FG001|Extension - After Crossover (CAS)|Death|0|||
164529970|NCT03075410|594311883|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
164529971|NCT03075410|594311884|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
164529972|NCT03075410|594311885|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
164529973|NCT03075410|594311886|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
164529974|NCT03075410|594311887|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
164529975|NCT03075410|594311888|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
164635617|NCT00465101|594690134|FG000|Overall Study|Withdrawal by Subject|25|||
164635618|NCT00465101|594690134|FG000|Overall Study|Physician Decision|1|||
164635619|NCT00465101|594690134|FG000|Overall Study|Withdrew consent prior to procedure|3|||
164635620|NCT00998166|594690135|FG000|Overall Study|Early Study Termination|8|||
164635621|NCT00933543|594690137|FG000|Overall Study|Adverse Event|2|||
164635622|NCT00933543|594690138|FG001|Overall Study|Adverse Event|1|||
164635623|NCT00933543|594690137|FG000|Overall Study|Lost to Follow-up|0|||
164635624|NCT00933543|594690138|FG001|Overall Study|Lost to Follow-up|1|||
164635625|NCT00933543|594690137|FG000|Overall Study|Withdrawal by Subject|0|||
164635626|NCT00933543|594690138|FG001|Overall Study|Withdrawal by Subject|1|||
164635627|NCT00933543|594690137|FG000|Overall Study|Lack of Efficacy|0|||
164635628|NCT00933543|594690138|FG001|Overall Study|Lack of Efficacy|3|||
164635629|NCT00933543|594690137|FG000|Overall Study|Other|1|||
164635630|NCT00933543|594690138|FG001|Overall Study|Other|1|||
164635631|NCT04988035|594690144|FG000|Overall Study|Death|19|||
164635632|NCT04988035|594690145|FG001|Overall Study|Death|13|||
164635633|NCT04988035|594690144|FG000|Overall Study|Lost to Follow-up|12|||
164635634|NCT04988035|594690145|FG001|Overall Study|Lost to Follow-up|6|||
164635635|NCT04988035|594690144|FG000|Overall Study|Protocol Violation|0|||
164635636|NCT04988035|594690145|FG001|Overall Study|Protocol Violation|1|||
164635637|NCT04988035|594690144|FG000|Overall Study|Withdrawal by Subject|2|||
164635638|NCT04988035|594690145|FG001|Overall Study|Withdrawal by Subject|4|||
164635639|NCT04988035|594690144|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
164635640|NCT04988035|594690145|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
164635641|NCT03532048|594690146|FG000|Overall Study|Lost to Follow-up|12|||
164635642|NCT03532048|594690147|FG001|Overall Study|Lost to Follow-up|17|||
164635643|NCT03532048|594690146|FG000|Overall Study|Withdrawal by Subject|7|||
164635644|NCT03532048|594690147|FG001|Overall Study|Withdrawal by Subject|0|||
164635645|NCT04366258|594690148|FG000|Baseline Assessments|Screen Failure|21|||
164635646|NCT04366258|594690148|FG000|Baseline Assessments|Early Termination|3|||
164635647|NCT00308555|594690149|FG000|Overall Study|Withdrawal by Subject|1|||
164635648|NCT00308555|594690150|FG001|Overall Study|Withdrawal by Subject|0|||
164635649|NCT00308555|594690149|FG000|Overall Study|Physician Decision|2|||
164635650|NCT00308555|594690150|FG001|Overall Study|Physician Decision|0|||
164635651|NCT04113746|594690155|FG000|Overall Study|Lost to Follow-up|4|||
164635652|NCT04113746|594690156|FG001|Overall Study|Lost to Follow-up|4|||
164635653|NCT04246593|594690158|FG000|Overall Study|Withdrawal by Subject|14|||
164635654|NCT04246593|594690159|FG001|Overall Study|Withdrawal by Subject|13|||
164529976|NCT03075410|594311889|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
164529977|NCT03075410|594311890|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
164529978|NCT03075410|594311891|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
164529979|NCT03075410|594311883|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
164529980|NCT03075410|594311884|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
164529981|NCT03075410|594311885|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
164529982|NCT03075410|594311886|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
164529983|NCT03075410|594311887|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
164529984|NCT03075410|594311888|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
164529985|NCT03075410|594311889|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
164529986|NCT03075410|594311890|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
164529987|NCT03075410|594311891|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
164529988|NCT02053792|594311892|FG000|Overall Study|Physician Decision|0|||
164529989|NCT02053792|594311893|FG001|Overall Study|Physician Decision|1|||
164529990|NCT02053792|594311892|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
164529991|NCT02053792|594311893|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
164529992|NCT02053792|594311892|FG000|Overall Study|Lack of Efficacy|1|||
164529993|NCT02053792|594311893|FG001|Overall Study|Lack of Efficacy|0|||
164529994|NCT02053792|594311892|FG000|Overall Study|Adverse Event|1|||
164529995|NCT02053792|594311893|FG001|Overall Study|Adverse Event|0|||
164529996|NCT02053792|594311892|FG000|Overall Study|Withdrawal by Subject|2|||
164529997|NCT02053792|594311893|FG001|Overall Study|Withdrawal by Subject|2|||
164529998|NCT02053792|594311892|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
164635655|NCT04246593|594690158|FG000|Overall Study|Lost to Follow-up|124|||
164635656|NCT04246593|594690159|FG001|Overall Study|Lost to Follow-up|71|||
164635657|NCT04246593|594690158|FG000|Overall Study|Moved out of area/became ineligible|3|||
164635658|NCT04246593|594690159|FG001|Overall Study|Moved out of area/became ineligible|1|||
164635659|NCT04246593|594690158|FG000|Overall Study|Reason unknown|4|||
164635660|NCT04246593|594690159|FG001|Overall Study|Reason unknown|2|||
164635661|NCT00429026|594690160|FG000|Overall Study|Inevaluable for response.|40|||
164635662|NCT00499694|594690165|FG000|Overall Study|Patient never received treatment.|1|||
164635663|NCT03958045|594690166|FG000|Overall Study|Withdrawal by Subject|1|||
164635664|NCT00674440|594690171|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
164635665|NCT00674440|594690171|FG000|Overall Study|did not have surgery, so unevaluable|7|||
164635666|NCT00674440|594690171|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
164635667|NCT01463631|594690172|FG000|Overall Study|Withdrawal by Subject|0|||
164635668|NCT01463631|594690173|FG001|Overall Study|Withdrawal by Subject|0|||
164635669|NCT01463631|594690174|FG002|Overall Study|Withdrawal by Subject|0|||
164635670|NCT01463631|594690175|FG003|Overall Study|Withdrawal by Subject|1|||
164635671|NCT01463631|594690172|FG000|Overall Study|Death|0|||
164635672|NCT01463631|594690173|FG001|Overall Study|Death|0|||
164635673|NCT01463631|594690174|FG002|Overall Study|Death|1|||
164635674|NCT01463631|594690175|FG003|Overall Study|Death|0|||
164635675|NCT01463631|594690172|FG000|Overall Study|Progressive Disease|0|||
164635676|NCT01463631|594690173|FG001|Overall Study|Progressive Disease|0|||
164635677|NCT01463631|594690174|FG002|Overall Study|Progressive Disease|0|||
164635678|NCT01463631|594690175|FG003|Overall Study|Progressive Disease|5|||
164635679|NCT04409262|594690184|FG000|Overall Study|Adverse Event|0|||
164635680|NCT04409262|594690185|FG001|Overall Study|Adverse Event|2|||
164635681|NCT04409262|594690184|FG000|Overall Study|Death|55|||
164635682|NCT04409262|594690185|FG001|Overall Study|Death|97|||
164635683|NCT04409262|594690184|FG000|Overall Study|Lost to Follow-up|12|||
164635684|NCT04409262|594690185|FG001|Overall Study|Lost to Follow-up|23|||
164635685|NCT04409262|594690184|FG000|Overall Study|Lack of Staff|0|||
164635686|NCT04409262|594690185|FG001|Overall Study|Lack of Staff|1|||
164635687|NCT04409262|594690184|FG000|Overall Study|Protocol Violation|3|||
164635688|NCT04409262|594690185|FG001|Overall Study|Protocol Violation|1|||
164635689|NCT04409262|594690184|FG000|Overall Study|Withdrawal by Subject|5|||
164635690|NCT04409262|594690185|FG001|Overall Study|Withdrawal by Subject|10|||
164635691|NCT00948896|594690188|FG000|Randomization to 24 Months of Age|Death|1|||
164635692|NCT00948896|594690189|FG001|Randomization to 24 Months of Age|Death|0|||
164635693|NCT00948896|594690190|FG002|Randomization to 24 Months of Age|Death|0|||
164635694|NCT00948896|594690191|FG003|Randomization to 24 Months of Age|Death|0|||
164635695|NCT00948896|594690192|FG004|Randomization to 24 Months of Age|Death|2|||
164635696|NCT00948896|594690193|FG005|Randomization to 24 Months of Age|Death|1|||
164635697|NCT00948896|594690194|FG006|Randomization to 24 Months of Age|Death|2|||
164635698|NCT00948896|594690195|FG007|Randomization to 24 Months of Age|Death|1|||
164635699|NCT00948896|594690188|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
164635700|NCT00948896|594690189|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
164635701|NCT00948896|594690190|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
164635702|NCT00948896|594690191|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
164635703|NCT00948896|594690192|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
164635704|NCT00948896|594690193|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
164635705|NCT00948896|594690194|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
164635706|NCT00948896|594690195|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
164635707|NCT00948896|594690188|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
164635708|NCT00948896|594690189|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
164635709|NCT00948896|594690190|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
164635710|NCT00948896|594690191|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
164635711|NCT00948896|594690192|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
164635712|NCT00948896|594690193|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
164635713|NCT00948896|594690194|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
164635714|NCT00948896|594690195|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
164635715|NCT00948896|594690188|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
164635716|NCT00948896|594690189|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
164635717|NCT00948896|594690190|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
164635718|NCT00948896|594690191|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
164635719|NCT00948896|594690192|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
164635720|NCT00948896|594690193|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
164148526|NCT01823835|592904897|FG005|Overall Study|Study Termination|0|||
164635721|NCT00948896|594690194|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
164635722|NCT00948896|594690195|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
164635723|NCT00948896|594690188|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
164635724|NCT00948896|594690189|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
164635725|NCT00948896|594690190|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
164635726|NCT00948896|594690191|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
164635727|NCT00948896|594690192|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
164635728|NCT00948896|594690193|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
164635729|NCT00948896|594690194|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
164635730|NCT00948896|594690195|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
164635731|NCT00948896|594690188|FG000|24 Months of Age to 36 Months of Age|Death|0|||
164635732|NCT00948896|594690189|FG001|24 Months of Age to 36 Months of Age|Death|2|||
164635733|NCT00948896|594690190|FG002|24 Months of Age to 36 Months of Age|Death|2|||
164635734|NCT00948896|594690191|FG003|24 Months of Age to 36 Months of Age|Death|0|||
164635735|NCT00948896|594690192|FG004|24 Months of Age to 36 Months of Age|Death|0|||
164635736|NCT00948896|594690193|FG005|24 Months of Age to 36 Months of Age|Death|1|||
164635737|NCT00948896|594690194|FG006|24 Months of Age to 36 Months of Age|Death|0|||
164635738|NCT00948896|594690195|FG007|24 Months of Age to 36 Months of Age|Death|0|||
164635739|NCT00948896|594690188|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
164635740|NCT00948896|594690189|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
164635741|NCT00948896|594690190|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
164635742|NCT00948896|594690191|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
164635743|NCT00948896|594690192|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
164635744|NCT00948896|594690193|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
164635745|NCT00948896|594690194|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
164635746|NCT00948896|594690195|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
164635747|NCT00948896|594690188|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
164635748|NCT00948896|594690189|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
164635749|NCT00948896|594690190|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
164635750|NCT00948896|594690191|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
164635751|NCT00948896|594690192|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
164635752|NCT00948896|594690193|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
164635753|NCT00948896|594690194|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
164635754|NCT00948896|594690195|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
164635755|NCT00948896|594690188|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
164635756|NCT00948896|594690189|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
164635757|NCT00948896|594690190|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
164635758|NCT00948896|594690191|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
164635759|NCT00948896|594690192|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
164635760|NCT00948896|594690193|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
164635761|NCT00948896|594690194|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
164635762|NCT00948896|594690195|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
164635763|NCT00948896|594690188|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
164635764|NCT00948896|594690189|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
164635765|NCT00948896|594690190|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
164635766|NCT00948896|594690191|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
164635767|NCT00948896|594690192|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
164635768|NCT00948896|594690193|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
164635769|NCT00948896|594690194|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
164635770|NCT00948896|594690195|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
164635771|NCT00945815|594690196|FG000|Overall Study|Death|3|||
164635772|NCT00945815|594690196|FG000|Overall Study|Not protocol specified|1|||
164635773|NCT00945815|594690196|FG000|Overall Study|Ineligible|3|||
164635774|NCT00945815|594690196|FG000|Overall Study|Did not begin protocol therapy|1|||
164635775|NCT01990339|594690201|FG000|Overall Study|Data Not Available|49|||
164635776|NCT01990339|594690201|FG000|Overall Study|Voluntary Withdrawal|1402|||
164635777|NCT01990339|594690201|FG000|Overall Study|Lost to Follow-up|861|||
164635778|NCT01038609|594690202|FG000|Overall Study|Adverse Event|0|||
164635779|NCT01038609|594690203|FG001|Overall Study|Adverse Event|0|||
164635780|NCT01038609|594690204|FG002|Overall Study|Adverse Event|1|||
164635781|NCT01038609|594690205|FG003|Overall Study|Adverse Event|0|||
164635782|NCT01038609|594690206|FG004|Overall Study|Adverse Event|0|||
164635783|NCT01038609|594690202|FG000|Overall Study|Dosing Error|0|||
164635784|NCT01038609|594690203|FG001|Overall Study|Dosing Error|0|||
164635785|NCT01038609|594690204|FG002|Overall Study|Dosing Error|0|||
164635786|NCT01038609|594690205|FG003|Overall Study|Dosing Error|1|||
164635787|NCT01038609|594690206|FG004|Overall Study|Dosing Error|1|||
164635788|NCT01038609|594690202|FG000|Overall Study|Death in the Family|1|||
164635789|NCT01038609|594690203|FG001|Overall Study|Death in the Family|0|||
164635790|NCT01038609|594690204|FG002|Overall Study|Death in the Family|0|||
164635791|NCT01038609|594690205|FG003|Overall Study|Death in the Family|0|||
164635792|NCT01038609|594690206|FG004|Overall Study|Death in the Family|0|||
164635793|NCT01038609|594690202|FG000|Overall Study|Refusal of Blood Draws|0|||
164635794|NCT01038609|594690203|FG001|Overall Study|Refusal of Blood Draws|1|||
164635795|NCT01038609|594690204|FG002|Overall Study|Refusal of Blood Draws|0|||
164635796|NCT01038609|594690205|FG003|Overall Study|Refusal of Blood Draws|0|||
164635797|NCT01038609|594690206|FG004|Overall Study|Refusal of Blood Draws|0|||
164635798|NCT01590810|594690207|FG000|Overall Study|Physician Decision|0|||
164635799|NCT01590810|594690208|FG001|Overall Study|Physician Decision|1|||
164635800|NCT01590810|594690209|FG002|Overall Study|Physician Decision|1|||
164635801|NCT01590810|594690210|FG003|Overall Study|Physician Decision|0|||
164635802|NCT01590810|594690211|FG004|Overall Study|Physician Decision|0|||
164635803|NCT01087944|594690213|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
164635804|NCT01087944|594690214|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
164635805|NCT01087944|594690213|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
164635806|NCT01087944|594690214|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
164635807|NCT00553319|594690215|FG000|Overall Study|Lost to Follow-up|10|||
164635808|NCT00553319|594690216|FG001|Overall Study|Lost to Follow-up|9|||
164635809|NCT00553319|594690217|FG002|Overall Study|Lost to Follow-up|5|||
164635810|NCT00553319|594690215|FG000|Overall Study|wanted treatment elsewhere|2|||
164635811|NCT00553319|594690216|FG001|Overall Study|wanted treatment elsewhere|1|||
164635812|NCT00553319|594690217|FG002|Overall Study|wanted treatment elsewhere|1|||
164635813|NCT00553319|594690215|FG000|Overall Study|non-compliance|0|||
164635814|NCT00553319|594690216|FG001|Overall Study|non-compliance|0|||
164635815|NCT00553319|594690217|FG002|Overall Study|non-compliance|2|||
164635816|NCT00553319|594690215|FG000|Overall Study|incarceration|1|||
164635817|NCT00553319|594690216|FG001|Overall Study|incarceration|0|||
164635818|NCT00553319|594690217|FG002|Overall Study|incarceration|0|||
164635819|NCT00553319|594690215|FG000|Overall Study|moved|1|||
164635820|NCT00553319|594690216|FG001|Overall Study|moved|0|||
164635821|NCT00553319|594690217|FG002|Overall Study|moved|1|||
164635822|NCT01731600|594690219|FG000|Overall Study|Adverse Event|2|||
164635823|NCT01731600|594690220|FG001|Overall Study|Adverse Event|0|||
164635824|NCT01731600|594690219|FG000|Overall Study|Withdrawal criteria|1|||
164635825|NCT01731600|594690220|FG001|Overall Study|Withdrawal criteria|0|||
164635826|NCT01731600|594690219|FG000|Overall Study|Other reasons|3|||
164635827|NCT01731600|594690220|FG001|Overall Study|Other reasons|0|||
164635828|NCT01130831|594690221|FG000|Overall Study|Withdrawal by Subject|7|||
164635829|NCT01130831|594690221|FG000|Overall Study|Death|4|||
164635830|NCT01130831|594690221|FG000|Overall Study|Information was missing|3|||
164635831|NCT01159665|594690222|FG000|Overall Study|Withdrawal by Subject|0|||
164635832|NCT01159665|594690223|FG001|Overall Study|Withdrawal by Subject|1|||
164635833|NCT01159665|594690224|FG002|Overall Study|Withdrawal by Subject|0|||
164635834|NCT01159665|594690225|FG003|Overall Study|Withdrawal by Subject|0|||
164635835|NCT01159665|594690226|FG004|Overall Study|Withdrawal by Subject|0|||
164635836|NCT01159665|594690227|FG005|Overall Study|Withdrawal by Subject|0|||
164635837|NCT02441517|594690228|FG000|Overall Study|Lost to Follow-up|1|||
164635838|NCT02441517|594690228|FG000|Overall Study|Withdrawal by Subject|2|||
164635839|NCT02441517|594690228|FG000|Overall Study|Study Terminated by Sponsor|1|||
164635840|NCT01883362|594690231|FG000|Treatment|Adverse Event|1|||
164635841|NCT01883362|594690232|FG001|Treatment|Adverse Event|8|||
164635842|NCT01883362|594690231|FG000|Treatment|Withdrawal by Subject|6|||
164635843|NCT01883362|594690232|FG001|Treatment|Withdrawal by Subject|2|||
164635844|NCT01883362|594690231|FG000|Treatment|Administrative problems|4|||
164635845|NCT01883362|594690232|FG001|Treatment|Administrative problems|1|||
164635846|NCT01883362|594690231|FG000|Treatment|Relapse|4|||
164635847|NCT01883362|594690232|FG001|Treatment|Relapse|2|||
164635848|NCT01883362|594690231|FG000|Treatment|Randomized, not treated|1|||
164635849|NCT01883362|594690232|FG001|Treatment|Randomized, not treated|1|||
164635850|NCT01883362|594690231|FG000|Post Treatment Follow-up|Protocol Violation|0|||
164635851|NCT01883362|594690232|FG001|Post Treatment Follow-up|Protocol Violation|1|||
164635852|NCT01883362|594690231|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
164635853|NCT01883362|594690232|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
164635854|NCT01883362|594690231|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
164635855|NCT01883362|594690232|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
164635856|NCT01883362|594690231|FG000|Post Treatment Follow-up|Administrative problems|2|||
164635857|NCT01883362|594690232|FG001|Post Treatment Follow-up|Administrative problems|0|||
164635858|NCT01883362|594690231|FG000|Post Treatment Follow-up|Death|8|||
164635859|NCT01883362|594690232|FG001|Post Treatment Follow-up|Death|4|||
164148527|NCT01823835|592904898|FG006|Overall Study|Study Termination|0|||
164529999|NCT02053792|594311893|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
164530000|NCT02053792|594311892|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
164530001|NCT02053792|594311893|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
164530002|NCT01427751|594311894|FG000|Overall Study|Adverse Event|18|||
164530003|NCT01427751|594311895|FG001|Overall Study|Adverse Event|2|||
164530004|NCT01427751|594311894|FG000|Overall Study|No further treatment benefit expected|5|||
164530005|NCT01427751|594311895|FG001|Overall Study|No further treatment benefit expected|1|||
164530006|NCT01427751|594311894|FG000|Overall Study|Lost to Follow-up|3|||
164530007|NCT01427751|594311895|FG001|Overall Study|Lost to Follow-up|1|||
164530008|NCT01427751|594311894|FG000|Overall Study|Withdrawal of consent|2|||
164530009|NCT01427751|594311895|FG001|Overall Study|Withdrawal of consent|2|||
164530010|NCT01427751|594311894|FG000|Overall Study|Protocol Violation|6|||
164530011|NCT01427751|594311895|FG001|Overall Study|Protocol Violation|4|||
164530012|NCT01427751|594311894|FG000|Overall Study|Death|2|||
164530013|NCT01427751|594311895|FG001|Overall Study|Death|0|||
164530014|NCT01427751|594311894|FG000|Overall Study|Other miscellaneous reasons|6|||
164530015|NCT01427751|594311895|FG001|Overall Study|Other miscellaneous reasons|4|||
164530016|NCT01028027|594311896|FG000|Overall Study|Lost to Follow-up|4|||
164530017|NCT01028027|594311897|FG001|Overall Study|Lost to Follow-up|1|||
164530018|NCT01028027|594311896|FG000|Overall Study|Withdrawal by Subject|5|||
164530019|NCT01028027|594311897|FG001|Overall Study|Withdrawal by Subject|3|||
164530020|NCT01028027|594311896|FG000|Overall Study|Adverse Event|4|||
164530021|NCT01028027|594311897|FG001|Overall Study|Adverse Event|7|||
164530022|NCT01028027|594311896|FG000|Overall Study|Protocol Violation|3|||
164530023|NCT01028027|594311897|FG001|Overall Study|Protocol Violation|1|||
164530024|NCT01028027|594311896|FG000|Overall Study|Lack of Efficacy|0|||
164530025|NCT01028027|594311897|FG001|Overall Study|Lack of Efficacy|1|||
164530026|NCT00368992|594311908|FG000|Overall Study|Ineligible|5|||
164530027|NCT00368992|594311908|FG000|Overall Study|Refused treatment|3|||
164530028|NCT00368992|594311908|FG000|Overall Study|Lack of Efficacy|63|||
164530029|NCT00368992|594311908|FG000|Overall Study|Adverse Event|26|||
164530030|NCT00368992|594311908|FG000|Overall Study|Death|4|||
164530031|NCT00368992|594311908|FG000|Overall Study|Other|9|||
164530032|NCT00790751|594311915|FG000|Overall Study|Protocol non-compliance|16|||
164530033|NCT00790751|594311916|FG001|Overall Study|Protocol non-compliance|16|||
164530034|NCT00790751|594311917|FG002|Overall Study|Protocol non-compliance|10|||
164530035|NCT00790751|594311918|FG003|Overall Study|Protocol non-compliance|11|||
164530036|NCT00790751|594311915|FG000|Overall Study|Lost to Follow-up|4|||
164530037|NCT00790751|594311916|FG001|Overall Study|Lost to Follow-up|9|||
164530038|NCT00790751|594311917|FG002|Overall Study|Lost to Follow-up|4|||
164530039|NCT00790751|594311918|FG003|Overall Study|Lost to Follow-up|5|||
164530040|NCT00790751|594311915|FG000|Overall Study|Adverse Event|5|||
164530041|NCT00790751|594311916|FG001|Overall Study|Adverse Event|3|||
164530042|NCT00790751|594311917|FG002|Overall Study|Adverse Event|5|||
164530043|NCT00790751|594311918|FG003|Overall Study|Adverse Event|4|||
164530044|NCT00790751|594311915|FG000|Overall Study|Requirement for restricted medication|0|||
164530045|NCT00790751|594311916|FG001|Overall Study|Requirement for restricted medication|2|||
164530046|NCT00790751|594311917|FG002|Overall Study|Requirement for restricted medication|0|||
164530047|NCT00790751|594311918|FG003|Overall Study|Requirement for restricted medication|0|||
164530048|NCT00790751|594311915|FG000|Overall Study|Death|0|||
164530049|NCT00790751|594311916|FG001|Overall Study|Death|0|||
164530050|NCT00790751|594311917|FG002|Overall Study|Death|1|||
164530051|NCT00790751|594311918|FG003|Overall Study|Death|0|||
164530052|NCT00790751|594311915|FG000|Overall Study|Physician Decision|0|||
164530053|NCT00790751|594311916|FG001|Overall Study|Physician Decision|0|||
164530054|NCT00790751|594311917|FG002|Overall Study|Physician Decision|0|||
164530055|NCT00790751|594311918|FG003|Overall Study|Physician Decision|1|||
164530056|NCT02427464|594311921|FG000|Overall Study|Adverse Event|6|||
164530057|NCT02427464|594311922|FG001|Overall Study|Adverse Event|1|||
164530058|NCT02427464|594311921|FG000|Overall Study|Lost to Follow-up|16|||
164530059|NCT02427464|594311922|FG001|Overall Study|Lost to Follow-up|5|||
164530060|NCT02427464|594311921|FG000|Overall Study|Physician Decision|2|||
164530061|NCT02427464|594311922|FG001|Overall Study|Physician Decision|0|||
164530062|NCT02427464|594311921|FG000|Overall Study|Withdrawal by Subject|10|||
164530063|NCT02427464|594311922|FG001|Overall Study|Withdrawal by Subject|8|||
164530064|NCT02427464|594311921|FG000|Overall Study|Noncompliance|16|||
164530065|NCT02427464|594311922|FG001|Overall Study|Noncompliance|10|||
164530066|NCT04443153|594311926|FG000|First intervention (8 weeks)|Withdrawal by Subject|2|||
164530067|NCT04443153|594311927|FG001|First intervention (8 weeks)|Withdrawal by Subject|0|||
164530068|NCT04443153|594311926|FG000|First intervention (8 weeks)|Lost to Follow-up|0|||
164530069|NCT04443153|594311927|FG001|First intervention (8 weeks)|Lost to Follow-up|2|||
164530070|NCT04443153|594311926|FG000|Second intervention (8 weeks)|Withdrawal by Subject|1|||
164530071|NCT04443153|594311927|FG001|Second intervention (8 weeks)|Withdrawal by Subject|1|||
164530072|NCT04443153|594311926|FG000|Second intervention (8 weeks)|Lost to Follow-up|2|||
164530073|NCT04443153|594311927|FG001|Second intervention (8 weeks)|Lost to Follow-up|0|||
164530074|NCT02572843|594311928|FG000|Accrual|Brain metastasis retrospectively detected|1|||
164635860|NCT01883362|594690231|FG000|Post Treatment Follow-up|Relapse|1|||
164635861|NCT01883362|594690232|FG001|Post Treatment Follow-up|Relapse|2|||
164635862|NCT01383317|594690233|FG000|Overall Study|Lost to Follow-up|2|||
164635863|NCT01383317|594690234|FG001|Overall Study|Lost to Follow-up|1|||
164635864|NCT01383317|594690233|FG000|Overall Study|Death|1|||
164635865|NCT01383317|594690234|FG001|Overall Study|Death|0|||
164635866|NCT01383317|594690233|FG000|Overall Study|Adverse Event|0|||
164635867|NCT01383317|594690234|FG001|Overall Study|Adverse Event|1|||
164635868|NCT00686894|594690235|FG000|Overall Study|Relapse|2|||
164635869|NCT00686894|594690235|FG000|Overall Study|Protocol Violation|4|||
164635870|NCT01230489|594690236|FG000|Overall Study|Death|2|||
164635871|NCT01230489|594690236|FG000|Overall Study|Adverse Event|2|||
164635872|NCT01230489|594690236|FG000|Overall Study|Treatment modality changed|1|||
164635873|NCT00967343|594690237|FG000|Overall Study|Study termination by sponsor|12|||
164635874|NCT00967343|594690237|FG000|Overall Study|Death|24|||
164635875|NCT00967343|594690237|FG000|Overall Study|Relapse|1|||
164635876|NCT00967343|594690237|FG000|Overall Study|Lost to Follow-up|1|||
164635877|NCT03575806|594692356|FG000|Overall Study|Withdrawal by Subject|0|||
164635878|NCT03575806|594692357|FG001|Overall Study|Withdrawal by Subject|2|||
164635879|NCT03575806|594692356|FG000|Overall Study|Protocol Violation|0|||
164635880|NCT03575806|594692357|FG001|Overall Study|Protocol Violation|2|||
164635881|NCT02842736|594692361|FG000|Overall Study|Lost to Follow-up|13|||
164635882|NCT02842736|594692361|FG000|Overall Study|Intervention for menstrual bleeding|17|||
164635883|NCT02842736|594692361|FG000|Overall Study|Withdrawal by Subject|4|||
164635884|NCT02842736|594692361|FG000|Overall Study|Pregnancy|3|||
164635885|NCT02842736|594692361|FG000|Overall Study|Hysterectomy for fibroids|2|||
164635886|NCT02842736|594692361|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
164635887|NCT02842736|594692361|FG000|Overall Study|IUD: Mirena|1|||
164635888|NCT02815540|594692365|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
164635889|NCT00798161|594692366|FG000|Overall Study|Adverse Event|3|||
164635890|NCT00798161|594692367|FG001|Overall Study|Adverse Event|4|||
164635891|NCT00798161|594692368|FG002|Overall Study|Adverse Event|6|||
164635892|NCT00798161|594692369|FG003|Overall Study|Adverse Event|6|||
164635893|NCT00798161|594692370|FG004|Overall Study|Adverse Event|5|||
164635894|NCT00798161|594692371|FG005|Overall Study|Adverse Event|2|||
164148528|NCT01823835|592904899|FG007|Overall Study|Study Termination|0|||
164530075|NCT02572843|594311928|FG000|Neoadjuvant chemotherapy|Physician Decision|2|||
164530076|NCT02572843|594311928|FG000|Neoadjuvant chemotherapy|Starting subsequent treatment due progressive disease clinically assessed|1|||
164530077|NCT02572843|594311928|FG000|Neoadjuvant chemotherapy|Withdrawal by Subject|1|||
164530078|NCT02572843|594311928|FG000|Neoadjuvant chemotherapy|Progressive disease|1|||
164530079|NCT02572843|594311928|FG000|Neoadjuvant immunotherapy|Progressive disease|2|||
164530080|NCT02572843|594311928|FG000|Neoadjuvant immunotherapy|Withdrawal by Subject|1|||
164530081|NCT02572843|594311928|FG000|Neoadjuvant immunotherapy|General status and respiratory capacity diminution|1|||
164530082|NCT02572843|594311928|FG000|Surgery|lost to follow up|7|||
164530083|NCT02572843|594311928|FG000|Surgery|Death|1|||
164530084|NCT01078454|594311934|FG000|Overall Study|Adverse Event|1|||
164530085|NCT01078454|594311935|FG001|Overall Study|Adverse Event|1|||
164530086|NCT01078454|594311934|FG000|Overall Study|Death|0|||
164530087|NCT01078454|594311935|FG001|Overall Study|Death|1|||
164530088|NCT04737187|594311936|FG000|Overall Study|Switched to marketed drug|32|||
164530089|NCT04737187|594311937|FG001|Overall Study|Switched to marketed drug|4|||
164530090|NCT04737187|594311936|FG000|Overall Study|Radiological Progressive Disease|145|||
164530091|NCT04737187|594311937|FG001|Overall Study|Radiological Progressive Disease|146|||
164530092|NCT04737187|594311936|FG000|Overall Study|Clinical Progressive Disease|20|||
164530093|NCT04737187|594311937|FG001|Overall Study|Clinical Progressive Disease|20|||
164530094|NCT04737187|594311936|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
164530095|NCT04737187|594311937|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
164530096|NCT04737187|594311936|FG000|Overall Study|Adverse Event|16|||
164530097|NCT04737187|594311937|FG001|Overall Study|Adverse Event|16|||
164530098|NCT04737187|594311936|FG000|Overall Study|Physician Decision|2|||
164530099|NCT04737187|594311937|FG001|Overall Study|Physician Decision|0|||
164530100|NCT04737187|594311936|FG000|Overall Study|Withdrawal by Subject|5|||
164530101|NCT04737187|594311937|FG001|Overall Study|Withdrawal by Subject|8|||
164530102|NCT05227703|594311938|FG000|Overall Study|Adverse Event|2|||
164530103|NCT05227703|594311939|FG001|Overall Study|Adverse Event|6|||
164530104|NCT05227703|594311940|FG002|Overall Study|Adverse Event|4|||
164530105|NCT05227703|594311938|FG000|Overall Study|Lack of Efficacy|4|||
164530106|NCT05227703|594311939|FG001|Overall Study|Lack of Efficacy|0|||
164530107|NCT05227703|594311940|FG002|Overall Study|Lack of Efficacy|1|||
164530108|NCT05227703|594311938|FG000|Overall Study|Physician Decision|2|||
164530109|NCT05227703|594311939|FG001|Overall Study|Physician Decision|2|||
164530110|NCT05227703|594311940|FG002|Overall Study|Physician Decision|1|||
164530111|NCT05227703|594311938|FG000|Overall Study|Protocol Violation|2|||
164530112|NCT05227703|594311939|FG001|Overall Study|Protocol Violation|1|||
164530113|NCT05227703|594311940|FG002|Overall Study|Protocol Violation|0|||
164530114|NCT05227703|594311938|FG000|Overall Study|Withdrawal by Subject|17|||
164530115|NCT05227703|594311939|FG001|Overall Study|Withdrawal by Subject|26|||
164635895|NCT00798161|594692372|FG006|Overall Study|Adverse Event|4|||
164635896|NCT00798161|594692366|FG000|Overall Study|Protocol Violation|2|||
164635897|NCT00798161|594692367|FG001|Overall Study|Protocol Violation|1|||
164635898|NCT00798161|594692368|FG002|Overall Study|Protocol Violation|3|||
164635899|NCT00798161|594692369|FG003|Overall Study|Protocol Violation|3|||
164635900|NCT00798161|594692370|FG004|Overall Study|Protocol Violation|3|||
164635901|NCT00798161|594692371|FG005|Overall Study|Protocol Violation|2|||
164635902|NCT00798161|594692372|FG006|Overall Study|Protocol Violation|0|||
164635903|NCT00798161|594692366|FG000|Overall Study|Lost to Follow-up|1|||
164635904|NCT00798161|594692367|FG001|Overall Study|Lost to Follow-up|3|||
164635905|NCT00798161|594692368|FG002|Overall Study|Lost to Follow-up|4|||
164635906|NCT00798161|594692369|FG003|Overall Study|Lost to Follow-up|3|||
164635907|NCT00798161|594692370|FG004|Overall Study|Lost to Follow-up|4|||
164635908|NCT00798161|594692371|FG005|Overall Study|Lost to Follow-up|0|||
164635909|NCT00798161|594692372|FG006|Overall Study|Lost to Follow-up|0|||
164635910|NCT00798161|594692366|FG000|Overall Study|Withdrawal by Subject|5|||
164635911|NCT00798161|594692367|FG001|Overall Study|Withdrawal by Subject|4|||
164635912|NCT00798161|594692368|FG002|Overall Study|Withdrawal by Subject|5|||
164635913|NCT00798161|594692369|FG003|Overall Study|Withdrawal by Subject|4|||
164635914|NCT00798161|594692370|FG004|Overall Study|Withdrawal by Subject|2|||
164635915|NCT00798161|594692371|FG005|Overall Study|Withdrawal by Subject|3|||
164635916|NCT00798161|594692372|FG006|Overall Study|Withdrawal by Subject|1|||
164635917|NCT00798161|594692366|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
164635918|NCT00798161|594692367|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
164635919|NCT00798161|594692368|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
164635920|NCT00798161|594692369|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
164635921|NCT00798161|594692370|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
164635922|NCT00798161|594692371|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
164635923|NCT00798161|594692372|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
164635924|NCT00726882|594692373|FG000|Overall Study|Withdrawal by Subject|5|||
164635925|NCT00726882|594692373|FG000|Overall Study|Lost to Follow-up|7|||
164635926|NCT00726882|594692373|FG000|Overall Study|Other|10|||
164635927|NCT00344968|594692374|FG000|Overall Study|Adverse Event|5|||
164635928|NCT00344968|594692375|FG001|Overall Study|Adverse Event|4|||
164635929|NCT00344968|594692376|FG002|Overall Study|Adverse Event|15|||
164635930|NCT00344968|594692374|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
164635931|NCT00344968|594692375|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
164635932|NCT00344968|594692376|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
164635933|NCT00344968|594692374|FG000|Overall Study|Protocol Violation|2|||
164635934|NCT00344968|594692375|FG001|Overall Study|Protocol Violation|2|||
164635935|NCT00344968|594692376|FG002|Overall Study|Protocol Violation|5|||
164635936|NCT00344968|594692374|FG000|Overall Study|Withdrawal by Subject|14|||
164635937|NCT00344968|594692375|FG001|Overall Study|Withdrawal by Subject|31|||
164635938|NCT00344968|594692376|FG002|Overall Study|Withdrawal by Subject|27|||
164635939|NCT00344968|594692374|FG000|Overall Study|Lost to Follow-up|24|||
164635940|NCT00344968|594692375|FG001|Overall Study|Lost to Follow-up|37|||
164635941|NCT00344968|594692376|FG002|Overall Study|Lost to Follow-up|37|||
164635942|NCT00344968|594692374|FG000|Overall Study|Death|11|||
164635943|NCT00344968|594692375|FG001|Overall Study|Death|27|||
164635944|NCT00344968|594692376|FG002|Overall Study|Death|31|||
164635945|NCT00344968|594692374|FG000|Overall Study|Other|0|||
164635946|NCT00344968|594692375|FG001|Overall Study|Other|1|||
164635947|NCT00344968|594692376|FG002|Overall Study|Other|0|||
164635948|NCT00594568|594692377|FG000|Initial Treatment|Adverse Event|51|||
164635949|NCT00594568|594692378|FG001|Initial Treatment|Adverse Event|121|||
164635950|NCT00594568|594692379|FG002|Initial Treatment|Adverse Event|144|||
164635951|NCT00594568|594692377|FG000|Initial Treatment|Death|6|||
164635952|NCT00594568|594692378|FG001|Initial Treatment|Death|11|||
164635953|NCT00594568|594692379|FG002|Initial Treatment|Death|15|||
164635954|NCT00594568|594692377|FG000|Initial Treatment|Lost to Follow-up|4|||
164635955|NCT00594568|594692378|FG001|Initial Treatment|Lost to Follow-up|1|||
164635956|NCT00594568|594692379|FG002|Initial Treatment|Lost to Follow-up|4|||
164635957|NCT00594568|594692377|FG000|Initial Treatment|Physician Decision|3|||
164635958|NCT00594568|594692378|FG001|Initial Treatment|Physician Decision|2|||
164635959|NCT00594568|594692379|FG002|Initial Treatment|Physician Decision|4|||
164635960|NCT00594568|594692377|FG000|Initial Treatment|Protocol Violation|2|||
164635961|NCT00594568|594692378|FG001|Initial Treatment|Protocol Violation|2|||
164635962|NCT00594568|594692379|FG002|Initial Treatment|Protocol Violation|5|||
164635963|NCT00594568|594692377|FG000|Initial Treatment|Withdrawal by Subject|25|||
164635964|NCT00594568|594692378|FG001|Initial Treatment|Withdrawal by Subject|31|||
164635965|NCT00594568|594692379|FG002|Initial Treatment|Withdrawal by Subject|46|||
164635966|NCT00594568|594692377|FG000|Initial Treatment|Sponsor decision|193|||
164635967|NCT00594568|594692378|FG001|Initial Treatment|Sponsor decision|142|||
164635968|NCT00594568|594692379|FG002|Initial Treatment|Sponsor decision|147|||
164635969|NCT00594568|594692377|FG000|Initial Treatment|Caregiver decision|21|||
164635970|NCT00594568|594692378|FG001|Initial Treatment|Caregiver decision|36|||
164635971|NCT00594568|594692379|FG002|Initial Treatment|Caregiver decision|36|||
164148529|NCT01823835|592904900|FG008|Overall Study|Study Termination|0|||
164635972|NCT00594568|594692377|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
164635973|NCT00594568|594692378|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
164635974|NCT00594568|594692379|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
164635975|NCT00594568|594692377|FG000|Initial Treatment|Entry criteria exclusion|0|||
164635976|NCT00594568|594692378|FG001|Initial Treatment|Entry criteria exclusion|1|||
164635977|NCT00594568|594692379|FG002|Initial Treatment|Entry criteria exclusion|1|||
164635978|NCT00594568|594692377|FG000|Delayed Start|Death|0|||
164635979|NCT00594568|594692378|FG001|Delayed Start|Death|0|||
164635980|NCT00594568|594692379|FG002|Delayed Start|Death|1|||
164148530|NCT01823835|592904901|FG009|Overall Study|Study Termination|0|||
164530116|NCT05227703|594311940|FG002|Overall Study|Withdrawal by Subject|32|||
164530117|NCT05227703|594311938|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
164530118|NCT05227703|594311939|FG001|Overall Study|Non-Compliance with Study Schedule|1|||
164530119|NCT05227703|594311940|FG002|Overall Study|Non-Compliance with Study Schedule|0|||
164530120|NCT05227703|594311938|FG000|Overall Study|Other|1|||
164530121|NCT05227703|594311939|FG001|Overall Study|Other|1|||
164530122|NCT05227703|594311940|FG002|Overall Study|Other|0|||
164530123|NCT03464097|594311947|FG000|Overall Study|Withdrawal by Subject|15|||
164530124|NCT03464097|594311948|FG001|Overall Study|Withdrawal by Subject|13|||
164530125|NCT03464097|594311949|FG002|Overall Study|Withdrawal by Subject|11|||
164530126|NCT03464097|594311947|FG000|Overall Study|Study terminated by sponsor|47|||
164530127|NCT03464097|594311948|FG001|Overall Study|Study terminated by sponsor|44|||
164530128|NCT03464097|594311949|FG002|Overall Study|Study terminated by sponsor|40|||
164530129|NCT03464097|594311947|FG000|Overall Study|Pregnancy|0|||
164530130|NCT03464097|594311948|FG001|Overall Study|Pregnancy|1|||
164530131|NCT03464097|594311949|FG002|Overall Study|Pregnancy|0|||
164530132|NCT03464097|594311947|FG000|Overall Study|Other reasons|5|||
164530133|NCT03464097|594311948|FG001|Overall Study|Other reasons|12|||
164530134|NCT03464097|594311949|FG002|Overall Study|Other reasons|14|||
164530135|NCT03464097|594311947|FG000|Overall Study|Lost to Follow-up|0|||
164530136|NCT03464097|594311948|FG001|Overall Study|Lost to Follow-up|1|||
164530137|NCT03464097|594311949|FG002|Overall Study|Lost to Follow-up|1|||
164530138|NCT03464097|594311947|FG000|Overall Study|Lack of Efficacy|11|||
164530139|NCT03464097|594311948|FG001|Overall Study|Lack of Efficacy|18|||
164530140|NCT03464097|594311949|FG002|Overall Study|Lack of Efficacy|30|||
164530141|NCT03464097|594311947|FG000|Overall Study|Death|1|||
164530142|NCT03464097|594311948|FG001|Overall Study|Death|0|||
164530143|NCT03464097|594311949|FG002|Overall Study|Death|0|||
164530144|NCT03464097|594311947|FG000|Overall Study|Adverse Event|13|||
164530145|NCT03464097|594311948|FG001|Overall Study|Adverse Event|6|||
164530146|NCT03464097|594311949|FG002|Overall Study|Adverse Event|8|||
164530147|NCT03035201|594311950|FG000|Overall Study|Death|9|||
164530148|NCT03035201|594311951|FG001|Overall Study|Death|12|||
164530149|NCT03035201|594311952|FG002|Overall Study|Death|9|||
164530150|NCT03035201|594311953|FG003|Overall Study|Death|10|||
164530151|NCT03035201|594311950|FG000|Overall Study|Withdrawal by Subject|51|||
164530152|NCT03035201|594311951|FG001|Overall Study|Withdrawal by Subject|49|||
164635981|NCT00594568|594692377|FG000|Delayed Start|Adverse Event|12|||
164635982|NCT00594568|594692378|FG001|Delayed Start|Adverse Event|2|||
164635983|NCT00594568|594692379|FG002|Delayed Start|Adverse Event|2|||
164635984|NCT00594568|594692377|FG000|Delayed Start|Withdrawal by Subject|4|||
164635985|NCT00594568|594692378|FG001|Delayed Start|Withdrawal by Subject|3|||
164635986|NCT00594568|594692379|FG002|Delayed Start|Withdrawal by Subject|0|||
164635987|NCT00594568|594692377|FG000|Delayed Start|Physician Decision|0|||
164635988|NCT00594568|594692378|FG001|Delayed Start|Physician Decision|0|||
164635989|NCT00594568|594692379|FG002|Delayed Start|Physician Decision|1|||
164635990|NCT00594568|594692377|FG000|Delayed Start|Lost to Follow-up|0|||
164635991|NCT00594568|594692378|FG001|Delayed Start|Lost to Follow-up|0|||
164635992|NCT00594568|594692379|FG002|Delayed Start|Lost to Follow-up|1|||
164635993|NCT00594568|594692377|FG000|Delayed Start|Caregiver Decision|5|||
164635994|NCT00594568|594692378|FG001|Delayed Start|Caregiver Decision|6|||
164635995|NCT00594568|594692379|FG002|Delayed Start|Caregiver Decision|2|||
164635996|NCT00594568|594692377|FG000|Delayed Start|Sponsor Decision|77|||
164635997|NCT00594568|594692378|FG001|Delayed Start|Sponsor Decision|66|||
164635998|NCT00594568|594692379|FG002|Delayed Start|Sponsor Decision|59|||
164635999|NCT00594568|594692377|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
164636000|NCT00594568|594692378|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
164636001|NCT00594568|594692379|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
164636002|NCT00594568|594692377|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
164636003|NCT00594568|594692378|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
164636004|NCT00594568|594692379|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
164636005|NCT00594568|594692377|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
164636006|NCT00594568|594692378|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
164636007|NCT00594568|594692379|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
164636008|NCT00594568|594692377|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
164636009|NCT00594568|594692378|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
164636010|NCT00594568|594692379|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
164636011|NCT00594568|594692377|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
164636012|NCT00594568|594692378|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
164636013|NCT00594568|594692379|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
164636014|NCT00594568|594692377|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
164636015|NCT00594568|594692378|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
164636016|NCT00594568|594692379|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
164636017|NCT02526017|594692380|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
164636018|NCT02526017|594692381|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
164636019|NCT02526017|594692382|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
164636020|NCT02526017|594692383|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
164636021|NCT02526017|594692384|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
164636022|NCT02526017|594692385|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
164636023|NCT02526017|594692386|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
164636024|NCT02526017|594692387|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
164636025|NCT02526017|594692388|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
164636026|NCT00423137|594692392|FG000|Overall Study|Lost to Follow-up|0|||
164636027|NCT00423137|594692393|FG001|Overall Study|Lost to Follow-up|0|||
164636028|NCT00423137|594692394|FG002|Overall Study|Lost to Follow-up|1|||
164636029|NCT00423137|594692395|FG003|Overall Study|Lost to Follow-up|0|||
164636030|NCT00423137|594692392|FG000|Overall Study|Protocol Violation|0|||
164636031|NCT00423137|594692393|FG001|Overall Study|Protocol Violation|0|||
164636032|NCT00423137|594692394|FG002|Overall Study|Protocol Violation|0|||
164636033|NCT00423137|594692395|FG003|Overall Study|Protocol Violation|1|||
164636034|NCT00423137|594692392|FG000|Overall Study|Adverse Event Study disease worse|1|||
164636035|NCT00423137|594692393|FG001|Overall Study|Adverse Event Study disease worse|0|||
164636036|NCT00423137|594692394|FG002|Overall Study|Adverse Event Study disease worse|3|||
164636037|NCT00423137|594692395|FG003|Overall Study|Adverse Event Study disease worse|1|||
164636038|NCT00423137|594692392|FG000|Overall Study|Adverse Event Other|0|||
164636039|NCT00423137|594692393|FG001|Overall Study|Adverse Event Other|0|||
164636040|NCT00423137|594692394|FG002|Overall Study|Adverse Event Other|2|||
164636041|NCT00423137|594692395|FG003|Overall Study|Adverse Event Other|0|||
164636042|NCT04196023|594692396|FG000|Overall Study|Withdrawal by Subject|0|||
164636043|NCT04196023|594692397|FG001|Overall Study|Withdrawal by Subject|1|||
164636044|NCT04196023|594692396|FG000|Overall Study|Adverse Event|3|||
164636045|NCT04196023|594692397|FG001|Overall Study|Adverse Event|1|||
164636046|NCT04196023|594692396|FG000|Overall Study|Lost to Follow-up|0|||
164636047|NCT04196023|594692397|FG001|Overall Study|Lost to Follow-up|1|||
164636048|NCT03358407|594692404|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
164636049|NCT03358407|594692405|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
164636050|NCT03358407|594692406|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
164636051|NCT03358407|594692407|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
164636052|NCT03358407|594692408|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
164636053|NCT03358407|594692409|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
164636054|NCT03358407|594692410|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
164636055|NCT03358407|594692411|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
164636056|NCT03358407|594692412|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
164636057|NCT03358407|594692413|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
164636058|NCT03358407|594692404|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164636059|NCT03358407|594692405|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164636060|NCT03358407|594692406|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164636061|NCT03358407|594692407|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164636062|NCT03358407|594692408|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
164636063|NCT03358407|594692409|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164636064|NCT03358407|594692410|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164636065|NCT03358407|594692411|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164636066|NCT03358407|594692412|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164636067|NCT03358407|594692413|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164636068|NCT03358407|594692404|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
164636069|NCT03358407|594692405|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
164530153|NCT03035201|594311952|FG002|Overall Study|Withdrawal by Subject|37|||
164530154|NCT03035201|594311953|FG003|Overall Study|Withdrawal by Subject|46|||
164530155|NCT03035201|594311950|FG000|Overall Study|Lost to Follow-up|67|||
164530156|NCT03035201|594311951|FG001|Overall Study|Lost to Follow-up|51|||
164530157|NCT03035201|594311952|FG002|Overall Study|Lost to Follow-up|64|||
164148531|NCT01823835|592904902|FG010|Overall Study|Study Termination|0|||
164636070|NCT03358407|594692406|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
164636071|NCT03358407|594692407|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
164636072|NCT03358407|594692408|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
164636073|NCT03358407|594692409|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
164636074|NCT03358407|594692410|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
164636075|NCT03358407|594692411|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
164636076|NCT03358407|594692412|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
164636077|NCT03358407|594692413|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
164636078|NCT03358407|594692404|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
164636079|NCT03358407|594692405|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
164636080|NCT03358407|594692406|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
164636081|NCT03358407|594692407|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
164636082|NCT03358407|594692408|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
164636083|NCT03358407|594692409|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
164636084|NCT03358407|594692410|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
164636085|NCT03358407|594692411|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
164636086|NCT03358407|594692412|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
164636087|NCT03358407|594692413|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
164636088|NCT03358407|594692404|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164636089|NCT03358407|594692405|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164636090|NCT03358407|594692406|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164636091|NCT03358407|594692407|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164636092|NCT03358407|594692408|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164636093|NCT03358407|594692409|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
164636094|NCT03358407|594692410|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
164636095|NCT03358407|594692411|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164636096|NCT03358407|594692412|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164636097|NCT03358407|594692413|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164636098|NCT03358407|594692404|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
164636099|NCT03358407|594692405|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
164636100|NCT03358407|594692406|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
164636101|NCT03358407|594692407|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
164636102|NCT03358407|594692408|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
164636103|NCT03358407|594692409|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
164636104|NCT03358407|594692410|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
164636105|NCT03358407|594692411|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
164636106|NCT03358407|594692412|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
164636107|NCT03358407|594692413|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
164636108|NCT00483574|594692414|FG000|Overall Study|Adverse Event|6|||
164636109|NCT00483574|594692415|FG001|Overall Study|Adverse Event|0|||
164636110|NCT00483574|594692414|FG000|Overall Study|Protocol Violation|28|||
164636111|NCT00483574|594692415|FG001|Overall Study|Protocol Violation|9|||
164636112|NCT00483574|594692414|FG000|Overall Study|Lost to Follow-up|16|||
164636113|NCT00483574|594692415|FG001|Overall Study|Lost to Follow-up|4|||
164636114|NCT00483574|594692414|FG000|Overall Study|Withdrawal by Subject|52|||
164636115|NCT00483574|594692415|FG001|Overall Study|Withdrawal by Subject|0|||
164636116|NCT00489411|594692416|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
164636117|NCT00489411|594692417|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
164636118|NCT00489411|594692416|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
164636119|NCT00489411|594692417|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
164636120|NCT00489411|594692416|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
164636121|NCT00489411|594692417|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
164636122|NCT00489411|594692416|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
164636123|NCT00489411|594692417|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
164636124|NCT00489411|594692416|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
164636125|NCT00489411|594692417|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
164636126|NCT03841331|594692418|FG000|Overall Study|Withdrawal by Subject|4|||
164636127|NCT03841331|594692419|FG001|Overall Study|Withdrawal by Subject|9|||
164636128|NCT03841331|594692418|FG000|Overall Study|Lost to Follow-up|5|||
164636129|NCT03841331|594692419|FG001|Overall Study|Lost to Follow-up|1|||
164530158|NCT03035201|594311953|FG003|Overall Study|Lost to Follow-up|69|||
164530159|NCT00001962|594313649|FG000|Overall Study|Lack of Efficacy|18|||
164530160|NCT00001962|594313649|FG000|Overall Study|Lack of Accrual|6|||
164530161|NCT00001962|594313649|FG000|Overall Study|Death|1|||
164530162|NCT00001962|594313649|FG000|Overall Study|Lost to Follow-up|2|||
164530163|NCT00001962|594313649|FG000|Overall Study|Adverse Event|1|||
164530164|NCT00604279|594313653|FG000|Overall Study|Lack of Efficacy|22|||
164530165|NCT00604279|594313654|FG001|Overall Study|Lack of Efficacy|9|||
164530166|NCT00604279|594313653|FG000|Overall Study|Lost to Follow-up|9|||
164148532|NCT01823835|592904903|FG011|Overall Study|Study Termination|1|||
164530167|NCT00604279|594313654|FG001|Overall Study|Lost to Follow-up|14|||
164530168|NCT00604279|594313653|FG000|Overall Study|Pregnancy|2|||
164530169|NCT00604279|594313654|FG001|Overall Study|Pregnancy|0|||
164530170|NCT00604279|594313653|FG000|Overall Study|Protocol Violation|3|||
164530171|NCT00604279|594313654|FG001|Overall Study|Protocol Violation|1|||
164148533|NCT01823835|592904904|FG012|Overall Study|Study Termination|0|||
164636130|NCT00779857|594692421|FG000|Overall Study|Death|1|||
164636131|NCT00779857|594692421|FG000|Overall Study|Withdrawal by Subject|3|||
164636132|NCT00779857|594692421|FG000|Overall Study|Missed Visit|2|||
164636133|NCT04640168|594692422|FG000|Overall Study|Withdrawal by Subject|8|||
164636134|NCT04640168|594692423|FG001|Overall Study|Withdrawal by Subject|7|||
164636135|NCT04640168|594692422|FG000|Overall Study|Lost to Follow-up|1|||
164636136|NCT04640168|594692423|FG001|Overall Study|Lost to Follow-up|0|||
164636137|NCT04640168|594692422|FG000|Overall Study|Enrolled but not treated|12|||
164636138|NCT04640168|594692423|FG001|Overall Study|Enrolled but not treated|12|||
164636139|NCT00442572|594692427|FG000|Overall Study|Relapse|8|||
164636140|NCT00442572|594692428|FG001|Overall Study|Relapse|1|||
164636141|NCT00442572|594692427|FG000|Overall Study|Lost to Follow-up|0|||
164636142|NCT00442572|594692428|FG001|Overall Study|Lost to Follow-up|1|||
164636143|NCT00442572|594692427|FG000|Overall Study|Withdrawal by Subject|0|||
164636144|NCT00442572|594692428|FG001|Overall Study|Withdrawal by Subject|1|||
164636145|NCT00634933|594692435|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
164636146|NCT00634933|594692436|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
164636147|NCT00634933|594692437|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
164636148|NCT00634933|594692438|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
164636149|NCT00634933|594692439|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
164636150|NCT00634933|594692435|FG000|Part A: Baseline to Week 24|Death|1|||
164636151|NCT00634933|594692436|FG001|Part A: Baseline to Week 24|Death|0|||
164636152|NCT00634933|594692437|FG002|Part A: Baseline to Week 24|Death|0|||
164636153|NCT00634933|594692438|FG003|Part A: Baseline to Week 24|Death|0|||
164636154|NCT00634933|594692439|FG004|Part A: Baseline to Week 24|Death|0|||
164636155|NCT00634933|594692435|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
164636156|NCT00634933|594692436|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
164636157|NCT00634933|594692437|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
164636158|NCT00634933|594692438|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
164636159|NCT00634933|594692439|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
164636160|NCT00634933|594692435|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
164636161|NCT00634933|594692436|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
164636162|NCT00634933|594692437|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
164636163|NCT00634933|594692438|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
164636164|NCT00634933|594692439|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
164636165|NCT00634933|594692435|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
164636166|NCT00634933|594692436|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
164636167|NCT00634933|594692437|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
164636168|NCT00634933|594692438|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
164636169|NCT00634933|594692439|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
164636170|NCT00634933|594692435|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
164636171|NCT00634933|594692436|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
164636172|NCT00634933|594692437|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
164636173|NCT00634933|594692438|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
164636174|NCT00634933|594692439|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
164636175|NCT00634933|594692435|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
164636176|NCT00634933|594692436|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
164636177|NCT00634933|594692437|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
164636178|NCT00634933|594692438|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
164636179|NCT00634933|594692439|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
164636180|NCT00634933|594692435|FG000|Part A: Baseline to Week 24|Other|1|||
164636181|NCT00634933|594692436|FG001|Part A: Baseline to Week 24|Other|8|||
164636182|NCT00634933|594692437|FG002|Part A: Baseline to Week 24|Other|5|||
164636183|NCT00634933|594692438|FG003|Part A: Baseline to Week 24|Other|0|||
164636184|NCT00634933|594692439|FG004|Part A: Baseline to Week 24|Other|0|||
164636185|NCT00634933|594692435|FG000|Between Part A and Part B|Physician Decision|0|||
164636186|NCT00634933|594692436|FG001|Between Part A and Part B|Physician Decision|1|||
164636187|NCT00634933|594692437|FG002|Between Part A and Part B|Physician Decision|0|||
164636188|NCT00634933|594692438|FG003|Between Part A and Part B|Physician Decision|0|||
164636189|NCT00634933|594692439|FG004|Between Part A and Part B|Physician Decision|0|||
164636190|NCT00634933|594692435|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
164636191|NCT00634933|594692436|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
164636192|NCT00634933|594692437|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
164636193|NCT00634933|594692438|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
164636194|NCT00634933|594692439|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
164636195|NCT00634933|594692435|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
164636196|NCT00634933|594692436|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
164636197|NCT00634933|594692437|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
164636198|NCT00634933|594692438|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
164636199|NCT00634933|594692439|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
164636200|NCT00634933|594692435|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
164636201|NCT00634933|594692436|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
164148534|NCT01823835|592904905|FG013|Overall Study|Study Termination|0|||
164148535|NCT01823835|592904906|FG014|Overall Study|Study Termination|0|||
164636202|NCT00634933|594692437|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
164636203|NCT00634933|594692438|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
164636204|NCT00634933|594692439|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
164636205|NCT00634933|594692435|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
164636206|NCT00634933|594692436|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
164636207|NCT00634933|594692437|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
164636208|NCT00634933|594692438|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
164636209|NCT00634933|594692439|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
164636210|NCT00634933|594692435|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
164636211|NCT00634933|594692436|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
164636212|NCT00634933|594692437|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
164636213|NCT00634933|594692438|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
164636214|NCT00634933|594692439|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
164636215|NCT00634933|594692435|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
164636216|NCT00634933|594692436|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
164636217|NCT00634933|594692437|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
164636218|NCT00634933|594692438|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
164636219|NCT00634933|594692439|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
164636220|NCT00634933|594692435|FG000|Part B: Week 24 to Week 52|Other|0|||
164636221|NCT00634933|594692436|FG001|Part B: Week 24 to Week 52|Other|0|||
164636222|NCT00634933|594692437|FG002|Part B: Week 24 to Week 52|Other|5|||
164636223|NCT00634933|594692438|FG003|Part B: Week 24 to Week 52|Other|0|||
164636224|NCT00634933|594692439|FG004|Part B: Week 24 to Week 52|Other|1|||
164636225|NCT04338685|594692440|FG000|Overall Study|Death|3|||
164636226|NCT04338685|594692441|FG001|Overall Study|Death|4|||
164636227|NCT04338685|594692442|FG002|Overall Study|Death|2|||
164636228|NCT04338685|594692443|FG003|Overall Study|Death|4|||
164636229|NCT04338685|594692444|FG004|Overall Study|Death|4|||
164636230|NCT04338685|594692445|FG005|Overall Study|Death|8|||
164636231|NCT04338685|594692446|FG006|Overall Study|Death|1|||
164636232|NCT04338685|594692447|FG007|Overall Study|Death|0|||
164636233|NCT04338685|594692448|FG008|Overall Study|Death|0|||
164636234|NCT04338685|594692440|FG000|Overall Study|Study terminated by Sponsor|0|||
164636235|NCT04338685|594692441|FG001|Overall Study|Study terminated by Sponsor|0|||
164636236|NCT04338685|594692442|FG002|Overall Study|Study terminated by Sponsor|1|||
164636237|NCT04338685|594692443|FG003|Overall Study|Study terminated by Sponsor|4|||
164636238|NCT04338685|594692444|FG004|Overall Study|Study terminated by Sponsor|0|||
164636239|NCT04338685|594692445|FG005|Overall Study|Study terminated by Sponsor|5|||
164636240|NCT04338685|594692446|FG006|Overall Study|Study terminated by Sponsor|2|||
164636241|NCT04338685|594692447|FG007|Overall Study|Study terminated by Sponsor|4|||
164636242|NCT04338685|594692448|FG008|Overall Study|Study terminated by Sponsor|1|||
164636243|NCT04338685|594692440|FG000|Overall Study|Withdrawal by Subject|1|||
164636244|NCT04338685|594692441|FG001|Overall Study|Withdrawal by Subject|2|||
164636245|NCT04338685|594692442|FG002|Overall Study|Withdrawal by Subject|0|||
164636246|NCT04338685|594692443|FG003|Overall Study|Withdrawal by Subject|2|||
164636247|NCT04338685|594692444|FG004|Overall Study|Withdrawal by Subject|0|||
164636248|NCT04338685|594692445|FG005|Overall Study|Withdrawal by Subject|5|||
164636249|NCT04338685|594692446|FG006|Overall Study|Withdrawal by Subject|1|||
164636250|NCT04338685|594692447|FG007|Overall Study|Withdrawal by Subject|1|||
164636251|NCT04338685|594692448|FG008|Overall Study|Withdrawal by Subject|0|||
164636252|NCT00234533|594692449|FG000|Overall Study|Withdrawal by Subject|6|||
164636253|NCT00234533|594692449|FG000|Overall Study|Adverse Event|2|||
164636254|NCT00234533|594692449|FG000|Overall Study|Enrolled but not treated|3|||
164636255|NCT00976989|594692450|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
164636256|NCT00976989|594692451|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
164636257|NCT00976989|594692452|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
164636258|NCT00976989|594692450|FG000|Overall Study|Death|5|||
164636259|NCT00976989|594692451|FG001|Overall Study|Death|7|||
164636260|NCT00976989|594692452|FG002|Overall Study|Death|10|||
164636261|NCT00976989|594692450|FG000|Overall Study|Refused Treatment|4|||
164636262|NCT00976989|594692451|FG001|Overall Study|Refused Treatment|3|||
164636263|NCT00976989|594692452|FG002|Overall Study|Refused Treatment|5|||
164636264|NCT00976989|594692450|FG000|Overall Study|Failure to Return|2|||
164636265|NCT00976989|594692451|FG001|Overall Study|Failure to Return|1|||
164636266|NCT00976989|594692452|FG002|Overall Study|Failure to Return|0|||
164636267|NCT00976989|594692450|FG000|Overall Study|Recurrence of Disease|0|||
164636268|NCT00976989|594692451|FG001|Overall Study|Recurrence of Disease|1|||
164636269|NCT00976989|594692452|FG002|Overall Study|Recurrence of Disease|0|||
164636270|NCT00976989|594692450|FG000|Overall Study|Other|1|||
164636271|NCT00976989|594692451|FG001|Overall Study|Other|0|||
164636272|NCT00976989|594692452|FG002|Overall Study|Other|1|||
164636273|NCT00570492|594692453|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
164636274|NCT00570492|594692454|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
164636275|NCT00570492|594692455|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
164636276|NCT00570492|594692453|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
164636277|NCT00570492|594692454|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
164636278|NCT00570492|594692455|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
164636279|NCT00570492|594692453|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
164636280|NCT00570492|594692454|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
164636281|NCT00570492|594692455|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
164636282|NCT00570492|594692453|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
164636283|NCT00570492|594692454|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
164636284|NCT00570492|594692455|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
164636285|NCT00570492|594692453|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
164636286|NCT00570492|594692454|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
164636287|NCT00570492|594692455|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
164636288|NCT00570492|594692453|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
164636289|NCT00570492|594692454|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
164636290|NCT00570492|594692455|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
164636291|NCT00570492|594692453|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
164636292|NCT00570492|594692454|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
164636293|NCT00570492|594692455|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
164636294|NCT00570492|594692453|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
164636295|NCT00570492|594692454|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
164636296|NCT00570492|594692455|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
164636297|NCT00570492|594692453|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
164636298|NCT00570492|594692454|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
164636299|NCT00570492|594692455|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
164636300|NCT00570492|594692453|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
164636301|NCT00570492|594692454|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
164636302|NCT00570492|594692455|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
164636303|NCT00570492|594692453|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
164636304|NCT00570492|594692454|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
164636305|NCT00570492|594692455|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
164636306|NCT00570492|594692453|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
164148614|NCT04895982|592904922|FG011|Overall Study|Other|0|||
164530172|NCT00604279|594313653|FG000|Overall Study|Withdrawal by Subject|16|||
164530173|NCT00604279|594313654|FG001|Overall Study|Withdrawal by Subject|5|||
164530174|NCT00604279|594313653|FG000|Overall Study|Adverse Event|4|||
164530175|NCT00604279|594313654|FG001|Overall Study|Adverse Event|5|||
164530176|NCT00604279|594313653|FG000|Overall Study|Other|8|||
164530177|NCT00604279|594313654|FG001|Overall Study|Other|4|||
164530178|NCT03938545|594313655|FG000|Overall Study|Lost to Follow-up|0|||
164530179|NCT03938545|594313656|FG001|Overall Study|Lost to Follow-up|0|||
164530180|NCT03938545|594313657|FG002|Overall Study|Lost to Follow-up|0|||
164530181|NCT03938545|594313658|FG003|Overall Study|Lost to Follow-up|1|||
164530182|NCT03938545|594313655|FG000|Overall Study|Non-compliance with study drug|0|||
164530183|NCT03938545|594313656|FG001|Overall Study|Non-compliance with study drug|0|||
164636307|NCT00570492|594692454|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
164636308|NCT00570492|594692455|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
164636309|NCT00570492|594692453|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
164636310|NCT00570492|594692454|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
164636311|NCT00570492|594692455|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
164636312|NCT00570492|594692453|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
164636313|NCT00570492|594692454|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
164636314|NCT00570492|594692455|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
164636315|NCT00908375|594692456|FG000|Overall Study|Withdrawal by Subject|2|||
164636316|NCT00908375|594692457|FG001|Overall Study|Withdrawal by Subject|4|||
164636317|NCT00908375|594692456|FG000|Overall Study|Lost to Follow-up|8|||
164636318|NCT00908375|594692457|FG001|Overall Study|Lost to Follow-up|6|||
164636319|NCT00903357|594692458|FG000|First Intervention|Withdrawal by Subject|5|||
164636320|NCT00903357|594692459|FG001|First Intervention|Withdrawal by Subject|3|||
164636321|NCT00903357|594692458|FG000|First Intervention|Flu|0|||
164636322|NCT00903357|594692459|FG001|First Intervention|Flu|1|||
164636323|NCT00903357|594692458|FG000|Wash Out Period of 2 Weeks|Flu|0|||
164636324|NCT00903357|594692459|FG001|Wash Out Period of 2 Weeks|Flu|1|||
164636325|NCT00903357|594692458|FG000|Second Intervention|Lost to Follow-up|1|||
164636326|NCT00903357|594692459|FG001|Second Intervention|Lost to Follow-up|0|||
164636327|NCT02279888|594692461|FG000|Overall Study|Death|326|||
164636328|NCT02279888|594692461|FG000|Overall Study|Withdrawal by Subject|38|||
164636329|NCT02279888|594692461|FG000|Overall Study|Lost to Follow-up|21|||
164636330|NCT02279888|594692461|FG000|Overall Study|Physician Decision|62|||
164636331|NCT02279888|594692461|FG000|Overall Study|Subject Non-compliance|43|||
164636332|NCT02279888|594692461|FG000|Overall Study|Not implanted|14|||
164636333|NCT02279888|594692461|FG000|Overall Study|Visit not performed|26|||
164636334|NCT00752206|594692462|FG000|Overall Study|Disease progression|8|||
164636335|NCT00752206|594692463|FG001|Overall Study|Disease progression|11|||
164636336|NCT00752206|594692462|FG000|Overall Study|Pregnancy|1|||
164636337|NCT00752206|594692463|FG001|Overall Study|Pregnancy|0|||
164636338|NCT01484691|594692464|FG000|Overall Study|Withdrawal by Subject|1|||
164636339|NCT01484691|594692465|FG001|Overall Study|Withdrawal by Subject|1|||
164636340|NCT01484691|594692466|FG002|Overall Study|Withdrawal by Subject|1|||
164636341|NCT01484691|594692464|FG000|Overall Study|Physician Decision|0|||
164636342|NCT01484691|594692465|FG001|Overall Study|Physician Decision|2|||
164636343|NCT01484691|594692466|FG002|Overall Study|Physician Decision|1|||
164636344|NCT03522506|594692467|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164636345|NCT03522506|594692468|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164636346|NCT03522506|594692469|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164636347|NCT03522506|594692470|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
164636348|NCT03522506|594692467|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
164636349|NCT03522506|594692468|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
164636350|NCT03522506|594692469|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
164636351|NCT03522506|594692470|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
164636352|NCT03480243|594692473|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
164636353|NCT03480243|594692473|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
164636354|NCT04365387|594692474|FG000|Overall Study|Adverse Event|4|||
164636355|NCT04365387|594692475|FG001|Overall Study|Adverse Event|2|||
164636356|NCT04365387|594692474|FG000|Overall Study|Participants request|14|||
164636357|NCT04365387|594692475|FG001|Overall Study|Participants request|14|||
164636358|NCT04365387|594692474|FG000|Overall Study|Lost to Follow-up|8|||
164636359|NCT04365387|594692475|FG001|Overall Study|Lost to Follow-up|5|||
164636360|NCT04365387|594692474|FG000|Overall Study|Protocol deviation|3|||
164636361|NCT04365387|594692475|FG001|Overall Study|Protocol deviation|4|||
164636362|NCT04365387|594692474|FG000|Overall Study|Participant compliance with visit schedule|1|||
164636363|NCT04365387|594692475|FG001|Overall Study|Participant compliance with visit schedule|0|||
164636364|NCT04365387|594692474|FG000|Overall Study|Participant incarcerated|1|||
164636365|NCT04365387|594692475|FG001|Overall Study|Participant incarcerated|0|||
164636366|NCT04365387|594692474|FG000|Overall Study|Participant moved out of town (relocated)|0|||
164636367|NCT04365387|594692475|FG001|Overall Study|Participant moved out of town (relocated)|1|||
164636368|NCT04365387|594692474|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
164636369|NCT04365387|594692475|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
164636370|NCT04365387|594692474|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
164636371|NCT04365387|594692475|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
164636372|NCT05770401|594692476|FG000|Overall Study|Lost to Follow-up|5|||
164636373|NCT05770401|594692477|FG001|Overall Study|Lost to Follow-up|4|||
164636374|NCT01683565|594692480|FG000|Overall Study|Lost to Follow-up|2|||
164636375|NCT01683565|594692481|FG001|Overall Study|Lost to Follow-up|0|||
164148615|NCT04895982|592904911|FG000|Overall Study|Protocol Violation|0|||
164530184|NCT03938545|594313657|FG002|Overall Study|Non-compliance with study drug|1|||
164530185|NCT03938545|594313658|FG003|Overall Study|Non-compliance with study drug|0|||
164530186|NCT03938545|594313655|FG000|Overall Study|Pregnancy|1|||
164530187|NCT03938545|594313656|FG001|Overall Study|Pregnancy|0|||
164530188|NCT03938545|594313657|FG002|Overall Study|Pregnancy|0|||
164530189|NCT03938545|594313658|FG003|Overall Study|Pregnancy|0|||
164530190|NCT03938545|594313655|FG000|Overall Study|Study terminated by sponsor|6|||
164530191|NCT03938545|594313656|FG001|Overall Study|Study terminated by sponsor|4|||
164530192|NCT03938545|594313657|FG002|Overall Study|Study terminated by sponsor|2|||
164530193|NCT03938545|594313658|FG003|Overall Study|Study terminated by sponsor|4|||
164530194|NCT03938545|594313655|FG000|Overall Study|Withdrawal by Subject|0|||
164530195|NCT03938545|594313656|FG001|Overall Study|Withdrawal by Subject|1|||
164636376|NCT01683565|594692480|FG000|Overall Study|Discontinued Intervention|1|||
164636377|NCT01683565|594692481|FG001|Overall Study|Discontinued Intervention|1|||
164636378|NCT00764465|594692482|FG000|Overall Study|Adverse Event|2|||
164636379|NCT00764465|594692483|FG001|Overall Study|Adverse Event|0|||
164636380|NCT00764465|594692484|FG002|Overall Study|Adverse Event|0|||
164636381|NCT00764465|594692485|FG003|Overall Study|Adverse Event|1|||
164636382|NCT00764465|594692486|FG004|Overall Study|Adverse Event|1|||
164636383|NCT00764465|594692487|FG005|Overall Study|Adverse Event|1|||
164636384|NCT00764465|594692482|FG000|Overall Study|Withdrawal by Subject|0|||
164636385|NCT00764465|594692483|FG001|Overall Study|Withdrawal by Subject|1|||
164636386|NCT00764465|594692484|FG002|Overall Study|Withdrawal by Subject|1|||
164636387|NCT00764465|594692485|FG003|Overall Study|Withdrawal by Subject|0|||
164636388|NCT00764465|594692486|FG004|Overall Study|Withdrawal by Subject|0|||
164636389|NCT00764465|594692487|FG005|Overall Study|Withdrawal by Subject|0|||
164636390|NCT01195662|594692488|FG000|Double Blind Treatment Period|Adverse Event|4|||
164636391|NCT01195662|594692489|FG001|Double Blind Treatment Period|Adverse Event|1|||
164636392|NCT01195662|594692490|FG002|Double Blind Treatment Period|Adverse Event|2|||
164636393|NCT01195662|594692488|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
164636394|NCT01195662|594692489|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
164636395|NCT01195662|594692490|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
164636396|NCT01195662|594692488|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
164636397|NCT01195662|594692489|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
164636398|NCT01195662|594692490|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
164636399|NCT01195662|594692488|FG000|Double Blind Treatment Period|Administrative reason|2|||
164636400|NCT01195662|594692489|FG001|Double Blind Treatment Period|Administrative reason|1|||
164636401|NCT01195662|594692490|FG002|Double Blind Treatment Period|Administrative reason|1|||
164636402|NCT01195662|594692488|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
164636403|NCT01195662|594692489|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
164636404|NCT01195662|594692490|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
164636405|NCT01195662|594692488|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
164636406|NCT01195662|594692489|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
164636407|NCT01195662|594692490|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
164636408|NCT01195662|594692488|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
164636409|NCT01195662|594692489|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
164636410|NCT01195662|594692490|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
164636411|NCT01195662|594692488|FG000|Double Blind Treatment Period|Non-specified|3|||
164636412|NCT01195662|594692489|FG001|Double Blind Treatment Period|Non-specified|0|||
164636413|NCT01195662|594692490|FG002|Double Blind Treatment Period|Non-specified|0|||
164636414|NCT01195662|594692488|FG000|Double Blind Treatment Period|Missing disposition information|0|||
164636415|NCT01195662|594692489|FG001|Double Blind Treatment Period|Missing disposition information|1|||
164636416|NCT01195662|594692490|FG002|Double Blind Treatment Period|Missing disposition information|1|||
164636417|NCT01195662|594692488|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
164636418|NCT01195662|594692489|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
164636419|NCT01195662|594692490|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
164636420|NCT01195662|594692488|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
164636421|NCT01195662|594692489|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
164636422|NCT01195662|594692490|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
164636423|NCT01326481|594692498|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
164636424|NCT04794491|594692499|FG000|Overall Study|Adverse Event|1|||
164636425|NCT04794491|594692499|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
164636426|NCT04794491|594692499|FG000|Overall Study|Noncompliance With Study Intervention|1|||
164636427|NCT04794491|594692499|FG000|Overall Study|Withdrawal by Subject|2|||
164636428|NCT00242658|594692502|FG000|Overall Study|Lost to Follow-up|22|||
164636429|NCT00242658|594692503|FG001|Overall Study|Lost to Follow-up|19|||
164636430|NCT04524507|594692505|FG000|Overall Study|Lost to Follow-up|2|||
164636431|NCT04524507|594692506|FG001|Overall Study|Lost to Follow-up|4|||
164530196|NCT03938545|594313657|FG002|Overall Study|Withdrawal by Subject|0|||
164530197|NCT03938545|594313658|FG003|Overall Study|Withdrawal by Subject|0|||
164530198|NCT03938545|594313655|FG000|Overall Study|Adverse Event|1|||
164530199|NCT03938545|594313656|FG001|Overall Study|Adverse Event|0|||
164636432|NCT04524507|594692505|FG000|Overall Study|Withdrawal by Subject|2|||
164636433|NCT04524507|594692506|FG001|Overall Study|Withdrawal by Subject|9|||
164636434|NCT04524507|594692505|FG000|Overall Study|Death|2|||
164636435|NCT04524507|594692506|FG001|Overall Study|Death|10|||
164636436|NCT00465894|594692518|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
164636437|NCT00465894|594692519|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
164636438|NCT00465894|594692518|FG000|Treatment For 12 Weeks|Family Issues|1|||
164636439|NCT00465894|594692519|FG001|Treatment For 12 Weeks|Family Issues|1|||
164636440|NCT00465894|594692518|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
164636441|NCT00465894|594692519|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
164636442|NCT03039699|594692520|FG000|Overall Study|Incorrect inclusion|5|||
164636443|NCT03039699|594692521|FG001|Overall Study|Incorrect inclusion|4|||
164636444|NCT03039699|594692520|FG000|Overall Study|Lack of data to assess study endpoint|5|||
164636445|NCT03039699|594692521|FG001|Overall Study|Lack of data to assess study endpoint|3|||
164636446|NCT03039699|594692520|FG000|Overall Study|Bacterial infection|12|||
164636447|NCT03039699|594692521|FG001|Overall Study|Bacterial infection|28|||
164636448|NCT00540228|594692522|FG000|Overall Study|Adverse Event|2|||
164636449|NCT00540228|594692523|FG001|Overall Study|Adverse Event|0|||
164636450|NCT00540228|594692524|FG002|Overall Study|Adverse Event|0|||
164636451|NCT00540228|594692525|FG003|Overall Study|Adverse Event|0|||
164636452|NCT00540228|594692526|FG004|Overall Study|Adverse Event|0|||
164636453|NCT00540228|594692522|FG000|Overall Study|Lost to Follow-up|1|||
164636454|NCT00540228|594692523|FG001|Overall Study|Lost to Follow-up|1|||
164636455|NCT00540228|594692524|FG002|Overall Study|Lost to Follow-up|0|||
164636456|NCT00540228|594692525|FG003|Overall Study|Lost to Follow-up|0|||
164636457|NCT00540228|594692526|FG004|Overall Study|Lost to Follow-up|0|||
164636458|NCT02569996|594692527|FG000|Overall Study|Adverse Event|6|||
164636459|NCT02569996|594692527|FG000|Overall Study|Physician Decision|3|||
164636460|NCT02569996|594692527|FG000|Overall Study|Progression of the disease|18|||
164636461|NCT02569996|594692527|FG000|Overall Study|New anti-lymphoma treatment|1|||
164636462|NCT02569996|594692527|FG000|Overall Study|Non-compliance|9|||
164636463|NCT02569996|594692527|FG000|Overall Study|Withdrawal by Subject|5|||
164636464|NCT02569996|594692527|FG000|Overall Study|Lost to Follow-up|5|||
164636465|NCT02569996|594692527|FG000|Overall Study|Complete remission|7|||
164636466|NCT02569996|594692527|FG000|Overall Study|Unknown reason|1|||
164636467|NCT01349816|594692528|FG000|Overall Study|Withdrawal by Subject|4|||
164636468|NCT01349816|594692528|FG000|Overall Study|Physician Decision|1|||
164636469|NCT01349816|594692528|FG000|Overall Study|Adverse Event|14|||
164636470|NCT01349816|594692528|FG000|Overall Study|Lost to Follow-up|2|||
164636471|NCT01349816|594692528|FG000|Overall Study|Protocol Violation|1|||
164636472|NCT01349816|594692528|FG000|Overall Study|Protocol-specified criteria|8|||
164636473|NCT01397409|594692532|FG000|Stage 2|Adverse Event|0|||
164636474|NCT01397409|594692533|FG001|Stage 2|Adverse Event|0|||
164636475|NCT01397409|594692534|FG002|Stage 2|Adverse Event|0|||
164636476|NCT01397409|594692535|FG003|Stage 2|Adverse Event|0|||
164636477|NCT01397409|594692536|FG004|Stage 2|Adverse Event|6|||
164636478|NCT01397409|594692537|FG005|Stage 2|Adverse Event|3|||
164636479|NCT01397409|594692538|FG006|Stage 2|Adverse Event|0|||
164636480|NCT01397409|594692539|FG007|Stage 2|Adverse Event|0|||
164636481|NCT01397409|594692540|FG008|Stage 2|Adverse Event|0|||
164636482|NCT01397409|594692541|FG009|Stage 2|Adverse Event|0|||
164636483|NCT01397409|594692532|FG000|Stage 2|Personal Reasons|0|||
164636484|NCT01397409|594692533|FG001|Stage 2|Personal Reasons|0|||
164636485|NCT01397409|594692534|FG002|Stage 2|Personal Reasons|0|||
164636486|NCT01397409|594692535|FG003|Stage 2|Personal Reasons|0|||
164636487|NCT01397409|594692536|FG004|Stage 2|Personal Reasons|1|||
164636488|NCT01397409|594692537|FG005|Stage 2|Personal Reasons|0|||
164636489|NCT01397409|594692538|FG006|Stage 2|Personal Reasons|0|||
164636490|NCT01397409|594692539|FG007|Stage 2|Personal Reasons|0|||
164636491|NCT01397409|594692540|FG008|Stage 2|Personal Reasons|0|||
164636492|NCT01397409|594692541|FG009|Stage 2|Personal Reasons|0|||
164636493|NCT01397409|594692532|FG000|Stage 2|Other Miscellaneous Reasons|0|||
164636494|NCT01397409|594692533|FG001|Stage 2|Other Miscellaneous Reasons|0|||
164636495|NCT01397409|594692534|FG002|Stage 2|Other Miscellaneous Reasons|0|||
164636496|NCT01397409|594692535|FG003|Stage 2|Other Miscellaneous Reasons|0|||
164636497|NCT01397409|594692536|FG004|Stage 2|Other Miscellaneous Reasons|1|||
164636498|NCT01397409|594692537|FG005|Stage 2|Other Miscellaneous Reasons|1|||
164636499|NCT01397409|594692538|FG006|Stage 2|Other Miscellaneous Reasons|0|||
164636500|NCT01397409|594692539|FG007|Stage 2|Other Miscellaneous Reasons|0|||
164636501|NCT01397409|594692540|FG008|Stage 2|Other Miscellaneous Reasons|0|||
164636502|NCT01397409|594692541|FG009|Stage 2|Other Miscellaneous Reasons|0|||
164636503|NCT01397409|594692532|FG000|Stage 3|Adverse Event|0|||
164636504|NCT01397409|594692533|FG001|Stage 3|Adverse Event|0|||
164636505|NCT01397409|594692534|FG002|Stage 3|Adverse Event|0|||
164636506|NCT01397409|594692535|FG003|Stage 3|Adverse Event|0|||
164636507|NCT01397409|594692536|FG004|Stage 3|Adverse Event|0|||
164636508|NCT01397409|594692537|FG005|Stage 3|Adverse Event|0|||
164636509|NCT01397409|594692538|FG006|Stage 3|Adverse Event|0|||
164636510|NCT01397409|594692539|FG007|Stage 3|Adverse Event|1|||
164636511|NCT01397409|594692540|FG008|Stage 3|Adverse Event|0|||
164530200|NCT03938545|594313657|FG002|Overall Study|Adverse Event|0|||
164530201|NCT03938545|594313658|FG003|Overall Study|Adverse Event|0|||
164530202|NCT00355056|594313659|FG000|Randomization Period|Early Termination|4|||
164530203|NCT00355056|594313660|FG001|Randomization Period|Early Termination|6|||
164530204|NCT01060540|594313661|FG000|Overall Study|Withdrawal by Subject|10|||
164530205|NCT01060540|594313662|FG001|Overall Study|Withdrawal by Subject|20|||
164636512|NCT01397409|594692541|FG009|Stage 3|Adverse Event|0|||
164636513|NCT01397409|594692532|FG000|Stage 3|Other Miscellaneous Reasons|0|||
164636514|NCT01397409|594692533|FG001|Stage 3|Other Miscellaneous Reasons|0|||
164636515|NCT01397409|594692534|FG002|Stage 3|Other Miscellaneous Reasons|0|||
164636516|NCT01397409|594692535|FG003|Stage 3|Other Miscellaneous Reasons|0|||
164636517|NCT01397409|594692536|FG004|Stage 3|Other Miscellaneous Reasons|0|||
164636518|NCT01397409|594692537|FG005|Stage 3|Other Miscellaneous Reasons|0|||
164636519|NCT01397409|594692538|FG006|Stage 3|Other Miscellaneous Reasons|0|||
164636520|NCT01397409|594692539|FG007|Stage 3|Other Miscellaneous Reasons|1|||
164636521|NCT01397409|594692540|FG008|Stage 3|Other Miscellaneous Reasons|0|||
164636522|NCT01397409|594692541|FG009|Stage 3|Other Miscellaneous Reasons|0|||
164636523|NCT03418727|594692542|FG000|Overall Study|Adverse Event|1|||
164636524|NCT03418727|594692543|FG001|Overall Study|Adverse Event|2|||
164636525|NCT03418727|594692544|FG002|Overall Study|Adverse Event|0|||
164636526|NCT03418727|594692542|FG000|Overall Study|Withdrawal by Subject|0|||
164636527|NCT03418727|594692543|FG001|Overall Study|Withdrawal by Subject|0|||
164636528|NCT03418727|594692544|FG002|Overall Study|Withdrawal by Subject|2|||
164636529|NCT02451137|594692546|FG000|Overall Study|Randomized but not treated|19|||
164636530|NCT02451137|594692547|FG001|Overall Study|Randomized but not treated|27|||
164636531|NCT02451137|594692546|FG000|Overall Study|Adverse Event|43|||
164636532|NCT02451137|594692547|FG001|Overall Study|Adverse Event|42|||
164636533|NCT02451137|594692546|FG000|Overall Study|Lack of Efficacy|4|||
164636534|NCT02451137|594692547|FG001|Overall Study|Lack of Efficacy|9|||
164636535|NCT02451137|594692546|FG000|Overall Study|Participant decision:discontinue insulin|41|||
164636536|NCT02451137|594692547|FG001|Overall Study|Participant decision:discontinue insulin|43|||
164636537|NCT02451137|594692546|FG000|Overall Study|Hypoglycemia|2|||
164636538|NCT02451137|594692547|FG001|Overall Study|Hypoglycemia|1|||
164636539|NCT02451137|594692546|FG000|Overall Study|Investigator's decision|23|||
164636540|NCT02451137|594692547|FG001|Overall Study|Investigator's decision|19|||
164636541|NCT02451137|594692546|FG000|Overall Study|Lost to Follow-up|53|||
164636542|NCT02451137|594692547|FG001|Overall Study|Lost to Follow-up|61|||
164636543|NCT02451137|594692546|FG000|Overall Study|Physician Decision|6|||
164636544|NCT02451137|594692547|FG001|Overall Study|Physician Decision|5|||
164636545|NCT02451137|594692546|FG000|Overall Study|Sponsor decision|13|||
164636546|NCT02451137|594692547|FG001|Overall Study|Sponsor decision|25|||
164636547|NCT02451137|594692546|FG000|Overall Study|Withdrawal by Subject|40|||
164636548|NCT02451137|594692547|FG001|Overall Study|Withdrawal by Subject|63|||
164636549|NCT02451137|594692546|FG000|Overall Study|Other than specified above|2|||
164636550|NCT02451137|594692547|FG001|Overall Study|Other than specified above|3|||
164636551|NCT02911285|594692548|FG000|Overall Study|Lost to Follow-up|8|||
164636552|NCT02911285|594692549|FG001|Overall Study|Lost to Follow-up|5|||
164636553|NCT02911285|594692548|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
164636554|NCT02911285|594692549|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
164636555|NCT02163759|594694238|FG000|Overall Study|Withdrawal by Subject|1|||
164636556|NCT02163759|594694239|FG001|Overall Study|Withdrawal by Subject|5|||
164636557|NCT02163759|594694240|FG002|Overall Study|Withdrawal by Subject|1|||
164636558|NCT02163759|594694238|FG000|Overall Study|Adverse Event|0|||
164636559|NCT02163759|594694239|FG001|Overall Study|Adverse Event|0|||
164636560|NCT02163759|594694240|FG002|Overall Study|Adverse Event|1|||
164636561|NCT02163759|594694238|FG000|Overall Study|Death|0|||
164636562|NCT02163759|594694239|FG001|Overall Study|Death|0|||
164636563|NCT02163759|594694240|FG002|Overall Study|Death|1|||
164636564|NCT01479777|594694247|FG000|Overall Study|Physician Decision|2|||
164636565|NCT00451191|594694251|FG000|Overall Study|withdrawal or received alternate tx|15|||
164636566|NCT00451191|594694252|FG001|Overall Study|withdrawal or received alternate tx|11|||
164636567|NCT00656669|594694256|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
164636568|NCT00656669|594694256|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
164636569|NCT00656669|594694256|FG000|AC (Cycles 6-9)|Adverse Event|1|||
164636570|NCT00656669|594694256|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
164636571|NCT00219349|594694261|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
164636572|NCT00219349|594694261|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
164636573|NCT00219349|594694261|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
164636574|NCT00219349|594694261|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
164636575|NCT01241591|594694263|FG000|Overall Study|Lack of Efficacy|5|||
164636576|NCT01241591|594694264|FG001|Overall Study|Lack of Efficacy|2|||
164636577|NCT01241591|594694265|FG002|Overall Study|Lack of Efficacy|2|||
164636578|NCT01241591|594694266|FG003|Overall Study|Lack of Efficacy|3|||
164636579|NCT01241591|594694263|FG000|Overall Study|Protocol Violation|5|||
164636580|NCT01241591|594694264|FG001|Overall Study|Protocol Violation|2|||
164636581|NCT01241591|594694265|FG002|Overall Study|Protocol Violation|3|||
164636582|NCT01241591|594694266|FG003|Overall Study|Protocol Violation|0|||
164636583|NCT01241591|594694263|FG000|Overall Study|Lost to Follow-up|1|||
164636584|NCT01241591|594694264|FG001|Overall Study|Lost to Follow-up|2|||
164636585|NCT01241591|594694265|FG002|Overall Study|Lost to Follow-up|2|||
164636586|NCT01241591|594694266|FG003|Overall Study|Lost to Follow-up|2|||
164636587|NCT01241591|594694263|FG000|Overall Study|Screen Failure|3|||
164636588|NCT01241591|594694264|FG001|Overall Study|Screen Failure|2|||
164636589|NCT01241591|594694265|FG002|Overall Study|Screen Failure|1|||
164636590|NCT01241591|594694266|FG003|Overall Study|Screen Failure|0|||
164636591|NCT01241591|594694263|FG000|Overall Study|Withdrawal by Subject|6|||
164636592|NCT01241591|594694264|FG001|Overall Study|Withdrawal by Subject|4|||
164636593|NCT01241591|594694265|FG002|Overall Study|Withdrawal by Subject|2|||
164636594|NCT01241591|594694266|FG003|Overall Study|Withdrawal by Subject|2|||
164636595|NCT01241591|594694263|FG000|Overall Study|Other|0|||
164636596|NCT01241591|594694264|FG001|Overall Study|Other|1|||
164636597|NCT01241591|594694265|FG002|Overall Study|Other|0|||
164636598|NCT01241591|594694266|FG003|Overall Study|Other|1|||
164636599|NCT01241591|594694263|FG000|Overall Study|Adverse Event|3|||
164636600|NCT01241591|594694264|FG001|Overall Study|Adverse Event|11|||
164636601|NCT01241591|594694265|FG002|Overall Study|Adverse Event|12|||
164636602|NCT01241591|594694266|FG003|Overall Study|Adverse Event|4|||
164636603|NCT01945034|594694267|FG000|Overall Study|Medication Error|0|||
164636604|NCT01945034|594694268|FG001|Overall Study|Medication Error|1|||
164636605|NCT01945034|594694269|FG002|Overall Study|Medication Error|0|||
164636606|NCT01945034|594694267|FG000|Overall Study|Withdrawal by Subject|0|||
164636607|NCT01945034|594694268|FG001|Overall Study|Withdrawal by Subject|3|||
164636608|NCT01945034|594694269|FG002|Overall Study|Withdrawal by Subject|1|||
164636609|NCT01945034|594694267|FG000|Overall Study|Other|0|||
164636610|NCT01945034|594694268|FG001|Overall Study|Other|1|||
164636611|NCT01945034|594694269|FG002|Overall Study|Other|3|||
164636612|NCT01945034|594694267|FG000|Overall Study|Lost to Follow-up|0|||
164636613|NCT01945034|594694268|FG001|Overall Study|Lost to Follow-up|0|||
164636614|NCT01945034|594694269|FG002|Overall Study|Lost to Follow-up|2|||
164636615|NCT01945034|594694267|FG000|Overall Study|Protocol Violation|1|||
164636616|NCT01945034|594694268|FG001|Overall Study|Protocol Violation|0|||
164636617|NCT01945034|594694269|FG002|Overall Study|Protocol Violation|1|||
164636618|NCT00700115|594694272|FG000|Overall Study|Withdrawal by Subject|1|||
164636619|NCT00700115|594694273|FG001|Overall Study|Withdrawal by Subject|0|||
164636620|NCT00700115|594694272|FG000|Overall Study|Lost to Follow-up|0|||
164636621|NCT00700115|594694273|FG001|Overall Study|Lost to Follow-up|1|||
164636622|NCT02389621|594694275|FG000|Treatment Period|Withdrawal by Subject|1|||
164636623|NCT02389621|594694276|FG001|Treatment Period|Withdrawal by Subject|1|||
164636624|NCT02389621|594694275|FG000|Posttreatment Period|Adverse Event|3|||
164636625|NCT02389621|594694276|FG001|Posttreatment Period|Adverse Event|1|||
164636626|NCT02389621|594694275|FG000|Posttreatment Period|Withdrawal by Subject|3|||
164636627|NCT02389621|594694276|FG001|Posttreatment Period|Withdrawal by Subject|2|||
164636628|NCT02389621|594694275|FG000|Posttreatment Period|Lost to Follow-up|1|||
164636629|NCT02389621|594694276|FG001|Posttreatment Period|Lost to Follow-up|1|||
164636630|NCT02389621|594694275|FG000|Posttreatment Period|Other - Miscellaneous|2|||
164636631|NCT02389621|594694276|FG001|Posttreatment Period|Other - Miscellaneous|0|||
164636632|NCT01300741|594694281|FG000|Overall Study|Lens deposits|1|||
164636633|NCT01300741|594694281|FG000|Overall Study|Lost to Follow-up|1|||
164636634|NCT01300741|594694281|FG000|Overall Study|Discomfort|1|||
164636635|NCT04854421|594694282|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
164636636|NCT04854421|594694283|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
164636637|NCT00718809|594694285|FG000|Overall Study|Disease progression|9|||
164636638|NCT00718809|594694286|FG001|Overall Study|Disease progression|7|||
164636639|NCT00718809|594694285|FG000|Overall Study|Adverse Event|1|||
164636640|NCT00718809|594694286|FG001|Overall Study|Adverse Event|1|||
164636641|NCT00718809|594694285|FG000|Overall Study|Withdrawal by Subject|0|||
164636642|NCT00718809|594694286|FG001|Overall Study|Withdrawal by Subject|1|||
164636643|NCT00718809|594694285|FG000|Overall Study|Lost to Follow-up|1|||
164636644|NCT00718809|594694286|FG001|Overall Study|Lost to Follow-up|0|||
164636645|NCT00718809|594694285|FG000|Overall Study|Noncompliance|1|||
164636646|NCT00718809|594694286|FG001|Overall Study|Noncompliance|0|||
164636647|NCT00536991|594694288|FG000|Overall Study|Withdrawal by Subject|10|||
164636648|NCT00536991|594694288|FG000|Overall Study|Physician Decision|1|||
164636649|NCT00536991|594694288|FG000|Overall Study|patient ineligible|2|||
164636650|NCT00054639|594694289|FG000|Overall Study|Lack of Efficacy|1|||
164636651|NCT00054639|594694289|FG000|Overall Study|Physician Decision|1|||
164636652|NCT03246152|594694300|FG000|Overall Study|Lost to Follow-up|2|||
164636653|NCT03246152|594694300|FG000|Overall Study|Protocol Violation|1|||
164636654|NCT04359758|594694304|FG000|Overall Study|Protocol Violation|3|||
164636655|NCT04359758|594694305|FG001|Overall Study|Protocol Violation|2|||
164636656|NCT03605758|594694306|FG000|Overall Study|Lost to Follow-up|2|||
164636657|NCT03605758|594694307|FG001|Overall Study|Lost to Follow-up|1|||
164636658|NCT03605758|594694306|FG000|Overall Study|Illness|0|||
164636659|NCT03605758|594694307|FG001|Overall Study|Illness|1|||
164636660|NCT03605758|594694306|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
164636661|NCT03605758|594694307|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
164636662|NCT04753606|594694310|FG000|Overall Study|Adverse Event|1|||
164636663|NCT04753606|594694311|FG001|Overall Study|Adverse Event|0|||
164636664|NCT04753606|594694312|FG002|Overall Study|Adverse Event|0|||
164636665|NCT01748162|594694315|FG000|Overall Study|no additional croup episodes to evaluate|2|||
164636666|NCT01748162|594694316|FG001|Overall Study|no additional croup episodes to evaluate|2|||
164636667|NCT01748162|594694315|FG000|Overall Study|participant consented but did not begin|0|||
164636668|NCT01748162|594694316|FG001|Overall Study|participant consented but did not begin|1|||
164636669|NCT01748162|594694315|FG000|Overall Study|reasons not available|3|||
164636670|NCT01748162|594694316|FG001|Overall Study|reasons not available|2|||
164636671|NCT03219372|594694317|FG000|Overall Study|Withdrawal by Subject|1|||
164636672|NCT03219372|594694318|FG001|Overall Study|Withdrawal by Subject|0|||
164636673|NCT04145531|594694319|FG000|Part A|Adverse Event|2|||
164636674|NCT04145531|594694320|FG001|Part A|Adverse Event|12|||
164636675|NCT04145531|594694321|FG002|Part A|Adverse Event|6|||
164636676|NCT04145531|594694322|FG003|Part A|Adverse Event|0|||
164636677|NCT04145531|594694319|FG000|Part A|Death|1|||
164636678|NCT04145531|594694320|FG001|Part A|Death|2|||
164636679|NCT04145531|594694321|FG002|Part A|Death|0|||
164636680|NCT04145531|594694322|FG003|Part A|Death|0|||
164636681|NCT04145531|594694319|FG000|Part A|Physician Decision|2|||
164636682|NCT04145531|594694320|FG001|Part A|Physician Decision|5|||
164636683|NCT04145531|594694321|FG002|Part A|Physician Decision|2|||
164636684|NCT04145531|594694322|FG003|Part A|Physician Decision|0|||
164636685|NCT04145531|594694319|FG000|Part A|Progressive disease|0|||
164636686|NCT04145531|594694320|FG001|Part A|Progressive disease|2|||
164636687|NCT04145531|594694321|FG002|Part A|Progressive disease|1|||
164636688|NCT04145531|594694322|FG003|Part A|Progressive disease|0|||
164636689|NCT04145531|594694319|FG000|Part A|Protocol deviation|0|||
164636690|NCT04145531|594694320|FG001|Part A|Protocol deviation|0|||
164636691|NCT04145531|594694321|FG002|Part A|Protocol deviation|1|||
164636692|NCT04145531|594694322|FG003|Part A|Protocol deviation|0|||
164636693|NCT04145531|594694319|FG000|Part A|Withdrawal by parent or guardian|1|||
164636694|NCT04145531|594694320|FG001|Part A|Withdrawal by parent or guardian|0|||
164636695|NCT04145531|594694321|FG002|Part A|Withdrawal by parent or guardian|0|||
164636696|NCT04145531|594694322|FG003|Part A|Withdrawal by parent or guardian|0|||
164636697|NCT04145531|594694319|FG000|Part A|Withdrawal by participant|0|||
164636698|NCT04145531|594694320|FG001|Part A|Withdrawal by participant|0|||
164636699|NCT04145531|594694321|FG002|Part A|Withdrawal by participant|1|||
164636700|NCT04145531|594694322|FG003|Part A|Withdrawal by participant|0|||
164636701|NCT04145531|594694319|FG000|Part A|Other|0|||
164636702|NCT04145531|594694320|FG001|Part A|Other|0|||
164636703|NCT04145531|594694321|FG002|Part A|Other|1|||
164636704|NCT04145531|594694322|FG003|Part A|Other|0|||
164636705|NCT04145531|594694319|FG000|Part B|Adverse Event|0|||
164636706|NCT04145531|594694320|FG001|Part B|Adverse Event|0|||
164636707|NCT04145531|594694321|FG002|Part B|Adverse Event|0|||
164636708|NCT04145531|594694322|FG003|Part B|Adverse Event|21|||
164636709|NCT04145531|594694319|FG000|Part B|Physician Decision|0|||
164636710|NCT04145531|594694320|FG001|Part B|Physician Decision|0|||
164636711|NCT04145531|594694321|FG002|Part B|Physician Decision|0|||
164636712|NCT04145531|594694322|FG003|Part B|Physician Decision|7|||
164636713|NCT04145531|594694319|FG000|Part B|Progressive disease|0|||
164636714|NCT04145531|594694320|FG001|Part B|Progressive disease|0|||
164636715|NCT04145531|594694321|FG002|Part B|Progressive disease|0|||
164636716|NCT04145531|594694322|FG003|Part B|Progressive disease|1|||
164636717|NCT04145531|594694319|FG000|Part B|Recurrent disease|0|||
164636718|NCT04145531|594694320|FG001|Part B|Recurrent disease|0|||
164636719|NCT04145531|594694321|FG002|Part B|Recurrent disease|0|||
164636720|NCT04145531|594694322|FG003|Part B|Recurrent disease|1|||
164636721|NCT04145531|594694319|FG000|Part B|Withdrawal by parent or guardian|0|||
164636722|NCT04145531|594694320|FG001|Part B|Withdrawal by parent or guardian|0|||
164636723|NCT04145531|594694321|FG002|Part B|Withdrawal by parent or guardian|0|||
164636724|NCT04145531|594694322|FG003|Part B|Withdrawal by parent or guardian|3|||
164636725|NCT04145531|594694319|FG000|Part B|Withdrawal by participant|0|||
164636726|NCT04145531|594694320|FG001|Part B|Withdrawal by participant|0|||
164636727|NCT04145531|594694321|FG002|Part B|Withdrawal by participant|0|||
164636728|NCT04145531|594694322|FG003|Part B|Withdrawal by participant|1|||
164636729|NCT04145531|594694319|FG000|Part B|Other|0|||
164636730|NCT04145531|594694320|FG001|Part B|Other|0|||
164636731|NCT04145531|594694321|FG002|Part B|Other|0|||
164636732|NCT04145531|594694322|FG003|Part B|Other|1|||
164636733|NCT02067728|594694323|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
164636734|NCT02067728|594694324|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
164636735|NCT02067728|594694323|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
164636736|NCT02067728|594694324|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
164636737|NCT02067728|594694323|FG000|6 Month Measurements|Unable to attend|114|||
164636738|NCT02067728|594694324|FG001|6 Month Measurements|Unable to attend|97|||
164636739|NCT03557775|594694325|FG000|Overall Study|Withdrawal by Subject|1|||
164636740|NCT03557775|594694326|FG001|Overall Study|Withdrawal by Subject|2|||
164636741|NCT03557775|594694327|FG002|Overall Study|Withdrawal by Subject|4|||
164636742|NCT03557775|594694325|FG000|Overall Study|Physician Decision|0|||
164636743|NCT03557775|594694326|FG001|Overall Study|Physician Decision|1|||
164636744|NCT03557775|594694327|FG002|Overall Study|Physician Decision|0|||
164636745|NCT01725217|594694328|FG000|Overall Study|Withdrawal by Subject|1|||
164636746|NCT01725217|594694329|FG001|Overall Study|Withdrawal by Subject|0|||
164636747|NCT01725217|594694330|FG002|Overall Study|Withdrawal by Subject|0|||
164636748|NCT00585468|594694335|FG000|First Intervention|Withdrawal by Subject|1|||
164636749|NCT00585468|594694336|FG001|First Intervention|Withdrawal by Subject|1|||
164636750|NCT00276458|594694337|FG000|Overall Study|Adverse Event|0|||
164636751|NCT00276458|594694338|FG001|Overall Study|Adverse Event|2|||
164636752|NCT00276458|594694337|FG000|Overall Study|Lost to Follow-up|2|||
164636753|NCT00276458|594694338|FG001|Overall Study|Lost to Follow-up|2|||
164636754|NCT00276458|594694337|FG000|Overall Study|Protocol Violation|4|||
164636755|NCT00276458|594694338|FG001|Overall Study|Protocol Violation|3|||
164636756|NCT00978120|594694339|FG000|Overall Study|Death|0|||
164636757|NCT00978120|594694340|FG001|Overall Study|Death|0|||
164636758|NCT00978120|594694341|FG002|Overall Study|Death|0|||
164636759|NCT00978120|594694342|FG003|Overall Study|Death|1|||
164636760|NCT00978120|594694339|FG000|Overall Study|Lost to Follow-up|0|||
164636761|NCT00978120|594694340|FG001|Overall Study|Lost to Follow-up|0|||
164636762|NCT00978120|594694341|FG002|Overall Study|Lost to Follow-up|3|||
164636763|NCT00978120|594694342|FG003|Overall Study|Lost to Follow-up|0|||
164636764|NCT00978120|594694339|FG000|Overall Study|Withdrawal by Subject|2|||
164636765|NCT00978120|594694340|FG001|Overall Study|Withdrawal by Subject|0|||
164636766|NCT00978120|594694341|FG002|Overall Study|Withdrawal by Subject|0|||
164636767|NCT00978120|594694342|FG003|Overall Study|Withdrawal by Subject|0|||
164636768|NCT00978120|594694339|FG000|Overall Study|Moved out of state|0|||
164636769|NCT00978120|594694340|FG001|Overall Study|Moved out of state|0|||
164636770|NCT00978120|594694341|FG002|Overall Study|Moved out of state|0|||
164636771|NCT00978120|594694342|FG003|Overall Study|Moved out of state|1|||
164636772|NCT01023815|594694344|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
164636773|NCT01023815|594694345|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
164636774|NCT01023815|594694346|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
164636775|NCT01023815|594694347|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
164636776|NCT01023815|594694344|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
164636777|NCT01023815|594694345|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
164636778|NCT01023815|594694346|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
164636779|NCT01023815|594694347|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
164636780|NCT01023815|594694344|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
164636781|NCT01023815|594694345|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
164636782|NCT01023815|594694346|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
164636783|NCT01023815|594694347|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
164636784|NCT01023815|594694344|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
164636785|NCT01023815|594694345|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
164636786|NCT01023815|594694346|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
164636787|NCT01023815|594694347|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
164636788|NCT01023815|594694344|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
164636789|NCT01023815|594694345|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
164636790|NCT01023815|594694346|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
164530206|NCT01060540|594313661|FG000|Overall Study|Lost to Follow-up|52|||
164530207|NCT01060540|594313662|FG001|Overall Study|Lost to Follow-up|43|||
164530208|NCT01060540|594313661|FG000|Overall Study|Death|2|||
164530209|NCT01060540|594313662|FG001|Overall Study|Death|1|||
164530210|NCT01060540|594313661|FG000|Overall Study|Physician Decision|0|||
164530211|NCT01060540|594313662|FG001|Overall Study|Physician Decision|1|||
164530212|NCT02647320|594313666|FG000|Overall Study|Adverse Event|0|||
164530213|NCT02647320|594313667|FG001|Overall Study|Adverse Event|1|||
164530214|NCT02647320|594313668|FG002|Overall Study|Adverse Event|3|||
164530215|NCT02647320|594313669|FG003|Overall Study|Adverse Event|2|||
164530216|NCT02647320|594313670|FG004|Overall Study|Adverse Event|1|||
164530217|NCT02647320|594313666|FG000|Overall Study|Protocol Violation|0|||
164530218|NCT02647320|594313667|FG001|Overall Study|Protocol Violation|0|||
164530219|NCT02647320|594313668|FG002|Overall Study|Protocol Violation|3|||
164530220|NCT02647320|594313669|FG003|Overall Study|Protocol Violation|0|||
164530221|NCT02647320|594313670|FG004|Overall Study|Protocol Violation|0|||
164530222|NCT02647320|594313666|FG000|Overall Study|Withdrawal by Subject|7|||
164530223|NCT02647320|594313667|FG001|Overall Study|Withdrawal by Subject|4|||
164530224|NCT02647320|594313668|FG002|Overall Study|Withdrawal by Subject|2|||
164530225|NCT02647320|594313669|FG003|Overall Study|Withdrawal by Subject|2|||
164530226|NCT02647320|594313670|FG004|Overall Study|Withdrawal by Subject|7|||
164530227|NCT02647320|594313666|FG000|Overall Study|Persistent hyperglycemia|0|||
164530228|NCT02647320|594313667|FG001|Overall Study|Persistent hyperglycemia|1|||
164530229|NCT02647320|594313668|FG002|Overall Study|Persistent hyperglycemia|1|||
164530230|NCT02647320|594313669|FG003|Overall Study|Persistent hyperglycemia|1|||
164530231|NCT02647320|594313670|FG004|Overall Study|Persistent hyperglycemia|1|||
164530232|NCT02647320|594313666|FG000|Overall Study|Study terminated by sponsor|1|||
164530233|NCT02647320|594313667|FG001|Overall Study|Study terminated by sponsor|1|||
164530234|NCT02647320|594313668|FG002|Overall Study|Study terminated by sponsor|1|||
164530235|NCT02647320|594313669|FG003|Overall Study|Study terminated by sponsor|1|||
164530236|NCT02647320|594313670|FG004|Overall Study|Study terminated by sponsor|2|||
164530237|NCT02647320|594313666|FG000|Overall Study|Reason not provided|0|||
164530238|NCT02647320|594313667|FG001|Overall Study|Reason not provided|0|||
164530239|NCT02647320|594313668|FG002|Overall Study|Reason not provided|1|||
164530240|NCT02647320|594313669|FG003|Overall Study|Reason not provided|0|||
164530241|NCT02647320|594313670|FG004|Overall Study|Reason not provided|2|||
164530242|NCT02647320|594313666|FG000|Overall Study|Lost to Follow-up|1|||
164530243|NCT02647320|594313667|FG001|Overall Study|Lost to Follow-up|1|||
164530244|NCT02647320|594313668|FG002|Overall Study|Lost to Follow-up|0|||
164530245|NCT02647320|594313669|FG003|Overall Study|Lost to Follow-up|0|||
164530246|NCT02647320|594313670|FG004|Overall Study|Lost to Follow-up|0|||
164530247|NCT02647320|594313666|FG000|Overall Study|Develop anemia|1|||
164530248|NCT02647320|594313667|FG001|Overall Study|Develop anemia|0|||
164530249|NCT02647320|594313668|FG002|Overall Study|Develop anemia|0|||
164530250|NCT02647320|594313669|FG003|Overall Study|Develop anemia|0|||
164530251|NCT02647320|594313670|FG004|Overall Study|Develop anemia|0|||
164530252|NCT02647320|594313666|FG000|Overall Study|Lack of Efficacy|0|||
164530253|NCT02647320|594313667|FG001|Overall Study|Lack of Efficacy|0|||
164530254|NCT02647320|594313668|FG002|Overall Study|Lack of Efficacy|0|||
164530255|NCT02647320|594313669|FG003|Overall Study|Lack of Efficacy|1|||
164530256|NCT02647320|594313670|FG004|Overall Study|Lack of Efficacy|0|||
164530257|NCT02647320|594313666|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
164530258|NCT02647320|594313667|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
164530259|NCT02647320|594313668|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
164530260|NCT02647320|594313669|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
164530261|NCT02647320|594313670|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
164530262|NCT00596427|594313671|FG000|Overall Study|Withdrawal by Subject|2|||
164530263|NCT00596427|594313672|FG001|Overall Study|Withdrawal by Subject|2|||
164530264|NCT00596427|594313671|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
164530265|NCT00596427|594313672|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
164530266|NCT00596427|594313671|FG000|Overall Study|Protocol Violation|1|||
164530267|NCT00596427|594313672|FG001|Overall Study|Protocol Violation|0|||
164530268|NCT02401867|594313673|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
164530269|NCT02401867|594313673|FG000|Analysis|Cervical assay could not be conducted|9|||
164530270|NCT01650246|594313674|FG000|Overall Study|Adverse Event|23|||
164530271|NCT01650246|594313674|FG000|Overall Study|Protocol Violation|5|||
164530272|NCT01650246|594313674|FG000|Overall Study|Sponsor terminated study|53|||
164530273|NCT01650246|594313674|FG000|Overall Study|Lost to Follow-up|5|||
164530274|NCT01650246|594313674|FG000|Overall Study|Withdrawal by Subject|26|||
164530275|NCT01650246|594313674|FG000|Overall Study|Death|1|||
164530276|NCT01650246|594313674|FG000|Overall Study|Lack of Efficacy|30|||
164530277|NCT00730171|594313679|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
164530278|NCT00730171|594313679|FG000|Overall Study|Adverse Event|193|||
164530279|NCT00730171|594313679|FG000|Overall Study|Protocol Violation|48|||
164530280|NCT00730171|594313679|FG000|Overall Study|Withdrawal by Subject|202|||
164530281|NCT00730171|594313679|FG000|Overall Study|Lost to Follow-up|121|||
164530282|NCT00730171|594313679|FG000|Overall Study|Insufficient Therapeutic Response|141|||
164530283|NCT00730171|594313679|FG000|Overall Study|Other|61|||
164530284|NCT01256658|594313680|FG000|Period 1|Lost to Follow-up|837|||
164530285|NCT01256658|594313681|FG001|Period 1|Lost to Follow-up|661|||
164530286|NCT01256658|594313680|FG000|Period 1|Withdrawal by Subject|35|||
164530287|NCT01256658|594313681|FG001|Period 1|Withdrawal by Subject|43|||
164530288|NCT01256658|594313680|FG000|Period 1|Death|48|||
164530289|NCT01256658|594313681|FG001|Period 1|Death|44|||
164530290|NCT00719563|594313682|FG000|Overall Study|Adverse Event|16|||
164530291|NCT00719563|594313683|FG001|Overall Study|Adverse Event|13|||
164530292|NCT00719563|594313682|FG000|Overall Study|Medical condition changed|3|||
164530293|NCT00719563|594313683|FG001|Overall Study|Medical condition changed|5|||
164530294|NCT00719563|594313682|FG000|Overall Study|Lack of Efficacy|3|||
164530295|NCT00719563|594313683|FG001|Overall Study|Lack of Efficacy|7|||
164530296|NCT00719563|594313682|FG000|Overall Study|Personal reasons|6|||
164530297|NCT00719563|594313683|FG001|Overall Study|Personal reasons|7|||
164530298|NCT00719563|594313682|FG000|Overall Study|Unknown reasons|4|||
164530299|NCT00719563|594313683|FG001|Overall Study|Unknown reasons|6|||
164530300|NCT00719563|594313682|FG000|Overall Study|Noncompliant|1|||
164530301|NCT00719563|594313683|FG001|Overall Study|Noncompliant|1|||
164530302|NCT00719563|594313682|FG000|Overall Study|Lost to Follow-up|5|||
164530303|NCT00719563|594313683|FG001|Overall Study|Lost to Follow-up|3|||
164530304|NCT02120625|594313688|FG000|Overall Study|Physician Decision|2|||
164530305|NCT00762970|594313691|FG000|Overall Study|Withdrawal by Subject|7|||
164636791|NCT01023815|594694347|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
164636792|NCT01977625|594694350|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
164636793|NCT01977625|594694351|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
164636794|NCT01977625|594694350|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
164636795|NCT01977625|594694351|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
164636796|NCT02304484|594694352|FG000|Overall Study|Death|9|||
164636797|NCT02304484|594694352|FG000|Overall Study|Withdrawal by Subject|14|||
164636798|NCT02304484|594694352|FG000|Overall Study|Lost to Follow-up|2|||
164636799|NCT02967055|594694353|FG000|Overall Study|Excluded|40|||
164636800|NCT02967055|594694353|FG000|Overall Study|Screen fail|3|||
164636801|NCT02967055|594694353|FG000|Overall Study|Lost to Follow-up|2|||
164636802|NCT02967055|594694353|FG000|Overall Study|Stopped due to side effects|3|||
164636803|NCT02967055|594694353|FG000|Overall Study|Stopped due to drug cost|1|||
164636804|NCT01298323|594694355|FG000|Overall Study|Adverse Event|2|||
164636805|NCT01298323|594694356|FG001|Overall Study|Adverse Event|4|||
164636806|NCT01298323|594694355|FG000|Overall Study|Death|11|||
164636807|NCT01298323|594694356|FG001|Overall Study|Death|16|||
164636808|NCT01298323|594694355|FG000|Overall Study|Lost to Follow-up|1|||
164636809|NCT01298323|594694356|FG001|Overall Study|Lost to Follow-up|0|||
164636810|NCT01298323|594694355|FG000|Overall Study|Withdrawal by Subject|6|||
164636811|NCT01298323|594694356|FG001|Overall Study|Withdrawal by Subject|3|||
164636812|NCT01298323|594694355|FG000|Overall Study|Protocol Violation|1|||
164636813|NCT01298323|594694356|FG001|Overall Study|Protocol Violation|0|||
164636814|NCT01298323|594694355|FG000|Overall Study|Other|10|||
164636815|NCT01298323|594694356|FG001|Overall Study|Other|9|||
164636816|NCT01298323|594694355|FG000|Overall Study|Ongoing|55|||
164636817|NCT01298323|594694356|FG001|Overall Study|Ongoing|55|||
164636818|NCT01298323|594694355|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164636819|NCT01298323|594694356|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
164636820|NCT01761565|594694357|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
164636821|NCT02161380|594694358|FG000|Overall Study|Lost to Follow-up|0|||
164636822|NCT02161380|594694359|FG001|Overall Study|Lost to Follow-up|1|||
164636823|NCT02161380|594694360|FG002|Overall Study|Lost to Follow-up|0|||
164636824|NCT02161380|594694361|FG003|Overall Study|Lost to Follow-up|0|||
164636825|NCT03655951|594694363|FG000|Overall Study|Lost to Follow-up|39|||
164636826|NCT03655951|594694364|FG001|Overall Study|Lost to Follow-up|20|||
164636827|NCT03655951|594694363|FG000|Overall Study|Withdrawal by Subject|0|||
164636828|NCT03655951|594694364|FG001|Overall Study|Withdrawal by Subject|1|||
164636829|NCT01078974|594694369|FG000|Overall Study|Adverse Event|3|||
164636830|NCT01393444|594694370|FG000|Overall Study|Withdrawal by Subject|1|||
164636831|NCT01393444|594694370|FG000|Overall Study|Determined ineligible during screening.|2|||
164636832|NCT01791543|594694372|FG000|Overall Study|Lost to Follow-up|1|||
164636833|NCT01791543|594694372|FG000|Overall Study|Adverse Event|1|||
164636834|NCT01740297|594695879|FG000|Overall Study|Withdrawal by Subject|4|||
164636835|NCT01740297|594695880|FG001|Overall Study|Withdrawal by Subject|16|||
164530306|NCT00762970|594313692|FG001|Overall Study|Withdrawal by Subject|4|||
164530307|NCT00762970|594313693|FG002|Overall Study|Withdrawal by Subject|0|||
164530308|NCT00762970|594313691|FG000|Overall Study|Protocol Violation|3|||
164530309|NCT00762970|594313692|FG001|Overall Study|Protocol Violation|1|||
164530310|NCT00762970|594313693|FG002|Overall Study|Protocol Violation|1|||
164530311|NCT00762970|594313691|FG000|Overall Study|Lost to Follow-up|1|||
164530312|NCT00762970|594313692|FG001|Overall Study|Lost to Follow-up|2|||
164530313|NCT00762970|594313693|FG002|Overall Study|Lost to Follow-up|0|||
164530314|NCT00762970|594313691|FG000|Overall Study|Difficulty of handling lens|1|||
164530315|NCT00762970|594313692|FG001|Overall Study|Difficulty of handling lens|2|||
164530316|NCT00762970|594313693|FG002|Overall Study|Difficulty of handling lens|0|||
164530317|NCT02901041|594313694|FG000|Overall Study|Withdrawal by PI|4|||
164530318|NCT02901041|594313695|FG001|Overall Study|Withdrawal by PI|8|||
164530319|NCT02901041|594313694|FG000|Overall Study|Withdrawal by Subject|7|||
164530320|NCT02901041|594313695|FG001|Overall Study|Withdrawal by Subject|3|||
164530321|NCT01480674|594313696|FG000|Overall Study|Death|23|||
164530322|NCT01480674|594313696|FG000|Overall Study|Lost to Follow-up|2|||
164530323|NCT01480674|594313696|FG000|Overall Study|visit not done|10|||
164636836|NCT01740297|594695881|FG002|Overall Study|Withdrawal by Subject|17|||
164636837|NCT01740297|594695879|FG000|Overall Study|Death|8|||
164636838|NCT01740297|594695880|FG001|Overall Study|Death|46|||
164636839|NCT01740297|594695881|FG002|Overall Study|Death|40|||
164636840|NCT01740297|594695879|FG000|Overall Study|Lost to Follow-up|1|||
164636841|NCT01740297|594695880|FG001|Overall Study|Lost to Follow-up|2|||
164636842|NCT01740297|594695881|FG002|Overall Study|Lost to Follow-up|4|||
164636843|NCT03280628|594695886|FG000|Overall Study|Lost to Follow-up|8|||
164636844|NCT03280628|594695887|FG001|Overall Study|Lost to Follow-up|6|||
164530324|NCT00975507|594313697|FG000|Overall Study|Adverse Event|1|||
164530325|NCT00975507|594313698|FG001|Overall Study|Adverse Event|0|||
164530326|NCT00975507|594313697|FG000|Overall Study|Lost to Follow-up|7|||
164530327|NCT00975507|594313698|FG001|Overall Study|Lost to Follow-up|1|||
164530328|NCT00975507|594313697|FG000|Overall Study|Protocol Violation|2|||
164530329|NCT00975507|594313698|FG001|Overall Study|Protocol Violation|0|||
164530330|NCT00975507|594313697|FG000|Overall Study|Withdrawal by Subject|10|||
164530331|NCT00975507|594313698|FG001|Overall Study|Withdrawal by Subject|3|||
164530332|NCT03249714|594313699|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
164530333|NCT03249714|594313700|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
164530334|NCT03249714|594313699|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
164530335|NCT03249714|594313700|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
164530336|NCT03249714|594313699|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
164530337|NCT03249714|594313700|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
164530338|NCT03249714|594313699|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
164530339|NCT03249714|594313700|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
164530340|NCT03818204|594313701|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
164530341|NCT03818204|594313702|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
164530342|NCT03818204|594313703|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
164530343|NCT03818204|594313704|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
164530344|NCT03818204|594313705|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
164530345|NCT03818204|594313706|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
164530346|NCT03818204|594313707|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
164530347|NCT03818204|594313708|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
164530348|NCT03818204|594313709|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
164530349|NCT03818204|594313710|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
164530350|NCT03818204|594313711|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
164530351|NCT03818204|594313712|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
164530352|NCT03818204|594313713|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
164530353|NCT03818204|594313714|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
164530354|NCT03818204|594313715|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
164530355|NCT03818204|594313716|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
164530356|NCT03818204|594313717|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
164530357|NCT03818204|594313718|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
164530358|NCT03818204|594313719|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
164530359|NCT03818204|594313701|FG000|Overall Study|Physician Decision|0|||
164530360|NCT03818204|594313702|FG001|Overall Study|Physician Decision|0|||
164530361|NCT03818204|594313703|FG002|Overall Study|Physician Decision|0|||
164530362|NCT03818204|594313704|FG003|Overall Study|Physician Decision|0|||
164530363|NCT03818204|594313705|FG004|Overall Study|Physician Decision|0|||
164530364|NCT03818204|594313706|FG005|Overall Study|Physician Decision|0|||
164530365|NCT03818204|594313707|FG006|Overall Study|Physician Decision|0|||
164530366|NCT03818204|594313708|FG007|Overall Study|Physician Decision|0|||
164530367|NCT03818204|594313709|FG008|Overall Study|Physician Decision|0|||
164530368|NCT03818204|594313710|FG009|Overall Study|Physician Decision|0|||
164530369|NCT03818204|594313711|FG010|Overall Study|Physician Decision|0|||
164530370|NCT03818204|594313712|FG011|Overall Study|Physician Decision|0|||
164530371|NCT03818204|594313713|FG012|Overall Study|Physician Decision|0|||
164530372|NCT03818204|594313714|FG013|Overall Study|Physician Decision|0|||
164530373|NCT03818204|594313715|FG014|Overall Study|Physician Decision|1|||
164530374|NCT03818204|594313716|FG015|Overall Study|Physician Decision|0|||
164530375|NCT03818204|594313717|FG016|Overall Study|Physician Decision|0|||
164530376|NCT03818204|594313718|FG017|Overall Study|Physician Decision|0|||
164530377|NCT03818204|594313719|FG018|Overall Study|Physician Decision|0|||
164530378|NCT00887250|594313722|FG000|Overall Study|Adverse Event|3|||
164530379|NCT00887250|594313723|FG001|Overall Study|Adverse Event|0|||
164530380|NCT00887250|594313724|FG002|Overall Study|Adverse Event|7|||
164530381|NCT00887250|594313722|FG000|Overall Study|Lack of Efficacy|9|||
164530382|NCT00887250|594313723|FG001|Overall Study|Lack of Efficacy|6|||
164530383|NCT00887250|594313724|FG002|Overall Study|Lack of Efficacy|1|||
164530384|NCT00887250|594313722|FG000|Overall Study|Lost to Follow-up|2|||
164530385|NCT00887250|594313723|FG001|Overall Study|Lost to Follow-up|3|||
164636845|NCT03280628|594695888|FG002|Overall Study|Lost to Follow-up|11|||
164636846|NCT00761462|594695889|FG000|Treatment|Subjects never received study medication|23|||
164636847|NCT00761462|594695890|FG001|Treatment|Subjects never received study medication|12|||
164636848|NCT00761462|594695889|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
164636849|NCT00761462|594695890|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
164636850|NCT00761462|594695889|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
164636851|NCT00761462|594695890|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
164636852|NCT00761462|594695889|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
164636853|NCT00761462|594695890|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
164636854|NCT00066573|594695917|FG000|Overall Study|Did not received protocol treatment|28|||
164636855|NCT00066573|594695918|FG001|Overall Study|Did not received protocol treatment|28|||
164636856|NCT01646268|594695922|FG000|Overall Study|Adverse Event|6|||
164636857|NCT01646268|594695923|FG001|Overall Study|Adverse Event|7|||
164636858|NCT01646268|594695922|FG000|Overall Study|Lack of Efficacy|1|||
164636859|NCT01646268|594695923|FG001|Overall Study|Lack of Efficacy|3|||
164636860|NCT01646268|594695922|FG000|Overall Study|Protocol Violation|0|||
164636861|NCT01646268|594695923|FG001|Overall Study|Protocol Violation|1|||
164636862|NCT01646268|594695922|FG000|Overall Study|Withdrawal by Subject|2|||
164636863|NCT01646268|594695923|FG001|Overall Study|Withdrawal by Subject|5|||
164636864|NCT01646268|594695922|FG000|Overall Study|Other|2|||
164636865|NCT01646268|594695923|FG001|Overall Study|Other|0|||
164636866|NCT02222246|594695924|FG000|Overall Study|No Emergency Department Visits|27|||
164636867|NCT02222246|594695925|FG001|Overall Study|No Emergency Department Visits|26|||
164636868|NCT02222246|594695924|FG000|Overall Study|Physician Decision|0|||
164636869|NCT02222246|594695925|FG001|Overall Study|Physician Decision|1|||
164636870|NCT01473602|594695930|FG000|Overall Study|Adverse Event|1|||
164636871|NCT01473602|594695931|FG001|Overall Study|Adverse Event|2|||
164636872|NCT01473602|594695930|FG000|Overall Study|Death|0|||
164636873|NCT01473602|594695931|FG001|Overall Study|Death|1|||
164636874|NCT01473602|594695930|FG000|Overall Study|Lost to Follow-up|1|||
164636875|NCT01473602|594695931|FG001|Overall Study|Lost to Follow-up|1|||
164636876|NCT01473602|594695930|FG000|Overall Study|Withdrawal by Subject|5|||
164636877|NCT01473602|594695931|FG001|Overall Study|Withdrawal by Subject|4|||
164636878|NCT01473602|594695930|FG000|Overall Study|Physician Decision|1|||
164636879|NCT01473602|594695931|FG001|Overall Study|Physician Decision|0|||
164636880|NCT00463385|594695932|FG000|Overall Study|Other|4|||
164636881|NCT00463385|594695933|FG001|Overall Study|Other|3|||
164636882|NCT00463385|594695934|FG002|Overall Study|Other|6|||
164636883|NCT00463385|594695935|FG003|Overall Study|Other|4|||
164636884|NCT00463385|594695932|FG000|Overall Study|Adverse Event|5|||
164636885|NCT00463385|594695933|FG001|Overall Study|Adverse Event|8|||
164636886|NCT00463385|594695934|FG002|Overall Study|Adverse Event|4|||
164636887|NCT00463385|594695935|FG003|Overall Study|Adverse Event|2|||
164636888|NCT00463385|594695932|FG000|Overall Study|Lack of Efficacy|6|||
164636889|NCT00463385|594695933|FG001|Overall Study|Lack of Efficacy|6|||
164636890|NCT00463385|594695934|FG002|Overall Study|Lack of Efficacy|7|||
164636891|NCT00463385|594695935|FG003|Overall Study|Lack of Efficacy|9|||
164636892|NCT00463385|594695932|FG000|Overall Study|Withdrawal by Subject|3|||
164636893|NCT00463385|594695933|FG001|Overall Study|Withdrawal by Subject|3|||
164636894|NCT00463385|594695934|FG002|Overall Study|Withdrawal by Subject|3|||
164636895|NCT00463385|594695935|FG003|Overall Study|Withdrawal by Subject|4|||
164636896|NCT00463385|594695932|FG000|Overall Study|Lost to Follow-up|0|||
164636897|NCT00463385|594695933|FG001|Overall Study|Lost to Follow-up|0|||
164636898|NCT00463385|594695934|FG002|Overall Study|Lost to Follow-up|0|||
164636899|NCT00463385|594695935|FG003|Overall Study|Lost to Follow-up|1|||
164636900|NCT00463385|594695932|FG000|Overall Study|Death|2|||
164636901|NCT00463385|594695933|FG001|Overall Study|Death|1|||
164636902|NCT00463385|594695934|FG002|Overall Study|Death|2|||
164636903|NCT00463385|594695935|FG003|Overall Study|Death|0|||
164636904|NCT00463385|594695932|FG000|Overall Study|Missing|2|||
164636905|NCT00463385|594695933|FG001|Overall Study|Missing|0|||
164636906|NCT00463385|594695934|FG002|Overall Study|Missing|0|||
164636907|NCT00463385|594695935|FG003|Overall Study|Missing|2|||
164636908|NCT00463385|594695932|FG000|Overall Study|1 participant received commercial drug|0|||
164636909|NCT00463385|594695933|FG001|Overall Study|1 participant received commercial drug|1|||
164636910|NCT00463385|594695934|FG002|Overall Study|1 participant received commercial drug|0|||
164636911|NCT00463385|594695935|FG003|Overall Study|1 participant received commercial drug|0|||
164636912|NCT00449761|594695937|FG000|Overall Study|Disease progression|12|||
164636913|NCT00449761|594695937|FG000|Overall Study|Death|5|||
164636914|NCT00449761|594695937|FG000|Overall Study|New cancer therapy|1|||
164636915|NCT00560573|594695938|FG000|Overall Study|Death|4|||
164636916|NCT00560573|594695939|FG001|Overall Study|Death|1|||
164636917|NCT00560573|594695940|FG002|Overall Study|Death|4|||
164530386|NCT00887250|594313724|FG002|Overall Study|Lost to Follow-up|1|||
164530387|NCT00887250|594313722|FG000|Overall Study|Protocol Violation|2|||
164530388|NCT00887250|594313723|FG001|Overall Study|Protocol Violation|2|||
164530389|NCT00887250|594313724|FG002|Overall Study|Protocol Violation|1|||
164530390|NCT00887250|594313722|FG000|Overall Study|Withdrawal by Subject|2|||
164530391|NCT00887250|594313723|FG001|Overall Study|Withdrawal by Subject|1|||
164530392|NCT00887250|594313724|FG002|Overall Study|Withdrawal by Subject|2|||
164530393|NCT00887250|594313722|FG000|Overall Study|Patient uncooperative|0|||
164530394|NCT00887250|594313723|FG001|Overall Study|Patient uncooperative|0|||
164530395|NCT00887250|594313724|FG002|Overall Study|Patient uncooperative|1|||
164530396|NCT05754333|594313725|FG000|Overall Study|Miscellaneous|3|||
164530397|NCT05754333|594313726|FG001|Overall Study|Miscellaneous|0|||
164530398|NCT05754333|594313727|FG002|Overall Study|Miscellaneous|0|||
164530399|NCT05754333|594313728|FG003|Overall Study|Miscellaneous|0|||
164530400|NCT05754333|594313725|FG000|Overall Study|Lost to Follow-up|2|||
164530401|NCT05754333|594313726|FG001|Overall Study|Lost to Follow-up|1|||
164530402|NCT05754333|594313727|FG002|Overall Study|Lost to Follow-up|0|||
164530403|NCT05754333|594313728|FG003|Overall Study|Lost to Follow-up|1|||
164530404|NCT00879762|594313729|FG000|Overall Study|Lost to Follow-up|3|||
164530405|NCT00879762|594313730|FG001|Overall Study|Lost to Follow-up|1|||
164530406|NCT04754477|594313733|FG000|Overall Study|Withdrawal by Subject|1|||
164530407|NCT02709096|594313738|FG000|Overall Study|non-compliance|1|||
164530408|NCT02709096|594313739|FG001|Overall Study|non-compliance|1|||
164530409|NCT00505284|594313740|FG000|Overall Study|Adverse Event|3|||
164636918|NCT00560573|594695941|FG003|Overall Study|Death|5|||
164636919|NCT00560573|594695942|FG004|Overall Study|Death|1|||
164636920|NCT00560573|594695943|FG005|Overall Study|Death|10|||
164636921|NCT00560573|594695938|FG000|Overall Study|Lost to Follow-up|0|||
164636922|NCT00560573|594695939|FG001|Overall Study|Lost to Follow-up|0|||
164636923|NCT00560573|594695940|FG002|Overall Study|Lost to Follow-up|0|||
164636924|NCT00560573|594695941|FG003|Overall Study|Lost to Follow-up|1|||
164636925|NCT00560573|594695942|FG004|Overall Study|Lost to Follow-up|1|||
164636926|NCT00560573|594695943|FG005|Overall Study|Lost to Follow-up|0|||
164636927|NCT00560573|594695938|FG000|Overall Study|Withdrawal by Subject|0|||
164636928|NCT00560573|594695939|FG001|Overall Study|Withdrawal by Subject|0|||
164636929|NCT00560573|594695940|FG002|Overall Study|Withdrawal by Subject|0|||
164636930|NCT00560573|594695941|FG003|Overall Study|Withdrawal by Subject|1|||
164636931|NCT00560573|594695942|FG004|Overall Study|Withdrawal by Subject|1|||
164636932|NCT00560573|594695943|FG005|Overall Study|Withdrawal by Subject|0|||
164636933|NCT00560573|594695938|FG000|Overall Study|Other|2|||
164636934|NCT00560573|594695939|FG001|Overall Study|Other|2|||
164636935|NCT00560573|594695940|FG002|Overall Study|Other|2|||
164636936|NCT00560573|594695941|FG003|Overall Study|Other|3|||
164636937|NCT00560573|594695942|FG004|Overall Study|Other|3|||
164636938|NCT00560573|594695943|FG005|Overall Study|Other|3|||
164636939|NCT00560573|594695938|FG000|Overall Study|Enrolled, not treated|0|||
164636940|NCT00560573|594695939|FG001|Overall Study|Enrolled, not treated|0|||
164636941|NCT00560573|594695940|FG002|Overall Study|Enrolled, not treated|0|||
164636942|NCT00560573|594695941|FG003|Overall Study|Enrolled, not treated|0|||
164636943|NCT00560573|594695942|FG004|Overall Study|Enrolled, not treated|1|||
164636944|NCT00560573|594695943|FG005|Overall Study|Enrolled, not treated|0|||
164636945|NCT01422876|594695947|FG000|Week 24|Lost to Follow-up|1|||
164636946|NCT01422876|594695948|FG001|Week 24|Lost to Follow-up|1|||
164636947|NCT01422876|594695949|FG002|Week 24|Lost to Follow-up|2|||
164636948|NCT01422876|594695950|FG003|Week 24|Lost to Follow-up|4|||
164636949|NCT01422876|594695951|FG004|Week 24|Lost to Follow-up|2|||
164636950|NCT01422876|594695952|FG005|Week 24|Lost to Follow-up|0|||
164636951|NCT01422876|594695953|FG006|Week 24|Lost to Follow-up|1|||
164636952|NCT01422876|594695954|FG007|Week 24|Lost to Follow-up|3|||
164636953|NCT01422876|594695955|FG008|Week 24|Lost to Follow-up|3|||
164636954|NCT01422876|594695956|FG009|Week 24|Lost to Follow-up|4|||
164636955|NCT01422876|594695947|FG000|Week 24|Consent withdrawn|5|||
164636956|NCT01422876|594695948|FG001|Week 24|Consent withdrawn|1|||
164636957|NCT01422876|594695949|FG002|Week 24|Consent withdrawn|3|||
164636958|NCT01422876|594695950|FG003|Week 24|Consent withdrawn|4|||
164636959|NCT01422876|594695951|FG004|Week 24|Consent withdrawn|5|||
164636960|NCT01422876|594695952|FG005|Week 24|Consent withdrawn|6|||
164636961|NCT01422876|594695953|FG006|Week 24|Consent withdrawn|5|||
164636962|NCT01422876|594695954|FG007|Week 24|Consent withdrawn|4|||
164636963|NCT01422876|594695955|FG008|Week 24|Consent withdrawn|3|||
164636964|NCT01422876|594695956|FG009|Week 24|Consent withdrawn|6|||
164636965|NCT01422876|594695947|FG000|Week 24|Death|0|||
164636966|NCT01422876|594695948|FG001|Week 24|Death|1|||
164636967|NCT01422876|594695949|FG002|Week 24|Death|0|||
164636968|NCT01422876|594695950|FG003|Week 24|Death|0|||
164636969|NCT01422876|594695951|FG004|Week 24|Death|0|||
164636970|NCT01422876|594695952|FG005|Week 24|Death|0|||
164636971|NCT01422876|594695953|FG006|Week 24|Death|0|||
164636972|NCT01422876|594695954|FG007|Week 24|Death|0|||
164636973|NCT01422876|594695955|FG008|Week 24|Death|0|||
164636974|NCT01422876|594695956|FG009|Week 24|Death|0|||
164636975|NCT01422876|594695947|FG000|Week 52|Lost to Follow-up|3|||
164636976|NCT01422876|594695948|FG001|Week 52|Lost to Follow-up|5|||
164636977|NCT01422876|594695949|FG002|Week 52|Lost to Follow-up|7|||
164636978|NCT01422876|594695950|FG003|Week 52|Lost to Follow-up|5|||
164636979|NCT01422876|594695951|FG004|Week 52|Lost to Follow-up|8|||
164636980|NCT01422876|594695952|FG005|Week 52|Lost to Follow-up|5|||
164636981|NCT01422876|594695953|FG006|Week 52|Lost to Follow-up|5|||
164636982|NCT01422876|594695954|FG007|Week 52|Lost to Follow-up|8|||
164636983|NCT01422876|594695955|FG008|Week 52|Lost to Follow-up|7|||
164636984|NCT01422876|594695956|FG009|Week 52|Lost to Follow-up|8|||
164636985|NCT01422876|594695947|FG000|Week 52|Consent withdrawn|9|||
164636986|NCT01422876|594695948|FG001|Week 52|Consent withdrawn|4|||
164636987|NCT01422876|594695949|FG002|Week 52|Consent withdrawn|6|||
164636988|NCT01422876|594695950|FG003|Week 52|Consent withdrawn|12|||
164636989|NCT01422876|594695951|FG004|Week 52|Consent withdrawn|7|||
164636990|NCT01422876|594695952|FG005|Week 52|Consent withdrawn|12|||
164636991|NCT01422876|594695953|FG006|Week 52|Consent withdrawn|10|||
164636992|NCT01422876|594695954|FG007|Week 52|Consent withdrawn|12|||
164636993|NCT01422876|594695955|FG008|Week 52|Consent withdrawn|13|||
164636994|NCT01422876|594695956|FG009|Week 52|Consent withdrawn|9|||
164636995|NCT01422876|594695947|FG000|Week 52|Death|0|||
164636996|NCT01422876|594695948|FG001|Week 52|Death|1|||
164636997|NCT01422876|594695949|FG002|Week 52|Death|0|||
164636998|NCT01422876|594695950|FG003|Week 52|Death|1|||
164636999|NCT01422876|594695951|FG004|Week 52|Death|0|||
164637000|NCT01422876|594695952|FG005|Week 52|Death|0|||
164637001|NCT01422876|594695953|FG006|Week 52|Death|1|||
164637002|NCT01422876|594695954|FG007|Week 52|Death|3|||
164637003|NCT01422876|594695955|FG008|Week 52|Death|1|||
164637004|NCT01422876|594695956|FG009|Week 52|Death|0|||
164637005|NCT01600755|594695957|FG000|Overall Study|Withdrawal by Subject|6|||
164637006|NCT00938392|594695962|FG000|Overall Study|Adverse Event|0|||
164637007|NCT00938392|594695963|FG001|Overall Study|Adverse Event|1|||
164637008|NCT00938392|594695962|FG000|Overall Study|Withdrawal by Subject|0|||
164637009|NCT00938392|594695963|FG001|Overall Study|Withdrawal by Subject|1|||
164637010|NCT00938392|594695962|FG000|Overall Study|Lost to Follow-up|2|||
164637011|NCT00938392|594695963|FG001|Overall Study|Lost to Follow-up|2|||
164637012|NCT00122954|594695964|FG000|Overall Study|Withdrawal by Subject|2|||
164637013|NCT00122954|594695965|FG001|Overall Study|Withdrawal by Subject|2|||
164637014|NCT00122954|594695964|FG000|Overall Study|Protocol Violation|0|||
164637015|NCT00122954|594695965|FG001|Overall Study|Protocol Violation|1|||
164637016|NCT00558831|594695966|FG000|Overall Study|Lost to Follow-up|1|||
164637017|NCT02204449|594695967|FG000|Overall Study|Lost to Follow-up|7|||
164637018|NCT02204449|594695968|FG001|Overall Study|Lost to Follow-up|9|||
164637019|NCT02204449|594695967|FG000|Overall Study|Death|0|||
164637020|NCT02204449|594695968|FG001|Overall Study|Death|1|||
164637021|NCT02204449|594695967|FG000|Overall Study|Withdrawal by Subject|0|||
164637022|NCT02204449|594695968|FG001|Overall Study|Withdrawal by Subject|1|||
164637023|NCT01491737|594695972|FG000|Overall Study|Withdrawal by Subject|20|||
164637024|NCT01491737|594695973|FG001|Overall Study|Withdrawal by Subject|17|||
164637025|NCT01491737|594695972|FG000|Overall Study|Lost to Follow-up|2|||
164637026|NCT01491737|594695973|FG001|Overall Study|Lost to Follow-up|10|||
164148616|NCT04895982|592904912|FG001|Overall Study|Protocol Violation|0|||
164637027|NCT01491737|594695972|FG000|Overall Study|Death|63|||
164637028|NCT01491737|594695973|FG001|Overall Study|Death|57|||
164637029|NCT01491737|594695972|FG000|Overall Study|Study Termination by Sponsor|36|||
164637030|NCT01491737|594695973|FG001|Overall Study|Study Termination by Sponsor|36|||
164637031|NCT01491737|594695972|FG000|Overall Study|Reason Not Specified|8|||
164637032|NCT01491737|594695973|FG001|Overall Study|Reason Not Specified|9|||
164637033|NCT03772574|594695974|FG000|Overall Study|Protocol Violation|2|||
164637034|NCT03772574|594695975|FG001|Overall Study|Protocol Violation|0|||
164637035|NCT03772574|594695976|FG002|Overall Study|Protocol Violation|0|||
164637036|NCT03772574|594695974|FG000|Overall Study|Discomfort|0|||
164637037|NCT03772574|594695975|FG001|Overall Study|Discomfort|5|||
164637038|NCT03772574|594695976|FG002|Overall Study|Discomfort|4|||
164637039|NCT02696382|594695977|FG000|Overall Study|Death|7|||
164637040|NCT02696382|594695978|FG001|Overall Study|Death|2|||
164637041|NCT02696382|594695977|FG000|Overall Study|Withdrawal by Subject|5|||
164637042|NCT02696382|594695978|FG001|Overall Study|Withdrawal by Subject|12|||
164637043|NCT02696382|594695977|FG000|Overall Study|Lost to Follow-up|4|||
164637044|NCT02696382|594695978|FG001|Overall Study|Lost to Follow-up|7|||
164637045|NCT02743117|594695982|FG000|Overall Study|Lost to Follow-up|0|||
164637046|NCT02743117|594695983|FG001|Overall Study|Lost to Follow-up|1|||
164637047|NCT02743117|594695982|FG000|Overall Study|Other|1|||
164637048|NCT02743117|594695983|FG001|Overall Study|Other|0|||
164637049|NCT04983589|594695984|FG000|Overall Study|Withdrawal by Subject|0|||
164637050|NCT04983589|594695985|FG001|Overall Study|Withdrawal by Subject|3|||
164637051|NCT04983589|594695984|FG000|Overall Study|COVID-19 Infection|1|||
164637052|NCT04983589|594695985|FG001|Overall Study|COVID-19 Infection|0|||
164637053|NCT04983589|594695984|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
164637054|NCT04983589|594695985|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
164637055|NCT02940392|594695988|FG000|Overall Study|Lost to Follow-up|3|||
164637056|NCT02940392|594695988|FG000|Overall Study|Retreatment|3|||
164637057|NCT02940392|594695988|FG000|Overall Study|Death|2|||
164637058|NCT00762073|594695991|FG000|Overall Study|Lack of Efficacy|1|||
164637059|NCT00762073|594695992|FG001|Overall Study|Lack of Efficacy|1|||
164637060|NCT00762073|594695993|FG002|Overall Study|Lack of Efficacy|0|||
164637061|NCT00762073|594695994|FG003|Overall Study|Lack of Efficacy|0|||
164637062|NCT00762073|594695991|FG000|Overall Study|Adverse Event|1|||
164637063|NCT00762073|594695992|FG001|Overall Study|Adverse Event|0|||
164637064|NCT00762073|594695993|FG002|Overall Study|Adverse Event|1|||
164637065|NCT00762073|594695994|FG003|Overall Study|Adverse Event|1|||
164637066|NCT00762073|594695991|FG000|Overall Study|Significant Subject Noncompliance|0|||
164637067|NCT00762073|594695992|FG001|Overall Study|Significant Subject Noncompliance|1|||
164637068|NCT00762073|594695993|FG002|Overall Study|Significant Subject Noncompliance|0|||
164637069|NCT00762073|594695994|FG003|Overall Study|Significant Subject Noncompliance|1|||
164637070|NCT00762073|594695991|FG000|Overall Study|Withdrawal by Subject|1|||
164637071|NCT00762073|594695992|FG001|Overall Study|Withdrawal by Subject|2|||
164637072|NCT00762073|594695993|FG002|Overall Study|Withdrawal by Subject|1|||
164637073|NCT00762073|594695994|FG003|Overall Study|Withdrawal by Subject|1|||
164637074|NCT00762073|594695991|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
164637075|NCT00762073|594695992|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
164637076|NCT00762073|594695993|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
164637077|NCT00762073|594695994|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
164637078|NCT02319642|594695995|FG000|Overall Study|Adverse Event|2|||
164637079|NCT02319642|594695996|FG001|Overall Study|Adverse Event|4|||
164637080|NCT02319642|594695995|FG000|Overall Study|Lack of Efficacy|1|||
164637081|NCT02319642|594695996|FG001|Overall Study|Lack of Efficacy|1|||
164637082|NCT02319642|594695995|FG000|Overall Study|Withdrawal by Subject|1|||
164637083|NCT02319642|594695996|FG001|Overall Study|Withdrawal by Subject|1|||
164637084|NCT01265875|594695997|FG000|Overall Study|Uncooperative/unreliable|1|||
164637085|NCT01049360|594696000|FG000|Period 1|Adverse Event|0|||
164637086|NCT01049360|594696001|FG001|Period 1|Adverse Event|1|||
164637087|NCT01049360|594696002|FG002|Period 1|Adverse Event|0|||
164637088|NCT01049360|594696003|FG003|Period 1|Adverse Event|1|||
164637089|NCT01049360|594696004|FG004|Period 1|Adverse Event|0|||
164637090|NCT01049360|594696005|FG005|Period 1|Adverse Event|0|||
164637091|NCT01049360|594696006|FG006|Period 1|Adverse Event|0|||
164637092|NCT01049360|594696007|FG007|Period 1|Adverse Event|1|||
164637093|NCT01049360|594696008|FG008|Period 1|Adverse Event|0|||
164637094|NCT01049360|594696009|FG009|Period 1|Adverse Event|0|||
164637095|NCT01049360|594696010|FG010|Period 1|Adverse Event|0|||
164637096|NCT01049360|594696011|FG011|Period 1|Adverse Event|0|||
164637097|NCT01049360|594696012|FG012|Period 1|Adverse Event|1|||
164637098|NCT01049360|594696013|FG013|Period 1|Adverse Event|1|||
164637099|NCT01049360|594696014|FG014|Period 1|Adverse Event|0|||
164637100|NCT01049360|594696015|FG015|Period 1|Adverse Event|0|||
164637101|NCT01049360|594696016|FG016|Period 1|Adverse Event|1|||
164637102|NCT01049360|594696017|FG017|Period 1|Adverse Event|0|||
164637103|NCT01049360|594696018|FG018|Period 1|Adverse Event|1|||
164637104|NCT01049360|594696019|FG019|Period 1|Adverse Event|0|||
164637105|NCT01049360|594696000|FG000|Period 1|Did not meet inc/exc criteria|0|||
164637106|NCT01049360|594696001|FG001|Period 1|Did not meet inc/exc criteria|0|||
164637107|NCT01049360|594696002|FG002|Period 1|Did not meet inc/exc criteria|0|||
164637108|NCT01049360|594696003|FG003|Period 1|Did not meet inc/exc criteria|0|||
164637109|NCT01049360|594696004|FG004|Period 1|Did not meet inc/exc criteria|0|||
164637110|NCT01049360|594696005|FG005|Period 1|Did not meet inc/exc criteria|0|||
164637111|NCT01049360|594696006|FG006|Period 1|Did not meet inc/exc criteria|0|||
164637112|NCT01049360|594696007|FG007|Period 1|Did not meet inc/exc criteria|1|||
164637113|NCT01049360|594696008|FG008|Period 1|Did not meet inc/exc criteria|1|||
164530410|NCT00505284|594313741|FG001|Overall Study|Adverse Event|7|||
164530411|NCT00505284|594313742|FG002|Overall Study|Adverse Event|9|||
164530412|NCT00505284|594313743|FG003|Overall Study|Adverse Event|14|||
164530413|NCT00505284|594313744|FG004|Overall Study|Adverse Event|22|||
164530414|NCT00505284|594313740|FG000|Overall Study|Protocol Violation|0|||
164530415|NCT00505284|594313741|FG001|Overall Study|Protocol Violation|1|||
164530416|NCT00505284|594313742|FG002|Overall Study|Protocol Violation|1|||
164530417|NCT00505284|594313743|FG003|Overall Study|Protocol Violation|0|||
164530418|NCT00505284|594313744|FG004|Overall Study|Protocol Violation|0|||
164530419|NCT00505284|594313740|FG000|Overall Study|Withdrawal by Subject|2|||
164530420|NCT00505284|594313741|FG001|Overall Study|Withdrawal by Subject|6|||
164530421|NCT00505284|594313742|FG002|Overall Study|Withdrawal by Subject|1|||
164530422|NCT00505284|594313743|FG003|Overall Study|Withdrawal by Subject|0|||
164530423|NCT00505284|594313744|FG004|Overall Study|Withdrawal by Subject|6|||
164530424|NCT00505284|594313740|FG000|Overall Study|Lack of Efficacy|0|||
164530425|NCT00505284|594313741|FG001|Overall Study|Lack of Efficacy|1|||
164530426|NCT00505284|594313742|FG002|Overall Study|Lack of Efficacy|1|||
164530427|NCT00505284|594313743|FG003|Overall Study|Lack of Efficacy|1|||
164530428|NCT00505284|594313744|FG004|Overall Study|Lack of Efficacy|1|||
164530429|NCT00505284|594313740|FG000|Overall Study|Physician Decision|0|||
164530430|NCT00505284|594313741|FG001|Overall Study|Physician Decision|1|||
164637114|NCT01049360|594696009|FG009|Period 1|Did not meet inc/exc criteria|0|||
164637115|NCT01049360|594696010|FG010|Period 1|Did not meet inc/exc criteria|0|||
164637116|NCT01049360|594696011|FG011|Period 1|Did not meet inc/exc criteria|0|||
164637117|NCT01049360|594696012|FG012|Period 1|Did not meet inc/exc criteria|0|||
164637118|NCT01049360|594696013|FG013|Period 1|Did not meet inc/exc criteria|0|||
164637119|NCT01049360|594696014|FG014|Period 1|Did not meet inc/exc criteria|0|||
164637120|NCT01049360|594696015|FG015|Period 1|Did not meet inc/exc criteria|0|||
164637121|NCT01049360|594696016|FG016|Period 1|Did not meet inc/exc criteria|0|||
164637122|NCT01049360|594696017|FG017|Period 1|Did not meet inc/exc criteria|0|||
164637123|NCT01049360|594696018|FG018|Period 1|Did not meet inc/exc criteria|0|||
164637124|NCT01049360|594696019|FG019|Period 1|Did not meet inc/exc criteria|0|||
164637125|NCT01049360|594696000|FG000|Period 1|Withdrawal by Subject|0|||
164637126|NCT01049360|594696001|FG001|Period 1|Withdrawal by Subject|0|||
164637127|NCT01049360|594696002|FG002|Period 1|Withdrawal by Subject|0|||
164637128|NCT01049360|594696003|FG003|Period 1|Withdrawal by Subject|0|||
164637129|NCT01049360|594696004|FG004|Period 1|Withdrawal by Subject|0|||
164637130|NCT01049360|594696005|FG005|Period 1|Withdrawal by Subject|0|||
164637131|NCT01049360|594696006|FG006|Period 1|Withdrawal by Subject|0|||
164637132|NCT01049360|594696007|FG007|Period 1|Withdrawal by Subject|0|||
164637133|NCT01049360|594696008|FG008|Period 1|Withdrawal by Subject|1|||
164637134|NCT01049360|594696009|FG009|Period 1|Withdrawal by Subject|0|||
164637135|NCT01049360|594696010|FG010|Period 1|Withdrawal by Subject|1|||
164637136|NCT01049360|594696011|FG011|Period 1|Withdrawal by Subject|0|||
164637137|NCT01049360|594696012|FG012|Period 1|Withdrawal by Subject|1|||
164637138|NCT01049360|594696013|FG013|Period 1|Withdrawal by Subject|0|||
164637139|NCT01049360|594696014|FG014|Period 1|Withdrawal by Subject|0|||
164637140|NCT01049360|594696015|FG015|Period 1|Withdrawal by Subject|0|||
164637141|NCT01049360|594696016|FG016|Period 1|Withdrawal by Subject|0|||
164637142|NCT01049360|594696017|FG017|Period 1|Withdrawal by Subject|0|||
164637143|NCT01049360|594696018|FG018|Period 1|Withdrawal by Subject|0|||
164637144|NCT01049360|594696019|FG019|Period 1|Withdrawal by Subject|0|||
164637145|NCT01049360|594696000|FG000|Period 2|Protocol Violation|0|||
164637146|NCT01049360|594696001|FG001|Period 2|Protocol Violation|0|||
164637147|NCT01049360|594696002|FG002|Period 2|Protocol Violation|0|||
164637148|NCT01049360|594696003|FG003|Period 2|Protocol Violation|1|||
164637149|NCT01049360|594696004|FG004|Period 2|Protocol Violation|0|||
164637150|NCT01049360|594696005|FG005|Period 2|Protocol Violation|0|||
164637151|NCT01049360|594696006|FG006|Period 2|Protocol Violation|0|||
164637152|NCT01049360|594696007|FG007|Period 2|Protocol Violation|0|||
164637153|NCT01049360|594696008|FG008|Period 2|Protocol Violation|0|||
164637154|NCT01049360|594696009|FG009|Period 2|Protocol Violation|0|||
164637155|NCT01049360|594696010|FG010|Period 2|Protocol Violation|0|||
164637156|NCT01049360|594696011|FG011|Period 2|Protocol Violation|0|||
164637157|NCT01049360|594696012|FG012|Period 2|Protocol Violation|0|||
164637158|NCT01049360|594696013|FG013|Period 2|Protocol Violation|0|||
164637159|NCT01049360|594696014|FG014|Period 2|Protocol Violation|1|||
164637160|NCT01049360|594696015|FG015|Period 2|Protocol Violation|1|||
164637161|NCT01049360|594696016|FG016|Period 2|Protocol Violation|0|||
164637162|NCT01049360|594696017|FG017|Period 2|Protocol Violation|0|||
164148617|NCT04895982|592904913|FG002|Overall Study|Protocol Violation|1|||
164637163|NCT01049360|594696018|FG018|Period 2|Protocol Violation|0|||
164637164|NCT01049360|594696019|FG019|Period 2|Protocol Violation|0|||
164637165|NCT01049360|594696000|FG000|Period 2|Adverse Event|0|||
164637166|NCT01049360|594696001|FG001|Period 2|Adverse Event|1|||
164637167|NCT01049360|594696002|FG002|Period 2|Adverse Event|0|||
164637168|NCT01049360|594696003|FG003|Period 2|Adverse Event|0|||
164637169|NCT01049360|594696004|FG004|Period 2|Adverse Event|0|||
164637170|NCT01049360|594696005|FG005|Period 2|Adverse Event|0|||
164637171|NCT01049360|594696006|FG006|Period 2|Adverse Event|0|||
164637172|NCT01049360|594696007|FG007|Period 2|Adverse Event|0|||
164637173|NCT01049360|594696008|FG008|Period 2|Adverse Event|1|||
164637174|NCT01049360|594696009|FG009|Period 2|Adverse Event|0|||
164637175|NCT01049360|594696010|FG010|Period 2|Adverse Event|0|||
164637176|NCT01049360|594696011|FG011|Period 2|Adverse Event|0|||
164637177|NCT01049360|594696012|FG012|Period 2|Adverse Event|0|||
164637178|NCT01049360|594696013|FG013|Period 2|Adverse Event|0|||
164637179|NCT01049360|594696014|FG014|Period 2|Adverse Event|0|||
164637180|NCT01049360|594696015|FG015|Period 2|Adverse Event|0|||
164637181|NCT01049360|594696016|FG016|Period 2|Adverse Event|0|||
164637182|NCT01049360|594696017|FG017|Period 2|Adverse Event|0|||
164637183|NCT01049360|594696018|FG018|Period 2|Adverse Event|0|||
164637184|NCT01049360|594696019|FG019|Period 2|Adverse Event|1|||
164637185|NCT01049360|594696000|FG000|Period 2|Withdrawal by Subject|0|||
164637186|NCT01049360|594696001|FG001|Period 2|Withdrawal by Subject|0|||
164637187|NCT01049360|594696002|FG002|Period 2|Withdrawal by Subject|0|||
164637188|NCT01049360|594696003|FG003|Period 2|Withdrawal by Subject|1|||
164637189|NCT01049360|594696004|FG004|Period 2|Withdrawal by Subject|0|||
164637190|NCT01049360|594696005|FG005|Period 2|Withdrawal by Subject|0|||
164637191|NCT01049360|594696006|FG006|Period 2|Withdrawal by Subject|0|||
164637192|NCT01049360|594696007|FG007|Period 2|Withdrawal by Subject|0|||
164637193|NCT01049360|594696008|FG008|Period 2|Withdrawal by Subject|0|||
164637194|NCT01049360|594696009|FG009|Period 2|Withdrawal by Subject|0|||
164637195|NCT01049360|594696010|FG010|Period 2|Withdrawal by Subject|0|||
164637196|NCT01049360|594696011|FG011|Period 2|Withdrawal by Subject|0|||
164637197|NCT01049360|594696012|FG012|Period 2|Withdrawal by Subject|0|||
164637198|NCT01049360|594696013|FG013|Period 2|Withdrawal by Subject|0|||
164637199|NCT01049360|594696014|FG014|Period 2|Withdrawal by Subject|1|||
164637200|NCT01049360|594696015|FG015|Period 2|Withdrawal by Subject|0|||
164637201|NCT01049360|594696016|FG016|Period 2|Withdrawal by Subject|0|||
164637202|NCT01049360|594696017|FG017|Period 2|Withdrawal by Subject|0|||
164637203|NCT01049360|594696018|FG018|Period 2|Withdrawal by Subject|0|||
164637204|NCT01049360|594696019|FG019|Period 2|Withdrawal by Subject|1|||
164637205|NCT01049360|594696000|FG000|Period 2|Lack of Efficacy|0|||
164637206|NCT01049360|594696001|FG001|Period 2|Lack of Efficacy|0|||
164637207|NCT01049360|594696002|FG002|Period 2|Lack of Efficacy|0|||
164637208|NCT01049360|594696003|FG003|Period 2|Lack of Efficacy|0|||
164637209|NCT01049360|594696004|FG004|Period 2|Lack of Efficacy|0|||
164637210|NCT01049360|594696005|FG005|Period 2|Lack of Efficacy|1|||
164637211|NCT01049360|594696006|FG006|Period 2|Lack of Efficacy|0|||
164637212|NCT01049360|594696007|FG007|Period 2|Lack of Efficacy|0|||
164637213|NCT01049360|594696008|FG008|Period 2|Lack of Efficacy|0|||
164637214|NCT01049360|594696009|FG009|Period 2|Lack of Efficacy|0|||
164637215|NCT01049360|594696010|FG010|Period 2|Lack of Efficacy|0|||
164637216|NCT01049360|594696011|FG011|Period 2|Lack of Efficacy|0|||
164637217|NCT01049360|594696012|FG012|Period 2|Lack of Efficacy|0|||
164637218|NCT01049360|594696013|FG013|Period 2|Lack of Efficacy|0|||
164637219|NCT01049360|594696014|FG014|Period 2|Lack of Efficacy|0|||
164637220|NCT01049360|594696015|FG015|Period 2|Lack of Efficacy|0|||
164637221|NCT01049360|594696016|FG016|Period 2|Lack of Efficacy|0|||
164637222|NCT01049360|594696017|FG017|Period 2|Lack of Efficacy|0|||
164637223|NCT01049360|594696018|FG018|Period 2|Lack of Efficacy|0|||
164637224|NCT01049360|594696019|FG019|Period 2|Lack of Efficacy|0|||
164637225|NCT01049360|594696000|FG000|Period 4|Protocol Violation|0|||
164637226|NCT01049360|594696001|FG001|Period 4|Protocol Violation|0|||
164637227|NCT01049360|594696002|FG002|Period 4|Protocol Violation|0|||
164637228|NCT01049360|594696003|FG003|Period 4|Protocol Violation|0|||
164637229|NCT01049360|594696004|FG004|Period 4|Protocol Violation|0|||
164637230|NCT01049360|594696005|FG005|Period 4|Protocol Violation|0|||
164637231|NCT01049360|594696006|FG006|Period 4|Protocol Violation|0|||
164637232|NCT01049360|594696007|FG007|Period 4|Protocol Violation|0|||
164637233|NCT01049360|594696008|FG008|Period 4|Protocol Violation|0|||
164637234|NCT01049360|594696009|FG009|Period 4|Protocol Violation|0|||
164637235|NCT01049360|594696010|FG010|Period 4|Protocol Violation|0|||
164637236|NCT01049360|594696011|FG011|Period 4|Protocol Violation|0|||
164637237|NCT01049360|594696012|FG012|Period 4|Protocol Violation|0|||
164637238|NCT01049360|594696013|FG013|Period 4|Protocol Violation|0|||
164637239|NCT01049360|594696014|FG014|Period 4|Protocol Violation|0|||
164637240|NCT01049360|594696015|FG015|Period 4|Protocol Violation|0|||
164637241|NCT01049360|594696016|FG016|Period 4|Protocol Violation|0|||
164637242|NCT01049360|594696017|FG017|Period 4|Protocol Violation|1|||
164637243|NCT01049360|594696018|FG018|Period 4|Protocol Violation|0|||
164637244|NCT01049360|594696019|FG019|Period 4|Protocol Violation|0|||
164637245|NCT01049360|594696000|FG000|Period 4|Withdrawal by Subject|0|||
164637246|NCT01049360|594696001|FG001|Period 4|Withdrawal by Subject|0|||
164637247|NCT01049360|594696002|FG002|Period 4|Withdrawal by Subject|0|||
164637248|NCT01049360|594696003|FG003|Period 4|Withdrawal by Subject|1|||
164637249|NCT01049360|594696004|FG004|Period 4|Withdrawal by Subject|0|||
164637250|NCT01049360|594696005|FG005|Period 4|Withdrawal by Subject|0|||
164637251|NCT01049360|594696006|FG006|Period 4|Withdrawal by Subject|0|||
164637252|NCT01049360|594696007|FG007|Period 4|Withdrawal by Subject|0|||
164637253|NCT01049360|594696008|FG008|Period 4|Withdrawal by Subject|0|||
164637254|NCT01049360|594696009|FG009|Period 4|Withdrawal by Subject|0|||
164637255|NCT01049360|594696010|FG010|Period 4|Withdrawal by Subject|0|||
164637256|NCT01049360|594696011|FG011|Period 4|Withdrawal by Subject|0|||
164637257|NCT01049360|594696012|FG012|Period 4|Withdrawal by Subject|0|||
164637258|NCT01049360|594696013|FG013|Period 4|Withdrawal by Subject|0|||
164637259|NCT01049360|594696014|FG014|Period 4|Withdrawal by Subject|0|||
164637260|NCT01049360|594696015|FG015|Period 4|Withdrawal by Subject|0|||
164637261|NCT01049360|594696016|FG016|Period 4|Withdrawal by Subject|0|||
164637262|NCT01049360|594696017|FG017|Period 4|Withdrawal by Subject|0|||
164637263|NCT01049360|594696018|FG018|Period 4|Withdrawal by Subject|0|||
164637264|NCT01049360|594696019|FG019|Period 4|Withdrawal by Subject|0|||
164637265|NCT05147311|594696022|FG000|Overall Study|Did not complete survey|2|||
164637266|NCT05147311|594696023|FG001|Overall Study|Did not complete survey|1|||
164637267|NCT05147311|594696022|FG000|Overall Study|Patient too sick|1|||
164637268|NCT05147311|594696023|FG001|Overall Study|Patient too sick|2|||
164637269|NCT05147311|594696022|FG000|Overall Study|Death|0|||
164637270|NCT05147311|594696023|FG001|Overall Study|Death|1|||
164637271|NCT05147311|594696022|FG000|Overall Study|Declined survey|1|||
164637272|NCT05147311|594696023|FG001|Overall Study|Declined survey|0|||
164637273|NCT00145795|594696025|FG000|Overall Study|Adverse Event|1|||
164637274|NCT00145795|594696026|FG001|Overall Study|Adverse Event|0|||
164637275|NCT04419558|594696027|FG000|DB Period (48 Weeks)|Adverse Event|6|||
164637276|NCT04419558|594696028|FG001|DB Period (48 Weeks)|Adverse Event|6|||
164637277|NCT04419558|594696027|FG000|DB Period (48 Weeks)|Death|14|||
164637278|NCT04419558|594696028|FG001|DB Period (48 Weeks)|Death|11|||
164637279|NCT04419558|594696027|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
164637280|NCT04419558|594696028|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
164637281|NCT04419558|594696027|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
164637282|NCT04419558|594696028|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
164637283|NCT04419558|594696027|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
164637284|NCT04419558|594696028|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
164637285|NCT04419558|594696027|FG000|DB Period (48 Weeks)|Disease Progression|1|||
164637286|NCT04419558|594696028|FG001|DB Period (48 Weeks)|Disease Progression|0|||
164637287|NCT04419558|594696027|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
164637288|NCT04419558|594696028|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
164637289|NCT04419558|594696027|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
164637290|NCT04419558|594696028|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
164637291|NCT04419558|594696027|FG000|DB Period (48 Weeks)|Participant Decision|4|||
164637292|NCT04419558|594696028|FG001|DB Period (48 Weeks)|Participant Decision|3|||
164637293|NCT04419558|594696027|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
164637294|NCT04419558|594696028|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
164637295|NCT04419558|594696027|FG000|OLE Period (48 Weeks)|Death|4|||
164637296|NCT04419558|594696028|FG001|OLE Period (48 Weeks)|Death|6|||
164637297|NCT04419558|594696027|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
164637298|NCT04419558|594696028|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
164637299|NCT04419558|594696027|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
164637300|NCT04419558|594696028|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
164637301|NCT01539512|594696032|FG000|Overall Study|Adverse Event|9|||
164637302|NCT01539512|594696033|FG001|Overall Study|Adverse Event|7|||
164637303|NCT01539512|594696032|FG000|Overall Study|Physician Decision|1|||
164637304|NCT01539512|594696033|FG001|Overall Study|Physician Decision|1|||
164637305|NCT01539512|594696032|FG000|Overall Study|Withdrawal by Subject|12|||
164637306|NCT01539512|594696033|FG001|Overall Study|Withdrawal by Subject|5|||
164637307|NCT01539512|594696032|FG000|Overall Study|Richter's Transformation|1|||
164637308|NCT01539512|594696033|FG001|Overall Study|Richter's Transformation|0|||
164637309|NCT02388906|594696034|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
164637310|NCT02388906|594696035|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
164637311|NCT02388906|594696034|FG000|Treatment Period|Disease progression|121|||
164637312|NCT02388906|594696035|FG001|Treatment Period|Disease progression|100|||
164637313|NCT02388906|594696034|FG000|Treatment Period|Study drug toxicity|41|||
164637314|NCT02388906|594696035|FG001|Treatment Period|Study drug toxicity|208|||
164637315|NCT02388906|594696034|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
164637316|NCT02388906|594696035|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
164637317|NCT02388906|594696034|FG000|Treatment Period|Participant request to stop treatment|5|||
164637318|NCT02388906|594696035|FG001|Treatment Period|Participant request to stop treatment|9|||
164637319|NCT02388906|594696034|FG000|Treatment Period|Participant withdrew consent|2|||
164637320|NCT02388906|594696035|FG001|Treatment Period|Participant withdrew consent|3|||
164637321|NCT02388906|594696034|FG000|Treatment Period|Poor/non-compliance|0|||
164637322|NCT02388906|594696035|FG001|Treatment Period|Poor/non-compliance|1|||
164637323|NCT02388906|594696034|FG000|Treatment Period|Participant no longer meets study criteria|0|||
164637324|NCT02388906|594696035|FG001|Treatment Period|Participant no longer meets study criteria|1|||
164637325|NCT02388906|594696034|FG000|Treatment Period|Other reasons|3|||
164637326|NCT02388906|594696035|FG001|Treatment Period|Other reasons|3|||
164637327|NCT02400281|594696036|FG000|Overall Study|Adverse Event|0|||
164637328|NCT02400281|594696037|FG001|Overall Study|Adverse Event|0|||
164637329|NCT02400281|594696038|FG002|Overall Study|Adverse Event|1|||
164637330|NCT02400281|594696039|FG003|Overall Study|Adverse Event|0|||
164637331|NCT02400281|594696040|FG004|Overall Study|Adverse Event|1|||
164637332|NCT02400281|594696041|FG005|Overall Study|Adverse Event|0|||
164637333|NCT02400281|594696036|FG000|Overall Study|Physician Decision|0|||
164637334|NCT02400281|594696037|FG001|Overall Study|Physician Decision|0|||
164637335|NCT02400281|594696038|FG002|Overall Study|Physician Decision|1|||
164637336|NCT02400281|594696039|FG003|Overall Study|Physician Decision|0|||
164637337|NCT02400281|594696040|FG004|Overall Study|Physician Decision|0|||
164637338|NCT02400281|594696041|FG005|Overall Study|Physician Decision|0|||
164637339|NCT00412360|594696042|FG000|Overall Study|Lost to Follow-up|0|||
164637340|NCT00412360|594696043|FG001|Overall Study|Lost to Follow-up|1|||
164637341|NCT00412360|594696042|FG000|Overall Study|Not Transplanted|1|||
164637342|NCT00412360|594696043|FG001|Overall Study|Not Transplanted|2|||
164637343|NCT03145207|594696044|FG000|Overall Study|volunteer started taking allergy shots|1|||
164637344|NCT03145207|594696044|FG000|Overall Study|baseline blood pressure high|1|||
164637345|NCT01790633|594696045|FG000|Overall Study|Protocol Violation|1|||
164637346|NCT01790633|594696046|FG001|Overall Study|Protocol Violation|2|||
164637347|NCT01790633|594696045|FG000|Overall Study|Did not have serology performed|47|||
164637348|NCT01790633|594696046|FG001|Overall Study|Did not have serology performed|0|||
164637349|NCT01790633|594696045|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
164637350|NCT01790633|594696046|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
164637351|NCT00157157|594696050|FG000|Overall Study|Withdrawal by Subject|6|||
164637352|NCT00157157|594696050|FG000|Overall Study|Physician Decision|1|||
164637353|NCT00157157|594696050|FG000|Overall Study|Lost to Follow-up|1|||
164637354|NCT00157157|594696050|FG000|Overall Study|Enrolled in another study|1|||
164637355|NCT00157157|594696050|FG000|Overall Study|Met exclusion criteria|1|||
164637356|NCT00157157|594696050|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
164637357|NCT00563706|594697445|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
164637358|NCT00563706|594697446|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
164637359|NCT00563706|594697447|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
164637360|NCT00563706|594697448|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
164637361|NCT00563706|594697449|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
164637362|NCT00563706|594697450|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
164637363|NCT00563706|594697451|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
164637364|NCT00563706|594697452|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
164637365|NCT00563706|594697453|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
164637366|NCT00563706|594697445|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
164637367|NCT00563706|594697446|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
164637368|NCT00563706|594697447|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
164637369|NCT00563706|594697448|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
164637370|NCT00563706|594697449|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
164637371|NCT00563706|594697450|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
164637372|NCT00563706|594697451|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
164637373|NCT00563706|594697452|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
164637374|NCT00563706|594697453|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
164637375|NCT00563706|594697445|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
164637376|NCT00563706|594697446|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
164637377|NCT00563706|594697447|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
164637378|NCT00563706|594697448|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
164637379|NCT00563706|594697449|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
164637380|NCT00563706|594697450|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
164637381|NCT00563706|594697451|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
164637382|NCT00563706|594697452|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
164637383|NCT00563706|594697453|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
164637384|NCT00563706|594697445|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
164637385|NCT00563706|594697446|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
164637386|NCT00563706|594697447|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
164637387|NCT00563706|594697448|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
164637388|NCT00563706|594697449|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
164637389|NCT00563706|594697450|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
164637390|NCT00563706|594697451|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
164637391|NCT00563706|594697452|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
164637392|NCT00563706|594697453|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
164637393|NCT00563706|594697445|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
164637394|NCT00563706|594697446|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
164637395|NCT00563706|594697447|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
164637396|NCT00563706|594697448|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
164637397|NCT00563706|594697449|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
164637398|NCT00563706|594697450|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
164637399|NCT00563706|594697451|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
164637400|NCT00563706|594697452|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
164637401|NCT00563706|594697453|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
164637402|NCT03839693|594697458|FG000|Overall Study|Lost to Follow-up|0|||
164637403|NCT03839693|594697459|FG001|Overall Study|Lost to Follow-up|2|||
164637404|NCT03839693|594697460|FG002|Overall Study|Lost to Follow-up|2|||
164637405|NCT03839693|594697458|FG000|Overall Study|Withdrawal by Subject|1|||
164637406|NCT03839693|594697459|FG001|Overall Study|Withdrawal by Subject|0|||
164637407|NCT03839693|594697460|FG002|Overall Study|Withdrawal by Subject|2|||
164637408|NCT03839693|594697458|FG000|Overall Study|subject moved out of the area|1|||
164637409|NCT03839693|594697459|FG001|Overall Study|subject moved out of the area|0|||
164637410|NCT03839693|594697460|FG002|Overall Study|subject moved out of the area|0|||
164637411|NCT00270205|594697461|FG000|Overall Study|Lost to Follow-up|1|||
164637412|NCT00270205|594697462|FG001|Overall Study|Lost to Follow-up|0|||
164637413|NCT00270205|594697463|FG002|Overall Study|Lost to Follow-up|0|||
164637414|NCT00270205|594697464|FG003|Overall Study|Lost to Follow-up|1|||
164637415|NCT00706901|594697465|FG000|Overall Study|Lost to Follow-up|2|||
164637416|NCT00706901|594697466|FG001|Overall Study|Lost to Follow-up|3|||
164637417|NCT00706901|594697467|FG002|Overall Study|Lost to Follow-up|2|||
164637418|NCT00706901|594697465|FG000|Overall Study|Withdrawal by Subject|4|||
164637419|NCT00706901|594697466|FG001|Overall Study|Withdrawal by Subject|2|||
164637420|NCT00706901|594697467|FG002|Overall Study|Withdrawal by Subject|5|||
164637421|NCT00706901|594697465|FG000|Overall Study|In Jail|1|||
164637422|NCT00706901|594697466|FG001|Overall Study|In Jail|0|||
164637423|NCT00706901|594697467|FG002|Overall Study|In Jail|1|||
164637424|NCT00706901|594697465|FG000|Overall Study|Death|1|||
164637425|NCT00706901|594697466|FG001|Overall Study|Death|0|||
164637426|NCT00706901|594697467|FG002|Overall Study|Death|0|||
164637427|NCT01339273|594697471|FG000|Overall Study|Lost to Follow-up|8|||
164637428|NCT01339273|594697472|FG001|Overall Study|Lost to Follow-up|8|||
164637429|NCT04478994|594697473|FG000|Overall Study|Withdrawal by Subject|1|||
164637430|NCT04478994|594697474|FG001|Overall Study|Withdrawal by Subject|1|||
164637431|NCT00457249|594697475|FG000|Overall Study|Lost to Follow-up|3|||
164637432|NCT00457249|594697476|FG001|Overall Study|Lost to Follow-up|0|||
164637433|NCT00457249|594697475|FG000|Overall Study|Protocol Violation|4|||
164637434|NCT00457249|594697476|FG001|Overall Study|Protocol Violation|1|||
164637435|NCT00457249|594697475|FG000|Overall Study|Withdrawal by Subject|3|||
164637436|NCT00457249|594697476|FG001|Overall Study|Withdrawal by Subject|1|||
164637437|NCT00457249|594697475|FG000|Overall Study|Serious Adverse Events|2|||
164637438|NCT00457249|594697476|FG001|Overall Study|Serious Adverse Events|0|||
164530431|NCT00505284|594313742|FG002|Overall Study|Physician Decision|0|||
164530432|NCT00505284|594313743|FG003|Overall Study|Physician Decision|0|||
164530433|NCT00505284|594313744|FG004|Overall Study|Physician Decision|0|||
164530434|NCT00505284|594313740|FG000|Overall Study|Other|5|||
164530435|NCT00505284|594313741|FG001|Overall Study|Other|0|||
164530436|NCT00505284|594313742|FG002|Overall Study|Other|0|||
164530437|NCT00505284|594313743|FG003|Overall Study|Other|4|||
164530438|NCT00505284|594313744|FG004|Overall Study|Other|4|||
164530439|NCT00940108|594313745|FG000|Overall Study|Adverse Event|2|||
164530440|NCT00940108|594313746|FG001|Overall Study|Adverse Event|4|||
164530441|NCT00940108|594313747|FG002|Overall Study|Adverse Event|0|||
164530442|NCT00940108|594313748|FG003|Overall Study|Adverse Event|2|||
164530443|NCT00940108|594313745|FG000|Overall Study|Withdrew Consent|2|||
164530444|NCT00940108|594313746|FG001|Overall Study|Withdrew Consent|1|||
164530445|NCT00940108|594313747|FG002|Overall Study|Withdrew Consent|0|||
164530446|NCT00940108|594313748|FG003|Overall Study|Withdrew Consent|1|||
164530447|NCT00940108|594313745|FG000|Overall Study|Dose 2 contraindicated|1|||
164530448|NCT00940108|594313746|FG001|Overall Study|Dose 2 contraindicated|1|||
164530449|NCT00940108|594313747|FG002|Overall Study|Dose 2 contraindicated|0|||
164530450|NCT00940108|594313748|FG003|Overall Study|Dose 2 contraindicated|1|||
164530451|NCT00940108|594313745|FG000|Overall Study|Declined further vaccination|0|||
164530452|NCT00940108|594313746|FG001|Overall Study|Declined further vaccination|1|||
164530453|NCT00940108|594313747|FG002|Overall Study|Declined further vaccination|3|||
164530454|NCT00940108|594313748|FG003|Overall Study|Declined further vaccination|0|||
164530455|NCT00940108|594313745|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
164530456|NCT00940108|594313746|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
164530457|NCT00940108|594313747|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
164530458|NCT00940108|594313748|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
164530459|NCT00940108|594313745|FG000|Overall Study|Viral illness after Dose 1|0|||
164530460|NCT00940108|594313746|FG001|Overall Study|Viral illness after Dose 1|1|||
164530461|NCT00940108|594313747|FG002|Overall Study|Viral illness after Dose 1|0|||
164530462|NCT00940108|594313748|FG003|Overall Study|Viral illness after Dose 1|0|||
164530463|NCT00940108|594313745|FG000|Overall Study|Diagnosed with H1N1|0|||
164530464|NCT00940108|594313746|FG001|Overall Study|Diagnosed with H1N1|0|||
164530465|NCT00940108|594313747|FG002|Overall Study|Diagnosed with H1N1|0|||
164530466|NCT00940108|594313748|FG003|Overall Study|Diagnosed with H1N1|1|||
164530467|NCT03581825|594313749|FG000|Period 1|Lens Discomfort|1|||
164530468|NCT03581825|594313750|FG001|Period 1|Lens Discomfort|0|||
164530469|NCT03581825|594313749|FG000|Period 2|Unsatisfactory Vision to Test|0|||
164530470|NCT03581825|594313750|FG001|Period 2|Unsatisfactory Vision to Test|1|||
164530471|NCT00770341|594313751|FG000|Overall Study|Did not meet eligibility criteria|1|||
164530472|NCT00770341|594313752|FG001|Overall Study|Did not meet eligibility criteria|0|||
164530473|NCT00770341|594313753|FG002|Overall Study|Did not meet eligibility criteria|0|||
164530474|NCT00770341|594313751|FG000|Overall Study|Withdrawal by Subject|0|||
164530475|NCT00770341|594313752|FG001|Overall Study|Withdrawal by Subject|1|||
164530476|NCT00770341|594313753|FG002|Overall Study|Withdrawal by Subject|0|||
164530477|NCT00770341|594313751|FG000|Overall Study|Clinical Adverse Event|3|||
164530478|NCT00770341|594313752|FG001|Overall Study|Clinical Adverse Event|1|||
164530479|NCT00770341|594313753|FG002|Overall Study|Clinical Adverse Event|2|||
164530480|NCT00770341|594313751|FG000|Overall Study|Laboratory adverse event|3|||
164530481|NCT00770341|594313752|FG001|Overall Study|Laboratory adverse event|3|||
164530482|NCT00770341|594313753|FG002|Overall Study|Laboratory adverse event|0|||
164530483|NCT00770341|594313751|FG000|Overall Study|Lack of Efficacy|3|||
164530484|NCT00770341|594313752|FG001|Overall Study|Lack of Efficacy|0|||
164530485|NCT00770341|594313753|FG002|Overall Study|Lack of Efficacy|1|||
164530486|NCT00770341|594313751|FG000|Overall Study|Other|1|||
164530487|NCT00770341|594313752|FG001|Overall Study|Other|0|||
164530488|NCT00770341|594313753|FG002|Overall Study|Other|0|||
164530489|NCT00770341|594313751|FG000|Overall Study|Not treated|1|||
164530490|NCT00770341|594313752|FG001|Overall Study|Not treated|0|||
164530491|NCT00770341|594313753|FG002|Overall Study|Not treated|0|||
164530492|NCT02739360|594313754|FG000|Overall Study|Adverse Event|1|||
164530493|NCT02739360|594313754|FG000|Overall Study|Study terminated by Sponsor|2|||
164530494|NCT00529958|594313755|FG000|2-Year Follow-up|Lost to Follow-up|1|||
164530495|NCT00529958|594313756|FG001|2-Year Follow-up|Lost to Follow-up|2|||
164530496|NCT00529958|594313757|FG002|2-Year Follow-up|Lost to Follow-up|2|||
164530497|NCT00529958|594313755|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
164530498|NCT00529958|594313756|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
164530499|NCT00529958|594313757|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
164530500|NCT00529958|594313755|FG000|5-Year Follow-up|Lost to Follow-up|2|||
164530501|NCT00529958|594313756|FG001|5-Year Follow-up|Lost to Follow-up|3|||
164530502|NCT00529958|594313757|FG002|5-Year Follow-up|Lost to Follow-up|1|||
164530503|NCT00529958|594313755|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
164530504|NCT00529958|594313756|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
164530505|NCT00529958|594313757|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
164637439|NCT04621227|594697479|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
164637440|NCT04621227|594697479|FG000|Period 3 (29 Days)|Adverse Event|1|||
164637441|NCT04621227|594697479|FG000|Period 8 (2 Days)|Adverse Event|1|||
164637442|NCT02916056|594697480|FG000|Overall Study|Adverse Event|6|||
164637443|NCT02916056|594697480|FG000|Overall Study|Lost to Follow-up|1|||
164637444|NCT02916056|594697480|FG000|Overall Study|Other|12|||
164637445|NCT02916056|594697480|FG000|Overall Study|Protocol Violation|1|||
164637446|NCT02916056|594697480|FG000|Overall Study|Withdrawal by Subject|8|||
164637447|NCT02916056|594697480|FG000|Overall Study|Study Terminated by Sponsor|269|||
164637448|NCT00124709|594697481|FG000|Overall Study|Randomized but did not take medication|3|||
164637449|NCT00124709|594697482|FG001|Overall Study|Randomized but did not take medication|1|||
164637450|NCT00124709|594697481|FG000|Overall Study|Adverse Event|3|||
164637451|NCT00124709|594697482|FG001|Overall Study|Adverse Event|0|||
164637452|NCT00124709|594697481|FG000|Overall Study|Lack of Efficacy|5|||
164637453|NCT00124709|594697482|FG001|Overall Study|Lack of Efficacy|10|||
164637454|NCT00124709|594697481|FG000|Overall Study|Protocol Violation|3|||
164637455|NCT00124709|594697482|FG001|Overall Study|Protocol Violation|5|||
164637456|NCT00124709|594697481|FG000|Overall Study|Withdrawal by Subject|127|||
164637457|NCT00124709|594697482|FG001|Overall Study|Withdrawal by Subject|136|||
164637458|NCT00124709|594697481|FG000|Overall Study|Lost to Follow-up|114|||
164637459|NCT00124709|594697482|FG001|Overall Study|Lost to Follow-up|120|||
164637460|NCT01728376|594697483|FG000|Overall Study|Adverse Event|1|||
164637461|NCT01728376|594697484|FG001|Overall Study|Adverse Event|1|||
164637462|NCT01728376|594697485|FG002|Overall Study|Adverse Event|1|||
164637463|NCT01728376|594697486|FG003|Overall Study|Adverse Event|1|||
164637464|NCT01728376|594697487|FG004|Overall Study|Adverse Event|1|||
164637465|NCT01728376|594697488|FG005|Overall Study|Adverse Event|0|||
164637466|NCT01728376|594697483|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
164637467|NCT01728376|594697484|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
164637468|NCT01728376|594697485|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
164637469|NCT01728376|594697486|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
164637470|NCT01728376|594697487|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
164637471|NCT01728376|594697488|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
164637472|NCT01728376|594697483|FG000|Overall Study|No relevant bacteria|2|||
164637473|NCT01728376|594697484|FG001|Overall Study|No relevant bacteria|0|||
164637474|NCT01728376|594697485|FG002|Overall Study|No relevant bacteria|0|||
164637475|NCT01728376|594697486|FG003|Overall Study|No relevant bacteria|0|||
164637476|NCT01728376|594697487|FG004|Overall Study|No relevant bacteria|1|||
164637477|NCT01728376|594697488|FG005|Overall Study|No relevant bacteria|1|||
164637478|NCT01728376|594697483|FG000|Overall Study|Did not receive treatment|0|||
164637479|NCT01728376|594697484|FG001|Overall Study|Did not receive treatment|1|||
164637480|NCT01728376|594697485|FG002|Overall Study|Did not receive treatment|0|||
164637481|NCT01728376|594697486|FG003|Overall Study|Did not receive treatment|0|||
164637482|NCT01728376|594697487|FG004|Overall Study|Did not receive treatment|0|||
164637483|NCT01728376|594697488|FG005|Overall Study|Did not receive treatment|0|||
164637484|NCT01728376|594697483|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
164637485|NCT01728376|594697484|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
164637486|NCT01728376|594697485|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
164637487|NCT01728376|594697486|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
164637488|NCT01728376|594697487|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
164637489|NCT01728376|594697488|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
164637490|NCT02856282|594697490|FG000|Overall Study|Withdrawal by Subject|1|||
164637491|NCT00057330|594697491|FG000|Overall Study|Adverse Event|9|||
164637492|NCT00057330|594697492|FG001|Overall Study|Adverse Event|12|||
164637493|NCT00057330|594697491|FG000|Overall Study|Death|1|||
164637494|NCT00057330|594697492|FG001|Overall Study|Death|0|||
164637495|NCT00057330|594697491|FG000|Overall Study|Protocol Violation|1|||
164637496|NCT00057330|594697492|FG001|Overall Study|Protocol Violation|1|||
164637497|NCT00057330|594697491|FG000|Overall Study|Withdrawal by Subject|115|||
164637498|NCT00057330|594697492|FG001|Overall Study|Withdrawal by Subject|84|||
164637499|NCT00057330|594697491|FG000|Overall Study|Lost to Follow-up|745|||
164637500|NCT00057330|594697492|FG001|Overall Study|Lost to Follow-up|617|||
164637501|NCT00057330|594697491|FG000|Overall Study|Physician Decision|1|||
164637502|NCT00057330|594697492|FG001|Overall Study|Physician Decision|0|||
164637503|NCT00057330|594697491|FG000|Overall Study|Other|260|||
164637504|NCT00057330|594697492|FG001|Overall Study|Other|206|||
164637505|NCT02094573|594697493|FG000|Overall Study|Adverse Event|4|||
164637506|NCT02094573|594697494|FG001|Overall Study|Adverse Event|14|||
164637507|NCT02094573|594697493|FG000|Overall Study|Clinical Progressive Disease|9|||
164637508|NCT02094573|594697494|FG001|Overall Study|Clinical Progressive Disease|13|||
164637509|NCT02094573|594697493|FG000|Overall Study|Death|11|||
164637510|NCT02094573|594697494|FG001|Overall Study|Death|3|||
164637511|NCT02094573|594697493|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
164637512|NCT02094573|594697494|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
164637513|NCT02094573|594697493|FG000|Overall Study|Non-compliance with Study Drug|1|||
164637514|NCT02094573|594697494|FG001|Overall Study|Non-compliance with Study Drug|1|||
164637515|NCT02094573|594697493|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
164637516|NCT02094573|594697494|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
164637517|NCT02094573|594697493|FG000|Overall Study|Physician Decision|4|||
164637518|NCT02094573|594697494|FG001|Overall Study|Physician Decision|4|||
164637519|NCT02094573|594697493|FG000|Overall Study|Site Terminated by Sponsor|10|||
164637520|NCT02094573|594697494|FG001|Overall Study|Site Terminated by Sponsor|17|||
164637521|NCT02094573|594697493|FG000|Overall Study|Withdrawal by Subject|6|||
164637522|NCT02094573|594697494|FG001|Overall Study|Withdrawal by Subject|8|||
164637523|NCT02094573|594697493|FG000|Overall Study|Randomized but not Treated|3|||
164637524|NCT02094573|594697494|FG001|Overall Study|Randomized but not Treated|0|||
164637525|NCT00643006|594697502|FG000|Overall Study|Lost to Follow-up|5|||
164637526|NCT00643006|594697503|FG001|Overall Study|Lost to Follow-up|4|||
164637527|NCT01308476|594697504|FG000|Overall Study|Lost to Follow-up|2|||
164637528|NCT01308476|594697505|FG001|Overall Study|Lost to Follow-up|2|||
164637529|NCT01308476|594697504|FG000|Overall Study|Other|1|||
164637530|NCT01308476|594697505|FG001|Overall Study|Other|0|||
164637531|NCT00812968|594697508|FG000|Overall Study|Relapse after erythroid response|6|||
164637532|NCT00812968|594697508|FG000|Overall Study|Disease progression|1|||
164637533|NCT00812968|594697508|FG000|Overall Study|No further treatment required|1|||
164637534|NCT00812968|594697508|FG000|Overall Study|Study closed due to marketing approval|3|||
164637535|NCT00494234|594697509|FG000|Overall Study|Withdrawal by Subject|1|||
164637536|NCT00494234|594697510|FG001|Overall Study|Withdrawal by Subject|0|||
164637537|NCT00494234|594697509|FG000|Overall Study|Disease progression|11|||
164637538|NCT00494234|594697510|FG001|Overall Study|Disease progression|8|||
164637539|NCT00494234|594697509|FG000|Overall Study|Death|2|||
164637540|NCT00494234|594697510|FG001|Overall Study|Death|1|||
164637541|NCT00505765|594697512|FG000|Overall Study|Withdrawal by Subject|1|||
164637542|NCT00505765|594697513|FG001|Overall Study|Withdrawal by Subject|0|||
164637543|NCT00505765|594697514|FG002|Overall Study|Withdrawal by Subject|0|||
164637544|NCT00505765|594697512|FG000|Overall Study|Adverse Event|1|||
164637545|NCT00505765|594697513|FG001|Overall Study|Adverse Event|2|||
164637546|NCT00505765|594697514|FG002|Overall Study|Adverse Event|0|||
164637547|NCT00505765|594697512|FG000|Overall Study|Noncompliance|0|||
164637548|NCT00505765|594697513|FG001|Overall Study|Noncompliance|1|||
164637549|NCT00505765|594697514|FG002|Overall Study|Noncompliance|3|||
164637550|NCT01012609|594697516|FG000|Overall Study|Withdrawal by Subject|1|||
164637551|NCT01012609|594697517|FG001|Overall Study|Withdrawal by Subject|1|||
164637552|NCT01453296|594697518|FG000|Treatment Period 1|Adverse Event|0|||
164637553|NCT01453296|594697519|FG001|Treatment Period 1|Adverse Event|1|||
164637554|NCT01453296|594697518|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
164637555|NCT01453296|594697519|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
164637556|NCT01453296|594697518|FG000|Treatment Period 2|Adverse Event|1|||
164637557|NCT01453296|594697519|FG001|Treatment Period 2|Adverse Event|0|||
164637558|NCT01453296|594697518|FG000|Treatment Period 2|Withdrawal by Subject|1|||
164637559|NCT01453296|594697519|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164637560|NCT00620776|594697520|FG000|Overall Study|Did not receive treatment|3|||
164637561|NCT00620776|594697521|FG001|Overall Study|Did not receive treatment|5|||
164637562|NCT00620776|594697520|FG000|Overall Study|Adverse Event|2|||
164637563|NCT00620776|594697521|FG001|Overall Study|Adverse Event|3|||
164637564|NCT00620776|594697520|FG000|Overall Study|Lack of Efficacy|2|||
164637565|NCT00620776|594697521|FG001|Overall Study|Lack of Efficacy|1|||
164637566|NCT00620776|594697520|FG000|Overall Study|Lost to Follow-up|2|||
164637567|NCT00620776|594697521|FG001|Overall Study|Lost to Follow-up|5|||
164637568|NCT00620776|594697520|FG000|Overall Study|Withdrawal by Subject|3|||
164637569|NCT00620776|594697521|FG001|Overall Study|Withdrawal by Subject|2|||
164637570|NCT00761969|594697522|FG000|Overall Study|Death|112|||
164637571|NCT00761969|594697523|FG001|Overall Study|Death|47|||
164637572|NCT00761969|594697522|FG000|Overall Study|Lost to Follow-up|88|||
164637573|NCT00761969|594697523|FG001|Overall Study|Lost to Follow-up|93|||
164637574|NCT03205046|594697526|FG000|Overall Study|Death|10|||
164637575|NCT03205046|594697527|FG001|Overall Study|Death|6|||
164637576|NCT03205046|594697526|FG000|Overall Study|Withdrawal by Subject|1|||
164637577|NCT03205046|594697527|FG001|Overall Study|Withdrawal by Subject|2|||
164637578|NCT03205046|594697526|FG000|Overall Study|Lost to Follow-up|0|||
164637579|NCT03205046|594697527|FG001|Overall Study|Lost to Follow-up|1|||
164637580|NCT03205046|594697526|FG000|Overall Study|Study terminated by sponsor|2|||
164637581|NCT03205046|594697527|FG001|Overall Study|Study terminated by sponsor|1|||
164637582|NCT01015118|594697529|FG000|Overall Study|Protocol Violation|5|||
164637583|NCT01015118|594697530|FG001|Overall Study|Protocol Violation|6|||
164637584|NCT01015118|594697529|FG000|Overall Study|Withdrawal by Subject|103|||
164637585|NCT01015118|594697530|FG001|Overall Study|Withdrawal by Subject|27|||
164637586|NCT01015118|594697529|FG000|Overall Study|Other Adverse Event (AE)|141|||
164637587|NCT01015118|594697530|FG001|Overall Study|Other Adverse Event (AE)|33|||
164637588|NCT01015118|594697529|FG000|Overall Study|Worsening or AE of underlying disease|5|||
164637589|NCT01015118|594697530|FG001|Overall Study|Worsening or AE of underlying disease|4|||
164637590|NCT01015118|594697529|FG000|Overall Study|Progressive disease|364|||
164637591|NCT01015118|594697530|FG001|Overall Study|Progressive disease|229|||
164637592|NCT01015118|594697529|FG000|Overall Study|Not treated|9|||
164637593|NCT01015118|594697530|FG001|Overall Study|Not treated|5|||
164637594|NCT01015118|594697529|FG000|Overall Study|Other than stated above|42|||
164637595|NCT01015118|594697530|FG001|Overall Study|Other than stated above|23|||
164637596|NCT00402298|594697543|FG000|Overall Study|Withdrawal by Subject|1|||
164637597|NCT00402298|594697544|FG001|Overall Study|Withdrawal by Subject|0|||
164637598|NCT00480077|594697545|FG000|Overall Study|Death|19|||
164637599|NCT00480077|594697546|FG001|Overall Study|Death|15|||
164637600|NCT00480077|594697545|FG000|Overall Study|early exit|12|||
164637601|NCT00480077|594697546|FG001|Overall Study|early exit|11|||
164637602|NCT00938366|594697551|FG000|Overall Study|Withdrawal by Subject|1|||
164637603|NCT00938366|594697552|FG001|Overall Study|Withdrawal by Subject|0|||
164637604|NCT01215968|594697553|FG000|Overall Study|Adverse Event|0|||
164637605|NCT01215968|594697554|FG001|Overall Study|Adverse Event|2|||
164637606|NCT01215968|594697553|FG000|Overall Study|Protocol Violation|2|||
164637607|NCT01215968|594697554|FG001|Overall Study|Protocol Violation|4|||
164637608|NCT01215968|594697553|FG000|Overall Study|Not received study drug|0|||
164637609|NCT01215968|594697554|FG001|Overall Study|Not received study drug|1|||
164637610|NCT01250418|594697555|FG000|Overall Study|monitor data failure|1|||
164637611|NCT01250418|594697556|FG001|Overall Study|monitor data failure|1|||
164637612|NCT05966129|594697558|FG000|Overall Study|Death|1|||
164637613|NCT05966129|594697559|FG001|Overall Study|Death|2|||
164637614|NCT05966129|594697558|FG000|Overall Study|Lost to Follow-up|63|||
164637615|NCT05966129|594697559|FG001|Overall Study|Lost to Follow-up|66|||
164637616|NCT05966129|594697558|FG000|Overall Study|Protocol Violation|1|||
164637617|NCT05966129|594697559|FG001|Overall Study|Protocol Violation|0|||
164637618|NCT05966129|594697558|FG000|Overall Study|Withdrawal by Subject|26|||
164637619|NCT05966129|594697559|FG001|Overall Study|Withdrawal by Subject|25|||
164637620|NCT05966129|594697558|FG000|Overall Study|Surgery not completed|63|||
164637621|NCT05966129|594697559|FG001|Overall Study|Surgery not completed|69|||
164637622|NCT05966129|594697558|FG000|Overall Study|Surgery logistics issue|2|||
164637623|NCT05966129|594697559|FG001|Overall Study|Surgery logistics issue|1|||
164637624|NCT05182840|594697560|FG000|Run-in Period|Not treated|0|||
164637625|NCT05182840|594697561|FG001|Run-in Period|Not treated|1|||
164637626|NCT05182840|594697562|FG002|Run-in Period|Not treated|0|||
164637627|NCT05182840|594697563|FG003|Run-in Period|Not treated|0|||
164637628|NCT05182840|594697564|FG004|Run-in Period|Not treated|0|||
164637629|NCT05182840|594697565|FG005|Run-in Period|Not treated|0|||
164637630|NCT05182840|594697566|FG006|Run-in Period|Not treated|0|||
164637631|NCT05182840|594697567|FG007|Run-in Period|Not treated|0|||
164637632|NCT05182840|594697568|FG008|Run-in Period|Not treated|0|||
164637633|NCT05182840|594697569|FG009|Run-in Period|Not treated|0|||
164637634|NCT05182840|594697560|FG000|Run-in Period|Other reason but not sponsor termination|14|||
164637635|NCT05182840|594697561|FG001|Run-in Period|Other reason but not sponsor termination|18|||
164637636|NCT05182840|594697562|FG002|Run-in Period|Other reason but not sponsor termination|0|||
164637637|NCT05182840|594697563|FG003|Run-in Period|Other reason but not sponsor termination|0|||
164637638|NCT05182840|594697564|FG004|Run-in Period|Other reason but not sponsor termination|0|||
164637639|NCT05182840|594697565|FG005|Run-in Period|Other reason but not sponsor termination|0|||
164637640|NCT05182840|594697566|FG006|Run-in Period|Other reason but not sponsor termination|0|||
164637641|NCT05182840|594697567|FG007|Run-in Period|Other reason but not sponsor termination|0|||
164637642|NCT05182840|594697568|FG008|Run-in Period|Other reason but not sponsor termination|0|||
164637643|NCT05182840|594697569|FG009|Run-in Period|Other reason but not sponsor termination|0|||
164637644|NCT05182840|594697560|FG000|Run-in Period|No reason available|2|||
164637645|NCT05182840|594697561|FG001|Run-in Period|No reason available|2|||
164637646|NCT05182840|594697562|FG002|Run-in Period|No reason available|0|||
164637647|NCT05182840|594697563|FG003|Run-in Period|No reason available|0|||
164637648|NCT05182840|594697564|FG004|Run-in Period|No reason available|0|||
164637649|NCT05182840|594697565|FG005|Run-in Period|No reason available|0|||
164637650|NCT05182840|594697566|FG006|Run-in Period|No reason available|0|||
164637651|NCT05182840|594697567|FG007|Run-in Period|No reason available|0|||
164637652|NCT05182840|594697568|FG008|Run-in Period|No reason available|0|||
164637653|NCT05182840|594697569|FG009|Run-in Period|No reason available|0|||
164637654|NCT05182840|594697560|FG000|Run-in Period|Burden of study procedures|2|||
164637655|NCT05182840|594697561|FG001|Run-in Period|Burden of study procedures|2|||
164637656|NCT05182840|594697562|FG002|Run-in Period|Burden of study procedures|0|||
164637657|NCT05182840|594697563|FG003|Run-in Period|Burden of study procedures|0|||
164637658|NCT05182840|594697564|FG004|Run-in Period|Burden of study procedures|0|||
164637659|NCT05182840|594697565|FG005|Run-in Period|Burden of study procedures|0|||
164637660|NCT05182840|594697566|FG006|Run-in Period|Burden of study procedures|0|||
164637661|NCT05182840|594697567|FG007|Run-in Period|Burden of study procedures|0|||
164637662|NCT05182840|594697568|FG008|Run-in Period|Burden of study procedures|0|||
164637663|NCT05182840|594697569|FG009|Run-in Period|Burden of study procedures|0|||
164637664|NCT05182840|594697560|FG000|Run-in Period|Change of residence|1|||
164637665|NCT05182840|594697561|FG001|Run-in Period|Change of residence|0|||
164637666|NCT05182840|594697562|FG002|Run-in Period|Change of residence|0|||
164637667|NCT05182840|594697563|FG003|Run-in Period|Change of residence|0|||
164637668|NCT05182840|594697564|FG004|Run-in Period|Change of residence|0|||
164637669|NCT05182840|594697565|FG005|Run-in Period|Change of residence|0|||
164637670|NCT05182840|594697566|FG006|Run-in Period|Change of residence|0|||
164637671|NCT05182840|594697567|FG007|Run-in Period|Change of residence|0|||
164637672|NCT05182840|594697568|FG008|Run-in Period|Change of residence|0|||
164637673|NCT05182840|594697569|FG009|Run-in Period|Change of residence|0|||
164637674|NCT05182840|594697560|FG000|Run-in Period|Adverse Event|5|||
164637675|NCT05182840|594697561|FG001|Run-in Period|Adverse Event|5|||
164637676|NCT05182840|594697562|FG002|Run-in Period|Adverse Event|0|||
164637677|NCT05182840|594697563|FG003|Run-in Period|Adverse Event|0|||
164637678|NCT05182840|594697564|FG004|Run-in Period|Adverse Event|0|||
164637679|NCT05182840|594697565|FG005|Run-in Period|Adverse Event|0|||
164637680|NCT05182840|594697566|FG006|Run-in Period|Adverse Event|0|||
164637681|NCT05182840|594697567|FG007|Run-in Period|Adverse Event|0|||
164637682|NCT05182840|594697568|FG008|Run-in Period|Adverse Event|0|||
164637683|NCT05182840|594697569|FG009|Run-in Period|Adverse Event|0|||
164637684|NCT05182840|594697560|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
164637685|NCT05182840|594697561|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
164637686|NCT05182840|594697562|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
164637687|NCT05182840|594697563|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
164637688|NCT05182840|594697564|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
164637689|NCT05182840|594697565|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
164637690|NCT05182840|594697566|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
164637691|NCT05182840|594697567|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
164637692|NCT05182840|594697568|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
164637693|NCT05182840|594697569|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
164637694|NCT05182840|594697560|FG000|Treatment Period|Reason missing|0|||
164637695|NCT05182840|594697561|FG001|Treatment Period|Reason missing|0|||
164637696|NCT05182840|594697562|FG002|Treatment Period|Reason missing|1|||
164637697|NCT05182840|594697563|FG003|Treatment Period|Reason missing|0|||
164637698|NCT05182840|594697564|FG004|Treatment Period|Reason missing|0|||
164637699|NCT05182840|594697565|FG005|Treatment Period|Reason missing|0|||
164637700|NCT05182840|594697566|FG006|Treatment Period|Reason missing|0|||
164637701|NCT05182840|594697567|FG007|Treatment Period|Reason missing|0|||
164637702|NCT05182840|594697568|FG008|Treatment Period|Reason missing|0|||
164637703|NCT05182840|594697569|FG009|Treatment Period|Reason missing|0|||
164637704|NCT05182840|594697560|FG000|Treatment Period|Other but not sponsor termination|0|||
164637705|NCT05182840|594697561|FG001|Treatment Period|Other but not sponsor termination|0|||
164637706|NCT05182840|594697562|FG002|Treatment Period|Other but not sponsor termination|8|||
164637707|NCT05182840|594697563|FG003|Treatment Period|Other but not sponsor termination|6|||
164637708|NCT05182840|594697564|FG004|Treatment Period|Other but not sponsor termination|6|||
164637709|NCT05182840|594697565|FG005|Treatment Period|Other but not sponsor termination|7|||
164637710|NCT05182840|594697566|FG006|Treatment Period|Other but not sponsor termination|5|||
164637711|NCT05182840|594697567|FG007|Treatment Period|Other but not sponsor termination|8|||
164637712|NCT05182840|594697568|FG008|Treatment Period|Other but not sponsor termination|7|||
164637713|NCT05182840|594697569|FG009|Treatment Period|Other but not sponsor termination|2|||
164637714|NCT05182840|594697560|FG000|Treatment Period|Protocol deviation|0|||
164637715|NCT05182840|594697561|FG001|Treatment Period|Protocol deviation|0|||
164637716|NCT05182840|594697562|FG002|Treatment Period|Protocol deviation|0|||
164637717|NCT05182840|594697563|FG003|Treatment Period|Protocol deviation|0|||
164637718|NCT05182840|594697564|FG004|Treatment Period|Protocol deviation|0|||
164637719|NCT05182840|594697565|FG005|Treatment Period|Protocol deviation|0|||
164637720|NCT05182840|594697566|FG006|Treatment Period|Protocol deviation|0|||
164637721|NCT05182840|594697567|FG007|Treatment Period|Protocol deviation|0|||
164637722|NCT05182840|594697568|FG008|Treatment Period|Protocol deviation|1|||
164637723|NCT05182840|594697569|FG009|Treatment Period|Protocol deviation|0|||
164637724|NCT05182840|594697560|FG000|Treatment Period|No reason available|0|||
164637725|NCT05182840|594697561|FG001|Treatment Period|No reason available|0|||
164637726|NCT05182840|594697562|FG002|Treatment Period|No reason available|0|||
164637727|NCT05182840|594697563|FG003|Treatment Period|No reason available|1|||
164637728|NCT05182840|594697564|FG004|Treatment Period|No reason available|0|||
164637729|NCT05182840|594697565|FG005|Treatment Period|No reason available|2|||
164637730|NCT05182840|594697566|FG006|Treatment Period|No reason available|0|||
164637731|NCT05182840|594697567|FG007|Treatment Period|No reason available|1|||
164637732|NCT05182840|594697568|FG008|Treatment Period|No reason available|0|||
164637733|NCT05182840|594697569|FG009|Treatment Period|No reason available|0|||
164637734|NCT05182840|594697560|FG000|Treatment Period|Burden of study procedures|0|||
164637735|NCT05182840|594697561|FG001|Treatment Period|Burden of study procedures|0|||
164637736|NCT05182840|594697562|FG002|Treatment Period|Burden of study procedures|0|||
164637737|NCT05182840|594697563|FG003|Treatment Period|Burden of study procedures|0|||
164637738|NCT05182840|594697564|FG004|Treatment Period|Burden of study procedures|1|||
164637739|NCT05182840|594697565|FG005|Treatment Period|Burden of study procedures|0|||
164637740|NCT05182840|594697566|FG006|Treatment Period|Burden of study procedures|0|||
164637741|NCT05182840|594697567|FG007|Treatment Period|Burden of study procedures|0|||
164637742|NCT05182840|594697568|FG008|Treatment Period|Burden of study procedures|0|||
164637743|NCT05182840|594697569|FG009|Treatment Period|Burden of study procedures|0|||
164637744|NCT05182840|594697560|FG000|Treatment Period|Change of residence|0|||
164637745|NCT05182840|594697561|FG001|Treatment Period|Change of residence|0|||
164637746|NCT05182840|594697562|FG002|Treatment Period|Change of residence|0|||
164637747|NCT05182840|594697563|FG003|Treatment Period|Change of residence|0|||
164637748|NCT05182840|594697564|FG004|Treatment Period|Change of residence|0|||
164637749|NCT05182840|594697565|FG005|Treatment Period|Change of residence|1|||
164637750|NCT05182840|594697566|FG006|Treatment Period|Change of residence|0|||
164637751|NCT05182840|594697567|FG007|Treatment Period|Change of residence|0|||
164637752|NCT05182840|594697568|FG008|Treatment Period|Change of residence|0|||
164637753|NCT05182840|594697569|FG009|Treatment Period|Change of residence|0|||
164637754|NCT05182840|594697560|FG000|Treatment Period|Adverse Event|0|||
164637755|NCT05182840|594697561|FG001|Treatment Period|Adverse Event|0|||
164637756|NCT05182840|594697562|FG002|Treatment Period|Adverse Event|4|||
164637757|NCT05182840|594697563|FG003|Treatment Period|Adverse Event|16|||
164637758|NCT05182840|594697564|FG004|Treatment Period|Adverse Event|12|||
164637759|NCT05182840|594697565|FG005|Treatment Period|Adverse Event|6|||
164637760|NCT05182840|594697566|FG006|Treatment Period|Adverse Event|4|||
164637761|NCT05182840|594697567|FG007|Treatment Period|Adverse Event|8|||
164637762|NCT05182840|594697568|FG008|Treatment Period|Adverse Event|16|||
164637763|NCT05182840|594697569|FG009|Treatment Period|Adverse Event|5|||
164637764|NCT05182840|594697560|FG000|Treatment Period|Not treated with study drug|0|||
164637765|NCT05182840|594697561|FG001|Treatment Period|Not treated with study drug|0|||
164637766|NCT05182840|594697562|FG002|Treatment Period|Not treated with study drug|0|||
164637767|NCT05182840|594697563|FG003|Treatment Period|Not treated with study drug|1|||
164637768|NCT05182840|594697564|FG004|Treatment Period|Not treated with study drug|0|||
164637769|NCT05182840|594697565|FG005|Treatment Period|Not treated with study drug|0|||
164637770|NCT05182840|594697566|FG006|Treatment Period|Not treated with study drug|1|||
164637771|NCT05182840|594697567|FG007|Treatment Period|Not treated with study drug|1|||
164637772|NCT05182840|594697568|FG008|Treatment Period|Not treated with study drug|0|||
164637773|NCT05182840|594697569|FG009|Treatment Period|Not treated with study drug|0|||
164637774|NCT04242498|594697572|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
164637775|NCT04242498|594697573|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
164637776|NCT04242498|594697574|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
164637777|NCT04242498|594697575|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
164637778|NCT04242498|594697576|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
164637779|NCT04242498|594697577|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
164637780|NCT04242498|594697578|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
164637781|NCT04242498|594697572|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
164637782|NCT04242498|594697573|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
164637783|NCT04242498|594697574|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
164637784|NCT04242498|594697575|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
164637785|NCT04242498|594697576|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
164637786|NCT04242498|594697577|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
164637787|NCT04242498|594697578|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
164637788|NCT04242498|594697572|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
164637789|NCT04242498|594697573|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
164637790|NCT04242498|594697574|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
164637791|NCT04242498|594697575|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
164637792|NCT04242498|594697576|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
164637793|NCT04242498|594697577|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
164637794|NCT04242498|594697578|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
164637795|NCT04242498|594697572|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
164637796|NCT04242498|594697573|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
164637797|NCT04242498|594697574|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
164637798|NCT04242498|594697575|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
164637799|NCT04242498|594697576|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
164637800|NCT04242498|594697577|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
164637801|NCT04242498|594697578|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
164637802|NCT04242498|594697572|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
164637803|NCT04242498|594697573|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
164637804|NCT04242498|594697574|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
164637805|NCT04242498|594697575|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
164637806|NCT04242498|594697576|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
164637807|NCT04242498|594697577|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
164637808|NCT04242498|594697578|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
164637809|NCT04242498|594697572|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
164637810|NCT04242498|594697573|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
164637811|NCT04242498|594697574|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
164637812|NCT04242498|594697575|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
164637813|NCT04242498|594697576|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
164637814|NCT04242498|594697577|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
164637815|NCT04242498|594697578|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
164637816|NCT04242498|594697572|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
164637817|NCT04242498|594697573|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
164637818|NCT04242498|594697574|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
164637819|NCT04242498|594697575|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
164637820|NCT04242498|594697576|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
164637821|NCT04242498|594697577|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
164637822|NCT04242498|594697578|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
164637823|NCT04242498|594697572|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
164530506|NCT03756129|594313758|FG000|Overall Study|Adverse Event|1|||
164530507|NCT03756129|594313759|FG001|Overall Study|Adverse Event|1|||
164530508|NCT03756129|594313760|FG002|Overall Study|Adverse Event|0|||
164530509|NCT03756129|594313761|FG003|Overall Study|Adverse Event|2|||
164530510|NCT03756129|594313762|FG004|Overall Study|Adverse Event|0|||
164530511|NCT03756129|594313763|FG005|Overall Study|Adverse Event|0|||
164530512|NCT03756129|594313758|FG000|Overall Study|Withdrawal by Subject|2|||
164530513|NCT03756129|594313759|FG001|Overall Study|Withdrawal by Subject|1|||
164530514|NCT03756129|594313760|FG002|Overall Study|Withdrawal by Subject|3|||
164530515|NCT03756129|594313761|FG003|Overall Study|Withdrawal by Subject|1|||
164530516|NCT03756129|594313762|FG004|Overall Study|Withdrawal by Subject|1|||
164530517|NCT03756129|594313763|FG005|Overall Study|Withdrawal by Subject|3|||
164530518|NCT03756129|594313758|FG000|Overall Study|Lost to Follow-up|0|||
164530519|NCT03756129|594313759|FG001|Overall Study|Lost to Follow-up|0|||
164530520|NCT03756129|594313760|FG002|Overall Study|Lost to Follow-up|0|||
164530521|NCT03756129|594313761|FG003|Overall Study|Lost to Follow-up|0|||
164530522|NCT03756129|594313762|FG004|Overall Study|Lost to Follow-up|0|||
164530523|NCT03756129|594313763|FG005|Overall Study|Lost to Follow-up|1|||
164530524|NCT03756129|594313758|FG000|Overall Study|Physician Decision|0|||
164530525|NCT03756129|594313759|FG001|Overall Study|Physician Decision|0|||
164530526|NCT03756129|594313760|FG002|Overall Study|Physician Decision|0|||
164530527|NCT03756129|594313761|FG003|Overall Study|Physician Decision|0|||
164530528|NCT03756129|594313762|FG004|Overall Study|Physician Decision|0|||
164530529|NCT03756129|594313763|FG005|Overall Study|Physician Decision|1|||
164530530|NCT01340651|594313764|FG000|Overall Study|Adverse Event|3|||
164530531|NCT01340651|594313764|FG000|Overall Study|Consent Withdrawn|2|||
164530532|NCT01340651|594313764|FG000|Overall Study|Commercial Supply per Sponsor|12|||
164530533|NCT01315353|594313765|FG000|Overall Study|Death|2|||
164530534|NCT01315353|594313766|FG001|Overall Study|Death|1|||
164530535|NCT01315353|594313767|FG002|Overall Study|Death|0|||
164530536|NCT01315353|594313765|FG000|Overall Study|Withdrawal by Subject|2|||
164530537|NCT01315353|594313766|FG001|Overall Study|Withdrawal by Subject|6|||
164530538|NCT01315353|594313767|FG002|Overall Study|Withdrawal by Subject|1|||
164530539|NCT01315353|594313765|FG000|Overall Study|Lost to Follow-up|13|||
164530540|NCT01315353|594313766|FG001|Overall Study|Lost to Follow-up|6|||
164530541|NCT01315353|594313767|FG002|Overall Study|Lost to Follow-up|6|||
164530542|NCT01315353|594313765|FG000|Overall Study|Unwilling to adhere to requirements|5|||
164530543|NCT01315353|594313766|FG001|Overall Study|Unwilling to adhere to requirements|5|||
164530544|NCT01315353|594313767|FG002|Overall Study|Unwilling to adhere to requirements|4|||
164530545|NCT01315353|594313765|FG000|Overall Study|Site closing|7|||
164530546|NCT01315353|594313766|FG001|Overall Study|Site closing|4|||
164530547|NCT01315353|594313767|FG002|Overall Study|Site closing|0|||
164530548|NCT01315353|594313765|FG000|Overall Study|Taken off study by site in error|0|||
164530549|NCT01315353|594313766|FG001|Overall Study|Taken off study by site in error|1|||
164530550|NCT01315353|594313767|FG002|Overall Study|Taken off study by site in error|0|||
164530551|NCT01315353|594313765|FG000|Overall Study|Inadvertent randomization/assignment|0|||
164530552|NCT01315353|594313766|FG001|Overall Study|Inadvertent randomization/assignment|0|||
164530553|NCT01315353|594313767|FG002|Overall Study|Inadvertent randomization/assignment|2|||
164530554|NCT04469270|594313768|FG000|Overall Study|Adverse Event|2|||
164530555|NCT04469270|594313769|FG001|Overall Study|Adverse Event|0|||
164530556|NCT04469270|594313768|FG000|Overall Study|Lost to Follow-up|4|||
164530557|NCT04469270|594313769|FG001|Overall Study|Lost to Follow-up|3|||
164530558|NCT04469270|594313768|FG000|Overall Study|Withdrawal by Subject|7|||
164530559|NCT04469270|594313769|FG001|Overall Study|Withdrawal by Subject|3|||
164530560|NCT04469270|594313768|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
164637824|NCT04242498|594697573|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
164637825|NCT04242498|594697574|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
164637826|NCT04242498|594697575|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
164637827|NCT04242498|594697576|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
164637828|NCT04242498|594697577|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
164637829|NCT04242498|594697578|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
164637830|NCT04242498|594697572|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
164637831|NCT04242498|594697573|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
164637832|NCT04242498|594697574|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
164637833|NCT04242498|594697575|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
164637834|NCT04242498|594697576|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
164637835|NCT04242498|594697577|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
164637836|NCT04242498|594697578|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
164637837|NCT04242498|594697572|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
164637838|NCT04242498|594697573|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
164637839|NCT04242498|594697574|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
164637840|NCT04242498|594697575|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
164637841|NCT04242498|594697576|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
164637842|NCT04242498|594697577|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
164637843|NCT04242498|594697578|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
164637844|NCT04242498|594697572|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
164637845|NCT04242498|594697573|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
164637846|NCT04242498|594697574|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
164637847|NCT04242498|594697575|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
164637848|NCT04242498|594697576|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
164637849|NCT04242498|594697577|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
164637850|NCT04242498|594697578|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
164637851|NCT04242498|594697572|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
164637852|NCT04242498|594697573|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
164637853|NCT04242498|594697574|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
164637854|NCT04242498|594697575|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
164637855|NCT04242498|594697576|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
164637856|NCT04242498|594697577|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
164637857|NCT04242498|594697578|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
164637858|NCT04242498|594697572|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
164637859|NCT04242498|594697573|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
164637860|NCT04242498|594697574|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
164637861|NCT04242498|594697575|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
164637862|NCT04242498|594697576|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
164637863|NCT04242498|594697577|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
164637864|NCT04242498|594697578|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
164637865|NCT04242498|594697572|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
164637866|NCT04242498|594697573|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
164637867|NCT04242498|594697574|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
164637868|NCT04242498|594697575|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
164637869|NCT04242498|594697576|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
164637870|NCT04242498|594697577|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
164637871|NCT04242498|594697578|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
164637872|NCT04242498|594697572|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
164637873|NCT04242498|594697573|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
164637874|NCT04242498|594697574|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
164637875|NCT04242498|594697575|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
164637876|NCT04242498|594697576|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
164637877|NCT04242498|594697577|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
164637878|NCT04242498|594697578|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
164637879|NCT04242498|594697572|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
164637880|NCT04242498|594697573|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
164637881|NCT04242498|594697574|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
164637882|NCT04242498|594697575|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
164637883|NCT04242498|594697576|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
164637884|NCT04242498|594697577|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
164637885|NCT04242498|594697578|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
164637886|NCT02396849|594697580|FG000|Overall Study|Lost to Follow-up|1|||
164637887|NCT02396849|594697581|FG001|Overall Study|Lost to Follow-up|1|||
164637888|NCT02396849|594697580|FG000|Overall Study|Did not tolerate intervention|1|||
164637889|NCT02396849|594697581|FG001|Overall Study|Did not tolerate intervention|1|||
164637890|NCT03328325|594697582|FG000|Overall Study|Lost to Follow-up|4|||
164637891|NCT03328325|594697582|FG000|Overall Study|Physician Decision|1|||
164637892|NCT03328325|594697582|FG000|Overall Study|Withdrawal by Subject|3|||
164637893|NCT03328325|594697582|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
164637894|NCT00931515|594697583|FG000|Overall Study|Lost to Follow-up|2|||
164637895|NCT00931515|594697584|FG001|Overall Study|Lost to Follow-up|5|||
164637896|NCT00828009|594697586|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
164637897|NCT00828009|594697586|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
164637898|NCT00828009|594697586|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
164637899|NCT00828009|594697586|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
164637900|NCT00828009|594697586|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
164637901|NCT00828009|594697586|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
164637902|NCT00828009|594697586|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
164637903|NCT00828009|594697586|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
164637904|NCT00828009|594697586|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
164637905|NCT00828009|594697586|FG000|Step 2 - Maintenance Therapy|Death|1|||
164637906|NCT00828009|594697586|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
164637907|NCT00828009|594697586|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
164637908|NCT00828009|594697586|FG000|Step 2 - Maintenance Therapy|Other|1|||
164637909|NCT04678557|594697587|FG000|Overall Study|Withdrawal by Subject|1|||
164637910|NCT04678557|594697588|FG001|Overall Study|Withdrawal by Subject|0|||
164637911|NCT04678557|594697587|FG000|Overall Study|Lack of Efficacy|0|||
164637912|NCT04678557|594697588|FG001|Overall Study|Lack of Efficacy|13|||
164637913|NCT04678557|594697587|FG000|Overall Study|Safety Evaluation|0|||
164637914|NCT04678557|594697588|FG001|Overall Study|Safety Evaluation|1|||
164637915|NCT02260804|594697589|FG000|Induction Study Period|Protocol Violation|2|||
164637916|NCT02260804|594697590|FG001|Induction Study Period|Protocol Violation|0|||
164637917|NCT02260804|594697589|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
164637918|NCT02260804|594697590|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
164637919|NCT02260804|594697589|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
164637920|NCT02260804|594697590|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
164637921|NCT02260804|594697589|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
164637922|NCT02260804|594697590|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
164637923|NCT02260804|594697589|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
164637924|NCT02260804|594697590|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
164637925|NCT02260804|594697589|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
164637926|NCT02260804|594697590|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
164637927|NCT02260804|594697589|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
164637928|NCT02260804|594697590|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
164637929|NCT02260804|594697589|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
164637930|NCT02260804|594697590|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
164637931|NCT02260804|594697589|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
164637932|NCT02260804|594697590|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
164637933|NCT02260804|594697589|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
164637934|NCT02260804|594697590|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
164637935|NCT02260804|594697589|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
164637936|NCT02260804|594697590|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
164637937|NCT00509223|594700434|FG000|Overall Study|Lost to Follow-up|1|||
164637938|NCT00509223|594700435|FG001|Overall Study|Lost to Follow-up|1|||
164637939|NCT00509223|594700434|FG000|Overall Study|Adverse Event|1|||
164637940|NCT00509223|594700435|FG001|Overall Study|Adverse Event|1|||
164637941|NCT00509223|594700434|FG000|Overall Study|Withdrawal by Subject|25|||
164637942|NCT00509223|594700435|FG001|Overall Study|Withdrawal by Subject|6|||
164637943|NCT00509223|594700434|FG000|Overall Study|Including: subject change of address|5|||
164637944|NCT00509223|594700435|FG001|Overall Study|Including: subject change of address|2|||
164637945|NCT00509223|594700434|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
164637946|NCT00509223|594700435|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
164637947|NCT01361308|594700436|FG000|Overall Study|Withdrawal by Subject|9|||
164637948|NCT01361308|594700437|FG001|Overall Study|Withdrawal by Subject|13|||
164637949|NCT01361308|594700436|FG000|Overall Study|Physician Decision|3|||
164637950|NCT01361308|594700437|FG001|Overall Study|Physician Decision|3|||
164637951|NCT01361308|594700436|FG000|Overall Study|Lack of Efficacy|2|||
164637952|NCT01361308|594700437|FG001|Overall Study|Lack of Efficacy|0|||
164637953|NCT01361308|594700436|FG000|Overall Study|Protocol Violation|1|||
164637954|NCT01361308|594700437|FG001|Overall Study|Protocol Violation|0|||
164637955|NCT01361308|594700436|FG000|Overall Study|Lost to Follow-up|5|||
164637956|NCT01361308|594700437|FG001|Overall Study|Lost to Follow-up|4|||
164637957|NCT01361308|594700436|FG000|Overall Study|Adverse Event|8|||
164637958|NCT01361308|594700437|FG001|Overall Study|Adverse Event|4|||
164637959|NCT01361308|594700436|FG000|Overall Study|Eligibility Criteria Not Met|2|||
164637960|NCT01361308|594700437|FG001|Overall Study|Eligibility Criteria Not Met|3|||
164637961|NCT01361308|594700436|FG000|Overall Study|Failed C-SSRS|5|||
164637962|NCT01361308|594700437|FG001|Overall Study|Failed C-SSRS|2|||
164637963|NCT01361308|594700436|FG000|Overall Study|Other|0|||
164637964|NCT01361308|594700437|FG001|Overall Study|Other|1|||
164637965|NCT02983305|594700438|FG000|Overall Study|incomplete data|2|||
164637966|NCT02983305|594700439|FG001|Overall Study|incomplete data|0|||
164637967|NCT00822237|594700440|FG000|Dose 1 Vaccination|Not vaccinated|3|||
164637968|NCT00822237|594700441|FG001|Dose 1 Vaccination|Not vaccinated|0|||
164637969|NCT00822237|594700440|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
164637970|NCT00822237|594700441|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
164637971|NCT00822237|594700440|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
164637972|NCT00822237|594700441|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
164637973|NCT00822237|594700440|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
164637974|NCT00822237|594700441|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
164637975|NCT00822237|594700440|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
164637976|NCT00822237|594700441|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
164637977|NCT03433482|594700442|FG000|Overall Study|Lost to Follow-up|1|||
164637978|NCT03433482|594700443|FG001|Overall Study|Lost to Follow-up|0|||
164637979|NCT03433482|594700444|FG002|Overall Study|Lost to Follow-up|1|||
164637980|NCT03433482|594700445|FG003|Overall Study|Lost to Follow-up|1|||
164637981|NCT03433482|594700442|FG000|Overall Study|Withdrawal by Subject|0|||
164637982|NCT03433482|594700443|FG001|Overall Study|Withdrawal by Subject|0|||
164637983|NCT03433482|594700444|FG002|Overall Study|Withdrawal by Subject|1|||
164637984|NCT03433482|594700445|FG003|Overall Study|Withdrawal by Subject|0|||
164637985|NCT03433482|594700442|FG000|Overall Study|Unknown reason|0|||
164637986|NCT03433482|594700443|FG001|Overall Study|Unknown reason|0|||
164637987|NCT03433482|594700444|FG002|Overall Study|Unknown reason|2|||
164637988|NCT03433482|594700445|FG003|Overall Study|Unknown reason|0|||
164637989|NCT02411110|594700446|FG000|Treatment Period 1|Adverse Event|4|||
164637990|NCT02411110|594700447|FG001|Treatment Period 1|Adverse Event|2|||
164637991|NCT02411110|594700446|FG000|Treatment Period 1|Lost to Follow-up|1|||
164637992|NCT02411110|594700447|FG001|Treatment Period 1|Lost to Follow-up|0|||
164637993|NCT02411110|594700446|FG000|Treatment Period 1|Personal Reasons|2|||
164637994|NCT02411110|594700447|FG001|Treatment Period 1|Personal Reasons|5|||
164637995|NCT02411110|594700446|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
164637996|NCT02411110|594700447|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
164637997|NCT02411110|594700446|FG000|Treatment Period 2|Adverse Event|1|||
164637998|NCT02411110|594700447|FG001|Treatment Period 2|Adverse Event|0|||
164530561|NCT04469270|594313769|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
164530562|NCT04469270|594313768|FG000|Overall Study|missing|1|||
164530563|NCT04469270|594313769|FG001|Overall Study|missing|0|||
164530564|NCT05572021|594313770|FG000|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|5|||
164530565|NCT05572021|594313771|FG001|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|0|||
164530566|NCT03432260|594313772|FG000|Overall Study|Lost to Follow-up|1|||
164530567|NCT03432260|594313773|FG001|Overall Study|Lost to Follow-up|1|||
164530568|NCT03432260|594313774|FG002|Overall Study|Lost to Follow-up|0|||
164530569|NCT03432260|594313775|FG003|Overall Study|Lost to Follow-up|0|||
164530570|NCT03432260|594313776|FG004|Overall Study|Lost to Follow-up|1|||
164530571|NCT02186847|594313778|FG000|Overall Study|Protocol Violation|3|||
164530572|NCT02186847|594313779|FG001|Overall Study|Protocol Violation|0|||
164530573|NCT05328167|594313780|FG000|Overall Study|Treatment cancelled prior to radioembolization|1|||
164530574|NCT05328167|594313780|FG000|Overall Study|imaging not obtained for primary outcome assessment|1|||
164530575|NCT00345293|594313781|FG000|Overall Study|Unable to access line for sample|1|||
164637999|NCT02411110|594700446|FG000|Treatment Period 2|Lost to Follow-up|0|||
164638000|NCT02411110|594700447|FG001|Treatment Period 2|Lost to Follow-up|2|||
164638001|NCT02411110|594700446|FG000|Treatment Period 2|Personal Reasons|0|||
164638002|NCT02411110|594700447|FG001|Treatment Period 2|Personal Reasons|2|||
164638003|NCT04888377|594700448|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
164638004|NCT04888377|594700449|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
164638005|NCT04888377|594700448|FG000|Overall Study|Physician Decision|6|||
164638006|NCT04888377|594700449|FG001|Overall Study|Physician Decision|6|||
164638007|NCT04888377|594700448|FG000|Overall Study|Withdrawal by Subject|7|||
164638008|NCT04888377|594700449|FG001|Overall Study|Withdrawal by Subject|3|||
164638009|NCT00526162|594700450|FG000|Overall Study|Device not implanted|3|||
164638010|NCT05279807|594700451|FG000|Overall Study|Withdrawal by Subject|1|||
164638011|NCT05279807|594700452|FG001|Overall Study|Withdrawal by Subject|0|||
164638012|NCT05279807|594700451|FG000|Overall Study|Adverse Event|0|||
164638013|NCT05279807|594700452|FG001|Overall Study|Adverse Event|1|||
164638014|NCT05279807|594700451|FG000|Overall Study|Laboratory Abnormal Results|1|||
164638015|NCT05279807|594700452|FG001|Overall Study|Laboratory Abnormal Results|0|||
164638016|NCT05299359|594700457|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
164638017|NCT05299359|594700458|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
164638018|NCT05299359|594700457|FG000|Main Part: Day 1 up to Day 366|Other|2|||
164638019|NCT05299359|594700458|FG001|Main Part: Day 1 up to Day 366|Other|0|||
164638020|NCT05299359|594700457|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
164638021|NCT05299359|594700458|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
164638022|NCT05299359|594700457|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
164638023|NCT05299359|594700458|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
164638024|NCT05299359|594700457|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
164638025|NCT05299359|594700458|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
164638026|NCT05299359|594700457|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
164638027|NCT05299359|594700458|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
164638028|NCT05299359|594700457|FG000|Extension Part: Day 1 to Day 366|Other|0|||
164638029|NCT05299359|594700458|FG001|Extension Part: Day 1 to Day 366|Other|1|||
164638030|NCT04242446|594700459|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
164638031|NCT04242446|594700460|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
164638032|NCT04242446|594700461|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
164638033|NCT04242446|594700462|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
164638034|NCT04242446|594700463|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
164638035|NCT04242446|594700464|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
164638036|NCT04242446|594700465|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
164638037|NCT04242446|594700459|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
164638038|NCT04242446|594700460|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
164638039|NCT04242446|594700461|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
164638040|NCT04242446|594700462|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
164638041|NCT04242446|594700463|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
164638042|NCT04242446|594700464|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
164638043|NCT04242446|594700465|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
164638044|NCT04242446|594700459|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
164638045|NCT04242446|594700460|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
164638046|NCT04242446|594700461|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
164638047|NCT04242446|594700462|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
164638048|NCT04242446|594700463|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
164638049|NCT04242446|594700464|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
164638050|NCT04242446|594700465|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
164638051|NCT04242446|594700459|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
164638052|NCT04242446|594700460|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
164638053|NCT04242446|594700461|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
164638054|NCT04242446|594700462|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
164638055|NCT04242446|594700463|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
164638056|NCT04242446|594700464|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
164638057|NCT04242446|594700465|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
164638058|NCT04242446|594700459|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
164638059|NCT04242446|594700460|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
164638060|NCT04242446|594700461|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
164638061|NCT04242446|594700462|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
164638062|NCT04242446|594700463|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
164638063|NCT04242446|594700464|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
164638064|NCT04242446|594700465|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
164638065|NCT04242446|594700459|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
164638066|NCT04242446|594700460|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
164638067|NCT04242446|594700461|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
164638068|NCT04242446|594700462|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
164638069|NCT04242446|594700463|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
164638070|NCT04242446|594700464|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
164638071|NCT04242446|594700465|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
164638072|NCT04242446|594700459|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
164638073|NCT04242446|594700460|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
164638074|NCT04242446|594700461|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
164638075|NCT04242446|594700462|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
164638076|NCT04242446|594700463|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
164638077|NCT04242446|594700464|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
164638078|NCT04242446|594700465|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
164638079|NCT04242446|594700459|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
164638080|NCT04242446|594700460|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
164638081|NCT04242446|594700461|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
164638082|NCT04242446|594700462|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
164638083|NCT04242446|594700463|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
164638084|NCT04242446|594700464|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
164638085|NCT04242446|594700465|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
164638086|NCT04242446|594700459|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
164638087|NCT04242446|594700460|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
164638088|NCT04242446|594700461|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
164638089|NCT04242446|594700462|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
164638090|NCT04242446|594700463|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
164638091|NCT04242446|594700464|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
164638092|NCT04242446|594700465|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
164638093|NCT04242446|594700459|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
164638094|NCT04242446|594700460|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
164638095|NCT04242446|594700461|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
164638096|NCT04242446|594700462|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
164638097|NCT04242446|594700463|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
164638098|NCT04242446|594700464|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
164638099|NCT04242446|594700465|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
164638100|NCT04242446|594700459|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
164638101|NCT04242446|594700460|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
164638102|NCT04242446|594700461|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
164638103|NCT04242446|594700462|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
164638104|NCT04242446|594700463|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
164638105|NCT04242446|594700464|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
164638106|NCT04242446|594700465|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
164638107|NCT04242446|594700459|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
164638108|NCT04242446|594700460|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
164638109|NCT04242446|594700461|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
164638110|NCT04242446|594700462|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
164638111|NCT04242446|594700463|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
164530576|NCT00345293|594313782|FG001|Overall Study|Unable to access line for sample|0|||
164530577|NCT00345293|594313781|FG000|Overall Study|Withdrawal by Subject|1|||
164530578|NCT00345293|594313782|FG001|Overall Study|Withdrawal by Subject|0|||
164530579|NCT03319849|594313783|FG000|Overall Study|Adverse Event|1|||
164530580|NCT03319849|594313784|FG001|Overall Study|Adverse Event|0|||
164530581|NCT03319849|594313783|FG000|Overall Study|Physician Decision|0|||
164530582|NCT03319849|594313784|FG001|Overall Study|Physician Decision|1|||
164530583|NCT03319849|594313783|FG000|Overall Study|Withdrawal by Subject|0|||
164530584|NCT03319849|594313784|FG001|Overall Study|Withdrawal by Subject|1|||
164530585|NCT03319849|594313783|FG000|Overall Study|COVID-19|0|||
164530586|NCT03319849|594313784|FG001|Overall Study|COVID-19|1|||
164530587|NCT03319849|594313783|FG000|Overall Study|Other|1|||
164530588|NCT03319849|594313784|FG001|Overall Study|Other|2|||
164530589|NCT03319849|594313783|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
164530590|NCT03319849|594313784|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
164530591|NCT03319849|594313783|FG000|Overall Study|Lost to Follow-up|0|||
164530592|NCT03319849|594313784|FG001|Overall Study|Lost to Follow-up|2|||
164530593|NCT00112047|594313789|FG000|Randomized Phase|Lost to Follow-up|26|||
164530594|NCT00112047|594313790|FG001|Randomized Phase|Lost to Follow-up|33|||
164638112|NCT04242446|594700464|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
164638113|NCT04242446|594700465|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
164638114|NCT04242446|594700459|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
164638115|NCT04242446|594700460|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
164638116|NCT04242446|594700461|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
164638117|NCT04242446|594700462|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
164638118|NCT04242446|594700463|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
164638119|NCT04242446|594700464|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
164638120|NCT04242446|594700465|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
164638121|NCT04242446|594700459|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
164638122|NCT04242446|594700460|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
164638123|NCT04242446|594700461|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
164638124|NCT04242446|594700462|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
164638125|NCT04242446|594700463|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
164638126|NCT04242446|594700464|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
164638127|NCT04242446|594700465|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
164638128|NCT04242446|594700459|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
164638129|NCT04242446|594700460|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
164638130|NCT04242446|594700461|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
164638131|NCT04242446|594700462|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
164638132|NCT04242446|594700463|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
164638133|NCT04242446|594700464|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
164638134|NCT04242446|594700465|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
164638135|NCT04242446|594700459|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
164638136|NCT04242446|594700460|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
164638137|NCT04242446|594700461|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
164638138|NCT04242446|594700462|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
164638139|NCT04242446|594700463|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
164638140|NCT04242446|594700464|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
164638141|NCT04242446|594700465|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
164638142|NCT04242446|594700459|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
164638143|NCT04242446|594700460|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
164638144|NCT04242446|594700461|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
164638145|NCT04242446|594700462|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
164638146|NCT04242446|594700463|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
164638147|NCT04242446|594700464|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
164638148|NCT04242446|594700465|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
164638149|NCT04242446|594700459|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
164638150|NCT04242446|594700460|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
164638151|NCT04242446|594700461|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
164638152|NCT04242446|594700462|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
164638153|NCT04242446|594700463|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
164638154|NCT04242446|594700464|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
164638155|NCT04242446|594700465|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
164638156|NCT04242446|594700459|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
164638157|NCT04242446|594700460|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
164638158|NCT04242446|594700461|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
164638159|NCT04242446|594700462|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
164638160|NCT04242446|594700463|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
164638161|NCT04242446|594700464|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
164638162|NCT04242446|594700465|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
164638163|NCT04242446|594700459|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
164530595|NCT00112047|594313789|FG000|Randomized Phase|Adverse Event|10|||
164530596|NCT00112047|594313790|FG001|Randomized Phase|Adverse Event|10|||
164530597|NCT00112047|594313789|FG000|Randomized Phase|Withrawal of consent|10|||
164530598|NCT00112047|594313790|FG001|Randomized Phase|Withrawal of consent|18|||
164530599|NCT00112047|594313789|FG000|Randomized Phase|Sub-optimal virological response|3|||
164530600|NCT00112047|594313790|FG001|Randomized Phase|Sub-optimal virological response|13|||
164530601|NCT00112047|594313789|FG000|Randomized Phase|Noncompliance|8|||
164530602|NCT00112047|594313790|FG001|Randomized Phase|Noncompliance|4|||
164530603|NCT00112047|594313789|FG000|Randomized Phase|Protocol Violation|2|||
164530604|NCT00112047|594313790|FG001|Randomized Phase|Protocol Violation|0|||
164638164|NCT04242446|594700460|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
164638165|NCT04242446|594700461|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
164638166|NCT04242446|594700462|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
164638167|NCT04242446|594700463|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
164638168|NCT04242446|594700464|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
164638169|NCT04242446|594700465|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
164638170|NCT04242446|594700459|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
164638171|NCT04242446|594700460|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
164638172|NCT04242446|594700461|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
164638173|NCT04242446|594700462|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
164638174|NCT04242446|594700463|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
164638175|NCT04242446|594700464|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
164638176|NCT04242446|594700465|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
164638177|NCT04242446|594700459|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
164638178|NCT04242446|594700460|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
164638179|NCT04242446|594700461|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
164638180|NCT04242446|594700462|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
164638181|NCT04242446|594700463|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
164638182|NCT04242446|594700464|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
164638183|NCT04242446|594700465|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
164638184|NCT04242446|594700459|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
164638185|NCT04242446|594700460|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
164638186|NCT04242446|594700461|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
164638187|NCT04242446|594700462|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
164638188|NCT04242446|594700463|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
164638189|NCT04242446|594700464|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
164638190|NCT04242446|594700465|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
164638191|NCT04242446|594700459|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
164638192|NCT04242446|594700460|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
164638193|NCT04242446|594700461|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
164638194|NCT04242446|594700462|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
164638195|NCT04242446|594700463|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
164638196|NCT04242446|594700464|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
164638197|NCT04242446|594700465|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
164638198|NCT03587116|594700466|FG000|Overall Study|Lost to Follow-up|0|||
164638199|NCT03587116|594700467|FG001|Overall Study|Lost to Follow-up|1|||
164638200|NCT03587116|594700466|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
164638201|NCT03587116|594700467|FG001|Overall Study|No Longer Met Eligibility Criteria|1|||
164638202|NCT03587116|594700466|FG000|Overall Study|Withdrawal by Subject|4|||
164638203|NCT03587116|594700467|FG001|Overall Study|Withdrawal by Subject|0|||
164638204|NCT05993299|594700468|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
164638205|NCT05993299|594700468|FG000|Overall Study|Ongoing|4|||
164638206|NCT05644756|594700469|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
164638207|NCT05644756|594700469|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
164638208|NCT03110107|594700470|FG000|Treatment Period|Disease Progression|3|||
164638209|NCT03110107|594700471|FG001|Treatment Period|Disease Progression|9|||
164638210|NCT03110107|594700472|FG002|Treatment Period|Disease Progression|8|||
164638211|NCT03110107|594700473|FG003|Treatment Period|Disease Progression|11|||
164638212|NCT03110107|594700474|FG004|Treatment Period|Disease Progression|8|||
164638213|NCT03110107|594700475|FG005|Treatment Period|Disease Progression|4|||
164638214|NCT03110107|594700476|FG006|Treatment Period|Disease Progression|6|||
164638215|NCT03110107|594700477|FG007|Treatment Period|Disease Progression|7|||
164638216|NCT03110107|594700478|FG008|Treatment Period|Disease Progression|2|||
164638217|NCT03110107|594700479|FG009|Treatment Period|Disease Progression|10|||
164638218|NCT03110107|594700480|FG010|Treatment Period|Disease Progression|5|||
164638219|NCT03110107|594700481|FG011|Treatment Period|Disease Progression|2|||
164638220|NCT03110107|594700482|FG012|Treatment Period|Disease Progression|0|||
164638221|NCT03110107|594700483|FG013|Treatment Period|Disease Progression|5|||
164638222|NCT03110107|594700484|FG014|Treatment Period|Disease Progression|14|||
164638223|NCT03110107|594700485|FG015|Treatment Period|Disease Progression|14|||
164638224|NCT03110107|594700486|FG016|Treatment Period|Disease Progression|4|||
164638225|NCT03110107|594700487|FG017|Treatment Period|Disease Progression|3|||
164638226|NCT03110107|594700488|FG018|Treatment Period|Disease Progression|16|||
164638227|NCT03110107|594700489|FG019|Treatment Period|Disease Progression|14|||
164638228|NCT03110107|594700490|FG020|Treatment Period|Disease Progression|12|||
164638229|NCT03110107|594700491|FG021|Treatment Period|Disease Progression|16|||
164638230|NCT03110107|594700492|FG022|Treatment Period|Disease Progression|18|||
164638231|NCT03110107|594700493|FG023|Treatment Period|Disease Progression|13|||
164638232|NCT03110107|594700494|FG024|Treatment Period|Disease Progression|16|||
164638233|NCT03110107|594700495|FG025|Treatment Period|Disease Progression|31|||
164638234|NCT03110107|594700470|FG000|Treatment Period|Study drug toxicity|1|||
164638235|NCT03110107|594700471|FG001|Treatment Period|Study drug toxicity|0|||
164638236|NCT03110107|594700472|FG002|Treatment Period|Study drug toxicity|1|||
164638237|NCT03110107|594700473|FG003|Treatment Period|Study drug toxicity|2|||
164638238|NCT03110107|594700474|FG004|Treatment Period|Study drug toxicity|0|||
164638239|NCT03110107|594700475|FG005|Treatment Period|Study drug toxicity|3|||
164638240|NCT03110107|594700476|FG006|Treatment Period|Study drug toxicity|1|||
164638241|NCT03110107|594700477|FG007|Treatment Period|Study drug toxicity|1|||
164638242|NCT03110107|594700478|FG008|Treatment Period|Study drug toxicity|3|||
164638243|NCT03110107|594700479|FG009|Treatment Period|Study drug toxicity|2|||
164638244|NCT03110107|594700480|FG010|Treatment Period|Study drug toxicity|0|||
164638245|NCT03110107|594700481|FG011|Treatment Period|Study drug toxicity|2|||
164638246|NCT03110107|594700482|FG012|Treatment Period|Study drug toxicity|0|||
164638247|NCT03110107|594700483|FG013|Treatment Period|Study drug toxicity|0|||
164638248|NCT03110107|594700484|FG014|Treatment Period|Study drug toxicity|2|||
164638249|NCT03110107|594700485|FG015|Treatment Period|Study drug toxicity|3|||
164638250|NCT03110107|594700486|FG016|Treatment Period|Study drug toxicity|3|||
164638251|NCT03110107|594700487|FG017|Treatment Period|Study drug toxicity|3|||
164638252|NCT03110107|594700488|FG018|Treatment Period|Study drug toxicity|1|||
164638253|NCT03110107|594700489|FG019|Treatment Period|Study drug toxicity|2|||
164638254|NCT03110107|594700490|FG020|Treatment Period|Study drug toxicity|2|||
164638255|NCT03110107|594700491|FG021|Treatment Period|Study drug toxicity|0|||
164638256|NCT03110107|594700492|FG022|Treatment Period|Study drug toxicity|2|||
164638257|NCT03110107|594700493|FG023|Treatment Period|Study drug toxicity|6|||
164638258|NCT03110107|594700494|FG024|Treatment Period|Study drug toxicity|7|||
164638259|NCT03110107|594700495|FG025|Treatment Period|Study drug toxicity|6|||
164638260|NCT03110107|594700470|FG000|Treatment Period|Death|0|||
164638261|NCT03110107|594700471|FG001|Treatment Period|Death|0|||
164638262|NCT03110107|594700472|FG002|Treatment Period|Death|0|||
164638263|NCT03110107|594700473|FG003|Treatment Period|Death|0|||
164638264|NCT03110107|594700474|FG004|Treatment Period|Death|0|||
164638265|NCT03110107|594700475|FG005|Treatment Period|Death|0|||
164638266|NCT03110107|594700476|FG006|Treatment Period|Death|0|||
164638267|NCT03110107|594700477|FG007|Treatment Period|Death|0|||
164638268|NCT03110107|594700478|FG008|Treatment Period|Death|0|||
164638269|NCT03110107|594700479|FG009|Treatment Period|Death|0|||
164638270|NCT03110107|594700480|FG010|Treatment Period|Death|0|||
164638271|NCT03110107|594700481|FG011|Treatment Period|Death|0|||
164638272|NCT03110107|594700482|FG012|Treatment Period|Death|1|||
164638273|NCT03110107|594700483|FG013|Treatment Period|Death|0|||
164638274|NCT03110107|594700484|FG014|Treatment Period|Death|0|||
164638275|NCT03110107|594700485|FG015|Treatment Period|Death|0|||
164638276|NCT03110107|594700486|FG016|Treatment Period|Death|0|||
164638277|NCT03110107|594700487|FG017|Treatment Period|Death|0|||
164638278|NCT03110107|594700488|FG018|Treatment Period|Death|0|||
164638279|NCT03110107|594700489|FG019|Treatment Period|Death|0|||
164638280|NCT03110107|594700490|FG020|Treatment Period|Death|0|||
164638281|NCT03110107|594700491|FG021|Treatment Period|Death|0|||
164638282|NCT03110107|594700492|FG022|Treatment Period|Death|0|||
164638283|NCT03110107|594700493|FG023|Treatment Period|Death|0|||
164638284|NCT03110107|594700494|FG024|Treatment Period|Death|0|||
164638285|NCT03110107|594700495|FG025|Treatment Period|Death|0|||
164638286|NCT03110107|594700470|FG000|Treatment Period|Adverse Event|0|||
164638287|NCT03110107|594700471|FG001|Treatment Period|Adverse Event|0|||
164638288|NCT03110107|594700472|FG002|Treatment Period|Adverse Event|1|||
164638289|NCT03110107|594700473|FG003|Treatment Period|Adverse Event|0|||
164638290|NCT03110107|594700474|FG004|Treatment Period|Adverse Event|0|||
164638291|NCT03110107|594700475|FG005|Treatment Period|Adverse Event|2|||
164638292|NCT03110107|594700476|FG006|Treatment Period|Adverse Event|0|||
164638293|NCT03110107|594700477|FG007|Treatment Period|Adverse Event|2|||
164638294|NCT03110107|594700478|FG008|Treatment Period|Adverse Event|0|||
164638295|NCT03110107|594700479|FG009|Treatment Period|Adverse Event|1|||
164638296|NCT03110107|594700480|FG010|Treatment Period|Adverse Event|0|||
164638297|NCT03110107|594700481|FG011|Treatment Period|Adverse Event|0|||
164638298|NCT03110107|594700482|FG012|Treatment Period|Adverse Event|0|||
164638299|NCT03110107|594700483|FG013|Treatment Period|Adverse Event|0|||
164638300|NCT03110107|594700484|FG014|Treatment Period|Adverse Event|0|||
164638301|NCT03110107|594700485|FG015|Treatment Period|Adverse Event|2|||
164638302|NCT03110107|594700486|FG016|Treatment Period|Adverse Event|0|||
164638303|NCT03110107|594700487|FG017|Treatment Period|Adverse Event|1|||
164638304|NCT03110107|594700488|FG018|Treatment Period|Adverse Event|2|||
164638305|NCT03110107|594700489|FG019|Treatment Period|Adverse Event|1|||
164638306|NCT03110107|594700490|FG020|Treatment Period|Adverse Event|4|||
164638307|NCT03110107|594700491|FG021|Treatment Period|Adverse Event|2|||
164638308|NCT03110107|594700492|FG022|Treatment Period|Adverse Event|2|||
164638309|NCT03110107|594700493|FG023|Treatment Period|Adverse Event|2|||
164638310|NCT03110107|594700494|FG024|Treatment Period|Adverse Event|2|||
164638311|NCT03110107|594700495|FG025|Treatment Period|Adverse Event|4|||
164638312|NCT03110107|594700470|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
164638313|NCT03110107|594700471|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
164638314|NCT03110107|594700472|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
164638315|NCT03110107|594700473|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
164638316|NCT03110107|594700474|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
164638317|NCT03110107|594700475|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
164638318|NCT03110107|594700476|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
164638319|NCT03110107|594700477|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
164638320|NCT03110107|594700478|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
164638321|NCT03110107|594700479|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
164638322|NCT03110107|594700480|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
164638323|NCT03110107|594700481|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
164638324|NCT03110107|594700482|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
164638325|NCT03110107|594700483|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
164638326|NCT03110107|594700484|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
164638327|NCT03110107|594700485|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
164638328|NCT03110107|594700486|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
164638329|NCT03110107|594700487|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
164638330|NCT03110107|594700488|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
164638331|NCT03110107|594700489|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
164638332|NCT03110107|594700490|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
164638333|NCT03110107|594700491|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
164638334|NCT03110107|594700492|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
164638335|NCT03110107|594700493|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
164638336|NCT03110107|594700494|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
164638337|NCT03110107|594700495|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
164638338|NCT03110107|594700470|FG000|Treatment Period|Participant withdrew consent|0|||
164638339|NCT03110107|594700471|FG001|Treatment Period|Participant withdrew consent|0|||
164638340|NCT03110107|594700472|FG002|Treatment Period|Participant withdrew consent|1|||
164638341|NCT03110107|594700473|FG003|Treatment Period|Participant withdrew consent|0|||
164638342|NCT03110107|594700474|FG004|Treatment Period|Participant withdrew consent|4|||
164638343|NCT03110107|594700475|FG005|Treatment Period|Participant withdrew consent|3|||
164638344|NCT03110107|594700476|FG006|Treatment Period|Participant withdrew consent|0|||
164638345|NCT03110107|594700477|FG007|Treatment Period|Participant withdrew consent|0|||
164638346|NCT03110107|594700478|FG008|Treatment Period|Participant withdrew consent|0|||
164638347|NCT03110107|594700479|FG009|Treatment Period|Participant withdrew consent|1|||
164638348|NCT03110107|594700480|FG010|Treatment Period|Participant withdrew consent|0|||
164638349|NCT03110107|594700481|FG011|Treatment Period|Participant withdrew consent|0|||
164638350|NCT03110107|594700482|FG012|Treatment Period|Participant withdrew consent|0|||
164638351|NCT03110107|594700483|FG013|Treatment Period|Participant withdrew consent|0|||
164638352|NCT03110107|594700484|FG014|Treatment Period|Participant withdrew consent|0|||
164638353|NCT03110107|594700485|FG015|Treatment Period|Participant withdrew consent|0|||
164638354|NCT03110107|594700486|FG016|Treatment Period|Participant withdrew consent|0|||
164638355|NCT03110107|594700487|FG017|Treatment Period|Participant withdrew consent|0|||
164638356|NCT03110107|594700488|FG018|Treatment Period|Participant withdrew consent|0|||
164638357|NCT03110107|594700489|FG019|Treatment Period|Participant withdrew consent|1|||
164638358|NCT03110107|594700490|FG020|Treatment Period|Participant withdrew consent|0|||
164638359|NCT03110107|594700491|FG021|Treatment Period|Participant withdrew consent|2|||
164638360|NCT03110107|594700492|FG022|Treatment Period|Participant withdrew consent|0|||
164638361|NCT03110107|594700493|FG023|Treatment Period|Participant withdrew consent|0|||
164638362|NCT03110107|594700494|FG024|Treatment Period|Participant withdrew consent|0|||
164638363|NCT03110107|594700495|FG025|Treatment Period|Participant withdrew consent|2|||
164638364|NCT03110107|594700470|FG000|Treatment Period|Participants no longer meets study criteria|0|||
164638365|NCT03110107|594700471|FG001|Treatment Period|Participants no longer meets study criteria|0|||
164638366|NCT03110107|594700472|FG002|Treatment Period|Participants no longer meets study criteria|0|||
164638367|NCT03110107|594700473|FG003|Treatment Period|Participants no longer meets study criteria|0|||
164638368|NCT03110107|594700474|FG004|Treatment Period|Participants no longer meets study criteria|0|||
164638369|NCT03110107|594700475|FG005|Treatment Period|Participants no longer meets study criteria|0|||
164638370|NCT03110107|594700476|FG006|Treatment Period|Participants no longer meets study criteria|0|||
164638371|NCT03110107|594700477|FG007|Treatment Period|Participants no longer meets study criteria|0|||
164638372|NCT03110107|594700478|FG008|Treatment Period|Participants no longer meets study criteria|0|||
164638373|NCT03110107|594700479|FG009|Treatment Period|Participants no longer meets study criteria|0|||
164638374|NCT03110107|594700480|FG010|Treatment Period|Participants no longer meets study criteria|0|||
164638375|NCT03110107|594700481|FG011|Treatment Period|Participants no longer meets study criteria|0|||
164638376|NCT03110107|594700482|FG012|Treatment Period|Participants no longer meets study criteria|0|||
164638377|NCT03110107|594700483|FG013|Treatment Period|Participants no longer meets study criteria|0|||
164638378|NCT03110107|594700484|FG014|Treatment Period|Participants no longer meets study criteria|0|||
164638379|NCT03110107|594700485|FG015|Treatment Period|Participants no longer meets study criteria|0|||
164638380|NCT03110107|594700486|FG016|Treatment Period|Participants no longer meets study criteria|0|||
164638381|NCT03110107|594700487|FG017|Treatment Period|Participants no longer meets study criteria|0|||
164638382|NCT03110107|594700488|FG018|Treatment Period|Participants no longer meets study criteria|0|||
164638383|NCT03110107|594700489|FG019|Treatment Period|Participants no longer meets study criteria|0|||
164638384|NCT03110107|594700490|FG020|Treatment Period|Participants no longer meets study criteria|0|||
164638385|NCT03110107|594700491|FG021|Treatment Period|Participants no longer meets study criteria|0|||
164638386|NCT03110107|594700492|FG022|Treatment Period|Participants no longer meets study criteria|0|||
164638387|NCT03110107|594700493|FG023|Treatment Period|Participants no longer meets study criteria|1|||
164638388|NCT03110107|594700494|FG024|Treatment Period|Participants no longer meets study criteria|0|||
164638389|NCT03110107|594700495|FG025|Treatment Period|Participants no longer meets study criteria|0|||
164638390|NCT03110107|594700470|FG000|Treatment Period|Other Reasons|0|||
164638391|NCT03110107|594700471|FG001|Treatment Period|Other Reasons|0|||
164638392|NCT03110107|594700472|FG002|Treatment Period|Other Reasons|1|||
164638393|NCT03110107|594700473|FG003|Treatment Period|Other Reasons|1|||
164638394|NCT03110107|594700474|FG004|Treatment Period|Other Reasons|0|||
164638395|NCT03110107|594700475|FG005|Treatment Period|Other Reasons|1|||
164638396|NCT03110107|594700476|FG006|Treatment Period|Other Reasons|0|||
164638397|NCT03110107|594700477|FG007|Treatment Period|Other Reasons|0|||
164638398|NCT03110107|594700478|FG008|Treatment Period|Other Reasons|0|||
164638399|NCT03110107|594700479|FG009|Treatment Period|Other Reasons|0|||
164638400|NCT03110107|594700480|FG010|Treatment Period|Other Reasons|0|||
164638401|NCT03110107|594700481|FG011|Treatment Period|Other Reasons|0|||
164638402|NCT03110107|594700482|FG012|Treatment Period|Other Reasons|0|||
164638403|NCT03110107|594700483|FG013|Treatment Period|Other Reasons|0|||
164638404|NCT03110107|594700484|FG014|Treatment Period|Other Reasons|0|||
164638405|NCT03110107|594700485|FG015|Treatment Period|Other Reasons|0|||
164638406|NCT03110107|594700486|FG016|Treatment Period|Other Reasons|0|||
164638407|NCT03110107|594700487|FG017|Treatment Period|Other Reasons|0|||
164638408|NCT03110107|594700488|FG018|Treatment Period|Other Reasons|0|||
164638409|NCT03110107|594700489|FG019|Treatment Period|Other Reasons|0|||
164638410|NCT03110107|594700490|FG020|Treatment Period|Other Reasons|0|||
164638411|NCT03110107|594700491|FG021|Treatment Period|Other Reasons|0|||
164638412|NCT03110107|594700492|FG022|Treatment Period|Other Reasons|0|||
164638413|NCT03110107|594700493|FG023|Treatment Period|Other Reasons|0|||
164638414|NCT03110107|594700494|FG024|Treatment Period|Other Reasons|1|||
164638415|NCT03110107|594700495|FG025|Treatment Period|Other Reasons|0|||
164638416|NCT03985982|594700499|FG000|Double-Blind Phase|Lost to Follow-up|4|||
164638417|NCT03985982|594700500|FG001|Double-Blind Phase|Lost to Follow-up|3|||
164638418|NCT03985982|594700501|FG002|Double-Blind Phase|Lost to Follow-up|0|||
164638419|NCT03985982|594700499|FG000|Double-Blind Phase|Physician Decision|1|||
164638420|NCT03985982|594700500|FG001|Double-Blind Phase|Physician Decision|0|||
164638421|NCT03985982|594700501|FG002|Double-Blind Phase|Physician Decision|0|||
164638422|NCT03985982|594700499|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
164638423|NCT03985982|594700500|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
164638424|NCT03985982|594700501|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
164638425|NCT03985982|594700499|FG000|Double-Blind Phase|COVID-19|1|||
164638426|NCT03985982|594700500|FG001|Double-Blind Phase|COVID-19|0|||
164638427|NCT03985982|594700501|FG002|Double-Blind Phase|COVID-19|0|||
164638428|NCT03985982|594700499|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
164638429|NCT03985982|594700500|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
164638430|NCT03985982|594700501|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
164638431|NCT03985982|594700499|FG000|Open-Label Phase|Lost to Follow-up|0|||
164638432|NCT03985982|594700500|FG001|Open-Label Phase|Lost to Follow-up|0|||
164638433|NCT03985982|594700501|FG002|Open-Label Phase|Lost to Follow-up|13|||
164638434|NCT03985982|594700499|FG000|Open-Label Phase|Physician Decision|0|||
164638435|NCT03985982|594700500|FG001|Open-Label Phase|Physician Decision|0|||
164638436|NCT03985982|594700501|FG002|Open-Label Phase|Physician Decision|2|||
164638437|NCT03985982|594700499|FG000|Open-Label Phase|Withdrawal by Subject|0|||
164638438|NCT03985982|594700500|FG001|Open-Label Phase|Withdrawal by Subject|0|||
164638439|NCT03985982|594700501|FG002|Open-Label Phase|Withdrawal by Subject|11|||
164638440|NCT05981365|594700503|FG000|Period 1|Adverse Event|1|||
164638441|NCT05981365|594700504|FG001|Period 1|Adverse Event|0|||
164638442|NCT03927989|594700507|FG000|Overall Study|Withdrawal by Subject|0|||
164638443|NCT03927989|594700508|FG001|Overall Study|Withdrawal by Subject|1|||
164638444|NCT02593175|594700509|FG000|Overall Study|Adverse Event|5|||
164638445|NCT02593175|594700509|FG000|Overall Study|Disease progression|4|||
164638446|NCT00478933|594700510|FG000|Overall Study|Protocol Violation|22|||
164638447|NCT00478933|594700510|FG000|Overall Study|Informed consent not verified|3|||
164638448|NCT00478933|594700510|FG000|Overall Study|Inadequate data available|53|||
164638449|NCT02506101|594700512|FG000|Overall Study|Transportation issues|1|||
164638450|NCT02506101|594700513|FG001|Overall Study|Transportation issues|0|||
164638451|NCT02506101|594700512|FG000|Overall Study|No enrollment and staff unavailability|1|||
164638452|NCT02506101|594700513|FG001|Overall Study|No enrollment and staff unavailability|0|||
164638453|NCT03586427|594700517|FG000|Overall Study|Lost to Follow-up|0|||
164638454|NCT03586427|594700518|FG001|Overall Study|Lost to Follow-up|3|||
164638455|NCT03586427|594700519|FG002|Overall Study|Lost to Follow-up|1|||
164638456|NCT03586427|594700520|FG003|Overall Study|Lost to Follow-up|3|||
164638457|NCT03586427|594700521|FG004|Overall Study|Lost to Follow-up|3|||
164638458|NCT03586427|594700517|FG000|Overall Study|Withdrawal by Subject|0|||
164638459|NCT03586427|594700518|FG001|Overall Study|Withdrawal by Subject|1|||
164638460|NCT03586427|594700519|FG002|Overall Study|Withdrawal by Subject|2|||
164638461|NCT03586427|594700520|FG003|Overall Study|Withdrawal by Subject|1|||
164638462|NCT03586427|594700521|FG004|Overall Study|Withdrawal by Subject|1|||
164638463|NCT03586427|594700517|FG000|Overall Study|Adverse Event|0|||
164638464|NCT03586427|594700518|FG001|Overall Study|Adverse Event|0|||
164638465|NCT03586427|594700519|FG002|Overall Study|Adverse Event|1|||
164638466|NCT03586427|594700520|FG003|Overall Study|Adverse Event|0|||
164638467|NCT03586427|594700521|FG004|Overall Study|Adverse Event|0|||
164638468|NCT03586427|594700517|FG000|Overall Study|Protocol Violation|0|||
164638469|NCT03586427|594700518|FG001|Overall Study|Protocol Violation|0|||
164638470|NCT03586427|594700519|FG002|Overall Study|Protocol Violation|1|||
164638471|NCT03586427|594700520|FG003|Overall Study|Protocol Violation|0|||
164638472|NCT03586427|594700521|FG004|Overall Study|Protocol Violation|1|||
164638473|NCT03586427|594700517|FG000|Overall Study|Noncompliance with study drug|0|||
164638474|NCT03586427|594700518|FG001|Overall Study|Noncompliance with study drug|0|||
164638475|NCT03586427|594700519|FG002|Overall Study|Noncompliance with study drug|1|||
164638476|NCT03586427|594700520|FG003|Overall Study|Noncompliance with study drug|0|||
164638477|NCT03586427|594700521|FG004|Overall Study|Noncompliance with study drug|0|||
164638478|NCT03193996|594700524|FG000|Overall Study|Withdrawal by Subject|4|||
164638479|NCT03193996|594700524|FG000|Overall Study|Lost to Follow-up|4|||
164638480|NCT03193996|594700524|FG000|Overall Study|Physician Decision|2|||
164638481|NCT03193996|594700524|FG000|Overall Study|Pregnancy|1|||
164638482|NCT03193996|594700524|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
164638483|NCT03193996|594700524|FG000|Overall Study|Complicating disease|1|||
164638484|NCT00593385|594700531|FG000|Overall Study|Death|14|||
164638485|NCT00593385|594700531|FG000|Overall Study|Lost to Follow-up|17|||
164638486|NCT00593385|594700531|FG000|Overall Study|Withdrawal by Subject|9|||
164638487|NCT01471197|594700532|FG000|Overall Study|Disease Progression|4|||
164638488|NCT01471197|594700533|FG001|Overall Study|Disease Progression|2|||
164638489|NCT01471197|594700532|FG000|Overall Study|Death|1|||
164638490|NCT01471197|594700533|FG001|Overall Study|Death|0|||
164638491|NCT01471197|594700532|FG000|Overall Study|Study Drug Toxicity|1|||
164638492|NCT01471197|594700533|FG001|Overall Study|Study Drug Toxicity|0|||
164638493|NCT00924313|594700536|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
164638494|NCT01298362|594700537|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
164638495|NCT01298362|594700538|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
164638496|NCT01207219|594700539|FG000|Overall Study|changed diagnosis during study period|5|||
164638497|NCT01207219|594700540|FG001|Overall Study|changed diagnosis during study period|3|||
164638498|NCT01207219|594700541|FG002|Overall Study|changed diagnosis during study period|1|||
164638499|NCT01207219|594700539|FG000|Overall Study|Lost to Follow-up|6|||
164638500|NCT01207219|594700540|FG001|Overall Study|Lost to Follow-up|8|||
164638501|NCT01207219|594700541|FG002|Overall Study|Lost to Follow-up|6|||
164638502|NCT00924820|594700543|FG000|Overall Study|Death|2|||
164638503|NCT00924820|594700543|FG000|Overall Study|Ineligible, Screen Failure|5|||
164638504|NCT01353586|594700544|FG000|Overall Study|Procedure terminated prior to ablation|3|||
164638505|NCT01353586|594700545|FG001|Overall Study|Procedure terminated prior to ablation|0|||
164638506|NCT01353586|594700544|FG000|Overall Study|Never had insertion of study catheter|4|||
164638507|NCT01353586|594700545|FG001|Overall Study|Never had insertion of study catheter|1|||
164638508|NCT01353586|594700544|FG000|Overall Study|Neurological exam not done|0|||
164638509|NCT01353586|594700545|FG001|Overall Study|Neurological exam not done|1|||
164638510|NCT03992456|594700546|FG000|Overall Study|Withdrawal by Subject|1|||
164638511|NCT03992456|594700547|FG001|Overall Study|Withdrawal by Subject|0|||
164638512|NCT03992456|594700546|FG000|Overall Study|Disease progression|4|||
164638513|NCT03992456|594700547|FG001|Overall Study|Disease progression|5|||
164638514|NCT03992456|594700546|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
164638515|NCT03992456|594700547|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
164638516|NCT01068418|594700548|FG000|Overall Study|Physician Decision|12|||
164638517|NCT00326625|594700551|FG000|Overall Study|Adverse Event|20|||
164638518|NCT00326625|594700552|FG001|Overall Study|Adverse Event|9|||
164638519|NCT00326625|594700551|FG000|Overall Study|Withdrawal by Subject|15|||
164638520|NCT00326625|594700552|FG001|Overall Study|Withdrawal by Subject|12|||
164638521|NCT00326625|594700551|FG000|Overall Study|Death|18|||
164638522|NCT00326625|594700552|FG001|Overall Study|Death|16|||
164638523|NCT00326625|594700551|FG000|Overall Study|Lost to Follow-up|1|||
164638524|NCT00326625|594700552|FG001|Overall Study|Lost to Follow-up|0|||
164638525|NCT00326625|594700551|FG000|Overall Study|prescheduled medical intervention|0|||
164638526|NCT00326625|594700552|FG001|Overall Study|prescheduled medical intervention|1|||
164638527|NCT02594384|594700553|FG000|Overall Study|Disease Progression|3|||
164638528|NCT02594384|594700554|FG001|Overall Study|Disease Progression|7|||
164638529|NCT02594384|594700555|FG002|Overall Study|Disease Progression|0|||
164638530|NCT02594384|594700556|FG003|Overall Study|Disease Progression|2|||
164638531|NCT02594384|594700557|FG004|Overall Study|Disease Progression|2|||
164638532|NCT02594384|594700558|FG005|Overall Study|Disease Progression|12|||
164638533|NCT02594384|594700559|FG006|Overall Study|Disease Progression|5|||
164638534|NCT02594384|594700560|FG007|Overall Study|Disease Progression|5|||
164638535|NCT02594384|594700553|FG000|Overall Study|Adverse Event|0|||
164638536|NCT02594384|594700554|FG001|Overall Study|Adverse Event|1|||
164638537|NCT02594384|594700555|FG002|Overall Study|Adverse Event|4|||
164638538|NCT02594384|594700556|FG003|Overall Study|Adverse Event|1|||
164638539|NCT02594384|594700557|FG004|Overall Study|Adverse Event|0|||
164638540|NCT02594384|594700558|FG005|Overall Study|Adverse Event|6|||
164638541|NCT02594384|594700559|FG006|Overall Study|Adverse Event|1|||
164638542|NCT02594384|594700560|FG007|Overall Study|Adverse Event|1|||
164638543|NCT02594384|594700553|FG000|Overall Study|Withdrawal by Subject|0|||
164638544|NCT02594384|594700554|FG001|Overall Study|Withdrawal by Subject|0|||
164638545|NCT02594384|594700555|FG002|Overall Study|Withdrawal by Subject|0|||
164638546|NCT02594384|594700556|FG003|Overall Study|Withdrawal by Subject|1|||
164638547|NCT02594384|594700557|FG004|Overall Study|Withdrawal by Subject|0|||
164638548|NCT02594384|594700558|FG005|Overall Study|Withdrawal by Subject|0|||
164638549|NCT02594384|594700559|FG006|Overall Study|Withdrawal by Subject|0|||
164638550|NCT02594384|594700560|FG007|Overall Study|Withdrawal by Subject|1|||
164638551|NCT02594384|594700553|FG000|Overall Study|Physician Decision|0|||
164638552|NCT02594384|594700554|FG001|Overall Study|Physician Decision|0|||
164638553|NCT02594384|594700555|FG002|Overall Study|Physician Decision|0|||
164638554|NCT02594384|594700556|FG003|Overall Study|Physician Decision|0|||
164638555|NCT02594384|594700557|FG004|Overall Study|Physician Decision|0|||
164638556|NCT02594384|594700558|FG005|Overall Study|Physician Decision|1|||
164638557|NCT02594384|594700559|FG006|Overall Study|Physician Decision|2|||
164638558|NCT02594384|594700560|FG007|Overall Study|Physician Decision|0|||
164638559|NCT02594384|594700553|FG000|Overall Study|Progressive Leukocytosis|0|||
164638560|NCT02594384|594700554|FG001|Overall Study|Progressive Leukocytosis|0|||
164638561|NCT02594384|594700555|FG002|Overall Study|Progressive Leukocytosis|1|||
164638562|NCT02594384|594700556|FG003|Overall Study|Progressive Leukocytosis|0|||
164638563|NCT02594384|594700557|FG004|Overall Study|Progressive Leukocytosis|0|||
164638564|NCT02594384|594700558|FG005|Overall Study|Progressive Leukocytosis|0|||
164638565|NCT02594384|594700559|FG006|Overall Study|Progressive Leukocytosis|0|||
164638566|NCT02594384|594700560|FG007|Overall Study|Progressive Leukocytosis|0|||
164638567|NCT02594384|594700553|FG000|Overall Study|Lack of Efficacy|0|||
164638568|NCT02594384|594700554|FG001|Overall Study|Lack of Efficacy|0|||
164638569|NCT02594384|594700555|FG002|Overall Study|Lack of Efficacy|0|||
164638570|NCT02594384|594700556|FG003|Overall Study|Lack of Efficacy|0|||
164638571|NCT02594384|594700557|FG004|Overall Study|Lack of Efficacy|1|||
164638572|NCT02594384|594700558|FG005|Overall Study|Lack of Efficacy|0|||
164638573|NCT02594384|594700559|FG006|Overall Study|Lack of Efficacy|0|||
164638574|NCT02594384|594700560|FG007|Overall Study|Lack of Efficacy|0|||
164638575|NCT02594384|594700553|FG000|Overall Study|Substantial noncompliance|0|||
164638576|NCT02594384|594700554|FG001|Overall Study|Substantial noncompliance|0|||
164638577|NCT02594384|594700555|FG002|Overall Study|Substantial noncompliance|0|||
164638578|NCT02594384|594700556|FG003|Overall Study|Substantial noncompliance|0|||
164638579|NCT02594384|594700557|FG004|Overall Study|Substantial noncompliance|0|||
164638580|NCT02594384|594700558|FG005|Overall Study|Substantial noncompliance|0|||
164638581|NCT02594384|594700559|FG006|Overall Study|Substantial noncompliance|1|||
164638582|NCT02594384|594700560|FG007|Overall Study|Substantial noncompliance|0|||
164638583|NCT03919669|594700563|FG000|Overall Study|Withdrawal by Subject|1|||
164638584|NCT03919669|594700564|FG001|Overall Study|Withdrawal by Subject|0|||
164638585|NCT03919669|594700565|FG002|Overall Study|Withdrawal by Subject|0|||
164638586|NCT00625846|594700566|FG000|Overall Study|Withdrawal by Subject|2|||
164638587|NCT00625846|594700567|FG001|Overall Study|Withdrawal by Subject|0|||
164638588|NCT00625846|594700568|FG002|Overall Study|Withdrawal by Subject|1|||
164638589|NCT00625846|594700569|FG003|Overall Study|Withdrawal by Subject|2|||
164638590|NCT02058849|594700572|FG000|Overall Study|Hospitalization|1|||
164638591|NCT02058849|594700573|FG001|Overall Study|Hospitalization|1|||
164638592|NCT02058849|594700572|FG000|Overall Study|Death|1|||
164638593|NCT02058849|594700573|FG001|Overall Study|Death|0|||
164638594|NCT02058849|594700572|FG000|Overall Study|Lost to Follow-up|1|||
164638595|NCT02058849|594700573|FG001|Overall Study|Lost to Follow-up|0|||
164638596|NCT02058849|594700572|FG000|Overall Study|Withdrawal by Subject|4|||
164638597|NCT02058849|594700573|FG001|Overall Study|Withdrawal by Subject|0|||
164638598|NCT02219477|594700574|FG000|Overall Study|Adverse Event|0|||
164638599|NCT02219477|594700575|FG001|Overall Study|Adverse Event|1|||
164638600|NCT02219477|594700576|FG002|Overall Study|Adverse Event|1|||
164638601|NCT02219477|594700574|FG000|Overall Study|Withdrawal by Subject|0|||
164638602|NCT02219477|594700575|FG001|Overall Study|Withdrawal by Subject|1|||
164638603|NCT02219477|594700576|FG002|Overall Study|Withdrawal by Subject|0|||
164638604|NCT01891669|594700578|FG000|Overall Study|Death|0|||
164638605|NCT01891669|594700579|FG001|Overall Study|Death|0|||
164638606|NCT01891669|594700580|FG002|Overall Study|Death|0|||
164638607|NCT01891669|594700581|FG003|Overall Study|Death|0|||
164638608|NCT01891669|594700582|FG004|Overall Study|Death|0|||
164638609|NCT01891669|594700583|FG005|Overall Study|Death|0|||
164638610|NCT01891669|594700584|FG006|Overall Study|Death|0|||
164638611|NCT01891669|594700585|FG007|Overall Study|Death|1|||
164638612|NCT01891669|594700586|FG008|Overall Study|Death|0|||
164638613|NCT01891669|594700587|FG009|Overall Study|Death|1|||
164638614|NCT01891669|594700578|FG000|Overall Study|Withdrawal by Subject|1|||
164638615|NCT01891669|594700579|FG001|Overall Study|Withdrawal by Subject|1|||
164638616|NCT01891669|594700580|FG002|Overall Study|Withdrawal by Subject|0|||
164638617|NCT01891669|594700581|FG003|Overall Study|Withdrawal by Subject|0|||
164638618|NCT01891669|594700582|FG004|Overall Study|Withdrawal by Subject|0|||
164638619|NCT01891669|594700583|FG005|Overall Study|Withdrawal by Subject|0|||
164638620|NCT01891669|594700584|FG006|Overall Study|Withdrawal by Subject|1|||
164638621|NCT01891669|594700585|FG007|Overall Study|Withdrawal by Subject|2|||
164638622|NCT01891669|594700586|FG008|Overall Study|Withdrawal by Subject|1|||
164638623|NCT01891669|594700587|FG009|Overall Study|Withdrawal by Subject|1|||
164638624|NCT01891669|594700578|FG000|Overall Study|Other|1|||
164638625|NCT01891669|594700579|FG001|Overall Study|Other|0|||
164638626|NCT01891669|594700580|FG002|Overall Study|Other|0|||
164638627|NCT01891669|594700581|FG003|Overall Study|Other|0|||
164638628|NCT01891669|594700582|FG004|Overall Study|Other|0|||
164638629|NCT01891669|594700583|FG005|Overall Study|Other|0|||
164638630|NCT01891669|594700584|FG006|Overall Study|Other|0|||
164638631|NCT01891669|594700585|FG007|Overall Study|Other|1|||
164638632|NCT01891669|594700586|FG008|Overall Study|Other|0|||
164638633|NCT01891669|594700587|FG009|Overall Study|Other|0|||
164638634|NCT04298229|594700592|FG000|Overall Study|Physician Decision|1|||
164638635|NCT04298229|594700593|FG001|Overall Study|Physician Decision|1|||
164638636|NCT04298229|594700592|FG000|Overall Study|Withdrawal by Subject|1|||
164638637|NCT04298229|594700593|FG001|Overall Study|Withdrawal by Subject|1|||
164638638|NCT04298229|594700592|FG000|Overall Study|Did not receive IV loop diuretics|2|||
164638639|NCT04298229|594700593|FG001|Overall Study|Did not receive IV loop diuretics|0|||
164638640|NCT00262119|594700594|FG000|Overall Study|Lost to Follow-up|38|||
164638641|NCT00262119|594700595|FG001|Overall Study|Lost to Follow-up|51|||
164638642|NCT00262119|594700596|FG002|Overall Study|Lost to Follow-up|42|||
164638643|NCT00262119|594700594|FG000|Overall Study|Death|20|||
164638644|NCT00262119|594700595|FG001|Overall Study|Death|19|||
164638645|NCT00262119|594700596|FG002|Overall Study|Death|16|||
164638646|NCT00859313|594700597|FG000|Overall Study|Lack of Efficacy|2|||
164638647|NCT00859313|594700597|FG000|Overall Study|Adverse Event|1|||
164638648|NCT00859313|594700597|FG000|Overall Study|staff error|1|||
164638649|NCT00071006|594700598|FG000|Overall Study|Lack of Efficacy|7|||
164638650|NCT00071006|594700598|FG000|Overall Study|Adverse Event|1|||
164638651|NCT00071006|594700598|FG000|Overall Study|Withdrawal by Subject|1|||
164638652|NCT00071006|594700598|FG000|Overall Study|Other|3|||
164638653|NCT05261126|594700603|FG000|Overall Study|Death|0|||
164638654|NCT05261126|594700604|FG001|Overall Study|Death|0|||
164638655|NCT05261126|594700605|FG002|Overall Study|Death|1|||
164638656|NCT05261126|594700606|FG003|Overall Study|Death|0|||
164638657|NCT05261126|594700607|FG004|Overall Study|Death|0|||
164638658|NCT05261126|594700603|FG000|Overall Study|Lost to Follow-up|0|||
164638659|NCT05261126|594700604|FG001|Overall Study|Lost to Follow-up|0|||
164638660|NCT05261126|594700605|FG002|Overall Study|Lost to Follow-up|0|||
164638661|NCT05261126|594700606|FG003|Overall Study|Lost to Follow-up|0|||
164638662|NCT05261126|594700607|FG004|Overall Study|Lost to Follow-up|1|||
164638663|NCT05261126|594700603|FG000|Overall Study|Physician Decision|1|||
164638664|NCT05261126|594700604|FG001|Overall Study|Physician Decision|0|||
164638665|NCT05261126|594700605|FG002|Overall Study|Physician Decision|0|||
164638666|NCT05261126|594700606|FG003|Overall Study|Physician Decision|0|||
164638667|NCT05261126|594700607|FG004|Overall Study|Physician Decision|0|||
164638668|NCT05261126|594700603|FG000|Overall Study|Screen Failure|0|||
164638669|NCT05261126|594700604|FG001|Overall Study|Screen Failure|0|||
164638670|NCT05261126|594700605|FG002|Overall Study|Screen Failure|0|||
164638671|NCT05261126|594700606|FG003|Overall Study|Screen Failure|0|||
164638672|NCT05261126|594700607|FG004|Overall Study|Screen Failure|1|||
164638673|NCT05261126|594700603|FG000|Overall Study|Withdrawal by Subject|1|||
164638674|NCT05261126|594700604|FG001|Overall Study|Withdrawal by Subject|0|||
164638675|NCT05261126|594700605|FG002|Overall Study|Withdrawal by Subject|1|||
164638676|NCT05261126|594700606|FG003|Overall Study|Withdrawal by Subject|1|||
164638677|NCT05261126|594700607|FG004|Overall Study|Withdrawal by Subject|0|||
164638678|NCT05261126|594700603|FG000|Overall Study|Not Recorded|0|||
164638679|NCT05261126|594700604|FG001|Overall Study|Not Recorded|0|||
164638680|NCT05261126|594700605|FG002|Overall Study|Not Recorded|0|||
164638681|NCT05261126|594700606|FG003|Overall Study|Not Recorded|1|||
164638682|NCT05261126|594700607|FG004|Overall Study|Not Recorded|0|||
164638683|NCT05939388|594700608|FG000|Overall Study|Lost to Follow-up|1|||
164638684|NCT03901274|594700609|FG000|Overall Study|Lost to Follow-up|120|||
164638685|NCT03901274|594700610|FG001|Overall Study|Lost to Follow-up|124|||
164638686|NCT03901274|594700609|FG000|Overall Study|Withdrawal by Subject|0|||
164638687|NCT03901274|594700610|FG001|Overall Study|Withdrawal by Subject|6|||
164638688|NCT05570604|594700611|FG000|Overall Study|Lost to Follow-up|1|||
164638689|NCT05570604|594700612|FG001|Overall Study|Lost to Follow-up|5|||
164638690|NCT05570604|594700611|FG000|Overall Study|Illness|2|||
164638691|NCT05570604|594700612|FG001|Overall Study|Illness|2|||
164638692|NCT04527380|594700619|FG000|Overall Study|Lack of Efficacy|0|||
164638693|NCT04527380|594700620|FG001|Overall Study|Lack of Efficacy|1|||
164638694|NCT04527380|594700619|FG000|Overall Study|Withdrawal by Subject|1|||
164638695|NCT04527380|594700620|FG001|Overall Study|Withdrawal by Subject|0|||
164638696|NCT05116241|594700635|FG000|Study|Withdrawal by Subject|5|||
164638697|NCT05116241|594700636|FG001|Study|Withdrawal by Subject|2|||
164638698|NCT05116241|594700637|FG002|Study|Withdrawal by Subject|1|||
164638699|NCT05116241|594700635|FG000|Study|Lost to Follow-up|0|||
164638700|NCT05116241|594700636|FG001|Study|Lost to Follow-up|2|||
164638701|NCT05116241|594700637|FG002|Study|Lost to Follow-up|2|||
164638702|NCT04410991|594700638|FG000|Overall Study|Poor compliance to protocol|5|||
164638703|NCT04410991|594700639|FG001|Overall Study|Poor compliance to protocol|4|||
164638704|NCT04410991|594700638|FG000|Overall Study|Withdrawal by Subject|59|||
164638705|NCT04410991|594700639|FG001|Overall Study|Withdrawal by Subject|55|||
164638706|NCT04410991|594700638|FG000|Overall Study|Other|10|||
164638707|NCT04410991|594700639|FG001|Overall Study|Other|4|||
164638708|NCT01054443|594700646|FG000|Overall Study|Withdrawal by Subject|0|||
164638709|NCT01054443|594700647|FG001|Overall Study|Withdrawal by Subject|0|||
164638710|NCT01054443|594700648|FG002|Overall Study|Withdrawal by Subject|0|||
164638711|NCT01054443|594700649|FG003|Overall Study|Withdrawal by Subject|1|||
164638712|NCT00985114|594700650|FG000|Overall Study|Adverse Event|1|||
164638713|NCT00985114|594700651|FG001|Overall Study|Adverse Event|0|||
164638714|NCT00985114|594700650|FG000|Overall Study|Withdrawal by Subject|0|||
164638715|NCT00985114|594700651|FG001|Overall Study|Withdrawal by Subject|2|||
164638716|NCT02950831|594700652|FG000|Overall Study|Lost to Follow-up|1|||
164638717|NCT02950831|594700652|FG000|Overall Study|Withdrawal by Subject|3|||
164638718|NCT02950831|594700652|FG000|Overall Study|stimulation trail failure|5|||
164638719|NCT01119118|594700653|FG000|Overall Study|Adverse Event|1|||
164638720|NCT01396434|594700660|FG000|Overall Study|Lost to Follow-up|1|||
164638721|NCT01396434|594700661|FG001|Overall Study|Lost to Follow-up|0|||
164638722|NCT01396434|594700662|FG002|Overall Study|Lost to Follow-up|0|||
164638723|NCT01396434|594700660|FG000|Overall Study|Other|10|||
164638724|NCT01396434|594700661|FG001|Overall Study|Other|0|||
164638725|NCT01396434|594700662|FG002|Overall Study|Other|0|||
164638726|NCT02985541|594702070|FG000|Overall Study|Withdrawal by Subject|33|||
164638727|NCT02985541|594702070|FG000|Overall Study|Lost to Follow-up|26|||
164638728|NCT02985541|594702070|FG000|Overall Study|Adverse Event|27|||
164638729|NCT02985541|594702070|FG000|Overall Study|Physician Decision|2|||
164638730|NCT02985541|594702070|FG000|Overall Study|Pregnancy|2|||
164638731|NCT02985541|594702070|FG000|Overall Study|Wish for pregnancy|44|||
164638732|NCT02985541|594702070|FG000|Overall Study|Other reason|5|||
164638733|NCT02985541|594702070|FG000|Overall Study|Not valid for analysis|2|||
164638734|NCT02383966|594702071|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
164638735|NCT02383966|594702072|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
164638736|NCT02383966|594702071|FG000|Overall Study|Randomized, but not treated|1|||
164638737|NCT02383966|594702072|FG001|Overall Study|Randomized, but not treated|3|||
164638738|NCT02503215|594702073|FG000|Overall Study|Unable to wear compression stockings|1|||
164638739|NCT02503215|594702073|FG000|Overall Study|Unable to use positive airway pressure|2|||
164638740|NCT00437294|594702078|FG000|Overall Study|Adverse Event|5|||
164638741|NCT00437294|594702079|FG001|Overall Study|Adverse Event|4|||
164638742|NCT00437294|594702078|FG000|Overall Study|Death|5|||
164638743|NCT00437294|594702079|FG001|Overall Study|Death|2|||
164638744|NCT00437294|594702078|FG000|Overall Study|Physician Decision|0|||
164638745|NCT00437294|594702079|FG001|Overall Study|Physician Decision|3|||
164638746|NCT00437294|594702078|FG000|Overall Study|Withdrawal by Subject|5|||
164638747|NCT00437294|594702079|FG001|Overall Study|Withdrawal by Subject|0|||
164638748|NCT00437294|594702078|FG000|Overall Study|Progressive Disease|19|||
164638749|NCT00437294|594702079|FG001|Overall Study|Progressive Disease|23|||
164638750|NCT00437294|594702078|FG000|Overall Study|Sponsor Decision|8|||
164638751|NCT00437294|594702079|FG001|Overall Study|Sponsor Decision|9|||
164638752|NCT00437294|594702078|FG000|Overall Study|Protocol Violation|0|||
164638753|NCT00437294|594702079|FG001|Overall Study|Protocol Violation|1|||
164638754|NCT00437294|594702078|FG000|Overall Study|Entry criteria not met|1|||
164638755|NCT00437294|594702079|FG001|Overall Study|Entry criteria not met|1|||
164638756|NCT02064231|594702081|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
164638757|NCT02064231|594702082|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
164638758|NCT02064231|594702083|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
164638759|NCT02064231|594702084|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
164638760|NCT02064231|594702081|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
164638761|NCT02064231|594702082|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
164638762|NCT02064231|594702083|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
164638763|NCT02064231|594702084|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
164638764|NCT02064231|594702081|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
164638765|NCT02064231|594702082|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
164638766|NCT02064231|594702083|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
164638767|NCT02064231|594702084|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
164638768|NCT02064231|594702081|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
164638769|NCT02064231|594702082|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
164638770|NCT02064231|594702083|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
164638771|NCT02064231|594702084|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
164638772|NCT00518531|594702085|FG000|Treatment Period 1|Adverse Event|5|||
164638773|NCT00518531|594702086|FG001|Treatment Period 1|Adverse Event|0|||
164638774|NCT00518531|594702085|FG000|Treatment Period 1|Lost to Follow-up|5|||
164638775|NCT00518531|594702086|FG001|Treatment Period 1|Lost to Follow-up|3|||
164638776|NCT00518531|594702085|FG000|Treatment Period 1|Physician Decision|1|||
164638777|NCT00518531|594702086|FG001|Treatment Period 1|Physician Decision|0|||
164638778|NCT00518531|594702085|FG000|Treatment Period 1|Protocol Violation|2|||
164638779|NCT00518531|594702086|FG001|Treatment Period 1|Protocol Violation|0|||
164638780|NCT00518531|594702085|FG000|Treatment Period 1|Withdrawal by Subject|4|||
164638781|NCT00518531|594702086|FG001|Treatment Period 1|Withdrawal by Subject|6|||
164638782|NCT00518531|594702085|FG000|Treatment Period 1|Early crossover|1|||
164638783|NCT00518531|594702086|FG001|Treatment Period 1|Early crossover|3|||
164638784|NCT00518531|594702085|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164638785|NCT00518531|594702086|FG001|Treatment Period 2|Withdrawal by Subject|8|||
164638786|NCT00518531|594702085|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
164638787|NCT00518531|594702086|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
164638788|NCT00518531|594702085|FG000|Treatment Period 2|Adverse Event|1|||
164638789|NCT00518531|594702086|FG001|Treatment Period 2|Adverse Event|7|||
164638790|NCT00518531|594702085|FG000|Treatment Period 2|Protocol-specified criteria|0|||
164638791|NCT00518531|594702086|FG001|Treatment Period 2|Protocol-specified criteria|1|||
164638792|NCT00518531|594702085|FG000|Treatment Period 2|Non-compliance|1|||
164638793|NCT00518531|594702086|FG001|Treatment Period 2|Non-compliance|2|||
164638794|NCT01741259|594702095|FG000|Overall Study|Protocol Violation|6|||
164638795|NCT01741259|594702096|FG001|Overall Study|Protocol Violation|4|||
164638796|NCT01741259|594702095|FG000|Overall Study|Withdrawal by Subject|0|||
164638797|NCT01741259|594702096|FG001|Overall Study|Withdrawal by Subject|2|||
164638798|NCT05604521|594702100|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
164638799|NCT05604521|594702101|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
164638800|NCT05604521|594702100|FG000|Overall Study|Adverse Event|1|||
164638801|NCT05604521|594702101|FG001|Overall Study|Adverse Event|0|||
164638802|NCT02875340|594702102|FG000|Overall Study|Death|2|||
164638803|NCT02875340|594702102|FG000|Overall Study|Withdrawal by Subject|2|||
164638804|NCT02875340|594702102|FG000|Overall Study|Physician Decision|3|||
164638805|NCT02875340|594702102|FG000|Overall Study|Adverse Event|1|||
164638806|NCT03526549|594702107|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
164638807|NCT03526549|594702108|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
164638808|NCT03526549|594702107|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
164638809|NCT03526549|594702108|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
164638810|NCT03526549|594702107|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
164638811|NCT03526549|594702108|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
164638812|NCT03526549|594702107|FG000|Open-label Phase|Adverse Event|4|||
164638813|NCT03526549|594702108|FG001|Open-label Phase|Adverse Event|0|||
164638814|NCT03526549|594702107|FG000|Open-label Phase|Withdrawal by Subject|54|||
164638815|NCT03526549|594702108|FG001|Open-label Phase|Withdrawal by Subject|0|||
164638816|NCT03526549|594702107|FG000|Open-label Phase|Lost to Follow-up|35|||
164638817|NCT03526549|594702108|FG001|Open-label Phase|Lost to Follow-up|0|||
164638818|NCT03526549|594702107|FG000|Open-label Phase|Other than Specified|5|||
164638819|NCT03526549|594702108|FG001|Open-label Phase|Other than Specified|0|||
164638820|NCT03253809|594702116|FG000|Overall Study|Unable to obtain study related data|14|||
164638821|NCT04637815|594702121|FG000|Overall Study|Death|1|||
164638822|NCT04637815|594702122|FG001|Overall Study|Death|0|||
164638823|NCT04637815|594702121|FG000|Overall Study|Lost to Follow-up|5|||
164638824|NCT04637815|594702122|FG001|Overall Study|Lost to Follow-up|2|||
164638825|NCT00455923|594702123|FG000|Overall Study|Pregnancy|0|||
164638826|NCT00455923|594702124|FG001|Overall Study|Pregnancy|2|||
164638827|NCT00455923|594702123|FG000|Overall Study|Other|3|||
164638828|NCT00455923|594702124|FG001|Overall Study|Other|1|||
164638829|NCT02353572|594702125|FG000|Overall Study|Withdrawal by Subject|1|||
164638830|NCT02353572|594702125|FG000|Overall Study|Study terminated|2|||
164638831|NCT02686749|594702128|FG000|Overall Study|terminated for poor enrollment|2|||
164638832|NCT02686749|594702129|FG001|Overall Study|terminated for poor enrollment|2|||
164638833|NCT01244516|594702130|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
164638834|NCT01244516|594702131|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
164638835|NCT01244516|594702132|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
164638836|NCT01244516|594702130|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
164638837|NCT01244516|594702131|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
164638838|NCT01244516|594702132|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
164638839|NCT01244516|594702130|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
164638840|NCT01244516|594702131|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
164638841|NCT01244516|594702132|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
164638842|NCT01244516|594702130|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
164638843|NCT01244516|594702131|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
164638844|NCT01244516|594702132|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
164638845|NCT01244516|594702130|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
164638846|NCT01244516|594702131|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
164638847|NCT01244516|594702132|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
164638848|NCT01244516|594702130|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
164638849|NCT01244516|594702131|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
164638850|NCT01244516|594702132|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
164638851|NCT01244516|594702130|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
164638852|NCT01244516|594702131|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
164638853|NCT01244516|594702132|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
164638854|NCT00483119|594702138|FG000|Overall Study|Adverse Event|0|||
164638855|NCT00483119|594702139|FG001|Overall Study|Adverse Event|1|||
164638856|NCT00483119|594702138|FG000|Overall Study|Physician Decision|1|||
164638857|NCT00483119|594702139|FG001|Overall Study|Physician Decision|0|||
164638858|NCT04409509|594702140|FG000|Overall Study|Failure to meet randomization requirement|1|||
164638859|NCT04409509|594702141|FG001|Overall Study|Failure to meet randomization requirement|0|||
164638860|NCT04409509|594702140|FG000|Overall Study|Adverse Event|0|||
164638861|NCT04409509|594702141|FG001|Overall Study|Adverse Event|1|||
164638862|NCT04409509|594702140|FG000|Overall Study|Death|11|||
164638863|NCT04409509|594702141|FG001|Overall Study|Death|10|||
164638864|NCT04409509|594702140|FG000|Overall Study|Non-compliance with study drug|0|||
164638865|NCT04409509|594702141|FG001|Overall Study|Non-compliance with study drug|1|||
164638866|NCT04409509|594702140|FG000|Overall Study|Lost to Follow-up|0|||
164638867|NCT04409509|594702141|FG001|Overall Study|Lost to Follow-up|3|||
164638868|NCT04409509|594702140|FG000|Overall Study|Withdrawal by Subject|0|||
164638869|NCT04409509|594702141|FG001|Overall Study|Withdrawal by Subject|3|||
164638870|NCT04409509|594702140|FG000|Overall Study|Randomized by mistake|0|||
164638871|NCT04409509|594702141|FG001|Overall Study|Randomized by mistake|1|||
164638872|NCT04409509|594702140|FG000|Overall Study|Other|1|||
164638873|NCT04409509|594702141|FG001|Overall Study|Other|1|||
164638874|NCT04668066|594702142|FG000|Part 1: Treatment Phase|Adverse Event|0|||
164638875|NCT04668066|594702143|FG001|Part 1: Treatment Phase|Adverse Event|0|||
164638876|NCT04668066|594702144|FG002|Part 1: Treatment Phase|Adverse Event|0|||
164638877|NCT04668066|594702145|FG003|Part 1: Treatment Phase|Adverse Event|0|||
164638878|NCT04668066|594702146|FG004|Part 1: Treatment Phase|Adverse Event|0|||
164638879|NCT04668066|594702147|FG005|Part 1: Treatment Phase|Adverse Event|0|||
164638880|NCT04668066|594702148|FG006|Part 1: Treatment Phase|Adverse Event|0|||
164638881|NCT04668066|594702149|FG007|Part 1: Treatment Phase|Adverse Event|0|||
164638882|NCT04668066|594702150|FG008|Part 1: Treatment Phase|Adverse Event|0|||
164638883|NCT04668066|594702151|FG009|Part 1: Treatment Phase|Adverse Event|0|||
164638884|NCT04668066|594702152|FG010|Part 1: Treatment Phase|Adverse Event|0|||
164638885|NCT04668066|594702153|FG011|Part 1: Treatment Phase|Adverse Event|1|||
164638886|NCT04668066|594702154|FG012|Part 1: Treatment Phase|Adverse Event|1|||
164638887|NCT04668066|594702155|FG013|Part 1: Treatment Phase|Adverse Event|0|||
164638888|NCT04668066|594702156|FG014|Part 1: Treatment Phase|Adverse Event|0|||
164638889|NCT04668066|594702157|FG015|Part 1: Treatment Phase|Adverse Event|0|||
164638890|NCT04668066|594702158|FG016|Part 1: Treatment Phase|Adverse Event|0|||
164638891|NCT04668066|594702159|FG017|Part 1: Treatment Phase|Adverse Event|0|||
164638892|NCT04668066|594702160|FG018|Part 1: Treatment Phase|Adverse Event|0|||
164638893|NCT04668066|594702142|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
164638894|NCT04668066|594702143|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
164638895|NCT04668066|594702144|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
164638896|NCT04668066|594702145|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
164638897|NCT04668066|594702146|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
164638898|NCT04668066|594702147|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
164638899|NCT04668066|594702148|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
164638900|NCT04668066|594702149|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
164638901|NCT04668066|594702150|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
164638902|NCT04668066|594702151|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
164638903|NCT04668066|594702152|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
164638904|NCT04668066|594702153|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
164638905|NCT04668066|594702154|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
164638906|NCT04668066|594702155|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
164638907|NCT04668066|594702156|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
164638908|NCT04668066|594702157|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
164638909|NCT04668066|594702158|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
164638910|NCT04668066|594702159|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
164638911|NCT04668066|594702160|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
164638912|NCT04668066|594702142|FG000|Part 1: Treatment Phase|Other|0|||
164638913|NCT04668066|594702143|FG001|Part 1: Treatment Phase|Other|0|||
164638914|NCT04668066|594702144|FG002|Part 1: Treatment Phase|Other|0|||
164638915|NCT04668066|594702145|FG003|Part 1: Treatment Phase|Other|0|||
164638916|NCT04668066|594702146|FG004|Part 1: Treatment Phase|Other|0|||
164638917|NCT04668066|594702147|FG005|Part 1: Treatment Phase|Other|0|||
164638918|NCT04668066|594702148|FG006|Part 1: Treatment Phase|Other|0|||
164638919|NCT04668066|594702149|FG007|Part 1: Treatment Phase|Other|0|||
164638920|NCT04668066|594702150|FG008|Part 1: Treatment Phase|Other|0|||
164638921|NCT04668066|594702151|FG009|Part 1: Treatment Phase|Other|0|||
164638922|NCT04668066|594702152|FG010|Part 1: Treatment Phase|Other|0|||
164638923|NCT04668066|594702153|FG011|Part 1: Treatment Phase|Other|1|||
164638924|NCT04668066|594702154|FG012|Part 1: Treatment Phase|Other|0|||
164638925|NCT04668066|594702155|FG013|Part 1: Treatment Phase|Other|0|||
164638926|NCT04668066|594702156|FG014|Part 1: Treatment Phase|Other|0|||
164638927|NCT04668066|594702157|FG015|Part 1: Treatment Phase|Other|0|||
164638928|NCT04668066|594702158|FG016|Part 1: Treatment Phase|Other|0|||
164638929|NCT04668066|594702159|FG017|Part 1: Treatment Phase|Other|0|||
164638930|NCT04668066|594702160|FG018|Part 1: Treatment Phase|Other|0|||
164638931|NCT04668066|594702142|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164638932|NCT04668066|594702143|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164638933|NCT04668066|594702144|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164638934|NCT04668066|594702145|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164638935|NCT04668066|594702146|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164638936|NCT04668066|594702147|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164638937|NCT04668066|594702148|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164638938|NCT04668066|594702149|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164638939|NCT04668066|594702150|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164638940|NCT04668066|594702151|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164638941|NCT04668066|594702152|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164638942|NCT04668066|594702153|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164638943|NCT04668066|594702154|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
164638944|NCT04668066|594702155|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164638945|NCT04668066|594702156|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164638946|NCT04668066|594702157|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
164638947|NCT04668066|594702158|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164638948|NCT04668066|594702159|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164638949|NCT04668066|594702160|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164638950|NCT04668066|594702142|FG000|Part 1: Follow-Up|Adverse Event|0|||
164638951|NCT04668066|594702143|FG001|Part 1: Follow-Up|Adverse Event|0|||
164638952|NCT04668066|594702144|FG002|Part 1: Follow-Up|Adverse Event|0|||
164638953|NCT04668066|594702145|FG003|Part 1: Follow-Up|Adverse Event|0|||
164638954|NCT04668066|594702146|FG004|Part 1: Follow-Up|Adverse Event|0|||
164638955|NCT04668066|594702147|FG005|Part 1: Follow-Up|Adverse Event|0|||
164638956|NCT04668066|594702148|FG006|Part 1: Follow-Up|Adverse Event|0|||
164638957|NCT04668066|594702149|FG007|Part 1: Follow-Up|Adverse Event|0|||
164638958|NCT04668066|594702150|FG008|Part 1: Follow-Up|Adverse Event|0|||
164638959|NCT04668066|594702151|FG009|Part 1: Follow-Up|Adverse Event|0|||
164638960|NCT04668066|594702152|FG010|Part 1: Follow-Up|Adverse Event|0|||
164638961|NCT04668066|594702153|FG011|Part 1: Follow-Up|Adverse Event|1|||
164638962|NCT04668066|594702154|FG012|Part 1: Follow-Up|Adverse Event|0|||
164638963|NCT04668066|594702155|FG013|Part 1: Follow-Up|Adverse Event|0|||
164638964|NCT04668066|594702156|FG014|Part 1: Follow-Up|Adverse Event|0|||
164638965|NCT04668066|594702157|FG015|Part 1: Follow-Up|Adverse Event|0|||
164638966|NCT04668066|594702158|FG016|Part 1: Follow-Up|Adverse Event|0|||
164638967|NCT04668066|594702159|FG017|Part 1: Follow-Up|Adverse Event|0|||
164638968|NCT04668066|594702160|FG018|Part 1: Follow-Up|Adverse Event|0|||
164638969|NCT04668066|594702142|FG000|Part 1: Follow-Up|Other|0|||
164638970|NCT04668066|594702143|FG001|Part 1: Follow-Up|Other|0|||
164638971|NCT04668066|594702144|FG002|Part 1: Follow-Up|Other|0|||
164638972|NCT04668066|594702145|FG003|Part 1: Follow-Up|Other|0|||
164638973|NCT04668066|594702146|FG004|Part 1: Follow-Up|Other|0|||
164638974|NCT04668066|594702147|FG005|Part 1: Follow-Up|Other|0|||
164638975|NCT04668066|594702148|FG006|Part 1: Follow-Up|Other|0|||
164638976|NCT04668066|594702149|FG007|Part 1: Follow-Up|Other|0|||
164638977|NCT04668066|594702150|FG008|Part 1: Follow-Up|Other|0|||
164638978|NCT04668066|594702151|FG009|Part 1: Follow-Up|Other|0|||
164638979|NCT04668066|594702152|FG010|Part 1: Follow-Up|Other|0|||
164638980|NCT04668066|594702153|FG011|Part 1: Follow-Up|Other|1|||
164638981|NCT04668066|594702154|FG012|Part 1: Follow-Up|Other|1|||
164638982|NCT04668066|594702155|FG013|Part 1: Follow-Up|Other|0|||
164638983|NCT04668066|594702156|FG014|Part 1: Follow-Up|Other|0|||
164638984|NCT04668066|594702157|FG015|Part 1: Follow-Up|Other|0|||
164638985|NCT04668066|594702158|FG016|Part 1: Follow-Up|Other|0|||
164638986|NCT04668066|594702159|FG017|Part 1: Follow-Up|Other|0|||
164638987|NCT04668066|594702160|FG018|Part 1: Follow-Up|Other|0|||
164638988|NCT04668066|594702142|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
164638989|NCT04668066|594702143|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
164638990|NCT04668066|594702144|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
164638991|NCT04668066|594702145|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
164638992|NCT04668066|594702146|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
164638993|NCT04668066|594702147|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
164638994|NCT04668066|594702148|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
164638995|NCT04668066|594702149|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
164638996|NCT04668066|594702150|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
164638997|NCT04668066|594702151|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
164638998|NCT04668066|594702152|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
164638999|NCT04668066|594702153|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
164639000|NCT04668066|594702154|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
164639001|NCT04668066|594702155|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
164639002|NCT04668066|594702156|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
164639003|NCT04668066|594702157|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
164639004|NCT04668066|594702158|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
164639005|NCT04668066|594702159|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
164639006|NCT04668066|594702160|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
164639007|NCT04668066|594702142|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164639008|NCT04668066|594702143|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164639009|NCT04668066|594702144|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164639010|NCT04668066|594702145|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164639011|NCT04668066|594702146|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164639012|NCT04668066|594702147|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164639013|NCT04668066|594702148|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164639014|NCT04668066|594702149|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164639015|NCT04668066|594702150|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164639016|NCT04668066|594702151|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164639017|NCT04668066|594702152|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164639018|NCT04668066|594702153|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164639019|NCT04668066|594702154|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164639020|NCT04668066|594702155|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164639021|NCT04668066|594702156|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164639022|NCT04668066|594702157|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164639023|NCT04668066|594702158|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164639024|NCT04668066|594702159|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164639025|NCT04668066|594702160|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
164639026|NCT04668066|594702142|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
164639027|NCT04668066|594702143|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
164639028|NCT04668066|594702144|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
164639029|NCT04668066|594702145|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
164639030|NCT04668066|594702146|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
164639031|NCT04668066|594702147|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
164639032|NCT04668066|594702148|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
164639033|NCT04668066|594702149|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
164639034|NCT04668066|594702150|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
164530605|NCT00112047|594313789|FG000|Randomized Phase|Pregnancy|3|||
164530606|NCT00112047|594313790|FG001|Randomized Phase|Pregnancy|1|||
164530607|NCT00112047|594313789|FG000|Randomized Phase|Death|1|||
164530608|NCT00112047|594313790|FG001|Randomized Phase|Death|3|||
164530609|NCT00112047|594313789|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
164530610|NCT00112047|594313790|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
164530611|NCT00112047|594313789|FG000|Randomized Phase|Inability to swallow pills|0|||
164530612|NCT00112047|594313790|FG001|Randomized Phase|Inability to swallow pills|1|||
164530613|NCT00112047|594313789|FG000|Randomized Phase|Incarceration|3|||
164530614|NCT00112047|594313790|FG001|Randomized Phase|Incarceration|2|||
164530615|NCT00112047|594313789|FG000|Randomized Phase|Moved out of State|0|||
164530616|NCT00112047|594313790|FG001|Randomized Phase|Moved out of State|1|||
164530617|NCT00112047|594313789|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
164530618|NCT00112047|594313790|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
164530619|NCT00112047|594313789|FG000|Randomized Phase|High Hepatitis B DNA|0|||
164530620|NCT00112047|594313790|FG001|Randomized Phase|High Hepatitis B DNA|1|||
164530621|NCT00112047|594313789|FG000|Atripla Phase|Adverse Event|2|||
164530622|NCT00112047|594313790|FG001|Atripla Phase|Adverse Event|1|||
164530623|NCT00112047|594313789|FG000|Atripla Phase|Lost to Follow-up|5|||
164530624|NCT00112047|594313790|FG001|Atripla Phase|Lost to Follow-up|7|||
164530625|NCT00112047|594313789|FG000|Atripla Phase|Pregnancy|0|||
164530626|NCT00112047|594313790|FG001|Atripla Phase|Pregnancy|1|||
164530627|NCT00112047|594313789|FG000|Atripla Phase|Death|0|||
164530628|NCT00112047|594313790|FG001|Atripla Phase|Death|2|||
164530629|NCT00112047|594313789|FG000|Atripla Phase|Withdrew consent|7|||
164530630|NCT00112047|594313790|FG001|Atripla Phase|Withdrew consent|7|||
164530631|NCT00112047|594313789|FG000|Atripla Phase|Sub-optimal virological response|0|||
164530632|NCT00112047|594313790|FG001|Atripla Phase|Sub-optimal virological response|1|||
164530633|NCT00112047|594313789|FG000|Atripla Phase|Non-compliance|1|||
164530634|NCT00112047|594313790|FG001|Atripla Phase|Non-compliance|0|||
164530635|NCT00112047|594313789|FG000|Atripla Phase|Other|3|||
164530636|NCT00112047|594313790|FG001|Atripla Phase|Other|1|||
164530637|NCT01307579|594313791|FG000|Overall Study|Death|3|||
164530638|NCT01307579|594313792|FG001|Overall Study|Death|6|||
164530639|NCT01307579|594313791|FG000|Overall Study|Physician Decision|26|||
164530640|NCT01307579|594313792|FG001|Overall Study|Physician Decision|29|||
164530641|NCT01307579|594313791|FG000|Overall Study|Withdrawal by Subject|7|||
164530642|NCT01307579|594313792|FG001|Overall Study|Withdrawal by Subject|3|||
164530643|NCT01307579|594313791|FG000|Overall Study|Institutional diagnosis of IFD|21|||
164530644|NCT01307579|594313792|FG001|Overall Study|Institutional diagnosis of IFD|36|||
164530645|NCT01307579|594313791|FG000|Overall Study|Begin conditioning for HSCT|42|||
164530646|NCT01307579|594313792|FG001|Overall Study|Begin conditioning for HSCT|44|||
164530647|NCT01307579|594313791|FG000|Overall Study|Refractory or relapsed AML|38|||
164530648|NCT01307579|594313792|FG001|Overall Study|Refractory or relapsed AML|23|||
164530649|NCT01307579|594313791|FG000|Overall Study|Ineligible|3|||
164530650|NCT01307579|594313792|FG001|Overall Study|Ineligible|4|||
164530651|NCT03727438|594313798|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
164530652|NCT03727438|594313799|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
164530653|NCT03727438|594313798|FG000|Intervention Period|Excluded (health)|1|||
164530654|NCT03727438|594313799|FG001|Intervention Period|Excluded (health)|0|||
164530655|NCT03727438|594313798|FG000|Intervention Period|Withdrawal by Subject|3|||
164530656|NCT03727438|594313799|FG001|Intervention Period|Withdrawal by Subject|1|||
164530657|NCT03727438|594313798|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
164530658|NCT03727438|594313799|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
164530659|NCT03727438|594313798|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
164530660|NCT03727438|594313799|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
164530661|NCT03727438|594313798|FG000|8 Week Assessment|Withdrawal by Subject|6|||
164530662|NCT03727438|594313799|FG001|8 Week Assessment|Withdrawal by Subject|1|||
164530663|NCT03727438|594313798|FG000|6 mo Assessment|did not complete assessment|10|||
164530664|NCT03727438|594313799|FG001|6 mo Assessment|did not complete assessment|11|||
164530665|NCT06729606|594313800|FG000|Overall Study|Adverse Event|0|||
164530666|NCT06729606|594313801|FG001|Overall Study|Adverse Event|2|||
164530667|NCT06729606|594313800|FG000|Overall Study|Death|1|||
164530668|NCT06729606|594313801|FG001|Overall Study|Death|0|||
164530669|NCT06729606|594313800|FG000|Overall Study|Physician Decision|0|||
164530670|NCT06729606|594313801|FG001|Overall Study|Physician Decision|1|||
164530671|NCT06729606|594313800|FG000|Overall Study|Withdrawal by Subject|2|||
164530672|NCT06729606|594313801|FG001|Overall Study|Withdrawal by Subject|4|||
164530673|NCT04873232|594313802|FG000|Overall Study|Lost to Follow-up|1|||
164530674|NCT04873232|594313803|FG001|Overall Study|Lost to Follow-up|4|||
164530675|NCT04873232|594313802|FG000|Overall Study|Withdrawal by Subject|1|||
164639035|NCT04668066|594702151|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
164639036|NCT04668066|594702152|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
164639037|NCT04668066|594702153|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
164639038|NCT04668066|594702154|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
164639039|NCT04668066|594702155|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
164530676|NCT04873232|594313803|FG001|Overall Study|Withdrawal by Subject|0|||
164530677|NCT03170349|594313810|FG000|At 30 Days Follow-up (±7 Days Window)|Death|1|||
164530678|NCT03170349|594313810|FG000|At 6 Months Follow-up (±30 Days Window)|Death|3|||
164530679|NCT03170349|594313810|FG000|At 6 Months Follow-up (±30 Days Window)|Withdrawal by Subject|1|||
164530680|NCT03170349|594313810|FG000|At 6 Months Follow-up (±30 Days Window)|Exited for Other Reasons|5|||
164530681|NCT03170349|594313810|FG000|At 1 Year Follow-up (±45 Days Window)|Death|6|||
164530682|NCT03170349|594313810|FG000|At 1 Year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
164530683|NCT03170349|594313810|FG000|At 2 Year Follow-up (±45 Days Window)|Death|13|||
164530684|NCT03170349|594313810|FG000|At 2 Year Follow-up (±45 Days Window)|Withdrawal by Subject|1|||
164530685|NCT03170349|594313810|FG000|At 2 Year Follow-up (±45 Days Window)|Missed Visit|4|||
164530686|NCT03170349|594313810|FG000|At 3 Year Follow-up (±45 Days Window)|Death|10|||
164530687|NCT03170349|594313810|FG000|At 3 Year Follow-up (±45 Days Window)|Lost to Follow-up|2|||
164530688|NCT03170349|594313810|FG000|At 3 Year Follow-up (±45 Days Window)|Withdrawal by Subject|2|||
164530689|NCT03170349|594313810|FG000|At 3 Year Follow-up (±45 Days Window)|Missed Visit|2|||
164530690|NCT03170349|594313810|FG000|At 4-year Follow-up (±45 Days Window)|Death|13|||
164530691|NCT03170349|594313810|FG000|At 4-year Follow-up (±45 Days Window)|Missed Visit|2|||
164530692|NCT03170349|594313810|FG000|At 4-year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
164530693|NCT02101034|594315403|FG000|Overall Study|Enrolled but did not start treatment|0|||
164530694|NCT02101034|594315404|FG001|Overall Study|Enrolled but did not start treatment|0|||
164530695|NCT02101034|594315405|FG002|Overall Study|Enrolled but did not start treatment|1|||
164530696|NCT02101034|594315406|FG003|Overall Study|Enrolled but did not start treatment|0|||
164530697|NCT02101034|594315407|FG004|Overall Study|Enrolled but did not start treatment|0|||
164530698|NCT00081770|594315408|FG000|Overall Study|Adverse Event|130|||
164530699|NCT00081770|594315409|FG001|Overall Study|Adverse Event|98|||
164530700|NCT00081770|594315410|FG002|Overall Study|Adverse Event|136|||
164530701|NCT00081770|594315408|FG000|Overall Study|Lack of Efficacy|262|||
164530702|NCT00081770|594315409|FG001|Overall Study|Lack of Efficacy|357|||
164530703|NCT00081770|594315410|FG002|Overall Study|Lack of Efficacy|211|||
164530704|NCT00081770|594315408|FG000|Overall Study|Lost to Follow-up|45|||
164530705|NCT00081770|594315409|FG001|Overall Study|Lost to Follow-up|34|||
164530706|NCT00081770|594315410|FG002|Overall Study|Lost to Follow-up|45|||
164530707|NCT00081770|594315408|FG000|Overall Study|Protocol Violation|15|||
164530708|NCT00081770|594315409|FG001|Overall Study|Protocol Violation|10|||
164530709|NCT00081770|594315410|FG002|Overall Study|Protocol Violation|10|||
164530710|NCT00081770|594315408|FG000|Overall Study|Withdrawal by Subject|45|||
164530711|NCT00081770|594315409|FG001|Overall Study|Withdrawal by Subject|40|||
164530712|NCT00081770|594315410|FG002|Overall Study|Withdrawal by Subject|42|||
164530713|NCT00081770|594315408|FG000|Overall Study|Did not meet protocol eligibility|2|||
164530714|NCT00081770|594315409|FG001|Overall Study|Did not meet protocol eligibility|0|||
164530715|NCT00081770|594315410|FG002|Overall Study|Did not meet protocol eligibility|3|||
164530716|NCT00081770|594315408|FG000|Overall Study|Administrative|1|||
164530717|NCT00081770|594315409|FG001|Overall Study|Administrative|0|||
164530718|NCT00081770|594315410|FG002|Overall Study|Administrative|1|||
164530719|NCT00081770|594315408|FG000|Overall Study|Other|2|||
164530720|NCT00081770|594315409|FG001|Overall Study|Other|7|||
164530721|NCT00081770|594315410|FG002|Overall Study|Other|8|||
164530722|NCT03435497|594315412|FG000|Overall Study|Lost to Follow-up|1|||
164530723|NCT03435497|594315413|FG001|Overall Study|Lost to Follow-up|0|||
164530724|NCT03435497|594315412|FG000|Overall Study|Death|1|||
164530725|NCT03435497|594315413|FG001|Overall Study|Death|0|||
164530726|NCT03435497|594315412|FG000|Overall Study|Withdrawal by Subject|0|||
164530727|NCT03435497|594315413|FG001|Overall Study|Withdrawal by Subject|4|||
164530728|NCT03435497|594315412|FG000|Overall Study|Wrong survey administered|0|||
164530729|NCT03435497|594315413|FG001|Overall Study|Wrong survey administered|2|||
164530730|NCT01072877|594315414|FG000|Overall Study|Lost to Follow-up|1|||
164530731|NCT01072877|594315415|FG001|Overall Study|Lost to Follow-up|1|||
164530732|NCT01072877|594315416|FG002|Overall Study|Lost to Follow-up|0|||
164530733|NCT01072877|594315417|FG003|Overall Study|Lost to Follow-up|2|||
164530734|NCT01072877|594315418|FG004|Overall Study|Lost to Follow-up|0|||
164530735|NCT00601419|594315419|FG000|Overall Study|Lost to Follow-up|3|||
164530736|NCT00601419|594315419|FG000|Overall Study|Missed Visits|1|||
164530737|NCT00995020|594315428|FG000|Overall Study|margin analysis not performed|2|||
164530738|NCT00995020|594315429|FG001|Overall Study|margin analysis not performed|5|||
164530739|NCT00995020|594315428|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
164530740|NCT00995020|594315429|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
164530741|NCT01614197|594315430|FG000|Overall Study|Withdrawal by Subject|0|||
164530742|NCT01614197|594315431|FG001|Overall Study|Withdrawal by Subject|1|||
164530743|NCT01614197|594315432|FG002|Overall Study|Withdrawal by Subject|0|||
164639040|NCT04668066|594702156|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
164639041|NCT04668066|594702157|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
164639042|NCT04668066|594702158|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
164639043|NCT04668066|594702159|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
164639044|NCT04668066|594702160|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
164639045|NCT04668066|594702142|FG000|Part 2: Treatment Phase|Other|0|||
164639046|NCT04668066|594702143|FG001|Part 2: Treatment Phase|Other|0|||
164639047|NCT04668066|594702144|FG002|Part 2: Treatment Phase|Other|0|||
164639048|NCT04668066|594702145|FG003|Part 2: Treatment Phase|Other|0|||
164639049|NCT04668066|594702146|FG004|Part 2: Treatment Phase|Other|0|||
164639050|NCT04668066|594702147|FG005|Part 2: Treatment Phase|Other|0|||
164639051|NCT04668066|594702148|FG006|Part 2: Treatment Phase|Other|0|||
164639052|NCT04668066|594702149|FG007|Part 2: Treatment Phase|Other|0|||
164639053|NCT04668066|594702150|FG008|Part 2: Treatment Phase|Other|0|||
164639054|NCT04668066|594702151|FG009|Part 2: Treatment Phase|Other|0|||
164639055|NCT04668066|594702152|FG010|Part 2: Treatment Phase|Other|0|||
164639056|NCT04668066|594702153|FG011|Part 2: Treatment Phase|Other|0|||
164639057|NCT04668066|594702154|FG012|Part 2: Treatment Phase|Other|0|||
164639058|NCT04668066|594702155|FG013|Part 2: Treatment Phase|Other|0|||
164639059|NCT04668066|594702156|FG014|Part 2: Treatment Phase|Other|0|||
164639060|NCT04668066|594702157|FG015|Part 2: Treatment Phase|Other|0|||
164639061|NCT04668066|594702158|FG016|Part 2: Treatment Phase|Other|0|||
164639062|NCT04668066|594702159|FG017|Part 2: Treatment Phase|Other|0|||
164639063|NCT04668066|594702160|FG018|Part 2: Treatment Phase|Other|1|||
164639064|NCT04668066|594702142|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
164639065|NCT04668066|594702143|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
164639066|NCT04668066|594702144|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
164639067|NCT04668066|594702145|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
164639068|NCT04668066|594702146|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
164639069|NCT04668066|594702147|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
164639070|NCT04668066|594702148|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
164639071|NCT04668066|594702149|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
164639072|NCT04668066|594702150|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
164639073|NCT04668066|594702151|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
164639074|NCT04668066|594702152|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
164639075|NCT04668066|594702153|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
164639076|NCT04668066|594702154|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
164639077|NCT04668066|594702155|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
164639078|NCT04668066|594702156|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
164639079|NCT04668066|594702157|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
164639080|NCT04668066|594702158|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
164639081|NCT04668066|594702159|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
164639082|NCT04668066|594702160|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
164639083|NCT02369874|594702161|FG000|Overall Study|Lost to Follow-up|2|||
164639084|NCT02369874|594702162|FG001|Overall Study|Lost to Follow-up|2|||
164639085|NCT02369874|594702163|FG002|Overall Study|Lost to Follow-up|2|||
164639086|NCT02369874|594702161|FG000|Overall Study|Withdrawal by Subject|7|||
164639087|NCT02369874|594702162|FG001|Overall Study|Withdrawal by Subject|9|||
164639088|NCT02369874|594702163|FG002|Overall Study|Withdrawal by Subject|27|||
164639089|NCT02369874|594702161|FG000|Overall Study|Miscellaneous|1|||
164639090|NCT02369874|594702162|FG001|Overall Study|Miscellaneous|1|||
164639091|NCT02369874|594702163|FG002|Overall Study|Miscellaneous|0|||
164639092|NCT02369874|594702161|FG000|Overall Study|On Treatment/Off Study|34|||
164639093|NCT02369874|594702162|FG001|Overall Study|On Treatment/Off Study|45|||
164639094|NCT02369874|594702163|FG002|Overall Study|On Treatment/Off Study|32|||
164639095|NCT02331680|594702164|FG000|Overall Study|Adverse Event|3|||
164639096|NCT02331680|594702165|FG001|Overall Study|Adverse Event|0|||
164639097|NCT02331680|594702166|FG002|Overall Study|Adverse Event|2|||
164639098|NCT02331680|594702164|FG000|Overall Study|Physician Decision|1|||
164639099|NCT02331680|594702165|FG001|Overall Study|Physician Decision|1|||
164639100|NCT02331680|594702166|FG002|Overall Study|Physician Decision|2|||
164639101|NCT02331680|594702164|FG000|Overall Study|Withdrawal by Subject|0|||
164639102|NCT02331680|594702165|FG001|Overall Study|Withdrawal by Subject|1|||
164639103|NCT02331680|594702166|FG002|Overall Study|Withdrawal by Subject|2|||
164639104|NCT02331680|594702164|FG000|Overall Study|Met withdrawal criteria|2|||
164639105|NCT02331680|594702165|FG001|Overall Study|Met withdrawal criteria|2|||
164639106|NCT02331680|594702166|FG002|Overall Study|Met withdrawal criteria|5|||
164639107|NCT02331680|594702164|FG000|Overall Study|Non-compliance with study drug|0|||
164639108|NCT02331680|594702165|FG001|Overall Study|Non-compliance with study drug|0|||
164639109|NCT02331680|594702166|FG002|Overall Study|Non-compliance with study drug|1|||
164639110|NCT02331680|594702164|FG000|Overall Study|Protocol Violation|0|||
164639111|NCT02331680|594702165|FG001|Overall Study|Protocol Violation|0|||
164639112|NCT02331680|594702166|FG002|Overall Study|Protocol Violation|3|||
164639113|NCT00596466|594702167|FG000|Overall Study|Lack of Efficacy|5|||
164639114|NCT00596466|594702167|FG000|Overall Study|Adverse Event|4|||
164639115|NCT00596466|594702167|FG000|Overall Study|Withdrawal by Subject|2|||
164639116|NCT00596466|594702167|FG000|Overall Study|Protocol Violation|2|||
164639117|NCT00596466|594702167|FG000|Overall Study|Unpecified|2|||
164639118|NCT00596466|594702167|FG000|Overall Study|Enrolled, not treated|2|||
164639119|NCT04505592|594702168|FG000|Overall Study|Death|2|||
164639120|NCT04505592|594702169|FG001|Overall Study|Death|1|||
164639121|NCT04479358|594702172|FG000|Overall Study|Withdrawal by Subject|0|||
164639122|NCT04479358|594702173|FG001|Overall Study|Withdrawal by Subject|0|||
164639123|NCT04479358|594702174|FG002|Overall Study|Withdrawal by Subject|1|||
164639124|NCT04479358|594702175|FG003|Overall Study|Withdrawal by Subject|0|||
164639125|NCT04479358|594702176|FG004|Overall Study|Withdrawal by Subject|0|||
164639126|NCT04479358|594702177|FG005|Overall Study|Withdrawal by Subject|1|||
164639127|NCT01958619|594702195|FG000|Overall Study|Protocol Violation|2|||
164639128|NCT01958619|594702196|FG001|Overall Study|Protocol Violation|0|||
164639129|NCT01958619|594702197|FG002|Overall Study|Protocol Violation|1|||
164639130|NCT01958619|594702198|FG003|Overall Study|Protocol Violation|0|||
164639131|NCT03795233|594702199|FG000|Overall Study|Withdrawal by Subject|2|||
164639132|NCT03795233|594702200|FG001|Overall Study|Withdrawal by Subject|1|||
164639133|NCT03795233|594702199|FG000|Overall Study|Lost to Follow-up|1|||
164639134|NCT03795233|594702200|FG001|Overall Study|Lost to Follow-up|0|||
164639135|NCT03795233|594702199|FG000|Overall Study|Death|1|||
164639136|NCT03795233|594702200|FG001|Overall Study|Death|0|||
164639137|NCT02756182|594702201|FG000|Overall Study|StudyTechnical Difficulties|4|||
164639138|NCT01965600|594702205|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
164639139|NCT01965600|594702206|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
164639140|NCT01965600|594702207|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
164639141|NCT01965600|594702208|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
164639142|NCT01965600|594702205|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
164639143|NCT01965600|594702206|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
164639144|NCT01965600|594702207|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
164639145|NCT01965600|594702208|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
164639146|NCT01965600|594702205|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
164639147|NCT01965600|594702206|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
164639148|NCT01965600|594702207|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
164639149|NCT01965600|594702208|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
164639150|NCT01965600|594702205|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
164639151|NCT01965600|594702206|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
164639152|NCT01965600|594702207|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
164639153|NCT01965600|594702208|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
164639154|NCT01965600|594702205|FG000|Second Intervention|Study terminated by Sponsor|0|||
164639155|NCT01965600|594702206|FG001|Second Intervention|Study terminated by Sponsor|0|||
164639156|NCT01965600|594702207|FG002|Second Intervention|Study terminated by Sponsor|2|||
164639157|NCT01965600|594702208|FG003|Second Intervention|Study terminated by Sponsor|2|||
164639158|NCT01100073|594703629|FG000|Overall Study|Lack of Efficacy|4|||
164639159|NCT01100073|594703629|FG000|Overall Study|Insufficient Tolerability|21|||
164639160|NCT01100073|594703629|FG000|Overall Study|Withdrawal by Subject|13|||
164639161|NCT01100073|594703629|FG000|Overall Study|Lost to Follow-up|39|||
164639162|NCT01100073|594703629|FG000|Overall Study|Lack of effect + patient's wish|2|||
164639163|NCT01100073|594703629|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
164639164|NCT01100073|594703629|FG000|Overall Study|Other|8|||
164639165|NCT01100073|594703629|FG000|Overall Study|Missing|5|||
164639166|NCT00299546|594703630|FG000|Overall Study|Death|3|||
164639167|NCT00299546|594703631|FG001|Overall Study|Death|2|||
164639168|NCT00299546|594703632|FG002|Overall Study|Death|0|||
164639169|NCT00299546|594703630|FG000|Overall Study|Lost to Follow-up|2|||
164639170|NCT00299546|594703631|FG001|Overall Study|Lost to Follow-up|2|||
164639171|NCT00299546|594703632|FG002|Overall Study|Lost to Follow-up|5|||
164639172|NCT00299546|594703630|FG000|Overall Study|Adverse Event|37|||
164639173|NCT00299546|594703631|FG001|Overall Study|Adverse Event|22|||
164639174|NCT00299546|594703632|FG002|Overall Study|Adverse Event|27|||
164639175|NCT00299546|594703630|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
164639176|NCT00299546|594703631|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
164639177|NCT00299546|594703632|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
164639178|NCT00299546|594703630|FG000|Overall Study|Other|24|||
164639179|NCT00299546|594703631|FG001|Overall Study|Other|26|||
164639180|NCT00299546|594703632|FG002|Overall Study|Other|19|||
164639181|NCT00299546|594703630|FG000|Overall Study|Not treated|0|||
164639182|NCT00299546|594703631|FG001|Overall Study|Not treated|1|||
164639183|NCT00299546|594703632|FG002|Overall Study|Not treated|1|||
164639184|NCT03099265|594703633|FG000|Overall Study|Adverse Event|1|||
164639185|NCT01656850|594703641|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
164639186|NCT01656850|594703642|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
164639187|NCT00396318|594703643|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
164639188|NCT00326118|594703644|FG000|Active Phase|Withdrawal by Subject|4|||
164639189|NCT00326118|594703645|FG001|Active Phase|Withdrawal by Subject|1|||
164639190|NCT00602927|594703646|FG000|Period 1: 13 Days|Protocol Violation|2|||
164639191|NCT00602927|594703647|FG001|Period 1: 13 Days|Protocol Violation|4|||
164639192|NCT00602927|594703646|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
164639193|NCT00602927|594703647|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
164639194|NCT00602927|594703646|FG000|Period 1: 13 Days|Time|1|||
164639195|NCT00602927|594703647|FG001|Period 1: 13 Days|Time|0|||
164639196|NCT00602927|594703646|FG000|Period 1: 13 Days|Claustrophobia|0|||
164639197|NCT00602927|594703647|FG001|Period 1: 13 Days|Claustrophobia|1|||
164639198|NCT00602927|594703646|FG000|Period 2: 14 Days|Protocol Violation|0|||
164639199|NCT00602927|594703647|FG001|Period 2: 14 Days|Protocol Violation|2|||
164639200|NCT00602927|594703646|FG000|Period 3: 13 Days|Protocol Violation|0|||
164639201|NCT00602927|594703647|FG001|Period 3: 13 Days|Protocol Violation|1|||
164639202|NCT00602927|594703646|FG000|Period 3: 13 Days|MRI data quality|2|||
164639203|NCT00602927|594703647|FG001|Period 3: 13 Days|MRI data quality|2|||
164639204|NCT00630994|594703648|FG000|Overall Study|Adverse Event|1|||
164639205|NCT00630994|594703648|FG000|Overall Study|Disease Progression|1|||
164639206|NCT00630994|594703648|FG000|Overall Study|Lack of Efficacy|1|||
164639207|NCT00630994|594703648|FG000|Overall Study|Other|1|||
164639208|NCT05553600|594703651|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
164639209|NCT05553600|594703652|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
164639210|NCT05553600|594703653|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
164639211|NCT05553600|594703654|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
164639212|NCT05553600|594703651|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
164639213|NCT05553600|594703652|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
164639214|NCT05553600|594703653|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
164639215|NCT05553600|594703654|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
164530744|NCT01614197|594315433|FG003|Overall Study|Withdrawal by Subject|0|||
164530745|NCT04281004|594315436|FG000|Overall Study|Physician Decision|1|||
164530746|NCT04281004|594315437|FG001|Overall Study|Physician Decision|0|||
164530747|NCT00701779|594315438|FG000|Overall Study|Adverse Event|6|||
164530748|NCT00701779|594315438|FG000|Overall Study|Lost to Follow-up|1|||
164530749|NCT00701779|594315438|FG000|Overall Study|Withdrawal by Subject|2|||
164530750|NCT02245672|594315439|FG000|Overall Study|Adverse Event|4|||
164530751|NCT02245672|594315440|FG001|Overall Study|Adverse Event|4|||
164530752|NCT02245672|594315441|FG002|Overall Study|Adverse Event|4|||
164530753|NCT02245672|594315439|FG000|Overall Study|Lost to Follow-up|3|||
164530754|NCT02245672|594315440|FG001|Overall Study|Lost to Follow-up|5|||
164530755|NCT02245672|594315441|FG002|Overall Study|Lost to Follow-up|1|||
164530756|NCT02245672|594315439|FG000|Overall Study|Withdrawal by Subject|6|||
164530757|NCT02245672|594315440|FG001|Overall Study|Withdrawal by Subject|3|||
164530758|NCT02245672|594315441|FG002|Overall Study|Withdrawal by Subject|0|||
164530759|NCT02245672|594315439|FG000|Overall Study|Randomized in error (not treated)|0|||
164530760|NCT02245672|594315440|FG001|Overall Study|Randomized in error (not treated)|1|||
164530761|NCT02245672|594315441|FG002|Overall Study|Randomized in error (not treated)|0|||
164530762|NCT01217957|594315444|FG000|Phase 1|Withdrawal by Patient|1|||
164530763|NCT01217957|594315445|FG001|Phase 1|Withdrawal by Patient|0|||
164530764|NCT01217957|594315446|FG002|Phase 1|Withdrawal by Patient|1|||
164530765|NCT01217957|594315447|FG003|Phase 1|Withdrawal by Patient|1|||
164530766|NCT01217957|594315448|FG004|Phase 1|Withdrawal by Patient|0|||
164530767|NCT01217957|594315444|FG000|Phase 2|Withdrawal by Patient|0|||
164530768|NCT01217957|594315445|FG001|Phase 2|Withdrawal by Patient|0|||
164530769|NCT01217957|594315446|FG002|Phase 2|Withdrawal by Patient|0|||
164530770|NCT01217957|594315447|FG003|Phase 2|Withdrawal by Patient|0|||
164530771|NCT01217957|594315448|FG004|Phase 2|Withdrawal by Patient|1|||
164530772|NCT00971932|594315449|FG000|Overall Study|Withdrawal by Subject|1|||
164530773|NCT00971932|594315449|FG000|Overall Study|Investigator's decision|2|||
164530774|NCT00971932|594315449|FG000|Overall Study|Ongoing|4|||
164530775|NCT01640054|594315450|FG000|Overall Study|Study-specific disc criteria|1|||
164530776|NCT01640054|594315450|FG000|Overall Study|Lack of Efficacy|3|||
164530777|NCT01640054|594315450|FG000|Overall Study|Adverse Event|2|||
164530778|NCT01206777|594315453|FG000|Overall Study|Death|1|||
164530779|NCT01206777|594315453|FG000|Overall Study|Adverse Event|1|||
164530780|NCT00876694|594315454|FG000|Overall Study|Adverse Event|10|||
164639216|NCT05553600|594703651|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
164639217|NCT05553600|594703652|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
164639218|NCT05553600|594703653|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
164639219|NCT05553600|594703654|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
164530781|NCT00876694|594315455|FG001|Overall Study|Adverse Event|7|||
164530782|NCT00876694|594315454|FG000|Overall Study|Subject withdrew consent|6|||
164530783|NCT00876694|594315455|FG001|Overall Study|Subject withdrew consent|4|||
164530784|NCT00876694|594315454|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164639220|NCT05553600|594703651|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
164639221|NCT05553600|594703652|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
164639222|NCT05553600|594703653|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
164639223|NCT05553600|594703654|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
164639224|NCT05553600|594703651|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
164639225|NCT05553600|594703652|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
164639226|NCT05553600|594703653|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
164639227|NCT05553600|594703654|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
164639228|NCT05553600|594703651|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
164639229|NCT05553600|594703652|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
164639230|NCT05553600|594703653|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
164639231|NCT05553600|594703654|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
164639232|NCT05553600|594703651|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
164639233|NCT05553600|594703652|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
164639234|NCT05553600|594703653|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
164639235|NCT05553600|594703654|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
164639236|NCT05553600|594703651|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
164639237|NCT05553600|594703652|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
164639238|NCT05553600|594703653|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
164639239|NCT05553600|594703654|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
164639240|NCT05553600|594703651|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
164639241|NCT05553600|594703652|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
164639242|NCT05553600|594703653|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
164639243|NCT05553600|594703654|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
164639244|NCT05553600|594703651|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
164639245|NCT05553600|594703652|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
164639246|NCT05553600|594703653|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
164639247|NCT05553600|594703654|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
164639248|NCT05553600|594703651|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
164639249|NCT05553600|594703652|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
164639250|NCT05553600|594703653|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
164639251|NCT05553600|594703654|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
164639252|NCT05553600|594703651|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
164639253|NCT05553600|594703652|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
164639254|NCT05553600|594703653|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
164639255|NCT05553600|594703654|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
164639256|NCT05027958|594703657|FG000|Overall Study|Lost to Follow-up|1|||
164639257|NCT05027958|594703658|FG001|Overall Study|Lost to Follow-up|1|||
164639258|NCT05027958|594703657|FG000|Overall Study|Non-compliance (missed one or more study visits)|1|||
164639259|NCT05027958|594703658|FG001|Overall Study|Non-compliance (missed one or more study visits)|0|||
164639260|NCT05027958|594703657|FG000|Overall Study|Physician Decision|1|||
164639261|NCT05027958|594703658|FG001|Overall Study|Physician Decision|4|||
164639262|NCT05027958|594703657|FG000|Overall Study|Adverse Event|0|||
164639263|NCT05027958|594703658|FG001|Overall Study|Adverse Event|1|||
164639264|NCT03155269|594703659|FG000|Overall Study|Withdrawal by Subject|4|||
164639265|NCT03155269|594703660|FG001|Overall Study|Withdrawal by Subject|5|||
164639266|NCT03155269|594703659|FG000|Overall Study|Lost to Follow-up|1|||
164639267|NCT03155269|594703660|FG001|Overall Study|Lost to Follow-up|2|||
164639268|NCT02871921|594703661|FG000|Overall Study|Withdrawal by Subject|34|||
164639269|NCT02871921|594703662|FG001|Overall Study|Withdrawal by Subject|27|||
164639270|NCT02871921|594703663|FG002|Overall Study|Withdrawal by Subject|27|||
164639271|NCT02871921|594703664|FG003|Overall Study|Withdrawal by Subject|30|||
164639272|NCT00910000|594703665|FG000|Overall Study|Adverse Event|0|||
164639273|NCT00910000|594703666|FG001|Overall Study|Adverse Event|3|||
164639274|NCT00910000|594703667|FG002|Overall Study|Adverse Event|2|||
164639275|NCT00910000|594703668|FG003|Overall Study|Adverse Event|2|||
164639276|NCT00910000|594703669|FG004|Overall Study|Adverse Event|0|||
164639277|NCT00910000|594703670|FG005|Overall Study|Adverse Event|1|||
164639278|NCT00910000|594703665|FG000|Overall Study|Withdrawal by Subject|0|||
164639279|NCT00910000|594703666|FG001|Overall Study|Withdrawal by Subject|0|||
164639280|NCT00910000|594703667|FG002|Overall Study|Withdrawal by Subject|1|||
164639281|NCT00910000|594703668|FG003|Overall Study|Withdrawal by Subject|0|||
164639282|NCT00910000|594703669|FG004|Overall Study|Withdrawal by Subject|1|||
164639283|NCT00910000|594703670|FG005|Overall Study|Withdrawal by Subject|0|||
164639284|NCT00337727|594703672|FG000|Overall Study|Adverse Event|5|||
164639285|NCT00337727|594703673|FG001|Overall Study|Adverse Event|3|||
164639286|NCT00337727|594703672|FG000|Overall Study|Lost to Follow-up|5|||
164639287|NCT00337727|594703673|FG001|Overall Study|Lost to Follow-up|4|||
164639288|NCT00337727|594703672|FG000|Overall Study|Physician Decision|1|||
164639289|NCT00337727|594703673|FG001|Overall Study|Physician Decision|0|||
164639290|NCT00337727|594703672|FG000|Overall Study|Protocol Violation|4|||
164639291|NCT00337727|594703673|FG001|Overall Study|Protocol Violation|0|||
164639292|NCT00337727|594703672|FG000|Overall Study|Withdrawal by Subject|3|||
164639293|NCT00337727|594703673|FG001|Overall Study|Withdrawal by Subject|5|||
164639294|NCT04456998|594703684|FG000|Overall Study|Adverse Event|0|||
164639295|NCT04456998|594703685|FG001|Overall Study|Adverse Event|4|||
164639296|NCT04456998|594703684|FG000|Overall Study|Protocol Deviation|0|||
164639297|NCT04456998|594703685|FG001|Overall Study|Protocol Deviation|1|||
164639298|NCT04456998|594703684|FG000|Overall Study|Withdrawal by Subject|0|||
164639299|NCT04456998|594703685|FG001|Overall Study|Withdrawal by Subject|1|||
164639300|NCT03707145|594703689|FG000|Overall Study|Lost to Follow-up|0|||
164639301|NCT03707145|594703690|FG001|Overall Study|Lost to Follow-up|1|||
164639302|NCT03707145|594703691|FG002|Overall Study|Lost to Follow-up|1|||
164639303|NCT03707145|594703692|FG003|Overall Study|Lost to Follow-up|0|||
164639304|NCT04221477|594703693|FG000|Overall Study|Adverse Event|1|||
164639305|NCT04221477|594703694|FG001|Overall Study|Adverse Event|1|||
164639306|NCT04221477|594703693|FG000|Overall Study|Death|5|||
164639307|NCT04221477|594703694|FG001|Overall Study|Death|4|||
164639308|NCT04221477|594703693|FG000|Overall Study|Lack of Efficacy|1|||
164639309|NCT04221477|594703694|FG001|Overall Study|Lack of Efficacy|2|||
164639310|NCT04221477|594703693|FG000|Overall Study|Lost to Follow-up|1|||
164639311|NCT04221477|594703694|FG001|Overall Study|Lost to Follow-up|2|||
164639312|NCT04221477|594703693|FG000|Overall Study|Non-compliance with Study Drug|1|||
164639313|NCT04221477|594703694|FG001|Overall Study|Non-compliance with Study Drug|0|||
164639314|NCT04221477|594703693|FG000|Overall Study|Reason not Specified|0|||
164639315|NCT04221477|594703694|FG001|Overall Study|Reason not Specified|5|||
164639316|NCT04221477|594703693|FG000|Overall Study|Physician Decision|0|||
164639317|NCT04221477|594703694|FG001|Overall Study|Physician Decision|6|||
164639318|NCT04221477|594703693|FG000|Overall Study|Withdrawal by Subject|10|||
164639319|NCT04221477|594703694|FG001|Overall Study|Withdrawal by Subject|14|||
164639320|NCT04221477|594703693|FG000|Overall Study|Ongoing in the Study|116|||
164639321|NCT04221477|594703694|FG001|Overall Study|Ongoing in the Study|102|||
164639322|NCT04784455|594703695|FG000|Overall Study|Death|4|||
164639323|NCT04882085|594703696|FG000|Overall Study|Death|6|||
164639324|NCT04882085|594703697|FG001|Overall Study|Death|9|||
164639325|NCT04882085|594703696|FG000|Overall Study|Withdrawal by Subject|0|||
164639326|NCT04882085|594703697|FG001|Overall Study|Withdrawal by Subject|3|||
164639327|NCT04882085|594703696|FG000|Overall Study|Randomized not treated|1|||
164639328|NCT04882085|594703697|FG001|Overall Study|Randomized not treated|0|||
164639329|NCT04455620|594703698|FG000|Overall Study|Withdrawal by Subject|0|||
164639330|NCT04455620|594703699|FG001|Overall Study|Withdrawal by Subject|0|||
164639331|NCT04455620|594703700|FG002|Overall Study|Withdrawal by Subject|2|||
164639332|NCT04455620|594703701|FG003|Overall Study|Withdrawal by Subject|0|||
164639333|NCT04455620|594703702|FG004|Overall Study|Withdrawal by Subject|1|||
164639334|NCT04455620|594703698|FG000|Overall Study|Lost to Follow-up|0|||
164639335|NCT04455620|594703699|FG001|Overall Study|Lost to Follow-up|0|||
164639336|NCT04455620|594703700|FG002|Overall Study|Lost to Follow-up|1|||
164639337|NCT04455620|594703701|FG003|Overall Study|Lost to Follow-up|1|||
164639338|NCT04455620|594703702|FG004|Overall Study|Lost to Follow-up|0|||
164639339|NCT04455620|594703698|FG000|Overall Study|Death|1|||
164639340|NCT04455620|594703699|FG001|Overall Study|Death|6|||
164639341|NCT04455620|594703700|FG002|Overall Study|Death|20|||
164639342|NCT04455620|594703701|FG003|Overall Study|Death|1|||
164639343|NCT04455620|594703702|FG004|Overall Study|Death|7|||
164639344|NCT04455620|594703698|FG000|Overall Study|Study Termination|0|||
164639345|NCT04455620|594703699|FG001|Overall Study|Study Termination|2|||
164639346|NCT04455620|594703700|FG002|Overall Study|Study Termination|1|||
164639347|NCT04455620|594703701|FG003|Overall Study|Study Termination|0|||
164639348|NCT04455620|594703702|FG004|Overall Study|Study Termination|6|||
164639349|NCT00965562|594703703|FG000|Overall Study|Lost to Follow-up|1|||
164639350|NCT00965562|594703704|FG001|Overall Study|Lost to Follow-up|2|||
164639351|NCT00965562|594703705|FG002|Overall Study|Lost to Follow-up|3|||
164639352|NCT00965562|594703703|FG000|Overall Study|Withdrawal by Subject|2|||
164639353|NCT00965562|594703704|FG001|Overall Study|Withdrawal by Subject|2|||
164639354|NCT00965562|594703705|FG002|Overall Study|Withdrawal by Subject|0|||
164639355|NCT05681715|594703706|FG000|Training Period (6-weeks)|Adverse Event|3|||
164639356|NCT05681715|594703707|FG001|Training Period (6-weeks)|Adverse Event|0|||
164639357|NCT05681715|594703708|FG002|Training Period (6-weeks)|Adverse Event|0|||
164639358|NCT05681715|594703706|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
164639359|NCT05681715|594703707|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
164639360|NCT05681715|594703708|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
164639361|NCT05681715|594703706|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
164639362|NCT05681715|594703707|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
164530785|NCT00876694|594315455|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164530786|NCT00876694|594315454|FG000|Overall Study|Abnormal test procedure result(s)|1|||
164530787|NCT00876694|594315455|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164530788|NCT00876694|594315454|FG000|Overall Study|Administrative problems|1|||
164530789|NCT00876694|594315455|FG001|Overall Study|Administrative problems|1|||
164530790|NCT00876694|594315454|FG000|Overall Study|Death|1|||
164530791|NCT00876694|594315455|FG001|Overall Study|Death|0|||
164530792|NCT00288509|594315456|FG000|Treatment Cycle 1|Adverse Event|1|||
164530793|NCT00288509|594315456|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
164530794|NCT00288509|594315456|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
164530795|NCT00288509|594315456|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
164530796|NCT00288509|594315456|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
164530797|NCT00288509|594315456|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
164530798|NCT00288509|594315456|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
164530799|NCT00288509|594315456|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
164530800|NCT00288509|594315456|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
164530801|NCT00288509|594315456|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
164530802|NCT00288509|594315456|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
164530803|NCT00288509|594315456|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
164530804|NCT00288509|594315456|FG000|Treatment Cycle 4|Physician Decision|4|||
164530805|NCT00288509|594315456|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
164530806|NCT00084266|594315457|FG000|Overall Study|Death|42|||
164530807|NCT00084266|594315458|FG001|Overall Study|Death|39|||
164530808|NCT00084266|594315457|FG000|Overall Study|Adverse Event|8|||
164530809|NCT00084266|594315458|FG001|Overall Study|Adverse Event|5|||
164530810|NCT00084266|594315457|FG000|Overall Study|Lack of Efficacy|2|||
164530811|NCT00084266|594315458|FG001|Overall Study|Lack of Efficacy|4|||
164530812|NCT00084266|594315457|FG000|Overall Study|Lost to Follow-up|5|||
164530813|NCT00084266|594315458|FG001|Overall Study|Lost to Follow-up|3|||
164530814|NCT00084266|594315457|FG000|Overall Study|Participant not willing to participate|3|||
164530815|NCT00084266|594315458|FG001|Overall Study|Participant not willing to participate|8|||
164530816|NCT00084266|594315457|FG000|Overall Study|Other|360|||
164530817|NCT00084266|594315458|FG001|Overall Study|Other|344|||
164530818|NCT00084266|594315457|FG000|Overall Study|Randomized not treated|21|||
164530819|NCT00084266|594315458|FG001|Overall Study|Randomized not treated|20|||
164530820|NCT01215422|594315459|FG000|Overall Study|Relocation|1|||
164530821|NCT01215422|594315460|FG001|Overall Study|Relocation|0|||
164530822|NCT01215422|594315461|FG002|Overall Study|Relocation|0|||
164530823|NCT01215422|594315462|FG003|Overall Study|Relocation|0|||
164530824|NCT01215422|594315459|FG000|Overall Study|Failed intubations|0|||
164530825|NCT01215422|594315460|FG001|Overall Study|Failed intubations|0|||
164530826|NCT01215422|594315461|FG002|Overall Study|Failed intubations|3|||
164530827|NCT01215422|594315462|FG003|Overall Study|Failed intubations|8|||
164530828|NCT01215422|594315459|FG000|Overall Study|Did not complete all intubations|7|||
164530829|NCT01215422|594315460|FG001|Overall Study|Did not complete all intubations|0|||
164530830|NCT01215422|594315461|FG002|Overall Study|Did not complete all intubations|0|||
164530831|NCT01215422|594315462|FG003|Overall Study|Did not complete all intubations|0|||
164530832|NCT01386788|594315465|FG000|Overall Study|Lost to Follow-up|2|||
164530833|NCT01259726|594315469|FG000|Overall Study|Death|1|||
164530834|NCT01259726|594315470|FG001|Overall Study|Death|0|||
164530835|NCT01259726|594315471|FG002|Overall Study|Death|0|||
164530836|NCT01259726|594315472|FG003|Overall Study|Death|0|||
164530837|NCT01259726|594315469|FG000|Overall Study|Physician Decision|2|||
164530838|NCT01259726|594315470|FG001|Overall Study|Physician Decision|0|||
164530839|NCT01259726|594315471|FG002|Overall Study|Physician Decision|1|||
164639363|NCT05681715|594703708|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
164639364|NCT05681715|594703706|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
164639365|NCT05681715|594703707|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
164639366|NCT05681715|594703708|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
164639367|NCT05681715|594703706|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
164639368|NCT05681715|594703707|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
164639369|NCT05681715|594703708|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
164639370|NCT05681715|594703706|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
164639371|NCT05681715|594703707|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
164639372|NCT05681715|594703708|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
164639373|NCT05681715|594703706|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
164639374|NCT05681715|594703707|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
164639375|NCT05681715|594703708|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
164639376|NCT05681715|594703706|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
164530840|NCT01259726|594315472|FG003|Overall Study|Physician Decision|1|||
164530841|NCT01259726|594315469|FG000|Overall Study|Withdrawal by Subject|1|||
164639377|NCT05681715|594703707|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
164530842|NCT01259726|594315470|FG001|Overall Study|Withdrawal by Subject|3|||
164530843|NCT01259726|594315471|FG002|Overall Study|Withdrawal by Subject|2|||
164530844|NCT01259726|594315472|FG003|Overall Study|Withdrawal by Subject|1|||
164530845|NCT01259726|594315469|FG000|Overall Study|Lost to Follow-up|1|||
164530846|NCT01259726|594315470|FG001|Overall Study|Lost to Follow-up|1|||
164530847|NCT01259726|594315471|FG002|Overall Study|Lost to Follow-up|1|||
164530848|NCT01259726|594315472|FG003|Overall Study|Lost to Follow-up|3|||
164530849|NCT01211197|594315474|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164530850|NCT01211197|594315475|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164530851|NCT01211197|594315476|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
164530852|NCT01211197|594315477|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164530853|NCT01211197|594315478|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164530854|NCT01211197|594315479|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164530855|NCT01211197|594315474|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
164530856|NCT01211197|594315475|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
164530857|NCT01211197|594315476|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
164530858|NCT01211197|594315477|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
164530859|NCT01211197|594315478|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
164530860|NCT01211197|594315479|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
164530861|NCT00261846|594315480|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
164530862|NCT00261846|594315481|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
164530863|NCT00261846|594315482|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
164530864|NCT00261846|594315483|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
164530865|NCT00261846|594315484|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
164530866|NCT00261846|594315485|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
164530867|NCT00261846|594315486|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
164530868|NCT00261846|594315487|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
164530869|NCT00261846|594315488|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
164530870|NCT00261846|594315489|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
164530871|NCT00261846|594315490|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
164530872|NCT00261846|594315491|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
164530873|NCT00261846|594315480|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
164530874|NCT00261846|594315481|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
164530875|NCT00261846|594315482|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
164530876|NCT00261846|594315483|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
164530877|NCT00261846|594315484|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
164530878|NCT00261846|594315485|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
164530879|NCT00261846|594315486|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
164530880|NCT00261846|594315487|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
164530881|NCT00261846|594315488|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
164530882|NCT00261846|594315489|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
164639378|NCT05681715|594703708|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
164639379|NCT05455684|594703709|FG000|Overall Study|Withdrawal by Subject|7|||
164639380|NCT05455684|594703710|FG001|Overall Study|Withdrawal by Subject|4|||
164639381|NCT05455684|594703709|FG000|Overall Study|Lost to Follow-up|3|||
164639382|NCT05455684|594703710|FG001|Overall Study|Lost to Follow-up|3|||
164639383|NCT05455684|594703709|FG000|Overall Study|Adverse Event|2|||
164639384|NCT05455684|594703710|FG001|Overall Study|Adverse Event|3|||
164639385|NCT05455684|594703709|FG000|Overall Study|Protocol Violation|1|||
164639386|NCT05455684|594703710|FG001|Overall Study|Protocol Violation|1|||
164639387|NCT05455684|594703709|FG000|Overall Study|Non-Compliant with study drug|0|||
164639388|NCT05455684|594703710|FG001|Overall Study|Non-Compliant with study drug|1|||
164639389|NCT05455684|594703709|FG000|Overall Study|Other|1|||
164639390|NCT05455684|594703710|FG001|Overall Study|Other|2|||
164639391|NCT05455684|594703709|FG000|Overall Study|Randomized but not treated|1|||
164639392|NCT05455684|594703710|FG001|Overall Study|Randomized but not treated|0|||
164639393|NCT05204563|594703711|FG000|Overall Study|Other than Specified|2|||
164639394|NCT05204563|594703712|FG001|Overall Study|Other than Specified|1|||
164639395|NCT05204563|594703711|FG000|Overall Study|Death|18|||
164639396|NCT05204563|594703712|FG001|Overall Study|Death|4|||
164639397|NCT05204563|594703711|FG000|Overall Study|Lost to Follow-up|6|||
164639398|NCT05204563|594703712|FG001|Overall Study|Lost to Follow-up|3|||
164639399|NCT05204563|594703711|FG000|Overall Study|Withdrawal by Subject|12|||
164639400|NCT05204563|594703712|FG001|Overall Study|Withdrawal by Subject|3|||
164639401|NCT05204563|594703711|FG000|Overall Study|Enrolled, Not Treated|1|||
164639402|NCT05204563|594703712|FG001|Overall Study|Enrolled, Not Treated|0|||
164639403|NCT05643573|594703713|FG000|Overall Study|Adverse Event|117|||
164639404|NCT05643573|594703714|FG001|Overall Study|Adverse Event|90|||
164148618|NCT04895982|592904914|FG003|Overall Study|Protocol Violation|1|||
164639405|NCT05643573|594703713|FG000|Overall Study|Death|53|||
164639406|NCT05643573|594703714|FG001|Overall Study|Death|57|||
164639407|NCT05643573|594703713|FG000|Overall Study|Lost to Follow-up|6|||
164639408|NCT05643573|594703714|FG001|Overall Study|Lost to Follow-up|3|||
164639409|NCT05643573|594703713|FG000|Overall Study|Other|18|||
164639410|NCT05643573|594703714|FG001|Overall Study|Other|15|||
164639411|NCT05643573|594703713|FG000|Overall Study|Outcome event|64|||
164639412|NCT05643573|594703714|FG001|Overall Study|Outcome event|36|||
164639413|NCT05643573|594703713|FG000|Overall Study|Physician Decision|33|||
164639414|NCT05643573|594703714|FG001|Overall Study|Physician Decision|19|||
164639415|NCT05643573|594703713|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
164639416|NCT05643573|594703714|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
164639417|NCT05643573|594703713|FG000|Overall Study|Site terminated by sponsor|10|||
164639418|NCT05643573|594703714|FG001|Overall Study|Site terminated by sponsor|10|||
164639419|NCT05643573|594703713|FG000|Overall Study|Study terminated by sponsor|1|||
164639420|NCT05643573|594703714|FG001|Overall Study|Study terminated by sponsor|0|||
164639421|NCT05643573|594703713|FG000|Overall Study|Withdrawal by Subject|178|||
164639422|NCT05643573|594703714|FG001|Overall Study|Withdrawal by Subject|130|||
164639423|NCT02268214|594703718|FG000|Overall Study|Subject no longer meets study criteria|0|||
164639424|NCT02268214|594703719|FG001|Overall Study|Subject no longer meets study criteria|2|||
164639425|NCT02268214|594703720|FG002|Overall Study|Subject no longer meets study criteria|0|||
164639426|NCT02268214|594703718|FG000|Overall Study|Pregnancy|2|||
164639427|NCT02268214|594703719|FG001|Overall Study|Pregnancy|2|||
164639428|NCT02268214|594703720|FG002|Overall Study|Pregnancy|1|||
164639429|NCT02268214|594703718|FG000|Overall Study|Lost to Follow-up|3|||
164639430|NCT02268214|594703719|FG001|Overall Study|Lost to Follow-up|3|||
164639431|NCT02268214|594703720|FG002|Overall Study|Lost to Follow-up|4|||
164639432|NCT02268214|594703718|FG000|Overall Study|Lack of Efficacy|1|||
164639433|NCT02268214|594703719|FG001|Overall Study|Lack of Efficacy|0|||
164639434|NCT02268214|594703720|FG002|Overall Study|Lack of Efficacy|2|||
164639435|NCT02268214|594703718|FG000|Overall Study|Adverse Event|11|||
164639436|NCT02268214|594703719|FG001|Overall Study|Adverse Event|14|||
164639437|NCT02268214|594703720|FG002|Overall Study|Adverse Event|9|||
164639438|NCT02268214|594703718|FG000|Overall Study|Withdrawal by Subject|4|||
164639439|NCT02268214|594703719|FG001|Overall Study|Withdrawal by Subject|5|||
164639440|NCT02268214|594703720|FG002|Overall Study|Withdrawal by Subject|10|||
164639441|NCT02268214|594703718|FG000|Overall Study|Subject request to discontinue treatment|10|||
164639442|NCT02268214|594703719|FG001|Overall Study|Subject request to discontinue treatment|8|||
164639443|NCT02268214|594703720|FG002|Overall Study|Subject request to discontinue treatment|6|||
164639444|NCT02268214|594703718|FG000|Overall Study|Poor/non-compliance|2|||
164639445|NCT02268214|594703719|FG001|Overall Study|Poor/non-compliance|1|||
164639446|NCT02268214|594703720|FG002|Overall Study|Poor/non-compliance|2|||
164639447|NCT02268214|594703718|FG000|Overall Study|Other reasons|7|||
164639448|NCT02268214|594703719|FG001|Overall Study|Other reasons|3|||
164639449|NCT02268214|594703720|FG002|Overall Study|Other reasons|3|||
164639450|NCT02268214|594703718|FG000|Overall Study|Not entering long-term period|2|||
164639451|NCT02268214|594703719|FG001|Overall Study|Not entering long-term period|3|||
164639452|NCT02268214|594703720|FG002|Overall Study|Not entering long-term period|5|||
164639453|NCT02951130|594703721|FG000|Overall Study|Protocol Violation|1|||
164639454|NCT02951130|594703722|FG001|Overall Study|Protocol Violation|1|||
164639455|NCT01233284|594703732|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
164639456|NCT01233284|594703733|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
164639457|NCT01233284|594703734|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
164639458|NCT01233284|594703735|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
164639459|NCT01233284|594703736|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
164639460|NCT01233284|594703732|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
164639461|NCT01233284|594703733|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
164639462|NCT01233284|594703734|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
164639463|NCT01233284|594703735|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
164639464|NCT01233284|594703736|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
164639465|NCT01233284|594703732|FG000|Period 1 (4 Weeks)|Other|0|||
164639466|NCT01233284|594703733|FG001|Period 1 (4 Weeks)|Other|0|||
164639467|NCT01233284|594703734|FG002|Period 1 (4 Weeks)|Other|1|||
164639468|NCT01233284|594703735|FG003|Period 1 (4 Weeks)|Other|0|||
164639469|NCT01233284|594703736|FG004|Period 1 (4 Weeks)|Other|0|||
164639470|NCT01233284|594703732|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164639471|NCT01233284|594703733|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164639472|NCT01233284|594703734|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
164639473|NCT01233284|594703735|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164639474|NCT01233284|594703736|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164639475|NCT01233284|594703732|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
164639476|NCT01233284|594703733|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
164639477|NCT01233284|594703734|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
164639478|NCT01233284|594703735|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
164639479|NCT01233284|594703736|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
164639480|NCT01233284|594703732|FG000|Period 3 (4 Weeks)|Other|0|||
164639481|NCT01233284|594703733|FG001|Period 3 (4 Weeks)|Other|0|||
164639482|NCT01233284|594703734|FG002|Period 3 (4 Weeks)|Other|0|||
164530883|NCT00261846|594315490|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
164530884|NCT00261846|594315491|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
164530885|NCT00261846|594315480|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
164530886|NCT00261846|594315481|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
164530887|NCT00261846|594315482|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
164530888|NCT00261846|594315483|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
164530889|NCT00261846|594315484|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
164530890|NCT00261846|594315485|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
164639483|NCT01233284|594703735|FG003|Period 3 (4 Weeks)|Other|1|||
164639484|NCT01233284|594703736|FG004|Period 3 (4 Weeks)|Other|0|||
164639485|NCT01233284|594703732|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
164639486|NCT01233284|594703733|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
164639487|NCT01233284|594703734|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
164639488|NCT01233284|594703735|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
164639489|NCT01233284|594703736|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
164639490|NCT01233284|594703732|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
164639491|NCT01233284|594703733|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
164639492|NCT01233284|594703734|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
164639493|NCT01233284|594703735|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
164639494|NCT01233284|594703736|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
164639495|NCT03759340|594703737|FG000|Overall Study|Adverse Event|2|||
164639496|NCT03759340|594703737|FG000|Overall Study|Lost to Follow-up|1|||
164639497|NCT03759340|594703737|FG000|Overall Study|Withdrawal by Subject|15|||
164639498|NCT03759340|594703737|FG000|Overall Study|Study Terminated by Sponsor|38|||
164639499|NCT02711306|594703743|FG000|Overall Study|Withdrawal by Subject|2|||
164639500|NCT02711306|594703744|FG001|Overall Study|Withdrawal by Subject|2|||
164639501|NCT00157820|594703752|FG000|Randomized|Physician Decision|4|||
164639502|NCT00157820|594703753|FG001|Randomized|Physician Decision|2|||
164639503|NCT00157820|594703754|FG002|Randomized|Physician Decision|3|||
164639504|NCT00157820|594703752|FG000|Randomized|Withdrawal by Subject|1|||
164639505|NCT00157820|594703753|FG001|Randomized|Withdrawal by Subject|2|||
164639506|NCT00157820|594703754|FG002|Randomized|Withdrawal by Subject|3|||
164639507|NCT00157820|594703752|FG000|Randomized|Protocol Violation|2|||
164639508|NCT00157820|594703753|FG001|Randomized|Protocol Violation|1|||
164639509|NCT00157820|594703754|FG002|Randomized|Protocol Violation|2|||
164639510|NCT00157820|594703752|FG000|1st 8 Month|Death|7|||
164639511|NCT00157820|594703753|FG001|1st 8 Month|Death|8|||
164639512|NCT00157820|594703754|FG002|1st 8 Month|Death|3|||
164639513|NCT00157820|594703752|FG000|1st 8 Month|Lost to Follow-up|1|||
164639514|NCT00157820|594703753|FG001|1st 8 Month|Lost to Follow-up|2|||
164639515|NCT00157820|594703754|FG002|1st 8 Month|Lost to Follow-up|1|||
164639516|NCT00157820|594703752|FG000|1st 8 Month|Premature cross-over|0|||
164639517|NCT00157820|594703753|FG001|1st 8 Month|Premature cross-over|2|||
164639518|NCT00157820|594703754|FG002|1st 8 Month|Premature cross-over|2|||
164639519|NCT00157820|594703752|FG000|2nd 8 Months|Death|3|||
164639520|NCT00157820|594703753|FG001|2nd 8 Months|Death|1|||
164639521|NCT00157820|594703754|FG002|2nd 8 Months|Death|3|||
164639522|NCT00157820|594703752|FG000|2nd 8 Months|Lost to Follow-up|1|||
164639523|NCT00157820|594703753|FG001|2nd 8 Months|Lost to Follow-up|5|||
164639524|NCT00157820|594703754|FG002|2nd 8 Months|Lost to Follow-up|2|||
164639525|NCT00157820|594703752|FG000|2nd 8 Months|Premature cross-over|1|||
164639526|NCT00157820|594703753|FG001|2nd 8 Months|Premature cross-over|7|||
164639527|NCT00157820|594703754|FG002|2nd 8 Months|Premature cross-over|9|||
164639528|NCT01676818|594703755|FG000|Overall Study|Physician Decision|1|||
164639529|NCT01676818|594703755|FG000|Overall Study|Withdrawal by Subject|1|||
164639530|NCT02207413|594703763|FG000|Overall Study|Withdrawal by Subject|1|||
164639531|NCT02207413|594703764|FG001|Overall Study|Withdrawal by Subject|0|||
164639532|NCT02207413|594703765|FG002|Overall Study|Withdrawal by Subject|0|||
164639533|NCT02207413|594703766|FG003|Overall Study|Withdrawal by Subject|0|||
164639534|NCT02207413|594703767|FG004|Overall Study|Withdrawal by Subject|3|||
164639535|NCT02207413|594703768|FG005|Overall Study|Withdrawal by Subject|7|||
164639536|NCT02207413|594703763|FG000|Overall Study|Lost to Follow-up|0|||
164639537|NCT02207413|594703764|FG001|Overall Study|Lost to Follow-up|0|||
164639538|NCT02207413|594703765|FG002|Overall Study|Lost to Follow-up|0|||
164639539|NCT02207413|594703766|FG003|Overall Study|Lost to Follow-up|1|||
164639540|NCT02207413|594703767|FG004|Overall Study|Lost to Follow-up|1|||
164530891|NCT00261846|594315486|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
164639541|NCT02207413|594703768|FG005|Overall Study|Lost to Follow-up|5|||
164639542|NCT02207413|594703763|FG000|Overall Study|Adverse Event|0|||
164639543|NCT02207413|594703764|FG001|Overall Study|Adverse Event|0|||
164639544|NCT02207413|594703765|FG002|Overall Study|Adverse Event|0|||
164639545|NCT02207413|594703766|FG003|Overall Study|Adverse Event|0|||
164148619|NCT04895982|592904915|FG004|Overall Study|Protocol Violation|1|||
164639546|NCT02207413|594703767|FG004|Overall Study|Adverse Event|2|||
164639547|NCT02207413|594703768|FG005|Overall Study|Adverse Event|1|||
164639548|NCT02207413|594703763|FG000|Overall Study|Migrated/moved from study area|0|||
164639549|NCT02207413|594703764|FG001|Overall Study|Migrated/moved from study area|0|||
164639550|NCT02207413|594703765|FG002|Overall Study|Migrated/moved from study area|0|||
164639551|NCT02207413|594703766|FG003|Overall Study|Migrated/moved from study area|0|||
164639552|NCT02207413|594703767|FG004|Overall Study|Migrated/moved from study area|1|||
164639553|NCT02207413|594703768|FG005|Overall Study|Migrated/moved from study area|0|||
164639554|NCT04075656|594703769|FG000|Overall Study|Withdrawal by Subject|5|||
164639555|NCT04075656|594703770|FG001|Overall Study|Withdrawal by Subject|5|||
164639556|NCT01519635|594705554|FG000|Overall Study|Withdrawal by Subject|0|||
164639557|NCT01519635|594705555|FG001|Overall Study|Withdrawal by Subject|1|||
164639558|NCT01519635|594705554|FG000|Overall Study|No possibility to put a catheter|1|||
164639559|NCT01519635|594705555|FG001|Overall Study|No possibility to put a catheter|2|||
164639560|NCT00347776|594705556|FG000|1.5 Month Follow-up|Death|2|||
164639561|NCT00347776|594705557|FG001|1.5 Month Follow-up|Death|0|||
164639562|NCT00347776|594705558|FG002|1.5 Month Follow-up|Death|0|||
164639563|NCT00347776|594705556|FG000|1.5 Month Follow-up|reached the endpoint|12|||
164530892|NCT00261846|594315487|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
164530893|NCT00261846|594315488|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
164530894|NCT00261846|594315489|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
164530895|NCT00261846|594315490|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
164530896|NCT00261846|594315491|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
164530897|NCT00261846|594315480|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
164530898|NCT00261846|594315481|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
164530899|NCT00261846|594315482|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
164530900|NCT00261846|594315483|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
164639564|NCT00347776|594705557|FG001|1.5 Month Follow-up|reached the endpoint|8|||
164639565|NCT00347776|594705558|FG002|1.5 Month Follow-up|reached the endpoint|12|||
164639566|NCT00347776|594705556|FG000|6 Month Follow-up|Death|2|||
164639567|NCT00347776|594705557|FG001|6 Month Follow-up|Death|1|||
164639568|NCT00347776|594705558|FG002|6 Month Follow-up|Death|3|||
164639569|NCT00347776|594705556|FG000|6 Month Follow-up|reached endpont|20|||
164639570|NCT00347776|594705557|FG001|6 Month Follow-up|reached endpont|12|||
164639571|NCT00347776|594705558|FG002|6 Month Follow-up|reached endpont|15|||
164639572|NCT00347776|594705556|FG000|12 Month Follow-up|Lost to Follow-up|7|||
164639573|NCT00347776|594705557|FG001|12 Month Follow-up|Lost to Follow-up|6|||
164639574|NCT00347776|594705558|FG002|12 Month Follow-up|Lost to Follow-up|6|||
164639575|NCT00347776|594705556|FG000|12 Month Follow-up|Death|3|||
164639576|NCT00347776|594705557|FG001|12 Month Follow-up|Death|4|||
164639577|NCT00347776|594705558|FG002|12 Month Follow-up|Death|4|||
164639578|NCT00347776|594705556|FG000|12 Month Follow-up|Reached endpoint|13|||
164639579|NCT00347776|594705557|FG001|12 Month Follow-up|Reached endpoint|6|||
164639580|NCT00347776|594705558|FG002|12 Month Follow-up|Reached endpoint|9|||
164639581|NCT00968539|594705559|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
164639582|NCT00968539|594705560|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
164639583|NCT02074982|594705563|FG000|Overall Study|Adverse Event|15|||
164639584|NCT02074982|594705564|FG001|Overall Study|Adverse Event|7|||
164639585|NCT02074982|594705563|FG000|Overall Study|Lack of Efficacy|6|||
164639586|NCT02074982|594705564|FG001|Overall Study|Lack of Efficacy|1|||
164639587|NCT02074982|594705563|FG000|Overall Study|Lost to Follow-up|9|||
164639588|NCT02074982|594705564|FG001|Overall Study|Lost to Follow-up|10|||
164639589|NCT02074982|594705563|FG000|Overall Study|Non-compliance with study treatment|0|||
164639590|NCT02074982|594705564|FG001|Overall Study|Non-compliance with study treatment|2|||
164639591|NCT02074982|594705563|FG000|Overall Study|Physician Decision|1|||
164639592|NCT02074982|594705564|FG001|Overall Study|Physician Decision|1|||
164639593|NCT02074982|594705563|FG000|Overall Study|Pregnancy|1|||
164639594|NCT02074982|594705564|FG001|Overall Study|Pregnancy|2|||
164639595|NCT02074982|594705563|FG000|Overall Study|Protocol deviation|4|||
164639596|NCT02074982|594705564|FG001|Overall Study|Protocol deviation|3|||
164639597|NCT02074982|594705563|FG000|Overall Study|Technical problems|0|||
164639598|NCT02074982|594705564|FG001|Overall Study|Technical problems|2|||
164639599|NCT02074982|594705563|FG000|Overall Study|Subject/guardian decision|15|||
164639600|NCT02074982|594705564|FG001|Overall Study|Subject/guardian decision|24|||
164639601|NCT02074982|594705563|FG000|Overall Study|Death|0|||
164639602|NCT02074982|594705564|FG001|Overall Study|Death|2|||
164639603|NCT02525627|594705571|FG000|Overall Study|Revision|1|||
164639604|NCT02525627|594705572|FG001|Overall Study|Revision|1|||
164639605|NCT02525627|594705571|FG000|Overall Study|Withdrawal by Subject|1|||
164639606|NCT02525627|594705572|FG001|Overall Study|Withdrawal by Subject|2|||
164639607|NCT02525627|594705571|FG000|Overall Study|Death|1|||
164639608|NCT02525627|594705572|FG001|Overall Study|Death|0|||
164639609|NCT02525627|594705571|FG000|Overall Study|Site terminated|11|||
164639610|NCT02525627|594705572|FG001|Overall Study|Site terminated|10|||
164639611|NCT01160770|594705573|FG000|Overall Study|Adverse Event|10|||
164639612|NCT01160770|594705573|FG000|Overall Study|Protocol Violation|2|||
164639613|NCT01160770|594705573|FG000|Overall Study|Subject/parent/caregiver request|33|||
164639614|NCT01160770|594705573|FG000|Overall Study|Physician Decision|1|||
164639615|NCT01160770|594705573|FG000|Overall Study|Lost to Follow-up|7|||
164639616|NCT01160770|594705573|FG000|Overall Study|Study termination or sponsor request|1|||
164639617|NCT01160770|594705573|FG000|Overall Study|Death|9|||
164639618|NCT01160770|594705573|FG000|Overall Study|Lack of Efficacy|15|||
164639619|NCT01160770|594705573|FG000|Overall Study|Other Reasons|1|||
164639620|NCT00242567|594705574|FG000|Overall Study|Adverse Event|70|||
164639621|NCT00242567|594705575|FG001|Overall Study|Adverse Event|43|||
164639622|NCT00242567|594705574|FG000|Overall Study|Disease Progression|17|||
164639623|NCT00242567|594705575|FG001|Overall Study|Disease Progression|22|||
164639624|NCT00242567|594705574|FG000|Overall Study|Symptomatic deterioration|9|||
164639625|NCT00242567|594705575|FG001|Overall Study|Symptomatic deterioration|3|||
164639626|NCT00242567|594705574|FG000|Overall Study|Lack of Efficacy|2|||
164639627|NCT00242567|594705575|FG001|Overall Study|Lack of Efficacy|2|||
164639628|NCT00242567|594705574|FG000|Overall Study|Lost to Follow-up|9|||
164639629|NCT00242567|594705575|FG001|Overall Study|Lost to Follow-up|19|||
164639630|NCT00242567|594705574|FG000|Overall Study|Withdrawal by Subject|33|||
164639631|NCT00242567|594705575|FG001|Overall Study|Withdrawal by Subject|28|||
164639632|NCT00242567|594705574|FG000|Overall Study|Protocol Violation|12|||
164639633|NCT00242567|594705575|FG001|Overall Study|Protocol Violation|12|||
164639634|NCT00242567|594705574|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
164639635|NCT00242567|594705575|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
164639636|NCT00242567|594705574|FG000|Overall Study|Other|14|||
164639637|NCT00242567|594705575|FG001|Overall Study|Other|9|||
164639638|NCT02116309|594705589|FG000|Overall Study|Lost to Follow-up|0|||
164639639|NCT02116309|594705590|FG001|Overall Study|Lost to Follow-up|1|||
164639640|NCT03292731|594705591|FG000|Overall Study|Protocol Violation|4|||
164639641|NCT03292731|594705592|FG001|Overall Study|Protocol Violation|11|||
164639642|NCT03292731|594705593|FG002|Overall Study|Protocol Violation|1|||
164639643|NCT00471237|594705594|FG000|Overall Study|Adverse Event|6|||
164639644|NCT00471237|594705595|FG001|Overall Study|Adverse Event|5|||
164639645|NCT00471237|594705596|FG002|Overall Study|Adverse Event|4|||
164639646|NCT00471237|594705597|FG003|Overall Study|Adverse Event|8|||
164639647|NCT00471237|594705598|FG004|Overall Study|Adverse Event|7|||
164639648|NCT00471237|594705599|FG005|Overall Study|Adverse Event|5|||
164639649|NCT00471237|594705600|FG006|Overall Study|Adverse Event|0|||
164639650|NCT00471237|594705594|FG000|Overall Study|Lost to Follow-up|1|||
164639651|NCT00471237|594705595|FG001|Overall Study|Lost to Follow-up|1|||
164639652|NCT00471237|594705596|FG002|Overall Study|Lost to Follow-up|0|||
164639653|NCT00471237|594705597|FG003|Overall Study|Lost to Follow-up|2|||
164639654|NCT00471237|594705598|FG004|Overall Study|Lost to Follow-up|3|||
164639655|NCT00471237|594705599|FG005|Overall Study|Lost to Follow-up|0|||
164639656|NCT00471237|594705600|FG006|Overall Study|Lost to Follow-up|0|||
164639657|NCT00471237|594705594|FG000|Overall Study|Protocol Violation|3|||
164639658|NCT00471237|594705595|FG001|Overall Study|Protocol Violation|6|||
164639659|NCT00471237|594705596|FG002|Overall Study|Protocol Violation|3|||
164639660|NCT00471237|594705597|FG003|Overall Study|Protocol Violation|2|||
164639661|NCT00471237|594705598|FG004|Overall Study|Protocol Violation|2|||
164639662|NCT00471237|594705599|FG005|Overall Study|Protocol Violation|4|||
164639663|NCT00471237|594705600|FG006|Overall Study|Protocol Violation|1|||
164639664|NCT00471237|594705594|FG000|Overall Study|Withdrawal by Subject|8|||
164639665|NCT00471237|594705595|FG001|Overall Study|Withdrawal by Subject|6|||
164639666|NCT00471237|594705596|FG002|Overall Study|Withdrawal by Subject|5|||
164639667|NCT00471237|594705597|FG003|Overall Study|Withdrawal by Subject|8|||
164639668|NCT00471237|594705598|FG004|Overall Study|Withdrawal by Subject|7|||
164639669|NCT00471237|594705599|FG005|Overall Study|Withdrawal by Subject|4|||
164639670|NCT00471237|594705600|FG006|Overall Study|Withdrawal by Subject|2|||
164639671|NCT00471237|594705594|FG000|Overall Study|Sponsor terminated study|20|||
164639672|NCT00471237|594705595|FG001|Overall Study|Sponsor terminated study|23|||
164639673|NCT00471237|594705596|FG002|Overall Study|Sponsor terminated study|19|||
164639674|NCT00471237|594705597|FG003|Overall Study|Sponsor terminated study|22|||
164639675|NCT00471237|594705598|FG004|Overall Study|Sponsor terminated study|18|||
164639676|NCT00471237|594705599|FG005|Overall Study|Sponsor terminated study|24|||
164639677|NCT00471237|594705600|FG006|Overall Study|Sponsor terminated study|0|||
164639678|NCT00471237|594705594|FG000|Overall Study|Non-compliance|0|||
164639679|NCT00471237|594705595|FG001|Overall Study|Non-compliance|1|||
164639680|NCT00471237|594705596|FG002|Overall Study|Non-compliance|0|||
164639681|NCT00471237|594705597|FG003|Overall Study|Non-compliance|1|||
164639682|NCT00471237|594705598|FG004|Overall Study|Non-compliance|0|||
164639683|NCT00471237|594705599|FG005|Overall Study|Non-compliance|0|||
164639684|NCT00471237|594705600|FG006|Overall Study|Non-compliance|0|||
164639685|NCT00471237|594705594|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
164639686|NCT00471237|594705595|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
164639687|NCT00471237|594705596|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
164639688|NCT00471237|594705597|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
164639689|NCT00471237|594705598|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
164639690|NCT00471237|594705599|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
164639691|NCT00471237|594705600|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
164639692|NCT00471237|594705594|FG000|Overall Study|Early stopping due to non-efficacy|1|||
164639693|NCT00471237|594705595|FG001|Overall Study|Early stopping due to non-efficacy|0|||
164639694|NCT00471237|594705596|FG002|Overall Study|Early stopping due to non-efficacy|0|||
164639695|NCT00471237|594705597|FG003|Overall Study|Early stopping due to non-efficacy|0|||
164639696|NCT00471237|594705598|FG004|Overall Study|Early stopping due to non-efficacy|1|||
164639697|NCT00471237|594705599|FG005|Overall Study|Early stopping due to non-efficacy|0|||
164639698|NCT00471237|594705600|FG006|Overall Study|Early stopping due to non-efficacy|0|||
164639699|NCT00471237|594705594|FG000|Overall Study|Participant planned to travel to abraod|1|||
164639700|NCT00471237|594705595|FG001|Overall Study|Participant planned to travel to abraod|0|||
164639701|NCT00471237|594705596|FG002|Overall Study|Participant planned to travel to abraod|0|||
164639702|NCT00471237|594705597|FG003|Overall Study|Participant planned to travel to abraod|0|||
164639703|NCT00471237|594705598|FG004|Overall Study|Participant planned to travel to abraod|0|||
164639704|NCT00471237|594705599|FG005|Overall Study|Participant planned to travel to abraod|1|||
164639705|NCT00471237|594705600|FG006|Overall Study|Participant planned to travel to abraod|0|||
164639706|NCT00471237|594705594|FG000|Overall Study|High parathyroid hormone|0|||
164639707|NCT00471237|594705595|FG001|Overall Study|High parathyroid hormone|0|||
164639708|NCT00471237|594705596|FG002|Overall Study|High parathyroid hormone|1|||
164639709|NCT00471237|594705597|FG003|Overall Study|High parathyroid hormone|0|||
164639710|NCT00471237|594705598|FG004|Overall Study|High parathyroid hormone|0|||
164639711|NCT00471237|594705599|FG005|Overall Study|High parathyroid hormone|0|||
164639712|NCT00471237|594705600|FG006|Overall Study|High parathyroid hormone|0|||
164639713|NCT00471237|594705594|FG000|Overall Study|Participant lost medication|0|||
164639714|NCT00471237|594705595|FG001|Overall Study|Participant lost medication|0|||
164639715|NCT00471237|594705596|FG002|Overall Study|Participant lost medication|0|||
164639716|NCT00471237|594705597|FG003|Overall Study|Participant lost medication|0|||
164639717|NCT00471237|594705598|FG004|Overall Study|Participant lost medication|1|||
164639718|NCT00471237|594705599|FG005|Overall Study|Participant lost medication|0|||
164639719|NCT00471237|594705600|FG006|Overall Study|Participant lost medication|0|||
164639720|NCT00471237|594705594|FG000|Overall Study|Administration of prohibited medicine|0|||
164639721|NCT00471237|594705595|FG001|Overall Study|Administration of prohibited medicine|0|||
164639722|NCT00471237|594705596|FG002|Overall Study|Administration of prohibited medicine|0|||
164639723|NCT00471237|594705597|FG003|Overall Study|Administration of prohibited medicine|0|||
164639724|NCT00471237|594705598|FG004|Overall Study|Administration of prohibited medicine|1|||
164639725|NCT00471237|594705599|FG005|Overall Study|Administration of prohibited medicine|0|||
164639726|NCT00471237|594705600|FG006|Overall Study|Administration of prohibited medicine|0|||
164639727|NCT00471237|594705594|FG000|Overall Study|Participant shifted residence|0|||
164639728|NCT00471237|594705595|FG001|Overall Study|Participant shifted residence|0|||
164639729|NCT00471237|594705596|FG002|Overall Study|Participant shifted residence|0|||
164639730|NCT00471237|594705597|FG003|Overall Study|Participant shifted residence|0|||
164639731|NCT00471237|594705598|FG004|Overall Study|Participant shifted residence|1|||
164639732|NCT00471237|594705599|FG005|Overall Study|Participant shifted residence|0|||
164639733|NCT00471237|594705600|FG006|Overall Study|Participant shifted residence|0|||
164639734|NCT00471237|594705594|FG000|Overall Study|Participant's decision|0|||
164639735|NCT00471237|594705595|FG001|Overall Study|Participant's decision|0|||
164639736|NCT00471237|594705596|FG002|Overall Study|Participant's decision|0|||
164639737|NCT00471237|594705597|FG003|Overall Study|Participant's decision|0|||
164639738|NCT00471237|594705598|FG004|Overall Study|Participant's decision|0|||
164639739|NCT00471237|594705599|FG005|Overall Study|Participant's decision|1|||
164639740|NCT00471237|594705600|FG006|Overall Study|Participant's decision|0|||
164639741|NCT00848965|594705601|FG000|Overall Study|Adverse Event|1|||
164639742|NCT00848965|594705601|FG000|Overall Study|Withdrawal by Subject|1|||
164639743|NCT00348348|594705602|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
164639744|NCT00348348|594705603|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
164639745|NCT00348348|594705602|FG000|Overall Study|Lack of Efficacy|1|||
164639746|NCT00348348|594705603|FG001|Overall Study|Lack of Efficacy|1|||
164639747|NCT00348348|594705602|FG000|Overall Study|Lost to Follow-up|8|||
164639748|NCT00348348|594705603|FG001|Overall Study|Lost to Follow-up|10|||
164639749|NCT00348348|594705602|FG000|Overall Study|Withdrawal by Subject|4|||
164639750|NCT00348348|594705603|FG001|Overall Study|Withdrawal by Subject|1|||
164639751|NCT00348348|594705602|FG000|Overall Study|Other|7|||
164639752|NCT00348348|594705603|FG001|Overall Study|Other|4|||
164639753|NCT00348348|594705602|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
164639754|NCT00348348|594705603|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
164639755|NCT00348348|594705602|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
164639756|NCT00348348|594705603|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
164639757|NCT00348348|594705602|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
164639758|NCT00348348|594705603|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
164639759|NCT00348348|594705602|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
164639760|NCT00348348|594705603|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
164639761|NCT00348348|594705602|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
164639762|NCT00348348|594705603|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
164639763|NCT00348348|594705602|FG000|Overall Study|Adverse event probably related to study|1|||
164639764|NCT00348348|594705603|FG001|Overall Study|Adverse event probably related to study|0|||
164639765|NCT03710824|594705604|FG000|Overall Study|Withdrawal by Subject|1|||
164639766|NCT03710824|594705604|FG000|Overall Study|Lost to Follow-up|3|||
164639767|NCT03710824|594705604|FG000|Overall Study|Adverse Event|25|||
164639768|NCT03710824|594705604|FG000|Overall Study|Treatment discontinuation|2|||
164639769|NCT01301625|594705606|FG000|Overall Study|Death|5|||
164639770|NCT01301625|594705606|FG000|Overall Study|Not Due|21|||
164639771|NCT01301625|594705606|FG000|Overall Study|Expected|8|||
164639772|NCT01301625|594705606|FG000|Overall Study|Lost to Follow-up|1|||
164639773|NCT00320801|594705612|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
164639774|NCT00320801|594705613|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
164639775|NCT00320801|594705614|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
164639776|NCT00320801|594705615|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
164639777|NCT00320801|594705612|FG000|Open-label Run-in Period|Adverse Event|33|||
164639778|NCT00320801|594705613|FG001|Open-label Run-in Period|Adverse Event|0|||
164639779|NCT00320801|594705614|FG002|Open-label Run-in Period|Adverse Event|0|||
164639780|NCT00320801|594705615|FG003|Open-label Run-in Period|Adverse Event|0|||
164639781|NCT00320801|594705612|FG000|Open-label Run-in Period|Administrative|10|||
164639782|NCT00320801|594705613|FG001|Open-label Run-in Period|Administrative|0|||
164639783|NCT00320801|594705614|FG002|Open-label Run-in Period|Administrative|0|||
164639784|NCT00320801|594705615|FG003|Open-label Run-in Period|Administrative|0|||
164639785|NCT00320801|594705612|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
164639786|NCT00320801|594705613|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
164639787|NCT00320801|594705614|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
164639788|NCT00320801|594705615|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
164639789|NCT00320801|594705612|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
164639790|NCT00320801|594705613|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
164639791|NCT00320801|594705614|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
164639792|NCT00320801|594705615|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
164639793|NCT00320801|594705612|FG000|Open-label Run-in Period|Did not qualify|1|||
164639794|NCT00320801|594705613|FG001|Open-label Run-in Period|Did not qualify|0|||
164639795|NCT00320801|594705614|FG002|Open-label Run-in Period|Did not qualify|0|||
164639796|NCT00320801|594705615|FG003|Open-label Run-in Period|Did not qualify|0|||
164639797|NCT00320801|594705612|FG000|Double-blind Phase|Withdrawal by Subject|0|||
164639798|NCT00320801|594705613|FG001|Double-blind Phase|Withdrawal by Subject|0|||
164639799|NCT00320801|594705614|FG002|Double-blind Phase|Withdrawal by Subject|1|||
164639800|NCT00320801|594705615|FG003|Double-blind Phase|Withdrawal by Subject|0|||
164639801|NCT00320801|594705612|FG000|Double-blind Phase|Adverse Event|0|||
164639802|NCT00320801|594705613|FG001|Double-blind Phase|Adverse Event|2|||
164639803|NCT00320801|594705614|FG002|Double-blind Phase|Adverse Event|8|||
164639804|NCT00320801|594705615|FG003|Double-blind Phase|Adverse Event|0|||
164639805|NCT00320801|594705612|FG000|Double-blind Phase|Administrative|0|||
164639806|NCT00320801|594705613|FG001|Double-blind Phase|Administrative|0|||
164639807|NCT00320801|594705614|FG002|Double-blind Phase|Administrative|4|||
164639808|NCT00320801|594705615|FG003|Double-blind Phase|Administrative|0|||
164639809|NCT00320801|594705612|FG000|Double-blind Phase|Lack of Efficacy|0|||
164639810|NCT00320801|594705613|FG001|Double-blind Phase|Lack of Efficacy|9|||
164639811|NCT00320801|594705614|FG002|Double-blind Phase|Lack of Efficacy|1|||
164639812|NCT00320801|594705615|FG003|Double-blind Phase|Lack of Efficacy|0|||
164639813|NCT00320801|594705612|FG000|Extension Phase|Withdrawal by Subject|0|||
164639814|NCT00320801|594705613|FG001|Extension Phase|Withdrawal by Subject|0|||
164639815|NCT00320801|594705614|FG002|Extension Phase|Withdrawal by Subject|0|||
164639816|NCT00320801|594705615|FG003|Extension Phase|Withdrawal by Subject|6|||
164639817|NCT00320801|594705612|FG000|Extension Phase|Adverse Event|0|||
164639818|NCT00320801|594705613|FG001|Extension Phase|Adverse Event|0|||
164639819|NCT00320801|594705614|FG002|Extension Phase|Adverse Event|0|||
164639820|NCT00320801|594705615|FG003|Extension Phase|Adverse Event|8|||
164639821|NCT00320801|594705612|FG000|Extension Phase|Administrative|0|||
164639822|NCT00320801|594705613|FG001|Extension Phase|Administrative|0|||
164639823|NCT00320801|594705614|FG002|Extension Phase|Administrative|0|||
164639824|NCT00320801|594705615|FG003|Extension Phase|Administrative|29|||
164639825|NCT00320801|594705612|FG000|Extension Phase|Lack of Efficacy|0|||
164639826|NCT00320801|594705613|FG001|Extension Phase|Lack of Efficacy|0|||
164639827|NCT00320801|594705614|FG002|Extension Phase|Lack of Efficacy|0|||
164639828|NCT00320801|594705615|FG003|Extension Phase|Lack of Efficacy|2|||
164639829|NCT00320801|594705612|FG000|Extension Phase|Lost to Follow-up|0|||
164639830|NCT00320801|594705613|FG001|Extension Phase|Lost to Follow-up|0|||
164639831|NCT00320801|594705614|FG002|Extension Phase|Lost to Follow-up|0|||
164639832|NCT00320801|594705615|FG003|Extension Phase|Lost to Follow-up|3|||
164639833|NCT00491322|594705616|FG000|Overall Study|Protocol Violation|1|||
164639834|NCT00491322|594705617|FG001|Overall Study|Protocol Violation|0|||
164639835|NCT00491322|594705616|FG000|Overall Study|Pregnancy|0|||
164639836|NCT00491322|594705617|FG001|Overall Study|Pregnancy|1|||
164639837|NCT06067191|594705620|FG000|Overall Study|Withdrawal by Subject|0|||
164639838|NCT06067191|594705621|FG001|Overall Study|Withdrawal by Subject|1|||
164639839|NCT00890409|594705625|FG000|Overall Study|Lost to Follow-up|20|||
164639840|NCT00890409|594705626|FG001|Overall Study|Lost to Follow-up|21|||
164639841|NCT03664024|594705629|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
164639842|NCT03664024|594705629|FG000|Overall Study|Lost to Follow-up|2|||
164639843|NCT03664024|594705629|FG000|Overall Study|Withdrawal by Subject|2|||
164639844|NCT03664024|594705629|FG000|Overall Study|Death|80|||
164639845|NCT01157065|594705630|FG000|Overall Study|Death|0|||
164639846|NCT01157065|594705631|FG001|Overall Study|Death|1|||
164639847|NCT02060188|594705632|FG000|Overall Study|Disease Progression|36|||
164639848|NCT02060188|594705633|FG001|Overall Study|Disease Progression|42|||
164639849|NCT02060188|594705634|FG002|Overall Study|Disease Progression|8|||
164639850|NCT02060188|594705635|FG003|Overall Study|Disease Progression|5|||
164639851|NCT02060188|594705636|FG004|Overall Study|Disease Progression|6|||
164639852|NCT02060188|594705637|FG005|Overall Study|Disease Progression|3|||
164530901|NCT00261846|594315484|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
164530902|NCT00261846|594315485|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
164530903|NCT00261846|594315486|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
164530904|NCT00261846|594315487|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
164530905|NCT00261846|594315488|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
164530906|NCT00261846|594315489|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
164530907|NCT00261846|594315490|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
164530908|NCT00261846|594315491|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
164530909|NCT00261846|594315480|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
164530910|NCT00261846|594315481|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
164530911|NCT00261846|594315482|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
164530912|NCT00261846|594315483|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
164530913|NCT00261846|594315484|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
164530914|NCT00261846|594315485|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
164530915|NCT00261846|594315486|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
164530916|NCT00261846|594315487|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
164530917|NCT00261846|594315488|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
164530918|NCT00261846|594315489|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
164530919|NCT00261846|594315490|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
164530920|NCT00261846|594315491|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
164530921|NCT00261846|594315480|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
164530922|NCT00261846|594315481|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
164530923|NCT00261846|594315482|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
164530924|NCT00261846|594315483|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
164530925|NCT00261846|594315484|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
164530926|NCT00261846|594315485|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
164530927|NCT00261846|594315486|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
164530928|NCT00261846|594315487|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
164530929|NCT00261846|594315488|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
164530930|NCT00261846|594315489|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
164530931|NCT00261846|594315490|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
164530932|NCT00261846|594315491|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
164530933|NCT00261846|594315480|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
164530934|NCT00261846|594315481|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
164639853|NCT02060188|594705638|FG006|Overall Study|Disease Progression|23|||
164639854|NCT02060188|594705639|FG007|Overall Study|Disease Progression|20|||
164639855|NCT02060188|594705640|FG008|Overall Study|Disease Progression|43|||
164639856|NCT02060188|594705632|FG000|Overall Study|Study Drug Toxicity|10|||
164639857|NCT02060188|594705633|FG001|Overall Study|Study Drug Toxicity|18|||
164639858|NCT02060188|594705634|FG002|Overall Study|Study Drug Toxicity|7|||
164639859|NCT02060188|594705635|FG003|Overall Study|Study Drug Toxicity|4|||
164639860|NCT02060188|594705636|FG004|Overall Study|Study Drug Toxicity|3|||
164639861|NCT02060188|594705637|FG005|Overall Study|Study Drug Toxicity|0|||
164639862|NCT02060188|594705638|FG006|Overall Study|Study Drug Toxicity|2|||
164639863|NCT02060188|594705639|FG007|Overall Study|Study Drug Toxicity|5|||
164639864|NCT02060188|594705640|FG008|Overall Study|Study Drug Toxicity|0|||
164639865|NCT02060188|594705632|FG000|Overall Study|Adverse event unrelated to study drug|2|||
164639866|NCT02060188|594705633|FG001|Overall Study|Adverse event unrelated to study drug|5|||
164639867|NCT02060188|594705634|FG002|Overall Study|Adverse event unrelated to study drug|6|||
164639868|NCT02060188|594705635|FG003|Overall Study|Adverse event unrelated to study drug|0|||
164639869|NCT02060188|594705636|FG004|Overall Study|Adverse event unrelated to study drug|1|||
164639870|NCT02060188|594705637|FG005|Overall Study|Adverse event unrelated to study drug|0|||
164639871|NCT02060188|594705638|FG006|Overall Study|Adverse event unrelated to study drug|4|||
164639872|NCT02060188|594705639|FG007|Overall Study|Adverse event unrelated to study drug|4|||
164639873|NCT02060188|594705640|FG008|Overall Study|Adverse event unrelated to study drug|1|||
164639874|NCT02060188|594705632|FG000|Overall Study|Participant request to discontinue study treatment|7|||
164639875|NCT02060188|594705633|FG001|Overall Study|Participant request to discontinue study treatment|7|||
164639876|NCT02060188|594705634|FG002|Overall Study|Participant request to discontinue study treatment|4|||
164639877|NCT02060188|594705635|FG003|Overall Study|Participant request to discontinue study treatment|0|||
164639878|NCT02060188|594705636|FG004|Overall Study|Participant request to discontinue study treatment|0|||
164639879|NCT02060188|594705637|FG005|Overall Study|Participant request to discontinue study treatment|0|||
164639880|NCT02060188|594705638|FG006|Overall Study|Participant request to discontinue study treatment|1|||
164639881|NCT02060188|594705639|FG007|Overall Study|Participant request to discontinue study treatment|1|||
164639882|NCT02060188|594705640|FG008|Overall Study|Participant request to discontinue study treatment|0|||
164639883|NCT02060188|594705632|FG000|Overall Study|Participant withdrew consent|3|||
164639884|NCT02060188|594705633|FG001|Overall Study|Participant withdrew consent|0|||
164639885|NCT02060188|594705634|FG002|Overall Study|Participant withdrew consent|0|||
164639886|NCT02060188|594705635|FG003|Overall Study|Participant withdrew consent|0|||
164639887|NCT02060188|594705636|FG004|Overall Study|Participant withdrew consent|0|||
164639888|NCT02060188|594705637|FG005|Overall Study|Participant withdrew consent|0|||
164639889|NCT02060188|594705638|FG006|Overall Study|Participant withdrew consent|0|||
164639890|NCT02060188|594705639|FG007|Overall Study|Participant withdrew consent|0|||
164639891|NCT02060188|594705640|FG008|Overall Study|Participant withdrew consent|0|||
164639892|NCT02060188|594705632|FG000|Overall Study|Maximum clinical benefit|13|||
164639893|NCT02060188|594705633|FG001|Overall Study|Maximum clinical benefit|38|||
164639894|NCT02060188|594705634|FG002|Overall Study|Maximum clinical benefit|19|||
164639895|NCT02060188|594705635|FG003|Overall Study|Maximum clinical benefit|0|||
164639896|NCT02060188|594705636|FG004|Overall Study|Maximum clinical benefit|0|||
164639897|NCT02060188|594705637|FG005|Overall Study|Maximum clinical benefit|0|||
164639898|NCT02060188|594705638|FG006|Overall Study|Maximum clinical benefit|0|||
164639899|NCT02060188|594705639|FG007|Overall Study|Maximum clinical benefit|10|||
164639900|NCT02060188|594705640|FG008|Overall Study|Maximum clinical benefit|0|||
164639901|NCT02060188|594705632|FG000|Overall Study|Other reason|3|||
164639902|NCT02060188|594705633|FG001|Overall Study|Other reason|7|||
164639903|NCT02060188|594705634|FG002|Overall Study|Other reason|0|||
164639904|NCT02060188|594705635|FG003|Overall Study|Other reason|1|||
164639905|NCT02060188|594705636|FG004|Overall Study|Other reason|0|||
164639906|NCT02060188|594705637|FG005|Overall Study|Other reason|0|||
164639907|NCT02060188|594705638|FG006|Overall Study|Other reason|0|||
164639908|NCT02060188|594705639|FG007|Overall Study|Other reason|9|||
164639909|NCT02060188|594705640|FG008|Overall Study|Other reason|0|||
164639910|NCT02060188|594705632|FG000|Overall Study|Death|0|||
164639911|NCT02060188|594705633|FG001|Overall Study|Death|1|||
164639912|NCT02060188|594705634|FG002|Overall Study|Death|0|||
164639913|NCT02060188|594705635|FG003|Overall Study|Death|0|||
164639914|NCT02060188|594705636|FG004|Overall Study|Death|0|||
164639915|NCT02060188|594705637|FG005|Overall Study|Death|0|||
164639916|NCT02060188|594705638|FG006|Overall Study|Death|0|||
164639917|NCT02060188|594705639|FG007|Overall Study|Death|1|||
164639918|NCT02060188|594705640|FG008|Overall Study|Death|0|||
164639919|NCT02060188|594705632|FG000|Overall Study|Administrative reasons by sponsor|0|||
164639920|NCT02060188|594705633|FG001|Overall Study|Administrative reasons by sponsor|1|||
164639921|NCT02060188|594705634|FG002|Overall Study|Administrative reasons by sponsor|0|||
164639922|NCT02060188|594705635|FG003|Overall Study|Administrative reasons by sponsor|0|||
164639923|NCT02060188|594705636|FG004|Overall Study|Administrative reasons by sponsor|0|||
164639924|NCT02060188|594705637|FG005|Overall Study|Administrative reasons by sponsor|0|||
164639925|NCT02060188|594705638|FG006|Overall Study|Administrative reasons by sponsor|0|||
164639926|NCT02060188|594705639|FG007|Overall Study|Administrative reasons by sponsor|0|||
164639927|NCT02060188|594705640|FG008|Overall Study|Administrative reasons by sponsor|0|||
164639928|NCT02060188|594705632|FG000|Overall Study|Lost to Follow-up|0|||
164639929|NCT02060188|594705633|FG001|Overall Study|Lost to Follow-up|0|||
164639930|NCT02060188|594705634|FG002|Overall Study|Lost to Follow-up|1|||
164639931|NCT02060188|594705635|FG003|Overall Study|Lost to Follow-up|0|||
164639932|NCT02060188|594705636|FG004|Overall Study|Lost to Follow-up|0|||
164639933|NCT02060188|594705637|FG005|Overall Study|Lost to Follow-up|0|||
164639934|NCT02060188|594705638|FG006|Overall Study|Lost to Follow-up|0|||
164639935|NCT02060188|594705639|FG007|Overall Study|Lost to Follow-up|0|||
164639936|NCT02060188|594705640|FG008|Overall Study|Lost to Follow-up|0|||
164639937|NCT03426995|594705641|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164639938|NCT03426995|594705642|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164639939|NCT03426995|594705643|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
164639940|NCT03426995|594705644|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164639941|NCT03426995|594705645|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164639942|NCT03426995|594705646|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164639943|NCT03426995|594705647|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164639944|NCT03426995|594705648|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164639945|NCT03426995|594705649|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164639946|NCT03426995|594705650|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164639947|NCT03426995|594705651|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164639948|NCT03426995|594705652|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164639949|NCT03426995|594705653|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164639950|NCT03426995|594705654|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164639951|NCT03426995|594705655|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164639952|NCT03426995|594705656|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164639953|NCT03426995|594705657|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164639954|NCT03426995|594705658|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164639955|NCT03426995|594705659|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164639956|NCT03426995|594705641|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164639957|NCT03426995|594705642|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164639958|NCT03426995|594705643|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164639959|NCT03426995|594705644|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164639960|NCT03426995|594705645|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164639961|NCT03426995|594705646|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
164639962|NCT03426995|594705647|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164639963|NCT03426995|594705648|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164639964|NCT03426995|594705649|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164639965|NCT03426995|594705650|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164639966|NCT03426995|594705651|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164639967|NCT03426995|594705652|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164639968|NCT03426995|594705653|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164639969|NCT03426995|594705654|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164639970|NCT03426995|594705655|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164639971|NCT03426995|594705656|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164639972|NCT03426995|594705657|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164639973|NCT03426995|594705658|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164639974|NCT03426995|594705659|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164639975|NCT03426995|594705641|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164639976|NCT03426995|594705642|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164639977|NCT03426995|594705643|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164639978|NCT03426995|594705644|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164639979|NCT03426995|594705645|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
164639980|NCT03426995|594705646|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
164639981|NCT03426995|594705647|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164639982|NCT03426995|594705648|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164639983|NCT03426995|594705649|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164639984|NCT03426995|594705650|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164639985|NCT03426995|594705651|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164639986|NCT03426995|594705652|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164639987|NCT03426995|594705653|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164639988|NCT03426995|594705654|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164639989|NCT03426995|594705655|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164639990|NCT03426995|594705656|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164639991|NCT03426995|594705657|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164639992|NCT03426995|594705658|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164639993|NCT03426995|594705659|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164639994|NCT03426995|594705641|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164639995|NCT03426995|594705642|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164639996|NCT03426995|594705643|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164639997|NCT03426995|594705644|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164639998|NCT03426995|594705645|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164639999|NCT03426995|594705646|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164640000|NCT03426995|594705647|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164640001|NCT03426995|594705648|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164640002|NCT03426995|594705649|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164640003|NCT03426995|594705650|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164640004|NCT03426995|594705651|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
164640005|NCT03426995|594705652|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164640006|NCT03426995|594705653|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164640007|NCT03426995|594705654|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164640008|NCT03426995|594705655|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164640009|NCT03426995|594705656|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164640010|NCT03426995|594705657|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164640011|NCT03426995|594705658|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164640012|NCT03426995|594705659|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164640013|NCT03426995|594705641|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164640014|NCT03426995|594705642|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164640015|NCT03426995|594705643|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164640016|NCT03426995|594705644|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164640017|NCT03426995|594705645|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164640018|NCT03426995|594705646|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164640019|NCT03426995|594705647|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164640020|NCT03426995|594705648|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
164640021|NCT03426995|594705649|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164640022|NCT03426995|594705650|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164640023|NCT03426995|594705651|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164640024|NCT03426995|594705652|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164640025|NCT03426995|594705653|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164640026|NCT03426995|594705654|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164640027|NCT03426995|594705655|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164640028|NCT03426995|594705656|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164640029|NCT03426995|594705657|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164640030|NCT03426995|594705658|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164640031|NCT03426995|594705659|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164640032|NCT03426995|594705641|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164640033|NCT03426995|594705642|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164640034|NCT03426995|594705643|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164640035|NCT03426995|594705644|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164640036|NCT03426995|594705645|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164640037|NCT03426995|594705646|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164640038|NCT03426995|594705647|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164640039|NCT03426995|594705648|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164640040|NCT03426995|594705649|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164640041|NCT03426995|594705650|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164640042|NCT03426995|594705651|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164640043|NCT03426995|594705652|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164640044|NCT03426995|594705653|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164640045|NCT03426995|594705654|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164640046|NCT03426995|594705655|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
164640047|NCT03426995|594705656|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
164640048|NCT03426995|594705657|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164640049|NCT03426995|594705658|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164640050|NCT03426995|594705659|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164640051|NCT03426995|594705641|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164640052|NCT03426995|594705642|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164640053|NCT03426995|594705643|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164640054|NCT03426995|594705644|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164640055|NCT03426995|594705645|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164640056|NCT03426995|594705646|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164640057|NCT03426995|594705647|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164148620|NCT04895982|592904916|FG005|Overall Study|Protocol Violation|0|||
164640058|NCT03426995|594705648|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164640059|NCT03426995|594705649|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164640060|NCT03426995|594705650|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164640061|NCT03426995|594705651|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164640062|NCT03426995|594705652|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164640063|NCT03426995|594705653|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164640064|NCT03426995|594705654|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164640065|NCT03426995|594705655|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
164640066|NCT03426995|594705656|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
164640067|NCT03426995|594705657|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164640068|NCT03426995|594705658|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164640069|NCT03426995|594705659|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164640070|NCT03075826|594705662|FG000|Overall Study|Withdrawal by Subject|1|||
164640071|NCT03075826|594705662|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
164640072|NCT00650806|594705664|FG000|Overall Study|Adverse Event|0|||
164640073|NCT00650806|594705665|FG001|Overall Study|Adverse Event|5|||
164640074|NCT00650806|594705666|FG002|Overall Study|Adverse Event|3|||
164640075|NCT00650806|594705667|FG003|Overall Study|Adverse Event|4|||
164640076|NCT00650806|594705664|FG000|Overall Study|Lost to Follow-up|7|||
164640077|NCT00650806|594705665|FG001|Overall Study|Lost to Follow-up|6|||
164640078|NCT00650806|594705666|FG002|Overall Study|Lost to Follow-up|11|||
164640079|NCT00650806|594705667|FG003|Overall Study|Lost to Follow-up|10|||
164640080|NCT00650806|594705664|FG000|Overall Study|Protocol Violation|0|||
164640081|NCT00650806|594705665|FG001|Overall Study|Protocol Violation|0|||
164640082|NCT00650806|594705666|FG002|Overall Study|Protocol Violation|0|||
164640083|NCT00650806|594705667|FG003|Overall Study|Protocol Violation|1|||
164640084|NCT00650806|594705664|FG000|Overall Study|Pregnancy|0|||
164640085|NCT00650806|594705665|FG001|Overall Study|Pregnancy|0|||
164640086|NCT00650806|594705666|FG002|Overall Study|Pregnancy|0|||
164640087|NCT00650806|594705667|FG003|Overall Study|Pregnancy|1|||
164640088|NCT00650806|594705664|FG000|Overall Study|Withdrawal by Subject|7|||
164640089|NCT00650806|594705665|FG001|Overall Study|Withdrawal by Subject|5|||
164640090|NCT00650806|594705666|FG002|Overall Study|Withdrawal by Subject|8|||
164640091|NCT00650806|594705667|FG003|Overall Study|Withdrawal by Subject|6|||
164640092|NCT00650806|594705664|FG000|Overall Study|Noncompliance with study drug regimen|1|||
164640093|NCT00650806|594705665|FG001|Overall Study|Noncompliance with study drug regimen|1|||
164640094|NCT00650806|594705666|FG002|Overall Study|Noncompliance with study drug regimen|0|||
164640095|NCT00650806|594705667|FG003|Overall Study|Noncompliance with study drug regimen|0|||
164640096|NCT00650806|594705664|FG000|Overall Study|Study terminated by sponsor|2|||
164640097|NCT00650806|594705665|FG001|Overall Study|Study terminated by sponsor|3|||
164640098|NCT00650806|594705666|FG002|Overall Study|Study terminated by sponsor|5|||
164640099|NCT00650806|594705667|FG003|Overall Study|Study terminated by sponsor|4|||
164640100|NCT00650806|594705664|FG000|Overall Study|Other|1|||
164640101|NCT00650806|594705665|FG001|Overall Study|Other|1|||
164640102|NCT00650806|594705666|FG002|Overall Study|Other|2|||
164640103|NCT00650806|594705667|FG003|Overall Study|Other|0|||
164640104|NCT02242942|594705668|FG000|Overall Study|Death|17|||
164640105|NCT02242942|594705669|FG001|Overall Study|Death|20|||
164640106|NCT02242942|594705670|FG002|Overall Study|Death|2|||
164640107|NCT02242942|594705668|FG000|Overall Study|Physician Decision|1|||
164640108|NCT02242942|594705669|FG001|Overall Study|Physician Decision|0|||
164640109|NCT02242942|594705670|FG002|Overall Study|Physician Decision|0|||
164640110|NCT02242942|594705668|FG000|Overall Study|Withdrawal by Subject|8|||
164640111|NCT02242942|594705669|FG001|Overall Study|Withdrawal by Subject|10|||
164640112|NCT02242942|594705670|FG002|Overall Study|Withdrawal by Subject|0|||
164640113|NCT02242942|594705668|FG000|Overall Study|On-going in Study|190|||
164640114|NCT02242942|594705669|FG001|Overall Study|On-going in Study|186|||
164640115|NCT02242942|594705670|FG002|Overall Study|On-going in Study|11|||
164640116|NCT04228107|594705674|FG000|Overall Study|Protocol Violation|1|||
164640117|NCT04228107|594705675|FG001|Overall Study|Protocol Violation|0|||
164640118|NCT04228107|594705674|FG000|Overall Study|Withdrawal by Subject|6|||
164640119|NCT04228107|594705675|FG001|Overall Study|Withdrawal by Subject|0|||
164640120|NCT04228107|594705674|FG000|Overall Study|Lost to Follow-up|18|||
164640121|NCT04228107|594705675|FG001|Overall Study|Lost to Follow-up|0|||
164640122|NCT04228107|594705674|FG000|Overall Study|No controller use data|1|||
164640123|NCT04228107|594705675|FG001|Overall Study|No controller use data|0|||
164640124|NCT04228107|594705674|FG000|Overall Study|No medication data collected|1|||
164640125|NCT04228107|594705675|FG001|Overall Study|No medication data collected|0|||
164640126|NCT03792633|594705676|FG000|Overall Study|Alternative Treatment|17|||
164640127|NCT03792633|594705677|FG001|Overall Study|Alternative Treatment|19|||
164640128|NCT03792633|594705676|FG000|Overall Study|Death|2|||
164640129|NCT03792633|594705677|FG001|Overall Study|Death|0|||
164640130|NCT03792633|594705676|FG000|Overall Study|Disease progression|8|||
164640131|NCT03792633|594705677|FG001|Overall Study|Disease progression|9|||
164640132|NCT03792633|594705676|FG000|Overall Study|Lost to Follow-up|1|||
164640133|NCT03792633|594705677|FG001|Overall Study|Lost to Follow-up|1|||
164640134|NCT03792633|594705676|FG000|Overall Study|Screen fail|1|||
164640135|NCT03792633|594705677|FG001|Overall Study|Screen fail|0|||
164640136|NCT03792633|594705676|FG000|Overall Study|Second malignancy|0|||
164640137|NCT03792633|594705677|FG001|Overall Study|Second malignancy|1|||
164640138|NCT00145119|594705678|FG000|Overall Study|Death|45|||
164640139|NCT04411641|594705679|FG000|DB Period|Other|7|||
164640140|NCT04411641|594705680|FG001|DB Period|Other|27|||
164640141|NCT04411641|594705681|FG002|DB Period|Other|0|||
164640142|NCT04411641|594705682|FG003|DB Period|Other|0|||
164640143|NCT04411641|594705679|FG000|DB Period|Withdrawal by Subject|67|||
164640144|NCT04411641|594705680|FG001|DB Period|Withdrawal by Subject|122|||
164640145|NCT04411641|594705681|FG002|DB Period|Withdrawal by Subject|0|||
164640146|NCT04411641|594705682|FG003|DB Period|Withdrawal by Subject|0|||
164640147|NCT04411641|594705679|FG000|DB Period|Progressive disease|76|||
164640148|NCT04411641|594705680|FG001|DB Period|Progressive disease|116|||
164640149|NCT04411641|594705681|FG002|DB Period|Progressive disease|0|||
164640150|NCT04411641|594705682|FG003|DB Period|Progressive disease|0|||
164640151|NCT04411641|594705679|FG000|DB Period|Poor compliance to protocol|1|||
164640152|NCT04411641|594705680|FG001|DB Period|Poor compliance to protocol|5|||
164640153|NCT04411641|594705681|FG002|DB Period|Poor compliance to protocol|0|||
164640154|NCT04411641|594705682|FG003|DB Period|Poor compliance to protocol|0|||
164640155|NCT04411641|594705679|FG000|DB Period|Lack of Efficacy|19|||
164640156|NCT04411641|594705680|FG001|DB Period|Lack of Efficacy|19|||
164640157|NCT04411641|594705681|FG002|DB Period|Lack of Efficacy|0|||
164640158|NCT04411641|594705682|FG003|DB Period|Lack of Efficacy|0|||
164640159|NCT04411641|594705679|FG000|DB Period|Adverse Event|13|||
164640160|NCT04411641|594705680|FG001|DB Period|Adverse Event|29|||
164640161|NCT04411641|594705681|FG002|DB Period|Adverse Event|0|||
164640162|NCT04411641|594705682|FG003|DB Period|Adverse Event|0|||
164640163|NCT04411641|594705679|FG000|DB Period|Randomized and not treated|2|||
164640164|NCT04411641|594705680|FG001|DB Period|Randomized and not treated|2|||
164640165|NCT04411641|594705681|FG002|DB Period|Randomized and not treated|0|||
164640166|NCT04411641|594705682|FG003|DB Period|Randomized and not treated|0|||
164640167|NCT04411641|594705679|FG000|OL|Withdrawal by Subject|0|||
164640168|NCT04411641|594705680|FG001|OL|Withdrawal by Subject|0|||
164640169|NCT04411641|594705681|FG002|OL|Withdrawal by Subject|6|||
164640170|NCT04411641|594705682|FG003|OL|Withdrawal by Subject|17|||
164640171|NCT04411641|594705679|FG000|OL|Progressive disease|0|||
164640172|NCT04411641|594705680|FG001|OL|Progressive disease|0|||
164640173|NCT04411641|594705681|FG002|OL|Progressive disease|1|||
164640174|NCT04411641|594705682|FG003|OL|Progressive disease|2|||
164640175|NCT04411641|594705679|FG000|OL|Poor compliance to protocol|0|||
164640176|NCT04411641|594705680|FG001|OL|Poor compliance to protocol|0|||
164640177|NCT04411641|594705681|FG002|OL|Poor compliance to protocol|1|||
164640178|NCT04411641|594705682|FG003|OL|Poor compliance to protocol|0|||
164640179|NCT04411641|594705679|FG000|OL|Adverse Event|0|||
164640180|NCT04411641|594705680|FG001|OL|Adverse Event|0|||
164640181|NCT04411641|594705681|FG002|OL|Adverse Event|1|||
164640182|NCT04411641|594705682|FG003|OL|Adverse Event|0|||
164640183|NCT04411641|594705679|FG000|OL|Other|0|||
164640184|NCT04411641|594705680|FG001|OL|Other|0|||
164640185|NCT04411641|594705681|FG002|OL|Other|0|||
164640186|NCT04411641|594705682|FG003|OL|Other|6|||
164640187|NCT04342390|594705683|FG000|Overall Study|Lost to Follow-up|3|||
164640188|NCT04342390|594705684|FG001|Overall Study|Lost to Follow-up|0|||
164640189|NCT04584294|594705685|FG000|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|3|||
164640190|NCT04584294|594705686|FG001|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|4|||
164640191|NCT04584294|594705685|FG000|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|16|||
164640192|NCT04584294|594705686|FG001|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|18|||
164640193|NCT04584294|594705685|FG000|Enrollment to Post-Visit - PATIENTS|Pregnancy|0|||
164640194|NCT04584294|594705686|FG001|Enrollment to Post-Visit - PATIENTS|Pregnancy|1|||
164640195|NCT04584294|594705685|FG000|3-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
164640196|NCT04584294|594705686|FG001|3-month Follow-up - PATIENTS|Withdrawal by Subject|1|||
164640197|NCT04584294|594705685|FG000|6-month Follow-up - PATIENTS|Withdrawal by Subject|4|||
164640198|NCT04584294|594705686|FG001|6-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
164640199|NCT04584294|594705685|FG000|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|3|||
164640200|NCT04584294|594705686|FG001|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|5|||
164640201|NCT02500732|594705692|FG000|Overall Study|Physician Decision|0|||
164640202|NCT02500732|594705693|FG001|Overall Study|Physician Decision|1|||
164640203|NCT03205605|594705694|FG000|Overall Study|Withdrawal by Subject|1|||
164640204|NCT01003691|594705695|FG000|Overall Study|Adverse Event|0|||
164640205|NCT01003691|594705696|FG001|Overall Study|Adverse Event|0|||
164640206|NCT01003691|594705697|FG002|Overall Study|Adverse Event|0|||
164640207|NCT01003691|594705698|FG003|Overall Study|Adverse Event|1|||
164640208|NCT01869959|594705699|FG000|Randomization Period|Physician Decision|0|||
164640209|NCT01869959|594705700|FG001|Randomization Period|Physician Decision|0|||
164640210|NCT01869959|594705701|FG002|Randomization Period|Physician Decision|0|||
164640211|NCT01869959|594705702|FG003|Randomization Period|Physician Decision|0|||
164640212|NCT01869959|594705703|FG004|Randomization Period|Physician Decision|1|||
164640213|NCT01869959|594705699|FG000|Treatment Period|Adverse Event|1|||
164640214|NCT01869959|594705700|FG001|Treatment Period|Adverse Event|0|||
164640215|NCT01869959|594705701|FG002|Treatment Period|Adverse Event|3|||
164640216|NCT01869959|594705702|FG003|Treatment Period|Adverse Event|1|||
164640217|NCT01869959|594705703|FG004|Treatment Period|Adverse Event|0|||
164640218|NCT01869959|594705699|FG000|Treatment Period|Sponsor decision|0|||
164640219|NCT01869959|594705700|FG001|Treatment Period|Sponsor decision|1|||
164640220|NCT01869959|594705701|FG002|Treatment Period|Sponsor decision|0|||
164640221|NCT01869959|594705702|FG003|Treatment Period|Sponsor decision|1|||
164640222|NCT01869959|594705703|FG004|Treatment Period|Sponsor decision|0|||
164640223|NCT01869959|594705699|FG000|Treatment Period|Withdrawal by Subject|0|||
164640224|NCT01869959|594705700|FG001|Treatment Period|Withdrawal by Subject|1|||
164640225|NCT01869959|594705701|FG002|Treatment Period|Withdrawal by Subject|0|||
164640226|NCT01869959|594705702|FG003|Treatment Period|Withdrawal by Subject|0|||
164640227|NCT01869959|594705703|FG004|Treatment Period|Withdrawal by Subject|0|||
164640228|NCT01392469|594707352|FG000|Overall Study|Adverse Event|2|||
164640229|NCT01392469|594707352|FG000|Overall Study|Withdrawal by Subject|1|||
164640230|NCT01392469|594707352|FG000|Overall Study|Protocol Violation|1|||
164640231|NCT03443973|594707359|FG000|Double-blind Treatment Period|Adverse Event|5|||
164640232|NCT03443973|594707360|FG001|Double-blind Treatment Period|Adverse Event|19|||
164640233|NCT03443973|594707361|FG002|Double-blind Treatment Period|Adverse Event|0|||
164640234|NCT03443973|594707362|FG003|Double-blind Treatment Period|Adverse Event|0|||
164640235|NCT03443973|594707359|FG000|Double-blind Treatment Period|Death|5|||
164640236|NCT03443973|594707360|FG001|Double-blind Treatment Period|Death|7|||
164640237|NCT03443973|594707361|FG002|Double-blind Treatment Period|Death|0|||
164640238|NCT03443973|594707362|FG003|Double-blind Treatment Period|Death|0|||
164640239|NCT03443973|594707359|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
164640240|NCT03443973|594707360|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
164640241|NCT03443973|594707361|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
164640242|NCT03443973|594707362|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
164640243|NCT03443973|594707359|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
164640244|NCT03443973|594707360|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
164640245|NCT03443973|594707361|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
164640246|NCT03443973|594707362|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
164640247|NCT03443973|594707359|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
164640248|NCT03443973|594707360|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
164640249|NCT03443973|594707361|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
164640250|NCT03443973|594707362|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
164640251|NCT03443973|594707359|FG000|Double-blind Treatment Period|Physician Decision|5|||
164640252|NCT03443973|594707360|FG001|Double-blind Treatment Period|Physician Decision|6|||
164640253|NCT03443973|594707361|FG002|Double-blind Treatment Period|Physician Decision|0|||
164640254|NCT03443973|594707362|FG003|Double-blind Treatment Period|Physician Decision|0|||
164640255|NCT03443973|594707359|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
164640256|NCT03443973|594707360|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
164640257|NCT03443973|594707361|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
164640258|NCT03443973|594707362|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
164640259|NCT03443973|594707359|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
164640260|NCT03443973|594707360|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
164640261|NCT03443973|594707361|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
164640262|NCT03443973|594707362|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
164640263|NCT03443973|594707359|FG000|Open-label Extension Period|Reason Not Specified|0|||
164640264|NCT03443973|594707360|FG001|Open-label Extension Period|Reason Not Specified|0|||
164640265|NCT03443973|594707361|FG002|Open-label Extension Period|Reason Not Specified|3|||
164640266|NCT03443973|594707362|FG003|Open-label Extension Period|Reason Not Specified|0|||
164640267|NCT03443973|594707359|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
164640268|NCT03443973|594707360|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
164640269|NCT03443973|594707361|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
164640270|NCT03443973|594707362|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
164640271|NCT04930536|594707363|FG000|Overall Study|Adverse Event|1|||
164640272|NCT04930536|594707364|FG001|Overall Study|Adverse Event|0|||
164640273|NCT04930536|594707363|FG000|Overall Study|Disease Progression|2|||
164640274|NCT04930536|594707364|FG001|Overall Study|Disease Progression|0|||
164640275|NCT04930536|594707363|FG000|Overall Study|Patient Decision|4|||
164640276|NCT04930536|594707364|FG001|Overall Study|Patient Decision|2|||
164640277|NCT04930536|594707363|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
164640278|NCT04930536|594707364|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
164640279|NCT00267020|594707365|FG000|Overall Study|Adverse Event|22|||
164640280|NCT00267020|594707366|FG001|Overall Study|Adverse Event|5|||
164640281|NCT00267020|594707365|FG000|Overall Study|Death|2|||
164640282|NCT00267020|594707366|FG001|Overall Study|Death|1|||
164640283|NCT00267020|594707365|FG000|Overall Study|Withdrawal by Subject|17|||
164640284|NCT00267020|594707366|FG001|Overall Study|Withdrawal by Subject|7|||
164640285|NCT00267020|594707365|FG000|Overall Study|Physician Decision|3|||
164640286|NCT00267020|594707366|FG001|Overall Study|Physician Decision|2|||
164640287|NCT00267020|594707365|FG000|Overall Study|Disease Progression|39|||
164640288|NCT00267020|594707366|FG001|Overall Study|Disease Progression|25|||
164640289|NCT00267020|594707365|FG000|Overall Study|Unrelated Complication|1|||
164640290|NCT00267020|594707366|FG001|Overall Study|Unrelated Complication|1|||
164640291|NCT00267020|594707365|FG000|Overall Study|Sponsor Request|1|||
164640292|NCT00267020|594707366|FG001|Overall Study|Sponsor Request|0|||
164640293|NCT00267020|594707365|FG000|Overall Study|Other|1|||
164640294|NCT00267020|594707366|FG001|Overall Study|Other|2|||
164640295|NCT04292171|594707370|FG000|Overall Study|Pharmacy error|2|||
164640296|NCT04292171|594707371|FG001|Overall Study|Pharmacy error|0|||
164640297|NCT04292171|594707370|FG000|Overall Study|Delivered prior to procedure|0|||
164640298|NCT04292171|594707371|FG001|Overall Study|Delivered prior to procedure|1|||
164640299|NCT04465916|594707372|FG000|Overall Study|Withdrawal by Subject|0|||
164640300|NCT04465916|594707373|FG001|Overall Study|Withdrawal by Subject|1|||
164640301|NCT01605370|594707375|FG000|Overall Study|Adverse Event|1|||
164640302|NCT01605370|594707376|FG001|Overall Study|Adverse Event|0|||
164640303|NCT01317199|594707377|FG000|Dose-escalation Phase 1|Physician Decision|5|||
164640304|NCT01317199|594707378|FG001|Dose-escalation Phase 1|Physician Decision|0|||
164640305|NCT01317199|594707379|FG002|Dose-escalation Phase 1|Physician Decision|0|||
164640306|NCT01317199|594707380|FG003|Dose-escalation Phase 1|Physician Decision|0|||
164640307|NCT01317199|594707377|FG000|Dose-escalation Phase 1|Disease progression|1|||
164640308|NCT01317199|594707378|FG001|Dose-escalation Phase 1|Disease progression|0|||
164640309|NCT01317199|594707379|FG002|Dose-escalation Phase 1|Disease progression|0|||
164640310|NCT01317199|594707380|FG003|Dose-escalation Phase 1|Disease progression|0|||
164640311|NCT01317199|594707377|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
164640312|NCT01317199|594707378|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
164640313|NCT01317199|594707379|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
164640314|NCT01317199|594707380|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
164640315|NCT01317199|594707377|FG000|Randomized Phase 2|Disease progression|0|||
164640316|NCT01317199|594707378|FG001|Randomized Phase 2|Disease progression|3|||
164640317|NCT01317199|594707379|FG002|Randomized Phase 2|Disease progression|7|||
164640318|NCT01317199|594707380|FG003|Randomized Phase 2|Disease progression|5|||
164640319|NCT01317199|594707377|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
164640320|NCT01317199|594707378|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
164640321|NCT01317199|594707379|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
164640322|NCT01317199|594707380|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
164640323|NCT01317199|594707377|FG000|Randomized Phase 2|Adverse Event|0|||
164640324|NCT01317199|594707378|FG001|Randomized Phase 2|Adverse Event|0|||
164640325|NCT01317199|594707379|FG002|Randomized Phase 2|Adverse Event|0|||
164640326|NCT01317199|594707380|FG003|Randomized Phase 2|Adverse Event|1|||
164640327|NCT01317199|594707377|FG000|Randomized Phase 2|Comorbidities|0|||
164640328|NCT01317199|594707378|FG001|Randomized Phase 2|Comorbidities|2|||
164640329|NCT01317199|594707379|FG002|Randomized Phase 2|Comorbidities|2|||
164640330|NCT01317199|594707380|FG003|Randomized Phase 2|Comorbidities|2|||
164640331|NCT01317199|594707377|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
164640332|NCT01317199|594707378|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
164640333|NCT01317199|594707379|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
164640334|NCT01317199|594707380|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
164640335|NCT01317199|594707377|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
164640336|NCT01317199|594707378|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
164640337|NCT01317199|594707379|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
164640338|NCT01317199|594707380|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
164640339|NCT01317199|594707377|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
164640340|NCT01317199|594707378|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
164640341|NCT01317199|594707379|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
164640342|NCT01317199|594707380|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
164640343|NCT01317199|594707377|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
164640344|NCT01317199|594707378|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
164640345|NCT01317199|594707379|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
164640346|NCT01317199|594707380|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
164640347|NCT01353209|594707381|FG000|Overall Study|Adverse Event|1|||
164640348|NCT01353209|594707382|FG001|Overall Study|Adverse Event|1|||
164640349|NCT03237325|594707396|FG000|Overall Study|Lost to Follow-up|3|||
164640350|NCT03237325|594707397|FG001|Overall Study|Lost to Follow-up|5|||
164640351|NCT03237325|594707396|FG000|Overall Study|Physician Decision|2|||
164640352|NCT03237325|594707397|FG001|Overall Study|Physician Decision|4|||
164640353|NCT03237325|594707396|FG000|Overall Study|Withdrawal by Subject|9|||
164640354|NCT03237325|594707397|FG001|Overall Study|Withdrawal by Subject|12|||
164640355|NCT03237325|594707396|FG000|Overall Study|Noncompliance with Study Procedures|1|||
164640356|NCT03237325|594707397|FG001|Overall Study|Noncompliance with Study Procedures|1|||
164640357|NCT03237325|594707396|FG000|Overall Study|Termination by Sponsor|0|||
164640358|NCT03237325|594707397|FG001|Overall Study|Termination by Sponsor|1|||
164640359|NCT03237325|594707396|FG000|Overall Study|Reason other than described|0|||
164640360|NCT03237325|594707397|FG001|Overall Study|Reason other than described|2|||
164640361|NCT02684370|594707398|FG000|Part A|Adverse Event|2|||
164640362|NCT02684370|594707399|FG001|Part A|Adverse Event|0|||
164640363|NCT02684370|594707400|FG002|Part A|Adverse Event|1|||
164640364|NCT02684370|594707401|FG003|Part A|Adverse Event|0|||
164640365|NCT02684370|594707402|FG004|Part A|Adverse Event|0|||
164640366|NCT02684370|594707403|FG005|Part A|Adverse Event|0|||
164640367|NCT02684370|594707398|FG000|Part A|Lost to Follow-up|1|||
164640368|NCT02684370|594707399|FG001|Part A|Lost to Follow-up|1|||
164640369|NCT02684370|594707400|FG002|Part A|Lost to Follow-up|0|||
164640370|NCT02684370|594707401|FG003|Part A|Lost to Follow-up|0|||
164640371|NCT02684370|594707402|FG004|Part A|Lost to Follow-up|0|||
164640372|NCT02684370|594707403|FG005|Part A|Lost to Follow-up|0|||
164640373|NCT02684370|594707398|FG000|Part A|Subject Withdrawal|1|||
164640374|NCT02684370|594707399|FG001|Part A|Subject Withdrawal|0|||
164640375|NCT02684370|594707400|FG002|Part A|Subject Withdrawal|3|||
164640376|NCT02684370|594707401|FG003|Part A|Subject Withdrawal|0|||
164640377|NCT02684370|594707402|FG004|Part A|Subject Withdrawal|0|||
164640378|NCT02684370|594707403|FG005|Part A|Subject Withdrawal|0|||
164640379|NCT02684370|594707398|FG000|Part A|Other|0|||
164640380|NCT02684370|594707399|FG001|Part A|Other|0|||
164640381|NCT02684370|594707400|FG002|Part A|Other|1|||
164640382|NCT02684370|594707401|FG003|Part A|Other|0|||
164640383|NCT02684370|594707402|FG004|Part A|Other|0|||
164640384|NCT02684370|594707403|FG005|Part A|Other|0|||
164640385|NCT02684370|594707398|FG000|Part B|Adverse Event|0|||
164640386|NCT02684370|594707399|FG001|Part B|Adverse Event|0|||
164640387|NCT02684370|594707400|FG002|Part B|Adverse Event|0|||
164640388|NCT02684370|594707401|FG003|Part B|Adverse Event|0|||
164640389|NCT02684370|594707402|FG004|Part B|Adverse Event|2|||
164640390|NCT02684370|594707403|FG005|Part B|Adverse Event|1|||
164640391|NCT02684370|594707398|FG000|Part B|Lost to Follow-up|0|||
164640392|NCT02684370|594707399|FG001|Part B|Lost to Follow-up|0|||
164640393|NCT02684370|594707400|FG002|Part B|Lost to Follow-up|0|||
164640394|NCT02684370|594707401|FG003|Part B|Lost to Follow-up|1|||
164640395|NCT02684370|594707402|FG004|Part B|Lost to Follow-up|2|||
164640396|NCT02684370|594707403|FG005|Part B|Lost to Follow-up|5|||
164640397|NCT02684370|594707398|FG000|Part B|Subject Withdrawal|0|||
164640398|NCT02684370|594707399|FG001|Part B|Subject Withdrawal|0|||
164640399|NCT02684370|594707400|FG002|Part B|Subject Withdrawal|0|||
164640400|NCT02684370|594707401|FG003|Part B|Subject Withdrawal|1|||
164640401|NCT02684370|594707402|FG004|Part B|Subject Withdrawal|1|||
164640402|NCT02684370|594707403|FG005|Part B|Subject Withdrawal|2|||
164640403|NCT00627094|594707405|FG000|Overall Study|Adverse Event|8|||
164640404|NCT00627094|594707406|FG001|Overall Study|Adverse Event|7|||
164640405|NCT00627094|594707405|FG000|Overall Study|Lost to Follow-up|1|||
164640406|NCT00627094|594707406|FG001|Overall Study|Lost to Follow-up|0|||
164640407|NCT00627094|594707405|FG000|Overall Study|Withdrawal by Subject|1|||
164640408|NCT00627094|594707406|FG001|Overall Study|Withdrawal by Subject|1|||
164640409|NCT00627094|594707405|FG000|Overall Study|ulcer healed|1|||
164640410|NCT00627094|594707406|FG001|Overall Study|ulcer healed|7|||
164640411|NCT00627094|594707405|FG000|Overall Study|Other reason|1|||
164640412|NCT00627094|594707406|FG001|Overall Study|Other reason|0|||
164640413|NCT00183170|594707408|FG000|First Intervention|Did not complete study|1|||
164640414|NCT00183170|594707409|FG001|First Intervention|Did not complete study|0|||
164640415|NCT00183170|594707408|FG000|First Intervention|Did not meet targeted BrAC|1|||
164640416|NCT00183170|594707409|FG001|First Intervention|Did not meet targeted BrAC|0|||
164640417|NCT00183170|594707408|FG000|Washout 1 Week|Did not complete study|6|||
164640418|NCT00183170|594707409|FG001|Washout 1 Week|Did not complete study|8|||
164640419|NCT00183170|594707408|FG000|Second Intervention|Did not complete study|1|||
164640420|NCT00183170|594707409|FG001|Second Intervention|Did not complete study|0|||
164640421|NCT00183170|594707408|FG000|Second Intervention|Did not meet targeted BrAC|0|||
164640422|NCT00183170|594707409|FG001|Second Intervention|Did not meet targeted BrAC|2|||
164640423|NCT05102162|594707410|FG000|Overall Study|Withdrawal by Subject|3|||
164640424|NCT05102162|594707411|FG001|Overall Study|Withdrawal by Subject|0|||
164640425|NCT05102162|594707410|FG000|Overall Study|Baseline cultures negative|4|||
164640426|NCT05102162|594707411|FG001|Overall Study|Baseline cultures negative|2|||
164640427|NCT05102162|594707410|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
164640428|NCT05102162|594707411|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
164640429|NCT05102162|594707410|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
164640430|NCT05102162|594707411|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
164640431|NCT01165424|594707412|FG000|Overall Study|Clinical adverse experiences|1|||
164640432|NCT01165424|594707412|FG000|Overall Study|Laboratory adverse experiences|1|||
164640433|NCT01165424|594707412|FG000|Overall Study|Did not meet entry criteria|1|||
164640434|NCT01165424|594707412|FG000|Overall Study|Participant moved (relocated)|1|||
164640435|NCT02181673|594707413|FG000|Up to Week 24|Adverse Event|2|||
164640436|NCT02181673|594707414|FG001|Up to Week 24|Adverse Event|0|||
164640437|NCT02181673|594707415|FG002|Up to Week 24|Adverse Event|3|||
164640438|NCT02181673|594707413|FG000|Up to Week 24|Death|1|||
164640439|NCT02181673|594707414|FG001|Up to Week 24|Death|0|||
164640440|NCT02181673|594707415|FG002|Up to Week 24|Death|0|||
164640441|NCT02181673|594707413|FG000|Up to Week 24|Lack of Efficacy|1|||
164640442|NCT02181673|594707414|FG001|Up to Week 24|Lack of Efficacy|0|||
164640443|NCT02181673|594707415|FG002|Up to Week 24|Lack of Efficacy|0|||
164640444|NCT02181673|594707413|FG000|Up to Week 24|Lost to Follow-up|1|||
164640445|NCT02181673|594707414|FG001|Up to Week 24|Lost to Follow-up|0|||
164640446|NCT02181673|594707415|FG002|Up to Week 24|Lost to Follow-up|0|||
164640447|NCT02181673|594707413|FG000|Up to Week 24|Physician Decision|0|||
164640448|NCT02181673|594707414|FG001|Up to Week 24|Physician Decision|0|||
164640449|NCT02181673|594707415|FG002|Up to Week 24|Physician Decision|3|||
164640450|NCT02181673|594707413|FG000|Up to Week 24|Withdrawal by Subject|10|||
164640451|NCT02181673|594707414|FG001|Up to Week 24|Withdrawal by Subject|0|||
164640452|NCT02181673|594707415|FG002|Up to Week 24|Withdrawal by Subject|1|||
164640453|NCT02181673|594707413|FG000|Up to Week 24|Other|2|||
164640454|NCT02181673|594707414|FG001|Up to Week 24|Other|0|||
164640455|NCT02181673|594707415|FG002|Up to Week 24|Other|3|||
164640456|NCT02181673|594707413|FG000|Up to Week 24|Randomized not Treated|0|||
164640457|NCT02181673|594707414|FG001|Up to Week 24|Randomized not Treated|0|||
164640458|NCT02181673|594707415|FG002|Up to Week 24|Randomized not Treated|1|||
164640459|NCT02181673|594707413|FG000|Week 24-Week 60|Adverse Event|0|||
164640460|NCT02181673|594707414|FG001|Week 24-Week 60|Adverse Event|4|||
164640461|NCT02181673|594707415|FG002|Week 24-Week 60|Adverse Event|10|||
164640462|NCT02181673|594707413|FG000|Week 24-Week 60|Other|0|||
164640463|NCT02181673|594707414|FG001|Week 24-Week 60|Other|2|||
164640464|NCT02181673|594707415|FG002|Week 24-Week 60|Other|1|||
164640465|NCT02181673|594707413|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
164640466|NCT02181673|594707414|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
164640467|NCT02181673|594707415|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
164640468|NCT02181673|594707413|FG000|Week 24-Week 60|Pregnancy|0|||
164640469|NCT02181673|594707414|FG001|Week 24-Week 60|Pregnancy|0|||
164640470|NCT02181673|594707415|FG002|Week 24-Week 60|Pregnancy|1|||
164640471|NCT02181673|594707413|FG000|Week 24-Week 60|Lack of Efficacy|0|||
164640472|NCT02181673|594707414|FG001|Week 24-Week 60|Lack of Efficacy|0|||
164640473|NCT02181673|594707415|FG002|Week 24-Week 60|Lack of Efficacy|1|||
164640474|NCT02181673|594707413|FG000|Week 24-Week 60|Lost to Follow-up|0|||
164640475|NCT02181673|594707414|FG001|Week 24-Week 60|Lost to Follow-up|0|||
164640476|NCT02181673|594707415|FG002|Week 24-Week 60|Lost to Follow-up|1|||
164640477|NCT02181673|594707413|FG000|Week 24-Week 60|Physician Decision|0|||
164640478|NCT02181673|594707414|FG001|Week 24-Week 60|Physician Decision|0|||
164640479|NCT02181673|594707415|FG002|Week 24-Week 60|Physician Decision|1|||
164640480|NCT00433771|594707416|FG000|Overall Study|screen fail|14|||
164640481|NCT00433771|594707416|FG000|Overall Study|Treated and later found to be ineligible|2|||
164640482|NCT00433771|594707416|FG000|Overall Study|Death|2|||
164640483|NCT00433771|594707416|FG000|Overall Study|Failure to deploy stent|1|||
164640484|NCT00138658|594707417|FG000|Overall Study|Adverse Event|23|||
164640485|NCT00138658|594707417|FG000|Overall Study|Death|1|||
164640486|NCT00138658|594707417|FG000|Overall Study|Disease Progression|21|||
164640487|NCT00138658|594707417|FG000|Overall Study|Physician Decision|11|||
164640488|NCT00138658|594707417|FG000|Overall Study|Withdrawal by Subject|5|||
164640489|NCT02050373|594707428|FG000|Overall Study|Adverse Event|4|||
164640490|NCT02050373|594707429|FG001|Overall Study|Adverse Event|7|||
164640491|NCT02050373|594707428|FG000|Overall Study|Death|3|||
164640492|NCT02050373|594707429|FG001|Overall Study|Death|3|||
164640493|NCT00807040|594707433|FG000|Overall Study|Death|24|||
164640494|NCT00807040|594707434|FG001|Overall Study|Death|29|||
164640495|NCT00807040|594707433|FG000|Overall Study|Withdrawal by Subject|8|||
164640496|NCT00807040|594707434|FG001|Overall Study|Withdrawal by Subject|6|||
164640497|NCT00807040|594707433|FG000|Overall Study|Lost to Follow-up|4|||
164640498|NCT00807040|594707434|FG001|Overall Study|Lost to Follow-up|6|||
164640499|NCT01067339|594707435|FG000|Overall Study|Withdrawal by Subject|6|||
164640500|NCT01067339|594707436|FG001|Overall Study|Withdrawal by Subject|5|||
164640501|NCT01179191|594707437|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
164640502|NCT01179191|594707437|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
164640503|NCT01179191|594707437|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
164640504|NCT01179191|594707437|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
164640505|NCT01179191|594707437|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
164640506|NCT01179191|594707437|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
164640507|NCT01179191|594707437|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
164640508|NCT01179191|594707437|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
164640509|NCT01179191|594707437|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
164640510|NCT01179191|594707437|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
164640511|NCT01179191|594707437|FG000|Maintenance Phase (8 Weeks)|Other|66|||
164640512|NCT00572910|594707442|FG000|Overall Study|Adverse Event|1|||
164640513|NCT00572910|594707443|FG001|Overall Study|Adverse Event|2|||
164640514|NCT00572910|594707444|FG002|Overall Study|Adverse Event|0|||
164640515|NCT00572910|594707445|FG003|Overall Study|Adverse Event|2|||
164640516|NCT00572910|594707446|FG004|Overall Study|Adverse Event|0|||
164640517|NCT00572910|594707447|FG005|Overall Study|Adverse Event|0|||
164640518|NCT00572910|594707448|FG006|Overall Study|Adverse Event|4|||
164640519|NCT00572910|594707449|FG007|Overall Study|Adverse Event|2|||
164640520|NCT00572910|594707450|FG008|Overall Study|Adverse Event|1|||
164640521|NCT00572910|594707451|FG009|Overall Study|Adverse Event|3|||
164640522|NCT00572910|594707452|FG010|Overall Study|Adverse Event|2|||
164640523|NCT00572910|594707442|FG000|Overall Study|Lost to Follow-up|0|||
164640524|NCT00572910|594707443|FG001|Overall Study|Lost to Follow-up|1|||
164640525|NCT00572910|594707444|FG002|Overall Study|Lost to Follow-up|1|||
164640526|NCT00572910|594707445|FG003|Overall Study|Lost to Follow-up|2|||
164640527|NCT00572910|594707446|FG004|Overall Study|Lost to Follow-up|1|||
164640528|NCT00572910|594707447|FG005|Overall Study|Lost to Follow-up|0|||
164640529|NCT00572910|594707448|FG006|Overall Study|Lost to Follow-up|0|||
164640530|NCT00572910|594707449|FG007|Overall Study|Lost to Follow-up|0|||
164640531|NCT00572910|594707450|FG008|Overall Study|Lost to Follow-up|0|||
164640532|NCT00572910|594707451|FG009|Overall Study|Lost to Follow-up|1|||
164640533|NCT00572910|594707452|FG010|Overall Study|Lost to Follow-up|0|||
164640534|NCT00572910|594707442|FG000|Overall Study|Withdrawal by Subject|3|||
164640535|NCT00572910|594707443|FG001|Overall Study|Withdrawal by Subject|0|||
164640536|NCT00572910|594707444|FG002|Overall Study|Withdrawal by Subject|1|||
164640537|NCT00572910|594707445|FG003|Overall Study|Withdrawal by Subject|0|||
164640538|NCT00572910|594707446|FG004|Overall Study|Withdrawal by Subject|1|||
164530935|NCT00261846|594315482|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
164530936|NCT00261846|594315483|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
164530937|NCT00261846|594315484|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
164530938|NCT00261846|594315485|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
164530939|NCT00261846|594315486|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
164530940|NCT00261846|594315487|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
164530941|NCT00261846|594315488|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
164530942|NCT00261846|594315489|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
164530943|NCT00261846|594315490|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
164530944|NCT00261846|594315491|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
164530945|NCT01636960|594315494|FG000|Induction Phase|Adverse Event|2|||
164530946|NCT01636960|594315494|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
164530947|NCT01636960|594315494|FG000|Maintenance Phase|Adverse Event|3|||
164530948|NCT01636960|594315494|FG000|Maintenance Phase|Progressive disease|1|||
164530949|NCT01209780|594315495|FG000|Overall Study|Adverse Event|0|||
164530950|NCT01209780|594315496|FG001|Overall Study|Adverse Event|1|||
164530951|NCT01209780|594315497|FG002|Overall Study|Adverse Event|0|||
164530952|NCT01209780|594315498|FG003|Overall Study|Adverse Event|0|||
164530953|NCT01209780|594315499|FG004|Overall Study|Adverse Event|0|||
164530954|NCT01209780|594315495|FG000|Overall Study|Withdrawal by Subject|9|||
164530955|NCT01209780|594315496|FG001|Overall Study|Withdrawal by Subject|2|||
164530956|NCT01209780|594315497|FG002|Overall Study|Withdrawal by Subject|1|||
164530957|NCT01209780|594315498|FG003|Overall Study|Withdrawal by Subject|1|||
164530958|NCT01209780|594315499|FG004|Overall Study|Withdrawal by Subject|0|||
164530959|NCT01209780|594315495|FG000|Overall Study|Lost to Follow-up|17|||
164530960|NCT01209780|594315496|FG001|Overall Study|Lost to Follow-up|12|||
164530961|NCT01209780|594315497|FG002|Overall Study|Lost to Follow-up|3|||
164530962|NCT01209780|594315498|FG003|Overall Study|Lost to Follow-up|9|||
164530963|NCT01209780|594315499|FG004|Overall Study|Lost to Follow-up|4|||
164530964|NCT01209780|594315495|FG000|Overall Study|Protocol Violation|0|||
164530965|NCT01209780|594315496|FG001|Overall Study|Protocol Violation|1|||
164530966|NCT01209780|594315497|FG002|Overall Study|Protocol Violation|0|||
164530967|NCT01209780|594315498|FG003|Overall Study|Protocol Violation|0|||
164530968|NCT01209780|594315499|FG004|Overall Study|Protocol Violation|0|||
164530969|NCT01209780|594315495|FG000|Overall Study|Inappropriate enrollment|0|||
164530970|NCT01209780|594315496|FG001|Overall Study|Inappropriate enrollment|2|||
164530971|NCT01209780|594315497|FG002|Overall Study|Inappropriate enrollment|0|||
164530972|NCT01209780|594315498|FG003|Overall Study|Inappropriate enrollment|0|||
164530973|NCT01209780|594315499|FG004|Overall Study|Inappropriate enrollment|1|||
164530974|NCT01745848|594315500|FG000|Overall Study|Adverse Event|6|||
164530975|NCT00928447|594315504|FG000|Overall Study|Withdrawal by Subject|1|||
164530976|NCT00928447|594315504|FG000|Overall Study|Investigator's decision|1|||
164530977|NCT00926211|594315506|FG000|Overall Study|Lost to Follow-up|1|||
164530978|NCT01242800|594315507|FG000|Overall Study|Patient refusal|0|||
164530979|NCT01242800|594315508|FG001|Overall Study|Patient refusal|10|||
164530980|NCT01242800|594315507|FG000|Overall Study|Physician Decision|0|||
164530981|NCT01242800|594315508|FG001|Overall Study|Physician Decision|1|||
164530982|NCT01242800|594315507|FG000|Overall Study|Disease progression|0|||
164530983|NCT01242800|594315508|FG001|Overall Study|Disease progression|3|||
164530984|NCT01242800|594315507|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
164530985|NCT01242800|594315508|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
164530986|NCT01242800|594315507|FG000|Overall Study|Reasons not reported|0|||
164530987|NCT01242800|594315508|FG001|Overall Study|Reasons not reported|4|||
164530988|NCT00511901|594315512|FG000|Overall Study|Withdrawal by Subject|1|||
164530989|NCT00511901|594315513|FG001|Overall Study|Withdrawal by Subject|3|||
164530990|NCT02447172|594315514|FG000|Overall Study|Adverse Event|11|||
164530991|NCT02447172|594315515|FG001|Overall Study|Adverse Event|8|||
164530992|NCT02447172|594315516|FG002|Overall Study|Adverse Event|7|||
164530993|NCT02447172|594315514|FG000|Overall Study|Death|3|||
164530994|NCT02447172|594315515|FG001|Overall Study|Death|1|||
164530995|NCT02447172|594315516|FG002|Overall Study|Death|0|||
164530996|NCT02447172|594315514|FG000|Overall Study|Protocol Violation|2|||
164530997|NCT02447172|594315515|FG001|Overall Study|Protocol Violation|1|||
164530998|NCT02447172|594315516|FG002|Overall Study|Protocol Violation|2|||
164530999|NCT02447172|594315514|FG000|Overall Study|Lost to Follow-up|7|||
164531000|NCT02447172|594315515|FG001|Overall Study|Lost to Follow-up|4|||
164531001|NCT02447172|594315516|FG002|Overall Study|Lost to Follow-up|4|||
164531002|NCT02447172|594315514|FG000|Overall Study|Withdrawal by Subject|5|||
164531003|NCT02447172|594315515|FG001|Overall Study|Withdrawal by Subject|1|||
164531004|NCT02447172|594315516|FG002|Overall Study|Withdrawal by Subject|3|||
164531005|NCT02447172|594315514|FG000|Overall Study|protocol specific treatment unrelated|3|||
164531006|NCT02447172|594315515|FG001|Overall Study|protocol specific treatment unrelated|0|||
164531007|NCT02447172|594315516|FG002|Overall Study|protocol specific treatment unrelated|2|||
164531008|NCT00585195|594315520|FG000|Overall Study|Adverse Event|0|||
164531009|NCT00585195|594315521|FG001|Overall Study|Adverse Event|0|||
164531010|NCT00585195|594315522|FG002|Overall Study|Adverse Event|0|||
164531011|NCT00585195|594315523|FG003|Overall Study|Adverse Event|0|||
164640539|NCT00572910|594707447|FG005|Overall Study|Withdrawal by Subject|3|||
164640540|NCT00572910|594707448|FG006|Overall Study|Withdrawal by Subject|0|||
164640541|NCT00572910|594707449|FG007|Overall Study|Withdrawal by Subject|2|||
164640542|NCT00572910|594707450|FG008|Overall Study|Withdrawal by Subject|2|||
164640543|NCT00572910|594707451|FG009|Overall Study|Withdrawal by Subject|2|||
164640544|NCT00572910|594707452|FG010|Overall Study|Withdrawal by Subject|1|||
164640545|NCT01833897|594707458|FG000|Overall Study|Lack of Efficacy|1|||
164640546|NCT01870921|594707459|FG000|Overall Study|Subject decision|80|||
164640547|NCT01870921|594707459|FG000|Overall Study|Severe non-compliance to protocol|7|||
164640548|NCT01870921|594707459|FG000|Overall Study|Subject Lost to Follow up|2|||
164640549|NCT01870921|594707459|FG000|Overall Study|Other|1|||
164640550|NCT00806416|594707460|FG000|Period 1 - Part I|Adverse Event|0|||
164640551|NCT00806416|594707461|FG001|Period 1 - Part I|Adverse Event|1|||
164640552|NCT00806416|594707462|FG002|Period 1 - Part I|Adverse Event|0|||
164640553|NCT00806416|594707463|FG003|Period 1 - Part I|Adverse Event|0|||
164640554|NCT00806416|594707460|FG000|Period 1 - Part I|Lost to Follow-up|0|||
164640555|NCT00806416|594707461|FG001|Period 1 - Part I|Lost to Follow-up|2|||
164640556|NCT00806416|594707462|FG002|Period 1 - Part I|Lost to Follow-up|0|||
164640557|NCT00806416|594707463|FG003|Period 1 - Part I|Lost to Follow-up|0|||
164640558|NCT00806416|594707460|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
164640559|NCT00806416|594707461|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
164640560|NCT00806416|594707462|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
164640561|NCT00806416|594707463|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
164640562|NCT00806416|594707460|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
164640563|NCT00806416|594707461|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
164640564|NCT00806416|594707462|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
164640565|NCT00806416|594707463|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
164640566|NCT01102972|594707469|FG000|Overall Study|Adverse Event|8|||
164640567|NCT01102972|594707470|FG001|Overall Study|Adverse Event|2|||
164640568|NCT01102972|594707469|FG000|Overall Study|Lack of Efficacy|2|||
164640569|NCT01102972|594707470|FG001|Overall Study|Lack of Efficacy|1|||
164640570|NCT01102972|594707469|FG000|Overall Study|Protocol Violation|1|||
164640571|NCT01102972|594707470|FG001|Overall Study|Protocol Violation|0|||
164640572|NCT01102972|594707469|FG000|Overall Study|Lost to Follow-up|10|||
164640573|NCT01102972|594707470|FG001|Overall Study|Lost to Follow-up|5|||
164640574|NCT01102972|594707469|FG000|Overall Study|Investigator Discretion|2|||
164640575|NCT01102972|594707470|FG001|Overall Study|Investigator Discretion|0|||
164640576|NCT01102972|594707469|FG000|Overall Study|Withdrawal by Subject|6|||
164640577|NCT01102972|594707470|FG001|Overall Study|Withdrawal by Subject|6|||
164640578|NCT00227591|594707478|FG000|Overall Study|Withdrawal by Subject|1|||
164640579|NCT01886105|594707479|FG000|Overall Study|Lack of Efficacy|3|||
164640580|NCT01360021|594707482|FG000|Overall Study|Eligibility criteria + other|2|||
164640581|NCT01360021|594707483|FG001|Overall Study|Eligibility criteria + other|1|||
164640582|NCT01360021|594707484|FG002|Overall Study|Eligibility criteria + other|1|||
164640583|NCT01360021|594707482|FG000|Overall Study|Protocol Violation|0|||
164640584|NCT01360021|594707483|FG001|Overall Study|Protocol Violation|0|||
164640585|NCT01360021|594707484|FG002|Overall Study|Protocol Violation|1|||
164640586|NCT01360021|594707482|FG000|Overall Study|Withdrawal by Subject|4|||
164640587|NCT01360021|594707483|FG001|Overall Study|Withdrawal by Subject|0|||
164640588|NCT01360021|594707484|FG002|Overall Study|Withdrawal by Subject|2|||
164640589|NCT01360021|594707482|FG000|Overall Study|Adverse Event|2|||
164640590|NCT01360021|594707483|FG001|Overall Study|Adverse Event|3|||
164640591|NCT01360021|594707484|FG002|Overall Study|Adverse Event|3|||
164640592|NCT05048875|594707486|FG000|Overall Study|Withdrawal by Subject|1|||
164640593|NCT05048875|594707487|FG001|Overall Study|Withdrawal by Subject|0|||
164640594|NCT05048875|594707488|FG002|Overall Study|Withdrawal by Subject|0|||
164640595|NCT05048875|594707489|FG003|Overall Study|Withdrawal by Subject|0|||
164640596|NCT05048875|594707490|FG004|Overall Study|Withdrawal by Subject|0|||
164640597|NCT05048875|594707491|FG005|Overall Study|Withdrawal by Subject|0|||
164640598|NCT05048875|594707492|FG006|Overall Study|Withdrawal by Subject|0|||
164640599|NCT05048875|594707493|FG007|Overall Study|Withdrawal by Subject|0|||
164640600|NCT05048875|594707486|FG000|Overall Study|Adverse Event|0|||
164640601|NCT05048875|594707487|FG001|Overall Study|Adverse Event|0|||
164640602|NCT05048875|594707488|FG002|Overall Study|Adverse Event|0|||
164640603|NCT05048875|594707489|FG003|Overall Study|Adverse Event|1|||
164640604|NCT05048875|594707490|FG004|Overall Study|Adverse Event|0|||
164640605|NCT05048875|594707491|FG005|Overall Study|Adverse Event|0|||
164640606|NCT05048875|594707492|FG006|Overall Study|Adverse Event|0|||
164640607|NCT05048875|594707493|FG007|Overall Study|Adverse Event|0|||
164640608|NCT02255422|594707494|FG000|Overall Study|Withdrawal by Subject|0|||
164640609|NCT02255422|594707495|FG001|Overall Study|Withdrawal by Subject|0|||
164640610|NCT02255422|594707496|FG002|Overall Study|Withdrawal by Subject|0|||
164640611|NCT02255422|594707497|FG003|Overall Study|Withdrawal by Subject|0|||
164640612|NCT02255422|594707498|FG004|Overall Study|Withdrawal by Subject|0|||
164640613|NCT02255422|594707499|FG005|Overall Study|Withdrawal by Subject|0|||
164640614|NCT02255422|594707500|FG006|Overall Study|Withdrawal by Subject|2|||
164640615|NCT02255422|594707494|FG000|Overall Study|Lost to Follow-up|0|||
164640616|NCT02255422|594707495|FG001|Overall Study|Lost to Follow-up|0|||
164640617|NCT02255422|594707496|FG002|Overall Study|Lost to Follow-up|1|||
164640618|NCT02255422|594707497|FG003|Overall Study|Lost to Follow-up|0|||
164640619|NCT02255422|594707498|FG004|Overall Study|Lost to Follow-up|0|||
164640620|NCT02255422|594707499|FG005|Overall Study|Lost to Follow-up|0|||
164640621|NCT02255422|594707500|FG006|Overall Study|Lost to Follow-up|0|||
164640622|NCT03179462|594707508|FG000|Overall Study|screening failure|1|||
164640623|NCT03179462|594707509|FG001|Overall Study|screening failure|2|||
164640624|NCT03179462|594707510|FG002|Overall Study|screening failure|0|||
164640625|NCT04410978|594707519|FG000|Overall Study|Poor compliance to protocol|2|||
164640626|NCT04410978|594707520|FG001|Overall Study|Poor compliance to protocol|4|||
164640627|NCT04410978|594707519|FG000|Overall Study|Withdrawal by Subject|64|||
164640628|NCT04410978|594707520|FG001|Overall Study|Withdrawal by Subject|66|||
164640629|NCT04410978|594707519|FG000|Overall Study|Other|6|||
164640630|NCT04410978|594707520|FG001|Overall Study|Other|7|||
164640631|NCT04410978|594707519|FG000|Overall Study|Missing study status|1|||
164640632|NCT04410978|594707520|FG001|Overall Study|Missing study status|0|||
164640633|NCT05153629|594707521|FG000|Overall Study|Withdrawal by Subject|0|||
164640634|NCT05153629|594707522|FG001|Overall Study|Withdrawal by Subject|2|||
164640635|NCT04089566|594707525|FG000|Overall Study|Death|0|||
164640636|NCT04089566|594707526|FG001|Overall Study|Death|6|||
164640637|NCT04089566|594707527|FG002|Overall Study|Death|10|||
164640638|NCT04089566|594707528|FG003|Overall Study|Death|0|||
164640639|NCT04089566|594707529|FG004|Overall Study|Death|0|||
164640640|NCT04089566|594707530|FG005|Overall Study|Death|0|||
164640641|NCT04089566|594707525|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
164640642|NCT04089566|594707526|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
164640643|NCT04089566|594707527|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
164640644|NCT04089566|594707528|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
164640645|NCT04089566|594707529|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
164640646|NCT04089566|594707530|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
164640647|NCT04089566|594707525|FG000|Overall Study|Reason not Specified|0|||
164640648|NCT04089566|594707526|FG001|Overall Study|Reason not Specified|4|||
164640649|NCT04089566|594707527|FG002|Overall Study|Reason not Specified|4|||
164640650|NCT04089566|594707528|FG003|Overall Study|Reason not Specified|1|||
164640651|NCT04089566|594707529|FG004|Overall Study|Reason not Specified|0|||
164640652|NCT04089566|594707530|FG005|Overall Study|Reason not Specified|0|||
164640653|NCT05403502|594707531|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
164640654|NCT05403502|594707531|FG000|Humalog Lead-In Period|Physician Decision|2|||
164640655|NCT05403502|594707531|FG000|Humalog Lead-In Period|Protocol Violation|1|||
164640656|NCT05403502|594707531|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
164640657|NCT05403502|594707531|FG000|Lyumjev Treatment Period|Physician Decision|2|||
164640658|NCT01593761|594707533|FG000|Overall Study|Lost to Follow-up|1|||
164640659|NCT01593761|594707533|FG000|Overall Study|culture negative for MRSA at baseline|5|||
164640660|NCT01593761|594707533|FG000|Overall Study|positive for hepatitis C virus|1|||
164640661|NCT01593761|594707533|FG000|Overall Study|secondary cellulitis|1|||
164640662|NCT02576951|594707534|FG000|Overall Study|Lost to Follow-up|0|||
164640663|NCT02576951|594707535|FG001|Overall Study|Lost to Follow-up|0|||
164640664|NCT02576951|594707536|FG002|Overall Study|Lost to Follow-up|2|||
164640665|NCT02576951|594707537|FG003|Overall Study|Lost to Follow-up|2|||
164640666|NCT02576951|594707534|FG000|Overall Study|Withdrawal by Subject|1|||
164640667|NCT02576951|594707535|FG001|Overall Study|Withdrawal by Subject|0|||
164640668|NCT02576951|594707536|FG002|Overall Study|Withdrawal by Subject|0|||
164640669|NCT02576951|594707537|FG003|Overall Study|Withdrawal by Subject|2|||
164640670|NCT02576951|594707534|FG000|Overall Study|Protocol Violation|0|||
164640671|NCT02576951|594707535|FG001|Overall Study|Protocol Violation|0|||
164640672|NCT02576951|594707536|FG002|Overall Study|Protocol Violation|0|||
164640673|NCT02576951|594707537|FG003|Overall Study|Protocol Violation|1|||
164640674|NCT03505606|594709252|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
164640675|NCT03505606|594709253|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
164640676|NCT03505606|594709254|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
164640677|NCT03505606|594709252|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
164640678|NCT03505606|594709253|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
164640679|NCT03505606|594709254|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
164640680|NCT03505606|594709252|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
164640681|NCT03505606|594709253|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
164640682|NCT03505606|594709254|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
164640683|NCT03505606|594709252|FG000|Overall Study|Poor compliance with refractive correction|0|||
164640684|NCT03505606|594709253|FG001|Overall Study|Poor compliance with refractive correction|0|||
164640685|NCT03505606|594709254|FG002|Overall Study|Poor compliance with refractive correction|1|||
164640686|NCT03505606|594709252|FG000|Overall Study|Insufficient anisometropia|0|||
164640687|NCT03505606|594709253|FG001|Overall Study|Insufficient anisometropia|0|||
164640688|NCT03505606|594709254|FG002|Overall Study|Insufficient anisometropia|2|||
164640689|NCT03505606|594709252|FG000|Overall Study|Ectopia Lentis|0|||
164640690|NCT03505606|594709253|FG001|Overall Study|Ectopia Lentis|0|||
164640691|NCT03505606|594709254|FG002|Overall Study|Ectopia Lentis|1|||
164640692|NCT03505606|594709252|FG000|Overall Study|alternation of amblyopic eye|0|||
164640693|NCT03505606|594709253|FG001|Overall Study|alternation of amblyopic eye|1|||
164640694|NCT03505606|594709254|FG002|Overall Study|alternation of amblyopic eye|0|||
164640695|NCT02087865|594709257|FG000|Overall Study|Withdrawal by Subject|6|||
164640696|NCT02087865|594709258|FG001|Overall Study|Withdrawal by Subject|0|||
164640697|NCT02087865|594709259|FG002|Overall Study|Withdrawal by Subject|1|||
164640698|NCT02087865|594709257|FG000|Overall Study|Lost to Follow-up|0|||
164640699|NCT02087865|594709258|FG001|Overall Study|Lost to Follow-up|0|||
164640700|NCT02087865|594709259|FG002|Overall Study|Lost to Follow-up|1|||
164640701|NCT02087865|594709257|FG000|Overall Study|Drug Non-compliance|0|||
164640702|NCT02087865|594709258|FG001|Overall Study|Drug Non-compliance|2|||
164640703|NCT02087865|594709259|FG002|Overall Study|Drug Non-compliance|0|||
164531012|NCT00585195|594315524|FG004|Overall Study|Adverse Event|2|||
164531013|NCT00585195|594315525|FG005|Overall Study|Adverse Event|1|||
164531014|NCT00585195|594315526|FG006|Overall Study|Adverse Event|0|||
164531015|NCT00585195|594315527|FG007|Overall Study|Adverse Event|1|||
164531016|NCT00585195|594315528|FG008|Overall Study|Adverse Event|0|||
164531017|NCT00585195|594315529|FG009|Overall Study|Adverse Event|0|||
164531018|NCT00585195|594315530|FG010|Overall Study|Adverse Event|3|||
164531019|NCT00585195|594315531|FG011|Overall Study|Adverse Event|0|||
164531020|NCT00585195|594315532|FG012|Overall Study|Adverse Event|8|||
164148621|NCT04895982|592904917|FG006|Overall Study|Protocol Violation|0|||
164640704|NCT02087865|594709257|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
164640705|NCT02087865|594709258|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
164640706|NCT02087865|594709259|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
164640707|NCT01319994|594709260|FG000|Overall Study|Protocol Violation|7|||
164640708|NCT01319994|594709261|FG001|Overall Study|Protocol Violation|6|||
164640709|NCT01340794|594709262|FG000|Overall Study|Withdrawal by Subject|0|||
164640710|NCT01340794|594709263|FG001|Overall Study|Withdrawal by Subject|1|||
164640711|NCT01432600|594709270|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
164640712|NCT01432600|594709271|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
164640713|NCT01432600|594709272|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
164640714|NCT00398632|594709273|FG000|Overall Study|Withdrawal by Subject|1|||
164640715|NCT00398632|594709273|FG000|Overall Study|Lack of Efficacy|1|||
164640716|NCT00640614|594709274|FG000|Overall Study|Lost to Follow-up|1|||
164640717|NCT00640614|594709275|FG001|Overall Study|Lost to Follow-up|0|||
164640718|NCT04633434|594709279|FG000|Overall Study|Lost to Follow-up|32|||
164640719|NCT04633434|594709280|FG001|Overall Study|Lost to Follow-up|32|||
164640720|NCT01005680|594709284|FG000|Overall Study|Lost to Follow-up|4|||
164640721|NCT01005680|594709285|FG001|Overall Study|Lost to Follow-up|6|||
164640722|NCT01005680|594709284|FG000|Overall Study|Withdrawal by Subject|1|||
164640723|NCT01005680|594709285|FG001|Overall Study|Withdrawal by Subject|4|||
164640724|NCT01005680|594709284|FG000|Overall Study|Physician Decision|1|||
164640725|NCT01005680|594709285|FG001|Overall Study|Physician Decision|1|||
164640726|NCT00297882|594709287|FG000|Day 14|Lack of Efficacy|12|||
164640727|NCT00297882|594709288|FG001|Day 14|Lack of Efficacy|49|||
164640728|NCT00297882|594709287|FG000|Day 28|Lost to Follow-up|13|||
164640729|NCT00297882|594709288|FG001|Day 28|Lost to Follow-up|23|||
164640730|NCT00297882|594709287|FG000|Day 28|Lack of Efficacy|3|||
164640731|NCT00297882|594709288|FG001|Day 28|Lack of Efficacy|0|||
164640732|NCT02118896|594709289|FG000|Overall Study|Death|4|||
164640733|NCT02118896|594709290|FG001|Overall Study|Death|0|||
164640734|NCT02118896|594709291|FG002|Overall Study|Death|4|||
164640735|NCT02118896|594709292|FG003|Overall Study|Death|6|||
164640736|NCT02118896|594709293|FG004|Overall Study|Death|3|||
164640737|NCT02118896|594709294|FG005|Overall Study|Death|1|||
164640738|NCT02118896|594709295|FG006|Overall Study|Death|0|||
164640739|NCT02118896|594709296|FG007|Overall Study|Death|0|||
164640740|NCT02118896|594709297|FG008|Overall Study|Death|0|||
164640741|NCT02118896|594709298|FG009|Overall Study|Death|0|||
164640742|NCT02118896|594709289|FG000|Overall Study|Adverse Event|5|||
164640743|NCT02118896|594709290|FG001|Overall Study|Adverse Event|4|||
164640744|NCT02118896|594709291|FG002|Overall Study|Adverse Event|4|||
164640745|NCT02118896|594709292|FG003|Overall Study|Adverse Event|5|||
164640746|NCT02118896|594709293|FG004|Overall Study|Adverse Event|5|||
164640747|NCT02118896|594709294|FG005|Overall Study|Adverse Event|9|||
164640748|NCT02118896|594709295|FG006|Overall Study|Adverse Event|1|||
164640749|NCT02118896|594709296|FG007|Overall Study|Adverse Event|1|||
164640750|NCT02118896|594709297|FG008|Overall Study|Adverse Event|4|||
164640751|NCT02118896|594709298|FG009|Overall Study|Adverse Event|0|||
164640752|NCT02118896|594709289|FG000|Overall Study|Consent withdrawn|2|||
164640753|NCT02118896|594709290|FG001|Overall Study|Consent withdrawn|0|||
164640754|NCT02118896|594709291|FG002|Overall Study|Consent withdrawn|3|||
164640755|NCT02118896|594709292|FG003|Overall Study|Consent withdrawn|4|||
164640756|NCT02118896|594709293|FG004|Overall Study|Consent withdrawn|1|||
164640757|NCT02118896|594709294|FG005|Overall Study|Consent withdrawn|4|||
164640758|NCT02118896|594709295|FG006|Overall Study|Consent withdrawn|0|||
164640759|NCT02118896|594709296|FG007|Overall Study|Consent withdrawn|0|||
164640760|NCT02118896|594709297|FG008|Overall Study|Consent withdrawn|0|||
164640761|NCT02118896|594709298|FG009|Overall Study|Consent withdrawn|0|||
164640762|NCT02118896|594709289|FG000|Overall Study|Non-compliance|2|||
164640763|NCT02118896|594709290|FG001|Overall Study|Non-compliance|1|||
164640764|NCT02118896|594709291|FG002|Overall Study|Non-compliance|1|||
164640765|NCT02118896|594709292|FG003|Overall Study|Non-compliance|5|||
164640766|NCT02118896|594709293|FG004|Overall Study|Non-compliance|0|||
164640767|NCT02118896|594709294|FG005|Overall Study|Non-compliance|1|||
164640768|NCT02118896|594709295|FG006|Overall Study|Non-compliance|0|||
164640769|NCT02118896|594709296|FG007|Overall Study|Non-compliance|1|||
164640770|NCT02118896|594709297|FG008|Overall Study|Non-compliance|0|||
164640771|NCT02118896|594709298|FG009|Overall Study|Non-compliance|0|||
164640772|NCT02118896|594709289|FG000|Overall Study|Pregnancy|1|||
164640773|NCT02118896|594709290|FG001|Overall Study|Pregnancy|1|||
164640774|NCT02118896|594709291|FG002|Overall Study|Pregnancy|0|||
164640775|NCT02118896|594709292|FG003|Overall Study|Pregnancy|0|||
164640776|NCT02118896|594709293|FG004|Overall Study|Pregnancy|1|||
164640777|NCT02118896|594709294|FG005|Overall Study|Pregnancy|3|||
164640778|NCT02118896|594709295|FG006|Overall Study|Pregnancy|1|||
164640779|NCT02118896|594709296|FG007|Overall Study|Pregnancy|0|||
164640780|NCT02118896|594709297|FG008|Overall Study|Pregnancy|0|||
164640781|NCT02118896|594709298|FG009|Overall Study|Pregnancy|0|||
164640782|NCT02118896|594709289|FG000|Overall Study|Lost to Follow-up|1|||
164640783|NCT02118896|594709290|FG001|Overall Study|Lost to Follow-up|2|||
164640784|NCT02118896|594709291|FG002|Overall Study|Lost to Follow-up|1|||
164531021|NCT00585195|594315533|FG013|Overall Study|Adverse Event|6|||
164531022|NCT00585195|594315534|FG014|Overall Study|Adverse Event|4|||
164531023|NCT00585195|594315535|FG015|Overall Study|Adverse Event|1|||
164531024|NCT00585195|594315536|FG016|Overall Study|Adverse Event|14|||
164531025|NCT00585195|594315537|FG017|Overall Study|Adverse Event|9|||
164531026|NCT00585195|594315538|FG018|Overall Study|Adverse Event|2|||
164531027|NCT00585195|594315539|FG019|Overall Study|Adverse Event|3|||
164531028|NCT00585195|594315540|FG020|Overall Study|Adverse Event|1|||
164531029|NCT00585195|594315520|FG000|Overall Study|Progressive Disease|2|||
164531030|NCT00585195|594315521|FG001|Overall Study|Progressive Disease|2|||
164531031|NCT00585195|594315522|FG002|Overall Study|Progressive Disease|5|||
164531032|NCT00585195|594315523|FG003|Overall Study|Progressive Disease|4|||
164531033|NCT00585195|594315524|FG004|Overall Study|Progressive Disease|6|||
164531034|NCT00585195|594315525|FG005|Overall Study|Progressive Disease|4|||
164531035|NCT00585195|594315526|FG006|Overall Study|Progressive Disease|6|||
164531036|NCT00585195|594315527|FG007|Overall Study|Progressive Disease|3|||
164531037|NCT00585195|594315528|FG008|Overall Study|Progressive Disease|0|||
164531038|NCT00585195|594315529|FG009|Overall Study|Progressive Disease|5|||
164531039|NCT00585195|594315530|FG010|Overall Study|Progressive Disease|2|||
164531040|NCT00585195|594315531|FG011|Overall Study|Progressive Disease|25|||
164531041|NCT00585195|594315532|FG012|Overall Study|Progressive Disease|29|||
164531042|NCT00585195|594315533|FG013|Overall Study|Progressive Disease|26|||
164531043|NCT00585195|594315534|FG014|Overall Study|Progressive Disease|21|||
164531044|NCT00585195|594315535|FG015|Overall Study|Progressive Disease|12|||
164531045|NCT00585195|594315536|FG016|Overall Study|Progressive Disease|94|||
164531046|NCT00585195|594315537|FG017|Overall Study|Progressive Disease|42|||
164531047|NCT00585195|594315538|FG018|Overall Study|Progressive Disease|4|||
164531048|NCT00585195|594315539|FG019|Overall Study|Progressive Disease|9|||
164531049|NCT00585195|594315540|FG020|Overall Study|Progressive Disease|8|||
164531050|NCT00585195|594315520|FG000|Overall Study|Withdrawal by Subject|1|||
164531051|NCT00585195|594315521|FG001|Overall Study|Withdrawal by Subject|1|||
164531052|NCT00585195|594315522|FG002|Overall Study|Withdrawal by Subject|2|||
164531053|NCT00585195|594315523|FG003|Overall Study|Withdrawal by Subject|2|||
164531054|NCT00585195|594315524|FG004|Overall Study|Withdrawal by Subject|0|||
164531055|NCT00585195|594315525|FG005|Overall Study|Withdrawal by Subject|0|||
164531056|NCT00585195|594315526|FG006|Overall Study|Withdrawal by Subject|0|||
164531057|NCT00585195|594315527|FG007|Overall Study|Withdrawal by Subject|1|||
164531058|NCT00585195|594315528|FG008|Overall Study|Withdrawal by Subject|0|||
164531059|NCT00585195|594315529|FG009|Overall Study|Withdrawal by Subject|0|||
164531060|NCT00585195|594315530|FG010|Overall Study|Withdrawal by Subject|3|||
164531061|NCT00585195|594315531|FG011|Overall Study|Withdrawal by Subject|8|||
164531062|NCT00585195|594315532|FG012|Overall Study|Withdrawal by Subject|15|||
164531063|NCT00585195|594315533|FG013|Overall Study|Withdrawal by Subject|0|||
164531064|NCT00585195|594315534|FG014|Overall Study|Withdrawal by Subject|3|||
164531065|NCT00585195|594315535|FG015|Overall Study|Withdrawal by Subject|0|||
164531066|NCT00585195|594315536|FG016|Overall Study|Withdrawal by Subject|7|||
164531067|NCT00585195|594315537|FG017|Overall Study|Withdrawal by Subject|1|||
164531068|NCT00585195|594315538|FG018|Overall Study|Withdrawal by Subject|2|||
164531069|NCT00585195|594315539|FG019|Overall Study|Withdrawal by Subject|2|||
164531070|NCT00585195|594315540|FG020|Overall Study|Withdrawal by Subject|0|||
164531071|NCT00585195|594315520|FG000|Overall Study|Other|0|||
164531072|NCT00585195|594315521|FG001|Overall Study|Other|1|||
164531073|NCT00585195|594315522|FG002|Overall Study|Other|1|||
164531074|NCT00585195|594315523|FG003|Overall Study|Other|1|||
164531075|NCT00585195|594315524|FG004|Overall Study|Other|0|||
164531076|NCT00585195|594315525|FG005|Overall Study|Other|1|||
164531077|NCT00585195|594315526|FG006|Overall Study|Other|0|||
164531078|NCT00585195|594315527|FG007|Overall Study|Other|0|||
164640785|NCT02118896|594709292|FG003|Overall Study|Lost to Follow-up|0|||
164531079|NCT00585195|594315528|FG008|Overall Study|Other|2|||
164531080|NCT00585195|594315529|FG009|Overall Study|Other|1|||
164531081|NCT00585195|594315530|FG010|Overall Study|Other|0|||
164531082|NCT00585195|594315531|FG011|Overall Study|Other|19|||
164531083|NCT00585195|594315532|FG012|Overall Study|Other|24|||
164531084|NCT00585195|594315533|FG013|Overall Study|Other|7|||
164640786|NCT02118896|594709293|FG004|Overall Study|Lost to Follow-up|2|||
164640787|NCT02118896|594709294|FG005|Overall Study|Lost to Follow-up|1|||
164531085|NCT00585195|594315534|FG014|Overall Study|Other|11|||
164531086|NCT00585195|594315535|FG015|Overall Study|Other|3|||
164531087|NCT00585195|594315536|FG016|Overall Study|Other|28|||
164531088|NCT00585195|594315537|FG017|Overall Study|Other|12|||
164531089|NCT00585195|594315538|FG018|Overall Study|Other|10|||
164531090|NCT00585195|594315539|FG019|Overall Study|Other|4|||
164640788|NCT02118896|594709295|FG006|Overall Study|Lost to Follow-up|0|||
164531091|NCT00585195|594315540|FG020|Overall Study|Other|2|||
164531092|NCT00585195|594315520|FG000|Overall Study|Randomized not treated|0|||
164531093|NCT00585195|594315521|FG001|Overall Study|Randomized not treated|0|||
164531094|NCT00585195|594315522|FG002|Overall Study|Randomized not treated|1|||
164531095|NCT00585195|594315523|FG003|Overall Study|Randomized not treated|0|||
164531096|NCT00585195|594315524|FG004|Overall Study|Randomized not treated|1|||
164531097|NCT00585195|594315525|FG005|Overall Study|Randomized not treated|0|||
164531098|NCT00585195|594315526|FG006|Overall Study|Randomized not treated|1|||
164531099|NCT00585195|594315527|FG007|Overall Study|Randomized not treated|0|||
164531100|NCT00585195|594315528|FG008|Overall Study|Randomized not treated|0|||
164531101|NCT00585195|594315529|FG009|Overall Study|Randomized not treated|0|||
164531102|NCT00585195|594315530|FG010|Overall Study|Randomized not treated|2|||
164531103|NCT00585195|594315531|FG011|Overall Study|Randomized not treated|0|||
164531104|NCT00585195|594315532|FG012|Overall Study|Randomized not treated|0|||
164531105|NCT00585195|594315533|FG013|Overall Study|Randomized not treated|0|||
164531106|NCT00585195|594315534|FG014|Overall Study|Randomized not treated|0|||
164531107|NCT00585195|594315535|FG015|Overall Study|Randomized not treated|1|||
164531108|NCT00585195|594315536|FG016|Overall Study|Randomized not treated|0|||
164531109|NCT00585195|594315537|FG017|Overall Study|Randomized not treated|1|||
164531110|NCT00585195|594315538|FG018|Overall Study|Randomized not treated|3|||
164531111|NCT00585195|594315539|FG019|Overall Study|Randomized not treated|0|||
164531112|NCT00585195|594315540|FG020|Overall Study|Randomized not treated|2|||
164531113|NCT00585195|594315520|FG000|Overall Study|Death|0|||
164531114|NCT00585195|594315521|FG001|Overall Study|Death|0|||
164531115|NCT00585195|594315522|FG002|Overall Study|Death|0|||
164531116|NCT00585195|594315523|FG003|Overall Study|Death|0|||
164531117|NCT00585195|594315524|FG004|Overall Study|Death|0|||
164531118|NCT00585195|594315525|FG005|Overall Study|Death|0|||
164531119|NCT00585195|594315526|FG006|Overall Study|Death|0|||
164531120|NCT00585195|594315527|FG007|Overall Study|Death|0|||
164531121|NCT00585195|594315528|FG008|Overall Study|Death|1|||
164531122|NCT00585195|594315529|FG009|Overall Study|Death|0|||
164531123|NCT00585195|594315530|FG010|Overall Study|Death|1|||
164531124|NCT00585195|594315531|FG011|Overall Study|Death|1|||
164531125|NCT00585195|594315532|FG012|Overall Study|Death|7|||
164531126|NCT00585195|594315533|FG013|Overall Study|Death|2|||
164531127|NCT00585195|594315534|FG014|Overall Study|Death|8|||
164531128|NCT00585195|594315535|FG015|Overall Study|Death|2|||
164531129|NCT00585195|594315536|FG016|Overall Study|Death|11|||
164531130|NCT00585195|594315537|FG017|Overall Study|Death|0|||
164531131|NCT00585195|594315538|FG018|Overall Study|Death|0|||
164531132|NCT00585195|594315539|FG019|Overall Study|Death|0|||
164531133|NCT00585195|594315540|FG020|Overall Study|Death|1|||
164531134|NCT00585195|594315520|FG000|Overall Study|Lost to Follow-up|0|||
164531135|NCT00585195|594315521|FG001|Overall Study|Lost to Follow-up|0|||
164531136|NCT00585195|594315522|FG002|Overall Study|Lost to Follow-up|0|||
164531137|NCT00585195|594315523|FG003|Overall Study|Lost to Follow-up|0|||
164531138|NCT00585195|594315524|FG004|Overall Study|Lost to Follow-up|0|||
164531139|NCT00585195|594315525|FG005|Overall Study|Lost to Follow-up|0|||
164531140|NCT00585195|594315526|FG006|Overall Study|Lost to Follow-up|0|||
164531141|NCT00585195|594315527|FG007|Overall Study|Lost to Follow-up|0|||
164531142|NCT00585195|594315528|FG008|Overall Study|Lost to Follow-up|0|||
164531143|NCT00585195|594315529|FG009|Overall Study|Lost to Follow-up|0|||
164531144|NCT00585195|594315530|FG010|Overall Study|Lost to Follow-up|0|||
164531145|NCT00585195|594315531|FG011|Overall Study|Lost to Follow-up|0|||
164531146|NCT00585195|594315532|FG012|Overall Study|Lost to Follow-up|1|||
164531147|NCT00585195|594315533|FG013|Overall Study|Lost to Follow-up|0|||
164531148|NCT00585195|594315534|FG014|Overall Study|Lost to Follow-up|0|||
164531149|NCT00585195|594315535|FG015|Overall Study|Lost to Follow-up|0|||
164531150|NCT00585195|594315536|FG016|Overall Study|Lost to Follow-up|0|||
164531151|NCT00585195|594315537|FG017|Overall Study|Lost to Follow-up|2|||
164531152|NCT00585195|594315538|FG018|Overall Study|Lost to Follow-up|0|||
164531153|NCT00585195|594315539|FG019|Overall Study|Lost to Follow-up|0|||
164531154|NCT00585195|594315540|FG020|Overall Study|Lost to Follow-up|0|||
164531155|NCT00585195|594315520|FG000|Overall Study|Site Terminated by Sponsor|0|||
164531156|NCT00585195|594315521|FG001|Overall Study|Site Terminated by Sponsor|0|||
164531157|NCT00585195|594315522|FG002|Overall Study|Site Terminated by Sponsor|0|||
164531158|NCT00585195|594315523|FG003|Overall Study|Site Terminated by Sponsor|0|||
164531159|NCT00585195|594315524|FG004|Overall Study|Site Terminated by Sponsor|0|||
164531160|NCT00585195|594315525|FG005|Overall Study|Site Terminated by Sponsor|0|||
164531161|NCT00585195|594315526|FG006|Overall Study|Site Terminated by Sponsor|0|||
164640789|NCT02118896|594709296|FG007|Overall Study|Lost to Follow-up|0|||
164640790|NCT02118896|594709297|FG008|Overall Study|Lost to Follow-up|0|||
164640791|NCT02118896|594709298|FG009|Overall Study|Lost to Follow-up|0|||
164640792|NCT02118896|594709289|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
164640793|NCT02118896|594709290|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
164640794|NCT02118896|594709291|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
164640795|NCT02118896|594709292|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
164640796|NCT02118896|594709293|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
164640797|NCT02118896|594709294|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
164640798|NCT02118896|594709295|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
164640799|NCT02118896|594709296|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
164640800|NCT02118896|594709297|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
164640801|NCT02118896|594709298|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
164640802|NCT02118896|594709289|FG000|Overall Study|Prohibited medication|0|||
164640803|NCT02118896|594709290|FG001|Overall Study|Prohibited medication|0|||
164640804|NCT02118896|594709291|FG002|Overall Study|Prohibited medication|0|||
164640805|NCT02118896|594709292|FG003|Overall Study|Prohibited medication|0|||
164640806|NCT02118896|594709293|FG004|Overall Study|Prohibited medication|1|||
164640807|NCT02118896|594709294|FG005|Overall Study|Prohibited medication|3|||
164640808|NCT02118896|594709295|FG006|Overall Study|Prohibited medication|0|||
164640809|NCT02118896|594709296|FG007|Overall Study|Prohibited medication|0|||
164640810|NCT02118896|594709297|FG008|Overall Study|Prohibited medication|0|||
164640811|NCT02118896|594709298|FG009|Overall Study|Prohibited medication|0|||
164640812|NCT02118896|594709289|FG000|Overall Study|Miscellaneous|1|||
164640813|NCT02118896|594709290|FG001|Overall Study|Miscellaneous|2|||
164640814|NCT02118896|594709291|FG002|Overall Study|Miscellaneous|0|||
164640815|NCT02118896|594709292|FG003|Overall Study|Miscellaneous|2|||
164640816|NCT02118896|594709293|FG004|Overall Study|Miscellaneous|0|||
164640817|NCT02118896|594709294|FG005|Overall Study|Miscellaneous|4|||
164640818|NCT02118896|594709295|FG006|Overall Study|Miscellaneous|0|||
164640819|NCT02118896|594709296|FG007|Overall Study|Miscellaneous|0|||
164640820|NCT02118896|594709297|FG008|Overall Study|Miscellaneous|0|||
164640821|NCT02118896|594709298|FG009|Overall Study|Miscellaneous|0|||
164640822|NCT04242264|594709299|FG000|Overall Study|Lost to Follow-up|2|||
164640823|NCT04242264|594709300|FG001|Overall Study|Lost to Follow-up|2|||
164640824|NCT04242264|594709301|FG002|Overall Study|Lost to Follow-up|1|||
164640825|NCT04242264|594709302|FG003|Overall Study|Lost to Follow-up|1|||
164640826|NCT04242264|594709299|FG000|Overall Study|Withdrawal by Subject|1|||
164640827|NCT04242264|594709300|FG001|Overall Study|Withdrawal by Subject|0|||
164640828|NCT04242264|594709301|FG002|Overall Study|Withdrawal by Subject|0|||
164640829|NCT04242264|594709302|FG003|Overall Study|Withdrawal by Subject|0|||
164640830|NCT02329834|594709303|FG000|Overall Study|Physician Decision|1|||
164640831|NCT02329834|594709304|FG001|Overall Study|Physician Decision|0|||
164640832|NCT00578448|594709307|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
164640833|NCT00578448|594709307|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
164640834|NCT00578448|594709307|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
164640835|NCT00578448|594709307|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
164640836|NCT01976104|594709311|FG000|Overall Study|Adverse Event|0|||
164640837|NCT01976104|594709312|FG001|Overall Study|Adverse Event|0|||
164640838|NCT01976104|594709313|FG002|Overall Study|Adverse Event|1|||
164640839|NCT01976104|594709314|FG003|Overall Study|Adverse Event|0|||
164640840|NCT01976104|594709311|FG000|Overall Study|Lost to Follow-up|3|||
164640841|NCT01976104|594709312|FG001|Overall Study|Lost to Follow-up|0|||
164640842|NCT01976104|594709313|FG002|Overall Study|Lost to Follow-up|1|||
164640843|NCT01976104|594709314|FG003|Overall Study|Lost to Follow-up|1|||
164640844|NCT01976104|594709311|FG000|Overall Study|Subject Choice|0|||
164640845|NCT01976104|594709312|FG001|Overall Study|Subject Choice|1|||
164640846|NCT01976104|594709313|FG002|Overall Study|Subject Choice|0|||
164640847|NCT01976104|594709314|FG003|Overall Study|Subject Choice|1|||
164640848|NCT01976104|594709311|FG000|Overall Study|Withdrawal by Subject|3|||
164640849|NCT01976104|594709312|FG001|Overall Study|Withdrawal by Subject|0|||
164640850|NCT01976104|594709313|FG002|Overall Study|Withdrawal by Subject|0|||
164640851|NCT01976104|594709314|FG003|Overall Study|Withdrawal by Subject|1|||
164640852|NCT01976104|594709311|FG000|Overall Study|Other|0|||
164640853|NCT01976104|594709312|FG001|Overall Study|Other|1|||
164640854|NCT01976104|594709313|FG002|Overall Study|Other|0|||
164640855|NCT01976104|594709314|FG003|Overall Study|Other|0|||
164640856|NCT01283009|594709315|FG000|Overall Study|Death|83|||
164640857|NCT01283009|594709316|FG001|Overall Study|Death|78|||
164640858|NCT01283009|594709315|FG000|Overall Study|Study ended early|23|||
164640859|NCT01283009|594709316|FG001|Overall Study|Study ended early|26|||
164640860|NCT01283009|594709315|FG000|Overall Study|Withdrawal by Subject|10|||
164640861|NCT01283009|594709316|FG001|Overall Study|Withdrawal by Subject|8|||
164640862|NCT01283009|594709315|FG000|Overall Study|Physician Decision|1|||
164640863|NCT01283009|594709316|FG001|Overall Study|Physician Decision|1|||
164640864|NCT01283009|594709315|FG000|Overall Study|Lost to Follow-up|1|||
164640865|NCT01283009|594709316|FG001|Overall Study|Lost to Follow-up|0|||
164640866|NCT01283009|594709315|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
164640867|NCT01283009|594709316|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
164640868|NCT04221373|594709317|FG000|Overall Study|Physician Decision|4|||
164640869|NCT04221373|594709318|FG001|Overall Study|Physician Decision|0|||
164640870|NCT04139642|594709328|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
164640871|NCT04139642|594709329|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
164640872|NCT00577031|594709336|FG000|Overall Study|Adverse Event|52|||
164640873|NCT00577031|594709336|FG000|Overall Study|Progression of disease|93|||
164640874|NCT00577031|594709336|FG000|Overall Study|Protocol Violation|5|||
164640875|NCT00577031|594709336|FG000|Overall Study|Participant withdrew consent|13|||
164640876|NCT00577031|594709336|FG000|Overall Study|Participant non-compliance|5|||
164640877|NCT00577031|594709336|FG000|Overall Study|Need for surgery|17|||
164640878|NCT00577031|594709336|FG000|Overall Study|Medical decision|14|||
164640879|NCT00577031|594709336|FG000|Overall Study|Death|6|||
164640880|NCT00557830|594709337|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
164640881|NCT00557830|594709338|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
164640882|NCT00557830|594709339|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
164640883|NCT00557830|594709337|FG000|Screening Treatment Phase|Adverse Event|2|||
164640884|NCT00557830|594709338|FG001|Screening Treatment Phase|Adverse Event|0|||
164640885|NCT00557830|594709339|FG002|Screening Treatment Phase|Adverse Event|0|||
164640886|NCT00557830|594709337|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
164640887|NCT00557830|594709338|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
164640888|NCT00557830|594709339|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
164640889|NCT00538473|594709340|FG000|Overall Study|Adverse Event|1|||
164640890|NCT00538473|594709341|FG001|Overall Study|Adverse Event|0|||
164640891|NCT01569074|594709342|FG000|Overall Study|Study stopped|6|||
164640892|NCT01569074|594709343|FG001|Overall Study|Study stopped|6|||
164640893|NCT01569074|594709344|FG002|Overall Study|Study stopped|8|||
164640894|NCT01569074|594709345|FG003|Overall Study|Study stopped|7|||
164640895|NCT01569074|594709346|FG004|Overall Study|Study stopped|7|||
164640896|NCT01569074|594709342|FG000|Overall Study|Study-specific discontinuation criteria|0|||
164640897|NCT01569074|594709343|FG001|Overall Study|Study-specific discontinuation criteria|1|||
164640898|NCT01569074|594709344|FG002|Overall Study|Study-specific discontinuation criteria|0|||
164640899|NCT01569074|594709345|FG003|Overall Study|Study-specific discontinuation criteria|0|||
164640900|NCT01569074|594709346|FG004|Overall Study|Study-specific discontinuation criteria|0|||
164640901|NCT01569074|594709342|FG000|Overall Study|Severe non-compliance to protocol|0|||
164640902|NCT01569074|594709343|FG001|Overall Study|Severe non-compliance to protocol|0|||
164640903|NCT01569074|594709344|FG002|Overall Study|Severe non-compliance to protocol|1|||
164640904|NCT01569074|594709345|FG003|Overall Study|Severe non-compliance to protocol|0|||
164640905|NCT01569074|594709346|FG004|Overall Study|Severe non-compliance to protocol|0|||
164640906|NCT01569074|594709342|FG000|Overall Study|eg change in circumstances|0|||
164640907|NCT01569074|594709343|FG001|Overall Study|eg change in circumstances|2|||
164640908|NCT01569074|594709344|FG002|Overall Study|eg change in circumstances|0|||
164640909|NCT01569074|594709345|FG003|Overall Study|eg change in circumstances|1|||
164640910|NCT01569074|594709346|FG004|Overall Study|eg change in circumstances|1|||
164640911|NCT01569074|594709342|FG000|Overall Study|Adverse Event|1|||
164640912|NCT01569074|594709343|FG001|Overall Study|Adverse Event|0|||
164640913|NCT01569074|594709344|FG002|Overall Study|Adverse Event|3|||
164640914|NCT01569074|594709345|FG003|Overall Study|Adverse Event|0|||
164640915|NCT01569074|594709346|FG004|Overall Study|Adverse Event|0|||
164640916|NCT00669110|594709347|FG000|Overall Study|Adverse Event|4|||
164640917|NCT00669110|594709348|FG001|Overall Study|Adverse Event|3|||
164640918|NCT00669110|594709347|FG000|Overall Study|Caregiver request|3|||
164640919|NCT00669110|594709348|FG001|Overall Study|Caregiver request|2|||
164640920|NCT00669110|594709347|FG000|Overall Study|Physician Decision|0|||
164640921|NCT00669110|594709348|FG001|Overall Study|Physician Decision|1|||
164640922|NCT00669110|594709347|FG000|Overall Study|Lost to Follow-up|1|||
164640923|NCT00669110|594709348|FG001|Overall Study|Lost to Follow-up|0|||
164640924|NCT00669110|594709347|FG000|Overall Study|Protocol Violation|0|||
164640925|NCT00669110|594709348|FG001|Overall Study|Protocol Violation|5|||
164640926|NCT00669110|594709347|FG000|Overall Study|Withdrawal by Subject|0|||
164640927|NCT00669110|594709348|FG001|Overall Study|Withdrawal by Subject|2|||
164640928|NCT05168657|594709351|FG000|Overall Study|Adverse Event|0|||
164640929|NCT05168657|594709352|FG001|Overall Study|Adverse Event|0|||
164640930|NCT05168657|594709353|FG002|Overall Study|Adverse Event|1|||
164640931|NCT05168657|594709354|FG003|Overall Study|Adverse Event|0|||
164640932|NCT05168657|594709355|FG004|Overall Study|Adverse Event|0|||
164640933|NCT05168657|594709356|FG005|Overall Study|Adverse Event|0|||
164640934|NCT05168657|594709357|FG006|Overall Study|Adverse Event|0|||
164640935|NCT05168657|594709358|FG007|Overall Study|Adverse Event|0|||
164640936|NCT00962013|594709359|FG000|Overall Study|Did not have surgery|1|||
164640937|NCT00962013|594709359|FG000|Overall Study|Death|8|||
164640938|NCT00962013|594709359|FG000|Overall Study|Lost to Follow-up|12|||
164640939|NCT00962013|594709359|FG000|Overall Study|Unable/Unwilling to return|6|||
164640940|NCT00962013|594709359|FG000|Overall Study|Withdrawal by Subject|8|||
164640941|NCT00962013|594709359|FG000|Overall Study|Removal of study device|3|||
164640942|NCT00962013|594709359|FG000|Overall Study|Site Termination|24|||
164640943|NCT00962013|594709359|FG000|Overall Study|No 5 year evaluation|6|||
164640944|NCT05275673|594709360|FG000|Overall Study|Study Termination by Sponsor|2|||
164640945|NCT05275673|594709361|FG001|Overall Study|Study Termination by Sponsor|3|||
164640946|NCT05275673|594709360|FG000|Overall Study|Death|1|||
164640947|NCT05275673|594709361|FG001|Overall Study|Death|0|||
164640948|NCT05275673|594709360|FG000|Overall Study|Withdrawal by Subject|1|||
164640949|NCT05275673|594709361|FG001|Overall Study|Withdrawal by Subject|0|||
164640950|NCT02325739|594709362|FG000|Phase I Part|Adverse Event|1|||
164640951|NCT02325739|594709363|FG001|Phase I Part|Adverse Event|0|||
164640952|NCT02325739|594709364|FG002|Phase I Part|Adverse Event|1|||
164640953|NCT02325739|594709365|FG003|Phase I Part|Adverse Event|2|||
164640954|NCT02325739|594709366|FG004|Phase I Part|Adverse Event|3|||
164640955|NCT02325739|594709367|FG005|Phase I Part|Adverse Event|1|||
164640956|NCT02325739|594709368|FG006|Phase I Part|Adverse Event|0|||
164640957|NCT02325739|594709369|FG007|Phase I Part|Adverse Event|2|||
164640958|NCT02325739|594709370|FG008|Phase I Part|Adverse Event|0|||
164640959|NCT02325739|594709371|FG009|Phase I Part|Adverse Event|0|||
164640960|NCT02325739|594709372|FG010|Phase I Part|Adverse Event|0|||
164640961|NCT02325739|594709362|FG000|Phase I Part|Progressive disease|9|||
164640962|NCT02325739|594709363|FG001|Phase I Part|Progressive disease|6|||
164640963|NCT02325739|594709364|FG002|Phase I Part|Progressive disease|3|||
164640964|NCT02325739|594709365|FG003|Phase I Part|Progressive disease|23|||
164640965|NCT02325739|594709366|FG004|Phase I Part|Progressive disease|14|||
164640966|NCT02325739|594709367|FG005|Phase I Part|Progressive disease|6|||
164640967|NCT02325739|594709368|FG006|Phase I Part|Progressive disease|6|||
164640968|NCT02325739|594709369|FG007|Phase I Part|Progressive disease|3|||
164640969|NCT02325739|594709370|FG008|Phase I Part|Progressive disease|0|||
164640970|NCT02325739|594709371|FG009|Phase I Part|Progressive disease|0|||
164640971|NCT02325739|594709372|FG010|Phase I Part|Progressive disease|0|||
164640972|NCT02325739|594709362|FG000|Phase I Part|Subject/guardian decision|1|||
164640973|NCT02325739|594709363|FG001|Phase I Part|Subject/guardian decision|0|||
164148622|NCT04895982|592904918|FG007|Overall Study|Protocol Violation|1|||
164640974|NCT02325739|594709364|FG002|Phase I Part|Subject/guardian decision|1|||
164640975|NCT02325739|594709365|FG003|Phase I Part|Subject/guardian decision|1|||
164640976|NCT02325739|594709366|FG004|Phase I Part|Subject/guardian decision|0|||
164640977|NCT02325739|594709367|FG005|Phase I Part|Subject/guardian decision|0|||
164640978|NCT02325739|594709368|FG006|Phase I Part|Subject/guardian decision|0|||
164640979|NCT02325739|594709369|FG007|Phase I Part|Subject/guardian decision|1|||
164640980|NCT02325739|594709370|FG008|Phase I Part|Subject/guardian decision|0|||
164640981|NCT02325739|594709371|FG009|Phase I Part|Subject/guardian decision|0|||
164640982|NCT02325739|594709372|FG010|Phase I Part|Subject/guardian decision|0|||
164640983|NCT02325739|594709362|FG000|Phase I Part|Death|0|||
164640984|NCT02325739|594709363|FG001|Phase I Part|Death|0|||
164640985|NCT02325739|594709364|FG002|Phase I Part|Death|0|||
164640986|NCT02325739|594709365|FG003|Phase I Part|Death|0|||
164640987|NCT02325739|594709366|FG004|Phase I Part|Death|2|||
164640988|NCT02325739|594709367|FG005|Phase I Part|Death|0|||
164640989|NCT02325739|594709368|FG006|Phase I Part|Death|0|||
164640990|NCT02325739|594709369|FG007|Phase I Part|Death|0|||
164640991|NCT02325739|594709370|FG008|Phase I Part|Death|0|||
164640992|NCT02325739|594709371|FG009|Phase I Part|Death|0|||
164640993|NCT02325739|594709372|FG010|Phase I Part|Death|0|||
164640994|NCT02325739|594709362|FG000|Phase II Part|Adverse Event|0|||
164640995|NCT02325739|594709363|FG001|Phase II Part|Adverse Event|0|||
164640996|NCT02325739|594709364|FG002|Phase II Part|Adverse Event|0|||
164640997|NCT02325739|594709365|FG003|Phase II Part|Adverse Event|0|||
164640998|NCT02325739|594709366|FG004|Phase II Part|Adverse Event|0|||
164640999|NCT02325739|594709367|FG005|Phase II Part|Adverse Event|0|||
164641000|NCT02325739|594709368|FG006|Phase II Part|Adverse Event|0|||
164641001|NCT02325739|594709369|FG007|Phase II Part|Adverse Event|0|||
164641002|NCT02325739|594709370|FG008|Phase II Part|Adverse Event|4|||
164641003|NCT02325739|594709371|FG009|Phase II Part|Adverse Event|5|||
164641004|NCT02325739|594709372|FG010|Phase II Part|Adverse Event|1|||
164641005|NCT02325739|594709362|FG000|Phase II Part|Physician Decision|0|||
164641006|NCT02325739|594709363|FG001|Phase II Part|Physician Decision|0|||
164641007|NCT02325739|594709364|FG002|Phase II Part|Physician Decision|0|||
164641008|NCT02325739|594709365|FG003|Phase II Part|Physician Decision|0|||
164641009|NCT02325739|594709366|FG004|Phase II Part|Physician Decision|0|||
164641010|NCT02325739|594709367|FG005|Phase II Part|Physician Decision|0|||
164641011|NCT02325739|594709368|FG006|Phase II Part|Physician Decision|0|||
164641012|NCT02325739|594709369|FG007|Phase II Part|Physician Decision|0|||
164641013|NCT02325739|594709370|FG008|Phase II Part|Physician Decision|0|||
164641014|NCT02325739|594709371|FG009|Phase II Part|Physician Decision|1|||
164641015|NCT02325739|594709372|FG010|Phase II Part|Physician Decision|0|||
164641016|NCT02325739|594709362|FG000|Phase II Part|Progressive disease|0|||
164641017|NCT02325739|594709363|FG001|Phase II Part|Progressive disease|0|||
164641018|NCT02325739|594709364|FG002|Phase II Part|Progressive disease|0|||
164641019|NCT02325739|594709365|FG003|Phase II Part|Progressive disease|0|||
164641020|NCT02325739|594709366|FG004|Phase II Part|Progressive disease|0|||
164641021|NCT02325739|594709367|FG005|Phase II Part|Progressive disease|0|||
164641022|NCT02325739|594709368|FG006|Phase II Part|Progressive disease|0|||
164641023|NCT02325739|594709369|FG007|Phase II Part|Progressive disease|0|||
164641024|NCT02325739|594709370|FG008|Phase II Part|Progressive disease|22|||
164641025|NCT02325739|594709371|FG009|Phase II Part|Progressive disease|29|||
164641026|NCT02325739|594709372|FG010|Phase II Part|Progressive disease|18|||
164641027|NCT02325739|594709362|FG000|Phase II Part|Subject/guardian decision|0|||
164641028|NCT02325739|594709363|FG001|Phase II Part|Subject/guardian decision|0|||
164641029|NCT02325739|594709364|FG002|Phase II Part|Subject/guardian decision|0|||
164641030|NCT02325739|594709365|FG003|Phase II Part|Subject/guardian decision|0|||
164641031|NCT02325739|594709366|FG004|Phase II Part|Subject/guardian decision|0|||
164641032|NCT02325739|594709367|FG005|Phase II Part|Subject/guardian decision|0|||
164641033|NCT02325739|594709368|FG006|Phase II Part|Subject/guardian decision|0|||
164641034|NCT02325739|594709369|FG007|Phase II Part|Subject/guardian decision|0|||
164641035|NCT02325739|594709370|FG008|Phase II Part|Subject/guardian decision|4|||
164641036|NCT02325739|594709371|FG009|Phase II Part|Subject/guardian decision|1|||
164641037|NCT02325739|594709372|FG010|Phase II Part|Subject/guardian decision|1|||
164641038|NCT02335411|594709373|FG000|Overall Study|Death|223|||
164641039|NCT02335411|594709374|FG001|Overall Study|Death|22|||
164641040|NCT02335411|594709375|FG002|Overall Study|Death|26|||
164641041|NCT02335411|594709373|FG000|Overall Study|Physician Decision|3|||
164641042|NCT02335411|594709374|FG001|Overall Study|Physician Decision|0|||
164641043|NCT02335411|594709375|FG002|Overall Study|Physician Decision|0|||
164641044|NCT02335411|594709373|FG000|Overall Study|Protocol Violation|1|||
164641045|NCT02335411|594709374|FG001|Overall Study|Protocol Violation|0|||
164641046|NCT02335411|594709375|FG002|Overall Study|Protocol Violation|0|||
164641047|NCT02335411|594709373|FG000|Overall Study|Withdrawal by Subject|11|||
164641048|NCT02335411|594709374|FG001|Overall Study|Withdrawal by Subject|0|||
164641049|NCT02335411|594709375|FG002|Overall Study|Withdrawal by Subject|3|||
164641050|NCT02335411|594709373|FG000|Overall Study|Sponsor Decision|12|||
164641051|NCT02335411|594709374|FG001|Overall Study|Sponsor Decision|3|||
164641052|NCT02335411|594709375|FG002|Overall Study|Sponsor Decision|2|||
164641053|NCT02335411|594709373|FG000|Overall Study|Adverse Event|9|||
164641054|NCT02335411|594709374|FG001|Overall Study|Adverse Event|0|||
164641055|NCT02335411|594709375|FG002|Overall Study|Adverse Event|0|||
164641056|NCT03843775|594709376|FG000|Overall Study|Adverse Event|1|||
164641057|NCT03843775|594709377|FG001|Overall Study|Adverse Event|1|||
164641058|NCT03843775|594709376|FG000|Overall Study|Lack of Efficacy|2|||
164641059|NCT03843775|594709377|FG001|Overall Study|Lack of Efficacy|6|||
164641060|NCT03843775|594709376|FG000|Overall Study|Withdrawal by Subject|0|||
164641061|NCT03843775|594709377|FG001|Overall Study|Withdrawal by Subject|1|||
164641062|NCT00530621|594709382|FG000|Overall Study|Adverse Event|11|||
164641063|NCT00530621|594709383|FG001|Overall Study|Adverse Event|8|||
164641064|NCT00530621|594709382|FG000|Overall Study|Physician Decision|2|||
164641065|NCT00530621|594709383|FG001|Overall Study|Physician Decision|4|||
164641066|NCT00530621|594709382|FG000|Overall Study|Progressive Disease (PD)|47|||
164641067|NCT00530621|594709383|FG001|Overall Study|Progressive Disease (PD)|40|||
164641068|NCT00530621|594709382|FG000|Overall Study|Sponsor Decision|12|||
164641069|NCT00530621|594709383|FG001|Overall Study|Sponsor Decision|15|||
164641070|NCT00530621|594709382|FG000|Overall Study|Subject Decision|4|||
164641071|NCT00530621|594709383|FG001|Overall Study|Subject Decision|7|||
164531162|NCT00585195|594315527|FG007|Overall Study|Site Terminated by Sponsor|0|||
164531163|NCT00585195|594315528|FG008|Overall Study|Site Terminated by Sponsor|0|||
164531164|NCT00585195|594315529|FG009|Overall Study|Site Terminated by Sponsor|0|||
164531165|NCT00585195|594315530|FG010|Overall Study|Site Terminated by Sponsor|0|||
164531166|NCT00585195|594315531|FG011|Overall Study|Site Terminated by Sponsor|0|||
164531167|NCT00585195|594315532|FG012|Overall Study|Site Terminated by Sponsor|1|||
164531168|NCT00585195|594315533|FG013|Overall Study|Site Terminated by Sponsor|0|||
164531169|NCT00585195|594315534|FG014|Overall Study|Site Terminated by Sponsor|0|||
164531170|NCT00585195|594315535|FG015|Overall Study|Site Terminated by Sponsor|0|||
164531171|NCT00585195|594315536|FG016|Overall Study|Site Terminated by Sponsor|0|||
164531172|NCT00585195|594315537|FG017|Overall Study|Site Terminated by Sponsor|0|||
164531173|NCT00585195|594315538|FG018|Overall Study|Site Terminated by Sponsor|0|||
164531174|NCT00585195|594315539|FG019|Overall Study|Site Terminated by Sponsor|0|||
164531175|NCT00585195|594315540|FG020|Overall Study|Site Terminated by Sponsor|0|||
164531176|NCT00585195|594315520|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
164531177|NCT00585195|594315521|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
164531178|NCT00585195|594315522|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
164531179|NCT00585195|594315523|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
164531180|NCT00585195|594315524|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
164531181|NCT00585195|594315525|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
164531182|NCT00585195|594315526|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
164531183|NCT00585195|594315527|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
164531184|NCT00585195|594315528|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
164531185|NCT00585195|594315529|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
164531186|NCT00585195|594315530|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
164531187|NCT00585195|594315531|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
164531188|NCT00585195|594315532|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
164531189|NCT00585195|594315533|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
164531190|NCT00585195|594315534|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
164531191|NCT00585195|594315535|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
164531192|NCT00585195|594315536|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
164531193|NCT00585195|594315537|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
164531194|NCT00585195|594315538|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
164531195|NCT00585195|594315539|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
164531196|NCT00585195|594315540|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
164531197|NCT02533570|594315541|FG000|Overall Study|Adverse Event|0|||
164531198|NCT02533570|594315542|FG001|Overall Study|Adverse Event|1|||
164531199|NCT02533570|594315543|FG002|Overall Study|Adverse Event|1|||
164531200|NCT01163916|594315544|FG000|Overall Study|Withdrawal by Subject|2|||
164531201|NCT01163916|594315545|FG001|Overall Study|Withdrawal by Subject|0|||
164531202|NCT01163916|594315546|FG002|Overall Study|Withdrawal by Subject|2|||
164531203|NCT01163916|594315544|FG000|Overall Study|Adverse Event|2|||
164531204|NCT01163916|594315545|FG001|Overall Study|Adverse Event|0|||
164531205|NCT01163916|594315546|FG002|Overall Study|Adverse Event|1|||
164531206|NCT01163916|594315544|FG000|Overall Study|Lack of Efficacy|2|||
164641072|NCT00530621|594709382|FG000|Overall Study|Death|3|||
164641073|NCT00530621|594709383|FG001|Overall Study|Death|6|||
164531207|NCT01163916|594315545|FG001|Overall Study|Lack of Efficacy|0|||
164641074|NCT00530621|594709382|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
164641075|NCT00530621|594709383|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
164641076|NCT02596009|594709384|FG000|Overall Study|Administrative problems|0|||
164148623|NCT04895982|592904919|FG008|Overall Study|Protocol Violation|0|||
164641077|NCT02596009|594709385|FG001|Overall Study|Administrative problems|1|||
164641078|NCT02596009|594709386|FG002|Overall Study|Administrative problems|0|||
164641079|NCT02596009|594709387|FG003|Overall Study|Administrative problems|0|||
164641080|NCT02596009|594709388|FG004|Overall Study|Administrative problems|0|||
164641081|NCT02596009|594709389|FG005|Overall Study|Administrative problems|0|||
164641082|NCT04611152|594709392|FG000|Overall Study|Adverse Event|9|||
164641083|NCT04611152|594709393|FG001|Overall Study|Adverse Event|8|||
164641084|NCT04611152|594709392|FG000|Overall Study|Non-compliance with study schedule|1|||
164641085|NCT04611152|594709393|FG001|Overall Study|Non-compliance with study schedule|3|||
164641086|NCT04611152|594709392|FG000|Overall Study|Withdrawal by Subject|5|||
164641087|NCT04611152|594709393|FG001|Overall Study|Withdrawal by Subject|6|||
164641088|NCT04611152|594709392|FG000|Overall Study|Lost to Follow-up|11|||
164641089|NCT04611152|594709393|FG001|Overall Study|Lost to Follow-up|2|||
164641090|NCT05012943|594709394|FG000|Overall Study|Adverse Event|2|||
164641091|NCT05012943|594709395|FG001|Overall Study|Adverse Event|1|||
164641092|NCT05012943|594709396|FG002|Overall Study|Adverse Event|0|||
164641093|NCT05012943|594709394|FG000|Overall Study|Withdrawal by Subject|1052|||
164641094|NCT05012943|594709395|FG001|Overall Study|Withdrawal by Subject|1006|||
164641095|NCT05012943|594709396|FG002|Overall Study|Withdrawal by Subject|20|||
164641096|NCT05012943|594709394|FG000|Overall Study|Death|25|||
164641097|NCT05012943|594709395|FG001|Overall Study|Death|17|||
164641098|NCT05012943|594709396|FG002|Overall Study|Death|4|||
164641099|NCT05012943|594709394|FG000|Overall Study|Lost to Follow-up|11|||
164641100|NCT05012943|594709395|FG001|Overall Study|Lost to Follow-up|24|||
164641101|NCT05012943|594709396|FG002|Overall Study|Lost to Follow-up|3|||
164641102|NCT05012943|594709394|FG000|Overall Study|Physician Decision|1|||
164641103|NCT05012943|594709395|FG001|Overall Study|Physician Decision|1|||
164641104|NCT05012943|594709396|FG002|Overall Study|Physician Decision|0|||
164641105|NCT05012943|594709394|FG000|Overall Study|Other than Specified|2|||
164531208|NCT01163916|594315546|FG002|Overall Study|Lack of Efficacy|1|||
164531209|NCT01163916|594315544|FG000|Overall Study|Other|24|||
164531210|NCT01163916|594315545|FG001|Overall Study|Other|4|||
164531211|NCT01163916|594315546|FG002|Overall Study|Other|16|||
164531212|NCT02337751|594315547|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
164531213|NCT02337751|594315548|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
164531214|NCT02337751|594315547|FG000|Overall Study|Voluntary Withdrawal|6|||
164531215|NCT02337751|594315548|FG001|Overall Study|Voluntary Withdrawal|8|||
164531216|NCT02337751|594315547|FG000|Overall Study|Lack of Efficacy|2|||
164531217|NCT02337751|594315548|FG001|Overall Study|Lack of Efficacy|5|||
164531218|NCT02337751|594315547|FG000|Overall Study|Investigator's Judgement|1|||
164531219|NCT02337751|594315548|FG001|Overall Study|Investigator's Judgement|0|||
164531220|NCT01009580|594315549|FG000|Overall Study|Adverse Event|4|||
164531221|NCT01009580|594315550|FG001|Overall Study|Adverse Event|4|||
164531222|NCT01009580|594315549|FG000|Overall Study|Lack of Efficacy|0|||
164531223|NCT01009580|594315550|FG001|Overall Study|Lack of Efficacy|1|||
164531224|NCT01009580|594315549|FG000|Overall Study|Protocol Violation|2|||
164531225|NCT01009580|594315550|FG001|Overall Study|Protocol Violation|3|||
164531226|NCT01009580|594315549|FG000|Overall Study|Withdrawal Criteria|4|||
164531227|NCT01009580|594315550|FG001|Overall Study|Withdrawal Criteria|6|||
164531228|NCT01009580|594315549|FG000|Overall Study|Unclassified|17|||
164531229|NCT01009580|594315550|FG001|Overall Study|Unclassified|21|||
164531230|NCT01101477|594317154|FG000|Overall Study|Protocol Violation|5|||
164531231|NCT01101477|594317155|FG001|Overall Study|Protocol Violation|3|||
164531232|NCT01101477|594317156|FG002|Overall Study|Protocol Violation|1|||
164531233|NCT01222507|594317157|FG000|Overall Study|Physician Decision|1|||
164531234|NCT01222507|594317157|FG000|Overall Study|Withdrawal by Subject|1|||
164641106|NCT05012943|594709395|FG001|Overall Study|Other than Specified|1|||
164641107|NCT05012943|594709396|FG002|Overall Study|Other than Specified|0|||
164641108|NCT00400985|594709397|FG000|Overall Study|Withdrawal by Subject|5|||
164531235|NCT00294554|594317163|FG000|Overall Study|Lack of Efficacy|0|||
164531236|NCT00294554|594317164|FG001|Overall Study|Lack of Efficacy|1|||
164531237|NCT00294554|594317163|FG000|Overall Study|Physician Decision|0|||
164641109|NCT00400985|594709397|FG000|Overall Study|system modification|8|||
164641110|NCT00400985|594709397|FG000|Overall Study|Death|30|||
164641111|NCT00400985|594709397|FG000|Overall Study|Lost to Follow-up|9|||
164531238|NCT00294554|594317164|FG001|Overall Study|Physician Decision|1|||
164531239|NCT00462865|594317165|FG000|Overall Study|Adverse Event|1|||
164531240|NCT02598557|594317166|FG000|Overall Study|Withdrawal by Subject|1|||
164531241|NCT02598557|594317167|FG001|Overall Study|Withdrawal by Subject|0|||
164531242|NCT02598557|594317168|FG002|Overall Study|Withdrawal by Subject|1|||
164641112|NCT04755283|594709399|FG000|Overall Study|Withdrawal by Subject|14|||
164641113|NCT04755283|594709400|FG001|Overall Study|Withdrawal by Subject|3|||
164641114|NCT04755283|594709401|FG002|Overall Study|Withdrawal by Subject|6|||
164641115|NCT04755283|594709399|FG000|Overall Study|Lost to Follow-up|0|||
164641116|NCT04755283|594709400|FG001|Overall Study|Lost to Follow-up|0|||
164531243|NCT02598557|594317166|FG000|Overall Study|Participant did not start treatment|2|||
164531244|NCT02598557|594317167|FG001|Overall Study|Participant did not start treatment|1|||
164641117|NCT04755283|594709401|FG002|Overall Study|Lost to Follow-up|1|||
164641118|NCT04755283|594709399|FG000|Overall Study|Death|31|||
164641119|NCT04755283|594709400|FG001|Overall Study|Death|36|||
164641120|NCT04755283|594709401|FG002|Overall Study|Death|34|||
164641121|NCT02851069|594709402|FG000|Overall Study|Failure to Return|3|||
164641122|NCT02851069|594709402|FG000|Overall Study|Other|3|||
164641123|NCT04115488|594709403|FG000|Overall Study|Adverse Event|8|||
164641124|NCT04115488|594709404|FG001|Overall Study|Adverse Event|4|||
164641125|NCT04115488|594709403|FG000|Overall Study|Withdrawal by Subject|3|||
164641126|NCT04115488|594709404|FG001|Overall Study|Withdrawal by Subject|6|||
164641127|NCT04115488|594709403|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
164641128|NCT04115488|594709404|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
164641129|NCT04115488|594709403|FG000|Overall Study|Patient 's location change|1|||
164641130|NCT04115488|594709404|FG001|Overall Study|Patient 's location change|0|||
164641131|NCT04115488|594709403|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
164641132|NCT04115488|594709404|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
164641133|NCT00885677|594709405|FG000|Overall Study|Death|40|||
164641134|NCT00885677|594709406|FG001|Overall Study|Death|34|||
164641135|NCT00885677|594709405|FG000|Overall Study|Lost to Follow-up|15|||
164641136|NCT00885677|594709406|FG001|Overall Study|Lost to Follow-up|13|||
164641137|NCT00885677|594709405|FG000|Overall Study|Protocol Violation|54|||
164531245|NCT02598557|594317168|FG002|Overall Study|Participant did not start treatment|1|||
164531246|NCT02598557|594317166|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
164531247|NCT02598557|594317167|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
164531248|NCT02598557|594317168|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
164531249|NCT02598557|594317166|FG000|Overall Study|Adverse Event|1|||
164531250|NCT02598557|594317167|FG001|Overall Study|Adverse Event|1|||
164531251|NCT02598557|594317168|FG002|Overall Study|Adverse Event|0|||
164531252|NCT06336603|594317169|FG000|Overall Study|Withdrawal by Subject|1|||
164531253|NCT06336603|594317169|FG000|Overall Study|Lost to Follow-up|2|||
164531254|NCT01295034|594317173|FG000|Overall Study|Lost to Follow-up|5|||
164531255|NCT01295034|594317174|FG001|Overall Study|Lost to Follow-up|5|||
164531256|NCT00824161|594317176|FG000|Overall Study|Withdrawal by Subject|1|||
164531257|NCT00824161|594317176|FG000|Overall Study|Screen Failure|1|||
164531258|NCT00667355|594317177|FG000|Overall Study|Adverse Event|5|||
164531259|NCT00667355|594317177|FG000|Overall Study|Lost to Follow-up|1|||
164531260|NCT00667355|594317177|FG000|Overall Study|Other reason was not specified|5|||
164531261|NCT01313637|594317178|FG000|Overall Study|Adverse Event|17|||
164531262|NCT01313637|594317179|FG001|Overall Study|Adverse Event|24|||
164531263|NCT01313637|594317180|FG002|Overall Study|Adverse Event|25|||
164531264|NCT01313637|594317181|FG003|Overall Study|Adverse Event|18|||
164531265|NCT01313637|594317178|FG000|Overall Study|Lack of Efficacy|44|||
164531266|NCT01313637|594317179|FG001|Overall Study|Lack of Efficacy|38|||
164531267|NCT01313637|594317180|FG002|Overall Study|Lack of Efficacy|37|||
164531268|NCT01313637|594317181|FG003|Overall Study|Lack of Efficacy|24|||
164531269|NCT01313637|594317178|FG000|Overall Study|Protocol Violation|4|||
164531270|NCT01313637|594317179|FG001|Overall Study|Protocol Violation|3|||
164531271|NCT01313637|594317180|FG002|Overall Study|Protocol Violation|11|||
164531272|NCT01313637|594317181|FG003|Overall Study|Protocol Violation|5|||
164531273|NCT01313637|594317178|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
164531274|NCT01313637|594317179|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
164531275|NCT01313637|594317180|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
164531276|NCT01313637|594317181|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
164531277|NCT01313637|594317178|FG000|Overall Study|Lost to Follow-up|0|||
164531278|NCT01313637|594317179|FG001|Overall Study|Lost to Follow-up|2|||
164531279|NCT01313637|594317180|FG002|Overall Study|Lost to Follow-up|1|||
164531280|NCT01313637|594317181|FG003|Overall Study|Lost to Follow-up|3|||
164531281|NCT01313637|594317178|FG000|Overall Study|Withdrawal by Subject|11|||
164531282|NCT01313637|594317179|FG001|Overall Study|Withdrawal by Subject|13|||
164531283|NCT01313637|594317180|FG002|Overall Study|Withdrawal by Subject|18|||
164531284|NCT01313637|594317181|FG003|Overall Study|Withdrawal by Subject|15|||
164531285|NCT00795951|594317184|FG000|Overall Study|Lost to Follow-up|1|||
164531286|NCT00795951|594317184|FG000|Overall Study|Withdrawal by Subject|1|||
164531287|NCT00655863|594317186|FG000|Overall Study|Lost to Follow-up|0|||
164531288|NCT00655863|594317187|FG001|Overall Study|Lost to Follow-up|0|||
164531289|NCT00655863|594317188|FG002|Overall Study|Lost to Follow-up|1|||
164531290|NCT03548987|594317189|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
164531291|NCT03548987|594317190|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
164531292|NCT03548987|594317189|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
164531293|NCT03548987|594317190|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
164531294|NCT03548987|594317189|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
164531295|NCT03548987|594317190|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
164531296|NCT03548987|594317189|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
164531297|NCT03548987|594317190|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
164531298|NCT03548987|594317189|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
164641138|NCT00885677|594709406|FG001|Overall Study|Protocol Violation|54|||
164531299|NCT03548987|594317190|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
164531300|NCT03548987|594317189|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
164531301|NCT03548987|594317190|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
164531302|NCT03548987|594317189|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
164531303|NCT03548987|594317190|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
164531304|NCT03548987|594317189|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
164531305|NCT03548987|594317190|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
164531306|NCT03548987|594317189|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
164531307|NCT03548987|594317190|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
164531308|NCT03548987|594317189|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
164531309|NCT03548987|594317190|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
164531310|NCT03548987|594317189|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
164531311|NCT03548987|594317190|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
164531312|NCT03548987|594317189|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
164531313|NCT03548987|594317190|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
164531314|NCT03548987|594317189|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
164531315|NCT03548987|594317190|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
164531316|NCT03548987|594317189|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
164531317|NCT03548987|594317190|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
164531318|NCT04661878|594317191|FG000|Overall Study|Lost to Follow-up|6|||
164531319|NCT04661878|594317192|FG001|Overall Study|Lost to Follow-up|5|||
164531320|NCT01323647|594317193|FG000|Overall Study|Migrated/moved from study area|2|||
164531321|NCT01323647|594317194|FG001|Overall Study|Migrated/moved from study area|0|||
164531322|NCT01323647|594317193|FG000|Overall Study|Withdrawal by Subject|5|||
164531323|NCT01323647|594317194|FG001|Overall Study|Withdrawal by Subject|0|||
164531324|NCT01323647|594317193|FG000|Overall Study|Lost to Follow-up|2|||
164531325|NCT01323647|594317194|FG001|Overall Study|Lost to Follow-up|0|||
164531326|NCT03603028|594317195|FG000|Overall Study|Withdrawal by Subject|1|||
164531327|NCT02768870|594317200|FG000|Overall Study|Death|1|||
164531328|NCT02768870|594317200|FG000|Overall Study|Reoperation|6|||
164531329|NCT02768870|594317200|FG000|Overall Study|Lost to Follow-up|1|||
164531330|NCT02768870|594317200|FG000|Overall Study|Exit|4|||
164531331|NCT02963610|594317201|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
164531332|NCT01774110|594317202|FG000|Overall Study|Lost to Follow-up|7|||
164531333|NCT00063154|594317203|FG000|Overall Study|Disease progression|27|||
164531334|NCT00063154|594317203|FG000|Overall Study|Adverse Event|2|||
164531335|NCT00063154|594317203|FG000|Overall Study|Physician Decision|10|||
164531336|NCT00063154|594317203|FG000|Overall Study|Death|3|||
164531337|NCT00063154|594317203|FG000|Overall Study|Reason unspecified|1|||
164531338|NCT00063154|594317203|FG000|Overall Study|Did not receive treatment|8|||
164531339|NCT02203695|594317204|FG000|Overall Study|Patient withdrew consent|1|||
164531340|NCT02203695|594317205|FG001|Overall Study|Patient withdrew consent|1|||
164531341|NCT02203695|594317204|FG000|Overall Study|Started non-study treatment|1|||
164531342|NCT02203695|594317205|FG001|Overall Study|Started non-study treatment|0|||
164531343|NCT00640016|594317206|FG000|Overall Study|Withdrawal by Subject|0|||
164531344|NCT00640016|594317207|FG001|Overall Study|Withdrawal by Subject|1|||
164531345|NCT00640016|594317208|FG002|Overall Study|Withdrawal by Subject|0|||
164531346|NCT00640016|594317209|FG003|Overall Study|Withdrawal by Subject|0|||
164531347|NCT00640016|594317206|FG000|Overall Study|Study termination|2|||
164531348|NCT00640016|594317207|FG001|Overall Study|Study termination|1|||
164531349|NCT00640016|594317208|FG002|Overall Study|Study termination|3|||
164531350|NCT00640016|594317209|FG003|Overall Study|Study termination|2|||
164531351|NCT00640016|594317206|FG000|Overall Study|Adverse Event|0|||
164531352|NCT00640016|594317207|FG001|Overall Study|Adverse Event|0|||
164531353|NCT00640016|594317208|FG002|Overall Study|Adverse Event|0|||
164531354|NCT00640016|594317209|FG003|Overall Study|Adverse Event|1|||
164531355|NCT02699983|594317211|FG000|Overall Study|Withdrawal by Subject|1|||
164531356|NCT02699983|594317212|FG001|Overall Study|Withdrawal by Subject|0|||
164531357|NCT03575143|594317213|FG000|Overall Study|Lost to Follow-up|0|||
164531358|NCT03575143|594317214|FG001|Overall Study|Lost to Follow-up|0|||
164531359|NCT03575143|594317215|FG002|Overall Study|Lost to Follow-up|4|||
164531360|NCT03575143|594317213|FG000|Overall Study|Withdrawal by Subject|0|||
164531361|NCT03575143|594317214|FG001|Overall Study|Withdrawal by Subject|0|||
164531362|NCT03575143|594317215|FG002|Overall Study|Withdrawal by Subject|5|||
164531363|NCT03575143|594317213|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
164531364|NCT03575143|594317214|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
164641139|NCT00885677|594709405|FG000|Overall Study|premature study closure|41|||
164531365|NCT03575143|594317215|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
164531366|NCT01287065|594317216|FG000|Treatment Period 1|Adverse Event|0|||
164531367|NCT01287065|594317217|FG001|Treatment Period 1|Adverse Event|0|||
164531368|NCT01287065|594317218|FG002|Treatment Period 1|Adverse Event|0|||
164531369|NCT01287065|594317219|FG003|Treatment Period 1|Adverse Event|0|||
164531370|NCT01287065|594317220|FG004|Treatment Period 1|Adverse Event|1|||
164641140|NCT00885677|594709406|FG001|Overall Study|premature study closure|44|||
164641141|NCT00885677|594709405|FG000|Overall Study|device/lead revision or replacement|7|||
164641142|NCT00885677|594709406|FG001|Overall Study|device/lead revision or replacement|6|||
164641143|NCT00885677|594709405|FG000|Overall Study|Heart transplantation|1|||
164641144|NCT00885677|594709406|FG001|Overall Study|Heart transplantation|0|||
164641145|NCT00885677|594709405|FG000|Overall Study|Inclusion/exclusion not met|25|||
164641146|NCT00885677|594709406|FG001|Overall Study|Inclusion/exclusion not met|27|||
164641147|NCT00167414|594709408|FG000|Overall Study|Death|10|||
164641148|NCT00795886|594709410|FG000|Overall Study|Death|10|||
164641149|NCT05554471|594709411|FG000|Overall Study|Physician Decision|2|||
164641150|NCT05554471|594709412|FG001|Overall Study|Physician Decision|1|||
164641151|NCT05554471|594709411|FG000|Overall Study|Lost to Follow-up|2|||
164641152|NCT05554471|594709412|FG001|Overall Study|Lost to Follow-up|1|||
164641153|NCT05554471|594709411|FG000|Overall Study|Death|0|||
164641154|NCT05554471|594709412|FG001|Overall Study|Death|1|||
164641155|NCT02062385|594709415|FG000|Overall Study|Adverse Event|19|||
164641156|NCT02062385|594709416|FG001|Overall Study|Adverse Event|13|||
164641157|NCT02062385|594709417|FG002|Overall Study|Adverse Event|1|||
164641158|NCT02062385|594709418|FG003|Overall Study|Adverse Event|0|||
164641159|NCT02062385|594709415|FG000|Overall Study|Protocol Violation|1|||
164641160|NCT02062385|594709416|FG001|Overall Study|Protocol Violation|0|||
164641161|NCT02062385|594709417|FG002|Overall Study|Protocol Violation|0|||
164641162|NCT02062385|594709418|FG003|Overall Study|Protocol Violation|0|||
164531371|NCT01287065|594317221|FG005|Treatment Period 1|Adverse Event|0|||
164531372|NCT01287065|594317216|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164531373|NCT01287065|594317217|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164531374|NCT01287065|594317218|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164531375|NCT01287065|594317219|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164531376|NCT01287065|594317220|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164531377|NCT01287065|594317221|FG005|Treatment Period 1|Withdrawal by Subject|1|||
164531378|NCT04781387|594317226|FG000|Overall Study|Withdrawal by Subject|1|||
164531379|NCT04781387|594317227|FG001|Overall Study|Withdrawal by Subject|0|||
164531380|NCT04781387|594317228|FG002|Overall Study|Withdrawal by Subject|1|||
164531381|NCT04781387|594317226|FG000|Overall Study|Lost to Follow-up|1|||
164531382|NCT04781387|594317227|FG001|Overall Study|Lost to Follow-up|0|||
164531383|NCT04781387|594317228|FG002|Overall Study|Lost to Follow-up|0|||
164531384|NCT01580969|594317229|FG000|Overall Study|Physician Decision|3|||
164531385|NCT01580969|594317230|FG001|Overall Study|Physician Decision|0|||
164531386|NCT01580969|594317231|FG002|Overall Study|Physician Decision|0|||
164531387|NCT02318797|594317232|FG000|Overall Study|Death|3|||
164531388|NCT02318797|594317233|FG001|Overall Study|Death|6|||
164531389|NCT02318797|594317232|FG000|Overall Study|Lost to Follow-up|85|||
164531390|NCT02318797|594317233|FG001|Overall Study|Lost to Follow-up|96|||
164531391|NCT01740323|594317236|FG000|Overall Study|Adverse Event|1|||
164531392|NCT01740323|594317237|FG001|Overall Study|Adverse Event|0|||
164531393|NCT01740323|594317236|FG000|Overall Study|Randomized but did not take study drug|1|||
164531394|NCT01740323|594317237|FG001|Overall Study|Randomized but did not take study drug|0|||
164531395|NCT02019927|594317238|FG000|Overall Study|Lost to Follow-up|2|||
164531396|NCT02019927|594317239|FG001|Overall Study|Lost to Follow-up|4|||
164531397|NCT02019927|594317240|FG002|Overall Study|Lost to Follow-up|1|||
164531398|NCT02019927|594317241|FG003|Overall Study|Lost to Follow-up|2|||
164531399|NCT02019927|594317242|FG004|Overall Study|Lost to Follow-up|3|||
164531400|NCT02019927|594317243|FG005|Overall Study|Lost to Follow-up|1|||
164531401|NCT06338462|594317248|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
164531402|NCT03181451|594317249|FG000|Overall Study|Adverse Event|0|||
164531403|NCT03181451|594317250|FG001|Overall Study|Adverse Event|1|||
164531404|NCT03181451|594317251|FG002|Overall Study|Adverse Event|0|||
164531405|NCT03181451|594317249|FG000|Overall Study|Withdrawal by Subject|0|||
164531406|NCT03181451|594317250|FG001|Overall Study|Withdrawal by Subject|1|||
164641163|NCT02062385|594709415|FG000|Overall Study|Incomplete EPI by database lock|2|||
164641164|NCT02062385|594709416|FG001|Overall Study|Incomplete EPI by database lock|0|||
164641165|NCT02062385|594709417|FG002|Overall Study|Incomplete EPI by database lock|0|||
164641166|NCT02062385|594709418|FG003|Overall Study|Incomplete EPI by database lock|0|||
164641167|NCT02062385|594709415|FG000|Overall Study|Moved|10|||
164641168|NCT02062385|594709416|FG001|Overall Study|Moved|11|||
164641169|NCT02062385|594709417|FG002|Overall Study|Moved|1|||
164641170|NCT02062385|594709418|FG003|Overall Study|Moved|0|||
164531407|NCT03181451|594317251|FG002|Overall Study|Withdrawal by Subject|0|||
164531408|NCT01259284|594317258|FG000|Overall Study|Study Termination|2|||
164531409|NCT01259284|594317259|FG001|Overall Study|Study Termination|0|||
164641171|NCT02062385|594709415|FG000|Overall Study|Withdrawn by parent/guardian|46|||
164641172|NCT02062385|594709416|FG001|Overall Study|Withdrawn by parent/guardian|41|||
164641173|NCT02062385|594709417|FG002|Overall Study|Withdrawn by parent/guardian|9|||
164641174|NCT02062385|594709418|FG003|Overall Study|Withdrawn by parent/guardian|8|||
164641175|NCT02062385|594709415|FG000|Overall Study|Death|0|||
164531410|NCT01259284|594317260|FG002|Overall Study|Study Termination|0|||
164531411|NCT00069238|594317261|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
164641176|NCT02062385|594709416|FG001|Overall Study|Death|0|||
164531412|NCT00069238|594317262|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
164531413|NCT00069238|594317263|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
164531414|NCT00069238|594317261|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
164531415|NCT00069238|594317262|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
164531416|NCT00069238|594317263|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
164531417|NCT00069238|594317261|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
164531418|NCT00069238|594317262|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
164531419|NCT00069238|594317263|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
164531420|NCT01001832|594317265|FG000|Short-term Period|Adverse Event|2|||
164531421|NCT01001832|594317266|FG001|Short-term Period|Adverse Event|3|||
164531422|NCT01001832|594317265|FG000|Long-term Period|Adverse Event|2|||
164531423|NCT01001832|594317266|FG001|Long-term Period|Adverse Event|1|||
164531424|NCT01001832|594317265|FG000|Long-term Period|Withdrawal by Subject|1|||
164531425|NCT01001832|594317266|FG001|Long-term Period|Withdrawal by Subject|0|||
164531426|NCT01001832|594317265|FG000|Long-term Period|Lack of Efficacy|0|||
164531427|NCT01001832|594317266|FG001|Long-term Period|Lack of Efficacy|2|||
164531428|NCT01001832|594317265|FG000|Long-term Period|Other|1|||
164531429|NCT01001832|594317266|FG001|Long-term Period|Other|2|||
164531430|NCT01001832|594317265|FG000|Follow-up Period|Withdrawal by Subject|1|||
164531431|NCT01001832|594317266|FG001|Follow-up Period|Withdrawal by Subject|0|||
164531432|NCT01001832|594317265|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
164531433|NCT01001832|594317266|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
164531434|NCT01001832|594317265|FG000|Follow-up Period|Other|2|||
164531435|NCT01001832|594317266|FG001|Follow-up Period|Other|1|||
164531436|NCT01326533|594317270|FG000|Overall Study|Lost to Follow-up|2|||
164531437|NCT01326533|594317271|FG001|Overall Study|Lost to Follow-up|0|||
164531438|NCT01326533|594317270|FG000|Overall Study|Withdrawal by Subject|1|||
164531439|NCT01326533|594317271|FG001|Overall Study|Withdrawal by Subject|0|||
164531440|NCT01326533|594317270|FG000|Overall Study|Adverse Event|1|||
164531441|NCT01326533|594317271|FG001|Overall Study|Adverse Event|0|||
164531442|NCT03353350|594317272|FG000|30-week Core Treatment Period|Protocol Violation|1|||
164531443|NCT03353350|594317273|FG001|30-week Core Treatment Period|Protocol Violation|1|||
164531444|NCT03353350|594317274|FG002|30-week Core Treatment Period|Protocol Violation|1|||
164531445|NCT03353350|594317275|FG003|30-week Core Treatment Period|Protocol Violation|0|||
164531446|NCT03353350|594317272|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
164531447|NCT03353350|594317273|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
164531448|NCT03353350|594317274|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
164531449|NCT03353350|594317275|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
164531450|NCT03353350|594317272|FG000|30-week Core Treatment Period|Adverse Event|0|||
164531451|NCT03353350|594317273|FG001|30-week Core Treatment Period|Adverse Event|4|||
164531452|NCT03353350|594317274|FG002|30-week Core Treatment Period|Adverse Event|2|||
164531453|NCT03353350|594317275|FG003|30-week Core Treatment Period|Adverse Event|3|||
164531454|NCT03353350|594317272|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
164531455|NCT03353350|594317273|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
164531456|NCT03353350|594317274|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
164531457|NCT03353350|594317275|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
164531458|NCT03353350|594317272|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
164531459|NCT03353350|594317273|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
164531460|NCT03353350|594317274|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
164531461|NCT03353350|594317275|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
164531462|NCT03353350|594317272|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
164531463|NCT03353350|594317273|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
164531464|NCT03353350|594317274|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
164531465|NCT03353350|594317275|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
164531466|NCT03353350|594317272|FG000|26-week Treatment Extension Period|Adverse Event|1|||
164531467|NCT03353350|594317273|FG001|26-week Treatment Extension Period|Adverse Event|0|||
164531468|NCT03353350|594317274|FG002|26-week Treatment Extension Period|Adverse Event|0|||
164531469|NCT03353350|594317275|FG003|26-week Treatment Extension Period|Adverse Event|1|||
164531470|NCT03353350|594317272|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
164531471|NCT03353350|594317273|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
164531472|NCT03353350|594317274|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
164531473|NCT03353350|594317275|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
164531474|NCT01012713|594317279|FG000|Overall Study|Lack of Efficacy|3|||
164531475|NCT00983931|594317280|FG000|14 Day Washout Period|Physician Decision|1|||
164531476|NCT02409368|594317285|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
164531477|NCT02409368|594317286|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
164531478|NCT02409368|594317287|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
164531479|NCT02409368|594317288|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
164531480|NCT02409368|594317285|FG000|ECOG Reclassification|Death|1|||
164531481|NCT02409368|594317286|FG001|ECOG Reclassification|Death|5|||
164531482|NCT02409368|594317287|FG002|ECOG Reclassification|Death|0|||
164641177|NCT02062385|594709417|FG002|Overall Study|Death|0|||
164641178|NCT02062385|594709418|FG003|Overall Study|Death|1|||
164641179|NCT02062385|594709415|FG000|Overall Study|Lost to Follow-up|0|||
164641180|NCT02062385|594709416|FG001|Overall Study|Lost to Follow-up|0|||
164641181|NCT02062385|594709417|FG002|Overall Study|Lost to Follow-up|1|||
164641182|NCT02062385|594709418|FG003|Overall Study|Lost to Follow-up|0|||
164641183|NCT03188991|594709419|FG000|Overall Study|Withdrawal by Subject|0|||
164641184|NCT03188991|594709420|FG001|Overall Study|Withdrawal by Subject|0|||
164641185|NCT03188991|594709421|FG002|Overall Study|Withdrawal by Subject|0|||
164641186|NCT03188991|594709422|FG003|Overall Study|Withdrawal by Subject|1|||
164641187|NCT00223990|594709423|FG000|Overall Study|Moved from area|2|||
164641188|NCT00223990|594709424|FG001|Overall Study|Moved from area|1|||
164641189|NCT00223990|594709423|FG000|Overall Study|Withdrawal by Subject|4|||
164641190|NCT00223990|594709424|FG001|Overall Study|Withdrawal by Subject|8|||
164641191|NCT00223990|594709423|FG000|Overall Study|Lost to Follow-up|1|||
164641192|NCT00223990|594709424|FG001|Overall Study|Lost to Follow-up|0|||
164641193|NCT02674568|594711181|FG000|Overall Study|Withdrawal by Subject|5|||
164641194|NCT02674568|594711181|FG000|Overall Study|Death|303|||
164641195|NCT02674568|594711181|FG000|Overall Study|Physician Decision|2|||
164641196|NCT02674568|594711181|FG000|Overall Study|Lost to Follow-up|9|||
164641197|NCT02674568|594711181|FG000|Overall Study|Other, Not Specified|20|||
164641198|NCT01808508|594711182|FG000|Overall Study|Lost to Follow-up|1|||
164641199|NCT01808508|594711183|FG001|Overall Study|Lost to Follow-up|0|||
164641200|NCT01808508|594711184|FG002|Overall Study|Lost to Follow-up|0|||
164641201|NCT03255226|594711185|FG000|Overall Study|Adverse Event|2|||
164641202|NCT03255226|594711185|FG000|Overall Study|Physician Decision|3|||
164641203|NCT03255226|594711185|FG000|Overall Study|Withdrawal by Subject|1|||
164641204|NCT03255226|594711185|FG000|Overall Study|Serum or blood sodium increased|4|||
164641205|NCT03255226|594711185|FG000|Overall Study|Serum or blood potassium increased|4|||
164641206|NCT03387423|594711186|FG000|Overall Study|Lost to Follow-up|16|||
164641207|NCT03387423|594711187|FG001|Overall Study|Lost to Follow-up|12|||
164641208|NCT03387423|594711188|FG002|Overall Study|Lost to Follow-up|1|||
164641209|NCT03387423|594711189|FG003|Overall Study|Lost to Follow-up|0|||
164531483|NCT02409368|594317288|FG003|ECOG Reclassification|Death|0|||
164531484|NCT02409368|594317285|FG000|ECOG Reclassification|Disease Progression|113|||
164531485|NCT02409368|594317286|FG001|ECOG Reclassification|Disease Progression|382|||
164531486|NCT02409368|594317287|FG002|ECOG Reclassification|Disease Progression|70|||
164531487|NCT02409368|594317288|FG003|ECOG Reclassification|Disease Progression|1|||
164531488|NCT02409368|594317285|FG000|ECOG Reclassification|Lost to Follow-up|1|||
164531489|NCT02409368|594317286|FG001|ECOG Reclassification|Lost to Follow-up|5|||
164531490|NCT02409368|594317287|FG002|ECOG Reclassification|Lost to Follow-up|0|||
164531491|NCT02409368|594317288|FG003|ECOG Reclassification|Lost to Follow-up|0|||
164531492|NCT02409368|594317285|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
164531493|NCT02409368|594317286|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
164531494|NCT02409368|594317287|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
164531495|NCT02409368|594317288|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
164531496|NCT02409368|594317285|FG000|ECOG Reclassification|Poor/non-compliance|0|||
164531497|NCT02409368|594317286|FG001|ECOG Reclassification|Poor/non-compliance|3|||
164531498|NCT02409368|594317287|FG002|ECOG Reclassification|Poor/non-compliance|2|||
164531499|NCT02409368|594317288|FG003|ECOG Reclassification|Poor/non-compliance|0|||
164531500|NCT02409368|594317285|FG000|ECOG Reclassification|Study drug toxicity|17|||
164531501|NCT02409368|594317286|FG001|ECOG Reclassification|Study drug toxicity|42|||
164641210|NCT03387423|594711186|FG000|Overall Study|Other|0|||
164641211|NCT03387423|594711187|FG001|Overall Study|Other|3|||
164641212|NCT03387423|594711188|FG002|Overall Study|Other|0|||
164641213|NCT03387423|594711189|FG003|Overall Study|Other|0|||
164641214|NCT03387423|594711186|FG000|Overall Study|Administrative Reason|166|||
164641215|NCT03387423|594711187|FG001|Overall Study|Administrative Reason|89|||
164641216|NCT03387423|594711188|FG002|Overall Study|Administrative Reason|17|||
164641217|NCT03387423|594711189|FG003|Overall Study|Administrative Reason|19|||
164641218|NCT03387423|594711186|FG000|Overall Study|Revocation Consent|76|||
164641219|NCT03387423|594711187|FG001|Overall Study|Revocation Consent|32|||
164641220|NCT03387423|594711188|FG002|Overall Study|Revocation Consent|3|||
164641221|NCT03387423|594711189|FG003|Overall Study|Revocation Consent|5|||
164641222|NCT03862807|594711192|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
164641223|NCT00798707|594711198|FG000|Overall Study|Adverse Event|6|||
164641224|NCT00798707|594711199|FG001|Overall Study|Adverse Event|8|||
164641225|NCT00798707|594711200|FG002|Overall Study|Adverse Event|8|||
164531502|NCT02409368|594317287|FG002|ECOG Reclassification|Study drug toxicity|7|||
164531503|NCT02409368|594317288|FG003|ECOG Reclassification|Study drug toxicity|0|||
164531504|NCT02409368|594317285|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
164531505|NCT02409368|594317286|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
164531506|NCT02409368|594317287|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
164531507|NCT02409368|594317288|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
164641226|NCT00798707|594711198|FG000|Overall Study|Failed to return|2|||
164641227|NCT00798707|594711199|FG001|Overall Study|Failed to return|2|||
164641228|NCT00798707|594711200|FG002|Overall Study|Failed to return|0|||
164641229|NCT00798707|594711198|FG000|Overall Study|Investigator|0|||
164641230|NCT00798707|594711199|FG001|Overall Study|Investigator|1|||
164641231|NCT00798707|594711200|FG002|Overall Study|Investigator|2|||
164641232|NCT00798707|594711198|FG000|Overall Study|Lack of Efficacy|2|||
164641233|NCT00798707|594711199|FG001|Overall Study|Lack of Efficacy|2|||
164641234|NCT00798707|594711200|FG002|Overall Study|Lack of Efficacy|1|||
164641235|NCT00798707|594711198|FG000|Overall Study|Lost to Follow-up|5|||
164641236|NCT00798707|594711199|FG001|Overall Study|Lost to Follow-up|6|||
164641237|NCT00798707|594711200|FG002|Overall Study|Lost to Follow-up|6|||
164641238|NCT00798707|594711198|FG000|Overall Study|Other|0|||
164531508|NCT02409368|594317285|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
164531509|NCT02409368|594317286|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
164531510|NCT02409368|594317287|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
164531511|NCT02409368|594317288|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
164531512|NCT02409368|594317285|FG000|ECOG Reclassification|Participant withdrew consent|2|||
164531513|NCT02409368|594317286|FG001|ECOG Reclassification|Participant withdrew consent|3|||
164531514|NCT02409368|594317287|FG002|ECOG Reclassification|Participant withdrew consent|4|||
164641239|NCT00798707|594711199|FG001|Overall Study|Other|1|||
164641240|NCT00798707|594711200|FG002|Overall Study|Other|0|||
164641241|NCT00798707|594711198|FG000|Overall Study|Protocol Violation|4|||
164641242|NCT00798707|594711199|FG001|Overall Study|Protocol Violation|0|||
164531515|NCT02409368|594317288|FG003|ECOG Reclassification|Participant withdrew consent|0|||
164531516|NCT02409368|594317285|FG000|ECOG Reclassification|Other Reasons|5|||
164531517|NCT02409368|594317286|FG001|ECOG Reclassification|Other Reasons|26|||
164641243|NCT00798707|594711200|FG002|Overall Study|Protocol Violation|2|||
164641244|NCT00798707|594711198|FG000|Overall Study|Withdrawal by Subject|3|||
164641245|NCT00798707|594711199|FG001|Overall Study|Withdrawal by Subject|8|||
164641246|NCT00798707|594711200|FG002|Overall Study|Withdrawal by Subject|2|||
164641247|NCT00798707|594711198|FG000|Overall Study|Randomized not treated|4|||
164641248|NCT00798707|594711199|FG001|Overall Study|Randomized not treated|5|||
164641249|NCT00798707|594711200|FG002|Overall Study|Randomized not treated|1|||
164531518|NCT02409368|594317287|FG002|ECOG Reclassification|Other Reasons|2|||
164531519|NCT02409368|594317288|FG003|ECOG Reclassification|Other Reasons|0|||
164531520|NCT02409368|594317285|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
164531521|NCT02409368|594317286|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
164531522|NCT02409368|594317287|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
164531523|NCT02409368|594317288|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
164531524|NCT01296347|594317289|FG000|Allocation|Withdrawal by Subject|1|||
164531525|NCT01296347|594317290|FG001|Allocation|Withdrawal by Subject|2|||
164531526|NCT01296347|594317289|FG000|Allocation|Lack of Efficacy|1|||
164531527|NCT01296347|594317290|FG001|Allocation|Lack of Efficacy|2|||
164531528|NCT01296347|594317289|FG000|Allocation|not received infusion|1|||
164531529|NCT01296347|594317290|FG001|Allocation|not received infusion|0|||
164531530|NCT01296347|594317289|FG000|6 Week Follow up|Death|0|||
164531531|NCT01296347|594317290|FG001|6 Week Follow up|Death|1|||
164641250|NCT01473589|594711201|FG000|Overall Study|Adverse Event|1|||
164641251|NCT01473589|594711202|FG001|Overall Study|Adverse Event|1|||
164641252|NCT01473589|594711201|FG000|Overall Study|Death|2|||
164641253|NCT01473589|594711202|FG001|Overall Study|Death|0|||
164641254|NCT01473589|594711201|FG000|Overall Study|Lost to Follow-up|2|||
164641255|NCT01473589|594711202|FG001|Overall Study|Lost to Follow-up|2|||
164641256|NCT01473589|594711201|FG000|Overall Study|Protocol Violation|1|||
164641257|NCT01473589|594711202|FG001|Overall Study|Protocol Violation|0|||
164641258|NCT01473589|594711201|FG000|Overall Study|Withdrawal by Subject|5|||
164641259|NCT01473589|594711202|FG001|Overall Study|Withdrawal by Subject|11|||
164641260|NCT01473589|594711201|FG000|Overall Study|Physician Decision|0|||
164531532|NCT01296347|594317289|FG000|3 Month Follow up|Death|1|||
164531533|NCT01296347|594317290|FG001|3 Month Follow up|Death|0|||
164531534|NCT01296347|594317289|FG000|3 Month Follow up|Lost to Follow-up|0|||
164531535|NCT01296347|594317290|FG001|3 Month Follow up|Lost to Follow-up|1|||
164531536|NCT01296347|594317289|FG000|6 Month Follow up|Death|2|||
164531537|NCT01296347|594317290|FG001|6 Month Follow up|Death|1|||
164531538|NCT01296347|594317289|FG000|6 Month Follow up|Lost to Follow-up|0|||
164531539|NCT01296347|594317290|FG001|6 Month Follow up|Lost to Follow-up|1|||
164531540|NCT01296347|594317289|FG000|12 Month Follow up|Lost to Follow-up|3|||
164531541|NCT01296347|594317290|FG001|12 Month Follow up|Lost to Follow-up|1|||
164641261|NCT01473589|594711202|FG001|Overall Study|Physician Decision|1|||
164641262|NCT01473589|594711201|FG000|Overall Study|Entry criteria not met|0|||
164641263|NCT01473589|594711202|FG001|Overall Study|Entry criteria not met|1|||
164641264|NCT01299272|594711203|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
164641265|NCT01299272|594711204|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
164641266|NCT01299272|594711205|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
164641267|NCT01299272|594711206|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
164641268|NCT01299272|594711203|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
164641269|NCT01299272|594711204|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
164641270|NCT01299272|594711205|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
164641271|NCT01299272|594711206|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
164641272|NCT01299272|594711203|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
164641273|NCT01299272|594711204|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
164641274|NCT01299272|594711205|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
164641275|NCT01299272|594711206|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
164641276|NCT01299272|594711203|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
164641277|NCT01299272|594711204|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
164641278|NCT01299272|594711205|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
164641279|NCT01299272|594711206|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
164641280|NCT01299272|594711203|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
164641281|NCT01299272|594711204|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
164641282|NCT01299272|594711205|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
164641283|NCT01299272|594711206|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
164641284|NCT01299272|594711203|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
164641285|NCT01299272|594711204|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
164641286|NCT01299272|594711205|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
164641287|NCT01299272|594711206|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
164641288|NCT01299272|594711203|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
164641289|NCT01299272|594711204|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
164641290|NCT01299272|594711205|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
164531542|NCT01296347|594317289|FG000|12 Month Follow up|Death|1|||
164531543|NCT01296347|594317290|FG001|12 Month Follow up|Death|1|||
164641291|NCT01299272|594711206|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
164641292|NCT01299272|594711203|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
164531544|NCT01296347|594317289|FG000|12 Month Follow up|Withdrawal by Subject|0|||
164531545|NCT01296347|594317290|FG001|12 Month Follow up|Withdrawal by Subject|1|||
164531546|NCT02668185|594317293|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
164531547|NCT02668185|594317294|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
164531548|NCT02668185|594317293|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
164641293|NCT01299272|594711204|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
164641294|NCT01299272|594711205|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
164641295|NCT01299272|594711206|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
164641296|NCT01299272|594711203|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
164641297|NCT01299272|594711204|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
164641298|NCT01299272|594711205|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
164641299|NCT01299272|594711206|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
164641300|NCT01299272|594711203|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
164641301|NCT01299272|594711204|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
164641302|NCT01299272|594711205|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
164641303|NCT01299272|594711206|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
164641304|NCT01299272|594711203|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
164641305|NCT01299272|594711204|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
164641306|NCT01299272|594711205|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
164641307|NCT01299272|594711206|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
164641308|NCT01299272|594711203|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
164641309|NCT01299272|594711204|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
164641310|NCT01299272|594711205|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
164641311|NCT01299272|594711206|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
164641312|NCT01299272|594711203|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
164531549|NCT02668185|594317294|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
164531550|NCT02668185|594317293|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
164531551|NCT02668185|594317294|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
164531552|NCT02668185|594317293|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
164531553|NCT02668185|594317294|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
164531554|NCT01013597|594317295|FG000|Overall Study|Withdrawal by Subject|1|||
164531555|NCT02678247|594317296|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
164531556|NCT02678247|594317297|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
164531557|NCT02678247|594317296|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
164531558|NCT02678247|594317297|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
164531559|NCT02678247|594317296|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
164531560|NCT02678247|594317297|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
164531561|NCT02678247|594317296|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
164531562|NCT02678247|594317297|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
164531563|NCT02678247|594317296|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
164531564|NCT02678247|594317297|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
164531565|NCT02678247|594317296|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
164531566|NCT02678247|594317297|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
164531567|NCT05677893|594318834|FG000|Overall Study|Withdrawal by Subject|0|||
164531568|NCT05677893|594318835|FG001|Overall Study|Withdrawal by Subject|0|||
164531569|NCT05677893|594318836|FG002|Overall Study|Withdrawal by Subject|0|||
164531570|NCT05677893|594318837|FG003|Overall Study|Withdrawal by Subject|0|||
164531571|NCT05677893|594318838|FG004|Overall Study|Withdrawal by Subject|1|||
164531572|NCT05677893|594318839|FG005|Overall Study|Withdrawal by Subject|1|||
164531573|NCT05677893|594318840|FG006|Overall Study|Withdrawal by Subject|0|||
164531574|NCT05677893|594318834|FG000|Overall Study|Others|1|||
164531575|NCT05677893|594318835|FG001|Overall Study|Others|0|||
164531576|NCT05677893|594318836|FG002|Overall Study|Others|0|||
164531577|NCT05677893|594318837|FG003|Overall Study|Others|0|||
164531578|NCT05677893|594318838|FG004|Overall Study|Others|0|||
164531579|NCT05677893|594318839|FG005|Overall Study|Others|0|||
164531580|NCT05677893|594318840|FG006|Overall Study|Others|0|||
164531581|NCT03217266|594318841|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
164531582|NCT03217266|594318842|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
164531583|NCT03217266|594318843|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
164531584|NCT03217266|594318844|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
164531585|NCT03217266|594318841|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
164531586|NCT03217266|594318842|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
164531587|NCT03217266|594318843|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
164531588|NCT03217266|594318844|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
164531589|NCT03217266|594318841|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
164531590|NCT03217266|594318842|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
164531591|NCT03217266|594318843|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
164531592|NCT03217266|594318844|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
164531593|NCT01390181|594318845|FG000|Overall Study|Lost to Follow-up|1|||
164531594|NCT01390181|594318845|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
164641313|NCT01299272|594711204|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
164531595|NCT00720941|594318851|FG000|Overall Study|Protocol Violation|1|||
164641314|NCT01299272|594711205|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
164641315|NCT01299272|594711206|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
164641316|NCT01299272|594711203|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
164641317|NCT01299272|594711204|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
164641318|NCT01299272|594711205|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
164531596|NCT00720941|594318852|FG001|Overall Study|Protocol Violation|2|||
164531597|NCT00720941|594318851|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
164531598|NCT00720941|594318852|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
164531599|NCT00720941|594318851|FG000|Overall Study|Lost to Follow-up|20|||
164531600|NCT00720941|594318852|FG001|Overall Study|Lost to Follow-up|15|||
164531601|NCT00720941|594318851|FG000|Overall Study|Physician Decision|14|||
164531602|NCT00720941|594318852|FG001|Overall Study|Physician Decision|12|||
164531603|NCT00720941|594318851|FG000|Overall Study|Withdrawal by Subject|29|||
164531604|NCT00720941|594318852|FG001|Overall Study|Withdrawal by Subject|36|||
164531605|NCT03511053|594318856|FG000|Overall Study|Withdrawal by Subject|1|||
164531606|NCT02425644|594318861|FG000|Overall Study|Lost to Follow-up|2|||
164531607|NCT02425644|594318862|FG001|Overall Study|Lost to Follow-up|3|||
164531608|NCT02425644|594318861|FG000|Overall Study|Withdrawal by Subject|41|||
164531609|NCT02425644|594318862|FG001|Overall Study|Withdrawal by Subject|36|||
164531610|NCT02425644|594318861|FG000|Overall Study|Lack of Efficacy|3|||
164531611|NCT02425644|594318862|FG001|Overall Study|Lack of Efficacy|10|||
164531612|NCT02425644|594318861|FG000|Overall Study|Adverse Event|13|||
164531613|NCT02425644|594318862|FG001|Overall Study|Adverse Event|3|||
164531614|NCT02425644|594318861|FG000|Overall Study|Death|0|||
164531615|NCT02425644|594318862|FG001|Overall Study|Death|2|||
164531616|NCT02425644|594318861|FG000|Overall Study|Other|18|||
164531617|NCT02425644|594318862|FG001|Overall Study|Other|17|||
164531618|NCT01786174|594318863|FG000|Overall Study|Discontinued Study Drug|2|||
164531619|NCT01786174|594318864|FG001|Overall Study|Discontinued Study Drug|0|||
164531620|NCT03628898|594318865|FG000|Overall Study|Device deficiency|1|||
164531621|NCT02720536|594318866|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
164531622|NCT02720536|594318866|FG000|Overall Study|PR - pregnancy|2|||
164531623|NCT02720536|594318866|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
164531624|NCT02720536|594318866|FG000|Overall Study|PR - death|1|||
164531625|NCT02720536|594318866|FG000|Overall Study|PR - adverse event|1|||
164531626|NCT02720536|594318866|FG000|Overall Study|PR - abnormal lab value(s)|1|||
164531627|NCT02720536|594318866|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
164531628|NCT03442985|594318867|FG000|Overall Study|Sponsor Request|55|||
164531629|NCT03442985|594318868|FG001|Overall Study|Sponsor Request|60|||
164531630|NCT03442985|594318869|FG002|Overall Study|Sponsor Request|54|||
164531631|NCT03442985|594318867|FG000|Overall Study|Lost to Follow-up|5|||
164531632|NCT03442985|594318868|FG001|Overall Study|Lost to Follow-up|2|||
164531633|NCT03442985|594318869|FG002|Overall Study|Lost to Follow-up|7|||
164531634|NCT03442985|594318867|FG000|Overall Study|Withdrawal by Subject|2|||
164531635|NCT03442985|594318868|FG001|Overall Study|Withdrawal by Subject|3|||
164531636|NCT03442985|594318869|FG002|Overall Study|Withdrawal by Subject|4|||
164531637|NCT03442985|594318867|FG000|Overall Study|Adverse Event|0|||
164531638|NCT03442985|594318868|FG001|Overall Study|Adverse Event|1|||
164531639|NCT03442985|594318869|FG002|Overall Study|Adverse Event|0|||
164531640|NCT00985166|594318870|FG000|Overall Study|Lost to Follow-up|3|||
164531641|NCT00985166|594318871|FG001|Overall Study|Lost to Follow-up|2|||
164531642|NCT00985166|594318872|FG002|Overall Study|Lost to Follow-up|2|||
164531643|NCT00985166|594318870|FG000|Overall Study|Withdrawal by Subject|3|||
164641319|NCT01299272|594711206|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
164641320|NCT01299272|594711203|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
164641321|NCT01299272|594711204|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
164641322|NCT01299272|594711205|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
164641323|NCT01299272|594711206|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
164641324|NCT01299272|594711203|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
164641325|NCT01299272|594711204|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
164641326|NCT01299272|594711205|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
164641327|NCT01299272|594711206|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
164641328|NCT01299272|594711203|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
164641329|NCT01299272|594711204|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
164641330|NCT01299272|594711205|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
164641331|NCT01299272|594711206|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
164641332|NCT01299272|594711203|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
164641333|NCT01299272|594711204|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
164641334|NCT01299272|594711205|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
164641335|NCT01299272|594711206|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
164531644|NCT00985166|594318871|FG001|Overall Study|Withdrawal by Subject|2|||
164531645|NCT00985166|594318872|FG002|Overall Study|Withdrawal by Subject|0|||
164641336|NCT01299272|594711203|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
164641337|NCT01299272|594711204|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
164641338|NCT01299272|594711205|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
164641339|NCT01299272|594711206|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
164641340|NCT01299272|594711203|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
164641341|NCT01299272|594711204|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
164641342|NCT01299272|594711205|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
164641343|NCT01299272|594711206|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
164641344|NCT01299272|594711203|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
164641345|NCT01299272|594711204|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
164641346|NCT01299272|594711205|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
164641347|NCT01299272|594711206|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
164641348|NCT01299272|594711203|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
164641349|NCT01299272|594711204|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
164641350|NCT01299272|594711205|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
164641351|NCT01299272|594711206|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
164641352|NCT01299272|594711203|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
164641353|NCT01299272|594711204|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
164641354|NCT01299272|594711205|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
164641355|NCT01299272|594711206|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
164641356|NCT01299272|594711203|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
164641357|NCT01299272|594711204|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
164641358|NCT01299272|594711205|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
164641359|NCT01299272|594711206|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
164641360|NCT01299272|594711203|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
164641361|NCT01299272|594711204|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
164641362|NCT01299272|594711205|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
164641363|NCT01299272|594711206|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
164641364|NCT03926728|594711207|FG000|Overall Study|Withdrawal by Subject|0|||
164641365|NCT03926728|594711208|FG001|Overall Study|Withdrawal by Subject|1|||
164641366|NCT03926728|594711209|FG002|Overall Study|Withdrawal by Subject|1|||
164641367|NCT03926728|594711210|FG003|Overall Study|Withdrawal by Subject|0|||
164641368|NCT03926728|594711211|FG004|Overall Study|Withdrawal by Subject|0|||
164641369|NCT03926728|594711212|FG005|Overall Study|Withdrawal by Subject|1|||
164641370|NCT03926728|594711213|FG006|Overall Study|Withdrawal by Subject|1|||
164641371|NCT03926728|594711214|FG007|Overall Study|Withdrawal by Subject|0|||
164641372|NCT03926728|594711215|FG008|Overall Study|Withdrawal by Subject|0|||
164641373|NCT03926728|594711216|FG009|Overall Study|Withdrawal by Subject|1|||
164641374|NCT03926728|594711217|FG010|Overall Study|Withdrawal by Subject|0|||
164641375|NCT03926728|594711218|FG011|Overall Study|Withdrawal by Subject|0|||
164641376|NCT03722849|594711225|FG000|Overall Study|Withdrawal by Subject|1|||
164641377|NCT03722849|594711226|FG001|Overall Study|Withdrawal by Subject|1|||
164641378|NCT02729545|594711227|FG000|Overall Study|Pregnancy|1|||
164641379|NCT02729545|594711228|FG001|Overall Study|Pregnancy|1|||
164641380|NCT02729545|594711227|FG000|Overall Study|Lost to Follow-up|0|||
164641381|NCT02729545|594711228|FG001|Overall Study|Lost to Follow-up|1|||
164641382|NCT02729545|594711227|FG000|Overall Study|Withdrawal by Subject|2|||
164641383|NCT02729545|594711228|FG001|Overall Study|Withdrawal by Subject|3|||
164641384|NCT03533608|594711229|FG000|Overall Study|Withdrawal by Subject|3|||
164641385|NCT03533608|594711229|FG000|Overall Study|Physician Decision|2|||
164641386|NCT00915473|594711230|FG000|Screening|Withdrawal by Subject|1|||
164641387|NCT00915473|594711231|FG001|Screening|Withdrawal by Subject|0|||
164641388|NCT00915473|594711230|FG000|4-week Follow Up|Lost to Follow-up|1|||
164641389|NCT00915473|594711231|FG001|4-week Follow Up|Lost to Follow-up|5|||
164641390|NCT01389024|594711232|FG000|Overall Study|Withdrawal by Subject|0|||
164641391|NCT01389024|594711233|FG001|Overall Study|Withdrawal by Subject|1|||
164641392|NCT01389024|594711232|FG000|Overall Study|Lost to Follow-up|1|||
164641393|NCT01389024|594711233|FG001|Overall Study|Lost to Follow-up|0|||
164641394|NCT00529802|594711235|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
164641395|NCT00529802|594711235|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
164641396|NCT00529802|594711235|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
164641397|NCT00529802|594711235|FG000|Evaluable for Primary Endpoint|Death|1|||
164641398|NCT00529802|594711235|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
164641399|NCT00529802|594711235|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
164641400|NCT00529802|594711235|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
164641401|NCT02209454|594711236|FG000|Second Period|Adverse Event|1|||
164641402|NCT02209454|594711237|FG001|Second Period|Adverse Event|0|||
164641403|NCT00826176|594711245|FG000|Overall Study|Lost to Follow-up|1|||
164641404|NCT00826176|594711246|FG001|Overall Study|Lost to Follow-up|0|||
164641405|NCT00826176|594711245|FG000|Overall Study|Subject Withdrew Consent|3|||
164641406|NCT00826176|594711246|FG001|Overall Study|Subject Withdrew Consent|0|||
164531646|NCT00985166|594318870|FG000|Overall Study|Test not done|2|||
164531647|NCT00985166|594318871|FG001|Overall Study|Test not done|0|||
164531648|NCT00985166|594318872|FG002|Overall Study|Test not done|4|||
164531649|NCT00985166|594318870|FG000|Overall Study|Other|1|||
164531650|NCT00985166|594318871|FG001|Overall Study|Other|0|||
164531651|NCT00985166|594318872|FG002|Overall Study|Other|1|||
164531652|NCT00300781|594318873|FG000|Overall Study|Disease Progression|55|||
164531653|NCT00300781|594318874|FG001|Overall Study|Disease Progression|52|||
164531654|NCT00300781|594318873|FG000|Overall Study|Adverse Event|5|||
164531655|NCT00300781|594318874|FG001|Overall Study|Adverse Event|6|||
164531656|NCT00300781|594318873|FG000|Overall Study|Withdrawal by Subject|1|||
164531657|NCT00300781|594318874|FG001|Overall Study|Withdrawal by Subject|2|||
164531658|NCT00300781|594318873|FG000|Overall Study|Physician Decision|1|||
164531659|NCT00300781|594318874|FG001|Overall Study|Physician Decision|0|||
164531660|NCT00300781|594318873|FG000|Overall Study|Not Recorded|0|||
164531661|NCT00300781|594318874|FG001|Overall Study|Not Recorded|1|||
164531662|NCT00300781|594318873|FG000|Overall Study|Symptomatic Deterioration|1|||
164531663|NCT00300781|594318874|FG001|Overall Study|Symptomatic Deterioration|0|||
164531664|NCT00300781|594318873|FG000|Overall Study|Lost to Follow-up|0|||
164531665|NCT00300781|594318874|FG001|Overall Study|Lost to Follow-up|1|||
164531666|NCT00567268|594318877|FG000|Overall Study|Protocol Violation|7|||
164531667|NCT00567268|594318877|FG000|Overall Study|Lost to Follow-up|36|||
164531668|NCT00567268|594318877|FG000|Overall Study|No Visit After First Day of Treatment|2|||
164531669|NCT00567268|594318877|FG000|Overall Study|No Drug Administration|4|||
164531670|NCT00567268|594318877|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
164531671|NCT02864381|594318878|FG000|Overall Study|Death|58|||
164531672|NCT02864381|594318879|FG001|Overall Study|Death|61|||
164531673|NCT02864381|594318878|FG000|Overall Study|Withdrew Consent|5|||
164531674|NCT02864381|594318879|FG001|Overall Study|Withdrew Consent|6|||
164531675|NCT02864381|594318878|FG000|Overall Study|Reason Unknown|7|||
164531676|NCT02864381|594318879|FG001|Overall Study|Reason Unknown|3|||
164531677|NCT02864381|594318878|FG000|Overall Study|Lost to Follow-up|1|||
164531678|NCT02864381|594318879|FG001|Overall Study|Lost to Follow-up|1|||
164531679|NCT02864381|594318878|FG000|Overall Study|Investigator's Discretion|1|||
164531680|NCT02864381|594318879|FG001|Overall Study|Investigator's Discretion|0|||
164531681|NCT02864381|594318878|FG000|Overall Study|Protocol Violation|0|||
164531682|NCT02864381|594318879|FG001|Overall Study|Protocol Violation|1|||
164531683|NCT02986334|594318880|FG000|Overall Study|Withdrawal by Subject|0|||
164531684|NCT02986334|594318881|FG001|Overall Study|Withdrawal by Subject|1|||
164531685|NCT02986334|594318882|FG002|Overall Study|Withdrawal by Subject|2|||
164531686|NCT02986334|594318880|FG000|Overall Study|Lost to Follow-up|1|||
164531687|NCT02986334|594318881|FG001|Overall Study|Lost to Follow-up|2|||
164531688|NCT02986334|594318882|FG002|Overall Study|Lost to Follow-up|1|||
164531689|NCT02986334|594318880|FG000|Overall Study|Adverse Event|0|||
164531690|NCT02986334|594318881|FG001|Overall Study|Adverse Event|2|||
164531691|NCT02986334|594318882|FG002|Overall Study|Adverse Event|1|||
164531692|NCT02986334|594318880|FG000|Overall Study|non compliance in phone ratings|2|||
164531693|NCT02986334|594318881|FG001|Overall Study|non compliance in phone ratings|1|||
164531694|NCT02986334|594318882|FG002|Overall Study|non compliance in phone ratings|2|||
164531695|NCT02986334|594318880|FG000|Overall Study|undisclosed comorbidities|0|||
164531696|NCT02986334|594318881|FG001|Overall Study|undisclosed comorbidities|1|||
164531697|NCT02986334|594318882|FG002|Overall Study|undisclosed comorbidities|1|||
164531698|NCT04142450|594318883|FG000|Overall Study|Screen Failure|1|||
164531699|NCT04142450|594318883|FG000|Overall Study|Lost to Follow-up|1|||
164531700|NCT02525861|594318884|FG000|Overall Study|Adverse Event|1|||
164531701|NCT02525861|594318885|FG001|Overall Study|Adverse Event|0|||
164531702|NCT02525861|594318884|FG000|Overall Study|Withdrawal by Subject|0|||
164531703|NCT02525861|594318885|FG001|Overall Study|Withdrawal by Subject|1|||
164531704|NCT02525861|594318884|FG000|Overall Study|Physician Decision|0|||
164531705|NCT02525861|594318885|FG001|Overall Study|Physician Decision|1|||
164531706|NCT00120406|594318886|FG000|Overall Study|Death|9|||
164641407|NCT00826176|594711245|FG000|Overall Study|Administrative|9|||
164641408|NCT00826176|594711246|FG001|Overall Study|Administrative|0|||
164531707|NCT00120406|594318887|FG001|Overall Study|Death|4|||
164531708|NCT00120406|594318886|FG000|Overall Study|Withdrawal by Subject|5|||
164531709|NCT00120406|594318887|FG001|Overall Study|Withdrawal by Subject|7|||
164531710|NCT00120406|594318886|FG000|Overall Study|Lost to Follow-up|5|||
164531711|NCT00120406|594318887|FG001|Overall Study|Lost to Follow-up|2|||
164531712|NCT00120406|594318886|FG000|Overall Study|received non-study stent|0|||
164531713|NCT00120406|594318887|FG001|Overall Study|received non-study stent|2|||
164531714|NCT00120406|594318886|FG000|Overall Study|patient moved but has not withdrawn|0|||
164531715|NCT00120406|594318887|FG001|Overall Study|patient moved but has not withdrawn|1|||
164531716|NCT01607554|594318893|FG000|Overall Study|Disease progression|2|||
164531717|NCT01138007|594318894|FG000|Overall Study|Adverse Event|4|||
164531718|NCT01138007|594318895|FG001|Overall Study|Adverse Event|12|||
164531719|NCT01138007|594318896|FG002|Overall Study|Adverse Event|9|||
164531720|NCT01138007|594318894|FG000|Overall Study|Lack of Efficacy|2|||
164531721|NCT01138007|594318895|FG001|Overall Study|Lack of Efficacy|0|||
164531722|NCT01138007|594318896|FG002|Overall Study|Lack of Efficacy|6|||
164531723|NCT01138007|594318894|FG000|Overall Study|Protocol Violation|2|||
164531724|NCT01138007|594318895|FG001|Overall Study|Protocol Violation|3|||
164531725|NCT01138007|594318896|FG002|Overall Study|Protocol Violation|2|||
164531726|NCT01138007|594318894|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
164531727|NCT01138007|594318895|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
164531728|NCT01138007|594318896|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
164531729|NCT01138007|594318894|FG000|Overall Study|Lost to Follow-up|3|||
164531730|NCT01138007|594318895|FG001|Overall Study|Lost to Follow-up|3|||
164531731|NCT01138007|594318896|FG002|Overall Study|Lost to Follow-up|5|||
164531732|NCT01138007|594318894|FG000|Overall Study|Physician Decision|0|||
164531733|NCT01138007|594318895|FG001|Overall Study|Physician Decision|5|||
164531734|NCT01138007|594318896|FG002|Overall Study|Physician Decision|3|||
164531735|NCT01138007|594318894|FG000|Overall Study|Withdrawal by Subject|5|||
164531736|NCT01138007|594318895|FG001|Overall Study|Withdrawal by Subject|6|||
164531737|NCT01138007|594318896|FG002|Overall Study|Withdrawal by Subject|15|||
164531738|NCT04572841|594318897|FG000|Overall Study|Adverse Event|1|||
164531739|NCT04572841|594318898|FG001|Overall Study|Adverse Event|1|||
164531740|NCT04572841|594318897|FG000|Overall Study|Withdrawal by Subject|2|||
164531741|NCT04572841|594318898|FG001|Overall Study|Withdrawal by Subject|1|||
164531742|NCT00712673|594318903|FG000|Overall Study|Adverse Event|3|||
164531743|NCT00712673|594318904|FG001|Overall Study|Adverse Event|3|||
164531744|NCT00712673|594318905|FG002|Overall Study|Adverse Event|21|||
164531745|NCT00712673|594318906|FG003|Overall Study|Adverse Event|26|||
164531746|NCT00712673|594318903|FG000|Overall Study|Lack of Efficacy|2|||
164531747|NCT00712673|594318904|FG001|Overall Study|Lack of Efficacy|8|||
164531748|NCT00712673|594318905|FG002|Overall Study|Lack of Efficacy|8|||
164531749|NCT00712673|594318906|FG003|Overall Study|Lack of Efficacy|6|||
164531750|NCT00712673|594318903|FG000|Overall Study|Poor Compliance to Protocol|3|||
164531751|NCT00712673|594318904|FG001|Overall Study|Poor Compliance to Protocol|3|||
164531752|NCT00712673|594318905|FG002|Overall Study|Poor Compliance to Protocol|4|||
164531753|NCT00712673|594318906|FG003|Overall Study|Poor Compliance to Protocol|16|||
164531754|NCT00712673|594318903|FG000|Overall Study|Lost to Follow-up|1|||
164531755|NCT00712673|594318904|FG001|Overall Study|Lost to Follow-up|0|||
164531756|NCT00712673|594318905|FG002|Overall Study|Lost to Follow-up|2|||
164531757|NCT00712673|594318906|FG003|Overall Study|Lost to Follow-up|0|||
164531758|NCT00712673|594318903|FG000|Overall Study|Withdrawal by Subject|6|||
164531759|NCT00712673|594318904|FG001|Overall Study|Withdrawal by Subject|7|||
164531760|NCT00712673|594318905|FG002|Overall Study|Withdrawal by Subject|15|||
164531761|NCT00712673|594318906|FG003|Overall Study|Withdrawal by Subject|20|||
164531762|NCT00712673|594318903|FG000|Overall Study|Familial and Personal Reasons|5|||
164531763|NCT00712673|594318904|FG001|Overall Study|Familial and Personal Reasons|0|||
164531764|NCT00712673|594318905|FG002|Overall Study|Familial and Personal Reasons|5|||
164531765|NCT00712673|594318906|FG003|Overall Study|Familial and Personal Reasons|2|||
164531766|NCT00712673|594318903|FG000|Overall Study|Investigator's Decision|1|||
164531767|NCT00712673|594318904|FG001|Overall Study|Investigator's Decision|0|||
164531768|NCT00712673|594318905|FG002|Overall Study|Investigator's Decision|0|||
164531769|NCT00712673|594318906|FG003|Overall Study|Investigator's Decision|0|||
164531770|NCT00712673|594318903|FG000|Overall Study|Protocol Violation|0|||
164531771|NCT00712673|594318904|FG001|Overall Study|Protocol Violation|0|||
164641409|NCT00740480|594711247|FG000|Overall Study|Adverse Event|1|||
164641410|NCT00740480|594711247|FG000|Overall Study|Physician Decision|1|||
164641411|NCT03079869|594711253|FG000|Overall Study|Adverse Event|6|||
164641412|NCT03079869|594711254|FG001|Overall Study|Adverse Event|8|||
164641413|NCT03079869|594711253|FG000|Overall Study|Withdrawal by Subject|4|||
164641414|NCT03079869|594711254|FG001|Overall Study|Withdrawal by Subject|1|||
164641415|NCT03079869|594711253|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
164641416|NCT03079869|594711254|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
164641417|NCT01325701|594711255|FG000|Overall Study|Adverse Event|12|||
164641418|NCT01325701|594711256|FG001|Overall Study|Adverse Event|0|||
164641419|NCT01325701|594711255|FG000|Overall Study|Protocol Violation|1|||
164641420|NCT01325701|594711256|FG001|Overall Study|Protocol Violation|0|||
164641421|NCT01325701|594711255|FG000|Overall Study|Physician Decision|2|||
164641422|NCT01325701|594711256|FG001|Overall Study|Physician Decision|2|||
164641423|NCT01325701|594711255|FG000|Overall Study|Withdrawal by Subject|2|||
164641424|NCT01325701|594711256|FG001|Overall Study|Withdrawal by Subject|1|||
164641425|NCT01325701|594711255|FG000|Overall Study|Rollerover Extension Study|4|||
164641426|NCT01325701|594711256|FG001|Overall Study|Rollerover Extension Study|0|||
164641427|NCT04484805|594711265|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
164641428|NCT04484805|594711266|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
164531772|NCT00712673|594318905|FG002|Overall Study|Protocol Violation|2|||
164531773|NCT00712673|594318906|FG003|Overall Study|Protocol Violation|0|||
164531774|NCT00846391|594318907|FG000|Overall Study|Physician Decision|0|||
164531775|NCT00846391|594318908|FG001|Overall Study|Physician Decision|0|||
164531776|NCT00846391|594318909|FG002|Overall Study|Physician Decision|1|||
164531777|NCT00846391|594318907|FG000|Overall Study|Study Terminated by Sponsor|1|||
164531778|NCT00846391|594318908|FG001|Overall Study|Study Terminated by Sponsor|2|||
164531779|NCT00846391|594318909|FG002|Overall Study|Study Terminated by Sponsor|2|||
164531780|NCT00325039|594318910|FG000|Overall Study|Lost to Follow-up|18|||
164531781|NCT00325039|594318911|FG001|Overall Study|Lost to Follow-up|14|||
164531782|NCT01009203|594318913|FG000|Overall Study|Withdrawal by Subject|1|||
164531783|NCT01009203|594318913|FG000|Overall Study|Adverse Event|5|||
164531784|NCT01009203|594318913|FG000|Overall Study|Treatment-unrelated death|1|||
164531785|NCT02974088|594318917|FG000|Overall Study|Lost to Follow-up|0|||
164531786|NCT02974088|594318918|FG001|Overall Study|Lost to Follow-up|2|||
164531787|NCT02974088|594318917|FG000|Overall Study|Adverse Event|0|||
164531788|NCT02974088|594318918|FG001|Overall Study|Adverse Event|1|||
164531789|NCT01032382|594318919|FG000|Overall Study|Disease dissemination|1|||
164531790|NCT01032382|594318920|FG001|Overall Study|Disease dissemination|1|||
164531791|NCT01032382|594318919|FG000|Overall Study|Treatment failure|3|||
164531792|NCT01032382|594318920|FG001|Overall Study|Treatment failure|1|||
164531793|NCT01032382|594318919|FG000|Overall Study|Index lesion relapse|1|||
164531794|NCT01032382|594318920|FG001|Overall Study|Index lesion relapse|3|||
164531795|NCT00985153|594318921|FG000|Overall Study|Lost to Follow-up|16|||
164531796|NCT00985153|594318922|FG001|Overall Study|Lost to Follow-up|19|||
164531797|NCT00985153|594318923|FG002|Overall Study|Lost to Follow-up|17|||
164531798|NCT00985153|594318924|FG003|Overall Study|Lost to Follow-up|20|||
164531799|NCT00985153|594318921|FG000|Overall Study|Protocol Violation|3|||
164531800|NCT00985153|594318922|FG001|Overall Study|Protocol Violation|2|||
164531801|NCT00985153|594318923|FG002|Overall Study|Protocol Violation|4|||
164531802|NCT00985153|594318924|FG003|Overall Study|Protocol Violation|3|||
164531803|NCT00985153|594318921|FG000|Overall Study|Withdrawal by Subject|6|||
164531804|NCT00985153|594318922|FG001|Overall Study|Withdrawal by Subject|11|||
164531805|NCT00985153|594318923|FG002|Overall Study|Withdrawal by Subject|11|||
164531806|NCT00985153|594318924|FG003|Overall Study|Withdrawal by Subject|10|||
164531807|NCT00985153|594318921|FG000|Overall Study|Missed One or More Bleeds|7|||
164531808|NCT00985153|594318922|FG001|Overall Study|Missed One or More Bleeds|7|||
164531809|NCT00985153|594318923|FG002|Overall Study|Missed One or More Bleeds|8|||
164531810|NCT00985153|594318924|FG003|Overall Study|Missed One or More Bleeds|10|||
164531811|NCT00985153|594318921|FG000|Overall Study|Incomplete Safety Follow-up|3|||
164531812|NCT00985153|594318922|FG001|Overall Study|Incomplete Safety Follow-up|5|||
164531813|NCT00985153|594318923|FG002|Overall Study|Incomplete Safety Follow-up|4|||
164531814|NCT00985153|594318924|FG003|Overall Study|Incomplete Safety Follow-up|4|||
164531815|NCT04508023|594318926|FG000|Overall Study|Withdrawal by Subject|1|||
164531816|NCT04508023|594318927|FG001|Overall Study|Withdrawal by Subject|2|||
164641429|NCT04484805|594711265|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
164641430|NCT04484805|594711266|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
164641431|NCT00539006|594711269|FG000|Pre-treatment|Other|0|||
164641432|NCT00539006|594711270|FG001|Pre-treatment|Other|1|||
164641433|NCT00539006|594711271|FG002|Pre-treatment|Other|0|||
164641434|NCT00539006|594711272|FG003|Pre-treatment|Other|0|||
164641435|NCT00539006|594711269|FG000|Treatment Period 1|Lost to Follow-up|0|||
164641436|NCT00539006|594711270|FG001|Treatment Period 1|Lost to Follow-up|0|||
164641437|NCT00539006|594711271|FG002|Treatment Period 1|Lost to Follow-up|1|||
164641438|NCT00539006|594711272|FG003|Treatment Period 1|Lost to Follow-up|0|||
164641439|NCT00539006|594711269|FG000|Treatment Period 1|Protocol Violation|0|||
164641440|NCT00539006|594711270|FG001|Treatment Period 1|Protocol Violation|0|||
164641441|NCT00539006|594711271|FG002|Treatment Period 1|Protocol Violation|1|||
164641442|NCT00539006|594711272|FG003|Treatment Period 1|Protocol Violation|0|||
164641443|NCT00539006|594711269|FG000|Treatment Period 1|Lack of Efficacy|0|||
164641444|NCT00539006|594711270|FG001|Treatment Period 1|Lack of Efficacy|0|||
164641445|NCT00539006|594711271|FG002|Treatment Period 1|Lack of Efficacy|0|||
164641446|NCT00539006|594711272|FG003|Treatment Period 1|Lack of Efficacy|1|||
164641447|NCT00539006|594711269|FG000|Washout|Adverse Event|2|||
164641448|NCT00539006|594711270|FG001|Washout|Adverse Event|1|||
164641449|NCT00539006|594711271|FG002|Washout|Adverse Event|0|||
164641450|NCT00539006|594711272|FG003|Washout|Adverse Event|0|||
164641451|NCT00539006|594711269|FG000|Washout|Protocol Violation|1|||
164641452|NCT00539006|594711270|FG001|Washout|Protocol Violation|1|||
164641453|NCT00539006|594711271|FG002|Washout|Protocol Violation|0|||
164641454|NCT00539006|594711272|FG003|Washout|Protocol Violation|0|||
164641455|NCT00539006|594711269|FG000|Washout|Withdrawal by Subject|0|||
164641456|NCT00539006|594711270|FG001|Washout|Withdrawal by Subject|2|||
164641457|NCT00539006|594711271|FG002|Washout|Withdrawal by Subject|0|||
164641458|NCT00539006|594711272|FG003|Washout|Withdrawal by Subject|0|||
164531817|NCT01668667|594318934|FG000|Overall Study|Adverse Event|3|||
164531818|NCT01668667|594318935|FG001|Overall Study|Adverse Event|6|||
164531819|NCT01668667|594318936|FG002|Overall Study|Adverse Event|4|||
164531820|NCT01668667|594318937|FG003|Overall Study|Adverse Event|4|||
164531821|NCT01668667|594318934|FG000|Overall Study|Lack of Efficacy|3|||
164531822|NCT01668667|594318935|FG001|Overall Study|Lack of Efficacy|2|||
164531823|NCT01668667|594318936|FG002|Overall Study|Lack of Efficacy|2|||
164531824|NCT01668667|594318937|FG003|Overall Study|Lack of Efficacy|3|||
164531825|NCT01668667|594318934|FG000|Overall Study|Protocol Violation|6|||
164531826|NCT01668667|594318935|FG001|Overall Study|Protocol Violation|10|||
164641459|NCT00539006|594711269|FG000|Washout|Failed to meet continuation criteria|16|||
164641460|NCT00539006|594711270|FG001|Washout|Failed to meet continuation criteria|5|||
164641461|NCT00539006|594711271|FG002|Washout|Failed to meet continuation criteria|14|||
164641462|NCT00539006|594711272|FG003|Washout|Failed to meet continuation criteria|6|||
164641463|NCT00539006|594711269|FG000|Washout|Other|1|||
164641464|NCT00539006|594711270|FG001|Washout|Other|1|||
164641465|NCT00539006|594711271|FG002|Washout|Other|2|||
164641466|NCT00539006|594711272|FG003|Washout|Other|3|||
164641467|NCT00539006|594711269|FG000|Treatment Period 2|Protocol Violation|1|||
164641468|NCT00539006|594711270|FG001|Treatment Period 2|Protocol Violation|0|||
164641469|NCT00539006|594711271|FG002|Treatment Period 2|Protocol Violation|0|||
164641470|NCT00539006|594711272|FG003|Treatment Period 2|Protocol Violation|0|||
164641471|NCT00539006|594711269|FG000|Treatment Period 2|Other|0|||
164641472|NCT00539006|594711270|FG001|Treatment Period 2|Other|1|||
164641473|NCT00539006|594711271|FG002|Treatment Period 2|Other|0|||
164641474|NCT00539006|594711272|FG003|Treatment Period 2|Other|0|||
164641475|NCT03733301|594711273|FG000|Overall Study|Screen Fail|1|||
164641476|NCT03733301|594711274|FG001|Overall Study|Screen Fail|0|||
164641477|NCT03733301|594711275|FG002|Overall Study|Screen Fail|0|||
164641478|NCT03733301|594711273|FG000|Overall Study|Non-compliance|1|||
164641479|NCT03733301|594711274|FG001|Overall Study|Non-compliance|0|||
164641480|NCT03733301|594711275|FG002|Overall Study|Non-compliance|0|||
164641481|NCT03733301|594711273|FG000|Overall Study|Lack of Efficacy|2|||
164641482|NCT03733301|594711274|FG001|Overall Study|Lack of Efficacy|3|||
164641483|NCT03733301|594711275|FG002|Overall Study|Lack of Efficacy|0|||
164641484|NCT03733301|594711273|FG000|Overall Study|Adverse Event|0|||
164641485|NCT03733301|594711274|FG001|Overall Study|Adverse Event|1|||
164641486|NCT03733301|594711275|FG002|Overall Study|Adverse Event|3|||
164641487|NCT03733301|594711273|FG000|Overall Study|Withdrawal by Subject|3|||
164641488|NCT03733301|594711274|FG001|Overall Study|Withdrawal by Subject|5|||
164641489|NCT03733301|594711275|FG002|Overall Study|Withdrawal by Subject|1|||
164641490|NCT01275170|594711282|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
164641491|NCT01275170|594711283|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
164641492|NCT01275170|594711284|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
164641493|NCT01275170|594711285|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
164641494|NCT01275170|594711286|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
164641495|NCT01275170|594711287|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
164641496|NCT01275170|594711288|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
164641497|NCT01275170|594711289|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
164641498|NCT03917654|594711294|FG000|Year 1|Withdrawal by Subject|1|||
164641499|NCT03917654|594711295|FG001|Year 1|Withdrawal by Subject|0|||
164641500|NCT03917654|594711296|FG002|Year 1|Withdrawal by Subject|0|||
164641501|NCT03917654|594711297|FG003|Year 1|Withdrawal by Subject|0|||
164641502|NCT03917654|594711298|FG004|Year 1|Withdrawal by Subject|0|||
164641503|NCT03917654|594711299|FG005|Year 1|Withdrawal by Subject|1|||
164641504|NCT03917654|594711300|FG006|Year 1|Withdrawal by Subject|6|||
164641505|NCT03917654|594711301|FG007|Year 1|Withdrawal by Subject|2|||
164641506|NCT03917654|594711302|FG008|Year 1|Withdrawal by Subject|5|||
164641507|NCT03917654|594711303|FG009|Year 1|Withdrawal by Subject|3|||
164641508|NCT03917654|594711304|FG010|Year 1|Withdrawal by Subject|1|||
164641509|NCT03917654|594711305|FG011|Year 1|Withdrawal by Subject|0|||
164641510|NCT03917654|594711294|FG000|Year 1|Travel|0|||
164641511|NCT03917654|594711295|FG001|Year 1|Travel|1|||
164641512|NCT03917654|594711296|FG002|Year 1|Travel|1|||
164641513|NCT03917654|594711297|FG003|Year 1|Travel|0|||
164641514|NCT03917654|594711298|FG004|Year 1|Travel|4|||
164641515|NCT03917654|594711299|FG005|Year 1|Travel|4|||
164641516|NCT03917654|594711300|FG006|Year 1|Travel|10|||
164641517|NCT03917654|594711301|FG007|Year 1|Travel|8|||
164641518|NCT03917654|594711302|FG008|Year 1|Travel|2|||
164641519|NCT03917654|594711303|FG009|Year 1|Travel|5|||
164641520|NCT03917654|594711304|FG010|Year 1|Travel|3|||
164641521|NCT03917654|594711305|FG011|Year 1|Travel|3|||
164641522|NCT03917654|594711294|FG000|Year 1|Subject moved away from site|0|||
164641523|NCT03917654|594711295|FG001|Year 1|Subject moved away from site|1|||
164641524|NCT03917654|594711296|FG002|Year 1|Subject moved away from site|0|||
164641525|NCT03917654|594711297|FG003|Year 1|Subject moved away from site|0|||
164641526|NCT03917654|594711298|FG004|Year 1|Subject moved away from site|0|||
164641527|NCT03917654|594711299|FG005|Year 1|Subject moved away from site|0|||
164641528|NCT03917654|594711300|FG006|Year 1|Subject moved away from site|1|||
164641529|NCT03917654|594711301|FG007|Year 1|Subject moved away from site|2|||
164641530|NCT03917654|594711302|FG008|Year 1|Subject moved away from site|1|||
164641531|NCT03917654|594711303|FG009|Year 1|Subject moved away from site|0|||
164641532|NCT03917654|594711304|FG010|Year 1|Subject moved away from site|0|||
164641533|NCT03917654|594711305|FG011|Year 1|Subject moved away from site|3|||
164641534|NCT03917654|594711294|FG000|Year 1|Spouse/Family member request|0|||
164641535|NCT03917654|594711295|FG001|Year 1|Spouse/Family member request|0|||
164641536|NCT03917654|594711296|FG002|Year 1|Spouse/Family member request|1|||
164641537|NCT03917654|594711297|FG003|Year 1|Spouse/Family member request|0|||
164641538|NCT03917654|594711298|FG004|Year 1|Spouse/Family member request|1|||
164641539|NCT03917654|594711299|FG005|Year 1|Spouse/Family member request|0|||
164641540|NCT03917654|594711300|FG006|Year 1|Spouse/Family member request|0|||
164641541|NCT03917654|594711301|FG007|Year 1|Spouse/Family member request|2|||
164641542|NCT03917654|594711302|FG008|Year 1|Spouse/Family member request|0|||
164641543|NCT03917654|594711303|FG009|Year 1|Spouse/Family member request|0|||
164641544|NCT03917654|594711304|FG010|Year 1|Spouse/Family member request|0|||
164641545|NCT03917654|594711305|FG011|Year 1|Spouse/Family member request|1|||
164641546|NCT03917654|594711294|FG000|Year 1|Death|0|||
164641547|NCT03917654|594711295|FG001|Year 1|Death|0|||
164641548|NCT03917654|594711296|FG002|Year 1|Death|0|||
164641549|NCT03917654|594711297|FG003|Year 1|Death|0|||
164641550|NCT03917654|594711298|FG004|Year 1|Death|0|||
164641551|NCT03917654|594711299|FG005|Year 1|Death|0|||
164641552|NCT03917654|594711300|FG006|Year 1|Death|0|||
164641553|NCT03917654|594711301|FG007|Year 1|Death|0|||
164641554|NCT03917654|594711302|FG008|Year 1|Death|1|||
164641555|NCT03917654|594711303|FG009|Year 1|Death|1|||
164641556|NCT03917654|594711304|FG010|Year 1|Death|0|||
164641557|NCT03917654|594711305|FG011|Year 1|Death|0|||
164641558|NCT03917654|594711294|FG000|Year 1|Lost to Follow-up|0|||
164641559|NCT03917654|594711295|FG001|Year 1|Lost to Follow-up|0|||
164641560|NCT03917654|594711296|FG002|Year 1|Lost to Follow-up|0|||
164641561|NCT03917654|594711297|FG003|Year 1|Lost to Follow-up|0|||
164641562|NCT03917654|594711298|FG004|Year 1|Lost to Follow-up|0|||
164641563|NCT03917654|594711299|FG005|Year 1|Lost to Follow-up|0|||
164641564|NCT03917654|594711300|FG006|Year 1|Lost to Follow-up|2|||
164641565|NCT03917654|594711301|FG007|Year 1|Lost to Follow-up|0|||
164641566|NCT03917654|594711302|FG008|Year 1|Lost to Follow-up|0|||
164641567|NCT03917654|594711303|FG009|Year 1|Lost to Follow-up|0|||
164641568|NCT03917654|594711304|FG010|Year 1|Lost to Follow-up|0|||
164641569|NCT03917654|594711305|FG011|Year 1|Lost to Follow-up|0|||
164641570|NCT03917654|594711294|FG000|Year 1|Missed visits|0|||
164641571|NCT03917654|594711295|FG001|Year 1|Missed visits|0|||
164641572|NCT03917654|594711296|FG002|Year 1|Missed visits|0|||
164641573|NCT03917654|594711297|FG003|Year 1|Missed visits|0|||
164641574|NCT03917654|594711298|FG004|Year 1|Missed visits|0|||
164641575|NCT03917654|594711299|FG005|Year 1|Missed visits|0|||
164641576|NCT03917654|594711300|FG006|Year 1|Missed visits|0|||
164641577|NCT03917654|594711301|FG007|Year 1|Missed visits|0|||
164641578|NCT03917654|594711302|FG008|Year 1|Missed visits|0|||
164641579|NCT03917654|594711303|FG009|Year 1|Missed visits|0|||
164641580|NCT03917654|594711304|FG010|Year 1|Missed visits|1|||
164641581|NCT03917654|594711305|FG011|Year 1|Missed visits|1|||
164641582|NCT03917654|594711294|FG000|Year 1|Pregnancy|0|||
164641583|NCT03917654|594711295|FG001|Year 1|Pregnancy|0|||
164641584|NCT03917654|594711296|FG002|Year 1|Pregnancy|0|||
164641585|NCT03917654|594711297|FG003|Year 1|Pregnancy|0|||
164641586|NCT03917654|594711298|FG004|Year 1|Pregnancy|0|||
164641587|NCT03917654|594711299|FG005|Year 1|Pregnancy|0|||
164641588|NCT03917654|594711300|FG006|Year 1|Pregnancy|0|||
164641589|NCT03917654|594711301|FG007|Year 1|Pregnancy|1|||
164641590|NCT03917654|594711302|FG008|Year 1|Pregnancy|0|||
164641591|NCT03917654|594711303|FG009|Year 1|Pregnancy|1|||
164641592|NCT03917654|594711304|FG010|Year 1|Pregnancy|0|||
164641593|NCT03917654|594711305|FG011|Year 1|Pregnancy|0|||
164641594|NCT03917654|594711294|FG000|Year 2|Travel|1|||
164641595|NCT03917654|594711295|FG001|Year 2|Travel|0|||
164641596|NCT03917654|594711296|FG002|Year 2|Travel|0|||
164641597|NCT03917654|594711297|FG003|Year 2|Travel|0|||
164641598|NCT03917654|594711298|FG004|Year 2|Travel|1|||
164641599|NCT03917654|594711299|FG005|Year 2|Travel|1|||
164641600|NCT03917654|594711300|FG006|Year 2|Travel|2|||
164641601|NCT03917654|594711301|FG007|Year 2|Travel|1|||
164641602|NCT03917654|594711302|FG008|Year 2|Travel|0|||
164641603|NCT03917654|594711303|FG009|Year 2|Travel|1|||
164641604|NCT03917654|594711304|FG010|Year 2|Travel|0|||
164641605|NCT03917654|594711305|FG011|Year 2|Travel|1|||
164641606|NCT03917654|594711294|FG000|Year 2|Married|1|||
164641607|NCT03917654|594711295|FG001|Year 2|Married|0|||
164641608|NCT03917654|594711296|FG002|Year 2|Married|0|||
164641609|NCT03917654|594711297|FG003|Year 2|Married|0|||
164641610|NCT03917654|594711298|FG004|Year 2|Married|0|||
164641611|NCT03917654|594711299|FG005|Year 2|Married|0|||
164641612|NCT03917654|594711300|FG006|Year 2|Married|1|||
164641613|NCT03917654|594711301|FG007|Year 2|Married|1|||
164641614|NCT03917654|594711302|FG008|Year 2|Married|0|||
164641615|NCT03917654|594711303|FG009|Year 2|Married|0|||
164641616|NCT03917654|594711304|FG010|Year 2|Married|0|||
164641617|NCT03917654|594711305|FG011|Year 2|Married|0|||
164641618|NCT03917654|594711294|FG000|Year 2|Subject moved away from site|1|||
164641619|NCT03917654|594711295|FG001|Year 2|Subject moved away from site|0|||
164641620|NCT03917654|594711296|FG002|Year 2|Subject moved away from site|0|||
164641621|NCT03917654|594711297|FG003|Year 2|Subject moved away from site|0|||
164641622|NCT03917654|594711298|FG004|Year 2|Subject moved away from site|1|||
164641623|NCT03917654|594711299|FG005|Year 2|Subject moved away from site|0|||
164641624|NCT03917654|594711300|FG006|Year 2|Subject moved away from site|2|||
164641625|NCT03917654|594711301|FG007|Year 2|Subject moved away from site|3|||
164641626|NCT03917654|594711302|FG008|Year 2|Subject moved away from site|0|||
164641627|NCT03917654|594711303|FG009|Year 2|Subject moved away from site|2|||
164641628|NCT03917654|594711304|FG010|Year 2|Subject moved away from site|0|||
164641629|NCT03917654|594711305|FG011|Year 2|Subject moved away from site|1|||
164641630|NCT03917654|594711294|FG000|Year 2|Year 2 Screening failure|0|||
164641631|NCT03917654|594711295|FG001|Year 2|Year 2 Screening failure|1|||
164641632|NCT03917654|594711296|FG002|Year 2|Year 2 Screening failure|0|||
164641633|NCT03917654|594711297|FG003|Year 2|Year 2 Screening failure|0|||
164641634|NCT03917654|594711298|FG004|Year 2|Year 2 Screening failure|2|||
164641635|NCT03917654|594711299|FG005|Year 2|Year 2 Screening failure|0|||
164641636|NCT03917654|594711300|FG006|Year 2|Year 2 Screening failure|4|||
164641637|NCT03917654|594711301|FG007|Year 2|Year 2 Screening failure|3|||
164641638|NCT03917654|594711302|FG008|Year 2|Year 2 Screening failure|10|||
164641639|NCT03917654|594711303|FG009|Year 2|Year 2 Screening failure|2|||
164641640|NCT03917654|594711304|FG010|Year 2|Year 2 Screening failure|1|||
164641641|NCT03917654|594711305|FG011|Year 2|Year 2 Screening failure|1|||
164641642|NCT03917654|594711294|FG000|Year 2|Death|0|||
164641643|NCT03917654|594711295|FG001|Year 2|Death|0|||
164641644|NCT03917654|594711296|FG002|Year 2|Death|0|||
164641645|NCT03917654|594711297|FG003|Year 2|Death|0|||
164641646|NCT03917654|594711298|FG004|Year 2|Death|0|||
164641647|NCT03917654|594711299|FG005|Year 2|Death|1|||
164641648|NCT03917654|594711300|FG006|Year 2|Death|0|||
164641649|NCT03917654|594711301|FG007|Year 2|Death|0|||
164641650|NCT03917654|594711302|FG008|Year 2|Death|1|||
164641651|NCT03917654|594711303|FG009|Year 2|Death|1|||
164641652|NCT03917654|594711304|FG010|Year 2|Death|0|||
164641653|NCT03917654|594711305|FG011|Year 2|Death|0|||
164641654|NCT03917654|594711294|FG000|Year 2|Withdrawal by Subject|0|||
164641655|NCT03917654|594711295|FG001|Year 2|Withdrawal by Subject|0|||
164641656|NCT03917654|594711296|FG002|Year 2|Withdrawal by Subject|0|||
164641657|NCT03917654|594711297|FG003|Year 2|Withdrawal by Subject|0|||
164641658|NCT03917654|594711298|FG004|Year 2|Withdrawal by Subject|0|||
164641659|NCT03917654|594711299|FG005|Year 2|Withdrawal by Subject|0|||
164641660|NCT03917654|594711300|FG006|Year 2|Withdrawal by Subject|3|||
164641661|NCT03917654|594711301|FG007|Year 2|Withdrawal by Subject|0|||
164641662|NCT03917654|594711302|FG008|Year 2|Withdrawal by Subject|2|||
164641663|NCT03917654|594711303|FG009|Year 2|Withdrawal by Subject|5|||
164641664|NCT03917654|594711304|FG010|Year 2|Withdrawal by Subject|0|||
164641665|NCT03917654|594711305|FG011|Year 2|Withdrawal by Subject|0|||
164641666|NCT03917654|594711294|FG000|Year 2|Spouse/family member request|0|||
164641667|NCT03917654|594711295|FG001|Year 2|Spouse/family member request|0|||
164641668|NCT03917654|594711296|FG002|Year 2|Spouse/family member request|0|||
164641669|NCT03917654|594711297|FG003|Year 2|Spouse/family member request|0|||
164641670|NCT03917654|594711298|FG004|Year 2|Spouse/family member request|0|||
164641671|NCT03917654|594711299|FG005|Year 2|Spouse/family member request|0|||
164641672|NCT03917654|594711300|FG006|Year 2|Spouse/family member request|1|||
164641673|NCT03917654|594711301|FG007|Year 2|Spouse/family member request|0|||
164641674|NCT03917654|594711302|FG008|Year 2|Spouse/family member request|0|||
164641675|NCT03917654|594711303|FG009|Year 2|Spouse/family member request|0|||
164641676|NCT03917654|594711304|FG010|Year 2|Spouse/family member request|0|||
164641677|NCT03917654|594711305|FG011|Year 2|Spouse/family member request|0|||
164641678|NCT03917654|594711294|FG000|Year 2|Lost to Follow-up|0|||
164641679|NCT03917654|594711295|FG001|Year 2|Lost to Follow-up|0|||
164641680|NCT03917654|594711296|FG002|Year 2|Lost to Follow-up|0|||
164641681|NCT03917654|594711297|FG003|Year 2|Lost to Follow-up|0|||
164641682|NCT03917654|594711298|FG004|Year 2|Lost to Follow-up|0|||
164641683|NCT03917654|594711299|FG005|Year 2|Lost to Follow-up|0|||
164641684|NCT03917654|594711300|FG006|Year 2|Lost to Follow-up|1|||
164641685|NCT03917654|594711301|FG007|Year 2|Lost to Follow-up|0|||
164641686|NCT03917654|594711302|FG008|Year 2|Lost to Follow-up|1|||
164641687|NCT03917654|594711303|FG009|Year 2|Lost to Follow-up|0|||
164641688|NCT03917654|594711304|FG010|Year 2|Lost to Follow-up|0|||
164641689|NCT03917654|594711305|FG011|Year 2|Lost to Follow-up|1|||
164641690|NCT03917654|594711294|FG000|Year 2|Adverse Event|0|||
164641691|NCT03917654|594711295|FG001|Year 2|Adverse Event|0|||
164641692|NCT03917654|594711296|FG002|Year 2|Adverse Event|0|||
164641693|NCT03917654|594711297|FG003|Year 2|Adverse Event|0|||
164641694|NCT03917654|594711298|FG004|Year 2|Adverse Event|0|||
164641695|NCT03917654|594711299|FG005|Year 2|Adverse Event|0|||
164641696|NCT03917654|594711300|FG006|Year 2|Adverse Event|0|||
164641697|NCT03917654|594711301|FG007|Year 2|Adverse Event|0|||
164641698|NCT03917654|594711302|FG008|Year 2|Adverse Event|0|||
164641699|NCT03917654|594711303|FG009|Year 2|Adverse Event|1|||
164641700|NCT03917654|594711304|FG010|Year 2|Adverse Event|0|||
164641701|NCT03917654|594711305|FG011|Year 2|Adverse Event|0|||
164641702|NCT04636437|594711307|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
164641703|NCT04636437|594711308|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
164641704|NCT04636437|594711309|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
164641705|NCT04636437|594711307|FG000|Overall Study|Started weight loss drug/program|2|||
164641706|NCT04636437|594711308|FG001|Overall Study|Started weight loss drug/program|1|||
164641707|NCT04636437|594711309|FG002|Overall Study|Started weight loss drug/program|1|||
164641708|NCT04636437|594711307|FG000|Overall Study|Lost to Follow-up|3|||
164641709|NCT04636437|594711308|FG001|Overall Study|Lost to Follow-up|1|||
164641710|NCT04636437|594711309|FG002|Overall Study|Lost to Follow-up|4|||
164641711|NCT04636437|594711307|FG000|Overall Study|Participant or physician decision|3|||
164641712|NCT04636437|594711308|FG001|Overall Study|Participant or physician decision|1|||
164641713|NCT04636437|594711309|FG002|Overall Study|Participant or physician decision|1|||
164641714|NCT00816166|594711310|FG000|Overall Study|Lost to Follow-up|6|||
164641715|NCT00816166|594711311|FG001|Overall Study|Lost to Follow-up|10|||
164641716|NCT00816166|594711310|FG000|Overall Study|Death|4|||
164641717|NCT00816166|594711311|FG001|Overall Study|Death|2|||
164641718|NCT01071278|594711312|FG000|Overall Study|Premature Discontinuation|254|||
164641719|NCT01071278|594711312|FG000|Overall Study|Completion Status Unknown|459|||
164641720|NCT02684162|594711313|FG000|Overall Study|Physician Decision|0|||
164641721|NCT02684162|594711314|FG001|Overall Study|Physician Decision|1|||
164641722|NCT02684162|594711315|FG002|Overall Study|Physician Decision|0|||
164641723|NCT01083121|594711318|FG000|Overall Study|Use of Humira outside the approved label|81|||
164641724|NCT03743571|594711320|FG000|Overall Study|Withdrawal by Subject|1|||
164641725|NCT03743571|594711321|FG001|Overall Study|Withdrawal by Subject|1|||
164641726|NCT03743571|594711320|FG000|Overall Study|Lost to Follow-up|1|||
164641727|NCT03743571|594711321|FG001|Overall Study|Lost to Follow-up|2|||
164641728|NCT01489865|594711322|FG000|Overall Study|Progression of Disease|4|||
164641729|NCT01489865|594711323|FG001|Overall Study|Progression of Disease|2|||
164641730|NCT01489865|594711324|FG002|Overall Study|Progression of Disease|2|||
164641731|NCT01489865|594711325|FG003|Overall Study|Progression of Disease|3|||
164641732|NCT01489865|594711326|FG004|Overall Study|Progression of Disease|1|||
164641733|NCT01489865|594711327|FG005|Overall Study|Progression of Disease|6|||
164641734|NCT01489865|594711328|FG006|Overall Study|Progression of Disease|3|||
164641735|NCT01489865|594711329|FG007|Overall Study|Progression of Disease|0|||
164641736|NCT01489865|594711330|FG008|Overall Study|Progression of Disease|23|||
164641737|NCT01489865|594711322|FG000|Overall Study|Adverse Event|2|||
164641738|NCT01489865|594711323|FG001|Overall Study|Adverse Event|0|||
164641739|NCT01489865|594711324|FG002|Overall Study|Adverse Event|0|||
164641740|NCT01489865|594711325|FG003|Overall Study|Adverse Event|0|||
164641741|NCT01489865|594711326|FG004|Overall Study|Adverse Event|1|||
164641742|NCT01489865|594711327|FG005|Overall Study|Adverse Event|0|||
164641743|NCT01489865|594711328|FG006|Overall Study|Adverse Event|2|||
164641744|NCT01489865|594711329|FG007|Overall Study|Adverse Event|0|||
164641745|NCT01489865|594711330|FG008|Overall Study|Adverse Event|5|||
164641746|NCT01489865|594711322|FG000|Overall Study|Death|0|||
164641747|NCT01489865|594711323|FG001|Overall Study|Death|1|||
164641748|NCT01489865|594711324|FG002|Overall Study|Death|0|||
164641749|NCT01489865|594711325|FG003|Overall Study|Death|0|||
164641750|NCT01489865|594711326|FG004|Overall Study|Death|1|||
164641751|NCT01489865|594711327|FG005|Overall Study|Death|0|||
164641752|NCT01489865|594711328|FG006|Overall Study|Death|0|||
164641753|NCT01489865|594711329|FG007|Overall Study|Death|0|||
164641754|NCT01489865|594711330|FG008|Overall Study|Death|2|||
164641755|NCT01489865|594711322|FG000|Overall Study|Withdrawal by Subject|0|||
164641756|NCT01489865|594711323|FG001|Overall Study|Withdrawal by Subject|0|||
164641757|NCT01489865|594711324|FG002|Overall Study|Withdrawal by Subject|0|||
164641758|NCT01489865|594711325|FG003|Overall Study|Withdrawal by Subject|0|||
164641759|NCT01489865|594711326|FG004|Overall Study|Withdrawal by Subject|0|||
164641760|NCT01489865|594711327|FG005|Overall Study|Withdrawal by Subject|1|||
164641761|NCT01489865|594711328|FG006|Overall Study|Withdrawal by Subject|1|||
164641762|NCT01489865|594711329|FG007|Overall Study|Withdrawal by Subject|0|||
164641763|NCT01489865|594711330|FG008|Overall Study|Withdrawal by Subject|2|||
164641764|NCT01489865|594711322|FG000|Overall Study|Shifted|0|||
164641765|NCT01489865|594711323|FG001|Overall Study|Shifted|0|||
164641766|NCT01489865|594711324|FG002|Overall Study|Shifted|1|||
164641767|NCT01489865|594711325|FG003|Overall Study|Shifted|0|||
164641768|NCT01489865|594711326|FG004|Overall Study|Shifted|0|||
164641769|NCT01489865|594711327|FG005|Overall Study|Shifted|0|||
164641770|NCT01489865|594711328|FG006|Overall Study|Shifted|0|||
164641771|NCT01489865|594711329|FG007|Overall Study|Shifted|0|||
164641772|NCT01489865|594711330|FG008|Overall Study|Shifted|0|||
164641773|NCT00972309|594711331|FG000|Overall Study|Switched to alternative treatment|0|||
164641774|NCT00972309|594711332|FG001|Overall Study|Switched to alternative treatment|2|||
164641775|NCT00972309|594711331|FG000|Overall Study|Refused further treatment|0|||
164641776|NCT00972309|594711332|FG001|Overall Study|Refused further treatment|1|||
164641777|NCT00972309|594711331|FG000|Overall Study|Late determination of ineligibility|0|||
164641778|NCT00972309|594711332|FG001|Overall Study|Late determination of ineligibility|1|||
164641779|NCT00972309|594711331|FG000|Overall Study|Second malignancy|1|||
164641780|NCT00972309|594711332|FG001|Overall Study|Second malignancy|1|||
164641781|NCT00972309|594711331|FG000|Overall Study|Visa issues|0|||
164641782|NCT00972309|594711332|FG001|Overall Study|Visa issues|1|||
164641783|NCT00972309|594711331|FG000|Overall Study|Secondary cancer (SCC)|0|||
164641784|NCT00972309|594711332|FG001|Overall Study|Secondary cancer (SCC)|1|||
164641785|NCT00972309|594711331|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
164641786|NCT00972309|594711332|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
164641787|NCT00972309|594711331|FG000|Overall Study|Lost to Follow-up|1|||
164641788|NCT00972309|594711332|FG001|Overall Study|Lost to Follow-up|1|||
164641789|NCT00972309|594711331|FG000|Overall Study|Disease progression on study|10|||
164641790|NCT00972309|594711332|FG001|Overall Study|Disease progression on study|4|||
164641791|NCT01821391|594711344|FG000|Overall Study|Adverse Event|1|||
164641792|NCT01821391|594711345|FG001|Overall Study|Adverse Event|0|||
164641793|NCT03417102|594711350|FG000|Overall Study|Adverse Event|0|||
164641794|NCT03417102|594711351|FG001|Overall Study|Adverse Event|1|||
164641795|NCT03417102|594711350|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
164641796|NCT03417102|594711351|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
164641797|NCT03417102|594711350|FG000|Overall Study|Other|0|||
164641798|NCT03417102|594711351|FG001|Overall Study|Other|1|||
164641799|NCT01118949|594712960|FG000|Overall Study|Adverse Event|5|||
164641800|NCT01118949|594712960|FG000|Overall Study|Withdrawal by Subject|4|||
164641801|NCT01017731|594712966|FG000|Overall Study|Lost to Follow-up|2|||
164641802|NCT01017731|594712966|FG000|Overall Study|Withdrawal by Subject|3|||
164641803|NCT01017731|594712966|FG000|Overall Study|Physician Decision|2|||
164641804|NCT01017731|594712966|FG000|Overall Study|Adverse Event|1|||
164641805|NCT00648739|594712968|FG000|Overall Study|Adverse Event|1|||
164641806|NCT00648739|594712969|FG001|Overall Study|Adverse Event|0|||
164641807|NCT00648739|594712970|FG002|Overall Study|Adverse Event|1|||
164641808|NCT00648739|594712971|FG003|Overall Study|Adverse Event|2|||
164641809|NCT00648739|594712972|FG004|Overall Study|Adverse Event|1|||
164641810|NCT00648739|594712973|FG005|Overall Study|Adverse Event|0|||
164641811|NCT00648739|594712974|FG006|Overall Study|Adverse Event|0|||
164641812|NCT00648739|594712968|FG000|Overall Study|Withdrawal by Subject|1|||
164641813|NCT00648739|594712969|FG001|Overall Study|Withdrawal by Subject|0|||
164641814|NCT00648739|594712970|FG002|Overall Study|Withdrawal by Subject|1|||
164641815|NCT00648739|594712971|FG003|Overall Study|Withdrawal by Subject|0|||
164641816|NCT00648739|594712972|FG004|Overall Study|Withdrawal by Subject|0|||
164641817|NCT00648739|594712973|FG005|Overall Study|Withdrawal by Subject|2|||
164641818|NCT00648739|594712974|FG006|Overall Study|Withdrawal by Subject|0|||
164641819|NCT00648739|594712968|FG000|Overall Study|Lack of Efficacy|0|||
164641820|NCT00648739|594712969|FG001|Overall Study|Lack of Efficacy|0|||
164641821|NCT00648739|594712970|FG002|Overall Study|Lack of Efficacy|0|||
164641822|NCT00648739|594712971|FG003|Overall Study|Lack of Efficacy|0|||
164641823|NCT00648739|594712972|FG004|Overall Study|Lack of Efficacy|1|||
164641824|NCT00648739|594712973|FG005|Overall Study|Lack of Efficacy|2|||
164641825|NCT00648739|594712974|FG006|Overall Study|Lack of Efficacy|0|||
164641826|NCT00648739|594712968|FG000|Overall Study|Investigator Considered it Advisable|0|||
164641827|NCT00648739|594712969|FG001|Overall Study|Investigator Considered it Advisable|0|||
164641828|NCT00648739|594712970|FG002|Overall Study|Investigator Considered it Advisable|0|||
164641829|NCT00648739|594712971|FG003|Overall Study|Investigator Considered it Advisable|0|||
164641830|NCT00648739|594712972|FG004|Overall Study|Investigator Considered it Advisable|0|||
164641831|NCT00648739|594712973|FG005|Overall Study|Investigator Considered it Advisable|1|||
164641832|NCT00648739|594712974|FG006|Overall Study|Investigator Considered it Advisable|1|||
164641833|NCT00648739|594712968|FG000|Overall Study|Death|0|||
164641834|NCT00648739|594712969|FG001|Overall Study|Death|1|||
164641835|NCT00648739|594712970|FG002|Overall Study|Death|0|||
164641836|NCT00648739|594712971|FG003|Overall Study|Death|0|||
164641837|NCT00648739|594712972|FG004|Overall Study|Death|0|||
164641838|NCT00648739|594712973|FG005|Overall Study|Death|0|||
164641839|NCT00648739|594712974|FG006|Overall Study|Death|0|||
164641840|NCT00648739|594712968|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
164641841|NCT00648739|594712969|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
164641842|NCT00648739|594712970|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
164641843|NCT00648739|594712971|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
164641844|NCT00648739|594712972|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
164641845|NCT00648739|594712973|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
164641846|NCT00648739|594712974|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
164641847|NCT00648739|594712968|FG000|Overall Study|Follow-up Visits Not Completed|0|||
164641848|NCT00648739|594712969|FG001|Overall Study|Follow-up Visits Not Completed|1|||
164641849|NCT00648739|594712970|FG002|Overall Study|Follow-up Visits Not Completed|0|||
164641850|NCT00648739|594712971|FG003|Overall Study|Follow-up Visits Not Completed|0|||
164641851|NCT00648739|594712972|FG004|Overall Study|Follow-up Visits Not Completed|0|||
164641852|NCT00648739|594712973|FG005|Overall Study|Follow-up Visits Not Completed|0|||
164641853|NCT00648739|594712974|FG006|Overall Study|Follow-up Visits Not Completed|0|||
164641854|NCT00685763|594712975|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
164641855|NCT00685763|594712975|FG000|Overall Study|Protocol Violation|1|||
164641856|NCT00698009|594712983|FG000|Overall Study|Withdrawal by Subject|1|||
164641857|NCT00564486|594712987|FG000|Overall Study|Adverse Event|0|||
164641858|NCT00564486|594712988|FG001|Overall Study|Adverse Event|1|||
164641859|NCT00564486|594712989|FG002|Overall Study|Adverse Event|0|||
164641860|NCT00564486|594712990|FG003|Overall Study|Adverse Event|0|||
164641861|NCT00564486|594712987|FG000|Overall Study|Withdrawal by Subject|4|||
164641862|NCT00564486|594712988|FG001|Overall Study|Withdrawal by Subject|0|||
164641863|NCT00564486|594712989|FG002|Overall Study|Withdrawal by Subject|0|||
164641864|NCT00564486|594712990|FG003|Overall Study|Withdrawal by Subject|5|||
164641865|NCT00564486|594712987|FG000|Overall Study|Subject refused to have blood drawn|0|||
164641866|NCT00564486|594712988|FG001|Overall Study|Subject refused to have blood drawn|0|||
164641867|NCT00564486|594712989|FG002|Overall Study|Subject refused to have blood drawn|1|||
164641868|NCT00564486|594712990|FG003|Overall Study|Subject refused to have blood drawn|0|||
164641869|NCT00564486|594712987|FG000|Overall Study|Lost to Follow-up|3|||
164641870|NCT00564486|594712988|FG001|Overall Study|Lost to Follow-up|0|||
164641871|NCT00564486|594712989|FG002|Overall Study|Lost to Follow-up|2|||
164641872|NCT00564486|594712990|FG003|Overall Study|Lost to Follow-up|2|||
164641873|NCT04362761|594712995|FG000|Part A (48 Weeks)|Adverse Event|2|||
164641874|NCT04362761|594712995|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
164641875|NCT04362761|594712995|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
164641876|NCT04362761|594712995|FG000|Part A (48 Weeks)|Other|5|||
164641877|NCT04362761|594712995|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
164641878|NCT04362761|594712995|FG000|Part B (86 Weeks)|Other|4|||
164641879|NCT03457727|594713001|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
164641880|NCT03457727|594713002|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
164641881|NCT03457727|594713003|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
164641882|NCT03457727|594713004|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
164641883|NCT00929201|594713005|FG000|Period 1|Withdrawal by Subject|0|||
164641884|NCT00929201|594713006|FG001|Period 1|Withdrawal by Subject|1|||
164641885|NCT00464308|594713012|FG000|Overall Study|Adverse Event|22|||
164641886|NCT00464308|594713013|FG001|Overall Study|Adverse Event|27|||
164641887|NCT00464308|594713014|FG002|Overall Study|Adverse Event|16|||
164641888|NCT00464308|594713012|FG000|Overall Study|Lost to Follow-up|29|||
164641889|NCT00464308|594713013|FG001|Overall Study|Lost to Follow-up|19|||
164641890|NCT00464308|594713014|FG002|Overall Study|Lost to Follow-up|20|||
164641891|NCT00464308|594713012|FG000|Overall Study|Patient discontinued and other reasons|17|||
164641892|NCT00464308|594713013|FG001|Overall Study|Patient discontinued and other reasons|17|||
164641893|NCT00464308|594713014|FG002|Overall Study|Patient discontinued and other reasons|23|||
164641894|NCT00464308|594713012|FG000|Overall Study|Physician Decision|1|||
164641895|NCT00464308|594713013|FG001|Overall Study|Physician Decision|0|||
164641896|NCT00464308|594713014|FG002|Overall Study|Physician Decision|0|||
164641897|NCT01721200|594713015|FG000|Overall Study|Lost to Follow-up|3|||
164641898|NCT01721200|594713016|FG001|Overall Study|Lost to Follow-up|5|||
164641899|NCT01513759|594713017|FG000|Overall Study|Protocol Violation|4|||
164641900|NCT01513759|594713017|FG000|Overall Study|Death during catheter placement|1|||
164641901|NCT03606109|594713018|FG000|Overall Study|Lost to Follow-up|2|||
164641902|NCT03606109|594713019|FG001|Overall Study|Lost to Follow-up|1|||
164641903|NCT03669640|594713020|FG000|Overall Study|Study Terminated by Sponsor|0|||
164641904|NCT03669640|594713021|FG001|Overall Study|Study Terminated by Sponsor|0|||
164641905|NCT03669640|594713022|FG002|Overall Study|Study Terminated by Sponsor|0|||
164641906|NCT03669640|594713023|FG003|Overall Study|Study Terminated by Sponsor|0|||
164641907|NCT03669640|594713024|FG004|Overall Study|Study Terminated by Sponsor|1|||
164641908|NCT03669640|594713025|FG005|Overall Study|Study Terminated by Sponsor|0|||
164641909|NCT03669640|594713020|FG000|Overall Study|Lost to Follow-up|0|||
164641910|NCT03669640|594713021|FG001|Overall Study|Lost to Follow-up|0|||
164641911|NCT03669640|594713022|FG002|Overall Study|Lost to Follow-up|2|||
164641912|NCT03669640|594713023|FG003|Overall Study|Lost to Follow-up|0|||
164641913|NCT03669640|594713024|FG004|Overall Study|Lost to Follow-up|0|||
164641914|NCT03669640|594713025|FG005|Overall Study|Lost to Follow-up|0|||
164641915|NCT03669640|594713020|FG000|Overall Study|Death|0|||
164641916|NCT03669640|594713021|FG001|Overall Study|Death|0|||
164641917|NCT03669640|594713022|FG002|Overall Study|Death|1|||
164641918|NCT03669640|594713023|FG003|Overall Study|Death|0|||
164641919|NCT03669640|594713024|FG004|Overall Study|Death|0|||
164641920|NCT03669640|594713025|FG005|Overall Study|Death|0|||
164641921|NCT03669640|594713020|FG000|Overall Study|Withdrawal by Subject|1|||
164641922|NCT03669640|594713021|FG001|Overall Study|Withdrawal by Subject|2|||
164641923|NCT03669640|594713022|FG002|Overall Study|Withdrawal by Subject|1|||
164641924|NCT03669640|594713023|FG003|Overall Study|Withdrawal by Subject|0|||
164641925|NCT03669640|594713024|FG004|Overall Study|Withdrawal by Subject|1|||
164641926|NCT03669640|594713025|FG005|Overall Study|Withdrawal by Subject|3|||
164641927|NCT03669640|594713020|FG000|Overall Study|Protocol Violation|1|||
164641928|NCT03669640|594713021|FG001|Overall Study|Protocol Violation|0|||
164641929|NCT03669640|594713022|FG002|Overall Study|Protocol Violation|0|||
164641930|NCT03669640|594713023|FG003|Overall Study|Protocol Violation|0|||
164641931|NCT03669640|594713024|FG004|Overall Study|Protocol Violation|0|||
164641932|NCT03669640|594713025|FG005|Overall Study|Protocol Violation|0|||
164641933|NCT03669640|594713020|FG000|Overall Study|Physician Decision|0|||
164641934|NCT03669640|594713021|FG001|Overall Study|Physician Decision|2|||
164641935|NCT03669640|594713022|FG002|Overall Study|Physician Decision|0|||
164641936|NCT03669640|594713023|FG003|Overall Study|Physician Decision|0|||
164641937|NCT03669640|594713024|FG004|Overall Study|Physician Decision|0|||
164641938|NCT03669640|594713025|FG005|Overall Study|Physician Decision|0|||
164641939|NCT03669640|594713020|FG000|Overall Study|Disease Relapse|1|||
164641940|NCT03669640|594713021|FG001|Overall Study|Disease Relapse|0|||
164641941|NCT03669640|594713022|FG002|Overall Study|Disease Relapse|0|||
164641942|NCT03669640|594713023|FG003|Overall Study|Disease Relapse|0|||
164641943|NCT03669640|594713024|FG004|Overall Study|Disease Relapse|0|||
164641944|NCT03669640|594713025|FG005|Overall Study|Disease Relapse|0|||
164641945|NCT03669640|594713020|FG000|Overall Study|Adverse Event|2|||
164641946|NCT03669640|594713021|FG001|Overall Study|Adverse Event|1|||
164641947|NCT03669640|594713022|FG002|Overall Study|Adverse Event|0|||
164641948|NCT03669640|594713023|FG003|Overall Study|Adverse Event|0|||
164641949|NCT03669640|594713024|FG004|Overall Study|Adverse Event|1|||
164641950|NCT03669640|594713025|FG005|Overall Study|Adverse Event|0|||
164641951|NCT03993288|594713026|FG000|Overall Study|Lost to Follow-up|2|||
164641952|NCT03993288|594713027|FG001|Overall Study|Lost to Follow-up|1|||
164641953|NCT03993288|594713026|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
164641954|NCT03993288|594713027|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
164641955|NCT03993288|594713026|FG000|Overall Study|wrong randomization|0|||
164641956|NCT03993288|594713027|FG001|Overall Study|wrong randomization|1|||
164641957|NCT03993288|594713026|FG000|Overall Study|improper enrollment|0|||
164641958|NCT03993288|594713027|FG001|Overall Study|improper enrollment|1|||
164641959|NCT03993288|594713026|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
164641960|NCT03993288|594713027|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
164641961|NCT03993288|594713026|FG000|Overall Study|developed SAE|2|||
164641962|NCT03993288|594713027|FG001|Overall Study|developed SAE|0|||
164641963|NCT03993288|594713026|FG000|Overall Study|consent withdrawal|1|||
164641964|NCT03993288|594713027|FG001|Overall Study|consent withdrawal|0|||
164641965|NCT03993288|594713026|FG000|Overall Study|did not follow the treatment schedule|1|||
164641966|NCT03993288|594713027|FG001|Overall Study|did not follow the treatment schedule|0|||
164641967|NCT03993288|594713026|FG000|Overall Study|did not follow the treatment regimen|1|||
164641968|NCT03993288|594713027|FG001|Overall Study|did not follow the treatment regimen|0|||
164641969|NCT03993288|594713026|FG000|Overall Study|Adverse Event|1|||
164641970|NCT03993288|594713027|FG001|Overall Study|Adverse Event|0|||
164641971|NCT03993288|594713026|FG000|Overall Study|Withdrawal by Subject|1|||
164641972|NCT03993288|594713027|FG001|Overall Study|Withdrawal by Subject|1|||
164641973|NCT03286426|594713028|FG000|Overall Study|Physician Decision|3|||
164641974|NCT01817764|594713029|FG000|Overall Study|Adverse Event|7|||
164641975|NCT01817764|594713030|FG001|Overall Study|Adverse Event|10|||
164641976|NCT01817764|594713029|FG000|Overall Study|Lack of Efficacy|9|||
164641977|NCT01817764|594713030|FG001|Overall Study|Lack of Efficacy|7|||
164641978|NCT01817764|594713029|FG000|Overall Study|Protocol Violation|7|||
164641979|NCT01817764|594713030|FG001|Overall Study|Protocol Violation|5|||
164641980|NCT01817764|594713029|FG000|Overall Study|Lost to Follow-up|1|||
164641981|NCT01817764|594713030|FG001|Overall Study|Lost to Follow-up|4|||
164641982|NCT01817764|594713029|FG000|Overall Study|Withdrawal by Subject|10|||
164641983|NCT01817764|594713030|FG001|Overall Study|Withdrawal by Subject|12|||
164641984|NCT01956123|594713031|FG000|COS Cycle 2|Protocol Violation|8|||
164641985|NCT01956123|594713032|FG001|COS Cycle 2|Protocol Violation|3|||
164641986|NCT01956123|594713033|FG002|COS Cycle 2|Protocol Violation|0|||
164641987|NCT01956123|594713034|FG003|COS Cycle 2|Protocol Violation|0|||
164641988|NCT01956123|594713031|FG000|COS Cycle 2|Adverse Event|3|||
164641989|NCT01956123|594713032|FG001|COS Cycle 2|Adverse Event|4|||
164641990|NCT01956123|594713033|FG002|COS Cycle 2|Adverse Event|0|||
164641991|NCT01956123|594713034|FG003|COS Cycle 2|Adverse Event|0|||
164641992|NCT01956123|594713031|FG000|COS Cycle 2|Personal Reasons|2|||
164641993|NCT01956123|594713032|FG001|COS Cycle 2|Personal Reasons|0|||
164641994|NCT01956123|594713033|FG002|COS Cycle 2|Personal Reasons|0|||
164641995|NCT01956123|594713034|FG003|COS Cycle 2|Personal Reasons|0|||
164641996|NCT01956123|594713031|FG000|COS Cycle 2|Withdrawal by Subject|1|||
164641997|NCT01956123|594713032|FG001|COS Cycle 2|Withdrawal by Subject|0|||
164641998|NCT01956123|594713033|FG002|COS Cycle 2|Withdrawal by Subject|0|||
164641999|NCT01956123|594713034|FG003|COS Cycle 2|Withdrawal by Subject|0|||
164642000|NCT01956123|594713031|FG000|COS Cycle 3|Protocol Violation|0|||
164642001|NCT01956123|594713032|FG001|COS Cycle 3|Protocol Violation|0|||
164642002|NCT01956123|594713033|FG002|COS Cycle 3|Protocol Violation|2|||
164642003|NCT01956123|594713034|FG003|COS Cycle 3|Protocol Violation|1|||
164642004|NCT01956123|594713031|FG000|COS Cycle 3|Adverse Event|0|||
164642005|NCT01956123|594713032|FG001|COS Cycle 3|Adverse Event|0|||
164148624|NCT04895982|592904920|FG009|Overall Study|Protocol Violation|0|||
164642006|NCT01956123|594713033|FG002|COS Cycle 3|Adverse Event|3|||
164642007|NCT01956123|594713034|FG003|COS Cycle 3|Adverse Event|0|||
164642008|NCT01956123|594713031|FG000|COS Cycle 3|Personal Reasons|0|||
164642009|NCT01956123|594713032|FG001|COS Cycle 3|Personal Reasons|0|||
164642010|NCT01956123|594713033|FG002|COS Cycle 3|Personal Reasons|1|||
164642011|NCT01956123|594713034|FG003|COS Cycle 3|Personal Reasons|0|||
164642012|NCT01956123|594713031|FG000|COS Cycle 3|Withdrawal by Subject|0|||
164642013|NCT01956123|594713032|FG001|COS Cycle 3|Withdrawal by Subject|0|||
164642014|NCT01956123|594713033|FG002|COS Cycle 3|Withdrawal by Subject|0|||
164642015|NCT01956123|594713034|FG003|COS Cycle 3|Withdrawal by Subject|1|||
164642016|NCT00366678|594713035|FG000|Infant Series|Withdrawal by Subject|8|||
164642017|NCT00366678|594713036|FG001|Infant Series|Withdrawal by Subject|6|||
164642018|NCT00366678|594713037|FG002|Infant Series|Withdrawal by Subject|0|||
164642019|NCT00366678|594713035|FG000|Infant Series|Protocol Violation|4|||
164642020|NCT00366678|594713036|FG001|Infant Series|Protocol Violation|3|||
164642021|NCT00366678|594713037|FG002|Infant Series|Protocol Violation|0|||
164642022|NCT00366678|594713035|FG000|Infant Series|Failed to return|1|||
164642023|NCT00366678|594713036|FG001|Infant Series|Failed to return|1|||
164642024|NCT00366678|594713037|FG002|Infant Series|Failed to return|0|||
164642025|NCT00366678|594713035|FG000|Infant Series|Adverse Event|1|||
164642026|NCT00366678|594713036|FG001|Infant Series|Adverse Event|0|||
164642027|NCT00366678|594713037|FG002|Infant Series|Adverse Event|0|||
164642028|NCT00366678|594713035|FG000|After Infant|Withdrawal by Subject|8|||
164642029|NCT00366678|594713036|FG001|After Infant|Withdrawal by Subject|4|||
164642030|NCT00366678|594713037|FG002|After Infant|Withdrawal by Subject|0|||
164642031|NCT00366678|594713035|FG000|After Infant|Lost to Follow-up|2|||
164642032|NCT00366678|594713036|FG001|After Infant|Lost to Follow-up|1|||
164642033|NCT00366678|594713037|FG002|After Infant|Lost to Follow-up|0|||
164642034|NCT00366678|594713035|FG000|After Infant|Failed to return|5|||
164642035|NCT00366678|594713036|FG001|After Infant|Failed to return|5|||
164642036|NCT00366678|594713037|FG002|After Infant|Failed to return|0|||
164642037|NCT00366678|594713035|FG000|After Infant|Adverse Event|1|||
164642038|NCT00366678|594713036|FG001|After Infant|Adverse Event|0|||
164642039|NCT00366678|594713037|FG002|After Infant|Adverse Event|0|||
164642040|NCT00366678|594713035|FG000|After Infant|Protocol Violation|1|||
164642041|NCT00366678|594713036|FG001|After Infant|Protocol Violation|0|||
164642042|NCT00366678|594713037|FG002|After Infant|Protocol Violation|0|||
164642043|NCT00366678|594713035|FG000|Toddler Dose|Protocol Violation|2|||
164642044|NCT00366678|594713036|FG001|Toddler Dose|Protocol Violation|1|||
164642045|NCT00366678|594713037|FG002|Toddler Dose|Protocol Violation|0|||
164642046|NCT00366678|594713035|FG000|Toddler Dose|Failed to return|1|||
164642047|NCT00366678|594713036|FG001|Toddler Dose|Failed to return|0|||
164642048|NCT00366678|594713037|FG002|Toddler Dose|Failed to return|0|||
164642049|NCT00366678|594713035|FG000|Toddler Dose|Withdrawal by Subject|1|||
164642050|NCT00366678|594713036|FG001|Toddler Dose|Withdrawal by Subject|0|||
164642051|NCT00366678|594713037|FG002|Toddler Dose|Withdrawal by Subject|0|||
164642052|NCT00366678|594713035|FG000|Toddler Dose|protocol deviation|1|||
164642053|NCT00366678|594713036|FG001|Toddler Dose|protocol deviation|0|||
164642054|NCT00366678|594713037|FG002|Toddler Dose|protocol deviation|0|||
164642055|NCT00388674|594713048|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
164642056|NCT00388674|594713049|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
164642057|NCT00388674|594713048|FG000|Initial Treatment|Adverse Event|22|||
164642058|NCT00388674|594713049|FG001|Initial Treatment|Adverse Event|87|||
164642059|NCT00388674|594713048|FG000|Initial Treatment|Death|215|||
164642060|NCT00388674|594713049|FG001|Initial Treatment|Death|216|||
164642061|NCT00388674|594713048|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
164642062|NCT00388674|594713049|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
164642063|NCT00388674|594713048|FG000|Initial Treatment|HCC|12|||
164642064|NCT00388674|594713049|FG001|Initial Treatment|HCC|20|||
164642065|NCT00388674|594713048|FG000|Initial Treatment|Lost to Follow-up|526|||
164642066|NCT00388674|594713049|FG001|Initial Treatment|Lost to Follow-up|624|||
164642067|NCT00388674|594713048|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
164642068|NCT00388674|594713049|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
164642069|NCT00388674|594713048|FG000|Initial Treatment|Never Treated with Study Medication|1|||
164642070|NCT00388674|594713049|FG001|Initial Treatment|Never Treated with Study Medication|7|||
164642071|NCT00388674|594713048|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
164642072|NCT00388674|594713049|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
164642073|NCT00388674|594713048|FG000|Initial Treatment|Not Defined|125|||
164642074|NCT00388674|594713049|FG001|Initial Treatment|Not Defined|172|||
164642075|NCT00388674|594713048|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
164642076|NCT00388674|594713049|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
164642077|NCT00388674|594713048|FG000|Initial Treatment|Pregnancy|26|||
164642078|NCT00388674|594713049|FG001|Initial Treatment|Pregnancy|16|||
164642079|NCT00388674|594713048|FG000|Initial Treatment|Study Drug Toxicity|5|||
164642080|NCT00388674|594713049|FG001|Initial Treatment|Study Drug Toxicity|92|||
164642081|NCT00388674|594713048|FG000|Initial Treatment|Participant Request|501|||
164642082|NCT00388674|594713049|FG001|Initial Treatment|Participant Request|673|||
164642083|NCT00388674|594713048|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
164642084|NCT00388674|594713049|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
164642085|NCT00388674|594713048|FG000|Initial Treatment|Not Reported|10|||
164531827|NCT01668667|594318936|FG002|Overall Study|Protocol Violation|12|||
164531828|NCT01668667|594318937|FG003|Overall Study|Protocol Violation|5|||
164531829|NCT01668667|594318934|FG000|Overall Study|Lost to Follow-up|9|||
164531830|NCT01668667|594318935|FG001|Overall Study|Lost to Follow-up|4|||
164531831|NCT01668667|594318936|FG002|Overall Study|Lost to Follow-up|7|||
164531832|NCT01668667|594318937|FG003|Overall Study|Lost to Follow-up|6|||
164531833|NCT01668667|594318934|FG000|Overall Study|Physician Decision|3|||
164531834|NCT01668667|594318935|FG001|Overall Study|Physician Decision|0|||
164531835|NCT01668667|594318936|FG002|Overall Study|Physician Decision|1|||
164531836|NCT01668667|594318937|FG003|Overall Study|Physician Decision|0|||
164531837|NCT01668667|594318934|FG000|Overall Study|Withdrawal by Subject|7|||
164531838|NCT01668667|594318935|FG001|Overall Study|Withdrawal by Subject|4|||
164531839|NCT01668667|594318936|FG002|Overall Study|Withdrawal by Subject|5|||
164531840|NCT01668667|594318937|FG003|Overall Study|Withdrawal by Subject|5|||
164531841|NCT04640077|594318938|FG000|Period 1|Withdrawal by Subject|4|||
164531842|NCT04640077|594318939|FG001|Period 1|Withdrawal by Subject|5|||
164531843|NCT04640077|594318940|FG002|Period 1|Withdrawal by Subject|0|||
164531844|NCT04640077|594318938|FG000|Period 1|Adverse Event|1|||
164531845|NCT04640077|594318939|FG001|Period 1|Adverse Event|1|||
164531846|NCT04640077|594318940|FG002|Period 1|Adverse Event|0|||
164531847|NCT04640077|594318938|FG000|Period 1|Screen Failure|2|||
164531848|NCT04640077|594318939|FG001|Period 1|Screen Failure|0|||
164531849|NCT04640077|594318940|FG002|Period 1|Screen Failure|0|||
164531850|NCT04640077|594318938|FG000|Period 2|Withdrawal by Subject|0|||
164531851|NCT04640077|594318939|FG001|Period 2|Withdrawal by Subject|0|||
164531852|NCT04640077|594318940|FG002|Period 2|Withdrawal by Subject|18|||
164531853|NCT04640077|594318938|FG000|Period 2|Adverse Event|0|||
164531854|NCT04640077|594318939|FG001|Period 2|Adverse Event|0|||
164531855|NCT04640077|594318940|FG002|Period 2|Adverse Event|6|||
164531856|NCT04640077|594318938|FG000|Period 2|Lost to Follow-up|0|||
164531857|NCT04640077|594318939|FG001|Period 2|Lost to Follow-up|0|||
164531858|NCT04640077|594318940|FG002|Period 2|Lost to Follow-up|2|||
164531859|NCT04640077|594318938|FG000|Period 2|Death|0|||
164531860|NCT04640077|594318939|FG001|Period 2|Death|0|||
164531861|NCT04640077|594318940|FG002|Period 2|Death|2|||
164531862|NCT04640077|594318938|FG000|Period 2|Progressive Disease|0|||
164531863|NCT04640077|594318939|FG001|Period 2|Progressive Disease|0|||
164531864|NCT04640077|594318940|FG002|Period 2|Progressive Disease|1|||
164531865|NCT04640077|594318938|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
164531866|NCT04640077|594318939|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
164642086|NCT00388674|594713049|FG001|Initial Treatment|Not Reported|12|||
164642087|NCT00388674|594713048|FG000|End of Study|Administrative Reason By Sponsor|299|||
164642088|NCT00388674|594713049|FG001|End of Study|Administrative Reason By Sponsor|253|||
164642089|NCT00388674|594713048|FG000|End of Study|Death|239|||
164642090|NCT00388674|594713049|FG001|End of Study|Death|262|||
164642091|NCT00388674|594713048|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
164642092|NCT00388674|594713049|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
164642093|NCT00388674|594713048|FG000|End of Study|HCC|8|||
164642094|NCT00388674|594713049|FG001|End of Study|HCC|7|||
164642095|NCT00388674|594713048|FG000|End of Study|Lost to Follow-up|587|||
164642096|NCT00388674|594713049|FG001|End of Study|Lost to Follow-up|715|||
164642097|NCT00388674|594713048|FG000|End of Study|Malignancy (Non-HCC)|1|||
164642098|NCT00388674|594713049|FG001|End of Study|Malignancy (Non-HCC)|1|||
164642099|NCT00388674|594713048|FG000|End of Study|Non-Study Related Comorbidities|3|||
164642100|NCT00388674|594713049|FG001|End of Study|Non-Study Related Comorbidities|4|||
164642101|NCT00388674|594713048|FG000|End of Study|Not Defined|135|||
164642102|NCT00388674|594713049|FG001|End of Study|Not Defined|214|||
164642103|NCT00388674|594713048|FG000|End of Study|Participant Withdrew Consent|437|||
164642104|NCT00388674|594713049|FG001|End of Study|Participant Withdrew Consent|673|||
164642105|NCT00388674|594713048|FG000|End of Study|No Off-Treatment Status Data|22|||
164642106|NCT00388674|594713049|FG001|End of Study|No Off-Treatment Status Data|30|||
164642107|NCT00388674|594713048|FG000|End of Study|Not Reported|0|||
164642108|NCT00388674|594713049|FG001|End of Study|Not Reported|1|||
164642109|NCT01569594|594713056|FG000|Overall Study|Physician Decision|4|||
164642110|NCT01569594|594713056|FG000|Overall Study|Death|13|||
164642111|NCT01569594|594713056|FG000|Overall Study|Lost to Follow-up|22|||
164642112|NCT01569594|594713056|FG000|Overall Study|Adverse Event|2|||
164531867|NCT04640077|594318940|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
164531868|NCT02240693|594318941|FG000|Overall Study|Adverse Event|0|||
164531869|NCT02240693|594318942|FG001|Overall Study|Adverse Event|0|||
164531870|NCT02240693|594318943|FG002|Overall Study|Adverse Event|0|||
164531871|NCT02240693|594318944|FG003|Overall Study|Adverse Event|0|||
164531872|NCT02240693|594318945|FG004|Overall Study|Adverse Event|1|||
164642113|NCT01569594|594713056|FG000|Overall Study|Withdrawal by Subject|13|||
164642114|NCT01569594|594713056|FG000|Overall Study|Other|4|||
164642115|NCT01569594|594713056|FG000|Overall Study|No ECM used|9|||
164642116|NCT01965431|594713057|FG000|Overall Study|Adverse Event|0|||
164642117|NCT01965431|594713058|FG001|Overall Study|Adverse Event|1|||
164642118|NCT01965431|594713059|FG002|Overall Study|Adverse Event|0|||
164642119|NCT01965431|594713060|FG003|Overall Study|Adverse Event|0|||
164642120|NCT01965431|594713061|FG004|Overall Study|Adverse Event|0|||
164642121|NCT01965431|594713062|FG005|Overall Study|Adverse Event|0|||
164642122|NCT01965431|594713057|FG000|Overall Study|Other than stated above|6|||
164642123|NCT01965431|594713058|FG001|Overall Study|Other than stated above|5|||
164642124|NCT01965431|594713059|FG002|Overall Study|Other than stated above|6|||
164642125|NCT01965431|594713060|FG003|Overall Study|Other than stated above|6|||
164642126|NCT01965431|594713061|FG004|Overall Study|Other than stated above|6|||
164642127|NCT01965431|594713062|FG005|Overall Study|Other than stated above|6|||
164642128|NCT04635631|594713063|FG000|Overall Study|Adverse Event|1|||
164642129|NCT04635631|594713063|FG000|Overall Study|Progressive disease|13|||
164642130|NCT04635631|594713063|FG000|Overall Study|Withdrawal by Subject|1|||
164642131|NCT00943826|594713064|FG000|Concurrent Phase|Adverse Event|50|||
164642132|NCT00943826|594713065|FG001|Concurrent Phase|Adverse Event|27|||
164642133|NCT00943826|594713064|FG000|Concurrent Phase|Withdrew consent|3|||
164642134|NCT00943826|594713065|FG001|Concurrent Phase|Withdrew consent|7|||
164642135|NCT00943826|594713064|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
164642136|NCT00943826|594713065|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
164642137|NCT00943826|594713064|FG000|Concurrent Phase|Administrative reasons|2|||
164642138|NCT00943826|594713065|FG001|Concurrent Phase|Administrative reasons|1|||
164642139|NCT00943826|594713064|FG000|Concurrent Phase|Protocol Violation|1|||
164642140|NCT00943826|594713065|FG001|Concurrent Phase|Protocol Violation|0|||
164642141|NCT00943826|594713064|FG000|Maintenance Phase|Adverse Event|31|||
164642142|NCT00943826|594713065|FG001|Maintenance Phase|Adverse Event|30|||
164642143|NCT00943826|594713064|FG000|Maintenance Phase|Withdrew consent|2|||
164642144|NCT00943826|594713065|FG001|Maintenance Phase|Withdrew consent|4|||
164642145|NCT00943826|594713064|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
164642146|NCT00943826|594713065|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
164642147|NCT00943826|594713064|FG000|Maintenance Phase|Administrative reasons|4|||
164642148|NCT00943826|594713065|FG001|Maintenance Phase|Administrative reasons|1|||
164642149|NCT00943826|594713064|FG000|Maintenance Phase|Failure to return|0|||
164642150|NCT00943826|594713065|FG001|Maintenance Phase|Failure to return|1|||
164642151|NCT00943826|594713064|FG000|Monotherapy Phase|Adverse Event|42|||
164642152|NCT00943826|594713065|FG001|Monotherapy Phase|Adverse Event|5|||
164642153|NCT00943826|594713064|FG000|Monotherapy Phase|Administrative reasons|11|||
164642154|NCT00943826|594713065|FG001|Monotherapy Phase|Administrative reasons|5|||
164642155|NCT00943826|594713064|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
164642156|NCT00943826|594713065|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
164642157|NCT00943826|594713064|FG000|Monotherapy Phase|Withdrew Consent|2|||
164642158|NCT00943826|594713065|FG001|Monotherapy Phase|Withdrew Consent|3|||
164642159|NCT00943826|594713064|FG000|Monotherapy Phase|Failure to return|2|||
164642160|NCT00943826|594713065|FG001|Monotherapy Phase|Failure to return|1|||
164642161|NCT00943826|594713064|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
164642162|NCT00943826|594713065|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
164642163|NCT00943826|594713064|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
164642164|NCT00943826|594713065|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
164642165|NCT00943826|594713064|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
164642166|NCT00943826|594713065|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
164642167|NCT00943826|594713064|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
164642168|NCT00943826|594713065|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
164642169|NCT04764669|594713066|FG000|Overall Study|Adverse Event|1|||
164642170|NCT04764669|594713067|FG001|Overall Study|Adverse Event|0|||
164642171|NCT04764669|594713068|FG002|Overall Study|Adverse Event|1|||
164642172|NCT04764669|594713069|FG003|Overall Study|Adverse Event|0|||
164642173|NCT04764669|594713066|FG000|Overall Study|Subject Choice|0|||
164642174|NCT04764669|594713067|FG001|Overall Study|Subject Choice|0|||
164642175|NCT04764669|594713068|FG002|Overall Study|Subject Choice|1|||
164642176|NCT04764669|594713069|FG003|Overall Study|Subject Choice|0|||
164642177|NCT04764669|594713066|FG000|Overall Study|Withdrawal by Subject|2|||
164642178|NCT04764669|594713067|FG001|Overall Study|Withdrawal by Subject|0|||
164642179|NCT04764669|594713068|FG002|Overall Study|Withdrawal by Subject|0|||
164642180|NCT04764669|594713069|FG003|Overall Study|Withdrawal by Subject|0|||
164642181|NCT00877799|594713071|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
164642182|NCT00877799|594713072|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
164642183|NCT00877799|594713073|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
164642184|NCT00877799|594713074|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
164642185|NCT00877799|594713075|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
164642186|NCT00877799|594713071|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
164642187|NCT00877799|594713072|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
164642188|NCT00877799|594713073|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
164642189|NCT00877799|594713074|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
164642190|NCT00877799|594713075|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
164642191|NCT00877799|594713071|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
164642192|NCT00877799|594713072|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
164642193|NCT00877799|594713073|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
164642194|NCT00877799|594713074|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
164642195|NCT00877799|594713075|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
164642196|NCT00877799|594713071|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
164642197|NCT00877799|594713072|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
164642198|NCT00877799|594713073|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
164642199|NCT00877799|594713074|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
164642200|NCT00877799|594713075|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
164642201|NCT00877799|594713071|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
164642202|NCT00877799|594713072|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
164642203|NCT00877799|594713073|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
164642204|NCT00877799|594713074|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
164642205|NCT00877799|594713075|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
164642206|NCT04054011|594713076|FG000|Overall Study|COVID|3|||
164642207|NCT00592007|594713077|FG000|Overall Study|Withdrawal by Subject|1|||
164642208|NCT00592007|594713077|FG000|Overall Study|patient ineligible (out of lab range)|1|||
164642209|NCT00595127|594713078|FG000|Overall Study|Death|6|||
164642210|NCT00595127|594713078|FG000|Overall Study|Relapsed|3|||
164642211|NCT00595127|594713078|FG000|Overall Study|joined another trial|1|||
164642212|NCT01785472|594713079|FG000|Overall Study|Adverse Event|5|||
164642213|NCT01785472|594713080|FG001|Overall Study|Adverse Event|4|||
164642214|NCT01785472|594713081|FG002|Overall Study|Adverse Event|6|||
164642215|NCT01785472|594713079|FG000|Overall Study|Lack of Efficacy|2|||
164642216|NCT01785472|594713080|FG001|Overall Study|Lack of Efficacy|0|||
164642217|NCT01785472|594713081|FG002|Overall Study|Lack of Efficacy|1|||
164642218|NCT01785472|594713079|FG000|Overall Study|Lost to Follow-up|1|||
164642219|NCT01785472|594713080|FG001|Overall Study|Lost to Follow-up|2|||
164642220|NCT01785472|594713081|FG002|Overall Study|Lost to Follow-up|0|||
164642221|NCT01785472|594713079|FG000|Overall Study|Physician Decision|1|||
164642222|NCT01785472|594713080|FG001|Overall Study|Physician Decision|1|||
164642223|NCT01785472|594713081|FG002|Overall Study|Physician Decision|1|||
164642224|NCT01785472|594713079|FG000|Overall Study|Protocol deviation|0|||
164642225|NCT01785472|594713080|FG001|Overall Study|Protocol deviation|2|||
164642226|NCT01785472|594713081|FG002|Overall Study|Protocol deviation|2|||
164642227|NCT01785472|594713079|FG000|Overall Study|Subject/guardian decision|15|||
164642228|NCT01785472|594713080|FG001|Overall Study|Subject/guardian decision|10|||
164642229|NCT01785472|594713081|FG002|Overall Study|Subject/guardian decision|11|||
164642230|NCT01785472|594713079|FG000|Overall Study|Technical problems|0|||
164642231|NCT01785472|594713080|FG001|Overall Study|Technical problems|0|||
164642232|NCT01785472|594713081|FG002|Overall Study|Technical problems|1|||
164642233|NCT01803464|594713083|FG000|Overall Study|Incomplete data|0|||
164642234|NCT01803464|594713084|FG001|Overall Study|Incomplete data|0|||
164642235|NCT01803464|594713085|FG002|Overall Study|Incomplete data|4|||
164642236|NCT01803464|594713086|FG003|Overall Study|Incomplete data|0|||
164642237|NCT01803464|594713083|FG000|Overall Study|Withdrawal by Subject|1|||
164642238|NCT01803464|594713084|FG001|Overall Study|Withdrawal by Subject|0|||
164642239|NCT01803464|594713085|FG002|Overall Study|Withdrawal by Subject|0|||
164642240|NCT01803464|594713086|FG003|Overall Study|Withdrawal by Subject|0|||
164642241|NCT01125358|594713092|FG000|Overall Study|Adverse Event|3|||
164642242|NCT01125358|594713093|FG001|Overall Study|Adverse Event|0|||
164642243|NCT01125358|594713094|FG002|Overall Study|Adverse Event|0|||
164642244|NCT01125358|594713095|FG003|Overall Study|Adverse Event|2|||
164642245|NCT01125358|594713092|FG000|Overall Study|Perceived Lack of Efficacy|6|||
164642246|NCT01125358|594713093|FG001|Overall Study|Perceived Lack of Efficacy|3|||
164642247|NCT01125358|594713094|FG002|Overall Study|Perceived Lack of Efficacy|7|||
164642248|NCT01125358|594713095|FG003|Overall Study|Perceived Lack of Efficacy|4|||
164642249|NCT01125358|594713092|FG000|Overall Study|Protocol Violation|1|||
164642250|NCT01125358|594713093|FG001|Overall Study|Protocol Violation|0|||
164642251|NCT01125358|594713094|FG002|Overall Study|Protocol Violation|0|||
164642252|NCT01125358|594713095|FG003|Overall Study|Protocol Violation|0|||
164642253|NCT01125358|594713092|FG000|Overall Study|Sponsor Decision|0|||
164642254|NCT01125358|594713093|FG001|Overall Study|Sponsor Decision|0|||
164642255|NCT01125358|594713094|FG002|Overall Study|Sponsor Decision|1|||
164642256|NCT01125358|594713095|FG003|Overall Study|Sponsor Decision|1|||
164642257|NCT01125358|594713092|FG000|Overall Study|Withdrawal by Subject|2|||
164642258|NCT01125358|594713093|FG001|Overall Study|Withdrawal by Subject|1|||
164642259|NCT01125358|594713094|FG002|Overall Study|Withdrawal by Subject|1|||
164642260|NCT01125358|594713095|FG003|Overall Study|Withdrawal by Subject|1|||
164642261|NCT02628418|594713098|FG000|Overall Study|Lost to Follow-up|1|||
164642262|NCT02628418|594713099|FG001|Overall Study|Lost to Follow-up|2|||
164642263|NCT03159611|594713103|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
164642264|NCT03159611|594713104|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
164642265|NCT03159611|594713103|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
164642266|NCT03159611|594713104|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
164642267|NCT03159611|594713103|FG000|Overall Study|Protocol Violation|7|||
164642268|NCT03159611|594713104|FG001|Overall Study|Protocol Violation|4|||
164642269|NCT03159611|594713103|FG000|Overall Study|Adverse Event|1|||
164642270|NCT03159611|594713104|FG001|Overall Study|Adverse Event|0|||
164642271|NCT03159611|594713103|FG000|Overall Study|Withdrawal by Subject|1|||
164642272|NCT03159611|594713104|FG001|Overall Study|Withdrawal by Subject|1|||
164642273|NCT03159611|594713103|FG000|Overall Study|Non-compliance with protocol requirement|3|||
164642274|NCT03159611|594713104|FG001|Overall Study|Non-compliance with protocol requirement|2|||
164642275|NCT03159611|594713103|FG000|Overall Study|Inability to perform procedures|1|||
164642276|NCT03159611|594713104|FG001|Overall Study|Inability to perform procedures|0|||
164642277|NCT01058707|594713112|FG000|Overall Study|Disease Progression|15|||
164642278|NCT01058707|594713113|FG001|Overall Study|Disease Progression|20|||
164642279|NCT01058707|594713114|FG002|Overall Study|Disease Progression|20|||
164642280|NCT01058707|594713115|FG003|Overall Study|Disease Progression|15|||
164642281|NCT01058707|594713116|FG004|Overall Study|Disease Progression|23|||
164642282|NCT01058707|594713117|FG005|Overall Study|Disease Progression|10|||
164642283|NCT01058707|594713118|FG006|Overall Study|Disease Progression|12|||
164642284|NCT01058707|594713112|FG000|Overall Study|Adverse Event|11|||
164642285|NCT01058707|594713113|FG001|Overall Study|Adverse Event|4|||
164642286|NCT01058707|594713114|FG002|Overall Study|Adverse Event|7|||
164642287|NCT01058707|594713115|FG003|Overall Study|Adverse Event|6|||
164642288|NCT01058707|594713116|FG004|Overall Study|Adverse Event|7|||
164642289|NCT01058707|594713117|FG005|Overall Study|Adverse Event|3|||
164642290|NCT01058707|594713118|FG006|Overall Study|Adverse Event|1|||
164642291|NCT01058707|594713112|FG000|Overall Study|Subject Decision|5|||
164642292|NCT01058707|594713113|FG001|Overall Study|Subject Decision|3|||
164642293|NCT01058707|594713114|FG002|Overall Study|Subject Decision|3|||
164642294|NCT01058707|594713115|FG003|Overall Study|Subject Decision|1|||
164642295|NCT01058707|594713116|FG004|Overall Study|Subject Decision|2|||
164642296|NCT01058707|594713117|FG005|Overall Study|Subject Decision|3|||
164642297|NCT01058707|594713118|FG006|Overall Study|Subject Decision|6|||
164642298|NCT01058707|594713112|FG000|Overall Study|Lost to Follow-up|0|||
164642299|NCT01058707|594713113|FG001|Overall Study|Lost to Follow-up|0|||
164642300|NCT01058707|594713114|FG002|Overall Study|Lost to Follow-up|1|||
164642301|NCT01058707|594713115|FG003|Overall Study|Lost to Follow-up|0|||
164642302|NCT01058707|594713116|FG004|Overall Study|Lost to Follow-up|0|||
164642303|NCT01058707|594713117|FG005|Overall Study|Lost to Follow-up|0|||
164642304|NCT01058707|594713118|FG006|Overall Study|Lost to Follow-up|0|||
164642305|NCT01058707|594713112|FG000|Overall Study|Reason Not Specified|0|||
164642306|NCT01058707|594713113|FG001|Overall Study|Reason Not Specified|3|||
164642307|NCT01058707|594713114|FG002|Overall Study|Reason Not Specified|2|||
164642308|NCT01058707|594713115|FG003|Overall Study|Reason Not Specified|0|||
164642309|NCT01058707|594713116|FG004|Overall Study|Reason Not Specified|7|||
164642310|NCT01058707|594713117|FG005|Overall Study|Reason Not Specified|1|||
164642311|NCT01058707|594713118|FG006|Overall Study|Reason Not Specified|7|||
164642312|NCT01875731|594713120|FG000|Overall Study|Fail to obtain lab sample|1|||
164642313|NCT01875731|594713121|FG001|Overall Study|Fail to obtain lab sample|0|||
164642314|NCT03222856|594713124|FG000|Overall Study|Adverse Event|6|||
164642315|NCT03222856|594713124|FG000|Overall Study|Death|1|||
164642316|NCT01035229|594714840|FG000|Overall Study|Adverse Event|61|||
164642317|NCT01035229|594714841|FG001|Overall Study|Adverse Event|14|||
164642318|NCT01035229|594714840|FG000|Overall Study|Withdrawal by Subject|20|||
164642319|NCT01035229|594714841|FG001|Overall Study|Withdrawal by Subject|7|||
164642320|NCT01035229|594714840|FG000|Overall Study|Lost to Follow-up|1|||
164642321|NCT01035229|594714841|FG001|Overall Study|Lost to Follow-up|0|||
164642322|NCT01035229|594714840|FG000|Overall Study|Administrative problems|1|||
164642323|NCT01035229|594714841|FG001|Overall Study|Administrative problems|1|||
164642324|NCT01035229|594714840|FG000|Overall Study|Death|13|||
164642325|NCT01035229|594714841|FG001|Overall Study|Death|5|||
164642326|NCT01035229|594714840|FG000|Overall Study|New cancer therapy|2|||
164642327|NCT01035229|594714841|FG001|Overall Study|New cancer therapy|0|||
164642328|NCT01035229|594714840|FG000|Overall Study|Protocol Violation|0|||
164642329|NCT01035229|594714841|FG001|Overall Study|Protocol Violation|2|||
164642330|NCT01035229|594714840|FG000|Overall Study|Sponsor's decision to end study|3|||
164642331|NCT01035229|594714841|FG001|Overall Study|Sponsor's decision to end study|3|||
164642332|NCT01035229|594714840|FG000|Overall Study|Disease Progression|261|||
164642333|NCT01035229|594714841|FG001|Overall Study|Disease Progression|152|||
164642334|NCT00359073|594714842|FG000|Overall Study|Withdrawal by Subject|1|||
164642335|NCT00359073|594714843|FG001|Overall Study|Withdrawal by Subject|1|||
164642336|NCT00359073|594714842|FG000|Overall Study|Eligibility criteria no longer met|3|||
164642337|NCT00359073|594714843|FG001|Overall Study|Eligibility criteria no longer met|0|||
164642338|NCT00359073|594714842|FG000|Overall Study|developed RV16 antibody|0|||
164642339|NCT00359073|594714843|FG001|Overall Study|developed RV16 antibody|1|||
164642340|NCT00684645|594714844|FG000|Overall Study|Death|2|||
164531873|NCT02240693|594318941|FG000|Overall Study|Withdrawal by Subject|0|||
164531874|NCT02240693|594318942|FG001|Overall Study|Withdrawal by Subject|0|||
164531875|NCT02240693|594318943|FG002|Overall Study|Withdrawal by Subject|2|||
164531876|NCT02240693|594318944|FG003|Overall Study|Withdrawal by Subject|1|||
164531877|NCT02240693|594318945|FG004|Overall Study|Withdrawal by Subject|0|||
164531878|NCT02240693|594318941|FG000|Overall Study|Other than specified|0|||
164531879|NCT02240693|594318942|FG001|Overall Study|Other than specified|0|||
164531880|NCT02240693|594318943|FG002|Overall Study|Other than specified|2|||
164531881|NCT02240693|594318944|FG003|Overall Study|Other than specified|0|||
164531882|NCT02240693|594318945|FG004|Overall Study|Other than specified|0|||
164531883|NCT03343301|594318946|FG000|Overall Study|Withdrawal by Subject|1|||
164531884|NCT03343301|594318947|FG001|Overall Study|Withdrawal by Subject|1|||
164531885|NCT03343301|594318946|FG000|Overall Study|Death|0|||
164531886|NCT03343301|594318947|FG001|Overall Study|Death|2|||
164531887|NCT03343301|594318946|FG000|Overall Study|Other|0|||
164531888|NCT03343301|594318947|FG001|Overall Study|Other|6|||
164531889|NCT03343301|594318946|FG000|Overall Study|Missing|2|||
164531890|NCT03343301|594318947|FG001|Overall Study|Missing|0|||
164531891|NCT02041520|594318948|FG000|Overall Study|Adverse Event|2|||
164531892|NCT02041520|594318949|FG001|Overall Study|Adverse Event|1|||
164531893|NCT02041520|594318948|FG000|Overall Study|Withdrawal by Subject|3|||
164531894|NCT02041520|594318949|FG001|Overall Study|Withdrawal by Subject|4|||
164531895|NCT02041520|594318948|FG000|Overall Study|Protocol Violation|1|||
164531896|NCT02041520|594318949|FG001|Overall Study|Protocol Violation|0|||
164531897|NCT02041520|594318948|FG000|Overall Study|Lost to Follow-up|0|||
164531898|NCT02041520|594318949|FG001|Overall Study|Lost to Follow-up|1|||
164531899|NCT02041520|594318948|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
164531900|NCT02041520|594318949|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
164531901|NCT00413972|594318950|FG000|Overall Study|Adverse Event|2|||
164531902|NCT00413972|594318951|FG001|Overall Study|Adverse Event|1|||
164531903|NCT00413972|594318952|FG002|Overall Study|Adverse Event|0|||
164531904|NCT00413972|594318953|FG003|Overall Study|Adverse Event|0|||
164531905|NCT00413972|594318950|FG000|Overall Study|Lost to Follow-up|1|||
164531906|NCT00413972|594318951|FG001|Overall Study|Lost to Follow-up|2|||
164531907|NCT00413972|594318952|FG002|Overall Study|Lost to Follow-up|1|||
164531908|NCT00413972|594318953|FG003|Overall Study|Lost to Follow-up|0|||
164531909|NCT00413972|594318950|FG000|Overall Study|Withdrawal by Subject|4|||
164531910|NCT00413972|594318951|FG001|Overall Study|Withdrawal by Subject|5|||
164531911|NCT00413972|594318952|FG002|Overall Study|Withdrawal by Subject|7|||
164531912|NCT00413972|594318953|FG003|Overall Study|Withdrawal by Subject|2|||
164531913|NCT00413972|594318950|FG000|Overall Study|Protocol Violation|0|||
164531914|NCT00413972|594318951|FG001|Overall Study|Protocol Violation|0|||
164642341|NCT00684645|594714844|FG000|Overall Study|Progressive disease|67|||
164642342|NCT00684645|594714844|FG000|Overall Study|Adverse Event|27|||
164642343|NCT00684645|594714844|FG000|Overall Study|Lost to Follow-up|3|||
164642344|NCT00684645|594714844|FG000|Overall Study|Other|15|||
164642345|NCT01819467|594714849|FG000|Overall Study|Physician Decision|20|||
164531915|NCT00413972|594318952|FG002|Overall Study|Protocol Violation|2|||
164531916|NCT00413972|594318953|FG003|Overall Study|Protocol Violation|0|||
164531917|NCT00413972|594318950|FG000|Overall Study|Other|0|||
164642346|NCT01819467|594714850|FG001|Overall Study|Physician Decision|9|||
164642347|NCT03514121|594714851|FG000|Overall Study|Withdrawal by Subject|0|||
164642348|NCT03514121|594714852|FG001|Overall Study|Withdrawal by Subject|0|||
164642349|NCT03514121|594714853|FG002|Overall Study|Withdrawal by Subject|0|||
164642350|NCT03514121|594714854|FG003|Overall Study|Withdrawal by Subject|0|||
164642351|NCT03514121|594714855|FG004|Overall Study|Withdrawal by Subject|1|||
164642352|NCT03514121|594714856|FG005|Overall Study|Withdrawal by Subject|2|||
164642353|NCT03514121|594714857|FG006|Overall Study|Withdrawal by Subject|1|||
164642354|NCT03514121|594714858|FG007|Overall Study|Withdrawal by Subject|1|||
164642355|NCT03514121|594714859|FG008|Overall Study|Withdrawal by Subject|7|||
164642356|NCT03514121|594714860|FG009|Overall Study|Withdrawal by Subject|2|||
164642357|NCT03514121|594714851|FG000|Overall Study|Death|0|||
164642358|NCT03514121|594714852|FG001|Overall Study|Death|0|||
164642359|NCT03514121|594714853|FG002|Overall Study|Death|0|||
164642360|NCT03514121|594714854|FG003|Overall Study|Death|0|||
164642361|NCT03514121|594714855|FG004|Overall Study|Death|0|||
164642362|NCT03514121|594714856|FG005|Overall Study|Death|3|||
164642363|NCT03514121|594714857|FG006|Overall Study|Death|2|||
164642364|NCT03514121|594714858|FG007|Overall Study|Death|1|||
164642365|NCT03514121|594714859|FG008|Overall Study|Death|26|||
164642366|NCT03514121|594714860|FG009|Overall Study|Death|3|||
164642367|NCT03514121|594714851|FG000|Overall Study|Lost to Follow-up|0|||
164642368|NCT03514121|594714852|FG001|Overall Study|Lost to Follow-up|0|||
164642369|NCT03514121|594714853|FG002|Overall Study|Lost to Follow-up|1|||
164642370|NCT03514121|594714854|FG003|Overall Study|Lost to Follow-up|0|||
164642371|NCT03514121|594714855|FG004|Overall Study|Lost to Follow-up|0|||
164642372|NCT03514121|594714856|FG005|Overall Study|Lost to Follow-up|0|||
164642373|NCT03514121|594714857|FG006|Overall Study|Lost to Follow-up|0|||
164642374|NCT03514121|594714858|FG007|Overall Study|Lost to Follow-up|0|||
164642375|NCT03514121|594714859|FG008|Overall Study|Lost to Follow-up|1|||
164642376|NCT03514121|594714860|FG009|Overall Study|Lost to Follow-up|0|||
164642377|NCT03514121|594714851|FG000|Overall Study|Adverse Event|0|||
164642378|NCT03514121|594714852|FG001|Overall Study|Adverse Event|0|||
164642379|NCT03514121|594714853|FG002|Overall Study|Adverse Event|0|||
164642380|NCT03514121|594714854|FG003|Overall Study|Adverse Event|0|||
164642381|NCT03514121|594714855|FG004|Overall Study|Adverse Event|0|||
164642382|NCT03514121|594714856|FG005|Overall Study|Adverse Event|0|||
164642383|NCT03514121|594714857|FG006|Overall Study|Adverse Event|1|||
164642384|NCT03514121|594714858|FG007|Overall Study|Adverse Event|0|||
164642385|NCT03514121|594714859|FG008|Overall Study|Adverse Event|0|||
164642386|NCT03514121|594714860|FG009|Overall Study|Adverse Event|0|||
164642387|NCT03514121|594714851|FG000|Overall Study|Other|0|||
164642388|NCT03514121|594714852|FG001|Overall Study|Other|1|||
164642389|NCT03514121|594714853|FG002|Overall Study|Other|1|||
164642390|NCT03514121|594714854|FG003|Overall Study|Other|0|||
164642391|NCT03514121|594714855|FG004|Overall Study|Other|1|||
164642392|NCT03514121|594714856|FG005|Overall Study|Other|2|||
164642393|NCT03514121|594714857|FG006|Overall Study|Other|3|||
164642394|NCT03514121|594714858|FG007|Overall Study|Other|2|||
164642395|NCT03514121|594714859|FG008|Overall Study|Other|7|||
164642396|NCT03514121|594714860|FG009|Overall Study|Other|3|||
164642397|NCT03514121|594714851|FG000|Overall Study|Study termination by Sponsor|0|||
164642398|NCT03514121|594714852|FG001|Overall Study|Study termination by Sponsor|0|||
164642399|NCT03514121|594714853|FG002|Overall Study|Study termination by Sponsor|0|||
164642400|NCT03514121|594714854|FG003|Overall Study|Study termination by Sponsor|0|||
164642401|NCT03514121|594714855|FG004|Overall Study|Study termination by Sponsor|0|||
164642402|NCT03514121|594714856|FG005|Overall Study|Study termination by Sponsor|0|||
164642403|NCT03514121|594714857|FG006|Overall Study|Study termination by Sponsor|0|||
164642404|NCT03514121|594714858|FG007|Overall Study|Study termination by Sponsor|0|||
164642405|NCT03514121|594714859|FG008|Overall Study|Study termination by Sponsor|11|||
164642406|NCT03514121|594714860|FG009|Overall Study|Study termination by Sponsor|3|||
164642407|NCT03514121|594714851|FG000|Overall Study|Investigator decision|0|||
164642408|NCT03514121|594714852|FG001|Overall Study|Investigator decision|0|||
164642409|NCT03514121|594714853|FG002|Overall Study|Investigator decision|0|||
164642410|NCT03514121|594714854|FG003|Overall Study|Investigator decision|0|||
164642411|NCT03514121|594714855|FG004|Overall Study|Investigator decision|0|||
164642412|NCT03514121|594714856|FG005|Overall Study|Investigator decision|0|||
164642413|NCT03514121|594714857|FG006|Overall Study|Investigator decision|0|||
164642414|NCT03514121|594714858|FG007|Overall Study|Investigator decision|0|||
164642415|NCT03514121|594714859|FG008|Overall Study|Investigator decision|1|||
164642416|NCT03514121|594714860|FG009|Overall Study|Investigator decision|0|||
164642417|NCT02545868|594714865|FG000|Overall Study|Lack of Efficacy|1|||
164642418|NCT02545868|594714866|FG001|Overall Study|Lack of Efficacy|1|||
164642419|NCT02545868|594714867|FG002|Overall Study|Lack of Efficacy|0|||
164642420|NCT02545868|594714865|FG000|Overall Study|Lost to Follow-up|1|||
164642421|NCT02545868|594714866|FG001|Overall Study|Lost to Follow-up|5|||
164642422|NCT02545868|594714867|FG002|Overall Study|Lost to Follow-up|1|||
164642423|NCT02545868|594714865|FG000|Overall Study|Non-compliance|1|||
164642424|NCT02545868|594714866|FG001|Overall Study|Non-compliance|1|||
164642425|NCT02545868|594714867|FG002|Overall Study|Non-compliance|1|||
164642426|NCT02545868|594714865|FG000|Overall Study|Treatment change|21|||
164642427|NCT02545868|594714866|FG001|Overall Study|Treatment change|19|||
164642428|NCT02545868|594714867|FG002|Overall Study|Treatment change|22|||
164642429|NCT02545868|594714865|FG000|Overall Study|Physician Decision|1|||
164642430|NCT02545868|594714866|FG001|Overall Study|Physician Decision|1|||
164642431|NCT02545868|594714867|FG002|Overall Study|Physician Decision|1|||
164642432|NCT02545868|594714865|FG000|Overall Study|Withdrawal by Subject|6|||
164642433|NCT02545868|594714866|FG001|Overall Study|Withdrawal by Subject|7|||
164642434|NCT02545868|594714867|FG002|Overall Study|Withdrawal by Subject|9|||
164642435|NCT03286400|594714872|FG000|Overall Study|Death|10|||
164642436|NCT03286400|594714872|FG000|Overall Study|Lost to Follow-up|10|||
164642437|NCT03286400|594714872|FG000|Overall Study|Physician Decision|1|||
164642438|NCT03286400|594714872|FG000|Overall Study|Scheduling difficulty|4|||
164642439|NCT03576131|594714875|FG000|Overall Study|Investigator decision|0|||
164642440|NCT03576131|594714876|FG001|Overall Study|Investigator decision|0|||
164642441|NCT03576131|594714877|FG002|Overall Study|Investigator decision|0|||
164642442|NCT03576131|594714878|FG003|Overall Study|Investigator decision|1|||
164642443|NCT03576131|594714879|FG004|Overall Study|Investigator decision|0|||
164642444|NCT03576131|594714880|FG005|Overall Study|Investigator decision|1|||
164642445|NCT03576131|594714881|FG006|Overall Study|Investigator decision|0|||
164642446|NCT03576131|594714882|FG007|Overall Study|Investigator decision|0|||
164642447|NCT03576131|594714875|FG000|Overall Study|Withdrawal by Subject|1|||
164642448|NCT03576131|594714876|FG001|Overall Study|Withdrawal by Subject|1|||
164642449|NCT03576131|594714877|FG002|Overall Study|Withdrawal by Subject|0|||
164642450|NCT03576131|594714878|FG003|Overall Study|Withdrawal by Subject|1|||
164642451|NCT03576131|594714879|FG004|Overall Study|Withdrawal by Subject|2|||
164642452|NCT03576131|594714880|FG005|Overall Study|Withdrawal by Subject|3|||
164642453|NCT03576131|594714881|FG006|Overall Study|Withdrawal by Subject|1|||
164642454|NCT03576131|594714882|FG007|Overall Study|Withdrawal by Subject|0|||
164642455|NCT03576131|594714875|FG000|Overall Study|Death|3|||
164642456|NCT03576131|594714876|FG001|Overall Study|Death|3|||
164642457|NCT03576131|594714877|FG002|Overall Study|Death|1|||
164642458|NCT03576131|594714878|FG003|Overall Study|Death|5|||
164642459|NCT03576131|594714879|FG004|Overall Study|Death|4|||
164642460|NCT03576131|594714880|FG005|Overall Study|Death|1|||
164642461|NCT03576131|594714881|FG006|Overall Study|Death|0|||
164642462|NCT03576131|594714882|FG007|Overall Study|Death|1|||
164642463|NCT03576131|594714875|FG000|Overall Study|New anti-cancer treatment|5|||
164642464|NCT03576131|594714876|FG001|Overall Study|New anti-cancer treatment|1|||
164642465|NCT03576131|594714877|FG002|Overall Study|New anti-cancer treatment|2|||
164642466|NCT03576131|594714878|FG003|Overall Study|New anti-cancer treatment|3|||
164642467|NCT03576131|594714879|FG004|Overall Study|New anti-cancer treatment|0|||
164642468|NCT03576131|594714880|FG005|Overall Study|New anti-cancer treatment|0|||
164642469|NCT03576131|594714881|FG006|Overall Study|New anti-cancer treatment|0|||
164642470|NCT03576131|594714882|FG007|Overall Study|New anti-cancer treatment|0|||
164642471|NCT03576131|594714875|FG000|Overall Study|Unspecified reason|0|||
164642472|NCT03576131|594714876|FG001|Overall Study|Unspecified reason|0|||
164642473|NCT03576131|594714877|FG002|Overall Study|Unspecified reason|1|||
164642474|NCT03576131|594714878|FG003|Overall Study|Unspecified reason|1|||
164642475|NCT03576131|594714879|FG004|Overall Study|Unspecified reason|1|||
164642476|NCT03576131|594714880|FG005|Overall Study|Unspecified reason|1|||
164642477|NCT03576131|594714881|FG006|Overall Study|Unspecified reason|0|||
164642478|NCT03576131|594714882|FG007|Overall Study|Unspecified reason|0|||
164642479|NCT03576131|594714875|FG000|Overall Study|Subject non-compliance|0|||
164642480|NCT03576131|594714876|FG001|Overall Study|Subject non-compliance|0|||
164642481|NCT03576131|594714877|FG002|Overall Study|Subject non-compliance|0|||
164642482|NCT03576131|594714878|FG003|Overall Study|Subject non-compliance|0|||
164642483|NCT03576131|594714879|FG004|Overall Study|Subject non-compliance|0|||
164642484|NCT03576131|594714880|FG005|Overall Study|Subject non-compliance|1|||
164642485|NCT03576131|594714881|FG006|Overall Study|Subject non-compliance|0|||
164642486|NCT03576131|594714882|FG007|Overall Study|Subject non-compliance|0|||
164642487|NCT01563029|594714883|FG000|Overall Study|Adverse Event|1|||
164642488|NCT01563029|594714884|FG001|Overall Study|Adverse Event|0|||
164642489|NCT01563029|594714885|FG002|Overall Study|Adverse Event|1|||
164642490|NCT01563029|594714886|FG003|Overall Study|Adverse Event|2|||
164642491|NCT01563029|594714887|FG004|Overall Study|Adverse Event|1|||
164642492|NCT01563029|594714883|FG000|Overall Study|Lack of Efficacy|42|||
164642493|NCT01563029|594714884|FG001|Overall Study|Lack of Efficacy|16|||
164642494|NCT01563029|594714885|FG002|Overall Study|Lack of Efficacy|23|||
164642495|NCT01563029|594714886|FG003|Overall Study|Lack of Efficacy|21|||
164642496|NCT01563029|594714887|FG004|Overall Study|Lack of Efficacy|19|||
164642497|NCT01563029|594714883|FG000|Overall Study|Protocol Violation|1|||
164642498|NCT01563029|594714884|FG001|Overall Study|Protocol Violation|2|||
164642499|NCT01563029|594714885|FG002|Overall Study|Protocol Violation|3|||
164642500|NCT01563029|594714886|FG003|Overall Study|Protocol Violation|1|||
164642501|NCT01563029|594714887|FG004|Overall Study|Protocol Violation|3|||
164642502|NCT01563029|594714883|FG000|Overall Study|Protocol defined stopping criteria|1|||
164642503|NCT01563029|594714884|FG001|Overall Study|Protocol defined stopping criteria|0|||
164642504|NCT01563029|594714885|FG002|Overall Study|Protocol defined stopping criteria|0|||
164642505|NCT01563029|594714886|FG003|Overall Study|Protocol defined stopping criteria|0|||
164642506|NCT01563029|594714887|FG004|Overall Study|Protocol defined stopping criteria|0|||
164642507|NCT01563029|594714883|FG000|Overall Study|Lost to Follow-up|1|||
164642508|NCT01563029|594714884|FG001|Overall Study|Lost to Follow-up|0|||
164642509|NCT01563029|594714885|FG002|Overall Study|Lost to Follow-up|1|||
164642510|NCT01563029|594714886|FG003|Overall Study|Lost to Follow-up|1|||
164642511|NCT01563029|594714887|FG004|Overall Study|Lost to Follow-up|1|||
164642512|NCT01563029|594714883|FG000|Overall Study|Physician Decision|3|||
164642513|NCT01563029|594714884|FG001|Overall Study|Physician Decision|5|||
164642514|NCT01563029|594714885|FG002|Overall Study|Physician Decision|2|||
164642515|NCT01563029|594714886|FG003|Overall Study|Physician Decision|4|||
164642516|NCT01563029|594714887|FG004|Overall Study|Physician Decision|2|||
164642517|NCT01563029|594714883|FG000|Overall Study|Withdrawal by Subject|4|||
164642518|NCT01563029|594714884|FG001|Overall Study|Withdrawal by Subject|1|||
164642519|NCT01563029|594714885|FG002|Overall Study|Withdrawal by Subject|3|||
164642520|NCT01563029|594714886|FG003|Overall Study|Withdrawal by Subject|4|||
164642521|NCT01563029|594714887|FG004|Overall Study|Withdrawal by Subject|3|||
164642522|NCT03069365|594714888|FG000|Overall Study|Adverse Event|1|||
164642523|NCT02780115|594714889|FG000|Overall Study|Withdrawal by Subject|0|||
164642524|NCT02780115|594714890|FG001|Overall Study|Withdrawal by Subject|1|||
164642525|NCT02780115|594714891|FG002|Overall Study|Withdrawal by Subject|1|||
164642526|NCT02780115|594714892|FG003|Overall Study|Withdrawal by Subject|0|||
164642527|NCT02780115|594714893|FG004|Overall Study|Withdrawal by Subject|0|||
164642528|NCT02780115|594714889|FG000|Overall Study|Adverse Event|0|||
164642529|NCT02780115|594714890|FG001|Overall Study|Adverse Event|0|||
164642530|NCT02780115|594714891|FG002|Overall Study|Adverse Event|0|||
164642531|NCT02780115|594714892|FG003|Overall Study|Adverse Event|1|||
164642532|NCT02780115|594714893|FG004|Overall Study|Adverse Event|1|||
164642533|NCT02860039|594714894|FG000|Overall Study|Death|4|||
164642534|NCT02860039|594714895|FG001|Overall Study|Death|0|||
164642535|NCT02860039|594714894|FG000|Overall Study|Lost to Follow-up|2|||
164642536|NCT02860039|594714895|FG001|Overall Study|Lost to Follow-up|2|||
164642537|NCT02860039|594714894|FG000|Overall Study|Protocol Violation|3|||
164642538|NCT02860039|594714895|FG001|Overall Study|Protocol Violation|1|||
164642539|NCT02860039|594714894|FG000|Overall Study|Withdrawal by Subject|1|||
164642540|NCT02860039|594714895|FG001|Overall Study|Withdrawal by Subject|0|||
164642541|NCT02860039|594714894|FG000|Overall Study|Not otherwise eligible|1|||
164642542|NCT02860039|594714895|FG001|Overall Study|Not otherwise eligible|1|||
164642543|NCT01257737|594714896|FG000|Overall Study|Lost to Follow-up|1|||
164642544|NCT01257737|594714897|FG001|Overall Study|Lost to Follow-up|2|||
164642545|NCT01257737|594714896|FG000|Overall Study|Liver transplant|1|||
164642546|NCT01257737|594714897|FG001|Overall Study|Liver transplant|0|||
164642547|NCT01257737|594714896|FG000|Overall Study|Relocation out of the country|0|||
164642548|NCT01257737|594714897|FG001|Overall Study|Relocation out of the country|1|||
164642549|NCT01257737|594714896|FG000|Overall Study|Withdrew from study|0|||
164642550|NCT01257737|594714897|FG001|Overall Study|Withdrew from study|1|||
164642551|NCT02723786|594714898|FG000|Overall Study|Lost to Follow-up|1|||
164642552|NCT00127192|594714899|FG000|Overall Study|Adverse Event|0|||
164642553|NCT00127192|594714900|FG001|Overall Study|Adverse Event|1|||
164642554|NCT00127192|594714901|FG002|Overall Study|Adverse Event|1|||
164642555|NCT00127192|594714902|FG003|Overall Study|Adverse Event|1|||
164642556|NCT00127192|594714903|FG004|Overall Study|Adverse Event|0|||
164642557|NCT00127192|594714899|FG000|Overall Study|Lack of Efficacy|2|||
164642558|NCT00127192|594714900|FG001|Overall Study|Lack of Efficacy|0|||
164642559|NCT00127192|594714901|FG002|Overall Study|Lack of Efficacy|0|||
164642560|NCT00127192|594714902|FG003|Overall Study|Lack of Efficacy|0|||
164642561|NCT00127192|594714903|FG004|Overall Study|Lack of Efficacy|2|||
164642562|NCT00127192|594714899|FG000|Overall Study|Withdrawal by Subject|0|||
164642563|NCT00127192|594714900|FG001|Overall Study|Withdrawal by Subject|0|||
164642564|NCT00127192|594714901|FG002|Overall Study|Withdrawal by Subject|1|||
164642565|NCT00127192|594714902|FG003|Overall Study|Withdrawal by Subject|0|||
164642566|NCT00127192|594714903|FG004|Overall Study|Withdrawal by Subject|3|||
164642567|NCT00127192|594714899|FG000|Overall Study|Adverse event in pre-treatment period|1|||
164642568|NCT00127192|594714900|FG001|Overall Study|Adverse event in pre-treatment period|0|||
164642569|NCT00127192|594714901|FG002|Overall Study|Adverse event in pre-treatment period|0|||
164642570|NCT00127192|594714902|FG003|Overall Study|Adverse event in pre-treatment period|0|||
164642571|NCT00127192|594714903|FG004|Overall Study|Adverse event in pre-treatment period|0|||
164642572|NCT03170271|594714906|FG000|Overall Study|Adverse Event|7|||
164642573|NCT03170271|594714907|FG001|Overall Study|Adverse Event|2|||
164642574|NCT03170271|594714906|FG000|Overall Study|Lost to Follow-up|0|||
164642575|NCT03170271|594714907|FG001|Overall Study|Lost to Follow-up|1|||
164642576|NCT03170271|594714906|FG000|Overall Study|Physician Decision|1|||
164531918|NCT00413972|594318951|FG001|Overall Study|Other|0|||
164531919|NCT00413972|594318952|FG002|Overall Study|Other|0|||
164531920|NCT00413972|594318953|FG003|Overall Study|Other|1|||
164531921|NCT00427895|594318956|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
164531922|NCT00427895|594318957|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
164642577|NCT03170271|594714907|FG001|Overall Study|Physician Decision|0|||
164642578|NCT03170271|594714906|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
164642579|NCT03170271|594714907|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
164642580|NCT03170271|594714906|FG000|Overall Study|Withdrawal by Subject|17|||
164642581|NCT03170271|594714907|FG001|Overall Study|Withdrawal by Subject|5|||
164642582|NCT03170271|594714906|FG000|Overall Study|Other|2|||
164531923|NCT00427895|594318958|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
164531924|NCT00427895|594318959|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
164531925|NCT00427895|594318960|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
164531926|NCT00427895|594318961|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
164531927|NCT00427895|594318962|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
164642583|NCT03170271|594714907|FG001|Overall Study|Other|2|||
164642584|NCT03170271|594714906|FG000|Overall Study|Randomized in error|4|||
164642585|NCT03170271|594714907|FG001|Overall Study|Randomized in error|0|||
164642586|NCT01036594|594714921|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
164642587|NCT01036594|594714922|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
164642588|NCT01036594|594714921|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
164642589|NCT01036594|594714922|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
164642590|NCT01036594|594714921|FG000|Week 12 Evaluation|Adverse Event|5|||
164642591|NCT01036594|594714922|FG001|Week 12 Evaluation|Adverse Event|0|||
164642592|NCT01036594|594714921|FG000|Week 12 Evaluation|Physician Decision|1|||
164642593|NCT01036594|594714922|FG001|Week 12 Evaluation|Physician Decision|0|||
164642594|NCT01036594|594714921|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
164642595|NCT01036594|594714922|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
164642596|NCT01036594|594714921|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
164642597|NCT01036594|594714922|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
164642598|NCT01036594|594714921|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
164642599|NCT01036594|594714922|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
164642600|NCT01036594|594714921|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
164642601|NCT01036594|594714922|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
164642602|NCT01036594|594714921|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
164642603|NCT01036594|594714922|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
164642604|NCT01612780|594714925|FG000|Overall Study|Treatment not completed|1|||
164642605|NCT01612780|594714925|FG000|Overall Study|Withdrawal by Subject|5|||
164642606|NCT03466060|594714926|FG000|Period 1|Test Lens Damage|0|||
164642607|NCT03466060|594714927|FG001|Period 1|Test Lens Damage|2|||
164642608|NCT03466060|594714928|FG002|Period 1|Test Lens Damage|0|||
164642609|NCT03466060|594714929|FG003|Period 1|Test Lens Damage|0|||
164642610|NCT03466060|594714930|FG004|Period 1|Test Lens Damage|0|||
164642611|NCT03466060|594714931|FG005|Period 1|Test Lens Damage|0|||
164642612|NCT03466060|594714926|FG000|Period 1|Withdrawal by Subject|0|||
164642613|NCT03466060|594714927|FG001|Period 1|Withdrawal by Subject|0|||
164642614|NCT03466060|594714928|FG002|Period 1|Withdrawal by Subject|2|||
164642615|NCT03466060|594714929|FG003|Period 1|Withdrawal by Subject|0|||
164642616|NCT03466060|594714930|FG004|Period 1|Withdrawal by Subject|0|||
164642617|NCT03466060|594714931|FG005|Period 1|Withdrawal by Subject|0|||
164642618|NCT03466060|594714926|FG000|Period 1|Lost to Follow-up|0|||
164642619|NCT03466060|594714927|FG001|Period 1|Lost to Follow-up|0|||
164642620|NCT03466060|594714928|FG002|Period 1|Lost to Follow-up|0|||
164642621|NCT03466060|594714929|FG003|Period 1|Lost to Follow-up|1|||
164642622|NCT03466060|594714930|FG004|Period 1|Lost to Follow-up|0|||
164642623|NCT03466060|594714931|FG005|Period 1|Lost to Follow-up|0|||
164642624|NCT03466060|594714926|FG000|Period 1|Grade 2 Conjunctivitis|0|||
164642625|NCT03466060|594714927|FG001|Period 1|Grade 2 Conjunctivitis|0|||
164642626|NCT03466060|594714928|FG002|Period 1|Grade 2 Conjunctivitis|1|||
164642627|NCT03466060|594714929|FG003|Period 1|Grade 2 Conjunctivitis|0|||
164642628|NCT03466060|594714930|FG004|Period 1|Grade 2 Conjunctivitis|0|||
164642629|NCT03466060|594714931|FG005|Period 1|Grade 2 Conjunctivitis|0|||
164642630|NCT03466060|594714926|FG000|Period 2|Lens Handling Difficulties|0|||
164642631|NCT03466060|594714927|FG001|Period 2|Lens Handling Difficulties|0|||
164642632|NCT03466060|594714928|FG002|Period 2|Lens Handling Difficulties|1|||
164642633|NCT03466060|594714929|FG003|Period 2|Lens Handling Difficulties|0|||
164642634|NCT03466060|594714930|FG004|Period 2|Lens Handling Difficulties|0|||
164642635|NCT03466060|594714931|FG005|Period 2|Lens Handling Difficulties|0|||
164642636|NCT03345485|594714934|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
164642637|NCT03345485|594714935|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
164642638|NCT03345485|594714936|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
164642639|NCT03345485|594714937|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
164642640|NCT03345485|594714938|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
164642641|NCT03345485|594714939|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
164642642|NCT03345485|594714940|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
164642643|NCT03345485|594714941|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
164642644|NCT03345485|594714942|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
164642645|NCT03345485|594714943|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
164642646|NCT03345485|594714944|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
164642647|NCT03345485|594714945|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
164642648|NCT03345485|594714946|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
164642649|NCT02985515|594714947|FG000|Olfaction Testing|Lost to Follow-up|0|||
164642650|NCT02985515|594714948|FG001|Olfaction Testing|Lost to Follow-up|5|||
164642651|NCT02985515|594714947|FG000|Olfaction Testing|Protocol Violation|0|||
164642652|NCT02985515|594714948|FG001|Olfaction Testing|Protocol Violation|3|||
164642653|NCT01610284|594714949|FG000|Randomization Phase|Adverse Event|1|||
164642654|NCT01610284|594714950|FG001|Randomization Phase|Adverse Event|0|||
164642655|NCT01610284|594714949|FG000|Randomization Phase|Physician Decision|1|||
164642656|NCT01610284|594714950|FG001|Randomization Phase|Physician Decision|1|||
164642657|NCT01610284|594714949|FG000|Randomization Phase|Death|0|||
164642658|NCT01610284|594714950|FG001|Randomization Phase|Death|1|||
164642659|NCT01610284|594714949|FG000|Treatment Phase|Adverse Event|80|||
164642660|NCT01610284|594714950|FG001|Treatment Phase|Adverse Event|12|||
164642661|NCT01610284|594714949|FG000|Treatment Phase|Lost to Follow-up|1|||
164642662|NCT01610284|594714950|FG001|Treatment Phase|Lost to Follow-up|0|||
164642663|NCT01610284|594714949|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
164642664|NCT01610284|594714950|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
164642665|NCT01610284|594714949|FG000|Treatment Phase|Physician Decision|27|||
164642666|NCT01610284|594714950|FG001|Treatment Phase|Physician Decision|24|||
164642667|NCT01610284|594714949|FG000|Treatment Phase|Progressive Disease|377|||
164642668|NCT01610284|594714950|FG001|Treatment Phase|Progressive Disease|486|||
164642669|NCT01610284|594714949|FG000|Treatment Phase|Protocol Deviation|2|||
164642670|NCT01610284|594714950|FG001|Treatment Phase|Protocol Deviation|3|||
164642671|NCT01610284|594714949|FG000|Treatment Phase|Study terminated by Sponsor|18|||
164642672|NCT01610284|594714950|FG001|Treatment Phase|Study terminated by Sponsor|15|||
164531928|NCT00427895|594318963|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
164531929|NCT00427895|594318956|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
164531930|NCT00427895|594318957|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
164531931|NCT00427895|594318958|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
164531932|NCT00427895|594318959|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
164531933|NCT00427895|594318960|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
164531934|NCT00427895|594318961|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
164531935|NCT00427895|594318962|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
164531936|NCT00427895|594318963|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
164531937|NCT00427895|594318956|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
164531938|NCT00427895|594318957|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
164531939|NCT00427895|594318958|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
164531940|NCT00427895|594318959|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
164531941|NCT00427895|594318960|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
164531942|NCT00427895|594318961|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
164531943|NCT00427895|594318962|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
164531944|NCT00427895|594318963|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
164531945|NCT00427895|594318956|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
164531946|NCT00427895|594318957|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
164531947|NCT00427895|594318958|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
164531948|NCT00427895|594318959|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
164531949|NCT00427895|594318960|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
164531950|NCT00427895|594318961|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
164531951|NCT00427895|594318962|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
164642673|NCT01610284|594714949|FG000|Treatment Phase|Subject/Guardian Decision|55|||
164642674|NCT01610284|594714950|FG001|Treatment Phase|Subject/Guardian Decision|23|||
164642675|NCT01610284|594714949|FG000|Treatment Phase|Death|6|||
164642676|NCT01610284|594714950|FG001|Treatment Phase|Death|5|||
164642677|NCT01610284|594714949|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
164642678|NCT01610284|594714950|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
164642679|NCT01610284|594714949|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
164642680|NCT01610284|594714950|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
164642681|NCT01610284|594714949|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
164642682|NCT01610284|594714950|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
164642683|NCT01610284|594714949|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
164642684|NCT01610284|594714950|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
164642685|NCT01610284|594714949|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
164642686|NCT01610284|594714950|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
164642687|NCT01610284|594714949|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
164642688|NCT01610284|594714950|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
164642689|NCT03020966|594714951|FG000|Overall Study|Withdrawal by Subject|2|||
164642690|NCT03020966|594714952|FG001|Overall Study|Withdrawal by Subject|0|||
164642691|NCT01856257|594714953|FG000|Overall Study|Death|2|||
164642692|NCT01856257|594714954|FG001|Overall Study|Death|0|||
164642693|NCT01856257|594714955|FG002|Overall Study|Death|0|||
164642694|NCT01856257|594714956|FG003|Overall Study|Death|0|||
164642695|NCT01856257|594714953|FG000|Overall Study|Physician Decision|0|||
164642696|NCT01856257|594714954|FG001|Overall Study|Physician Decision|0|||
164642697|NCT01856257|594714955|FG002|Overall Study|Physician Decision|0|||
164642698|NCT01856257|594714956|FG003|Overall Study|Physician Decision|1|||
164642699|NCT01856257|594714953|FG000|Overall Study|Withdrawal by Subject|1|||
164642700|NCT01856257|594714954|FG001|Overall Study|Withdrawal by Subject|1|||
164642701|NCT01856257|594714955|FG002|Overall Study|Withdrawal by Subject|0|||
164642702|NCT01856257|594714956|FG003|Overall Study|Withdrawal by Subject|0|||
164642703|NCT01856257|594714953|FG000|Overall Study|Donor complication|0|||
164642704|NCT01856257|594714954|FG001|Overall Study|Donor complication|0|||
164642705|NCT01856257|594714955|FG002|Overall Study|Donor complication|0|||
164642706|NCT01856257|594714956|FG003|Overall Study|Donor complication|1|||
164642707|NCT04935931|594714960|FG000|Overall Study|Withdrawal by Subject|1|||
164642708|NCT00424632|594714963|FG000|Overall Study|Death|0|||
164642709|NCT00424632|594714964|FG001|Overall Study|Death|0|||
164642710|NCT00424632|594714965|FG002|Overall Study|Death|0|||
164642711|NCT00424632|594714966|FG003|Overall Study|Death|0|||
164642712|NCT00424632|594714967|FG004|Overall Study|Death|0|||
164642713|NCT00424632|594714968|FG005|Overall Study|Death|2|||
164642714|NCT00424632|594714969|FG006|Overall Study|Death|0|||
164642715|NCT00424632|594714970|FG007|Overall Study|Death|0|||
164642716|NCT00424632|594714971|FG008|Overall Study|Death|0|||
164642717|NCT00424632|594714972|FG009|Overall Study|Death|0|||
164642718|NCT00424632|594714963|FG000|Overall Study|Adverse Event|0|||
164642719|NCT00424632|594714964|FG001|Overall Study|Adverse Event|0|||
164642720|NCT00424632|594714965|FG002|Overall Study|Adverse Event|0|||
164642721|NCT00424632|594714966|FG003|Overall Study|Adverse Event|0|||
164642722|NCT00424632|594714967|FG004|Overall Study|Adverse Event|0|||
164642723|NCT00424632|594714968|FG005|Overall Study|Adverse Event|0|||
164642724|NCT00424632|594714969|FG006|Overall Study|Adverse Event|0|||
164642725|NCT00424632|594714970|FG007|Overall Study|Adverse Event|0|||
164642726|NCT00424632|594714971|FG008|Overall Study|Adverse Event|3|||
164642727|NCT00424632|594714972|FG009|Overall Study|Adverse Event|2|||
164642728|NCT00424632|594714963|FG000|Overall Study|Global deterioration of health status|0|||
164642729|NCT00424632|594714964|FG001|Overall Study|Global deterioration of health status|0|||
164642730|NCT00424632|594714965|FG002|Overall Study|Global deterioration of health status|0|||
164642731|NCT00424632|594714966|FG003|Overall Study|Global deterioration of health status|1|||
164642732|NCT00424632|594714967|FG004|Overall Study|Global deterioration of health status|1|||
164642733|NCT00424632|594714968|FG005|Overall Study|Global deterioration of health status|0|||
164642734|NCT00424632|594714969|FG006|Overall Study|Global deterioration of health status|0|||
164642735|NCT00424632|594714970|FG007|Overall Study|Global deterioration of health status|0|||
164642736|NCT00424632|594714971|FG008|Overall Study|Global deterioration of health status|0|||
164642737|NCT00424632|594714972|FG009|Overall Study|Global deterioration of health status|0|||
164642738|NCT00424632|594714963|FG000|Overall Study|Objective progression or relapse|1|||
164642739|NCT00424632|594714964|FG001|Overall Study|Objective progression or relapse|1|||
164642740|NCT00424632|594714965|FG002|Overall Study|Objective progression or relapse|1|||
164642741|NCT00424632|594714966|FG003|Overall Study|Objective progression or relapse|2|||
164642742|NCT00424632|594714967|FG004|Overall Study|Objective progression or relapse|2|||
164642743|NCT00424632|594714968|FG005|Overall Study|Objective progression or relapse|13|||
164642744|NCT00424632|594714969|FG006|Overall Study|Objective progression or relapse|7|||
164642745|NCT00424632|594714970|FG007|Overall Study|Objective progression or relapse|3|||
164642746|NCT00424632|594714971|FG008|Overall Study|Objective progression or relapse|12|||
164642747|NCT00424632|594714972|FG009|Overall Study|Objective progression or relapse|4|||
164642748|NCT00424632|594714963|FG000|Overall Study|Other|0|||
164642749|NCT00424632|594714964|FG001|Overall Study|Other|0|||
164642750|NCT00424632|594714965|FG002|Overall Study|Other|0|||
164642751|NCT00424632|594714966|FG003|Overall Study|Other|1|||
164642752|NCT00424632|594714967|FG004|Overall Study|Other|0|||
164531952|NCT00427895|594318963|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
164531953|NCT00427895|594318956|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
164531954|NCT00427895|594318957|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
164642753|NCT00424632|594714968|FG005|Overall Study|Other|0|||
164642754|NCT00424632|594714969|FG006|Overall Study|Other|0|||
164642755|NCT00424632|594714970|FG007|Overall Study|Other|0|||
164642756|NCT00424632|594714971|FG008|Overall Study|Other|1|||
164642757|NCT00424632|594714972|FG009|Overall Study|Other|0|||
164531955|NCT00427895|594318958|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
164531956|NCT00427895|594318959|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
164531957|NCT00427895|594318960|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
164531958|NCT00427895|594318961|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
164531959|NCT00427895|594318962|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
164531960|NCT00427895|594318963|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
164531961|NCT00427895|594318956|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
164531962|NCT00427895|594318957|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
164531963|NCT00427895|594318958|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
164531964|NCT00427895|594318959|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
164531965|NCT00427895|594318960|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
164531966|NCT00427895|594318961|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
164531967|NCT00427895|594318962|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
164531968|NCT00427895|594318963|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
164642758|NCT01984229|594714973|FG000|Safety Follow-up Period|Adverse Event|1|||
164642759|NCT01984229|594714974|FG001|Safety Follow-up Period|Adverse Event|1|||
164642760|NCT01984229|594714973|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
164642761|NCT01984229|594714974|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
164642762|NCT02072174|594714975|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
164642763|NCT02072174|594714976|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
164642764|NCT02072174|594714975|FG000|Overall Study|Protocol Violation|16|||
164642765|NCT02072174|594714976|FG001|Overall Study|Protocol Violation|23|||
164642766|NCT02072174|594714975|FG000|Overall Study|Physician Decision|0|||
164642767|NCT02072174|594714976|FG001|Overall Study|Physician Decision|1|||
164642768|NCT02072174|594714975|FG000|Overall Study|Non-compliance with protocol requirement|2|||
164642769|NCT02072174|594714976|FG001|Overall Study|Non-compliance with protocol requirement|0|||
164642770|NCT05674721|594714977|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
164642771|NCT05674721|594714978|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
164642772|NCT05674721|594714977|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
164642773|NCT05674721|594714978|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
164642774|NCT03506425|594714993|FG000|Overall Study|Adverse Event|1|||
164642775|NCT03506425|594714994|FG001|Overall Study|Adverse Event|3|||
164642776|NCT03506425|594714995|FG002|Overall Study|Adverse Event|0|||
164642777|NCT03506425|594714993|FG000|Overall Study|Death|1|||
164642778|NCT03506425|594714994|FG001|Overall Study|Death|0|||
164642779|NCT03506425|594714995|FG002|Overall Study|Death|0|||
164642780|NCT03506425|594714993|FG000|Overall Study|Withdrawal by Subject|0|||
164642781|NCT03506425|594714994|FG001|Overall Study|Withdrawal by Subject|0|||
164642782|NCT03506425|594714995|FG002|Overall Study|Withdrawal by Subject|1|||
164642783|NCT03930615|594714998|FG000|Overall Study|Death|9|||
164642784|NCT03930615|594714999|FG001|Overall Study|Death|3|||
164642785|NCT03930615|594714998|FG000|Overall Study|Lost to Follow-up|1|||
164642786|NCT03930615|594714999|FG001|Overall Study|Lost to Follow-up|2|||
164642787|NCT03930615|594714998|FG000|Overall Study|Physician Decision|3|||
164642788|NCT03930615|594714999|FG001|Overall Study|Physician Decision|4|||
164642789|NCT03930615|594714998|FG000|Overall Study|Withdrawal by Subject|13|||
164642790|NCT03930615|594714999|FG001|Overall Study|Withdrawal by Subject|2|||
164642791|NCT03930615|594714998|FG000|Overall Study|Not treated|1|||
164642792|NCT03930615|594714999|FG001|Overall Study|Not treated|1|||
164642793|NCT00605839|594715002|FG000|Overall Study|Protocol Violation|1|||
164642794|NCT00605839|594715003|FG001|Overall Study|Protocol Violation|0|||
164642795|NCT00605839|594715004|FG002|Overall Study|Protocol Violation|0|||
164642796|NCT02864953|594715005|FG000|Overall Study|Adverse Event|22|||
164642797|NCT02864953|594715006|FG001|Overall Study|Adverse Event|19|||
164642798|NCT02864953|594715005|FG000|Overall Study|Withdrawal by Subject|1|||
164642799|NCT02864953|594715006|FG001|Overall Study|Withdrawal by Subject|0|||
164642800|NCT02864953|594715005|FG000|Overall Study|Physician Decision|4|||
164531969|NCT00427895|594318956|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
164642801|NCT02864953|594715006|FG001|Overall Study|Physician Decision|2|||
164642802|NCT02864953|594715005|FG000|Overall Study|Death|3|||
164642803|NCT02864953|594715006|FG001|Overall Study|Death|13|||
164642804|NCT02864953|594715005|FG000|Overall Study|Reason not specified|14|||
164642805|NCT02864953|594715006|FG001|Overall Study|Reason not specified|12|||
164642806|NCT02864953|594715005|FG000|Overall Study|Withdrew Prior to Dosing|9|||
164642807|NCT02864953|594715006|FG001|Overall Study|Withdrew Prior to Dosing|8|||
164642808|NCT00981019|594715007|FG000|Overall Study|Did not respond|65|||
164642809|NCT00981019|594715007|FG000|Overall Study|Did not match target population|94|||
164531970|NCT00427895|594318957|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
164531971|NCT00427895|594318958|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
164531972|NCT00427895|594318959|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
164531973|NCT00427895|594318960|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
164531974|NCT00427895|594318961|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
164531975|NCT00427895|594318962|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
164531976|NCT00427895|594318963|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
164531977|NCT00427895|594318956|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
164531978|NCT00427895|594318957|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
164531979|NCT00427895|594318958|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
164531980|NCT00427895|594318959|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
164531981|NCT00427895|594318960|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
164531982|NCT00427895|594318961|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
164531983|NCT00427895|594318962|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
164531984|NCT00427895|594318963|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
164642810|NCT00981019|594715007|FG000|Overall Study|Inadvertent exclusion|239|||
164642811|NCT00981019|594715007|FG000|Overall Study|Hit the survey after closure|79|||
164531985|NCT00427895|594318956|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
164531986|NCT00427895|594318957|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
164531987|NCT00427895|594318958|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
164642812|NCT00358670|594715008|FG000|Overall Study|Adverse Event|26|||
164642813|NCT00358670|594715009|FG001|Overall Study|Adverse Event|29|||
164642814|NCT00358670|594715008|FG000|Overall Study|Lack of Efficacy|20|||
164642815|NCT00358670|594715009|FG001|Overall Study|Lack of Efficacy|23|||
164531988|NCT00427895|594318959|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
164531989|NCT00427895|594318960|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
164531990|NCT00427895|594318961|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
164531991|NCT00427895|594318962|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
164531992|NCT00427895|594318963|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
164531993|NCT00427895|594318956|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
164531994|NCT00427895|594318957|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
164531995|NCT00427895|594318958|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
164642816|NCT00358670|594715008|FG000|Overall Study|Protocol Violation|6|||
164642817|NCT00358670|594715009|FG001|Overall Study|Protocol Violation|9|||
164642818|NCT00358670|594715008|FG000|Overall Study|Lost to Follow-up|4|||
164642819|NCT00358670|594715009|FG001|Overall Study|Lost to Follow-up|5|||
164642820|NCT00358670|594715008|FG000|Overall Study|Withdrawal by Subject|13|||
164642821|NCT00358670|594715009|FG001|Overall Study|Withdrawal by Subject|24|||
164642822|NCT00358670|594715008|FG000|Overall Study|Protocol Defined Clinical Event|0|||
164642823|NCT00358670|594715009|FG001|Overall Study|Protocol Defined Clinical Event|1|||
164642824|NCT00358670|594715008|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
164642825|NCT00358670|594715009|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
164642826|NCT00358670|594715008|FG000|Overall Study|Administrative|153|||
164642827|NCT00358670|594715009|FG001|Overall Study|Administrative|125|||
164642828|NCT00865306|594715010|FG000|Controlled Trial|Lost to Follow-up|1|||
164642829|NCT00865306|594715011|FG001|Controlled Trial|Lost to Follow-up|1|||
164642830|NCT00865306|594715010|FG000|Controlled Trial|Difficulty commuting|2|||
164642831|NCT00865306|594715011|FG001|Controlled Trial|Difficulty commuting|0|||
164642832|NCT00865306|594715010|FG000|Controlled Trial|Improved btw baseline and first session|1|||
164642833|NCT00865306|594715011|FG001|Controlled Trial|Improved btw baseline and first session|0|||
164642834|NCT00865306|594715010|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
164642835|NCT00865306|594715011|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
164642836|NCT00865306|594715010|FG000|Controlled Trial|Withdrawal by Subject|0|||
164642837|NCT00865306|594715011|FG001|Controlled Trial|Withdrawal by Subject|1|||
164642838|NCT05083559|594715012|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
164642839|NCT05083559|594715013|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
164642840|NCT05083559|594715012|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
164642841|NCT05083559|594715013|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
164642842|NCT05083559|594715012|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
164642843|NCT05083559|594715013|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
164642844|NCT02704130|594715014|FG000|Overall Study|Physician Decision|5|||
164642845|NCT02704130|594715015|FG001|Overall Study|Physician Decision|3|||
164642846|NCT00352664|594715018|FG000|Overall Study|Withdrawal by Subject|7|||
164642847|NCT00352664|594715019|FG001|Overall Study|Withdrawal by Subject|0|||
164531996|NCT00427895|594318959|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
164531997|NCT00427895|594318960|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
164642848|NCT01608321|594715020|FG000|Overall Study|Withdrawal by Subject|1|||
164642849|NCT01608321|594715021|FG001|Overall Study|Withdrawal by Subject|0|||
164642850|NCT00391092|594716707|FG000|Overall Study|Death|78|||
164642851|NCT00391092|594716708|FG001|Overall Study|Death|81|||
164642852|NCT00391092|594716707|FG000|Overall Study|Lost to Follow-up|13|||
164642853|NCT00391092|594716708|FG001|Overall Study|Lost to Follow-up|18|||
164642854|NCT00391092|594716707|FG000|Overall Study|Alive on treatment|29|||
164642855|NCT00391092|594716708|FG001|Overall Study|Alive on treatment|33|||
164642856|NCT00391092|594716707|FG000|Overall Study|Alive in follow-up|88|||
164642857|NCT00391092|594716708|FG001|Overall Study|Alive in follow-up|84|||
164642858|NCT01777191|594716709|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
164642859|NCT01777191|594716710|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
164642860|NCT01777191|594716709|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
164642861|NCT01777191|594716710|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
164642862|NCT01777191|594716709|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
164642863|NCT01777191|594716710|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
164642864|NCT01777191|594716709|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
164642865|NCT01777191|594716710|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
164642866|NCT01777191|594716709|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
164642867|NCT01777191|594716710|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
164642868|NCT01777191|594716709|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
164642869|NCT01777191|594716710|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
164642870|NCT01777191|594716709|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
164642871|NCT01777191|594716710|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
164642872|NCT01777191|594716709|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
164642873|NCT01777191|594716710|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
164642874|NCT01777191|594716709|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
164642875|NCT01777191|594716710|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
164642876|NCT01777191|594716709|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
164642877|NCT01777191|594716710|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
164642878|NCT01777191|594716709|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
164642879|NCT01777191|594716710|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
164642880|NCT01461369|594716711|FG000|Overall Study|Lack of Efficacy|2|||
164642881|NCT01461369|594716712|FG001|Overall Study|Lack of Efficacy|0|||
164642882|NCT01461369|594716713|FG002|Overall Study|Lack of Efficacy|6|||
164642883|NCT01461369|594716711|FG000|Overall Study|Lost to Follow-up|0|||
164642884|NCT01461369|594716712|FG001|Overall Study|Lost to Follow-up|0|||
164642885|NCT01461369|594716713|FG002|Overall Study|Lost to Follow-up|3|||
164642886|NCT01461369|594716711|FG000|Overall Study|Adverse Event|9|||
164642887|NCT01461369|594716712|FG001|Overall Study|Adverse Event|12|||
164642888|NCT01461369|594716713|FG002|Overall Study|Adverse Event|4|||
164642889|NCT01461369|594716711|FG000|Overall Study|Protocol Violation|1|||
164642890|NCT01461369|594716712|FG001|Overall Study|Protocol Violation|2|||
164642891|NCT01461369|594716713|FG002|Overall Study|Protocol Violation|2|||
164642892|NCT01461369|594716711|FG000|Overall Study|Withdrawal by Subject|1|||
164642893|NCT01461369|594716712|FG001|Overall Study|Withdrawal by Subject|3|||
164642894|NCT01461369|594716713|FG002|Overall Study|Withdrawal by Subject|2|||
164642895|NCT00734617|594716716|FG000|Overall Study|Adverse Event|4|||
164642896|NCT00734617|594716717|FG001|Overall Study|Adverse Event|7|||
164642897|NCT00734617|594716716|FG000|Overall Study|Withdrawal by Subject|103|||
164642898|NCT00734617|594716717|FG001|Overall Study|Withdrawal by Subject|95|||
164642899|NCT00568776|594716720|FG000|Overall Study|Adverse Event|8|||
164642900|NCT00568776|594716721|FG001|Overall Study|Adverse Event|8|||
164642901|NCT00568776|594716722|FG002|Overall Study|Adverse Event|10|||
164642902|NCT00568776|594716723|FG003|Overall Study|Adverse Event|8|||
164642903|NCT00568776|594716720|FG000|Overall Study|Death|0|||
164642904|NCT00568776|594716721|FG001|Overall Study|Death|1|||
164642905|NCT00568776|594716722|FG002|Overall Study|Death|4|||
164642906|NCT00568776|594716723|FG003|Overall Study|Death|3|||
164642907|NCT00568776|594716720|FG000|Overall Study|Physician Decision|0|||
164642908|NCT00568776|594716721|FG001|Overall Study|Physician Decision|2|||
164642909|NCT00568776|594716722|FG002|Overall Study|Physician Decision|0|||
164642910|NCT00568776|594716723|FG003|Overall Study|Physician Decision|0|||
164642911|NCT00568776|594716720|FG000|Overall Study|Lack of Efficacy|2|||
164642912|NCT00568776|594716721|FG001|Overall Study|Lack of Efficacy|2|||
164642913|NCT00568776|594716722|FG002|Overall Study|Lack of Efficacy|2|||
164642914|NCT00568776|594716723|FG003|Overall Study|Lack of Efficacy|4|||
164642915|NCT00568776|594716720|FG000|Overall Study|Lost to Follow-up|1|||
164642916|NCT00568776|594716721|FG001|Overall Study|Lost to Follow-up|1|||
164642917|NCT00568776|594716722|FG002|Overall Study|Lost to Follow-up|1|||
164642918|NCT00568776|594716723|FG003|Overall Study|Lost to Follow-up|1|||
164642919|NCT00568776|594716720|FG000|Overall Study|Protocol Violation|1|||
164642920|NCT00568776|594716721|FG001|Overall Study|Protocol Violation|0|||
164642921|NCT00568776|594716722|FG002|Overall Study|Protocol Violation|1|||
164642922|NCT00568776|594716723|FG003|Overall Study|Protocol Violation|1|||
164642923|NCT00568776|594716720|FG000|Overall Study|Withdrawal by Subject|13|||
164642924|NCT00568776|594716721|FG001|Overall Study|Withdrawal by Subject|15|||
164642925|NCT00568776|594716722|FG002|Overall Study|Withdrawal by Subject|13|||
164642926|NCT00568776|594716723|FG003|Overall Study|Withdrawal by Subject|7|||
164642927|NCT00568776|594716720|FG000|Overall Study|Loss of Caregiver|0|||
164642928|NCT00568776|594716721|FG001|Overall Study|Loss of Caregiver|2|||
164642929|NCT00568776|594716722|FG002|Overall Study|Loss of Caregiver|1|||
164642930|NCT00568776|594716723|FG003|Overall Study|Loss of Caregiver|2|||
164642931|NCT00568776|594716720|FG000|Overall Study|Sponsor Decision|2|||
164642932|NCT00568776|594716721|FG001|Overall Study|Sponsor Decision|2|||
164642933|NCT00568776|594716722|FG002|Overall Study|Sponsor Decision|41|||
164642934|NCT00568776|594716723|FG003|Overall Study|Sponsor Decision|42|||
164642935|NCT00568776|594716720|FG000|Overall Study|Miscellaeneous|3|||
164642936|NCT00568776|594716721|FG001|Overall Study|Miscellaeneous|3|||
164642937|NCT00568776|594716722|FG002|Overall Study|Miscellaeneous|1|||
164642938|NCT00568776|594716723|FG003|Overall Study|Miscellaeneous|4|||
164642939|NCT03692078|594716724|FG000|Overall Study|Adverse Event|0|||
164642940|NCT03692078|594716725|FG001|Overall Study|Adverse Event|0|||
164642941|NCT03692078|594716726|FG002|Overall Study|Adverse Event|0|||
164642942|NCT03692078|594716727|FG003|Overall Study|Adverse Event|0|||
164642943|NCT03692078|594716728|FG004|Overall Study|Adverse Event|0|||
164642944|NCT03692078|594716729|FG005|Overall Study|Adverse Event|1|||
164642945|NCT03692078|594716730|FG006|Overall Study|Adverse Event|0|||
164642946|NCT03692078|594716724|FG000|Overall Study|Enrollment Closed|5|||
164642947|NCT03692078|594716725|FG001|Overall Study|Enrollment Closed|0|||
164642948|NCT03692078|594716726|FG002|Overall Study|Enrollment Closed|0|||
164642949|NCT03692078|594716727|FG003|Overall Study|Enrollment Closed|0|||
164642950|NCT03692078|594716728|FG004|Overall Study|Enrollment Closed|0|||
164642951|NCT03692078|594716729|FG005|Overall Study|Enrollment Closed|0|||
164642952|NCT03692078|594716730|FG006|Overall Study|Enrollment Closed|0|||
164642953|NCT03692078|594716724|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
164642954|NCT03692078|594716725|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
164642955|NCT03692078|594716726|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
164642956|NCT03692078|594716727|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
164642957|NCT03692078|594716728|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
164642958|NCT03692078|594716729|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
164642959|NCT03692078|594716730|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
164642960|NCT03692078|594716724|FG000|Overall Study|Withdrawal by Subject|0|||
164642961|NCT03692078|594716725|FG001|Overall Study|Withdrawal by Subject|2|||
164642962|NCT03692078|594716726|FG002|Overall Study|Withdrawal by Subject|0|||
164642963|NCT03692078|594716727|FG003|Overall Study|Withdrawal by Subject|1|||
164642964|NCT03692078|594716728|FG004|Overall Study|Withdrawal by Subject|5|||
164642965|NCT03692078|594716729|FG005|Overall Study|Withdrawal by Subject|3|||
164642966|NCT03692078|594716730|FG006|Overall Study|Withdrawal by Subject|3|||
164642967|NCT01615822|594716736|FG000|Period 1|Withdrawal by Subject|0|||
164642968|NCT01615822|594716737|FG001|Period 1|Withdrawal by Subject|1|||
164642969|NCT01615822|594716738|FG002|Period 1|Withdrawal by Subject|0|||
164642970|NCT01615822|594716736|FG000|Period 1|Adverse Event|1|||
164642971|NCT01615822|594716737|FG001|Period 1|Adverse Event|1|||
164642972|NCT01615822|594716738|FG002|Period 1|Adverse Event|0|||
164642973|NCT01615822|594716736|FG000|Period 2|Lost to Follow-up|0|||
164642974|NCT01615822|594716737|FG001|Period 2|Lost to Follow-up|1|||
164642975|NCT01615822|594716738|FG002|Period 2|Lost to Follow-up|2|||
164642976|NCT02861534|594716739|FG000|Overall Study|Death|541|||
164642977|NCT02861534|594716740|FG001|Overall Study|Death|552|||
164642978|NCT02861534|594716739|FG000|Overall Study|Lost to Follow-up|14|||
164642979|NCT02861534|594716740|FG001|Overall Study|Lost to Follow-up|14|||
164642980|NCT02861534|594716739|FG000|Overall Study|Site Terminated by Sponsor|4|||
164642981|NCT02861534|594716740|FG001|Overall Study|Site Terminated by Sponsor|3|||
164642982|NCT02861534|594716739|FG000|Overall Study|Withdrawal by Subject|15|||
164642983|NCT02861534|594716740|FG001|Overall Study|Withdrawal by Subject|18|||
164642984|NCT02886494|594716741|FG000|Overall Study|Adverse Event|1|||
164642985|NCT02886494|594716742|FG001|Overall Study|Adverse Event|0|||
164642986|NCT02886494|594716741|FG000|Overall Study|Withdrawal by Subject|12|||
164642987|NCT02886494|594716742|FG001|Overall Study|Withdrawal by Subject|3|||
164642988|NCT02886494|594716741|FG000|Overall Study|Protocol Violation|4|||
164642989|NCT02886494|594716742|FG001|Overall Study|Protocol Violation|1|||
164642990|NCT00769132|594716746|FG000|Period 1|Adverse Event|1|||
164642991|NCT00769132|594716747|FG001|Period 1|Adverse Event|0|||
164642992|NCT00769132|594716748|FG002|Period 1|Adverse Event|0|||
164642993|NCT00769132|594716749|FG003|Period 1|Adverse Event|1|||
164642994|NCT00769132|594716746|FG000|Period 2|Withdrawal by Subject|0|||
164642995|NCT00769132|594716747|FG001|Period 2|Withdrawal by Subject|0|||
164642996|NCT00769132|594716748|FG002|Period 2|Withdrawal by Subject|0|||
164642997|NCT00769132|594716749|FG003|Period 2|Withdrawal by Subject|1|||
164642998|NCT00769132|594716746|FG000|Period 3|Withdrawal by Subject|1|||
164642999|NCT00769132|594716747|FG001|Period 3|Withdrawal by Subject|0|||
164643000|NCT00769132|594716748|FG002|Period 3|Withdrawal by Subject|0|||
164643001|NCT00769132|594716749|FG003|Period 3|Withdrawal by Subject|0|||
164643002|NCT00769132|594716746|FG000|Period 4|Withdrawal by Subject|0|||
164643003|NCT00769132|594716747|FG001|Period 4|Withdrawal by Subject|1|||
164643004|NCT00769132|594716748|FG002|Period 4|Withdrawal by Subject|0|||
164643005|NCT00769132|594716749|FG003|Period 4|Withdrawal by Subject|0|||
164643006|NCT00566631|594716750|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
164643007|NCT00566631|594716750|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
164643008|NCT00566631|594716750|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
164643009|NCT00566631|594716750|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
164643010|NCT00566631|594716750|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
164643011|NCT00566631|594716750|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
164643012|NCT00566631|594716750|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
164643013|NCT00566631|594716750|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
164643014|NCT00566631|594716750|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
164643015|NCT00566631|594716750|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
164643016|NCT00566631|594716750|FG000|Part 2: Extension Phase|Adverse Event|11|||
164643017|NCT00566631|594716750|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
164643018|NCT00566631|594716750|FG000|Part 2: Extension Phase|Death|1|||
164643019|NCT00566631|594716750|FG000|Part 2: Extension Phase|Other|5|||
164643020|NCT00537056|594716755|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
164643021|NCT00244881|594716761|FG000|Overall Study|Withdrawal by Subject|3|||
164643022|NCT01060007|594716765|FG000|Overall Study|Withdrawal by Subject|1|||
164643023|NCT01060007|594716765|FG000|Overall Study|Inevaluable for response at surgery|3|||
164643024|NCT00445458|594716766|FG000|Overall Study|Disease Progression|3|||
164643025|NCT00445458|594716767|FG001|Overall Study|Disease Progression|4|||
164643026|NCT00445458|594716768|FG002|Overall Study|Disease Progression|54|||
164643027|NCT00445458|594716769|FG003|Overall Study|Disease Progression|27|||
164643028|NCT00445458|594716766|FG000|Overall Study|Withdrawal by Subject|0|||
164643029|NCT00445458|594716767|FG001|Overall Study|Withdrawal by Subject|0|||
164643030|NCT00445458|594716768|FG002|Overall Study|Withdrawal by Subject|7|||
164643031|NCT00445458|594716769|FG003|Overall Study|Withdrawal by Subject|0|||
164643032|NCT00445458|594716766|FG000|Overall Study|Adverse Event|0|||
164643033|NCT00445458|594716767|FG001|Overall Study|Adverse Event|0|||
164643034|NCT00445458|594716768|FG002|Overall Study|Adverse Event|3|||
164643035|NCT00445458|594716769|FG003|Overall Study|Adverse Event|0|||
164643036|NCT00445458|594716766|FG000|Overall Study|Death|0|||
164643037|NCT00445458|594716767|FG001|Overall Study|Death|1|||
164643038|NCT00445458|594716768|FG002|Overall Study|Death|2|||
164643039|NCT00445458|594716769|FG003|Overall Study|Death|0|||
164643040|NCT00445458|594716766|FG000|Overall Study|Physician Decision|0|||
164643041|NCT00445458|594716767|FG001|Overall Study|Physician Decision|0|||
164643042|NCT00445458|594716768|FG002|Overall Study|Physician Decision|1|||
164643043|NCT00445458|594716769|FG003|Overall Study|Physician Decision|1|||
164643044|NCT00445458|594716766|FG000|Overall Study|Surgery|0|||
164643045|NCT00445458|594716767|FG001|Overall Study|Surgery|0|||
164643046|NCT00445458|594716768|FG002|Overall Study|Surgery|1|||
164643047|NCT00445458|594716769|FG003|Overall Study|Surgery|0|||
164643048|NCT01393626|594716774|FG000|Overall Study|Adverse Event|2|||
164643049|NCT01393626|594716775|FG001|Overall Study|Adverse Event|1|||
164643050|NCT01393626|594716776|FG002|Overall Study|Adverse Event|5|||
164643051|NCT01393626|594716777|FG003|Overall Study|Adverse Event|0|||
164643052|NCT01393626|594716774|FG000|Overall Study|Did not meet entrance criteria|1|||
164643053|NCT01393626|594716775|FG001|Overall Study|Did not meet entrance criteria|0|||
164643054|NCT01393626|594716776|FG002|Overall Study|Did not meet entrance criteria|0|||
164643055|NCT01393626|594716777|FG003|Overall Study|Did not meet entrance criteria|0|||
164643056|NCT01393626|594716774|FG000|Overall Study|Lack of Efficacy|6|||
164643057|NCT01393626|594716775|FG001|Overall Study|Lack of Efficacy|6|||
164643058|NCT01393626|594716776|FG002|Overall Study|Lack of Efficacy|4|||
164643059|NCT01393626|594716777|FG003|Overall Study|Lack of Efficacy|1|||
164643060|NCT01393626|594716774|FG000|Overall Study|Lost to Follow-up|1|||
164643061|NCT01393626|594716775|FG001|Overall Study|Lost to Follow-up|1|||
164643062|NCT01393626|594716776|FG002|Overall Study|Lost to Follow-up|1|||
164643063|NCT01393626|594716777|FG003|Overall Study|Lost to Follow-up|0|||
164643064|NCT01393626|594716774|FG000|Overall Study|Withdrawal by Subject|6|||
164643065|NCT01393626|594716775|FG001|Overall Study|Withdrawal by Subject|4|||
164643066|NCT01393626|594716776|FG002|Overall Study|Withdrawal by Subject|0|||
164643067|NCT01393626|594716777|FG003|Overall Study|Withdrawal by Subject|0|||
164643068|NCT01393626|594716774|FG000|Overall Study|Other|1|||
164643069|NCT01393626|594716775|FG001|Overall Study|Other|0|||
164643070|NCT01393626|594716776|FG002|Overall Study|Other|0|||
164643071|NCT01393626|594716777|FG003|Overall Study|Other|0|||
164643072|NCT01393626|594716774|FG000|Overall Study|Protocol Violation|1|||
164643073|NCT01393626|594716775|FG001|Overall Study|Protocol Violation|0|||
164643074|NCT01393626|594716776|FG002|Overall Study|Protocol Violation|2|||
164643075|NCT01393626|594716777|FG003|Overall Study|Protocol Violation|0|||
164643076|NCT02426125|594716778|FG000|Overall Study|Lost to Follow-up|14|||
164643077|NCT02426125|594716779|FG001|Overall Study|Lost to Follow-up|12|||
164643078|NCT02426125|594716778|FG000|Overall Study|Withdrawal by Subject|13|||
164643079|NCT02426125|594716779|FG001|Overall Study|Withdrawal by Subject|14|||
164643080|NCT02426125|594716778|FG000|Overall Study|Death|185|||
164643081|NCT02426125|594716779|FG001|Overall Study|Death|200|||
164643082|NCT02426125|594716778|FG000|Overall Study|Randomized, But Never Treated|5|||
164643083|NCT02426125|594716779|FG001|Overall Study|Randomized, But Never Treated|2|||
164643084|NCT00077766|594716782|FG000|Overall Study|Adverse Event|1|||
164643085|NCT00077766|594716783|FG001|Overall Study|Adverse Event|1|||
164643086|NCT00077766|594716782|FG000|Overall Study|Withdrawal by Subject|4|||
164643087|NCT00077766|594716783|FG001|Overall Study|Withdrawal by Subject|3|||
164643088|NCT00077766|594716782|FG000|Overall Study|Death|12|||
164531998|NCT00427895|594318961|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
164531999|NCT00427895|594318962|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
164532000|NCT00427895|594318963|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
164532001|NCT00427895|594318956|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
164532002|NCT00427895|594318957|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
164532003|NCT00427895|594318958|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
164532004|NCT00427895|594318959|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
164532005|NCT00427895|594318960|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
164532006|NCT00427895|594318961|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
164532007|NCT00427895|594318962|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
164532008|NCT00427895|594318963|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
164643089|NCT00077766|594716783|FG001|Overall Study|Death|10|||
164643090|NCT00077766|594716782|FG000|Overall Study|Lost to Follow-up|2|||
164643091|NCT00077766|594716783|FG001|Overall Study|Lost to Follow-up|0|||
164643092|NCT00077766|594716782|FG000|Overall Study|Protocol Violation|1|||
164643093|NCT00077766|594716783|FG001|Overall Study|Protocol Violation|0|||
164643094|NCT00077766|594716782|FG000|Overall Study|Kidney Transplantation|9|||
164643095|NCT00077766|594716783|FG001|Overall Study|Kidney Transplantation|5|||
164643096|NCT00077766|594716782|FG000|Overall Study|Transplantation|5|||
164643097|NCT00077766|594716783|FG001|Overall Study|Transplantation|1|||
164643098|NCT00077766|594716782|FG000|Overall Study|Investigators Discretion|1|||
164643099|NCT00077766|594716783|FG001|Overall Study|Investigators Discretion|0|||
164643100|NCT00077766|594716782|FG000|Overall Study|Participant's decision|1|||
164643101|NCT00077766|594716783|FG001|Overall Study|Participant's decision|0|||
164532009|NCT00427895|594318956|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
164532010|NCT00427895|594318957|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
164532011|NCT00427895|594318958|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
164532012|NCT00427895|594318959|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
164532013|NCT00427895|594318960|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
164532014|NCT00427895|594318961|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
164532015|NCT00427895|594318962|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
164532016|NCT00427895|594318963|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
164532017|NCT00427895|594318956|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
164532018|NCT00427895|594318957|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
164532019|NCT00427895|594318958|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
164532020|NCT00427895|594318959|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
164532021|NCT00427895|594318960|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
164532022|NCT00427895|594318961|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
164532023|NCT00427895|594318962|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
164532024|NCT00427895|594318963|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
164532025|NCT00427895|594318956|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
164532026|NCT00427895|594318957|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
164532027|NCT00427895|594318958|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
164532028|NCT00427895|594318959|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
164532029|NCT00427895|594318960|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
164532030|NCT00427895|594318961|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
164532031|NCT00427895|594318962|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
164532032|NCT00427895|594318963|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
164532033|NCT00427895|594318956|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
164532034|NCT00427895|594318957|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
164532035|NCT00427895|594318958|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
164532036|NCT00427895|594318959|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
164532037|NCT00427895|594318960|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
164532038|NCT00427895|594318961|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
164532039|NCT00427895|594318962|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
164532040|NCT00427895|594318963|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
164532041|NCT00427895|594318956|FG000|Vax 1/Year 1 Follow-up|Death|1|||
164532042|NCT00427895|594318957|FG001|Vax 1/Year 1 Follow-up|Death|0|||
164532043|NCT00427895|594318958|FG002|Vax 1/Year 1 Follow-up|Death|0|||
164532044|NCT00427895|594318959|FG003|Vax 1/Year 1 Follow-up|Death|0|||
164532045|NCT00427895|594318960|FG004|Vax 1/Year 1 Follow-up|Death|0|||
164532046|NCT00427895|594318961|FG005|Vax 1/Year 1 Follow-up|Death|0|||
164532047|NCT00427895|594318962|FG006|Vax 1/Year 1 Follow-up|Death|0|||
164532048|NCT00427895|594318963|FG007|Vax 1/Year 1 Follow-up|Death|0|||
164532049|NCT00427895|594318956|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
164532050|NCT00427895|594318957|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
164643102|NCT00077766|594716782|FG000|Overall Study|Dialysis Discontinued|1|||
164643103|NCT00077766|594716783|FG001|Overall Study|Dialysis Discontinued|0|||
164643104|NCT00077766|594716782|FG000|Overall Study|Dialysis|0|||
164643105|NCT00077766|594716783|FG001|Overall Study|Dialysis|1|||
164643106|NCT00077766|594716782|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
164532051|NCT00427895|594318958|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
164532052|NCT00427895|594318959|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
164643107|NCT00077766|594716783|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
164643108|NCT00077766|594716782|FG000|Overall Study|Started Nocturnal Dialysis|0|||
164643109|NCT00077766|594716783|FG001|Overall Study|Started Nocturnal Dialysis|1|||
164643110|NCT00077766|594716782|FG000|Overall Study|Stop Dialysis|0|||
164643111|NCT00077766|594716783|FG001|Overall Study|Stop Dialysis|1|||
164643112|NCT00077766|594716782|FG000|Overall Study|Participants Vacation|2|||
164643113|NCT00077766|594716783|FG001|Overall Study|Participants Vacation|1|||
164643114|NCT00938015|594716784|FG000|Overall Study|Death|2|||
164643115|NCT00938015|594716784|FG000|Overall Study|Lost to Follow-up|32|||
164643116|NCT00938015|594716784|FG000|Overall Study|Adverse Event|32|||
164643117|NCT00938015|594716784|FG000|Overall Study|Non-responder|52|||
164643118|NCT00938015|594716784|FG000|Overall Study|Reason not related to Etanercept|29|||
164643119|NCT03186794|594716785|FG000|Overall Study|Physician Decision|2|||
164643120|NCT03186794|594716785|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
164643121|NCT02057549|594716787|FG000|Overall Study|Lost to Follow-up|1|||
164643122|NCT02057549|594716788|FG001|Overall Study|Lost to Follow-up|0|||
164643123|NCT02057549|594716787|FG000|Overall Study|Physician Decision|1|||
164643124|NCT02057549|594716788|FG001|Overall Study|Physician Decision|0|||
164643125|NCT02057549|594716787|FG000|Overall Study|Withdrawal by Subject|1|||
164643126|NCT02057549|594716788|FG001|Overall Study|Withdrawal by Subject|0|||
164643127|NCT01418365|594716791|FG000|First Intervention|Withdrawal by Subject|0|||
164643128|NCT01418365|594716792|FG001|First Intervention|Withdrawal by Subject|1|||
164643129|NCT01418365|594716791|FG000|First Intervention|Non-compliance|1|||
164643130|NCT01418365|594716792|FG001|First Intervention|Non-compliance|0|||
164643131|NCT01418365|594716791|FG000|Second Intervention|Withdrawal by Subject|0|||
164532053|NCT00427895|594318960|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
164532054|NCT00427895|594318961|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
164532055|NCT00427895|594318962|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
164532056|NCT00427895|594318963|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
164532057|NCT00427895|594318956|FG000|Vax 1/Year 1 Follow-up|Other|0|||
164532058|NCT00427895|594318957|FG001|Vax 1/Year 1 Follow-up|Other|0|||
164532059|NCT00427895|594318958|FG002|Vax 1/Year 1 Follow-up|Other|0|||
164643132|NCT01418365|594716792|FG001|Second Intervention|Withdrawal by Subject|1|||
164643133|NCT02575807|594716797|FG000|Overall Study|Death|8|||
164643134|NCT02575807|594716798|FG001|Overall Study|Death|3|||
164643135|NCT02575807|594716799|FG002|Overall Study|Death|7|||
164643136|NCT02575807|594716800|FG003|Overall Study|Death|0|||
164643137|NCT02575807|594716801|FG004|Overall Study|Death|1|||
164643138|NCT02575807|594716797|FG000|Overall Study|Study terminated by Sponsor|0|||
164532060|NCT00427895|594318959|FG003|Vax 1/Year 1 Follow-up|Other|2|||
164532061|NCT00427895|594318960|FG004|Vax 1/Year 1 Follow-up|Other|0|||
164643139|NCT02575807|594716798|FG001|Overall Study|Study terminated by Sponsor|1|||
164643140|NCT02575807|594716799|FG002|Overall Study|Study terminated by Sponsor|7|||
164532062|NCT00427895|594318961|FG005|Vax 1/Year 1 Follow-up|Other|0|||
164532063|NCT00427895|594318962|FG006|Vax 1/Year 1 Follow-up|Other|0|||
164532064|NCT00427895|594318963|FG007|Vax 1/Year 1 Follow-up|Other|0|||
164532065|NCT00427895|594318956|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
164532066|NCT00427895|594318957|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
164532067|NCT00427895|594318958|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
164643141|NCT02575807|594716800|FG003|Overall Study|Study terminated by Sponsor|0|||
164643142|NCT02575807|594716801|FG004|Overall Study|Study terminated by Sponsor|1|||
164643143|NCT02575807|594716797|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
164643144|NCT02575807|594716798|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
164643145|NCT02575807|594716799|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
164532068|NCT00427895|594318959|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
164532069|NCT00427895|594318960|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
164532070|NCT00427895|594318961|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
164532071|NCT00427895|594318962|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
164532072|NCT00427895|594318963|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
164532073|NCT02796560|594318971|FG000|Overall Study|Adverse Event|2|||
164532074|NCT02796560|594318972|FG001|Overall Study|Adverse Event|0|||
164532075|NCT02796560|594318971|FG000|Overall Study|Withdrawal by Subject|2|||
164532076|NCT02796560|594318972|FG001|Overall Study|Withdrawal by Subject|2|||
164532077|NCT03816332|594318974|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
164532078|NCT03816332|594318974|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
164643146|NCT02575807|594716800|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
164643147|NCT02575807|594716801|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
164643148|NCT02575807|594716797|FG000|Overall Study|Terminated due to physician decision|0|||
164643149|NCT02575807|594716798|FG001|Overall Study|Terminated due to physician decision|0|||
164643150|NCT02575807|594716799|FG002|Overall Study|Terminated due to physician decision|1|||
164643151|NCT02575807|594716800|FG003|Overall Study|Terminated due to physician decision|0|||
164532079|NCT05330312|594318975|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
164532080|NCT05330312|594318976|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
164532081|NCT05330312|594318977|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
164532082|NCT05330312|594318975|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
164532083|NCT05330312|594318976|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
164532084|NCT05330312|594318977|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
164532085|NCT05330312|594318975|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
164532086|NCT05330312|594318976|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
164532087|NCT05330312|594318977|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
164532088|NCT05330312|594318975|FG000|Pivotal Investigation - Part 2|Death|1|||
164532089|NCT05330312|594318976|FG001|Pivotal Investigation - Part 2|Death|4|||
164532090|NCT05330312|594318977|FG002|Pivotal Investigation - Part 2|Death|0|||
164532091|NCT03534284|594318978|FG000|Overall Study|Death|2|||
164532092|NCT03534284|594318979|FG001|Overall Study|Death|3|||
164532093|NCT03534284|594318980|FG002|Overall Study|Death|3|||
164532094|NCT03534284|594318978|FG000|Overall Study|Withdrawal by Subject|5|||
164532095|NCT03534284|594318979|FG001|Overall Study|Withdrawal by Subject|0|||
164532096|NCT03534284|594318980|FG002|Overall Study|Withdrawal by Subject|0|||
164532097|NCT03316300|594318981|FG000|Overall Study|Withdrawal by Subject|3|||
164532098|NCT03316300|594318982|FG001|Overall Study|Withdrawal by Subject|2|||
164532099|NCT03316300|594318981|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
164532100|NCT03316300|594318982|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
164532101|NCT03316300|594318981|FG000|Overall Study|Adverse Event|1|||
164532102|NCT03316300|594318982|FG001|Overall Study|Adverse Event|0|||
164532103|NCT03316300|594318981|FG000|Overall Study|COVID-19|0|||
164532104|NCT03316300|594318982|FG001|Overall Study|COVID-19|1|||
164532105|NCT03164564|594318984|FG000|Overall Study|Death|3|||
164532106|NCT03164564|594318985|FG001|Overall Study|Death|0|||
164532107|NCT03164564|594318984|FG000|Overall Study|Withdrawal by Subject|20|||
164532108|NCT03164564|594318985|FG001|Overall Study|Withdrawal by Subject|15|||
164532109|NCT03164564|594318984|FG000|Overall Study|Lost to Follow-up|2|||
164532110|NCT03164564|594318985|FG001|Overall Study|Lost to Follow-up|0|||
164532111|NCT03164564|594318984|FG000|Overall Study|Physician Decision|0|||
164532112|NCT03164564|594318985|FG001|Overall Study|Physician Decision|1|||
164532113|NCT03164564|594318984|FG000|Overall Study|Adverse Event|0|||
164532114|NCT03164564|594318985|FG001|Overall Study|Adverse Event|1|||
164532115|NCT03164564|594318984|FG000|Overall Study|Ongoing|1586|||
164532116|NCT03164564|594318985|FG001|Overall Study|Ongoing|1586|||
164532117|NCT00423930|594318986|FG000|Overall Study|Withdrawal by Subject|2|||
164532118|NCT04002401|594318987|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
164532119|NCT04002401|594318987|FG000|Overall Study|Death|10|||
164532120|NCT04002401|594318987|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
164532121|NCT04002401|594318987|FG000|Overall Study|Enrolled but Never Treated|1|||
164532122|NCT04002401|594318987|FG000|Overall Study|Lost to Follow-up|1|||
164532123|NCT02881957|594318988|FG000|Overall Study|Comfort care|0|||
164532124|NCT02881957|594318989|FG001|Overall Study|Comfort care|1|||
164532125|NCT02881957|594318988|FG000|Overall Study|Concurrent trial enrollment|0|||
164532126|NCT02881957|594318989|FG001|Overall Study|Concurrent trial enrollment|1|||
164532127|NCT02881957|594318988|FG000|Overall Study|Discharged within 48 hours|0|||
164532128|NCT02881957|594318989|FG001|Overall Study|Discharged within 48 hours|1|||
164532129|NCT02881957|594318988|FG000|Overall Study|Withdrawal by Subject|2|||
164532130|NCT02881957|594318989|FG001|Overall Study|Withdrawal by Subject|1|||
164532131|NCT02881957|594318988|FG000|Overall Study|Protocol Violation|1|||
164532132|NCT02881957|594318989|FG001|Overall Study|Protocol Violation|0|||
164643152|NCT02575807|594716801|FG004|Overall Study|Terminated due to physician decision|0|||
164643153|NCT02575807|594716797|FG000|Overall Study|Subject ineligible - medical implant|0|||
164643154|NCT02575807|594716798|FG001|Overall Study|Subject ineligible - medical implant|0|||
164532133|NCT05269355|594318995|FG000|Overall Study|Progressive Disease|104|||
164532134|NCT05269355|594318996|FG001|Overall Study|Progressive Disease|68|||
164532135|NCT05269355|594318995|FG000|Overall Study|Study Terminated by Sponsor|87|||
164532136|NCT05269355|594318996|FG001|Overall Study|Study Terminated by Sponsor|29|||
164532137|NCT05269355|594318995|FG000|Overall Study|Adverse Event|15|||
164532138|NCT05269355|594318996|FG001|Overall Study|Adverse Event|8|||
164532139|NCT05269355|594318995|FG000|Overall Study|Withdrawal by Subject|18|||
164532140|NCT05269355|594318996|FG001|Overall Study|Withdrawal by Subject|5|||
164532141|NCT05269355|594318995|FG000|Overall Study|Physician Decision|6|||
164532142|NCT05269355|594318996|FG001|Overall Study|Physician Decision|4|||
164532143|NCT05269355|594318995|FG000|Overall Study|Death|3|||
164532144|NCT05269355|594318996|FG001|Overall Study|Death|5|||
164532145|NCT05269355|594318995|FG000|Overall Study|Other Than Specified|5|||
164532146|NCT05269355|594318996|FG001|Overall Study|Other Than Specified|1|||
164643155|NCT02575807|594716799|FG002|Overall Study|Subject ineligible - medical implant|0|||
164643156|NCT02575807|594716800|FG003|Overall Study|Subject ineligible - medical implant|1|||
164643157|NCT02575807|594716801|FG004|Overall Study|Subject ineligible - medical implant|0|||
164532147|NCT05269355|594318995|FG000|Overall Study|Randomized But Not Treated|1|||
164532148|NCT05269355|594318996|FG001|Overall Study|Randomized But Not Treated|0|||
164532149|NCT01050790|594318997|FG000|Overall Study|Adverse Event|1|||
164532150|NCT03705832|594318998|FG000|Overall Study|Physician Decision|0|||
164532151|NCT03705832|594318999|FG001|Overall Study|Physician Decision|1|||
164532152|NCT03705832|594318998|FG000|Overall Study|Withdrawal by Subject|1|||
164532153|NCT03705832|594318999|FG001|Overall Study|Withdrawal by Subject|0|||
164532154|NCT01880528|594319000|FG000|Overall Study|Other|1|||
164532155|NCT01880528|594319001|FG001|Overall Study|Other|1|||
164532156|NCT00081497|594319002|FG000|Overall Study|Adverse Event|2|||
164532157|NCT00081497|594319003|FG001|Overall Study|Adverse Event|0|||
164532158|NCT00081497|594319002|FG000|Overall Study|Death|0|||
164532159|NCT00081497|594319003|FG001|Overall Study|Death|1|||
164532160|NCT00081497|594319002|FG000|Overall Study|Withdrawal by Subject|1|||
164532161|NCT00081497|594319003|FG001|Overall Study|Withdrawal by Subject|0|||
164532162|NCT00081497|594319002|FG000|Overall Study|Non-compliance|0|||
164532163|NCT00081497|594319003|FG001|Overall Study|Non-compliance|1|||
164532164|NCT01439360|594319004|FG000|Overall Study|Adverse Event|4|||
164532165|NCT01439360|594319005|FG001|Overall Study|Adverse Event|16|||
164532166|NCT01439360|594319004|FG000|Overall Study|Lost to Follow-up|43|||
164532167|NCT01439360|594319005|FG001|Overall Study|Lost to Follow-up|58|||
164532168|NCT01439360|594319004|FG000|Overall Study|Others|10|||
164532169|NCT01439360|594319005|FG001|Overall Study|Others|5|||
164532170|NCT01439360|594319004|FG000|Overall Study|Protocol Violation|1|||
164532171|NCT01439360|594319005|FG001|Overall Study|Protocol Violation|0|||
164532172|NCT01439360|594319004|FG000|Overall Study|Withdrawal by Subject|140|||
164532173|NCT01439360|594319005|FG001|Overall Study|Withdrawal by Subject|129|||
164532174|NCT02390245|594319007|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
164532175|NCT02390245|594319008|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
164532176|NCT02390245|594319009|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
164532177|NCT02390245|594319007|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
164532178|NCT02390245|594319008|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
164532179|NCT02390245|594319009|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
164532180|NCT01929980|594320489|FG000|Overall Study|Physician Decision|1|||
164532181|NCT05580588|594320490|FG000|Overall Study|Lack of Efficacy|12|||
164532182|NCT00756470|594320493|FG000|Overall Study|Withdrawal by Subject|1|||
164532183|NCT00756470|594320493|FG000|Overall Study|Adverse Event|4|||
164532184|NCT00892723|594320494|FG000|Overall Study|Lost to Follow-up|1|||
164532185|NCT00892723|594320495|FG001|Overall Study|Lost to Follow-up|3|||
164532186|NCT00892723|594320496|FG002|Overall Study|Lost to Follow-up|1|||
164532187|NCT00892723|594320494|FG000|Overall Study|Withdrawal by Subject|1|||
164532188|NCT00892723|594320495|FG001|Overall Study|Withdrawal by Subject|1|||
164532189|NCT00892723|594320496|FG002|Overall Study|Withdrawal by Subject|1|||
164532190|NCT00150969|594320499|FG000|24 Month Main Study|Adverse Event|3|||
164643158|NCT02575807|594716797|FG000|Overall Study|Withdrawal by Subject|0|||
164643159|NCT02575807|594716798|FG001|Overall Study|Withdrawal by Subject|0|||
164643160|NCT02575807|594716799|FG002|Overall Study|Withdrawal by Subject|1|||
164643161|NCT02575807|594716800|FG003|Overall Study|Withdrawal by Subject|1|||
164643162|NCT02575807|594716801|FG004|Overall Study|Withdrawal by Subject|2|||
164643163|NCT03319368|594716802|FG000|Overall Study|Discharge swabs not collected from resident|57|||
164643164|NCT03319368|594716803|FG001|Overall Study|Discharge swabs not collected from resident|46|||
164643165|NCT02180659|594716806|FG000|Overall Study|Adverse Event|1|||
164643166|NCT02180659|594716807|FG001|Overall Study|Adverse Event|0|||
164643167|NCT02180659|594716806|FG000|Overall Study|Lost to Follow-up|4|||
164643168|NCT02180659|594716807|FG001|Overall Study|Lost to Follow-up|2|||
164643169|NCT02180659|594716806|FG000|Overall Study|Subject incarcerated during conduct|1|||
164643170|NCT02180659|594716807|FG001|Overall Study|Subject incarcerated during conduct|0|||
164643171|NCT02180659|594716806|FG000|Overall Study|Withdrawal by Subject|0|||
164643172|NCT02180659|594716807|FG001|Overall Study|Withdrawal by Subject|2|||
164643173|NCT02180659|594716806|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
164643174|NCT02180659|594716807|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
164643175|NCT04150107|594716808|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
164643176|NCT04150107|594716809|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
164643177|NCT04150107|594716808|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
164643178|NCT04150107|594716809|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
164643179|NCT00824993|594716814|FG000|Overall Study|Withdrawal by Subject|1|||
164643180|NCT00824993|594716815|FG001|Overall Study|Withdrawal by Subject|1|||
164643181|NCT00824993|594716814|FG000|Overall Study|Malignancy Relapse|9|||
164643182|NCT00824993|594716815|FG001|Overall Study|Malignancy Relapse|10|||
164643183|NCT00824993|594716814|FG000|Overall Study|Rapid Bone Loss|0|||
164643184|NCT00824993|594716815|FG001|Overall Study|Rapid Bone Loss|1|||
164643185|NCT00824993|594716814|FG000|Overall Study|Non-Compliant|2|||
164643186|NCT00824993|594716815|FG001|Overall Study|Non-Compliant|1|||
164643187|NCT00824993|594716814|FG000|Overall Study|Insurance Issue|2|||
164643188|NCT00824993|594716815|FG001|Overall Study|Insurance Issue|1|||
164643189|NCT00824993|594716814|FG000|Overall Study|Death|0|||
164643190|NCT00824993|594716815|FG001|Overall Study|Death|3|||
164643191|NCT00440193|594716816|FG000|Treatment Period|Adverse Event|74|||
164643192|NCT00440193|594716817|FG001|Treatment Period|Adverse Event|67|||
164643193|NCT00440193|594716816|FG000|Treatment Period|Death|19|||
164643194|NCT00440193|594716817|FG001|Treatment Period|Death|22|||
164643195|NCT00440193|594716816|FG000|Treatment Period|Lack of Efficacy|0|||
164643196|NCT00440193|594716817|FG001|Treatment Period|Lack of Efficacy|1|||
164643197|NCT00440193|594716816|FG000|Treatment Period|Lost to Follow-up|12|||
164643198|NCT00440193|594716817|FG001|Treatment Period|Lost to Follow-up|18|||
164643199|NCT00440193|594716816|FG000|Treatment Period|Physician Decision|3|||
164643200|NCT00440193|594716817|FG001|Treatment Period|Physician Decision|6|||
164643201|NCT00440193|594716816|FG000|Treatment Period|Protocol Violation|16|||
164643202|NCT00440193|594716817|FG001|Treatment Period|Protocol Violation|19|||
164643203|NCT00440193|594716816|FG000|Treatment Period|Withdrawal by Subject|36|||
164643204|NCT00440193|594716817|FG001|Treatment Period|Withdrawal by Subject|77|||
164643205|NCT00440193|594716816|FG000|Treatment Period|Clinical endpoint reached|28|||
164643206|NCT00440193|594716817|FG001|Treatment Period|Clinical endpoint reached|25|||
164643207|NCT00440193|594716816|FG000|Treatment Period|Study terminated by sponsor|102|||
164643208|NCT00440193|594716817|FG001|Treatment Period|Study terminated by sponsor|94|||
164643209|NCT00440193|594716816|FG000|Treatment Period|Protocol driven decision point|2|||
164643210|NCT00440193|594716817|FG001|Treatment Period|Protocol driven decision point|2|||
164643211|NCT00440193|594716816|FG000|Treatment Period|Switch to commercial drug|0|||
164643212|NCT00440193|594716817|FG001|Treatment Period|Switch to commercial drug|2|||
164643213|NCT00440193|594716816|FG000|Treatment Period|Technical problems|1|||
164643214|NCT00440193|594716817|FG001|Treatment Period|Technical problems|1|||
164643215|NCT00440193|594716816|FG000|Treatment Period|Participant convenience|5|||
164643216|NCT00440193|594716817|FG001|Treatment Period|Participant convenience|2|||
164643217|NCT00440193|594716816|FG000|Treatment Period|Participant did not receive treatment|7|||
164643218|NCT00440193|594716817|FG001|Treatment Period|Participant did not receive treatment|13|||
164643219|NCT00440193|594716816|FG000|Treatment Period|Site closed by investigator|0|||
164643220|NCT00440193|594716817|FG001|Treatment Period|Site closed by investigator|2|||
164643221|NCT00440193|594716816|FG000|Observational Period|Adverse Event|2|||
164643222|NCT00440193|594716817|FG001|Observational Period|Adverse Event|2|||
164643223|NCT00440193|594716816|FG000|Observational Period|Death|15|||
164643224|NCT00440193|594716817|FG001|Observational Period|Death|20|||
164643225|NCT00440193|594716816|FG000|Observational Period|Lost to Follow-up|12|||
164643226|NCT00440193|594716817|FG001|Observational Period|Lost to Follow-up|8|||
164643227|NCT00440193|594716816|FG000|Observational Period|Protocol Violation|1|||
164643228|NCT00440193|594716817|FG001|Observational Period|Protocol Violation|0|||
164643229|NCT00440193|594716816|FG000|Observational Period|Withdrawal by Subject|11|||
164643230|NCT00440193|594716817|FG001|Observational Period|Withdrawal by Subject|8|||
164643231|NCT00440193|594716816|FG000|Observational Period|Physician Decision|1|||
164643232|NCT00440193|594716817|FG001|Observational Period|Physician Decision|0|||
164643233|NCT00440193|594716816|FG000|Observational Period|Clinical endpoint reached|1|||
164643234|NCT00440193|594716817|FG001|Observational Period|Clinical endpoint reached|0|||
164643235|NCT00440193|594716816|FG000|Observational Period|Participant convenience|2|||
164643236|NCT00440193|594716817|FG001|Observational Period|Participant convenience|0|||
164643237|NCT00834366|594716818|FG000|Treatment Period 1|Adverse Event|1|||
164643238|NCT00834366|594716819|FG001|Treatment Period 1|Adverse Event|1|||
164643239|NCT03409328|594716825|FG000|Overall Study|Lost to Follow-up|6|||
164643240|NCT03409328|594716826|FG001|Overall Study|Lost to Follow-up|3|||
164643241|NCT00518011|594716827|FG000|Overall Study|Death|1|||
164643242|NCT00518011|594716828|FG001|Overall Study|Death|1|||
164643243|NCT00518011|594716827|FG000|Overall Study|Adverse Event|2|||
164643244|NCT00518011|594716828|FG001|Overall Study|Adverse Event|3|||
164643245|NCT00518011|594716827|FG000|Overall Study|Disease Progression|2|||
164643246|NCT00518011|594716828|FG001|Overall Study|Disease Progression|2|||
164643247|NCT00518011|594716827|FG000|Overall Study|Other Reasons|3|||
164643248|NCT00518011|594716828|FG001|Overall Study|Other Reasons|2|||
164643249|NCT00518011|594716827|FG000|Overall Study|Withdrawal by Subject|1|||
164643250|NCT00518011|594716828|FG001|Overall Study|Withdrawal by Subject|0|||
164643251|NCT02998645|594716829|FG000|Treatment Period 1|Adverse Event|6|||
164643252|NCT02998645|594716829|FG000|Treatment Period 1|Death|5|||
164643253|NCT02998645|594716829|FG000|Treatment Period 1|Technical Problems|4|||
164643254|NCT02998645|594716829|FG000|Treatment Period 1|Lack of Efficacy|2|||
164643255|NCT02998645|594716829|FG000|Treatment Period 1|Progressive disease|1|||
164643256|NCT02998645|594716829|FG000|Treatment Period 1|Subject/guardian decision|1|||
164643257|NCT02998645|594716829|FG000|Treatment Period 2|Lack of Efficacy|5|||
164643258|NCT02998645|594716829|FG000|Treatment Period 2|Adverse Event|2|||
164643259|NCT02998645|594716829|FG000|Treatment Period 2|Progressive disease|2|||
164643260|NCT02998645|594716829|FG000|Treatment Period 2|Physician Decision|1|||
164643261|NCT00090259|594716830|FG000|Overall Study|Lost to Follow-up|30|||
164643262|NCT00090259|594716831|FG001|Overall Study|Lost to Follow-up|26|||
164643263|NCT00090259|594716830|FG000|Overall Study|Withdrawal by Subject|21|||
164643264|NCT00090259|594716831|FG001|Overall Study|Withdrawal by Subject|15|||
164643265|NCT00090259|594716830|FG000|Overall Study|Investigator site closed|11|||
164643266|NCT00090259|594716831|FG001|Overall Study|Investigator site closed|7|||
164643267|NCT00478673|594716832|FG000|30-Days Post-Procedure|Death|2|||
164643268|NCT00478673|594716832|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
164643269|NCT00478673|594716832|FG000|30-Days Post-Procedure|Missed Visit|7|||
164643270|NCT00478673|594716832|FG000|12-Months Post-Procedure|Death|23|||
164643271|NCT00478673|594716832|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
164643272|NCT00478673|594716832|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
164643273|NCT00478673|594716832|FG000|12-Months Post-Procedure|Missed Visit|25|||
164643274|NCT00478673|594716832|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
164643275|NCT03701516|594716833|FG000|Period 1|Lost to Follow-up|0|||
164643276|NCT03701516|594716834|FG001|Period 1|Lost to Follow-up|1|||
164643277|NCT03701516|594716833|FG000|Period 1|Adverse Event|0|||
164643278|NCT03701516|594716834|FG001|Period 1|Adverse Event|2|||
164643279|NCT03701516|594716833|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
164643280|NCT03701516|594716834|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
164643281|NCT03701516|594716833|FG000|Period 1|Non Compliance to Protocol|2|||
164643282|NCT03701516|594716834|FG001|Period 1|Non Compliance to Protocol|1|||
164643283|NCT03701516|594716833|FG000|Period 1|Withdrawal by Subject|0|||
164643284|NCT03701516|594716834|FG001|Period 1|Withdrawal by Subject|1|||
164643285|NCT03701516|594716833|FG000|Period 2|failed to meet all eligibility creiteria|1|||
164643286|NCT03701516|594716834|FG001|Period 2|failed to meet all eligibility creiteria|0|||
164643287|NCT03701516|594716833|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
164643288|NCT03701516|594716834|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
164643289|NCT03644927|594716840|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
164643290|NCT03644927|594716841|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
164643291|NCT00956813|594716842|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
164643292|NCT00956813|594716843|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
164643293|NCT00956813|594716842|FG000|Flaxseed and Placebo|Ineligible|3|||
164643294|NCT00956813|594716843|FG001|Flaxseed and Placebo|Ineligible|1|||
164643295|NCT04797637|594716844|FG000|Overall Study|Lost to Follow-up|23|||
164643296|NCT04797637|594716845|FG001|Overall Study|Lost to Follow-up|32|||
164643297|NCT04797637|594716844|FG000|Overall Study|Withdrawal by Subject|0|||
164643298|NCT04797637|594716845|FG001|Overall Study|Withdrawal by Subject|1|||
164643299|NCT02380248|594716846|FG000|Overall Study|Lost to Follow-up|11|||
164643300|NCT02380248|594716846|FG000|Overall Study|Withdrawal by Subject|3|||
164643301|NCT03083639|594716847|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
164643302|NCT03083639|594716848|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
164643303|NCT03083639|594716847|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
164643304|NCT03083639|594716848|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
164643305|NCT00960687|594716849|FG000|Washout Period of 7 Days|Adverse Event|3|||
164643306|NCT00960687|594716850|FG001|Washout Period of 7 Days|Adverse Event|2|||
164643307|NCT00960687|594716849|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
164643308|NCT00960687|594716850|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
164643309|NCT03611751|594716857|FG000|Pre-treatment|Randomized but not treated|1|||
164643310|NCT03611751|594716858|FG001|Pre-treatment|Randomized but not treated|1|||
164643311|NCT03611751|594716859|FG002|Pre-treatment|Randomized but not treated|0|||
164643312|NCT03611751|594716857|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
164643313|NCT03611751|594716858|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
164643314|NCT03611751|594716859|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
164643315|NCT03611751|594716857|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
164643316|NCT03611751|594716858|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
164643317|NCT03611751|594716859|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
164643318|NCT03611751|594716857|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
164643319|NCT03611751|594716858|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
164643320|NCT03611751|594716859|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
164643321|NCT03611751|594716857|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
164643322|NCT03611751|594716858|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
164643323|NCT03611751|594716859|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
164643324|NCT03611751|594716857|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
164643325|NCT03611751|594716858|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
164643326|NCT03611751|594716859|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
164643327|NCT03611751|594716857|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
164643328|NCT03611751|594716858|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
164643329|NCT03611751|594716859|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
164643330|NCT03611751|594716857|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
164643331|NCT03611751|594716858|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
164643332|NCT03611751|594716859|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
164643333|NCT03611751|594716857|FG000|Treatment Week 0 - Week 16|Death|0|||
164643334|NCT03611751|594716858|FG001|Treatment Week 0 - Week 16|Death|0|||
164643335|NCT03611751|594716859|FG002|Treatment Week 0 - Week 16|Death|1|||
164643336|NCT03611751|594716857|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
164643337|NCT03611751|594716858|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
164643338|NCT03611751|594716859|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
164643339|NCT03611751|594716857|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
164643340|NCT03611751|594716858|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
164643341|NCT03611751|594716859|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
164643342|NCT03611751|594716857|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
164643343|NCT03611751|594716858|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
164643344|NCT03611751|594716859|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
164643345|NCT03611751|594716857|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
164643346|NCT03611751|594716858|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
164643347|NCT03611751|594716859|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
164643348|NCT03611751|594716857|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
164643349|NCT03611751|594716858|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
164643350|NCT03611751|594716859|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
164643351|NCT03611751|594716857|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
164643352|NCT03611751|594716858|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
164643353|NCT03611751|594716859|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
164643354|NCT03611751|594716857|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
164643355|NCT03611751|594716858|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
164643356|NCT03611751|594716859|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
164643357|NCT03611751|594716857|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
164643358|NCT03611751|594716858|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
164643359|NCT03611751|594716859|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
164643360|NCT03611751|594716857|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
164643361|NCT03611751|594716858|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
164643362|NCT03611751|594716859|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
164643363|NCT03611751|594716857|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
164643364|NCT03611751|594716858|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
164643365|NCT03611751|594716859|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
164643366|NCT03611751|594716857|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
164643367|NCT03611751|594716858|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
164643368|NCT03611751|594716859|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
164643369|NCT03611751|594716857|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
164643370|NCT03611751|594716858|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
164643371|NCT03611751|594716859|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
164643372|NCT03611751|594716857|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
164643373|NCT03611751|594716858|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
164643374|NCT03611751|594716859|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
164643375|NCT03611751|594716857|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
164643376|NCT03611751|594716858|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
164643377|NCT03611751|594716859|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
164643378|NCT01023022|594716860|FG000|Overall Study|Death|5|||
164643379|NCT01023022|594716860|FG000|Overall Study|Lost to Follow-up|7|||
164643380|NCT01023022|594716860|FG000|Overall Study|due to technical issues|2|||
164643381|NCT03128931|594716862|FG000|Overall Study|Physician Decision|1|||
164643382|NCT03128931|594716862|FG000|Overall Study|Equipment Issues|3|||
164643383|NCT05378269|594718816|FG000|Overall Study|Protocol Violation|1|||
164643384|NCT05378269|594718817|FG001|Overall Study|Protocol Violation|0|||
164643385|NCT05378269|594718818|FG002|Overall Study|Protocol Violation|2|||
164643386|NCT05378269|594718819|FG003|Overall Study|Protocol Violation|0|||
164643387|NCT05378269|594718820|FG004|Overall Study|Protocol Violation|0|||
164643388|NCT01371006|594718821|FG000|Overall Study|Adverse Event|1|||
164643389|NCT01371006|594718822|FG001|Overall Study|Adverse Event|0|||
164643390|NCT03256526|594718823|FG000|Overall Study|Adverse Event|1|||
164643391|NCT03256526|594718824|FG001|Overall Study|Adverse Event|0|||
164643392|NCT03256526|594718825|FG002|Overall Study|Adverse Event|1|||
164643393|NCT03256526|594718823|FG000|Overall Study|Lost to Follow-up|1|||
164643394|NCT03256526|594718824|FG001|Overall Study|Lost to Follow-up|0|||
164643395|NCT03256526|594718825|FG002|Overall Study|Lost to Follow-up|2|||
164643396|NCT00891527|594718826|FG000|Overall Study|Withdrawal by Subject|2|||
164643397|NCT01186744|594718827|FG000|Overall Study|Lack of Efficacy|156|||
164643398|NCT01186744|594718828|FG001|Overall Study|Lack of Efficacy|99|||
164643399|NCT01186744|594718829|FG002|Overall Study|Lack of Efficacy|0|||
164643400|NCT01186744|594718830|FG003|Overall Study|Lack of Efficacy|2|||
164643401|NCT01186744|594718831|FG004|Overall Study|Lack of Efficacy|2|||
164643402|NCT01186744|594718832|FG005|Overall Study|Lack of Efficacy|5|||
164643403|NCT01186744|594718827|FG000|Overall Study|Protocol Violation|1|||
164643404|NCT01186744|594718828|FG001|Overall Study|Protocol Violation|2|||
164643405|NCT01186744|594718829|FG002|Overall Study|Protocol Violation|0|||
164643406|NCT01186744|594718830|FG003|Overall Study|Protocol Violation|1|||
164643407|NCT01186744|594718831|FG004|Overall Study|Protocol Violation|1|||
164643408|NCT01186744|594718832|FG005|Overall Study|Protocol Violation|2|||
164643409|NCT01186744|594718827|FG000|Overall Study|Lost to Follow-up|15|||
164643410|NCT01186744|594718828|FG001|Overall Study|Lost to Follow-up|16|||
164643411|NCT01186744|594718829|FG002|Overall Study|Lost to Follow-up|2|||
164643412|NCT01186744|594718830|FG003|Overall Study|Lost to Follow-up|1|||
164643413|NCT01186744|594718831|FG004|Overall Study|Lost to Follow-up|1|||
164643414|NCT01186744|594718832|FG005|Overall Study|Lost to Follow-up|4|||
164643415|NCT01186744|594718827|FG000|Overall Study|Screen failure|1|||
164643416|NCT01186744|594718828|FG001|Overall Study|Screen failure|1|||
164643417|NCT01186744|594718829|FG002|Overall Study|Screen failure|0|||
164643418|NCT01186744|594718830|FG003|Overall Study|Screen failure|1|||
164643419|NCT01186744|594718831|FG004|Overall Study|Screen failure|0|||
164643420|NCT01186744|594718832|FG005|Overall Study|Screen failure|0|||
164643421|NCT01186744|594718827|FG000|Overall Study|Withdrawal by Subject|14|||
164643422|NCT01186744|594718828|FG001|Overall Study|Withdrawal by Subject|10|||
164643423|NCT01186744|594718829|FG002|Overall Study|Withdrawal by Subject|2|||
164643424|NCT01186744|594718830|FG003|Overall Study|Withdrawal by Subject|5|||
164643425|NCT01186744|594718831|FG004|Overall Study|Withdrawal by Subject|0|||
164643426|NCT01186744|594718832|FG005|Overall Study|Withdrawal by Subject|6|||
164643427|NCT01186744|594718827|FG000|Overall Study|Study terminated by Sponsor|1|||
164643428|NCT01186744|594718828|FG001|Overall Study|Study terminated by Sponsor|0|||
164643429|NCT01186744|594718829|FG002|Overall Study|Study terminated by Sponsor|0|||
164643430|NCT01186744|594718830|FG003|Overall Study|Study terminated by Sponsor|0|||
164643431|NCT01186744|594718831|FG004|Overall Study|Study terminated by Sponsor|0|||
164643432|NCT01186744|594718832|FG005|Overall Study|Study terminated by Sponsor|0|||
164643433|NCT01186744|594718827|FG000|Overall Study|Other|9|||
164643434|NCT01186744|594718828|FG001|Overall Study|Other|10|||
164643435|NCT01186744|594718829|FG002|Overall Study|Other|1|||
164643436|NCT01186744|594718830|FG003|Overall Study|Other|2|||
164643437|NCT01186744|594718831|FG004|Overall Study|Other|1|||
164643438|NCT01186744|594718832|FG005|Overall Study|Other|5|||
164643439|NCT01186744|594718827|FG000|Overall Study|Adverse Event|10|||
164643440|NCT01186744|594718828|FG001|Overall Study|Adverse Event|14|||
164643441|NCT01186744|594718829|FG002|Overall Study|Adverse Event|1|||
164643442|NCT01186744|594718830|FG003|Overall Study|Adverse Event|0|||
164643443|NCT01186744|594718831|FG004|Overall Study|Adverse Event|1|||
164643444|NCT01186744|594718832|FG005|Overall Study|Adverse Event|4|||
164643445|NCT01186744|594718827|FG000|Overall Study|Death|1|||
164643446|NCT01186744|594718828|FG001|Overall Study|Death|0|||
164643447|NCT01186744|594718829|FG002|Overall Study|Death|0|||
164643448|NCT01186744|594718830|FG003|Overall Study|Death|0|||
164643449|NCT01186744|594718831|FG004|Overall Study|Death|0|||
164643450|NCT01186744|594718832|FG005|Overall Study|Death|0|||
164643451|NCT03515837|594718835|FG000|Overall Study|Death|219|||
164643452|NCT03515837|594718836|FG001|Overall Study|Death|227|||
164643453|NCT03515837|594718835|FG000|Overall Study|Lost to Follow-up|0|||
164643454|NCT03515837|594718836|FG001|Overall Study|Lost to Follow-up|1|||
164643455|NCT03515837|594718835|FG000|Overall Study|Withdrawal by Subject|0|||
164643456|NCT03515837|594718836|FG001|Overall Study|Withdrawal by Subject|4|||
164643457|NCT03515837|594718835|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
164643458|NCT03515837|594718836|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
164643459|NCT01856686|594718837|FG000|Overall Study|Lost to Follow-up|5|||
164643460|NCT01856686|594718838|FG001|Overall Study|Lost to Follow-up|11|||
164643461|NCT00602979|594718841|FG000|Overall Study|Lost to Follow-up|3|||
164643462|NCT00602979|594718842|FG001|Overall Study|Lost to Follow-up|2|||
164643463|NCT00602979|594718843|FG002|Overall Study|Lost to Follow-up|3|||
164643464|NCT00602979|594718844|FG003|Overall Study|Lost to Follow-up|2|||
164643465|NCT00602979|594718845|FG004|Overall Study|Lost to Follow-up|3|||
164643466|NCT00602979|594718841|FG000|Overall Study|Failed Intubation|0|||
164643467|NCT00602979|594718842|FG001|Overall Study|Failed Intubation|1|||
164643468|NCT00602979|594718843|FG002|Overall Study|Failed Intubation|0|||
164643469|NCT00602979|594718844|FG003|Overall Study|Failed Intubation|1|||
164643470|NCT00602979|594718845|FG004|Overall Study|Failed Intubation|0|||
164643471|NCT02406742|594718850|FG000|Overall Study|Progression of Disease|5|||
164643472|NCT02406742|594718851|FG001|Overall Study|Progression of Disease|1|||
164643473|NCT02406742|594718852|FG002|Overall Study|Progression of Disease|6|||
164643474|NCT02406742|594718850|FG000|Overall Study|Adverse Event|3|||
164643475|NCT02406742|594718851|FG001|Overall Study|Adverse Event|0|||
164643476|NCT02406742|594718852|FG002|Overall Study|Adverse Event|2|||
164643477|NCT02406742|594718850|FG000|Overall Study|Death|1|||
164643478|NCT02406742|594718851|FG001|Overall Study|Death|0|||
164643479|NCT02406742|594718852|FG002|Overall Study|Death|0|||
164643480|NCT02406742|594718850|FG000|Overall Study|Lack of Efficacy|0|||
164643481|NCT02406742|594718851|FG001|Overall Study|Lack of Efficacy|0|||
164643482|NCT02406742|594718852|FG002|Overall Study|Lack of Efficacy|1|||
164643483|NCT02406742|594718850|FG000|Overall Study|Withdrawal by Participant|1|||
164643484|NCT02406742|594718851|FG001|Overall Study|Withdrawal by Participant|2|||
164643485|NCT02406742|594718852|FG002|Overall Study|Withdrawal by Participant|0|||
164643486|NCT02406742|594718850|FG000|Overall Study|Physician Decision|1|||
164643487|NCT02406742|594718851|FG001|Overall Study|Physician Decision|2|||
164643488|NCT02406742|594718852|FG002|Overall Study|Physician Decision|1|||
164643489|NCT02406742|594718850|FG000|Overall Study|Transition to other treatment|2|||
164643490|NCT02406742|594718851|FG001|Overall Study|Transition to other treatment|0|||
164643491|NCT02406742|594718852|FG002|Overall Study|Transition to other treatment|1|||
164643492|NCT02406742|594718850|FG000|Overall Study|Other Reasons|1|||
164643493|NCT02406742|594718851|FG001|Overall Study|Other Reasons|11|||
164643494|NCT02406742|594718852|FG002|Overall Study|Other Reasons|5|||
164643495|NCT02367729|594718853|FG000|Overall Study|Organic disorder diagnosed|2|||
164643496|NCT02367729|594718854|FG001|Overall Study|Organic disorder diagnosed|1|||
164643497|NCT02367729|594718853|FG000|Overall Study|Adverse Event|1|||
164643498|NCT02367729|594718854|FG001|Overall Study|Adverse Event|2|||
164643499|NCT02367729|594718853|FG000|Overall Study|Withdrawal by Subject|0|||
164643500|NCT02367729|594718854|FG001|Overall Study|Withdrawal by Subject|5|||
164643501|NCT00759174|594718855|FG000|Overall Study|Other|0|||
164643502|NCT00759174|594718856|FG001|Overall Study|Other|2|||
164643503|NCT01890109|594718857|FG000|Overall Study|Withdrawal by Subject|0|||
164643504|NCT01890109|594718858|FG001|Overall Study|Withdrawal by Subject|3|||
164643505|NCT01890109|594718857|FG000|Overall Study|Lost to Follow-up|1|||
164643506|NCT01890109|594718858|FG001|Overall Study|Lost to Follow-up|2|||
164643507|NCT01643928|594718859|FG000|Overall Study|Lost to Follow-up|1|||
164643508|NCT01643928|594718860|FG001|Overall Study|Lost to Follow-up|0|||
164643509|NCT01643928|594718861|FG002|Overall Study|Lost to Follow-up|2|||
164643510|NCT01643928|594718862|FG003|Overall Study|Lost to Follow-up|0|||
164643511|NCT01643928|594718863|FG004|Overall Study|Lost to Follow-up|0|||
164643512|NCT01643928|594718859|FG000|Overall Study|Withdrawal by Subject|2|||
164643513|NCT01643928|594718860|FG001|Overall Study|Withdrawal by Subject|0|||
164643514|NCT01643928|594718861|FG002|Overall Study|Withdrawal by Subject|0|||
164643515|NCT01643928|594718862|FG003|Overall Study|Withdrawal by Subject|1|||
164643516|NCT01643928|594718863|FG004|Overall Study|Withdrawal by Subject|0|||
164643517|NCT01643928|594718859|FG000|Overall Study|Pregnancy|0|||
164643518|NCT01643928|594718860|FG001|Overall Study|Pregnancy|0|||
164643519|NCT01643928|594718861|FG002|Overall Study|Pregnancy|0|||
164643520|NCT01643928|594718862|FG003|Overall Study|Pregnancy|1|||
164643521|NCT01643928|594718863|FG004|Overall Study|Pregnancy|0|||
164643522|NCT01643928|594718859|FG000|Overall Study|Other|5|||
164643523|NCT01643928|594718860|FG001|Overall Study|Other|1|||
164643524|NCT01643928|594718861|FG002|Overall Study|Other|1|||
164643525|NCT01643928|594718862|FG003|Overall Study|Other|0|||
164643526|NCT01643928|594718863|FG004|Overall Study|Other|0|||
164643527|NCT01643928|594718859|FG000|Overall Study|Adverse Event|2|||
164643528|NCT01643928|594718860|FG001|Overall Study|Adverse Event|1|||
164643529|NCT01643928|594718861|FG002|Overall Study|Adverse Event|0|||
164643530|NCT01643928|594718862|FG003|Overall Study|Adverse Event|1|||
164643531|NCT01643928|594718863|FG004|Overall Study|Adverse Event|2|||
164643532|NCT00996632|594718865|FG000|Overall Study|Physician Decision|0|||
164643533|NCT00996632|594718866|FG001|Overall Study|Physician Decision|0|||
164643534|NCT00916617|594718872|FG000|Overall Study|Adverse Event|3|||
164643535|NCT00916617|594718873|FG001|Overall Study|Adverse Event|2|||
164643536|NCT00916617|594718874|FG002|Overall Study|Adverse Event|6|||
164643537|NCT00916617|594718875|FG003|Overall Study|Adverse Event|3|||
164643538|NCT00916617|594718872|FG000|Overall Study|Withdrawal by Subject|3|||
164643539|NCT00916617|594718873|FG001|Overall Study|Withdrawal by Subject|2|||
164643540|NCT00916617|594718874|FG002|Overall Study|Withdrawal by Subject|0|||
164643541|NCT00916617|594718875|FG003|Overall Study|Withdrawal by Subject|1|||
164643542|NCT00916617|594718872|FG000|Overall Study|Caregiver Request|3|||
164643543|NCT00916617|594718873|FG001|Overall Study|Caregiver Request|2|||
164643544|NCT00916617|594718874|FG002|Overall Study|Caregiver Request|1|||
164643545|NCT00916617|594718875|FG003|Overall Study|Caregiver Request|0|||
164643546|NCT00916617|594718872|FG000|Overall Study|Physician Decision|1|||
164643547|NCT00916617|594718873|FG001|Overall Study|Physician Decision|1|||
164643548|NCT00916617|594718874|FG002|Overall Study|Physician Decision|0|||
164643549|NCT00916617|594718875|FG003|Overall Study|Physician Decision|0|||
164643550|NCT00916617|594718872|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
164643551|NCT00916617|594718873|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
164643552|NCT00916617|594718874|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
164643553|NCT00916617|594718875|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
164643554|NCT00916617|594718872|FG000|Overall Study|Lost to Follow-up|2|||
164643555|NCT00916617|594718873|FG001|Overall Study|Lost to Follow-up|1|||
164643556|NCT00916617|594718874|FG002|Overall Study|Lost to Follow-up|0|||
164643557|NCT00916617|594718875|FG003|Overall Study|Lost to Follow-up|0|||
164643558|NCT00916617|594718872|FG000|Overall Study|Lack of Efficacy|1|||
164643559|NCT00916617|594718873|FG001|Overall Study|Lack of Efficacy|0|||
164643560|NCT00916617|594718874|FG002|Overall Study|Lack of Efficacy|0|||
164643561|NCT00916617|594718875|FG003|Overall Study|Lack of Efficacy|0|||
164643562|NCT00916617|594718872|FG000|Overall Study|Other|2|||
164643563|NCT00916617|594718873|FG001|Overall Study|Other|0|||
164643564|NCT00916617|594718874|FG002|Overall Study|Other|0|||
164643565|NCT00916617|594718875|FG003|Overall Study|Other|2|||
164643566|NCT00499252|594718877|FG000|Overall Study|Adverse Event|3|||
164643567|NCT00499252|594718877|FG000|Overall Study|Refused further treatment|2|||
164643568|NCT00499252|594718877|FG000|Overall Study|Ineligible|4|||
164643569|NCT00499252|594718877|FG000|Overall Study|<no further label>|3|||
164643570|NCT02230332|594718878|FG000|Overall Study|Adverse Event|2|||
164643571|NCT02230332|594718879|FG001|Overall Study|Adverse Event|1|||
164643572|NCT02230332|594718878|FG000|Overall Study|Lost to Follow-up|1|||
164643573|NCT02230332|594718879|FG001|Overall Study|Lost to Follow-up|0|||
164643574|NCT02230332|594718878|FG000|Overall Study|Protocol Violation|1|||
164643575|NCT02230332|594718879|FG001|Overall Study|Protocol Violation|0|||
164643576|NCT01260194|594718881|FG000|Overall Study|Withdrawal of Consent|1|||
164643577|NCT02086968|594718883|FG000|Overall Study|Adverse Event|1|||
164643578|NCT02086968|594718884|FG001|Overall Study|Adverse Event|5|||
164643579|NCT02086968|594718883|FG000|Overall Study|Lost to Follow-up|2|||
164643580|NCT02086968|594718884|FG001|Overall Study|Lost to Follow-up|3|||
164643581|NCT02086968|594718883|FG000|Overall Study|Study drug received outside protocol|0|||
164643582|NCT02086968|594718884|FG001|Overall Study|Study drug received outside protocol|1|||
164643583|NCT02086968|594718883|FG000|Overall Study|Physician Decision|4|||
164643584|NCT02086968|594718884|FG001|Overall Study|Physician Decision|0|||
164643585|NCT02086968|594718883|FG000|Overall Study|Withdrawal by Subject|1|||
164643586|NCT02086968|594718884|FG001|Overall Study|Withdrawal by Subject|4|||
164643587|NCT00556166|594718890|FG000|Overall Study|Withdrawal by Subject|1|||
164643588|NCT03359473|594718891|FG000|Overall Study|Adverse Event|0|||
164643589|NCT03359473|594718892|FG001|Overall Study|Adverse Event|2|||
164643590|NCT03359473|594718893|FG002|Overall Study|Adverse Event|5|||
164643591|NCT03359473|594718894|FG003|Overall Study|Adverse Event|3|||
164643592|NCT03359473|594718891|FG000|Overall Study|Lost to Follow-up|0|||
164643593|NCT03359473|594718892|FG001|Overall Study|Lost to Follow-up|1|||
164643594|NCT03359473|594718893|FG002|Overall Study|Lost to Follow-up|0|||
164643595|NCT03359473|594718894|FG003|Overall Study|Lost to Follow-up|0|||
164643596|NCT03359473|594718891|FG000|Overall Study|Physician Decision|0|||
164643597|NCT03359473|594718892|FG001|Overall Study|Physician Decision|1|||
164643598|NCT03359473|594718893|FG002|Overall Study|Physician Decision|0|||
164643599|NCT03359473|594718894|FG003|Overall Study|Physician Decision|1|||
164643600|NCT03359473|594718891|FG000|Overall Study|Withdrawal by Subject|1|||
164643601|NCT03359473|594718892|FG001|Overall Study|Withdrawal by Subject|2|||
164643602|NCT03359473|594718893|FG002|Overall Study|Withdrawal by Subject|1|||
164643603|NCT03359473|594718894|FG003|Overall Study|Withdrawal by Subject|0|||
164643604|NCT03359473|594718891|FG000|Overall Study|Protocol-defined stopping criteria|1|||
164643605|NCT03359473|594718892|FG001|Overall Study|Protocol-defined stopping criteria|0|||
164643606|NCT03359473|594718893|FG002|Overall Study|Protocol-defined stopping criteria|0|||
164643607|NCT03359473|594718894|FG003|Overall Study|Protocol-defined stopping criteria|1|||
164643608|NCT04101721|594718898|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
164643609|NCT04101721|594718899|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
164643610|NCT04101721|594718898|FG000|Overall Study|Death|0|||
164643611|NCT04101721|594718899|FG001|Overall Study|Death|1|||
164643612|NCT04101721|594718898|FG000|Overall Study|Lost to Follow-up|0|||
164643613|NCT04101721|594718899|FG001|Overall Study|Lost to Follow-up|3|||
164643614|NCT01215955|594718900|FG000|Overall Study|Adverse Event|1|||
164643615|NCT01215955|594718901|FG001|Overall Study|Adverse Event|4|||
164643616|NCT01215955|594718902|FG002|Overall Study|Adverse Event|2|||
164643617|NCT01215955|594718903|FG003|Overall Study|Adverse Event|3|||
164643618|NCT01215955|594718900|FG000|Overall Study|Death|2|||
164643619|NCT01215955|594718901|FG001|Overall Study|Death|0|||
164643620|NCT01215955|594718902|FG002|Overall Study|Death|1|||
164643621|NCT01215955|594718903|FG003|Overall Study|Death|3|||
164643622|NCT01215955|594718900|FG000|Overall Study|Entry Criteria Not Met|1|||
164643623|NCT01215955|594718901|FG001|Overall Study|Entry Criteria Not Met|3|||
164643624|NCT01215955|594718902|FG002|Overall Study|Entry Criteria Not Met|4|||
164643625|NCT01215955|594718903|FG003|Overall Study|Entry Criteria Not Met|7|||
164643626|NCT01215955|594718900|FG000|Overall Study|Lack of Efficacy|1|||
164643627|NCT01215955|594718901|FG001|Overall Study|Lack of Efficacy|2|||
164643628|NCT01215955|594718902|FG002|Overall Study|Lack of Efficacy|1|||
164643629|NCT01215955|594718903|FG003|Overall Study|Lack of Efficacy|0|||
164643630|NCT01215955|594718900|FG000|Overall Study|Lost to Follow-up|4|||
164643631|NCT01215955|594718901|FG001|Overall Study|Lost to Follow-up|4|||
164643632|NCT01215955|594718902|FG002|Overall Study|Lost to Follow-up|8|||
164643633|NCT01215955|594718903|FG003|Overall Study|Lost to Follow-up|9|||
164643634|NCT01215955|594718900|FG000|Overall Study|Physician Decision|4|||
164643635|NCT01215955|594718901|FG001|Overall Study|Physician Decision|10|||
164643636|NCT01215955|594718902|FG002|Overall Study|Physician Decision|8|||
164643637|NCT01215955|594718903|FG003|Overall Study|Physician Decision|11|||
164643638|NCT01215955|594718900|FG000|Overall Study|Protocol Violation|17|||
164643639|NCT01215955|594718901|FG001|Overall Study|Protocol Violation|13|||
164643640|NCT01215955|594718902|FG002|Overall Study|Protocol Violation|8|||
164643641|NCT01215955|594718903|FG003|Overall Study|Protocol Violation|8|||
164643642|NCT01215955|594718900|FG000|Overall Study|Sponsor Decision|1|||
164643643|NCT01215955|594718901|FG001|Overall Study|Sponsor Decision|2|||
164643644|NCT01215955|594718902|FG002|Overall Study|Sponsor Decision|0|||
164643645|NCT01215955|594718903|FG003|Overall Study|Sponsor Decision|1|||
164643646|NCT01215955|594718900|FG000|Overall Study|Withdrawal by Subject|14|||
164643647|NCT01215955|594718901|FG001|Overall Study|Withdrawal by Subject|15|||
164643648|NCT01215955|594718902|FG002|Overall Study|Withdrawal by Subject|13|||
164643649|NCT01215955|594718903|FG003|Overall Study|Withdrawal by Subject|9|||
164643650|NCT01215955|594718900|FG000|Overall Study|Quality Issues|0|||
164643651|NCT01215955|594718901|FG001|Overall Study|Quality Issues|0|||
164643652|NCT01215955|594718902|FG002|Overall Study|Quality Issues|3|||
164643653|NCT01215955|594718903|FG003|Overall Study|Quality Issues|2|||
164643654|NCT05013749|594718904|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
164643655|NCT05013749|594718905|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
164643656|NCT05013749|594718904|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
164643657|NCT05013749|594718905|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
164643658|NCT02858076|594718906|FG000|Overall Study|Death|6|||
164643659|NCT02858076|594718907|FG001|Overall Study|Death|3|||
164643660|NCT02858076|594718906|FG000|Overall Study|Withdrawal by Subject|1|||
164643661|NCT02858076|594718907|FG001|Overall Study|Withdrawal by Subject|5|||
164643662|NCT02858076|594718906|FG000|Overall Study|Lost to Follow-up|2|||
164643663|NCT02858076|594718907|FG001|Overall Study|Lost to Follow-up|7|||
164643664|NCT02858076|594718906|FG000|Overall Study|Completed Out of Window|1|||
164643665|NCT02858076|594718907|FG001|Overall Study|Completed Out of Window|3|||
164643666|NCT02643394|594718908|FG000|Overall Study|Protocol Violation|4|||
164643667|NCT02643394|594718909|FG001|Overall Study|Protocol Violation|5|||
164643668|NCT00943384|594718910|FG000|Overall Study|Dispositioned prior to treatment|23|||
164643669|NCT00943384|594718910|FG000|Overall Study|Treated off protocol-protocol violation|5|||
164643670|NCT00943384|594718910|FG000|Overall Study|Lost to Follow-up|16|||
164643671|NCT00943384|594718910|FG000|Overall Study|Withdrawal by Subject|5|||
164643672|NCT00096200|594718911|FG000|Overall Study|Adverse Event|0|||
164643673|NCT00096200|594718912|FG001|Overall Study|Adverse Event|4|||
164643674|NCT00096200|594718913|FG002|Overall Study|Adverse Event|0|||
164643675|NCT00096200|594718911|FG000|Overall Study|Withdrawal by Subject|1|||
164643676|NCT00096200|594718912|FG001|Overall Study|Withdrawal by Subject|2|||
164643677|NCT00096200|594718913|FG002|Overall Study|Withdrawal by Subject|0|||
164643678|NCT00096200|594718911|FG000|Overall Study|Ineligible pathology|0|||
164643679|NCT00096200|594718912|FG001|Overall Study|Ineligible pathology|1|||
164643680|NCT00096200|594718913|FG002|Overall Study|Ineligible pathology|0|||
164643681|NCT03014570|594718921|FG000|Overall Study|COVID-19 Restrictions|38|||
164643682|NCT03014570|594718922|FG001|Overall Study|COVID-19 Restrictions|24|||
164643683|NCT03014570|594718921|FG000|Overall Study|Death|70|||
164643684|NCT03014570|594718922|FG001|Overall Study|Death|79|||
164643685|NCT03014570|594718921|FG000|Overall Study|Transfer from facility|11|||
164643686|NCT03014570|594718922|FG001|Overall Study|Transfer from facility|14|||
164643687|NCT03014570|594718921|FG000|Overall Study|Hospitalized|5|||
164643688|NCT03014570|594718922|FG001|Overall Study|Hospitalized|3|||
164643689|NCT03014570|594718921|FG000|Overall Study|Transfer within facility|1|||
164643690|NCT03014570|594718922|FG001|Overall Study|Transfer within facility|0|||
164643691|NCT03014570|594718921|FG000|Overall Study|Site refusal|0|||
164643692|NCT03014570|594718922|FG001|Overall Study|Site refusal|11|||
164643693|NCT03239340|594718925|FG000|Overall Study|Other|26|||
164643694|NCT03239340|594718925|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
164643695|NCT03239340|594718925|FG000|Overall Study|Death|40|||
164643696|NCT03239340|594718925|FG000|Overall Study|Lost to Follow-up|2|||
164643697|NCT03239340|594718925|FG000|Overall Study|Physician Decision|16|||
164643698|NCT03239340|594718925|FG000|Overall Study|Withdrawal by Subject|27|||
164643699|NCT03539952|594718927|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
164643700|NCT03539952|594718928|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
164643701|NCT03539952|594718927|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
164643702|NCT03539952|594718928|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
164643703|NCT03539952|594718927|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
164643704|NCT03539952|594718928|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
164643705|NCT03539952|594718927|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
164643706|NCT03539952|594718928|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
164643707|NCT03539952|594718927|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
164643708|NCT03539952|594718928|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
164643709|NCT03539952|594718927|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
164643710|NCT03539952|594718928|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
164643711|NCT03539952|594718927|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
164643712|NCT03539952|594718928|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
164643713|NCT00777920|594718929|FG000|Overall Study|Adverse Event|39|||
164643714|NCT00777920|594718929|FG000|Overall Study|Withdrawal of Consent|4|||
164643715|NCT00777920|594718929|FG000|Overall Study|Lost to Follow-up|1|||
164643716|NCT00777920|594718929|FG000|Overall Study|Investigator's discretion|1|||
164643717|NCT00777920|594718929|FG000|Overall Study|Clinical status did not improve|1|||
164643718|NCT00777920|594718929|FG000|Overall Study|Other, not specified|4|||
164643719|NCT02332655|594718930|FG000|Overall Study|Lack of Efficacy|1|||
164643720|NCT01977482|594718931|FG000|Overall Study|Adverse Event|0|||
164643721|NCT01977482|594718932|FG001|Overall Study|Adverse Event|1|||
164643722|NCT01977482|594718933|FG002|Overall Study|Adverse Event|1|||
164643723|NCT01977482|594718934|FG003|Overall Study|Adverse Event|0|||
164643724|NCT01977482|594718935|FG004|Overall Study|Adverse Event|2|||
164643725|NCT01977482|594718936|FG005|Overall Study|Adverse Event|0|||
164643726|NCT01977482|594718931|FG000|Overall Study|Lost to Follow-up|1|||
164643727|NCT01977482|594718932|FG001|Overall Study|Lost to Follow-up|0|||
164643728|NCT01977482|594718933|FG002|Overall Study|Lost to Follow-up|0|||
164643729|NCT01977482|594718934|FG003|Overall Study|Lost to Follow-up|0|||
164643730|NCT01977482|594718935|FG004|Overall Study|Lost to Follow-up|0|||
164643731|NCT01977482|594718936|FG005|Overall Study|Lost to Follow-up|0|||
164643732|NCT01977482|594718931|FG000|Overall Study|Physician Decision|0|||
164643733|NCT01977482|594718932|FG001|Overall Study|Physician Decision|1|||
164643734|NCT01977482|594718933|FG002|Overall Study|Physician Decision|0|||
164643735|NCT01977482|594718934|FG003|Overall Study|Physician Decision|0|||
164643736|NCT01977482|594718935|FG004|Overall Study|Physician Decision|0|||
164643737|NCT01977482|594718936|FG005|Overall Study|Physician Decision|0|||
164643738|NCT01977482|594718931|FG000|Overall Study|Protocol Violation|0|||
164643739|NCT01977482|594718932|FG001|Overall Study|Protocol Violation|0|||
164643740|NCT01977482|594718933|FG002|Overall Study|Protocol Violation|1|||
164643741|NCT01977482|594718934|FG003|Overall Study|Protocol Violation|0|||
164643742|NCT01977482|594718935|FG004|Overall Study|Protocol Violation|0|||
164643743|NCT01977482|594718936|FG005|Overall Study|Protocol Violation|0|||
164643744|NCT01977482|594718931|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
164643745|NCT01977482|594718932|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
164643746|NCT01977482|594718933|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
164643747|NCT01977482|594718934|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
164643748|NCT01977482|594718935|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
164643749|NCT01977482|594718936|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
164643750|NCT01977482|594718931|FG000|Overall Study|Withdrawal by Subject|2|||
164643751|NCT01977482|594718932|FG001|Overall Study|Withdrawal by Subject|4|||
164643752|NCT01977482|594718933|FG002|Overall Study|Withdrawal by Subject|1|||
164643753|NCT01977482|594718934|FG003|Overall Study|Withdrawal by Subject|3|||
164643754|NCT01977482|594718935|FG004|Overall Study|Withdrawal by Subject|1|||
164643755|NCT01977482|594718936|FG005|Overall Study|Withdrawal by Subject|5|||
164643756|NCT01964898|594720029|FG000|Overall Study|ineligible post-randomization|1|||
164643757|NCT01964898|594720030|FG001|Overall Study|ineligible post-randomization|1|||
164643758|NCT01964898|594720029|FG000|Overall Study|did not receive the allocated interventi|2|||
164643759|NCT01964898|594720030|FG001|Overall Study|did not receive the allocated interventi|1|||
164643760|NCT01964898|594720029|FG000|Overall Study|Lost to Follow-up|3|||
164643761|NCT01964898|594720030|FG001|Overall Study|Lost to Follow-up|5|||
164643762|NCT01964898|594720029|FG000|Overall Study|Withdrawal by Subject|1|||
164643763|NCT01964898|594720030|FG001|Overall Study|Withdrawal by Subject|0|||
164643764|NCT02325401|594720031|FG000|Overall Study|Withdrawal by Subject|0|||
164643765|NCT02325401|594720032|FG001|Overall Study|Withdrawal by Subject|1|||
164643766|NCT02325401|594720033|FG002|Overall Study|Withdrawal by Subject|1|||
164643767|NCT02428231|594720036|FG000|Overall Study|Other|10|||
164643768|NCT02428231|594720037|FG001|Overall Study|Other|16|||
164643769|NCT02428231|594720036|FG000|Overall Study|Required Symptomatic Therapy|0|||
164643770|NCT02428231|594720037|FG001|Overall Study|Required Symptomatic Therapy|1|||
164643771|NCT02428231|594720036|FG000|Overall Study|Adverse Event|3|||
164643772|NCT02428231|594720037|FG001|Overall Study|Adverse Event|0|||
164643773|NCT02957682|594720040|FG000|Overall Study|Adverse Event|64|||
164643774|NCT02957682|594720041|FG001|Overall Study|Adverse Event|67|||
164643775|NCT02957682|594720040|FG000|Overall Study|Poor Compliance to Protocol|30|||
164643776|NCT02957682|594720041|FG001|Overall Study|Poor Compliance to Protocol|26|||
164643777|NCT02957682|594720040|FG000|Overall Study|Physician Decision|4|||
164643778|NCT02957682|594720041|FG001|Overall Study|Physician Decision|4|||
164643779|NCT02957682|594720040|FG000|Overall Study|Study Terminated by Sponsor|4|||
164643780|NCT02957682|594720041|FG001|Overall Study|Study Terminated by Sponsor|3|||
164643781|NCT02957682|594720040|FG000|Overall Study|Subject Moved|10|||
164643782|NCT02957682|594720041|FG001|Overall Study|Subject Moved|16|||
164643783|NCT02957682|594720040|FG000|Overall Study|Withdrawal by Subject|64|||
164643784|NCT02957682|594720041|FG001|Overall Study|Withdrawal by Subject|33|||
164643785|NCT02957682|594720040|FG000|Overall Study|Related to IMP Administration|3|||
164643786|NCT02957682|594720041|FG001|Overall Study|Related to IMP Administration|6|||
164643787|NCT02957682|594720040|FG000|Overall Study|Non-disclosed|16|||
164643788|NCT02957682|594720041|FG001|Overall Study|Non-disclosed|12|||
164643789|NCT02957682|594720040|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
164643790|NCT02957682|594720041|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
164643791|NCT00765999|594720042|FG000|Overall Study|Adverse Event|203|||
164643792|NCT00765999|594720042|FG000|Overall Study|Insufficient Therapeutic Response|100|||
164643793|NCT00765999|594720042|FG000|Overall Study|Protocol Violation|95|||
164643794|NCT00765999|594720042|FG000|Overall Study|Consent Withdrawn|202|||
164643795|NCT00765999|594720042|FG000|Overall Study|Lost to Follow-up|131|||
164643796|NCT00765999|594720042|FG000|Overall Study|Study Terminated by Sponsor|2|||
164643797|NCT00765999|594720042|FG000|Overall Study|Other Miscellaneous Reasons|51|||
164643798|NCT00203892|594720043|FG000|Overall Study|Physician Decision|1|||
164643799|NCT00203892|594720044|FG001|Overall Study|Physician Decision|2|||
164643800|NCT00203892|594720045|FG002|Overall Study|Physician Decision|0|||
164643801|NCT00203892|594720043|FG000|Overall Study|Death|1|||
164643802|NCT00203892|594720044|FG001|Overall Study|Death|0|||
164643803|NCT00203892|594720045|FG002|Overall Study|Death|0|||
164643804|NCT02341482|594720049|FG000|Overall Study|Adverse Event|1|||
164643805|NCT03000075|594720053|FG000|Part A|Adverse Event|4|||
164643806|NCT03000075|594720054|FG001|Part A|Adverse Event|0|||
164643807|NCT03000075|594720055|FG002|Part A|Adverse Event|0|||
164643808|NCT03000075|594720056|FG003|Part A|Adverse Event|0|||
164643809|NCT03000075|594720057|FG004|Part A|Adverse Event|0|||
164643810|NCT03000075|594720058|FG005|Part A|Adverse Event|0|||
164643811|NCT03000075|594720059|FG006|Part A|Adverse Event|0|||
164643812|NCT03000075|594720053|FG000|Part B|Not dosed due to AE|0|||
164643813|NCT03000075|594720054|FG001|Part B|Not dosed due to AE|0|||
164643814|NCT03000075|594720055|FG002|Part B|Not dosed due to AE|0|||
164643815|NCT03000075|594720056|FG003|Part B|Not dosed due to AE|0|||
164643816|NCT03000075|594720057|FG004|Part B|Not dosed due to AE|0|||
164643817|NCT03000075|594720058|FG005|Part B|Not dosed due to AE|2|||
164643818|NCT03000075|594720059|FG006|Part B|Not dosed due to AE|1|||
164643819|NCT03000075|594720053|FG000|Part B|Adverse Event|0|||
164643820|NCT03000075|594720054|FG001|Part B|Adverse Event|0|||
164643821|NCT03000075|594720055|FG002|Part B|Adverse Event|0|||
164643822|NCT03000075|594720056|FG003|Part B|Adverse Event|0|||
164643823|NCT03000075|594720057|FG004|Part B|Adverse Event|1|||
164643824|NCT03000075|594720058|FG005|Part B|Adverse Event|0|||
164643825|NCT03000075|594720059|FG006|Part B|Adverse Event|0|||
164643826|NCT00111007|594720060|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
164643827|NCT00111007|594720061|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
164643828|NCT00111007|594720060|FG000|Double-blind (DB) Treatment|Death|5|||
164643829|NCT00111007|594720061|FG001|Double-blind (DB) Treatment|Death|2|||
164643830|NCT00111007|594720060|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
164643831|NCT00111007|594720061|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
164643832|NCT00111007|594720060|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
164643833|NCT00111007|594720061|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
164643834|NCT00111007|594720060|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
164643835|NCT00111007|594720061|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
164643836|NCT00111007|594720060|FG000|Double-blind (DB) Treatment|Relapse|1|||
164643837|NCT00111007|594720061|FG001|Double-blind (DB) Treatment|Relapse|0|||
164643838|NCT00111007|594720060|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
164643839|NCT00111007|594720061|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
164643840|NCT00111007|594720060|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
164643841|NCT00111007|594720061|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
164643842|NCT00111007|594720060|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
164643843|NCT00111007|594720061|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
164643844|NCT00111007|594720060|FG000|Active Follow-up|Adverse Event|1|||
164643845|NCT00111007|594720061|FG001|Active Follow-up|Adverse Event|0|||
164643846|NCT00111007|594720060|FG000|Active Follow-up|Death|2|||
164643847|NCT00111007|594720061|FG001|Active Follow-up|Death|0|||
164643848|NCT00111007|594720060|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
164643849|NCT00111007|594720061|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
164643850|NCT00111007|594720060|FG000|Long Term Follow-up|Death|34|||
164643851|NCT00111007|594720061|FG001|Long Term Follow-up|Death|39|||
164643852|NCT00111007|594720060|FG000|Long Term Follow-up|Lost to Follow-up|1|||
164643853|NCT00111007|594720061|FG001|Long Term Follow-up|Lost to Follow-up|1|||
164643854|NCT00111007|594720060|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
164643855|NCT00111007|594720061|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
164643856|NCT00111007|594720060|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
164643857|NCT00111007|594720061|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
164643858|NCT00111007|594720060|FG000|Long Term Follow-up|Missing|10|||
164643859|NCT00111007|594720061|FG001|Long Term Follow-up|Missing|3|||
164643860|NCT01495793|594720062|FG000|Overall Study|Lost to Follow-up|1|||
164643861|NCT01495793|594720062|FG000|Overall Study|Violation of inclusion criteria|1|||
164643862|NCT01154673|594720063|FG000|Overall Study|Lost to Follow-up|1|||
164643863|NCT01154673|594720064|FG001|Overall Study|Lost to Follow-up|0|||
164643864|NCT01154673|594720063|FG000|Overall Study|moved out of province|1|||
164643865|NCT01154673|594720064|FG001|Overall Study|moved out of province|0|||
164643866|NCT03332212|594720065|FG000|Overall Study|Not treated|0|||
164643867|NCT03332212|594720066|FG001|Overall Study|Not treated|1|||
164643868|NCT03332212|594720067|FG002|Overall Study|Not treated|0|||
164643869|NCT03332212|594720068|FG003|Overall Study|Not treated|0|||
164643870|NCT03332212|594720065|FG000|Overall Study|Adverse Event|0|||
164643871|NCT03332212|594720066|FG001|Overall Study|Adverse Event|0|||
164643872|NCT03332212|594720067|FG002|Overall Study|Adverse Event|0|||
164643873|NCT03332212|594720068|FG003|Overall Study|Adverse Event|1|||
164643874|NCT03332212|594720065|FG000|Overall Study|worsening of disease under study|1|||
164643875|NCT03332212|594720066|FG001|Overall Study|worsening of disease under study|1|||
164643876|NCT03332212|594720067|FG002|Overall Study|worsening of disease under study|0|||
164643877|NCT03332212|594720068|FG003|Overall Study|worsening of disease under study|0|||
164643878|NCT02362646|594720072|FG000|Overall Study|Death|15|||
164643879|NCT02362646|594720073|FG001|Overall Study|Death|8|||
164643880|NCT02362646|594720072|FG000|Overall Study|Withdrawal by Subject|2|||
164643881|NCT02362646|594720073|FG001|Overall Study|Withdrawal by Subject|2|||
164643882|NCT02362646|594720072|FG000|Overall Study|received transplant|21|||
164643883|NCT02362646|594720073|FG001|Overall Study|received transplant|14|||
164643884|NCT01216319|594720077|FG000|Overall Study|Lost to Follow-up|2|||
164643885|NCT01216319|594720077|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
164643886|NCT00929864|594720078|FG000|Overall Study|Death|1|||
164643887|NCT00929864|594720079|FG001|Overall Study|Death|1|||
164643888|NCT00929864|594720078|FG000|Overall Study|Adverse Event|11|||
164643889|NCT00929864|594720079|FG001|Overall Study|Adverse Event|30|||
164643890|NCT00929864|594720078|FG000|Overall Study|Lack of Efficacy|19|||
164643891|NCT00929864|594720079|FG001|Overall Study|Lack of Efficacy|16|||
164643892|NCT00929864|594720078|FG000|Overall Study|Lost to Follow-up|7|||
164643893|NCT00929864|594720079|FG001|Overall Study|Lost to Follow-up|12|||
164643894|NCT00929864|594720078|FG000|Overall Study|Withdrawal by Subject|20|||
164643895|NCT00929864|594720079|FG001|Overall Study|Withdrawal by Subject|9|||
164643896|NCT00929864|594720078|FG000|Overall Study|No longer met criteria|2|||
164643897|NCT00929864|594720079|FG001|Overall Study|No longer met criteria|1|||
164643898|NCT00929864|594720078|FG000|Overall Study|Poor or non-compliance|3|||
164643899|NCT00929864|594720079|FG001|Overall Study|Poor or non-compliance|3|||
164643900|NCT00929864|594720078|FG000|Overall Study|Pregnancy|0|||
164643901|NCT00929864|594720079|FG001|Overall Study|Pregnancy|3|||
164643902|NCT00929864|594720078|FG000|Overall Study|Administrative reason by Sponsor|1|||
164643903|NCT00929864|594720079|FG001|Overall Study|Administrative reason by Sponsor|1|||
164643904|NCT00929864|594720078|FG000|Overall Study|Non-specified|2|||
164643905|NCT00929864|594720079|FG001|Overall Study|Non-specified|7|||
164643906|NCT02666768|594720080|FG000|Overall Study|Withdrawal by Subject|4|||
164643907|NCT03728257|594720081|FG000|Overall Study|Death|3|||
164643908|NCT03728257|594720082|FG001|Overall Study|Death|0|||
164643909|NCT03940742|594720083|FG000|Overall Study|Lost to Follow-up|0|||
164643910|NCT03940742|594720084|FG001|Overall Study|Lost to Follow-up|0|||
164643911|NCT03940742|594720085|FG002|Overall Study|Lost to Follow-up|0|||
164643912|NCT03940742|594720086|FG003|Overall Study|Lost to Follow-up|1|||
164643913|NCT03428217|594720088|FG000|Overall Study|Death|89|||
164643914|NCT03428217|594720089|FG001|Overall Study|Death|93|||
164643915|NCT03428217|594720088|FG000|Overall Study|Withdrawal by Subject|8|||
164643916|NCT03428217|594720089|FG001|Overall Study|Withdrawal by Subject|7|||
164643917|NCT03428217|594720088|FG000|Overall Study|Lost to Follow-up|1|||
164643918|NCT03428217|594720089|FG001|Overall Study|Lost to Follow-up|3|||
164643919|NCT03428217|594720088|FG000|Overall Study|Study terminated by sponsor|124|||
164643920|NCT03428217|594720089|FG001|Overall Study|Study terminated by sponsor|118|||
164643921|NCT03428217|594720088|FG000|Overall Study|Other, Not Specified|1|||
164643922|NCT03428217|594720089|FG001|Overall Study|Other, Not Specified|0|||
164643923|NCT00621309|594720090|FG000|Overall Study|Withdrawal by Subject|2|||
164643924|NCT00621309|594720091|FG001|Overall Study|Withdrawal by Subject|0|||
164643925|NCT00621309|594720092|FG002|Overall Study|Withdrawal by Subject|1|||
164643926|NCT00621309|594720093|FG003|Overall Study|Withdrawal by Subject|1|||
164643927|NCT00621309|594720094|FG004|Overall Study|Withdrawal by Subject|1|||
164643928|NCT00621309|594720095|FG005|Overall Study|Withdrawal by Subject|1|||
164643929|NCT00905437|594720096|FG000|Overall Study|Adverse Event|3|||
164643930|NCT00905437|594720097|FG001|Overall Study|Adverse Event|2|||
164643931|NCT00905437|594720096|FG000|Overall Study|Lost to Follow-up|0|||
164643932|NCT00905437|594720097|FG001|Overall Study|Lost to Follow-up|1|||
164643933|NCT00905437|594720096|FG000|Overall Study|Withdrawal by Subject|0|||
164643934|NCT00905437|594720097|FG001|Overall Study|Withdrawal by Subject|1|||
164643935|NCT00905437|594720096|FG000|Overall Study|Other|5|||
164643936|NCT00905437|594720097|FG001|Overall Study|Other|6|||
164643937|NCT05246111|594720098|FG000|Period 01|NOT ELIGIBLE IC5|1|||
164643938|NCT05246111|594720099|FG001|Period 01|NOT ELIGIBLE IC5|0|||
164643939|NCT01306968|594720102|FG000|Overall Study|Lost to Follow-up|1|||
164643940|NCT01306968|594720103|FG001|Overall Study|Lost to Follow-up|1|||
164643941|NCT01306968|594720104|FG002|Overall Study|Lost to Follow-up|0|||
164643942|NCT01306968|594720105|FG003|Overall Study|Lost to Follow-up|0|||
164643943|NCT01306968|594720102|FG000|Overall Study|Physician Decision|0|||
164643944|NCT01306968|594720103|FG001|Overall Study|Physician Decision|1|||
164643945|NCT01306968|594720104|FG002|Overall Study|Physician Decision|0|||
164643946|NCT01306968|594720105|FG003|Overall Study|Physician Decision|0|||
164643947|NCT01306968|594720102|FG000|Overall Study|Relocated and left active duty|0|||
164643948|NCT01306968|594720103|FG001|Overall Study|Relocated and left active duty|1|||
164643949|NCT01306968|594720104|FG002|Overall Study|Relocated and left active duty|1|||
164643950|NCT01306968|594720105|FG003|Overall Study|Relocated and left active duty|1|||
164643951|NCT01306968|594720102|FG000|Overall Study|Withdrew - time commitment|0|||
164643952|NCT01306968|594720103|FG001|Overall Study|Withdrew - time commitment|0|||
164643953|NCT01306968|594720104|FG002|Overall Study|Withdrew - time commitment|0|||
164643954|NCT01306968|594720105|FG003|Overall Study|Withdrew - time commitment|2|||
164643955|NCT01306968|594720102|FG000|Overall Study|Withdrew over privacy concerns|0|||
164643956|NCT01306968|594720103|FG001|Overall Study|Withdrew over privacy concerns|0|||
164643957|NCT01306968|594720104|FG002|Overall Study|Withdrew over privacy concerns|0|||
164643958|NCT01306968|594720105|FG003|Overall Study|Withdrew over privacy concerns|1|||
164643959|NCT02736695|594720106|FG000|Overall Study|Ineligible|6|||
164643960|NCT02736695|594720107|FG001|Overall Study|Ineligible|0|||
164643961|NCT01329562|594720110|FG000|Overall Study|Protocol Violation|5|||
164643962|NCT01329562|594720111|FG001|Overall Study|Protocol Violation|3|||
164643963|NCT01329562|594720110|FG000|Overall Study|Lost to Follow-up|1|||
164643964|NCT01329562|594720111|FG001|Overall Study|Lost to Follow-up|1|||
164643965|NCT01329562|594720110|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
164643966|NCT01329562|594720111|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
164643967|NCT01329562|594720110|FG000|Overall Study|Physician Decision|0|||
164643968|NCT01329562|594720111|FG001|Overall Study|Physician Decision|1|||
164643969|NCT03252015|594720112|FG000|Overall Study|Withdrawal by Subject|0|||
164643970|NCT03252015|594720113|FG001|Overall Study|Withdrawal by Subject|1|||
164643971|NCT03252015|594720114|FG002|Overall Study|Withdrawal by Subject|1|||
164643972|NCT03252015|594720115|FG003|Overall Study|Withdrawal by Subject|0|||
164643973|NCT03252015|594720112|FG000|Overall Study|Adverse Event|1|||
164643974|NCT03252015|594720113|FG001|Overall Study|Adverse Event|0|||
164643975|NCT03252015|594720114|FG002|Overall Study|Adverse Event|0|||
164643976|NCT03252015|594720115|FG003|Overall Study|Adverse Event|1|||
164643977|NCT04993339|594720116|FG000|Overall Study|Lost to Follow-up|0|||
164643978|NCT04993339|594720117|FG001|Overall Study|Lost to Follow-up|1|||
164643979|NCT04993339|594720116|FG000|Overall Study|no MRI scan|3|||
164643980|NCT04993339|594720117|FG001|Overall Study|no MRI scan|1|||
164643981|NCT03151226|594720118|FG000|Overall Study|Withdrawal by Subject|2|||
164643982|NCT03151226|594720118|FG000|Overall Study|not wear device correctly|1|||
164643983|NCT00061568|594720119|FG000|Overall Study|Lost to Follow-up|12|||
164643984|NCT00061568|594720120|FG001|Overall Study|Lost to Follow-up|0|||
164643985|NCT00061568|594720119|FG000|Overall Study|Death|6|||
164643986|NCT00061568|594720120|FG001|Overall Study|Death|0|||
164643987|NCT00061568|594720119|FG000|Overall Study|Withdrawal by Subject|1|||
164643988|NCT00061568|594720120|FG001|Overall Study|Withdrawal by Subject|0|||
164643989|NCT01381068|594720121|FG000|Overall Study|Death|1|||
164643990|NCT01381068|594720122|FG001|Overall Study|Death|0|||
164643991|NCT00903409|594720123|FG000|Overall Study|Adverse Event|11|||
164643992|NCT00903409|594720124|FG001|Overall Study|Adverse Event|9|||
164643993|NCT00903409|594720123|FG000|Overall Study|Non-compliance with Protocol|1|||
164643994|NCT00903409|594720124|FG001|Overall Study|Non-compliance with Protocol|1|||
164643995|NCT00903409|594720123|FG000|Overall Study|Laboratory Abnormality|2|||
164643996|NCT00903409|594720124|FG001|Overall Study|Laboratory Abnormality|0|||
164643997|NCT00903409|594720123|FG000|Overall Study|Withdrawal by Subject|8|||
164643998|NCT00903409|594720124|FG001|Overall Study|Withdrawal by Subject|8|||
164643999|NCT00903409|594720123|FG000|Overall Study|Other|2|||
164644000|NCT00903409|594720124|FG001|Overall Study|Other|3|||
164644001|NCT00903409|594720123|FG000|Overall Study|Lost to Follow-up|2|||
164644002|NCT00903409|594720124|FG001|Overall Study|Lost to Follow-up|6|||
164644003|NCT00797316|594720125|FG000|Overall Study|Administrative problems|1|||
164644004|NCT00797316|594720126|FG001|Overall Study|Administrative problems|0|||
164644005|NCT00797316|594720125|FG000|Overall Study|Adverse Event|5|||
164644006|NCT00797316|594720126|FG001|Overall Study|Adverse Event|3|||
164644007|NCT00797316|594720125|FG000|Overall Study|Lost to Follow-up|4|||
164644008|NCT00797316|594720126|FG001|Overall Study|Lost to Follow-up|8|||
164644009|NCT00797316|594720125|FG000|Overall Study|Protocol Deviation|1|||
164644010|NCT00797316|594720126|FG001|Overall Study|Protocol Deviation|2|||
164644011|NCT00797316|594720125|FG000|Overall Study|Patient withdrew consent|12|||
164644012|NCT00797316|594720126|FG001|Overall Study|Patient withdrew consent|6|||
164644013|NCT00797316|594720125|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164644014|NCT00797316|594720126|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
164644015|NCT00402779|594720129|FG000|Overall Study|Screen Failure|77|||
164644016|NCT00402779|594720130|FG001|Overall Study|Screen Failure|76|||
164644017|NCT01907516|594720135|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
164644018|NCT01907516|594720136|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
164644019|NCT01907516|594720135|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
164644020|NCT01907516|594720136|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
164644021|NCT01907516|594720135|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
164644022|NCT01907516|594720136|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
164644023|NCT01907516|594720135|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
164644024|NCT01907516|594720136|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
164644025|NCT02184988|594720137|FG000|Overall Study|Pregnancy|2|||
164644026|NCT02184988|594720137|FG000|Overall Study|Adverse Event|2|||
164644027|NCT02184988|594720137|FG000|Overall Study|moving away/travelling/unable to complet|6|||
164644028|NCT02184988|594720137|FG000|Overall Study|work scheduling issues|4|||
164644029|NCT02184988|594720137|FG000|Overall Study|various other reasons|9|||
164644030|NCT02184988|594720137|FG000|Overall Study|Lost to Follow-up|32|||
164644031|NCT03075215|594720139|FG000|12-Month Primary Endpoint|Death|152|||
164644032|NCT03075215|594720139|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
164644033|NCT03075215|594720139|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
164644034|NCT03075215|594720139|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
164644035|NCT00690573|594720148|FG000|Overall Study|Lack of Efficacy|8|||
164644036|NCT00690573|594720148|FG000|Overall Study|Withdrawal by Subject|1|||
164644037|NCT01126359|594720149|FG000|First Intervention (20-minutes)|Physician Decision|0|||
164644038|NCT01126359|594720150|FG001|First Intervention (20-minutes)|Physician Decision|1|||
164644039|NCT00526227|594720157|FG000|Overall Study|Device not implanted|1|||
164644040|NCT00526227|594720157|FG000|Overall Study|Death|1|||
164644041|NCT01525407|594720158|FG000|Overall Study|Change in recipient treatment plan|2|||
164644042|NCT01525407|594720159|FG001|Overall Study|Change in recipient treatment plan|2|||
164644043|NCT01525407|594720158|FG000|Overall Study|Withdrawal by Subject|0|||
164644044|NCT01525407|594720159|FG001|Overall Study|Withdrawal by Subject|1|||
164644045|NCT01525407|594720158|FG000|Overall Study|Transplant was delayed|0|||
164644046|NCT01525407|594720159|FG001|Overall Study|Transplant was delayed|1|||
164644047|NCT01525407|594720158|FG000|Overall Study|Delay in Transplant|1|||
164644048|NCT01525407|594720159|FG001|Overall Study|Delay in Transplant|0|||
164644049|NCT05257109|594720160|FG000|Overall Study|Withdrawal by Subject|1|||
164644050|NCT05257109|594720161|FG001|Overall Study|Withdrawal by Subject|0|||
164644051|NCT05257109|594720162|FG002|Overall Study|Withdrawal by Subject|0|||
164644052|NCT05257109|594720163|FG003|Overall Study|Withdrawal by Subject|0|||
164644053|NCT00858234|594721723|FG000|Overall Study|Adverse Event|6|||
164644054|NCT00858234|594721723|FG000|Overall Study|Progressive disease|2|||
164644055|NCT00858234|594721723|FG000|Overall Study|Status unknown|1|||
164644056|NCT01678924|594721724|FG000|Overall Study|Adverse Event|1|||
164644057|NCT01678924|594721725|FG001|Overall Study|Adverse Event|1|||
164644058|NCT01678924|594721726|FG002|Overall Study|Adverse Event|0|||
164644059|NCT01678924|594721727|FG003|Overall Study|Adverse Event|1|||
164644060|NCT01678924|594721724|FG000|Overall Study|Lack of Efficacy|7|||
164644061|NCT01678924|594721725|FG001|Overall Study|Lack of Efficacy|2|||
164644062|NCT01678924|594721726|FG002|Overall Study|Lack of Efficacy|0|||
164644063|NCT01678924|594721727|FG003|Overall Study|Lack of Efficacy|5|||
164644064|NCT01678924|594721724|FG000|Overall Study|Lost to Follow-up|0|||
164644065|NCT01678924|594721725|FG001|Overall Study|Lost to Follow-up|4|||
164644066|NCT01678924|594721726|FG002|Overall Study|Lost to Follow-up|0|||
164644067|NCT01678924|594721727|FG003|Overall Study|Lost to Follow-up|2|||
164644068|NCT01678924|594721724|FG000|Overall Study|Personal Reasons|2|||
164644069|NCT01678924|594721725|FG001|Overall Study|Personal Reasons|2|||
164644070|NCT01678924|594721726|FG002|Overall Study|Personal Reasons|2|||
164644071|NCT01678924|594721727|FG003|Overall Study|Personal Reasons|7|||
164644072|NCT01678924|594721724|FG000|Overall Study|Withdrawal by Subject|0|||
164644073|NCT01678924|594721725|FG001|Overall Study|Withdrawal by Subject|3|||
164644074|NCT01678924|594721726|FG002|Overall Study|Withdrawal by Subject|0|||
164644075|NCT01678924|594721727|FG003|Overall Study|Withdrawal by Subject|2|||
164644076|NCT01678924|594721724|FG000|Overall Study|Unable to attend scheduled visits|0|||
164644077|NCT01678924|594721725|FG001|Overall Study|Unable to attend scheduled visits|0|||
164644078|NCT01678924|594721726|FG002|Overall Study|Unable to attend scheduled visits|0|||
164644079|NCT01678924|594721727|FG003|Overall Study|Unable to attend scheduled visits|1|||
164644080|NCT02253654|594721728|FG000|Overall Study|Withdrawal by Subject|12|||
164644081|NCT02253654|594721729|FG001|Overall Study|Withdrawal by Subject|4|||
164644082|NCT02253654|594721728|FG000|Overall Study|Decision by Sponsor|1|||
164644083|NCT02253654|594721729|FG001|Overall Study|Decision by Sponsor|1|||
164644084|NCT02253654|594721728|FG000|Overall Study|Lost to Follow-up|2|||
164644085|NCT02253654|594721729|FG001|Overall Study|Lost to Follow-up|5|||
164644086|NCT02253654|594721728|FG000|Overall Study|Death|4|||
164644087|NCT02253654|594721729|FG001|Overall Study|Death|7|||
164644088|NCT02253654|594721728|FG000|Overall Study|Did Not Receive Study Treatment|4|||
164644089|NCT02253654|594721729|FG001|Overall Study|Did Not Receive Study Treatment|1|||
164644090|NCT01614925|594721730|FG000|Overall Study|Withdrawal by Subject|1|||
164644091|NCT01614925|594721731|FG001|Overall Study|Withdrawal by Subject|0|||
164644092|NCT01614925|594721730|FG000|Overall Study|Protocol Violation|3|||
164644093|NCT01614925|594721731|FG001|Overall Study|Protocol Violation|2|||
164644094|NCT02953262|594721740|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
164644095|NCT02953262|594721741|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
164644096|NCT02953262|594721742|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
164644097|NCT02953262|594721743|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
164644098|NCT01652573|594721744|FG000|Overall Study|Adverse Event|0|||
164644099|NCT01652573|594721745|FG001|Overall Study|Adverse Event|1|||
164644100|NCT03284424|594721746|FG000|Overall Study|Death|70|||
164644101|NCT03284424|594721747|FG001|Overall Study|Death|24|||
164644102|NCT03284424|594721746|FG000|Overall Study|Lost to Follow-up|3|||
164644103|NCT03284424|594721747|FG001|Overall Study|Lost to Follow-up|1|||
164644104|NCT03284424|594721746|FG000|Overall Study|Physician Decision|1|||
164644105|NCT03284424|594721747|FG001|Overall Study|Physician Decision|2|||
164644106|NCT03284424|594721746|FG000|Overall Study|Withdrawal by Subject|4|||
164644107|NCT03284424|594721747|FG001|Overall Study|Withdrawal by Subject|5|||
164644108|NCT03284424|594721746|FG000|Overall Study|Sponsor's decision|27|||
164644109|NCT03284424|594721747|FG001|Overall Study|Sponsor's decision|22|||
164644110|NCT01052038|594721748|FG000|Overall Study|Lost to Follow-up|2|||
164644111|NCT01052038|594721749|FG001|Overall Study|Lost to Follow-up|3|||
164644112|NCT01052038|594721750|FG002|Overall Study|Lost to Follow-up|1|||
164644113|NCT01052038|594721748|FG000|Overall Study|Protocol Violation|2|||
164644114|NCT01052038|594721749|FG001|Overall Study|Protocol Violation|3|||
164644115|NCT01052038|594721750|FG002|Overall Study|Protocol Violation|3|||
164644116|NCT03349437|594721751|FG000|Screening|Screen Fail|4|||
164644117|NCT03349437|594721752|FG001|Screening|Screen Fail|0|||
164644118|NCT03349437|594721753|FG002|Screening|Screen Fail|0|||
164644119|NCT03349437|594721751|FG000|Screening|Withdrawn|1|||
164644120|NCT03349437|594721752|FG001|Screening|Withdrawn|0|||
164644121|NCT03349437|594721753|FG002|Screening|Withdrawn|0|||
164644122|NCT05723835|594721758|FG000|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|4|||
164644123|NCT05723835|594721759|FG001|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
164644124|NCT05723835|594721760|FG002|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|3|||
164644125|NCT05723835|594721761|FG003|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
164644126|NCT05723835|594721762|FG004|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|6|||
164644127|NCT05723835|594721763|FG005|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|7|||
164644128|NCT05723835|594721764|FG006|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|2|||
164644129|NCT05723835|594721765|FG007|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|9|||
164644130|NCT05226286|594721766|FG000|Overall Study|Screen failures prior to implant|62|||
164644131|NCT05226286|594721766|FG000|Overall Study|Withdrawal by Subject|13|||
164644132|NCT05226286|594721766|FG000|Overall Study|Lost to Follow-up|3|||
164644133|NCT05226286|594721766|FG000|Overall Study|Physician Decision|1|||
164644134|NCT05226286|594721766|FG000|Overall Study|Adverse Event|1|||
164644135|NCT05226286|594721766|FG000|Overall Study|Death|1|||
164644136|NCT05226286|594721766|FG000|Overall Study|Device explant with no planned replacement|1|||
164644137|NCT05226286|594721766|FG000|Overall Study|Planned surgery with an implanted metal material closer than allowed in research protocol|1|||
164644138|NCT05226286|594721766|FG000|Overall Study|Transitioned to urethral catheter/suprapubic tube|1|||
164644139|NCT00602641|594721767|FG000|Overall Study|Never started protocol therapy|6|||
164644140|NCT00602641|594721768|FG001|Overall Study|Never started protocol therapy|2|||
164644141|NCT00602641|594721767|FG000|Overall Study|Still on treatment at time of analysis|8|||
164644142|NCT00602641|594721768|FG001|Overall Study|Still on treatment at time of analysis|15|||
164644143|NCT00602641|594721767|FG000|Overall Study|Adverse Event|62|||
164644144|NCT00602641|594721768|FG001|Overall Study|Adverse Event|53|||
164644145|NCT00602641|594721767|FG000|Overall Study|Disease progression|38|||
164644146|NCT00602641|594721768|FG001|Overall Study|Disease progression|55|||
164644147|NCT00602641|594721767|FG000|Overall Study|Death|6|||
164644148|NCT00602641|594721768|FG001|Overall Study|Death|5|||
164644149|NCT00602641|594721767|FG000|Overall Study|Withdrawal by Subject|15|||
164644150|NCT00602641|594721768|FG001|Overall Study|Withdrawal by Subject|12|||
164644151|NCT00602641|594721767|FG000|Overall Study|Alternative therapy|5|||
164644152|NCT00602641|594721768|FG001|Overall Study|Alternative therapy|2|||
164644153|NCT00602641|594721767|FG000|Overall Study|Other Complicating Disease|5|||
164644154|NCT00602641|594721768|FG001|Overall Study|Other Complicating Disease|2|||
164644155|NCT00602641|594721767|FG000|Overall Study|Physician Decision|5|||
164644156|NCT00602641|594721768|FG001|Overall Study|Physician Decision|4|||
164644157|NCT00602641|594721767|FG000|Overall Study|Administrative Closure|1|||
164644158|NCT00602641|594721768|FG001|Overall Study|Administrative Closure|1|||
164644159|NCT00602641|594721767|FG000|Overall Study|Other|3|||
164644160|NCT00602641|594721768|FG001|Overall Study|Other|1|||
164644161|NCT03901339|594721769|FG000|Overall Study|Death|220|||
164644162|NCT03901339|594721770|FG001|Overall Study|Death|192|||
164644163|NCT03901339|594721769|FG000|Overall Study|Informed consent withdrawn|13|||
164644164|NCT03901339|594721770|FG001|Overall Study|Informed consent withdrawn|40|||
164644165|NCT03901339|594721769|FG000|Overall Study|Sponsor request|30|||
164644166|NCT03901339|594721770|FG001|Overall Study|Sponsor request|23|||
164644167|NCT03901339|594721769|FG000|Overall Study|Reason not specified|5|||
164644168|NCT03901339|594721770|FG001|Overall Study|Reason not specified|7|||
164644169|NCT03901339|594721769|FG000|Overall Study|Lost to Follow-up|4|||
164644170|NCT03901339|594721770|FG001|Overall Study|Lost to Follow-up|7|||
164644171|NCT03901339|594721769|FG000|Overall Study|Covid19|0|||
164644172|NCT03901339|594721770|FG001|Overall Study|Covid19|2|||
164644173|NCT01988337|594721773|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
164644174|NCT00457418|594721774|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
164644175|NCT00457418|594721774|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
164644176|NCT00457418|594721774|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
164644177|NCT00457418|594721774|FG000|Post PK Maintenance|Adverse Event|10|||
164644178|NCT00457418|594721774|FG000|Post PK Maintenance|Progression of Disease|6|||
164644179|NCT00457418|594721774|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
164644180|NCT00457418|594721774|FG000|Post PK Maintenance|Lost to Follow-up|1|||
164644181|NCT00110084|594721777|FG000|Overall Study|Adverse Event|9|||
164644182|NCT00110084|594721777|FG000|Overall Study|Death|1|||
164148625|NCT04895982|592904921|FG010|Overall Study|Protocol Violation|0|||
164644183|NCT00110084|594721777|FG000|Overall Study|Patient Refusal|10|||
164644184|NCT00110084|594721777|FG000|Overall Study|Alternate Therapy|5|||
164644185|NCT00110084|594721777|FG000|Overall Study|Intercurrent Illness|1|||
164644186|NCT00110084|594721777|FG000|Overall Study|Other|2|||
164644187|NCT04854707|594721779|FG000|Overall Study|Lack of Efficacy|78|||
164644188|NCT04854707|594721780|FG001|Overall Study|Lack of Efficacy|59|||
164644189|NCT04854707|594721781|FG002|Overall Study|Lack of Efficacy|30|||
164644190|NCT01071083|594721792|FG000|Overall Study|Adverse Event|1|||
164644191|NCT01071083|594721793|FG001|Overall Study|Adverse Event|0|||
164644192|NCT01071083|594721794|FG002|Overall Study|Adverse Event|1|||
164644193|NCT01071083|594721795|FG003|Overall Study|Adverse Event|0|||
164644194|NCT01071083|594721796|FG004|Overall Study|Adverse Event|1|||
164644195|NCT01071083|594721792|FG000|Overall Study|Withdrawal by Subject|3|||
164644196|NCT01071083|594721793|FG001|Overall Study|Withdrawal by Subject|0|||
164644197|NCT01071083|594721794|FG002|Overall Study|Withdrawal by Subject|2|||
164644198|NCT01071083|594721795|FG003|Overall Study|Withdrawal by Subject|0|||
164644199|NCT01071083|594721796|FG004|Overall Study|Withdrawal by Subject|3|||
164644200|NCT01071083|594721792|FG000|Overall Study|Physician Decision|1|||
164644201|NCT01071083|594721793|FG001|Overall Study|Physician Decision|0|||
164644202|NCT01071083|594721794|FG002|Overall Study|Physician Decision|0|||
164644203|NCT01071083|594721795|FG003|Overall Study|Physician Decision|1|||
164644204|NCT01071083|594721796|FG004|Overall Study|Physician Decision|1|||
164644205|NCT01071083|594721792|FG000|Overall Study|Early Rescue|1|||
164644206|NCT01071083|594721793|FG001|Overall Study|Early Rescue|0|||
164644207|NCT01071083|594721794|FG002|Overall Study|Early Rescue|0|||
164644208|NCT01071083|594721795|FG003|Overall Study|Early Rescue|0|||
164644209|NCT01071083|594721796|FG004|Overall Study|Early Rescue|1|||
164644210|NCT01071083|594721792|FG000|Overall Study|Subject Moved|0|||
164644211|NCT01071083|594721793|FG001|Overall Study|Subject Moved|1|||
164644212|NCT01071083|594721794|FG002|Overall Study|Subject Moved|0|||
164644213|NCT01071083|594721795|FG003|Overall Study|Subject Moved|0|||
164644214|NCT01071083|594721796|FG004|Overall Study|Subject Moved|0|||
164644215|NCT01071083|594721792|FG000|Overall Study|Images Not Usable (Motion)|0|||
164644216|NCT01071083|594721793|FG001|Overall Study|Images Not Usable (Motion)|1|||
164644217|NCT01071083|594721794|FG002|Overall Study|Images Not Usable (Motion)|0|||
164644218|NCT01071083|594721795|FG003|Overall Study|Images Not Usable (Motion)|0|||
164644219|NCT01071083|594721796|FG004|Overall Study|Images Not Usable (Motion)|0|||
164644220|NCT01071083|594721792|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
164644221|NCT01071083|594721793|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
164644222|NCT01071083|594721794|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
164644223|NCT01071083|594721795|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
164644224|NCT01071083|594721796|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
164644225|NCT01071083|594721792|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
164644226|NCT01071083|594721793|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
164644227|NCT01071083|594721794|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
164644228|NCT01071083|594721795|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
164644229|NCT01071083|594721796|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
164644230|NCT01071083|594721792|FG000|Overall Study|Subject Refused to Continue|1|||
164644231|NCT01071083|594721793|FG001|Overall Study|Subject Refused to Continue|0|||
164644232|NCT01071083|594721794|FG002|Overall Study|Subject Refused to Continue|0|||
164644233|NCT01071083|594721795|FG003|Overall Study|Subject Refused to Continue|0|||
164644234|NCT01071083|594721796|FG004|Overall Study|Subject Refused to Continue|0|||
164644235|NCT00038467|594721797|FG000|Overall Study|Adverse Event|170|||
164644236|NCT00038467|594721798|FG001|Overall Study|Adverse Event|145|||
164644237|NCT00038467|594721797|FG000|Overall Study|Withdrawal by Subject|150|||
164644238|NCT00038467|594721798|FG001|Overall Study|Withdrawal by Subject|107|||
164644239|NCT00038467|594721797|FG000|Overall Study|Protocol Violation|19|||
164644240|NCT00038467|594721798|FG001|Overall Study|Protocol Violation|22|||
164644241|NCT00038467|594721797|FG000|Overall Study|Death|22|||
164644242|NCT00038467|594721798|FG001|Overall Study|Death|16|||
164644243|NCT00038467|594721797|FG000|Overall Study|Lost to Follow-up|15|||
164644244|NCT00038467|594721798|FG001|Overall Study|Lost to Follow-up|10|||
164644245|NCT00038467|594721797|FG000|Overall Study|Recurrence|109|||
164644246|NCT00038467|594721798|FG001|Overall Study|Recurrence|179|||
164644247|NCT00038467|594721797|FG000|Overall Study|Randomized, but not treated|31|||
164644248|NCT00038467|594721798|FG001|Overall Study|Randomized, but not treated|35|||
164644249|NCT00038467|594721797|FG000|Overall Study|Other|26|||
164644250|NCT00038467|594721798|FG001|Overall Study|Other|28|||
164644251|NCT01523301|594721799|FG000|Overall Study|Adverse Event|25|||
164644252|NCT01523301|594721800|FG001|Overall Study|Adverse Event|16|||
164644253|NCT01523301|594721799|FG000|Overall Study|Lack of Efficacy|0|||
164644254|NCT01523301|594721800|FG001|Overall Study|Lack of Efficacy|2|||
164644255|NCT01523301|594721799|FG000|Overall Study|Protocol Violation|3|||
164644256|NCT01523301|594721800|FG001|Overall Study|Protocol Violation|4|||
164644257|NCT01523301|594721799|FG000|Overall Study|Lost to Follow-up|1|||
164644258|NCT01523301|594721800|FG001|Overall Study|Lost to Follow-up|0|||
164644259|NCT01523301|594721799|FG000|Overall Study|Withdrawal by Subject|6|||
164644260|NCT01523301|594721800|FG001|Overall Study|Withdrawal by Subject|8|||
164644261|NCT01523301|594721799|FG000|Overall Study|Other Reason|0|||
164644262|NCT01523301|594721800|FG001|Overall Study|Other Reason|2|||
164644263|NCT01339000|594721801|FG000|Overall Study|study closed due to lack of drug supply|1|||
164644264|NCT01339000|594721802|FG001|Overall Study|study closed due to lack of drug supply|0|||
164644265|NCT00728988|594721803|FG000|Overall Study|Not Treated|2|||
164644266|NCT00728988|594721804|FG001|Overall Study|Not Treated|2|||
164644267|NCT00728988|594721803|FG000|Overall Study|Death|1|||
164644268|NCT00728988|594721804|FG001|Overall Study|Death|1|||
164644269|NCT00728988|594721803|FG000|Overall Study|Adverse Event|3|||
164644270|NCT00728988|594721804|FG001|Overall Study|Adverse Event|2|||
164644271|NCT00728988|594721803|FG000|Overall Study|Other|85|||
164644272|NCT00728988|594721804|FG001|Overall Study|Other|77|||
164644273|NCT00728988|594721803|FG000|Overall Study|Withdrawal by Subject|2|||
164644274|NCT00728988|594721804|FG001|Overall Study|Withdrawal by Subject|6|||
164644275|NCT02017535|594721807|FG000|Overall Study|Withdrawal by Subject|1|||
164644276|NCT02017535|594721808|FG001|Overall Study|Withdrawal by Subject|0|||
164644277|NCT02017535|594721809|FG002|Overall Study|Withdrawal by Subject|0|||
164644278|NCT02017535|594721810|FG003|Overall Study|Withdrawal by Subject|0|||
164644279|NCT05511428|594721811|FG000|Overall Study|Withdrawal by Subject|1|||
164644280|NCT05511428|594721811|FG000|Overall Study|Adverse Event|1|||
164644281|NCT04088734|594721812|FG000|Overall Study|Other, Not Specified|5|||
164644282|NCT03829462|594721813|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
164644283|NCT03829462|594721814|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
164644284|NCT03829462|594721813|FG000|Overall Study|No treatment due to progression disease|0|||
164644285|NCT03829462|594721814|FG001|Overall Study|No treatment due to progression disease|1|||
164644286|NCT00664066|594721819|FG000|Overall Study|Study terminated|3|||
164644287|NCT00481871|594721821|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
164644288|NCT00481871|594721822|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
164644289|NCT00481871|594721823|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
164644290|NCT00481871|594721824|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
164644291|NCT00481871|594721825|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
164644292|NCT02146365|594721833|FG000|Overall Study|Lost to Follow-up|2|||
164644293|NCT02146365|594721834|FG001|Overall Study|Lost to Follow-up|1|||
164644294|NCT02146365|594721835|FG002|Overall Study|Lost to Follow-up|3|||
164644295|NCT02146365|594721836|FG003|Overall Study|Lost to Follow-up|3|||
164644296|NCT02146365|594721837|FG004|Overall Study|Lost to Follow-up|1|||
164644297|NCT02146365|594721838|FG005|Overall Study|Lost to Follow-up|1|||
164644298|NCT02146365|594721839|FG006|Overall Study|Lost to Follow-up|0|||
164644299|NCT02146365|594721840|FG007|Overall Study|Lost to Follow-up|1|||
164644300|NCT02146365|594721833|FG000|Overall Study|Withdrawal by Subject|1|||
164644301|NCT02146365|594721834|FG001|Overall Study|Withdrawal by Subject|2|||
164644302|NCT02146365|594721835|FG002|Overall Study|Withdrawal by Subject|1|||
164644303|NCT02146365|594721836|FG003|Overall Study|Withdrawal by Subject|5|||
164644304|NCT02146365|594721837|FG004|Overall Study|Withdrawal by Subject|1|||
164644305|NCT02146365|594721838|FG005|Overall Study|Withdrawal by Subject|0|||
164644306|NCT02146365|594721839|FG006|Overall Study|Withdrawal by Subject|0|||
164644307|NCT02146365|594721840|FG007|Overall Study|Withdrawal by Subject|0|||
164644308|NCT02146365|594721833|FG000|Overall Study|Unable to Comply with Protocol|0|||
164644309|NCT02146365|594721834|FG001|Overall Study|Unable to Comply with Protocol|1|||
164644310|NCT02146365|594721835|FG002|Overall Study|Unable to Comply with Protocol|1|||
164644311|NCT02146365|594721836|FG003|Overall Study|Unable to Comply with Protocol|0|||
164644312|NCT02146365|594721837|FG004|Overall Study|Unable to Comply with Protocol|0|||
164644313|NCT02146365|594721838|FG005|Overall Study|Unable to Comply with Protocol|0|||
164644314|NCT02146365|594721839|FG006|Overall Study|Unable to Comply with Protocol|0|||
164644315|NCT02146365|594721840|FG007|Overall Study|Unable to Comply with Protocol|0|||
164644316|NCT02146365|594721833|FG000|Overall Study|Other|1|||
164644317|NCT02146365|594721834|FG001|Overall Study|Other|0|||
164644318|NCT02146365|594721835|FG002|Overall Study|Other|2|||
164644319|NCT02146365|594721836|FG003|Overall Study|Other|1|||
164644320|NCT02146365|594721837|FG004|Overall Study|Other|0|||
164644321|NCT02146365|594721838|FG005|Overall Study|Other|0|||
164644322|NCT02146365|594721839|FG006|Overall Study|Other|0|||
164644323|NCT02146365|594721840|FG007|Overall Study|Other|0|||
164644324|NCT00975000|594721841|FG000|Overall Study|Other|1|||
164644325|NCT00975000|594721842|FG001|Overall Study|Other|0|||
164644326|NCT00975000|594721841|FG000|Overall Study|Adverse Event|1|||
164644327|NCT00975000|594721842|FG001|Overall Study|Adverse Event|1|||
164644328|NCT00975000|594721841|FG000|Overall Study|Withdrawal by Subject|2|||
164644329|NCT00975000|594721842|FG001|Overall Study|Withdrawal by Subject|2|||
164644330|NCT00975000|594721841|FG000|Overall Study|Lost to Follow-up|0|||
164644331|NCT00975000|594721842|FG001|Overall Study|Lost to Follow-up|1|||
164644332|NCT00975000|594721841|FG000|Overall Study|Protocol-specified Criteria|1|||
164644333|NCT00975000|594721842|FG001|Overall Study|Protocol-specified Criteria|0|||
164644334|NCT00975000|594721841|FG000|Overall Study|Non-compliance|0|||
164644335|NCT00975000|594721842|FG001|Overall Study|Non-compliance|1|||
164644336|NCT00902486|594721845|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
164644337|NCT00902486|594721846|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
164644338|NCT00902486|594721847|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
164644339|NCT00902486|594721848|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
164644340|NCT00902486|594721849|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
164644341|NCT00902486|594721850|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
164644342|NCT00902486|594721845|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
164644343|NCT00902486|594721846|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
164644344|NCT00902486|594721847|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
164644345|NCT00902486|594721848|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
164644346|NCT00902486|594721849|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
164644347|NCT00902486|594721850|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
164644348|NCT00902486|594721845|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
164644349|NCT00902486|594721846|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
164644350|NCT00902486|594721847|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
164644351|NCT00902486|594721848|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
164644352|NCT00902486|594721849|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
164644353|NCT00902486|594721850|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
164644354|NCT00902486|594721845|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
164644355|NCT00902486|594721846|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
164644356|NCT00902486|594721847|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
164644357|NCT00902486|594721848|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
164644358|NCT00902486|594721849|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
164644359|NCT00902486|594721850|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
164644360|NCT00902486|594721845|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
164644361|NCT00902486|594721846|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
164644362|NCT00902486|594721847|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
164644363|NCT00902486|594721848|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
164644364|NCT00902486|594721849|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
164644365|NCT00902486|594721850|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
164644366|NCT00902486|594721845|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
164644367|NCT00902486|594721846|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
164644368|NCT00902486|594721847|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
164644369|NCT00902486|594721848|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
164644370|NCT00902486|594721849|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
164644371|NCT00902486|594721850|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
164644372|NCT00902486|594721845|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
164644373|NCT00902486|594721846|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
164644374|NCT00902486|594721847|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
164644375|NCT00902486|594721848|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
164644376|NCT00902486|594721849|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
164644377|NCT00902486|594721850|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
164644378|NCT00902486|594721845|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
164644379|NCT00902486|594721846|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
164644380|NCT00902486|594721847|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
164644381|NCT00902486|594721848|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
164644382|NCT00902486|594721849|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
164644383|NCT00902486|594721850|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
164644384|NCT00902486|594721845|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
164644385|NCT00902486|594721846|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
164644386|NCT00902486|594721847|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
164644387|NCT00902486|594721848|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
164644388|NCT00902486|594721849|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
164644389|NCT00902486|594721850|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
164644390|NCT00902486|594721845|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
164644391|NCT00902486|594721846|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
164644392|NCT00902486|594721847|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
164644393|NCT00902486|594721848|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
164644394|NCT00902486|594721849|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
164644395|NCT00902486|594721850|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
164644396|NCT00902486|594721845|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
164644397|NCT00902486|594721846|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
164644398|NCT00902486|594721847|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
164644399|NCT00902486|594721848|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
164644400|NCT00902486|594721849|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
164644401|NCT00902486|594721850|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
164644402|NCT01843660|594721851|FG000|Overall Study|Other|30|||
164644403|NCT00209560|594721852|FG000|Overall Study|Lack of Efficacy|1|||
164644404|NCT00209560|594721853|FG001|Overall Study|Lack of Efficacy|0|||
164644405|NCT04439110|594721854|FG000|Overall Study|Ineligible|2|||
164644406|NCT04439110|594721854|FG000|Overall Study|Adverse Event|4|||
164644407|NCT04439110|594721854|FG000|Overall Study|Death|2|||
164644408|NCT04439110|594721854|FG000|Overall Study|Disease proression|25|||
164644409|NCT04439110|594721854|FG000|Overall Study|Withdrawal by Subject|1|||
164644410|NCT04439110|594721854|FG000|Overall Study|Alternative therapy|1|||
164644411|NCT04439110|594721854|FG000|Overall Study|Other complicating disease|1|||
164644412|NCT04439110|594721854|FG000|Overall Study|Personal reasons|1|||
164644413|NCT04439110|594721854|FG000|Overall Study|Still on treatment|1|||
164644414|NCT01721369|594721857|FG000|Overall Study|Not initial etiological diagnosis|12|||
164644415|NCT01211613|594723345|FG000|Overall Study|Lost to Follow-up|2|||
164644416|NCT01211613|594723346|FG001|Overall Study|Lost to Follow-up|2|||
164644417|NCT01211613|594723347|FG002|Overall Study|Lost to Follow-up|2|||
164644418|NCT01211613|594723345|FG000|Overall Study|Withdrawal by Subject|1|||
164644419|NCT01211613|594723346|FG001|Overall Study|Withdrawal by Subject|0|||
164644420|NCT01211613|594723347|FG002|Overall Study|Withdrawal by Subject|0|||
164644421|NCT03853213|594723348|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
164644422|NCT03853213|594723349|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
164644423|NCT03853213|594723348|FG000|Overall Study|Other (e.g., too busy)|0|||
164644424|NCT03853213|594723349|FG001|Overall Study|Other (e.g., too busy)|2|||
164644425|NCT03044431|594723350|FG000|Overall Study|Lost to Follow-up|59|||
164644426|NCT04470622|594723351|FG000|Overall Study|Withdrawal by Subject|0|||
164644427|NCT04470622|594723352|FG001|Overall Study|Withdrawal by Subject|1|||
164644428|NCT04470622|594723351|FG000|Overall Study|Screen Failure|0|||
164644429|NCT04470622|594723352|FG001|Overall Study|Screen Failure|1|||
164644430|NCT04470622|594723351|FG000|Overall Study|Death|0|||
164644431|NCT04470622|594723352|FG001|Overall Study|Death|1|||
164644432|NCT02576054|594723355|FG000|Overall Study|Withdrawal by Subject|1|||
164644433|NCT00791154|594723358|FG000|Overall Study|Noncompliance|0|||
164644434|NCT00791154|594723359|FG001|Overall Study|Noncompliance|1|||
164644435|NCT00791154|594723360|FG002|Overall Study|Noncompliance|0|||
164644436|NCT00791154|594723361|FG003|Overall Study|Noncompliance|0|||
164644437|NCT00791154|594723362|FG004|Overall Study|Noncompliance|1|||
164644438|NCT00791154|594723363|FG005|Overall Study|Noncompliance|1|||
164644439|NCT00791154|594723364|FG006|Overall Study|Noncompliance|1|||
164644440|NCT00791154|594723358|FG000|Overall Study|Adverse Event|0|||
164644441|NCT00791154|594723359|FG001|Overall Study|Adverse Event|0|||
164644442|NCT00791154|594723360|FG002|Overall Study|Adverse Event|0|||
164644443|NCT00791154|594723361|FG003|Overall Study|Adverse Event|0|||
164644444|NCT00791154|594723362|FG004|Overall Study|Adverse Event|2|||
164644445|NCT00791154|594723363|FG005|Overall Study|Adverse Event|0|||
164644446|NCT00791154|594723364|FG006|Overall Study|Adverse Event|1|||
164644447|NCT00791154|594723358|FG000|Overall Study|Full Consent withdrawn|1|||
164644448|NCT00791154|594723359|FG001|Overall Study|Full Consent withdrawn|3|||
164644449|NCT00791154|594723360|FG002|Overall Study|Full Consent withdrawn|0|||
164644450|NCT00791154|594723361|FG003|Overall Study|Full Consent withdrawn|0|||
164644451|NCT00791154|594723362|FG004|Overall Study|Full Consent withdrawn|1|||
164644452|NCT00791154|594723363|FG005|Overall Study|Full Consent withdrawn|3|||
164644453|NCT00791154|594723364|FG006|Overall Study|Full Consent withdrawn|1|||
164644454|NCT00791154|594723358|FG000|Overall Study|Lost to Follow-up|0|||
164644455|NCT00791154|594723359|FG001|Overall Study|Lost to Follow-up|0|||
164644456|NCT00791154|594723360|FG002|Overall Study|Lost to Follow-up|0|||
164644457|NCT00791154|594723361|FG003|Overall Study|Lost to Follow-up|1|||
164644458|NCT00791154|594723362|FG004|Overall Study|Lost to Follow-up|2|||
164644459|NCT00791154|594723363|FG005|Overall Study|Lost to Follow-up|0|||
164644460|NCT00791154|594723364|FG006|Overall Study|Lost to Follow-up|4|||
164644461|NCT00791154|594723358|FG000|Overall Study|Death|5|||
164644462|NCT00791154|594723359|FG001|Overall Study|Death|4|||
164644463|NCT00791154|594723360|FG002|Overall Study|Death|4|||
164644464|NCT00791154|594723361|FG003|Overall Study|Death|7|||
164644465|NCT00791154|594723362|FG004|Overall Study|Death|54|||
164644466|NCT00791154|594723363|FG005|Overall Study|Death|54|||
164644467|NCT00791154|594723364|FG006|Overall Study|Death|52|||
164644468|NCT00791154|594723358|FG000|Overall Study|Other event|0|||
164644469|NCT00791154|594723359|FG001|Overall Study|Other event|0|||
164644470|NCT00791154|594723360|FG002|Overall Study|Other event|2|||
164644471|NCT00791154|594723361|FG003|Overall Study|Other event|0|||
164644472|NCT00791154|594723362|FG004|Overall Study|Other event|2|||
164644473|NCT00791154|594723363|FG005|Overall Study|Other event|4|||
164644474|NCT00791154|594723364|FG006|Overall Study|Other event|2|||
164644475|NCT00953927|594723365|FG000|Overall Study|Lost to Follow-up|61|||
164644476|NCT00953927|594723366|FG001|Overall Study|Lost to Follow-up|65|||
164644477|NCT00953927|594723365|FG000|Overall Study|Withdrawal by Subject|36|||
164644478|NCT00953927|594723366|FG001|Overall Study|Withdrawal by Subject|25|||
164644479|NCT00953927|594723365|FG000|Overall Study|Death|7|||
164644480|NCT00953927|594723366|FG001|Overall Study|Death|4|||
164644481|NCT00953927|594723365|FG000|Overall Study|Other study discontinuation|1|||
164644482|NCT00953927|594723366|FG001|Overall Study|Other study discontinuation|1|||
164644483|NCT00934622|594723367|FG000|Overall Study|Lost to Follow-up|7|||
164644484|NCT00934622|594723367|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
164644485|NCT00468312|594723370|FG000|Overall Study|Adverse Event|2|||
164644486|NCT00468312|594723371|FG001|Overall Study|Adverse Event|1|||
164644487|NCT00468312|594723370|FG000|Overall Study|Lack of Efficacy|0|||
164644488|NCT00468312|594723371|FG001|Overall Study|Lack of Efficacy|1|||
164644489|NCT00468312|594723370|FG000|Overall Study|Withdrawal by Subject|0|||
164644490|NCT00468312|594723371|FG001|Overall Study|Withdrawal by Subject|1|||
164644491|NCT00468312|594723370|FG000|Overall Study|Protocol Violation|2|||
164644492|NCT00468312|594723371|FG001|Overall Study|Protocol Violation|1|||
164644493|NCT00468312|594723370|FG000|Overall Study|Did not meet protocol eligibility|0|||
164644494|NCT00468312|594723371|FG001|Overall Study|Did not meet protocol eligibility|1|||
164644495|NCT01396161|594723372|FG000|Overall Study|Withdrawal by Subject|0|||
164644496|NCT01396161|594723373|FG001|Overall Study|Withdrawal by Subject|0|||
164644497|NCT01396161|594723374|FG002|Overall Study|Withdrawal by Subject|0|||
164644498|NCT01396161|594723375|FG003|Overall Study|Withdrawal by Subject|0|||
164644499|NCT01396161|594723376|FG004|Overall Study|Withdrawal by Subject|1|||
164644500|NCT01396161|594723377|FG005|Overall Study|Withdrawal by Subject|0|||
164644501|NCT01396161|594723378|FG006|Overall Study|Withdrawal by Subject|0|||
164644502|NCT01396161|594723372|FG000|Overall Study|Other|0|||
164644503|NCT01396161|594723373|FG001|Overall Study|Other|0|||
164644504|NCT01396161|594723374|FG002|Overall Study|Other|0|||
164644505|NCT01396161|594723375|FG003|Overall Study|Other|0|||
164644506|NCT01396161|594723376|FG004|Overall Study|Other|0|||
164644507|NCT01396161|594723377|FG005|Overall Study|Other|0|||
164644508|NCT01396161|594723378|FG006|Overall Study|Other|1|||
164644509|NCT02962739|594723379|FG000|Overall Study|Withdrawal by Subject|0|||
164644510|NCT02962739|594723380|FG001|Overall Study|Withdrawal by Subject|1|||
164644511|NCT02962739|594723381|FG002|Overall Study|Withdrawal by Subject|0|||
164644512|NCT02962739|594723382|FG003|Overall Study|Withdrawal by Subject|0|||
164644513|NCT02962739|594723383|FG004|Overall Study|Withdrawal by Subject|0|||
164644514|NCT02962739|594723384|FG005|Overall Study|Withdrawal by Subject|0|||
164644515|NCT02962739|594723379|FG000|Overall Study|Protocol Violation|0|||
164644516|NCT02962739|594723380|FG001|Overall Study|Protocol Violation|0|||
164644517|NCT02962739|594723381|FG002|Overall Study|Protocol Violation|1|||
164644518|NCT02962739|594723382|FG003|Overall Study|Protocol Violation|0|||
164644519|NCT02962739|594723383|FG004|Overall Study|Protocol Violation|1|||
164644520|NCT02962739|594723384|FG005|Overall Study|Protocol Violation|0|||
164644521|NCT03343054|594723385|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
164644522|NCT03343054|594723386|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
164644523|NCT03343054|594723387|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
164644524|NCT03343054|594723385|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
164644525|NCT03343054|594723386|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
164644526|NCT03343054|594723387|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
164644527|NCT03343054|594723385|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
164644528|NCT03343054|594723386|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
164644529|NCT03343054|594723387|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
164644530|NCT03343054|594723385|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
164644531|NCT03343054|594723386|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
164644532|NCT03343054|594723387|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
164644533|NCT00981409|594723392|FG000|Overall Study|Adverse Event|4|||
164644534|NCT00981409|594723393|FG001|Overall Study|Adverse Event|0|||
164644535|NCT00981409|594723392|FG000|Overall Study|Protocol Violation|0|||
164644536|NCT00981409|594723393|FG001|Overall Study|Protocol Violation|1|||
164644537|NCT00981409|594723392|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
164644538|NCT00981409|594723393|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
164644539|NCT00450177|594723394|FG000|Overall Study|Adverse Event|7|||
164644540|NCT00450177|594723395|FG001|Overall Study|Adverse Event|4|||
164644541|NCT00450177|594723394|FG000|Overall Study|Withdrawal by Subject|1|||
164644542|NCT00450177|594723395|FG001|Overall Study|Withdrawal by Subject|6|||
164644543|NCT00450177|594723394|FG000|Overall Study|Withdrawal by Primary Team|1|||
164644544|NCT00450177|594723395|FG001|Overall Study|Withdrawal by Primary Team|1|||
164644545|NCT03869684|594723400|FG000|Overall Study|Adverse Event|0|||
164644546|NCT03869684|594723401|FG001|Overall Study|Adverse Event|3|||
164148626|NCT04895982|592904922|FG011|Overall Study|Protocol Violation|0|||
164644547|NCT03869684|594723402|FG002|Overall Study|Adverse Event|1|||
164644548|NCT03869684|594723400|FG000|Overall Study|Withdrawal by Subject|1|||
164644549|NCT03869684|594723401|FG001|Overall Study|Withdrawal by Subject|0|||
164644550|NCT03869684|594723402|FG002|Overall Study|Withdrawal by Subject|0|||
164644551|NCT03869684|594723400|FG000|Overall Study|Lost to Follow-up|1|||
164644552|NCT03869684|594723401|FG001|Overall Study|Lost to Follow-up|0|||
164644553|NCT03869684|594723402|FG002|Overall Study|Lost to Follow-up|0|||
164644554|NCT03869684|594723400|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
164644555|NCT03869684|594723401|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
164644556|NCT03869684|594723402|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
164644557|NCT04056299|594723403|FG000|Overall Study|Sponsor discontinued study|3|||
164644558|NCT04056299|594723404|FG001|Overall Study|Sponsor discontinued study|3|||
164644559|NCT01227954|594723409|FG000|Overall Study|Protocol Violation|6|||
164644560|NCT01227954|594723409|FG000|Overall Study|No protocol treatment|7|||
164644561|NCT00078312|594723413|FG000|Overall Study|Adverse Event|43|||
164644562|NCT00078312|594723413|FG000|Overall Study|Lack of Efficacy|15|||
164644563|NCT00078312|594723413|FG000|Overall Study|Lost to Follow-up|41|||
164644564|NCT00078312|594723413|FG000|Overall Study|Physician Decision|9|||
164644565|NCT00078312|594723413|FG000|Overall Study|Protocol Violation|3|||
164644566|NCT00078312|594723413|FG000|Overall Study|Withdrawal by Subject|33|||
164644567|NCT00078312|594723413|FG000|Overall Study|Miscellaneous|33|||
164644568|NCT01268683|594723416|FG000|Overall Study|Lost to Follow-up|1|||
164644569|NCT01268683|594723416|FG000|Overall Study|Death|1|||
164644570|NCT04256759|594723419|FG000|Overall Study|Physician Decision|1|||
164644571|NCT04256759|594723419|FG000|Overall Study|Lack of Efficacy|1|||
164644572|NCT03901352|594723424|FG000|Double-blind Phase|Adverse Event|6|||
164644573|NCT03901352|594723425|FG001|Double-blind Phase|Adverse Event|4|||
164644574|NCT03901352|594723424|FG000|Double-blind Phase|Death|1|||
164644575|NCT03901352|594723425|FG001|Double-blind Phase|Death|0|||
164644576|NCT03901352|594723424|FG000|Double-blind Phase|Lack of Efficacy|0|||
164644577|NCT03901352|594723425|FG001|Double-blind Phase|Lack of Efficacy|1|||
164644578|NCT03901352|594723424|FG000|Double-blind Phase|Protocol Violation|0|||
164644579|NCT03901352|594723425|FG001|Double-blind Phase|Protocol Violation|1|||
164644580|NCT03901352|594723424|FG000|Double-blind Phase|Withdrawal by Subject|10|||
164644581|NCT03901352|594723425|FG001|Double-blind Phase|Withdrawal by Subject|8|||
164644582|NCT03901352|594723424|FG000|Open-label Extension Phase|Adverse Event|24|||
164644583|NCT03901352|594723425|FG001|Open-label Extension Phase|Adverse Event|0|||
164644584|NCT03901352|594723424|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
164644585|NCT03901352|594723425|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
164644586|NCT03901352|594723424|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
164644587|NCT03901352|594723425|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
164644588|NCT03901352|594723424|FG000|Open-label Extension Phase|Other|1|||
164644589|NCT03901352|594723425|FG001|Open-label Extension Phase|Other|0|||
164644590|NCT01826201|594723428|FG000|Overall Study|Non compliance with protocol|4|||
164644591|NCT02742818|594723429|FG000|Overall Study|Adverse Event|0|||
164644592|NCT02742818|594723430|FG001|Overall Study|Adverse Event|1|||
164644593|NCT02742818|594723429|FG000|Overall Study|Protocol Violation|0|||
164644594|NCT02742818|594723430|FG001|Overall Study|Protocol Violation|1|||
164644595|NCT04701658|594723431|FG000|Overall Study|Lost to Follow-up|6|||
164644596|NCT03387735|594723434|FG000|Overall Study|Lost to Follow-up|4|||
164644597|NCT03387735|594723435|FG001|Overall Study|Lost to Follow-up|8|||
164644598|NCT03387735|594723434|FG000|Overall Study|Death|4|||
164644599|NCT03387735|594723435|FG001|Overall Study|Death|8|||
164644600|NCT03099161|594723436|FG000|Overall Study|Adverse Event|0|||
164644601|NCT03099161|594723437|FG001|Overall Study|Adverse Event|0|||
164644602|NCT03099161|594723438|FG002|Overall Study|Adverse Event|2|||
164644603|NCT03099161|594723436|FG000|Overall Study|Physician Decision|2|||
164644604|NCT03099161|594723437|FG001|Overall Study|Physician Decision|0|||
164644605|NCT03099161|594723438|FG002|Overall Study|Physician Decision|0|||
164644606|NCT03099161|594723436|FG000|Overall Study|Progressive Disease|1|||
164644607|NCT03099161|594723437|FG001|Overall Study|Progressive Disease|4|||
164644608|NCT03099161|594723438|FG002|Overall Study|Progressive Disease|1|||
164644609|NCT05302414|594723441|FG000|Pretest to Posttest|Lost to Follow-up|12|||
164644610|NCT05302414|594723442|FG001|Pretest to Posttest|Lost to Follow-up|8|||
164644611|NCT05302414|594723443|FG002|Pretest to Posttest|Lost to Follow-up|8|||
164644612|NCT05302414|594723441|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
164644613|NCT05302414|594723442|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
164644614|NCT05302414|594723443|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
164644615|NCT00742859|594723444|FG000|Overall Study|Adverse Event|5|||
164644616|NCT00742859|594723445|FG001|Overall Study|Adverse Event|6|||
164644617|NCT00742859|594723446|FG002|Overall Study|Adverse Event|3|||
164644618|NCT00742859|594723447|FG003|Overall Study|Adverse Event|1|||
164644619|NCT00742859|594723444|FG000|Overall Study|Death|1|||
164644620|NCT00742859|594723445|FG001|Overall Study|Death|0|||
164644621|NCT00742859|594723446|FG002|Overall Study|Death|0|||
164644622|NCT00742859|594723447|FG003|Overall Study|Death|1|||
164644623|NCT00742859|594723444|FG000|Overall Study|Physician Decision|1|||
164644624|NCT00742859|594723445|FG001|Overall Study|Physician Decision|2|||
164644625|NCT00742859|594723446|FG002|Overall Study|Physician Decision|0|||
164644626|NCT00742859|594723447|FG003|Overall Study|Physician Decision|0|||
164644627|NCT00742859|594723444|FG000|Overall Study|Withdrawal by Subject|4|||
164644628|NCT00742859|594723445|FG001|Overall Study|Withdrawal by Subject|2|||
164644629|NCT00742859|594723446|FG002|Overall Study|Withdrawal by Subject|4|||
164644630|NCT00742859|594723447|FG003|Overall Study|Withdrawal by Subject|1|||
164644631|NCT00742859|594723444|FG000|Overall Study|Endpoint|0|||
164644632|NCT00742859|594723445|FG001|Overall Study|Endpoint|1|||
164644633|NCT00742859|594723446|FG002|Overall Study|Endpoint|1|||
164644634|NCT00742859|594723447|FG003|Overall Study|Endpoint|2|||
164644635|NCT00742859|594723444|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
164644636|NCT00742859|594723445|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
164644637|NCT00742859|594723446|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
164644638|NCT00742859|594723447|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
164644639|NCT00742859|594723444|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
164644640|NCT00742859|594723445|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
164644641|NCT00742859|594723446|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
164644642|NCT00742859|594723447|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
164644643|NCT00742859|594723444|FG000|Overall Study|Sponsor request patient out of town|0|||
164644644|NCT00742859|594723445|FG001|Overall Study|Sponsor request patient out of town|0|||
164644645|NCT00742859|594723446|FG002|Overall Study|Sponsor request patient out of town|1|||
164644646|NCT00742859|594723447|FG003|Overall Study|Sponsor request patient out of town|1|||
164644647|NCT00742859|594723444|FG000|Overall Study|Site error|0|||
164644648|NCT00742859|594723445|FG001|Overall Study|Site error|0|||
164644649|NCT00742859|594723446|FG002|Overall Study|Site error|1|||
164644650|NCT00742859|594723447|FG003|Overall Study|Site error|1|||
164644651|NCT01346501|594723449|FG000|Overall Study|Initiated Other Biological Agents|3|||
164644652|NCT01346501|594723450|FG001|Overall Study|Initiated Other Biological Agents|1|||
164644653|NCT01346501|594723449|FG000|Overall Study|Other|8|||
164644654|NCT01346501|594723450|FG001|Overall Study|Other|12|||
164644655|NCT02564952|594723451|FG000|Overall Study|Adverse Event|6|||
164644656|NCT02564952|594723451|FG000|Overall Study|Lost to Follow-up|1|||
164644657|NCT02564952|594723451|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
164644658|NCT02564952|594723451|FG000|Overall Study|Withdrawal by Subject|1|||
164644659|NCT02564952|594723451|FG000|Overall Study|Low Efficacy|1|||
164644660|NCT02564952|594723451|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
164644661|NCT03972709|594723458|FG000|Overall Study|Withdrawal by Subject|18|||
164644662|NCT03972709|594723459|FG001|Overall Study|Withdrawal by Subject|7|||
164644663|NCT03972709|594723460|FG002|Overall Study|Withdrawal by Subject|14|||
164644664|NCT03972709|594723458|FG000|Overall Study|Study Terminated by Sponsor|48|||
164644665|NCT03972709|594723459|FG001|Overall Study|Study Terminated by Sponsor|25|||
164644666|NCT03972709|594723460|FG002|Overall Study|Study Terminated by Sponsor|50|||
164644667|NCT03972709|594723458|FG000|Overall Study|Physician Decision|1|||
164644668|NCT03972709|594723459|FG001|Overall Study|Physician Decision|0|||
164644669|NCT03972709|594723460|FG002|Overall Study|Physician Decision|0|||
164644670|NCT03972709|594723458|FG000|Overall Study|COVID-19|0|||
164644671|NCT03972709|594723459|FG001|Overall Study|COVID-19|1|||
164644672|NCT03972709|594723460|FG002|Overall Study|COVID-19|1|||
164644673|NCT03972709|594723458|FG000|Overall Study|Lost to Follow-up|6|||
164644674|NCT03972709|594723459|FG001|Overall Study|Lost to Follow-up|1|||
164644675|NCT03972709|594723460|FG002|Overall Study|Lost to Follow-up|2|||
164644676|NCT03972709|594723458|FG000|Overall Study|Death|5|||
164644677|NCT03972709|594723459|FG001|Overall Study|Death|1|||
164644678|NCT03972709|594723460|FG002|Overall Study|Death|4|||
164644679|NCT03972709|594723458|FG000|Overall Study|Adverse Event|3|||
164644680|NCT03972709|594723459|FG001|Overall Study|Adverse Event|1|||
164644681|NCT03972709|594723460|FG002|Overall Study|Adverse Event|4|||
164644682|NCT03972709|594723458|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
164644683|NCT03972709|594723459|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
164644684|NCT03972709|594723460|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
164644685|NCT03972709|594723458|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
164644686|NCT03972709|594723459|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
164644687|NCT03972709|594723460|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
164644688|NCT03972709|594723458|FG000|Overall Study|Subject Unable to be Contacted|0|||
164644689|NCT03972709|594723459|FG001|Overall Study|Subject Unable to be Contacted|1|||
164644690|NCT03972709|594723460|FG002|Overall Study|Subject Unable to be Contacted|0|||
164644691|NCT03972709|594723458|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
164644692|NCT03972709|594723459|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
164644693|NCT03972709|594723460|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
164644694|NCT03972709|594723458|FG000|Overall Study|Subject Moved|0|||
164644695|NCT03972709|594723459|FG001|Overall Study|Subject Moved|1|||
164644696|NCT03972709|594723460|FG002|Overall Study|Subject Moved|0|||
164644697|NCT03972709|594723458|FG000|Overall Study|Missed Study Visits|1|||
164644698|NCT03972709|594723459|FG001|Overall Study|Missed Study Visits|0|||
164644699|NCT03972709|594723460|FG002|Overall Study|Missed Study Visits|0|||
164644700|NCT05349188|594723461|FG000|Overall Study|Withdrawal by Subject|1|||
164644701|NCT05349188|594723462|FG001|Overall Study|Withdrawal by Subject|0|||
164644702|NCT03193190|594723474|FG000|Stage 1|Arm Terminated by Sponsor|0|||
164644703|NCT03193190|594723475|FG001|Stage 1|Arm Terminated by Sponsor|0|||
164644704|NCT03193190|594723476|FG002|Stage 1|Arm Terminated by Sponsor|0|||
164644705|NCT03193190|594723477|FG003|Stage 1|Arm Terminated by Sponsor|1|||
164644706|NCT03193190|594723478|FG004|Stage 1|Arm Terminated by Sponsor|0|||
164644707|NCT03193190|594723479|FG005|Stage 1|Arm Terminated by Sponsor|2|||
164644708|NCT03193190|594723480|FG006|Stage 1|Arm Terminated by Sponsor|0|||
164644709|NCT03193190|594723481|FG007|Stage 1|Arm Terminated by Sponsor|0|||
164644710|NCT03193190|594723482|FG008|Stage 1|Arm Terminated by Sponsor|0|||
164644711|NCT03193190|594723483|FG009|Stage 1|Arm Terminated by Sponsor|0|||
164644712|NCT03193190|594723484|FG010|Stage 1|Arm Terminated by Sponsor|0|||
164644713|NCT03193190|594723485|FG011|Stage 1|Arm Terminated by Sponsor|0|||
164644714|NCT03193190|594723486|FG012|Stage 1|Arm Terminated by Sponsor|0|||
164644715|NCT03193190|594723487|FG013|Stage 1|Arm Terminated by Sponsor|0|||
164644716|NCT03193190|594723488|FG014|Stage 1|Arm Terminated by Sponsor|0|||
164644717|NCT03193190|594723489|FG015|Stage 1|Arm Terminated by Sponsor|0|||
164644718|NCT03193190|594723474|FG000|Stage 1|Death|22|||
164644719|NCT03193190|594723475|FG001|Stage 1|Death|8|||
164644720|NCT03193190|594723476|FG002|Stage 1|Death|23|||
164644721|NCT03193190|594723477|FG003|Stage 1|Death|14|||
164644722|NCT03193190|594723478|FG004|Stage 1|Death|34|||
164644723|NCT03193190|594723479|FG005|Stage 1|Death|28|||
164644724|NCT03193190|594723480|FG006|Stage 1|Death|19|||
164644725|NCT03193190|594723481|FG007|Stage 1|Death|21|||
164644726|NCT03193190|594723482|FG008|Stage 1|Death|14|||
164644727|NCT03193190|594723483|FG009|Stage 1|Death|10|||
164644728|NCT03193190|594723484|FG010|Stage 1|Death|59|||
164644729|NCT03193190|594723485|FG011|Stage 1|Death|14|||
164644730|NCT03193190|594723486|FG012|Stage 1|Death|14|||
164644731|NCT03193190|594723487|FG013|Stage 1|Death|0|||
164644732|NCT03193190|594723488|FG014|Stage 1|Death|0|||
164644733|NCT03193190|594723489|FG015|Stage 1|Death|0|||
164644734|NCT03193190|594723474|FG000|Stage 1|Lost to Follow-up|2|||
164644735|NCT03193190|594723475|FG001|Stage 1|Lost to Follow-up|1|||
164644736|NCT03193190|594723476|FG002|Stage 1|Lost to Follow-up|1|||
164644737|NCT03193190|594723477|FG003|Stage 1|Lost to Follow-up|0|||
164644738|NCT03193190|594723478|FG004|Stage 1|Lost to Follow-up|0|||
164644739|NCT03193190|594723479|FG005|Stage 1|Lost to Follow-up|0|||
164644740|NCT03193190|594723480|FG006|Stage 1|Lost to Follow-up|1|||
164644741|NCT03193190|594723481|FG007|Stage 1|Lost to Follow-up|0|||
164644742|NCT03193190|594723482|FG008|Stage 1|Lost to Follow-up|0|||
164644743|NCT03193190|594723483|FG009|Stage 1|Lost to Follow-up|0|||
164644744|NCT03193190|594723484|FG010|Stage 1|Lost to Follow-up|0|||
164644745|NCT03193190|594723485|FG011|Stage 1|Lost to Follow-up|0|||
164644746|NCT03193190|594723486|FG012|Stage 1|Lost to Follow-up|0|||
164644747|NCT03193190|594723487|FG013|Stage 1|Lost to Follow-up|0|||
164644748|NCT03193190|594723488|FG014|Stage 1|Lost to Follow-up|0|||
164644749|NCT03193190|594723489|FG015|Stage 1|Lost to Follow-up|0|||
164644750|NCT03193190|594723474|FG000|Stage 1|Reason not Specified|1|||
164644751|NCT03193190|594723475|FG001|Stage 1|Reason not Specified|0|||
164644752|NCT03193190|594723476|FG002|Stage 1|Reason not Specified|0|||
164644753|NCT03193190|594723477|FG003|Stage 1|Reason not Specified|1|||
164644754|NCT03193190|594723478|FG004|Stage 1|Reason not Specified|0|||
164644755|NCT03193190|594723479|FG005|Stage 1|Reason not Specified|1|||
164644756|NCT03193190|594723480|FG006|Stage 1|Reason not Specified|2|||
164644757|NCT03193190|594723481|FG007|Stage 1|Reason not Specified|2|||
164644758|NCT03193190|594723482|FG008|Stage 1|Reason not Specified|0|||
164644759|NCT03193190|594723483|FG009|Stage 1|Reason not Specified|1|||
164644760|NCT03193190|594723484|FG010|Stage 1|Reason not Specified|3|||
164644761|NCT03193190|594723485|FG011|Stage 1|Reason not Specified|0|||
164644762|NCT03193190|594723486|FG012|Stage 1|Reason not Specified|1|||
164644763|NCT03193190|594723487|FG013|Stage 1|Reason not Specified|0|||
164644764|NCT03193190|594723488|FG014|Stage 1|Reason not Specified|0|||
164644765|NCT03193190|594723489|FG015|Stage 1|Reason not Specified|0|||
164644766|NCT03193190|594723474|FG000|Stage 1|Physician Decision|0|||
164644767|NCT03193190|594723475|FG001|Stage 1|Physician Decision|0|||
164644768|NCT03193190|594723476|FG002|Stage 1|Physician Decision|0|||
164644769|NCT03193190|594723477|FG003|Stage 1|Physician Decision|0|||
164644770|NCT03193190|594723478|FG004|Stage 1|Physician Decision|0|||
164644771|NCT03193190|594723479|FG005|Stage 1|Physician Decision|0|||
164644772|NCT03193190|594723480|FG006|Stage 1|Physician Decision|0|||
164644773|NCT03193190|594723481|FG007|Stage 1|Physician Decision|0|||
164644774|NCT03193190|594723482|FG008|Stage 1|Physician Decision|0|||
164644775|NCT03193190|594723483|FG009|Stage 1|Physician Decision|0|||
164644776|NCT03193190|594723484|FG010|Stage 1|Physician Decision|0|||
164644777|NCT03193190|594723485|FG011|Stage 1|Physician Decision|1|||
164644778|NCT03193190|594723486|FG012|Stage 1|Physician Decision|0|||
164301035|NCT03938259|593478407|FG000|Overall Study|unable to establish baseline for ventilation|1|||
164644779|NCT03193190|594723487|FG013|Stage 1|Physician Decision|0|||
164644780|NCT03193190|594723488|FG014|Stage 1|Physician Decision|0|||
164644781|NCT03193190|594723489|FG015|Stage 1|Physician Decision|0|||
164644782|NCT03193190|594723474|FG000|Stage 1|Progressive Disease|1|||
164644783|NCT03193190|594723475|FG001|Stage 1|Progressive Disease|0|||
164644784|NCT03193190|594723476|FG002|Stage 1|Progressive Disease|0|||
164644785|NCT03193190|594723477|FG003|Stage 1|Progressive Disease|0|||
164644786|NCT03193190|594723478|FG004|Stage 1|Progressive Disease|0|||
164644787|NCT03193190|594723479|FG005|Stage 1|Progressive Disease|0|||
164644788|NCT03193190|594723480|FG006|Stage 1|Progressive Disease|0|||
164644789|NCT03193190|594723481|FG007|Stage 1|Progressive Disease|0|||
164644790|NCT03193190|594723482|FG008|Stage 1|Progressive Disease|0|||
164644791|NCT03193190|594723483|FG009|Stage 1|Progressive Disease|0|||
164644792|NCT03193190|594723484|FG010|Stage 1|Progressive Disease|0|||
164644793|NCT03193190|594723485|FG011|Stage 1|Progressive Disease|0|||
164644794|NCT03193190|594723486|FG012|Stage 1|Progressive Disease|0|||
164644795|NCT03193190|594723487|FG013|Stage 1|Progressive Disease|0|||
164644796|NCT03193190|594723488|FG014|Stage 1|Progressive Disease|0|||
164644797|NCT03193190|594723489|FG015|Stage 1|Progressive Disease|0|||
164644798|NCT03193190|594723474|FG000|Stage 1|Study Terminated By Sponsor|3|||
164644799|NCT03193190|594723475|FG001|Stage 1|Study Terminated By Sponsor|0|||
164644800|NCT03193190|594723476|FG002|Stage 1|Study Terminated By Sponsor|0|||
164644801|NCT03193190|594723477|FG003|Stage 1|Study Terminated By Sponsor|0|||
164644802|NCT03193190|594723478|FG004|Stage 1|Study Terminated By Sponsor|6|||
164644803|NCT03193190|594723479|FG005|Stage 1|Study Terminated By Sponsor|0|||
164644804|NCT03193190|594723480|FG006|Stage 1|Study Terminated By Sponsor|0|||
164644805|NCT03193190|594723481|FG007|Stage 1|Study Terminated By Sponsor|0|||
164644806|NCT03193190|594723482|FG008|Stage 1|Study Terminated By Sponsor|0|||
164644807|NCT03193190|594723483|FG009|Stage 1|Study Terminated By Sponsor|0|||
164644808|NCT03193190|594723484|FG010|Stage 1|Study Terminated By Sponsor|0|||
164644809|NCT03193190|594723485|FG011|Stage 1|Study Terminated By Sponsor|0|||
164644810|NCT03193190|594723486|FG012|Stage 1|Study Terminated By Sponsor|0|||
164644811|NCT03193190|594723487|FG013|Stage 1|Study Terminated By Sponsor|0|||
164644812|NCT03193190|594723488|FG014|Stage 1|Study Terminated By Sponsor|0|||
164644813|NCT03193190|594723489|FG015|Stage 1|Study Terminated By Sponsor|0|||
164644814|NCT03193190|594723474|FG000|Stage 1|Withdrawal by Subject|6|||
164644815|NCT03193190|594723475|FG001|Stage 1|Withdrawal by Subject|0|||
164644816|NCT03193190|594723476|FG002|Stage 1|Withdrawal by Subject|1|||
164644817|NCT03193190|594723477|FG003|Stage 1|Withdrawal by Subject|0|||
164644818|NCT03193190|594723478|FG004|Stage 1|Withdrawal by Subject|2|||
164644819|NCT03193190|594723479|FG005|Stage 1|Withdrawal by Subject|0|||
164644820|NCT03193190|594723480|FG006|Stage 1|Withdrawal by Subject|3|||
164644821|NCT03193190|594723481|FG007|Stage 1|Withdrawal by Subject|2|||
164644822|NCT03193190|594723482|FG008|Stage 1|Withdrawal by Subject|2|||
164644823|NCT03193190|594723483|FG009|Stage 1|Withdrawal by Subject|4|||
164644824|NCT03193190|594723484|FG010|Stage 1|Withdrawal by Subject|9|||
164644825|NCT03193190|594723485|FG011|Stage 1|Withdrawal by Subject|1|||
164644826|NCT03193190|594723486|FG012|Stage 1|Withdrawal by Subject|0|||
164644827|NCT03193190|594723487|FG013|Stage 1|Withdrawal by Subject|0|||
164644828|NCT03193190|594723488|FG014|Stage 1|Withdrawal by Subject|0|||
164644829|NCT03193190|594723489|FG015|Stage 1|Withdrawal by Subject|0|||
164644830|NCT03193190|594723474|FG000|Stage 2|Death|0|||
164644831|NCT03193190|594723475|FG001|Stage 2|Death|0|||
164644832|NCT03193190|594723476|FG002|Stage 2|Death|0|||
164644833|NCT03193190|594723477|FG003|Stage 2|Death|0|||
164644834|NCT03193190|594723478|FG004|Stage 2|Death|0|||
164644835|NCT03193190|594723479|FG005|Stage 2|Death|0|||
164644836|NCT03193190|594723480|FG006|Stage 2|Death|0|||
164644837|NCT03193190|594723481|FG007|Stage 2|Death|0|||
164644838|NCT03193190|594723482|FG008|Stage 2|Death|0|||
164644839|NCT03193190|594723483|FG009|Stage 2|Death|0|||
164644840|NCT03193190|594723484|FG010|Stage 2|Death|0|||
164644841|NCT03193190|594723485|FG011|Stage 2|Death|0|||
164644842|NCT03193190|594723486|FG012|Stage 2|Death|0|||
164644843|NCT03193190|594723487|FG013|Stage 2|Death|14|||
164644844|NCT03193190|594723488|FG014|Stage 2|Death|4|||
164644845|NCT03193190|594723489|FG015|Stage 2|Death|1|||
164644846|NCT03193190|594723474|FG000|Stage 2|Lost to Follow-up|0|||
164644847|NCT03193190|594723475|FG001|Stage 2|Lost to Follow-up|0|||
164644848|NCT03193190|594723476|FG002|Stage 2|Lost to Follow-up|0|||
164644849|NCT03193190|594723477|FG003|Stage 2|Lost to Follow-up|0|||
164644850|NCT03193190|594723478|FG004|Stage 2|Lost to Follow-up|0|||
164644851|NCT03193190|594723479|FG005|Stage 2|Lost to Follow-up|0|||
164644852|NCT03193190|594723480|FG006|Stage 2|Lost to Follow-up|0|||
164644853|NCT03193190|594723481|FG007|Stage 2|Lost to Follow-up|0|||
164644854|NCT03193190|594723482|FG008|Stage 2|Lost to Follow-up|0|||
164644855|NCT03193190|594723483|FG009|Stage 2|Lost to Follow-up|0|||
164644856|NCT03193190|594723484|FG010|Stage 2|Lost to Follow-up|0|||
164644857|NCT03193190|594723485|FG011|Stage 2|Lost to Follow-up|0|||
164644858|NCT03193190|594723486|FG012|Stage 2|Lost to Follow-up|0|||
164644859|NCT03193190|594723487|FG013|Stage 2|Lost to Follow-up|0|||
164644860|NCT03193190|594723488|FG014|Stage 2|Lost to Follow-up|1|||
164644861|NCT03193190|594723489|FG015|Stage 2|Lost to Follow-up|0|||
164644862|NCT03193190|594723474|FG000|Stage 2|Withdrawal by Subject|0|||
164644863|NCT03193190|594723475|FG001|Stage 2|Withdrawal by Subject|0|||
164644864|NCT03193190|594723476|FG002|Stage 2|Withdrawal by Subject|0|||
164644865|NCT03193190|594723477|FG003|Stage 2|Withdrawal by Subject|0|||
164644866|NCT03193190|594723478|FG004|Stage 2|Withdrawal by Subject|0|||
164644867|NCT03193190|594723479|FG005|Stage 2|Withdrawal by Subject|0|||
164644868|NCT03193190|594723480|FG006|Stage 2|Withdrawal by Subject|0|||
164644869|NCT03193190|594723481|FG007|Stage 2|Withdrawal by Subject|0|||
164644870|NCT03193190|594723482|FG008|Stage 2|Withdrawal by Subject|0|||
164644871|NCT03193190|594723483|FG009|Stage 2|Withdrawal by Subject|0|||
164644872|NCT03193190|594723484|FG010|Stage 2|Withdrawal by Subject|0|||
164644873|NCT03193190|594723485|FG011|Stage 2|Withdrawal by Subject|0|||
164644874|NCT03193190|594723486|FG012|Stage 2|Withdrawal by Subject|0|||
164644875|NCT03193190|594723487|FG013|Stage 2|Withdrawal by Subject|1|||
164644876|NCT03193190|594723488|FG014|Stage 2|Withdrawal by Subject|1|||
164644877|NCT03193190|594723489|FG015|Stage 2|Withdrawal by Subject|0|||
164644878|NCT03532295|594723490|FG000|Overall Study|Did not start treatment|0|||
164644879|NCT03532295|594723491|FG001|Overall Study|Did not start treatment|2|||
164644880|NCT05004181|594723492|FG000|Overall Study|Withdrawal of consent|0|||
164644881|NCT05004181|594723493|FG001|Overall Study|Withdrawal of consent|0|||
164644882|NCT05004181|594723494|FG002|Overall Study|Withdrawal of consent|1|||
164644883|NCT05004181|594723495|FG003|Overall Study|Withdrawal of consent|3|||
164644884|NCT05004181|594723496|FG004|Overall Study|Withdrawal of consent|3|||
164644885|NCT05004181|594723497|FG005|Overall Study|Withdrawal of consent|0|||
164644886|NCT05004181|594723498|FG006|Overall Study|Withdrawal of consent|30|||
164644887|NCT05004181|594723499|FG007|Overall Study|Withdrawal of consent|9|||
164644888|NCT05004181|594723500|FG008|Overall Study|Withdrawal of consent|3|||
164644889|NCT05004181|594723501|FG009|Overall Study|Withdrawal of consent|2|||
164644890|NCT05004181|594723502|FG010|Overall Study|Withdrawal of consent|5|||
164644891|NCT05004181|594723503|FG011|Overall Study|Withdrawal of consent|1|||
164644892|NCT05004181|594723492|FG000|Overall Study|Lost to Follow-up|2|||
164644893|NCT05004181|594723493|FG001|Overall Study|Lost to Follow-up|4|||
164644894|NCT05004181|594723494|FG002|Overall Study|Lost to Follow-up|2|||
164644895|NCT05004181|594723495|FG003|Overall Study|Lost to Follow-up|3|||
164644896|NCT05004181|594723496|FG004|Overall Study|Lost to Follow-up|5|||
164644897|NCT05004181|594723497|FG005|Overall Study|Lost to Follow-up|2|||
164644898|NCT05004181|594723498|FG006|Overall Study|Lost to Follow-up|15|||
164644899|NCT05004181|594723499|FG007|Overall Study|Lost to Follow-up|12|||
164644900|NCT05004181|594723500|FG008|Overall Study|Lost to Follow-up|38|||
164644901|NCT05004181|594723501|FG009|Overall Study|Lost to Follow-up|6|||
164644902|NCT05004181|594723502|FG010|Overall Study|Lost to Follow-up|6|||
164644903|NCT05004181|594723503|FG011|Overall Study|Lost to Follow-up|0|||
164644904|NCT05004181|594723492|FG000|Overall Study|Death|0|||
164644905|NCT05004181|594723493|FG001|Overall Study|Death|0|||
164644906|NCT05004181|594723494|FG002|Overall Study|Death|0|||
164644907|NCT05004181|594723495|FG003|Overall Study|Death|0|||
164644908|NCT05004181|594723496|FG004|Overall Study|Death|0|||
164644909|NCT05004181|594723497|FG005|Overall Study|Death|0|||
164644910|NCT05004181|594723498|FG006|Overall Study|Death|1|||
164644911|NCT05004181|594723499|FG007|Overall Study|Death|0|||
164644912|NCT05004181|594723500|FG008|Overall Study|Death|2|||
164644913|NCT05004181|594723501|FG009|Overall Study|Death|0|||
164644914|NCT05004181|594723502|FG010|Overall Study|Death|0|||
164644915|NCT05004181|594723503|FG011|Overall Study|Death|0|||
164644916|NCT05004181|594723492|FG000|Overall Study|Physician Decision|0|||
164644917|NCT05004181|594723493|FG001|Overall Study|Physician Decision|0|||
164644918|NCT05004181|594723494|FG002|Overall Study|Physician Decision|0|||
164644919|NCT05004181|594723495|FG003|Overall Study|Physician Decision|0|||
164644920|NCT05004181|594723496|FG004|Overall Study|Physician Decision|0|||
164644921|NCT05004181|594723497|FG005|Overall Study|Physician Decision|0|||
164644922|NCT05004181|594723498|FG006|Overall Study|Physician Decision|2|||
164644923|NCT05004181|594723499|FG007|Overall Study|Physician Decision|0|||
164644924|NCT05004181|594723500|FG008|Overall Study|Physician Decision|7|||
164644925|NCT05004181|594723501|FG009|Overall Study|Physician Decision|0|||
164644926|NCT05004181|594723502|FG010|Overall Study|Physician Decision|0|||
164644927|NCT05004181|594723503|FG011|Overall Study|Physician Decision|0|||
164644928|NCT05004181|594723492|FG000|Overall Study|Withdrawal by Subject|2|||
164644929|NCT05004181|594723493|FG001|Overall Study|Withdrawal by Subject|3|||
164644930|NCT05004181|594723494|FG002|Overall Study|Withdrawal by Subject|2|||
164644931|NCT05004181|594723495|FG003|Overall Study|Withdrawal by Subject|2|||
164644932|NCT05004181|594723496|FG004|Overall Study|Withdrawal by Subject|4|||
164644933|NCT05004181|594723497|FG005|Overall Study|Withdrawal by Subject|2|||
164644934|NCT05004181|594723498|FG006|Overall Study|Withdrawal by Subject|4|||
164644935|NCT05004181|594723499|FG007|Overall Study|Withdrawal by Subject|22|||
164644936|NCT05004181|594723500|FG008|Overall Study|Withdrawal by Subject|8|||
164644937|NCT05004181|594723501|FG009|Overall Study|Withdrawal by Subject|1|||
164644938|NCT05004181|594723502|FG010|Overall Study|Withdrawal by Subject|3|||
164644939|NCT05004181|594723503|FG011|Overall Study|Withdrawal by Subject|2|||
164644940|NCT05004181|594723492|FG000|Overall Study|Protocol Violation|2|||
164644941|NCT05004181|594723493|FG001|Overall Study|Protocol Violation|3|||
164644942|NCT05004181|594723494|FG002|Overall Study|Protocol Violation|0|||
164644943|NCT05004181|594723495|FG003|Overall Study|Protocol Violation|0|||
164644944|NCT05004181|594723496|FG004|Overall Study|Protocol Violation|1|||
164644945|NCT05004181|594723497|FG005|Overall Study|Protocol Violation|0|||
164644946|NCT05004181|594723498|FG006|Overall Study|Protocol Violation|16|||
164644947|NCT05004181|594723499|FG007|Overall Study|Protocol Violation|18|||
164644948|NCT05004181|594723500|FG008|Overall Study|Protocol Violation|2|||
164644949|NCT05004181|594723501|FG009|Overall Study|Protocol Violation|2|||
164644950|NCT05004181|594723502|FG010|Overall Study|Protocol Violation|2|||
164644951|NCT05004181|594723503|FG011|Overall Study|Protocol Violation|1|||
164644952|NCT05004181|594723492|FG000|Overall Study|Not further specified|1|||
164644953|NCT05004181|594723493|FG001|Overall Study|Not further specified|0|||
164644954|NCT05004181|594723494|FG002|Overall Study|Not further specified|0|||
164644955|NCT05004181|594723495|FG003|Overall Study|Not further specified|0|||
164644956|NCT05004181|594723496|FG004|Overall Study|Not further specified|0|||
164644957|NCT05004181|594723497|FG005|Overall Study|Not further specified|0|||
164644958|NCT05004181|594723498|FG006|Overall Study|Not further specified|1|||
164644959|NCT05004181|594723499|FG007|Overall Study|Not further specified|0|||
164644960|NCT05004181|594723500|FG008|Overall Study|Not further specified|2|||
164644961|NCT05004181|594723501|FG009|Overall Study|Not further specified|1|||
164644962|NCT05004181|594723502|FG010|Overall Study|Not further specified|0|||
164644963|NCT05004181|594723503|FG011|Overall Study|Not further specified|1|||
164644964|NCT03868059|594723505|FG000|Overall Study|Adverse Event|3|||
164644965|NCT03868059|594723505|FG000|Overall Study|Lost to Follow-up|3|||
164644966|NCT03868059|594723505|FG000|Overall Study|Withdrawal by Subject|6|||
164644967|NCT04278872|594723506|FG000|Overall Study|Adverse Event|1|||
164644968|NCT04278872|594723507|FG001|Overall Study|Adverse Event|0|||
164644969|NCT04278872|594723506|FG000|Overall Study|Protocol Violation|0|||
164644970|NCT04278872|594723507|FG001|Overall Study|Protocol Violation|1|||
164644971|NCT04278872|594723506|FG000|Overall Study|Study Termination|2|||
164644972|NCT04278872|594723507|FG001|Overall Study|Study Termination|0|||
164644973|NCT01298661|594723508|FG000|Overall Study|Withdrawal by Subject|2|||
164644974|NCT01298661|594723509|FG001|Overall Study|Withdrawal by Subject|0|||
164644975|NCT01298661|594723510|FG002|Overall Study|Withdrawal by Subject|2|||
164644976|NCT01607398|594724654|FG000|Overall Study|Adverse Event|0|||
164644977|NCT01607398|594724655|FG001|Overall Study|Adverse Event|2|||
164644978|NCT01607398|594724654|FG000|Overall Study|Severe COPD|2|||
164644979|NCT01607398|594724655|FG001|Overall Study|Severe COPD|0|||
164644980|NCT02239692|594724656|FG000|Overall Study|Incomplete colonoscopy|1|||
164644981|NCT02239692|594724657|FG001|Overall Study|Incomplete colonoscopy|2|||
164644982|NCT02239692|594724656|FG000|Overall Study|Adverse Event|0|||
164644983|NCT02239692|594724657|FG001|Overall Study|Adverse Event|1|||
164644984|NCT02239692|594724656|FG000|Overall Study|Physician Decision|0|||
164644985|NCT02239692|594724657|FG001|Overall Study|Physician Decision|1|||
164644986|NCT02239692|594724656|FG000|Overall Study|Lost to Follow-up|1|||
164644987|NCT02239692|594724657|FG001|Overall Study|Lost to Follow-up|4|||
164644988|NCT02239692|594724656|FG000|Overall Study|Withdrawal by Subject|3|||
164644989|NCT02239692|594724657|FG001|Overall Study|Withdrawal by Subject|5|||
164644990|NCT02239692|594724656|FG000|Overall Study|Other reason|1|||
164644991|NCT02239692|594724657|FG001|Overall Study|Other reason|0|||
164644992|NCT01901146|594724659|FG000|Neoadjuvant Phase|Death|1|||
164644993|NCT01901146|594724660|FG001|Neoadjuvant Phase|Death|2|||
164644994|NCT01901146|594724661|FG002|Neoadjuvant Phase|Death|0|||
164644995|NCT01901146|594724662|FG003|Neoadjuvant Phase|Death|0|||
164644996|NCT01901146|594724663|FG004|Neoadjuvant Phase|Death|0|||
164644997|NCT01901146|594724659|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
164644998|NCT01901146|594724660|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
164644999|NCT01901146|594724661|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
164645000|NCT01901146|594724662|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
164645001|NCT01901146|594724663|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
164645002|NCT01901146|594724659|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
164645003|NCT01901146|594724660|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
164645004|NCT01901146|594724661|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
164645005|NCT01901146|594724662|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
164645006|NCT01901146|594724663|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
164645007|NCT01901146|594724659|FG000|Neoadjuvant Phase|Physician Decision|1|||
164645008|NCT01901146|594724660|FG001|Neoadjuvant Phase|Physician Decision|2|||
164645009|NCT01901146|594724661|FG002|Neoadjuvant Phase|Physician Decision|0|||
164645010|NCT01901146|594724662|FG003|Neoadjuvant Phase|Physician Decision|0|||
164645011|NCT01901146|594724663|FG004|Neoadjuvant Phase|Physician Decision|0|||
164645012|NCT01901146|594724659|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
164645013|NCT01901146|594724660|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
164645014|NCT01901146|594724661|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
164645015|NCT01901146|594724662|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
164645016|NCT01901146|594724663|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
164645017|NCT01901146|594724659|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
164645018|NCT01901146|594724660|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
164645019|NCT01901146|594724661|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
164645020|NCT01901146|594724662|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
164645021|NCT01901146|594724663|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
164645022|NCT01901146|594724659|FG000|Adjuvant Phase|Other|0|||
164645023|NCT01901146|594724660|FG001|Adjuvant Phase|Other|0|||
164645024|NCT01901146|594724661|FG002|Adjuvant Phase|Other|1|||
164645025|NCT01901146|594724662|FG003|Adjuvant Phase|Other|0|||
164645026|NCT01901146|594724663|FG004|Adjuvant Phase|Other|0|||
164645027|NCT01901146|594724659|FG000|Adjuvant Phase|Death|0|||
164645028|NCT01901146|594724660|FG001|Adjuvant Phase|Death|0|||
164645029|NCT01901146|594724661|FG002|Adjuvant Phase|Death|0|||
164645030|NCT01901146|594724662|FG003|Adjuvant Phase|Death|0|||
164645031|NCT01901146|594724663|FG004|Adjuvant Phase|Death|3|||
164645032|NCT01901146|594724659|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
164645033|NCT01901146|594724660|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
164645034|NCT01901146|594724661|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
164645035|NCT01901146|594724662|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
164645036|NCT01901146|594724663|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
164645037|NCT01901146|594724659|FG000|Adjuvant Phase|Physician Decision|0|||
164645038|NCT01901146|594724660|FG001|Adjuvant Phase|Physician Decision|0|||
164645039|NCT01901146|594724661|FG002|Adjuvant Phase|Physician Decision|9|||
164645040|NCT01901146|594724662|FG003|Adjuvant Phase|Physician Decision|2|||
164645041|NCT01901146|594724663|FG004|Adjuvant Phase|Physician Decision|4|||
164645042|NCT01901146|594724659|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
164645043|NCT01901146|594724660|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
164645044|NCT01901146|594724661|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
164645045|NCT01901146|594724662|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
164645046|NCT01901146|594724663|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
164645047|NCT02675426|594724664|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
164645048|NCT02675426|594724665|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
164645049|NCT02675426|594724666|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
164645050|NCT02675426|594724667|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
164645051|NCT02675426|594724664|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
164645052|NCT02675426|594724665|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
164645053|NCT02675426|594724666|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
164645054|NCT02675426|594724667|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
164645055|NCT02675426|594724664|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
164645056|NCT02675426|594724665|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
164645057|NCT02675426|594724666|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
164645058|NCT02675426|594724667|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
164645059|NCT02675426|594724664|FG000|Period 1: Week 1 to Week 12|Other|2|||
164645060|NCT02675426|594724665|FG001|Period 1: Week 1 to Week 12|Other|1|||
164645061|NCT02675426|594724666|FG002|Period 1: Week 1 to Week 12|Other|0|||
164645062|NCT02675426|594724667|FG003|Period 1: Week 1 to Week 12|Other|2|||
164645063|NCT02675426|594724664|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
164645064|NCT02675426|594724665|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
164645065|NCT02675426|594724666|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
164645066|NCT02675426|594724667|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
164645067|NCT02675426|594724664|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
164645068|NCT02675426|594724665|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
164645069|NCT02675426|594724666|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
164645070|NCT02675426|594724667|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
164645071|NCT02675426|594724664|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
164645072|NCT02675426|594724665|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
164645073|NCT02675426|594724666|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
164645074|NCT02675426|594724667|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
164645075|NCT02675426|594724664|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
164645076|NCT02675426|594724665|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
164645077|NCT02675426|594724666|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
164645078|NCT02675426|594724667|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
164645079|NCT02675426|594724664|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
164645080|NCT02675426|594724665|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
164645081|NCT02675426|594724666|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
164645082|NCT02675426|594724667|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
164645083|NCT02675426|594724664|FG000|Period 2: Week 12 to Week 260|Other|8|||
164645084|NCT02675426|594724665|FG001|Period 2: Week 12 to Week 260|Other|12|||
164645085|NCT02675426|594724666|FG002|Period 2: Week 12 to Week 260|Other|23|||
164645086|NCT02675426|594724667|FG003|Period 2: Week 12 to Week 260|Other|15|||
164645087|NCT03724968|594724670|FG000|Overall Study|Insurance issues|0|||
164645088|NCT03724968|594724671|FG001|Overall Study|Insurance issues|1|||
164645089|NCT03724968|594724670|FG000|Overall Study|Study closed|0|||
164645090|NCT03724968|594724671|FG001|Overall Study|Study closed|1|||
164645091|NCT01784419|594724672|FG000|Overall Study|Adverse Event|3|||
164645092|NCT02237118|594724673|FG000|Overall Study|Protocol Violation|0|||
164645093|NCT02237118|594724674|FG001|Overall Study|Protocol Violation|1|||
164645094|NCT02237118|594724673|FG000|Overall Study|consent withdrawn|1|||
164645095|NCT02237118|594724674|FG001|Overall Study|consent withdrawn|0|||
164645096|NCT00080288|594724675|FG000|Overall Study|Adverse Event|7|||
164645097|NCT00080288|594724676|FG001|Overall Study|Adverse Event|4|||
164645098|NCT00080288|594724675|FG000|Overall Study|Lost to Follow-up|3|||
164645099|NCT00080288|594724676|FG001|Overall Study|Lost to Follow-up|5|||
164645100|NCT00080288|594724675|FG000|Overall Study|Physician Decision|6|||
164645101|NCT00080288|594724676|FG001|Overall Study|Physician Decision|2|||
164645102|NCT00080288|594724675|FG000|Overall Study|Withdrawal by Subject|3|||
164645103|NCT00080288|594724676|FG001|Overall Study|Withdrawal by Subject|16|||
164645104|NCT00080288|594724675|FG000|Overall Study|Miscellaneous|11|||
164645105|NCT00080288|594724676|FG001|Overall Study|Miscellaneous|11|||
164645106|NCT03978117|594724681|FG000|Overall Study|self- withdrawal or PI withdrawal|26|||
164645107|NCT03978117|594724682|FG001|Overall Study|self- withdrawal or PI withdrawal|26|||
164645108|NCT03978117|594724681|FG000|Overall Study|Lost to Follow-up|4|||
164645109|NCT03978117|594724682|FG001|Overall Study|Lost to Follow-up|4|||
164645110|NCT03976076|594724683|FG000|Overall Study|Withdrawal by Subject|2|||
164645111|NCT00414011|594724684|FG000|Overall Study|Physician Decision|3|||
164645112|NCT00414011|594724684|FG000|Overall Study|Withdrawal by Subject|2|||
164645113|NCT02923115|594724685|FG000|Overall Study|Lost to Follow-up|0|||
164645114|NCT02923115|594724686|FG001|Overall Study|Lost to Follow-up|0|||
164645115|NCT02923115|594724687|FG002|Overall Study|Lost to Follow-up|0|||
164645116|NCT02923115|594724688|FG003|Overall Study|Lost to Follow-up|1|||
164645117|NCT02923115|594724689|FG004|Overall Study|Lost to Follow-up|0|||
164645118|NCT02923115|594724690|FG005|Overall Study|Lost to Follow-up|0|||
164645119|NCT02923115|594724685|FG000|Overall Study|Withdrawal by Subject|0|||
164645120|NCT02923115|594724686|FG001|Overall Study|Withdrawal by Subject|1|||
164645121|NCT02923115|594724687|FG002|Overall Study|Withdrawal by Subject|0|||
164645122|NCT02923115|594724688|FG003|Overall Study|Withdrawal by Subject|0|||
164645123|NCT02923115|594724689|FG004|Overall Study|Withdrawal by Subject|0|||
164645124|NCT02923115|594724690|FG005|Overall Study|Withdrawal by Subject|0|||
164645125|NCT02923115|594724685|FG000|Overall Study|Randomized, but not dosed|0|||
164645126|NCT02923115|594724686|FG001|Overall Study|Randomized, but not dosed|0|||
164645127|NCT02923115|594724687|FG002|Overall Study|Randomized, but not dosed|3|||
164645128|NCT02923115|594724688|FG003|Overall Study|Randomized, but not dosed|1|||
164645129|NCT02923115|594724689|FG004|Overall Study|Randomized, but not dosed|5|||
164645130|NCT02923115|594724690|FG005|Overall Study|Randomized, but not dosed|0|||
164645131|NCT01296152|594724691|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
164645132|NCT03981614|594724692|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
164645133|NCT03981614|594724693|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
164645134|NCT03981614|594724694|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
164645135|NCT00756652|594724695|FG000|Original Phase|Withdrawal by Subject|864|||
164645136|NCT00756652|594724696|FG001|Original Phase|Withdrawal by Subject|23|||
164645137|NCT00756652|594724695|FG000|Original Phase|Lost to Follow-up|601|||
164645138|NCT00756652|594724696|FG001|Original Phase|Lost to Follow-up|0|||
164645139|NCT00756652|594724695|FG000|Original Phase|Other Discontinuation|797|||
164645140|NCT00756652|594724696|FG001|Original Phase|Other Discontinuation|5|||
164645141|NCT00756652|594724695|FG000|Original Phase|Participant Noncompliance|18622|||
164645142|NCT00756652|594724696|FG001|Original Phase|Participant Noncompliance|424|||
164645143|NCT00756652|594724695|FG000|Original Phase|Unknown Discontinuation Reason|2|||
164645144|NCT00756652|594724696|FG001|Original Phase|Unknown Discontinuation Reason|0|||
164645145|NCT00756652|594724695|FG000|Original Phase|Participants without data|3259|||
164645146|NCT00756652|594724696|FG001|Original Phase|Participants without data|466|||
164645147|NCT00756652|594724695|FG000|Original Phase|Death|168|||
164645148|NCT00756652|594724696|FG001|Original Phase|Death|1|||
164645149|NCT00756652|594724695|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
164645150|NCT00756652|594724696|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
164645151|NCT00756652|594724695|FG000|Re-Op Phase|Withdrawal by Subject|62|||
164645152|NCT00756652|594724696|FG001|Re-Op Phase|Withdrawal by Subject|0|||
164645153|NCT00756652|594724695|FG000|Re-Op Phase|Death|6|||
164645154|NCT00756652|594724696|FG001|Re-Op Phase|Death|0|||
164645155|NCT00756652|594724695|FG000|Re-Op Phase|Lost to Follow-up|340|||
164645156|NCT00756652|594724696|FG001|Re-Op Phase|Lost to Follow-up|0|||
164645157|NCT00756652|594724695|FG000|Re-Op Phase|Site Closed|2454|||
164645158|NCT00756652|594724696|FG001|Re-Op Phase|Site Closed|0|||
164645159|NCT00756652|594724695|FG000|Re-Op Phase|Withdrawn after explant|14|||
164645160|NCT00756652|594724696|FG001|Re-Op Phase|Withdrawn after explant|0|||
164645161|NCT04732728|594724697|FG000|Overall Study|Death|12|||
164645162|NCT04732728|594724697|FG000|Overall Study|Withdrawn|136|||
164645163|NCT04971226|594724698|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
164645164|NCT04971226|594724699|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
164645165|NCT04971226|594724700|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
164645166|NCT04971226|594724701|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
164645167|NCT04971226|594724698|FG000|Overall Study|Adverse Event|6|||
164645168|NCT04971226|594724699|FG001|Overall Study|Adverse Event|5|||
164645169|NCT04971226|594724700|FG002|Overall Study|Adverse Event|11|||
164645170|NCT04971226|594724701|FG003|Overall Study|Adverse Event|10|||
164645171|NCT04971226|594724698|FG000|Overall Study|Progressive disease|2|||
164645172|NCT04971226|594724699|FG001|Overall Study|Progressive disease|0|||
164645173|NCT04971226|594724700|FG002|Overall Study|Progressive disease|3|||
164645174|NCT04971226|594724701|FG003|Overall Study|Progressive disease|1|||
164645175|NCT04971226|594724698|FG000|Overall Study|Protocol Deviation|1|||
164645176|NCT04971226|594724699|FG001|Overall Study|Protocol Deviation|0|||
164645177|NCT04971226|594724700|FG002|Overall Study|Protocol Deviation|1|||
164645178|NCT04971226|594724701|FG003|Overall Study|Protocol Deviation|1|||
164645179|NCT04971226|594724698|FG000|Overall Study|Subject Decision|0|||
164645180|NCT04971226|594724699|FG001|Overall Study|Subject Decision|1|||
164645181|NCT04971226|594724700|FG002|Overall Study|Subject Decision|1|||
164645182|NCT04971226|594724701|FG003|Overall Study|Subject Decision|1|||
164645183|NCT04971226|594724698|FG000|Overall Study|Pregnancy|0|||
164645184|NCT04971226|594724699|FG001|Overall Study|Pregnancy|0|||
164645185|NCT04971226|594724700|FG002|Overall Study|Pregnancy|0|||
164645186|NCT04971226|594724701|FG003|Overall Study|Pregnancy|1|||
164645187|NCT04971226|594724698|FG000|Overall Study|Participants not treated|1|||
164645188|NCT04971226|594724699|FG001|Overall Study|Participants not treated|0|||
164645189|NCT04971226|594724700|FG002|Overall Study|Participants not treated|2|||
164645190|NCT04971226|594724701|FG003|Overall Study|Participants not treated|1|||
164645191|NCT06065176|594724705|FG000|Overall Study|Lost to Follow-up|11|||
164645192|NCT06065176|594724706|FG001|Overall Study|Lost to Follow-up|11|||
164645193|NCT06065176|594724707|FG002|Overall Study|Lost to Follow-up|10|||
164645194|NCT06065176|594724705|FG000|Overall Study|Withdrawal by Subject|1|||
164645195|NCT06065176|594724706|FG001|Overall Study|Withdrawal by Subject|1|||
164645196|NCT06065176|594724707|FG002|Overall Study|Withdrawal by Subject|2|||
164645197|NCT06065176|594724705|FG000|Overall Study|No longer met eligibility requirements to continue participation.|3|||
164645198|NCT06065176|594724706|FG001|Overall Study|No longer met eligibility requirements to continue participation.|5|||
164645199|NCT06065176|594724707|FG002|Overall Study|No longer met eligibility requirements to continue participation.|1|||
164645200|NCT03889197|594724708|FG000|Overall Study|Withdrawal by Subject|1|||
164645201|NCT03889197|594724709|FG001|Overall Study|Withdrawal by Subject|0|||
164645202|NCT03889197|594724708|FG000|Overall Study|Physician Decision|0|||
164645203|NCT03889197|594724709|FG001|Overall Study|Physician Decision|1|||
164645204|NCT03889197|594724708|FG000|Overall Study|met exclusion criteria|0|||
164645205|NCT03889197|594724709|FG001|Overall Study|met exclusion criteria|1|||
164645206|NCT03889197|594724708|FG000|Overall Study|Protocol Violation|1|||
164645207|NCT03889197|594724709|FG001|Overall Study|Protocol Violation|0|||
164645208|NCT04083378|594724712|FG000|Overall Study|Death|18|||
164645209|NCT04083378|594724713|FG001|Overall Study|Death|4|||
164645210|NCT04083378|594724712|FG000|Overall Study|Lost to Follow-up|4|||
164645211|NCT04083378|594724713|FG001|Overall Study|Lost to Follow-up|0|||
164645212|NCT05824273|594724714|FG000|Overall Study|Lost to Follow-up|16|||
164645213|NCT05824273|594724715|FG001|Overall Study|Lost to Follow-up|13|||
164645214|NCT04644237|594724721|FG000|Overall Study|Death|4|||
164645215|NCT04644237|594724722|FG001|Overall Study|Death|2|||
164645216|NCT04644237|594724721|FG000|Overall Study|Adverse Event|18|||
164645217|NCT04644237|594724722|FG001|Overall Study|Adverse Event|19|||
164645218|NCT04644237|594724721|FG000|Overall Study|Progressive Disease|61|||
164645219|NCT04644237|594724722|FG001|Overall Study|Progressive Disease|23|||
164645220|NCT04644237|594724721|FG000|Overall Study|Clinical Progression|4|||
164645221|NCT04644237|594724722|FG001|Overall Study|Clinical Progression|1|||
164645222|NCT04644237|594724721|FG000|Overall Study|Withdrawal by Subject|4|||
164645223|NCT04644237|594724722|FG001|Overall Study|Withdrawal by Subject|2|||
164645224|NCT04644237|594724721|FG000|Overall Study|Physician Decision|4|||
164645225|NCT04644237|594724722|FG001|Overall Study|Physician Decision|0|||
164645226|NCT04644237|594724721|FG000|Overall Study|Other|6|||
164645227|NCT04644237|594724722|FG001|Overall Study|Other|3|||
164645228|NCT04644237|594724721|FG000|Overall Study|Randomized but not Treated|1|||
164645229|NCT04644237|594724722|FG001|Overall Study|Randomized but not Treated|0|||
164645230|NCT03131817|594724723|FG000|Overall Study|Participant developed cognitive decline and was unable to provide regular symptom assessments|1|||
164645231|NCT02949219|594724725|FG000|Overall Study|Withdrawal by Subject|1|||
164645232|NCT03494816|594724726|FG000|Overall Study|Protocol Violation|2|||
164645233|NCT03494816|594724726|FG000|Overall Study|Physician Decision|2|||
164645234|NCT03494816|594724726|FG000|Overall Study|Did not start trial treatment|1|||
164645235|NCT03494816|594724726|FG000|Overall Study|Adverse Event|1|||
164645236|NCT00633217|594724740|FG000|Overall Study|Adverse Event|5|||
164645237|NCT00633217|594724741|FG001|Overall Study|Adverse Event|9|||
164645238|NCT00633217|594724740|FG000|Overall Study|Lack of Efficacy|0|||
164645239|NCT00633217|594724741|FG001|Overall Study|Lack of Efficacy|2|||
164645240|NCT00633217|594724740|FG000|Overall Study|Protocol Violation|3|||
164645241|NCT00633217|594724741|FG001|Overall Study|Protocol Violation|7|||
164645242|NCT00633217|594724740|FG000|Overall Study|Lost to Follow-up|2|||
164645243|NCT00633217|594724741|FG001|Overall Study|Lost to Follow-up|2|||
164645244|NCT00633217|594724740|FG000|Overall Study|Investigator Discretion|2|||
164645245|NCT00633217|594724741|FG001|Overall Study|Investigator Discretion|0|||
164645246|NCT00633217|594724740|FG000|Overall Study|Withdrew Consent|3|||
164645247|NCT00633217|594724741|FG001|Overall Study|Withdrew Consent|3|||
164645248|NCT05838755|594724742|FG000|Overall Study|Adverse Event|1|||
164645249|NCT05838755|594724743|FG001|Overall Study|Adverse Event|0|||
164645250|NCT05838755|594724744|FG002|Overall Study|Adverse Event|0|||
164645251|NCT05838755|594724742|FG000|Overall Study|Lack of Efficacy|1|||
164645252|NCT05838755|594724743|FG001|Overall Study|Lack of Efficacy|0|||
164645253|NCT05838755|594724744|FG002|Overall Study|Lack of Efficacy|1|||
164645254|NCT05838755|594724742|FG000|Overall Study|Lost to Follow-up|0|||
164645255|NCT05838755|594724743|FG001|Overall Study|Lost to Follow-up|1|||
164645256|NCT05838755|594724744|FG002|Overall Study|Lost to Follow-up|4|||
164645257|NCT05838755|594724742|FG000|Overall Study|Withdrawal by Subject|0|||
164645258|NCT05838755|594724743|FG001|Overall Study|Withdrawal by Subject|2|||
164645259|NCT05838755|594724744|FG002|Overall Study|Withdrawal by Subject|0|||
164645260|NCT05838755|594724742|FG000|Overall Study|Study terminated by sponsor|26|||
164645261|NCT05838755|594724743|FG001|Overall Study|Study terminated by sponsor|27|||
164645262|NCT05838755|594724744|FG002|Overall Study|Study terminated by sponsor|26|||
164645263|NCT05838755|594724742|FG000|Overall Study|Randomized, not treated|2|||
164645264|NCT05838755|594724743|FG001|Overall Study|Randomized, not treated|0|||
164645265|NCT05838755|594724744|FG002|Overall Study|Randomized, not treated|1|||
164645266|NCT05838755|594724742|FG000|Overall Study|Pregnancy|0|||
164645267|NCT05838755|594724743|FG001|Overall Study|Pregnancy|1|||
164645268|NCT05838755|594724744|FG002|Overall Study|Pregnancy|0|||
164645269|NCT01283282|594724745|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
164645270|NCT01283282|594724746|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
164645271|NCT01283282|594724745|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
164645272|NCT01283282|594724746|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
164645273|NCT01283282|594724745|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
164645274|NCT01283282|594724746|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
164645275|NCT01682681|594724747|FG000|Overall Study|Lack of Efficacy|62|||
164645276|NCT01682681|594724747|FG000|Overall Study|Withdrawal by Subject|1|||
164645277|NCT01682681|594724747|FG000|Overall Study|Moved to other hospital|10|||
164645278|NCT01682681|594724747|FG000|Overall Study|Lost to Follow-up|174|||
164645279|NCT01682681|594724747|FG000|Overall Study|Adverse Event|46|||
164645280|NCT01682681|594724747|FG000|Overall Study|tapering of topiramate|5|||
164645281|NCT01682681|594724747|FG000|Overall Study|Other|21|||
164645282|NCT01682681|594724747|FG000|Overall Study|Low compliance|13|||
164645283|NCT02044094|594724750|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
164645284|NCT02044094|594724750|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
164645285|NCT02044094|594724750|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
164645286|NCT02044094|594724750|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
164645287|NCT02044094|594724750|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
164645288|NCT02044094|594724750|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
164645289|NCT02044094|594724750|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
164645290|NCT02044094|594724750|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
164645291|NCT02392377|594724751|FG000|Overall Study|Withdrawal by Subject|0|||
164645292|NCT02392377|594724752|FG001|Overall Study|Withdrawal by Subject|1|||
164645293|NCT00005879|594724753|FG000|Overall Study|Withdrawal by Subject|8|||
164645294|NCT00005879|594724754|FG001|Overall Study|Withdrawal by Subject|10|||
164645295|NCT01238172|594724755|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
164645296|NCT01238172|594724756|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
164645297|NCT01238172|594724755|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
164645298|NCT01238172|594724756|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
164645299|NCT05022121|594724757|FG000|Overall Study|Lack of Efficacy|1|||
164645300|NCT05022121|594724758|FG001|Overall Study|Lack of Efficacy|0|||
164645301|NCT05022121|594724757|FG000|Overall Study|Lost to Follow-up|0|||
164645302|NCT05022121|594724758|FG001|Overall Study|Lost to Follow-up|2|||
164645303|NCT01020773|594726605|FG000|Overall Study|Withdrawal by Subject|4|||
164645304|NCT01020773|594726606|FG001|Overall Study|Withdrawal by Subject|3|||
164645305|NCT03302299|594726607|FG000|Overall Study|Protocol Violation|1|||
164645306|NCT01458132|594726608|FG000|Overall Study|Other|15|||
164645307|NCT01458132|594726609|FG001|Overall Study|Other|3|||
164645308|NCT01788163|594726615|FG000|Overall Study|Other|53|||
164645309|NCT01788163|594726616|FG001|Overall Study|Other|0|||
164645310|NCT01788163|594726617|FG002|Overall Study|Other|0|||
164645311|NCT01788163|594726618|FG003|Overall Study|Other|0|||
164645312|NCT01788163|594726619|FG004|Overall Study|Other|0|||
164645313|NCT01788163|594726620|FG005|Overall Study|Other|7|||
164645314|NCT01788163|594726621|FG006|Overall Study|Other|1|||
164645315|NCT01788163|594726622|FG007|Overall Study|Other|48|||
164645316|NCT01788163|594726623|FG008|Overall Study|Other|15|||
164645317|NCT01788163|594726615|FG000|Overall Study|Withdrawal by Subject|2|||
164645318|NCT01788163|594726616|FG001|Overall Study|Withdrawal by Subject|0|||
164645319|NCT01788163|594726617|FG002|Overall Study|Withdrawal by Subject|0|||
164645320|NCT01788163|594726618|FG003|Overall Study|Withdrawal by Subject|0|||
164645321|NCT01788163|594726619|FG004|Overall Study|Withdrawal by Subject|0|||
164645322|NCT01788163|594726620|FG005|Overall Study|Withdrawal by Subject|0|||
164645323|NCT01788163|594726621|FG006|Overall Study|Withdrawal by Subject|0|||
164645324|NCT01788163|594726622|FG007|Overall Study|Withdrawal by Subject|0|||
164645325|NCT01788163|594726623|FG008|Overall Study|Withdrawal by Subject|1|||
164645326|NCT02803138|594726626|FG000|Overall Study|Failure to return|38|||
164645327|NCT02803138|594726626|FG000|Overall Study|Insufficient virological response|2|||
164645328|NCT02803138|594726626|FG000|Overall Study|Withdrawn consent|1|||
164645329|NCT02803138|594726626|FG000|Overall Study|Death|1|||
164645330|NCT02803138|594726626|FG000|Overall Study|Other, not specified|28|||
164645331|NCT00424515|594726627|FG000|Overall Study|Progressive Disease|10|||
164645332|NCT00424515|594726628|FG001|Overall Study|Progressive Disease|11|||
164645333|NCT00424515|594726627|FG000|Overall Study|Adverse Event|0|||
164645334|NCT00424515|594726628|FG001|Overall Study|Adverse Event|1|||
164645335|NCT00424515|594726627|FG000|Overall Study|Intercurrent Illness|0|||
164645336|NCT00424515|594726628|FG001|Overall Study|Intercurrent Illness|1|||
164645337|NCT00424515|594726627|FG000|Overall Study|Withdrawal by Subject|1|||
164645338|NCT00424515|594726628|FG001|Overall Study|Withdrawal by Subject|0|||
164645339|NCT04318535|594726629|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
164645340|NCT04318535|594726630|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
164645341|NCT04318535|594726631|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
164645342|NCT00021229|594726633|FG000|Overall Study|Adverse Event|10|||
164645343|NCT00021229|594726634|FG001|Overall Study|Adverse Event|5|||
164645344|NCT00021229|594726635|FG002|Overall Study|Adverse Event|2|||
164645345|NCT00021229|594726633|FG000|Overall Study|Death|0|||
164645346|NCT00021229|594726634|FG001|Overall Study|Death|1|||
164645347|NCT00021229|594726635|FG002|Overall Study|Death|0|||
164645348|NCT00021229|594726633|FG000|Overall Study|Withdrawal by Subject|7|||
164645349|NCT00021229|594726634|FG001|Overall Study|Withdrawal by Subject|7|||
164645350|NCT00021229|594726635|FG002|Overall Study|Withdrawal by Subject|1|||
164645351|NCT00021229|594726633|FG000|Overall Study|Progressive Disease|15|||
164645352|NCT00021229|594726634|FG001|Overall Study|Progressive Disease|19|||
164645353|NCT00021229|594726635|FG002|Overall Study|Progressive Disease|12|||
164645354|NCT00021229|594726633|FG000|Overall Study|Protocol Violation|1|||
164645355|NCT00021229|594726634|FG001|Overall Study|Protocol Violation|1|||
164645356|NCT00021229|594726635|FG002|Overall Study|Protocol Violation|0|||
164645357|NCT00021229|594726633|FG000|Overall Study|Physician Decision|0|||
164645358|NCT00021229|594726634|FG001|Overall Study|Physician Decision|0|||
164645359|NCT00021229|594726635|FG002|Overall Study|Physician Decision|1|||
164645360|NCT00021229|594726633|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
164645361|NCT00021229|594726634|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
164645362|NCT00021229|594726635|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
164645363|NCT00297492|594726639|FG000|Set Quit Date|Lost to Follow-up|7|||
164645364|NCT00297492|594726640|FG001|Set Quit Date|Lost to Follow-up|13|||
164645365|NCT00297492|594726641|FG002|Set Quit Date|Lost to Follow-up|5|||
164645366|NCT00297492|594726639|FG000|6 Month Follow-up|Lost to Follow-up|63|||
164645367|NCT00297492|594726640|FG001|6 Month Follow-up|Lost to Follow-up|49|||
164645368|NCT00297492|594726641|FG002|6 Month Follow-up|Lost to Follow-up|27|||
164645369|NCT02156466|594726642|FG000|Overall Study|Adverse Event|0|||
164645370|NCT02156466|594726643|FG001|Overall Study|Adverse Event|0|||
164645371|NCT02156466|594726644|FG002|Overall Study|Adverse Event|1|||
164645372|NCT02156466|594726645|FG003|Overall Study|Adverse Event|1|||
164645373|NCT02156466|594726646|FG004|Overall Study|Adverse Event|0|||
164645374|NCT02156466|594726642|FG000|Overall Study|Quantiferon Positivity|0|||
164645375|NCT02156466|594726643|FG001|Overall Study|Quantiferon Positivity|0|||
164645376|NCT02156466|594726644|FG002|Overall Study|Quantiferon Positivity|0|||
164645377|NCT02156466|594726645|FG003|Overall Study|Quantiferon Positivity|1|||
164645378|NCT02156466|594726646|FG004|Overall Study|Quantiferon Positivity|0|||
164645379|NCT00569231|594726647|FG000|Overall Study|Study unrelated surgery|1|||
164645380|NCT00569231|594726647|FG000|Overall Study|Airfare expense|2|||
164645381|NCT00569231|594726647|FG000|Overall Study|Withdrawal by Subject|1|||
164645382|NCT00569231|594726647|FG000|Overall Study|Car accident injury|1|||
164645383|NCT00569231|594726647|FG000|Overall Study|Non-compliance|2|||
164645384|NCT03456726|594726648|FG000|Overall Study|Disease Progression|6|||
164645385|NCT03456726|594726649|FG001|Overall Study|Disease Progression|1|||
164645386|NCT03456726|594726648|FG000|Overall Study|Adverse Event|4|||
164645387|NCT03456726|594726649|FG001|Overall Study|Adverse Event|2|||
164645388|NCT03456726|594726648|FG000|Overall Study|Withdrawal by Subject|1|||
164645389|NCT03456726|594726649|FG001|Overall Study|Withdrawal by Subject|0|||
164645390|NCT03456726|594726648|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
164645391|NCT03456726|594726649|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
164645392|NCT00306852|594726650|FG000|Overall Study|Death|14|||
164645393|NCT00306852|594726651|FG001|Overall Study|Death|14|||
164645394|NCT00306852|594726650|FG000|Overall Study|Lost to Follow-up|15|||
164645395|NCT00306852|594726651|FG001|Overall Study|Lost to Follow-up|24|||
164645396|NCT00817778|594726652|FG000|Overall Study|Adverse Event|1|||
164645397|NCT00817778|594726653|FG001|Overall Study|Adverse Event|0|||
164645398|NCT00817778|594726652|FG000|Overall Study|Withdrawal by Subject|1|||
164645399|NCT00817778|594726653|FG001|Overall Study|Withdrawal by Subject|1|||
164645400|NCT00817778|594726652|FG000|Overall Study|Protocol Violation|0|||
164645401|NCT00817778|594726653|FG001|Overall Study|Protocol Violation|1|||
164645402|NCT00817778|594726652|FG000|Overall Study|Study-specific discontinuation criteria|0|||
164645403|NCT00817778|594726653|FG001|Overall Study|Study-specific discontinuation criteria|1|||
164645404|NCT00817778|594726652|FG000|Overall Study|Poor venous access|1|||
164645405|NCT00817778|594726653|FG001|Overall Study|Poor venous access|0|||
164645406|NCT00883740|594726654|FG000|First Intervention|Lost to Follow-up|1|||
164645407|NCT00883740|594726655|FG001|First Intervention|Lost to Follow-up|0|||
164645408|NCT00883740|594726654|FG000|First Intervention|No longer willing to participate|2|||
164645409|NCT00883740|594726655|FG001|First Intervention|No longer willing to participate|0|||
164645410|NCT00883740|594726654|FG000|First Intervention|Protocol Violation|3|||
164645411|NCT00883740|594726655|FG001|First Intervention|Protocol Violation|6|||
164645412|NCT00883740|594726654|FG000|First Intervention|Adverse Event|1|||
164645413|NCT00883740|594726655|FG001|First Intervention|Adverse Event|2|||
164645414|NCT00883740|594726654|FG000|Second Intervention|Protocol Violation|1|||
164645415|NCT00883740|594726655|FG001|Second Intervention|Protocol Violation|0|||
164645416|NCT00883740|594726654|FG000|Second Intervention|No longer willing to participate|0|||
164645417|NCT00883740|594726655|FG001|Second Intervention|No longer willing to participate|1|||
164645418|NCT01875991|594726656|FG000|Overall Study|Withdrawal by Subject|6|||
164645419|NCT01875991|594726657|FG001|Overall Study|Withdrawal by Subject|6|||
164645420|NCT01875991|594726656|FG000|Overall Study|Sponsor Decision|1|||
164645421|NCT01875991|594726657|FG001|Overall Study|Sponsor Decision|0|||
164645422|NCT00103259|594726658|FG000|Overall Study|Death|3|||
164645423|NCT00103259|594726659|FG001|Overall Study|Death|2|||
164645424|NCT00103259|594726658|FG000|Overall Study|Withdrawal by Subject|2|||
164645425|NCT00103259|594726659|FG001|Overall Study|Withdrawal by Subject|3|||
164645426|NCT00103259|594726658|FG000|Overall Study|alternative therapy|1|||
164645427|NCT00103259|594726659|FG001|Overall Study|alternative therapy|0|||
164645428|NCT00103259|594726658|FG000|Overall Study|other (reasons were not specified)|2|||
164645429|NCT00103259|594726659|FG001|Overall Study|other (reasons were not specified)|1|||
164645430|NCT00103259|594726658|FG000|Overall Study|ineligible/no protocol therapy|4|||
164645431|NCT00103259|594726659|FG001|Overall Study|ineligible/no protocol therapy|6|||
164645432|NCT03224234|594726660|FG000|Main Study|Lost to Follow-up|5|||
164645433|NCT03224234|594726661|FG001|Main Study|Lost to Follow-up|5|||
164645434|NCT02610842|594726662|FG000|Overall Study|Lost to Follow-up|5|||
164645435|NCT02494583|594726665|FG000|Overall Study|Death|224|||
164645436|NCT02494583|594726666|FG001|Overall Study|Death|214|||
164645437|NCT02494583|594726667|FG002|Overall Study|Death|225|||
164645438|NCT02494583|594726665|FG000|Overall Study|Lost to Follow-up|1|||
164645439|NCT02494583|594726666|FG001|Overall Study|Lost to Follow-up|0|||
164645440|NCT02494583|594726667|FG002|Overall Study|Lost to Follow-up|0|||
164645441|NCT02494583|594726665|FG000|Overall Study|Protocol Violation|1|||
164645442|NCT02494583|594726666|FG001|Overall Study|Protocol Violation|2|||
164645443|NCT02494583|594726667|FG002|Overall Study|Protocol Violation|0|||
164645444|NCT02494583|594726665|FG000|Overall Study|Screen Failure|0|||
164645445|NCT02494583|594726666|FG001|Overall Study|Screen Failure|1|||
164645446|NCT02494583|594726667|FG002|Overall Study|Screen Failure|0|||
164645447|NCT02494583|594726665|FG000|Overall Study|Transferred to Extension Study|15|||
164645448|NCT02494583|594726666|FG001|Overall Study|Transferred to Extension Study|15|||
164645449|NCT02494583|594726667|FG002|Overall Study|Transferred to Extension Study|6|||
164645450|NCT02494583|594726665|FG000|Overall Study|Did Not Continue on Extension Study|8|||
164645451|NCT02494583|594726666|FG001|Overall Study|Did Not Continue on Extension Study|10|||
164645452|NCT02494583|594726667|FG002|Overall Study|Did Not Continue on Extension Study|4|||
164645453|NCT02494583|594726665|FG000|Overall Study|Withdrawal by Subject|7|||
164645454|NCT02494583|594726666|FG001|Overall Study|Withdrawal by Subject|15|||
164645455|NCT02494583|594726667|FG002|Overall Study|Withdrawal by Subject|15|||
164645456|NCT00627458|594726668|FG000|Overall Study|Migrated from study area|1|||
164645457|NCT00627458|594726669|FG001|Overall Study|Migrated from study area|0|||
164645458|NCT00627458|594726670|FG002|Overall Study|Migrated from study area|1|||
164645459|NCT00627458|594726668|FG000|Overall Study|Withdrawal by Subject|2|||
164645460|NCT00627458|594726669|FG001|Overall Study|Withdrawal by Subject|6|||
164645461|NCT00627458|594726670|FG002|Overall Study|Withdrawal by Subject|5|||
164645462|NCT00627458|594726668|FG000|Overall Study|Lost to Follow-up|1|||
164645463|NCT00627458|594726669|FG001|Overall Study|Lost to Follow-up|1|||
164645464|NCT00627458|594726670|FG002|Overall Study|Lost to Follow-up|0|||
164645465|NCT03151707|594726671|FG000|Overall Study|Lost to Follow-up|6|||
164645466|NCT04439149|594726672|FG000|Overall Study|Ineligible|1|||
164645467|NCT04439149|594726672|FG000|Overall Study|Never start protocol therapy|1|||
164645468|NCT04439149|594726672|FG000|Overall Study|Adverse Event|4|||
164645469|NCT04439149|594726672|FG000|Overall Study|Disease Progression|14|||
164645470|NCT04439149|594726672|FG000|Overall Study|Complicating disease|1|||
164645471|NCT04439149|594726672|FG000|Overall Study|Withdrawal by Subject|3|||
164645472|NCT02617446|594726673|FG000|Overall Study|Withdrawal by Subject|0|||
164645473|NCT02617446|594726674|FG001|Overall Study|Withdrawal by Subject|2|||
164645474|NCT02617446|594726675|FG002|Overall Study|Withdrawal by Subject|0|||
164645475|NCT02617446|594726673|FG000|Overall Study|Adverse Event|1|||
164645476|NCT02617446|594726674|FG001|Overall Study|Adverse Event|0|||
164645477|NCT02617446|594726675|FG002|Overall Study|Adverse Event|5|||
164645478|NCT02617446|594726673|FG000|Overall Study|Lost to Follow-up|3|||
164645479|NCT02617446|594726674|FG001|Overall Study|Lost to Follow-up|0|||
164645480|NCT02617446|594726675|FG002|Overall Study|Lost to Follow-up|0|||
164645481|NCT02617446|594726673|FG000|Overall Study|Death|0|||
164645482|NCT02617446|594726674|FG001|Overall Study|Death|0|||
164645483|NCT02617446|594726675|FG002|Overall Study|Death|2|||
164645484|NCT00530088|594726684|FG000|Overall Study|Disease Progression|4|||
164645485|NCT00530088|594726684|FG000|Overall Study|Physician Decision|4|||
164645486|NCT00530088|594726684|FG000|Overall Study|Other Not Specified|2|||
164645487|NCT05264506|594726687|FG000|Overall Study|Adverse Event|59|||
164645488|NCT05264506|594726687|FG000|Overall Study|Lost to Follow-up|204|||
164645489|NCT05264506|594726687|FG000|Overall Study|Protocol Violation|185|||
164645490|NCT05264506|594726687|FG000|Overall Study|Pregnancy|60|||
164645491|NCT05264506|594726687|FG000|Overall Study|Physician Decision|6|||
164645492|NCT05264506|594726687|FG000|Overall Study|Non-compliance with Study Drug|29|||
164645493|NCT05264506|594726687|FG000|Overall Study|Study termination|677|||
164645494|NCT05264506|594726687|FG000|Overall Study|Withdrawal by Subject|208|||
164645495|NCT05264506|594726687|FG000|Overall Study|Discontinued prior treatment|89|||
164645496|NCT04521608|594726688|FG000|Overall Study|Death|8|||
164645497|NCT04521608|594726689|FG001|Overall Study|Death|9|||
164645498|NCT04521608|594726688|FG000|Overall Study|Withdrawal by Subject|25|||
164645499|NCT04521608|594726689|FG001|Overall Study|Withdrawal by Subject|18|||
164645500|NCT04521608|594726688|FG000|Overall Study|Disease Progression|3|||
164645501|NCT04521608|594726689|FG001|Overall Study|Disease Progression|10|||
164645502|NCT04521608|594726688|FG000|Overall Study|Complicating Disease|6|||
164645503|NCT04521608|594726689|FG001|Overall Study|Complicating Disease|3|||
164645504|NCT04521608|594726688|FG000|Overall Study|Lost Contact|25|||
164645505|NCT04521608|594726689|FG001|Overall Study|Lost Contact|27|||
164645506|NCT04521608|594726688|FG000|Overall Study|Ineligible|1|||
164645507|NCT04521608|594726689|FG001|Overall Study|Ineligible|0|||
164645508|NCT04521608|594726688|FG000|Overall Study|Refused Further Study Participation|13|||
164645509|NCT04521608|594726689|FG001|Overall Study|Refused Further Study Participation|7|||
164645510|NCT00644228|594726690|FG000|Randomization & Eligibility|Ineligible|31|||
164645511|NCT00644228|594726691|FG001|Randomization & Eligibility|Ineligible|21|||
164645512|NCT00644228|594726690|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
164645513|NCT00644228|594726691|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
164645514|NCT00644228|594726690|FG000|Randomization & Eligibility|Invalid Consent|0|||
164645515|NCT00644228|594726691|FG001|Randomization & Eligibility|Invalid Consent|1|||
164645516|NCT00644228|594726690|FG000|Induction Therapy|Adverse Event|22|||
164645517|NCT00644228|594726691|FG001|Induction Therapy|Adverse Event|55|||
164645518|NCT00644228|594726690|FG000|Induction Therapy|Withdrawal by Subject|10|||
164645519|NCT00644228|594726691|FG001|Induction Therapy|Withdrawal by Subject|3|||
164645520|NCT00644228|594726690|FG000|Induction Therapy|Progression/Relapse|24|||
164645521|NCT00644228|594726691|FG001|Induction Therapy|Progression/Relapse|12|||
164645522|NCT00644228|594726690|FG000|Induction Therapy|Death|3|||
164645523|NCT00644228|594726691|FG001|Induction Therapy|Death|7|||
164645524|NCT00644228|594726690|FG000|Induction Therapy|Not Protocol-Specified|24|||
164645525|NCT00644228|594726691|FG001|Induction Therapy|Not Protocol-Specified|28|||
164645526|NCT00644228|594726690|FG000|Maintenance|Adverse Event|27|||
164645527|NCT00644228|594726691|FG001|Maintenance|Adverse Event|31|||
164645528|NCT00644228|594726690|FG000|Maintenance|Withdrawal by Subject|6|||
164645529|NCT00644228|594726691|FG001|Maintenance|Withdrawal by Subject|4|||
164645530|NCT00644228|594726690|FG000|Maintenance|Progression/Relapse|67|||
164645531|NCT00644228|594726691|FG001|Maintenance|Progression/Relapse|42|||
164645532|NCT00644228|594726690|FG000|Maintenance|Death|3|||
164645533|NCT00644228|594726691|FG001|Maintenance|Death|3|||
164645534|NCT00644228|594726690|FG000|Maintenance|Not Protocol-Specified|14|||
164645535|NCT00644228|594726691|FG001|Maintenance|Not Protocol-Specified|15|||
164645536|NCT00644228|594726690|FG000|Maintenance|On Treatment|26|||
164645537|NCT00644228|594726691|FG001|Maintenance|On Treatment|40|||
164645538|NCT06078124|594726692|FG000|Overall Study|Lost to Follow-up|14|||
164645539|NCT06078124|594726693|FG001|Overall Study|Lost to Follow-up|14|||
164645540|NCT03252756|594726702|FG000|Overall Study|Protocol Violation|2|||
164645541|NCT03252756|594726703|FG001|Overall Study|Protocol Violation|4|||
164645542|NCT03252756|594726702|FG000|Overall Study|COVID-19 Pandemic|1|||
164645543|NCT03252756|594726703|FG001|Overall Study|COVID-19 Pandemic|1|||
164645544|NCT03252756|594726702|FG000|Overall Study|Study Drug Expiration|0|||
164645545|NCT03252756|594726703|FG001|Overall Study|Study Drug Expiration|1|||
164645546|NCT02061293|594726704|FG000|Overall Study|Elevated Blood Pressure|1|||
164645547|NCT02061293|594726705|FG001|Overall Study|Elevated Blood Pressure|1|||
164645548|NCT04066894|594726706|FG000|Overall Study|Lack of Efficacy|1|||
164645549|NCT04066894|594726706|FG000|Overall Study|Screen Failure|1|||
164645550|NCT01500434|594726713|FG000|Overall Study|Death|1|||
164645551|NCT01500434|594726713|FG000|Overall Study|Withdrawal by Subject|1|||
164645552|NCT01500434|594726713|FG000|Overall Study|Missed 12-month follow-up|5|||
164645553|NCT00083226|594726714|FG000|Overall Study|Lack of Efficacy|19|||
164645554|NCT00083226|594726714|FG000|Overall Study|Adverse Event|9|||
164645555|NCT00083226|594726714|FG000|Overall Study|Death|4|||
164645556|NCT00083226|594726714|FG000|Overall Study|Withdrawal by Subject|4|||
164645557|NCT00083226|594726714|FG000|Overall Study|Other|2|||
164645558|NCT00083226|594726714|FG000|Overall Study|ineligible or not receiving treatment|4|||
164645559|NCT00909857|594726715|FG000|Overall Study|Withdrawal by Subject|6|||
164645560|NCT00909857|594726716|FG001|Overall Study|Withdrawal by Subject|10|||
164645561|NCT00909857|594726715|FG000|Overall Study|Adverse Event|5|||
164645562|NCT00909857|594726716|FG001|Overall Study|Adverse Event|5|||
164645563|NCT00909857|594726715|FG000|Overall Study|Lost to Follow-up|2|||
164645564|NCT00909857|594726716|FG001|Overall Study|Lost to Follow-up|5|||
164645565|NCT00909857|594726715|FG000|Overall Study|Protocol Violation|2|||
164645566|NCT00909857|594726716|FG001|Overall Study|Protocol Violation|1|||
164645567|NCT00909857|594726715|FG000|Overall Study|Pregnancy|1|||
164645568|NCT00909857|594726716|FG001|Overall Study|Pregnancy|0|||
164645569|NCT00909857|594726715|FG000|Overall Study|Other|1|||
164645570|NCT00909857|594726716|FG001|Overall Study|Other|0|||
164645571|NCT00909857|594726715|FG000|Overall Study|Did not receive study medication|19|||
164645572|NCT00909857|594726716|FG001|Overall Study|Did not receive study medication|24|||
164645573|NCT00604175|594726723|FG000|Entry Through Week 28|Death|2|||
164645574|NCT00604175|594726724|FG001|Entry Through Week 28|Death|0|||
164645575|NCT00604175|594726725|FG002|Entry Through Week 28|Death|0|||
164645576|NCT00604175|594726723|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
164645577|NCT00604175|594726724|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
164645578|NCT00604175|594726725|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
164645579|NCT00604175|594726723|FG000|Entry Through Week 28|Lost to Follow-up|4|||
164645580|NCT00604175|594726724|FG001|Entry Through Week 28|Lost to Follow-up|3|||
164645581|NCT00604175|594726725|FG002|Entry Through Week 28|Lost to Follow-up|0|||
164645582|NCT00604175|594726723|FG000|Entry Through Week 28|Ineligible|1|||
164645583|NCT00604175|594726724|FG001|Entry Through Week 28|Ineligible|0|||
164645584|NCT00604175|594726725|FG002|Entry Through Week 28|Ineligible|0|||
164645585|NCT00604175|594726723|FG000|Entry Through Week 28|Did not start intervention|2|||
164645586|NCT00604175|594726724|FG001|Entry Through Week 28|Did not start intervention|0|||
164645587|NCT00604175|594726725|FG002|Entry Through Week 28|Did not start intervention|1|||
164645588|NCT00604175|594726723|FG000|Week 29 Through Week 72|Death|0|||
164645589|NCT00604175|594726724|FG001|Week 29 Through Week 72|Death|0|||
164645590|NCT00604175|594726725|FG002|Week 29 Through Week 72|Death|1|||
164645591|NCT00604175|594726723|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
164645592|NCT00604175|594726724|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
164645593|NCT00604175|594726725|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
164645594|NCT00604175|594726723|FG000|Week 29 Through Week 72|Site closure|0|||
164645595|NCT00604175|594726724|FG001|Week 29 Through Week 72|Site closure|1|||
164645596|NCT00604175|594726725|FG002|Week 29 Through Week 72|Site closure|0|||
164645597|NCT00604175|594726723|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
164645598|NCT00604175|594726724|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
164645599|NCT00604175|594726725|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
164645600|NCT03353415|594726726|FG000|Masked CGM Wear|Lost to Follow-up|2|||
164645601|NCT03353415|594726726|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
164645602|NCT03205163|594726727|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
164645603|NCT03205163|594726728|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
164645604|NCT00131937|594726729|FG000|Overall Study|Adverse Event|3|||
164645605|NCT00131937|594726729|FG000|Overall Study|Withdrawal by Subject|2|||
164645606|NCT00131937|594726729|FG000|Overall Study|Physician Decision|1|||
164645607|NCT00131937|594726729|FG000|Overall Study|Disease Progression|7|||
164645608|NCT00131937|594726729|FG000|Overall Study|Alternative therapy|1|||
164645609|NCT04647253|594726732|FG000|Overall Study|Death ≤ 365 Days|16|||
164645610|NCT04647253|594726733|FG001|Overall Study|Death ≤ 365 Days|7|||
164645611|NCT04647253|594726732|FG000|Overall Study|Physician Decision|0|||
164645612|NCT04647253|594726733|FG001|Overall Study|Physician Decision|1|||
164645613|NCT04647253|594726732|FG000|Overall Study|Withdrawal by Subject|7|||
164645614|NCT04647253|594726733|FG001|Overall Study|Withdrawal by Subject|2|||
164645615|NCT04647253|594726732|FG000|Overall Study|Missed 12-Month Visit|9|||
164645616|NCT04647253|594726733|FG001|Overall Study|Missed 12-Month Visit|7|||
164645617|NCT04647253|594726732|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
164645618|NCT04647253|594726733|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
164645619|NCT02038959|594728147|FG000|Overall Study|Withdrawal by Subject|6|||
164645620|NCT02038959|594728148|FG001|Overall Study|Withdrawal by Subject|8|||
164645621|NCT00819091|594728154|FG000|Overall Study|Adverse Event|3|||
164645622|NCT00819091|594728155|FG001|Overall Study|Adverse Event|5|||
164645623|NCT00819091|594728154|FG000|Overall Study|Protocol Violation|0|||
164645624|NCT00819091|594728155|FG001|Overall Study|Protocol Violation|1|||
164645625|NCT00819091|594728154|FG000|Overall Study|Lost to Follow-up|2|||
164645626|NCT00819091|594728155|FG001|Overall Study|Lost to Follow-up|0|||
164645627|NCT00819091|594728154|FG000|Overall Study|Withdrawal by Subject|1|||
164645628|NCT00819091|594728155|FG001|Overall Study|Withdrawal by Subject|2|||
164645629|NCT00819091|594728154|FG000|Overall Study|Other|1|||
164645630|NCT00819091|594728155|FG001|Overall Study|Other|2|||
164645631|NCT00265239|594728156|FG000|Overall Study|Adverse Event|2|||
164645632|NCT00265239|594728157|FG001|Overall Study|Adverse Event|1|||
164645633|NCT04071366|594728158|FG000|Part 1: Open-label (29 Days)|Death|4|||
164645634|NCT04071366|594728159|FG001|Part 1: Open-label (29 Days)|Death|2|||
164645635|NCT04071366|594728160|FG002|Part 1: Open-label (29 Days)|Death|8|||
164645636|NCT04071366|594728161|FG003|Part 1: Open-label (29 Days)|Death|0|||
164645637|NCT04071366|594728162|FG004|Part 1: Open-label (29 Days)|Death|0|||
164645638|NCT04071366|594728158|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
164645639|NCT04071366|594728159|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
164645640|NCT04071366|594728160|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
164645641|NCT04071366|594728161|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
164645642|NCT04071366|594728162|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
164645643|NCT04071366|594728158|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
164645644|NCT04071366|594728159|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
164645645|NCT04071366|594728160|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
164645646|NCT04071366|594728161|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
164645647|NCT04071366|594728162|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
164645648|NCT04071366|594728158|FG000|Part 2: Randomized (29 Days)|Death|0|||
164645649|NCT04071366|594728159|FG001|Part 2: Randomized (29 Days)|Death|0|||
164645650|NCT04071366|594728160|FG002|Part 2: Randomized (29 Days)|Death|0|||
164645651|NCT04071366|594728161|FG003|Part 2: Randomized (29 Days)|Death|2|||
164645652|NCT04071366|594728162|FG004|Part 2: Randomized (29 Days)|Death|2|||
164645653|NCT04071366|594728158|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
164645654|NCT04071366|594728159|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
164645655|NCT04071366|594728160|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
164645656|NCT04071366|594728161|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
164645657|NCT04071366|594728162|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
164645658|NCT04071366|594728158|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
164645659|NCT04071366|594728159|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
164645660|NCT04071366|594728160|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
164645661|NCT04071366|594728161|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
164645662|NCT04071366|594728162|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
164645663|NCT04071366|594728158|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
164645664|NCT04071366|594728159|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
164645665|NCT04071366|594728160|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
164645666|NCT04071366|594728161|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
164645667|NCT04071366|594728162|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
164645668|NCT04071366|594728158|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
164645669|NCT04071366|594728159|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
164645670|NCT04071366|594728160|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
164645671|NCT04071366|594728161|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
164645672|NCT04071366|594728162|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
164645673|NCT04071366|594728158|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
164645674|NCT04071366|594728159|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
164645675|NCT04071366|594728160|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
164645676|NCT04071366|594728161|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
164645677|NCT04071366|594728162|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
164645678|NCT04071366|594728158|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
164645679|NCT04071366|594728159|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
164645680|NCT04071366|594728160|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
164645681|NCT04071366|594728161|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
164645682|NCT04071366|594728162|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
164645683|NCT01336608|594728165|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
164645684|NCT01336608|594728166|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164645685|NCT01336608|594728167|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164645686|NCT01336608|594728168|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164645687|NCT01336608|594728165|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
164645688|NCT01336608|594728166|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164645689|NCT01336608|594728167|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164645690|NCT01336608|594728168|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164645691|NCT01336608|594728165|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
164645692|NCT01336608|594728166|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
164645693|NCT01336608|594728167|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
164645694|NCT01336608|594728168|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
164645695|NCT01336608|594728165|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
164645696|NCT01336608|594728166|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
164645697|NCT01336608|594728167|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
164645698|NCT01336608|594728168|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
164645699|NCT01336608|594728165|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
164645700|NCT01336608|594728166|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164645701|NCT01336608|594728167|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164645702|NCT01336608|594728168|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164645703|NCT01336608|594728165|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
164645704|NCT01336608|594728166|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
164645705|NCT01336608|594728167|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
164645706|NCT01336608|594728168|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
164645707|NCT01336608|594728165|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
164645708|NCT01336608|594728166|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
164645709|NCT01336608|594728167|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
164645710|NCT01336608|594728168|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
164645711|NCT01336608|594728165|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
164645712|NCT01336608|594728166|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
164645713|NCT01336608|594728167|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
164645714|NCT01336608|594728168|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
164645715|NCT01336608|594728165|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
164645716|NCT01336608|594728166|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
164645717|NCT01336608|594728167|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
164645718|NCT01336608|594728168|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
164645719|NCT01336608|594728165|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
164645720|NCT01336608|594728166|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
164645721|NCT01336608|594728167|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
164645722|NCT01336608|594728168|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
164645723|NCT01336608|594728165|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164645724|NCT01336608|594728166|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
164645725|NCT01336608|594728167|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164645726|NCT01336608|594728168|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164645727|NCT01336608|594728165|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
164645728|NCT01336608|594728166|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
164645729|NCT01336608|594728167|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
164645730|NCT01336608|594728168|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
164645731|NCT01336608|594728165|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
164645732|NCT01336608|594728166|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
164645733|NCT01336608|594728167|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
164645734|NCT01336608|594728168|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
164645735|NCT00399490|594728171|FG000|Overall Study|Adverse Event|19|||
164645736|NCT00399490|594728171|FG000|Overall Study|Lack of Efficacy|31|||
164645737|NCT00399490|594728171|FG000|Overall Study|Lost to Follow-up|5|||
164645738|NCT00399490|594728171|FG000|Overall Study|Withdrawal by Subject|18|||
164645739|NCT00399490|594728171|FG000|Overall Study|Other|25|||
164645740|NCT02437890|594728172|FG000|Overall Study|Non-compliance to study drug|0|||
164645741|NCT02437890|594728173|FG001|Overall Study|Non-compliance to study drug|1|||
164645742|NCT02437890|594728174|FG002|Overall Study|Non-compliance to study drug|0|||
164645743|NCT02437890|594728175|FG003|Overall Study|Non-compliance to study drug|0|||
164645744|NCT02437890|594728176|FG004|Overall Study|Non-compliance to study drug|1|||
164645745|NCT02437890|594728172|FG000|Overall Study|Sponsor's decision|1|||
164645746|NCT02437890|594728173|FG001|Overall Study|Sponsor's decision|1|||
164645747|NCT02437890|594728174|FG002|Overall Study|Sponsor's decision|4|||
164645748|NCT02437890|594728175|FG003|Overall Study|Sponsor's decision|0|||
164645749|NCT02437890|594728176|FG004|Overall Study|Sponsor's decision|2|||
164645750|NCT02437890|594728172|FG000|Overall Study|Physician Decision|0|||
164645751|NCT02437890|594728173|FG001|Overall Study|Physician Decision|0|||
164645752|NCT02437890|594728174|FG002|Overall Study|Physician Decision|0|||
164645753|NCT02437890|594728175|FG003|Overall Study|Physician Decision|1|||
164645754|NCT02437890|594728176|FG004|Overall Study|Physician Decision|0|||
164645755|NCT02437890|594728172|FG000|Overall Study|Unable to attend visit(s)|1|||
164645756|NCT02437890|594728173|FG001|Overall Study|Unable to attend visit(s)|0|||
164645757|NCT02437890|594728174|FG002|Overall Study|Unable to attend visit(s)|0|||
164645758|NCT02437890|594728175|FG003|Overall Study|Unable to attend visit(s)|0|||
164645759|NCT02437890|594728176|FG004|Overall Study|Unable to attend visit(s)|0|||
164645760|NCT02437890|594728172|FG000|Overall Study|Lack of Efficacy|1|||
164645761|NCT02437890|594728173|FG001|Overall Study|Lack of Efficacy|3|||
164645762|NCT02437890|594728174|FG002|Overall Study|Lack of Efficacy|0|||
164645763|NCT02437890|594728175|FG003|Overall Study|Lack of Efficacy|3|||
164645764|NCT02437890|594728176|FG004|Overall Study|Lack of Efficacy|1|||
164645765|NCT02437890|594728172|FG000|Overall Study|Adverse Event|4|||
164645766|NCT02437890|594728173|FG001|Overall Study|Adverse Event|9|||
164645767|NCT02437890|594728174|FG002|Overall Study|Adverse Event|5|||
164645768|NCT02437890|594728175|FG003|Overall Study|Adverse Event|11|||
164645769|NCT02437890|594728176|FG004|Overall Study|Adverse Event|7|||
164645770|NCT02437890|594728172|FG000|Overall Study|Withdrawal by Subject|1|||
164645771|NCT02437890|594728173|FG001|Overall Study|Withdrawal by Subject|2|||
164645772|NCT02437890|594728174|FG002|Overall Study|Withdrawal by Subject|6|||
164645773|NCT02437890|594728175|FG003|Overall Study|Withdrawal by Subject|5|||
164645774|NCT02437890|594728176|FG004|Overall Study|Withdrawal by Subject|5|||
164645775|NCT02437890|594728172|FG000|Overall Study|Death|0|||
164645776|NCT02437890|594728173|FG001|Overall Study|Death|0|||
164645777|NCT02437890|594728174|FG002|Overall Study|Death|0|||
164645778|NCT02437890|594728175|FG003|Overall Study|Death|2|||
164645779|NCT02437890|594728176|FG004|Overall Study|Death|0|||
164645780|NCT02328547|594728177|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
164645781|NCT02328547|594728178|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
164645782|NCT02328547|594728177|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
164645783|NCT02328547|594728178|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
164645784|NCT00344305|594728179|FG000|Overall Study|Lost to Follow-up|2|||
164645785|NCT00344305|594728180|FG001|Overall Study|Lost to Follow-up|0|||
164645786|NCT00344305|594728179|FG000|Overall Study|Participant was not contacted in window|0|||
164645787|NCT00344305|594728180|FG001|Overall Study|Participant was not contacted in window|1|||
164645788|NCT01190098|594728181|FG000|Overall Study|Adverse Event|2|||
164645789|NCT01190098|594728182|FG001|Overall Study|Adverse Event|0|||
164645790|NCT01190098|594728181|FG000|Overall Study|Patient coomorbidity|0|||
164645791|NCT01190098|594728182|FG001|Overall Study|Patient coomorbidity|1|||
164645792|NCT01190098|594728181|FG000|Overall Study|Lack of transportation|1|||
164645793|NCT01190098|594728182|FG001|Overall Study|Lack of transportation|0|||
164645794|NCT01190098|594728181|FG000|Overall Study|Other|0|||
164645795|NCT01190098|594728182|FG001|Overall Study|Other|1|||
164645796|NCT01422720|594728184|FG000|Overall Study|Adverse Event|16|||
164645797|NCT01422720|594728184|FG000|Overall Study|Lack of Efficacy|1|||
164645798|NCT01422720|594728184|FG000|Overall Study|Withdrawal by Subject|4|||
164645799|NCT01422720|594728184|FG000|Overall Study|Ineligibility|1|||
164645800|NCT01796860|594728187|FG000|Overall Study|Withdrawal by Subject|3|||
164645801|NCT00068406|594728196|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
164645802|NCT00068406|594728196|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
164645803|NCT02609178|594728197|FG000|First Crown|Withdrawal by Subject|0|||
164645804|NCT02609178|594728198|FG001|First Crown|Withdrawal by Subject|0|||
164645805|NCT02609178|594728199|FG002|First Crown|Withdrawal by Subject|1|||
164645806|NCT02609178|594728200|FG003|First Crown|Withdrawal by Subject|1|||
164645807|NCT02609178|594728201|FG004|First Crown|Withdrawal by Subject|0|||
164645808|NCT02609178|594728202|FG005|First Crown|Withdrawal by Subject|0|||
164645809|NCT02866695|594728203|FG000|Overall Study|Adverse Event|1|||
164645810|NCT02866695|594728203|FG000|Overall Study|Lost to Follow-up|1|||
164645811|NCT03891875|594728206|FG000|Overall Study|Withdrawal by Subject|20|||
164645812|NCT03891875|594728207|FG001|Overall Study|Withdrawal by Subject|3|||
164645813|NCT03891875|594728206|FG000|Overall Study|Adverse Event|10|||
164645814|NCT03891875|594728207|FG001|Overall Study|Adverse Event|4|||
164645815|NCT03891875|594728206|FG000|Overall Study|Physician Decision|1|||
164645816|NCT03891875|594728207|FG001|Overall Study|Physician Decision|1|||
164645817|NCT03891875|594728206|FG000|Overall Study|Protocol Violation|1|||
164645818|NCT03891875|594728207|FG001|Overall Study|Protocol Violation|0|||
164645819|NCT03891875|594728206|FG000|Overall Study|Lost to Follow-up|1|||
164645820|NCT03891875|594728207|FG001|Overall Study|Lost to Follow-up|0|||
164645821|NCT03891875|594728206|FG000|Overall Study|COVID-19 infection|1|||
164645822|NCT03891875|594728207|FG001|Overall Study|COVID-19 infection|0|||
164645823|NCT00285012|594728223|FG000|Assigned to Study Treatment (Tx)|Other|2|||
164645824|NCT00285012|594728224|FG001|Assigned to Study Treatment (Tx)|Other|3|||
164645825|NCT00285012|594728223|FG000|Received Study Tx|Death|2|||
164645826|NCT00285012|594728224|FG001|Received Study Tx|Death|1|||
164645827|NCT00285012|594728223|FG000|Received Study Tx|Adverse Event|5|||
164645828|NCT00285012|594728224|FG001|Received Study Tx|Adverse Event|11|||
164645829|NCT00285012|594728223|FG000|Received Study Tx|Lack of Efficacy|0|||
164645830|NCT00285012|594728224|FG001|Received Study Tx|Lack of Efficacy|3|||
164645831|NCT00285012|594728223|FG000|Received Study Tx|Lost to Follow-up|29|||
164645832|NCT00285012|594728224|FG001|Received Study Tx|Lost to Follow-up|31|||
164645833|NCT00285012|594728223|FG000|Received Study Tx|Withdrawal by Subject|31|||
164645834|NCT00285012|594728224|FG001|Received Study Tx|Withdrawal by Subject|43|||
164645835|NCT00285012|594728223|FG000|Received Study Tx|Other|5|||
164645836|NCT00285012|594728224|FG001|Received Study Tx|Other|5|||
164645837|NCT05631093|594728227|FG000|Overall Study|Death|0|||
164645838|NCT05631093|594728228|FG001|Overall Study|Death|1|||
164645839|NCT05631093|594728227|FG000|Overall Study|Lost to Follow-up|1|||
164645840|NCT05631093|594728228|FG001|Overall Study|Lost to Follow-up|2|||
164645841|NCT05631093|594728227|FG000|Overall Study|Physician Decision|1|||
164645842|NCT05631093|594728228|FG001|Overall Study|Physician Decision|0|||
164645843|NCT05631093|594728227|FG000|Overall Study|Withdrawal by Subject|4|||
164645844|NCT05631093|594728228|FG001|Overall Study|Withdrawal by Subject|1|||
164645845|NCT05631093|594728227|FG000|Overall Study|Ongoing|353|||
164645846|NCT05631093|594728228|FG001|Overall Study|Ongoing|177|||
164645847|NCT05631093|594728227|FG000|Overall Study|Adverse Event|0|||
164645848|NCT05631093|594728228|FG001|Overall Study|Adverse Event|1|||
164645849|NCT02873195|594728229|FG000|Overall Study|Ineligible|5|||
164645850|NCT02873195|594728230|FG001|Overall Study|Ineligible|0|||
164645851|NCT03107715|594728231|FG000|Overall Study|did not deliver at the home hospital|4|||
164645852|NCT03107715|594728232|FG001|Overall Study|did not deliver at the home hospital|6|||
164645853|NCT03107715|594728231|FG000|Overall Study|infant stillborn|0|||
164645854|NCT03107715|594728232|FG001|Overall Study|infant stillborn|1|||
164645855|NCT04223193|594728235|FG000|Overall Study|Adverse Event|6|||
164645856|NCT04223193|594728236|FG001|Overall Study|Adverse Event|36|||
164645857|NCT04223193|594728235|FG000|Overall Study|Lack of Efficacy|2|||
164645858|NCT04223193|594728236|FG001|Overall Study|Lack of Efficacy|2|||
164645859|NCT04223193|594728235|FG000|Overall Study|Lost to Follow-up|1|||
164645860|NCT04223193|594728236|FG001|Overall Study|Lost to Follow-up|1|||
164645861|NCT04223193|594728235|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
164645862|NCT04223193|594728236|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
164645863|NCT04223193|594728235|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|3|||
164645864|NCT04223193|594728236|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
164645865|NCT04223193|594728235|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164645866|NCT04223193|594728236|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164645867|NCT04223193|594728235|FG000|Overall Study|Physician Decision|0|||
164645868|NCT04223193|594728236|FG001|Overall Study|Physician Decision|1|||
164645869|NCT04223193|594728235|FG000|Overall Study|Protocol Violation|1|||
164645870|NCT04223193|594728236|FG001|Overall Study|Protocol Violation|1|||
164645871|NCT04223193|594728235|FG000|Overall Study|Site Terminated by Sponsor|1|||
164645872|NCT04223193|594728236|FG001|Overall Study|Site Terminated by Sponsor|3|||
164645873|NCT04223193|594728235|FG000|Overall Study|Withdrawal by Subject|5|||
164645874|NCT04223193|594728236|FG001|Overall Study|Withdrawal by Subject|6|||
164645875|NCT04223193|594728235|FG000|Overall Study|Other|3|||
164645876|NCT04223193|594728236|FG001|Overall Study|Other|6|||
164645877|NCT03594175|594728237|FG000|Overall Study|Not treated|8|||
164148627|NCT04895982|592904911|FG000|Overall Study|Lost to Follow-up|0|||
164645878|NCT03594175|594728238|FG001|Overall Study|Not treated|1|||
164645879|NCT03594175|594728239|FG002|Overall Study|Not treated|5|||
164645880|NCT03594175|594728237|FG000|Overall Study|Adverse Event|3|||
164645881|NCT03594175|594728238|FG001|Overall Study|Adverse Event|0|||
164645882|NCT03594175|594728239|FG002|Overall Study|Adverse Event|0|||
164645883|NCT03594175|594728237|FG000|Overall Study|Withdrawal by Subject|3|||
164645884|NCT03594175|594728238|FG001|Overall Study|Withdrawal by Subject|0|||
164645885|NCT03594175|594728239|FG002|Overall Study|Withdrawal by Subject|0|||
164645886|NCT03594175|594728237|FG000|Overall Study|Protocol Violation|2|||
164645887|NCT03594175|594728238|FG001|Overall Study|Protocol Violation|2|||
164645888|NCT03594175|594728239|FG002|Overall Study|Protocol Violation|2|||
164645889|NCT03732677|594728240|FG000|Overall Study|Terminated the study|154|||
164645890|NCT03732677|594728241|FG001|Overall Study|Terminated the study|197|||
164645891|NCT03732677|594728240|FG000|Overall Study|Continuing study off treatment|379|||
164645892|NCT03732677|594728241|FG001|Overall Study|Continuing study off treatment|333|||
164645893|NCT00096031|594728243|FG000|Overall Study|Adverse Event|3|||
164645894|NCT00096031|594728243|FG000|Overall Study|Lack of Efficacy|42|||
164645895|NCT00096031|594728243|FG000|Overall Study|Death|4|||
164645896|NCT00096031|594728243|FG000|Overall Study|Withdrawal by Subject|1|||
164645897|NCT00096031|594728243|FG000|Overall Study|Ineligible|8|||
164645898|NCT00096031|594728243|FG000|Overall Study|Not protocol specified|5|||
164645899|NCT00483717|594728244|FG000|Overall Study|Protocol Violation|5|||
164645900|NCT00483717|594728245|FG001|Overall Study|Protocol Violation|7|||
164645901|NCT00483717|594728244|FG000|Overall Study|Time of dosing missing|1|||
164645902|NCT00483717|594728245|FG001|Overall Study|Time of dosing missing|1|||
164645903|NCT00483717|594728244|FG000|Overall Study|No treatment for migraine|16|||
164645904|NCT00483717|594728245|FG001|Overall Study|No treatment for migraine|13|||
164645905|NCT00483717|594728244|FG000|Overall Study|Lost to Follow-up|1|||
164645906|NCT00483717|594728245|FG001|Overall Study|Lost to Follow-up|0|||
164645907|NCT00483717|594728244|FG000|Overall Study|Withdrawal by Subject|1|||
164645908|NCT00483717|594728245|FG001|Overall Study|Withdrawal by Subject|0|||
164645909|NCT03878108|594728246|FG000|Overall Study|Adverse Event|1|||
164645910|NCT03878108|594728247|FG001|Overall Study|Adverse Event|0|||
164645911|NCT04822701|594728252|FG000|Overall Study|Not treated|2|||
164645912|NCT04822701|594728253|FG001|Overall Study|Not treated|0|||
164645913|NCT04822701|594728252|FG000|Overall Study|Lost to Follow-up|1|||
164645914|NCT04822701|594728253|FG001|Overall Study|Lost to Follow-up|0|||
164645915|NCT04822701|594728252|FG000|Overall Study|Withdrawal by Subject|1|||
164645916|NCT04822701|594728253|FG001|Overall Study|Withdrawal by Subject|0|||
164645917|NCT04502862|594728254|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
164645918|NCT04502862|594728255|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
164645919|NCT04502862|594728254|FG000|Overall Study|Withdrawal by Subject|1|||
164645920|NCT04502862|594728255|FG001|Overall Study|Withdrawal by Subject|0|||
164645921|NCT04502862|594728254|FG000|Overall Study|Adverse Event|1|||
164645922|NCT04502862|594728255|FG001|Overall Study|Adverse Event|1|||
164645923|NCT02706353|594728256|FG000|Dose Level 1|Disease Progression|1|||
164645924|NCT02706353|594728257|FG001|Dose Level 1|Disease Progression|0|||
164645925|NCT02706353|594728258|FG002|Dose Level 1|Disease Progression|0|||
164645926|NCT02706353|594728259|FG003|Dose Level 1|Disease Progression|0|||
164645927|NCT02706353|594728260|FG004|Dose Level 1|Disease Progression|0|||
164645928|NCT02706353|594728261|FG005|Dose Level 1|Disease Progression|0|||
164645929|NCT02706353|594728256|FG000|Dose Level 3|Disease Progression|0|||
164645930|NCT02706353|594728257|FG001|Dose Level 3|Disease Progression|0|||
164645931|NCT02706353|594728258|FG002|Dose Level 3|Disease Progression|2|||
164645932|NCT02706353|594728259|FG003|Dose Level 3|Disease Progression|0|||
164645933|NCT02706353|594728260|FG004|Dose Level 3|Disease Progression|0|||
164645934|NCT02706353|594728261|FG005|Dose Level 3|Disease Progression|0|||
164645935|NCT02706353|594728256|FG000|Dose Level 4|Disease Progression|0|||
164645936|NCT02706353|594728257|FG001|Dose Level 4|Disease Progression|0|||
164645937|NCT02706353|594728258|FG002|Dose Level 4|Disease Progression|0|||
164645938|NCT02706353|594728259|FG003|Dose Level 4|Disease Progression|1|||
164645939|NCT02706353|594728260|FG004|Dose Level 4|Disease Progression|0|||
164645940|NCT02706353|594728261|FG005|Dose Level 4|Disease Progression|0|||
164645941|NCT02706353|594728256|FG000|Dose Level 4|Toxicity|0|||
164645942|NCT02706353|594728257|FG001|Dose Level 4|Toxicity|0|||
164645943|NCT02706353|594728258|FG002|Dose Level 4|Toxicity|0|||
164645944|NCT02706353|594728259|FG003|Dose Level 4|Toxicity|1|||
164645945|NCT02706353|594728260|FG004|Dose Level 4|Toxicity|0|||
164645946|NCT02706353|594728261|FG005|Dose Level 4|Toxicity|0|||
164645947|NCT02706353|594728256|FG000|Dose Level 4|Death|0|||
164645948|NCT02706353|594728257|FG001|Dose Level 4|Death|0|||
164645949|NCT02706353|594728258|FG002|Dose Level 4|Death|0|||
164645950|NCT02706353|594728259|FG003|Dose Level 4|Death|1|||
164645951|NCT02706353|594728260|FG004|Dose Level 4|Death|0|||
164645952|NCT02706353|594728261|FG005|Dose Level 4|Death|0|||
164645953|NCT02706353|594728256|FG000|Dose Level 5|Toxicity|0|||
164645954|NCT02706353|594728257|FG001|Dose Level 5|Toxicity|0|||
164645955|NCT02706353|594728258|FG002|Dose Level 5|Toxicity|0|||
164645956|NCT02706353|594728259|FG003|Dose Level 5|Toxicity|0|||
164645957|NCT02706353|594728260|FG004|Dose Level 5|Toxicity|1|||
164645958|NCT02706353|594728261|FG005|Dose Level 5|Toxicity|0|||
164645959|NCT02706353|594728256|FG000|Dose Level 5|Disease Progression|0|||
164645960|NCT02706353|594728257|FG001|Dose Level 5|Disease Progression|0|||
164645961|NCT02706353|594728258|FG002|Dose Level 5|Disease Progression|0|||
164645962|NCT02706353|594728259|FG003|Dose Level 5|Disease Progression|0|||
164645963|NCT02706353|594728260|FG004|Dose Level 5|Disease Progression|3|||
164645964|NCT02706353|594728261|FG005|Dose Level 5|Disease Progression|2|||
164645965|NCT02706353|594728256|FG000|Dose Level 5|Death|0|||
164645966|NCT02706353|594728257|FG001|Dose Level 5|Death|0|||
164645967|NCT02706353|594728258|FG002|Dose Level 5|Death|0|||
164645968|NCT02706353|594728259|FG003|Dose Level 5|Death|0|||
164645969|NCT02706353|594728260|FG004|Dose Level 5|Death|1|||
164645970|NCT02706353|594728261|FG005|Dose Level 5|Death|6|||
164645971|NCT02706353|594728256|FG000|Dose Level 5|Withdrawal by Subject|0|||
164645972|NCT02706353|594728257|FG001|Dose Level 5|Withdrawal by Subject|0|||
164645973|NCT02706353|594728258|FG002|Dose Level 5|Withdrawal by Subject|0|||
164645974|NCT02706353|594728259|FG003|Dose Level 5|Withdrawal by Subject|0|||
164645975|NCT02706353|594728260|FG004|Dose Level 5|Withdrawal by Subject|0|||
164645976|NCT02706353|594728261|FG005|Dose Level 5|Withdrawal by Subject|2|||
164645977|NCT03560466|594728262|FG000|Overall Study|Adverse Event|1|||
164645978|NCT03560466|594728263|FG001|Overall Study|Adverse Event|2|||
164645979|NCT03560466|594728264|FG002|Overall Study|Adverse Event|0|||
164645980|NCT03560466|594728262|FG000|Overall Study|Poor Compliance to Protocol|0|||
164645981|NCT03560466|594728263|FG001|Overall Study|Poor Compliance to Protocol|2|||
164645982|NCT03560466|594728264|FG002|Overall Study|Poor Compliance to Protocol|0|||
164645983|NCT03560466|594728262|FG000|Overall Study|Other|6|||
164645984|NCT03560466|594728263|FG001|Overall Study|Other|8|||
164645985|NCT03560466|594728264|FG002|Overall Study|Other|1|||
164645986|NCT00545441|594729821|FG000|Overall Study|Fistula draining at 6 months|2|||
164645987|NCT00545441|594729822|FG001|Overall Study|Fistula draining at 6 months|4|||
164645988|NCT00545441|594729821|FG000|Overall Study|Lost to Follow-up|9|||
164645989|NCT00545441|594729822|FG001|Overall Study|Lost to Follow-up|5|||
164645990|NCT00545441|594729821|FG000|Overall Study|Technical failure|0|||
164645991|NCT00545441|594729822|FG001|Overall Study|Technical failure|1|||
164645992|NCT00545441|594729821|FG000|Overall Study|Withdrawal by Subject|1|||
164645993|NCT00545441|594729822|FG001|Overall Study|Withdrawal by Subject|1|||
164645994|NCT00545441|594729821|FG000|Overall Study|Persistence or recurrence of fistula|5|||
164645995|NCT00545441|594729822|FG001|Overall Study|Persistence or recurrence of fistula|2|||
164645996|NCT00545441|594729821|FG000|Overall Study|Patients were not treated|1|||
164645997|NCT00545441|594729822|FG001|Overall Study|Patients were not treated|3|||
164645998|NCT03911960|594729823|FG000|Overall Study|Lost to Follow-up|5|||
164645999|NCT03911960|594729824|FG001|Overall Study|Lost to Follow-up|3|||
164646000|NCT01858558|594729825|FG000|Overall Study|Death|1|||
164646001|NCT01858558|594729826|FG001|Overall Study|Death|1|||
164646002|NCT01858558|594729825|FG000|Overall Study|Lost to Follow-up|1|||
164646003|NCT01858558|594729826|FG001|Overall Study|Lost to Follow-up|0|||
164646004|NCT01858558|594729825|FG000|Overall Study|Disease progression|3|||
164646005|NCT01858558|594729826|FG001|Overall Study|Disease progression|1|||
164646006|NCT01858558|594729825|FG000|Overall Study|Product contamination|2|||
164646007|NCT01858558|594729826|FG001|Overall Study|Product contamination|0|||
164646008|NCT01858558|594729825|FG000|Overall Study|Failed expansion of cell product|2|||
164646009|NCT01858558|594729826|FG001|Overall Study|Failed expansion of cell product|0|||
164646010|NCT04723173|594729833|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
164646011|NCT02996448|594729834|FG000|Overall Study|Study terminated due to adverse effects|3|||
164646012|NCT00606801|594729835|FG000|Intervention|Protocol Violation|3|||
164646013|NCT00606801|594729836|FG001|Intervention|Protocol Violation|3|||
164646014|NCT02082262|594729837|FG000|Overall Study|Withdrawal by Subject|3|||
164646015|NCT02082262|594729837|FG000|Overall Study|Adverse Event|48|||
164646016|NCT01726335|594729842|FG000|Overall Study|Lost to Follow-up|2|||
164646017|NCT01726335|594729842|FG000|Overall Study|Withdrawal by Subject|15|||
164646018|NCT01726335|594729842|FG000|Overall Study|Adverse Event|4|||
164646019|NCT01726335|594729842|FG000|Overall Study|Lost to Follow-up|2|||
164646020|NCT01726335|594729842|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
164646021|NCT01586624|594729843|FG000|Overall Study|Adverse Event|3|||
164646022|NCT01586624|594729844|FG001|Overall Study|Adverse Event|0|||
164646023|NCT01586624|594729845|FG002|Overall Study|Adverse Event|2|||
164646024|NCT01586624|594729846|FG003|Overall Study|Adverse Event|1|||
164646025|NCT01586624|594729847|FG004|Overall Study|Adverse Event|3|||
164646026|NCT01586624|594729848|FG005|Overall Study|Adverse Event|3|||
164646027|NCT01586624|594729849|FG006|Overall Study|Adverse Event|2|||
164646028|NCT01586624|594729850|FG007|Overall Study|Adverse Event|3|||
164646029|NCT01586624|594729843|FG000|Overall Study|Physician Decision|0|||
164646030|NCT01586624|594729844|FG001|Overall Study|Physician Decision|1|||
164646031|NCT01586624|594729845|FG002|Overall Study|Physician Decision|1|||
164646032|NCT01586624|594729846|FG003|Overall Study|Physician Decision|0|||
164646033|NCT01586624|594729847|FG004|Overall Study|Physician Decision|2|||
164646034|NCT01586624|594729848|FG005|Overall Study|Physician Decision|0|||
164646035|NCT01586624|594729849|FG006|Overall Study|Physician Decision|1|||
164646036|NCT01586624|594729850|FG007|Overall Study|Physician Decision|1|||
164646037|NCT01586624|594729843|FG000|Overall Study|Withdrawal by Subject|0|||
164646038|NCT01586624|594729844|FG001|Overall Study|Withdrawal by Subject|0|||
164646039|NCT01586624|594729845|FG002|Overall Study|Withdrawal by Subject|0|||
164646040|NCT01586624|594729846|FG003|Overall Study|Withdrawal by Subject|1|||
164646041|NCT01586624|594729847|FG004|Overall Study|Withdrawal by Subject|0|||
164646042|NCT01586624|594729848|FG005|Overall Study|Withdrawal by Subject|0|||
164646043|NCT01586624|594729849|FG006|Overall Study|Withdrawal by Subject|0|||
164646044|NCT01586624|594729850|FG007|Overall Study|Withdrawal by Subject|0|||
164646045|NCT01586624|594729843|FG000|Overall Study|Evidence of disease progression|1|||
164646046|NCT01586624|594729844|FG001|Overall Study|Evidence of disease progression|3|||
164646047|NCT01586624|594729845|FG002|Overall Study|Evidence of disease progression|2|||
164646048|NCT01586624|594729846|FG003|Overall Study|Evidence of disease progression|5|||
164646049|NCT01586624|594729847|FG004|Overall Study|Evidence of disease progression|3|||
164646050|NCT01586624|594729848|FG005|Overall Study|Evidence of disease progression|5|||
164646051|NCT01586624|594729849|FG006|Overall Study|Evidence of disease progression|4|||
164646052|NCT01586624|594729850|FG007|Overall Study|Evidence of disease progression|6|||
164646053|NCT01586624|594729843|FG000|Overall Study|Screen failure (no treatment received)|0|||
164646054|NCT01586624|594729844|FG001|Overall Study|Screen failure (no treatment received)|0|||
164646055|NCT01586624|594729845|FG002|Overall Study|Screen failure (no treatment received)|0|||
164646056|NCT01586624|594729846|FG003|Overall Study|Screen failure (no treatment received)|0|||
164646057|NCT01586624|594729847|FG004|Overall Study|Screen failure (no treatment received)|0|||
164646058|NCT01586624|594729848|FG005|Overall Study|Screen failure (no treatment received)|0|||
164646059|NCT01586624|594729849|FG006|Overall Study|Screen failure (no treatment received)|1|||
164646060|NCT01586624|594729850|FG007|Overall Study|Screen failure (no treatment received)|0|||
164646061|NCT00647426|594729863|FG000|Overall Study|Withdrawal by Subject|2|||
164646062|NCT01537549|594729864|FG000|Overall Study|Lost to Follow-up|1|||
164646063|NCT01537549|594729864|FG000|Overall Study|Withdrawal by Subject|2|||
164646064|NCT01286207|594729865|FG000|Overall Study|Adverse Event|27|||
164646065|NCT01286207|594729866|FG001|Overall Study|Adverse Event|41|||
164646066|NCT01286207|594729867|FG002|Overall Study|Adverse Event|8|||
164646067|NCT01286207|594729865|FG000|Overall Study|Lost to Follow-up|49|||
164646068|NCT01286207|594729866|FG001|Overall Study|Lost to Follow-up|43|||
164646069|NCT01286207|594729867|FG002|Overall Study|Lost to Follow-up|20|||
164646070|NCT01286207|594729865|FG000|Overall Study|Withdrawal by Subject|93|||
164646071|NCT01286207|594729866|FG001|Overall Study|Withdrawal by Subject|79|||
164646072|NCT01286207|594729867|FG002|Overall Study|Withdrawal by Subject|41|||
164646073|NCT01286207|594729865|FG000|Overall Study|Lack of Response|92|||
164646074|NCT01286207|594729866|FG001|Overall Study|Lack of Response|38|||
164646075|NCT01286207|594729867|FG002|Overall Study|Lack of Response|8|||
164646076|NCT01286207|594729865|FG000|Overall Study|Other|37|||
164646077|NCT01286207|594729866|FG001|Overall Study|Other|47|||
164646078|NCT01286207|594729867|FG002|Overall Study|Other|13|||
164646079|NCT02748616|594729877|FG000|Overall Study|Lost to Follow-up|1|||
164646080|NCT02748616|594729877|FG000|Overall Study|Withdrawal by Subject|2|||
164646081|NCT02748616|594729877|FG000|Overall Study|Physician Decision|2|||
164646082|NCT02748616|594729877|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
164646083|NCT02018042|594729878|FG000|Overall Study|Withdrawal by Subject|1|||
164646084|NCT03231709|594729879|FG000|Treatment Period 1|Reason not Specified|0|||
164646085|NCT03231709|594729880|FG001|Treatment Period 1|Reason not Specified|1|||
164646086|NCT03231709|594729879|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
164646087|NCT03231709|594729880|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
164646088|NCT02419469|594729881|FG000|Overall Study|Withdrawal by Subject|1|||
164646089|NCT01785875|594729882|FG000|Overall Study|Withdrawal by Subject|41|||
164646090|NCT01785875|594729883|FG001|Overall Study|Withdrawal by Subject|34|||
164646091|NCT01785875|594729884|FG002|Overall Study|Withdrawal by Subject|36|||
164646092|NCT01785875|594729882|FG000|Overall Study|Lost to Follow-up|19|||
164646093|NCT01785875|594729883|FG001|Overall Study|Lost to Follow-up|22|||
164646094|NCT01785875|594729884|FG002|Overall Study|Lost to Follow-up|6|||
164646095|NCT01785875|594729882|FG000|Overall Study|Death|27|||
164646096|NCT01785875|594729883|FG001|Overall Study|Death|16|||
164646097|NCT01785875|594729884|FG002|Overall Study|Death|7|||
164646098|NCT01785875|594729882|FG000|Overall Study|Sponsor Decision|0|||
164646099|NCT01785875|594729883|FG001|Overall Study|Sponsor Decision|2|||
164646100|NCT01785875|594729884|FG002|Overall Study|Sponsor Decision|0|||
164646101|NCT01785875|594729882|FG000|Overall Study|Protocol Specified Criteria|207|||
164646102|NCT01785875|594729883|FG001|Overall Study|Protocol Specified Criteria|214|||
164646103|NCT01785875|594729884|FG002|Overall Study|Protocol Specified Criteria|55|||
164646104|NCT01785875|594729882|FG000|Overall Study|Missing|0|||
164646105|NCT01785875|594729883|FG001|Overall Study|Missing|1|||
164646106|NCT01785875|594729884|FG002|Overall Study|Missing|3|||
164646107|NCT04840901|594729887|FG000|Overall Study|Lost to Follow-up|3|||
164646108|NCT04840901|594729888|FG001|Overall Study|Lost to Follow-up|1|||
164646109|NCT04840901|594729887|FG000|Overall Study|Moved|1|||
164646110|NCT04840901|594729888|FG001|Overall Study|Moved|0|||
164646111|NCT04840901|594729887|FG000|Overall Study|Unable to comply with study schedule|0|||
164646112|NCT04840901|594729888|FG001|Overall Study|Unable to comply with study schedule|1|||
164646113|NCT04840901|594729887|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
164646114|NCT04840901|594729888|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
164646115|NCT01414062|594729889|FG000|Overall Study|Lost to Follow-up|3|||
164646116|NCT01414062|594729890|FG001|Overall Study|Lost to Follow-up|2|||
164646117|NCT01414062|594729889|FG000|Overall Study|Left Country|1|||
164646118|NCT01414062|594729890|FG001|Overall Study|Left Country|1|||
164646119|NCT01414062|594729889|FG000|Overall Study|Family Disapproval|1|||
164646120|NCT01414062|594729890|FG001|Overall Study|Family Disapproval|0|||
164646121|NCT01414062|594729889|FG000|Overall Study|Withdrawal by Subject|0|||
164646122|NCT01414062|594729890|FG001|Overall Study|Withdrawal by Subject|1|||
164646123|NCT04075292|594729891|FG000|Overall Study|Withdrawal by Subject|1|||
164646124|NCT04075292|594729892|FG001|Overall Study|Withdrawal by Subject|9|||
164646125|NCT04075292|594729891|FG000|Overall Study|Death|2|||
164646126|NCT04075292|594729892|FG001|Overall Study|Death|5|||
164646127|NCT04075292|594729891|FG000|Overall Study|Remained on study at time of DCO|74|||
164646128|NCT04075292|594729892|FG001|Overall Study|Remained on study at time of DCO|64|||
164646129|NCT00902265|594729895|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
164646130|NCT00902265|594729895|FG000|Overall Study|Adverse Event|2|||
164646131|NCT00902265|594729895|FG000|Overall Study|Lack of Efficacy|2|||
164646132|NCT00902265|594729895|FG000|Overall Study|Protocol Violation|1|||
164646133|NCT05016765|594729897|FG000|Overall Study|Lost to Follow-up|4|||
164646134|NCT01988493|594729898|FG000|Overall Study|Randomized but not treated|0|||
164646135|NCT01988493|594729899|FG001|Overall Study|Randomized but not treated|0|||
164646136|NCT01988493|594729900|FG002|Overall Study|Randomized but not treated|0|||
164646137|NCT01988493|594729901|FG003|Overall Study|Randomized but not treated|0|||
164646138|NCT01988493|594729902|FG004|Overall Study|Randomized but not treated|1|||
164646139|NCT00185731|594729907|FG000|Overall Study|Withdrawal by Subject|1|||
164646140|NCT00185731|594729907|FG000|Overall Study|Not Eligible|1|||
164646141|NCT03087773|594729908|FG000|Overall Study|Withdrawal by Subject|8|||
164646142|NCT03087773|594729909|FG001|Overall Study|Withdrawal by Subject|4|||
164646143|NCT03087773|594729908|FG000|Overall Study|Lost to Follow-up|12|||
164646144|NCT03087773|594729909|FG001|Overall Study|Lost to Follow-up|8|||
164646145|NCT05144477|594729912|FG000|Overall Study|Withdrawal by Subject|1|||
164646146|NCT05144477|594729913|FG001|Overall Study|Withdrawal by Subject|1|||
164646147|NCT01787188|594729918|FG000|Overall Study|Adverse Event|2|||
164646148|NCT01787188|594729919|FG001|Overall Study|Adverse Event|4|||
164646149|NCT01787188|594729920|FG002|Overall Study|Adverse Event|6|||
164646150|NCT01787188|594729918|FG000|Overall Study|Lack of Efficacy|7|||
164646151|NCT01787188|594729919|FG001|Overall Study|Lack of Efficacy|3|||
164646152|NCT01787188|594729920|FG002|Overall Study|Lack of Efficacy|5|||
164646153|NCT01787188|594729918|FG000|Overall Study|Non-compliance with Study Drug|0|||
164646154|NCT01787188|594729919|FG001|Overall Study|Non-compliance with Study Drug|1|||
164646155|NCT01787188|594729920|FG002|Overall Study|Non-compliance with Study Drug|0|||
164646156|NCT01787188|594729918|FG000|Overall Study|Withdrawal by Subject|4|||
164646157|NCT01787188|594729919|FG001|Overall Study|Withdrawal by Subject|3|||
164646158|NCT01787188|594729920|FG002|Overall Study|Withdrawal by Subject|2|||
164646159|NCT01787188|594729918|FG000|Overall Study|Protocol Violation|3|||
164646160|NCT01787188|594729919|FG001|Overall Study|Protocol Violation|2|||
164646161|NCT01787188|594729920|FG002|Overall Study|Protocol Violation|3|||
164646162|NCT01787188|594729918|FG000|Overall Study|Lost to Follow-up|1|||
164646163|NCT01787188|594729919|FG001|Overall Study|Lost to Follow-up|2|||
164646164|NCT01787188|594729920|FG002|Overall Study|Lost to Follow-up|2|||
164646165|NCT01787188|594729918|FG000|Overall Study|Other, including patient moved|0|||
164646166|NCT01787188|594729919|FG001|Overall Study|Other, including patient moved|3|||
164646167|NCT01787188|594729920|FG002|Overall Study|Other, including patient moved|0|||
164646168|NCT00854607|594729921|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
164646169|NCT01783483|594729927|FG000|Overall Study|Death|3|||
164646170|NCT01783483|594729928|FG001|Overall Study|Death|3|||
164646171|NCT01783483|594729927|FG000|Overall Study|Lost to Follow-up|14|||
164646172|NCT01783483|594729928|FG001|Overall Study|Lost to Follow-up|10|||
164646173|NCT01783483|594729927|FG000|Overall Study|Withdrawal by Subject|2|||
164646174|NCT01783483|594729928|FG001|Overall Study|Withdrawal by Subject|1|||
164646175|NCT01783483|594729927|FG000|Overall Study|Physician Decision|1|||
164646176|NCT01783483|594729928|FG001|Overall Study|Physician Decision|1|||
164646177|NCT02268045|594729929|FG000|Overall Study|Death|4|||
164646178|NCT02268045|594729930|FG001|Overall Study|Death|4|||
164646179|NCT02268045|594729929|FG000|Overall Study|Disease Progression|2|||
164646180|NCT02268045|594729930|FG001|Overall Study|Disease Progression|1|||
164646181|NCT02268045|594729929|FG000|Overall Study|Adverse Event|7|||
164646182|NCT02268045|594729930|FG001|Overall Study|Adverse Event|7|||
164646183|NCT02268045|594729929|FG000|Overall Study|Withdrawal by Subject|2|||
164646184|NCT02268045|594729930|FG001|Overall Study|Withdrawal by Subject|6|||
164646185|NCT02268045|594729929|FG000|Overall Study|Physician Decision|0|||
164646186|NCT02268045|594729930|FG001|Overall Study|Physician Decision|1|||
164646187|NCT02268045|594729929|FG000|Overall Study|Protocol Violation|1|||
164646188|NCT02268045|594729930|FG001|Overall Study|Protocol Violation|1|||
164646189|NCT01766310|594729931|FG000|Overall Study|Lost to Follow-up|1|||
164646190|NCT01766310|594729932|FG001|Overall Study|Lost to Follow-up|3|||
164646191|NCT00835068|594729933|FG000|Overall Study|Death|1|||
164646192|NCT00835068|594729934|FG001|Overall Study|Death|0|||
164646193|NCT00835068|594729933|FG000|Overall Study|Adverse Event|0|||
164646194|NCT00835068|594729934|FG001|Overall Study|Adverse Event|1|||
164646195|NCT00835068|594729933|FG000|Overall Study|Other|8|||
164646196|NCT00835068|594729934|FG001|Overall Study|Other|0|||
164646197|NCT00835068|594729933|FG000|Overall Study|Withdrawal by Subject|1|||
164646198|NCT00835068|594729934|FG001|Overall Study|Withdrawal by Subject|0|||
164646199|NCT01591499|594729935|FG000|Baseline Visit|Withdrawal by Subject|0|||
164646200|NCT01591499|594729936|FG001|Baseline Visit|Withdrawal by Subject|2|||
164646201|NCT01591499|594729937|FG002|Baseline Visit|Withdrawal by Subject|0|||
164646202|NCT01591499|594729938|FG003|Baseline Visit|Withdrawal by Subject|2|||
164646203|NCT01591499|594729935|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
164646204|NCT01591499|594729936|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
164646205|NCT01591499|594729937|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
164646206|NCT01591499|594729938|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
164646207|NCT01591499|594729935|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
164646208|NCT01591499|594729936|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
164646209|NCT01591499|594729937|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
164646210|NCT01591499|594729938|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
164646211|NCT02125734|594729939|FG000|Period 2|Adverse Event|0|||
164646212|NCT02125734|594729940|FG001|Period 2|Adverse Event|1|||
164646213|NCT01308762|594729941|FG000|Overall Study|Protocol Violation|0|||
164646214|NCT01308762|594729942|FG001|Overall Study|Protocol Violation|1|||
164646215|NCT01308762|594729943|FG002|Overall Study|Protocol Violation|0|||
164646216|NCT00646282|594729944|FG000|Overall Study|Protocol terminated|4|||
164646217|NCT00646282|594729945|FG001|Overall Study|Protocol terminated|4|||
164646218|NCT01556490|594729946|FG000|Randomized Patients Summary|Protocol Violation|22|||
164646219|NCT01556490|594729947|FG001|Randomized Patients Summary|Protocol Violation|23|||
164646220|NCT01556490|594729946|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
164646221|NCT01556490|594729947|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
164646222|NCT00902278|594729948|FG000|Overall Study|Physician Decision|1|||
164646223|NCT00902278|594729949|FG001|Overall Study|Physician Decision|0|||
164646224|NCT00902278|594729950|FG002|Overall Study|Physician Decision|2|||
164646225|NCT00902278|594729951|FG003|Overall Study|Physician Decision|0|||
164646226|NCT00902278|594729952|FG004|Overall Study|Physician Decision|1|||
164646227|NCT00902278|594729948|FG000|Overall Study|Lost to Follow-up|3|||
164646228|NCT00902278|594729949|FG001|Overall Study|Lost to Follow-up|2|||
164646229|NCT00902278|594729950|FG002|Overall Study|Lost to Follow-up|3|||
164646230|NCT00902278|594729951|FG003|Overall Study|Lost to Follow-up|0|||
164646231|NCT00902278|594729952|FG004|Overall Study|Lost to Follow-up|1|||
164646232|NCT01652872|594729955|FG000|Overall Study|Death|36|||
164646233|NCT01652872|594729956|FG001|Overall Study|Death|39|||
164646234|NCT01652872|594729955|FG000|Overall Study|Lost to Follow-up|28|||
164646235|NCT01652872|594729956|FG001|Overall Study|Lost to Follow-up|23|||
164646236|NCT01652872|594729955|FG000|Overall Study|Decision by sponsor|5|||
164646237|NCT01652872|594729956|FG001|Overall Study|Decision by sponsor|7|||
164646238|NCT01652872|594729955|FG000|Overall Study|Withdrawal by Subject|76|||
164646239|NCT01652872|594729956|FG001|Overall Study|Withdrawal by Subject|84|||
164646240|NCT00758706|594729957|FG000|Overall Study|Adverse Event|4|||
164646241|NCT00758706|594729958|FG001|Overall Study|Adverse Event|4|||
164646242|NCT03985293|594729965|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
164646243|NCT03985293|594729966|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
164646244|NCT03985293|594729967|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
164646245|NCT03985293|594729968|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
164646246|NCT03985293|594729969|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
164646247|NCT03985293|594729970|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
164646248|NCT03985293|594729965|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
164646249|NCT03985293|594729966|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
164646250|NCT03985293|594729967|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
164646251|NCT03985293|594729968|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
164646252|NCT03985293|594729969|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
164646253|NCT03985293|594729970|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
164646254|NCT03985293|594729965|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
164646255|NCT03985293|594729966|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
164646256|NCT03985293|594729967|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
164646257|NCT03985293|594729968|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
164646258|NCT03985293|594729969|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
164646259|NCT03985293|594729970|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
164646260|NCT03985293|594729965|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
164646261|NCT03985293|594729966|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
164646262|NCT03985293|594729967|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
164646263|NCT03985293|594729968|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
164646264|NCT03985293|594729969|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
164646265|NCT03985293|594729970|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
164646266|NCT03985293|594729965|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
164646267|NCT03985293|594729966|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
164646268|NCT03985293|594729967|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
164646269|NCT03985293|594729968|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
164646270|NCT03985293|594729969|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
164646271|NCT03985293|594729970|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
164646272|NCT03985293|594729965|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
164646273|NCT03985293|594729966|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
164646274|NCT03985293|594729967|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
164646275|NCT03985293|594729968|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
164646276|NCT03985293|594729969|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
164646277|NCT03985293|594729970|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
164646278|NCT03985293|594729965|FG000|FOLLOW-UP|Lost to Follow-up|0|||
164646279|NCT03985293|594729966|FG001|FOLLOW-UP|Lost to Follow-up|0|||
164646280|NCT03985293|594729967|FG002|FOLLOW-UP|Lost to Follow-up|1|||
164646281|NCT03985293|594729968|FG003|FOLLOW-UP|Lost to Follow-up|0|||
164646282|NCT03985293|594729969|FG004|FOLLOW-UP|Lost to Follow-up|0|||
164646283|NCT03985293|594729970|FG005|FOLLOW-UP|Lost to Follow-up|0|||
164646284|NCT02588651|594729971|FG000|Overall Study|Adverse Event|1|||
164646285|NCT02588651|594729971|FG000|Overall Study|Withdrawal by Subject|2|||
164646286|NCT02588651|594729971|FG000|Overall Study|Death|1|||
164646287|NCT02588651|594729971|FG000|Overall Study|Lack of Efficacy|13|||
164646288|NCT02588651|594729971|FG000|Overall Study|Lost to Follow-up|1|||
164646289|NCT02588651|594729971|FG000|Overall Study|Physician Decision|1|||
164646290|NCT02588651|594729971|FG000|Overall Study|Disease progression|2|||
164646291|NCT05899218|594729972|FG000|Overall Study|Lost to Follow-up|2|||
164646292|NCT05899218|594729973|FG001|Overall Study|Lost to Follow-up|2|||
164646293|NCT05899218|594729972|FG000|Overall Study|deemed ineligible out of country|1|||
164646294|NCT05899218|594729973|FG001|Overall Study|deemed ineligible out of country|0|||
164646295|NCT02587325|594729978|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
164646296|NCT02587325|594729979|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
164646297|NCT02587325|594729980|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
164646298|NCT02587325|594729981|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
164646299|NCT02587325|594729982|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
164646300|NCT02587325|594729978|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
164646301|NCT02587325|594729979|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
164646302|NCT02587325|594729980|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
164646303|NCT02587325|594729981|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
164646304|NCT02587325|594729982|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
164646305|NCT02587325|594729978|FG000|32-Week Optional Extension Part|Adverse Event|0|||
164646306|NCT02587325|594729979|FG001|32-Week Optional Extension Part|Adverse Event|0|||
164646307|NCT02587325|594729980|FG002|32-Week Optional Extension Part|Adverse Event|1|||
164646308|NCT02587325|594729981|FG003|32-Week Optional Extension Part|Adverse Event|0|||
164646309|NCT02587325|594729982|FG004|32-Week Optional Extension Part|Adverse Event|0|||
164646310|NCT02587325|594729978|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
164646311|NCT02587325|594729979|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
164646312|NCT02587325|594729980|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
164646313|NCT02587325|594729981|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
164646314|NCT02587325|594729982|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
164646315|NCT00390572|594729983|FG000|Overall Study|Lost to Follow-up|8|||
164646316|NCT00390572|594729984|FG001|Overall Study|Lost to Follow-up|4|||
164646317|NCT00390572|594729983|FG000|Overall Study|health condition|0|||
164646318|NCT00390572|594729984|FG001|Overall Study|health condition|1|||
164646319|NCT02913261|594729991|FG000|Overall Study|Technical problems|0|||
164646320|NCT02913261|594729992|FG001|Overall Study|Technical problems|1|||
164646321|NCT02913261|594729991|FG000|Overall Study|Lack of Efficacy|32|||
164646322|NCT02913261|594729992|FG001|Overall Study|Lack of Efficacy|69|||
164646323|NCT02913261|594729991|FG000|Overall Study|Adverse Event|27|||
164646324|NCT02913261|594729992|FG001|Overall Study|Adverse Event|5|||
164646325|NCT02913261|594729991|FG000|Overall Study|Death|25|||
164646326|NCT02913261|594729992|FG001|Overall Study|Death|22|||
164646327|NCT02913261|594729991|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
164646328|NCT02913261|594729992|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
164646329|NCT02913261|594729991|FG000|Overall Study|Disease relapse|8|||
164646330|NCT02913261|594729992|FG001|Overall Study|Disease relapse|13|||
164646331|NCT02913261|594729991|FG000|Overall Study|Physician Decision|8|||
164646332|NCT02913261|594729992|FG001|Overall Study|Physician Decision|9|||
164646333|NCT02913261|594729991|FG000|Overall Study|Subject/guardian decision|4|||
164646334|NCT02913261|594729992|FG001|Overall Study|Subject/guardian decision|6|||
164646335|NCT02913261|594729991|FG000|Overall Study|Graft loss|2|||
164646336|NCT02913261|594729992|FG001|Overall Study|Graft loss|0|||
164646337|NCT01074307|594731976|FG000|Overall Study|No primary endpoint evaluation|14|||
164646338|NCT01074307|594731977|FG001|Overall Study|No primary endpoint evaluation|6|||
164646339|NCT01074307|594731976|FG000|Overall Study|Exclusion criterion|0|||
164646340|NCT01074307|594731977|FG001|Overall Study|Exclusion criterion|1|||
164646341|NCT01074307|594731976|FG000|Overall Study|Protocol Violation|8|||
164646342|NCT01074307|594731977|FG001|Overall Study|Protocol Violation|5|||
164646343|NCT02703454|594731985|FG000|Overall Study|Not treated|1|||
164646344|NCT02703454|594731986|FG001|Overall Study|Not treated|3|||
164646345|NCT02703454|594731985|FG000|Overall Study|Withdrawal by Subject|4|||
164646346|NCT02703454|594731986|FG001|Overall Study|Withdrawal by Subject|3|||
164646347|NCT02703454|594731985|FG000|Overall Study|Lost to Follow-up|1|||
164646348|NCT02703454|594731986|FG001|Overall Study|Lost to Follow-up|2|||
164646349|NCT02703454|594731985|FG000|Overall Study|Study discontinuation|5|||
164646350|NCT02703454|594731986|FG001|Overall Study|Study discontinuation|8|||
164646351|NCT02284373|594731987|FG000|Overall Study|Withdrawal by Subject|0|||
164646352|NCT02284373|594731988|FG001|Overall Study|Withdrawal by Subject|1|||
164646353|NCT02284373|594731989|FG002|Overall Study|Withdrawal by Subject|0|||
164646354|NCT02284373|594731987|FG000|Overall Study|Other|0|||
164646355|NCT02284373|594731988|FG001|Overall Study|Other|1|||
164646356|NCT02284373|594731989|FG002|Overall Study|Other|0|||
164646357|NCT02284373|594731987|FG000|Overall Study|Lost to Follow-up|0|||
164646358|NCT02284373|594731988|FG001|Overall Study|Lost to Follow-up|1|||
164646359|NCT02284373|594731989|FG002|Overall Study|Lost to Follow-up|0|||
164646360|NCT02016755|594731990|FG000|Overall Study|Major amputation of index limb|2|||
164646361|NCT02016755|594731990|FG000|Overall Study|Adverse Event|2|||
164646362|NCT02016755|594731990|FG000|Overall Study|Physician Decision|1|||
164646363|NCT02016755|594731990|FG000|Overall Study|Death|2|||
164646364|NCT03174925|594732002|FG000|Overall Study|Elastographic images not retrievable|2|||
164646365|NCT03174925|594732002|FG000|Overall Study|Elastography image not interpretable|1|||
164646366|NCT04247594|594732005|FG000|Overall Study|Withdrawal by Subject|4|||
164646367|NCT04440163|594732007|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
164646368|NCT04440163|594732008|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
164646369|NCT04440163|594732009|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
164646370|NCT04440163|594732010|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
164646371|NCT04440163|594732011|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
164646372|NCT04440163|594732012|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
164646373|NCT04440163|594732013|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
164646374|NCT04440163|594732014|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
164646375|NCT04440163|594732007|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
164646376|NCT04440163|594732008|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
164646377|NCT04440163|594732009|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
164646378|NCT04440163|594732010|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
164646379|NCT04440163|594732011|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
164646380|NCT04440163|594732012|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
164646381|NCT04440163|594732013|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
164646382|NCT04440163|594732014|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
164646383|NCT04440163|594732007|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
164646384|NCT04440163|594732008|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
164646385|NCT04440163|594732009|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
164646386|NCT04440163|594732010|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
164646387|NCT04440163|594732011|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
164646388|NCT04440163|594732012|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
164646389|NCT04440163|594732013|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
164646390|NCT04440163|594732014|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
164646391|NCT04440163|594732007|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
164646392|NCT04440163|594732008|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
164646393|NCT04440163|594732009|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
164646394|NCT04440163|594732010|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
164646395|NCT04440163|594732011|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
164646396|NCT04440163|594732012|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
164646397|NCT04440163|594732013|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
164646398|NCT04440163|594732014|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
164646399|NCT04440163|594732007|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
164646400|NCT04440163|594732008|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
164646401|NCT04440163|594732009|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
164646402|NCT04440163|594732010|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
164646403|NCT04440163|594732011|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
164646404|NCT04440163|594732012|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
164646405|NCT04440163|594732013|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
164646406|NCT04440163|594732014|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
164646407|NCT04440163|594732007|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
164646408|NCT04440163|594732008|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
164646409|NCT04440163|594732009|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
164646410|NCT04440163|594732010|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
164646411|NCT04440163|594732011|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
164646412|NCT04440163|594732012|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
164646413|NCT04440163|594732013|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
164646414|NCT04440163|594732014|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
164646415|NCT04440163|594732007|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
164646416|NCT04440163|594732008|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
164646417|NCT04440163|594732009|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
164646418|NCT04440163|594732010|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
164646419|NCT04440163|594732011|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
164646420|NCT04440163|594732012|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
164646421|NCT04440163|594732013|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
164646422|NCT04440163|594732014|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
164646423|NCT04440163|594732007|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
164646424|NCT04440163|594732008|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
164646425|NCT04440163|594732009|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
164646426|NCT04440163|594732010|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
164646427|NCT04440163|594732011|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
164646428|NCT04440163|594732012|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
164646429|NCT04440163|594732013|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
164646430|NCT04440163|594732014|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
164646431|NCT04440163|594732007|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
164646432|NCT04440163|594732008|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
164646433|NCT04440163|594732009|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
164646434|NCT04440163|594732010|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
164646435|NCT04440163|594732011|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
164646436|NCT04440163|594732012|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
164646437|NCT04440163|594732013|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
164646438|NCT04440163|594732014|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
164646439|NCT04440163|594732007|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
164646440|NCT04440163|594732008|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
164646441|NCT04440163|594732009|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
164646442|NCT04440163|594732010|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
164646443|NCT04440163|594732011|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
164646444|NCT04440163|594732012|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
164646445|NCT04440163|594732013|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
164646446|NCT04440163|594732014|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
164646447|NCT04440163|594732007|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
164646448|NCT04440163|594732008|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
164646449|NCT04440163|594732009|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
164646450|NCT04440163|594732010|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
164646451|NCT04440163|594732011|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
164646452|NCT04440163|594732012|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
164646453|NCT04440163|594732013|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
164646454|NCT04440163|594732014|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
164646455|NCT04440163|594732007|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
164646456|NCT04440163|594732008|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
164646457|NCT04440163|594732009|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
164646458|NCT04440163|594732010|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
164646459|NCT04440163|594732011|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
164646460|NCT04440163|594732012|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
164646461|NCT04440163|594732013|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
164646462|NCT04440163|594732014|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
164646463|NCT00589693|594732018|FG000|Overall Study|randomized in error|12|||
164646464|NCT00589693|594732019|FG001|Overall Study|randomized in error|6|||
164646465|NCT00589693|594732018|FG000|Overall Study|Adverse Event|4|||
164646466|NCT00589693|594732019|FG001|Overall Study|Adverse Event|4|||
164646467|NCT00589693|594732018|FG000|Overall Study|Death|26|||
164646468|NCT00589693|594732019|FG001|Overall Study|Death|16|||
164646469|NCT00589693|594732018|FG000|Overall Study|Lack of Efficacy|0|||
164646470|NCT00589693|594732019|FG001|Overall Study|Lack of Efficacy|1|||
164646471|NCT00589693|594732018|FG000|Overall Study|Lost to Follow-up|1|||
164646472|NCT00589693|594732019|FG001|Overall Study|Lost to Follow-up|0|||
164646473|NCT00589693|594732018|FG000|Overall Study|Physician Decision|0|||
164646474|NCT00589693|594732019|FG001|Overall Study|Physician Decision|1|||
164646475|NCT00589693|594732018|FG000|Overall Study|Protocol Violation|1|||
164646476|NCT00589693|594732019|FG001|Overall Study|Protocol Violation|1|||
164646477|NCT01128153|594732020|FG000|Overall Study|Adverse Event|1|||
164646478|NCT01128153|594732021|FG001|Overall Study|Adverse Event|3|||
164646479|NCT01128153|594732020|FG000|Overall Study|Condition under investigation worsened|8|||
164646480|NCT01128153|594732021|FG001|Overall Study|Condition under investigation worsened|7|||
164646481|NCT01128153|594732020|FG000|Overall Study|Withdrawal by Subject|2|||
164646482|NCT01128153|594732021|FG001|Overall Study|Withdrawal by Subject|3|||
164646483|NCT01128153|594732020|FG000|Overall Study|Incorrect enrolment to study|2|||
164646484|NCT01128153|594732021|FG001|Overall Study|Incorrect enrolment to study|1|||
164646485|NCT01128153|594732020|FG000|Overall Study|Protocol Violation|2|||
164646486|NCT01128153|594732021|FG001|Overall Study|Protocol Violation|0|||
164646487|NCT01128153|594732020|FG000|Overall Study|Developed discontinuation criteria|1|||
164646488|NCT01128153|594732021|FG001|Overall Study|Developed discontinuation criteria|1|||
164646489|NCT01954082|594732022|FG000|Overall Study|Study Suspension|42|||
164646490|NCT01954082|594732023|FG001|Overall Study|Study Suspension|36|||
164646491|NCT01954082|594732022|FG000|Overall Study|Adverse Event|10|||
164646492|NCT01954082|594732023|FG001|Overall Study|Adverse Event|4|||
164646493|NCT01954082|594732022|FG000|Overall Study|Intolerance|0|||
164646494|NCT01954082|594732023|FG001|Overall Study|Intolerance|1|||
164646495|NCT01954082|594732022|FG000|Overall Study|Non-compliance|6|||
164646496|NCT01954082|594732023|FG001|Overall Study|Non-compliance|4|||
164646497|NCT01954082|594732022|FG000|Overall Study|Physician Decision|2|||
164646498|NCT01954082|594732023|FG001|Overall Study|Physician Decision|0|||
164646499|NCT01954082|594732022|FG000|Overall Study|Parent Decision|1|||
164646500|NCT01954082|594732023|FG001|Overall Study|Parent Decision|0|||
164646501|NCT01954082|594732022|FG000|Overall Study|Withdrawal by Subject|0|||
164646502|NCT01954082|594732023|FG001|Overall Study|Withdrawal by Subject|1|||
164646503|NCT01954082|594732022|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
164646504|NCT01954082|594732023|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
164646505|NCT01954082|594732022|FG000|Overall Study|Redirection of Care|0|||
164646506|NCT01954082|594732023|FG001|Overall Study|Redirection of Care|2|||
164646507|NCT01954082|594732022|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
164646508|NCT01954082|594732023|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
164646509|NCT01954082|594732022|FG000|Overall Study|Comfort Care|0|||
164646510|NCT01954082|594732023|FG001|Overall Study|Comfort Care|1|||
164646511|NCT01954082|594732022|FG000|Overall Study|Infant Moved|0|||
164646512|NCT01954082|594732023|FG001|Overall Study|Infant Moved|1|||
164646513|NCT01954082|594732022|FG000|Overall Study|Randomized not Treated|4|||
164646514|NCT01954082|594732023|FG001|Overall Study|Randomized not Treated|2|||
164646515|NCT01682512|594732024|FG000|Overall Study|Adverse Event|6|||
164646516|NCT01682512|594732025|FG001|Overall Study|Adverse Event|5|||
164646517|NCT01682512|594732026|FG002|Overall Study|Adverse Event|2|||
164646518|NCT01682512|594732024|FG000|Overall Study|Withdrawal by Subject|2|||
164646519|NCT01682512|594732025|FG001|Overall Study|Withdrawal by Subject|6|||
164646520|NCT01682512|594732026|FG002|Overall Study|Withdrawal by Subject|3|||
164646521|NCT01682512|594732024|FG000|Overall Study|Physician Decision|0|||
164646522|NCT01682512|594732025|FG001|Overall Study|Physician Decision|2|||
164646523|NCT01682512|594732026|FG002|Overall Study|Physician Decision|0|||
164646524|NCT01682512|594732024|FG000|Overall Study|Study terminated by sponsor|46|||
164646525|NCT01682512|594732025|FG001|Overall Study|Study terminated by sponsor|43|||
164646526|NCT01682512|594732026|FG002|Overall Study|Study terminated by sponsor|0|||
164646527|NCT01682512|594732024|FG000|Overall Study|Lost to Follow-up|3|||
164646528|NCT01682512|594732025|FG001|Overall Study|Lost to Follow-up|0|||
164646529|NCT01682512|594732026|FG002|Overall Study|Lost to Follow-up|2|||
164646530|NCT01682512|594732024|FG000|Overall Study|Protocol Violation|2|||
164646531|NCT01682512|594732025|FG001|Overall Study|Protocol Violation|3|||
164646532|NCT01682512|594732026|FG002|Overall Study|Protocol Violation|2|||
164646533|NCT01682512|594732024|FG000|Overall Study|Primary lack of efficacy|10|||
164646534|NCT01682512|594732025|FG001|Overall Study|Primary lack of efficacy|7|||
164646535|NCT01682512|594732026|FG002|Overall Study|Primary lack of efficacy|7|||
164646536|NCT01682512|594732024|FG000|Overall Study|Secondary lack of efficacy|1|||
164646537|NCT01682512|594732025|FG001|Overall Study|Secondary lack of efficacy|1|||
164646538|NCT01682512|594732026|FG002|Overall Study|Secondary lack of efficacy|0|||
164646539|NCT01682512|594732024|FG000|Overall Study|Other than stated above|2|||
164646540|NCT01682512|594732025|FG001|Overall Study|Other than stated above|4|||
164646541|NCT01682512|594732026|FG002|Overall Study|Other than stated above|2|||
164646542|NCT01377233|594732027|FG000|Open-label|Adverse Event|1|||
164646543|NCT01377233|594732028|FG001|Open-label|Adverse Event|0|||
164646544|NCT01377233|594732029|FG002|Open-label|Adverse Event|0|||
164646545|NCT01377233|594732030|FG003|Open-label|Adverse Event|0|||
164646546|NCT01377233|594732031|FG004|Open-label|Adverse Event|0|||
164646547|NCT01377233|594732027|FG000|Open-label|Withdrawal by Subject|3|||
164646548|NCT01377233|594732028|FG001|Open-label|Withdrawal by Subject|0|||
164646549|NCT01377233|594732029|FG002|Open-label|Withdrawal by Subject|0|||
164646550|NCT01377233|594732030|FG003|Open-label|Withdrawal by Subject|0|||
164646551|NCT01377233|594732031|FG004|Open-label|Withdrawal by Subject|0|||
164646552|NCT01377233|594732027|FG000|Double-blind|Adverse Event|0|||
164646553|NCT01377233|594732028|FG001|Double-blind|Adverse Event|1|||
164646554|NCT01377233|594732029|FG002|Double-blind|Adverse Event|2|||
164646555|NCT01377233|594732030|FG003|Double-blind|Adverse Event|2|||
164646556|NCT01377233|594732031|FG004|Double-blind|Adverse Event|0|||
164646557|NCT01377233|594732027|FG000|Double-blind|Protocol Violation|0|||
164646558|NCT01377233|594732028|FG001|Double-blind|Protocol Violation|0|||
164646559|NCT01377233|594732029|FG002|Double-blind|Protocol Violation|0|||
164646560|NCT01377233|594732030|FG003|Double-blind|Protocol Violation|0|||
164646561|NCT01377233|594732031|FG004|Double-blind|Protocol Violation|1|||
164646562|NCT01377233|594732027|FG000|Double-blind|Withdrawal by Subject|0|||
164646563|NCT01377233|594732028|FG001|Double-blind|Withdrawal by Subject|0|||
164646564|NCT01377233|594732029|FG002|Double-blind|Withdrawal by Subject|0|||
164646565|NCT01377233|594732030|FG003|Double-blind|Withdrawal by Subject|1|||
164646566|NCT01377233|594732031|FG004|Double-blind|Withdrawal by Subject|0|||
164646567|NCT01377233|594732027|FG000|Double-blind|Administrative or other|0|||
164646568|NCT01377233|594732028|FG001|Double-blind|Administrative or other|0|||
164646569|NCT01377233|594732029|FG002|Double-blind|Administrative or other|0|||
164646570|NCT01377233|594732030|FG003|Double-blind|Administrative or other|1|||
164646571|NCT01377233|594732031|FG004|Double-blind|Administrative or other|1|||
164646572|NCT03137082|594732032|FG000|Overall Study|Withdrawal by Subject|1|||
164646573|NCT03137082|594732033|FG001|Overall Study|Withdrawal by Subject|1|||
164646574|NCT03137082|594732032|FG000|Overall Study|Lost to Follow-up|1|||
164646575|NCT03137082|594732033|FG001|Overall Study|Lost to Follow-up|0|||
164646576|NCT00417027|594732034|FG000|Overall Study|Protocol Violation|0|||
164646577|NCT00417027|594732035|FG001|Overall Study|Protocol Violation|5|||
164646578|NCT00417027|594732036|FG002|Overall Study|Protocol Violation|5|||
164646579|NCT04285983|594732037|FG000|Overall Study|Protocol Violation|6|||
164646580|NCT02787785|594732038|FG000|Overall Study|Death|3|||
164646581|NCT02787785|594732039|FG001|Overall Study|Death|4|||
164646582|NCT02787785|594732038|FG000|Overall Study|Lost to Follow-up|1|||
164646583|NCT02787785|594732039|FG001|Overall Study|Lost to Follow-up|1|||
164646584|NCT02787785|594732038|FG000|Overall Study|Withdrawal by Subject|0|||
164646585|NCT02787785|594732039|FG001|Overall Study|Withdrawal by Subject|5|||
164646586|NCT01440595|594732050|FG000|Overall Study|Lost to Follow-up|0|||
164646587|NCT01440595|594732051|FG001|Overall Study|Lost to Follow-up|1|||
164646588|NCT01440595|594732052|FG002|Overall Study|Lost to Follow-up|0|||
164646589|NCT01440595|594732050|FG000|Overall Study|Study terminated by sponsor.|1|||
164646590|NCT01440595|594732051|FG001|Overall Study|Study terminated by sponsor.|2|||
164646591|NCT01440595|594732052|FG002|Overall Study|Study terminated by sponsor.|1|||
164646592|NCT01850108|594732053|FG000|Overall Study|Lost to Follow-up|4|||
164646593|NCT01850108|594732053|FG000|Overall Study|Not eligible|1|||
164646594|NCT01850108|594732053|FG000|Overall Study|Failed engraftment|2|||
164646595|NCT01850108|594732053|FG000|Overall Study|Physician Decision|1|||
164646596|NCT01447628|594732056|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
164646597|NCT01447628|594732057|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
164646598|NCT01447628|594732058|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
164646599|NCT01447628|594732059|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
164646600|NCT00965263|594732068|FG000|Overall Study|Physician Decision|2|||
164646601|NCT00965263|594732069|FG001|Overall Study|Physician Decision|0|||
164646602|NCT00965263|594732068|FG000|Overall Study|Family emergency|0|||
164646603|NCT00965263|594732069|FG001|Overall Study|Family emergency|1|||
164646604|NCT00965263|594732068|FG000|Overall Study|Protocol Violation|0|||
164646605|NCT00965263|594732069|FG001|Overall Study|Protocol Violation|2|||
164646606|NCT03496207|594732070|FG000|Base Study|Adverse Event|0|||
164646607|NCT03496207|594732071|FG001|Base Study|Adverse Event|0|||
164646608|NCT03496207|594732072|FG002|Base Study|Adverse Event|1|||
164646609|NCT03496207|594732073|FG003|Base Study|Adverse Event|1|||
164646610|NCT03496207|594732074|FG004|Base Study|Adverse Event|4|||
164646611|NCT03496207|594732070|FG000|Base Study|Death|0|||
164646612|NCT03496207|594732071|FG001|Base Study|Death|0|||
164646613|NCT03496207|594732072|FG002|Base Study|Death|0|||
164646614|NCT03496207|594732073|FG003|Base Study|Death|0|||
164646615|NCT03496207|594732074|FG004|Base Study|Death|1|||
164646616|NCT03496207|594732070|FG000|Base Study|Withdrawal by Subject|0|||
164646617|NCT03496207|594732071|FG001|Base Study|Withdrawal by Subject|0|||
164646618|NCT03496207|594732072|FG002|Base Study|Withdrawal by Subject|1|||
164646619|NCT03496207|594732073|FG003|Base Study|Withdrawal by Subject|0|||
164646620|NCT03496207|594732074|FG004|Base Study|Withdrawal by Subject|1|||
164646621|NCT03496207|594732070|FG000|Extension Period|Adverse Event|0|||
164646622|NCT03496207|594732071|FG001|Extension Period|Adverse Event|0|||
164646623|NCT03496207|594732072|FG002|Extension Period|Adverse Event|0|||
164646624|NCT03496207|594732073|FG003|Extension Period|Adverse Event|1|||
164646625|NCT03496207|594732074|FG004|Extension Period|Adverse Event|1|||
164646626|NCT03496207|594732070|FG000|Extension Period|Death|1|||
164646627|NCT03496207|594732071|FG001|Extension Period|Death|0|||
164646628|NCT03496207|594732072|FG002|Extension Period|Death|0|||
164646629|NCT03496207|594732073|FG003|Extension Period|Death|1|||
164646630|NCT03496207|594732074|FG004|Extension Period|Death|2|||
164646631|NCT03496207|594732070|FG000|Extension Period|Withdrawal by Subject|1|||
164646632|NCT03496207|594732071|FG001|Extension Period|Withdrawal by Subject|0|||
164646633|NCT03496207|594732072|FG002|Extension Period|Withdrawal by Subject|0|||
164646634|NCT03496207|594732073|FG003|Extension Period|Withdrawal by Subject|1|||
164646635|NCT03496207|594732074|FG004|Extension Period|Withdrawal by Subject|1|||
164646636|NCT03496207|594732070|FG000|Extension Period|Elevated hemoglobin levels|0|||
164646637|NCT03496207|594732071|FG001|Extension Period|Elevated hemoglobin levels|0|||
164646638|NCT03496207|594732072|FG002|Extension Period|Elevated hemoglobin levels|0|||
164646639|NCT03496207|594732073|FG003|Extension Period|Elevated hemoglobin levels|0|||
164646640|NCT03496207|594732074|FG004|Extension Period|Elevated hemoglobin levels|1|||
164646641|NCT02756078|594732075|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
164646642|NCT02756078|594732076|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
164646643|NCT02756078|594732075|FG000|Period 1|Lost to Follow-up|0|||
164646644|NCT02756078|594732076|FG001|Period 1|Lost to Follow-up|2|||
164646645|NCT02756078|594732075|FG000|Period 1|Protocol Violation|0|||
164646646|NCT02756078|594732076|FG001|Period 1|Protocol Violation|1|||
164646647|NCT02756078|594732075|FG000|Period 1|Adverse Event|1|||
164646648|NCT02756078|594732076|FG001|Period 1|Adverse Event|10|||
164646649|NCT02756078|594732075|FG000|Period 1|Withdrawal by Subject|6|||
164646650|NCT02756078|594732076|FG001|Period 1|Withdrawal by Subject|6|||
164646651|NCT02756078|594732075|FG000|Period 1|Lens Discomfort|2|||
164646652|NCT02756078|594732076|FG001|Period 1|Lens Discomfort|2|||
164646653|NCT02756078|594732075|FG000|Period 2|Adverse Event|3|||
164646654|NCT02756078|594732076|FG001|Period 2|Adverse Event|5|||
164646655|NCT02756078|594732075|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
164646656|NCT02756078|594732076|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
164646657|NCT02756078|594732075|FG000|Period 2|Withdrawal by Subject|3|||
164646658|NCT02756078|594732076|FG001|Period 2|Withdrawal by Subject|1|||
164646659|NCT00810615|594732077|FG000|Overall Study|Withdrawal by Subject|1|||
164646660|NCT00810615|594732078|FG001|Overall Study|Withdrawal by Subject|1|||
164646661|NCT02058368|594732081|FG000|Overall Study|Adverse Event|15|||
164646662|NCT02058368|594732082|FG001|Overall Study|Adverse Event|20|||
164646663|NCT02058368|594732081|FG000|Overall Study|Lack of Efficacy|0|||
164646664|NCT02058368|594732082|FG001|Overall Study|Lack of Efficacy|1|||
164646665|NCT02058368|594732081|FG000|Overall Study|Protocol Violation|0|||
164646666|NCT02058368|594732082|FG001|Overall Study|Protocol Violation|4|||
164646667|NCT02058368|594732081|FG000|Overall Study|Lost to Follow-up|2|||
164646668|NCT02058368|594732082|FG001|Overall Study|Lost to Follow-up|0|||
164646669|NCT02058368|594732081|FG000|Overall Study|Physician Decision|2|||
164646670|NCT02058368|594732082|FG001|Overall Study|Physician Decision|3|||
164646671|NCT02058368|594732081|FG000|Overall Study|Withdrawal by Subject|22|||
164646672|NCT02058368|594732082|FG001|Overall Study|Withdrawal by Subject|26|||
164646673|NCT02181842|594732083|FG000|Overall Study|Case Report Forms Uncollected|2|||
164646674|NCT02441179|594732084|FG000|Overall Study|Withdrawal by Subject|1|||
164646675|NCT02441179|594732085|FG001|Overall Study|Withdrawal by Subject|1|||
164646676|NCT01488071|594732086|FG000|Overall Study|Adverse Event|15|||
164646677|NCT01488071|594732087|FG001|Overall Study|Adverse Event|23|||
164646678|NCT01488071|594732086|FG000|Overall Study|Lack of Efficacy|11|||
164646679|NCT01488071|594732087|FG001|Overall Study|Lack of Efficacy|17|||
164646680|NCT01488071|594732086|FG000|Overall Study|Non-compliance with study drug|2|||
164646681|NCT01488071|594732087|FG001|Overall Study|Non-compliance with study drug|0|||
164646682|NCT01488071|594732086|FG000|Overall Study|Protocol Violation|5|||
164646683|NCT01488071|594732087|FG001|Overall Study|Protocol Violation|7|||
164646684|NCT01488071|594732086|FG000|Overall Study|Withdrawal of Consent|14|||
164646685|NCT01488071|594732087|FG001|Overall Study|Withdrawal of Consent|12|||
164646686|NCT01488071|594732086|FG000|Overall Study|Lost to Follow-up|1|||
164646687|NCT01488071|594732087|FG001|Overall Study|Lost to Follow-up|0|||
164646688|NCT01488071|594732086|FG000|Overall Study|Administrative or Other Reason(s)|5|||
164646689|NCT01488071|594732087|FG001|Overall Study|Administrative or Other Reason(s)|4|||
164646690|NCT02139306|594732088|FG000|Overall Study|Withdrawal by Subject|4|||
164646691|NCT02139306|594732089|FG001|Overall Study|Withdrawal by Subject|6|||
164646692|NCT02139306|594732088|FG000|Overall Study|Adverse Event|3|||
164646693|NCT02139306|594732089|FG001|Overall Study|Adverse Event|4|||
164646694|NCT02139306|594732088|FG000|Overall Study|Physician Decision|0|||
164646695|NCT02139306|594732089|FG001|Overall Study|Physician Decision|1|||
164646696|NCT02139306|594732088|FG000|Overall Study|Other Unspecified|2|||
164646697|NCT02139306|594732089|FG001|Overall Study|Other Unspecified|3|||
164646698|NCT02139306|594732088|FG000|Overall Study|Protocol Violation|4|||
164646699|NCT02139306|594732089|FG001|Overall Study|Protocol Violation|0|||
164646700|NCT04449354|594732090|FG000|Overall Study|Withdrawal by Subject|1|||
164646701|NCT05789420|594732091|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
164646702|NCT05789420|594732091|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
164646703|NCT02278952|594732092|FG000|Overall Study|Insufficient Sample|6|||
164646704|NCT01220128|594732093|FG000|Overall Study|Progressive disease|0|||
164646705|NCT01220128|594732094|FG001|Overall Study|Progressive disease|0|||
164646706|NCT01220128|594732095|FG002|Overall Study|Progressive disease|2|||
164646707|NCT01220128|594732096|FG003|Overall Study|Progressive disease|0|||
164646708|NCT01220128|594732097|FG004|Overall Study|Progressive disease|0|||
164646709|NCT01220128|594732098|FG005|Overall Study|Progressive disease|0|||
164646710|NCT01220128|594732099|FG006|Overall Study|Progressive disease|0|||
164646711|NCT01220128|594732093|FG000|Overall Study|Sponsor study termination|0|||
164646712|NCT01220128|594732094|FG001|Overall Study|Sponsor study termination|1|||
164646713|NCT01220128|594732095|FG002|Overall Study|Sponsor study termination|0|||
164646714|NCT01220128|594732096|FG003|Overall Study|Sponsor study termination|0|||
164646715|NCT01220128|594732097|FG004|Overall Study|Sponsor study termination|0|||
164646716|NCT01220128|594732098|FG005|Overall Study|Sponsor study termination|0|||
164646717|NCT01220128|594732099|FG006|Overall Study|Sponsor study termination|1|||
164646718|NCT01220128|594732093|FG000|Overall Study|Adverse event, serious fatal|2|||
164646719|NCT01220128|594732094|FG001|Overall Study|Adverse event, serious fatal|0|||
164646720|NCT01220128|594732095|FG002|Overall Study|Adverse event, serious fatal|0|||
164646721|NCT01220128|594732096|FG003|Overall Study|Adverse event, serious fatal|0|||
164646722|NCT01220128|594732097|FG004|Overall Study|Adverse event, serious fatal|0|||
164646723|NCT01220128|594732098|FG005|Overall Study|Adverse event, serious fatal|0|||
164646724|NCT01220128|594732099|FG006|Overall Study|Adverse event, serious fatal|1|||
164646725|NCT01220128|594732093|FG000|Overall Study|Adverse event, non-fatal|1|||
164646726|NCT01220128|594732094|FG001|Overall Study|Adverse event, non-fatal|0|||
164646727|NCT01220128|594732095|FG002|Overall Study|Adverse event, non-fatal|0|||
164646728|NCT01220128|594732096|FG003|Overall Study|Adverse event, non-fatal|0|||
164646729|NCT01220128|594732097|FG004|Overall Study|Adverse event, non-fatal|0|||
164646730|NCT01220128|594732098|FG005|Overall Study|Adverse event, non-fatal|0|||
164646731|NCT01220128|594732099|FG006|Overall Study|Adverse event, non-fatal|3|||
164646732|NCT01220128|594732093|FG000|Overall Study|Other|0|||
164646733|NCT01220128|594732094|FG001|Overall Study|Other|0|||
164646734|NCT01220128|594732095|FG002|Overall Study|Other|1|||
164646735|NCT01220128|594732096|FG003|Overall Study|Other|0|||
164646736|NCT01220128|594732097|FG004|Overall Study|Other|0|||
164646737|NCT01220128|594732098|FG005|Overall Study|Other|0|||
164646738|NCT01220128|594732099|FG006|Overall Study|Other|0|||
164646739|NCT01220128|594732093|FG000|Overall Study|Consent withdrawn by subject|1|||
164646740|NCT01220128|594732094|FG001|Overall Study|Consent withdrawn by subject|0|||
164646741|NCT01220128|594732095|FG002|Overall Study|Consent withdrawn by subject|0|||
164646742|NCT01220128|594732096|FG003|Overall Study|Consent withdrawn by subject|0|||
164646743|NCT01220128|594732097|FG004|Overall Study|Consent withdrawn by subject|0|||
164646744|NCT01220128|594732098|FG005|Overall Study|Consent withdrawn by subject|0|||
164646745|NCT01220128|594732099|FG006|Overall Study|Consent withdrawn by subject|0|||
164646746|NCT02304302|594732124|FG000|Overall Study|Adverse Event|2|||
164646747|NCT02304302|594732125|FG001|Overall Study|Adverse Event|3|||
164646748|NCT02304302|594732124|FG000|Overall Study|Lost to Follow-up|1|||
164646749|NCT02304302|594732125|FG001|Overall Study|Lost to Follow-up|4|||
164646750|NCT02304302|594732124|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
164646751|NCT02304302|594732125|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
164646752|NCT00391118|594732126|FG000|Overall Study|Adverse Event|3|||
164646753|NCT00391118|594732127|FG001|Overall Study|Adverse Event|10|||
164646754|NCT00391118|594732128|FG002|Overall Study|Adverse Event|7|||
164646755|NCT00391118|594732126|FG000|Overall Study|Lost to Follow-up|0|||
164646756|NCT00391118|594732127|FG001|Overall Study|Lost to Follow-up|2|||
164646757|NCT00391118|594732128|FG002|Overall Study|Lost to Follow-up|3|||
164646758|NCT00391118|594732126|FG000|Overall Study|Withdrawal by Subject|0|||
164646759|NCT00391118|594732127|FG001|Overall Study|Withdrawal by Subject|9|||
164646760|NCT00391118|594732128|FG002|Overall Study|Withdrawal by Subject|1|||
164646761|NCT00391118|594732126|FG000|Overall Study|Death|0|||
164646762|NCT00391118|594732127|FG001|Overall Study|Death|1|||
164646763|NCT00391118|594732128|FG002|Overall Study|Death|0|||
164646764|NCT00391118|594732126|FG000|Overall Study|Physician Decision|0|||
164646765|NCT00391118|594732127|FG001|Overall Study|Physician Decision|3|||
164646766|NCT00391118|594732128|FG002|Overall Study|Physician Decision|0|||
164646767|NCT00391118|594732126|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
164646768|NCT00391118|594732127|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
164646769|NCT00391118|594732128|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
164646770|NCT00391118|594732126|FG000|Overall Study|Progressive Disease|7|||
164646771|NCT00391118|594732127|FG001|Overall Study|Progressive Disease|26|||
164646772|NCT00391118|594732128|FG002|Overall Study|Progressive Disease|43|||
164646773|NCT00391118|594732126|FG000|Overall Study|Sponsor Decision|0|||
164646774|NCT00391118|594732127|FG001|Overall Study|Sponsor Decision|1|||
164646775|NCT00391118|594732128|FG002|Overall Study|Sponsor Decision|3|||
164646776|NCT00391118|594732126|FG000|Overall Study|Protocol Violation|1|||
164646777|NCT00391118|594732127|FG001|Overall Study|Protocol Violation|0|||
164646778|NCT00391118|594732128|FG002|Overall Study|Protocol Violation|0|||
164646779|NCT03078192|594732131|FG000|Overall Study|Withdrawal by Subject|2|||
164646780|NCT03078192|594732132|FG001|Overall Study|Withdrawal by Subject|1|||
164646781|NCT03078192|594732131|FG000|Overall Study|screen failure|0|||
164646782|NCT03078192|594732132|FG001|Overall Study|screen failure|3|||
164646783|NCT01311505|594732133|FG000|First Intervention Period|Protocol Violation|0|||
164646784|NCT01311505|594732134|FG001|First Intervention Period|Protocol Violation|1|||
164646785|NCT00532779|594732138|FG000|Overall Study|Adverse Event|122|||
164646786|NCT00532779|594732139|FG001|Overall Study|Adverse Event|112|||
164646787|NCT00532779|594732140|FG002|Overall Study|Adverse Event|56|||
164646788|NCT00532779|594732138|FG000|Overall Study|Lost to Follow-up|76|||
164646789|NCT00532779|594732139|FG001|Overall Study|Lost to Follow-up|65|||
164646790|NCT00532779|594732140|FG002|Overall Study|Lost to Follow-up|66|||
164646791|NCT00532779|594732138|FG000|Overall Study|Withdrawal by Subject|63|||
164646792|NCT00532779|594732139|FG001|Overall Study|Withdrawal by Subject|60|||
164646793|NCT00532779|594732140|FG002|Overall Study|Withdrawal by Subject|90|||
164646794|NCT00532779|594732138|FG000|Overall Study|Lack of Efficacy|12|||
164646795|NCT00532779|594732139|FG001|Overall Study|Lack of Efficacy|12|||
164646796|NCT00532779|594732140|FG002|Overall Study|Lack of Efficacy|40|||
164646797|NCT00532779|594732138|FG000|Overall Study|Protocol Violation|5|||
164646798|NCT00532779|594732139|FG001|Overall Study|Protocol Violation|9|||
164646799|NCT00532779|594732140|FG002|Overall Study|Protocol Violation|7|||
164646800|NCT00532779|594732138|FG000|Overall Study|Pregnancy|2|||
164646801|NCT00532779|594732139|FG001|Overall Study|Pregnancy|5|||
164646802|NCT00532779|594732140|FG002|Overall Study|Pregnancy|3|||
164646803|NCT00532779|594732138|FG000|Overall Study|Death|0|||
164646804|NCT00532779|594732139|FG001|Overall Study|Death|1|||
164646805|NCT00532779|594732140|FG002|Overall Study|Death|0|||
164646806|NCT00532779|594732138|FG000|Overall Study|Drug noncompliance, moved, other|14|||
164646807|NCT00532779|594732139|FG001|Overall Study|Drug noncompliance, moved, other|23|||
164646808|NCT00532779|594732140|FG002|Overall Study|Drug noncompliance, moved, other|29|||
164646809|NCT00828516|594732147|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
164646810|NCT00689273|594732148|FG000|Overall Study|Adverse Event|3|||
164646811|NCT00689273|594732149|FG001|Overall Study|Adverse Event|1|||
164646812|NCT00689273|594732148|FG000|Overall Study|Lack of Efficacy|3|||
164646813|NCT00689273|594732149|FG001|Overall Study|Lack of Efficacy|0|||
164646814|NCT00689273|594732148|FG000|Overall Study|Lost to Follow-up|0|||
164646815|NCT00689273|594732149|FG001|Overall Study|Lost to Follow-up|2|||
164646816|NCT00689273|594732148|FG000|Overall Study|Other|6|||
164646817|NCT00689273|594732149|FG001|Overall Study|Other|2|||
164646818|NCT00689273|594732148|FG000|Overall Study|Randomized but not Treated|1|||
164646819|NCT00689273|594732149|FG001|Overall Study|Randomized but not Treated|0|||
164646820|NCT02787746|594732152|FG000|Overall Study|Adverse Event|42|||
164646821|NCT02787746|594732152|FG000|Overall Study|Withdrawal by Subject|65|||
164646822|NCT02787746|594732152|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
164646823|NCT01142466|594734116|FG000|Overall Study|Adverse Event|2|||
164646824|NCT01142466|594734117|FG001|Overall Study|Adverse Event|1|||
164646825|NCT01142466|594734116|FG000|Overall Study|Withdrawal by Subject|1|||
164646826|NCT01142466|594734117|FG001|Overall Study|Withdrawal by Subject|1|||
164646827|NCT00700310|594734122|FG000|Overall Study|Adverse Event|6|||
164646828|NCT00700310|594734123|FG001|Overall Study|Adverse Event|10|||
164646829|NCT00700310|594734124|FG002|Overall Study|Adverse Event|5|||
164646830|NCT00700310|594734125|FG003|Overall Study|Adverse Event|11|||
164646831|NCT00700310|594734122|FG000|Overall Study|Lost to Follow-up|4|||
164646832|NCT00700310|594734123|FG001|Overall Study|Lost to Follow-up|1|||
164646833|NCT00700310|594734124|FG002|Overall Study|Lost to Follow-up|0|||
164646834|NCT00700310|594734125|FG003|Overall Study|Lost to Follow-up|1|||
164646835|NCT00700310|594734122|FG000|Overall Study|Withdrawal by Subject|8|||
164646836|NCT00700310|594734123|FG001|Overall Study|Withdrawal by Subject|9|||
164646837|NCT00700310|594734124|FG002|Overall Study|Withdrawal by Subject|8|||
164646838|NCT00700310|594734125|FG003|Overall Study|Withdrawal by Subject|8|||
164646839|NCT00700310|594734122|FG000|Overall Study|Lack of Efficacy|0|||
164646840|NCT00700310|594734123|FG001|Overall Study|Lack of Efficacy|3|||
164646841|NCT00700310|594734124|FG002|Overall Study|Lack of Efficacy|0|||
164646842|NCT00700310|594734125|FG003|Overall Study|Lack of Efficacy|1|||
164646843|NCT00700310|594734122|FG000|Overall Study|Administrative/Other|1|||
164646844|NCT00700310|594734123|FG001|Overall Study|Administrative/Other|3|||
164646845|NCT00700310|594734124|FG002|Overall Study|Administrative/Other|1|||
164646846|NCT00700310|594734125|FG003|Overall Study|Administrative/Other|3|||
164646847|NCT00700310|594734122|FG000|Overall Study|Randomized, Not Treated|2|||
164646848|NCT00700310|594734123|FG001|Overall Study|Randomized, Not Treated|0|||
164646849|NCT00700310|594734124|FG002|Overall Study|Randomized, Not Treated|2|||
164646850|NCT00700310|594734125|FG003|Overall Study|Randomized, Not Treated|2|||
164646851|NCT02414854|594734126|FG000|Overall Study|Adverse Event|9|||
164646852|NCT02414854|594734127|FG001|Overall Study|Adverse Event|7|||
164646853|NCT02414854|594734128|FG002|Overall Study|Adverse Event|1|||
164646854|NCT02414854|594734129|FG003|Overall Study|Adverse Event|12|||
164646855|NCT02414854|594734126|FG000|Overall Study|Poor compliance to protocol|1|||
164646856|NCT02414854|594734127|FG001|Overall Study|Poor compliance to protocol|1|||
164646857|NCT02414854|594734128|FG002|Overall Study|Poor compliance to protocol|2|||
164646858|NCT02414854|594734129|FG003|Overall Study|Poor compliance to protocol|2|||
164646859|NCT02414854|594734126|FG000|Overall Study|Other than specified above|12|||
164646860|NCT02414854|594734127|FG001|Overall Study|Other than specified above|37|||
164646861|NCT02414854|594734128|FG002|Overall Study|Other than specified above|17|||
164646862|NCT02414854|594734129|FG003|Overall Study|Other than specified above|37|||
164646863|NCT01355523|594734130|FG000|Overall Study|Withdrawal by Subject|1|||
164646864|NCT01355523|594734131|FG001|Overall Study|Withdrawal by Subject|4|||
164646865|NCT01355523|594734130|FG000|Overall Study|Lost to Follow-up|0|||
164646866|NCT01355523|594734131|FG001|Overall Study|Lost to Follow-up|2|||
164646867|NCT01355523|594734130|FG000|Overall Study|Protocol Violation|0|||
164646868|NCT01355523|594734131|FG001|Overall Study|Protocol Violation|2|||
164646869|NCT01355523|594734130|FG000|Overall Study|Adverse Event|0|||
164646870|NCT01355523|594734131|FG001|Overall Study|Adverse Event|2|||
164646871|NCT00303316|594734132|FG000|Overall Study|Protocol Violation|1|||
164646872|NCT00303316|594734133|FG001|Overall Study|Protocol Violation|0|||
164646873|NCT00303316|594734132|FG000|Overall Study|Lost to Follow-up|0|||
164646874|NCT00303316|594734133|FG001|Overall Study|Lost to Follow-up|1|||
164646875|NCT00303316|594734132|FG000|Overall Study|Withdrawal by Subject|1|||
164646876|NCT00303316|594734133|FG001|Overall Study|Withdrawal by Subject|2|||
164646877|NCT02162511|594734136|FG000|Overall Study|Lack of Efficacy|0|||
164646878|NCT02162511|594734137|FG001|Overall Study|Lack of Efficacy|0|||
164646879|NCT02162511|594734138|FG002|Overall Study|Lack of Efficacy|2|||
164646880|NCT01160198|594734139|FG000|Overall Study|Withdrawal by Subject|2|||
164646881|NCT01160198|594734140|FG001|Overall Study|Withdrawal by Subject|1|||
164646882|NCT01160198|594734141|FG002|Overall Study|Withdrawal by Subject|0|||
164646883|NCT01160198|594734139|FG000|Overall Study|Adverse Event|0|||
164646884|NCT01160198|594734140|FG001|Overall Study|Adverse Event|1|||
164646885|NCT01160198|594734141|FG002|Overall Study|Adverse Event|0|||
164646886|NCT01160198|594734139|FG000|Overall Study|Lost to Follow-up|0|||
164646887|NCT01160198|594734140|FG001|Overall Study|Lost to Follow-up|1|||
164646888|NCT01160198|594734141|FG002|Overall Study|Lost to Follow-up|0|||
164646889|NCT01160198|594734139|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
164646890|NCT01160198|594734140|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
164646891|NCT01160198|594734141|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
164646892|NCT01408576|594734142|FG000|Overall Study|Lack of Efficacy|17|||
164646893|NCT01408576|594734143|FG001|Overall Study|Lack of Efficacy|30|||
164646894|NCT01408576|594734144|FG002|Overall Study|Lack of Efficacy|48|||
164646895|NCT01408576|594734142|FG000|Overall Study|Protocol Violation|1|||
164646896|NCT01408576|594734143|FG001|Overall Study|Protocol Violation|2|||
164646897|NCT01408576|594734144|FG002|Overall Study|Protocol Violation|2|||
164646898|NCT01408576|594734142|FG000|Overall Study|Lost to Follow-up|10|||
164646899|NCT01408576|594734143|FG001|Overall Study|Lost to Follow-up|9|||
164646900|NCT01408576|594734144|FG002|Overall Study|Lost to Follow-up|17|||
164646901|NCT01408576|594734142|FG000|Overall Study|Withdrawal by Subject|34|||
164646902|NCT01408576|594734143|FG001|Overall Study|Withdrawal by Subject|60|||
164646903|NCT01408576|594734144|FG002|Overall Study|Withdrawal by Subject|66|||
164646904|NCT01408576|594734142|FG000|Overall Study|Sponsor terminated study|89|||
164646905|NCT01408576|594734143|FG001|Overall Study|Sponsor terminated study|333|||
164646906|NCT01408576|594734144|FG002|Overall Study|Sponsor terminated study|330|||
164646907|NCT01408576|594734142|FG000|Overall Study|AE, serious fatal|4|||
164646908|NCT01408576|594734143|FG001|Overall Study|AE, serious fatal|4|||
164646909|NCT01408576|594734144|FG002|Overall Study|AE, serious fatal|1|||
164646910|NCT01408576|594734142|FG000|Overall Study|SAE, non-fatal|11|||
164646911|NCT01408576|594734143|FG001|Overall Study|SAE, non-fatal|23|||
164646912|NCT01408576|594734144|FG002|Overall Study|SAE, non-fatal|14|||
164646913|NCT01408576|594734142|FG000|Overall Study|AE, non-serious non-fatal|12|||
164646914|NCT01408576|594734143|FG001|Overall Study|AE, non-serious non-fatal|19|||
164646915|NCT01408576|594734144|FG002|Overall Study|AE, non-serious non-fatal|11|||
164646916|NCT01408576|594734142|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
164646917|NCT01408576|594734143|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
164646918|NCT01408576|594734144|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
164646919|NCT01408576|594734142|FG000|Overall Study|AE, unknown type|0|||
164646920|NCT01408576|594734143|FG001|Overall Study|AE, unknown type|1|||
164646921|NCT01408576|594734144|FG002|Overall Study|AE, unknown type|0|||
164646922|NCT01408576|594734142|FG000|Overall Study|Other|10|||
164646923|NCT01408576|594734143|FG001|Overall Study|Other|16|||
164646924|NCT01408576|594734144|FG002|Overall Study|Other|18|||
164646925|NCT00802529|594734145|FG000|Overall Study|Lost to Follow-up|0|||
164646926|NCT00802529|594734146|FG001|Overall Study|Lost to Follow-up|1|||
164646927|NCT00552617|594734149|FG000|Overall Study|Not Treated|0|||
164646928|NCT00552617|594734150|FG001|Overall Study|Not Treated|0|||
164646929|NCT00552617|594734151|FG002|Overall Study|Not Treated|1|||
164646930|NCT00552617|594734152|FG003|Overall Study|Not Treated|0|||
164646931|NCT00552617|594734153|FG004|Overall Study|Not Treated|0|||
164646932|NCT00552617|594734154|FG005|Overall Study|Not Treated|0|||
164646933|NCT00552617|594734155|FG006|Overall Study|Not Treated|0|||
164646934|NCT00552617|594734156|FG007|Overall Study|Not Treated|0|||
164646935|NCT00552617|594734157|FG008|Overall Study|Not Treated|0|||
164646936|NCT00552617|594734158|FG009|Overall Study|Not Treated|1|||
164646937|NCT00552617|594734149|FG000|Overall Study|Lost to Follow-up|0|||
164646938|NCT00552617|594734150|FG001|Overall Study|Lost to Follow-up|0|||
164646939|NCT00552617|594734151|FG002|Overall Study|Lost to Follow-up|0|||
164646940|NCT00552617|594734152|FG003|Overall Study|Lost to Follow-up|1|||
164646941|NCT00552617|594734153|FG004|Overall Study|Lost to Follow-up|0|||
164646942|NCT00552617|594734154|FG005|Overall Study|Lost to Follow-up|2|||
164646943|NCT00552617|594734155|FG006|Overall Study|Lost to Follow-up|0|||
164646944|NCT00552617|594734156|FG007|Overall Study|Lost to Follow-up|0|||
164646945|NCT00552617|594734157|FG008|Overall Study|Lost to Follow-up|2|||
164646946|NCT00552617|594734158|FG009|Overall Study|Lost to Follow-up|0|||
164646947|NCT04651218|594734159|FG000|Overall Study|Withdrawal by Subject|0|||
164646948|NCT04651218|594734160|FG001|Overall Study|Withdrawal by Subject|2|||
164646949|NCT02476851|594734161|FG000|Overall Study|Protocol Violation|1|||
164646950|NCT02476851|594734162|FG001|Overall Study|Protocol Violation|1|||
164646951|NCT01399125|594734165|FG000|Overall Study|Adverse Event|32|||
164646952|NCT01399125|594734166|FG001|Overall Study|Adverse Event|30|||
164646953|NCT01399125|594734165|FG000|Overall Study|Abnormal Lab values|0|||
164646954|NCT01399125|594734166|FG001|Overall Study|Abnormal Lab values|1|||
164646955|NCT01399125|594734165|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
164646956|NCT01399125|594734166|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
164646957|NCT01399125|594734165|FG000|Overall Study|Withdrawal by Subject|5|||
164646958|NCT01399125|594734166|FG001|Overall Study|Withdrawal by Subject|8|||
164646959|NCT01399125|594734165|FG000|Overall Study|Lost to Follow-up|2|||
164646960|NCT01399125|594734166|FG001|Overall Study|Lost to Follow-up|3|||
164646961|NCT01399125|594734165|FG000|Overall Study|Administrative Problems|7|||
164646962|NCT01399125|594734166|FG001|Overall Study|Administrative Problems|11|||
164646963|NCT01399125|594734165|FG000|Overall Study|Death|0|||
164646964|NCT01399125|594734166|FG001|Overall Study|Death|1|||
164646965|NCT01399125|594734165|FG000|Overall Study|Protocol Deviation|5|||
164646966|NCT01399125|594734166|FG001|Overall Study|Protocol Deviation|2|||
164646967|NCT01902134|594734167|FG000|Overall Study|Adverse Event|3|||
164646968|NCT01902134|594734168|FG001|Overall Study|Adverse Event|1|||
164646969|NCT01902134|594734169|FG002|Overall Study|Adverse Event|2|||
164646970|NCT01902134|594734170|FG003|Overall Study|Adverse Event|1|||
164646971|NCT01902134|594734171|FG004|Overall Study|Adverse Event|1|||
164646972|NCT01902134|594734172|FG005|Overall Study|Adverse Event|3|||
164646973|NCT01902134|594734167|FG000|Overall Study|Lack of Efficacy|0|||
164646974|NCT01902134|594734168|FG001|Overall Study|Lack of Efficacy|0|||
164646975|NCT01902134|594734169|FG002|Overall Study|Lack of Efficacy|2|||
164646976|NCT01902134|594734170|FG003|Overall Study|Lack of Efficacy|0|||
164646977|NCT01902134|594734171|FG004|Overall Study|Lack of Efficacy|0|||
164646978|NCT01902134|594734172|FG005|Overall Study|Lack of Efficacy|1|||
164646979|NCT01902134|594734167|FG000|Overall Study|Physician Decision|0|||
164646980|NCT01902134|594734168|FG001|Overall Study|Physician Decision|1|||
164646981|NCT01902134|594734169|FG002|Overall Study|Physician Decision|0|||
164646982|NCT01902134|594734170|FG003|Overall Study|Physician Decision|0|||
164646983|NCT01902134|594734171|FG004|Overall Study|Physician Decision|0|||
164646984|NCT01902134|594734172|FG005|Overall Study|Physician Decision|0|||
164646985|NCT01902134|594734167|FG000|Overall Study|Protocol Violation|0|||
164646986|NCT01902134|594734168|FG001|Overall Study|Protocol Violation|0|||
164646987|NCT01902134|594734169|FG002|Overall Study|Protocol Violation|0|||
164646988|NCT01902134|594734170|FG003|Overall Study|Protocol Violation|0|||
164646989|NCT01902134|594734171|FG004|Overall Study|Protocol Violation|0|||
164646990|NCT01902134|594734172|FG005|Overall Study|Protocol Violation|1|||
164646991|NCT01902134|594734167|FG000|Overall Study|Withdrawal by Subject|4|||
164646992|NCT01902134|594734168|FG001|Overall Study|Withdrawal by Subject|8|||
164646993|NCT01902134|594734169|FG002|Overall Study|Withdrawal by Subject|9|||
164646994|NCT01902134|594734170|FG003|Overall Study|Withdrawal by Subject|1|||
164646995|NCT01902134|594734171|FG004|Overall Study|Withdrawal by Subject|5|||
164646996|NCT01902134|594734172|FG005|Overall Study|Withdrawal by Subject|4|||
164646997|NCT01902134|594734167|FG000|Overall Study|no compliance|1|||
164646998|NCT01902134|594734168|FG001|Overall Study|no compliance|0|||
164646999|NCT01902134|594734169|FG002|Overall Study|no compliance|0|||
164647000|NCT01902134|594734170|FG003|Overall Study|no compliance|0|||
164647001|NCT01902134|594734171|FG004|Overall Study|no compliance|0|||
164647002|NCT01902134|594734172|FG005|Overall Study|no compliance|0|||
164647003|NCT01902134|594734167|FG000|Overall Study|Other|0|||
164647004|NCT01902134|594734168|FG001|Overall Study|Other|1|||
164647005|NCT01902134|594734169|FG002|Overall Study|Other|2|||
164647006|NCT01902134|594734170|FG003|Overall Study|Other|0|||
164647007|NCT01902134|594734171|FG004|Overall Study|Other|1|||
164647008|NCT01902134|594734172|FG005|Overall Study|Other|0|||
164647009|NCT00305110|594734173|FG000|Overall Study|Missing data|29|||
164647010|NCT00337129|594734174|FG000|Overall Study|Adverse Event|4|||
164647011|NCT00337129|594734174|FG000|Overall Study|Withdrawal by Subject|1|||
164647012|NCT00337129|594734174|FG000|Overall Study|Lack of Efficacy|32|||
164647013|NCT00337129|594734174|FG000|Overall Study|Death|2|||
164647014|NCT00337129|594734174|FG000|Overall Study|not protocol specified|1|||
164647015|NCT01272193|594734180|FG000|Overall Study|Adverse Event|1|||
164647016|NCT01272193|594734181|FG001|Overall Study|Adverse Event|1|||
164647017|NCT01272193|594734180|FG000|Overall Study|Lack of Efficacy|0|||
164647018|NCT01272193|594734181|FG001|Overall Study|Lack of Efficacy|3|||
164647019|NCT01272193|594734180|FG000|Overall Study|Withdrawal Criteria|1|||
164647020|NCT01272193|594734181|FG001|Overall Study|Withdrawal Criteria|1|||
164647021|NCT01272193|594734180|FG000|Overall Study|Unclassified|8|||
164647022|NCT01272193|594734181|FG001|Overall Study|Unclassified|7|||
164647023|NCT03578276|594734188|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
164647024|NCT03578276|594734189|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
164647025|NCT02626182|594734190|FG000|Overall Study|Adverse Event|2|||
164647026|NCT02626182|594734191|FG001|Overall Study|Adverse Event|0|||
164647027|NCT01084603|594734196|FG000|Baseline|Withdrawal by Subject|2|||
164647028|NCT01084603|594734196|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
164647029|NCT01084603|594734196|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
164647030|NCT01084603|594734196|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
164647031|NCT01084603|594734196|FG000|Washout Period 4|Adverse Event|1|||
164647032|NCT02766088|594734198|FG000|Overall Study|Sponsor study termination|498|||
164647033|NCT02766088|594734198|FG000|Overall Study|Migrated/moved from the study area|1|||
164647034|NCT02766088|594734198|FG000|Overall Study|Lost to Follow-up|5|||
164647035|NCT02766088|594734198|FG000|Overall Study|Other|1|||
164647036|NCT02766088|594734198|FG000|Overall Study|Death|1|||
164647037|NCT02360397|594734199|FG000|Overall Study|Incomplete screening|3|||
164647038|NCT02360397|594734199|FG000|Overall Study|Adverse Event|1|||
164647039|NCT01508325|594734200|FG000|Overall Study|Withdrawal by Subject|8|||
164647040|NCT01508325|594734201|FG001|Overall Study|Withdrawal by Subject|9|||
164647041|NCT01508325|594734200|FG000|Overall Study|Protocol Violation|0|||
164647042|NCT01508325|594734201|FG001|Overall Study|Protocol Violation|3|||
164647043|NCT01508325|594734200|FG000|Overall Study|Physician Decision|2|||
164647044|NCT01508325|594734201|FG001|Overall Study|Physician Decision|1|||
164647045|NCT01508325|594734200|FG000|Overall Study|Adverse Event|1|||
164647046|NCT01508325|594734201|FG001|Overall Study|Adverse Event|0|||
164647047|NCT01508325|594734200|FG000|Overall Study|Lost to Follow-up|5|||
164647048|NCT01508325|594734201|FG001|Overall Study|Lost to Follow-up|6|||
164647049|NCT01508325|594734200|FG000|Overall Study|Other|2|||
164647050|NCT01508325|594734201|FG001|Overall Study|Other|2|||
164647051|NCT00763269|594734208|FG000|Overall Study|Lost to Follow-up|12|||
164647052|NCT00763269|594734209|FG001|Overall Study|Lost to Follow-up|13|||
164647053|NCT03543046|594734210|FG000|Overall Study|Adverse Event|1|||
164647054|NCT03543046|594734211|FG001|Overall Study|Adverse Event|1|||
164647055|NCT03543046|594734210|FG000|Overall Study|Physician Decision|1|||
164647056|NCT03543046|594734211|FG001|Overall Study|Physician Decision|1|||
164647057|NCT03543046|594734210|FG000|Overall Study|Protocol Violation|1|||
164647058|NCT03543046|594734211|FG001|Overall Study|Protocol Violation|0|||
164647059|NCT04936334|594734214|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
164647060|NCT04057118|594734217|FG000|Overall Study|Adverse Event|1|||
164647061|NCT04057118|594734218|FG001|Overall Study|Adverse Event|0|||
164647062|NCT04057118|594734219|FG002|Overall Study|Adverse Event|1|||
164647063|NCT04057118|594734220|FG003|Overall Study|Adverse Event|1|||
164647064|NCT04057118|594734217|FG000|Overall Study|Physician Decision|0|||
164647065|NCT04057118|594734218|FG001|Overall Study|Physician Decision|0|||
164647066|NCT04057118|594734219|FG002|Overall Study|Physician Decision|1|||
164647067|NCT04057118|594734220|FG003|Overall Study|Physician Decision|1|||
164647068|NCT04057118|594734217|FG000|Overall Study|Withdrawal by Subject|2|||
164647069|NCT04057118|594734218|FG001|Overall Study|Withdrawal by Subject|2|||
164647070|NCT04057118|594734219|FG002|Overall Study|Withdrawal by Subject|0|||
164647071|NCT04057118|594734220|FG003|Overall Study|Withdrawal by Subject|2|||
164647072|NCT04057118|594734217|FG000|Overall Study|Not Specific|0|||
164647073|NCT04057118|594734218|FG001|Overall Study|Not Specific|0|||
164647074|NCT04057118|594734219|FG002|Overall Study|Not Specific|1|||
164647075|NCT04057118|594734220|FG003|Overall Study|Not Specific|1|||
164647076|NCT03402126|594734221|FG000|Overall Study|Lost to Follow-up|6|||
164647077|NCT03402126|594734221|FG000|Overall Study|Protocol Violation|10|||
164647078|NCT03402126|594734221|FG000|Overall Study|Sponsor request/Study termination|29|||
164647079|NCT03402126|594734221|FG000|Overall Study|Study product no longer in use|1|||
164647080|NCT03402126|594734221|FG000|Overall Study|Technical problems|1|||
164647081|NCT03402126|594734221|FG000|Overall Study|Withdrawal by Subject|6|||
164647082|NCT03402126|594734221|FG000|Overall Study|Physician Decision|2|||
164647083|NCT03402126|594734221|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
164647084|NCT03402126|594734221|FG000|Overall Study|Death|4|||
164647085|NCT01347879|594734222|FG000|Overall Study|Adverse Event|0|||
164647086|NCT01347879|594734223|FG001|Overall Study|Adverse Event|12|||
164647087|NCT01347879|594734222|FG000|Overall Study|Lost to Follow-up|2|||
164647088|NCT01347879|594734223|FG001|Overall Study|Lost to Follow-up|0|||
164647089|NCT01347879|594734222|FG000|Overall Study|Withdrawal by Subject|3|||
164647090|NCT01347879|594734223|FG001|Overall Study|Withdrawal by Subject|2|||
164647091|NCT01347879|594734222|FG000|Overall Study|Other|2|||
164647092|NCT01347879|594734223|FG001|Overall Study|Other|3|||
164647093|NCT03747939|594734224|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
164647094|NCT03747939|594734225|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
164647095|NCT03747939|594734226|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
164647096|NCT03747939|594734227|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
164647097|NCT03747939|594734224|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
164647098|NCT03747939|594734225|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
164647099|NCT03747939|594734226|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
164647100|NCT03747939|594734227|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
164647101|NCT03747939|594734224|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
164647102|NCT03747939|594734225|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
164647103|NCT03747939|594734226|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
164647104|NCT03747939|594734227|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
164647105|NCT03747939|594734224|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
164647106|NCT03747939|594734225|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
164647107|NCT03747939|594734226|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
164647108|NCT03747939|594734227|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
164647109|NCT03747939|594734224|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
164647110|NCT03747939|594734225|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
164647111|NCT03747939|594734226|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
164647112|NCT03747939|594734227|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
164647113|NCT03747939|594734224|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
164647114|NCT03747939|594734225|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
164647115|NCT03747939|594734226|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
164647116|NCT03747939|594734227|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
164647117|NCT03747939|594734224|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
164647118|NCT03747939|594734225|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
164647119|NCT03747939|594734226|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
164647120|NCT03747939|594734227|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
164647121|NCT03747939|594734224|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
164647122|NCT03747939|594734225|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
164647123|NCT03747939|594734226|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
164647124|NCT03747939|594734227|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
164647125|NCT03747939|594734224|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
164647126|NCT03747939|594734225|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
164647127|NCT03747939|594734226|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
164647128|NCT03747939|594734227|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
164647129|NCT03747939|594734224|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
164647130|NCT03747939|594734225|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
164647131|NCT03747939|594734226|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
164647132|NCT03747939|594734227|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
164647133|NCT03747939|594734224|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
164647134|NCT03747939|594734225|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
164647135|NCT03747939|594734226|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
164647136|NCT03747939|594734227|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
164647137|NCT03747939|594734224|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
164647138|NCT03747939|594734225|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
164647139|NCT03747939|594734226|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
164647140|NCT03747939|594734227|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
164647141|NCT03747939|594734224|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
164647142|NCT03747939|594734225|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
164647143|NCT03747939|594734226|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
164647144|NCT03747939|594734227|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
164647145|NCT03747939|594734224|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
164647146|NCT03747939|594734225|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
164647147|NCT03747939|594734226|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
164647148|NCT03747939|594734227|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
164647149|NCT03273712|594734228|FG000|Overall Study|Death|5|||
164647150|NCT03273712|594734228|FG000|Overall Study|Adverse Event|1|||
164647151|NCT03273712|594734228|FG000|Overall Study|Disease Progression|1|||
164647152|NCT03959137|594734231|FG000|Overall Study|Protocol Violation|6|||
164647153|NCT01542736|594734233|FG000|Overall Study|Death|1|||
164647154|NCT03674827|594734234|FG000|Treatment Phase|Adverse Event|0|||
164647155|NCT03674827|594734235|FG001|Treatment Phase|Adverse Event|0|||
164647156|NCT03674827|594734236|FG002|Treatment Phase|Adverse Event|0|||
164647157|NCT03674827|594734237|FG003|Treatment Phase|Adverse Event|0|||
164647158|NCT03674827|594734238|FG004|Treatment Phase|Adverse Event|0|||
164647159|NCT03674827|594734239|FG005|Treatment Phase|Adverse Event|2|||
164647160|NCT03674827|594734234|FG000|Treatment Phase|Death|2|||
164647161|NCT03674827|594734235|FG001|Treatment Phase|Death|0|||
164647162|NCT03674827|594734236|FG002|Treatment Phase|Death|0|||
164647163|NCT03674827|594734237|FG003|Treatment Phase|Death|0|||
164647164|NCT03674827|594734238|FG004|Treatment Phase|Death|1|||
164647165|NCT03674827|594734239|FG005|Treatment Phase|Death|0|||
164647166|NCT03674827|594734234|FG000|Treatment Phase|Progressive Disease|0|||
164647167|NCT03674827|594734235|FG001|Treatment Phase|Progressive Disease|4|||
164647168|NCT03674827|594734236|FG002|Treatment Phase|Progressive Disease|3|||
164647169|NCT03674827|594734237|FG003|Treatment Phase|Progressive Disease|4|||
164647170|NCT03674827|594734238|FG004|Treatment Phase|Progressive Disease|4|||
164647171|NCT03674827|594734239|FG005|Treatment Phase|Progressive Disease|9|||
164647172|NCT03674827|594734234|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
164647173|NCT03674827|594734235|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
164647174|NCT03674827|594734236|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
164647175|NCT03674827|594734237|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
164647176|NCT03674827|594734238|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
164647177|NCT03674827|594734239|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
164647178|NCT03674827|594734234|FG000|Treatment Phase|Withdrawal by Subject|0|||
164647179|NCT03674827|594734235|FG001|Treatment Phase|Withdrawal by Subject|0|||
164647180|NCT03674827|594734236|FG002|Treatment Phase|Withdrawal by Subject|0|||
164647181|NCT03674827|594734237|FG003|Treatment Phase|Withdrawal by Subject|0|||
164647182|NCT03674827|594734238|FG004|Treatment Phase|Withdrawal by Subject|0|||
164647183|NCT03674827|594734239|FG005|Treatment Phase|Withdrawal by Subject|1|||
164647184|NCT03674827|594734234|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
164647185|NCT03674827|594734235|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
164647186|NCT03674827|594734236|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
164647187|NCT03674827|594734237|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
164647188|NCT03674827|594734238|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
164647189|NCT03674827|594734239|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
164647190|NCT03674827|594734234|FG000|Treatment Phase|Other|0|||
164647191|NCT03674827|594734235|FG001|Treatment Phase|Other|1|||
164647192|NCT03674827|594734236|FG002|Treatment Phase|Other|0|||
164647193|NCT03674827|594734237|FG003|Treatment Phase|Other|0|||
164647194|NCT03674827|594734238|FG004|Treatment Phase|Other|0|||
164647195|NCT03674827|594734239|FG005|Treatment Phase|Other|1|||
164647196|NCT03674827|594734234|FG000|Long-Term Follow-up Phase|Death|2|||
164647197|NCT03674827|594734235|FG001|Long-Term Follow-up Phase|Death|4|||
164647198|NCT03674827|594734236|FG002|Long-Term Follow-up Phase|Death|2|||
164647199|NCT03674827|594734237|FG003|Long-Term Follow-up Phase|Death|3|||
164647200|NCT03674827|594734238|FG004|Long-Term Follow-up Phase|Death|2|||
164647201|NCT03674827|594734239|FG005|Long-Term Follow-up Phase|Death|6|||
164647202|NCT03674827|594734234|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
164647203|NCT03674827|594734235|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
164647204|NCT03674827|594734236|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
164647205|NCT03674827|594734237|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
164647206|NCT03674827|594734238|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
164647207|NCT03674827|594734239|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
164647208|NCT03674827|594734234|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
164647209|NCT03674827|594734235|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
164647210|NCT03674827|594734236|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
164647211|NCT03674827|594734237|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
164647212|NCT03674827|594734238|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
164647213|NCT03674827|594734239|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
164647214|NCT00363129|594734240|FG000|Overall Study|Withdrawal by Subject|11|||
164647215|NCT00363129|594734241|FG001|Overall Study|Withdrawal by Subject|18|||
164647216|NCT00363129|594734240|FG000|Overall Study|Adverse Event|8|||
164647217|NCT00363129|594734241|FG001|Overall Study|Adverse Event|3|||
164647218|NCT00363129|594734240|FG000|Overall Study|Alternate Treatment|2|||
164647219|NCT00363129|594734241|FG001|Overall Study|Alternate Treatment|4|||
164647220|NCT00363129|594734240|FG000|Overall Study|Other Medical Problems|2|||
164647221|NCT00363129|594734241|FG001|Overall Study|Other Medical Problems|4|||
164647222|NCT00363129|594734240|FG000|Overall Study|Death|0|||
164647223|NCT00363129|594734241|FG001|Overall Study|Death|1|||
164647224|NCT00363129|594734240|FG000|Overall Study|Other Reasons|6|||
164647225|NCT00363129|594734241|FG001|Overall Study|Other Reasons|3|||
164647226|NCT00420849|594734242|FG000|Overall Study|Lack of Efficacy|154|||
164647227|NCT00420849|594734242|FG000|Overall Study|Adverse Event|107|||
164647228|NCT00420849|594734242|FG000|Overall Study|Withdrawal by Subject|28|||
164647229|NCT00420849|594734242|FG000|Overall Study|Death|18|||
164647230|NCT00420849|594734242|FG000|Overall Study|Other|14|||
164647231|NCT00420849|594734242|FG000|Overall Study|Transplant|8|||
164647232|NCT00420849|594734242|FG000|Overall Study|Protocol Violation|1|||
164647233|NCT00420849|594734242|FG000|Overall Study|Lost to Follow-up|1|||
164647234|NCT01345058|594734243|FG000|Overall Study|Withdrawal by Subject|1|||
164647235|NCT01345058|594734244|FG001|Overall Study|Withdrawal by Subject|0|||
164647236|NCT01345058|594734243|FG000|Overall Study|Participant Reported Increase in Events|1|||
164647237|NCT01345058|594734244|FG001|Overall Study|Participant Reported Increase in Events|0|||
164647238|NCT01345058|594734243|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
164647239|NCT01345058|594734244|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
164647240|NCT01345058|594734243|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
164647241|NCT01345058|594734244|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
164647242|NCT01345058|594734243|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
164647243|NCT01345058|594734244|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
164647244|NCT01892020|594734246|FG000|Period 1|Adverse Event|1|||
164647245|NCT01892020|594734247|FG001|Period 1|Adverse Event|1|||
164647246|NCT01892020|594734246|FG000|Period 1|Protocol Violation|2|||
164647247|NCT01892020|594734247|FG001|Period 1|Protocol Violation|4|||
164647248|NCT01892020|594734246|FG000|Period 1|Unclassified|0|||
164647249|NCT01892020|594734247|FG001|Period 1|Unclassified|1|||
164647250|NCT01892020|594734246|FG000|Period 2|Protocol Violation|1|||
164647251|NCT01892020|594734247|FG001|Period 2|Protocol Violation|0|||
164647252|NCT02149199|594734252|FG000|Overall Study|Study specific withdrawal criteria|4|||
164647253|NCT02149199|594734253|FG001|Overall Study|Study specific withdrawal criteria|21|||
164647254|NCT02149199|594734254|FG002|Overall Study|Study specific withdrawal criteria|6|||
164647255|NCT02149199|594734252|FG000|Overall Study|Other|20|||
164647256|NCT02149199|594734253|FG001|Overall Study|Other|25|||
164647257|NCT02149199|594734254|FG002|Overall Study|Other|20|||
164647258|NCT02149199|594734252|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
164647259|NCT02149199|594734253|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
164647260|NCT02149199|594734254|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
164647261|NCT02149199|594734252|FG000|Overall Study|Withdrawal by Subject|75|||
164647262|NCT02149199|594734253|FG001|Overall Study|Withdrawal by Subject|93|||
164647263|NCT02149199|594734254|FG002|Overall Study|Withdrawal by Subject|77|||
164647264|NCT02149199|594734252|FG000|Overall Study|Protocol Violation|16|||
164647265|NCT02149199|594734253|FG001|Overall Study|Protocol Violation|13|||
164647266|NCT02149199|594734254|FG002|Overall Study|Protocol Violation|15|||
164647267|NCT02149199|594734252|FG000|Overall Study|Lost to Follow-up|3|||
164647268|NCT02149199|594734253|FG001|Overall Study|Lost to Follow-up|12|||
164647269|NCT02149199|594734254|FG002|Overall Study|Lost to Follow-up|11|||
164647270|NCT02149199|594734252|FG000|Overall Study|Death|0|||
164647271|NCT02149199|594734253|FG001|Overall Study|Death|0|||
164647272|NCT02149199|594734254|FG002|Overall Study|Death|1|||
164647273|NCT02149199|594734252|FG000|Overall Study|Adverse Event|6|||
164647274|NCT02149199|594734253|FG001|Overall Study|Adverse Event|15|||
164647275|NCT02149199|594734254|FG002|Overall Study|Adverse Event|9|||
164647276|NCT01915498|594734257|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
164647277|NCT01915498|594734258|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
164647278|NCT01915498|594734259|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
164647279|NCT01915498|594734260|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
164647280|NCT01915498|594734261|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
164647281|NCT01915498|594734262|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
164647282|NCT01915498|594734263|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
164647283|NCT01915498|594734264|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
164647284|NCT01915498|594734265|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
164647285|NCT01915498|594734266|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
164647286|NCT01915498|594734267|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
164647287|NCT01915498|594734268|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
164647288|NCT01915498|594734269|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
164647289|NCT01915498|594734270|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
164647290|NCT01915498|594734271|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
164647291|NCT01915498|594734272|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
164647292|NCT01915498|594734273|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
164647293|NCT01915498|594734274|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
164647294|NCT01915498|594734275|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
164647295|NCT01915498|594734257|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
164647296|NCT01915498|594734258|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
164647297|NCT01915498|594734259|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
164647298|NCT01915498|594734260|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
164647299|NCT01915498|594734261|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
164647300|NCT01915498|594734262|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
164647301|NCT01915498|594734263|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
164647302|NCT01915498|594734264|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
164647303|NCT01915498|594734265|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
164647304|NCT01915498|594734266|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
164647305|NCT01915498|594734267|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
164647306|NCT01915498|594734268|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
164647307|NCT01915498|594734269|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
164647308|NCT01915498|594734270|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
164647309|NCT01915498|594734271|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
164647310|NCT01915498|594734272|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
164647311|NCT01915498|594734273|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
164647312|NCT01915498|594734274|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
164647313|NCT01915498|594734275|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
164647314|NCT01915498|594734257|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
164647315|NCT01915498|594734258|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164647316|NCT01915498|594734259|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164647317|NCT01915498|594734260|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164647318|NCT01915498|594734261|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164647319|NCT01915498|594734262|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
164647320|NCT01915498|594734263|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164647321|NCT01915498|594734264|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164647322|NCT01915498|594734265|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164647323|NCT01915498|594734266|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164647324|NCT01915498|594734267|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164647325|NCT01915498|594734268|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164647326|NCT01915498|594734269|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164647327|NCT01915498|594734270|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164647328|NCT01915498|594734271|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
164647329|NCT01915498|594734272|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164647330|NCT01915498|594734273|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164647331|NCT01915498|594734274|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
164647332|NCT01915498|594734275|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164647333|NCT01915498|594734257|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164647334|NCT01915498|594734258|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164647335|NCT01915498|594734259|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164647336|NCT01915498|594734260|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164647337|NCT01915498|594734261|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164647338|NCT01915498|594734262|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164647339|NCT01915498|594734263|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164647340|NCT01915498|594734264|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164647341|NCT01915498|594734265|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164647342|NCT01915498|594734266|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164647343|NCT01915498|594734267|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
164647344|NCT01915498|594734268|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164647345|NCT01915498|594734269|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164647346|NCT01915498|594734270|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
164647347|NCT01915498|594734271|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164647348|NCT01915498|594734272|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164647349|NCT01915498|594734273|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
164647350|NCT01915498|594734274|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
164647351|NCT01915498|594734275|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164647352|NCT01915498|594734257|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
164647353|NCT01915498|594734258|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
164647354|NCT01915498|594734259|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
164647355|NCT01915498|594734260|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
164647356|NCT01915498|594734261|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
164647357|NCT01915498|594734262|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
164647358|NCT01915498|594734263|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
164647359|NCT01915498|594734264|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
164647360|NCT01915498|594734265|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
164647361|NCT01915498|594734266|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
164647362|NCT01915498|594734267|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
164647363|NCT01915498|594734268|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
164647364|NCT01915498|594734269|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
164647365|NCT01915498|594734270|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
164647366|NCT01915498|594734271|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
164647367|NCT01915498|594734272|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
164647368|NCT01915498|594734273|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
164647369|NCT01915498|594734274|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
164647370|NCT01915498|594734275|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
164647371|NCT01915498|594734257|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
164647372|NCT01915498|594734258|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
164647373|NCT01915498|594734259|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
164647374|NCT01915498|594734260|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
164647375|NCT01915498|594734261|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
164647376|NCT01915498|594734262|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
164647377|NCT01915498|594734263|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
164647378|NCT01915498|594734264|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
164647379|NCT01915498|594734265|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
164647380|NCT01915498|594734266|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
164647381|NCT01915498|594734267|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
164647382|NCT01915498|594734268|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
164647383|NCT01915498|594734269|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
164647384|NCT01915498|594734270|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
164647385|NCT01915498|594734271|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
164647386|NCT01915498|594734272|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
164647387|NCT01915498|594734273|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
164647388|NCT01915498|594734274|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
164647389|NCT01915498|594734275|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
164647390|NCT01915498|594734257|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164647391|NCT01915498|594734258|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164647392|NCT01915498|594734259|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164647393|NCT01915498|594734260|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164647394|NCT01915498|594734261|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
164647395|NCT01915498|594734262|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164647396|NCT01915498|594734263|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164647397|NCT01915498|594734264|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164647398|NCT01915498|594734265|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164647399|NCT01915498|594734266|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
164647400|NCT01915498|594734267|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164647401|NCT01915498|594734268|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164647402|NCT01915498|594734269|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164647403|NCT01915498|594734270|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164647404|NCT01915498|594734271|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164647405|NCT01915498|594734272|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164647406|NCT01915498|594734273|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164647407|NCT01915498|594734274|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164647408|NCT01915498|594734275|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164647409|NCT01915498|594734257|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
164647410|NCT01915498|594734258|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
164647411|NCT01915498|594734259|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
164647412|NCT01915498|594734260|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
164647413|NCT01915498|594734261|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
164647414|NCT01915498|594734262|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
164647415|NCT01915498|594734263|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
164647416|NCT01915498|594734264|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
164647417|NCT01915498|594734265|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
164647418|NCT01915498|594734266|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
164647419|NCT01915498|594734267|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
164647420|NCT01915498|594734268|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
164647421|NCT01915498|594734269|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
164647422|NCT01915498|594734270|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
164647423|NCT01915498|594734271|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
164647424|NCT01915498|594734272|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
164647425|NCT01915498|594734273|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
164647426|NCT01915498|594734274|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
164647427|NCT01915498|594734275|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
164647428|NCT01915498|594734257|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164647429|NCT01915498|594734258|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164647430|NCT01915498|594734259|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164647431|NCT01915498|594734260|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164647432|NCT01915498|594734261|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164647433|NCT01915498|594734262|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164647434|NCT01915498|594734263|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164647435|NCT01915498|594734264|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164647436|NCT01915498|594734265|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164647437|NCT01915498|594734266|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164647438|NCT01915498|594734267|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
164647439|NCT01915498|594734268|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164647440|NCT01915498|594734269|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164647441|NCT01915498|594734270|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164647442|NCT01915498|594734271|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164647443|NCT01915498|594734272|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164647444|NCT01915498|594734273|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164647445|NCT01915498|594734274|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164647446|NCT01915498|594734275|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164647447|NCT01915498|594734257|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
164647448|NCT01915498|594734258|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
164647449|NCT01915498|594734259|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
164647450|NCT01915498|594734260|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
164647451|NCT01915498|594734261|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
164647452|NCT01915498|594734262|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
164647453|NCT01915498|594734263|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
164647454|NCT01915498|594734264|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
164647455|NCT01915498|594734265|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
164647456|NCT01915498|594734266|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
164647457|NCT01915498|594734267|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
164647458|NCT01915498|594734268|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
164647459|NCT01915498|594734269|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
164647460|NCT01915498|594734270|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
164647461|NCT01915498|594734271|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
164647462|NCT01915498|594734272|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
164647463|NCT01915498|594734273|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
164647464|NCT01915498|594734274|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
164647465|NCT01915498|594734275|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
164647466|NCT01915498|594734257|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
164647467|NCT01915498|594734258|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
164647468|NCT01915498|594734259|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
164647469|NCT01915498|594734260|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
164647470|NCT01915498|594734261|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
164647471|NCT01915498|594734262|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
164647472|NCT01915498|594734263|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
164647473|NCT01915498|594734264|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
164647474|NCT01915498|594734265|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
164647475|NCT01915498|594734266|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
164647476|NCT01915498|594734267|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
164647477|NCT01915498|594734268|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
164647478|NCT01915498|594734269|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
164647479|NCT01915498|594734270|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
164647480|NCT01915498|594734271|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
164647481|NCT01915498|594734272|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
164647482|NCT01915498|594734273|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
164647483|NCT01915498|594734274|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
164647484|NCT01915498|594734275|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
164647485|NCT01915498|594734257|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164647486|NCT01915498|594734258|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164647487|NCT01915498|594734259|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164647488|NCT01915498|594734260|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164647489|NCT01915498|594734261|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164647490|NCT01915498|594734262|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164647491|NCT01915498|594734263|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164647492|NCT01915498|594734264|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164647493|NCT01915498|594734265|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164647494|NCT01915498|594734266|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164647495|NCT01915498|594734267|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164647496|NCT01915498|594734268|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164647497|NCT01915498|594734269|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164647498|NCT01915498|594734270|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164647499|NCT01915498|594734271|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164647500|NCT01915498|594734272|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164647501|NCT01915498|594734273|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164647502|NCT01915498|594734274|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164647503|NCT01915498|594734275|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
164647504|NCT01915498|594734257|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164647505|NCT01915498|594734258|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164647506|NCT01915498|594734259|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164647507|NCT01915498|594734260|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164647508|NCT01915498|594734261|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164647509|NCT01915498|594734262|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164647510|NCT01915498|594734263|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164647511|NCT01915498|594734264|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164647512|NCT01915498|594734265|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164647513|NCT01915498|594734266|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164647514|NCT01915498|594734267|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164647515|NCT01915498|594734268|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164647516|NCT01915498|594734269|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164647517|NCT01915498|594734270|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164647518|NCT01915498|594734271|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164647519|NCT01915498|594734272|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164647520|NCT01915498|594734273|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164647521|NCT01915498|594734274|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164647522|NCT01915498|594734275|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
164647523|NCT01915498|594734257|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164647524|NCT01915498|594734258|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164647525|NCT01915498|594734259|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164647526|NCT01915498|594734260|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164647527|NCT01915498|594734261|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164647528|NCT01915498|594734262|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164647529|NCT01915498|594734263|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164647530|NCT01915498|594734264|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164647531|NCT01915498|594734265|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164647532|NCT01915498|594734266|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164647533|NCT01915498|594734267|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164647534|NCT01915498|594734268|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164647535|NCT01915498|594734269|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164647536|NCT01915498|594734270|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164647537|NCT01915498|594734271|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164647538|NCT01915498|594734272|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164647539|NCT01915498|594734273|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164647540|NCT01915498|594734274|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164647541|NCT01915498|594734275|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
164647542|NCT00314262|594734281|FG000|Overall Study|Adverse Event|2|||
164647543|NCT00314262|594734281|FG000|Overall Study|Withdrawal by Subject|2|||
164647544|NCT00314262|594734281|FG000|Overall Study|Physician Decision|1|||
164647545|NCT01185639|594734282|FG000|Overall Study|Progressed and didn't receive therapy|2|||
164647546|NCT02662556|594734283|FG000|Overall Study|Adverse Event|4|||
164647547|NCT02662556|594734283|FG000|Overall Study|Lack of Efficacy|4|||
164647548|NCT03703297|594734284|FG000|Overall Study|Death|115|||
164647549|NCT03703297|594734285|FG001|Overall Study|Death|0|||
164647550|NCT03703297|594734286|FG002|Overall Study|Death|144|||
164647551|NCT03703297|594734284|FG000|Overall Study|Withdrawal by Subject|9|||
164647552|NCT03703297|594734285|FG001|Overall Study|Withdrawal by Subject|0|||
164647553|NCT03703297|594734286|FG002|Overall Study|Withdrawal by Subject|11|||
164647554|NCT03703297|594734284|FG000|Overall Study|Ongoing at the time of DCO|140|||
164647555|NCT03703297|594734285|FG001|Overall Study|Ongoing at the time of DCO|200|||
164647556|NCT03703297|594734286|FG002|Overall Study|Ongoing at the time of DCO|111|||
164148628|NCT04895982|592904912|FG001|Overall Study|Lost to Follow-up|0|||
164148629|NCT04895982|592904913|FG002|Overall Study|Lost to Follow-up|1|||
164148630|NCT04895982|592904914|FG003|Overall Study|Lost to Follow-up|0|||
164148631|NCT04895982|592904915|FG004|Overall Study|Lost to Follow-up|0|||
164148632|NCT04895982|592904916|FG005|Overall Study|Lost to Follow-up|1|||
164148633|NCT04895982|592904917|FG006|Overall Study|Lost to Follow-up|0|||
164148634|NCT04895982|592904918|FG007|Overall Study|Lost to Follow-up|0|||
164148635|NCT04895982|592904919|FG008|Overall Study|Lost to Follow-up|1|||
164148636|NCT04895982|592904920|FG009|Overall Study|Lost to Follow-up|0|||
164148637|NCT04895982|592904921|FG010|Overall Study|Lost to Follow-up|0|||
164148638|NCT04895982|592904922|FG011|Overall Study|Lost to Follow-up|0|||
164148719|NCT03207867|592904948|FG012|Overall Study|Physician Decision|0|||
164148720|NCT03207867|592904949|FG013|Overall Study|Physician Decision|0|||
164148721|NCT03207867|592904950|FG014|Overall Study|Physician Decision|2|||
164148722|NCT03207867|592904951|FG015|Overall Study|Physician Decision|1|||
164148723|NCT03207867|592904952|FG016|Overall Study|Physician Decision|1|||
164148724|NCT03207867|592904953|FG017|Overall Study|Physician Decision|2|||
164148725|NCT03207867|592904954|FG018|Overall Study|Physician Decision|1|||
164148726|NCT03207867|592904955|FG019|Overall Study|Physician Decision|3|||
164148727|NCT03207867|592904956|FG020|Overall Study|Physician Decision|0|||
164148728|NCT03207867|592904957|FG021|Overall Study|Physician Decision|0|||
164148729|NCT03207867|592904958|FG022|Overall Study|Physician Decision|0|||
164148730|NCT03207867|592904959|FG023|Overall Study|Physician Decision|0|||
164148731|NCT03207867|592904936|FG000|Overall Study|Progressive Disease|7|||
164148732|NCT03207867|592904937|FG001|Overall Study|Progressive Disease|7|||
164148733|NCT03207867|592904938|FG002|Overall Study|Progressive Disease|9|||
164148734|NCT03207867|592904939|FG003|Overall Study|Progressive Disease|10|||
164148735|NCT03207867|592904940|FG004|Overall Study|Progressive Disease|11|||
164148736|NCT03207867|592904941|FG005|Overall Study|Progressive Disease|10|||
164148737|NCT03207867|592904942|FG006|Overall Study|Progressive Disease|9|||
164148738|NCT03207867|592904943|FG007|Overall Study|Progressive Disease|8|||
164148739|NCT03207867|592904944|FG008|Overall Study|Progressive Disease|19|||
164142616|NCT05833139|592884355|FG000|Study Period 2|Adverse Event|1|||
164142827|NCT02794246|592884390|FG000|Overall Study|Withdrawal by Subject|2|||
164142828|NCT02794246|592884390|FG000|Overall Study|Physician Decision|4|||
164142987|NCT00863772|592884484|FG000|Overall Study|Adverse Event|1|||
164142988|NCT00863772|592884485|FG001|Overall Study|Adverse Event|4|||
164142989|NCT00863772|592884486|FG002|Overall Study|Adverse Event|0|||
164142990|NCT00863772|592884484|FG000|Overall Study|Lack of Efficacy|4|||
164142991|NCT00863772|592884485|FG001|Overall Study|Lack of Efficacy|2|||
164142992|NCT00863772|592884486|FG002|Overall Study|Lack of Efficacy|4|||
164142999|NCT00863772|592884484|FG000|Overall Study|Withdrawal by Subject|4|||
164143000|NCT00863772|592884485|FG001|Overall Study|Withdrawal by Subject|7|||
164143001|NCT00863772|592884486|FG002|Overall Study|Withdrawal by Subject|5|||
164143002|NCT00863772|592884484|FG000|Overall Study|Study terminated by sponsor|44|||
164143003|NCT00863772|592884485|FG001|Overall Study|Study terminated by sponsor|45|||
164143004|NCT00863772|592884486|FG002|Overall Study|Study terminated by sponsor|36|||
164143005|NCT00863772|592884484|FG000|Overall Study|Entered extension study|6|||
164143006|NCT00863772|592884485|FG001|Overall Study|Entered extension study|4|||
164143007|NCT00863772|592884486|FG002|Overall Study|Entered extension study|9|||
164143008|NCT00863772|592884484|FG000|Overall Study|Other|1|||
164143009|NCT00863772|592884485|FG001|Overall Study|Other|2|||
164143010|NCT00863772|592884486|FG002|Overall Study|Other|4|||
164143011|NCT00863772|592884484|FG000|Overall Study|Randomized but not Treated|1|||
164143012|NCT00863772|592884485|FG001|Overall Study|Randomized but not Treated|0|||
164143013|NCT00863772|592884486|FG002|Overall Study|Randomized but not Treated|0|||
164143014|NCT00205803|592884491|FG000|Infant Series|Lost to Follow-up|10|||
164143015|NCT00205803|592884492|FG001|Infant Series|Lost to Follow-up|4|||
164143016|NCT00205803|592884491|FG000|Infant Series|Withdrawal by Subject|2|||
164143017|NCT00205803|592884492|FG001|Infant Series|Withdrawal by Subject|5|||
164143018|NCT00205803|592884491|FG000|Infant Series|Physician Decision|3|||
164143019|NCT00205803|592884492|FG001|Infant Series|Physician Decision|1|||
164143020|NCT00205803|592884491|FG000|Infant Series|Protocol Violation|1|||
164143021|NCT00205803|592884492|FG001|Infant Series|Protocol Violation|0|||
164143022|NCT00205803|592884491|FG000|Infant Series|Lost Kaiser coverage|0|||
164143023|NCT00205803|592884492|FG001|Infant Series|Lost Kaiser coverage|1|||
164143024|NCT00205803|592884491|FG000|Infant Series|Non-compliant|1|||
164143025|NCT00205803|592884492|FG001|Infant Series|Non-compliant|0|||
164143026|NCT00205803|592884491|FG000|Infant Series|Sponsor request|1|||
164143027|NCT00205803|592884492|FG001|Infant Series|Sponsor request|0|||
164143028|NCT00205803|592884491|FG000|After Infant Series|Adverse Event|1|||
164143029|NCT00205803|592884492|FG001|After Infant Series|Adverse Event|1|||
164143030|NCT00205803|592884491|FG000|After Infant Series|Protocol Violation|1|||
164143031|NCT00205803|592884492|FG001|After Infant Series|Protocol Violation|1|||
164143032|NCT00205803|592884491|FG000|After Infant Series|Lost to Follow-up|2|||
164143033|NCT00205803|592884492|FG001|After Infant Series|Lost to Follow-up|1|||
164143034|NCT00205803|592884491|FG000|After Infant Series|Physician Decision|3|||
164143035|NCT00205803|592884492|FG001|After Infant Series|Physician Decision|2|||
164143036|NCT00205803|592884491|FG000|After Infant Series|Withdrawal by Subject|1|||
164143037|NCT00205803|592884492|FG001|After Infant Series|Withdrawal by Subject|4|||
164143038|NCT00205803|592884491|FG000|After Infant Series|Other|10|||
164143039|NCT00205803|592884492|FG001|After Infant Series|Other|4|||
164143040|NCT00205803|592884491|FG000|Toddler Dose|Lost to Follow-up|2|||
164143041|NCT00205803|592884492|FG001|Toddler Dose|Lost to Follow-up|3|||
164143042|NCT05038800|592884494|FG000|Overall Study|Death|1|||
164143043|NCT05038800|592884495|FG001|Overall Study|Death|1|||
164143044|NCT05038800|592884496|FG002|Overall Study|Death|5|||
164143045|NCT05038800|592884497|FG003|Overall Study|Death|3|||
164143046|NCT05038800|592884498|FG004|Overall Study|Death|1|||
164143047|NCT05038800|592884494|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164143048|NCT05038800|592884495|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164143049|NCT05038800|592884496|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164143050|NCT05038800|592884497|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164143051|NCT05038800|592884498|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
164143052|NCT05038800|592884494|FG000|Overall Study|Lack of Efficacy|0|||
164143053|NCT05038800|592884495|FG001|Overall Study|Lack of Efficacy|0|||
164143054|NCT05038800|592884496|FG002|Overall Study|Lack of Efficacy|0|||
164143055|NCT05038800|592884497|FG003|Overall Study|Lack of Efficacy|0|||
164143056|NCT05038800|592884498|FG004|Overall Study|Lack of Efficacy|1|||
164143117|NCT01831258|592886500|FG000|Overall Study|Withdrawal by Subject|2|||
164143118|NCT01831258|592886501|FG001|Overall Study|Withdrawal by Subject|1|||
164143119|NCT01831258|592886500|FG000|Overall Study|Lost to Follow-up|3|||
164143120|NCT01831258|592886501|FG001|Overall Study|Lost to Follow-up|2|||
164143121|NCT01753297|592886506|FG000|Overall Study|Lost to Follow-up|7|||
164143122|NCT01753297|592886507|FG001|Overall Study|Lost to Follow-up|2|||
164143123|NCT01753297|592886506|FG000|Overall Study|Withdrawal by Subject|26|||
164143124|NCT01753297|592886507|FG001|Overall Study|Withdrawal by Subject|23|||
164143125|NCT01753297|592886506|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
164143126|NCT01753297|592886507|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
164143127|NCT01753297|592886506|FG000|Overall Study|Death|0|||
164143128|NCT01753297|592886507|FG001|Overall Study|Death|2|||
164143129|NCT01753297|592886506|FG000|Overall Study|Did not attend end of study visit|7|||
164143130|NCT01753297|592886507|FG001|Overall Study|Did not attend end of study visit|8|||
164143131|NCT02533180|592886508|FG000|Overall Study|Death|0|||
164143132|NCT02533180|592886509|FG001|Overall Study|Death|2|||
164143133|NCT02533180|592886508|FG000|Overall Study|Lost to Follow-up|0|||
164143134|NCT02533180|592886509|FG001|Overall Study|Lost to Follow-up|1|||
164143135|NCT02533180|592886508|FG000|Overall Study|Physician Decision|0|||
164143136|NCT02533180|592886509|FG001|Overall Study|Physician Decision|1|||
164143137|NCT02533180|592886508|FG000|Overall Study|Withdrawal by Subject|2|||
164143138|NCT02533180|592886509|FG001|Overall Study|Withdrawal by Subject|5|||
164143139|NCT02533180|592886508|FG000|Overall Study|Screen Failure|37|||
164143140|NCT02533180|592886509|FG001|Overall Study|Screen Failure|0|||
164143141|NCT02533180|592886508|FG000|Overall Study|Protocol Deviation|0|||
164143142|NCT02533180|592886509|FG001|Overall Study|Protocol Deviation|1|||
164143143|NCT02533180|592886508|FG000|Overall Study|Non-compliance|0|||
164143144|NCT02533180|592886509|FG001|Overall Study|Non-compliance|1|||
164143145|NCT01174043|592886510|FG000|Overall Study|Disease progression|5|||
164143146|NCT01174043|592886510|FG000|Overall Study|Adverse Event|3|||
164143147|NCT01174043|592886510|FG000|Overall Study|Death|1|||
164143148|NCT01174043|592886510|FG000|Overall Study|Withdrawal by Subject|2|||
164143149|NCT00794339|592886516|FG000|Overall Study|Withdrawal by Subject|3|||
164143150|NCT00794339|592886516|FG000|Overall Study|Ineligible|4|||
164143151|NCT00794339|592886516|FG000|Overall Study|Tx prior to ATSM|3|||
164143152|NCT00794339|592886516|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
164143153|NCT00794339|592886516|FG000|Overall Study|Tx not per protocol|1|||
164143154|NCT00492778|592886523|FG000|Overall Study|Ineligible by Pathology Review|8|||
164143155|NCT00492778|592886524|FG001|Overall Study|Ineligible by Pathology Review|1|||
164143156|NCT03717012|592886539|FG000|Overall Study|Due to trial termination|1|||
164143157|NCT03717012|592886540|FG001|Overall Study|Due to trial termination|2|||
164143158|NCT03717012|592886539|FG000|Overall Study|Protocol Violation|0|||
164143159|NCT03717012|592886540|FG001|Overall Study|Protocol Violation|2|||
164143160|NCT03717012|592886539|FG000|Overall Study|Adverse Event|0|||
164143161|NCT03717012|592886540|FG001|Overall Study|Adverse Event|1|||
164143162|NCT03717012|592886539|FG000|Overall Study|Lung transplant|0|||
164143163|NCT03717012|592886540|FG001|Overall Study|Lung transplant|1|||
164143164|NCT00789035|592886541|FG000|Overall Study|Adverse Event|0|||
164143165|NCT00789035|592886542|FG001|Overall Study|Adverse Event|2|||
164143166|NCT00789035|592886543|FG002|Overall Study|Adverse Event|0|||
164143167|NCT00789035|592886544|FG003|Overall Study|Adverse Event|1|||
164143168|NCT00789035|592886545|FG004|Overall Study|Adverse Event|3|||
164143169|NCT00789035|592886541|FG000|Overall Study|Lack of Efficacy|3|||
164143170|NCT00789035|592886542|FG001|Overall Study|Lack of Efficacy|0|||
164143171|NCT00789035|592886543|FG002|Overall Study|Lack of Efficacy|0|||
164143172|NCT00789035|592886544|FG003|Overall Study|Lack of Efficacy|0|||
164143173|NCT00789035|592886545|FG004|Overall Study|Lack of Efficacy|2|||
164143174|NCT00789035|592886541|FG000|Overall Study|Protocol Violation|1|||
164143175|NCT00789035|592886542|FG001|Overall Study|Protocol Violation|0|||
164143176|NCT00789035|592886543|FG002|Overall Study|Protocol Violation|0|||
164143177|NCT00789035|592886544|FG003|Overall Study|Protocol Violation|0|||
164143178|NCT00789035|592886545|FG004|Overall Study|Protocol Violation|0|||
164143179|NCT00789035|592886541|FG000|Overall Study|Withdrawal by Subject|0|||
164143180|NCT00789035|592886542|FG001|Overall Study|Withdrawal by Subject|2|||
164143181|NCT00789035|592886543|FG002|Overall Study|Withdrawal by Subject|0|||
164143182|NCT00789035|592886544|FG003|Overall Study|Withdrawal by Subject|0|||
164143183|NCT00789035|592886545|FG004|Overall Study|Withdrawal by Subject|0|||
164143184|NCT00789035|592886541|FG000|Overall Study|Other reason not defined above|2|||
164143185|NCT00789035|592886542|FG001|Overall Study|Other reason not defined above|3|||
164143186|NCT00789035|592886543|FG002|Overall Study|Other reason not defined above|1|||
164143187|NCT00789035|592886544|FG003|Overall Study|Other reason not defined above|0|||
164143188|NCT00789035|592886545|FG004|Overall Study|Other reason not defined above|1|||
164143189|NCT04414618|592886546|FG000|Overall Study|Death|3|||
164143190|NCT04414618|592886547|FG001|Overall Study|Death|3|||
164143191|NCT04414618|592886546|FG000|Overall Study|Withdrawal by Subject|2|||
164143192|NCT04414618|592886547|FG001|Overall Study|Withdrawal by Subject|1|||
164143193|NCT04414618|592886546|FG000|Overall Study|Lost to Follow-up|2|||
164143194|NCT04414618|592886547|FG001|Overall Study|Lost to Follow-up|3|||
164143195|NCT04414618|592886546|FG000|Overall Study|Physician Decision|1|||
164143196|NCT04414618|592886547|FG001|Overall Study|Physician Decision|0|||
164143197|NCT00658879|592886548|FG000|Overall Study|Protocol Violation|1|||
164143198|NCT02640690|592886549|FG000|Overall Study|Lost to Follow-up|7|||
164143199|NCT02640690|592886550|FG001|Overall Study|Lost to Follow-up|7|||
164143200|NCT02640690|592886549|FG000|Overall Study|Withdrawal by Subject|16|||
164143201|NCT02640690|592886550|FG001|Overall Study|Withdrawal by Subject|20|||
164143202|NCT02640690|592886549|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
164143203|NCT02640690|592886550|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
164143204|NCT01118975|592886551|FG000|Overall Study|Adverse Event|0|||
164143205|NCT01118975|592886552|FG001|Overall Study|Adverse Event|1|||
164143206|NCT01645787|592886553|FG000|Washout (2 Weeks)|Adverse Event|1|||
164143207|NCT01645787|592886554|FG001|Washout (2 Weeks)|Adverse Event|0|||
164143208|NCT02806024|592886557|FG000|Overall Study|Night Delivery|1|||
164143209|NCT02806024|592886558|FG001|Overall Study|Night Delivery|1|||
164143210|NCT02806024|592886557|FG000|Overall Study|DVT during antepartum admission|0|||
164143211|NCT02806024|592886558|FG001|Overall Study|DVT during antepartum admission|1|||
164143212|NCT01098474|592886559|FG000|Active Phase|Other|0|||
164143213|NCT01098474|592886560|FG001|Active Phase|Other|0|||
164143214|NCT01098474|592886561|FG002|Active Phase|Other|3|||
164143215|NCT01098474|592886562|FG003|Active Phase|Other|0|||
164143216|NCT01098474|592886563|FG004|Active Phase|Other|0|||
164143217|NCT01098474|592886564|FG005|Active Phase|Other|0|||
164143218|NCT01098474|592886559|FG000|Active Phase|Withdrawal by Subject|1|||
164143219|NCT01098474|592886560|FG001|Active Phase|Withdrawal by Subject|1|||
164143220|NCT01098474|592886561|FG002|Active Phase|Withdrawal by Subject|2|||
164143221|NCT01098474|592886562|FG003|Active Phase|Withdrawal by Subject|0|||
164143222|NCT01098474|592886563|FG004|Active Phase|Withdrawal by Subject|0|||
164143223|NCT01098474|592886564|FG005|Active Phase|Withdrawal by Subject|0|||
164143224|NCT01098474|592886559|FG000|Active Phase|Lost to Follow-up|1|||
164143225|NCT01098474|592886560|FG001|Active Phase|Lost to Follow-up|0|||
164143226|NCT01098474|592886561|FG002|Active Phase|Lost to Follow-up|0|||
164143227|NCT01098474|592886562|FG003|Active Phase|Lost to Follow-up|0|||
164143228|NCT01098474|592886563|FG004|Active Phase|Lost to Follow-up|0|||
164143229|NCT01098474|592886564|FG005|Active Phase|Lost to Follow-up|0|||
164143230|NCT01098474|592886559|FG000|Follow Up Phase|Travelled out of study area|0|||
164143231|NCT01098474|592886560|FG001|Follow Up Phase|Travelled out of study area|0|||
164143232|NCT01098474|592886561|FG002|Follow Up Phase|Travelled out of study area|0|||
164143233|NCT01098474|592886562|FG003|Follow Up Phase|Travelled out of study area|0|||
164143234|NCT01098474|592886563|FG004|Follow Up Phase|Travelled out of study area|1|||
164143235|NCT01098474|592886564|FG005|Follow Up Phase|Travelled out of study area|0|||
164143236|NCT01098474|592886559|FG000|Follow Up Phase|Other|0|||
164143237|NCT01098474|592886560|FG001|Follow Up Phase|Other|0|||
164143238|NCT01098474|592886561|FG002|Follow Up Phase|Other|0|||
164143239|NCT01098474|592886562|FG003|Follow Up Phase|Other|0|||
164143240|NCT01098474|592886563|FG004|Follow Up Phase|Other|0|||
164143241|NCT01098474|592886564|FG005|Follow Up Phase|Other|4|||
164143242|NCT01098474|592886559|FG000|Follow Up Phase|Withdrawal by Subject|0|||
164143243|NCT01098474|592886560|FG001|Follow Up Phase|Withdrawal by Subject|0|||
164143244|NCT01098474|592886561|FG002|Follow Up Phase|Withdrawal by Subject|0|||
164143245|NCT01098474|592886562|FG003|Follow Up Phase|Withdrawal by Subject|2|||
164143246|NCT01098474|592886563|FG004|Follow Up Phase|Withdrawal by Subject|0|||
164143247|NCT01098474|592886564|FG005|Follow Up Phase|Withdrawal by Subject|1|||
164143248|NCT01098474|592886559|FG000|Follow Up Phase|Lost to Follow-up|0|||
164143249|NCT01098474|592886560|FG001|Follow Up Phase|Lost to Follow-up|0|||
164143250|NCT01098474|592886561|FG002|Follow Up Phase|Lost to Follow-up|0|||
164143251|NCT01098474|592886562|FG003|Follow Up Phase|Lost to Follow-up|0|||
164143252|NCT01098474|592886563|FG004|Follow Up Phase|Lost to Follow-up|1|||
164143253|NCT01098474|592886564|FG005|Follow Up Phase|Lost to Follow-up|0|||
164143254|NCT00711880|592886569|FG000|Overall Study|Adverse Event|11|||
164143255|NCT00711880|592886570|FG001|Overall Study|Adverse Event|2|||
164143256|NCT00711880|592886569|FG000|Overall Study|Patient non-compliance|1|||
164143257|NCT00711880|592886570|FG001|Overall Study|Patient non-compliance|0|||
164143258|NCT00711880|592886569|FG000|Overall Study|Lack of Efficacy|1|||
164143259|NCT00711880|592886570|FG001|Overall Study|Lack of Efficacy|5|||
164143260|NCT00704132|592886571|FG000|Overall Study|Clinical Adverse Experience|1|||
164143261|NCT00704132|592886572|FG001|Overall Study|Clinical Adverse Experience|0|||
164143262|NCT00704132|592886571|FG000|Overall Study|Lack of Efficacy|0|||
164143263|NCT00704132|592886572|FG001|Overall Study|Lack of Efficacy|1|||
164143264|NCT00704132|592886571|FG000|Overall Study|Withdrawal by Subject|0|||
164143265|NCT00704132|592886572|FG001|Overall Study|Withdrawal by Subject|1|||
164143266|NCT00442962|592886573|FG000|Overall Study|Pregnancy|1|||
164143267|NCT00442962|592886573|FG000|Overall Study|Lost to Follow-up|7|||
164143268|NCT04238650|592886574|FG000|Overall Study|Withdrawal by Subject|0|||
164143269|NCT04238650|592886575|FG001|Overall Study|Withdrawal by Subject|1|||
164143270|NCT03348163|592886576|FG000|Overall Study|Withdrawal by Subject|2|||
164143271|NCT03348163|592886577|FG001|Overall Study|Withdrawal by Subject|0|||
164143272|NCT02756208|592886578|FG000|Overall Study|Withdrawal by Subject|1|||
164143273|NCT02756208|592886579|FG001|Overall Study|Withdrawal by Subject|0|||
164143274|NCT02756208|592886580|FG002|Overall Study|Withdrawal by Subject|1|||
164143275|NCT02756208|592886581|FG003|Overall Study|Withdrawal by Subject|3|||
164143276|NCT02756208|592886578|FG000|Overall Study|Lost to Follow-up|3|||
164143277|NCT02756208|592886579|FG001|Overall Study|Lost to Follow-up|1|||
164143278|NCT02756208|592886580|FG002|Overall Study|Lost to Follow-up|1|||
164143279|NCT02756208|592886581|FG003|Overall Study|Lost to Follow-up|1|||
164143280|NCT02756208|592886578|FG000|Overall Study|Physician Decision|1|||
164143281|NCT02756208|592886579|FG001|Overall Study|Physician Decision|0|||
164143282|NCT02756208|592886580|FG002|Overall Study|Physician Decision|0|||
164143283|NCT02756208|592886581|FG003|Overall Study|Physician Decision|0|||
164143284|NCT02756208|592886578|FG000|Overall Study|Protocol Violation|0|||
164143285|NCT02756208|592886579|FG001|Overall Study|Protocol Violation|1|||
164143286|NCT02756208|592886580|FG002|Overall Study|Protocol Violation|0|||
164143287|NCT02756208|592886581|FG003|Overall Study|Protocol Violation|0|||
164143288|NCT02585778|592886582|FG000|Overall Study|Adverse Event|17|||
164143289|NCT02585778|592886583|FG001|Overall Study|Adverse Event|4|||
164143290|NCT02585778|592886582|FG000|Overall Study|Participant did not wish to continue|9|||
164143291|NCT02585778|592886583|FG001|Overall Study|Participant did not wish to continue|4|||
164143292|NCT02585778|592886582|FG000|Overall Study|Poor compliance to study protocol|0|||
164143293|NCT02585778|592886583|FG001|Overall Study|Poor compliance to study protocol|2|||
164143294|NCT02585778|592886582|FG000|Overall Study|Death|0|||
164143295|NCT02585778|592886583|FG001|Overall Study|Death|1|||
164143296|NCT02585778|592886582|FG000|Overall Study|Randomized but not treated|1|||
164143297|NCT02585778|592886583|FG001|Overall Study|Randomized but not treated|2|||
164143298|NCT02585778|592886582|FG000|Overall Study|Other than specified above|6|||
164143299|NCT02585778|592886583|FG001|Overall Study|Other than specified above|2|||
164143300|NCT05246670|592886586|FG000|Overall Study|Withdrawal by Subject|2|||
164143301|NCT05246670|592886587|FG001|Overall Study|Withdrawal by Subject|3|||
164143302|NCT05246670|592886588|FG002|Overall Study|Withdrawal by Subject|0|||
164143303|NCT05246670|592886589|FG003|Overall Study|Withdrawal by Subject|1|||
164143304|NCT05246670|592886586|FG000|Overall Study|Adverse Event|0|||
164143305|NCT05246670|592886587|FG001|Overall Study|Adverse Event|0|||
164143306|NCT05246670|592886588|FG002|Overall Study|Adverse Event|1|||
164143307|NCT05246670|592886589|FG003|Overall Study|Adverse Event|0|||
164143308|NCT05246670|592886586|FG000|Overall Study|Physician Decision|1|||
164143309|NCT05246670|592886587|FG001|Overall Study|Physician Decision|0|||
164143310|NCT05246670|592886588|FG002|Overall Study|Physician Decision|0|||
164143311|NCT05246670|592886589|FG003|Overall Study|Physician Decision|0|||
164143312|NCT05246670|592886586|FG000|Overall Study|Protocol Violation|1|||
164143354|NCT00879411|592886603|FG000|Overall Study|lost to follow-up (non-AE)|162|||
164143355|NCT05124691|592886604|FG000|Phase II|Eligibility criteria|0|||
164143356|NCT05124691|592886605|FG001|Phase II|Eligibility criteria|1|||
164143357|NCT05124691|592886606|FG002|Phase II|Eligibility criteria|0|||
164143358|NCT05124691|592886604|FG000|Phase II|Withdrawal by Subject|6|||
164143359|NCT05124691|592886605|FG001|Phase II|Withdrawal by Subject|2|||
164143360|NCT05124691|592886606|FG002|Phase II|Withdrawal by Subject|3|||
164143361|NCT05124691|592886604|FG000|Phase III|Withdrawal by Subject|6|||
164143362|NCT05124691|592886605|FG001|Phase III|Withdrawal by Subject|4|||
164143363|NCT05124691|592886606|FG002|Phase III|Withdrawal by Subject|4|||
164143364|NCT05124691|592886604|FG000|Phase III|Lost to Follow-up|1|||
164143365|NCT05124691|592886605|FG001|Phase III|Lost to Follow-up|0|||
164143366|NCT05124691|592886606|FG002|Phase III|Lost to Follow-up|0|||
164143367|NCT05211726|592886607|FG000|Overall Study|Withdrawal by Subject|2|||
164143368|NCT05211726|592886608|FG001|Overall Study|Withdrawal by Subject|3|||
164143369|NCT05211726|592886607|FG000|Overall Study|Protocol Violation|0|||
164143370|NCT05211726|592886608|FG001|Overall Study|Protocol Violation|1|||
164143371|NCT02714426|592886618|FG000|Overall Study|Withdrawal by Subject|2|||
164143372|NCT02714426|592886619|FG001|Overall Study|Withdrawal by Subject|2|||
164143373|NCT03456453|592886623|FG000|Overall Study|Withdrawal by Subject|2|||
164143374|NCT03456453|592886624|FG001|Overall Study|Withdrawal by Subject|0|||
164143375|NCT03456453|592886623|FG000|Overall Study|Not released to community|1|||
164143376|NCT03456453|592886624|FG001|Overall Study|Not released to community|5|||
164143377|NCT03456453|592886623|FG000|Overall Study|Lost to Follow-up|0|||
164143378|NCT03456453|592886624|FG001|Overall Study|Lost to Follow-up|2|||
164143379|NCT00896480|592886625|FG000|Overall Study|Disease progression/recurrence|21|||
164143380|NCT00725205|592886630|FG000|Overall Study|Adverse Event|22|||
164143381|NCT00725205|592886630|FG000|Overall Study|Investigator Discontinued|1|||
164143382|NCT00725205|592886630|FG000|Overall Study|Non-compliance With Protocol|14|||
164143383|NCT00725205|592886630|FG000|Overall Study|Other|8|||
164143384|NCT00725205|592886630|FG000|Overall Study|Protocol Defined Clinical Event|1|||
164143385|NCT00725205|592886630|FG000|Overall Study|Treatment Failure|41|||
164143386|NCT03014180|592886631|FG000|Overall Study|Protocol Violation|2|||
164143387|NCT02212379|592886635|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
164143388|NCT02212379|592886635|FG000|From Baseline to Week 48|Adverse Event|7|||
164143389|NCT02212379|592886635|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
164143390|NCT02212379|592886635|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
164143391|NCT02212379|592886635|FG000|From Week 48 to Week 96|Adverse Event|1|||
164143392|NCT02212379|592886635|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
164143393|NCT04784533|592886636|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
164143394|NCT04784533|592886637|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
164143395|NCT04784533|592886638|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
164143396|NCT04784533|592886639|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
164143397|NCT04784533|592886640|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
164143398|NCT04784533|592886641|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
164143399|NCT04784533|592886642|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
164143400|NCT04784533|592886643|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
164143401|NCT04784533|592886644|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
164143402|NCT04784533|592886645|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
164143403|NCT04784533|592886636|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
164143404|NCT04784533|592886637|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
164143405|NCT04784533|592886638|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
164143406|NCT04784533|592886639|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
164143407|NCT04784533|592886640|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
164143408|NCT04784533|592886641|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
164143409|NCT04784533|592886642|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
164143410|NCT04784533|592886643|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
164143411|NCT04784533|592886644|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
164143412|NCT04784533|592886645|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
164143413|NCT04784533|592886636|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
164143414|NCT04784533|592886637|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
164143415|NCT04784533|592886638|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
164143416|NCT04784533|592886639|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
164143417|NCT04784533|592886640|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
164143418|NCT04784533|592886641|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
164143419|NCT04784533|592886642|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
164143420|NCT04784533|592886643|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
164143421|NCT04784533|592886644|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
164143562|NCT03922529|592888460|FG001|Overall Study|Adverse Event|0|||
164143422|NCT04784533|592886645|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
164143423|NCT04784533|592886636|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
164143424|NCT04784533|592886637|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
164143425|NCT04784533|592886638|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
164143426|NCT04784533|592886639|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
164143427|NCT04784533|592886640|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
164143428|NCT04784533|592886641|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
164143429|NCT04784533|592886642|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
164143430|NCT04784533|592886643|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
164143431|NCT04784533|592886644|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
164143432|NCT04784533|592886645|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
164143433|NCT04784533|592886636|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
164143434|NCT04784533|592886637|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
164143435|NCT04784533|592886638|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
164143436|NCT04784533|592886639|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
164143437|NCT04784533|592886640|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
164143438|NCT04784533|592886641|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
164143439|NCT04784533|592886642|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
164143440|NCT04784533|592886643|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
164143441|NCT04784533|592886644|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
164143442|NCT04784533|592886645|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
164143443|NCT04784533|592886636|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
164143444|NCT04784533|592886637|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
164143445|NCT04784533|592886638|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
164143446|NCT04784533|592886639|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
164143447|NCT04784533|592886640|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
164143448|NCT04784533|592886641|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
164143449|NCT04784533|592886642|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
164143450|NCT04784533|592886643|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
164143451|NCT04784533|592886644|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
164143452|NCT04784533|592886645|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
164143453|NCT04784533|592886636|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
164143454|NCT04784533|592886637|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
164143455|NCT04784533|592886638|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
164143456|NCT04784533|592886639|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
164143457|NCT04784533|592886640|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
164143458|NCT04784533|592886641|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
164143459|NCT04784533|592886642|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
164143460|NCT04784533|592886643|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
164143461|NCT04784533|592886644|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
164143462|NCT04784533|592886645|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
164143463|NCT04784533|592886636|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
164143464|NCT04784533|592886637|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
164143465|NCT04784533|592886638|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
164143466|NCT04784533|592886639|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
164143467|NCT04784533|592886640|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
164143468|NCT04784533|592886641|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
164143469|NCT04784533|592886642|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
164143470|NCT04784533|592886643|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
164143471|NCT04784533|592886644|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
164143472|NCT04784533|592886645|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
164143473|NCT04784533|592886636|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
164143474|NCT04784533|592886637|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
164143475|NCT04784533|592886638|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
164143476|NCT04784533|592886639|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
164143477|NCT04784533|592886640|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
164143478|NCT04784533|592886641|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
164143479|NCT04784533|592886642|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
164143480|NCT04784533|592886643|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
164143481|NCT04784533|592886644|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
164143482|NCT04784533|592886645|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
164143483|NCT02105974|592886646|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
164143484|NCT02105974|592886647|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
164143485|NCT02105974|592886648|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
164143486|NCT02105974|592886646|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
164143487|NCT02105974|592886647|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
164144024|NCT00086281|592888578|FG007|Phase 1|Serious Adverse Event|0|||
164143488|NCT02105974|592886648|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
164143489|NCT02105974|592886646|FG000|2 Week Run-in Period|Adverse Event|6|||
164143490|NCT02105974|592886647|FG001|2 Week Run-in Period|Adverse Event|0|||
164143491|NCT02105974|592886648|FG002|2 Week Run-in Period|Adverse Event|0|||
164143492|NCT02105974|592886646|FG000|2 Week Run-in Period|Study closed/terminated|1|||
164143493|NCT02105974|592886647|FG001|2 Week Run-in Period|Study closed/terminated|0|||
164143494|NCT02105974|592886648|FG002|2 Week Run-in Period|Study closed/terminated|0|||
164143495|NCT02105974|592886646|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
164143496|NCT02105974|592886647|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
164143497|NCT02105974|592886648|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
164143498|NCT02105974|592886646|FG000|2 Week Run-in Period|Withdrew consent|23|||
164143499|NCT02105974|592886647|FG001|2 Week Run-in Period|Withdrew consent|0|||
164143500|NCT02105974|592886648|FG002|2 Week Run-in Period|Withdrew consent|0|||
164143501|NCT02105974|592886646|FG000|2 Week Run-in Period|Investigator discretion|8|||
164143502|NCT02105974|592886647|FG001|2 Week Run-in Period|Investigator discretion|0|||
164143503|NCT02105974|592886648|FG002|2 Week Run-in Period|Investigator discretion|0|||
164143504|NCT02105974|592886646|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
164143505|NCT02105974|592886647|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
164143506|NCT02105974|592886648|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
164143507|NCT02105974|592886646|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
164143508|NCT02105974|592886647|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
164143509|NCT02105974|592886648|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
164143510|NCT02105974|592886646|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
164143511|NCT02105974|592886647|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
164143512|NCT02105974|592886648|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
164143513|NCT02105974|592886646|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
164143514|NCT02105974|592886647|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
164143515|NCT02105974|592886648|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
164143516|NCT02105974|592886646|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
164143517|NCT02105974|592886647|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
164143518|NCT02105974|592886648|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
164143519|NCT02105974|592886646|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
164143520|NCT02105974|592886647|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
164143521|NCT02105974|592886648|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
164143522|NCT02105974|592886646|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
164143523|NCT02105974|592886647|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
164143524|NCT02105974|592886648|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
164143525|NCT02682927|592886664|FG000|Overall Study|Adverse Event|0|||
164143526|NCT02682927|592886665|FG001|Overall Study|Adverse Event|0|||
164143527|NCT02682927|592886666|FG002|Overall Study|Adverse Event|5|||
164143528|NCT02682927|592886667|FG003|Overall Study|Adverse Event|1|||
164143529|NCT02682927|592886668|FG004|Overall Study|Adverse Event|0|||
164143530|NCT02682927|592886669|FG005|Overall Study|Adverse Event|2|||
164143531|NCT02682927|592886664|FG000|Overall Study|Death|0|||
164143532|NCT02682927|592886665|FG001|Overall Study|Death|0|||
164143533|NCT02682927|592886666|FG002|Overall Study|Death|0|||
164143534|NCT02682927|592886667|FG003|Overall Study|Death|1|||
164143535|NCT02682927|592886668|FG004|Overall Study|Death|0|||
164143536|NCT02682927|592886669|FG005|Overall Study|Death|0|||
164143537|NCT02682927|592886664|FG000|Overall Study|Lack of Efficacy|1|||
164143538|NCT02682927|592886665|FG001|Overall Study|Lack of Efficacy|0|||
164143539|NCT02682927|592886666|FG002|Overall Study|Lack of Efficacy|0|||
164143540|NCT02682927|592886667|FG003|Overall Study|Lack of Efficacy|1|||
164143541|NCT02682927|592886668|FG004|Overall Study|Lack of Efficacy|0|||
164143542|NCT02682927|592886669|FG005|Overall Study|Lack of Efficacy|0|||
164143543|NCT02682927|592886664|FG000|Overall Study|Other|0|||
164143544|NCT02682927|592886665|FG001|Overall Study|Other|0|||
164143545|NCT02682927|592886666|FG002|Overall Study|Other|0|||
164143546|NCT02682927|592886667|FG003|Overall Study|Other|2|||
164143547|NCT02682927|592886668|FG004|Overall Study|Other|0|||
164143548|NCT02682927|592886669|FG005|Overall Study|Other|0|||
164143549|NCT02682927|592886664|FG000|Overall Study|Withdrawal by Subject|2|||
164143550|NCT02682927|592886665|FG001|Overall Study|Withdrawal by Subject|0|||
164143551|NCT02682927|592886666|FG002|Overall Study|Withdrawal by Subject|1|||
164143552|NCT02682927|592886667|FG003|Overall Study|Withdrawal by Subject|0|||
164143553|NCT02682927|592886668|FG004|Overall Study|Withdrawal by Subject|1|||
164143554|NCT02682927|592886669|FG005|Overall Study|Withdrawal by Subject|1|||
164143555|NCT03922529|592888459|FG000|Overall Study|Withdrawal by Subject|13|||
164143556|NCT03922529|592888460|FG001|Overall Study|Withdrawal by Subject|12|||
164143557|NCT03922529|592888459|FG000|Overall Study|Death|7|||
164143558|NCT03922529|592888460|FG001|Overall Study|Death|12|||
164143559|NCT03922529|592888459|FG000|Overall Study|Lost to Follow-up|12|||
164143560|NCT03922529|592888460|FG001|Overall Study|Lost to Follow-up|19|||
164143561|NCT03922529|592888459|FG000|Overall Study|Adverse Event|1|||
164143563|NCT03922529|592888459|FG000|Overall Study|Death after withdrawal|1|||
164143564|NCT03922529|592888460|FG001|Overall Study|Death after withdrawal|0|||
164143565|NCT03922529|592888459|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
164143566|NCT03922529|592888460|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
164143567|NCT03922529|592888459|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
164143568|NCT03922529|592888460|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
164143569|NCT02465398|592888461|FG000|Overall Study|Death|7|||
164143570|NCT02465398|592888461|FG000|Overall Study|Revision|7|||
164143571|NCT02465398|592888461|FG000|Overall Study|did not receive study device|1|||
164143572|NCT02465398|592888461|FG000|Overall Study|Withdrawal by Subject|1|||
164143573|NCT02465398|592888461|FG000|Overall Study|Lost to Follow-up|14|||
164143574|NCT02540850|592888462|FG000|Overall Study|Lost to Follow-up|69|||
164143575|NCT02540850|592888463|FG001|Overall Study|Lost to Follow-up|66|||
164143576|NCT02540850|592888464|FG002|Overall Study|Lost to Follow-up|34|||
164143577|NCT03760185|592888467|FG000|Overall Study|Lost to Follow-up|1|||
164143578|NCT03760185|592888468|FG001|Overall Study|Lost to Follow-up|1|||
164143579|NCT00230178|592888469|FG000|Overall Study|Adverse Event|1|||
164143580|NCT00230178|592888470|FG001|Overall Study|Adverse Event|5|||
164143581|NCT00230178|592888471|FG002|Overall Study|Adverse Event|2|||
164143582|NCT00230178|592888469|FG000|Overall Study|Withdrawal by Subject|0|||
164143583|NCT00230178|592888470|FG001|Overall Study|Withdrawal by Subject|0|||
164143584|NCT00230178|592888471|FG002|Overall Study|Withdrawal by Subject|1|||
164143585|NCT00230178|592888469|FG000|Overall Study|Various other reasons|3|||
164143586|NCT00230178|592888470|FG001|Overall Study|Various other reasons|2|||
164143587|NCT00230178|592888471|FG002|Overall Study|Various other reasons|4|||
164143588|NCT01275729|592888474|FG000|Overall Study|Death|3|||
164143589|NCT01275729|592888474|FG000|Overall Study|Withdrawal by Subject|1|||
164143590|NCT02252406|592888479|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
164143591|NCT02252406|592888480|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
164143592|NCT02252406|592888479|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
164143593|NCT02252406|592888480|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
164143594|NCT02252406|592888479|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
164143595|NCT02252406|592888480|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
164143596|NCT02252406|592888479|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
164143597|NCT02252406|592888480|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
164143598|NCT02252406|592888479|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
164143599|NCT02252406|592888480|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
164143600|NCT00447876|592888481|FG000|Overall Study|Withdrawal by Subject|1|||
164143601|NCT00447876|592888482|FG001|Overall Study|Withdrawal by Subject|4|||
164143602|NCT00447876|592888481|FG000|Overall Study|Lost to Follow-up|1|||
164143603|NCT00447876|592888482|FG001|Overall Study|Lost to Follow-up|0|||
164143604|NCT00447876|592888481|FG000|Overall Study|Deterioration of symptomology|1|||
164143605|NCT00447876|592888482|FG001|Overall Study|Deterioration of symptomology|0|||
164143606|NCT00005957|592888483|FG000|Overall Study|No treated|3|||
164143607|NCT00005957|592888484|FG001|Overall Study|No treated|9|||
164143608|NCT00005957|592888483|FG000|Overall Study|Crossover to the other arm|5|||
164143609|NCT00005957|592888484|FG001|Overall Study|Crossover to the other arm|19|||
164143610|NCT01609023|592888485|FG000|Overall Study|Lack of Efficacy|3|||
164143611|NCT01609023|592888485|FG000|Overall Study|Withdrawal by Subject|4|||
164143612|NCT01609023|592888485|FG000|Overall Study|Lost to Follow-up|8|||
164143613|NCT01609023|592888485|FG000|Overall Study|Toxicity|3|||
164143614|NCT01609023|592888485|FG000|Overall Study|Disease progression|10|||
164143615|NCT01609023|592888485|FG000|Overall Study|Physician Decision|2|||
164143616|NCT01609023|592888485|FG000|Overall Study|Death|2|||
164143617|NCT01609023|592888485|FG000|Overall Study|Personal reasons|1|||
164143618|NCT04172597|592888486|FG000|Overall Study|Disease Progression|0|||
164143619|NCT04172597|592888487|FG001|Overall Study|Disease Progression|0|||
164143620|NCT04172597|592888488|FG002|Overall Study|Disease Progression|0|||
164143621|NCT04172597|592888489|FG003|Overall Study|Disease Progression|0|||
164143622|NCT04172597|592888490|FG004|Overall Study|Disease Progression|1|||
164143623|NCT02952586|592888494|FG000|Lead-In Phase (7 Days)|Death|0|||
164143624|NCT02952586|592888495|FG001|Lead-In Phase (7 Days)|Death|1|||
164143625|NCT02952586|592888494|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
164143626|NCT02952586|592888495|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
164143627|NCT02952586|592888494|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
164143628|NCT02952586|592888495|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
164143629|NCT02952586|592888494|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
164143630|NCT02952586|592888495|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
164143631|NCT02952586|592888494|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
164143632|NCT02952586|592888495|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
164143633|NCT02952586|592888494|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
164143634|NCT02952586|592888495|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
164143635|NCT02952586|592888494|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
164143636|NCT02952586|592888495|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
164143637|NCT02952586|592888494|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
164143638|NCT02952586|592888495|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
164143639|NCT02952586|592888494|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
164143640|NCT02952586|592888495|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
164143641|NCT02952586|592888494|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
164143642|NCT02952586|592888495|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
164143643|NCT02952586|592888494|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
164143644|NCT02952586|592888495|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
164143645|NCT02952586|592888494|FG000|CRT for Cisplatin (63 Days)|Death|3|||
164143646|NCT02952586|592888495|FG001|CRT for Cisplatin (63 Days)|Death|8|||
164143647|NCT02952586|592888494|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
164143648|NCT02952586|592888495|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
164143649|NCT02952586|592888494|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
164143650|NCT02952586|592888495|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
164143651|NCT02952586|592888494|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
164143652|NCT02952586|592888495|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
164143653|NCT02952586|592888494|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
164143654|NCT02952586|592888495|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
164143655|NCT02952586|592888494|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
164143656|NCT02952586|592888495|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
164143657|NCT02952586|592888494|FG000|CRT for Cisplatin (63 Days)|Other|1|||
164143658|NCT02952586|592888495|FG001|CRT for Cisplatin (63 Days)|Other|1|||
164143659|NCT02952586|592888494|FG000|CRT for IMRT (63 Days)|Death|5|||
164143660|NCT02952586|592888495|FG001|CRT for IMRT (63 Days)|Death|8|||
164143661|NCT02952586|592888494|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
164143662|NCT02952586|592888495|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
164143663|NCT02952586|592888494|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
164143664|NCT02952586|592888495|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
164143665|NCT02952586|592888494|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
164143666|NCT02952586|592888495|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
164143667|NCT02952586|592888494|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
164143668|NCT02952586|592888495|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
164143669|NCT02952586|592888494|FG000|CRT for IMRT (63 Days)|Other|1|||
164143670|NCT02952586|592888495|FG001|CRT for IMRT (63 Days)|Other|0|||
164143671|NCT02952586|592888494|FG000|Maintenance Phase (12 Months)|Death|17|||
164143672|NCT02952586|592888495|FG001|Maintenance Phase (12 Months)|Death|11|||
164143673|NCT02952586|592888494|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
164143674|NCT02952586|592888495|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
164143675|NCT02952586|592888494|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
164143676|NCT02952586|592888495|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
164143677|NCT02952586|592888494|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
164143678|NCT02952586|592888495|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
164143679|NCT02952586|592888494|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
164143680|NCT02952586|592888495|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
164143681|NCT02952586|592888494|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
164143682|NCT02952586|592888495|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
164143683|NCT02952586|592888494|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
164143684|NCT02952586|592888495|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
164143685|NCT02952586|592888494|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
164143686|NCT02952586|592888495|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
164143687|NCT02952586|592888494|FG000|Maintenance Phase (12 Months)|Other|2|||
164143688|NCT02952586|592888495|FG001|Maintenance Phase (12 Months)|Other|1|||
164143689|NCT02952586|592888494|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
164143690|NCT02952586|592888495|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
164143691|NCT02952586|592888494|FG000|Follow-Up Phase (90 Days)|Death|12|||
164143692|NCT02952586|592888495|FG001|Follow-Up Phase (90 Days)|Death|10|||
164143693|NCT02952586|592888494|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
164143694|NCT02952586|592888495|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
164143695|NCT02952586|592888494|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
164143696|NCT02952586|592888495|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
164143697|NCT02952586|592888494|FG000|Follow-Up Phase (90 Days)|Other|7|||
164143698|NCT02952586|592888495|FG001|Follow-Up Phase (90 Days)|Other|5|||
164143699|NCT02952586|592888494|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
164143700|NCT02952586|592888495|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
164143701|NCT02952586|592888494|FG000|LT Follow-up (up to 45 Months)|Death|51|||
164143702|NCT02952586|592888495|FG001|LT Follow-up (up to 45 Months)|Death|31|||
164143703|NCT02952586|592888494|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
164143704|NCT02952586|592888495|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
164143705|NCT02952586|592888494|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
164143706|NCT02952586|592888495|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
164143707|NCT02952586|592888494|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
164143708|NCT02952586|592888495|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
164143709|NCT04974749|592888496|FG000|Overall Study|Withdrawal by Subject|2|||
164143710|NCT04974749|592888496|FG000|Overall Study|Gestation|1|||
164143711|NCT01520870|592888497|FG000|Overall Study|Withdrawal by Subject|2|||
164143712|NCT00796107|592888503|FG000|Overall Study|Lack of Efficacy|1|||
164143713|NCT00796107|592888503|FG000|Overall Study|Progressive Disease|5|||
164143714|NCT02075515|592888508|FG000|Overall Study|Serious Adverse Event|1|||
164143715|NCT02075515|592888509|FG001|Overall Study|Serious Adverse Event|1|||
164143716|NCT02075515|592888510|FG002|Overall Study|Serious Adverse Event|1|||
164143717|NCT02075515|592888508|FG000|Overall Study|Non-Serious Adverse Event|0|||
164143718|NCT02075515|592888509|FG001|Overall Study|Non-Serious Adverse Event|1|||
164143719|NCT02075515|592888510|FG002|Overall Study|Non-Serious Adverse Event|0|||
164143720|NCT02075515|592888508|FG000|Overall Study|Withdrawal by Subject|2|||
164143721|NCT02075515|592888509|FG001|Overall Study|Withdrawal by Subject|0|||
164143722|NCT02075515|592888510|FG002|Overall Study|Withdrawal by Subject|1|||
164143723|NCT02075515|592888508|FG000|Overall Study|Lost to Follow-up|1|||
164143724|NCT02075515|592888509|FG001|Overall Study|Lost to Follow-up|3|||
164143725|NCT02075515|592888510|FG002|Overall Study|Lost to Follow-up|6|||
164143726|NCT00626561|592888511|FG000|Overall Study|Withdrawal by Subject|2|||
164143727|NCT00626561|592888511|FG000|Overall Study|Disease Progression|2|||
164143728|NCT02797171|592888512|FG000|Overall Study|Lost to Follow-up|2|||
164143729|NCT02797171|592888513|FG001|Overall Study|Lost to Follow-up|0|||
164143730|NCT02797171|592888514|FG002|Overall Study|Lost to Follow-up|2|||
164143731|NCT02797171|592888515|FG003|Overall Study|Lost to Follow-up|1|||
164143732|NCT02797171|592888516|FG004|Overall Study|Lost to Follow-up|2|||
164143733|NCT02797171|592888517|FG005|Overall Study|Lost to Follow-up|0|||
164143734|NCT02797171|592888512|FG000|Overall Study|Withdrawal by Subject|1|||
164143735|NCT02797171|592888513|FG001|Overall Study|Withdrawal by Subject|1|||
164143736|NCT02797171|592888514|FG002|Overall Study|Withdrawal by Subject|0|||
164143737|NCT02797171|592888515|FG003|Overall Study|Withdrawal by Subject|0|||
164143738|NCT02797171|592888516|FG004|Overall Study|Withdrawal by Subject|0|||
164143739|NCT02797171|592888517|FG005|Overall Study|Withdrawal by Subject|0|||
164143740|NCT02797171|592888512|FG000|Overall Study|Protocol Violation|1|||
164143741|NCT02797171|592888513|FG001|Overall Study|Protocol Violation|0|||
164143742|NCT02797171|592888514|FG002|Overall Study|Protocol Violation|0|||
164143743|NCT02797171|592888515|FG003|Overall Study|Protocol Violation|0|||
164143744|NCT02797171|592888516|FG004|Overall Study|Protocol Violation|0|||
164143745|NCT02797171|592888517|FG005|Overall Study|Protocol Violation|0|||
164143746|NCT02797171|592888512|FG000|Overall Study|Participant unable to adhere|0|||
164143747|NCT02797171|592888513|FG001|Overall Study|Participant unable to adhere|1|||
164143748|NCT02797171|592888514|FG002|Overall Study|Participant unable to adhere|0|||
164143749|NCT02797171|592888515|FG003|Overall Study|Participant unable to adhere|0|||
164143750|NCT02797171|592888516|FG004|Overall Study|Participant unable to adhere|0|||
164143751|NCT02797171|592888517|FG005|Overall Study|Participant unable to adhere|0|||
164143752|NCT02797171|592888512|FG000|Overall Study|Not Randomized|0|||
164143753|NCT02797171|592888513|FG001|Overall Study|Not Randomized|0|||
164143754|NCT02797171|592888514|FG002|Overall Study|Not Randomized|0|||
164143755|NCT02797171|592888515|FG003|Overall Study|Not Randomized|0|||
164143756|NCT02797171|592888516|FG004|Overall Study|Not Randomized|0|||
164143757|NCT02797171|592888517|FG005|Overall Study|Not Randomized|1|||
164143758|NCT01372748|592888518|FG000|Overall Study|Lost to Follow-up|16|||
164143759|NCT01372748|592888519|FG001|Overall Study|Lost to Follow-up|34|||
164143760|NCT01372748|592888518|FG000|Overall Study|Withdrawal by Subject|7|||
164143761|NCT01372748|592888519|FG001|Overall Study|Withdrawal by Subject|5|||
164143762|NCT00606632|592888520|FG000|Overall Study|Withdrawal by Subject|13|||
164143763|NCT00606632|592888520|FG000|Overall Study|Miscellaneous reasons|9|||
164143764|NCT03908437|592888521|FG000|Overall Study|Death|0|||
164143765|NCT03908437|592888522|FG001|Overall Study|Death|1|||
164143766|NCT03908437|592888521|FG000|Overall Study|Lost to Follow-up|31|||
164143767|NCT03908437|592888522|FG001|Overall Study|Lost to Follow-up|24|||
164143768|NCT03633825|592888523|FG000|Enrollment|Did not post on network|5066|||
164143769|NCT03633825|592888524|FG001|Enrollment|Did not post on network|5080|||
164143770|NCT03633825|592888523|FG000|Enrollment|Post not classified as crisis|13967|||
164143771|NCT03633825|592888524|FG001|Enrollment|Post not classified as crisis|13757|||
164143772|NCT03633825|592888523|FG000|Follow up|Lost to Follow-up|478|||
164143773|NCT03633825|592888524|FG001|Follow up|Lost to Follow-up|450|||
164143774|NCT03682107|592888525|FG000|Overall Study|Withdrawal by Subject|0|||
164143775|NCT03682107|592888526|FG001|Overall Study|Withdrawal by Subject|1|||
164143776|NCT03682107|592888527|FG002|Overall Study|Withdrawal by Subject|0|||
164143777|NCT03682107|592888528|FG003|Overall Study|Withdrawal by Subject|0|||
164143778|NCT03682107|592888529|FG004|Overall Study|Withdrawal by Subject|0|||
164143779|NCT00214383|592888532|FG000|Overall Study|Lost to Follow-up|16|||
164143780|NCT00214383|592888533|FG001|Overall Study|Lost to Follow-up|26|||
164143781|NCT01890434|592888534|FG000|Overall Study|Adverse Event|8|||
164143782|NCT01890434|592888534|FG000|Overall Study|PCI at external hospital|1|||
164143783|NCT01890434|592888534|FG000|Overall Study|Assessment discrepancy|1|||
164143784|NCT01890434|592888534|FG000|Overall Study|CRC didn't contact participant for FU|1|||
164143785|NCT01890434|592888534|FG000|Overall Study|Could not get whole set of images|1|||
164143786|NCT01890434|592888534|FG000|Overall Study|Decline to return for GSPECT|1|||
164143787|NCT01890434|592888534|FG000|Overall Study|GSPECT at rest was not done|1|||
164143788|NCT01890434|592888534|FG000|Overall Study|Participant didn't complete MRI|1|||
164143789|NCT01890434|592888534|FG000|Overall Study|Uncontactable by phone|1|||
164143790|NCT01890434|592888534|FG000|Overall Study|Moved out of position|1|||
164143791|NCT01890434|592888534|FG000|Overall Study|Unable to contact|1|||
164143792|NCT01890434|592888534|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
164143793|NCT00428116|592888535|FG000|Overall Study|Death|1|||
164143794|NCT00428116|592888536|FG001|Overall Study|Death|0|||
164143795|NCT00428116|592888535|FG000|Overall Study|Withdrawal by Subject|1|||
164143796|NCT00428116|592888536|FG001|Overall Study|Withdrawal by Subject|0|||
164143797|NCT00428116|592888535|FG000|Overall Study|Lost to Follow-up|1|||
164143798|NCT00428116|592888536|FG001|Overall Study|Lost to Follow-up|0|||
164143799|NCT01038297|592888537|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
164143800|NCT01038297|592888538|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
164143801|NCT01038297|592888539|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
164143802|NCT02257385|592888542|FG000|Overall Study|Adverse Event|12|||
164143803|NCT02257385|592888543|FG001|Overall Study|Adverse Event|8|||
164143804|NCT02257385|592888542|FG000|Overall Study|Lack of Efficacy|1|||
164143805|NCT02257385|592888543|FG001|Overall Study|Lack of Efficacy|2|||
164143806|NCT02257385|592888542|FG000|Overall Study|Protocol Violation|5|||
164143807|NCT02257385|592888543|FG001|Overall Study|Protocol Violation|7|||
164143808|NCT02257385|592888542|FG000|Overall Study|Lost to Follow-up|0|||
164143809|NCT02257385|592888543|FG001|Overall Study|Lost to Follow-up|1|||
164143810|NCT02257385|592888542|FG000|Overall Study|Withdrawal by Subject|4|||
164143811|NCT02257385|592888543|FG001|Overall Study|Withdrawal by Subject|4|||
164143812|NCT01449370|592888546|FG000|Overall Study|Disease Progression|5|||
164143813|NCT01449370|592888547|FG001|Overall Study|Disease Progression|4|||
164143814|NCT01449370|592888548|FG002|Overall Study|Disease Progression|8|||
164143815|NCT01449370|592888549|FG003|Overall Study|Disease Progression|3|||
164143816|NCT01449370|592888550|FG004|Overall Study|Disease Progression|3|||
164143817|NCT01449370|592888551|FG005|Overall Study|Disease Progression|3|||
164143818|NCT01449370|592888552|FG006|Overall Study|Disease Progression|3|||
164143819|NCT01449370|592888553|FG007|Overall Study|Disease Progression|2|||
164143820|NCT01449370|592888554|FG008|Overall Study|Disease Progression|9|||
164143821|NCT01449370|592888555|FG009|Overall Study|Disease Progression|1|||
164143822|NCT01449370|592888556|FG010|Overall Study|Disease Progression|3|||
164143823|NCT01449370|592888557|FG011|Overall Study|Disease Progression|3|||
164143824|NCT01449370|592888558|FG012|Overall Study|Disease Progression|2|||
164143825|NCT01449370|592888559|FG013|Overall Study|Disease Progression|8|||
164143826|NCT01449370|592888560|FG014|Overall Study|Disease Progression|3|||
164143827|NCT01449370|592888561|FG015|Overall Study|Disease Progression|1|||
164143828|NCT01449370|592888562|FG016|Overall Study|Disease Progression|4|||
164143829|NCT01449370|592888563|FG017|Overall Study|Disease Progression|3|||
164143830|NCT01449370|592888564|FG018|Overall Study|Disease Progression|1|||
164143831|NCT01449370|592888565|FG019|Overall Study|Disease Progression|2|||
164143832|NCT01449370|592888566|FG020|Overall Study|Disease Progression|5|||
164143833|NCT01449370|592888567|FG021|Overall Study|Disease Progression|2|||
164143834|NCT01449370|592888568|FG022|Overall Study|Disease Progression|3|||
164143835|NCT01449370|592888569|FG023|Overall Study|Disease Progression|7|||
164143836|NCT01449370|592888570|FG024|Overall Study|Disease Progression|3|||
164143837|NCT01449370|592888546|FG000|Overall Study|Adverse Event|1|||
164143838|NCT01449370|592888547|FG001|Overall Study|Adverse Event|2|||
164143839|NCT01449370|592888548|FG002|Overall Study|Adverse Event|0|||
164143840|NCT01449370|592888549|FG003|Overall Study|Adverse Event|1|||
164143841|NCT01449370|592888550|FG004|Overall Study|Adverse Event|0|||
164143842|NCT01449370|592888551|FG005|Overall Study|Adverse Event|0|||
164143843|NCT01449370|592888552|FG006|Overall Study|Adverse Event|0|||
164143844|NCT01449370|592888553|FG007|Overall Study|Adverse Event|0|||
164143845|NCT01449370|592888554|FG008|Overall Study|Adverse Event|1|||
164143846|NCT01449370|592888555|FG009|Overall Study|Adverse Event|1|||
164143847|NCT01449370|592888556|FG010|Overall Study|Adverse Event|0|||
164143848|NCT01449370|592888557|FG011|Overall Study|Adverse Event|0|||
164143849|NCT01449370|592888558|FG012|Overall Study|Adverse Event|0|||
164143850|NCT01449370|592888559|FG013|Overall Study|Adverse Event|2|||
164143851|NCT01449370|592888560|FG014|Overall Study|Adverse Event|0|||
164143852|NCT01449370|592888561|FG015|Overall Study|Adverse Event|1|||
164143853|NCT01449370|592888562|FG016|Overall Study|Adverse Event|0|||
164143854|NCT01449370|592888563|FG017|Overall Study|Adverse Event|0|||
164143855|NCT01449370|592888564|FG018|Overall Study|Adverse Event|1|||
164143856|NCT01449370|592888565|FG019|Overall Study|Adverse Event|1|||
164143857|NCT01449370|592888566|FG020|Overall Study|Adverse Event|0|||
164143858|NCT01449370|592888567|FG021|Overall Study|Adverse Event|1|||
164143859|NCT01449370|592888568|FG022|Overall Study|Adverse Event|0|||
164143860|NCT01449370|592888569|FG023|Overall Study|Adverse Event|1|||
164143861|NCT01449370|592888570|FG024|Overall Study|Adverse Event|3|||
164143862|NCT01449370|592888546|FG000|Overall Study|Participant Decision|0|||
164143863|NCT01449370|592888547|FG001|Overall Study|Participant Decision|0|||
164143864|NCT01449370|592888548|FG002|Overall Study|Participant Decision|0|||
164143865|NCT01449370|592888549|FG003|Overall Study|Participant Decision|0|||
164143866|NCT01449370|592888550|FG004|Overall Study|Participant Decision|0|||
164143867|NCT01449370|592888551|FG005|Overall Study|Participant Decision|0|||
164143868|NCT01449370|592888552|FG006|Overall Study|Participant Decision|0|||
164143869|NCT01449370|592888553|FG007|Overall Study|Participant Decision|1|||
164143870|NCT01449370|592888554|FG008|Overall Study|Participant Decision|1|||
164143871|NCT01449370|592888555|FG009|Overall Study|Participant Decision|0|||
164143872|NCT01449370|592888556|FG010|Overall Study|Participant Decision|0|||
164143873|NCT01449370|592888557|FG011|Overall Study|Participant Decision|0|||
164143874|NCT01449370|592888558|FG012|Overall Study|Participant Decision|1|||
164143875|NCT01449370|592888559|FG013|Overall Study|Participant Decision|1|||
164143876|NCT01449370|592888560|FG014|Overall Study|Participant Decision|0|||
164143877|NCT01449370|592888561|FG015|Overall Study|Participant Decision|1|||
164143878|NCT01449370|592888562|FG016|Overall Study|Participant Decision|3|||
164143879|NCT01449370|592888563|FG017|Overall Study|Participant Decision|0|||
164143880|NCT01449370|592888564|FG018|Overall Study|Participant Decision|1|||
164143881|NCT01449370|592888565|FG019|Overall Study|Participant Decision|0|||
164143882|NCT01449370|592888566|FG020|Overall Study|Participant Decision|0|||
164143883|NCT01449370|592888567|FG021|Overall Study|Participant Decision|1|||
164143884|NCT01449370|592888568|FG022|Overall Study|Participant Decision|0|||
164143885|NCT01449370|592888569|FG023|Overall Study|Participant Decision|0|||
164143886|NCT01449370|592888570|FG024|Overall Study|Participant Decision|1|||
164143887|NCT01449370|592888546|FG000|Overall Study|Lost to Follow-up|0|||
164143888|NCT01449370|592888547|FG001|Overall Study|Lost to Follow-up|0|||
164143889|NCT01449370|592888548|FG002|Overall Study|Lost to Follow-up|0|||
164143890|NCT01449370|592888549|FG003|Overall Study|Lost to Follow-up|0|||
164143891|NCT01449370|592888550|FG004|Overall Study|Lost to Follow-up|0|||
164143892|NCT01449370|592888551|FG005|Overall Study|Lost to Follow-up|0|||
164143893|NCT01449370|592888552|FG006|Overall Study|Lost to Follow-up|0|||
164143894|NCT01449370|592888553|FG007|Overall Study|Lost to Follow-up|0|||
164143895|NCT01449370|592888554|FG008|Overall Study|Lost to Follow-up|0|||
164143896|NCT01449370|592888555|FG009|Overall Study|Lost to Follow-up|0|||
164143897|NCT01449370|592888556|FG010|Overall Study|Lost to Follow-up|0|||
164143898|NCT01449370|592888557|FG011|Overall Study|Lost to Follow-up|0|||
164143899|NCT01449370|592888558|FG012|Overall Study|Lost to Follow-up|0|||
164143900|NCT01449370|592888559|FG013|Overall Study|Lost to Follow-up|0|||
164143901|NCT01449370|592888560|FG014|Overall Study|Lost to Follow-up|0|||
164143902|NCT01449370|592888561|FG015|Overall Study|Lost to Follow-up|0|||
164143903|NCT01449370|592888562|FG016|Overall Study|Lost to Follow-up|0|||
164143904|NCT01449370|592888563|FG017|Overall Study|Lost to Follow-up|0|||
164143905|NCT01449370|592888564|FG018|Overall Study|Lost to Follow-up|0|||
164143906|NCT01449370|592888565|FG019|Overall Study|Lost to Follow-up|0|||
164143907|NCT01449370|592888566|FG020|Overall Study|Lost to Follow-up|1|||
164143908|NCT01449370|592888567|FG021|Overall Study|Lost to Follow-up|0|||
164143909|NCT01449370|592888568|FG022|Overall Study|Lost to Follow-up|0|||
164143910|NCT01449370|592888569|FG023|Overall Study|Lost to Follow-up|0|||
164143911|NCT01449370|592888570|FG024|Overall Study|Lost to Follow-up|0|||
164143912|NCT01449370|592888546|FG000|Overall Study|Other|0|||
164143913|NCT01449370|592888547|FG001|Overall Study|Other|0|||
164143914|NCT01449370|592888548|FG002|Overall Study|Other|0|||
164143915|NCT01449370|592888549|FG003|Overall Study|Other|0|||
164143916|NCT01449370|592888550|FG004|Overall Study|Other|0|||
164143917|NCT01449370|592888551|FG005|Overall Study|Other|0|||
164143918|NCT01449370|592888552|FG006|Overall Study|Other|0|||
164143919|NCT01449370|592888553|FG007|Overall Study|Other|0|||
164143920|NCT01449370|592888554|FG008|Overall Study|Other|1|||
164143921|NCT01449370|592888555|FG009|Overall Study|Other|1|||
164143922|NCT01449370|592888556|FG010|Overall Study|Other|0|||
164143923|NCT01449370|592888557|FG011|Overall Study|Other|0|||
164143924|NCT01449370|592888558|FG012|Overall Study|Other|0|||
164143925|NCT01449370|592888559|FG013|Overall Study|Other|0|||
164143926|NCT01449370|592888560|FG014|Overall Study|Other|0|||
164143927|NCT01449370|592888561|FG015|Overall Study|Other|0|||
164143928|NCT01449370|592888562|FG016|Overall Study|Other|0|||
164143929|NCT01449370|592888563|FG017|Overall Study|Other|0|||
164143930|NCT01449370|592888564|FG018|Overall Study|Other|0|||
164143931|NCT01449370|592888565|FG019|Overall Study|Other|0|||
164143932|NCT01449370|592888566|FG020|Overall Study|Other|0|||
164143933|NCT01449370|592888567|FG021|Overall Study|Other|0|||
164143934|NCT01449370|592888568|FG022|Overall Study|Other|1|||
164143935|NCT01449370|592888569|FG023|Overall Study|Other|1|||
164143936|NCT01449370|592888570|FG024|Overall Study|Other|0|||
164143937|NCT01449370|592888546|FG000|Overall Study|Medication Prohibited by Protocol|0|||
164143938|NCT01449370|592888547|FG001|Overall Study|Medication Prohibited by Protocol|0|||
164143939|NCT01449370|592888548|FG002|Overall Study|Medication Prohibited by Protocol|0|||
164143940|NCT01449370|592888549|FG003|Overall Study|Medication Prohibited by Protocol|0|||
164143941|NCT01449370|592888550|FG004|Overall Study|Medication Prohibited by Protocol|0|||
164143942|NCT01449370|592888551|FG005|Overall Study|Medication Prohibited by Protocol|0|||
164143943|NCT01449370|592888552|FG006|Overall Study|Medication Prohibited by Protocol|0|||
164143944|NCT01449370|592888553|FG007|Overall Study|Medication Prohibited by Protocol|0|||
164143945|NCT01449370|592888554|FG008|Overall Study|Medication Prohibited by Protocol|0|||
164143946|NCT01449370|592888555|FG009|Overall Study|Medication Prohibited by Protocol|0|||
164143947|NCT01449370|592888556|FG010|Overall Study|Medication Prohibited by Protocol|0|||
164143948|NCT01449370|592888557|FG011|Overall Study|Medication Prohibited by Protocol|0|||
164143949|NCT01449370|592888558|FG012|Overall Study|Medication Prohibited by Protocol|0|||
164143950|NCT01449370|592888559|FG013|Overall Study|Medication Prohibited by Protocol|0|||
164143951|NCT01449370|592888560|FG014|Overall Study|Medication Prohibited by Protocol|0|||
164143952|NCT01449370|592888561|FG015|Overall Study|Medication Prohibited by Protocol|0|||
164143953|NCT01449370|592888562|FG016|Overall Study|Medication Prohibited by Protocol|0|||
164143954|NCT01449370|592888563|FG017|Overall Study|Medication Prohibited by Protocol|0|||
164143955|NCT01449370|592888564|FG018|Overall Study|Medication Prohibited by Protocol|0|||
164143956|NCT01449370|592888565|FG019|Overall Study|Medication Prohibited by Protocol|0|||
164143957|NCT01449370|592888566|FG020|Overall Study|Medication Prohibited by Protocol|0|||
164143958|NCT01449370|592888567|FG021|Overall Study|Medication Prohibited by Protocol|0|||
164143959|NCT01449370|592888568|FG022|Overall Study|Medication Prohibited by Protocol|0|||
164143960|NCT01449370|592888569|FG023|Overall Study|Medication Prohibited by Protocol|1|||
164143961|NCT01449370|592888570|FG024|Overall Study|Medication Prohibited by Protocol|0|||
164143962|NCT01449370|592888546|FG000|Overall Study|Death|0|||
164143963|NCT01449370|592888547|FG001|Overall Study|Death|0|||
164143964|NCT01449370|592888548|FG002|Overall Study|Death|0|||
164143965|NCT01449370|592888549|FG003|Overall Study|Death|0|||
164143966|NCT01449370|592888550|FG004|Overall Study|Death|0|||
164143967|NCT01449370|592888551|FG005|Overall Study|Death|0|||
164143968|NCT01449370|592888552|FG006|Overall Study|Death|0|||
164143969|NCT01449370|592888553|FG007|Overall Study|Death|0|||
164143970|NCT01449370|592888554|FG008|Overall Study|Death|0|||
164143971|NCT01449370|592888555|FG009|Overall Study|Death|0|||
164143972|NCT01449370|592888556|FG010|Overall Study|Death|0|||
164143973|NCT01449370|592888557|FG011|Overall Study|Death|0|||
164143974|NCT01449370|592888558|FG012|Overall Study|Death|0|||
164143975|NCT01449370|592888559|FG013|Overall Study|Death|0|||
164143976|NCT01449370|592888560|FG014|Overall Study|Death|0|||
164143977|NCT01449370|592888561|FG015|Overall Study|Death|0|||
164143978|NCT01449370|592888562|FG016|Overall Study|Death|0|||
164143979|NCT01449370|592888563|FG017|Overall Study|Death|0|||
164143980|NCT01449370|592888564|FG018|Overall Study|Death|0|||
164143981|NCT01449370|592888565|FG019|Overall Study|Death|0|||
164143982|NCT01449370|592888566|FG020|Overall Study|Death|0|||
164143983|NCT01449370|592888567|FG021|Overall Study|Death|0|||
164143984|NCT01449370|592888568|FG022|Overall Study|Death|0|||
164143985|NCT01449370|592888569|FG023|Overall Study|Death|0|||
164143986|NCT01449370|592888570|FG024|Overall Study|Death|1|||
164143987|NCT00086281|592888571|FG000|Phase 1|Adverse Event|0|||
164143988|NCT00086281|592888572|FG001|Phase 1|Adverse Event|0|||
164143989|NCT00086281|592888573|FG002|Phase 1|Adverse Event|0|||
164143990|NCT00086281|592888574|FG003|Phase 1|Adverse Event|0|||
164143991|NCT00086281|592888575|FG004|Phase 1|Adverse Event|0|||
164143992|NCT00086281|592888576|FG005|Phase 1|Adverse Event|0|||
164143993|NCT00086281|592888577|FG006|Phase 1|Adverse Event|0|||
164143994|NCT00086281|592888578|FG007|Phase 1|Adverse Event|0|||
164143995|NCT00086281|592888579|FG008|Phase 1|Adverse Event|0|||
164143996|NCT00086281|592888580|FG009|Phase 1|Adverse Event|1|||
164143997|NCT00086281|592888581|FG010|Phase 1|Adverse Event|2|||
164143998|NCT00086281|592888582|FG011|Phase 1|Adverse Event|1|||
164143999|NCT00086281|592888583|FG012|Phase 1|Adverse Event|1|||
164144000|NCT00086281|592888584|FG013|Phase 1|Adverse Event|1|||
164144001|NCT00086281|592888585|FG014|Phase 1|Adverse Event|2|||
164144002|NCT00086281|592888571|FG000|Phase 1|Protocol Violation|0|||
164144003|NCT00086281|592888572|FG001|Phase 1|Protocol Violation|0|||
164144004|NCT00086281|592888573|FG002|Phase 1|Protocol Violation|0|||
164144005|NCT00086281|592888574|FG003|Phase 1|Protocol Violation|0|||
164144006|NCT00086281|592888575|FG004|Phase 1|Protocol Violation|0|||
164144007|NCT00086281|592888576|FG005|Phase 1|Protocol Violation|0|||
164144008|NCT00086281|592888577|FG006|Phase 1|Protocol Violation|0|||
164144009|NCT00086281|592888578|FG007|Phase 1|Protocol Violation|0|||
164144010|NCT00086281|592888579|FG008|Phase 1|Protocol Violation|0|||
164144011|NCT00086281|592888580|FG009|Phase 1|Protocol Violation|0|||
164144012|NCT00086281|592888581|FG010|Phase 1|Protocol Violation|1|||
164144013|NCT00086281|592888582|FG011|Phase 1|Protocol Violation|0|||
164144014|NCT00086281|592888583|FG012|Phase 1|Protocol Violation|0|||
164144015|NCT00086281|592888584|FG013|Phase 1|Protocol Violation|0|||
164144016|NCT00086281|592888585|FG014|Phase 1|Protocol Violation|0|||
164144017|NCT00086281|592888571|FG000|Phase 1|Serious Adverse Event|0|||
164144018|NCT00086281|592888572|FG001|Phase 1|Serious Adverse Event|0|||
164144019|NCT00086281|592888573|FG002|Phase 1|Serious Adverse Event|0|||
164144020|NCT00086281|592888574|FG003|Phase 1|Serious Adverse Event|0|||
164144021|NCT00086281|592888575|FG004|Phase 1|Serious Adverse Event|0|||
164144022|NCT00086281|592888576|FG005|Phase 1|Serious Adverse Event|0|||
164144023|NCT00086281|592888577|FG006|Phase 1|Serious Adverse Event|0|||
164144048|NCT00908310|592888589|FG000|Overall Study|Withdrawal by Subject|7|||
164144049|NCT00908310|592888589|FG000|Overall Study|Lost to Follow-up|7|||
164144050|NCT00908310|592888589|FG000|Overall Study|Screening failure|5|||
164144051|NCT00908310|592888589|FG000|Overall Study|Other reasons|4|||
164144052|NCT00351533|592888592|FG000|Overall Study|Extubated before first BAL|1|||
164144053|NCT00351533|592888593|FG001|Overall Study|Extubated before first BAL|0|||
164144054|NCT00351533|592888592|FG000|Overall Study|Lost to Follow-up|1|||
164144055|NCT00351533|592888593|FG001|Overall Study|Lost to Follow-up|3|||
164144056|NCT00351533|592888592|FG000|Overall Study|Physician Decision|0|||
164144057|NCT00351533|592888593|FG001|Overall Study|Physician Decision|1|||
164144058|NCT00351533|592888592|FG000|Overall Study|Withdrawal by Subject|0|||
164144059|NCT00351533|592888593|FG001|Overall Study|Withdrawal by Subject|1|||
164144060|NCT01885195|592888594|FG000|Overall Study|Adverse Event|29|||
164144061|NCT01885195|592888594|FG000|Overall Study|Death|1|||
164144062|NCT01885195|592888594|FG000|Overall Study|Disease Progression|67|||
164144063|NCT01885195|592888594|FG000|Overall Study|Protocol Deviation|2|||
164144064|NCT01885195|592888594|FG000|Overall Study|Physician Decision|3|||
164144065|NCT01885195|592888594|FG000|Overall Study|Patient/guardian decision|8|||
164144066|NCT03390426|592888597|FG000|Overall Study|Protocol Violation|0|||
164144067|NCT03390426|592888598|FG001|Overall Study|Protocol Violation|1|||
164144068|NCT00259272|592888599|FG000|Overall Study|Adverse Event|2|||
164144069|NCT00259272|592888600|FG001|Overall Study|Adverse Event|1|||
164144070|NCT00259272|592888601|FG002|Overall Study|Adverse Event|0|||
164144071|NCT00259272|592888602|FG003|Overall Study|Adverse Event|3|||
164144072|NCT00259272|592888599|FG000|Overall Study|Lack of Efficacy|5|||
164144073|NCT00259272|592888600|FG001|Overall Study|Lack of Efficacy|1|||
164144074|NCT00259272|592888601|FG002|Overall Study|Lack of Efficacy|2|||
164144075|NCT00259272|592888602|FG003|Overall Study|Lack of Efficacy|6|||
164144076|NCT00259272|592888599|FG000|Overall Study|Physician Decision|1|||
164144077|NCT00259272|592888600|FG001|Overall Study|Physician Decision|2|||
164144078|NCT00259272|592888601|FG002|Overall Study|Physician Decision|1|||
164144079|NCT00259272|592888602|FG003|Overall Study|Physician Decision|3|||
164144080|NCT00259272|592888599|FG000|Overall Study|Protocol Violation|2|||
164144081|NCT00259272|592888600|FG001|Overall Study|Protocol Violation|0|||
164144082|NCT00259272|592888601|FG002|Overall Study|Protocol Violation|0|||
164144083|NCT00259272|592888602|FG003|Overall Study|Protocol Violation|1|||
164144084|NCT00259272|592888599|FG000|Overall Study|Sponsor Decision|0|||
164144085|NCT00259272|592888600|FG001|Overall Study|Sponsor Decision|1|||
164144086|NCT00259272|592888601|FG002|Overall Study|Sponsor Decision|0|||
164144087|NCT00259272|592888602|FG003|Overall Study|Sponsor Decision|0|||
164144088|NCT00259272|592888599|FG000|Overall Study|Withdrawal by Subject|4|||
164144089|NCT00259272|592888600|FG001|Overall Study|Withdrawal by Subject|2|||
164144090|NCT00259272|592888601|FG002|Overall Study|Withdrawal by Subject|2|||
164144091|NCT00259272|592888602|FG003|Overall Study|Withdrawal by Subject|7|||
164144092|NCT00259272|592888599|FG000|Overall Study|Lost to Follow-up|1|||
164144093|NCT00259272|592888600|FG001|Overall Study|Lost to Follow-up|0|||
164144094|NCT00259272|592888601|FG002|Overall Study|Lost to Follow-up|0|||
164144095|NCT00259272|592888602|FG003|Overall Study|Lost to Follow-up|1|||
164144096|NCT03301623|592888605|FG000|Overall Study|Death|3|||
164144097|NCT03301623|592888606|FG001|Overall Study|Death|1|||
164144098|NCT03301623|592888605|FG000|Overall Study|Withdrawal by Subject|11|||
164144099|NCT03301623|592888606|FG001|Overall Study|Withdrawal by Subject|13|||
164144100|NCT03301623|592888605|FG000|Overall Study|Lost to Follow-up|3|||
164144101|NCT03301623|592888606|FG001|Overall Study|Lost to Follow-up|1|||
164144102|NCT02516553|592888607|FG000|Overall Study|Progressive disease|2|||
164144103|NCT02516553|592888608|FG001|Overall Study|Progressive disease|2|||
164144104|NCT02516553|592888609|FG002|Overall Study|Progressive disease|3|||
164144105|NCT02516553|592888610|FG003|Overall Study|Progressive disease|5|||
164144106|NCT02516553|592888611|FG004|Overall Study|Progressive disease|3|||
164144107|NCT02516553|592888612|FG005|Overall Study|Progressive disease|0|||
164144108|NCT02516553|592888613|FG006|Overall Study|Progressive disease|5|||
164144109|NCT02516553|592888614|FG007|Overall Study|Progressive disease|5|||
164144110|NCT02516553|592888615|FG008|Overall Study|Progressive disease|11|||
164144111|NCT02516553|592888616|FG009|Overall Study|Progressive disease|3|||
164144112|NCT02516553|592888617|FG010|Overall Study|Progressive disease|10|||
164144113|NCT02516553|592888618|FG011|Overall Study|Progressive disease|8|||
164144114|NCT02516553|592888619|FG012|Overall Study|Progressive disease|8|||
164144115|NCT02516553|592888620|FG013|Overall Study|Progressive disease|2|||
164144116|NCT02516553|592888621|FG014|Overall Study|Progressive disease|2|||
164144117|NCT02516553|592888622|FG015|Overall Study|Progressive disease|2|||
164144118|NCT02516553|592888623|FG016|Overall Study|Progressive disease|1|||
164144119|NCT02516553|592888624|FG017|Overall Study|Progressive disease|9|||
164144120|NCT02516553|592888625|FG018|Overall Study|Progressive disease|12|||
164144121|NCT02516553|592888626|FG019|Overall Study|Progressive disease|7|||
164144122|NCT02516553|592888627|FG020|Overall Study|Progressive disease|16|||
164144123|NCT02516553|592888628|FG021|Overall Study|Progressive disease|18|||
164144124|NCT02516553|592888607|FG000|Overall Study|Dose limiting toxicity|0|||
164144125|NCT02516553|592888608|FG001|Overall Study|Dose limiting toxicity|0|||
164144126|NCT02516553|592888609|FG002|Overall Study|Dose limiting toxicity|0|||
164144127|NCT02516553|592888610|FG003|Overall Study|Dose limiting toxicity|0|||
164144128|NCT02516553|592888611|FG004|Overall Study|Dose limiting toxicity|3|||
164144129|NCT02516553|592888612|FG005|Overall Study|Dose limiting toxicity|1|||
164144130|NCT02516553|592888613|FG006|Overall Study|Dose limiting toxicity|1|||
164144131|NCT02516553|592888614|FG007|Overall Study|Dose limiting toxicity|0|||
164144132|NCT02516553|592888615|FG008|Overall Study|Dose limiting toxicity|1|||
164144133|NCT02516553|592888616|FG009|Overall Study|Dose limiting toxicity|0|||
164144134|NCT02516553|592888617|FG010|Overall Study|Dose limiting toxicity|0|||
164144135|NCT02516553|592888618|FG011|Overall Study|Dose limiting toxicity|1|||
164144136|NCT02516553|592888619|FG012|Overall Study|Dose limiting toxicity|0|||
164144137|NCT02516553|592888620|FG013|Overall Study|Dose limiting toxicity|1|||
164144138|NCT02516553|592888621|FG014|Overall Study|Dose limiting toxicity|0|||
164144139|NCT02516553|592888622|FG015|Overall Study|Dose limiting toxicity|0|||
164144140|NCT02516553|592888623|FG016|Overall Study|Dose limiting toxicity|1|||
164144141|NCT02516553|592888624|FG017|Overall Study|Dose limiting toxicity|1|||
164144142|NCT02516553|592888625|FG018|Overall Study|Dose limiting toxicity|0|||
164144143|NCT02516553|592888626|FG019|Overall Study|Dose limiting toxicity|2|||
164144144|NCT02516553|592888627|FG020|Overall Study|Dose limiting toxicity|0|||
164144145|NCT02516553|592888628|FG021|Overall Study|Dose limiting toxicity|0|||
164144146|NCT02516553|592888607|FG000|Overall Study|Other Adverse Events|0|||
164144147|NCT02516553|592888608|FG001|Overall Study|Other Adverse Events|0|||
164144148|NCT02516553|592888609|FG002|Overall Study|Other Adverse Events|0|||
164144149|NCT02516553|592888610|FG003|Overall Study|Other Adverse Events|1|||
164144150|NCT02516553|592888611|FG004|Overall Study|Other Adverse Events|0|||
164144151|NCT02516553|592888612|FG005|Overall Study|Other Adverse Events|1|||
164144152|NCT02516553|592888613|FG006|Overall Study|Other Adverse Events|0|||
164144153|NCT02516553|592888614|FG007|Overall Study|Other Adverse Events|0|||
164144154|NCT02516553|592888615|FG008|Overall Study|Other Adverse Events|0|||
164144155|NCT02516553|592888616|FG009|Overall Study|Other Adverse Events|1|||
164144156|NCT02516553|592888617|FG010|Overall Study|Other Adverse Events|3|||
164144157|NCT02516553|592888618|FG011|Overall Study|Other Adverse Events|2|||
164144158|NCT02516553|592888619|FG012|Overall Study|Other Adverse Events|0|||
164144159|NCT02516553|592888620|FG013|Overall Study|Other Adverse Events|1|||
164144160|NCT02516553|592888621|FG014|Overall Study|Other Adverse Events|0|||
164144161|NCT02516553|592888622|FG015|Overall Study|Other Adverse Events|0|||
164144162|NCT02516553|592888623|FG016|Overall Study|Other Adverse Events|0|||
164144163|NCT02516553|592888624|FG017|Overall Study|Other Adverse Events|2|||
164144164|NCT02516553|592888625|FG018|Overall Study|Other Adverse Events|1|||
164144165|NCT02516553|592888626|FG019|Overall Study|Other Adverse Events|2|||
164144166|NCT02516553|592888627|FG020|Overall Study|Other Adverse Events|2|||
164144167|NCT02516553|592888628|FG021|Overall Study|Other Adverse Events|1|||
164144168|NCT02516553|592888607|FG000|Overall Study|Refused to continue trial medication|0|||
164144169|NCT02516553|592888608|FG001|Overall Study|Refused to continue trial medication|0|||
164144170|NCT02516553|592888609|FG002|Overall Study|Refused to continue trial medication|0|||
164144171|NCT02516553|592888610|FG003|Overall Study|Refused to continue trial medication|0|||
164144172|NCT02516553|592888611|FG004|Overall Study|Refused to continue trial medication|0|||
164144173|NCT02516553|592888612|FG005|Overall Study|Refused to continue trial medication|0|||
164144174|NCT02516553|592888613|FG006|Overall Study|Refused to continue trial medication|0|||
164144175|NCT02516553|592888614|FG007|Overall Study|Refused to continue trial medication|0|||
164144176|NCT02516553|592888615|FG008|Overall Study|Refused to continue trial medication|0|||
164144177|NCT02516553|592888616|FG009|Overall Study|Refused to continue trial medication|0|||
164144178|NCT02516553|592888617|FG010|Overall Study|Refused to continue trial medication|1|||
164144179|NCT02516553|592888618|FG011|Overall Study|Refused to continue trial medication|0|||
164144180|NCT02516553|592888619|FG012|Overall Study|Refused to continue trial medication|0|||
164144181|NCT02516553|592888620|FG013|Overall Study|Refused to continue trial medication|0|||
164144182|NCT02516553|592888621|FG014|Overall Study|Refused to continue trial medication|0|||
164144183|NCT02516553|592888622|FG015|Overall Study|Refused to continue trial medication|0|||
164144184|NCT02516553|592888623|FG016|Overall Study|Refused to continue trial medication|0|||
164144185|NCT02516553|592888624|FG017|Overall Study|Refused to continue trial medication|0|||
164144186|NCT02516553|592888625|FG018|Overall Study|Refused to continue trial medication|1|||
164144187|NCT02516553|592888626|FG019|Overall Study|Refused to continue trial medication|0|||
164144188|NCT02516553|592888627|FG020|Overall Study|Refused to continue trial medication|0|||
164144189|NCT02516553|592888628|FG021|Overall Study|Refused to continue trial medication|1|||
164144190|NCT02516553|592888607|FG000|Overall Study|other reasons than listed|0|||
164144191|NCT02516553|592888608|FG001|Overall Study|other reasons than listed|0|||
164144192|NCT02516553|592888609|FG002|Overall Study|other reasons than listed|0|||
164144193|NCT02516553|592888610|FG003|Overall Study|other reasons than listed|0|||
164144194|NCT02516553|592888611|FG004|Overall Study|other reasons than listed|0|||
164144195|NCT02516553|592888612|FG005|Overall Study|other reasons than listed|0|||
164144196|NCT02516553|592888613|FG006|Overall Study|other reasons than listed|0|||
164144197|NCT02516553|592888614|FG007|Overall Study|other reasons than listed|1|||
164144198|NCT02516553|592888615|FG008|Overall Study|other reasons than listed|1|||
164144199|NCT02516553|592888616|FG009|Overall Study|other reasons than listed|0|||
164144200|NCT02516553|592888617|FG010|Overall Study|other reasons than listed|1|||
164144201|NCT02516553|592888618|FG011|Overall Study|other reasons than listed|1|||
164144202|NCT02516553|592888619|FG012|Overall Study|other reasons than listed|0|||
164144203|NCT02516553|592888620|FG013|Overall Study|other reasons than listed|0|||
164144204|NCT02516553|592888621|FG014|Overall Study|other reasons than listed|0|||
164144205|NCT02516553|592888622|FG015|Overall Study|other reasons than listed|0|||
164144206|NCT02516553|592888623|FG016|Overall Study|other reasons than listed|0|||
164144207|NCT02516553|592888624|FG017|Overall Study|other reasons than listed|0|||
164144208|NCT02516553|592888625|FG018|Overall Study|other reasons than listed|0|||
164144209|NCT02516553|592888626|FG019|Overall Study|other reasons than listed|0|||
164144210|NCT02516553|592888627|FG020|Overall Study|other reasons than listed|2|||
164144211|NCT02516553|592888628|FG021|Overall Study|other reasons than listed|2|||
164144212|NCT00315731|592888630|FG000|Overall Study|Lost to Follow-up|1|||
164144213|NCT00315731|592888630|FG000|Overall Study|Death|5|||
164144214|NCT01680497|592888632|FG000|Overall Study|Lost to Follow-up|2|||
164144215|NCT03462459|592888634|FG000|Overall Study|Death|1|||
164144216|NCT03462459|592888635|FG001|Overall Study|Death|0|||
164144217|NCT03462459|592888634|FG000|Overall Study|Lack of Efficacy|2|||
164144218|NCT03462459|592888635|FG001|Overall Study|Lack of Efficacy|4|||
164144219|NCT03462459|592888634|FG000|Overall Study|Lost to Follow-up|1|||
164144220|NCT03462459|592888635|FG001|Overall Study|Lost to Follow-up|3|||
164144221|NCT03462459|592888634|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
164144222|NCT03462459|592888635|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
164144223|NCT03462459|592888634|FG000|Overall Study|Withdrawal by Subject|3|||
164144224|NCT03462459|592888635|FG001|Overall Study|Withdrawal by Subject|2|||
164144225|NCT03462459|592888634|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
164144226|NCT03462459|592888635|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
164144227|NCT01177059|592888636|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
164144228|NCT01177059|592888636|FG000|Overall Study|Withdrew consent|2|||
164144229|NCT01177059|592888636|FG000|Overall Study|Lost to Follow-up|18|||
164144230|NCT01243775|592888637|FG000|Overall Study|Withdrawal by Subject|2|||
164144231|NCT04051619|592888638|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
164144232|NCT04051619|592888639|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
164144233|NCT04051619|592888638|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
164144234|NCT04051619|592888639|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
164144235|NCT05938621|592889795|FG000|Overall Study|Lost to Follow-up|1|||
164144236|NCT05938621|592889796|FG001|Overall Study|Lost to Follow-up|5|||
164144237|NCT05938621|592889797|FG002|Overall Study|Lost to Follow-up|2|||
164144238|NCT05938621|592889798|FG003|Overall Study|Lost to Follow-up|2|||
164144239|NCT02731638|592889799|FG000|Overall Study|Lost to Follow-up|6|||
164144240|NCT02731638|592889800|FG001|Overall Study|Lost to Follow-up|9|||
164144241|NCT04158245|592889801|FG000|Overall Study|Lost to Follow-up|1|||
164144242|NCT02454608|592889802|FG000|Double-Blind Period|Lack of Efficacy|0|||
164144243|NCT02454608|592889803|FG001|Double-Blind Period|Lack of Efficacy|2|||
164144244|NCT02454608|592889804|FG002|Double-Blind Period|Lack of Efficacy|0|||
164144245|NCT02454608|592889802|FG000|Open Label Period|Lost to Follow-up|0|||
164144246|NCT02454608|592889803|FG001|Open Label Period|Lost to Follow-up|0|||
164144247|NCT02454608|592889804|FG002|Open Label Period|Lost to Follow-up|11|||
164144248|NCT02454608|592889802|FG000|Open Label Period|Withdrawal by Subject|0|||
164144249|NCT02454608|592889803|FG001|Open Label Period|Withdrawal by Subject|0|||
164144250|NCT02454608|592889804|FG002|Open Label Period|Withdrawal by Subject|8|||
164144251|NCT04856930|592889805|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
164144252|NCT04856930|592889806|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
164144253|NCT04856930|592889807|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
164144254|NCT04856930|592889805|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
164144255|NCT04856930|592889806|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
164144256|NCT04856930|592889807|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
164144257|NCT04856930|592889805|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
164144258|NCT04856930|592889806|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
164144259|NCT04856930|592889807|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
164144260|NCT04856930|592889805|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
164144261|NCT04856930|592889806|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
164144262|NCT04856930|592889807|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
164144263|NCT04856930|592889805|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
164144264|NCT04856930|592889806|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
164144265|NCT04856930|592889807|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
164144266|NCT04856930|592889805|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
164144267|NCT04856930|592889806|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
164144268|NCT04856930|592889807|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
164144269|NCT04856930|592889805|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
164144270|NCT04856930|592889806|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
164144271|NCT04856930|592889807|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
164144272|NCT04856930|592889805|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
164144273|NCT04856930|592889806|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
164144274|NCT04856930|592889807|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
164144275|NCT04856930|592889805|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
164144276|NCT04856930|592889806|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
164144277|NCT04856930|592889807|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
164144278|NCT04856930|592889805|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
164144279|NCT04856930|592889806|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
164144280|NCT04856930|592889807|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
164144281|NCT04856930|592889805|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
164144282|NCT04856930|592889806|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
164144283|NCT04856930|592889807|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
164144284|NCT04856930|592889805|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
164144285|NCT04856930|592889806|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
164144286|NCT04856930|592889807|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
164144287|NCT04856930|592889805|FG000|Extension Period (16 Weeks)|Other than specified|0|||
164144288|NCT04856930|592889806|FG001|Extension Period (16 Weeks)|Other than specified|0|||
164144289|NCT04856930|592889807|FG002|Extension Period (16 Weeks)|Other than specified|1|||
164144290|NCT04856930|592889805|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
164144291|NCT04856930|592889806|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
164144292|NCT04856930|592889807|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
164144293|NCT04856930|592889805|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
164144294|NCT04856930|592889806|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
164144295|NCT04856930|592889807|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
164144296|NCT04856930|592889805|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
164144297|NCT04856930|592889806|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
164144298|NCT04856930|592889807|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
164144299|NCT04856930|592889805|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
164144300|NCT04856930|592889806|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
164144301|NCT04856930|592889807|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
164144302|NCT00678210|592889808|FG000|Overall Study|Adverse Event|1|||
164144303|NCT00678210|592889809|FG001|Overall Study|Adverse Event|2|||
164144304|NCT00678210|592889810|FG002|Overall Study|Adverse Event|3|||
164144305|NCT00678210|592889811|FG003|Overall Study|Adverse Event|3|||
164144306|NCT00678210|592889808|FG000|Overall Study|Lack of Efficacy|2|||
164144307|NCT00678210|592889809|FG001|Overall Study|Lack of Efficacy|3|||
164144308|NCT00678210|592889810|FG002|Overall Study|Lack of Efficacy|1|||
164144309|NCT00678210|592889811|FG003|Overall Study|Lack of Efficacy|9|||
164144310|NCT00678210|592889808|FG000|Overall Study|Lost to Follow-up|4|||
164144311|NCT00678210|592889809|FG001|Overall Study|Lost to Follow-up|2|||
164144312|NCT00678210|592889810|FG002|Overall Study|Lost to Follow-up|0|||
164144313|NCT00678210|592889811|FG003|Overall Study|Lost to Follow-up|1|||
164144314|NCT00678210|592889808|FG000|Overall Study|Withdrawal by Subject|3|||
164144315|NCT00678210|592889809|FG001|Overall Study|Withdrawal by Subject|4|||
164144316|NCT00678210|592889810|FG002|Overall Study|Withdrawal by Subject|1|||
164144317|NCT00678210|592889811|FG003|Overall Study|Withdrawal by Subject|7|||
164144318|NCT00678210|592889808|FG000|Overall Study|Other|1|||
164144319|NCT00678210|592889809|FG001|Overall Study|Other|0|||
164144320|NCT00678210|592889810|FG002|Overall Study|Other|1|||
164144321|NCT00678210|592889811|FG003|Overall Study|Other|0|||
164144322|NCT01383707|592889814|FG000|Overall Study|Consent withdrawal|6|||
164144323|NCT01383707|592889814|FG000|Overall Study|Death|19|||
164144324|NCT01383707|592889814|FG000|Overall Study|Other|8|||
164144325|NCT01383707|592889814|FG000|Overall Study|Sponsor's decision|2|||
164144326|NCT01383707|592889814|FG000|Overall Study|Adverse Event|14|||
164144327|NCT01383707|592889814|FG000|Overall Study|Progressive disease|23|||
164144328|NCT02473523|592889826|FG000|Overall Study|Death|1|||
164144329|NCT02473523|592889826|FG000|Overall Study|Lost to Follow-up|1|||
164144330|NCT02111603|592889829|FG000|Overall Study|Withdrawal by Subject|1|||
164144331|NCT00976911|592889830|FG000|Overall Study|Withdrawal by Subject|4|||
164144332|NCT00976911|592889831|FG001|Overall Study|Withdrawal by Subject|6|||
164144333|NCT00976911|592889830|FG000|Overall Study|Death|138|||
164144334|NCT00976911|592889831|FG001|Overall Study|Death|126|||
164144335|NCT00976911|592889830|FG000|Overall Study|Adverse Event|0|||
164144336|NCT00976911|592889831|FG001|Overall Study|Adverse Event|1|||
164144337|NCT00976911|592889830|FG000|Overall Study|Protocol Violation|2|||
164144338|NCT00976911|592889831|FG001|Overall Study|Protocol Violation|0|||
164144339|NCT00976911|592889830|FG000|Overall Study|Other|8|||
164144340|NCT00976911|592889831|FG001|Overall Study|Other|9|||
164144341|NCT00976911|592889830|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
164144342|NCT00976911|592889831|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
164144343|NCT02954991|592889832|FG000|Overall Study|Death|92|||
164144344|NCT02954991|592889833|FG001|Overall Study|Death|11|||
164144345|NCT02954991|592889834|FG002|Overall Study|Death|2|||
164144346|NCT02954991|592889832|FG000|Overall Study|Lost to Follow-up|3|||
164144349|NCT02954991|592889832|FG000|Overall Study|Withdrawal by Subject|9|||
164144350|NCT02954991|592889833|FG001|Overall Study|Withdrawal by Subject|8|||
164144351|NCT02954991|592889834|FG002|Overall Study|Withdrawal by Subject|1|||
164144352|NCT02954991|592889832|FG000|Overall Study|Study Terminated by Sponsor|18|||
164144353|NCT02954991|592889833|FG001|Overall Study|Study Terminated by Sponsor|10|||
164144354|NCT02954991|592889834|FG002|Overall Study|Study Terminated by Sponsor|1|||
164144355|NCT02954991|592889832|FG000|Overall Study|Miscellaneous|2|||
164144356|NCT02954991|592889833|FG001|Overall Study|Miscellaneous|1|||
164144357|NCT02954991|592889834|FG002|Overall Study|Miscellaneous|1|||
164144358|NCT00576316|592889835|FG000|Overall Study|Adverse Event|9|||
164144359|NCT00576316|592889835|FG000|Overall Study|Withdrawal by Subject|2|||
164144360|NCT00576316|592889835|FG000|Overall Study|Protocol Violation|9|||
164144361|NCT02552303|592889838|FG000|Allocation|Withdrawal by Subject|2|||
164144362|NCT02552303|592889839|FG001|Allocation|Withdrawal by Subject|1|||
164144363|NCT02552303|592889840|FG002|Allocation|Withdrawal by Subject|1|||
164144364|NCT02552303|592889841|FG003|Allocation|Withdrawal by Subject|1|||
164144365|NCT02552303|592889838|FG000|Allocation|ineligible|1|||
164144366|NCT02552303|592889839|FG001|Allocation|ineligible|1|||
164144367|NCT02552303|592889840|FG002|Allocation|ineligible|0|||
164144368|NCT02552303|592889841|FG003|Allocation|ineligible|0|||
164144369|NCT02552303|592889838|FG000|Follow-Up|Lost to Follow-up|0|||
164144370|NCT02552303|592889839|FG001|Follow-Up|Lost to Follow-up|0|||
164144371|NCT02552303|592889840|FG002|Follow-Up|Lost to Follow-up|1|||
164144372|NCT02552303|592889841|FG003|Follow-Up|Lost to Follow-up|0|||
164144373|NCT02552303|592889838|FG000|Follow-Up|ineligible|0|||
164144374|NCT02552303|592889839|FG001|Follow-Up|ineligible|2|||
164144375|NCT02552303|592889840|FG002|Follow-Up|ineligible|0|||
164144376|NCT02552303|592889841|FG003|Follow-Up|ineligible|0|||
164144377|NCT01582152|592889842|FG000|Overall Study|Disease Progression|4|||
164144378|NCT01582152|592889843|FG001|Overall Study|Disease Progression|5|||
164144379|NCT01582152|592889842|FG000|Overall Study|Adverse Event|2|||
164144380|NCT01582152|592889843|FG001|Overall Study|Adverse Event|1|||
164144381|NCT03055624|592889844|FG000|Overall Study|Study closed|9|||
164144382|NCT02437903|592889847|FG000|Overall Study|Adverse Event|1|||
164144383|NCT02437903|592889847|FG000|Overall Study|Withdrawal by Subject|1|||
164144384|NCT02437903|592889847|FG000|Overall Study|Lost to Follow-up|3|||
164144385|NCT00799825|592889851|FG000|Overall Study|Adverse Event|1|||
164144386|NCT00799825|592889851|FG000|Overall Study|Withdrawal by Subject|6|||
164144387|NCT00799825|592889851|FG000|Overall Study|Lost to Follow-up|38|||
164144388|NCT00799825|592889851|FG000|Overall Study|Pregnancy|3|||
164144389|NCT00362336|592889852|FG000|Overall Study|Serious Adverse Event|1|||
164144390|NCT00362336|592889853|FG001|Overall Study|Serious Adverse Event|0|||
164144391|NCT00362336|592889854|FG002|Overall Study|Serious Adverse Event|1|||
164144392|NCT00362336|592889852|FG000|Overall Study|Protocol Violation|0|||
164144393|NCT00362336|592889853|FG001|Overall Study|Protocol Violation|0|||
164144394|NCT00362336|592889854|FG002|Overall Study|Protocol Violation|1|||
164144395|NCT00362336|592889852|FG000|Overall Study|Lost to Follow-up|6|||
164144396|NCT00362336|592889853|FG001|Overall Study|Lost to Follow-up|4|||
164144397|NCT00362336|592889854|FG002|Overall Study|Lost to Follow-up|0|||
164144398|NCT00362336|592889852|FG000|Overall Study|Withdrawal by Subject|3|||
164144399|NCT00362336|592889853|FG001|Overall Study|Withdrawal by Subject|3|||
164144400|NCT00362336|592889854|FG002|Overall Study|Withdrawal by Subject|1|||
164144401|NCT02289456|592889855|FG000|Induction Period|Death|2|||
164144402|NCT02289456|592889855|FG000|Induction Period|Adverse Event|11|||
164144403|NCT02289456|592889855|FG000|Induction Period|Progressive Disease (PD)|4|||
164144404|NCT02289456|592889855|FG000|Induction Period|Symptomatic Deterioration|4|||
164144405|NCT02289456|592889855|FG000|Induction Period|Withdrawal by Subject|2|||
164144406|NCT02289456|592889855|FG000|Induction Period|Miscellaneous|1|||
164144407|NCT02289456|592889855|FG000|Monotherapy Period|Death|1|||
164144408|NCT02289456|592889855|FG000|Monotherapy Period|Adverse Event|1|||
164144409|NCT02289456|592889855|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
164144410|NCT02289456|592889855|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
164144411|NCT02289456|592889855|FG000|Monotherapy Period|Withdrawal by Subject|2|||
164144412|NCT02289456|592889855|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
164144413|NCT02289456|592889855|FG000|Monotherapy Period|Miscellaneous|1|||
164144414|NCT01625988|592889856|FG000|Overall Study|Lost to Follow-up|5|||
164144415|NCT01625988|592889857|FG001|Overall Study|Lost to Follow-up|6|||
164144416|NCT01625988|592889856|FG000|Overall Study|Withdrawal by Subject|8|||
164144417|NCT01625988|592889857|FG001|Overall Study|Withdrawal by Subject|3|||
164144418|NCT01625988|592889856|FG000|Overall Study|Adverse Event|0|||
164144419|NCT01625988|592889857|FG001|Overall Study|Adverse Event|1|||
164144420|NCT01625988|592889856|FG000|Overall Study|Lack of Efficacy|0|||
164144421|NCT01625988|592889857|FG001|Overall Study|Lack of Efficacy|1|||
164144422|NCT01625988|592889856|FG000|Overall Study|Randomized Inappropriately|1|||
164144423|NCT01625988|592889857|FG001|Overall Study|Randomized Inappropriately|0|||
164144424|NCT01625988|592889856|FG000|Overall Study|Protocol Violation|0|||
164144425|NCT01625988|592889857|FG001|Overall Study|Protocol Violation|2|||
164144426|NCT02681510|592889858|FG000|Overall Study|Withdrawal by Subject|1|||
164144427|NCT02681510|592889858|FG000|Overall Study|Lost to Follow-up|9|||
164144428|NCT00134901|592889868|FG000|Overall Study|Lost to Follow-up|5|||
164144430|NCT00134901|592889868|FG000|Overall Study|discontinued intervention|12|||
164144431|NCT00134901|592889869|FG001|Overall Study|discontinued intervention|10|||
164144432|NCT04841577|592889870|FG000|Overall Study|Adverse Event|5|||
164144433|NCT04841577|592889871|FG001|Overall Study|Adverse Event|10|||
164144434|NCT04841577|592889870|FG000|Overall Study|Lost to Follow-up|8|||
164144435|NCT04841577|592889871|FG001|Overall Study|Lost to Follow-up|7|||
164144436|NCT04841577|592889870|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
164144437|NCT04841577|592889871|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
164144438|NCT04841577|592889870|FG000|Overall Study|Other|0|||
164144439|NCT04841577|592889871|FG001|Overall Study|Other|1|||
164144440|NCT01004003|592889874|FG000|Overall Study|Progressive disease|2|||
164144441|NCT01004003|592889875|FG001|Overall Study|Progressive disease|1|||
164144442|NCT01004003|592889876|FG002|Overall Study|Progressive disease|1|||
164144443|NCT01004003|592889877|FG003|Overall Study|Progressive disease|0|||
164144444|NCT01004003|592889878|FG004|Overall Study|Progressive disease|2|||
164144445|NCT01004003|592889879|FG005|Overall Study|Progressive disease|1|||
164144446|NCT01004003|592889880|FG006|Overall Study|Progressive disease|1|||
164144447|NCT01004003|592889881|FG007|Overall Study|Progressive disease|39|||
164144448|NCT01004003|592889882|FG008|Overall Study|Progressive disease|22|||
164144449|NCT01004003|592889874|FG000|Overall Study|Adverse Event|4|||
164144450|NCT01004003|592889875|FG001|Overall Study|Adverse Event|2|||
164144451|NCT01004003|592889876|FG002|Overall Study|Adverse Event|3|||
164144452|NCT01004003|592889877|FG003|Overall Study|Adverse Event|3|||
164144453|NCT01004003|592889878|FG004|Overall Study|Adverse Event|2|||
164144454|NCT01004003|592889879|FG005|Overall Study|Adverse Event|2|||
164144455|NCT01004003|592889880|FG006|Overall Study|Adverse Event|7|||
164144456|NCT01004003|592889881|FG007|Overall Study|Adverse Event|21|||
164144457|NCT01004003|592889882|FG008|Overall Study|Adverse Event|6|||
164144458|NCT01004003|592889874|FG000|Overall Study|Refused to continue taking trial med.|0|||
164144459|NCT01004003|592889875|FG001|Overall Study|Refused to continue taking trial med.|0|||
164144460|NCT01004003|592889876|FG002|Overall Study|Refused to continue taking trial med.|0|||
164144461|NCT01004003|592889877|FG003|Overall Study|Refused to continue taking trial med.|0|||
164144462|NCT01004003|592889878|FG004|Overall Study|Refused to continue taking trial med.|0|||
164144463|NCT01004003|592889879|FG005|Overall Study|Refused to continue taking trial med.|0|||
164144464|NCT01004003|592889880|FG006|Overall Study|Refused to continue taking trial med.|0|||
164144465|NCT01004003|592889881|FG007|Overall Study|Refused to continue taking trial med.|0|||
164144466|NCT01004003|592889882|FG008|Overall Study|Refused to continue taking trial med.|2|||
164144467|NCT01004003|592889874|FG000|Overall Study|Other|0|||
164144468|NCT01004003|592889875|FG001|Overall Study|Other|0|||
164144469|NCT01004003|592889876|FG002|Overall Study|Other|0|||
164144470|NCT01004003|592889877|FG003|Overall Study|Other|0|||
164144471|NCT01004003|592889878|FG004|Overall Study|Other|0|||
164144472|NCT01004003|592889879|FG005|Overall Study|Other|1|||
164144473|NCT01004003|592889880|FG006|Overall Study|Other|0|||
164144474|NCT01004003|592889881|FG007|Overall Study|Other|0|||
164144475|NCT01004003|592889882|FG008|Overall Study|Other|0|||
164144476|NCT01589497|592889886|FG000|Overall Study|Withdrawal by Subject|0|||
164144477|NCT01589497|592889887|FG001|Overall Study|Withdrawal by Subject|1|||
164144478|NCT01589497|592889888|FG002|Overall Study|Withdrawal by Subject|0|||
164144479|NCT01589497|592889889|FG003|Overall Study|Withdrawal by Subject|1|||
164144480|NCT01589497|592889886|FG000|Overall Study|Death|1|||
164144481|NCT01589497|592889887|FG001|Overall Study|Death|0|||
164144482|NCT01589497|592889888|FG002|Overall Study|Death|0|||
164144483|NCT01589497|592889889|FG003|Overall Study|Death|0|||
164144484|NCT01589497|592889886|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
164144485|NCT01589497|592889887|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
164144486|NCT01589497|592889888|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
164144487|NCT01589497|592889889|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
164144488|NCT04123561|592889896|FG000|Overall Study|Lost to Follow-up|20|||
164144489|NCT04123561|592889897|FG001|Overall Study|Lost to Follow-up|12|||
164144490|NCT04123561|592889898|FG002|Overall Study|Lost to Follow-up|5|||
164144491|NCT04123561|592889896|FG000|Overall Study|Withdrawal by Subject|9|||
164144492|NCT04123561|592889897|FG001|Overall Study|Withdrawal by Subject|7|||
164144493|NCT04123561|592889898|FG002|Overall Study|Withdrawal by Subject|9|||
164144494|NCT04123561|592889896|FG000|Overall Study|Lack of Efficacy|7|||
164144495|NCT04123561|592889897|FG001|Overall Study|Lack of Efficacy|8|||
164144496|NCT04123561|592889898|FG002|Overall Study|Lack of Efficacy|6|||
164144497|NCT04123561|592889896|FG000|Overall Study|Adverse Event|5|||
164144498|NCT04123561|592889897|FG001|Overall Study|Adverse Event|2|||
164144499|NCT04123561|592889898|FG002|Overall Study|Adverse Event|3|||
164144500|NCT04123561|592889896|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
164144501|NCT04123561|592889897|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
164144502|NCT04123561|592889898|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
164144503|NCT04123561|592889896|FG000|Overall Study|Death|0|||
164144504|NCT04123561|592889897|FG001|Overall Study|Death|0|||
164144505|NCT04123561|592889898|FG002|Overall Study|Death|1|||
164144506|NCT04123561|592889896|FG000|Overall Study|Protocol Violation|0|||
164144509|NCT01653912|592889906|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
164144510|NCT01653912|592889907|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
164144511|NCT01653912|592889908|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
164144512|NCT01653912|592889909|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
164144513|NCT01653912|592889910|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
164144514|NCT01653912|592889911|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
164144515|NCT01653912|592889906|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
164144516|NCT01653912|592889907|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
164144517|NCT01653912|592889908|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
164144518|NCT01653912|592889909|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
164144519|NCT01653912|592889910|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
164144520|NCT01653912|592889911|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
164144521|NCT01653912|592889906|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
164144522|NCT01653912|592889907|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
164144523|NCT01653912|592889908|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
164144524|NCT01653912|592889909|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
164144525|NCT01653912|592889910|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
164144526|NCT01653912|592889911|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
164144527|NCT01653912|592889906|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
164144528|NCT01653912|592889907|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
164144529|NCT01653912|592889908|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
164144530|NCT01653912|592889909|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
164144531|NCT01653912|592889910|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
164144532|NCT01653912|592889911|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
164144533|NCT01653912|592889906|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
164144534|NCT01653912|592889907|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
164144535|NCT01653912|592889908|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
164144536|NCT01653912|592889909|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
164144537|NCT01653912|592889910|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
164144538|NCT01653912|592889911|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
164144539|NCT01653912|592889906|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
164144540|NCT01653912|592889907|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
164144541|NCT01653912|592889908|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
164144542|NCT01653912|592889909|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
164144543|NCT01653912|592889910|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
164144544|NCT01653912|592889911|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
164144545|NCT01653912|592889906|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
164144546|NCT01653912|592889907|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
164144547|NCT01653912|592889908|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
164144548|NCT01653912|592889909|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
164144549|NCT01653912|592889910|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
164144550|NCT01653912|592889911|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
164144551|NCT00708227|592889912|FG000|Overall Study|Physician Decision|0|||
164144552|NCT00708227|592889913|FG001|Overall Study|Physician Decision|3|||
164144553|NCT00708227|592889914|FG002|Overall Study|Physician Decision|1|||
164144554|NCT00708227|592889915|FG003|Overall Study|Physician Decision|2|||
164144555|NCT00708227|592889912|FG000|Overall Study|Withdrawal by Subject|1|||
164144556|NCT00708227|592889913|FG001|Overall Study|Withdrawal by Subject|2|||
164144557|NCT00708227|592889914|FG002|Overall Study|Withdrawal by Subject|0|||
164144558|NCT00708227|592889915|FG003|Overall Study|Withdrawal by Subject|1|||
164144559|NCT04007991|592889916|FG000|Overall Study|Withdrawal by Subject|1|||
164144560|NCT04007991|592889917|FG001|Overall Study|Withdrawal by Subject|1|||
164144561|NCT04007991|592889916|FG000|Overall Study|Physician Decision|1|||
164144562|NCT04007991|592889917|FG001|Overall Study|Physician Decision|1|||
164144563|NCT04007991|592889916|FG000|Overall Study|Non-compliance with Study Drug|0|||
164144564|NCT04007991|592889917|FG001|Overall Study|Non-compliance with Study Drug|1|||
164144565|NCT04007991|592889916|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
164144566|NCT04007991|592889917|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
164144567|NCT04007991|592889916|FG000|Overall Study|Adverse event, non-fatal|5|||
164144568|NCT04007991|592889917|FG001|Overall Study|Adverse event, non-fatal|0|||
164144569|NCT04007991|592889916|FG000|Overall Study|Lost to Follow-up|2|||
164144570|NCT04007991|592889917|FG001|Overall Study|Lost to Follow-up|1|||
164144571|NCT01987479|592889918|FG000|Overall Study|Protocol Violation|1|||
164144572|NCT01987479|592889918|FG000|Overall Study|Physician Decision|2|||
164144573|NCT01987479|592889918|FG000|Overall Study|Participant/legal guardian decision|1|||
164144574|NCT01987479|592889918|FG000|Overall Study|Other|5|||
164144575|NCT01987479|592889918|FG000|Overall Study|Lost to Follow-up|1|||
164144576|NCT01987479|592889918|FG000|Overall Study|Adverse Event|7|||
164144577|NCT03654599|592889921|FG000|Overall Study|Lost to Follow-up|14|||
164144578|NCT03654599|592889922|FG001|Overall Study|Lost to Follow-up|12|||
164144579|NCT03654599|592889921|FG000|Overall Study|Death|8|||
164144580|NCT03654599|592889922|FG001|Overall Study|Death|6|||
164144581|NCT03654599|592889921|FG000|Overall Study|Withdrawal by Subject|6|||
164144582|NCT03654599|592889922|FG001|Overall Study|Withdrawal by Subject|4|||
164144583|NCT01290302|592891703|FG000|Overall Study|Adverse Event|2|||
164144584|NCT01290302|592891704|FG001|Overall Study|Adverse Event|0|||
164144585|NCT01290302|592891703|FG000|Overall Study|Withdrawal by Subject|1|||
164144586|NCT01290302|592891704|FG001|Overall Study|Withdrawal by Subject|0|||
164144587|NCT01290302|592891703|FG000|Overall Study|Physician Decision|0|||
164144588|NCT01290302|592891704|FG001|Overall Study|Physician Decision|2|||
164144589|NCT01290302|592891703|FG000|Overall Study|Expiration of time for screening window|1|||
164144590|NCT01290302|592891704|FG001|Overall Study|Expiration of time for screening window|0|||
164144591|NCT03816878|592891707|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
164144592|NCT03816878|592891708|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
164144593|NCT03816878|592891707|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
164144594|NCT03816878|592891708|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
164144595|NCT03355469|592891709|FG000|Overall Study|COVID-19|3|||
164144596|NCT03355469|592891710|FG001|Overall Study|COVID-19|2|||
164144597|NCT03355469|592891711|FG002|Overall Study|COVID-19|3|||
164144598|NCT03355469|592891712|FG003|Overall Study|COVID-19|3|||
164144599|NCT03355469|592891709|FG000|Overall Study|Lost to Follow-up|1|||
164144600|NCT03355469|592891710|FG001|Overall Study|Lost to Follow-up|0|||
164144601|NCT03355469|592891711|FG002|Overall Study|Lost to Follow-up|1|||
164144602|NCT03355469|592891712|FG003|Overall Study|Lost to Follow-up|0|||
164144603|NCT03355469|592891709|FG000|Overall Study|Withdrawal by Subject|2|||
164144604|NCT03355469|592891710|FG001|Overall Study|Withdrawal by Subject|1|||
164144605|NCT03355469|592891711|FG002|Overall Study|Withdrawal by Subject|0|||
164144606|NCT03355469|592891712|FG003|Overall Study|Withdrawal by Subject|3|||
164144607|NCT02291510|592891713|FG000|Overall Study|Adverse Event|0|||
164144608|NCT02291510|592891714|FG001|Overall Study|Adverse Event|0|||
164144609|NCT02291510|592891715|FG002|Overall Study|Adverse Event|0|||
164144610|NCT02291510|592891716|FG003|Overall Study|Adverse Event|1|||
164144611|NCT04825912|592891722|FG000|Overall Study|Death|3|||
164144612|NCT04825912|592891722|FG000|Overall Study|Withdrawal by Subject|1|||
164144613|NCT01009814|592891725|FG000|Overall Study|No longer met study criteria|1|||
164144614|NCT01009814|592891726|FG001|Overall Study|No longer met study criteria|1|||
164144615|NCT01009814|592891727|FG002|Overall Study|No longer met study criteria|0|||
164144616|NCT01009814|592891728|FG003|Overall Study|No longer met study criteria|0|||
164144617|NCT01009814|592891729|FG004|Overall Study|No longer met study criteria|0|||
164144618|NCT01173120|592891730|FG000|Overall Study|Lack of Efficacy|2|||
164144619|NCT01173120|592891730|FG000|Overall Study|Lost to Follow-up|1|||
164144620|NCT01173120|592891730|FG000|Overall Study|Participant Decision|2|||
164144621|NCT01173120|592891730|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
164144622|NCT01173120|592891730|FG000|Overall Study|Switch-Participant Decision|12|||
164144623|NCT01173120|592891730|FG000|Overall Study|Switch-Difficulty With Device|12|||
164144624|NCT01977417|592891734|FG000|Overall Study|Adverse Event|1|||
164144625|NCT01977417|592891735|FG001|Overall Study|Adverse Event|0|||
164144626|NCT01977417|592891734|FG000|Overall Study|Withdrawal by Subject|2|||
164144627|NCT01977417|592891735|FG001|Overall Study|Withdrawal by Subject|4|||
164144628|NCT01977417|592891734|FG000|Overall Study|Female enrollment goal met|0|||
164144629|NCT01977417|592891735|FG001|Overall Study|Female enrollment goal met|2|||
164144630|NCT02906358|592891736|FG000|Overall Study|Withdrawal by Subject|10|||
164144631|NCT02906358|592891737|FG001|Overall Study|Withdrawal by Subject|7|||
164144632|NCT02906358|592891736|FG000|Overall Study|Lost to Follow-up|12|||
164144633|NCT02906358|592891737|FG001|Overall Study|Lost to Follow-up|15|||
164144634|NCT02699684|592891738|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
164144635|NCT02699684|592891739|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
164144636|NCT00616421|592891742|FG000|Overall Study|Withdrawal by Subject|9|||
164144637|NCT00616421|592891743|FG001|Overall Study|Withdrawal by Subject|11|||
164144638|NCT00616421|592891744|FG002|Overall Study|Withdrawal by Subject|8|||
164144639|NCT00616421|592891742|FG000|Overall Study|Lost to Follow-up|12|||
164144640|NCT00616421|592891743|FG001|Overall Study|Lost to Follow-up|26|||
164144641|NCT00616421|592891744|FG002|Overall Study|Lost to Follow-up|30|||
164144642|NCT00616421|592891742|FG000|Overall Study|Inappropriate enrollment|3|||
164144643|NCT00616421|592891743|FG001|Overall Study|Inappropriate enrollment|0|||
164144644|NCT00616421|592891744|FG002|Overall Study|Inappropriate enrollment|1|||
164144645|NCT00616421|592891742|FG000|Overall Study|Administrative reason|1|||
164144646|NCT00616421|592891743|FG001|Overall Study|Administrative reason|0|||
164144647|NCT00616421|592891744|FG002|Overall Study|Administrative reason|0|||
164144648|NCT00616421|592891742|FG000|Overall Study|Protocol Violation|0|||
164144649|NCT00616421|592891743|FG001|Overall Study|Protocol Violation|1|||
164144650|NCT00616421|592891744|FG002|Overall Study|Protocol Violation|2|||
164144651|NCT00616421|592891742|FG000|Overall Study|Unable to classify|1|||
164144652|NCT00616421|592891743|FG001|Overall Study|Unable to classify|0|||
164144653|NCT00616421|592891744|FG002|Overall Study|Unable to classify|0|||
164144654|NCT01495702|592891745|FG000|Randomized Phase|Randomized But Not Treated|1|||
164144655|NCT01495702|592891746|FG001|Randomized Phase|Randomized But Not Treated|4|||
164144662|NCT01495702|592891745|FG000|Randomized Phase|Investigators Discretion|2|||
164144663|NCT01495702|592891746|FG001|Randomized Phase|Investigators Discretion|0|||
164144664|NCT01495702|592891745|FG000|Randomized Phase|Withdrew Consent|10|||
164144665|NCT01495702|592891746|FG001|Randomized Phase|Withdrew Consent|18|||
164144666|NCT01495702|592891745|FG000|Randomized Phase|Lost to Follow-up|4|||
164144667|NCT01495702|592891746|FG001|Randomized Phase|Lost to Follow-up|3|||
164144668|NCT01495702|592891745|FG000|Randomized Phase|Participant Noncompliance|1|||
164144669|NCT01495702|592891746|FG001|Randomized Phase|Participant Noncompliance|0|||
164144670|NCT01495702|592891745|FG000|Randomized Phase|Protocol Violation|3|||
164144671|NCT01495702|592891746|FG001|Randomized Phase|Protocol Violation|1|||
164144672|NCT04152863|592891747|FG000|Overall Study|Death|13|||
164144673|NCT04152863|592891748|FG001|Overall Study|Death|12|||
164144674|NCT04152863|592891749|FG002|Overall Study|Death|7|||
164144675|NCT04152863|592891747|FG000|Overall Study|Physician Decision|1|||
164144676|NCT04152863|592891748|FG001|Overall Study|Physician Decision|1|||
164144677|NCT04152863|592891749|FG002|Overall Study|Physician Decision|1|||
164144678|NCT04152863|592891747|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
164144679|NCT04152863|592891748|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
164144680|NCT04152863|592891749|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
164144681|NCT04152863|592891747|FG000|Overall Study|Withdrawal by Subject|2|||
164144682|NCT04152863|592891748|FG001|Overall Study|Withdrawal by Subject|1|||
164144683|NCT04152863|592891749|FG002|Overall Study|Withdrawal by Subject|3|||
164144684|NCT01644617|592891753|FG000|Overall Study|Withdrawal by Subject|3|||
164144685|NCT01644617|592891754|FG001|Overall Study|Withdrawal by Subject|4|||
164144686|NCT01644617|592891755|FG002|Overall Study|Withdrawal by Subject|1|||
164144687|NCT01644617|592891753|FG000|Overall Study|Lost to Follow-up|0|||
164144688|NCT01644617|592891754|FG001|Overall Study|Lost to Follow-up|1|||
164144689|NCT01644617|592891755|FG002|Overall Study|Lost to Follow-up|0|||
164144690|NCT01644617|592891753|FG000|Overall Study|Adverse Event|3|||
164144691|NCT01644617|592891754|FG001|Overall Study|Adverse Event|0|||
164144692|NCT01644617|592891755|FG002|Overall Study|Adverse Event|6|||
164144693|NCT03593395|592891762|FG000|Overall Study|Lost to Follow-up|48|||
164144694|NCT03593395|592891763|FG001|Overall Study|Lost to Follow-up|3|||
164144695|NCT03593395|592891762|FG000|Overall Study|Withdrawal by Subject|5|||
164144696|NCT03593395|592891763|FG001|Overall Study|Withdrawal by Subject|24|||
164144697|NCT03593395|592891762|FG000|Overall Study|Death|2|||
164144698|NCT03593395|592891763|FG001|Overall Study|Death|3|||
164144699|NCT03593395|592891762|FG000|Overall Study|Physician Decision|0|||
164144700|NCT03593395|592891763|FG001|Overall Study|Physician Decision|6|||
164144701|NCT03593395|592891762|FG000|Overall Study|Participant Relocated|19|||
164144702|NCT03593395|592891763|FG001|Overall Study|Participant Relocated|3|||
164144703|NCT03593395|592891762|FG000|Overall Study|No Information|1|||
164144704|NCT03593395|592891763|FG001|Overall Study|No Information|7|||
164144705|NCT00741338|592891764|FG000|Overall Study|Adverse Event|0|||
164144706|NCT00741338|592891765|FG001|Overall Study|Adverse Event|1|||
164144707|NCT03713632|592891766|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
164144708|NCT03713632|592891767|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
164144709|NCT03713632|592891768|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
164144710|NCT03713632|592891769|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
164144711|NCT03713632|592891770|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
164144712|NCT03713632|592891766|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
164144713|NCT03713632|592891767|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
164144714|NCT03713632|592891768|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
164144715|NCT03713632|592891769|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
164144716|NCT03713632|592891770|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
164144717|NCT03713632|592891766|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
164144718|NCT03713632|592891767|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
164144719|NCT03713632|592891768|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
164144720|NCT03713632|592891769|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
164144721|NCT03713632|592891770|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
164144722|NCT03713632|592891766|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
164144723|NCT03713632|592891767|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
164144724|NCT03713632|592891768|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
164144725|NCT03713632|592891769|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
164144726|NCT03713632|592891770|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
164144727|NCT03713632|592891766|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
164144728|NCT03713632|592891767|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
164144729|NCT03713632|592891768|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
164144730|NCT03713632|592891769|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
164144731|NCT03713632|592891770|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
164144732|NCT03713632|592891766|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
164144733|NCT03713632|592891767|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
164144734|NCT03713632|592891768|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
164144735|NCT03713632|592891769|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
164144736|NCT03713632|592891770|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
164144737|NCT03713632|592891766|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
164144738|NCT03713632|592891767|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
164144739|NCT03713632|592891768|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
164144740|NCT03713632|592891769|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
164144741|NCT03713632|592891770|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
164144742|NCT03713632|592891766|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
164144743|NCT03713632|592891767|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
164144744|NCT03713632|592891768|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
164144745|NCT03713632|592891769|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
164144746|NCT03713632|592891770|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
164144747|NCT03713632|592891766|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
164144748|NCT03713632|592891767|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
164144749|NCT03713632|592891768|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
164144750|NCT03713632|592891769|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
164144751|NCT03713632|592891770|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
164144752|NCT03713632|592891766|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
164144753|NCT03713632|592891767|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
164144754|NCT03713632|592891768|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
164144755|NCT03713632|592891769|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
164144756|NCT03713632|592891770|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
164144757|NCT03713632|592891766|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
164144758|NCT03713632|592891767|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
164144759|NCT03713632|592891768|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
164144760|NCT03713632|592891769|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
164144761|NCT03713632|592891770|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
164144762|NCT03713632|592891766|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
164144763|NCT03713632|592891767|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
164144764|NCT03713632|592891768|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
164144765|NCT03713632|592891769|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
164144766|NCT03713632|592891770|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
164144767|NCT03713632|592891766|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
164144768|NCT03713632|592891767|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
164144769|NCT03713632|592891768|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
164144770|NCT03713632|592891769|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
164144771|NCT03713632|592891770|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
164144772|NCT03713632|592891766|FG000|Treatment Period 2 (After Week 16)|Death|0|||
164144773|NCT03713632|592891767|FG001|Treatment Period 2 (After Week 16)|Death|1|||
164144774|NCT03713632|592891768|FG002|Treatment Period 2 (After Week 16)|Death|0|||
164144775|NCT03713632|592891769|FG003|Treatment Period 2 (After Week 16)|Death|0|||
164144776|NCT03713632|592891770|FG004|Treatment Period 2 (After Week 16)|Death|0|||
164144777|NCT03713632|592891766|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
164144778|NCT03713632|592891767|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
164144779|NCT03713632|592891768|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
164144780|NCT03713632|592891769|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
164144781|NCT03713632|592891770|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
164144782|NCT01524978|592891774|FG000|Overall Study|Other|16|||
164144783|NCT01524978|592891775|FG001|Overall Study|Other|2|||
164144784|NCT01524978|592891776|FG002|Overall Study|Other|1|||
164144785|NCT01524978|592891777|FG003|Overall Study|Other|2|||
164144786|NCT01524978|592891778|FG004|Overall Study|Other|1|||
164144787|NCT01524978|592891779|FG005|Overall Study|Other|3|||
164144788|NCT01524978|592891780|FG006|Overall Study|Other|17|||
164144789|NCT01524978|592891781|FG007|Overall Study|Other|1|||
164144790|NCT01524978|592891782|FG008|Overall Study|Other|2|||
164144791|NCT01524978|592891783|FG009|Overall Study|Other|2|||
164144792|NCT01524978|592891784|FG010|Overall Study|Other|5|||
164144793|NCT01524978|592891774|FG000|Overall Study|Withdrawal by Subject|12|||
164144794|NCT01524978|592891775|FG001|Overall Study|Withdrawal by Subject|0|||
164144795|NCT01524978|592891776|FG002|Overall Study|Withdrawal by Subject|1|||
164144796|NCT01524978|592891777|FG003|Overall Study|Withdrawal by Subject|1|||
164144797|NCT01524978|592891778|FG004|Overall Study|Withdrawal by Subject|3|||
164144798|NCT01524978|592891779|FG005|Overall Study|Withdrawal by Subject|1|||
164144799|NCT01524978|592891780|FG006|Overall Study|Withdrawal by Subject|6|||
164144800|NCT01524978|592891781|FG007|Overall Study|Withdrawal by Subject|2|||
164144801|NCT01524978|592891782|FG008|Overall Study|Withdrawal by Subject|4|||
164144802|NCT01524978|592891783|FG009|Overall Study|Withdrawal by Subject|0|||
164144803|NCT01524978|592891784|FG010|Overall Study|Withdrawal by Subject|5|||
164144804|NCT01524978|592891774|FG000|Overall Study|Lost to Follow-up|0|||
164144805|NCT01524978|592891775|FG001|Overall Study|Lost to Follow-up|0|||
164144806|NCT01524978|592891776|FG002|Overall Study|Lost to Follow-up|3|||
164144831|NCT03790657|592891794|FG000|Overall Study|Withdrawal by Subject|1|||
164144832|NCT03790657|592891795|FG001|Overall Study|Withdrawal by Subject|1|||
164144833|NCT03126435|592891796|FG000|Overall Study|Death|90|||
164144834|NCT03126435|592891797|FG001|Overall Study|Death|84|||
164144835|NCT03126435|592891796|FG000|Overall Study|Lost to Follow-up|4|||
164144836|NCT03126435|592891797|FG001|Overall Study|Lost to Follow-up|3|||
164144837|NCT03126435|592891796|FG000|Overall Study|Physician Decision|0|||
164144838|NCT03126435|592891797|FG001|Overall Study|Physician Decision|1|||
164144839|NCT03126435|592891796|FG000|Overall Study|Withdrawal by Subject|6|||
164144840|NCT03126435|592891797|FG001|Overall Study|Withdrawal by Subject|12|||
164144841|NCT03126435|592891796|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
164144842|NCT03126435|592891797|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
164144843|NCT02370238|592891804|FG000|Overall Study|Death|42|||
164144844|NCT02370238|592891805|FG001|Overall Study|Death|35|||
164144845|NCT02370238|592891804|FG000|Overall Study|Lost to Follow-up|1|||
164144846|NCT02370238|592891805|FG001|Overall Study|Lost to Follow-up|3|||
164144847|NCT02370238|592891804|FG000|Overall Study|Withdrawal by Subject|2|||
164144848|NCT02370238|592891805|FG001|Overall Study|Withdrawal by Subject|6|||
164144849|NCT02370238|592891804|FG000|Overall Study|Other|2|||
164144850|NCT02370238|592891805|FG001|Overall Study|Other|1|||
164144851|NCT01937871|592891806|FG000|Overall Study|Adverse Event|6|||
164144852|NCT01937871|592891807|FG001|Overall Study|Adverse Event|6|||
164144853|NCT01937871|592891808|FG002|Overall Study|Adverse Event|2|||
164144854|NCT01937871|592891806|FG000|Overall Study|Lost to Follow-up|8|||
164144855|NCT01937871|592891807|FG001|Overall Study|Lost to Follow-up|2|||
164144856|NCT01937871|592891808|FG002|Overall Study|Lost to Follow-up|4|||
164144857|NCT01937871|592891806|FG000|Overall Study|Withdrawal by Subject|9|||
164144858|NCT01937871|592891807|FG001|Overall Study|Withdrawal by Subject|6|||
164144859|NCT01937871|592891808|FG002|Overall Study|Withdrawal by Subject|4|||
164144860|NCT01937871|592891806|FG000|Overall Study|Physician Decision|0|||
164144861|NCT01937871|592891807|FG001|Overall Study|Physician Decision|1|||
164144862|NCT01937871|592891808|FG002|Overall Study|Physician Decision|0|||
164144863|NCT01937871|592891806|FG000|Overall Study|Entry Criteria Not Met|1|||
164144864|NCT01937871|592891807|FG001|Overall Study|Entry Criteria Not Met|2|||
164144865|NCT01937871|592891808|FG002|Overall Study|Entry Criteria Not Met|1|||
164144866|NCT02652949|592891809|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
164144867|NCT02652949|592891809|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
164144868|NCT02652949|592891809|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
164144869|NCT02652949|592891809|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
164144870|NCT02652949|592891809|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
164144871|NCT02652949|592891809|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
164144872|NCT02652949|592891809|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
164144873|NCT02652949|592891809|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
164144874|NCT02652949|592891809|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
164144875|NCT02652949|592891809|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
164144876|NCT02652949|592891809|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
164144877|NCT02652949|592891809|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
164144878|NCT02652949|592891809|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
164144879|NCT02652949|592891809|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
164144880|NCT02652949|592891809|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
164144881|NCT02652949|592891809|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
164144882|NCT02652949|592891809|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
164144883|NCT01973595|592891810|FG000|Washout|Withdrawal by Subject|1|||
164144884|NCT01973595|592891811|FG001|Washout|Withdrawal by Subject|0|||
164144885|NCT01973595|592891812|FG002|Washout|Withdrawal by Subject|1|||
164144886|NCT01973595|592891813|FG003|Washout|Withdrawal by Subject|0|||
164144887|NCT01141205|592891814|FG000|Overall Study|Physician Decision|1|||
164144888|NCT01141205|592891815|FG001|Overall Study|Physician Decision|1|||
164144889|NCT01141205|592891814|FG000|Overall Study|Lost to Follow-up|1|||
164144890|NCT01141205|592891815|FG001|Overall Study|Lost to Follow-up|0|||
164144891|NCT01141205|592891814|FG000|Overall Study|Withdrawal by Subject|1|||
164144892|NCT01141205|592891815|FG001|Overall Study|Withdrawal by Subject|1|||
164144893|NCT03837743|592891821|FG000|Overall Study|Adverse Event|1|||
164144894|NCT03837743|592891821|FG000|Overall Study|Withdrawal by Subject|2|||
164144895|NCT05199090|592891822|FG000|Overall Study|Adverse Event|1|||
164144896|NCT05199090|592891823|FG001|Overall Study|Adverse Event|4|||
164144897|NCT05199090|592891824|FG002|Overall Study|Adverse Event|0|||
164144898|NCT05199090|592891825|FG003|Overall Study|Adverse Event|0|||
164144899|NCT05199090|592891826|FG004|Overall Study|Adverse Event|0|||
164144900|NCT05199090|592891827|FG005|Overall Study|Adverse Event|0|||
164144901|NCT05199090|592891822|FG000|Overall Study|Lost to Follow-up|1|||
164144902|NCT05199090|592891823|FG001|Overall Study|Lost to Follow-up|0|||
164144903|NCT05199090|592891824|FG002|Overall Study|Lost to Follow-up|1|||
164144904|NCT05199090|592891825|FG003|Overall Study|Lost to Follow-up|4|||
164144905|NCT05199090|592891826|FG004|Overall Study|Lost to Follow-up|0|||
164144906|NCT05199090|592891827|FG005|Overall Study|Lost to Follow-up|5|||
164144913|NCT05199090|592891822|FG000|Overall Study|Study terminated by sponsor|0|||
164144914|NCT05199090|592891823|FG001|Overall Study|Study terminated by sponsor|6|||
164144915|NCT05199090|592891824|FG002|Overall Study|Study terminated by sponsor|0|||
164144916|NCT05199090|592891825|FG003|Overall Study|Study terminated by sponsor|0|||
164144917|NCT05199090|592891826|FG004|Overall Study|Study terminated by sponsor|0|||
164144918|NCT05199090|592891827|FG005|Overall Study|Study terminated by sponsor|5|||
164144919|NCT05199090|592891822|FG000|Overall Study|Subject decision|0|||
164144920|NCT05199090|592891823|FG001|Overall Study|Subject decision|4|||
164144921|NCT05199090|592891824|FG002|Overall Study|Subject decision|0|||
164144922|NCT05199090|592891825|FG003|Overall Study|Subject decision|2|||
164144923|NCT05199090|592891826|FG004|Overall Study|Subject decision|5|||
164144924|NCT05199090|592891827|FG005|Overall Study|Subject decision|2|||
164144925|NCT04868968|592891828|FG000|Overall Study|Lost to Follow-up|1|||
164144926|NCT00384930|592891831|FG000|Overall Study|Adverse Event|5|||
164144927|NCT00384930|592891832|FG001|Overall Study|Adverse Event|4|||
164144928|NCT00384930|592891833|FG002|Overall Study|Adverse Event|12|||
164144929|NCT00384930|592891834|FG003|Overall Study|Adverse Event|11|||
164144930|NCT00384930|592891835|FG004|Overall Study|Adverse Event|14|||
164144931|NCT00384930|592891831|FG000|Overall Study|Entry Criteria Not Met|2|||
164144932|NCT00384930|592891832|FG001|Overall Study|Entry Criteria Not Met|6|||
164144933|NCT00384930|592891833|FG002|Overall Study|Entry Criteria Not Met|7|||
164144934|NCT00384930|592891834|FG003|Overall Study|Entry Criteria Not Met|8|||
164144935|NCT00384930|592891835|FG004|Overall Study|Entry Criteria Not Met|4|||
164144936|NCT00384930|592891831|FG000|Overall Study|Lack of Efficacy|1|||
164144937|NCT00384930|592891832|FG001|Overall Study|Lack of Efficacy|1|||
164144938|NCT00384930|592891833|FG002|Overall Study|Lack of Efficacy|2|||
164144939|NCT00384930|592891834|FG003|Overall Study|Lack of Efficacy|1|||
164144940|NCT00384930|592891835|FG004|Overall Study|Lack of Efficacy|2|||
164144941|NCT00384930|592891831|FG000|Overall Study|Lost to Follow-up|5|||
164144942|NCT00384930|592891832|FG001|Overall Study|Lost to Follow-up|3|||
164144943|NCT00384930|592891833|FG002|Overall Study|Lost to Follow-up|0|||
164144944|NCT00384930|592891834|FG003|Overall Study|Lost to Follow-up|4|||
164144945|NCT00384930|592891835|FG004|Overall Study|Lost to Follow-up|6|||
164144946|NCT00384930|592891831|FG000|Overall Study|Physician Decision|0|||
164144947|NCT00384930|592891832|FG001|Overall Study|Physician Decision|1|||
164144948|NCT00384930|592891833|FG002|Overall Study|Physician Decision|1|||
164144949|NCT00384930|592891834|FG003|Overall Study|Physician Decision|0|||
164144950|NCT00384930|592891835|FG004|Overall Study|Physician Decision|1|||
164144951|NCT00384930|592891831|FG000|Overall Study|Protocol Violation|1|||
164144952|NCT00384930|592891832|FG001|Overall Study|Protocol Violation|0|||
164144953|NCT00384930|592891833|FG002|Overall Study|Protocol Violation|1|||
164144954|NCT00384930|592891834|FG003|Overall Study|Protocol Violation|6|||
164144955|NCT00384930|592891835|FG004|Overall Study|Protocol Violation|4|||
164144956|NCT00384930|592891831|FG000|Overall Study|Sponsor Decision|3|||
164144957|NCT00384930|592891832|FG001|Overall Study|Sponsor Decision|4|||
164144958|NCT00384930|592891833|FG002|Overall Study|Sponsor Decision|0|||
164144959|NCT00384930|592891834|FG003|Overall Study|Sponsor Decision|5|||
164144960|NCT00384930|592891835|FG004|Overall Study|Sponsor Decision|0|||
164144961|NCT00384930|592891831|FG000|Overall Study|Withdrawal by Subject|9|||
164144962|NCT00384930|592891832|FG001|Overall Study|Withdrawal by Subject|7|||
164144963|NCT00384930|592891833|FG002|Overall Study|Withdrawal by Subject|7|||
164144964|NCT00384930|592891834|FG003|Overall Study|Withdrawal by Subject|6|||
164144965|NCT00384930|592891835|FG004|Overall Study|Withdrawal by Subject|16|||
164144966|NCT00384930|592891831|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
164144967|NCT00384930|592891832|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
164144968|NCT00384930|592891833|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
164144969|NCT00384930|592891834|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
164144970|NCT00384930|592891835|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
164144971|NCT01547130|592891840|FG000|Overall Study|Lost to Follow-up|9|||
164144972|NCT01547130|592891841|FG001|Overall Study|Lost to Follow-up|5|||
164144973|NCT01685840|592891842|FG000|Overall Study|Death|77|||
164144974|NCT01685840|592891843|FG001|Overall Study|Death|66|||
164144975|NCT01685840|592891842|FG000|Overall Study|Lost to Follow-up|27|||
164144976|NCT01685840|592891843|FG001|Overall Study|Lost to Follow-up|25|||
164144977|NCT01685840|592891842|FG000|Overall Study|Physician Decision|3|||
164144978|NCT01685840|592891843|FG001|Overall Study|Physician Decision|7|||
164144979|NCT01685840|592891842|FG000|Overall Study|Withdrawal by Subject|14|||
164144980|NCT01685840|592891843|FG001|Overall Study|Withdrawal by Subject|17|||
164144981|NCT01685840|592891842|FG000|Overall Study|Futility|197|||
164144982|NCT01685840|592891843|FG001|Overall Study|Futility|200|||
164144983|NCT01685840|592891842|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
164144984|NCT01685840|592891843|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
164144985|NCT00710866|592891844|FG000|Overall Study|Protocol Violation|5|||
164144986|NCT00710866|592891845|FG001|Overall Study|Protocol Violation|4|||
164144987|NCT00710866|592891844|FG000|Overall Study|Withdrawal by Subject|2|||
164144988|NCT00710866|592891845|FG001|Overall Study|Withdrawal by Subject|1|||
164144989|NCT00710866|592891844|FG000|Overall Study|Lost to Follow-up|1|||
164144990|NCT00710866|592891845|FG001|Overall Study|Lost to Follow-up|0|||
164144991|NCT00710866|592891844|FG000|Overall Study|Failed to meet eligibility|1|||
164144992|NCT00710866|592891845|FG001|Overall Study|Failed to meet eligibility|1|||
164144993|NCT04487067|592891851|FG000|Overall Study|Adverse Event|3|||
164144994|NCT04487067|592891851|FG000|Overall Study|Death Other Than Progressive Disease|60|||
164144995|NCT04487067|592891851|FG000|Overall Study|Death Due To Progressive Disease|40|||
164144996|NCT04487067|592891851|FG000|Overall Study|Lost to Follow-up|3|||
164144997|NCT04487067|592891851|FG000|Overall Study|Progressive Disease|1|||
164144998|NCT04487067|592891851|FG000|Overall Study|Protocol Violation|3|||
164144999|NCT04487067|592891851|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
164145000|NCT04487067|592891851|FG000|Overall Study|Withdrawal by Subject|15|||
164145001|NCT04324021|592891852|FG000|Overall Study|Adverse Event|1|||
164145002|NCT04324021|592891853|FG001|Overall Study|Adverse Event|0|||
164145003|NCT04324021|592891854|FG002|Overall Study|Adverse Event|0|||
164145004|NCT04324021|592891852|FG000|Overall Study|Lack of Efficacy|0|||
164145005|NCT04324021|592891853|FG001|Overall Study|Lack of Efficacy|0|||
164145006|NCT04324021|592891854|FG002|Overall Study|Lack of Efficacy|1|||
164145007|NCT04324021|592891852|FG000|Overall Study|Death|1|||
164145008|NCT04324021|592891853|FG001|Overall Study|Death|1|||
164145009|NCT04324021|592891854|FG002|Overall Study|Death|0|||
164145010|NCT00246324|592891855|FG000|Overall Study|Withdrawal by Subject|1|||
164145011|NCT00299130|592891856|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
164145012|NCT00299130|592891857|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
164145013|NCT00299130|592891858|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
164145014|NCT00299130|592891856|FG000|Treatment Period (up to 5 Years)|Death|1|||
164145015|NCT00299130|592891857|FG001|Treatment Period (up to 5 Years)|Death|3|||
164145016|NCT00299130|592891858|FG002|Treatment Period (up to 5 Years)|Death|1|||
164145017|NCT00299130|592891856|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
164145018|NCT00299130|592891857|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
164145019|NCT00299130|592891858|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
164145020|NCT00299130|592891856|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
164145021|NCT00299130|592891857|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
164145022|NCT00299130|592891858|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
164145023|NCT00299130|592891856|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
164145024|NCT00299130|592891857|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
164145025|NCT00299130|592891858|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
164145026|NCT00299130|592891856|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
164145027|NCT00299130|592891857|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
164145028|NCT00299130|592891858|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
164145029|NCT00299130|592891856|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
164145030|NCT00299130|592891857|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
164145031|NCT00299130|592891858|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
164145032|NCT00299130|592891856|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
164145033|NCT00299130|592891857|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
164145034|NCT00299130|592891858|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
164145035|NCT00299130|592891856|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
164145036|NCT00299130|592891857|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
164145037|NCT00299130|592891858|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
164145038|NCT00299130|592891856|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
164145039|NCT00299130|592891857|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
164145040|NCT00299130|592891858|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
164145041|NCT00299130|592891856|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
164145042|NCT00299130|592891857|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
164145043|NCT00299130|592891858|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
164145044|NCT00299130|592891856|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
164145045|NCT00299130|592891857|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
164145046|NCT00299130|592891858|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
164145047|NCT00299130|592891856|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
164145048|NCT00299130|592891857|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
164145049|NCT00299130|592891858|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
164145050|NCT00299130|592891856|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
164145051|NCT00299130|592891857|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
164145052|NCT00299130|592891858|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
164145053|NCT00299130|592891856|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
164145054|NCT00299130|592891857|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
164145055|NCT00299130|592891858|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
164145056|NCT00299130|592891856|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
164145057|NCT00299130|592891857|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
164145058|NCT00299130|592891858|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
164145059|NCT00299130|592891856|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
164145060|NCT00299130|592891857|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
164145061|NCT00299130|592891858|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
164145062|NCT01098487|592891860|FG000|Overall Study|Adverse Event|22|||
164145063|NCT01098487|592891860|FG000|Overall Study|Lack of Efficacy|11|||
164145064|NCT01098487|592891860|FG000|Overall Study|Withdrawal by Subject|7|||
164145065|NCT01098487|592891860|FG000|Overall Study|Lost to Follow-up|3|||
164145066|NCT01098487|592891860|FG000|Overall Study|Physician Decision|1|||
164145067|NCT00345631|592891861|FG000|Overall Study|Withdrawal by Subject|1|||
164145068|NCT00345631|592891862|FG001|Overall Study|Withdrawal by Subject|0|||
164145069|NCT00345631|592891863|FG002|Overall Study|Withdrawal by Subject|1|||
164145070|NCT00345631|592891861|FG000|Overall Study|Adverse Event|0|||
164145071|NCT00345631|592891862|FG001|Overall Study|Adverse Event|1|||
164145072|NCT00345631|592891863|FG002|Overall Study|Adverse Event|0|||
164145073|NCT00345631|592891861|FG000|Overall Study|Lost to Follow-up|3|||
164145074|NCT00345631|592891862|FG001|Overall Study|Lost to Follow-up|7|||
164145075|NCT00345631|592891863|FG002|Overall Study|Lost to Follow-up|4|||
164145076|NCT00345631|592891861|FG000|Overall Study|Other reasons|0|||
164145077|NCT00345631|592891862|FG001|Overall Study|Other reasons|0|||
164145078|NCT00345631|592891863|FG002|Overall Study|Other reasons|1|||
164145079|NCT03371459|592891868|FG000|Washout|Lost to Follow-up|0|||
164145080|NCT03371459|592891869|FG001|Washout|Lost to Follow-up|1|||
164145081|NCT01374269|592891872|FG000|Overall Study|Withdrawal by Subject|4|||
164145082|NCT01374269|592891873|FG001|Overall Study|Withdrawal by Subject|0|||
164145083|NCT01374269|592891872|FG000|Overall Study|Lost to Follow-up|1|||
164145084|NCT01374269|592891873|FG001|Overall Study|Lost to Follow-up|3|||
164145085|NCT01374269|592891872|FG000|Overall Study|closed research|1|||
164145086|NCT01374269|592891873|FG001|Overall Study|closed research|2|||
164145087|NCT04559347|592894179|FG000|Overall Study|Death|1|||
164145088|NCT04559347|592894180|FG001|Overall Study|Death|0|||
164145089|NCT04559347|592894179|FG000|Overall Study|Thoracotomy conversion|1|||
164145090|NCT04559347|592894180|FG001|Overall Study|Thoracotomy conversion|1|||
164145091|NCT04559347|592894179|FG000|Overall Study|Provider unavailable|2|||
164145092|NCT04559347|592894180|FG001|Overall Study|Provider unavailable|1|||
164145093|NCT04559347|592894179|FG000|Overall Study|Other|2|||
164145094|NCT04559347|592894180|FG001|Overall Study|Other|1|||
164145095|NCT00615199|592894181|FG000|Overall Study|Adverse Event|3|||
164145096|NCT00615199|592894182|FG001|Overall Study|Adverse Event|1|||
164145097|NCT00615199|592894183|FG002|Overall Study|Adverse Event|1|||
164145098|NCT00615199|592894184|FG003|Overall Study|Adverse Event|0|||
164145099|NCT00615199|592894181|FG000|Overall Study|Lack of Efficacy|2|||
164145100|NCT00615199|592894182|FG001|Overall Study|Lack of Efficacy|0|||
164145101|NCT00615199|592894183|FG002|Overall Study|Lack of Efficacy|0|||
164145102|NCT00615199|592894184|FG003|Overall Study|Lack of Efficacy|1|||
164145103|NCT00615199|592894181|FG000|Overall Study|Lost to Follow-up|1|||
164145104|NCT00615199|592894182|FG001|Overall Study|Lost to Follow-up|0|||
164145105|NCT00615199|592894183|FG002|Overall Study|Lost to Follow-up|0|||
164145106|NCT00615199|592894184|FG003|Overall Study|Lost to Follow-up|0|||
164145107|NCT00615199|592894181|FG000|Overall Study|Other|0|||
164145108|NCT00615199|592894182|FG001|Overall Study|Other|0|||
164145109|NCT00615199|592894183|FG002|Overall Study|Other|0|||
164145110|NCT00615199|592894184|FG003|Overall Study|Other|1|||
164145111|NCT00615199|592894181|FG000|Overall Study|Withdrawal by Subject|2|||
164145112|NCT00615199|592894182|FG001|Overall Study|Withdrawal by Subject|1|||
164145113|NCT00615199|592894183|FG002|Overall Study|Withdrawal by Subject|0|||
164145114|NCT00615199|592894184|FG003|Overall Study|Withdrawal by Subject|0|||
164145115|NCT00459355|592894185|FG000|Overall Study|Subject no longer met inc criteria|20|||
164145116|NCT00459355|592894186|FG001|Overall Study|Subject no longer met inc criteria|18|||
164145117|NCT00618371|592894189|FG000|Overall Study|Withdrawal by Subject|2|||
164145118|NCT02969382|592894190|FG000|Overall Study|Adverse Event|8|||
164145119|NCT02969382|592894191|FG001|Overall Study|Adverse Event|10|||
164145120|NCT02969382|592894190|FG000|Overall Study|Lack of Efficacy|4|||
164145121|NCT02969382|592894191|FG001|Overall Study|Lack of Efficacy|5|||
164145122|NCT02969382|592894190|FG000|Overall Study|Death|0|||
164145123|NCT02969382|592894191|FG001|Overall Study|Death|1|||
164145124|NCT02969382|592894190|FG000|Overall Study|PROTOCOL DEVIATION|0|||
164145125|NCT02969382|592894191|FG001|Overall Study|PROTOCOL DEVIATION|1|||
164145126|NCT02969382|592894190|FG000|Overall Study|Withdrawal by Subject|14|||
164145127|NCT02969382|592894191|FG001|Overall Study|Withdrawal by Subject|9|||
164145128|NCT00886015|592894199|FG000|Overall Study|Death|0|||
164145129|NCT00886015|592894200|FG001|Overall Study|Death|2|||
164145130|NCT02013817|592894201|FG000|Overall Study|Adverse Event|12|||
164145131|NCT02013817|592894201|FG000|Overall Study|Withdrawal by Subject|4|||
164145132|NCT02013817|592894201|FG000|Overall Study|Death|2|||
164145133|NCT02013817|592894201|FG000|Overall Study|Other|9|||
164145134|NCT01145508|592894202|FG000|Overall Study|Adverse Event|1|||
164145135|NCT01145508|592894203|FG001|Overall Study|Adverse Event|0|||
164145136|NCT01145508|592894202|FG000|Overall Study|Death|1|||
164145137|NCT01145508|592894203|FG001|Overall Study|Death|0|||
164145138|NCT01145508|592894202|FG000|Overall Study|Physician Decision|2|||
164145139|NCT01145508|592894203|FG001|Overall Study|Physician Decision|1|||
164145140|NCT01145508|592894202|FG000|Overall Study|Never started treatment|1|||
164145141|NCT01145508|592894203|FG001|Overall Study|Never started treatment|1|||
164145142|NCT01611857|592894204|FG000|Overall Study|Withdrawal by Subject|0|||
164145143|NCT01611857|592894205|FG001|Overall Study|Withdrawal by Subject|2|||
164145144|NCT03971474|592894206|FG000|Overall Study|Adverse Event|11|||
164145145|NCT03971474|592894207|FG001|Overall Study|Adverse Event|7|||
164145146|NCT03971474|592894206|FG000|Overall Study|Refusal unrelated to adverse event|5|||
164145147|NCT03971474|592894207|FG001|Overall Study|Refusal unrelated to adverse event|1|||
164145148|NCT03971474|592894206|FG000|Overall Study|Progression/relapse|40|||
164145149|NCT03971474|592894207|FG001|Overall Study|Progression/relapse|47|||
164145150|NCT03971474|592894206|FG000|Overall Study|Death|6|||
164145151|NCT03971474|592894207|FG001|Overall Study|Death|3|||
164145152|NCT03971474|592894206|FG000|Overall Study|Other - not protocol specified|5|||
164145153|NCT03971474|592894207|FG001|Overall Study|Other - not protocol specified|4|||
164145154|NCT03971474|592894206|FG000|Overall Study|On treatment|0|||
164145155|NCT03971474|592894207|FG001|Overall Study|On treatment|7|||
164145156|NCT01023035|592894209|FG000|Treatment Period|Adverse Event|27|||
164145157|NCT01023035|592894210|FG001|Treatment Period|Adverse Event|32|||
164145158|NCT01023035|592894211|FG002|Treatment Period|Adverse Event|50|||
164145159|NCT01023035|592894209|FG000|Treatment Period|Non-Medical Reasons|19|||
164145160|NCT01023035|592894210|FG001|Treatment Period|Non-Medical Reasons|22|||
164145161|NCT01023035|592894211|FG002|Treatment Period|Non-Medical Reasons|44|||
164145162|NCT01023035|592894209|FG000|Treatment Period|Treatment Failure|26|||
164145163|NCT01023035|592894210|FG001|Treatment Period|Treatment Failure|31|||
164145164|NCT01023035|592894211|FG002|Treatment Period|Treatment Failure|24|||
164145165|NCT01023035|592894209|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
164145166|NCT01023035|592894210|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
164145167|NCT01023035|592894211|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
164145168|NCT01023035|592894209|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
164145169|NCT01023035|592894210|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
164145170|NCT01023035|592894211|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
164145171|NCT01807065|592894212|FG000|Overall Study|Receive no sip-T due to IV access|1|||
164145172|NCT01807065|592894213|FG001|Overall Study|Receive no sip-T due to IV access|1|||
164145173|NCT01482312|592894215|FG000|Period 1, 90 Minutes of Wear|Other|1|||
164145174|NCT01482312|592894216|FG001|Period 1, 90 Minutes of Wear|Other|0|||
164145175|NCT01482312|592894217|FG002|Period 1, 90 Minutes of Wear|Other|0|||
164145176|NCT01482312|592894215|FG000|Period 2, 90 Minutes of Wear|Other|1|||
164145177|NCT01482312|592894216|FG001|Period 2, 90 Minutes of Wear|Other|0|||
164145178|NCT01482312|592894217|FG002|Period 2, 90 Minutes of Wear|Other|0|||
164145179|NCT01699815|592894218|FG000|Overall Study|Protocol Violation|4|||
164145180|NCT01699815|592894219|FG001|Overall Study|Protocol Violation|7|||
164145181|NCT01699815|592894218|FG000|Overall Study|record could not be located|1|||
164145182|NCT01699815|592894219|FG001|Overall Study|record could not be located|0|||
164145183|NCT01699815|592894218|FG000|Overall Study|Adverse Event|0|||
164145184|NCT01699815|592894219|FG001|Overall Study|Adverse Event|1|||
164145185|NCT01295320|592894220|FG000|Overall Study|Adverse Event|2|||
164145186|NCT01295320|592894220|FG000|Overall Study|Lost to Follow-up|4|||
164145187|NCT01295320|592894220|FG000|Overall Study|Withdrawal by Subject|2|||
164145188|NCT01295320|592894220|FG000|Overall Study|Subject was bedridden|1|||
164145189|NCT01295320|592894220|FG000|Overall Study|Unable to travel|1|||
164145190|NCT00462904|592894221|FG000|Overall Study|Lost to Follow-up|1|||
164145191|NCT00699816|592894224|FG000|Overall Study|Protocol Violation|1|||
164145192|NCT00699816|592894225|FG001|Overall Study|Protocol Violation|3|||
164145193|NCT00560391|592894226|FG000|Overall Study|Still on treatment|0|||
164145194|NCT00560391|592894227|FG001|Overall Study|Still on treatment|0|||
164145195|NCT00560391|592894228|FG002|Overall Study|Still on treatment|0|||
164145196|NCT00560391|592894229|FG003|Overall Study|Still on treatment|1|||
164145197|NCT00560391|592894230|FG004|Overall Study|Still on treatment|2|||
164145198|NCT03668808|592894231|FG000|First Intervention|Withdrawal by Subject|2|||
164145199|NCT03668808|592894232|FG001|First Intervention|Withdrawal by Subject|2|||
164145200|NCT00280735|592894233|FG000|Overall Study|Adverse Event|5|||
164145201|NCT00280735|592894233|FG000|Overall Study|Lack of Efficacy|3|||
164145202|NCT00280735|592894233|FG000|Overall Study|Withdrawal by Subject|8|||
164145203|NCT00280735|592894233|FG000|Overall Study|Intercurrent Illness|2|||
164145204|NCT01895777|592894234|FG000|Overall Study|Adverse Event|1|||
164145205|NCT01895777|592894235|FG001|Overall Study|Adverse Event|2|||
164145206|NCT01895777|592894234|FG000|Overall Study|Lost to Follow-up|2|||
164145207|NCT01895777|592894235|FG001|Overall Study|Lost to Follow-up|0|||
164145208|NCT01895777|592894234|FG000|Overall Study|Not treated|1|||
164145209|NCT01895777|592894235|FG001|Overall Study|Not treated|0|||
164145210|NCT01895777|592894234|FG000|Overall Study|Other reasons|3|||
164145211|NCT01895777|592894235|FG001|Overall Study|Other reasons|2|||
164145212|NCT01895777|592894234|FG000|Overall Study|Non-compliance with the CTP|2|||
164145213|NCT01895777|592894235|FG001|Overall Study|Non-compliance with the CTP|1|||
164145214|NCT02125877|592894245|FG000|Overall Study|Physician Decision|1|||
164145215|NCT02125877|592894246|FG001|Overall Study|Physician Decision|0|||
164145216|NCT02125877|592894245|FG000|Overall Study|Death|0|||
164145218|NCT02125877|592894245|FG000|Overall Study|Administrative problems|0|||
164145219|NCT02125877|592894246|FG001|Overall Study|Administrative problems|1|||
164145220|NCT02125877|592894245|FG000|Overall Study|Participant/guardian decision|0|||
164145221|NCT02125877|592894246|FG001|Overall Study|Participant/guardian decision|2|||
164145222|NCT02125877|592894245|FG000|Overall Study|Withdrawal by Subject|2|||
164145223|NCT02125877|592894246|FG001|Overall Study|Withdrawal by Subject|1|||
164145224|NCT02125877|592894245|FG000|Overall Study|Protocol deviation|4|||
164145225|NCT02125877|592894246|FG001|Overall Study|Protocol deviation|1|||
164145226|NCT02125877|592894245|FG000|Overall Study|Adverse Event|6|||
164145227|NCT02125877|592894246|FG001|Overall Study|Adverse Event|4|||
164145228|NCT04223752|592894247|FG000|Overall Study|Participant enrolled in error|0|||
164145229|NCT04223752|592894248|FG001|Overall Study|Participant enrolled in error|0|||
164145230|NCT04223752|592894249|FG002|Overall Study|Participant enrolled in error|0|||
164145231|NCT04223752|592894250|FG003|Overall Study|Participant enrolled in error|0|||
164145232|NCT04223752|592894251|FG004|Overall Study|Participant enrolled in error|1|||
164145233|NCT04223752|592894247|FG000|Overall Study|Death|0|||
164145234|NCT04223752|592894248|FG001|Overall Study|Death|0|||
164145235|NCT04223752|592894249|FG002|Overall Study|Death|0|||
164145236|NCT04223752|592894250|FG003|Overall Study|Death|2|||
164145237|NCT04223752|592894251|FG004|Overall Study|Death|1|||
164145238|NCT01822366|592894252|FG000|Overall Study|Lost to Follow-up|5|||
164145239|NCT01822366|592894253|FG001|Overall Study|Lost to Follow-up|1|||
164145240|NCT01822366|592894254|FG002|Overall Study|Lost to Follow-up|5|||
164145241|NCT01822366|592894255|FG003|Overall Study|Lost to Follow-up|1|||
164145242|NCT01822366|592894252|FG000|Overall Study|Withdrawal by Subject|0|||
164145243|NCT01822366|592894253|FG001|Overall Study|Withdrawal by Subject|6|||
164145244|NCT01822366|592894254|FG002|Overall Study|Withdrawal by Subject|0|||
164145245|NCT01822366|592894255|FG003|Overall Study|Withdrawal by Subject|6|||
164145246|NCT01822366|592894252|FG000|Overall Study|Partial Intervention Completion|0|||
164145247|NCT01822366|592894253|FG001|Overall Study|Partial Intervention Completion|15|||
164145248|NCT01822366|592894254|FG002|Overall Study|Partial Intervention Completion|0|||
164145249|NCT01822366|592894255|FG003|Overall Study|Partial Intervention Completion|15|||
164145250|NCT03489109|592894256|FG000|Overall Study|Lost to Follow-up|1|||
164145251|NCT03489109|592894257|FG001|Overall Study|Lost to Follow-up|2|||
164145252|NCT02552732|592894258|FG000|Overall Study|Lost to Follow-up|2|||
164145253|NCT02552732|592894258|FG000|Overall Study|Physician Decision|1|||
164145254|NCT02552732|592894258|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
164145255|NCT02552732|592894258|FG000|Overall Study|Withdrawal by Subject|6|||
164145256|NCT05061420|592894259|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
164145257|NCT05061420|592894260|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
164145258|NCT05061420|592894261|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
164145259|NCT05061420|592894259|FG000|Overall Study|Progressive disease|11|||
164145260|NCT05061420|592894260|FG001|Overall Study|Progressive disease|15|||
164145261|NCT05061420|592894261|FG002|Overall Study|Progressive disease|14|||
164145262|NCT05061420|592894259|FG000|Overall Study|Withdrawal by Subject|2|||
164145263|NCT05061420|592894260|FG001|Overall Study|Withdrawal by Subject|0|||
164145264|NCT05061420|592894261|FG002|Overall Study|Withdrawal by Subject|1|||
164145265|NCT05061420|592894259|FG000|Overall Study|Not related to COVID-19|2|||
164145266|NCT05061420|592894260|FG001|Overall Study|Not related to COVID-19|0|||
164145267|NCT05061420|592894261|FG002|Overall Study|Not related to COVID-19|0|||
164145268|NCT00025259|592894263|FG000|Overall Study|Death|1|||
164145269|NCT00025259|592894264|FG001|Overall Study|Death|3|||
164145270|NCT00025259|592894265|FG002|Overall Study|Death|0|||
164145271|NCT00025259|592894266|FG003|Overall Study|Death|3|||
164145272|NCT00025259|592894267|FG004|Overall Study|Death|0|||
164145273|NCT00025259|592894268|FG005|Overall Study|Death|1|||
164145274|NCT00025259|592894269|FG006|Overall Study|Death|2|||
164145275|NCT00025259|592894263|FG000|Overall Study|Lack of Efficacy|2|||
164145276|NCT00025259|592894264|FG001|Overall Study|Lack of Efficacy|46|||
164145277|NCT00025259|592894265|FG002|Overall Study|Lack of Efficacy|60|||
164145278|NCT00025259|592894266|FG003|Overall Study|Lack of Efficacy|78|||
164145279|NCT00025259|592894267|FG004|Overall Study|Lack of Efficacy|11|||
164145280|NCT00025259|592894268|FG005|Overall Study|Lack of Efficacy|30|||
164145281|NCT00025259|592894269|FG006|Overall Study|Lack of Efficacy|38|||
164145282|NCT00025259|592894263|FG000|Overall Study|Lost to Follow-up|2|||
164145283|NCT00025259|592894264|FG001|Overall Study|Lost to Follow-up|9|||
164145284|NCT00025259|592894265|FG002|Overall Study|Lost to Follow-up|13|||
164145285|NCT00025259|592894266|FG003|Overall Study|Lost to Follow-up|13|||
164145286|NCT00025259|592894267|FG004|Overall Study|Lost to Follow-up|1|||
164145287|NCT00025259|592894268|FG005|Overall Study|Lost to Follow-up|3|||
164145288|NCT00025259|592894269|FG006|Overall Study|Lost to Follow-up|1|||
164145289|NCT00025259|592894263|FG000|Overall Study|Physician Decision|12|||
164145290|NCT00025259|592894264|FG001|Overall Study|Physician Decision|1|||
164145291|NCT00025259|592894265|FG002|Overall Study|Physician Decision|0|||
164145292|NCT00025259|592894266|FG003|Overall Study|Physician Decision|5|||
164145293|NCT00025259|592894267|FG004|Overall Study|Physician Decision|4|||
164145294|NCT00025259|592894268|FG005|Overall Study|Physician Decision|2|||
164145295|NCT00025259|592894269|FG006|Overall Study|Physician Decision|1|||
164145303|NCT00025259|592894263|FG000|Overall Study|Withdrawal by Subject|9|||
164145304|NCT00025259|592894264|FG001|Overall Study|Withdrawal by Subject|27|||
164145305|NCT00025259|592894265|FG002|Overall Study|Withdrawal by Subject|6|||
164145306|NCT00025259|592894266|FG003|Overall Study|Withdrawal by Subject|14|||
164145307|NCT00025259|592894267|FG004|Overall Study|Withdrawal by Subject|11|||
164145308|NCT00025259|592894268|FG005|Overall Study|Withdrawal by Subject|8|||
164145309|NCT00025259|592894269|FG006|Overall Study|Withdrawal by Subject|3|||
164145310|NCT00025259|592894263|FG000|Overall Study|Ineligible|14|||
164145311|NCT00025259|592894264|FG001|Overall Study|Ineligible|1|||
164145312|NCT00025259|592894265|FG002|Overall Study|Ineligible|0|||
164145313|NCT00025259|592894266|FG003|Overall Study|Ineligible|0|||
164145314|NCT00025259|592894267|FG004|Overall Study|Ineligible|6|||
164145315|NCT00025259|592894268|FG005|Overall Study|Ineligible|0|||
164145316|NCT00025259|592894269|FG006|Overall Study|Ineligible|1|||
164145317|NCT00025259|592894263|FG000|Overall Study|Randomization error|1|||
164145318|NCT00025259|592894264|FG001|Overall Study|Randomization error|0|||
164145319|NCT00025259|592894265|FG002|Overall Study|Randomization error|0|||
164145320|NCT00025259|592894266|FG003|Overall Study|Randomization error|0|||
164145321|NCT00025259|592894267|FG004|Overall Study|Randomization error|1|||
164145322|NCT00025259|592894268|FG005|Overall Study|Randomization error|7|||
164145323|NCT00025259|592894269|FG006|Overall Study|Randomization error|2|||
164145324|NCT00025259|592894263|FG000|Overall Study|Adverse Event|1|||
164145325|NCT00025259|592894264|FG001|Overall Study|Adverse Event|0|||
164145326|NCT00025259|592894265|FG002|Overall Study|Adverse Event|0|||
164145327|NCT00025259|592894266|FG003|Overall Study|Adverse Event|0|||
164145328|NCT00025259|592894267|FG004|Overall Study|Adverse Event|0|||
164145329|NCT00025259|592894268|FG005|Overall Study|Adverse Event|0|||
164145330|NCT00025259|592894269|FG006|Overall Study|Adverse Event|0|||
164145331|NCT03138655|592894274|FG000|Overall Study|Adverse Event|2|||
164145332|NCT03138655|592894275|FG001|Overall Study|Adverse Event|1|||
164145333|NCT03138655|592894276|FG002|Overall Study|Adverse Event|2|||
164145334|NCT03138655|592894277|FG003|Overall Study|Adverse Event|1|||
164145335|NCT03138655|592894278|FG004|Overall Study|Adverse Event|1|||
164145336|NCT03138655|592894279|FG005|Overall Study|Adverse Event|4|||
164145337|NCT03138655|592894280|FG006|Overall Study|Adverse Event|2|||
164145338|NCT03138655|592894281|FG007|Overall Study|Adverse Event|2|||
164145339|NCT03138655|592894274|FG000|Overall Study|Withdrawal by Subject|0|||
164145340|NCT03138655|592894275|FG001|Overall Study|Withdrawal by Subject|1|||
164145341|NCT03138655|592894276|FG002|Overall Study|Withdrawal by Subject|0|||
164145342|NCT03138655|592894277|FG003|Overall Study|Withdrawal by Subject|0|||
164145343|NCT03138655|592894278|FG004|Overall Study|Withdrawal by Subject|0|||
164145344|NCT03138655|592894279|FG005|Overall Study|Withdrawal by Subject|0|||
164145345|NCT03138655|592894280|FG006|Overall Study|Withdrawal by Subject|1|||
164145346|NCT03138655|592894281|FG007|Overall Study|Withdrawal by Subject|0|||
164145347|NCT03138655|592894274|FG000|Overall Study|Reason not Specified|1|||
164145348|NCT03138655|592894275|FG001|Overall Study|Reason not Specified|0|||
164145349|NCT03138655|592894276|FG002|Overall Study|Reason not Specified|0|||
164145350|NCT03138655|592894277|FG003|Overall Study|Reason not Specified|2|||
164145351|NCT03138655|592894278|FG004|Overall Study|Reason not Specified|1|||
164145352|NCT03138655|592894279|FG005|Overall Study|Reason not Specified|1|||
164145353|NCT03138655|592894280|FG006|Overall Study|Reason not Specified|0|||
164145354|NCT03138655|592894281|FG007|Overall Study|Reason not Specified|0|||
164145355|NCT02027428|592894282|FG000|Induction|Never treated|7|||
164145356|NCT02027428|592894283|FG001|Induction|Never treated|0|||
164145357|NCT02027428|592894284|FG002|Induction|Never treated|0|||
164145358|NCT02027428|592894282|FG000|Induction|Progressive disease|77|||
164145359|NCT02027428|592894283|FG001|Induction|Progressive disease|0|||
164145360|NCT02027428|592894284|FG002|Induction|Progressive disease|0|||
164145361|NCT02027428|592894282|FG000|Induction|Adverse Event|51|||
164145362|NCT02027428|592894283|FG001|Induction|Adverse Event|0|||
164145363|NCT02027428|592894284|FG002|Induction|Adverse Event|0|||
164145364|NCT02027428|592894282|FG000|Induction|Withdrawal by Subject|22|||
164145365|NCT02027428|592894283|FG001|Induction|Withdrawal by Subject|0|||
164145366|NCT02027428|592894284|FG002|Induction|Withdrawal by Subject|0|||
164145367|NCT02027428|592894282|FG000|Induction|Death|21|||
164145368|NCT02027428|592894283|FG001|Induction|Death|0|||
164145369|NCT02027428|592894284|FG002|Induction|Death|0|||
164145370|NCT02027428|592894282|FG000|Induction|Symptomatic deterioration|16|||
164145371|NCT02027428|592894283|FG001|Induction|Symptomatic deterioration|0|||
164145372|NCT02027428|592894284|FG002|Induction|Symptomatic deterioration|0|||
164145373|NCT02027428|592894282|FG000|Induction|Study terminated by sponsor|12|||
164145374|NCT02027428|592894283|FG001|Induction|Study terminated by sponsor|0|||
164145375|NCT02027428|592894284|FG002|Induction|Study terminated by sponsor|0|||
164145376|NCT02027428|592894282|FG000|Induction|Protocol Violation|1|||
164145377|NCT02027428|592894283|FG001|Induction|Protocol Violation|0|||
164145378|NCT02027428|592894284|FG002|Induction|Protocol Violation|0|||
164145379|NCT02027428|592894282|FG000|Induction|Miscellaneous|14|||
164145380|NCT02027428|592894283|FG001|Induction|Miscellaneous|0|||
164145381|NCT02027428|592894284|FG002|Induction|Miscellaneous|0|||
164145382|NCT02027428|592894282|FG000|Induction|Induction Treatment Ongoing|4|||
164145460|NCT01198132|592894311|FG000|Overall Study|Lack of Efficacy|2|||
164145383|NCT02027428|592894283|FG001|Induction|Induction Treatment Ongoing|0|||
164145384|NCT02027428|592894284|FG002|Induction|Induction Treatment Ongoing|0|||
164145385|NCT02027428|592894282|FG000|Maintenance|Death|0|||
164145386|NCT02027428|592894283|FG001|Maintenance|Death|3|||
164145387|NCT02027428|592894284|FG002|Maintenance|Death|2|||
164145388|NCT02027428|592894282|FG000|Maintenance|Adverse Event|0|||
164145389|NCT02027428|592894283|FG001|Maintenance|Adverse Event|21|||
164145390|NCT02027428|592894284|FG002|Maintenance|Adverse Event|1|||
164145391|NCT02027428|592894282|FG000|Maintenance|Progressive disease|0|||
164145392|NCT02027428|592894283|FG001|Maintenance|Progressive disease|84|||
164145393|NCT02027428|592894284|FG002|Maintenance|Progressive disease|47|||
164145394|NCT02027428|592894282|FG000|Maintenance|Symptomatic deterioration|0|||
164145395|NCT02027428|592894283|FG001|Maintenance|Symptomatic deterioration|4|||
164145396|NCT02027428|592894284|FG002|Maintenance|Symptomatic deterioration|1|||
164145397|NCT02027428|592894282|FG000|Maintenance|Withdrawal by Subject|0|||
164145398|NCT02027428|592894283|FG001|Maintenance|Withdrawal by Subject|6|||
164145399|NCT02027428|592894284|FG002|Maintenance|Withdrawal by Subject|5|||
164145400|NCT02027428|592894282|FG000|Maintenance|Protocol Violation|0|||
164145401|NCT02027428|592894283|FG001|Maintenance|Protocol Violation|0|||
164145402|NCT02027428|592894284|FG002|Maintenance|Protocol Violation|1|||
164145403|NCT02027428|592894282|FG000|Maintenance|Other|0|||
164145404|NCT02027428|592894283|FG001|Maintenance|Other|6|||
164145405|NCT02027428|592894284|FG002|Maintenance|Other|3|||
164145406|NCT02027428|592894282|FG000|Survival Follow-up|Death|0|||
164145407|NCT02027428|592894283|FG001|Survival Follow-up|Death|78|||
164145408|NCT02027428|592894284|FG002|Survival Follow-up|Death|45|||
164145409|NCT02027428|592894282|FG000|Survival Follow-up|Lost to Follow-up|0|||
164145410|NCT02027428|592894283|FG001|Survival Follow-up|Lost to Follow-up|1|||
164145411|NCT02027428|592894284|FG002|Survival Follow-up|Lost to Follow-up|1|||
164145412|NCT01128543|592894285|FG000|Overall Study|Withdrawal by Subject|3|||
164145413|NCT01128543|592894285|FG000|Overall Study|Protocol Violation|1|||
164145414|NCT03340974|592894289|FG000|Completion of Study -Long Term Follow up|Death|8|||
164145415|NCT03340974|592894290|FG001|Completion of Study -Long Term Follow up|Death|5|||
164145416|NCT03340974|592894291|FG002|Completion of Study -Long Term Follow up|Death|5|||
164145417|NCT03340974|592894292|FG003|Completion of Study -Long Term Follow up|Death|7|||
164145418|NCT03340974|592894289|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
164145419|NCT03340974|592894290|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
164145420|NCT03340974|592894291|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
164145421|NCT03340974|592894292|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
164145422|NCT03340974|592894289|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
164145423|NCT03340974|592894290|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
164145424|NCT03340974|592894291|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
164145425|NCT03340974|592894292|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
164145426|NCT03340974|592894289|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
164145427|NCT03340974|592894290|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
164145428|NCT03340974|592894291|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
164145429|NCT03340974|592894292|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
164145430|NCT00396565|592894304|FG000|Overall Study|Physician Decision|3|||
164145431|NCT00396565|592894305|FG001|Overall Study|Physician Decision|1|||
164145432|NCT00396565|592894306|FG002|Overall Study|Physician Decision|2|||
164145433|NCT00396565|592894304|FG000|Overall Study|Adverse Event|5|||
164145434|NCT00396565|592894305|FG001|Overall Study|Adverse Event|13|||
164145435|NCT00396565|592894306|FG002|Overall Study|Adverse Event|3|||
164145436|NCT00396565|592894304|FG000|Overall Study|Withdrawal by Subject|8|||
164145437|NCT00396565|592894305|FG001|Overall Study|Withdrawal by Subject|13|||
164145438|NCT00396565|592894306|FG002|Overall Study|Withdrawal by Subject|1|||
164145439|NCT00396565|592894304|FG000|Overall Study|Lack of Efficacy|32|||
164145440|NCT00396565|592894305|FG001|Overall Study|Lack of Efficacy|64|||
164145441|NCT00396565|592894306|FG002|Overall Study|Lack of Efficacy|11|||
164145442|NCT04877457|592894307|FG000|Overall Study|Early termination of study due to low enrollment|2|||
164145443|NCT04877457|592894308|FG001|Overall Study|Early termination of study due to low enrollment|1|||
164145444|NCT02211417|592894309|FG000|Overall Study|Withdrawal by Subject|11|||
164145445|NCT02211417|592894310|FG001|Overall Study|Withdrawal by Subject|8|||
164145446|NCT02211417|592894309|FG000|Overall Study|Protocol Violation|1|||
164145447|NCT02211417|592894310|FG001|Overall Study|Protocol Violation|0|||
164145448|NCT02211417|592894309|FG000|Overall Study|Pregnancy|0|||
164145449|NCT02211417|592894310|FG001|Overall Study|Pregnancy|1|||
164145450|NCT02211417|592894309|FG000|Overall Study|Lost to Follow-up|2|||
164145451|NCT02211417|592894310|FG001|Overall Study|Lost to Follow-up|3|||
164145452|NCT02211417|592894309|FG000|Overall Study|Adverse Event|1|||
164145453|NCT02211417|592894310|FG001|Overall Study|Adverse Event|4|||
164145454|NCT01198132|592894311|FG000|Overall Study|Withdrawal by Subject|4|||
164145455|NCT01198132|592894312|FG001|Overall Study|Withdrawal by Subject|5|||
164145456|NCT01198132|592894311|FG000|Overall Study|Physician Decision|5|||
164145457|NCT01198132|592894312|FG001|Overall Study|Physician Decision|4|||
164145458|NCT01198132|592894311|FG000|Overall Study|Other Unspecified|3|||
164145459|NCT01198132|592894312|FG001|Overall Study|Other Unspecified|6|||
164145462|NCT01198132|592894311|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
164145463|NCT01198132|592894312|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
164145464|NCT01198132|592894311|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
164145465|NCT01198132|592894312|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
164145466|NCT01198132|592894311|FG000|Overall Study|Adverse Event|0|||
164145467|NCT01198132|592894312|FG001|Overall Study|Adverse Event|1|||
164145468|NCT01198132|592894311|FG000|Overall Study|Protocol Violation|1|||
164145469|NCT01198132|592894312|FG001|Overall Study|Protocol Violation|0|||
164145470|NCT04697069|592894313|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
164145471|NCT04697069|592894314|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
164145472|NCT04697069|592894313|FG000|Overall Study|Study termination|2|||
164145473|NCT04697069|592894314|FG001|Overall Study|Study termination|1|||
164145474|NCT05180227|592894315|FG000|Overall Study|Hypertension at screening|1|||
164145475|NCT05180227|592894315|FG000|Overall Study|Lost to Follow-up|1|||
164145476|NCT02924727|592894316|FG000|Overall Study|Withdrawal by Subject|2|||
164145477|NCT02924727|592894317|FG001|Overall Study|Withdrawal by Subject|4|||
164145478|NCT02924727|592894316|FG000|Overall Study|Lost to Follow-up|2|||
164145479|NCT02924727|592894317|FG001|Overall Study|Lost to Follow-up|5|||
164145480|NCT02924727|592894316|FG000|Overall Study|Death|221|||
164145481|NCT02924727|592894317|FG001|Overall Study|Death|247|||
164145482|NCT02924727|592894316|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
164145483|NCT02924727|592894317|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
164145484|NCT02185053|592894318|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
164145485|NCT02185053|592894319|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
164145486|NCT02185053|592894320|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
164145487|NCT02185053|592894318|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
164145488|NCT02185053|592894319|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
164145489|NCT02185053|592894320|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
164145490|NCT02185053|592894318|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
164145491|NCT02185053|592894319|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
164145492|NCT02185053|592894320|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
164145493|NCT02185053|592894318|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
164145494|NCT02185053|592894319|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
164145495|NCT02185053|592894320|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
164145496|NCT02185053|592894318|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
164145497|NCT02185053|592894319|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
164145498|NCT02185053|592894320|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
164145499|NCT02185053|592894318|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
164145500|NCT02185053|592894319|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
164145501|NCT02185053|592894320|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
164145502|NCT02185053|592894318|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
164145503|NCT02185053|592894319|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
164145504|NCT02185053|592894320|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
164145505|NCT02185053|592894318|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
164145506|NCT02185053|592894319|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
164145507|NCT02185053|592894320|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
164145508|NCT02521376|592894323|FG000|Overall Study|Enrolled, But Not Treated|1|||
164145509|NCT02521376|592894324|FG001|Overall Study|Enrolled, But Not Treated|0|||
164145510|NCT02521376|592894325|FG002|Overall Study|Enrolled, But Not Treated|0|||
164145511|NCT02521376|592894326|FG003|Overall Study|Enrolled, But Not Treated|0|||
164145512|NCT00338728|592894327|FG000|Overall Study|Screen Failure|14|||
164145513|NCT00340678|592894330|FG000|Overall Study|Lost to Follow-up|1|||
164145514|NCT00340678|592894331|FG001|Overall Study|Lost to Follow-up|0|||
164145515|NCT00340678|592894332|FG002|Overall Study|Lost to Follow-up|0|||
164145516|NCT00340678|592894333|FG003|Overall Study|Lost to Follow-up|0|||
164145517|NCT04803305|592894334|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
164145518|NCT04803305|592894335|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
164145519|NCT04803305|592894334|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
164145520|NCT04803305|592894335|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
164145521|NCT04803305|592894334|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
164145522|NCT04803305|592894335|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
164145523|NCT04803305|592894334|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
164145524|NCT04803305|592894335|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
164145525|NCT04803305|592894334|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
164145526|NCT04803305|592894335|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
164145527|NCT04803305|592894334|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
164145528|NCT04803305|592894335|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
164145529|NCT04803305|592894334|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
164145530|NCT04803305|592894335|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
164145531|NCT04803305|592894334|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
164145532|NCT04803305|592894335|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
164145533|NCT01862484|592894337|FG000|Overall Study|Lack of Efficacy|1|||
164145534|NCT01862484|592894338|FG001|Overall Study|Lack of Efficacy|1|||
164145535|NCT01862484|592894337|FG000|Overall Study|Lost to Follow-up|1|||
164145536|NCT01862484|592894338|FG001|Overall Study|Lost to Follow-up|2|||
164145537|NCT01862484|592894337|FG000|Overall Study|Protocol Violation|0|||
164145538|NCT01862484|592894338|FG001|Overall Study|Protocol Violation|2|||
164145539|NCT01862484|592894337|FG000|Overall Study|Withdrawal by Subject|0|||
164145540|NCT01862484|592894338|FG001|Overall Study|Withdrawal by Subject|3|||
164145541|NCT00996892|592894339|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
164145542|NCT00996892|592894340|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
164145543|NCT00996892|592894341|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
164145544|NCT00996892|592894342|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
164145545|NCT00996892|592894343|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
164145546|NCT00996892|592894344|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
164145547|NCT00996892|592894345|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
164145548|NCT00996892|592894346|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
164145549|NCT00996892|592894347|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
164145550|NCT00996892|592894348|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
164145551|NCT00996892|592894349|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
164145552|NCT00996892|592894350|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
164145553|NCT00996892|592894351|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
164145554|NCT00996892|592894352|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
164145555|NCT00996892|592894353|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
164145556|NCT00996892|592894354|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
164145557|NCT00996892|592894355|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
164145558|NCT00996892|592894356|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
164145559|NCT00996892|592894357|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
164145560|NCT00996892|592894358|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
164145561|NCT00996892|592894339|FG000|Dose-Escalation Stage 1|Death|1|||
164145562|NCT00996892|592894340|FG001|Dose-Escalation Stage 1|Death|0|||
164145563|NCT00996892|592894341|FG002|Dose-Escalation Stage 1|Death|0|||
164145564|NCT00996892|592894342|FG003|Dose-Escalation Stage 1|Death|0|||
164145565|NCT00996892|592894343|FG004|Dose-Escalation Stage 1|Death|0|||
164145566|NCT00996892|592894344|FG005|Dose-Escalation Stage 1|Death|1|||
164145567|NCT00996892|592894345|FG006|Dose-Escalation Stage 1|Death|0|||
164145568|NCT00996892|592894346|FG007|Dose-Escalation Stage 1|Death|0|||
164145569|NCT00996892|592894347|FG008|Dose-Escalation Stage 1|Death|0|||
164145570|NCT00996892|592894348|FG009|Dose-Escalation Stage 1|Death|0|||
164145571|NCT00996892|592894349|FG010|Dose-Escalation Stage 1|Death|0|||
164145572|NCT00996892|592894350|FG011|Dose-Escalation Stage 1|Death|0|||
164145573|NCT00996892|592894351|FG012|Dose-Escalation Stage 1|Death|0|||
164145574|NCT00996892|592894352|FG013|Dose-Escalation Stage 1|Death|0|||
164145575|NCT00996892|592894353|FG014|Dose-Escalation Stage 1|Death|0|||
164145576|NCT00996892|592894354|FG015|Dose-Escalation Stage 1|Death|0|||
164145577|NCT00996892|592894355|FG016|Dose-Escalation Stage 1|Death|0|||
164145578|NCT00996892|592894356|FG017|Dose-Escalation Stage 1|Death|0|||
164145579|NCT00996892|592894357|FG018|Dose-Escalation Stage 1|Death|0|||
164145580|NCT00996892|592894358|FG019|Dose-Escalation Stage 1|Death|0|||
164145581|NCT00996892|592894339|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
164145582|NCT00996892|592894340|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
164145583|NCT00996892|592894341|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
164145584|NCT00996892|592894342|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
164145585|NCT00996892|592894343|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
164145586|NCT00996892|592894344|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
164145587|NCT00996892|592894345|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
164145588|NCT00996892|592894346|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
164145589|NCT00996892|592894347|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
164145590|NCT00996892|592894348|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
164145591|NCT00996892|592894349|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
164145592|NCT00996892|592894350|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
164145593|NCT00996892|592894351|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
164145594|NCT00996892|592894352|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
164145595|NCT00996892|592894353|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
164145596|NCT00996892|592894354|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
164145597|NCT00996892|592894355|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
164145598|NCT00996892|592894356|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
164145599|NCT00996892|592894357|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
164145600|NCT00996892|592894358|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
164145601|NCT00996892|592894339|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145602|NCT00996892|592894340|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
164145603|NCT00996892|592894341|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145604|NCT00996892|592894342|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
164145605|NCT00996892|592894343|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
164145606|NCT00996892|592894344|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
164145607|NCT00996892|592894345|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
164145608|NCT00996892|592894346|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145609|NCT00996892|592894347|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145610|NCT00996892|592894348|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145611|NCT00996892|592894349|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145612|NCT00996892|592894350|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145613|NCT00996892|592894351|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145614|NCT00996892|592894352|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145615|NCT00996892|592894353|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145616|NCT00996892|592894354|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145617|NCT00996892|592894355|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145618|NCT00996892|592894356|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145619|NCT00996892|592894357|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145620|NCT00996892|592894358|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145621|NCT00996892|592894339|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
164145622|NCT00996892|592894340|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
164145623|NCT00996892|592894341|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
164145624|NCT00996892|592894342|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
164145625|NCT00996892|592894343|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
164145626|NCT00996892|592894344|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
164145627|NCT00996892|592894345|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
164145628|NCT00996892|592894346|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
164145629|NCT00996892|592894347|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
164145630|NCT00996892|592894348|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
164145631|NCT00996892|592894349|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
164145632|NCT00996892|592894350|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
164145633|NCT00996892|592894351|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
164145634|NCT00996892|592894352|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
164145635|NCT00996892|592894353|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
164145636|NCT00996892|592894354|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
164145637|NCT00996892|592894355|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
164145638|NCT00996892|592894356|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
164145639|NCT00996892|592894357|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
164145640|NCT00996892|592894358|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
164145641|NCT00996892|592894339|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
164145642|NCT00996892|592894340|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
164145643|NCT00996892|592894341|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
164145644|NCT00996892|592894342|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
164145645|NCT00996892|592894343|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
164145646|NCT00996892|592894344|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
164145647|NCT00996892|592894345|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
164145648|NCT00996892|592894346|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
164145649|NCT00996892|592894347|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
164145650|NCT00996892|592894348|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
164145651|NCT00996892|592894349|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
164145652|NCT00996892|592894350|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
164145653|NCT00996892|592894351|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
164145654|NCT00996892|592894352|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
164145655|NCT00996892|592894353|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
164145656|NCT00996892|592894354|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
164145657|NCT00996892|592894355|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
164145658|NCT00996892|592894356|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
164145659|NCT00996892|592894357|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
164145660|NCT00996892|592894358|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
164145661|NCT00996892|592894339|FG000|Dose-Escalation Stage 1A|Death|0|||
164145662|NCT00996892|592894340|FG001|Dose-Escalation Stage 1A|Death|0|||
164145663|NCT00996892|592894341|FG002|Dose-Escalation Stage 1A|Death|0|||
164145664|NCT00996892|592894342|FG003|Dose-Escalation Stage 1A|Death|0|||
164145665|NCT00996892|592894343|FG004|Dose-Escalation Stage 1A|Death|0|||
164145666|NCT00996892|592894344|FG005|Dose-Escalation Stage 1A|Death|0|||
164145667|NCT00996892|592894345|FG006|Dose-Escalation Stage 1A|Death|0|||
164145668|NCT00996892|592894346|FG007|Dose-Escalation Stage 1A|Death|0|||
164145669|NCT00996892|592894347|FG008|Dose-Escalation Stage 1A|Death|0|||
164145670|NCT00996892|592894348|FG009|Dose-Escalation Stage 1A|Death|2|||
164145671|NCT00996892|592894349|FG010|Dose-Escalation Stage 1A|Death|0|||
164145672|NCT00996892|592894350|FG011|Dose-Escalation Stage 1A|Death|1|||
164145673|NCT00996892|592894351|FG012|Dose-Escalation Stage 1A|Death|1|||
164145674|NCT00996892|592894352|FG013|Dose-Escalation Stage 1A|Death|0|||
164145675|NCT00996892|592894353|FG014|Dose-Escalation Stage 1A|Death|0|||
164145676|NCT00996892|592894354|FG015|Dose-Escalation Stage 1A|Death|0|||
164145677|NCT00996892|592894355|FG016|Dose-Escalation Stage 1A|Death|0|||
164145678|NCT00996892|592894356|FG017|Dose-Escalation Stage 1A|Death|0|||
164145679|NCT00996892|592894357|FG018|Dose-Escalation Stage 1A|Death|0|||
164145681|NCT00996892|592894339|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
164145682|NCT00996892|592894340|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
164145683|NCT00996892|592894341|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
164145684|NCT00996892|592894342|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
164145685|NCT00996892|592894343|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
164145686|NCT00996892|592894344|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
164145687|NCT00996892|592894345|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
164145688|NCT00996892|592894346|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
164145689|NCT00996892|592894347|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
164145690|NCT00996892|592894348|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
164145691|NCT00996892|592894349|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
164145692|NCT00996892|592894350|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
164145693|NCT00996892|592894351|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
164145694|NCT00996892|592894352|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
164145695|NCT00996892|592894353|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
164145696|NCT00996892|592894354|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
164145697|NCT00996892|592894355|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
164145698|NCT00996892|592894356|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
164145699|NCT00996892|592894357|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
164145700|NCT00996892|592894358|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
164145701|NCT00996892|592894339|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145702|NCT00996892|592894340|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145703|NCT00996892|592894341|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145704|NCT00996892|592894342|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145705|NCT00996892|592894343|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145706|NCT00996892|592894344|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145707|NCT00996892|592894345|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145708|NCT00996892|592894346|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145709|NCT00996892|592894347|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145710|NCT00996892|592894348|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
164145711|NCT00996892|592894349|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
164145712|NCT00996892|592894350|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
164145713|NCT00996892|592894351|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
164145714|NCT00996892|592894352|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145715|NCT00996892|592894353|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145716|NCT00996892|592894354|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145717|NCT00996892|592894355|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145718|NCT00996892|592894356|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145719|NCT00996892|592894357|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145720|NCT00996892|592894358|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145721|NCT00996892|592894339|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
164145722|NCT00996892|592894340|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
164145723|NCT00996892|592894341|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
164145724|NCT00996892|592894342|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
164145725|NCT00996892|592894343|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
164145726|NCT00996892|592894344|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
164145727|NCT00996892|592894345|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
164145728|NCT00996892|592894346|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
164145729|NCT00996892|592894347|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
164145730|NCT00996892|592894348|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
164145731|NCT00996892|592894349|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
164145732|NCT00996892|592894350|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
164145733|NCT00996892|592894351|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
164145734|NCT00996892|592894352|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
164145735|NCT00996892|592894353|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
164145736|NCT00996892|592894354|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
164145737|NCT00996892|592894355|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
164145738|NCT00996892|592894356|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
164145739|NCT00996892|592894357|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
164145740|NCT00996892|592894358|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
164145741|NCT00996892|592894339|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
164145742|NCT00996892|592894340|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
164145743|NCT00996892|592894341|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
164145744|NCT00996892|592894342|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
164145745|NCT00996892|592894343|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
164145746|NCT00996892|592894344|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
164145747|NCT00996892|592894345|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
164145748|NCT00996892|592894346|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
164145749|NCT00996892|592894347|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
164145750|NCT00996892|592894348|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
164145751|NCT00996892|592894349|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
164145752|NCT00996892|592894350|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
164145753|NCT00996892|592894351|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
164145754|NCT00996892|592894352|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
164145755|NCT00996892|592894353|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
164145756|NCT00996892|592894354|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
164145757|NCT00996892|592894355|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
164145758|NCT00996892|592894356|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
164145759|NCT00996892|592894357|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
164145760|NCT00996892|592894358|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
164145761|NCT00996892|592894339|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
164145762|NCT00996892|592894340|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
164145763|NCT00996892|592894341|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
164145764|NCT00996892|592894342|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
164145765|NCT00996892|592894343|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
164145766|NCT00996892|592894344|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
164145767|NCT00996892|592894345|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
164145768|NCT00996892|592894346|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
164145769|NCT00996892|592894347|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
164145770|NCT00996892|592894348|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
164145771|NCT00996892|592894349|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
164145772|NCT00996892|592894350|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
164145773|NCT00996892|592894351|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
164145774|NCT00996892|592894352|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
164145775|NCT00996892|592894353|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
164145776|NCT00996892|592894354|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
164145777|NCT00996892|592894355|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
164145778|NCT00996892|592894356|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
164145779|NCT00996892|592894357|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
164145780|NCT00996892|592894358|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
164145781|NCT00996892|592894339|FG000|Expansion Stage 2|Adverse Event|0|||
164145782|NCT00996892|592894340|FG001|Expansion Stage 2|Adverse Event|0|||
164145783|NCT00996892|592894341|FG002|Expansion Stage 2|Adverse Event|0|||
164145784|NCT00996892|592894342|FG003|Expansion Stage 2|Adverse Event|0|||
164145785|NCT00996892|592894343|FG004|Expansion Stage 2|Adverse Event|0|||
164145786|NCT00996892|592894344|FG005|Expansion Stage 2|Adverse Event|0|||
164145787|NCT00996892|592894345|FG006|Expansion Stage 2|Adverse Event|0|||
164145788|NCT00996892|592894346|FG007|Expansion Stage 2|Adverse Event|0|||
164145789|NCT00996892|592894347|FG008|Expansion Stage 2|Adverse Event|0|||
164145790|NCT00996892|592894348|FG009|Expansion Stage 2|Adverse Event|0|||
164145791|NCT00996892|592894349|FG010|Expansion Stage 2|Adverse Event|0|||
164145792|NCT00996892|592894350|FG011|Expansion Stage 2|Adverse Event|0|||
164145793|NCT00996892|592894351|FG012|Expansion Stage 2|Adverse Event|0|||
164145794|NCT00996892|592894352|FG013|Expansion Stage 2|Adverse Event|0|||
164145795|NCT00996892|592894353|FG014|Expansion Stage 2|Adverse Event|0|||
164145796|NCT00996892|592894354|FG015|Expansion Stage 2|Adverse Event|0|||
164145797|NCT00996892|592894355|FG016|Expansion Stage 2|Adverse Event|0|||
164145798|NCT00996892|592894356|FG017|Expansion Stage 2|Adverse Event|0|||
164145799|NCT00996892|592894357|FG018|Expansion Stage 2|Adverse Event|3|||
164145800|NCT00996892|592894358|FG019|Expansion Stage 2|Adverse Event|0|||
164145801|NCT00996892|592894339|FG000|Expansion Stage 2|Death|0|||
164145802|NCT00996892|592894340|FG001|Expansion Stage 2|Death|0|||
164145803|NCT00996892|592894341|FG002|Expansion Stage 2|Death|0|||
164145804|NCT00996892|592894342|FG003|Expansion Stage 2|Death|0|||
164145805|NCT00996892|592894343|FG004|Expansion Stage 2|Death|0|||
164145806|NCT00996892|592894344|FG005|Expansion Stage 2|Death|0|||
164145807|NCT00996892|592894345|FG006|Expansion Stage 2|Death|0|||
164145808|NCT00996892|592894346|FG007|Expansion Stage 2|Death|0|||
164145809|NCT00996892|592894347|FG008|Expansion Stage 2|Death|0|||
164145810|NCT00996892|592894348|FG009|Expansion Stage 2|Death|0|||
164145811|NCT00996892|592894349|FG010|Expansion Stage 2|Death|0|||
164145812|NCT00996892|592894350|FG011|Expansion Stage 2|Death|0|||
164145813|NCT00996892|592894351|FG012|Expansion Stage 2|Death|0|||
164145814|NCT00996892|592894352|FG013|Expansion Stage 2|Death|0|||
164145815|NCT00996892|592894353|FG014|Expansion Stage 2|Death|0|||
164145816|NCT00996892|592894354|FG015|Expansion Stage 2|Death|0|||
164145817|NCT00996892|592894355|FG016|Expansion Stage 2|Death|0|||
164145818|NCT00996892|592894356|FG017|Expansion Stage 2|Death|0|||
164145819|NCT00996892|592894357|FG018|Expansion Stage 2|Death|2|||
164145820|NCT00996892|592894358|FG019|Expansion Stage 2|Death|0|||
164145821|NCT00996892|592894339|FG000|Expansion Stage 2|Physician Decision|0|||
164145822|NCT00996892|592894340|FG001|Expansion Stage 2|Physician Decision|0|||
164145823|NCT00996892|592894341|FG002|Expansion Stage 2|Physician Decision|0|||
164145824|NCT00996892|592894342|FG003|Expansion Stage 2|Physician Decision|0|||
164145825|NCT00996892|592894343|FG004|Expansion Stage 2|Physician Decision|0|||
164145826|NCT00996892|592894344|FG005|Expansion Stage 2|Physician Decision|0|||
164145827|NCT00996892|592894345|FG006|Expansion Stage 2|Physician Decision|0|||
164145828|NCT00996892|592894346|FG007|Expansion Stage 2|Physician Decision|0|||
164145829|NCT00996892|592894347|FG008|Expansion Stage 2|Physician Decision|0|||
164145830|NCT00996892|592894348|FG009|Expansion Stage 2|Physician Decision|0|||
164145831|NCT00996892|592894349|FG010|Expansion Stage 2|Physician Decision|0|||
164145832|NCT00996892|592894350|FG011|Expansion Stage 2|Physician Decision|0|||
164145833|NCT00996892|592894351|FG012|Expansion Stage 2|Physician Decision|0|||
164145834|NCT00996892|592894352|FG013|Expansion Stage 2|Physician Decision|0|||
164145835|NCT00996892|592894353|FG014|Expansion Stage 2|Physician Decision|0|||
164145836|NCT00996892|592894354|FG015|Expansion Stage 2|Physician Decision|0|||
164145837|NCT00996892|592894355|FG016|Expansion Stage 2|Physician Decision|0|||
164145838|NCT00996892|592894356|FG017|Expansion Stage 2|Physician Decision|0|||
164145839|NCT00996892|592894357|FG018|Expansion Stage 2|Physician Decision|1|||
164145840|NCT00996892|592894358|FG019|Expansion Stage 2|Physician Decision|0|||
164145841|NCT00996892|592894339|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
164145842|NCT00996892|592894340|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
164145843|NCT00996892|592894341|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
164145844|NCT00996892|592894342|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
164145845|NCT00996892|592894343|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
164145846|NCT00996892|592894344|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
164145847|NCT00996892|592894345|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
164145848|NCT00996892|592894346|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
164145849|NCT00996892|592894347|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
164145850|NCT00996892|592894348|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
164145851|NCT00996892|592894349|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
164145852|NCT00996892|592894350|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
164145853|NCT00996892|592894351|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
164145854|NCT00996892|592894352|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
164145855|NCT00996892|592894353|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
164145856|NCT00996892|592894354|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
164145857|NCT00996892|592894355|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
164145858|NCT00996892|592894356|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
164145859|NCT00996892|592894357|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
164145860|NCT00996892|592894358|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
164145861|NCT00996892|592894339|FG000|Expansion Stage 2|Disease Progression|0|||
164145862|NCT00996892|592894340|FG001|Expansion Stage 2|Disease Progression|0|||
164145863|NCT00996892|592894341|FG002|Expansion Stage 2|Disease Progression|0|||
164145864|NCT00996892|592894342|FG003|Expansion Stage 2|Disease Progression|0|||
164145865|NCT00996892|592894343|FG004|Expansion Stage 2|Disease Progression|0|||
164145866|NCT00996892|592894344|FG005|Expansion Stage 2|Disease Progression|0|||
164145867|NCT00996892|592894345|FG006|Expansion Stage 2|Disease Progression|0|||
164145868|NCT00996892|592894346|FG007|Expansion Stage 2|Disease Progression|0|||
164145869|NCT00996892|592894347|FG008|Expansion Stage 2|Disease Progression|0|||
164145870|NCT00996892|592894348|FG009|Expansion Stage 2|Disease Progression|0|||
164145871|NCT00996892|592894349|FG010|Expansion Stage 2|Disease Progression|0|||
164145872|NCT00996892|592894350|FG011|Expansion Stage 2|Disease Progression|0|||
164145873|NCT00996892|592894351|FG012|Expansion Stage 2|Disease Progression|0|||
164145874|NCT00996892|592894352|FG013|Expansion Stage 2|Disease Progression|0|||
164145875|NCT00996892|592894353|FG014|Expansion Stage 2|Disease Progression|0|||
164145876|NCT00996892|592894354|FG015|Expansion Stage 2|Disease Progression|0|||
164145877|NCT00996892|592894355|FG016|Expansion Stage 2|Disease Progression|0|||
164145878|NCT00996892|592894356|FG017|Expansion Stage 2|Disease Progression|0|||
164145879|NCT00996892|592894357|FG018|Expansion Stage 2|Disease Progression|28|||
164145880|NCT00996892|592894358|FG019|Expansion Stage 2|Disease Progression|0|||
164145881|NCT00996892|592894339|FG000|Expansion Stage 2A|Adverse Event|0|||
164145882|NCT00996892|592894340|FG001|Expansion Stage 2A|Adverse Event|0|||
164145883|NCT00996892|592894341|FG002|Expansion Stage 2A|Adverse Event|0|||
164145884|NCT00996892|592894342|FG003|Expansion Stage 2A|Adverse Event|0|||
164145885|NCT00996892|592894343|FG004|Expansion Stage 2A|Adverse Event|0|||
164145886|NCT00996892|592894344|FG005|Expansion Stage 2A|Adverse Event|0|||
164145887|NCT00996892|592894345|FG006|Expansion Stage 2A|Adverse Event|0|||
164145888|NCT00996892|592894346|FG007|Expansion Stage 2A|Adverse Event|0|||
164145889|NCT00996892|592894347|FG008|Expansion Stage 2A|Adverse Event|0|||
164145890|NCT00996892|592894348|FG009|Expansion Stage 2A|Adverse Event|0|||
164145891|NCT00996892|592894349|FG010|Expansion Stage 2A|Adverse Event|0|||
164145892|NCT00996892|592894350|FG011|Expansion Stage 2A|Adverse Event|0|||
164145893|NCT00996892|592894351|FG012|Expansion Stage 2A|Adverse Event|0|||
164145894|NCT00996892|592894352|FG013|Expansion Stage 2A|Adverse Event|0|||
164145895|NCT00996892|592894353|FG014|Expansion Stage 2A|Adverse Event|0|||
164145896|NCT00996892|592894354|FG015|Expansion Stage 2A|Adverse Event|0|||
164145897|NCT00996892|592894355|FG016|Expansion Stage 2A|Adverse Event|0|||
164145898|NCT00996892|592894356|FG017|Expansion Stage 2A|Adverse Event|0|||
164145899|NCT00996892|592894357|FG018|Expansion Stage 2A|Adverse Event|0|||
164145900|NCT00996892|592894358|FG019|Expansion Stage 2A|Adverse Event|8|||
164145901|NCT00996892|592894339|FG000|Expansion Stage 2A|Physician Decision|0|||
164145902|NCT00996892|592894340|FG001|Expansion Stage 2A|Physician Decision|0|||
164145903|NCT00996892|592894341|FG002|Expansion Stage 2A|Physician Decision|0|||
164145904|NCT00996892|592894342|FG003|Expansion Stage 2A|Physician Decision|0|||
164145905|NCT00996892|592894343|FG004|Expansion Stage 2A|Physician Decision|0|||
164145906|NCT00996892|592894344|FG005|Expansion Stage 2A|Physician Decision|0|||
164145907|NCT00996892|592894345|FG006|Expansion Stage 2A|Physician Decision|0|||
164145908|NCT00996892|592894346|FG007|Expansion Stage 2A|Physician Decision|0|||
164145909|NCT00996892|592894347|FG008|Expansion Stage 2A|Physician Decision|0|||
164145910|NCT00996892|592894348|FG009|Expansion Stage 2A|Physician Decision|0|||
164145911|NCT00996892|592894349|FG010|Expansion Stage 2A|Physician Decision|0|||
164145912|NCT00996892|592894350|FG011|Expansion Stage 2A|Physician Decision|0|||
164145913|NCT00996892|592894351|FG012|Expansion Stage 2A|Physician Decision|0|||
164145914|NCT00996892|592894352|FG013|Expansion Stage 2A|Physician Decision|0|||
164145915|NCT00996892|592894353|FG014|Expansion Stage 2A|Physician Decision|0|||
164145916|NCT00996892|592894354|FG015|Expansion Stage 2A|Physician Decision|0|||
164145917|NCT00996892|592894355|FG016|Expansion Stage 2A|Physician Decision|0|||
164145918|NCT00996892|592894356|FG017|Expansion Stage 2A|Physician Decision|0|||
164145919|NCT00996892|592894357|FG018|Expansion Stage 2A|Physician Decision|0|||
164145920|NCT00996892|592894358|FG019|Expansion Stage 2A|Physician Decision|2|||
164145921|NCT00996892|592894339|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
164145922|NCT00996892|592894340|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
164145923|NCT00996892|592894341|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
164145924|NCT00996892|592894342|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
164145925|NCT00996892|592894343|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
164145926|NCT00996892|592894344|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
164145927|NCT00996892|592894345|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
164145928|NCT00996892|592894346|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
164145929|NCT00996892|592894347|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
164145930|NCT00996892|592894348|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
164145931|NCT00996892|592894349|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
164145932|NCT00996892|592894350|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
164145933|NCT00996892|592894351|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
164145934|NCT00996892|592894352|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
164145935|NCT00996892|592894353|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
164145936|NCT00996892|592894354|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
164145937|NCT00996892|592894355|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
164145938|NCT00996892|592894356|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
164145939|NCT00996892|592894357|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
164145940|NCT00996892|592894358|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
164145941|NCT00996892|592894339|FG000|Expansion Stage 2A|Disease Progression|0|||
164145942|NCT00996892|592894340|FG001|Expansion Stage 2A|Disease Progression|0|||
164145943|NCT00996892|592894341|FG002|Expansion Stage 2A|Disease Progression|0|||
164145944|NCT00996892|592894342|FG003|Expansion Stage 2A|Disease Progression|0|||
164145945|NCT00996892|592894343|FG004|Expansion Stage 2A|Disease Progression|0|||
164145946|NCT00996892|592894344|FG005|Expansion Stage 2A|Disease Progression|0|||
164145947|NCT00996892|592894345|FG006|Expansion Stage 2A|Disease Progression|0|||
164145948|NCT00996892|592894346|FG007|Expansion Stage 2A|Disease Progression|0|||
164145949|NCT00996892|592894347|FG008|Expansion Stage 2A|Disease Progression|0|||
164145950|NCT00996892|592894348|FG009|Expansion Stage 2A|Disease Progression|0|||
164145951|NCT00996892|592894349|FG010|Expansion Stage 2A|Disease Progression|0|||
164145952|NCT00996892|592894350|FG011|Expansion Stage 2A|Disease Progression|0|||
164145953|NCT00996892|592894351|FG012|Expansion Stage 2A|Disease Progression|0|||
164145954|NCT00996892|592894352|FG013|Expansion Stage 2A|Disease Progression|0|||
164145955|NCT00996892|592894353|FG014|Expansion Stage 2A|Disease Progression|0|||
164145956|NCT00996892|592894354|FG015|Expansion Stage 2A|Disease Progression|0|||
164145957|NCT00996892|592894355|FG016|Expansion Stage 2A|Disease Progression|0|||
164145958|NCT00996892|592894356|FG017|Expansion Stage 2A|Disease Progression|0|||
164145959|NCT00996892|592894357|FG018|Expansion Stage 2A|Disease Progression|0|||
164145960|NCT00996892|592894358|FG019|Expansion Stage 2A|Disease Progression|31|||
164145961|NCT00993421|592894359|FG000|Overall Study|Adverse Event|2|||
164145962|NCT00993421|592894360|FG001|Overall Study|Adverse Event|7|||
164145963|NCT00993421|592894361|FG002|Overall Study|Adverse Event|6|||
164145964|NCT00993421|592894362|FG003|Overall Study|Adverse Event|9|||
164145965|NCT00993421|592894363|FG004|Overall Study|Adverse Event|5|||
164145966|NCT00993421|592894364|FG005|Overall Study|Adverse Event|7|||
164145967|NCT00993421|592894365|FG006|Overall Study|Adverse Event|1|||
164145968|NCT00993421|592894359|FG000|Overall Study|Sponsor Decision|36|||
164145969|NCT00993421|592894360|FG001|Overall Study|Sponsor Decision|31|||
164145970|NCT00993421|592894361|FG002|Overall Study|Sponsor Decision|28|||
164145971|NCT00993421|592894362|FG003|Overall Study|Sponsor Decision|30|||
164145972|NCT00993421|592894363|FG004|Overall Study|Sponsor Decision|38|||
164145973|NCT00993421|592894364|FG005|Overall Study|Sponsor Decision|30|||
164145974|NCT00993421|592894365|FG006|Overall Study|Sponsor Decision|29|||
164145975|NCT00993421|592894359|FG000|Overall Study|Lost to Follow-up|3|||
164145976|NCT00993421|592894360|FG001|Overall Study|Lost to Follow-up|5|||
164145977|NCT00993421|592894361|FG002|Overall Study|Lost to Follow-up|5|||
164145978|NCT00993421|592894362|FG003|Overall Study|Lost to Follow-up|0|||
164145979|NCT00993421|592894363|FG004|Overall Study|Lost to Follow-up|0|||
164145980|NCT00993421|592894364|FG005|Overall Study|Lost to Follow-up|0|||
164145981|NCT00993421|592894365|FG006|Overall Study|Lost to Follow-up|6|||
164145982|NCT00993421|592894359|FG000|Overall Study|Withdrawal by Subject|3|||
164145983|NCT00993421|592894360|FG001|Overall Study|Withdrawal by Subject|2|||
164145984|NCT00993421|592894361|FG002|Overall Study|Withdrawal by Subject|3|||
164145985|NCT00993421|592894362|FG003|Overall Study|Withdrawal by Subject|3|||
164145986|NCT00993421|592894363|FG004|Overall Study|Withdrawal by Subject|3|||
164145987|NCT00993421|592894364|FG005|Overall Study|Withdrawal by Subject|5|||
164145988|NCT00993421|592894365|FG006|Overall Study|Withdrawal by Subject|3|||
164145989|NCT00993421|592894359|FG000|Overall Study|Death|0|||
164145990|NCT00993421|592894360|FG001|Overall Study|Death|0|||
164145991|NCT00993421|592894361|FG002|Overall Study|Death|0|||
164145992|NCT00993421|592894362|FG003|Overall Study|Death|0|||
164145993|NCT00993421|592894363|FG004|Overall Study|Death|0|||
164145994|NCT00993421|592894364|FG005|Overall Study|Death|0|||
164145995|NCT00993421|592894365|FG006|Overall Study|Death|1|||
164145996|NCT00993421|592894359|FG000|Overall Study|Entry Criteria Exclusion|0|||
164145997|NCT00993421|592894360|FG001|Overall Study|Entry Criteria Exclusion|0|||
164145998|NCT00993421|592894361|FG002|Overall Study|Entry Criteria Exclusion|1|||
164145999|NCT00993421|592894362|FG003|Overall Study|Entry Criteria Exclusion|3|||
164146000|NCT00993421|592894363|FG004|Overall Study|Entry Criteria Exclusion|0|||
164146001|NCT00993421|592894364|FG005|Overall Study|Entry Criteria Exclusion|1|||
164146002|NCT00993421|592894365|FG006|Overall Study|Entry Criteria Exclusion|0|||
164146003|NCT00993421|592894359|FG000|Overall Study|Physician Decision|0|||
164146004|NCT00993421|592894360|FG001|Overall Study|Physician Decision|0|||
164146005|NCT00993421|592894361|FG002|Overall Study|Physician Decision|0|||
164146006|NCT00993421|592894362|FG003|Overall Study|Physician Decision|0|||
164146007|NCT00993421|592894363|FG004|Overall Study|Physician Decision|0|||
164146008|NCT00993421|592894364|FG005|Overall Study|Physician Decision|1|||
164146009|NCT00993421|592894365|FG006|Overall Study|Physician Decision|1|||
164146010|NCT00993421|592894359|FG000|Overall Study|Protocol Violation|0|||
164146011|NCT00993421|592894360|FG001|Overall Study|Protocol Violation|0|||
164146012|NCT00993421|592894361|FG002|Overall Study|Protocol Violation|0|||
164146013|NCT00993421|592894362|FG003|Overall Study|Protocol Violation|0|||
164146014|NCT00993421|592894363|FG004|Overall Study|Protocol Violation|0|||
164146015|NCT00993421|592894364|FG005|Overall Study|Protocol Violation|2|||
164146016|NCT00993421|592894365|FG006|Overall Study|Protocol Violation|1|||
164146017|NCT02759692|592894366|FG000|Period 1|Test article no longer available|1|||
164146018|NCT02759692|592894367|FG001|Period 1|Test article no longer available|1|||
164146019|NCT02759692|592894366|FG000|Period 1|No longer meets eligibility criteria.|1|||
164146020|NCT02759692|592894367|FG001|Period 1|No longer meets eligibility criteria.|0|||
164146021|NCT02759692|592894366|FG000|Period 1|Miss-Randomized|1|||
164146022|NCT02759692|592894367|FG001|Period 1|Miss-Randomized|1|||
164146023|NCT02759692|592894366|FG000|Period 2|Lost to Follow-up|1|||
164146024|NCT02759692|592894367|FG001|Period 2|Lost to Follow-up|0|||
164146025|NCT02759692|592894366|FG000|Period 2|Test article no longer available|0|||
164146026|NCT02759692|592894367|FG001|Period 2|Test article no longer available|1|||
164146027|NCT01954745|592894373|FG000|Overall Study|Radiological Progression|11|||
164146028|NCT01954745|592894373|FG000|Overall Study|Clinical Progression|5|||
164146029|NCT01954745|592894373|FG000|Overall Study|Adverse Event|2|||
164146030|NCT01954745|592894373|FG000|Overall Study|Death|1|||
164146031|NCT05314816|592894374|FG000|Overall Study|Lost to Follow-up|5|||
164146032|NCT05314816|592894375|FG001|Overall Study|Lost to Follow-up|0|||
164146033|NCT05314816|592894376|FG002|Overall Study|Lost to Follow-up|1|||
164146034|NCT05314816|592894374|FG000|Overall Study|Protocol Violation|13|||
164146035|NCT05314816|592894375|FG001|Overall Study|Protocol Violation|8|||
164146036|NCT05314816|592894376|FG002|Overall Study|Protocol Violation|0|||
164146037|NCT04042376|592894377|FG000|Overall Study|Withdrawal by Subject|1|||
164146038|NCT04042376|592894377|FG000|Overall Study|Death|3|||
164146039|NCT02551666|592894378|FG000|Overall Study|Withdrawal by Subject|1|||
164146040|NCT02551666|592894379|FG001|Overall Study|Withdrawal by Subject|3|||
164146041|NCT05422625|592894380|FG000|Overall Study|Withdrawal by Subject|1|||
164146042|NCT05422625|592894381|FG001|Overall Study|Withdrawal by Subject|0|||
164146043|NCT01433055|592895978|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
164146044|NCT01433055|592895979|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
164146045|NCT01433055|592895978|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
164146046|NCT01433055|592895979|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
164146047|NCT00733005|592895985|FG000|Overall Study|Adverse Event|0|||
164146048|NCT00733005|592895986|FG001|Overall Study|Adverse Event|1|||
164146049|NCT00733005|592895985|FG000|Overall Study|Treatment Failure|0|||
164146050|NCT00733005|592895986|FG001|Overall Study|Treatment Failure|1|||
164146051|NCT00733005|592895985|FG000|Overall Study|Withdrawal by Subject|0|||
164146052|NCT00733005|592895986|FG001|Overall Study|Withdrawal by Subject|1|||
164146053|NCT00733005|592895985|FG000|Overall Study|Protocol Violation|2|||
164146054|NCT00733005|592895986|FG001|Overall Study|Protocol Violation|0|||
164146055|NCT01769456|592895987|FG000|Overall Study|Lost to Follow-up|19|||
164146056|NCT01769456|592895987|FG000|Overall Study|Withdrawal by Subject|3|||
164146057|NCT01769456|592895987|FG000|Overall Study|Did not receive PCC intervention|6|||
164146058|NCT01769456|592895987|FG000|Overall Study|Moved out of the area|3|||
164146059|NCT01769456|592895987|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
164146060|NCT01769456|592895987|FG000|Overall Study|Parental request to youth to withdraw|1|||
164146061|NCT05244122|592895994|FG000|Overall Study|Withdrawal by Subject|318|||
164146062|NCT02653625|592895999|FG000|Overall Study|Adverse Event|1|||
164146063|NCT02653625|592895999|FG000|Overall Study|Non-compliance with Study Drug|1|||
164146064|NCT02653625|592895999|FG000|Overall Study|Protocol Violation|1|||
164146065|NCT02653625|592895999|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
164146066|NCT03965689|592896002|FG000|Overall Study|Too sick to get study intervention|2|||
164146067|NCT05377749|592896003|FG000|3 Weeks|Lost to Follow-up|2|||
164146068|NCT05377749|592896004|FG001|3 Weeks|Lost to Follow-up|4|||
164146069|NCT05377749|592896003|FG000|3 Weeks|Withdrawal by Subject|1|||
164146070|NCT05377749|592896004|FG001|3 Weeks|Withdrawal by Subject|1|||
164146071|NCT02090725|592896006|FG000|Overall Study|Withdrawal by Subject|1|||
164146072|NCT02090725|592896006|FG000|Overall Study|participants moved from area|3|||
164146073|NCT00764881|592896007|FG000|Overall Study|Adverse Event|5|||
164146074|NCT00764881|592896008|FG001|Overall Study|Adverse Event|1|||
164146075|NCT00764881|592896007|FG000|Overall Study|Withdrawal by Subject|1|||
164146076|NCT00764881|592896008|FG001|Overall Study|Withdrawal by Subject|3|||
164146077|NCT00764881|592896007|FG000|Overall Study|Protocol Violation|2|||
164146078|NCT00764881|592896008|FG001|Overall Study|Protocol Violation|2|||
164146079|NCT00764881|592896007|FG000|Overall Study|Lost to Follow-up|2|||
164146080|NCT00764881|592896008|FG001|Overall Study|Lost to Follow-up|0|||
164146081|NCT00764881|592896007|FG000|Overall Study|Noncompliant|1|||
164146082|NCT00764881|592896008|FG001|Overall Study|Noncompliant|0|||
164146083|NCT00764881|592896007|FG000|Overall Study|Accidentally discontinued study drug|1|||
164146084|NCT00764881|592896008|FG001|Overall Study|Accidentally discontinued study drug|0|||
164146085|NCT00764881|592896007|FG000|Overall Study|Wished to become pregnant|1|||
164146086|NCT00764881|592896008|FG001|Overall Study|Wished to become pregnant|0|||
164146087|NCT00764881|592896007|FG000|Overall Study|Carcinoma detected|1|||
164146088|NCT00764881|592896008|FG001|Overall Study|Carcinoma detected|0|||
164146089|NCT00764881|592896007|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
164146090|NCT00764881|592896008|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
164146091|NCT00764881|592896007|FG000|Overall Study|no treatment or no observation|2|||
164146092|NCT00764881|592896008|FG001|Overall Study|no treatment or no observation|2|||
164146093|NCT01214655|592896009|FG000|Part A|Progressive Disease|7|||
164146094|NCT01214655|592896010|FG001|Part A|Progressive Disease|0|||
164146095|NCT01214655|592896011|FG002|Part A|Progressive Disease|0|||
164146096|NCT01214655|592896009|FG000|Part A|Physician Decision|1|||
164146097|NCT01214655|592896010|FG001|Part A|Physician Decision|0|||
164146098|NCT01214655|592896011|FG002|Part A|Physician Decision|0|||
164146099|NCT01214655|592896009|FG000|Part B|Progressive disease|0|||
164146100|NCT01214655|592896010|FG001|Part B|Progressive disease|10|||
164146101|NCT01214655|592896011|FG002|Part B|Progressive disease|0|||
164146102|NCT01214655|592896009|FG000|Part B|Death|0|||
164146103|NCT01214655|592896010|FG001|Part B|Death|1|||
164146104|NCT01214655|592896011|FG002|Part B|Death|0|||
164146105|NCT01214655|592896009|FG000|Part B|Withdrawal by Subject|0|||
164146106|NCT01214655|592896010|FG001|Part B|Withdrawal by Subject|2|||
164146107|NCT01214655|592896011|FG002|Part B|Withdrawal by Subject|0|||
164146108|NCT01214655|592896009|FG000|Part C|Progressive Disease|0|||
164146109|NCT01214655|592896010|FG001|Part C|Progressive Disease|0|||
164146110|NCT01214655|592896011|FG002|Part C|Progressive Disease|5|||
164146111|NCT01214655|592896009|FG000|Part C|Death|0|||
164146112|NCT01214655|592896010|FG001|Part C|Death|0|||
164146113|NCT01214655|592896011|FG002|Part C|Death|1|||
164146114|NCT01214655|592896009|FG000|Part C|Physician Decision|0|||
164146115|NCT01214655|592896010|FG001|Part C|Physician Decision|0|||
164146116|NCT01214655|592896011|FG002|Part C|Physician Decision|1|||
164146117|NCT05256134|592896014|FG000|Overall Study|Study Terminated by Sponsor|11|||
164146118|NCT05256134|592896015|FG001|Overall Study|Study Terminated by Sponsor|10|||
164146119|NCT05256134|592896014|FG000|Overall Study|Withdrawal by Subject|1|||
164146120|NCT05256134|592896015|FG001|Overall Study|Withdrawal by Subject|3|||
164146121|NCT01692626|592896016|FG000|Overall Study|Death|0|||
164146122|NCT01692626|592896017|FG001|Overall Study|Death|1|||
164146123|NCT01692626|592896016|FG000|Overall Study|Adverse Event|2|||
164146124|NCT01692626|592896017|FG001|Overall Study|Adverse Event|3|||
164146125|NCT01692626|592896016|FG000|Overall Study|Protocol Violation|1|||
164146126|NCT01692626|592896017|FG001|Overall Study|Protocol Violation|2|||
164146127|NCT01692626|592896016|FG000|Overall Study|Withdrawal by Subject|1|||
164146128|NCT01692626|592896017|FG001|Overall Study|Withdrawal by Subject|0|||
164146129|NCT00855894|592896018|FG000|Overall Study|Death|31|||
164146130|NCT00855894|592896018|FG000|Overall Study|Patient's decision|1|||
164146131|NCT00855894|592896018|FG000|Overall Study|Disease progression|1|||
164146132|NCT01434810|592896033|FG000|Overall Study|Did not receive treatment|11|||
164146133|NCT01434810|592896034|FG001|Overall Study|Did not receive treatment|3|||
164146134|NCT01434810|592896033|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
164146135|NCT01434810|592896034|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
164146136|NCT02794870|592896036|FG000|Overall Study|Withdrawal by Subject|2|||
164146137|NCT02794870|592896037|FG001|Overall Study|Withdrawal by Subject|0|||
164146138|NCT02439970|592896042|FG000|Overall Study|Study Terminated|2|||
164146140|NCT01121562|592896044|FG000|Overall Study|Objective progression or relapse|8|||
164146141|NCT01121562|592896044|FG000|Overall Study|Withdrawal by Subject|1|||
164146142|NCT01121562|592896044|FG000|Overall Study|Adverse Event|1|||
164146143|NCT01121562|592896044|FG000|Overall Study|Sponsor Decision|1|||
164146144|NCT01121562|592896044|FG000|Overall Study|Met study discontinuation criteria|1|||
164146145|NCT02540083|592896047|FG000|Overall Study|Withdrawal by Subject|16|||
164146146|NCT00185588|592896048|FG000|Overall Study|Adverse Event|3|||
164146147|NCT00185588|592896049|FG001|Overall Study|Adverse Event|1|||
164146148|NCT00185588|592896050|FG002|Overall Study|Adverse Event|4|||
164146149|NCT00185588|592896051|FG003|Overall Study|Adverse Event|2|||
164146150|NCT00185588|592896048|FG000|Overall Study|Lost to Follow-up|0|||
164146151|NCT00185588|592896049|FG001|Overall Study|Lost to Follow-up|0|||
164146152|NCT00185588|592896050|FG002|Overall Study|Lost to Follow-up|1|||
164146153|NCT00185588|592896051|FG003|Overall Study|Lost to Follow-up|2|||
164146154|NCT00185588|592896048|FG000|Overall Study|Withdrawal by Subject|0|||
164146155|NCT00185588|592896049|FG001|Overall Study|Withdrawal by Subject|1|||
164146156|NCT00185588|592896050|FG002|Overall Study|Withdrawal by Subject|0|||
164146157|NCT00185588|592896051|FG003|Overall Study|Withdrawal by Subject|0|||
164146158|NCT00185588|592896048|FG000|Overall Study|Physician Decision|0|||
164146159|NCT00185588|592896049|FG001|Overall Study|Physician Decision|0|||
164146160|NCT00185588|592896050|FG002|Overall Study|Physician Decision|1|||
164146161|NCT00185588|592896051|FG003|Overall Study|Physician Decision|0|||
164146162|NCT00398866|592896052|FG000|Overall Study|Adverse Event|1|||
164146163|NCT00398866|592896053|FG001|Overall Study|Adverse Event|0|||
164146164|NCT00398866|592896054|FG002|Overall Study|Adverse Event|0|||
164146165|NCT00398866|592896052|FG000|Overall Study|Lack of Efficacy|0|||
164146166|NCT00398866|592896053|FG001|Overall Study|Lack of Efficacy|0|||
164146167|NCT00398866|592896054|FG002|Overall Study|Lack of Efficacy|1|||
164146168|NCT00398866|592896052|FG000|Overall Study|Lost to Follow-up|7|||
164146169|NCT00398866|592896053|FG001|Overall Study|Lost to Follow-up|6|||
164146170|NCT00398866|592896054|FG002|Overall Study|Lost to Follow-up|4|||
164146171|NCT00398866|592896052|FG000|Overall Study|Withdrawal by Subject|5|||
164146172|NCT00398866|592896053|FG001|Overall Study|Withdrawal by Subject|1|||
164146173|NCT00398866|592896054|FG002|Overall Study|Withdrawal by Subject|2|||
164146174|NCT00398866|592896052|FG000|Overall Study|Unable to complete requirements of study|1|||
164146175|NCT00398866|592896053|FG001|Overall Study|Unable to complete requirements of study|1|||
164146176|NCT00398866|592896054|FG002|Overall Study|Unable to complete requirements of study|1|||
164146177|NCT01569295|592896063|FG000|Overall Study|Progressive Disease|75|||
164146178|NCT01569295|592896064|FG001|Overall Study|Progressive Disease|139|||
164146179|NCT01569295|592896063|FG000|Overall Study|Adverse Event|39|||
164146180|NCT01569295|592896064|FG001|Overall Study|Adverse Event|14|||
164146181|NCT01569295|592896063|FG000|Overall Study|Withdrawal by Subject|25|||
164146182|NCT01569295|592896064|FG001|Overall Study|Withdrawal by Subject|12|||
164146183|NCT01569295|592896063|FG000|Overall Study|Death|19|||
164146184|NCT01569295|592896064|FG001|Overall Study|Death|15|||
164146185|NCT01569295|592896063|FG000|Overall Study|Physician Decision|13|||
164146186|NCT01569295|592896064|FG001|Overall Study|Physician Decision|18|||
164146187|NCT01569295|592896063|FG000|Overall Study|Study Terminated by Sponsor|24|||
164146188|NCT01569295|592896064|FG001|Overall Study|Study Terminated by Sponsor|2|||
164146189|NCT01569295|592896063|FG000|Overall Study|Other Reason not Specified|3|||
164146190|NCT01569295|592896064|FG001|Overall Study|Other Reason not Specified|5|||
164146191|NCT01569295|592896063|FG000|Overall Study|Non-Compliance with Study Drug|6|||
164146192|NCT01569295|592896064|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164146193|NCT01569295|592896063|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
164146194|NCT01569295|592896064|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
164146195|NCT01569295|592896063|FG000|Overall Study|Lost to Follow-up|1|||
164146196|NCT01569295|592896064|FG001|Overall Study|Lost to Follow-up|1|||
164146197|NCT02064296|592896065|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
164146198|NCT02064296|592896066|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
164146199|NCT02064296|592896067|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
164146200|NCT02064296|592896065|FG000|Intervention|Withdrawal by Subject|0|||
164146201|NCT02064296|592896066|FG001|Intervention|Withdrawal by Subject|1|||
164146202|NCT02064296|592896067|FG002|Intervention|Withdrawal by Subject|2|||
164146203|NCT01814553|592896073|FG000|Overall Study|PD per clinical progression|6|||
164146204|NCT01814553|592896074|FG001|Overall Study|PD per clinical progression|8|||
164146205|NCT01814553|592896073|FG000|Overall Study|Other Adverse Event|4|||
164146206|NCT01814553|592896074|FG001|Overall Study|Other Adverse Event|5|||
164146207|NCT01814553|592896073|FG000|Overall Study|Withdrawal by Subject|1|||
164146208|NCT01814553|592896074|FG001|Overall Study|Withdrawal by Subject|1|||
164146209|NCT01814553|592896073|FG000|Overall Study|Other than stated|7|||
164146210|NCT01814553|592896074|FG001|Overall Study|Other than stated|8|||
164146211|NCT03151304|592896075|FG000|Overall Study|Termination of study by Sponsor|23|||
164146212|NCT03151304|592896075|FG000|Overall Study|missing|3|||
164146213|NCT03151304|592896075|FG000|Overall Study|Withdrawal by Subject|8|||
164146214|NCT03151304|592896075|FG000|Overall Study|multiple reasons|30|||
164146215|NCT04759768|592896081|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
164146441|NCT05026177|592898059|FG001|Overall Study|Adverse Event|33|||
164146216|NCT04759768|592896082|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
164146217|NCT04759768|592896081|FG000|Washout (7 Days)|Physician Decision|0|||
164146218|NCT04759768|592896082|FG001|Washout (7 Days)|Physician Decision|1|||
164146219|NCT02996487|592896083|FG000|Overall Study|Lost to Follow-up|1|||
164146220|NCT02996487|592896084|FG001|Overall Study|Lost to Follow-up|1|||
164146221|NCT02996487|592896085|FG002|Overall Study|Lost to Follow-up|0|||
164146222|NCT02996487|592896083|FG000|Overall Study|Death|0|||
164146223|NCT02996487|592896084|FG001|Overall Study|Death|1|||
164146224|NCT02996487|592896085|FG002|Overall Study|Death|0|||
164146225|NCT02996487|592896083|FG000|Overall Study|Withdrawal by Subject|2|||
164146226|NCT02996487|592896084|FG001|Overall Study|Withdrawal by Subject|3|||
164146227|NCT02996487|592896085|FG002|Overall Study|Withdrawal by Subject|0|||
164146228|NCT02800642|592896086|FG000|Overall Study|Death|3|||
164146229|NCT02800642|592896086|FG000|Overall Study|Other|10|||
164146230|NCT02800642|592896086|FG000|Overall Study|Physician Decision|2|||
164146231|NCT02800642|592896086|FG000|Overall Study|Adverse Event|6|||
164146232|NCT02800642|592896086|FG000|Overall Study|Withdrawal by Subject|3|||
164146233|NCT02800642|592896086|FG000|Overall Study|Lost to Follow-up|1|||
164146234|NCT02859142|592896087|FG000|Overall Study|Adverse Event|1|||
164146235|NCT02859142|592896088|FG001|Overall Study|Adverse Event|2|||
164146236|NCT02859142|592896087|FG000|Overall Study|Lost to Follow-up|1|||
164146237|NCT02859142|592896088|FG001|Overall Study|Lost to Follow-up|4|||
164146238|NCT02859142|592896087|FG000|Overall Study|Withdrawal by Subject|2|||
164146239|NCT02859142|592896088|FG001|Overall Study|Withdrawal by Subject|0|||
164146240|NCT02859142|592896087|FG000|Overall Study|Scheduling difficulties|0|||
164146241|NCT02859142|592896088|FG001|Overall Study|Scheduling difficulties|3|||
164146242|NCT02374346|592896089|FG000|Overall Study|operated or discharged during weekend|48|||
164146243|NCT05299528|592896090|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
164146244|NCT05299528|592896091|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
164146245|NCT05299528|592896092|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
164146246|NCT05299528|592896093|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
164146247|NCT05299528|592896094|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
164146248|NCT05299528|592896095|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
164146249|NCT05299528|592896096|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
164146250|NCT05299528|592896090|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
164146251|NCT05299528|592896091|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
164146252|NCT05299528|592896092|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
164146253|NCT05299528|592896093|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
164146254|NCT05299528|592896094|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
164146255|NCT05299528|592896095|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
164146256|NCT05299528|592896096|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
164146257|NCT05299528|592896090|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
164146258|NCT05299528|592896091|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
164146259|NCT05299528|592896092|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
164146260|NCT05299528|592896093|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
164146261|NCT05299528|592896094|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
164146262|NCT05299528|592896095|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
164146263|NCT05299528|592896096|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
164146264|NCT00490841|592896097|FG000|Overall Study|Death|5|||
164146265|NCT00490841|592896097|FG000|Overall Study|Withdrawal by Subject|4|||
164146266|NCT00490841|592896097|FG000|Overall Study|Lost to Follow-up|1|||
164146267|NCT00490841|592896097|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
164146268|NCT01277211|592896098|FG000|Overall Study|Adverse Event|60|||
164146269|NCT01277211|592896099|FG001|Overall Study|Adverse Event|22|||
164146270|NCT01277211|592896098|FG000|Overall Study|Pregnancy|9|||
164146271|NCT01277211|592896099|FG001|Overall Study|Pregnancy|4|||
164146272|NCT01277211|592896098|FG000|Overall Study|Lost to Follow-up|14|||
164146273|NCT01277211|592896099|FG001|Overall Study|Lost to Follow-up|9|||
164146274|NCT01277211|592896098|FG000|Overall Study|Did not wish to continue|17|||
164146275|NCT01277211|592896099|FG001|Overall Study|Did not wish to continue|0|||
164146276|NCT01277211|592896098|FG000|Overall Study|Withdrew Consent|9|||
164146277|NCT01277211|592896099|FG001|Overall Study|Withdrew Consent|9|||
164146278|NCT01277211|592896098|FG000|Overall Study|Non-compliance with protocol|13|||
164146279|NCT01277211|592896099|FG001|Overall Study|Non-compliance with protocol|4|||
164146280|NCT01277211|592896098|FG000|Overall Study|Did not meet protocol eligibility|1|||
164146281|NCT01277211|592896099|FG001|Overall Study|Did not meet protocol eligibility|0|||
164146282|NCT01277211|592896098|FG000|Overall Study|Administrative|3|||
164146283|NCT01277211|592896099|FG001|Overall Study|Administrative|0|||
164146284|NCT01277211|592896098|FG000|Overall Study|Pregnancy wish|0|||
164146285|NCT01277211|592896099|FG001|Overall Study|Pregnancy wish|2|||
164146286|NCT01277211|592896098|FG000|Overall Study|Discontinued prior to treatment|24|||
164146287|NCT01277211|592896099|FG001|Overall Study|Discontinued prior to treatment|13|||
164146288|NCT01107197|592896102|FG000|Overall Study|Death|12|||
164146289|NCT01107197|592896103|FG001|Overall Study|Death|10|||
164146290|NCT01107197|592896102|FG000|Overall Study|Lost to Follow-up|5|||
164146291|NCT01107197|592896103|FG001|Overall Study|Lost to Follow-up|8|||
164146292|NCT01107197|592896102|FG000|Overall Study|Withdrawal by Subject|3|||
164146293|NCT01107197|592896103|FG001|Overall Study|Withdrawal by Subject|5|||
164146294|NCT03516513|592896104|FG000|Overall Study|Withdrawal by Subject|2|||
164146295|NCT03516513|592896105|FG001|Overall Study|Withdrawal by Subject|2|||
164146296|NCT03516513|592896106|FG002|Overall Study|Withdrawal by Subject|0|||
164146297|NCT03516513|592896107|FG003|Overall Study|Withdrawal by Subject|0|||
164146298|NCT01301729|592896109|FG000|Overall Study|Withdrawal by Subject|2|||
164146299|NCT01301729|592896109|FG000|Overall Study|Participant did not Return for Treatment|1|||
164146300|NCT01301729|592896109|FG000|Overall Study|Violated Selection Criteria|1|||
164146301|NCT03071276|592896110|FG000|Overall Study|Adverse Event|1|||
164146302|NCT03071276|592896110|FG000|Overall Study|Lack of Efficacy|14|||
164146303|NCT00447993|592896111|FG000|Overall Study|Lost to Follow-up|0|||
164146304|NCT00447993|592896112|FG001|Overall Study|Lost to Follow-up|0|||
164146305|NCT00447993|592896113|FG002|Overall Study|Lost to Follow-up|2|||
164146306|NCT00447993|592896114|FG003|Overall Study|Lost to Follow-up|2|||
164146307|NCT00447993|592896111|FG000|Overall Study|Withdrawal by Subject|0|||
164146308|NCT00447993|592896112|FG001|Overall Study|Withdrawal by Subject|0|||
164146309|NCT00447993|592896113|FG002|Overall Study|Withdrawal by Subject|2|||
164146310|NCT00447993|592896114|FG003|Overall Study|Withdrawal by Subject|2|||
164146311|NCT04614246|592896115|FG000|Overall Study|Adverse Event|0|||
164146312|NCT04614246|592896116|FG001|Overall Study|Adverse Event|1|||
164146313|NCT04614246|592896117|FG002|Overall Study|Adverse Event|1|||
164146314|NCT04614246|592896118|FG003|Overall Study|Adverse Event|2|||
164146315|NCT04614246|592896119|FG004|Overall Study|Adverse Event|1|||
164146316|NCT04614246|592896115|FG000|Overall Study|Lost to Follow-up|0|||
164146317|NCT04614246|592896116|FG001|Overall Study|Lost to Follow-up|1|||
164146318|NCT04614246|592896117|FG002|Overall Study|Lost to Follow-up|0|||
164146319|NCT04614246|592896118|FG003|Overall Study|Lost to Follow-up|1|||
164146320|NCT04614246|592896119|FG004|Overall Study|Lost to Follow-up|3|||
164146321|NCT04614246|592896115|FG000|Overall Study|Other reason|0|||
164146322|NCT04614246|592896116|FG001|Overall Study|Other reason|1|||
164146323|NCT04614246|592896117|FG002|Overall Study|Other reason|2|||
164146324|NCT04614246|592896118|FG003|Overall Study|Other reason|0|||
164146325|NCT04614246|592896119|FG004|Overall Study|Other reason|0|||
164146326|NCT04614246|592896115|FG000|Overall Study|Withdrawal by Subject|4|||
164146327|NCT04614246|592896116|FG001|Overall Study|Withdrawal by Subject|2|||
164146328|NCT04614246|592896117|FG002|Overall Study|Withdrawal by Subject|4|||
164146329|NCT04614246|592896118|FG003|Overall Study|Withdrawal by Subject|3|||
164146330|NCT04614246|592896119|FG004|Overall Study|Withdrawal by Subject|4|||
164146331|NCT04614246|592896115|FG000|Overall Study|Physician Decision|0|||
164146332|NCT04614246|592896116|FG001|Overall Study|Physician Decision|2|||
164146333|NCT04614246|592896117|FG002|Overall Study|Physician Decision|1|||
164146334|NCT04614246|592896118|FG003|Overall Study|Physician Decision|0|||
164146335|NCT04614246|592896119|FG004|Overall Study|Physician Decision|0|||
164146336|NCT04614246|592896115|FG000|Overall Study|Study terminated by sponsor|10|||
164146337|NCT04614246|592896116|FG001|Overall Study|Study terminated by sponsor|15|||
164146338|NCT04614246|592896117|FG002|Overall Study|Study terminated by sponsor|12|||
164146339|NCT04614246|592896118|FG003|Overall Study|Study terminated by sponsor|13|||
164146340|NCT04614246|592896119|FG004|Overall Study|Study terminated by sponsor|9|||
164146341|NCT04614246|592896115|FG000|Overall Study|Pregnancy|2|||
164146342|NCT04614246|592896116|FG001|Overall Study|Pregnancy|0|||
164146343|NCT04614246|592896117|FG002|Overall Study|Pregnancy|1|||
164146344|NCT04614246|592896118|FG003|Overall Study|Pregnancy|0|||
164146345|NCT04614246|592896119|FG004|Overall Study|Pregnancy|0|||
164146346|NCT04380961|592896129|FG000|Overall Study|Lost to Follow-up|17|||
164146347|NCT04380961|592896130|FG001|Overall Study|Lost to Follow-up|11|||
164146348|NCT04380961|592896129|FG000|Overall Study|Withdrawal by Subject|3|||
164146349|NCT04380961|592896130|FG001|Overall Study|Withdrawal by Subject|0|||
164146350|NCT04380961|592896129|FG000|Overall Study|Death|22|||
164146351|NCT04380961|592896130|FG001|Overall Study|Death|16|||
164146352|NCT04380961|592896129|FG000|Overall Study|Other|1|||
164146353|NCT04380961|592896130|FG001|Overall Study|Other|0|||
164146354|NCT04380961|592896129|FG000|Overall Study|Randomized but Not Treated|1|||
164146355|NCT04380961|592896130|FG001|Overall Study|Randomized but Not Treated|2|||
164146356|NCT01059786|592898030|FG000|Overall Study|Did not receive 6 cycles.|0|||
164146357|NCT01059786|592898031|FG001|Overall Study|Did not receive 6 cycles.|0|||
164146358|NCT01059786|592898032|FG002|Overall Study|Did not receive 6 cycles.|4|||
164146359|NCT01059786|592898033|FG003|Overall Study|Did not receive 6 cycles.|1|||
164146360|NCT01059786|592898034|FG004|Overall Study|Did not receive 6 cycles.|0|||
164146361|NCT04205812|592898035|FG000|Randomized Treatment Period|Ongoing|28|||
164146362|NCT04205812|592898036|FG001|Randomized Treatment Period|Ongoing|138|||
164146363|NCT04205812|592898035|FG000|Randomized Treatment Period|Death|94|||
164146364|NCT04205812|592898036|FG001|Randomized Treatment Period|Death|226|||
164146365|NCT04205812|592898035|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
164146366|NCT04205812|592898036|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
164146367|NCT04205812|592898035|FG000|Randomized Treatment Period|Physician Decision|1|||
164146368|NCT04205812|592898036|FG001|Randomized Treatment Period|Physician Decision|4|||
164146369|NCT04205812|592898035|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
164146370|NCT04205812|592898036|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
164146371|NCT04205812|592898035|FG000|Randomized Treatment Period|Progressive Disease|0|||
164146372|NCT04205812|592898036|FG001|Randomized Treatment Period|Progressive Disease|1|||
164146373|NCT04205812|592898035|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
164146374|NCT04205812|592898036|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
164146375|NCT04205812|592898035|FG000|Monotherapy Treatment Period|Ongoing|17|||
164146376|NCT04205812|592898036|FG001|Monotherapy Treatment Period|Ongoing|0|||
164146377|NCT04205812|592898035|FG000|Monotherapy Treatment Period|Death|39|||
164146378|NCT04205812|592898036|FG001|Monotherapy Treatment Period|Death|0|||
164146379|NCT04205812|592898035|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
164146380|NCT04205812|592898036|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
164146381|NCT04205812|592898035|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
164146382|NCT04205812|592898036|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
164146383|NCT00371033|592898037|FG000|Overall Study|Lost to Follow-up|3|||
164146384|NCT00371033|592898038|FG001|Overall Study|Lost to Follow-up|2|||
164146385|NCT00371033|592898037|FG000|Overall Study|No longer interested|2|||
164146386|NCT00371033|592898038|FG001|Overall Study|No longer interested|0|||
164146387|NCT00371033|592898037|FG000|Overall Study|Uknown|3|||
164146388|NCT00371033|592898038|FG001|Overall Study|Uknown|1|||
164146389|NCT02514447|592898039|FG000|Overall Study|Withdrawal by Subject|3|||
164146390|NCT02514447|592898040|FG001|Overall Study|Withdrawal by Subject|1|||
164146391|NCT02514447|592898041|FG002|Overall Study|Withdrawal by Subject|1|||
164146392|NCT02514447|592898042|FG003|Overall Study|Withdrawal by Subject|0|||
164146393|NCT02514447|592898043|FG004|Overall Study|Withdrawal by Subject|0|||
164146394|NCT02514447|592898044|FG005|Overall Study|Withdrawal by Subject|0|||
164146395|NCT02514447|592898045|FG006|Overall Study|Withdrawal by Subject|0|||
164146396|NCT02514447|592898046|FG007|Overall Study|Withdrawal by Subject|1|||
164146397|NCT02514447|592898047|FG008|Overall Study|Withdrawal by Subject|1|||
164146398|NCT02514447|592898039|FG000|Overall Study|Death|24|||
164146399|NCT02514447|592898040|FG001|Overall Study|Death|28|||
164146400|NCT02514447|592898041|FG002|Overall Study|Death|29|||
164146401|NCT02514447|592898042|FG003|Overall Study|Death|0|||
164146402|NCT02514447|592898043|FG004|Overall Study|Death|3|||
164146403|NCT02514447|592898044|FG005|Overall Study|Death|4|||
164146404|NCT02514447|592898045|FG006|Overall Study|Death|8|||
164146405|NCT02514447|592898046|FG007|Overall Study|Death|6|||
164146406|NCT02514447|592898047|FG008|Overall Study|Death|5|||
164146407|NCT02514447|592898039|FG000|Overall Study|Lost to Follow-up|1|||
164146408|NCT02514447|592898040|FG001|Overall Study|Lost to Follow-up|0|||
164146409|NCT02514447|592898041|FG002|Overall Study|Lost to Follow-up|0|||
164146410|NCT02514447|592898042|FG003|Overall Study|Lost to Follow-up|0|||
164146411|NCT02514447|592898043|FG004|Overall Study|Lost to Follow-up|0|||
164146412|NCT02514447|592898044|FG005|Overall Study|Lost to Follow-up|0|||
164146413|NCT02514447|592898045|FG006|Overall Study|Lost to Follow-up|0|||
164146414|NCT02514447|592898046|FG007|Overall Study|Lost to Follow-up|0|||
164146415|NCT02514447|592898047|FG008|Overall Study|Lost to Follow-up|1|||
164146416|NCT02514447|592898039|FG000|Overall Study|Sponsor Termination of Study|0|||
164146417|NCT02514447|592898040|FG001|Overall Study|Sponsor Termination of Study|1|||
164146418|NCT02514447|592898041|FG002|Overall Study|Sponsor Termination of Study|1|||
164146419|NCT02514447|592898042|FG003|Overall Study|Sponsor Termination of Study|0|||
164146420|NCT02514447|592898043|FG004|Overall Study|Sponsor Termination of Study|0|||
164146421|NCT02514447|592898044|FG005|Overall Study|Sponsor Termination of Study|0|||
164146422|NCT02514447|592898045|FG006|Overall Study|Sponsor Termination of Study|0|||
164146423|NCT02514447|592898046|FG007|Overall Study|Sponsor Termination of Study|0|||
164146424|NCT02514447|592898047|FG008|Overall Study|Sponsor Termination of Study|0|||
164146425|NCT02514447|592898039|FG000|Overall Study|Study completion per Investigator|1|||
164146426|NCT02514447|592898040|FG001|Overall Study|Study completion per Investigator|0|||
164146427|NCT02514447|592898041|FG002|Overall Study|Study completion per Investigator|1|||
164146428|NCT02514447|592898042|FG003|Overall Study|Study completion per Investigator|2|||
164146429|NCT02514447|592898043|FG004|Overall Study|Study completion per Investigator|0|||
164146430|NCT02514447|592898044|FG005|Overall Study|Study completion per Investigator|0|||
164146431|NCT02514447|592898045|FG006|Overall Study|Study completion per Investigator|0|||
164146432|NCT02514447|592898046|FG007|Overall Study|Study completion per Investigator|0|||
164146433|NCT02514447|592898047|FG008|Overall Study|Study completion per Investigator|1|||
164146434|NCT03130777|592898052|FG000|Overall Study|Death|0|||
164146435|NCT03130777|592898053|FG001|Overall Study|Death|1|||
164146436|NCT03130777|592898052|FG000|Overall Study|Did not meet eligibility criteria|1|||
164146437|NCT03130777|592898053|FG001|Overall Study|Did not meet eligibility criteria|0|||
164146438|NCT05929651|592898057|FG000|Overall Study|Protocol Deviation|1|||
164146439|NCT05929651|592898057|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
164146440|NCT05026177|592898058|FG000|Overall Study|Adverse Event|33|||
164146446|NCT05026177|592898058|FG000|Overall Study|Noncompliance with study drug|6|||
164146447|NCT05026177|592898059|FG001|Overall Study|Noncompliance with study drug|2|||
164146448|NCT05026177|592898060|FG002|Overall Study|Noncompliance with study drug|1|||
164146449|NCT05026177|592898058|FG000|Overall Study|Physician Decision|4|||
164146450|NCT05026177|592898059|FG001|Overall Study|Physician Decision|1|||
164146451|NCT05026177|592898060|FG002|Overall Study|Physician Decision|0|||
164146452|NCT05026177|592898058|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
164146453|NCT05026177|592898059|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
164146454|NCT05026177|592898060|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
164146455|NCT05026177|592898058|FG000|Overall Study|Withdrawal by Subject|53|||
164146456|NCT05026177|592898059|FG001|Overall Study|Withdrawal by Subject|51|||
164146457|NCT05026177|592898060|FG002|Overall Study|Withdrawal by Subject|55|||
164146458|NCT05026177|592898058|FG000|Overall Study|Protocol Violation|0|||
164146459|NCT05026177|592898059|FG001|Overall Study|Protocol Violation|1|||
164146460|NCT05026177|592898060|FG002|Overall Study|Protocol Violation|0|||
164146461|NCT05026177|592898058|FG000|Overall Study|Study terminated by sponsor|70|||
164146462|NCT05026177|592898059|FG001|Overall Study|Study terminated by sponsor|74|||
164146463|NCT05026177|592898060|FG002|Overall Study|Study terminated by sponsor|67|||
164146464|NCT05026177|592898058|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
164146465|NCT05026177|592898059|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
164146466|NCT05026177|592898060|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
164146467|NCT05026177|592898058|FG000|Overall Study|Starting alternative treatment|0|||
164146468|NCT05026177|592898059|FG001|Overall Study|Starting alternative treatment|1|||
164146469|NCT05026177|592898060|FG002|Overall Study|Starting alternative treatment|1|||
164146470|NCT05026177|592898058|FG000|Overall Study|Noncompliance with study procedures|0|||
164146471|NCT05026177|592898059|FG001|Overall Study|Noncompliance with study procedures|1|||
164146472|NCT05026177|592898060|FG002|Overall Study|Noncompliance with study procedures|1|||
164146473|NCT05026177|592898058|FG000|Overall Study|Met stopping criteria|0|||
164146474|NCT05026177|592898059|FG001|Overall Study|Met stopping criteria|0|||
164146475|NCT05026177|592898060|FG002|Overall Study|Met stopping criteria|1|||
164146476|NCT05026177|592898058|FG000|Overall Study|Health issues preventing continuation|0|||
164146477|NCT05026177|592898059|FG001|Overall Study|Health issues preventing continuation|0|||
164146478|NCT05026177|592898060|FG002|Overall Study|Health issues preventing continuation|1|||
164146479|NCT05026177|592898058|FG000|Overall Study|Randomized in error, not treated|0|||
164146480|NCT05026177|592898059|FG001|Overall Study|Randomized in error, not treated|0|||
164146481|NCT05026177|592898060|FG002|Overall Study|Randomized in error, not treated|2|||
164146482|NCT05109611|592898063|FG000|Overall Study|Adverse Event|13|||
164146483|NCT05109611|592898064|FG001|Overall Study|Adverse Event|10|||
164146484|NCT05109611|592898063|FG000|Overall Study|Withdrawal by Subject|1|||
164146485|NCT05109611|592898064|FG001|Overall Study|Withdrawal by Subject|0|||
164146486|NCT05109611|592898063|FG000|Overall Study|Lost to Follow-up|1|||
164146487|NCT05109611|592898064|FG001|Overall Study|Lost to Follow-up|2|||
164146488|NCT05109611|592898063|FG000|Overall Study|Protocol Violation|0|||
164146489|NCT05109611|592898064|FG001|Overall Study|Protocol Violation|4|||
164146490|NCT05109611|592898063|FG000|Overall Study|Information unavailable|1|||
164146491|NCT05109611|592898064|FG001|Overall Study|Information unavailable|1|||
164146492|NCT03203850|592898068|FG000|Overall Study|Subject/guardian decision|4|||
164146493|NCT03203850|592898069|FG001|Overall Study|Subject/guardian decision|3|||
164146494|NCT03203850|592898068|FG000|Overall Study|Adverse Event|3|||
164146495|NCT03203850|592898069|FG001|Overall Study|Adverse Event|0|||
164146496|NCT03203850|592898068|FG000|Overall Study|Death|1|||
164146497|NCT03203850|592898069|FG001|Overall Study|Death|0|||
164146498|NCT02717455|592898070|FG000|Overall Study|Adverse Event|1|||
164146499|NCT02717455|592898071|FG001|Overall Study|Adverse Event|0|||
164146500|NCT02717455|592898072|FG002|Overall Study|Adverse Event|0|||
164146501|NCT02717455|592898073|FG003|Overall Study|Adverse Event|2|||
164146502|NCT02717455|592898074|FG004|Overall Study|Adverse Event|2|||
164146503|NCT02717455|592898075|FG005|Overall Study|Adverse Event|2|||
164146504|NCT02717455|592898070|FG000|Overall Study|Withdrawal by Subject|1|||
164146505|NCT02717455|592898071|FG001|Overall Study|Withdrawal by Subject|1|||
164146506|NCT02717455|592898072|FG002|Overall Study|Withdrawal by Subject|0|||
164146507|NCT02717455|592898073|FG003|Overall Study|Withdrawal by Subject|2|||
164146508|NCT02717455|592898074|FG004|Overall Study|Withdrawal by Subject|2|||
164146509|NCT02717455|592898075|FG005|Overall Study|Withdrawal by Subject|1|||
164146510|NCT02717455|592898070|FG000|Overall Study|Death|1|||
164146511|NCT02717455|592898071|FG001|Overall Study|Death|0|||
164146512|NCT02717455|592898072|FG002|Overall Study|Death|0|||
164146513|NCT02717455|592898073|FG003|Overall Study|Death|0|||
164146514|NCT02717455|592898074|FG004|Overall Study|Death|1|||
164146515|NCT02717455|592898075|FG005|Overall Study|Death|0|||
164146516|NCT02717455|592898070|FG000|Overall Study|Did not receive study drug|0|||
164146517|NCT02717455|592898071|FG001|Overall Study|Did not receive study drug|0|||
164146518|NCT02717455|592898072|FG002|Overall Study|Did not receive study drug|0|||
164146519|NCT02717455|592898073|FG003|Overall Study|Did not receive study drug|1|||
164146520|NCT02717455|592898074|FG004|Overall Study|Did not receive study drug|0|||
164146521|NCT02717455|592898075|FG005|Overall Study|Did not receive study drug|1|||
164146522|NCT02717455|592898070|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
164146523|NCT02717455|592898071|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
164146524|NCT02717455|592898072|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
164146525|NCT02717455|592898073|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
164146526|NCT02717455|592898074|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
164146527|NCT02717455|592898075|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
164146528|NCT02717455|592898070|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
164146529|NCT02717455|592898071|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
164146530|NCT02717455|592898072|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
164146531|NCT02717455|592898073|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
164146532|NCT02717455|592898074|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
164146533|NCT02717455|592898075|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
164146534|NCT02301390|592898078|FG000|Overall Study|Withdrawal by Subject|3|||
164146535|NCT02301390|592898079|FG001|Overall Study|Withdrawal by Subject|5|||
164146536|NCT02301390|592898078|FG000|Overall Study|Protocol Violation|1|||
164146537|NCT02301390|592898079|FG001|Overall Study|Protocol Violation|0|||
164146538|NCT02301390|592898078|FG000|Overall Study|Physician Decision|1|||
164146539|NCT02301390|592898079|FG001|Overall Study|Physician Decision|0|||
164146540|NCT02301390|592898078|FG000|Overall Study|Lost to Follow-up|0|||
164146541|NCT02301390|592898079|FG001|Overall Study|Lost to Follow-up|1|||
164146542|NCT02301390|592898078|FG000|Overall Study|Death|2|||
164146543|NCT02301390|592898079|FG001|Overall Study|Death|2|||
164146544|NCT02301390|592898078|FG000|Overall Study|Procedure not completed|0|||
164146545|NCT02301390|592898079|FG001|Overall Study|Procedure not completed|4|||
164146546|NCT02301390|592898078|FG000|Overall Study|Missed multiple visits|1|||
164146547|NCT02301390|592898079|FG001|Overall Study|Missed multiple visits|1|||
164146548|NCT02301390|592898078|FG000|Overall Study|study terminated|2|||
164146549|NCT02301390|592898079|FG001|Overall Study|study terminated|0|||
164146550|NCT02481869|592898082|FG000|Overall Study|Lost to Follow-up|3|||
164146551|NCT02481869|592898083|FG001|Overall Study|Lost to Follow-up|4|||
164146552|NCT02481869|592898082|FG000|Overall Study|Withdrawal by Subject|2|||
164146553|NCT02481869|592898083|FG001|Overall Study|Withdrawal by Subject|0|||
164146554|NCT01153425|592898086|FG000|Overall Study|Withdrawal by Subject|3|||
164146555|NCT01153425|592898087|FG001|Overall Study|Withdrawal by Subject|3|||
164146556|NCT03154125|592898088|FG000|Overall Study|Lost to Follow-up|11|||
164146557|NCT03154125|592898089|FG001|Overall Study|Lost to Follow-up|11|||
164146558|NCT03154125|592898090|FG002|Overall Study|Lost to Follow-up|0|||
164146559|NCT03154125|592898088|FG000|Overall Study|Withdrawal by Subject|49|||
164146560|NCT03154125|592898089|FG001|Overall Study|Withdrawal by Subject|55|||
164146561|NCT03154125|592898090|FG002|Overall Study|Withdrawal by Subject|8|||
164146562|NCT03154125|592898088|FG000|Overall Study|Physician Decision|13|||
164146563|NCT03154125|592898089|FG001|Overall Study|Physician Decision|6|||
164146564|NCT03154125|592898090|FG002|Overall Study|Physician Decision|0|||
164146565|NCT03154125|592898088|FG000|Overall Study|Protocol Violation|3|||
164146566|NCT03154125|592898089|FG001|Overall Study|Protocol Violation|5|||
164146567|NCT03154125|592898090|FG002|Overall Study|Protocol Violation|0|||
164146568|NCT00810511|592898091|FG000|Overall Study|Protocol Violation|0|||
164146569|NCT00810511|592898092|FG001|Overall Study|Protocol Violation|1|||
164146570|NCT00810511|592898091|FG000|Overall Study|Lack of Efficacy|9|||
164146571|NCT00810511|592898092|FG001|Overall Study|Lack of Efficacy|1|||
164146572|NCT00810511|592898091|FG000|Overall Study|death in the family|0|||
164146573|NCT00810511|592898092|FG001|Overall Study|death in the family|1|||
164146574|NCT00810511|592898091|FG000|Overall Study|Lost to Follow-up|1|||
164146575|NCT00810511|592898092|FG001|Overall Study|Lost to Follow-up|0|||
164146576|NCT00810511|592898091|FG000|Overall Study|deposits on contact lens|0|||
164146577|NCT00810511|592898092|FG001|Overall Study|deposits on contact lens|1|||
164146578|NCT00911300|592898094|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
164146579|NCT00911300|592898095|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
164146580|NCT00911300|592898094|FG000|Overall Study|Death|1|||
164146581|NCT00911300|592898095|FG001|Overall Study|Death|0|||
164146582|NCT00911300|592898094|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
164146583|NCT00911300|592898095|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
164146584|NCT00911300|592898094|FG000|Overall Study|Adverse Event|14|||
164146585|NCT00911300|592898095|FG001|Overall Study|Adverse Event|6|||
164146586|NCT00911300|592898094|FG000|Overall Study|Protocol Violation|3|||
164146587|NCT00911300|592898095|FG001|Overall Study|Protocol Violation|2|||
164146588|NCT00911300|592898094|FG000|Overall Study|Consent Withdrawn|4|||
164146589|NCT00911300|592898095|FG001|Overall Study|Consent Withdrawn|12|||
164146590|NCT00911300|592898094|FG000|Overall Study|Coronary Angiography Performed|1|||
164146591|NCT00911300|592898095|FG001|Overall Study|Coronary Angiography Performed|0|||
164146592|NCT00911300|592898094|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
164146593|NCT00911300|592898095|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
164146594|NCT00911300|592898094|FG000|Overall Study|Received Commercial Treatment|1|||
164146595|NCT00911300|592898095|FG001|Overall Study|Received Commercial Treatment|0|||
164146596|NCT00911300|592898094|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
164146597|NCT00911300|592898095|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
164146598|NCT00911300|592898094|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
164146599|NCT00911300|592898095|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
164146600|NCT00911300|592898094|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
164146601|NCT00911300|592898095|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
164146602|NCT00911300|592898094|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
164146603|NCT00911300|592898095|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
164146604|NCT00911300|592898094|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
164146605|NCT00911300|592898095|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
164146606|NCT00911300|592898094|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
164146607|NCT00911300|592898095|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
164146608|NCT00911300|592898094|FG000|Overall Study|International Normalized Ratio Too High|0|||
164146609|NCT00911300|592898095|FG001|Overall Study|International Normalized Ratio Too High|1|||
164146610|NCT00911300|592898094|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
164146611|NCT00911300|592898095|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
164146612|NCT00911300|592898094|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
164146613|NCT00911300|592898095|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
164146614|NCT00911300|592898094|FG000|Overall Study|Physician Decision|0|||
164146615|NCT00911300|592898095|FG001|Overall Study|Physician Decision|1|||
164146616|NCT00911300|592898094|FG000|Overall Study|Treatment Stopped by Mistake|0|||
164146617|NCT00911300|592898095|FG001|Overall Study|Treatment Stopped by Mistake|1|||
164146618|NCT00911300|592898094|FG000|Overall Study|Randomized; No Study Medication Received|0|||
164146619|NCT00911300|592898095|FG001|Overall Study|Randomized; No Study Medication Received|2|||
164146620|NCT03022370|592898096|FG000|Overall Study|Death|6|||
164146621|NCT03022370|592898097|FG001|Overall Study|Death|12|||
164146622|NCT03022370|592898096|FG000|Overall Study|Lost to Follow-up|174|||
164146623|NCT03022370|592898097|FG001|Overall Study|Lost to Follow-up|109|||
164146624|NCT01965860|592898101|FG000|Overall Study|Pregnancy|1|||
164146625|NCT01965860|592898102|FG001|Overall Study|Pregnancy|0|||
164146626|NCT01965860|592898103|FG002|Overall Study|Pregnancy|1|||
164146627|NCT01965860|592898101|FG000|Overall Study|Logistics|1|||
164146628|NCT01965860|592898102|FG001|Overall Study|Logistics|0|||
164146629|NCT01965860|592898103|FG002|Overall Study|Logistics|0|||
164146630|NCT03571828|592898110|FG000|Overall Study|Withdrawal by Subject|1|||
164146631|NCT03571828|592898111|FG001|Overall Study|Withdrawal by Subject|0|||
164146632|NCT03571828|592898110|FG000|Overall Study|Decision by sponsor|5|||
164146633|NCT03571828|592898111|FG001|Overall Study|Decision by sponsor|1|||
164146634|NCT03571828|592898110|FG000|Overall Study|Death|2|||
164146635|NCT03571828|592898111|FG001|Overall Study|Death|0|||
164146636|NCT00666328|592898112|FG000|Overall Study|Death|2|||
164146637|NCT00666328|592898112|FG000|Overall Study|Lost to Follow-up|2|||
164146638|NCT00666328|592898112|FG000|Overall Study|No longer met eligibility criteria|1|||
164146639|NCT02288325|592898113|FG000|Run-in Period|Adverse Event|48|||
164146640|NCT02288325|592898114|FG001|Run-in Period|Adverse Event|0|||
164146641|NCT02288325|592898115|FG002|Run-in Period|Adverse Event|0|||
164146642|NCT02288325|592898113|FG000|Run-in Period|Lack of Efficacy|16|||
164146643|NCT02288325|592898114|FG001|Run-in Period|Lack of Efficacy|0|||
164146644|NCT02288325|592898115|FG002|Run-in Period|Lack of Efficacy|0|||
164146645|NCT02288325|592898113|FG000|Run-in Period|Withdrawal of Consent|28|||
164146646|NCT02288325|592898114|FG001|Run-in Period|Withdrawal of Consent|0|||
164146647|NCT02288325|592898115|FG002|Run-in Period|Withdrawal of Consent|0|||
164146648|NCT02288325|592898113|FG000|Run-in Period|Lost to Follow-up|25|||
164146649|NCT02288325|592898114|FG001|Run-in Period|Lost to Follow-up|0|||
164146650|NCT02288325|592898115|FG002|Run-in Period|Lost to Follow-up|0|||
164146651|NCT02288325|592898113|FG000|Run-in Period|Protocol Violation|17|||
164146652|NCT02288325|592898114|FG001|Run-in Period|Protocol Violation|0|||
164146653|NCT02288325|592898115|FG002|Run-in Period|Protocol Violation|0|||
164146654|NCT02288325|592898113|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
164146655|NCT02288325|592898114|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
164146656|NCT02288325|592898115|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
164146657|NCT02288325|592898113|FG000|Run-in Period|Reason not Specified|8|||
164146658|NCT02288325|592898114|FG001|Run-in Period|Reason not Specified|0|||
164146659|NCT02288325|592898115|FG002|Run-in Period|Reason not Specified|0|||
164146660|NCT02288325|592898113|FG000|Stabilization Period|Adverse Event|13|||
164146661|NCT02288325|592898114|FG001|Stabilization Period|Adverse Event|0|||
164146662|NCT02288325|592898115|FG002|Stabilization Period|Adverse Event|0|||
164146663|NCT02288325|592898113|FG000|Stabilization Period|Lack of Efficacy|22|||
164146664|NCT02288325|592898114|FG001|Stabilization Period|Lack of Efficacy|0|||
164146665|NCT02288325|592898115|FG002|Stabilization Period|Lack of Efficacy|0|||
164146666|NCT02288325|592898113|FG000|Stabilization Period|Withdrawal of Consent|23|||
164146667|NCT02288325|592898114|FG001|Stabilization Period|Withdrawal of Consent|0|||
164146668|NCT02288325|592898115|FG002|Stabilization Period|Withdrawal of Consent|0|||
164146669|NCT02288325|592898113|FG000|Stabilization Period|Lost to Follow-up|12|||
164146670|NCT02288325|592898114|FG001|Stabilization Period|Lost to Follow-up|0|||
164146671|NCT02288325|592898115|FG002|Stabilization Period|Lost to Follow-up|0|||
164146672|NCT02288325|592898113|FG000|Stabilization Period|Protocol Violation|8|||
164146673|NCT02288325|592898114|FG001|Stabilization Period|Protocol Violation|0|||
164146674|NCT02288325|592898115|FG002|Stabilization Period|Protocol Violation|0|||
164146675|NCT02288325|592898113|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
164146676|NCT02288325|592898114|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
164146677|NCT02288325|592898115|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
164146678|NCT02288325|592898113|FG000|Stabilization Period|Reason not Specified|15|||
164146679|NCT02288325|592898114|FG001|Stabilization Period|Reason not Specified|0|||
164146680|NCT02288325|592898115|FG002|Stabilization Period|Reason not Specified|0|||
164146681|NCT02288325|592898113|FG000|Double-blind Treatment Period|Adverse Event|0|||
164146682|NCT02288325|592898114|FG001|Double-blind Treatment Period|Adverse Event|2|||
164146683|NCT02288325|592898115|FG002|Double-blind Treatment Period|Adverse Event|5|||
164146684|NCT02288325|592898113|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
164146685|NCT02288325|592898114|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
164146686|NCT02288325|592898115|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
164146687|NCT02288325|592898113|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
164146688|NCT02288325|592898114|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
164146689|NCT02288325|592898115|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
164146690|NCT02288325|592898113|FG000|Double-blind Treatment Period|Protocol Violation|0|||
164146691|NCT02288325|592898114|FG001|Double-blind Treatment Period|Protocol Violation|1|||
164146692|NCT02288325|592898115|FG002|Double-blind Treatment Period|Protocol Violation|2|||
164146693|NCT02288325|592898113|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
164146694|NCT02288325|592898114|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
164146695|NCT02288325|592898115|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
164146696|NCT02288325|592898113|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
164146697|NCT02288325|592898114|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
164146698|NCT02288325|592898115|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
164146699|NCT00769379|592898119|FG000|Overall Study|No follow up data mapped to Other.|3|||
164146700|NCT00769379|592898120|FG001|Overall Study|No follow up data mapped to Other.|13|||
164146701|NCT03607487|592898121|FG000|Overall Study|Withdrawal by Subject|2|||
164146702|NCT03607487|592898122|FG001|Overall Study|Withdrawal by Subject|0|||
164146703|NCT03607487|592898123|FG002|Overall Study|Withdrawal by Subject|0|||
164146704|NCT03607487|592898124|FG003|Overall Study|Withdrawal by Subject|1|||
164146705|NCT04759703|592898126|FG000|Overall Study|Withdrawal by Subject|4|||
164146706|NCT04759703|592898127|FG001|Overall Study|Withdrawal by Subject|9|||
164146707|NCT04759703|592898126|FG000|Overall Study|Adverse Event|1|||
164146708|NCT04759703|592898127|FG001|Overall Study|Adverse Event|0|||
164146709|NCT04759703|592898126|FG000|Overall Study|Lost to Follow-up|2|||
164146710|NCT04759703|592898127|FG001|Overall Study|Lost to Follow-up|0|||
164146711|NCT04186845|592898135|FG000|Overall Study|Death|2|||
164146712|NCT04186845|592898135|FG000|Overall Study|Lost to Follow-up|1|||
164146713|NCT04186845|592898135|FG000|Overall Study|Physician Decision|1|||
164146714|NCT04186845|592898135|FG000|Overall Study|Protocol Violation|1|||
164146715|NCT04186845|592898135|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
164146716|NCT04186845|592898135|FG000|Overall Study|Biopsy ordered but not done|1|||
164146717|NCT04186845|592898135|FG000|Overall Study|It was previously confirmed|1|||
164146718|NCT04186845|592898135|FG000|Overall Study|Patient cancelled scheduled scans|2|||
164146719|NCT04186845|592898135|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
164146720|NCT04186845|592898135|FG000|Overall Study|Subject refused confirmatory imaging|1|||
164146721|NCT04186845|592898135|FG000|Overall Study|Too small to biopsy|1|||
164146722|NCT04036110|592898136|FG000|Overall Study|Lost to Follow-up|3|||
164146723|NCT04036110|592898137|FG001|Overall Study|Lost to Follow-up|2|||
164146724|NCT04036110|592898138|FG002|Overall Study|Lost to Follow-up|1|||
164146725|NCT04036110|592898136|FG000|Overall Study|Study Suspended|4|||
164146726|NCT04036110|592898137|FG001|Overall Study|Study Suspended|5|||
164146727|NCT04036110|592898138|FG002|Overall Study|Study Suspended|1|||
164146728|NCT00534404|592898141|FG000|Overall Study|Death|0|||
164146729|NCT00534404|592898142|FG001|Overall Study|Death|0|||
164146730|NCT00534404|592898143|FG002|Overall Study|Death|2|||
164146731|NCT00534404|592898141|FG000|Overall Study|Withdrawal by Subject|8|||
164146732|NCT00534404|592898142|FG001|Overall Study|Withdrawal by Subject|2|||
164146733|NCT00534404|592898143|FG002|Overall Study|Withdrawal by Subject|38|||
164146734|NCT00534404|592898141|FG000|Overall Study|Removed by study staff|2|||
164146735|NCT00534404|592898142|FG001|Overall Study|Removed by study staff|3|||
164146736|NCT00534404|592898143|FG002|Overall Study|Removed by study staff|1|||
164146737|NCT00534404|592898141|FG000|Overall Study|Lost to Follow-up|170|||
164146738|NCT00534404|592898142|FG001|Overall Study|Lost to Follow-up|138|||
164146739|NCT00534404|592898143|FG002|Overall Study|Lost to Follow-up|201|||
164146740|NCT02676765|592898144|FG000|Overall Study|Lost to Follow-up|0|||
164146741|NCT02676765|592898145|FG001|Overall Study|Lost to Follow-up|1|||
164146742|NCT02565511|592898146|FG000|Overall Study|Study terminated by Sponsor|35|||
164146743|NCT02565511|592898147|FG001|Overall Study|Study terminated by Sponsor|22|||
164146744|NCT02565511|592898148|FG002|Overall Study|Study terminated by Sponsor|235|||
164146745|NCT02565511|592898149|FG003|Overall Study|Study terminated by Sponsor|156|||
164146746|NCT02565511|592898146|FG000|Overall Study|Withdrawal by Subject|3|||
164146747|NCT02565511|592898147|FG001|Overall Study|Withdrawal by Subject|0|||
164146748|NCT02565511|592898148|FG002|Overall Study|Withdrawal by Subject|12|||
164146749|NCT02565511|592898149|FG003|Overall Study|Withdrawal by Subject|5|||
164146750|NCT02565511|592898146|FG000|Overall Study|Adverse Event|0|||
164146751|NCT02565511|592898147|FG001|Overall Study|Adverse Event|0|||
164146752|NCT02565511|592898148|FG002|Overall Study|Adverse Event|1|||
164146753|NCT02565511|592898149|FG003|Overall Study|Adverse Event|1|||
164146754|NCT02565511|592898146|FG000|Overall Study|Lost to Follow-up|4|||
164146755|NCT02565511|592898147|FG001|Overall Study|Lost to Follow-up|1|||
164146756|NCT02565511|592898148|FG002|Overall Study|Lost to Follow-up|0|||
164146757|NCT02565511|592898149|FG003|Overall Study|Lost to Follow-up|1|||
164146758|NCT02565511|592898146|FG000|Overall Study|Physician Decision|0|||
164146759|NCT02565511|592898147|FG001|Overall Study|Physician Decision|0|||
164146760|NCT02565511|592898148|FG002|Overall Study|Physician Decision|0|||
164146761|NCT02565511|592898149|FG003|Overall Study|Physician Decision|1|||
164146762|NCT02565511|592898146|FG000|Overall Study|Protocol deviation|0|||
164146763|NCT02565511|592898147|FG001|Overall Study|Protocol deviation|0|||
164146764|NCT02565511|592898148|FG002|Overall Study|Protocol deviation|3|||
164146765|NCT02565511|592898149|FG003|Overall Study|Protocol deviation|0|||
164146766|NCT01941498|592898150|FG000|Overall Study|Relocated out of state|1|||
164146767|NCT00104572|592898152|FG000|Overall Study|Withdrawal by Subject|3|||
164146768|NCT00104572|592898153|FG001|Overall Study|Withdrawal by Subject|3|||
164146769|NCT00104572|592898154|FG002|Overall Study|Withdrawal by Subject|0|||
164146770|NCT00098774|592898155|FG000|Overall Study|Adverse Event|2|||
164146771|NCT00098774|592898155|FG000|Overall Study|Disease Progression|9|||
164146772|NCT00098774|592898155|FG000|Overall Study|Withdrawal by Subject|1|||
164146773|NCT00098774|592898155|FG000|Overall Study|Failed (to respond) during induction|4|||
164146774|NCT00098774|592898155|FG000|Overall Study|Physician Decision|2|||
164146775|NCT03097991|592898156|FG000|Overall Study|Didn't meet study criteria|8|||
164146776|NCT03097991|592898157|FG001|Overall Study|Didn't meet study criteria|0|||
164146777|NCT03097991|592898156|FG000|Overall Study|Withdrawal by Subject|12|||
164146778|NCT03097991|592898157|FG001|Overall Study|Withdrawal by Subject|6|||
164146779|NCT03097991|592898156|FG000|Overall Study|Death of Baby|3|||
164146780|NCT03097991|592898157|FG001|Overall Study|Death of Baby|1|||
164146781|NCT03097991|592898156|FG000|Overall Study|Lost to Follow-up|24|||
164146782|NCT03097991|592898157|FG001|Overall Study|Lost to Follow-up|38|||
164146783|NCT03097991|592898156|FG000|Overall Study|Adverse Event|3|||
164146784|NCT03097991|592898157|FG001|Overall Study|Adverse Event|5|||
164146785|NCT01755091|592898158|FG000|Overall Study|Withdrawal by Subject|6|||
164146786|NCT01755091|592898159|FG001|Overall Study|Withdrawal by Subject|1|||
164146787|NCT01755091|592898160|FG002|Overall Study|Withdrawal by Subject|3|||
164146788|NCT01755091|592898158|FG000|Overall Study|Adverse Event|1|||
164146789|NCT01755091|592898159|FG001|Overall Study|Adverse Event|1|||
164146790|NCT01755091|592898160|FG002|Overall Study|Adverse Event|1|||
164146791|NCT01755091|592898158|FG000|Overall Study|Lost to Follow-up|1|||
164146792|NCT01755091|592898159|FG001|Overall Study|Lost to Follow-up|0|||
164146793|NCT01755091|592898160|FG002|Overall Study|Lost to Follow-up|1|||
164146794|NCT01755091|592898158|FG000|Overall Study|Physician Decision|1|||
164146795|NCT01755091|592898159|FG001|Overall Study|Physician Decision|1|||
164146796|NCT01755091|592898160|FG002|Overall Study|Physician Decision|2|||
164146797|NCT03452943|592898161|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
164146798|NCT03452943|592898162|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
164146799|NCT03452943|592898161|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
164146800|NCT03452943|592898162|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
164146801|NCT03452943|592898161|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
164146802|NCT03452943|592898162|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
164146803|NCT03452943|592898161|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
164146804|NCT03452943|592898162|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
164146805|NCT03452943|592898161|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
164146806|NCT03452943|592898162|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
164146807|NCT03452943|592898161|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
164146808|NCT03452943|592898162|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
164146809|NCT01330303|592898167|FG000|Period 1|Adverse Event|1|||
164146810|NCT01330303|592898168|FG001|Period 1|Adverse Event|0|||
164146811|NCT01330303|592898167|FG000|Period 1|Protocol Violation|0|||
164146812|NCT01330303|592898168|FG001|Period 1|Protocol Violation|1|||
164146813|NCT01330303|592898167|FG000|Period 1|Withdrawal by Subject|0|||
164146814|NCT01330303|592898168|FG001|Period 1|Withdrawal by Subject|1|||
164146815|NCT00796757|592898169|FG000|Overall Study|Withdrawal by Subject|14|||
164146816|NCT00796757|592898169|FG000|Overall Study|Death|61|||
164146817|NCT00796757|592898169|FG000|Overall Study|Protocol Violation|1|||
164146818|NCT00796757|592898169|FG000|Overall Study|Participant noncompliance|1|||
164146819|NCT00796757|592898169|FG000|Overall Study|Investigator's decision|2|||
164146820|NCT00796757|592898169|FG000|Overall Study|Other|7|||
164146825|NCT00352417|592898172|FG000|Overall Study|Withdrawal by Subject|1|||
164146826|NCT00352417|592898173|FG001|Overall Study|Withdrawal by Subject|2|||
164146827|NCT00352417|592898172|FG000|Overall Study|Lost to Follow-up|1|||
164146828|NCT00352417|592898173|FG001|Overall Study|Lost to Follow-up|0|||
164146829|NCT00352417|592898172|FG000|Overall Study|Schedule Change|2|||
164146830|NCT00352417|592898173|FG001|Overall Study|Schedule Change|1|||
164146831|NCT02447744|592898174|FG000|Overall Study|Withdrawal by Subject|3|||
164146832|NCT02447744|592898175|FG001|Overall Study|Withdrawal by Subject|1|||
164146833|NCT02447744|592898174|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
164146834|NCT02447744|592898175|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
164146835|NCT00912912|592898176|FG000|Overall Study|Withdrawal by Subject|1|||
164146836|NCT00912912|592898176|FG000|Overall Study|Disease Progression|3|||
164146837|NCT00306995|592898177|FG000|Study Part I|Withdrawal by Subject|0|||
164146838|NCT00306995|592898178|FG001|Study Part I|Withdrawal by Subject|0|||
164146839|NCT00306995|592898179|FG002|Study Part I|Withdrawal by Subject|0|||
164146840|NCT00306995|592898180|FG003|Study Part I|Withdrawal by Subject|0|||
164146841|NCT00306995|592898181|FG004|Study Part I|Withdrawal by Subject|0|||
164146842|NCT00306995|592898182|FG005|Study Part I|Withdrawal by Subject|0|||
164146843|NCT00306995|592898183|FG006|Study Part I|Withdrawal by Subject|1|||
164146844|NCT00306995|592898177|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
164146845|NCT00306995|592898178|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
164146846|NCT00306995|592898179|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
164146847|NCT00306995|592898180|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
164146848|NCT00306995|592898181|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
164146849|NCT00306995|592898182|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
164146850|NCT00306995|592898183|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
164146851|NCT06419907|592899884|FG000|Overall Study|Protocol Violation|0|||
164146852|NCT06419907|592899885|FG001|Overall Study|Protocol Violation|3|||
164146853|NCT06419907|592899886|FG002|Overall Study|Protocol Violation|0|||
164146854|NCT06419907|592899887|FG003|Overall Study|Protocol Violation|1|||
164146855|NCT06419907|592899884|FG000|Overall Study|Lost to Follow-up|0|||
164146856|NCT06419907|592899885|FG001|Overall Study|Lost to Follow-up|0|||
164146857|NCT06419907|592899886|FG002|Overall Study|Lost to Follow-up|2|||
164146858|NCT06419907|592899887|FG003|Overall Study|Lost to Follow-up|1|||
164146859|NCT03573830|592899888|FG000|Overall Study|Dropped without completing treatment|0|||
164146860|NCT03573830|592899889|FG001|Overall Study|Dropped without completing treatment|7|||
164146861|NCT03573830|592899888|FG000|Overall Study|Lost to Follow-up|4|||
164146862|NCT03573830|592899889|FG001|Overall Study|Lost to Follow-up|0|||
164146863|NCT00266630|592899890|FG000|Overall Study|Adverse Event|8|||
164146864|NCT00266630|592899891|FG001|Overall Study|Adverse Event|6|||
164146865|NCT00266630|592899890|FG000|Overall Study|Lack of Efficacy|1|||
164146866|NCT00266630|592899891|FG001|Overall Study|Lack of Efficacy|4|||
164146867|NCT00266630|592899890|FG000|Overall Study|Entry Criteria not met|1|||
164146868|NCT00266630|592899891|FG001|Overall Study|Entry Criteria not met|0|||
164146869|NCT00266630|592899890|FG000|Overall Study|Protocol Violation|1|||
164146870|NCT00266630|592899891|FG001|Overall Study|Protocol Violation|3|||
164146871|NCT00266630|592899890|FG000|Overall Study|Physician Decision|1|||
164146872|NCT00266630|592899891|FG001|Overall Study|Physician Decision|2|||
164146873|NCT00266630|592899890|FG000|Overall Study|Withdrawal by Subject|10|||
164146874|NCT00266630|592899891|FG001|Overall Study|Withdrawal by Subject|2|||
164146875|NCT00266630|592899890|FG000|Overall Study|Lost to Follow-up|1|||
164146876|NCT00266630|592899891|FG001|Overall Study|Lost to Follow-up|0|||
164146877|NCT00266630|592899890|FG000|Overall Study|Other|19|||
164146878|NCT00266630|592899891|FG001|Overall Study|Other|11|||
164146879|NCT03284723|592899896|FG000|Overall Study|Death|0|||
164146880|NCT03284723|592899897|FG001|Overall Study|Death|0|||
164146881|NCT03284723|592899898|FG002|Overall Study|Death|0|||
164146882|NCT03284723|592899899|FG003|Overall Study|Death|1|||
164146883|NCT03284723|592899900|FG004|Overall Study|Death|0|||
164146884|NCT03284723|592899901|FG005|Overall Study|Death|0|||
164146885|NCT03284723|592899902|FG006|Overall Study|Death|1|||
164146886|NCT03284723|592899903|FG007|Overall Study|Death|0|||
164146887|NCT03284723|592899904|FG008|Overall Study|Death|0|||
164146888|NCT03284723|592899905|FG009|Overall Study|Death|2|||
164146889|NCT03284723|592899906|FG010|Overall Study|Death|1|||
164146890|NCT03284723|592899907|FG011|Overall Study|Death|0|||
164146891|NCT03284723|592899896|FG000|Overall Study|Lost to Follow-up|0|||
164146892|NCT03284723|592899897|FG001|Overall Study|Lost to Follow-up|0|||
164146893|NCT03284723|592899898|FG002|Overall Study|Lost to Follow-up|0|||
164146894|NCT03284723|592899899|FG003|Overall Study|Lost to Follow-up|0|||
164146895|NCT03284723|592899900|FG004|Overall Study|Lost to Follow-up|0|||
164146896|NCT03284723|592899901|FG005|Overall Study|Lost to Follow-up|2|||
164146897|NCT03284723|592899902|FG006|Overall Study|Lost to Follow-up|1|||
164146898|NCT03284723|592899903|FG007|Overall Study|Lost to Follow-up|0|||
164146899|NCT03284723|592899904|FG008|Overall Study|Lost to Follow-up|0|||
164146900|NCT03284723|592899905|FG009|Overall Study|Lost to Follow-up|2|||
164146901|NCT03284723|592899906|FG010|Overall Study|Lost to Follow-up|0|||
164146902|NCT03284723|592899907|FG011|Overall Study|Lost to Follow-up|0|||
164146903|NCT03284723|592899896|FG000|Overall Study|Study Terminated By Sponsor|0|||
164146904|NCT03284723|592899897|FG001|Overall Study|Study Terminated By Sponsor|0|||
164146905|NCT03284723|592899898|FG002|Overall Study|Study Terminated By Sponsor|0|||
164146906|NCT03284723|592899899|FG003|Overall Study|Study Terminated By Sponsor|0|||
164146907|NCT03284723|592899900|FG004|Overall Study|Study Terminated By Sponsor|1|||
164146908|NCT03284723|592899901|FG005|Overall Study|Study Terminated By Sponsor|0|||
164146909|NCT03284723|592899902|FG006|Overall Study|Study Terminated By Sponsor|0|||
164146910|NCT03284723|592899903|FG007|Overall Study|Study Terminated By Sponsor|0|||
164146911|NCT03284723|592899904|FG008|Overall Study|Study Terminated By Sponsor|1|||
164146912|NCT03284723|592899905|FG009|Overall Study|Study Terminated By Sponsor|1|||
164146913|NCT03284723|592899906|FG010|Overall Study|Study Terminated By Sponsor|1|||
164146914|NCT03284723|592899907|FG011|Overall Study|Study Terminated By Sponsor|1|||
164146915|NCT03284723|592899896|FG000|Overall Study|Withdrawal by Subject|0|||
164146916|NCT03284723|592899897|FG001|Overall Study|Withdrawal by Subject|0|||
164146917|NCT03284723|592899898|FG002|Overall Study|Withdrawal by Subject|0|||
164146918|NCT03284723|592899899|FG003|Overall Study|Withdrawal by Subject|0|||
164146919|NCT03284723|592899900|FG004|Overall Study|Withdrawal by Subject|5|||
164146920|NCT03284723|592899901|FG005|Overall Study|Withdrawal by Subject|3|||
164146921|NCT03284723|592899902|FG006|Overall Study|Withdrawal by Subject|1|||
164146922|NCT03284723|592899903|FG007|Overall Study|Withdrawal by Subject|0|||
164146923|NCT03284723|592899904|FG008|Overall Study|Withdrawal by Subject|6|||
164146924|NCT03284723|592899905|FG009|Overall Study|Withdrawal by Subject|0|||
164146925|NCT03284723|592899906|FG010|Overall Study|Withdrawal by Subject|3|||
164146926|NCT03284723|592899907|FG011|Overall Study|Withdrawal by Subject|1|||
164146927|NCT03284723|592899896|FG000|Overall Study|Other|1|||
164146928|NCT03284723|592899897|FG001|Overall Study|Other|0|||
164146929|NCT03284723|592899898|FG002|Overall Study|Other|1|||
164146930|NCT03284723|592899899|FG003|Overall Study|Other|0|||
164146931|NCT03284723|592899900|FG004|Overall Study|Other|1|||
164146932|NCT03284723|592899901|FG005|Overall Study|Other|0|||
164146933|NCT03284723|592899902|FG006|Overall Study|Other|0|||
164146934|NCT03284723|592899903|FG007|Overall Study|Other|0|||
164146935|NCT03284723|592899904|FG008|Overall Study|Other|0|||
164146936|NCT03284723|592899905|FG009|Overall Study|Other|0|||
164146937|NCT03284723|592899906|FG010|Overall Study|Other|1|||
164146938|NCT03284723|592899907|FG011|Overall Study|Other|0|||
164146939|NCT03284723|592899896|FG000|Overall Study|Adverse Event|0|||
164146940|NCT03284723|592899897|FG001|Overall Study|Adverse Event|0|||
164146941|NCT03284723|592899898|FG002|Overall Study|Adverse Event|0|||
164146942|NCT03284723|592899899|FG003|Overall Study|Adverse Event|0|||
164146943|NCT03284723|592899900|FG004|Overall Study|Adverse Event|0|||
164146944|NCT03284723|592899901|FG005|Overall Study|Adverse Event|0|||
164146945|NCT03284723|592899902|FG006|Overall Study|Adverse Event|0|||
164146946|NCT03284723|592899903|FG007|Overall Study|Adverse Event|0|||
164146947|NCT03284723|592899904|FG008|Overall Study|Adverse Event|1|||
164146948|NCT03284723|592899905|FG009|Overall Study|Adverse Event|0|||
164146949|NCT03284723|592899906|FG010|Overall Study|Adverse Event|0|||
164146950|NCT03284723|592899907|FG011|Overall Study|Adverse Event|0|||
164146951|NCT00064987|592899912|FG000|Overall Study|Physician Decision|3|||
164146952|NCT00064987|592899913|FG001|Overall Study|Physician Decision|0|||
164146953|NCT01499095|592899914|FG000|Overall Study|Randomized But Not Treated|1|||
164146954|NCT01499095|592899915|FG001|Overall Study|Randomized But Not Treated|1|||
164146955|NCT01499095|592899914|FG000|Overall Study|Adverse Event|12|||
164146956|NCT01499095|592899915|FG001|Overall Study|Adverse Event|7|||
164146957|NCT01499095|592899914|FG000|Overall Study|Lack of Efficacy|2|||
164146958|NCT01499095|592899915|FG001|Overall Study|Lack of Efficacy|1|||
164146959|NCT01499095|592899914|FG000|Overall Study|Protocol Violation|6|||
164146960|NCT01499095|592899915|FG001|Overall Study|Protocol Violation|7|||
164146961|NCT01499095|592899914|FG000|Overall Study|Received Rescue Therapy|32|||
164146962|NCT01499095|592899915|FG001|Overall Study|Received Rescue Therapy|40|||
164146963|NCT01499095|592899914|FG000|Overall Study|Diverse Reasons|22|||
164146964|NCT01499095|592899915|FG001|Overall Study|Diverse Reasons|25|||
164146965|NCT01499095|592899914|FG000|Overall Study|Lost to Follow-up|6|||
164146966|NCT01499095|592899915|FG001|Overall Study|Lost to Follow-up|4|||
164146967|NCT01499095|592899914|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
164146968|NCT01499095|592899915|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
164146969|NCT01499095|592899914|FG000|Overall Study|Hypoglycemia|3|||
164146970|NCT01499095|592899915|FG001|Overall Study|Hypoglycemia|1|||
164146971|NCT01499095|592899914|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
164146972|NCT01499095|592899915|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
164146973|NCT01499095|592899914|FG000|Overall Study|Change in Injection Schedule|2|||
164146974|NCT01499095|592899915|FG001|Overall Study|Change in Injection Schedule|0|||
164146975|NCT01499095|592899914|FG000|Overall Study|Perceived Lack of Efficacy|1|||
164146976|NCT01499095|592899915|FG001|Overall Study|Perceived Lack of Efficacy|1|||
164146977|NCT01368497|592899916|FG000|Overall Study|Lost to Follow-up|2|||
164146978|NCT00443729|592899920|FG000|Overall Study|Never Treated|0|||
164146979|NCT00443729|592899921|FG001|Overall Study|Never Treated|1|||
164146980|NCT00443729|592899920|FG000|Overall Study|Lack of Efficacy|4|||
164146981|NCT00443729|592899921|FG001|Overall Study|Lack of Efficacy|2|||
164146982|NCT00443729|592899920|FG000|Overall Study|Lost to Follow-up|0|||
164146988|NCT00443729|592899920|FG000|Overall Study|Withdrawal by Subject|3|||
164146989|NCT00443729|592899921|FG001|Overall Study|Withdrawal by Subject|1|||
164146990|NCT00782626|592899925|FG000|Overall Study|Adverse Event|1|||
164146991|NCT00782626|592899925|FG000|Overall Study|Progressive Disease|5|||
164146992|NCT00782626|592899925|FG000|Overall Study|Other Complicating Disease|1|||
164146993|NCT00077207|592899928|FG000|Overall Study|Adverse Event|5|||
164146994|NCT00077207|592899928|FG000|Overall Study|Lack of Efficacy|12|||
164146995|NCT00077207|592899928|FG000|Overall Study|Physician Decision|6|||
164146996|NCT00077207|592899928|FG000|Overall Study|Withdrawal by Subject|6|||
164146997|NCT00077207|592899928|FG000|Overall Study|Ineligible|1|||
164146998|NCT03052751|592899931|FG000|Dosing Period 1|Adverse Event|0|||
164146999|NCT03052751|592899932|FG001|Dosing Period 1|Adverse Event|1|||
164147000|NCT03052751|592899933|FG002|Dosing Period 1|Adverse Event|0|||
164147001|NCT03052751|592899934|FG003|Dosing Period 1|Adverse Event|0|||
164147002|NCT03052751|592899935|FG004|Dosing Period 1|Adverse Event|0|||
164147003|NCT03052751|592899936|FG005|Dosing Period 1|Adverse Event|0|||
164147004|NCT03052751|592899931|FG000|Dosing Period 2|Adverse Event|0|||
164147005|NCT03052751|592899932|FG001|Dosing Period 2|Adverse Event|0|||
164147006|NCT03052751|592899933|FG002|Dosing Period 2|Adverse Event|3|||
164147007|NCT03052751|592899934|FG003|Dosing Period 2|Adverse Event|0|||
164147008|NCT03052751|592899935|FG004|Dosing Period 2|Adverse Event|0|||
164147009|NCT03052751|592899936|FG005|Dosing Period 2|Adverse Event|0|||
164147010|NCT03052751|592899931|FG000|Observation Period|Adverse Event|0|||
164147011|NCT03052751|592899932|FG001|Observation Period|Adverse Event|0|||
164147012|NCT03052751|592899933|FG002|Observation Period|Adverse Event|0|||
164147013|NCT03052751|592899934|FG003|Observation Period|Adverse Event|0|||
164147014|NCT03052751|592899935|FG004|Observation Period|Adverse Event|1|||
164147015|NCT03052751|592899936|FG005|Observation Period|Adverse Event|0|||
164147016|NCT01427608|592899941|FG000|Overall Study|Death|1|||
164147017|NCT01427608|592899942|FG001|Overall Study|Death|0|||
164147018|NCT01427608|592899941|FG000|Overall Study|Withdrawal by Subject|7|||
164147019|NCT01427608|592899942|FG001|Overall Study|Withdrawal by Subject|3|||
164147020|NCT01427608|592899941|FG000|Overall Study|Relapsed-all cause|13|||
164147021|NCT01427608|592899942|FG001|Overall Study|Relapsed-all cause|34|||
164147022|NCT01427608|592899941|FG000|Overall Study|Events not attributed to study meds|0|||
164147023|NCT01427608|592899942|FG001|Overall Study|Events not attributed to study meds|1|||
164147024|NCT01027702|592899945|FG000|Overall Study|Received subsequent therapy|1|||
164147025|NCT01027702|592899946|FG001|Overall Study|Received subsequent therapy|2|||
164147026|NCT01027702|592899947|FG002|Overall Study|Received subsequent therapy|0|||
164147027|NCT01027702|592899948|FG003|Overall Study|Received subsequent therapy|4|||
164147028|NCT01027702|592899949|FG004|Overall Study|Received subsequent therapy|1|||
164147029|NCT01027702|592899950|FG005|Overall Study|Received subsequent therapy|0|||
164147030|NCT01027702|592899951|FG006|Overall Study|Received subsequent therapy|1|||
164147031|NCT01027702|592899945|FG000|Overall Study|Death|0|||
164147032|NCT01027702|592899946|FG001|Overall Study|Death|0|||
164147033|NCT01027702|592899947|FG002|Overall Study|Death|1|||
164147034|NCT01027702|592899948|FG003|Overall Study|Death|0|||
164147035|NCT01027702|592899949|FG004|Overall Study|Death|0|||
164147036|NCT01027702|592899950|FG005|Overall Study|Death|0|||
164147037|NCT01027702|592899951|FG006|Overall Study|Death|0|||
164147038|NCT00403585|592899952|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
164147039|NCT00403585|592899952|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
164147040|NCT00403585|592899952|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
164147041|NCT02862730|592899955|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
164147042|NCT02862730|592899956|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
164147043|NCT02862730|592899957|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
164147044|NCT02862730|592899958|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
164147045|NCT02862730|592899959|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
164147046|NCT02862730|592899960|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
164147047|NCT02862730|592899961|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
164147048|NCT02862730|592899955|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
164147049|NCT02862730|592899956|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
164147050|NCT02862730|592899957|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
164147051|NCT02862730|592899958|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
164147052|NCT02862730|592899959|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
164147053|NCT02862730|592899960|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
164147054|NCT02862730|592899961|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
164147055|NCT02862730|592899955|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
164147056|NCT02862730|592899956|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
164147057|NCT02862730|592899957|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
164147058|NCT02862730|592899958|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
164147059|NCT02862730|592899959|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
164147060|NCT02862730|592899960|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
164147061|NCT02862730|592899961|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
164147062|NCT02862730|592899955|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
164147063|NCT02862730|592899956|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
164147064|NCT02862730|592899957|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
164147065|NCT02862730|592899958|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
164147066|NCT02862730|592899959|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
164147067|NCT02862730|592899960|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
164147068|NCT02862730|592899961|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
164147069|NCT02121652|592899962|FG000|Overall Study|Lost to Follow-up|2|||
164147070|NCT02121652|592899963|FG001|Overall Study|Lost to Follow-up|1|||
164147071|NCT02121652|592899962|FG000|Overall Study|Death|1|||
164147072|NCT02121652|592899963|FG001|Overall Study|Death|0|||
164147073|NCT02121652|592899962|FG000|Overall Study|Withdrawal by Subject|3|||
164147074|NCT02121652|592899963|FG001|Overall Study|Withdrawal by Subject|3|||
164147075|NCT01090414|592899964|FG000|Study 101-99|Progressive Disease|28|||
164147076|NCT01090414|592899965|FG001|Study 101-99|Progressive Disease|48|||
164147077|NCT01090414|592899966|FG002|Study 101-99|Progressive Disease|10|||
164147078|NCT01090414|592899967|FG003|Study 101-99|Progressive Disease|4|||
164147079|NCT01090414|592899964|FG000|Study 101-99|Adverse Event|10|||
164147080|NCT01090414|592899965|FG001|Study 101-99|Adverse Event|28|||
164147081|NCT01090414|592899966|FG002|Study 101-99|Adverse Event|18|||
164147082|NCT01090414|592899967|FG003|Study 101-99|Adverse Event|0|||
164147083|NCT01090414|592899964|FG000|Study 101-99|Investigator Request|1|||
164147084|NCT01090414|592899965|FG001|Study 101-99|Investigator Request|11|||
164147085|NCT01090414|592899966|FG002|Study 101-99|Investigator Request|4|||
164147086|NCT01090414|592899967|FG003|Study 101-99|Investigator Request|0|||
164147087|NCT01090414|592899964|FG000|Study 101-99|Death|3|||
164147088|NCT01090414|592899965|FG001|Study 101-99|Death|8|||
164147089|NCT01090414|592899966|FG002|Study 101-99|Death|1|||
164147090|NCT01090414|592899967|FG003|Study 101-99|Death|0|||
164147091|NCT01090414|592899964|FG000|Study 101-99|Sponsor Discontinued Study|0|||
164147092|NCT01090414|592899965|FG001|Study 101-99|Sponsor Discontinued Study|7|||
164147093|NCT01090414|592899966|FG002|Study 101-99|Sponsor Discontinued Study|5|||
164147094|NCT01090414|592899967|FG003|Study 101-99|Sponsor Discontinued Study|0|||
164147095|NCT01090414|592899964|FG000|Study 101-99|Other (Unknown Reasons)|3|||
164147096|NCT01090414|592899965|FG001|Study 101-99|Other (Unknown Reasons)|3|||
164147097|NCT01090414|592899966|FG002|Study 101-99|Other (Unknown Reasons)|0|||
164147098|NCT01090414|592899967|FG003|Study 101-99|Other (Unknown Reasons)|0|||
164147099|NCT01090414|592899964|FG000|Study 101-99|Withdrew Consent|0|||
164147100|NCT01090414|592899965|FG001|Study 101-99|Withdrew Consent|2|||
164147101|NCT01090414|592899966|FG002|Study 101-99|Withdrew Consent|3|||
164147102|NCT01090414|592899967|FG003|Study 101-99|Withdrew Consent|1|||
164147103|NCT01090414|592899964|FG000|Study 101-99|Participant Request|3|||
164147104|NCT01090414|592899965|FG001|Study 101-99|Participant Request|1|||
164147105|NCT01090414|592899966|FG002|Study 101-99|Participant Request|0|||
164147106|NCT01090414|592899967|FG003|Study 101-99|Participant Request|0|||
164147107|NCT04342819|592899968|FG000|Overall Study|Declined|4|||
164147108|NCT04342819|592899968|FG000|Overall Study|Not meeeting selection criteria|1|||
164147109|NCT00668317|592899969|FG000|Overall Study|Adverse Event|2|||
164147110|NCT01526655|592899970|FG000|Overall Study|Withdrawal by Subject|0|||
164147111|NCT01526655|592899971|FG001|Overall Study|Withdrawal by Subject|1|||
164147112|NCT04753216|592899972|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
164147113|NCT04753216|592899972|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
164147114|NCT04753216|592899972|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
164147115|NCT02001987|592899973|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
164147116|NCT02001987|592899973|FG000|Core Study Period (24 Weeks)|Death|1|||
164147117|NCT02001987|592899973|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
164147118|NCT02001987|592899973|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
164147119|NCT02001987|592899973|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
164147120|NCT02001987|592899973|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
164147121|NCT02001987|592899973|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
164147122|NCT02001987|592899973|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
164147123|NCT02001987|592899973|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
164147124|NCT02001987|592899973|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
164147125|NCT02001987|592899973|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
164147126|NCT02001987|592899973|FG000|LTE Period (52 Weeks)|Other|3|||
164147127|NCT04138823|592899981|FG000|Overall Study|Clinical disease progression|0|||
164147128|NCT04138823|592899982|FG001|Overall Study|Clinical disease progression|0|||
164147129|NCT04138823|592899983|FG002|Overall Study|Clinical disease progression|1|||
164147130|NCT04138823|592899981|FG000|Overall Study|Objective disease progression|3|||
164147131|NCT04138823|592899982|FG001|Overall Study|Objective disease progression|2|||
164147132|NCT04138823|592899983|FG002|Overall Study|Objective disease progression|5|||
164147133|NCT04868500|592899984|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
164147134|NCT04868500|592899985|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
164147135|NCT04868500|592899984|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
164147136|NCT04868500|592899985|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
164147141|NCT02466685|592899987|FG000|Overall Study|Withdrawal by Subject|1|||
164147142|NCT02466685|592899988|FG001|Overall Study|Withdrawal by Subject|0|||
164147143|NCT02466685|592899987|FG000|Overall Study|Physician Decision|1|||
164147144|NCT02466685|592899988|FG001|Overall Study|Physician Decision|1|||
164147145|NCT02593110|592899989|FG000|Overall Study|Withdrawal by Subject|0|||
164147146|NCT02593110|592899990|FG001|Overall Study|Withdrawal by Subject|3|||
164147147|NCT02593110|592899991|FG002|Overall Study|Withdrawal by Subject|3|||
164147148|NCT02593110|592899992|FG003|Overall Study|Withdrawal by Subject|2|||
164147149|NCT02593110|592899989|FG000|Overall Study|Death|0|||
164147150|NCT02593110|592899990|FG001|Overall Study|Death|0|||
164147151|NCT02593110|592899991|FG002|Overall Study|Death|1|||
164147152|NCT02593110|592899992|FG003|Overall Study|Death|0|||
164147153|NCT01130597|592899993|FG000|Overall Study|Protocol-specified (High K+)|1|||
164147154|NCT01130597|592899993|FG000|Overall Study|Adverse Event|4|||
164147155|NCT01130597|592899993|FG000|Overall Study|Death|1|||
164147156|NCT01130597|592899993|FG000|Overall Study|Protocol Violation|1|||
164147157|NCT05794503|592899998|FG000|Overall Study|Operation Cancelled|2|||
164147158|NCT05794503|592899999|FG001|Overall Study|Operation Cancelled|0|||
164147159|NCT05794503|592899998|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
164147160|NCT05794503|592899999|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
164147161|NCT05794503|592899998|FG000|Overall Study|Protocol Violation|1|||
164147162|NCT05794503|592899999|FG001|Overall Study|Protocol Violation|0|||
164147163|NCT03052127|592900000|FG000|Overall Study|Withdrawal by Subject|0|||
164147164|NCT03052127|592900001|FG001|Overall Study|Withdrawal by Subject|0|||
164147165|NCT03052127|592900002|FG002|Overall Study|Withdrawal by Subject|0|||
164147166|NCT03052127|592900003|FG003|Overall Study|Withdrawal by Subject|0|||
164147167|NCT03052127|592900004|FG004|Overall Study|Withdrawal by Subject|0|||
164147168|NCT03052127|592900005|FG005|Overall Study|Withdrawal by Subject|0|||
164147169|NCT03052127|592900006|FG006|Overall Study|Withdrawal by Subject|0|||
164147170|NCT03052127|592900007|FG007|Overall Study|Withdrawal by Subject|1|||
164147171|NCT03052127|592900008|FG008|Overall Study|Withdrawal by Subject|1|||
164147172|NCT03052127|592900009|FG009|Overall Study|Withdrawal by Subject|1|||
164147173|NCT03052127|592900010|FG010|Overall Study|Withdrawal by Subject|0|||
164147174|NCT03052127|592900011|FG011|Overall Study|Withdrawal by Subject|0|||
164147175|NCT03052127|592900000|FG000|Overall Study|Discontinuation by Sponsor|0|||
164147176|NCT03052127|592900001|FG001|Overall Study|Discontinuation by Sponsor|0|||
164147177|NCT03052127|592900002|FG002|Overall Study|Discontinuation by Sponsor|0|||
164147178|NCT03052127|592900003|FG003|Overall Study|Discontinuation by Sponsor|0|||
164147179|NCT03052127|592900004|FG004|Overall Study|Discontinuation by Sponsor|0|||
164147180|NCT03052127|592900005|FG005|Overall Study|Discontinuation by Sponsor|0|||
164147181|NCT03052127|592900006|FG006|Overall Study|Discontinuation by Sponsor|0|||
164147182|NCT03052127|592900007|FG007|Overall Study|Discontinuation by Sponsor|0|||
164147183|NCT03052127|592900008|FG008|Overall Study|Discontinuation by Sponsor|4|||
164147184|NCT03052127|592900009|FG009|Overall Study|Discontinuation by Sponsor|2|||
164147185|NCT03052127|592900010|FG010|Overall Study|Discontinuation by Sponsor|5|||
164147186|NCT03052127|592900011|FG011|Overall Study|Discontinuation by Sponsor|13|||
164147187|NCT03052127|592900000|FG000|Overall Study|Inability to comply with trial requirements|0|||
164147188|NCT03052127|592900001|FG001|Overall Study|Inability to comply with trial requirements|0|||
164147189|NCT03052127|592900002|FG002|Overall Study|Inability to comply with trial requirements|1|||
164147190|NCT03052127|592900003|FG003|Overall Study|Inability to comply with trial requirements|0|||
164147191|NCT03052127|592900004|FG004|Overall Study|Inability to comply with trial requirements|0|||
164147192|NCT03052127|592900005|FG005|Overall Study|Inability to comply with trial requirements|0|||
164147193|NCT03052127|592900006|FG006|Overall Study|Inability to comply with trial requirements|0|||
164147194|NCT03052127|592900007|FG007|Overall Study|Inability to comply with trial requirements|0|||
164147195|NCT03052127|592900008|FG008|Overall Study|Inability to comply with trial requirements|0|||
164147196|NCT03052127|592900009|FG009|Overall Study|Inability to comply with trial requirements|0|||
164147197|NCT03052127|592900010|FG010|Overall Study|Inability to comply with trial requirements|0|||
164147198|NCT03052127|592900011|FG011|Overall Study|Inability to comply with trial requirements|0|||
164147199|NCT03052127|592900000|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
164147200|NCT03052127|592900001|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
164147201|NCT03052127|592900002|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
164147202|NCT03052127|592900003|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
164147203|NCT03052127|592900004|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
164147204|NCT03052127|592900005|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
164147205|NCT03052127|592900006|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
164147206|NCT03052127|592900007|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
164147207|NCT03052127|592900008|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
164147208|NCT03052127|592900009|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
164147209|NCT03052127|592900010|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
164147210|NCT03052127|592900011|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
164147211|NCT03694327|592900012|FG000|Overall Study|Lost to Follow-up|13|||
164147212|NCT03694327|592900013|FG001|Overall Study|Lost to Follow-up|23|||
164147213|NCT01464931|592900016|FG000|Overall Study|Withdrawal by Subject|1|||
164147214|NCT01464931|592900017|FG001|Overall Study|Withdrawal by Subject|0|||
164147215|NCT01982812|592900018|FG000|Overall Study|Death|1|||
164147216|NCT01982812|592900019|FG001|Overall Study|Death|5|||
164147217|NCT01982812|592900018|FG000|Overall Study|Adverse Event|0|||
164147218|NCT01982812|592900019|FG001|Overall Study|Adverse Event|5|||
164147219|NCT00307437|592900021|FG000|Controlled Period|Adverse Event|7|||
164147220|NCT00307437|592900022|FG001|Controlled Period|Adverse Event|2|||
164147221|NCT00307437|592900023|FG002|Controlled Period|Adverse Event|5|||
164147222|NCT00307437|592900024|FG003|Controlled Period|Adverse Event|0|||
164147223|NCT00307437|592900025|FG004|Controlled Period|Adverse Event|0|||
164147224|NCT00307437|592900026|FG005|Controlled Period|Adverse Event|0|||
164147225|NCT00307437|592900027|FG006|Controlled Period|Adverse Event|0|||
164147226|NCT00307437|592900021|FG000|Controlled Period|Death|0|||
164147227|NCT00307437|592900022|FG001|Controlled Period|Death|0|||
164147228|NCT00307437|592900023|FG002|Controlled Period|Death|1|||
164147229|NCT00307437|592900024|FG003|Controlled Period|Death|0|||
164147230|NCT00307437|592900025|FG004|Controlled Period|Death|0|||
164147231|NCT00307437|592900026|FG005|Controlled Period|Death|0|||
164147232|NCT00307437|592900027|FG006|Controlled Period|Death|0|||
164147233|NCT00307437|592900021|FG000|Controlled Period|Lack of Efficacy|2|||
164147234|NCT00307437|592900022|FG001|Controlled Period|Lack of Efficacy|0|||
164147235|NCT00307437|592900023|FG002|Controlled Period|Lack of Efficacy|0|||
164147236|NCT00307437|592900024|FG003|Controlled Period|Lack of Efficacy|0|||
164147237|NCT00307437|592900025|FG004|Controlled Period|Lack of Efficacy|0|||
164147238|NCT00307437|592900026|FG005|Controlled Period|Lack of Efficacy|0|||
164147239|NCT00307437|592900027|FG006|Controlled Period|Lack of Efficacy|0|||
164147240|NCT00307437|592900021|FG000|Controlled Period|Lost to Follow-up|2|||
164147241|NCT00307437|592900022|FG001|Controlled Period|Lost to Follow-up|3|||
164147242|NCT00307437|592900023|FG002|Controlled Period|Lost to Follow-up|0|||
164147243|NCT00307437|592900024|FG003|Controlled Period|Lost to Follow-up|0|||
164147244|NCT00307437|592900025|FG004|Controlled Period|Lost to Follow-up|0|||
164147245|NCT00307437|592900026|FG005|Controlled Period|Lost to Follow-up|0|||
164147246|NCT00307437|592900027|FG006|Controlled Period|Lost to Follow-up|0|||
164147247|NCT00307437|592900021|FG000|Controlled Period|Other|5|||
164147248|NCT00307437|592900022|FG001|Controlled Period|Other|1|||
164147249|NCT00307437|592900023|FG002|Controlled Period|Other|3|||
164147250|NCT00307437|592900024|FG003|Controlled Period|Other|0|||
164147251|NCT00307437|592900025|FG004|Controlled Period|Other|0|||
164147252|NCT00307437|592900026|FG005|Controlled Period|Other|0|||
164147253|NCT00307437|592900027|FG006|Controlled Period|Other|0|||
164147254|NCT00307437|592900021|FG000|After Controlled Period|Adverse Event|0|||
164147255|NCT00307437|592900022|FG001|After Controlled Period|Adverse Event|0|||
164147256|NCT00307437|592900023|FG002|After Controlled Period|Adverse Event|0|||
164147257|NCT00307437|592900024|FG003|After Controlled Period|Adverse Event|18|||
164147258|NCT00307437|592900025|FG004|After Controlled Period|Adverse Event|16|||
164147259|NCT00307437|592900026|FG005|After Controlled Period|Adverse Event|31|||
164147260|NCT00307437|592900027|FG006|After Controlled Period|Adverse Event|40|||
164147261|NCT00307437|592900021|FG000|After Controlled Period|Death|0|||
164147262|NCT00307437|592900022|FG001|After Controlled Period|Death|0|||
164147263|NCT00307437|592900023|FG002|After Controlled Period|Death|0|||
164147264|NCT00307437|592900024|FG003|After Controlled Period|Death|3|||
164147265|NCT00307437|592900025|FG004|After Controlled Period|Death|1|||
164147266|NCT00307437|592900026|FG005|After Controlled Period|Death|1|||
164147267|NCT00307437|592900027|FG006|After Controlled Period|Death|3|||
164147268|NCT00307437|592900021|FG000|After Controlled Period|Lack of Efficacy|0|||
164147269|NCT00307437|592900022|FG001|After Controlled Period|Lack of Efficacy|0|||
164147270|NCT00307437|592900023|FG002|After Controlled Period|Lack of Efficacy|0|||
164147271|NCT00307437|592900024|FG003|After Controlled Period|Lack of Efficacy|15|||
164147272|NCT00307437|592900025|FG004|After Controlled Period|Lack of Efficacy|17|||
164147273|NCT00307437|592900026|FG005|After Controlled Period|Lack of Efficacy|37|||
164147274|NCT00307437|592900027|FG006|After Controlled Period|Lack of Efficacy|24|||
164147275|NCT00307437|592900021|FG000|After Controlled Period|Lost to Follow-up|0|||
164147276|NCT00307437|592900022|FG001|After Controlled Period|Lost to Follow-up|0|||
164147277|NCT00307437|592900023|FG002|After Controlled Period|Lost to Follow-up|0|||
164147278|NCT00307437|592900024|FG003|After Controlled Period|Lost to Follow-up|7|||
164147279|NCT00307437|592900025|FG004|After Controlled Period|Lost to Follow-up|12|||
164147280|NCT00307437|592900026|FG005|After Controlled Period|Lost to Follow-up|13|||
164147281|NCT00307437|592900027|FG006|After Controlled Period|Lost to Follow-up|18|||
164147282|NCT00307437|592900021|FG000|After Controlled Period|Other|0|||
164147283|NCT00307437|592900022|FG001|After Controlled Period|Other|0|||
164147284|NCT00307437|592900023|FG002|After Controlled Period|Other|0|||
164147285|NCT00307437|592900024|FG003|After Controlled Period|Other|15|||
164147286|NCT00307437|592900025|FG004|After Controlled Period|Other|9|||
164147287|NCT00307437|592900026|FG005|After Controlled Period|Other|40|||
164147288|NCT00307437|592900027|FG006|After Controlled Period|Other|28|||
164147289|NCT03017612|592900030|FG000|Overall Study|Adverse Event|2|||
164147290|NCT00985491|592900034|FG000|Overall Study|Adverse Event|8|||
164147291|NCT00985491|592900034|FG000|Overall Study|device migration|7|||
164147370|NCT05168202|592902025|FG001|Overall Study|Adverse Event|1|||
164147292|NCT00985491|592900034|FG000|Overall Study|Withdrawal by Subject|1|||
164147293|NCT00985491|592900034|FG000|Overall Study|implant failure|3|||
164147294|NCT01893346|592900035|FG000|Overall Study|Lost to Follow-up|0|||
164147295|NCT01893346|592900036|FG001|Overall Study|Lost to Follow-up|1|||
164147296|NCT01893346|592900037|FG002|Overall Study|Lost to Follow-up|0|||
164147297|NCT01893346|592900038|FG003|Overall Study|Lost to Follow-up|0|||
164147298|NCT01893346|592900035|FG000|Overall Study|Protocol Violation|1|||
164147299|NCT01893346|592900036|FG001|Overall Study|Protocol Violation|0|||
164147300|NCT01893346|592900037|FG002|Overall Study|Protocol Violation|0|||
164147301|NCT01893346|592900038|FG003|Overall Study|Protocol Violation|0|||
164147302|NCT01893346|592900035|FG000|Overall Study|Withdrawal by Subject|2|||
164147303|NCT01893346|592900036|FG001|Overall Study|Withdrawal by Subject|0|||
164147304|NCT01893346|592900037|FG002|Overall Study|Withdrawal by Subject|0|||
164147305|NCT01893346|592900038|FG003|Overall Study|Withdrawal by Subject|0|||
164147306|NCT02933255|592900044|FG000|Overall Study|Discontinued due to study closure.|1|||
164147307|NCT02933255|592900045|FG001|Overall Study|Discontinued due to study closure.|0|||
164147308|NCT00721227|592900046|FG000|Overall Study|Lost to Follow-up|3|||
164147309|NCT00721227|592900047|FG001|Overall Study|Lost to Follow-up|0|||
164147310|NCT00721227|592900046|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
164147311|NCT00721227|592900047|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
164147312|NCT01632280|592900061|FG000|Overall Study|Withdrawal by Subject|1|||
164147313|NCT01632280|592900062|FG001|Overall Study|Withdrawal by Subject|0|||
164147314|NCT05221320|592902011|FG000|Overall Study|Lack of Efficacy|3|||
164147315|NCT05221320|592902012|FG001|Overall Study|Lack of Efficacy|7|||
164147316|NCT05221320|592902013|FG002|Overall Study|Lack of Efficacy|10|||
164147317|NCT05221320|592902014|FG003|Overall Study|Lack of Efficacy|1|||
164147318|NCT05221320|592902015|FG004|Overall Study|Lack of Efficacy|0|||
164147319|NCT05221320|592902016|FG005|Overall Study|Lack of Efficacy|0|||
164147320|NCT05221320|592902011|FG000|Overall Study|Physician Decision|1|||
164147321|NCT05221320|592902012|FG001|Overall Study|Physician Decision|0|||
164147322|NCT05221320|592902013|FG002|Overall Study|Physician Decision|3|||
164147323|NCT05221320|592902014|FG003|Overall Study|Physician Decision|1|||
164147324|NCT05221320|592902015|FG004|Overall Study|Physician Decision|0|||
164147325|NCT05221320|592902016|FG005|Overall Study|Physician Decision|0|||
164147326|NCT05221320|592902011|FG000|Overall Study|Withdrawal by Subject|0|||
164147327|NCT05221320|592902012|FG001|Overall Study|Withdrawal by Subject|3|||
164147328|NCT05221320|592902013|FG002|Overall Study|Withdrawal by Subject|1|||
164147329|NCT05221320|592902014|FG003|Overall Study|Withdrawal by Subject|0|||
164147330|NCT05221320|592902015|FG004|Overall Study|Withdrawal by Subject|0|||
164147331|NCT05221320|592902016|FG005|Overall Study|Withdrawal by Subject|0|||
164147332|NCT05221320|592902011|FG000|Overall Study|Death|0|||
164147333|NCT05221320|592902012|FG001|Overall Study|Death|5|||
164147334|NCT05221320|592902013|FG002|Overall Study|Death|6|||
164147335|NCT05221320|592902014|FG003|Overall Study|Death|0|||
164147336|NCT05221320|592902015|FG004|Overall Study|Death|1|||
164147337|NCT05221320|592902016|FG005|Overall Study|Death|0|||
164147338|NCT06473519|592902017|FG000|Overall Study|Lost to Follow-up|2|||
164147339|NCT06473519|592902018|FG001|Overall Study|Lost to Follow-up|5|||
164147340|NCT06473519|592902017|FG000|Overall Study|Withdrawal by Subject|1|||
164147341|NCT06473519|592902018|FG001|Overall Study|Withdrawal by Subject|4|||
164147342|NCT06473519|592902017|FG000|Overall Study|Randomized but not vaccinated|1|||
164147343|NCT06473519|592902018|FG001|Overall Study|Randomized but not vaccinated|2|||
164147344|NCT02586688|592902019|FG000|Overall Study|Lost to Follow-up|2|||
164147345|NCT02586688|592902020|FG001|Overall Study|Lost to Follow-up|1|||
164147346|NCT02586688|592902019|FG000|Overall Study|Withdrawal by Subject|1|||
164147347|NCT02586688|592902020|FG001|Overall Study|Withdrawal by Subject|1|||
164147348|NCT02586688|592902019|FG000|Overall Study|Adverse Event|3|||
164147349|NCT02586688|592902020|FG001|Overall Study|Adverse Event|1|||
164147350|NCT04856917|592902021|FG000|Overall Study|Withdrawal by Subject|4|||
164147351|NCT04856917|592902022|FG001|Overall Study|Withdrawal by Subject|3|||
164147352|NCT04856917|592902023|FG002|Overall Study|Withdrawal by Subject|1|||
164147353|NCT04856917|592902021|FG000|Overall Study|Lost to Follow-up|3|||
164147354|NCT04856917|592902022|FG001|Overall Study|Lost to Follow-up|1|||
164147355|NCT04856917|592902023|FG002|Overall Study|Lost to Follow-up|1|||
164147356|NCT04856917|592902021|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
164147357|NCT04856917|592902022|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
164147358|NCT04856917|592902023|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
164147359|NCT04856917|592902021|FG000|Overall Study|Other|1|||
164147360|NCT04856917|592902022|FG001|Overall Study|Other|1|||
164147361|NCT04856917|592902023|FG002|Overall Study|Other|0|||
164147362|NCT05168202|592902024|FG000|Overall Study|Progressive Disease|4|||
164147363|NCT05168202|592902025|FG001|Overall Study|Progressive Disease|4|||
164147364|NCT05168202|592902026|FG002|Overall Study|Progressive Disease|2|||
164147365|NCT05168202|592902027|FG003|Overall Study|Progressive Disease|3|||
164147366|NCT05168202|592902028|FG004|Overall Study|Progressive Disease|2|||
164147367|NCT05168202|592902029|FG005|Overall Study|Progressive Disease|3|||
164147368|NCT05168202|592902030|FG006|Overall Study|Progressive Disease|2|||
164147369|NCT05168202|592902024|FG000|Overall Study|Adverse Event|2|||
164147383|NCT05168202|592902024|FG000|Overall Study|Withdrawal by Subject|0|||
164147384|NCT05168202|592902025|FG001|Overall Study|Withdrawal by Subject|0|||
164147385|NCT05168202|592902026|FG002|Overall Study|Withdrawal by Subject|1|||
164147386|NCT05168202|592902027|FG003|Overall Study|Withdrawal by Subject|1|||
164147387|NCT05168202|592902028|FG004|Overall Study|Withdrawal by Subject|1|||
164147388|NCT05168202|592902029|FG005|Overall Study|Withdrawal by Subject|1|||
164147389|NCT05168202|592902030|FG006|Overall Study|Withdrawal by Subject|0|||
164147390|NCT05168202|592902024|FG000|Overall Study|Disease Relapse|0|||
164147391|NCT05168202|592902025|FG001|Overall Study|Disease Relapse|1|||
164147392|NCT05168202|592902026|FG002|Overall Study|Disease Relapse|0|||
164147393|NCT05168202|592902027|FG003|Overall Study|Disease Relapse|1|||
164147394|NCT05168202|592902028|FG004|Overall Study|Disease Relapse|1|||
164147395|NCT05168202|592902029|FG005|Overall Study|Disease Relapse|0|||
164147396|NCT05168202|592902030|FG006|Overall Study|Disease Relapse|0|||
164147397|NCT05168202|592902024|FG000|Overall Study|Other Reasons|0|||
164147398|NCT05168202|592902025|FG001|Overall Study|Other Reasons|0|||
164147399|NCT05168202|592902026|FG002|Overall Study|Other Reasons|0|||
164147400|NCT05168202|592902027|FG003|Overall Study|Other Reasons|0|||
164147401|NCT05168202|592902028|FG004|Overall Study|Other Reasons|0|||
164147402|NCT05168202|592902029|FG005|Overall Study|Other Reasons|2|||
164147403|NCT05168202|592902030|FG006|Overall Study|Other Reasons|1|||
164147404|NCT05168202|592902024|FG000|Overall Study|Physician Decision|0|||
164147405|NCT05168202|592902025|FG001|Overall Study|Physician Decision|1|||
164147406|NCT05168202|592902026|FG002|Overall Study|Physician Decision|1|||
164147407|NCT05168202|592902027|FG003|Overall Study|Physician Decision|0|||
164147408|NCT05168202|592902028|FG004|Overall Study|Physician Decision|0|||
164147409|NCT05168202|592902029|FG005|Overall Study|Physician Decision|0|||
164147410|NCT05168202|592902030|FG006|Overall Study|Physician Decision|0|||
164147411|NCT05168202|592902024|FG000|Overall Study|Study Terminated by Sponsor|0|||
164147412|NCT05168202|592902025|FG001|Overall Study|Study Terminated by Sponsor|0|||
164147413|NCT05168202|592902026|FG002|Overall Study|Study Terminated by Sponsor|0|||
164147414|NCT05168202|592902027|FG003|Overall Study|Study Terminated by Sponsor|1|||
164147415|NCT05168202|592902028|FG004|Overall Study|Study Terminated by Sponsor|0|||
164147416|NCT05168202|592902029|FG005|Overall Study|Study Terminated by Sponsor|0|||
164147417|NCT05168202|592902030|FG006|Overall Study|Study Terminated by Sponsor|0|||
164147418|NCT04011722|592902034|FG000|30 Days|Death|5|||
164147419|NCT04011722|592902035|FG001|30 Days|Death|1|||
164147420|NCT04011722|592902034|FG000|1 Year|Death|13|||
164147421|NCT04011722|592902035|FG001|1 Year|Death|5|||
164147422|NCT04011722|592902034|FG000|1 Year|Withdrawal by Subject|8|||
164147423|NCT04011722|592902035|FG001|1 Year|Withdrawal by Subject|2|||
164147424|NCT04011722|592902034|FG000|1 Year|Missed Visit|6|||
164147425|NCT04011722|592902035|FG001|1 Year|Missed Visit|1|||
164147426|NCT04011722|592902034|FG000|1 Year|Pending Visit|0|||
164147427|NCT04011722|592902035|FG001|1 Year|Pending Visit|11|||
164147428|NCT04011722|592902034|FG000|1 Year|Not Yet Due|0|||
164147429|NCT04011722|592902035|FG001|1 Year|Not Yet Due|9|||
164147430|NCT04011722|592902034|FG000|2 Year|Death|16|||
164147431|NCT04011722|592902035|FG001|2 Year|Death|1|||
164147432|NCT04011722|592902034|FG000|2 Year|Withdrawal by Subject|10|||
164147433|NCT04011722|592902035|FG001|2 Year|Withdrawal by Subject|1|||
164147434|NCT04011722|592902034|FG000|2 Year|Missed Visit|9|||
164147435|NCT04011722|592902035|FG001|2 Year|Missed Visit|0|||
164147436|NCT04011722|592902034|FG000|2 Year|Visit Pending|1|||
164147437|NCT04011722|592902035|FG001|2 Year|Visit Pending|3|||
164147438|NCT04011722|592902034|FG000|2 Year|Not Yet Due|43|||
164147439|NCT04011722|592902035|FG001|2 Year|Not Yet Due|54|||
164147440|NCT04011722|592902034|FG000|3 Year|Death|10|||
164147441|NCT04011722|592902035|FG001|3 Year|Death|0|||
164147442|NCT04011722|592902034|FG000|3 Year|Withdrawal by Subject|2|||
164147443|NCT04011722|592902035|FG001|3 Year|Withdrawal by Subject|0|||
164147444|NCT04011722|592902034|FG000|3 Year|Missed Visit|2|||
164147445|NCT04011722|592902035|FG001|3 Year|Missed Visit|0|||
164147446|NCT04011722|592902034|FG000|3 Year|Pending Visit|34|||
164147447|NCT04011722|592902035|FG001|3 Year|Pending Visit|0|||
164147448|NCT04011722|592902034|FG000|3 Year|Not Yet Due|99|||
164147449|NCT04011722|592902035|FG001|3 Year|Not Yet Due|0|||
164147450|NCT05626231|592902038|FG000|Provider Enrollment|Worked part-time|4|||
164147451|NCT05626231|592902038|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
164147452|NCT05626231|592902038|FG000|Provider Enrollment|Non-clinical employee|1|||
164147453|NCT05626231|592902038|FG000|Provider Enrollment|Provider does not see clients|3|||
164147454|NCT05626231|592902038|FG000|Provider Enrollment|Other|5|||
164147455|NCT06195930|592902039|FG000|Overall Study|Adverse Event|4|||
164147456|NCT00233948|592902048|FG000|Overall Study|Adverse Event|1|||
164147457|NCT00233948|592902049|FG001|Overall Study|Adverse Event|0|||
164147458|NCT00233948|592902050|FG002|Overall Study|Adverse Event|0|||
164147459|NCT00233948|592902051|FG003|Overall Study|Adverse Event|0|||
164147460|NCT00233948|592902052|FG004|Overall Study|Adverse Event|0|||
164147461|NCT00233948|592902053|FG005|Overall Study|Adverse Event|0|||
164147462|NCT01567462|592902054|FG000|Overall Study|Withdrawal by Subject|4|||
164147463|NCT01567462|592902055|FG001|Overall Study|Withdrawal by Subject|7|||
164147464|NCT02548156|592902056|FG000|Washout Period 1|Lost to Follow-up|0|||
164147465|NCT02548156|592902057|FG001|Washout Period 1|Lost to Follow-up|0|||
164147466|NCT02548156|592902058|FG002|Washout Period 1|Lost to Follow-up|0|||
164147467|NCT02548156|592902059|FG003|Washout Period 1|Lost to Follow-up|0|||
164147468|NCT02548156|592902060|FG004|Washout Period 1|Lost to Follow-up|1|||
164147469|NCT02548156|592902061|FG005|Washout Period 1|Lost to Follow-up|0|||
164147470|NCT00444587|592902068|FG000|Overall Study|Death|2|||
164147471|NCT00444587|592902069|FG001|Overall Study|Death|1|||
164147472|NCT00444587|592902068|FG000|Overall Study|Progression of the disease|73|||
164147473|NCT00444587|592902069|FG001|Overall Study|Progression of the disease|8|||
164147474|NCT00444587|592902068|FG000|Overall Study|Refused treatment/did not cooperate|4|||
164147475|NCT00444587|592902069|FG001|Overall Study|Refused treatment/did not cooperate|1|||
164147476|NCT00444587|592902068|FG000|Overall Study|Investigator decision|3|||
164147477|NCT00444587|592902069|FG001|Overall Study|Investigator decision|0|||
164147478|NCT00444587|592902068|FG000|Overall Study|Protocol Violation|1|||
164147479|NCT00444587|592902069|FG001|Overall Study|Protocol Violation|0|||
164147480|NCT00444587|592902068|FG000|Overall Study|Missing|0|||
164147481|NCT00444587|592902069|FG001|Overall Study|Missing|5|||
164147482|NCT00196326|592902070|FG000|Overall Study|Did not meet protocol requirements|64|||
164147483|NCT00196326|592902070|FG000|Overall Study|Non-compliance with the protocol|81|||
164147484|NCT00196326|592902070|FG000|Overall Study|Physician Decision|3|||
164147485|NCT00196326|592902070|FG000|Overall Study|Withdrawal by Subject|225|||
164147486|NCT00196326|592902070|FG000|Overall Study|Adverse Event|253|||
164147487|NCT00196326|592902070|FG000|Overall Study|Pregnancy|34|||
164147488|NCT00196326|592902070|FG000|Overall Study|Lost to Follow-up|304|||
164147489|NCT00196326|592902070|FG000|Overall Study|Other|22|||
164147490|NCT01473407|592902073|FG000|Overall Study|Physician Decision|1|||
164147491|NCT01473407|592902074|FG001|Overall Study|Physician Decision|4|||
164147492|NCT01473407|592902073|FG000|Overall Study|Lost to Follow-up|10|||
164147493|NCT01473407|592902074|FG001|Overall Study|Lost to Follow-up|4|||
164147494|NCT01473407|592902073|FG000|Overall Study|Adverse Event|8|||
164147495|NCT01473407|592902074|FG001|Overall Study|Adverse Event|8|||
164147496|NCT01473407|592902073|FG000|Overall Study|Randomization Error|3|||
164147497|NCT01473407|592902074|FG001|Overall Study|Randomization Error|1|||
164147498|NCT01473407|592902073|FG000|Overall Study|Withdrawal by Subject|4|||
164147499|NCT01473407|592902074|FG001|Overall Study|Withdrawal by Subject|7|||
164147500|NCT01473407|592902073|FG000|Overall Study|Kidney Transplant|7|||
164147501|NCT01473407|592902074|FG001|Overall Study|Kidney Transplant|6|||
164147502|NCT01473407|592902073|FG000|Overall Study|Vacation/Travel|1|||
164147503|NCT01473407|592902074|FG001|Overall Study|Vacation/Travel|1|||
164147504|NCT01473407|592902073|FG000|Overall Study|Elevated Hemoglobin|1|||
164147505|NCT01473407|592902074|FG001|Overall Study|Elevated Hemoglobin|0|||
164147506|NCT01473407|592902073|FG000|Overall Study|Patient Received Aranesp|1|||
164147507|NCT01473407|592902074|FG001|Overall Study|Patient Received Aranesp|0|||
164147508|NCT01473407|592902073|FG000|Overall Study|Patient Lost Green Card Status|1|||
164147509|NCT01473407|592902074|FG001|Overall Study|Patient Lost Green Card Status|0|||
164147510|NCT01473407|592902073|FG000|Overall Study|Temperature Excursion|2|||
164147511|NCT01473407|592902074|FG001|Overall Study|Temperature Excursion|3|||
164147512|NCT01473407|592902073|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
164147513|NCT01473407|592902074|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
164147514|NCT01473407|592902073|FG000|Overall Study|Sponsor's Decision|10|||
164147515|NCT01473407|592902074|FG001|Overall Study|Sponsor's Decision|10|||
164147516|NCT01473407|592902073|FG000|Overall Study|Site Closure|1|||
164147517|NCT01473407|592902074|FG001|Overall Study|Site Closure|0|||
164147518|NCT02422797|592902075|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
164147519|NCT02422797|592902076|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
164147520|NCT02422797|592902075|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
164147521|NCT02422797|592902076|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
164147522|NCT02422797|592902075|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
164147523|NCT02422797|592902076|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
164147524|NCT02422797|592902075|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
164147525|NCT02422797|592902076|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
164147526|NCT02422797|592902075|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
164147527|NCT02422797|592902076|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
164147528|NCT02422797|592902075|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
164147529|NCT02422797|592902076|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
164147530|NCT02422797|592902075|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
164147531|NCT02422797|592902076|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
164147532|NCT02422797|592902075|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
164147533|NCT02422797|592902076|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
164147534|NCT02422797|592902075|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
164147535|NCT02422797|592902076|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
164147536|NCT02422797|592902075|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
164147537|NCT02422797|592902076|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
164147538|NCT02422797|592902075|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
164147539|NCT02422797|592902076|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
164147540|NCT02422797|592902075|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
164147541|NCT02422797|592902076|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
164147542|NCT02422797|592902075|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
164147543|NCT02422797|592902076|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
164147544|NCT02422797|592902075|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
164147545|NCT02422797|592902076|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
164147546|NCT02422797|592902075|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
164147547|NCT02422797|592902076|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
164147548|NCT02422797|592902075|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
164147549|NCT02422797|592902076|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
164147550|NCT02422797|592902075|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
164147551|NCT02422797|592902076|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
164147552|NCT02422797|592902075|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
164147553|NCT02422797|592902076|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
164147554|NCT02422797|592902075|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
164147555|NCT02422797|592902076|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
164147556|NCT02422797|592902075|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
164147557|NCT02422797|592902076|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
164147558|NCT02422797|592902075|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
164147559|NCT02422797|592902076|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
164147560|NCT05223920|592902077|FG000|Overall Study|Adverse Event|6|||
164147561|NCT05223920|592902078|FG001|Overall Study|Adverse Event|3|||
164147562|NCT05223920|592902077|FG000|Overall Study|Death|2|||
164147563|NCT05223920|592902078|FG001|Overall Study|Death|0|||
164147564|NCT05223920|592902077|FG000|Overall Study|Disease Progression|1|||
164147565|NCT05223920|592902078|FG001|Overall Study|Disease Progression|2|||
164147566|NCT05223920|592902077|FG000|Overall Study|Physician Decision|1|||
164147567|NCT05223920|592902078|FG001|Overall Study|Physician Decision|2|||
164147568|NCT05223920|592902077|FG000|Overall Study|Sponsor decision|11|||
164147569|NCT05223920|592902078|FG001|Overall Study|Sponsor decision|9|||
164147570|NCT05223920|592902077|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
164147571|NCT05223920|592902078|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
164147572|NCT05223920|592902077|FG000|Overall Study|Subject decision|1|||
164147573|NCT05223920|592902078|FG001|Overall Study|Subject decision|0|||
164147574|NCT05223920|592902077|FG000|Overall Study|Withdrawal by Subject|1|||
164147575|NCT05223920|592902078|FG001|Overall Study|Withdrawal by Subject|6|||
164147576|NCT04071405|592902079|FG000|Overall Study|Protocol Violation|3|||
164147577|NCT00369941|592902082|FG000|Overall Study|Never Treated|1|||
164147578|NCT00369941|592902083|FG001|Overall Study|Never Treated|2|||
164147579|NCT00369941|592902082|FG000|Overall Study|Adverse Event|14|||
164147580|NCT00369941|592902083|FG001|Overall Study|Adverse Event|28|||
164147581|NCT00369941|592902082|FG000|Overall Study|Lack of Efficacy|6|||
164147582|NCT00369941|592902083|FG001|Overall Study|Lack of Efficacy|10|||
164147583|NCT00369941|592902082|FG000|Overall Study|Lost to Follow-up|12|||
164147584|NCT00369941|592902083|FG001|Overall Study|Lost to Follow-up|22|||
164147585|NCT00369941|592902082|FG000|Overall Study|Protocol Violation|5|||
164147586|NCT00369941|592902083|FG001|Overall Study|Protocol Violation|3|||
164147587|NCT00369941|592902082|FG000|Overall Study|Withdrawal by Subject|5|||
164147588|NCT00369941|592902083|FG001|Overall Study|Withdrawal by Subject|18|||
164147589|NCT00369941|592902082|FG000|Overall Study|Pregnancy|4|||
164147590|NCT00369941|592902083|FG001|Overall Study|Pregnancy|2|||
164147591|NCT00369941|592902082|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
164147592|NCT00369941|592902083|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
164147593|NCT00369941|592902082|FG000|Overall Study|Moved|11|||
164147594|NCT00369941|592902083|FG001|Overall Study|Moved|5|||
164147595|NCT00369941|592902082|FG000|Overall Study|Treatment with Prohibited Medication|3|||
164147596|NCT00369941|592902083|FG001|Overall Study|Treatment with Prohibited Medication|1|||
164147597|NCT00369941|592902082|FG000|Overall Study|Employment Interfered with Study Visits|1|||
164147598|NCT00369941|592902083|FG001|Overall Study|Employment Interfered with Study Visits|0|||
164147599|NCT00369941|592902082|FG000|Overall Study|Study Site Terminated|2|||
164147600|NCT00369941|592902083|FG001|Overall Study|Study Site Terminated|0|||
164147601|NCT00369941|592902082|FG000|Overall Study|Miscellaneous|3|||
164147602|NCT00369941|592902083|FG001|Overall Study|Miscellaneous|3|||
164147603|NCT03685344|592902084|FG000|Overall Study|Withdrawal by Subject|1|||
164147604|NCT03685344|592902085|FG001|Overall Study|Withdrawal by Subject|1|||
164147605|NCT03685344|592902086|FG002|Overall Study|Withdrawal by Subject|2|||
164147606|NCT03685344|592902087|FG003|Overall Study|Withdrawal by Subject|0|||
164147607|NCT03685344|592902084|FG000|Overall Study|Physician Decision|1|||
164147608|NCT03685344|592902085|FG001|Overall Study|Physician Decision|1|||
164147609|NCT03685344|592902086|FG002|Overall Study|Physician Decision|5|||
164147610|NCT03685344|592902087|FG003|Overall Study|Physician Decision|0|||
164147615|NCT02276807|592902088|FG000|Overall Study|Withdrawal by Subject|8|||
164147616|NCT02276807|592902089|FG001|Overall Study|Withdrawal by Subject|7|||
164147617|NCT02276807|592902088|FG000|Overall Study|Lost to Follow-up|10|||
164147618|NCT02276807|592902089|FG001|Overall Study|Lost to Follow-up|10|||
164147619|NCT00261950|592902090|FG000|Overall Study|Lost to Follow-up|2|||
164147620|NCT00261950|592902090|FG000|Overall Study|Death|6|||
164147621|NCT00261950|592902090|FG000|Overall Study|Withdrawal by Subject|5|||
164147622|NCT00261950|592902090|FG000|Overall Study|Other|1|||
164147623|NCT00261950|592902090|FG000|Overall Study|Physician Decision|1|||
164147624|NCT00261950|592902090|FG000|Overall Study|Protocol specified Criteria|11|||
164147625|NCT03288714|592902091|FG000|Overall Study|Lost to Follow-up|2|||
164147626|NCT03288714|592902092|FG001|Overall Study|Lost to Follow-up|1|||
164147627|NCT03288714|592902091|FG000|Overall Study|Non-compliance with study schedule|2|||
164147628|NCT03288714|592902092|FG001|Overall Study|Non-compliance with study schedule|0|||
164147629|NCT03288714|592902091|FG000|Overall Study|Withdrawal by Subject|3|||
164147630|NCT03288714|592902092|FG001|Overall Study|Withdrawal by Subject|1|||
164147631|NCT03288714|592902091|FG000|Overall Study|Clinical Worsening|2|||
164147632|NCT03288714|592902092|FG001|Overall Study|Clinical Worsening|1|||
164147633|NCT03288714|592902091|FG000|Overall Study|Adverse Event|1|||
164147634|NCT03288714|592902092|FG001|Overall Study|Adverse Event|0|||
164147635|NCT02232984|592902097|FG000|Overall Study|Withdrawal by Subject|5|||
164147636|NCT02232984|592902097|FG000|Overall Study|Death|1|||
164147637|NCT02232984|592902097|FG000|Overall Study|Investigator withdrawal|10|||
164147638|NCT02232984|592902097|FG000|Overall Study|Device implant unsuccessful|53|||
164147639|NCT02232984|592902097|FG000|Overall Study|not disclosed by site|7|||
164147640|NCT02232984|592902097|FG000|Overall Study|Protocol Violation|1|||
164147641|NCT01884337|592902100|FG000|Treatment|Adverse Event|2|||
164147642|NCT01884337|592902101|FG001|Treatment|Adverse Event|2|||
164147643|NCT01884337|592902100|FG000|Treatment|Subj. request to discont. treatment|2|||
164147644|NCT01884337|592902101|FG001|Treatment|Subj. request to discont. treatment|0|||
164147645|NCT01884337|592902100|FG000|Follow-up Period|Lost to Follow-up|1|||
164147646|NCT01884337|592902101|FG001|Follow-up Period|Lost to Follow-up|1|||
164147647|NCT02455518|592902102|FG000|Overall Study|Protocol Violation|0|||
164147648|NCT02455518|592902103|FG001|Overall Study|Protocol Violation|1|||
164147649|NCT02455518|592902104|FG002|Overall Study|Protocol Violation|1|||
164147650|NCT02455518|592902105|FG003|Overall Study|Protocol Violation|3|||
164147651|NCT02508935|592902106|FG000|Overall Study|Withdrawal by Subject|1|||
164147652|NCT02508935|592902106|FG000|Overall Study|Withdrawal by Caregiver|8|||
164147653|NCT02508935|592902106|FG000|Overall Study|Pain Score <4|1|||
164147654|NCT02508935|592902106|FG000|Overall Study|Emesis|3|||
164147655|NCT02508935|592902106|FG000|Overall Study|Adverse Event|3|||
164147656|NCT02508935|592902106|FG000|Overall Study|Protocol Violation|1|||
164147657|NCT02508935|592902106|FG000|Overall Study|Physician Decision|1|||
164147658|NCT02508935|592902106|FG000|Overall Study|Trial terminated by sponsor|5|||
164147659|NCT00535405|592902114|FG000|Overall Study|Adverse Event|6|||
164147660|NCT00535405|592902115|FG001|Overall Study|Adverse Event|8|||
164147661|NCT00535405|592902116|FG002|Overall Study|Adverse Event|3|||
164147662|NCT00535405|592902117|FG003|Overall Study|Adverse Event|8|||
164147663|NCT00535405|592902118|FG004|Overall Study|Adverse Event|6|||
164147664|NCT00535405|592902114|FG000|Overall Study|Lost to Follow-up|1|||
164147665|NCT00535405|592902115|FG001|Overall Study|Lost to Follow-up|3|||
164147666|NCT00535405|592902116|FG002|Overall Study|Lost to Follow-up|3|||
164147667|NCT00535405|592902117|FG003|Overall Study|Lost to Follow-up|2|||
164147668|NCT00535405|592902118|FG004|Overall Study|Lost to Follow-up|1|||
164147669|NCT00535405|592902114|FG000|Overall Study|Physician Decision|3|||
164147670|NCT00535405|592902115|FG001|Overall Study|Physician Decision|2|||
164147671|NCT00535405|592902116|FG002|Overall Study|Physician Decision|0|||
164147672|NCT00535405|592902117|FG003|Overall Study|Physician Decision|1|||
164147673|NCT00535405|592902118|FG004|Overall Study|Physician Decision|1|||
164147674|NCT00535405|592902114|FG000|Overall Study|Protocol Violation|2|||
164147675|NCT00535405|592902115|FG001|Overall Study|Protocol Violation|2|||
164147676|NCT00535405|592902116|FG002|Overall Study|Protocol Violation|2|||
164147677|NCT00535405|592902117|FG003|Overall Study|Protocol Violation|1|||
164147678|NCT00535405|592902118|FG004|Overall Study|Protocol Violation|0|||
164147679|NCT00535405|592902114|FG000|Overall Study|Withdrawal by Subject|5|||
164147680|NCT00535405|592902115|FG001|Overall Study|Withdrawal by Subject|11|||
164147681|NCT00535405|592902116|FG002|Overall Study|Withdrawal by Subject|10|||
164147682|NCT00535405|592902117|FG003|Overall Study|Withdrawal by Subject|10|||
164147683|NCT00535405|592902118|FG004|Overall Study|Withdrawal by Subject|8|||
164147684|NCT01332292|592902121|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
164147685|NCT01332292|592902122|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
164147686|NCT01332292|592902121|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
164147687|NCT01332292|592902122|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
164147688|NCT01332292|592902121|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
164147689|NCT01332292|592902122|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
164147690|NCT03910673|592902124|FG000|Overall Study|Adverse Event|0|||
164147691|NCT03910673|592902125|FG001|Overall Study|Adverse Event|0|||
164147692|NCT03910673|592902126|FG002|Overall Study|Adverse Event|0|||
164147711|NCT02006732|592902129|FG000|Overall Study|Withdrawal by Subject|3|||
164147712|NCT02006732|592902130|FG001|Overall Study|Withdrawal by Subject|0|||
164147713|NCT02006732|592902131|FG002|Overall Study|Withdrawal by Subject|4|||
164147714|NCT02006732|592902132|FG003|Overall Study|Withdrawal by Subject|1|||
164147715|NCT02969044|592902150|FG000|Overall Study|Withdrawal by Subject|2|||
164147716|NCT02969044|592902151|FG001|Overall Study|Withdrawal by Subject|6|||
164147717|NCT02969044|592902150|FG000|Overall Study|Adverse Event|3|||
164147718|NCT02969044|592902151|FG001|Overall Study|Adverse Event|0|||
164147719|NCT04650204|592902152|FG000|Overall Study|Study was Terminated|2|||
164147720|NCT04650204|592902153|FG001|Overall Study|Study was Terminated|1|||
164147721|NCT03164616|592902155|FG000|Overall Study|Death|250|||
164147722|NCT03164616|592902156|FG001|Overall Study|Death|264|||
164147723|NCT03164616|592902157|FG002|Overall Study|Death|279|||
164147724|NCT03164616|592902155|FG000|Overall Study|Lost to Follow-up|2|||
164147725|NCT03164616|592902156|FG001|Overall Study|Lost to Follow-up|2|||
164147726|NCT03164616|592902157|FG002|Overall Study|Lost to Follow-up|2|||
164147727|NCT03164616|592902155|FG000|Overall Study|Withdrawal by Subject|6|||
164147728|NCT03164616|592902156|FG001|Overall Study|Withdrawal by Subject|7|||
164147729|NCT03164616|592902157|FG002|Overall Study|Withdrawal by Subject|16|||
164147730|NCT03548337|592902158|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
164147731|NCT03548337|592902159|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
164147732|NCT03548337|592902158|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
164147733|NCT03548337|592902159|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
164147734|NCT03548337|592902158|FG000|Infant Series|Lost to Follow-up|2|||
164147735|NCT03548337|592902159|FG001|Infant Series|Lost to Follow-up|1|||
164147736|NCT03548337|592902158|FG000|Infant Series|Adverse Event|0|||
164147737|NCT03548337|592902159|FG001|Infant Series|Adverse Event|2|||
164147738|NCT03548337|592902158|FG000|Infant Series|Randomized but Not Vaccinated|1|||
164147739|NCT03548337|592902159|FG001|Infant Series|Randomized but Not Vaccinated|0|||
164147740|NCT03548337|592902158|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
164147741|NCT03548337|592902159|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
164147742|NCT04502212|592902161|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
164147743|NCT04502212|592902161|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
164147744|NCT01911273|592902163|FG000|Overall Study|Progression of Disease|1|||
164147745|NCT01911273|592902164|FG001|Overall Study|Progression of Disease|0|||
164147746|NCT01911273|592902163|FG000|Overall Study|Withdrawal by Subject|0|||
164147747|NCT01911273|592902164|FG001|Overall Study|Withdrawal by Subject|2|||
164147748|NCT02503787|592902169|FG000|Enrollment|Withdrawal by Subject|6|||
164147749|NCT02503787|592902169|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
164147750|NCT02503787|592902169|FG000|Enrollment|Physician Decision|2|||
164147751|NCT02503787|592902169|FG000|Enrollment|Insurance issue|2|||
164147752|NCT02503787|592902169|FG000|Enrollment|Lost to Follow-up|1|||
164147753|NCT02503787|592902169|FG000|Enrollment|Study closure|1|||
164147754|NCT02503787|592902169|FG000|Enrollment|Adverse Event|1|||
164147755|NCT02503787|592902169|FG000|Enrollment|Protocol Violation|1|||
164147756|NCT02503787|592902169|FG000|Enrollment|Inability to implant system|1|||
164147757|NCT02503787|592902169|FG000|Enrollment|Unable to be programmed|1|||
164147758|NCT02503787|592902169|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
164147759|NCT02503787|592902169|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
164147760|NCT02503787|592902169|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
164147761|NCT02503787|592902169|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
164147762|NCT02503787|592902169|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
164147763|NCT02503787|592902169|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
164147764|NCT04787627|592902170|FG000|Overall Study|Withdrawal by Subject|3|||
164147765|NCT04787627|592902171|FG001|Overall Study|Withdrawal by Subject|0|||
164147766|NCT04787627|592902170|FG000|Overall Study|Physician Decision|2|||
164147767|NCT04787627|592902171|FG001|Overall Study|Physician Decision|0|||
164147768|NCT04787627|592902170|FG000|Overall Study|Excluded|0|||
164147769|NCT04787627|592902171|FG001|Overall Study|Excluded|1|||
164147770|NCT00548093|592902172|FG000|Overall Study|Death|33|||
164147771|NCT00548093|592902173|FG001|Overall Study|Death|13|||
164147772|NCT00548093|592902172|FG000|Overall Study|Lost to Follow-up|3|||
164147773|NCT00548093|592902173|FG001|Overall Study|Lost to Follow-up|1|||
164147774|NCT00548093|592902172|FG000|Overall Study|Objective progression or relapse|1|||
164147775|NCT00548093|592902173|FG001|Overall Study|Objective progression or relapse|1|||
164147776|NCT00548093|592902172|FG000|Overall Study|Other|11|||
164147777|NCT00548093|592902173|FG001|Overall Study|Other|1|||
164147778|NCT00548093|592902172|FG000|Overall Study|Withdrawal by Subject|1|||
164147779|NCT00548093|592902173|FG001|Overall Study|Withdrawal by Subject|0|||
164147780|NCT00548093|592902172|FG000|Overall Study|Completed post-treatment follow-up|1|||
164147781|NCT00548093|592902173|FG001|Overall Study|Completed post-treatment follow-up|0|||
164147782|NCT02359994|592902175|FG000|Overall Population Study|Adverse Event|1|||
164147783|NCT02359994|592902176|FG001|Overall Population Study|Adverse Event|1|||
164147784|NCT02359994|592902175|FG000|Overall Population Study|Death|1|||
164147785|NCT02359994|592902176|FG001|Overall Population Study|Death|5|||
164147786|NCT02359994|592902175|FG000|Overall Population Study|Lost to Follow-up|1|||
164147787|NCT02359994|592902176|FG001|Overall Population Study|Lost to Follow-up|1|||
164147788|NCT02359994|592902175|FG000|Overall Population Study|Withdrawal by Subject|1|||
164147789|NCT02359994|592902176|FG001|Overall Population Study|Withdrawal by Subject|0|||
164147790|NCT02359994|592902175|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
164147791|NCT02359994|592902176|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
164147792|NCT02359994|592902175|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
164147793|NCT02359994|592902176|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
164147794|NCT02359994|592902175|FG000|Extended Oncology 24-Month Survival|Death|19|||
164147795|NCT02359994|592902176|FG001|Extended Oncology 24-Month Survival|Death|21|||
164147796|NCT02359994|592902175|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
164147797|NCT02359994|592902176|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
164147798|NCT01320150|592902177|FG000|Overall Study|Protocol Violation|15|||
164147799|NCT01320150|592902177|FG000|Overall Study|Withdrawal by Subject|5|||
164147800|NCT01320150|592902177|FG000|Overall Study|Death|2|||
164147801|NCT01320150|592902177|FG000|Overall Study|Lost to Follow-up|44|||
164147802|NCT00919854|592902178|FG000|Overall Study|Adverse Event|1|||
164147803|NCT00143247|592902184|FG000|Overall Study|Death|8|||
164147804|NCT00143247|592902184|FG000|Overall Study|Adverse Event|19|||
164147805|NCT00143247|592902184|FG000|Overall Study|Lack of Efficacy|3|||
164147806|NCT00143247|592902184|FG000|Overall Study|Withdrawal by Subject|55|||
164147807|NCT00143247|592902184|FG000|Overall Study|Study terminated by sponsor|31|||
164147808|NCT00143247|592902184|FG000|Overall Study|Protocol Violation|15|||
164147809|NCT00143247|592902184|FG000|Overall Study|Lost to Follow-up|12|||
164147810|NCT00143247|592902184|FG000|Overall Study|following inaccurate lab adverse event|1|||
164147811|NCT00143247|592902184|FG000|Overall Study|Other|12|||
164147812|NCT00489827|592902185|FG000|Overall Study|Intraoperative exclusion criteria|1|||
164147813|NCT00489827|592902186|FG001|Overall Study|Intraoperative exclusion criteria|1|||
164147814|NCT00489827|592902185|FG000|Overall Study|Intraoperative exclusion criteria|1|||
164147815|NCT00489827|592902186|FG001|Overall Study|Intraoperative exclusion criteria|1|||
164147816|NCT02766283|592902187|FG000|Overall Study|Lost to Follow-up|27|||
164147817|NCT03086551|592902188|FG000|First Intervention|Failure to meet inclusion criterion|1|||
164147818|NCT03086551|592902189|FG001|First Intervention|Failure to meet inclusion criterion|0|||
164147819|NCT03086551|592902188|FG000|First Intervention|Lost to Follow-up|0|||
164147820|NCT03086551|592902189|FG001|First Intervention|Lost to Follow-up|1|||
164147821|NCT03086551|592902188|FG000|Washout|Lost to Follow-up|1|||
164147822|NCT03086551|592902189|FG001|Washout|Lost to Follow-up|2|||
164147823|NCT03086551|592902188|FG000|Washout|Withdrawal by Subject|2|||
164147824|NCT03086551|592902189|FG001|Washout|Withdrawal by Subject|1|||
164147825|NCT03736031|592902191|FG000|Overall Study|Death|2|||
164147826|NCT03736031|592902192|FG001|Overall Study|Death|4|||
164147827|NCT03736031|592902191|FG000|Overall Study|Lost to Follow-up|21|||
164147828|NCT03736031|592902192|FG001|Overall Study|Lost to Follow-up|2|||
164147829|NCT03736031|592902191|FG000|Overall Study|Withdrawal by Subject|9|||
164147830|NCT03736031|592902192|FG001|Overall Study|Withdrawal by Subject|0|||
164147831|NCT00451178|592902193|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
164147832|NCT00451178|592902194|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
164147833|NCT00451178|592902193|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
164147834|NCT00451178|592902194|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
164147835|NCT00451178|592902193|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
164147836|NCT00451178|592902194|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
164147837|NCT00451178|592902193|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
164147838|NCT00451178|592902194|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
164147839|NCT00451178|592902193|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
164147840|NCT00451178|592902194|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
164147841|NCT00451178|592902193|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
164147842|NCT00451178|592902194|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
164147843|NCT00451178|592902193|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
164147844|NCT00451178|592902194|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
164147845|NCT00451178|592902193|FG000|Prior to Maintenance Therapy|PD|2|||
164147846|NCT00451178|592902194|FG001|Prior to Maintenance Therapy|PD|0|||
164147847|NCT00451178|592902193|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
164147848|NCT00451178|592902194|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
164147849|NCT00451178|592902193|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
164147850|NCT00451178|592902194|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
164147851|NCT00451178|592902193|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
164147852|NCT00451178|592902194|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
164147853|NCT00451178|592902193|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
164147854|NCT00451178|592902194|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
164147855|NCT00451178|592902193|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
164147856|NCT00451178|592902194|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
164147857|NCT00451178|592902193|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
164147858|NCT00451178|592902194|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
164147859|NCT00451178|592902193|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
164147860|NCT00451178|592902194|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
164147861|NCT02603146|592904753|FG000|Overall Study|Lost to Follow-up|5|||
164147862|NCT02603146|592904754|FG001|Overall Study|Lost to Follow-up|6|||
164147863|NCT02603146|592904753|FG000|Overall Study|Withdrawal by Subject|8|||
164147864|NCT02603146|592904754|FG001|Overall Study|Withdrawal by Subject|10|||
164147865|NCT02603146|592904753|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
164147866|NCT02603146|592904754|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
164147867|NCT02603146|592904753|FG000|Overall Study|Participant moved|2|||
164147868|NCT02603146|592904754|FG001|Overall Study|Participant moved|0|||
164147869|NCT02603146|592904753|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
164147870|NCT02603146|592904754|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
164147871|NCT03300817|592904763|FG000|Overall Study|Withdrawal by Subject|1|||
164147872|NCT03300817|592904763|FG000|Overall Study|Adverse Event|1|||
164147873|NCT03300817|592904763|FG000|Overall Study|Subject Found to be Ineligible|2|||
164147874|NCT03729596|592904766|FG000|Overall Study|Death|3|||
164147875|NCT03729596|592904767|FG001|Overall Study|Death|5|||
164147876|NCT03729596|592904768|FG002|Overall Study|Death|4|||
164147877|NCT03729596|592904769|FG003|Overall Study|Death|1|||
164147878|NCT03729596|592904770|FG004|Overall Study|Death|0|||
164147879|NCT03729596|592904771|FG005|Overall Study|Death|34|||
164147880|NCT03729596|592904772|FG006|Overall Study|Death|18|||
164147881|NCT03729596|592904773|FG007|Overall Study|Death|14|||
164147882|NCT03729596|592904774|FG008|Overall Study|Death|19|||
164147883|NCT03729596|592904775|FG009|Overall Study|Death|9|||
164147884|NCT03729596|592904766|FG000|Overall Study|Lost to Follow-up|0|||
164147885|NCT03729596|592904767|FG001|Overall Study|Lost to Follow-up|0|||
164147886|NCT03729596|592904768|FG002|Overall Study|Lost to Follow-up|0|||
164147887|NCT03729596|592904769|FG003|Overall Study|Lost to Follow-up|0|||
164147888|NCT03729596|592904770|FG004|Overall Study|Lost to Follow-up|0|||
164147889|NCT03729596|592904771|FG005|Overall Study|Lost to Follow-up|0|||
164147890|NCT03729596|592904772|FG006|Overall Study|Lost to Follow-up|1|||
164147891|NCT03729596|592904773|FG007|Overall Study|Lost to Follow-up|0|||
164147892|NCT03729596|592904774|FG008|Overall Study|Lost to Follow-up|0|||
164147893|NCT03729596|592904775|FG009|Overall Study|Lost to Follow-up|1|||
164147894|NCT03729596|592904766|FG000|Overall Study|protocol amendment|0|||
164147895|NCT03729596|592904767|FG001|Overall Study|protocol amendment|1|||
164147896|NCT03729596|592904768|FG002|Overall Study|protocol amendment|3|||
164147897|NCT03729596|592904769|FG003|Overall Study|protocol amendment|6|||
164147898|NCT03729596|592904770|FG004|Overall Study|protocol amendment|5|||
164147899|NCT03729596|592904771|FG005|Overall Study|protocol amendment|0|||
164147900|NCT03729596|592904772|FG006|Overall Study|protocol amendment|0|||
164147901|NCT03729596|592904773|FG007|Overall Study|protocol amendment|0|||
164147902|NCT03729596|592904774|FG008|Overall Study|protocol amendment|0|||
164147903|NCT03729596|592904775|FG009|Overall Study|protocol amendment|0|||
164147904|NCT03729596|592904766|FG000|Overall Study|Withdrawal by Subject|0|||
164147905|NCT03729596|592904767|FG001|Overall Study|Withdrawal by Subject|0|||
164147906|NCT03729596|592904768|FG002|Overall Study|Withdrawal by Subject|0|||
164147907|NCT03729596|592904769|FG003|Overall Study|Withdrawal by Subject|0|||
164147908|NCT03729596|592904770|FG004|Overall Study|Withdrawal by Subject|0|||
164147909|NCT03729596|592904771|FG005|Overall Study|Withdrawal by Subject|4|||
164147910|NCT03729596|592904772|FG006|Overall Study|Withdrawal by Subject|2|||
164147911|NCT03729596|592904773|FG007|Overall Study|Withdrawal by Subject|3|||
164147912|NCT03729596|592904774|FG008|Overall Study|Withdrawal by Subject|2|||
164147913|NCT03729596|592904775|FG009|Overall Study|Withdrawal by Subject|3|||
164147914|NCT03729596|592904766|FG000|Overall Study|study terminated by sponsor|0|||
164147915|NCT03729596|592904767|FG001|Overall Study|study terminated by sponsor|0|||
164147916|NCT03729596|592904768|FG002|Overall Study|study terminated by sponsor|0|||
164147917|NCT03729596|592904769|FG003|Overall Study|study terminated by sponsor|0|||
164147918|NCT03729596|592904770|FG004|Overall Study|study terminated by sponsor|1|||
164147919|NCT03729596|592904771|FG005|Overall Study|study terminated by sponsor|3|||
164147920|NCT03729596|592904772|FG006|Overall Study|study terminated by sponsor|0|||
164147921|NCT03729596|592904773|FG007|Overall Study|study terminated by sponsor|1|||
164147922|NCT03729596|592904774|FG008|Overall Study|study terminated by sponsor|0|||
164147923|NCT03729596|592904775|FG009|Overall Study|study terminated by sponsor|0|||
164147924|NCT03713593|592904776|FG000|Overall Study|Sponsor Decision|73|||
164147925|NCT03713593|592904777|FG001|Overall Study|Sponsor Decision|41|||
164147926|NCT03713593|592904776|FG000|Overall Study|Lost to Follow-up|2|||
164147927|NCT03713593|592904777|FG001|Overall Study|Lost to Follow-up|1|||
164147928|NCT03713593|592904776|FG000|Overall Study|Death|314|||
164147929|NCT03713593|592904777|FG001|Overall Study|Death|349|||
164147930|NCT03713593|592904776|FG000|Overall Study|Withdrawal by Subject|6|||
164147931|NCT03713593|592904777|FG001|Overall Study|Withdrawal by Subject|8|||
164147932|NCT02789137|592904787|FG000|Overall Study|Dropped out/Died|58|||
164147933|NCT00445432|592904788|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
164147934|NCT00445432|592904789|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
164147935|NCT00445432|592904790|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
164147936|NCT00445432|592904791|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
164147937|NCT00445432|592904788|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
164147938|NCT00445432|592904789|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
164147939|NCT00445432|592904790|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
164147940|NCT00445432|592904791|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
164147941|NCT00445432|592904788|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
164147942|NCT00445432|592904789|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
164147943|NCT00445432|592904790|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
164147944|NCT00445432|592904791|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
164147945|NCT00445432|592904788|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
164147946|NCT00445432|592904789|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
164147947|NCT00445432|592904790|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
164147948|NCT00445432|592904791|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
164147949|NCT00445432|592904788|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
164147950|NCT00445432|592904789|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
164147951|NCT00445432|592904790|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
164147952|NCT00445432|592904791|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
164147953|NCT00445432|592904788|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
164147954|NCT00445432|592904789|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
164147955|NCT00445432|592904790|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
164147956|NCT00445432|592904791|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
164147957|NCT00445432|592904788|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
164147958|NCT00445432|592904789|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
164147959|NCT00445432|592904790|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
164147960|NCT00445432|592904791|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
164147961|NCT00799058|592904798|FG000|Overall Study|Withdrawal by Subject|2|||
164147962|NCT00799058|592904799|FG001|Overall Study|Withdrawal by Subject|2|||
164147963|NCT00799058|592904800|FG002|Overall Study|Withdrawal by Subject|2|||
164147964|NCT00799058|592904798|FG000|Overall Study|Lost to Follow-up|1|||
164147965|NCT00799058|592904799|FG001|Overall Study|Lost to Follow-up|2|||
164147966|NCT00799058|592904800|FG002|Overall Study|Lost to Follow-up|1|||
164147967|NCT00799058|592904798|FG000|Overall Study|Adverse Event|0|||
164147968|NCT00799058|592904799|FG001|Overall Study|Adverse Event|2|||
164147969|NCT00799058|592904800|FG002|Overall Study|Adverse Event|0|||
164147970|NCT00799058|592904798|FG000|Overall Study|Pregnancy|1|||
164147971|NCT00799058|592904799|FG001|Overall Study|Pregnancy|0|||
164147972|NCT00799058|592904800|FG002|Overall Study|Pregnancy|0|||
164147973|NCT00799058|592904798|FG000|Overall Study|Not adherent|3|||
164147974|NCT00799058|592904799|FG001|Overall Study|Not adherent|2|||
164147975|NCT00799058|592904800|FG002|Overall Study|Not adherent|1|||
164147976|NCT00799058|592904798|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
164147977|NCT00799058|592904799|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
164147978|NCT00799058|592904800|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
164147979|NCT00799058|592904798|FG000|Overall Study|IP dispensing error|1|||
164147980|NCT00799058|592904799|FG001|Overall Study|IP dispensing error|0|||
164147981|NCT00799058|592904800|FG002|Overall Study|IP dispensing error|0|||
164147982|NCT00799058|592904798|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
164147983|NCT00799058|592904799|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
164147984|NCT00799058|592904800|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
164147985|NCT00799058|592904798|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
164147986|NCT00799058|592904799|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
164147987|NCT00799058|592904800|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
164147988|NCT00799058|592904798|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
164147989|NCT00799058|592904799|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
164147990|NCT00799058|592904800|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
164147991|NCT00799058|592904798|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
164147992|NCT00799058|592904799|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
164147993|NCT00799058|592904800|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
164147994|NCT02088697|592904807|FG000|Period I|Physician Decision|1|||
164147995|NCT02088697|592904808|FG001|Period I|Physician Decision|4|||
164147996|NCT02088697|592904807|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
164147997|NCT02088697|592904808|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
164147998|NCT01995513|592904809|FG000|Period 1: First Open Label Treatment|Other|34|||
164147999|NCT01995513|592904810|FG001|Period 1: First Open Label Treatment|Other|0|||
164148000|NCT01995513|592904811|FG002|Period 1: First Open Label Treatment|Other|0|||
164148001|NCT01995513|592904812|FG003|Period 1: First Open Label Treatment|Other|0|||
164148002|NCT01995513|592904809|FG000|Period 1: First Open Label Treatment|Death|14|||
164148003|NCT01995513|592904810|FG001|Period 1: First Open Label Treatment|Death|0|||
164148004|NCT01995513|592904811|FG002|Period 1: First Open Label Treatment|Death|0|||
164148005|NCT01995513|592904812|FG003|Period 1: First Open Label Treatment|Death|0|||
164148006|NCT01995513|592904809|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
164148007|NCT01995513|592904810|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
164148008|NCT01995513|592904811|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
164148009|NCT01995513|592904812|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
164148010|NCT01995513|592904809|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
164148011|NCT01995513|592904810|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
164148012|NCT01995513|592904811|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
164148013|NCT01995513|592904812|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
164148014|NCT01995513|592904809|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
164148015|NCT01995513|592904810|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
164148016|NCT01995513|592904811|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
164148017|NCT01995513|592904812|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
164148018|NCT01995513|592904809|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
164148019|NCT01995513|592904810|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
164148020|NCT01995513|592904811|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
164148021|NCT01995513|592904812|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
164148022|NCT01995513|592904809|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
164148023|NCT01995513|592904810|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
164148024|NCT01995513|592904811|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
164148025|NCT01995513|592904812|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
164148026|NCT01995513|592904809|FG000|Period 1: Second Open Label Treatment|Other|0|||
164148027|NCT01995513|592904810|FG001|Period 1: Second Open Label Treatment|Other|2|||
164148028|NCT01995513|592904811|FG002|Period 1: Second Open Label Treatment|Other|0|||
164148029|NCT01995513|592904812|FG003|Period 1: Second Open Label Treatment|Other|0|||
164148030|NCT01995513|592904809|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
164148031|NCT01995513|592904810|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
164148032|NCT01995513|592904811|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
164148033|NCT01995513|592904812|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
164148034|NCT01995513|592904809|FG000|Period 2: Double Blind Treatment|Death|0|||
164148035|NCT01995513|592904810|FG001|Period 2: Double Blind Treatment|Death|0|||
164148036|NCT01995513|592904811|FG002|Period 2: Double Blind Treatment|Death|0|||
164148037|NCT01995513|592904812|FG003|Period 2: Double Blind Treatment|Death|1|||
164148038|NCT01995513|592904809|FG000|Period 2: Double Blind Treatment|Other|0|||
164148039|NCT01995513|592904810|FG001|Period 2: Double Blind Treatment|Other|0|||
164148040|NCT01995513|592904811|FG002|Period 2: Double Blind Treatment|Other|3|||
164148041|NCT01995513|592904812|FG003|Period 2: Double Blind Treatment|Other|3|||
164148042|NCT01995513|592904809|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
164148043|NCT01995513|592904810|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
164148044|NCT01995513|592904811|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
164148045|NCT01995513|592904812|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
164148046|NCT01995513|592904809|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
164148047|NCT01995513|592904810|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
164148048|NCT01995513|592904811|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
164148049|NCT01995513|592904812|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
164148050|NCT01995513|592904809|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
164148051|NCT01995513|592904810|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
164148052|NCT01995513|592904811|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
164148053|NCT01995513|592904812|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
164148054|NCT01995513|592904809|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
164148055|NCT01995513|592904810|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
164148056|NCT01995513|592904811|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
164148057|NCT01995513|592904812|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
164148058|NCT01232452|592904813|FG000|Overall Study|Adverse Event|17|||
164148059|NCT01232452|592904814|FG001|Overall Study|Adverse Event|15|||
164148060|NCT01232452|592904813|FG000|Overall Study|Withdrawal by Subject|11|||
164148061|NCT01232452|592904814|FG001|Overall Study|Withdrawal by Subject|8|||
164148062|NCT01232452|592904813|FG000|Overall Study|Physician Decision|8|||
164148063|NCT01232452|592904814|FG001|Overall Study|Physician Decision|12|||
164148064|NCT01232452|592904813|FG000|Overall Study|Protocol entry criterion not met|0|||
164148065|NCT01232452|592904814|FG001|Overall Study|Protocol entry criterion not met|2|||
164148066|NCT01232452|592904813|FG000|Overall Study|Sponsor Decision|3|||
164148067|NCT01232452|592904814|FG001|Overall Study|Sponsor Decision|1|||
164148068|NCT01232452|592904813|FG000|Overall Study|Protocol Violation|0|||
164148069|NCT01232452|592904814|FG001|Overall Study|Protocol Violation|1|||
164148074|NCT00247676|592904819|FG000|Overall Study|Withdrawal by Subject|2|||
164148075|NCT03594071|592904820|FG000|Overall Study|Re-operation|3|||
164148076|NCT03594071|592904820|FG000|Overall Study|Missed visit|2|||
164148077|NCT05219448|592904821|FG000|Overall Study|Lost to Follow-up|9|||
164148078|NCT05219448|592904822|FG001|Overall Study|Lost to Follow-up|0|||
164148079|NCT01750190|592904823|FG000|Overall Study|Adverse Event|47|||
164148080|NCT01750190|592904824|FG001|Overall Study|Adverse Event|19|||
164148081|NCT01750190|592904823|FG000|Overall Study|Death|38|||
164148082|NCT01750190|592904824|FG001|Overall Study|Death|11|||
164148083|NCT01750190|592904823|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
164148084|NCT01750190|592904824|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
164148085|NCT01750190|592904823|FG000|Overall Study|Lost to Follow-up|28|||
164148086|NCT01750190|592904824|FG001|Overall Study|Lost to Follow-up|7|||
164148087|NCT01750190|592904823|FG000|Overall Study|Physician Decision|16|||
164148088|NCT01750190|592904824|FG001|Overall Study|Physician Decision|17|||
164148089|NCT01750190|592904823|FG000|Overall Study|Protocol Violation|6|||
164148090|NCT01750190|592904824|FG001|Overall Study|Protocol Violation|5|||
164148091|NCT01750190|592904823|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
164148092|NCT01750190|592904824|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
164148093|NCT01750190|592904823|FG000|Overall Study|Withdrawal by Subject|83|||
164148094|NCT01750190|592904824|FG001|Overall Study|Withdrawal by Subject|89|||
164148095|NCT01750190|592904823|FG000|Overall Study|Kidney Transplant|8|||
164148096|NCT01750190|592904824|FG001|Overall Study|Kidney Transplant|4|||
164148097|NCT01750190|592904823|FG000|Overall Study|Dialysis|22|||
164148098|NCT01750190|592904824|FG001|Overall Study|Dialysis|8|||
164148099|NCT01750190|592904823|FG000|Overall Study|Other than Specified|13|||
164148100|NCT01750190|592904824|FG001|Overall Study|Other than Specified|4|||
164148101|NCT02287922|592904825|FG000|Overall Study|Adverse Event|1|||
164148102|NCT02287922|592904826|FG001|Overall Study|Adverse Event|1|||
164148103|NCT02287922|592904827|FG002|Overall Study|Adverse Event|3|||
164148104|NCT02287922|592904828|FG003|Overall Study|Adverse Event|4|||
164148105|NCT02287922|592904825|FG000|Overall Study|Withdrawal by Subject|1|||
164148106|NCT02287922|592904826|FG001|Overall Study|Withdrawal by Subject|1|||
164148107|NCT02287922|592904827|FG002|Overall Study|Withdrawal by Subject|1|||
164148108|NCT02287922|592904828|FG003|Overall Study|Withdrawal by Subject|2|||
164148109|NCT02287922|592904825|FG000|Overall Study|Lost to Follow-up|0|||
164148110|NCT02287922|592904826|FG001|Overall Study|Lost to Follow-up|0|||
164148111|NCT02287922|592904827|FG002|Overall Study|Lost to Follow-up|1|||
164148112|NCT02287922|592904828|FG003|Overall Study|Lost to Follow-up|0|||
164148113|NCT02287922|592904825|FG000|Overall Study|Sponsor's decision|0|||
164148114|NCT02287922|592904826|FG001|Overall Study|Sponsor's decision|0|||
164148115|NCT02287922|592904827|FG002|Overall Study|Sponsor's decision|0|||
164148116|NCT02287922|592904828|FG003|Overall Study|Sponsor's decision|1|||
164148117|NCT02287922|592904825|FG000|Overall Study|Other|1|||
164148118|NCT02287922|592904826|FG001|Overall Study|Other|0|||
164148119|NCT02287922|592904827|FG002|Overall Study|Other|2|||
164148120|NCT02287922|592904828|FG003|Overall Study|Other|0|||
164148121|NCT02906670|592904831|FG000|Cohort 1, QW|Radiological Progression|1|||
164148122|NCT02906670|592904832|FG001|Cohort 1, QW|Radiological Progression|0|||
164148123|NCT02906670|592904833|FG002|Cohort 1, QW|Radiological Progression|0|||
164148124|NCT02906670|592904834|FG003|Cohort 1, QW|Radiological Progression|0|||
164148125|NCT02906670|592904835|FG004|Cohort 1, QW|Radiological Progression|0|||
164148126|NCT02906670|592904836|FG005|Cohort 1, QW|Radiological Progression|0|||
164148127|NCT02906670|592904837|FG006|Cohort 1, QW|Radiological Progression|0|||
164148128|NCT02906670|592904838|FG007|Cohort 1, QW|Radiological Progression|0|||
164148129|NCT02906670|592904839|FG008|Cohort 1, QW|Radiological Progression|0|||
164148130|NCT02906670|592904840|FG009|Cohort 1, QW|Radiological Progression|0|||
164148131|NCT02906670|592904831|FG000|Cohort 2, QW|Radiological Progression|0|||
164148132|NCT02906670|592904832|FG001|Cohort 2, QW|Radiological Progression|1|||
164148133|NCT02906670|592904833|FG002|Cohort 2, QW|Radiological Progression|0|||
164148134|NCT02906670|592904834|FG003|Cohort 2, QW|Radiological Progression|0|||
164148135|NCT02906670|592904835|FG004|Cohort 2, QW|Radiological Progression|0|||
164148136|NCT02906670|592904836|FG005|Cohort 2, QW|Radiological Progression|0|||
164148137|NCT02906670|592904837|FG006|Cohort 2, QW|Radiological Progression|0|||
164148138|NCT02906670|592904838|FG007|Cohort 2, QW|Radiological Progression|0|||
164148139|NCT02906670|592904839|FG008|Cohort 2, QW|Radiological Progression|0|||
164148140|NCT02906670|592904840|FG009|Cohort 2, QW|Radiological Progression|0|||
164148141|NCT02906670|592904831|FG000|Cohort 3, QW|Radiological Progression|0|||
164148142|NCT02906670|592904832|FG001|Cohort 3, QW|Radiological Progression|0|||
164148143|NCT02906670|592904833|FG002|Cohort 3, QW|Radiological Progression|2|||
164148144|NCT02906670|592904834|FG003|Cohort 3, QW|Radiological Progression|0|||
164148145|NCT02906670|592904835|FG004|Cohort 3, QW|Radiological Progression|0|||
164148146|NCT02906670|592904836|FG005|Cohort 3, QW|Radiological Progression|0|||
164148147|NCT02906670|592904837|FG006|Cohort 3, QW|Radiological Progression|0|||
164148148|NCT02906670|592904838|FG007|Cohort 3, QW|Radiological Progression|0|||
164148149|NCT02906670|592904839|FG008|Cohort 3, QW|Radiological Progression|0|||
164148150|NCT02906670|592904840|FG009|Cohort 3, QW|Radiological Progression|0|||
164148151|NCT02906670|592904831|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
164148152|NCT02906670|592904832|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
164148153|NCT02906670|592904833|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
164148154|NCT02906670|592904834|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
164148155|NCT02906670|592904835|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
164148156|NCT02906670|592904836|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
164148157|NCT02906670|592904837|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
164148158|NCT02906670|592904838|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
164148159|NCT02906670|592904839|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
164148160|NCT02906670|592904840|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
164148161|NCT02906670|592904831|FG000|Cohort 4, Q2W|Radiological Progression|0|||
164148162|NCT02906670|592904832|FG001|Cohort 4, Q2W|Radiological Progression|0|||
164148163|NCT02906670|592904833|FG002|Cohort 4, Q2W|Radiological Progression|0|||
164148164|NCT02906670|592904834|FG003|Cohort 4, Q2W|Radiological Progression|0|||
164148165|NCT02906670|592904835|FG004|Cohort 4, Q2W|Radiological Progression|0|||
164148166|NCT02906670|592904836|FG005|Cohort 4, Q2W|Radiological Progression|1|||
164148167|NCT02906670|592904837|FG006|Cohort 4, Q2W|Radiological Progression|0|||
164148168|NCT02906670|592904838|FG007|Cohort 4, Q2W|Radiological Progression|0|||
164148169|NCT02906670|592904839|FG008|Cohort 4, Q2W|Radiological Progression|0|||
164148170|NCT02906670|592904840|FG009|Cohort 4, Q2W|Radiological Progression|0|||
164148171|NCT02906670|592904831|FG000|Cohort 4, Q2W|Clinical Progression|0|||
164148172|NCT02906670|592904832|FG001|Cohort 4, Q2W|Clinical Progression|0|||
164148173|NCT02906670|592904833|FG002|Cohort 4, Q2W|Clinical Progression|0|||
164148174|NCT02906670|592904834|FG003|Cohort 4, Q2W|Clinical Progression|0|||
164148175|NCT02906670|592904835|FG004|Cohort 4, Q2W|Clinical Progression|0|||
164148176|NCT02906670|592904836|FG005|Cohort 4, Q2W|Clinical Progression|2|||
164148177|NCT02906670|592904837|FG006|Cohort 4, Q2W|Clinical Progression|0|||
164148178|NCT02906670|592904838|FG007|Cohort 4, Q2W|Clinical Progression|0|||
164148179|NCT02906670|592904839|FG008|Cohort 4, Q2W|Clinical Progression|0|||
164148180|NCT02906670|592904840|FG009|Cohort 4, Q2W|Clinical Progression|0|||
164148181|NCT02906670|592904831|FG000|Cohort 5, Q2W|Radiological Progression|0|||
164148182|NCT02906670|592904832|FG001|Cohort 5, Q2W|Radiological Progression|0|||
164148183|NCT02906670|592904833|FG002|Cohort 5, Q2W|Radiological Progression|0|||
164148184|NCT02906670|592904834|FG003|Cohort 5, Q2W|Radiological Progression|0|||
164148185|NCT02906670|592904835|FG004|Cohort 5, Q2W|Radiological Progression|0|||
164148186|NCT02906670|592904836|FG005|Cohort 5, Q2W|Radiological Progression|0|||
164148187|NCT02906670|592904837|FG006|Cohort 5, Q2W|Radiological Progression|4|||
164148188|NCT02906670|592904838|FG007|Cohort 5, Q2W|Radiological Progression|0|||
164148189|NCT02906670|592904839|FG008|Cohort 5, Q2W|Radiological Progression|0|||
164148190|NCT02906670|592904840|FG009|Cohort 5, Q2W|Radiological Progression|0|||
164148191|NCT02906670|592904831|FG000|Cohort 5, Q2W|Clinical Progression|0|||
164148192|NCT02906670|592904832|FG001|Cohort 5, Q2W|Clinical Progression|0|||
164148193|NCT02906670|592904833|FG002|Cohort 5, Q2W|Clinical Progression|0|||
164148194|NCT02906670|592904834|FG003|Cohort 5, Q2W|Clinical Progression|0|||
164148195|NCT02906670|592904835|FG004|Cohort 5, Q2W|Clinical Progression|0|||
164148196|NCT02906670|592904836|FG005|Cohort 5, Q2W|Clinical Progression|0|||
164148197|NCT02906670|592904837|FG006|Cohort 5, Q2W|Clinical Progression|1|||
164148198|NCT02906670|592904838|FG007|Cohort 5, Q2W|Clinical Progression|0|||
164148199|NCT02906670|592904839|FG008|Cohort 5, Q2W|Clinical Progression|0|||
164148200|NCT02906670|592904840|FG009|Cohort 5, Q2W|Clinical Progression|0|||
164148201|NCT02906670|592904831|FG000|Cohort 5, Q2W|Adverse Event|0|||
164148202|NCT02906670|592904832|FG001|Cohort 5, Q2W|Adverse Event|0|||
164148203|NCT02906670|592904833|FG002|Cohort 5, Q2W|Adverse Event|0|||
164148204|NCT02906670|592904834|FG003|Cohort 5, Q2W|Adverse Event|0|||
164148205|NCT02906670|592904835|FG004|Cohort 5, Q2W|Adverse Event|0|||
164148206|NCT02906670|592904836|FG005|Cohort 5, Q2W|Adverse Event|0|||
164148207|NCT02906670|592904837|FG006|Cohort 5, Q2W|Adverse Event|1|||
164148208|NCT02906670|592904838|FG007|Cohort 5, Q2W|Adverse Event|0|||
164148209|NCT02906670|592904839|FG008|Cohort 5, Q2W|Adverse Event|0|||
164148210|NCT02906670|592904840|FG009|Cohort 5, Q2W|Adverse Event|0|||
164148211|NCT02906670|592904831|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
164148212|NCT02906670|592904832|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
164148213|NCT02906670|592904833|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
164148214|NCT02906670|592904834|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
164148215|NCT02906670|592904835|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
164148216|NCT02906670|592904836|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
164148217|NCT02906670|592904837|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
164148218|NCT02906670|592904838|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
164148219|NCT02906670|592904839|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
164148220|NCT02906670|592904840|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
164148221|NCT02906670|592904831|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
164148222|NCT02906670|592904832|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
164148223|NCT02906670|592904833|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
164148224|NCT02906670|592904834|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
164148225|NCT02906670|592904835|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
164148226|NCT02906670|592904836|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
164148227|NCT02906670|592904837|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
164148228|NCT02906670|592904838|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
164148229|NCT02906670|592904839|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
164148230|NCT02906670|592904840|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
164148231|NCT02906670|592904831|FG000|Cohort 5P, Q2W|Adverse Event|0|||
164148232|NCT02906670|592904832|FG001|Cohort 5P, Q2W|Adverse Event|0|||
164148233|NCT02906670|592904833|FG002|Cohort 5P, Q2W|Adverse Event|0|||
164148234|NCT02906670|592904834|FG003|Cohort 5P, Q2W|Adverse Event|0|||
164148235|NCT02906670|592904835|FG004|Cohort 5P, Q2W|Adverse Event|0|||
164148236|NCT02906670|592904836|FG005|Cohort 5P, Q2W|Adverse Event|0|||
164148237|NCT02906670|592904837|FG006|Cohort 5P, Q2W|Adverse Event|0|||
164148238|NCT02906670|592904838|FG007|Cohort 5P, Q2W|Adverse Event|1|||
164148239|NCT02906670|592904839|FG008|Cohort 5P, Q2W|Adverse Event|0|||
164148240|NCT02906670|592904840|FG009|Cohort 5P, Q2W|Adverse Event|0|||
164148241|NCT02906670|592904831|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
164148242|NCT02906670|592904832|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
164148243|NCT02906670|592904833|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
164148244|NCT02906670|592904834|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
164148245|NCT02906670|592904835|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
164148246|NCT02906670|592904836|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
164148247|NCT02906670|592904837|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
164148248|NCT02906670|592904838|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
164148249|NCT02906670|592904839|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
164148250|NCT02906670|592904840|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
164148251|NCT02906670|592904831|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
164148252|NCT02906670|592904832|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
164148253|NCT02906670|592904833|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
164148254|NCT02906670|592904834|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
164148255|NCT02906670|592904835|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
164148256|NCT02906670|592904836|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
164148257|NCT02906670|592904837|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
164148258|NCT02906670|592904838|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
164148259|NCT02906670|592904839|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
164148260|NCT02906670|592904840|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
164148261|NCT02906670|592904831|FG000|Cohort 4P, QW|Radiological Progression|0|||
164148262|NCT02906670|592904832|FG001|Cohort 4P, QW|Radiological Progression|0|||
164148263|NCT02906670|592904833|FG002|Cohort 4P, QW|Radiological Progression|0|||
164148264|NCT02906670|592904834|FG003|Cohort 4P, QW|Radiological Progression|3|||
164148265|NCT02906670|592904835|FG004|Cohort 4P, QW|Radiological Progression|0|||
164148266|NCT02906670|592904836|FG005|Cohort 4P, QW|Radiological Progression|0|||
164148267|NCT02906670|592904837|FG006|Cohort 4P, QW|Radiological Progression|0|||
164148268|NCT02906670|592904838|FG007|Cohort 4P, QW|Radiological Progression|0|||
164148269|NCT02906670|592904839|FG008|Cohort 4P, QW|Radiological Progression|0|||
164148270|NCT02906670|592904840|FG009|Cohort 4P, QW|Radiological Progression|0|||
164148271|NCT02906670|592904831|FG000|Cohort 7P, Q2W|Adverse Event|0|||
164148272|NCT02906670|592904832|FG001|Cohort 7P, Q2W|Adverse Event|0|||
164148273|NCT02906670|592904833|FG002|Cohort 7P, Q2W|Adverse Event|0|||
164148274|NCT02906670|592904834|FG003|Cohort 7P, Q2W|Adverse Event|0|||
164148275|NCT02906670|592904835|FG004|Cohort 7P, Q2W|Adverse Event|0|||
164148276|NCT02906670|592904836|FG005|Cohort 7P, Q2W|Adverse Event|0|||
164148277|NCT02906670|592904837|FG006|Cohort 7P, Q2W|Adverse Event|0|||
164148278|NCT02906670|592904838|FG007|Cohort 7P, Q2W|Adverse Event|0|||
164148279|NCT02906670|592904839|FG008|Cohort 7P, Q2W|Adverse Event|0|||
164148280|NCT02906670|592904840|FG009|Cohort 7P, Q2W|Adverse Event|1|||
164148281|NCT02906670|592904831|FG000|Cohort 7P, Q2W|Physician Decision|0|||
164148282|NCT02906670|592904832|FG001|Cohort 7P, Q2W|Physician Decision|0|||
164148283|NCT02906670|592904833|FG002|Cohort 7P, Q2W|Physician Decision|0|||
164148284|NCT02906670|592904834|FG003|Cohort 7P, Q2W|Physician Decision|0|||
164148285|NCT02906670|592904835|FG004|Cohort 7P, Q2W|Physician Decision|0|||
164148286|NCT02906670|592904836|FG005|Cohort 7P, Q2W|Physician Decision|0|||
164148287|NCT02906670|592904837|FG006|Cohort 7P, Q2W|Physician Decision|0|||
164148288|NCT02906670|592904838|FG007|Cohort 7P, Q2W|Physician Decision|0|||
164148289|NCT02906670|592904839|FG008|Cohort 7P, Q2W|Physician Decision|0|||
164148290|NCT02906670|592904840|FG009|Cohort 7P, Q2W|Physician Decision|1|||
164148291|NCT02906670|592904831|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
164148292|NCT02906670|592904832|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
164148293|NCT02906670|592904833|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
164148294|NCT02906670|592904834|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
164148295|NCT02906670|592904835|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
164148296|NCT02906670|592904836|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
164148297|NCT02906670|592904837|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
164148298|NCT02906670|592904838|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
164148299|NCT02906670|592904839|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
164148300|NCT02906670|592904840|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
164148301|NCT02906670|592904831|FG000|Cohort 5P, QW|Radiological Progression|0|||
164148302|NCT02906670|592904832|FG001|Cohort 5P, QW|Radiological Progression|0|||
164148303|NCT02906670|592904833|FG002|Cohort 5P, QW|Radiological Progression|0|||
164148304|NCT02906670|592904834|FG003|Cohort 5P, QW|Radiological Progression|0|||
164148305|NCT02906670|592904835|FG004|Cohort 5P, QW|Radiological Progression|3|||
164148306|NCT02906670|592904836|FG005|Cohort 5P, QW|Radiological Progression|0|||
164148307|NCT02906670|592904837|FG006|Cohort 5P, QW|Radiological Progression|0|||
164148308|NCT02906670|592904838|FG007|Cohort 5P, QW|Radiological Progression|0|||
164148309|NCT02906670|592904839|FG008|Cohort 5P, QW|Radiological Progression|0|||
164148310|NCT02906670|592904840|FG009|Cohort 5P, QW|Radiological Progression|0|||
164148311|NCT00958828|592904841|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
164148312|NCT00958828|592904842|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
164148313|NCT00958828|592904841|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
164148314|NCT00958828|592904842|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
164148315|NCT02673775|592904855|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
164148316|NCT02673775|592904856|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
164148317|NCT02673775|592904855|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
164148318|NCT02673775|592904856|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
164148319|NCT02673775|592904855|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
164148320|NCT02673775|592904856|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
164148321|NCT02673775|592904855|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
164148322|NCT02673775|592904856|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
164148323|NCT03762239|592904857|FG000|Overall Study|Appointment to the doctor|1|||
164148324|NCT03762239|592904858|FG001|Overall Study|Appointment to the doctor|1|||
164148325|NCT02016183|592904859|FG000|Overall Study|Case Report Forms Uncollected|13|||
164148326|NCT02016183|592904859|FG000|Overall Study|Protocol Violation|52|||
164148327|NCT00770328|592904860|FG000|Overall Study|Adverse Event|11|||
164148328|NCT00770328|592904861|FG001|Overall Study|Adverse Event|2|||
164148329|NCT00770328|592904860|FG000|Overall Study|Lost to Follow-up|2|||
164148330|NCT00770328|592904861|FG001|Overall Study|Lost to Follow-up|2|||
164148331|NCT02286843|592904864|FG000|Overall Study|Not Treated|4|||
164148332|NCT02286843|592904864|FG000|Overall Study|Protocol Violation|1|||
164148333|NCT02286843|592904864|FG000|Overall Study|Withdrawal by Subject|1|||
164148334|NCT02536846|592904865|FG000|Overall Study|Withdrawal by Subject|1|||
164148335|NCT04388553|592904866|FG000|Overall Study|Protocol Violation|1|||
164148336|NCT04388553|592904867|FG001|Overall Study|Protocol Violation|0|||
164148337|NCT04604795|592904868|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
164148338|NCT04604795|592904869|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
164148339|NCT04604795|592904870|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
164148340|NCT04604795|592904871|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
164148341|NCT04604795|592904872|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
164148342|NCT04604795|592904873|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
164148343|NCT04604795|592904874|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
164148344|NCT04604795|592904875|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
164148345|NCT04604795|592904876|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
164148346|NCT04604795|592904877|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
164148347|NCT04604795|592904868|FG000|Part B: Up to Day 14|Adverse Event|0|||
164148348|NCT04604795|592904869|FG001|Part B: Up to Day 14|Adverse Event|0|||
164148349|NCT04604795|592904870|FG002|Part B: Up to Day 14|Adverse Event|0|||
164148350|NCT04604795|592904871|FG003|Part B: Up to Day 14|Adverse Event|0|||
164148351|NCT04604795|592904872|FG004|Part B: Up to Day 14|Adverse Event|2|||
164148352|NCT04604795|592904873|FG005|Part B: Up to Day 14|Adverse Event|1|||
164148353|NCT04604795|592904874|FG006|Part B: Up to Day 14|Adverse Event|0|||
164148354|NCT04604795|592904875|FG007|Part B: Up to Day 14|Adverse Event|0|||
164148355|NCT04604795|592904876|FG008|Part B: Up to Day 14|Adverse Event|0|||
164148356|NCT04604795|592904877|FG009|Part B: Up to Day 14|Adverse Event|0|||
164148357|NCT04604795|592904868|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
164148358|NCT04604795|592904869|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
164148359|NCT04604795|592904870|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
164148360|NCT04604795|592904871|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
164148361|NCT04604795|592904872|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
164148362|NCT04604795|592904873|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
164148363|NCT04604795|592904874|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
164148364|NCT04604795|592904875|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
164148365|NCT04604795|592904876|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
164148366|NCT04604795|592904877|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
164148367|NCT04604795|592904868|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
164148368|NCT04604795|592904869|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
164148369|NCT04604795|592904870|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
164148370|NCT04604795|592904871|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
164148371|NCT04604795|592904872|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
164148372|NCT04604795|592904873|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
164148373|NCT04604795|592904874|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
164148374|NCT04604795|592904875|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
164148375|NCT04604795|592904876|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
164148376|NCT04604795|592904877|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
164148377|NCT04604795|592904868|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
164148378|NCT04604795|592904869|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
164148379|NCT04604795|592904870|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
164148380|NCT04604795|592904871|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
164148381|NCT04604795|592904872|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
164148382|NCT04604795|592904873|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
164148383|NCT04604795|592904874|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
164148384|NCT04604795|592904875|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
164148385|NCT04604795|592904876|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
164148386|NCT04604795|592904877|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
164148387|NCT04604795|592904868|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
164148388|NCT04604795|592904869|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
164148389|NCT04604795|592904870|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
164148390|NCT04604795|592904871|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
164148391|NCT04604795|592904872|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
164148392|NCT04604795|592904873|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
164148393|NCT04604795|592904874|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
164148394|NCT04604795|592904875|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
164148395|NCT04604795|592904876|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
164148396|NCT04604795|592904877|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
164148397|NCT00174954|592904882|FG000|Overall Study|Adverse Event|2|||
164148398|NCT00174954|592904882|FG000|Overall Study|No tophi found in MRI|1|||
164148399|NCT00174954|592904882|FG000|Overall Study|Physician Decision|1|||
164148400|NCT00839254|592904883|FG000|Overall Study|Protocol Violation|0|||
164148401|NCT00839254|592904884|FG001|Overall Study|Protocol Violation|1|||
164148402|NCT00839254|592904885|FG002|Overall Study|Protocol Violation|1|||
164148403|NCT00839254|592904886|FG003|Overall Study|Protocol Violation|1|||
164148404|NCT00839254|592904887|FG004|Overall Study|Protocol Violation|0|||
164148405|NCT00839254|592904888|FG005|Overall Study|Protocol Violation|0|||
164148406|NCT00839254|592904889|FG006|Overall Study|Protocol Violation|1|||
164148407|NCT00839254|592904890|FG007|Overall Study|Protocol Violation|2|||
164148408|NCT00839254|592904883|FG000|Overall Study|Physician Decision|0|||
164148409|NCT00839254|592904884|FG001|Overall Study|Physician Decision|1|||
164148410|NCT00839254|592904885|FG002|Overall Study|Physician Decision|0|||
164148411|NCT00839254|592904886|FG003|Overall Study|Physician Decision|0|||
164148412|NCT00839254|592904887|FG004|Overall Study|Physician Decision|0|||
164148413|NCT00839254|592904888|FG005|Overall Study|Physician Decision|0|||
164148414|NCT00839254|592904889|FG006|Overall Study|Physician Decision|0|||
164148415|NCT00839254|592904890|FG007|Overall Study|Physician Decision|1|||
164148416|NCT00839254|592904883|FG000|Overall Study|Wrong treatment number allocation|0|||
164148417|NCT00839254|592904884|FG001|Overall Study|Wrong treatment number allocation|1|||
164148418|NCT00839254|592904885|FG002|Overall Study|Wrong treatment number allocation|0|||
164148419|NCT00839254|592904886|FG003|Overall Study|Wrong treatment number allocation|0|||
164148420|NCT00839254|592904887|FG004|Overall Study|Wrong treatment number allocation|0|||
164148421|NCT00839254|592904888|FG005|Overall Study|Wrong treatment number allocation|1|||
164148422|NCT00839254|592904889|FG006|Overall Study|Wrong treatment number allocation|0|||
164148423|NCT00839254|592904890|FG007|Overall Study|Wrong treatment number allocation|0|||
164148424|NCT00839254|592904883|FG000|Overall Study|Adverse Event|12|||
164148425|NCT00839254|592904884|FG001|Overall Study|Adverse Event|6|||
164148426|NCT00839254|592904885|FG002|Overall Study|Adverse Event|3|||
164148427|NCT00839254|592904886|FG003|Overall Study|Adverse Event|5|||
164148428|NCT00839254|592904887|FG004|Overall Study|Adverse Event|2|||
164148429|NCT00839254|592904888|FG005|Overall Study|Adverse Event|1|||
164148430|NCT00839254|592904889|FG006|Overall Study|Adverse Event|0|||
164148431|NCT00839254|592904890|FG007|Overall Study|Adverse Event|1|||
164148432|NCT00839254|592904883|FG000|Overall Study|Withdrawal by Subject|87|||
164148433|NCT00839254|592904884|FG001|Overall Study|Withdrawal by Subject|53|||
164148434|NCT00839254|592904885|FG002|Overall Study|Withdrawal by Subject|54|||
164148435|NCT00839254|592904886|FG003|Overall Study|Withdrawal by Subject|32|||
164148436|NCT00839254|592904887|FG004|Overall Study|Withdrawal by Subject|27|||
164148437|NCT00839254|592904888|FG005|Overall Study|Withdrawal by Subject|15|||
164148438|NCT00839254|592904889|FG006|Overall Study|Withdrawal by Subject|22|||
164148439|NCT00839254|592904890|FG007|Overall Study|Withdrawal by Subject|9|||
164148440|NCT00839254|592904883|FG000|Overall Study|Wrong group allocation|0|||
164148441|NCT00839254|592904884|FG001|Overall Study|Wrong group allocation|0|||
164148442|NCT00839254|592904885|FG002|Overall Study|Wrong group allocation|0|||
164148443|NCT00839254|592904886|FG003|Overall Study|Wrong group allocation|0|||
164148444|NCT00839254|592904887|FG004|Overall Study|Wrong group allocation|0|||
164148445|NCT00839254|592904888|FG005|Overall Study|Wrong group allocation|0|||
164148446|NCT00839254|592904889|FG006|Overall Study|Wrong group allocation|1|||
164148447|NCT00839254|592904890|FG007|Overall Study|Wrong group allocation|0|||
164148448|NCT00839254|592904883|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
164148449|NCT00839254|592904884|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
164148450|NCT00839254|592904885|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
164148451|NCT00839254|592904886|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
164148452|NCT00839254|592904887|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
164148453|NCT00839254|592904888|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
164148454|NCT00839254|592904889|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
164148455|NCT00839254|592904890|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
164148456|NCT00839254|592904883|FG000|Overall Study|Withdrawn due to non-compliance|2|||
164148457|NCT00839254|592904884|FG001|Overall Study|Withdrawn due to non-compliance|0|||
164148458|NCT00839254|592904885|FG002|Overall Study|Withdrawn due to non-compliance|0|||
164148459|NCT00839254|592904886|FG003|Overall Study|Withdrawn due to non-compliance|0|||
164148460|NCT00839254|592904887|FG004|Overall Study|Withdrawn due to non-compliance|0|||
164148461|NCT00839254|592904888|FG005|Overall Study|Withdrawn due to non-compliance|0|||
164148462|NCT00839254|592904889|FG006|Overall Study|Withdrawn due to non-compliance|0|||
164148463|NCT00839254|592904890|FG007|Overall Study|Withdrawn due to non-compliance|0|||
164148464|NCT00839254|592904883|FG000|Overall Study|Lost to Follow-up|51|||
164148465|NCT00839254|592904884|FG001|Overall Study|Lost to Follow-up|30|||
164148466|NCT00839254|592904885|FG002|Overall Study|Lost to Follow-up|32|||
164148467|NCT00839254|592904886|FG003|Overall Study|Lost to Follow-up|24|||
164148468|NCT00839254|592904887|FG004|Overall Study|Lost to Follow-up|8|||
164148469|NCT00839254|592904888|FG005|Overall Study|Lost to Follow-up|8|||
164148470|NCT00839254|592904889|FG006|Overall Study|Lost to Follow-up|4|||
164148471|NCT00839254|592904890|FG007|Overall Study|Lost to Follow-up|2|||
164148472|NCT04597632|592904891|FG000|Overall Study|Withdrawal by Subject|10|||
164148473|NCT04597632|592904891|FG000|Overall Study|Lost to Follow-up|1|||
164148474|NCT04597632|592904891|FG000|Overall Study|Death|1|||
164148475|NCT04597632|592904891|FG000|Overall Study|Adverse Event|5|||
164148476|NCT01823835|592904892|FG000|Overall Study|Adverse Event|0|||
164148477|NCT01823835|592904893|FG001|Overall Study|Adverse Event|0|||
164148478|NCT01823835|592904894|FG002|Overall Study|Adverse Event|0|||
164148479|NCT01823835|592904895|FG003|Overall Study|Adverse Event|0|||
164148480|NCT01823835|592904896|FG004|Overall Study|Adverse Event|1|||
164148481|NCT01823835|592904897|FG005|Overall Study|Adverse Event|0|||
164148482|NCT01823835|592904898|FG006|Overall Study|Adverse Event|1|||
164148483|NCT01823835|592904899|FG007|Overall Study|Adverse Event|0|||
164148484|NCT01823835|592904900|FG008|Overall Study|Adverse Event|0|||
164148485|NCT01823835|592904901|FG009|Overall Study|Adverse Event|0|||
164148486|NCT01823835|592904902|FG010|Overall Study|Adverse Event|1|||
164148487|NCT01823835|592904903|FG011|Overall Study|Adverse Event|2|||
164148488|NCT01823835|592904904|FG012|Overall Study|Adverse Event|0|||
164148489|NCT01823835|592904905|FG013|Overall Study|Adverse Event|0|||
164148490|NCT01823835|592904906|FG014|Overall Study|Adverse Event|0|||
164148491|NCT01823835|592904892|FG000|Overall Study|Physician Decision|0|||
164148492|NCT01823835|592904893|FG001|Overall Study|Physician Decision|0|||
164148493|NCT01823835|592904894|FG002|Overall Study|Physician Decision|0|||
164148494|NCT01823835|592904895|FG003|Overall Study|Physician Decision|0|||
164148495|NCT01823835|592904896|FG004|Overall Study|Physician Decision|0|||
164148496|NCT01823835|592904897|FG005|Overall Study|Physician Decision|0|||
164148497|NCT01823835|592904898|FG006|Overall Study|Physician Decision|0|||
164148498|NCT01823835|592904899|FG007|Overall Study|Physician Decision|0|||
164148499|NCT01823835|592904900|FG008|Overall Study|Physician Decision|0|||
164148500|NCT01823835|592904901|FG009|Overall Study|Physician Decision|0|||
164148501|NCT01823835|592904902|FG010|Overall Study|Physician Decision|0|||
164148502|NCT01823835|592904903|FG011|Overall Study|Physician Decision|2|||
164148503|NCT01823835|592904904|FG012|Overall Study|Physician Decision|0|||
164148504|NCT01823835|592904905|FG013|Overall Study|Physician Decision|0|||
164148505|NCT01823835|592904906|FG014|Overall Study|Physician Decision|0|||
164148506|NCT01823835|592904892|FG000|Overall Study|Progressive Disease|3|||
164148507|NCT01823835|592904893|FG001|Overall Study|Progressive Disease|4|||
164148508|NCT01823835|592904894|FG002|Overall Study|Progressive Disease|3|||
164148509|NCT01823835|592904895|FG003|Overall Study|Progressive Disease|6|||
164148510|NCT01823835|592904896|FG004|Overall Study|Progressive Disease|4|||
164148511|NCT01823835|592904897|FG005|Overall Study|Progressive Disease|6|||
164148512|NCT01823835|592904898|FG006|Overall Study|Progressive Disease|5|||
164148513|NCT01823835|592904899|FG007|Overall Study|Progressive Disease|3|||
164148514|NCT01823835|592904900|FG008|Overall Study|Progressive Disease|3|||
164148515|NCT01823835|592904901|FG009|Overall Study|Progressive Disease|18|||
164148516|NCT01823835|592904902|FG010|Overall Study|Progressive Disease|8|||
164148517|NCT01823835|592904903|FG011|Overall Study|Progressive Disease|46|||
164148518|NCT01823835|592904904|FG012|Overall Study|Progressive Disease|18|||
164148519|NCT01823835|592904905|FG013|Overall Study|Progressive Disease|4|||
164148520|NCT01823835|592904906|FG014|Overall Study|Progressive Disease|6|||
164148521|NCT01823835|592904892|FG000|Overall Study|Study Termination|0|||
164148522|NCT01823835|592904893|FG001|Overall Study|Study Termination|0|||
164148523|NCT01823835|592904894|FG002|Overall Study|Study Termination|0|||
164148536|NCT01823835|592904892|FG000|Overall Study|Withdrawal by Subject|0|||
164148537|NCT01823835|592904893|FG001|Overall Study|Withdrawal by Subject|0|||
164148538|NCT01823835|592904894|FG002|Overall Study|Withdrawal by Subject|1|||
164148539|NCT01823835|592904895|FG003|Overall Study|Withdrawal by Subject|0|||
164148540|NCT01823835|592904896|FG004|Overall Study|Withdrawal by Subject|0|||
164148541|NCT01823835|592904897|FG005|Overall Study|Withdrawal by Subject|0|||
164148542|NCT01823835|592904898|FG006|Overall Study|Withdrawal by Subject|0|||
164148543|NCT01823835|592904899|FG007|Overall Study|Withdrawal by Subject|0|||
164148544|NCT01823835|592904900|FG008|Overall Study|Withdrawal by Subject|0|||
164148545|NCT01823835|592904901|FG009|Overall Study|Withdrawal by Subject|1|||
164148546|NCT01823835|592904902|FG010|Overall Study|Withdrawal by Subject|1|||
164148547|NCT01823835|592904903|FG011|Overall Study|Withdrawal by Subject|2|||
164148548|NCT01823835|592904904|FG012|Overall Study|Withdrawal by Subject|1|||
164148549|NCT01823835|592904905|FG013|Overall Study|Withdrawal by Subject|0|||
164148550|NCT01823835|592904906|FG014|Overall Study|Withdrawal by Subject|0|||
164148551|NCT00509795|592904907|FG000|Overall Study|Adverse Event|4|||
164148552|NCT00509795|592904908|FG001|Overall Study|Adverse Event|3|||
164148553|NCT00509795|592904909|FG002|Overall Study|Adverse Event|5|||
164148554|NCT00509795|592904910|FG003|Overall Study|Adverse Event|4|||
164148555|NCT00509795|592904907|FG000|Overall Study|Death|3|||
164148556|NCT00509795|592904908|FG001|Overall Study|Death|1|||
164148557|NCT00509795|592904909|FG002|Overall Study|Death|2|||
164148558|NCT00509795|592904910|FG003|Overall Study|Death|7|||
164148559|NCT00509795|592904907|FG000|Overall Study|Lack of Efficacy|0|||
164148560|NCT00509795|592904908|FG001|Overall Study|Lack of Efficacy|0|||
164148561|NCT00509795|592904909|FG002|Overall Study|Lack of Efficacy|2|||
164148562|NCT00509795|592904910|FG003|Overall Study|Lack of Efficacy|2|||
164148563|NCT00509795|592904907|FG000|Overall Study|Lost to Follow-up|1|||
164148564|NCT00509795|592904908|FG001|Overall Study|Lost to Follow-up|2|||
164148565|NCT00509795|592904909|FG002|Overall Study|Lost to Follow-up|4|||
164148566|NCT00509795|592904910|FG003|Overall Study|Lost to Follow-up|4|||
164148567|NCT00509795|592904907|FG000|Overall Study|OTHER|1|||
164148568|NCT00509795|592904908|FG001|Overall Study|OTHER|0|||
164148569|NCT00509795|592904909|FG002|Overall Study|OTHER|4|||
164148570|NCT00509795|592904910|FG003|Overall Study|OTHER|1|||
164148571|NCT00509795|592904907|FG000|Overall Study|Protocol Violation|3|||
164148572|NCT00509795|592904908|FG001|Overall Study|Protocol Violation|0|||
164148573|NCT00509795|592904909|FG002|Overall Study|Protocol Violation|3|||
164148574|NCT00509795|592904910|FG003|Overall Study|Protocol Violation|1|||
164148575|NCT00509795|592904907|FG000|Overall Study|Withdrawal by Subject|10|||
164148576|NCT00509795|592904908|FG001|Overall Study|Withdrawal by Subject|5|||
164148577|NCT00509795|592904909|FG002|Overall Study|Withdrawal by Subject|7|||
164148578|NCT00509795|592904910|FG003|Overall Study|Withdrawal by Subject|8|||
164148579|NCT04895982|592904911|FG000|Overall Study|Withdrawal by Subject|0|||
164148580|NCT04895982|592904912|FG001|Overall Study|Withdrawal by Subject|0|||
164148581|NCT04895982|592904913|FG002|Overall Study|Withdrawal by Subject|0|||
164148582|NCT04895982|592904914|FG003|Overall Study|Withdrawal by Subject|0|||
164148583|NCT04895982|592904915|FG004|Overall Study|Withdrawal by Subject|0|||
164148584|NCT04895982|592904916|FG005|Overall Study|Withdrawal by Subject|1|||
164148585|NCT04895982|592904917|FG006|Overall Study|Withdrawal by Subject|1|||
164148586|NCT04895982|592904918|FG007|Overall Study|Withdrawal by Subject|0|||
164148587|NCT04895982|592904919|FG008|Overall Study|Withdrawal by Subject|0|||
164148588|NCT04895982|592904920|FG009|Overall Study|Withdrawal by Subject|1|||
164148589|NCT04895982|592904921|FG010|Overall Study|Withdrawal by Subject|0|||
164148590|NCT04895982|592904922|FG011|Overall Study|Withdrawal by Subject|1|||
164148591|NCT04895982|592904911|FG000|Overall Study|Withdrawal by parent/guardian|2|||
164148592|NCT04895982|592904912|FG001|Overall Study|Withdrawal by parent/guardian|3|||
164148593|NCT04895982|592904913|FG002|Overall Study|Withdrawal by parent/guardian|3|||
164148594|NCT04895982|592904914|FG003|Overall Study|Withdrawal by parent/guardian|1|||
164148595|NCT04895982|592904915|FG004|Overall Study|Withdrawal by parent/guardian|3|||
164148596|NCT04895982|592904916|FG005|Overall Study|Withdrawal by parent/guardian|2|||
164148597|NCT04895982|592904917|FG006|Overall Study|Withdrawal by parent/guardian|1|||
164148598|NCT04895982|592904918|FG007|Overall Study|Withdrawal by parent/guardian|0|||
164148599|NCT04895982|592904919|FG008|Overall Study|Withdrawal by parent/guardian|3|||
164148600|NCT04895982|592904920|FG009|Overall Study|Withdrawal by parent/guardian|0|||
164148601|NCT04895982|592904921|FG010|Overall Study|Withdrawal by parent/guardian|0|||
164148602|NCT04895982|592904922|FG011|Overall Study|Withdrawal by parent/guardian|0|||
164148603|NCT04895982|592904911|FG000|Overall Study|Other|0|||
164148604|NCT04895982|592904912|FG001|Overall Study|Other|0|||
164148605|NCT04895982|592904913|FG002|Overall Study|Other|1|||
164148606|NCT04895982|592904914|FG003|Overall Study|Other|1|||
164148607|NCT04895982|592904915|FG004|Overall Study|Other|0|||
164148608|NCT04895982|592904916|FG005|Overall Study|Other|0|||
164148609|NCT04895982|592904917|FG006|Overall Study|Other|0|||
164148610|NCT04895982|592904918|FG007|Overall Study|Other|0|||
164148611|NCT04895982|592904919|FG008|Overall Study|Other|0|||
164148612|NCT04895982|592904920|FG009|Overall Study|Other|1|||
164148613|NCT04895982|592904921|FG010|Overall Study|Other|0|||
164148639|NCT04895982|592904911|FG000|Overall Study|Refused further study procedures|0|||
164148640|NCT04895982|592904912|FG001|Overall Study|Refused further study procedures|0|||
164148641|NCT04895982|592904913|FG002|Overall Study|Refused further study procedures|1|||
164148642|NCT04895982|592904914|FG003|Overall Study|Refused further study procedures|0|||
164148643|NCT04895982|592904915|FG004|Overall Study|Refused further study procedures|0|||
164148644|NCT04895982|592904916|FG005|Overall Study|Refused further study procedures|0|||
164148645|NCT04895982|592904917|FG006|Overall Study|Refused further study procedures|0|||
164148646|NCT04895982|592904918|FG007|Overall Study|Refused further study procedures|0|||
164148647|NCT04895982|592904919|FG008|Overall Study|Refused further study procedures|0|||
164148648|NCT04895982|592904920|FG009|Overall Study|Refused further study procedures|0|||
164148649|NCT04895982|592904921|FG010|Overall Study|Refused further study procedures|0|||
164148650|NCT04895982|592904922|FG011|Overall Study|Refused further study procedures|0|||
164148651|NCT02215967|592904932|FG000|Overall Study|Patient became ineligible for treatment|0|||
164148652|NCT02215967|592904933|FG001|Overall Study|Patient became ineligible for treatment|0|||
164148653|NCT02215967|592904934|FG002|Overall Study|Patient became ineligible for treatment|0|||
164148654|NCT02215967|592904935|FG003|Overall Study|Patient became ineligible for treatment|3|||
164148655|NCT02215967|592904932|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
164148656|NCT02215967|592904933|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
164148657|NCT02215967|592904934|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
164148658|NCT02215967|592904935|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
164148659|NCT03207867|592904936|FG000|Overall Study|Adverse Event|1|||
164148660|NCT03207867|592904937|FG001|Overall Study|Adverse Event|0|||
164148661|NCT03207867|592904938|FG002|Overall Study|Adverse Event|1|||
164148662|NCT03207867|592904939|FG003|Overall Study|Adverse Event|0|||
164148663|NCT03207867|592904940|FG004|Overall Study|Adverse Event|0|||
164148664|NCT03207867|592904941|FG005|Overall Study|Adverse Event|2|||
164148665|NCT03207867|592904942|FG006|Overall Study|Adverse Event|1|||
164148666|NCT03207867|592904943|FG007|Overall Study|Adverse Event|1|||
164148667|NCT03207867|592904944|FG008|Overall Study|Adverse Event|2|||
164148668|NCT03207867|592904945|FG009|Overall Study|Adverse Event|2|||
164148669|NCT03207867|592904946|FG010|Overall Study|Adverse Event|0|||
164148670|NCT03207867|592904947|FG011|Overall Study|Adverse Event|0|||
164148671|NCT03207867|592904948|FG012|Overall Study|Adverse Event|0|||
164148672|NCT03207867|592904949|FG013|Overall Study|Adverse Event|0|||
164148673|NCT03207867|592904950|FG014|Overall Study|Adverse Event|0|||
164148674|NCT03207867|592904951|FG015|Overall Study|Adverse Event|0|||
164148675|NCT03207867|592904952|FG016|Overall Study|Adverse Event|3|||
164148676|NCT03207867|592904953|FG017|Overall Study|Adverse Event|1|||
164148677|NCT03207867|592904954|FG018|Overall Study|Adverse Event|2|||
164148678|NCT03207867|592904955|FG019|Overall Study|Adverse Event|1|||
164148679|NCT03207867|592904956|FG020|Overall Study|Adverse Event|0|||
164148680|NCT03207867|592904957|FG021|Overall Study|Adverse Event|0|||
164148681|NCT03207867|592904958|FG022|Overall Study|Adverse Event|0|||
164148682|NCT03207867|592904959|FG023|Overall Study|Adverse Event|0|||
164148683|NCT03207867|592904936|FG000|Overall Study|Death|0|||
164148684|NCT03207867|592904937|FG001|Overall Study|Death|0|||
164148685|NCT03207867|592904938|FG002|Overall Study|Death|0|||
164148686|NCT03207867|592904939|FG003|Overall Study|Death|0|||
164148687|NCT03207867|592904940|FG004|Overall Study|Death|0|||
164148688|NCT03207867|592904941|FG005|Overall Study|Death|1|||
164148689|NCT03207867|592904942|FG006|Overall Study|Death|0|||
164148690|NCT03207867|592904943|FG007|Overall Study|Death|3|||
164148691|NCT03207867|592904944|FG008|Overall Study|Death|1|||
164148692|NCT03207867|592904945|FG009|Overall Study|Death|2|||
164148693|NCT03207867|592904946|FG010|Overall Study|Death|0|||
164148694|NCT03207867|592904947|FG011|Overall Study|Death|1|||
164148695|NCT03207867|592904948|FG012|Overall Study|Death|0|||
164148696|NCT03207867|592904949|FG013|Overall Study|Death|1|||
164148697|NCT03207867|592904950|FG014|Overall Study|Death|0|||
164148698|NCT03207867|592904951|FG015|Overall Study|Death|0|||
164148699|NCT03207867|592904952|FG016|Overall Study|Death|0|||
164148700|NCT03207867|592904953|FG017|Overall Study|Death|2|||
164148701|NCT03207867|592904954|FG018|Overall Study|Death|0|||
164148702|NCT03207867|592904955|FG019|Overall Study|Death|1|||
164148703|NCT03207867|592904956|FG020|Overall Study|Death|0|||
164148704|NCT03207867|592904957|FG021|Overall Study|Death|0|||
164148705|NCT03207867|592904958|FG022|Overall Study|Death|0|||
164148706|NCT03207867|592904959|FG023|Overall Study|Death|0|||
164148707|NCT03207867|592904936|FG000|Overall Study|Physician Decision|3|||
164148708|NCT03207867|592904937|FG001|Overall Study|Physician Decision|5|||
164148709|NCT03207867|592904938|FG002|Overall Study|Physician Decision|0|||
164148710|NCT03207867|592904939|FG003|Overall Study|Physician Decision|3|||
164148711|NCT03207867|592904940|FG004|Overall Study|Physician Decision|2|||
164148712|NCT03207867|592904941|FG005|Overall Study|Physician Decision|0|||
164148713|NCT03207867|592904942|FG006|Overall Study|Physician Decision|0|||
164148714|NCT03207867|592904943|FG007|Overall Study|Physician Decision|0|||
164148715|NCT03207867|592904944|FG008|Overall Study|Physician Decision|4|||
164148716|NCT03207867|592904945|FG009|Overall Study|Physician Decision|2|||
164148717|NCT03207867|592904946|FG010|Overall Study|Physician Decision|0|||
164148718|NCT03207867|592904947|FG011|Overall Study|Physician Decision|4|||
164148740|NCT03207867|592904945|FG009|Overall Study|Progressive Disease|23|||
164148741|NCT03207867|592904946|FG010|Overall Study|Progressive Disease|2|||
164148742|NCT03207867|592904947|FG011|Overall Study|Progressive Disease|24|||
164148743|NCT03207867|592904948|FG012|Overall Study|Progressive Disease|3|||
164148744|NCT03207867|592904949|FG013|Overall Study|Progressive Disease|11|||
164148745|NCT03207867|592904950|FG014|Overall Study|Progressive Disease|9|||
164148746|NCT03207867|592904951|FG015|Overall Study|Progressive Disease|5|||
164148747|NCT03207867|592904952|FG016|Overall Study|Progressive Disease|10|||
164148748|NCT03207867|592904953|FG017|Overall Study|Progressive Disease|14|||
164148749|NCT03207867|592904954|FG018|Overall Study|Progressive Disease|13|||
164148750|NCT03207867|592904955|FG019|Overall Study|Progressive Disease|14|||
164148751|NCT03207867|592904956|FG020|Overall Study|Progressive Disease|6|||
164148752|NCT03207867|592904957|FG021|Overall Study|Progressive Disease|3|||
164148753|NCT03207867|592904958|FG022|Overall Study|Progressive Disease|3|||
164148754|NCT03207867|592904959|FG023|Overall Study|Progressive Disease|3|||
164148755|NCT03207867|592904936|FG000|Overall Study|Patient/guardian Decision|0|||
164148756|NCT03207867|592904937|FG001|Overall Study|Patient/guardian Decision|0|||
164148757|NCT03207867|592904938|FG002|Overall Study|Patient/guardian Decision|1|||
164148758|NCT03207867|592904939|FG003|Overall Study|Patient/guardian Decision|1|||
164148759|NCT03207867|592904940|FG004|Overall Study|Patient/guardian Decision|1|||
164148760|NCT03207867|592904941|FG005|Overall Study|Patient/guardian Decision|2|||
164148761|NCT03207867|592904942|FG006|Overall Study|Patient/guardian Decision|1|||
164148762|NCT03207867|592904943|FG007|Overall Study|Patient/guardian Decision|0|||
164148763|NCT03207867|592904944|FG008|Overall Study|Patient/guardian Decision|1|||
164148764|NCT03207867|592904945|FG009|Overall Study|Patient/guardian Decision|0|||
164148765|NCT03207867|592904946|FG010|Overall Study|Patient/guardian Decision|0|||
164148766|NCT03207867|592904947|FG011|Overall Study|Patient/guardian Decision|1|||
164148767|NCT03207867|592904948|FG012|Overall Study|Patient/guardian Decision|0|||
164148768|NCT03207867|592904949|FG013|Overall Study|Patient/guardian Decision|1|||
164148769|NCT03207867|592904950|FG014|Overall Study|Patient/guardian Decision|2|||
164148770|NCT03207867|592904951|FG015|Overall Study|Patient/guardian Decision|0|||
164148771|NCT03207867|592904952|FG016|Overall Study|Patient/guardian Decision|1|||
164148772|NCT03207867|592904953|FG017|Overall Study|Patient/guardian Decision|3|||
164148773|NCT03207867|592904954|FG018|Overall Study|Patient/guardian Decision|4|||
164148774|NCT03207867|592904955|FG019|Overall Study|Patient/guardian Decision|1|||
164148775|NCT03207867|592904956|FG020|Overall Study|Patient/guardian Decision|0|||
164148776|NCT03207867|592904957|FG021|Overall Study|Patient/guardian Decision|0|||
164148777|NCT03207867|592904958|FG022|Overall Study|Patient/guardian Decision|0|||
164148778|NCT03207867|592904959|FG023|Overall Study|Patient/guardian Decision|0|||
164148779|NCT03560037|592907153|FG000|Overall Study|Protocol Violation|1|||
164148780|NCT03560037|592907154|FG001|Overall Study|Protocol Violation|0|||
164148781|NCT03560037|592907153|FG000|Overall Study|Physician Decision|0|||
164148782|NCT03560037|592907154|FG001|Overall Study|Physician Decision|1|||
164148783|NCT03620708|592907155|FG000|Overall Study|Lost to Follow-up|1|||
164148784|NCT03620708|592907156|FG001|Overall Study|Lost to Follow-up|1|||
164148785|NCT03620708|592907157|FG002|Overall Study|Lost to Follow-up|2|||
164148786|NCT03620708|592907155|FG000|Overall Study|Withdrawal by Subject|0|||
164148787|NCT03620708|592907156|FG001|Overall Study|Withdrawal by Subject|0|||
164148788|NCT03620708|592907157|FG002|Overall Study|Withdrawal by Subject|1|||
164148789|NCT02498613|592907158|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
164148790|NCT02498613|592907159|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
164148791|NCT02498613|592907160|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
164148792|NCT02498613|592907161|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
164148793|NCT02498613|592907158|FG000|Overall Study|Withdrawal by Subject|3|||
164148794|NCT02498613|592907159|FG001|Overall Study|Withdrawal by Subject|1|||
164148795|NCT02498613|592907160|FG002|Overall Study|Withdrawal by Subject|0|||
164148796|NCT02498613|592907161|FG003|Overall Study|Withdrawal by Subject|0|||
164148797|NCT05126693|592907162|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
164148798|NCT05126693|592907163|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
164148799|NCT05126693|592907162|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
164148800|NCT05126693|592907163|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
164148801|NCT05126693|592907162|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
164148802|NCT05126693|592907163|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
164148803|NCT05061134|592907165|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
164148804|NCT05061134|592907166|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
164148805|NCT05061134|592907167|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
164148806|NCT05061134|592907165|FG000|Overall Study|Subject not treated|0|||
164148807|NCT05061134|592907166|FG001|Overall Study|Subject not treated|0|||
164148808|NCT05061134|592907167|FG002|Overall Study|Subject not treated|2|||
164148809|NCT05061134|592907165|FG000|Overall Study|Other|0|||
164148810|NCT05061134|592907166|FG001|Overall Study|Other|0|||
164148811|NCT05061134|592907167|FG002|Overall Study|Other|9|||
164148812|NCT05061134|592907165|FG000|Overall Study|Withdrawal by Subject|9|||
164148813|NCT05061134|592907166|FG001|Overall Study|Withdrawal by Subject|8|||
164148814|NCT05061134|592907167|FG002|Overall Study|Withdrawal by Subject|5|||
164148815|NCT05061134|592907165|FG000|Overall Study|Study Terminated by Sponsor|22|||
164148816|NCT05061134|592907166|FG001|Overall Study|Study Terminated by Sponsor|14|||
164148817|NCT05061134|592907167|FG002|Overall Study|Study Terminated by Sponsor|7|||
164148818|NCT05061134|592907165|FG000|Overall Study|Progressive Disease|1|||
164148819|NCT05061134|592907166|FG001|Overall Study|Progressive Disease|2|||
164148820|NCT05061134|592907167|FG002|Overall Study|Progressive Disease|0|||
164148821|NCT05061134|592907165|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
164148822|NCT05061134|592907166|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
164148823|NCT05061134|592907167|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
164148824|NCT05061134|592907165|FG000|Overall Study|Lost to Follow-up|1|||
164148825|NCT05061134|592907166|FG001|Overall Study|Lost to Follow-up|0|||
164148826|NCT05061134|592907167|FG002|Overall Study|Lost to Follow-up|0|||
164148827|NCT05061134|592907165|FG000|Overall Study|Physician Decision|1|||
164148828|NCT05061134|592907166|FG001|Overall Study|Physician Decision|1|||
164148829|NCT05061134|592907167|FG002|Overall Study|Physician Decision|0|||
164148830|NCT05061134|592907165|FG000|Overall Study|Disease progression|1|||
164148831|NCT05061134|592907166|FG001|Overall Study|Disease progression|0|||
164148832|NCT05061134|592907167|FG002|Overall Study|Disease progression|0|||
164148833|NCT05061134|592907165|FG000|Overall Study|Death|43|||
164148834|NCT05061134|592907166|FG001|Overall Study|Death|23|||
164148835|NCT05061134|592907167|FG002|Overall Study|Death|14|||
164148836|NCT05061134|592907165|FG000|Overall Study|Database lock|2|||
164148837|NCT05061134|592907166|FG001|Overall Study|Database lock|0|||
164148838|NCT05061134|592907167|FG002|Overall Study|Database lock|0|||
164148839|NCT03631199|592907171|FG000|Overall Study|Progressive disease|9|||
164148840|NCT03631199|592907172|FG001|Overall Study|Progressive disease|5|||
164148841|NCT03631199|592907173|FG002|Overall Study|Progressive disease|5|||
164148842|NCT03631199|592907174|FG003|Overall Study|Progressive disease|149|||
164148843|NCT03631199|592907175|FG004|Overall Study|Progressive disease|148|||
164148844|NCT03631199|592907171|FG000|Overall Study|Physician Decision|0|||
164148845|NCT03631199|592907172|FG001|Overall Study|Physician Decision|2|||
164148846|NCT03631199|592907173|FG002|Overall Study|Physician Decision|3|||
164148847|NCT03631199|592907174|FG003|Overall Study|Physician Decision|19|||
164148848|NCT03631199|592907175|FG004|Overall Study|Physician Decision|13|||
164148849|NCT03631199|592907171|FG000|Overall Study|Adverse Event|1|||
164148850|NCT03631199|592907172|FG001|Overall Study|Adverse Event|1|||
164148851|NCT03631199|592907173|FG002|Overall Study|Adverse Event|0|||
164148852|NCT03631199|592907174|FG003|Overall Study|Adverse Event|28|||
164148853|NCT03631199|592907175|FG004|Overall Study|Adverse Event|29|||
164148854|NCT03631199|592907171|FG000|Overall Study|Death|0|||
164148855|NCT03631199|592907172|FG001|Overall Study|Death|1|||
164148856|NCT03631199|592907173|FG002|Overall Study|Death|0|||
164148857|NCT03631199|592907174|FG003|Overall Study|Death|35|||
164148858|NCT03631199|592907175|FG004|Overall Study|Death|48|||
164148859|NCT03631199|592907171|FG000|Overall Study|Subject decision|0|||
164148860|NCT03631199|592907172|FG001|Overall Study|Subject decision|1|||
164148861|NCT03631199|592907173|FG002|Overall Study|Subject decision|0|||
164148862|NCT03631199|592907174|FG003|Overall Study|Subject decision|12|||
164148863|NCT03631199|592907175|FG004|Overall Study|Subject decision|12|||
164148864|NCT03631199|592907171|FG000|Overall Study|No treated|0|||
164148865|NCT03631199|592907172|FG001|Overall Study|No treated|0|||
164148866|NCT03631199|592907173|FG002|Overall Study|No treated|0|||
164148867|NCT03631199|592907174|FG003|Overall Study|No treated|0|||
164148868|NCT03631199|592907175|FG004|Overall Study|No treated|1|||
164148869|NCT03631199|592907171|FG000|Overall Study|Treatment ongoing|0|||
164148870|NCT03631199|592907172|FG001|Overall Study|Treatment ongoing|1|||
164148871|NCT03631199|592907173|FG002|Overall Study|Treatment ongoing|1|||
164148872|NCT03631199|592907174|FG003|Overall Study|Treatment ongoing|76|||
164148873|NCT03631199|592907175|FG004|Overall Study|Treatment ongoing|71|||
164148874|NCT03631199|592907171|FG000|Overall Study|Guardian decision|0|||
164148875|NCT03631199|592907172|FG001|Overall Study|Guardian decision|0|||
164148876|NCT03631199|592907173|FG002|Overall Study|Guardian decision|0|||
164148877|NCT03631199|592907174|FG003|Overall Study|Guardian decision|1|||
164148878|NCT03631199|592907175|FG004|Overall Study|Guardian decision|1|||
164148879|NCT03999996|592907176|FG000|Prior to Booster|Adverse Event|2|||
164148880|NCT03999996|592907177|FG001|Prior to Booster|Adverse Event|0|||
164148881|NCT03999996|592907178|FG002|Prior to Booster|Adverse Event|0|||
164148882|NCT03999996|592907179|FG003|Prior to Booster|Adverse Event|0|||
164148883|NCT03999996|592907176|FG000|Prior to Booster|Lost to Follow-up|17|||
164148884|NCT03999996|592907177|FG001|Prior to Booster|Lost to Follow-up|22|||
164148885|NCT03999996|592907178|FG002|Prior to Booster|Lost to Follow-up|0|||
164148886|NCT03999996|592907179|FG003|Prior to Booster|Lost to Follow-up|0|||
164148887|NCT03999996|592907176|FG000|Prior to Booster|Withdrawal of Consent|51|||
164148888|NCT03999996|592907177|FG001|Prior to Booster|Withdrawal of Consent|8|||
164148889|NCT03999996|592907178|FG002|Prior to Booster|Withdrawal of Consent|0|||
164148890|NCT03999996|592907179|FG003|Prior to Booster|Withdrawal of Consent|0|||
164148891|NCT03999996|592907176|FG000|Prior to Booster|Death|0|||
164148892|NCT03999996|592907177|FG001|Prior to Booster|Death|1|||
164148893|NCT03999996|592907178|FG002|Prior to Booster|Death|0|||
164148894|NCT03999996|592907179|FG003|Prior to Booster|Death|0|||
164148895|NCT03999996|592907176|FG000|Prior to Booster|Reason Not Specified|27|||
164148896|NCT03999996|592907177|FG001|Prior to Booster|Reason Not Specified|4|||
164148897|NCT03999996|592907178|FG002|Prior to Booster|Reason Not Specified|0|||
164148898|NCT03999996|592907179|FG003|Prior to Booster|Reason Not Specified|0|||
164148899|NCT03999996|592907176|FG000|Booster Phase|Lost to Follow-up|0|||
164148900|NCT03999996|592907177|FG001|Booster Phase|Lost to Follow-up|0|||
164148901|NCT03999996|592907178|FG002|Booster Phase|Lost to Follow-up|3|||
164148902|NCT03999996|592907179|FG003|Booster Phase|Lost to Follow-up|3|||
164148903|NCT03999996|592907176|FG000|Booster Phase|Withdrawal of Consent|0|||
164148904|NCT03999996|592907177|FG001|Booster Phase|Withdrawal of Consent|0|||
164148905|NCT03999996|592907178|FG002|Booster Phase|Withdrawal of Consent|0|||
164148906|NCT03999996|592907179|FG003|Booster Phase|Withdrawal of Consent|1|||
164148907|NCT03999996|592907176|FG000|Booster Phase|Reason Not Specified|0|||
164148908|NCT03999996|592907177|FG001|Booster Phase|Reason Not Specified|0|||
164148909|NCT03999996|592907178|FG002|Booster Phase|Reason Not Specified|0|||
164148910|NCT03999996|592907179|FG003|Booster Phase|Reason Not Specified|1|||
164148911|NCT03690388|592907180|FG000|Overall Study|Adverse Event|8|||
164148912|NCT03690388|592907181|FG001|Overall Study|Adverse Event|1|||
164148913|NCT03690388|592907180|FG000|Overall Study|Radiographic Progression|14|||
164148914|NCT03690388|592907181|FG001|Overall Study|Radiographic Progression|29|||
164148915|NCT03690388|592907180|FG000|Overall Study|Clinical deterioration|10|||
164148916|NCT03690388|592907181|FG001|Overall Study|Clinical deterioration|6|||
164148917|NCT03690388|592907180|FG000|Overall Study|Withdrawal by Subject|2|||
164148918|NCT03690388|592907181|FG001|Overall Study|Withdrawal by Subject|0|||
164148919|NCT03690388|592907180|FG000|Overall Study|Lack of Efficacy|1|||
164148920|NCT03690388|592907181|FG001|Overall Study|Lack of Efficacy|0|||
164148921|NCT03690388|592907180|FG000|Overall Study|Lost to Follow-up|1|||
164148922|NCT03690388|592907181|FG001|Overall Study|Lost to Follow-up|0|||
164148923|NCT03765788|592907182|FG000|Overall Study|Subject decision|2|||
164148924|NCT03765788|592907183|FG001|Overall Study|Subject decision|3|||
164148925|NCT03765788|592907182|FG000|Overall Study|Physician Decision|2|||
164148926|NCT03765788|592907183|FG001|Overall Study|Physician Decision|4|||
164148927|NCT03765788|592907182|FG000|Overall Study|Death|0|||
164148928|NCT03765788|592907183|FG001|Overall Study|Death|1|||
164148929|NCT03765788|592907182|FG000|Overall Study|Lost to Follow-up|1|||
164148930|NCT03765788|592907183|FG001|Overall Study|Lost to Follow-up|0|||
164148931|NCT00001521|592907184|FG000|Overall Study|Withdrawal by Subject|3|||
164148932|NCT00001521|592907185|FG001|Overall Study|Withdrawal by Subject|3|||
164148933|NCT00001521|592907184|FG000|Overall Study|Physician Decision|1|||
164148934|NCT00001521|592907185|FG001|Overall Study|Physician Decision|1|||
164148935|NCT00001521|592907184|FG000|Overall Study|Noncompliant|6|||
164148936|NCT00001521|592907185|FG001|Overall Study|Noncompliant|3|||
164148937|NCT03176134|592907186|FG000|Overall Study|Lost to Follow-up|0|||
164148938|NCT03176134|592907187|FG001|Overall Study|Lost to Follow-up|2|||
164148939|NCT03176134|592907188|FG002|Overall Study|Lost to Follow-up|0|||
164148940|NCT03176134|592907189|FG003|Overall Study|Lost to Follow-up|0|||
164148941|NCT03176134|592907190|FG004|Overall Study|Lost to Follow-up|0|||
164148942|NCT03176134|592907191|FG005|Overall Study|Lost to Follow-up|0|||
164148943|NCT03176134|592907192|FG006|Overall Study|Lost to Follow-up|0|||
164148944|NCT03176134|592907193|FG007|Overall Study|Lost to Follow-up|0|||
164148945|NCT03176134|592907186|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
164148946|NCT03176134|592907187|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164148947|NCT03176134|592907188|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
164148948|NCT03176134|592907189|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
164148949|NCT03176134|592907190|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
164148950|NCT03176134|592907191|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
164148951|NCT03176134|592907192|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
164148952|NCT03176134|592907193|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
164148953|NCT03410056|592907198|FG000|Overall Study|Decision by Sponsor|0|||
164148954|NCT03410056|592907199|FG001|Overall Study|Decision by Sponsor|0|||
164148955|NCT03410056|592907200|FG002|Overall Study|Decision by Sponsor|3|||
164148956|NCT03410056|592907201|FG003|Overall Study|Decision by Sponsor|0|||
164148957|NCT03410056|592907202|FG004|Overall Study|Decision by Sponsor|0|||
164148958|NCT03410056|592907203|FG005|Overall Study|Decision by Sponsor|0|||
164148959|NCT03410056|592907204|FG006|Overall Study|Decision by Sponsor|0|||
164148960|NCT03410056|592907198|FG000|Overall Study|Withdrawal by Subject|0|||
164148961|NCT03410056|592907199|FG001|Overall Study|Withdrawal by Subject|2|||
164148962|NCT03410056|592907200|FG002|Overall Study|Withdrawal by Subject|5|||
164148963|NCT03410056|592907201|FG003|Overall Study|Withdrawal by Subject|5|||
164148964|NCT03410056|592907202|FG004|Overall Study|Withdrawal by Subject|0|||
164148965|NCT03410056|592907203|FG005|Overall Study|Withdrawal by Subject|0|||
164148966|NCT03410056|592907204|FG006|Overall Study|Withdrawal by Subject|0|||
164148967|NCT01130532|592907208|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
164148968|NCT01130532|592907209|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
164148969|NCT01130532|592907210|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
164148970|NCT01130532|592907211|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
164148971|NCT01130532|592907208|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
164148972|NCT01130532|592907209|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
164148973|NCT01130532|592907210|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
164148974|NCT01130532|592907211|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
164148975|NCT01130532|592907208|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
164148976|NCT01130532|592907209|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
164148977|NCT01130532|592907210|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
164148978|NCT01130532|592907211|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
164148979|NCT01130532|592907208|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
164148980|NCT01130532|592907209|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
164148981|NCT01130532|592907210|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
164148982|NCT01130532|592907211|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
164148983|NCT01130532|592907208|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
164148984|NCT01130532|592907209|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
164148985|NCT01130532|592907210|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
164148986|NCT01130532|592907211|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
164148987|NCT01130532|592907208|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
164148988|NCT01130532|592907209|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
164148989|NCT01130532|592907210|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
164148990|NCT01130532|592907211|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
164148991|NCT01130532|592907208|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
164148992|NCT01130532|592907209|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
164148993|NCT01130532|592907210|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
164148994|NCT01130532|592907211|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
164148995|NCT01130532|592907208|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
164148996|NCT01130532|592907209|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
164148997|NCT01130532|592907210|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
164148998|NCT01130532|592907211|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
164148999|NCT01130532|592907208|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
164149000|NCT01130532|592907209|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
164149001|NCT01130532|592907210|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
164149002|NCT01130532|592907211|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
164149003|NCT01130532|592907208|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
164149004|NCT01130532|592907209|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
164149005|NCT01130532|592907210|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
164149006|NCT01130532|592907211|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
164149007|NCT01130532|592907208|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
164149008|NCT01130532|592907209|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
164149009|NCT01130532|592907210|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
164149010|NCT01130532|592907211|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
164149011|NCT02762929|592907212|FG000|Overall Study|Adverse Event|0|||
164149012|NCT02762929|592907213|FG001|Overall Study|Adverse Event|0|||
164149013|NCT02762929|592907214|FG002|Overall Study|Adverse Event|0|||
164149014|NCT02762929|592907215|FG003|Overall Study|Adverse Event|1|||
164149015|NCT02762929|592907216|FG004|Overall Study|Adverse Event|0|||
164149016|NCT02762929|592907217|FG005|Overall Study|Adverse Event|0|||
164149017|NCT02762929|592907212|FG000|Overall Study|Lost to Follow-up|1|||
164149018|NCT02762929|592907213|FG001|Overall Study|Lost to Follow-up|2|||
164149019|NCT02762929|592907214|FG002|Overall Study|Lost to Follow-up|0|||
164149020|NCT02762929|592907215|FG003|Overall Study|Lost to Follow-up|1|||
164149021|NCT02762929|592907216|FG004|Overall Study|Lost to Follow-up|0|||
164149022|NCT02762929|592907217|FG005|Overall Study|Lost to Follow-up|0|||
164149023|NCT02762929|592907212|FG000|Overall Study|Withdrawal by Subject|0|||
164149024|NCT02762929|592907213|FG001|Overall Study|Withdrawal by Subject|1|||
164149025|NCT02762929|592907214|FG002|Overall Study|Withdrawal by Subject|0|||
164149026|NCT02762929|592907215|FG003|Overall Study|Withdrawal by Subject|0|||
164149027|NCT02762929|592907216|FG004|Overall Study|Withdrawal by Subject|0|||
164149028|NCT02762929|592907217|FG005|Overall Study|Withdrawal by Subject|0|||
164149029|NCT02762929|592907212|FG000|Overall Study|exclusionary medication disclosed late|0|||
164149030|NCT02762929|592907213|FG001|Overall Study|exclusionary medication disclosed late|0|||
164149031|NCT02762929|592907214|FG002|Overall Study|exclusionary medication disclosed late|0|||
164149032|NCT02762929|592907215|FG003|Overall Study|exclusionary medication disclosed late|1|||
164149033|NCT02762929|592907216|FG004|Overall Study|exclusionary medication disclosed late|0|||
164149034|NCT02762929|592907217|FG005|Overall Study|exclusionary medication disclosed late|0|||
164149035|NCT02656303|592907218|FG000|Overall Study|Adverse Event|3|||
164149036|NCT02656303|592907219|FG001|Overall Study|Adverse Event|2|||
164149037|NCT02656303|592907220|FG002|Overall Study|Adverse Event|0|||
164149038|NCT02656303|592907218|FG000|Overall Study|Death|12|||
164149039|NCT02656303|592907219|FG001|Overall Study|Death|4|||
164149040|NCT02656303|592907220|FG002|Overall Study|Death|1|||
164149041|NCT02656303|592907218|FG000|Overall Study|Lack of Efficacy|1|||
164149042|NCT02656303|592907219|FG001|Overall Study|Lack of Efficacy|0|||
164149043|NCT02656303|592907220|FG002|Overall Study|Lack of Efficacy|0|||
164149044|NCT02656303|592907218|FG000|Overall Study|Non-Compliance with Study|1|||
164149045|NCT02656303|592907219|FG001|Overall Study|Non-Compliance with Study|1|||
164149046|NCT02656303|592907220|FG002|Overall Study|Non-Compliance with Study|0|||
164149047|NCT02656303|592907218|FG000|Overall Study|Investigator Decision|2|||
164149048|NCT02656303|592907219|FG001|Overall Study|Investigator Decision|1|||
164149049|NCT02656303|592907220|FG002|Overall Study|Investigator Decision|0|||
164149050|NCT02656303|592907218|FG000|Overall Study|Progressive Disease|25|||
164149051|NCT02656303|592907219|FG001|Overall Study|Progressive Disease|14|||
164149052|NCT02656303|592907220|FG002|Overall Study|Progressive Disease|10|||
164149053|NCT02656303|592907218|FG000|Overall Study|Study Terminated by Sponsor|20|||
164149054|NCT02656303|592907219|FG001|Overall Study|Study Terminated by Sponsor|7|||
164149055|NCT02656303|592907220|FG002|Overall Study|Study Terminated by Sponsor|5|||
164149056|NCT02656303|592907218|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
164149057|NCT02656303|592907219|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
164149058|NCT02656303|592907220|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
164149059|NCT02656303|592907218|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
164149060|NCT02656303|592907219|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
164149061|NCT02656303|592907220|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
164149062|NCT02656303|592907218|FG000|Overall Study|Reason not Specified|1|||
164149063|NCT02656303|592907219|FG001|Overall Study|Reason not Specified|1|||
164149064|NCT02656303|592907220|FG002|Overall Study|Reason not Specified|2|||
164149065|NCT03041311|592907223|FG000|Overall Study|Death|39|||
164149066|NCT03041311|592907224|FG001|Overall Study|Death|42|||
164149067|NCT03041311|592907223|FG000|Overall Study|Lost to Follow-up|0|||
164149068|NCT03041311|592907224|FG001|Overall Study|Lost to Follow-up|1|||
164149069|NCT03041311|592907223|FG000|Overall Study|Withdrawal by Subject|8|||
164149070|NCT03041311|592907224|FG001|Overall Study|Withdrawal by Subject|5|||
164149071|NCT03041311|592907223|FG000|Overall Study|Sponsor Terminated Study|2|||
164149072|NCT03041311|592907224|FG001|Overall Study|Sponsor Terminated Study|4|||
164149073|NCT03041311|592907223|FG000|Overall Study|Disease Progression|3|||
164149074|NCT03041311|592907224|FG001|Overall Study|Disease Progression|1|||
164149075|NCT03041311|592907223|FG000|Overall Study|Randomized in error, did not receive drug|2|||
164149076|NCT03041311|592907224|FG001|Overall Study|Randomized in error, did not receive drug|0|||
164149077|NCT01842438|592907225|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
164149078|NCT01842438|592907226|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
164149079|NCT01842438|592907225|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
164149080|NCT01842438|592907226|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
164149081|NCT01842438|592907225|FG000|T2: 6month Follow-up|Death|0|||
164149082|NCT01842438|592907226|FG001|T2: 6month Follow-up|Death|1|||
164149083|NCT04909853|592907227|FG000|Part 1|Assigned but not treated|0|||
164149084|NCT04909853|592907228|FG001|Part 1|Assigned but not treated|0|||
164149085|NCT04909853|592907229|FG002|Part 1|Assigned but not treated|1|||
164149086|NCT04909853|592907230|FG003|Part 1|Assigned but not treated|0|||
164149087|NCT04909853|592907227|FG000|Part 2|Adverse Event|0|||
164149088|NCT04909853|592907228|FG001|Part 2|Adverse Event|0|||
164149089|NCT04909853|592907229|FG002|Part 2|Adverse Event|0|||
164149090|NCT04909853|592907230|FG003|Part 2|Adverse Event|1|||
164149091|NCT02366689|592907240|FG000|Overall Study|Withdrawal by Subject|1|||
164149092|NCT02366689|592907241|FG001|Overall Study|Withdrawal by Subject|0|||
164149093|NCT02366689|592907242|FG002|Overall Study|Withdrawal by Subject|1|||
164149094|NCT02366689|592907240|FG000|Overall Study|Lost to Follow-up|3|||
164149095|NCT02366689|592907241|FG001|Overall Study|Lost to Follow-up|2|||
164149096|NCT02366689|592907242|FG002|Overall Study|Lost to Follow-up|0|||
164149097|NCT02366689|592907240|FG000|Overall Study|Pregnancy|0|||
164149098|NCT02366689|592907241|FG001|Overall Study|Pregnancy|1|||
164149099|NCT02366689|592907242|FG002|Overall Study|Pregnancy|1|||
164149100|NCT03718832|592907243|FG000|Analysis Sample|Withdrawal by Subject|18|||
164149101|NCT03718832|592907244|FG001|Analysis Sample|Withdrawal by Subject|15|||
164149102|NCT03718832|592907243|FG000|Analysis Sample|Legal hold on data|1|||
164149103|NCT03718832|592907244|FG001|Analysis Sample|Legal hold on data|0|||
164149104|NCT03718832|592907243|FG000|Analysis Sample|Participant from treated household|0|||
164149105|NCT03718832|592907244|FG001|Analysis Sample|Participant from treated household|1|||
164149106|NCT03718832|592907243|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
164149107|NCT03718832|592907244|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
164149108|NCT01996241|592907245|FG000|Overall Study|Lost to Follow-up|252|||
164149109|NCT01996241|592907246|FG001|Overall Study|Lost to Follow-up|235|||
164149110|NCT01720225|592907250|FG000|Overall Study|Withdrawal by Subject|0|||
164149111|NCT01720225|592907251|FG001|Overall Study|Withdrawal by Subject|1|||
164149112|NCT01720225|592907250|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
164149113|NCT01720225|592907251|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
164149114|NCT02604407|592907252|FG000|Overall Study|Adverse Event|0|||
164149115|NCT02604407|592907253|FG001|Overall Study|Adverse Event|7|||
164149116|NCT02604407|592907254|FG002|Overall Study|Adverse Event|5|||
164149117|NCT02604407|592907252|FG000|Overall Study|Protocol Violation|2|||
164149118|NCT02604407|592907253|FG001|Overall Study|Protocol Violation|0|||
164149119|NCT02604407|592907254|FG002|Overall Study|Protocol Violation|0|||
164149120|NCT02604407|592907252|FG000|Overall Study|Withdrawal by Subject|3|||
164149121|NCT02604407|592907253|FG001|Overall Study|Withdrawal by Subject|3|||
164149122|NCT02604407|592907254|FG002|Overall Study|Withdrawal by Subject|5|||
164149123|NCT02604407|592907252|FG000|Overall Study|Lost to Follow-up|2|||
164149124|NCT02604407|592907253|FG001|Overall Study|Lost to Follow-up|1|||
164149125|NCT02604407|592907254|FG002|Overall Study|Lost to Follow-up|2|||
164149126|NCT02604407|592907252|FG000|Overall Study|Lack of Efficacy|1|||
164149127|NCT02604407|592907253|FG001|Overall Study|Lack of Efficacy|0|||
164149128|NCT02604407|592907254|FG002|Overall Study|Lack of Efficacy|0|||
164149129|NCT02604407|592907252|FG000|Overall Study|Other|3|||
164149130|NCT02604407|592907253|FG001|Overall Study|Other|1|||
164149131|NCT02604407|592907254|FG002|Overall Study|Other|4|||
164149132|NCT00661193|592907255|FG000|Overall Study|Adverse Event|2|||
164149133|NCT00661193|592907256|FG001|Overall Study|Adverse Event|1|||
164149134|NCT00661193|592907255|FG000|Overall Study|Withdrawal by Subject|3|||
164149135|NCT00661193|592907256|FG001|Overall Study|Withdrawal by Subject|1|||
164149136|NCT00661193|592907255|FG000|Overall Study|Progression|27|||
164149137|NCT00661193|592907256|FG001|Overall Study|Progression|24|||
164149138|NCT00661193|592907255|FG000|Overall Study|Not protocol specified|1|||
164149139|NCT00661193|592907256|FG001|Overall Study|Not protocol specified|0|||
164149140|NCT02964312|592907263|FG000|Overall Study|Lost to Follow-up|28|||
164149141|NCT02964312|592907263|FG000|Overall Study|Withdrawal by Subject|11|||
164149142|NCT02964312|592907263|FG000|Overall Study|Lack of Efficacy|10|||
164149143|NCT02964312|592907263|FG000|Overall Study|Did not consent to long-term FU|14|||
164149144|NCT02964312|592907263|FG000|Overall Study|Death|1|||
164149145|NCT00191191|592907266|FG000|Overall Study|Entry Criteria Exclusion|2|||
164149146|NCT00191191|592907267|FG001|Overall Study|Entry Criteria Exclusion|0|||
164149147|NCT00191191|592907266|FG000|Overall Study|Treated with Another Systemic Agent|1|||
164149148|NCT00191191|592907267|FG001|Overall Study|Treated with Another Systemic Agent|1|||
164149149|NCT00191191|592907266|FG000|Overall Study|Adverse Event|11|||
164149150|NCT00191191|592907267|FG001|Overall Study|Adverse Event|21|||
164149151|NCT00191191|592907266|FG000|Overall Study|Progressive Disease|84|||
164149152|NCT00191191|592907267|FG001|Overall Study|Progressive Disease|72|||
164149153|NCT00191191|592907266|FG000|Overall Study|Toxicity After Dose Reduction|7|||
164149154|NCT00191191|592907267|FG001|Overall Study|Toxicity After Dose Reduction|8|||
164149155|NCT00191191|592907266|FG000|Overall Study|Family/Caregiver Decision|5|||
164149156|NCT00191191|592907267|FG001|Overall Study|Family/Caregiver Decision|7|||
164149157|NCT00191191|592907266|FG000|Overall Study|Lost to Follow-up|1|||
164149158|NCT00191191|592907267|FG001|Overall Study|Lost to Follow-up|0|||
164149159|NCT00191191|592907266|FG000|Overall Study|Physician Decision|3|||
164149160|NCT00191191|592907267|FG001|Overall Study|Physician Decision|2|||
164149161|NCT00191191|592907266|FG000|Overall Study|Good Clinical Practice Violation|0|||
164149162|NCT00191191|592907267|FG001|Overall Study|Good Clinical Practice Violation|1|||
164149163|NCT03280264|592907275|FG000|Overall Study|Adverse Event|1|||
164149164|NCT03280264|592907275|FG000|Overall Study|Physician Decision|1|||
164149165|NCT03280264|592907275|FG000|Overall Study|Withdrawal by Subject|1|||
164149166|NCT04882241|592907276|FG000|Overall Study|Ongoing in study|46|||
164149167|NCT04882241|592907277|FG001|Overall Study|Ongoing in study|48|||
164149168|NCT04882241|592907278|FG002|Overall Study|Ongoing in study|0|||
164149169|NCT04882241|592907279|FG003|Overall Study|Ongoing in study|0|||
164149170|NCT04882241|592907276|FG000|Overall Study|Death|13|||
164149171|NCT04882241|592907277|FG001|Overall Study|Death|13|||
164149172|NCT04882241|592907278|FG002|Overall Study|Death|0|||
164149173|NCT04882241|592907279|FG003|Overall Study|Death|0|||
164149174|NCT00524420|592907286|FG000|Overall Study|Lack of Efficacy|1|||
164149175|NCT00524420|592907287|FG001|Overall Study|Lack of Efficacy|0|||
164149176|NCT00577863|592907288|FG000|Overall Study|Adverse Event|4|||
164149177|NCT00577863|592907289|FG001|Overall Study|Adverse Event|2|||
164149178|NCT00577863|592907288|FG000|Overall Study|Death|1|||
164149179|NCT00577863|592907289|FG001|Overall Study|Death|0|||
164149180|NCT00577863|592907288|FG000|Overall Study|Lost to Follow-up|2|||
164149181|NCT00577863|592907289|FG001|Overall Study|Lost to Follow-up|2|||
164149182|NCT00577863|592907288|FG000|Overall Study|Entry Criteria Exclusion|1|||
164149183|NCT00577863|592907289|FG001|Overall Study|Entry Criteria Exclusion|0|||
164149184|NCT00577863|592907288|FG000|Overall Study|Withdrawal by Subject|0|||
164149185|NCT00577863|592907289|FG001|Overall Study|Withdrawal by Subject|2|||
164149186|NCT00577863|592907288|FG000|Overall Study|Sponsor Decision|2|||
164149187|NCT00577863|592907289|FG001|Overall Study|Sponsor Decision|7|||
164149188|NCT00577863|592907288|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
164149189|NCT00577863|592907289|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
164149190|NCT02738138|592907293|FG000|Overall Study|Adverse Event|0|||
164149191|NCT02738138|592907294|FG001|Overall Study|Adverse Event|1|||
164149192|NCT02738138|592907293|FG000|Overall Study|Lost to Follow-up|2|||
164149193|NCT02738138|592907294|FG001|Overall Study|Lost to Follow-up|0|||
164149194|NCT02738138|592907293|FG000|Overall Study|Other - not further specified|1|||
164149195|NCT02738138|592907294|FG001|Overall Study|Other - not further specified|0|||
164149196|NCT03639779|592907303|FG000|Overall Study|Lost to Follow-up|1|||
164149197|NCT02413229|592907306|FG000|Overall Study|Adverse Event|0|||
164149198|NCT02413229|592907307|FG001|Overall Study|Adverse Event|0|||
164149199|NCT02413229|592907308|FG002|Overall Study|Adverse Event|0|||
164149200|NCT02413229|592907309|FG003|Overall Study|Adverse Event|1|||
164149201|NCT02413229|592907310|FG004|Overall Study|Adverse Event|0|||
164149202|NCT02413229|592907311|FG005|Overall Study|Adverse Event|0|||
164149203|NCT02413229|592907312|FG006|Overall Study|Adverse Event|0|||
164149204|NCT02413229|592907313|FG007|Overall Study|Adverse Event|1|||
164149205|NCT02413229|592907306|FG000|Overall Study|Lost to Follow-up|0|||
164149206|NCT02413229|592907307|FG001|Overall Study|Lost to Follow-up|0|||
164149207|NCT02413229|592907308|FG002|Overall Study|Lost to Follow-up|1|||
164149208|NCT02413229|592907309|FG003|Overall Study|Lost to Follow-up|0|||
164149209|NCT02413229|592907310|FG004|Overall Study|Lost to Follow-up|2|||
164149210|NCT02413229|592907311|FG005|Overall Study|Lost to Follow-up|0|||
164149211|NCT02413229|592907312|FG006|Overall Study|Lost to Follow-up|0|||
164149212|NCT02413229|592907313|FG007|Overall Study|Lost to Follow-up|0|||
164149213|NCT02413229|592907306|FG000|Overall Study|Withdrawal by Subject|1|||
164149214|NCT02413229|592907307|FG001|Overall Study|Withdrawal by Subject|1|||
164149215|NCT02413229|592907308|FG002|Overall Study|Withdrawal by Subject|0|||
164149216|NCT02413229|592907309|FG003|Overall Study|Withdrawal by Subject|0|||
164149217|NCT02413229|592907310|FG004|Overall Study|Withdrawal by Subject|1|||
164149218|NCT02413229|592907311|FG005|Overall Study|Withdrawal by Subject|0|||
164149219|NCT02413229|592907312|FG006|Overall Study|Withdrawal by Subject|0|||
164149220|NCT02413229|592907313|FG007|Overall Study|Withdrawal by Subject|2|||
164149221|NCT02413229|592907306|FG000|Overall Study|Progressive Disease|0|||
164149222|NCT02413229|592907307|FG001|Overall Study|Progressive Disease|0|||
164149223|NCT02413229|592907308|FG002|Overall Study|Progressive Disease|0|||
164149224|NCT02413229|592907309|FG003|Overall Study|Progressive Disease|0|||
164149225|NCT02413229|592907310|FG004|Overall Study|Progressive Disease|0|||
164149226|NCT02413229|592907311|FG005|Overall Study|Progressive Disease|0|||
164149227|NCT02413229|592907312|FG006|Overall Study|Progressive Disease|0|||
164149228|NCT02413229|592907313|FG007|Overall Study|Progressive Disease|1|||
164149229|NCT02932462|592907314|FG000|Overall Study|Adverse Event|1|||
164149230|NCT02932462|592907315|FG001|Overall Study|Adverse Event|2|||
164149231|NCT02932462|592907314|FG000|Overall Study|Lost to Follow-up|4|||
164149232|NCT02932462|592907315|FG001|Overall Study|Lost to Follow-up|1|||
164149233|NCT02932462|592907314|FG000|Overall Study|Protocol Violation|0|||
164149234|NCT02932462|592907315|FG001|Overall Study|Protocol Violation|5|||
164149235|NCT02932462|592907314|FG000|Overall Study|Withdrawal by Subject|1|||
164149236|NCT02932462|592907315|FG001|Overall Study|Withdrawal by Subject|4|||
164149237|NCT02932462|592907314|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164149238|NCT02932462|592907315|FG001|Overall Study|Non-Compliance With Study Drug|1|||
164149239|NCT02932462|592907314|FG000|Overall Study|Progressive Disease|1|||
164149240|NCT02932462|592907315|FG001|Overall Study|Progressive Disease|0|||
164149241|NCT05024747|592907319|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
164149242|NCT05024747|592907320|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
164149243|NCT05024747|592907319|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
164149244|NCT05024747|592907320|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
164149245|NCT05024747|592907319|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
164149246|NCT05024747|592907320|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
164149247|NCT00662649|592907321|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
164149248|NCT00662649|592907322|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
164149249|NCT00662649|592907323|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
164149250|NCT00662649|592907324|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
164149251|NCT00662649|592907325|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
164149252|NCT00662649|592907321|FG000|Core Study (24 Months)|Adverse Event|22|||
164149253|NCT00662649|592907322|FG001|Core Study (24 Months)|Adverse Event|13|||
164149254|NCT00662649|592907323|FG002|Core Study (24 Months)|Adverse Event|18|||
164149255|NCT00662649|592907324|FG003|Core Study (24 Months)|Adverse Event|0|||
164149256|NCT00662649|592907325|FG004|Core Study (24 Months)|Adverse Event|0|||
164149257|NCT00662649|592907321|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
164149258|NCT00662649|592907322|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
164149259|NCT00662649|592907323|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
164149260|NCT00662649|592907324|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
164149261|NCT00662649|592907325|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
164149262|NCT00662649|592907321|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
164149263|NCT00662649|592907322|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
164149264|NCT00662649|592907323|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
164149265|NCT00662649|592907324|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
164149266|NCT00662649|592907325|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
164149267|NCT00662649|592907321|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
164149268|NCT00662649|592907322|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
164149269|NCT00662649|592907323|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
164149270|NCT00662649|592907324|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
164149271|NCT00662649|592907325|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
164149272|NCT00662649|592907321|FG000|Core Study (24 Months)|Protocol Violation|5|||
164149273|NCT00662649|592907322|FG001|Core Study (24 Months)|Protocol Violation|5|||
164149274|NCT00662649|592907323|FG002|Core Study (24 Months)|Protocol Violation|4|||
164149275|NCT00662649|592907324|FG003|Core Study (24 Months)|Protocol Violation|0|||
164149276|NCT00662649|592907325|FG004|Core Study (24 Months)|Protocol Violation|0|||
164149277|NCT00662649|592907321|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
164149278|NCT00662649|592907322|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
164149279|NCT00662649|592907323|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
164149280|NCT00662649|592907324|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
164149281|NCT00662649|592907325|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
164149282|NCT00662649|592907321|FG000|Core Study (24 Months)|Death|1|||
164149283|NCT00662649|592907322|FG001|Core Study (24 Months)|Death|0|||
164149284|NCT00662649|592907323|FG002|Core Study (24 Months)|Death|2|||
164149285|NCT00662649|592907324|FG003|Core Study (24 Months)|Death|0|||
164149286|NCT00662649|592907325|FG004|Core Study (24 Months)|Death|0|||
164149287|NCT00662649|592907321|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
164149288|NCT00662649|592907322|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
164149289|NCT00662649|592907323|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
164149290|NCT00662649|592907324|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
164149291|NCT00662649|592907325|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
164149292|NCT00662649|592907321|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
164149293|NCT00662649|592907322|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
164149294|NCT00662649|592907323|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
164149295|NCT00662649|592907324|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
164149296|NCT00662649|592907325|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
164149297|NCT00662649|592907321|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
164149298|NCT00662649|592907322|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
164149299|NCT00662649|592907323|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
164149300|NCT00662649|592907324|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
164149301|NCT00662649|592907325|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
164149302|NCT00662649|592907321|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
164149303|NCT00662649|592907322|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
164149304|NCT00662649|592907323|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
164149305|NCT00662649|592907324|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
164149306|NCT00662649|592907325|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
164149307|NCT00662649|592907321|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
164149308|NCT00662649|592907322|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
164149309|NCT00662649|592907323|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
164149310|NCT00662649|592907324|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
164149311|NCT00662649|592907325|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
164149312|NCT00662649|592907321|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
164149313|NCT00662649|592907322|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
164149314|NCT00662649|592907323|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
164149315|NCT00662649|592907324|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
164149316|NCT00662649|592907325|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
164149317|NCT00662649|592907321|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
164149318|NCT00662649|592907322|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
164149319|NCT00662649|592907323|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
164149320|NCT00662649|592907324|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
164149321|NCT00662649|592907325|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
164149322|NCT00662649|592907321|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
164149323|NCT00662649|592907322|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
164149324|NCT00662649|592907323|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
164149325|NCT00662649|592907324|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
164149326|NCT00662649|592907325|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
164149327|NCT00662649|592907321|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
164149328|NCT00662649|592907322|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
164149329|NCT00662649|592907323|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
164149330|NCT00662649|592907324|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
164149331|NCT00662649|592907325|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
164149332|NCT04688671|592907330|FG000|Overall Study|Adverse Event|3|||
164149333|NCT04688671|592907331|FG001|Overall Study|Adverse Event|1|||
164149334|NCT04688671|592907330|FG000|Overall Study|Withdrawal by Subject|3|||
164149335|NCT04688671|592907331|FG001|Overall Study|Withdrawal by Subject|1|||
164149336|NCT04688671|592907330|FG000|Overall Study|Lack of Efficacy|1|||
164149337|NCT04688671|592907331|FG001|Overall Study|Lack of Efficacy|1|||
164149338|NCT04688671|592907330|FG000|Overall Study|Protocol Violation|1|||
164149339|NCT04688671|592907331|FG001|Overall Study|Protocol Violation|0|||
164149340|NCT04688671|592907330|FG000|Overall Study|Lost to Follow-up|0|||
164149341|NCT04688671|592907331|FG001|Overall Study|Lost to Follow-up|1|||
164149342|NCT01960257|592907332|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
164149343|NCT01960257|592907333|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
164149344|NCT01960257|592907334|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
164149345|NCT01960257|592907332|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
164149346|NCT01960257|592907333|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
164149347|NCT01960257|592907334|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
164149348|NCT01960257|592907332|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
164149349|NCT01960257|592907333|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
164149350|NCT01960257|592907334|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
164149351|NCT01942993|592907335|FG000|Overall Study|Lost to Follow-up|1|||
164149352|NCT01942993|592907335|FG000|Overall Study|Physician Decision|1|||
164149353|NCT01349192|592907339|FG000|Overall Study|Protocol Violation|0|||
164149354|NCT01349192|592907340|FG001|Overall Study|Protocol Violation|1|||
164149355|NCT01349192|592907339|FG000|Overall Study|Withdrawal by Subject|0|||
164149356|NCT01349192|592907340|FG001|Overall Study|Withdrawal by Subject|2|||
164149357|NCT01349192|592907339|FG000|Overall Study|Lost to Follow-up|1|||
164149358|NCT01349192|592907340|FG001|Overall Study|Lost to Follow-up|3|||
164149359|NCT01349192|592907339|FG000|Overall Study|Failure to adhere to Protocol|2|||
164149360|NCT01349192|592907340|FG001|Overall Study|Failure to adhere to Protocol|0|||
164149361|NCT03749330|592907341|FG000|Overall Study|Clinicians left work in the CICU|0|||
164149362|NCT03749330|592907342|FG001|Overall Study|Clinicians left work in the CICU|2|||
164149363|NCT03749330|592907343|FG002|Overall Study|Clinicians left work in the CICU|0|||
164149364|NCT03749330|592907344|FG003|Overall Study|Clinicians left work in the CICU|0|||
164149365|NCT03749330|592907345|FG004|Overall Study|Clinicians left work in the CICU|0|||
164149366|NCT03749330|592907346|FG005|Overall Study|Clinicians left work in the CICU|0|||
164149367|NCT02038010|592907350|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
164149368|NCT02038010|592907351|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
164149369|NCT02038010|592907352|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
164149370|NCT02038010|592907353|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
164149371|NCT02038010|592907350|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
164149372|NCT02038010|592907351|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
164149373|NCT02038010|592907352|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
164149374|NCT02038010|592907353|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
164149375|NCT02038010|592907350|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
164149376|NCT02038010|592907351|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
164149377|NCT02038010|592907352|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
164149378|NCT02038010|592907353|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
164149379|NCT02038010|592907350|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
164149380|NCT02038010|592907351|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
164149381|NCT02038010|592907352|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
164149382|NCT02038010|592907353|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
164149383|NCT02038010|592907350|FG000|Follow Up|Death|4|||
164149384|NCT02038010|592907351|FG001|Follow Up|Death|3|||
164149385|NCT02038010|592907352|FG002|Follow Up|Death|0|||
164149386|NCT02038010|592907353|FG003|Follow Up|Death|0|||
164149387|NCT02038010|592907350|FG000|Follow Up|Other|3|||
164149388|NCT02038010|592907351|FG001|Follow Up|Other|0|||
164149389|NCT02038010|592907352|FG002|Follow Up|Other|0|||
164149390|NCT02038010|592907353|FG003|Follow Up|Other|0|||
164149391|NCT02105467|592907357|FG000|Period 1|Lost to Follow-up|1|||
164149392|NCT02105467|592907358|FG001|Period 1|Lost to Follow-up|0|||
164149393|NCT02105467|592907357|FG000|Period 1|Death|1|||
164149394|NCT02105467|592907358|FG001|Period 1|Death|0|||
164149395|NCT02105467|592907357|FG000|Period 2|Lost to Follow-up|1|||
164149396|NCT02105467|592907358|FG001|Period 2|Lost to Follow-up|0|||
164149397|NCT02105467|592907357|FG000|Period 2|Death|1|||
164149398|NCT02105467|592907358|FG001|Period 2|Death|0|||
164149399|NCT02105467|592907357|FG000|Period 2|Withdrawal by Subject|0|||
164149400|NCT02105467|592907358|FG001|Period 2|Withdrawal by Subject|2|||
164149401|NCT02105467|592907357|FG000|Period 3|Lost to Follow-up|0|||
164149402|NCT02105467|592907358|FG001|Period 3|Lost to Follow-up|1|||
164149403|NCT03908125|592907359|FG000|Overall Study|Withdrawal by Subject|92|||
164149404|NCT03908125|592907359|FG000|Overall Study|Lost to Follow-up|8|||
164149405|NCT02262325|592907360|FG000|Overall Study|Death|16|||
164149406|NCT02262325|592907360|FG000|Overall Study|Lost to Follow-up|1|||
164149407|NCT02815995|592907361|FG000|Overall Study|Disease Progression|3|||
164149408|NCT02815995|592907362|FG001|Overall Study|Disease Progression|7|||
164149409|NCT02815995|592907363|FG002|Overall Study|Disease Progression|2|||
164149410|NCT02815995|592907364|FG003|Overall Study|Disease Progression|4|||
164149411|NCT02815995|592907365|FG004|Overall Study|Disease Progression|3|||
164149412|NCT02815995|592907366|FG005|Overall Study|Disease Progression|9|||
164149413|NCT02815995|592907367|FG006|Overall Study|Disease Progression|3|||
164149414|NCT02815995|592907368|FG007|Overall Study|Disease Progression|1|||
164149415|NCT02815995|592907361|FG000|Overall Study|Adverse Event|1|||
164149416|NCT02815995|592907362|FG001|Overall Study|Adverse Event|2|||
164149417|NCT02815995|592907363|FG002|Overall Study|Adverse Event|2|||
164149418|NCT02815995|592907364|FG003|Overall Study|Adverse Event|0|||
164149419|NCT02815995|592907365|FG004|Overall Study|Adverse Event|0|||
164149420|NCT02815995|592907366|FG005|Overall Study|Adverse Event|1|||
164149421|NCT02815995|592907367|FG006|Overall Study|Adverse Event|0|||
164149422|NCT02815995|592907368|FG007|Overall Study|Adverse Event|0|||
164149423|NCT02815995|592907361|FG000|Overall Study|Pregnancy|0|||
164149424|NCT02815995|592907362|FG001|Overall Study|Pregnancy|0|||
164149425|NCT02815995|592907363|FG002|Overall Study|Pregnancy|0|||
164149426|NCT02815995|592907364|FG003|Overall Study|Pregnancy|0|||
164149427|NCT02815995|592907365|FG004|Overall Study|Pregnancy|0|||
164149428|NCT02815995|592907366|FG005|Overall Study|Pregnancy|0|||
164149429|NCT02815995|592907367|FG006|Overall Study|Pregnancy|1|||
164149430|NCT02815995|592907368|FG007|Overall Study|Pregnancy|0|||
164149431|NCT01071915|592907372|FG000|Overall Study|Adverse Event|3|||
164149432|NCT01071915|592907372|FG000|Overall Study|Physician Decision|2|||
164149433|NCT01071915|592907372|FG000|Overall Study|Withdrawal by Subject|2|||
164149434|NCT01071915|592907372|FG000|Overall Study|Miscellaneous Reasons|2|||
164149435|NCT00344448|592907374|FG000|Screening|Withdrawal by Subject|0|||
164149436|NCT00344448|592907375|FG001|Screening|Withdrawal by Subject|1|||
164149437|NCT00344448|592907374|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
164149438|NCT00344448|592907375|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
164149439|NCT00344448|592907374|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
164149440|NCT00344448|592907375|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
164149441|NCT00344448|592907374|FG000|Open Label|Withdrawal by Subject|1|||
164149442|NCT00344448|592907375|FG001|Open Label|Withdrawal by Subject|1|||
164149443|NCT00344448|592907374|FG000|Open Label|Study terminated|1|||
164149444|NCT00344448|592907375|FG001|Open Label|Study terminated|0|||
164149445|NCT03519087|592907376|FG000|Clinic Evaluation|Physician Decision|15|||
164149446|NCT03519087|592907377|FG001|Clinic Evaluation|Physician Decision|18|||
164149447|NCT03519087|592907378|FG002|Clinic Evaluation|Physician Decision|0|||
164149448|NCT03519087|592907379|FG003|Clinic Evaluation|Physician Decision|0|||
164149449|NCT03519087|592907380|FG004|Clinic Evaluation|Physician Decision|0|||
164149450|NCT03519087|592907376|FG000|Clinic Evaluation|Protocol Violation|1|||
164149451|NCT03519087|592907377|FG001|Clinic Evaluation|Protocol Violation|0|||
164149452|NCT03519087|592907378|FG002|Clinic Evaluation|Protocol Violation|0|||
164149453|NCT03519087|592907379|FG003|Clinic Evaluation|Protocol Violation|0|||
164149454|NCT03519087|592907380|FG004|Clinic Evaluation|Protocol Violation|0|||
164149455|NCT03519087|592907376|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
164149456|NCT03519087|592907377|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
164149457|NCT03519087|592907378|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
164149458|NCT03519087|592907379|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
164149459|NCT03519087|592907380|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
164149460|NCT03519087|592907376|FG000|Re-randomization for Treatment|Not appropriate|2|||
164149461|NCT03519087|592907377|FG001|Re-randomization for Treatment|Not appropriate|3|||
164149462|NCT03519087|592907378|FG002|Re-randomization for Treatment|Not appropriate|0|||
164149463|NCT03519087|592907379|FG003|Re-randomization for Treatment|Not appropriate|0|||
164149464|NCT03519087|592907380|FG004|Re-randomization for Treatment|Not appropriate|0|||
164149465|NCT03519087|592907376|FG000|Laboratory Testing|Lost to Follow-up|0|||
164149466|NCT03519087|592907377|FG001|Laboratory Testing|Lost to Follow-up|0|||
164149467|NCT03519087|592907378|FG002|Laboratory Testing|Lost to Follow-up|2|||
164149468|NCT03519087|592907379|FG003|Laboratory Testing|Lost to Follow-up|3|||
164149469|NCT03519087|592907380|FG004|Laboratory Testing|Lost to Follow-up|6|||
164149470|NCT03519087|592907376|FG000|Laboratory Testing|Protocol Violation|0|||
164149471|NCT03519087|592907377|FG001|Laboratory Testing|Protocol Violation|0|||
164149472|NCT03519087|592907378|FG002|Laboratory Testing|Protocol Violation|0|||
164149473|NCT03519087|592907379|FG003|Laboratory Testing|Protocol Violation|1|||
164149474|NCT03519087|592907380|FG004|Laboratory Testing|Protocol Violation|0|||
164149475|NCT01137071|592907381|FG000|Overall Study|Disease Progression|11|||
164149476|NCT01137071|592907381|FG000|Overall Study|Withdrawal by Subject|2|||
164149477|NCT01137071|592907381|FG000|Overall Study|Wrongly Included|1|||
164149478|NCT04807400|592907382|FG000|Overall Study|Adverse Event|2|||
164149479|NCT04807400|592907383|FG001|Overall Study|Adverse Event|3|||
164149480|NCT04807400|592907384|FG002|Overall Study|Adverse Event|3|||
164149481|NCT04807400|592907382|FG000|Overall Study|Death|2|||
164149482|NCT04807400|592907383|FG001|Overall Study|Death|0|||
164149483|NCT04807400|592907384|FG002|Overall Study|Death|0|||
164149484|NCT04807400|592907382|FG000|Overall Study|Lost to Follow-up|8|||
164149485|NCT04807400|592907383|FG001|Overall Study|Lost to Follow-up|6|||
164149486|NCT04807400|592907384|FG002|Overall Study|Lost to Follow-up|6|||
164149487|NCT04807400|592907382|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164149488|NCT04807400|592907383|FG001|Overall Study|Non-Compliance With Study Drug|4|||
164149489|NCT04807400|592907384|FG002|Overall Study|Non-Compliance With Study Drug|1|||
164149490|NCT04807400|592907382|FG000|Overall Study|Participant Decision|20|||
164149491|NCT04807400|592907383|FG001|Overall Study|Participant Decision|19|||
164149492|NCT04807400|592907384|FG002|Overall Study|Participant Decision|26|||
164149493|NCT04807400|592907382|FG000|Overall Study|Physician Decision|0|||
164149494|NCT04807400|592907383|FG001|Overall Study|Physician Decision|1|||
164149495|NCT04807400|592907384|FG002|Overall Study|Physician Decision|0|||
164149496|NCT04807400|592907382|FG000|Overall Study|Protocol Violation|4|||
164149497|NCT04807400|592907383|FG001|Overall Study|Protocol Violation|3|||
164149498|NCT04807400|592907384|FG002|Overall Study|Protocol Violation|7|||
164149499|NCT04807400|592907382|FG000|Overall Study|Withdrawal by Subject|13|||
164149500|NCT04807400|592907383|FG001|Overall Study|Withdrawal by Subject|9|||
164149501|NCT04807400|592907384|FG002|Overall Study|Withdrawal by Subject|20|||
164149502|NCT04807400|592907382|FG000|Overall Study|Mis-randomized|1|||
164149503|NCT04807400|592907383|FG001|Overall Study|Mis-randomized|0|||
164149504|NCT04807400|592907384|FG002|Overall Study|Mis-randomized|0|||
164149505|NCT04194645|592907387|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149506|NCT04194645|592907388|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149507|NCT04194645|592907389|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149508|NCT04194645|592907390|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149509|NCT04194645|592907391|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149510|NCT04194645|592907392|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149511|NCT04194645|592907393|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149512|NCT04194645|592907394|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149513|NCT04194645|592907395|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149514|NCT04194645|592907396|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
164149515|NCT04194645|592907397|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149516|NCT04194645|592907398|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149517|NCT04194645|592907399|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149518|NCT04194645|592907400|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149519|NCT04194645|592907401|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149520|NCT03076775|592907402|FG000|Overall Study|Lost to Follow-up|1|||
164149521|NCT03076775|592907403|FG001|Overall Study|Lost to Follow-up|0|||
164149522|NCT01783886|592907404|FG000|Overall Study|Lost to Follow-up|0|||
164149523|NCT01783886|592907405|FG001|Overall Study|Lost to Follow-up|3|||
164149524|NCT01783886|592907406|FG002|Overall Study|Lost to Follow-up|0|||
164149525|NCT01783886|592907404|FG000|Overall Study|Protocol deviation|0|||
164149526|NCT01783886|592907405|FG001|Overall Study|Protocol deviation|0|||
164149527|NCT01783886|592907406|FG002|Overall Study|Protocol deviation|2|||
164149528|NCT01783886|592907404|FG000|Overall Study|Withdrawal of consent by participant|1|||
164149529|NCT01783886|592907405|FG001|Overall Study|Withdrawal of consent by participant|3|||
164149530|NCT01783886|592907406|FG002|Overall Study|Withdrawal of consent by participant|4|||
164149531|NCT01783886|592907404|FG000|Overall Study|Adverse Event|4|||
164149532|NCT01783886|592907405|FG001|Overall Study|Adverse Event|5|||
164149533|NCT01783886|592907406|FG002|Overall Study|Adverse Event|4|||
164149534|NCT00940316|592907407|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
164149535|NCT00940316|592907408|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
164149536|NCT00940316|592907409|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
164149537|NCT00940316|592907407|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
164149538|NCT00940316|592907408|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
164149539|NCT00940316|592907409|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
164149540|NCT00940316|592907407|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
164149541|NCT00940316|592907408|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
164149542|NCT00940316|592907409|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
164149543|NCT00940316|592907407|FG000|Treated After Cycle 5|Adverse Event|0|||
164149544|NCT00940316|592907408|FG001|Treated After Cycle 5|Adverse Event|0|||
164149545|NCT00940316|592907409|FG002|Treated After Cycle 5|Adverse Event|1|||
164149546|NCT00940316|592907407|FG000|Treated After Cycle 5|Progressive disease|0|||
164149547|NCT00940316|592907408|FG001|Treated After Cycle 5|Progressive disease|1|||
164149548|NCT00940316|592907409|FG002|Treated After Cycle 5|Progressive disease|0|||
164149549|NCT02290405|592907410|FG000|Overall Study|Withdrawal by Subject|1|||
164149550|NCT02290405|592907411|FG001|Overall Study|Withdrawal by Subject|0|||
164149551|NCT01068262|592909448|FG000|Overall Study|Adverse Event|2|||
164149552|NCT01068262|592909449|FG001|Overall Study|Adverse Event|0|||
164149553|NCT01068262|592909450|FG002|Overall Study|Adverse Event|1|||
164149554|NCT01068262|592909451|FG003|Overall Study|Adverse Event|0|||
164149555|NCT01068262|592909448|FG000|Overall Study|Protocol Violation|1|||
164149556|NCT01068262|592909449|FG001|Overall Study|Protocol Violation|0|||
164149557|NCT01068262|592909450|FG002|Overall Study|Protocol Violation|0|||
164149558|NCT01068262|592909451|FG003|Overall Study|Protocol Violation|0|||
164149559|NCT01068262|592909448|FG000|Overall Study|Withdrawal by Subject|0|||
164149560|NCT01068262|592909449|FG001|Overall Study|Withdrawal by Subject|1|||
164149561|NCT01068262|592909450|FG002|Overall Study|Withdrawal by Subject|0|||
164149562|NCT01068262|592909451|FG003|Overall Study|Withdrawal by Subject|0|||
164149563|NCT04182490|592909452|FG000|Overall Study|Withdrawal by Subject|3|||
164149564|NCT04182490|592909453|FG001|Overall Study|Withdrawal by Subject|3|||
164149565|NCT04182490|592909452|FG000|Overall Study|Lost to Follow-up|0|||
164149566|NCT04182490|592909453|FG001|Overall Study|Lost to Follow-up|1|||
164149567|NCT04182490|592909452|FG000|Overall Study|Physician Decision|0|||
164149568|NCT04182490|592909453|FG001|Overall Study|Physician Decision|1|||
164149569|NCT01811472|592909459|FG000|Overall Study|Adverse Event|1|||
164149570|NCT01811472|592909460|FG001|Overall Study|Adverse Event|0|||
164149571|NCT01811472|592909461|FG002|Overall Study|Adverse Event|4|||
164149572|NCT01811472|592909459|FG000|Overall Study|Lost to Follow-up|0|||
164149573|NCT01811472|592909460|FG001|Overall Study|Lost to Follow-up|0|||
164149574|NCT01811472|592909461|FG002|Overall Study|Lost to Follow-up|1|||
164149575|NCT01811472|592909459|FG000|Overall Study|Subject/guardian decision|1|||
164149576|NCT01811472|592909460|FG001|Overall Study|Subject/guardian decision|0|||
164149577|NCT01811472|592909461|FG002|Overall Study|Subject/guardian decision|0|||
164149578|NCT04108299|592909470|FG000|Overall Study|Not interested in participating|2|||
164149579|NCT04108299|592909471|FG001|Overall Study|Not interested in participating|1|||
164149580|NCT04108299|592909472|FG002|Overall Study|Not interested in participating|2|||
164149581|NCT04108299|592909473|FG003|Overall Study|Not interested in participating|1|||
164149582|NCT02009722|592909480|FG000|Overall Study|Protocol Violation|1|||
164149583|NCT02009722|592909481|FG001|Overall Study|Protocol Violation|2|||
164149584|NCT02009722|592909480|FG000|Overall Study|Did not receive intervention|0|||
164149585|NCT02009722|592909481|FG001|Overall Study|Did not receive intervention|1|||
164149586|NCT02955212|592909482|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
164149587|NCT02955212|592909483|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
164149588|NCT02955212|592909482|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
164149589|NCT02955212|592909483|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
164149590|NCT02955212|592909482|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
164149591|NCT02955212|592909483|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
164149592|NCT02955212|592909482|FG000|Period 1: Double-blind Treatment Period|Other|3|||
164149593|NCT02955212|592909483|FG001|Period 1: Double-blind Treatment Period|Other|2|||
164149594|NCT02955212|592909482|FG000|Period 2: Open-label Extension|Adverse Event|11|||
164149595|NCT02955212|592909483|FG001|Period 2: Open-label Extension|Adverse Event|7|||
164149596|NCT02955212|592909482|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
164149597|NCT02955212|592909483|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
164149598|NCT02955212|592909482|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
164149599|NCT02955212|592909483|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
164149600|NCT02955212|592909482|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
164149601|NCT02955212|592909483|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
164149602|NCT02955212|592909482|FG000|Period 2: Open-label Extension|Other|2|||
164149603|NCT02955212|592909483|FG001|Period 2: Open-label Extension|Other|4|||
164149604|NCT02454933|592909492|FG000|Overall Study|Progressive disease|10|||
164149605|NCT02454933|592909493|FG001|Overall Study|Progressive disease|7|||
164149606|NCT02454933|592909492|FG000|Overall Study|Adverse Event|1|||
164149607|NCT02454933|592909493|FG001|Overall Study|Adverse Event|1|||
164149608|NCT02454933|592909492|FG000|Overall Study|Withdrawal by Subject|0|||
164149609|NCT02454933|592909493|FG001|Overall Study|Withdrawal by Subject|3|||
164149610|NCT02454933|592909492|FG000|Overall Study|Lost to Follow-up|1|||
164149611|NCT02454933|592909493|FG001|Overall Study|Lost to Follow-up|0|||
164149612|NCT02515331|592909505|FG000|Overall Study|Withdrawal by Subject|0|||
164149613|NCT02515331|592909506|FG001|Overall Study|Withdrawal by Subject|0|||
164149614|NCT02515331|592909507|FG002|Overall Study|Withdrawal by Subject|1|||
164149615|NCT02515331|592909505|FG000|Overall Study|Protocol deviation|0|||
164149616|NCT02515331|592909506|FG001|Overall Study|Protocol deviation|0|||
164149617|NCT02515331|592909507|FG002|Overall Study|Protocol deviation|3|||
164149618|NCT02515331|592909505|FG000|Overall Study|Adverse Event|2|||
164149619|NCT02515331|592909506|FG001|Overall Study|Adverse Event|0|||
164149620|NCT02515331|592909507|FG002|Overall Study|Adverse Event|0|||
164149621|NCT00124748|592909508|FG000|Overall Study|Adverse Event|8|||
164149622|NCT00124748|592909509|FG001|Overall Study|Adverse Event|39|||
164149623|NCT00124748|592909508|FG000|Overall Study|Abnormal laboratory Value|2|||
164149624|NCT00124748|592909509|FG001|Overall Study|Abnormal laboratory Value|2|||
164149625|NCT00124748|592909508|FG000|Overall Study|Abnormal Procedure|0|||
164149626|NCT00124748|592909509|FG001|Overall Study|Abnormal Procedure|1|||
164149627|NCT00124748|592909508|FG000|Overall Study|Lack of Efficacy|20|||
164149628|NCT00124748|592909509|FG001|Overall Study|Lack of Efficacy|41|||
164149629|NCT00124748|592909508|FG000|Overall Study|No longer requires study drug|1|||
164149630|NCT00124748|592909509|FG001|Overall Study|No longer requires study drug|1|||
164149631|NCT00124748|592909508|FG000|Overall Study|Protocol Violation|3|||
164149632|NCT00124748|592909509|FG001|Overall Study|Protocol Violation|1|||
164149633|NCT00124748|592909508|FG000|Overall Study|Withdrawal by Subject|5|||
164149634|NCT00124748|592909509|FG001|Overall Study|Withdrawal by Subject|15|||
164149635|NCT00124748|592909508|FG000|Overall Study|Lost to Follow-up|2|||
164149636|NCT00124748|592909509|FG001|Overall Study|Lost to Follow-up|7|||
164149637|NCT00124748|592909508|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
164149638|NCT00124748|592909509|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
164149639|NCT00124748|592909508|FG000|Overall Study|Death|1|||
164149640|NCT00124748|592909509|FG001|Overall Study|Death|3|||
164149641|NCT00322712|592909510|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
164149642|NCT02071225|592909511|FG000|Overall Study|Withdrawal of Consent|2|||
164149643|NCT02071225|592909511|FG000|Overall Study|Protocol Deviation|1|||
164149644|NCT02071225|592909511|FG000|Overall Study|Lost to Follow-up|2|||
164149645|NCT02071225|592909511|FG000|Overall Study|Death|25|||
164149646|NCT04176250|592909514|FG000|Overall Study|Adverse Event|0|||
164149647|NCT04176250|592909515|FG001|Overall Study|Adverse Event|1|||
164149648|NCT04176250|592909516|FG002|Overall Study|Adverse Event|0|||
164149649|NCT04176250|592909517|FG003|Overall Study|Adverse Event|1|||
164149650|NCT04176250|592909518|FG004|Overall Study|Adverse Event|0|||
164149651|NCT04176250|592909519|FG005|Overall Study|Adverse Event|1|||
164149652|NCT04176250|592909514|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
164149653|NCT04176250|592909515|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
164149654|NCT04176250|592909516|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
164149655|NCT04176250|592909517|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
164149656|NCT04176250|592909518|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
164149657|NCT04176250|592909519|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
164149658|NCT04176250|592909514|FG000|Overall Study|Withdrawal by Subject|0|||
164149659|NCT04176250|592909515|FG001|Overall Study|Withdrawal by Subject|0|||
164149660|NCT04176250|592909516|FG002|Overall Study|Withdrawal by Subject|0|||
164149661|NCT04176250|592909517|FG003|Overall Study|Withdrawal by Subject|0|||
164149662|NCT04176250|592909518|FG004|Overall Study|Withdrawal by Subject|0|||
164149663|NCT04176250|592909519|FG005|Overall Study|Withdrawal by Subject|1|||
164149664|NCT04176250|592909514|FG000|Overall Study|Randomized in error|0|||
164149665|NCT04176250|592909515|FG001|Overall Study|Randomized in error|0|||
164149666|NCT04176250|592909516|FG002|Overall Study|Randomized in error|0|||
164149667|NCT04176250|592909517|FG003|Overall Study|Randomized in error|0|||
164149668|NCT04176250|592909518|FG004|Overall Study|Randomized in error|1|||
164149669|NCT04176250|592909519|FG005|Overall Study|Randomized in error|0|||
164149670|NCT00758524|592909520|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
164149671|NCT00758524|592909521|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
164149672|NCT00758524|592909522|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
164149673|NCT00758524|592909523|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
164149674|NCT00758524|592909524|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
164149675|NCT00758524|592909525|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
164149676|NCT00758524|592909526|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
164149677|NCT00758524|592909527|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
164149678|NCT00758524|592909528|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
164149679|NCT00758524|592909529|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
164149680|NCT00758524|592909530|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
164149681|NCT00758524|592909531|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
164149682|NCT00758524|592909532|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
164149683|NCT00758524|592909533|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
164149684|NCT00758524|592909534|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
164149685|NCT00758524|592909535|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
164149686|NCT00758524|592909536|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
164149687|NCT00758524|592909520|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
164149688|NCT00758524|592909521|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
164149689|NCT00758524|592909522|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
164149690|NCT00758524|592909523|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
164149691|NCT00758524|592909524|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
164149692|NCT00758524|592909525|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
164149693|NCT00758524|592909526|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
164149694|NCT00758524|592909527|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
164149695|NCT00758524|592909528|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
164149696|NCT00758524|592909529|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
164149697|NCT00758524|592909530|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
164149698|NCT00758524|592909531|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
164149699|NCT00758524|592909532|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
164149700|NCT00758524|592909533|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
164149701|NCT00758524|592909534|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
164149702|NCT00758524|592909535|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
164149703|NCT00758524|592909536|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
164149704|NCT00758524|592909520|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
164149705|NCT00758524|592909521|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
164149706|NCT00758524|592909522|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
164149707|NCT00758524|592909523|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
164149708|NCT00758524|592909524|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
164149709|NCT00758524|592909525|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
164149710|NCT00758524|592909526|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
164149711|NCT00758524|592909527|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
164149712|NCT00758524|592909528|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
164149713|NCT00758524|592909529|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
164149714|NCT00758524|592909530|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
164149715|NCT00758524|592909531|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
164149716|NCT00758524|592909532|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
164149717|NCT00758524|592909533|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
164149718|NCT00758524|592909534|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
164149719|NCT00758524|592909535|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
164149720|NCT00758524|592909536|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
164149721|NCT00758524|592909520|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149722|NCT00758524|592909521|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
164149723|NCT00758524|592909522|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
164149724|NCT00758524|592909523|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149725|NCT00758524|592909524|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
164149726|NCT00758524|592909525|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
164149727|NCT00758524|592909526|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149728|NCT00758524|592909527|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149729|NCT00758524|592909528|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149730|NCT00758524|592909529|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149731|NCT00758524|592909530|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149732|NCT00758524|592909531|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149733|NCT00758524|592909532|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149734|NCT00758524|592909533|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149735|NCT00758524|592909534|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149736|NCT00758524|592909535|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149737|NCT00758524|592909536|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149738|NCT00758524|592909520|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149739|NCT00758524|592909521|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149740|NCT00758524|592909522|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
164149741|NCT00758524|592909523|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
164149742|NCT00758524|592909524|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149743|NCT00758524|592909525|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149744|NCT00758524|592909526|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149745|NCT00758524|592909527|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149746|NCT00758524|592909528|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149747|NCT00758524|592909529|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149748|NCT00758524|592909530|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149749|NCT00758524|592909531|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149750|NCT00758524|592909532|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149751|NCT00758524|592909533|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149752|NCT00758524|592909534|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149753|NCT00758524|592909535|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149754|NCT00758524|592909536|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149755|NCT00758524|592909520|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149756|NCT00758524|592909521|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149757|NCT00758524|592909522|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149758|NCT00758524|592909523|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149759|NCT00758524|592909524|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
164149760|NCT00758524|592909525|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149761|NCT00758524|592909526|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149762|NCT00758524|592909527|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149763|NCT00758524|592909528|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149764|NCT00758524|592909529|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149765|NCT00758524|592909530|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149766|NCT00758524|592909531|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149767|NCT00758524|592909532|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149768|NCT00758524|592909533|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149769|NCT00758524|592909534|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149770|NCT00758524|592909535|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149771|NCT00758524|592909536|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149772|NCT00758524|592909520|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149773|NCT00758524|592909521|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
164149774|NCT00758524|592909522|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149775|NCT00758524|592909523|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149776|NCT00758524|592909524|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149777|NCT00758524|592909525|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149778|NCT00758524|592909526|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149779|NCT00758524|592909527|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149843|NCT01342081|592909539|FG000|Overall Study|Adverse Event|1|||
164149780|NCT00758524|592909528|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149781|NCT00758524|592909529|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149782|NCT00758524|592909530|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149783|NCT00758524|592909531|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149784|NCT00758524|592909532|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149785|NCT00758524|592909533|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149786|NCT00758524|592909534|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149787|NCT00758524|592909535|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149788|NCT00758524|592909536|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149789|NCT00758524|592909520|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149790|NCT00758524|592909521|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
164149791|NCT00758524|592909522|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149792|NCT00758524|592909523|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149793|NCT00758524|592909524|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149794|NCT00758524|592909525|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149795|NCT00758524|592909526|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149796|NCT00758524|592909527|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149797|NCT00758524|592909528|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149798|NCT00758524|592909529|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149799|NCT00758524|592909530|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149800|NCT00758524|592909531|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149801|NCT00758524|592909532|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149802|NCT00758524|592909533|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149803|NCT00758524|592909534|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149804|NCT00758524|592909535|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149805|NCT00758524|592909536|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149806|NCT00758524|592909520|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149807|NCT00758524|592909521|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149808|NCT00758524|592909522|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149809|NCT00758524|592909523|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149810|NCT00758524|592909524|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149811|NCT00758524|592909525|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149812|NCT00758524|592909526|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149813|NCT00758524|592909527|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149814|NCT00758524|592909528|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
164149815|NCT00758524|592909529|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149816|NCT00758524|592909530|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149817|NCT00758524|592909531|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149818|NCT00758524|592909532|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149819|NCT00758524|592909533|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149820|NCT00758524|592909534|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149821|NCT00758524|592909535|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149822|NCT00758524|592909536|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149823|NCT00758524|592909520|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149824|NCT00758524|592909521|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149825|NCT00758524|592909522|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149826|NCT00758524|592909523|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149827|NCT00758524|592909524|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149828|NCT00758524|592909525|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149829|NCT00758524|592909526|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
164149830|NCT00758524|592909527|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149831|NCT00758524|592909528|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149832|NCT00758524|592909529|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149833|NCT00758524|592909530|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149834|NCT00758524|592909531|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149835|NCT00758524|592909532|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149836|NCT00758524|592909533|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149837|NCT00758524|592909534|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149838|NCT00758524|592909535|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149839|NCT00758524|592909536|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149840|NCT01342081|592909539|FG000|Overall Study|Did not receive allocated intervention|0|||
164149841|NCT01342081|592909540|FG001|Overall Study|Did not receive allocated intervention|0|||
164149842|NCT01342081|592909541|FG002|Overall Study|Did not receive allocated intervention|1|||
164149844|NCT01342081|592909540|FG001|Overall Study|Adverse Event|0|||
164149845|NCT01342081|592909541|FG002|Overall Study|Adverse Event|0|||
164149846|NCT01342081|592909539|FG000|Overall Study|Physician Decision|0|||
164149847|NCT01342081|592909540|FG001|Overall Study|Physician Decision|1|||
164149848|NCT01342081|592909541|FG002|Overall Study|Physician Decision|0|||
164149849|NCT01342081|592909539|FG000|Overall Study|Withdrawal by Subject|1|||
164149850|NCT01342081|592909540|FG001|Overall Study|Withdrawal by Subject|1|||
164149851|NCT01342081|592909541|FG002|Overall Study|Withdrawal by Subject|0|||
164149852|NCT04720053|592909543|FG000|Overall Study|Lost to Follow-up|12|||
164149853|NCT01350271|592909544|FG000|Overall Study|Lost to Follow-up|21|||
164149854|NCT01350271|592909545|FG001|Overall Study|Lost to Follow-up|17|||
164149855|NCT01350271|592909546|FG002|Overall Study|Lost to Follow-up|26|||
164149856|NCT01973439|592909547|FG000|Overall Study|Lost samples from one PK Day|2|||
164149857|NCT01973439|592909547|FG000|Overall Study|Vomiting after commencing once daily|1|||
164149858|NCT01973439|592909547|FG000|Overall Study|PK curve incomplete|2|||
164149859|NCT02500589|592909552|FG000|Overall Study|Withdrawal by Subject|11|||
164149860|NCT02500589|592909553|FG001|Overall Study|Withdrawal by Subject|14|||
164149861|NCT02500589|592909552|FG000|Overall Study|Lost to Follow-up|10|||
164149862|NCT02500589|592909553|FG001|Overall Study|Lost to Follow-up|12|||
164149863|NCT02500589|592909552|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
164149864|NCT02500589|592909553|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
164149865|NCT02500589|592909552|FG000|Overall Study|Death|7|||
164149866|NCT02500589|592909553|FG001|Overall Study|Death|5|||
164149867|NCT03656744|592909558|FG000|Overall Study|Adverse Event|1|||
164149868|NCT03656744|592909559|FG001|Overall Study|Adverse Event|4|||
164149869|NCT03656744|592909560|FG002|Overall Study|Adverse Event|1|||
164149870|NCT03656744|592909558|FG000|Overall Study|Protocol Violation|1|||
164149871|NCT03656744|592909559|FG001|Overall Study|Protocol Violation|0|||
164149872|NCT03656744|592909560|FG002|Overall Study|Protocol Violation|0|||
164149873|NCT03656744|592909558|FG000|Overall Study|Lost to Follow-up|2|||
164149874|NCT03656744|592909559|FG001|Overall Study|Lost to Follow-up|2|||
164149875|NCT03656744|592909560|FG002|Overall Study|Lost to Follow-up|0|||
164149876|NCT03656744|592909558|FG000|Overall Study|Withdrawal by Subject|0|||
164149877|NCT03656744|592909559|FG001|Overall Study|Withdrawal by Subject|1|||
164149878|NCT03656744|592909560|FG002|Overall Study|Withdrawal by Subject|0|||
164149879|NCT03656744|592909558|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
164149880|NCT03656744|592909559|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
164149881|NCT03656744|592909560|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
164149882|NCT00996489|592909561|FG000|Overall Study|Device failure|45|||
164149883|NCT00996489|592909561|FG000|Overall Study|Discontinued|116|||
164149884|NCT03142191|592909562|FG000|Placebo Controlled Period|Death|0|||
164149885|NCT03142191|592909563|FG001|Placebo Controlled Period|Death|1|||
164149886|NCT03142191|592909564|FG002|Placebo Controlled Period|Death|1|||
164149887|NCT03142191|592909565|FG003|Placebo Controlled Period|Death|0|||
164149888|NCT03142191|592909566|FG004|Placebo Controlled Period|Death|0|||
164149889|NCT03142191|592909562|FG000|Placebo Controlled Period|Adverse Event|4|||
164149890|NCT03142191|592909563|FG001|Placebo Controlled Period|Adverse Event|5|||
164149891|NCT03142191|592909564|FG002|Placebo Controlled Period|Adverse Event|1|||
164149892|NCT03142191|592909565|FG003|Placebo Controlled Period|Adverse Event|0|||
164149893|NCT03142191|592909566|FG004|Placebo Controlled Period|Adverse Event|0|||
164149894|NCT03142191|592909562|FG000|Placebo Controlled Period|Progressive Disease|1|||
164149895|NCT03142191|592909563|FG001|Placebo Controlled Period|Progressive Disease|0|||
164149896|NCT03142191|592909564|FG002|Placebo Controlled Period|Progressive Disease|1|||
164149897|NCT03142191|592909565|FG003|Placebo Controlled Period|Progressive Disease|0|||
164149898|NCT03142191|592909566|FG004|Placebo Controlled Period|Progressive Disease|0|||
164149899|NCT03142191|592909562|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
164149900|NCT03142191|592909563|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
164149901|NCT03142191|592909564|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
164149902|NCT03142191|592909565|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
164149903|NCT03142191|592909566|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
164149904|NCT03142191|592909562|FG000|Placebo Controlled Period|Other Reasons|1|||
164149905|NCT03142191|592909563|FG001|Placebo Controlled Period|Other Reasons|0|||
164149906|NCT03142191|592909564|FG002|Placebo Controlled Period|Other Reasons|0|||
164149907|NCT03142191|592909565|FG003|Placebo Controlled Period|Other Reasons|0|||
164149908|NCT03142191|592909566|FG004|Placebo Controlled Period|Other Reasons|0|||
164149909|NCT03142191|592909562|FG000|Active Treatment Extension Period|Death|2|||
164149910|NCT03142191|592909563|FG001|Active Treatment Extension Period|Death|1|||
164149911|NCT03142191|592909564|FG002|Active Treatment Extension Period|Death|1|||
164149912|NCT03142191|592909565|FG003|Active Treatment Extension Period|Death|1|||
164149913|NCT03142191|592909566|FG004|Active Treatment Extension Period|Death|0|||
164149914|NCT03142191|592909562|FG000|Active Treatment Extension Period|Adverse Event|6|||
164149915|NCT03142191|592909563|FG001|Active Treatment Extension Period|Adverse Event|5|||
164149916|NCT03142191|592909564|FG002|Active Treatment Extension Period|Adverse Event|4|||
164149917|NCT03142191|592909565|FG003|Active Treatment Extension Period|Adverse Event|1|||
164149918|NCT03142191|592909566|FG004|Active Treatment Extension Period|Adverse Event|0|||
164149919|NCT03142191|592909562|FG000|Active Treatment Extension Period|Progressive Disease|10|||
164149920|NCT03142191|592909563|FG001|Active Treatment Extension Period|Progressive Disease|5|||
164149921|NCT03142191|592909564|FG002|Active Treatment Extension Period|Progressive Disease|4|||
164149922|NCT03142191|592909565|FG003|Active Treatment Extension Period|Progressive Disease|1|||
164149923|NCT03142191|592909566|FG004|Active Treatment Extension Period|Progressive Disease|2|||
164149924|NCT03142191|592909562|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
164149925|NCT03142191|592909563|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
164149926|NCT03142191|592909564|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
164149927|NCT03142191|592909565|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
164149928|NCT03142191|592909566|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
164149929|NCT03142191|592909562|FG000|Active Treatment Extension Period|Physician Decision|2|||
164149930|NCT03142191|592909563|FG001|Active Treatment Extension Period|Physician Decision|0|||
164149931|NCT03142191|592909564|FG002|Active Treatment Extension Period|Physician Decision|0|||
164149932|NCT03142191|592909565|FG003|Active Treatment Extension Period|Physician Decision|0|||
164149933|NCT03142191|592909566|FG004|Active Treatment Extension Period|Physician Decision|0|||
164149934|NCT03142191|592909562|FG000|Active Treatment Extension Period|Other Reasons|3|||
164149935|NCT03142191|592909563|FG001|Active Treatment Extension Period|Other Reasons|3|||
164149936|NCT03142191|592909564|FG002|Active Treatment Extension Period|Other Reasons|3|||
164149937|NCT03142191|592909565|FG003|Active Treatment Extension Period|Other Reasons|8|||
164149938|NCT03142191|592909566|FG004|Active Treatment Extension Period|Other Reasons|3|||
164149939|NCT03142191|592909562|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
164149940|NCT03142191|592909563|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
164149941|NCT03142191|592909564|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
164149942|NCT03142191|592909565|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
164149943|NCT03142191|592909566|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
164149944|NCT01130493|592909571|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
164149945|NCT01130493|592909572|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
164149946|NCT01130493|592909573|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
164149947|NCT01130493|592909571|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
164149948|NCT01130493|592909572|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
164149949|NCT01130493|592909573|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
164149950|NCT01130493|592909571|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
164149951|NCT01130493|592909572|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
164149952|NCT01130493|592909573|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
164149953|NCT01130493|592909571|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
164149954|NCT01130493|592909572|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
164149955|NCT01130493|592909573|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
164149956|NCT01130493|592909571|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
164149957|NCT01130493|592909572|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
164149958|NCT01130493|592909573|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
164149959|NCT01130493|592909571|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
164149960|NCT01130493|592909572|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
164149961|NCT01130493|592909573|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
164149962|NCT01130493|592909571|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
164149963|NCT01130493|592909572|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
164149964|NCT01130493|592909573|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
164149965|NCT01130493|592909571|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
164149966|NCT01130493|592909572|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
164149967|NCT01130493|592909573|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
164149968|NCT01130493|592909571|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
164149969|NCT01130493|592909572|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
164149970|NCT01130493|592909573|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
164149971|NCT01130493|592909571|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
164149972|NCT01130493|592909572|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
164149973|NCT01130493|592909573|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
164149974|NCT01130493|592909571|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
164149975|NCT01130493|592909572|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
164149976|NCT01130493|592909573|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
164149977|NCT01130493|592909571|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
164149978|NCT01130493|592909572|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
164149979|NCT01130493|592909573|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
164149980|NCT01130493|592909571|FG000|Part 2: OLE|Adverse Event|0|||
164149981|NCT01130493|592909572|FG001|Part 2: OLE|Adverse Event|2|||
164149982|NCT01130493|592909573|FG002|Part 2: OLE|Adverse Event|1|||
164149983|NCT01130493|592909571|FG000|Part 2: OLE|Withdrawal by Subject|0|||
164149984|NCT01130493|592909572|FG001|Part 2: OLE|Withdrawal by Subject|1|||
164149985|NCT01130493|592909573|FG002|Part 2: OLE|Withdrawal by Subject|4|||
164149986|NCT03541317|592909574|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
164149987|NCT03541317|592909575|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
164149988|NCT03541317|592909576|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
164149989|NCT03541317|592909577|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
164149990|NCT03541317|592909578|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
164149991|NCT03541317|592909579|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
164149992|NCT00879086|592909582|FG000|Overall Study|Adverse Event|3|||
164149993|NCT00879086|592909583|FG001|Overall Study|Adverse Event|15|||
164149994|NCT00879086|592909582|FG000|Overall Study|Participant choice|2|||
164149995|NCT00879086|592909583|FG001|Overall Study|Participant choice|2|||
164149996|NCT00879086|592909582|FG000|Overall Study|Progression of disease|40|||
164149997|NCT00879086|592909583|FG001|Overall Study|Progression of disease|26|||
164149998|NCT00879086|592909582|FG000|Overall Study|Withdrawal of consent|2|||
164149999|NCT00879086|592909583|FG001|Overall Study|Withdrawal of consent|1|||
164150000|NCT00879086|592909582|FG000|Overall Study|Other|4|||
164150001|NCT00879086|592909583|FG001|Overall Study|Other|6|||
164150002|NCT00879086|592909582|FG000|Overall Study|Death|1|||
164150003|NCT00879086|592909583|FG001|Overall Study|Death|2|||
164150004|NCT04728802|592909584|FG000|Overall Study|Withdrawal by Subject|4|||
164150005|NCT04728802|592909585|FG001|Overall Study|Withdrawal by Subject|20|||
164150006|NCT04728802|592909584|FG000|Overall Study|Physician Decision|7|||
164150007|NCT04728802|592909585|FG001|Overall Study|Physician Decision|7|||
164150008|NCT04728802|592909584|FG000|Overall Study|Protocol Violation|10|||
164150009|NCT04728802|592909585|FG001|Overall Study|Protocol Violation|4|||
164150010|NCT04728802|592909584|FG000|Overall Study|Transfer|1|||
164150011|NCT04728802|592909585|FG001|Overall Study|Transfer|0|||
164150012|NCT04728802|592909584|FG000|Overall Study|Death|4|||
164150013|NCT04728802|592909585|FG001|Overall Study|Death|5|||
164150014|NCT04728802|592909584|FG000|Overall Study|Other|3|||
164150015|NCT04728802|592909585|FG001|Overall Study|Other|0|||
164150016|NCT02517463|592909590|FG000|Overall Study|Lost to Follow-up|5|||
164150017|NCT02517463|592909591|FG001|Overall Study|Lost to Follow-up|2|||
164150018|NCT02296931|592909594|FG000|Overall Study|Protocol Violation|0|||
164150019|NCT02296931|592909595|FG001|Overall Study|Protocol Violation|2|||
164150020|NCT01590277|592909596|FG000|Overall Study|Withdrawal by Subject|3|||
164150021|NCT01590277|592909596|FG000|Overall Study|Withdrawal by Subject|2|||
164150022|NCT01590277|592909596|FG000|Overall Study|Withdrawal by Subject|1|||
164150023|NCT01590277|592909596|FG000|Overall Study|Withdrawal by Subject|1|||
164150024|NCT04386616|592909597|FG000|Overall Study|Death|22|||
164150025|NCT04386616|592909598|FG001|Overall Study|Death|22|||
164150026|NCT04386616|592909599|FG002|Overall Study|Death|21|||
164150027|NCT04386616|592909597|FG000|Overall Study|Lost to Follow-up|5|||
164150028|NCT04386616|592909598|FG001|Overall Study|Lost to Follow-up|8|||
164150029|NCT04386616|592909599|FG002|Overall Study|Lost to Follow-up|6|||
164150030|NCT04386616|592909597|FG000|Overall Study|Withdrawal by Subject|2|||
164150031|NCT04386616|592909598|FG001|Overall Study|Withdrawal by Subject|4|||
164150032|NCT04386616|592909599|FG002|Overall Study|Withdrawal by Subject|1|||
164150033|NCT04386616|592909597|FG000|Overall Study|Adverse Event|1|||
164150034|NCT04386616|592909598|FG001|Overall Study|Adverse Event|1|||
164150035|NCT04386616|592909599|FG002|Overall Study|Adverse Event|0|||
164150036|NCT01377012|592909600|FG000|Core Study|Study terminated by Sponsor|47|||
164150037|NCT01377012|592909601|FG001|Core Study|Study terminated by Sponsor|54|||
164150038|NCT01377012|592909602|FG002|Core Study|Study terminated by Sponsor|46|||
164150039|NCT01377012|592909600|FG000|Core Study|Technical problems|1|||
164150040|NCT01377012|592909601|FG001|Core Study|Technical problems|0|||
164150041|NCT01377012|592909602|FG002|Core Study|Technical problems|0|||
164150042|NCT01377012|592909600|FG000|Core Study|Withdrawal by Subject|15|||
164150043|NCT01377012|592909601|FG001|Core Study|Withdrawal by Subject|23|||
164150044|NCT01377012|592909602|FG002|Core Study|Withdrawal by Subject|18|||
164150045|NCT01377012|592909600|FG000|Core Study|Protocol Violation|7|||
164150046|NCT01377012|592909601|FG001|Core Study|Protocol Violation|3|||
164150047|NCT01377012|592909602|FG002|Core Study|Protocol Violation|2|||
164150048|NCT01377012|592909600|FG000|Core Study|Pregnancy|0|||
164150049|NCT01377012|592909601|FG001|Core Study|Pregnancy|0|||
164150050|NCT01377012|592909602|FG002|Core Study|Pregnancy|1|||
164150051|NCT01377012|592909600|FG000|Core Study|Physician Decision|5|||
164150052|NCT01377012|592909601|FG001|Core Study|Physician Decision|4|||
164150053|NCT01377012|592909602|FG002|Core Study|Physician Decision|10|||
164150054|NCT01377012|592909600|FG000|Core Study|Non-Compliant with study treatment|0|||
164150055|NCT01377012|592909601|FG001|Core Study|Non-Compliant with study treatment|0|||
164150056|NCT01377012|592909602|FG002|Core Study|Non-Compliant with study treatment|1|||
164150057|NCT01377012|592909600|FG000|Core Study|No Longer require treatment|0|||
164150058|NCT01377012|592909601|FG001|Core Study|No Longer require treatment|0|||
164150059|NCT01377012|592909602|FG002|Core Study|No Longer require treatment|1|||
164150060|NCT01377012|592909600|FG000|Core Study|Lost to Follow-up|7|||
164150061|NCT01377012|592909601|FG001|Core Study|Lost to Follow-up|5|||
164150062|NCT01377012|592909602|FG002|Core Study|Lost to Follow-up|4|||
164150063|NCT01377012|592909600|FG000|Core Study|Lack of Efficacy|41|||
164150064|NCT01377012|592909601|FG001|Core Study|Lack of Efficacy|28|||
164150065|NCT01377012|592909602|FG002|Core Study|Lack of Efficacy|37|||
164150066|NCT01377012|592909600|FG000|Core Study|Death|1|||
164150067|NCT01377012|592909601|FG001|Core Study|Death|1|||
164150068|NCT01377012|592909602|FG002|Core Study|Death|1|||
164150069|NCT01377012|592909600|FG000|Core Study|Adverse Event|10|||
164150070|NCT01377012|592909601|FG001|Core Study|Adverse Event|14|||
164150071|NCT01377012|592909602|FG002|Core Study|Adverse Event|13|||
164150072|NCT01377012|592909600|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
164150073|NCT01377012|592909601|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
164150074|NCT01377012|592909602|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
164150075|NCT01377012|592909600|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
164150076|NCT01377012|592909601|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
164150077|NCT01377012|592909602|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
164150078|NCT01377012|592909600|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
164150079|NCT01377012|592909601|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
164150080|NCT01377012|592909602|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
164150081|NCT01377012|592909600|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
164150082|NCT01377012|592909601|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
164150083|NCT01377012|592909602|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
164150084|NCT01377012|592909600|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
164150085|NCT01377012|592909601|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
164150086|NCT01377012|592909602|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
164150087|NCT01377012|592909600|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
164150088|NCT01377012|592909601|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
164150089|NCT01377012|592909602|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
164150090|NCT00805961|592909603|FG000|Modality Therapy|Withdrawal by Subject|1|||
164150091|NCT00805961|592909603|FG000|Modality Therapy|Adverse Event|1|||
164150092|NCT00805961|592909603|FG000|Modality Therapy|Disease Progression|2|||
164150093|NCT00805961|592909603|FG000|Treatment-Free Interval|Adverse Event|3|||
164150094|NCT00805961|592909603|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
164150095|NCT00805961|592909603|FG000|Treatment-Free Interval|Physician Decision|1|||
164150096|NCT00805961|592909603|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
164150097|NCT00805961|592909603|FG000|Maintenance Treatment|Lack of Efficacy|13|||
164150098|NCT00805961|592909603|FG000|Maintenance Treatment|Intercurrent Illness|7|||
164150099|NCT00805961|592909603|FG000|Maintenance Treatment|Adverse Event|6|||
164150100|NCT00805961|592909603|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
164150101|NCT00805961|592909603|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
164150102|NCT00805961|592909603|FG000|Maintenance Treatment|Withdrawn Consent|1|||
164150103|NCT05022212|592909611|FG000|Overall Study|Lost to Follow-up|0|||
164150104|NCT05022212|592909612|FG001|Overall Study|Lost to Follow-up|2|||
164150105|NCT02905032|592909613|FG000|Overall Study|Withdrawal by Subject|2|||
164150106|NCT02905032|592909614|FG001|Overall Study|Withdrawal by Subject|0|||
164150107|NCT02905032|592909615|FG002|Overall Study|Withdrawal by Subject|0|||
164150108|NCT02905032|592909613|FG000|Overall Study|Protocol Violation|6|||
164150109|NCT02905032|592909614|FG001|Overall Study|Protocol Violation|12|||
164150110|NCT02905032|592909615|FG002|Overall Study|Protocol Violation|0|||
164150111|NCT00739063|592909616|FG000|Overall Study|Screen failures|8|||
164150112|NCT04917861|592909618|FG000|Main Study (196 Days)|Adverse Event|0|||
164150113|NCT04917861|592909619|FG001|Main Study (196 Days)|Adverse Event|1|||
164150114|NCT04917861|592909620|FG002|Main Study (196 Days)|Adverse Event|0|||
164150115|NCT04917861|592909621|FG003|Main Study (196 Days)|Adverse Event|0|||
164150116|NCT04917861|592909618|FG000|Main Study (196 Days)|Death|0|||
164150117|NCT04917861|592909619|FG001|Main Study (196 Days)|Death|0|||
164150118|NCT04917861|592909620|FG002|Main Study (196 Days)|Death|0|||
164150119|NCT04917861|592909621|FG003|Main Study (196 Days)|Death|1|||
164150120|NCT04917861|592909618|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
164150121|NCT04917861|592909619|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
164150122|NCT04917861|592909620|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
164150123|NCT04917861|592909621|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
164150124|NCT04917861|592909618|FG000|Main Study (196 Days)|Physician Decision|0|||
164150125|NCT04917861|592909619|FG001|Main Study (196 Days)|Physician Decision|0|||
164150126|NCT04917861|592909620|FG002|Main Study (196 Days)|Physician Decision|0|||
164150127|NCT04917861|592909621|FG003|Main Study (196 Days)|Physician Decision|1|||
164150128|NCT04917861|592909618|FG000|Main Study (196 Days)|Pregnancy|1|||
164150129|NCT04917861|592909619|FG001|Main Study (196 Days)|Pregnancy|1|||
164150130|NCT04917861|592909620|FG002|Main Study (196 Days)|Pregnancy|0|||
164150131|NCT04917861|592909621|FG003|Main Study (196 Days)|Pregnancy|0|||
164150132|NCT04917861|592909618|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
164150133|NCT04917861|592909619|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
164150134|NCT04917861|592909620|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
164150135|NCT04917861|592909621|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
164150136|NCT04917861|592909618|FG000|Main Study (196 Days)|Other Than Specified|1|||
164150137|NCT04917861|592909619|FG001|Main Study (196 Days)|Other Than Specified|0|||
164150138|NCT04917861|592909620|FG002|Main Study (196 Days)|Other Than Specified|1|||
164150139|NCT04917861|592909621|FG003|Main Study (196 Days)|Other Than Specified|2|||
164150140|NCT04917861|592909618|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
164150141|NCT04917861|592909619|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
164150142|NCT04917861|592909620|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
164150143|NCT04917861|592909621|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
164150144|NCT04917861|592909618|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
164150145|NCT04917861|592909619|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
164150146|NCT04917861|592909620|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
164150147|NCT04917861|592909621|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
164150148|NCT04917861|592909618|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
164150149|NCT04917861|592909619|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
164150150|NCT04917861|592909620|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
164150151|NCT04917861|592909621|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
164150152|NCT04917861|592909618|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
164150153|NCT04917861|592909619|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
164150154|NCT04917861|592909620|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
164150155|NCT04917861|592909621|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
164150156|NCT04917861|592909618|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
164150157|NCT04917861|592909619|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
164150158|NCT04917861|592909620|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
164150159|NCT04917861|592909621|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
164150160|NCT04917861|592909618|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
164150161|NCT04917861|592909619|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
164150162|NCT04917861|592909620|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
164150163|NCT04917861|592909621|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
164150164|NCT01260701|592909622|FG000|Overall Study|Adverse Event|9|||
164150165|NCT01260701|592909622|FG000|Overall Study|Withdrawal by Subject|2|||
164150166|NCT01260701|592909622|FG000|Overall Study|Progression|53|||
164150167|NCT01260701|592909622|FG000|Overall Study|Death|2|||
164150168|NCT01260701|592909622|FG000|Overall Study|Not protocol specified|3|||
164150169|NCT01260701|592909622|FG000|Overall Study|Under review|1|||
164150170|NCT01260701|592909622|FG000|Overall Study|Ineligible|4|||
164150171|NCT01260701|592909622|FG000|Overall Study|Did not begin protocol therapy|1|||
164150172|NCT00720382|592909623|FG000|Overall Study|Adverse Event|54|||
164150173|NCT00720382|592909624|FG001|Overall Study|Adverse Event|17|||
164150174|NCT00720382|592909623|FG000|Overall Study|Lack of Efficacy|18|||
164150175|NCT00720382|592909624|FG001|Overall Study|Lack of Efficacy|7|||
164150176|NCT00720382|592909623|FG000|Overall Study|Non-Compliance|15|||
164150177|NCT00720382|592909624|FG001|Overall Study|Non-Compliance|5|||
164150178|NCT00720382|592909623|FG000|Overall Study|Withdrawal by Subject|47|||
164150179|NCT00720382|592909624|FG001|Overall Study|Withdrawal by Subject|11|||
164150180|NCT00720382|592909623|FG000|Overall Study|Lost to Follow-up|28|||
164150181|NCT00720382|592909624|FG001|Overall Study|Lost to Follow-up|14|||
164150182|NCT00720382|592909623|FG000|Overall Study|administrative|14|||
164150183|NCT00720382|592909624|FG001|Overall Study|administrative|5|||
164150184|NCT05192889|592909626|FG000|Block 1: All Eligible Patients|Death|2|||
164150185|NCT05192889|592909627|FG001|Block 1: All Eligible Patients|Death|0|||
164150186|NCT05192889|592909628|FG002|Block 1: All Eligible Patients|Death|0|||
164150187|NCT05192889|592909626|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
164150188|NCT05192889|592909627|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
164150189|NCT05192889|592909628|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
164150190|NCT05192889|592909626|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
164150191|NCT05192889|592909627|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
164150192|NCT05192889|592909628|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
164150193|NCT04467840|592910889|FG000|Overall Study|Death|35|||
164150194|NCT04467840|592910890|FG001|Overall Study|Death|39|||
164150195|NCT04467840|592910889|FG000|Overall Study|Withdrawal by Subject|8|||
164150196|NCT04467840|592910890|FG001|Overall Study|Withdrawal by Subject|4|||
164150197|NCT04467840|592910889|FG000|Overall Study|Adverse Event|2|||
164150198|NCT04467840|592910890|FG001|Overall Study|Adverse Event|0|||
164150199|NCT04467840|592910889|FG000|Overall Study|Lost to Follow-up|1|||
164150200|NCT04467840|592910890|FG001|Overall Study|Lost to Follow-up|3|||
164150201|NCT04467840|592910889|FG000|Overall Study|Physician Decision|1|||
164150202|NCT04467840|592910890|FG001|Overall Study|Physician Decision|0|||
164150203|NCT04467840|592910889|FG000|Overall Study|Other|1|||
164150204|NCT04467840|592910890|FG001|Overall Study|Other|5|||
164150205|NCT04467840|592910889|FG000|Overall Study|Missing study completion status|3|||
164150206|NCT04467840|592910890|FG001|Overall Study|Missing study completion status|1|||
164150207|NCT06082843|592910897|FG000|Overall Study|Withdrawal by Subject|0|||
164150208|NCT06082843|592910898|FG001|Overall Study|Withdrawal by Subject|2|||
164150209|NCT06082843|592910897|FG000|Overall Study|Study terminated by sponsor|12|||
164150210|NCT06082843|592910898|FG001|Overall Study|Study terminated by sponsor|8|||
164150211|NCT00696423|592910901|FG000|Overall Study|Lost to Follow-up|0|||
164150212|NCT00696423|592910902|FG001|Overall Study|Lost to Follow-up|5|||
164150213|NCT03989102|592910903|FG000|Year 1|Withdrawal by Subject|6|||
164150214|NCT03989102|592910904|FG001|Year 1|Withdrawal by Subject|2|||
164150215|NCT03989102|592910905|FG002|Year 1|Withdrawal by Subject|7|||
164150216|NCT03989102|592910903|FG000|Year 1|Lost to Follow-up|5|||
164150217|NCT03989102|592910904|FG001|Year 1|Lost to Follow-up|2|||
164150218|NCT03989102|592910905|FG002|Year 1|Lost to Follow-up|5|||
164150219|NCT03989102|592910903|FG000|Year 1|Subject met withdrawal criteria|1|||
164150220|NCT03989102|592910904|FG001|Year 1|Subject met withdrawal criteria|0|||
164150221|NCT03989102|592910905|FG002|Year 1|Subject met withdrawal criteria|1|||
164150222|NCT03989102|592910903|FG000|Year 2|Lost to Follow-up|7|||
164150223|NCT03989102|592910904|FG001|Year 2|Lost to Follow-up|3|||
164150224|NCT03989102|592910905|FG002|Year 2|Lost to Follow-up|4|||
164150225|NCT03989102|592910903|FG000|Year 2|Withdrawal by Subject|3|||
164150226|NCT03989102|592910904|FG001|Year 2|Withdrawal by Subject|1|||
164150227|NCT03989102|592910905|FG002|Year 2|Withdrawal by Subject|2|||
164150228|NCT03989102|592910903|FG000|Year 2|Subject non-compliant|3|||
164150229|NCT03989102|592910904|FG001|Year 2|Subject non-compliant|2|||
164150230|NCT03989102|592910905|FG002|Year 2|Subject non-compliant|0|||
164150231|NCT03989102|592910903|FG000|Year 2|Travel|1|||
164150232|NCT03989102|592910904|FG001|Year 2|Travel|0|||
164150233|NCT03989102|592910905|FG002|Year 2|Travel|1|||
164150234|NCT03989102|592910903|FG000|Year 2|P16 missing|4|||
164150235|NCT03989102|592910904|FG001|Year 2|P16 missing|2|||
164150236|NCT03989102|592910905|FG002|Year 2|P16 missing|1|||
164150237|NCT03989102|592910903|FG000|Year 2|P11 missing|1|||
164150238|NCT03989102|592910904|FG001|Year 2|P11 missing|3|||
164150239|NCT03989102|592910905|FG002|Year 2|P11 missing|7|||
164150240|NCT03989102|592910903|FG000|Year 2|Definitive displacement outside the study site|0|||
164150241|NCT03989102|592910904|FG001|Year 2|Definitive displacement outside the study site|1|||
164150242|NCT03989102|592910905|FG002|Year 2|Definitive displacement outside the study site|0|||
164150243|NCT03989102|592910903|FG000|Year 2|Subject missed last study visit|0|||
164150244|NCT03989102|592910904|FG001|Year 2|Subject missed last study visit|1|||
164150245|NCT03989102|592910905|FG002|Year 2|Subject missed last study visit|0|||
164150246|NCT03989102|592910903|FG000|Year 2|Death|0|||
164150247|NCT03989102|592910904|FG001|Year 2|Death|1|||
164150248|NCT03989102|592910905|FG002|Year 2|Death|0|||
164150249|NCT03989102|592910903|FG000|Year 2|Subject not reachable|0|||
164150250|NCT03989102|592910904|FG001|Year 2|Subject not reachable|0|||
164150251|NCT03989102|592910905|FG002|Year 2|Subject not reachable|1|||
164150252|NCT03989102|592910903|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
164150253|NCT03989102|592910904|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
164150254|NCT03989102|592910905|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
164150255|NCT03989102|592910903|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
164150256|NCT03989102|592910904|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
164150257|NCT03989102|592910905|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
164150258|NCT03989102|592910903|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
164150259|NCT03989102|592910904|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
164150260|NCT03989102|592910905|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
164150261|NCT03989102|592910903|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
164150262|NCT03989102|592910904|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
164150263|NCT03989102|592910905|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
164150264|NCT03989102|592910903|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
164150265|NCT03989102|592910904|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
164150266|NCT03989102|592910905|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
164150267|NCT03989102|592910903|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
164150268|NCT03989102|592910904|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
164150269|NCT03989102|592910905|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
164150270|NCT04054765|592910906|FG000|Baseline|Withdrawal by Subject|5|||
164150271|NCT04054765|592910907|FG001|Baseline|Withdrawal by Subject|3|||
164150272|NCT04054765|592910906|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
164150273|NCT04054765|592910907|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
164150274|NCT04054765|592910906|FG000|3-month Follow up|Withdrawal by Subject|0|||
164150275|NCT04054765|592910907|FG001|3-month Follow up|Withdrawal by Subject|3|||
164150276|NCT04054765|592910906|FG000|6-month Follow up|Lost to Follow-up|32|||
164150277|NCT04054765|592910907|FG001|6-month Follow up|Lost to Follow-up|32|||
164150278|NCT01290068|592910908|FG000|Overall Study|Adverse Event|1|||
164150279|NCT01290068|592910909|FG001|Overall Study|Adverse Event|3|||
164150280|NCT01290068|592910908|FG000|Overall Study|Lost to Follow-up|3|||
164150281|NCT01290068|592910909|FG001|Overall Study|Lost to Follow-up|0|||
164150282|NCT01290068|592910908|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
164150283|NCT01290068|592910909|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
164150284|NCT01290068|592910908|FG000|Overall Study|Other|3|||
164150285|NCT01290068|592910909|FG001|Overall Study|Other|1|||
164150286|NCT02719184|592910912|FG000|Overall Study|Other than listed|1|||
164150287|NCT02719184|592910913|FG001|Overall Study|Other than listed|12|||
164150288|NCT02719184|592910914|FG002|Overall Study|Other than listed|13|||
164150289|NCT02719184|592910915|FG003|Overall Study|Other than listed|22|||
164150290|NCT02719184|592910916|FG004|Overall Study|Other than listed|9|||
164150291|NCT02719184|592910912|FG000|Overall Study|Withdrawal by Subject|5|||
164150292|NCT02719184|592910913|FG001|Overall Study|Withdrawal by Subject|3|||
164150293|NCT02719184|592910914|FG002|Overall Study|Withdrawal by Subject|6|||
164150294|NCT02719184|592910915|FG003|Overall Study|Withdrawal by Subject|6|||
164150295|NCT02719184|592910916|FG004|Overall Study|Withdrawal by Subject|0|||
164150296|NCT02719184|592910912|FG000|Overall Study|Lost to Follow-up|0|||
164150297|NCT02719184|592910913|FG001|Overall Study|Lost to Follow-up|4|||
164150298|NCT02719184|592910914|FG002|Overall Study|Lost to Follow-up|1|||
164150299|NCT02719184|592910915|FG003|Overall Study|Lost to Follow-up|3|||
164150300|NCT02719184|592910916|FG004|Overall Study|Lost to Follow-up|0|||
164150301|NCT02719184|592910912|FG000|Overall Study|Protocol Violation|0|||
164150302|NCT02719184|592910913|FG001|Overall Study|Protocol Violation|3|||
164150303|NCT02719184|592910914|FG002|Overall Study|Protocol Violation|0|||
164150304|NCT02719184|592910915|FG003|Overall Study|Protocol Violation|2|||
164150305|NCT02719184|592910916|FG004|Overall Study|Protocol Violation|0|||
164150306|NCT02719184|592910912|FG000|Overall Study|Adverse Event|0|||
164150307|NCT02719184|592910913|FG001|Overall Study|Adverse Event|0|||
164150308|NCT02719184|592910914|FG002|Overall Study|Adverse Event|0|||
164150309|NCT02719184|592910915|FG003|Overall Study|Adverse Event|3|||
164150310|NCT02719184|592910916|FG004|Overall Study|Adverse Event|0|||
164150311|NCT00545714|592910917|FG000|Induction Phase (6 Months)|Physician Decision|3|||
164150312|NCT00545714|592910917|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
164150313|NCT00545714|592910917|FG000|Induction Phase (6 Months)|Disease Progression|1|||
164150314|NCT00545714|592910917|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
164150315|NCT00545714|592910917|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
164150316|NCT00545714|592910917|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
164150317|NCT00545714|592910917|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
164150318|NCT00545714|592910917|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
164150319|NCT00545714|592910917|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
164150320|NCT00545714|592910917|FG000|Maintenance Phase (36 Months)|Death|2|||
164150321|NCT04428034|592910920|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
164150322|NCT02556801|592910923|FG000|Overall Study|Lost to Follow-up|1|||
164150323|NCT02556801|592910924|FG001|Overall Study|Lost to Follow-up|0|||
164150324|NCT02556801|592910925|FG002|Overall Study|Lost to Follow-up|2|||
164150325|NCT02556801|592910926|FG003|Overall Study|Lost to Follow-up|0|||
164150326|NCT02556801|592910923|FG000|Overall Study|Withdrawal by Subject|1|||
164150327|NCT02556801|592910924|FG001|Overall Study|Withdrawal by Subject|1|||
164150328|NCT02556801|592910925|FG002|Overall Study|Withdrawal by Subject|1|||
164150329|NCT02556801|592910926|FG003|Overall Study|Withdrawal by Subject|0|||
164150330|NCT02556801|592910923|FG000|Overall Study|Protocol Violation|0|||
164150331|NCT02556801|592910924|FG001|Overall Study|Protocol Violation|3|||
164150332|NCT02556801|592910925|FG002|Overall Study|Protocol Violation|1|||
164150333|NCT02556801|592910926|FG003|Overall Study|Protocol Violation|1|||
164150334|NCT02556801|592910923|FG000|Overall Study|Adverse Event|0|||
164150335|NCT02556801|592910924|FG001|Overall Study|Adverse Event|2|||
164150336|NCT02556801|592910925|FG002|Overall Study|Adverse Event|0|||
164150337|NCT02556801|592910926|FG003|Overall Study|Adverse Event|3|||
164150338|NCT02556801|592910923|FG000|Overall Study|Pregnancy|0|||
164150339|NCT02556801|592910924|FG001|Overall Study|Pregnancy|1|||
164150340|NCT02556801|592910925|FG002|Overall Study|Pregnancy|0|||
164150341|NCT02556801|592910926|FG003|Overall Study|Pregnancy|0|||
164150342|NCT02556801|592910923|FG000|Overall Study|Personal reasons patient|0|||
164150343|NCT02556801|592910924|FG001|Overall Study|Personal reasons patient|0|||
164150344|NCT02556801|592910925|FG002|Overall Study|Personal reasons patient|0|||
164150345|NCT02556801|592910926|FG003|Overall Study|Personal reasons patient|1|||
164150346|NCT01431079|592910929|FG000|Overall Study|Lost to Follow-up|35|||
164150347|NCT01431079|592910930|FG001|Overall Study|Lost to Follow-up|39|||
164150348|NCT01626690|592910931|FG000|Overall Study|Protocol Violation|1|||
164150349|NCT01626690|592910932|FG001|Overall Study|Protocol Violation|0|||
164150350|NCT01626690|592910931|FG000|Overall Study|Adverse Event|1|||
164150351|NCT01626690|592910932|FG001|Overall Study|Adverse Event|0|||
164150352|NCT02676882|592910933|FG000|Overall Study|Adverse Event|1|||
164150353|NCT02676882|592910934|FG001|Overall Study|Adverse Event|0|||
164150354|NCT02676882|592910933|FG000|Overall Study|Lost to Follow-up|1|||
164150355|NCT02676882|592910934|FG001|Overall Study|Lost to Follow-up|0|||
164150356|NCT02676882|592910933|FG000|Overall Study|Withdrawal by Subject|1|||
164150357|NCT02676882|592910934|FG001|Overall Study|Withdrawal by Subject|2|||
164150358|NCT00114140|592910935|FG000|Overall Study|Protocol Violation|7|||
164150359|NCT02414958|592910936|FG000|Overall Study|Adverse Event|6|||
164150360|NCT02414958|592910937|FG001|Overall Study|Adverse Event|6|||
164150361|NCT02414958|592910938|FG002|Overall Study|Adverse Event|3|||
164150362|NCT02414958|592910936|FG000|Overall Study|Protocol Violation|10|||
164150363|NCT02414958|592910937|FG001|Overall Study|Protocol Violation|3|||
164150364|NCT02414958|592910938|FG002|Overall Study|Protocol Violation|1|||
164150365|NCT02414958|592910936|FG000|Overall Study|Lost to Follow-up|7|||
164150366|NCT02414958|592910937|FG001|Overall Study|Lost to Follow-up|4|||
164150367|NCT02414958|592910938|FG002|Overall Study|Lost to Follow-up|0|||
164150368|NCT02414958|592910936|FG000|Overall Study|Withdrawal by Subject|5|||
164150369|NCT02414958|592910937|FG001|Overall Study|Withdrawal by Subject|3|||
164150370|NCT02414958|592910938|FG002|Overall Study|Withdrawal by Subject|5|||
164150371|NCT02414958|592910936|FG000|Overall Study|Other than specified|4|||
164150372|NCT02414958|592910937|FG001|Overall Study|Other than specified|4|||
164150373|NCT02414958|592910938|FG002|Overall Study|Other than specified|5|||
164150374|NCT00811733|592910940|FG000|Overall Study|Investigator Discretion|10|||
164150375|NCT00811733|592910941|FG001|Overall Study|Investigator Discretion|8|||
164150376|NCT00811733|592910940|FG000|Overall Study|Withdrawal by Subject|1|||
164150377|NCT00811733|592910941|FG001|Overall Study|Withdrawal by Subject|2|||
164150378|NCT00793871|592910942|FG000|Overall Study|Death|50|||
164150379|NCT00793871|592910942|FG000|Overall Study|Lost to Follow-up|3|||
164150380|NCT00793871|592910942|FG000|Overall Study|Study terminated by the Sponsor|7|||
164150381|NCT00111241|592910945|FG000|Overall Study|Lost to Follow-up|1|||
164150382|NCT00111241|592910946|FG001|Overall Study|Lost to Follow-up|0|||
164150383|NCT00111241|592910945|FG000|Overall Study|Withdrawal by Subject|4|||
164150384|NCT00111241|592910946|FG001|Overall Study|Withdrawal by Subject|0|||
164150385|NCT00111241|592910945|FG000|Overall Study|Protocol Violation|9|||
164150386|NCT00111241|592910946|FG001|Overall Study|Protocol Violation|8|||
164150387|NCT00111241|592910945|FG000|Overall Study|Adverse Event|1|||
164150388|NCT00111241|592910946|FG001|Overall Study|Adverse Event|0|||
164150389|NCT02096744|592910957|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
164150390|NCT02096744|592910958|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
164150391|NCT02096744|592910957|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
164150392|NCT02096744|592910958|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
164150393|NCT02096744|592910957|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
164150394|NCT02096744|592910958|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
164150395|NCT05724589|592910964|FG000|Overall Study|Lost to Follow-up|1|||
164150396|NCT01070953|592910965|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
164150397|NCT01070953|592910965|FG000|Participants for Safety Evaluation|Off-label use|283|||
164150398|NCT01070953|592910965|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
164150399|NCT01070953|592910965|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
164150400|NCT01070953|592910965|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
164150401|NCT01070953|592910965|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
164150402|NCT01070953|592910965|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
164150403|NCT01070953|592910965|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
164150404|NCT01070953|592910965|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
164150405|NCT01070953|592910965|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
164150406|NCT04700137|592910968|FG000|Overall Study|Lost to Follow-up|1|||
164150407|NCT04700137|592910969|FG001|Overall Study|Lost to Follow-up|6|||
164150408|NCT04700137|592910970|FG002|Overall Study|Lost to Follow-up|1|||
164150409|NCT04700137|592910971|FG003|Overall Study|Lost to Follow-up|1|||
164150410|NCT04700137|592910968|FG000|Overall Study|Withdrawal by Subject|0|||
164150411|NCT04700137|592910969|FG001|Overall Study|Withdrawal by Subject|0|||
164150412|NCT04700137|592910970|FG002|Overall Study|Withdrawal by Subject|1|||
164150413|NCT04700137|592910971|FG003|Overall Study|Withdrawal by Subject|0|||
164150414|NCT04700137|592910968|FG000|Overall Study|Death|0|||
164150415|NCT04700137|592910969|FG001|Overall Study|Death|0|||
164150416|NCT04700137|592910970|FG002|Overall Study|Death|1|||
164150417|NCT04700137|592910971|FG003|Overall Study|Death|0|||
164150418|NCT03449446|592910977|FG000|Overall Study|Randomized but Never Treated|0|||
164150419|NCT03449446|592910978|FG001|Overall Study|Randomized but Never Treated|0|||
164150420|NCT03449446|592910979|FG002|Overall Study|Randomized but Never Treated|1|||
164150421|NCT03449446|592910980|FG003|Overall Study|Randomized but Never Treated|1|||
164150422|NCT03449446|592910981|FG004|Overall Study|Randomized but Never Treated|1|||
164150423|NCT03449446|592910982|FG005|Overall Study|Randomized but Never Treated|0|||
164150424|NCT03449446|592910983|FG006|Overall Study|Randomized but Never Treated|0|||
164150425|NCT03449446|592910977|FG000|Overall Study|Unknown Reason|33|||
164150426|NCT03449446|592910978|FG001|Overall Study|Unknown Reason|1|||
164150427|NCT03449446|592910979|FG002|Overall Study|Unknown Reason|1|||
164150428|NCT03449446|592910980|FG003|Overall Study|Unknown Reason|1|||
164150429|NCT03449446|592910981|FG004|Overall Study|Unknown Reason|2|||
164150430|NCT03449446|592910982|FG005|Overall Study|Unknown Reason|2|||
164150431|NCT03449446|592910983|FG006|Overall Study|Unknown Reason|0|||
164150432|NCT03449446|592910977|FG000|Overall Study|Withdrew Consent|1|||
164150433|NCT03449446|592910978|FG001|Overall Study|Withdrew Consent|3|||
164150434|NCT03449446|592910979|FG002|Overall Study|Withdrew Consent|1|||
164150435|NCT03449446|592910980|FG003|Overall Study|Withdrew Consent|4|||
164150436|NCT03449446|592910981|FG004|Overall Study|Withdrew Consent|4|||
164150437|NCT03449446|592910982|FG005|Overall Study|Withdrew Consent|4|||
164150438|NCT03449446|592910983|FG006|Overall Study|Withdrew Consent|1|||
164150439|NCT03449446|592910977|FG000|Overall Study|Adverse Event|1|||
164150440|NCT03449446|592910978|FG001|Overall Study|Adverse Event|2|||
164150441|NCT03449446|592910979|FG002|Overall Study|Adverse Event|1|||
164150442|NCT03449446|592910980|FG003|Overall Study|Adverse Event|0|||
164150443|NCT03449446|592910981|FG004|Overall Study|Adverse Event|0|||
164150444|NCT03449446|592910982|FG005|Overall Study|Adverse Event|2|||
164150445|NCT03449446|592910983|FG006|Overall Study|Adverse Event|0|||
164150446|NCT03449446|592910977|FG000|Overall Study|Lost to Follow-up|0|||
164150447|NCT03449446|592910978|FG001|Overall Study|Lost to Follow-up|0|||
164150448|NCT03449446|592910979|FG002|Overall Study|Lost to Follow-up|2|||
164150449|NCT03449446|592910980|FG003|Overall Study|Lost to Follow-up|1|||
164150450|NCT03449446|592910981|FG004|Overall Study|Lost to Follow-up|3|||
164150451|NCT03449446|592910982|FG005|Overall Study|Lost to Follow-up|0|||
164150452|NCT03449446|592910983|FG006|Overall Study|Lost to Follow-up|0|||
164150453|NCT03449446|592910977|FG000|Overall Study|Investigator's Discretion|0|||
164150454|NCT03449446|592910978|FG001|Overall Study|Investigator's Discretion|1|||
164150455|NCT03449446|592910979|FG002|Overall Study|Investigator's Discretion|1|||
164150456|NCT03449446|592910980|FG003|Overall Study|Investigator's Discretion|2|||
164150457|NCT03449446|592910981|FG004|Overall Study|Investigator's Discretion|0|||
164150458|NCT03449446|592910982|FG005|Overall Study|Investigator's Discretion|0|||
164150459|NCT03449446|592910983|FG006|Overall Study|Investigator's Discretion|0|||
164150460|NCT03449446|592910977|FG000|Overall Study|Non Compliance with Study Drug|1|||
164150461|NCT03449446|592910978|FG001|Overall Study|Non Compliance with Study Drug|0|||
164150462|NCT03449446|592910979|FG002|Overall Study|Non Compliance with Study Drug|0|||
164150463|NCT03449446|592910980|FG003|Overall Study|Non Compliance with Study Drug|0|||
164150464|NCT03449446|592910981|FG004|Overall Study|Non Compliance with Study Drug|0|||
164150465|NCT03449446|592910982|FG005|Overall Study|Non Compliance with Study Drug|0|||
164150466|NCT03449446|592910983|FG006|Overall Study|Non Compliance with Study Drug|0|||
164150467|NCT03449446|592910977|FG000|Overall Study|Protocol Violation|0|||
164150468|NCT03449446|592910978|FG001|Overall Study|Protocol Violation|0|||
164150469|NCT03449446|592910979|FG002|Overall Study|Protocol Violation|0|||
164150470|NCT03449446|592910980|FG003|Overall Study|Protocol Violation|0|||
164150471|NCT03449446|592910981|FG004|Overall Study|Protocol Violation|1|||
164150472|NCT03449446|592910982|FG005|Overall Study|Protocol Violation|1|||
164150473|NCT03449446|592910983|FG006|Overall Study|Protocol Violation|0|||
164150474|NCT03449446|592910977|FG000|Overall Study|Death|0|||
164150475|NCT03449446|592910978|FG001|Overall Study|Death|0|||
164150476|NCT03449446|592910979|FG002|Overall Study|Death|0|||
164150477|NCT03449446|592910980|FG003|Overall Study|Death|0|||
164150478|NCT03449446|592910981|FG004|Overall Study|Death|1|||
164150479|NCT03449446|592910982|FG005|Overall Study|Death|0|||
164150480|NCT03449446|592910983|FG006|Overall Study|Death|0|||
164150481|NCT03180645|592910996|FG000|Overall Study|Adverse Event|0|||
164150482|NCT03180645|592910997|FG001|Overall Study|Adverse Event|1|||
164150483|NCT03180645|592910998|FG002|Overall Study|Adverse Event|2|||
164150484|NCT04208750|592910999|FG000|Overall Study|Lost to Follow-up|16|||
164150485|NCT04208750|592911000|FG001|Overall Study|Lost to Follow-up|15|||
164150486|NCT02201277|592911004|FG000|Overall Study|Death|3|||
164150487|NCT02201277|592911005|FG001|Overall Study|Death|4|||
164150488|NCT02201277|592911004|FG000|Overall Study|Lost to Follow-up|2|||
164150489|NCT02201277|592911005|FG001|Overall Study|Lost to Follow-up|1|||
164150490|NCT02201277|592911004|FG000|Overall Study|Failed retrieval|1|||
164150491|NCT02201277|592911005|FG001|Overall Study|Failed retrieval|0|||
164150492|NCT02201277|592911004|FG000|Overall Study|Physician Decision|1|||
164150493|NCT02201277|592911005|FG001|Overall Study|Physician Decision|0|||
164150494|NCT00866359|592911007|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
164150495|NCT00866359|592911008|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
164150496|NCT00866359|592911009|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
164150497|NCT00866359|592911010|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
164150498|NCT00866359|592911007|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
164150499|NCT00866359|592911008|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
164150500|NCT00866359|592911009|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
164150501|NCT00866359|592911010|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
164150502|NCT00866359|592911007|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
164150503|NCT00866359|592911008|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
164150504|NCT00866359|592911009|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
164150505|NCT00866359|592911010|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
164150506|NCT00866359|592911007|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
164150507|NCT00866359|592911008|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
164150508|NCT00866359|592911009|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
164150509|NCT00866359|592911010|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
164150510|NCT00866359|592911007|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
164150511|NCT00866359|592911008|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
164150512|NCT00866359|592911009|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
164150513|NCT00866359|592911010|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
164150514|NCT00866359|592911007|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
164150515|NCT00866359|592911008|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
164150516|NCT00866359|592911009|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
164150595|NCT04515147|592912234|FG001|Overall Study|Miscellaneous|0|||
164150517|NCT00866359|592911010|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
164150518|NCT01625091|592911011|FG000|Intervention|Death|1|||
164150519|NCT01625091|592911012|FG001|Intervention|Death|1|||
164150520|NCT01625091|592911011|FG000|Intervention|Withdrawal by Subject|4|||
164150521|NCT01625091|592911012|FG001|Intervention|Withdrawal by Subject|1|||
164150522|NCT01625091|592911011|FG000|Intervention|Adverse Event|0|||
164150523|NCT01625091|592911012|FG001|Intervention|Adverse Event|2|||
164150524|NCT01625091|592911011|FG000|Intervention|Lost to Follow-up|4|||
164150525|NCT01625091|592911012|FG001|Intervention|Lost to Follow-up|4|||
164150526|NCT01625091|592911011|FG000|Intervention|Study termination|2|||
164150527|NCT01625091|592911012|FG001|Intervention|Study termination|3|||
164150528|NCT01625091|592911011|FG000|Post-intervention|Death|0|||
164150529|NCT01625091|592911012|FG001|Post-intervention|Death|1|||
164150530|NCT01625091|592911011|FG000|Post-intervention|Lost to Follow-up|2|||
164150531|NCT01625091|592911012|FG001|Post-intervention|Lost to Follow-up|0|||
164150532|NCT01625091|592911011|FG000|Post-intervention|Study termination|2|||
164150533|NCT01625091|592911012|FG001|Post-intervention|Study termination|1|||
164150534|NCT02163057|592911013|FG000|Overall Study|Participant Refusal to Continue|2|||
164150535|NCT02163057|592911014|FG001|Overall Study|Participant Refusal to Continue|2|||
164150536|NCT02163057|592911013|FG000|Overall Study|Participant Significant Noncompliance|0|||
164150537|NCT02163057|592911014|FG001|Overall Study|Participant Significant Noncompliance|1|||
164150538|NCT02163057|592911013|FG000|Overall Study|Progression of Disease|1|||
164150539|NCT02163057|592911014|FG001|Overall Study|Progression of Disease|2|||
164150540|NCT01547390|592911021|FG000|Overall Study|Withdrawal by Subject|10|||
164150541|NCT01547390|592911022|FG001|Overall Study|Withdrawal by Subject|7|||
164150542|NCT01547390|592911021|FG000|Overall Study|termination of pregnancy|0|||
164150543|NCT01547390|592911022|FG001|Overall Study|termination of pregnancy|1|||
164150544|NCT01547390|592911021|FG000|Overall Study|Lost to Follow-up|0|||
164150545|NCT01547390|592911022|FG001|Overall Study|Lost to Follow-up|2|||
164150546|NCT01547390|592911021|FG000|Overall Study|Adverse Event|3|||
164150547|NCT01547390|592911022|FG001|Overall Study|Adverse Event|0|||
164150548|NCT00265759|592912223|FG000|Overall Study|Withdrawal by Subject|0|||
164150549|NCT00265759|592912224|FG001|Overall Study|Withdrawal by Subject|1|||
164150550|NCT00265759|592912225|FG002|Overall Study|Withdrawal by Subject|2|||
164150551|NCT00265759|592912226|FG003|Overall Study|Withdrawal by Subject|2|||
164150552|NCT00265759|592912223|FG000|Overall Study|Cancel|0|||
164150553|NCT00265759|592912224|FG001|Overall Study|Cancel|0|||
164150554|NCT00265759|592912225|FG002|Overall Study|Cancel|0|||
164150555|NCT00265759|592912226|FG003|Overall Study|Cancel|3|||
164150556|NCT00265759|592912223|FG000|Overall Study|Ineligible|0|||
164150557|NCT00265759|592912224|FG001|Overall Study|Ineligible|0|||
164150558|NCT00265759|592912225|FG002|Overall Study|Ineligible|0|||
164150559|NCT00265759|592912226|FG003|Overall Study|Ineligible|1|||
164150560|NCT00265759|592912223|FG000|Overall Study|Bilateral disease|0|||
164150561|NCT00265759|592912224|FG001|Overall Study|Bilateral disease|0|||
164150562|NCT00265759|592912225|FG002|Overall Study|Bilateral disease|0|||
164150563|NCT00265759|592912226|FG003|Overall Study|Bilateral disease|2|||
164150564|NCT00265759|592912223|FG000|Overall Study|Discontinued due to intolerability|0|||
164150565|NCT00265759|592912224|FG001|Overall Study|Discontinued due to intolerability|0|||
164150566|NCT00265759|592912225|FG002|Overall Study|Discontinued due to intolerability|0|||
164150567|NCT00265759|592912226|FG003|Overall Study|Discontinued due to intolerability|1|||
164150568|NCT04653454|592912227|FG000|Overall Study|Withdrawal by Subject|1|||
164150569|NCT04653454|592912227|FG000|Overall Study|Physician Decision|40|||
164150570|NCT05525520|592912229|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
164150571|NCT05525520|592912230|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
164150572|NCT05525520|592912229|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
164150573|NCT05525520|592912230|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
164150574|NCT05878093|592912231|FG000|Overall Study|Withdrawal by Subject|3|||
164150575|NCT05878093|592912232|FG001|Overall Study|Withdrawal by Subject|1|||
164150576|NCT04515147|592912233|FG000|Overall Study|Withdrawal by Subject|1|||
164150577|NCT04515147|592912234|FG001|Overall Study|Withdrawal by Subject|0|||
164150578|NCT04515147|592912235|FG002|Overall Study|Withdrawal by Subject|10|||
164150579|NCT04515147|592912236|FG003|Overall Study|Withdrawal by Subject|18|||
164150580|NCT04515147|592912237|FG004|Overall Study|Withdrawal by Subject|1|||
164150581|NCT04515147|592912238|FG005|Overall Study|Withdrawal by Subject|8|||
164150582|NCT04515147|592912233|FG000|Overall Study|Lost to Follow-up|0|||
164150583|NCT04515147|592912234|FG001|Overall Study|Lost to Follow-up|1|||
164150584|NCT04515147|592912235|FG002|Overall Study|Lost to Follow-up|5|||
164150585|NCT04515147|592912236|FG003|Overall Study|Lost to Follow-up|6|||
164150586|NCT04515147|592912237|FG004|Overall Study|Lost to Follow-up|2|||
164150587|NCT04515147|592912238|FG005|Overall Study|Lost to Follow-up|1|||
164150588|NCT04515147|592912233|FG000|Overall Study|Adverse Event|0|||
164150589|NCT04515147|592912234|FG001|Overall Study|Adverse Event|0|||
164150590|NCT04515147|592912235|FG002|Overall Study|Adverse Event|0|||
164150591|NCT04515147|592912236|FG003|Overall Study|Adverse Event|2|||
164150592|NCT04515147|592912237|FG004|Overall Study|Adverse Event|0|||
164150593|NCT04515147|592912238|FG005|Overall Study|Adverse Event|0|||
164150594|NCT04515147|592912233|FG000|Overall Study|Miscellaneous|0|||
164150596|NCT04515147|592912235|FG002|Overall Study|Miscellaneous|0|||
164150597|NCT04515147|592912236|FG003|Overall Study|Miscellaneous|1|||
164150598|NCT04515147|592912237|FG004|Overall Study|Miscellaneous|0|||
164150599|NCT04515147|592912238|FG005|Overall Study|Miscellaneous|1|||
164150600|NCT04123405|592912239|FG000|Overall Study|Adverse Event|1|||
164150601|NCT04123405|592912240|FG001|Overall Study|Adverse Event|2|||
164150602|NCT04123405|592912241|FG002|Overall Study|Adverse Event|3|||
164150603|NCT04123405|592912242|FG003|Overall Study|Adverse Event|3|||
164150604|NCT04123405|592912239|FG000|Overall Study|Exclusion criteria met|1|||
164150605|NCT04123405|592912240|FG001|Overall Study|Exclusion criteria met|2|||
164150606|NCT04123405|592912241|FG002|Overall Study|Exclusion criteria met|0|||
164150607|NCT04123405|592912242|FG003|Overall Study|Exclusion criteria met|2|||
164150608|NCT04123405|592912239|FG000|Overall Study|Withdrawal by Subject|1|||
164150609|NCT04123405|592912240|FG001|Overall Study|Withdrawal by Subject|3|||
164150610|NCT04123405|592912241|FG002|Overall Study|Withdrawal by Subject|0|||
164150611|NCT04123405|592912242|FG003|Overall Study|Withdrawal by Subject|2|||
164150612|NCT04123405|592912239|FG000|Overall Study|Contact to subject lost|0|||
164150613|NCT04123405|592912240|FG001|Overall Study|Contact to subject lost|0|||
164150614|NCT04123405|592912241|FG002|Overall Study|Contact to subject lost|0|||
164150615|NCT04123405|592912242|FG003|Overall Study|Contact to subject lost|1|||
164150616|NCT04123405|592912239|FG000|Overall Study|screening failure|1|||
164150617|NCT04123405|592912240|FG001|Overall Study|screening failure|0|||
164150618|NCT04123405|592912241|FG002|Overall Study|screening failure|0|||
164150619|NCT04123405|592912242|FG003|Overall Study|screening failure|0|||
164150620|NCT01050530|592912243|FG000|Overall Study|Adverse Event|6|||
164150621|NCT01050530|592912244|FG001|Overall Study|Adverse Event|3|||
164150622|NCT01050530|592912243|FG000|Overall Study|Lack of Efficacy|1|||
164150623|NCT01050530|592912244|FG001|Overall Study|Lack of Efficacy|4|||
164150624|NCT01050530|592912243|FG000|Overall Study|Withdrawal by Subject|0|||
164150625|NCT01050530|592912244|FG001|Overall Study|Withdrawal by Subject|3|||
164150626|NCT01050530|592912243|FG000|Overall Study|Protocol Violation|1|||
164150627|NCT01050530|592912244|FG001|Overall Study|Protocol Violation|0|||
164150628|NCT01202175|592912252|FG000|Overall Study|Lost to Follow-up|2|||
164150629|NCT01202175|592912252|FG000|Overall Study|Withdrawal by Subject|1|||
164150630|NCT01202175|592912252|FG000|Overall Study|Adverse Event|2|||
164150631|NCT02790437|592912253|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
164150632|NCT02790437|592912254|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
164150633|NCT02790437|592912253|FG000|Overall Study|Adverse Event|1|||
164150634|NCT02790437|592912254|FG001|Overall Study|Adverse Event|0|||
164150635|NCT02790437|592912253|FG000|Overall Study|Withdrawal by Subject|1|||
164150636|NCT02790437|592912254|FG001|Overall Study|Withdrawal by Subject|0|||
164150637|NCT04747470|592912255|FG000|Overall Study|Death|0|||
164150638|NCT04747470|592912256|FG001|Overall Study|Death|3|||
164150639|NCT04747470|592912257|FG002|Overall Study|Death|2|||
164150640|NCT04747470|592912258|FG003|Overall Study|Death|2|||
164150641|NCT04747470|592912259|FG004|Overall Study|Death|2|||
164150642|NCT04747470|592912260|FG005|Overall Study|Death|0|||
164150643|NCT04747470|592912261|FG006|Overall Study|Death|0|||
164150644|NCT04747470|592912262|FG007|Overall Study|Death|0|||
164150645|NCT04747470|592912263|FG008|Overall Study|Death|0|||
164150646|NCT04747470|592912264|FG009|Overall Study|Death|0|||
164150647|NCT04747470|592912265|FG010|Overall Study|Death|0|||
164150648|NCT04747470|592912255|FG000|Overall Study|Withdrew Consent|0|||
164150649|NCT04747470|592912256|FG001|Overall Study|Withdrew Consent|0|||
164150650|NCT04747470|592912257|FG002|Overall Study|Withdrew Consent|0|||
164150651|NCT04747470|592912258|FG003|Overall Study|Withdrew Consent|1|||
164150652|NCT04747470|592912259|FG004|Overall Study|Withdrew Consent|0|||
164150653|NCT04747470|592912260|FG005|Overall Study|Withdrew Consent|0|||
164150654|NCT04747470|592912261|FG006|Overall Study|Withdrew Consent|0|||
164150655|NCT04747470|592912262|FG007|Overall Study|Withdrew Consent|0|||
164150656|NCT04747470|592912263|FG008|Overall Study|Withdrew Consent|0|||
164150657|NCT04747470|592912264|FG009|Overall Study|Withdrew Consent|0|||
164150658|NCT04747470|592912265|FG010|Overall Study|Withdrew Consent|0|||
164150659|NCT04747470|592912255|FG000|Overall Study|Study Terminated by Sponsor|0|||
164150660|NCT04747470|592912256|FG001|Overall Study|Study Terminated by Sponsor|0|||
164150661|NCT04747470|592912257|FG002|Overall Study|Study Terminated by Sponsor|1|||
164150662|NCT04747470|592912258|FG003|Overall Study|Study Terminated by Sponsor|0|||
164150663|NCT04747470|592912259|FG004|Overall Study|Study Terminated by Sponsor|2|||
164150664|NCT04747470|592912260|FG005|Overall Study|Study Terminated by Sponsor|0|||
164150665|NCT04747470|592912261|FG006|Overall Study|Study Terminated by Sponsor|0|||
164150666|NCT04747470|592912262|FG007|Overall Study|Study Terminated by Sponsor|0|||
164150667|NCT04747470|592912263|FG008|Overall Study|Study Terminated by Sponsor|0|||
164150668|NCT04747470|592912264|FG009|Overall Study|Study Terminated by Sponsor|0|||
164150669|NCT04747470|592912265|FG010|Overall Study|Study Terminated by Sponsor|0|||
164150670|NCT01125189|592912272|FG000|Treatment Period|Lack of Efficacy|15|||
164150671|NCT01125189|592912273|FG001|Treatment Period|Lack of Efficacy|18|||
164150672|NCT01125189|592912274|FG002|Treatment Period|Lack of Efficacy|25|||
164150673|NCT01125189|592912272|FG000|Treatment Period|Adverse Event|7|||
164150674|NCT01125189|592912273|FG001|Treatment Period|Adverse Event|8|||
164150675|NCT01125189|592912274|FG002|Treatment Period|Adverse Event|8|||
164150676|NCT01125189|592912272|FG000|Treatment Period|Withdrawal by Subject|3|||
164150677|NCT01125189|592912273|FG001|Treatment Period|Withdrawal by Subject|1|||
164150678|NCT01125189|592912274|FG002|Treatment Period|Withdrawal by Subject|1|||
164150679|NCT01125189|592912272|FG000|Treatment Period|Death|1|||
164150680|NCT01125189|592912273|FG001|Treatment Period|Death|0|||
164150681|NCT01125189|592912274|FG002|Treatment Period|Death|0|||
164150682|NCT01125189|592912272|FG000|Treatment Period|Lost to Follow-up|1|||
164150683|NCT01125189|592912273|FG001|Treatment Period|Lost to Follow-up|2|||
164150684|NCT01125189|592912274|FG002|Treatment Period|Lost to Follow-up|1|||
164150685|NCT01125189|592912272|FG000|Treatment Period|Poor compliance/noncompliance|0|||
164150686|NCT01125189|592912273|FG001|Treatment Period|Poor compliance/noncompliance|1|||
164150687|NCT01125189|592912274|FG002|Treatment Period|Poor compliance/noncompliance|0|||
164150688|NCT01125189|592912272|FG000|Treatment Period|Participants requested to discontinue|1|||
164150689|NCT01125189|592912273|FG001|Treatment Period|Participants requested to discontinue|3|||
164150690|NCT01125189|592912274|FG002|Treatment Period|Participants requested to discontinue|4|||
164150691|NCT01125189|592912272|FG000|Treatment Period|Other reasons|1|||
164150692|NCT01125189|592912273|FG001|Treatment Period|Other reasons|1|||
164150693|NCT01125189|592912274|FG002|Treatment Period|Other reasons|0|||
164150694|NCT01125189|592912272|FG000|Treatment Period|Completed 24 week treatment period only|2|||
164150695|NCT01125189|592912273|FG001|Treatment Period|Completed 24 week treatment period only|1|||
164150696|NCT01125189|592912274|FG002|Treatment Period|Completed 24 week treatment period only|2|||
164150697|NCT01125189|592912272|FG000|Follow up Period|Withdrawal by Subject|3|||
164150698|NCT01125189|592912273|FG001|Follow up Period|Withdrawal by Subject|2|||
164150699|NCT01125189|592912274|FG002|Follow up Period|Withdrawal by Subject|5|||
164150700|NCT01125189|592912272|FG000|Follow up Period|Death|1|||
164150701|NCT01125189|592912273|FG001|Follow up Period|Death|0|||
164150702|NCT01125189|592912274|FG002|Follow up Period|Death|0|||
164150703|NCT01125189|592912272|FG000|Follow up Period|Lost to Follow-up|12|||
164150704|NCT01125189|592912273|FG001|Follow up Period|Lost to Follow-up|9|||
164150705|NCT01125189|592912274|FG002|Follow up Period|Lost to Follow-up|6|||
164150706|NCT01125189|592912272|FG000|Follow up Period|Other reasons|4|||
164150707|NCT01125189|592912273|FG001|Follow up Period|Other reasons|4|||
164150708|NCT01125189|592912274|FG002|Follow up Period|Other reasons|5|||
164150709|NCT00110396|592912275|FG000|Overall Study|Adverse Event|15|||
164150710|NCT00110396|592912275|FG000|Overall Study|Lost to Follow-up|1|||
164150711|NCT00110396|592912275|FG000|Overall Study|Administration of plasmapheresis|1|||
164150712|NCT00110396|592912275|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
164150713|NCT00110396|592912275|FG000|Overall Study|Lack of Efficacy|1|||
164150714|NCT00110396|592912275|FG000|Overall Study|Decided not to continue treatment|1|||
164150715|NCT00110396|592912275|FG000|Overall Study|Patient non-compliance|1|||
164150716|NCT00110396|592912275|FG000|Overall Study|Patient refused to continue|1|||
164150717|NCT00110396|592912275|FG000|Overall Study|Patient refused to participate|1|||
164150718|NCT00110396|592912275|FG000|Overall Study|Patient will|1|||
164150719|NCT00110396|592912275|FG000|Overall Study|Patient's decision|1|||
164150720|NCT00110396|592912275|FG000|Overall Study|Participation in MS vaccine study|1|||
164150721|NCT00110396|592912275|FG000|Overall Study|Pregnancy|1|||
164150722|NCT00110396|592912275|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
164150723|NCT00110396|592912275|FG000|Overall Study|Protocol Violation|2|||
164150724|NCT00110396|592912275|FG000|Overall Study|Patient refused to come back|1|||
164150725|NCT00110396|592912275|FG000|Overall Study|The patient has refused|2|||
164150726|NCT00110396|592912275|FG000|Overall Study|The patient has refused to visit site|1|||
164150727|NCT00110396|592912275|FG000|Overall Study|Patient is to be administered copaxone|1|||
164150728|NCT01269918|592912276|FG000|Overall Study|Did not receive study drug|0|||
164150729|NCT01269918|592912277|FG001|Overall Study|Did not receive study drug|3|||
164150730|NCT00245466|592912278|FG000|Overall Study|Adverse Event|2|||
164150731|NCT00245466|592912279|FG001|Overall Study|Adverse Event|8|||
164150732|NCT00245466|592912280|FG002|Overall Study|Adverse Event|4|||
164150733|NCT00245466|592912278|FG000|Overall Study|Low prostate specific antigen suppr|16|||
164150734|NCT00245466|592912279|FG001|Overall Study|Low prostate specific antigen suppr|14|||
164150735|NCT00245466|592912280|FG002|Overall Study|Low prostate specific antigen suppr|5|||
164150736|NCT00245466|592912278|FG000|Overall Study|Insufficient testosterone suppr|12|||
164150737|NCT00245466|592912279|FG001|Overall Study|Insufficient testosterone suppr|12|||
164150738|NCT00245466|592912280|FG002|Overall Study|Insufficient testosterone suppr|21|||
164150739|NCT00245466|592912278|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
164150740|NCT00245466|592912279|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
164150741|NCT00245466|592912280|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
164150742|NCT00245466|592912278|FG000|Overall Study|Withdrawal by Subject|2|||
164150743|NCT00245466|592912279|FG001|Overall Study|Withdrawal by Subject|2|||
164150744|NCT00245466|592912280|FG002|Overall Study|Withdrawal by Subject|1|||
164150745|NCT00245466|592912278|FG000|Overall Study|Lost to Follow-up|3|||
164150746|NCT00245466|592912279|FG001|Overall Study|Lost to Follow-up|0|||
164150747|NCT00245466|592912280|FG002|Overall Study|Lost to Follow-up|0|||
164150748|NCT00245466|592912278|FG000|Overall Study|Disease progression|0|||
164150749|NCT00245466|592912279|FG001|Overall Study|Disease progression|3|||
164150750|NCT00245466|592912280|FG002|Overall Study|Disease progression|1|||
164150751|NCT00245466|592912278|FG000|Overall Study|Protocol Violation|1|||
164150752|NCT00245466|592912279|FG001|Overall Study|Protocol Violation|2|||
164150753|NCT00245466|592912280|FG002|Overall Study|Protocol Violation|2|||
164150754|NCT00245466|592912278|FG000|Overall Study|Death|0|||
164150755|NCT00245466|592912279|FG001|Overall Study|Death|2|||
164150756|NCT00245466|592912280|FG002|Overall Study|Death|0|||
164150757|NCT00245466|592912278|FG000|Overall Study|Administrative reasons|0|||
164150758|NCT00245466|592912279|FG001|Overall Study|Administrative reasons|1|||
164150759|NCT00245466|592912280|FG002|Overall Study|Administrative reasons|0|||
164150760|NCT00856193|592912281|FG000|Period 2|Abnormal test procedure results|0|||
164150761|NCT00856193|592912282|FG001|Period 2|Abnormal test procedure results|1|||
164150762|NCT00856193|592912281|FG000|Period 2|Lost to Follow-up|0|||
164150763|NCT00856193|592912282|FG001|Period 2|Lost to Follow-up|1|||
164150764|NCT03885661|592912283|FG000|Overall Study|Withdrawal by Subject|0|||
164150765|NCT03885661|592912284|FG001|Overall Study|Withdrawal by Subject|1|||
164150766|NCT03885661|592912283|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
164150767|NCT03885661|592912284|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
164150768|NCT05064397|592912285|FG000|Overall Study|Adverse Event|4|||
164150769|NCT05064397|592912285|FG000|Overall Study|Lack of Efficacy|12|||
164150770|NCT05064397|592912285|FG000|Overall Study|Withdrawal by Subject|3|||
164150771|NCT05064397|592912285|FG000|Overall Study|Lost to Follow-up|1|||
164150772|NCT05064397|592912285|FG000|Overall Study|Other reasons|3|||
164150773|NCT04542057|592912286|FG000|Overall Study|Death|3|||
164150774|NCT04542057|592912287|FG001|Overall Study|Death|1|||
164150775|NCT04542057|592912286|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
164150776|NCT04542057|592912287|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
164150777|NCT04542057|592912286|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
164150778|NCT04542057|592912287|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
164150779|NCT04542057|592912286|FG000|Overall Study|Adverse Event|15|||
164150780|NCT04542057|592912287|FG001|Overall Study|Adverse Event|6|||
164150781|NCT04542057|592912286|FG000|Overall Study|COVID-19 adverse event|6|||
164150782|NCT04542057|592912287|FG001|Overall Study|COVID-19 adverse event|4|||
164150783|NCT04542057|592912286|FG000|Overall Study|Lack of Efficacy|2|||
164150784|NCT04542057|592912287|FG001|Overall Study|Lack of Efficacy|5|||
164150785|NCT04542057|592912286|FG000|Overall Study|Study terminated by sponsor|1|||
164150786|NCT04542057|592912287|FG001|Overall Study|Study terminated by sponsor|0|||
164150787|NCT04542057|592912286|FG000|Overall Study|Investigator discretion|2|||
164150788|NCT04542057|592912287|FG001|Overall Study|Investigator discretion|1|||
164150789|NCT04542057|592912286|FG000|Overall Study|Withdrawal by Subject|52|||
164150790|NCT04542057|592912287|FG001|Overall Study|Withdrawal by Subject|30|||
164150791|NCT04542057|592912286|FG000|Overall Study|Lost to Follow-up|8|||
164150792|NCT04542057|592912287|FG001|Overall Study|Lost to Follow-up|11|||
164150793|NCT04542057|592912286|FG000|Overall Study|Other|2|||
164150794|NCT04542057|592912287|FG001|Overall Study|Other|2|||
164150795|NCT02324582|592912288|FG000|Overall Study|Screen Failures|0|||
164150796|NCT02324582|592912289|FG001|Overall Study|Screen Failures|5|||
164150797|NCT00129545|592912293|FG000|Overall Study|Death|5|||
164150798|NCT00129545|592912294|FG001|Overall Study|Death|60|||
164150799|NCT00129545|592912295|FG002|Overall Study|Death|44|||
164150800|NCT00129545|592912293|FG000|Overall Study|Withdrawal by Subject|3|||
164150801|NCT00129545|592912294|FG001|Overall Study|Withdrawal by Subject|18|||
164150802|NCT00129545|592912295|FG002|Overall Study|Withdrawal by Subject|44|||
164150803|NCT00129545|592912293|FG000|Overall Study|Lost to Follow-up|2|||
164150804|NCT00129545|592912294|FG001|Overall Study|Lost to Follow-up|22|||
164150805|NCT00129545|592912295|FG002|Overall Study|Lost to Follow-up|13|||
164150806|NCT00129545|592912293|FG000|Overall Study|Physician Decision|0|||
164150807|NCT00129545|592912294|FG001|Overall Study|Physician Decision|3|||
164150808|NCT00129545|592912295|FG002|Overall Study|Physician Decision|10|||
164150809|NCT00129545|592912293|FG000|Overall Study|Device not implanted|16|||
164150810|NCT00129545|592912294|FG001|Overall Study|Device not implanted|61|||
164150811|NCT00129545|592912295|FG002|Overall Study|Device not implanted|0|||
164150812|NCT03624192|592912296|FG000|Overall Study|Lost to Follow-up|1|||
164150813|NCT03624192|592912297|FG001|Overall Study|Lost to Follow-up|1|||
164150814|NCT04660331|592912298|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
164150815|NCT04660331|592912299|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
164150816|NCT04660331|592912300|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
164150817|NCT01640249|592912302|FG000|Period 1|Withdrawal by Subject|1|||
164150818|NCT01640249|592912303|FG001|Period 1|Withdrawal by Subject|0|||
164150819|NCT01640249|592912304|FG002|Period 1|Withdrawal by Subject|0|||
164150820|NCT01640249|592912305|FG003|Period 1|Withdrawal by Subject|0|||
164150821|NCT01640249|592912306|FG004|Period 1|Withdrawal by Subject|0|||
164150822|NCT01640249|592912307|FG005|Period 1|Withdrawal by Subject|1|||
164150823|NCT01640249|592912308|FG006|Period 1|Withdrawal by Subject|0|||
164150824|NCT00065156|592912309|FG000|Overall Study|Adverse Event|37|||
164150825|NCT00065156|592912309|FG000|Overall Study|Lack of Efficacy|52|||
164150826|NCT00065156|592912309|FG000|Overall Study|Withdrawal by Subject|8|||
164150827|NCT00065156|592912309|FG000|Overall Study|Lost to Follow-up|1|||
164150828|NCT00065156|592912309|FG000|Overall Study|Death|11|||
164150829|NCT00065156|592912309|FG000|Overall Study|Study Closed by Sponsor|2|||
164150830|NCT00065156|592912309|FG000|Overall Study|Disease Progression|7|||
164150831|NCT00065156|592912309|FG000|Overall Study|Investigator Decision|2|||
164150832|NCT00065156|592912309|FG000|Overall Study|Non-Compliance|2|||
164150833|NCT00065156|592912309|FG000|Overall Study|Loss of Response|1|||
164150834|NCT00065156|592912309|FG000|Overall Study|Secondary Malign Disease|1|||
164150835|NCT00312338|592912310|FG000|Overall Study|Adverse Event|7|||
164150836|NCT00312338|592912311|FG001|Overall Study|Adverse Event|2|||
164150837|NCT00312338|592912310|FG000|Overall Study|Lost to Follow-up|9|||
164150838|NCT00312338|592912311|FG001|Overall Study|Lost to Follow-up|1|||
164150839|NCT00312338|592912310|FG000|Overall Study|Withdrawal by Subject|4|||
164150840|NCT00312338|592912311|FG001|Overall Study|Withdrawal by Subject|0|||
164150841|NCT00312338|592912310|FG000|Overall Study|Subsequent infection|2|||
164150842|NCT00312338|592912311|FG001|Overall Study|Subsequent infection|0|||
164150843|NCT00100828|592912312|FG000|Overall Study|Physician Decision|6|||
164150844|NCT04583735|592912313|FG000|Double-masked Treatment Period|Adverse Event|0|||
164150845|NCT04583735|592912314|FG001|Double-masked Treatment Period|Adverse Event|1|||
164150846|NCT04583735|592912313|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
164150847|NCT04583735|592912314|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
164150848|NCT04583735|592912313|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
164150849|NCT04583735|592912314|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
164150850|NCT04583735|592912313|FG000|Open-label Treatment Period|Adverse Event|1|||
164150851|NCT04583735|592912314|FG001|Open-label Treatment Period|Adverse Event|1|||
164150852|NCT04583735|592912313|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
164150853|NCT04583735|592912314|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
164150854|NCT04583735|592912313|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
164150855|NCT04583735|592912314|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
164150856|NCT01176513|592912315|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
164150857|NCT01215136|592912316|FG000|Overall Study|Adverse Event|2|||
164150858|NCT01215136|592912317|FG001|Overall Study|Adverse Event|9|||
164150859|NCT01215136|592912316|FG000|Overall Study|Disease Progression|3|||
164150860|NCT01215136|592912317|FG001|Overall Study|Disease Progression|14|||
164150861|NCT01215136|592912316|FG000|Overall Study|Symptomatic Deterioration|1|||
164150862|NCT01215136|592912317|FG001|Overall Study|Symptomatic Deterioration|1|||
164150863|NCT01215136|592912316|FG000|Overall Study|Death|0|||
164150864|NCT01215136|592912317|FG001|Overall Study|Death|2|||
164150865|NCT01215136|592912316|FG000|Overall Study|Withdrawal by Subject|0|||
164150866|NCT01215136|592912317|FG001|Overall Study|Withdrawal by Subject|1|||
164150867|NCT01125917|592912322|FG000|Overall Study|Adverse Event|43|||
164150868|NCT01125917|592912322|FG000|Overall Study|Lost to Follow-up|23|||
164150869|NCT01125917|592912322|FG000|Overall Study|Withdrawal by Subject|31|||
164150870|NCT01125917|592912322|FG000|Overall Study|Administrative|223|||
164150871|NCT01125917|592912322|FG000|Overall Study|Lack of Efficacy|19|||
164150872|NCT04421131|592912324|FG000|Overall Study|Lost to Follow-up|1|||
164150873|NCT04421131|592912324|FG000|Overall Study|Protocol Violation|2|||
164150874|NCT04421131|592912324|FG000|Overall Study|App crashed|5|||
164150875|NCT02308124|592912325|FG000|Overall Study|Lost to Follow-up|6|||
164150876|NCT02308124|592912326|FG001|Overall Study|Lost to Follow-up|6|||
164150877|NCT02308124|592912327|FG002|Overall Study|Lost to Follow-up|6|||
164150878|NCT02308124|592912325|FG000|Overall Study|Adverse Event|0|||
164150879|NCT02308124|592912326|FG001|Overall Study|Adverse Event|2|||
164150880|NCT02308124|592912327|FG002|Overall Study|Adverse Event|2|||
164150881|NCT01957176|592912329|FG000|Overall Study|Adverse Event|2|||
164150882|NCT01957176|592912330|FG001|Overall Study|Adverse Event|0|||
164150883|NCT01957176|592912329|FG000|Overall Study|Physician Decision|2|||
164150884|NCT01957176|592912330|FG001|Overall Study|Physician Decision|1|||
164150885|NCT01957176|592912329|FG000|Overall Study|Withdrawal by Subject|1|||
164150886|NCT01957176|592912330|FG001|Overall Study|Withdrawal by Subject|0|||
164150887|NCT00952731|592912331|FG000|Overall Study|Drug supply expired|1|||
164150888|NCT00952731|592912332|FG001|Overall Study|Drug supply expired|0|||
164150889|NCT01449812|592912333|FG000|Overall Study|Migrated/moved from study area|1|||
164150890|NCT01449812|592912334|FG001|Overall Study|Migrated/moved from study area|0|||
164150891|NCT01449812|592912335|FG002|Overall Study|Migrated/moved from study area|0|||
164150892|NCT01449812|592912333|FG000|Overall Study|Withdrawal by Subject|0|||
164150893|NCT01449812|592912334|FG001|Overall Study|Withdrawal by Subject|0|||
164150894|NCT01449812|592912335|FG002|Overall Study|Withdrawal by Subject|1|||
164150895|NCT01449812|592912333|FG000|Overall Study|Lost to Follow-up|1|||
164150896|NCT01449812|592912334|FG001|Overall Study|Lost to Follow-up|0|||
164150897|NCT01449812|592912335|FG002|Overall Study|Lost to Follow-up|0|||
164150898|NCT04075487|592915694|FG000|Overall Study|Withdrawal by Subject|1|||
164150899|NCT05655546|592915697|FG000|Overall Study|Withdrawal by Subject|2|||
164150900|NCT05655546|592915698|FG001|Overall Study|Withdrawal by Subject|4|||
164150901|NCT03493685|592915699|FG000|Overall Study|Death|4|||
164150902|NCT03493685|592915700|FG001|Overall Study|Death|3|||
164150903|NCT03493685|592915699|FG000|Overall Study|Lost to Follow-up|3|||
164150904|NCT03493685|592915700|FG001|Overall Study|Lost to Follow-up|2|||
164150905|NCT03493685|592915699|FG000|Overall Study|Physician Decision|2|||
164150906|NCT03493685|592915700|FG001|Overall Study|Physician Decision|0|||
164150907|NCT03493685|592915699|FG000|Overall Study|Withdrawal by Subject|7|||
164150908|NCT03493685|592915700|FG001|Overall Study|Withdrawal by Subject|11|||
164150909|NCT04452669|592915701|FG000|Overall Study|Death|1|||
164150910|NCT04452669|592915702|FG001|Overall Study|Death|4|||
164150911|NCT04576507|592915706|FG000|Overall Study|Adverse Event|4|||
164150912|NCT04576507|592915706|FG000|Overall Study|Withdrawal by Subject|1|||
164150913|NCT02721732|592915707|FG000|Overall Study|Adverse Event|2|||
164150914|NCT02721732|592915708|FG001|Overall Study|Adverse Event|0|||
164150915|NCT02721732|592915709|FG002|Overall Study|Adverse Event|2|||
164150916|NCT02721732|592915710|FG003|Overall Study|Adverse Event|0|||
164150917|NCT02721732|592915711|FG004|Overall Study|Adverse Event|1|||
164150918|NCT02721732|592915712|FG005|Overall Study|Adverse Event|0|||
164150919|NCT02721732|592915713|FG006|Overall Study|Adverse Event|1|||
164150920|NCT02721732|592915714|FG007|Overall Study|Adverse Event|0|||
164150921|NCT02721732|592915715|FG008|Overall Study|Adverse Event|1|||
164150922|NCT02721732|592915716|FG009|Overall Study|Adverse Event|1|||
164150923|NCT02721732|592915707|FG000|Overall Study|Death|0|||
164150924|NCT02721732|592915708|FG001|Overall Study|Death|0|||
164150925|NCT02721732|592915709|FG002|Overall Study|Death|0|||
164150926|NCT02721732|592915710|FG003|Overall Study|Death|0|||
164150927|NCT02721732|592915711|FG004|Overall Study|Death|1|||
164150928|NCT02721732|592915712|FG005|Overall Study|Death|0|||
164150929|NCT02721732|592915713|FG006|Overall Study|Death|1|||
164150930|NCT02721732|592915714|FG007|Overall Study|Death|0|||
164150931|NCT02721732|592915715|FG008|Overall Study|Death|0|||
164150932|NCT02721732|592915716|FG009|Overall Study|Death|1|||
164150933|NCT02721732|592915707|FG000|Overall Study|Lack of Efficacy|12|||
164150934|NCT02721732|592915708|FG001|Overall Study|Lack of Efficacy|11|||
164150935|NCT02721732|592915709|FG002|Overall Study|Lack of Efficacy|18|||
164150936|NCT02721732|592915710|FG003|Overall Study|Lack of Efficacy|5|||
164150937|NCT02721732|592915711|FG004|Overall Study|Lack of Efficacy|21|||
164150938|NCT02721732|592915712|FG005|Overall Study|Lack of Efficacy|2|||
164150939|NCT02721732|592915713|FG006|Overall Study|Lack of Efficacy|8|||
164150940|NCT02721732|592915714|FG007|Overall Study|Lack of Efficacy|11|||
164150941|NCT02721732|592915715|FG008|Overall Study|Lack of Efficacy|10|||
164150942|NCT02721732|592915716|FG009|Overall Study|Lack of Efficacy|20|||
164150943|NCT02721732|592915707|FG000|Overall Study|Physician Decision|0|||
164150944|NCT02721732|592915708|FG001|Overall Study|Physician Decision|0|||
164150945|NCT02721732|592915709|FG002|Overall Study|Physician Decision|1|||
164150946|NCT02721732|592915710|FG003|Overall Study|Physician Decision|0|||
164150947|NCT02721732|592915711|FG004|Overall Study|Physician Decision|0|||
164150948|NCT02721732|592915712|FG005|Overall Study|Physician Decision|0|||
164150949|NCT02721732|592915713|FG006|Overall Study|Physician Decision|0|||
164150950|NCT02721732|592915714|FG007|Overall Study|Physician Decision|0|||
164150951|NCT02721732|592915715|FG008|Overall Study|Physician Decision|0|||
164150952|NCT02721732|592915716|FG009|Overall Study|Physician Decision|0|||
164150953|NCT02721732|592915707|FG000|Overall Study|Withdrawal by Subject|1|||
164150954|NCT02721732|592915708|FG001|Overall Study|Withdrawal by Subject|0|||
164150955|NCT02721732|592915709|FG002|Overall Study|Withdrawal by Subject|0|||
164150956|NCT02721732|592915710|FG003|Overall Study|Withdrawal by Subject|0|||
164150957|NCT02721732|592915711|FG004|Overall Study|Withdrawal by Subject|3|||
164150958|NCT02721732|592915712|FG005|Overall Study|Withdrawal by Subject|0|||
164150959|NCT02721732|592915713|FG006|Overall Study|Withdrawal by Subject|1|||
164150960|NCT02721732|592915714|FG007|Overall Study|Withdrawal by Subject|1|||
164150961|NCT02721732|592915715|FG008|Overall Study|Withdrawal by Subject|0|||
164150962|NCT02721732|592915716|FG009|Overall Study|Withdrawal by Subject|1|||
164150963|NCT02721732|592915707|FG000|Overall Study|Participant Choice|1|||
164150964|NCT02721732|592915708|FG001|Overall Study|Participant Choice|0|||
164150965|NCT02721732|592915709|FG002|Overall Study|Participant Choice|0|||
164150966|NCT02721732|592915710|FG003|Overall Study|Participant Choice|0|||
164150967|NCT02721732|592915711|FG004|Overall Study|Participant Choice|0|||
164150968|NCT02721732|592915712|FG005|Overall Study|Participant Choice|0|||
164150969|NCT02721732|592915713|FG006|Overall Study|Participant Choice|0|||
164150970|NCT02721732|592915714|FG007|Overall Study|Participant Choice|0|||
164150971|NCT02721732|592915715|FG008|Overall Study|Participant Choice|0|||
164150972|NCT02721732|592915716|FG009|Overall Study|Participant Choice|1|||
164150973|NCT02721732|592915707|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
164150974|NCT02721732|592915708|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
164150975|NCT02721732|592915709|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
164150976|NCT02721732|592915710|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
164150977|NCT02721732|592915711|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
164150978|NCT02721732|592915712|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
164150979|NCT02721732|592915713|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
164150980|NCT02721732|592915714|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
164150981|NCT02721732|592915715|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
164151053|NCT02848001|592915734|FG010|Overall Study|other reasons|0|||
164150982|NCT02721732|592915716|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
164150983|NCT02721732|592915707|FG000|Overall Study|Progression and withdrew consent|1|||
164150984|NCT02721732|592915708|FG001|Overall Study|Progression and withdrew consent|1|||
164150985|NCT02721732|592915709|FG002|Overall Study|Progression and withdrew consent|0|||
164150986|NCT02721732|592915710|FG003|Overall Study|Progression and withdrew consent|0|||
164150987|NCT02721732|592915711|FG004|Overall Study|Progression and withdrew consent|0|||
164150988|NCT02721732|592915712|FG005|Overall Study|Progression and withdrew consent|0|||
164150989|NCT02721732|592915713|FG006|Overall Study|Progression and withdrew consent|0|||
164150990|NCT02721732|592915714|FG007|Overall Study|Progression and withdrew consent|0|||
164150991|NCT02721732|592915715|FG008|Overall Study|Progression and withdrew consent|0|||
164150992|NCT02721732|592915716|FG009|Overall Study|Progression and withdrew consent|1|||
164150993|NCT02721732|592915707|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
164150994|NCT02721732|592915708|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
164150995|NCT02721732|592915709|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
164150996|NCT02721732|592915710|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
164150997|NCT02721732|592915711|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
164150998|NCT02721732|592915712|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
164150999|NCT02721732|592915713|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
164151000|NCT02721732|592915714|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
164151001|NCT02721732|592915715|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
164151002|NCT02721732|592915716|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
164151003|NCT04100018|592915722|FG000|Pre-Treatment Period|Not Reported|0|||
164151004|NCT04100018|592915723|FG001|Pre-Treatment Period|Not Reported|4|||
164151005|NCT04100018|592915722|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
164151006|NCT04100018|592915723|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
164151007|NCT04100018|592915722|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
164151008|NCT04100018|592915723|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
164151009|NCT04100018|592915722|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
164151010|NCT04100018|592915723|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
164151011|NCT04100018|592915722|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
164151012|NCT04100018|592915723|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
164151013|NCT04100018|592915722|FG000|Treatment Period|Ongoing Treatment|1|||
164151014|NCT04100018|592915723|FG001|Treatment Period|Ongoing Treatment|0|||
164151015|NCT04100018|592915722|FG000|Treatment Period|Other Reason|26|||
164151016|NCT04100018|592915723|FG001|Treatment Period|Other Reason|37|||
164151017|NCT04100018|592915722|FG000|Treatment Period|Completed treatment as per protocol|1|||
164151018|NCT04100018|592915723|FG001|Treatment Period|Completed treatment as per protocol|2|||
164151019|NCT04100018|592915722|FG000|Treatment Period|Maximum clinical benefit|3|||
164151020|NCT04100018|592915723|FG001|Treatment Period|Maximum clinical benefit|0|||
164151021|NCT04100018|592915722|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
164151022|NCT04100018|592915723|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
164151023|NCT04100018|592915722|FG000|Treatment Period|Study drug toxicity|67|||
164151024|NCT04100018|592915723|FG001|Treatment Period|Study drug toxicity|28|||
164151025|NCT04100018|592915722|FG000|Treatment Period|Disease Progression|284|||
164151026|NCT04100018|592915723|FG001|Treatment Period|Disease Progression|327|||
164151027|NCT04100018|592915722|FG000|Treatment Period|Administrative reasons by sponsor|16|||
164151028|NCT04100018|592915723|FG001|Treatment Period|Administrative reasons by sponsor|30|||
164151029|NCT04100018|592915722|FG000|Treatment Period|Poor/Non-Compliance|1|||
164151030|NCT04100018|592915723|FG001|Treatment Period|Poor/Non-Compliance|0|||
164151031|NCT04100018|592915722|FG000|Treatment Period|Lost to Follow-up|2|||
164151032|NCT04100018|592915723|FG001|Treatment Period|Lost to Follow-up|2|||
164151033|NCT04100018|592915722|FG000|Treatment Period|Death|16|||
164151034|NCT04100018|592915723|FG001|Treatment Period|Death|11|||
164151035|NCT04100018|592915722|FG000|Treatment Period|Participant withdrew consent|10|||
164151036|NCT04100018|592915723|FG001|Treatment Period|Participant withdrew consent|10|||
164151037|NCT04100018|592915722|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
164151038|NCT04100018|592915723|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
164151039|NCT04100018|592915722|FG000|Treatment Period|Adverse Event|14|||
164151040|NCT04100018|592915723|FG001|Treatment Period|Adverse Event|6|||
164151041|NCT04100018|592915722|FG000|Treatment Period|Lack of Efficacy|4|||
164151042|NCT04100018|592915723|FG001|Treatment Period|Lack of Efficacy|2|||
164151043|NCT02848001|592915724|FG000|Overall Study|other reasons|0|||
164151044|NCT02848001|592915725|FG001|Overall Study|other reasons|0|||
164151045|NCT02848001|592915726|FG002|Overall Study|other reasons|1|||
164151046|NCT02848001|592915727|FG003|Overall Study|other reasons|0|||
164151047|NCT02848001|592915728|FG004|Overall Study|other reasons|4|||
164151048|NCT02848001|592915729|FG005|Overall Study|other reasons|1|||
164151049|NCT02848001|592915730|FG006|Overall Study|other reasons|0|||
164151050|NCT02848001|592915731|FG007|Overall Study|other reasons|2|||
164151051|NCT02848001|592915732|FG008|Overall Study|other reasons|2|||
164151052|NCT02848001|592915733|FG009|Overall Study|other reasons|3|||
164151054|NCT02848001|592915735|FG011|Overall Study|other reasons|1|||
164151055|NCT02848001|592915736|FG012|Overall Study|other reasons|1|||
164151056|NCT02848001|592915737|FG013|Overall Study|other reasons|0|||
164151057|NCT02848001|592915738|FG014|Overall Study|other reasons|0|||
164151058|NCT02848001|592915739|FG015|Overall Study|other reasons|2|||
164151059|NCT02848001|592915740|FG016|Overall Study|other reasons|1|||
164151060|NCT02848001|592915724|FG000|Overall Study|Lack of Efficacy|0|||
164151061|NCT02848001|592915725|FG001|Overall Study|Lack of Efficacy|1|||
164151062|NCT02848001|592915726|FG002|Overall Study|Lack of Efficacy|1|||
164151063|NCT02848001|592915727|FG003|Overall Study|Lack of Efficacy|2|||
164151064|NCT02848001|592915728|FG004|Overall Study|Lack of Efficacy|3|||
164151065|NCT02848001|592915729|FG005|Overall Study|Lack of Efficacy|0|||
164151066|NCT02848001|592915730|FG006|Overall Study|Lack of Efficacy|1|||
164151067|NCT02848001|592915731|FG007|Overall Study|Lack of Efficacy|0|||
164151068|NCT02848001|592915732|FG008|Overall Study|Lack of Efficacy|0|||
164151069|NCT02848001|592915733|FG009|Overall Study|Lack of Efficacy|1|||
164151070|NCT02848001|592915734|FG010|Overall Study|Lack of Efficacy|0|||
164151071|NCT02848001|592915735|FG011|Overall Study|Lack of Efficacy|2|||
164151072|NCT02848001|592915736|FG012|Overall Study|Lack of Efficacy|0|||
164151073|NCT02848001|592915737|FG013|Overall Study|Lack of Efficacy|2|||
164151074|NCT02848001|592915738|FG014|Overall Study|Lack of Efficacy|2|||
164151075|NCT02848001|592915739|FG015|Overall Study|Lack of Efficacy|0|||
164151076|NCT02848001|592915740|FG016|Overall Study|Lack of Efficacy|0|||
164151077|NCT02848001|592915724|FG000|Overall Study|Progressive Disease|2|||
164151078|NCT02848001|592915725|FG001|Overall Study|Progressive Disease|1|||
164151079|NCT02848001|592915726|FG002|Overall Study|Progressive Disease|0|||
164151080|NCT02848001|592915727|FG003|Overall Study|Progressive Disease|4|||
164151081|NCT02848001|592915728|FG004|Overall Study|Progressive Disease|3|||
164151082|NCT02848001|592915729|FG005|Overall Study|Progressive Disease|0|||
164151083|NCT02848001|592915730|FG006|Overall Study|Progressive Disease|4|||
164151084|NCT02848001|592915731|FG007|Overall Study|Progressive Disease|1|||
164151085|NCT02848001|592915732|FG008|Overall Study|Progressive Disease|0|||
164151086|NCT02848001|592915733|FG009|Overall Study|Progressive Disease|2|||
164151087|NCT02848001|592915734|FG010|Overall Study|Progressive Disease|3|||
164151088|NCT02848001|592915735|FG011|Overall Study|Progressive Disease|2|||
164151089|NCT02848001|592915736|FG012|Overall Study|Progressive Disease|1|||
164151090|NCT02848001|592915737|FG013|Overall Study|Progressive Disease|0|||
164151091|NCT02848001|592915738|FG014|Overall Study|Progressive Disease|2|||
164151092|NCT02848001|592915739|FG015|Overall Study|Progressive Disease|4|||
164151093|NCT02848001|592915740|FG016|Overall Study|Progressive Disease|0|||
164151094|NCT02848001|592915724|FG000|Overall Study|Adverse Event|0|||
164151095|NCT02848001|592915725|FG001|Overall Study|Adverse Event|0|||
164151096|NCT02848001|592915726|FG002|Overall Study|Adverse Event|0|||
164151097|NCT02848001|592915727|FG003|Overall Study|Adverse Event|0|||
164151098|NCT02848001|592915728|FG004|Overall Study|Adverse Event|2|||
164151099|NCT02848001|592915729|FG005|Overall Study|Adverse Event|0|||
164151100|NCT02848001|592915730|FG006|Overall Study|Adverse Event|0|||
164151101|NCT02848001|592915731|FG007|Overall Study|Adverse Event|0|||
164151102|NCT02848001|592915732|FG008|Overall Study|Adverse Event|0|||
164151103|NCT02848001|592915733|FG009|Overall Study|Adverse Event|1|||
164151104|NCT02848001|592915734|FG010|Overall Study|Adverse Event|0|||
164151105|NCT02848001|592915735|FG011|Overall Study|Adverse Event|1|||
164151106|NCT02848001|592915736|FG012|Overall Study|Adverse Event|1|||
164151107|NCT02848001|592915737|FG013|Overall Study|Adverse Event|0|||
164151108|NCT02848001|592915738|FG014|Overall Study|Adverse Event|2|||
164151109|NCT02848001|592915739|FG015|Overall Study|Adverse Event|0|||
164151110|NCT02848001|592915740|FG016|Overall Study|Adverse Event|0|||
164151111|NCT02848001|592915724|FG000|Overall Study|Death|0|||
164151112|NCT02848001|592915725|FG001|Overall Study|Death|0|||
164151113|NCT02848001|592915726|FG002|Overall Study|Death|0|||
164151114|NCT02848001|592915727|FG003|Overall Study|Death|1|||
164151115|NCT02848001|592915728|FG004|Overall Study|Death|3|||
164151116|NCT02848001|592915729|FG005|Overall Study|Death|1|||
164151117|NCT02848001|592915730|FG006|Overall Study|Death|2|||
164151118|NCT02848001|592915731|FG007|Overall Study|Death|3|||
164151119|NCT02848001|592915732|FG008|Overall Study|Death|4|||
164151120|NCT02848001|592915733|FG009|Overall Study|Death|1|||
164151121|NCT02848001|592915734|FG010|Overall Study|Death|0|||
164151122|NCT02848001|592915735|FG011|Overall Study|Death|1|||
164151123|NCT02848001|592915736|FG012|Overall Study|Death|3|||
164151124|NCT02848001|592915737|FG013|Overall Study|Death|0|||
164151125|NCT02848001|592915738|FG014|Overall Study|Death|2|||
164151126|NCT02848001|592915739|FG015|Overall Study|Death|3|||
164151127|NCT02848001|592915740|FG016|Overall Study|Death|0|||
164151128|NCT02848001|592915724|FG000|Overall Study|Physician Decision|0|||
164151129|NCT02848001|592915725|FG001|Overall Study|Physician Decision|0|||
164151130|NCT02848001|592915726|FG002|Overall Study|Physician Decision|0|||
164151131|NCT02848001|592915727|FG003|Overall Study|Physician Decision|0|||
164151132|NCT02848001|592915728|FG004|Overall Study|Physician Decision|0|||
164151133|NCT02848001|592915729|FG005|Overall Study|Physician Decision|0|||
164151134|NCT02848001|592915730|FG006|Overall Study|Physician Decision|0|||
164151135|NCT02848001|592915731|FG007|Overall Study|Physician Decision|0|||
164151136|NCT02848001|592915732|FG008|Overall Study|Physician Decision|1|||
164151137|NCT02848001|592915733|FG009|Overall Study|Physician Decision|1|||
164151138|NCT02848001|592915734|FG010|Overall Study|Physician Decision|0|||
164151139|NCT02848001|592915735|FG011|Overall Study|Physician Decision|0|||
164151140|NCT02848001|592915736|FG012|Overall Study|Physician Decision|2|||
164151141|NCT02848001|592915737|FG013|Overall Study|Physician Decision|0|||
164151142|NCT02848001|592915738|FG014|Overall Study|Physician Decision|0|||
164151143|NCT02848001|592915739|FG015|Overall Study|Physician Decision|0|||
164151144|NCT02848001|592915740|FG016|Overall Study|Physician Decision|0|||
164151145|NCT02848001|592915724|FG000|Overall Study|Withdrawal by Subject|0|||
164151146|NCT02848001|592915725|FG001|Overall Study|Withdrawal by Subject|0|||
164151147|NCT02848001|592915726|FG002|Overall Study|Withdrawal by Subject|0|||
164151148|NCT02848001|592915727|FG003|Overall Study|Withdrawal by Subject|0|||
164151149|NCT02848001|592915728|FG004|Overall Study|Withdrawal by Subject|0|||
164151150|NCT02848001|592915729|FG005|Overall Study|Withdrawal by Subject|1|||
164151151|NCT02848001|592915730|FG006|Overall Study|Withdrawal by Subject|1|||
164151152|NCT02848001|592915731|FG007|Overall Study|Withdrawal by Subject|1|||
164151153|NCT02848001|592915732|FG008|Overall Study|Withdrawal by Subject|0|||
164151154|NCT02848001|592915733|FG009|Overall Study|Withdrawal by Subject|0|||
164151155|NCT02848001|592915734|FG010|Overall Study|Withdrawal by Subject|0|||
164151156|NCT02848001|592915735|FG011|Overall Study|Withdrawal by Subject|0|||
164151157|NCT02848001|592915736|FG012|Overall Study|Withdrawal by Subject|0|||
164151158|NCT02848001|592915737|FG013|Overall Study|Withdrawal by Subject|0|||
164151159|NCT02848001|592915738|FG014|Overall Study|Withdrawal by Subject|0|||
164151160|NCT02848001|592915739|FG015|Overall Study|Withdrawal by Subject|0|||
164151161|NCT02848001|592915740|FG016|Overall Study|Withdrawal by Subject|0|||
164151162|NCT04358081|592915741|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
164151163|NCT04358081|592915742|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
164151164|NCT04358081|592915743|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
164151165|NCT04358081|592915741|FG000|Treatment Phase of Study|Adverse Event|1|||
164151166|NCT04358081|592915742|FG001|Treatment Phase of Study|Adverse Event|0|||
164151167|NCT04358081|592915743|FG002|Treatment Phase of Study|Adverse Event|1|||
164151168|NCT04358081|592915741|FG000|Treatment Phase of Study|Physician Decision|2|||
164151169|NCT04358081|592915742|FG001|Treatment Phase of Study|Physician Decision|0|||
164151170|NCT04358081|592915743|FG002|Treatment Phase of Study|Physician Decision|1|||
164151171|NCT04358081|592915741|FG000|Treatment Phase of Study|Protocol Violation|1|||
164151172|NCT04358081|592915742|FG001|Treatment Phase of Study|Protocol Violation|0|||
164151173|NCT04358081|592915743|FG002|Treatment Phase of Study|Protocol Violation|0|||
164151174|NCT04358081|592915741|FG000|Study Completion Phase|Death|0|||
164151175|NCT04358081|592915742|FG001|Study Completion Phase|Death|0|||
164151176|NCT04358081|592915743|FG002|Study Completion Phase|Death|1|||
164151177|NCT04358081|592915741|FG000|Study Completion Phase|Lost to Follow-up|1|||
164151178|NCT04358081|592915742|FG001|Study Completion Phase|Lost to Follow-up|0|||
164151179|NCT04358081|592915743|FG002|Study Completion Phase|Lost to Follow-up|1|||
164151180|NCT00725283|592915747|FG000|Overall Study|Missing Code|3|||
164151181|NCT00725283|592915747|FG000|Overall Study|Death|5|||
164151182|NCT00725283|592915747|FG000|Overall Study|Other|6|||
164151183|NCT00725283|592915747|FG000|Overall Study|Withdrawal by Subject|10|||
164151184|NCT03103087|592915748|FG000|Overall Study|Did not receive any study drug|1|||
164151185|NCT03103087|592915749|FG001|Overall Study|Did not receive any study drug|0|||
164151186|NCT03103087|592915750|FG002|Overall Study|Did not receive any study drug|0|||
164151187|NCT03103087|592915748|FG000|Overall Study|Protocol Violation|1|||
164151188|NCT03103087|592915749|FG001|Overall Study|Protocol Violation|2|||
164151189|NCT03103087|592915750|FG002|Overall Study|Protocol Violation|1|||
164151190|NCT03103087|592915748|FG000|Overall Study|Lack of Efficacy|2|||
164151191|NCT03103087|592915749|FG001|Overall Study|Lack of Efficacy|1|||
164151192|NCT03103087|592915750|FG002|Overall Study|Lack of Efficacy|1|||
164151193|NCT03103087|592915748|FG000|Overall Study|Pregnancy|0|||
164151194|NCT03103087|592915749|FG001|Overall Study|Pregnancy|0|||
164151195|NCT03103087|592915750|FG002|Overall Study|Pregnancy|1|||
164151196|NCT03103087|592915748|FG000|Overall Study|Adverse Event|2|||
164151197|NCT03103087|592915749|FG001|Overall Study|Adverse Event|15|||
164151198|NCT03103087|592915750|FG002|Overall Study|Adverse Event|6|||
164151199|NCT03103087|592915748|FG000|Overall Study|Withdrawal by Subject|13|||
164151200|NCT03103087|592915749|FG001|Overall Study|Withdrawal by Subject|6|||
164151201|NCT03103087|592915750|FG002|Overall Study|Withdrawal by Subject|6|||
164151202|NCT03103087|592915748|FG000|Overall Study|Lost to Follow-up|4|||
164151203|NCT03103087|592915749|FG001|Overall Study|Lost to Follow-up|2|||
164151204|NCT03103087|592915750|FG002|Overall Study|Lost to Follow-up|7|||
164151205|NCT03103087|592915748|FG000|Overall Study|Other reason not reported|1|||
164151206|NCT03103087|592915749|FG001|Overall Study|Other reason not reported|3|||
164151207|NCT03103087|592915750|FG002|Overall Study|Other reason not reported|5|||
164151208|NCT00118157|592915751|FG000|Overall Study|Adverse Event|2|||
164151209|NCT00118157|592915751|FG000|Overall Study|Death|8|||
164151210|NCT00118157|592915751|FG000|Overall Study|Withdrawal by Subject|2|||
164151211|NCT00413699|592915752|FG000|Initial Period|Death|25|||
164151212|NCT00413699|592915753|FG001|Initial Period|Death|30|||
164151213|NCT00413699|592915754|FG002|Initial Period|Death|0|||
164151214|NCT00413699|592915752|FG000|Initial Period|Lack of Efficacy|59|||
164151215|NCT00413699|592915753|FG001|Initial Period|Lack of Efficacy|115|||
164151216|NCT00413699|592915754|FG002|Initial Period|Lack of Efficacy|0|||
164151217|NCT00413699|592915752|FG000|Initial Period|Lost to Follow-up|31|||
164151218|NCT00413699|592915753|FG001|Initial Period|Lost to Follow-up|101|||
164151219|NCT00413699|592915754|FG002|Initial Period|Lost to Follow-up|0|||
164151220|NCT00413699|592915752|FG000|Initial Period|Protocol Violation|38|||
164151221|NCT00413699|592915753|FG001|Initial Period|Protocol Violation|89|||
164151222|NCT00413699|592915754|FG002|Initial Period|Protocol Violation|0|||
164151223|NCT00413699|592915752|FG000|Initial Period|Pregnancy|10|||
164151224|NCT00413699|592915753|FG001|Initial Period|Pregnancy|8|||
164151225|NCT00413699|592915754|FG002|Initial Period|Pregnancy|0|||
164151226|NCT00413699|592915752|FG000|Initial Period|Did not meet entrance criteria|2|||
164151227|NCT00413699|592915753|FG001|Initial Period|Did not meet entrance criteria|2|||
164151228|NCT00413699|592915754|FG002|Initial Period|Did not meet entrance criteria|0|||
164151229|NCT00413699|592915752|FG000|Initial Period|Medication error without adverse event|0|||
164151230|NCT00413699|592915753|FG001|Initial Period|Medication error without adverse event|1|||
164151231|NCT00413699|592915754|FG002|Initial Period|Medication error without adverse event|0|||
164151232|NCT00413699|592915752|FG000|Initial Period|Study terminated by Sponsor|0|||
164151233|NCT00413699|592915753|FG001|Initial Period|Study terminated by Sponsor|1|||
164151234|NCT00413699|592915754|FG002|Initial Period|Study terminated by Sponsor|0|||
164151235|NCT00413699|592915752|FG000|Initial Period|Other|67|||
164151236|NCT00413699|592915753|FG001|Initial Period|Other|211|||
164151237|NCT00413699|592915754|FG002|Initial Period|Other|0|||
164151238|NCT00413699|592915752|FG000|Initial Period|Adverse event related to study drug|178|||
164151239|NCT00413699|592915753|FG001|Initial Period|Adverse event related to study drug|527|||
164151240|NCT00413699|592915754|FG002|Initial Period|Adverse event related to study drug|0|||
164151241|NCT00413699|592915752|FG000|Initial Period|Adverse event not related to study drug|113|||
164151242|NCT00413699|592915753|FG001|Initial Period|Adverse event not related to study drug|248|||
164151243|NCT00413699|592915754|FG002|Initial Period|Adverse event not related to study drug|0|||
164151244|NCT00413699|592915752|FG000|Initial Period|Missing end of study page|0|||
164151245|NCT00413699|592915753|FG001|Initial Period|Missing end of study page|4|||
164151246|NCT00413699|592915754|FG002|Initial Period|Missing end of study page|0|||
164151247|NCT00413699|592915752|FG000|Initial Period|No longer willing to participate|116|||
164151248|NCT00413699|592915753|FG001|Initial Period|No longer willing to participate|368|||
164151249|NCT00413699|592915754|FG002|Initial Period|No longer willing to participate|0|||
164151250|NCT00413699|592915752|FG000|Extension Period|No Longer Willing to Participate|0|||
164151251|NCT00413699|592915753|FG001|Extension Period|No Longer Willing to Participate|0|||
164151252|NCT00413699|592915754|FG002|Extension Period|No Longer Willing to Participate|2|||
164151253|NCT00413699|592915752|FG000|Extension Period|Protocol Violation|0|||
164151254|NCT00413699|592915753|FG001|Extension Period|Protocol Violation|0|||
164151255|NCT00413699|592915754|FG002|Extension Period|Protocol Violation|1|||
164151256|NCT00413699|592915752|FG000|Extension Period|Adverse Event|0|||
164151257|NCT00413699|592915753|FG001|Extension Period|Adverse Event|0|||
164151258|NCT00413699|592915754|FG002|Extension Period|Adverse Event|2|||
164151259|NCT02115269|592915756|FG000|Overall Study|Lost to Follow-up|43|||
164151260|NCT02115269|592915756|FG000|Overall Study|Did not complete patient diary|3|||
164151261|NCT02115269|592915756|FG000|Overall Study|Moved to another city|7|||
164151262|NCT02115269|592915756|FG000|Overall Study|Withdrawal by Subject|2|||
164151263|NCT02115269|592915756|FG000|Overall Study|Didn't take study drug|2|||
164151264|NCT05989672|592915757|FG000|Overall Study|Adverse Event|3|||
164151265|NCT05989672|592915758|FG001|Overall Study|Adverse Event|0|||
164151266|NCT05989672|592915759|FG002|Overall Study|Adverse Event|0|||
164151267|NCT03283566|592915760|FG000|Overall Study|Lost to Follow-up|1|||
164151268|NCT03283566|592915761|FG001|Overall Study|Lost to Follow-up|2|||
164151269|NCT02760004|592915762|FG000|Overall Study|Lost to Follow-up|13|||
164151270|NCT02760004|592915763|FG001|Overall Study|Lost to Follow-up|22|||
164151271|NCT01495000|592915764|FG000|Overall Study|Lost to Follow-up|2|||
164151272|NCT01495000|592915765|FG001|Overall Study|Lost to Follow-up|2|||
164151273|NCT01495000|592915764|FG000|Overall Study|Protocol Violation|1|||
164151274|NCT01495000|592915765|FG001|Overall Study|Protocol Violation|0|||
164151275|NCT01495000|592915764|FG000|Overall Study|Withdrawal by Subject|10|||
164151276|NCT01495000|592915765|FG001|Overall Study|Withdrawal by Subject|10|||
164151277|NCT02070965|592915766|FG000|Overall Study|Lost to Follow-up|0|||
164151278|NCT02070965|592915767|FG001|Overall Study|Lost to Follow-up|1|||
164151279|NCT02070965|592915768|FG002|Overall Study|Lost to Follow-up|0|||
164151280|NCT02070965|592915766|FG000|Overall Study|Withdrawal by Subject|1|||
164151281|NCT02070965|592915767|FG001|Overall Study|Withdrawal by Subject|1|||
164151282|NCT02070965|592915768|FG002|Overall Study|Withdrawal by Subject|1|||
164151283|NCT02070965|592915766|FG000|Overall Study|Subject moved|1|||
164151284|NCT02070965|592915767|FG001|Overall Study|Subject moved|0|||
164151285|NCT02070965|592915768|FG002|Overall Study|Subject moved|0|||
164151286|NCT03889886|592915769|FG000|Overall Study|Other|0|||
164151287|NCT03889886|592915770|FG001|Overall Study|Other|1|||
164151288|NCT03889886|592915771|FG002|Overall Study|Other|0|||
164151289|NCT03889886|592915772|FG003|Overall Study|Other|1|||
164151290|NCT03889886|592915769|FG000|Overall Study|Withdrawal by Subject|0|||
164151441|NCT03172494|592915839|FG001|Overall Study|Lack of Efficacy|0|||
164151291|NCT03889886|592915770|FG001|Overall Study|Withdrawal by Subject|0|||
164151292|NCT03889886|592915771|FG002|Overall Study|Withdrawal by Subject|1|||
164151293|NCT03889886|592915772|FG003|Overall Study|Withdrawal by Subject|0|||
164151294|NCT03889886|592915769|FG000|Overall Study|Adverse Event|0|||
164151295|NCT03889886|592915770|FG001|Overall Study|Adverse Event|0|||
164151296|NCT03889886|592915771|FG002|Overall Study|Adverse Event|0|||
164151297|NCT03889886|592915772|FG003|Overall Study|Adverse Event|6|||
164151298|NCT01308424|592915774|FG000|Baseline Eligibility|Screen Failures|71|||
164151299|NCT01308424|592915775|FG001|Baseline Eligibility|Screen Failures|0|||
164151300|NCT01308424|592915776|FG002|Baseline Eligibility|Screen Failures|0|||
164151301|NCT01308424|592915774|FG000|Randomization|Adverse Event|0|||
164151302|NCT01308424|592915775|FG001|Randomization|Adverse Event|1|||
164151303|NCT01308424|592915776|FG002|Randomization|Adverse Event|1|||
164151304|NCT01308424|592915774|FG000|Randomization|Lost to Follow-up|0|||
164151305|NCT01308424|592915775|FG001|Randomization|Lost to Follow-up|1|||
164151306|NCT01308424|592915776|FG002|Randomization|Lost to Follow-up|0|||
164151307|NCT01308424|592915774|FG000|Randomization|Physician Decision|0|||
164151308|NCT01308424|592915775|FG001|Randomization|Physician Decision|1|||
164151309|NCT01308424|592915776|FG002|Randomization|Physician Decision|1|||
164151310|NCT00948155|592915777|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
164151311|NCT00948155|592915778|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
164151312|NCT00948155|592915777|FG000|Washout 14 Days|Lost to Follow-up|1|||
164151313|NCT00948155|592915778|FG001|Washout 14 Days|Lost to Follow-up|2|||
164151314|NCT05767905|592915779|FG000|Overall Study|Adverse Event|0|||
164151315|NCT05767905|592915780|FG001|Overall Study|Adverse Event|0|||
164151316|NCT05767905|592915781|FG002|Overall Study|Adverse Event|1|||
164151317|NCT01841593|592915782|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
164151318|NCT01841593|592915783|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
164151319|NCT01841593|592915782|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
164151320|NCT01841593|592915783|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
164151321|NCT02635984|592915784|FG000|Overall Study|Lost to Follow-up|2|||
164151322|NCT02635984|592915785|FG001|Overall Study|Lost to Follow-up|4|||
164151323|NCT02635984|592915784|FG000|Overall Study|Study Arm Closed|1|||
164151324|NCT02635984|592915785|FG001|Overall Study|Study Arm Closed|0|||
164151325|NCT00307086|592915788|FG000|Overall Study|ineligible|5|||
164151326|NCT01487525|592915789|FG000|Overall Study|Withdrawal by Subject|0|||
164151327|NCT01487525|592915790|FG001|Overall Study|Withdrawal by Subject|1|||
164151328|NCT03518008|592915791|FG000|Period 2, Second Week of Wear|Family emergency|0|||
164151329|NCT03518008|592915792|FG001|Period 2, Second Week of Wear|Family emergency|1|||
164151330|NCT02501928|592915797|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
164151331|NCT02501928|592915798|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
164151332|NCT02501928|592915799|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
164151333|NCT02501928|592915800|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
164151334|NCT02501928|592915801|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
164151335|NCT02501928|592915802|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
164151336|NCT01197911|592915803|FG000|Overall Study|Adverse Event|0|||
164151337|NCT01197911|592915804|FG001|Overall Study|Adverse Event|0|||
164151338|NCT01197911|592915805|FG002|Overall Study|Adverse Event|1|||
164151339|NCT00838526|592915806|FG000|Overall Study|Adverse Event|3|||
164151340|NCT00838526|592915807|FG001|Overall Study|Adverse Event|12|||
164151341|NCT00838526|592915806|FG000|Overall Study|Lost to Follow-up|4|||
164151342|NCT00838526|592915807|FG001|Overall Study|Lost to Follow-up|12|||
164151343|NCT00838526|592915806|FG000|Overall Study|Withdrawal by Subject|4|||
164151344|NCT00838526|592915807|FG001|Overall Study|Withdrawal by Subject|5|||
164151345|NCT00838526|592915806|FG000|Overall Study|Lack of Efficacy|2|||
164151346|NCT00838526|592915807|FG001|Overall Study|Lack of Efficacy|3|||
164151347|NCT00838526|592915806|FG000|Overall Study|Other|11|||
164151348|NCT00838526|592915807|FG001|Overall Study|Other|7|||
164151349|NCT04338022|592915809|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
164151350|NCT04338022|592915810|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
164151351|NCT04338022|592915809|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
164151352|NCT04338022|592915810|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
164151353|NCT04338022|592915809|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
164151354|NCT04338022|592915810|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
164151355|NCT04338022|592915809|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
164151356|NCT04338022|592915810|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
164151357|NCT04338022|592915809|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
164151358|NCT04338022|592915810|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
164151359|NCT04338022|592915809|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
164151360|NCT04338022|592915810|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
164151361|NCT04338022|592915809|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
164151362|NCT04338022|592915810|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
164151363|NCT04338022|592915809|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
164151364|NCT04338022|592915810|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
164151365|NCT04338022|592915809|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
164151366|NCT04338022|592915810|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
164151367|NCT04338022|592915809|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
164151368|NCT04338022|592915810|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
164151369|NCT04338022|592915809|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
164151370|NCT04338022|592915810|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
164151371|NCT04338022|592915809|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
164151372|NCT04338022|592915810|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
164151373|NCT04338022|592915809|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
164151374|NCT04338022|592915810|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
164151375|NCT04338022|592915809|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
164151376|NCT04338022|592915810|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
164151377|NCT00786409|592915811|FG000|Overall Study|Withdrawal by Subject|2|||
164151378|NCT00786409|592915811|FG000|Overall Study|Adverse Event|2|||
164151379|NCT00786409|592915811|FG000|Overall Study|Pregnancy|2|||
164151380|NCT00786409|592915811|FG000|Overall Study|Lost to Follow-up|1|||
164151381|NCT00610129|592915812|FG000|Overall Study|Not treated since patients ineligible|3|||
164151382|NCT02273388|592915815|FG000|Overall Study|Adverse Event|0|||
164151383|NCT02273388|592915816|FG001|Overall Study|Adverse Event|0|||
164151384|NCT02273388|592915817|FG002|Overall Study|Adverse Event|0|||
164151385|NCT02273388|592915818|FG003|Overall Study|Adverse Event|0|||
164151386|NCT02273388|592915819|FG004|Overall Study|Adverse Event|0|||
164151387|NCT02273388|592915820|FG005|Overall Study|Adverse Event|0|||
164151388|NCT02273388|592915821|FG006|Overall Study|Adverse Event|1|||
164151389|NCT02273388|592915822|FG007|Overall Study|Adverse Event|2|||
164151390|NCT02273388|592915823|FG008|Overall Study|Adverse Event|0|||
164151391|NCT02273388|592915824|FG009|Overall Study|Adverse Event|0|||
164151392|NCT02273388|592915825|FG010|Overall Study|Adverse Event|0|||
164151393|NCT02273388|592915826|FG011|Overall Study|Adverse Event|0|||
164151394|NCT02273388|592915815|FG000|Overall Study|Adverse Event study disease worse|4|||
164151395|NCT02273388|592915816|FG001|Overall Study|Adverse Event study disease worse|3|||
164151396|NCT02273388|592915817|FG002|Overall Study|Adverse Event study disease worse|3|||
164151397|NCT02273388|592915818|FG003|Overall Study|Adverse Event study disease worse|2|||
164151398|NCT02273388|592915819|FG004|Overall Study|Adverse Event study disease worse|4|||
164151399|NCT02273388|592915820|FG005|Overall Study|Adverse Event study disease worse|3|||
164151400|NCT02273388|592915821|FG006|Overall Study|Adverse Event study disease worse|14|||
164151401|NCT02273388|592915822|FG007|Overall Study|Adverse Event study disease worse|6|||
164151402|NCT02273388|592915823|FG008|Overall Study|Adverse Event study disease worse|6|||
164151403|NCT02273388|592915824|FG009|Overall Study|Adverse Event study disease worse|5|||
164151404|NCT02273388|592915825|FG010|Overall Study|Adverse Event study disease worse|10|||
164151405|NCT02273388|592915826|FG011|Overall Study|Adverse Event study disease worse|1|||
164151406|NCT02273388|592915815|FG000|Overall Study|Sponsor decision|0|||
164151407|NCT02273388|592915816|FG001|Overall Study|Sponsor decision|0|||
164151408|NCT02273388|592915817|FG002|Overall Study|Sponsor decision|0|||
164151409|NCT02273388|592915818|FG003|Overall Study|Sponsor decision|0|||
164151410|NCT02273388|592915819|FG004|Overall Study|Sponsor decision|0|||
164151411|NCT02273388|592915820|FG005|Overall Study|Sponsor decision|0|||
164151412|NCT02273388|592915821|FG006|Overall Study|Sponsor decision|0|||
164151413|NCT02273388|592915822|FG007|Overall Study|Sponsor decision|0|||
164151414|NCT02273388|592915823|FG008|Overall Study|Sponsor decision|0|||
164151415|NCT02273388|592915824|FG009|Overall Study|Sponsor decision|0|||
164151416|NCT02273388|592915825|FG010|Overall Study|Sponsor decision|0|||
164151417|NCT02273388|592915826|FG011|Overall Study|Sponsor decision|1|||
164151418|NCT04331808|592915827|FG000|Overall Study|Withdrew consent|1|||
164151419|NCT04331808|592915828|FG001|Overall Study|Withdrew consent|0|||
164151420|NCT04331808|592915829|FG002|Overall Study|Withdrew consent|2|||
164151421|NCT04331808|592915830|FG003|Overall Study|Withdrew consent|3|||
164151422|NCT02445963|592915831|FG000|Overall Study|Lost to Follow-up|1|||
164151423|NCT02445963|592915832|FG001|Overall Study|Lost to Follow-up|0|||
164151424|NCT02445963|592915833|FG002|Overall Study|Lost to Follow-up|0|||
164151425|NCT02445963|592915834|FG003|Overall Study|Lost to Follow-up|0|||
164151426|NCT02445963|592915831|FG000|Overall Study|Change in employment|1|||
164151427|NCT02445963|592915832|FG001|Overall Study|Change in employment|0|||
164151428|NCT02445963|592915833|FG002|Overall Study|Change in employment|0|||
164151429|NCT02445963|592915834|FG003|Overall Study|Change in employment|0|||
164151430|NCT02445963|592915831|FG000|Overall Study|Symptoms post-vaccination|0|||
164151431|NCT02445963|592915832|FG001|Overall Study|Symptoms post-vaccination|0|||
164151432|NCT02445963|592915833|FG002|Overall Study|Symptoms post-vaccination|1|||
164151433|NCT02445963|592915834|FG003|Overall Study|Symptoms post-vaccination|0|||
164151434|NCT03172494|592915838|FG000|Overall Study|Adverse Event|5|||
164151435|NCT03172494|592915839|FG001|Overall Study|Adverse Event|1|||
164151436|NCT03172494|592915840|FG002|Overall Study|Adverse Event|15|||
164151437|NCT03172494|592915838|FG000|Overall Study|Protocol Violation|3|||
164151438|NCT03172494|592915839|FG001|Overall Study|Protocol Violation|2|||
164151439|NCT03172494|592915840|FG002|Overall Study|Protocol Violation|1|||
164151440|NCT03172494|592915838|FG000|Overall Study|Lack of Efficacy|0|||
164151442|NCT03172494|592915840|FG002|Overall Study|Lack of Efficacy|4|||
164151443|NCT03172494|592915838|FG000|Overall Study|Pregnancy|0|||
164151444|NCT03172494|592915839|FG001|Overall Study|Pregnancy|1|||
164151445|NCT03172494|592915840|FG002|Overall Study|Pregnancy|0|||
164151446|NCT03172494|592915838|FG000|Overall Study|Withdrawal by Subject|10|||
164151447|NCT03172494|592915839|FG001|Overall Study|Withdrawal by Subject|8|||
164151448|NCT03172494|592915840|FG002|Overall Study|Withdrawal by Subject|8|||
164151449|NCT03172494|592915838|FG000|Overall Study|Severe hypoglycaemic episode|0|||
164151450|NCT03172494|592915839|FG001|Overall Study|Severe hypoglycaemic episode|0|||
164151451|NCT03172494|592915840|FG002|Overall Study|Severe hypoglycaemic episode|1|||
164151452|NCT03172494|592915838|FG000|Overall Study|Non-compliance towards treatment|2|||
164151453|NCT03172494|592915839|FG001|Overall Study|Non-compliance towards treatment|0|||
164151454|NCT03172494|592915840|FG002|Overall Study|Non-compliance towards treatment|0|||
164151455|NCT04233073|592915841|FG000|Overall Study|Death|5|||
164151456|NCT00143390|592915842|FG000|Overall Study|Death|2|||
164151457|NCT00143390|592915843|FG001|Overall Study|Death|0|||
164151458|NCT00143390|592915842|FG000|Overall Study|Not meeting entry criteria|2|||
164151459|NCT00143390|592915843|FG001|Overall Study|Not meeting entry criteria|5|||
164151460|NCT00143390|592915842|FG000|Overall Study|Withdrawal by Subject|4|||
164151461|NCT00143390|592915843|FG001|Overall Study|Withdrawal by Subject|4|||
164151462|NCT00143390|592915842|FG000|Overall Study|Progressive disease|119|||
164151463|NCT00143390|592915843|FG001|Overall Study|Progressive disease|115|||
164151464|NCT00143390|592915842|FG000|Overall Study|Protocol Violation|2|||
164151465|NCT00143390|592915843|FG001|Overall Study|Protocol Violation|0|||
164151466|NCT00143390|592915842|FG000|Overall Study|Study termination|10|||
164151467|NCT00143390|592915843|FG001|Overall Study|Study termination|15|||
164151468|NCT00143390|592915842|FG000|Overall Study|Adverse Event|9|||
164151469|NCT00143390|592915843|FG001|Overall Study|Adverse Event|8|||
164151470|NCT00143390|592915842|FG000|Overall Study|Other|1|||
164151471|NCT00143390|592915843|FG001|Overall Study|Other|2|||
164151472|NCT00243412|592915845|FG000|Overall Study|Death|0|||
164151473|NCT00243412|592915846|FG001|Overall Study|Death|1|||
164151474|NCT00243412|592915845|FG000|Overall Study|Adverse Event|4|||
164151475|NCT00243412|592915846|FG001|Overall Study|Adverse Event|2|||
164151476|NCT00243412|592915845|FG000|Overall Study|Lost to Follow-up|0|||
164151477|NCT00243412|592915846|FG001|Overall Study|Lost to Follow-up|1|||
164151478|NCT00243412|592915845|FG000|Overall Study|Physician Decision|1|||
164151479|NCT00243412|592915846|FG001|Overall Study|Physician Decision|1|||
164151480|NCT00243412|592915845|FG000|Overall Study|Withdrawal by Subject|4|||
164151481|NCT00243412|592915846|FG001|Overall Study|Withdrawal by Subject|5|||
164151482|NCT00243412|592915845|FG000|Overall Study|Other|1|||
164151483|NCT00243412|592915846|FG001|Overall Study|Other|1|||
164151484|NCT00041132|592915847|FG000|Overall Study|Adverse Event|19|||
164151485|NCT00041132|592915847|FG000|Overall Study|Death|1|||
164151486|NCT00041132|592915847|FG000|Overall Study|Not Eligible|7|||
164151487|NCT00041132|592915847|FG000|Overall Study|Withdrawal by Subject|1|||
164151488|NCT00041132|592915847|FG000|Overall Study|Physician Decision|2|||
164151489|NCT02764151|592915848|FG000|Overall Study|Subject refused further follow-up|0|||
164151490|NCT02764151|592915849|FG001|Overall Study|Subject refused further follow-up|0|||
164151491|NCT02764151|592915850|FG002|Overall Study|Subject refused further follow-up|0|||
164151492|NCT02764151|592915851|FG003|Overall Study|Subject refused further follow-up|1|||
164151493|NCT02764151|592915848|FG000|Overall Study|Other|0|||
164151494|NCT02764151|592915849|FG001|Overall Study|Other|0|||
164151495|NCT02764151|592915850|FG002|Overall Study|Other|0|||
164151496|NCT02764151|592915851|FG003|Overall Study|Other|2|||
164151497|NCT01450683|592915855|FG000|Overall Study|Adverse Event|2|||
164151498|NCT00625872|592915857|FG000|Overall Study|Withdrawal by Subject|1|||
164151499|NCT00625872|592915858|FG001|Overall Study|Withdrawal by Subject|0|||
164151500|NCT00625872|592915857|FG000|Overall Study|Does not meet inclusion criteria|1|||
164151501|NCT00625872|592915858|FG001|Overall Study|Does not meet inclusion criteria|0|||
164151502|NCT00625872|592915857|FG000|Overall Study|Terminated by sponsor|2|||
164151503|NCT00625872|592915858|FG001|Overall Study|Terminated by sponsor|5|||
164151504|NCT00625872|592915857|FG000|Overall Study|Randomized but not treated|0|||
164151505|NCT00625872|592915858|FG001|Overall Study|Randomized but not treated|1|||
164151506|NCT01512160|592915859|FG000|Overall Study|Lost to Follow-up|1|||
164151507|NCT01512160|592915860|FG001|Overall Study|Lost to Follow-up|0|||
164151508|NCT01512160|592915861|FG002|Overall Study|Lost to Follow-up|0|||
164151509|NCT01512160|592915862|FG003|Overall Study|Lost to Follow-up|0|||
164151510|NCT01512160|592915859|FG000|Overall Study|Withdrawal by Subject|1|||
164151511|NCT01512160|592915860|FG001|Overall Study|Withdrawal by Subject|0|||
164151512|NCT01512160|592915861|FG002|Overall Study|Withdrawal by Subject|0|||
164151513|NCT01512160|592915862|FG003|Overall Study|Withdrawal by Subject|1|||
164151514|NCT02729909|592915863|FG000|Overall Study|Lost to Follow-up|0|||
164151515|NCT02729909|592915864|FG001|Overall Study|Lost to Follow-up|1|||
164151516|NCT02729909|592915863|FG000|Overall Study|Lack of Efficacy|0|||
164151517|NCT02729909|592915864|FG001|Overall Study|Lack of Efficacy|2|||
164151518|NCT02729909|592915863|FG000|Overall Study|Significant Protocol Deviation|0|||
164151519|NCT02729909|592915864|FG001|Overall Study|Significant Protocol Deviation|2|||
164151520|NCT02729909|592915863|FG000|Overall Study|Voluntary Withdrawal|1|||
164151521|NCT02729909|592915864|FG001|Overall Study|Voluntary Withdrawal|0|||
164151522|NCT04779879|592915868|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
164151523|NCT04779879|592915869|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
164151524|NCT04779879|592915870|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
164151525|NCT04779879|592915871|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
164151526|NCT04779879|592915872|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
164151527|NCT04779879|592915873|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
164151528|NCT04779879|592915868|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
164151529|NCT04779879|592915869|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
164151530|NCT04779879|592915870|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
164151531|NCT04779879|592915871|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
164151532|NCT04779879|592915872|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
164151533|NCT04779879|592915873|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
164151534|NCT04779879|592915868|FG000|Part C: Up to Week 36|Death|0|||
164151535|NCT04779879|592915869|FG001|Part C: Up to Week 36|Death|0|||
164151536|NCT04779879|592915870|FG002|Part C: Up to Week 36|Death|0|||
164151537|NCT04779879|592915871|FG003|Part C: Up to Week 36|Death|0|||
164151538|NCT04779879|592915872|FG004|Part C: Up to Week 36|Death|0|||
164151539|NCT04779879|592915873|FG005|Part C: Up to Week 36|Death|1|||
164151540|NCT04779879|592915868|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
164151541|NCT04779879|592915869|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
164151542|NCT04779879|592915870|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
164151543|NCT04779879|592915871|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
164151544|NCT04779879|592915872|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
164151545|NCT04779879|592915873|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
164151546|NCT05101343|592915874|FG000|Overall Study|Withdrawal by Subject|2|||
164151547|NCT05101343|592915875|FG001|Overall Study|Withdrawal by Subject|1|||
164151548|NCT02854527|592915876|FG000|Overall Study|Adverse Event|0|||
164151549|NCT02854527|592915877|FG001|Overall Study|Adverse Event|0|||
164151550|NCT02854527|592915878|FG002|Overall Study|Adverse Event|0|||
164151551|NCT02854527|592915879|FG003|Overall Study|Adverse Event|0|||
164151552|NCT02854527|592915880|FG004|Overall Study|Adverse Event|1|||
164151553|NCT02854527|592915881|FG005|Overall Study|Adverse Event|0|||
164151554|NCT02854527|592915882|FG006|Overall Study|Adverse Event|0|||
164151555|NCT02854527|592915883|FG007|Overall Study|Adverse Event|0|||
164151556|NCT02854527|592915884|FG008|Overall Study|Adverse Event|0|||
164151557|NCT02854527|592915885|FG009|Overall Study|Adverse Event|0|||
164151558|NCT02854527|592915876|FG000|Overall Study|Lost to Follow-up|0|||
164151559|NCT02854527|592915877|FG001|Overall Study|Lost to Follow-up|0|||
164151560|NCT02854527|592915878|FG002|Overall Study|Lost to Follow-up|0|||
164151561|NCT02854527|592915879|FG003|Overall Study|Lost to Follow-up|1|||
164151562|NCT02854527|592915880|FG004|Overall Study|Lost to Follow-up|0|||
164151563|NCT02854527|592915881|FG005|Overall Study|Lost to Follow-up|0|||
164151564|NCT02854527|592915882|FG006|Overall Study|Lost to Follow-up|0|||
164151565|NCT02854527|592915883|FG007|Overall Study|Lost to Follow-up|0|||
164151566|NCT02854527|592915884|FG008|Overall Study|Lost to Follow-up|0|||
164151567|NCT02854527|592915885|FG009|Overall Study|Lost to Follow-up|0|||
164151568|NCT01959295|592915886|FG000|Overall Study|Adverse Event|2|||
164151569|NCT01959295|592915887|FG001|Overall Study|Adverse Event|0|||
164151570|NCT01959295|592915886|FG000|Overall Study|Lost to Follow-up|0|||
164151571|NCT01959295|592915887|FG001|Overall Study|Lost to Follow-up|2|||
164151572|NCT01959295|592915886|FG000|Overall Study|Physician Decision|2|||
164151573|NCT01959295|592915887|FG001|Overall Study|Physician Decision|3|||
164151574|NCT01959295|592915886|FG000|Overall Study|Protocol Violation|16|||
164151575|NCT01959295|592915887|FG001|Overall Study|Protocol Violation|5|||
164151576|NCT01959295|592915886|FG000|Overall Study|Withdrawal by Subject|3|||
164151577|NCT01959295|592915887|FG001|Overall Study|Withdrawal by Subject|1|||
164151578|NCT01959295|592915886|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
164151579|NCT01959295|592915887|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
164151580|NCT01682811|592915890|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
164151581|NCT01682811|592915891|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
164151582|NCT01682811|592915892|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
164151583|NCT01682811|592915893|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
164151584|NCT01682811|592915894|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
164151585|NCT01682811|592915895|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
164151586|NCT01682811|592915896|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
164151587|NCT01682811|592915890|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
164151588|NCT01682811|592915891|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
164151589|NCT01682811|592915892|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
164151590|NCT01682811|592915893|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
164151591|NCT01682811|592915894|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
164151592|NCT01682811|592915895|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
164151593|NCT01682811|592915896|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
164151594|NCT01682811|592915890|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
164151595|NCT01682811|592915891|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
164151596|NCT01682811|592915892|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
164151597|NCT01682811|592915893|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
164151598|NCT01682811|592915894|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
164151599|NCT01682811|592915895|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
164151600|NCT01682811|592915896|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
164151601|NCT01682811|592915890|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
164151602|NCT01682811|592915891|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
164151603|NCT01682811|592915892|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
164151604|NCT01682811|592915893|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
164151605|NCT01682811|592915894|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
164151606|NCT01682811|592915895|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
164151607|NCT01682811|592915896|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
164151608|NCT01128179|592915897|FG000|Overall Study|Death|1|||
164151609|NCT01128179|592915898|FG001|Overall Study|Death|0|||
164151610|NCT01128179|592915897|FG000|Overall Study|Protocol Violation|1|||
164151611|NCT01128179|592915898|FG001|Overall Study|Protocol Violation|0|||
164151612|NCT02694328|592915902|FG000|Overall Study|Adverse Event|27|||
164151613|NCT02694328|592915903|FG001|Overall Study|Adverse Event|33|||
164151614|NCT02694328|592915902|FG000|Overall Study|Withdrawal by Subject|27|||
164151615|NCT02694328|592915903|FG001|Overall Study|Withdrawal by Subject|23|||
164151616|NCT02694328|592915902|FG000|Overall Study|Lost to Follow-up|26|||
164151617|NCT02694328|592915903|FG001|Overall Study|Lost to Follow-up|22|||
164151618|NCT02694328|592915902|FG000|Overall Study|Noncompliant with study drug|11|||
164151619|NCT02694328|592915903|FG001|Overall Study|Noncompliant with study drug|8|||
164151620|NCT02694328|592915902|FG000|Overall Study|Incarceration|1|||
164151621|NCT02694328|592915903|FG001|Overall Study|Incarceration|1|||
164151622|NCT02694328|592915902|FG000|Overall Study|Lack of Efficacy|1|||
164151623|NCT02694328|592915903|FG001|Overall Study|Lack of Efficacy|2|||
164151624|NCT02694328|592915902|FG000|Overall Study|Pregnancy|1|||
164151625|NCT02694328|592915903|FG001|Overall Study|Pregnancy|1|||
164151626|NCT02694328|592915902|FG000|Overall Study|Protocol Violation|6|||
164151627|NCT02694328|592915903|FG001|Overall Study|Protocol Violation|5|||
164151628|NCT02694328|592915902|FG000|Overall Study|Abnormal Laboratory Value|0|||
164151629|NCT02694328|592915903|FG001|Overall Study|Abnormal Laboratory Value|3|||
164151630|NCT03511105|592917876|FG000|Overall Study|Adverse Event|1|||
164151631|NCT03511105|592917877|FG001|Overall Study|Adverse Event|0|||
164151632|NCT03511105|592917876|FG000|Overall Study|Withdrew consent|1|||
164151633|NCT03511105|592917877|FG001|Overall Study|Withdrew consent|0|||
164151634|NCT02810457|592917878|FG000|Overall Study|Randomised but no treatment received|2|||
164151635|NCT02810457|592917879|FG001|Overall Study|Randomised but no treatment received|1|||
164151636|NCT02810457|592917878|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
164151637|NCT02810457|592917879|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
164151638|NCT02810457|592917878|FG000|Overall Study|Adverse Event|37|||
164151639|NCT02810457|592917879|FG001|Overall Study|Adverse Event|43|||
164151640|NCT02810457|592917878|FG000|Overall Study|Patient decision|31|||
164151641|NCT02810457|592917879|FG001|Overall Study|Patient decision|35|||
164151642|NCT02810457|592917878|FG000|Overall Study|Patient lost to follow-up|2|||
164151643|NCT02810457|592917879|FG001|Overall Study|Patient lost to follow-up|2|||
164151644|NCT02810457|592917878|FG000|Overall Study|Death|39|||
164151645|NCT02810457|592917879|FG001|Overall Study|Death|28|||
164151646|NCT02810457|592917878|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
164151647|NCT02810457|592917879|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
164151648|NCT02810457|592917878|FG000|Overall Study|Clinical progression|15|||
164151649|NCT02810457|592917879|FG001|Overall Study|Clinical progression|16|||
164151650|NCT02810457|592917878|FG000|Overall Study|Investigator decision|3|||
164151651|NCT02810457|592917879|FG001|Overall Study|Investigator decision|2|||
164151652|NCT02810457|592917878|FG000|Overall Study|Patient ineligibility|3|||
164151653|NCT02810457|592917879|FG001|Overall Study|Patient ineligibility|0|||
164151654|NCT02810457|592917878|FG000|Overall Study|Miscalculated PD|1|||
164151655|NCT02810457|592917879|FG001|Overall Study|Miscalculated PD|0|||
164151656|NCT02810457|592917878|FG000|Overall Study|Physician Decision|0|||
164151657|NCT02810457|592917879|FG001|Overall Study|Physician Decision|1|||
164151658|NCT01962103|592917880|FG000|Phase 1|Adverse Event|4|||
164151659|NCT01962103|592917881|FG001|Phase 1|Adverse Event|0|||
164151660|NCT01962103|592917882|FG002|Phase 1|Adverse Event|2|||
164151661|NCT01962103|592917883|FG003|Phase 1|Adverse Event|1|||
164151662|NCT01962103|592917884|FG004|Phase 1|Adverse Event|2|||
164151663|NCT01962103|592917885|FG005|Phase 1|Adverse Event|2|||
164151664|NCT01962103|592917886|FG006|Phase 1|Adverse Event|0|||
164151665|NCT01962103|592917887|FG007|Phase 1|Adverse Event|0|||
164151666|NCT01962103|592917888|FG008|Phase 1|Adverse Event|0|||
164151667|NCT01962103|592917880|FG000|Phase 1|Progressive Disease|8|||
164151668|NCT01962103|592917881|FG001|Phase 1|Progressive Disease|6|||
164151669|NCT01962103|592917882|FG002|Phase 1|Progressive Disease|8|||
164151670|NCT01962103|592917883|FG003|Phase 1|Progressive Disease|4|||
164151671|NCT01962103|592917884|FG004|Phase 1|Progressive Disease|5|||
164151672|NCT01962103|592917885|FG005|Phase 1|Progressive Disease|4|||
164151673|NCT01962103|592917886|FG006|Phase 1|Progressive Disease|0|||
164151674|NCT01962103|592917887|FG007|Phase 1|Progressive Disease|0|||
164151675|NCT01962103|592917888|FG008|Phase 1|Progressive Disease|0|||
164151676|NCT01962103|592917880|FG000|Phase 1|Withdrawal by Subject|0|||
164151677|NCT01962103|592917881|FG001|Phase 1|Withdrawal by Subject|0|||
164151678|NCT01962103|592917882|FG002|Phase 1|Withdrawal by Subject|0|||
164151679|NCT01962103|592917883|FG003|Phase 1|Withdrawal by Subject|2|||
164151680|NCT01962103|592917884|FG004|Phase 1|Withdrawal by Subject|0|||
164151681|NCT01962103|592917885|FG005|Phase 1|Withdrawal by Subject|0|||
164151682|NCT01962103|592917886|FG006|Phase 1|Withdrawal by Subject|0|||
164151683|NCT01962103|592917887|FG007|Phase 1|Withdrawal by Subject|0|||
164151684|NCT01962103|592917888|FG008|Phase 1|Withdrawal by Subject|0|||
164151685|NCT01962103|592917880|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
164151686|NCT01962103|592917881|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
164151687|NCT01962103|592917882|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
164151688|NCT01962103|592917883|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
164151689|NCT01962103|592917884|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
164151690|NCT01962103|592917885|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
164151691|NCT01962103|592917886|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
164151692|NCT01962103|592917887|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
164151693|NCT01962103|592917888|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
164151694|NCT01962103|592917880|FG000|Phase 1|Physician Decision|0|||
164151695|NCT01962103|592917881|FG001|Phase 1|Physician Decision|0|||
164151696|NCT01962103|592917882|FG002|Phase 1|Physician Decision|0|||
164151697|NCT01962103|592917883|FG003|Phase 1|Physician Decision|1|||
164151698|NCT01962103|592917884|FG004|Phase 1|Physician Decision|0|||
164151699|NCT01962103|592917885|FG005|Phase 1|Physician Decision|0|||
164151700|NCT01962103|592917886|FG006|Phase 1|Physician Decision|0|||
164151701|NCT01962103|592917887|FG007|Phase 1|Physician Decision|0|||
164151702|NCT01962103|592917888|FG008|Phase 1|Physician Decision|0|||
164151703|NCT01962103|592917880|FG000|Phase 1|Symptomatic Deterioration|3|||
164151704|NCT01962103|592917881|FG001|Phase 1|Symptomatic Deterioration|2|||
164151705|NCT01962103|592917882|FG002|Phase 1|Symptomatic Deterioration|2|||
164151706|NCT01962103|592917883|FG003|Phase 1|Symptomatic Deterioration|2|||
164151707|NCT01962103|592917884|FG004|Phase 1|Symptomatic Deterioration|1|||
164151708|NCT01962103|592917885|FG005|Phase 1|Symptomatic Deterioration|1|||
164151709|NCT01962103|592917886|FG006|Phase 1|Symptomatic Deterioration|0|||
164151710|NCT01962103|592917887|FG007|Phase 1|Symptomatic Deterioration|0|||
164151711|NCT01962103|592917888|FG008|Phase 1|Symptomatic Deterioration|0|||
164151712|NCT01962103|592917880|FG000|Phase 1|Miscellaneous|1|||
164151713|NCT01962103|592917881|FG001|Phase 1|Miscellaneous|0|||
164151714|NCT01962103|592917882|FG002|Phase 1|Miscellaneous|0|||
164151715|NCT01962103|592917883|FG003|Phase 1|Miscellaneous|0|||
164151716|NCT01962103|592917884|FG004|Phase 1|Miscellaneous|0|||
164151717|NCT01962103|592917885|FG005|Phase 1|Miscellaneous|0|||
164151718|NCT01962103|592917886|FG006|Phase 1|Miscellaneous|0|||
164151719|NCT01962103|592917887|FG007|Phase 1|Miscellaneous|0|||
164151720|NCT01962103|592917888|FG008|Phase 1|Miscellaneous|0|||
164151721|NCT01962103|592917880|FG000|Phase 2|Adverse Event|0|||
164151722|NCT01962103|592917881|FG001|Phase 2|Adverse Event|0|||
164151723|NCT01962103|592917882|FG002|Phase 2|Adverse Event|0|||
164151724|NCT01962103|592917883|FG003|Phase 2|Adverse Event|0|||
164151725|NCT01962103|592917884|FG004|Phase 2|Adverse Event|0|||
164151726|NCT01962103|592917885|FG005|Phase 2|Adverse Event|0|||
164151727|NCT01962103|592917886|FG006|Phase 2|Adverse Event|1|||
164151728|NCT01962103|592917887|FG007|Phase 2|Adverse Event|0|||
164151729|NCT01962103|592917888|FG008|Phase 2|Adverse Event|3|||
164151730|NCT01962103|592917880|FG000|Phase 2|Progressive Disease|0|||
164151731|NCT01962103|592917881|FG001|Phase 2|Progressive Disease|0|||
164151732|NCT01962103|592917882|FG002|Phase 2|Progressive Disease|0|||
164151733|NCT01962103|592917883|FG003|Phase 2|Progressive Disease|0|||
164151734|NCT01962103|592917884|FG004|Phase 2|Progressive Disease|0|||
164151735|NCT01962103|592917885|FG005|Phase 2|Progressive Disease|0|||
164151736|NCT01962103|592917886|FG006|Phase 2|Progressive Disease|11|||
164151737|NCT01962103|592917887|FG007|Phase 2|Progressive Disease|12|||
164151738|NCT01962103|592917888|FG008|Phase 2|Progressive Disease|11|||
164151739|NCT01962103|592917880|FG000|Phase 2|Symptomatic Deterioration|0|||
164151740|NCT01962103|592917881|FG001|Phase 2|Symptomatic Deterioration|0|||
164151741|NCT01962103|592917882|FG002|Phase 2|Symptomatic Deterioration|0|||
164151742|NCT01962103|592917883|FG003|Phase 2|Symptomatic Deterioration|0|||
164151743|NCT01962103|592917884|FG004|Phase 2|Symptomatic Deterioration|0|||
164151744|NCT01962103|592917885|FG005|Phase 2|Symptomatic Deterioration|0|||
164151745|NCT01962103|592917886|FG006|Phase 2|Symptomatic Deterioration|2|||
164151746|NCT01962103|592917887|FG007|Phase 2|Symptomatic Deterioration|2|||
164151747|NCT01962103|592917888|FG008|Phase 2|Symptomatic Deterioration|0|||
164151748|NCT02750618|592917889|FG000|Overall Study|Withdrawal by Subject|1|||
164151749|NCT02094300|592917896|FG000|Overall Study|Death|7|||
164151750|NCT02094300|592917896|FG000|Overall Study|Lost to Follow-up|10|||
164151751|NCT02094300|592917896|FG000|Overall Study|Still be eligible for follow-up|3|||
164151752|NCT00276484|592917897|FG000|Overall Study|Adverse Event|4|||
164151753|NCT00276484|592917898|FG001|Overall Study|Adverse Event|7|||
164151754|NCT00276484|592917897|FG000|Overall Study|Lost to Follow-up|1|||
164151755|NCT00276484|592917898|FG001|Overall Study|Lost to Follow-up|1|||
164151756|NCT00276484|592917897|FG000|Overall Study|Protocol Violation|0|||
164151757|NCT00276484|592917898|FG001|Overall Study|Protocol Violation|1|||
164151758|NCT00276484|592917897|FG000|Overall Study|Withdrawal by Subject|4|||
164151759|NCT00276484|592917898|FG001|Overall Study|Withdrawal by Subject|3|||
164151760|NCT00276484|592917897|FG000|Overall Study|Could not take time off work|0|||
164151761|NCT00276484|592917898|FG001|Overall Study|Could not take time off work|1|||
164151762|NCT03347110|592917912|FG000|Overall Study|Other (Participant is incarcerated)|1|||
164151763|NCT03347110|592917912|FG000|Overall Study|Withdrawal by Subject|9|||
164151764|NCT03347110|592917912|FG000|Overall Study|Lost to Follow-up|1|||
164151765|NCT03347110|592917912|FG000|Overall Study|Lack of Efficacy|2|||
164151766|NCT03347110|592917912|FG000|Overall Study|Adverse Event, non-fatal|9|||
164151767|NCT00116779|592917913|FG000|Overall Study|Adverse Event|4|||
164151768|NCT00116779|592917914|FG001|Overall Study|Adverse Event|2|||
164151769|NCT00116779|592917913|FG000|Overall Study|Protocol Violation|1|||
164151770|NCT00116779|592917914|FG001|Overall Study|Protocol Violation|4|||
164151771|NCT00116779|592917913|FG000|Overall Study|Withdrawal by Subject|4|||
164151772|NCT00116779|592917914|FG001|Overall Study|Withdrawal by Subject|1|||
164151773|NCT00116779|592917913|FG000|Overall Study|Inadequate testosterone suppression|7|||
164151774|NCT00116779|592917914|FG001|Overall Study|Inadequate testosterone suppression|9|||
164151775|NCT00116779|592917913|FG000|Overall Study|Physician Decision|3|||
164151776|NCT00116779|592917914|FG001|Overall Study|Physician Decision|1|||
164151777|NCT00116779|592917913|FG000|Overall Study|Elevated PSA levels|2|||
164151778|NCT00116779|592917914|FG001|Overall Study|Elevated PSA levels|2|||
164151779|NCT01321879|592917918|FG000|Overall Study|Lack of Efficacy|5|||
164151780|NCT01321879|592917918|FG000|Overall Study|Adverse Event|5|||
164151781|NCT01321879|592917918|FG000|Overall Study|Death|3|||
164151782|NCT01321879|592917918|FG000|Overall Study|Withdrawal by Subject|1|||
164151783|NCT02687451|592917919|FG000|Overall Study|Withdrawal by Subject|1|||
164151784|NCT02687451|592917920|FG001|Overall Study|Withdrawal by Subject|0|||
164151785|NCT02687451|592917921|FG002|Overall Study|Withdrawal by Subject|0|||
164151786|NCT02687451|592917922|FG003|Overall Study|Withdrawal by Subject|0|||
164151787|NCT02687451|592917923|FG004|Overall Study|Withdrawal by Subject|0|||
164151788|NCT02687451|592917924|FG005|Overall Study|Withdrawal by Subject|1|||
164151789|NCT01518322|592917931|FG000|Overall Study|FeNO measurement was missing|13|||
164151790|NCT00707239|592917932|FG000|Overall Study|Adverse Event|5|||
164151791|NCT00707239|592917933|FG001|Overall Study|Adverse Event|3|||
164151792|NCT00707239|592917934|FG002|Overall Study|Adverse Event|2|||
164151793|NCT00707239|592917932|FG000|Overall Study|Death|3|||
164151794|NCT00707239|592917933|FG001|Overall Study|Death|1|||
164151795|NCT00707239|592917934|FG002|Overall Study|Death|3|||
164151796|NCT00707239|592917932|FG000|Overall Study|Physician Decision|1|||
164151797|NCT00707239|592917933|FG001|Overall Study|Physician Decision|1|||
164151798|NCT00707239|592917934|FG002|Overall Study|Physician Decision|2|||
164151799|NCT00707239|592917932|FG000|Overall Study|Protocol Violation|0|||
164151800|NCT00707239|592917933|FG001|Overall Study|Protocol Violation|0|||
164151801|NCT00707239|592917934|FG002|Overall Study|Protocol Violation|1|||
164151802|NCT00707239|592917932|FG000|Overall Study|Lack of Efficacy|1|||
164151803|NCT00707239|592917933|FG001|Overall Study|Lack of Efficacy|2|||
164151804|NCT00707239|592917934|FG002|Overall Study|Lack of Efficacy|0|||
164151805|NCT00707239|592917932|FG000|Overall Study|Randomized, but not treated|1|||
164151806|NCT00707239|592917933|FG001|Overall Study|Randomized, but not treated|1|||
164151807|NCT00707239|592917934|FG002|Overall Study|Randomized, but not treated|1|||
164151808|NCT00707239|592917932|FG000|Overall Study|Other|8|||
164151809|NCT00707239|592917933|FG001|Overall Study|Other|3|||
164151810|NCT00707239|592917934|FG002|Overall Study|Other|5|||
164151811|NCT03472014|592917935|FG000|Overall Study|Lost to Follow-up|4|||
164151812|NCT03652051|592917941|FG000|Stage 1|Adverse Event|0|||
164151813|NCT03652051|592917942|FG001|Stage 1|Adverse Event|5|||
164151814|NCT03652051|592917943|FG002|Stage 1|Adverse Event|7|||
164151815|NCT03652051|592917944|FG003|Stage 1|Adverse Event|1|||
164151816|NCT03652051|592917941|FG000|Stage 1|Withdrawal by Subject|0|||
164151817|NCT03652051|592917942|FG001|Stage 1|Withdrawal by Subject|0|||
164151818|NCT03652051|592917943|FG002|Stage 1|Withdrawal by Subject|1|||
164151819|NCT03652051|592917944|FG003|Stage 1|Withdrawal by Subject|0|||
164151820|NCT03652051|592917941|FG000|Stage 2|Adverse Event|0|||
164151821|NCT03652051|592917942|FG001|Stage 2|Adverse Event|2|||
164151822|NCT03652051|592917943|FG002|Stage 2|Adverse Event|1|||
164151823|NCT03652051|592917944|FG003|Stage 2|Adverse Event|0|||
164151824|NCT03652051|592917941|FG000|Stage 2|Protocol Violation|0|||
164151825|NCT03652051|592917942|FG001|Stage 2|Protocol Violation|1|||
164151826|NCT03652051|592917943|FG002|Stage 2|Protocol Violation|6|||
164151827|NCT03652051|592917944|FG003|Stage 2|Protocol Violation|0|||
164151828|NCT03652051|592917941|FG000|Stage 2|Lost to Follow-up|0|||
164151829|NCT03652051|592917942|FG001|Stage 2|Lost to Follow-up|2|||
164151830|NCT03652051|592917943|FG002|Stage 2|Lost to Follow-up|0|||
164151831|NCT03652051|592917944|FG003|Stage 2|Lost to Follow-up|3|||
164151832|NCT03652051|592917941|FG000|Stage 2|Withdrawal by Subject|0|||
164151833|NCT03652051|592917942|FG001|Stage 2|Withdrawal by Subject|11|||
164151834|NCT03652051|592917943|FG002|Stage 2|Withdrawal by Subject|9|||
164151835|NCT03652051|592917944|FG003|Stage 2|Withdrawal by Subject|3|||
164151836|NCT01930162|592917945|FG000|Overall Study|Abnormal test procedure result(s)|4|||
164151837|NCT01930162|592917945|FG000|Overall Study|Death|1|||
164151838|NCT02394600|592917948|FG000|Overall Study|Adverse Event|3|||
164151839|NCT02394600|592917949|FG001|Overall Study|Adverse Event|0|||
164151840|NCT02394600|592917948|FG000|Overall Study|Lost to Follow-up|0|||
164151841|NCT02394600|592917949|FG001|Overall Study|Lost to Follow-up|1|||
164151842|NCT02394600|592917948|FG000|Overall Study|Withdrawal by Subject|0|||
164151843|NCT02394600|592917949|FG001|Overall Study|Withdrawal by Subject|1|||
164151844|NCT02394600|592917948|FG000|Overall Study|Protocol Violation|1|||
164151845|NCT02394600|592917949|FG001|Overall Study|Protocol Violation|0|||
164151846|NCT02569801|592917950|FG000|Overall Study|Withdrawal by Subject|9|||
164151847|NCT02569801|592917951|FG001|Overall Study|Withdrawal by Subject|9|||
164151848|NCT02569801|592917950|FG000|Overall Study|Sponsor Decision|13|||
164151849|NCT02569801|592917951|FG001|Overall Study|Sponsor Decision|14|||
164151850|NCT02569801|592917950|FG000|Overall Study|Progressive Disease|2|||
164151851|NCT02569801|592917951|FG001|Overall Study|Progressive Disease|7|||
164151852|NCT02569801|592917950|FG000|Overall Study|Lost to Follow-up|0|||
164151853|NCT02569801|592917951|FG001|Overall Study|Lost to Follow-up|1|||
164151854|NCT02569801|592917950|FG000|Overall Study|Death|12|||
164151855|NCT02569801|592917951|FG001|Overall Study|Death|4|||
164151856|NCT03442751|592917954|FG000|Overall Study|Withdrawal by Subject|3|||
164151857|NCT03442751|592917955|FG001|Overall Study|Withdrawal by Subject|1|||
164151858|NCT03442751|592917954|FG000|Overall Study|Lost to Follow-up|3|||
164151859|NCT03442751|592917955|FG001|Overall Study|Lost to Follow-up|0|||
164151860|NCT03934541|592917956|FG000|Overall Study|Study Terminated by Sponsor|0|||
164151861|NCT03934541|592917957|FG001|Overall Study|Study Terminated by Sponsor|1|||
164151862|NCT03934541|592917958|FG002|Overall Study|Study Terminated by Sponsor|0|||
164151863|NCT03934541|592917959|FG003|Overall Study|Study Terminated by Sponsor|0|||
164151864|NCT01928472|592917962|FG000|Overall Study|Death|0|||
164151865|NCT01928472|592917963|FG001|Overall Study|Death|0|||
164151866|NCT01928472|592917964|FG002|Overall Study|Death|1|||
164151867|NCT01928472|592917965|FG003|Overall Study|Death|0|||
164151868|NCT01928472|592917962|FG000|Overall Study|Withdrawal by Subject|4|||
164151869|NCT01928472|592917963|FG001|Overall Study|Withdrawal by Subject|4|||
164151870|NCT01928472|592917964|FG002|Overall Study|Withdrawal by Subject|1|||
164151871|NCT01928472|592917965|FG003|Overall Study|Withdrawal by Subject|2|||
164151872|NCT01928472|592917962|FG000|Overall Study|Lost to Follow-up|2|||
164151873|NCT01928472|592917963|FG001|Overall Study|Lost to Follow-up|3|||
164151874|NCT01928472|592917964|FG002|Overall Study|Lost to Follow-up|4|||
164151875|NCT01928472|592917965|FG003|Overall Study|Lost to Follow-up|0|||
164151876|NCT01928472|592917962|FG000|Overall Study|Administrative Reason|2|||
164151877|NCT01928472|592917963|FG001|Overall Study|Administrative Reason|1|||
164151878|NCT01928472|592917964|FG002|Overall Study|Administrative Reason|0|||
164151879|NCT01928472|592917965|FG003|Overall Study|Administrative Reason|0|||
164151880|NCT01928472|592917962|FG000|Overall Study|Unclassified|0|||
164151881|NCT01928472|592917963|FG001|Overall Study|Unclassified|0|||
164151882|NCT01928472|592917964|FG002|Overall Study|Unclassified|1|||
164151883|NCT01928472|592917965|FG003|Overall Study|Unclassified|0|||
164151884|NCT04620746|592917966|FG000|Overall Study|Adverse Event|2|||
164151885|NCT04620746|592917967|FG001|Overall Study|Adverse Event|0|||
164151886|NCT04620746|592917966|FG000|Overall Study|Uniterpretable skin test|1|||
164151887|NCT04620746|592917967|FG001|Overall Study|Uniterpretable skin test|0|||
164151888|NCT04620746|592917966|FG000|Overall Study|Withdrawal by Subject|0|||
164151889|NCT04620746|592917967|FG001|Overall Study|Withdrawal by Subject|1|||
164151890|NCT03404674|592917977|FG000|Overall Study|Inability to Attend Future Visits|0|||
164151891|NCT03404674|592917978|FG001|Overall Study|Inability to Attend Future Visits|1|||
164151892|NCT03404674|592917979|FG002|Overall Study|Inability to Attend Future Visits|1|||
164151893|NCT03404674|592917980|FG003|Overall Study|Inability to Attend Future Visits|0|||
164151894|NCT03404674|592917981|FG004|Overall Study|Inability to Attend Future Visits|0|||
164151895|NCT03404674|592917982|FG005|Overall Study|Inability to Attend Future Visits|0|||
164151896|NCT03404674|592917977|FG000|Overall Study|Behavioral Problems|0|||
164151897|NCT03404674|592917978|FG001|Overall Study|Behavioral Problems|0|||
164151898|NCT03404674|592917979|FG002|Overall Study|Behavioral Problems|1|||
164151899|NCT03404674|592917980|FG003|Overall Study|Behavioral Problems|0|||
164151900|NCT03404674|592917981|FG004|Overall Study|Behavioral Problems|0|||
164151901|NCT03404674|592917982|FG005|Overall Study|Behavioral Problems|0|||
164151902|NCT03404674|592917977|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
164151903|NCT03404674|592917978|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
164151904|NCT03404674|592917979|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
164151905|NCT03404674|592917980|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
164151906|NCT03404674|592917981|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
164151907|NCT03404674|592917982|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
164151908|NCT01526057|592917991|FG000|Overall Study|Withdrawal by Subject|3|||
164151909|NCT01526057|592917992|FG001|Overall Study|Withdrawal by Subject|2|||
164151910|NCT01526057|592917993|FG002|Overall Study|Withdrawal by Subject|2|||
164151911|NCT01526057|592917991|FG000|Overall Study|Adverse Event|3|||
164151912|NCT01526057|592917992|FG001|Overall Study|Adverse Event|1|||
164151913|NCT01526057|592917993|FG002|Overall Study|Adverse Event|1|||
164151914|NCT01526057|592917991|FG000|Overall Study|Death|1|||
164151915|NCT01526057|592917992|FG001|Overall Study|Death|0|||
164151916|NCT01526057|592917993|FG002|Overall Study|Death|0|||
164151917|NCT01526057|592917991|FG000|Overall Study|Lost to Follow-up|1|||
164151918|NCT01526057|592917992|FG001|Overall Study|Lost to Follow-up|0|||
164151919|NCT01526057|592917993|FG002|Overall Study|Lost to Follow-up|1|||
164151920|NCT01526057|592917991|FG000|Overall Study|Other|1|||
164151921|NCT01526057|592917992|FG001|Overall Study|Other|0|||
164151922|NCT01526057|592917993|FG002|Overall Study|Other|1|||
164151923|NCT01526057|592917991|FG000|Overall Study|Protocol Violation|0|||
164151924|NCT01526057|592917992|FG001|Overall Study|Protocol Violation|0|||
164151925|NCT01526057|592917993|FG002|Overall Study|Protocol Violation|1|||
164151926|NCT02123446|592917994|FG000|Washout Period (1 Day)|Physician Decision|1|||
164151927|NCT02123446|592917995|FG001|Washout Period (1 Day)|Physician Decision|0|||
164151928|NCT02553772|592917997|FG000|Overall Study|Adverse Event|2|||
164151929|NCT02553772|592917998|FG001|Overall Study|Adverse Event|3|||
164151930|NCT02553772|592917997|FG000|Overall Study|Lost to Follow-up|2|||
164151931|NCT02553772|592917998|FG001|Overall Study|Lost to Follow-up|1|||
164151932|NCT02553772|592917997|FG000|Overall Study|Withdrawal of Consent|1|||
164151933|NCT02553772|592917998|FG001|Overall Study|Withdrawal of Consent|1|||
164151934|NCT02553772|592917997|FG000|Overall Study|Lack of Efficacy|1|||
164151935|NCT02553772|592917998|FG001|Overall Study|Lack of Efficacy|0|||
164151936|NCT02553772|592917997|FG000|Overall Study|Other Miscellaneous Reasons|0|||
164151937|NCT02553772|592917998|FG001|Overall Study|Other Miscellaneous Reasons|1|||
164151938|NCT02860546|592917999|FG000|Overall Study|Clinical Progression|6|||
164151939|NCT02860546|592917999|FG000|Overall Study|Radiological Progression|12|||
164151940|NCT02466321|592918000|FG000|Overall Study|Death|26|||
164151941|NCT02466321|592918000|FG000|Overall Study|Revision|6|||
164151942|NCT02466321|592918000|FG000|Overall Study|Lost to Follow-up|60|||
164151943|NCT02466321|592918000|FG000|Overall Study|Did not receive study device|1|||
164151944|NCT01855828|592918001|FG000|Overall Study|Adverse Event|1|||
164151945|NCT01855828|592918001|FG000|Overall Study|Withdrawal by Subject|1|||
164151946|NCT00489255|592918010|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
164151947|NCT00489255|592918011|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
164151948|NCT00489255|592918010|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
164151949|NCT00489255|592918011|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
164151950|NCT00489255|592918010|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
164151951|NCT00489255|592918011|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
164151952|NCT00489255|592918010|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
164151953|NCT00489255|592918011|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
164151954|NCT00489255|592918010|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
164151955|NCT00489255|592918011|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
164151956|NCT00489255|592918010|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
164151957|NCT00489255|592918011|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
164151958|NCT00489255|592918010|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
164151959|NCT00489255|592918011|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
164151960|NCT00489255|592918010|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
164151961|NCT00489255|592918011|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
164151962|NCT00489255|592918010|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
164151963|NCT00489255|592918011|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
164151964|NCT00489255|592918010|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
164151965|NCT00489255|592918011|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
164151966|NCT03953612|592918012|FG000|Overall Study|Randomized but did not start|1|||
164151967|NCT03953612|592918013|FG001|Overall Study|Randomized but did not start|1|||
164151968|NCT03953612|592918014|FG002|Overall Study|Randomized but did not start|1|||
164151969|NCT03953612|592918012|FG000|Overall Study|Withdrawal by Subject|2|||
164151970|NCT03953612|592918013|FG001|Overall Study|Withdrawal by Subject|1|||
164151971|NCT03953612|592918014|FG002|Overall Study|Withdrawal by Subject|0|||
164151972|NCT03485352|592918015|FG000|Overall Study|Lost to Follow-up|9|||
164151973|NCT00852202|592918026|FG000|Overall Study|Adverse Event|2|||
164151974|NCT00852202|592918027|FG001|Overall Study|Adverse Event|3|||
164151975|NCT00852202|592918028|FG002|Overall Study|Adverse Event|7|||
164151976|NCT00852202|592918026|FG000|Overall Study|Lack of Efficacy|4|||
164151977|NCT00852202|592918027|FG001|Overall Study|Lack of Efficacy|1|||
164151978|NCT00852202|592918028|FG002|Overall Study|Lack of Efficacy|2|||
164151979|NCT00852202|592918026|FG000|Overall Study|Protocol Violation|2|||
164151980|NCT00852202|592918027|FG001|Overall Study|Protocol Violation|2|||
164151981|NCT00852202|592918028|FG002|Overall Study|Protocol Violation|7|||
164151982|NCT00852202|592918026|FG000|Overall Study|Withdrawal by Subject|3|||
164151983|NCT00852202|592918027|FG001|Overall Study|Withdrawal by Subject|1|||
164151984|NCT00852202|592918028|FG002|Overall Study|Withdrawal by Subject|2|||
164151985|NCT00852202|592918026|FG000|Overall Study|Lost to Follow-up|5|||
164151986|NCT00852202|592918027|FG001|Overall Study|Lost to Follow-up|5|||
164151987|NCT00852202|592918028|FG002|Overall Study|Lost to Follow-up|6|||
164151988|NCT00852202|592918026|FG000|Overall Study|pregnancy,moving away and surgery|1|||
164151989|NCT00852202|592918027|FG001|Overall Study|pregnancy,moving away and surgery|0|||
164151990|NCT00852202|592918028|FG002|Overall Study|pregnancy,moving away and surgery|2|||
164151991|NCT02552121|592918031|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
164151992|NCT02552121|592918032|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
164151993|NCT02552121|592918033|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
164151994|NCT02552121|592918034|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
164151995|NCT02552121|592918035|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
164151996|NCT02552121|592918036|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
164151997|NCT02552121|592918037|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
164151998|NCT02552121|592918038|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
164151999|NCT02552121|592918031|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
164152000|NCT02552121|592918032|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
164152001|NCT02552121|592918033|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
164152002|NCT02552121|592918034|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
164152003|NCT02552121|592918035|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
164152004|NCT02552121|592918036|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
164152005|NCT02552121|592918037|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
164152006|NCT02552121|592918038|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
164152007|NCT02552121|592918031|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
164152008|NCT02552121|592918032|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
164152009|NCT02552121|592918033|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
164152010|NCT02552121|592918034|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
164152011|NCT02552121|592918035|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
164152012|NCT02552121|592918036|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
164152013|NCT02552121|592918037|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
164152014|NCT02552121|592918038|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
164152015|NCT02552121|592918031|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
164152016|NCT02552121|592918032|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
164152017|NCT02552121|592918033|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
164152018|NCT02552121|592918034|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
164152019|NCT02552121|592918035|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
164152020|NCT02552121|592918036|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
164152021|NCT02552121|592918037|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
164152022|NCT02552121|592918038|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
164152023|NCT02552121|592918031|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
164152024|NCT02552121|592918032|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
164152025|NCT02552121|592918033|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
164152026|NCT02552121|592918034|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
164152027|NCT02552121|592918035|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
164152028|NCT02552121|592918036|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
164152029|NCT02552121|592918037|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
164152030|NCT02552121|592918038|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
164152031|NCT02552121|592918031|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
164152032|NCT02552121|592918032|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
164152033|NCT02552121|592918033|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
164152034|NCT02552121|592918034|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
164152035|NCT02552121|592918035|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
164152036|NCT02552121|592918036|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
164152037|NCT02552121|592918037|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
164152038|NCT02552121|592918038|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
164152039|NCT02552121|592918031|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
164152040|NCT02552121|592918032|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
164152041|NCT02552121|592918033|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
164152042|NCT02552121|592918034|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
164152043|NCT02552121|592918035|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
164152044|NCT02552121|592918036|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
164152045|NCT02552121|592918037|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
164152046|NCT02552121|592918038|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
164152047|NCT02552121|592918031|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
164152048|NCT02552121|592918032|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
164152049|NCT02552121|592918033|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
164152050|NCT02552121|592918034|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
164152051|NCT02552121|592918035|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
164152052|NCT02552121|592918036|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
164152053|NCT02552121|592918037|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
164152054|NCT02552121|592918038|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
164152055|NCT02552121|592918031|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
164152056|NCT02552121|592918032|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
164152057|NCT02552121|592918033|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
164152058|NCT02552121|592918034|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
164152059|NCT02552121|592918035|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
164152060|NCT02552121|592918036|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
164152061|NCT02552121|592918037|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
164152062|NCT02552121|592918038|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
164152063|NCT02552121|592918031|FG000|Part 2: Cohort Expansion|Death|0|||
164152064|NCT02552121|592918032|FG001|Part 2: Cohort Expansion|Death|0|||
164152065|NCT02552121|592918033|FG002|Part 2: Cohort Expansion|Death|1|||
164152066|NCT02552121|592918034|FG003|Part 2: Cohort Expansion|Death|0|||
164152067|NCT02552121|592918035|FG004|Part 2: Cohort Expansion|Death|0|||
164152068|NCT02552121|592918036|FG005|Part 2: Cohort Expansion|Death|0|||
164152069|NCT02552121|592918037|FG006|Part 2: Cohort Expansion|Death|0|||
164152070|NCT02552121|592918038|FG007|Part 2: Cohort Expansion|Death|0|||
164152071|NCT03629184|592918039|FG000|Overall Study|Withdrawal by Subject|2|||
164152072|NCT03629184|592918040|FG001|Overall Study|Withdrawal by Subject|1|||
164152073|NCT03629184|592918039|FG000|Overall Study|Physician Decision|1|||
164152074|NCT03629184|592918040|FG001|Overall Study|Physician Decision|0|||
164152075|NCT00853099|592919408|FG000|Double-blind Period|Adverse Event|7|||
164152076|NCT00853099|592919409|FG001|Double-blind Period|Adverse Event|9|||
164152077|NCT00853099|592919410|FG002|Double-blind Period|Adverse Event|13|||
164152078|NCT00853099|592919411|FG003|Double-blind Period|Adverse Event|0|||
164152079|NCT00853099|592919408|FG000|Double-blind Period|Withdrawal by Subject|2|||
164152080|NCT00853099|592919409|FG001|Double-blind Period|Withdrawal by Subject|3|||
164152081|NCT00853099|592919410|FG002|Double-blind Period|Withdrawal by Subject|0|||
164152082|NCT00853099|592919411|FG003|Double-blind Period|Withdrawal by Subject|0|||
164152083|NCT00853099|592919408|FG000|Double-blind Period|Lack of Efficacy|14|||
164152084|NCT00853099|592919409|FG001|Double-blind Period|Lack of Efficacy|17|||
164152085|NCT00853099|592919410|FG002|Double-blind Period|Lack of Efficacy|16|||
164152086|NCT00853099|592919411|FG003|Double-blind Period|Lack of Efficacy|0|||
164152087|NCT00853099|592919408|FG000|Double-blind Period|Other|0|||
164152088|NCT00853099|592919409|FG001|Double-blind Period|Other|0|||
164152089|NCT00853099|592919410|FG002|Double-blind Period|Other|1|||
164152090|NCT00853099|592919411|FG003|Double-blind Period|Other|0|||
164152091|NCT00853099|592919408|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
164152092|NCT00853099|592919409|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
164152093|NCT00853099|592919410|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
164152094|NCT00853099|592919411|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
164152095|NCT00853099|592919408|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
164152096|NCT00853099|592919409|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
164152097|NCT00853099|592919410|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
164152098|NCT00853099|592919411|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
164152099|NCT00853099|592919408|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
164152100|NCT00853099|592919409|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
164152101|NCT00853099|592919410|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
164152102|NCT00853099|592919411|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
164152103|NCT00853099|592919408|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
164152104|NCT00853099|592919409|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
164152105|NCT00853099|592919410|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
164152106|NCT00853099|592919411|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
164152107|NCT00853099|592919408|FG000|Double-blind + Open-label Periods|Other|0|||
164152108|NCT00853099|592919409|FG001|Double-blind + Open-label Periods|Other|0|||
164152109|NCT00853099|592919410|FG002|Double-blind + Open-label Periods|Other|0|||
164152110|NCT00853099|592919411|FG003|Double-blind + Open-label Periods|Other|6|||
164152111|NCT02439216|592919415|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
164152112|NCT02439216|592919416|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
164152113|NCT02439216|592919417|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
164152114|NCT02439216|592919418|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
164152115|NCT02439216|592919419|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
164152116|NCT02439216|592919420|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
164152117|NCT02439216|592919421|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
164152118|NCT02439216|592919422|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
164152119|NCT02439216|592919423|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
164152120|NCT02439216|592919415|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
164152121|NCT02439216|592919416|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
164152122|NCT02439216|592919417|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
164152123|NCT02439216|592919418|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
164152124|NCT02439216|592919419|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
164152125|NCT02439216|592919420|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
164152126|NCT02439216|592919421|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
164152127|NCT02439216|592919422|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
164152128|NCT02439216|592919423|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
164152129|NCT02439216|592919415|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
164152130|NCT02439216|592919416|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
164152131|NCT02439216|592919417|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
164152132|NCT02439216|592919418|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
164152133|NCT02439216|592919419|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
164152134|NCT02439216|592919420|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
164152135|NCT02439216|592919421|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
164152136|NCT02439216|592919422|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
164152137|NCT02439216|592919423|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
164152138|NCT02439216|592919415|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
164152139|NCT02439216|592919416|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
164152140|NCT02439216|592919417|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
164152141|NCT02439216|592919418|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
164152142|NCT02439216|592919419|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
164152143|NCT02439216|592919420|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
164152144|NCT02439216|592919421|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
164152145|NCT02439216|592919422|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
164152146|NCT02439216|592919423|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
164152147|NCT02439216|592919415|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
164152148|NCT02439216|592919416|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
164152149|NCT02439216|592919417|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
164152150|NCT02439216|592919418|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
164152151|NCT02439216|592919419|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
164152152|NCT02439216|592919420|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
164152153|NCT02439216|592919421|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
164152154|NCT02439216|592919422|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
164152155|NCT02439216|592919423|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
164152156|NCT00470535|592919431|FG000|Overall Study|Disease Progression|13|||
164152157|NCT00470535|592919431|FG000|Overall Study|Withdrawal by Subject|1|||
164152158|NCT00470535|592919431|FG000|Overall Study|Adverse Event|1|||
164152159|NCT00470535|592919431|FG000|Overall Study|Death|1|||
164152160|NCT00470535|592919431|FG000|Overall Study|Other|2|||
164152161|NCT00725491|592919434|FG000|Overall Study|Adverse Event|3|||
164152162|NCT00725491|592919435|FG001|Overall Study|Adverse Event|2|||
164152163|NCT00725491|592919434|FG000|Overall Study|Pregnancy|0|||
164152164|NCT00725491|592919435|FG001|Overall Study|Pregnancy|3|||
164152165|NCT00725491|592919434|FG000|Overall Study|Risk for hyperstimulation|2|||
164152166|NCT00725491|592919435|FG001|Overall Study|Risk for hyperstimulation|9|||
164152167|NCT00725491|592919434|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
164152168|NCT00725491|592919435|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
164152169|NCT00725491|592919434|FG000|Overall Study|Fertilization failure|0|||
164152170|NCT00725491|592919435|FG001|Overall Study|Fertilization failure|1|||
164152171|NCT00725491|592919434|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
164152172|NCT00725491|592919435|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
164152173|NCT00942357|592919438|FG000|Overall Study|Ineligible|37|||
164152174|NCT00942357|592919439|FG001|Overall Study|Ineligible|40|||
164152175|NCT00897715|592919440|FG000|Overall Study|Lost to Follow-up|0|||
164152176|NCT00897715|592919441|FG001|Overall Study|Lost to Follow-up|1|||
164152177|NCT00897715|592919440|FG000|Overall Study|Physician Decision|1|||
164152178|NCT00897715|592919441|FG001|Overall Study|Physician Decision|0|||
164152179|NCT00897715|592919440|FG000|Overall Study|increased risk of infection|1|||
164152180|NCT00897715|592919441|FG001|Overall Study|increased risk of infection|0|||
164152181|NCT01641640|592919442|FG000|Overall Study|Enrolled but not treated|1|||
164152182|NCT01641640|592919442|FG000|Overall Study|Efficacy failure|29|||
164152183|NCT01641640|592919442|FG000|Overall Study|Lost to Follow-up|3|||
164152184|NCT01641640|592919442|FG000|Overall Study|Withdrawal by Subject|2|||
164152185|NCT01641640|592919442|FG000|Overall Study|Adverse Event|1|||
164152186|NCT01199939|592919444|FG000|Overall Study|Adverse Event|4|||
164152187|NCT01199939|592919444|FG000|Overall Study|Protocol Violation|3|||
164152188|NCT01199939|592919444|FG000|Overall Study|Lost to Follow-up|2|||
164152189|NCT01199939|592919444|FG000|Overall Study|Reached a virologic endpoint|4|||
164152190|NCT03238651|592919445|FG000|Overall Study|Other|0|||
164152191|NCT03238651|592919446|FG001|Overall Study|Other|0|||
164152192|NCT03238651|592919447|FG002|Overall Study|Other|0|||
164152193|NCT03238651|592919448|FG003|Overall Study|Other|0|||
164152194|NCT03238651|592919449|FG004|Overall Study|Other|1|||
164152195|NCT03238651|592919445|FG000|Overall Study|Progressive Disease|2|||
164152196|NCT03238651|592919446|FG001|Overall Study|Progressive Disease|2|||
164152197|NCT03238651|592919447|FG002|Overall Study|Progressive Disease|2|||
164152198|NCT03238651|592919448|FG003|Overall Study|Progressive Disease|2|||
164152199|NCT03238651|592919449|FG004|Overall Study|Progressive Disease|0|||
164152200|NCT03238651|592919445|FG000|Overall Study|Withdrawal by Subject|0|||
164152201|NCT03238651|592919446|FG001|Overall Study|Withdrawal by Subject|1|||
164152202|NCT03238651|592919447|FG002|Overall Study|Withdrawal by Subject|0|||
164152203|NCT03238651|592919448|FG003|Overall Study|Withdrawal by Subject|1|||
164152204|NCT03238651|592919449|FG004|Overall Study|Withdrawal by Subject|0|||
164152205|NCT03238651|592919445|FG000|Overall Study|Adverse Event|1|||
164152206|NCT03238651|592919446|FG001|Overall Study|Adverse Event|3|||
164152207|NCT03238651|592919447|FG002|Overall Study|Adverse Event|2|||
164152208|NCT03238651|592919448|FG003|Overall Study|Adverse Event|0|||
164152209|NCT03238651|592919449|FG004|Overall Study|Adverse Event|0|||
164152210|NCT03875508|592919450|FG000|Overall Study|Adverse Event|1|||
164152211|NCT03875508|592919450|FG000|Overall Study|Lost to Follow-up|8|||
164152212|NCT03875508|592919450|FG000|Overall Study|Lack of Efficacy|1|||
164152213|NCT03875508|592919450|FG000|Overall Study|Other, not specified|2|||
164152214|NCT00711087|592919451|FG000|Overall Study|Lost to Follow-up|1|||
164152215|NCT00711087|592919452|FG001|Overall Study|Lost to Follow-up|0|||
164152216|NCT02137252|592919453|FG000|Overall Study|trial terminated early|2|||
164152217|NCT02137252|592919454|FG001|Overall Study|trial terminated early|1|||
164152218|NCT00428246|592919456|FG000|Overall Study|Withdrawal by Subject|0|||
164152219|NCT00428246|592919457|FG001|Overall Study|Withdrawal by Subject|0|||
164152220|NCT00428246|592919458|FG002|Overall Study|Withdrawal by Subject|1|||
164152221|NCT00428246|592919456|FG000|Overall Study|Adverse Event|1|||
164152222|NCT00428246|592919457|FG001|Overall Study|Adverse Event|0|||
164152223|NCT00428246|592919458|FG002|Overall Study|Adverse Event|0|||
164152224|NCT02603887|592919461|FG000|Stage 1|Adverse Event|4|||
164152225|NCT02603887|592919461|FG000|Stage 1|Disease progression|1|||
164152226|NCT02603887|592919461|FG000|Stage 2|FDA guidance|1|||
164152227|NCT03535740|592919464|FG000|Overall Study|Death|44|||
164152228|NCT03535740|592919464|FG000|Overall Study|Lost to Follow-up|1|||
164152229|NCT03535740|592919464|FG000|Overall Study|Withdrawal by Subject|13|||
164152230|NCT03535740|592919464|FG000|Overall Study|Site terminated by Sponsor|45|||
164152231|NCT05198518|592919467|FG000|Screening Visit|Deemed unable to participate|58|||
164152232|NCT05198518|592919468|FG001|Screening Visit|Deemed unable to participate|0|||
164152233|NCT05198518|592919469|FG002|Screening Visit|Deemed unable to participate|0|||
164152234|NCT01870778|592919476|FG000|Overall Study|Withdrawal by Subject|8|||
164152235|NCT01870778|592919477|FG001|Overall Study|Withdrawal by Subject|7|||
164152236|NCT01870778|592919476|FG000|Overall Study|Lost to Follow-up|0|||
164152237|NCT01870778|592919477|FG001|Overall Study|Lost to Follow-up|2|||
164152238|NCT05317312|592919478|FG000|Overall Study|Withdrawal by Subject|0|||
164152239|NCT05317312|592919479|FG001|Overall Study|Withdrawal by Subject|1|||
164152240|NCT05317312|592919480|FG002|Overall Study|Withdrawal by Subject|0|||
164152241|NCT05317312|592919481|FG003|Overall Study|Withdrawal by Subject|0|||
164152242|NCT05317312|592919478|FG000|Overall Study|Lost to Follow-up|0|||
164152243|NCT05317312|592919479|FG001|Overall Study|Lost to Follow-up|0|||
164152244|NCT05317312|592919480|FG002|Overall Study|Lost to Follow-up|0|||
164152245|NCT05317312|592919481|FG003|Overall Study|Lost to Follow-up|1|||
164152246|NCT05317312|592919478|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
164152247|NCT05317312|592919479|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
164152248|NCT05317312|592919480|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
164152249|NCT05317312|592919481|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
164152250|NCT00124917|592919482|FG000|Overall Study|Physician Decision|3|||
164152251|NCT00613171|592919485|FG000|Overall Study|Adverse Event|7|||
164152252|NCT00613171|592919485|FG000|Overall Study|Withdrawal by Subject|3|||
164152253|NCT00613171|592919485|FG000|Overall Study|Reason not Specified|4|||
164152254|NCT00951496|592919490|FG000|Overall Study|Did not initiate study treatment|10|||
164152255|NCT00951496|592919491|FG001|Overall Study|Did not initiate study treatment|8|||
164152256|NCT00951496|592919492|FG002|Overall Study|Did not initiate study treatment|13|||
164152257|NCT01169350|592919495|FG000|Overall Study|Physician Decision|3|||
164152258|NCT01169350|592919495|FG000|Overall Study|Lost to Follow-up|2|||
164152259|NCT04870710|592919497|FG000|Overall Study|Lost to Follow-up|3|||
164152260|NCT01042093|592919498|FG000|Overall Study|Protocol Violation|2|||
164152261|NCT01042093|592919499|FG001|Overall Study|Protocol Violation|2|||
164152262|NCT01042093|592919500|FG002|Overall Study|Protocol Violation|2|||
164152263|NCT01042093|592919501|FG003|Overall Study|Protocol Violation|3|||
164152264|NCT01042093|592919498|FG000|Overall Study|Withdrawal by Subject|0|||
164152265|NCT01042093|592919499|FG001|Overall Study|Withdrawal by Subject|0|||
164152266|NCT01042093|592919500|FG002|Overall Study|Withdrawal by Subject|0|||
164152267|NCT01042093|592919501|FG003|Overall Study|Withdrawal by Subject|1|||
164152268|NCT01329900|592919502|FG000|Overall Study|Elevated creatinine/renal function|1|||
164152269|NCT01866098|592919503|FG000|Overall Study|Lost to Follow-up|11|||
164152270|NCT01866098|592919504|FG001|Overall Study|Lost to Follow-up|18|||
164152271|NCT01866098|592919505|FG002|Overall Study|Lost to Follow-up|13|||
164152272|NCT01866098|592919503|FG000|Overall Study|Physician Decision|0|||
164152273|NCT01866098|592919504|FG001|Overall Study|Physician Decision|1|||
164152274|NCT01866098|592919505|FG002|Overall Study|Physician Decision|2|||
164152275|NCT01866098|592919503|FG000|Overall Study|Adverse Event|1|||
164152276|NCT01866098|592919504|FG001|Overall Study|Adverse Event|5|||
164152277|NCT01866098|592919505|FG002|Overall Study|Adverse Event|4|||
164152278|NCT01866098|592919503|FG000|Overall Study|Protocol Violation|1|||
164152279|NCT01866098|592919504|FG001|Overall Study|Protocol Violation|0|||
164152280|NCT01866098|592919505|FG002|Overall Study|Protocol Violation|0|||
164152281|NCT01866098|592919503|FG000|Overall Study|Withdrawal by Subject|1|||
164152282|NCT01866098|592919504|FG001|Overall Study|Withdrawal by Subject|2|||
164152283|NCT01866098|592919505|FG002|Overall Study|Withdrawal by Subject|0|||
164152284|NCT01866098|592919503|FG000|Overall Study|Unrelated Hospitalization|2|||
164152285|NCT01866098|592919504|FG001|Overall Study|Unrelated Hospitalization|0|||
164152286|NCT01866098|592919505|FG002|Overall Study|Unrelated Hospitalization|1|||
164152287|NCT01866098|592919503|FG000|Overall Study|Non-compliance|1|||
164152288|NCT01866098|592919504|FG001|Overall Study|Non-compliance|0|||
164152289|NCT01866098|592919505|FG002|Overall Study|Non-compliance|1|||
164152290|NCT01866098|592919503|FG000|Overall Study|Pregnancy|2|||
164152291|NCT01866098|592919504|FG001|Overall Study|Pregnancy|0|||
164152292|NCT01866098|592919505|FG002|Overall Study|Pregnancy|0|||
164152293|NCT01866098|592919503|FG000|Overall Study|Death|0|||
164152294|NCT01866098|592919504|FG001|Overall Study|Death|1|||
164152295|NCT01866098|592919505|FG002|Overall Study|Death|0|||
164152296|NCT04239027|592919506|FG000|Overall Study|Adverse Event|4|||
164152297|NCT04239027|592919506|FG000|Overall Study|Withdrawal by Subject|9|||
164152298|NCT04239027|592919506|FG000|Overall Study|Death|1|||
164152299|NCT04239027|592919506|FG000|Overall Study|Physician Decision|9|||
164152300|NCT04239027|592919506|FG000|Overall Study|Lost to Follow-up|2|||
164152301|NCT04239027|592919506|FG000|Overall Study|Lack of Efficacy|1|||
164152302|NCT01184079|592919513|FG000|Overall Study|Lost to Follow-up|14|||
164152303|NCT01184079|592919514|FG001|Overall Study|Lost to Follow-up|2|||
164152304|NCT01876446|592919517|FG000|Overall Study|Death|0|||
164152305|NCT01876446|592919518|FG001|Overall Study|Death|1|||
164152306|NCT01876446|592919517|FG000|Overall Study|Withdrawal by Subject|1|||
164152307|NCT01876446|592919518|FG001|Overall Study|Withdrawal by Subject|2|||
164152308|NCT01876446|592919517|FG000|Overall Study|Physician Decision|1|||
164152309|NCT01876446|592919518|FG001|Overall Study|Physician Decision|3|||
164152310|NCT02108912|592919519|FG000|Overall Study|Lost to Follow-up|1|||
164152311|NCT02108912|592919520|FG001|Overall Study|Lost to Follow-up|1|||
164152312|NCT02108912|592919519|FG000|Overall Study|lack of transportation|1|||
164152313|NCT02108912|592919520|FG001|Overall Study|lack of transportation|0|||
164152314|NCT02108912|592919519|FG000|Overall Study|high blood pressure|1|||
164152315|NCT02108912|592919520|FG001|Overall Study|high blood pressure|0|||
164152316|NCT01808573|592919526|FG000|Overall Study|Death|212|||
164152317|NCT01808573|592919527|FG001|Overall Study|Death|240|||
164152318|NCT01808573|592919526|FG000|Overall Study|Withdrawal by Subject|12|||
164152319|NCT01808573|592919527|FG001|Overall Study|Withdrawal by Subject|10|||
164152320|NCT01808573|592919526|FG000|Overall Study|Lost to Follow-up|3|||
164152321|NCT01808573|592919527|FG001|Overall Study|Lost to Follow-up|0|||
164152322|NCT01808573|592919526|FG000|Overall Study|Discontinuation of study by sponsor|79|||
164152323|NCT01808573|592919527|FG001|Overall Study|Discontinuation of study by sponsor|64|||
164152324|NCT01808573|592919526|FG000|Overall Study|Randomized in Error|1|||
164152325|NCT01808573|592919527|FG001|Overall Study|Randomized in Error|0|||
164152326|NCT00995774|592919530|FG000|Training Period 2|Withdrawal by Subject|2|||
164152327|NCT00995774|592919531|FG001|Training Period 2|Withdrawal by Subject|0|||
164152328|NCT01523002|592919532|FG000|Period 1|Withdrawal by Subject|1|||
164152329|NCT01523002|592919533|FG001|Period 1|Withdrawal by Subject|3|||
164152330|NCT01523002|592919532|FG000|Period 1|Lost to Follow-up|1|||
164152331|NCT01523002|592919533|FG001|Period 1|Lost to Follow-up|0|||
164152332|NCT01523002|592919532|FG000|Period 1|Adverse Event|0|||
164152333|NCT01523002|592919533|FG001|Period 1|Adverse Event|8|||
164152334|NCT01523002|592919532|FG000|Period 2|Withdrawal by Subject|4|||
164152335|NCT01523002|592919533|FG001|Period 2|Withdrawal by Subject|1|||
164152336|NCT01523002|592919532|FG000|Period 2|Adverse Event|2|||
164152337|NCT01523002|592919533|FG001|Period 2|Adverse Event|5|||
164152338|NCT01523002|592919532|FG000|Period 3|Withdrawal by Subject|1|||
164152339|NCT01523002|592919533|FG001|Period 3|Withdrawal by Subject|0|||
164152340|NCT01523002|592919532|FG000|Period 3|Adverse Event|3|||
164152341|NCT01523002|592919533|FG001|Period 3|Adverse Event|0|||
164152342|NCT01256502|592919534|FG000|Overall Study|Had scaffold removed|4|||
164152343|NCT01256502|592919534|FG000|Overall Study|Personal reasons|5|||
164152344|NCT01256502|592919534|FG000|Overall Study|Protocol deviation|1|||
164152345|NCT01245283|592919535|FG000|Overall Study|Lost to Follow-up|14|||
164152346|NCT01245283|592919536|FG001|Overall Study|Lost to Follow-up|11|||
164152347|NCT01245283|592919537|FG002|Overall Study|Lost to Follow-up|11|||
164152348|NCT01982955|592919542|FG000|Overall Study|Randomized but not treated|0|||
164152349|NCT01982955|592919543|FG001|Overall Study|Randomized but not treated|0|||
164152350|NCT01982955|592919544|FG002|Overall Study|Randomized but not treated|0|||
164152351|NCT01982955|592919545|FG003|Overall Study|Randomized but not treated|1|||
164152352|NCT01982955|592919546|FG004|Overall Study|Randomized but not treated|0|||
164152353|NCT02575833|592919547|FG000|Overall Study|Withdrawal by Subject|0|||
164152354|NCT02575833|592919548|FG001|Overall Study|Withdrawal by Subject|1|||
164152355|NCT02575833|592919547|FG000|Overall Study|Lost to Follow-up|1|||
164152356|NCT02575833|592919548|FG001|Overall Study|Lost to Follow-up|0|||
164152357|NCT03093259|592919549|FG000|Overall Study|Adverse Event|1|||
164152358|NCT03093259|592919550|FG001|Overall Study|Adverse Event|0|||
164152359|NCT03093259|592919549|FG000|Overall Study|Withdrawal by Subject|1|||
164152360|NCT03093259|592919550|FG001|Overall Study|Withdrawal by Subject|0|||
164152361|NCT02633787|592919551|FG000|Overall Study|Withdrawal by Subject|1|||
164152362|NCT00768248|592919552|FG000|Overall Study|Research coordinator didn't collect data|1|||
164152363|NCT00768248|592919553|FG001|Overall Study|Research coordinator didn't collect data|1|||
164152364|NCT02548143|592919558|FG000|Overall Study|Adverse Event|1|||
164152365|NCT02548143|592919559|FG001|Overall Study|Adverse Event|0|||
164152366|NCT02548143|592919558|FG000|Overall Study|Withdrawal by Subject|0|||
164152367|NCT02548143|592919559|FG001|Overall Study|Withdrawal by Subject|1|||
164152368|NCT05825404|592921258|FG000|First Intervention (Weeks 2-5)|Death|0|||
164152369|NCT05825404|592921259|FG001|First Intervention (Weeks 2-5)|Death|1|||
164152370|NCT05825404|592921258|FG000|Second Intervention (Weeks 8-11)|Death|0|||
164152371|NCT05825404|592921259|FG001|Second Intervention (Weeks 8-11)|Death|1|||
164152372|NCT02243605|592921260|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
164152373|NCT02243605|592921261|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
164152374|NCT02243605|592921260|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
164152375|NCT02243605|592921261|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
164152376|NCT02243605|592921260|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
164152377|NCT02243605|592921261|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
164152378|NCT02243605|592921260|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
164152379|NCT02243605|592921261|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
164152380|NCT02243605|592921260|FG000|Stage 2 - Final Analysis Population|Progression|0|||
164152381|NCT02243605|592921261|FG001|Stage 2 - Final Analysis Population|Progression|1|||
164152382|NCT01557504|592921264|FG000|Overall Study|Physician Decision|1|||
164152383|NCT01557504|592921265|FG001|Overall Study|Physician Decision|0|||
164152384|NCT01321749|592921271|FG000|Overall Study|Lost to Follow-up|4|||
164152385|NCT01321749|592921272|FG001|Overall Study|Lost to Follow-up|11|||
164152386|NCT01321749|592921271|FG000|Overall Study|Protocol Violation|4|||
164152387|NCT01321749|592921272|FG001|Overall Study|Protocol Violation|7|||
164152388|NCT01321749|592921271|FG000|Overall Study|Withdrawal by Subject|5|||
164152389|NCT01321749|592921272|FG001|Overall Study|Withdrawal by Subject|4|||
164152390|NCT04179838|592921276|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
164152391|NCT04179838|592921277|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
164152392|NCT04179838|592921276|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
164152393|NCT04179838|592921277|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
164152394|NCT02763046|592921278|FG000|Overall Study|Adverse Event|5|||
164152395|NCT02763046|592921279|FG001|Overall Study|Adverse Event|4|||
164152396|NCT02763046|592921280|FG002|Overall Study|Adverse Event|0|||
164152397|NCT02763046|592921278|FG000|Overall Study|Lack of Efficacy|1|||
164152398|NCT02763046|592921279|FG001|Overall Study|Lack of Efficacy|1|||
164152399|NCT02763046|592921280|FG002|Overall Study|Lack of Efficacy|3|||
164152400|NCT02763046|592921278|FG000|Overall Study|Physician Decision|1|||
164152401|NCT02763046|592921279|FG001|Overall Study|Physician Decision|0|||
164152402|NCT02763046|592921280|FG002|Overall Study|Physician Decision|1|||
164152403|NCT02763046|592921278|FG000|Overall Study|Subject/guardian decision|2|||
164152404|NCT02763046|592921279|FG001|Overall Study|Subject/guardian decision|0|||
164152405|NCT02763046|592921280|FG002|Overall Study|Subject/guardian decision|4|||
164152406|NCT00818766|592921285|FG000|Overall Study|Could not be Contacted on Day 28|11|||
164152407|NCT00818766|592921286|FG001|Overall Study|Could not be Contacted on Day 28|10|||
164152408|NCT00818766|592921285|FG000|Overall Study|Death|1|||
164152409|NCT00818766|592921286|FG001|Overall Study|Death|0|||
164152410|NCT00818766|592921285|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
164152411|NCT00818766|592921286|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
164152412|NCT00086684|592921287|FG000|Overall Study|Adverse Event|12|||
164152413|NCT00086684|592921288|FG001|Overall Study|Adverse Event|17|||
164152414|NCT00086684|592921289|FG002|Overall Study|Adverse Event|14|||
164152415|NCT00086684|592921287|FG000|Overall Study|Lack of Efficacy|6|||
164152416|NCT00086684|592921288|FG001|Overall Study|Lack of Efficacy|6|||
164152417|NCT00086684|592921289|FG002|Overall Study|Lack of Efficacy|5|||
164152418|NCT00086684|592921287|FG000|Overall Study|Lost to Follow-up|15|||
164152419|NCT00086684|592921288|FG001|Overall Study|Lost to Follow-up|8|||
164152420|NCT00086684|592921289|FG002|Overall Study|Lost to Follow-up|10|||
164152421|NCT00086684|592921287|FG000|Overall Study|Protocol Violation|8|||
164152422|NCT00086684|592921288|FG001|Overall Study|Protocol Violation|3|||
164152423|NCT00086684|592921289|FG002|Overall Study|Protocol Violation|0|||
164152424|NCT00086684|592921287|FG000|Overall Study|Withdrawal by Subject|0|||
164152425|NCT00086684|592921288|FG001|Overall Study|Withdrawal by Subject|4|||
164152426|NCT00086684|592921289|FG002|Overall Study|Withdrawal by Subject|10|||
164152427|NCT00086684|592921287|FG000|Overall Study|NONCOMPLIANCE|5|||
164152428|NCT00086684|592921288|FG001|Overall Study|NONCOMPLIANCE|7|||
164152429|NCT00086684|592921289|FG002|Overall Study|NONCOMPLIANCE|6|||
164152430|NCT00086684|592921287|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
164152431|NCT00086684|592921288|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
164152432|NCT00086684|592921289|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
164152433|NCT00086684|592921287|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
164152434|NCT00086684|592921288|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
164152435|NCT00086684|592921289|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
164152436|NCT00086684|592921287|FG000|Overall Study|Other|4|||
164152437|NCT00086684|592921288|FG001|Overall Study|Other|2|||
164152438|NCT00086684|592921289|FG002|Overall Study|Other|3|||
164152439|NCT01103180|592921292|FG000|Overall Study|Withdrawal by Subject|8|||
164152440|NCT01103180|592921293|FG001|Overall Study|Withdrawal by Subject|13|||
164152441|NCT01103180|592921292|FG000|Overall Study|Lost to Follow-up|13|||
164152442|NCT01103180|592921293|FG001|Overall Study|Lost to Follow-up|7|||
164152443|NCT01103180|592921292|FG000|Overall Study|Physician Decision|1|||
164152444|NCT01103180|592921293|FG001|Overall Study|Physician Decision|0|||
164152445|NCT01103180|592921292|FG000|Overall Study|Protocol Violation|0|||
164152446|NCT01103180|592921293|FG001|Overall Study|Protocol Violation|1|||
164152447|NCT01173523|592921294|FG000|Overall Study|Clinical Progression|1|||
164152448|NCT01173523|592921295|FG001|Overall Study|Clinical Progression|1|||
164152449|NCT01173523|592921294|FG000|Overall Study|Progressive Disease|10|||
164152450|NCT01173523|592921295|FG001|Overall Study|Progressive Disease|8|||
164152451|NCT01173523|592921294|FG000|Overall Study|Other|2|||
164152452|NCT01173523|592921295|FG001|Overall Study|Other|3|||
164152453|NCT01067105|592921296|FG000|Overall Study|Adverse Event|14|||
164152454|NCT01067105|592921296|FG000|Overall Study|Protocol Violation|48|||
164152455|NCT01067105|592921296|FG000|Overall Study|Withdrawal by Subject|36|||
164152456|NCT01067105|592921296|FG000|Overall Study|Lost to Follow-up|6|||
164152457|NCT01067105|592921296|FG000|Overall Study|Physician Decision|6|||
164152458|NCT01067105|592921296|FG000|Overall Study|Other|31|||
164152459|NCT01866826|592921297|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
164152460|NCT01866826|592921298|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
164152461|NCT01866826|592921297|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
164152462|NCT01866826|592921298|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
164152463|NCT01866826|592921297|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
164152464|NCT01866826|592921298|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
164152465|NCT02493660|592921299|FG000|Overall Study|Physician Decision|0|||
164152466|NCT02493660|592921300|FG001|Overall Study|Physician Decision|1|||
164152467|NCT02493660|592921299|FG000|Overall Study|Adverse Event|4|||
164152468|NCT02493660|592921300|FG001|Overall Study|Adverse Event|2|||
164152469|NCT02493660|592921299|FG000|Overall Study|Withdrawal by Subject|2|||
164152470|NCT02493660|592921300|FG001|Overall Study|Withdrawal by Subject|3|||
164152471|NCT02493660|592921299|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
164152472|NCT02493660|592921300|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
164152473|NCT02493660|592921299|FG000|Overall Study|Protocol Violation|0|||
164152474|NCT02493660|592921300|FG001|Overall Study|Protocol Violation|1|||
164152475|NCT02493660|592921299|FG000|Overall Study|Death|0|||
164152476|NCT02493660|592921300|FG001|Overall Study|Death|1|||
164152477|NCT02493660|592921299|FG000|Overall Study|Lost to Follow-up|2|||
164152478|NCT02493660|592921300|FG001|Overall Study|Lost to Follow-up|4|||
164152479|NCT00709995|592921301|FG000|Overall Study|Adverse Event|4|||
164152480|NCT00709995|592921302|FG001|Overall Study|Adverse Event|2|||
164152481|NCT00709995|592921301|FG000|Overall Study|Withdrawal by Subject|1|||
164152482|NCT00709995|592921302|FG001|Overall Study|Withdrawal by Subject|3|||
164152483|NCT01276041|592921303|FG000|Overall Study|Adverse Event|2|||
164152484|NCT01276041|592921303|FG000|Overall Study|Protocol Violation|1|||
164152485|NCT00638508|592921304|FG000|Overall Study|Physician Decision|5|||
164152486|NCT00638508|592921305|FG001|Overall Study|Physician Decision|2|||
164152487|NCT03500198|592921306|FG000|Overall Study|Lost to Follow-up|0|||
164152488|NCT03500198|592921307|FG001|Overall Study|Lost to Follow-up|1|||
164152489|NCT00654095|592921308|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
164152490|NCT00654095|592921308|FG000|Overall Study|Elevated triglyceride level (2)|1|||
164152491|NCT00654095|592921308|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
164152492|NCT00654095|592921308|FG000|Overall Study|Adverse Event|11|||
164152493|NCT00654095|592921308|FG000|Overall Study|Withdrawal by Subject|5|||
164152494|NCT00654095|592921308|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
164152495|NCT00654095|592921308|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
164152496|NCT00654095|592921308|FG000|Overall Study|Did not meet inclusion criteria|1|||
164152497|NCT00595621|592921314|FG000|Open Label Run in|Adverse Event|1|||
164152498|NCT00595621|592921315|FG001|Open Label Run in|Adverse Event|0|||
164152499|NCT00595621|592921314|FG000|Open Label Run in|Physician Decision|1|||
164152500|NCT00595621|592921315|FG001|Open Label Run in|Physician Decision|0|||
164152501|NCT00595621|592921314|FG000|Open Label Run in|Withdrawal by Subject|1|||
164152502|NCT00595621|592921315|FG001|Open Label Run in|Withdrawal by Subject|0|||
164152503|NCT00595621|592921314|FG000|Randomization and Study|Adverse Event|2|||
164152504|NCT00595621|592921315|FG001|Randomization and Study|Adverse Event|0|||
164152505|NCT00595621|592921314|FG000|Randomization and Study|Withdrawal by Subject|0|||
164152506|NCT00595621|592921315|FG001|Randomization and Study|Withdrawal by Subject|1|||
164152507|NCT02440464|592921316|FG000|Overall Study|Withdrawal by Subject|3|||
164152508|NCT02440464|592921317|FG001|Overall Study|Withdrawal by Subject|2|||
164152509|NCT00324987|592921318|FG000|Overall Study|Adverse Event|2|||
164152510|NCT00324987|592921319|FG001|Overall Study|Adverse Event|1|||
164152511|NCT00324987|592921318|FG000|Overall Study|Withdrawal by Subject|1|||
164152512|NCT00324987|592921319|FG001|Overall Study|Withdrawal by Subject|1|||
164152513|NCT00324987|592921318|FG000|Overall Study|Progression|1|||
164152514|NCT00324987|592921319|FG001|Overall Study|Progression|1|||
164152515|NCT00324987|592921318|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
164152516|NCT00324987|592921319|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
164152517|NCT02968576|592921321|FG000|Overall Study|Pregnancy|0|||
164152518|NCT02968576|592921322|FG001|Overall Study|Pregnancy|1|||
164152519|NCT02058069|592921325|FG000|Overall Study|Exclusion due to implant size|5|||
164152520|NCT02058069|592921325|FG000|Overall Study|Withdrawal by Subject|6|||
164152521|NCT02222922|592921326|FG000|Overall Study|Death|0|||
164152522|NCT02222922|592921327|FG001|Overall Study|Death|0|||
164152523|NCT02222922|592921328|FG002|Overall Study|Death|0|||
164152524|NCT02222922|592921329|FG003|Overall Study|Death|0|||
164152525|NCT02222922|592921330|FG004|Overall Study|Death|13|||
164152526|NCT02222922|592921331|FG005|Overall Study|Death|0|||
164152527|NCT02222922|592921332|FG006|Overall Study|Death|0|||
164152528|NCT02222922|592921333|FG007|Overall Study|Death|0|||
164152529|NCT02222922|592921334|FG008|Overall Study|Death|2|||
164152530|NCT02222922|592921326|FG000|Overall Study|Lost to Follow-up|0|||
164152531|NCT02222922|592921327|FG001|Overall Study|Lost to Follow-up|0|||
164152532|NCT02222922|592921328|FG002|Overall Study|Lost to Follow-up|1|||
164152533|NCT02222922|592921329|FG003|Overall Study|Lost to Follow-up|0|||
164152534|NCT02222922|592921330|FG004|Overall Study|Lost to Follow-up|9|||
164152535|NCT02222922|592921331|FG005|Overall Study|Lost to Follow-up|1|||
164152536|NCT02222922|592921332|FG006|Overall Study|Lost to Follow-up|0|||
164152537|NCT02222922|592921333|FG007|Overall Study|Lost to Follow-up|0|||
164152538|NCT02222922|592921334|FG008|Overall Study|Lost to Follow-up|0|||
164152539|NCT02222922|592921326|FG000|Overall Study|Other|0|||
164152540|NCT02222922|592921327|FG001|Overall Study|Other|0|||
164152541|NCT02222922|592921328|FG002|Overall Study|Other|0|||
164152542|NCT02222922|592921329|FG003|Overall Study|Other|2|||
164152543|NCT02222922|592921330|FG004|Overall Study|Other|10|||
164152544|NCT02222922|592921331|FG005|Overall Study|Other|2|||
164152545|NCT02222922|592921332|FG006|Overall Study|Other|2|||
164152546|NCT02222922|592921333|FG007|Overall Study|Other|4|||
164152547|NCT02222922|592921334|FG008|Overall Study|Other|1|||
164152548|NCT02222922|592921326|FG000|Overall Study|Participant refused further follow-up|1|||
164152549|NCT02222922|592921327|FG001|Overall Study|Participant refused further follow-up|0|||
164152550|NCT02222922|592921328|FG002|Overall Study|Participant refused further follow-up|0|||
164152551|NCT02222922|592921329|FG003|Overall Study|Participant refused further follow-up|1|||
164152552|NCT02222922|592921330|FG004|Overall Study|Participant refused further follow-up|6|||
164152553|NCT02222922|592921331|FG005|Overall Study|Participant refused further follow-up|0|||
164152554|NCT02222922|592921332|FG006|Overall Study|Participant refused further follow-up|0|||
164152555|NCT02222922|592921333|FG007|Overall Study|Participant refused further follow-up|0|||
164152556|NCT02222922|592921334|FG008|Overall Study|Participant refused further follow-up|3|||
164152557|NCT01998919|592921335|FG000|Overall Study|Death|2|||
164152558|NCT01998919|592921336|FG001|Overall Study|Death|2|||
164152559|NCT01998919|592921335|FG000|Overall Study|Adverse Event|0|||
164152560|NCT01998919|592921336|FG001|Overall Study|Adverse Event|5|||
164152561|NCT01998919|592921335|FG000|Overall Study|Disease progression|31|||
164152562|NCT01998919|592921336|FG001|Overall Study|Disease progression|22|||
164152563|NCT01998919|592921335|FG000|Overall Study|Withdrawal by Subject|2|||
164152564|NCT01998919|592921336|FG001|Overall Study|Withdrawal by Subject|4|||
164152565|NCT01998919|592921335|FG000|Overall Study|Lost to Follow-up|2|||
164152566|NCT01998919|592921336|FG001|Overall Study|Lost to Follow-up|0|||
164152567|NCT01998919|592921335|FG000|Overall Study|Other|5|||
164152568|NCT01998919|592921336|FG001|Overall Study|Other|2|||
164152569|NCT00927589|592921338|FG000|Overall Study|Death|1|||
164152570|NCT00927589|592921338|FG000|Overall Study|Physician Decision|1|||
164152571|NCT00927589|592921338|FG000|Overall Study|Withdrawal by Subject|3|||
164152572|NCT00927589|592921338|FG000|Overall Study|Adverse Event|2|||
164152573|NCT00927589|592921338|FG000|Overall Study|Disease Progression|8|||
164152574|NCT00927589|592921338|FG000|Overall Study|Non-compliance|1|||
164152575|NCT01778530|592921341|FG000|Overall Study|Progression on study|1|||
164152576|NCT01778530|592921341|FG000|Overall Study|Adverse event/side effect|1|||
164152577|NCT02792517|592921349|FG000|Overall Study|Withdrawal by Subject|10|||
164152578|NCT02792517|592921349|FG000|Overall Study|Decision by Sponsor|7|||
164152579|NCT02792517|592921349|FG000|Overall Study|Lost to Follow-up|3|||
164152580|NCT00882518|592921350|FG000|Overall Study|Adverse Event|9|||
164152581|NCT00882518|592921351|FG001|Overall Study|Adverse Event|18|||
164152582|NCT00882518|592921350|FG000|Overall Study|Withdrawal by Subject|9|||
164152583|NCT00882518|592921351|FG001|Overall Study|Withdrawal by Subject|13|||
164152584|NCT00882518|592921350|FG000|Overall Study|Lack of Efficacy|12|||
164152585|NCT00882518|592921351|FG001|Overall Study|Lack of Efficacy|9|||
164152586|NCT00882518|592921350|FG000|Overall Study|Severe non-compliance to protocol|3|||
164152587|NCT00882518|592921351|FG001|Overall Study|Severe non-compliance to protocol|1|||
164152588|NCT00882518|592921350|FG000|Overall Study|Incorrect enrolment|4|||
164152589|NCT00882518|592921351|FG001|Overall Study|Incorrect enrolment|2|||
164152590|NCT00882518|592921350|FG000|Overall Study|Central lab closure for National day|1|||
164152591|NCT00882518|592921351|FG001|Overall Study|Central lab closure for National day|0|||
164152592|NCT00882518|592921350|FG000|Overall Study|Allocating random number by mistake|0|||
164152593|NCT00882518|592921351|FG001|Overall Study|Allocating random number by mistake|1|||
164152594|NCT01958437|592921352|FG000|Overall Study|Incidental MRI findings|0|||
164152595|NCT01958437|592921353|FG001|Overall Study|Incidental MRI findings|0|||
164152596|NCT01958437|592921354|FG002|Overall Study|Incidental MRI findings|1|||
164152597|NCT01958437|592921355|FG003|Overall Study|Incidental MRI findings|1|||
164152598|NCT01998841|592921367|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
164152599|NCT01998841|592921368|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
164152600|NCT01998841|592921369|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
164152601|NCT01998841|592921370|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
164152602|NCT01998841|592921371|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
164152603|NCT01998841|592921367|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
164152604|NCT01998841|592921368|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
164152605|NCT01998841|592921369|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
164152606|NCT01998841|592921370|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
164152607|NCT01998841|592921371|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
164152608|NCT00972595|592921372|FG000|Period 1|Adverse Event|1|||
164152609|NCT00972595|592921373|FG001|Period 1|Adverse Event|0|||
164152610|NCT01461538|592921374|FG000|Overall Study|Death|15|||
164152611|NCT01461538|592921375|FG001|Overall Study|Death|6|||
164152612|NCT01461538|592921376|FG002|Overall Study|Death|2|||
164152613|NCT01461538|592921374|FG000|Overall Study|Study Stopped by Sponsor|2|||
164152614|NCT01461538|592921375|FG001|Overall Study|Study Stopped by Sponsor|1|||
164152615|NCT01461538|592921376|FG002|Overall Study|Study Stopped by Sponsor|0|||
164152616|NCT01461538|592921374|FG000|Overall Study|Withdrawal by Subject|1|||
164152617|NCT01461538|592921375|FG001|Overall Study|Withdrawal by Subject|1|||
164152618|NCT01461538|592921376|FG002|Overall Study|Withdrawal by Subject|0|||
164152619|NCT00141778|592921377|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
164152620|NCT00141778|592921378|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
164152621|NCT00141778|592921379|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
164152622|NCT00141778|592921377|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
164152623|NCT00141778|592921378|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
164152624|NCT00141778|592921379|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
164152625|NCT00141778|592921377|FG000|Started Study Medication|Withdrawal by Subject|0|||
164152626|NCT00141778|592921378|FG001|Started Study Medication|Withdrawal by Subject|2|||
164152627|NCT00141778|592921379|FG002|Started Study Medication|Withdrawal by Subject|0|||
164152628|NCT00141778|592921377|FG000|Started Study Medication|Difficulty Swallowing|0|||
164152629|NCT00141778|592921378|FG001|Started Study Medication|Difficulty Swallowing|1|||
164152630|NCT00141778|592921379|FG002|Started Study Medication|Difficulty Swallowing|0|||
164152631|NCT00141778|592921377|FG000|Started Study Medication|Chest Discomfort|0|||
164152632|NCT00141778|592921378|FG001|Started Study Medication|Chest Discomfort|0|||
164152633|NCT00141778|592921379|FG002|Started Study Medication|Chest Discomfort|1|||
164152634|NCT01406574|592921381|FG000|Overall Study|Adverse Event|0|||
164152635|NCT01406574|592921382|FG001|Overall Study|Adverse Event|0|||
164152636|NCT01406574|592921383|FG002|Overall Study|Adverse Event|1|||
164152637|NCT01406574|592921384|FG003|Overall Study|Adverse Event|3|||
164152638|NCT01406574|592921381|FG000|Overall Study|Physician Decision|0|||
164152639|NCT01406574|592921382|FG001|Overall Study|Physician Decision|0|||
164152640|NCT01406574|592921383|FG002|Overall Study|Physician Decision|0|||
164152641|NCT01406574|592921384|FG003|Overall Study|Physician Decision|1|||
164152642|NCT01406574|592921381|FG000|Overall Study|Withdrawal by Subject|0|||
164152643|NCT01406574|592921382|FG001|Overall Study|Withdrawal by Subject|1|||
164152644|NCT01406574|592921383|FG002|Overall Study|Withdrawal by Subject|0|||
164152645|NCT01406574|592921384|FG003|Overall Study|Withdrawal by Subject|0|||
164152646|NCT01406574|592921381|FG000|Overall Study|Definite progression of primary disease|1|||
164152647|NCT01406574|592921382|FG001|Overall Study|Definite progression of primary disease|0|||
164152648|NCT01406574|592921383|FG002|Overall Study|Definite progression of primary disease|0|||
164152649|NCT01406574|592921384|FG003|Overall Study|Definite progression of primary disease|0|||
164152650|NCT04052620|592921385|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
164152651|NCT04052620|592921386|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
164152652|NCT04052620|592921385|FG000|Overall Study|Withdrawal by Subject|1|||
164152653|NCT04052620|592921386|FG001|Overall Study|Withdrawal by Subject|0|||
164152654|NCT04052620|592921385|FG000|Overall Study|Lost to Follow-up|1|||
164152655|NCT04052620|592921386|FG001|Overall Study|Lost to Follow-up|1|||
164152656|NCT04052620|592921385|FG000|Overall Study|Adverse Event|1|||
164152657|NCT04052620|592921386|FG001|Overall Study|Adverse Event|0|||
164152658|NCT04052620|592921385|FG000|Overall Study|Subject did not meet study Criteria|0|||
164152659|NCT04052620|592921386|FG001|Overall Study|Subject did not meet study Criteria|1|||
164152660|NCT04052620|592921385|FG000|Overall Study|Screened failure, randomized by mistake|0|||
164152661|NCT04052620|592921386|FG001|Overall Study|Screened failure, randomized by mistake|1|||
164152662|NCT04052620|592921385|FG000|Overall Study|Personal reasons|2|||
164152663|NCT04052620|592921386|FG001|Overall Study|Personal reasons|4|||
164152664|NCT04052620|592921385|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
164152665|NCT04052620|592921386|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
164152666|NCT03552380|592921388|FG000|Study Treatment|Disease Progression|3|||
164152667|NCT03552380|592921389|FG001|Study Treatment|Disease Progression|4|||
164152668|NCT03552380|592921388|FG000|Study Treatment|Adverse Event|2|||
164152669|NCT03552380|592921389|FG001|Study Treatment|Adverse Event|2|||
164152670|NCT03552380|592921388|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
164152671|NCT03552380|592921389|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
164152672|NCT03552380|592921388|FG000|Follow up|Death|3|||
164152673|NCT03552380|592921389|FG001|Follow up|Death|4|||
164152674|NCT03552380|592921388|FG000|Follow up|Site IRB terminated|0|||
164152675|NCT03552380|592921389|FG001|Follow up|Site IRB terminated|1|||
164152676|NCT03447743|592921390|FG000|Overall Study|Withdrawal by Subject|2|||
164152677|NCT03447743|592921390|FG000|Overall Study|Lost to Follow-up|3|||
164152678|NCT03447743|592921390|FG000|Overall Study|Adverse Event|1|||
164152679|NCT03447743|592921390|FG000|Overall Study|Did not meet criteria to continue|1|||
164152680|NCT01112059|592921391|FG000|Overall Study|Withdrawal by Subject|1|||
164152681|NCT01112059|592921392|FG001|Overall Study|Withdrawal by Subject|0|||
164152682|NCT03567980|592921399|FG000|Overall Study|Adverse Event|1|||
164152683|NCT01610492|592921400|FG000|Overall Study|Adverse Event|1|||
164152684|NCT01610492|592921400|FG000|Overall Study|Lack of Efficacy|3|||
164152685|NCT01610492|592921400|FG000|Overall Study|Other: Reached stopping criteria|1|||
164152686|NCT01610492|592921400|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
164152687|NCT01757275|592921402|FG000|Overall Study|Lost to Follow-up|1|||
164152688|NCT01757275|592921403|FG001|Overall Study|Lost to Follow-up|2|||
164152689|NCT01757275|592921402|FG000|Overall Study|Adverse Event|3|||
164152690|NCT01757275|592921403|FG001|Overall Study|Adverse Event|3|||
164152691|NCT01757275|592921402|FG000|Overall Study|Withdrawal by Subject|2|||
164152692|NCT01757275|592921403|FG001|Overall Study|Withdrawal by Subject|4|||
164152693|NCT01757275|592921402|FG000|Overall Study|Not treated|3|||
164152694|NCT01757275|592921403|FG001|Overall Study|Not treated|4|||
164152695|NCT01821807|592921408|FG000|Overall Study|Lost to Follow-up|3|||
164152696|NCT01821807|592921409|FG001|Overall Study|Lost to Follow-up|1|||
164152697|NCT01401452|592921410|FG000|Overall Study|Adverse reaction|9|||
164152698|NCT01401452|592921410|FG000|Overall Study|Lost to Follow-up|12|||
164152699|NCT01401452|592921410|FG000|Overall Study|Lack of Efficacy|30|||
164152700|NCT01401452|592921410|FG000|Overall Study|Participant developed breast cancer|1|||
164152701|NCT01401452|592921410|FG000|Overall Study|Tx stopped due to financial reasons|1|||
164152702|NCT01401452|592921410|FG000|Overall Study|Tx stopped by psychiatrist|1|||
164152703|NCT01401452|592921410|FG000|Overall Study|No more visits within the 36 wk followup|4|||
164152704|NCT01401452|592921410|FG000|Overall Study|Subject did not come to follow up visits|2|||
164152705|NCT01401452|592921410|FG000|Overall Study|Subject didn't return for routine visits|1|||
164152706|NCT01401452|592921410|FG000|Overall Study|Subject moved to another city|1|||
164152707|NCT01401452|592921410|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
164152708|NCT01401452|592921410|FG000|Overall Study|Psoriatic arthritis|1|||
164152709|NCT01401452|592921410|FG000|Overall Study|Participant stopped Tx|2|||
164152710|NCT01401452|592921410|FG000|Overall Study|Discontinuation for personal reasons|1|||
164152711|NCT01401452|592921410|FG000|Overall Study|Treatment failure|1|||
164152712|NCT01401452|592921410|FG000|Overall Study|Unsatisfactory output|1|||
164152713|NCT01401452|592921410|FG000|Overall Study|Subject withdrew because of Tx success|1|||
164152714|NCT01401452|592921410|FG000|Overall Study|Subject chose to discontinue treatment|1|||
164152715|NCT01401452|592921410|FG000|Overall Study|Participant withdrew consent|1|||
164152716|NCT00550459|592921411|FG000|Overall Study|Adverse Event|0|||
164152717|NCT00550459|592921412|FG001|Overall Study|Adverse Event|2|||
164152718|NCT00550459|592921411|FG000|Overall Study|Withdrawal by Subject|1|||
164152719|NCT00550459|592921412|FG001|Overall Study|Withdrawal by Subject|1|||
164152720|NCT00584454|592921413|FG000|Overall Study|Adverse Event|1|||
164152721|NCT00584454|592921413|FG000|Overall Study|Relocation|1|||
164152722|NCT00584454|592921413|FG000|Overall Study|Clinical Hold|2|||
164152723|NCT02404805|592921414|FG000|Overall Study|Withdrawal by Subject|1|||
164152724|NCT02404805|592921415|FG001|Overall Study|Withdrawal by Subject|0|||
164152725|NCT02404805|592921416|FG002|Overall Study|Withdrawal by Subject|0|||
164152726|NCT02404805|592921417|FG003|Overall Study|Withdrawal by Subject|0|||
164152727|NCT02404805|592921418|FG004|Overall Study|Withdrawal by Subject|0|||
164152728|NCT02404805|592921419|FG005|Overall Study|Withdrawal by Subject|0|||
164152729|NCT01742897|592921420|FG000|Overall Study|Adverse Event|3|||
164152730|NCT01742897|592921420|FG000|Overall Study|Withdrawal by Subject|1|||
164152731|NCT01742897|592921420|FG000|Overall Study|Other|1|||
164152732|NCT01459783|592921422|FG000|Baseline to 6 Months|Death|1|||
164152733|NCT01459783|592921423|FG001|Baseline to 6 Months|Death|0|||
164152734|NCT01459783|592921422|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
164152735|NCT01459783|592921423|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
164152736|NCT01459783|592921422|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
164152737|NCT01459783|592921423|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
164152738|NCT01459783|592921422|FG000|6 Months to 12 Months|Death|0|||
164152739|NCT01459783|592921423|FG001|6 Months to 12 Months|Death|1|||
164152740|NCT01459783|592921422|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
164152741|NCT01459783|592921423|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
164152742|NCT01459783|592921422|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
164152743|NCT01459783|592921423|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
164152744|NCT01459783|592921422|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
164152745|NCT01459783|592921423|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
164152746|NCT04211831|592921424|FG000|Overall Study|Withdrawal by Subject|4|||
164152747|NCT04211831|592921425|FG001|Overall Study|Withdrawal by Subject|1|||
164152748|NCT04211831|592921426|FG002|Overall Study|Withdrawal by Subject|1|||
164152749|NCT04211831|592921424|FG000|Overall Study|Protocol Violation|0|||
164152750|NCT04211831|592921425|FG001|Overall Study|Protocol Violation|0|||
164152751|NCT04211831|592921426|FG002|Overall Study|Protocol Violation|1|||
164152752|NCT04211831|592921424|FG000|Overall Study|Adverse Event|0|||
164152753|NCT04211831|592921425|FG001|Overall Study|Adverse Event|1|||
164152754|NCT04211831|592921426|FG002|Overall Study|Adverse Event|0|||
164152755|NCT04211831|592921424|FG000|Overall Study|Lack of Efficacy|0|||
164152756|NCT04211831|592921425|FG001|Overall Study|Lack of Efficacy|0|||
164152757|NCT04211831|592921426|FG002|Overall Study|Lack of Efficacy|1|||
164152758|NCT04211831|592921424|FG000|Overall Study|Lost to Follow-up|0|||
164152759|NCT04211831|592921425|FG001|Overall Study|Lost to Follow-up|0|||
164152760|NCT04211831|592921426|FG002|Overall Study|Lost to Follow-up|2|||
164152761|NCT04211831|592921424|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
164152762|NCT04211831|592921425|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
164152763|NCT04211831|592921426|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
164152764|NCT04211831|592921424|FG000|Overall Study|Other|0|||
164152765|NCT04211831|592921425|FG001|Overall Study|Other|1|||
164152766|NCT04211831|592921426|FG002|Overall Study|Other|0|||
164152767|NCT00967330|592921427|FG000|Overall Study|Protocol Violation|3|||
164152768|NCT00967330|592921428|FG001|Overall Study|Protocol Violation|4|||
164152769|NCT00967330|592921427|FG000|Overall Study|Regular|10|||
164152770|NCT00967330|592921428|FG001|Overall Study|Regular|3|||
164152771|NCT00967330|592921427|FG000|Overall Study|Withdrawal by Subject|6|||
164152772|NCT00967330|592921428|FG001|Overall Study|Withdrawal by Subject|0|||
164152773|NCT00967330|592921427|FG000|Overall Study|Lost to Follow-up|1|||
164152774|NCT00967330|592921428|FG001|Overall Study|Lost to Follow-up|1|||
164152775|NCT00967330|592921427|FG000|Overall Study|Death|102|||
164152776|NCT00967330|592921428|FG001|Overall Study|Death|51|||
164152777|NCT00967330|592921427|FG000|Overall Study|Severe protocol deviation|0|||
164152778|NCT00967330|592921428|FG001|Overall Study|Severe protocol deviation|1|||
164152779|NCT04563754|592923292|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
164152780|NCT04563754|592923293|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
164152781|NCT04563754|592923294|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
164152782|NCT04563754|592923292|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
164152783|NCT04563754|592923293|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
164152784|NCT04563754|592923294|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
164152785|NCT04563754|592923292|FG000|Follow up|Lost to Follow-up|61|||
164152786|NCT04563754|592923293|FG001|Follow up|Lost to Follow-up|23|||
164152787|NCT04563754|592923294|FG002|Follow up|Lost to Follow-up|5|||
164152788|NCT04563754|592923292|FG000|Follow up|Death|0|||
164152789|NCT04563754|592923293|FG001|Follow up|Death|2|||
164152790|NCT04563754|592923294|FG002|Follow up|Death|0|||
164152791|NCT04563754|592923292|FG000|Follow up|Ongoing|0|||
164152792|NCT04563754|592923293|FG001|Follow up|Ongoing|28|||
164152793|NCT04563754|592923294|FG002|Follow up|Ongoing|0|||
164152794|NCT00070564|592923295|FG000|Overall Study|Progression|2|||
164152795|NCT00070564|592923296|FG001|Overall Study|Progression|4|||
164152796|NCT00070564|592923297|FG002|Overall Study|Progression|7|||
164152797|NCT00070564|592923298|FG003|Overall Study|Progression|7|||
164152798|NCT00070564|592923299|FG004|Overall Study|Progression|1|||
164152799|NCT00070564|592923300|FG005|Overall Study|Progression|0|||
164152800|NCT00070564|592923295|FG000|Overall Study|Delinquent|1|||
164152801|NCT00070564|592923296|FG001|Overall Study|Delinquent|4|||
164152802|NCT00070564|592923297|FG002|Overall Study|Delinquent|2|||
164152803|NCT00070564|592923298|FG003|Overall Study|Delinquent|0|||
164152804|NCT00070564|592923299|FG004|Overall Study|Delinquent|0|||
164152805|NCT00070564|592923300|FG005|Overall Study|Delinquent|0|||
164152806|NCT00070564|592923295|FG000|Overall Study|Adverse Event|150|||
164152807|NCT00070564|592923296|FG001|Overall Study|Adverse Event|142|||
164152808|NCT00070564|592923297|FG002|Overall Study|Adverse Event|120|||
164152809|NCT00070564|592923298|FG003|Overall Study|Adverse Event|108|||
164152810|NCT00070564|592923299|FG004|Overall Study|Adverse Event|63|||
164152811|NCT00070564|592923300|FG005|Overall Study|Adverse Event|36|||
164152812|NCT00070564|592923295|FG000|Overall Study|Death|4|||
164152813|NCT00070564|592923296|FG001|Overall Study|Death|1|||
164152814|NCT00070564|592923297|FG002|Overall Study|Death|5|||
164152815|NCT00070564|592923298|FG003|Overall Study|Death|3|||
164152816|NCT00070564|592923299|FG004|Overall Study|Death|0|||
164152817|NCT00070564|592923300|FG005|Overall Study|Death|1|||
164152818|NCT00070564|592923295|FG000|Overall Study|Other, not protocol specified|17|||
164152819|NCT00070564|592923296|FG001|Overall Study|Other, not protocol specified|15|||
164152820|NCT00070564|592923297|FG002|Overall Study|Other, not protocol specified|14|||
164152821|NCT00070564|592923298|FG003|Overall Study|Other, not protocol specified|19|||
164152822|NCT00070564|592923299|FG004|Overall Study|Other, not protocol specified|6|||
164152823|NCT00070564|592923300|FG005|Overall Study|Other, not protocol specified|7|||
164152824|NCT00070564|592923295|FG000|Overall Study|Withdrawal by Subject|26|||
164152825|NCT00070564|592923296|FG001|Overall Study|Withdrawal by Subject|37|||
164152826|NCT00070564|592923297|FG002|Overall Study|Withdrawal by Subject|23|||
164152827|NCT00070564|592923298|FG003|Overall Study|Withdrawal by Subject|30|||
164152828|NCT00070564|592923299|FG004|Overall Study|Withdrawal by Subject|8|||
164152829|NCT00070564|592923300|FG005|Overall Study|Withdrawal by Subject|8|||
164152830|NCT00070564|592923295|FG000|Overall Study|Not reported|0|||
164152831|NCT00070564|592923296|FG001|Overall Study|Not reported|0|||
164152832|NCT00070564|592923297|FG002|Overall Study|Not reported|0|||
164152833|NCT00070564|592923298|FG003|Overall Study|Not reported|0|||
164152834|NCT00070564|592923299|FG004|Overall Study|Not reported|1|||
164152835|NCT00070564|592923300|FG005|Overall Study|Not reported|0|||
164152836|NCT04796961|592923301|FG000|Overall Study|Lost to Follow-up|10|||
164152837|NCT04796961|592923301|FG000|Overall Study|Withdrawal by Subject|3|||
164152838|NCT04796961|592923301|FG000|Overall Study|Left Organization|10|||
164152839|NCT02325973|592923302|FG000|Overall Study|Death|5|||
164152840|NCT02325973|592923302|FG000|Overall Study|Withdrawal by subject or investigator|16|||
164152841|NCT01490086|592923306|FG000|Overall Study|Consent withdrawn|4|||
164152842|NCT01490086|592923307|FG001|Overall Study|Consent withdrawn|4|||
164152843|NCT01490086|592923308|FG002|Overall Study|Consent withdrawn|3|||
164152844|NCT01490086|592923309|FG003|Overall Study|Consent withdrawn|0|||
164152845|NCT01490086|592923310|FG004|Overall Study|Consent withdrawn|1|||
164152846|NCT01490086|592923306|FG000|Overall Study|Non-compliance|0|||
164152847|NCT01490086|592923307|FG001|Overall Study|Non-compliance|1|||
164152848|NCT01490086|592923308|FG002|Overall Study|Non-compliance|0|||
164152849|NCT01490086|592923309|FG003|Overall Study|Non-compliance|0|||
164152850|NCT01490086|592923310|FG004|Overall Study|Non-compliance|0|||
164152851|NCT01490086|592923306|FG000|Overall Study|Abnormal laboratory findings|1|||
164152852|NCT01490086|592923307|FG001|Overall Study|Abnormal laboratory findings|0|||
164152853|NCT01490086|592923308|FG002|Overall Study|Abnormal laboratory findings|0|||
164152854|NCT01490086|592923309|FG003|Overall Study|Abnormal laboratory findings|0|||
164152855|NCT01490086|592923310|FG004|Overall Study|Abnormal laboratory findings|0|||
164152856|NCT01490086|592923306|FG000|Overall Study|Lost to Follow-up|0|||
164152857|NCT01490086|592923307|FG001|Overall Study|Lost to Follow-up|0|||
164152858|NCT01490086|592923308|FG002|Overall Study|Lost to Follow-up|0|||
164152859|NCT01490086|592923309|FG003|Overall Study|Lost to Follow-up|0|||
164152860|NCT01490086|592923310|FG004|Overall Study|Lost to Follow-up|1|||
164152861|NCT01490086|592923306|FG000|Overall Study|Physician Decision|3|||
164152862|NCT01490086|592923307|FG001|Overall Study|Physician Decision|4|||
164152863|NCT01490086|592923308|FG002|Overall Study|Physician Decision|2|||
164152864|NCT01490086|592923309|FG003|Overall Study|Physician Decision|3|||
164152865|NCT01490086|592923310|FG004|Overall Study|Physician Decision|1|||
164152866|NCT01490086|592923306|FG000|Overall Study|Adverse Event|0|||
164152867|NCT01490086|592923307|FG001|Overall Study|Adverse Event|0|||
164152868|NCT01490086|592923308|FG002|Overall Study|Adverse Event|1|||
164152869|NCT01490086|592923309|FG003|Overall Study|Adverse Event|2|||
164152870|NCT01490086|592923310|FG004|Overall Study|Adverse Event|0|||
164152871|NCT01490086|592923306|FG000|Overall Study|Lack of Efficacy|0|||
164152872|NCT01490086|592923307|FG001|Overall Study|Lack of Efficacy|3|||
164152873|NCT01490086|592923308|FG002|Overall Study|Lack of Efficacy|1|||
164152874|NCT01490086|592923309|FG003|Overall Study|Lack of Efficacy|0|||
164152875|NCT01490086|592923310|FG004|Overall Study|Lack of Efficacy|8|||
164152876|NCT01490086|592923306|FG000|Overall Study|Worsening of symptoms|0|||
164152877|NCT01490086|592923307|FG001|Overall Study|Worsening of symptoms|1|||
164152878|NCT01490086|592923308|FG002|Overall Study|Worsening of symptoms|0|||
164152879|NCT01490086|592923309|FG003|Overall Study|Worsening of symptoms|1|||
164152880|NCT01490086|592923310|FG004|Overall Study|Worsening of symptoms|0|||
164152881|NCT01490086|592923306|FG000|Overall Study|Subject uncontrollable and abusive|0|||
164152882|NCT01490086|592923307|FG001|Overall Study|Subject uncontrollable and abusive|1|||
164152883|NCT01490086|592923308|FG002|Overall Study|Subject uncontrollable and abusive|0|||
164152884|NCT01490086|592923309|FG003|Overall Study|Subject uncontrollable and abusive|0|||
164152885|NCT01490086|592923310|FG004|Overall Study|Subject uncontrollable and abusive|0|||
164152886|NCT01490086|592923306|FG000|Overall Study|Subject left hospital|0|||
164152887|NCT01490086|592923307|FG001|Overall Study|Subject left hospital|1|||
164152888|NCT01490086|592923308|FG002|Overall Study|Subject left hospital|0|||
164152889|NCT01490086|592923309|FG003|Overall Study|Subject left hospital|1|||
164152890|NCT01490086|592923310|FG004|Overall Study|Subject left hospital|0|||
164152891|NCT00679211|592923313|FG000|Overall Study|Progressive disease|82|||
164152892|NCT00679211|592923313|FG000|Overall Study|Adverse Event|7|||
164152893|NCT00679211|592923313|FG000|Overall Study|Withdrawal by Subject|2|||
164152894|NCT00679211|592923313|FG000|Overall Study|Physician Decision|5|||
164152895|NCT00679211|592923313|FG000|Overall Study|Refused to undergo protocol procedures|1|||
164152896|NCT00679211|592923313|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
164152897|NCT00679211|592923313|FG000|Overall Study|Other|1|||
164152898|NCT01922037|592923314|FG000|Overall Study|Withdrawal by Subject|2|||
164152899|NCT01922037|592923315|FG001|Overall Study|Withdrawal by Subject|44|||
164152900|NCT01922037|592923314|FG000|Overall Study|Adverse Event|1|||
164152901|NCT01922037|592923315|FG001|Overall Study|Adverse Event|7|||
164152902|NCT01922037|592923314|FG000|Overall Study|Death|0|||
164152903|NCT01922037|592923315|FG001|Overall Study|Death|5|||
164152904|NCT01922037|592923314|FG000|Overall Study|Pregnancy|0|||
164152905|NCT01922037|592923315|FG001|Overall Study|Pregnancy|2|||
164152906|NCT01922037|592923314|FG000|Overall Study|Participant non-compliance|4|||
164152907|NCT01922037|592923315|FG001|Overall Study|Participant non-compliance|46|||
164152908|NCT01922037|592923314|FG000|Overall Study|Investigator/Sponsor decision|1|||
164152909|NCT01922037|592923315|FG001|Overall Study|Investigator/Sponsor decision|4|||
164152910|NCT01922037|592923314|FG000|Overall Study|Other unspecified|2|||
164152911|NCT01922037|592923315|FG001|Overall Study|Other unspecified|66|||
164152912|NCT00931528|592923316|FG000|Overall Study|Protocol Violation|9|||
164152913|NCT00931528|592923317|FG001|Overall Study|Protocol Violation|12|||
164152914|NCT00931528|592923316|FG000|Overall Study|Withdrawal by Subject|4|||
164152915|NCT00931528|592923317|FG001|Overall Study|Withdrawal by Subject|12|||
164152916|NCT00931528|592923316|FG000|Overall Study|Lost to Follow-up|6|||
164152917|NCT00931528|592923317|FG001|Overall Study|Lost to Follow-up|13|||
164152918|NCT00931528|592923316|FG000|Overall Study|Assessment outside of Time Frame|22|||
164152919|NCT00931528|592923317|FG001|Overall Study|Assessment outside of Time Frame|23|||
164152920|NCT01470248|592923318|FG000|Overall Study|Withdrawal by Subject|1|||
164152921|NCT05842967|592923321|FG000|Period 1: SSA|Adverse Event|1|||
164152922|NCT05842967|592923322|FG001|Period 1: SSA|Adverse Event|1|||
164152923|NCT05842967|592923323|FG002|Period 1: SSA|Adverse Event|0|||
164152924|NCT05842967|592923324|FG003|Period 1: SSA|Adverse Event|0|||
164152925|NCT05842967|592923321|FG000|Period 1: SSA|Death|1|||
164152926|NCT05842967|592923322|FG001|Period 1: SSA|Death|0|||
164152927|NCT05842967|592923323|FG002|Period 1: SSA|Death|0|||
164152928|NCT05842967|592923324|FG003|Period 1: SSA|Death|0|||
164152929|NCT05842967|592923321|FG000|Period 1: SSA|Lost to Follow-up|16|||
164152930|NCT05842967|592923322|FG001|Period 1: SSA|Lost to Follow-up|4|||
164152931|NCT05842967|592923323|FG002|Period 1: SSA|Lost to Follow-up|0|||
164152932|NCT05842967|592923324|FG003|Period 1: SSA|Lost to Follow-up|0|||
164152933|NCT05842967|592923321|FG000|Period 1: SSA|Physician Decision|1|||
164152934|NCT05842967|592923322|FG001|Period 1: SSA|Physician Decision|0|||
164152935|NCT05842967|592923323|FG002|Period 1: SSA|Physician Decision|0|||
164152936|NCT05842967|592923324|FG003|Period 1: SSA|Physician Decision|0|||
164152937|NCT05842967|592923321|FG000|Period 1: SSA|Withdrawal by Subject|2|||
164152938|NCT05842967|592923322|FG001|Period 1: SSA|Withdrawal by Subject|2|||
164152939|NCT05842967|592923323|FG002|Period 1: SSA|Withdrawal by Subject|0|||
164152940|NCT05842967|592923324|FG003|Period 1: SSA|Withdrawal by Subject|0|||
164152941|NCT05842967|592923321|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
164152942|NCT05842967|592923322|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
164152943|NCT05842967|592923323|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
164152944|NCT05842967|592923324|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
164152945|NCT05842967|592923321|FG000|Period 2: SSB|Adverse Event|0|||
164152946|NCT05842967|592923322|FG001|Period 2: SSB|Adverse Event|0|||
164152947|NCT05842967|592923323|FG002|Period 2: SSB|Adverse Event|2|||
164152948|NCT05842967|592923324|FG003|Period 2: SSB|Adverse Event|0|||
164152949|NCT05842967|592923321|FG000|Period 2: SSB|Lost to Follow-up|0|||
164152950|NCT05842967|592923322|FG001|Period 2: SSB|Lost to Follow-up|0|||
164152951|NCT05842967|592923323|FG002|Period 2: SSB|Lost to Follow-up|4|||
164152952|NCT05842967|592923324|FG003|Period 2: SSB|Lost to Follow-up|3|||
164152953|NCT05842967|592923321|FG000|Period 2: SSB|Withdrawal by Subject|0|||
164152954|NCT05842967|592923322|FG001|Period 2: SSB|Withdrawal by Subject|0|||
164152955|NCT05842967|592923323|FG002|Period 2: SSB|Withdrawal by Subject|1|||
164152956|NCT05842967|592923324|FG003|Period 2: SSB|Withdrawal by Subject|0|||
164152957|NCT05842967|592923321|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
164152958|NCT05842967|592923322|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
164152959|NCT05842967|592923323|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
164152960|NCT05842967|592923324|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
164152961|NCT05842967|592923321|FG000|Period 2: SSB|Protocol Violation|0|||
164152962|NCT05842967|592923322|FG001|Period 2: SSB|Protocol Violation|0|||
164152963|NCT05842967|592923323|FG002|Period 2: SSB|Protocol Violation|0|||
164152964|NCT05842967|592923324|FG003|Period 2: SSB|Protocol Violation|1|||
164152965|NCT02572570|592923330|FG000|Overall Study|Study Terminated|27|||
164152966|NCT00611923|592923331|FG000|Overall Study|Withdrawal by Subject|2|||
164152967|NCT00611923|592923332|FG001|Overall Study|Withdrawal by Subject|2|||
164152968|NCT02302833|592923346|FG000|Overall Study|Lost to Follow-up|3|||
164152969|NCT04429503|592923347|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
164152970|NCT04429503|592923348|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
164153263|NCT00262028|592923424|FG000|Overall Study|Protocol Violation|0|||
164152971|NCT04429503|592923349|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
164152972|NCT04429503|592923350|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
164152973|NCT04429503|592923351|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
164152974|NCT04429503|592923352|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
164152975|NCT04429503|592923347|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
164152976|NCT04429503|592923348|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
164152977|NCT04429503|592923349|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
164152978|NCT04429503|592923350|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
164152979|NCT04429503|592923351|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
164152980|NCT04429503|592923352|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
164152981|NCT04429503|592923347|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
164152982|NCT04429503|592923348|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
164152983|NCT04429503|592923349|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
164152984|NCT04429503|592923350|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
164152985|NCT04429503|592923351|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
164152986|NCT04429503|592923352|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
164152987|NCT04429503|592923347|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
164152988|NCT04429503|592923348|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
164152989|NCT04429503|592923349|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
164152990|NCT04429503|592923350|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
164152991|NCT04429503|592923351|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
164152992|NCT04429503|592923352|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
164152993|NCT04429503|592923347|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
164152994|NCT04429503|592923348|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
164152995|NCT04429503|592923349|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
164152996|NCT04429503|592923350|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
164152997|NCT04429503|592923351|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
164152998|NCT04429503|592923352|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
164152999|NCT04429503|592923347|FG000|Main Study (Up to Wk 96)|Death|9|||
164153000|NCT04429503|592923348|FG001|Main Study (Up to Wk 96)|Death|18|||
164153001|NCT04429503|592923349|FG002|Main Study (Up to Wk 96)|Death|5|||
164153002|NCT04429503|592923350|FG003|Main Study (Up to Wk 96)|Death|0|||
164153003|NCT04429503|592923351|FG004|Main Study (Up to Wk 96)|Death|0|||
164153004|NCT04429503|592923352|FG005|Main Study (Up to Wk 96)|Death|0|||
164153005|NCT04429503|592923347|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
164153006|NCT04429503|592923348|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
164153007|NCT04429503|592923349|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
164153008|NCT04429503|592923350|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
164153009|NCT04429503|592923351|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
164153010|NCT04429503|592923352|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
164153011|NCT04429503|592923347|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
164153012|NCT04429503|592923348|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
164153013|NCT04429503|592923349|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
164153014|NCT04429503|592923350|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
164153015|NCT04429503|592923351|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
164153016|NCT04429503|592923352|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
164153017|NCT04429503|592923347|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
164153018|NCT04429503|592923348|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
164153019|NCT04429503|592923349|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
164153020|NCT04429503|592923350|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
164153021|NCT04429503|592923351|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
164153022|NCT04429503|592923352|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
164153023|NCT04429503|592923347|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
164153024|NCT04429503|592923348|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
164153025|NCT04429503|592923349|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
164153026|NCT04429503|592923350|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
164153027|NCT04429503|592923351|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
164153028|NCT04429503|592923352|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
164153029|NCT04429503|592923347|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
164153030|NCT04429503|592923348|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
164153031|NCT04429503|592923349|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
164153032|NCT04429503|592923350|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
164153033|NCT04429503|592923351|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
164153034|NCT04429503|592923352|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
164153035|NCT04429503|592923347|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
164153036|NCT04429503|592923348|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
164153037|NCT04429503|592923349|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
164153038|NCT04429503|592923350|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
164153039|NCT04429503|592923351|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
164153040|NCT04429503|592923352|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
164153041|NCT05516108|592923353|FG000|Overall Study|Time Commitment|3|||
164153042|NCT05516108|592923354|FG001|Overall Study|Time Commitment|1|||
164153043|NCT05516108|592923353|FG000|Overall Study|Reason Unknown|2|||
164153044|NCT05516108|592923354|FG001|Overall Study|Reason Unknown|4|||
164153045|NCT03664232|592923355|FG000|Overall Study|Withdrawal by Subject|0|||
164153046|NCT03664232|592923356|FG001|Overall Study|Withdrawal by Subject|1|||
164153047|NCT03664232|592923357|FG002|Overall Study|Withdrawal by Subject|0|||
164153048|NCT03664232|592923358|FG003|Overall Study|Withdrawal by Subject|1|||
164153049|NCT03664232|592923355|FG000|Overall Study|Adverse Event|0|||
164153050|NCT03664232|592923356|FG001|Overall Study|Adverse Event|0|||
164153051|NCT03664232|592923357|FG002|Overall Study|Adverse Event|1|||
164153052|NCT03664232|592923358|FG003|Overall Study|Adverse Event|0|||
164153053|NCT03664232|592923355|FG000|Overall Study|Other-Non-compliance with study drug|0|||
164153054|NCT03664232|592923356|FG001|Overall Study|Other-Non-compliance with study drug|1|||
164153055|NCT03664232|592923357|FG002|Overall Study|Other-Non-compliance with study drug|0|||
164153056|NCT03664232|592923358|FG003|Overall Study|Other-Non-compliance with study drug|2|||
164153057|NCT03664232|592923355|FG000|Overall Study|Other-Unspecified|0|||
164153058|NCT03664232|592923356|FG001|Overall Study|Other-Unspecified|3|||
164153059|NCT03664232|592923357|FG002|Overall Study|Other-Unspecified|0|||
164153060|NCT03664232|592923358|FG003|Overall Study|Other-Unspecified|1|||
164153061|NCT03664232|592923355|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
164153062|NCT03664232|592923356|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
164153063|NCT03664232|592923357|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
164153064|NCT03664232|592923358|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
164153065|NCT02717507|592923359|FG000|Overall Study|Lost to Follow-up|5|||
164153066|NCT02717507|592923360|FG001|Overall Study|Lost to Follow-up|8|||
164153067|NCT02717507|592923359|FG000|Overall Study|Pregnancy|1|||
164153068|NCT02717507|592923360|FG001|Overall Study|Pregnancy|1|||
164153069|NCT02717507|592923359|FG000|Overall Study|Protocol Violation|2|||
164153070|NCT02717507|592923360|FG001|Overall Study|Protocol Violation|2|||
164153071|NCT02717507|592923359|FG000|Overall Study|Withdrawal by Subject|20|||
164153072|NCT02717507|592923360|FG001|Overall Study|Withdrawal by Subject|20|||
164153073|NCT02717507|592923359|FG000|Overall Study|Relapse|1|||
164153074|NCT02717507|592923360|FG001|Overall Study|Relapse|1|||
164153075|NCT02717507|592923359|FG000|Overall Study|Cardiac Event|2|||
164153076|NCT02717507|592923360|FG001|Overall Study|Cardiac Event|6|||
164153077|NCT05017246|592923361|FG000|Overall Study|Withdrawal by Subject|5|||
164153078|NCT05017246|592923362|FG001|Overall Study|Withdrawal by Subject|3|||
164153079|NCT05017246|592923361|FG000|Overall Study|Determined to be ineligible|0|||
164153080|NCT05017246|592923362|FG001|Overall Study|Determined to be ineligible|1|||
164153081|NCT05017246|592923361|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
164153082|NCT05017246|592923362|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
164153083|NCT05017246|592923361|FG000|Overall Study|Technical failure|1|||
164153084|NCT05017246|592923362|FG001|Overall Study|Technical failure|3|||
164153085|NCT00970593|592923363|FG000|Overall Study|Adverse Event|1|||
164153086|NCT00970593|592923364|FG001|Overall Study|Adverse Event|1|||
164153087|NCT00970593|592923365|FG002|Overall Study|Adverse Event|0|||
164153088|NCT00970593|592923366|FG003|Overall Study|Adverse Event|0|||
164153089|NCT00970593|592923367|FG004|Overall Study|Adverse Event|0|||
164153090|NCT00970593|592923368|FG005|Overall Study|Adverse Event|0|||
164153091|NCT00970593|592923369|FG006|Overall Study|Adverse Event|0|||
164153092|NCT00970593|592923363|FG000|Overall Study|Discontinuation of study by sponsor|0|||
164153093|NCT00970593|592923364|FG001|Overall Study|Discontinuation of study by sponsor|0|||
164153094|NCT00970593|592923365|FG002|Overall Study|Discontinuation of study by sponsor|5|||
164153095|NCT00970593|592923366|FG003|Overall Study|Discontinuation of study by sponsor|0|||
164153096|NCT00970593|592923367|FG004|Overall Study|Discontinuation of study by sponsor|0|||
164153097|NCT00970593|592923368|FG005|Overall Study|Discontinuation of study by sponsor|0|||
164153098|NCT00970593|592923369|FG006|Overall Study|Discontinuation of study by sponsor|2|||
164153099|NCT00970593|592923363|FG000|Overall Study|Withdrawal by Subject|0|||
164153100|NCT00970593|592923364|FG001|Overall Study|Withdrawal by Subject|0|||
164153101|NCT00970593|592923365|FG002|Overall Study|Withdrawal by Subject|1|||
164153102|NCT00970593|592923366|FG003|Overall Study|Withdrawal by Subject|0|||
164153103|NCT00970593|592923367|FG004|Overall Study|Withdrawal by Subject|0|||
164153104|NCT00970593|592923368|FG005|Overall Study|Withdrawal by Subject|0|||
164153105|NCT00970593|592923369|FG006|Overall Study|Withdrawal by Subject|0|||
164153106|NCT02203357|592923370|FG000|Overall Study|Lost to Follow-up|58|||
164153107|NCT02203357|592923371|FG001|Overall Study|Lost to Follow-up|66|||
164153108|NCT02203357|592923372|FG002|Overall Study|Lost to Follow-up|70|||
164153109|NCT02288312|592923381|FG000|Overall Study|Pregnancy|1|||
164153110|NCT02288312|592923382|FG001|Overall Study|Pregnancy|0|||
164153111|NCT02288312|592923383|FG002|Overall Study|Pregnancy|0|||
164153112|NCT02002221|592923384|FG000|Overall Study|Adverse Event|2|||
164153113|NCT02002221|592923385|FG001|Overall Study|Adverse Event|1|||
164153114|NCT02002221|592923384|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164153115|NCT02002221|592923385|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
164153116|NCT02002221|592923384|FG000|Overall Study|Patient withdrew consent|0|||
164153117|NCT02002221|592923385|FG001|Overall Study|Patient withdrew consent|1|||
164153118|NCT01068860|592923386|FG000|Overall Study|Withdrawal by Subject|0|||
164153119|NCT01068860|592923387|FG001|Overall Study|Withdrawal by Subject|0|||
164153120|NCT01068860|592923388|FG002|Overall Study|Withdrawal by Subject|0|||
164153121|NCT01068860|592923389|FG003|Overall Study|Withdrawal by Subject|0|||
164153122|NCT01068860|592923390|FG004|Overall Study|Withdrawal by Subject|0|||
164153123|NCT01068860|592923391|FG005|Overall Study|Withdrawal by Subject|2|||
164153124|NCT01068860|592923392|FG006|Overall Study|Withdrawal by Subject|0|||
164153125|NCT01068860|592923393|FG007|Overall Study|Withdrawal by Subject|0|||
164153126|NCT01068860|592923394|FG008|Overall Study|Withdrawal by Subject|0|||
164153127|NCT01068860|592923395|FG009|Overall Study|Withdrawal by Subject|3|||
164153128|NCT01068860|592923386|FG000|Overall Study|Administrative problems; misrandomized|0|||
164153129|NCT01068860|592923387|FG001|Overall Study|Administrative problems; misrandomized|0|||
164153130|NCT01068860|592923388|FG002|Overall Study|Administrative problems; misrandomized|0|||
164153131|NCT01068860|592923389|FG003|Overall Study|Administrative problems; misrandomized|1|||
164153132|NCT01068860|592923390|FG004|Overall Study|Administrative problems; misrandomized|0|||
164153133|NCT01068860|592923391|FG005|Overall Study|Administrative problems; misrandomized|0|||
164153134|NCT01068860|592923392|FG006|Overall Study|Administrative problems; misrandomized|0|||
164153135|NCT01068860|592923393|FG007|Overall Study|Administrative problems; misrandomized|0|||
164153136|NCT01068860|592923394|FG008|Overall Study|Administrative problems; misrandomized|0|||
164153137|NCT01068860|592923395|FG009|Overall Study|Administrative problems; misrandomized|1|||
164153138|NCT01068860|592923386|FG000|Overall Study|Lost to Follow-up|0|||
164153139|NCT01068860|592923387|FG001|Overall Study|Lost to Follow-up|1|||
164153140|NCT01068860|592923388|FG002|Overall Study|Lost to Follow-up|0|||
164153141|NCT01068860|592923389|FG003|Overall Study|Lost to Follow-up|0|||
164153142|NCT01068860|592923390|FG004|Overall Study|Lost to Follow-up|0|||
164153143|NCT01068860|592923391|FG005|Overall Study|Lost to Follow-up|0|||
164153144|NCT01068860|592923392|FG006|Overall Study|Lost to Follow-up|0|||
164153145|NCT01068860|592923393|FG007|Overall Study|Lost to Follow-up|0|||
164153146|NCT01068860|592923394|FG008|Overall Study|Lost to Follow-up|0|||
164153147|NCT01068860|592923395|FG009|Overall Study|Lost to Follow-up|0|||
164153148|NCT02568072|592923396|FG000|Overall Study|Unavailable for appointment|23|||
164153149|NCT02568072|592923396|FG000|Overall Study|Unable to contact|3|||
164153150|NCT02568072|592923396|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
164153151|NCT02568072|592923396|FG000|Overall Study|Withdrawal by Subject|1|||
164153152|NCT02568072|592923396|FG000|Overall Study|Sustained injury, marathon not run|24|||
164153153|NCT05263908|592923400|FG000|Overall Study|No informed consent for publication of study results|397|||
164153154|NCT05263908|592923400|FG000|Overall Study|CRF not collected|1|||
164153155|NCT02714218|592923401|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164153156|NCT02714218|592923402|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
164153157|NCT02714218|592923403|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164153158|NCT02714218|592923401|FG000|Pre-Treatment Period|Other reasons|0|||
164153159|NCT02714218|592923402|FG001|Pre-Treatment Period|Other reasons|1|||
164153160|NCT02714218|592923403|FG002|Pre-Treatment Period|Other reasons|0|||
164153161|NCT02714218|592923401|FG000|Treatment Period|Disease Progression|55|||
164153162|NCT02714218|592923402|FG001|Treatment Period|Disease Progression|52|||
164153163|NCT02714218|592923403|FG002|Treatment Period|Disease Progression|14|||
164153164|NCT02714218|592923401|FG000|Treatment Period|Study drug toxicity|46|||
164153165|NCT02714218|592923402|FG001|Treatment Period|Study drug toxicity|70|||
164153166|NCT02714218|592923403|FG002|Treatment Period|Study drug toxicity|6|||
164153167|NCT02714218|592923401|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
164153168|NCT02714218|592923402|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
164153169|NCT02714218|592923403|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
164153170|NCT02714218|592923401|FG000|Treatment Period|Request to discontinue treatment|1|||
164153171|NCT02714218|592923402|FG001|Treatment Period|Request to discontinue treatment|4|||
164153172|NCT02714218|592923403|FG002|Treatment Period|Request to discontinue treatment|1|||
164153173|NCT02714218|592923401|FG000|Treatment Period|Participant withdrew consent|2|||
164153174|NCT02714218|592923402|FG001|Treatment Period|Participant withdrew consent|2|||
164153175|NCT02714218|592923403|FG002|Treatment Period|Participant withdrew consent|0|||
164153176|NCT02714218|592923401|FG000|Treatment Period|Maximum clinical benefit|4|||
164153177|NCT02714218|592923402|FG001|Treatment Period|Maximum clinical benefit|2|||
164153178|NCT02714218|592923403|FG002|Treatment Period|Maximum clinical benefit|0|||
164153179|NCT02714218|592923401|FG000|Treatment Period|Administrative reason by sponsor|2|||
164153180|NCT02714218|592923402|FG001|Treatment Period|Administrative reason by sponsor|1|||
164153181|NCT02714218|592923403|FG002|Treatment Period|Administrative reason by sponsor|0|||
164153182|NCT02714218|592923401|FG000|Treatment Period|Other reasons|6|||
164153183|NCT02714218|592923402|FG001|Treatment Period|Other reasons|6|||
164153184|NCT02714218|592923403|FG002|Treatment Period|Other reasons|0|||
164153185|NCT02714218|592923401|FG000|Treatment Period|Completed treatment as per protocol|36|||
164153186|NCT02714218|592923402|FG001|Treatment Period|Completed treatment as per protocol|27|||
164153187|NCT02714218|592923403|FG002|Treatment Period|Completed treatment as per protocol|3|||
164153188|NCT02714218|592923401|FG000|Treatment Period|Not reported|9|||
164153189|NCT02714218|592923402|FG001|Treatment Period|Not reported|6|||
164153190|NCT02714218|592923403|FG002|Treatment Period|Not reported|0|||
164153191|NCT03743051|592923404|FG000|Overall Study|Adverse Event|5|||
164153192|NCT03743051|592923405|FG001|Overall Study|Adverse Event|9|||
164153193|NCT03743051|592923404|FG000|Overall Study|Death|27|||
164153194|NCT03743051|592923405|FG001|Overall Study|Death|26|||
164153195|NCT03743051|592923404|FG000|Overall Study|Lost to Follow-up|4|||
164153196|NCT03743051|592923405|FG001|Overall Study|Lost to Follow-up|8|||
164153197|NCT03743051|592923404|FG000|Overall Study|Withdrawal by Subject|32|||
164153198|NCT03743051|592923405|FG001|Overall Study|Withdrawal by Subject|19|||
164153199|NCT03743051|592923404|FG000|Overall Study|Physician Decision|10|||
164153200|NCT03743051|592923405|FG001|Overall Study|Physician Decision|15|||
164153201|NCT03743051|592923404|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
164153202|NCT03743051|592923405|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
164153203|NCT00840749|592923408|FG000|Overall Study|Death|1|||
164153204|NCT00840749|592923409|FG001|Overall Study|Death|2|||
164153205|NCT00840749|592923408|FG000|Overall Study|not treated on study arm|11|||
164153206|NCT00840749|592923409|FG001|Overall Study|not treated on study arm|11|||
164153207|NCT00840749|592923408|FG000|Overall Study|study closed|19|||
164153208|NCT00840749|592923409|FG001|Overall Study|study closed|14|||
164153209|NCT02550561|592923410|FG000|Overall Study|Lost to Follow-up|5|||
164153210|NCT02550561|592923410|FG000|Overall Study|Withdrawal by Subject|1|||
164153211|NCT03411863|592923415|FG000|Overall Study|Withdrawal by Subject|3|||
164153212|NCT03411863|592923416|FG001|Overall Study|Withdrawal by Subject|1|||
164153213|NCT03411863|592923415|FG000|Overall Study|Physician Decision|0|||
164153214|NCT03411863|592923416|FG001|Overall Study|Physician Decision|1|||
164153215|NCT02766335|592923417|FG000|Initial Registration|Adverse Event|6|||
164153216|NCT02766335|592923418|FG001|Initial Registration|Adverse Event|3|||
164153217|NCT02766335|592923419|FG002|Initial Registration|Adverse Event|0|||
164153218|NCT02766335|592923417|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
164153219|NCT02766335|592923418|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
164153220|NCT02766335|592923419|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
164153221|NCT02766335|592923417|FG000|Initial Registration|Progression/relapse|49|||
164153222|NCT02766335|592923418|FG001|Initial Registration|Progression/relapse|15|||
164153223|NCT02766335|592923419|FG002|Initial Registration|Progression/relapse|0|||
164153224|NCT02766335|592923417|FG000|Initial Registration|Death|1|||
164153225|NCT02766335|592923418|FG001|Initial Registration|Death|3|||
164153226|NCT02766335|592923419|FG002|Initial Registration|Death|0|||
164153227|NCT02766335|592923417|FG000|Initial Registration|not protocol specified|1|||
164153228|NCT02766335|592923418|FG001|Initial Registration|not protocol specified|9|||
164153229|NCT02766335|592923419|FG002|Initial Registration|not protocol specified|0|||
164153230|NCT02766335|592923417|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
164153231|NCT02766335|592923418|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
164153232|NCT02766335|592923419|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
164153233|NCT02766335|592923417|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
164153234|NCT02766335|592923418|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
164153235|NCT02766335|592923419|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
164153236|NCT00262028|592923424|FG000|Overall Study|Withdrawal by Subject|6|||
164153237|NCT00262028|592923425|FG001|Overall Study|Withdrawal by Subject|3|||
164153238|NCT00262028|592923426|FG002|Overall Study|Withdrawal by Subject|6|||
164153239|NCT00262028|592923427|FG003|Overall Study|Withdrawal by Subject|5|||
164153240|NCT00262028|592923428|FG004|Overall Study|Withdrawal by Subject|2|||
164153241|NCT00262028|592923429|FG005|Overall Study|Withdrawal by Subject|3|||
164153242|NCT00262028|592923430|FG006|Overall Study|Withdrawal by Subject|5|||
164153243|NCT00262028|592923431|FG007|Overall Study|Withdrawal by Subject|7|||
164153244|NCT00262028|592923432|FG008|Overall Study|Withdrawal by Subject|2|||
164153245|NCT00262028|592923424|FG000|Overall Study|Lost to Follow-up|7|||
164153246|NCT00262028|592923425|FG001|Overall Study|Lost to Follow-up|7|||
164153247|NCT00262028|592923426|FG002|Overall Study|Lost to Follow-up|5|||
164153248|NCT00262028|592923427|FG003|Overall Study|Lost to Follow-up|5|||
164153249|NCT00262028|592923428|FG004|Overall Study|Lost to Follow-up|4|||
164153250|NCT00262028|592923429|FG005|Overall Study|Lost to Follow-up|3|||
164153251|NCT00262028|592923430|FG006|Overall Study|Lost to Follow-up|3|||
164153252|NCT00262028|592923431|FG007|Overall Study|Lost to Follow-up|5|||
164153253|NCT00262028|592923432|FG008|Overall Study|Lost to Follow-up|6|||
164153254|NCT00262028|592923424|FG000|Overall Study|Administrative Reason|11|||
164153255|NCT00262028|592923425|FG001|Overall Study|Administrative Reason|14|||
164153256|NCT00262028|592923426|FG002|Overall Study|Administrative Reason|9|||
164153257|NCT00262028|592923427|FG003|Overall Study|Administrative Reason|12|||
164153258|NCT00262028|592923428|FG004|Overall Study|Administrative Reason|6|||
164153259|NCT00262028|592923429|FG005|Overall Study|Administrative Reason|7|||
164153260|NCT00262028|592923430|FG006|Overall Study|Administrative Reason|4|||
164153261|NCT00262028|592923431|FG007|Overall Study|Administrative Reason|6|||
164153262|NCT00262028|592923432|FG008|Overall Study|Administrative Reason|10|||
164153264|NCT00262028|592923425|FG001|Overall Study|Protocol Violation|0|||
164153265|NCT00262028|592923426|FG002|Overall Study|Protocol Violation|0|||
164153266|NCT00262028|592923427|FG003|Overall Study|Protocol Violation|1|||
164153267|NCT00262028|592923428|FG004|Overall Study|Protocol Violation|0|||
164153268|NCT00262028|592923429|FG005|Overall Study|Protocol Violation|0|||
164153269|NCT00262028|592923430|FG006|Overall Study|Protocol Violation|0|||
164153270|NCT00262028|592923431|FG007|Overall Study|Protocol Violation|0|||
164153271|NCT00262028|592923432|FG008|Overall Study|Protocol Violation|0|||
164153272|NCT00262028|592923424|FG000|Overall Study|Unable to classify|0|||
164153273|NCT00262028|592923425|FG001|Overall Study|Unable to classify|3|||
164153274|NCT00262028|592923426|FG002|Overall Study|Unable to classify|0|||
164153275|NCT00262028|592923427|FG003|Overall Study|Unable to classify|0|||
164153276|NCT00262028|592923428|FG004|Overall Study|Unable to classify|0|||
164153277|NCT00262028|592923429|FG005|Overall Study|Unable to classify|0|||
164153278|NCT00262028|592923430|FG006|Overall Study|Unable to classify|0|||
164153279|NCT00262028|592923431|FG007|Overall Study|Unable to classify|0|||
164153280|NCT00262028|592923432|FG008|Overall Study|Unable to classify|1|||
164153281|NCT03164551|592923433|FG000|Overall Study|Imaging discontinued prior completion|8|||
164153282|NCT03164551|592923434|FG001|Overall Study|Imaging discontinued prior completion|0|||
164153283|NCT03164551|592923433|FG000|Overall Study|Participant was non-compliant|1|||
164153284|NCT03164551|592923434|FG001|Overall Study|Participant was non-compliant|0|||
164153285|NCT03164551|592923433|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
164153286|NCT03164551|592923434|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
164153287|NCT03164551|592923433|FG000|Overall Study|Other|8|||
164153288|NCT03164551|592923434|FG001|Overall Study|Other|2|||
164153289|NCT01515423|592923435|FG000|Open Label Phase|Adverse Event|57|||
164153290|NCT01515423|592923436|FG001|Open Label Phase|Adverse Event|0|||
164153291|NCT01515423|592923437|FG002|Open Label Phase|Adverse Event|0|||
164153292|NCT01515423|592923435|FG000|Open Label Phase|Death|2|||
164153293|NCT01515423|592923436|FG001|Open Label Phase|Death|0|||
164153294|NCT01515423|592923437|FG002|Open Label Phase|Death|0|||
164153295|NCT01515423|592923435|FG000|Open Label Phase|Lack of Efficacy|117|||
164153296|NCT01515423|592923436|FG001|Open Label Phase|Lack of Efficacy|0|||
164153297|NCT01515423|592923437|FG002|Open Label Phase|Lack of Efficacy|0|||
164153298|NCT01515423|592923435|FG000|Open Label Phase|Lost to Follow-up|21|||
164153299|NCT01515423|592923436|FG001|Open Label Phase|Lost to Follow-up|0|||
164153300|NCT01515423|592923437|FG002|Open Label Phase|Lost to Follow-up|0|||
164153301|NCT01515423|592923435|FG000|Open Label Phase|Withdrawal by Subject|118|||
164153302|NCT01515423|592923436|FG001|Open Label Phase|Withdrawal by Subject|0|||
164153303|NCT01515423|592923437|FG002|Open Label Phase|Withdrawal by Subject|0|||
164153304|NCT01515423|592923435|FG000|Open Label Phase|excluded from DB Phase|70|||
164153305|NCT01515423|592923436|FG001|Open Label Phase|excluded from DB Phase|0|||
164153306|NCT01515423|592923437|FG002|Open Label Phase|excluded from DB Phase|0|||
164153307|NCT01515423|592923435|FG000|Open Label Phase|Other|28|||
164153308|NCT01515423|592923436|FG001|Open Label Phase|Other|0|||
164153309|NCT01515423|592923437|FG002|Open Label Phase|Other|0|||
164153310|NCT01515423|592923435|FG000|DOUBLE BLIND|Adverse Event|0|||
164153311|NCT01515423|592923436|FG001|DOUBLE BLIND|Adverse Event|15|||
164153312|NCT01515423|592923437|FG002|DOUBLE BLIND|Adverse Event|13|||
164153313|NCT01515423|592923435|FG000|DOUBLE BLIND|Death|0|||
164153314|NCT01515423|592923436|FG001|DOUBLE BLIND|Death|1|||
164153315|NCT01515423|592923437|FG002|DOUBLE BLIND|Death|2|||
164153316|NCT01515423|592923435|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
164153317|NCT01515423|592923436|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
164153318|NCT01515423|592923437|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
164153319|NCT01515423|592923435|FG000|DOUBLE BLIND|Pregnancy|0|||
164153320|NCT01515423|592923436|FG001|DOUBLE BLIND|Pregnancy|2|||
164153321|NCT01515423|592923437|FG002|DOUBLE BLIND|Pregnancy|0|||
164153322|NCT01515423|592923435|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
164153323|NCT01515423|592923436|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
164153324|NCT01515423|592923437|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
164153325|NCT01515423|592923435|FG000|DOUBLE BLIND|Other|0|||
164153326|NCT01515423|592923436|FG001|DOUBLE BLIND|Other|6|||
164153327|NCT01515423|592923437|FG002|DOUBLE BLIND|Other|12|||
164153328|NCT01515423|592923435|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
164153329|NCT01515423|592923436|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
164153330|NCT01515423|592923437|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
164153331|NCT01422213|592923442|FG000|Overall Study|Adverse Event|8|||
164153332|NCT01422213|592923443|FG001|Overall Study|Adverse Event|7|||
164153333|NCT01422213|592923444|FG002|Overall Study|Adverse Event|11|||
164153334|NCT01422213|592923442|FG000|Overall Study|Lack of Efficacy|10|||
164153335|NCT01422213|592923443|FG001|Overall Study|Lack of Efficacy|2|||
164153336|NCT01422213|592923444|FG002|Overall Study|Lack of Efficacy|2|||
164153337|NCT01422213|592923442|FG000|Overall Study|Non-compliance with study drug|0|||
164153338|NCT01422213|592923443|FG001|Overall Study|Non-compliance with study drug|1|||
164153339|NCT01422213|592923444|FG002|Overall Study|Non-compliance with study drug|0|||
164153340|NCT01422213|592923442|FG000|Overall Study|Protocol Violation|0|||
164153341|NCT01422213|592923443|FG001|Overall Study|Protocol Violation|2|||
164153342|NCT01422213|592923444|FG002|Overall Study|Protocol Violation|4|||
164153343|NCT01422213|592923442|FG000|Overall Study|Withdrawal of Consent|7|||
164153344|NCT01422213|592923443|FG001|Overall Study|Withdrawal of Consent|3|||
164153345|NCT01422213|592923444|FG002|Overall Study|Withdrawal of Consent|5|||
164153346|NCT01422213|592923442|FG000|Overall Study|Lost to Follow-up|3|||
164153347|NCT01422213|592923443|FG001|Overall Study|Lost to Follow-up|3|||
164153348|NCT01422213|592923444|FG002|Overall Study|Lost to Follow-up|5|||
164153349|NCT01422213|592923442|FG000|Overall Study|Administrative or Other Reason(s)|5|||
164153350|NCT01422213|592923443|FG001|Overall Study|Administrative or Other Reason(s)|4|||
164153351|NCT01422213|592923444|FG002|Overall Study|Administrative or Other Reason(s)|2|||
164153352|NCT00476190|592923456|FG000|Overall Study|Ineligible|1|||
164153353|NCT00476190|592923457|FG001|Overall Study|Ineligible|1|||
164153354|NCT00476190|592923456|FG000|Overall Study|Induction Death|2|||
164153355|NCT00476190|592923457|FG001|Overall Study|Induction Death|0|||
164153356|NCT00476190|592923456|FG000|Overall Study|Induction Failure|2|||
164153357|NCT00476190|592923457|FG001|Overall Study|Induction Failure|4|||
164153358|NCT00476190|592923456|FG000|Overall Study|Lost to Follow-up|1|||
164153359|NCT00476190|592923457|FG001|Overall Study|Lost to Follow-up|0|||
164153360|NCT00476190|592923456|FG000|Overall Study|Relapse/Progression|5|||
164153361|NCT00476190|592923457|FG001|Overall Study|Relapse/Progression|2|||
164153362|NCT00476190|592923456|FG000|Overall Study|Remission Death|0|||
164153363|NCT00476190|592923457|FG001|Overall Study|Remission Death|1|||
164153364|NCT00476190|592923456|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
164153365|NCT00476190|592923457|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
164153366|NCT00476190|592923456|FG000|Overall Study|Withdrawal by Subject|6|||
164153367|NCT00476190|592923457|FG001|Overall Study|Withdrawal by Subject|2|||
164153368|NCT00476190|592923456|FG000|Overall Study|Other|9|||
164153369|NCT00476190|592923457|FG001|Overall Study|Other|10|||
164153370|NCT04782076|592923458|FG000|Overall Study|Family Emergency|1|||
164153371|NCT02189837|592923462|FG000|Overall Study|Withdrawal by Subject|2|||
164153372|NCT02189837|592923463|FG001|Overall Study|Withdrawal by Subject|1|||
164153373|NCT02189837|592923464|FG002|Overall Study|Withdrawal by Subject|3|||
164153374|NCT02189837|592923465|FG003|Overall Study|Withdrawal by Subject|1|||
164153375|NCT02189837|592923462|FG000|Overall Study|Sponsor Decision|0|||
164153376|NCT02189837|592923463|FG001|Overall Study|Sponsor Decision|0|||
164153377|NCT02189837|592923464|FG002|Overall Study|Sponsor Decision|0|||
164153378|NCT02189837|592923465|FG003|Overall Study|Sponsor Decision|1|||
164153379|NCT02201784|592923470|FG000|Overall Study|Failure to achieve adequate block|2|||
164153380|NCT02201784|592923471|FG001|Overall Study|Failure to achieve adequate block|0|||
164153381|NCT00258960|592923472|FG000|Overall Study|Death|2|||
164153382|NCT00258960|592923472|FG000|Overall Study|Disease Progression|7|||
164153383|NCT00258960|592923472|FG000|Overall Study|Adverse Event|4|||
164153384|NCT00258960|592923472|FG000|Overall Study|Physician Decision|1|||
164153385|NCT00258960|592923472|FG000|Overall Study|Withdrawal by Subject|1|||
164153386|NCT00258960|592923472|FG000|Overall Study|Mistake|2|||
164153387|NCT00473590|592923473|FG000|Overall Study|Adverse Event|3|||
164153388|NCT00473590|592923474|FG001|Overall Study|Adverse Event|3|||
164153389|NCT00473590|592923473|FG000|Overall Study|Death|4|||
164153390|NCT00473590|592923474|FG001|Overall Study|Death|2|||
164153391|NCT00473590|592923473|FG000|Overall Study|Progression not resulting in death|24|||
164153392|NCT00473590|592923474|FG001|Overall Study|Progression not resulting in death|20|||
164153393|NCT00473590|592923473|FG000|Overall Study|Non-protocol-specified therapy|7|||
164153394|NCT00473590|592923474|FG001|Overall Study|Non-protocol-specified therapy|5|||
164153395|NCT00473590|592923473|FG000|Overall Study|Physician Decision|2|||
164153396|NCT00473590|592923474|FG001|Overall Study|Physician Decision|4|||
164153397|NCT00473590|592923473|FG000|Overall Study|Withdrawal by Subject|5|||
164153398|NCT00473590|592923474|FG001|Overall Study|Withdrawal by Subject|3|||
164153399|NCT00473590|592923473|FG000|Overall Study|Other|0|||
164153400|NCT00473590|592923474|FG001|Overall Study|Other|1|||
164153401|NCT04199104|592925463|FG000|Overall Study|Death|148|||
164153402|NCT04199104|592925464|FG001|Overall Study|Death|134|||
164153403|NCT04199104|592925463|FG000|Overall Study|Lost to Follow-up|1|||
164153404|NCT04199104|592925464|FG001|Overall Study|Lost to Follow-up|1|||
164153405|NCT04199104|592925463|FG000|Overall Study|Withdrawal by Subject|4|||
164153406|NCT04199104|592925464|FG001|Overall Study|Withdrawal by Subject|4|||
164153407|NCT04199104|592925463|FG000|Overall Study|Participants Ongoing|103|||
164153408|NCT04199104|592925464|FG001|Overall Study|Participants Ongoing|116|||
164153409|NCT04023396|592925465|FG000|Overall Study|Adverse Event|16|||
164153410|NCT04023396|592925465|FG000|Overall Study|Death|1|||
164153411|NCT04023396|592925465|FG000|Overall Study|Lost to Follow-up|1|||
164153412|NCT04023396|592925465|FG000|Overall Study|Withdrawal by Subject|14|||
164153413|NCT04023396|592925465|FG000|Overall Study|Pregnancy|4|||
164153414|NCT04023396|592925465|FG000|Overall Study|Lack of Efficacy|3|||
164153415|NCT04023396|592925465|FG000|Overall Study|Physician Decision|4|||
164153416|NCT04023396|592925465|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
164153417|NCT04075825|592925470|FG000|Overall Study|Withdrawal by Subject|6|||
164153418|NCT04075825|592925471|FG001|Overall Study|Withdrawal by Subject|8|||
164153419|NCT04075825|592925470|FG000|Overall Study|Physician Decision|3|||
164153420|NCT04075825|592925471|FG001|Overall Study|Physician Decision|1|||
164153421|NCT04075825|592925470|FG000|Overall Study|Lost to Follow-up|5|||
164153422|NCT04075825|592925471|FG001|Overall Study|Lost to Follow-up|1|||
164153423|NCT04075825|592925470|FG000|Overall Study|Participation in New Clinical Trial|1|||
164153424|NCT04075825|592925471|FG001|Overall Study|Participation in New Clinical Trial|1|||
164153425|NCT04075825|592925470|FG000|Overall Study|Reason Not Specified|2|||
164153426|NCT04075825|592925471|FG001|Overall Study|Reason Not Specified|2|||
164153427|NCT01168232|592925472|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
164153428|NCT01168232|592925472|FG000|Overall Study|Ineligible- Wrong cell type|6|||
164153429|NCT01168232|592925472|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
164153430|NCT03879135|592925479|FG000|Overall Study|Physician Decision|0|||
164153431|NCT03879135|592925480|FG001|Overall Study|Physician Decision|0|||
164153432|NCT03879135|592925481|FG002|Overall Study|Physician Decision|0|||
164153433|NCT03879135|592925482|FG003|Overall Study|Physician Decision|1|||
164153434|NCT03879135|592925483|FG004|Overall Study|Physician Decision|0|||
164153435|NCT03879135|592925484|FG005|Overall Study|Physician Decision|0|||
164153436|NCT03879135|592925479|FG000|Overall Study|Withdrawal by Subject|0|||
164153437|NCT03879135|592925480|FG001|Overall Study|Withdrawal by Subject|0|||
164153438|NCT03879135|592925481|FG002|Overall Study|Withdrawal by Subject|0|||
164153439|NCT03879135|592925482|FG003|Overall Study|Withdrawal by Subject|0|||
164153440|NCT03879135|592925483|FG004|Overall Study|Withdrawal by Subject|0|||
164153441|NCT03879135|592925484|FG005|Overall Study|Withdrawal by Subject|1|||
164153442|NCT03879135|592925479|FG000|Overall Study|Site Closed by Sponsor|0|||
164153443|NCT03879135|592925480|FG001|Overall Study|Site Closed by Sponsor|0|||
164153444|NCT03879135|592925481|FG002|Overall Study|Site Closed by Sponsor|0|||
164153445|NCT03879135|592925482|FG003|Overall Study|Site Closed by Sponsor|1|||
164153446|NCT03879135|592925483|FG004|Overall Study|Site Closed by Sponsor|1|||
164153447|NCT03879135|592925484|FG005|Overall Study|Site Closed by Sponsor|0|||
164153448|NCT05201794|592925485|FG000|Overall Study|Withdrawal by Subject|13|||
164153449|NCT05201794|592925486|FG001|Overall Study|Withdrawal by Subject|12|||
164153450|NCT05201794|592925487|FG002|Overall Study|Withdrawal by Subject|14|||
164153451|NCT05201794|592925488|FG003|Overall Study|Withdrawal by Subject|0|||
164153452|NCT05201794|592925485|FG000|Overall Study|Adverse Event|5|||
164153453|NCT05201794|592925486|FG001|Overall Study|Adverse Event|5|||
164153454|NCT05201794|592925487|FG002|Overall Study|Adverse Event|4|||
164153455|NCT05201794|592925488|FG003|Overall Study|Adverse Event|0|||
164153456|NCT05201794|592925485|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
164153457|NCT05201794|592925486|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
164153458|NCT05201794|592925487|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
164153459|NCT05201794|592925488|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164153460|NCT05201794|592925485|FG000|Overall Study|Non-Compliance With Study Drug|2|||
164153461|NCT05201794|592925486|FG001|Overall Study|Non-Compliance With Study Drug|3|||
164153462|NCT05201794|592925487|FG002|Overall Study|Non-Compliance With Study Drug|3|||
164153463|NCT05201794|592925488|FG003|Overall Study|Non-Compliance With Study Drug|0|||
164153464|NCT05201794|592925485|FG000|Overall Study|Physician Decision|1|||
164153465|NCT05201794|592925486|FG001|Overall Study|Physician Decision|3|||
164153466|NCT05201794|592925487|FG002|Overall Study|Physician Decision|2|||
164153467|NCT05201794|592925488|FG003|Overall Study|Physician Decision|0|||
164153468|NCT05201794|592925485|FG000|Overall Study|Lost to Follow-up|2|||
164153469|NCT05201794|592925486|FG001|Overall Study|Lost to Follow-up|2|||
164153470|NCT05201794|592925487|FG002|Overall Study|Lost to Follow-up|0|||
164153471|NCT05201794|592925488|FG003|Overall Study|Lost to Follow-up|0|||
164153472|NCT05201794|592925485|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
164153473|NCT05201794|592925486|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
164153474|NCT05201794|592925487|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
164153475|NCT05201794|592925488|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
164153476|NCT05201794|592925485|FG000|Overall Study|Protocol Violation|2|||
164153477|NCT05201794|592925486|FG001|Overall Study|Protocol Violation|0|||
164153478|NCT05201794|592925487|FG002|Overall Study|Protocol Violation|1|||
164153479|NCT05201794|592925488|FG003|Overall Study|Protocol Violation|0|||
164153480|NCT05201794|592925485|FG000|Overall Study|Death|1|||
164153481|NCT05201794|592925486|FG001|Overall Study|Death|0|||
164153482|NCT05201794|592925487|FG002|Overall Study|Death|0|||
164153483|NCT05201794|592925488|FG003|Overall Study|Death|0|||
164153484|NCT05201794|592925485|FG000|Overall Study|Site Terminated By Sponsor|0|||
164153485|NCT05201794|592925486|FG001|Overall Study|Site Terminated By Sponsor|1|||
164153486|NCT05201794|592925487|FG002|Overall Study|Site Terminated By Sponsor|0|||
164153487|NCT05201794|592925488|FG003|Overall Study|Site Terminated By Sponsor|0|||
164153488|NCT05201794|592925485|FG000|Overall Study|Other|3|||
164153489|NCT05201794|592925486|FG001|Overall Study|Other|3|||
164153490|NCT05201794|592925487|FG002|Overall Study|Other|3|||
164153491|NCT05201794|592925488|FG003|Overall Study|Other|0|||
164153492|NCT05201794|592925485|FG000|Overall Study|Randomized But Not Treated|1|||
164153493|NCT05201794|592925486|FG001|Overall Study|Randomized But Not Treated|2|||
164153494|NCT05201794|592925487|FG002|Overall Study|Randomized But Not Treated|1|||
164153495|NCT05201794|592925488|FG003|Overall Study|Randomized But Not Treated|0|||
164153496|NCT03428958|592925489|FG000|Overall Study|Adverse Event|0|||
164153497|NCT03428958|592925490|FG001|Overall Study|Adverse Event|0|||
164153498|NCT03428958|592925491|FG002|Overall Study|Adverse Event|0|||
164153499|NCT03428958|592925492|FG003|Overall Study|Adverse Event|1|||
164153500|NCT03428958|592925493|FG004|Overall Study|Adverse Event|0|||
164153501|NCT03428958|592925494|FG005|Overall Study|Adverse Event|2|||
164153502|NCT03428958|592925495|FG006|Overall Study|Adverse Event|1|||
164153503|NCT03428958|592925496|FG007|Overall Study|Adverse Event|0|||
164153504|NCT03428958|592925497|FG008|Overall Study|Adverse Event|0|||
164153505|NCT03428958|592925498|FG009|Overall Study|Adverse Event|0|||
164153506|NCT03428958|592925499|FG010|Overall Study|Adverse Event|0|||
164153507|NCT03428958|592925500|FG011|Overall Study|Adverse Event|0|||
164153508|NCT03428958|592925501|FG012|Overall Study|Adverse Event|0|||
164153509|NCT03428958|592925502|FG013|Overall Study|Adverse Event|0|||
164153510|NCT03428958|592925503|FG014|Overall Study|Adverse Event|0|||
164153511|NCT03428958|592925504|FG015|Overall Study|Adverse Event|0|||
164153512|NCT03428958|592925505|FG016|Overall Study|Adverse Event|0|||
164153513|NCT03428958|592925489|FG000|Overall Study|Clinical Progression|2|||
164153514|NCT03428958|592925490|FG001|Overall Study|Clinical Progression|3|||
164153515|NCT03428958|592925491|FG002|Overall Study|Clinical Progression|2|||
164153516|NCT03428958|592925492|FG003|Overall Study|Clinical Progression|1|||
164153517|NCT03428958|592925493|FG004|Overall Study|Clinical Progression|0|||
164153518|NCT03428958|592925494|FG005|Overall Study|Clinical Progression|2|||
164153519|NCT03428958|592925495|FG006|Overall Study|Clinical Progression|0|||
164153520|NCT03428958|592925496|FG007|Overall Study|Clinical Progression|0|||
164153521|NCT03428958|592925497|FG008|Overall Study|Clinical Progression|0|||
164153522|NCT03428958|592925498|FG009|Overall Study|Clinical Progression|0|||
164153523|NCT03428958|592925499|FG010|Overall Study|Clinical Progression|0|||
164153524|NCT03428958|592925500|FG011|Overall Study|Clinical Progression|0|||
164153525|NCT03428958|592925501|FG012|Overall Study|Clinical Progression|0|||
164153526|NCT03428958|592925502|FG013|Overall Study|Clinical Progression|0|||
164153527|NCT03428958|592925503|FG014|Overall Study|Clinical Progression|0|||
164153528|NCT03428958|592925504|FG015|Overall Study|Clinical Progression|0|||
164153529|NCT03428958|592925505|FG016|Overall Study|Clinical Progression|0|||
164153530|NCT03428958|592925489|FG000|Overall Study|Progression per RECIST|6|||
164153531|NCT03428958|592925490|FG001|Overall Study|Progression per RECIST|6|||
164153532|NCT03428958|592925491|FG002|Overall Study|Progression per RECIST|7|||
164153533|NCT03428958|592925492|FG003|Overall Study|Progression per RECIST|4|||
164153534|NCT03428958|592925493|FG004|Overall Study|Progression per RECIST|0|||
164153535|NCT03428958|592925494|FG005|Overall Study|Progression per RECIST|7|||
164153536|NCT03428958|592925495|FG006|Overall Study|Progression per RECIST|8|||
164153537|NCT03428958|592925496|FG007|Overall Study|Progression per RECIST|0|||
164153538|NCT03428958|592925497|FG008|Overall Study|Progression per RECIST|0|||
164153539|NCT03428958|592925498|FG009|Overall Study|Progression per RECIST|0|||
164153540|NCT03428958|592925499|FG010|Overall Study|Progression per RECIST|0|||
164153541|NCT03428958|592925500|FG011|Overall Study|Progression per RECIST|0|||
164153542|NCT03428958|592925501|FG012|Overall Study|Progression per RECIST|1|||
164153543|NCT03428958|592925502|FG013|Overall Study|Progression per RECIST|0|||
164153544|NCT03428958|592925503|FG014|Overall Study|Progression per RECIST|0|||
164153545|NCT03428958|592925504|FG015|Overall Study|Progression per RECIST|0|||
164153546|NCT03428958|592925505|FG016|Overall Study|Progression per RECIST|0|||
164153547|NCT03428958|592925489|FG000|Overall Study|Death|2|||
164153548|NCT03428958|592925490|FG001|Overall Study|Death|2|||
164153549|NCT03428958|592925491|FG002|Overall Study|Death|0|||
164153550|NCT03428958|592925492|FG003|Overall Study|Death|0|||
164153551|NCT03428958|592925493|FG004|Overall Study|Death|0|||
164153552|NCT03428958|592925494|FG005|Overall Study|Death|7|||
164153553|NCT03428958|592925495|FG006|Overall Study|Death|9|||
164153554|NCT03428958|592925496|FG007|Overall Study|Death|6|||
164153555|NCT03428958|592925497|FG008|Overall Study|Death|0|||
164153556|NCT03428958|592925498|FG009|Overall Study|Death|0|||
164153557|NCT03428958|592925499|FG010|Overall Study|Death|3|||
164153558|NCT03428958|592925500|FG011|Overall Study|Death|0|||
164153559|NCT03428958|592925501|FG012|Overall Study|Death|4|||
164153560|NCT03428958|592925502|FG013|Overall Study|Death|0|||
164153561|NCT03428958|592925503|FG014|Overall Study|Death|0|||
164153562|NCT03428958|592925504|FG015|Overall Study|Death|0|||
164153563|NCT03428958|592925505|FG016|Overall Study|Death|0|||
164153564|NCT03428958|592925489|FG000|Overall Study|Lost to Follow-up|0|||
164153565|NCT03428958|592925490|FG001|Overall Study|Lost to Follow-up|0|||
164153566|NCT03428958|592925491|FG002|Overall Study|Lost to Follow-up|0|||
164153567|NCT03428958|592925492|FG003|Overall Study|Lost to Follow-up|0|||
164153568|NCT03428958|592925493|FG004|Overall Study|Lost to Follow-up|0|||
164153569|NCT03428958|592925494|FG005|Overall Study|Lost to Follow-up|1|||
164153570|NCT03428958|592925495|FG006|Overall Study|Lost to Follow-up|1|||
164153571|NCT03428958|592925496|FG007|Overall Study|Lost to Follow-up|0|||
164153572|NCT03428958|592925497|FG008|Overall Study|Lost to Follow-up|0|||
164153573|NCT03428958|592925498|FG009|Overall Study|Lost to Follow-up|0|||
164153574|NCT03428958|592925499|FG010|Overall Study|Lost to Follow-up|0|||
164153575|NCT03428958|592925500|FG011|Overall Study|Lost to Follow-up|0|||
164153576|NCT03428958|592925501|FG012|Overall Study|Lost to Follow-up|0|||
164153577|NCT03428958|592925502|FG013|Overall Study|Lost to Follow-up|0|||
164153578|NCT03428958|592925503|FG014|Overall Study|Lost to Follow-up|0|||
164153579|NCT03428958|592925504|FG015|Overall Study|Lost to Follow-up|0|||
164153580|NCT03428958|592925505|FG016|Overall Study|Lost to Follow-up|0|||
164153581|NCT03428958|592925489|FG000|Overall Study|Physician/Sponsor Decision|1|||
164153582|NCT03428958|592925490|FG001|Overall Study|Physician/Sponsor Decision|0|||
164153583|NCT03428958|592925491|FG002|Overall Study|Physician/Sponsor Decision|1|||
164153584|NCT03428958|592925492|FG003|Overall Study|Physician/Sponsor Decision|0|||
164153585|NCT03428958|592925493|FG004|Overall Study|Physician/Sponsor Decision|0|||
164153586|NCT03428958|592925494|FG005|Overall Study|Physician/Sponsor Decision|2|||
164153587|NCT03428958|592925495|FG006|Overall Study|Physician/Sponsor Decision|2|||
164153588|NCT03428958|592925496|FG007|Overall Study|Physician/Sponsor Decision|2|||
164153589|NCT03428958|592925497|FG008|Overall Study|Physician/Sponsor Decision|0|||
164153590|NCT03428958|592925498|FG009|Overall Study|Physician/Sponsor Decision|0|||
164153591|NCT03428958|592925499|FG010|Overall Study|Physician/Sponsor Decision|2|||
164153592|NCT03428958|592925500|FG011|Overall Study|Physician/Sponsor Decision|0|||
164153593|NCT03428958|592925501|FG012|Overall Study|Physician/Sponsor Decision|4|||
164153594|NCT03428958|592925502|FG013|Overall Study|Physician/Sponsor Decision|0|||
164153595|NCT03428958|592925503|FG014|Overall Study|Physician/Sponsor Decision|0|||
164153596|NCT03428958|592925504|FG015|Overall Study|Physician/Sponsor Decision|0|||
164153597|NCT03428958|592925505|FG016|Overall Study|Physician/Sponsor Decision|0|||
164153598|NCT03428958|592925489|FG000|Overall Study|Withdrawal by Subject|0|||
164153599|NCT03428958|592925490|FG001|Overall Study|Withdrawal by Subject|0|||
164153600|NCT03428958|592925491|FG002|Overall Study|Withdrawal by Subject|2|||
164153601|NCT03428958|592925492|FG003|Overall Study|Withdrawal by Subject|0|||
164153602|NCT03428958|592925493|FG004|Overall Study|Withdrawal by Subject|0|||
164153603|NCT03428958|592925494|FG005|Overall Study|Withdrawal by Subject|2|||
164153604|NCT03428958|592925495|FG006|Overall Study|Withdrawal by Subject|4|||
164153605|NCT03428958|592925496|FG007|Overall Study|Withdrawal by Subject|1|||
164153606|NCT03428958|592925497|FG008|Overall Study|Withdrawal by Subject|0|||
164153607|NCT03428958|592925498|FG009|Overall Study|Withdrawal by Subject|0|||
164153608|NCT03428958|592925499|FG010|Overall Study|Withdrawal by Subject|0|||
164153609|NCT03428958|592925500|FG011|Overall Study|Withdrawal by Subject|0|||
164153610|NCT03428958|592925501|FG012|Overall Study|Withdrawal by Subject|0|||
164153611|NCT03428958|592925502|FG013|Overall Study|Withdrawal by Subject|0|||
164153612|NCT03428958|592925503|FG014|Overall Study|Withdrawal by Subject|0|||
164153613|NCT03428958|592925504|FG015|Overall Study|Withdrawal by Subject|0|||
164153614|NCT03428958|592925505|FG016|Overall Study|Withdrawal by Subject|0|||
164153615|NCT03874117|592925506|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
164153616|NCT03874117|592925507|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
164153617|NCT03874117|592925506|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
164153618|NCT03874117|592925507|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
164153619|NCT03874117|592925506|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
164153620|NCT03874117|592925507|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
164153621|NCT03874117|592925506|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
164153622|NCT03874117|592925507|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
164153623|NCT03874117|592925506|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
164153624|NCT03874117|592925507|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
164153625|NCT04510090|592925508|FG000|FE-HS|Withdrawal by Subject|0|||
164153626|NCT04510090|592925509|FG001|FE-HS|Withdrawal by Subject|0|||
164153627|NCT04510090|592925510|FG002|FE-HS|Withdrawal by Subject|0|||
164153628|NCT04510090|592925511|FG003|FE-HS|Withdrawal by Subject|0|||
164153629|NCT04510090|592925512|FG004|FE-HS|Withdrawal by Subject|1|||
164153630|NCT04510090|592925513|FG005|FE-HS|Withdrawal by Subject|0|||
164153631|NCT04510090|592925514|FG006|FE-HS|Withdrawal by Subject|0|||
164153632|NCT04510090|592925515|FG007|FE-HS|Withdrawal by Subject|0|||
164153633|NCT01127256|592925516|FG000|Overall Study|Adverse Event|13|||
164153634|NCT01127256|592925517|FG001|Overall Study|Adverse Event|13|||
164153635|NCT01127256|592925516|FG000|Overall Study|Lack of Efficacy|4|||
164153636|NCT01127256|592925517|FG001|Overall Study|Lack of Efficacy|0|||
164153637|NCT01127256|592925516|FG000|Overall Study|Lost to Follow-up|16|||
164153638|NCT01127256|592925517|FG001|Overall Study|Lost to Follow-up|17|||
164153639|NCT01127256|592925516|FG000|Overall Study|Withdrawal by Subject|5|||
164153640|NCT01127256|592925517|FG001|Overall Study|Withdrawal by Subject|9|||
164153641|NCT01127256|592925516|FG000|Overall Study|Protocol Violation|1|||
164153642|NCT01127256|592925517|FG001|Overall Study|Protocol Violation|0|||
164153643|NCT03657797|592925520|FG000|Overall Study|Lost to Follow-up|0|||
164153644|NCT03657797|592925521|FG001|Overall Study|Lost to Follow-up|1|||
164153645|NCT03657797|592925522|FG002|Overall Study|Lost to Follow-up|1|||
164153646|NCT03657797|592925523|FG003|Overall Study|Lost to Follow-up|0|||
164153647|NCT03657797|592925520|FG000|Overall Study|Physician Decision|0|||
164153648|NCT03657797|592925521|FG001|Overall Study|Physician Decision|1|||
164153649|NCT03657797|592925522|FG002|Overall Study|Physician Decision|0|||
164153650|NCT03657797|592925523|FG003|Overall Study|Physician Decision|0|||
164153651|NCT03657797|592925520|FG000|Overall Study|Withdrawal by Subject|0|||
164153652|NCT03657797|592925521|FG001|Overall Study|Withdrawal by Subject|1|||
164153653|NCT03657797|592925522|FG002|Overall Study|Withdrawal by Subject|2|||
164153654|NCT03657797|592925523|FG003|Overall Study|Withdrawal by Subject|0|||
164153655|NCT03657797|592925520|FG000|Overall Study|Adverse Event|0|||
164153656|NCT03657797|592925521|FG001|Overall Study|Adverse Event|0|||
164153657|NCT03657797|592925522|FG002|Overall Study|Adverse Event|2|||
164153658|NCT03657797|592925523|FG003|Overall Study|Adverse Event|0|||
164153659|NCT00711243|592925524|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
164153660|NCT00711243|592925525|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
164153661|NCT00711243|592925526|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
164153662|NCT00711243|592925527|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
164153663|NCT00711243|592925528|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
164153664|NCT00711243|592925529|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
164153665|NCT00711243|592925524|FG000|Reached First Response/4 Cycles|Death|0|||
164153666|NCT00711243|592925525|FG001|Reached First Response/4 Cycles|Death|0|||
164153667|NCT00711243|592925526|FG002|Reached First Response/4 Cycles|Death|0|||
164153668|NCT00711243|592925527|FG003|Reached First Response/4 Cycles|Death|0|||
164153669|NCT00711243|592925528|FG004|Reached First Response/4 Cycles|Death|0|||
164153670|NCT00711243|592925529|FG005|Reached First Response/4 Cycles|Death|2|||
164153671|NCT00711243|592925524|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
164153672|NCT00711243|592925525|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
164153673|NCT00711243|592925526|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
164153674|NCT00711243|592925527|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
164153675|NCT00711243|592925528|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
164153676|NCT00711243|592925529|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
164153677|NCT00711243|592925524|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
164153678|NCT00711243|592925525|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
164153679|NCT00711243|592925526|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
164153680|NCT00711243|592925527|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
164153681|NCT00711243|592925528|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
164153682|NCT00711243|592925529|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
164153683|NCT00711243|592925524|FG000|Treated Cycle 5 After First Response|Death|0|||
164153684|NCT00711243|592925525|FG001|Treated Cycle 5 After First Response|Death|0|||
164153685|NCT00711243|592925526|FG002|Treated Cycle 5 After First Response|Death|0|||
164153686|NCT00711243|592925527|FG003|Treated Cycle 5 After First Response|Death|0|||
164153687|NCT00711243|592925528|FG004|Treated Cycle 5 After First Response|Death|0|||
164153688|NCT00711243|592925529|FG005|Treated Cycle 5 After First Response|Death|2|||
164153689|NCT00711243|592925524|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
164153690|NCT00711243|592925525|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
164153691|NCT00711243|592925526|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
164153692|NCT00711243|592925527|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
164153693|NCT00711243|592925528|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
164153694|NCT00711243|592925529|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
164153695|NCT00711243|592925524|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
164153696|NCT00711243|592925525|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
164153697|NCT00711243|592925526|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
164153698|NCT00711243|592925527|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
164153699|NCT00711243|592925528|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
164153700|NCT00711243|592925529|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
164153701|NCT01402570|592925532|FG000|Overall Study|Adverse Event|1|||
164153702|NCT03642262|592925533|FG000|Period 1|Withdrawal by Subject|1|||
164153703|NCT03642262|592925534|FG001|Period 1|Withdrawal by Subject|1|||
164153704|NCT03642262|592925533|FG000|Period 1|Adverse Event|0|||
164153705|NCT03642262|592925534|FG001|Period 1|Adverse Event|1|||
164153706|NCT02019472|592925535|FG000|Overall Study|Adverse Event|14|||
164153707|NCT02019472|592925536|FG001|Overall Study|Adverse Event|23|||
164153708|NCT02019472|592925537|FG002|Overall Study|Adverse Event|17|||
164153709|NCT02019472|592925535|FG000|Overall Study|Death|0|||
164153710|NCT02019472|592925536|FG001|Overall Study|Death|1|||
164153711|NCT02019472|592925537|FG002|Overall Study|Death|1|||
164153712|NCT02019472|592925535|FG000|Overall Study|Lack of Efficacy|7|||
164153713|NCT02019472|592925536|FG001|Overall Study|Lack of Efficacy|4|||
164153714|NCT02019472|592925537|FG002|Overall Study|Lack of Efficacy|4|||
164153715|NCT02019472|592925535|FG000|Overall Study|Lost to Follow-up|0|||
164153716|NCT02019472|592925536|FG001|Overall Study|Lost to Follow-up|2|||
164153717|NCT02019472|592925537|FG002|Overall Study|Lost to Follow-up|1|||
164153718|NCT02019472|592925535|FG000|Overall Study|Physician Decision|1|||
164153719|NCT02019472|592925536|FG001|Overall Study|Physician Decision|2|||
164153720|NCT02019472|592925537|FG002|Overall Study|Physician Decision|0|||
164153721|NCT02019472|592925535|FG000|Overall Study|Pregnancy|1|||
164153722|NCT02019472|592925536|FG001|Overall Study|Pregnancy|2|||
164153723|NCT02019472|592925537|FG002|Overall Study|Pregnancy|2|||
164153724|NCT02019472|592925535|FG000|Overall Study|Withdrawal by Subject|11|||
164153725|NCT02019472|592925536|FG001|Overall Study|Withdrawal by Subject|10|||
164153726|NCT02019472|592925537|FG002|Overall Study|Withdrawal by Subject|11|||
164153727|NCT02019472|592925535|FG000|Overall Study|Other|3|||
164153728|NCT02019472|592925536|FG001|Overall Study|Other|8|||
164153729|NCT02019472|592925537|FG002|Overall Study|Other|6|||
164153730|NCT00513695|592925540|FG000|Overall Study|Discontinued therapy|2|||
164153731|NCT00513695|592925540|FG000|Overall Study|Progression prior to surgery|3|||
164153732|NCT02157935|592925541|FG000|Overall Study|Withdrawal by Subject|25|||
164153733|NCT02157935|592925542|FG001|Overall Study|Withdrawal by Subject|39|||
164153734|NCT02157935|592925541|FG000|Overall Study|Screen failure|1|||
164153735|NCT02157935|592925542|FG001|Overall Study|Screen failure|2|||
164153736|NCT02157935|592925541|FG000|Overall Study|Protocol Violation|1|||
164153737|NCT02157935|592925542|FG001|Overall Study|Protocol Violation|0|||
164153738|NCT02157935|592925541|FG000|Overall Study|Progressive disease|0|||
164153739|NCT02157935|592925542|FG001|Overall Study|Progressive disease|2|||
164153740|NCT02157935|592925541|FG000|Overall Study|Other|5|||
164153741|NCT02157935|592925542|FG001|Overall Study|Other|12|||
164153742|NCT02157935|592925541|FG000|Overall Study|Lack of Efficacy|0|||
164153743|NCT02157935|592925542|FG001|Overall Study|Lack of Efficacy|1|||
164153744|NCT02157935|592925541|FG000|Overall Study|Death|4|||
164153745|NCT02157935|592925542|FG001|Overall Study|Death|4|||
164153746|NCT02157935|592925541|FG000|Overall Study|Adverse Event|3|||
164153747|NCT02157935|592925542|FG001|Overall Study|Adverse Event|5|||
164153748|NCT01417156|592925543|FG000|Overall Study|Adverse Event|12|||
164153749|NCT01417156|592925543|FG000|Overall Study|Protocol Violation|2|||
164153750|NCT03192488|592925544|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
164153751|NCT03192488|592925545|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
164153752|NCT03192488|592925546|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
164153753|NCT03192488|592925547|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
164153754|NCT03192488|592925548|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
164153755|NCT03192488|592925549|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
164153756|NCT03192488|592925544|FG000|Third Intervention (d1)|Adverse Event|0|||
164153757|NCT03192488|592925545|FG001|Third Intervention (d1)|Adverse Event|0|||
164153758|NCT03192488|592925546|FG002|Third Intervention (d1)|Adverse Event|0|||
164153759|NCT03192488|592925547|FG003|Third Intervention (d1)|Adverse Event|0|||
164153760|NCT03192488|592925548|FG004|Third Intervention (d1)|Adverse Event|1|||
164153761|NCT03192488|592925549|FG005|Third Intervention (d1)|Adverse Event|0|||
164153762|NCT04565145|592925551|FG000|Overall Study|Withdrawal by Subject|1|||
164153763|NCT04565145|592925552|FG001|Overall Study|Withdrawal by Subject|1|||
164153764|NCT02547428|592925553|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
164153765|NCT02547428|592925554|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
164153766|NCT02547428|592925553|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
164153767|NCT02547428|592925554|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
164153768|NCT02547428|592925553|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
164153769|NCT02547428|592925554|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
164153770|NCT02547428|592925553|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
164153771|NCT02547428|592925554|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
164153772|NCT02547428|592925553|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
164153773|NCT02547428|592925554|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
164153774|NCT02547428|592925553|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
164153775|NCT02547428|592925554|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
164153776|NCT02547428|592925553|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
164153777|NCT02547428|592925554|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
164153778|NCT02547428|592925553|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
164153779|NCT02547428|592925554|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
164153780|NCT00742209|592925567|FG000|Overall Study|Adverse Event|11|||
164153781|NCT00742209|592925568|FG001|Overall Study|Adverse Event|4|||
164153782|NCT00742209|592925569|FG002|Overall Study|Adverse Event|17|||
164153783|NCT00742209|592925570|FG003|Overall Study|Adverse Event|16|||
164153784|NCT00742209|592925571|FG004|Overall Study|Adverse Event|13|||
164153785|NCT00742209|592925567|FG000|Overall Study|Participant Withdrew Consent|8|||
164153786|NCT00742209|592925568|FG001|Overall Study|Participant Withdrew Consent|4|||
164153787|NCT00742209|592925569|FG002|Overall Study|Participant Withdrew Consent|14|||
164153788|NCT00742209|592925570|FG003|Overall Study|Participant Withdrew Consent|7|||
164153789|NCT00742209|592925571|FG004|Overall Study|Participant Withdrew Consent|4|||
164153790|NCT00742209|592925567|FG000|Overall Study|Protocol Violation|6|||
164153791|NCT00742209|592925568|FG001|Overall Study|Protocol Violation|5|||
164153792|NCT00742209|592925569|FG002|Overall Study|Protocol Violation|4|||
164153793|NCT00742209|592925570|FG003|Overall Study|Protocol Violation|5|||
164153794|NCT00742209|592925571|FG004|Overall Study|Protocol Violation|3|||
164153795|NCT00742209|592925567|FG000|Overall Study|Lost to Follow-up|3|||
164153796|NCT00742209|592925568|FG001|Overall Study|Lost to Follow-up|4|||
164153797|NCT00742209|592925569|FG002|Overall Study|Lost to Follow-up|5|||
164153798|NCT00742209|592925570|FG003|Overall Study|Lost to Follow-up|5|||
164153799|NCT00742209|592925571|FG004|Overall Study|Lost to Follow-up|3|||
164153800|NCT00742209|592925567|FG000|Overall Study|Lack of Efficacy|6|||
164153801|NCT00742209|592925568|FG001|Overall Study|Lack of Efficacy|1|||
164153802|NCT00742209|592925569|FG002|Overall Study|Lack of Efficacy|1|||
164153803|NCT00742209|592925570|FG003|Overall Study|Lack of Efficacy|3|||
164153804|NCT00742209|592925571|FG004|Overall Study|Lack of Efficacy|1|||
164153805|NCT00742209|592925567|FG000|Overall Study|Investigator Discretion|0|||
164153806|NCT00742209|592925568|FG001|Overall Study|Investigator Discretion|0|||
164153807|NCT00742209|592925569|FG002|Overall Study|Investigator Discretion|5|||
164153808|NCT00742209|592925570|FG003|Overall Study|Investigator Discretion|1|||
164153809|NCT00742209|592925571|FG004|Overall Study|Investigator Discretion|1|||
164153810|NCT02003209|592925572|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
164153811|NCT02003209|592925573|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
164153812|NCT00485264|592925576|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
164153813|NCT00485264|592925577|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
164153814|NCT00485264|592925578|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
164153815|NCT00485264|592925579|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
164153816|NCT00485264|592925580|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
164153817|NCT00485264|592925581|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
164153818|NCT00485264|592925576|FG000|Overall Study|Death|1|||
164153819|NCT00485264|592925577|FG001|Overall Study|Death|0|||
164153820|NCT00485264|592925578|FG002|Overall Study|Death|0|||
164153821|NCT00485264|592925579|FG003|Overall Study|Death|0|||
164153822|NCT00485264|592925580|FG004|Overall Study|Death|1|||
164153823|NCT00485264|592925581|FG005|Overall Study|Death|0|||
164153824|NCT00485264|592925576|FG000|Overall Study|Adverse Event|1|||
164153825|NCT00485264|592925577|FG001|Overall Study|Adverse Event|0|||
164153826|NCT00485264|592925578|FG002|Overall Study|Adverse Event|2|||
164153827|NCT00485264|592925579|FG003|Overall Study|Adverse Event|3|||
164153828|NCT00485264|592925580|FG004|Overall Study|Adverse Event|1|||
164153829|NCT00485264|592925581|FG005|Overall Study|Adverse Event|3|||
164153830|NCT00485264|592925576|FG000|Overall Study|Pregnancy|4|||
164153831|NCT00485264|592925577|FG001|Overall Study|Pregnancy|0|||
164153832|NCT00485264|592925578|FG002|Overall Study|Pregnancy|0|||
164153833|NCT00485264|592925579|FG003|Overall Study|Pregnancy|0|||
164153834|NCT00485264|592925580|FG004|Overall Study|Pregnancy|0|||
164153835|NCT00485264|592925581|FG005|Overall Study|Pregnancy|0|||
164153836|NCT00485264|592925576|FG000|Overall Study|Disallowed Medication|0|||
164153837|NCT00485264|592925577|FG001|Overall Study|Disallowed Medication|0|||
164153838|NCT00485264|592925578|FG002|Overall Study|Disallowed Medication|0|||
164153839|NCT00485264|592925579|FG003|Overall Study|Disallowed Medication|0|||
164153840|NCT00485264|592925580|FG004|Overall Study|Disallowed Medication|0|||
164153841|NCT00485264|592925581|FG005|Overall Study|Disallowed Medication|1|||
164153842|NCT00485264|592925576|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
164153843|NCT00485264|592925577|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
164153844|NCT00485264|592925578|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
164153845|NCT00485264|592925579|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
164153846|NCT00485264|592925580|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
164153847|NCT00485264|592925581|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
164153848|NCT00485264|592925576|FG000|Overall Study|Lack of Efficacy|0|||
164153849|NCT00485264|592925577|FG001|Overall Study|Lack of Efficacy|1|||
164153850|NCT00485264|592925578|FG002|Overall Study|Lack of Efficacy|0|||
164153851|NCT00485264|592925579|FG003|Overall Study|Lack of Efficacy|0|||
164153852|NCT00485264|592925580|FG004|Overall Study|Lack of Efficacy|0|||
164153853|NCT00485264|592925581|FG005|Overall Study|Lack of Efficacy|0|||
164153854|NCT00485264|592925576|FG000|Overall Study|Guardian Consent Withdrawn|1|||
164153855|NCT00485264|592925577|FG001|Overall Study|Guardian Consent Withdrawn|0|||
164153856|NCT00485264|592925578|FG002|Overall Study|Guardian Consent Withdrawn|0|||
164153857|NCT00485264|592925579|FG003|Overall Study|Guardian Consent Withdrawn|0|||
164153858|NCT00485264|592925580|FG004|Overall Study|Guardian Consent Withdrawn|1|||
164153859|NCT00485264|592925581|FG005|Overall Study|Guardian Consent Withdrawn|0|||
164153860|NCT00485264|592925576|FG000|Overall Study|Physician Decision|0|||
164153861|NCT00485264|592925577|FG001|Overall Study|Physician Decision|2|||
164153862|NCT00485264|592925578|FG002|Overall Study|Physician Decision|0|||
164153863|NCT00485264|592925579|FG003|Overall Study|Physician Decision|0|||
164153864|NCT00485264|592925580|FG004|Overall Study|Physician Decision|0|||
164153865|NCT00485264|592925581|FG005|Overall Study|Physician Decision|0|||
164153866|NCT00485264|592925576|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
164153867|NCT00485264|592925577|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
164153868|NCT00485264|592925578|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
164153869|NCT00485264|592925579|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
164153870|NCT00485264|592925580|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
164153871|NCT00485264|592925581|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
164153872|NCT00485264|592925576|FG000|Overall Study|Not Able to Attend Clinic|5|||
164153873|NCT00485264|592925577|FG001|Overall Study|Not Able to Attend Clinic|0|||
164153874|NCT00485264|592925578|FG002|Overall Study|Not Able to Attend Clinic|0|||
164153875|NCT00485264|592925579|FG003|Overall Study|Not Able to Attend Clinic|1|||
164153876|NCT00485264|592925580|FG004|Overall Study|Not Able to Attend Clinic|1|||
164153877|NCT00485264|592925581|FG005|Overall Study|Not Able to Attend Clinic|2|||
164153878|NCT00485264|592925576|FG000|Overall Study|Non-Compliant|17|||
164153879|NCT00485264|592925577|FG001|Overall Study|Non-Compliant|2|||
164153880|NCT00485264|592925578|FG002|Overall Study|Non-Compliant|1|||
164153881|NCT00485264|592925579|FG003|Overall Study|Non-Compliant|0|||
164153882|NCT00485264|592925580|FG004|Overall Study|Non-Compliant|1|||
164153883|NCT00485264|592925581|FG005|Overall Study|Non-Compliant|0|||
164153884|NCT00485264|592925576|FG000|Overall Study|Lost to Follow-up|2|||
164153885|NCT00485264|592925577|FG001|Overall Study|Lost to Follow-up|1|||
164153886|NCT00485264|592925578|FG002|Overall Study|Lost to Follow-up|1|||
164153887|NCT00485264|592925579|FG003|Overall Study|Lost to Follow-up|0|||
164153888|NCT00485264|592925580|FG004|Overall Study|Lost to Follow-up|0|||
164153889|NCT00485264|592925581|FG005|Overall Study|Lost to Follow-up|1|||
164153890|NCT00485264|592925576|FG000|Overall Study|Other Reason|3|||
164153891|NCT00485264|592925577|FG001|Overall Study|Other Reason|0|||
164153892|NCT00485264|592925578|FG002|Overall Study|Other Reason|0|||
164153893|NCT00485264|592925579|FG003|Overall Study|Other Reason|0|||
164153894|NCT00485264|592925580|FG004|Overall Study|Other Reason|0|||
164153895|NCT00485264|592925581|FG005|Overall Study|Other Reason|0|||
164153896|NCT01514461|592925582|FG000|Overall Study|Adverse Event|2|||
164153897|NCT01514461|592925583|FG001|Overall Study|Adverse Event|1|||
164153898|NCT01514461|592925584|FG002|Overall Study|Adverse Event|3|||
164153899|NCT01514461|592925582|FG000|Overall Study|Physician Decision|1|||
164153900|NCT01514461|592925583|FG001|Overall Study|Physician Decision|1|||
164153901|NCT01514461|592925584|FG002|Overall Study|Physician Decision|0|||
164153902|NCT01514461|592925582|FG000|Overall Study|Patient/guardian decision|1|||
164153903|NCT01514461|592925583|FG001|Overall Study|Patient/guardian decision|1|||
164153904|NCT01514461|592925584|FG002|Overall Study|Patient/guardian decision|1|||
164153905|NCT01514461|592925582|FG000|Overall Study|Death|1|||
164153906|NCT01514461|592925583|FG001|Overall Study|Death|0|||
164153907|NCT01514461|592925584|FG002|Overall Study|Death|0|||
164153908|NCT02548832|592925585|FG000|Overall Study|Lost to Follow-up|2|||
164153909|NCT02548832|592925586|FG001|Overall Study|Lost to Follow-up|2|||
164153910|NCT02548832|592925587|FG002|Overall Study|Lost to Follow-up|2|||
164153911|NCT03565900|592925588|FG000|Overall Study|Disposition Unknown|4|||
164153912|NCT03565900|592925589|FG001|Overall Study|Disposition Unknown|1|||
164153913|NCT03565900|592925588|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
164153914|NCT03565900|592925589|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
164153915|NCT03565900|592925588|FG000|Overall Study|Withdrawal by Subject|4|||
164153916|NCT03565900|592925589|FG001|Overall Study|Withdrawal by Subject|5|||
164153917|NCT03565900|592925588|FG000|Overall Study|Randomized By Mistake|0|||
164153918|NCT03565900|592925589|FG001|Overall Study|Randomized By Mistake|2|||
164153919|NCT03565900|592925588|FG000|Overall Study|Physician Decision|7|||
164153920|NCT03565900|592925589|FG001|Overall Study|Physician Decision|11|||
164153921|NCT03565900|592925588|FG000|Overall Study|Death|9|||
164153922|NCT03565900|592925589|FG001|Overall Study|Death|7|||
164153923|NCT01037218|592925590|FG000|Overall Study|Adverse Event|4|||
164153924|NCT01037218|592925591|FG001|Overall Study|Adverse Event|2|||
164153925|NCT01037218|592925592|FG002|Overall Study|Adverse Event|2|||
164153926|NCT01037218|592925593|FG003|Overall Study|Adverse Event|1|||
164153927|NCT01037218|592925590|FG000|Overall Study|Lack of Efficacy|0|||
164153928|NCT01037218|592925591|FG001|Overall Study|Lack of Efficacy|2|||
164153929|NCT01037218|592925592|FG002|Overall Study|Lack of Efficacy|1|||
164153930|NCT01037218|592925593|FG003|Overall Study|Lack of Efficacy|5|||
164153931|NCT01037218|592925590|FG000|Overall Study|Lost to Follow-up|3|||
164153932|NCT01037218|592925591|FG001|Overall Study|Lost to Follow-up|5|||
164153933|NCT01037218|592925592|FG002|Overall Study|Lost to Follow-up|4|||
164153934|NCT01037218|592925593|FG003|Overall Study|Lost to Follow-up|2|||
164153935|NCT01037218|592925590|FG000|Overall Study|Withdrawal by Subject|6|||
164153936|NCT01037218|592925591|FG001|Overall Study|Withdrawal by Subject|7|||
164153937|NCT01037218|592925592|FG002|Overall Study|Withdrawal by Subject|7|||
164153938|NCT01037218|592925593|FG003|Overall Study|Withdrawal by Subject|4|||
164153939|NCT01037218|592925590|FG000|Overall Study|Partner Withdrew Consent|0|||
164153940|NCT01037218|592925591|FG001|Overall Study|Partner Withdrew Consent|3|||
164153941|NCT01037218|592925592|FG002|Overall Study|Partner Withdrew Consent|2|||
164153942|NCT01037218|592925593|FG003|Overall Study|Partner Withdrew Consent|1|||
164153943|NCT01037218|592925590|FG000|Overall Study|Protocol Violation|0|||
164153944|NCT01037218|592925591|FG001|Overall Study|Protocol Violation|0|||
164153945|NCT01037218|592925592|FG002|Overall Study|Protocol Violation|2|||
164153946|NCT01037218|592925593|FG003|Overall Study|Protocol Violation|2|||
164153947|NCT01037218|592925590|FG000|Overall Study|Various|3|||
164153948|NCT01037218|592925591|FG001|Overall Study|Various|2|||
164153949|NCT01037218|592925592|FG002|Overall Study|Various|3|||
164153950|NCT01037218|592925593|FG003|Overall Study|Various|1|||
164153951|NCT00513240|592925594|FG000|Overall Study|Did not have intended surgery|3|||
164153952|NCT00513240|592925595|FG001|Overall Study|Did not have intended surgery|0|||
164153953|NCT00513240|592925594|FG000|Overall Study|Death|3|||
164153954|NCT00513240|592925595|FG001|Overall Study|Death|3|||
164153955|NCT00513240|592925594|FG000|Overall Study|Withdrawal by Subject|7|||
164153956|NCT00513240|592925595|FG001|Overall Study|Withdrawal by Subject|4|||
164153957|NCT01113892|592925601|FG000|Overall Study|Lost to Follow-up|2|||
164153958|NCT01113892|592925602|FG001|Overall Study|Lost to Follow-up|2|||
164153959|NCT01113892|592925601|FG000|Overall Study|Withdrawal by Subject|1|||
164153960|NCT01113892|592925602|FG001|Overall Study|Withdrawal by Subject|1|||
164153961|NCT01113892|592925601|FG000|Overall Study|Death|2|||
164153962|NCT01113892|592925602|FG001|Overall Study|Death|4|||
164153963|NCT01113892|592925601|FG000|Overall Study|Graft no longer evaluable|9|||
164153964|NCT01113892|592925602|FG001|Overall Study|Graft no longer evaluable|9|||
164153965|NCT00789854|592925603|FG000|Overall Study|Adverse Event|28|||
164153966|NCT00789854|592925604|FG001|Overall Study|Adverse Event|23|||
164153967|NCT00789854|592925605|FG002|Overall Study|Adverse Event|18|||
164153968|NCT00789854|592925603|FG000|Overall Study|Lost to Follow-up|1|||
164153969|NCT00789854|592925604|FG001|Overall Study|Lost to Follow-up|1|||
164153970|NCT00789854|592925605|FG002|Overall Study|Lost to Follow-up|4|||
164153971|NCT00789854|592925603|FG000|Overall Study|Withdrawal by Subject|9|||
164153972|NCT00789854|592925604|FG001|Overall Study|Withdrawal by Subject|6|||
164153973|NCT00789854|592925605|FG002|Overall Study|Withdrawal by Subject|17|||
164153974|NCT00789854|592925603|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
164153975|NCT00789854|592925604|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
164153976|NCT00789854|592925605|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
164153977|NCT00789854|592925603|FG000|Overall Study|Severe non-compliance to the protocol|3|||
164153978|NCT00789854|592925604|FG001|Overall Study|Severe non-compliance to the protocol|0|||
164153979|NCT00789854|592925605|FG002|Overall Study|Severe non-compliance to the protocol|0|||
164153980|NCT00789854|592925603|FG000|Overall Study|Safety reasons|0|||
164153981|NCT00789854|592925604|FG001|Overall Study|Safety reasons|0|||
164153982|NCT00789854|592925605|FG002|Overall Study|Safety reasons|2|||
164153983|NCT00789854|592925603|FG000|Overall Study|Other|6|||
164153984|NCT00789854|592925604|FG001|Overall Study|Other|0|||
164153985|NCT00789854|592925605|FG002|Overall Study|Other|5|||
164153986|NCT03473925|592925606|FG000|Overall Study|Death|48|||
164153987|NCT03473925|592925607|FG001|Overall Study|Death|44|||
164153988|NCT03473925|592925606|FG000|Overall Study|Sponsor Decision|2|||
164153989|NCT03473925|592925607|FG001|Overall Study|Sponsor Decision|7|||
164153990|NCT03473925|592925606|FG000|Overall Study|Withdrawal by Subject|1|||
164153991|NCT03473925|592925607|FG001|Overall Study|Withdrawal by Subject|3|||
164153992|NCT03473925|592925606|FG000|Overall Study|Not Treated|1|||
164153993|NCT03473925|592925607|FG001|Overall Study|Not Treated|1|||
164153994|NCT02756611|592925609|FG000|Overall Study|Death|70|||
164153995|NCT02756611|592925609|FG000|Overall Study|Withdrawal by Subject|2|||
164153996|NCT02756611|592925609|FG000|Overall Study|Lost to Follow-up|3|||
164153997|NCT02756611|592925609|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
164153998|NCT02756611|592925609|FG000|Overall Study|Other|10|||
164153999|NCT03125798|592925610|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
164154000|NCT03125798|592925611|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
164154001|NCT03125798|592925610|FG000|Overall Study|Conversion to thoracotomy|7|||
164154002|NCT03125798|592925611|FG001|Overall Study|Conversion to thoracotomy|7|||
164154003|NCT01949662|592925614|FG000|Overall Study|Death|9|||
164154004|NCT01949662|592925615|FG001|Overall Study|Death|7|||
164154005|NCT01949662|592925614|FG000|Overall Study|Discharged before an agitation event|8|||
164154006|NCT01949662|592925615|FG001|Overall Study|Discharged before an agitation event|3|||
164154007|NCT01949662|592925614|FG000|Overall Study|Dropped out|1|||
164154008|NCT01949662|592925615|FG001|Overall Study|Dropped out|3|||
164154009|NCT01949662|592925614|FG000|Overall Study|Ineligible|0|||
164154010|NCT01949662|592925615|FG001|Overall Study|Ineligible|1|||
164154011|NCT02291237|592925616|FG000|Overall Study|Study Terminated by Sponsor|72|||
164154012|NCT02291237|592925617|FG001|Overall Study|Study Terminated by Sponsor|67|||
164154013|NCT02291237|592925616|FG000|Overall Study|Adverse Event|1|||
164154014|NCT02291237|592925617|FG001|Overall Study|Adverse Event|3|||
164154015|NCT02291237|592925616|FG000|Overall Study|Investigator's Discretion|0|||
164154016|NCT02291237|592925617|FG001|Overall Study|Investigator's Discretion|3|||
164154017|NCT02291237|592925616|FG000|Overall Study|Withdrew Consent|11|||
164154018|NCT02291237|592925617|FG001|Overall Study|Withdrew Consent|11|||
164154019|NCT02291237|592925616|FG000|Overall Study|Lost to Follow-up|0|||
164154020|NCT02291237|592925617|FG001|Overall Study|Lost to Follow-up|2|||
164154021|NCT02291237|592925616|FG000|Overall Study|Subject Required Prohibited Medication|2|||
164154022|NCT02291237|592925617|FG001|Overall Study|Subject Required Prohibited Medication|0|||
164154023|NCT00456300|592925620|FG000|Overall Study|Adverse Event|1|||
164154024|NCT00456300|592925621|FG001|Overall Study|Adverse Event|0|||
164154025|NCT02586155|592925635|FG000|Overall Study|Adverse Event|2|||
164154026|NCT02586155|592925636|FG001|Overall Study|Adverse Event|3|||
164154027|NCT02586155|592925635|FG000|Overall Study|Withdrawal by Subject|31|||
164154028|NCT02586155|592925636|FG001|Overall Study|Withdrawal by Subject|24|||
164154029|NCT02586155|592925635|FG000|Overall Study|Lost to Follow-up|7|||
164154030|NCT02586155|592925636|FG001|Overall Study|Lost to Follow-up|13|||
164154031|NCT02586155|592925635|FG000|Overall Study|Death|61|||
164154032|NCT02586155|592925636|FG001|Overall Study|Death|72|||
164154033|NCT02586155|592925635|FG000|Overall Study|Other reasons|26|||
164154034|NCT02586155|592925636|FG001|Overall Study|Other reasons|15|||
164154035|NCT01522456|592925637|FG000|Overall Study|Adverse Event|2|||
164154036|NCT01522456|592925637|FG000|Overall Study|Lost to Follow-up|2|||
164154037|NCT01522456|592925637|FG000|Overall Study|Withdrawal by Subject|2|||
164154038|NCT01522456|592925637|FG000|Overall Study|Pregnancy|1|||
164154039|NCT01522456|592925637|FG000|Overall Study|Tolerability Assessment|1|||
164154040|NCT02072980|592925638|FG000|Period 2, Second Wear|Adverse Event|0|||
164154041|NCT02072980|592925639|FG001|Period 2, Second Wear|Adverse Event|1|||
164154042|NCT00916383|592925640|FG000|Overall Study|Adverse Event|1|||
164154043|NCT00916383|592925640|FG000|Overall Study|Death|1|||
164154044|NCT00916383|592925640|FG000|Overall Study|Protocol Violation|1|||
164154045|NCT02899962|592925641|FG000|Open-label Phase|Adverse Event|2|||
164154046|NCT02899962|592925642|FG001|Open-label Phase|Adverse Event|0|||
164154047|NCT02899962|592925643|FG002|Open-label Phase|Adverse Event|0|||
164154048|NCT02899962|592925641|FG000|Open-label Phase|Lost to Follow-up|9|||
164154049|NCT02899962|592925642|FG001|Open-label Phase|Lost to Follow-up|0|||
164154050|NCT02899962|592925643|FG002|Open-label Phase|Lost to Follow-up|0|||
164154051|NCT02899962|592925641|FG000|Open-label Phase|Other reasons|9|||
164154052|NCT02899962|592925642|FG001|Open-label Phase|Other reasons|0|||
164154053|NCT02899962|592925643|FG002|Open-label Phase|Other reasons|0|||
164154054|NCT02899962|592925641|FG000|Open-label Phase|Withdrawal by Subject|7|||
164154055|NCT02899962|592925642|FG001|Open-label Phase|Withdrawal by Subject|0|||
164154056|NCT02899962|592925643|FG002|Open-label Phase|Withdrawal by Subject|0|||
164154057|NCT02899962|592925641|FG000|Maintenance Phase|Adverse Event|0|||
164154058|NCT02899962|592925642|FG001|Maintenance Phase|Adverse Event|2|||
164154059|NCT02899962|592925643|FG002|Maintenance Phase|Adverse Event|1|||
164154060|NCT02899962|592925641|FG000|Maintenance Phase|Death|0|||
164154061|NCT02899962|592925642|FG001|Maintenance Phase|Death|0|||
164154062|NCT02899962|592925643|FG002|Maintenance Phase|Death|1|||
164154063|NCT02899962|592925641|FG000|Maintenance Phase|Lack of Efficacy|0|||
164154064|NCT02899962|592925642|FG001|Maintenance Phase|Lack of Efficacy|20|||
164154065|NCT02899962|592925643|FG002|Maintenance Phase|Lack of Efficacy|16|||
164154066|NCT02899962|592925641|FG000|Maintenance Phase|Lost to Follow-up|0|||
164154067|NCT02899962|592925642|FG001|Maintenance Phase|Lost to Follow-up|12|||
164154068|NCT02899962|592925643|FG002|Maintenance Phase|Lost to Follow-up|14|||
164154069|NCT02899962|592925641|FG000|Maintenance Phase|Other reasons|0|||
164154070|NCT02899962|592925642|FG001|Maintenance Phase|Other reasons|9|||
164154071|NCT02899962|592925643|FG002|Maintenance Phase|Other reasons|13|||
164154072|NCT02899962|592925641|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
164154073|NCT02899962|592925642|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
164154074|NCT02899962|592925643|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
164154075|NCT02899962|592925641|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
164154076|NCT02899962|592925642|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
164154077|NCT02899962|592925643|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
164154078|NCT02899962|592925641|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164154079|NCT02899962|592925642|FG001|Maintenance Phase|Withdrawal by Subject|30|||
164154080|NCT02899962|592925643|FG002|Maintenance Phase|Withdrawal by Subject|36|||
164154081|NCT02601014|592925646|FG000|Overall Study|Adverse Event|3|||
164154082|NCT02601014|592925647|FG001|Overall Study|Adverse Event|3|||
164154083|NCT02601014|592925646|FG000|Overall Study|Death|3|||
164154084|NCT02601014|592925647|FG001|Overall Study|Death|1|||
164154085|NCT02601014|592925646|FG000|Overall Study|Disease progression|4|||
164154086|NCT02601014|592925647|FG001|Overall Study|Disease progression|8|||
164154087|NCT02623725|592925649|FG000|Overall Study|Non compliance with protocol|9|||
164154088|NCT02623725|592925650|FG001|Overall Study|Non compliance with protocol|3|||
164154089|NCT02623725|592925649|FG000|Overall Study|Serious adverse event|0|||
164154090|NCT02623725|592925650|FG001|Overall Study|Serious adverse event|2|||
164154091|NCT02623725|592925649|FG000|Overall Study|Withdrawal by Subject|7|||
164154092|NCT02623725|592925650|FG001|Overall Study|Withdrawal by Subject|1|||
164154093|NCT03918629|592925651|FG000|Overall Study|Adverse Event|19|||
164154094|NCT03918629|592925652|FG001|Overall Study|Adverse Event|20|||
164154095|NCT03918629|592925651|FG000|Overall Study|Death|14|||
164154096|NCT03918629|592925652|FG001|Overall Study|Death|7|||
164154097|NCT03918629|592925651|FG000|Overall Study|Lost to Follow-up|36|||
164154098|NCT03918629|592925652|FG001|Overall Study|Lost to Follow-up|28|||
164154099|NCT03918629|592925651|FG000|Overall Study|Physician Decision|1|||
164154100|NCT03918629|592925652|FG001|Overall Study|Physician Decision|0|||
164154101|NCT03918629|592925651|FG000|Overall Study|Protocol Violation|7|||
164154102|NCT03918629|592925652|FG001|Overall Study|Protocol Violation|4|||
164154103|NCT03918629|592925651|FG000|Overall Study|Withdrawal by Subject|47|||
164154104|NCT03918629|592925652|FG001|Overall Study|Withdrawal by Subject|47|||
164154105|NCT03918629|592925651|FG000|Overall Study|Other|7|||
164154106|NCT03918629|592925652|FG001|Overall Study|Other|11|||
164154107|NCT03918629|592925651|FG000|Overall Study|Randomized but not vaccinated|2|||
164154108|NCT03918629|592925652|FG001|Overall Study|Randomized but not vaccinated|1|||
164154109|NCT01891864|592925654|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
164154110|NCT01891864|592925655|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
164154111|NCT01891864|592925656|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
164154112|NCT01891864|592925657|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
164154113|NCT01891864|592925658|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
164154114|NCT01891864|592925659|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
164154115|NCT01891864|592925654|FG000|Treatment Period 1|Physician Decision|0|||
164154116|NCT01891864|592925655|FG001|Treatment Period 1|Physician Decision|1|||
164154117|NCT01891864|592925656|FG002|Treatment Period 1|Physician Decision|0|||
164154118|NCT01891864|592925657|FG003|Treatment Period 1|Physician Decision|0|||
164154119|NCT01891864|592925658|FG004|Treatment Period 1|Physician Decision|0|||
164154120|NCT01891864|592925659|FG005|Treatment Period 1|Physician Decision|0|||
164154121|NCT01891864|592925654|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
164154122|NCT01891864|592925655|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
164154123|NCT01891864|592925656|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
164154124|NCT01891864|592925657|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
164154125|NCT01891864|592925658|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
164154126|NCT01891864|592925659|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
164154127|NCT01891864|592925654|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
164154128|NCT01891864|592925655|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
164154129|NCT01891864|592925656|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
164154130|NCT01891864|592925657|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
164154131|NCT01891864|592925658|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
164154132|NCT01891864|592925659|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
164154133|NCT01891864|592925654|FG000|Treatment Period 1|Withdrawal by Subject|2|||
164154134|NCT01891864|592925655|FG001|Treatment Period 1|Withdrawal by Subject|5|||
164154135|NCT01891864|592925656|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164154136|NCT01891864|592925657|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164154137|NCT01891864|592925658|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164154138|NCT01891864|592925659|FG005|Treatment Period 1|Withdrawal by Subject|0|||
164154139|NCT01891864|592925654|FG000|Treatment Period 1|Lost to Follow-up|1|||
164154140|NCT01891864|592925655|FG001|Treatment Period 1|Lost to Follow-up|0|||
164154141|NCT01891864|592925656|FG002|Treatment Period 1|Lost to Follow-up|0|||
164154142|NCT01891864|592925657|FG003|Treatment Period 1|Lost to Follow-up|0|||
164154143|NCT01891864|592925658|FG004|Treatment Period 1|Lost to Follow-up|0|||
164154144|NCT01891864|592925659|FG005|Treatment Period 1|Lost to Follow-up|0|||
164154145|NCT01891864|592925654|FG000|Treatment Period 2|Protocol Violation|0|||
164154146|NCT01891864|592925655|FG001|Treatment Period 2|Protocol Violation|0|||
164154147|NCT01891864|592925656|FG002|Treatment Period 2|Protocol Violation|0|||
164154148|NCT01891864|592925657|FG003|Treatment Period 2|Protocol Violation|1|||
164154149|NCT01891864|592925658|FG004|Treatment Period 2|Protocol Violation|0|||
164154150|NCT01891864|592925659|FG005|Treatment Period 2|Protocol Violation|0|||
164154151|NCT01891864|592925654|FG000|Treatment Period 2|Physician Decision|0|||
164154152|NCT01891864|592925655|FG001|Treatment Period 2|Physician Decision|0|||
164154153|NCT01891864|592925656|FG002|Treatment Period 2|Physician Decision|1|||
164154154|NCT01891864|592925657|FG003|Treatment Period 2|Physician Decision|0|||
164154155|NCT01891864|592925658|FG004|Treatment Period 2|Physician Decision|0|||
164154156|NCT01891864|592925659|FG005|Treatment Period 2|Physician Decision|0|||
164154157|NCT01891864|592925654|FG000|Treatment Period 2|Site Termination|0|||
164154158|NCT01891864|592925655|FG001|Treatment Period 2|Site Termination|0|||
164154159|NCT01891864|592925656|FG002|Treatment Period 2|Site Termination|1|||
164154160|NCT01891864|592925657|FG003|Treatment Period 2|Site Termination|2|||
164154161|NCT01891864|592925658|FG004|Treatment Period 2|Site Termination|0|||
164154162|NCT01891864|592925659|FG005|Treatment Period 2|Site Termination|0|||
164154163|NCT01891864|592925654|FG000|Treatment Period 2|Lack of Efficacy|0|||
164154164|NCT01891864|592925655|FG001|Treatment Period 2|Lack of Efficacy|0|||
164154165|NCT01891864|592925656|FG002|Treatment Period 2|Lack of Efficacy|1|||
164154166|NCT01891864|592925657|FG003|Treatment Period 2|Lack of Efficacy|0|||
164154167|NCT01891864|592925658|FG004|Treatment Period 2|Lack of Efficacy|1|||
164154168|NCT01891864|592925659|FG005|Treatment Period 2|Lack of Efficacy|0|||
164154169|NCT01891864|592925654|FG000|Treatment Period 2|Adverse Event|0|||
164154170|NCT01891864|592925655|FG001|Treatment Period 2|Adverse Event|0|||
164154171|NCT01891864|592925656|FG002|Treatment Period 2|Adverse Event|1|||
164154172|NCT01891864|592925657|FG003|Treatment Period 2|Adverse Event|2|||
164154173|NCT01891864|592925658|FG004|Treatment Period 2|Adverse Event|0|||
164154174|NCT01891864|592925659|FG005|Treatment Period 2|Adverse Event|4|||
164154175|NCT01891864|592925654|FG000|Treatment Period 2|Termination of Site|0|||
164154176|NCT01891864|592925655|FG001|Treatment Period 2|Termination of Site|0|||
164154177|NCT01891864|592925656|FG002|Treatment Period 2|Termination of Site|0|||
164154178|NCT01891864|592925657|FG003|Treatment Period 2|Termination of Site|0|||
164154179|NCT01891864|592925658|FG004|Treatment Period 2|Termination of Site|2|||
164154180|NCT01891864|592925659|FG005|Treatment Period 2|Termination of Site|0|||
164154181|NCT01891864|592925654|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164154182|NCT01891864|592925655|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164154183|NCT01891864|592925656|FG002|Treatment Period 2|Withdrawal by Subject|3|||
164154184|NCT01891864|592925657|FG003|Treatment Period 2|Withdrawal by Subject|4|||
164154185|NCT01891864|592925658|FG004|Treatment Period 2|Withdrawal by Subject|1|||
164154186|NCT01891864|592925659|FG005|Treatment Period 2|Withdrawal by Subject|1|||
164154187|NCT01891864|592925654|FG000|Extension Period|Lack of Efficacy|0|||
164154188|NCT01891864|592925655|FG001|Extension Period|Lack of Efficacy|0|||
164154189|NCT01891864|592925656|FG002|Extension Period|Lack of Efficacy|0|||
164154190|NCT01891864|592925657|FG003|Extension Period|Lack of Efficacy|1|||
164154191|NCT01891864|592925658|FG004|Extension Period|Lack of Efficacy|1|||
164154192|NCT01891864|592925659|FG005|Extension Period|Lack of Efficacy|0|||
164154193|NCT01891864|592925654|FG000|Extension Period|Pregnancy|0|||
164154194|NCT01891864|592925655|FG001|Extension Period|Pregnancy|0|||
164154195|NCT01891864|592925656|FG002|Extension Period|Pregnancy|1|||
164154196|NCT01891864|592925657|FG003|Extension Period|Pregnancy|0|||
164154197|NCT01891864|592925658|FG004|Extension Period|Pregnancy|0|||
164154198|NCT01891864|592925659|FG005|Extension Period|Pregnancy|0|||
164154199|NCT01891864|592925654|FG000|Extension Period|Adverse Event|0|||
164154200|NCT01891864|592925655|FG001|Extension Period|Adverse Event|0|||
164154201|NCT01891864|592925656|FG002|Extension Period|Adverse Event|4|||
164154202|NCT01891864|592925657|FG003|Extension Period|Adverse Event|2|||
164154203|NCT01891864|592925658|FG004|Extension Period|Adverse Event|2|||
164154204|NCT01891864|592925659|FG005|Extension Period|Adverse Event|0|||
164154205|NCT01891864|592925654|FG000|Extension Period|Withdrawal by Subject|0|||
164154206|NCT01891864|592925655|FG001|Extension Period|Withdrawal by Subject|0|||
164154207|NCT01891864|592925656|FG002|Extension Period|Withdrawal by Subject|1|||
164154208|NCT01891864|592925657|FG003|Extension Period|Withdrawal by Subject|2|||
164154209|NCT01891864|592925658|FG004|Extension Period|Withdrawal by Subject|4|||
164154210|NCT01891864|592925659|FG005|Extension Period|Withdrawal by Subject|0|||
164154211|NCT01891864|592925654|FG000|Extension Period|Lost to Follow-up|0|||
164154212|NCT01891864|592925655|FG001|Extension Period|Lost to Follow-up|0|||
164154213|NCT01891864|592925656|FG002|Extension Period|Lost to Follow-up|2|||
164154214|NCT01891864|592925657|FG003|Extension Period|Lost to Follow-up|0|||
164154215|NCT01891864|592925658|FG004|Extension Period|Lost to Follow-up|0|||
164154216|NCT01891864|592925659|FG005|Extension Period|Lost to Follow-up|0|||
164154217|NCT02698163|592925660|FG000|Overall Study|Lost to Follow-up|0|||
164154218|NCT02698163|592925661|FG001|Overall Study|Lost to Follow-up|1|||
164154219|NCT01133067|592925662|FG000|Overall Study|Death|136|||
164154220|NCT01133067|592925662|FG000|Overall Study|Lost to Follow-up|3|||
164154221|NCT00349973|592925663|FG000|Overall Study|Adverse Event|3|||
164154222|NCT00349973|592925664|FG001|Overall Study|Adverse Event|3|||
164154223|NCT00349973|592925663|FG000|Overall Study|Withdrawal by Subject|1|||
164154224|NCT00349973|592925664|FG001|Overall Study|Withdrawal by Subject|0|||
164154225|NCT04021914|592928102|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
164154226|NCT00803790|592928106|FG000|Period 1|Adverse Event|0|||
164154227|NCT00803790|592928107|FG001|Period 1|Adverse Event|1|||
164154228|NCT00803790|592928108|FG002|Period 1|Adverse Event|0|||
164154229|NCT00803790|592928109|FG003|Period 1|Adverse Event|0|||
164154230|NCT00803790|592928106|FG000|Period 1|Lost to Follow-up|1|||
164154231|NCT00803790|592928107|FG001|Period 1|Lost to Follow-up|2|||
164154232|NCT00803790|592928108|FG002|Period 1|Lost to Follow-up|0|||
164154233|NCT00803790|592928109|FG003|Period 1|Lost to Follow-up|0|||
164154234|NCT00803790|592928106|FG000|Period 1|Withdrawal by Subject|8|||
164154235|NCT00803790|592928107|FG001|Period 1|Withdrawal by Subject|6|||
164154236|NCT00803790|592928108|FG002|Period 1|Withdrawal by Subject|0|||
164154237|NCT00803790|592928109|FG003|Period 1|Withdrawal by Subject|0|||
164154238|NCT00803790|592928106|FG000|Period 1|positive drug screen or personal reasons|0|||
164154239|NCT00803790|592928107|FG001|Period 1|positive drug screen or personal reasons|3|||
164154240|NCT00803790|592928108|FG002|Period 1|positive drug screen or personal reasons|0|||
164154241|NCT00803790|592928109|FG003|Period 1|positive drug screen or personal reasons|4|||
164154242|NCT00803790|592928106|FG000|Period 1|Protocol Violation|0|||
164154243|NCT00803790|592928107|FG001|Period 1|Protocol Violation|0|||
164154244|NCT00803790|592928108|FG002|Period 1|Protocol Violation|1|||
164154245|NCT00803790|592928109|FG003|Period 1|Protocol Violation|0|||
164154246|NCT00803790|592928106|FG000|Period 2|Adverse Event|0|||
164154247|NCT00803790|592928107|FG001|Period 2|Adverse Event|0|||
164154248|NCT00803790|592928108|FG002|Period 2|Adverse Event|1|||
164154249|NCT00803790|592928109|FG003|Period 2|Adverse Event|1|||
164154250|NCT00803790|592928106|FG000|Period 2|Withdrawal by Subject|1|||
164154251|NCT00803790|592928107|FG001|Period 2|Withdrawal by Subject|0|||
164154252|NCT00803790|592928108|FG002|Period 2|Withdrawal by Subject|0|||
164154253|NCT00803790|592928109|FG003|Period 2|Withdrawal by Subject|0|||
164154254|NCT00803790|592928106|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
164154255|NCT00803790|592928107|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
164154256|NCT00803790|592928108|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
164154257|NCT00803790|592928109|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
164154258|NCT04581824|592928111|FG000|Overall Study|Lost to Follow-up|1|||
164154259|NCT04581824|592928112|FG001|Overall Study|Lost to Follow-up|0|||
164154260|NCT04581824|592928111|FG000|Overall Study|Withdrawal by Subject|2|||
164154261|NCT04581824|592928112|FG001|Overall Study|Withdrawal by Subject|7|||
164154262|NCT04581824|592928111|FG000|Overall Study|Study terminated by sponsor|37|||
164154263|NCT04581824|592928112|FG001|Overall Study|Study terminated by sponsor|23|||
164154264|NCT05012098|592928113|FG000|Overall Study|Disease progression|5|||
164154265|NCT05012098|592928114|FG001|Overall Study|Disease progression|2|||
164154266|NCT05012098|592928113|FG000|Overall Study|Adverse Event|1|||
164154267|NCT05012098|592928114|FG001|Overall Study|Adverse Event|0|||
164154268|NCT05012098|592928113|FG000|Overall Study|Withdrawal by Subject|1|||
164154269|NCT05012098|592928114|FG001|Overall Study|Withdrawal by Subject|0|||
164154270|NCT05012098|592928113|FG000|Overall Study|Discontinuation per protocol|1|||
164154271|NCT05012098|592928114|FG001|Overall Study|Discontinuation per protocol|0|||
164154272|NCT05573464|592928115|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
164154273|NCT05573464|592928116|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
164154274|NCT05573464|592928115|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
164154275|NCT05573464|592928116|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
164154276|NCT05573464|592928115|FG000|12-week Treatment Period|Protocol Violation|3|||
164154277|NCT05573464|592928116|FG001|12-week Treatment Period|Protocol Violation|1|||
164154278|NCT05573464|592928115|FG000|12-week Treatment Period|Physician Decision|1|||
164154279|NCT05573464|592928116|FG001|12-week Treatment Period|Physician Decision|2|||
164154280|NCT05573464|592928115|FG000|12-week Treatment Period|Lost to Follow-up|2|||
164154281|NCT05573464|592928116|FG001|12-week Treatment Period|Lost to Follow-up|0|||
164154282|NCT05573464|592928115|FG000|12-week Treatment Period|Adverse Event|20|||
164154283|NCT05573464|592928116|FG001|12-week Treatment Period|Adverse Event|9|||
164154284|NCT05573464|592928115|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
164154285|NCT05573464|592928116|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
164154286|NCT05573464|592928115|FG000|12-week Treatment Period|Randomised, not treated|0|||
164154287|NCT05573464|592928116|FG001|12-week Treatment Period|Randomised, not treated|1|||
164154288|NCT05573464|592928115|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
164154289|NCT05573464|592928116|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
164154290|NCT05573464|592928115|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
164154291|NCT05573464|592928116|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
164154292|NCT05573464|592928115|FG000|52-week Treatment Period|Protocol Violation|1|||
164154293|NCT05573464|592928116|FG001|52-week Treatment Period|Protocol Violation|1|||
164154294|NCT05573464|592928115|FG000|52-week Treatment Period|Physician Decision|2|||
164154295|NCT05573464|592928116|FG001|52-week Treatment Period|Physician Decision|2|||
164154296|NCT05573464|592928115|FG000|52-week Treatment Period|Lost to Follow-up|1|||
164154297|NCT05573464|592928116|FG001|52-week Treatment Period|Lost to Follow-up|1|||
164154298|NCT05573464|592928115|FG000|52-week Treatment Period|Adverse Event|11|||
164154299|NCT05573464|592928116|FG001|52-week Treatment Period|Adverse Event|8|||
164154300|NCT05573464|592928115|FG000|52-week Treatment Period|Death|1|||
164154301|NCT05573464|592928116|FG001|52-week Treatment Period|Death|1|||
164154302|NCT05734157|592928117|FG000|Overall Study|Death|3|||
164154303|NCT05734157|592928117|FG000|Overall Study|Withdrawal by Subject|2|||
164154304|NCT05734157|592928117|FG000|Overall Study|Lost to Follow-up|1|||
164154305|NCT05734157|592928117|FG000|Overall Study|Telephone call|3|||
164154306|NCT04815083|592928118|FG000|Overall Study|Physician Decision|1|||
164154307|NCT04815083|592928118|FG000|Overall Study|Study pause|2|||
164154308|NCT04815083|592928118|FG000|Overall Study|Screening failure|4|||
164154309|NCT06025721|592928119|FG000|Overall Study|Physician Decision|1|||
164154310|NCT06025721|592928119|FG000|Overall Study|Protocol Violation|1|||
164154311|NCT06025721|592928119|FG000|Overall Study|Incarceration|1|||
164154312|NCT01749826|592928120|FG000|Overall Study|Study Terminated|20|||
164154313|NCT01749826|592928121|FG001|Overall Study|Study Terminated|0|||
164154314|NCT01730053|592928124|FG000|Overall Study|Participant moved|0|||
164154315|NCT01730053|592928125|FG001|Overall Study|Participant moved|0|||
164154316|NCT01730053|592928126|FG002|Overall Study|Participant moved|1|||
164154317|NCT01730053|592928127|FG003|Overall Study|Participant moved|0|||
164154318|NCT01730053|592928128|FG004|Overall Study|Participant moved|0|||
164154319|NCT01730053|592928129|FG005|Overall Study|Participant moved|0|||
164154320|NCT01730053|592928124|FG000|Overall Study|Physician Decision|0|||
164154321|NCT01730053|592928125|FG001|Overall Study|Physician Decision|0|||
164154322|NCT01730053|592928126|FG002|Overall Study|Physician Decision|0|||
164154323|NCT01730053|592928127|FG003|Overall Study|Physician Decision|1|||
164154324|NCT01730053|592928128|FG004|Overall Study|Physician Decision|0|||
164154325|NCT01730053|592928129|FG005|Overall Study|Physician Decision|0|||
164154326|NCT01730053|592928124|FG000|Overall Study|Adverse Event|2|||
164154327|NCT01730053|592928125|FG001|Overall Study|Adverse Event|6|||
164154328|NCT01730053|592928126|FG002|Overall Study|Adverse Event|3|||
164154329|NCT01730053|592928127|FG003|Overall Study|Adverse Event|3|||
164154330|NCT01730053|592928128|FG004|Overall Study|Adverse Event|2|||
164154331|NCT01730053|592928129|FG005|Overall Study|Adverse Event|2|||
164154332|NCT01730053|592928124|FG000|Overall Study|Poor compliance to protocol|1|||
164154333|NCT01730053|592928125|FG001|Overall Study|Poor compliance to protocol|2|||
164154334|NCT01730053|592928126|FG002|Overall Study|Poor compliance to protocol|2|||
164154335|NCT01730053|592928127|FG003|Overall Study|Poor compliance to protocol|0|||
164154336|NCT01730053|592928128|FG004|Overall Study|Poor compliance to protocol|0|||
164154337|NCT01730053|592928129|FG005|Overall Study|Poor compliance to protocol|2|||
164154338|NCT01730053|592928124|FG000|Overall Study|Other than specified|2|||
164154339|NCT01730053|592928125|FG001|Overall Study|Other than specified|6|||
164154340|NCT01730053|592928126|FG002|Overall Study|Other than specified|5|||
164154341|NCT01730053|592928127|FG003|Overall Study|Other than specified|4|||
164154342|NCT01730053|592928128|FG004|Overall Study|Other than specified|7|||
164154343|NCT01730053|592928129|FG005|Overall Study|Other than specified|9|||
164154344|NCT02068508|592928130|FG000|Overall Study|Case report forms uncollected|27|||
164154345|NCT02068508|592928130|FG000|Overall Study|Patient did not visit the study site|1|||
164154346|NCT02068508|592928130|FG000|Overall Study|Protocol Violation|4|||
164154347|NCT00813150|592928131|FG000|Treatment Period|Adverse Event|16|||
164154348|NCT00813150|592928132|FG001|Treatment Period|Adverse Event|15|||
164154349|NCT00813150|592928131|FG000|Treatment Period|Death|2|||
164154350|NCT00813150|592928132|FG001|Treatment Period|Death|0|||
164154351|NCT00813150|592928131|FG000|Treatment Period|Progressive disease|1|||
164154352|NCT00813150|592928132|FG001|Treatment Period|Progressive disease|0|||
164154353|NCT00813150|592928131|FG000|Treatment Period|Complete response|0|||
164154354|NCT00813150|592928132|FG001|Treatment Period|Complete response|1|||
164154355|NCT00813150|592928131|FG000|Treatment Period|Stable disease|1|||
164154356|NCT00813150|592928132|FG001|Treatment Period|Stable disease|2|||
164154357|NCT00813150|592928131|FG000|Treatment Period|Protocol Violation|3|||
164154358|NCT00813150|592928132|FG001|Treatment Period|Protocol Violation|4|||
164154359|NCT00813150|592928131|FG000|Treatment Period|Withdrawal by Subject|5|||
164154360|NCT00813150|592928132|FG001|Treatment Period|Withdrawal by Subject|3|||
164154361|NCT00813150|592928131|FG000|Treatment Period|Non compliance|0|||
164154362|NCT00813150|592928132|FG001|Treatment Period|Non compliance|1|||
164154363|NCT00813150|592928131|FG000|Treatment Period|Reason not specified|3|||
164154364|NCT00813150|592928132|FG001|Treatment Period|Reason not specified|4|||
164154365|NCT00813150|592928131|FG000|Treatment Period|Data not available|1|||
164154366|NCT00813150|592928132|FG001|Treatment Period|Data not available|2|||
164154367|NCT00813150|592928131|FG000|Long Term Follow-up|Death|0|||
164154368|NCT00813150|592928132|FG001|Long Term Follow-up|Death|4|||
164154369|NCT00813150|592928131|FG000|Long Term Follow-up|Other|0|||
164154370|NCT00813150|592928132|FG001|Long Term Follow-up|Other|3|||
164154371|NCT00813150|592928131|FG000|Long Term Follow-up|Lost to Follow-up|2|||
164154372|NCT00813150|592928132|FG001|Long Term Follow-up|Lost to Follow-up|0|||
164154373|NCT00813150|592928131|FG000|Long Term Follow-up|Progression/Relapse|22|||
164154374|NCT00813150|592928132|FG001|Long Term Follow-up|Progression/Relapse|24|||
164154375|NCT05085834|592928133|FG000|Overall Study|Lost to Follow-up|9|||
164154376|NCT05085834|592928134|FG001|Overall Study|Lost to Follow-up|2|||
164154377|NCT05085834|592928133|FG000|Overall Study|Adverse Event|6|||
164154378|NCT05085834|592928134|FG001|Overall Study|Adverse Event|0|||
164154379|NCT05085834|592928133|FG000|Overall Study|Death|1|||
164154380|NCT05085834|592928134|FG001|Overall Study|Death|0|||
164154381|NCT05085834|592928133|FG000|Overall Study|Inability to swallow the pill|0|||
164154382|NCT05085834|592928134|FG001|Overall Study|Inability to swallow the pill|1|||
164154383|NCT01823328|592928139|FG000|Overall Study|Withdrawal by Subject|8|||
164154384|NCT01823328|592928140|FG001|Overall Study|Withdrawal by Subject|6|||
164154385|NCT01662635|592928141|FG000|Overall Study|scarce samples for evaluation|30|||
164154386|NCT01217112|592928142|FG000|Overall Study|Adverse Event|0|||
164154387|NCT01217112|592928143|FG001|Overall Study|Adverse Event|2|||
164154388|NCT01217112|592928144|FG002|Overall Study|Adverse Event|0|||
164154389|NCT01217112|592928145|FG003|Overall Study|Adverse Event|2|||
164154390|NCT01217112|592928146|FG004|Overall Study|Adverse Event|0|||
164154391|NCT01217112|592928142|FG000|Overall Study|Withdrawal by Subject|0|||
164154392|NCT01217112|592928143|FG001|Overall Study|Withdrawal by Subject|0|||
164154393|NCT01217112|592928144|FG002|Overall Study|Withdrawal by Subject|1|||
164154394|NCT01217112|592928145|FG003|Overall Study|Withdrawal by Subject|0|||
164154395|NCT01217112|592928146|FG004|Overall Study|Withdrawal by Subject|0|||
164154396|NCT01217112|592928142|FG000|Overall Study|Physician Decision|0|||
164154397|NCT01217112|592928143|FG001|Overall Study|Physician Decision|0|||
164154398|NCT01217112|592928144|FG002|Overall Study|Physician Decision|0|||
164154399|NCT01217112|592928145|FG003|Overall Study|Physician Decision|0|||
164154400|NCT01217112|592928146|FG004|Overall Study|Physician Decision|1|||
164154401|NCT01401361|592928147|FG000|Overall Study|Withdrawal by Subject|16|||
164154402|NCT01401361|592928147|FG000|Overall Study|Lack of Efficacy|6|||
164154403|NCT01401361|592928147|FG000|Overall Study|Physician Decision|1|||
164154404|NCT01401361|592928147|FG000|Overall Study|Lost to Follow-up|3|||
164154405|NCT01401361|592928147|FG000|Overall Study|Subject/family decision post procedure|2|||
164154406|NCT00595920|592928150|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
164154407|NCT00351468|592928151|FG000|Overall Study|Adverse Event|42|||
164154408|NCT00351468|592928151|FG000|Overall Study|Withdrawal by Subject|39|||
164154409|NCT00351468|592928151|FG000|Overall Study|Various -follow up w clinical team|39|||
164154410|NCT00351468|592928151|FG000|Overall Study|Lack of Efficacy|32|||
164154411|NCT00351468|592928151|FG000|Overall Study|Non-compliance|8|||
164154412|NCT00351468|592928151|FG000|Overall Study|Lost to Follow-up|4|||
164154413|NCT00351468|592928151|FG000|Overall Study|Protocol Violation|3|||
164154414|NCT03588910|592928152|FG000|Overall Study|Withdrawal by Subject|1|||
164154415|NCT03588910|592928153|FG001|Overall Study|Withdrawal by Subject|0|||
164154416|NCT03588910|592928152|FG000|Overall Study|Allergy|2|||
164154417|NCT03588910|592928153|FG001|Overall Study|Allergy|0|||
164154418|NCT03588910|592928152|FG000|Overall Study|Protocol Violation|0|||
164154419|NCT03588910|592928153|FG001|Overall Study|Protocol Violation|3|||
164154420|NCT03588910|592928152|FG000|Overall Study|Did not complete Day 1 Survey|5|||
164154421|NCT03588910|592928153|FG001|Overall Study|Did not complete Day 1 Survey|10|||
164154422|NCT03588910|592928152|FG000|Overall Study|Did not complete Day 7 Survey|5|||
164154423|NCT03588910|592928153|FG001|Overall Study|Did not complete Day 7 Survey|2|||
164154424|NCT03096314|592928154|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
164154425|NCT03096314|592928155|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
164154426|NCT00471822|592928156|FG000|Overall Study|Protocol Violation|2|||
164154427|NCT03318861|592928157|FG000|Overall Study|Death|2|||
164154428|NCT03318861|592928158|FG001|Overall Study|Death|3|||
164154429|NCT03318861|592928159|FG002|Overall Study|Death|3|||
164154430|NCT03318861|592928160|FG003|Overall Study|Death|2|||
164154431|NCT03318861|592928161|FG004|Overall Study|Death|2|||
164154432|NCT03318861|592928157|FG000|Overall Study|Enrolled But Never Treated|0|||
164154433|NCT03318861|592928158|FG001|Overall Study|Enrolled But Never Treated|1|||
164154434|NCT03318861|592928159|FG002|Overall Study|Enrolled But Never Treated|0|||
164154435|NCT03318861|592928160|FG003|Overall Study|Enrolled But Never Treated|1|||
164154436|NCT03318861|592928161|FG004|Overall Study|Enrolled But Never Treated|1|||
164154437|NCT03318861|592928157|FG000|Overall Study|Informed Consent Withdraw|0|||
164154438|NCT03318861|592928158|FG001|Overall Study|Informed Consent Withdraw|0|||
164154439|NCT03318861|592928159|FG002|Overall Study|Informed Consent Withdraw|0|||
164154440|NCT03318861|592928160|FG003|Overall Study|Informed Consent Withdraw|1|||
164154441|NCT03318861|592928161|FG004|Overall Study|Informed Consent Withdraw|0|||
164154442|NCT03318861|592928157|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
164154443|NCT03318861|592928158|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
164154444|NCT03318861|592928159|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
164154445|NCT03318861|592928160|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
164154446|NCT03318861|592928161|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
164154447|NCT01892501|592928162|FG000|Overall Study|Protocol Violation|2|||
164154448|NCT01892501|592928162|FG000|Overall Study|Puncture not carried out|9|||
164154449|NCT01892501|592928162|FG000|Overall Study|Radiological monitoring not carried out|5|||
164154450|NCT01892501|592928162|FG000|Overall Study|Non-contributory histological result|12|||
164154451|NCT04335123|592928165|FG000|Overall Study|Withdrawal by Subject|2|||
164154452|NCT04335123|592928166|FG001|Overall Study|Withdrawal by Subject|0|||
164154453|NCT04335123|592928165|FG000|Overall Study|Physician Decision|2|||
164154454|NCT04335123|592928166|FG001|Overall Study|Physician Decision|0|||
164154455|NCT01254643|592928167|FG000|Overall Study|Withdrawal by Subject|1|||
164154456|NCT03359850|592928173|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
164154457|NCT03359850|592928174|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
164154458|NCT03359850|592928173|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
164154459|NCT03359850|592928174|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
164154460|NCT03359850|592928173|FG000|Extension Phase (Up to 28 Months)|Death|2|||
164154461|NCT03359850|592928174|FG001|Extension Phase (Up to 28 Months)|Death|4|||
164154462|NCT03359850|592928173|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
164154463|NCT03359850|592928174|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
164154464|NCT03359850|592928173|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
164154465|NCT03359850|592928174|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
164154466|NCT03817125|592928192|FG000|Overall Study|Adverse Event|1|||
164154467|NCT03817125|592928193|FG001|Overall Study|Adverse Event|0|||
164154468|NCT03817125|592928192|FG000|Overall Study|Physician Decision|0|||
164154469|NCT03817125|592928193|FG001|Overall Study|Physician Decision|1|||
164154470|NCT03817125|592928192|FG000|Overall Study|Lack of Efficacy|1|||
164154471|NCT03817125|592928193|FG001|Overall Study|Lack of Efficacy|5|||
164154472|NCT00942084|592928194|FG000|Overall Study|Death|2|||
164154473|NCT01062425|592928195|FG000|Overall Study|Protocol Violation|3|||
164154474|NCT01062425|592928196|FG001|Overall Study|Protocol Violation|6|||
164154475|NCT01433471|592928199|FG000|Overall Study|Withdrawal by Subject|0|||
164154476|NCT01433471|592928200|FG001|Overall Study|Withdrawal by Subject|1|||
164154477|NCT00395629|592928203|FG000|Core Study|Adverse Event|0|||
164154478|NCT00395629|592928204|FG001|Core Study|Adverse Event|3|||
164154479|NCT00395629|592928205|FG002|Core Study|Adverse Event|4|||
164154480|NCT00395629|592928203|FG000|Core Study|Abnormal laboratory value(s)|0|||
164154481|NCT00395629|592928204|FG001|Core Study|Abnormal laboratory value(s)|0|||
164154482|NCT00395629|592928205|FG002|Core Study|Abnormal laboratory value(s)|1|||
164154483|NCT00395629|592928203|FG000|Core Study|Protocol Violation|1|||
164154484|NCT00395629|592928204|FG001|Core Study|Protocol Violation|0|||
164154485|NCT00395629|592928205|FG002|Core Study|Protocol Violation|0|||
164154486|NCT00395629|592928203|FG000|Core Study|Withdrawal by Subject|0|||
164154487|NCT00395629|592928204|FG001|Core Study|Withdrawal by Subject|1|||
164154488|NCT00395629|592928205|FG002|Core Study|Withdrawal by Subject|1|||
164154489|NCT00395629|592928203|FG000|Core Study|Lost to Follow-up|0|||
164154490|NCT00395629|592928204|FG001|Core Study|Lost to Follow-up|0|||
164154491|NCT00395629|592928205|FG002|Core Study|Lost to Follow-up|1|||
164154492|NCT00395629|592928203|FG000|Extension Study|Adverse Event|0|||
164154493|NCT00395629|592928204|FG001|Extension Study|Adverse Event|0|||
164154494|NCT00395629|592928205|FG002|Extension Study|Adverse Event|2|||
164154495|NCT00395629|592928203|FG000|Extension Study|Administrative problems|0|||
164154496|NCT00395629|592928204|FG001|Extension Study|Administrative problems|0|||
164154497|NCT00395629|592928205|FG002|Extension Study|Administrative problems|1|||
164154498|NCT03428152|592928206|FG000|Overall Study|Physician Decision|4|||
164154499|NCT03428152|592928207|FG001|Overall Study|Physician Decision|2|||
164154500|NCT03428152|592928206|FG000|Overall Study|Protocol Violation|3|||
164154501|NCT03428152|592928207|FG001|Overall Study|Protocol Violation|5|||
164154502|NCT03428152|592928206|FG000|Overall Study|Lack of Efficacy|0|||
164154503|NCT03428152|592928207|FG001|Overall Study|Lack of Efficacy|4|||
164154504|NCT01686373|592928208|FG000|Overall Study|Lost to Follow-up|3|||
164154505|NCT01686373|592928209|FG001|Overall Study|Lost to Follow-up|0|||
164154506|NCT01686373|592928208|FG000|Overall Study|Withdrawal by Subject|0|||
164154507|NCT01686373|592928209|FG001|Overall Study|Withdrawal by Subject|1|||
164154508|NCT01686373|592928208|FG000|Overall Study|Adverse Event|0|||
164154509|NCT01686373|592928209|FG001|Overall Study|Adverse Event|1|||
164154510|NCT00191477|592928213|FG000|Overall Study|Tumor Recurrence|49|||
164154511|NCT00191477|592928214|FG001|Overall Study|Tumor Recurrence|48|||
164154512|NCT00191477|592928213|FG000|Overall Study|Death, Study Disease|1|||
164154513|NCT00191477|592928214|FG001|Overall Study|Death, Study Disease|1|||
164154514|NCT00191477|592928213|FG000|Overall Study|Death, Other Cause|3|||
164154515|NCT00191477|592928214|FG001|Overall Study|Death, Other Cause|6|||
164154516|NCT00191477|592928213|FG000|Overall Study|Lost to Follow-up|23|||
164154517|NCT00191477|592928214|FG001|Overall Study|Lost to Follow-up|21|||
164154518|NCT00191477|592928213|FG000|Overall Study|Protocol Violation|1|||
164154519|NCT00191477|592928214|FG001|Overall Study|Protocol Violation|1|||
164154520|NCT00191477|592928213|FG000|Overall Study|Treatment Change|2|||
164154521|NCT00191477|592928214|FG001|Overall Study|Treatment Change|0|||
164154522|NCT00191477|592928213|FG000|Overall Study|Withdrawal by Subject|2|||
164154523|NCT00191477|592928214|FG001|Overall Study|Withdrawal by Subject|0|||
164154524|NCT00191477|592928213|FG000|Overall Study|Other|2|||
164154525|NCT00191477|592928214|FG001|Overall Study|Other|0|||
164154526|NCT00191477|592928213|FG000|Overall Study|Not Eligible|41|||
164154527|NCT00191477|592928214|FG001|Overall Study|Not Eligible|38|||
164154528|NCT00191477|592928213|FG000|Overall Study|Pathological Specimen Lost|1|||
164154529|NCT00191477|592928214|FG001|Overall Study|Pathological Specimen Lost|0|||
164154530|NCT00191477|592928213|FG000|Overall Study|Discontinued Prior to Instillation|13|||
164154531|NCT00191477|592928214|FG001|Overall Study|Discontinued Prior to Instillation|14|||
164154532|NCT06481709|592928215|FG000|Overall Study|Withdrawal by Subject|0|||
164154533|NCT06481709|592928216|FG001|Overall Study|Withdrawal by Subject|0|||
164154534|NCT06481709|592928217|FG002|Overall Study|Withdrawal by Subject|2|||
164154535|NCT06481709|592928218|FG003|Overall Study|Withdrawal by Subject|0|||
164154536|NCT01108718|592928220|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
164154537|NCT01108718|592928221|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
164154538|NCT02857816|592928224|FG000|Overall Study|Screen Failure|33|||
164154539|NCT02857816|592928224|FG000|Overall Study|Withdrawal by Subject|4|||
164154540|NCT02857816|592928224|FG000|Overall Study|Lost to Follow-up|1|||
164154541|NCT00729937|592928225|FG000|Overall Study|Lost to Follow-up|49|||
164154542|NCT00729937|592928226|FG001|Overall Study|Lost to Follow-up|58|||
164154543|NCT00729937|592928227|FG002|Overall Study|Lost to Follow-up|18|||
164154544|NCT00729937|592928228|FG003|Overall Study|Lost to Follow-up|33|||
164154545|NCT00729937|592928229|FG004|Overall Study|Lost to Follow-up|18|||
164154546|NCT00729937|592928230|FG005|Overall Study|Lost to Follow-up|23|||
164154547|NCT00729937|592928225|FG000|Overall Study|Physician Decision|7|||
164154548|NCT00729937|592928226|FG001|Overall Study|Physician Decision|16|||
164154549|NCT00729937|592928227|FG002|Overall Study|Physician Decision|2|||
164154550|NCT00729937|592928228|FG003|Overall Study|Physician Decision|0|||
164154551|NCT00729937|592928229|FG004|Overall Study|Physician Decision|5|||
164154552|NCT00729937|592928230|FG005|Overall Study|Physician Decision|8|||
164154553|NCT00729937|592928225|FG000|Overall Study|Death|1|||
164154554|NCT00729937|592928226|FG001|Overall Study|Death|0|||
164154555|NCT00729937|592928227|FG002|Overall Study|Death|1|||
164154556|NCT00729937|592928228|FG003|Overall Study|Death|0|||
164154557|NCT00729937|592928229|FG004|Overall Study|Death|0|||
164154558|NCT00729937|592928230|FG005|Overall Study|Death|1|||
164154559|NCT00729937|592928225|FG000|Overall Study|Withdrawal by Subject|3|||
164154560|NCT00729937|592928226|FG001|Overall Study|Withdrawal by Subject|5|||
164154561|NCT00729937|592928227|FG002|Overall Study|Withdrawal by Subject|6|||
164154562|NCT00729937|592928228|FG003|Overall Study|Withdrawal by Subject|0|||
164154563|NCT00729937|592928229|FG004|Overall Study|Withdrawal by Subject|4|||
164154564|NCT00729937|592928230|FG005|Overall Study|Withdrawal by Subject|2|||
164154565|NCT00729937|592928225|FG000|Overall Study|Randomized but not treated|12|||
164154566|NCT00729937|592928226|FG001|Overall Study|Randomized but not treated|6|||
164154567|NCT00729937|592928227|FG002|Overall Study|Randomized but not treated|1|||
164154568|NCT00729937|592928228|FG003|Overall Study|Randomized but not treated|0|||
164154569|NCT00729937|592928229|FG004|Overall Study|Randomized but not treated|1|||
164154570|NCT00729937|592928230|FG005|Overall Study|Randomized but not treated|3|||
164154571|NCT00729937|592928225|FG000|Overall Study|Did not meet eligibility criteria|2|||
164154572|NCT00729937|592928226|FG001|Overall Study|Did not meet eligibility criteria|1|||
164154573|NCT00729937|592928227|FG002|Overall Study|Did not meet eligibility criteria|0|||
164154574|NCT00729937|592928228|FG003|Overall Study|Did not meet eligibility criteria|0|||
164154575|NCT00729937|592928229|FG004|Overall Study|Did not meet eligibility criteria|0|||
164154576|NCT00729937|592928230|FG005|Overall Study|Did not meet eligibility criteria|0|||
164154577|NCT00729937|592928225|FG000|Overall Study|Incarcerated|0|||
164154578|NCT00729937|592928226|FG001|Overall Study|Incarcerated|2|||
164154579|NCT00729937|592928227|FG002|Overall Study|Incarcerated|1|||
164154580|NCT00729937|592928228|FG003|Overall Study|Incarcerated|1|||
164154581|NCT00729937|592928229|FG004|Overall Study|Incarcerated|0|||
164154582|NCT00729937|592928230|FG005|Overall Study|Incarcerated|0|||
164154583|NCT02198963|592928234|FG000|Overall Study|Adverse Event|1|||
164154584|NCT02198963|592928234|FG000|Overall Study|Withdrawal by Subject|6|||
164154585|NCT00281957|592928235|FG000|Overall Study|Adverse Event|7|||
164154586|NCT00281957|592928236|FG001|Overall Study|Adverse Event|2|||
164154587|NCT00281957|592928235|FG000|Overall Study|Death|1|||
164154588|NCT00281957|592928236|FG001|Overall Study|Death|0|||
164154589|NCT00281957|592928235|FG000|Overall Study|Progression/relapse|47|||
164154590|NCT00281957|592928236|FG001|Overall Study|Progression/relapse|35|||
164154591|NCT00281957|592928235|FG000|Overall Study|Not protocol specified|8|||
164154592|NCT00281957|592928236|FG001|Overall Study|Not protocol specified|1|||
164154593|NCT00281957|592928235|FG000|Overall Study|Not eligible|1|||
164154594|NCT00281957|592928236|FG001|Overall Study|Not eligible|2|||
164154595|NCT00281957|592928235|FG000|Overall Study|Did not start treatment|3|||
164154596|NCT00281957|592928236|FG001|Overall Study|Did not start treatment|1|||
164154597|NCT00281957|592928235|FG000|Overall Study|Refusal unrelated to adverse events|0|||
164154598|NCT00281957|592928236|FG001|Overall Study|Refusal unrelated to adverse events|1|||
164154599|NCT03281876|592928244|FG000|Overall Study|Adverse Event|4|||
164154600|NCT03281876|592928245|FG001|Overall Study|Adverse Event|15|||
164154601|NCT03281876|592928244|FG000|Overall Study|Lost to Follow-up|1|||
164154602|NCT03281876|592928245|FG001|Overall Study|Lost to Follow-up|4|||
164154603|NCT03281876|592928244|FG000|Overall Study|Withdrawal by Subject|11|||
164154604|NCT03281876|592928245|FG001|Overall Study|Withdrawal by Subject|15|||
164154605|NCT03281876|592928244|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
164154606|NCT03281876|592928245|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164154607|NCT03281876|592928244|FG000|Overall Study|OTHER|5|||
164154608|NCT03281876|592928245|FG001|Overall Study|OTHER|5|||
164154609|NCT02208089|592928246|FG000|Overall Study|Withdrawal by Subject|1|||
164154610|NCT02208089|592928247|FG001|Overall Study|Withdrawal by Subject|0|||
164154611|NCT02208089|592928246|FG000|Overall Study|Lost to Follow-up|6|||
164154612|NCT02208089|592928247|FG001|Overall Study|Lost to Follow-up|0|||
164154613|NCT02443740|592928248|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
164154614|NCT02443740|592928249|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
164154615|NCT02443740|592928250|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
164154616|NCT02443740|592928251|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
164154617|NCT02443740|592928252|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
164154618|NCT02443740|592928253|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
164154619|NCT02443740|592928254|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
164154620|NCT02443740|592928255|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
164154621|NCT02443740|592928256|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
164154622|NCT02443740|592928257|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
164154623|NCT02443740|592928258|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
164154624|NCT02443740|592928248|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
164154625|NCT02443740|592928249|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
164154626|NCT02443740|592928250|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
164154627|NCT02443740|592928251|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
164154628|NCT02443740|592928252|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
164154629|NCT02443740|592928253|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
164154630|NCT02443740|592928254|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
164154631|NCT02443740|592928255|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
164154632|NCT02443740|592928256|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
164154633|NCT02443740|592928257|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
164154634|NCT02443740|592928258|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
164154635|NCT02443740|592928248|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
164154636|NCT02443740|592928249|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
164154637|NCT02443740|592928250|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
164154638|NCT02443740|592928251|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
164154639|NCT02443740|592928252|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
164154640|NCT02443740|592928253|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
164154641|NCT02443740|592928254|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
164154642|NCT02443740|592928255|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
164154643|NCT02443740|592928256|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
164154644|NCT02443740|592928257|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
164154645|NCT02443740|592928258|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
164154646|NCT01478373|592928259|FG000|Treatment Phase|Protocol Violation|1|||
164154647|NCT01478373|592928259|FG000|Survival Phase|Adverse Event|8|||
164154648|NCT01478373|592928259|FG000|Survival Phase|Protocol Violation|1|||
164154649|NCT01478373|592928259|FG000|Survival Phase|crossover to another study|2|||
164154650|NCT01478373|592928259|FG000|Survival Phase|Progressive Disease|27|||
164154651|NCT00683657|592928261|FG000|Overall Study|Adverse Event|0|||
164154652|NCT00683657|592928262|FG001|Overall Study|Adverse Event|1|||
164154653|NCT00683657|592928261|FG000|Overall Study|Subject Withdrew Consent|1|||
164154654|NCT00683657|592928262|FG001|Overall Study|Subject Withdrew Consent|0|||
164154655|NCT01074944|592928263|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
164154656|NCT01074944|592928264|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
164154657|NCT01074944|592928265|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
164154658|NCT01074944|592928266|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
164154659|NCT01074944|592928267|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
164154660|NCT01074944|592928263|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
164154661|NCT01074944|592928264|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
164154662|NCT01074944|592928265|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
164154663|NCT01074944|592928266|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
164154664|NCT01074944|592928267|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
164154665|NCT01074944|592928263|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
164154666|NCT01074944|592928264|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
164154667|NCT01074944|592928265|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
164154668|NCT01074944|592928266|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
164154669|NCT01074944|592928267|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
164154670|NCT01074944|592928263|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
164154671|NCT01074944|592928264|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
164154672|NCT01074944|592928265|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
164154673|NCT01074944|592928266|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
164154674|NCT01074944|592928267|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
164154675|NCT01074944|592928263|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
164154676|NCT01074944|592928264|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
164154677|NCT01074944|592928265|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
164154678|NCT01074944|592928266|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
164154679|NCT01074944|592928267|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
164154680|NCT01074944|592928263|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
164154681|NCT01074944|592928264|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
164154682|NCT01074944|592928265|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
164154683|NCT01074944|592928266|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
164154684|NCT01074944|592928267|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
164154685|NCT01074944|592928263|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
164154686|NCT01074944|592928264|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
164154687|NCT01074944|592928265|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
164154688|NCT01074944|592928266|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
164154689|NCT01074944|592928267|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
164154690|NCT01074944|592928263|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
164154691|NCT01074944|592928264|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
164154692|NCT01074944|592928265|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
164154693|NCT01074944|592928266|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
164154694|NCT01074944|592928267|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
164154695|NCT01074944|592928263|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
164154696|NCT01074944|592928264|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
164154697|NCT01074944|592928265|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
164154698|NCT01074944|592928266|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
164154699|NCT01074944|592928267|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
164154700|NCT01074944|592928263|FG000|Long Term Treatment|Adverse Event|0|||
164154701|NCT01074944|592928264|FG001|Long Term Treatment|Adverse Event|0|||
164154702|NCT01074944|592928265|FG002|Long Term Treatment|Adverse Event|0|||
164154703|NCT01074944|592928266|FG003|Long Term Treatment|Adverse Event|3|||
164154704|NCT01074944|592928267|FG004|Long Term Treatment|Adverse Event|0|||
164154705|NCT01074944|592928263|FG000|Long Term Treatment|Lost to Follow-up|0|||
164154706|NCT01074944|592928264|FG001|Long Term Treatment|Lost to Follow-up|0|||
164154707|NCT01074944|592928265|FG002|Long Term Treatment|Lost to Follow-up|0|||
164154708|NCT01074944|592928266|FG003|Long Term Treatment|Lost to Follow-up|2|||
164154709|NCT01074944|592928267|FG004|Long Term Treatment|Lost to Follow-up|0|||
164154710|NCT01074944|592928263|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
164154711|NCT01074944|592928264|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
164154712|NCT01074944|592928265|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
164154713|NCT01074944|592928266|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
164154714|NCT01074944|592928267|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
164154715|NCT01074944|592928263|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
164154716|NCT01074944|592928264|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
164154717|NCT01074944|592928265|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
164154718|NCT01074944|592928266|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
164154719|NCT01074944|592928267|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
164154720|NCT01074944|592928263|FG000|Long Term Treatment|Withdrawal by Subject|0|||
164154721|NCT01074944|592928264|FG001|Long Term Treatment|Withdrawal by Subject|0|||
164154722|NCT01074944|592928265|FG002|Long Term Treatment|Withdrawal by Subject|0|||
164154723|NCT01074944|592928266|FG003|Long Term Treatment|Withdrawal by Subject|2|||
164154724|NCT01074944|592928267|FG004|Long Term Treatment|Withdrawal by Subject|0|||
164154725|NCT01074944|592928263|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
164154726|NCT01074944|592928264|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
164154727|NCT01074944|592928265|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
164154728|NCT01074944|592928266|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
164154729|NCT01074944|592928267|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
164154730|NCT01074944|592928263|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
164154731|NCT01074944|592928264|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
164154732|NCT01074944|592928265|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
164154733|NCT01074944|592928266|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
164154734|NCT01074944|592928267|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
164154735|NCT03200717|592928271|FG000|Overall Study|Progressive disease|24|||
164154736|NCT03200717|592928272|FG001|Overall Study|Progressive disease|5|||
164154737|NCT03200717|592928271|FG000|Overall Study|Adverse Event|11|||
164154738|NCT03200717|592928272|FG001|Overall Study|Adverse Event|8|||
164154739|NCT03200717|592928271|FG000|Overall Study|Physician Decision|3|||
164154740|NCT03200717|592928272|FG001|Overall Study|Physician Decision|2|||
164154741|NCT03200717|592928271|FG000|Overall Study|Death|2|||
164154742|NCT03200717|592928272|FG001|Overall Study|Death|0|||
164154743|NCT03200717|592928271|FG000|Overall Study|Subject/Guardian Decision|1|||
164154744|NCT03200717|592928272|FG001|Overall Study|Subject/Guardian Decision|0|||
164154745|NCT05373108|592928275|FG000|Overall Study|Withdrawal by Subject|2|||
164154746|NCT02892331|592928277|FG000|Overall Study|Withdrawal by Subject|0|||
164154747|NCT02892331|592928278|FG001|Overall Study|Withdrawal by Subject|1|||
164154748|NCT02892331|592928279|FG002|Overall Study|Withdrawal by Subject|1|||
164154749|NCT02892331|592928277|FG000|Overall Study|Sick family member|0|||
164154750|NCT02892331|592928278|FG001|Overall Study|Sick family member|0|||
164154751|NCT02892331|592928279|FG002|Overall Study|Sick family member|1|||
164154752|NCT02892331|592928277|FG000|Overall Study|Corona virus pandemic|1|||
164154753|NCT02892331|592928278|FG001|Overall Study|Corona virus pandemic|0|||
164154754|NCT02892331|592928279|FG002|Overall Study|Corona virus pandemic|1|||
164154755|NCT02892331|592928277|FG000|Overall Study|Lost to Follow-up|1|||
164154756|NCT02892331|592928278|FG001|Overall Study|Lost to Follow-up|0|||
164154757|NCT02892331|592928279|FG002|Overall Study|Lost to Follow-up|1|||
164154758|NCT02892331|592928277|FG000|Overall Study|Blood pressure was too elevated|0|||
164154759|NCT02892331|592928278|FG001|Overall Study|Blood pressure was too elevated|1|||
164154760|NCT02892331|592928279|FG002|Overall Study|Blood pressure was too elevated|0|||
164154761|NCT02892331|592928277|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
164154762|NCT02892331|592928278|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
164154763|NCT02892331|592928279|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
164154764|NCT00752128|592928280|FG000|Overall Study|Withdrawal by Subject|4|||
164154765|NCT04135937|592928281|FG000|Overall Study|Lost to Follow-up|2|||
164154766|NCT04135937|592928281|FG000|Overall Study|Withdrawal by Subject|1|||
164154767|NCT05620082|592928282|FG000|Overall Study|Discharged before study end|1|||
164154768|NCT05620082|592928283|FG001|Overall Study|Discharged before study end|4|||
164154769|NCT05620082|592928284|FG002|Overall Study|Discharged before study end|0|||
164154770|NCT05620082|592928282|FG000|Overall Study|Moved to a different ward|1|||
164154771|NCT05620082|592928283|FG001|Overall Study|Moved to a different ward|0|||
164154772|NCT05620082|592928284|FG002|Overall Study|Moved to a different ward|0|||
164154773|NCT05620082|592928282|FG000|Overall Study|Feeling too unwell|1|||
164154774|NCT05620082|592928283|FG001|Overall Study|Feeling too unwell|0|||
164154775|NCT05620082|592928284|FG002|Overall Study|Feeling too unwell|0|||
164154776|NCT00625820|592928285|FG000|Overall Study|Withdrawal by Subject|1|||
164154777|NCT02141438|592930365|FG000|Overall Study|Death|1308|||
164154778|NCT02141438|592930365|FG000|Overall Study|Lost to Follow-up|84|||
164154779|NCT02141438|592930365|FG000|Overall Study|Withdrawal by Subject|52|||
164154780|NCT02141438|592930365|FG000|Overall Study|Physician Decision|1|||
164154781|NCT02141438|592930365|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
164154782|NCT02546986|592930368|FG000|Treatment Period|Progressive Disease|20|||
164154783|NCT02546986|592930369|FG001|Treatment Period|Progressive Disease|22|||
164154784|NCT02546986|592930368|FG000|Treatment Period|Adverse Event|14|||
164154785|NCT02546986|592930369|FG001|Treatment Period|Adverse Event|6|||
164154786|NCT02546986|592930368|FG000|Treatment Period|Symptomatic Deterioration|4|||
164154787|NCT02546986|592930369|FG001|Treatment Period|Symptomatic Deterioration|3|||
164154788|NCT02546986|592930368|FG000|Treatment Period|Death|3|||
164154789|NCT02546986|592930369|FG001|Treatment Period|Death|4|||
164154790|NCT02546986|592930368|FG000|Treatment Period|Physician Decision|1|||
164154791|NCT02546986|592930369|FG001|Treatment Period|Physician Decision|2|||
164154792|NCT02546986|592930368|FG000|Treatment Period|Protocol Violation|1|||
164154793|NCT02546986|592930369|FG001|Treatment Period|Protocol Violation|0|||
164154794|NCT02546986|592930368|FG000|Treatment Period|Withdrawal by Subject|1|||
164154795|NCT02546986|592930369|FG001|Treatment Period|Withdrawal by Subject|1|||
164154796|NCT02546986|592930368|FG000|Treatment Period|Non-compliance with Study Drug|0|||
164154797|NCT02546986|592930369|FG001|Treatment Period|Non-compliance with Study Drug|1|||
164154798|NCT02546986|592930368|FG000|Treatment Period|Study Terminated by Sponsor|0|||
164154799|NCT02546986|592930369|FG001|Treatment Period|Study Terminated by Sponsor|1|||
164154800|NCT02546986|592930368|FG000|Treatment Period|Miscellaneous|7|||
164154801|NCT02546986|592930369|FG001|Treatment Period|Miscellaneous|9|||
164154802|NCT02546986|592930368|FG000|Survival Follow-Up Phase|Missing Status|3|||
164154803|NCT02546986|592930369|FG001|Survival Follow-Up Phase|Missing Status|5|||
164154804|NCT02546986|592930368|FG000|Survival Follow-Up Phase|Death|18|||
164154805|NCT02546986|592930369|FG001|Survival Follow-Up Phase|Death|12|||
164154806|NCT02546986|592930368|FG000|Survival Follow-Up Phase|Alive|13|||
164154807|NCT02546986|592930369|FG001|Survival Follow-Up Phase|Alive|16|||
164154808|NCT02546986|592930368|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
164154809|NCT02546986|592930369|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
164154810|NCT02513160|592930370|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
164154811|NCT02513160|592930371|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
164154812|NCT02513160|592930372|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
164154813|NCT02513160|592930373|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
164154814|NCT02513160|592930370|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
164154815|NCT02513160|592930371|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
164154816|NCT02513160|592930372|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
164154817|NCT02513160|592930373|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
164154818|NCT02513160|592930370|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
164154819|NCT02513160|592930371|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
164154820|NCT02513160|592930372|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
164154821|NCT02513160|592930373|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
164154822|NCT02513160|592930370|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
164154823|NCT02513160|592930371|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
164154824|NCT02513160|592930372|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
164154825|NCT02513160|592930373|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
164154826|NCT02513160|592930370|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
164154827|NCT02513160|592930371|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
164154828|NCT02513160|592930372|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
164154829|NCT02513160|592930373|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
164154830|NCT02513160|592930370|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
164154831|NCT02513160|592930371|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
164154832|NCT02513160|592930372|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
164154833|NCT02513160|592930373|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
164154834|NCT02513160|592930370|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
164154835|NCT02513160|592930371|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
164154836|NCT02513160|592930372|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
164154837|NCT02513160|592930373|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
164154838|NCT02513160|592930370|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
164154839|NCT02513160|592930371|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
164154840|NCT02513160|592930372|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
164154841|NCT02513160|592930373|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
164154842|NCT02513160|592930370|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
164154843|NCT02513160|592930371|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
164154844|NCT02513160|592930372|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
164154845|NCT02513160|592930373|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
164154846|NCT02513160|592930370|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
164154847|NCT02513160|592930371|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
164154848|NCT02513160|592930372|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
164154849|NCT02513160|592930373|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
164154850|NCT02513160|592930370|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
164154851|NCT02513160|592930371|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
164154852|NCT02513160|592930372|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
164154853|NCT02513160|592930373|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
164154854|NCT02513160|592930370|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
164154855|NCT02513160|592930371|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
164154856|NCT02513160|592930372|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
164154857|NCT02513160|592930373|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
164154858|NCT00437021|592930374|FG000|Overall Study|Adverse Event|0|||
164154859|NCT00437021|592930375|FG001|Overall Study|Adverse Event|0|||
164154860|NCT00437021|592930376|FG002|Overall Study|Adverse Event|0|||
164154861|NCT00437021|592930377|FG003|Overall Study|Adverse Event|0|||
164154862|NCT00437021|592930378|FG004|Overall Study|Adverse Event|0|||
164154863|NCT00437021|592930379|FG005|Overall Study|Adverse Event|0|||
164154864|NCT00437021|592930380|FG006|Overall Study|Adverse Event|1|||
164154865|NCT00437021|592930381|FG007|Overall Study|Adverse Event|0|||
164154866|NCT00437021|592930382|FG008|Overall Study|Adverse Event|0|||
164154867|NCT00437021|592930383|FG009|Overall Study|Adverse Event|0|||
164154868|NCT00437021|592930384|FG010|Overall Study|Adverse Event|0|||
164154869|NCT00437021|592930385|FG011|Overall Study|Adverse Event|0|||
164154870|NCT00437021|592930374|FG000|Overall Study|Lost to Follow-up|0|||
164154871|NCT00437021|592930375|FG001|Overall Study|Lost to Follow-up|3|||
164154872|NCT00437021|592930376|FG002|Overall Study|Lost to Follow-up|0|||
164154873|NCT00437021|592930377|FG003|Overall Study|Lost to Follow-up|0|||
164154874|NCT00437021|592930378|FG004|Overall Study|Lost to Follow-up|0|||
164154875|NCT00437021|592930379|FG005|Overall Study|Lost to Follow-up|2|||
164154876|NCT00437021|592930380|FG006|Overall Study|Lost to Follow-up|0|||
164154877|NCT00437021|592930381|FG007|Overall Study|Lost to Follow-up|1|||
164154878|NCT00437021|592930382|FG008|Overall Study|Lost to Follow-up|0|||
164154879|NCT00437021|592930383|FG009|Overall Study|Lost to Follow-up|0|||
164154880|NCT00437021|592930384|FG010|Overall Study|Lost to Follow-up|0|||
164154881|NCT00437021|592930385|FG011|Overall Study|Lost to Follow-up|0|||
164154882|NCT00437021|592930374|FG000|Overall Study|Withdrawal by Subject|2|||
164154883|NCT00437021|592930375|FG001|Overall Study|Withdrawal by Subject|1|||
164154884|NCT00437021|592930376|FG002|Overall Study|Withdrawal by Subject|0|||
164154885|NCT00437021|592930377|FG003|Overall Study|Withdrawal by Subject|0|||
164154886|NCT00437021|592930378|FG004|Overall Study|Withdrawal by Subject|0|||
164154887|NCT00437021|592930379|FG005|Overall Study|Withdrawal by Subject|0|||
164154888|NCT00437021|592930380|FG006|Overall Study|Withdrawal by Subject|0|||
164154889|NCT00437021|592930381|FG007|Overall Study|Withdrawal by Subject|0|||
164154890|NCT00437021|592930382|FG008|Overall Study|Withdrawal by Subject|0|||
164154891|NCT00437021|592930383|FG009|Overall Study|Withdrawal by Subject|0|||
164154892|NCT00437021|592930384|FG010|Overall Study|Withdrawal by Subject|0|||
164154893|NCT00437021|592930385|FG011|Overall Study|Withdrawal by Subject|0|||
164154894|NCT04162847|592930386|FG000|Overall Study|Withdrawal by Subject|7|||
164154895|NCT04162847|592930387|FG001|Overall Study|Withdrawal by Subject|1|||
164154896|NCT03985800|592930388|FG000|Overall Study|Death|1|||
164154897|NCT03985800|592930389|FG001|Overall Study|Death|2|||
164154898|NCT03985800|592930388|FG000|Overall Study|Withdrawal by Subject|3|||
164154899|NCT03985800|592930389|FG001|Overall Study|Withdrawal by Subject|6|||
164154900|NCT03985800|592930388|FG000|Overall Study|Protocol Violation|2|||
164154901|NCT03985800|592930389|FG001|Overall Study|Protocol Violation|0|||
164154902|NCT05258773|592930390|FG000|Overall Study|Screen Failure|1|||
164154903|NCT05258773|592930391|FG001|Overall Study|Screen Failure|1|||
164154904|NCT05258773|592930390|FG000|Overall Study|Adverse Event|1|||
164154905|NCT05258773|592930391|FG001|Overall Study|Adverse Event|0|||
164154906|NCT05258773|592930390|FG000|Overall Study|Withdrawal by Subject|0|||
164154907|NCT05258773|592930391|FG001|Overall Study|Withdrawal by Subject|1|||
164154908|NCT03018288|592930392|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
164154909|NCT03018288|592930393|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
164154910|NCT03018288|592930394|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
164154911|NCT03018288|592930395|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
164154912|NCT03018288|592930392|FG000|Overall Study|Participant withdrew consent.|0|||
164154913|NCT03018288|592930393|FG001|Overall Study|Participant withdrew consent.|0|||
164154914|NCT03018288|592930394|FG002|Overall Study|Participant withdrew consent.|1|||
164154915|NCT03018288|592930395|FG003|Overall Study|Participant withdrew consent.|0|||
164154916|NCT03018288|592930392|FG000|Overall Study|Switched to alternative treatment.|0|||
164154917|NCT03018288|592930393|FG001|Overall Study|Switched to alternative treatment.|0|||
164154918|NCT03018288|592930394|FG002|Overall Study|Switched to alternative treatment.|1|||
164154919|NCT03018288|592930395|FG003|Overall Study|Switched to alternative treatment.|0|||
164154920|NCT03018288|592930392|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
164154921|NCT03018288|592930393|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
164154922|NCT03018288|592930394|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
164154923|NCT03018288|592930395|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
164154924|NCT03018288|592930392|FG000|Overall Study|Screen failures|0|||
164154925|NCT03018288|592930393|FG001|Overall Study|Screen failures|0|||
164154926|NCT03018288|592930394|FG002|Overall Study|Screen failures|0|||
164154927|NCT03018288|592930395|FG003|Overall Study|Screen failures|51|||
164154928|NCT03018288|592930392|FG000|Overall Study|Chose treatment outside of UNC|0|||
164154929|NCT03018288|592930393|FG001|Overall Study|Chose treatment outside of UNC|0|||
164154930|NCT03018288|592930394|FG002|Overall Study|Chose treatment outside of UNC|0|||
164154931|NCT03018288|592930395|FG003|Overall Study|Chose treatment outside of UNC|1|||
164154932|NCT03018288|592930392|FG000|Overall Study|Unable to comply with protocol requirements|1|||
164154933|NCT03018288|592930393|FG001|Overall Study|Unable to comply with protocol requirements|1|||
164154934|NCT03018288|592930394|FG002|Overall Study|Unable to comply with protocol requirements|0|||
164154935|NCT03018288|592930395|FG003|Overall Study|Unable to comply with protocol requirements|1|||
164154936|NCT03018288|592930392|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
164154937|NCT03018288|592930393|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
164154938|NCT03018288|592930394|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
164154939|NCT03018288|592930395|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
164154940|NCT03018288|592930392|FG000|Overall Study|Physician Decision|0|||
164154941|NCT03018288|592930393|FG001|Overall Study|Physician Decision|0|||
164154942|NCT03018288|592930394|FG002|Overall Study|Physician Decision|0|||
164154943|NCT03018288|592930395|FG003|Overall Study|Physician Decision|1|||
164154944|NCT04173507|592930398|FG000|Overall Study|On Treatment|3|||
164154945|NCT04173507|592930398|FG000|Overall Study|Adverse Event|3|||
164154946|NCT04173507|592930398|FG000|Overall Study|Progression/Relapse|34|||
164154947|NCT04173507|592930398|FG000|Overall Study|Death|2|||
164154948|NCT02832687|592930399|FG000|Overall Study|Adverse Event|0|||
164154949|NCT02832687|592930400|FG001|Overall Study|Adverse Event|2|||
164154950|NCT04231825|592930401|FG000|Overall Study|Protocol Violation|3|||
164154951|NCT04231825|592930402|FG001|Overall Study|Protocol Violation|3|||
164154952|NCT04231825|592930401|FG000|Overall Study|Lost to Follow-up|0|||
164154953|NCT04231825|592930402|FG001|Overall Study|Lost to Follow-up|1|||
164154954|NCT02844933|592930403|FG000|Overall Study|Discontinued due to premature termination of study|3|||
164154955|NCT02844933|592930404|FG001|Overall Study|Discontinued due to premature termination of study|2|||
164154956|NCT01479465|592930405|FG000|Overall Study|Disease Progression|9|||
164154957|NCT01479465|592930406|FG001|Overall Study|Disease Progression|61|||
164154958|NCT01479465|592930407|FG002|Overall Study|Disease Progression|65|||
164154959|NCT01479465|592930408|FG003|Overall Study|Disease Progression|70|||
164154960|NCT01479465|592930405|FG000|Overall Study|Study Discontinued by Sponsor|0|||
164154961|NCT01479465|592930406|FG001|Overall Study|Study Discontinued by Sponsor|7|||
164154962|NCT01479465|592930407|FG002|Overall Study|Study Discontinued by Sponsor|5|||
164154963|NCT01479465|592930408|FG003|Overall Study|Study Discontinued by Sponsor|3|||
164154964|NCT01479465|592930405|FG000|Overall Study|Adverse Event|0|||
164154965|NCT01479465|592930406|FG001|Overall Study|Adverse Event|3|||
164154966|NCT01479465|592930407|FG002|Overall Study|Adverse Event|6|||
164154967|NCT01479465|592930408|FG003|Overall Study|Adverse Event|4|||
164154968|NCT01479465|592930405|FG000|Overall Study|Investigator Discretion|1|||
164154969|NCT01479465|592930406|FG001|Overall Study|Investigator Discretion|4|||
164154970|NCT01479465|592930407|FG002|Overall Study|Investigator Discretion|2|||
164154971|NCT01479465|592930408|FG003|Overall Study|Investigator Discretion|4|||
164154972|NCT01479465|592930405|FG000|Overall Study|Subject Request|1|||
164154973|NCT01479465|592930406|FG001|Overall Study|Subject Request|3|||
164154974|NCT01479465|592930407|FG002|Overall Study|Subject Request|4|||
164154975|NCT01479465|592930408|FG003|Overall Study|Subject Request|2|||
164154976|NCT01479465|592930405|FG000|Overall Study|Subject Withdrew Consent|0|||
164154977|NCT01479465|592930406|FG001|Overall Study|Subject Withdrew Consent|5|||
164154978|NCT01479465|592930407|FG002|Overall Study|Subject Withdrew Consent|2|||
164154979|NCT01479465|592930408|FG003|Overall Study|Subject Withdrew Consent|1|||
164154980|NCT01479465|592930405|FG000|Overall Study|Protocol Violation|0|||
164154981|NCT01479465|592930406|FG001|Overall Study|Protocol Violation|1|||
164154982|NCT01479465|592930407|FG002|Overall Study|Protocol Violation|1|||
164154983|NCT01479465|592930408|FG003|Overall Study|Protocol Violation|0|||
164154984|NCT01479465|592930405|FG000|Overall Study|Death|0|||
164154985|NCT01479465|592930406|FG001|Overall Study|Death|0|||
164154986|NCT01479465|592930407|FG002|Overall Study|Death|0|||
164154987|NCT01479465|592930408|FG003|Overall Study|Death|1|||
164154988|NCT01479465|592930405|FG000|Overall Study|Lost to Follow-up|0|||
164154989|NCT01479465|592930406|FG001|Overall Study|Lost to Follow-up|0|||
164154990|NCT01479465|592930407|FG002|Overall Study|Lost to Follow-up|1|||
164154991|NCT01479465|592930408|FG003|Overall Study|Lost to Follow-up|0|||
164154992|NCT01439802|592930410|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
164154993|NCT01439802|592930410|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
164154994|NCT02392481|592930414|FG000|Overall Study|Adverse Event|0|||
164154995|NCT02392481|592930415|FG001|Overall Study|Adverse Event|0|||
164154996|NCT02392481|592930416|FG002|Overall Study|Adverse Event|1|||
164154997|NCT02392481|592930417|FG003|Overall Study|Adverse Event|2|||
164154998|NCT02392481|592930414|FG000|Overall Study|Withdrawal by Subject|0|||
164154999|NCT02392481|592930415|FG001|Overall Study|Withdrawal by Subject|0|||
164155000|NCT02392481|592930416|FG002|Overall Study|Withdrawal by Subject|1|||
164155001|NCT02392481|592930417|FG003|Overall Study|Withdrawal by Subject|0|||
164155002|NCT02502149|592930418|FG000|Intermediate|Discontinued prematurely|1|||
164155003|NCT02502149|592930419|FG001|Intermediate|Discontinued prematurely|0|||
164155004|NCT02502149|592930420|FG002|Intermediate|Discontinued prematurely|0|||
164155005|NCT02502149|592930421|FG003|Intermediate|Discontinued prematurely|0|||
164155006|NCT02502149|592930422|FG004|Intermediate|Discontinued prematurely|0|||
164155007|NCT04067050|592930423|FG000|One Month|Lost to Follow-up|4|||
164155008|NCT04067050|592930424|FG001|One Month|Lost to Follow-up|0|||
164155009|NCT04067050|592930423|FG000|Two Month|Lost to Follow-up|1|||
164155010|NCT04067050|592930424|FG001|Two Month|Lost to Follow-up|0|||
164155011|NCT04067050|592930423|FG000|Two Month|Adverse Event|1|||
164155012|NCT04067050|592930424|FG001|Two Month|Adverse Event|0|||
164155013|NCT02088177|592930432|FG000|Overall Study|Lost to Follow-up|3|||
164155014|NCT01234350|592930433|FG000|Overall Study|Adverse Event|277|||
164155015|NCT01234350|592930434|FG001|Overall Study|Adverse Event|92|||
164155016|NCT01234350|592930433|FG000|Overall Study|Withdrawal by Subject|61|||
164155017|NCT01234350|592930434|FG001|Overall Study|Withdrawal by Subject|36|||
164155018|NCT01234350|592930433|FG000|Overall Study|Lost to Follow-up|115|||
164155019|NCT01234350|592930434|FG001|Overall Study|Lost to Follow-up|47|||
164155020|NCT01234350|592930433|FG000|Overall Study|Covers a diverse set of reasons|234|||
164155021|NCT01234350|592930434|FG001|Overall Study|Covers a diverse set of reasons|92|||
164155022|NCT00289848|592930435|FG000|Overall Study|Adverse Event|6|||
164155023|NCT00289848|592930436|FG001|Overall Study|Adverse Event|4|||
164155024|NCT00289848|592930435|FG000|Overall Study|Death|1|||
164155025|NCT00289848|592930436|FG001|Overall Study|Death|0|||
164155026|NCT00289848|592930435|FG000|Overall Study|Lack of Efficacy|20|||
164155027|NCT00289848|592930436|FG001|Overall Study|Lack of Efficacy|24|||
164155028|NCT00289848|592930435|FG000|Overall Study|Lost to Follow-up|3|||
164155029|NCT00289848|592930436|FG001|Overall Study|Lost to Follow-up|1|||
164155030|NCT00289848|592930435|FG000|Overall Study|Protocol Violation|5|||
164155031|NCT00289848|592930436|FG001|Overall Study|Protocol Violation|2|||
164155032|NCT00289848|592930435|FG000|Overall Study|Withdrawal by Subject|5|||
164155033|NCT00289848|592930436|FG001|Overall Study|Withdrawal by Subject|11|||
164155034|NCT00289848|592930435|FG000|Overall Study|Patient Moved|6|||
164155035|NCT00289848|592930436|FG001|Overall Study|Patient Moved|2|||
164155036|NCT00289848|592930435|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
164155037|NCT00289848|592930436|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
164155038|NCT01836471|592930445|FG000|Overall Study|Pregnancy|1|||
164155039|NCT01836471|592930446|FG001|Overall Study|Pregnancy|0|||
164155040|NCT01836471|592930447|FG002|Overall Study|Pregnancy|0|||
164155041|NCT01836471|592930448|FG003|Overall Study|Pregnancy|0|||
164155042|NCT01836471|592930449|FG004|Overall Study|Pregnancy|0|||
164155043|NCT01836471|592930445|FG000|Overall Study|Withdrawal by Subject|3|||
164155044|NCT01836471|592930446|FG001|Overall Study|Withdrawal by Subject|4|||
164155045|NCT01836471|592930447|FG002|Overall Study|Withdrawal by Subject|1|||
164155046|NCT01836471|592930448|FG003|Overall Study|Withdrawal by Subject|0|||
164155047|NCT01836471|592930449|FG004|Overall Study|Withdrawal by Subject|2|||
164155048|NCT01836471|592930445|FG000|Overall Study|Physician Decision|0|||
164155049|NCT01836471|592930446|FG001|Overall Study|Physician Decision|1|||
164155050|NCT01836471|592930447|FG002|Overall Study|Physician Decision|0|||
164155051|NCT01836471|592930448|FG003|Overall Study|Physician Decision|0|||
164155052|NCT01836471|592930449|FG004|Overall Study|Physician Decision|0|||
164155053|NCT01836471|592930445|FG000|Overall Study|Lost to Follow-up|0|||
164155054|NCT01836471|592930446|FG001|Overall Study|Lost to Follow-up|0|||
164155055|NCT01836471|592930447|FG002|Overall Study|Lost to Follow-up|0|||
164155056|NCT01836471|592930448|FG003|Overall Study|Lost to Follow-up|1|||
164155057|NCT01836471|592930449|FG004|Overall Study|Lost to Follow-up|1|||
164155058|NCT01836471|592930445|FG000|Overall Study|Adverse Event|6|||
164155059|NCT01836471|592930446|FG001|Overall Study|Adverse Event|3|||
164155060|NCT01836471|592930447|FG002|Overall Study|Adverse Event|1|||
164155061|NCT01836471|592930448|FG003|Overall Study|Adverse Event|1|||
164155062|NCT01836471|592930449|FG004|Overall Study|Adverse Event|2|||
164155063|NCT01836471|592930445|FG000|Overall Study|Non compliance with tx|1|||
164155064|NCT01836471|592930446|FG001|Overall Study|Non compliance with tx|1|||
164155065|NCT01836471|592930447|FG002|Overall Study|Non compliance with tx|0|||
164155066|NCT01836471|592930448|FG003|Overall Study|Non compliance with tx|0|||
164155067|NCT01836471|592930449|FG004|Overall Study|Non compliance with tx|0|||
164155068|NCT02570308|592930452|FG000|Overall Study|Death|1|||
164155069|NCT02570308|592930453|FG001|Overall Study|Death|5|||
164155070|NCT02570308|592930454|FG002|Overall Study|Death|4|||
164155071|NCT02570308|592930455|FG003|Overall Study|Death|4|||
164155072|NCT02570308|592930456|FG004|Overall Study|Death|69|||
164155073|NCT02570308|592930452|FG000|Overall Study|Lost to Follow-up|0|||
164155074|NCT02570308|592930453|FG001|Overall Study|Lost to Follow-up|0|||
164155075|NCT02570308|592930454|FG002|Overall Study|Lost to Follow-up|0|||
164155076|NCT02570308|592930455|FG003|Overall Study|Lost to Follow-up|0|||
164155077|NCT02570308|592930456|FG004|Overall Study|Lost to Follow-up|2|||
164155078|NCT02570308|592930452|FG000|Overall Study|Withdrawal by Subject|0|||
164155079|NCT02570308|592930453|FG001|Overall Study|Withdrawal by Subject|0|||
164155080|NCT02570308|592930454|FG002|Overall Study|Withdrawal by Subject|0|||
164155081|NCT02570308|592930455|FG003|Overall Study|Withdrawal by Subject|0|||
164155082|NCT02570308|592930456|FG004|Overall Study|Withdrawal by Subject|1|||
164155083|NCT02570308|592930452|FG000|Overall Study|Other|0|||
164155084|NCT02570308|592930453|FG001|Overall Study|Other|0|||
164155085|NCT02570308|592930454|FG002|Overall Study|Other|0|||
164155086|NCT02570308|592930455|FG003|Overall Study|Other|0|||
164155087|NCT02570308|592930456|FG004|Overall Study|Other|2|||
164155088|NCT01960413|592930457|FG000|Overall Study|Withdrawal by Subject|1|||
164155089|NCT01960413|592930458|FG001|Overall Study|Withdrawal by Subject|1|||
164155090|NCT01960413|592930457|FG000|Overall Study|Physician Decision|1|||
164155091|NCT01960413|592930458|FG001|Overall Study|Physician Decision|0|||
164155092|NCT01960413|592930457|FG000|Overall Study|Lost to Follow-up|2|||
164155093|NCT01960413|592930458|FG001|Overall Study|Lost to Follow-up|0|||
164155094|NCT02285361|592930459|FG000|Overall Study|Protocol Violation|43|||
164155095|NCT02285361|592930459|FG000|Overall Study|Lost to Follow-up|5|||
164155096|NCT02285361|592930459|FG000|Overall Study|Not taken GIOTRIF|2|||
164155097|NCT02285361|592930459|FG000|Overall Study|Consented prior to the contract date|1|||
164155098|NCT01283464|592930460|FG000|Overall Study|Lost to Follow-up|0|||
164155099|NCT01283464|592930461|FG001|Overall Study|Lost to Follow-up|1|||
164155100|NCT01283464|592930460|FG000|Overall Study|Withdrawal by Subject|1|||
164155101|NCT01283464|592930461|FG001|Overall Study|Withdrawal by Subject|0|||
164155102|NCT01283464|592930460|FG000|Overall Study|Physician Decision|1|||
164155103|NCT01283464|592930461|FG001|Overall Study|Physician Decision|0|||
164155104|NCT03051100|592930462|FG000|Overall Study|Withdrawal by Subject|1|||
164155105|NCT03051100|592930463|FG001|Overall Study|Withdrawal by Subject|0|||
164155106|NCT02626026|592930464|FG000|Overall Study|Randomized but Never Treated|0|||
164155107|NCT02626026|592930465|FG001|Overall Study|Randomized but Never Treated|0|||
164155108|NCT02626026|592930466|FG002|Overall Study|Randomized but Never Treated|0|||
164155109|NCT02626026|592930467|FG003|Overall Study|Randomized but Never Treated|0|||
164155110|NCT02626026|592930468|FG004|Overall Study|Randomized but Never Treated|1|||
164155111|NCT02626026|592930469|FG005|Overall Study|Randomized but Never Treated|0|||
164155112|NCT01778855|592930470|FG000|Overall Study|Death|0|||
164155113|NCT01778855|592930471|FG001|Overall Study|Death|1|||
164155114|NCT02059135|592930472|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
164155115|NCT02059135|592930473|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
164155116|NCT02059135|592930472|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
164155117|NCT02059135|592930473|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
164155118|NCT02059135|592930472|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
164155119|NCT02059135|592930473|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
164155120|NCT02059135|592930472|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
164155121|NCT02059135|592930473|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
164155122|NCT02059135|592930472|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
164155123|NCT02059135|592930473|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
164155124|NCT02059135|592930472|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
164155125|NCT02059135|592930473|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
164155126|NCT02059135|592930472|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
164155127|NCT02059135|592930473|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
164155128|NCT02059135|592930472|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
164155129|NCT02059135|592930473|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
164155130|NCT05921903|592930474|FG000|Overall Study|Unsolicited non-SAE|0|||
164155131|NCT05921903|592930475|FG001|Overall Study|Unsolicited non-SAE|1|||
164155132|NCT05921903|592930476|FG002|Overall Study|Unsolicited non-SAE|0|||
164155133|NCT05921903|592930474|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
164155134|NCT05921903|592930475|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
164155135|NCT05921903|592930476|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
164155136|NCT05921903|592930474|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
164155137|NCT05921903|592930475|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
164155138|NCT05921903|592930476|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
164155139|NCT03305848|592930477|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
164155140|NCT03305848|592930477|FG000|Overall Study|Physician Decision|2|||
164155141|NCT05366010|592930479|FG000|Overall Study|Withdrawal by Subject|1|||
164155142|NCT05366010|592930479|FG000|Overall Study|Protocol Violation|1|||
164155143|NCT05366010|592930479|FG000|Overall Study|Lost to Follow-up|2|||
164155144|NCT05366010|592930479|FG000|Overall Study|Screen Failure|2|||
164155145|NCT02224157|592930480|FG000|Overall Study|Severe non-compliance to protocol|2|||
164155146|NCT02224157|592930481|FG001|Overall Study|Severe non-compliance to protocol|2|||
164155147|NCT02224157|592930480|FG000|Overall Study|Other|13|||
164155148|NCT02224157|592930481|FG001|Overall Study|Other|10|||
164155149|NCT02224157|592930480|FG000|Overall Study|Subject decision|58|||
164155150|NCT02224157|592930481|FG001|Overall Study|Subject decision|50|||
164155151|NCT02224157|592930480|FG000|Overall Study|Prematurely closed site|4|||
164155152|NCT02224157|592930481|FG001|Overall Study|Prematurely closed site|2|||
164155153|NCT02224157|592930480|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
164155154|NCT02224157|592930481|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
164155155|NCT02224157|592930480|FG000|Overall Study|Lost to Follow-up|27|||
164155156|NCT02224157|592930481|FG001|Overall Study|Lost to Follow-up|35|||
164155157|NCT02224157|592930480|FG000|Overall Study|Death|1|||
164155158|NCT02224157|592930481|FG001|Overall Study|Death|1|||
164155159|NCT02224157|592930480|FG000|Overall Study|Adverse Event|1|||
164155160|NCT02224157|592930481|FG001|Overall Study|Adverse Event|3|||
164155161|NCT05906628|592930482|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
164155162|NCT05906628|592930483|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
164155163|NCT05906628|592930482|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
164155164|NCT05906628|592930483|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
164155165|NCT05906628|592930482|FG000|16-Week DBVC Period|Protocol Violation|4|||
164155166|NCT05906628|592930483|FG001|16-Week DBVC Period|Protocol Violation|2|||
164155167|NCT05906628|592930482|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
164155168|NCT05906628|592930483|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
164155169|NCT05906628|592930482|FG000|16-Week OLE Period|Death|1|||
164155170|NCT05906628|592930483|FG001|16-Week OLE Period|Death|0|||
164155171|NCT05906628|592930482|FG000|16-Week OLE Period|Lost to Follow-up|1|||
164155172|NCT05906628|592930483|FG001|16-Week OLE Period|Lost to Follow-up|1|||
164155173|NCT05906628|592930482|FG000|16-Week OLE Period|Protocol Violation|0|||
164155174|NCT05906628|592930483|FG001|16-Week OLE Period|Protocol Violation|1|||
164155175|NCT05906628|592930482|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
164155176|NCT05906628|592930483|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
164155177|NCT02301169|592930484|FG000|Overall Study|Adverse Event|1|||
164155178|NCT02301169|592930485|FG001|Overall Study|Adverse Event|0|||
164155179|NCT03762265|592930486|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
164155180|NCT03762265|592930487|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
164155181|NCT03762265|592930486|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
164155182|NCT03762265|592930487|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
164155183|NCT03762265|592930486|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
164155184|NCT03762265|592930487|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
164155185|NCT03762265|592930486|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
164155186|NCT03762265|592930487|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
164155187|NCT03762265|592930486|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
164155188|NCT03762265|592930487|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
164155189|NCT03762265|592930486|FG000|BT Period: Weeks 1 to 37|Other|0|||
164155190|NCT03762265|592930487|FG001|BT Period: Weeks 1 to 37|Other|1|||
164155191|NCT03762265|592930486|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
164155192|NCT03762265|592930487|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
164155193|NCT03762265|592930486|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
164155194|NCT03762265|592930487|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
164155195|NCT03762265|592930486|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
164155196|NCT03762265|592930487|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
164155197|NCT03762265|592930486|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
164155198|NCT03762265|592930487|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
164155199|NCT03762265|592930486|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
164155200|NCT03762265|592930487|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
164155201|NCT03762265|592930486|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
164155202|NCT03762265|592930487|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
164155203|NCT03762265|592930486|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
164155204|NCT03762265|592930487|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
164155205|NCT03762265|592930486|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
164155206|NCT03762265|592930487|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
164155207|NCT03762265|592930486|FG000|LTE Period: Weeks 61 to 109|Other|1|||
164155208|NCT03762265|592930487|FG001|LTE Period: Weeks 61 to 109|Other|0|||
164155209|NCT00765102|592930488|FG000|Overall Study|Progressive disease|18|||
164155210|NCT00765102|592930488|FG000|Overall Study|Adverse Event|6|||
164155211|NCT00765102|592930488|FG000|Overall Study|Physician Decision|4|||
164155212|NCT00765102|592930488|FG000|Overall Study|Withdrawal by Subject|2|||
164155213|NCT00765102|592930488|FG000|Overall Study|Protocol Violation|1|||
164155214|NCT02289729|592930491|FG000|Overall Study|Lack of Efficacy|3|||
164155215|NCT02289729|592930491|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
164155216|NCT02289729|592930491|FG000|Overall Study|Withdrawal by Subject|1|||
164155217|NCT02289729|592930491|FG000|Overall Study|Death|1|||
164155218|NCT00470470|592930492|FG000|Overall Study|Adverse Event|2|||
164155219|NCT00470470|592930492|FG000|Overall Study|Death|2|||
164155220|NCT00470470|592930492|FG000|Overall Study|Not treated|1|||
164155221|NCT02046603|592930493|FG000|Overall Study|Other|11|||
164155222|NCT02046603|592930494|FG001|Overall Study|Other|66|||
164155223|NCT02046603|592930493|FG000|Overall Study|Protocol Violation|0|||
164155224|NCT02046603|592930494|FG001|Overall Study|Protocol Violation|1|||
164155225|NCT02046603|592930493|FG000|Overall Study|Participant/legal guardian decision|1|||
164155226|NCT02046603|592930494|FG001|Overall Study|Participant/legal guardian decision|3|||
164155227|NCT02046603|592930493|FG000|Overall Study|Physician Decision|2|||
164155228|NCT02046603|592930494|FG001|Overall Study|Physician Decision|1|||
164155229|NCT02046603|592930493|FG000|Overall Study|Lost to Follow-up|1|||
164155230|NCT02046603|592930494|FG001|Overall Study|Lost to Follow-up|2|||
164155231|NCT02046603|592930493|FG000|Overall Study|Death|0|||
164155232|NCT02046603|592930494|FG001|Overall Study|Death|1|||
164155233|NCT02046603|592930493|FG000|Overall Study|Adverse Event|0|||
164155234|NCT02046603|592930494|FG001|Overall Study|Adverse Event|1|||
164155235|NCT02461160|592930495|FG000|Overall Study|Lost to Follow-up|0|||
164155236|NCT02461160|592930496|FG001|Overall Study|Lost to Follow-up|0|||
164155237|NCT02461160|592930497|FG002|Overall Study|Lost to Follow-up|0|||
164155238|NCT02461160|592930498|FG003|Overall Study|Lost to Follow-up|0|||
164155239|NCT02461160|592930499|FG004|Overall Study|Lost to Follow-up|0|||
164155240|NCT02461160|592930500|FG005|Overall Study|Lost to Follow-up|0|||
164155241|NCT02461160|592930501|FG006|Overall Study|Lost to Follow-up|0|||
164155242|NCT02461160|592930502|FG007|Overall Study|Lost to Follow-up|1|||
164155243|NCT02461160|592930503|FG008|Overall Study|Lost to Follow-up|0|||
164155244|NCT02461160|592930504|FG009|Overall Study|Lost to Follow-up|0|||
164155245|NCT02461160|592930505|FG010|Overall Study|Lost to Follow-up|0|||
164155246|NCT02461160|592930506|FG011|Overall Study|Lost to Follow-up|0|||
164155247|NCT02461160|592930507|FG012|Overall Study|Lost to Follow-up|0|||
164155248|NCT00193050|592930508|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
164155249|NCT00193050|592930508|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
164155250|NCT00193050|592930508|FG000|Neoadjuvant Treatment|Physician Decision|2|||
164155251|NCT00193050|592930508|FG000|Neoadjuvant Treatment|Adverse Event|2|||
164155252|NCT00193050|592930508|FG000|Adjuvant|Physician Decision|5|||
164155253|NCT00193050|592930508|FG000|Adjuvant|Intercurrent Hospitalization|3|||
164155254|NCT00193050|592930508|FG000|Adjuvant|Lack of Efficacy|2|||
164155255|NCT02431364|592930509|FG000|Overall Study|Adverse Event|0|||
164155256|NCT02431364|592930510|FG001|Overall Study|Adverse Event|1|||
164155257|NCT02431364|592930511|FG002|Overall Study|Adverse Event|0|||
164155258|NCT02431364|592930512|FG003|Overall Study|Adverse Event|0|||
164155259|NCT02431364|592930513|FG004|Overall Study|Adverse Event|0|||
164155260|NCT02431364|592930509|FG000|Overall Study|Randomized but never treated|0|||
164155261|NCT02431364|592930510|FG001|Overall Study|Randomized but never treated|0|||
164155262|NCT02431364|592930511|FG002|Overall Study|Randomized but never treated|0|||
164155263|NCT02431364|592930512|FG003|Overall Study|Randomized but never treated|1|||
164155264|NCT02431364|592930513|FG004|Overall Study|Randomized but never treated|0|||
164155265|NCT00061932|592930514|FG000|Overall Study|Withdrawal by Subject|13|||
164155266|NCT00061932|592930515|FG001|Overall Study|Withdrawal by Subject|4|||
164155267|NCT03367819|592930516|FG000|Overall Study|Adverse Event|4|||
164155268|NCT03367819|592930517|FG001|Overall Study|Adverse Event|4|||
164155269|NCT03367819|592930516|FG000|Overall Study|Progressive Disease|15|||
164155270|NCT03367819|592930517|FG001|Overall Study|Progressive Disease|13|||
164155271|NCT03367819|592930516|FG000|Overall Study|Withdrawal by Subject|1|||
164155272|NCT03367819|592930517|FG001|Overall Study|Withdrawal by Subject|0|||
164155273|NCT03367819|592930516|FG000|Overall Study|Other|4|||
164155274|NCT03367819|592930517|FG001|Overall Study|Other|2|||
164155275|NCT00445146|592930520|FG000|Overall Study|Withdrew Consent|29|||
164155276|NCT00445146|592930520|FG000|Overall Study|Lack of Efficacy|28|||
164155277|NCT00445146|592930520|FG000|Overall Study|Investigator's Discretion|22|||
164155278|NCT00445146|592930520|FG000|Overall Study|Adverse Event|13|||
164155279|NCT00445146|592930520|FG000|Overall Study|Lost to Follow-up|13|||
164155280|NCT00445146|592930520|FG000|Overall Study|Death|9|||
164155281|NCT00445146|592930520|FG000|Overall Study|Protocol Violation|4|||
164155282|NCT00445146|592930520|FG000|Overall Study|Pregnancy|1|||
164155283|NCT02456740|592930521|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
164155284|NCT02456740|592930522|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
164155285|NCT02456740|592930523|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
164155286|NCT02456740|592930524|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
164155287|NCT02456740|592930525|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
164155288|NCT02456740|592930526|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
164155289|NCT02456740|592930527|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
164155290|NCT02456740|592930528|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
164155291|NCT02456740|592930529|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
164155292|NCT02456740|592930521|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
164155293|NCT02456740|592930522|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
164155294|NCT02456740|592930523|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
164155295|NCT02456740|592930524|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
164155296|NCT02456740|592930525|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
164155297|NCT02456740|592930526|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
164155298|NCT02456740|592930527|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
164155299|NCT02456740|592930528|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
164155300|NCT02456740|592930529|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
164155301|NCT02456740|592930521|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
164155302|NCT02456740|592930522|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
164155303|NCT02456740|592930523|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
164155446|NCT02445248|592932284|FG000|Overall Study|Lost to Follow-up|1|||
164155304|NCT02456740|592930524|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
164155305|NCT02456740|592930525|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
164155306|NCT02456740|592930526|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
164155307|NCT02456740|592930527|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
164155308|NCT02456740|592930528|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
164155309|NCT02456740|592930529|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
164155310|NCT02456740|592930521|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
164155311|NCT02456740|592930522|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
164155312|NCT02456740|592930523|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
164155313|NCT02456740|592930524|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
164155314|NCT02456740|592930525|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
164155315|NCT02456740|592930526|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
164155316|NCT02456740|592930527|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
164155317|NCT02456740|592930528|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
164155318|NCT02456740|592930529|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
164155319|NCT02456740|592930521|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
164155320|NCT02456740|592930522|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
164155321|NCT02456740|592930523|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
164155322|NCT02456740|592930524|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
164155323|NCT02456740|592930525|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
164155324|NCT02456740|592930526|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
164155325|NCT02456740|592930527|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
164155326|NCT02456740|592930528|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
164155327|NCT02456740|592930529|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
164155328|NCT02456740|592930521|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
164155329|NCT02456740|592930522|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
164155330|NCT02456740|592930523|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
164155331|NCT02456740|592930524|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
164155332|NCT02456740|592930525|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
164155333|NCT02456740|592930526|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
164155334|NCT02456740|592930527|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
164155335|NCT02456740|592930528|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
164155336|NCT02456740|592930529|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
164155337|NCT02456740|592930521|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
164155338|NCT02456740|592930522|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
164155339|NCT02456740|592930523|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
164155340|NCT02456740|592930524|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
164155341|NCT02456740|592930525|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
164155342|NCT02456740|592930526|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
164155343|NCT02456740|592930527|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
164155344|NCT02456740|592930528|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
164155345|NCT02456740|592930529|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
164155346|NCT04720105|592930533|FG000|Overall Study|Lack of Efficacy|1|||
164155347|NCT04720105|592930533|FG000|Overall Study|Lost to Follow-up|1|||
164155348|NCT04720105|592930533|FG000|Overall Study|Withdrawal by Subject|3|||
164155349|NCT02654054|592930538|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
164155350|NCT02654054|592930539|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
164155351|NCT02654054|592930540|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
164155352|NCT02654054|592930538|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
164155353|NCT02654054|592930539|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164155354|NCT02654054|592930540|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
164155355|NCT02654054|592930538|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
164155356|NCT02654054|592930539|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
164155357|NCT02654054|592930540|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
164155358|NCT02654054|592930538|FG000|Post-Treatment Follow-Up Period|Other|1|||
164155359|NCT02654054|592930539|FG001|Post-Treatment Follow-Up Period|Other|0|||
164155360|NCT02654054|592930540|FG002|Post-Treatment Follow-Up Period|Other|4|||
164155361|NCT02654054|592930538|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
164155362|NCT02654054|592930539|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
164155363|NCT02654054|592930540|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
164155364|NCT04871776|592930541|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
164155365|NCT04871776|592930542|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
164155366|NCT04871776|592930543|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
164155367|NCT04871776|592930541|FG000|Overall Study|Did not meet eligibility criteria|1|||
164155368|NCT04871776|592930542|FG001|Overall Study|Did not meet eligibility criteria|1|||
164155369|NCT04871776|592930543|FG002|Overall Study|Did not meet eligibility criteria|1|||
164155370|NCT02844543|592932247|FG000|Overall Study|Withdrawal by Subject|4|||
164155371|NCT02844543|592932247|FG000|Overall Study|Did not meet eligibility criteria|1|||
164155372|NCT03349060|592932248|FG000|Overall Study|Adverse Event|9|||
164155373|NCT03349060|592932249|FG001|Overall Study|Adverse Event|9|||
164155374|NCT03349060|592932250|FG002|Overall Study|Adverse Event|7|||
164155375|NCT03349060|592932248|FG000|Overall Study|Lack of Efficacy|1|||
164155376|NCT03349060|592932249|FG001|Overall Study|Lack of Efficacy|0|||
164155377|NCT03349060|592932250|FG002|Overall Study|Lack of Efficacy|2|||
164155378|NCT03349060|592932248|FG000|Overall Study|Lost to Follow-up|2|||
164155379|NCT03349060|592932249|FG001|Overall Study|Lost to Follow-up|1|||
164155380|NCT03349060|592932250|FG002|Overall Study|Lost to Follow-up|1|||
164155381|NCT03349060|592932248|FG000|Overall Study|Protocol Violation|2|||
164155382|NCT03349060|592932249|FG001|Overall Study|Protocol Violation|2|||
164155383|NCT03349060|592932250|FG002|Overall Study|Protocol Violation|1|||
164155384|NCT03349060|592932248|FG000|Overall Study|Withdrawal by Subject|5|||
164155385|NCT03349060|592932249|FG001|Overall Study|Withdrawal by Subject|3|||
164155386|NCT03349060|592932250|FG002|Overall Study|Withdrawal by Subject|4|||
164155387|NCT03349060|592932248|FG000|Overall Study|Medication error,no linked adverse event|0|||
164155388|NCT03349060|592932249|FG001|Overall Study|Medication error,no linked adverse event|0|||
164155389|NCT03349060|592932250|FG002|Overall Study|Medication error,no linked adverse event|1|||
164155390|NCT03349060|592932248|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
164155391|NCT03349060|592932249|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
164155392|NCT03349060|592932250|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
164155393|NCT03349060|592932248|FG000|Overall Study|Other|2|||
164155394|NCT03349060|592932249|FG001|Overall Study|Other|1|||
164155395|NCT03349060|592932250|FG002|Overall Study|Other|0|||
164155396|NCT02861586|592932251|FG000|Overall Study|Withdrawal by Subject|1|||
164155397|NCT02861586|592932252|FG001|Overall Study|Withdrawal by Subject|2|||
164155398|NCT02861586|592932253|FG002|Overall Study|Withdrawal by Subject|0|||
164155399|NCT02861586|592932254|FG003|Overall Study|Withdrawal by Subject|0|||
164155400|NCT02861586|592932255|FG004|Overall Study|Withdrawal by Subject|0|||
164155401|NCT02861586|592932256|FG005|Overall Study|Withdrawal by Subject|1|||
164155402|NCT02861586|592932257|FG006|Overall Study|Withdrawal by Subject|1|||
164155403|NCT02861586|592932258|FG007|Overall Study|Withdrawal by Subject|0|||
164155404|NCT02861586|592932251|FG000|Overall Study|Lost to Follow-up|3|||
164155405|NCT02861586|592932252|FG001|Overall Study|Lost to Follow-up|1|||
164155406|NCT02861586|592932253|FG002|Overall Study|Lost to Follow-up|1|||
164155407|NCT02861586|592932254|FG003|Overall Study|Lost to Follow-up|0|||
164155408|NCT02861586|592932255|FG004|Overall Study|Lost to Follow-up|0|||
164155409|NCT02861586|592932256|FG005|Overall Study|Lost to Follow-up|3|||
164155410|NCT02861586|592932257|FG006|Overall Study|Lost to Follow-up|0|||
164155411|NCT02861586|592932258|FG007|Overall Study|Lost to Follow-up|0|||
164155412|NCT02861586|592932251|FG000|Overall Study|Adverse Event|0|||
164155413|NCT02861586|592932252|FG001|Overall Study|Adverse Event|0|||
164155414|NCT02861586|592932253|FG002|Overall Study|Adverse Event|0|||
164155415|NCT02861586|592932254|FG003|Overall Study|Adverse Event|0|||
164155416|NCT02861586|592932255|FG004|Overall Study|Adverse Event|0|||
164155417|NCT02861586|592932256|FG005|Overall Study|Adverse Event|1|||
164155418|NCT02861586|592932257|FG006|Overall Study|Adverse Event|0|||
164155419|NCT02861586|592932258|FG007|Overall Study|Adverse Event|0|||
164155420|NCT04710576|592932259|FG000|Overall Study|Participants still in the study|73|||
164155421|NCT04710576|592932260|FG001|Overall Study|Participants still in the study|70|||
164155422|NCT04710576|592932261|FG002|Overall Study|Participants still in the study|60|||
164155423|NCT04710576|592932259|FG000|Overall Study|Death|2|||
164155424|NCT04710576|592932260|FG001|Overall Study|Death|7|||
164155425|NCT04710576|592932261|FG002|Overall Study|Death|12|||
164155426|NCT04710576|592932259|FG000|Overall Study|Withdrawal by Subject|4|||
164155427|NCT04710576|592932260|FG001|Overall Study|Withdrawal by Subject|3|||
164155428|NCT04710576|592932261|FG002|Overall Study|Withdrawal by Subject|7|||
164155429|NCT04710576|592932259|FG000|Overall Study|Sponsor decision|1|||
164155430|NCT04710576|592932260|FG001|Overall Study|Sponsor decision|0|||
164155431|NCT04710576|592932261|FG002|Overall Study|Sponsor decision|0|||
164155432|NCT04796909|592932262|FG000|Overall Study|Withdrawal by Subject|1|||
164155433|NCT04796909|592932263|FG001|Overall Study|Withdrawal by Subject|1|||
164155434|NCT00075816|592932278|FG000|Overall Study|Did not undergo transplantation|14|||
164155435|NCT00075816|592932279|FG001|Overall Study|Did not undergo transplantation|11|||
164155436|NCT02445248|592932284|FG000|Overall Study|Death|45|||
164155437|NCT02445248|592932285|FG001|Overall Study|Death|12|||
164155438|NCT02445248|592932284|FG000|Overall Study|Progressive disease|13|||
164155439|NCT02445248|592932285|FG001|Overall Study|Progressive disease|1|||
164155440|NCT02445248|592932284|FG000|Overall Study|Subject decision|8|||
164155441|NCT02445248|592932285|FG001|Overall Study|Subject decision|0|||
164155442|NCT02445248|592932284|FG000|Overall Study|Physician Decision|5|||
164155443|NCT02445248|592932285|FG001|Overall Study|Physician Decision|0|||
164155444|NCT02445248|592932284|FG000|Overall Study|Adverse Event|1|||
164155445|NCT02445248|592932285|FG001|Overall Study|Adverse Event|0|||
164155447|NCT02445248|592932285|FG001|Overall Study|Lost to Follow-up|0|||
164155448|NCT01120184|592932286|FG000|Overall Study|Adverse Event|0|||
164155449|NCT01120184|592932287|FG001|Overall Study|Adverse Event|1|||
164155450|NCT01120184|592932288|FG002|Overall Study|Adverse Event|0|||
164155451|NCT01120184|592932286|FG000|Overall Study|Lost to Follow-up|13|||
164155452|NCT01120184|592932287|FG001|Overall Study|Lost to Follow-up|13|||
164155453|NCT01120184|592932288|FG002|Overall Study|Lost to Follow-up|11|||
164155454|NCT01120184|592932286|FG000|Overall Study|Physician Decision|9|||
164155455|NCT01120184|592932287|FG001|Overall Study|Physician Decision|1|||
164155456|NCT01120184|592932288|FG002|Overall Study|Physician Decision|3|||
164155457|NCT01120184|592932286|FG000|Overall Study|Reason not Specified|8|||
164155458|NCT01120184|592932287|FG001|Overall Study|Reason not Specified|3|||
164155459|NCT01120184|592932288|FG002|Overall Study|Reason not Specified|12|||
164155460|NCT01120184|592932286|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
164155461|NCT01120184|592932287|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
164155462|NCT01120184|592932288|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
164155463|NCT01120184|592932286|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
164155464|NCT01120184|592932287|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
164155465|NCT01120184|592932288|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
164155466|NCT01120184|592932286|FG000|Overall Study|Death|170|||
164155467|NCT01120184|592932287|FG001|Overall Study|Death|176|||
164155468|NCT01120184|592932288|FG002|Overall Study|Death|169|||
164155469|NCT02596971|592932291|FG000|Overall Study|Death|5|||
164155470|NCT02596971|592932292|FG001|Overall Study|Death|1|||
164155471|NCT02596971|592932293|FG002|Overall Study|Death|5|||
164155472|NCT02596971|592932291|FG000|Overall Study|Withdrawal by Subject|5|||
164155473|NCT02596971|592932292|FG001|Overall Study|Withdrawal by Subject|1|||
164155474|NCT02596971|592932293|FG002|Overall Study|Withdrawal by Subject|4|||
164155475|NCT00824772|592932294|FG000|Overall Study|Withdrawal by Subject|8|||
164155476|NCT00683618|592932295|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
164155477|NCT00683618|592932296|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
164155478|NCT00683618|592932297|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
164155479|NCT00683618|592932295|FG000|Randomised Treatment Period|Protocol Violation|0|||
164155480|NCT00683618|592932296|FG001|Randomised Treatment Period|Protocol Violation|1|||
164155481|NCT00683618|592932297|FG002|Randomised Treatment Period|Protocol Violation|0|||
164155482|NCT00683618|592932295|FG000|Randomised Treatment Period|Adverse Event|2|||
164155483|NCT00683618|592932296|FG001|Randomised Treatment Period|Adverse Event|0|||
164155484|NCT00683618|592932297|FG002|Randomised Treatment Period|Adverse Event|2|||
164155485|NCT00683618|592932295|FG000|Randomised Treatment Period|Reason not provided|0|||
164155486|NCT00683618|592932296|FG001|Randomised Treatment Period|Reason not provided|0|||
164155487|NCT00683618|592932297|FG002|Randomised Treatment Period|Reason not provided|2|||
164155488|NCT00683618|592932295|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
164155489|NCT00683618|592932296|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
164155490|NCT00683618|592932297|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
164155491|NCT00683618|592932295|FG000|Extension Treatment Period|Adverse Event|1|||
164155492|NCT00683618|592932296|FG001|Extension Treatment Period|Adverse Event|0|||
164155493|NCT00683618|592932297|FG002|Extension Treatment Period|Adverse Event|0|||
164155494|NCT00683618|592932295|FG000|Extension Treatment Period|Protocol Violation|1|||
164155495|NCT00683618|592932296|FG001|Extension Treatment Period|Protocol Violation|0|||
164155496|NCT00683618|592932297|FG002|Extension Treatment Period|Protocol Violation|0|||
164155497|NCT04570670|592932298|FG000|Overall Study|Withdrawal by Subject|1|||
164155498|NCT04570670|592932299|FG001|Overall Study|Withdrawal by Subject|0|||
164155499|NCT00318474|592932301|FG000|Overall Study|Adverse Event|1|||
164155500|NCT00318474|592932302|FG001|Overall Study|Adverse Event|1|||
164155501|NCT00318474|592932301|FG000|Overall Study|Lost to Follow-up|0|||
164155502|NCT00318474|592932302|FG001|Overall Study|Lost to Follow-up|1|||
164155503|NCT00318474|592932301|FG000|Overall Study|Pregnancy|0|||
164155504|NCT00318474|592932302|FG001|Overall Study|Pregnancy|2|||
164155505|NCT00318474|592932301|FG000|Overall Study|Protocol Violation|1|||
164155506|NCT00318474|592932302|FG001|Overall Study|Protocol Violation|0|||
164155507|NCT00318474|592932301|FG000|Overall Study|Withdrawal by Subject|3|||
164155508|NCT00318474|592932302|FG001|Overall Study|Withdrawal by Subject|2|||
164155509|NCT00318474|592932301|FG000|Overall Study|Fall in GFR|3|||
164155510|NCT00318474|592932302|FG001|Overall Study|Fall in GFR|3|||
164155511|NCT00318474|592932301|FG000|Overall Study|Post-therapy hyperflycemia|0|||
164155512|NCT00318474|592932302|FG001|Overall Study|Post-therapy hyperflycemia|1|||
164155513|NCT00318474|592932301|FG000|Overall Study|Trial terminated|10|||
164155514|NCT00318474|592932302|FG001|Overall Study|Trial terminated|7|||
164155515|NCT02383017|592932303|FG000|Overall Study|Injury Sustained Outside Study|1|||
164155516|NCT02383017|592932304|FG001|Overall Study|Injury Sustained Outside Study|0|||
164155517|NCT02383017|592932303|FG000|Overall Study|Compliance|3|||
164155518|NCT02383017|592932304|FG001|Overall Study|Compliance|2|||
164155519|NCT02383017|592932303|FG000|Overall Study|Found to be Hypogonadal|1|||
164155520|NCT02383017|592932304|FG001|Overall Study|Found to be Hypogonadal|0|||
164155521|NCT04341363|592932309|FG000|Overall Study|Adverse Event|1|||
164155522|NCT04341363|592932309|FG000|Overall Study|Withdrawal by Subject|1|||
164155523|NCT00063934|592932310|FG000|Overall Study|Ineligible|1|||
164155524|NCT02069015|592932311|FG000|Overall Study|Lost to Follow-up|39|||
164155525|NCT02069015|592932312|FG001|Overall Study|Lost to Follow-up|32|||
164155526|NCT02069015|592932311|FG000|Overall Study|Withdrawal by Subject|1|||
164155527|NCT02069015|592932312|FG001|Overall Study|Withdrawal by Subject|1|||
164155528|NCT00923013|592932320|FG000|Overall Study|Refused further treatment|0|||
164155529|NCT00923013|592932321|FG001|Overall Study|Refused further treatment|1|||
164155530|NCT00923013|592932322|FG002|Overall Study|Refused further treatment|2|||
164155531|NCT00923013|592932323|FG003|Overall Study|Refused further treatment|0|||
164155532|NCT00923013|592932324|FG004|Overall Study|Refused further treatment|0|||
164155533|NCT00923013|592932325|FG005|Overall Study|Refused further treatment|0|||
164155534|NCT00923013|592932320|FG000|Overall Study|Switched to alternative treatment|0|||
164155535|NCT00923013|592932321|FG001|Overall Study|Switched to alternative treatment|1|||
164155536|NCT00923013|592932322|FG002|Overall Study|Switched to alternative treatment|0|||
164155537|NCT00923013|592932323|FG003|Overall Study|Switched to alternative treatment|0|||
164155538|NCT00923013|592932324|FG004|Overall Study|Switched to alternative treatment|0|||
164155539|NCT00923013|592932325|FG005|Overall Study|Switched to alternative treatment|0|||
164155540|NCT00923013|592932320|FG000|Overall Study|Death on study|2|||
164155541|NCT00923013|592932321|FG001|Overall Study|Death on study|2|||
164155542|NCT00923013|592932322|FG002|Overall Study|Death on study|0|||
164155543|NCT00923013|592932323|FG003|Overall Study|Death on study|1|||
164155544|NCT00923013|592932324|FG004|Overall Study|Death on study|0|||
164155545|NCT00923013|592932325|FG005|Overall Study|Death on study|0|||
164155546|NCT01060072|592932328|FG000|Overall Study|Adverse Event|1|||
164155547|NCT01060072|592932329|FG001|Overall Study|Adverse Event|1|||
164155548|NCT01060072|592932328|FG000|Overall Study|Physician Decision|0|||
164155549|NCT01060072|592932329|FG001|Overall Study|Physician Decision|2|||
164155550|NCT01060072|592932328|FG000|Overall Study|Protocol Violation|0|||
164155551|NCT01060072|592932329|FG001|Overall Study|Protocol Violation|1|||
164155552|NCT01060072|592932328|FG000|Overall Study|Acute cholecystitis|1|||
164155553|NCT01060072|592932329|FG001|Overall Study|Acute cholecystitis|0|||
164155554|NCT01060072|592932328|FG000|Overall Study|Excluded Medications|0|||
164155555|NCT01060072|592932329|FG001|Overall Study|Excluded Medications|1|||
164155556|NCT01149863|592932342|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
164155557|NCT03326193|592932344|FG000|Overall Study|Sponsor decision|35|||
164155558|NCT00822692|592932347|FG000|Overall Study|Lost to Follow-up|17|||
164155559|NCT00822692|592932348|FG001|Overall Study|Lost to Follow-up|25|||
164155560|NCT02452476|592932350|FG000|Overall Study|Death|4|||
164155561|NCT02452476|592932351|FG001|Overall Study|Death|7|||
164155562|NCT02452476|592932350|FG000|Overall Study|Lost to Follow-up|1|||
164155563|NCT02452476|592932351|FG001|Overall Study|Lost to Follow-up|1|||
164155564|NCT02452476|592932350|FG000|Overall Study|Physician Decision|1|||
164155565|NCT02452476|592932351|FG001|Overall Study|Physician Decision|1|||
164155566|NCT02452476|592932350|FG000|Overall Study|Not treated|5|||
164155567|NCT02452476|592932351|FG001|Overall Study|Not treated|1|||
164155568|NCT02348112|592932352|FG000|Overall Study|Withdrawal by Subject|32|||
164155569|NCT02348112|592932353|FG001|Overall Study|Withdrawal by Subject|29|||
164155570|NCT02348112|592932352|FG000|Overall Study|Lost to Follow-up|24|||
164155571|NCT02348112|592932353|FG001|Overall Study|Lost to Follow-up|20|||
164155572|NCT02348112|592932352|FG000|Overall Study|Physician Decision|17|||
164155573|NCT02348112|592932353|FG001|Overall Study|Physician Decision|15|||
164155574|NCT02348112|592932352|FG000|Overall Study|Site closed due to PI leaving|0|||
164155575|NCT02348112|592932353|FG001|Overall Study|Site closed due to PI leaving|30|||
164155576|NCT02348112|592932352|FG000|Overall Study|Sponsor withdrawal|0|||
164155577|NCT02348112|592932353|FG001|Overall Study|Sponsor withdrawal|7|||
164155578|NCT02348112|592932352|FG000|Overall Study|Death|0|||
164155579|NCT02348112|592932353|FG001|Overall Study|Death|1|||
164155580|NCT01408043|592932354|FG000|Overall Study|unable to collect cells|1|||
164155581|NCT00946920|592932356|FG000|Overall Study|Withdrawal by Subject|28|||
164155582|NCT00946920|592932357|FG001|Overall Study|Withdrawal by Subject|15|||
164155583|NCT00946920|592932356|FG000|Overall Study|Lost to Follow-up|2|||
164155584|NCT00946920|592932357|FG001|Overall Study|Lost to Follow-up|2|||
164155585|NCT00946920|592932356|FG000|Overall Study|Physician Decision|5|||
164155586|NCT00946920|592932357|FG001|Overall Study|Physician Decision|2|||
164155587|NCT00946920|592932356|FG000|Overall Study|Adverse Event|41|||
164155588|NCT00946920|592932357|FG001|Overall Study|Adverse Event|14|||
164155589|NCT00946920|592932356|FG000|Overall Study|Protocol Violation|16|||
164155590|NCT00946920|592932357|FG001|Overall Study|Protocol Violation|8|||
164155591|NCT00946920|592932356|FG000|Overall Study|Miscellaneous reasons|18|||
164155592|NCT00946920|592932357|FG001|Overall Study|Miscellaneous reasons|3|||
164155593|NCT01168427|592932358|FG000|Overall Study|Patient exited prior to implant|1|||
164155594|NCT00640315|592932359|FG000|Overall Study|Withdrawal by Subject|0|||
164155595|NCT00640315|592932360|FG001|Overall Study|Withdrawal by Subject|1|||
164155596|NCT00397514|592932361|FG000|Overall Study|Withdrawal by Subject|1|||
164155597|NCT00397514|592932361|FG000|Overall Study|Pacing wire malfunction|1|||
164155598|NCT00397514|592932361|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
164155599|NCT00397514|592932361|FG000|Overall Study|early extubation|2|||
164155600|NCT00397514|592932361|FG000|Overall Study|poor echocardiographic windows|1|||
164155601|NCT01530464|592932362|FG000|Washout (24h)|Withdrawal by Subject|1|||
164155602|NCT01530464|592932363|FG001|Washout (24h)|Withdrawal by Subject|0|||
164155603|NCT01530464|592932362|FG000|Washout (24h)|Withdrawal by Subject|0|||
164155604|NCT01530464|592932363|FG001|Washout (24h)|Withdrawal by Subject|1|||
164155605|NCT01709500|592932364|FG000|Overall Study|Randomized but not treated|0|||
164155606|NCT01709500|592932365|FG001|Overall Study|Randomized but not treated|1|||
164155607|NCT01709500|592932364|FG000|Overall Study|Adverse Event|5|||
164155608|NCT01709500|592932365|FG001|Overall Study|Adverse Event|1|||
164155609|NCT01709500|592932364|FG000|Overall Study|Poor compliance to protocol|2|||
164155610|NCT01709500|592932365|FG001|Overall Study|Poor compliance to protocol|1|||
164155611|NCT01709500|592932364|FG000|Overall Study|Other|3|||
164155612|NCT01709500|592932365|FG001|Overall Study|Other|1|||
164155613|NCT01709500|592932364|FG000|Overall Study|Related to IMP administration|1|||
164155614|NCT01709500|592932365|FG001|Overall Study|Related to IMP administration|0|||
164155615|NCT01709500|592932364|FG000|Overall Study|Treatment ongoing|156|||
164155616|NCT01709500|592932365|FG001|Overall Study|Treatment ongoing|78|||
164155617|NCT02107131|592932366|FG000|Overall Study|Lost to Follow-up|4|||
164155618|NCT02107131|592932367|FG001|Overall Study|Lost to Follow-up|4|||
164155619|NCT02107131|592932366|FG000|Overall Study|Physician Decision|1|||
164155620|NCT02107131|592932367|FG001|Overall Study|Physician Decision|0|||
164155621|NCT02107131|592932366|FG000|Overall Study|Withdrawal by Subject|2|||
164155622|NCT02107131|592932367|FG001|Overall Study|Withdrawal by Subject|0|||
164155623|NCT02107131|592932366|FG000|Overall Study|mental instability|1|||
164155624|NCT02107131|592932367|FG001|Overall Study|mental instability|0|||
164155625|NCT02107131|592932366|FG000|Overall Study|Death|0|||
164155626|NCT02107131|592932367|FG001|Overall Study|Death|1|||
164155627|NCT02107131|592932366|FG000|Overall Study|Protocol Violation|0|||
164155628|NCT02107131|592932367|FG001|Overall Study|Protocol Violation|4|||
164155629|NCT02286713|592932368|FG000|One Week Follow-Up|Death|1|||
164155630|NCT02286713|592932369|FG001|One Week Follow-Up|Death|0|||
164155631|NCT02286713|592932368|FG000|One Week Follow-Up|Lost to Follow-up|17|||
164155632|NCT02286713|592932369|FG001|One Week Follow-Up|Lost to Follow-up|21|||
164155633|NCT02286713|592932368|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
164155634|NCT02286713|592932369|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
164155635|NCT02286713|592932368|FG000|Three Month Follow-Up|Death|1|||
164155636|NCT02286713|592932369|FG001|Three Month Follow-Up|Death|1|||
164155637|NCT02286713|592932368|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
164155638|NCT02286713|592932369|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
164155639|NCT02286713|592932368|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
164155640|NCT02286713|592932369|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
164155641|NCT02286713|592932368|FG000|Six Month Follow-Up|Death|2|||
164155642|NCT02286713|592932369|FG001|Six Month Follow-Up|Death|0|||
164155643|NCT02286713|592932368|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
164155644|NCT02286713|592932369|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
164155645|NCT04314037|592932370|FG000|Treatment Period 2|Adverse Event|1|||
164155646|NCT04314037|592932371|FG001|Treatment Period 2|Adverse Event|0|||
164155647|NCT04314037|592932370|FG000|Treatment Period 3|Protocol Violation|1|||
164155648|NCT04314037|592932371|FG001|Treatment Period 3|Protocol Violation|0|||
164155649|NCT04314037|592932370|FG000|Treatment Period 3|Adverse Event|0|||
164155650|NCT04314037|592932371|FG001|Treatment Period 3|Adverse Event|1|||
164155651|NCT00856492|592932374|FG000|Overall Study|Ineligible or withdrew consent|1|||
164155652|NCT00856492|592932375|FG001|Overall Study|Ineligible or withdrew consent|1|||
164155653|NCT00856492|592932376|FG002|Overall Study|Ineligible or withdrew consent|2|||
164155654|NCT06389487|592932377|FG000|Overall Study|Lost to Follow-up|9|||
164155655|NCT06389487|592932378|FG001|Overall Study|Lost to Follow-up|5|||
164155656|NCT06389487|592932379|FG002|Overall Study|Lost to Follow-up|13|||
164155657|NCT06389487|592932377|FG000|Overall Study|Protocol Violation|0|||
164155658|NCT06389487|592932378|FG001|Overall Study|Protocol Violation|0|||
164155659|NCT06389487|592932379|FG002|Overall Study|Protocol Violation|2|||
164155660|NCT06389487|592932377|FG000|Overall Study|Withdrawal by Subject|2|||
164155661|NCT06389487|592932378|FG001|Overall Study|Withdrawal by Subject|2|||
164155662|NCT06389487|592932379|FG002|Overall Study|Withdrawal by Subject|1|||
164155663|NCT06389487|592932377|FG000|Overall Study|Other|1|||
164155664|NCT06389487|592932378|FG001|Overall Study|Other|0|||
164155665|NCT06389487|592932379|FG002|Overall Study|Other|1|||
164155666|NCT00955409|592933993|FG000|Overall Study|Lack of Efficacy|1|||
164155667|NCT00955409|592933994|FG001|Overall Study|Lack of Efficacy|0|||
164155668|NCT00955409|592933995|FG002|Overall Study|Lack of Efficacy|0|||
164155669|NCT00955409|592933996|FG003|Overall Study|Lack of Efficacy|0|||
164155670|NCT00955409|592933997|FG004|Overall Study|Lack of Efficacy|0|||
164155671|NCT00955409|592933998|FG005|Overall Study|Lack of Efficacy|0|||
164155672|NCT00955409|592933999|FG006|Overall Study|Lack of Efficacy|0|||
164155673|NCT00955409|592934000|FG007|Overall Study|Lack of Efficacy|0|||
164155674|NCT00955409|592934001|FG008|Overall Study|Lack of Efficacy|0|||
164155675|NCT00955409|592934002|FG009|Overall Study|Lack of Efficacy|0|||
164155676|NCT00955409|592933993|FG000|Overall Study|Withdrawal by Subject|1|||
164155677|NCT00955409|592933994|FG001|Overall Study|Withdrawal by Subject|0|||
164155678|NCT00955409|592933995|FG002|Overall Study|Withdrawal by Subject|5|||
164155679|NCT00955409|592933996|FG003|Overall Study|Withdrawal by Subject|2|||
164155680|NCT00955409|592933997|FG004|Overall Study|Withdrawal by Subject|0|||
164155681|NCT00955409|592933998|FG005|Overall Study|Withdrawal by Subject|0|||
164155682|NCT00955409|592933999|FG006|Overall Study|Withdrawal by Subject|2|||
164155683|NCT00955409|592934000|FG007|Overall Study|Withdrawal by Subject|0|||
164155684|NCT00955409|592934001|FG008|Overall Study|Withdrawal by Subject|1|||
164155685|NCT00955409|592934002|FG009|Overall Study|Withdrawal by Subject|0|||
164155686|NCT00955409|592933993|FG000|Overall Study|Caregiver Request|2|||
164155687|NCT00955409|592933994|FG001|Overall Study|Caregiver Request|0|||
164155688|NCT00955409|592933995|FG002|Overall Study|Caregiver Request|6|||
164155689|NCT00955409|592933996|FG003|Overall Study|Caregiver Request|5|||
164155690|NCT00955409|592933997|FG004|Overall Study|Caregiver Request|0|||
164155691|NCT00955409|592933998|FG005|Overall Study|Caregiver Request|2|||
164155692|NCT00955409|592933999|FG006|Overall Study|Caregiver Request|3|||
164155693|NCT00955409|592934000|FG007|Overall Study|Caregiver Request|1|||
164155694|NCT00955409|592934001|FG008|Overall Study|Caregiver Request|3|||
164155695|NCT00955409|592934002|FG009|Overall Study|Caregiver Request|0|||
164155696|NCT00955409|592933993|FG000|Overall Study|Investigator Request|0|||
164155697|NCT00955409|592933994|FG001|Overall Study|Investigator Request|0|||
164155698|NCT00955409|592933995|FG002|Overall Study|Investigator Request|1|||
164155699|NCT00955409|592933996|FG003|Overall Study|Investigator Request|0|||
164155700|NCT00955409|592933997|FG004|Overall Study|Investigator Request|0|||
164155701|NCT00955409|592933998|FG005|Overall Study|Investigator Request|0|||
164155702|NCT00955409|592933999|FG006|Overall Study|Investigator Request|0|||
164155703|NCT00955409|592934000|FG007|Overall Study|Investigator Request|0|||
164155704|NCT00955409|592934001|FG008|Overall Study|Investigator Request|0|||
164155705|NCT00955409|592934002|FG009|Overall Study|Investigator Request|0|||
164155706|NCT00955409|592933993|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
164155707|NCT00955409|592933994|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
164155708|NCT00955409|592933995|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
164155709|NCT00955409|592933996|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
164155710|NCT00955409|592933997|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
164155711|NCT00955409|592933998|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
164155712|NCT00955409|592933999|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
164155713|NCT00955409|592934000|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
164155714|NCT00955409|592934001|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
164155715|NCT00955409|592934002|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
164155716|NCT00955409|592933993|FG000|Overall Study|Lost to Follow-up|0|||
164155717|NCT00955409|592933994|FG001|Overall Study|Lost to Follow-up|0|||
164155718|NCT00955409|592933995|FG002|Overall Study|Lost to Follow-up|1|||
164155719|NCT00955409|592933996|FG003|Overall Study|Lost to Follow-up|0|||
164155720|NCT00955409|592933997|FG004|Overall Study|Lost to Follow-up|0|||
164155721|NCT00955409|592933998|FG005|Overall Study|Lost to Follow-up|0|||
164155722|NCT00955409|592933999|FG006|Overall Study|Lost to Follow-up|1|||
164155723|NCT00955409|592934000|FG007|Overall Study|Lost to Follow-up|0|||
164155724|NCT00955409|592934001|FG008|Overall Study|Lost to Follow-up|0|||
164155725|NCT00955409|592934002|FG009|Overall Study|Lost to Follow-up|0|||
164155726|NCT00955409|592933993|FG000|Overall Study|Failed to Return|2|||
164155727|NCT00955409|592933994|FG001|Overall Study|Failed to Return|0|||
164155728|NCT00955409|592933995|FG002|Overall Study|Failed to Return|0|||
164155729|NCT00955409|592933996|FG003|Overall Study|Failed to Return|0|||
164155730|NCT00955409|592933997|FG004|Overall Study|Failed to Return|0|||
164155731|NCT00955409|592933998|FG005|Overall Study|Failed to Return|0|||
164155732|NCT00955409|592933999|FG006|Overall Study|Failed to Return|0|||
164155733|NCT00955409|592934000|FG007|Overall Study|Failed to Return|2|||
164155734|NCT00955409|592934001|FG008|Overall Study|Failed to Return|0|||
164155735|NCT00955409|592934002|FG009|Overall Study|Failed to Return|0|||
164155736|NCT00955409|592933993|FG000|Overall Study|Adverse Event (AE)|2|||
164155737|NCT00955409|592933994|FG001|Overall Study|Adverse Event (AE)|0|||
164155738|NCT00955409|592933995|FG002|Overall Study|Adverse Event (AE)|0|||
164155739|NCT00955409|592933996|FG003|Overall Study|Adverse Event (AE)|0|||
164155740|NCT00955409|592933997|FG004|Overall Study|Adverse Event (AE)|0|||
164155741|NCT00955409|592933998|FG005|Overall Study|Adverse Event (AE)|1|||
164155742|NCT00955409|592933999|FG006|Overall Study|Adverse Event (AE)|2|||
164155743|NCT00955409|592934000|FG007|Overall Study|Adverse Event (AE)|0|||
164155744|NCT00955409|592934001|FG008|Overall Study|Adverse Event (AE)|2|||
164155745|NCT00955409|592934002|FG009|Overall Study|Adverse Event (AE)|0|||
164155746|NCT00955409|592933993|FG000|Overall Study|Reason not Specified|2|||
164155747|NCT00955409|592933994|FG001|Overall Study|Reason not Specified|1|||
164155748|NCT00955409|592933995|FG002|Overall Study|Reason not Specified|13|||
164155749|NCT00955409|592933996|FG003|Overall Study|Reason not Specified|1|||
164155750|NCT00955409|592933997|FG004|Overall Study|Reason not Specified|2|||
164155751|NCT00955409|592933998|FG005|Overall Study|Reason not Specified|0|||
164155752|NCT00955409|592933999|FG006|Overall Study|Reason not Specified|16|||
164155753|NCT00955409|592934000|FG007|Overall Study|Reason not Specified|0|||
164155754|NCT00955409|592934001|FG008|Overall Study|Reason not Specified|8|||
164155755|NCT00955409|592934002|FG009|Overall Study|Reason not Specified|1|||
164155756|NCT00485732|592934003|FG000|Overall Study|Protocol Violation|1|||
164155757|NCT00485732|592934004|FG001|Overall Study|Protocol Violation|3|||
164155758|NCT00485732|592934003|FG000|Overall Study|Withdrawal by Subject|5|||
164155759|NCT00485732|592934004|FG001|Overall Study|Withdrawal by Subject|4|||
164155760|NCT00485732|592934003|FG000|Overall Study|Lost to Follow-up|2|||
164155761|NCT00485732|592934004|FG001|Overall Study|Lost to Follow-up|2|||
164155762|NCT05423093|592934006|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
164155763|NCT05423093|592934006|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
164155764|NCT05423093|592934006|FG000|Attended Intervention Session|Lost to Follow-up|3|||
164155765|NCT05423093|592934006|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
164155766|NCT05423093|592934006|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
164155767|NCT03593525|592934007|FG000|Overall Study|Withdrawal by Subject|1|||
164155768|NCT03593525|592934008|FG001|Overall Study|Withdrawal by Subject|0|||
164155769|NCT03593525|592934007|FG000|Overall Study|Lost to Follow-up|7|||
164155770|NCT03593525|592934008|FG001|Overall Study|Lost to Follow-up|5|||
164155771|NCT00210210|592934011|FG000|Overall Study|Withdrawal by Subject|3|||
164155772|NCT00210210|592934012|FG001|Overall Study|Withdrawal by Subject|2|||
164155773|NCT00210210|592934011|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
164155774|NCT00210210|592934012|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
164155775|NCT01002989|592934015|FG000|Overall Study|exclusion criteria, no consent|5|||
164155776|NCT02954601|592934016|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
164155777|NCT02954601|592934017|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
164155778|NCT02954601|592934018|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
164155779|NCT02954601|592934019|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
164155780|NCT00917852|592934023|FG000|Overall Study|Death|6|||
164155781|NCT00471081|592934024|FG000|Active Phase|Protocol Violation|1|||
164155782|NCT00471081|592934025|FG001|Active Phase|Protocol Violation|1|||
164155783|NCT00471081|592934024|FG000|Active Phase|Withdrawal by Subject|0|||
164155784|NCT00471081|592934025|FG001|Active Phase|Withdrawal by Subject|3|||
164155785|NCT00471081|592934024|FG000|Active Phase|Lost to Follow-up|0|||
164155786|NCT00471081|592934025|FG001|Active Phase|Lost to Follow-up|1|||
164155787|NCT00471081|592934024|FG000|Active Phase|Lost health plan/insurance|1|||
164155788|NCT00471081|592934025|FG001|Active Phase|Lost health plan/insurance|8|||
164155789|NCT00471081|592934024|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
164155790|NCT00471081|592934025|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
164155791|NCT00471081|592934024|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
164155792|NCT00471081|592934025|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
164155793|NCT00471081|592934024|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
164155794|NCT00471081|592934025|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
164155795|NCT02393950|592934030|FG000|Overall Study|Adverse Event|1|||
164155796|NCT02393950|592934031|FG001|Overall Study|Adverse Event|0|||
164155797|NCT02393950|592934030|FG000|Overall Study|Withdrawal by Subject|0|||
164155798|NCT02393950|592934031|FG001|Overall Study|Withdrawal by Subject|1|||
164155799|NCT05486091|592934032|FG000|Overall Study|Withdrawal by Subject|1|||
164155800|NCT05486091|592934032|FG000|Overall Study|Lost to Follow-up|2|||
164155801|NCT03871543|592934047|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
164155802|NCT03871543|592934047|FG000|Period 1|Investigator Error|1|||
164155803|NCT03871543|592934047|FG000|Period 1|Protocol Violation|2|||
164155804|NCT03871543|592934047|FG000|Period 1|COVID-19 Related|1|||
164155805|NCT03871543|592934047|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
164155806|NCT03871543|592934047|FG000|Period 1|Withdrawal by Subject|10|||
164155807|NCT03871543|592934047|FG000|Period 2|Adverse Event|1|||
164155808|NCT03871543|592934047|FG000|Period 2|Withdrawal by Subject|1|||
164155809|NCT01894919|592934048|FG000|Overall Study|Withdrawal by Subject|1|||
164155810|NCT01894919|592934049|FG001|Overall Study|Withdrawal by Subject|0|||
164155811|NCT01894919|592934050|FG002|Overall Study|Withdrawal by Subject|0|||
164155812|NCT01894919|592934051|FG003|Overall Study|Withdrawal by Subject|0|||
164155813|NCT01894919|592934052|FG004|Overall Study|Withdrawal by Subject|1|||
164155814|NCT01894919|592934053|FG005|Overall Study|Withdrawal by Subject|0|||
164155815|NCT01894919|592934054|FG006|Overall Study|Withdrawal by Subject|0|||
164155816|NCT01894919|592934055|FG007|Overall Study|Withdrawal by Subject|0|||
164155817|NCT01894919|592934056|FG008|Overall Study|Withdrawal by Subject|0|||
164155818|NCT01894919|592934057|FG009|Overall Study|Withdrawal by Subject|1|||
164155819|NCT01894919|592934058|FG010|Overall Study|Withdrawal by Subject|1|||
164155820|NCT01894919|592934059|FG011|Overall Study|Withdrawal by Subject|0|||
164155821|NCT01894919|592934060|FG012|Overall Study|Withdrawal by Subject|0|||
164155822|NCT01894919|592934048|FG000|Overall Study|Adverse Event|0|||
164155823|NCT01894919|592934049|FG001|Overall Study|Adverse Event|0|||
164155824|NCT01894919|592934050|FG002|Overall Study|Adverse Event|0|||
164155825|NCT01894919|592934051|FG003|Overall Study|Adverse Event|0|||
164155826|NCT01894919|592934052|FG004|Overall Study|Adverse Event|0|||
164155827|NCT01894919|592934053|FG005|Overall Study|Adverse Event|0|||
164155828|NCT01894919|592934054|FG006|Overall Study|Adverse Event|0|||
164155829|NCT01894919|592934055|FG007|Overall Study|Adverse Event|0|||
164155830|NCT01894919|592934056|FG008|Overall Study|Adverse Event|0|||
164155831|NCT01894919|592934057|FG009|Overall Study|Adverse Event|0|||
164155832|NCT01894919|592934058|FG010|Overall Study|Adverse Event|1|||
164155833|NCT01894919|592934059|FG011|Overall Study|Adverse Event|0|||
164155834|NCT01894919|592934060|FG012|Overall Study|Adverse Event|0|||
164155835|NCT01894919|592934048|FG000|Overall Study|Other-Unspecified|1|||
164155836|NCT01894919|592934049|FG001|Overall Study|Other-Unspecified|0|||
164155837|NCT01894919|592934050|FG002|Overall Study|Other-Unspecified|0|||
164155838|NCT01894919|592934051|FG003|Overall Study|Other-Unspecified|0|||
164155839|NCT01894919|592934052|FG004|Overall Study|Other-Unspecified|0|||
164155840|NCT01894919|592934053|FG005|Overall Study|Other-Unspecified|0|||
164155841|NCT01894919|592934054|FG006|Overall Study|Other-Unspecified|0|||
164155842|NCT01894919|592934055|FG007|Overall Study|Other-Unspecified|0|||
164155843|NCT01894919|592934056|FG008|Overall Study|Other-Unspecified|0|||
164155844|NCT01894919|592934057|FG009|Overall Study|Other-Unspecified|0|||
164155845|NCT01894919|592934058|FG010|Overall Study|Other-Unspecified|0|||
164155846|NCT01894919|592934059|FG011|Overall Study|Other-Unspecified|0|||
164155847|NCT01894919|592934060|FG012|Overall Study|Other-Unspecified|0|||
164155848|NCT01894919|592934048|FG000|Overall Study|Lost to Follow-up|0|||
164155849|NCT01894919|592934049|FG001|Overall Study|Lost to Follow-up|0|||
164155850|NCT01894919|592934050|FG002|Overall Study|Lost to Follow-up|0|||
164155851|NCT01894919|592934051|FG003|Overall Study|Lost to Follow-up|0|||
164155852|NCT01894919|592934052|FG004|Overall Study|Lost to Follow-up|2|||
164155853|NCT01894919|592934053|FG005|Overall Study|Lost to Follow-up|0|||
164155854|NCT01894919|592934054|FG006|Overall Study|Lost to Follow-up|0|||
164155855|NCT01894919|592934055|FG007|Overall Study|Lost to Follow-up|0|||
164155856|NCT01894919|592934056|FG008|Overall Study|Lost to Follow-up|0|||
164155857|NCT01894919|592934057|FG009|Overall Study|Lost to Follow-up|0|||
164155858|NCT01894919|592934058|FG010|Overall Study|Lost to Follow-up|0|||
164155859|NCT01894919|592934059|FG011|Overall Study|Lost to Follow-up|0|||
164155860|NCT01894919|592934060|FG012|Overall Study|Lost to Follow-up|0|||
164155861|NCT03711188|592934063|FG000|Overall Study|Disease progression|11|||
164155862|NCT03711188|592934063|FG000|Overall Study|Adverse Event|1|||
164155863|NCT03534687|592934064|FG000|Overall Study|Lost to Follow-up|7|||
164155864|NCT03534687|592934065|FG001|Overall Study|Lost to Follow-up|2|||
164155865|NCT00314340|592934067|FG000|Overall Study|lost interest|1|||
164155866|NCT00957801|592934068|FG000|Overall Study|Withdrawal by Subject|0|||
164155867|NCT00957801|592934069|FG001|Overall Study|Withdrawal by Subject|0|||
164155868|NCT00957801|592934070|FG002|Overall Study|Withdrawal by Subject|0|||
164155869|NCT00957801|592934071|FG003|Overall Study|Withdrawal by Subject|1|||
164155870|NCT03776357|592934075|FG000|Overall Study|Lost to Follow-up|3|||
164155871|NCT01286467|592934076|FG000|Overall Study|Death|1|||
164155872|NCT01286467|592934077|FG001|Overall Study|Death|1|||
164155873|NCT01286467|592934078|FG002|Overall Study|Death|1|||
164155874|NCT01286467|592934079|FG003|Overall Study|Death|0|||
164155875|NCT01286467|592934076|FG000|Overall Study|Lost to Follow-up|0|||
164155876|NCT01286467|592934077|FG001|Overall Study|Lost to Follow-up|0|||
164155877|NCT01286467|592934078|FG002|Overall Study|Lost to Follow-up|0|||
164155878|NCT01286467|592934079|FG003|Overall Study|Lost to Follow-up|1|||
164155879|NCT01286467|592934076|FG000|Overall Study|Withdrawal by Subject|0|||
164155880|NCT01286467|592934077|FG001|Overall Study|Withdrawal by Subject|0|||
164155881|NCT01286467|592934078|FG002|Overall Study|Withdrawal by Subject|1|||
164155882|NCT01286467|592934079|FG003|Overall Study|Withdrawal by Subject|0|||
164155883|NCT01286467|592934076|FG000|Overall Study|Physician Decision|0|||
164155884|NCT01286467|592934077|FG001|Overall Study|Physician Decision|0|||
164155885|NCT01286467|592934078|FG002|Overall Study|Physician Decision|0|||
164155886|NCT01286467|592934079|FG003|Overall Study|Physician Decision|1|||
164155887|NCT01286467|592934076|FG000|Overall Study|Disease progression|3|||
164155888|NCT01286467|592934077|FG001|Overall Study|Disease progression|2|||
164155889|NCT01286467|592934078|FG002|Overall Study|Disease progression|2|||
164155890|NCT01286467|592934079|FG003|Overall Study|Disease progression|3|||
164155891|NCT01286467|592934076|FG000|Overall Study|Adverse Event|0|||
164155892|NCT01286467|592934077|FG001|Overall Study|Adverse Event|1|||
164155893|NCT01286467|592934078|FG002|Overall Study|Adverse Event|2|||
164155894|NCT01286467|592934079|FG003|Overall Study|Adverse Event|3|||
164155895|NCT01286467|592934076|FG000|Overall Study|Study drug stop longer than 14 days|0|||
164155896|NCT01286467|592934077|FG001|Overall Study|Study drug stop longer than 14 days|0|||
164155897|NCT01286467|592934078|FG002|Overall Study|Study drug stop longer than 14 days|1|||
164155898|NCT01286467|592934079|FG003|Overall Study|Study drug stop longer than 14 days|0|||
164155899|NCT03335475|592934080|FG000|Overall Study|Did not wear accelerometer|4|||
164155900|NCT03335475|592934081|FG001|Overall Study|Did not wear accelerometer|0|||
164155901|NCT03335475|592934080|FG000|Overall Study|Withdrawal by Subject|0|||
164155902|NCT03335475|592934081|FG001|Overall Study|Withdrawal by Subject|1|||
164155903|NCT04886596|592934082|FG000|Overall Study|Adverse Event|442|||
164155904|NCT04886596|592934083|FG001|Overall Study|Adverse Event|441|||
164155905|NCT04886596|592934082|FG000|Overall Study|Lost to Follow-up|448|||
164155906|NCT04886596|592934083|FG001|Overall Study|Lost to Follow-up|465|||
164155907|NCT04886596|592934082|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
164155908|NCT04886596|592934083|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
164155909|NCT04886596|592934082|FG000|Overall Study|Migrated/moved from the study area|201|||
164155910|NCT04886596|592934083|FG001|Overall Study|Migrated/moved from the study area|184|||
164155911|NCT04886596|592934082|FG000|Overall Study|Other|298|||
164155912|NCT04886596|592934083|FG001|Overall Study|Other|326|||
164155913|NCT02211209|592934084|FG000|Overall Study|Investigator judgment|0|||
164155914|NCT02211209|592934085|FG001|Overall Study|Investigator judgment|1|||
164155915|NCT02211209|592934084|FG000|Overall Study|Voluntary withdrawal|1|||
164155916|NCT02211209|592934085|FG001|Overall Study|Voluntary withdrawal|4|||
164155917|NCT02211209|592934084|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
164155918|NCT02211209|592934085|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
164155919|NCT02211209|592934084|FG000|Overall Study|Reason Not Specified|1|||
164155920|NCT02211209|592934085|FG001|Overall Study|Reason Not Specified|0|||
164155921|NCT03751098|592934091|FG000|Overall Study|Withdrawal by Subject|0|||
164155922|NCT03751098|592934092|FG001|Overall Study|Withdrawal by Subject|1|||
164155923|NCT02964247|592934094|FG000|Overall Study|Lost to Follow-up|2|||
164155924|NCT02964247|592934095|FG001|Overall Study|Lost to Follow-up|0|||
164155925|NCT02964247|592934094|FG000|Overall Study|Withdrawal by Subject|1|||
164155926|NCT02964247|592934095|FG001|Overall Study|Withdrawal by Subject|2|||
164155927|NCT06018129|592934096|FG000|Overall Study|Death|1|||
164155928|NCT06018129|592934097|FG001|Overall Study|Death|1|||
164155929|NCT06018129|592934098|FG002|Overall Study|Death|2|||
164155930|NCT06018129|592934096|FG000|Overall Study|Sponsor Decision|2|||
164155931|NCT06018129|592934097|FG001|Overall Study|Sponsor Decision|2|||
164155932|NCT06018129|592934098|FG002|Overall Study|Sponsor Decision|1|||
164155933|NCT03832686|592934099|FG000|Overall Study|Lost to Follow-up|6|||
164155934|NCT03832686|592934100|FG001|Overall Study|Lost to Follow-up|9|||
164155935|NCT03832686|592934099|FG000|Overall Study|Discontinued Intervention|5|||
164155936|NCT03832686|592934100|FG001|Overall Study|Discontinued Intervention|4|||
164155937|NCT02208362|592934101|FG000|Overall Study|Participant did not complete treatment|0|||
164155938|NCT02208362|592934102|FG001|Overall Study|Participant did not complete treatment|1|||
164155939|NCT02208362|592934103|FG002|Overall Study|Participant did not complete treatment|0|||
164155940|NCT02208362|592934104|FG003|Overall Study|Participant did not complete treatment|0|||
164155941|NCT02208362|592934105|FG004|Overall Study|Participant did not complete treatment|0|||
164155942|NCT02208362|592934106|FG005|Overall Study|Participant did not complete treatment|0|||
164155943|NCT02208362|592934107|FG006|Overall Study|Participant did not complete treatment|1|||
164155944|NCT02208362|592934108|FG007|Overall Study|Participant did not complete treatment|1|||
164155945|NCT02208362|592934109|FG008|Overall Study|Participant did not complete treatment|2|||
164155946|NCT02208362|592934110|FG009|Overall Study|Participant did not complete treatment|0|||
164155947|NCT02208362|592934111|FG010|Overall Study|Participant did not complete treatment|1|||
164155948|NCT02208362|592934112|FG011|Overall Study|Participant did not complete treatment|0|||
164155949|NCT02208362|592934101|FG000|Overall Study|Participant received disallowed treatment|0|||
164155950|NCT02208362|592934102|FG001|Overall Study|Participant received disallowed treatment|0|||
164155951|NCT02208362|592934103|FG002|Overall Study|Participant received disallowed treatment|0|||
164155952|NCT02208362|592934104|FG003|Overall Study|Participant received disallowed treatment|0|||
164155953|NCT02208362|592934105|FG004|Overall Study|Participant received disallowed treatment|0|||
164155954|NCT02208362|592934106|FG005|Overall Study|Participant received disallowed treatment|0|||
164155955|NCT02208362|592934107|FG006|Overall Study|Participant received disallowed treatment|0|||
164155956|NCT02208362|592934108|FG007|Overall Study|Participant received disallowed treatment|0|||
164155957|NCT02208362|592934109|FG008|Overall Study|Participant received disallowed treatment|1|||
164155958|NCT02208362|592934110|FG009|Overall Study|Participant received disallowed treatment|0|||
164155959|NCT02208362|592934111|FG010|Overall Study|Participant received disallowed treatment|0|||
164155960|NCT02208362|592934112|FG011|Overall Study|Participant received disallowed treatment|0|||
164155961|NCT02235454|592934115|FG000|Overall Study|Withdrawal by Subject|2|||
164155962|NCT03323398|592934116|FG000|Overall Study|Other than Specified|0|||
164155963|NCT03323398|592934117|FG001|Overall Study|Other than Specified|1|||
164155964|NCT03323398|592934118|FG002|Overall Study|Other than Specified|2|||
164155965|NCT03323398|592934119|FG003|Overall Study|Other than Specified|0|||
164155966|NCT03323398|592934120|FG004|Overall Study|Other than Specified|0|||
164155967|NCT03323398|592934121|FG005|Overall Study|Other than Specified|0|||
164155968|NCT03323398|592934122|FG006|Overall Study|Other than Specified|1|||
164155969|NCT03323398|592934123|FG007|Overall Study|Other than Specified|0|||
164155970|NCT03323398|592934124|FG008|Overall Study|Other than Specified|2|||
164155971|NCT03323398|592934116|FG000|Overall Study|Lost to Follow-up|1|||
164155972|NCT03323398|592934117|FG001|Overall Study|Lost to Follow-up|2|||
164155973|NCT03323398|592934118|FG002|Overall Study|Lost to Follow-up|1|||
164155974|NCT03323398|592934119|FG003|Overall Study|Lost to Follow-up|0|||
164155975|NCT03323398|592934120|FG004|Overall Study|Lost to Follow-up|0|||
164155976|NCT03323398|592934121|FG005|Overall Study|Lost to Follow-up|0|||
164155977|NCT03323398|592934122|FG006|Overall Study|Lost to Follow-up|0|||
164155978|NCT03323398|592934123|FG007|Overall Study|Lost to Follow-up|0|||
164155979|NCT03323398|592934124|FG008|Overall Study|Lost to Follow-up|0|||
164155980|NCT03323398|592934116|FG000|Overall Study|Death|4|||
164155981|NCT03323398|592934117|FG001|Overall Study|Death|6|||
164155982|NCT03323398|592934118|FG002|Overall Study|Death|2|||
164155983|NCT03323398|592934119|FG003|Overall Study|Death|2|||
164155984|NCT03323398|592934120|FG004|Overall Study|Death|1|||
164155985|NCT03323398|592934121|FG005|Overall Study|Death|2|||
164155986|NCT03323398|592934122|FG006|Overall Study|Death|0|||
164155987|NCT03323398|592934123|FG007|Overall Study|Death|0|||
164155988|NCT03323398|592934124|FG008|Overall Study|Death|6|||
164155989|NCT03323398|592934116|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
164155990|NCT03323398|592934117|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
164155991|NCT03323398|592934118|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
164155992|NCT03323398|592934119|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
164155993|NCT03323398|592934120|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
164155994|NCT03323398|592934121|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
164155995|NCT03323398|592934122|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
164155996|NCT03323398|592934123|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
164155997|NCT03323398|592934124|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
164155998|NCT03323398|592934116|FG000|Overall Study|Withdrawal by Subject|2|||
164155999|NCT03323398|592934117|FG001|Overall Study|Withdrawal by Subject|1|||
164156000|NCT03323398|592934118|FG002|Overall Study|Withdrawal by Subject|3|||
164156001|NCT03323398|592934119|FG003|Overall Study|Withdrawal by Subject|0|||
164156002|NCT03323398|592934120|FG004|Overall Study|Withdrawal by Subject|0|||
164156003|NCT03323398|592934121|FG005|Overall Study|Withdrawal by Subject|1|||
164156004|NCT03323398|592934122|FG006|Overall Study|Withdrawal by Subject|0|||
164156005|NCT03323398|592934123|FG007|Overall Study|Withdrawal by Subject|0|||
164156006|NCT03323398|592934124|FG008|Overall Study|Withdrawal by Subject|0|||
164156007|NCT03323398|592934116|FG000|Overall Study|Participant was Put on Hospice|0|||
164156008|NCT03323398|592934117|FG001|Overall Study|Participant was Put on Hospice|0|||
164156009|NCT03323398|592934118|FG002|Overall Study|Participant was Put on Hospice|0|||
164156010|NCT03323398|592934119|FG003|Overall Study|Participant was Put on Hospice|0|||
164156011|NCT03323398|592934120|FG004|Overall Study|Participant was Put on Hospice|0|||
164156012|NCT03323398|592934121|FG005|Overall Study|Participant was Put on Hospice|0|||
164156013|NCT03323398|592934122|FG006|Overall Study|Participant was Put on Hospice|1|||
164156014|NCT03323398|592934123|FG007|Overall Study|Participant was Put on Hospice|0|||
164156015|NCT03323398|592934124|FG008|Overall Study|Participant was Put on Hospice|0|||
164156016|NCT03323398|592934116|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
164156017|NCT03323398|592934117|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
164156018|NCT03323398|592934118|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
164156019|NCT03323398|592934119|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
164156020|NCT03323398|592934120|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
164156021|NCT03323398|592934121|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
164156022|NCT03323398|592934122|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
164156023|NCT03323398|592934123|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
164156024|NCT03323398|592934124|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
164156025|NCT03641469|592934125|FG000|Overall Study|Ineligible|2|||
164156026|NCT03641469|592934125|FG000|Overall Study|Withdrawal by Subject|5|||
164156027|NCT03641469|592934125|FG000|Overall Study|Physician Decision|1|||
164156028|NCT03641469|592934125|FG000|Overall Study|Protocol Violation|1|||
164156029|NCT03641469|592934125|FG000|Overall Study|Lost to Follow-up|2|||
164156030|NCT05479435|592934126|FG000|Overall Study|Withdrawal by Subject|1|||
164156031|NCT05479435|592934127|FG001|Overall Study|Withdrawal by Subject|0|||
164156032|NCT05479435|592934128|FG002|Overall Study|Withdrawal by Subject|0|||
164156033|NCT05479435|592934126|FG000|Overall Study|Covid 19|0|||
164156034|NCT05479435|592934127|FG001|Overall Study|Covid 19|0|||
164156035|NCT05479435|592934128|FG002|Overall Study|Covid 19|2|||
164156036|NCT00955617|592934130|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
164156037|NCT00955617|592934131|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
164156038|NCT00955617|592934130|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
164156039|NCT00955617|592934131|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
164156040|NCT00955617|592934130|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
164156041|NCT00955617|592934131|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
164156042|NCT00955617|592934130|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
164156043|NCT00955617|592934131|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
164156044|NCT00858273|592934132|FG000|Overall Study|Protocol Violation|3|||
164156045|NCT00858273|592934133|FG001|Overall Study|Protocol Violation|5|||
164156046|NCT00982657|592934134|FG000|Overall Study|Death|1|||
164156047|NCT00982657|592934135|FG001|Overall Study|Death|0|||
164156048|NCT00982657|592934136|FG002|Overall Study|Death|1|||
164156049|NCT00982657|592934137|FG003|Overall Study|Death|1|||
164156050|NCT00982657|592934134|FG000|Overall Study|Withdrawal by Subject|0|||
164156051|NCT00982657|592934135|FG001|Overall Study|Withdrawal by Subject|0|||
164156052|NCT00982657|592934136|FG002|Overall Study|Withdrawal by Subject|1|||
164156053|NCT00982657|592934137|FG003|Overall Study|Withdrawal by Subject|3|||
164156054|NCT00982657|592934134|FG000|Overall Study|Other|0|||
164156055|NCT00982657|592934135|FG001|Overall Study|Other|0|||
164156056|NCT00982657|592934136|FG002|Overall Study|Other|0|||
164156057|NCT00982657|592934137|FG003|Overall Study|Other|4|||
164156058|NCT00982657|592934134|FG000|Overall Study|On going at date of cut-off|0|||
164156059|NCT00982657|592934135|FG001|Overall Study|On going at date of cut-off|0|||
164156060|NCT00982657|592934136|FG002|Overall Study|On going at date of cut-off|0|||
164156061|NCT00982657|592934137|FG003|Overall Study|On going at date of cut-off|1|||
164156062|NCT02764762|592935517|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
164156063|NCT02764762|592935517|FG000|Overall Study|Lost to Follow-up|4|||
164156064|NCT02764762|592935517|FG000|Overall Study|Voluntary Withdrawal|8|||
164156065|NCT02764762|592935517|FG000|Overall Study|Site Termination|1|||
164156066|NCT02764762|592935517|FG000|Overall Study|Lack of Efficacy|16|||
164156067|NCT02764762|592935517|FG000|Overall Study|Reason not Specified|1|||
164156068|NCT00370552|592935518|FG000|Overall Study|Adverse Event|2|||
164156069|NCT00370552|592935519|FG001|Overall Study|Adverse Event|2|||
164156070|NCT00370552|592935520|FG002|Overall Study|Adverse Event|2|||
164156071|NCT00370552|592935518|FG000|Overall Study|Disease progression|23|||
164156072|NCT00370552|592935519|FG001|Overall Study|Disease progression|23|||
164156073|NCT00370552|592935520|FG002|Overall Study|Disease progression|15|||
164156074|NCT00370552|592935518|FG000|Overall Study|Maximum clinical benefit|3|||
164156075|NCT00370552|592935519|FG001|Overall Study|Maximum clinical benefit|5|||
164156076|NCT00370552|592935520|FG002|Overall Study|Maximum clinical benefit|5|||
164156077|NCT00370552|592935518|FG000|Overall Study|Poor or noncompliance|0|||
164156078|NCT00370552|592935519|FG001|Overall Study|Poor or noncompliance|0|||
164156079|NCT00370552|592935520|FG002|Overall Study|Poor or noncompliance|1|||
164156080|NCT00370552|592935518|FG000|Overall Study|Study drug toxicity|11|||
164156081|NCT00370552|592935519|FG001|Overall Study|Study drug toxicity|8|||
164156082|NCT00370552|592935520|FG002|Overall Study|Study drug toxicity|6|||
164156083|NCT00370552|592935518|FG000|Overall Study|Withdrawal by Subject|2|||
164156084|NCT00370552|592935519|FG001|Overall Study|Withdrawal by Subject|0|||
164156085|NCT00370552|592935520|FG002|Overall Study|Withdrawal by Subject|1|||
164156086|NCT00370552|592935518|FG000|Overall Study|Still on treatment|1|||
164156087|NCT00370552|592935519|FG001|Overall Study|Still on treatment|3|||
164156088|NCT00370552|592935520|FG002|Overall Study|Still on treatment|2|||
164156089|NCT00370552|592935518|FG000|Overall Study|Never treated|1|||
164156090|NCT00370552|592935519|FG001|Overall Study|Never treated|0|||
164156091|NCT00370552|592935520|FG002|Overall Study|Never treated|0|||
164156092|NCT00370552|592935518|FG000|Overall Study|Physician Decision|1|||
164156093|NCT00370552|592935519|FG001|Overall Study|Physician Decision|1|||
164156094|NCT00370552|592935520|FG002|Overall Study|Physician Decision|0|||
164156095|NCT00370552|592935518|FG000|Overall Study|Investigator decision|2|||
164156096|NCT00370552|592935519|FG001|Overall Study|Investigator decision|1|||
164156097|NCT00370552|592935520|FG002|Overall Study|Investigator decision|0|||
164156098|NCT00370552|592935518|FG000|Overall Study|High risk of allergic reaction|0|||
164156099|NCT00370552|592935519|FG001|Overall Study|High risk of allergic reaction|1|||
164156100|NCT00370552|592935520|FG002|Overall Study|High risk of allergic reaction|0|||
164156101|NCT00370552|592935518|FG000|Overall Study|Planned radiation for palliation|0|||
164156102|NCT00370552|592935519|FG001|Overall Study|Planned radiation for palliation|1|||
164156103|NCT00370552|592935520|FG002|Overall Study|Planned radiation for palliation|0|||
164156104|NCT03499067|592935521|FG000|First Intervention|Physician Decision|2|||
164156105|NCT03499067|592935522|FG001|First Intervention|Physician Decision|1|||
164156106|NCT03499067|592935521|FG000|First Intervention|Withdrawal by Subject|3|||
164156107|NCT03499067|592935522|FG001|First Intervention|Withdrawal by Subject|6|||
164156108|NCT02342678|592935523|FG000|Overall Study|Lost to Follow-up|0|||
164156109|NCT02342678|592935524|FG001|Overall Study|Lost to Follow-up|1|||
164156110|NCT02342678|592935523|FG000|Overall Study|Too busy to complete study|0|||
164156111|NCT02342678|592935524|FG001|Overall Study|Too busy to complete study|2|||
164156112|NCT02342678|592935523|FG000|Overall Study|Family illness/emergency|0|||
164156113|NCT02342678|592935524|FG001|Overall Study|Family illness/emergency|1|||
164156114|NCT02342678|592935523|FG000|Overall Study|Illness/medical reason|1|||
164156115|NCT02342678|592935524|FG001|Overall Study|Illness/medical reason|1|||
164156116|NCT03876743|592935528|FG000|Overall Study|Lost to Follow-up|6|||
164156117|NCT03876743|592935529|FG001|Overall Study|Lost to Follow-up|4|||
164156118|NCT03876743|592935530|FG002|Overall Study|Lost to Follow-up|4|||
164156119|NCT03876743|592935531|FG003|Overall Study|Lost to Follow-up|7|||
164156120|NCT03889418|592935532|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
164156121|NCT03889418|592935533|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
164156122|NCT03889418|592935534|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
164156123|NCT03889418|592935535|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
164156124|NCT03889418|592935536|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
164156125|NCT03889418|592935537|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
164156126|NCT03889418|592935538|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
164156127|NCT03889418|592935539|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
164156128|NCT03889418|592935540|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
164156129|NCT03889418|592935541|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
164156130|NCT03889418|592935532|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
164156131|NCT03889418|592935533|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
164156132|NCT03889418|592935534|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
164156274|NCT04740918|592935599|FG001|Overall Study|Death|6|||
164156133|NCT03889418|592935535|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
164156134|NCT03889418|592935536|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
164156135|NCT03889418|592935537|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
164156136|NCT03889418|592935538|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
164156137|NCT03889418|592935539|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
164156138|NCT03889418|592935540|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
164156139|NCT03889418|592935541|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
164156140|NCT03889418|592935532|FG000|October-December 2019 (Month 7-9)|Death|0|||
164156141|NCT03889418|592935533|FG001|October-December 2019 (Month 7-9)|Death|0|||
164156142|NCT03889418|592935534|FG002|October-December 2019 (Month 7-9)|Death|0|||
164156143|NCT03889418|592935535|FG003|October-December 2019 (Month 7-9)|Death|0|||
164156144|NCT03889418|592935536|FG004|October-December 2019 (Month 7-9)|Death|0|||
164156145|NCT03889418|592935537|FG005|October-December 2019 (Month 7-9)|Death|0|||
164156146|NCT03889418|592935538|FG006|October-December 2019 (Month 7-9)|Death|0|||
164156147|NCT03889418|592935539|FG007|October-December 2019 (Month 7-9)|Death|0|||
164156148|NCT03889418|592935540|FG008|October-December 2019 (Month 7-9)|Death|1|||
164156149|NCT03889418|592935541|FG009|October-December 2019 (Month 7-9)|Death|0|||
164156150|NCT03889418|592935532|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
164156151|NCT03889418|592935533|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
164156152|NCT03889418|592935534|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
164156153|NCT03889418|592935535|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
164156154|NCT03889418|592935536|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
164156155|NCT03889418|592935537|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
164156156|NCT03889418|592935538|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
164156157|NCT03889418|592935539|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
164156158|NCT03889418|592935540|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
164156159|NCT03889418|592935541|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
164156160|NCT03889418|592935532|FG000|April - June 2020 (Month 13-15)|Death|0|||
164156161|NCT03889418|592935533|FG001|April - June 2020 (Month 13-15)|Death|1|||
164156162|NCT03889418|592935534|FG002|April - June 2020 (Month 13-15)|Death|0|||
164156163|NCT03889418|592935535|FG003|April - June 2020 (Month 13-15)|Death|0|||
164156164|NCT03889418|592935536|FG004|April - June 2020 (Month 13-15)|Death|0|||
164156165|NCT03889418|592935537|FG005|April - June 2020 (Month 13-15)|Death|0|||
164156166|NCT03889418|592935538|FG006|April - June 2020 (Month 13-15)|Death|0|||
164156167|NCT03889418|592935539|FG007|April - June 2020 (Month 13-15)|Death|0|||
164156168|NCT03889418|592935540|FG008|April - June 2020 (Month 13-15)|Death|0|||
164156169|NCT03889418|592935541|FG009|April - June 2020 (Month 13-15)|Death|0|||
164156170|NCT03889418|592935532|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
164156171|NCT03889418|592935533|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
164156172|NCT03889418|592935534|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
164156173|NCT03889418|592935535|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
164156174|NCT03889418|592935536|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
164156175|NCT03889418|592935537|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
164156176|NCT03889418|592935538|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
164156177|NCT03889418|592935539|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
164156178|NCT03889418|592935540|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
164156179|NCT03889418|592935541|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
164156180|NCT03889418|592935532|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
164156181|NCT03889418|592935533|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
164156182|NCT03889418|592935534|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
164156183|NCT03889418|592935535|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
164156184|NCT03889418|592935536|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
164156185|NCT03889418|592935537|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
164156186|NCT03889418|592935538|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
164156187|NCT03889418|592935539|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
164156188|NCT03889418|592935540|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
164156189|NCT03889418|592935541|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
164156190|NCT03889418|592935532|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
164156191|NCT03889418|592935533|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
164156192|NCT03889418|592935534|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
164156193|NCT03889418|592935535|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
164156194|NCT03889418|592935536|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
164156195|NCT03889418|592935537|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
164156196|NCT03889418|592935538|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
164156197|NCT03889418|592935539|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
164156198|NCT03889418|592935540|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
164156199|NCT03889418|592935541|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
164156200|NCT00837148|592935546|FG000|Overall Study|Adverse Event|1|||
164156201|NCT00837148|592935546|FG000|Overall Study|Death|1|||
164156202|NCT00931411|592935549|FG000|First Intervention - 42 Days|Adverse Event|2|||
164156203|NCT00931411|592935550|FG001|First Intervention - 42 Days|Adverse Event|3|||
164156204|NCT00931411|592935549|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
164156205|NCT00931411|592935550|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
164156206|NCT00931411|592935549|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
164156207|NCT00931411|592935550|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
164156208|NCT01827111|592935551|FG000|Overall Study|Disease Progression|1|||
164156209|NCT03181633|592935554|FG000|Overall Study|Withdrawal by Subject|1|||
164156210|NCT03181633|592935554|FG000|Overall Study|Missing follow-up visit|1|||
164156211|NCT04383327|592935561|FG000|Overall Study|Lost to Follow-up|112|||
164156212|NCT04383327|592935562|FG001|Overall Study|Lost to Follow-up|14|||
164156213|NCT04383327|592935563|FG002|Overall Study|Lost to Follow-up|78|||
164156214|NCT04383327|592935564|FG003|Overall Study|Lost to Follow-up|13|||
164156215|NCT04383327|592935565|FG004|Overall Study|Lost to Follow-up|110|||
164156216|NCT04383327|592935566|FG005|Overall Study|Lost to Follow-up|13|||
164156217|NCT04383327|592935567|FG006|Overall Study|Lost to Follow-up|74|||
164156218|NCT04383327|592935568|FG007|Overall Study|Lost to Follow-up|13|||
164156219|NCT04383327|592935569|FG008|Overall Study|Lost to Follow-up|78|||
164156220|NCT04383327|592935570|FG009|Overall Study|Lost to Follow-up|10|||
164156221|NCT04383327|592935571|FG010|Overall Study|Lost to Follow-up|160|||
164156222|NCT04383327|592935572|FG011|Overall Study|Lost to Follow-up|13|||
164156223|NCT04837196|592935573|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
164156224|NCT04837196|592935574|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
164156225|NCT04837196|592935575|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
164156226|NCT04837196|592935576|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
164156227|NCT04837196|592935577|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
164156228|NCT04837196|592935573|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
164156229|NCT04837196|592935574|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
164156230|NCT04837196|592935575|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
164156231|NCT04837196|592935576|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
164156232|NCT04837196|592935577|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
164156233|NCT04837196|592935573|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
164156234|NCT04837196|592935574|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
164156235|NCT04837196|592935575|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
164156236|NCT04837196|592935576|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
164156237|NCT04837196|592935577|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
164156238|NCT04837196|592935573|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
164156239|NCT04837196|592935574|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
164156240|NCT04837196|592935575|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
164156241|NCT04837196|592935576|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
164156242|NCT04837196|592935577|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
164156243|NCT04837196|592935573|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
164156244|NCT04837196|592935574|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
164156245|NCT04837196|592935575|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
164156246|NCT04837196|592935576|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
164156247|NCT04837196|592935577|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
164156248|NCT00991887|592935578|FG000|Overall Study|Lost to Follow-up|2|||
164156249|NCT00991887|592935579|FG001|Overall Study|Lost to Follow-up|1|||
164156250|NCT01306305|592935580|FG000|Overall Study|Lost to Follow-up|1|||
164156251|NCT01306305|592935581|FG001|Overall Study|Lost to Follow-up|0|||
164156252|NCT01306305|592935580|FG000|Overall Study|Withdrew consent|1|||
164156253|NCT01306305|592935581|FG001|Overall Study|Withdrew consent|0|||
164156254|NCT04030299|592935582|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
164156255|NCT04030299|592935582|FG000|Overall Study|Withdrawal by Subject|3|||
164156256|NCT01964976|592935583|FG000|Overall Study|Protocol Violation|31|||
164156257|NCT00699998|592935584|FG000|Overall Study|Withdrawal by Subject|194|||
164156258|NCT00699998|592935585|FG001|Overall Study|Withdrawal by Subject|83|||
164156259|NCT00699998|592935586|FG002|Overall Study|Withdrawal by Subject|202|||
164156260|NCT00699998|592935587|FG003|Overall Study|Withdrawal by Subject|80|||
164156261|NCT00699998|592935584|FG000|Overall Study|Physician Decision|3|||
164156262|NCT00699998|592935585|FG001|Overall Study|Physician Decision|2|||
164156263|NCT00699998|592935586|FG002|Overall Study|Physician Decision|1|||
164156264|NCT00699998|592935587|FG003|Overall Study|Physician Decision|1|||
164156265|NCT00699998|592935584|FG000|Overall Study|Lost to Follow-up|2|||
164156266|NCT00699998|592935585|FG001|Overall Study|Lost to Follow-up|1|||
164156267|NCT00699998|592935586|FG002|Overall Study|Lost to Follow-up|3|||
164156268|NCT00699998|592935587|FG003|Overall Study|Lost to Follow-up|1|||
164156269|NCT04616612|592935594|FG000|Overall Study|Lost to Follow-up|6|||
164156270|NCT04616612|592935595|FG001|Overall Study|Lost to Follow-up|3|||
164156271|NCT04740918|592935598|FG000|Overall Study|Study Terminated by Sponsor|41|||
164156272|NCT04740918|592935599|FG001|Overall Study|Study Terminated by Sponsor|32|||
164156273|NCT04740918|592935598|FG000|Overall Study|Death|3|||
164156275|NCT04740918|592935598|FG000|Overall Study|Withdrawal by Subject|5|||
164156276|NCT04740918|592935599|FG001|Overall Study|Withdrawal by Subject|4|||
164156277|NCT04740918|592935598|FG000|Overall Study|Lost to Follow-up|1|||
164156278|NCT04740918|592935599|FG001|Overall Study|Lost to Follow-up|3|||
164156279|NCT04740918|592935598|FG000|Overall Study|Progressive disease|0|||
164156280|NCT04740918|592935599|FG001|Overall Study|Progressive disease|1|||
164156281|NCT01256879|592935602|FG000|Overall Study|Withdrawal by Subject|1|||
164156282|NCT00725920|592935603|FG000|Overall Study|Lack of Efficacy|3|||
164156283|NCT00725920|592935604|FG001|Overall Study|Lack of Efficacy|6|||
164156284|NCT01288079|592935605|FG000|Overall Study|Withdrawal by Subject|2|||
164156285|NCT01288079|592935606|FG001|Overall Study|Withdrawal by Subject|4|||
164156286|NCT01288079|592935607|FG002|Overall Study|Withdrawal by Subject|1|||
164156287|NCT01288079|592935608|FG003|Overall Study|Withdrawal by Subject|0|||
164156288|NCT01288079|592935605|FG000|Overall Study|Adverse Event|2|||
164156289|NCT01288079|592935606|FG001|Overall Study|Adverse Event|1|||
164156290|NCT01288079|592935607|FG002|Overall Study|Adverse Event|2|||
164156291|NCT01288079|592935608|FG003|Overall Study|Adverse Event|3|||
164156292|NCT01288079|592935605|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
164156293|NCT01288079|592935606|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
164156294|NCT01288079|592935607|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
164156295|NCT01288079|592935608|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
164156296|NCT01288079|592935605|FG000|Overall Study|Condition under Investigation Worsened|0|||
164156297|NCT01288079|592935606|FG001|Overall Study|Condition under Investigation Worsened|0|||
164156298|NCT01288079|592935607|FG002|Overall Study|Condition under Investigation Worsened|0|||
164156299|NCT01288079|592935608|FG003|Overall Study|Condition under Investigation Worsened|1|||
164156300|NCT01288079|592935605|FG000|Overall Study|Lack of Efficacy|2|||
164156301|NCT01288079|592935606|FG001|Overall Study|Lack of Efficacy|2|||
164156302|NCT01288079|592935607|FG002|Overall Study|Lack of Efficacy|0|||
164156303|NCT01288079|592935608|FG003|Overall Study|Lack of Efficacy|2|||
164156304|NCT01288079|592935605|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
164156305|NCT01288079|592935606|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
164156306|NCT01288079|592935607|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
164156307|NCT01288079|592935608|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
164156308|NCT01288079|592935605|FG000|Overall Study|Lost to Follow-up|1|||
164156309|NCT01288079|592935606|FG001|Overall Study|Lost to Follow-up|1|||
164156310|NCT01288079|592935607|FG002|Overall Study|Lost to Follow-up|1|||
164156311|NCT01288079|592935608|FG003|Overall Study|Lost to Follow-up|0|||
164156312|NCT01288079|592935605|FG000|Overall Study|Other or Study Termination|11|||
164156313|NCT01288079|592935606|FG001|Overall Study|Other or Study Termination|15|||
164156314|NCT01288079|592935607|FG002|Overall Study|Other or Study Termination|14|||
164156315|NCT01288079|592935608|FG003|Overall Study|Other or Study Termination|8|||
164156316|NCT03170544|592935609|FG000|Part 1|Lost to Follow-up|1|||
164156317|NCT03170544|592935610|FG001|Part 1|Lost to Follow-up|0|||
164156318|NCT03170544|592935611|FG002|Part 1|Lost to Follow-up|0|||
164156319|NCT03170544|592935612|FG003|Part 1|Lost to Follow-up|0|||
164156320|NCT03170544|592935613|FG004|Part 1|Lost to Follow-up|0|||
164156321|NCT03170544|592935614|FG005|Part 1|Lost to Follow-up|0|||
164156322|NCT03170544|592935615|FG006|Part 1|Lost to Follow-up|0|||
164156323|NCT03170544|592935616|FG007|Part 1|Lost to Follow-up|0|||
164156324|NCT03170544|592935617|FG008|Part 1|Lost to Follow-up|0|||
164156325|NCT03170544|592935618|FG009|Part 1|Lost to Follow-up|0|||
164156326|NCT03170544|592935619|FG010|Part 1|Lost to Follow-up|0|||
164156327|NCT03170544|592935620|FG011|Part 1|Lost to Follow-up|0|||
164156328|NCT03170544|592935609|FG000|Part 1|Not treated|0|||
164156329|NCT03170544|592935610|FG001|Part 1|Not treated|0|||
164156330|NCT03170544|592935611|FG002|Part 1|Not treated|0|||
164156331|NCT03170544|592935612|FG003|Part 1|Not treated|1|||
164156332|NCT03170544|592935613|FG004|Part 1|Not treated|0|||
164156333|NCT03170544|592935614|FG005|Part 1|Not treated|0|||
164156334|NCT03170544|592935615|FG006|Part 1|Not treated|0|||
164156335|NCT03170544|592935616|FG007|Part 1|Not treated|0|||
164156336|NCT03170544|592935617|FG008|Part 1|Not treated|0|||
164156337|NCT03170544|592935618|FG009|Part 1|Not treated|0|||
164156338|NCT03170544|592935619|FG010|Part 1|Not treated|0|||
164156339|NCT03170544|592935620|FG011|Part 1|Not treated|0|||
164156340|NCT02387840|592935621|FG000|Overall Study|Death|0|||
164156341|NCT02387840|592935622|FG001|Overall Study|Death|0|||
164156342|NCT02387840|592935623|FG002|Overall Study|Death|0|||
164156343|NCT02387840|592935624|FG003|Overall Study|Death|0|||
164156344|NCT02387840|592935625|FG004|Overall Study|Death|0|||
164156345|NCT02387840|592935626|FG005|Overall Study|Death|1|||
164156346|NCT01213966|592935627|FG000|Overall Study|Protocol Violation|1|||
164156347|NCT01213966|592935628|FG001|Overall Study|Protocol Violation|0|||
164156348|NCT01213966|592935629|FG002|Overall Study|Protocol Violation|3|||
164156349|NCT01213966|592935630|FG003|Overall Study|Protocol Violation|1|||
164156350|NCT00420420|592935646|FG000|Overall Study|Adverse Event|5|||
164156351|NCT00420420|592935647|FG001|Overall Study|Adverse Event|3|||
164156352|NCT00420420|592935646|FG000|Overall Study|Protocol Violation|1|||
164156353|NCT00420420|592935647|FG001|Overall Study|Protocol Violation|1|||
164156354|NCT00420420|592935646|FG000|Overall Study|Withdrawal by Subject|1|||
164156355|NCT00420420|592935647|FG001|Overall Study|Withdrawal by Subject|0|||
164156356|NCT00420420|592935646|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
164156357|NCT00420420|592935647|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
164156358|NCT00273182|592935648|FG000|Overall Study|Death|450|||
164156359|NCT00273182|592935648|FG000|Overall Study|Lost to Follow-up|88|||
164156360|NCT00273182|592935648|FG000|Overall Study|Withdrawal by Subject|257|||
164156361|NCT00273182|592935648|FG000|Overall Study|Device/System Explant|154|||
164156362|NCT00273182|592935648|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
164156363|NCT00359424|592935649|FG000|Overall Study|Death|99|||
164156364|NCT00359424|592935650|FG001|Overall Study|Death|58|||
164156365|NCT00359424|592935649|FG000|Overall Study|Lost to Follow-up|19|||
164156366|NCT00359424|592935650|FG001|Overall Study|Lost to Follow-up|7|||
164156367|NCT00359424|592935649|FG000|Overall Study|Withdrawal by Subject|10|||
164156368|NCT00359424|592935650|FG001|Overall Study|Withdrawal by Subject|2|||
164156369|NCT00359424|592935649|FG000|Overall Study|follow up not conducted|2|||
164156370|NCT00359424|592935650|FG001|Overall Study|follow up not conducted|0|||
164156371|NCT01609790|592935654|FG000|Overall Study|Protocol Violation|1|||
164156372|NCT01609790|592935655|FG001|Overall Study|Protocol Violation|7|||
164156373|NCT01609790|592935656|FG002|Overall Study|Protocol Violation|8|||
164156374|NCT03760744|592937928|FG000|Overall Study|Lost to Follow-up|3|||
164156375|NCT03760744|592937929|FG001|Overall Study|Lost to Follow-up|0|||
164156376|NCT05207865|592937930|FG000|Open-Label Treatment Phase|Adverse Event|7|||
164156377|NCT05207865|592937930|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
164156378|NCT05207865|592937930|FG000|Open-Label Treatment Phase|Non-compliance|3|||
164156379|NCT05207865|592937930|FG000|Open-Label Treatment Phase|Other|17|||
164156380|NCT05207865|592937930|FG000|Open-Label Treatment Phase|Physician Decision|2|||
164156381|NCT05207865|592937930|FG000|Open-Label Treatment Phase|Pregnancy|1|||
164156382|NCT05207865|592937930|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
164156383|NCT05207865|592937930|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
164156384|NCT05207865|592937930|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
164156385|NCT05207865|592937930|FG000|Follow-up Phase|Lost to Follow-up|1|||
164156386|NCT05207865|592937930|FG000|Follow-up Phase|Non-compliance|1|||
164156387|NCT05207865|592937930|FG000|Follow-up Phase|Not reported|2|||
164156388|NCT05207865|592937930|FG000|Follow-up Phase|Not collected|11|||
164156389|NCT00739882|592937931|FG000|Double-blind Period|Adverse Event|1|||
164156390|NCT00739882|592937932|FG001|Double-blind Period|Adverse Event|2|||
164156391|NCT00739882|592937931|FG000|Double-blind Period|Protocol Violation|1|||
164156392|NCT00739882|592937932|FG001|Double-blind Period|Protocol Violation|0|||
164156393|NCT00739882|592937931|FG000|Double-blind Period|Lack of Efficacy|1|||
164156394|NCT00739882|592937932|FG001|Double-blind Period|Lack of Efficacy|1|||
164156395|NCT00739882|592937931|FG000|Double-blind Period|Other|16|||
164156396|NCT00739882|592937932|FG001|Double-blind Period|Other|8|||
164156397|NCT00739882|592937931|FG000|Open-label Period|Adverse Event|1|||
164156398|NCT00739882|592937932|FG001|Open-label Period|Adverse Event|0|||
164156399|NCT00739882|592937931|FG000|Open-label Period|Other|9|||
164156400|NCT00739882|592937932|FG001|Open-label Period|Other|5|||
164156401|NCT03055338|592937935|FG000|Overall Study|Lost to Follow-up|9|||
164156402|NCT03055338|592937936|FG001|Overall Study|Lost to Follow-up|2|||
164156403|NCT03055338|592937937|FG002|Overall Study|Lost to Follow-up|3|||
164156404|NCT03055338|592937935|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
164156405|NCT03055338|592937936|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
164156406|NCT03055338|592937937|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
164156407|NCT03055338|592937935|FG000|Overall Study|Physician Decision|0|||
164156408|NCT03055338|592937936|FG001|Overall Study|Physician Decision|0|||
164156409|NCT03055338|592937937|FG002|Overall Study|Physician Decision|2|||
164156410|NCT03055338|592937935|FG000|Overall Study|Withdrawal by Subject|9|||
164156411|NCT03055338|592937936|FG001|Overall Study|Withdrawal by Subject|8|||
164156412|NCT03055338|592937937|FG002|Overall Study|Withdrawal by Subject|7|||
164156413|NCT00975611|592937938|FG000|Overall Study|Screen Fail|16|||
164156414|NCT00975611|592937938|FG000|Overall Study|Physician Decision|1|||
164156415|NCT03058705|592937939|FG000|Overall Study|Withdrawal by Subject|2|||
164156416|NCT03058705|592937939|FG000|Overall Study|Physician Decision|2|||
164156417|NCT01880554|592937940|FG000|Overall Study|Protocol Violation|14|||
164156418|NCT01880554|592937940|FG000|Overall Study|Simon's design requirements|2|||
164156419|NCT01415518|592937941|FG000|Overall Study|Withdrawal by Subject|2|||
164156420|NCT01415518|592937942|FG001|Overall Study|Withdrawal by Subject|12|||
164156421|NCT01415518|592937941|FG000|Overall Study|Protocol Violation|6|||
164156422|NCT01415518|592937942|FG001|Overall Study|Protocol Violation|8|||
164156423|NCT01415518|592937941|FG000|Overall Study|Lost to Follow-up|3|||
164156424|NCT01415518|592937942|FG001|Overall Study|Lost to Follow-up|5|||
164156425|NCT01415518|592937941|FG000|Overall Study|Adverse Event|3|||
164156426|NCT01415518|592937942|FG001|Overall Study|Adverse Event|4|||
164156427|NCT01415518|592937941|FG000|Overall Study|Death|1|||
164156428|NCT01415518|592937942|FG001|Overall Study|Death|1|||
164156429|NCT01415518|592937941|FG000|Overall Study|Condition under Investigation Worsened|1|||
164156430|NCT01415518|592937942|FG001|Overall Study|Condition under Investigation Worsened|1|||
164156431|NCT01102257|592937950|FG000|Overall Study|Adverse Event|1|||
164156432|NCT01102257|592937951|FG001|Overall Study|Adverse Event|0|||
164156433|NCT01102257|592937950|FG000|Overall Study|Adverse Event|1|||
164156434|NCT01102257|592937951|FG001|Overall Study|Adverse Event|0|||
164156435|NCT03752970|592937952|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
164156436|NCT03752970|592937953|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
164156437|NCT03752970|592937954|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
164156438|NCT03752970|592937952|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
164156439|NCT03752970|592937953|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
164156440|NCT03752970|592937954|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
164156441|NCT03752970|592937952|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
164156442|NCT03752970|592937953|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
164156443|NCT03752970|592937954|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
164156444|NCT03752970|592937952|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
164156445|NCT03752970|592937953|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
164156446|NCT03752970|592937954|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
164156447|NCT03752970|592937952|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
164156448|NCT03752970|592937953|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
164156449|NCT03752970|592937954|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
164156450|NCT03976362|592937955|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
164156451|NCT03976362|592937956|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
164156452|NCT03976362|592937957|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
164156453|NCT03976362|592937955|FG000|Induction Phase|Death|62|||
164156454|NCT03976362|592937956|FG001|Induction Phase|Death|0|||
164156455|NCT03976362|592937957|FG002|Induction Phase|Death|0|||
164156456|NCT03976362|592937955|FG000|Maintenance Phase|Participants Ongoing|0|||
164156457|NCT03976362|592937956|FG001|Maintenance Phase|Participants Ongoing|106|||
164156458|NCT03976362|592937957|FG002|Maintenance Phase|Participants Ongoing|103|||
164156459|NCT03976362|592937955|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164156460|NCT03976362|592937956|FG001|Maintenance Phase|Withdrawal by Subject|4|||
164156461|NCT03976362|592937957|FG002|Maintenance Phase|Withdrawal by Subject|4|||
164156462|NCT03976362|592937955|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
164156463|NCT03976362|592937956|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
164156464|NCT03976362|592937957|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
164156465|NCT03976362|592937955|FG000|Maintenance Phase|Death|0|||
164156466|NCT03976362|592937956|FG001|Maintenance Phase|Death|186|||
164156467|NCT03976362|592937957|FG002|Maintenance Phase|Death|187|||
164156468|NCT04767282|592937958|FG000|Overall Study|Refused or did not begin surveys|6|||
164156469|NCT04767282|592937959|FG001|Overall Study|Refused or did not begin surveys|2|||
164156470|NCT04767282|592937960|FG002|Overall Study|Refused or did not begin surveys|2|||
164156471|NCT04767282|592937958|FG000|Overall Study|Duplicate household previously enrolled|2|||
164156472|NCT04767282|592937959|FG001|Overall Study|Duplicate household previously enrolled|0|||
164156473|NCT04767282|592937960|FG002|Overall Study|Duplicate household previously enrolled|8|||
164156474|NCT04767282|592937958|FG000|Overall Study|Unable to confirm legal guardian|0|||
164156475|NCT04767282|592937959|FG001|Overall Study|Unable to confirm legal guardian|2|||
164156476|NCT04767282|592937960|FG002|Overall Study|Unable to confirm legal guardian|8|||
164156477|NCT04767282|592937958|FG000|Overall Study|Withdrawal by Subject|0|||
164156478|NCT04767282|592937959|FG001|Overall Study|Withdrawal by Subject|0|||
164156479|NCT04767282|592937960|FG002|Overall Study|Withdrawal by Subject|6|||
164156480|NCT04767282|592937958|FG000|Overall Study|Survey comprehension challenges|4|||
164156481|NCT04767282|592937959|FG001|Overall Study|Survey comprehension challenges|0|||
164156482|NCT04767282|592937960|FG002|Overall Study|Survey comprehension challenges|0|||
164156483|NCT01467713|592937962|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
164156484|NCT01467713|592937963|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
164156485|NCT01467713|592937964|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
164156486|NCT01467713|592937965|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
164156487|NCT01467713|592937962|FG000|Overall Study|Major Protocol Deviation|2|||
164156488|NCT01467713|592937963|FG001|Overall Study|Major Protocol Deviation|4|||
164156489|NCT01467713|592937964|FG002|Overall Study|Major Protocol Deviation|4|||
164156490|NCT01467713|592937965|FG003|Overall Study|Major Protocol Deviation|1|||
164156491|NCT01467713|592937962|FG000|Overall Study|Lost to Follow-up|9|||
164156492|NCT01467713|592937963|FG001|Overall Study|Lost to Follow-up|12|||
164156493|NCT01467713|592937964|FG002|Overall Study|Lost to Follow-up|6|||
164156494|NCT01467713|592937965|FG003|Overall Study|Lost to Follow-up|9|||
164156495|NCT01467713|592937962|FG000|Overall Study|Voluntary Withdrawal|18|||
164156496|NCT01467713|592937963|FG001|Overall Study|Voluntary Withdrawal|14|||
164156497|NCT01467713|592937964|FG002|Overall Study|Voluntary Withdrawal|21|||
164156498|NCT01467713|592937965|FG003|Overall Study|Voluntary Withdrawal|20|||
164156499|NCT01467713|592937962|FG000|Overall Study|Study Termination|23|||
164156500|NCT01467713|592937963|FG001|Overall Study|Study Termination|33|||
164156501|NCT01467713|592937964|FG002|Overall Study|Study Termination|28|||
164156502|NCT01467713|592937965|FG003|Overall Study|Study Termination|29|||
164156503|NCT01467713|592937962|FG000|Overall Study|Pregnancy|0|||
164156504|NCT01467713|592937963|FG001|Overall Study|Pregnancy|1|||
164156505|NCT01467713|592937964|FG002|Overall Study|Pregnancy|1|||
164156506|NCT01467713|592937965|FG003|Overall Study|Pregnancy|3|||
164156507|NCT01467713|592937962|FG000|Overall Study|Relapse|35|||
164156508|NCT01467713|592937963|FG001|Overall Study|Relapse|25|||
164156509|NCT01467713|592937964|FG002|Overall Study|Relapse|28|||
164156510|NCT01467713|592937965|FG003|Overall Study|Relapse|35|||
164156511|NCT01467713|592937962|FG000|Overall Study|Reason not Specified|6|||
164156512|NCT01467713|592937963|FG001|Overall Study|Reason not Specified|11|||
164156513|NCT01467713|592937964|FG002|Overall Study|Reason not Specified|8|||
164156514|NCT01467713|592937965|FG003|Overall Study|Reason not Specified|7|||
164156515|NCT04846569|592937966|FG000|Overall Study|Withdrawal by Subject|3|||
164156516|NCT04846569|592937967|FG001|Overall Study|Withdrawal by Subject|1|||
164156517|NCT02525783|592937968|FG000|Overall Study|Lost to Follow-up|10|||
164156518|NCT02512302|592937969|FG000|Period 1|Adverse Event|0|||
164156519|NCT02512302|592937970|FG001|Period 1|Adverse Event|1|||
164156520|NCT02512302|592937971|FG002|Period 1|Adverse Event|0|||
164156521|NCT02512302|592937972|FG003|Period 1|Adverse Event|0|||
164156522|NCT02512302|592937973|FG004|Period 1|Adverse Event|0|||
164156523|NCT02512302|592937974|FG005|Period 1|Adverse Event|0|||
164156524|NCT02512302|592937975|FG006|Period 1|Adverse Event|0|||
164156525|NCT02512302|592937976|FG007|Period 1|Adverse Event|0|||
164156526|NCT02512302|592937977|FG008|Period 1|Adverse Event|0|||
164156527|NCT02512302|592937978|FG009|Period 1|Adverse Event|0|||
164156528|NCT02512302|592937969|FG000|Period 2|Adverse Event|0|||
164156529|NCT02512302|592937970|FG001|Period 2|Adverse Event|0|||
164156530|NCT02512302|592937971|FG002|Period 2|Adverse Event|0|||
164156531|NCT02512302|592937972|FG003|Period 2|Adverse Event|0|||
164156532|NCT02512302|592937973|FG004|Period 2|Adverse Event|0|||
164156533|NCT02512302|592937974|FG005|Period 2|Adverse Event|0|||
164156534|NCT02512302|592937975|FG006|Period 2|Adverse Event|0|||
164156535|NCT02512302|592937976|FG007|Period 2|Adverse Event|0|||
164156536|NCT02512302|592937977|FG008|Period 2|Adverse Event|0|||
164156537|NCT02512302|592937978|FG009|Period 2|Adverse Event|1|||
164156538|NCT02512302|592937969|FG000|Period 3|Lost to Follow-up|0|||
164156539|NCT02512302|592937970|FG001|Period 3|Lost to Follow-up|0|||
164156540|NCT02512302|592937971|FG002|Period 3|Lost to Follow-up|1|||
164156541|NCT02512302|592937972|FG003|Period 3|Lost to Follow-up|0|||
164156542|NCT02512302|592937973|FG004|Period 3|Lost to Follow-up|0|||
164156543|NCT02512302|592937974|FG005|Period 3|Lost to Follow-up|0|||
164156544|NCT02512302|592937975|FG006|Period 3|Lost to Follow-up|0|||
164156545|NCT02512302|592937976|FG007|Period 3|Lost to Follow-up|0|||
164156546|NCT02512302|592937977|FG008|Period 3|Lost to Follow-up|0|||
164156547|NCT02512302|592937978|FG009|Period 3|Lost to Follow-up|0|||
164156548|NCT02512302|592937969|FG000|Period 4|Adverse Event|0|||
164156549|NCT02512302|592937970|FG001|Period 4|Adverse Event|0|||
164156550|NCT02512302|592937971|FG002|Period 4|Adverse Event|0|||
164156551|NCT02512302|592937972|FG003|Period 4|Adverse Event|0|||
164156552|NCT02512302|592937973|FG004|Period 4|Adverse Event|0|||
164156553|NCT02512302|592937974|FG005|Period 4|Adverse Event|0|||
164156554|NCT02512302|592937975|FG006|Period 4|Adverse Event|1|||
164156555|NCT02512302|592937976|FG007|Period 4|Adverse Event|0|||
164156556|NCT02512302|592937977|FG008|Period 4|Adverse Event|0|||
164156557|NCT02512302|592937978|FG009|Period 4|Adverse Event|0|||
164156558|NCT01735916|592937989|FG000|Overall Study|Subject not eligible to be randomized|11|||
164156559|NCT01735916|592937990|FG001|Overall Study|Subject not eligible to be randomized|0|||
164156560|NCT01735916|592937991|FG002|Overall Study|Subject not eligible to be randomized|0|||
164156561|NCT01735916|592937989|FG000|Overall Study|Early termination of study by sponsor|4|||
164156562|NCT01735916|592937990|FG001|Overall Study|Early termination of study by sponsor|19|||
164156563|NCT01735916|592937991|FG002|Overall Study|Early termination of study by sponsor|7|||
164156564|NCT01735916|592937989|FG000|Overall Study|Withdrawal by Subject|3|||
164156565|NCT01735916|592937990|FG001|Overall Study|Withdrawal by Subject|0|||
164156566|NCT01735916|592937991|FG002|Overall Study|Withdrawal by Subject|0|||
164156567|NCT05177484|592937997|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
164156568|NCT05177484|592937998|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
164156569|NCT05177484|592937997|FG000|Overall Study|Inadvertently withdrawn|3|||
164156570|NCT05177484|592937998|FG001|Overall Study|Inadvertently withdrawn|1|||
164156571|NCT05177484|592937997|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
164156572|NCT05177484|592937998|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
164156573|NCT01379768|592937999|FG000|Overall Study|Adverse Event|1|||
164156574|NCT01379768|592938000|FG001|Overall Study|Adverse Event|1|||
164156575|NCT01379768|592938001|FG002|Overall Study|Adverse Event|0|||
164156576|NCT01379768|592937999|FG000|Overall Study|Lost to Follow-up|2|||
164156577|NCT01379768|592938000|FG001|Overall Study|Lost to Follow-up|0|||
164156578|NCT01379768|592938001|FG002|Overall Study|Lost to Follow-up|0|||
164156579|NCT03334435|592938006|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
164156580|NCT03334435|592938007|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
164156581|NCT03334435|592938008|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
164156582|NCT03334435|592938009|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
164156583|NCT03334435|592938010|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
164156584|NCT03334435|592938011|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
164156585|NCT03334435|592938012|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
164156586|NCT03334435|592938013|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
164156587|NCT03334435|592938014|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
164156588|NCT03334435|592938015|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
164156589|NCT03334435|592938016|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
164156590|NCT03334435|592938017|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
164156591|NCT03334435|592938018|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
164156592|NCT03334435|592938019|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
164156593|NCT03334435|592938020|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
164156594|NCT03334435|592938006|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
164156595|NCT03334435|592938007|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
164156596|NCT03334435|592938008|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
164156597|NCT03334435|592938009|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
164156598|NCT03334435|592938010|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
164156599|NCT03334435|592938011|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
164156600|NCT03334435|592938012|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
164156601|NCT03334435|592938013|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
164156602|NCT03334435|592938014|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
164156603|NCT03334435|592938015|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
164156604|NCT03334435|592938016|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
164156605|NCT03334435|592938017|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
164156606|NCT03334435|592938018|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
164156607|NCT03334435|592938019|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
164156608|NCT03334435|592938020|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
164156609|NCT03334435|592938006|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
164156610|NCT03334435|592938007|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
164156611|NCT03334435|592938008|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
164156612|NCT03334435|592938009|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
164156613|NCT03334435|592938010|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
164156614|NCT03334435|592938011|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
164156615|NCT03334435|592938012|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
164156616|NCT03334435|592938013|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
164156617|NCT03334435|592938014|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
164156618|NCT03334435|592938015|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
164156619|NCT03334435|592938016|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
164156620|NCT03334435|592938017|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
164156621|NCT03334435|592938018|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
164156622|NCT03334435|592938019|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
164156623|NCT03334435|592938020|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
164156624|NCT03334435|592938006|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
164156625|NCT03334435|592938007|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
164156626|NCT03334435|592938008|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
164156627|NCT03334435|592938009|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
164156628|NCT03334435|592938010|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
164156629|NCT03334435|592938011|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
164156630|NCT03334435|592938012|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
164156631|NCT03334435|592938013|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
164156632|NCT03334435|592938014|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
164156633|NCT03334435|592938015|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
164156634|NCT03334435|592938016|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
164156635|NCT03334435|592938017|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
164156636|NCT03334435|592938018|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
164156637|NCT03334435|592938019|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
164156638|NCT03334435|592938020|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
164156639|NCT03334435|592938006|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
164156640|NCT03334435|592938007|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
164156641|NCT03334435|592938008|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
164156642|NCT03334435|592938009|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
164156643|NCT03334435|592938010|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
164156644|NCT03334435|592938011|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
164156645|NCT03334435|592938012|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
164156646|NCT03334435|592938013|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
164156647|NCT03334435|592938014|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
164156648|NCT03334435|592938015|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
164156649|NCT03334435|592938016|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
164156650|NCT03334435|592938017|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
164156651|NCT03334435|592938018|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
164156652|NCT03334435|592938019|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
164156653|NCT03334435|592938020|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
164156654|NCT03334435|592938006|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156655|NCT03334435|592938007|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156656|NCT03334435|592938008|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156657|NCT03334435|592938009|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
164156658|NCT03334435|592938010|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156659|NCT03334435|592938011|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156660|NCT03334435|592938012|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156661|NCT03334435|592938013|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156662|NCT03334435|592938014|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156663|NCT03334435|592938015|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156664|NCT03334435|592938016|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156665|NCT03334435|592938017|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156666|NCT03334435|592938018|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156667|NCT03334435|592938019|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156668|NCT03334435|592938020|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156669|NCT03334435|592938006|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
164156670|NCT03334435|592938007|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
164156671|NCT03334435|592938008|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
164156672|NCT03334435|592938009|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
164156673|NCT03334435|592938010|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
164156674|NCT03334435|592938011|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
164156675|NCT03334435|592938012|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
164156676|NCT03334435|592938013|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
164156677|NCT03334435|592938014|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
164156678|NCT03334435|592938015|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
164156679|NCT03334435|592938016|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
164156680|NCT03334435|592938017|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
164156681|NCT03334435|592938018|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
164156682|NCT03334435|592938019|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
164156683|NCT03334435|592938020|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
164156684|NCT03334435|592938006|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
164156685|NCT03334435|592938007|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
164156686|NCT03334435|592938008|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
164156687|NCT03334435|592938009|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
164156688|NCT03334435|592938010|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
164156689|NCT03334435|592938011|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
164156690|NCT03334435|592938012|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
164156691|NCT03334435|592938013|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
164156692|NCT03334435|592938014|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
164156693|NCT03334435|592938015|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
164156694|NCT03334435|592938016|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
164156695|NCT03334435|592938017|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
164156696|NCT03334435|592938018|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
164156697|NCT03334435|592938019|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
164156698|NCT03334435|592938020|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
164156699|NCT03334435|592938006|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
164156700|NCT03334435|592938007|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
164156701|NCT03334435|592938008|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
164156702|NCT03334435|592938009|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
164156703|NCT03334435|592938010|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
164156906|NCT00460603|592938029|FG004|Phase 1|Withdrawal by Subject|3|||
164156704|NCT03334435|592938011|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
164156705|NCT03334435|592938012|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
164156706|NCT03334435|592938013|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
164156707|NCT03334435|592938014|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
164156708|NCT03334435|592938015|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
164156709|NCT03334435|592938016|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
164156710|NCT03334435|592938017|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
164156711|NCT03334435|592938018|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
164156712|NCT03334435|592938019|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
164156713|NCT03334435|592938020|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
164156714|NCT03334435|592938006|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
164156715|NCT03334435|592938007|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
164156716|NCT03334435|592938008|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
164156717|NCT03334435|592938009|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
164156718|NCT03334435|592938010|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
164156719|NCT03334435|592938011|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
164156720|NCT03334435|592938012|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
164156721|NCT03334435|592938013|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
164156722|NCT03334435|592938014|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
164156723|NCT03334435|592938015|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
164156724|NCT03334435|592938016|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
164156725|NCT03334435|592938017|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
164156726|NCT03334435|592938018|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
164156727|NCT03334435|592938019|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
164156728|NCT03334435|592938020|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
164156729|NCT03334435|592938006|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
164156730|NCT03334435|592938007|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
164156731|NCT03334435|592938008|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
164156732|NCT03334435|592938009|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
164156733|NCT03334435|592938010|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
164156734|NCT03334435|592938011|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
164156735|NCT03334435|592938012|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
164156736|NCT03334435|592938013|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
164156737|NCT03334435|592938014|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
164156738|NCT03334435|592938015|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
164156739|NCT03334435|592938016|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
164156740|NCT03334435|592938017|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
164156741|NCT03334435|592938018|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
164156742|NCT03334435|592938019|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
164156743|NCT03334435|592938020|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
164156744|NCT03334435|592938006|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
164156745|NCT03334435|592938007|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
164156746|NCT03334435|592938008|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
164156747|NCT03334435|592938009|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
164156748|NCT03334435|592938010|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
164156749|NCT03334435|592938011|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
164156750|NCT03334435|592938012|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
164156751|NCT03334435|592938013|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
164156752|NCT03334435|592938014|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
164156753|NCT03334435|592938015|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
164156754|NCT03334435|592938016|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
164156755|NCT03334435|592938017|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
164156756|NCT03334435|592938018|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
164156757|NCT03334435|592938019|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
164156758|NCT03334435|592938020|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
164156759|NCT03334435|592938006|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156760|NCT03334435|592938007|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156761|NCT03334435|592938008|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156762|NCT03334435|592938009|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156763|NCT03334435|592938010|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156764|NCT03334435|592938011|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156765|NCT03334435|592938012|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156766|NCT03334435|592938013|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156767|NCT03334435|592938014|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156768|NCT03334435|592938015|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156769|NCT03334435|592938016|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156770|NCT03334435|592938017|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
164156771|NCT03334435|592938018|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156772|NCT03334435|592938019|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
164156773|NCT03334435|592938020|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156774|NCT03334435|592938006|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156775|NCT03334435|592938007|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156776|NCT03334435|592938008|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156777|NCT03334435|592938009|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156778|NCT03334435|592938010|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156779|NCT03334435|592938011|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
164156780|NCT03334435|592938012|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156781|NCT03334435|592938013|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156782|NCT03334435|592938014|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156783|NCT03334435|592938015|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156784|NCT03334435|592938016|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156785|NCT03334435|592938017|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156786|NCT03334435|592938018|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156787|NCT03334435|592938019|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156788|NCT03334435|592938020|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
164156789|NCT03334435|592938006|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
164156790|NCT03334435|592938007|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
164156791|NCT03334435|592938008|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
164156792|NCT03334435|592938009|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
164156793|NCT03334435|592938010|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
164156794|NCT03334435|592938011|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
164156795|NCT03334435|592938012|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
164156796|NCT03334435|592938013|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
164156797|NCT03334435|592938014|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
164156798|NCT03334435|592938015|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
164156799|NCT03334435|592938016|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
164156800|NCT03334435|592938017|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
164156801|NCT03334435|592938018|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
164156802|NCT03334435|592938019|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
164156803|NCT03334435|592938020|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
164156804|NCT03334435|592938006|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
164156805|NCT03334435|592938007|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
164156806|NCT03334435|592938008|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
164156807|NCT03334435|592938009|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
164156808|NCT03334435|592938010|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
164156809|NCT03334435|592938011|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
164156810|NCT03334435|592938012|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
164156811|NCT03334435|592938013|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
164156812|NCT03334435|592938014|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
164156813|NCT03334435|592938015|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
164156814|NCT03334435|592938016|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
164156815|NCT03334435|592938017|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
164156816|NCT03334435|592938018|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
164156817|NCT03334435|592938019|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
164156818|NCT03334435|592938020|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
164156819|NCT03334435|592938006|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
164156820|NCT03334435|592938007|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
164156821|NCT03334435|592938008|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
164156822|NCT03334435|592938009|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
164156823|NCT03334435|592938010|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
164156824|NCT03334435|592938011|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
164156825|NCT03334435|592938012|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
164156826|NCT03334435|592938013|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
164156827|NCT03334435|592938014|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
164156828|NCT03334435|592938015|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
164156907|NCT00460603|592938030|FG005|Phase 1|Withdrawal by Subject|0|||
164156829|NCT03334435|592938016|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
164156830|NCT03334435|592938017|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
164156831|NCT03334435|592938018|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
164156832|NCT03334435|592938019|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
164156833|NCT03334435|592938020|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
164156834|NCT03334435|592938006|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
164156835|NCT03334435|592938007|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
164156836|NCT03334435|592938008|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
164156837|NCT03334435|592938009|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
164156838|NCT03334435|592938010|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
164156839|NCT03334435|592938011|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
164156840|NCT03334435|592938012|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
164156841|NCT03334435|592938013|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
164156842|NCT03334435|592938014|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
164156843|NCT03334435|592938015|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
164156844|NCT03334435|592938016|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
164156845|NCT03334435|592938017|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
164156846|NCT03334435|592938018|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
164156847|NCT03334435|592938019|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
164156848|NCT03334435|592938020|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
164156849|NCT03334435|592938006|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
164156850|NCT03334435|592938007|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
164156851|NCT03334435|592938008|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
164156852|NCT03334435|592938009|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
164156853|NCT03334435|592938010|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
164156854|NCT03334435|592938011|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
164156855|NCT03334435|592938012|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
164156856|NCT03334435|592938013|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
164156857|NCT03334435|592938014|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
164156858|NCT03334435|592938015|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
164156859|NCT03334435|592938016|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
164156860|NCT03334435|592938017|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
164156861|NCT03334435|592938018|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
164156862|NCT03334435|592938019|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
164156863|NCT03334435|592938020|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
164156864|NCT03922321|592938021|FG000|Overall Study|Participant Moved|1|||
164156865|NCT03922321|592938021|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
164156866|NCT00460603|592938025|FG000|Phase 1|Death|1|||
164156867|NCT00460603|592938026|FG001|Phase 1|Death|0|||
164156868|NCT00460603|592938027|FG002|Phase 1|Death|0|||
164156869|NCT00460603|592938028|FG003|Phase 1|Death|2|||
164156870|NCT00460603|592938029|FG004|Phase 1|Death|0|||
164156871|NCT00460603|592938030|FG005|Phase 1|Death|0|||
164156872|NCT00460603|592938031|FG006|Phase 1|Death|0|||
164156873|NCT00460603|592938032|FG007|Phase 1|Death|0|||
164156874|NCT00460603|592938033|FG008|Phase 1|Death|1|||
164156875|NCT00460603|592938034|FG009|Phase 1|Death|0|||
164156876|NCT00460603|592938035|FG010|Phase 1|Death|0|||
164156877|NCT00460603|592938036|FG011|Phase 1|Death|0|||
164156878|NCT00460603|592938025|FG000|Phase 1|Adverse Event|3|||
164156879|NCT00460603|592938026|FG001|Phase 1|Adverse Event|1|||
164156880|NCT00460603|592938027|FG002|Phase 1|Adverse Event|1|||
164156881|NCT00460603|592938028|FG003|Phase 1|Adverse Event|2|||
164156882|NCT00460603|592938029|FG004|Phase 1|Adverse Event|0|||
164156883|NCT00460603|592938030|FG005|Phase 1|Adverse Event|0|||
164156884|NCT00460603|592938031|FG006|Phase 1|Adverse Event|3|||
164156885|NCT00460603|592938032|FG007|Phase 1|Adverse Event|0|||
164156886|NCT00460603|592938033|FG008|Phase 1|Adverse Event|4|||
164156887|NCT00460603|592938034|FG009|Phase 1|Adverse Event|0|||
164156888|NCT00460603|592938035|FG010|Phase 1|Adverse Event|0|||
164156889|NCT00460603|592938036|FG011|Phase 1|Adverse Event|0|||
164156890|NCT00460603|592938025|FG000|Phase 1|Lack of Efficacy|1|||
164156891|NCT00460603|592938026|FG001|Phase 1|Lack of Efficacy|0|||
164156892|NCT00460603|592938027|FG002|Phase 1|Lack of Efficacy|1|||
164156893|NCT00460603|592938028|FG003|Phase 1|Lack of Efficacy|2|||
164156894|NCT00460603|592938029|FG004|Phase 1|Lack of Efficacy|2|||
164156895|NCT00460603|592938030|FG005|Phase 1|Lack of Efficacy|2|||
164156896|NCT00460603|592938031|FG006|Phase 1|Lack of Efficacy|2|||
164156897|NCT00460603|592938032|FG007|Phase 1|Lack of Efficacy|2|||
164156898|NCT00460603|592938033|FG008|Phase 1|Lack of Efficacy|11|||
164156899|NCT00460603|592938034|FG009|Phase 1|Lack of Efficacy|0|||
164156900|NCT00460603|592938035|FG010|Phase 1|Lack of Efficacy|0|||
164156901|NCT00460603|592938036|FG011|Phase 1|Lack of Efficacy|0|||
164156902|NCT00460603|592938025|FG000|Phase 1|Withdrawal by Subject|1|||
164156903|NCT00460603|592938026|FG001|Phase 1|Withdrawal by Subject|2|||
164156904|NCT00460603|592938027|FG002|Phase 1|Withdrawal by Subject|1|||
164156905|NCT00460603|592938028|FG003|Phase 1|Withdrawal by Subject|1|||
164156908|NCT00460603|592938031|FG006|Phase 1|Withdrawal by Subject|1|||
164156909|NCT00460603|592938032|FG007|Phase 1|Withdrawal by Subject|0|||
164156910|NCT00460603|592938033|FG008|Phase 1|Withdrawal by Subject|2|||
164156911|NCT00460603|592938034|FG009|Phase 1|Withdrawal by Subject|0|||
164156912|NCT00460603|592938035|FG010|Phase 1|Withdrawal by Subject|0|||
164156913|NCT00460603|592938036|FG011|Phase 1|Withdrawal by Subject|0|||
164156914|NCT00460603|592938025|FG000|Phase 1|Other|0|||
164156915|NCT00460603|592938026|FG001|Phase 1|Other|3|||
164156916|NCT00460603|592938027|FG002|Phase 1|Other|1|||
164156917|NCT00460603|592938028|FG003|Phase 1|Other|1|||
164156918|NCT00460603|592938029|FG004|Phase 1|Other|1|||
164156919|NCT00460603|592938030|FG005|Phase 1|Other|2|||
164156920|NCT00460603|592938031|FG006|Phase 1|Other|0|||
164156921|NCT00460603|592938032|FG007|Phase 1|Other|1|||
164156922|NCT00460603|592938033|FG008|Phase 1|Other|0|||
164156923|NCT00460603|592938034|FG009|Phase 1|Other|0|||
164156924|NCT00460603|592938035|FG010|Phase 1|Other|0|||
164156925|NCT00460603|592938036|FG011|Phase 1|Other|0|||
164156926|NCT00460603|592938025|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
164156927|NCT00460603|592938026|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
164156928|NCT00460603|592938027|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
164156929|NCT00460603|592938028|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
164156930|NCT00460603|592938029|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
164156931|NCT00460603|592938030|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
164156932|NCT00460603|592938031|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
164156933|NCT00460603|592938032|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
164156934|NCT00460603|592938033|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
164156935|NCT00460603|592938034|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
164156936|NCT00460603|592938035|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
164156937|NCT00460603|592938036|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
164156938|NCT00460603|592938025|FG000|Phase 2|Adverse Event|0|||
164156939|NCT00460603|592938026|FG001|Phase 2|Adverse Event|0|||
164156940|NCT00460603|592938027|FG002|Phase 2|Adverse Event|0|||
164156941|NCT00460603|592938028|FG003|Phase 2|Adverse Event|0|||
164156942|NCT00460603|592938029|FG004|Phase 2|Adverse Event|0|||
164156943|NCT00460603|592938030|FG005|Phase 2|Adverse Event|0|||
164156944|NCT00460603|592938031|FG006|Phase 2|Adverse Event|0|||
164156945|NCT00460603|592938032|FG007|Phase 2|Adverse Event|0|||
164156946|NCT00460603|592938033|FG008|Phase 2|Adverse Event|0|||
164156947|NCT00460603|592938034|FG009|Phase 2|Adverse Event|12|||
164156948|NCT00460603|592938035|FG010|Phase 2|Adverse Event|9|||
164156949|NCT00460603|592938036|FG011|Phase 2|Adverse Event|10|||
164156950|NCT00460603|592938025|FG000|Phase 2|Death|0|||
164156951|NCT00460603|592938026|FG001|Phase 2|Death|0|||
164156952|NCT00460603|592938027|FG002|Phase 2|Death|0|||
164156953|NCT00460603|592938028|FG003|Phase 2|Death|0|||
164156954|NCT00460603|592938029|FG004|Phase 2|Death|0|||
164156955|NCT00460603|592938030|FG005|Phase 2|Death|0|||
164156956|NCT00460603|592938031|FG006|Phase 2|Death|0|||
164156957|NCT00460603|592938032|FG007|Phase 2|Death|0|||
164156958|NCT00460603|592938033|FG008|Phase 2|Death|0|||
164156959|NCT00460603|592938034|FG009|Phase 2|Death|4|||
164156960|NCT00460603|592938035|FG010|Phase 2|Death|2|||
164156961|NCT00460603|592938036|FG011|Phase 2|Death|2|||
164156962|NCT00460603|592938025|FG000|Phase 2|Protocol Violation|0|||
164156963|NCT00460603|592938026|FG001|Phase 2|Protocol Violation|0|||
164156964|NCT00460603|592938027|FG002|Phase 2|Protocol Violation|0|||
164156965|NCT00460603|592938028|FG003|Phase 2|Protocol Violation|0|||
164156966|NCT00460603|592938029|FG004|Phase 2|Protocol Violation|0|||
164156967|NCT00460603|592938030|FG005|Phase 2|Protocol Violation|0|||
164156968|NCT00460603|592938031|FG006|Phase 2|Protocol Violation|0|||
164156969|NCT00460603|592938032|FG007|Phase 2|Protocol Violation|0|||
164156970|NCT00460603|592938033|FG008|Phase 2|Protocol Violation|0|||
164156971|NCT00460603|592938034|FG009|Phase 2|Protocol Violation|1|||
164156972|NCT00460603|592938035|FG010|Phase 2|Protocol Violation|1|||
164156973|NCT00460603|592938036|FG011|Phase 2|Protocol Violation|0|||
164156974|NCT00460603|592938025|FG000|Phase 2|Lost to Follow-up|0|||
164156975|NCT00460603|592938026|FG001|Phase 2|Lost to Follow-up|0|||
164156976|NCT00460603|592938027|FG002|Phase 2|Lost to Follow-up|0|||
164156977|NCT00460603|592938028|FG003|Phase 2|Lost to Follow-up|0|||
164156978|NCT00460603|592938029|FG004|Phase 2|Lost to Follow-up|0|||
164156979|NCT00460603|592938030|FG005|Phase 2|Lost to Follow-up|0|||
164156980|NCT00460603|592938031|FG006|Phase 2|Lost to Follow-up|0|||
164156981|NCT00460603|592938032|FG007|Phase 2|Lost to Follow-up|0|||
164156982|NCT00460603|592938033|FG008|Phase 2|Lost to Follow-up|0|||
164156983|NCT00460603|592938034|FG009|Phase 2|Lost to Follow-up|1|||
164156984|NCT00460603|592938035|FG010|Phase 2|Lost to Follow-up|0|||
164156985|NCT00460603|592938036|FG011|Phase 2|Lost to Follow-up|0|||
164156986|NCT00460603|592938025|FG000|Phase 2|Other|0|||
164156987|NCT00460603|592938026|FG001|Phase 2|Other|0|||
164156988|NCT00460603|592938027|FG002|Phase 2|Other|0|||
164156989|NCT00460603|592938028|FG003|Phase 2|Other|0|||
164156990|NCT00460603|592938029|FG004|Phase 2|Other|0|||
164156991|NCT00460603|592938030|FG005|Phase 2|Other|0|||
164156992|NCT00460603|592938031|FG006|Phase 2|Other|0|||
164156993|NCT00460603|592938032|FG007|Phase 2|Other|0|||
164156994|NCT00460603|592938033|FG008|Phase 2|Other|0|||
164156995|NCT00460603|592938034|FG009|Phase 2|Other|6|||
164156996|NCT00460603|592938035|FG010|Phase 2|Other|16|||
164156997|NCT00460603|592938036|FG011|Phase 2|Other|7|||
164156998|NCT00460603|592938025|FG000|Phase 2|Objective Progression or Relapse|0|||
164156999|NCT00460603|592938026|FG001|Phase 2|Objective Progression or Relapse|0|||
164157000|NCT00460603|592938027|FG002|Phase 2|Objective Progression or Relapse|0|||
164157001|NCT00460603|592938028|FG003|Phase 2|Objective Progression or Relapse|0|||
164157002|NCT00460603|592938029|FG004|Phase 2|Objective Progression or Relapse|0|||
164157003|NCT00460603|592938030|FG005|Phase 2|Objective Progression or Relapse|0|||
164157004|NCT00460603|592938031|FG006|Phase 2|Objective Progression or Relapse|0|||
164157005|NCT00460603|592938032|FG007|Phase 2|Objective Progression or Relapse|0|||
164157006|NCT00460603|592938033|FG008|Phase 2|Objective Progression or Relapse|0|||
164157007|NCT00460603|592938034|FG009|Phase 2|Objective Progression or Relapse|9|||
164157008|NCT00460603|592938035|FG010|Phase 2|Objective Progression or Relapse|10|||
164157009|NCT00460603|592938036|FG011|Phase 2|Objective Progression or Relapse|17|||
164157010|NCT00460603|592938025|FG000|Phase 2|Global Deterioration of Health Status|0|||
164157011|NCT00460603|592938026|FG001|Phase 2|Global Deterioration of Health Status|0|||
164157012|NCT00460603|592938027|FG002|Phase 2|Global Deterioration of Health Status|0|||
164157013|NCT00460603|592938028|FG003|Phase 2|Global Deterioration of Health Status|0|||
164157014|NCT00460603|592938029|FG004|Phase 2|Global Deterioration of Health Status|0|||
164157015|NCT00460603|592938030|FG005|Phase 2|Global Deterioration of Health Status|0|||
164157016|NCT00460603|592938031|FG006|Phase 2|Global Deterioration of Health Status|0|||
164157017|NCT00460603|592938032|FG007|Phase 2|Global Deterioration of Health Status|0|||
164157018|NCT00460603|592938033|FG008|Phase 2|Global Deterioration of Health Status|0|||
164157019|NCT00460603|592938034|FG009|Phase 2|Global Deterioration of Health Status|0|||
164157020|NCT00460603|592938035|FG010|Phase 2|Global Deterioration of Health Status|1|||
164157021|NCT00460603|592938036|FG011|Phase 2|Global Deterioration of Health Status|0|||
164157022|NCT00460603|592938025|FG000|Phase 2|Withdrawal by Subject|0|||
164157023|NCT00460603|592938026|FG001|Phase 2|Withdrawal by Subject|0|||
164157024|NCT00460603|592938027|FG002|Phase 2|Withdrawal by Subject|0|||
164157025|NCT00460603|592938028|FG003|Phase 2|Withdrawal by Subject|0|||
164157026|NCT00460603|592938029|FG004|Phase 2|Withdrawal by Subject|0|||
164157027|NCT00460603|592938030|FG005|Phase 2|Withdrawal by Subject|0|||
164157028|NCT00460603|592938031|FG006|Phase 2|Withdrawal by Subject|0|||
164157029|NCT00460603|592938032|FG007|Phase 2|Withdrawal by Subject|0|||
164157030|NCT00460603|592938033|FG008|Phase 2|Withdrawal by Subject|0|||
164157031|NCT00460603|592938034|FG009|Phase 2|Withdrawal by Subject|5|||
164157032|NCT00460603|592938035|FG010|Phase 2|Withdrawal by Subject|4|||
164157033|NCT00460603|592938036|FG011|Phase 2|Withdrawal by Subject|5|||
164157034|NCT00460603|592938025|FG000|Phase 2|Randomized, but not treated|0|||
164157035|NCT00460603|592938026|FG001|Phase 2|Randomized, but not treated|0|||
164157036|NCT00460603|592938027|FG002|Phase 2|Randomized, but not treated|0|||
164157037|NCT00460603|592938028|FG003|Phase 2|Randomized, but not treated|0|||
164157038|NCT00460603|592938029|FG004|Phase 2|Randomized, but not treated|0|||
164157039|NCT00460603|592938030|FG005|Phase 2|Randomized, but not treated|0|||
164157040|NCT00460603|592938031|FG006|Phase 2|Randomized, but not treated|0|||
164157041|NCT00460603|592938032|FG007|Phase 2|Randomized, but not treated|0|||
164157042|NCT00460603|592938033|FG008|Phase 2|Randomized, but not treated|0|||
164157043|NCT00460603|592938034|FG009|Phase 2|Randomized, but not treated|3|||
164157044|NCT00460603|592938035|FG010|Phase 2|Randomized, but not treated|0|||
164157045|NCT00460603|592938036|FG011|Phase 2|Randomized, but not treated|0|||
164157046|NCT01651117|592938040|FG000|Overall Study|Death|2|||
164157047|NCT01651117|592938041|FG001|Overall Study|Death|3|||
164157048|NCT01651117|592938042|FG002|Overall Study|Death|2|||
164157049|NCT01651117|592938043|FG003|Overall Study|Death|2|||
164157050|NCT02075203|592938045|FG000|Overall Study|Withdrawal by Subject|1|||
164157051|NCT02075203|592938046|FG001|Overall Study|Withdrawal by Subject|0|||
164157052|NCT02075203|592938047|FG002|Overall Study|Withdrawal by Subject|1|||
164157053|NCT02075203|592938045|FG000|Overall Study|Adverse Event|1|||
164157054|NCT02075203|592938046|FG001|Overall Study|Adverse Event|0|||
164157055|NCT02075203|592938047|FG002|Overall Study|Adverse Event|0|||
164157056|NCT02075203|592938045|FG000|Overall Study|participant refused to use contraception|1|||
164157057|NCT02075203|592938046|FG001|Overall Study|participant refused to use contraception|0|||
164157058|NCT02075203|592938047|FG002|Overall Study|participant refused to use contraception|0|||
164157059|NCT00350207|592938048|FG000|Overall Study|Adverse Event|5|||
164157060|NCT00350207|592938049|FG001|Overall Study|Adverse Event|2|||
164157061|NCT00350207|592938050|FG002|Overall Study|Adverse Event|2|||
164157062|NCT00350207|592938048|FG000|Overall Study|Lack of Efficacy|1|||
164157063|NCT00350207|592938049|FG001|Overall Study|Lack of Efficacy|0|||
164157064|NCT00350207|592938050|FG002|Overall Study|Lack of Efficacy|2|||
164157065|NCT00350207|592938048|FG000|Overall Study|Lost to Follow-up|1|||
164157066|NCT00350207|592938049|FG001|Overall Study|Lost to Follow-up|0|||
164157067|NCT00350207|592938050|FG002|Overall Study|Lost to Follow-up|1|||
164157068|NCT00350207|592938048|FG000|Overall Study|Withdrawal by Subject|0|||
164157069|NCT00350207|592938049|FG001|Overall Study|Withdrawal by Subject|1|||
164157070|NCT00350207|592938050|FG002|Overall Study|Withdrawal by Subject|1|||
164157071|NCT00350207|592938048|FG000|Overall Study|Other|1|||
164157072|NCT00350207|592938049|FG001|Overall Study|Other|3|||
164157073|NCT00350207|592938050|FG002|Overall Study|Other|1|||
164157074|NCT03802825|592938051|FG000|Overall Study|Lost to follow-up for intervention|12|||
164157075|NCT03802825|592938052|FG001|Overall Study|Lost to follow-up for intervention|3|||
164157076|NCT03802825|592938051|FG000|Overall Study|Received only 1 component of intervention|0|||
164157077|NCT03802825|592938052|FG001|Overall Study|Received only 1 component of intervention|13|||
164157078|NCT00568451|592938055|FG000|Overall Study|Disease Progression|0|||
164157079|NCT00568451|592938056|FG001|Overall Study|Disease Progression|0|||
164157080|NCT00568451|592938057|FG002|Overall Study|Disease Progression|2|||
164157081|NCT00568451|592938058|FG003|Overall Study|Disease Progression|7|||
164157082|NCT02996968|592938060|FG000|Overall Study|Withdrawal by Subject|1|||
164157083|NCT02996968|592938061|FG001|Overall Study|Withdrawal by Subject|0|||
164157084|NCT01293695|592938062|FG000|Overall Study|Withdrawal by Subject|7|||
164157085|NCT01293695|592938063|FG001|Overall Study|Withdrawal by Subject|1|||
164157086|NCT01293695|592938062|FG000|Overall Study|Lost to Follow-up|8|||
164157087|NCT01293695|592938063|FG001|Overall Study|Lost to Follow-up|6|||
164157088|NCT00791778|592938065|FG000|Double-blind Treatment|Adverse Event|49|||
164157089|NCT00791778|592938066|FG001|Double-blind Treatment|Adverse Event|9|||
164157090|NCT00791778|592938065|FG000|Double-blind Treatment|Physician Decision|6|||
164157091|NCT00791778|592938066|FG001|Double-blind Treatment|Physician Decision|26|||
164157092|NCT00791778|592938065|FG000|Double-blind Treatment|Protocol Violation|0|||
164157093|NCT00791778|592938066|FG001|Double-blind Treatment|Protocol Violation|4|||
164157094|NCT00791778|592938065|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
164157095|NCT00791778|592938066|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
164157096|NCT00791778|592938065|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
164157097|NCT00791778|592938066|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
164157098|NCT00791778|592938065|FG000|Follow-up|Withdrawal by Subject|3|||
164157099|NCT00791778|592938066|FG001|Follow-up|Withdrawal by Subject|0|||
164157100|NCT00791778|592938065|FG000|Follow-up|Lost to Follow-up|2|||
164157101|NCT00791778|592938066|FG001|Follow-up|Lost to Follow-up|1|||
164157102|NCT03313180|592938067|FG000|Overall Study|Adverse Event|120|||
164157103|NCT03313180|592938067|FG000|Overall Study|Lost to Follow-up|3|||
164157104|NCT03313180|592938067|FG000|Overall Study|Withdrawal by Subject|39|||
164157105|NCT03313180|592938067|FG000|Overall Study|Other than listed above|15|||
164157106|NCT03313180|592938067|FG000|Overall Study|Covid-19 related|2|||
164157107|NCT01058642|592938069|FG000|Treatment Period 1|Adverse Event|0|||
164157108|NCT01058642|592938070|FG001|Treatment Period 1|Adverse Event|1|||
164157109|NCT01058642|592938071|FG002|Treatment Period 1|Adverse Event|1|||
164157110|NCT01058642|592938072|FG003|Treatment Period 1|Adverse Event|0|||
164157111|NCT01058642|592938069|FG000|Treatment Period 1|Physician Decision|0|||
164157112|NCT01058642|592938070|FG001|Treatment Period 1|Physician Decision|0|||
164157113|NCT01058642|592938071|FG002|Treatment Period 1|Physician Decision|1|||
164157114|NCT01058642|592938072|FG003|Treatment Period 1|Physician Decision|0|||
164157115|NCT01058642|592938069|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164157116|NCT01058642|592938070|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164157117|NCT01058642|592938071|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164157118|NCT01058642|592938072|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164157119|NCT01058642|592938069|FG000|Treatment Period 1|Lack of Efficacy|0|||
164157120|NCT01058642|592938070|FG001|Treatment Period 1|Lack of Efficacy|0|||
164157121|NCT01058642|592938071|FG002|Treatment Period 1|Lack of Efficacy|0|||
164157122|NCT01058642|592938072|FG003|Treatment Period 1|Lack of Efficacy|1|||
164157123|NCT01058642|592938069|FG000|Treatment Period 1|Protocol Violation|0|||
164157124|NCT01058642|592938070|FG001|Treatment Period 1|Protocol Violation|0|||
164157125|NCT01058642|592938071|FG002|Treatment Period 1|Protocol Violation|0|||
164157126|NCT01058642|592938072|FG003|Treatment Period 1|Protocol Violation|1|||
164157127|NCT01058642|592938069|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
164157128|NCT01058642|592938070|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
164157129|NCT01058642|592938071|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
164157130|NCT01058642|592938072|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
164157131|NCT01704495|592938073|FG000|Subjects Randomized|Other Reason|3|||
164157132|NCT01704495|592938074|FG001|Subjects Randomized|Other Reason|2|||
164157133|NCT01704495|592938075|FG002|Subjects Randomized|Other Reason|3|||
164157134|NCT01704495|592938076|FG003|Subjects Randomized|Other Reason|2|||
164157135|NCT01704495|592938073|FG000|Subjects Randomized|Discontinuation criteria met|4|||
164157136|NCT01704495|592938074|FG001|Subjects Randomized|Discontinuation criteria met|2|||
164157137|NCT01704495|592938075|FG002|Subjects Randomized|Discontinuation criteria met|2|||
164157138|NCT01704495|592938076|FG003|Subjects Randomized|Discontinuation criteria met|0|||
164157139|NCT01704495|592938073|FG000|Subjects Randomized|Adverse Event|8|||
164157140|NCT01704495|592938074|FG001|Subjects Randomized|Adverse Event|2|||
164157141|NCT01704495|592938075|FG002|Subjects Randomized|Adverse Event|0|||
164157142|NCT01704495|592938076|FG003|Subjects Randomized|Adverse Event|7|||
164157143|NCT01704495|592938073|FG000|Subjects Randomized|Withdrawal by Subject|5|||
164157144|NCT01704495|592938074|FG001|Subjects Randomized|Withdrawal by Subject|5|||
164157145|NCT01704495|592938075|FG002|Subjects Randomized|Withdrawal by Subject|5|||
164157146|NCT01704495|592938076|FG003|Subjects Randomized|Withdrawal by Subject|5|||
164157147|NCT01704495|592938073|FG000|Subjects Randomized|Protocol Violation|1|||
164157148|NCT01704495|592938074|FG001|Subjects Randomized|Protocol Violation|1|||
164157149|NCT01704495|592938075|FG002|Subjects Randomized|Protocol Violation|2|||
164157150|NCT01704495|592938076|FG003|Subjects Randomized|Protocol Violation|0|||
164157151|NCT01704495|592938073|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
164157152|NCT01704495|592938074|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
164157153|NCT01704495|592938075|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
164157154|NCT01704495|592938076|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
164157155|NCT01704495|592938073|FG000|Optional Safety Extension|Adverse Event|0|||
164157156|NCT01704495|592938074|FG001|Optional Safety Extension|Adverse Event|4|||
164157157|NCT01704495|592938075|FG002|Optional Safety Extension|Adverse Event|0|||
164157158|NCT01704495|592938076|FG003|Optional Safety Extension|Adverse Event|1|||
164157159|NCT01704495|592938073|FG000|Optional Safety Extension|Other reason|27|||
164157160|NCT01704495|592938074|FG001|Optional Safety Extension|Other reason|29|||
164157161|NCT01704495|592938075|FG002|Optional Safety Extension|Other reason|30|||
164157162|NCT01704495|592938076|FG003|Optional Safety Extension|Other reason|28|||
164157163|NCT01704495|592938073|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
164157164|NCT01704495|592938074|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
164157165|NCT01704495|592938075|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
164157166|NCT01704495|592938076|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
164157167|NCT01256450|592938077|FG000|Open-label Titration|Adverse Event|39|||
164157168|NCT01256450|592938078|FG001|Open-label Titration|Adverse Event|0|||
164157169|NCT01256450|592938079|FG002|Open-label Titration|Adverse Event|0|||
164157170|NCT01256450|592938077|FG000|Open-label Titration|Lost to Follow-up|7|||
164157171|NCT01256450|592938078|FG001|Open-label Titration|Lost to Follow-up|0|||
164157172|NCT01256450|592938079|FG002|Open-label Titration|Lost to Follow-up|0|||
164157173|NCT01256450|592938077|FG000|Open-label Titration|Lack of analgesic effect|30|||
164157174|NCT01256450|592938078|FG001|Open-label Titration|Lack of analgesic effect|0|||
164157175|NCT01256450|592938079|FG002|Open-label Titration|Lack of analgesic effect|0|||
164157176|NCT01256450|592938077|FG000|Open-label Titration|Non-compliance|9|||
164157177|NCT01256450|592938078|FG001|Open-label Titration|Non-compliance|0|||
164157178|NCT01256450|592938079|FG002|Open-label Titration|Non-compliance|0|||
164157179|NCT01256450|592938077|FG000|Open-label Titration|Screen failure|1|||
164157180|NCT01256450|592938078|FG001|Open-label Titration|Screen failure|0|||
164157181|NCT01256450|592938079|FG002|Open-label Titration|Screen failure|0|||
164157182|NCT01256450|592938077|FG000|Open-label Titration|Other|13|||
164157183|NCT01256450|592938078|FG001|Open-label Titration|Other|0|||
164157184|NCT01256450|592938079|FG002|Open-label Titration|Other|0|||
164157185|NCT01256450|592938077|FG000|Double-blind Treatment|Adverse Event|0|||
164157186|NCT01256450|592938078|FG001|Double-blind Treatment|Adverse Event|8|||
164157187|NCT01256450|592938079|FG002|Double-blind Treatment|Adverse Event|6|||
164157188|NCT01256450|592938077|FG000|Double-blind Treatment|Lost to Follow-up|0|||
164157189|NCT01256450|592938078|FG001|Double-blind Treatment|Lost to Follow-up|1|||
164157190|NCT01256450|592938079|FG002|Double-blind Treatment|Lost to Follow-up|7|||
164157191|NCT01256450|592938077|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
164157192|NCT01256450|592938078|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
164157193|NCT01256450|592938079|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
164157194|NCT01256450|592938077|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
164157195|NCT01256450|592938078|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
164157196|NCT01256450|592938079|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
164157197|NCT01256450|592938077|FG000|Double-blind Treatment|Non-compliance|0|||
164157198|NCT01256450|592938078|FG001|Double-blind Treatment|Non-compliance|5|||
164157199|NCT01256450|592938079|FG002|Double-blind Treatment|Non-compliance|4|||
164157200|NCT01256450|592938077|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
164157201|NCT01256450|592938078|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
164157202|NCT01256450|592938079|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
164157203|NCT01256450|592938077|FG000|Double-blind Treatment|Other|0|||
164157204|NCT01256450|592938078|FG001|Double-blind Treatment|Other|9|||
164157205|NCT01256450|592938079|FG002|Double-blind Treatment|Other|12|||
164157206|NCT00891020|592938080|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
164157207|NCT00891020|592938081|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
164157208|NCT00891020|592938082|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
164157209|NCT00891020|592938080|FG000|24 Week Treatment Period|Death|0|||
164157210|NCT00891020|592938081|FG001|24 Week Treatment Period|Death|2|||
164157211|NCT00891020|592938082|FG002|24 Week Treatment Period|Death|0|||
164157212|NCT00891020|592938080|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
164157213|NCT00891020|592938081|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
164157214|NCT00891020|592938082|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
164157215|NCT00891020|592938080|FG000|24 Week Treatment Period|Failure to return|4|||
164157216|NCT00891020|592938081|FG001|24 Week Treatment Period|Failure to return|5|||
164157217|NCT00891020|592938082|FG002|24 Week Treatment Period|Failure to return|5|||
164157218|NCT00891020|592938080|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
164157219|NCT00891020|592938081|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
164157220|NCT00891020|592938082|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
164157221|NCT00891020|592938080|FG000|24 Week Treatment Period|Other protocol violation|1|||
164157222|NCT00891020|592938081|FG001|24 Week Treatment Period|Other protocol violation|1|||
164157223|NCT00891020|592938082|FG002|24 Week Treatment Period|Other protocol violation|2|||
164157224|NCT00891020|592938080|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
164157225|NCT00891020|592938081|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
164157226|NCT00891020|592938082|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
164157227|NCT00891020|592938080|FG000|24 Week Treatment Period|Withdrew consent|6|||
164157228|NCT00891020|592938081|FG001|24 Week Treatment Period|Withdrew consent|3|||
164157229|NCT00891020|592938082|FG002|24 Week Treatment Period|Withdrew consent|15|||
164157230|NCT00891020|592938080|FG000|24 Week Treatment Period|Administrative/Other|5|||
164157231|NCT00891020|592938081|FG001|24 Week Treatment Period|Administrative/Other|6|||
164157232|NCT00891020|592938082|FG002|24 Week Treatment Period|Administrative/Other|1|||
164157233|NCT00891020|592938080|FG000|Long-term Extension Period|Adverse Event|1|||
164157234|NCT00891020|592938081|FG001|Long-term Extension Period|Adverse Event|11|||
164157235|NCT00891020|592938082|FG002|Long-term Extension Period|Adverse Event|10|||
164157236|NCT00891020|592938080|FG000|Long-term Extension Period|Death|0|||
164157237|NCT00891020|592938081|FG001|Long-term Extension Period|Death|0|||
164157238|NCT00891020|592938082|FG002|Long-term Extension Period|Death|1|||
164157239|NCT00891020|592938080|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
164157240|NCT00891020|592938081|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
164157241|NCT00891020|592938082|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
164157242|NCT00891020|592938080|FG000|Long-term Extension Period|Protocol Violation|0|||
164157243|NCT00891020|592938081|FG001|Long-term Extension Period|Protocol Violation|1|||
164157244|NCT00891020|592938082|FG002|Long-term Extension Period|Protocol Violation|1|||
164157245|NCT00891020|592938080|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
164157246|NCT00891020|592938081|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
164157247|NCT00891020|592938082|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
164157248|NCT00891020|592938080|FG000|Long-term Extension Period|Failure to return|0|||
164157249|NCT00891020|592938081|FG001|Long-term Extension Period|Failure to return|2|||
164157250|NCT00891020|592938082|FG002|Long-term Extension Period|Failure to return|3|||
164157251|NCT00891020|592938080|FG000|Long-term Extension Period|Administrative|1|||
164157252|NCT00891020|592938081|FG001|Long-term Extension Period|Administrative|2|||
164157253|NCT00891020|592938082|FG002|Long-term Extension Period|Administrative|2|||
164157254|NCT04177095|592938090|FG000|Overall Study|Withdrawal by Subject|3|||
164157255|NCT04177095|592938090|FG000|Overall Study|Screen Failure|3|||
164157256|NCT04177095|592938090|FG000|Overall Study|Problems with the Trugraf assay|1|||
164157257|NCT02275819|592938091|FG000|Overall Study|Adverse Event|0|||
164157258|NCT02275819|592938092|FG001|Overall Study|Adverse Event|1|||
164157259|NCT01346059|592938093|FG000|Overall Study|Withdrawal by Subject|1|||
164157260|NCT01346059|592938094|FG001|Overall Study|Withdrawal by Subject|0|||
164157261|NCT02556775|592938095|FG000|Overall Study|Withdrawal by Subject|1|||
164157262|NCT02556775|592938096|FG001|Overall Study|Withdrawal by Subject|0|||
164157263|NCT02556775|592938097|FG002|Overall Study|Withdrawal by Subject|1|||
164157264|NCT02556775|592938098|FG003|Overall Study|Withdrawal by Subject|0|||
164157265|NCT02556775|592938095|FG000|Overall Study|Lost to Follow-up|1|||
164157266|NCT02556775|592938096|FG001|Overall Study|Lost to Follow-up|0|||
164157267|NCT02556775|592938097|FG002|Overall Study|Lost to Follow-up|0|||
164157268|NCT02556775|592938098|FG003|Overall Study|Lost to Follow-up|0|||
164157269|NCT00777296|592938099|FG000|Overall Study|Adverse Event|0|||
164157270|NCT00777296|592938100|FG001|Overall Study|Adverse Event|1|||
164157271|NCT00777296|592938101|FG002|Overall Study|Adverse Event|0|||
164157272|NCT00777296|592938102|FG003|Overall Study|Adverse Event|1|||
164157273|NCT00777296|592938099|FG000|Overall Study|Withdrawal by Subject|1|||
164157274|NCT00777296|592938100|FG001|Overall Study|Withdrawal by Subject|0|||
164157275|NCT00777296|592938101|FG002|Overall Study|Withdrawal by Subject|0|||
164157276|NCT00777296|592938102|FG003|Overall Study|Withdrawal by Subject|0|||
164157277|NCT00777296|592938099|FG000|Overall Study|CRF form not completed|0|||
164157278|NCT00777296|592938100|FG001|Overall Study|CRF form not completed|0|||
164157279|NCT00777296|592938101|FG002|Overall Study|CRF form not completed|2|||
164157280|NCT00777296|592938102|FG003|Overall Study|CRF form not completed|0|||
164157281|NCT00658723|592938103|FG000|Overall Study|Lost to Follow-up|0|||
164157282|NCT00658723|592938104|FG001|Overall Study|Lost to Follow-up|2|||
164157283|NCT00658723|592938105|FG002|Overall Study|Lost to Follow-up|2|||
164157284|NCT00658723|592938103|FG000|Overall Study|Death|2|||
164157285|NCT00658723|592938104|FG001|Overall Study|Death|1|||
164157286|NCT00658723|592938105|FG002|Overall Study|Death|4|||
164157287|NCT00658723|592938103|FG000|Overall Study|Scheduling Issue|1|||
164157288|NCT00658723|592938104|FG001|Overall Study|Scheduling Issue|1|||
164157289|NCT00658723|592938105|FG002|Overall Study|Scheduling Issue|0|||
164157290|NCT00658723|592938103|FG000|Overall Study|Withdrawal by Subject|1|||
164157291|NCT00658723|592938104|FG001|Overall Study|Withdrawal by Subject|0|||
164157292|NCT00658723|592938105|FG002|Overall Study|Withdrawal by Subject|1|||
164157293|NCT00092118|592938106|FG000|Overall Study|Adverse Event|35|||
164157294|NCT00092118|592938107|FG001|Overall Study|Adverse Event|32|||
164157295|NCT00092118|592938106|FG000|Overall Study|Lack of Efficacy|12|||
164157296|NCT00092118|592938107|FG001|Overall Study|Lack of Efficacy|14|||
164157297|NCT00092118|592938106|FG000|Overall Study|Lost to Follow-up|4|||
164157298|NCT00092118|592938107|FG001|Overall Study|Lost to Follow-up|3|||
164157299|NCT00092118|592938106|FG000|Overall Study|Protocol Violation|23|||
164157300|NCT00092118|592938107|FG001|Overall Study|Protocol Violation|25|||
164157301|NCT00092118|592938106|FG000|Overall Study|Withdrawal by Subject|4|||
164157302|NCT00092118|592938107|FG001|Overall Study|Withdrawal by Subject|10|||
164157303|NCT00092118|592938106|FG000|Overall Study|Other|6|||
164157304|NCT00092118|592938107|FG001|Overall Study|Other|5|||
164157305|NCT01139125|592938108|FG000|Overall Study|Withdrawal by Subject|1|||
164157306|NCT01592786|592938109|FG000|Overall Study|Adverse Event|60|||
164157307|NCT01592786|592938109|FG000|Overall Study|Lack of Efficacy|19|||
164157308|NCT01592786|592938109|FG000|Overall Study|Protocol Violation|14|||
164157309|NCT01592786|592938109|FG000|Overall Study|Withdrawal by Subject|23|||
164157310|NCT01592786|592938109|FG000|Overall Study|Lost to Follow-up|19|||
164157311|NCT01592786|592938109|FG000|Overall Study|Other|3|||
164157312|NCT02025725|592938110|FG000|Overall Study|Adverse Event|5|||
164157313|NCT02025725|592938111|FG001|Overall Study|Adverse Event|0|||
164157314|NCT02025725|592938110|FG000|Overall Study|Lost to Follow-up|2|||
164157315|NCT02025725|592938111|FG001|Overall Study|Lost to Follow-up|0|||
164157316|NCT02025725|592938110|FG000|Overall Study|Protocol Violation|1|||
164157317|NCT02025725|592938111|FG001|Overall Study|Protocol Violation|1|||
164157318|NCT02025725|592938110|FG000|Overall Study|Withdrawal by Subject|3|||
164157319|NCT02025725|592938111|FG001|Overall Study|Withdrawal by Subject|2|||
164157320|NCT02025725|592938110|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
164157321|NCT02025725|592938111|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
164157322|NCT00235755|592938113|FG000|4-Week Titration Phase|Adverse Event|6|||
164157323|NCT00235755|592938114|FG001|4-Week Titration Phase|Adverse Event|14|||
164157324|NCT00235755|592938115|FG002|4-Week Titration Phase|Adverse Event|20|||
164157325|NCT00235755|592938113|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
164157326|NCT00235755|592938114|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
164157327|NCT00235755|592938115|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
164157328|NCT00235755|592938113|FG000|4-Week Titration Phase|Protocol Violation|2|||
164157329|NCT00235755|592938114|FG001|4-Week Titration Phase|Protocol Violation|2|||
164157330|NCT00235755|592938115|FG002|4-Week Titration Phase|Protocol Violation|1|||
164157331|NCT00235755|592938113|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
164157332|NCT00235755|592938114|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
164157333|NCT00235755|592938115|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
164157334|NCT00235755|592938113|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
164157335|NCT00235755|592938114|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
164157336|NCT00235755|592938115|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
164157337|NCT00235755|592938113|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
164157338|NCT00235755|592938114|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
164157339|NCT00235755|592938115|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
164157340|NCT00235755|592938113|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
164157341|NCT00235755|592938114|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
164157342|NCT00235755|592938115|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
164157343|NCT00235755|592938113|FG000|12-Week Maintenance Phase|Adverse Event|8|||
164157344|NCT00235755|592938114|FG001|12-Week Maintenance Phase|Adverse Event|12|||
164157345|NCT00235755|592938115|FG002|12-Week Maintenance Phase|Adverse Event|26|||
164157346|NCT00235755|592938113|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
164157347|NCT00235755|592938114|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
164157348|NCT00235755|592938115|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
164157349|NCT00235755|592938113|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
164157350|NCT00235755|592938114|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
164157351|NCT00235755|592938115|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
164157352|NCT00235755|592938113|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
164157353|NCT00235755|592938114|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
164157354|NCT00235755|592938115|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
164157355|NCT00235755|592938113|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
164157356|NCT00235755|592938114|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
164157357|NCT00235755|592938115|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
164157358|NCT00235755|592938113|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
164157359|NCT00235755|592938114|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
164157360|NCT00235755|592938115|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
164157361|NCT01532934|592938120|FG000|Overall Study|Lost to Follow-up|11|||
164157362|NCT01532934|592938121|FG001|Overall Study|Lost to Follow-up|11|||
164157363|NCT01532934|592938120|FG000|Overall Study|In controlled environment|3|||
164157364|NCT01532934|592938121|FG001|Overall Study|In controlled environment|2|||
164157365|NCT00468819|592938122|FG000|Overall Study|Withdrawal by Subject|4|||
164157366|NCT00468819|592938123|FG001|Overall Study|Withdrawal by Subject|0|||
164157367|NCT00468819|592938124|FG002|Overall Study|Withdrawal by Subject|1|||
164157368|NCT00468819|592938122|FG000|Overall Study|Lost to Follow-up|0|||
164157369|NCT00468819|592938123|FG001|Overall Study|Lost to Follow-up|0|||
164157370|NCT00468819|592938124|FG002|Overall Study|Lost to Follow-up|1|||
164157371|NCT00468819|592938122|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
164157372|NCT00468819|592938123|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
164157373|NCT00468819|592938124|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
164157374|NCT02723344|592938125|FG000|Overall Study|Lost to Follow-up|0|||
164157375|NCT02723344|592938126|FG001|Overall Study|Lost to Follow-up|4|||
164157376|NCT03759392|592938128|FG000|Overall Study|Adverse Event|12|||
164157377|NCT03759392|592938129|FG001|Overall Study|Adverse Event|4|||
164157378|NCT03759392|592938128|FG000|Overall Study|Death|2|||
164157379|NCT03759392|592938129|FG001|Overall Study|Death|1|||
164157380|NCT03759392|592938128|FG000|Overall Study|Withdrawal by Subject|2|||
164157381|NCT03759392|592938129|FG001|Overall Study|Withdrawal by Subject|0|||
164157382|NCT03759392|592938128|FG000|Overall Study|Protocol Violation|2|||
164157383|NCT03759392|592938129|FG001|Overall Study|Protocol Violation|0|||
164157384|NCT03759392|592938128|FG000|Overall Study|Physician Decision|0|||
164157385|NCT03759392|592938129|FG001|Overall Study|Physician Decision|1|||
164157386|NCT03759392|592938128|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
164157387|NCT03759392|592938129|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
164157388|NCT03759392|592938128|FG000|Overall Study|No longer able to take medicines|1|||
164157389|NCT03759392|592938129|FG001|Overall Study|No longer able to take medicines|0|||
164157390|NCT03759392|592938128|FG000|Overall Study|Stopped taking study drug|1|||
164157391|NCT03759392|592938129|FG001|Overall Study|Stopped taking study drug|0|||
164157392|NCT04762160|592938130|FG000|Overall Study|Study terminated early due to business reasons|5|||
164157393|NCT05364931|592940098|FG000|Overall Study|Adverse Event|0|||
164157394|NCT05364931|592940099|FG001|Overall Study|Adverse Event|2|||
164157395|NCT05364931|592940100|FG002|Overall Study|Adverse Event|1|||
164157396|NCT05364931|592940101|FG003|Overall Study|Adverse Event|0|||
164157397|NCT05364931|592940098|FG000|Overall Study|Lost to Follow-up|1|||
164157398|NCT05364931|592940099|FG001|Overall Study|Lost to Follow-up|0|||
164157399|NCT05364931|592940100|FG002|Overall Study|Lost to Follow-up|0|||
164157400|NCT05364931|592940101|FG003|Overall Study|Lost to Follow-up|0|||
164157401|NCT05364931|592940098|FG000|Overall Study|Withdrawal by Subject|1|||
164157402|NCT05364931|592940099|FG001|Overall Study|Withdrawal by Subject|1|||
164157403|NCT05364931|592940100|FG002|Overall Study|Withdrawal by Subject|3|||
164157404|NCT05364931|592940101|FG003|Overall Study|Withdrawal by Subject|2|||
164157405|NCT05364931|592940098|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
164157406|NCT05364931|592940099|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
164157407|NCT05364931|592940100|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
164157408|NCT05364931|592940101|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
164157409|NCT05364931|592940098|FG000|Overall Study|Discontinued|1|||
164157410|NCT05364931|592940099|FG001|Overall Study|Discontinued|0|||
164157411|NCT05364931|592940100|FG002|Overall Study|Discontinued|0|||
164157412|NCT05364931|592940101|FG003|Overall Study|Discontinued|0|||
164157413|NCT01100086|592940104|FG000|Period 1|Withdrawal by Subject|1|||
164157414|NCT01100086|592940105|FG001|Period 1|Withdrawal by Subject|0|||
164157415|NCT01611935|592940108|FG000|Overall Study|Family Declined Participation|1|||
164157416|NCT01611935|592940109|FG001|Overall Study|Family Declined Participation|0|||
164157417|NCT04168112|592940110|FG000|Overall Study|Lost to Follow-up|1|||
164157418|NCT04168112|592940111|FG001|Overall Study|Lost to Follow-up|0|||
164157419|NCT04168112|592940110|FG000|Overall Study|Withdrawal by Subject|1|||
164157420|NCT04168112|592940111|FG001|Overall Study|Withdrawal by Subject|0|||
164157421|NCT02275546|592940114|FG000|Treatment Period 2|Withdrawal by Subject|2|||
164157422|NCT02275546|592940115|FG001|Treatment Period 2|Withdrawal by Subject|1|||
164157423|NCT02275546|592940114|FG000|Treatment Period 2|Protocol Violation|0|||
164157424|NCT02275546|592940115|FG001|Treatment Period 2|Protocol Violation|1|||
164157425|NCT04227197|592940121|FG000|Randomization|Protocol Violation|1|||
164157426|NCT04227197|592940122|FG001|Randomization|Protocol Violation|0|||
164157427|NCT04227197|592940121|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
164157428|NCT04227197|592940122|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
164157429|NCT04227197|592940121|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
164157430|NCT04227197|592940122|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
164157431|NCT04227197|592940121|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
164157432|NCT04227197|592940122|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
164157433|NCT04227197|592940121|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
164157434|NCT04227197|592940122|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
164157435|NCT04227197|592940121|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
164157436|NCT04227197|592940122|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
164157437|NCT04227197|592940121|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
164157438|NCT04227197|592940122|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
164157439|NCT00570141|592940127|FG000|Overall Study|Adverse Event|1|||
164157440|NCT00570141|592940127|FG000|Overall Study|Missed visits|1|||
164157441|NCT00570141|592940127|FG000|Overall Study|Lost to Follow-up|1|||
164157442|NCT02549859|592940132|FG000|Long-term 60 Hz DBS|Study Closed|1|||
164157443|NCT01209949|592940140|FG000|Overall Study|Lost to Follow-up|3|||
164157444|NCT00729612|592940141|FG000|Overall Study|Non evaluable for response|10|||
164157445|NCT00708552|592940142|FG000|Overall Study|Adverse Event|10|||
164157446|NCT00708552|592940143|FG001|Overall Study|Adverse Event|3|||
164157447|NCT00708552|592940144|FG002|Overall Study|Adverse Event|4|||
164157448|NCT00708552|592940145|FG003|Overall Study|Adverse Event|6|||
164157449|NCT00708552|592940142|FG000|Overall Study|Lack of Efficacy|0|||
164157450|NCT00708552|592940143|FG001|Overall Study|Lack of Efficacy|4|||
164157451|NCT00708552|592940144|FG002|Overall Study|Lack of Efficacy|1|||
164157452|NCT00708552|592940145|FG003|Overall Study|Lack of Efficacy|0|||
164157453|NCT00708552|592940142|FG000|Overall Study|Protocol Violation|0|||
164157454|NCT00708552|592940143|FG001|Overall Study|Protocol Violation|0|||
164157455|NCT00708552|592940144|FG002|Overall Study|Protocol Violation|2|||
164157456|NCT00708552|592940145|FG003|Overall Study|Protocol Violation|4|||
164157457|NCT00708552|592940142|FG000|Overall Study|Lost to Follow-up|4|||
164157458|NCT00708552|592940143|FG001|Overall Study|Lost to Follow-up|2|||
164157459|NCT00708552|592940144|FG002|Overall Study|Lost to Follow-up|0|||
164157460|NCT00708552|592940145|FG003|Overall Study|Lost to Follow-up|1|||
164157461|NCT00708552|592940142|FG000|Overall Study|Physician Decision|1|||
164157462|NCT00708552|592940143|FG001|Overall Study|Physician Decision|2|||
164157463|NCT00708552|592940144|FG002|Overall Study|Physician Decision|0|||
164157464|NCT00708552|592940145|FG003|Overall Study|Physician Decision|0|||
164157465|NCT00708552|592940142|FG000|Overall Study|Withdrawal by Subject|12|||
164157466|NCT00708552|592940143|FG001|Overall Study|Withdrawal by Subject|7|||
164157467|NCT00708552|592940144|FG002|Overall Study|Withdrawal by Subject|8|||
164157468|NCT00708552|592940145|FG003|Overall Study|Withdrawal by Subject|10|||
164157469|NCT02309411|592940146|FG000|Overall Study|Physician Decision|1|||
164157470|NCT02309411|592940147|FG001|Overall Study|Physician Decision|0|||
164157471|NCT02309411|592940148|FG002|Overall Study|Physician Decision|0|||
164157472|NCT02309411|592940146|FG000|Overall Study|Withdrawal by Subject|1|||
164157473|NCT02309411|592940147|FG001|Overall Study|Withdrawal by Subject|1|||
164157474|NCT02309411|592940148|FG002|Overall Study|Withdrawal by Subject|0|||
164157475|NCT00495391|592940150|FG000|Overall Study|Lack of Efficacy|34|||
164157476|NCT00495391|592940151|FG001|Overall Study|Lack of Efficacy|18|||
164157477|NCT00495391|592940150|FG000|Overall Study|Withdrawal by Subject|2|||
164157478|NCT00495391|592940151|FG001|Overall Study|Withdrawal by Subject|3|||
164157479|NCT03214224|592940152|FG000|Overall Study|Protocol Violation|1|||
164157480|NCT03214224|592940152|FG000|Overall Study|Withdrawal by Subject|2|||
164157481|NCT03214224|592940152|FG000|Overall Study|Practice controls or therapists|6|||
164157482|NCT02712320|592940161|FG000|Overall Study|Lost to Follow-up|1|||
164157483|NCT02712320|592940161|FG000|Overall Study|Withdrawal by Subject|1|||
164157484|NCT02712320|592940161|FG000|Overall Study|Transferred to another facility|1|||
164157485|NCT02712320|592940161|FG000|Overall Study|Treating with the prohibited medications|2|||
164157486|NCT05266053|592940162|FG000|Overall Study|Withdrawal by Subject|8|||
164157487|NCT05266053|592940163|FG001|Overall Study|Withdrawal by Subject|4|||
164157488|NCT05344560|592940164|FG000|Period 1|Subject out of visit window|1|||
164157489|NCT05344560|592940165|FG001|Period 1|Subject out of visit window|1|||
164157490|NCT05344560|592940164|FG000|Period 2|Covid-19 Related|1|||
164157491|NCT05344560|592940165|FG001|Period 2|Covid-19 Related|0|||
164157492|NCT05344560|592940164|FG000|Period 2|Adverse Event|1|||
164157493|NCT05344560|592940165|FG001|Period 2|Adverse Event|0|||
164157494|NCT05344560|592940164|FG000|Period 2|Subject out of visit window|1|||
164157495|NCT05344560|592940165|FG001|Period 2|Subject out of visit window|1|||
164157496|NCT05344560|592940164|FG000|Period 3|Subject out of visit window|1|||
164157497|NCT05344560|592940165|FG001|Period 3|Subject out of visit window|0|||
164157498|NCT01051960|592940170|FG000|Overall Study|Adverse Event|1|||
164157499|NCT00391768|592940174|FG000|Overall Study|Withdrawal by Subject|0|||
164157500|NCT00391768|592940175|FG001|Overall Study|Withdrawal by Subject|0|||
164157501|NCT00391768|592940176|FG002|Overall Study|Withdrawal by Subject|1|||
164157502|NCT00391768|592940177|FG003|Overall Study|Withdrawal by Subject|0|||
164157503|NCT00391768|592940178|FG004|Overall Study|Withdrawal by Subject|0|||
164157504|NCT00391768|592940179|FG005|Overall Study|Withdrawal by Subject|1|||
164157505|NCT00391768|592940180|FG006|Overall Study|Withdrawal by Subject|1|||
164157506|NCT00391768|592940174|FG000|Overall Study|Lost to Follow-up|0|||
164157507|NCT00391768|592940175|FG001|Overall Study|Lost to Follow-up|0|||
164157508|NCT00391768|592940176|FG002|Overall Study|Lost to Follow-up|0|||
164157509|NCT00391768|592940177|FG003|Overall Study|Lost to Follow-up|1|||
164157510|NCT00391768|592940178|FG004|Overall Study|Lost to Follow-up|2|||
164157511|NCT00391768|592940179|FG005|Overall Study|Lost to Follow-up|2|||
164157512|NCT00391768|592940180|FG006|Overall Study|Lost to Follow-up|3|||
164157513|NCT01082328|592940183|FG000|Overall Study|Adverse Event|1|||
164157514|NCT00031590|592940184|FG000|Overall Study|Adverse Event|1|||
164157515|NCT00031590|592940184|FG000|Overall Study|Withdrawal by parents|2|||
164157516|NCT05506046|592940185|FG000|Overall Study|Lost to Follow-up|89|||
164157517|NCT05506046|592940186|FG001|Overall Study|Lost to Follow-up|101|||
164157518|NCT05506046|592940187|FG002|Overall Study|Lost to Follow-up|102|||
164157519|NCT05506046|592940188|FG003|Overall Study|Lost to Follow-up|99|||
164157520|NCT00444535|592940191|FG000|Overall Study|Withdrawal by Subject|5|||
164157521|NCT00444535|592940191|FG000|Overall Study|Physician Decision|5|||
164157522|NCT00444535|592940191|FG000|Overall Study|progressive disease|1|||
164157523|NCT00444535|592940191|FG000|Overall Study|Adverse Event|2|||
164157524|NCT01568892|592940192|FG000|Open-label Phase|Adverse Event|2|||
164157525|NCT01568892|592940193|FG001|Open-label Phase|Adverse Event|0|||
164157526|NCT01568892|592940192|FG000|Open-label Phase|Lack of Efficacy|4|||
164157527|NCT01568892|592940193|FG001|Open-label Phase|Lack of Efficacy|2|||
164157528|NCT01568892|592940192|FG000|Open-label Phase|Lost to Follow-up|0|||
164157529|NCT01568892|592940193|FG001|Open-label Phase|Lost to Follow-up|1|||
164157530|NCT01697748|592940204|FG000|Overall Study|ineligible skin incision|1|||
164157531|NCT01697748|592940205|FG001|Overall Study|ineligible skin incision|2|||
164157532|NCT01697748|592940204|FG000|Overall Study|ineligible uterine incision|4|||
164157533|NCT01697748|592940205|FG001|Overall Study|ineligible uterine incision|1|||
164157534|NCT01697748|592940204|FG000|Overall Study|Lost to Follow-up|53|||
164157535|NCT01697748|592940205|FG001|Overall Study|Lost to Follow-up|65|||
164157536|NCT02375971|592940209|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
164157537|NCT02375971|592940210|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
164157538|NCT02375971|592940211|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
164157539|NCT02375971|592940209|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
164157540|NCT02375971|592940210|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
164157541|NCT02375971|592940211|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
164157542|NCT02375971|592940209|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
164157543|NCT02375971|592940210|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
164157544|NCT02375971|592940211|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
164157545|NCT02375971|592940209|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
164157546|NCT02375971|592940210|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
164157547|NCT02375971|592940211|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
164157548|NCT02375971|592940209|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
164157549|NCT02375971|592940210|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
164157550|NCT02375971|592940211|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
164157551|NCT02375971|592940209|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
164157552|NCT02375971|592940210|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
164157553|NCT02375971|592940211|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
164157554|NCT02375971|592940209|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
164157555|NCT02375971|592940210|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
164157556|NCT02375971|592940211|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
164157557|NCT02375971|592940209|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
164157558|NCT02375971|592940210|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
164157559|NCT02375971|592940211|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
164157560|NCT02172664|592940217|FG000|Overall Study|Lost to Follow-up|4|||
164157561|NCT02172664|592940218|FG001|Overall Study|Lost to Follow-up|4|||
164157562|NCT02172664|592940217|FG000|Overall Study|Death|1|||
164157563|NCT02172664|592940218|FG001|Overall Study|Death|1|||
164157564|NCT02172664|592940217|FG000|Overall Study|Moved out of area|1|||
164157565|NCT02172664|592940218|FG001|Overall Study|Moved out of area|1|||
164157566|NCT01909934|592940219|FG000|Overall Study|Withdrawal by Subject|3|||
164157567|NCT01909934|592940219|FG000|Overall Study|Lost to Follow-up|1|||
164157568|NCT01909934|592940219|FG000|Overall Study|Death|25|||
164157569|NCT01909934|592940219|FG000|Overall Study|Withdrawal of Informed Consent|1|||
164157570|NCT01909934|592940219|FG000|Overall Study|Reason Not Specified|1|||
164157571|NCT03810092|592940220|FG000|Overall Study|no ground support|17|||
164157572|NCT03810092|592940220|FG000|Overall Study|ADL not done at J0|16|||
164157573|NCT03810092|592940220|FG000|Overall Study|No hemoglobin measure at J5|27|||
164157574|NCT00806403|592940221|FG000|Overall Study|Death|4|||
164157575|NCT00806403|592940222|FG001|Overall Study|Death|3|||
164157576|NCT01320293|592940225|FG000|Overall Study|Lack of Efficacy|1|||
164157577|NCT01320293|592940225|FG000|Overall Study|Adverse Event|1|||
164157578|NCT01787292|592940228|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
164157579|NCT01787292|592940229|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
164157580|NCT01787292|592940228|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
164157581|NCT01787292|592940229|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
164157582|NCT01147068|592940230|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
164157583|NCT01147068|592940231|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
164157584|NCT01147068|592940232|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
164157585|NCT01147068|592940233|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
164157586|NCT01147068|592940234|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
164157587|NCT01147068|592940235|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
164157588|NCT01147068|592940236|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
164157589|NCT01147068|592940230|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
164157590|NCT01147068|592940231|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
164157591|NCT01147068|592940232|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
164157592|NCT01147068|592940233|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
164157593|NCT01147068|592940234|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
164157594|NCT01147068|592940235|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
164157595|NCT01147068|592940236|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
164157596|NCT01147068|592940230|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
164157597|NCT01147068|592940231|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
164157598|NCT01147068|592940232|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
164157599|NCT01147068|592940233|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
164157600|NCT01147068|592940234|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
164157601|NCT01147068|592940235|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
164157602|NCT01147068|592940236|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
164157603|NCT01147068|592940230|FG000|Subjects That Received 2nd Dose|Other|0|||
164157604|NCT01147068|592940231|FG001|Subjects That Received 2nd Dose|Other|3|||
164157605|NCT01147068|592940232|FG002|Subjects That Received 2nd Dose|Other|3|||
164157606|NCT01147068|592940233|FG003|Subjects That Received 2nd Dose|Other|0|||
164157607|NCT01147068|592940234|FG004|Subjects That Received 2nd Dose|Other|1|||
164157608|NCT01147068|592940235|FG005|Subjects That Received 2nd Dose|Other|0|||
164157609|NCT01147068|592940236|FG006|Subjects That Received 2nd Dose|Other|0|||
164157610|NCT01147068|592940230|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
164157611|NCT01147068|592940231|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
164157612|NCT01147068|592940232|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
164157613|NCT01147068|592940233|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
164157614|NCT01147068|592940234|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
164157615|NCT01147068|592940235|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
164157616|NCT01147068|592940236|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
164157617|NCT01147068|592940230|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
164157618|NCT01147068|592940231|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
164157619|NCT01147068|592940232|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
164157620|NCT01147068|592940233|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
164157621|NCT01147068|592940234|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
164157622|NCT01147068|592940235|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
164157623|NCT01147068|592940236|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
164157624|NCT01147068|592940230|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
164157625|NCT01147068|592940231|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
164157626|NCT01147068|592940232|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
164157627|NCT01147068|592940233|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
164157628|NCT01147068|592940234|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
164157629|NCT01147068|592940235|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
164157630|NCT01147068|592940236|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
164157631|NCT02962648|592940238|FG000|Overall Study|Withdrawal by Subject|3|||
164157632|NCT02962648|592940238|FG000|Overall Study|Lost to Follow-up|3|||
164157633|NCT02962648|592940238|FG000|Overall Study|Physician Decision|1|||
164157634|NCT02962648|592940238|FG000|Overall Study|Subject had problems with transportation|2|||
164157635|NCT01597778|592940240|FG000|Overall Study|Death|7|||
164157636|NCT01597778|592940241|FG001|Overall Study|Death|10|||
164157637|NCT01597778|592940240|FG000|Overall Study|Withdrawal by Subject|3|||
164157638|NCT01597778|592940241|FG001|Overall Study|Withdrawal by Subject|4|||
164157639|NCT01597778|592940240|FG000|Overall Study|Adverse Event|1|||
164157640|NCT01597778|592940241|FG001|Overall Study|Adverse Event|1|||
164157641|NCT01597778|592940240|FG000|Overall Study|Protocol Violation|1|||
164157642|NCT01597778|592940241|FG001|Overall Study|Protocol Violation|11|||
164157643|NCT01597778|592940240|FG000|Overall Study|Transplanted off protocol|2|||
164157644|NCT01597778|592940241|FG001|Overall Study|Transplanted off protocol|3|||
164157645|NCT03267212|592940242|FG000|First Intervention|Lost to Follow-up|0|||
164157646|NCT03267212|592940243|FG001|First Intervention|Lost to Follow-up|2|||
164157647|NCT03267212|592940242|FG000|First Intervention|Withdrawal by Subject|1|||
164157648|NCT03267212|592940243|FG001|First Intervention|Withdrawal by Subject|1|||
164157649|NCT03267212|592940242|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
164157650|NCT03267212|592940243|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
164157651|NCT05691712|592940244|FG000|Overall Study|Adverse Event|0|||
164157652|NCT05691712|592940245|FG001|Overall Study|Adverse Event|1|||
164157653|NCT05691712|592940246|FG002|Overall Study|Adverse Event|2|||
164157654|NCT05691712|592940247|FG003|Overall Study|Adverse Event|1|||
164157655|NCT05691712|592940244|FG000|Overall Study|Withdrawal by Subject|2|||
164157656|NCT05691712|592940245|FG001|Overall Study|Withdrawal by Subject|3|||
164157657|NCT05691712|592940246|FG002|Overall Study|Withdrawal by Subject|3|||
164157658|NCT05691712|592940247|FG003|Overall Study|Withdrawal by Subject|1|||
164157659|NCT05691712|592940244|FG000|Overall Study|Death|1|||
164157660|NCT05691712|592940245|FG001|Overall Study|Death|0|||
164157661|NCT05691712|592940246|FG002|Overall Study|Death|0|||
164157662|NCT05691712|592940247|FG003|Overall Study|Death|0|||
164157663|NCT05691712|592940244|FG000|Overall Study|Pregnancy|0|||
164157664|NCT05691712|592940245|FG001|Overall Study|Pregnancy|1|||
164157665|NCT05691712|592940246|FG002|Overall Study|Pregnancy|0|||
164157666|NCT05691712|592940247|FG003|Overall Study|Pregnancy|0|||
164157667|NCT05691712|592940244|FG000|Overall Study|Assigned Treatment by Mistake|1|||
164157668|NCT05691712|592940245|FG001|Overall Study|Assigned Treatment by Mistake|0|||
164157669|NCT05691712|592940246|FG002|Overall Study|Assigned Treatment by Mistake|0|||
164157670|NCT05691712|592940247|FG003|Overall Study|Assigned Treatment by Mistake|1|||
164157671|NCT05303194|592940248|FG000|Overall Study|Lost to Follow-up|1|||
164157672|NCT05303194|592940249|FG001|Overall Study|Lost to Follow-up|1|||
164157673|NCT05303194|592940248|FG000|Overall Study|Withdrawal by Subject|0|||
164157674|NCT05303194|592940249|FG001|Overall Study|Withdrawal by Subject|1|||
164157675|NCT00226499|592940259|FG000|Overall Study|Adverse Event|10|||
164157676|NCT00226499|592940260|FG001|Overall Study|Adverse Event|6|||
164157677|NCT00226499|592940261|FG002|Overall Study|Adverse Event|3|||
164157678|NCT00226499|592940259|FG000|Overall Study|Others|1064|||
164157679|NCT00226499|592940260|FG001|Overall Study|Others|1066|||
164157680|NCT00226499|592940261|FG002|Overall Study|Others|356|||
164157681|NCT02524847|592940262|FG000|Overall Study|Adverse Event|4|||
164157682|NCT02524847|592940262|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
164157683|NCT02524847|592940262|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
164157684|NCT02524847|592940262|FG000|Overall Study|Death|1|||
164157685|NCT02524847|592940262|FG000|Overall Study|Reason not Specified|1|||
164157686|NCT04352101|592940263|FG000|Overall Study|Physician Decision|2|||
164157687|NCT04352101|592940264|FG001|Overall Study|Physician Decision|1|||
164157688|NCT05795153|592941807|FG000|Overall Study|Adverse Event|2|||
164157689|NCT05795153|592941807|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164157690|NCT05795153|592941807|FG000|Overall Study|Lost to Follow-up|1|||
164157691|NCT05795153|592941807|FG000|Overall Study|Subject decision|2|||
164157692|NCT03668119|592941808|FG000|Pre-treatment|Disease Progression|1|||
164157693|NCT03668119|592941809|FG001|Pre-treatment|Disease Progression|0|||
164157694|NCT03668119|592941808|FG000|Treatment|Disease Progression|76|||
164157695|NCT03668119|592941809|FG001|Treatment|Disease Progression|57|||
164157696|NCT03668119|592941808|FG000|Treatment|Study drug toxicity|19|||
164157697|NCT03668119|592941809|FG001|Treatment|Study drug toxicity|1|||
164157698|NCT03668119|592941808|FG000|Treatment|Death|3|||
164157699|NCT03668119|592941809|FG001|Treatment|Death|0|||
164157700|NCT03668119|592941808|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
164157701|NCT03668119|592941809|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
164157702|NCT03668119|592941808|FG000|Treatment|Withdrawal by Subject|1|||
164157703|NCT03668119|592941809|FG001|Treatment|Withdrawal by Subject|1|||
164157704|NCT03668119|592941808|FG000|Treatment|Participant request to discontinue study treatment|3|||
164157705|NCT03668119|592941809|FG001|Treatment|Participant request to discontinue study treatment|1|||
164157706|NCT03668119|592941808|FG000|Treatment|Maximum Clinical Benefit|0|||
164157707|NCT03668119|592941809|FG001|Treatment|Maximum Clinical Benefit|1|||
164157708|NCT03668119|592941808|FG000|Treatment|Participants completed treatment|27|||
164157709|NCT03668119|592941809|FG001|Treatment|Participants completed treatment|11|||
164157710|NCT03668119|592941808|FG000|Treatment|Other reasons|2|||
164157711|NCT03668119|592941809|FG001|Treatment|Other reasons|1|||
164157712|NCT03769168|592941810|FG000|Overall Study|Adverse Event|0|||
164157713|NCT03769168|592941811|FG001|Overall Study|Adverse Event|1|||
164157714|NCT03769168|592941810|FG000|Overall Study|Lack of Efficacy|2|||
164157715|NCT03769168|592941811|FG001|Overall Study|Lack of Efficacy|4|||
164157716|NCT03769168|592941810|FG000|Overall Study|Post study access to treatment|3|||
164157717|NCT03769168|592941811|FG001|Overall Study|Post study access to treatment|11|||
164157718|NCT03769168|592941810|FG000|Overall Study|Physician Decision|1|||
164157719|NCT03769168|592941811|FG001|Overall Study|Physician Decision|4|||
164157720|NCT03769168|592941810|FG000|Overall Study|Subject Decision|2|||
164157721|NCT03769168|592941811|FG001|Overall Study|Subject Decision|4|||
164157722|NCT03769168|592941810|FG000|Overall Study|Guardian decision|1|||
164157723|NCT03769168|592941811|FG001|Overall Study|Guardian decision|0|||
164157724|NCT05142722|592941812|FG000|Overall Study|Lost to Follow-up|16|||
164157725|NCT05142722|592941813|FG001|Overall Study|Lost to Follow-up|38|||
164157726|NCT05142722|592941812|FG000|Overall Study|Withdrawal by Subject|20|||
164157727|NCT05142722|592941813|FG001|Overall Study|Withdrawal by Subject|27|||
164157728|NCT05142722|592941812|FG000|Overall Study|Death|11|||
164157729|NCT05142722|592941813|FG001|Overall Study|Death|17|||
164157730|NCT05142722|592941812|FG000|Overall Study|Physician Decision|0|||
164157731|NCT05142722|592941813|FG001|Overall Study|Physician Decision|1|||
164157732|NCT05142722|592941812|FG000|Overall Study|Participant Moved Away|0|||
164157733|NCT05142722|592941813|FG001|Overall Study|Participant Moved Away|2|||
164157734|NCT05142722|592941812|FG000|Overall Study|Adverse Event|2|||
164157735|NCT05142722|592941813|FG001|Overall Study|Adverse Event|1|||
164157736|NCT03896503|592941816|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
164157737|NCT03896503|592941817|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
164157738|NCT03896503|592941818|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
164157739|NCT03896503|592941819|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
164157740|NCT03896503|592941820|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
164157741|NCT03896503|592941821|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
164157742|NCT03896503|592941822|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
164157743|NCT03896503|592941823|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
164157744|NCT03896503|592941816|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
164157745|NCT03896503|592941817|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
164157746|NCT03896503|592941818|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
164157747|NCT03896503|592941819|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
164157748|NCT03896503|592941820|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
164157749|NCT03896503|592941821|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
164157750|NCT03896503|592941822|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
164157751|NCT03896503|592941823|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
164157752|NCT03896503|592941816|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
164157753|NCT03896503|592941817|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
164157754|NCT03896503|592941818|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
164157755|NCT03896503|592941819|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
164157756|NCT03896503|592941820|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
164157757|NCT03896503|592941821|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
164157758|NCT03896503|592941822|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
164157759|NCT03896503|592941823|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
164157760|NCT03896503|592941816|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
164157761|NCT03896503|592941817|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
164157762|NCT03896503|592941818|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
164157763|NCT03896503|592941819|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
164157764|NCT03896503|592941820|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
164157765|NCT03896503|592941821|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
164157766|NCT03896503|592941822|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
164157767|NCT03896503|592941823|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
164157768|NCT03896503|592941816|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157769|NCT03896503|592941817|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157770|NCT03896503|592941818|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
164157771|NCT03896503|592941819|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157772|NCT03896503|592941820|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157773|NCT03896503|592941821|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157774|NCT03896503|592941822|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
164157775|NCT03896503|592941823|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157776|NCT03896503|592941816|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
164157777|NCT03896503|592941817|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
164157778|NCT03896503|592941818|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
164157779|NCT03896503|592941819|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
164157780|NCT03896503|592941820|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
164157781|NCT03896503|592941821|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
164157782|NCT03896503|592941822|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
164157783|NCT03896503|592941823|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
164157784|NCT03896503|592941816|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
164157785|NCT03896503|592941817|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
164157786|NCT03896503|592941818|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
164157787|NCT03896503|592941819|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
164157788|NCT03896503|592941820|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
164157789|NCT03896503|592941821|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
164157790|NCT03896503|592941822|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
164157791|NCT03896503|592941823|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
164157792|NCT03896503|592941816|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
164157793|NCT03896503|592941817|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
164157794|NCT03896503|592941818|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
164157795|NCT03896503|592941819|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
164157796|NCT03896503|592941820|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
164157797|NCT03896503|592941821|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
164157798|NCT03896503|592941822|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
164157799|NCT03896503|592941823|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
164157800|NCT03896503|592941816|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
164157801|NCT03896503|592941817|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
164157802|NCT03896503|592941818|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
164157803|NCT03896503|592941819|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
164157804|NCT03896503|592941820|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
164157805|NCT03896503|592941821|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
164157806|NCT03896503|592941822|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
164157807|NCT03896503|592941823|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
164157808|NCT03896503|592941816|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157809|NCT03896503|592941817|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157810|NCT03896503|592941818|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157811|NCT03896503|592941819|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157812|NCT03896503|592941820|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157813|NCT03896503|592941821|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
164157814|NCT03896503|592941822|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157815|NCT03896503|592941823|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157816|NCT03896503|592941816|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
164157817|NCT03896503|592941817|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
164157818|NCT03896503|592941818|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
164157819|NCT03896503|592941819|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
164157820|NCT03896503|592941820|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
164157821|NCT03896503|592941821|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
164157822|NCT03896503|592941822|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
164157823|NCT03896503|592941823|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
164157824|NCT05400655|592941824|FG000|Part 1A: Period 2|Withdrawal by Subject|0|||
164157825|NCT05400655|592941825|FG001|Part 1A: Period 2|Withdrawal by Subject|0|||
164157826|NCT05400655|592941826|FG002|Part 1A: Period 2|Withdrawal by Subject|0|||
164157827|NCT05400655|592941827|FG003|Part 1A: Period 2|Withdrawal by Subject|1|||
164157828|NCT05400655|592941828|FG004|Part 1A: Period 2|Withdrawal by Subject|0|||
164157829|NCT05400655|592941829|FG005|Part 1A: Period 2|Withdrawal by Subject|0|||
164157830|NCT05400655|592941830|FG006|Part 1A: Period 2|Withdrawal by Subject|0|||
164157831|NCT05400655|592941831|FG007|Part 1A: Period 2|Withdrawal by Subject|0|||
164157832|NCT05400655|592941832|FG008|Part 1A: Period 2|Withdrawal by Subject|0|||
164157833|NCT05400655|592941833|FG009|Part 1A: Period 2|Withdrawal by Subject|0|||
164157834|NCT05400655|592941834|FG010|Part 1A: Period 2|Withdrawal by Subject|0|||
164157835|NCT05400655|592941835|FG011|Part 1A: Period 2|Withdrawal by Subject|0|||
164157836|NCT05400655|592941836|FG012|Part 1A: Period 2|Withdrawal by Subject|0|||
164157837|NCT05400655|592941837|FG013|Part 1A: Period 2|Withdrawal by Subject|0|||
164157838|NCT05400655|592941838|FG014|Part 1A: Period 2|Withdrawal by Subject|0|||
164157839|NCT05400655|592941839|FG015|Part 1A: Period 2|Withdrawal by Subject|0|||
164157840|NCT05400655|592941840|FG016|Part 1A: Period 2|Withdrawal by Subject|0|||
164157841|NCT05400655|592941841|FG017|Part 1A: Period 2|Withdrawal by Subject|0|||
164157842|NCT05400655|592941842|FG018|Part 1A: Period 2|Withdrawal by Subject|0|||
164157843|NCT05400655|592941843|FG019|Part 1A: Period 2|Withdrawal by Subject|0|||
164157844|NCT05400655|592941844|FG020|Part 1A: Period 2|Withdrawal by Subject|0|||
164157845|NCT05400655|592941845|FG021|Part 1A: Period 2|Withdrawal by Subject|0|||
164157846|NCT05400655|592941824|FG000|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157847|NCT05400655|592941825|FG001|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157848|NCT05400655|592941826|FG002|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157849|NCT05400655|592941827|FG003|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157850|NCT05400655|592941828|FG004|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157851|NCT05400655|592941829|FG005|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157852|NCT05400655|592941830|FG006|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157853|NCT05400655|592941831|FG007|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157854|NCT05400655|592941832|FG008|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157855|NCT05400655|592941833|FG009|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157856|NCT05400655|592941834|FG010|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157857|NCT05400655|592941835|FG011|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157858|NCT05400655|592941836|FG012|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
164157859|NCT05400655|592941837|FG013|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157860|NCT05400655|592941838|FG014|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157861|NCT05400655|592941839|FG015|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157862|NCT05400655|592941840|FG016|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
164157863|NCT05400655|592941841|FG017|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157864|NCT05400655|592941842|FG018|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
164157865|NCT05400655|592941843|FG019|Part 1B/Part 2 - Period 1|Withdrawal by Subject|2|||
164157866|NCT05400655|592941844|FG020|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157867|NCT05400655|592941845|FG021|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157868|NCT05400655|592941824|FG000|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157869|NCT05400655|592941825|FG001|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157870|NCT05400655|592941826|FG002|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157871|NCT05400655|592941827|FG003|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157872|NCT05400655|592941828|FG004|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157873|NCT05400655|592941829|FG005|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157874|NCT05400655|592941830|FG006|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157875|NCT05400655|592941831|FG007|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157876|NCT05400655|592941832|FG008|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157877|NCT05400655|592941833|FG009|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157878|NCT05400655|592941834|FG010|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157879|NCT05400655|592941835|FG011|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157880|NCT05400655|592941836|FG012|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157881|NCT05400655|592941837|FG013|Part 1B/Part 2 - Period 1|Adverse Event|1|||
164157882|NCT05400655|592941838|FG014|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157883|NCT05400655|592941839|FG015|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157884|NCT05400655|592941840|FG016|Part 1B/Part 2 - Period 1|Adverse Event|2|||
164157885|NCT05400655|592941841|FG017|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157886|NCT05400655|592941842|FG018|Part 1B/Part 2 - Period 1|Adverse Event|1|||
164157887|NCT05400655|592941843|FG019|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157888|NCT05400655|592941844|FG020|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157889|NCT05400655|592941845|FG021|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157890|NCT05400655|592941824|FG000|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157891|NCT05400655|592941825|FG001|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157892|NCT05400655|592941826|FG002|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157893|NCT05400655|592941827|FG003|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157894|NCT05400655|592941828|FG004|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157895|NCT05400655|592941829|FG005|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157896|NCT05400655|592941830|FG006|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157897|NCT05400655|592941831|FG007|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157898|NCT05400655|592941832|FG008|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157899|NCT05400655|592941833|FG009|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157900|NCT05400655|592941834|FG010|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157901|NCT05400655|592941835|FG011|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157902|NCT05400655|592941836|FG012|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157903|NCT05400655|592941837|FG013|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157904|NCT05400655|592941838|FG014|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157905|NCT05400655|592941839|FG015|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157906|NCT05400655|592941840|FG016|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
164157907|NCT05400655|592941841|FG017|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
164157908|NCT05400655|592941842|FG018|Part 1B/Part 2 - Period 1|Lost to Follow-up|3|||
164157909|NCT05400655|592941843|FG019|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157910|NCT05400655|592941844|FG020|Part 1B/Part 2 - Period 1|Lost to Follow-up|7|||
164157911|NCT05400655|592941845|FG021|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
164157912|NCT05400655|592941824|FG000|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157913|NCT05400655|592941825|FG001|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157914|NCT05400655|592941826|FG002|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157915|NCT05400655|592941827|FG003|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157916|NCT05400655|592941828|FG004|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157917|NCT05400655|592941829|FG005|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157918|NCT05400655|592941830|FG006|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157919|NCT05400655|592941831|FG007|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157920|NCT05400655|592941832|FG008|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157921|NCT05400655|592941833|FG009|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157922|NCT05400655|592941834|FG010|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157923|NCT05400655|592941835|FG011|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157924|NCT05400655|592941836|FG012|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157925|NCT05400655|592941837|FG013|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157926|NCT05400655|592941838|FG014|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157927|NCT05400655|592941839|FG015|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157928|NCT05400655|592941840|FG016|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157929|NCT05400655|592941841|FG017|Part 1B/Part 2 - Period 1|Physician Decision|3|||
164157930|NCT05400655|592941842|FG018|Part 1B/Part 2 - Period 1|Physician Decision|2|||
164157931|NCT05400655|592941843|FG019|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157932|NCT05400655|592941844|FG020|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157933|NCT05400655|592941845|FG021|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164158292|NCT03817853|592941915|FG002|Follow-up Phase|Death|1|||
164157934|NCT05400655|592941824|FG000|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157935|NCT05400655|592941825|FG001|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157936|NCT05400655|592941826|FG002|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157937|NCT05400655|592941827|FG003|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157938|NCT05400655|592941828|FG004|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157939|NCT05400655|592941829|FG005|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157940|NCT05400655|592941830|FG006|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157941|NCT05400655|592941831|FG007|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157942|NCT05400655|592941832|FG008|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157943|NCT05400655|592941833|FG009|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157944|NCT05400655|592941834|FG010|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157945|NCT05400655|592941835|FG011|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157946|NCT05400655|592941836|FG012|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157947|NCT05400655|592941837|FG013|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157948|NCT05400655|592941838|FG014|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157949|NCT05400655|592941839|FG015|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157950|NCT05400655|592941840|FG016|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
164157951|NCT05400655|592941841|FG017|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157952|NCT05400655|592941842|FG018|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
164157953|NCT05400655|592941843|FG019|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
164157954|NCT05400655|592941844|FG020|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
164157955|NCT05400655|592941845|FG021|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
164157956|NCT01068678|592941854|FG000|Overall Study|Lack of Efficacy|3|||
164157957|NCT01068678|592941855|FG001|Overall Study|Lack of Efficacy|2|||
164157958|NCT01068678|592941854|FG000|Overall Study|Protocol Violation|5|||
164157959|NCT01068678|592941855|FG001|Overall Study|Protocol Violation|1|||
164157960|NCT01068678|592941854|FG000|Overall Study|Withdrawal criteria|12|||
164157961|NCT01068678|592941855|FG001|Overall Study|Withdrawal criteria|6|||
164157962|NCT01068678|592941854|FG000|Overall Study|Unclassified|18|||
164157963|NCT01068678|592941855|FG001|Overall Study|Unclassified|15|||
164157964|NCT05161481|592941856|FG000|Overall Study|Withdrawal of consent|0|||
164157965|NCT05161481|592941857|FG001|Overall Study|Withdrawal of consent|1|||
164157966|NCT05161481|592941858|FG002|Overall Study|Withdrawal of consent|1|||
164157967|NCT05161481|592941856|FG000|Overall Study|Study terminated by sponsor|3|||
164157968|NCT05161481|592941857|FG001|Overall Study|Study terminated by sponsor|3|||
164157969|NCT05161481|592941858|FG002|Overall Study|Study terminated by sponsor|2|||
164157970|NCT05161481|592941856|FG000|Overall Study|Adverse Event|3|||
164157971|NCT05161481|592941857|FG001|Overall Study|Adverse Event|0|||
164157972|NCT05161481|592941858|FG002|Overall Study|Adverse Event|6|||
164157973|NCT05161481|592941856|FG000|Overall Study|Randomised in error and was not treated|1|||
164157974|NCT05161481|592941857|FG001|Overall Study|Randomised in error and was not treated|0|||
164157975|NCT05161481|592941858|FG002|Overall Study|Randomised in error and was not treated|0|||
164157976|NCT05161481|592941856|FG000|Overall Study|Subject decision|0|||
164157977|NCT05161481|592941857|FG001|Overall Study|Subject decision|0|||
164157978|NCT05161481|592941858|FG002|Overall Study|Subject decision|1|||
164157979|NCT03827291|592941859|FG000|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|5|||
164157980|NCT03827291|592941860|FG001|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|0|||
164157981|NCT04795466|592941861|FG000|Overall Study|Adverse Event|3|||
164157982|NCT04795466|592941862|FG001|Overall Study|Adverse Event|1|||
164157983|NCT04795466|592941861|FG000|Overall Study|Physician Decision|1|||
164157984|NCT04795466|592941862|FG001|Overall Study|Physician Decision|0|||
164157985|NCT04795466|592941861|FG000|Overall Study|Withdrawal by Subject|2|||
164157986|NCT04795466|592941862|FG001|Overall Study|Withdrawal by Subject|1|||
164157987|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
164157988|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
164157989|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
164157990|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
164157991|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
164157992|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
164157993|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
164157994|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
164157995|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
164157996|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
164157997|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
164157998|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
164157999|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
164158000|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
164158001|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
164158002|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
164158003|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
164158004|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
164158005|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
164158006|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
164158007|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
164158008|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
164158009|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
164158010|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
164158011|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
164158012|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
164158013|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
164158014|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
164158015|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
164158016|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
164158017|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
164158018|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
164158019|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
164158020|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
164158021|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
164158022|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
164158023|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
164158024|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
164158025|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
164158026|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
164158027|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
164158028|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
164158029|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
164158030|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
164158031|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
164158032|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
164158033|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
164158034|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
164158035|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
164158036|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
164158037|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
164158038|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
164158039|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Site closed|0|||
164158040|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Site closed|0|||
164158041|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Site closed|1|||
164158042|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Site closed|0|||
164158043|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
164158044|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
164158045|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
164158046|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
164158047|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
164158048|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
164158049|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
164158050|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
164158051|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
164158052|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
164158053|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
164158054|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
164158055|NCT00838903|592941865|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
164158056|NCT00838903|592941866|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
164158057|NCT00838903|592941867|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
164158058|NCT00838903|592941868|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
164158059|NCT00838903|592941865|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
164158060|NCT00838903|592941866|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
164158061|NCT00838903|592941867|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
164158062|NCT00838903|592941868|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
164158063|NCT00838903|592941865|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
164158064|NCT00838903|592941866|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
164158065|NCT00838903|592941867|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
164158066|NCT00838903|592941868|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
164158067|NCT00838903|592941865|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
164158068|NCT00838903|592941866|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
164158069|NCT00838903|592941867|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
164158070|NCT00838903|592941868|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
164158071|NCT00838903|592941865|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
164158072|NCT00838903|592941866|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
164158073|NCT00838903|592941867|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
164158074|NCT00838903|592941868|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
164158075|NCT00838903|592941865|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
164158076|NCT00838903|592941866|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
164158077|NCT00838903|592941867|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
164158078|NCT00838903|592941868|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
164158079|NCT00838903|592941865|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
164158080|NCT00838903|592941866|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
164158081|NCT00838903|592941867|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
164158082|NCT00838903|592941868|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
164158083|NCT00838903|592941865|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
164158084|NCT00838903|592941866|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
164158085|NCT00838903|592941867|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
164158086|NCT00838903|592941868|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
164158087|NCT00838903|592941865|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
164158088|NCT00838903|592941866|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
164158089|NCT00838903|592941867|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
164158090|NCT00838903|592941868|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
164158091|NCT00838903|592941865|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
164158092|NCT00838903|592941866|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
164158093|NCT00838903|592941867|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
164158094|NCT00838903|592941868|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
164158095|NCT00838903|592941865|FG000|Follow-up Period (8 Weeks)|Missing|1|||
164158096|NCT00838903|592941866|FG001|Follow-up Period (8 Weeks)|Missing|2|||
164158097|NCT00838903|592941867|FG002|Follow-up Period (8 Weeks)|Missing|1|||
164158098|NCT00838903|592941868|FG003|Follow-up Period (8 Weeks)|Missing|1|||
164158099|NCT00536939|592941869|FG000|Overall Study|Withdrawal by Subject|1|||
164158100|NCT00536939|592941870|FG001|Overall Study|Withdrawal by Subject|0|||
164158101|NCT00536939|592941869|FG000|Overall Study|Other Complicating Disease|1|||
164158102|NCT00536939|592941870|FG001|Overall Study|Other Complicating Disease|0|||
164158103|NCT04225715|592941871|FG000|Overall Study|Reason not Specified|1|||
164158104|NCT04225715|592941872|FG001|Overall Study|Reason not Specified|0|||
164158105|NCT04225715|592941873|FG002|Overall Study|Reason not Specified|0|||
164158106|NCT04225715|592941874|FG003|Overall Study|Reason not Specified|0|||
164158107|NCT04225715|592941875|FG004|Overall Study|Reason not Specified|0|||
164158108|NCT04225715|592941876|FG005|Overall Study|Reason not Specified|0|||
164158109|NCT04225715|592941877|FG006|Overall Study|Reason not Specified|0|||
164158110|NCT04225715|592941878|FG007|Overall Study|Reason not Specified|0|||
164158111|NCT04225715|592941879|FG008|Overall Study|Reason not Specified|0|||
164158112|NCT04225715|592941871|FG000|Overall Study|Protocol Violation|1|||
164158113|NCT04225715|592941872|FG001|Overall Study|Protocol Violation|0|||
164158114|NCT04225715|592941873|FG002|Overall Study|Protocol Violation|0|||
164158115|NCT04225715|592941874|FG003|Overall Study|Protocol Violation|0|||
164158116|NCT04225715|592941875|FG004|Overall Study|Protocol Violation|0|||
164158117|NCT04225715|592941876|FG005|Overall Study|Protocol Violation|9|||
164158118|NCT04225715|592941877|FG006|Overall Study|Protocol Violation|0|||
164158119|NCT04225715|592941878|FG007|Overall Study|Protocol Violation|0|||
164158120|NCT04225715|592941879|FG008|Overall Study|Protocol Violation|0|||
164158121|NCT04225715|592941871|FG000|Overall Study|Withdrawal by Subject|4|||
164158122|NCT04225715|592941872|FG001|Overall Study|Withdrawal by Subject|1|||
164158123|NCT04225715|592941873|FG002|Overall Study|Withdrawal by Subject|1|||
164158124|NCT04225715|592941874|FG003|Overall Study|Withdrawal by Subject|0|||
164158125|NCT04225715|592941875|FG004|Overall Study|Withdrawal by Subject|3|||
164158126|NCT04225715|592941876|FG005|Overall Study|Withdrawal by Subject|1|||
164158127|NCT04225715|592941877|FG006|Overall Study|Withdrawal by Subject|1|||
164158128|NCT04225715|592941878|FG007|Overall Study|Withdrawal by Subject|1|||
164158129|NCT04225715|592941879|FG008|Overall Study|Withdrawal by Subject|0|||
164158130|NCT04225715|592941871|FG000|Overall Study|Adverse Event|0|||
164158131|NCT04225715|592941872|FG001|Overall Study|Adverse Event|0|||
164158132|NCT04225715|592941873|FG002|Overall Study|Adverse Event|0|||
164158133|NCT04225715|592941874|FG003|Overall Study|Adverse Event|0|||
164158134|NCT04225715|592941875|FG004|Overall Study|Adverse Event|0|||
164158135|NCT04225715|592941876|FG005|Overall Study|Adverse Event|0|||
164158136|NCT04225715|592941877|FG006|Overall Study|Adverse Event|0|||
164158137|NCT04225715|592941878|FG007|Overall Study|Adverse Event|0|||
164158138|NCT04225715|592941879|FG008|Overall Study|Adverse Event|1|||
164158139|NCT04225715|592941871|FG000|Overall Study|Arm Terminated By Sponsor|0|||
164158140|NCT04225715|592941872|FG001|Overall Study|Arm Terminated By Sponsor|0|||
164158141|NCT04225715|592941873|FG002|Overall Study|Arm Terminated By Sponsor|0|||
164158142|NCT04225715|592941874|FG003|Overall Study|Arm Terminated By Sponsor|0|||
164158143|NCT04225715|592941875|FG004|Overall Study|Arm Terminated By Sponsor|0|||
164158144|NCT04225715|592941876|FG005|Overall Study|Arm Terminated By Sponsor|0|||
164158145|NCT04225715|592941877|FG006|Overall Study|Arm Terminated By Sponsor|0|||
164158146|NCT04225715|592941878|FG007|Overall Study|Arm Terminated By Sponsor|17|||
164158147|NCT04225715|592941879|FG008|Overall Study|Arm Terminated By Sponsor|18|||
164158148|NCT01894841|592941880|FG000|Overall Study|Withdrawal by Subject|9|||
164158149|NCT01894841|592941881|FG001|Overall Study|Withdrawal by Subject|4|||
164158150|NCT01894841|592941880|FG000|Overall Study|Withdrawn by investigator|2|||
164158151|NCT01894841|592941881|FG001|Overall Study|Withdrawn by investigator|2|||
164158152|NCT01894841|592941880|FG000|Overall Study|Lost to Follow-up|7|||
164158153|NCT01894841|592941881|FG001|Overall Study|Lost to Follow-up|3|||
164158154|NCT02955355|592941882|FG000|Overall Study|Adverse Event|4|||
164158155|NCT02955355|592941882|FG000|Overall Study|Death|1|||
164158156|NCT02955355|592941882|FG000|Overall Study|Physician Decision|21|||
164158157|NCT02955355|592941882|FG000|Overall Study|Site Terminated by Sponsor|35|||
164158158|NCT02955355|592941882|FG000|Overall Study|Withdrawal by Subject|19|||
164158159|NCT02955355|592941882|FG000|Overall Study|Reason Not Specified|5|||
164158160|NCT02612623|592941883|FG000|Overall Study|Withdrawal by Subject|0|||
164158161|NCT02612623|592941884|FG001|Overall Study|Withdrawal by Subject|1|||
164158162|NCT02612623|592941885|FG002|Overall Study|Withdrawal by Subject|0|||
164158163|NCT02612623|592941886|FG003|Overall Study|Withdrawal by Subject|0|||
164158164|NCT02612623|592941883|FG000|Overall Study|Adverse Event|1|||
164158165|NCT02612623|592941884|FG001|Overall Study|Adverse Event|0|||
164158166|NCT02612623|592941885|FG002|Overall Study|Adverse Event|1|||
164158167|NCT02612623|592941886|FG003|Overall Study|Adverse Event|0|||
164158168|NCT04878432|592941890|FG000|Overall Study|Adverse Event|1|||
164158169|NCT04878432|592941890|FG000|Overall Study|Death|2|||
164158170|NCT04878432|592941890|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
164158171|NCT04878432|592941890|FG000|Overall Study|Withdrawal by Subject|6|||
164158172|NCT04878432|592941890|FG000|Overall Study|Progressive Disease|7|||
164158173|NCT04878432|592941890|FG000|Overall Study|New Therapy for Study Indication|7|||
164158174|NCT04878432|592941890|FG000|Overall Study|Physician Decision|11|||
164158175|NCT03971071|592941891|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
164158176|NCT03971071|592941892|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
164158177|NCT03971071|592941893|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
164158178|NCT03971071|592941894|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
164158179|NCT03971071|592941895|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
164158180|NCT03971071|592941891|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
164158181|NCT03971071|592941892|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
164158182|NCT03971071|592941893|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
164158183|NCT03971071|592941894|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
164158184|NCT03971071|592941895|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
164158185|NCT03971071|592941891|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
164158186|NCT03971071|592941892|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
164158187|NCT03971071|592941893|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
164158188|NCT03971071|592941894|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
164158189|NCT03971071|592941895|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
164158190|NCT03971071|592941891|FG000|Open-label Treatment Period|Sponsor decision|0|||
164158191|NCT03971071|592941892|FG001|Open-label Treatment Period|Sponsor decision|0|||
164158192|NCT03971071|592941893|FG002|Open-label Treatment Period|Sponsor decision|0|||
164158193|NCT03971071|592941894|FG003|Open-label Treatment Period|Sponsor decision|0|||
164158194|NCT03971071|592941895|FG004|Open-label Treatment Period|Sponsor decision|1|||
164158195|NCT03971071|592941891|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
164158196|NCT03971071|592941892|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
164158197|NCT03971071|592941893|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
164158198|NCT03971071|592941894|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
164158199|NCT03971071|592941895|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
164158200|NCT03971071|592941891|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
164158201|NCT03971071|592941892|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
164158202|NCT03971071|592941893|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
164158203|NCT03971071|592941894|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
164158204|NCT03971071|592941895|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
164158205|NCT00360282|592941897|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
164158206|NCT00360282|592941898|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
164158207|NCT00360282|592941899|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
164158208|NCT00360282|592941900|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
164158209|NCT00360282|592941897|FG000|Second Intervention|Adverse Event|0|||
164158210|NCT00360282|592941898|FG001|Second Intervention|Adverse Event|1|||
164158211|NCT00360282|592941899|FG002|Second Intervention|Adverse Event|0|||
164158212|NCT00360282|592941900|FG003|Second Intervention|Adverse Event|0|||
164158213|NCT00925704|592941901|FG000|First Intervention|Withdrew consent|0|||
164158214|NCT00925704|592941902|FG001|First Intervention|Withdrew consent|0|||
164158215|NCT00925704|592941903|FG002|First Intervention|Withdrew consent|0|||
164158216|NCT00925704|592941904|FG003|First Intervention|Withdrew consent|1|||
164158217|NCT00925704|592941905|FG004|First Intervention|Withdrew consent|1|||
164158218|NCT00925704|592941906|FG005|First Intervention|Withdrew consent|0|||
164158219|NCT00925704|592941901|FG000|Second Intervention|Withdrawal by Subject|1|||
164158220|NCT00925704|592941902|FG001|Second Intervention|Withdrawal by Subject|0|||
164158221|NCT00925704|592941903|FG002|Second Intervention|Withdrawal by Subject|0|||
164158222|NCT00925704|592941904|FG003|Second Intervention|Withdrawal by Subject|0|||
164158223|NCT00925704|592941905|FG004|Second Intervention|Withdrawal by Subject|1|||
164158224|NCT00925704|592941906|FG005|Second Intervention|Withdrawal by Subject|0|||
164158225|NCT00925704|592941901|FG000|Third Intervention|Withdrew consent|0|||
164158226|NCT00925704|592941902|FG001|Third Intervention|Withdrew consent|0|||
164158227|NCT00925704|592941903|FG002|Third Intervention|Withdrew consent|0|||
164158228|NCT00925704|592941904|FG003|Third Intervention|Withdrew consent|0|||
164158229|NCT00925704|592941905|FG004|Third Intervention|Withdrew consent|0|||
164158230|NCT00925704|592941906|FG005|Third Intervention|Withdrew consent|1|||
164158231|NCT04537078|592941909|FG000|Overall Study|Protocol Violation|3|||
164158232|NCT04537078|592941910|FG001|Overall Study|Protocol Violation|2|||
164158233|NCT04537078|592941909|FG000|Overall Study|Lost to Follow-up|1|||
164158234|NCT04537078|592941910|FG001|Overall Study|Lost to Follow-up|0|||
164158235|NCT04537078|592941909|FG000|Overall Study|Withdrawal by Subject|0|||
164158236|NCT04537078|592941910|FG001|Overall Study|Withdrawal by Subject|1|||
164158237|NCT03207815|592941911|FG000|Overall Study|Protocol Violation|3|||
164158238|NCT03207815|592941912|FG001|Overall Study|Protocol Violation|1|||
164158239|NCT03207815|592941911|FG000|Overall Study|Adverse Event|1|||
164158240|NCT03207815|592941912|FG001|Overall Study|Adverse Event|2|||
164158241|NCT03207815|592941911|FG000|Overall Study|Lost to Follow-up|1|||
164158242|NCT03207815|592941912|FG001|Overall Study|Lost to Follow-up|2|||
164158243|NCT03207815|592941911|FG000|Overall Study|Investigator's Discretion|1|||
164158244|NCT03207815|592941912|FG001|Overall Study|Investigator's Discretion|1|||
164158245|NCT03207815|592941911|FG000|Overall Study|Lack of Efficacy|0|||
164158246|NCT03207815|592941912|FG001|Overall Study|Lack of Efficacy|1|||
164158247|NCT03207815|592941911|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
164158248|NCT03207815|592941912|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
164158249|NCT03207815|592941911|FG000|Overall Study|Withdrew Consent|1|||
164158250|NCT03207815|592941912|FG001|Overall Study|Withdrew Consent|0|||
164158251|NCT03817853|592941913|FG000|Induction Phase|Adverse Event|5|||
164158252|NCT03817853|592941914|FG001|Induction Phase|Adverse Event|0|||
164158253|NCT03817853|592941915|FG002|Induction Phase|Adverse Event|0|||
164158254|NCT03817853|592941913|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
164158255|NCT03817853|592941914|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
164158256|NCT03817853|592941915|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
164158257|NCT03817853|592941913|FG000|Induction Phase|Physician Decision|2|||
164158258|NCT03817853|592941914|FG001|Induction Phase|Physician Decision|0|||
164158259|NCT03817853|592941915|FG002|Induction Phase|Physician Decision|0|||
164158260|NCT03817853|592941913|FG000|Induction Phase|Progressive Disease|6|||
164158261|NCT03817853|592941914|FG001|Induction Phase|Progressive Disease|0|||
164158262|NCT03817853|592941915|FG002|Induction Phase|Progressive Disease|0|||
164158263|NCT03817853|592941913|FG000|Induction Phase|Withdrawal by Subject|4|||
164158264|NCT03817853|592941914|FG001|Induction Phase|Withdrawal by Subject|0|||
164158265|NCT03817853|592941915|FG002|Induction Phase|Withdrawal by Subject|0|||
164158266|NCT03817853|592941913|FG000|Maintenance Phase|Adverse Event|0|||
164158267|NCT03817853|592941914|FG001|Maintenance Phase|Adverse Event|8|||
164158268|NCT03817853|592941915|FG002|Maintenance Phase|Adverse Event|0|||
164158269|NCT03817853|592941913|FG000|Maintenance Phase|Death|0|||
164158270|NCT03817853|592941914|FG001|Maintenance Phase|Death|5|||
164158271|NCT03817853|592941915|FG002|Maintenance Phase|Death|0|||
164158272|NCT03817853|592941913|FG000|Maintenance Phase|Progressive Disease|0|||
164158273|NCT03817853|592941914|FG001|Maintenance Phase|Progressive Disease|7|||
164158274|NCT03817853|592941915|FG002|Maintenance Phase|Progressive Disease|0|||
164158275|NCT03817853|592941913|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164158276|NCT03817853|592941914|FG001|Maintenance Phase|Withdrawal by Subject|2|||
164158277|NCT03817853|592941915|FG002|Maintenance Phase|Withdrawal by Subject|0|||
164158278|NCT03817853|592941913|FG000|Maintenance Phase|Physician Decision|0|||
164158279|NCT03817853|592941914|FG001|Maintenance Phase|Physician Decision|1|||
164158280|NCT03817853|592941915|FG002|Maintenance Phase|Physician Decision|0|||
164158281|NCT03817853|592941913|FG000|Maintenance Phase|Various reasons|0|||
164158282|NCT03817853|592941914|FG001|Maintenance Phase|Various reasons|4|||
164158283|NCT03817853|592941915|FG002|Maintenance Phase|Various reasons|0|||
164158284|NCT03817853|592941913|FG000|Maintenance Phase|Protocol Deviation|0|||
164158285|NCT03817853|592941914|FG001|Maintenance Phase|Protocol Deviation|1|||
164158286|NCT03817853|592941915|FG002|Maintenance Phase|Protocol Deviation|0|||
164158287|NCT03817853|592941913|FG000|Follow-up Phase|Adverse Event|0|||
164158288|NCT03817853|592941914|FG001|Follow-up Phase|Adverse Event|0|||
164158289|NCT03817853|592941915|FG002|Follow-up Phase|Adverse Event|2|||
164158290|NCT03817853|592941913|FG000|Follow-up Phase|Death|0|||
164158291|NCT03817853|592941914|FG001|Follow-up Phase|Death|0|||
164158293|NCT03817853|592941913|FG000|Follow-up Phase|Progressive Disease|0|||
164158294|NCT03817853|592941914|FG001|Follow-up Phase|Progressive Disease|0|||
164158295|NCT03817853|592941915|FG002|Follow-up Phase|Progressive Disease|3|||
164158296|NCT03817853|592941913|FG000|Follow-up Phase|Withdrawal by Subject|0|||
164158297|NCT03817853|592941914|FG001|Follow-up Phase|Withdrawal by Subject|0|||
164158298|NCT03817853|592941915|FG002|Follow-up Phase|Withdrawal by Subject|1|||
164158299|NCT01620138|592941916|FG000|Overall Study|Withdrawal by Subject|3|||
164158300|NCT01620138|592941917|FG001|Overall Study|Withdrawal by Subject|0|||
164158301|NCT01620138|592941916|FG000|Overall Study|Lack of Efficacy|1|||
164158302|NCT01620138|592941917|FG001|Overall Study|Lack of Efficacy|0|||
164158303|NCT01620138|592941916|FG000|Overall Study|Adverse Event|2|||
164158304|NCT01620138|592941917|FG001|Overall Study|Adverse Event|0|||
164158305|NCT05005507|592941920|FG000|Overall Study|Premature termination of study|1|||
164158306|NCT03866512|592941922|FG000|Overall Study|Lost to Follow-up|1|||
164158307|NCT03866512|592941923|FG001|Overall Study|Lost to Follow-up|2|||
164158308|NCT03866512|592941924|FG002|Overall Study|Lost to Follow-up|1|||
164158309|NCT03866512|592941922|FG000|Overall Study|Cannulation issues|0|||
164158310|NCT03866512|592941923|FG001|Overall Study|Cannulation issues|1|||
164158311|NCT03866512|592941924|FG002|Overall Study|Cannulation issues|2|||
164158312|NCT00320710|592941925|FG000|Overall Study|Disease progression|24|||
164158313|NCT00320710|592941926|FG001|Overall Study|Disease progression|19|||
164158314|NCT00320710|592941927|FG002|Overall Study|Disease progression|2|||
164158315|NCT00320710|592941925|FG000|Overall Study|Death|10|||
164158316|NCT00320710|592941926|FG001|Overall Study|Death|7|||
164158317|NCT00320710|592941927|FG002|Overall Study|Death|1|||
164158318|NCT00320710|592941925|FG000|Overall Study|Administrative problems|1|||
164158319|NCT00320710|592941926|FG001|Overall Study|Administrative problems|2|||
164158320|NCT00320710|592941927|FG002|Overall Study|Administrative problems|0|||
164158321|NCT00320710|592941925|FG000|Overall Study|Withdrawal by Subject|20|||
164158322|NCT00320710|592941926|FG001|Overall Study|Withdrawal by Subject|26|||
164158323|NCT00320710|592941927|FG002|Overall Study|Withdrawal by Subject|1|||
164158324|NCT00320710|592941925|FG000|Overall Study|Protocol Violation|6|||
164158325|NCT00320710|592941926|FG001|Overall Study|Protocol Violation|5|||
164158326|NCT00320710|592941927|FG002|Overall Study|Protocol Violation|0|||
164158327|NCT00320710|592941925|FG000|Overall Study|Abnormal test procedure result(s)|2|||
164158328|NCT00320710|592941926|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164158329|NCT00320710|592941927|FG002|Overall Study|Abnormal test procedure result(s)|0|||
164158330|NCT00320710|592941925|FG000|Overall Study|Abnormal laboratory value(s)|12|||
164158331|NCT00320710|592941926|FG001|Overall Study|Abnormal laboratory value(s)|3|||
164158332|NCT00320710|592941927|FG002|Overall Study|Abnormal laboratory value(s)|0|||
164158333|NCT00320710|592941925|FG000|Overall Study|Adverse Event|18|||
164158334|NCT00320710|592941926|FG001|Overall Study|Adverse Event|14|||
164158335|NCT00320710|592941927|FG002|Overall Study|Adverse Event|1|||
164158336|NCT00320710|592941925|FG000|Overall Study|Lost to Follow-up|1|||
164158337|NCT00320710|592941926|FG001|Overall Study|Lost to Follow-up|0|||
164158338|NCT00320710|592941927|FG002|Overall Study|Lost to Follow-up|0|||
164158339|NCT00997373|592941933|FG000|Overall Study|Withdrawal by Subject|5|||
164158340|NCT00997373|592941934|FG001|Overall Study|Withdrawal by Subject|0|||
164158341|NCT00997373|592941933|FG000|Overall Study|wrong tumor type|4|||
164158342|NCT00997373|592941934|FG001|Overall Study|wrong tumor type|0|||
164158343|NCT00997373|592941933|FG000|Overall Study|could not have hysterectomy|6|||
164158344|NCT00997373|592941934|FG001|Overall Study|could not have hysterectomy|0|||
164158345|NCT04578457|592941935|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
164158346|NCT04578457|592941935|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
164158347|NCT04578457|592941935|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
164158348|NCT04578457|592941935|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
164158349|NCT00832455|592941936|FG000|Overall Study|Adverse Event|13|||
164158350|NCT00832455|592941936|FG000|Overall Study|Lost to Follow-up|26|||
164158351|NCT00832455|592941936|FG000|Overall Study|Protocol Violation|4|||
164158352|NCT00832455|592941936|FG000|Overall Study|Withdrawal by Subject|17|||
164158353|NCT00832455|592941936|FG000|Overall Study|Screening Failure|2|||
164158354|NCT00832455|592941936|FG000|Overall Study|Stopped Medication|4|||
164158355|NCT00832455|592941936|FG000|Overall Study|Parent misunderstood study|1|||
164158356|NCT00832455|592941936|FG000|Overall Study|Parent dissatisfied|1|||
164158357|NCT00832455|592941936|FG000|Overall Study|No improvement|3|||
164158358|NCT00832455|592941936|FG000|Overall Study|Patient moved|1|||
164158359|NCT02841995|592941944|FG000|Overall Study|Disease progression|5|||
164158360|NCT02841995|592941945|FG001|Overall Study|Disease progression|11|||
164158361|NCT02841995|592941946|FG002|Overall Study|Disease progression|8|||
164158362|NCT02841995|592941944|FG000|Overall Study|Withdrawal by Subject|2|||
164158363|NCT02841995|592941945|FG001|Overall Study|Withdrawal by Subject|4|||
164158364|NCT02841995|592941946|FG002|Overall Study|Withdrawal by Subject|4|||
164158365|NCT02841995|592941944|FG000|Overall Study|Adverse Event|2|||
164158366|NCT02841995|592941945|FG001|Overall Study|Adverse Event|0|||
164158367|NCT02841995|592941946|FG002|Overall Study|Adverse Event|1|||
164158368|NCT02841995|592941944|FG000|Overall Study|Investigator decision|2|||
164158369|NCT02841995|592941945|FG001|Overall Study|Investigator decision|0|||
164158370|NCT02841995|592941946|FG002|Overall Study|Investigator decision|1|||
164158371|NCT02841995|592941944|FG000|Overall Study|Death|0|||
164158372|NCT02841995|592941945|FG001|Overall Study|Death|0|||
164158373|NCT02841995|592941946|FG002|Overall Study|Death|2|||
164158374|NCT02841995|592941944|FG000|Overall Study|Noncompliance to protocol|1|||
164158375|NCT02841995|592941945|FG001|Overall Study|Noncompliance to protocol|0|||
164158376|NCT02841995|592941946|FG002|Overall Study|Noncompliance to protocol|0|||
164158377|NCT02841995|592941944|FG000|Overall Study|Sponsor decision|1|||
164158378|NCT02841995|592941945|FG001|Overall Study|Sponsor decision|0|||
164158379|NCT02841995|592941946|FG002|Overall Study|Sponsor decision|0|||
164158380|NCT02841995|592941944|FG000|Overall Study|Other|4|||
164158381|NCT02841995|592941945|FG001|Overall Study|Other|1|||
164158382|NCT02841995|592941946|FG002|Overall Study|Other|5|||
164158383|NCT02755103|592941948|FG000|Overall Study|Lost to Follow-up|17|||
164158384|NCT02755103|592941949|FG001|Overall Study|Lost to Follow-up|15|||
164158385|NCT02755103|592941948|FG000|Overall Study|Death|0|||
164158386|NCT02755103|592941949|FG001|Overall Study|Death|1|||
164158387|NCT02755103|592941948|FG000|Overall Study|Physician Decision|0|||
164158388|NCT02755103|592941949|FG001|Overall Study|Physician Decision|1|||
164158389|NCT02755103|592941948|FG000|Overall Study|Pregnancy|0|||
164158390|NCT02755103|592941949|FG001|Overall Study|Pregnancy|1|||
164158391|NCT02755103|592941948|FG000|Overall Study|Withdrawal by Subject|3|||
164158392|NCT02755103|592941949|FG001|Overall Study|Withdrawal by Subject|0|||
164158393|NCT00739661|592941957|FG000|Overall Study|Adverse Event|2|||
164158394|NCT00739661|592941958|FG001|Overall Study|Adverse Event|0|||
164158395|NCT00739661|592941957|FG000|Overall Study|Physician decision to withdraw patient|1|||
164158396|NCT00739661|592941958|FG001|Overall Study|Physician decision to withdraw patient|0|||
164158397|NCT00739661|592941957|FG000|Overall Study|Patient decision to withdraw|9|||
164158398|NCT00739661|592941958|FG001|Overall Study|Patient decision to withdraw|4|||
164158399|NCT00739661|592941957|FG000|Overall Study|Disease progression, radiographic|33|||
164158400|NCT00739661|592941958|FG001|Overall Study|Disease progression, radiographic|37|||
164158401|NCT00739661|592941957|FG000|Overall Study|Reason for discontinuation not available|1|||
164158402|NCT00739661|592941958|FG001|Overall Study|Reason for discontinuation not available|1|||
164158403|NCT03839628|592941961|FG000|Overall Study|Withdrawal by Subject|1|||
164158404|NCT01289678|592941962|FG000|Overall Study|Physician Decision|6|||
164158405|NCT03539302|592941965|FG000|Overall Study|Spontaneous cardio version|0|||
164158406|NCT03539302|592941966|FG001|Overall Study|Spontaneous cardio version|0|||
164158407|NCT03539302|592941967|FG002|Overall Study|Spontaneous cardio version|0|||
164158408|NCT03539302|592941968|FG003|Overall Study|Spontaneous cardio version|0|||
164158409|NCT03539302|592941969|FG004|Overall Study|Spontaneous cardio version|0|||
164158410|NCT03539302|592941970|FG005|Overall Study|Spontaneous cardio version|1|||
164158411|NCT03539302|592941971|FG006|Overall Study|Spontaneous cardio version|1|||
164158412|NCT04564092|592941973|FG000|Overall Study|Withdrawal by Subject|1|||
164158413|NCT02362360|592941979|FG000|Period 1|Lack of Efficacy|1|||
164158414|NCT02362360|592941980|FG001|Period 1|Lack of Efficacy|0|||
164158415|NCT02362360|592941979|FG000|Period 1|Withdrawal by Subject|2|||
164158416|NCT02362360|592941980|FG001|Period 1|Withdrawal by Subject|1|||
164158417|NCT04146012|592941981|FG000|Overall Study|Study Terminated|30|||
164158418|NCT04146012|592941982|FG001|Overall Study|Study Terminated|15|||
164158419|NCT03817190|592941983|FG000|Overall Study|Early Termination|13|||
164158420|NCT03817190|592941984|FG001|Overall Study|Early Termination|20|||
164158421|NCT03817190|592941983|FG000|Overall Study|Adverse Event|10|||
164158422|NCT03817190|592941984|FG001|Overall Study|Adverse Event|17|||
164158423|NCT03817190|592941983|FG000|Overall Study|Withdrawal by Subject|12|||
164158424|NCT03817190|592941984|FG001|Overall Study|Withdrawal by Subject|8|||
164158425|NCT03817190|592941983|FG000|Overall Study|Lost to Follow-up|11|||
164158426|NCT03817190|592941984|FG001|Overall Study|Lost to Follow-up|7|||
164158427|NCT03817190|592941983|FG000|Overall Study|Lack of Efficacy|7|||
164158428|NCT03817190|592941984|FG001|Overall Study|Lack of Efficacy|5|||
164158429|NCT03817190|592941983|FG000|Overall Study|Investigator Decision|5|||
164158430|NCT03817190|592941984|FG001|Overall Study|Investigator Decision|1|||
164158431|NCT03817190|592941983|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
164158432|NCT03817190|592941984|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
164158433|NCT03817190|592941983|FG000|Overall Study|Lack of Contact|1|||
164158434|NCT03817190|592941984|FG001|Overall Study|Lack of Contact|0|||
164158435|NCT03817190|592941983|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
164158436|NCT03817190|592941984|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
164158437|NCT01546025|592941985|FG000|Overall Study|Lost to Follow-up|0|||
164158438|NCT01546025|592941986|FG001|Overall Study|Lost to Follow-up|1|||
164158439|NCT00868530|592941987|FG000|Overall Study|Adverse Event|3|||
164158440|NCT00868530|592941987|FG000|Overall Study|Lost to Follow-up|1|||
164158441|NCT04955691|592943714|FG000|Period 2|Discontinued intervention|1|||
164158442|NCT04955691|592943715|FG001|Period 2|Discontinued intervention|2|||
164158443|NCT05336227|592943716|FG000|Overall Study|Adverse Event|1|||
164158444|NCT05336227|592943717|FG001|Overall Study|Adverse Event|0|||
164158445|NCT05336227|592943716|FG000|Overall Study|Lost to Follow-up|2|||
164158446|NCT05336227|592943717|FG001|Overall Study|Lost to Follow-up|0|||
164158447|NCT05336227|592943716|FG000|Overall Study|Withdrawal by Subject|1|||
164158448|NCT05336227|592943717|FG001|Overall Study|Withdrawal by Subject|0|||
164158449|NCT05086744|592943718|FG000|Part A|Adverse Event|0|||
164158450|NCT05086744|592943719|FG001|Part A|Adverse Event|1|||
164158451|NCT05086744|592943718|FG000|Part A|Lack of Efficacy|3|||
164158452|NCT05086744|592943719|FG001|Part A|Lack of Efficacy|0|||
164158453|NCT05086744|592943718|FG000|Part A|Protocol deviation|1|||
164158454|NCT05086744|592943719|FG001|Part A|Protocol deviation|0|||
164158455|NCT05086744|592943718|FG000|Part A|Subject decision|1|||
164158456|NCT05086744|592943719|FG001|Part A|Subject decision|0|||
164158457|NCT05086744|592943718|FG000|Part B|Adverse Event|0|||
164158458|NCT05086744|592943719|FG001|Part B|Adverse Event|1|||
164158459|NCT05086744|592943718|FG000|Part B|Lack of Efficacy|0|||
164158460|NCT05086744|592943719|FG001|Part B|Lack of Efficacy|1|||
164158461|NCT05086744|592943718|FG000|Part B|Study terminated by sponsor|1|||
164158462|NCT05086744|592943719|FG001|Part B|Study terminated by sponsor|6|||
164158463|NCT04050462|592943720|FG000|Overall Study|Withdrawal by Subject|1|||
164158464|NCT04050462|592943721|FG001|Overall Study|Withdrawal by Subject|0|||
164158465|NCT04050462|592943722|FG002|Overall Study|Withdrawal by Subject|0|||
164158466|NCT05151744|592943725|FG000|Overall Study|Adverse Event|6|||
164158467|NCT05151744|592943726|FG001|Overall Study|Adverse Event|2|||
164158468|NCT05151744|592943725|FG000|Overall Study|Death|1|||
164158469|NCT05151744|592943726|FG001|Overall Study|Death|2|||
164158470|NCT05151744|592943725|FG000|Overall Study|Lack of Efficacy|1|||
164158471|NCT05151744|592943726|FG001|Overall Study|Lack of Efficacy|1|||
164158472|NCT05151744|592943725|FG000|Overall Study|Lost to Follow-up|2|||
164158473|NCT05151744|592943726|FG001|Overall Study|Lost to Follow-up|2|||
164158474|NCT05151744|592943725|FG000|Overall Study|Need for Rescue Treatment|0|||
164158475|NCT05151744|592943726|FG001|Overall Study|Need for Rescue Treatment|1|||
164158476|NCT05151744|592943725|FG000|Overall Study|Non-compliance with Study Drug|0|||
164158477|NCT05151744|592943726|FG001|Overall Study|Non-compliance with Study Drug|1|||
164158478|NCT05151744|592943725|FG000|Overall Study|Reason not Specified|10|||
164158479|NCT05151744|592943726|FG001|Overall Study|Reason not Specified|0|||
164158480|NCT05151744|592943725|FG000|Overall Study|Physician Decision|2|||
164158481|NCT05151744|592943726|FG001|Overall Study|Physician Decision|1|||
164158482|NCT05151744|592943725|FG000|Overall Study|Protocol Violation|1|||
164158483|NCT05151744|592943726|FG001|Overall Study|Protocol Violation|0|||
164158484|NCT05151744|592943725|FG000|Overall Study|Withdrawal by Subject|6|||
164158485|NCT05151744|592943726|FG001|Overall Study|Withdrawal by Subject|3|||
164158486|NCT04053868|592943727|FG000|Overall Study|Withdrawal by Subject|1|||
164158487|NCT04053868|592943728|FG001|Overall Study|Withdrawal by Subject|0|||
164158488|NCT05731700|592943729|FG000|Overall Study|Death|1|||
164158489|NCT01682226|592943732|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
164158490|NCT01682226|592943732|FG000|Overall Study|Participants did not receive treatment|2|||
164158491|NCT01682226|592943732|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
164158492|NCT03771898|592943741|FG000|Overall Study|Adverse Event|1|||
164158493|NCT03771898|592943742|FG001|Overall Study|Adverse Event|0|||
164158494|NCT03771898|592943743|FG002|Overall Study|Adverse Event|0|||
164158495|NCT03771898|592943744|FG003|Overall Study|Adverse Event|0|||
164158496|NCT03771898|592943745|FG004|Overall Study|Adverse Event|0|||
164158497|NCT03771898|592943741|FG000|Overall Study|Lost to Follow-up|1|||
164158498|NCT03771898|592943742|FG001|Overall Study|Lost to Follow-up|1|||
164158499|NCT03771898|592943743|FG002|Overall Study|Lost to Follow-up|1|||
164158500|NCT03771898|592943744|FG003|Overall Study|Lost to Follow-up|0|||
164158501|NCT03771898|592943745|FG004|Overall Study|Lost to Follow-up|0|||
164158502|NCT03771898|592943741|FG000|Overall Study|Withdrawal by parent/guardian|1|||
164158503|NCT03771898|592943742|FG001|Overall Study|Withdrawal by parent/guardian|1|||
164158504|NCT03771898|592943743|FG002|Overall Study|Withdrawal by parent/guardian|0|||
164158505|NCT03771898|592943744|FG003|Overall Study|Withdrawal by parent/guardian|0|||
164158506|NCT03771898|592943745|FG004|Overall Study|Withdrawal by parent/guardian|0|||
164158507|NCT03771898|592943741|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
164158508|NCT03771898|592943742|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
164158509|NCT03771898|592943743|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
164158510|NCT03771898|592943744|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
164158511|NCT03771898|592943745|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
164158512|NCT03123120|592943746|FG000|Overall Study|Lost to Follow-up|0|||
164158513|NCT03123120|592943747|FG001|Overall Study|Lost to Follow-up|1|||
164158514|NCT03123120|592943746|FG000|Overall Study|Withdrawal by Subject|0|||
164158515|NCT03123120|592943747|FG001|Overall Study|Withdrawal by Subject|1|||
164158516|NCT03135548|592943751|FG000|Overall Study|Lost to Follow-up|3|||
164158517|NCT03135548|592943752|FG001|Overall Study|Lost to Follow-up|0|||
164158518|NCT03135548|592943753|FG002|Overall Study|Lost to Follow-up|0|||
164158519|NCT03135548|592943751|FG000|Overall Study|Withdrawal by Subject|2|||
164158520|NCT03135548|592943752|FG001|Overall Study|Withdrawal by Subject|2|||
164158521|NCT03135548|592943753|FG002|Overall Study|Withdrawal by Subject|1|||
164158522|NCT03135548|592943751|FG000|Overall Study|Other than listed|0|||
164158523|NCT03135548|592943752|FG001|Overall Study|Other than listed|2|||
164158524|NCT03135548|592943753|FG002|Overall Study|Other than listed|2|||
164158525|NCT02632175|592943754|FG000|Overall Study|Withdrawal by Subject|6|||
164158526|NCT02632175|592943754|FG000|Overall Study|Lost to Follow-up|1|||
164158527|NCT02632175|592943754|FG000|Overall Study|Lack of Efficacy|18|||
164158528|NCT02632175|592943754|FG000|Overall Study|Required alternative (or prohibited) therapy|1|||
164158529|NCT02632175|592943754|FG000|Overall Study|Subject noncompliance|3|||
164158530|NCT02632175|592943754|FG000|Overall Study|other|2|||
164158531|NCT02088554|592943755|FG000|Overall Study|Exited before procedure|130|||
164158532|NCT02088554|592943755|FG000|Overall Study|Attempted but not implanted|31|||
164158533|NCT02088554|592943755|FG000|Overall Study|Implant not attempted|19|||
164158534|NCT02088554|592943755|FG000|Overall Study|Pending next visit|532|||
164158535|NCT02088554|592943755|FG000|Overall Study|Death|170|||
164158536|NCT02088554|592943755|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
164158537|NCT02088554|592943755|FG000|Overall Study|Lost to Follow-up|23|||
164158538|NCT02088554|592943755|FG000|Overall Study|Explanted|32|||
164158539|NCT02088554|592943755|FG000|Overall Study|Any other reason not covered by previous categories|11|||
164158540|NCT04623216|592943756|FG000|Overall Study|Death|5|||
164158541|NCT04623216|592943757|FG001|Overall Study|Death|2|||
164158542|NCT04623216|592943758|FG002|Overall Study|Death|0|||
164158543|NCT04623216|592943759|FG003|Overall Study|Death|0|||
164158544|NCT04623216|592943756|FG000|Overall Study|Terminated by Sponsor|3|||
164158545|NCT04623216|592943757|FG001|Overall Study|Terminated by Sponsor|2|||
164158546|NCT04623216|592943758|FG002|Overall Study|Terminated by Sponsor|2|||
164158547|NCT04623216|592943759|FG003|Overall Study|Terminated by Sponsor|0|||
164158548|NCT04623216|592943756|FG000|Overall Study|Physician Decision|1|||
164158549|NCT04623216|592943757|FG001|Overall Study|Physician Decision|0|||
164158550|NCT04623216|592943758|FG002|Overall Study|Physician Decision|0|||
164158551|NCT04623216|592943759|FG003|Overall Study|Physician Decision|0|||
164158552|NCT03521154|592943762|FG000|Overall Study|Ongoing study at data cut-off|111|||
164158553|NCT03521154|592943763|FG001|Overall Study|Ongoing study at data cut-off|52|||
164158554|NCT05468164|592943764|FG000|Treatment Period 4|Adverse Event|0|||
164158555|NCT05468164|592943765|FG001|Treatment Period 4|Adverse Event|0|||
164158556|NCT05468164|592943766|FG002|Treatment Period 4|Adverse Event|0|||
164158557|NCT05468164|592943767|FG003|Treatment Period 4|Adverse Event|1|||
164158558|NCT04632927|592943768|FG000|Overall Study|Adverse Event|0|||
164158559|NCT04632927|592943769|FG001|Overall Study|Adverse Event|1|||
164158560|NCT04632927|592943768|FG000|Overall Study|Lack of Efficacy|0|||
164158561|NCT04632927|592943769|FG001|Overall Study|Lack of Efficacy|4|||
164158562|NCT04632927|592943768|FG000|Overall Study|Loss of efficacy|0|||
164158563|NCT04632927|592943769|FG001|Overall Study|Loss of efficacy|1|||
164158564|NCT04632927|592943768|FG000|Overall Study|Non-compliance with study drug|0|||
164158565|NCT04632927|592943769|FG001|Overall Study|Non-compliance with study drug|1|||
164158566|NCT04632927|592943768|FG000|Overall Study|Physician Decision|0|||
164158567|NCT04632927|592943769|FG001|Overall Study|Physician Decision|1|||
164158568|NCT04632927|592943768|FG000|Overall Study|Subject decision|0|||
164158569|NCT04632927|592943769|FG001|Overall Study|Subject decision|1|||
164158570|NCT04632927|592943768|FG000|Overall Study|Withdrawal by Subject|0|||
164158571|NCT04632927|592943769|FG001|Overall Study|Withdrawal by Subject|1|||
164158572|NCT03168711|592943777|FG000|Overall Study|Adverse Event|2|||
164158573|NCT03168711|592943778|FG001|Overall Study|Adverse Event|0|||
164158574|NCT03168711|592943777|FG000|Overall Study|Withdrawal by Subject|0|||
164158575|NCT03168711|592943778|FG001|Overall Study|Withdrawal by Subject|1|||
164158576|NCT03168711|592943777|FG000|Overall Study|Death|0|||
164158577|NCT03168711|592943778|FG001|Overall Study|Death|1|||
164158578|NCT01671007|592943780|FG000|Overall Study|Other reasons than listed|166|||
164158579|NCT01671007|592943781|FG001|Overall Study|Other reasons than listed|373|||
164158580|NCT01671007|592943782|FG002|Overall Study|Other reasons than listed|197|||
164158581|NCT01671007|592943783|FG003|Overall Study|Other reasons than listed|228|||
164158582|NCT01671007|592943784|FG004|Overall Study|Other reasons than listed|14|||
164158583|NCT01671007|592943785|FG005|Overall Study|Other reasons than listed|71|||
164158584|NCT01671007|592943786|FG006|Overall Study|Other reasons than listed|17|||
164158585|NCT01671007|592943787|FG007|Overall Study|Other reasons than listed|66|||
164158586|NCT01671007|592943788|FG008|Overall Study|Other reasons than listed|0|||
164158587|NCT01671007|592943780|FG000|Overall Study|Withdrawal by Subject|36|||
164158588|NCT01671007|592943781|FG001|Overall Study|Withdrawal by Subject|59|||
164158589|NCT01671007|592943782|FG002|Overall Study|Withdrawal by Subject|53|||
164158590|NCT01671007|592943783|FG003|Overall Study|Withdrawal by Subject|58|||
164158591|NCT01671007|592943784|FG004|Overall Study|Withdrawal by Subject|4|||
164158592|NCT01671007|592943785|FG005|Overall Study|Withdrawal by Subject|15|||
164158593|NCT01671007|592943786|FG006|Overall Study|Withdrawal by Subject|1|||
164158594|NCT01671007|592943787|FG007|Overall Study|Withdrawal by Subject|19|||
164158595|NCT01671007|592943788|FG008|Overall Study|Withdrawal by Subject|0|||
164158596|NCT01671007|592943780|FG000|Overall Study|Lost to Follow-up|93|||
164158597|NCT01671007|592943781|FG001|Overall Study|Lost to Follow-up|142|||
164158598|NCT01671007|592943782|FG002|Overall Study|Lost to Follow-up|91|||
164158599|NCT01671007|592943783|FG003|Overall Study|Lost to Follow-up|63|||
164158600|NCT01671007|592943784|FG004|Overall Study|Lost to Follow-up|7|||
164158601|NCT01671007|592943785|FG005|Overall Study|Lost to Follow-up|20|||
164158602|NCT01671007|592943786|FG006|Overall Study|Lost to Follow-up|2|||
164158603|NCT01671007|592943787|FG007|Overall Study|Lost to Follow-up|28|||
164158604|NCT01671007|592943788|FG008|Overall Study|Lost to Follow-up|0|||
164158605|NCT01671007|592943780|FG000|Overall Study|No end of study case report form|3|||
164158606|NCT01671007|592943781|FG001|Overall Study|No end of study case report form|1|||
164158607|NCT01671007|592943782|FG002|Overall Study|No end of study case report form|0|||
164158608|NCT01671007|592943783|FG003|Overall Study|No end of study case report form|2|||
164158609|NCT01671007|592943784|FG004|Overall Study|No end of study case report form|0|||
164158610|NCT01671007|592943785|FG005|Overall Study|No end of study case report form|0|||
164158611|NCT01671007|592943786|FG006|Overall Study|No end of study case report form|0|||
164158612|NCT01671007|592943787|FG007|Overall Study|No end of study case report form|0|||
164158613|NCT01671007|592943788|FG008|Overall Study|No end of study case report form|0|||
164158614|NCT01671007|592943780|FG000|Overall Study|Not eligible|23|||
164158615|NCT01671007|592943781|FG001|Overall Study|Not eligible|76|||
164158616|NCT01671007|592943782|FG002|Overall Study|Not eligible|25|||
164158617|NCT01671007|592943783|FG003|Overall Study|Not eligible|17|||
164158618|NCT01671007|592943784|FG004|Overall Study|Not eligible|0|||
164158619|NCT01671007|592943785|FG005|Overall Study|Not eligible|6|||
164158620|NCT01671007|592943786|FG006|Overall Study|Not eligible|1|||
164158621|NCT01671007|592943787|FG007|Overall Study|Not eligible|19|||
164158622|NCT01671007|592943788|FG008|Overall Study|Not eligible|0|||
164158623|NCT03877068|592943789|FG000|Overall Study|Physician Decision|9|||
164158624|NCT03877068|592943790|FG001|Overall Study|Physician Decision|3|||
164158625|NCT00449865|592943791|FG000|Overall Study|Withdrawal by Subject|110|||
164158626|NCT00449865|592943792|FG001|Overall Study|Withdrawal by Subject|110|||
164158627|NCT00449865|592943791|FG000|Overall Study|Lost to Follow-up|36|||
164158628|NCT00449865|592943792|FG001|Overall Study|Lost to Follow-up|37|||
164158629|NCT00449865|592943791|FG000|Overall Study|Physician Decision|13|||
164158630|NCT00449865|592943792|FG001|Overall Study|Physician Decision|12|||
164158631|NCT00449865|592943791|FG000|Overall Study|Death|31|||
164158632|NCT00449865|592943792|FG001|Overall Study|Death|40|||
164158633|NCT00449865|592943791|FG000|Overall Study|Protocol Violation|8|||
164158634|NCT00449865|592943792|FG001|Overall Study|Protocol Violation|7|||
164158635|NCT00449865|592943791|FG000|Overall Study|Study was stopped|324|||
164158636|NCT00449865|592943792|FG001|Overall Study|Study was stopped|328|||
164158637|NCT00406367|592943793|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
164158638|NCT00406367|592943794|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
164158639|NCT00406367|592943793|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
164158640|NCT00406367|592943794|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
164158641|NCT00406367|592943793|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
164158642|NCT00406367|592943794|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
164158643|NCT00406367|592943793|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
164158644|NCT00406367|592943794|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
164158645|NCT00406367|592943793|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
164158646|NCT00406367|592943794|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
164158647|NCT00406367|592943793|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
164158648|NCT00406367|592943794|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
164158649|NCT00406367|592943793|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
164158650|NCT00406367|592943794|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
164158651|NCT00406367|592943793|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
164158652|NCT00406367|592943794|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
164158653|NCT00406367|592943793|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
164158654|NCT00406367|592943794|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
164158655|NCT00406367|592943793|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
164158656|NCT00406367|592943794|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
164158657|NCT00406367|592943793|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
164158658|NCT00406367|592943794|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
164158659|NCT00406367|592943793|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
164158660|NCT00406367|592943794|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
164158661|NCT03922308|592943795|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
164158662|NCT03922308|592943796|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
164158663|NCT03922308|592943797|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
164158664|NCT03922308|592943795|FG000|Overall Study|Lost to Follow-up|1|||
164158665|NCT03922308|592943796|FG001|Overall Study|Lost to Follow-up|0|||
164158666|NCT03922308|592943797|FG002|Overall Study|Lost to Follow-up|0|||
164158667|NCT03922308|592943795|FG000|Overall Study|Reason not Specified|0|||
164158668|NCT03922308|592943796|FG001|Overall Study|Reason not Specified|2|||
164158669|NCT03922308|592943797|FG002|Overall Study|Reason not Specified|1|||
164158670|NCT03252535|592943798|FG000|Overall Study|Withdrawal by Subject|1|||
164158671|NCT03252535|592943799|FG001|Overall Study|Withdrawal by Subject|0|||
164158672|NCT03252535|592943800|FG002|Overall Study|Withdrawal by Subject|0|||
164158673|NCT03252535|592943798|FG000|Overall Study|Physician Decision|0|||
164158674|NCT03252535|592943799|FG001|Overall Study|Physician Decision|1|||
164158675|NCT03252535|592943800|FG002|Overall Study|Physician Decision|0|||
164158676|NCT03252535|592943798|FG000|Overall Study|Met discontinuation criteria|0|||
164158677|NCT03252535|592943799|FG001|Overall Study|Met discontinuation criteria|1|||
164158678|NCT03252535|592943800|FG002|Overall Study|Met discontinuation criteria|0|||
164158679|NCT02588612|592943801|FG000|Overall Study|Physician Decision|1|||
164158680|NCT02588612|592943801|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
164158681|NCT02588612|592943801|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
164158682|NCT02588612|592943801|FG000|Overall Study|Death prior to T-cell infusion|1|||
164158683|NCT00506415|592943802|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
164158684|NCT00506415|592943803|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
164158685|NCT00506415|592943804|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
164158686|NCT00506415|592943805|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
164158687|NCT00506415|592943802|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
164158688|NCT00506415|592943803|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
164158689|NCT00506415|592943804|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
164158690|NCT00506415|592943805|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
164158691|NCT00506415|592943802|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
164158692|NCT00506415|592943803|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
164158693|NCT00506415|592943804|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
164158694|NCT00506415|592943805|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
164158695|NCT00506415|592943802|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
164158696|NCT00506415|592943803|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
164158697|NCT00506415|592943804|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
164158698|NCT00506415|592943805|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
164158699|NCT00506415|592943802|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
164158700|NCT00506415|592943803|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
164158701|NCT00506415|592943804|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
164158702|NCT00506415|592943805|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
164158703|NCT00506415|592943802|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
164158704|NCT00506415|592943803|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
164158705|NCT00506415|592943804|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
164158706|NCT00506415|592943805|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
164158707|NCT00506415|592943802|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
164158708|NCT00506415|592943803|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
164158709|NCT00506415|592943804|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
164158710|NCT00506415|592943805|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
164158711|NCT00506415|592943802|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
164158712|NCT00506415|592943803|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
164158713|NCT00506415|592943804|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
164158714|NCT00506415|592943805|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
164158715|NCT00506415|592943802|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
164158716|NCT00506415|592943803|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
164158717|NCT00506415|592943804|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
164158718|NCT00506415|592943805|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
164158719|NCT00506415|592943802|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
164158720|NCT00506415|592943803|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
164158721|NCT00506415|592943804|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
164158722|NCT00506415|592943805|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
164158723|NCT00506415|592943802|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
164158724|NCT00506415|592943803|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
164158725|NCT00506415|592943804|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
164158726|NCT00506415|592943805|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
164158727|NCT00506415|592943802|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
164158728|NCT00506415|592943803|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
164158729|NCT00506415|592943804|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
164158730|NCT00506415|592943805|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
164158731|NCT00506415|592943802|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
164158732|NCT00506415|592943803|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
164158733|NCT00506415|592943804|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
164158734|NCT00506415|592943805|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
164158735|NCT00506415|592943802|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
164158736|NCT00506415|592943803|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
164158737|NCT00506415|592943804|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
164158738|NCT00506415|592943805|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
164158739|NCT00506415|592943802|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
164158740|NCT00506415|592943803|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
164158741|NCT00506415|592943804|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
164158742|NCT00506415|592943805|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
164158743|NCT00506415|592943802|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
164158744|NCT00506415|592943803|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
164158745|NCT00506415|592943804|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
164158746|NCT00506415|592943805|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
164158747|NCT00506415|592943802|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
164158748|NCT00506415|592943803|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
164158749|NCT00506415|592943804|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
164158750|NCT00506415|592943805|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
164158751|NCT00506415|592943802|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
164158752|NCT00506415|592943803|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
164158753|NCT00506415|592943804|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
164158754|NCT00506415|592943805|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
164158755|NCT00506415|592943802|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
164158756|NCT00506415|592943803|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
164158757|NCT00506415|592943804|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
164158758|NCT00506415|592943805|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
164158759|NCT00506415|592943802|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
164158760|NCT00506415|592943803|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
164158761|NCT00506415|592943804|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
164158762|NCT00506415|592943805|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
164158763|NCT00506415|592943802|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
164158764|NCT00506415|592943803|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
164158765|NCT00506415|592943804|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
164158766|NCT00506415|592943805|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
164158767|NCT00506415|592943802|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
164158768|NCT00506415|592943803|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
164158769|NCT00506415|592943804|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
164158770|NCT00506415|592943805|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
164158771|NCT00506415|592943802|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
164158772|NCT00506415|592943803|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
164158773|NCT00506415|592943804|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
164158774|NCT00506415|592943805|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
164158775|NCT00506415|592943802|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
164158776|NCT00506415|592943803|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
164158777|NCT00506415|592943804|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
164158778|NCT00506415|592943805|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
164158779|NCT03809663|592943806|FG000|Overall Study|Decision by sponsor|24|||
164158780|NCT03809663|592943807|FG001|Overall Study|Decision by sponsor|18|||
164158781|NCT03809663|592943808|FG002|Overall Study|Decision by sponsor|20|||
164158782|NCT03809663|592943809|FG003|Overall Study|Decision by sponsor|20|||
164158783|NCT03809663|592943810|FG004|Overall Study|Decision by sponsor|0|||
164158784|NCT03809663|592943811|FG005|Overall Study|Decision by sponsor|0|||
164158785|NCT03809663|592943806|FG000|Overall Study|Withdrawal by Subject|26|||
164158786|NCT03809663|592943807|FG001|Overall Study|Withdrawal by Subject|22|||
164158787|NCT03809663|592943808|FG002|Overall Study|Withdrawal by Subject|27|||
164158788|NCT03809663|592943809|FG003|Overall Study|Withdrawal by Subject|26|||
164158789|NCT03809663|592943810|FG004|Overall Study|Withdrawal by Subject|0|||
164158790|NCT03809663|592943811|FG005|Overall Study|Withdrawal by Subject|0|||
164158791|NCT03809663|592943806|FG000|Overall Study|Lost to Follow-up|1|||
164158792|NCT03809663|592943807|FG001|Overall Study|Lost to Follow-up|4|||
164158793|NCT03809663|592943808|FG002|Overall Study|Lost to Follow-up|1|||
164158794|NCT03809663|592943809|FG003|Overall Study|Lost to Follow-up|1|||
164158795|NCT03809663|592943810|FG004|Overall Study|Lost to Follow-up|0|||
164158796|NCT03809663|592943811|FG005|Overall Study|Lost to Follow-up|0|||
164158797|NCT03376789|592943812|FG000|Overall Study|Withdrawal by Subject|3|||
164158798|NCT03376789|592943813|FG001|Overall Study|Withdrawal by Subject|5|||
164158799|NCT03376789|592943812|FG000|Overall Study|Protocol Violation|0|||
164158800|NCT03376789|592943813|FG001|Overall Study|Protocol Violation|1|||
164158801|NCT03376789|592943812|FG000|Overall Study|Adverse Event|0|||
164158802|NCT03376789|592943813|FG001|Overall Study|Adverse Event|1|||
164158803|NCT03376789|592943812|FG000|Overall Study|Lost to Follow-up|1|||
164158804|NCT03376789|592943813|FG001|Overall Study|Lost to Follow-up|1|||
164158805|NCT03376789|592943812|FG000|Overall Study|Per sponsor due to noncompliance|1|||
164158806|NCT03376789|592943813|FG001|Overall Study|Per sponsor due to noncompliance|0|||
164158807|NCT03376789|592943812|FG000|Overall Study|Subject off study medication|0|||
164158808|NCT03376789|592943813|FG001|Overall Study|Subject off study medication|1|||
164158809|NCT01703260|592943814|FG000|Overall Study|Adverse Event|1|||
164158810|NCT01703260|592943815|FG001|Overall Study|Adverse Event|2|||
164158811|NCT01703260|592943816|FG002|Overall Study|Adverse Event|2|||
164158812|NCT01703260|592943814|FG000|Overall Study|Lost to Follow-up|1|||
164158813|NCT01703260|592943815|FG001|Overall Study|Lost to Follow-up|0|||
164158814|NCT01703260|592943816|FG002|Overall Study|Lost to Follow-up|0|||
164158815|NCT01703260|592943814|FG000|Overall Study|Withdrawal by Subject|0|||
164158816|NCT01703260|592943815|FG001|Overall Study|Withdrawal by Subject|0|||
164158817|NCT01703260|592943816|FG002|Overall Study|Withdrawal by Subject|1|||
164158818|NCT01703260|592943814|FG000|Overall Study|Study Termination|1|||
164158819|NCT01703260|592943815|FG001|Overall Study|Study Termination|2|||
164158820|NCT01703260|592943816|FG002|Overall Study|Study Termination|0|||
164158821|NCT02042014|592943817|FG000|Overall Study|Adverse Event|1|||
164158822|NCT02042014|592943817|FG000|Overall Study|Physician Decision|7|||
164158823|NCT02792062|592943821|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
164158824|NCT02792062|592943822|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
164158825|NCT02792062|592943823|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
164158826|NCT02792062|592943824|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
164158827|NCT02792062|592943825|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
164158828|NCT02792062|592943826|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
164158829|NCT02883062|592943829|FG000|Overall Study|Withdrawal by Subject|6|||
164158830|NCT02883062|592943830|FG001|Overall Study|Withdrawal by Subject|0|||
164158831|NCT04578535|592943831|FG000|Overall Study|Lost to Follow-up|1|||
164158832|NCT04578535|592943832|FG001|Overall Study|Lost to Follow-up|0|||
164158833|NCT04578535|592943833|FG002|Overall Study|Lost to Follow-up|0|||
164158834|NCT04578535|592943834|FG003|Overall Study|Lost to Follow-up|1|||
164158835|NCT04578535|592943835|FG004|Overall Study|Lost to Follow-up|0|||
164158836|NCT04578535|592943836|FG005|Overall Study|Lost to Follow-up|2|||
164158837|NCT04578535|592943831|FG000|Overall Study|Pregnancy|1|||
164158838|NCT04578535|592943832|FG001|Overall Study|Pregnancy|0|||
164158839|NCT04578535|592943833|FG002|Overall Study|Pregnancy|0|||
164158840|NCT04578535|592943834|FG003|Overall Study|Pregnancy|0|||
164158841|NCT04578535|592943835|FG004|Overall Study|Pregnancy|0|||
164158842|NCT04578535|592943836|FG005|Overall Study|Pregnancy|0|||
164158843|NCT04578535|592943831|FG000|Overall Study|Withdrawal by Subject|0|||
164158844|NCT04578535|592943832|FG001|Overall Study|Withdrawal by Subject|0|||
164158845|NCT04578535|592943833|FG002|Overall Study|Withdrawal by Subject|0|||
164158846|NCT04578535|592943834|FG003|Overall Study|Withdrawal by Subject|1|||
164158847|NCT04578535|592943835|FG004|Overall Study|Withdrawal by Subject|1|||
164158848|NCT04578535|592943836|FG005|Overall Study|Withdrawal by Subject|5|||
164158849|NCT04578535|592943831|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
164158850|NCT04578535|592943832|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
164158851|NCT04578535|592943833|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
164158852|NCT04578535|592943834|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
164158853|NCT04578535|592943835|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
164158854|NCT04578535|592943836|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
164158855|NCT00380874|592943837|FG000|Overall Study|Adverse Event|7|||
164158856|NCT00380874|592943838|FG001|Overall Study|Adverse Event|7|||
164158857|NCT00380874|592943837|FG000|Overall Study|Death|1|||
164158858|NCT00380874|592943838|FG001|Overall Study|Death|0|||
164158859|NCT00380874|592943837|FG000|Overall Study|Withdrawal by Subject|2|||
164158860|NCT00380874|592943838|FG001|Overall Study|Withdrawal by Subject|1|||
164158861|NCT00380874|592943837|FG000|Overall Study|Not related to study drug|3|||
164158862|NCT00380874|592943838|FG001|Overall Study|Not related to study drug|2|||
164158863|NCT03380429|592943839|FG000|Overall Study|Physician Decision|0|||
164158864|NCT03380429|592943840|FG001|Overall Study|Physician Decision|1|||
164158865|NCT03380429|592943841|FG002|Overall Study|Physician Decision|0|||
164158866|NCT03380429|592943842|FG003|Overall Study|Physician Decision|1|||
164158867|NCT03380429|592943843|FG004|Overall Study|Physician Decision|1|||
164158868|NCT03380429|592943839|FG000|Overall Study|Withdrawal by Subject|3|||
164158869|NCT03380429|592943840|FG001|Overall Study|Withdrawal by Subject|3|||
164158870|NCT03380429|592943841|FG002|Overall Study|Withdrawal by Subject|5|||
164158871|NCT03380429|592943842|FG003|Overall Study|Withdrawal by Subject|2|||
164158872|NCT03380429|592943843|FG004|Overall Study|Withdrawal by Subject|1|||
164158873|NCT03380429|592943839|FG000|Overall Study|Lost to Follow-up|0|||
164158874|NCT03380429|592943840|FG001|Overall Study|Lost to Follow-up|2|||
164158875|NCT03380429|592943841|FG002|Overall Study|Lost to Follow-up|4|||
164158876|NCT03380429|592943842|FG003|Overall Study|Lost to Follow-up|3|||
164158877|NCT03380429|592943843|FG004|Overall Study|Lost to Follow-up|1|||
164158878|NCT03380429|592943839|FG000|Overall Study|Protocol Violation|1|||
164158879|NCT03380429|592943840|FG001|Overall Study|Protocol Violation|0|||
164158880|NCT03380429|592943841|FG002|Overall Study|Protocol Violation|1|||
164158881|NCT03380429|592943842|FG003|Overall Study|Protocol Violation|0|||
164158882|NCT03380429|592943843|FG004|Overall Study|Protocol Violation|1|||
164158883|NCT03380429|592943839|FG000|Overall Study|Lack of Efficacy|0|||
164158884|NCT03380429|592943840|FG001|Overall Study|Lack of Efficacy|0|||
164158885|NCT03380429|592943841|FG002|Overall Study|Lack of Efficacy|0|||
164158886|NCT03380429|592943842|FG003|Overall Study|Lack of Efficacy|2|||
164158887|NCT03380429|592943843|FG004|Overall Study|Lack of Efficacy|1|||
164158888|NCT03380429|592943839|FG000|Overall Study|Adverse Event|1|||
164158889|NCT03380429|592943840|FG001|Overall Study|Adverse Event|1|||
164158890|NCT03380429|592943841|FG002|Overall Study|Adverse Event|1|||
164158891|NCT03380429|592943842|FG003|Overall Study|Adverse Event|2|||
164158892|NCT03380429|592943843|FG004|Overall Study|Adverse Event|0|||
164158893|NCT01707290|592943848|FG000|Overall Study|Adverse event (AE)|1|||
164158894|NCT01707290|592943849|FG001|Overall Study|Adverse event (AE)|0|||
164158895|NCT01707290|592943848|FG000|Overall Study|Physician Decision|1|||
164158896|NCT01707290|592943849|FG001|Overall Study|Physician Decision|0|||
164158897|NCT01707290|592943848|FG000|Overall Study|Lost to Follow-up|3|||
164158898|NCT01707290|592943849|FG001|Overall Study|Lost to Follow-up|0|||
164158899|NCT01707290|592943848|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
164158900|NCT01707290|592943849|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
164158901|NCT01707290|592943848|FG000|Overall Study|Commercial drug available|60|||
164158902|NCT01707290|592943849|FG001|Overall Study|Commercial drug available|1|||
164158903|NCT01707290|592943848|FG000|Overall Study|Other unspecified|17|||
164158904|NCT01707290|592943849|FG001|Overall Study|Other unspecified|0|||
164158905|NCT02314026|592943850|FG000|Overall Study|Protocol Violation|28|||
164158906|NCT01139775|592943851|FG000|Overall Study|Adverse Event|0|||
164158907|NCT01139775|592943852|FG001|Overall Study|Adverse Event|6|||
164158908|NCT01139775|592943853|FG002|Overall Study|Adverse Event|2|||
164158909|NCT01139775|592943851|FG000|Overall Study|Protocol Violation|0|||
164158910|NCT01139775|592943852|FG001|Overall Study|Protocol Violation|5|||
164158911|NCT01139775|592943853|FG002|Overall Study|Protocol Violation|0|||
164158912|NCT01139775|592943851|FG000|Overall Study|Withdrawal by Subject|1|||
164158913|NCT01139775|592943852|FG001|Overall Study|Withdrawal by Subject|0|||
164158914|NCT01139775|592943853|FG002|Overall Study|Withdrawal by Subject|2|||
164158915|NCT01139775|592943851|FG000|Overall Study|Physician Decision|0|||
164158916|NCT01139775|592943852|FG001|Overall Study|Physician Decision|2|||
164158917|NCT01139775|592943853|FG002|Overall Study|Physician Decision|2|||
164158918|NCT01882985|592943856|FG000|Overall Study|Lost to Follow-up|1|||
164158919|NCT01882985|592943856|FG000|Overall Study|Withdrawal by Subject|1|||
164158920|NCT03193853|592943863|FG000|Overall Study|Death|6|||
164158921|NCT04129125|592943864|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
164158922|NCT04129125|592943864|FG000|Overall Study|Study device was not used|3|||
164158923|NCT00740636|592943871|FG000|Overall Study|Adverse Event|0|||
164158924|NCT00740636|592943872|FG001|Overall Study|Adverse Event|2|||
164158925|NCT00740636|592943871|FG000|Overall Study|Patient Ineligible|0|||
164158926|NCT00740636|592943872|FG001|Overall Study|Patient Ineligible|1|||
164158927|NCT00740636|592943871|FG000|Overall Study|Patient Not Treated|0|||
164158928|NCT00740636|592943872|FG001|Overall Study|Patient Not Treated|1|||
164158929|NCT00740636|592943871|FG000|Overall Study|Progressive Disease|1|||
164158930|NCT00740636|592943872|FG001|Overall Study|Progressive Disease|0|||
164158931|NCT00740636|592943871|FG000|Overall Study|Death|1|||
164158932|NCT00740636|592943872|FG001|Overall Study|Death|0|||
164158933|NCT02174627|592943877|FG000|Overall Study|Missing|0|||
164158934|NCT02174627|592943878|FG001|Overall Study|Missing|1|||
164158935|NCT02174627|592943877|FG000|Overall Study|Incorrect enrolment before randomization|0|||
164158936|NCT02174627|592943878|FG001|Overall Study|Incorrect enrolment before randomization|1|||
164158937|NCT02174627|592943877|FG000|Overall Study|Participant decision|84|||
164158938|NCT02174627|592943878|FG001|Overall Study|Participant decision|128|||
164158939|NCT02166333|592943879|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
164158940|NCT02166333|592943880|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
164158941|NCT02166333|592943881|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
164158942|NCT02166333|592943882|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
164158943|NCT02166333|592943883|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
164158944|NCT02166333|592943884|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
164158945|NCT02166333|592943879|FG000|Stage 1|Death|4|||
164158946|NCT02166333|592943880|FG001|Stage 1|Death|0|||
164158947|NCT02166333|592943881|FG002|Stage 1|Death|2|||
164158948|NCT02166333|592943882|FG003|Stage 1|Death|0|||
164158949|NCT02166333|592943883|FG004|Stage 1|Death|3|||
164158950|NCT02166333|592943884|FG005|Stage 1|Death|2|||
164158951|NCT02166333|592943879|FG000|Stage 1|Lost to Follow-up|12|||
164158952|NCT02166333|592943880|FG001|Stage 1|Lost to Follow-up|0|||
164158953|NCT02166333|592943881|FG002|Stage 1|Lost to Follow-up|6|||
164158954|NCT02166333|592943882|FG003|Stage 1|Lost to Follow-up|0|||
164158955|NCT02166333|592943883|FG004|Stage 1|Lost to Follow-up|3|||
164158956|NCT02166333|592943884|FG005|Stage 1|Lost to Follow-up|3|||
164158957|NCT02166333|592943879|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
164158958|NCT02166333|592943880|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
164158959|NCT02166333|592943881|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
164159267|NCT02632409|592946228|FG001|Treatment Period|Death|0|||
164158960|NCT02166333|592943882|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
164158961|NCT02166333|592943883|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
164158962|NCT02166333|592943884|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
164158963|NCT02166333|592943879|FG000|Stage 2|Death|4|||
164158964|NCT02166333|592943880|FG001|Stage 2|Death|2|||
164158965|NCT02166333|592943881|FG002|Stage 2|Death|1|||
164158966|NCT02166333|592943882|FG003|Stage 2|Death|0|||
164158967|NCT02166333|592943883|FG004|Stage 2|Death|0|||
164158968|NCT02166333|592943884|FG005|Stage 2|Death|1|||
164158969|NCT02166333|592943879|FG000|Stage 2|Lost to Follow-up|23|||
164158970|NCT02166333|592943880|FG001|Stage 2|Lost to Follow-up|4|||
164158971|NCT02166333|592943881|FG002|Stage 2|Lost to Follow-up|11|||
164158972|NCT02166333|592943882|FG003|Stage 2|Lost to Follow-up|9|||
164158973|NCT02166333|592943883|FG004|Stage 2|Lost to Follow-up|3|||
164158974|NCT02166333|592943884|FG005|Stage 2|Lost to Follow-up|6|||
164158975|NCT02269098|592943885|FG000|Overall Study|Lost to Follow-up|14|||
164158976|NCT02269098|592943886|FG001|Overall Study|Lost to Follow-up|9|||
164158977|NCT00503698|592943887|FG000|Overall Study|Protocol Violation|5|||
164158978|NCT00503698|592943888|FG001|Overall Study|Protocol Violation|6|||
164158979|NCT00503698|592943887|FG000|Overall Study|Adverse Event|52|||
164158980|NCT00503698|592943888|FG001|Overall Study|Adverse Event|41|||
164158981|NCT00503698|592943887|FG000|Overall Study|Death|1|||
164158982|NCT00503698|592943888|FG001|Overall Study|Death|0|||
164158983|NCT00503698|592943887|FG000|Overall Study|Lack of Efficacy|3|||
164158984|NCT00503698|592943888|FG001|Overall Study|Lack of Efficacy|4|||
164158985|NCT00503698|592943887|FG000|Overall Study|Trial terminated|216|||
164158986|NCT00503698|592943888|FG001|Overall Study|Trial terminated|253|||
164158987|NCT00503698|592943887|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
164158988|NCT00503698|592943888|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
164158989|NCT00503698|592943887|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
164158990|NCT00503698|592943888|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
164158991|NCT00503698|592943887|FG000|Overall Study|Any condition in exclusion criteria|4|||
164158992|NCT00503698|592943888|FG001|Overall Study|Any condition in exclusion criteria|6|||
164158993|NCT00503698|592943887|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
164158994|NCT00503698|592943888|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
164158995|NCT00503698|592943887|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
164158996|NCT00503698|592943888|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
164158997|NCT00503698|592943887|FG000|Overall Study|Critically ill|2|||
164158998|NCT00503698|592943888|FG001|Overall Study|Critically ill|0|||
164158999|NCT00503698|592943887|FG000|Overall Study|Unclassified|48|||
164159000|NCT00503698|592943888|FG001|Overall Study|Unclassified|32|||
164159001|NCT00503698|592943887|FG000|Overall Study|Not exposed to trial drug|11|||
164159002|NCT00503698|592943888|FG001|Overall Study|Not exposed to trial drug|6|||
164159003|NCT00682786|592943893|FG000|Overall Study|Withdrawal by Subject|2|||
164159004|NCT00682786|592943894|FG001|Overall Study|Withdrawal by Subject|2|||
164159005|NCT00682786|592943893|FG000|Overall Study|Did not receive irinotecan|0|||
164159006|NCT00682786|592943894|FG001|Overall Study|Did not receive irinotecan|1|||
164159007|NCT03644342|592943895|FG000|Overall Study|Adverse Event|2|||
164159008|NCT03644342|592943896|FG001|Overall Study|Adverse Event|0|||
164159009|NCT03644342|592943895|FG000|Overall Study|Protocol Violation|0|||
164159010|NCT03644342|592943896|FG001|Overall Study|Protocol Violation|1|||
164159011|NCT02462603|592943899|FG000|Overall Study|Investigator Decision|1|||
164159012|NCT02462603|592943899|FG000|Overall Study|Non-Compliance|1|||
164159013|NCT02462603|592943899|FG000|Overall Study|Withdrawal by Subject|2|||
164159014|NCT01831635|592943900|FG000|Overall Study|Withdrawal by Subject|0|||
164159015|NCT01831635|592943901|FG001|Overall Study|Withdrawal by Subject|2|||
164159016|NCT01831635|592943902|FG002|Overall Study|Withdrawal by Subject|0|||
164159017|NCT01991743|592943905|FG000|Overall Study|external cephalic version not performed|0|||
164159018|NCT01991743|592943906|FG001|Overall Study|external cephalic version not performed|0|||
164159019|NCT01991743|592943907|FG002|Overall Study|external cephalic version not performed|1|||
164159020|NCT01991743|592943908|FG003|Overall Study|external cephalic version not performed|0|||
164159021|NCT05271370|592946128|FG000|Overall Study|Study early termination|8|||
164159022|NCT05271370|592946129|FG001|Overall Study|Study early termination|16|||
164159023|NCT05271370|592946130|FG002|Overall Study|Study early termination|29|||
164159024|NCT04066244|592946142|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
164159025|NCT04066244|592946143|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
164159026|NCT04066244|592946144|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
164159027|NCT04066244|592946145|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
164159028|NCT04066244|592946146|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
164159029|NCT04066244|592946147|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
164159030|NCT04066244|592946142|FG000|Part 2 (Cohort 5)|Death|0|||
164159031|NCT04066244|592946143|FG001|Part 2 (Cohort 5)|Death|0|||
164159032|NCT04066244|592946144|FG002|Part 2 (Cohort 5)|Death|0|||
164159033|NCT04066244|592946145|FG003|Part 2 (Cohort 5)|Death|0|||
164159034|NCT04066244|592946146|FG004|Part 2 (Cohort 5)|Death|0|||
164159035|NCT04066244|592946147|FG005|Part 2 (Cohort 5)|Death|2|||
164159036|NCT04066244|592946142|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
164159037|NCT04066244|592946143|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
164159038|NCT04066244|592946144|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
164159039|NCT04066244|592946145|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
164159040|NCT04066244|592946146|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
164159041|NCT04066244|592946147|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
164159042|NCT04066244|592946142|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
164159043|NCT04066244|592946143|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
164159044|NCT04066244|592946144|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
164159045|NCT04066244|592946145|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
164159046|NCT04066244|592946146|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
164159047|NCT04066244|592946147|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
164159048|NCT00866281|592946148|FG000|Overall Study|Adverse Event|1|||
164159049|NCT00866281|592946149|FG001|Overall Study|Adverse Event|0|||
164159050|NCT00866281|592946148|FG000|Overall Study|Withdrawal by participants|3|||
164159051|NCT00866281|592946149|FG001|Overall Study|Withdrawal by participants|0|||
164159052|NCT00866281|592946148|FG000|Overall Study|Disease progression|3|||
164159053|NCT00866281|592946149|FG001|Overall Study|Disease progression|11|||
164159054|NCT00866281|592946148|FG000|Overall Study|New cancer therapy|0|||
164159055|NCT00866281|592946149|FG001|Overall Study|New cancer therapy|4|||
164159056|NCT00529087|592946152|FG000|Overall Study|Adverse Event|10|||
164159057|NCT00529087|592946153|FG001|Overall Study|Adverse Event|13|||
164159058|NCT00529087|592946154|FG002|Overall Study|Adverse Event|4|||
164159059|NCT00529087|592946152|FG000|Overall Study|Lost to Follow-up|6|||
164159060|NCT00529087|592946153|FG001|Overall Study|Lost to Follow-up|4|||
164159061|NCT00529087|592946154|FG002|Overall Study|Lost to Follow-up|1|||
164159062|NCT00529087|592946152|FG000|Overall Study|Protocol Violation|8|||
164159063|NCT00529087|592946153|FG001|Overall Study|Protocol Violation|7|||
164159064|NCT00529087|592946154|FG002|Overall Study|Protocol Violation|6|||
164159065|NCT00529087|592946152|FG000|Overall Study|Withdrawal by Subject|3|||
164159066|NCT00529087|592946153|FG001|Overall Study|Withdrawal by Subject|3|||
164159067|NCT00529087|592946154|FG002|Overall Study|Withdrawal by Subject|3|||
164159068|NCT00529087|592946152|FG000|Overall Study|Protocol deviation|1|||
164159069|NCT00529087|592946153|FG001|Overall Study|Protocol deviation|1|||
164159070|NCT00529087|592946154|FG002|Overall Study|Protocol deviation|2|||
164159071|NCT02283268|592946157|FG000|Overall Study|Withdrawal by Subject|1|||
164159072|NCT00333983|592946158|FG000|Overall Study|Lost to Follow-up|2|||
164159073|NCT00333983|592946159|FG001|Overall Study|Lost to Follow-up|1|||
164159074|NCT00333983|592946160|FG002|Overall Study|Lost to Follow-up|0|||
164159075|NCT00333983|592946158|FG000|Overall Study|Adverse Event|1|||
164159076|NCT00333983|592946159|FG001|Overall Study|Adverse Event|1|||
164159077|NCT00333983|592946160|FG002|Overall Study|Adverse Event|1|||
164159078|NCT00333983|592946158|FG000|Overall Study|Withdrawal by Subject|0|||
164159079|NCT00333983|592946159|FG001|Overall Study|Withdrawal by Subject|3|||
164159080|NCT00333983|592946160|FG002|Overall Study|Withdrawal by Subject|1|||
164159081|NCT03656068|592946161|FG000|Overall Study|Withdrawal by Subject|4|||
164159082|NCT03656068|592946161|FG000|Overall Study|Adverse Event|1|||
164159083|NCT01436370|592946162|FG000|Overall Study|Lost to Follow-up|0|||
164159084|NCT01436370|592946163|FG001|Overall Study|Lost to Follow-up|0|||
164159085|NCT01436370|592946164|FG002|Overall Study|Lost to Follow-up|0|||
164159086|NCT01436370|592946165|FG003|Overall Study|Lost to Follow-up|0|||
164159087|NCT01436370|592946166|FG004|Overall Study|Lost to Follow-up|1|||
164159088|NCT01436370|592946167|FG005|Overall Study|Lost to Follow-up|0|||
164159089|NCT01436370|592946168|FG006|Overall Study|Lost to Follow-up|0|||
164159090|NCT01436370|592946169|FG007|Overall Study|Lost to Follow-up|0|||
164159091|NCT02770170|592946170|FG000|Overall Study|Withdrawal by Subject|0|||
164159092|NCT02770170|592946171|FG001|Overall Study|Withdrawal by Subject|0|||
164159093|NCT02770170|592946172|FG002|Overall Study|Withdrawal by Subject|0|||
164159094|NCT02770170|592946173|FG003|Overall Study|Withdrawal by Subject|2|||
164159095|NCT02770170|592946170|FG000|Overall Study|due to pregnancy|1|||
164159096|NCT02770170|592946171|FG001|Overall Study|due to pregnancy|0|||
164159097|NCT02770170|592946172|FG002|Overall Study|due to pregnancy|0|||
164159098|NCT02770170|592946173|FG003|Overall Study|due to pregnancy|0|||
164159099|NCT02770170|592946170|FG000|Overall Study|Lack of Efficacy|2|||
164159100|NCT02770170|592946171|FG001|Overall Study|Lack of Efficacy|0|||
164159101|NCT02770170|592946172|FG002|Overall Study|Lack of Efficacy|0|||
164159102|NCT02770170|592946173|FG003|Overall Study|Lack of Efficacy|1|||
164159103|NCT02770170|592946170|FG000|Overall Study|Adverse Event|4|||
164159104|NCT02770170|592946171|FG001|Overall Study|Adverse Event|3|||
164159105|NCT02770170|592946172|FG002|Overall Study|Adverse Event|5|||
164159106|NCT02770170|592946173|FG003|Overall Study|Adverse Event|3|||
164159107|NCT02770170|592946170|FG000|Overall Study|due to disease worsening|0|||
164159108|NCT02770170|592946171|FG001|Overall Study|due to disease worsening|0|||
164159109|NCT02770170|592946172|FG002|Overall Study|due to disease worsening|0|||
164159110|NCT02770170|592946173|FG003|Overall Study|due to disease worsening|1|||
164159111|NCT03270657|592946174|FG000|Overall Study|Withdrawal by Subject|1|||
164159112|NCT00162981|592946175|FG000|Overall Study|Adverse Event|2|||
164159113|NCT00162981|592946176|FG001|Overall Study|Adverse Event|5|||
164159114|NCT00162981|592946175|FG000|Overall Study|Withdrawal by Subject|1|||
164159115|NCT00162981|592946176|FG001|Overall Study|Withdrawal by Subject|1|||
164159116|NCT00162981|592946175|FG000|Overall Study|Physician Decision|1|||
164159117|NCT00162981|592946176|FG001|Overall Study|Physician Decision|0|||
164159118|NCT00171210|592946177|FG000|Overall Study|Adverse Event|16|||
164159119|NCT00171210|592946178|FG001|Overall Study|Adverse Event|27|||
164159120|NCT00171210|592946177|FG000|Overall Study|Abnormal laboratory value(s)|6|||
164159121|NCT00171210|592946178|FG001|Overall Study|Abnormal laboratory value(s)|3|||
164159122|NCT00171210|592946177|FG000|Overall Study|Abnormal test procedure result(s)|0|||
164159123|NCT00171210|592946178|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164159124|NCT00171210|592946177|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
164159125|NCT00171210|592946178|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
164159126|NCT00171210|592946177|FG000|Overall Study|Protocol Violation|0|||
164159127|NCT00171210|592946178|FG001|Overall Study|Protocol Violation|2|||
164159128|NCT00171210|592946177|FG000|Overall Study|Withdrawal by Subject|32|||
164159129|NCT00171210|592946178|FG001|Overall Study|Withdrawal by Subject|30|||
164159130|NCT00171210|592946177|FG000|Overall Study|Lost to Follow-up|1|||
164159131|NCT00171210|592946178|FG001|Overall Study|Lost to Follow-up|0|||
164159132|NCT00171210|592946177|FG000|Overall Study|Administrative problems|1|||
164159133|NCT00171210|592946178|FG001|Overall Study|Administrative problems|1|||
164159134|NCT00171210|592946177|FG000|Overall Study|Death|2|||
164159135|NCT00171210|592946178|FG001|Overall Study|Death|3|||
164159136|NCT00171210|592946177|FG000|Overall Study|Stopped at end of core|0|||
164159137|NCT00171210|592946178|FG001|Overall Study|Stopped at end of core|32|||
164159138|NCT00171210|592946177|FG000|Overall Study|Stopped at end of extension 1|0|||
164159139|NCT00171210|592946178|FG001|Overall Study|Stopped at end of extension 1|1|||
164159140|NCT03187301|592946181|FG000|Titration Period|Adverse Event|0|||
164159141|NCT03187301|592946182|FG001|Titration Period|Adverse Event|0|||
164159142|NCT03187301|592946183|FG002|Titration Period|Adverse Event|0|||
164159143|NCT03187301|592946184|FG003|Titration Period|Adverse Event|0|||
164159144|NCT03187301|592946185|FG004|Titration Period|Adverse Event|0|||
164159145|NCT03187301|592946186|FG005|Titration Period|Adverse Event|0|||
164159146|NCT03187301|592946187|FG006|Titration Period|Adverse Event|5|||
164159147|NCT03187301|592946181|FG000|Titration Period|Withdrawal by Subject|0|||
164159148|NCT03187301|592946182|FG001|Titration Period|Withdrawal by Subject|0|||
164159149|NCT03187301|592946183|FG002|Titration Period|Withdrawal by Subject|0|||
164159150|NCT03187301|592946184|FG003|Titration Period|Withdrawal by Subject|0|||
164159151|NCT03187301|592946185|FG004|Titration Period|Withdrawal by Subject|0|||
164159152|NCT03187301|592946186|FG005|Titration Period|Withdrawal by Subject|0|||
164159153|NCT03187301|592946187|FG006|Titration Period|Withdrawal by Subject|1|||
164159154|NCT03187301|592946181|FG000|Titration Period|Exclusion Criteria Met|0|||
164159155|NCT03187301|592946182|FG001|Titration Period|Exclusion Criteria Met|0|||
164159156|NCT03187301|592946183|FG002|Titration Period|Exclusion Criteria Met|0|||
164159157|NCT03187301|592946184|FG003|Titration Period|Exclusion Criteria Met|0|||
164159158|NCT03187301|592946185|FG004|Titration Period|Exclusion Criteria Met|0|||
164159159|NCT03187301|592946186|FG005|Titration Period|Exclusion Criteria Met|0|||
164159160|NCT03187301|592946187|FG006|Titration Period|Exclusion Criteria Met|1|||
164159161|NCT03187301|592946181|FG000|Pre-Intervention|Withdrawal by Subject|1|||
164159162|NCT03187301|592946182|FG001|Pre-Intervention|Withdrawal by Subject|0|||
164159163|NCT03187301|592946183|FG002|Pre-Intervention|Withdrawal by Subject|0|||
164159164|NCT03187301|592946184|FG003|Pre-Intervention|Withdrawal by Subject|0|||
164159165|NCT03187301|592946185|FG004|Pre-Intervention|Withdrawal by Subject|0|||
164159166|NCT03187301|592946186|FG005|Pre-Intervention|Withdrawal by Subject|0|||
164159167|NCT03187301|592946187|FG006|Pre-Intervention|Withdrawal by Subject|0|||
164159168|NCT01966120|592946193|FG000|Overall Study|Withdrawal by Subject|0|||
164159169|NCT01966120|592946194|FG001|Overall Study|Withdrawal by Subject|5|||
164159170|NCT01966120|592946193|FG000|Overall Study|Lost to Follow-up|1|||
164159171|NCT01966120|592946194|FG001|Overall Study|Lost to Follow-up|1|||
164159172|NCT00461630|592946195|FG000|Overall Study|Death|798|||
164159173|NCT00461630|592946196|FG001|Overall Study|Death|732|||
164159174|NCT00461630|592946195|FG000|Overall Study|Lost to Follow-up|108|||
164159175|NCT00461630|592946196|FG001|Overall Study|Lost to Follow-up|95|||
164159176|NCT03309943|592946200|FG000|Overall Study|Withdrawal by Subject|0|||
164159177|NCT03309943|592946201|FG001|Overall Study|Withdrawal by Subject|1|||
164159178|NCT03309943|592946200|FG000|Overall Study|Inappropriate behavior towards staff|0|||
164159179|NCT03309943|592946201|FG001|Overall Study|Inappropriate behavior towards staff|1|||
164159180|NCT03123393|592946202|FG000|Overall Study|Study Terminated by Sponsor|6|||
164159181|NCT03123393|592946203|FG001|Overall Study|Study Terminated by Sponsor|9|||
164159182|NCT03123393|592946202|FG000|Overall Study|Withdrawal by Subject|2|||
164159183|NCT03123393|592946203|FG001|Overall Study|Withdrawal by Subject|1|||
164159184|NCT03123393|592946202|FG000|Overall Study|Reason not Specified|13|||
164159185|NCT03123393|592946203|FG001|Overall Study|Reason not Specified|13|||
164159186|NCT01609296|592946205|FG000|Overall Study|Death|253|||
164159187|NCT01609296|592946205|FG000|Overall Study|Withdrawal by Subject|151|||
164159188|NCT01609296|592946205|FG000|Overall Study|Lost to Follow-up|21|||
164159189|NCT01609296|592946205|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
164159190|NCT01609296|592946205|FG000|Overall Study|missed visit but known to be alive|28|||
164159191|NCT02230904|592946208|FG000|Overall Study|Safety follow up could not take place|0|||
164159192|NCT02230904|592946209|FG001|Overall Study|Safety follow up could not take place|1|||
164159193|NCT01464333|592946213|FG000|Overall Study|Adverse Event|34|||
164159194|NCT01464333|592946213|FG000|Overall Study|Lack of Efficacy|72|||
164159195|NCT01464333|592946213|FG000|Overall Study|Withdrawal by Subject|11|||
164159196|NCT01464333|592946213|FG000|Overall Study|Other|4|||
164159197|NCT01464333|592946213|FG000|Overall Study|No Hospital Visit|42|||
164159198|NCT05047211|592946217|FG000|Overall Study|Lost to Follow-up|8|||
164159199|NCT05047211|592946218|FG001|Overall Study|Lost to Follow-up|5|||
164159200|NCT00561392|592946219|FG000|Overall Study|Adverse Event|38|||
164159201|NCT00561392|592946219|FG000|Overall Study|Lack of Efficacy|2|||
164159202|NCT00561392|592946219|FG000|Overall Study|Protocol Violation|1|||
164159203|NCT00561392|592946219|FG000|Overall Study|Withdrawal by Subject|8|||
164159204|NCT00561392|592946219|FG000|Overall Study|Administrative problems|4|||
164159205|NCT03321968|592946220|FG000|Overall Study|Withdrawal by Subject|1|||
164159206|NCT03321968|592946221|FG001|Overall Study|Withdrawal by Subject|2|||
164159207|NCT03321968|592946222|FG002|Overall Study|Withdrawal by Subject|1|||
164159208|NCT03321968|592946220|FG000|Overall Study|Lost to Follow-up|2|||
164159209|NCT03321968|592946221|FG001|Overall Study|Lost to Follow-up|0|||
164159210|NCT03321968|592946222|FG002|Overall Study|Lost to Follow-up|1|||
164159211|NCT03321968|592946220|FG000|Overall Study|Other than specified|0|||
164159212|NCT03321968|592946221|FG001|Overall Study|Other than specified|0|||
164159213|NCT03321968|592946222|FG002|Overall Study|Other than specified|1|||
164159214|NCT03822468|592946223|FG000|Treatment Period|Progressive disease|98|||
164159215|NCT03822468|592946224|FG001|Treatment Period|Progressive disease|94|||
164159216|NCT03822468|592946223|FG000|Treatment Period|Adverse Event|21|||
164159217|NCT03822468|592946224|FG001|Treatment Period|Adverse Event|24|||
164159218|NCT03822468|592946223|FG000|Treatment Period|Withdrawal by Subject|9|||
164159219|NCT03822468|592946224|FG001|Treatment Period|Withdrawal by Subject|5|||
164159220|NCT03822468|592946223|FG000|Treatment Period|Physician Decision|9|||
164159221|NCT03822468|592946224|FG001|Treatment Period|Physician Decision|7|||
164159222|NCT03822468|592946223|FG000|Treatment Period|Protocol Violation|2|||
164159223|NCT03822468|592946224|FG001|Treatment Period|Protocol Violation|1|||
164159224|NCT03822468|592946223|FG000|Treatment Period|Death|2|||
164159225|NCT03822468|592946224|FG001|Treatment Period|Death|3|||
164159226|NCT03822468|592946223|FG000|Treatment Period|Lost to Follow-up|1|||
164159227|NCT03822468|592946224|FG001|Treatment Period|Lost to Follow-up|1|||
164159228|NCT03822468|592946223|FG000|Treatment Period|Sponsor decision|46|||
164159229|NCT03822468|592946224|FG001|Treatment Period|Sponsor decision|53|||
164159230|NCT03822468|592946223|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
164159231|NCT03822468|592946224|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
164159232|NCT03822468|592946223|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
164159233|NCT03822468|592946224|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
164159234|NCT03822468|592946223|FG000|Post-treatment Efficacy Follow-up|Death|1|||
164159235|NCT03822468|592946224|FG001|Post-treatment Efficacy Follow-up|Death|0|||
164159236|NCT03822468|592946223|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
164159237|NCT03822468|592946224|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
164159238|NCT03822468|592946223|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
164159239|NCT03822468|592946224|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
164159240|NCT03822468|592946223|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
164159241|NCT03822468|592946224|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
164159242|NCT03822468|592946223|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
164159243|NCT03822468|592946224|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
164159244|NCT02198664|592946225|FG000|Overall Study|Adverse Event|2|||
164159245|NCT02198664|592946226|FG001|Overall Study|Adverse Event|0|||
164159246|NCT02198664|592946225|FG000|Overall Study|Withdrawal by Subject|11|||
164159247|NCT02198664|592946226|FG001|Overall Study|Withdrawal by Subject|8|||
164159248|NCT02198664|592946225|FG000|Overall Study|Failure to tolerate|2|||
164159249|NCT02198664|592946226|FG001|Overall Study|Failure to tolerate|0|||
164159250|NCT02198664|592946225|FG000|Overall Study|Not stated|1|||
164159251|NCT02198664|592946226|FG001|Overall Study|Not stated|0|||
164159252|NCT02632409|592946227|FG000|Randomized|AE unrelated to study Drug|0|||
164159253|NCT02632409|592946228|FG001|Randomized|AE unrelated to study Drug|1|||
164159254|NCT02632409|592946227|FG000|Randomized|Participant withdrew consent|2|||
164159255|NCT02632409|592946228|FG001|Randomized|Participant withdrew consent|1|||
164159256|NCT02632409|592946227|FG000|Randomized|No Longer meets study criteria|5|||
164159257|NCT02632409|592946228|FG001|Randomized|No Longer meets study criteria|0|||
164159258|NCT02632409|592946227|FG000|Randomized|other reasons|1|||
164159259|NCT02632409|592946228|FG001|Randomized|other reasons|0|||
164159260|NCT02632409|592946227|FG000|Treatment Period|Ongoing Treatment|20|||
164159261|NCT02632409|592946228|FG001|Treatment Period|Ongoing Treatment|21|||
164159262|NCT02632409|592946227|FG000|Treatment Period|Disease Recurrence|147|||
164159263|NCT02632409|592946228|FG001|Treatment Period|Disease Recurrence|90|||
164159264|NCT02632409|592946227|FG000|Treatment Period|Study Drug Toxicity|8|||
164159265|NCT02632409|592946228|FG001|Treatment Period|Study Drug Toxicity|49|||
164159266|NCT02632409|592946227|FG000|Treatment Period|Death|1|||
164159268|NCT02632409|592946227|FG000|Treatment Period|AE unrelated to study drug|15|||
164159269|NCT02632409|592946228|FG001|Treatment Period|AE unrelated to study drug|16|||
164159270|NCT02632409|592946227|FG000|Treatment Period|Request to discontinue treatment|4|||
164159271|NCT02632409|592946228|FG001|Treatment Period|Request to discontinue treatment|19|||
164159272|NCT02632409|592946227|FG000|Treatment Period|Participant withdrew consent|7|||
164159273|NCT02632409|592946228|FG001|Treatment Period|Participant withdrew consent|5|||
164159274|NCT02632409|592946227|FG000|Treatment Period|Lost to Follow-up|0|||
164159275|NCT02632409|592946228|FG001|Treatment Period|Lost to Follow-up|1|||
164159276|NCT02632409|592946227|FG000|Treatment Period|Maximum clinical benefit|1|||
164159277|NCT02632409|592946228|FG001|Treatment Period|Maximum clinical benefit|0|||
164159278|NCT02632409|592946227|FG000|Treatment Period|No longer meets study criteria|3|||
164159279|NCT02632409|592946228|FG001|Treatment Period|No longer meets study criteria|0|||
164159280|NCT02632409|592946227|FG000|Treatment Period|Administrative Reason by sponsor|0|||
164159281|NCT02632409|592946228|FG001|Treatment Period|Administrative Reason by sponsor|1|||
164159282|NCT02632409|592946227|FG000|Treatment Period|Other Reasons|10|||
164159283|NCT02632409|592946228|FG001|Treatment Period|Other Reasons|6|||
164159284|NCT04426006|592946229|FG000|Inclusion|Protocol Violation|1|||
164159285|NCT04426006|592946229|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
164159286|NCT04426006|592946229|FG000|Inclusion|Blood sample at inclusion not done|1|||
164159287|NCT04426006|592946229|FG000|3 Months|Lost to Follow-up|17|||
164159288|NCT04426006|592946229|FG000|12 Months|Lost to Follow-up|38|||
164159289|NCT01262872|592946232|FG000|Step 2|Death|0|||
164159290|NCT01262872|592946233|FG001|Step 2|Death|0|||
164159291|NCT01262872|592946234|FG002|Step 2|Death|0|||
164159292|NCT01262872|592946235|FG003|Step 2|Death|1|||
164159293|NCT01262872|592946236|FG004|Step 2|Death|0|||
164159294|NCT01262872|592946237|FG005|Step 2|Death|2|||
164159295|NCT01262872|592946238|FG006|Step 2|Death|2|||
164159296|NCT01262872|592946239|FG007|Step 2|Death|1|||
164159297|NCT01262872|592946232|FG000|Step 2|Protocol Violation|0|||
164159298|NCT01262872|592946233|FG001|Step 2|Protocol Violation|0|||
164159299|NCT01262872|592946234|FG002|Step 2|Protocol Violation|1|||
164159300|NCT01262872|592946235|FG003|Step 2|Protocol Violation|0|||
164159301|NCT01262872|592946236|FG004|Step 2|Protocol Violation|0|||
164159302|NCT01262872|592946237|FG005|Step 2|Protocol Violation|0|||
164159303|NCT01262872|592946238|FG006|Step 2|Protocol Violation|3|||
164159304|NCT01262872|592946239|FG007|Step 2|Protocol Violation|1|||
164159305|NCT01262872|592946232|FG000|Step 2|Withdrawal by Subject|0|||
164159306|NCT01262872|592946233|FG001|Step 2|Withdrawal by Subject|0|||
164159307|NCT01262872|592946234|FG002|Step 2|Withdrawal by Subject|4|||
164159308|NCT01262872|592946235|FG003|Step 2|Withdrawal by Subject|6|||
164159309|NCT01262872|592946236|FG004|Step 2|Withdrawal by Subject|3|||
164159310|NCT01262872|592946237|FG005|Step 2|Withdrawal by Subject|1|||
164159311|NCT01262872|592946238|FG006|Step 2|Withdrawal by Subject|2|||
164159312|NCT01262872|592946239|FG007|Step 2|Withdrawal by Subject|1|||
164159313|NCT01262872|592946232|FG000|Step 2|Migrated/moved from study area|0|||
164159314|NCT01262872|592946233|FG001|Step 2|Migrated/moved from study area|0|||
164159315|NCT01262872|592946234|FG002|Step 2|Migrated/moved from study area|4|||
164159316|NCT01262872|592946235|FG003|Step 2|Migrated/moved from study area|3|||
164159317|NCT01262872|592946236|FG004|Step 2|Migrated/moved from study area|2|||
164159318|NCT01262872|592946237|FG005|Step 2|Migrated/moved from study area|6|||
164159319|NCT01262872|592946238|FG006|Step 2|Migrated/moved from study area|2|||
164159320|NCT01262872|592946239|FG007|Step 2|Migrated/moved from study area|3|||
164159321|NCT01000155|592946242|FG000|Overall Study|Withdrawal by Subject|1|||
164159322|NCT01000155|592946242|FG000|Overall Study|Adverse Event|1|||
164159323|NCT00720213|592946245|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
164159324|NCT00720213|592946246|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
164159325|NCT00720213|592946247|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
164159326|NCT01198470|592946248|FG000|Overall Study|Adverse Event|2|||
164159327|NCT01924689|592946252|FG000|Overall Study|Death|0|||
164159328|NCT01924689|592946253|FG001|Overall Study|Death|1|||
164159329|NCT01924689|592946254|FG002|Overall Study|Death|0|||
164159330|NCT01924689|592946255|FG003|Overall Study|Death|1|||
164159331|NCT01924689|592946256|FG004|Overall Study|Death|0|||
164159332|NCT01924689|592946257|FG005|Overall Study|Death|0|||
164159333|NCT01924689|592946252|FG000|Overall Study|Disease progression|0|||
164159334|NCT01924689|592946253|FG001|Overall Study|Disease progression|0|||
164159335|NCT01924689|592946254|FG002|Overall Study|Disease progression|2|||
164159336|NCT01924689|592946255|FG003|Overall Study|Disease progression|0|||
164159337|NCT01924689|592946256|FG004|Overall Study|Disease progression|3|||
164159338|NCT01924689|592946257|FG005|Overall Study|Disease progression|2|||
164159339|NCT01924689|592946252|FG000|Overall Study|New therapy or study|3|||
164159340|NCT01924689|592946253|FG001|Overall Study|New therapy or study|2|||
164159341|NCT01924689|592946254|FG002|Overall Study|New therapy or study|1|||
164159342|NCT01924689|592946255|FG003|Overall Study|New therapy or study|4|||
164159343|NCT01924689|592946256|FG004|Overall Study|New therapy or study|2|||
164159344|NCT01924689|592946257|FG005|Overall Study|New therapy or study|0|||
164159345|NCT01924689|592946252|FG000|Overall Study|Withdrawal of consent|0|||
164159346|NCT01924689|592946253|FG001|Overall Study|Withdrawal of consent|0|||
164159347|NCT01924689|592946254|FG002|Overall Study|Withdrawal of consent|1|||
164159348|NCT01924689|592946255|FG003|Overall Study|Withdrawal of consent|1|||
164159349|NCT01924689|592946256|FG004|Overall Study|Withdrawal of consent|0|||
164159350|NCT01924689|592946257|FG005|Overall Study|Withdrawal of consent|0|||
164159351|NCT01924689|592946252|FG000|Overall Study|Other|0|||
164159352|NCT01924689|592946253|FG001|Overall Study|Other|0|||
164159353|NCT01924689|592946254|FG002|Overall Study|Other|0|||
164159354|NCT01924689|592946255|FG003|Overall Study|Other|0|||
164159355|NCT01924689|592946256|FG004|Overall Study|Other|1|||
164159356|NCT01924689|592946257|FG005|Overall Study|Other|0|||
164159357|NCT05271175|592946258|FG000|One Week Follow up|Lost to Follow-up|10|||
164159358|NCT05271175|592946259|FG001|One Week Follow up|Lost to Follow-up|7|||
164159359|NCT05271175|592946260|FG002|One Week Follow up|Lost to Follow-up|5|||
164159360|NCT05271175|592946258|FG000|One Month Follow up|Lost to Follow-up|12|||
164159361|NCT05271175|592946259|FG001|One Month Follow up|Lost to Follow-up|7|||
164159362|NCT05271175|592946260|FG002|One Month Follow up|Lost to Follow-up|9|||
164159363|NCT05271175|592946258|FG000|Six Months Follow up|Lost to Follow-up|8|||
164159364|NCT05271175|592946259|FG001|Six Months Follow up|Lost to Follow-up|2|||
164159365|NCT05271175|592946260|FG002|Six Months Follow up|Lost to Follow-up|2|||
164159366|NCT02492867|592946261|FG000|Overall Study|Alternate therapy|1|||
164159367|NCT02492867|592946261|FG000|Overall Study|Withdrawal by Subject|2|||
164159368|NCT02492867|592946261|FG000|Overall Study|Disease progression after treatment started|1|||
164159369|NCT02492867|592946261|FG000|Overall Study|Death|1|||
164159370|NCT03296527|592946262|FG000|Overall Study|Adverse Event|15|||
164159371|NCT03296527|592946263|FG001|Overall Study|Adverse Event|33|||
164159372|NCT03296527|592946262|FG000|Overall Study|Protocol Deviation|4|||
164159373|NCT03296527|592946263|FG001|Overall Study|Protocol Deviation|0|||
164159374|NCT03296527|592946262|FG000|Overall Study|Participant withdrew consent|3|||
164159375|NCT03296527|592946263|FG001|Overall Study|Participant withdrew consent|1|||
164159376|NCT03296527|592946262|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
164159377|NCT03296527|592946263|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
164159378|NCT03296527|592946262|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
164159379|NCT03296527|592946263|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
164159380|NCT03296527|592946262|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
164159381|NCT03296527|592946263|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
164159382|NCT03296527|592946262|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
164159383|NCT03296527|592946263|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
164159384|NCT03296527|592946262|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
164159385|NCT03296527|592946263|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
164159386|NCT01597973|592946264|FG000|Overall Study|Found ineligible before study medication started|4|||
164159387|NCT01597973|592946265|FG001|Overall Study|Found ineligible before study medication started|2|||
164159388|NCT01597973|592946264|FG000|Overall Study|Eligible pathogen not confirmed|14|||
164159389|NCT01597973|592946265|FG001|Overall Study|Eligible pathogen not confirmed|15|||
164159390|NCT01597973|592946264|FG000|Overall Study|LAR not authorized to consent|0|||
164159391|NCT01597973|592946265|FG001|Overall Study|LAR not authorized to consent|1|||
164159392|NCT01597973|592946264|FG000|Overall Study|Ineligible due to early seizures|1|||
164159393|NCT01597973|592946265|FG001|Overall Study|Ineligible due to early seizures|0|||
164159394|NCT01597973|592946264|FG000|Overall Study|Ineligible due to non-target infection|1|||
164159395|NCT01597973|592946265|FG001|Overall Study|Ineligible due to non-target infection|1|||
164159396|NCT01326845|592946266|FG000|Overall Study|Administrative Problems|5|||
164159397|NCT01326845|592946267|FG001|Overall Study|Administrative Problems|2|||
164159398|NCT01326845|592946266|FG000|Overall Study|Adverse Event|1|||
164159399|NCT01326845|592946267|FG001|Overall Study|Adverse Event|0|||
164159400|NCT01326845|592946266|FG000|Overall Study|Misisng|1|||
164159401|NCT01326845|592946267|FG001|Overall Study|Misisng|3|||
164159402|NCT01662492|592946272|FG000|Overall Study|Other miscellaneous reasons.|1|||
164159403|NCT01662492|592946273|FG001|Overall Study|Other miscellaneous reasons.|0|||
164159404|NCT01662492|592946274|FG002|Overall Study|Other miscellaneous reasons.|1|||
164159405|NCT01662492|592946272|FG000|Overall Study|Withdrawal by Subject|0|||
164159406|NCT01662492|592946273|FG001|Overall Study|Withdrawal by Subject|0|||
164159407|NCT01662492|592946274|FG002|Overall Study|Withdrawal by Subject|1|||
164159408|NCT01662492|592946272|FG000|Overall Study|Protocol Violation|1|||
164159409|NCT01662492|592946273|FG001|Overall Study|Protocol Violation|0|||
164159410|NCT01662492|592946274|FG002|Overall Study|Protocol Violation|0|||
164159411|NCT01662492|592946272|FG000|Overall Study|Lost to Follow-up|0|||
164159412|NCT01662492|592946273|FG001|Overall Study|Lost to Follow-up|0|||
164159413|NCT01662492|592946274|FG002|Overall Study|Lost to Follow-up|2|||
164159414|NCT01662492|592946272|FG000|Overall Study|Lack of Efficacy|1|||
164159415|NCT01662492|592946273|FG001|Overall Study|Lack of Efficacy|1|||
164159416|NCT01662492|592946274|FG002|Overall Study|Lack of Efficacy|2|||
164159417|NCT01591096|592946275|FG000|Overall Study|Adverse Event|1|||
164159418|NCT03655405|592946276|FG000|Overall Study|Death after initial data collection|4|||
164159419|NCT03655405|592946277|FG001|Overall Study|Death after initial data collection|2|||
164159420|NCT03655405|592946276|FG000|Overall Study|Died before initial data collection|1|||
164159421|NCT03655405|592946277|FG001|Overall Study|Died before initial data collection|2|||
164159422|NCT03655405|592946276|FG000|Overall Study|Protocol Violation|0|||
164159423|NCT03655405|592946277|FG001|Overall Study|Protocol Violation|1|||
164159424|NCT02859337|592946278|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
164159425|NCT02859337|592946279|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
164159426|NCT02859337|592946280|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
164159427|NCT02859337|592946278|FG000|Overall Study|Withdrawal by Subject|3|||
164159428|NCT02859337|592946279|FG001|Overall Study|Withdrawal by Subject|1|||
164159429|NCT02859337|592946280|FG002|Overall Study|Withdrawal by Subject|0|||
164159430|NCT02859337|592946278|FG000|Overall Study|Lost to Follow-up|1|||
164159431|NCT02859337|592946279|FG001|Overall Study|Lost to Follow-up|0|||
164159432|NCT02859337|592946280|FG002|Overall Study|Lost to Follow-up|0|||
164159433|NCT00833105|592947610|FG000|Overall Study|Withdrawal by Subject|1|||
164159434|NCT00833105|592947610|FG000|Overall Study|Adverse Event|2|||
164159435|NCT02898597|592947611|FG000|Overall Study|Protocol Violation|4|||
164159436|NCT02898597|592947612|FG001|Overall Study|Protocol Violation|2|||
164159437|NCT02898597|592947611|FG000|Overall Study|Lost to Follow-up|0|||
164159438|NCT02898597|592947612|FG001|Overall Study|Lost to Follow-up|9|||
164159439|NCT02898597|592947611|FG000|Overall Study|Death|0|||
164159440|NCT02898597|592947612|FG001|Overall Study|Death|1|||
164159441|NCT01081769|592947618|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
164159442|NCT01081769|592947619|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
164159443|NCT01081769|592947618|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
164159444|NCT01081769|592947619|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
164159445|NCT01081769|592947618|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
164159446|NCT01081769|592947619|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
164159447|NCT01081769|592947618|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
164159448|NCT01081769|592947619|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
164159449|NCT01081769|592947618|FG000|CORE Intent-To-Treat|Adverse Event|14|||
164159450|NCT01081769|592947619|FG001|CORE Intent-To-Treat|Adverse Event|11|||
164159451|NCT01081769|592947618|FG000|CORE Intent-To-Treat|Death|1|||
164159452|NCT01081769|592947619|FG001|CORE Intent-To-Treat|Death|1|||
164159453|NCT01081769|592947618|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
164159454|NCT01081769|592947619|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
164159455|NCT01081769|592947618|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
164159456|NCT01081769|592947619|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
164159457|NCT01081769|592947618|FG000|CORE Intent-To-Treat|Pregnancy|1|||
164159458|NCT01081769|592947619|FG001|CORE Intent-To-Treat|Pregnancy|0|||
164159459|NCT01081769|592947618|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
164159460|NCT01081769|592947619|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
164159461|NCT01081769|592947618|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
164159462|NCT01081769|592947619|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
164159463|NCT01081769|592947618|FG000|CORE Intent-To-Treat|Other|0|||
164159464|NCT01081769|592947619|FG001|CORE Intent-To-Treat|Other|1|||
164159465|NCT01081769|592947618|FG000|CORE Intent-To-Treat|Ineligibility|3|||
164159466|NCT01081769|592947619|FG001|CORE Intent-To-Treat|Ineligibility|4|||
164159467|NCT01081769|592947618|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
164159468|NCT01081769|592947619|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
164159469|NCT01081769|592947618|FG000|CORE Intent-To-Treat|Patient Moved|2|||
164159470|NCT01081769|592947619|FG001|CORE Intent-To-Treat|Patient Moved|2|||
164159471|NCT01681212|592947620|FG000|Overall Study|No longer met study criteria|5|||
164159472|NCT01681212|592947620|FG000|Overall Study|Administrative reason by sponsor|1|||
164159473|NCT01464424|592947621|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
164159474|NCT01464424|592947622|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
164159475|NCT02282813|592947625|FG000|Overall Study|Withdrawal by Subject|4|||
164159476|NCT02282813|592947626|FG001|Overall Study|Withdrawal by Subject|5|||
164159477|NCT02282813|592947627|FG002|Overall Study|Withdrawal by Subject|0|||
164159478|NCT02282813|592947625|FG000|Overall Study|Adverse Event|3|||
164159479|NCT02282813|592947626|FG001|Overall Study|Adverse Event|10|||
164159480|NCT02282813|592947627|FG002|Overall Study|Adverse Event|1|||
164159481|NCT02282813|592947625|FG000|Overall Study|Subject non-compliance|1|||
164159482|NCT02282813|592947626|FG001|Overall Study|Subject non-compliance|4|||
164159483|NCT02282813|592947627|FG002|Overall Study|Subject non-compliance|0|||
164159484|NCT02282813|592947625|FG000|Overall Study|Physician Decision|0|||
164159485|NCT02282813|592947626|FG001|Overall Study|Physician Decision|3|||
164159486|NCT02282813|592947627|FG002|Overall Study|Physician Decision|1|||
164159487|NCT02282813|592947625|FG000|Overall Study|Lost to Follow-up|2|||
164159488|NCT02282813|592947626|FG001|Overall Study|Lost to Follow-up|0|||
164159489|NCT02282813|592947627|FG002|Overall Study|Lost to Follow-up|1|||
164159490|NCT02282813|592947625|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
164159491|NCT02282813|592947626|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
164159492|NCT02282813|592947627|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
164159493|NCT02282813|592947625|FG000|Overall Study|Lack of Efficacy|1|||
164159494|NCT02282813|592947626|FG001|Overall Study|Lack of Efficacy|0|||
164159495|NCT02282813|592947627|FG002|Overall Study|Lack of Efficacy|0|||
164159496|NCT02282813|592947625|FG000|Overall Study|Administrative reasons|0|||
164159497|NCT02282813|592947626|FG001|Overall Study|Administrative reasons|1|||
164159498|NCT02282813|592947627|FG002|Overall Study|Administrative reasons|0|||
164159499|NCT00529308|592947628|FG000|Overall Study|Withdrawal by Subject|1|||
164159500|NCT00529308|592947629|FG001|Overall Study|Withdrawal by Subject|1|||
164159501|NCT06509438|592947630|FG000|Overall Study|Adverse Event|1|||
164159502|NCT06509438|592947630|FG000|Overall Study|Lost to Follow-up|3|||
164159503|NCT03331796|592947631|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
164159504|NCT03331796|592947632|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
164159505|NCT03331796|592947633|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
164159506|NCT03331796|592947631|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
164159507|NCT03331796|592947632|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
164159508|NCT03331796|592947633|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
164159509|NCT03331796|592947631|FG000|Extended Follow-up|Adverse Event|1|||
164159510|NCT03331796|592947632|FG001|Extended Follow-up|Adverse Event|0|||
164159511|NCT03331796|592947633|FG002|Extended Follow-up|Adverse Event|1|||
164159512|NCT03331796|592947631|FG000|Extended Follow-up|Lost to Follow-up|0|||
164159513|NCT03331796|592947632|FG001|Extended Follow-up|Lost to Follow-up|0|||
164159514|NCT03331796|592947633|FG002|Extended Follow-up|Lost to Follow-up|1|||
164159515|NCT03331796|592947631|FG000|Extended Follow-up|Withdrawal by Subject|1|||
164159516|NCT03331796|592947632|FG001|Extended Follow-up|Withdrawal by Subject|0|||
164159517|NCT03331796|592947633|FG002|Extended Follow-up|Withdrawal by Subject|0|||
164159518|NCT03331796|592947631|FG000|Extended Follow-up|Termination of Funding|0|||
164159519|NCT03331796|592947632|FG001|Extended Follow-up|Termination of Funding|1|||
164159520|NCT03331796|592947633|FG002|Extended Follow-up|Termination of Funding|0|||
164159521|NCT01808066|592947636|FG000|Overall Study|Withdrawal by Subject|15|||
164159522|NCT02949973|592947641|FG000|Overall Study|Physician Decision|1|||
164159523|NCT01420068|592947642|FG000|Overall Study|Administrative problems|1|||
164159524|NCT01420068|592947643|FG001|Overall Study|Administrative problems|3|||
164159525|NCT01420068|592947642|FG000|Overall Study|Withdrawal by Subject|1|||
164159526|NCT01420068|592947643|FG001|Overall Study|Withdrawal by Subject|2|||
164159527|NCT01252095|592947644|FG000|Overall Study|Disease progression|1|||
164159528|NCT01252095|592947645|FG001|Overall Study|Disease progression|0|||
164159529|NCT00365794|592947646|FG000|Overall Study|Withdrawal by Subject|2|||
164159530|NCT00586703|592947647|FG000|Overall Study|Death|12|||
164159531|NCT04760626|592947648|FG000|Overall Study|Withdrawal by Subject|24|||
164159532|NCT04760626|592947649|FG001|Overall Study|Withdrawal by Subject|20|||
164159533|NCT04760626|592947648|FG000|Overall Study|Lost to Follow-up|14|||
164159534|NCT04760626|592947649|FG001|Overall Study|Lost to Follow-up|19|||
164159535|NCT04760626|592947648|FG000|Overall Study|Physician Decision|3|||
164159536|NCT04760626|592947649|FG001|Overall Study|Physician Decision|5|||
164159537|NCT04760626|592947648|FG000|Overall Study|Death|3|||
164159538|NCT04760626|592947649|FG001|Overall Study|Death|6|||
164159539|NCT04760626|592947648|FG000|Overall Study|Site closure|1|||
164159540|NCT04760626|592947649|FG001|Overall Study|Site closure|0|||
164159541|NCT00745901|592947652|FG000|Overall Study|Adverse Event|3|||
164159542|NCT00745901|592947653|FG001|Overall Study|Adverse Event|4|||
164159543|NCT00745901|592947652|FG000|Overall Study|Protocol Violation|0|||
164159544|NCT00745901|592947653|FG001|Overall Study|Protocol Violation|1|||
164159545|NCT00745901|592947652|FG000|Overall Study|Withdrawal by Subject|1|||
164159546|NCT00745901|592947653|FG001|Overall Study|Withdrawal by Subject|0|||
164159547|NCT00745901|592947652|FG000|Overall Study|Lost to Follow-up|7|||
164159548|NCT00745901|592947653|FG001|Overall Study|Lost to Follow-up|4|||
164159549|NCT00745901|592947652|FG000|Overall Study|Pregnancy|2|||
164159550|NCT00745901|592947653|FG001|Overall Study|Pregnancy|4|||
164159551|NCT00745901|592947652|FG000|Overall Study|Lack of compliance|2|||
164159552|NCT00745901|592947653|FG001|Overall Study|Lack of compliance|2|||
164159553|NCT00745901|592947652|FG000|Overall Study|Patient's next menses did not start with|1|||
164159554|NCT00745901|592947653|FG001|Overall Study|Patient's next menses did not start with|0|||
164159555|NCT00745901|592947652|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
164159556|NCT00745901|592947653|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
164159557|NCT00745901|592947652|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
164159558|NCT00745901|592947653|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
164159559|NCT00745901|592947652|FG000|Overall Study|Patient didn't take any study medication|7|||
164159560|NCT00745901|592947653|FG001|Overall Study|Patient didn't take any study medication|3|||
164159561|NCT02554682|592947655|FG000|Overall Study|Lost to Follow-up|11|||
164159562|NCT02554682|592947656|FG001|Overall Study|Lost to Follow-up|9|||
164159563|NCT02554682|592947657|FG002|Overall Study|Lost to Follow-up|4|||
164159564|NCT02554682|592947658|FG003|Overall Study|Lost to Follow-up|3|||
164159565|NCT02554682|592947659|FG004|Overall Study|Lost to Follow-up|2|||
164159566|NCT02554682|592947660|FG005|Overall Study|Lost to Follow-up|1|||
164159567|NCT02554682|592947661|FG006|Overall Study|Lost to Follow-up|6|||
164159568|NCT02554682|592947662|FG007|Overall Study|Lost to Follow-up|6|||
164159569|NCT02554682|592947663|FG008|Overall Study|Lost to Follow-up|2|||
164159570|NCT02554682|592947664|FG009|Overall Study|Lost to Follow-up|2|||
164159571|NCT02554682|592947655|FG000|Overall Study|Withdrawal by Subject|2|||
164159572|NCT02554682|592947656|FG001|Overall Study|Withdrawal by Subject|1|||
164159573|NCT02554682|592947657|FG002|Overall Study|Withdrawal by Subject|0|||
164159574|NCT02554682|592947658|FG003|Overall Study|Withdrawal by Subject|0|||
164159575|NCT02554682|592947659|FG004|Overall Study|Withdrawal by Subject|0|||
164159576|NCT02554682|592947660|FG005|Overall Study|Withdrawal by Subject|0|||
164159577|NCT02554682|592947661|FG006|Overall Study|Withdrawal by Subject|0|||
164159578|NCT02554682|592947662|FG007|Overall Study|Withdrawal by Subject|0|||
164159579|NCT02554682|592947663|FG008|Overall Study|Withdrawal by Subject|0|||
164159580|NCT02554682|592947664|FG009|Overall Study|Withdrawal by Subject|0|||
164159581|NCT02554682|592947655|FG000|Overall Study|Physician Decision|2|||
164159582|NCT02554682|592947656|FG001|Overall Study|Physician Decision|2|||
164159583|NCT02554682|592947657|FG002|Overall Study|Physician Decision|0|||
164159584|NCT02554682|592947658|FG003|Overall Study|Physician Decision|0|||
164159585|NCT02554682|592947659|FG004|Overall Study|Physician Decision|0|||
164159586|NCT02554682|592947660|FG005|Overall Study|Physician Decision|0|||
164159587|NCT02554682|592947661|FG006|Overall Study|Physician Decision|0|||
164159588|NCT02554682|592947662|FG007|Overall Study|Physician Decision|0|||
164159589|NCT02554682|592947663|FG008|Overall Study|Physician Decision|0|||
164159590|NCT02554682|592947664|FG009|Overall Study|Physician Decision|0|||
164159591|NCT00884117|592947667|FG000|Overall Study|Adverse Event|2|||
164159592|NCT00884117|592947667|FG000|Overall Study|Withdrawal by Subject|89|||
164159593|NCT00884117|592947667|FG000|Overall Study|Death|3|||
164159594|NCT00884117|592947667|FG000|Overall Study|Lost to Follow-up|143|||
164159595|NCT00884117|592947667|FG000|Overall Study|Other|12|||
164159596|NCT01753310|592947668|FG000|Overall Study|Entered into open label extension study|25|||
164159597|NCT01753310|592947669|FG001|Overall Study|Entered into open label extension study|22|||
164159598|NCT01753310|592947668|FG000|Overall Study|Adverse Event|1|||
164159599|NCT01753310|592947669|FG001|Overall Study|Adverse Event|0|||
164159600|NCT01753310|592947668|FG000|Overall Study|Lost to Follow-up|2|||
164159601|NCT01753310|592947669|FG001|Overall Study|Lost to Follow-up|0|||
164159602|NCT01753310|592947668|FG000|Overall Study|Subject decision|2|||
164159603|NCT01753310|592947669|FG001|Overall Study|Subject decision|2|||
164159604|NCT01753310|592947668|FG000|Overall Study|Sponsor decision|1|||
164159605|NCT01753310|592947669|FG001|Overall Study|Sponsor decision|0|||
164159606|NCT01753310|592947668|FG000|Overall Study|Withdrawal by Subject|1|||
164159607|NCT01753310|592947669|FG001|Overall Study|Withdrawal by Subject|0|||
164159608|NCT02946463|592947670|FG000|Primary Evaluation Period|Physician Decision|0|||
164159609|NCT02946463|592947671|FG001|Primary Evaluation Period|Physician Decision|1|||
164159610|NCT02946463|592947672|FG002|Primary Evaluation Period|Physician Decision|0|||
164159611|NCT02946463|592947673|FG003|Primary Evaluation Period|Physician Decision|0|||
164159612|NCT02946463|592947670|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
164159613|NCT02946463|592947671|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
164159614|NCT02946463|592947672|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
164159615|NCT02946463|592947673|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
164159616|NCT02946463|592947670|FG000|Extension Period|Death|4|||
164159617|NCT02946463|592947671|FG001|Extension Period|Death|4|||
164159618|NCT02946463|592947672|FG002|Extension Period|Death|0|||
164159619|NCT02946463|592947673|FG003|Extension Period|Death|0|||
164159620|NCT02946463|592947670|FG000|Extension Period|Withdrawal by Subject|4|||
164159621|NCT02946463|592947671|FG001|Extension Period|Withdrawal by Subject|3|||
164159622|NCT02946463|592947672|FG002|Extension Period|Withdrawal by Subject|0|||
164159623|NCT02946463|592947673|FG003|Extension Period|Withdrawal by Subject|0|||
164159624|NCT02946463|592947670|FG000|Extension Period|Other than specified|2|||
164159625|NCT02946463|592947671|FG001|Extension Period|Other than specified|3|||
164159626|NCT02946463|592947672|FG002|Extension Period|Other than specified|2|||
164159627|NCT02946463|592947673|FG003|Extension Period|Other than specified|0|||
164159628|NCT02946463|592947670|FG000|Extension Period|Physician Decision|1|||
164159629|NCT02946463|592947671|FG001|Extension Period|Physician Decision|4|||
164159630|NCT02946463|592947672|FG002|Extension Period|Physician Decision|0|||
164159631|NCT02946463|592947673|FG003|Extension Period|Physician Decision|0|||
164159632|NCT02946463|592947670|FG000|Extension Period|Pregnancy|3|||
164159633|NCT02946463|592947671|FG001|Extension Period|Pregnancy|1|||
164159634|NCT02946463|592947672|FG002|Extension Period|Pregnancy|0|||
164159635|NCT02946463|592947673|FG003|Extension Period|Pregnancy|0|||
164159636|NCT02946463|592947670|FG000|Extension Period|Adverse Event|1|||
164159637|NCT02946463|592947671|FG001|Extension Period|Adverse Event|2|||
164159638|NCT02946463|592947672|FG002|Extension Period|Adverse Event|0|||
164159639|NCT02946463|592947673|FG003|Extension Period|Adverse Event|0|||
164159640|NCT02946463|592947670|FG000|Extension Period|Lost to Follow-up|1|||
164159641|NCT02946463|592947671|FG001|Extension Period|Lost to Follow-up|0|||
164159642|NCT02946463|592947672|FG002|Extension Period|Lost to Follow-up|0|||
164159643|NCT02946463|592947673|FG003|Extension Period|Lost to Follow-up|0|||
164159644|NCT02022202|592947674|FG000|Overall Study|Withdrawal by Subject|2|||
164159645|NCT02022202|592947674|FG000|Overall Study|Disease Progression|3|||
164159646|NCT02022202|592947674|FG000|Overall Study|Desire go to immediately to surgery|3|||
164159647|NCT05581641|592947676|FG000|Overall Study|Withdrawal by Subject|0|||
164159648|NCT05581641|592947677|FG001|Overall Study|Withdrawal by Subject|1|||
164159649|NCT05581641|592947678|FG002|Overall Study|Withdrawal by Subject|3|||
164159650|NCT05581641|592947679|FG003|Overall Study|Withdrawal by Subject|1|||
164159651|NCT05581641|592947676|FG000|Overall Study|Lost to Follow-up|0|||
164159652|NCT05581641|592947677|FG001|Overall Study|Lost to Follow-up|1|||
164159653|NCT05581641|592947678|FG002|Overall Study|Lost to Follow-up|0|||
164159654|NCT05581641|592947679|FG003|Overall Study|Lost to Follow-up|1|||
164159655|NCT05581641|592947676|FG000|Overall Study|Protocol Violation|1|||
164159656|NCT05581641|592947677|FG001|Overall Study|Protocol Violation|0|||
164159657|NCT05581641|592947678|FG002|Overall Study|Protocol Violation|0|||
164159658|NCT05581641|592947679|FG003|Overall Study|Protocol Violation|0|||
164159659|NCT05581641|592947676|FG000|Overall Study|Other|1|||
164159660|NCT05581641|592947677|FG001|Overall Study|Other|0|||
164159661|NCT05581641|592947678|FG002|Overall Study|Other|2|||
164159662|NCT05581641|592947679|FG003|Overall Study|Other|1|||
164159663|NCT04390763|592947680|FG000|Safety run-in Part|Adverse Event|4|||
164159664|NCT04390763|592947681|FG001|Safety run-in Part|Adverse Event|0|||
164159665|NCT04390763|592947682|FG002|Safety run-in Part|Adverse Event|0|||
164159666|NCT04390763|592947683|FG003|Safety run-in Part|Adverse Event|0|||
164159667|NCT04390763|592947680|FG000|Safety run-in Part|Physician Decision|1|||
164159668|NCT04390763|592947681|FG001|Safety run-in Part|Physician Decision|0|||
164159669|NCT04390763|592947682|FG002|Safety run-in Part|Physician Decision|0|||
164159670|NCT04390763|592947683|FG003|Safety run-in Part|Physician Decision|0|||
164159671|NCT04390763|592947680|FG000|Safety run-in Part|Progressive Disease|6|||
164159672|NCT04390763|592947681|FG001|Safety run-in Part|Progressive Disease|0|||
164159673|NCT04390763|592947682|FG002|Safety run-in Part|Progressive Disease|0|||
164159674|NCT04390763|592947683|FG003|Safety run-in Part|Progressive Disease|0|||
164159675|NCT04390763|592947680|FG000|Randomized Part|Adverse Event|0|||
164159676|NCT04390763|592947681|FG001|Randomized Part|Adverse Event|11|||
164159677|NCT04390763|592947682|FG002|Randomized Part|Adverse Event|5|||
164159678|NCT04390763|592947683|FG003|Randomized Part|Adverse Event|5|||
164159679|NCT04390763|592947680|FG000|Randomized Part|Death|0|||
164159680|NCT04390763|592947681|FG001|Randomized Part|Death|3|||
164159681|NCT04390763|592947682|FG002|Randomized Part|Death|4|||
164159682|NCT04390763|592947683|FG003|Randomized Part|Death|2|||
164159683|NCT04390763|592947680|FG000|Randomized Part|Physician Decision|0|||
164159684|NCT04390763|592947681|FG001|Randomized Part|Physician Decision|2|||
164159685|NCT04390763|592947682|FG002|Randomized Part|Physician Decision|2|||
164159686|NCT04390763|592947683|FG003|Randomized Part|Physician Decision|9|||
164159687|NCT04390763|592947680|FG000|Randomized Part|Progressive Disease|0|||
164159688|NCT04390763|592947681|FG001|Randomized Part|Progressive Disease|24|||
164159689|NCT04390763|592947682|FG002|Randomized Part|Progressive Disease|31|||
164159690|NCT04390763|592947683|FG003|Randomized Part|Progressive Disease|23|||
164159691|NCT04390763|592947680|FG000|Randomized Part|Study terminated by sponsor|0|||
164159692|NCT04390763|592947681|FG001|Randomized Part|Study terminated by sponsor|1|||
164159693|NCT04390763|592947682|FG002|Randomized Part|Study terminated by sponsor|0|||
164159694|NCT04390763|592947683|FG003|Randomized Part|Study terminated by sponsor|0|||
164159695|NCT04390763|592947680|FG000|Randomized Part|Participant Decision|0|||
164159696|NCT04390763|592947681|FG001|Randomized Part|Participant Decision|5|||
164159697|NCT04390763|592947682|FG002|Randomized Part|Participant Decision|7|||
164159698|NCT04390763|592947683|FG003|Randomized Part|Participant Decision|6|||
164159699|NCT04390763|592947680|FG000|Randomized Part|Not treated|0|||
164159700|NCT04390763|592947681|FG001|Randomized Part|Not treated|4|||
164159701|NCT04390763|592947682|FG002|Randomized Part|Not treated|2|||
164159702|NCT04390763|592947683|FG003|Randomized Part|Not treated|7|||
164159703|NCT01786993|592947684|FG000|Overall Study|Death|6|||
164159704|NCT01786993|592947685|FG001|Overall Study|Death|7|||
164159705|NCT01786993|592947684|FG000|Overall Study|Withdrawal by Subject|3|||
164159706|NCT01786993|592947685|FG001|Overall Study|Withdrawal by Subject|2|||
164159707|NCT01786993|592947684|FG000|Overall Study|Lost to Follow-up|0|||
164159708|NCT01786993|592947685|FG001|Overall Study|Lost to Follow-up|1|||
164159709|NCT01786993|592947684|FG000|Overall Study|Subject Non-Compliance|1|||
164159710|NCT01786993|592947685|FG001|Overall Study|Subject Non-Compliance|0|||
164159711|NCT01786993|592947684|FG000|Overall Study|System Explant|1|||
164159712|NCT01786993|592947685|FG001|Overall Study|System Explant|0|||
164159713|NCT01786993|592947684|FG000|Overall Study|Hospice Admission|1|||
164159714|NCT01786993|592947685|FG001|Overall Study|Hospice Admission|0|||
164159715|NCT00450437|592947686|FG000|Overall Study|Withdrawal by Subject|10|||
164159716|NCT00450437|592947687|FG001|Overall Study|Withdrawal by Subject|2|||
164159717|NCT00450437|592947688|FG002|Overall Study|Withdrawal by Subject|0|||
164159718|NCT00450437|592947689|FG003|Overall Study|Withdrawal by Subject|1|||
164159719|NCT00450437|592947686|FG000|Overall Study|Lost to Follow-up|31|||
164159720|NCT00450437|592947687|FG001|Overall Study|Lost to Follow-up|12|||
164159721|NCT00450437|592947688|FG002|Overall Study|Lost to Follow-up|19|||
164159722|NCT00450437|592947689|FG003|Overall Study|Lost to Follow-up|9|||
164159723|NCT00450437|592947686|FG000|Overall Study|Protocol Violation|0|||
164159724|NCT00450437|592947687|FG001|Overall Study|Protocol Violation|1|||
164159725|NCT00450437|592947688|FG002|Overall Study|Protocol Violation|0|||
164159726|NCT00450437|592947689|FG003|Overall Study|Protocol Violation|1|||
164159727|NCT00450437|592947686|FG000|Overall Study|Inappropriate enrollment|4|||
164159728|NCT00450437|592947687|FG001|Overall Study|Inappropriate enrollment|1|||
164159729|NCT00450437|592947688|FG002|Overall Study|Inappropriate enrollment|3|||
164159730|NCT00450437|592947689|FG003|Overall Study|Inappropriate enrollment|0|||
164159731|NCT00450437|592947686|FG000|Overall Study|Administrative reason|0|||
164159732|NCT00450437|592947687|FG001|Overall Study|Administrative reason|0|||
164159733|NCT00450437|592947688|FG002|Overall Study|Administrative reason|1|||
164159734|NCT00450437|592947689|FG003|Overall Study|Administrative reason|0|||
164159735|NCT00450437|592947686|FG000|Overall Study|Unable to Classify|1|||
164159736|NCT00450437|592947687|FG001|Overall Study|Unable to Classify|0|||
164159737|NCT00450437|592947688|FG002|Overall Study|Unable to Classify|1|||
164159738|NCT00450437|592947689|FG003|Overall Study|Unable to Classify|0|||
164159739|NCT01890122|592947690|FG000|Overall Study|Adverse Event|1|||
164159740|NCT01890122|592947691|FG001|Overall Study|Adverse Event|1|||
164159741|NCT01890122|592947692|FG002|Overall Study|Adverse Event|1|||
164159742|NCT01890122|592947693|FG003|Overall Study|Adverse Event|2|||
164159743|NCT01890122|592947690|FG000|Overall Study|Major Protocol Deviation|3|||
164159744|NCT01890122|592947691|FG001|Overall Study|Major Protocol Deviation|1|||
164159745|NCT01890122|592947692|FG002|Overall Study|Major Protocol Deviation|0|||
164159746|NCT01890122|592947693|FG003|Overall Study|Major Protocol Deviation|1|||
164159747|NCT01890122|592947690|FG000|Overall Study|Lost to Follow-up|0|||
164159748|NCT01890122|592947691|FG001|Overall Study|Lost to Follow-up|1|||
164159749|NCT01890122|592947692|FG002|Overall Study|Lost to Follow-up|2|||
164159750|NCT01890122|592947693|FG003|Overall Study|Lost to Follow-up|2|||
164159751|NCT01890122|592947690|FG000|Overall Study|Voluntary Withdrawal|8|||
164159752|NCT01890122|592947691|FG001|Overall Study|Voluntary Withdrawal|8|||
164159753|NCT01890122|592947692|FG002|Overall Study|Voluntary Withdrawal|2|||
164159754|NCT01890122|592947693|FG003|Overall Study|Voluntary Withdrawal|11|||
164159755|NCT01890122|592947690|FG000|Overall Study|Lack of Efficacy|14|||
164159756|NCT01890122|592947691|FG001|Overall Study|Lack of Efficacy|24|||
164159757|NCT01890122|592947692|FG002|Overall Study|Lack of Efficacy|7|||
164159758|NCT01890122|592947693|FG003|Overall Study|Lack of Efficacy|41|||
164159759|NCT01890122|592947690|FG000|Overall Study|Reason not Specified|0|||
164159760|NCT01890122|592947691|FG001|Overall Study|Reason not Specified|1|||
164159761|NCT01890122|592947692|FG002|Overall Study|Reason not Specified|1|||
164159762|NCT01890122|592947693|FG003|Overall Study|Reason not Specified|2|||
164159763|NCT01890122|592947690|FG000|Overall Study|Randomized but not Treated|1|||
164159764|NCT01890122|592947691|FG001|Overall Study|Randomized but not Treated|1|||
164159765|NCT01890122|592947692|FG002|Overall Study|Randomized but not Treated|0|||
164159766|NCT01890122|592947693|FG003|Overall Study|Randomized but not Treated|0|||
164159767|NCT04025879|592947694|FG000|Randomization|Participant withdrew consent|0|||
164159768|NCT04025879|592947695|FG001|Randomization|Participant withdrew consent|1|||
164159769|NCT04025879|592947694|FG000|Randomization|Participant no longer met study criteria|1|||
164159770|NCT04025879|592947695|FG001|Randomization|Participant no longer met study criteria|1|||
164159771|NCT04025879|592947694|FG000|Treatment|Ongoing treatment|10|||
164159772|NCT04025879|592947695|FG001|Treatment|Ongoing treatment|8|||
164159773|NCT04025879|592947694|FG000|Treatment|Disease progression/recurrence|36|||
164159774|NCT04025879|592947695|FG001|Treatment|Disease progression/recurrence|72|||
164159775|NCT04025879|592947694|FG000|Treatment|Study drug toxicity|36|||
164159776|NCT04025879|592947695|FG001|Treatment|Study drug toxicity|13|||
164159777|NCT04025879|592947694|FG000|Treatment|Death|2|||
164159778|NCT04025879|592947695|FG001|Treatment|Death|0|||
164159779|NCT04025879|592947694|FG000|Treatment|Adverse event unrelated to study drug|21|||
164159780|NCT04025879|592947695|FG001|Treatment|Adverse event unrelated to study drug|14|||
164159781|NCT04025879|592947694|FG000|Treatment|Participant request to discontinue study treatment|16|||
164159782|NCT04025879|592947695|FG001|Treatment|Participant request to discontinue study treatment|8|||
164159783|NCT04025879|592947694|FG000|Treatment|Participant withdrew consent|1|||
164159784|NCT04025879|592947695|FG001|Treatment|Participant withdrew consent|3|||
164159785|NCT04025879|592947694|FG000|Treatment|Participant no longer meets study criteria|3|||
164159786|NCT04025879|592947695|FG001|Treatment|Participant no longer meets study criteria|2|||
164159787|NCT04025879|592947694|FG000|Treatment|Lost to Follow-up|1|||
164159788|NCT04025879|592947695|FG001|Treatment|Lost to Follow-up|0|||
164159789|NCT04025879|592947694|FG000|Treatment|Other reasons|15|||
164159790|NCT04025879|592947695|FG001|Treatment|Other reasons|17|||
164159791|NCT04025879|592947694|FG000|Treatment|Administrative reason by sponsor|0|||
164159792|NCT04025879|592947695|FG001|Treatment|Administrative reason by sponsor|1|||
164159793|NCT04025879|592947694|FG000|Treatment|Not reported|2|||
164159794|NCT04025879|592947695|FG001|Treatment|Not reported|0|||
164159795|NCT01565889|592947700|FG000|Part A|Withdrawal by Subject|1|||
164159796|NCT01565889|592947701|FG001|Part A|Withdrawal by Subject|0|||
164159797|NCT01565889|592947702|FG002|Part A|Withdrawal by Subject|0|||
164159798|NCT01565889|592947703|FG003|Part A|Withdrawal by Subject|0|||
164159799|NCT01565889|592947704|FG004|Part A|Withdrawal by Subject|0|||
164159800|NCT01565889|592947705|FG005|Part A|Withdrawal by Subject|0|||
164159801|NCT01565889|592947700|FG000|Part B|Withdrawal by Subject|0|||
164159802|NCT01565889|592947701|FG001|Part B|Withdrawal by Subject|0|||
164159803|NCT01565889|592947702|FG002|Part B|Withdrawal by Subject|0|||
164159804|NCT01565889|592947703|FG003|Part B|Withdrawal by Subject|0|||
164159805|NCT01565889|592947704|FG004|Part B|Withdrawal by Subject|0|||
164159806|NCT01565889|592947705|FG005|Part B|Withdrawal by Subject|1|||
164159807|NCT01565889|592947700|FG000|Part B|Lack of Efficacy|0|||
164159808|NCT01565889|592947701|FG001|Part B|Lack of Efficacy|0|||
164159809|NCT01565889|592947702|FG002|Part B|Lack of Efficacy|0|||
164159810|NCT01565889|592947703|FG003|Part B|Lack of Efficacy|0|||
164159811|NCT01565889|592947704|FG004|Part B|Lack of Efficacy|0|||
164159812|NCT01565889|592947705|FG005|Part B|Lack of Efficacy|2|||
164159813|NCT01565889|592947700|FG000|Part B|Lost to Follow-up|0|||
164159814|NCT01565889|592947701|FG001|Part B|Lost to Follow-up|0|||
164159815|NCT01565889|592947702|FG002|Part B|Lost to Follow-up|0|||
164159816|NCT01565889|592947703|FG003|Part B|Lost to Follow-up|0|||
164159817|NCT01565889|592947704|FG004|Part B|Lost to Follow-up|0|||
164159818|NCT01565889|592947705|FG005|Part B|Lost to Follow-up|1|||
164159819|NCT00122382|592947706|FG000|Double-Blind Study|Adverse Event|9|||
164159820|NCT00122382|592947707|FG001|Double-Blind Study|Adverse Event|11|||
164159821|NCT00122382|592947708|FG002|Double-Blind Study|Adverse Event|0|||
164159822|NCT00122382|592947706|FG000|Double-Blind Study|Death|2|||
164159823|NCT00122382|592947707|FG001|Double-Blind Study|Death|2|||
164159824|NCT00122382|592947708|FG002|Double-Blind Study|Death|0|||
164159825|NCT00122382|592947706|FG000|Double-Blind Study|Lack of Efficacy|0|||
164159826|NCT00122382|592947707|FG001|Double-Blind Study|Lack of Efficacy|8|||
164159827|NCT00122382|592947708|FG002|Double-Blind Study|Lack of Efficacy|0|||
164159828|NCT00122382|592947706|FG000|Double-Blind Study|Lost to Follow-up|2|||
164159829|NCT00122382|592947707|FG001|Double-Blind Study|Lost to Follow-up|1|||
164159830|NCT00122382|592947708|FG002|Double-Blind Study|Lost to Follow-up|0|||
164159831|NCT00122382|592947706|FG000|Double-Blind Study|Pregnancy|2|||
164159832|NCT00122382|592947707|FG001|Double-Blind Study|Pregnancy|0|||
164159833|NCT00122382|592947708|FG002|Double-Blind Study|Pregnancy|0|||
164159834|NCT00122382|592947706|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
164159835|NCT00122382|592947707|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
164159836|NCT00122382|592947708|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
164159837|NCT00122382|592947706|FG000|Double-Blind Study|Withdrawal of Consent|7|||
164159838|NCT00122382|592947707|FG001|Double-Blind Study|Withdrawal of Consent|3|||
164159839|NCT00122382|592947708|FG002|Double-Blind Study|Withdrawal of Consent|0|||
164159840|NCT00122382|592947706|FG000|Double-Blind Study|Protocol Violation|1|||
164159841|NCT00122382|592947707|FG001|Double-Blind Study|Protocol Violation|0|||
164159842|NCT00122382|592947708|FG002|Double-Blind Study|Protocol Violation|0|||
164159843|NCT00122382|592947706|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
164159844|NCT00122382|592947707|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
164159845|NCT00122382|592947708|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
164159846|NCT00122382|592947706|FG000|Double-Blind Study|Randomized but not treated|0|||
164159847|NCT00122382|592947707|FG001|Double-Blind Study|Randomized but not treated|2|||
164159848|NCT00122382|592947708|FG002|Double-Blind Study|Randomized but not treated|0|||
164159849|NCT00122382|592947706|FG000|Open-Label Study|Adverse Event|0|||
164159850|NCT00122382|592947707|FG001|Open-Label Study|Adverse Event|0|||
164159851|NCT00122382|592947708|FG002|Open-Label Study|Adverse Event|11|||
164159852|NCT00122382|592947706|FG000|Open-Label Study|Death|0|||
164159853|NCT00122382|592947707|FG001|Open-Label Study|Death|0|||
164159854|NCT00122382|592947708|FG002|Open-Label Study|Death|2|||
164159855|NCT00122382|592947706|FG000|Open-Label Study|Lack of Efficacy|0|||
164159856|NCT00122382|592947707|FG001|Open-Label Study|Lack of Efficacy|0|||
164159857|NCT00122382|592947708|FG002|Open-Label Study|Lack of Efficacy|3|||
164159858|NCT00122382|592947706|FG000|Open-Label Study|Lost to Follow-up|0|||
164159859|NCT00122382|592947707|FG001|Open-Label Study|Lost to Follow-up|0|||
164159860|NCT00122382|592947708|FG002|Open-Label Study|Lost to Follow-up|3|||
164159861|NCT00122382|592947706|FG000|Open-Label Study|Pregnancy|0|||
164159862|NCT00122382|592947707|FG001|Open-Label Study|Pregnancy|0|||
164159863|NCT00122382|592947708|FG002|Open-Label Study|Pregnancy|2|||
164159864|NCT00122382|592947706|FG000|Open-Label Study|Poor/Non-Compliance|0|||
164159865|NCT00122382|592947707|FG001|Open-Label Study|Poor/Non-Compliance|0|||
164159866|NCT00122382|592947708|FG002|Open-Label Study|Poor/Non-Compliance|1|||
164159867|NCT00122382|592947706|FG000|Open-Label Study|Withdrawal of Consent|0|||
164159868|NCT00122382|592947707|FG001|Open-Label Study|Withdrawal of Consent|0|||
164159869|NCT00122382|592947708|FG002|Open-Label Study|Withdrawal of Consent|4|||
164159870|NCT02040805|592947709|FG000|Overall Study|Lost to Follow-up|14|||
164159871|NCT02040805|592947710|FG001|Overall Study|Lost to Follow-up|9|||
164159872|NCT02040805|592947709|FG000|Overall Study|Withdrawal by Subject|28|||
164159873|NCT02040805|592947710|FG001|Overall Study|Withdrawal by Subject|41|||
164159874|NCT00908544|592947711|FG000|Overall Study|Withdrawal by Subject|2|||
164159875|NCT00908544|592947712|FG001|Overall Study|Withdrawal by Subject|4|||
164159876|NCT00908544|592947711|FG000|Overall Study|Lack of Efficacy|0|||
164159877|NCT00908544|592947712|FG001|Overall Study|Lack of Efficacy|1|||
164159878|NCT00908544|592947711|FG000|Overall Study|Pregnancy|1|||
164159879|NCT00908544|592947712|FG001|Overall Study|Pregnancy|0|||
164159880|NCT00908544|592947711|FG000|Overall Study|Relocation abroad|1|||
164159881|NCT00908544|592947712|FG001|Overall Study|Relocation abroad|1|||
164159882|NCT00908544|592947711|FG000|Overall Study|Unable to visit sutdy center|1|||
164159883|NCT00908544|592947712|FG001|Overall Study|Unable to visit sutdy center|0|||
164159884|NCT00071110|592947715|FG000|Overall Study|Protocol Violation|0|||
164159885|NCT00071110|592947716|FG001|Overall Study|Protocol Violation|4|||
164159886|NCT03859427|592947724|FG000|Overall Study|Withdrawal by Subject|4|||
164159887|NCT03859427|592947725|FG001|Overall Study|Withdrawal by Subject|7|||
164159888|NCT03859427|592947724|FG000|Overall Study|Decision by sponsor|0|||
164159889|NCT03859427|592947725|FG001|Overall Study|Decision by sponsor|3|||
164159890|NCT03859427|592947724|FG000|Overall Study|Lost to Follow-up|3|||
164159891|NCT03859427|592947725|FG001|Overall Study|Lost to Follow-up|2|||
164159892|NCT03859427|592947724|FG000|Overall Study|Death|22|||
164159893|NCT03859427|592947725|FG001|Overall Study|Death|25|||
164159894|NCT00722137|592947729|FG000|Overall Study|Overt Disease Progression|5|||
164159895|NCT00722137|592947730|FG001|Overall Study|Overt Disease Progression|4|||
164159896|NCT00722137|592947729|FG000|Overall Study|Adverse Event|17|||
164159897|NCT00722137|592947730|FG001|Overall Study|Adverse Event|21|||
164159898|NCT00722137|592947729|FG000|Overall Study|Death|12|||
164159899|NCT00722137|592947730|FG001|Overall Study|Death|7|||
164159900|NCT00722137|592947729|FG000|Overall Study|Withdrawal by Subject|6|||
164159901|NCT00722137|592947730|FG001|Overall Study|Withdrawal by Subject|9|||
164159902|NCT00722137|592947729|FG000|Overall Study|Other Reason Unknown|3|||
164159903|NCT00722137|592947730|FG001|Overall Study|Other Reason Unknown|4|||
164159904|NCT00722137|592947729|FG000|Overall Study|Randomized But Not Treated|2|||
164159905|NCT00722137|592947730|FG001|Overall Study|Randomized But Not Treated|3|||
164159906|NCT00848718|592947731|FG000|Overall Study|Adverse Event|2|||
164159907|NCT00848718|592947732|FG001|Overall Study|Adverse Event|2|||
164159908|NCT00848718|592947733|FG002|Overall Study|Adverse Event|1|||
164159909|NCT00848718|592947734|FG003|Overall Study|Adverse Event|1|||
164159910|NCT00848718|592947735|FG004|Overall Study|Adverse Event|1|||
164159911|NCT00848718|592947736|FG005|Overall Study|Adverse Event|0|||
164159912|NCT00848718|592947737|FG006|Overall Study|Adverse Event|0|||
164159913|NCT00848718|592947738|FG007|Overall Study|Adverse Event|1|||
164159914|NCT00848718|592947739|FG008|Overall Study|Adverse Event|1|||
164159915|NCT00848718|592947740|FG009|Overall Study|Adverse Event|0|||
164159916|NCT00848718|592947741|FG010|Overall Study|Adverse Event|0|||
164159917|NCT00848718|592947742|FG011|Overall Study|Adverse Event|0|||
164159918|NCT00848718|592947743|FG012|Overall Study|Adverse Event|2|||
164159919|NCT00848718|592947731|FG000|Overall Study|Lack of Efficacy|0|||
164159920|NCT00848718|592947732|FG001|Overall Study|Lack of Efficacy|0|||
164159921|NCT00848718|592947733|FG002|Overall Study|Lack of Efficacy|1|||
164159922|NCT00848718|592947734|FG003|Overall Study|Lack of Efficacy|0|||
164159923|NCT00848718|592947735|FG004|Overall Study|Lack of Efficacy|0|||
164159924|NCT00848718|592947736|FG005|Overall Study|Lack of Efficacy|0|||
164159925|NCT00848718|592947737|FG006|Overall Study|Lack of Efficacy|1|||
164159926|NCT00848718|592947738|FG007|Overall Study|Lack of Efficacy|0|||
164159927|NCT00848718|592947739|FG008|Overall Study|Lack of Efficacy|0|||
164159928|NCT00848718|592947740|FG009|Overall Study|Lack of Efficacy|0|||
164159929|NCT00848718|592947741|FG010|Overall Study|Lack of Efficacy|0|||
164159930|NCT00848718|592947742|FG011|Overall Study|Lack of Efficacy|0|||
164159931|NCT00848718|592947743|FG012|Overall Study|Lack of Efficacy|0|||
164159932|NCT00848718|592947731|FG000|Overall Study|Physician Decision|0|||
164159933|NCT00848718|592947732|FG001|Overall Study|Physician Decision|1|||
164159934|NCT00848718|592947733|FG002|Overall Study|Physician Decision|0|||
164159935|NCT00848718|592947734|FG003|Overall Study|Physician Decision|0|||
164159936|NCT00848718|592947735|FG004|Overall Study|Physician Decision|1|||
164159937|NCT00848718|592947736|FG005|Overall Study|Physician Decision|1|||
164159938|NCT00848718|592947737|FG006|Overall Study|Physician Decision|0|||
164159939|NCT00848718|592947738|FG007|Overall Study|Physician Decision|0|||
164159940|NCT00848718|592947739|FG008|Overall Study|Physician Decision|1|||
164159941|NCT00848718|592947740|FG009|Overall Study|Physician Decision|2|||
164159942|NCT00848718|592947741|FG010|Overall Study|Physician Decision|0|||
164159943|NCT00848718|592947742|FG011|Overall Study|Physician Decision|0|||
164159944|NCT00848718|592947743|FG012|Overall Study|Physician Decision|1|||
164159945|NCT00848718|592947731|FG000|Overall Study|Progressive disease before treatment|1|||
164159946|NCT00848718|592947732|FG001|Overall Study|Progressive disease before treatment|5|||
164159947|NCT00848718|592947733|FG002|Overall Study|Progressive disease before treatment|1|||
164159948|NCT00848718|592947734|FG003|Overall Study|Progressive disease before treatment|3|||
164159949|NCT00848718|592947735|FG004|Overall Study|Progressive disease before treatment|4|||
164159950|NCT00848718|592947736|FG005|Overall Study|Progressive disease before treatment|4|||
164159951|NCT00848718|592947737|FG006|Overall Study|Progressive disease before treatment|2|||
164159952|NCT00848718|592947738|FG007|Overall Study|Progressive disease before treatment|1|||
164159953|NCT00848718|592947739|FG008|Overall Study|Progressive disease before treatment|2|||
164159954|NCT00848718|592947740|FG009|Overall Study|Progressive disease before treatment|7|||
164159955|NCT00848718|592947741|FG010|Overall Study|Progressive disease before treatment|3|||
164159956|NCT00848718|592947742|FG011|Overall Study|Progressive disease before treatment|6|||
164159957|NCT00848718|592947743|FG012|Overall Study|Progressive disease before treatment|2|||
164159958|NCT00848718|592947731|FG000|Overall Study|Protocol Violation|0|||
164159959|NCT00848718|592947732|FG001|Overall Study|Protocol Violation|1|||
164159960|NCT00848718|592947733|FG002|Overall Study|Protocol Violation|0|||
164159961|NCT00848718|592947734|FG003|Overall Study|Protocol Violation|0|||
164159962|NCT00848718|592947735|FG004|Overall Study|Protocol Violation|0|||
164159963|NCT00848718|592947736|FG005|Overall Study|Protocol Violation|0|||
164159964|NCT00848718|592947737|FG006|Overall Study|Protocol Violation|0|||
164159965|NCT00848718|592947738|FG007|Overall Study|Protocol Violation|1|||
164159966|NCT00848718|592947739|FG008|Overall Study|Protocol Violation|0|||
164159967|NCT00848718|592947740|FG009|Overall Study|Protocol Violation|0|||
164159968|NCT00848718|592947741|FG010|Overall Study|Protocol Violation|0|||
164159969|NCT00848718|592947742|FG011|Overall Study|Protocol Violation|0|||
164159970|NCT00848718|592947743|FG012|Overall Study|Protocol Violation|1|||
164159971|NCT00848718|592947731|FG000|Overall Study|Withdrawal by Subject|1|||
164159972|NCT00848718|592947732|FG001|Overall Study|Withdrawal by Subject|0|||
164159973|NCT00848718|592947733|FG002|Overall Study|Withdrawal by Subject|0|||
164159974|NCT00848718|592947734|FG003|Overall Study|Withdrawal by Subject|1|||
164159975|NCT00848718|592947735|FG004|Overall Study|Withdrawal by Subject|0|||
164159976|NCT00848718|592947736|FG005|Overall Study|Withdrawal by Subject|0|||
164159977|NCT00848718|592947737|FG006|Overall Study|Withdrawal by Subject|0|||
164159978|NCT00848718|592947738|FG007|Overall Study|Withdrawal by Subject|0|||
164159979|NCT00848718|592947739|FG008|Overall Study|Withdrawal by Subject|0|||
164159980|NCT00848718|592947740|FG009|Overall Study|Withdrawal by Subject|0|||
164159981|NCT00848718|592947741|FG010|Overall Study|Withdrawal by Subject|1|||
164159982|NCT00848718|592947742|FG011|Overall Study|Withdrawal by Subject|0|||
164159983|NCT00848718|592947743|FG012|Overall Study|Withdrawal by Subject|0|||
164159984|NCT00848718|592947731|FG000|Overall Study|Progressive disease during treatment|3|||
164159985|NCT00848718|592947732|FG001|Overall Study|Progressive disease during treatment|0|||
164159986|NCT00848718|592947733|FG002|Overall Study|Progressive disease during treatment|3|||
164159987|NCT00848718|592947734|FG003|Overall Study|Progressive disease during treatment|0|||
164159988|NCT00848718|592947735|FG004|Overall Study|Progressive disease during treatment|0|||
164159989|NCT00848718|592947736|FG005|Overall Study|Progressive disease during treatment|0|||
164159990|NCT00848718|592947737|FG006|Overall Study|Progressive disease during treatment|0|||
164159991|NCT00848718|592947738|FG007|Overall Study|Progressive disease during treatment|2|||
164159992|NCT00848718|592947739|FG008|Overall Study|Progressive disease during treatment|0|||
164159993|NCT00848718|592947740|FG009|Overall Study|Progressive disease during treatment|0|||
164159994|NCT00848718|592947741|FG010|Overall Study|Progressive disease during treatment|0|||
164159995|NCT00848718|592947742|FG011|Overall Study|Progressive disease during treatment|0|||
164159996|NCT00848718|592947743|FG012|Overall Study|Progressive disease during treatment|2|||
164159997|NCT02389829|592947744|FG000|Overall Study|Lost to Follow-up|0|||
164159998|NCT02389829|592947745|FG001|Overall Study|Lost to Follow-up|1|||
164159999|NCT04031846|592947746|FG000|Overall Study|Lost to Follow-up|4|||
164160000|NCT04031846|592947747|FG001|Overall Study|Lost to Follow-up|4|||
164160001|NCT04031846|592947746|FG000|Overall Study|Physician Decision|0|||
164160002|NCT04031846|592947747|FG001|Overall Study|Physician Decision|1|||
164160003|NCT04031846|592947746|FG000|Overall Study|Protocol Violation|1|||
164160004|NCT04031846|592947747|FG001|Overall Study|Protocol Violation|1|||
164160005|NCT04031846|592947746|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
164160006|NCT04031846|592947747|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
164160007|NCT00571727|592947748|FG000|Overall Study|Did not enter in this study|1|||
164160008|NCT00571727|592947748|FG000|Overall Study|Non-compliance|4|||
164160009|NCT00571727|592947748|FG000|Overall Study|Lost to Follow-up|30|||
164160010|NCT00571727|592947748|FG000|Overall Study|Poor growth|1|||
164160011|NCT00571727|592947748|FG000|Overall Study|Parent/patient decision|2|||
164160012|NCT00571727|592947748|FG000|Overall Study|Participant transferred to commercial drug|14|||
164160013|NCT00571727|592947748|FG000|Overall Study|Unable to provide study drug|6|||
164160014|NCT00571727|592947748|FG000|Overall Study|On-treatment at end of study|8|||
164160015|NCT01622673|592947749|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164160016|NCT01622673|592947750|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164160017|NCT01622673|592947751|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164160018|NCT01622673|592947752|FG003|Treatment Period 1|Withdrawal by Subject|1|||
164160019|NCT01622673|592947753|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164160020|NCT01622673|592947754|FG005|Treatment Period 1|Withdrawal by Subject|0|||
164160021|NCT01622673|592947749|FG000|Treatment Period 1|Protocol Violation|0|||
164160022|NCT01622673|592947750|FG001|Treatment Period 1|Protocol Violation|1|||
164160023|NCT01622673|592947751|FG002|Treatment Period 1|Protocol Violation|0|||
164160024|NCT01622673|592947752|FG003|Treatment Period 1|Protocol Violation|0|||
164160025|NCT01622673|592947753|FG004|Treatment Period 1|Protocol Violation|0|||
164160026|NCT01622673|592947754|FG005|Treatment Period 1|Protocol Violation|0|||
164160027|NCT01622673|592947749|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164160028|NCT01622673|592947750|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164160029|NCT01622673|592947751|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164160030|NCT01622673|592947752|FG003|Treatment Period 2|Withdrawal by Subject|1|||
164160031|NCT01622673|592947753|FG004|Treatment Period 2|Withdrawal by Subject|0|||
164160032|NCT01622673|592947754|FG005|Treatment Period 2|Withdrawal by Subject|0|||
164160033|NCT01622673|592947749|FG000|Treatment Period 3|Protocol Violation|0|||
164160034|NCT01622673|592947750|FG001|Treatment Period 3|Protocol Violation|1|||
164160035|NCT01622673|592947751|FG002|Treatment Period 3|Protocol Violation|0|||
164160036|NCT01622673|592947752|FG003|Treatment Period 3|Protocol Violation|0|||
164160037|NCT01622673|592947753|FG004|Treatment Period 3|Protocol Violation|0|||
164160038|NCT01622673|592947754|FG005|Treatment Period 3|Protocol Violation|0|||
164160039|NCT01295671|592949051|FG000|Overall Study|Lost to Follow-up|4|||
164160040|NCT01295671|592949052|FG001|Overall Study|Lost to Follow-up|6|||
164160041|NCT01295671|592949053|FG002|Overall Study|Lost to Follow-up|3|||
164160042|NCT01295671|592949051|FG000|Overall Study|Withdrawal by Subject|3|||
164160043|NCT01295671|592949052|FG001|Overall Study|Withdrawal by Subject|1|||
164160044|NCT01295671|592949053|FG002|Overall Study|Withdrawal by Subject|0|||
164160045|NCT02395848|592949056|FG000|Overall Study|Lost to Follow-up|2|||
164160046|NCT02276560|592949057|FG000|Overall Study|Adverse Event|1|||
164160047|NCT02276560|592949058|FG001|Overall Study|Adverse Event|0|||
164160048|NCT02276560|592949059|FG002|Overall Study|Adverse Event|0|||
164160049|NCT02366637|592949061|FG000|First Intervention Period|Adverse Event|0|||
164160050|NCT02366637|592949062|FG001|First Intervention Period|Adverse Event|1|||
164160051|NCT02366637|592949061|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
164160052|NCT02366637|592949062|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
164160053|NCT02366637|592949061|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
164160054|NCT02366637|592949062|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
164160055|NCT01609010|592949065|FG000|Overall Study|Stable disease (SD)|22|||
164160056|NCT01609010|592949066|FG001|Overall Study|Stable disease (SD)|16|||
164160057|NCT01609010|592949065|FG000|Overall Study|Progressive disease (PD)|8|||
164160058|NCT01609010|592949066|FG001|Overall Study|Progressive disease (PD)|10|||
164160059|NCT01609010|592949065|FG000|Overall Study|Adverse Event|3|||
164160060|NCT01609010|592949066|FG001|Overall Study|Adverse Event|6|||
164160061|NCT01609010|592949065|FG000|Overall Study|Withdrawal by Subject|2|||
164160062|NCT01609010|592949066|FG001|Overall Study|Withdrawal by Subject|2|||
164160063|NCT01609010|592949065|FG000|Overall Study|Other|2|||
164160064|NCT01609010|592949066|FG001|Overall Study|Other|0|||
164160065|NCT01609010|592949065|FG000|Overall Study|Other malignancy|1|||
164160066|NCT01609010|592949066|FG001|Overall Study|Other malignancy|0|||
164160067|NCT01609010|592949065|FG000|Overall Study|Pathology review|2|||
164160068|NCT01609010|592949066|FG001|Overall Study|Pathology review|1|||
164160069|NCT01609010|592949065|FG000|Overall Study|Protocol Violation|1|||
164160070|NCT01609010|592949066|FG001|Overall Study|Protocol Violation|1|||
164160071|NCT01609010|592949065|FG000|Overall Study|New cancer|1|||
164160072|NCT01609010|592949066|FG001|Overall Study|New cancer|0|||
164160073|NCT01609010|592949065|FG000|Overall Study|Lost to Follow-up|1|||
164160074|NCT01609010|592949066|FG001|Overall Study|Lost to Follow-up|1|||
164160075|NCT01134107|592949068|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
164160076|NCT01134107|592949069|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
164160077|NCT01134107|592949068|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
164160078|NCT01134107|592949069|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
164160079|NCT01134107|592949068|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
164160080|NCT01134107|592949069|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
164160081|NCT01134107|592949068|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
164160082|NCT01134107|592949069|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
164160083|NCT01134107|592949068|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
164160084|NCT01134107|592949069|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
164160085|NCT01134107|592949068|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
164160086|NCT01134107|592949069|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
164160087|NCT01134107|592949068|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
164160088|NCT01134107|592949069|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
164160089|NCT04541589|592949079|FG000|Treatment Period|Adverse Event|8|||
164160090|NCT04541589|592949080|FG001|Treatment Period|Adverse Event|2|||
164160091|NCT04541589|592949079|FG000|Treatment Period|Physician Decision|3|||
164160092|NCT04541589|592949080|FG001|Treatment Period|Physician Decision|1|||
164160093|NCT04541589|592949079|FG000|Treatment Period|Subject decision|7|||
164160094|NCT04541589|592949080|FG001|Treatment Period|Subject decision|4|||
164160095|NCT04541589|592949079|FG000|Treatment Period|Withdrawal by Subject|1|||
164160096|NCT04541589|592949080|FG001|Treatment Period|Withdrawal by Subject|0|||
164160097|NCT04541589|592949079|FG000|Safety Follow-up Period|Adverse Event|2|||
164160098|NCT04541589|592949080|FG001|Safety Follow-up Period|Adverse Event|1|||
164160099|NCT04541589|592949079|FG000|Safety Follow-up Period|Physician Decision|1|||
164160100|NCT04541589|592949080|FG001|Safety Follow-up Period|Physician Decision|0|||
164160101|NCT04541589|592949079|FG000|Safety Follow-up Period|Subject decision|5|||
164160102|NCT04541589|592949080|FG001|Safety Follow-up Period|Subject decision|3|||
164160103|NCT04541589|592949079|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
164160104|NCT04541589|592949080|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
164160105|NCT03581123|592949083|FG000|2-month Follow-up|Withdrawal by Subject|5|||
164160106|NCT03581123|592949084|FG001|2-month Follow-up|Withdrawal by Subject|4|||
164160107|NCT03581123|592949085|FG002|2-month Follow-up|Withdrawal by Subject|6|||
164160108|NCT03581123|592949086|FG003|2-month Follow-up|Withdrawal by Subject|4|||
164160109|NCT03581123|592949083|FG000|2-month Follow-up|Lost to Follow-up|8|||
164160110|NCT03581123|592949084|FG001|2-month Follow-up|Lost to Follow-up|1|||
164160111|NCT03581123|592949085|FG002|2-month Follow-up|Lost to Follow-up|2|||
164160112|NCT03581123|592949086|FG003|2-month Follow-up|Lost to Follow-up|2|||
164160113|NCT03581123|592949083|FG000|6-Month Follow-up|Withdrawal by Subject|2|||
164160114|NCT03581123|592949084|FG001|6-Month Follow-up|Withdrawal by Subject|0|||
164160115|NCT03581123|592949085|FG002|6-Month Follow-up|Withdrawal by Subject|1|||
164160116|NCT03581123|592949086|FG003|6-Month Follow-up|Withdrawal by Subject|2|||
164160117|NCT03581123|592949083|FG000|6-Month Follow-up|Lost to Follow-up|3|||
164160118|NCT03581123|592949084|FG001|6-Month Follow-up|Lost to Follow-up|3|||
164160119|NCT03581123|592949085|FG002|6-Month Follow-up|Lost to Follow-up|1|||
164160120|NCT03581123|592949086|FG003|6-Month Follow-up|Lost to Follow-up|1|||
164160121|NCT03581123|592949083|FG000|12-Month Follow-up|Lost to Follow-up|4|||
164160122|NCT03581123|592949084|FG001|12-Month Follow-up|Lost to Follow-up|3|||
164160123|NCT03581123|592949085|FG002|12-Month Follow-up|Lost to Follow-up|4|||
164160124|NCT03581123|592949086|FG003|12-Month Follow-up|Lost to Follow-up|5|||
164160125|NCT04195685|592949087|FG000|Overall Study|Withdrawal by Subject|6|||
164160126|NCT04195685|592949088|FG001|Overall Study|Withdrawal by Subject|2|||
164160127|NCT04195685|592949087|FG000|Overall Study|Lost to Follow-up|1|||
164160128|NCT04195685|592949088|FG001|Overall Study|Lost to Follow-up|4|||
164160129|NCT00455403|592949095|FG000|Overall Study|Lost to Follow-up|2|||
164160130|NCT00455403|592949096|FG001|Overall Study|Lost to Follow-up|1|||
164160131|NCT00455403|592949095|FG000|Overall Study|Withdrawal by Subject|1|||
164160132|NCT00455403|592949096|FG001|Overall Study|Withdrawal by Subject|3|||
164160133|NCT00455403|592949095|FG000|Overall Study|Protocol Violation|0|||
164160134|NCT00455403|592949096|FG001|Overall Study|Protocol Violation|2|||
164160135|NCT04509076|592949097|FG000|Overall Study|Withdrawal by Subject|1|||
164160136|NCT04509076|592949098|FG001|Overall Study|Withdrawal by Subject|2|||
164160137|NCT04509076|592949097|FG000|Overall Study|Lost to Follow-up|1|||
164160138|NCT04509076|592949098|FG001|Overall Study|Lost to Follow-up|2|||
164160139|NCT00558701|592949102|FG000|Overall Study|Protocol Deviations|1|||
164160140|NCT00558701|592949103|FG001|Overall Study|Protocol Deviations|4|||
164160141|NCT00427648|592949104|FG000|Overall Study|Protocol Violation|1|||
164160142|NCT00427648|592949105|FG001|Overall Study|Protocol Violation|2|||
164160143|NCT00427648|592949104|FG000|Overall Study|Adverse Event|0|||
164160144|NCT00427648|592949105|FG001|Overall Study|Adverse Event|1|||
164160145|NCT01532518|592949106|FG000|Overall Study|Withdrawal by Subject|0|||
164160146|NCT01532518|592949107|FG001|Overall Study|Withdrawal by Subject|0|||
164160147|NCT01532518|592949108|FG002|Overall Study|Withdrawal by Subject|1|||
164160148|NCT03591874|592949113|FG000|Overall Study|Adverse Event|4|||
164160149|NCT03591874|592949114|FG001|Overall Study|Adverse Event|0|||
164160150|NCT03591874|592949113|FG000|Overall Study|Withdrawal by Subject|2|||
164160151|NCT03591874|592949114|FG001|Overall Study|Withdrawal by Subject|1|||
164160152|NCT03591874|592949113|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
164160153|NCT03591874|592949114|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
164160154|NCT03591874|592949113|FG000|Overall Study|On Study at Time of Study Termination|12|||
164160155|NCT03591874|592949114|FG001|Overall Study|On Study at Time of Study Termination|6|||
164160156|NCT02259010|592949115|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
164160157|NCT03194542|592949116|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
164160158|NCT03194542|592949117|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
164160159|NCT03194542|592949118|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
164160160|NCT03194542|592949119|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
164160161|NCT03194542|592949116|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
164160162|NCT03194542|592949117|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
164160163|NCT03194542|592949118|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
164160164|NCT03194542|592949119|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
164160165|NCT03194542|592949116|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
164160166|NCT03194542|592949117|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
164160167|NCT03194542|592949118|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
164160168|NCT03194542|592949119|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
164160169|NCT03194542|592949116|FG000|Overall Study|Loss of Response|4|||
164160170|NCT03194542|592949117|FG001|Overall Study|Loss of Response|2|||
164160171|NCT03194542|592949118|FG002|Overall Study|Loss of Response|3|||
164160172|NCT03194542|592949119|FG003|Overall Study|Loss of Response|4|||
164160173|NCT03194542|592949116|FG000|Overall Study|Physician Decision|0|||
164160174|NCT03194542|592949117|FG001|Overall Study|Physician Decision|1|||
164160175|NCT03194542|592949118|FG002|Overall Study|Physician Decision|0|||
164160176|NCT03194542|592949119|FG003|Overall Study|Physician Decision|0|||
164160177|NCT03194542|592949116|FG000|Overall Study|Lack of Efficacy|2|||
164160178|NCT03194542|592949117|FG001|Overall Study|Lack of Efficacy|2|||
164160179|NCT03194542|592949118|FG002|Overall Study|Lack of Efficacy|2|||
164160180|NCT03194542|592949119|FG003|Overall Study|Lack of Efficacy|6|||
164160181|NCT03194542|592949116|FG000|Overall Study|Withdrawal by Subject|2|||
164160182|NCT03194542|592949117|FG001|Overall Study|Withdrawal by Subject|1|||
164160183|NCT03194542|592949118|FG002|Overall Study|Withdrawal by Subject|5|||
164160184|NCT03194542|592949119|FG003|Overall Study|Withdrawal by Subject|4|||
164160185|NCT03194542|592949116|FG000|Overall Study|Progressive Disease|1|||
164160186|NCT03194542|592949117|FG001|Overall Study|Progressive Disease|0|||
164160187|NCT03194542|592949118|FG002|Overall Study|Progressive Disease|1|||
164160188|NCT03194542|592949119|FG003|Overall Study|Progressive Disease|1|||
164160189|NCT03194542|592949116|FG000|Overall Study|Adverse Event|1|||
164160190|NCT03194542|592949117|FG001|Overall Study|Adverse Event|2|||
164160191|NCT03194542|592949118|FG002|Overall Study|Adverse Event|0|||
164160192|NCT03194542|592949119|FG003|Overall Study|Adverse Event|5|||
164160193|NCT03194542|592949116|FG000|Overall Study|Death|1|||
164160194|NCT03194542|592949117|FG001|Overall Study|Death|2|||
164160195|NCT03194542|592949118|FG002|Overall Study|Death|0|||
164160196|NCT03194542|592949119|FG003|Overall Study|Death|5|||
164160197|NCT03194542|592949116|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
164160198|NCT03194542|592949117|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
164160199|NCT03194542|592949118|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
164160200|NCT03194542|592949119|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
164160201|NCT02640664|592949122|FG000|Epoch 1|Withdrawal of informed consent|1|||
164160202|NCT02640664|592949123|FG001|Epoch 1|Withdrawal of informed consent|0|||
164160203|NCT02640664|592949124|FG002|Epoch 1|Withdrawal of informed consent|0|||
164160204|NCT02640664|592949122|FG000|Epoch 1|Death|0|||
164160205|NCT02640664|592949123|FG001|Epoch 1|Death|0|||
164160206|NCT02640664|592949124|FG002|Epoch 1|Death|1|||
164160207|NCT02640664|592949122|FG000|Epoch 2|Withdrawal of informed consent|3|||
164160208|NCT02640664|592949123|FG001|Epoch 2|Withdrawal of informed consent|4|||
164160209|NCT02640664|592949124|FG002|Epoch 2|Withdrawal of informed consent|2|||
164160210|NCT02640664|592949122|FG000|Epoch 2|Subject/guardian decision|0|||
164160211|NCT02640664|592949123|FG001|Epoch 2|Subject/guardian decision|2|||
164160212|NCT02640664|592949124|FG002|Epoch 2|Subject/guardian decision|2|||
164160213|NCT02640664|592949122|FG000|Epoch 2|Lost to Follow-up|3|||
164160214|NCT02640664|592949123|FG001|Epoch 2|Lost to Follow-up|4|||
164160215|NCT02640664|592949124|FG002|Epoch 2|Lost to Follow-up|1|||
164160216|NCT02640664|592949122|FG000|Epoch 2|Death|0|||
164160217|NCT02640664|592949123|FG001|Epoch 2|Death|0|||
164160218|NCT02640664|592949124|FG002|Epoch 2|Death|1|||
164160219|NCT05514873|592949125|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
164160220|NCT05514873|592949125|FG000|Main Treatment Period|Adverse Event|2|||
164160221|NCT05514873|592949125|FG000|Extension Treatment Period|Lost to Follow-up|3|||
164160222|NCT02729025|592949129|FG000|Overall Study|Sponsor Decision|0|||
164160223|NCT02729025|592949130|FG001|Overall Study|Sponsor Decision|1|||
164160224|NCT03525678|592949134|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
164160225|NCT03525678|592949135|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
164160226|NCT03525678|592949136|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
164160227|NCT03525678|592949137|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
164160228|NCT03525678|592949138|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
164160229|NCT03525678|592949134|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
164160230|NCT03525678|592949135|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
164160231|NCT03525678|592949136|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
164160232|NCT03525678|592949137|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
164160233|NCT03525678|592949138|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
164160234|NCT03525678|592949134|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
164160235|NCT03525678|592949135|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
164160236|NCT03525678|592949136|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
164160237|NCT03525678|592949137|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
164160238|NCT03525678|592949138|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
164160239|NCT03525678|592949134|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
164160240|NCT03525678|592949135|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
164160241|NCT03525678|592949136|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
164160242|NCT03525678|592949137|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
164160243|NCT03525678|592949138|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
164160244|NCT03525678|592949134|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
164160245|NCT03525678|592949135|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
164160246|NCT03525678|592949136|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
164160247|NCT03525678|592949137|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
164160248|NCT03525678|592949138|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
164160249|NCT03525678|592949134|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
164160250|NCT03525678|592949135|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
164160251|NCT03525678|592949136|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
164160252|NCT03525678|592949137|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
164160253|NCT03525678|592949138|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
164160254|NCT05343000|592950838|FG000|Overall Study|Physician Decision|2|||
164160255|NCT04432831|592950839|FG000|Overall Study|Withdrawal by Subject|24|||
164160256|NCT04432831|592950840|FG001|Overall Study|Withdrawal by Subject|28|||
164160257|NCT04432831|592950841|FG002|Overall Study|Withdrawal by Subject|21|||
164160258|NCT04432831|592950839|FG000|Overall Study|Death|23|||
164160259|NCT04432831|592950840|FG001|Overall Study|Death|23|||
164160260|NCT04432831|592950841|FG002|Overall Study|Death|17|||
164160261|NCT04432831|592950839|FG000|Overall Study|Lost to Follow-up|15|||
164160262|NCT04432831|592950840|FG001|Overall Study|Lost to Follow-up|15|||
164160263|NCT04432831|592950841|FG002|Overall Study|Lost to Follow-up|12|||
164160264|NCT04432831|592950839|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
164160265|NCT04432831|592950840|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
164160266|NCT04432831|592950841|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
164160267|NCT04432831|592950839|FG000|Overall Study|Reason Not Specified|7|||
164160268|NCT04432831|592950840|FG001|Overall Study|Reason Not Specified|11|||
164160269|NCT04432831|592950841|FG002|Overall Study|Reason Not Specified|9|||
164160270|NCT04432831|592950839|FG000|Overall Study|Adverse Event|7|||
164160271|NCT04432831|592950840|FG001|Overall Study|Adverse Event|7|||
164160272|NCT04432831|592950841|FG002|Overall Study|Adverse Event|7|||
164160273|NCT04432831|592950839|FG000|Overall Study|Physician Decision|1|||
164160274|NCT04432831|592950840|FG001|Overall Study|Physician Decision|3|||
164160275|NCT04432831|592950841|FG002|Overall Study|Physician Decision|6|||
164160276|NCT04432831|592950839|FG000|Overall Study|Protocol Violation|1|||
164160277|NCT04432831|592950840|FG001|Overall Study|Protocol Violation|0|||
164160278|NCT04432831|592950841|FG002|Overall Study|Protocol Violation|2|||
164160279|NCT04432831|592950839|FG000|Overall Study|Pregnancy|0|||
164160280|NCT04432831|592950840|FG001|Overall Study|Pregnancy|1|||
164160281|NCT04432831|592950841|FG002|Overall Study|Pregnancy|0|||
164160282|NCT04432831|592950839|FG000|Overall Study|Lack of Efficacy|0|||
164160283|NCT04432831|592950840|FG001|Overall Study|Lack of Efficacy|0|||
164160284|NCT04432831|592950841|FG002|Overall Study|Lack of Efficacy|2|||
164160285|NCT03782792|592950842|FG000|Overall Study|Patient left the country|0|||
164160286|NCT03782792|592950843|FG001|Overall Study|Patient left the country|1|||
164160287|NCT03782792|592950842|FG000|Overall Study|Withdrawal by Subject|1|||
164160288|NCT03782792|592950843|FG001|Overall Study|Withdrawal by Subject|2|||
164160289|NCT00617890|592950844|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
164160290|NCT00617890|592950845|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
164160291|NCT00617890|592950846|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
164160292|NCT00617890|592950847|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
164160293|NCT00617890|592950844|FG000|Overall Study|Lack of Efficacy|23|||
164160294|NCT00617890|592950845|FG001|Overall Study|Lack of Efficacy|26|||
164160295|NCT00617890|592950846|FG002|Overall Study|Lack of Efficacy|30|||
164160296|NCT00617890|592950847|FG003|Overall Study|Lack of Efficacy|97|||
164160297|NCT00617890|592950844|FG000|Overall Study|Lost to Follow-up|0|||
164160298|NCT00617890|592950845|FG001|Overall Study|Lost to Follow-up|0|||
164160299|NCT00617890|592950846|FG002|Overall Study|Lost to Follow-up|1|||
164160300|NCT00617890|592950847|FG003|Overall Study|Lost to Follow-up|2|||
164160301|NCT00617890|592950844|FG000|Overall Study|Withdrawal by Subject|4|||
164160302|NCT00617890|592950845|FG001|Overall Study|Withdrawal by Subject|1|||
164160303|NCT00617890|592950846|FG002|Overall Study|Withdrawal by Subject|0|||
164160304|NCT00617890|592950847|FG003|Overall Study|Withdrawal by Subject|2|||
164160305|NCT00617890|592950844|FG000|Overall Study|Protocol Violation|2|||
164160306|NCT00617890|592950845|FG001|Overall Study|Protocol Violation|1|||
164160307|NCT00617890|592950846|FG002|Overall Study|Protocol Violation|0|||
164160308|NCT00617890|592950847|FG003|Overall Study|Protocol Violation|0|||
164160309|NCT00617890|592950844|FG000|Overall Study|Adverse Event|1|||
164160310|NCT00617890|592950845|FG001|Overall Study|Adverse Event|0|||
164160311|NCT00617890|592950846|FG002|Overall Study|Adverse Event|3|||
164160312|NCT00617890|592950847|FG003|Overall Study|Adverse Event|8|||
164160313|NCT00617890|592950844|FG000|Overall Study|Not treated|1|||
164160314|NCT00617890|592950845|FG001|Overall Study|Not treated|0|||
164160315|NCT00617890|592950846|FG002|Overall Study|Not treated|1|||
164160316|NCT00617890|592950847|FG003|Overall Study|Not treated|1|||
164160317|NCT00154284|592950851|FG000|Overall Study|Adverse Event|6|||
164160318|NCT00154284|592950852|FG001|Overall Study|Adverse Event|9|||
164160319|NCT00154284|592950851|FG000|Overall Study|Abnormal laboratory value(s)|0|||
164160320|NCT00154284|592950852|FG001|Overall Study|Abnormal laboratory value(s)|1|||
164160321|NCT00154284|592950851|FG000|Overall Study|Lack of Efficacy|1|||
164160322|NCT00154284|592950852|FG001|Overall Study|Lack of Efficacy|2|||
164160323|NCT00154284|592950851|FG000|Overall Study|Protocol Violation|0|||
164160324|NCT00154284|592950852|FG001|Overall Study|Protocol Violation|1|||
164160325|NCT02058537|592950861|FG000|Overall Study|Withdrawal by Subject|1|||
164160326|NCT01780038|592950864|FG000|Overall Study|Lost to Follow-up|4|||
164160327|NCT01780038|592950865|FG001|Overall Study|Lost to Follow-up|1|||
164160328|NCT01085630|592950866|FG000|Overall Study|Insufficient data|1|||
164160329|NCT01085630|592950867|FG001|Overall Study|Insufficient data|0|||
164160330|NCT01085630|592950866|FG000|Overall Study|Ineligible|3|||
164160331|NCT01085630|592950867|FG001|Overall Study|Ineligible|0|||
164160332|NCT02609607|592950873|FG000|Overall Study|Lost to Follow-up|0|||
164160333|NCT02609607|592950874|FG001|Overall Study|Lost to Follow-up|1|||
164160334|NCT03691207|592950880|FG000|Overall Study|Death|41|||
164160335|NCT03691207|592950881|FG001|Overall Study|Death|26|||
164160336|NCT03691207|592950880|FG000|Overall Study|Lost to Follow-up|1|||
164160337|NCT03691207|592950881|FG001|Overall Study|Lost to Follow-up|1|||
164160338|NCT03691207|592950880|FG000|Overall Study|Withdrawal by Subject|2|||
164160339|NCT03691207|592950881|FG001|Overall Study|Withdrawal by Subject|8|||
164160340|NCT03691207|592950880|FG000|Overall Study|Sponsor decision|1|||
164160341|NCT03691207|592950881|FG001|Overall Study|Sponsor decision|7|||
164160342|NCT00651261|592950882|FG000|Overall Study|Adverse Event|32|||
164160343|NCT00651261|592950883|FG001|Overall Study|Adverse Event|22|||
164160344|NCT00651261|592950882|FG000|Overall Study|Death|18|||
164160345|NCT00651261|592950883|FG001|Overall Study|Death|18|||
164160346|NCT00651261|592950882|FG000|Overall Study|Withdrawal by Subject|22|||
164160347|NCT00651261|592950883|FG001|Overall Study|Withdrawal by Subject|40|||
164160348|NCT00651261|592950882|FG000|Overall Study|Induction failure|24|||
164160349|NCT00651261|592950883|FG001|Overall Study|Induction failure|35|||
164160350|NCT00651261|592950882|FG000|Overall Study|Disease progression|58|||
164160351|NCT00651261|592950883|FG001|Overall Study|Disease progression|58|||
164160352|NCT00651261|592950882|FG000|Overall Study|Alternative therapy|109|||
164160353|NCT00651261|592950883|FG001|Overall Study|Alternative therapy|107|||
164160354|NCT00651261|592950882|FG000|Overall Study|Other disease or participant decisions|23|||
164160355|NCT00651261|592950883|FG001|Overall Study|Other disease or participant decisions|23|||
164160356|NCT00651261|592950882|FG000|Overall Study|Never treated|5|||
164160357|NCT00651261|592950883|FG001|Overall Study|Never treated|3|||
164160358|NCT02027545|592950884|FG000|Overall Study|Failed to sign HIPAA|0|||
164160359|NCT02027545|592950885|FG001|Overall Study|Failed to sign HIPAA|2|||
164160360|NCT02027545|592950884|FG000|Overall Study|Failed to attend study visit|2|||
164160361|NCT02027545|592950885|FG001|Overall Study|Failed to attend study visit|0|||
164160362|NCT02027545|592950884|FG000|Overall Study|Protocol Violation|1|||
164160363|NCT02027545|592950885|FG001|Overall Study|Protocol Violation|0|||
164160364|NCT03351608|592950886|FG000|Overall Study|Lost to Follow-up|0|||
164160365|NCT03351608|592950887|FG001|Overall Study|Lost to Follow-up|1|||
164160366|NCT03351608|592950888|FG002|Overall Study|Lost to Follow-up|1|||
164160367|NCT03351608|592950889|FG003|Overall Study|Lost to Follow-up|1|||
164160368|NCT03351608|592950890|FG004|Overall Study|Lost to Follow-up|1|||
164160369|NCT03351608|592950886|FG000|Overall Study|Physician Decision|1|||
164160370|NCT03351608|592950887|FG001|Overall Study|Physician Decision|0|||
164160371|NCT03351608|592950888|FG002|Overall Study|Physician Decision|0|||
164160372|NCT03351608|592950889|FG003|Overall Study|Physician Decision|2|||
164160373|NCT03351608|592950890|FG004|Overall Study|Physician Decision|1|||
164160374|NCT03351608|592950886|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
164160375|NCT03351608|592950887|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
164160376|NCT03351608|592950888|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
164160377|NCT03351608|592950889|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
164160378|NCT03351608|592950890|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
164160379|NCT03351608|592950886|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164160380|NCT03351608|592950887|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164160381|NCT03351608|592950888|FG002|Overall Study|Withdrawal by parent/guardian|1|||
164160382|NCT03351608|592950889|FG003|Overall Study|Withdrawal by parent/guardian|1|||
164160383|NCT03351608|592950890|FG004|Overall Study|Withdrawal by parent/guardian|0|||
164160384|NCT03351608|592950886|FG000|Overall Study|Other|0|||
164160385|NCT03351608|592950887|FG001|Overall Study|Other|1|||
164160386|NCT03351608|592950888|FG002|Overall Study|Other|1|||
164160387|NCT03351608|592950889|FG003|Overall Study|Other|3|||
164160388|NCT03351608|592950890|FG004|Overall Study|Other|0|||
164160389|NCT02877004|592950891|FG000|Overall Study|Pregnancy|0|||
164160390|NCT02877004|592950892|FG001|Overall Study|Pregnancy|0|||
164160391|NCT02877004|592950893|FG002|Overall Study|Pregnancy|1|||
164160392|NCT02727478|592950894|FG000|Overall Study|Withdrawal by Subject|8|||
164160393|NCT02727478|592950895|FG001|Overall Study|Withdrawal by Subject|10|||
164160394|NCT02633293|592950896|FG000|Overall Study|Death|56|||
164160395|NCT02633293|592950896|FG000|Overall Study|Progressive Disease|12|||
164160396|NCT02633293|592950896|FG000|Overall Study|Adverse Event|29|||
164160397|NCT02633293|592950896|FG000|Overall Study|Withdrawal by Subject|41|||
164160398|NCT02633293|592950896|FG000|Overall Study|Protocol Violation|1|||
164160399|NCT02633293|592950896|FG000|Overall Study|Lost to Follow-up|1|||
164160400|NCT02633293|592950896|FG000|Overall Study|Study Terminated by Sponsor|24|||
164160401|NCT02633293|592950896|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
164160402|NCT02633293|592950896|FG000|Overall Study|Lung Transplant|5|||
164160403|NCT02633293|592950896|FG000|Overall Study|Lack of Efficacy|2|||
164160404|NCT02633293|592950896|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
164160405|NCT01343043|592950897|FG000|Overall Study|Disease progression before treatment|1|||
164160406|NCT01343043|592950898|FG001|Overall Study|Disease progression before treatment|0|||
164160407|NCT01343043|592950899|FG002|Overall Study|Disease progression before treatment|0|||
164160408|NCT01343043|592950900|FG003|Overall Study|Disease progression before treatment|0|||
164160409|NCT01343043|592950897|FG000|Overall Study|Withdrawal by Subject|1|||
164160410|NCT01343043|592950898|FG001|Overall Study|Withdrawal by Subject|0|||
164160411|NCT01343043|592950899|FG002|Overall Study|Withdrawal by Subject|0|||
164160412|NCT01343043|592950900|FG003|Overall Study|Withdrawal by Subject|0|||
164160413|NCT01343043|592950897|FG000|Overall Study|Death|1|||
164160414|NCT01343043|592950898|FG001|Overall Study|Death|1|||
164160415|NCT01343043|592950899|FG002|Overall Study|Death|0|||
164160416|NCT01343043|592950900|FG003|Overall Study|Death|1|||
164160417|NCT00502242|592950909|FG000|Overall Study|Lack of Efficacy|1|||
164160418|NCT00502242|592950910|FG001|Overall Study|Lack of Efficacy|11|||
164160419|NCT00502242|592950909|FG000|Overall Study|Adverse Event|31|||
164160420|NCT00502242|592950910|FG001|Overall Study|Adverse Event|20|||
164160421|NCT00502242|592950909|FG000|Overall Study|Physician Decision|2|||
164160422|NCT00502242|592950910|FG001|Overall Study|Physician Decision|3|||
164160423|NCT00502242|592950909|FG000|Overall Study|Other - Unspecified|8|||
164160424|NCT00502242|592950910|FG001|Overall Study|Other - Unspecified|14|||
164160425|NCT00502242|592950909|FG000|Overall Study|Protocol Violation|3|||
164160426|NCT00502242|592950910|FG001|Overall Study|Protocol Violation|1|||
164160427|NCT00502242|592950909|FG000|Overall Study|Withdrawal by Subject|6|||
164160428|NCT00502242|592950910|FG001|Overall Study|Withdrawal by Subject|7|||
164160429|NCT00778817|592950911|FG000|Overall Study|Adverse Event|2|||
164160430|NCT00778817|592950911|FG000|Overall Study|Withdrawal by Subject|2|||
164160431|NCT02509507|592950912|FG000|Overall Study|Death|21|||
164160432|NCT02509507|592950913|FG001|Overall Study|Death|3|||
164160433|NCT02509507|592950914|FG002|Overall Study|Death|22|||
164160434|NCT02509507|592950915|FG003|Overall Study|Death|14|||
164160435|NCT02509507|592950916|FG004|Overall Study|Death|8|||
164160436|NCT02509507|592950917|FG005|Overall Study|Death|12|||
164160437|NCT02509507|592950918|FG006|Overall Study|Death|5|||
164160438|NCT02509507|592950919|FG007|Overall Study|Death|4|||
164160439|NCT02509507|592950920|FG008|Overall Study|Death|8|||
164160440|NCT02509507|592950912|FG000|Overall Study|Lost to Follow-up|0|||
164160441|NCT02509507|592950913|FG001|Overall Study|Lost to Follow-up|1|||
164160442|NCT02509507|592950914|FG002|Overall Study|Lost to Follow-up|0|||
164160443|NCT02509507|592950915|FG003|Overall Study|Lost to Follow-up|0|||
164160444|NCT02509507|592950916|FG004|Overall Study|Lost to Follow-up|0|||
164160445|NCT02509507|592950917|FG005|Overall Study|Lost to Follow-up|2|||
164160446|NCT02509507|592950918|FG006|Overall Study|Lost to Follow-up|0|||
164160447|NCT02509507|592950919|FG007|Overall Study|Lost to Follow-up|0|||
164160448|NCT02509507|592950920|FG008|Overall Study|Lost to Follow-up|0|||
164160449|NCT02509507|592950912|FG000|Overall Study|Withdrawal by Subject|2|||
164160450|NCT02509507|592950913|FG001|Overall Study|Withdrawal by Subject|0|||
164160451|NCT02509507|592950914|FG002|Overall Study|Withdrawal by Subject|1|||
164160452|NCT02509507|592950915|FG003|Overall Study|Withdrawal by Subject|4|||
164160453|NCT02509507|592950916|FG004|Overall Study|Withdrawal by Subject|1|||
164160454|NCT02509507|592950917|FG005|Overall Study|Withdrawal by Subject|3|||
164160455|NCT02509507|592950918|FG006|Overall Study|Withdrawal by Subject|4|||
164160456|NCT02509507|592950919|FG007|Overall Study|Withdrawal by Subject|0|||
164160457|NCT02509507|592950920|FG008|Overall Study|Withdrawal by Subject|1|||
164160458|NCT02356588|592950921|FG000|Overall Study|Lack of Efficacy|4|||
164160459|NCT02356588|592950922|FG001|Overall Study|Lack of Efficacy|10|||
164160460|NCT02356588|592950921|FG000|Overall Study|Adverse Event|0|||
164160461|NCT02356588|592950922|FG001|Overall Study|Adverse Event|2|||
164160462|NCT02356588|592950921|FG000|Overall Study|Withdrawal by Subject|1|||
164160463|NCT02356588|592950922|FG001|Overall Study|Withdrawal by Subject|0|||
164160464|NCT02356588|592950921|FG000|Overall Study|Protocol Violation|0|||
164160465|NCT02356588|592950922|FG001|Overall Study|Protocol Violation|1|||
164160466|NCT01418378|592950923|FG000|Overall Study|Death|1|||
164160467|NCT01418378|592950924|FG001|Overall Study|Death|2|||
164160468|NCT01418378|592950923|FG000|Overall Study|Physician Decision|0|||
164160469|NCT01418378|592950924|FG001|Overall Study|Physician Decision|1|||
164160470|NCT01418378|592950923|FG000|Overall Study|ligament imbalance|0|||
164160471|NCT01418378|592950924|FG001|Overall Study|ligament imbalance|1|||
164160472|NCT01418378|592950923|FG000|Overall Study|developed chronic myopathy|0|||
164160473|NCT01418378|592950924|FG001|Overall Study|developed chronic myopathy|1|||
164160474|NCT01812109|592950929|FG000|Overall Study|research personnel delay|16|||
164160475|NCT01812109|592950929|FG000|Overall Study|NIRS Unattainable|17|||
164160476|NCT00442897|592950930|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
164160477|NCT00442897|592950931|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
164160478|NCT00442897|592950930|FG000|Base Study (12 Week Follow-up)|Death|0|||
164160479|NCT00442897|592950931|FG001|Base Study (12 Week Follow-up)|Death|1|||
164160480|NCT00442897|592950930|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
164160481|NCT00442897|592950931|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
164160482|NCT00442897|592950930|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
164160483|NCT00442897|592950931|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
164160484|NCT00442897|592950930|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
164160485|NCT00442897|592950931|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
164160486|NCT00442897|592950930|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
164160487|NCT00442897|592950931|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
164160488|NCT00442897|592950930|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
164160489|NCT00442897|592950931|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
164160490|NCT00442897|592950930|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
164160787|NCT04157348|592952984|FG001|Open-label Extension Period|Death|1|||
164160491|NCT00442897|592950931|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
164160492|NCT03448419|592950932|FG000|Overall Study|Adverse Event|10|||
164160493|NCT03448419|592950933|FG001|Overall Study|Adverse Event|9|||
164160494|NCT03448419|592950932|FG000|Overall Study|Lost to Follow-up|0|||
164160495|NCT03448419|592950933|FG001|Overall Study|Lost to Follow-up|2|||
164160496|NCT03448419|592950932|FG000|Overall Study|Withdrawal by Subject|3|||
164160497|NCT03448419|592950933|FG001|Overall Study|Withdrawal by Subject|1|||
164160498|NCT03448419|592950932|FG000|Overall Study|Not treated|0|||
164160499|NCT03448419|592950933|FG001|Overall Study|Not treated|1|||
164160500|NCT03448419|592950932|FG000|Overall Study|Patient did not attend all visits|0|||
164160501|NCT03448419|592950933|FG001|Overall Study|Patient did not attend all visits|2|||
164160502|NCT03448419|592950932|FG000|Overall Study|Withdrawn by Sponsor|0|||
164160503|NCT03448419|592950933|FG001|Overall Study|Withdrawn by Sponsor|1|||
164160504|NCT04548193|592950944|FG000|Overall Study|Lost to Follow-up|0|||
164160505|NCT04548193|592950945|FG001|Overall Study|Lost to Follow-up|1|||
164160506|NCT04548193|592950944|FG000|Overall Study|Death|0|||
164160507|NCT04548193|592950945|FG001|Overall Study|Death|1|||
164160508|NCT04548193|592950944|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
164160509|NCT04548193|592950945|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
164160510|NCT04548193|592950944|FG000|Overall Study|Withdrawal by Subject|2|||
164160511|NCT04548193|592950945|FG001|Overall Study|Withdrawal by Subject|2|||
164160512|NCT00630825|592950946|FG000|Overall Study|Adverse Event|4|||
164160513|NCT00630825|592950947|FG001|Overall Study|Adverse Event|4|||
164160514|NCT00630825|592950948|FG002|Overall Study|Adverse Event|3|||
164160515|NCT00630825|592950949|FG003|Overall Study|Adverse Event|1|||
164160516|NCT00630825|592950946|FG000|Overall Study|Entry Criteria Not Met|1|||
164160517|NCT00630825|592950947|FG001|Overall Study|Entry Criteria Not Met|0|||
164160518|NCT00630825|592950948|FG002|Overall Study|Entry Criteria Not Met|2|||
164160519|NCT00630825|592950949|FG003|Overall Study|Entry Criteria Not Met|1|||
164160520|NCT00630825|592950946|FG000|Overall Study|Lost to Follow-up|1|||
164160521|NCT00630825|592950947|FG001|Overall Study|Lost to Follow-up|1|||
164160522|NCT00630825|592950948|FG002|Overall Study|Lost to Follow-up|1|||
164160523|NCT00630825|592950949|FG003|Overall Study|Lost to Follow-up|1|||
164160524|NCT00630825|592950946|FG000|Overall Study|Physician Decision|1|||
164160525|NCT00630825|592950947|FG001|Overall Study|Physician Decision|0|||
164160526|NCT00630825|592950948|FG002|Overall Study|Physician Decision|0|||
164160527|NCT00630825|592950949|FG003|Overall Study|Physician Decision|0|||
164160528|NCT00630825|592950946|FG000|Overall Study|Withdrawal by Subject|2|||
164160529|NCT00630825|592950947|FG001|Overall Study|Withdrawal by Subject|2|||
164160530|NCT00630825|592950948|FG002|Overall Study|Withdrawal by Subject|2|||
164160531|NCT00630825|592950949|FG003|Overall Study|Withdrawal by Subject|3|||
164160532|NCT04610346|592950950|FG000|Overall Study|Withdrawal by Subject|1|||
164160533|NCT04610346|592950951|FG001|Overall Study|Withdrawal by Subject|1|||
164160534|NCT04610346|592950950|FG000|Overall Study|did not complete shelter onboarding|2|||
164160535|NCT04610346|592950951|FG001|Overall Study|did not complete shelter onboarding|1|||
164160536|NCT00931255|592950952|FG000|Overall Study|Follow up biopsy not done|2|||
164160537|NCT00931255|592950953|FG001|Overall Study|Follow up biopsy not done|3|||
164160538|NCT02019264|592950956|FG000|Overall Study|Not treated|6|||
164160539|NCT02019264|592950957|FG001|Overall Study|Not treated|4|||
164160540|NCT02019264|592950956|FG000|Overall Study|Lost to Follow-up|50|||
164160541|NCT02019264|592950957|FG001|Overall Study|Lost to Follow-up|47|||
164160542|NCT02019264|592950956|FG000|Overall Study|Withdrawal by Subject|142|||
164160543|NCT02019264|592950957|FG001|Overall Study|Withdrawal by Subject|117|||
164160544|NCT02019264|592950956|FG000|Overall Study|Administrative reason|36|||
164160545|NCT02019264|592950957|FG001|Overall Study|Administrative reason|28|||
164160546|NCT02019264|592950956|FG000|Overall Study|Missing|14|||
164160547|NCT02019264|592950957|FG001|Overall Study|Missing|11|||
164160548|NCT02187198|592950958|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
164160549|NCT02187198|592950959|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
164160550|NCT02187198|592950958|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
164160551|NCT02187198|592950959|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
164160552|NCT00546377|592950960|FG000|Overall Study|Deemed ineligible|1|||
164160553|NCT00546377|592950960|FG000|Overall Study|Adverse Event|6|||
164160554|NCT01575834|592950961|FG000|Overall Study|Withdrawal by Subject|352|||
164160555|NCT01575834|592950962|FG001|Overall Study|Withdrawal by Subject|390|||
164160556|NCT01575834|592950961|FG000|Overall Study|Death|81|||
164160557|NCT01575834|592950962|FG001|Overall Study|Death|74|||
164160558|NCT01575834|592950961|FG000|Overall Study|Other|70|||
164160559|NCT01575834|592950962|FG001|Overall Study|Other|70|||
164160560|NCT01575834|592950961|FG000|Overall Study|Adverse Event|63|||
164160561|NCT01575834|592950962|FG001|Overall Study|Adverse Event|61|||
164160562|NCT01575834|592950961|FG000|Overall Study|Lost to Follow-up|55|||
164160563|NCT01575834|592950962|FG001|Overall Study|Lost to Follow-up|68|||
164160564|NCT01575834|592950961|FG000|Overall Study|Noncompliance|52|||
164160565|NCT01575834|592950962|FG001|Overall Study|Noncompliance|27|||
164160566|NCT01575834|592950961|FG000|Overall Study|Administrative decision|15|||
164160567|NCT01575834|592950962|FG001|Overall Study|Administrative decision|33|||
164160568|NCT01575834|592950961|FG000|Overall Study|Ineligibility Determined|5|||
164160569|NCT01575834|592950962|FG001|Overall Study|Ineligibility Determined|8|||
164160570|NCT01575834|592950961|FG000|Overall Study|Protocol Deviation|4|||
164160571|NCT01575834|592950962|FG001|Overall Study|Protocol Deviation|3|||
164160572|NCT01575834|592950961|FG000|Overall Study|Requirement for Alternative Therapy|2|||
164160573|NCT01575834|592950962|FG001|Overall Study|Requirement for Alternative Therapy|4|||
164160574|NCT00488644|592950964|FG000|Overall Study|Not Eligible|1|||
164160575|NCT00488644|592950964|FG000|Overall Study|Not Evaluable|1|||
164160576|NCT01956773|592950971|FG000|Overall Study|Lost to Follow-up|628|||
164160577|NCT01956773|592950972|FG001|Overall Study|Lost to Follow-up|1|||
164160578|NCT01383174|592950973|FG000|3 Month Assessment|Death|0|||
164160579|NCT01383174|592950974|FG001|3 Month Assessment|Death|1|||
164160580|NCT01383174|592950973|FG000|3 Month Assessment|Lost to Follow-up|2|||
164160581|NCT01383174|592950974|FG001|3 Month Assessment|Lost to Follow-up|0|||
164160582|NCT01383174|592950973|FG000|3 Month Assessment|Refused to complete|4|||
164160583|NCT01383174|592950974|FG001|3 Month Assessment|Refused to complete|0|||
164160584|NCT01383174|592950973|FG000|6 Month Assessment|Lost to Follow-up|1|||
164160585|NCT01383174|592950974|FG001|6 Month Assessment|Lost to Follow-up|1|||
164160586|NCT01383174|592950973|FG000|6 Month Assessment|Refused to complete|4|||
164160587|NCT01383174|592950974|FG001|6 Month Assessment|Refused to complete|0|||
164160588|NCT01153815|592950977|FG000|Overall Study|Adverse Event|3|||
164160589|NCT01153815|592950978|FG001|Overall Study|Adverse Event|1|||
164160590|NCT01153815|592950977|FG000|Overall Study|Withdrawal by Subject|6|||
164160591|NCT01153815|592950978|FG001|Overall Study|Withdrawal by Subject|4|||
164160592|NCT02169271|592950979|FG000|Overall Study|Protocol Violation|1|||
164160593|NCT02169271|592950980|FG001|Overall Study|Protocol Violation|2|||
164160594|NCT04926831|592950981|FG000|Overall Study|Withdrawal by Subject|2|||
164160595|NCT04926831|592950981|FG000|Overall Study|Adverse Event|2|||
164160596|NCT00564850|592950982|FG000|Overall Study|Protocol Violation|2|||
164160597|NCT00030901|592950985|FG000|Initial Registration|Ineligible|167|||
164160598|NCT00030901|592950986|FG001|Initial Registration|Ineligible|0|||
164160599|NCT00030901|592950987|FG002|Initial Registration|Ineligible|0|||
164160600|NCT00030901|592950985|FG000|Randomization|Adverse Event|0|||
164160601|NCT00030901|592950986|FG001|Randomization|Adverse Event|11|||
164160602|NCT00030901|592950987|FG002|Randomization|Adverse Event|7|||
164160603|NCT00030901|592950985|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
164160604|NCT00030901|592950986|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
164160605|NCT00030901|592950987|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
164160606|NCT00030901|592950985|FG000|Randomization|Progression/Relapse|0|||
164160607|NCT00030901|592950986|FG001|Randomization|Progression/Relapse|22|||
164160608|NCT00030901|592950987|FG002|Randomization|Progression/Relapse|21|||
164160609|NCT00030901|592950985|FG000|Randomization|Death|0|||
164160610|NCT00030901|592950986|FG001|Randomization|Death|1|||
164160611|NCT00030901|592950987|FG002|Randomization|Death|3|||
164160612|NCT00030901|592950985|FG000|Randomization|Other|0|||
164160613|NCT00030901|592950986|FG001|Randomization|Other|36|||
164160614|NCT00030901|592950987|FG002|Randomization|Other|33|||
164160615|NCT00030901|592950985|FG000|Randomization|Ineligible|0|||
164160616|NCT00030901|592950986|FG001|Randomization|Ineligible|15|||
164160617|NCT00030901|592950987|FG002|Randomization|Ineligible|14|||
164160618|NCT01806051|592950990|FG000|Overall Study|Withdrawal by Subject|6|||
164160619|NCT02576847|592950991|FG000|Overall Study|Adverse Event|27|||
164160620|NCT02576847|592950991|FG000|Overall Study|Lost to Follow-up|22|||
164160621|NCT02576847|592950991|FG000|Overall Study|Physician Decision|1|||
164160622|NCT02576847|592950991|FG000|Overall Study|Pregnancy|1|||
164160623|NCT02576847|592950991|FG000|Overall Study|Protocol Violation|3|||
164160624|NCT02576847|592950991|FG000|Overall Study|Withdrawal by Subject|78|||
164160625|NCT02576847|592950991|FG000|Overall Study|Other|5|||
164160626|NCT01205776|592950992|FG000|Overall Study|Lost to Follow-up|53|||
164160627|NCT01205776|592950993|FG001|Overall Study|Lost to Follow-up|61|||
164160628|NCT01205776|592950992|FG000|Overall Study|Withdrawal by Subject|11|||
164160629|NCT01205776|592950993|FG001|Overall Study|Withdrawal by Subject|34|||
164160630|NCT02418182|592950994|FG000|Overall Study|Unable to re-consent|18|||
164160631|NCT02418182|592950995|FG001|Overall Study|Unable to re-consent|15|||
164160632|NCT02418182|592950994|FG000|Overall Study|Lost to Follow-up|0|||
164160633|NCT02418182|592950995|FG001|Overall Study|Lost to Follow-up|2|||
164160634|NCT02431676|592950996|FG000|Overall Study|no lab obtained|0|||
164160635|NCT02431676|592950997|FG001|Overall Study|no lab obtained|1|||
164160636|NCT02431676|592950998|FG002|Overall Study|no lab obtained|2|||
164160637|NCT00298272|592952922|FG000|Double-blind Phase|Adverse Event|2|||
164160638|NCT00298272|592952923|FG001|Double-blind Phase|Adverse Event|0|||
164160639|NCT00298272|592952922|FG000|Double-blind Phase|Failure to Return|2|||
164160640|NCT00298272|592952923|FG001|Double-blind Phase|Failure to Return|0|||
164160641|NCT00298272|592952922|FG000|Double-blind Phase|Protocol Violation|2|||
164160642|NCT00298272|592952923|FG001|Double-blind Phase|Protocol Violation|0|||
164160643|NCT00298272|592952922|FG000|Double-blind Phase|Withdrawal by Subject|2|||
164160644|NCT00298272|592952923|FG001|Double-blind Phase|Withdrawal by Subject|0|||
164160645|NCT00298272|592952922|FG000|Open Label Retreatment Phase|Adverse Event|1|||
164160646|NCT00298272|592952923|FG001|Open Label Retreatment Phase|Adverse Event|2|||
164160647|NCT00298272|592952922|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
164160648|NCT00298272|592952923|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
164160649|NCT00298272|592952922|FG000|Open Label Retreatment Phase|Failure to Return|1|||
164160650|NCT00298272|592952923|FG001|Open Label Retreatment Phase|Failure to Return|0|||
164160651|NCT00298272|592952922|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
164160652|NCT00298272|592952923|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
164160653|NCT00298272|592952922|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
164160654|NCT00298272|592952923|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
164160655|NCT00298272|592952922|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
164160656|NCT00298272|592952923|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
164160657|NCT00298272|592952922|FG000|Safety Follow-up Phase|Failure to Return|1|||
164160658|NCT00298272|592952923|FG001|Safety Follow-up Phase|Failure to Return|1|||
164160659|NCT00298272|592952922|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
164160660|NCT00298272|592952923|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
164160661|NCT00298272|592952922|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
164160662|NCT00298272|592952923|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
164160663|NCT05253573|592952924|FG000|Overall Study|Death|1|||
164160664|NCT05253573|592952925|FG001|Overall Study|Death|0|||
164160665|NCT01344824|592952926|FG000|Overall Study|Adverse Event|15|||
164160666|NCT01344824|592952926|FG000|Overall Study|Withdrawal by Subject|6|||
164160667|NCT01344824|592952926|FG000|Overall Study|Other complicating disease|1|||
164160668|NCT01344824|592952926|FG000|Overall Study|Progression|15|||
164160669|NCT00566020|592952927|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
164160670|NCT00566020|592952928|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
164160671|NCT00566020|592952927|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
164160672|NCT00566020|592952928|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
164160673|NCT00566020|592952927|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
164160674|NCT00566020|592952928|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
164160675|NCT00566020|592952927|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
164160676|NCT00566020|592952928|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
164160677|NCT00566020|592952927|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
164160678|NCT00566020|592952928|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
164160679|NCT00566020|592952927|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
164160680|NCT00566020|592952928|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
164160681|NCT01754129|592952929|FG000|Overall Study|Death|13|||
164160682|NCT01754129|592952929|FG000|Overall Study|Duodopa discontinuation|9|||
164160683|NCT01754129|592952929|FG000|Overall Study|Lost to Follow-up|7|||
164160684|NCT01754129|592952929|FG000|Overall Study|Withdrew consent|1|||
164160685|NCT01754129|592952929|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
164160686|NCT02126579|592952930|FG000|Overall Study|disease progression|0|||
164160687|NCT02126579|592952931|FG001|Overall Study|disease progression|0|||
164160688|NCT02126579|592952932|FG002|Overall Study|disease progression|0|||
164160689|NCT02126579|592952933|FG003|Overall Study|disease progression|1|||
164160690|NCT02126579|592952934|FG004|Overall Study|disease progression|0|||
164160691|NCT02126579|592952935|FG005|Overall Study|disease progression|0|||
164160692|NCT02126579|592952936|FG006|Overall Study|disease progression|1|||
164160693|NCT04630002|592952937|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
164160694|NCT04630002|592952938|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
164160695|NCT04630002|592952939|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
164160696|NCT04630002|592952937|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
164160697|NCT04630002|592952938|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
164160698|NCT04630002|592952939|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
164160699|NCT04630002|592952937|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
164160700|NCT04630002|592952938|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
164160701|NCT04630002|592952939|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
164160702|NCT04630002|592952937|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
164160703|NCT04630002|592952938|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
164160704|NCT04630002|592952939|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
164160705|NCT04630002|592952937|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
164160706|NCT04630002|592952938|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
164160707|NCT04630002|592952939|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
164160708|NCT04630002|592952937|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
164160709|NCT04630002|592952938|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
164160710|NCT04630002|592952939|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
164160711|NCT04630002|592952937|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
164160712|NCT04630002|592952938|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
164160713|NCT04630002|592952939|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
164161076|NCT03483961|592954922|FG001|Overall Study|Adverse Event|0|||
164160714|NCT04630002|592952937|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
164160715|NCT04630002|592952938|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
164160716|NCT04630002|592952939|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
164160717|NCT04498182|592952941|FG000|Overall Study|Adverse Event|2|||
164160718|NCT04498182|592952942|FG001|Overall Study|Adverse Event|3|||
164160719|NCT04498182|592952943|FG002|Overall Study|Adverse Event|2|||
164160720|NCT04498182|592952941|FG000|Overall Study|Withdrawal of Consent|3|||
164160721|NCT04498182|592952942|FG001|Overall Study|Withdrawal of Consent|4|||
164160722|NCT04498182|592952943|FG002|Overall Study|Withdrawal of Consent|3|||
164160723|NCT04498182|592952941|FG000|Overall Study|Non-Compliant|1|||
164160724|NCT04498182|592952942|FG001|Overall Study|Non-Compliant|0|||
164160725|NCT04498182|592952943|FG002|Overall Study|Non-Compliant|1|||
164160726|NCT04498182|592952941|FG000|Overall Study|Lost to Follow-up|0|||
164160727|NCT04498182|592952942|FG001|Overall Study|Lost to Follow-up|0|||
164160728|NCT04498182|592952943|FG002|Overall Study|Lost to Follow-up|1|||
164160729|NCT04498182|592952941|FG000|Overall Study|Investigator Decision|0|||
164160730|NCT04498182|592952942|FG001|Overall Study|Investigator Decision|0|||
164160731|NCT04498182|592952943|FG002|Overall Study|Investigator Decision|1|||
164160732|NCT04498182|592952941|FG000|Overall Study|Protocol Violation|1|||
164160733|NCT04498182|592952942|FG001|Overall Study|Protocol Violation|0|||
164160734|NCT04498182|592952943|FG002|Overall Study|Protocol Violation|2|||
164160735|NCT02182843|592952944|FG000|Overall Study|Withdrawal by Subject|7|||
164160736|NCT02182843|592952944|FG000|Overall Study|Lost to Follow-up|2|||
164160737|NCT02182843|592952944|FG000|Overall Study|Adverse Event|1|||
164160738|NCT00288626|592952956|FG000|Overall Study|Death|3|||
164160739|NCT00288626|592952956|FG000|Overall Study|Withdrawal by Subject|4|||
164160740|NCT01372618|592952957|FG000|Overall Study|PI Died. Study Terminated|9|||
164160741|NCT00558467|592952958|FG000|Overall Study|Adverse Event|1|||
164160742|NCT00558467|592952959|FG001|Overall Study|Adverse Event|2|||
164160743|NCT00558467|592952958|FG000|Overall Study|Lack of Efficacy|0|||
164160744|NCT00558467|592952959|FG001|Overall Study|Lack of Efficacy|1|||
164160745|NCT00558467|592952958|FG000|Overall Study|Patient moving out of state|0|||
164160746|NCT00558467|592952959|FG001|Overall Study|Patient moving out of state|1|||
164160747|NCT01684423|592952962|FG000|Overall Study|Withdrawal by Subject|0|||
164160748|NCT01684423|592952963|FG001|Overall Study|Withdrawal by Subject|0|||
164160749|NCT01684423|592952964|FG002|Overall Study|Withdrawal by Subject|1|||
164160750|NCT01684423|592952965|FG003|Overall Study|Withdrawal by Subject|0|||
164160751|NCT01684423|592952966|FG004|Overall Study|Withdrawal by Subject|0|||
164160752|NCT01741688|592952967|FG000|Overall Study|Lack of insurance coverage|2|||
164160753|NCT01741688|592952967|FG000|Overall Study|Withdrawal by Subject|1|||
164160754|NCT03850496|592952972|FG000|Overall Study|Withdrawal by Subject|1|||
164160755|NCT03850496|592952973|FG001|Overall Study|Withdrawal by Subject|0|||
164160756|NCT03850496|592952974|FG002|Overall Study|Withdrawal by Subject|0|||
164160757|NCT03850496|592952972|FG000|Overall Study|Lost to Follow-up|0|||
164160758|NCT03850496|592952973|FG001|Overall Study|Lost to Follow-up|1|||
164160759|NCT03850496|592952974|FG002|Overall Study|Lost to Follow-up|4|||
164160760|NCT00869999|592952977|FG000|Overall Study|Withdrawal by Subject|1|||
164160761|NCT00869999|592952977|FG000|Overall Study|removed prior to starting therapy|1|||
164160762|NCT03674112|592952981|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
164160763|NCT03674112|592952982|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
164160764|NCT03674112|592952981|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
164160765|NCT03674112|592952982|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
164160766|NCT03674112|592952981|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
164160767|NCT03674112|592952982|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
164160768|NCT03674112|592952981|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
164160769|NCT03674112|592952982|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
164160770|NCT03674112|592952981|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
164160771|NCT03674112|592952982|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
164160772|NCT03674112|592952981|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
164160773|NCT03674112|592952982|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
164160774|NCT03674112|592952981|FG000|Follow-Up Period (≥3 Years)|Death|2|||
164160775|NCT03674112|592952982|FG001|Follow-Up Period (≥3 Years)|Death|0|||
164160776|NCT03674112|592952981|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
164160777|NCT03674112|592952982|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
164160778|NCT04157348|592952983|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
164160779|NCT04157348|592952984|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
164160780|NCT04157348|592952983|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
164160781|NCT04157348|592952984|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
164160782|NCT04157348|592952983|FG000|Double-blind Treatment Period|Adverse Event|0|||
164160783|NCT04157348|592952984|FG001|Double-blind Treatment Period|Adverse Event|1|||
164160784|NCT04157348|592952983|FG000|Open-label Extension Period|Adverse Event|1|||
164160785|NCT04157348|592952984|FG001|Open-label Extension Period|Adverse Event|1|||
164160786|NCT04157348|592952983|FG000|Open-label Extension Period|Death|0|||
164160788|NCT04157348|592952983|FG000|Open-label Extension Period|Lack of Efficacy|2|||
164160789|NCT04157348|592952984|FG001|Open-label Extension Period|Lack of Efficacy|2|||
164160790|NCT04157348|592952983|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
164160791|NCT04157348|592952984|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
164160792|NCT04157348|592952983|FG000|Open-label Extension Period|Ongoing|60|||
164160793|NCT04157348|592952984|FG001|Open-label Extension Period|Ongoing|57|||
164160794|NCT04157348|592952983|FG000|Open-label Extension Period|other reasons|1|||
164160795|NCT04157348|592952984|FG001|Open-label Extension Period|other reasons|1|||
164160796|NCT02220764|592952987|FG000|Overall Study|Lost to Follow-up|3|||
164160797|NCT02220764|592952988|FG001|Overall Study|Lost to Follow-up|1|||
164160798|NCT02220764|592952987|FG000|Overall Study|Death|1|||
164160799|NCT02220764|592952988|FG001|Overall Study|Death|0|||
164160800|NCT03020992|592952989|FG000|Overall Study|Adverse Event|5|||
164160801|NCT03020992|592952989|FG000|Overall Study|Withdrawal by Subject|1|||
164160802|NCT05000164|592952990|FG000|Overall Study|Adverse Event|1|||
164160803|NCT05000164|592952990|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
164160804|NCT05000164|592952990|FG000|Overall Study|Lens Discomfort|3|||
164160805|NCT05000164|592952990|FG000|Overall Study|Withdrew Consent during Study|2|||
164160806|NCT05000164|592952990|FG000|Overall Study|Subject Withdrawn by PI|2|||
164160807|NCT05000164|592952990|FG000|Overall Study|Other Fractured Test Article|1|||
164160808|NCT01006122|592952991|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
164160809|NCT01006122|592952992|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
164160810|NCT01006122|592952991|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
164160811|NCT01006122|592952992|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
164160812|NCT01006122|592952991|FG000|First Double-blind Intervention Period|Pregnancy|0|||
164160813|NCT01006122|592952992|FG001|First Double-blind Intervention Period|Pregnancy|1|||
164160814|NCT01006122|592952991|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
164160815|NCT01006122|592952992|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
164160816|NCT01006122|592952991|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
164160817|NCT01006122|592952992|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
164160818|NCT01006122|592952991|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
164160819|NCT01006122|592952992|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
164160820|NCT01006122|592952991|FG000|First Double-blind Intervention Period|Other|3|||
164160821|NCT01006122|592952992|FG001|First Double-blind Intervention Period|Other|0|||
164160822|NCT01006122|592952991|FG000|First Double-blind Intervention Period|Adverse Event|0|||
164160823|NCT01006122|592952992|FG001|First Double-blind Intervention Period|Adverse Event|4|||
164160824|NCT01006122|592952991|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
164160825|NCT01006122|592952992|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
164160826|NCT01006122|592952991|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
164160827|NCT01006122|592952992|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
164160828|NCT01006122|592952991|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
164160829|NCT01006122|592952992|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
164160830|NCT01006122|592952991|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
164160831|NCT01006122|592952992|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
164160832|NCT01006122|592952991|FG000|Second Double-blind Intervention Period|Death|0|||
164160833|NCT01006122|592952992|FG001|Second Double-blind Intervention Period|Death|1|||
164160834|NCT03493854|592952993|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
164160835|NCT03493854|592952994|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
164160836|NCT03493854|592952993|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
164160837|NCT03493854|592952994|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
164160838|NCT03493854|592952993|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
164160839|NCT03493854|592952994|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
164160840|NCT03493854|592952993|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
164160841|NCT03493854|592952994|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
164160842|NCT03493854|592952993|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
164160843|NCT03493854|592952994|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
164160844|NCT03493854|592952993|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
164160845|NCT03493854|592952994|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
164160846|NCT03493854|592952993|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
164160847|NCT03493854|592952994|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
164160848|NCT03493854|592952993|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
164160849|NCT03493854|592952994|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
164160850|NCT03493854|592952993|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
164160851|NCT03493854|592952994|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
164160852|NCT03493854|592952993|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
164160853|NCT03493854|592952994|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
164160854|NCT03493854|592952993|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
164160855|NCT03493854|592952994|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
164160856|NCT03493854|592952993|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
164160857|NCT03493854|592952994|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
164160858|NCT03493854|592952993|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
164160859|NCT03493854|592952994|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
164160860|NCT03493854|592952993|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
164160861|NCT03493854|592952994|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
164160862|NCT03493854|592952993|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
164160863|NCT03493854|592952994|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
164160864|NCT03493854|592952993|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
164160865|NCT03493854|592952994|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
164160866|NCT03493854|592952993|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
164160867|NCT03493854|592952994|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
164160868|NCT03493854|592952993|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
164160869|NCT03493854|592952994|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
164160870|NCT00410813|592952997|FG000|Overall Study|Adverse Event|6|||
164160871|NCT00410813|592952998|FG001|Overall Study|Adverse Event|11|||
164160872|NCT00410813|592952997|FG000|Overall Study|Progression|32|||
164160873|NCT00410813|592952998|FG001|Overall Study|Progression|21|||
164160874|NCT00410813|592952997|FG000|Overall Study|Not protocol specified|3|||
164160875|NCT00410813|592952998|FG001|Overall Study|Not protocol specified|4|||
164160876|NCT00410813|592952997|FG000|Overall Study|Ineligible|2|||
164160877|NCT00410813|592952998|FG001|Overall Study|Ineligible|4|||
164160878|NCT00410813|592952997|FG000|Overall Study|Death|0|||
164160879|NCT00410813|592952998|FG001|Overall Study|Death|2|||
164160880|NCT04526288|592953002|FG000|Overall Study|Disease Progression|1|||
164160881|NCT04526288|592953003|FG001|Overall Study|Disease Progression|0|||
164160882|NCT02097745|592953004|FG000|Overall Study|Adverse Event|25|||
164160883|NCT02097745|592953004|FG000|Overall Study|Death|16|||
164160884|NCT02097745|592953004|FG000|Overall Study|Failure to Return|14|||
164160885|NCT02097745|592953004|FG000|Overall Study|Administrative/Other|27|||
164160886|NCT02097745|592953004|FG000|Overall Study|Reason Not Specified|96|||
164160887|NCT02748356|592953005|FG000|Overall Study|Withdrawal by Subject|1|||
164160888|NCT00425750|592953006|FG000|Overall Study|Death|1|||
164160889|NCT00425750|592953006|FG000|Overall Study|Withdrawal by Subject|3|||
164160890|NCT00425750|592953006|FG000|Overall Study|Adverse Event|3|||
164160891|NCT00425750|592953006|FG000|Overall Study|Progression of disease|18|||
164160892|NCT00996125|592953007|FG000|Overall Study|Adverse Event|0|||
164160893|NCT00996125|592953008|FG001|Overall Study|Adverse Event|2|||
164160894|NCT00996125|592953007|FG000|Overall Study|Lost to Follow-up|1|||
164160895|NCT00996125|592953008|FG001|Overall Study|Lost to Follow-up|6|||
164160896|NCT00996125|592953007|FG000|Overall Study|Withdrawal by Subject|4|||
164160897|NCT00996125|592953008|FG001|Overall Study|Withdrawal by Subject|3|||
164160898|NCT00952068|592953010|FG000|Overall Study|Adverse Event|3|||
164160899|NCT00952068|592953010|FG000|Overall Study|Withdrawal by Subject|4|||
164160900|NCT04331067|592953011|FG000|Overall Study|Adverse Event|1|||
164160901|NCT04331067|592953012|FG001|Overall Study|Adverse Event|3|||
164160902|NCT04331067|592953013|FG002|Overall Study|Adverse Event|1|||
164160903|NCT04331067|592953011|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
164160904|NCT04331067|592953012|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
164160905|NCT04331067|592953013|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
164160906|NCT05236764|592953014|FG000|Overall Study|In follow up (ongoing)|1|||
164160907|NCT05236764|592953014|FG000|Overall Study|Taken off study - secondary graft failure|1|||
164160908|NCT05236764|592953014|FG000|Overall Study|Death|1|||
164160909|NCT02062450|592953020|FG000|Overall Study|No follow-up visit|124|||
164160910|NCT01796392|592953024|FG000|Overall Study|Withdrawal by Subject|2|||
164160911|NCT01796392|592953025|FG001|Overall Study|Withdrawal by Subject|0|||
164160912|NCT01796392|592953024|FG000|Overall Study|Death|5|||
164160913|NCT01796392|592953025|FG001|Overall Study|Death|1|||
164160914|NCT01796392|592953024|FG000|Overall Study|Excluded for medical reasons|1|||
164160915|NCT01796392|592953025|FG001|Overall Study|Excluded for medical reasons|2|||
164160916|NCT01796392|592953024|FG000|Overall Study|Lost to Follow-up|1|||
164160917|NCT01796392|592953025|FG001|Overall Study|Lost to Follow-up|0|||
164160918|NCT03482635|592953026|FG000|Overall Study|Lack of Efficacy|0|||
164160919|NCT03482635|592953027|FG001|Overall Study|Lack of Efficacy|0|||
164160920|NCT03482635|592953028|FG002|Overall Study|Lack of Efficacy|1|||
164160921|NCT03482635|592953029|FG003|Overall Study|Lack of Efficacy|3|||
164160922|NCT03482635|592953026|FG000|Overall Study|Adverse Event|2|||
164160923|NCT03482635|592953027|FG001|Overall Study|Adverse Event|2|||
164160924|NCT03482635|592953028|FG002|Overall Study|Adverse Event|0|||
164160925|NCT03482635|592953029|FG003|Overall Study|Adverse Event|3|||
164160926|NCT03482635|592953026|FG000|Overall Study|Withdrawal by Subject|2|||
164160927|NCT03482635|592953027|FG001|Overall Study|Withdrawal by Subject|1|||
164160928|NCT03482635|592953028|FG002|Overall Study|Withdrawal by Subject|0|||
164160929|NCT03482635|592953029|FG003|Overall Study|Withdrawal by Subject|1|||
164160930|NCT03482635|592953026|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
164160931|NCT03482635|592953027|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
164160932|NCT03482635|592953028|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
164160933|NCT03482635|592953029|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
164160934|NCT03482635|592953026|FG000|Overall Study|Not treated|0|||
164160935|NCT03482635|592953027|FG001|Overall Study|Not treated|0|||
164160936|NCT03482635|592953028|FG002|Overall Study|Not treated|0|||
164160937|NCT03482635|592953029|FG003|Overall Study|Not treated|1|||
164160938|NCT00979654|592953030|FG000|Overall Study|Lost to Follow-up|1|||
164160939|NCT00979654|592953030|FG000|Overall Study|Withdrawal by Subject|22|||
164160940|NCT00979654|592953030|FG000|Overall Study|Death|1|||
164160941|NCT00979654|592953030|FG000|Overall Study|Lack of Efficacy|6|||
164160942|NCT00979654|592953030|FG000|Overall Study|Adverse Event|1|||
164160943|NCT00979654|592953030|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
164160944|NCT00979654|592953030|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
164160945|NCT00979654|592953030|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
164160946|NCT00979654|592953030|FG000|Overall Study|Serious Adverse Event|1|||
164160947|NCT00979654|592953030|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
164160948|NCT01804946|592953031|FG000|Overall Study|Protocol Violation|1|||
164160949|NCT01804946|592953032|FG001|Overall Study|Protocol Violation|0|||
164160950|NCT01804946|592953031|FG000|Overall Study|Adverse Event|0|||
164160951|NCT01804946|592953032|FG001|Overall Study|Adverse Event|1|||
164160952|NCT01804946|592953031|FG000|Overall Study|Insufficient data available|0|||
164160953|NCT01804946|592953032|FG001|Overall Study|Insufficient data available|1|||
164160954|NCT01804946|592953031|FG000|Overall Study|Do not meet inclusion criteria|1|||
164160955|NCT01804946|592953032|FG001|Overall Study|Do not meet inclusion criteria|2|||
164160956|NCT01129557|592953034|FG000|Overall Study|Adverse Event|1|||
164160957|NCT01129557|592953035|FG001|Overall Study|Adverse Event|2|||
164160958|NCT01129557|592953036|FG002|Overall Study|Adverse Event|2|||
164160959|NCT01129557|592953034|FG000|Overall Study|Novartis terminated study early|3|||
164160960|NCT01129557|592953035|FG001|Overall Study|Novartis terminated study early|3|||
164160961|NCT01129557|592953036|FG002|Overall Study|Novartis terminated study early|2|||
164160962|NCT01486446|592953037|FG000|Overall Study|Adverse Event|1|||
164160963|NCT01486446|592953038|FG001|Overall Study|Adverse Event|0|||
164160964|NCT01445730|592953039|FG000|Overall Study|Adverse Event|1|||
164160965|NCT01445730|592953039|FG000|Overall Study|For the advice of a dentist|1|||
164160966|NCT01445730|592953039|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
164160967|NCT01367886|592953044|FG000|Overall Study|Lost to Follow-up|4|||
164160968|NCT01367886|592953044|FG000|Overall Study|Lack of Efficacy|2|||
164160969|NCT01367886|592953044|FG000|Overall Study|Death|1|||
164160970|NCT01167140|592953049|FG000|Overall Study|Withdrawal by Subject|1|||
164160971|NCT00985504|592953050|FG000|Acute Treatment Period|Adverse Event|3|||
164160972|NCT00985504|592953051|FG001|Acute Treatment Period|Adverse Event|4|||
164160973|NCT00985504|592953050|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
164160974|NCT00985504|592953051|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
164160975|NCT00985504|592953050|FG000|Acute Treatment Period|Protocol Violation|2|||
164160976|NCT00985504|592953051|FG001|Acute Treatment Period|Protocol Violation|0|||
164160977|NCT00985504|592953050|FG000|Acute Treatment Period|Sponsor Decision|0|||
164160978|NCT00985504|592953051|FG001|Acute Treatment Period|Sponsor Decision|1|||
164160979|NCT00985504|592953050|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
164160980|NCT00985504|592953051|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
164160981|NCT00985504|592953050|FG000|Optimization Period|Adverse Event|7|||
164160982|NCT00985504|592953051|FG001|Optimization Period|Adverse Event|9|||
164160983|NCT00985504|592953050|FG000|Optimization Period|Death|0|||
164160984|NCT00985504|592953051|FG001|Optimization Period|Death|1|||
164160985|NCT00985504|592953050|FG000|Optimization Period|Lack of Efficacy|5|||
164160986|NCT00985504|592953051|FG001|Optimization Period|Lack of Efficacy|3|||
164160987|NCT00985504|592953050|FG000|Optimization Period|Lost to Follow-up|0|||
164160988|NCT00985504|592953051|FG001|Optimization Period|Lost to Follow-up|1|||
164160989|NCT00985504|592953050|FG000|Optimization Period|Physician Decision|1|||
164160990|NCT00985504|592953051|FG001|Optimization Period|Physician Decision|0|||
164160991|NCT00985504|592953050|FG000|Optimization Period|Protocol Violation|3|||
164160992|NCT00985504|592953051|FG001|Optimization Period|Protocol Violation|1|||
164160993|NCT00985504|592953050|FG000|Optimization Period|Withdrawal by Subject|10|||
164160994|NCT00985504|592953051|FG001|Optimization Period|Withdrawal by Subject|8|||
164160995|NCT03805412|592953052|FG000|Overall Study|Lost to Follow-up|0|||
164160996|NCT03805412|592953053|FG001|Overall Study|Lost to Follow-up|1|||
164160997|NCT03711786|592953056|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
164160998|NCT03711786|592953057|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
164160999|NCT03711786|592953056|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
164161000|NCT03711786|592953057|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
164161001|NCT03711786|592953056|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
164161002|NCT03711786|592953057|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
164161003|NCT03711786|592953056|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
164161004|NCT03711786|592953057|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
164161077|NCT03483961|592954923|FG002|Overall Study|Adverse Event|1|||
164161005|NCT03711786|592953056|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
164161006|NCT03711786|592953057|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
164161007|NCT03711786|592953056|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
164161008|NCT03711786|592953057|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
164161009|NCT00669669|592953062|FG000|Overall Study|To late to start treatment|1|||
164161010|NCT04390113|592953063|FG000|Overall Study|Not Treated|0|||
164161011|NCT04390113|592953064|FG001|Overall Study|Not Treated|1|||
164161012|NCT04390113|592953063|FG000|Overall Study|Adverse Event|1|||
164161013|NCT04390113|592953064|FG001|Overall Study|Adverse Event|0|||
164161014|NCT04390113|592953063|FG000|Overall Study|Death|2|||
164161015|NCT04390113|592953064|FG001|Overall Study|Death|1|||
164161016|NCT04390113|592953063|FG000|Overall Study|Physician Decision|1|||
164161017|NCT04390113|592953064|FG001|Overall Study|Physician Decision|3|||
164161018|NCT04390113|592953063|FG000|Overall Study|Study Terminated by Sponsor|5|||
164161019|NCT04390113|592953064|FG001|Overall Study|Study Terminated by Sponsor|3|||
164161020|NCT04390113|592953063|FG000|Overall Study|Withdrawal by Subject|10|||
164161021|NCT04390113|592953064|FG001|Overall Study|Withdrawal by Subject|5|||
164161022|NCT04390113|592953063|FG000|Overall Study|Other|1|||
164161023|NCT04390113|592953064|FG001|Overall Study|Other|0|||
164161024|NCT04390113|592953063|FG000|Overall Study|Missing|0|||
164161025|NCT04390113|592953064|FG001|Overall Study|Missing|1|||
164161026|NCT01611883|592953065|FG000|Overall Study|Adverse Event|1|||
164161027|NCT01611883|592953066|FG001|Overall Study|Adverse Event|1|||
164161028|NCT03379727|592953068|FG000|Overall Study|Lack of Efficacy|73|||
164161029|NCT03379727|592953068|FG000|Overall Study|Adverse Event|32|||
164161030|NCT03379727|592953068|FG000|Overall Study|Death|18|||
164161031|NCT03379727|592953068|FG000|Overall Study|Patient/guardian decision|17|||
164161032|NCT03379727|592953068|FG000|Overall Study|Physician Decision|104|||
164161033|NCT03379727|592953068|FG000|Overall Study|Protocol Violation|4|||
164161034|NCT03379727|592953068|FG000|Overall Study|Lost to Follow-up|1|||
164161035|NCT00734994|592953074|FG000|Overall Study|Withdrawal by Subject|1|||
164161036|NCT03100903|592954911|FG000|Overall Study|Withdrawal by Subject|0|||
164161037|NCT03100903|592954912|FG001|Overall Study|Withdrawal by Subject|0|||
164161038|NCT03100903|592954913|FG002|Overall Study|Withdrawal by Subject|1|||
164161039|NCT04659993|592954914|FG000|Overall Study|Withdrawal by Subject|2|||
164161040|NCT04659993|592954914|FG000|Overall Study|Lost to Follow-up|2|||
164161041|NCT01540487|592954917|FG000|Overall Study|Protocol Violation|1|||
164161042|NCT01540487|592954918|FG001|Overall Study|Protocol Violation|0|||
164161043|NCT03503370|592954919|FG000|Overall Study|Death|3|||
164161044|NCT03503370|592954920|FG001|Overall Study|Death|1|||
164161045|NCT03483961|592954921|FG000|Overall Study|Lost to Follow-up|7|||
164161046|NCT03483961|592954922|FG001|Overall Study|Lost to Follow-up|6|||
164161047|NCT03483961|592954923|FG002|Overall Study|Lost to Follow-up|6|||
164161048|NCT03483961|592954924|FG003|Overall Study|Lost to Follow-up|6|||
164161049|NCT03483961|592954925|FG004|Overall Study|Lost to Follow-up|6|||
164161050|NCT03483961|592954926|FG005|Overall Study|Lost to Follow-up|4|||
164161051|NCT03483961|592954927|FG006|Overall Study|Lost to Follow-up|4|||
164161052|NCT03483961|592954928|FG007|Overall Study|Lost to Follow-up|11|||
164161053|NCT03483961|592954929|FG008|Overall Study|Lost to Follow-up|1|||
164161054|NCT03483961|592954930|FG009|Overall Study|Lost to Follow-up|0|||
164161055|NCT03483961|592954921|FG000|Overall Study|Withdrawal by Subject|3|||
164161056|NCT03483961|592954922|FG001|Overall Study|Withdrawal by Subject|4|||
164161057|NCT03483961|592954923|FG002|Overall Study|Withdrawal by Subject|5|||
164161058|NCT03483961|592954924|FG003|Overall Study|Withdrawal by Subject|3|||
164161059|NCT03483961|592954925|FG004|Overall Study|Withdrawal by Subject|4|||
164161060|NCT03483961|592954926|FG005|Overall Study|Withdrawal by Subject|2|||
164161061|NCT03483961|592954927|FG006|Overall Study|Withdrawal by Subject|1|||
164161062|NCT03483961|592954928|FG007|Overall Study|Withdrawal by Subject|2|||
164161063|NCT03483961|592954929|FG008|Overall Study|Withdrawal by Subject|1|||
164161064|NCT03483961|592954930|FG009|Overall Study|Withdrawal by Subject|0|||
164161065|NCT03483961|592954921|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
164161066|NCT03483961|592954922|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
164161067|NCT03483961|592954923|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
164161068|NCT03483961|592954924|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
164161069|NCT03483961|592954925|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
164161070|NCT03483961|592954926|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
164161071|NCT03483961|592954927|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
164161072|NCT03483961|592954928|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
164161073|NCT03483961|592954929|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
164161074|NCT03483961|592954930|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
164161075|NCT03483961|592954921|FG000|Overall Study|Adverse Event|0|||
164161078|NCT03483961|592954924|FG003|Overall Study|Adverse Event|0|||
164161079|NCT03483961|592954925|FG004|Overall Study|Adverse Event|0|||
164161080|NCT03483961|592954926|FG005|Overall Study|Adverse Event|0|||
164161081|NCT03483961|592954927|FG006|Overall Study|Adverse Event|0|||
164161082|NCT03483961|592954928|FG007|Overall Study|Adverse Event|0|||
164161083|NCT03483961|592954929|FG008|Overall Study|Adverse Event|0|||
164161084|NCT03483961|592954930|FG009|Overall Study|Adverse Event|0|||
164161085|NCT00457002|592954931|FG000|Overall Study|Death|40|||
164161086|NCT00457002|592954932|FG001|Overall Study|Death|47|||
164161087|NCT00457002|592954931|FG000|Overall Study|Adverse Event|284|||
164161088|NCT00457002|592954932|FG001|Overall Study|Adverse Event|260|||
164161089|NCT00457002|592954931|FG000|Overall Study|Withdrawal by Subject|299|||
164161090|NCT00457002|592954932|FG001|Overall Study|Withdrawal by Subject|271|||
164161091|NCT00457002|592954931|FG000|Overall Study|Lost to Follow-up|72|||
164161092|NCT00457002|592954932|FG001|Overall Study|Lost to Follow-up|71|||
164161093|NCT00457002|592954931|FG000|Overall Study|Poor/Non-compliance|46|||
164161094|NCT00457002|592954932|FG001|Overall Study|Poor/Non-compliance|33|||
164161095|NCT00457002|592954931|FG000|Overall Study|No longer met criteria|41|||
164161096|NCT00457002|592954932|FG001|Overall Study|No longer met criteria|37|||
164161097|NCT00457002|592954931|FG000|Overall Study|Administrative reason by Sponsor|1|||
164161098|NCT00457002|592954932|FG001|Overall Study|Administrative reason by Sponsor|0|||
164161099|NCT00457002|592954931|FG000|Overall Study|non-specified|29|||
164161100|NCT00457002|592954932|FG001|Overall Study|non-specified|38|||
164161101|NCT00457002|592954931|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
164161102|NCT00457002|592954932|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
164161103|NCT01623310|592954933|FG000|Overall Study|Adverse Event|21|||
164161104|NCT01623310|592954933|FG000|Overall Study|Lost to Follow-up|18|||
164161105|NCT01623310|592954933|FG000|Overall Study|Lack of Efficacy|6|||
164161106|NCT01623310|592954933|FG000|Overall Study|Protocol Violation|6|||
164161107|NCT01623310|592954933|FG000|Overall Study|Withdrawal by Subject|25|||
164161108|NCT01623310|592954933|FG000|Overall Study|Became potentially child-bearing|1|||
164161109|NCT01623310|592954933|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
164161110|NCT01623310|592954933|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
164161111|NCT00326716|592954934|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
164161112|NCT00326716|592954935|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
164161113|NCT00326716|592954936|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
164161114|NCT00326716|592954937|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
164161115|NCT00684411|592954938|FG000|Overall Study|New Primary Cancer|1|||
164161116|NCT00684411|592954938|FG000|Overall Study|Disease Progression|10|||
164161117|NCT00684411|592954938|FG000|Overall Study|Adverse Event|1|||
164161118|NCT00734162|592954939|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
164161119|NCT00734162|592954940|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
164161120|NCT00734162|592954941|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
164161121|NCT00734162|592954942|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
164161122|NCT00734162|592954939|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
164161123|NCT00734162|592954940|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
164161124|NCT00734162|592954941|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
164161125|NCT00734162|592954942|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
164161126|NCT00734162|592954939|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
164161127|NCT00734162|592954940|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
164161128|NCT00734162|592954941|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
164161129|NCT00734162|592954942|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
164161130|NCT00734162|592954939|FG000|Open-Label Phase|Withdrew Consent|1|||
164161131|NCT00734162|592954940|FG001|Open-Label Phase|Withdrew Consent|0|||
164161132|NCT00734162|592954941|FG002|Open-Label Phase|Withdrew Consent|1|||
164161133|NCT00734162|592954942|FG003|Open-Label Phase|Withdrew Consent|1|||
164161134|NCT00734162|592954939|FG000|Open-Label Phase|Lost to Follow-up|1|||
164161135|NCT00734162|592954940|FG001|Open-Label Phase|Lost to Follow-up|2|||
164161136|NCT00734162|592954941|FG002|Open-Label Phase|Lost to Follow-up|0|||
164161137|NCT00734162|592954942|FG003|Open-Label Phase|Lost to Follow-up|1|||
164161138|NCT00734162|592954939|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
164161139|NCT00734162|592954940|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
164161140|NCT00734162|592954941|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
164161141|NCT00734162|592954942|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
164161142|NCT04134767|592954943|FG000|Overall Study|Death|0|||
164161143|NCT04134767|592954944|FG001|Overall Study|Death|1|||
164161144|NCT04134767|592954943|FG000|Overall Study|Removed for harassing staff|0|||
164161145|NCT04134767|592954944|FG001|Overall Study|Removed for harassing staff|1|||
164161146|NCT04134767|592954943|FG000|Overall Study|Lost to Follow-up|44|||
164161147|NCT04134767|592954944|FG001|Overall Study|Lost to Follow-up|40|||
164161148|NCT05483686|592954948|FG000|Overall Study|Lost to Follow-up|5|||
164161149|NCT05483686|592954949|FG001|Overall Study|Lost to Follow-up|7|||
164161150|NCT05780983|592954950|FG000|Overall Study|Withdrawal by Subject|1|||
164161151|NCT06028438|592954954|FG000|Overall Study|Adverse Event|3|||
164161152|NCT06028438|592954955|FG001|Overall Study|Adverse Event|9|||
164161153|NCT06028438|592954954|FG000|Overall Study|Lack of Efficacy|1|||
164161154|NCT06028438|592954955|FG001|Overall Study|Lack of Efficacy|1|||
164161155|NCT06028438|592954954|FG000|Overall Study|Lost to Follow-up|1|||
164161156|NCT06028438|592954955|FG001|Overall Study|Lost to Follow-up|0|||
164161157|NCT06028438|592954954|FG000|Overall Study|Withdrawal by Subject|1|||
164161158|NCT06028438|592954955|FG001|Overall Study|Withdrawal by Subject|0|||
164161159|NCT06028438|592954954|FG000|Overall Study|Other|3|||
164161160|NCT06028438|592954955|FG001|Overall Study|Other|3|||
164161161|NCT01017874|592954957|FG000|Overall Study|Withdrawal by Subject|23|||
164161162|NCT01017874|592954958|FG001|Overall Study|Withdrawal by Subject|20|||
164161163|NCT01017874|592954957|FG000|Overall Study|Sponsor decision|3|||
164161164|NCT01017874|592954958|FG001|Overall Study|Sponsor decision|1|||
164161165|NCT01017874|592954957|FG000|Overall Study|Lost to Follow-up|3|||
164161166|NCT01017874|592954958|FG001|Overall Study|Lost to Follow-up|2|||
164161167|NCT01017874|592954957|FG000|Overall Study|Physician Decision|1|||
164161168|NCT01017874|592954958|FG001|Overall Study|Physician Decision|3|||
164161169|NCT00808210|592954959|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
164161170|NCT00808210|592954960|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
164161171|NCT00808210|592954959|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
164161172|NCT00808210|592954960|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
164161173|NCT00808210|592954959|FG000|Double-Blind TX Period|Adverse Event|0|||
164161174|NCT00808210|592954960|FG001|Double-Blind TX Period|Adverse Event|1|||
164161175|NCT00808210|592954959|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
164161176|NCT00808210|592954960|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
164161177|NCT00808210|592954959|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
164161178|NCT00808210|592954960|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
164161179|NCT00808210|592954959|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
164161180|NCT00808210|592954960|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
164161181|NCT02044302|592954961|FG000|Overall Study|study terminated|2|||
164161182|NCT02044302|592954962|FG001|Overall Study|study terminated|0|||
164161183|NCT03150719|592954964|FG000|Overall Study|Adverse Event|0|||
164161184|NCT03150719|592954965|FG001|Overall Study|Adverse Event|1|||
164161185|NCT03150719|592954964|FG000|Overall Study|Death|0|||
164161186|NCT03150719|592954965|FG001|Overall Study|Death|1|||
164161187|NCT03150719|592954964|FG000|Overall Study|Other|1|||
164161188|NCT03150719|592954965|FG001|Overall Study|Other|0|||
164161189|NCT01790984|592954966|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
164161190|NCT01790984|592954967|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
164161191|NCT01790984|592954968|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
164161192|NCT01790984|592954969|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
164161193|NCT01346696|592954971|FG000|Overall Study|Death|1|||
164161194|NCT01051791|592954973|FG000|Overall Study|Failed screening|3|||
164161195|NCT01051791|592954973|FG000|Overall Study|Withdrawal by Subject|1|||
164161196|NCT01954056|592954980|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
164161197|NCT01954056|592954981|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
164161198|NCT02155283|592955000|FG000|Overall Study|Lost to Follow-up|3|||
164161199|NCT02155283|592955000|FG000|Overall Study|Withdrawal by Subject|1|||
164161200|NCT02155283|592955000|FG000|Overall Study|Protocol Violation|3|||
164161201|NCT02268916|592955020|FG000|Overall Study|Lost to Follow-up|1|||
164161202|NCT02268916|592955021|FG001|Overall Study|Lost to Follow-up|1|||
164161203|NCT02268916|592955020|FG000|Overall Study|Withdrawal by Subject|6|||
164161204|NCT02268916|592955021|FG001|Overall Study|Withdrawal by Subject|5|||
164161205|NCT02268916|592955020|FG000|Overall Study|Participant did not have diabetes|1|||
164161206|NCT02268916|592955021|FG001|Overall Study|Participant did not have diabetes|0|||
164161207|NCT02268916|592955020|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
164161208|NCT02268916|592955021|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
164161209|NCT00594165|592955026|FG000|Overall Study|Major protocol violation|1|||
164161210|NCT00594165|592955026|FG000|Overall Study|Lack of Efficacy|12|||
164161211|NCT00594165|592955026|FG000|Overall Study|Adverse Event|52|||
164161212|NCT00594165|592955026|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
164161213|NCT00594165|592955026|FG000|Overall Study|Subject withdrew consent|27|||
164161214|NCT00594165|592955026|FG000|Overall Study|Study ended per sponsor|102|||
164161215|NCT00594165|592955026|FG000|Overall Study|Lost to Follow-up|4|||
164161216|NCT00594165|592955026|FG000|Overall Study|Other: PI discretion|5|||
164161217|NCT00594165|592955026|FG000|Overall Study|Other: Subject moving|3|||
164161218|NCT00594165|592955026|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
164161219|NCT00594165|592955026|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
164161220|NCT00594165|592955026|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
164161221|NCT00594165|592955026|FG000|Overall Study|Other: Site terminated participation|2|||
164161222|NCT04830969|592955027|FG000|Overall Study|Withdrawal by Subject|6|||
164161223|NCT04830969|592955028|FG001|Overall Study|Withdrawal by Subject|2|||
164161224|NCT04830969|592955027|FG000|Overall Study|Protocol Violation|3|||
164161225|NCT04830969|592955028|FG001|Overall Study|Protocol Violation|9|||
164161226|NCT04830969|592955027|FG000|Overall Study|Lost to Follow-up|4|||
164161227|NCT04830969|592955028|FG001|Overall Study|Lost to Follow-up|4|||
164161228|NCT04639219|592955031|FG000|Overall Study|Withdrawal by Subject|8|||
164161229|NCT04639219|592955031|FG000|Overall Study|Lost to Follow-up|6|||
164161230|NCT04639219|592955031|FG000|Overall Study|Death|55|||
164161231|NCT02712554|592955034|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
164161232|NCT02712554|592955035|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
164161233|NCT02712554|592955034|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
164161234|NCT02712554|592955035|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
164161235|NCT02712554|592955034|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
164161236|NCT02712554|592955035|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
164161237|NCT02712554|592955034|FG000|Part B: Qualification Phase|Adverse Event|0|||
164161238|NCT02712554|592955035|FG001|Part B: Qualification Phase|Adverse Event|1|||
164161239|NCT02712554|592955034|FG000|Part B: Treatment Phase|Adverse Event|0|||
164161240|NCT02712554|592955035|FG001|Part B: Treatment Phase|Adverse Event|1|||
164161241|NCT02712554|592955034|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
164161242|NCT02712554|592955035|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
164161243|NCT02712554|592955034|FG000|Part B: Treatment Phase|Other|0|||
164161244|NCT02712554|592955035|FG001|Part B: Treatment Phase|Other|1|||
164161245|NCT02503540|592955036|FG000|Overall Study|Death|2|||
164161246|NCT02503540|592955036|FG000|Overall Study|Withdrawal by Subject|1|||
164161247|NCT01205269|592955039|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
164161248|NCT01205269|592955040|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
164161249|NCT01205269|592955041|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
164161250|NCT01205269|592955042|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
164161251|NCT01205269|592955043|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
164161252|NCT01205269|592955044|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
164161253|NCT03830333|592955046|FG000|Overall Study|Death|0|||
164161254|NCT03830333|592955047|FG001|Overall Study|Death|1|||
164161255|NCT03830333|592955046|FG000|Overall Study|Withdrawal by Subject|5|||
164161256|NCT03830333|592955047|FG001|Overall Study|Withdrawal by Subject|1|||
164161257|NCT03830333|592955046|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
164161258|NCT03830333|592955047|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
164161259|NCT00987337|592955048|FG000|Overall Study|Adverse Event|10|||
164161260|NCT00987337|592955049|FG001|Overall Study|Adverse Event|9|||
164161261|NCT00987337|592955050|FG002|Overall Study|Adverse Event|8|||
164161262|NCT00987337|592955048|FG000|Overall Study|Insufficient Virologic Response|10|||
164161263|NCT00987337|592955049|FG001|Overall Study|Insufficient Virologic Response|7|||
164161264|NCT00987337|592955050|FG002|Overall Study|Insufficient Virologic Response|12|||
164161265|NCT00987337|592955048|FG000|Overall Study|Virologic Breakthrough|2|||
164161266|NCT00987337|592955049|FG001|Overall Study|Virologic Breakthrough|2|||
164161267|NCT00987337|592955050|FG002|Overall Study|Virologic Breakthrough|8|||
164161268|NCT00987337|592955048|FG000|Overall Study|Lost to Follow-up|10|||
164161269|NCT00987337|592955049|FG001|Overall Study|Lost to Follow-up|6|||
164161270|NCT00987337|592955050|FG002|Overall Study|Lost to Follow-up|2|||
164161271|NCT00987337|592955048|FG000|Overall Study|Withdrawal by Subject|6|||
164161272|NCT00987337|592955049|FG001|Overall Study|Withdrawal by Subject|9|||
164161273|NCT00987337|592955050|FG002|Overall Study|Withdrawal by Subject|9|||
164161274|NCT00987337|592955048|FG000|Overall Study|Other|0|||
164161275|NCT00987337|592955049|FG001|Overall Study|Other|2|||
164161276|NCT00987337|592955050|FG002|Overall Study|Other|5|||
164161277|NCT00987337|592955048|FG000|Overall Study|Protocol Violation|1|||
164161278|NCT00987337|592955049|FG001|Overall Study|Protocol Violation|0|||
164161279|NCT00987337|592955050|FG002|Overall Study|Protocol Violation|2|||
164161280|NCT00987337|592955048|FG000|Overall Study|Participant Relapsed|18|||
164161281|NCT00987337|592955049|FG001|Overall Study|Participant Relapsed|20|||
164161282|NCT00987337|592955050|FG002|Overall Study|Participant Relapsed|5|||
164161283|NCT02747108|592955054|FG000|Overall Study|Death|2|||
164161284|NCT02747108|592955055|FG001|Overall Study|Death|2|||
164161285|NCT02747108|592955054|FG000|Overall Study|Withdrawal by Subject|1|||
164161286|NCT02747108|592955055|FG001|Overall Study|Withdrawal by Subject|0|||
164161287|NCT02747108|592955054|FG000|Overall Study|Protocol Violation|2|||
164161288|NCT02747108|592955055|FG001|Overall Study|Protocol Violation|0|||
164161289|NCT03103152|592955056|FG000|Overall Study|Physician Decision|5|||
164161290|NCT03103152|592955057|FG001|Overall Study|Physician Decision|2|||
164161291|NCT03103152|592955058|FG002|Overall Study|Physician Decision|6|||
164161292|NCT03103152|592955059|FG003|Overall Study|Physician Decision|3|||
164161293|NCT03103152|592955060|FG004|Overall Study|Physician Decision|3|||
164161294|NCT03103152|592955061|FG005|Overall Study|Physician Decision|1|||
164161295|NCT03103152|592955056|FG000|Overall Study|Protocol Violation|2|||
164161296|NCT03103152|592955057|FG001|Overall Study|Protocol Violation|2|||
164161297|NCT03103152|592955058|FG002|Overall Study|Protocol Violation|1|||
164161298|NCT03103152|592955059|FG003|Overall Study|Protocol Violation|2|||
164161299|NCT03103152|592955060|FG004|Overall Study|Protocol Violation|1|||
164161300|NCT03103152|592955061|FG005|Overall Study|Protocol Violation|1|||
164161301|NCT03103152|592955056|FG000|Overall Study|Inter-current illness|0|||
164161302|NCT03103152|592955057|FG001|Overall Study|Inter-current illness|0|||
164161303|NCT03103152|592955058|FG002|Overall Study|Inter-current illness|1|||
164161304|NCT03103152|592955059|FG003|Overall Study|Inter-current illness|0|||
164161305|NCT03103152|592955060|FG004|Overall Study|Inter-current illness|0|||
164161306|NCT03103152|592955061|FG005|Overall Study|Inter-current illness|0|||
164161307|NCT03103152|592955056|FG000|Overall Study|Death|0|||
164161308|NCT03103152|592955057|FG001|Overall Study|Death|1|||
164161309|NCT03103152|592955058|FG002|Overall Study|Death|0|||
164161310|NCT03103152|592955059|FG003|Overall Study|Death|0|||
164161311|NCT03103152|592955060|FG004|Overall Study|Death|0|||
164161312|NCT03103152|592955061|FG005|Overall Study|Death|0|||
164161313|NCT03103152|592955056|FG000|Overall Study|Adverse Event|0|||
164161314|NCT03103152|592955057|FG001|Overall Study|Adverse Event|0|||
164161315|NCT03103152|592955058|FG002|Overall Study|Adverse Event|1|||
164161316|NCT03103152|592955059|FG003|Overall Study|Adverse Event|0|||
164161317|NCT03103152|592955060|FG004|Overall Study|Adverse Event|0|||
164161318|NCT03103152|592955061|FG005|Overall Study|Adverse Event|1|||
164161319|NCT03103152|592955056|FG000|Overall Study|Withdrawal by Subject|1|||
164161320|NCT03103152|592955057|FG001|Overall Study|Withdrawal by Subject|0|||
164161321|NCT03103152|592955058|FG002|Overall Study|Withdrawal by Subject|1|||
164161322|NCT03103152|592955059|FG003|Overall Study|Withdrawal by Subject|1|||
164161323|NCT03103152|592955060|FG004|Overall Study|Withdrawal by Subject|1|||
164161324|NCT03103152|592955061|FG005|Overall Study|Withdrawal by Subject|1|||
164161325|NCT03103152|592955056|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
164161326|NCT03103152|592955057|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
164161327|NCT03103152|592955058|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
164161328|NCT03103152|592955059|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
164161329|NCT03103152|592955060|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
164161330|NCT03103152|592955061|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
164161331|NCT03103152|592955056|FG000|Overall Study|Unacceptable side effects|0|||
164161332|NCT03103152|592955057|FG001|Overall Study|Unacceptable side effects|0|||
164161333|NCT03103152|592955058|FG002|Overall Study|Unacceptable side effects|0|||
164161334|NCT03103152|592955059|FG003|Overall Study|Unacceptable side effects|0|||
164161335|NCT03103152|592955060|FG004|Overall Study|Unacceptable side effects|0|||
164161336|NCT03103152|592955061|FG005|Overall Study|Unacceptable side effects|1|||
164161337|NCT03103152|592955056|FG000|Overall Study|Lost to Follow-up|0|||
164161338|NCT03103152|592955057|FG001|Overall Study|Lost to Follow-up|1|||
164161339|NCT03103152|592955058|FG002|Overall Study|Lost to Follow-up|0|||
164161340|NCT03103152|592955059|FG003|Overall Study|Lost to Follow-up|1|||
164161341|NCT03103152|592955060|FG004|Overall Study|Lost to Follow-up|0|||
164161342|NCT03103152|592955061|FG005|Overall Study|Lost to Follow-up|1|||
164161343|NCT03103152|592955056|FG000|Overall Study|Testicular pain|0|||
164161344|NCT03103152|592955057|FG001|Overall Study|Testicular pain|0|||
164161345|NCT03103152|592955058|FG002|Overall Study|Testicular pain|0|||
164161346|NCT03103152|592955059|FG003|Overall Study|Testicular pain|1|||
164161347|NCT03103152|592955060|FG004|Overall Study|Testicular pain|0|||
164161348|NCT03103152|592955061|FG005|Overall Study|Testicular pain|0|||
164161349|NCT05966584|592955062|FG000|Overall Study|Lost to Follow-up|1|||
164161350|NCT06360588|592956907|FG000|Overall Study|Adverse Event|3|||
164161351|NCT06360588|592956907|FG000|Overall Study|Death|2|||
164161352|NCT06360588|592956907|FG000|Overall Study|Disease Progression|14|||
164161353|NCT06360588|592956907|FG000|Overall Study|Withdrawal by Subject|1|||
164161354|NCT06360588|592956907|FG000|Overall Study|Lack of Efficacy|1|||
164161355|NCT06360588|592956907|FG000|Overall Study|Ineligible|1|||
164161356|NCT04010240|592956908|FG000|Overall Study|IHC not performed|2299|||
164161357|NCT01481766|592956909|FG000|4 months|Lost to Follow-up|3|||
164161358|NCT01481766|592956910|FG001|4 months|Lost to Follow-up|2|||
164161359|NCT01481766|592956911|FG002|4 months|Lost to Follow-up|1|||
164161360|NCT01481766|592956912|FG003|4 months|Lost to Follow-up|5|||
164161361|NCT01481766|592956909|FG000|12 months|Lost to Follow-up|7|||
164161362|NCT01481766|592956910|FG001|12 months|Lost to Follow-up|8|||
164161363|NCT01481766|592956911|FG002|12 months|Lost to Follow-up|5|||
164161364|NCT01481766|592956912|FG003|12 months|Lost to Follow-up|3|||
164161365|NCT00347958|592956913|FG000|Overall Study|Adverse Event|1|||
164161366|NCT00347958|592956913|FG000|Overall Study|Protocol Violation|2|||
164161367|NCT00347958|592956913|FG000|Overall Study|Withdrawal by Subject|1|||
164161368|NCT00754234|592956914|FG000|Overall Study|Withdrawal by Subject|3|||
164161369|NCT00570687|592956915|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161370|NCT00570687|592956916|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161371|NCT00570687|592956917|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161372|NCT00570687|592956918|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161373|NCT00570687|592956919|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
164161374|NCT00570687|592956920|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
164161375|NCT00570687|592956921|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
164161376|NCT00570687|592956922|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
164161377|NCT00570687|592956923|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
164161378|NCT00570687|592956924|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
164161379|NCT00570687|592956915|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161380|NCT00570687|592956916|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161381|NCT00570687|592956917|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161382|NCT00570687|592956918|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161383|NCT00570687|592956919|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161384|NCT00570687|592956920|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161385|NCT00570687|592956921|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161386|NCT00570687|592956922|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161387|NCT00570687|592956923|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
164161388|NCT00570687|592956924|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161389|NCT00570687|592956915|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161390|NCT00570687|592956916|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161391|NCT00570687|592956917|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161392|NCT00570687|592956918|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161393|NCT00570687|592956919|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161394|NCT00570687|592956920|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161395|NCT00570687|592956921|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
164161396|NCT00570687|592956922|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161397|NCT00570687|592956923|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161398|NCT00570687|592956924|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161399|NCT03263936|592956925|FG000|Overall Study|Adverse Event|0|||
164161400|NCT03263936|592956926|FG001|Overall Study|Adverse Event|1|||
164161401|NCT03263936|592956927|FG002|Overall Study|Adverse Event|0|||
164161402|NCT03263936|592956925|FG000|Overall Study|Death|0|||
164161403|NCT03263936|592956926|FG001|Overall Study|Death|1|||
164161404|NCT03263936|592956927|FG002|Overall Study|Death|0|||
164161405|NCT04545489|592956929|FG000|Overall Study|Withdrawal by Subject|12|||
164161406|NCT04545489|592956930|FG001|Overall Study|Withdrawal by Subject|4|||
164161407|NCT04545489|592956929|FG000|Overall Study|Lost to Follow-up|17|||
164161408|NCT04545489|592956930|FG001|Overall Study|Lost to Follow-up|18|||
164161409|NCT04545489|592956929|FG000|Overall Study|12month BP not collected|4|||
164161410|NCT04545489|592956930|FG001|Overall Study|12month BP not collected|4|||
164161411|NCT00652626|592956931|FG000|Initial Treatment Phase|Adverse Event|0|||
164161412|NCT00652626|592956932|FG001|Initial Treatment Phase|Adverse Event|0|||
164161413|NCT00652626|592956933|FG002|Initial Treatment Phase|Adverse Event|0|||
164161414|NCT00652626|592956934|FG003|Initial Treatment Phase|Adverse Event|0|||
164161415|NCT00652626|592956935|FG004|Initial Treatment Phase|Adverse Event|1|||
164161416|NCT00652626|592956936|FG005|Initial Treatment Phase|Adverse Event|0|||
164161417|NCT00652626|592956937|FG006|Initial Treatment Phase|Adverse Event|0|||
164161418|NCT00652626|592956931|FG000|Initial Treatment Phase|Protocol Violation|0|||
164161419|NCT00652626|592956932|FG001|Initial Treatment Phase|Protocol Violation|0|||
164161420|NCT00652626|592956933|FG002|Initial Treatment Phase|Protocol Violation|0|||
164161421|NCT00652626|592956934|FG003|Initial Treatment Phase|Protocol Violation|1|||
164161422|NCT00652626|592956935|FG004|Initial Treatment Phase|Protocol Violation|0|||
164161423|NCT00652626|592956936|FG005|Initial Treatment Phase|Protocol Violation|0|||
164161424|NCT00652626|592956937|FG006|Initial Treatment Phase|Protocol Violation|0|||
164161425|NCT00652626|592956931|FG000|Initial Treatment Phase|Physician Decision|0|||
164161426|NCT00652626|592956932|FG001|Initial Treatment Phase|Physician Decision|0|||
164161427|NCT00652626|592956933|FG002|Initial Treatment Phase|Physician Decision|0|||
164161428|NCT00652626|592956934|FG003|Initial Treatment Phase|Physician Decision|0|||
164161429|NCT00652626|592956935|FG004|Initial Treatment Phase|Physician Decision|1|||
164161430|NCT00652626|592956936|FG005|Initial Treatment Phase|Physician Decision|0|||
164161431|NCT00652626|592956937|FG006|Initial Treatment Phase|Physician Decision|0|||
164161432|NCT00652626|592956931|FG000|Initial Treatment Phase|Sponsor Request|0|||
164161433|NCT00652626|592956932|FG001|Initial Treatment Phase|Sponsor Request|0|||
164161434|NCT00652626|592956933|FG002|Initial Treatment Phase|Sponsor Request|1|||
164161435|NCT00652626|592956934|FG003|Initial Treatment Phase|Sponsor Request|0|||
164161436|NCT00652626|592956935|FG004|Initial Treatment Phase|Sponsor Request|0|||
164161437|NCT00652626|592956936|FG005|Initial Treatment Phase|Sponsor Request|0|||
164161438|NCT00652626|592956937|FG006|Initial Treatment Phase|Sponsor Request|0|||
164161439|NCT00652626|592956931|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
164161440|NCT00652626|592956932|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
164161441|NCT00652626|592956933|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
164161442|NCT00652626|592956934|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
164161443|NCT00652626|592956935|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
164161444|NCT00652626|592956936|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
164161445|NCT00652626|592956937|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
164161446|NCT00652626|592956931|FG000|Extension Phase|Withdrawal by Subject|0|||
164161447|NCT00652626|592956932|FG001|Extension Phase|Withdrawal by Subject|0|||
164161448|NCT00652626|592956933|FG002|Extension Phase|Withdrawal by Subject|0|||
164161449|NCT00652626|592956934|FG003|Extension Phase|Withdrawal by Subject|0|||
164161450|NCT00652626|592956935|FG004|Extension Phase|Withdrawal by Subject|0|||
164161451|NCT00652626|592956936|FG005|Extension Phase|Withdrawal by Subject|2|||
164161452|NCT00652626|592956937|FG006|Extension Phase|Withdrawal by Subject|0|||
164161453|NCT00652626|592956931|FG000|Extension Phase|Adverse Event|0|||
164161454|NCT00652626|592956932|FG001|Extension Phase|Adverse Event|0|||
164161455|NCT00652626|592956933|FG002|Extension Phase|Adverse Event|0|||
164161456|NCT00652626|592956934|FG003|Extension Phase|Adverse Event|0|||
164161457|NCT00652626|592956935|FG004|Extension Phase|Adverse Event|0|||
164161458|NCT00652626|592956936|FG005|Extension Phase|Adverse Event|2|||
164161459|NCT00652626|592956937|FG006|Extension Phase|Adverse Event|1|||
164161460|NCT00652626|592956931|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
164161461|NCT00652626|592956932|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
164161462|NCT00652626|592956933|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
164161463|NCT00652626|592956934|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
164161464|NCT00652626|592956935|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
164161465|NCT00652626|592956936|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
164161466|NCT00652626|592956937|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
164161467|NCT00652626|592956931|FG000|Extension Phase|Physician Decision|0|||
164161468|NCT00652626|592956932|FG001|Extension Phase|Physician Decision|0|||
164161469|NCT00652626|592956933|FG002|Extension Phase|Physician Decision|0|||
164161470|NCT00652626|592956934|FG003|Extension Phase|Physician Decision|0|||
164161471|NCT00652626|592956935|FG004|Extension Phase|Physician Decision|0|||
164161472|NCT00652626|592956936|FG005|Extension Phase|Physician Decision|1|||
164161473|NCT00652626|592956937|FG006|Extension Phase|Physician Decision|1|||
164161474|NCT00652626|592956931|FG000|Extension Phase|Death|0|||
164161475|NCT00652626|592956932|FG001|Extension Phase|Death|0|||
164161476|NCT00652626|592956933|FG002|Extension Phase|Death|0|||
164161477|NCT00652626|592956934|FG003|Extension Phase|Death|0|||
164161478|NCT00652626|592956935|FG004|Extension Phase|Death|0|||
164161479|NCT00652626|592956936|FG005|Extension Phase|Death|1|||
164161480|NCT00652626|592956937|FG006|Extension Phase|Death|1|||
164161481|NCT04003636|592956938|FG000|Overall Study|Death|409|||
164161482|NCT04003636|592956939|FG001|Overall Study|Death|443|||
164161483|NCT04003636|592956938|FG000|Overall Study|Lost to Follow-up|0|||
164161484|NCT04003636|592956939|FG001|Overall Study|Lost to Follow-up|1|||
164161485|NCT04003636|592956938|FG000|Overall Study|Withdrawal by Subject|5|||
164161486|NCT04003636|592956939|FG001|Overall Study|Withdrawal by Subject|2|||
164161487|NCT04003636|592956938|FG000|Overall Study|Participant On-going|119|||
164161488|NCT04003636|592956939|FG001|Overall Study|Participant On-going|90|||
164161489|NCT00454246|592956940|FG000|Overall Study|Adverse Event|2|||
164161490|NCT00454246|592956941|FG001|Overall Study|Adverse Event|2|||
164161491|NCT00454246|592956942|FG002|Overall Study|Adverse Event|0|||
164161492|NCT00454246|592956940|FG000|Overall Study|Violation of selection criteria at entry|6|||
164161493|NCT00454246|592956941|FG001|Overall Study|Violation of selection criteria at entry|0|||
164161494|NCT00454246|592956942|FG002|Overall Study|Violation of selection criteria at entry|0|||
164161495|NCT00454246|592956940|FG000|Overall Study|Protocol Violation|1|||
164161496|NCT00454246|592956941|FG001|Overall Study|Protocol Violation|0|||
164161497|NCT00454246|592956942|FG002|Overall Study|Protocol Violation|0|||
164161498|NCT00454246|592956940|FG000|Overall Study|Refused Treatment|1|||
164161499|NCT00454246|592956941|FG001|Overall Study|Refused Treatment|1|||
164161500|NCT00454246|592956942|FG002|Overall Study|Refused Treatment|0|||
164161501|NCT00454246|592956940|FG000|Overall Study|Failure to return|1|||
164161502|NCT00454246|592956941|FG001|Overall Study|Failure to return|0|||
164161503|NCT00454246|592956942|FG002|Overall Study|Failure to return|0|||
164161504|NCT00454246|592956940|FG000|Overall Study|Early termination of study|62|||
164161505|NCT00454246|592956941|FG001|Overall Study|Early termination of study|26|||
164161506|NCT00454246|592956942|FG002|Overall Study|Early termination of study|9|||
164161507|NCT00356603|592956943|FG000|Overall Study|Other|6|||
164161508|NCT00356603|592956944|FG001|Overall Study|Other|3|||
164161509|NCT05326529|592956945|FG000|Overall Study|Lack of Efficacy|0|||
164161510|NCT05326529|592956946|FG001|Overall Study|Lack of Efficacy|1|||
164161511|NCT05326529|592956947|FG002|Overall Study|Lack of Efficacy|0|||
164161512|NCT05326529|592956945|FG000|Overall Study|Physician Decision|0|||
164161513|NCT05326529|592956946|FG001|Overall Study|Physician Decision|0|||
164161514|NCT05326529|592956947|FG002|Overall Study|Physician Decision|2|||
164161515|NCT01262287|592956949|FG000|Overall Study|Lost to Follow-up|2|||
164161516|NCT01262287|592956950|FG001|Overall Study|Lost to Follow-up|1|||
164161517|NCT00932373|592956951|FG000|Overall Study|Progressive disease|3|||
164161518|NCT00932373|592956952|FG001|Overall Study|Progressive disease|1|||
164161519|NCT00932373|592956953|FG002|Overall Study|Progressive disease|0|||
164161520|NCT00932373|592956954|FG003|Overall Study|Progressive disease|0|||
164161521|NCT00932373|592956955|FG004|Overall Study|Progressive disease|10|||
164161522|NCT00932373|592956956|FG005|Overall Study|Progressive disease|1|||
164161523|NCT00932373|592956957|FG006|Overall Study|Progressive disease|0|||
164161524|NCT00932373|592956958|FG007|Overall Study|Progressive disease|2|||
164161525|NCT00932373|592956959|FG008|Overall Study|Progressive disease|1|||
164161526|NCT00932373|592956960|FG009|Overall Study|Progressive disease|9|||
164161527|NCT00932373|592956961|FG010|Overall Study|Progressive disease|2|||
164161528|NCT00932373|592956951|FG000|Overall Study|Adverse Event|0|||
164161529|NCT00932373|592956952|FG001|Overall Study|Adverse Event|0|||
164161530|NCT00932373|592956953|FG002|Overall Study|Adverse Event|0|||
164161531|NCT00932373|592956954|FG003|Overall Study|Adverse Event|0|||
164161532|NCT00932373|592956955|FG004|Overall Study|Adverse Event|2|||
164161533|NCT00932373|592956956|FG005|Overall Study|Adverse Event|1|||
164161534|NCT00932373|592956957|FG006|Overall Study|Adverse Event|0|||
164161535|NCT00932373|592956958|FG007|Overall Study|Adverse Event|1|||
164161536|NCT00932373|592956959|FG008|Overall Study|Adverse Event|0|||
164161537|NCT00932373|592956960|FG009|Overall Study|Adverse Event|2|||
164161538|NCT00932373|592956961|FG010|Overall Study|Adverse Event|1|||
164161539|NCT00932373|592956951|FG000|Overall Study|Physician Decision|0|||
164161540|NCT00932373|592956952|FG001|Overall Study|Physician Decision|0|||
164161541|NCT00932373|592956953|FG002|Overall Study|Physician Decision|1|||
164161542|NCT00932373|592956954|FG003|Overall Study|Physician Decision|0|||
164161543|NCT00932373|592956955|FG004|Overall Study|Physician Decision|2|||
164161544|NCT00932373|592956956|FG005|Overall Study|Physician Decision|0|||
164161545|NCT00932373|592956957|FG006|Overall Study|Physician Decision|0|||
164161546|NCT00932373|592956958|FG007|Overall Study|Physician Decision|0|||
164161547|NCT00932373|592956959|FG008|Overall Study|Physician Decision|0|||
164161548|NCT00932373|592956960|FG009|Overall Study|Physician Decision|1|||
164161549|NCT00932373|592956961|FG010|Overall Study|Physician Decision|0|||
164161550|NCT00932373|592956951|FG000|Overall Study|Dose limiting toxicity|0|||
164161551|NCT00932373|592956952|FG001|Overall Study|Dose limiting toxicity|0|||
164161552|NCT00932373|592956953|FG002|Overall Study|Dose limiting toxicity|0|||
164161553|NCT00932373|592956954|FG003|Overall Study|Dose limiting toxicity|0|||
164161554|NCT00932373|592956955|FG004|Overall Study|Dose limiting toxicity|0|||
164161555|NCT00932373|592956956|FG005|Overall Study|Dose limiting toxicity|1|||
164161556|NCT00932373|592956957|FG006|Overall Study|Dose limiting toxicity|0|||
164161557|NCT00932373|592956958|FG007|Overall Study|Dose limiting toxicity|0|||
164161558|NCT00932373|592956959|FG008|Overall Study|Dose limiting toxicity|0|||
164161559|NCT00932373|592956960|FG009|Overall Study|Dose limiting toxicity|0|||
164161560|NCT00932373|592956961|FG010|Overall Study|Dose limiting toxicity|0|||
164161561|NCT00932373|592956951|FG000|Overall Study|Withdrawal by Subject|0|||
164161562|NCT00932373|592956952|FG001|Overall Study|Withdrawal by Subject|0|||
164161563|NCT00932373|592956953|FG002|Overall Study|Withdrawal by Subject|0|||
164161564|NCT00932373|592956954|FG003|Overall Study|Withdrawal by Subject|0|||
164161565|NCT00932373|592956955|FG004|Overall Study|Withdrawal by Subject|0|||
164161566|NCT00932373|592956956|FG005|Overall Study|Withdrawal by Subject|0|||
164161567|NCT00932373|592956957|FG006|Overall Study|Withdrawal by Subject|0|||
164161568|NCT00932373|592956958|FG007|Overall Study|Withdrawal by Subject|0|||
164161569|NCT00932373|592956959|FG008|Overall Study|Withdrawal by Subject|1|||
164161570|NCT00932373|592956960|FG009|Overall Study|Withdrawal by Subject|0|||
164161571|NCT00932373|592956961|FG010|Overall Study|Withdrawal by Subject|0|||
164161572|NCT00932373|592956951|FG000|Overall Study|Clinical progression|0|||
164161573|NCT00932373|592956952|FG001|Overall Study|Clinical progression|0|||
164161574|NCT00932373|592956953|FG002|Overall Study|Clinical progression|0|||
164161575|NCT00932373|592956954|FG003|Overall Study|Clinical progression|0|||
164161576|NCT00932373|592956955|FG004|Overall Study|Clinical progression|0|||
164161577|NCT00932373|592956956|FG005|Overall Study|Clinical progression|0|||
164161578|NCT00932373|592956957|FG006|Overall Study|Clinical progression|1|||
164161579|NCT00932373|592956958|FG007|Overall Study|Clinical progression|0|||
164161580|NCT00932373|592956959|FG008|Overall Study|Clinical progression|0|||
164161581|NCT00932373|592956960|FG009|Overall Study|Clinical progression|0|||
164161582|NCT00932373|592956961|FG010|Overall Study|Clinical progression|0|||
164161583|NCT00932373|592956951|FG000|Overall Study|Lack of Efficacy|0|||
164161584|NCT00932373|592956952|FG001|Overall Study|Lack of Efficacy|0|||
164161585|NCT00932373|592956953|FG002|Overall Study|Lack of Efficacy|0|||
164161586|NCT00932373|592956954|FG003|Overall Study|Lack of Efficacy|0|||
164161587|NCT00932373|592956955|FG004|Overall Study|Lack of Efficacy|0|||
164161588|NCT00932373|592956956|FG005|Overall Study|Lack of Efficacy|0|||
164161589|NCT00932373|592956957|FG006|Overall Study|Lack of Efficacy|0|||
164161590|NCT00932373|592956958|FG007|Overall Study|Lack of Efficacy|0|||
164161591|NCT00932373|592956959|FG008|Overall Study|Lack of Efficacy|0|||
164161592|NCT00932373|592956960|FG009|Overall Study|Lack of Efficacy|1|||
164161593|NCT00932373|592956961|FG010|Overall Study|Lack of Efficacy|0|||
164161594|NCT02492984|592956964|FG000|Overall Study|Adverse Event|1|||
164161595|NCT02492984|592956965|FG001|Overall Study|Adverse Event|0|||
164161596|NCT02492984|592956964|FG000|Overall Study|Protocol Violation|1|||
164161597|NCT02492984|592956965|FG001|Overall Study|Protocol Violation|0|||
164161598|NCT02492984|592956964|FG000|Overall Study|Withdrawal by Subject|1|||
164161599|NCT02492984|592956965|FG001|Overall Study|Withdrawal by Subject|0|||
164161600|NCT01841762|592956966|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
164161601|NCT01841762|592956966|FG000|Treatment Period|Adverse Event|16|||
164161602|NCT01841762|592956966|FG000|Treatment Period|Death|1|||
164161603|NCT01841762|592956966|FG000|Treatment Period|Withdrawal by Subject|7|||
164161604|NCT01841762|592956966|FG000|Treatment Period|Lost to Follow-up|1|||
164161605|NCT01841762|592956966|FG000|Treatment Period|Physician Decision|2|||
164161606|NCT01841762|592956966|FG000|Treatment Period|Other, including non-compliance|5|||
164161607|NCT01841762|592956966|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
164161608|NCT01841762|592956966|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
164161609|NCT01841762|592956966|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
164161610|NCT01841762|592956966|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
164161611|NCT06152224|592956971|FG000|Overall Study|Withdrawal by Subject|1|||
164161612|NCT06152224|592956972|FG001|Overall Study|Withdrawal by Subject|0|||
164161613|NCT06152224|592956971|FG000|Overall Study|Lost to Follow-up|0|||
164161614|NCT06152224|592956972|FG001|Overall Study|Lost to Follow-up|1|||
164161615|NCT06152224|592956971|FG000|Overall Study|On Follow Up|18|||
164161616|NCT06152224|592956972|FG001|Overall Study|On Follow Up|18|||
164161617|NCT05625802|592956973|FG000|Overall Study|Lost to Follow-up|1|||
164161618|NCT05625802|592956974|FG001|Overall Study|Lost to Follow-up|0|||
164161619|NCT01164579|592956975|FG000|Overall Study|Lack of Efficacy|0|||
164161620|NCT01164579|592956976|FG001|Overall Study|Lack of Efficacy|0|||
164161621|NCT01164579|592956977|FG002|Overall Study|Lack of Efficacy|6|||
164161622|NCT01164579|592956975|FG000|Overall Study|Lost to Follow-up|1|||
164161623|NCT01164579|592956976|FG001|Overall Study|Lost to Follow-up|1|||
164161624|NCT01164579|592956977|FG002|Overall Study|Lost to Follow-up|0|||
164161625|NCT01164579|592956975|FG000|Overall Study|Withdrawal by Subject|2|||
164161626|NCT01164579|592956976|FG001|Overall Study|Withdrawal by Subject|5|||
164161627|NCT01164579|592956977|FG002|Overall Study|Withdrawal by Subject|3|||
164161628|NCT01164579|592956975|FG000|Overall Study|Protocol Violation|0|||
164161629|NCT01164579|592956976|FG001|Overall Study|Protocol Violation|1|||
164161630|NCT01164579|592956977|FG002|Overall Study|Protocol Violation|2|||
164161631|NCT01164579|592956975|FG000|Overall Study|Adverse Event|4|||
164161632|NCT01164579|592956976|FG001|Overall Study|Adverse Event|2|||
164161633|NCT01164579|592956977|FG002|Overall Study|Adverse Event|5|||
164161634|NCT01164579|592956975|FG000|Overall Study|Reason not specified|1|||
164161635|NCT01164579|592956976|FG001|Overall Study|Reason not specified|0|||
164161636|NCT01164579|592956977|FG002|Overall Study|Reason not specified|0|||
164161637|NCT01163851|592956981|FG000|Overall Study|Site Closure|0|||
164161638|NCT01163851|592956982|FG001|Overall Study|Site Closure|1|||
164161639|NCT01163851|592956981|FG000|Overall Study|Enrolled but not treated|1|||
164161640|NCT01163851|592956982|FG001|Overall Study|Enrolled but not treated|0|||
164161641|NCT00789373|592956983|FG000|Induction|Adverse Event|64|||
164161642|NCT00789373|592956984|FG001|Induction|Adverse Event|0|||
164161643|NCT00789373|592956985|FG002|Induction|Adverse Event|0|||
164161644|NCT00789373|592956983|FG000|Induction|Death Due to study disease|24|||
164161645|NCT00789373|592956984|FG001|Induction|Death Due to study disease|0|||
164161646|NCT00789373|592956985|FG002|Induction|Death Due to study disease|0|||
164161647|NCT00789373|592956983|FG000|Induction|Death due to adverse event|19|||
164161648|NCT00789373|592956984|FG001|Induction|Death due to adverse event|0|||
164161649|NCT00789373|592956985|FG002|Induction|Death due to adverse event|0|||
164161650|NCT00789373|592956983|FG000|Induction|Death due to toxicity|11|||
164161651|NCT00789373|592956984|FG001|Induction|Death due to toxicity|0|||
164161652|NCT00789373|592956985|FG002|Induction|Death due to toxicity|0|||
164161653|NCT00789373|592956983|FG000|Induction|Death due to procedure|1|||
164161654|NCT00789373|592956984|FG001|Induction|Death due to procedure|0|||
164161655|NCT00789373|592956985|FG002|Induction|Death due to procedure|0|||
164161656|NCT00789373|592956983|FG000|Induction|Investigator decision|7|||
164161657|NCT00789373|592956984|FG001|Induction|Investigator decision|0|||
164161658|NCT00789373|592956985|FG002|Induction|Investigator decision|0|||
164161659|NCT00789373|592956983|FG000|Induction|Protocol entry criteria not met|9|||
164161660|NCT00789373|592956984|FG001|Induction|Protocol entry criteria not met|0|||
164161661|NCT00789373|592956985|FG002|Induction|Protocol entry criteria not met|0|||
164161662|NCT00789373|592956983|FG000|Induction|Lost to Follow-up|6|||
164161663|NCT00789373|592956984|FG001|Induction|Lost to Follow-up|0|||
164161664|NCT00789373|592956985|FG002|Induction|Lost to Follow-up|0|||
164161665|NCT00789373|592956983|FG000|Induction|Protocol Violation|1|||
164161666|NCT00789373|592956984|FG001|Induction|Protocol Violation|0|||
164161667|NCT00789373|592956985|FG002|Induction|Protocol Violation|0|||
164161668|NCT00789373|592956983|FG000|Induction|Progressive Disease|220|||
164161669|NCT00789373|592956984|FG001|Induction|Progressive Disease|0|||
164161670|NCT00789373|592956985|FG002|Induction|Progressive Disease|0|||
164161671|NCT00789373|592956983|FG000|Induction|Withdrawal by Subject|37|||
164161672|NCT00789373|592956984|FG001|Induction|Withdrawal by Subject|0|||
164161673|NCT00789373|592956985|FG002|Induction|Withdrawal by Subject|0|||
164161674|NCT00789373|592956983|FG000|Maintenance|Adverse Event|0|||
164161675|NCT00789373|592956984|FG001|Maintenance|Adverse Event|65|||
164161676|NCT00789373|592956985|FG002|Maintenance|Adverse Event|12|||
164161677|NCT00789373|592956983|FG000|Maintenance|Death due to study disease|0|||
164161678|NCT00789373|592956984|FG001|Maintenance|Death due to study disease|3|||
164161679|NCT00789373|592956985|FG002|Maintenance|Death due to study disease|1|||
164161680|NCT00789373|592956983|FG000|Maintenance|Death due to adverse event|0|||
164161681|NCT00789373|592956984|FG001|Maintenance|Death due to adverse event|4|||
164161682|NCT00789373|592956985|FG002|Maintenance|Death due to adverse event|1|||
164161683|NCT00789373|592956983|FG000|Maintenance|Death due to toxicity|0|||
164161684|NCT00789373|592956984|FG001|Maintenance|Death due to toxicity|1|||
164161685|NCT00789373|592956985|FG002|Maintenance|Death due to toxicity|2|||
164161686|NCT00789373|592956983|FG000|Maintenance|Investigator Decision|0|||
164161687|NCT00789373|592956984|FG001|Maintenance|Investigator Decision|4|||
164161688|NCT00789373|592956985|FG002|Maintenance|Investigator Decision|2|||
164161689|NCT00789373|592956983|FG000|Maintenance|Protocol entry criteria not met|0|||
164161690|NCT00789373|592956984|FG001|Maintenance|Protocol entry criteria not met|2|||
164161691|NCT00789373|592956985|FG002|Maintenance|Protocol entry criteria not met|0|||
164161692|NCT00789373|592956983|FG000|Maintenance|Lost to Follow-up|0|||
164161693|NCT00789373|592956984|FG001|Maintenance|Lost to Follow-up|2|||
164161694|NCT00789373|592956985|FG002|Maintenance|Lost to Follow-up|0|||
164161695|NCT00789373|592956983|FG000|Maintenance|Progressive Disease|0|||
164161696|NCT00789373|592956984|FG001|Maintenance|Progressive Disease|253|||
164161697|NCT00789373|592956985|FG002|Maintenance|Progressive Disease|152|||
164161698|NCT00789373|592956983|FG000|Maintenance|Withdrawal by Subject|0|||
164161699|NCT00789373|592956984|FG001|Maintenance|Withdrawal by Subject|21|||
164161700|NCT00789373|592956985|FG002|Maintenance|Withdrawal by Subject|8|||
164161701|NCT00789373|592956983|FG000|Maintenance|Sponsor Decision|0|||
164161702|NCT00789373|592956984|FG001|Maintenance|Sponsor Decision|0|||
164161703|NCT00789373|592956985|FG002|Maintenance|Sponsor Decision|2|||
164161704|NCT00789373|592956983|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
164161705|NCT00789373|592956984|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
164161706|NCT00789373|592956985|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
164161707|NCT04938180|592956986|FG000|Overall Study|Adverse Event|1|||
164161708|NCT01964222|592956987|FG000|Overall Study|Lost to Follow-up|7|||
164161709|NCT01964222|592956988|FG001|Overall Study|Lost to Follow-up|5|||
164161710|NCT01964222|592956987|FG000|Overall Study|Withdrawal by Subject|6|||
164161711|NCT01964222|592956988|FG001|Overall Study|Withdrawal by Subject|6|||
164161712|NCT01964222|592956987|FG000|Overall Study|Screening Failure|2|||
164161713|NCT01964222|592956988|FG001|Overall Study|Screening Failure|0|||
164161714|NCT01019694|592956993|FG000|Overall Study|Adverse Event|12|||
164161715|NCT01019694|592956994|FG001|Overall Study|Adverse Event|16|||
164161716|NCT01019694|592956995|FG002|Overall Study|Adverse Event|19|||
164161717|NCT01019694|592956993|FG000|Overall Study|Protocol Violation|2|||
164161718|NCT01019694|592956994|FG001|Overall Study|Protocol Violation|6|||
164161719|NCT01019694|592956995|FG002|Overall Study|Protocol Violation|4|||
164161720|NCT01019694|592956993|FG000|Overall Study|Lost to Follow-up|5|||
164161721|NCT01019694|592956994|FG001|Overall Study|Lost to Follow-up|3|||
164161722|NCT01019694|592956995|FG002|Overall Study|Lost to Follow-up|3|||
164161723|NCT01019694|592956993|FG000|Overall Study|Withdrawal by Subject|4|||
164161724|NCT01019694|592956994|FG001|Overall Study|Withdrawal by Subject|6|||
164161725|NCT01019694|592956995|FG002|Overall Study|Withdrawal by Subject|12|||
164161726|NCT01019694|592956993|FG000|Overall Study|Not treated|0|||
164161727|NCT01019694|592956994|FG001|Overall Study|Not treated|2|||
164161728|NCT01019694|592956995|FG002|Overall Study|Not treated|3|||
164161729|NCT01019694|592956993|FG000|Overall Study|Other reason (not specified)|1|||
164161730|NCT01019694|592956994|FG001|Overall Study|Other reason (not specified)|5|||
164161731|NCT01019694|592956995|FG002|Overall Study|Other reason (not specified)|6|||
164161732|NCT00441129|592957001|FG000|Overall Study|Withdrawal by Subject|6|||
164161733|NCT00441129|592957002|FG001|Overall Study|Withdrawal by Subject|14|||
164161734|NCT00463047|592957003|FG000|Titration Period 1|Adverse Event|10|||
164161735|NCT00463047|592957004|FG001|Titration Period 1|Adverse Event|8|||
164161736|NCT00463047|592957003|FG000|Titration Period 1|Lack of Efficacy|10|||
164161737|NCT00463047|592957004|FG001|Titration Period 1|Lack of Efficacy|4|||
164161738|NCT00463047|592957003|FG000|Titration Period 1|Lost to Follow-up|2|||
164161739|NCT00463047|592957004|FG001|Titration Period 1|Lost to Follow-up|0|||
164161740|NCT00463047|592957003|FG000|Titration Period 1|Non-compliance with study medication|3|||
164161741|NCT00463047|592957004|FG001|Titration Period 1|Non-compliance with study medication|5|||
164161742|NCT00463047|592957003|FG000|Titration Period 1|Protocol Violation|5|||
164161743|NCT00463047|592957004|FG001|Titration Period 1|Protocol Violation|5|||
164161744|NCT00463047|592957003|FG000|Titration Period 1|Withdrawal by Subject|3|||
164161745|NCT00463047|592957004|FG001|Titration Period 1|Withdrawal by Subject|5|||
164161746|NCT00463047|592957003|FG000|Titration Period 1|Non-compliance procedures|4|||
164161747|NCT00463047|592957004|FG001|Titration Period 1|Non-compliance procedures|10|||
164161748|NCT00463047|592957003|FG000|Titration Period 1|Other|0|||
164161749|NCT00463047|592957004|FG001|Titration Period 1|Other|2|||
164161750|NCT00463047|592957003|FG000|Titration Period 2|Adverse Event|9|||
164161751|NCT00463047|592957004|FG001|Titration Period 2|Adverse Event|9|||
164161752|NCT00463047|592957003|FG000|Titration Period 2|Lack of Efficacy|6|||
164161753|NCT00463047|592957004|FG001|Titration Period 2|Lack of Efficacy|4|||
164161754|NCT00463047|592957003|FG000|Titration Period 2|Withdrawal by Subject|1|||
164161755|NCT00463047|592957004|FG001|Titration Period 2|Withdrawal by Subject|0|||
164161756|NCT00463047|592957003|FG000|Titration Period 2|Protocol Violation|2|||
164161757|NCT00463047|592957004|FG001|Titration Period 2|Protocol Violation|3|||
164161758|NCT00463047|592957003|FG000|Titration Period 2|Lost to Follow-up|1|||
164161992|NCT01637922|592958842|FG000|Overall Study|Lost to Follow-up|2|||
164161759|NCT00463047|592957004|FG001|Titration Period 2|Lost to Follow-up|2|||
164161760|NCT00463047|592957003|FG000|Titration Period 2|Non-compliance study medication|4|||
164161761|NCT00463047|592957004|FG001|Titration Period 2|Non-compliance study medication|2|||
164161762|NCT00463047|592957003|FG000|Titration Period 2|Non-compliance procedures|4|||
164161763|NCT00463047|592957004|FG001|Titration Period 2|Non-compliance procedures|1|||
164161764|NCT00463047|592957003|FG000|Titration Period 2|Other|3|||
164161765|NCT00463047|592957004|FG001|Titration Period 2|Other|2|||
164161766|NCT00463047|592957003|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
164161767|NCT00463047|592957004|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
164161768|NCT00463047|592957003|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
164161769|NCT00463047|592957004|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
164161770|NCT00463047|592957003|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
164161771|NCT00463047|592957004|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
164161772|NCT00463047|592957003|FG000|Double-Blind Treatment Period 1|Other|1|||
164161773|NCT00463047|592957004|FG001|Double-Blind Treatment Period 1|Other|0|||
164161774|NCT00463047|592957003|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
164161775|NCT00463047|592957004|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
164161776|NCT00463047|592957003|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
164161777|NCT00463047|592957004|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
164161778|NCT00463047|592957003|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
164161779|NCT00463047|592957004|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
164161780|NCT04278417|592957017|FG000|Overall Study|Withdrawal by Subject|20|||
164161781|NCT04278417|592957018|FG001|Overall Study|Withdrawal by Subject|20|||
164161782|NCT04278417|592957017|FG000|Overall Study|Progressive disease|0|||
164161783|NCT04278417|592957018|FG001|Overall Study|Progressive disease|2|||
164161784|NCT04278417|592957017|FG000|Overall Study|Physician Decision|4|||
164161785|NCT04278417|592957018|FG001|Overall Study|Physician Decision|6|||
164161786|NCT04278417|592957017|FG000|Overall Study|Lost to Follow-up|11|||
164161787|NCT04278417|592957018|FG001|Overall Study|Lost to Follow-up|13|||
164161788|NCT04278417|592957017|FG000|Overall Study|Death|8|||
164161789|NCT04278417|592957018|FG001|Overall Study|Death|9|||
164161790|NCT04278417|592957017|FG000|Overall Study|Adverse Event|3|||
164161791|NCT04278417|592957018|FG001|Overall Study|Adverse Event|5|||
164161792|NCT01732458|592957020|FG000|Overall Study|Lost to Follow-up|0|||
164161793|NCT01732458|592957021|FG001|Overall Study|Lost to Follow-up|2|||
164161794|NCT01732458|592957022|FG002|Overall Study|Lost to Follow-up|0|||
164161795|NCT01732458|592957023|FG003|Overall Study|Lost to Follow-up|0|||
164161796|NCT01732458|592957020|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164161797|NCT01732458|592957021|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164161798|NCT01732458|592957022|FG002|Overall Study|Non-Compliance With Study Drug|1|||
164161799|NCT01732458|592957023|FG003|Overall Study|Non-Compliance With Study Drug|0|||
164161800|NCT01732458|592957020|FG000|Overall Study|Physician Decision|1|||
164161801|NCT01732458|592957021|FG001|Overall Study|Physician Decision|2|||
164161802|NCT01732458|592957022|FG002|Overall Study|Physician Decision|2|||
164161803|NCT01732458|592957023|FG003|Overall Study|Physician Decision|0|||
164161804|NCT01732458|592957020|FG000|Overall Study|Protocol Violation|2|||
164161805|NCT01732458|592957021|FG001|Overall Study|Protocol Violation|0|||
164161806|NCT01732458|592957022|FG002|Overall Study|Protocol Violation|0|||
164161807|NCT01732458|592957023|FG003|Overall Study|Protocol Violation|2|||
164161808|NCT01732458|592957020|FG000|Overall Study|Screen Failure|0|||
164161809|NCT01732458|592957021|FG001|Overall Study|Screen Failure|1|||
164161810|NCT01732458|592957022|FG002|Overall Study|Screen Failure|0|||
164161811|NCT01732458|592957023|FG003|Overall Study|Screen Failure|0|||
164161812|NCT05870371|592957024|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
164161813|NCT05870371|592957025|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
164161814|NCT02203721|592957026|FG000|Overall Study|Lost to Follow-up|1|||
164161815|NCT02203721|592957027|FG001|Overall Study|Lost to Follow-up|0|||
164161816|NCT02203721|592957026|FG000|Overall Study|Death|0|||
164161817|NCT02203721|592957027|FG001|Overall Study|Death|2|||
164161818|NCT02203721|592957026|FG000|Overall Study|Illness|0|||
164161819|NCT02203721|592957027|FG001|Overall Study|Illness|1|||
164161820|NCT00703157|592957028|FG000|Overall Study|Lost to Follow-up|0|||
164161821|NCT00703157|592957029|FG001|Overall Study|Lost to Follow-up|1|||
164161822|NCT00703157|592957028|FG000|Overall Study|source data permanently lost/ other|4|||
164161823|NCT00703157|592957029|FG001|Overall Study|source data permanently lost/ other|1|||
164161824|NCT00347009|592957030|FG000|Overall Study|Death|1|||
164161825|NCT00347009|592957030|FG000|Overall Study|Adverse Event|6|||
164161826|NCT00347009|592957030|FG000|Overall Study|Withdrawal by Subject|3|||
164161827|NCT00347009|592957030|FG000|Overall Study|Physician Decision|5|||
164161828|NCT00347009|592957030|FG000|Overall Study|Lost to Follow-up|4|||
164161829|NCT00347009|592957030|FG000|Overall Study|Protocol Violation|2|||
164161830|NCT00347009|592957030|FG000|Overall Study|Adverse Laboratory Experience|1|||
164161831|NCT00347009|592957030|FG000|Overall Study|Insufficient Viral Suppression|3|||
164161832|NCT00347009|592957030|FG000|Overall Study|Increased ALT/HBV DNA|1|||
164161833|NCT00347009|592957030|FG000|Overall Study|Serious Adverse Event|1|||
164161834|NCT04495751|592957031|FG000|Overall Study|Withdrawal by Subject|1|||
164161835|NCT04495751|592957032|FG001|Overall Study|Withdrawal by Subject|0|||
164161836|NCT04495751|592957031|FG000|Overall Study|Lost to Follow-up|1|||
164161837|NCT04495751|592957032|FG001|Overall Study|Lost to Follow-up|0|||
164161838|NCT00708461|592957033|FG000|Overall Study|Lost to Follow-up|18|||
164161839|NCT00708461|592957034|FG001|Overall Study|Lost to Follow-up|11|||
164161840|NCT00708461|592957033|FG000|Overall Study|Withdrawal by Subject|8|||
164161841|NCT00708461|592957034|FG001|Overall Study|Withdrawal by Subject|9|||
164161842|NCT00708461|592957033|FG000|Overall Study|left workforce|115|||
164161843|NCT00708461|592957034|FG001|Overall Study|left workforce|180|||
164161844|NCT02907177|592957035|FG000|Overall Study|Death|0|||
164161845|NCT02907177|592957036|FG001|Overall Study|Death|1|||
164161846|NCT02907177|592957035|FG000|Overall Study|Physician Decision|3|||
164161847|NCT02907177|592957036|FG001|Overall Study|Physician Decision|3|||
164161848|NCT02907177|592957035|FG000|Overall Study|Withdrawal by Subject|15|||
164161849|NCT02907177|592957036|FG001|Overall Study|Withdrawal by Subject|7|||
164161850|NCT02907177|592957035|FG000|Overall Study|Sponsor's Decision|50|||
164161851|NCT02907177|592957036|FG001|Overall Study|Sponsor's Decision|57|||
164161852|NCT02968173|592957037|FG000|Overall Study|Withdrawal by Subject|1|||
164161853|NCT04681066|592957038|FG000|Overall Study|Lost to Follow-up|3|||
164161854|NCT04681066|592957039|FG001|Overall Study|Lost to Follow-up|1|||
164161855|NCT04681066|592957040|FG002|Overall Study|Lost to Follow-up|2|||
164161856|NCT04681066|592957041|FG003|Overall Study|Lost to Follow-up|1|||
164161857|NCT04681066|592957038|FG000|Overall Study|Withdrawal by Subject|2|||
164161858|NCT04681066|592957039|FG001|Overall Study|Withdrawal by Subject|1|||
164161859|NCT04681066|592957040|FG002|Overall Study|Withdrawal by Subject|0|||
164161860|NCT04681066|592957041|FG003|Overall Study|Withdrawal by Subject|3|||
164161861|NCT04681066|592957038|FG000|Overall Study|Death|0|||
164161862|NCT04681066|592957039|FG001|Overall Study|Death|1|||
164161863|NCT04681066|592957040|FG002|Overall Study|Death|0|||
164161864|NCT04681066|592957041|FG003|Overall Study|Death|0|||
164161865|NCT04495829|592957045|FG000|Overall Study|Lost to Follow-up|2|||
164161866|NCT04495829|592957045|FG000|Overall Study|Inclusion criterion not met|3|||
164161867|NCT00314327|592957052|FG000|Overall Study|Withdrawal by Subject|1|||
164161868|NCT01207687|592957053|FG000|Overall Study|Adverse Event|1|||
164161869|NCT01207687|592957053|FG000|Overall Study|Withdrawal by Subject|1|||
164161870|NCT03474965|592957054|FG000|Overall Study|Pregnancy|1|||
164161871|NCT03474965|592957055|FG001|Overall Study|Pregnancy|0|||
164161872|NCT03474965|592957056|FG002|Overall Study|Pregnancy|0|||
164161873|NCT03474965|592957057|FG003|Overall Study|Pregnancy|0|||
164161874|NCT03474965|592957054|FG000|Overall Study|Lost to Follow-up|0|||
164161875|NCT03474965|592957055|FG001|Overall Study|Lost to Follow-up|0|||
164161876|NCT03474965|592957056|FG002|Overall Study|Lost to Follow-up|1|||
164161877|NCT03474965|592957057|FG003|Overall Study|Lost to Follow-up|0|||
164161878|NCT03474965|592957054|FG000|Overall Study|Death|1|||
164161879|NCT03474965|592957055|FG001|Overall Study|Death|0|||
164161880|NCT03474965|592957056|FG002|Overall Study|Death|0|||
164161881|NCT03474965|592957057|FG003|Overall Study|Death|0|||
164161882|NCT03474965|592957054|FG000|Overall Study|Adverse Event|1|||
164161883|NCT03474965|592957055|FG001|Overall Study|Adverse Event|0|||
164161884|NCT03474965|592957056|FG002|Overall Study|Adverse Event|0|||
164161885|NCT03474965|592957057|FG003|Overall Study|Adverse Event|1|||
164161886|NCT03474965|592957054|FG000|Overall Study|Physician Decision|3|||
164161887|NCT03474965|592957055|FG001|Overall Study|Physician Decision|1|||
164161888|NCT03474965|592957056|FG002|Overall Study|Physician Decision|2|||
164161889|NCT03474965|592957057|FG003|Overall Study|Physician Decision|0|||
164161890|NCT03474965|592957054|FG000|Overall Study|Participant Decision|7|||
164161891|NCT03474965|592957055|FG001|Overall Study|Participant Decision|0|||
164161892|NCT03474965|592957056|FG002|Overall Study|Participant Decision|1|||
164161893|NCT03474965|592957057|FG003|Overall Study|Participant Decision|0|||
164161894|NCT03474965|592957054|FG000|Overall Study|Guardian Decision|4|||
164161895|NCT03474965|592957055|FG001|Overall Study|Guardian Decision|2|||
164161896|NCT03474965|592957056|FG002|Overall Study|Guardian Decision|7|||
164161897|NCT03474965|592957057|FG003|Overall Study|Guardian Decision|2|||
164161898|NCT03868930|592958821|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
164161899|NCT03868930|592958822|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
164161900|NCT03868930|592958821|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
164161901|NCT03868930|592958822|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
164161902|NCT03868930|592958821|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
164161903|NCT03868930|592958822|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
164161904|NCT03868930|592958821|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
164161905|NCT03868930|592958822|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
164161906|NCT03868930|592958821|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
164161907|NCT03868930|592958822|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
164161908|NCT02151851|592958827|FG000|Overall Study|Lack of Efficacy|67|||
164161909|NCT02151851|592958828|FG001|Overall Study|Lack of Efficacy|94|||
164161910|NCT02151851|592958827|FG000|Overall Study|Protocol Violation|0|||
164161911|NCT02151851|592958828|FG001|Overall Study|Protocol Violation|1|||
164161912|NCT02151851|592958827|FG000|Overall Study|Withdrawal by Subject|2|||
164161913|NCT02151851|592958828|FG001|Overall Study|Withdrawal by Subject|5|||
164161914|NCT02151851|592958827|FG000|Overall Study|Medical impairment|1|||
164161915|NCT02151851|592958828|FG001|Overall Study|Medical impairment|0|||
164161916|NCT02151851|592958827|FG000|Overall Study|Low compliance to study visits|0|||
164161917|NCT02151851|592958828|FG001|Overall Study|Low compliance to study visits|1|||
164161918|NCT02151851|592958827|FG000|Overall Study|Subject entered into study in error|0|||
164161919|NCT02151851|592958828|FG001|Overall Study|Subject entered into study in error|1|||
164161920|NCT02151851|592958827|FG000|Overall Study|Adverse Event|6|||
164161921|NCT02151851|592958828|FG001|Overall Study|Adverse Event|28|||
164161922|NCT02159053|592958829|FG000|Overall Study|Death|2|||
164161923|NCT02159053|592958830|FG001|Overall Study|Death|0|||
164161924|NCT02159053|592958831|FG002|Overall Study|Death|1|||
164161925|NCT02159053|592958829|FG000|Overall Study|Physician Decision|0|||
164161926|NCT02159053|592958830|FG001|Overall Study|Physician Decision|1|||
164161927|NCT02159053|592958831|FG002|Overall Study|Physician Decision|1|||
164161928|NCT02159053|592958829|FG000|Overall Study|Lack of Efficacy|3|||
164161929|NCT02159053|592958830|FG001|Overall Study|Lack of Efficacy|4|||
164161930|NCT02159053|592958831|FG002|Overall Study|Lack of Efficacy|7|||
164161931|NCT02159053|592958829|FG000|Overall Study|Adverse Event|7|||
164161932|NCT02159053|592958830|FG001|Overall Study|Adverse Event|6|||
164161933|NCT02159053|592958831|FG002|Overall Study|Adverse Event|5|||
164161934|NCT02159053|592958829|FG000|Overall Study|Participants/guardian decision|8|||
164161935|NCT02159053|592958830|FG001|Overall Study|Participants/guardian decision|10|||
164161936|NCT02159053|592958831|FG002|Overall Study|Participants/guardian decision|6|||
164161937|NCT02640950|592958832|FG000|Overall Study|Adverse Event|1|||
164161938|NCT02640950|592958832|FG000|Overall Study|Withdrawal by Subject|1|||
164161939|NCT03048747|592958833|FG000|Overall Study|Adverse Event|2|||
164161940|NCT03048747|592958833|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
164161941|NCT03048747|592958833|FG000|Overall Study|Physician Decision|1|||
164161942|NCT00915018|592958836|FG000|Overall Study|Death|75|||
164161943|NCT00915018|592958837|FG001|Overall Study|Death|70|||
164161944|NCT00915018|592958836|FG000|Overall Study|Lost to Follow-up|10|||
164161945|NCT00915018|592958837|FG001|Overall Study|Lost to Follow-up|5|||
164161946|NCT00915018|592958836|FG000|Overall Study|Withdrawal by Subject|38|||
164161947|NCT00915018|592958837|FG001|Overall Study|Withdrawal by Subject|27|||
164161948|NCT00915018|592958836|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
164161949|NCT00915018|592958837|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
164161950|NCT02582242|592958838|FG000|Overall Study|Adverse Event|4|||
164161951|NCT02582242|592958839|FG001|Overall Study|Adverse Event|3|||
164161952|NCT02582242|592958838|FG000|Overall Study|Protocol Violation|3|||
164161953|NCT02582242|592958839|FG001|Overall Study|Protocol Violation|1|||
164161954|NCT02582242|592958838|FG000|Overall Study|Lost to Follow-up|0|||
164161955|NCT02582242|592958839|FG001|Overall Study|Lost to Follow-up|1|||
164161956|NCT02582242|592958838|FG000|Overall Study|Withdrawal by Subject|11|||
164161957|NCT02582242|592958839|FG001|Overall Study|Withdrawal by Subject|11|||
164161958|NCT02582242|592958838|FG000|Overall Study|Unclassified|2|||
164161959|NCT02582242|592958839|FG001|Overall Study|Unclassified|1|||
164161960|NCT00300885|592958840|FG000|Treatment|Adverse Event|134|||
164161961|NCT00300885|592958841|FG001|Treatment|Adverse Event|82|||
164161962|NCT00300885|592958840|FG000|Treatment|Death|20|||
164161963|NCT00300885|592958841|FG001|Treatment|Death|7|||
164161964|NCT00300885|592958840|FG000|Treatment|Lack of Efficacy|1|||
164161965|NCT00300885|592958841|FG001|Treatment|Lack of Efficacy|1|||
164161966|NCT00300885|592958840|FG000|Treatment|Lost to Follow-up|3|||
164161967|NCT00300885|592958841|FG001|Treatment|Lost to Follow-up|2|||
164161968|NCT00300885|592958840|FG000|Treatment|Physician Decision|4|||
164161969|NCT00300885|592958841|FG001|Treatment|Physician Decision|5|||
164161970|NCT00300885|592958840|FG000|Treatment|Protocol Violation|11|||
164161971|NCT00300885|592958841|FG001|Treatment|Protocol Violation|11|||
164161972|NCT00300885|592958840|FG000|Treatment|Withdrawal by Subject|26|||
164161973|NCT00300885|592958841|FG001|Treatment|Withdrawal by Subject|23|||
164161974|NCT00300885|592958840|FG000|Treatment|Disease progression|171|||
164161975|NCT00300885|592958841|FG001|Treatment|Disease progression|238|||
164161976|NCT00300885|592958840|FG000|Treatment|Random code broken (subject died)|0|||
164161977|NCT00300885|592958841|FG001|Treatment|Random code broken (subject died)|1|||
164161978|NCT00300885|592958840|FG000|Treatment|Non-compliant with study medication|3|||
164161979|NCT00300885|592958841|FG001|Treatment|Non-compliant with study medication|4|||
164161980|NCT00300885|592958840|FG000|Follow-up|Death|141|||
164161981|NCT00300885|592958841|FG001|Follow-up|Death|163|||
164161982|NCT00300885|592958840|FG000|Follow-up|Lost to Follow-up|11|||
164161983|NCT00300885|592958841|FG001|Follow-up|Lost to Follow-up|7|||
164161984|NCT00300885|592958840|FG000|Follow-up|Withdrawal by Subject|26|||
164161985|NCT00300885|592958841|FG001|Follow-up|Withdrawal by Subject|25|||
164161986|NCT01637922|592958842|FG000|Overall Study|Adverse Event|0|||
164161987|NCT01637922|592958843|FG001|Overall Study|Adverse Event|1|||
164161988|NCT01637922|592958842|FG000|Overall Study|Protocol Violation|0|||
164161989|NCT01637922|592958843|FG001|Overall Study|Protocol Violation|1|||
164161990|NCT01637922|592958842|FG000|Overall Study|Withdrawal by Subject|0|||
164161991|NCT01637922|592958843|FG001|Overall Study|Withdrawal by Subject|3|||
164161993|NCT01637922|592958843|FG001|Overall Study|Lost to Follow-up|0|||
164161994|NCT00638404|592958844|FG000|Overall Study|Physician Decision|8|||
164161995|NCT00638404|592958845|FG001|Overall Study|Physician Decision|0|||
164161996|NCT02101736|592958846|FG000|Overall Study|Protocol Violation|3|||
164161997|NCT02101736|592958847|FG001|Overall Study|Protocol Violation|0|||
164161998|NCT02101736|592958846|FG000|Overall Study|Withdrawal by Subject|1|||
164161999|NCT02101736|592958847|FG001|Overall Study|Withdrawal by Subject|1|||
164162000|NCT02282631|592958848|FG000|Overall Study|Lost to Follow-up|2|||
164162001|NCT02282631|592958849|FG001|Overall Study|Lost to Follow-up|0|||
164162002|NCT00459290|592958850|FG000|Overall Study|Adverse Event|3|||
164162003|NCT00459290|592958850|FG000|Overall Study|Ineligible|2|||
164162004|NCT00687271|592958851|FG000|Overall Study|Adverse Event|1|||
164162005|NCT00687271|592958852|FG001|Overall Study|Adverse Event|3|||
164162006|NCT00687271|592958853|FG002|Overall Study|Adverse Event|1|||
164162007|NCT00687271|592958854|FG003|Overall Study|Adverse Event|0|||
164162008|NCT00687271|592958851|FG000|Overall Study|Lost to Follow-up|0|||
164162009|NCT00687271|592958852|FG001|Overall Study|Lost to Follow-up|1|||
164162010|NCT00687271|592958853|FG002|Overall Study|Lost to Follow-up|0|||
164162011|NCT00687271|592958854|FG003|Overall Study|Lost to Follow-up|0|||
164162012|NCT00687271|592958851|FG000|Overall Study|Protocol Violation|2|||
164162013|NCT00687271|592958852|FG001|Overall Study|Protocol Violation|1|||
164162014|NCT00687271|592958853|FG002|Overall Study|Protocol Violation|1|||
164162015|NCT00687271|592958854|FG003|Overall Study|Protocol Violation|0|||
164162016|NCT00687271|592958851|FG000|Overall Study|Withdrawal by Subject|0|||
164162017|NCT00687271|592958852|FG001|Overall Study|Withdrawal by Subject|1|||
164162018|NCT00687271|592958853|FG002|Overall Study|Withdrawal by Subject|3|||
164162019|NCT00687271|592958854|FG003|Overall Study|Withdrawal by Subject|0|||
164162020|NCT02453334|592958855|FG000|Overall Study|Death|15|||
164162021|NCT02453334|592958856|FG001|Overall Study|Death|13|||
164162022|NCT02453334|592958855|FG000|Overall Study|Adverse Event|2|||
164162023|NCT02453334|592958856|FG001|Overall Study|Adverse Event|1|||
164162024|NCT02453334|592958855|FG000|Overall Study|Lost to Follow-up|5|||
164162025|NCT02453334|592958856|FG001|Overall Study|Lost to Follow-up|9|||
164162026|NCT02453334|592958855|FG000|Overall Study|Physician Decision|1|||
164162027|NCT02453334|592958856|FG001|Overall Study|Physician Decision|0|||
164162028|NCT02453334|592958855|FG000|Overall Study|Withdrawal by Subject|17|||
164162029|NCT02453334|592958856|FG001|Overall Study|Withdrawal by Subject|13|||
164162030|NCT02453334|592958855|FG000|Overall Study|Other reason|1|||
164162031|NCT02453334|592958856|FG001|Overall Study|Other reason|4|||
164162032|NCT02693106|592958861|FG000|Overall Study|No time|3|||
164162033|NCT03981900|592958862|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
164162034|NCT03981900|592958862|FG000|Overall Study|Adverse Event|5|||
164162035|NCT03981900|592958862|FG000|Overall Study|Protocol Violation|1|||
164162036|NCT03981900|592958862|FG000|Overall Study|Withdrawal by Subject|7|||
164162037|NCT03981900|592958862|FG000|Overall Study|Lost to Follow-up|46|||
164162038|NCT03981900|592958862|FG000|Overall Study|Decision of the researcher|3|||
164162039|NCT03981900|592958862|FG000|Overall Study|Death|3|||
164162040|NCT03981900|592958862|FG000|Overall Study|Other|5|||
164162041|NCT04090060|592958875|FG000|Overall Study|Lost to Follow-up|76|||
164162042|NCT04090060|592958876|FG001|Overall Study|Lost to Follow-up|77|||
164162043|NCT03337113|592958883|FG000|Overall Study|Adverse Event|1|||
164162044|NCT03337113|592958884|FG001|Overall Study|Adverse Event|1|||
164162045|NCT03337113|592958885|FG002|Overall Study|Adverse Event|0|||
164162046|NCT03337113|592958886|FG003|Overall Study|Adverse Event|1|||
164162047|NCT03337113|592958883|FG000|Overall Study|Physician Decision|0|||
164162048|NCT03337113|592958884|FG001|Overall Study|Physician Decision|2|||
164162049|NCT03337113|592958885|FG002|Overall Study|Physician Decision|0|||
164162050|NCT03337113|592958886|FG003|Overall Study|Physician Decision|1|||
164162051|NCT03337113|592958883|FG000|Overall Study|Withdrawal by Subject|0|||
164162052|NCT03337113|592958884|FG001|Overall Study|Withdrawal by Subject|0|||
164162053|NCT03337113|592958885|FG002|Overall Study|Withdrawal by Subject|1|||
164162054|NCT03337113|592958886|FG003|Overall Study|Withdrawal by Subject|0|||
164162055|NCT00507455|592958892|FG000|Overall Study|Adverse Event|3|||
164162056|NCT00507455|592958893|FG001|Overall Study|Adverse Event|3|||
164162057|NCT00507455|592958894|FG002|Overall Study|Adverse Event|6|||
164162058|NCT00507455|592958892|FG000|Overall Study|Withdrawal by Subject|2|||
164162059|NCT00507455|592958893|FG001|Overall Study|Withdrawal by Subject|1|||
164162060|NCT00507455|592958894|FG002|Overall Study|Withdrawal by Subject|2|||
164162061|NCT00507455|592958892|FG000|Overall Study|Protocol Violation|4|||
164162062|NCT00507455|592958893|FG001|Overall Study|Protocol Violation|1|||
164162063|NCT00507455|592958894|FG002|Overall Study|Protocol Violation|1|||
164162064|NCT00507455|592958892|FG000|Overall Study|Lost to Follow-up|2|||
164162065|NCT00507455|592958893|FG001|Overall Study|Lost to Follow-up|0|||
164162066|NCT00507455|592958894|FG002|Overall Study|Lost to Follow-up|2|||
164162067|NCT00507455|592958892|FG000|Overall Study|Lack of Efficacy|0|||
164162068|NCT00507455|592958893|FG001|Overall Study|Lack of Efficacy|1|||
164162069|NCT00507455|592958894|FG002|Overall Study|Lack of Efficacy|0|||
164162070|NCT00507455|592958892|FG000|Overall Study|Other - miscellaneous reason|1|||
164162071|NCT00507455|592958893|FG001|Overall Study|Other - miscellaneous reason|0|||
164162146|NCT02527434|592958932|FG001|Overall Study|Site closure|0|||
164162072|NCT00507455|592958894|FG002|Overall Study|Other - miscellaneous reason|1|||
164162073|NCT02176655|592958895|FG000|Overall Study|Subjects did not treat|6|||
164162074|NCT01372995|592958896|FG000|Overall Study|Spouse withdrew participant from study|0|||
164162075|NCT01372995|592958897|FG001|Overall Study|Spouse withdrew participant from study|1|||
164162076|NCT01372995|592958898|FG002|Overall Study|Spouse withdrew participant from study|0|||
164162077|NCT01372995|592958896|FG000|Overall Study|Physician Decision|0|||
164162078|NCT01372995|592958897|FG001|Overall Study|Physician Decision|0|||
164162079|NCT01372995|592958898|FG002|Overall Study|Physician Decision|1|||
164162080|NCT06110494|592958904|FG000|Overall Study|Protocol Violation|2|||
164162081|NCT06110494|592958905|FG001|Overall Study|Protocol Violation|0|||
164162082|NCT06110494|592958906|FG002|Overall Study|Protocol Violation|1|||
164162083|NCT06110494|592958904|FG000|Overall Study|Dixon's test for outlier analysis|1|||
164162084|NCT06110494|592958905|FG001|Overall Study|Dixon's test for outlier analysis|1|||
164162085|NCT06110494|592958906|FG002|Overall Study|Dixon's test for outlier analysis|0|||
164162086|NCT00105079|592958907|FG000|Overall Study|Adverse Event|5|||
164162087|NCT00105079|592958908|FG001|Overall Study|Adverse Event|12|||
164162088|NCT00105079|592958907|FG000|Overall Study|Death|3|||
164162089|NCT00105079|592958908|FG001|Overall Study|Death|1|||
164162090|NCT00105079|592958907|FG000|Overall Study|Lost to Follow-up|12|||
164162091|NCT00105079|592958908|FG001|Overall Study|Lost to Follow-up|12|||
164162092|NCT00105079|592958907|FG000|Overall Study|Lack of Efficacy|9|||
164162093|NCT00105079|592958908|FG001|Overall Study|Lack of Efficacy|3|||
164162094|NCT00105079|592958907|FG000|Overall Study|Refused treatment|6|||
164162095|NCT00105079|592958908|FG001|Overall Study|Refused treatment|4|||
164162096|NCT00105079|592958907|FG000|Overall Study|Violation of selection criteria at entry|0|||
164162097|NCT00105079|592958908|FG001|Overall Study|Violation of selection criteria at entry|2|||
164162098|NCT00105079|592958907|FG000|Overall Study|Protocol Violation|1|||
164162099|NCT00105079|592958908|FG001|Overall Study|Protocol Violation|0|||
164162100|NCT00105079|592958907|FG000|Overall Study|Other|3|||
164162101|NCT00105079|592958908|FG001|Overall Study|Other|1|||
164162102|NCT01464593|592958909|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
164162103|NCT01737710|592958919|FG000|Overall Study|Lost to Follow-up|0|||
164162104|NCT01737710|592958920|FG001|Overall Study|Lost to Follow-up|2|||
164162105|NCT01737710|592958921|FG002|Overall Study|Lost to Follow-up|2|||
164162106|NCT01737710|592958922|FG003|Overall Study|Lost to Follow-up|0|||
164162107|NCT01737710|592958923|FG004|Overall Study|Lost to Follow-up|0|||
164162108|NCT01737710|592958919|FG000|Overall Study|Withdrawal by Subject|1|||
164162109|NCT01737710|592958920|FG001|Overall Study|Withdrawal by Subject|1|||
164162110|NCT01737710|592958921|FG002|Overall Study|Withdrawal by Subject|1|||
164162111|NCT01737710|592958922|FG003|Overall Study|Withdrawal by Subject|0|||
164162112|NCT01737710|592958923|FG004|Overall Study|Withdrawal by Subject|0|||
164162113|NCT01737710|592958919|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
164162114|NCT01737710|592958920|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
164162115|NCT01737710|592958921|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
164162116|NCT01737710|592958922|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
164162117|NCT01737710|592958923|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
164162118|NCT00921557|592958928|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
164162119|NCT00921557|592958929|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
164162120|NCT00921557|592958930|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
164162121|NCT00921557|592958928|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
164162122|NCT00921557|592958929|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
164162123|NCT00921557|592958930|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
164162124|NCT00921557|592958928|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
164162125|NCT00921557|592958929|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
164162126|NCT00921557|592958930|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
164162127|NCT00921557|592958928|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
164162128|NCT00921557|592958929|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
164162129|NCT00921557|592958930|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
164162130|NCT00921557|592958928|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
164162131|NCT00921557|592958929|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
164162132|NCT00921557|592958930|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
164162133|NCT02527434|592958931|FG000|Overall Study|Lost to Follow-up|2|||
164162134|NCT02527434|592958932|FG001|Overall Study|Lost to Follow-up|2|||
164162135|NCT02527434|592958933|FG002|Overall Study|Lost to Follow-up|0|||
164162136|NCT02527434|592958931|FG000|Overall Study|Death|19|||
164162137|NCT02527434|592958932|FG001|Overall Study|Death|6|||
164162138|NCT02527434|592958933|FG002|Overall Study|Death|17|||
164162139|NCT02527434|592958931|FG000|Overall Study|Withdrawal by Subject|5|||
164162140|NCT02527434|592958932|FG001|Overall Study|Withdrawal by Subject|3|||
164162141|NCT02527434|592958933|FG002|Overall Study|Withdrawal by Subject|3|||
164162142|NCT02527434|592958931|FG000|Overall Study|Reason Not Specified|1|||
164162143|NCT02527434|592958932|FG001|Overall Study|Reason Not Specified|0|||
164162144|NCT02527434|592958933|FG002|Overall Study|Reason Not Specified|0|||
164162145|NCT02527434|592958931|FG000|Overall Study|Site closure|1|||
164162147|NCT02527434|592958933|FG002|Overall Study|Site closure|0|||
164162148|NCT02589639|592958947|FG000|Overall Study|Lost to Follow-up|1|||
164162149|NCT02589639|592958948|FG001|Overall Study|Lost to Follow-up|0|||
164162150|NCT02589639|592958949|FG002|Overall Study|Lost to Follow-up|0|||
164162151|NCT02589639|592958947|FG000|Overall Study|Protocol Violation|1|||
164162152|NCT02589639|592958948|FG001|Overall Study|Protocol Violation|0|||
164162153|NCT02589639|592958949|FG002|Overall Study|Protocol Violation|0|||
164162154|NCT02589639|592958947|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
164162155|NCT02589639|592958948|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
164162156|NCT02589639|592958949|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
164162157|NCT02589639|592958947|FG000|Overall Study|Adverse Event|4|||
164162158|NCT02589639|592958948|FG001|Overall Study|Adverse Event|5|||
164162159|NCT02589639|592958949|FG002|Overall Study|Adverse Event|3|||
164162160|NCT02589639|592958947|FG000|Overall Study|Other reason than specified above|1|||
164162161|NCT02589639|592958948|FG001|Overall Study|Other reason than specified above|2|||
164162162|NCT02589639|592958949|FG002|Overall Study|Other reason than specified above|1|||
164162163|NCT02589639|592958947|FG000|Overall Study|Not Treated|0|||
164162164|NCT02589639|592958948|FG001|Overall Study|Not Treated|3|||
164162165|NCT02589639|592958949|FG002|Overall Study|Not Treated|0|||
164162166|NCT01276756|592958952|FG000|Overall Study|Lost to Follow-up|2|||
164162167|NCT01276756|592958953|FG001|Overall Study|Lost to Follow-up|0|||
164162168|NCT01276756|592958952|FG000|Overall Study|Adverse Event|3|||
164162169|NCT01276756|592958953|FG001|Overall Study|Adverse Event|2|||
164162170|NCT05868577|592958954|FG000|Overall Study|Lost to Follow-up|5|||
164162171|NCT05868577|592958955|FG001|Overall Study|Lost to Follow-up|5|||
164162172|NCT02522884|592958958|FG000|Overall Study|Withdrawal by Subject|6|||
164162173|NCT02522884|592958958|FG000|Overall Study|Death|3|||
164162174|NCT02522884|592958958|FG000|Overall Study|Missed 12-month Follow-up|9|||
164162175|NCT03289754|592958959|FG000|Overall Study|Screen Failure or Failure to Meet Follow-up|3|||
164162176|NCT04873934|592958960|FG000|Overall Study|Adverse Event|0|||
164162177|NCT04873934|592958961|FG001|Overall Study|Adverse Event|1|||
164162178|NCT04873934|592958960|FG000|Overall Study|Death|0|||
164162179|NCT04873934|592958961|FG001|Overall Study|Death|2|||
164162180|NCT04873934|592958960|FG000|Overall Study|Lost to Follow-up|13|||
164162181|NCT04873934|592958961|FG001|Overall Study|Lost to Follow-up|9|||
164162182|NCT04873934|592958960|FG000|Overall Study|Physician Decision|1|||
164162183|NCT04873934|592958961|FG001|Overall Study|Physician Decision|1|||
164162184|NCT04873934|592958960|FG000|Overall Study|Protocol deviation|2|||
164162185|NCT04873934|592958961|FG001|Overall Study|Protocol deviation|1|||
164162186|NCT04873934|592958960|FG000|Overall Study|Subject decision|1|||
164162187|NCT04873934|592958961|FG001|Overall Study|Subject decision|8|||
164162188|NCT04873934|592958960|FG000|Overall Study|Withdrew consent|0|||
164162189|NCT04873934|592958961|FG001|Overall Study|Withdrew consent|4|||
164162190|NCT04873934|592958960|FG000|Overall Study|Missing|1|||
164162191|NCT04873934|592958961|FG001|Overall Study|Missing|0|||
164162192|NCT03584854|592958963|FG000|Overall Study|Primary outcome not measured|1|||
164162193|NCT03584854|592958964|FG001|Overall Study|Primary outcome not measured|2|||
164162194|NCT02630251|592958965|FG000|Overall Study|Physician Decision|0|||
164162195|NCT02630251|592958966|FG001|Overall Study|Physician Decision|0|||
164162196|NCT02630251|592958967|FG002|Overall Study|Physician Decision|1|||
164162197|NCT02630251|592958968|FG003|Overall Study|Physician Decision|0|||
164162198|NCT02134015|592958969|FG000|Overall Study|Protocol Violation|0|||
164162199|NCT02134015|592958970|FG001|Overall Study|Protocol Violation|1|||
164162200|NCT02134015|592958969|FG000|Overall Study|Death|2|||
164162201|NCT02134015|592958970|FG001|Overall Study|Death|1|||
164162202|NCT02134015|592958969|FG000|Overall Study|Reason not provided|1|||
164162203|NCT02134015|592958970|FG001|Overall Study|Reason not provided|2|||
164162204|NCT02134015|592958969|FG000|Overall Study|Clinical progression|14|||
164162205|NCT02134015|592958970|FG001|Overall Study|Clinical progression|7|||
164162206|NCT02134015|592958969|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
164162207|NCT02134015|592958970|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
164162208|NCT02134015|592958969|FG000|Overall Study|Study terminated by sponsor|2|||
164162209|NCT02134015|592958970|FG001|Overall Study|Study terminated by sponsor|3|||
164162210|NCT02134015|592958969|FG000|Overall Study|Adverse Event|9|||
164162211|NCT02134015|592958970|FG001|Overall Study|Adverse Event|10|||
164162212|NCT02134015|592958969|FG000|Overall Study|Withdrawal by Subject|3|||
164162213|NCT02134015|592958970|FG001|Overall Study|Withdrawal by Subject|7|||
164162214|NCT01777282|592958973|FG000|Overall Study|Persistent Hyperglycemia|0|||
164162215|NCT01777282|592958974|FG001|Overall Study|Persistent Hyperglycemia|0|||
164162216|NCT01777282|592958975|FG002|Overall Study|Persistent Hyperglycemia|1|||
164162217|NCT01777282|592958976|FG003|Overall Study|Persistent Hyperglycemia|0|||
164162218|NCT01777282|592958977|FG004|Overall Study|Persistent Hyperglycemia|0|||
164162219|NCT01777282|592958973|FG000|Overall Study|New Antidiabetic Medication|0|||
164162220|NCT01777282|592958974|FG001|Overall Study|New Antidiabetic Medication|0|||
164162221|NCT01777282|592958975|FG002|Overall Study|New Antidiabetic Medication|1|||
164162222|NCT01777282|592958976|FG003|Overall Study|New Antidiabetic Medication|0|||
164162223|NCT01777282|592958977|FG004|Overall Study|New Antidiabetic Medication|0|||
164162224|NCT01777282|592958973|FG000|Overall Study|Adverse Event|4|||
164162225|NCT01777282|592958974|FG001|Overall Study|Adverse Event|4|||
164162226|NCT01777282|592958975|FG002|Overall Study|Adverse Event|2|||
164162227|NCT01777282|592958976|FG003|Overall Study|Adverse Event|1|||
164162228|NCT01777282|592958977|FG004|Overall Study|Adverse Event|3|||
164162229|NCT01777282|592958973|FG000|Overall Study|Withdrawal by Subject|4|||
164162230|NCT01777282|592958974|FG001|Overall Study|Withdrawal by Subject|0|||
164162231|NCT01777282|592958975|FG002|Overall Study|Withdrawal by Subject|0|||
164162232|NCT01777282|592958976|FG003|Overall Study|Withdrawal by Subject|1|||
164162233|NCT01777282|592958977|FG004|Overall Study|Withdrawal by Subject|2|||
164162234|NCT01777282|592958973|FG000|Overall Study|Protocol Violation|2|||
164162235|NCT01777282|592958974|FG001|Overall Study|Protocol Violation|0|||
164162236|NCT01777282|592958975|FG002|Overall Study|Protocol Violation|1|||
164162237|NCT01777282|592958976|FG003|Overall Study|Protocol Violation|0|||
164162238|NCT01777282|592958977|FG004|Overall Study|Protocol Violation|2|||
164162239|NCT01777282|592958973|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
164162240|NCT01777282|592958974|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
164162241|NCT01777282|592958975|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
164162242|NCT01777282|592958976|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
164162243|NCT01777282|592958977|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
164162244|NCT04015518|592958978|FG000|Overall Study|Adverse Event|6|||
164162245|NCT04015518|592958979|FG001|Overall Study|Adverse Event|1|||
164162246|NCT04015518|592958980|FG002|Overall Study|Adverse Event|1|||
164162247|NCT04015518|592958981|FG003|Overall Study|Adverse Event|3|||
164162248|NCT04015518|592958982|FG004|Overall Study|Adverse Event|3|||
164162249|NCT04015518|592958978|FG000|Overall Study|Lack of Efficacy|1|||
164162250|NCT04015518|592958979|FG001|Overall Study|Lack of Efficacy|0|||
164162251|NCT04015518|592958980|FG002|Overall Study|Lack of Efficacy|1|||
164162252|NCT04015518|592958981|FG003|Overall Study|Lack of Efficacy|0|||
164162253|NCT04015518|592958982|FG004|Overall Study|Lack of Efficacy|4|||
164162254|NCT04015518|592958978|FG000|Overall Study|Lost to Follow-up|0|||
164162255|NCT04015518|592958979|FG001|Overall Study|Lost to Follow-up|0|||
164162256|NCT04015518|592958980|FG002|Overall Study|Lost to Follow-up|0|||
164162257|NCT04015518|592958981|FG003|Overall Study|Lost to Follow-up|0|||
164162258|NCT04015518|592958982|FG004|Overall Study|Lost to Follow-up|1|||
164162259|NCT04015518|592958978|FG000|Overall Study|Withdrawal by Subject|0|||
164162260|NCT04015518|592958979|FG001|Overall Study|Withdrawal by Subject|1|||
164162261|NCT04015518|592958980|FG002|Overall Study|Withdrawal by Subject|0|||
164162262|NCT04015518|592958981|FG003|Overall Study|Withdrawal by Subject|1|||
164162263|NCT04015518|592958982|FG004|Overall Study|Withdrawal by Subject|1|||
164162264|NCT04015518|592958978|FG000|Overall Study|Patient did not come for consecutive visits|0|||
164162265|NCT04015518|592958979|FG001|Overall Study|Patient did not come for consecutive visits|1|||
164162266|NCT04015518|592958980|FG002|Overall Study|Patient did not come for consecutive visits|0|||
164162267|NCT04015518|592958981|FG003|Overall Study|Patient did not come for consecutive visits|0|||
164162268|NCT04015518|592958982|FG004|Overall Study|Patient did not come for consecutive visits|0|||
164162269|NCT04015518|592958978|FG000|Overall Study|not willing to travel due to Covid-19|0|||
164162270|NCT04015518|592958979|FG001|Overall Study|not willing to travel due to Covid-19|0|||
164162271|NCT04015518|592958980|FG002|Overall Study|not willing to travel due to Covid-19|1|||
164162272|NCT04015518|592958981|FG003|Overall Study|not willing to travel due to Covid-19|0|||
164162273|NCT04015518|592958982|FG004|Overall Study|not willing to travel due to Covid-19|0|||
164162274|NCT04015518|592958978|FG000|Overall Study|Patient wants to discontinue treatment|0|||
164162275|NCT04015518|592958979|FG001|Overall Study|Patient wants to discontinue treatment|0|||
164162276|NCT04015518|592958980|FG002|Overall Study|Patient wants to discontinue treatment|0|||
164162277|NCT04015518|592958981|FG003|Overall Study|Patient wants to discontinue treatment|1|||
164162278|NCT04015518|592958982|FG004|Overall Study|Patient wants to discontinue treatment|0|||
164162279|NCT04015518|592958978|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
164162280|NCT04015518|592958979|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
164162281|NCT04015518|592958980|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
164162282|NCT04015518|592958981|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
164162283|NCT04015518|592958982|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
164162284|NCT04015518|592958978|FG000|Overall Study|Pregnancy|0|||
164162285|NCT04015518|592958979|FG001|Overall Study|Pregnancy|0|||
164162286|NCT04015518|592958980|FG002|Overall Study|Pregnancy|0|||
164162287|NCT04015518|592958981|FG003|Overall Study|Pregnancy|0|||
164162288|NCT04015518|592958982|FG004|Overall Study|Pregnancy|1|||
164162289|NCT04015518|592958978|FG000|Overall Study|Personal reasons|1|||
164162290|NCT04015518|592958979|FG001|Overall Study|Personal reasons|0|||
164162291|NCT04015518|592958980|FG002|Overall Study|Personal reasons|0|||
164162292|NCT04015518|592958981|FG003|Overall Study|Personal reasons|0|||
164162293|NCT04015518|592958982|FG004|Overall Study|Personal reasons|1|||
164162294|NCT04015518|592958978|FG000|Overall Study|Withdrew consent|1|||
164162295|NCT04015518|592958979|FG001|Overall Study|Withdrew consent|0|||
164162296|NCT04015518|592958980|FG002|Overall Study|Withdrew consent|0|||
164162297|NCT04015518|592958981|FG003|Overall Study|Withdrew consent|0|||
164162298|NCT04015518|592958982|FG004|Overall Study|Withdrew consent|0|||
164162299|NCT04015518|592958978|FG000|Overall Study|Prostate carcinoma|1|||
164162300|NCT04015518|592958979|FG001|Overall Study|Prostate carcinoma|0|||
164162301|NCT04015518|592958980|FG002|Overall Study|Prostate carcinoma|0|||
164162302|NCT04015518|592958981|FG003|Overall Study|Prostate carcinoma|0|||
164162303|NCT04015518|592958982|FG004|Overall Study|Prostate carcinoma|0|||
164162304|NCT04015518|592958978|FG000|Overall Study|Could not keep appointments due to work|1|||
164162305|NCT04015518|592958979|FG001|Overall Study|Could not keep appointments due to work|0|||
164162306|NCT04015518|592958980|FG002|Overall Study|Could not keep appointments due to work|0|||
164162307|NCT04015518|592958981|FG003|Overall Study|Could not keep appointments due to work|0|||
164162308|NCT04015518|592958982|FG004|Overall Study|Could not keep appointments due to work|0|||
164162309|NCT02186873|592960432|FG000|Overall Study|Adverse Event|1|||
164162310|NCT02186873|592960433|FG001|Overall Study|Adverse Event|3|||
164162311|NCT02186873|592960432|FG000|Overall Study|Lack of Efficacy|0|||
164162312|NCT02186873|592960433|FG001|Overall Study|Lack of Efficacy|1|||
164162313|NCT02186873|592960432|FG000|Overall Study|Lost to Follow-up|1|||
164162314|NCT02186873|592960433|FG001|Overall Study|Lost to Follow-up|2|||
164162315|NCT02186873|592960432|FG000|Overall Study|Withdrawal by Subject|7|||
164162316|NCT02186873|592960433|FG001|Overall Study|Withdrawal by Subject|2|||
164162317|NCT03694002|592960434|FG000|Overall Study|Progression|4|||
164162318|NCT03694002|592960435|FG001|Overall Study|Progression|2|||
164162319|NCT03694002|592960434|FG000|Overall Study|Adverse Event|2|||
164162320|NCT03694002|592960435|FG001|Overall Study|Adverse Event|0|||
164162321|NCT03694002|592960434|FG000|Overall Study|Other not protocol specified|1|||
164162322|NCT03694002|592960435|FG001|Overall Study|Other not protocol specified|0|||
164162323|NCT03694002|592960434|FG000|Overall Study|Ineligible|0|||
164162324|NCT03694002|592960435|FG001|Overall Study|Ineligible|1|||
164162325|NCT03694002|592960434|FG000|Overall Study|Withdrew consent before starting treatment|0|||
164162326|NCT03694002|592960435|FG001|Overall Study|Withdrew consent before starting treatment|3|||
164162327|NCT01760655|592960436|FG000|Overall Study|Death|18|||
164162328|NCT01760655|592960436|FG000|Overall Study|Physician Decision|1|||
164162329|NCT01568034|592960438|FG000|Overall Study|Withdrawal by Subject|1|||
164162330|NCT01568034|592960439|FG001|Overall Study|Withdrawal by Subject|0|||
164162331|NCT01568034|592960440|FG002|Overall Study|Withdrawal by Subject|0|||
164162332|NCT01568034|592960441|FG003|Overall Study|Withdrawal by Subject|0|||
164162333|NCT01068730|592960442|FG000|Period 3|Personal reason|1|||
164162334|NCT01068730|592960443|FG001|Period 3|Personal reason|0|||
164162335|NCT01068730|592960444|FG002|Period 3|Personal reason|0|||
164162336|NCT01068730|592960445|FG003|Period 3|Personal reason|0|||
164162337|NCT01068730|592960442|FG000|Period 4|Family emergency|0|||
164162338|NCT01068730|592960443|FG001|Period 4|Family emergency|1|||
164162339|NCT01068730|592960444|FG002|Period 4|Family emergency|0|||
164162340|NCT01068730|592960445|FG003|Period 4|Family emergency|0|||
164162341|NCT01515865|592960449|FG000|Part A (Open-label)|Other|3|||
164162342|NCT01515865|592960450|FG001|Part A (Open-label)|Other|0|||
164162343|NCT01515865|592960451|FG002|Part A (Open-label)|Other|0|||
164162344|NCT01515865|592960449|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
164162345|NCT01515865|592960450|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
164162346|NCT01515865|592960451|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
164162347|NCT01515865|592960449|FG000|Part B (Open-label)|Other|1|||
164162348|NCT01515865|592960450|FG001|Part B (Open-label)|Other|0|||
164162349|NCT01515865|592960451|FG002|Part B (Open-label)|Other|0|||
164162350|NCT02510664|592960454|FG000|Overall Study|Transferred Care|9|||
164162351|NCT02510664|592960455|FG001|Overall Study|Transferred Care|9|||
164162352|NCT02510664|592960456|FG002|Overall Study|Transferred Care|0|||
164162353|NCT02510664|592960454|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
164162354|NCT02510664|592960455|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
164162355|NCT02510664|592960456|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
164162356|NCT02510664|592960454|FG000|Overall Study|Time Constraints|1|||
164162357|NCT02510664|592960455|FG001|Overall Study|Time Constraints|1|||
164162358|NCT02510664|592960456|FG002|Overall Study|Time Constraints|0|||
164162359|NCT01297517|592960462|FG000|Overall Study|Adverse Event|21|||
164162360|NCT01297517|592960463|FG001|Overall Study|Adverse Event|7|||
164162361|NCT01297517|592960464|FG002|Overall Study|Adverse Event|16|||
164162362|NCT01297517|592960462|FG000|Overall Study|Lost to Follow-up|1|||
164162363|NCT01297517|592960463|FG001|Overall Study|Lost to Follow-up|0|||
164162364|NCT01297517|592960464|FG002|Overall Study|Lost to Follow-up|1|||
164162365|NCT01297517|592960462|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
164162366|NCT01297517|592960463|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
164162367|NCT01297517|592960464|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
164162368|NCT01297517|592960462|FG000|Overall Study|Noncompliance|1|||
164162369|NCT01297517|592960463|FG001|Overall Study|Noncompliance|0|||
164162370|NCT01297517|592960464|FG002|Overall Study|Noncompliance|0|||
164162371|NCT01297517|592960462|FG000|Overall Study|Protocol Violation|1|||
164162372|NCT01297517|592960463|FG001|Overall Study|Protocol Violation|1|||
164162373|NCT01297517|592960464|FG002|Overall Study|Protocol Violation|1|||
164162374|NCT01297517|592960462|FG000|Overall Study|Inadequate Control of IOP|1|||
164162375|NCT01297517|592960463|FG001|Overall Study|Inadequate Control of IOP|1|||
164162376|NCT01297517|592960464|FG002|Overall Study|Inadequate Control of IOP|2|||
164162377|NCT02914613|592960465|FG000|Overall Study|Withdrawal by Subject|1|||
164162378|NCT02914613|592960466|FG001|Overall Study|Withdrawal by Subject|2|||
164162379|NCT02914613|592960465|FG000|Overall Study|Adverse Event|1|||
164162380|NCT02914613|592960466|FG001|Overall Study|Adverse Event|0|||
164162381|NCT00423332|592960467|FG000|Overall Study|Adverse Event|6|||
164162382|NCT00423332|592960468|FG001|Overall Study|Adverse Event|2|||
164162383|NCT00423332|592960467|FG000|Overall Study|Withdrawal by Subject|1|||
164162384|NCT00423332|592960468|FG001|Overall Study|Withdrawal by Subject|0|||
164162385|NCT00423332|592960467|FG000|Overall Study|Condition under investigation worsened|1|||
164162386|NCT00423332|592960468|FG001|Overall Study|Condition under investigation worsened|1|||
164162387|NCT00423332|592960467|FG000|Overall Study|Progressive at Week 6|0|||
164162388|NCT00423332|592960468|FG001|Overall Study|Progressive at Week 6|1|||
164162389|NCT00423332|592960467|FG000|Overall Study|Unblinded before 12 weeks|1|||
164162390|NCT00423332|592960468|FG001|Overall Study|Unblinded before 12 weeks|3|||
164162391|NCT02035202|592960469|FG000|Overall Study|Lost to Follow-up|8|||
164162392|NCT02035202|592960470|FG001|Overall Study|Lost to Follow-up|16|||
164162393|NCT02035202|592960471|FG002|Overall Study|Lost to Follow-up|2|||
164162394|NCT00402688|592960473|FG000|Overall Study|Adverse Event|12|||
164162395|NCT00402688|592960474|FG001|Overall Study|Adverse Event|9|||
164162396|NCT00402688|592960475|FG002|Overall Study|Adverse Event|3|||
164162397|NCT00402688|592960473|FG000|Overall Study|Withdrawal by Subject|3|||
164162398|NCT00402688|592960474|FG001|Overall Study|Withdrawal by Subject|1|||
164162399|NCT00402688|592960475|FG002|Overall Study|Withdrawal by Subject|1|||
164162400|NCT00402688|592960473|FG000|Overall Study|Physician Decision|0|||
164162401|NCT00402688|592960474|FG001|Overall Study|Physician Decision|0|||
164162402|NCT00402688|592960475|FG002|Overall Study|Physician Decision|1|||
164162403|NCT00402688|592960473|FG000|Overall Study|Lack of Efficacy|4|||
164162404|NCT00402688|592960474|FG001|Overall Study|Lack of Efficacy|4|||
164162405|NCT00402688|592960475|FG002|Overall Study|Lack of Efficacy|5|||
164162406|NCT00402688|592960473|FG000|Overall Study|Protocol Violation|1|||
164162407|NCT00402688|592960474|FG001|Overall Study|Protocol Violation|1|||
164162408|NCT00402688|592960475|FG002|Overall Study|Protocol Violation|1|||
164162409|NCT00402688|592960473|FG000|Overall Study|Lost to Follow-up|1|||
164162410|NCT00402688|592960474|FG001|Overall Study|Lost to Follow-up|0|||
164162411|NCT00402688|592960475|FG002|Overall Study|Lost to Follow-up|2|||
164162412|NCT00402688|592960473|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
164162413|NCT00402688|592960474|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
164162414|NCT00402688|592960475|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
164162415|NCT00402688|592960473|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
164162416|NCT00402688|592960474|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
164162417|NCT00402688|592960475|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
164162418|NCT00402688|592960473|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
164162419|NCT00402688|592960474|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
164162420|NCT00402688|592960475|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
164162421|NCT00758485|592960476|FG000|Overall Study|Lost to Follow-up|0|||
164162422|NCT00758485|592960477|FG001|Overall Study|Lost to Follow-up|1|||
164162423|NCT00758485|592960476|FG000|Overall Study|Not Treated|1|||
164162424|NCT00758485|592960477|FG001|Overall Study|Not Treated|2|||
164162425|NCT01136356|592960478|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
164162426|NCT01136356|592960479|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
164162427|NCT01136356|592960478|FG000|First 18-day Withdrawal|Physician Decision|1|||
164162428|NCT01136356|592960479|FG001|First 18-day Withdrawal|Physician Decision|0|||
164162429|NCT01136356|592960478|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
164162430|NCT01136356|592960479|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
164162431|NCT00656292|592960480|FG000|Overall Study|Withdrawal by Subject|2|||
164162432|NCT00656292|592960481|FG001|Overall Study|Withdrawal by Subject|3|||
164162433|NCT00656292|592960480|FG000|Overall Study|Screen failure|1|||
164162434|NCT00656292|592960481|FG001|Overall Study|Screen failure|2|||
164162435|NCT03259425|592960482|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
164162436|NCT04157296|592960483|FG000|Overall Study|Withdrawal by Subject|0|||
164162437|NCT04157296|592960484|FG001|Overall Study|Withdrawal by Subject|1|||
164162438|NCT04157296|592960483|FG000|Overall Study|Did not obtain second fMRI.|0|||
164162439|NCT04157296|592960484|FG001|Overall Study|Did not obtain second fMRI.|1|||
164162440|NCT04157296|592960483|FG000|Overall Study|MRI failed/no second fMRI|0|||
164162441|NCT04157296|592960484|FG001|Overall Study|MRI failed/no second fMRI|1|||
164162442|NCT02088905|592960487|FG000|Overall Study|Withdrawal by Subject|5|||
164162443|NCT02088905|592960488|FG001|Overall Study|Withdrawal by Subject|1|||
164162444|NCT02649439|592960494|FG000|Overall Study|Switched to alternative treatment|6|||
164162445|NCT02649439|592960495|FG001|Overall Study|Switched to alternative treatment|4|||
164162446|NCT02649439|592960494|FG000|Overall Study|Patient decision|1|||
164162447|NCT02649439|592960495|FG001|Overall Study|Patient decision|0|||
164162448|NCT02649439|592960494|FG000|Overall Study|Patient going out of country|1|||
164162449|NCT02649439|592960495|FG001|Overall Study|Patient going out of country|0|||
164162450|NCT02649439|592960494|FG000|Overall Study|To start finasteride|1|||
164162451|NCT02649439|592960495|FG001|Overall Study|To start finasteride|0|||
164162452|NCT02649439|592960494|FG000|Overall Study|Physician Decision|1|||
164162453|NCT02649439|592960495|FG001|Overall Study|Physician Decision|0|||
164162454|NCT02649439|592960494|FG000|Overall Study|Disease progression on study|12|||
164162455|NCT02649439|592960495|FG001|Overall Study|Disease progression on study|13|||
164162456|NCT02649439|592960494|FG000|Overall Study|Refused further treatment|1|||
164162457|NCT02649439|592960495|FG001|Overall Study|Refused further treatment|0|||
164162458|NCT02649439|592960494|FG000|Overall Study|Refused further follow up|2|||
164162459|NCT02649439|592960495|FG001|Overall Study|Refused further follow up|7|||
164162460|NCT02649439|592960494|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
164162461|NCT02649439|592960495|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
164162462|NCT02649439|592960494|FG000|Overall Study|No treatment, per protocol|1|||
164162463|NCT02649439|592960495|FG001|Overall Study|No treatment, per protocol|0|||
164162464|NCT02649439|592960494|FG000|Overall Study|PSA DT makes ineligible|0|||
164162465|NCT02649439|592960495|FG001|Overall Study|PSA DT makes ineligible|1|||
164162466|NCT02649439|592960494|FG000|Overall Study|Rising PSA No Mets|0|||
164162467|NCT02649439|592960495|FG001|Overall Study|Rising PSA No Mets|1|||
164162468|NCT02649439|592960494|FG000|Overall Study|Rising PSA|0|||
164162469|NCT02649439|592960495|FG001|Overall Study|Rising PSA|1|||
164162470|NCT02649439|592960494|FG000|Overall Study|Signed follow up protocol|0|||
164162471|NCT02649439|592960495|FG001|Overall Study|Signed follow up protocol|1|||
164162472|NCT02097238|592960498|FG000|Overall Study|Death|1|||
164162473|NCT02097238|592960498|FG000|Overall Study|Physician Decision|1|||
164162474|NCT02097238|592960498|FG000|Overall Study|Progressive Disease|17|||
164162475|NCT01282372|592960506|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
164162476|NCT01282372|592960506|FG000|Overall Study|Lost to Follow-up|23|||
164162477|NCT01282372|592960506|FG000|Overall Study|Withdrawal by Subject|11|||
164162478|NCT01282372|592960506|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
164162479|NCT01282372|592960506|FG000|Overall Study|Death|1|||
164162480|NCT01282372|592960506|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
164162481|NCT01282372|592960506|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
164162482|NCT01282372|592960506|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
164162483|NCT01282372|592960506|FG000|Overall Study|Adverse Event|12|||
164162484|NCT02993250|592960508|FG000|Overall Study|Lost to Follow-up|0|||
164162485|NCT02993250|592960509|FG001|Overall Study|Lost to Follow-up|1|||
164162486|NCT02861807|592960511|FG000|Overall Study|Lost to Follow-up|7|||
164162487|NCT02861807|592960512|FG001|Overall Study|Lost to Follow-up|6|||
164162488|NCT02861807|592960511|FG000|Overall Study|Withdrawal by Subject|5|||
164162489|NCT02861807|592960512|FG001|Overall Study|Withdrawal by Subject|8|||
164162490|NCT00568061|592960517|FG000|Overall Study|Inclusion / exclusion criteria|5|||
164162491|NCT00568061|592960518|FG001|Overall Study|Inclusion / exclusion criteria|1|||
164162492|NCT00568061|592960517|FG000|Overall Study|Adverse Event|0|||
164162493|NCT00568061|592960518|FG001|Overall Study|Adverse Event|1|||
164162494|NCT05027451|592960519|FG000|Overall Study|Lost to Follow-up|1|||
164162495|NCT05027451|592960520|FG001|Overall Study|Lost to Follow-up|1|||
164162496|NCT00356148|592960521|FG000|Overall Study|Reoperation within 30 days|2|||
164162497|NCT00356148|592960522|FG001|Overall Study|Reoperation within 30 days|1|||
164162498|NCT02693002|592960524|FG000|Overall Study|Withdrawal by Subject|1|||
164162499|NCT02693002|592960525|FG001|Overall Study|Withdrawal by Subject|0|||
164162500|NCT00812981|592960526|FG000|Overall Study|Other|0|||
164162501|NCT00812981|592960527|FG001|Overall Study|Other|1|||
164162502|NCT04666259|592960529|FG000|Treatment Phase|Physician Decision|9|||
164162503|NCT04666259|592960530|FG001|Treatment Phase|Physician Decision|3|||
164162504|NCT04666259|592960531|FG002|Treatment Phase|Physician Decision|3|||
164162505|NCT04666259|592960529|FG000|Treatment Phase|Adverse Event|3|||
164162506|NCT04666259|592960530|FG001|Treatment Phase|Adverse Event|1|||
164162507|NCT04666259|592960531|FG002|Treatment Phase|Adverse Event|0|||
164162508|NCT04666259|592960529|FG000|Treatment Phase|Subject decision|1|||
164162509|NCT04666259|592960530|FG001|Treatment Phase|Subject decision|2|||
164162510|NCT04666259|592960531|FG002|Treatment Phase|Subject decision|0|||
164162511|NCT04666259|592960529|FG000|Treatment Phase|Progressive disease|0|||
164162512|NCT04666259|592960530|FG001|Treatment Phase|Progressive disease|1|||
164162513|NCT04666259|592960531|FG002|Treatment Phase|Progressive disease|0|||
164162514|NCT04666259|592960529|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
164162515|NCT04666259|592960530|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
164162516|NCT04666259|592960531|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
164162517|NCT04666259|592960529|FG000|Safety Follow-up Phase|Physician Decision|2|||
164162518|NCT04666259|592960530|FG001|Safety Follow-up Phase|Physician Decision|0|||
164162519|NCT04666259|592960531|FG002|Safety Follow-up Phase|Physician Decision|0|||
164162520|NCT04666259|592960529|FG000|Safety Follow-up Phase|Subject decision|1|||
164162521|NCT04666259|592960530|FG001|Safety Follow-up Phase|Subject decision|0|||
164162522|NCT04666259|592960531|FG002|Safety Follow-up Phase|Subject decision|0|||
164162523|NCT04666259|592960529|FG000|Safety Follow-up Phase|Death|0|||
164162524|NCT04666259|592960530|FG001|Safety Follow-up Phase|Death|1|||
164162525|NCT04666259|592960531|FG002|Safety Follow-up Phase|Death|0|||
164162526|NCT02737930|592960532|FG000|Overall Study|Withdrawal by Subject|0|||
164162527|NCT02737930|592960533|FG001|Overall Study|Withdrawal by Subject|1|||
164162528|NCT04178122|592960534|FG000|Overall Study|Withdrawal by Subject|1|||
164162529|NCT04178122|592960535|FG001|Overall Study|Withdrawal by Subject|1|||
164162530|NCT04178122|592960534|FG000|Overall Study|Death|2|||
164162531|NCT04178122|592960535|FG001|Overall Study|Death|0|||
164162532|NCT04178122|592960534|FG000|Overall Study|Did not complete testing|3|||
164162533|NCT04178122|592960535|FG001|Overall Study|Did not complete testing|13|||
164162534|NCT03124407|592960536|FG000|Overall Study|Lost to Follow-up|1|||
164162535|NCT03124407|592960537|FG001|Overall Study|Lost to Follow-up|0|||
164162536|NCT03124407|592960538|FG002|Overall Study|Lost to Follow-up|0|||
164162537|NCT03124407|592960539|FG003|Overall Study|Lost to Follow-up|0|||
164162538|NCT03124407|592960536|FG000|Overall Study|Adverse Event|0|||
164162539|NCT03124407|592960537|FG001|Overall Study|Adverse Event|0|||
164162540|NCT03124407|592960538|FG002|Overall Study|Adverse Event|1|||
164162541|NCT03124407|592960539|FG003|Overall Study|Adverse Event|0|||
164162542|NCT05343364|592960540|FG000|Overall Study|Miscellaneous|0|||
164162543|NCT05343364|592960541|FG001|Overall Study|Miscellaneous|1|||
164162544|NCT01791894|592960542|FG000|Overall Study|Adverse Event|1|||
164162545|NCT00984542|592960545|FG000|Overall Study|disease progression|19|||
164162546|NCT00984542|592960545|FG000|Overall Study|toxicity|7|||
164162547|NCT00984542|592960545|FG000|Overall Study|Death|7|||
164162548|NCT00984542|592960545|FG000|Overall Study|complicating disease|3|||
164162549|NCT00984542|592960545|FG000|Overall Study|Withdrawal by Subject|3|||
164162550|NCT00984542|592960545|FG000|Overall Study|clinical deterioration|2|||
164162551|NCT01422889|592960546|FG000|Overall Study|No Data Entered for Study Stent|9|||
164162552|NCT01757184|592960547|FG000|Double-blind Period|Adverse Event|1|||
164162553|NCT01757184|592960548|FG001|Double-blind Period|Adverse Event|0|||
164162554|NCT01757184|592960549|FG002|Double-blind Period|Adverse Event|0|||
164162555|NCT01757184|592960550|FG003|Double-blind Period|Adverse Event|0|||
164162556|NCT01757184|592960547|FG000|Open-label Period|Lost to Follow-up|0|||
164162557|NCT01757184|592960548|FG001|Open-label Period|Lost to Follow-up|0|||
164162558|NCT01757184|592960549|FG002|Open-label Period|Lost to Follow-up|2|||
164162559|NCT01757184|592960550|FG003|Open-label Period|Lost to Follow-up|0|||
164162560|NCT01757184|592960547|FG000|Open-label Period|Withdrawal by Subject|0|||
164162561|NCT01757184|592960548|FG001|Open-label Period|Withdrawal by Subject|0|||
164162562|NCT01757184|592960549|FG002|Open-label Period|Withdrawal by Subject|1|||
164162563|NCT01757184|592960550|FG003|Open-label Period|Withdrawal by Subject|1|||
164162564|NCT01757184|592960547|FG000|Open-label Period|Discontinued by Sponsor|0|||
164162565|NCT01757184|592960548|FG001|Open-label Period|Discontinued by Sponsor|0|||
164162566|NCT01757184|592960549|FG002|Open-label Period|Discontinued by Sponsor|1|||
164162567|NCT01757184|592960550|FG003|Open-label Period|Discontinued by Sponsor|2|||
164162568|NCT04468347|592960553|FG000|Overall Study|Withdrawal by Subject|0|||
164162569|NCT04468347|592960554|FG001|Overall Study|Withdrawal by Subject|1|||
164162570|NCT04468347|592960555|FG002|Overall Study|Withdrawal by Subject|3|||
164162571|NCT04468347|592960556|FG003|Overall Study|Withdrawal by Subject|3|||
164162572|NCT04468347|592960553|FG000|Overall Study|Lost to Follow-up|0|||
164162573|NCT04468347|592960554|FG001|Overall Study|Lost to Follow-up|0|||
164162574|NCT04468347|592960555|FG002|Overall Study|Lost to Follow-up|1|||
164162575|NCT04468347|592960556|FG003|Overall Study|Lost to Follow-up|1|||
164162576|NCT04468347|592960553|FG000|Overall Study|Physician Decision|1|||
164162577|NCT04468347|592960554|FG001|Overall Study|Physician Decision|0|||
164162578|NCT04468347|592960555|FG002|Overall Study|Physician Decision|2|||
164162579|NCT04468347|592960556|FG003|Overall Study|Physician Decision|0|||
164162580|NCT04468347|592960553|FG000|Overall Study|Protocol Violation|1|||
164162581|NCT04468347|592960554|FG001|Overall Study|Protocol Violation|0|||
164162582|NCT04468347|592960555|FG002|Overall Study|Protocol Violation|0|||
164162583|NCT04468347|592960556|FG003|Overall Study|Protocol Violation|0|||
164162584|NCT00994461|592960557|FG000|Overall Study|Adverse Event|2|||
164162585|NCT00994461|592960558|FG001|Overall Study|Adverse Event|1|||
164162586|NCT00994461|592960559|FG002|Overall Study|Adverse Event|0|||
164162587|NCT04339062|592960560|FG000|Overall Study|Death|0|||
164162588|NCT04339062|592960561|FG001|Overall Study|Death|1|||
164162589|NCT04586244|592960562|FG000|Overall Study|Lost to Follow-up|1|||
164162590|NCT04586244|592960563|FG001|Overall Study|Lost to Follow-up|0|||
164162591|NCT04586244|592960564|FG002|Overall Study|Lost to Follow-up|0|||
164162592|NCT04586244|592960565|FG003|Overall Study|Lost to Follow-up|1|||
164162593|NCT04586244|592960566|FG004|Overall Study|Lost to Follow-up|0|||
164162594|NCT04586244|592960562|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
164162595|NCT04586244|592960563|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
164162596|NCT04586244|592960564|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
164162597|NCT04586244|592960565|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
164162598|NCT04586244|592960566|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
164162599|NCT02505217|592960567|FG000|Overall Study|Withdrawal by Subject|1|||
164162600|NCT02505217|592960568|FG001|Overall Study|Withdrawal by Subject|2|||
164162601|NCT00153179|592960574|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
164162602|NCT00153179|592960575|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
164162603|NCT00153179|592960576|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
164162604|NCT00153179|592960577|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
164162605|NCT03517540|592960578|FG000|Overall Study|Protocol Violation|2|||
164162606|NCT03517540|592960579|FG001|Overall Study|Protocol Violation|0|||
164162607|NCT03517540|592960580|FG002|Overall Study|Protocol Violation|0|||
164162608|NCT03517540|592960581|FG003|Overall Study|Protocol Violation|1|||
164162609|NCT03517540|592960578|FG000|Overall Study|Adverse Event|9|||
164162610|NCT03517540|592960579|FG001|Overall Study|Adverse Event|3|||
164162611|NCT03517540|592960580|FG002|Overall Study|Adverse Event|8|||
164162612|NCT03517540|592960581|FG003|Overall Study|Adverse Event|1|||
164162613|NCT03517540|592960578|FG000|Overall Study|Withdrawal by Subject|3|||
164162614|NCT03517540|592960579|FG001|Overall Study|Withdrawal by Subject|4|||
164162615|NCT03517540|592960580|FG002|Overall Study|Withdrawal by Subject|1|||
164162616|NCT03517540|592960581|FG003|Overall Study|Withdrawal by Subject|3|||
164162617|NCT00615550|592960586|FG000|Overall Study|Lost to Follow-up|6|||
164162618|NCT00615550|592960587|FG001|Overall Study|Lost to Follow-up|1|||
164162619|NCT01408303|592960588|FG000|Overall Study|Adverse Event|3|||
164162620|NCT01408303|592960589|FG001|Overall Study|Adverse Event|7|||
164162621|NCT01408303|592960590|FG002|Overall Study|Adverse Event|2|||
164162622|NCT01408303|592960588|FG000|Overall Study|Lost to Follow-up|0|||
164162623|NCT01408303|592960589|FG001|Overall Study|Lost to Follow-up|1|||
164162624|NCT01408303|592960590|FG002|Overall Study|Lost to Follow-up|2|||
164162625|NCT01408303|592960588|FG000|Overall Study|Withdrawal by Subject|2|||
164162626|NCT01408303|592960589|FG001|Overall Study|Withdrawal by Subject|3|||
164162627|NCT01408303|592960590|FG002|Overall Study|Withdrawal by Subject|1|||
164162628|NCT01408303|592960588|FG000|Overall Study|Protocol Violation|0|||
164162629|NCT01408303|592960589|FG001|Overall Study|Protocol Violation|1|||
164162630|NCT01408303|592960590|FG002|Overall Study|Protocol Violation|0|||
164162631|NCT01408303|592960588|FG000|Overall Study|Noncompliance|1|||
164162632|NCT01408303|592960589|FG001|Overall Study|Noncompliance|0|||
164162633|NCT01408303|592960590|FG002|Overall Study|Noncompliance|1|||
164162634|NCT01801865|592960591|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
164162635|NCT01801865|592960591|FG000|Overall Study|Physician Decision|7|||
164162636|NCT02644668|592960592|FG000|Overall Study|Adverse Event|2|||
164162637|NCT02644668|592960593|FG001|Overall Study|Adverse Event|0|||
164162638|NCT02644668|592960594|FG002|Overall Study|Adverse Event|1|||
164162639|NCT02644668|592960592|FG000|Overall Study|Protocol Violation|0|||
164162640|NCT02644668|592960593|FG001|Overall Study|Protocol Violation|0|||
164162641|NCT02644668|592960594|FG002|Overall Study|Protocol Violation|1|||
164162642|NCT02644668|592960592|FG000|Overall Study|Withdrawal by Subject|0|||
164162643|NCT02644668|592960593|FG001|Overall Study|Withdrawal by Subject|0|||
164162644|NCT02644668|592960594|FG002|Overall Study|Withdrawal by Subject|1|||
164162645|NCT01500382|592960597|FG000|Washout Period|Study site went out of business|0|||
164162646|NCT01500382|592960598|FG001|Washout Period|Study site went out of business|0|||
164162647|NCT01500382|592960599|FG002|Washout Period|Study site went out of business|1|||
164162648|NCT01500382|592960600|FG003|Washout Period|Study site went out of business|0|||
164162649|NCT05763875|592960601|FG000|Overall Study|Subject decision|5|||
164162650|NCT05763875|592960602|FG001|Overall Study|Subject decision|2|||
164162651|NCT05763875|592960603|FG002|Overall Study|Subject decision|1|||
164162652|NCT05763875|592960601|FG000|Overall Study|Lost to Follow-up|4|||
164162653|NCT05763875|592960602|FG001|Overall Study|Lost to Follow-up|1|||
164162654|NCT05763875|592960603|FG002|Overall Study|Lost to Follow-up|2|||
164162655|NCT05763875|592960601|FG000|Overall Study|Adverse Event|1|||
164162656|NCT05763875|592960602|FG001|Overall Study|Adverse Event|0|||
164162657|NCT05763875|592960603|FG002|Overall Study|Adverse Event|0|||
164162658|NCT00068393|592962252|FG000|Overall Study|Adverse Event|2|||
164162659|NCT00068393|592962252|FG000|Overall Study|Death|3|||
164162660|NCT00068393|592962252|FG000|Overall Study|Withdrawal by Subject|3|||
164162661|NCT00068393|592962252|FG000|Overall Study|Alternative treatment|1|||
164162662|NCT00068393|592962252|FG000|Overall Study|Quality of life worsening|1|||
164162663|NCT01399047|592962253|FG000|Overall Study|Withdrawal by Subject|0|||
164162664|NCT01399047|592962254|FG001|Overall Study|Withdrawal by Subject|1|||
164162665|NCT03300505|592962260|FG000|Overall Study|Death|0|||
164162666|NCT03300505|592962261|FG001|Overall Study|Death|1|||
164162667|NCT03300505|592962262|FG002|Overall Study|Death|0|||
164162668|NCT03300505|592962260|FG000|Overall Study|Withdrawal by Subject|0|||
164162669|NCT03300505|592962261|FG001|Overall Study|Withdrawal by Subject|1|||
164162670|NCT03300505|592962262|FG002|Overall Study|Withdrawal by Subject|1|||
164162671|NCT03300505|592962260|FG000|Overall Study|Sponsor Termination|0|||
164162672|NCT03300505|592962261|FG001|Overall Study|Sponsor Termination|1|||
164162673|NCT03300505|592962262|FG002|Overall Study|Sponsor Termination|0|||
164162674|NCT03300505|592962260|FG000|Overall Study|Adverse Event|0|||
164162675|NCT03300505|592962261|FG001|Overall Study|Adverse Event|0|||
164162676|NCT03300505|592962262|FG002|Overall Study|Adverse Event|2|||
164162677|NCT01108341|592962265|FG000|Overall Study|Death|2|||
164162678|NCT01108341|592962265|FG000|Overall Study|Withdrawal by Subject|1|||
164162679|NCT01108341|592962265|FG000|Overall Study|Lost to Follow-up|1|||
164162680|NCT01108341|592962265|FG000|Overall Study|Other|1|||
164162681|NCT00769067|592962269|FG000|Overall Study|Death|89|||
164162682|NCT00769067|592962270|FG001|Overall Study|Death|86|||
164162683|NCT00769067|592962269|FG000|Overall Study|Lost to Follow-up|3|||
164162684|NCT00769067|592962270|FG001|Overall Study|Lost to Follow-up|1|||
164162685|NCT00769067|592962269|FG000|Overall Study|Study terminated by sponsor|1|||
164162686|NCT00769067|592962270|FG001|Overall Study|Study terminated by sponsor|3|||
164162687|NCT00769067|592962269|FG000|Overall Study|Other|1|||
164162688|NCT00769067|592962270|FG001|Overall Study|Other|3|||
164162689|NCT00769067|592962269|FG000|Overall Study|Withdrawal by Subject|0|||
164162690|NCT00769067|592962270|FG001|Overall Study|Withdrawal by Subject|1|||
164162691|NCT04981470|592962273|FG000|Overall Study|Device failure in all 4 patients|4|||
164162692|NCT04402138|592962274|FG000|Overall Study|Progressive Disease|2|||
164162693|NCT04402138|592962274|FG000|Overall Study|Adverse Event|1|||
164162694|NCT03056638|592962277|FG000|Overall Study|Death|1|||
164162695|NCT03056638|592962278|FG001|Overall Study|Death|0|||
164162696|NCT00784238|592962279|FG000|Overall Study|Adverse Event|14|||
164162697|NCT00784238|592962279|FG000|Overall Study|Death|2|||
164162698|NCT00784238|592962279|FG000|Overall Study|Lack of Efficacy|33|||
164162699|NCT00784238|592962279|FG000|Overall Study|Lost to Follow-up|29|||
164162700|NCT00784238|592962279|FG000|Overall Study|Pregnancy|1|||
164162701|NCT00784238|592962279|FG000|Overall Study|Withdrawal by Subject|26|||
164162702|NCT00784238|592962279|FG000|Overall Study|Other|14|||
164162703|NCT02530125|592962280|FG000|Completed Treatment|Early termination of study|1|||
164162704|NCT02530125|592962280|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
164162705|NCT00468481|592962282|FG000|Overall Study|Adverse Event|13|||
164162706|NCT00468481|592962283|FG001|Overall Study|Adverse Event|3|||
164162707|NCT00468481|592962282|FG000|Overall Study|Lost to Follow-up|25|||
164162708|NCT00468481|592962283|FG001|Overall Study|Lost to Follow-up|8|||
164162709|NCT00468481|592962282|FG000|Overall Study|Pregnancy|2|||
164162710|NCT00468481|592962283|FG001|Overall Study|Pregnancy|0|||
164162711|NCT00468481|592962282|FG000|Overall Study|Protocol Violation|18|||
164162712|NCT00468481|592962283|FG001|Overall Study|Protocol Violation|8|||
164162713|NCT00468481|592962282|FG000|Overall Study|Withdrawal by Subject|12|||
164162714|NCT00468481|592962283|FG001|Overall Study|Withdrawal by Subject|3|||
164162715|NCT00468481|592962282|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
164162716|NCT00468481|592962283|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
164162717|NCT00468481|592962282|FG000|Overall Study|Prohibited Medication|1|||
164162718|NCT00468481|592962283|FG001|Overall Study|Prohibited Medication|1|||
164162719|NCT00468481|592962282|FG000|Overall Study|Egg Donor|1|||
164162720|NCT00468481|592962283|FG001|Overall Study|Egg Donor|0|||
164162721|NCT00468481|592962282|FG000|Overall Study|Moved out of area|4|||
164162722|NCT00468481|592962283|FG001|Overall Study|Moved out of area|1|||
164162723|NCT00468481|592962282|FG000|Overall Study|Non-Compliance|5|||
164162724|NCT00468481|592962283|FG001|Overall Study|Non-Compliance|0|||
164162725|NCT00468481|592962282|FG000|Overall Study|Other|6|||
164162726|NCT00468481|592962283|FG001|Overall Study|Other|0|||
164162727|NCT00078767|592962284|FG000|Overall Study|Withdrawal by Subject|1|||
164162728|NCT00078767|592962285|FG001|Overall Study|Withdrawal by Subject|1|||
164162729|NCT00728468|592962286|FG000|Overall Study|Enrolled but not treated|1|||
164162730|NCT00728468|592962286|FG000|Overall Study|Death|1|||
164162731|NCT00728468|592962286|FG000|Overall Study|Protocol Violation|4|||
164162732|NCT00728468|592962286|FG000|Overall Study|Objective progression or relapse|9|||
164162733|NCT00728468|592962286|FG000|Overall Study|Study terminated by sponsor|1|||
164162734|NCT00596687|592962287|FG000|Overall Study|< 24 hours of insulin treatment|8|||
164162735|NCT00596687|592962288|FG001|Overall Study|< 24 hours of insulin treatment|6|||
164162736|NCT00596687|592962287|FG000|Overall Study|continuous insulin infusion during TPN|2|||
164162737|NCT00596687|592962288|FG001|Overall Study|continuous insulin infusion during TPN|1|||
164162738|NCT00596687|592962287|FG000|Overall Study|Withdrawal by Subject|3|||
164162739|NCT00596687|592962288|FG001|Overall Study|Withdrawal by Subject|1|||
164162740|NCT00596687|592962287|FG000|Overall Study|cancelled surgery|1|||
164162741|NCT00596687|592962288|FG001|Overall Study|cancelled surgery|1|||
164162742|NCT06098339|592962289|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
164162743|NCT06098339|592962290|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
164162744|NCT06098339|592962289|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
164162745|NCT06098339|592962290|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
164162746|NCT03831113|592962291|FG000|Overall Study|Withdrawal by Subject|0|||
164162747|NCT03831113|592962292|FG001|Overall Study|Withdrawal by Subject|2|||
164162748|NCT03831113|592962291|FG000|Overall Study|Protocol Violation|0|||
164162749|NCT03831113|592962292|FG001|Overall Study|Protocol Violation|9|||
164162750|NCT03508726|592962293|FG000|Overall Study|Withdrawal by Subject|0|||
164162751|NCT03508726|592962294|FG001|Overall Study|Withdrawal by Subject|1|||
164162752|NCT02498444|592962295|FG000|Overall Study|Withdrawal by Subject|3|||
164162753|NCT02498444|592962296|FG001|Overall Study|Withdrawal by Subject|0|||
164162754|NCT02498444|592962295|FG000|Overall Study|Physician Decision|1|||
164162755|NCT02498444|592962296|FG001|Overall Study|Physician Decision|0|||
164162756|NCT05656534|592962299|FG000|Overall Study|Withdrawal by Subject|1|||
164162757|NCT05656534|592962300|FG001|Overall Study|Withdrawal by Subject|1|||
164162758|NCT05656534|592962301|FG002|Overall Study|Withdrawal by Subject|0|||
164162759|NCT05656534|592962302|FG003|Overall Study|Withdrawal by Subject|0|||
164162760|NCT05656534|592962299|FG000|Overall Study|Physician Decision|1|||
164162761|NCT05656534|592962300|FG001|Overall Study|Physician Decision|1|||
164162762|NCT05656534|592962301|FG002|Overall Study|Physician Decision|0|||
164162763|NCT05656534|592962302|FG003|Overall Study|Physician Decision|0|||
164162764|NCT00302328|592962310|FG000|Overall Study|Physician Decision|0|||
164162765|NCT00302328|592962311|FG001|Overall Study|Physician Decision|1|||
164162766|NCT00302328|592962312|FG002|Overall Study|Physician Decision|0|||
164162767|NCT00386360|592962317|FG000|Overall Study|Adverse Event|4|||
164162768|NCT00386360|592962318|FG001|Overall Study|Adverse Event|2|||
164162769|NCT00386360|592962317|FG000|Overall Study|Physician Decision|2|||
164162770|NCT00386360|592962318|FG001|Overall Study|Physician Decision|2|||
164162771|NCT00386360|592962317|FG000|Overall Study|Lost to Follow-up|0|||
164162772|NCT00386360|592962318|FG001|Overall Study|Lost to Follow-up|2|||
164162773|NCT00386360|592962317|FG000|Overall Study|Protocol Violation|0|||
164162774|NCT00386360|592962318|FG001|Overall Study|Protocol Violation|3|||
164162775|NCT00386360|592962317|FG000|Overall Study|Withdrawal by Subject|3|||
164162776|NCT00386360|592962318|FG001|Overall Study|Withdrawal by Subject|6|||
164162777|NCT00386360|592962317|FG000|Overall Study|Did not take any study medication|0|||
164162778|NCT00386360|592962318|FG001|Overall Study|Did not take any study medication|2|||
164162779|NCT02490371|592962321|FG000|Overall Study|Lost to Follow-up|1|||
164162780|NCT02490371|592962322|FG001|Overall Study|Lost to Follow-up|1|||
164162781|NCT01718535|592962323|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
164162782|NCT01718535|592962324|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
164162783|NCT01718535|592962325|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
164162784|NCT01718535|592962326|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
164162785|NCT01718535|592962327|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
164162786|NCT01718535|592962328|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
164162787|NCT01718535|592962329|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
164162788|NCT01718535|592962330|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
164162789|NCT01718535|592962331|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
164162790|NCT01718535|592962332|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
164162791|NCT02476578|592962335|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
164162792|NCT02476578|592962336|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
164162793|NCT02476578|592962335|FG000|Overall Study|Lost to Follow-up|6|||
164162794|NCT02476578|592962336|FG001|Overall Study|Lost to Follow-up|13|||
164162795|NCT01073605|592962337|FG000|Overall Study|Ongoing at Cutoff Date|1|||
164162796|NCT01073605|592962338|FG001|Overall Study|Ongoing at Cutoff Date|1|||
164162797|NCT01073605|592962339|FG002|Overall Study|Ongoing at Cutoff Date|0|||
164162798|NCT01073605|592962337|FG000|Overall Study|Adverse Event|2|||
164162799|NCT01073605|592962338|FG001|Overall Study|Adverse Event|1|||
164162800|NCT01073605|592962339|FG002|Overall Study|Adverse Event|0|||
164162801|NCT01073605|592962337|FG000|Overall Study|Lost to Follow-up|3|||
164162802|NCT01073605|592962338|FG001|Overall Study|Lost to Follow-up|4|||
164162803|NCT01073605|592962339|FG002|Overall Study|Lost to Follow-up|9|||
164162804|NCT01073605|592962337|FG000|Overall Study|Other|25|||
164162805|NCT01073605|592962338|FG001|Overall Study|Other|21|||
164162806|NCT01073605|592962339|FG002|Overall Study|Other|29|||
164162807|NCT01073605|592962337|FG000|Overall Study|Withdrawal by Subject|31|||
164162808|NCT01073605|592962338|FG001|Overall Study|Withdrawal by Subject|39|||
164162809|NCT01073605|592962339|FG002|Overall Study|Withdrawal by Subject|22|||
164162810|NCT01073605|592962337|FG000|Overall Study|Randomized But Not Treated|0|||
164162811|NCT01073605|592962338|FG001|Overall Study|Randomized But Not Treated|1|||
164162812|NCT01073605|592962339|FG002|Overall Study|Randomized But Not Treated|1|||
164162813|NCT03018080|592962340|FG000|Overall Study|Death|12|||
164162814|NCT03018080|592962341|FG001|Overall Study|Death|19|||
164162815|NCT03491462|592962342|FG000|Overall Study|Lost to Follow-up|2|||
164162816|NCT03491462|592962343|FG001|Overall Study|Lost to Follow-up|0|||
164162817|NCT03491462|592962342|FG000|Overall Study|Adverse Event|11|||
164162818|NCT03491462|592962343|FG001|Overall Study|Adverse Event|1|||
164162819|NCT03491462|592962342|FG000|Overall Study|Physician Decision|3|||
164162820|NCT03491462|592962343|FG001|Overall Study|Physician Decision|0|||
164162821|NCT03491462|592962342|FG000|Overall Study|Withdrawal by Subject|22|||
164162822|NCT03491462|592962343|FG001|Overall Study|Withdrawal by Subject|15|||
164162823|NCT00740792|592962344|FG000|Overall Study|Adverse Event|3|||
164162824|NCT00740792|592962345|FG001|Overall Study|Adverse Event|1|||
164162825|NCT00740792|592962346|FG002|Overall Study|Adverse Event|1|||
164162826|NCT00740792|592962347|FG003|Overall Study|Adverse Event|3|||
164162827|NCT00740792|592962344|FG000|Overall Study|Lack of Efficacy|1|||
164162828|NCT00740792|592962345|FG001|Overall Study|Lack of Efficacy|1|||
164162829|NCT00740792|592962346|FG002|Overall Study|Lack of Efficacy|0|||
164162830|NCT00740792|592962347|FG003|Overall Study|Lack of Efficacy|3|||
164162831|NCT00740792|592962344|FG000|Overall Study|Lost to Follow-up|2|||
164162832|NCT00740792|592962345|FG001|Overall Study|Lost to Follow-up|1|||
164162833|NCT00740792|592962346|FG002|Overall Study|Lost to Follow-up|0|||
164162834|NCT00740792|592962347|FG003|Overall Study|Lost to Follow-up|0|||
164162835|NCT00740792|592962344|FG000|Overall Study|Protocol Violation|0|||
164162836|NCT00740792|592962345|FG001|Overall Study|Protocol Violation|1|||
164162837|NCT00740792|592962346|FG002|Overall Study|Protocol Violation|0|||
164162838|NCT00740792|592962347|FG003|Overall Study|Protocol Violation|2|||
164162839|NCT00740792|592962344|FG000|Overall Study|Withdrawal by Subject|1|||
164162840|NCT00740792|592962345|FG001|Overall Study|Withdrawal by Subject|1|||
164162841|NCT00740792|592962346|FG002|Overall Study|Withdrawal by Subject|0|||
164162842|NCT00740792|592962347|FG003|Overall Study|Withdrawal by Subject|0|||
164162843|NCT00740792|592962344|FG000|Overall Study|administrative|3|||
164162844|NCT00740792|592962345|FG001|Overall Study|administrative|3|||
164162845|NCT00740792|592962346|FG002|Overall Study|administrative|8|||
164162846|NCT00740792|592962347|FG003|Overall Study|administrative|2|||
164162847|NCT00026494|592962350|FG000|Overall Study|Withdrawal by Subject|1|||
164162848|NCT00026494|592962351|FG001|Overall Study|Withdrawal by Subject|0|||
164162849|NCT00026494|592962352|FG002|Overall Study|Withdrawal by Subject|1|||
164162850|NCT00026494|592962353|FG003|Overall Study|Withdrawal by Subject|0|||
164162851|NCT00026494|592962350|FG000|Overall Study|Patient non-compliance|1|||
164162852|NCT00026494|592962351|FG001|Overall Study|Patient non-compliance|0|||
164162853|NCT00026494|592962352|FG002|Overall Study|Patient non-compliance|0|||
164162854|NCT00026494|592962353|FG003|Overall Study|Patient non-compliance|0|||
164162855|NCT00026494|592962350|FG000|Overall Study|Patient not treated|0|||
164162856|NCT00026494|592962351|FG001|Overall Study|Patient not treated|0|||
164162857|NCT00026494|592962352|FG002|Overall Study|Patient not treated|2|||
164162858|NCT00026494|592962353|FG003|Overall Study|Patient not treated|0|||
164162859|NCT00026494|592962350|FG000|Overall Study|Clinical progression|0|||
164162860|NCT00026494|592962351|FG001|Overall Study|Clinical progression|0|||
164162861|NCT00026494|592962352|FG002|Overall Study|Clinical progression|3|||
164162862|NCT00026494|592962353|FG003|Overall Study|Clinical progression|0|||
164162863|NCT01455597|592962354|FG000|Overall Study|Adverse Event|7|||
164162864|NCT01455597|592962355|FG001|Overall Study|Adverse Event|0|||
164162865|NCT01455597|592962356|FG002|Overall Study|Adverse Event|5|||
164162866|NCT01455597|592962357|FG003|Overall Study|Adverse Event|1|||
164162867|NCT01455597|592962354|FG000|Overall Study|Lack of Efficacy|0|||
164162868|NCT01455597|592962355|FG001|Overall Study|Lack of Efficacy|1|||
164162869|NCT01455597|592962356|FG002|Overall Study|Lack of Efficacy|2|||
164162870|NCT01455597|592962357|FG003|Overall Study|Lack of Efficacy|0|||
164162871|NCT01455597|592962354|FG000|Overall Study|Lost to Follow-up|3|||
164162872|NCT01455597|592962355|FG001|Overall Study|Lost to Follow-up|0|||
164162873|NCT01455597|592962356|FG002|Overall Study|Lost to Follow-up|2|||
164162874|NCT01455597|592962357|FG003|Overall Study|Lost to Follow-up|1|||
164162875|NCT01455597|592962354|FG000|Overall Study|Withdrew Consent|6|||
164162876|NCT01455597|592962355|FG001|Overall Study|Withdrew Consent|5|||
164162877|NCT01455597|592962356|FG002|Overall Study|Withdrew Consent|8|||
164162878|NCT01455597|592962357|FG003|Overall Study|Withdrew Consent|5|||
164162879|NCT01455597|592962354|FG000|Overall Study|Reason not Specified|1|||
164162880|NCT01455597|592962355|FG001|Overall Study|Reason not Specified|2|||
164162881|NCT01455597|592962356|FG002|Overall Study|Reason not Specified|3|||
164162882|NCT01455597|592962357|FG003|Overall Study|Reason not Specified|3|||
164162883|NCT03412734|592962361|FG000|Overall Study|Incorrect labeling of samples|2|||
164162884|NCT03412734|592962362|FG001|Overall Study|Incorrect labeling of samples|0|||
164162885|NCT03412734|592962361|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
164162886|NCT03412734|592962362|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
164162887|NCT03777436|592962363|FG000|Placebo-controlled Phase|Adverse Event|8|||
164162888|NCT03777436|592962364|FG001|Placebo-controlled Phase|Adverse Event|10|||
164162889|NCT03777436|592962365|FG002|Placebo-controlled Phase|Adverse Event|0|||
164162890|NCT03777436|592962363|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
164162891|NCT03777436|592962364|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
164162892|NCT03777436|592962365|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
164162893|NCT03777436|592962363|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
164162894|NCT03777436|592962364|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
164162895|NCT03777436|592962365|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
164162896|NCT03777436|592962363|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
164162897|NCT03777436|592962364|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
164162898|NCT03777436|592962365|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
164162899|NCT03777436|592962363|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
164162900|NCT03777436|592962364|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
164162901|NCT03777436|592962365|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
164162902|NCT03777436|592962363|FG000|Placebo-controlled Phase|Physician Decision|0|||
164162903|NCT03777436|592962364|FG001|Placebo-controlled Phase|Physician Decision|1|||
164162904|NCT03777436|592962365|FG002|Placebo-controlled Phase|Physician Decision|0|||
164162905|NCT03777436|592962363|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
164162906|NCT03777436|592962364|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
164162907|NCT03777436|592962365|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
164162908|NCT03777436|592962363|FG000|Apremilast Extension Phase|Adverse Event|0|||
164162909|NCT03777436|592962364|FG001|Apremilast Extension Phase|Adverse Event|0|||
164162910|NCT03777436|592962365|FG002|Apremilast Extension Phase|Adverse Event|6|||
164162911|NCT03777436|592962363|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
164162912|NCT03777436|592962364|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
164162913|NCT03777436|592962365|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
164162914|NCT03777436|592962363|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
164162915|NCT03777436|592962364|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
164162916|NCT03777436|592962365|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
164162917|NCT03777436|592962363|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
164162918|NCT03777436|592962364|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
164162919|NCT03777436|592962365|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
164162920|NCT03777436|592962363|FG000|Apremilast Extension Phase|Miscellaneous|0|||
164162921|NCT03777436|592962364|FG001|Apremilast Extension Phase|Miscellaneous|0|||
164162922|NCT03777436|592962365|FG002|Apremilast Extension Phase|Miscellaneous|1|||
164162923|NCT00685399|592962366|FG000|Treatment Period 1|Withdrawal by Subject|2|||
164162924|NCT00685399|592962367|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164162925|NCT00685399|592962368|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164162926|NCT00685399|592962369|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164162927|NCT00685399|592962370|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164162928|NCT00685399|592962371|FG005|Treatment Period 1|Withdrawal by Subject|0|||
164162929|NCT00685399|592962372|FG006|Treatment Period 1|Withdrawal by Subject|0|||
164162930|NCT00685399|592962373|FG007|Treatment Period 1|Withdrawal by Subject|0|||
164162931|NCT00685399|592962366|FG000|Treatment Period 1|Protocol Violation|1|||
164162932|NCT00685399|592962367|FG001|Treatment Period 1|Protocol Violation|0|||
164162933|NCT00685399|592962368|FG002|Treatment Period 1|Protocol Violation|0|||
164162934|NCT00685399|592962369|FG003|Treatment Period 1|Protocol Violation|0|||
164162935|NCT00685399|592962370|FG004|Treatment Period 1|Protocol Violation|0|||
164162936|NCT00685399|592962371|FG005|Treatment Period 1|Protocol Violation|0|||
164162937|NCT00685399|592962372|FG006|Treatment Period 1|Protocol Violation|0|||
164162938|NCT00685399|592962373|FG007|Treatment Period 1|Protocol Violation|0|||
164162939|NCT00685399|592962366|FG000|Treatment Period 1|Administrative|2|||
164162940|NCT00685399|592962367|FG001|Treatment Period 1|Administrative|0|||
164162941|NCT00685399|592962368|FG002|Treatment Period 1|Administrative|0|||
164162942|NCT00685399|592962369|FG003|Treatment Period 1|Administrative|0|||
164162943|NCT00685399|592962370|FG004|Treatment Period 1|Administrative|0|||
164162944|NCT00685399|592962371|FG005|Treatment Period 1|Administrative|0|||
164162945|NCT00685399|592962372|FG006|Treatment Period 1|Administrative|0|||
164162946|NCT00685399|592962373|FG007|Treatment Period 1|Administrative|0|||
164162947|NCT00685399|592962366|FG000|Treatment Period 1|Lack of Efficacy|1|||
164162948|NCT00685399|592962367|FG001|Treatment Period 1|Lack of Efficacy|0|||
164162949|NCT00685399|592962368|FG002|Treatment Period 1|Lack of Efficacy|0|||
164162950|NCT00685399|592962369|FG003|Treatment Period 1|Lack of Efficacy|0|||
164162951|NCT00685399|592962370|FG004|Treatment Period 1|Lack of Efficacy|0|||
164162952|NCT00685399|592962371|FG005|Treatment Period 1|Lack of Efficacy|0|||
164162953|NCT00685399|592962372|FG006|Treatment Period 1|Lack of Efficacy|0|||
164162954|NCT00685399|592962373|FG007|Treatment Period 1|Lack of Efficacy|0|||
164162955|NCT00685399|592962366|FG000|Treatment Period 2|Administrative Problems|0|||
164162956|NCT00685399|592962367|FG001|Treatment Period 2|Administrative Problems|2|||
164162957|NCT00685399|592962368|FG002|Treatment Period 2|Administrative Problems|1|||
164162958|NCT00685399|592962369|FG003|Treatment Period 2|Administrative Problems|0|||
164162959|NCT00685399|592962370|FG004|Treatment Period 2|Administrative Problems|0|||
164162960|NCT00685399|592962371|FG005|Treatment Period 2|Administrative Problems|0|||
164162961|NCT00685399|592962372|FG006|Treatment Period 2|Administrative Problems|0|||
164162962|NCT00685399|592962373|FG007|Treatment Period 2|Administrative Problems|0|||
164162963|NCT00685399|592962366|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164162964|NCT00685399|592962367|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164162965|NCT00685399|592962368|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164162966|NCT00685399|592962369|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164162967|NCT00685399|592962370|FG004|Treatment Period 2|Withdrawal by Subject|0|||
164162968|NCT00685399|592962371|FG005|Treatment Period 2|Withdrawal by Subject|0|||
164162969|NCT00685399|592962372|FG006|Treatment Period 2|Withdrawal by Subject|0|||
164162970|NCT00685399|592962373|FG007|Treatment Period 2|Withdrawal by Subject|2|||
164162971|NCT00685399|592962366|FG000|Treatment Period 2|Adverse Event|0|||
164162972|NCT00685399|592962367|FG001|Treatment Period 2|Adverse Event|0|||
164162973|NCT00685399|592962368|FG002|Treatment Period 2|Adverse Event|0|||
164162974|NCT00685399|592962369|FG003|Treatment Period 2|Adverse Event|0|||
164162975|NCT00685399|592962370|FG004|Treatment Period 2|Adverse Event|0|||
164162976|NCT00685399|592962371|FG005|Treatment Period 2|Adverse Event|1|||
164162977|NCT00685399|592962372|FG006|Treatment Period 2|Adverse Event|0|||
164162978|NCT00685399|592962373|FG007|Treatment Period 2|Adverse Event|0|||
164162979|NCT00685399|592962366|FG000|Treatment Period 2|Lack of Efficacy|0|||
164162980|NCT00685399|592962367|FG001|Treatment Period 2|Lack of Efficacy|10|||
164162981|NCT00685399|592962368|FG002|Treatment Period 2|Lack of Efficacy|2|||
164162982|NCT00685399|592962369|FG003|Treatment Period 2|Lack of Efficacy|0|||
164162983|NCT00685399|592962370|FG004|Treatment Period 2|Lack of Efficacy|0|||
164162984|NCT00685399|592962371|FG005|Treatment Period 2|Lack of Efficacy|1|||
164162985|NCT00685399|592962372|FG006|Treatment Period 2|Lack of Efficacy|0|||
164162986|NCT00685399|592962373|FG007|Treatment Period 2|Lack of Efficacy|0|||
164162987|NCT00685399|592962366|FG000|Extension|Administrative Issues|0|||
164162988|NCT00685399|592962367|FG001|Extension|Administrative Issues|0|||
164162989|NCT00685399|592962368|FG002|Extension|Administrative Issues|0|||
164162990|NCT00685399|592962369|FG003|Extension|Administrative Issues|1|||
164162991|NCT00685399|592962370|FG004|Extension|Administrative Issues|0|||
164162992|NCT00685399|592962371|FG005|Extension|Administrative Issues|0|||
164162993|NCT00685399|592962372|FG006|Extension|Administrative Issues|0|||
164162994|NCT00685399|592962373|FG007|Extension|Administrative Issues|0|||
164162995|NCT00685399|592962366|FG000|Extension|Withdrawal by Subject|0|||
164162996|NCT00685399|592962367|FG001|Extension|Withdrawal by Subject|0|||
164162997|NCT00685399|592962368|FG002|Extension|Withdrawal by Subject|0|||
164162998|NCT00685399|592962369|FG003|Extension|Withdrawal by Subject|1|||
164162999|NCT00685399|592962370|FG004|Extension|Withdrawal by Subject|0|||
164163000|NCT00685399|592962371|FG005|Extension|Withdrawal by Subject|0|||
164163001|NCT00685399|592962372|FG006|Extension|Withdrawal by Subject|0|||
164163002|NCT00685399|592962373|FG007|Extension|Withdrawal by Subject|0|||
164163003|NCT00685399|592962366|FG000|Extension|Protocol Violation|0|||
164163004|NCT00685399|592962367|FG001|Extension|Protocol Violation|0|||
164163005|NCT00685399|592962368|FG002|Extension|Protocol Violation|0|||
164163006|NCT00685399|592962369|FG003|Extension|Protocol Violation|1|||
164163007|NCT00685399|592962370|FG004|Extension|Protocol Violation|0|||
164163008|NCT00685399|592962371|FG005|Extension|Protocol Violation|0|||
164163009|NCT00685399|592962372|FG006|Extension|Protocol Violation|0|||
164163010|NCT00685399|592962373|FG007|Extension|Protocol Violation|0|||
164163011|NCT00685399|592962366|FG000|Extension|Lack of Efficacy|0|||
164163012|NCT00685399|592962367|FG001|Extension|Lack of Efficacy|0|||
164163013|NCT00685399|592962368|FG002|Extension|Lack of Efficacy|0|||
164163014|NCT00685399|592962369|FG003|Extension|Lack of Efficacy|2|||
164163015|NCT00685399|592962370|FG004|Extension|Lack of Efficacy|0|||
164163016|NCT00685399|592962371|FG005|Extension|Lack of Efficacy|0|||
164163017|NCT00685399|592962372|FG006|Extension|Lack of Efficacy|0|||
164163018|NCT00685399|592962373|FG007|Extension|Lack of Efficacy|0|||
164163019|NCT00685399|592962366|FG000|Extension|Adverse Event|0|||
164163020|NCT00685399|592962367|FG001|Extension|Adverse Event|0|||
164163021|NCT00685399|592962368|FG002|Extension|Adverse Event|0|||
164163022|NCT00685399|592962369|FG003|Extension|Adverse Event|2|||
164163023|NCT00685399|592962370|FG004|Extension|Adverse Event|0|||
164163024|NCT00685399|592962371|FG005|Extension|Adverse Event|0|||
164163025|NCT00685399|592962372|FG006|Extension|Adverse Event|0|||
164163026|NCT00685399|592962373|FG007|Extension|Adverse Event|0|||
164163027|NCT03363776|592962374|FG000|Overall Study|Progressive disease|2|||
164163028|NCT03363776|592962375|FG001|Overall Study|Progressive disease|3|||
164163029|NCT03363776|592962376|FG002|Overall Study|Progressive disease|1|||
164163030|NCT03363776|592962374|FG000|Overall Study|Study drug toxicity|0|||
164163031|NCT03363776|592962375|FG001|Overall Study|Study drug toxicity|0|||
164163032|NCT03363776|592962376|FG002|Overall Study|Study drug toxicity|1|||
164163033|NCT03363776|592962374|FG000|Overall Study|Death|1|||
164163034|NCT03363776|592962375|FG001|Overall Study|Death|0|||
164163035|NCT03363776|592962376|FG002|Overall Study|Death|0|||
164163036|NCT01562782|592962377|FG000|Overall Study|Withdrawal by Subject|3|||
164163037|NCT01562782|592962378|FG001|Overall Study|Withdrawal by Subject|3|||
164163038|NCT01562782|592962377|FG000|Overall Study|screen failure|1|||
164163039|NCT01562782|592962378|FG001|Overall Study|screen failure|2|||
164163040|NCT01421225|592962383|FG000|Overall Study|Withdrawal by Subject|0|||
164163041|NCT01421225|592962384|FG001|Overall Study|Withdrawal by Subject|1|||
164163042|NCT02343939|592962400|FG000|Overall Study|Death|0|||
164163043|NCT02343939|592962401|FG001|Overall Study|Death|15|||
164163044|NCT02343939|592962402|FG002|Overall Study|Death|4|||
164163045|NCT02343939|592962403|FG003|Overall Study|Death|2|||
164163046|NCT02343939|592962404|FG004|Overall Study|Death|5|||
164163047|NCT02343939|592962405|FG005|Overall Study|Death|11|||
164163048|NCT02343939|592962406|FG006|Overall Study|Death|8|||
164163049|NCT02343939|592962407|FG007|Overall Study|Death|22|||
164163050|NCT02343939|592962408|FG008|Overall Study|Death|1|||
164163051|NCT02343939|592962400|FG000|Overall Study|Study terminated by sponsor|0|||
164163052|NCT02343939|592962401|FG001|Overall Study|Study terminated by sponsor|27|||
164163053|NCT02343939|592962402|FG002|Overall Study|Study terminated by sponsor|0|||
164163054|NCT02343939|592962403|FG003|Overall Study|Study terminated by sponsor|1|||
164163055|NCT02343939|592962404|FG004|Overall Study|Study terminated by sponsor|1|||
164163056|NCT02343939|592962405|FG005|Overall Study|Study terminated by sponsor|5|||
164163057|NCT02343939|592962406|FG006|Overall Study|Study terminated by sponsor|3|||
164163058|NCT02343939|592962407|FG007|Overall Study|Study terminated by sponsor|4|||
164163059|NCT02343939|592962408|FG008|Overall Study|Study terminated by sponsor|0|||
164163060|NCT02343939|592962400|FG000|Overall Study|Withdrew consent|3|||
164163061|NCT02343939|592962401|FG001|Overall Study|Withdrew consent|6|||
164163062|NCT02343939|592962402|FG002|Overall Study|Withdrew consent|1|||
164163063|NCT02343939|592962403|FG003|Overall Study|Withdrew consent|2|||
164163064|NCT02343939|592962404|FG004|Overall Study|Withdrew consent|2|||
164163065|NCT02343939|592962405|FG005|Overall Study|Withdrew consent|0|||
164163066|NCT02343939|592962406|FG006|Overall Study|Withdrew consent|0|||
164163067|NCT02343939|592962407|FG007|Overall Study|Withdrew consent|8|||
164163068|NCT02343939|592962408|FG008|Overall Study|Withdrew consent|6|||
164163069|NCT02343939|592962400|FG000|Overall Study|Treatment failure|0|||
164163070|NCT02343939|592962401|FG001|Overall Study|Treatment failure|0|||
164163071|NCT02343939|592962402|FG002|Overall Study|Treatment failure|0|||
164163072|NCT02343939|592962403|FG003|Overall Study|Treatment failure|0|||
164163073|NCT02343939|592962404|FG004|Overall Study|Treatment failure|0|||
164163074|NCT02343939|592962405|FG005|Overall Study|Treatment failure|0|||
164163075|NCT02343939|592962406|FG006|Overall Study|Treatment failure|2|||
164163076|NCT02343939|592962407|FG007|Overall Study|Treatment failure|1|||
164163077|NCT02343939|592962408|FG008|Overall Study|Treatment failure|0|||
164163078|NCT02343939|592962400|FG000|Overall Study|Investigator's discretion|0|||
164163079|NCT02343939|592962401|FG001|Overall Study|Investigator's discretion|0|||
164163080|NCT02343939|592962402|FG002|Overall Study|Investigator's discretion|0|||
164163081|NCT02343939|592962403|FG003|Overall Study|Investigator's discretion|1|||
164163082|NCT02343939|592962404|FG004|Overall Study|Investigator's discretion|0|||
164163083|NCT02343939|592962405|FG005|Overall Study|Investigator's discretion|0|||
164163084|NCT02343939|592962406|FG006|Overall Study|Investigator's discretion|1|||
164163085|NCT02343939|592962407|FG007|Overall Study|Investigator's discretion|0|||
164163086|NCT02343939|592962408|FG008|Overall Study|Investigator's discretion|0|||
164163087|NCT02343939|592962400|FG000|Overall Study|Adverse Event|0|||
164163088|NCT02343939|592962401|FG001|Overall Study|Adverse Event|0|||
164163089|NCT02343939|592962402|FG002|Overall Study|Adverse Event|0|||
164163090|NCT02343939|592962403|FG003|Overall Study|Adverse Event|0|||
164163091|NCT02343939|592962404|FG004|Overall Study|Adverse Event|0|||
164163092|NCT02343939|592962405|FG005|Overall Study|Adverse Event|1|||
164163093|NCT02343939|592962406|FG006|Overall Study|Adverse Event|0|||
164163094|NCT02343939|592962407|FG007|Overall Study|Adverse Event|0|||
164163095|NCT02343939|592962408|FG008|Overall Study|Adverse Event|0|||
164163096|NCT02343939|592962400|FG000|Overall Study|Never Treated With ENTO|0|||
164163097|NCT02343939|592962401|FG001|Overall Study|Never Treated With ENTO|0|||
164163098|NCT02343939|592962402|FG002|Overall Study|Never Treated With ENTO|0|||
164163099|NCT02343939|592962403|FG003|Overall Study|Never Treated With ENTO|0|||
164163100|NCT02343939|592962404|FG004|Overall Study|Never Treated With ENTO|0|||
164163101|NCT02343939|592962405|FG005|Overall Study|Never Treated With ENTO|0|||
164163102|NCT02343939|592962406|FG006|Overall Study|Never Treated With ENTO|1|||
164163103|NCT02343939|592962407|FG007|Overall Study|Never Treated With ENTO|2|||
164163104|NCT02343939|592962408|FG008|Overall Study|Never Treated With ENTO|0|||
164163105|NCT02064816|592962409|FG000|Overall Study|Adverse Event|3|||
164163106|NCT02064816|592962410|FG001|Overall Study|Adverse Event|2|||
164163107|NCT02064816|592962409|FG000|Overall Study|Withdrawal by Subject|2|||
164163108|NCT02064816|592962410|FG001|Overall Study|Withdrawal by Subject|1|||
164163109|NCT02064816|592962409|FG000|Overall Study|Lost to Follow-up|2|||
164163110|NCT02064816|592962410|FG001|Overall Study|Lost to Follow-up|1|||
164163111|NCT02064816|592962409|FG000|Overall Study|Therapeutic failure|0|||
164163112|NCT02064816|592962410|FG001|Overall Study|Therapeutic failure|1|||
164163113|NCT02064816|592962409|FG000|Overall Study|Other|1|||
164163114|NCT02064816|592962410|FG001|Overall Study|Other|3|||
164163115|NCT05107492|592962411|FG000|Overall Study|Lost to Follow-up|1|||
164163116|NCT05107492|592962412|FG001|Overall Study|Lost to Follow-up|0|||
164163117|NCT03896022|592962413|FG000|Overall Study|Withdrawal by Subject|1|||
164163118|NCT03896022|592962414|FG001|Overall Study|Withdrawal by Subject|0|||
164163119|NCT03896022|592962415|FG002|Overall Study|Withdrawal by Subject|0|||
164163120|NCT03896022|592962413|FG000|Overall Study|Did not have procedure|3|||
164163121|NCT03896022|592962414|FG001|Overall Study|Did not have procedure|0|||
164163122|NCT03896022|592962415|FG002|Overall Study|Did not have procedure|0|||
164163123|NCT02741076|592962416|FG000|Overall Study|Adverse Event|0|||
164163124|NCT02741076|592962417|FG001|Overall Study|Adverse Event|1|||
164163125|NCT02741076|592962418|FG002|Overall Study|Adverse Event|1|||
164163126|NCT02741076|592962419|FG003|Overall Study|Adverse Event|0|||
164163127|NCT02741076|592962416|FG000|Overall Study|Lack of Efficacy|1|||
164163128|NCT02741076|592962417|FG001|Overall Study|Lack of Efficacy|0|||
164163129|NCT02741076|592962418|FG002|Overall Study|Lack of Efficacy|0|||
164163130|NCT02741076|592962419|FG003|Overall Study|Lack of Efficacy|0|||
164163131|NCT02741076|592962416|FG000|Overall Study|Withdrawal by Subject|0|||
164163132|NCT02741076|592962417|FG001|Overall Study|Withdrawal by Subject|1|||
164163133|NCT02741076|592962418|FG002|Overall Study|Withdrawal by Subject|0|||
164163134|NCT02741076|592962419|FG003|Overall Study|Withdrawal by Subject|0|||
164163135|NCT02741076|592962416|FG000|Overall Study|Sponsor Request|2|||
164163136|NCT02741076|592962417|FG001|Overall Study|Sponsor Request|3|||
164163137|NCT02741076|592962418|FG002|Overall Study|Sponsor Request|0|||
164163138|NCT02741076|592962419|FG003|Overall Study|Sponsor Request|1|||
164163139|NCT02741076|592962416|FG000|Overall Study|No additional information available|0|||
164163140|NCT02741076|592962417|FG001|Overall Study|No additional information available|0|||
164163141|NCT02741076|592962418|FG002|Overall Study|No additional information available|1|||
164163142|NCT02741076|592962419|FG003|Overall Study|No additional information available|1|||
164163143|NCT01779440|592962420|FG000|Overall Study|Withdrawal by Subject|3|||
164163144|NCT01779440|592962421|FG001|Overall Study|Withdrawal by Subject|5|||
164163145|NCT00550745|592962426|FG000|Overall Study|Death|20|||
164163146|NCT00550745|592962427|FG001|Overall Study|Death|16|||
164163147|NCT00550745|592962426|FG000|Overall Study|Lost to Follow-up|45|||
164163148|NCT00550745|592962427|FG001|Overall Study|Lost to Follow-up|30|||
164163149|NCT00550745|592962426|FG000|Overall Study|Physician Decision|0|||
164163150|NCT00550745|592962427|FG001|Overall Study|Physician Decision|2|||
164163151|NCT00550745|592962426|FG000|Overall Study|Protocol Violation|4|||
164163152|NCT00550745|592962427|FG001|Overall Study|Protocol Violation|2|||
164163153|NCT00550745|592962426|FG000|Overall Study|Withdrawal by Subject|17|||
164163154|NCT00550745|592962427|FG001|Overall Study|Withdrawal by Subject|10|||
164163155|NCT00550745|592962426|FG000|Overall Study|Screen failure|1|||
164163156|NCT00550745|592962427|FG001|Overall Study|Screen failure|0|||
164163157|NCT00764660|592962428|FG000|Overall Study|Adverse Event|6|||
164163158|NCT00764660|592962429|FG001|Overall Study|Adverse Event|3|||
164163159|NCT00764660|592962428|FG000|Overall Study|Lost to Follow-up|3|||
164163160|NCT00764660|592962429|FG001|Overall Study|Lost to Follow-up|4|||
164163161|NCT00764660|592962428|FG000|Overall Study|Withdrawal by Subject|7|||
164163162|NCT00764660|592962429|FG001|Overall Study|Withdrawal by Subject|3|||
164163163|NCT00764660|592962428|FG000|Overall Study|Noncompliance With Protocol|5|||
164163164|NCT00764660|592962429|FG001|Overall Study|Noncompliance With Protocol|1|||
164163165|NCT00764660|592962428|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
164163166|NCT00764660|592962429|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
164163167|NCT01131455|592962430|FG000|Overall Study|Death of PI|6|||
164163168|NCT01131455|592962431|FG001|Overall Study|Death of PI|4|||
164163169|NCT01131455|592962432|FG002|Overall Study|Death of PI|0|||
164163170|NCT05119595|592963645|FG000|Overall Study|Death|1|||
164163171|NCT05119595|592963645|FG000|Overall Study|Lost to Follow-up|7|||
164163172|NCT01806961|592963646|FG000|Overall Study|sponsor decision|16|||
164163173|NCT00839800|592963649|FG000|Overall Study|Adverse Event|8|||
164163174|NCT00839800|592963650|FG001|Overall Study|Adverse Event|12|||
164163175|NCT00839800|592963649|FG000|Overall Study|Lost to Follow-up|31|||
164163176|NCT00839800|592963650|FG001|Overall Study|Lost to Follow-up|26|||
164163177|NCT00839800|592963649|FG000|Overall Study|Withdrawal by Subject|28|||
164163178|NCT00839800|592963650|FG001|Overall Study|Withdrawal by Subject|34|||
164163179|NCT00839800|592963649|FG000|Overall Study|Incorrect Enrolment|3|||
164163180|NCT00839800|592963650|FG001|Overall Study|Incorrect Enrolment|3|||
164163181|NCT00839800|592963649|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
164163182|NCT00839800|592963650|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
164163183|NCT00839800|592963649|FG000|Overall Study|Safety Reasons|2|||
164163184|NCT00839800|592963650|FG001|Overall Study|Safety Reasons|1|||
164163185|NCT00839800|592963649|FG000|Overall Study|Other|8|||
164163186|NCT00839800|592963650|FG001|Overall Study|Other|14|||
164163187|NCT00839800|592963649|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
164163188|NCT00839800|592963650|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
164163189|NCT00912743|592963659|FG000|Overall Study|Adverse Event|3|||
164163190|NCT00912743|592963660|FG001|Overall Study|Adverse Event|1|||
164163191|NCT00912743|592963659|FG000|Overall Study|Lack of Efficacy|9|||
164163192|NCT00912743|592963660|FG001|Overall Study|Lack of Efficacy|18|||
164163193|NCT00912743|592963659|FG000|Overall Study|Toxicity|0|||
164163194|NCT00912743|592963660|FG001|Overall Study|Toxicity|1|||
164163195|NCT00912743|592963659|FG000|Overall Study|End of treatment form was not collected|1|||
164163196|NCT00912743|592963660|FG001|Overall Study|End of treatment form was not collected|0|||
164163197|NCT00179660|592963670|FG000|Overall Study|Adverse Event|7|||
164163198|NCT00179660|592963670|FG000|Overall Study|Lack of therapeutic effect|28|||
164163199|NCT00179660|592963670|FG000|Overall Study|Withdrawal by Subject|2|||
164163200|NCT00179660|592963670|FG000|Overall Study|Lost to Follow-up|1|||
164163201|NCT00179660|592963670|FG000|Overall Study|Death|3|||
164163202|NCT00179660|592963670|FG000|Overall Study|Other - Unspecified|9|||
164163203|NCT04478695|592963671|FG000|Overall Study|Death|1|||
164163204|NCT04478695|592963672|FG001|Overall Study|Death|0|||
164163205|NCT00644917|592963673|FG000|Overall Study|Withdrawal by Subject|2|||
164163206|NCT00178685|592963674|FG000|Overall Study|Death|3|||
164163207|NCT00178685|592963675|FG001|Overall Study|Death|3|||
164163208|NCT00178685|592963676|FG002|Overall Study|Death|6|||
164163209|NCT00178685|592963674|FG000|Overall Study|Lost to Follow-up|100|||
164163210|NCT00178685|592963675|FG001|Overall Study|Lost to Follow-up|187|||
164163211|NCT00178685|592963676|FG002|Overall Study|Lost to Follow-up|183|||
164163212|NCT00178685|592963674|FG000|Overall Study|Withdrawal by Subject|8|||
164163213|NCT00178685|592963675|FG001|Overall Study|Withdrawal by Subject|14|||
164163214|NCT00178685|592963676|FG002|Overall Study|Withdrawal by Subject|7|||
164163215|NCT00927862|592963677|FG000|Overall Study|Missing data needed for endpt analyses|27|||
164163216|NCT00927862|592963678|FG001|Overall Study|Missing data needed for endpt analyses|45|||
164163217|NCT00820248|592963679|FG000|Overall Study|No treated|4|||
164163218|NCT00820248|592963680|FG001|Overall Study|No treated|1|||
164163219|NCT01057810|592963694|FG000|Overall Study|Disease progression|156|||
164163220|NCT01057810|592963695|FG001|Overall Study|Disease progression|197|||
164163221|NCT01057810|592963694|FG000|Overall Study|Study drug toxicity|5|||
164163222|NCT01057810|592963695|FG001|Overall Study|Study drug toxicity|114|||
164163223|NCT01057810|592963694|FG000|Overall Study|Adverse event unrelated to study drug|13|||
164163224|NCT01057810|592963695|FG001|Overall Study|Adverse event unrelated to study drug|29|||
164163225|NCT01057810|592963694|FG000|Overall Study|Withdrawal by Subject|10|||
164163226|NCT01057810|592963695|FG001|Overall Study|Withdrawal by Subject|25|||
164163227|NCT01057810|592963694|FG000|Overall Study|Death|2|||
164163228|NCT01057810|592963695|FG001|Overall Study|Death|12|||
164163229|NCT01057810|592963694|FG000|Overall Study|Maximum clinical benefit|5|||
164163230|NCT01057810|592963695|FG001|Overall Study|Maximum clinical benefit|5|||
164163231|NCT01057810|592963694|FG000|Overall Study|Poor/non-compliance|0|||
164163232|NCT01057810|592963695|FG001|Overall Study|Poor/non-compliance|1|||
164163233|NCT01057810|592963694|FG000|Overall Study|No longer met study criteria|0|||
164163234|NCT01057810|592963695|FG001|Overall Study|No longer met study criteria|1|||
164163235|NCT01057810|592963694|FG000|Overall Study|Other|7|||
164163236|NCT01057810|592963695|FG001|Overall Study|Other|14|||
164163237|NCT00267969|592963696|FG000|Controlled Period|Adverse Event|6|||
164163238|NCT00267969|592963697|FG001|Controlled Period|Adverse Event|0|||
164163239|NCT00267969|592963698|FG002|Controlled Period|Adverse Event|2|||
164163240|NCT00267969|592963699|FG003|Controlled Period|Adverse Event|0|||
164163241|NCT00267969|592963700|FG004|Controlled Period|Adverse Event|0|||
164163242|NCT00267969|592963701|FG005|Controlled Period|Adverse Event|0|||
164163243|NCT00267969|592963702|FG006|Controlled Period|Adverse Event|0|||
164163244|NCT00267969|592963696|FG000|Controlled Period|Lack of Efficacy|3|||
164163245|NCT00267969|592963697|FG001|Controlled Period|Lack of Efficacy|0|||
164163246|NCT00267969|592963698|FG002|Controlled Period|Lack of Efficacy|1|||
164163247|NCT00267969|592963699|FG003|Controlled Period|Lack of Efficacy|0|||
164163248|NCT00267969|592963700|FG004|Controlled Period|Lack of Efficacy|0|||
164163249|NCT00267969|592963701|FG005|Controlled Period|Lack of Efficacy|0|||
164163250|NCT00267969|592963702|FG006|Controlled Period|Lack of Efficacy|0|||
164163251|NCT00267969|592963696|FG000|Controlled Period|Lost to Follow-up|1|||
164163252|NCT00267969|592963697|FG001|Controlled Period|Lost to Follow-up|0|||
164163253|NCT00267969|592963698|FG002|Controlled Period|Lost to Follow-up|1|||
164163254|NCT00267969|592963699|FG003|Controlled Period|Lost to Follow-up|0|||
164163255|NCT00267969|592963700|FG004|Controlled Period|Lost to Follow-up|0|||
164163256|NCT00267969|592963701|FG005|Controlled Period|Lost to Follow-up|0|||
164163257|NCT00267969|592963702|FG006|Controlled Period|Lost to Follow-up|0|||
164163258|NCT00267969|592963696|FG000|Controlled Period|Randomized but not treated|0|||
164163259|NCT00267969|592963697|FG001|Controlled Period|Randomized but not treated|0|||
164163260|NCT00267969|592963698|FG002|Controlled Period|Randomized but not treated|1|||
164163261|NCT00267969|592963699|FG003|Controlled Period|Randomized but not treated|0|||
164163262|NCT00267969|592963700|FG004|Controlled Period|Randomized but not treated|0|||
164163263|NCT00267969|592963701|FG005|Controlled Period|Randomized but not treated|0|||
164163264|NCT00267969|592963702|FG006|Controlled Period|Randomized but not treated|0|||
164163265|NCT00267969|592963696|FG000|Controlled Period|Other|2|||
164163266|NCT00267969|592963697|FG001|Controlled Period|Other|1|||
164163267|NCT00267969|592963698|FG002|Controlled Period|Other|6|||
164163268|NCT00267969|592963699|FG003|Controlled Period|Other|0|||
164163269|NCT00267969|592963700|FG004|Controlled Period|Other|0|||
164163270|NCT00267969|592963701|FG005|Controlled Period|Other|0|||
164163271|NCT00267969|592963702|FG006|Controlled Period|Other|0|||
164163272|NCT00267969|592963696|FG000|After Controlled Period|Adverse Event|0|||
164163273|NCT00267969|592963697|FG001|After Controlled Period|Adverse Event|0|||
164163274|NCT00267969|592963698|FG002|After Controlled Period|Adverse Event|0|||
164163275|NCT00267969|592963699|FG003|After Controlled Period|Adverse Event|7|||
164163276|NCT00267969|592963700|FG004|After Controlled Period|Adverse Event|8|||
164163277|NCT00267969|592963701|FG005|After Controlled Period|Adverse Event|23|||
164163278|NCT00267969|592963702|FG006|After Controlled Period|Adverse Event|21|||
164163279|NCT00267969|592963696|FG000|After Controlled Period|Death|0|||
164163280|NCT00267969|592963697|FG001|After Controlled Period|Death|0|||
164163281|NCT00267969|592963698|FG002|After Controlled Period|Death|0|||
164163282|NCT00267969|592963699|FG003|After Controlled Period|Death|1|||
164163283|NCT00267969|592963700|FG004|After Controlled Period|Death|2|||
164163284|NCT00267969|592963701|FG005|After Controlled Period|Death|0|||
164163285|NCT00267969|592963702|FG006|After Controlled Period|Death|1|||
164163286|NCT00267969|592963696|FG000|After Controlled Period|Lack of Efficacy|0|||
164163287|NCT00267969|592963697|FG001|After Controlled Period|Lack of Efficacy|0|||
164163288|NCT00267969|592963698|FG002|After Controlled Period|Lack of Efficacy|0|||
164163289|NCT00267969|592963699|FG003|After Controlled Period|Lack of Efficacy|10|||
164163290|NCT00267969|592963700|FG004|After Controlled Period|Lack of Efficacy|6|||
164163291|NCT00267969|592963701|FG005|After Controlled Period|Lack of Efficacy|28|||
164163292|NCT00267969|592963702|FG006|After Controlled Period|Lack of Efficacy|15|||
164163293|NCT00267969|592963696|FG000|After Controlled Period|Lost to Follow-up|0|||
164163294|NCT00267969|592963697|FG001|After Controlled Period|Lost to Follow-up|0|||
164163295|NCT00267969|592963698|FG002|After Controlled Period|Lost to Follow-up|0|||
164163296|NCT00267969|592963699|FG003|After Controlled Period|Lost to Follow-up|5|||
164163297|NCT00267969|592963700|FG004|After Controlled Period|Lost to Follow-up|8|||
164163298|NCT00267969|592963701|FG005|After Controlled Period|Lost to Follow-up|9|||
164163299|NCT00267969|592963702|FG006|After Controlled Period|Lost to Follow-up|10|||
164163300|NCT00267969|592963696|FG000|After Controlled Period|Other|0|||
164163301|NCT00267969|592963697|FG001|After Controlled Period|Other|0|||
164163302|NCT00267969|592963698|FG002|After Controlled Period|Other|0|||
164163303|NCT00267969|592963699|FG003|After Controlled Period|Other|13|||
164163304|NCT00267969|592963700|FG004|After Controlled Period|Other|11|||
164163305|NCT00267969|592963701|FG005|After Controlled Period|Other|22|||
164163306|NCT00267969|592963702|FG006|After Controlled Period|Other|25|||
164163307|NCT00862823|592963703|FG000|First Intervention|Withdrawal by Subject|1|||
164163308|NCT00862823|592963704|FG001|First Intervention|Withdrawal by Subject|1|||
164163309|NCT00887315|592963705|FG000|Overall Study|Study termination|7|||
164163310|NCT00887315|592963706|FG001|Overall Study|Study termination|4|||
164163311|NCT00619892|592963711|FG000|Overall Study|Adverse Event|3|||
164163312|NCT00619892|592963712|FG001|Overall Study|Adverse Event|0|||
164163313|NCT00619892|592963711|FG000|Overall Study|Lost to Follow-up|0|||
164163314|NCT00619892|592963712|FG001|Overall Study|Lost to Follow-up|1|||
164163315|NCT00619892|592963711|FG000|Overall Study|Intercurrent illness|0|||
164163316|NCT00619892|592963712|FG001|Overall Study|Intercurrent illness|1|||
164163317|NCT00857896|592963718|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
164163318|NCT02308540|592963719|FG000|Overall Study|Lost to Follow-up|0|||
164163319|NCT02308540|592963720|FG001|Overall Study|Lost to Follow-up|0|||
164163320|NCT02308540|592963721|FG002|Overall Study|Lost to Follow-up|0|||
164163321|NCT02308540|592963722|FG003|Overall Study|Lost to Follow-up|0|||
164163322|NCT02308540|592963723|FG004|Overall Study|Lost to Follow-up|0|||
164163323|NCT02308540|592963724|FG005|Overall Study|Lost to Follow-up|1|||
164163324|NCT01091662|592963725|FG000|Overall Study|Adverse Event|1|||
164163325|NCT01091662|592963726|FG001|Overall Study|Adverse Event|9|||
164163326|NCT01091662|592963725|FG000|Overall Study|Physician Decision|1|||
164163327|NCT01091662|592963726|FG001|Overall Study|Physician Decision|1|||
164163328|NCT01091662|592963725|FG000|Overall Study|Withdrawal by Subject|7|||
164163329|NCT01091662|592963726|FG001|Overall Study|Withdrawal by Subject|6|||
164163330|NCT01091662|592963725|FG000|Overall Study|met exit criteria|7|||
164163331|NCT01091662|592963726|FG001|Overall Study|met exit criteria|13|||
164163332|NCT01091662|592963725|FG000|Overall Study|met exclusion criteria|1|||
164163333|NCT01091662|592963726|FG001|Overall Study|met exclusion criteria|0|||
164163334|NCT01091662|592963725|FG000|Overall Study|Lost to Follow-up|0|||
164163335|NCT01091662|592963726|FG001|Overall Study|Lost to Follow-up|1|||
164163336|NCT01091662|592963725|FG000|Overall Study|Pregnancy|0|||
164163337|NCT01091662|592963726|FG001|Overall Study|Pregnancy|1|||
164163338|NCT01091662|592963725|FG000|Overall Study|Protocol Violation|0|||
164163339|NCT01091662|592963726|FG001|Overall Study|Protocol Violation|2|||
164163340|NCT01091662|592963725|FG000|Overall Study|unable to swallow capsule|0|||
164163341|NCT01091662|592963726|FG001|Overall Study|unable to swallow capsule|1|||
164163342|NCT04109391|592963727|FG000|Overall Study|Adverse Event|2|||
164163343|NCT04109391|592963728|FG001|Overall Study|Adverse Event|2|||
164163344|NCT04109391|592963729|FG002|Overall Study|Adverse Event|0|||
164163345|NCT04109391|592963727|FG000|Overall Study|Withdrawal by Subject|2|||
164163346|NCT04109391|592963728|FG001|Overall Study|Withdrawal by Subject|0|||
164163347|NCT04109391|592963729|FG002|Overall Study|Withdrawal by Subject|0|||
164163348|NCT04109391|592963727|FG000|Overall Study|Pregnancy|1|||
164163349|NCT04109391|592963728|FG001|Overall Study|Pregnancy|0|||
164163350|NCT04109391|592963729|FG002|Overall Study|Pregnancy|0|||
164163351|NCT04109391|592963727|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
164163352|NCT04109391|592963728|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
164163353|NCT04109391|592963729|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
164163354|NCT04109391|592963727|FG000|Overall Study|Lost to Follow-up|0|||
164163355|NCT04109391|592963728|FG001|Overall Study|Lost to Follow-up|0|||
164163356|NCT04109391|592963729|FG002|Overall Study|Lost to Follow-up|1|||
164163357|NCT04109391|592963727|FG000|Overall Study|Lack of Efficacy|2|||
164163358|NCT04109391|592963728|FG001|Overall Study|Lack of Efficacy|2|||
164163359|NCT04109391|592963729|FG002|Overall Study|Lack of Efficacy|3|||
164163360|NCT02285166|592963730|FG000|Overall Study|Case Report Forms Uncollected|564|||
164163361|NCT02285166|592963730|FG000|Overall Study|Protocol Deviation|402|||
164163362|NCT00443079|592963731|FG000|Overall Study|Lost to Follow-up|0|||
164163363|NCT00443079|592963732|FG001|Overall Study|Lost to Follow-up|1|||
164163364|NCT01106911|592963733|FG000|Overall Study|Physician Decision|2|||
164163365|NCT01106911|592963733|FG000|Overall Study|deemed ineligible after screening|3|||
164163366|NCT05708976|592963743|FG000|Overall Study|Withdrawal by Subject|0|||
164163367|NCT05708976|592963744|FG001|Overall Study|Withdrawal by Subject|1|||
164163368|NCT02684097|592963745|FG000|Overall Study|Lack of Efficacy|13|||
164163369|NCT02684097|592963746|FG001|Overall Study|Lack of Efficacy|6|||
164163370|NCT03218826|592963747|FG000|Overall Study|Non-compliance with protocol|1|||
164163371|NCT03218826|592963748|FG001|Overall Study|Non-compliance with protocol|0|||
164163372|NCT03218826|592963749|FG002|Overall Study|Non-compliance with protocol|2|||
164163373|NCT03218826|592963750|FG003|Overall Study|Non-compliance with protocol|1|||
164163374|NCT03218826|592963751|FG004|Overall Study|Non-compliance with protocol|1|||
164163375|NCT02858583|592963754|FG000|Overall Study|Declined consent|1|||
164163376|NCT02858583|592963755|FG001|Overall Study|Declined consent|1|||
164163377|NCT03564119|592963762|FG000|Overall Study|Adverse Event|4|||
164163378|NCT03564119|592963763|FG001|Overall Study|Adverse Event|0|||
164163379|NCT03564119|592963762|FG000|Overall Study|Lost to Follow-up|1|||
164163380|NCT03564119|592963763|FG001|Overall Study|Lost to Follow-up|4|||
164163381|NCT03564119|592963762|FG000|Overall Study|Protocol Violation|1|||
164163382|NCT03564119|592963763|FG001|Overall Study|Protocol Violation|0|||
164163383|NCT03564119|592963762|FG000|Overall Study|Withdrawal by Subject|9|||
164163384|NCT03564119|592963763|FG001|Overall Study|Withdrawal by Subject|4|||
164163385|NCT03564119|592963762|FG000|Overall Study|Other Than Specified|0|||
164163386|NCT03564119|592963763|FG001|Overall Study|Other Than Specified|1|||
164163387|NCT00634036|592963764|FG000|Overall Study|Lost to Follow-up|1|||
164163388|NCT00634036|592963765|FG001|Overall Study|Lost to Follow-up|1|||
164163389|NCT00634036|592963764|FG000|Overall Study|Withdrawal by Subject|1|||
164163390|NCT00634036|592963765|FG001|Overall Study|Withdrawal by Subject|1|||
164163391|NCT00961350|592963766|FG000|Overall Study|Adverse Event|18|||
164163392|NCT00961350|592963767|FG001|Overall Study|Adverse Event|33|||
164163393|NCT00961350|592963766|FG000|Overall Study|Withdrawal by Subject|10|||
164163394|NCT00961350|592963767|FG001|Overall Study|Withdrawal by Subject|10|||
164163395|NCT00961350|592963766|FG000|Overall Study|Lost to Follow-up|3|||
164163396|NCT00961350|592963767|FG001|Overall Study|Lost to Follow-up|3|||
164163397|NCT00961350|592963766|FG000|Overall Study|Misc|16|||
164163398|NCT00961350|592963767|FG001|Overall Study|Misc|21|||
164163399|NCT03867201|592963768|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
164163400|NCT03867201|592963769|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
164163401|NCT03867201|592963768|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
164163402|NCT03867201|592963769|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
164163403|NCT03867201|592963768|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
164163404|NCT03867201|592963769|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
164163405|NCT03867201|592963768|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
164163406|NCT03867201|592963769|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
164163407|NCT03867201|592963768|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
164163408|NCT03867201|592963769|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
164163409|NCT03867201|592963768|FG000|Open-Label Period From Week 12|Adverse Event|5|||
164163410|NCT03867201|592963769|FG001|Open-Label Period From Week 12|Adverse Event|11|||
164163411|NCT03867201|592963768|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
164163412|NCT03867201|592963769|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
164163413|NCT03867201|592963768|FG000|Open-Label Period From Week 12|Physician Decision|6|||
164163414|NCT03867201|592963769|FG001|Open-Label Period From Week 12|Physician Decision|3|||
164163415|NCT03867201|592963768|FG000|Open-Label Period From Week 12|Pregnancy|2|||
164163416|NCT03867201|592963769|FG001|Open-Label Period From Week 12|Pregnancy|2|||
164163417|NCT03867201|592963768|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
164163418|NCT03867201|592963769|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
164163419|NCT03867201|592963768|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
164163420|NCT03867201|592963769|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
164163421|NCT03867201|592963768|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
164163422|NCT03867201|592963769|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
164163423|NCT03867201|592963768|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
164163424|NCT03867201|592963769|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
164163425|NCT01190410|592964982|FG000|Overall Study|Adverse Event|0|||
164163426|NCT01190410|592964983|FG001|Overall Study|Adverse Event|3|||
164163427|NCT01190410|592964982|FG000|Overall Study|Lack of Efficacy|0|||
164163428|NCT01190410|592964983|FG001|Overall Study|Lack of Efficacy|2|||
164163429|NCT01190410|592964982|FG000|Overall Study|Withdrawal by Subject|0|||
164163430|NCT01190410|592964983|FG001|Overall Study|Withdrawal by Subject|2|||
164163431|NCT01190410|592964982|FG000|Overall Study|Administrative decision|1|||
164163432|NCT01190410|592964983|FG001|Overall Study|Administrative decision|0|||
164163433|NCT01190410|592964982|FG000|Overall Study|PI discretion|0|||
164163434|NCT01190410|592964983|FG001|Overall Study|PI discretion|2|||
164163435|NCT01283334|592964987|FG000|Overall Study|Withdrawal by Subject|1|||
164163436|NCT01283334|592964987|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
164163437|NCT01283334|592964987|FG000|Overall Study|Adverse Event|4|||
164163438|NCT01283334|592964987|FG000|Overall Study|Physician Decision|1|||
164163439|NCT03467217|592964988|FG000|Overall Study|Trial stopped early|5|||
164163440|NCT03467217|592964989|FG001|Overall Study|Trial stopped early|2|||
164163441|NCT03467217|592964988|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
164163442|NCT03467217|592964989|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
164163443|NCT03467217|592964988|FG000|Overall Study|Lost to Follow-up|0|||
164163444|NCT03467217|592964989|FG001|Overall Study|Lost to Follow-up|2|||
164163445|NCT04390503|592964990|FG000|Overall Study|Physician Decision|2|||
164163446|NCT04390503|592964991|FG001|Overall Study|Physician Decision|1|||
164163447|NCT04390503|592964990|FG000|Overall Study|Adverse Event|1|||
164163448|NCT04390503|592964991|FG001|Overall Study|Adverse Event|0|||
164163449|NCT03656692|592964995|FG000|Overall Study|Worsening of disease activity|2|||
164163450|NCT03656692|592964995|FG000|Overall Study|Physician Decision|1|||
164163451|NCT03233529|592964999|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
164163452|NCT03233529|592964999|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
164163453|NCT03260244|592965000|FG000|Overall Study|Death|19|||
164163454|NCT03260244|592965000|FG000|Overall Study|Lost to Follow-up|60|||
164163455|NCT03260244|592965000|FG000|Overall Study|Withdrawal by Subject|48|||
164163456|NCT03260244|592965000|FG000|Overall Study|Procedure Not Performed|21|||
164163457|NCT03260244|592965000|FG000|Overall Study|Enrollment Criteria Not Met|31|||
164163458|NCT03260244|592965000|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
164163459|NCT03260244|592965000|FG000|Overall Study|Subject Noncompliance|6|||
164163460|NCT03260244|592965000|FG000|Overall Study|No inducible Arrhythmia|2|||
164163461|NCT03260244|592965000|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
164163462|NCT03260244|592965000|FG000|Overall Study|Screen Failure|2|||
164163463|NCT03260244|592965000|FG000|Overall Study|Treated Off Label|69|||
164163464|NCT03260244|592965000|FG000|Overall Study|No Radiofrequency Ablation|14|||
164163465|NCT01177293|592965001|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
164163466|NCT01177293|592965002|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
164163467|NCT00594100|592965003|FG000|Procedure|Technical Failure|9|||
164163468|NCT00594100|592965003|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
164163469|NCT00594100|592965003|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
164163470|NCT00594100|592965003|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
164163471|NCT02448537|592965004|FG000|Overall Study|Withdrawal by Subject|1|||
164163472|NCT02448537|592965005|FG001|Overall Study|Withdrawal by Subject|1|||
164163473|NCT02448537|592965006|FG002|Overall Study|Withdrawal by Subject|1|||
164163474|NCT03528369|592965007|FG000|Overall Study|Withdrawal by Subject|2|||
164163475|NCT03528369|592965008|FG001|Overall Study|Withdrawal by Subject|0|||
164163476|NCT03528369|592965009|FG002|Overall Study|Withdrawal by Subject|0|||
164163477|NCT03528369|592965007|FG000|Overall Study|Lost to Follow-up|1|||
164163478|NCT03528369|592965008|FG001|Overall Study|Lost to Follow-up|0|||
164163479|NCT03528369|592965009|FG002|Overall Study|Lost to Follow-up|0|||
164163480|NCT03528369|592965007|FG000|Overall Study|Adverse Event|0|||
164163481|NCT03528369|592965008|FG001|Overall Study|Adverse Event|1|||
164163482|NCT03528369|592965009|FG002|Overall Study|Adverse Event|0|||
164163483|NCT04725812|592965010|FG000|Overall Study|Withdrawal by Subject|1|||
164163484|NCT02801617|592965014|FG000|Overall Study|Protocol Violation|2|||
164163485|NCT02801617|592965015|FG001|Overall Study|Protocol Violation|6|||
164163486|NCT04747886|592965016|FG000|Overall Study|Withdrawal by Subject|1|||
164163487|NCT04747886|592965017|FG001|Overall Study|Withdrawal by Subject|4|||
164163488|NCT02237196|592965018|FG000|Overall Study|Adverse Event|0|||
164163489|NCT02237196|592965019|FG001|Overall Study|Adverse Event|1|||
164163490|NCT02237196|592965020|FG002|Overall Study|Adverse Event|1|||
164163491|NCT02237196|592965021|FG003|Overall Study|Adverse Event|0|||
164163492|NCT02237196|592965018|FG000|Overall Study|Lost to Follow-up|4|||
164163493|NCT02237196|592965019|FG001|Overall Study|Lost to Follow-up|2|||
164163494|NCT02237196|592965020|FG002|Overall Study|Lost to Follow-up|4|||
164163495|NCT02237196|592965021|FG003|Overall Study|Lost to Follow-up|6|||
164163496|NCT02237196|592965018|FG000|Overall Study|Physician Decision|2|||
164163497|NCT02237196|592965019|FG001|Overall Study|Physician Decision|0|||
164163498|NCT02237196|592965020|FG002|Overall Study|Physician Decision|0|||
164163499|NCT02237196|592965021|FG003|Overall Study|Physician Decision|1|||
164163500|NCT02237196|592965018|FG000|Overall Study|Pregnancy|0|||
164163501|NCT02237196|592965019|FG001|Overall Study|Pregnancy|0|||
164163502|NCT02237196|592965020|FG002|Overall Study|Pregnancy|1|||
164163503|NCT02237196|592965021|FG003|Overall Study|Pregnancy|1|||
164163504|NCT02237196|592965018|FG000|Overall Study|Withdrawal by Subject|1|||
164163505|NCT02237196|592965019|FG001|Overall Study|Withdrawal by Subject|1|||
164163506|NCT02237196|592965020|FG002|Overall Study|Withdrawal by Subject|4|||
164163507|NCT02237196|592965021|FG003|Overall Study|Withdrawal by Subject|1|||
164163508|NCT02237196|592965018|FG000|Overall Study|Site Error|1|||
164163509|NCT02237196|592965019|FG001|Overall Study|Site Error|2|||
164163510|NCT02237196|592965020|FG002|Overall Study|Site Error|0|||
164163511|NCT02237196|592965021|FG003|Overall Study|Site Error|2|||
164163512|NCT01814696|592965023|FG000|Overall Study|Withdrawal by Subject|1|||
164163513|NCT01814696|592965024|FG001|Overall Study|Withdrawal by Subject|0|||
164163514|NCT01814696|592965023|FG000|Overall Study|Randomized to wrong group|1|||
164163515|NCT01814696|592965024|FG001|Overall Study|Randomized to wrong group|0|||
164163516|NCT05310071|592965026|FG000|Overall Study|Death|0|||
164163517|NCT05310071|592965027|FG001|Overall Study|Death|3|||
164163518|NCT05310071|592965026|FG000|Overall Study|Adverse Event|4|||
164163519|NCT05310071|592965027|FG001|Overall Study|Adverse Event|31|||
164163520|NCT05310071|592965026|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
164163521|NCT05310071|592965027|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
164163522|NCT05310071|592965026|FG000|Overall Study|Protocol Deviation|2|||
164163523|NCT05310071|592965027|FG001|Overall Study|Protocol Deviation|0|||
164163524|NCT05310071|592965026|FG000|Overall Study|Randomized by Mistake|0|||
164163525|NCT05310071|592965027|FG001|Overall Study|Randomized by Mistake|1|||
164163526|NCT05310071|592965026|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
164163527|NCT05310071|592965027|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
164163528|NCT05310071|592965026|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
164163529|NCT05310071|592965027|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
164163530|NCT05310071|592965026|FG000|Overall Study|Site Terminated by Sponsor|0|||
164163531|NCT05310071|592965027|FG001|Overall Study|Site Terminated by Sponsor|2|||
164163532|NCT05310071|592965026|FG000|Overall Study|Study Terminated by Sponsor|282|||
164163533|NCT05310071|592965027|FG001|Overall Study|Study Terminated by Sponsor|559|||
164163534|NCT05310071|592965026|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
164163535|NCT05310071|592965027|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
164163536|NCT05310071|592965026|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
164163537|NCT05310071|592965027|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
164163538|NCT05310071|592965026|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
164163539|NCT05310071|592965027|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
164163540|NCT05310071|592965026|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
164163541|NCT05310071|592965027|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
164163542|NCT05310071|592965026|FG000|Overall Study|Withdrawal by Participant - Other|25|||
164163543|NCT05310071|592965027|FG001|Overall Study|Withdrawal by Participant - Other|30|||
164163544|NCT05310071|592965026|FG000|Overall Study|Lost to Follow-up|2|||
164163545|NCT05310071|592965027|FG001|Overall Study|Lost to Follow-up|4|||
164163546|NCT05310071|592965026|FG000|Overall Study|Reason Not Specified|1|||
164163547|NCT05310071|592965027|FG001|Overall Study|Reason Not Specified|3|||
164163548|NCT02105987|592965028|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
164163549|NCT02105987|592965029|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
164163550|NCT02105987|592965030|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
164163551|NCT02105987|592965031|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
164163552|NCT02105987|592965032|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
164163553|NCT02105987|592965033|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
164163554|NCT02105987|592965028|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
164163555|NCT02105987|592965029|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
164163556|NCT02105987|592965030|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
164163557|NCT02105987|592965031|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
164163558|NCT02105987|592965032|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
164163559|NCT02105987|592965033|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
164163560|NCT02105987|592965028|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
164163561|NCT02105987|592965029|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
164163562|NCT02105987|592965030|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
164163563|NCT02105987|592965031|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
164163564|NCT02105987|592965032|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
164163565|NCT02105987|592965033|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
164163566|NCT02105987|592965028|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
164163567|NCT02105987|592965029|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
164163568|NCT02105987|592965030|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
164163569|NCT02105987|592965031|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
164163570|NCT02105987|592965032|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
164163571|NCT02105987|592965033|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
164163572|NCT02105987|592965028|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
164163573|NCT02105987|592965029|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
164163574|NCT02105987|592965030|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
164163575|NCT02105987|592965031|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
164163576|NCT02105987|592965032|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
164163577|NCT02105987|592965033|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
164163578|NCT02105987|592965028|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
164163579|NCT02105987|592965029|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
164163580|NCT02105987|592965030|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
164163581|NCT02105987|592965031|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
164163582|NCT02105987|592965032|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
164163583|NCT02105987|592965033|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
164163584|NCT02105987|592965028|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
164163585|NCT02105987|592965029|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
164163586|NCT02105987|592965030|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
164163587|NCT02105987|592965031|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
164163588|NCT02105987|592965032|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
164163589|NCT02105987|592965033|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
164163590|NCT02105987|592965028|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
164163591|NCT02105987|592965029|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
164163592|NCT02105987|592965030|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
164163593|NCT02105987|592965031|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
164163594|NCT02105987|592965032|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
164163595|NCT02105987|592965033|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
164163596|NCT02105987|592965028|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
164163597|NCT02105987|592965029|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
164163598|NCT02105987|592965030|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
164163599|NCT02105987|592965031|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
164163600|NCT02105987|592965032|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
164163601|NCT02105987|592965033|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
164163602|NCT02105987|592965028|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
164163603|NCT02105987|592965029|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
164163604|NCT02105987|592965030|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
164163605|NCT02105987|592965031|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
164163606|NCT02105987|592965032|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
164163607|NCT02105987|592965033|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
164163608|NCT02105987|592965028|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
164163609|NCT02105987|592965029|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
164163610|NCT02105987|592965030|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
164163611|NCT02105987|592965031|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
164163612|NCT02105987|592965032|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
164163613|NCT02105987|592965033|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
164163614|NCT02105987|592965028|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
164163615|NCT02105987|592965029|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
164163616|NCT02105987|592965030|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
164163617|NCT02105987|592965031|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
164163618|NCT02105987|592965032|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
164163619|NCT02105987|592965033|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
164163620|NCT02105987|592965028|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
164163621|NCT02105987|592965029|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
164163622|NCT02105987|592965030|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
164163623|NCT02105987|592965031|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
164163624|NCT02105987|592965032|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
164163625|NCT02105987|592965033|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
164163626|NCT02105987|592965028|FG000|Continuation Phase|Protocol Violation|0|||
164163627|NCT02105987|592965029|FG001|Continuation Phase|Protocol Violation|0|||
164163628|NCT02105987|592965030|FG002|Continuation Phase|Protocol Violation|0|||
164163629|NCT02105987|592965031|FG003|Continuation Phase|Protocol Violation|0|||
164163630|NCT02105987|592965032|FG004|Continuation Phase|Protocol Violation|1|||
164163631|NCT02105987|592965033|FG005|Continuation Phase|Protocol Violation|0|||
164163632|NCT02418949|592965034|FG000|Overall Study|Withdrawal by Subject|1|||
164163633|NCT02418949|592965035|FG001|Overall Study|Withdrawal by Subject|0|||
164163634|NCT02418949|592965036|FG002|Overall Study|Withdrawal by Subject|1|||
164163635|NCT02418949|592965037|FG003|Overall Study|Withdrawal by Subject|1|||
164163636|NCT02418949|592965034|FG000|Overall Study|Lost to Follow-up|1|||
164163637|NCT02418949|592965035|FG001|Overall Study|Lost to Follow-up|0|||
164163638|NCT02418949|592965036|FG002|Overall Study|Lost to Follow-up|1|||
164163639|NCT02418949|592965037|FG003|Overall Study|Lost to Follow-up|0|||
164163640|NCT02418949|592965034|FG000|Overall Study|Physician Decision|1|||
164163641|NCT02418949|592965035|FG001|Overall Study|Physician Decision|1|||
164163642|NCT02418949|592965036|FG002|Overall Study|Physician Decision|1|||
164163643|NCT02418949|592965037|FG003|Overall Study|Physician Decision|0|||
164163644|NCT00396656|592965038|FG000|First Treatment Period|Withdrawal by Subject|0|||
164163645|NCT00396656|592965039|FG001|First Treatment Period|Withdrawal by Subject|2|||
164163646|NCT00396656|592965038|FG000|Second Treatment Period|Adverse Event|0|||
164163647|NCT00396656|592965039|FG001|Second Treatment Period|Adverse Event|1|||
164163648|NCT01303172|592965041|FG000|Overall Study|Physician Decision|9|||
164163649|NCT01303172|592965042|FG001|Overall Study|Physician Decision|6|||
164163650|NCT01303172|592965041|FG000|Overall Study|Adverse Event|5|||
164163651|NCT01303172|592965042|FG001|Overall Study|Adverse Event|2|||
164163652|NCT01303172|592965041|FG000|Overall Study|Withdrawal by Subject|4|||
164163653|NCT01303172|592965042|FG001|Overall Study|Withdrawal by Subject|2|||
164163654|NCT01303172|592965041|FG000|Overall Study|Death|20|||
164163655|NCT01303172|592965042|FG001|Overall Study|Death|7|||
164163656|NCT01303172|592965041|FG000|Overall Study|Lack of Efficacy|25|||
164163657|NCT01303172|592965042|FG001|Overall Study|Lack of Efficacy|17|||
164163658|NCT00462709|592965043|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
164163659|NCT00462709|592965043|FG000|Overall Study|Lost to Follow-up|10|||
164163660|NCT00462709|592965043|FG000|Overall Study|Withdrawal by Subject|8|||
164163661|NCT00462709|592965043|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
164163662|NCT00462709|592965043|FG000|Overall Study|Death|2|||
164163663|NCT00462709|592965043|FG000|Overall Study|Logistical reasons|2|||
164163664|NCT00462709|592965043|FG000|Overall Study|Physician Decision|1|||
164163665|NCT00462709|592965043|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
164163666|NCT02099110|592965048|FG000|Overall Study|Protocol Violation|2|||
164163667|NCT02099110|592965049|FG001|Overall Study|Protocol Violation|1|||
164163668|NCT02099110|592965050|FG002|Overall Study|Protocol Violation|0|||
164163669|NCT02099110|592965051|FG003|Overall Study|Protocol Violation|3|||
164163670|NCT02099110|592965052|FG004|Overall Study|Protocol Violation|1|||
164163671|NCT02099110|592965048|FG000|Overall Study|Participant moved|1|||
164163672|NCT02099110|592965049|FG001|Overall Study|Participant moved|1|||
164163673|NCT02099110|592965050|FG002|Overall Study|Participant moved|1|||
164163674|NCT02099110|592965051|FG003|Overall Study|Participant moved|0|||
164163675|NCT02099110|592965052|FG004|Overall Study|Participant moved|2|||
164163676|NCT02099110|592965048|FG000|Overall Study|Withdrawal by Subject|7|||
164163677|NCT02099110|592965049|FG001|Overall Study|Withdrawal by Subject|11|||
164163678|NCT02099110|592965050|FG002|Overall Study|Withdrawal by Subject|13|||
164163679|NCT02099110|592965051|FG003|Overall Study|Withdrawal by Subject|9|||
164163680|NCT02099110|592965052|FG004|Overall Study|Withdrawal by Subject|13|||
164163681|NCT02099110|592965048|FG000|Overall Study|Adverse Event|3|||
164163682|NCT02099110|592965049|FG001|Overall Study|Adverse Event|5|||
164163683|NCT02099110|592965050|FG002|Overall Study|Adverse Event|2|||
164163684|NCT02099110|592965051|FG003|Overall Study|Adverse Event|3|||
164163685|NCT02099110|592965052|FG004|Overall Study|Adverse Event|2|||
164163686|NCT02099110|592965048|FG000|Overall Study|Lost to Follow-up|6|||
164163687|NCT02099110|592965049|FG001|Overall Study|Lost to Follow-up|12|||
164163688|NCT02099110|592965050|FG002|Overall Study|Lost to Follow-up|11|||
164163689|NCT02099110|592965051|FG003|Overall Study|Lost to Follow-up|5|||
164163690|NCT02099110|592965052|FG004|Overall Study|Lost to Follow-up|6|||
164163691|NCT02099110|592965048|FG000|Overall Study|Death|0|||
164163692|NCT02099110|592965049|FG001|Overall Study|Death|1|||
164163693|NCT02099110|592965050|FG002|Overall Study|Death|0|||
164163694|NCT02099110|592965051|FG003|Overall Study|Death|0|||
164163695|NCT02099110|592965052|FG004|Overall Study|Death|0|||
164163696|NCT02099110|592965048|FG000|Overall Study|Screen failure|0|||
164163697|NCT02099110|592965049|FG001|Overall Study|Screen failure|0|||
164163698|NCT02099110|592965050|FG002|Overall Study|Screen failure|0|||
164163699|NCT02099110|592965051|FG003|Overall Study|Screen failure|0|||
164163700|NCT02099110|592965052|FG004|Overall Study|Screen failure|1|||
164163701|NCT02099110|592965048|FG000|Overall Study|Non-compliance with study drug|2|||
164163702|NCT02099110|592965049|FG001|Overall Study|Non-compliance with study drug|0|||
164163703|NCT02099110|592965050|FG002|Overall Study|Non-compliance with study drug|0|||
164163704|NCT02099110|592965051|FG003|Overall Study|Non-compliance with study drug|0|||
164163705|NCT02099110|592965052|FG004|Overall Study|Non-compliance with study drug|1|||
164163706|NCT02099110|592965048|FG000|Overall Study|Physician Decision|3|||
164163707|NCT02099110|592965049|FG001|Overall Study|Physician Decision|0|||
164163708|NCT02099110|592965050|FG002|Overall Study|Physician Decision|1|||
164163709|NCT02099110|592965051|FG003|Overall Study|Physician Decision|2|||
164163710|NCT02099110|592965052|FG004|Overall Study|Physician Decision|1|||
164163711|NCT03515811|592965059|FG000|Overall Study|Lost to Follow-up|2|||
164163712|NCT03515811|592965060|FG001|Overall Study|Lost to Follow-up|1|||
164163713|NCT03515811|592965059|FG000|Overall Study|Protocol Violation|1|||
164163714|NCT03515811|592965060|FG001|Overall Study|Protocol Violation|1|||
164163715|NCT03515811|592965059|FG000|Overall Study|Death|1|||
164163716|NCT03515811|592965060|FG001|Overall Study|Death|1|||
164163717|NCT03515811|592965059|FG000|Overall Study|Withdrawal by Subject|0|||
164163718|NCT03515811|592965060|FG001|Overall Study|Withdrawal by Subject|2|||
164163719|NCT03515811|592965059|FG000|Overall Study|Technical Problems|1|||
164163720|NCT03515811|592965060|FG001|Overall Study|Technical Problems|0|||
164163721|NCT03515811|592965059|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
164163722|NCT03515811|592965060|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
164163723|NCT03515811|592965059|FG000|Overall Study|COVID-19|0|||
164163724|NCT03515811|592965060|FG001|Overall Study|COVID-19|1|||
164163725|NCT00237458|592965061|FG000|Overall Study|Lack of Efficacy|1|||
164163726|NCT00237458|592965061|FG000|Overall Study|Adverse Event|1|||
164163727|NCT00237458|592965061|FG000|Overall Study|Withdrawal by Subject|1|||
164163728|NCT04657198|592965062|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
164163729|NCT04657198|592965063|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
164163730|NCT04657198|592965064|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
164163731|NCT02977572|592965065|FG000|Overall Study|Exclusion criterion|2|||
164163732|NCT02977572|592965066|FG001|Overall Study|Exclusion criterion|2|||
164163733|NCT01166438|592965069|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
164163734|NCT01166438|592965070|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
164163735|NCT01166438|592965069|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
164163736|NCT01166438|592965070|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
164163737|NCT01166438|592965069|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
164163738|NCT01166438|592965070|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
164163739|NCT01166438|592965069|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
164163740|NCT01166438|592965070|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
164163741|NCT01166438|592965069|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
164163742|NCT01166438|592965070|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
164163743|NCT01166438|592965069|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
164163744|NCT01166438|592965070|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
164163745|NCT01075256|592965071|FG000|Overall Study|Withdrawal by Subject|1|||
164163746|NCT01075256|592965072|FG001|Overall Study|Withdrawal by Subject|0|||
164163747|NCT01075256|592965073|FG002|Overall Study|Withdrawal by Subject|0|||
164163748|NCT03502070|592965074|FG000|Overall Study|Withdrawal by Subject|1|||
164163749|NCT03502070|592965074|FG000|Overall Study|Screen Failure|1|||
164163750|NCT01197534|592965079|FG000|Overall Study|Not reported|16|||
164163751|NCT01197534|592965080|FG001|Overall Study|Not reported|10|||
164163752|NCT01197534|592965081|FG002|Overall Study|Not reported|16|||
164163753|NCT01197534|592965079|FG000|Overall Study|Enrolment in long term extension|57|||
164163754|NCT01197534|592965080|FG001|Overall Study|Enrolment in long term extension|66|||
164163755|NCT01197534|592965081|FG002|Overall Study|Enrolment in long term extension|119|||
164163756|NCT01197534|592965079|FG000|Overall Study|Severe non-compliance to protocol|3|||
164163757|NCT01197534|592965080|FG001|Overall Study|Severe non-compliance to protocol|4|||
164163758|NCT01197534|592965081|FG002|Overall Study|Severe non-compliance to protocol|1|||
164163759|NCT01197534|592965079|FG000|Overall Study|Lack of therapeutic response|9|||
164163760|NCT01197534|592965080|FG001|Overall Study|Lack of therapeutic response|4|||
164163761|NCT01197534|592965081|FG002|Overall Study|Lack of therapeutic response|9|||
164163762|NCT01197534|592965079|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
164163763|NCT01197534|592965080|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
164163764|NCT01197534|592965081|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
164163765|NCT01197534|592965079|FG000|Overall Study|Lost to Follow-up|1|||
164163766|NCT01197534|592965080|FG001|Overall Study|Lost to Follow-up|4|||
164163767|NCT01197534|592965081|FG002|Overall Study|Lost to Follow-up|2|||
164163768|NCT01197534|592965079|FG000|Overall Study|Adverse Event|35|||
164163769|NCT01197534|592965080|FG001|Overall Study|Adverse Event|36|||
164163770|NCT01197534|592965081|FG002|Overall Study|Adverse Event|24|||
164163771|NCT02593097|592965090|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
164163772|NCT02593097|592965091|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
164163773|NCT02593097|592965090|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
164163774|NCT02593097|592965091|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
164163775|NCT02593097|592965090|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
164163776|NCT02593097|592965091|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
164163777|NCT02593097|592965090|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
164163778|NCT02593097|592965091|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
164163779|NCT02593097|592965090|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
164163780|NCT02593097|592965091|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
164163781|NCT03759587|592965092|FG000|Overall Study|Adverse Event|5|||
164163782|NCT03759587|592965092|FG000|Overall Study|Progressive Disease|10|||
164163783|NCT03759587|592965092|FG000|Overall Study|Site Terminated by Sponsor|3|||
164163784|NCT03759587|592965092|FG000|Overall Study|Withdrawal by Subject|1|||
164163785|NCT00591565|592965095|FG000|Overall Study|lost follow up, withdrawn|5|||
164163786|NCT00454363|592965096|FG000|Overall Study|Adverse Event|1|||
164163787|NCT00454363|592965097|FG001|Overall Study|Adverse Event|2|||
164163788|NCT00454363|592965096|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
164163789|NCT00454363|592965097|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
164163790|NCT01554527|592965099|FG000|Overall Study|Withdrawal by Subject|1|||
164163791|NCT01554527|592965100|FG001|Overall Study|Withdrawal by Subject|0|||
164163792|NCT01554527|592965101|FG002|Overall Study|Withdrawal by Subject|3|||
164163793|NCT01554527|592965099|FG000|Overall Study|Lost to Follow-up|0|||
164163794|NCT01554527|592965100|FG001|Overall Study|Lost to Follow-up|0|||
164163795|NCT01554527|592965101|FG002|Overall Study|Lost to Follow-up|4|||
164163796|NCT01554527|592965099|FG000|Overall Study|Physician Decision|0|||
164163797|NCT01554527|592965100|FG001|Overall Study|Physician Decision|0|||
164163798|NCT01554527|592965101|FG002|Overall Study|Physician Decision|1|||
164163799|NCT01863667|592965108|FG000|Overall Study|Adverse Event|1|||
164163800|NCT01863667|592965109|FG001|Overall Study|Adverse Event|0|||
164163801|NCT01863667|592965108|FG000|Overall Study|Study terminated by Sponsor|30|||
164163802|NCT01863667|592965109|FG001|Overall Study|Study terminated by Sponsor|30|||
164163803|NCT01863667|592965108|FG000|Overall Study|Withdrawal by Subject|2|||
164163804|NCT01863667|592965109|FG001|Overall Study|Withdrawal by Subject|2|||
164163805|NCT01537042|592965112|FG000|Overall Study|Adverse Event|0|||
164163806|NCT01537042|592965113|FG001|Overall Study|Adverse Event|2|||
164163807|NCT01537042|592965112|FG000|Overall Study|Lack of Efficacy|0|||
164163808|NCT01537042|592965113|FG001|Overall Study|Lack of Efficacy|1|||
164163809|NCT01537042|592965112|FG000|Overall Study|Protocol Violation|0|||
164163810|NCT01537042|592965113|FG001|Overall Study|Protocol Violation|1|||
164163811|NCT01537042|592965112|FG000|Overall Study|Other|0|||
164163812|NCT01537042|592965113|FG001|Overall Study|Other|1|||
164163813|NCT00315458|592965116|FG000|Overall Study|Administrative|0|||
164163814|NCT00315458|592965117|FG001|Overall Study|Administrative|3|||
164163815|NCT00315458|592965118|FG002|Overall Study|Administrative|8|||
164163816|NCT00315458|592965119|FG003|Overall Study|Administrative|21|||
164163817|NCT00315458|592965116|FG000|Overall Study|Adverse Event|2|||
164163818|NCT00315458|592965117|FG001|Overall Study|Adverse Event|4|||
164163819|NCT00315458|592965118|FG002|Overall Study|Adverse Event|23|||
164163820|NCT00315458|592965119|FG003|Overall Study|Adverse Event|3|||
164163821|NCT00315458|592965116|FG000|Overall Study|Lost to Follow-up|1|||
164163822|NCT00315458|592965117|FG001|Overall Study|Lost to Follow-up|2|||
164163823|NCT00315458|592965118|FG002|Overall Study|Lost to Follow-up|0|||
164163824|NCT00315458|592965119|FG003|Overall Study|Lost to Follow-up|2|||
164163825|NCT00315458|592965116|FG000|Overall Study|Withdrawal by Subject|0|||
164163826|NCT00315458|592965117|FG001|Overall Study|Withdrawal by Subject|3|||
164163827|NCT00315458|592965118|FG002|Overall Study|Withdrawal by Subject|0|||
164163828|NCT00315458|592965119|FG003|Overall Study|Withdrawal by Subject|2|||
164163829|NCT00315458|592965116|FG000|Overall Study|Lack of Efficacy|0|||
164163830|NCT00315458|592965117|FG001|Overall Study|Lack of Efficacy|0|||
164163831|NCT00315458|592965118|FG002|Overall Study|Lack of Efficacy|20|||
164163832|NCT00315458|592965119|FG003|Overall Study|Lack of Efficacy|1|||
164163833|NCT00315458|592965116|FG000|Overall Study|Did not qualify|0|||
164163834|NCT00315458|592965117|FG001|Overall Study|Did not qualify|0|||
164163835|NCT00315458|592965118|FG002|Overall Study|Did not qualify|1|||
164163836|NCT00315458|592965119|FG003|Overall Study|Did not qualify|0|||
164163837|NCT00086619|592965122|FG000|Overall Study|Withdrawal by Subject|6|||
164163838|NCT00086619|592965123|FG001|Overall Study|Withdrawal by Subject|6|||
164163839|NCT00086619|592965122|FG000|Overall Study|Adverse Event|8|||
164163840|NCT00086619|592965123|FG001|Overall Study|Adverse Event|10|||
164163841|NCT00086619|592965122|FG000|Overall Study|Protocol Violation|1|||
164163842|NCT00086619|592965123|FG001|Overall Study|Protocol Violation|1|||
164163843|NCT00489918|592965124|FG000|Overall Study|Withdrawal by Subject|2|||
164163844|NCT00489918|592965125|FG001|Overall Study|Withdrawal by Subject|1|||
164163845|NCT00489918|592965126|FG002|Overall Study|Withdrawal by Subject|1|||
164163846|NCT00489918|592965127|FG003|Overall Study|Withdrawal by Subject|0|||
164163847|NCT00489918|592965128|FG004|Overall Study|Withdrawal by Subject|1|||
164163848|NCT00489918|592965124|FG000|Overall Study|Adverse Event|0|||
164163849|NCT00489918|592965125|FG001|Overall Study|Adverse Event|1|||
164163850|NCT00489918|592965126|FG002|Overall Study|Adverse Event|1|||
164163851|NCT00489918|592965127|FG003|Overall Study|Adverse Event|0|||
164163852|NCT00489918|592965128|FG004|Overall Study|Adverse Event|0|||
164163853|NCT00489918|592965124|FG000|Overall Study|Lost to Follow-up|0|||
164163854|NCT00489918|592965125|FG001|Overall Study|Lost to Follow-up|0|||
164163855|NCT00489918|592965126|FG002|Overall Study|Lost to Follow-up|1|||
164163856|NCT00489918|592965127|FG003|Overall Study|Lost to Follow-up|1|||
164163857|NCT00489918|592965128|FG004|Overall Study|Lost to Follow-up|0|||
164163858|NCT00489918|592965124|FG000|Overall Study|Physician Decision|0|||
164163859|NCT00489918|592965125|FG001|Overall Study|Physician Decision|0|||
164163860|NCT00489918|592965126|FG002|Overall Study|Physician Decision|1|||
164163861|NCT00489918|592965127|FG003|Overall Study|Physician Decision|0|||
164163862|NCT00489918|592965128|FG004|Overall Study|Physician Decision|0|||
164163863|NCT02748213|592965129|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
164163864|NCT02748213|592965130|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
164163865|NCT02748213|592965129|FG000|Overall Study|Abnormal Laboratory Test|1|||
164163866|NCT02748213|592965130|FG001|Overall Study|Abnormal Laboratory Test|0|||
164163867|NCT02748213|592965129|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
164163868|NCT02748213|592965130|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
164163869|NCT02748213|592965129|FG000|Overall Study|Death|5|||
164163870|NCT02748213|592965130|FG001|Overall Study|Death|3|||
164163871|NCT02748213|592965129|FG000|Overall Study|Insufficient Therapeutic Response|56|||
164163872|NCT02748213|592965130|FG001|Overall Study|Insufficient Therapeutic Response|57|||
164163873|NCT02748213|592965129|FG000|Overall Study|Violation of Selection Criteria|2|||
164163874|NCT02748213|592965130|FG001|Overall Study|Violation of Selection Criteria|0|||
164163875|NCT02748213|592965129|FG000|Overall Study|Protocol Violation|6|||
164163876|NCT02748213|592965130|FG001|Overall Study|Protocol Violation|4|||
164163877|NCT02748213|592965129|FG000|Overall Study|Refused Treatment*|6|||
164163878|NCT02748213|592965130|FG001|Overall Study|Refused Treatment*|6|||
164163879|NCT02748213|592965129|FG000|Overall Study|Failure to Return|1|||
164163880|NCT02748213|592965130|FG001|Overall Study|Failure to Return|0|||
164163881|NCT02748213|592965129|FG000|Overall Study|Other|30|||
164163882|NCT02748213|592965130|FG001|Overall Study|Other|29|||
164163883|NCT03232931|592966597|FG000|Overall Study|Physician Decision|1|||
164163884|NCT03232931|592966598|FG001|Overall Study|Physician Decision|1|||
164163885|NCT03232931|592966597|FG000|Overall Study|Withdrawal by Subject|6|||
164163886|NCT03232931|592966598|FG001|Overall Study|Withdrawal by Subject|0|||
164163887|NCT03232931|592966597|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
164163888|NCT03232931|592966598|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
164163889|NCT03232931|592966597|FG000|Overall Study|Parent did not record voice|1|||
164163890|NCT03232931|592966598|FG001|Overall Study|Parent did not record voice|2|||
164163891|NCT03232931|592966597|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
164163892|NCT03232931|592966598|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
164163893|NCT01270464|592966602|FG000|Overall Study|Protocol Violation|4|||
164163894|NCT01270464|592966603|FG001|Overall Study|Protocol Violation|3|||
164163895|NCT01270464|592966604|FG002|Overall Study|Protocol Violation|2|||
164163896|NCT01270464|592966602|FG000|Overall Study|Lack of Efficacy|2|||
164163897|NCT01270464|592966603|FG001|Overall Study|Lack of Efficacy|3|||
164163898|NCT01270464|592966604|FG002|Overall Study|Lack of Efficacy|1|||
164163899|NCT01270464|592966602|FG000|Overall Study|Adverse Event|9|||
164163900|NCT01270464|592966603|FG001|Overall Study|Adverse Event|1|||
164163901|NCT01270464|592966604|FG002|Overall Study|Adverse Event|7|||
164163902|NCT01270464|592966602|FG000|Overall Study|Withdrawal by Subject|2|||
164163903|NCT01270464|592966603|FG001|Overall Study|Withdrawal by Subject|1|||
164163904|NCT01270464|592966604|FG002|Overall Study|Withdrawal by Subject|4|||
164163905|NCT01270464|592966602|FG000|Overall Study|Lost to Follow-up|2|||
164163906|NCT01270464|592966603|FG001|Overall Study|Lost to Follow-up|3|||
164163907|NCT01270464|592966604|FG002|Overall Study|Lost to Follow-up|1|||
164163908|NCT01270464|592966602|FG000|Overall Study|Other|1|||
164163909|NCT01270464|592966603|FG001|Overall Study|Other|1|||
164163910|NCT01270464|592966604|FG002|Overall Study|Other|3|||
164163911|NCT01750697|592966606|FG000|Overall Study|Transferred Back to Local Hospital|1|||
164163912|NCT01750697|592966606|FG000|Overall Study|Physician and Family Decision|1|||
164163913|NCT01750697|592966606|FG000|Overall Study|Transferred to Adult Services|5|||
164163914|NCT01750697|592966606|FG000|Overall Study|Physician Decision|1|||
164163915|NCT01750697|592966606|FG000|Overall Study|Withdrawal by Subject|1|||
164163916|NCT00384839|592966620|FG000|Overall Study|Adverse Event|4|||
164163917|NCT00384839|592966620|FG000|Overall Study|Investigator Request|1|||
164163918|NCT00384839|592966620|FG000|Overall Study|Patient Request|1|||
164163919|NCT00384839|592966620|FG000|Overall Study|Ineligible|2|||
164163920|NCT02049814|592966623|FG000|Overall Study|Reason not Specified|4|||
164163921|NCT02049814|592966624|FG001|Overall Study|Reason not Specified|3|||
164163922|NCT02049814|592966623|FG000|Overall Study|Pregnancy|1|||
164163923|NCT02049814|592966624|FG001|Overall Study|Pregnancy|0|||
164163924|NCT02049814|592966623|FG000|Overall Study|Lost to Follow-up|2|||
164163925|NCT02049814|592966624|FG001|Overall Study|Lost to Follow-up|3|||
164163926|NCT02049814|592966623|FG000|Overall Study|Serious Protocol Violation|5|||
164163927|NCT02049814|592966624|FG001|Overall Study|Serious Protocol Violation|7|||
164163928|NCT02049814|592966623|FG000|Overall Study|Study Termination|0|||
164163929|NCT02049814|592966624|FG001|Overall Study|Study Termination|1|||
164163930|NCT02049814|592966623|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
164163931|NCT02049814|592966624|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
164163932|NCT02049814|592966623|FG000|Overall Study|Voluntary withdrawal|9|||
164163933|NCT02049814|592966624|FG001|Overall Study|Voluntary withdrawal|8|||
164163934|NCT02714595|592966627|FG000|Overall Study|Lost to Follow-up|1|||
164163935|NCT02714595|592966628|FG001|Overall Study|Lost to Follow-up|0|||
164163936|NCT02714595|592966627|FG000|Overall Study|Withdrawal by Subject|1|||
164163937|NCT02714595|592966628|FG001|Overall Study|Withdrawal by Subject|2|||
164163938|NCT02714595|592966627|FG000|Overall Study|Lack of Efficacy|0|||
164163939|NCT02714595|592966628|FG001|Overall Study|Lack of Efficacy|1|||
164163940|NCT02714595|592966627|FG000|Overall Study|Death|30|||
164163941|NCT02714595|592966628|FG001|Overall Study|Death|9|||
164163942|NCT02714595|592966627|FG000|Overall Study|Other-Miscellaneous|0|||
164163943|NCT02714595|592966628|FG001|Overall Study|Other-Miscellaneous|1|||
164163944|NCT00713258|592966629|FG000|Overall Study|Adverse Event|2|||
164163945|NCT00713258|592966630|FG001|Overall Study|Adverse Event|4|||
164163946|NCT00713258|592966629|FG000|Overall Study|Non-Compliance|2|||
164163947|NCT00713258|592966630|FG001|Overall Study|Non-Compliance|1|||
164163948|NCT00713258|592966629|FG000|Overall Study|Other|1|||
164163949|NCT00713258|592966630|FG001|Overall Study|Other|1|||
164163950|NCT01322490|592966631|FG000|Treatment Period|Adverse Event|12|||
164163951|NCT01322490|592966632|FG001|Treatment Period|Adverse Event|18|||
164163952|NCT01322490|592966633|FG002|Treatment Period|Adverse Event|15|||
164163953|NCT01322490|592966631|FG000|Treatment Period|Death|5|||
164163954|NCT01322490|592966632|FG001|Treatment Period|Death|7|||
164163955|NCT01322490|592966633|FG002|Treatment Period|Death|3|||
164163956|NCT01322490|592966631|FG000|Treatment Period|Lack of Efficacy|89|||
164163957|NCT01322490|592966632|FG001|Treatment Period|Lack of Efficacy|100|||
164163958|NCT01322490|592966633|FG002|Treatment Period|Lack of Efficacy|112|||
164163959|NCT01322490|592966631|FG000|Treatment Period|Physician Decision|0|||
164163960|NCT01322490|592966632|FG001|Treatment Period|Physician Decision|2|||
164163961|NCT01322490|592966633|FG002|Treatment Period|Physician Decision|1|||
164163962|NCT01322490|592966631|FG000|Treatment Period|Protocol Violation|7|||
164163963|NCT01322490|592966632|FG001|Treatment Period|Protocol Violation|5|||
164163964|NCT01322490|592966633|FG002|Treatment Period|Protocol Violation|4|||
164163965|NCT01322490|592966631|FG000|Treatment Period|Withdrawal by Subject|14|||
164163966|NCT01322490|592966632|FG001|Treatment Period|Withdrawal by Subject|16|||
164163967|NCT01322490|592966633|FG002|Treatment Period|Withdrawal by Subject|11|||
164163968|NCT01322490|592966631|FG000|Treatment Period|Non-compliance with study drug|0|||
164163969|NCT01322490|592966632|FG001|Treatment Period|Non-compliance with study drug|0|||
164163970|NCT01322490|592966633|FG002|Treatment Period|Non-compliance with study drug|1|||
164163971|NCT01322490|592966631|FG000|Treatment Period|Other per report|2|||
164163972|NCT01322490|592966632|FG001|Treatment Period|Other per report|2|||
164163973|NCT01322490|592966633|FG002|Treatment Period|Other per report|1|||
164163974|NCT01322490|592966631|FG000|Treatment Period|Randomized but Not Treated|3|||
164163975|NCT01322490|592966632|FG001|Treatment Period|Randomized but Not Treated|3|||
164163976|NCT01322490|592966633|FG002|Treatment Period|Randomized but Not Treated|5|||
164163977|NCT01322490|592966631|FG000|Long Term Follow-up Period|Death|235|||
164163978|NCT01322490|592966632|FG001|Long Term Follow-up Period|Death|239|||
164163979|NCT01322490|592966633|FG002|Long Term Follow-up Period|Death|236|||
164163980|NCT01322490|592966631|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
164163981|NCT01322490|592966632|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
164163982|NCT01322490|592966633|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
164163983|NCT01322490|592966631|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
164163984|NCT01322490|592966632|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
164163985|NCT01322490|592966633|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
164163986|NCT01322490|592966631|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
164163987|NCT01322490|592966632|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
164163988|NCT01322490|592966633|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
164163989|NCT01322490|592966631|FG000|Long Term Follow-up Period|Other per report|3|||
164163990|NCT01322490|592966632|FG001|Long Term Follow-up Period|Other per report|2|||
164163991|NCT01322490|592966633|FG002|Long Term Follow-up Period|Other per report|2|||
164163992|NCT01322490|592966631|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
164163993|NCT01322490|592966632|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
164163994|NCT01322490|592966633|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
164163995|NCT02257489|592966636|FG000|Overall Study|Withdrawal by Subject|0|||
164163996|NCT02257489|592966637|FG001|Overall Study|Withdrawal by Subject|0|||
164163997|NCT02257489|592966638|FG002|Overall Study|Withdrawal by Subject|0|||
164163998|NCT02257489|592966639|FG003|Overall Study|Withdrawal by Subject|1|||
164163999|NCT02257489|592966640|FG004|Overall Study|Withdrawal by Subject|0|||
164164000|NCT02257489|592966641|FG005|Overall Study|Withdrawal by Subject|0|||
164164001|NCT02257489|592966642|FG006|Overall Study|Withdrawal by Subject|0|||
164164002|NCT02257489|592966643|FG007|Overall Study|Withdrawal by Subject|0|||
164164003|NCT02257489|592966644|FG008|Overall Study|Withdrawal by Subject|0|||
164164004|NCT04606394|592966645|FG000|Overall Study|Withdrawal by Subject|3|||
164164005|NCT04606394|592966645|FG000|Overall Study|Exclusion criteria screen failure|12|||
164164006|NCT01431716|592966646|FG000|Overall Study|Withdrawal of consent|1|||
164164007|NCT02484456|592966649|FG000|Washout Period|Withdrawal by Subject|0|||
164164008|NCT02484456|592966650|FG001|Washout Period|Withdrawal by Subject|1|||
164164009|NCT02484456|592966649|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
164164010|NCT02484456|592966650|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
164164011|NCT02484456|592966649|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
164164012|NCT02484456|592966650|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
164164013|NCT02484456|592966649|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
164164014|NCT02484456|592966650|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
164164015|NCT00708214|592966651|FG000|Overall Study|Other Adverse Event|3|||
164164016|NCT00708214|592966652|FG001|Overall Study|Other Adverse Event|6|||
164164017|NCT00708214|592966653|FG002|Overall Study|Other Adverse Event|2|||
164164018|NCT00708214|592966651|FG000|Overall Study|Other|0|||
164164019|NCT00708214|592966652|FG001|Overall Study|Other|1|||
164164020|NCT00708214|592966653|FG002|Overall Study|Other|1|||
164164021|NCT00708214|592966651|FG000|Overall Study|Progressive Disease|4|||
164164022|NCT00708214|592966652|FG001|Overall Study|Progressive Disease|6|||
164164023|NCT00708214|592966653|FG002|Overall Study|Progressive Disease|5|||
164164024|NCT02199795|592966654|FG000|Overall Study|no longer met inclusion criteria|1|||
164164025|NCT02199795|592966655|FG001|Overall Study|no longer met inclusion criteria|0|||
164164026|NCT02199795|592966654|FG000|Overall Study|withdrew due to shoulder pain|1|||
164164027|NCT02199795|592966655|FG001|Overall Study|withdrew due to shoulder pain|0|||
164164028|NCT01908829|592966659|FG000|Overall Study|Adverse Event|13|||
164164029|NCT01908829|592966660|FG001|Overall Study|Adverse Event|11|||
164164030|NCT01908829|592966661|FG002|Overall Study|Adverse Event|13|||
164164031|NCT01908829|592966659|FG000|Overall Study|Lost to Follow-up|4|||
164164032|NCT01908829|592966660|FG001|Overall Study|Lost to Follow-up|2|||
164164033|NCT01908829|592966661|FG002|Overall Study|Lost to Follow-up|1|||
164164034|NCT01908829|592966659|FG000|Overall Study|Randomized no double-blind drug received|1|||
164164035|NCT01908829|592966660|FG001|Overall Study|Randomized no double-blind drug received|0|||
164164036|NCT01908829|592966661|FG002|Overall Study|Randomized no double-blind drug received|1|||
164164037|NCT01908829|592966659|FG000|Overall Study|Discontinued (no EoT page)|2|||
164164038|NCT01908829|592966660|FG001|Overall Study|Discontinued (no EoT page)|0|||
164164039|NCT01908829|592966661|FG002|Overall Study|Discontinued (no EoT page)|0|||
164164040|NCT01908829|592966659|FG000|Overall Study|Miscellaneous|0|||
164164041|NCT01908829|592966660|FG001|Overall Study|Miscellaneous|2|||
164164042|NCT01908829|592966661|FG002|Overall Study|Miscellaneous|0|||
164164043|NCT01908829|592966659|FG000|Overall Study|Protocol Violation|2|||
164164044|NCT01908829|592966660|FG001|Overall Study|Protocol Violation|2|||
164164045|NCT01908829|592966661|FG002|Overall Study|Protocol Violation|0|||
164164046|NCT01908829|592966659|FG000|Overall Study|Lack of Efficacy|1|||
164164047|NCT01908829|592966660|FG001|Overall Study|Lack of Efficacy|3|||
164164048|NCT01908829|592966661|FG002|Overall Study|Lack of Efficacy|2|||
164164049|NCT01908829|592966659|FG000|Overall Study|Withdrawal by Subject|26|||
164164050|NCT01908829|592966660|FG001|Overall Study|Withdrawal by Subject|29|||
164164051|NCT01908829|592966661|FG002|Overall Study|Withdrawal by Subject|22|||
164164052|NCT01339923|592966662|FG000|Overall Study|Adverse Event|1|||
164164053|NCT01339923|592966663|FG001|Overall Study|Adverse Event|1|||
164164054|NCT01339923|592966664|FG002|Overall Study|Adverse Event|1|||
164164055|NCT01339923|592966665|FG003|Overall Study|Adverse Event|0|||
164164056|NCT01339923|592966666|FG004|Overall Study|Adverse Event|0|||
164164057|NCT01339923|592966667|FG005|Overall Study|Adverse Event|0|||
164164058|NCT01339923|592966668|FG006|Overall Study|Adverse Event|1|||
164164059|NCT01339923|592966662|FG000|Overall Study|Inappropriate Enrollment|1|||
164164060|NCT01339923|592966663|FG001|Overall Study|Inappropriate Enrollment|0|||
164164061|NCT01339923|592966664|FG002|Overall Study|Inappropriate Enrollment|0|||
164164062|NCT01339923|592966665|FG003|Overall Study|Inappropriate Enrollment|0|||
164164063|NCT01339923|592966666|FG004|Overall Study|Inappropriate Enrollment|0|||
164164064|NCT01339923|592966667|FG005|Overall Study|Inappropriate Enrollment|1|||
164164065|NCT01339923|592966668|FG006|Overall Study|Inappropriate Enrollment|0|||
164164066|NCT01339923|592966662|FG000|Overall Study|Lost to Follow-up|4|||
164164067|NCT01339923|592966663|FG001|Overall Study|Lost to Follow-up|4|||
164164068|NCT01339923|592966664|FG002|Overall Study|Lost to Follow-up|0|||
164164069|NCT01339923|592966665|FG003|Overall Study|Lost to Follow-up|3|||
164164070|NCT01339923|592966666|FG004|Overall Study|Lost to Follow-up|1|||
164164071|NCT01339923|592966667|FG005|Overall Study|Lost to Follow-up|1|||
164164072|NCT01339923|592966668|FG006|Overall Study|Lost to Follow-up|5|||
164164073|NCT01339923|592966662|FG000|Overall Study|Protocol Violation|0|||
164164074|NCT01339923|592966663|FG001|Overall Study|Protocol Violation|0|||
164164075|NCT01339923|592966664|FG002|Overall Study|Protocol Violation|0|||
164164076|NCT01339923|592966665|FG003|Overall Study|Protocol Violation|0|||
164164077|NCT01339923|592966666|FG004|Overall Study|Protocol Violation|0|||
164164078|NCT01339923|592966667|FG005|Overall Study|Protocol Violation|3|||
164164079|NCT01339923|592966668|FG006|Overall Study|Protocol Violation|1|||
164164080|NCT01339923|592966662|FG000|Overall Study|Unable to Classify|1|||
164164081|NCT01339923|592966663|FG001|Overall Study|Unable to Classify|0|||
164164082|NCT01339923|592966664|FG002|Overall Study|Unable to Classify|1|||
164164083|NCT01339923|592966665|FG003|Overall Study|Unable to Classify|0|||
164164084|NCT01339923|592966666|FG004|Overall Study|Unable to Classify|0|||
164164085|NCT01339923|592966667|FG005|Overall Study|Unable to Classify|1|||
164164086|NCT01339923|592966668|FG006|Overall Study|Unable to Classify|5|||
164164087|NCT01339923|592966662|FG000|Overall Study|Withdrawal by Subject|7|||
164164088|NCT01339923|592966663|FG001|Overall Study|Withdrawal by Subject|11|||
164164089|NCT01339923|592966664|FG002|Overall Study|Withdrawal by Subject|6|||
164164090|NCT01339923|592966665|FG003|Overall Study|Withdrawal by Subject|1|||
164164091|NCT01339923|592966666|FG004|Overall Study|Withdrawal by Subject|4|||
164164092|NCT01339923|592966667|FG005|Overall Study|Withdrawal by Subject|3|||
164164093|NCT01339923|592966668|FG006|Overall Study|Withdrawal by Subject|2|||
164164094|NCT00828568|592966680|FG000|Randomized|Withdrawal by Subject|1|||
164164095|NCT00828568|592966681|FG001|Randomized|Withdrawal by Subject|0|||
164164096|NCT00828568|592966682|FG002|Randomized|Withdrawal by Subject|2|||
164164097|NCT00828568|592966680|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
164164098|NCT00828568|592966681|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
164164099|NCT00828568|592966682|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
164164100|NCT00828568|592966680|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
164164101|NCT00828568|592966681|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
164164102|NCT00828568|592966682|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
164164103|NCT00828568|592966680|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
164164104|NCT00828568|592966681|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
164164105|NCT00828568|592966682|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
164164106|NCT00828568|592966680|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
164164107|NCT00828568|592966681|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
164164108|NCT00828568|592966682|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
164164109|NCT02091089|592966684|FG000|Overall Study|Lost to Follow-up|2|||
164164110|NCT00460811|592966685|FG000|Overall Study|Adverse Event|4|||
164164111|NCT00460811|592966686|FG001|Overall Study|Adverse Event|6|||
164164112|NCT00460811|592966687|FG002|Overall Study|Adverse Event|3|||
164164113|NCT00460811|592966688|FG003|Overall Study|Adverse Event|10|||
164164114|NCT00460811|592966689|FG004|Overall Study|Adverse Event|2|||
164164115|NCT00460811|592966685|FG000|Overall Study|Noncompliance|1|||
164164116|NCT00460811|592966686|FG001|Overall Study|Noncompliance|0|||
164164117|NCT00460811|592966687|FG002|Overall Study|Noncompliance|0|||
164164118|NCT00460811|592966688|FG003|Overall Study|Noncompliance|2|||
164164119|NCT00460811|592966689|FG004|Overall Study|Noncompliance|1|||
164164120|NCT00460811|592966685|FG000|Overall Study|Withdrawal by Subject|7|||
164164121|NCT00460811|592966686|FG001|Overall Study|Withdrawal by Subject|7|||
164164122|NCT00460811|592966687|FG002|Overall Study|Withdrawal by Subject|6|||
164164123|NCT00460811|592966688|FG003|Overall Study|Withdrawal by Subject|3|||
164164124|NCT00460811|592966689|FG004|Overall Study|Withdrawal by Subject|11|||
164164125|NCT00460811|592966685|FG000|Overall Study|Physician Decision|1|||
164164126|NCT00460811|592966686|FG001|Overall Study|Physician Decision|0|||
164164127|NCT00460811|592966687|FG002|Overall Study|Physician Decision|0|||
164164128|NCT00460811|592966688|FG003|Overall Study|Physician Decision|0|||
164164129|NCT00460811|592966689|FG004|Overall Study|Physician Decision|0|||
164164130|NCT00460811|592966685|FG000|Overall Study|Lost to Follow-up|3|||
164164131|NCT00460811|592966686|FG001|Overall Study|Lost to Follow-up|2|||
164164132|NCT00460811|592966687|FG002|Overall Study|Lost to Follow-up|5|||
164164133|NCT00460811|592966688|FG003|Overall Study|Lost to Follow-up|3|||
164164134|NCT00460811|592966689|FG004|Overall Study|Lost to Follow-up|6|||
164164135|NCT02821754|592966690|FG000|Overall Study|Procedure not required prior to amendment change|13|||
164164136|NCT02821754|592966691|FG001|Overall Study|Procedure not required prior to amendment change|11|||
164164137|NCT02821754|592966692|FG002|Overall Study|Procedure not required prior to amendment change|0|||
164164138|NCT02821754|592966690|FG000|Overall Study|Participant's Clinical status|2|||
164164139|NCT02821754|592966691|FG001|Overall Study|Participant's Clinical status|0|||
164164140|NCT02821754|592966692|FG002|Overall Study|Participant's Clinical status|0|||
164164141|NCT02821754|592966690|FG000|Overall Study|Participant removed for noncompliance|1|||
164164142|NCT02821754|592966691|FG001|Overall Study|Participant removed for noncompliance|0|||
164164143|NCT02821754|592966692|FG002|Overall Study|Participant removed for noncompliance|0|||
164164144|NCT02821754|592966690|FG000|Overall Study|Drug not available.|0|||
164164145|NCT02821754|592966691|FG001|Overall Study|Drug not available.|0|||
164164146|NCT02821754|592966692|FG002|Overall Study|Drug not available.|1|||
164164147|NCT02821754|592966690|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
164164148|NCT02821754|592966691|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
164164149|NCT02821754|592966692|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
164164150|NCT00364923|592966697|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
164164151|NCT00364923|592966697|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
164164152|NCT00766636|592966701|FG000|Overall Study|Withdrawal by Subject|1|||
164164153|NCT00766636|592966702|FG001|Overall Study|Withdrawal by Subject|1|||
164164154|NCT00766636|592966701|FG000|Overall Study|Incomplete Treatment|0|||
164164155|NCT00766636|592966702|FG001|Overall Study|Incomplete Treatment|1|||
164164156|NCT00766636|592966701|FG000|Overall Study|Adverse Event|1|||
164164157|NCT00766636|592966702|FG001|Overall Study|Adverse Event|0|||
164164158|NCT00766636|592966701|FG000|Overall Study|Disease Progression|1|||
164164159|NCT00766636|592966702|FG001|Overall Study|Disease Progression|0|||
164164160|NCT01355575|592966703|FG000|Overall Study|Withdrawal by Subject|2|||
164164161|NCT02477332|592966706|FG000|Overall Study|Adverse Event|0|||
164164162|NCT02477332|592966707|FG001|Overall Study|Adverse Event|1|||
164164163|NCT02477332|592966708|FG002|Overall Study|Adverse Event|1|||
164164164|NCT02477332|592966709|FG003|Overall Study|Adverse Event|2|||
164164165|NCT02477332|592966710|FG004|Overall Study|Adverse Event|1|||
164164166|NCT02477332|592966711|FG005|Overall Study|Adverse Event|2|||
164164167|NCT02477332|592966706|FG000|Overall Study|Lack of Efficacy|1|||
164164168|NCT02477332|592966707|FG001|Overall Study|Lack of Efficacy|2|||
164164169|NCT02477332|592966708|FG002|Overall Study|Lack of Efficacy|1|||
164164170|NCT02477332|592966709|FG003|Overall Study|Lack of Efficacy|2|||
164164171|NCT02477332|592966710|FG004|Overall Study|Lack of Efficacy|1|||
164164172|NCT02477332|592966711|FG005|Overall Study|Lack of Efficacy|1|||
164164173|NCT02477332|592966706|FG000|Overall Study|Non-compliance with study treatment|0|||
164164174|NCT02477332|592966707|FG001|Overall Study|Non-compliance with study treatment|1|||
164164175|NCT02477332|592966708|FG002|Overall Study|Non-compliance with study treatment|2|||
164164176|NCT02477332|592966709|FG003|Overall Study|Non-compliance with study treatment|0|||
164164177|NCT02477332|592966710|FG004|Overall Study|Non-compliance with study treatment|0|||
164164178|NCT02477332|592966711|FG005|Overall Study|Non-compliance with study treatment|0|||
164164179|NCT02477332|592966706|FG000|Overall Study|Pregnancy|0|||
164164180|NCT02477332|592966707|FG001|Overall Study|Pregnancy|0|||
164164181|NCT02477332|592966708|FG002|Overall Study|Pregnancy|0|||
164164182|NCT02477332|592966709|FG003|Overall Study|Pregnancy|1|||
164164183|NCT02477332|592966710|FG004|Overall Study|Pregnancy|0|||
164164184|NCT02477332|592966711|FG005|Overall Study|Pregnancy|0|||
164164185|NCT02477332|592966706|FG000|Overall Study|Protocol Violation|2|||
164164186|NCT02477332|592966707|FG001|Overall Study|Protocol Violation|0|||
164164187|NCT02477332|592966708|FG002|Overall Study|Protocol Violation|3|||
164164188|NCT02477332|592966709|FG003|Overall Study|Protocol Violation|3|||
164164189|NCT02477332|592966710|FG004|Overall Study|Protocol Violation|1|||
164164190|NCT02477332|592966711|FG005|Overall Study|Protocol Violation|1|||
164164191|NCT02477332|592966706|FG000|Overall Study|Technical problems|0|||
164164192|NCT02477332|592966707|FG001|Overall Study|Technical problems|0|||
164164193|NCT02477332|592966708|FG002|Overall Study|Technical problems|1|||
164164194|NCT02477332|592966709|FG003|Overall Study|Technical problems|0|||
164164195|NCT02477332|592966710|FG004|Overall Study|Technical problems|0|||
164164196|NCT02477332|592966711|FG005|Overall Study|Technical problems|0|||
164164197|NCT02477332|592966706|FG000|Overall Study|Lost to Follow-up|0|||
164164198|NCT02477332|592966707|FG001|Overall Study|Lost to Follow-up|0|||
164164199|NCT02477332|592966708|FG002|Overall Study|Lost to Follow-up|2|||
164164200|NCT02477332|592966709|FG003|Overall Study|Lost to Follow-up|0|||
164164201|NCT02477332|592966710|FG004|Overall Study|Lost to Follow-up|0|||
164164202|NCT02477332|592966711|FG005|Overall Study|Lost to Follow-up|0|||
164164203|NCT02477332|592966706|FG000|Overall Study|Physician Decision|0|||
164164204|NCT02477332|592966707|FG001|Overall Study|Physician Decision|0|||
164164205|NCT02477332|592966708|FG002|Overall Study|Physician Decision|1|||
164164206|NCT02477332|592966709|FG003|Overall Study|Physician Decision|3|||
164164207|NCT02477332|592966710|FG004|Overall Study|Physician Decision|0|||
164164208|NCT02477332|592966711|FG005|Overall Study|Physician Decision|1|||
164164209|NCT02477332|592966706|FG000|Overall Study|Withdrawal by Subject|0|||
164164210|NCT02477332|592966707|FG001|Overall Study|Withdrawal by Subject|3|||
164164211|NCT02477332|592966708|FG002|Overall Study|Withdrawal by Subject|1|||
164164212|NCT02477332|592966709|FG003|Overall Study|Withdrawal by Subject|2|||
164164213|NCT02477332|592966710|FG004|Overall Study|Withdrawal by Subject|1|||
164164214|NCT02477332|592966711|FG005|Overall Study|Withdrawal by Subject|0|||
164164215|NCT03627546|592966720|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
164164216|NCT03627546|592966721|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
164164217|NCT03627546|592966722|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
164164218|NCT03627546|592966720|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
164164219|NCT03627546|592966721|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
164164220|NCT03627546|592966722|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
164164221|NCT02837731|592966724|FG000|Allocation|Admitted to General Floor|3|||
164164222|NCT02837731|592966725|FG001|Allocation|Admitted to General Floor|4|||
164164223|NCT02837731|592966724|FG000|Allocation|Immediate surgery/withdrew|2|||
164164224|NCT02837731|592966725|FG001|Allocation|Immediate surgery/withdrew|0|||
164164225|NCT02837731|592966724|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
164164226|NCT02837731|592966725|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
164164227|NCT02837731|592966724|FG000|Allocation|Withdrawal by Subject|2|||
164164228|NCT02837731|592966725|FG001|Allocation|Withdrawal by Subject|0|||
164164229|NCT02837731|592966724|FG000|Allocation|Device not available|1|||
164164230|NCT02837731|592966725|FG001|Allocation|Device not available|0|||
164164231|NCT02837731|592966724|FG000|Allocation|Protocol not implemented|7|||
164164232|NCT02837731|592966725|FG001|Allocation|Protocol not implemented|0|||
164164233|NCT02837731|592966724|FG000|Allocation|Moribund/Do not resuscitate|2|||
164164234|NCT02837731|592966725|FG001|Allocation|Moribund/Do not resuscitate|0|||
164164235|NCT02837731|592966724|FG000|Allocation|Did not meet sepsis criteria|1|||
164164236|NCT02837731|592966725|FG001|Allocation|Did not meet sepsis criteria|2|||
164164237|NCT02837731|592966724|FG000|Allocation|Known aortic abnormalities|0|||
164164238|NCT02837731|592966725|FG001|Allocation|Known aortic abnormalities|1|||
164164239|NCT02965573|592966726|FG000|Overall Study|Lack of Efficacy|1|||
164164240|NCT02965573|592966727|FG001|Overall Study|Lack of Efficacy|0|||
164164241|NCT00523848|592966729|FG000|Overall Study|Adverse Event|11|||
164164242|NCT00523848|592966729|FG000|Overall Study|Withdrawal by Subject|2|||
164164243|NCT00523848|592966729|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
164164244|NCT00523848|592966729|FG000|Overall Study|Disease Progression|5|||
164164245|NCT00523848|592966729|FG000|Overall Study|Other, unspecified|4|||
164164246|NCT01209520|592966733|FG000|Overall Study|Withdrawal by Subject|3|||
164164247|NCT03291431|592966735|FG000|Overall Study|Protocol Violation|2|||
164164248|NCT03291431|592966736|FG001|Overall Study|Protocol Violation|1|||
164164249|NCT03291431|592966735|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
164164250|NCT03291431|592966736|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
164164251|NCT03291431|592966735|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
164164252|NCT03291431|592966736|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
164164253|NCT06868654|592966737|FG000|Overall Study|Death|4|||
164164254|NCT06868654|592966738|FG001|Overall Study|Death|14|||
164164255|NCT06868654|592966737|FG000|Overall Study|Lost to Follow-up|0|||
164164256|NCT06868654|592966738|FG001|Overall Study|Lost to Follow-up|1|||
164164257|NCT06868654|592966737|FG000|Overall Study|Withdrawal by Subject|5|||
164164258|NCT06868654|592966738|FG001|Overall Study|Withdrawal by Subject|3|||
164164259|NCT06868654|592966737|FG000|Overall Study|Physician Decision|0|||
164164260|NCT06868654|592966738|FG001|Overall Study|Physician Decision|1|||
164164261|NCT06868654|592966737|FG000|Overall Study|Ongoing|23|||
164164262|NCT06868654|592966738|FG001|Overall Study|Ongoing|21|||
164164263|NCT04925557|592968496|FG000|Overall Study|Study closed|5|||
164164264|NCT04925557|592968497|FG001|Overall Study|Study closed|3|||
164164265|NCT01736397|592968498|FG000|Overall Study|Lack of Efficacy|1|||
164164266|NCT01736397|592968499|FG001|Overall Study|Lack of Efficacy|11|||
164164267|NCT01736397|592968498|FG000|Overall Study|Withdrawal by Subject|6|||
164164268|NCT01736397|592968499|FG001|Overall Study|Withdrawal by Subject|5|||
164164269|NCT01736397|592968498|FG000|Overall Study|Lost to Follow-up|0|||
164164270|NCT01736397|592968499|FG001|Overall Study|Lost to Follow-up|1|||
164164271|NCT01736397|592968498|FG000|Overall Study|Adverse Event|6|||
164164272|NCT01736397|592968499|FG001|Overall Study|Adverse Event|3|||
164164273|NCT01736397|592968498|FG000|Overall Study|Not stated|1|||
164164274|NCT01736397|592968499|FG001|Overall Study|Not stated|4|||
164164275|NCT00076752|592968500|FG000|Overall Study|Death|2|||
164164276|NCT00076752|592968500|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
164164277|NCT01288937|592968501|FG000|Overall Study|Adverse Event|1|||
164164278|NCT01288937|592968502|FG001|Overall Study|Adverse Event|0|||
164164279|NCT02875613|592968506|FG000|Overall Study|Withdrawal by Subject|1|||
164164280|NCT02875613|592968506|FG000|Overall Study|Screen Failure|1|||
164164281|NCT00892151|592968507|FG000|Overall Study|Protocol Violation|1|||
164164282|NCT04075682|592968508|FG000|Overall Study|Lost to Follow-up|5|||
164164283|NCT04075682|592968509|FG001|Overall Study|Lost to Follow-up|5|||
164164284|NCT04075682|592968510|FG002|Overall Study|Lost to Follow-up|2|||
164164285|NCT04075682|592968511|FG003|Overall Study|Lost to Follow-up|2|||
164164286|NCT04075682|592968508|FG000|Overall Study|Withdrawal by Subject|1|||
164164287|NCT04075682|592968509|FG001|Overall Study|Withdrawal by Subject|0|||
164164288|NCT04075682|592968510|FG002|Overall Study|Withdrawal by Subject|1|||
164164289|NCT04075682|592968511|FG003|Overall Study|Withdrawal by Subject|0|||
164164290|NCT04075682|592968508|FG000|Overall Study|Protocol Violation|0|||
164164291|NCT04075682|592968509|FG001|Overall Study|Protocol Violation|1|||
164164292|NCT04075682|592968510|FG002|Overall Study|Protocol Violation|1|||
164164293|NCT04075682|592968511|FG003|Overall Study|Protocol Violation|0|||
164164294|NCT04075682|592968508|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
164164295|NCT04075682|592968509|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
164164296|NCT04075682|592968510|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
164164297|NCT04075682|592968511|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
164164298|NCT04075682|592968508|FG000|Overall Study|Lost study phone the first day of study participation|0|||
164164299|NCT04075682|592968509|FG001|Overall Study|Lost study phone the first day of study participation|1|||
164164300|NCT04075682|592968510|FG002|Overall Study|Lost study phone the first day of study participation|0|||
164164301|NCT04075682|592968511|FG003|Overall Study|Lost study phone the first day of study participation|0|||
164164302|NCT01222520|592968512|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
164164303|NCT01222520|592968513|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
164164304|NCT01222520|592968512|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
164164305|NCT01222520|592968513|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
164164306|NCT01222520|592968512|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
164164307|NCT01222520|592968513|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
164164308|NCT01222520|592968512|FG000|Double-blind Period|Adverse Event|0|||
164164309|NCT01222520|592968513|FG001|Double-blind Period|Adverse Event|1|||
164164310|NCT01222520|592968512|FG000|Double-blind Period|Lack of Efficacy|0|||
164164311|NCT01222520|592968513|FG001|Double-blind Period|Lack of Efficacy|1|||
164164312|NCT01222520|592968512|FG000|Double-blind Period|Study medication stolen|1|||
164164313|NCT01222520|592968513|FG001|Double-blind Period|Study medication stolen|0|||
164164314|NCT01896128|592968514|FG000|Overall Study|Withdrawal by Subject|3|||
164164315|NCT01896128|592968515|FG001|Overall Study|Withdrawal by Subject|3|||
164164316|NCT00954941|592968516|FG000|Overall Study|Received treatment at home|1|||
164164317|NCT00954941|592968517|FG001|Overall Study|Received treatment at home|0|||
164164318|NCT00954941|592968516|FG000|Overall Study|Withdrawal by Subject|1|||
164164319|NCT00954941|592968517|FG001|Overall Study|Withdrawal by Subject|0|||
164164320|NCT00954941|592968516|FG000|Overall Study|Insurance Denial|2|||
164164321|NCT00954941|592968517|FG001|Overall Study|Insurance Denial|2|||
164164322|NCT00954941|592968516|FG000|Overall Study|Physician Decision|2|||
164164323|NCT00954941|592968517|FG001|Overall Study|Physician Decision|2|||
164164324|NCT00954941|592968516|FG000|Overall Study|Ineligible|2|||
164164325|NCT00954941|592968517|FG001|Overall Study|Ineligible|2|||
164164326|NCT00954941|592968516|FG000|Overall Study|Adverse Event|0|||
164164327|NCT00954941|592968517|FG001|Overall Study|Adverse Event|1|||
164164328|NCT01996254|592968518|FG000|Overall Study|Change in Eligibility|0|||
164164329|NCT01996254|592968519|FG001|Overall Study|Change in Eligibility|2|||
164164330|NCT01996254|592968520|FG002|Overall Study|Change in Eligibility|0|||
164164331|NCT01996254|592968518|FG000|Overall Study|Withdrawal by Subject|0|||
164164332|NCT01996254|592968519|FG001|Overall Study|Withdrawal by Subject|3|||
164164333|NCT01996254|592968520|FG002|Overall Study|Withdrawal by Subject|4|||
164164334|NCT01996254|592968518|FG000|Overall Study|Lost to Follow-up|1|||
164164335|NCT01996254|592968519|FG001|Overall Study|Lost to Follow-up|0|||
164164336|NCT01996254|592968520|FG002|Overall Study|Lost to Follow-up|4|||
164164337|NCT03423173|592968521|FG000|Overall Study|Randomized but not vaccinated|1|||
164164338|NCT03423173|592968522|FG001|Overall Study|Randomized but not vaccinated|0|||
164164339|NCT03423173|592968523|FG002|Overall Study|Randomized but not vaccinated|2|||
164164340|NCT03423173|592968524|FG003|Overall Study|Randomized but not vaccinated|1|||
164164341|NCT03423173|592968521|FG000|Overall Study|Adverse Event|1|||
164164342|NCT03423173|592968522|FG001|Overall Study|Adverse Event|1|||
164164343|NCT03423173|592968523|FG002|Overall Study|Adverse Event|1|||
164164344|NCT03423173|592968524|FG003|Overall Study|Adverse Event|1|||
164164345|NCT03423173|592968521|FG000|Overall Study|Lost to Follow-up|10|||
164164346|NCT03423173|592968522|FG001|Overall Study|Lost to Follow-up|19|||
164164347|NCT03423173|592968523|FG002|Overall Study|Lost to Follow-up|17|||
164164348|NCT03423173|592968524|FG003|Overall Study|Lost to Follow-up|22|||
164164349|NCT03423173|592968521|FG000|Overall Study|Withdrawal of consent|4|||
164164350|NCT03423173|592968522|FG001|Overall Study|Withdrawal of consent|10|||
164164351|NCT03423173|592968523|FG002|Overall Study|Withdrawal of consent|4|||
164164352|NCT03423173|592968524|FG003|Overall Study|Withdrawal of consent|5|||
164164353|NCT03423173|592968521|FG000|Overall Study|Death|1|||
164164354|NCT03423173|592968522|FG001|Overall Study|Death|0|||
164164355|NCT03423173|592968523|FG002|Overall Study|Death|0|||
164164356|NCT03423173|592968524|FG003|Overall Study|Death|0|||
164164357|NCT03423173|592968521|FG000|Overall Study|Reason not Specified|2|||
164164358|NCT03423173|592968522|FG001|Overall Study|Reason not Specified|5|||
164164359|NCT03423173|592968523|FG002|Overall Study|Reason not Specified|3|||
164164360|NCT03423173|592968524|FG003|Overall Study|Reason not Specified|1|||
164164361|NCT02920008|592968525|FG000|Overall Study|Death|117|||
164164362|NCT02920008|592968526|FG001|Overall Study|Death|127|||
164164363|NCT02920008|592968525|FG000|Overall Study|Withdrawal by Subject|3|||
164164364|NCT02920008|592968526|FG001|Overall Study|Withdrawal by Subject|6|||
164164365|NCT02920008|592968525|FG000|Overall Study|Lost to Follow-up|0|||
164164366|NCT02920008|592968526|FG001|Overall Study|Lost to Follow-up|1|||
164164367|NCT02411396|592968528|FG000|Overall Study|Lost to Follow-up|31|||
164164368|NCT02411396|592968528|FG000|Overall Study|Death|10|||
164164369|NCT02016105|592968535|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
164164370|NCT02016105|592968536|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
164164371|NCT02016105|592968537|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
164164372|NCT02016105|592968538|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
164164373|NCT02016105|592968539|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
164164374|NCT02016105|592968540|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
164164375|NCT02016105|592968535|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
164164376|NCT02016105|592968536|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
164164377|NCT02016105|592968537|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
164164378|NCT02016105|592968538|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
164164379|NCT02016105|592968539|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
164164380|NCT02016105|592968540|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
164164381|NCT02016105|592968535|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
164164382|NCT02016105|592968536|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
164164383|NCT02016105|592968537|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
164164384|NCT02016105|592968538|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
164164385|NCT02016105|592968539|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
164164386|NCT02016105|592968540|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
164164387|NCT02016105|592968535|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
164164388|NCT02016105|592968536|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
164164389|NCT02016105|592968537|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
164164390|NCT02016105|592968538|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
164164391|NCT02016105|592968539|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
164164392|NCT02016105|592968540|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
164164393|NCT02016105|592968535|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
164164394|NCT02016105|592968536|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
164164395|NCT02016105|592968537|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
164164396|NCT02016105|592968538|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
164164397|NCT02016105|592968539|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
164164398|NCT02016105|592968540|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
164164399|NCT02016105|592968535|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
164164400|NCT02016105|592968536|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
164164401|NCT02016105|592968537|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
164164402|NCT02016105|592968538|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
164164403|NCT02016105|592968539|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
164164404|NCT02016105|592968540|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
164164405|NCT02016105|592968535|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
164164406|NCT02016105|592968536|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
164164407|NCT02016105|592968537|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
164164408|NCT02016105|592968538|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
164164409|NCT02016105|592968539|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
164164410|NCT02016105|592968540|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
164164411|NCT02016105|592968535|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
164164412|NCT02016105|592968536|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
164164413|NCT02016105|592968537|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
164164414|NCT02016105|592968538|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
164164415|NCT02016105|592968539|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
164164416|NCT02016105|592968540|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
164164417|NCT02016105|592968535|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
164164418|NCT02016105|592968536|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
164164419|NCT02016105|592968537|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
164164420|NCT02016105|592968538|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
164164421|NCT02016105|592968539|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
164164422|NCT02016105|592968540|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
164164423|NCT02016105|592968535|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
164164424|NCT02016105|592968536|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
164164425|NCT02016105|592968537|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
164164426|NCT02016105|592968538|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
164164427|NCT02016105|592968539|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
164164428|NCT02016105|592968540|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
164164429|NCT02016105|592968535|FG000|TREATMENT PERIOD 2|Death|0|||
164164430|NCT02016105|592968536|FG001|TREATMENT PERIOD 2|Death|0|||
164164431|NCT02016105|592968537|FG002|TREATMENT PERIOD 2|Death|0|||
164164432|NCT02016105|592968538|FG003|TREATMENT PERIOD 2|Death|0|||
164164433|NCT02016105|592968539|FG004|TREATMENT PERIOD 2|Death|0|||
164164434|NCT02016105|592968540|FG005|TREATMENT PERIOD 2|Death|1|||
164164435|NCT02016105|592968535|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
164164436|NCT02016105|592968536|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
164164437|NCT02016105|592968537|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
164164438|NCT02016105|592968538|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
164164439|NCT02016105|592968539|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
164164440|NCT02016105|592968540|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
164164441|NCT02016105|592968535|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
164164442|NCT02016105|592968536|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
164164443|NCT02016105|592968537|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
164164444|NCT02016105|592968538|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
164164445|NCT02016105|592968539|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
164164446|NCT02016105|592968540|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
164164447|NCT02016105|592968535|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
164164448|NCT02016105|592968536|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
164164449|NCT02016105|592968537|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
164164450|NCT02016105|592968538|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
164164451|NCT02016105|592968539|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
164164452|NCT02016105|592968540|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
164164453|NCT02016105|592968535|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
164164454|NCT02016105|592968536|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
164164455|NCT02016105|592968537|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
164164456|NCT02016105|592968538|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
164164457|NCT02016105|592968539|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
164164458|NCT02016105|592968540|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
164164459|NCT02016105|592968535|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
164164460|NCT02016105|592968536|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
164164461|NCT02016105|592968537|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
164164462|NCT02016105|592968538|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
164164463|NCT02016105|592968539|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
164164464|NCT02016105|592968540|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
164164465|NCT02016105|592968535|FG000|EXTENSION PERIOD|Adverse Event|0|||
164164466|NCT02016105|592968536|FG001|EXTENSION PERIOD|Adverse Event|0|||
164164467|NCT02016105|592968537|FG002|EXTENSION PERIOD|Adverse Event|2|||
164164468|NCT02016105|592968538|FG003|EXTENSION PERIOD|Adverse Event|0|||
164164469|NCT02016105|592968539|FG004|EXTENSION PERIOD|Adverse Event|1|||
164164470|NCT02016105|592968540|FG005|EXTENSION PERIOD|Adverse Event|0|||
164164471|NCT02016105|592968535|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
164164472|NCT02016105|592968536|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
164164473|NCT02016105|592968537|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
164164474|NCT02016105|592968538|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
164164475|NCT02016105|592968539|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
164164476|NCT02016105|592968540|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
164164477|NCT02016105|592968535|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
164164478|NCT02016105|592968536|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
164164479|NCT02016105|592968537|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
164164480|NCT02016105|592968538|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
164164481|NCT02016105|592968539|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
164164482|NCT02016105|592968540|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
164164483|NCT02016105|592968535|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
164164484|NCT02016105|592968536|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
164164485|NCT02016105|592968537|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
164164486|NCT02016105|592968538|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
164164487|NCT02016105|592968539|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
164164488|NCT02016105|592968540|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
164164489|NCT00090493|592968541|FG000|Overall Study|Physician Decision|2|||
164164490|NCT02071706|592968542|FG000|Overall Study|Adverse Event|1|||
164164491|NCT02071706|592968542|FG000|Overall Study|Withdrawal by Subject|2|||
164164492|NCT02865499|592968545|FG000|Baseline|Adverse Event|1|||
164164493|NCT02865499|592968545|FG000|Baseline|Withdrawal by Subject|1|||
164164494|NCT02247440|592968546|FG000|Overall Study|Withdrawal by Subject|1|||
164164495|NCT02247440|592968546|FG000|Overall Study|Lack of Efficacy|3|||
164164496|NCT02792192|592968547|FG000|Overall Study|Death|1|||
164164497|NCT02792192|592968548|FG001|Overall Study|Death|0|||
164164498|NCT02792192|592968549|FG002|Overall Study|Death|0|||
164164499|NCT02792192|592968550|FG003|Overall Study|Death|0|||
164164500|NCT02792192|592968547|FG000|Overall Study|Informed Consent Withdrawn|4|||
164164501|NCT02792192|592968548|FG001|Overall Study|Informed Consent Withdrawn|0|||
164164502|NCT02792192|592968549|FG002|Overall Study|Informed Consent Withdrawn|0|||
164164503|NCT02792192|592968550|FG003|Overall Study|Informed Consent Withdrawn|0|||
164164504|NCT02792192|592968547|FG000|Overall Study|Physician Decision|1|||
164164505|NCT02792192|592968548|FG001|Overall Study|Physician Decision|0|||
164164506|NCT02792192|592968549|FG002|Overall Study|Physician Decision|0|||
164164507|NCT02792192|592968550|FG003|Overall Study|Physician Decision|0|||
164164508|NCT02792192|592968547|FG000|Overall Study|Progressive Disease|0|||
164164509|NCT02792192|592968548|FG001|Overall Study|Progressive Disease|1|||
164164510|NCT02792192|592968549|FG002|Overall Study|Progressive Disease|0|||
164164511|NCT02792192|592968550|FG003|Overall Study|Progressive Disease|0|||
164164512|NCT02792192|592968547|FG000|Overall Study|Study Terminated By Sponsor|6|||
164164513|NCT02792192|592968548|FG001|Overall Study|Study Terminated By Sponsor|10|||
164164514|NCT02792192|592968549|FG002|Overall Study|Study Terminated By Sponsor|0|||
164164515|NCT02792192|592968550|FG003|Overall Study|Study Terminated By Sponsor|0|||
164164516|NCT02320058|592968551|FG000|Overall Study|Death|25|||
164164517|NCT02320058|592968552|FG001|Overall Study|Death|10|||
164164518|NCT02320058|592968551|FG000|Overall Study|Lost to Follow-up|4|||
164164519|NCT02320058|592968552|FG001|Overall Study|Lost to Follow-up|0|||
164164520|NCT02320058|592968551|FG000|Overall Study|Other reasons|4|||
164164521|NCT02320058|592968552|FG001|Overall Study|Other reasons|1|||
164164522|NCT02320058|592968551|FG000|Overall Study|Withdrawal by Subject|8|||
164164523|NCT02320058|592968552|FG001|Overall Study|Withdrawal by Subject|2|||
164164524|NCT02320058|592968551|FG000|Overall Study|Not reported|1|||
164164525|NCT02320058|592968552|FG001|Overall Study|Not reported|0|||
164164526|NCT00729157|592968553|FG000|Overall Study|Withdrawal by Subject|1|||
164164527|NCT00661609|592968554|FG000|Overall Study|Adverse Event|4|||
164164528|NCT00661609|592968554|FG000|Overall Study|Death|20|||
164164529|NCT00661609|592968554|FG000|Overall Study|Withdrawal by Subject|2|||
164164530|NCT00661609|592968554|FG000|Overall Study|PI Decision|1|||
164164531|NCT00661609|592968554|FG000|Overall Study|Survival follow up stage discontinued|11|||
164164532|NCT00661609|592968554|FG000|Overall Study|Disease progression|3|||
164164533|NCT03521115|592968556|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
164164534|NCT03521115|592968557|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
164164535|NCT03521115|592968556|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
164164536|NCT03521115|592968557|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
164164537|NCT01430403|592968560|FG000|Overall Study|Lost to Follow-up|5|||
164164538|NCT01430403|592968561|FG001|Overall Study|Lost to Follow-up|5|||
164164539|NCT01430403|592968562|FG002|Overall Study|Lost to Follow-up|3|||
164164540|NCT01430403|592968560|FG000|Overall Study|Physician Decision|1|||
164164541|NCT01430403|592968561|FG001|Overall Study|Physician Decision|0|||
164164542|NCT01430403|592968562|FG002|Overall Study|Physician Decision|0|||
164164543|NCT01430403|592968560|FG000|Overall Study|Protocol Violation|2|||
164164544|NCT01430403|592968561|FG001|Overall Study|Protocol Violation|3|||
164164545|NCT01430403|592968562|FG002|Overall Study|Protocol Violation|2|||
164164546|NCT01430403|592968560|FG000|Overall Study|Withdrawal by Subject|9|||
164164547|NCT01430403|592968561|FG001|Overall Study|Withdrawal by Subject|1|||
164164548|NCT01430403|592968562|FG002|Overall Study|Withdrawal by Subject|3|||
164164549|NCT02677922|592968565|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
164164550|NCT02677922|592968566|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
164164551|NCT02677922|592968567|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
164164552|NCT02677922|592968568|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
164164553|NCT02677922|592968569|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
164164554|NCT02677922|592968570|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
164164555|NCT02677922|592968565|FG000|Treatment Period|Adverse Event|0|||
164164556|NCT02677922|592968566|FG001|Treatment Period|Adverse Event|0|||
164164557|NCT02677922|592968567|FG002|Treatment Period|Adverse Event|1|||
164164558|NCT02677922|592968568|FG003|Treatment Period|Adverse Event|3|||
164164559|NCT02677922|592968569|FG004|Treatment Period|Adverse Event|5|||
164164560|NCT02677922|592968570|FG005|Treatment Period|Adverse Event|2|||
164164561|NCT02677922|592968565|FG000|Treatment Period|Progressive Disease|1|||
164164562|NCT02677922|592968566|FG001|Treatment Period|Progressive Disease|1|||
164164563|NCT02677922|592968567|FG002|Treatment Period|Progressive Disease|0|||
164164564|NCT02677922|592968568|FG003|Treatment Period|Progressive Disease|0|||
164164565|NCT02677922|592968569|FG004|Treatment Period|Progressive Disease|8|||
164164566|NCT02677922|592968570|FG005|Treatment Period|Progressive Disease|7|||
164164567|NCT02677922|592968565|FG000|Treatment Period|Lack of Efficacy|0|||
164164568|NCT02677922|592968566|FG001|Treatment Period|Lack of Efficacy|0|||
164164569|NCT02677922|592968567|FG002|Treatment Period|Lack of Efficacy|0|||
164164570|NCT02677922|592968568|FG003|Treatment Period|Lack of Efficacy|1|||
164164571|NCT02677922|592968569|FG004|Treatment Period|Lack of Efficacy|1|||
164164572|NCT02677922|592968570|FG005|Treatment Period|Lack of Efficacy|6|||
164164573|NCT02677922|592968565|FG000|Treatment Period|Withdrawal by Subject|0|||
164164574|NCT02677922|592968566|FG001|Treatment Period|Withdrawal by Subject|0|||
164164575|NCT02677922|592968567|FG002|Treatment Period|Withdrawal by Subject|1|||
164164576|NCT02677922|592968568|FG003|Treatment Period|Withdrawal by Subject|3|||
164164577|NCT02677922|592968569|FG004|Treatment Period|Withdrawal by Subject|5|||
164164578|NCT02677922|592968570|FG005|Treatment Period|Withdrawal by Subject|5|||
164164579|NCT02677922|592968565|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
164164580|NCT02677922|592968566|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
164164581|NCT02677922|592968567|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
164164582|NCT02677922|592968568|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
164164583|NCT02677922|592968569|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
164164584|NCT02677922|592968570|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
164164585|NCT02677922|592968565|FG000|Treatment Period|Disease Relapse|0|||
164164586|NCT02677922|592968566|FG001|Treatment Period|Disease Relapse|0|||
164164587|NCT02677922|592968567|FG002|Treatment Period|Disease Relapse|0|||
164164588|NCT02677922|592968568|FG003|Treatment Period|Disease Relapse|3|||
164164589|NCT02677922|592968569|FG004|Treatment Period|Disease Relapse|6|||
164164590|NCT02677922|592968570|FG005|Treatment Period|Disease Relapse|1|||
164164591|NCT02677922|592968565|FG000|Treatment Period|Allogeneic HSCT|1|||
164164592|NCT02677922|592968566|FG001|Treatment Period|Allogeneic HSCT|0|||
164164593|NCT02677922|592968567|FG002|Treatment Period|Allogeneic HSCT|0|||
164164594|NCT02677922|592968568|FG003|Treatment Period|Allogeneic HSCT|1|||
164164595|NCT02677922|592968569|FG004|Treatment Period|Allogeneic HSCT|4|||
164164596|NCT02677922|592968570|FG005|Treatment Period|Allogeneic HSCT|1|||
164164597|NCT02677922|592968565|FG000|Treatment Period|Other Reasons|0|||
164164598|NCT02677922|592968566|FG001|Treatment Period|Other Reasons|0|||
164164599|NCT02677922|592968567|FG002|Treatment Period|Other Reasons|0|||
164164600|NCT02677922|592968568|FG003|Treatment Period|Other Reasons|1|||
164164601|NCT02677922|592968569|FG004|Treatment Period|Other Reasons|3|||
164164602|NCT02677922|592968570|FG005|Treatment Period|Other Reasons|5|||
164164603|NCT02677922|592968565|FG000|Treatment Period|Death|0|||
164164604|NCT02677922|592968566|FG001|Treatment Period|Death|0|||
164164605|NCT02677922|592968567|FG002|Treatment Period|Death|0|||
164164606|NCT02677922|592968568|FG003|Treatment Period|Death|0|||
164164607|NCT02677922|592968569|FG004|Treatment Period|Death|12|||
164164608|NCT02677922|592968570|FG005|Treatment Period|Death|1|||
164164609|NCT02677922|592968565|FG000|Treatment Period|Non-compliance with Study Drug|0|||
164164610|NCT02677922|592968566|FG001|Treatment Period|Non-compliance with Study Drug|0|||
164164611|NCT02677922|592968567|FG002|Treatment Period|Non-compliance with Study Drug|0|||
164164612|NCT02677922|592968568|FG003|Treatment Period|Non-compliance with Study Drug|0|||
164164613|NCT02677922|592968569|FG004|Treatment Period|Non-compliance with Study Drug|1|||
164164614|NCT02677922|592968570|FG005|Treatment Period|Non-compliance with Study Drug|0|||
164164615|NCT02677922|592968565|FG000|Treatment Period|Physician Decision|0|||
164164616|NCT02677922|592968566|FG001|Treatment Period|Physician Decision|0|||
164164617|NCT02677922|592968567|FG002|Treatment Period|Physician Decision|0|||
164164618|NCT02677922|592968568|FG003|Treatment Period|Physician Decision|0|||
164164619|NCT02677922|592968569|FG004|Treatment Period|Physician Decision|0|||
164164620|NCT02677922|592968570|FG005|Treatment Period|Physician Decision|1|||
164164621|NCT02677922|592968565|FG000|Treatment Period|Symptomatic Deterioration|0|||
164164622|NCT02677922|592968566|FG001|Treatment Period|Symptomatic Deterioration|0|||
164164623|NCT02677922|592968567|FG002|Treatment Period|Symptomatic Deterioration|0|||
164164624|NCT02677922|592968568|FG003|Treatment Period|Symptomatic Deterioration|0|||
164164625|NCT02677922|592968569|FG004|Treatment Period|Symptomatic Deterioration|1|||
164164626|NCT02677922|592968570|FG005|Treatment Period|Symptomatic Deterioration|0|||
164164627|NCT00637000|592968575|FG000|Overall Study|Withdrawal by Subject|4|||
164164628|NCT00637000|592968576|FG001|Overall Study|Withdrawal by Subject|3|||
164164629|NCT00562302|592968579|FG000|Overall Study|Lost to Follow-up|3|||
164164630|NCT00562302|592968580|FG001|Overall Study|Lost to Follow-up|3|||
164164631|NCT00562302|592968579|FG000|Overall Study|Adverse Event|0|||
164164632|NCT00562302|592968580|FG001|Overall Study|Adverse Event|6|||
164164633|NCT00562302|592968579|FG000|Overall Study|Non-compliance|1|||
164164634|NCT00562302|592968580|FG001|Overall Study|Non-compliance|2|||
164164635|NCT00562302|592968579|FG000|Overall Study|Withdrawal by Subject|7|||
164164636|NCT00562302|592968580|FG001|Overall Study|Withdrawal by Subject|8|||
164164637|NCT00562302|592968579|FG000|Overall Study|Death|1|||
164164638|NCT00562302|592968580|FG001|Overall Study|Death|2|||
164164639|NCT00562302|592968579|FG000|Overall Study|Lung resection prior to study completion|7|||
164164640|NCT00562302|592968580|FG001|Overall Study|Lung resection prior to study completion|7|||
164164641|NCT00562302|592968579|FG000|Overall Study|Not stated|1|||
164164642|NCT00562302|592968580|FG001|Overall Study|Not stated|4|||
164164643|NCT03615144|592968581|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
164164644|NCT03615144|592968582|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
164164645|NCT04791319|592968583|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
164164646|NCT04791319|592968584|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
164164647|NCT04791319|592968585|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
164164648|NCT04791319|592968586|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
164164649|NCT04791319|592968587|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
164164650|NCT04791319|592968588|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
164164651|NCT04791319|592968589|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
164164652|NCT04791319|592968590|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
164164653|NCT04791319|592968591|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
164164654|NCT04791319|592968592|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
164164655|NCT04791319|592968593|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
164164656|NCT04791319|592968583|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
164164657|NCT04791319|592968584|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
164164658|NCT04791319|592968585|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
164164659|NCT04791319|592968586|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
164164660|NCT04791319|592968587|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
164164661|NCT04791319|592968588|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
164164662|NCT04791319|592968589|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
164164663|NCT04791319|592968590|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
164164664|NCT04791319|592968591|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
164164665|NCT04791319|592968592|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
164164666|NCT04791319|592968593|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
164164667|NCT04791319|592968583|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
164164668|NCT04791319|592968584|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
164164669|NCT04791319|592968585|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
164164670|NCT04791319|592968586|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
164164671|NCT04791319|592968587|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
164164672|NCT04791319|592968588|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
164164673|NCT04791319|592968589|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
164164674|NCT04791319|592968590|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
164164675|NCT04791319|592968591|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
164164676|NCT04791319|592968592|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
164164677|NCT04791319|592968593|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
164164678|NCT04791319|592968583|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
164164679|NCT04791319|592968584|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
164164680|NCT04791319|592968585|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
164164681|NCT04791319|592968586|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
164164682|NCT04791319|592968587|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
164164683|NCT04791319|592968588|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
164164684|NCT04791319|592968589|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
164164685|NCT04791319|592968590|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
164164686|NCT04791319|592968591|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
164164687|NCT04791319|592968592|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
164164688|NCT04791319|592968593|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
164164689|NCT04791319|592968583|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
164164690|NCT04791319|592968584|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
164164691|NCT04791319|592968585|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
164164692|NCT04791319|592968586|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
164164693|NCT04791319|592968587|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
164164694|NCT04791319|592968588|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
164164695|NCT04791319|592968589|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
164164696|NCT04791319|592968590|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
164164697|NCT04791319|592968591|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
164164698|NCT04791319|592968592|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
164164699|NCT04791319|592968593|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
164164700|NCT04791319|592968583|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
164164701|NCT04791319|592968584|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
164164702|NCT04791319|592968585|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
164164703|NCT04791319|592968586|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
164164704|NCT04791319|592968587|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
164164705|NCT04791319|592968588|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
164164706|NCT04791319|592968589|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
164164707|NCT04791319|592968590|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
164164708|NCT04791319|592968591|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
164164709|NCT04791319|592968592|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
164164710|NCT04791319|592968593|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
164164711|NCT04791319|592968583|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
164164712|NCT04791319|592968584|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
164164713|NCT04791319|592968585|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
164164714|NCT04791319|592968586|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
164164715|NCT04791319|592968587|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
164164716|NCT04791319|592968588|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
164164717|NCT04791319|592968589|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
164164718|NCT04791319|592968590|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
164164719|NCT04791319|592968591|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
164164720|NCT04791319|592968592|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
164164721|NCT04791319|592968593|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
164164790|NCT00014495|592968631|FG000|Overall Study|Death|0|||
164164722|NCT04791319|592968583|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
164164723|NCT04791319|592968584|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
164164724|NCT04791319|592968585|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
164164725|NCT04791319|592968586|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
164164726|NCT04791319|592968587|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
164164727|NCT04791319|592968588|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
164164728|NCT04791319|592968589|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
164164729|NCT04791319|592968590|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
164164730|NCT04791319|592968591|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
164164731|NCT04791319|592968592|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
164164732|NCT04791319|592968593|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
164164733|NCT04791319|592968583|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
164164734|NCT04791319|592968584|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
164164735|NCT04791319|592968585|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
164164736|NCT04791319|592968586|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
164164737|NCT04791319|592968587|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
164164738|NCT04791319|592968588|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
164164739|NCT04791319|592968589|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
164164740|NCT04791319|592968590|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
164164741|NCT04791319|592968591|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
164164742|NCT04791319|592968592|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
164164743|NCT04791319|592968593|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
164164744|NCT01860040|592968596|FG000|Overall Study|Withdrawal by Subject|1|||
164164745|NCT01860040|592968597|FG001|Overall Study|Withdrawal by Subject|0|||
164164746|NCT01931995|592968598|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
164164747|NCT01931995|592968599|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
164164748|NCT01931995|592968598|FG000|First Intervention (1 Day)|Physician Decision|1|||
164164749|NCT01931995|592968599|FG001|First Intervention (1 Day)|Physician Decision|1|||
164164750|NCT01931995|592968598|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
164164751|NCT01931995|592968599|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
164164752|NCT00791661|592968600|FG000|7 Day Wash-out|Adverse Event|0|||
164164753|NCT00791661|592968601|FG001|7 Day Wash-out|Adverse Event|0|||
164164754|NCT00791661|592968602|FG002|7 Day Wash-out|Adverse Event|1|||
164164755|NCT00791661|592968600|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
164164756|NCT00791661|592968601|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
164164757|NCT00791661|592968602|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
164164758|NCT00679289|592968621|FG000|Overall Study|Progressive disease|4|||
164164759|NCT00679289|592968622|FG001|Overall Study|Progressive disease|5|||
164164760|NCT00679289|592968623|FG002|Overall Study|Progressive disease|18|||
164164761|NCT00679289|592968621|FG000|Overall Study|Withdrawal by Subject|0|||
164164762|NCT00679289|592968622|FG001|Overall Study|Withdrawal by Subject|1|||
164164763|NCT00679289|592968623|FG002|Overall Study|Withdrawal by Subject|1|||
164164764|NCT00679289|592968621|FG000|Overall Study|Adverse Event|0|||
164164765|NCT00679289|592968622|FG001|Overall Study|Adverse Event|0|||
164164766|NCT00679289|592968623|FG002|Overall Study|Adverse Event|3|||
164164767|NCT00679289|592968621|FG000|Overall Study|Physician Decision|1|||
164164768|NCT00679289|592968622|FG001|Overall Study|Physician Decision|0|||
164164769|NCT00679289|592968623|FG002|Overall Study|Physician Decision|1|||
164164770|NCT00937040|592968624|FG000|Overall Study|Adverse Event|5|||
164164771|NCT00937040|592968625|FG001|Overall Study|Adverse Event|8|||
164164772|NCT00937040|592968624|FG000|Overall Study|Lost to Follow-up|12|||
164164773|NCT00937040|592968625|FG001|Overall Study|Lost to Follow-up|12|||
164164774|NCT00937040|592968624|FG000|Overall Study|Protocol Violation|3|||
164164775|NCT00937040|592968625|FG001|Overall Study|Protocol Violation|0|||
164164776|NCT00937040|592968624|FG000|Overall Study|Withdrawal by Subject|13|||
164164777|NCT00937040|592968625|FG001|Overall Study|Withdrawal by Subject|7|||
164164778|NCT00937040|592968624|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
164164779|NCT00937040|592968625|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
164164780|NCT00937040|592968624|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
164164781|NCT00937040|592968625|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
164164782|NCT00183885|592968628|FG000|Overall Study|Adverse Event|11|||
164164783|NCT00183885|592968628|FG000|Overall Study|Death|1|||
164164784|NCT00183885|592968628|FG000|Overall Study|Lost to Follow-up|3|||
164164785|NCT00183885|592968628|FG000|Overall Study|Physician Decision|6|||
164164786|NCT00183885|592968628|FG000|Overall Study|Withdrawal by Subject|5|||
164164787|NCT00183885|592968628|FG000|Overall Study|Switched to alternative treatment|8|||
164164788|NCT00183885|592968628|FG000|Overall Study|Treatment delayed too long|4|||
164164789|NCT00183885|592968628|FG000|Overall Study|Developed second malignancy|1|||
164164791|NCT00014495|592968632|FG001|Overall Study|Death|0|||
164164792|NCT00014495|592968633|FG002|Overall Study|Death|1|||
164164793|NCT00014495|592968634|FG003|Overall Study|Death|0|||
164164794|NCT00014495|592968631|FG000|Overall Study|Clinical deterioration|0|||
164164795|NCT00014495|592968632|FG001|Overall Study|Clinical deterioration|0|||
164164796|NCT00014495|592968633|FG002|Overall Study|Clinical deterioration|0|||
164164797|NCT00014495|592968634|FG003|Overall Study|Clinical deterioration|1|||
164164798|NCT00403481|592968635|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
164164799|NCT00403481|592968635|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
164164800|NCT00403481|592968635|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
164164801|NCT00403481|592968635|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
164164802|NCT00403481|592968635|FG000|Olm 40 mg|Adverse Event|2|||
164164803|NCT00403481|592968635|FG000|Olm 40 mg|Protocol Violation|1|||
164164804|NCT00403481|592968635|FG000|Olm 40 mg|Withdrawal by Subject|1|||
164164805|NCT00403481|592968635|FG000|Olm 40 mg|Other|1|||
164164806|NCT00403481|592968635|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
164164807|NCT00403481|592968635|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
164164808|NCT00403481|592968635|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
164164809|NCT00403481|592968635|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
164164810|NCT00403481|592968635|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
164164811|NCT00403481|592968635|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
164164812|NCT02929589|592968637|FG000|Overall Study|Withdrawal by Subject|1|||
164164813|NCT02929589|592968638|FG001|Overall Study|Withdrawal by Subject|0|||
164164814|NCT02929589|592968639|FG002|Overall Study|Withdrawal by Subject|0|||
164164815|NCT02929589|592968640|FG003|Overall Study|Withdrawal by Subject|0|||
164164816|NCT02929589|592968637|FG000|Overall Study|Physician Decision|2|||
164164817|NCT02929589|592968638|FG001|Overall Study|Physician Decision|0|||
164164818|NCT02929589|592968639|FG002|Overall Study|Physician Decision|0|||
164164819|NCT02929589|592968640|FG003|Overall Study|Physician Decision|0|||
164164820|NCT00520533|592968647|FG000|Overall Study|Death|1|||
164164821|NCT00520533|592968647|FG000|Overall Study|Suspension of the study for safety reasons|1|||
164164822|NCT00520533|592968647|FG000|Overall Study|Withdrawal by Subject|1|||
164164823|NCT00520533|592968647|FG000|Overall Study|Physician Decision|1|||
164164824|NCT00697463|592968659|FG000|Overall Study|Withdrawal by Subject|1|||
164164825|NCT02568189|592968660|FG000|Overall Study|Protocol Violation|0|||
164164826|NCT02568189|592968661|FG001|Overall Study|Protocol Violation|0|||
164164827|NCT02568189|592968662|FG002|Overall Study|Protocol Violation|19|||
164164828|NCT02568189|592968663|FG003|Overall Study|Protocol Violation|18|||
164164829|NCT00603473|592968666|FG000|Overall Study|Adverse Event|4|||
164164830|NCT00603473|592968666|FG000|Overall Study|Lack of Efficacy|4|||
164164831|NCT00603473|592968666|FG000|Overall Study|Protocol Violation|1|||
164164832|NCT03850483|592968670|FG000|Treatment for Stage 1|Adverse Event|1|||
164164833|NCT03850483|592968671|FG001|Treatment for Stage 1|Adverse Event|1|||
164164834|NCT03850483|592968672|FG002|Treatment for Stage 1|Adverse Event|3|||
164164835|NCT03850483|592968673|FG003|Treatment for Stage 1|Adverse Event|0|||
164164836|NCT03850483|592968674|FG004|Treatment for Stage 1|Adverse Event|2|||
164164837|NCT03850483|592968675|FG005|Treatment for Stage 1|Adverse Event|0|||
164164838|NCT03850483|592968676|FG006|Treatment for Stage 1|Adverse Event|2|||
164164839|NCT03850483|592968677|FG007|Treatment for Stage 1|Adverse Event|2|||
164164840|NCT03850483|592968678|FG008|Treatment for Stage 1|Adverse Event|0|||
164164841|NCT03850483|592968679|FG009|Treatment for Stage 1|Adverse Event|0|||
164164842|NCT03850483|592968670|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
164164843|NCT03850483|592968671|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
164164844|NCT03850483|592968672|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
164164845|NCT03850483|592968673|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
164164846|NCT03850483|592968674|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
164164847|NCT03850483|592968675|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
164164848|NCT03850483|592968676|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
164164849|NCT03850483|592968677|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
164164850|NCT03850483|592968678|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
164164851|NCT03850483|592968679|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
164164852|NCT03850483|592968670|FG000|Treatment for Stage 1|Protocol Violation|1|||
164164853|NCT03850483|592968671|FG001|Treatment for Stage 1|Protocol Violation|0|||
164164854|NCT03850483|592968672|FG002|Treatment for Stage 1|Protocol Violation|0|||
164164855|NCT03850483|592968673|FG003|Treatment for Stage 1|Protocol Violation|0|||
164164856|NCT03850483|592968674|FG004|Treatment for Stage 1|Protocol Violation|0|||
164164857|NCT03850483|592968675|FG005|Treatment for Stage 1|Protocol Violation|0|||
164164858|NCT03850483|592968676|FG006|Treatment for Stage 1|Protocol Violation|1|||
164164859|NCT03850483|592968677|FG007|Treatment for Stage 1|Protocol Violation|0|||
164164860|NCT03850483|592968678|FG008|Treatment for Stage 1|Protocol Violation|0|||
164164861|NCT03850483|592968679|FG009|Treatment for Stage 1|Protocol Violation|0|||
164164862|NCT03850483|592968670|FG000|Treatment for Stage 1|Physician Decision|0|||
164164863|NCT03850483|592968671|FG001|Treatment for Stage 1|Physician Decision|0|||
164164864|NCT03850483|592968672|FG002|Treatment for Stage 1|Physician Decision|0|||
164164865|NCT03850483|592968673|FG003|Treatment for Stage 1|Physician Decision|0|||
164164866|NCT03850483|592968674|FG004|Treatment for Stage 1|Physician Decision|0|||
164164867|NCT03850483|592968675|FG005|Treatment for Stage 1|Physician Decision|1|||
164164868|NCT03850483|592968676|FG006|Treatment for Stage 1|Physician Decision|0|||
164164869|NCT03850483|592968677|FG007|Treatment for Stage 1|Physician Decision|0|||
164164870|NCT03850483|592968678|FG008|Treatment for Stage 1|Physician Decision|0|||
164164871|NCT03850483|592968679|FG009|Treatment for Stage 1|Physician Decision|0|||
164164872|NCT03850483|592968670|FG000|Treatment for Stage 1|Other|0|||
164164873|NCT03850483|592968671|FG001|Treatment for Stage 1|Other|0|||
164164874|NCT03850483|592968672|FG002|Treatment for Stage 1|Other|0|||
164164875|NCT03850483|592968673|FG003|Treatment for Stage 1|Other|0|||
164164876|NCT03850483|592968674|FG004|Treatment for Stage 1|Other|2|||
164164877|NCT03850483|592968675|FG005|Treatment for Stage 1|Other|1|||
164164878|NCT03850483|592968676|FG006|Treatment for Stage 1|Other|0|||
164164879|NCT03850483|592968677|FG007|Treatment for Stage 1|Other|0|||
164164880|NCT03850483|592968678|FG008|Treatment for Stage 1|Other|0|||
164164881|NCT03850483|592968679|FG009|Treatment for Stage 1|Other|0|||
164164882|NCT03850483|592968670|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
164164883|NCT03850483|592968671|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
164164884|NCT03850483|592968672|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
164164885|NCT03850483|592968673|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
164164886|NCT03850483|592968674|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
164164887|NCT03850483|592968675|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
164164888|NCT03850483|592968676|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
164164889|NCT03850483|592968677|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
164164890|NCT03850483|592968678|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
164164891|NCT03850483|592968679|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
164164892|NCT03850483|592968670|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
164164893|NCT03850483|592968671|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
164164894|NCT03850483|592968672|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
164164895|NCT03850483|592968673|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
164164896|NCT03850483|592968674|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
164164897|NCT03850483|592968675|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
164164898|NCT03850483|592968676|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
164164899|NCT03850483|592968677|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
164164900|NCT03850483|592968678|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
164164901|NCT03850483|592968679|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
164164902|NCT03850483|592968670|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
164164903|NCT03850483|592968671|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
164164904|NCT03850483|592968672|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
164164905|NCT03850483|592968673|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
164164906|NCT03850483|592968674|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
164164907|NCT03850483|592968675|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
164164908|NCT03850483|592968676|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
164164909|NCT03850483|592968677|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
164164910|NCT03850483|592968678|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
164164911|NCT03850483|592968679|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
164164912|NCT03850483|592968670|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
164164913|NCT03850483|592968671|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
164164914|NCT03850483|592968672|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
164164915|NCT03850483|592968673|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
164164916|NCT03850483|592968674|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
164164917|NCT03850483|592968675|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
164164918|NCT03850483|592968676|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
164164919|NCT03850483|592968677|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
164164920|NCT03850483|592968678|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
164164921|NCT03850483|592968679|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
164164922|NCT03850483|592968670|FG000|Treatment for Stage 1|Death|0|||
164164923|NCT03850483|592968671|FG001|Treatment for Stage 1|Death|0|||
164164924|NCT03850483|592968672|FG002|Treatment for Stage 1|Death|0|||
164164925|NCT03850483|592968673|FG003|Treatment for Stage 1|Death|0|||
164164926|NCT03850483|592968674|FG004|Treatment for Stage 1|Death|0|||
164164927|NCT03850483|592968675|FG005|Treatment for Stage 1|Death|1|||
164164928|NCT03850483|592968676|FG006|Treatment for Stage 1|Death|0|||
164164929|NCT03850483|592968677|FG007|Treatment for Stage 1|Death|0|||
164164930|NCT03850483|592968678|FG008|Treatment for Stage 1|Death|0|||
164164931|NCT03850483|592968679|FG009|Treatment for Stage 1|Death|0|||
164164932|NCT03850483|592968670|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
164164933|NCT03850483|592968671|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
164164934|NCT03850483|592968672|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
164164935|NCT03850483|592968673|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
164164936|NCT03850483|592968674|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
164164937|NCT03850483|592968675|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
164164938|NCT03850483|592968676|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
164164939|NCT03850483|592968677|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
164164940|NCT03850483|592968678|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
164164941|NCT03850483|592968679|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
164164942|NCT03850483|592968670|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
164164943|NCT03850483|592968671|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
164164944|NCT03850483|592968672|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
164164945|NCT03850483|592968673|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
164164946|NCT03850483|592968674|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
164164947|NCT03850483|592968675|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
164164948|NCT03850483|592968676|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
164164949|NCT03850483|592968677|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
164164950|NCT03850483|592968678|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
164164951|NCT03850483|592968679|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
164164952|NCT03850483|592968670|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
164164953|NCT03850483|592968671|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
164164954|NCT03850483|592968672|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
164164955|NCT03850483|592968673|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
164164956|NCT03850483|592968674|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
164164957|NCT03850483|592968675|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
164164958|NCT03850483|592968676|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
164164959|NCT03850483|592968677|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
164164960|NCT03850483|592968678|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
164164961|NCT03850483|592968679|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
164164962|NCT03850483|592968670|FG000|Follow-up for Stage 1|Physician Decision|0|||
164164963|NCT03850483|592968671|FG001|Follow-up for Stage 1|Physician Decision|0|||
164164964|NCT03850483|592968672|FG002|Follow-up for Stage 1|Physician Decision|0|||
164164965|NCT03850483|592968673|FG003|Follow-up for Stage 1|Physician Decision|0|||
164164966|NCT03850483|592968674|FG004|Follow-up for Stage 1|Physician Decision|1|||
164164967|NCT03850483|592968675|FG005|Follow-up for Stage 1|Physician Decision|0|||
164164968|NCT03850483|592968676|FG006|Follow-up for Stage 1|Physician Decision|1|||
164164969|NCT03850483|592968677|FG007|Follow-up for Stage 1|Physician Decision|0|||
164164970|NCT03850483|592968678|FG008|Follow-up for Stage 1|Physician Decision|0|||
164164971|NCT03850483|592968679|FG009|Follow-up for Stage 1|Physician Decision|0|||
164164972|NCT03850483|592968670|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
164164973|NCT03850483|592968671|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
164164974|NCT03850483|592968672|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
164164975|NCT03850483|592968673|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
164164976|NCT03850483|592968674|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
164164977|NCT03850483|592968675|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
164164978|NCT03850483|592968676|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
164164979|NCT03850483|592968677|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
164164980|NCT03850483|592968678|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
164164981|NCT03850483|592968679|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
164164982|NCT03850483|592968670|FG000|Follow-up for Stage 1|Adverse Event|0|||
164164983|NCT03850483|592968671|FG001|Follow-up for Stage 1|Adverse Event|0|||
164164984|NCT03850483|592968672|FG002|Follow-up for Stage 1|Adverse Event|1|||
164164985|NCT03850483|592968673|FG003|Follow-up for Stage 1|Adverse Event|0|||
164164986|NCT03850483|592968674|FG004|Follow-up for Stage 1|Adverse Event|0|||
164164987|NCT03850483|592968675|FG005|Follow-up for Stage 1|Adverse Event|1|||
164164988|NCT03850483|592968676|FG006|Follow-up for Stage 1|Adverse Event|0|||
164164989|NCT03850483|592968677|FG007|Follow-up for Stage 1|Adverse Event|0|||
164164990|NCT03850483|592968678|FG008|Follow-up for Stage 1|Adverse Event|0|||
164164991|NCT03850483|592968679|FG009|Follow-up for Stage 1|Adverse Event|0|||
164164992|NCT03850483|592968670|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
164164993|NCT03850483|592968671|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
164164994|NCT03850483|592968672|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
164164995|NCT03850483|592968673|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
164164996|NCT03850483|592968674|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
164164997|NCT03850483|592968675|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
164164998|NCT03850483|592968676|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
164164999|NCT03850483|592968677|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
164165000|NCT03850483|592968678|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
164165001|NCT03850483|592968679|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
164165002|NCT03850483|592968670|FG000|Follow-up for Stage 1|Other|0|||
164165003|NCT03850483|592968671|FG001|Follow-up for Stage 1|Other|2|||
164165004|NCT03850483|592968672|FG002|Follow-up for Stage 1|Other|0|||
164165005|NCT03850483|592968673|FG003|Follow-up for Stage 1|Other|2|||
164165006|NCT03850483|592968674|FG004|Follow-up for Stage 1|Other|0|||
164165007|NCT03850483|592968675|FG005|Follow-up for Stage 1|Other|1|||
164165008|NCT03850483|592968676|FG006|Follow-up for Stage 1|Other|0|||
164165009|NCT03850483|592968677|FG007|Follow-up for Stage 1|Other|0|||
164165010|NCT03850483|592968678|FG008|Follow-up for Stage 1|Other|0|||
164165011|NCT03850483|592968679|FG009|Follow-up for Stage 1|Other|0|||
164165012|NCT03850483|592968670|FG000|Treatment for Stage 2|Adverse Event|0|||
164165013|NCT03850483|592968671|FG001|Treatment for Stage 2|Adverse Event|0|||
164165014|NCT03850483|592968672|FG002|Treatment for Stage 2|Adverse Event|0|||
164165015|NCT03850483|592968673|FG003|Treatment for Stage 2|Adverse Event|0|||
164165016|NCT03850483|592968674|FG004|Treatment for Stage 2|Adverse Event|0|||
164165017|NCT03850483|592968675|FG005|Treatment for Stage 2|Adverse Event|0|||
164165018|NCT03850483|592968676|FG006|Treatment for Stage 2|Adverse Event|0|||
164165019|NCT03850483|592968677|FG007|Treatment for Stage 2|Adverse Event|0|||
164165020|NCT03850483|592968678|FG008|Treatment for Stage 2|Adverse Event|0|||
164165021|NCT03850483|592968679|FG009|Treatment for Stage 2|Adverse Event|1|||
164165022|NCT03850483|592968670|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
164165023|NCT03850483|592968671|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
164165024|NCT03850483|592968672|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
164165025|NCT03850483|592968673|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
164165026|NCT03850483|592968674|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
164165027|NCT03850483|592968675|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
164165028|NCT03850483|592968676|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
164165029|NCT03850483|592968677|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
164165030|NCT03850483|592968678|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
164165031|NCT03850483|592968679|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
164165032|NCT03850483|592968670|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
164165033|NCT03850483|592968671|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
164165034|NCT03850483|592968672|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
164165035|NCT03850483|592968673|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
164165036|NCT03850483|592968674|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
164165037|NCT03850483|592968675|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
164165038|NCT03850483|592968676|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
164165039|NCT03850483|592968677|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
164165040|NCT03850483|592968678|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
164165041|NCT03850483|592968679|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
164165042|NCT03850483|592968670|FG000|Treatment for Stage 2|Physician Decision|0|||
164165043|NCT03850483|592968671|FG001|Treatment for Stage 2|Physician Decision|0|||
164165044|NCT03850483|592968672|FG002|Treatment for Stage 2|Physician Decision|0|||
164165045|NCT03850483|592968673|FG003|Treatment for Stage 2|Physician Decision|0|||
164165046|NCT03850483|592968674|FG004|Treatment for Stage 2|Physician Decision|0|||
164165047|NCT03850483|592968675|FG005|Treatment for Stage 2|Physician Decision|0|||
164165048|NCT03850483|592968676|FG006|Treatment for Stage 2|Physician Decision|0|||
164165049|NCT03850483|592968677|FG007|Treatment for Stage 2|Physician Decision|0|||
164165050|NCT03850483|592968678|FG008|Treatment for Stage 2|Physician Decision|0|||
164165051|NCT03850483|592968679|FG009|Treatment for Stage 2|Physician Decision|1|||
164165052|NCT03850483|592968670|FG000|Treatment for Stage 2|Protocol Violation|0|||
164165053|NCT03850483|592968671|FG001|Treatment for Stage 2|Protocol Violation|0|||
164165054|NCT03850483|592968672|FG002|Treatment for Stage 2|Protocol Violation|0|||
164165055|NCT03850483|592968673|FG003|Treatment for Stage 2|Protocol Violation|0|||
164165056|NCT03850483|592968674|FG004|Treatment for Stage 2|Protocol Violation|0|||
164165057|NCT03850483|592968675|FG005|Treatment for Stage 2|Protocol Violation|0|||
164165058|NCT03850483|592968676|FG006|Treatment for Stage 2|Protocol Violation|0|||
164165059|NCT03850483|592968677|FG007|Treatment for Stage 2|Protocol Violation|0|||
164165060|NCT03850483|592968678|FG008|Treatment for Stage 2|Protocol Violation|1|||
164165061|NCT03850483|592968679|FG009|Treatment for Stage 2|Protocol Violation|0|||
164165062|NCT03850483|592968670|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
164165063|NCT03850483|592968671|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
164165064|NCT03850483|592968672|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
164165065|NCT03850483|592968673|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
164165066|NCT03850483|592968674|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
164165067|NCT03850483|592968675|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
164165068|NCT03850483|592968676|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
164165069|NCT03850483|592968677|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
164165070|NCT03850483|592968678|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
164165071|NCT03850483|592968679|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
164165072|NCT03850483|592968670|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
164165073|NCT03850483|592968671|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
164165074|NCT03850483|592968672|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
164165075|NCT03850483|592968673|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
164165076|NCT03850483|592968674|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
164165077|NCT03850483|592968675|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
164165078|NCT03850483|592968676|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
164165079|NCT03850483|592968677|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
164165080|NCT03850483|592968678|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
164165081|NCT03850483|592968679|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
164165082|NCT03850483|592968670|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
164165083|NCT03850483|592968671|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
164165084|NCT03850483|592968672|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
164165085|NCT03850483|592968673|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
164165086|NCT03850483|592968674|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
164165087|NCT03850483|592968675|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
164165088|NCT03850483|592968676|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
164165089|NCT03850483|592968677|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
164165090|NCT03850483|592968678|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
164165091|NCT03850483|592968679|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
164165092|NCT03850483|592968670|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
164165093|NCT03850483|592968671|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
164165094|NCT03850483|592968672|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
164165095|NCT03850483|592968673|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
164165096|NCT03850483|592968674|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
164165097|NCT03850483|592968675|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
164165098|NCT03850483|592968676|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
164165099|NCT03850483|592968677|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
164165100|NCT03850483|592968678|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
164165101|NCT03850483|592968679|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
164165102|NCT03850483|592968670|FG000|Follow-up For Stage 2|Other|0|||
164165103|NCT03850483|592968671|FG001|Follow-up For Stage 2|Other|0|||
164165104|NCT03850483|592968672|FG002|Follow-up For Stage 2|Other|0|||
164165105|NCT03850483|592968673|FG003|Follow-up For Stage 2|Other|0|||
164165106|NCT03850483|592968674|FG004|Follow-up For Stage 2|Other|0|||
164165107|NCT03850483|592968675|FG005|Follow-up For Stage 2|Other|0|||
164165108|NCT03850483|592968676|FG006|Follow-up For Stage 2|Other|0|||
164165109|NCT03850483|592968677|FG007|Follow-up For Stage 2|Other|0|||
164165110|NCT03850483|592968678|FG008|Follow-up For Stage 2|Other|0|||
164165111|NCT03850483|592968679|FG009|Follow-up For Stage 2|Other|1|||
164165112|NCT03225105|592968680|FG000|Overall Study|Withdrawal by Subject|1|||
164165113|NCT03225105|592968681|FG001|Overall Study|Withdrawal by Subject|0|||
164165114|NCT03225105|592968682|FG002|Overall Study|Withdrawal by Subject|0|||
164165115|NCT03225105|592968683|FG003|Overall Study|Withdrawal by Subject|0|||
164165116|NCT03225105|592968680|FG000|Overall Study|Death|0|||
164165117|NCT03225105|592968681|FG001|Overall Study|Death|4|||
164165118|NCT03225105|592968682|FG002|Overall Study|Death|2|||
164165119|NCT03225105|592968683|FG003|Overall Study|Death|0|||
164165120|NCT03225105|592968680|FG000|Overall Study|Study termination per Sponsor Decision|2|||
164165121|NCT03225105|592968681|FG001|Overall Study|Study termination per Sponsor Decision|0|||
164165122|NCT03225105|592968682|FG002|Overall Study|Study termination per Sponsor Decision|3|||
164165123|NCT03225105|592968683|FG003|Overall Study|Study termination per Sponsor Decision|3|||
164165124|NCT05488470|592970454|FG000|Overall Study|Physician Decision|2|||
164165125|NCT05488470|592970454|FG000|Overall Study|Withdrawal by Subject|1|||
164165126|NCT05488470|592970454|FG000|Overall Study|Death|1|||
164165127|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
164165128|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
164165129|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
164165130|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
164165131|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Death|0|||
164165132|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Death|0|||
164165133|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Death|1|||
164165134|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Death|0|||
164165135|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
164165136|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
164165137|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
164165138|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
164165139|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
164165140|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
164165141|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
164165142|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
164165143|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
164165144|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
164165145|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
164165146|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
164165147|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
164165148|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
164165149|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
164165150|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
164165151|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
164165152|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
164165153|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
164165154|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
164165155|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
164165156|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
164165157|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
164165158|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
164165159|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
164165160|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
164165161|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
164165162|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
164165163|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
164165164|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
164165165|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
164165166|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
164165167|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
164165168|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
164165169|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
164165170|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
164165171|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Other|8|||
164165172|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Other|14|||
164165173|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Other|8|||
164165174|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Other|23|||
164165175|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
164165176|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
164165177|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
164165178|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
164165179|NCT01106677|592970456|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
164165180|NCT01106677|592970457|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
164165181|NCT01106677|592970458|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
164165182|NCT01106677|592970459|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
164165183|NCT01106677|592970456|FG000|Extension Period: Week 26 to Week 52|Death|0|||
164165184|NCT01106677|592970457|FG001|Extension Period: Week 26 to Week 52|Death|0|||
164165185|NCT01106677|592970458|FG002|Extension Period: Week 26 to Week 52|Death|0|||
164165186|NCT01106677|592970459|FG003|Extension Period: Week 26 to Week 52|Death|1|||
164165187|NCT01106677|592970456|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
164165188|NCT01106677|592970457|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
164165189|NCT01106677|592970458|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
164165190|NCT01106677|592970459|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
164165191|NCT01106677|592970456|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
164165192|NCT01106677|592970457|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
164165193|NCT01106677|592970458|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
164165194|NCT01106677|592970459|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
164165195|NCT01106677|592970456|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
164165196|NCT01106677|592970457|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
164165197|NCT01106677|592970458|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
164165198|NCT01106677|592970459|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
164165199|NCT01106677|592970456|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
164165200|NCT01106677|592970457|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
164165201|NCT01106677|592970458|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
164165202|NCT01106677|592970459|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
164165203|NCT01106677|592970456|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
164165204|NCT01106677|592970457|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
164165205|NCT01106677|592970458|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
164165206|NCT01106677|592970459|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
164165207|NCT01106677|592970456|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
164165208|NCT01106677|592970457|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
164165209|NCT01106677|592970458|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
164165210|NCT01106677|592970459|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
164165211|NCT01106677|592970456|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
164165212|NCT01106677|592970457|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
164165213|NCT01106677|592970458|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
164165214|NCT01106677|592970459|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
164165215|NCT01106677|592970456|FG000|Extension Period: Week 26 to Week 52|Other|6|||
164165216|NCT01106677|592970457|FG001|Extension Period: Week 26 to Week 52|Other|5|||
164165217|NCT01106677|592970458|FG002|Extension Period: Week 26 to Week 52|Other|8|||
164165218|NCT01106677|592970459|FG003|Extension Period: Week 26 to Week 52|Other|5|||
164165219|NCT00972816|592970460|FG000|Overall Study|Adverse Event|0|||
164165220|NCT00972816|592970461|FG001|Overall Study|Adverse Event|0|||
164165221|NCT00972816|592970462|FG002|Overall Study|Adverse Event|1|||
164165222|NCT00972816|592970463|FG003|Overall Study|Adverse Event|0|||
164165223|NCT00972816|592970464|FG004|Overall Study|Adverse Event|0|||
164165224|NCT00972816|592970465|FG005|Overall Study|Adverse Event|0|||
164165225|NCT00972816|592970466|FG006|Overall Study|Adverse Event|0|||
164165226|NCT00972816|592970467|FG007|Overall Study|Adverse Event|0|||
164165227|NCT00972816|592970460|FG000|Overall Study|Withdrawal by Subject|4|||
164165228|NCT00972816|592970461|FG001|Overall Study|Withdrawal by Subject|2|||
164165229|NCT00972816|592970462|FG002|Overall Study|Withdrawal by Subject|1|||
164165230|NCT00972816|592970463|FG003|Overall Study|Withdrawal by Subject|3|||
164165231|NCT00972816|592970464|FG004|Overall Study|Withdrawal by Subject|0|||
164165232|NCT00972816|592970465|FG005|Overall Study|Withdrawal by Subject|1|||
164165233|NCT00972816|592970466|FG006|Overall Study|Withdrawal by Subject|1|||
164165234|NCT00972816|592970467|FG007|Overall Study|Withdrawal by Subject|2|||
164165235|NCT00972816|592970460|FG000|Overall Study|Lost to Follow-up|11|||
164165236|NCT00972816|592970461|FG001|Overall Study|Lost to Follow-up|9|||
164165237|NCT00972816|592970462|FG002|Overall Study|Lost to Follow-up|7|||
164165238|NCT00972816|592970463|FG003|Overall Study|Lost to Follow-up|5|||
164165239|NCT00972816|592970464|FG004|Overall Study|Lost to Follow-up|11|||
164165240|NCT00972816|592970465|FG005|Overall Study|Lost to Follow-up|10|||
164165241|NCT00972816|592970466|FG006|Overall Study|Lost to Follow-up|7|||
164165242|NCT00972816|592970467|FG007|Overall Study|Lost to Follow-up|7|||
164165243|NCT00972816|592970460|FG000|Overall Study|Inappropriate enrolment|0|||
164165244|NCT00972816|592970461|FG001|Overall Study|Inappropriate enrolment|0|||
164165245|NCT00972816|592970462|FG002|Overall Study|Inappropriate enrolment|0|||
164165246|NCT00972816|592970463|FG003|Overall Study|Inappropriate enrolment|0|||
164165247|NCT00972816|592970464|FG004|Overall Study|Inappropriate enrolment|0|||
164165248|NCT00972816|592970465|FG005|Overall Study|Inappropriate enrolment|0|||
164165249|NCT00972816|592970466|FG006|Overall Study|Inappropriate enrolment|2|||
164165250|NCT00972816|592970467|FG007|Overall Study|Inappropriate enrolment|0|||
164165251|NCT00972816|592970460|FG000|Overall Study|Unable to classify|2|||
164165252|NCT00972816|592970461|FG001|Overall Study|Unable to classify|0|||
164165253|NCT00972816|592970462|FG002|Overall Study|Unable to classify|0|||
164165254|NCT00972816|592970463|FG003|Overall Study|Unable to classify|0|||
164165255|NCT00972816|592970464|FG004|Overall Study|Unable to classify|1|||
164165256|NCT00972816|592970465|FG005|Overall Study|Unable to classify|0|||
164165257|NCT00972816|592970466|FG006|Overall Study|Unable to classify|0|||
164165258|NCT00972816|592970467|FG007|Overall Study|Unable to classify|0|||
164165259|NCT03806933|592970468|FG000|Main Period|Physician Decision|0|||
164165260|NCT03806933|592970469|FG001|Main Period|Physician Decision|0|||
164165261|NCT03806933|592970470|FG002|Main Period|Physician Decision|0|||
164165262|NCT03806933|592970471|FG003|Main Period|Physician Decision|1|||
164165263|NCT03806933|592970468|FG000|Main Period|Pregnancy|0|||
164165264|NCT03806933|592970469|FG001|Main Period|Pregnancy|0|||
164165265|NCT03806933|592970470|FG002|Main Period|Pregnancy|1|||
164165266|NCT03806933|592970471|FG003|Main Period|Pregnancy|0|||
164165267|NCT03806933|592970468|FG000|Main Period|Withdrawal by Subject|2|||
164165268|NCT03806933|592970469|FG001|Main Period|Withdrawal by Subject|1|||
164165269|NCT03806933|592970470|FG002|Main Period|Withdrawal by Subject|1|||
164165270|NCT03806933|592970471|FG003|Main Period|Withdrawal by Subject|2|||
164165271|NCT03806933|592970468|FG000|Main Period|Lost to Follow-up|2|||
164165272|NCT03806933|592970469|FG001|Main Period|Lost to Follow-up|2|||
164165273|NCT03806933|592970470|FG002|Main Period|Lost to Follow-up|0|||
164165274|NCT03806933|592970471|FG003|Main Period|Lost to Follow-up|0|||
164165275|NCT03806933|592970468|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
164165276|NCT03806933|592970469|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
164165277|NCT03806933|592970470|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
164165278|NCT03806933|592970471|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
164165279|NCT05088603|592970472|FG000|Overall Study|Protocol Violation|6|||
164165280|NCT05088603|592970473|FG001|Overall Study|Protocol Violation|1|||
164165281|NCT01868438|592970474|FG000|First Intervention|Withdrawal by Subject|5|||
164165282|NCT01868438|592970475|FG001|First Intervention|Withdrawal by Subject|1|||
164165283|NCT01868438|592970474|FG000|First Intervention|Lost to Follow-up|2|||
164165284|NCT01868438|592970475|FG001|First Intervention|Lost to Follow-up|3|||
164165285|NCT01868438|592970474|FG000|First Intervention|Meeting the non-redosing criteria|0|||
164165286|NCT01868438|592970475|FG001|First Intervention|Meeting the non-redosing criteria|1|||
164165287|NCT01868438|592970474|FG000|Second Intervention|Adverse Event|3|||
164165288|NCT01868438|592970475|FG001|Second Intervention|Adverse Event|3|||
164165289|NCT00955955|592970477|FG000|Overall Study|Lost to Follow-up|2|||
164165290|NCT00955955|592970478|FG001|Overall Study|Lost to Follow-up|0|||
164165291|NCT00955955|592970479|FG002|Overall Study|Lost to Follow-up|0|||
164165292|NCT01053663|592970483|FG000|Overall Study|Death|2|||
164165293|NCT01053663|592970483|FG000|Overall Study|Lost to Follow-up|1|||
164165294|NCT01053663|592970483|FG000|Overall Study|Poor IV Access|1|||
164165295|NCT01053663|592970483|FG000|Overall Study|Transferred to Another Hospital|1|||
164165296|NCT01053663|592970483|FG000|Overall Study|Negative Influenza Diagnosis|1|||
164165297|NCT03533114|592970486|FG000|Overall|Adverse Event|16|||
164165298|NCT03533114|592970487|FG001|Overall|Adverse Event|11|||
164165299|NCT03533114|592970486|FG000|Overall|Consent Withdrawal by Participant|7|||
164165300|NCT03533114|592970487|FG001|Overall|Consent Withdrawal by Participant|6|||
164165301|NCT03533114|592970486|FG000|Overall|Lack of Efficacy|5|||
164165302|NCT03533114|592970487|FG001|Overall|Lack of Efficacy|3|||
164165303|NCT03533114|592970486|FG000|Overall|Lost to Follow-up|1|||
164165304|NCT03533114|592970487|FG001|Overall|Lost to Follow-up|1|||
164165305|NCT03533114|592970486|FG000|Overall|Physician Decision|0|||
164165306|NCT03533114|592970487|FG001|Overall|Physician Decision|2|||
164165307|NCT03533114|592970486|FG000|Overall|Protocol deviation|1|||
164165308|NCT03533114|592970487|FG001|Overall|Protocol deviation|1|||
164165309|NCT03533114|592970486|FG000|Overall|Failure to meet randomization criteria|1|||
164165310|NCT03533114|592970487|FG001|Overall|Failure to meet randomization criteria|2|||
164165311|NCT03533114|592970486|FG000|Overall|Non-Compliance with study drug|0|||
164165312|NCT03533114|592970487|FG001|Overall|Non-Compliance with study drug|1|||
164165313|NCT03533114|592970486|FG000|Overall|Other|0|||
164165314|NCT03533114|592970487|FG001|Overall|Other|1|||
164165315|NCT03533114|592970486|FG000|Open Label Titration and Optimization|Adverse Event|11|||
164165316|NCT03533114|592970487|FG001|Open Label Titration and Optimization|Adverse Event|8|||
164165317|NCT03533114|592970486|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
164165318|NCT03533114|592970487|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
164165319|NCT03533114|592970486|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
164165320|NCT03533114|592970487|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
164165321|NCT03533114|592970486|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
164165322|NCT03533114|592970487|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
164165323|NCT03533114|592970486|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
164165324|NCT03533114|592970487|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
164165325|NCT03533114|592970486|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
164165326|NCT03533114|592970487|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
164165327|NCT03533114|592970486|FG000|Stable Dose|Adverse Event|0|||
164165328|NCT03533114|592970487|FG001|Stable Dose|Adverse Event|2|||
164165329|NCT03533114|592970486|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
164165330|NCT03533114|592970487|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
164165331|NCT03533114|592970486|FG000|Stable Dose|Lack of Efficacy|1|||
164165332|NCT03533114|592970487|FG001|Stable Dose|Lack of Efficacy|0|||
164165333|NCT03533114|592970486|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
164165334|NCT03533114|592970487|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
164165335|NCT03533114|592970486|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
164165336|NCT03533114|592970487|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
164165337|NCT03533114|592970486|FG000|Open-Label Safety Extension|Adverse Event|3|||
164165338|NCT03533114|592970487|FG001|Open-Label Safety Extension|Adverse Event|0|||
164165339|NCT03533114|592970486|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
164165340|NCT03533114|592970487|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
164165341|NCT03533114|592970486|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
164165342|NCT03533114|592970487|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
164165343|NCT03533114|592970486|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
164165344|NCT03533114|592970487|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
164165345|NCT03533114|592970486|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
164165346|NCT03533114|592970487|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
164165347|NCT01862250|592970488|FG000|Overall Study|Adverse Event|4|||
164165348|NCT03852264|592970489|FG000|Third Research Visit|Lost to Follow-up|1|||
164165349|NCT03852264|592970490|FG001|Third Research Visit|Lost to Follow-up|0|||
164165350|NCT02244463|592970495|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
164165351|NCT02244463|592970496|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
164165352|NCT02244463|592970497|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
164165353|NCT02244463|592970498|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
164165354|NCT02244463|592970499|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
164165355|NCT02244463|592970500|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
164165356|NCT02244463|592970495|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
164165357|NCT02244463|592970496|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
164165358|NCT02244463|592970497|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
164165359|NCT02244463|592970498|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
164165360|NCT02244463|592970499|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
164165361|NCT02244463|592970500|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
164165362|NCT02244463|592970495|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
164165363|NCT02244463|592970496|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
164165364|NCT02244463|592970497|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
164165365|NCT02244463|592970498|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
164165366|NCT02244463|592970499|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
164165367|NCT02244463|592970500|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
164165368|NCT02244463|592970495|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
164165369|NCT02244463|592970496|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
164165370|NCT02244463|592970497|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
164165371|NCT02244463|592970498|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
164165372|NCT02244463|592970499|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
164165373|NCT02244463|592970500|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
164165374|NCT02244463|592970495|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
164165375|NCT02244463|592970496|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
164165376|NCT02244463|592970497|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
164165377|NCT02244463|592970498|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
164165378|NCT02244463|592970499|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
164165379|NCT02244463|592970500|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
164165380|NCT02244463|592970495|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
164165381|NCT02244463|592970496|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
164165382|NCT02244463|592970497|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
164165383|NCT02244463|592970498|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
164165384|NCT02244463|592970499|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
164165385|NCT02244463|592970500|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
164165386|NCT02244463|592970495|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
164165387|NCT02244463|592970496|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
164165388|NCT02244463|592970497|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
164165389|NCT02244463|592970498|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
164165390|NCT02244463|592970499|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
164165391|NCT02244463|592970500|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
164165392|NCT02244463|592970495|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
164165393|NCT02244463|592970496|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
164165394|NCT02244463|592970497|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
164165395|NCT02244463|592970498|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
164165396|NCT02244463|592970499|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
164165397|NCT02244463|592970500|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
164165398|NCT02244463|592970495|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
164165399|NCT02244463|592970496|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
164165400|NCT02244463|592970497|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
164165401|NCT02244463|592970498|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
164165402|NCT02244463|592970499|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
164165403|NCT02244463|592970500|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
164165404|NCT02244463|592970495|FG000|Period 5: Phase II|Disease Progression|0|||
164165405|NCT02244463|592970496|FG001|Period 5: Phase II|Disease Progression|0|||
164165406|NCT02244463|592970497|FG002|Period 5: Phase II|Disease Progression|0|||
164165407|NCT02244463|592970498|FG003|Period 5: Phase II|Disease Progression|0|||
164165408|NCT02244463|592970499|FG004|Period 5: Phase II|Disease Progression|10|||
164165409|NCT02244463|592970500|FG005|Period 5: Phase II|Disease Progression|11|||
164165410|NCT02244463|592970495|FG000|Period 5: Phase II|Physician Decision|0|||
164165411|NCT02244463|592970496|FG001|Period 5: Phase II|Physician Decision|0|||
164165412|NCT02244463|592970497|FG002|Period 5: Phase II|Physician Decision|0|||
164165413|NCT02244463|592970498|FG003|Period 5: Phase II|Physician Decision|0|||
164165414|NCT02244463|592970499|FG004|Period 5: Phase II|Physician Decision|3|||
164165415|NCT02244463|592970500|FG005|Period 5: Phase II|Physician Decision|2|||
164165416|NCT02244463|592970495|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
164165417|NCT02244463|592970496|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
164165418|NCT02244463|592970497|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
164165419|NCT02244463|592970498|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
164165420|NCT02244463|592970499|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
164165421|NCT02244463|592970500|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
164165422|NCT02244463|592970495|FG000|Period 5: Phase II|Intercurrent Illness|0|||
164165423|NCT02244463|592970496|FG001|Period 5: Phase II|Intercurrent Illness|0|||
164165424|NCT02244463|592970497|FG002|Period 5: Phase II|Intercurrent Illness|0|||
164165425|NCT02244463|592970498|FG003|Period 5: Phase II|Intercurrent Illness|0|||
164165426|NCT02244463|592970499|FG004|Period 5: Phase II|Intercurrent Illness|2|||
164165427|NCT02244463|592970500|FG005|Period 5: Phase II|Intercurrent Illness|0|||
164165428|NCT02244463|592970495|FG000|Period 5: Phase II|Adverse Event|0|||
164165429|NCT02244463|592970496|FG001|Period 5: Phase II|Adverse Event|0|||
164165430|NCT02244463|592970497|FG002|Period 5: Phase II|Adverse Event|0|||
164165431|NCT02244463|592970498|FG003|Period 5: Phase II|Adverse Event|0|||
164165432|NCT02244463|592970499|FG004|Period 5: Phase II|Adverse Event|0|||
164165433|NCT02244463|592970500|FG005|Period 5: Phase II|Adverse Event|2|||
164165434|NCT02244463|592970495|FG000|Period 5: Phase II|Still On treatment|0|||
164165435|NCT02244463|592970496|FG001|Period 5: Phase II|Still On treatment|0|||
164165436|NCT02244463|592970497|FG002|Period 5: Phase II|Still On treatment|0|||
164165437|NCT02244463|592970498|FG003|Period 5: Phase II|Still On treatment|0|||
164165438|NCT02244463|592970499|FG004|Period 5: Phase II|Still On treatment|0|||
164165439|NCT02244463|592970500|FG005|Period 5: Phase II|Still On treatment|3|||
164165440|NCT05481125|592970501|FG000|Overall Study|Adverse Event|1|||
164165441|NCT05481125|592970502|FG001|Overall Study|Adverse Event|0|||
164165442|NCT05481125|592970501|FG000|Overall Study|Lost to Follow-up|0|||
164165443|NCT05481125|592970502|FG001|Overall Study|Lost to Follow-up|1|||
164165444|NCT05481125|592970501|FG000|Overall Study|Withdrawal by Subject|0|||
164165445|NCT05481125|592970502|FG001|Overall Study|Withdrawal by Subject|1|||
164165446|NCT01769508|592970507|FG000|Overall Study|Death|3|||
164165447|NCT01769508|592970507|FG000|Overall Study|Withdrawal by Subject|1|||
164165448|NCT01769508|592970507|FG000|Overall Study|Adverse Event|1|||
164165449|NCT01769508|592970507|FG000|Overall Study|Lost to Follow-up|1|||
164165450|NCT00839527|592970510|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
164165451|NCT00839527|592970511|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
164165452|NCT00839527|592970512|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
164165453|NCT00839527|592970510|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
164165454|NCT00839527|592970511|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
164165455|NCT00839527|592970512|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
164165456|NCT00839527|592970510|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
164165457|NCT00839527|592970511|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
164165458|NCT00839527|592970512|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
164165459|NCT00839527|592970510|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
164165460|NCT00839527|592970511|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
164165461|NCT00839527|592970512|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
164165462|NCT00839527|592970510|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
164165463|NCT00839527|592970511|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
164165464|NCT00839527|592970512|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
164165465|NCT00839527|592970510|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
164165466|NCT00839527|592970511|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
164165467|NCT00839527|592970512|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
164165468|NCT00839527|592970510|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
164165469|NCT00839527|592970511|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
164165470|NCT00839527|592970512|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
164165471|NCT00839527|592970510|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
164165472|NCT00839527|592970511|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
164165473|NCT00839527|592970512|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
164165474|NCT00839527|592970510|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
164165475|NCT00839527|592970511|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
164165476|NCT00839527|592970512|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
164165477|NCT00839527|592970510|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
164165478|NCT00839527|592970511|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
164165479|NCT00839527|592970512|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
164165480|NCT00839527|592970510|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
164165481|NCT00839527|592970511|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
164165482|NCT00839527|592970512|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
164165483|NCT00839527|592970510|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
164165484|NCT00839527|592970511|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
164165485|NCT00839527|592970512|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
164165486|NCT00839527|592970510|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
164165487|NCT00839527|592970511|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
164165488|NCT00839527|592970512|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
164165489|NCT00839527|592970510|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
164165490|NCT00839527|592970511|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
164165491|NCT00839527|592970512|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
164165492|NCT00839527|592970510|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
164165493|NCT00839527|592970511|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
164165494|NCT00839527|592970512|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
164165495|NCT00839527|592970510|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
164165496|NCT00839527|592970511|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
164165497|NCT00839527|592970512|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
164165498|NCT00839527|592970510|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
164165499|NCT00839527|592970511|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
164165500|NCT00839527|592970512|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
164165501|NCT00839527|592970510|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
164165502|NCT00839527|592970511|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
164165503|NCT00839527|592970512|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
164165504|NCT00839527|592970510|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
164165505|NCT00839527|592970511|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
164165506|NCT00839527|592970512|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
164165796|NCT02477826|592970547|FG002|Treatment Period|Pregnancy|0|||
164165507|NCT00839527|592970510|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
164165508|NCT00839527|592970511|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
164165509|NCT00839527|592970512|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
164165510|NCT00839527|592970510|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
164165511|NCT00839527|592970511|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
164165512|NCT00839527|592970512|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
164165513|NCT00839527|592970510|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
164165514|NCT00839527|592970511|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
164165515|NCT00839527|592970512|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
164165516|NCT00839527|592970510|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
164165517|NCT00839527|592970511|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
164165518|NCT00839527|592970512|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
164165519|NCT00839527|592970510|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
164165520|NCT00839527|592970511|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
164165521|NCT00839527|592970512|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
164165522|NCT02295020|592970513|FG000|Overall Study|Adverse Event|0|||
164165523|NCT02295020|592970514|FG001|Overall Study|Adverse Event|1|||
164165524|NCT02295020|592970513|FG000|Overall Study|Withdrawal by Subject|3|||
164165525|NCT02295020|592970514|FG001|Overall Study|Withdrawal by Subject|2|||
164165526|NCT02751450|592970515|FG000|Overall Study|Adverse Event|1|||
164165527|NCT02751450|592970516|FG001|Overall Study|Adverse Event|0|||
164165528|NCT01290679|592970517|FG000|Overall Study|Adverse Event|2|||
164165529|NCT01290679|592970518|FG001|Overall Study|Adverse Event|0|||
164165530|NCT01290679|592970517|FG000|Overall Study|Lost to Follow-up|8|||
164165531|NCT01290679|592970518|FG001|Overall Study|Lost to Follow-up|10|||
164165532|NCT01290679|592970517|FG000|Overall Study|Protocol Violation|0|||
164165533|NCT01290679|592970518|FG001|Overall Study|Protocol Violation|1|||
164165534|NCT01290679|592970517|FG000|Overall Study|Withdrawal by Subject|6|||
164165535|NCT01290679|592970518|FG001|Overall Study|Withdrawal by Subject|5|||
164165536|NCT01290679|592970517|FG000|Overall Study|Subject Entered Another Trial|0|||
164165537|NCT01290679|592970518|FG001|Overall Study|Subject Entered Another Trial|5|||
164165538|NCT01855243|592970519|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
164165539|NCT01855243|592970520|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
164165540|NCT01855243|592970521|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
164165541|NCT02587598|592970524|FG000|Overall Study|Death|4|||
164165542|NCT02587598|592970525|FG001|Overall Study|Death|8|||
164165543|NCT02587598|592970526|FG002|Overall Study|Death|4|||
164165544|NCT02587598|592970527|FG003|Overall Study|Death|16|||
164165545|NCT02587598|592970528|FG004|Overall Study|Death|9|||
164165546|NCT02587598|592970529|FG005|Overall Study|Death|4|||
164165547|NCT02587598|592970530|FG006|Overall Study|Death|6|||
164165548|NCT02587598|592970531|FG007|Overall Study|Death|7|||
164165549|NCT02587598|592970532|FG008|Overall Study|Death|9|||
164165550|NCT02587598|592970533|FG009|Overall Study|Death|1|||
164165551|NCT02587598|592970534|FG010|Overall Study|Death|3|||
164165552|NCT02587598|592970524|FG000|Overall Study|Study Terminated by the Sponsor|0|||
164165553|NCT02587598|592970525|FG001|Overall Study|Study Terminated by the Sponsor|1|||
164165554|NCT02587598|592970526|FG002|Overall Study|Study Terminated by the Sponsor|0|||
164165555|NCT02587598|592970527|FG003|Overall Study|Study Terminated by the Sponsor|3|||
164165556|NCT02587598|592970528|FG004|Overall Study|Study Terminated by the Sponsor|0|||
164165557|NCT02587598|592970529|FG005|Overall Study|Study Terminated by the Sponsor|1|||
164165558|NCT02587598|592970530|FG006|Overall Study|Study Terminated by the Sponsor|0|||
164165559|NCT02587598|592970531|FG007|Overall Study|Study Terminated by the Sponsor|0|||
164165560|NCT02587598|592970532|FG008|Overall Study|Study Terminated by the Sponsor|0|||
164165561|NCT02587598|592970533|FG009|Overall Study|Study Terminated by the Sponsor|1|||
164165562|NCT02587598|592970534|FG010|Overall Study|Study Terminated by the Sponsor|6|||
164165563|NCT02587598|592970524|FG000|Overall Study|Reason for study withdrawal not specified|0|||
164165564|NCT02587598|592970525|FG001|Overall Study|Reason for study withdrawal not specified|1|||
164165565|NCT02587598|592970526|FG002|Overall Study|Reason for study withdrawal not specified|0|||
164165566|NCT02587598|592970527|FG003|Overall Study|Reason for study withdrawal not specified|0|||
164165567|NCT02587598|592970528|FG004|Overall Study|Reason for study withdrawal not specified|0|||
164165568|NCT02587598|592970529|FG005|Overall Study|Reason for study withdrawal not specified|0|||
164165569|NCT02587598|592970530|FG006|Overall Study|Reason for study withdrawal not specified|0|||
164165570|NCT02587598|592970531|FG007|Overall Study|Reason for study withdrawal not specified|0|||
164165571|NCT02587598|592970532|FG008|Overall Study|Reason for study withdrawal not specified|0|||
164165572|NCT02587598|592970533|FG009|Overall Study|Reason for study withdrawal not specified|0|||
164165573|NCT02587598|592970534|FG010|Overall Study|Reason for study withdrawal not specified|0|||
164165574|NCT02587598|592970524|FG000|Overall Study|Withdrawal by Subject|0|||
164165575|NCT02587598|592970525|FG001|Overall Study|Withdrawal by Subject|1|||
164165576|NCT02587598|592970526|FG002|Overall Study|Withdrawal by Subject|0|||
164165577|NCT02587598|592970527|FG003|Overall Study|Withdrawal by Subject|2|||
164165578|NCT02587598|592970528|FG004|Overall Study|Withdrawal by Subject|3|||
164165579|NCT02587598|592970529|FG005|Overall Study|Withdrawal by Subject|1|||
164165580|NCT02587598|592970530|FG006|Overall Study|Withdrawal by Subject|0|||
164165581|NCT02587598|592970531|FG007|Overall Study|Withdrawal by Subject|0|||
164165582|NCT02587598|592970532|FG008|Overall Study|Withdrawal by Subject|0|||
164165583|NCT02587598|592970533|FG009|Overall Study|Withdrawal by Subject|1|||
164165584|NCT02587598|592970534|FG010|Overall Study|Withdrawal by Subject|2|||
164165585|NCT02587598|592970524|FG000|Overall Study|Physician Decision|0|||
164165586|NCT02587598|592970525|FG001|Overall Study|Physician Decision|0|||
164165587|NCT02587598|592970526|FG002|Overall Study|Physician Decision|0|||
164165588|NCT02587598|592970527|FG003|Overall Study|Physician Decision|0|||
164165589|NCT02587598|592970528|FG004|Overall Study|Physician Decision|0|||
164165590|NCT02587598|592970529|FG005|Overall Study|Physician Decision|0|||
164165591|NCT02587598|592970530|FG006|Overall Study|Physician Decision|0|||
164165592|NCT02587598|592970531|FG007|Overall Study|Physician Decision|0|||
164165593|NCT02587598|592970532|FG008|Overall Study|Physician Decision|0|||
164165594|NCT02587598|592970533|FG009|Overall Study|Physician Decision|0|||
164165595|NCT02587598|592970534|FG010|Overall Study|Physician Decision|3|||
164165596|NCT01704651|592970541|FG000|Overall Study|Pre-op withdrawal by subject|1|||
164165597|NCT01704651|592970542|FG001|Overall Study|Pre-op withdrawal by subject|1|||
164165598|NCT01704651|592970541|FG000|Overall Study|Pre-op change in treatment plan|1|||
164165599|NCT01704651|592970542|FG001|Overall Study|Pre-op change in treatment plan|4|||
164165600|NCT01704651|592970541|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
164165601|NCT01704651|592970542|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
164165602|NCT01704651|592970541|FG000|Overall Study|Post-op did not have laparotomy|2|||
164165603|NCT01704651|592970542|FG001|Overall Study|Post-op did not have laparotomy|1|||
164165604|NCT02477826|592970545|FG000|Pre-Treatment|Adverse events unrelated to study drug|0|||
164165605|NCT02477826|592970546|FG001|Pre-Treatment|Adverse events unrelated to study drug|1|||
164165606|NCT02477826|592970547|FG002|Pre-Treatment|Adverse events unrelated to study drug|2|||
164165607|NCT02477826|592970548|FG003|Pre-Treatment|Adverse events unrelated to study drug|1|||
164165608|NCT02477826|592970549|FG004|Pre-Treatment|Adverse events unrelated to study drug|0|||
164165609|NCT02477826|592970550|FG005|Pre-Treatment|Adverse events unrelated to study drug|0|||
164165610|NCT02477826|592970551|FG006|Pre-Treatment|Adverse events unrelated to study drug|1|||
164165611|NCT02477826|592970552|FG007|Pre-Treatment|Adverse events unrelated to study drug|5|||
164165612|NCT02477826|592970553|FG008|Pre-Treatment|Adverse events unrelated to study drug|0|||
164165613|NCT02477826|592970554|FG009|Pre-Treatment|Adverse events unrelated to study drug|0|||
164165614|NCT02477826|592970545|FG000|Pre-Treatment|Other reasons|4|||
164165615|NCT02477826|592970546|FG001|Pre-Treatment|Other reasons|1|||
164165616|NCT02477826|592970547|FG002|Pre-Treatment|Other reasons|4|||
164165617|NCT02477826|592970548|FG003|Pre-Treatment|Other reasons|1|||
164165618|NCT02477826|592970549|FG004|Pre-Treatment|Other reasons|4|||
164165619|NCT02477826|592970550|FG005|Pre-Treatment|Other reasons|2|||
164165620|NCT02477826|592970551|FG006|Pre-Treatment|Other reasons|0|||
164165621|NCT02477826|592970552|FG007|Pre-Treatment|Other reasons|0|||
164165622|NCT02477826|592970553|FG008|Pre-Treatment|Other reasons|0|||
164165623|NCT02477826|592970554|FG009|Pre-Treatment|Other reasons|0|||
164165624|NCT02477826|592970545|FG000|Pre-Treatment|Subject no longer meets study criteria|1|||
164165625|NCT02477826|592970546|FG001|Pre-Treatment|Subject no longer meets study criteria|2|||
164165626|NCT02477826|592970547|FG002|Pre-Treatment|Subject no longer meets study criteria|1|||
164165627|NCT02477826|592970548|FG003|Pre-Treatment|Subject no longer meets study criteria|0|||
164165628|NCT02477826|592970549|FG004|Pre-Treatment|Subject no longer meets study criteria|1|||
164165629|NCT02477826|592970550|FG005|Pre-Treatment|Subject no longer meets study criteria|0|||
164165630|NCT02477826|592970551|FG006|Pre-Treatment|Subject no longer meets study criteria|0|||
164165631|NCT02477826|592970552|FG007|Pre-Treatment|Subject no longer meets study criteria|1|||
164165632|NCT02477826|592970553|FG008|Pre-Treatment|Subject no longer meets study criteria|0|||
164165633|NCT02477826|592970554|FG009|Pre-Treatment|Subject no longer meets study criteria|0|||
164165634|NCT02477826|592970545|FG000|Pre-Treatment|Subject withdrew consent|0|||
164165635|NCT02477826|592970546|FG001|Pre-Treatment|Subject withdrew consent|0|||
164165636|NCT02477826|592970547|FG002|Pre-Treatment|Subject withdrew consent|3|||
164165637|NCT02477826|592970548|FG003|Pre-Treatment|Subject withdrew consent|0|||
164165638|NCT02477826|592970549|FG004|Pre-Treatment|Subject withdrew consent|0|||
164165639|NCT02477826|592970550|FG005|Pre-Treatment|Subject withdrew consent|1|||
164165640|NCT02477826|592970551|FG006|Pre-Treatment|Subject withdrew consent|0|||
164165641|NCT02477826|592970552|FG007|Pre-Treatment|Subject withdrew consent|1|||
164165642|NCT02477826|592970553|FG008|Pre-Treatment|Subject withdrew consent|0|||
164165643|NCT02477826|592970554|FG009|Pre-Treatment|Subject withdrew consent|3|||
164165644|NCT02477826|592970545|FG000|Pre-Treatment|Subject request to discontinue study treatment|0|||
164165645|NCT02477826|592970546|FG001|Pre-Treatment|Subject request to discontinue study treatment|1|||
164165646|NCT02477826|592970547|FG002|Pre-Treatment|Subject request to discontinue study treatment|0|||
164165647|NCT02477826|592970548|FG003|Pre-Treatment|Subject request to discontinue study treatment|0|||
164165648|NCT02477826|592970549|FG004|Pre-Treatment|Subject request to discontinue study treatment|0|||
164165649|NCT02477826|592970550|FG005|Pre-Treatment|Subject request to discontinue study treatment|0|||
164165797|NCT02477826|592970548|FG003|Treatment Period|Pregnancy|0|||
164165650|NCT02477826|592970551|FG006|Pre-Treatment|Subject request to discontinue study treatment|0|||
164165651|NCT02477826|592970552|FG007|Pre-Treatment|Subject request to discontinue study treatment|0|||
164165652|NCT02477826|592970553|FG008|Pre-Treatment|Subject request to discontinue study treatment|0|||
164165653|NCT02477826|592970554|FG009|Pre-Treatment|Subject request to discontinue study treatment|1|||
164165654|NCT02477826|592970545|FG000|Pre-Treatment|Death|0|||
164165655|NCT02477826|592970546|FG001|Pre-Treatment|Death|0|||
164165656|NCT02477826|592970547|FG002|Pre-Treatment|Death|0|||
164165657|NCT02477826|592970548|FG003|Pre-Treatment|Death|0|||
164165658|NCT02477826|592970549|FG004|Pre-Treatment|Death|0|||
164165659|NCT02477826|592970550|FG005|Pre-Treatment|Death|0|||
164165660|NCT02477826|592970551|FG006|Pre-Treatment|Death|1|||
164165661|NCT02477826|592970552|FG007|Pre-Treatment|Death|0|||
164165662|NCT02477826|592970553|FG008|Pre-Treatment|Death|0|||
164165663|NCT02477826|592970554|FG009|Pre-Treatment|Death|0|||
164165664|NCT02477826|592970545|FG000|Treatment Period|Not reported|8|||
164165665|NCT02477826|592970546|FG001|Treatment Period|Not reported|6|||
164165666|NCT02477826|592970547|FG002|Treatment Period|Not reported|4|||
164165667|NCT02477826|592970548|FG003|Treatment Period|Not reported|4|||
164165668|NCT02477826|592970549|FG004|Treatment Period|Not reported|2|||
164165669|NCT02477826|592970550|FG005|Treatment Period|Not reported|1|||
164165670|NCT02477826|592970551|FG006|Treatment Period|Not reported|14|||
164165671|NCT02477826|592970552|FG007|Treatment Period|Not reported|8|||
164165672|NCT02477826|592970553|FG008|Treatment Period|Not reported|5|||
164165673|NCT02477826|592970554|FG009|Treatment Period|Not reported|2|||
164165674|NCT02477826|592970545|FG000|Treatment Period|Other reasons|5|||
164165675|NCT02477826|592970546|FG001|Treatment Period|Other reasons|6|||
164165676|NCT02477826|592970547|FG002|Treatment Period|Other reasons|12|||
164165677|NCT02477826|592970548|FG003|Treatment Period|Other reasons|7|||
164165678|NCT02477826|592970549|FG004|Treatment Period|Other reasons|5|||
164165679|NCT02477826|592970550|FG005|Treatment Period|Other reasons|1|||
164165680|NCT02477826|592970551|FG006|Treatment Period|Other reasons|8|||
164165681|NCT02477826|592970552|FG007|Treatment Period|Other reasons|8|||
164165682|NCT02477826|592970553|FG008|Treatment Period|Other reasons|21|||
164165683|NCT02477826|592970554|FG009|Treatment Period|Other reasons|1|||
164165684|NCT02477826|592970545|FG000|Treatment Period|Administrative reason by sponsor|0|||
164165685|NCT02477826|592970546|FG001|Treatment Period|Administrative reason by sponsor|3|||
164165686|NCT02477826|592970547|FG002|Treatment Period|Administrative reason by sponsor|0|||
164165687|NCT02477826|592970548|FG003|Treatment Period|Administrative reason by sponsor|0|||
164165688|NCT02477826|592970549|FG004|Treatment Period|Administrative reason by sponsor|0|||
164165689|NCT02477826|592970550|FG005|Treatment Period|Administrative reason by sponsor|0|||
164165690|NCT02477826|592970551|FG006|Treatment Period|Administrative reason by sponsor|0|||
164165691|NCT02477826|592970552|FG007|Treatment Period|Administrative reason by sponsor|0|||
164165692|NCT02477826|592970553|FG008|Treatment Period|Administrative reason by sponsor|0|||
164165693|NCT02477826|592970554|FG009|Treatment Period|Administrative reason by sponsor|0|||
164165694|NCT02477826|592970545|FG000|Treatment Period|Participant meet no longer study criteria|1|||
164165695|NCT02477826|592970546|FG001|Treatment Period|Participant meet no longer study criteria|1|||
164165696|NCT02477826|592970547|FG002|Treatment Period|Participant meet no longer study criteria|0|||
164165697|NCT02477826|592970548|FG003|Treatment Period|Participant meet no longer study criteria|0|||
164165698|NCT02477826|592970549|FG004|Treatment Period|Participant meet no longer study criteria|1|||
164165699|NCT02477826|592970550|FG005|Treatment Period|Participant meet no longer study criteria|1|||
164165700|NCT02477826|592970551|FG006|Treatment Period|Participant meet no longer study criteria|0|||
164165701|NCT02477826|592970552|FG007|Treatment Period|Participant meet no longer study criteria|1|||
164165702|NCT02477826|592970553|FG008|Treatment Period|Participant meet no longer study criteria|0|||
164165703|NCT02477826|592970554|FG009|Treatment Period|Participant meet no longer study criteria|0|||
164165704|NCT02477826|592970545|FG000|Treatment Period|Poor/Non Compliance|1|||
164165705|NCT02477826|592970546|FG001|Treatment Period|Poor/Non Compliance|0|||
164165706|NCT02477826|592970547|FG002|Treatment Period|Poor/Non Compliance|2|||
164165707|NCT02477826|592970548|FG003|Treatment Period|Poor/Non Compliance|0|||
164165708|NCT02477826|592970549|FG004|Treatment Period|Poor/Non Compliance|0|||
164165709|NCT02477826|592970550|FG005|Treatment Period|Poor/Non Compliance|1|||
164165710|NCT02477826|592970551|FG006|Treatment Period|Poor/Non Compliance|1|||
164165711|NCT02477826|592970552|FG007|Treatment Period|Poor/Non Compliance|0|||
164165712|NCT02477826|592970553|FG008|Treatment Period|Poor/Non Compliance|0|||
164165713|NCT02477826|592970554|FG009|Treatment Period|Poor/Non Compliance|1|||
164165714|NCT02477826|592970545|FG000|Treatment Period|Maximum Clinical Benefit|3|||
164165715|NCT02477826|592970546|FG001|Treatment Period|Maximum Clinical Benefit|3|||
164165716|NCT02477826|592970547|FG002|Treatment Period|Maximum Clinical Benefit|1|||
164165717|NCT02477826|592970548|FG003|Treatment Period|Maximum Clinical Benefit|1|||
164165718|NCT02477826|592970549|FG004|Treatment Period|Maximum Clinical Benefit|3|||
164165719|NCT02477826|592970550|FG005|Treatment Period|Maximum Clinical Benefit|0|||
164165720|NCT02477826|592970551|FG006|Treatment Period|Maximum Clinical Benefit|3|||
164165721|NCT02477826|592970552|FG007|Treatment Period|Maximum Clinical Benefit|2|||
164165722|NCT02477826|592970553|FG008|Treatment Period|Maximum Clinical Benefit|2|||
164165723|NCT02477826|592970554|FG009|Treatment Period|Maximum Clinical Benefit|2|||
164165724|NCT02477826|592970545|FG000|Treatment Period|Lost to Follow-up|0|||
164165725|NCT02477826|592970546|FG001|Treatment Period|Lost to Follow-up|0|||
164165726|NCT02477826|592970547|FG002|Treatment Period|Lost to Follow-up|1|||
164165727|NCT02477826|592970548|FG003|Treatment Period|Lost to Follow-up|1|||
164165728|NCT02477826|592970549|FG004|Treatment Period|Lost to Follow-up|0|||
164165729|NCT02477826|592970550|FG005|Treatment Period|Lost to Follow-up|0|||
164165730|NCT02477826|592970551|FG006|Treatment Period|Lost to Follow-up|2|||
164165731|NCT02477826|592970552|FG007|Treatment Period|Lost to Follow-up|2|||
164165732|NCT02477826|592970553|FG008|Treatment Period|Lost to Follow-up|0|||
164165733|NCT02477826|592970554|FG009|Treatment Period|Lost to Follow-up|0|||
164165734|NCT02477826|592970545|FG000|Treatment Period|Participant withdrew Consent|5|||
164165735|NCT02477826|592970546|FG001|Treatment Period|Participant withdrew Consent|5|||
164165736|NCT02477826|592970547|FG002|Treatment Period|Participant withdrew Consent|3|||
164165737|NCT02477826|592970548|FG003|Treatment Period|Participant withdrew Consent|3|||
164165738|NCT02477826|592970549|FG004|Treatment Period|Participant withdrew Consent|1|||
164165739|NCT02477826|592970550|FG005|Treatment Period|Participant withdrew Consent|3|||
164165740|NCT02477826|592970551|FG006|Treatment Period|Participant withdrew Consent|3|||
164165741|NCT02477826|592970552|FG007|Treatment Period|Participant withdrew Consent|3|||
164165742|NCT02477826|592970553|FG008|Treatment Period|Participant withdrew Consent|2|||
164165743|NCT02477826|592970554|FG009|Treatment Period|Participant withdrew Consent|3|||
164165744|NCT02477826|592970545|FG000|Treatment Period|Participant request to discontinue treatment|5|||
164165745|NCT02477826|592970546|FG001|Treatment Period|Participant request to discontinue treatment|3|||
164165746|NCT02477826|592970547|FG002|Treatment Period|Participant request to discontinue treatment|15|||
164165747|NCT02477826|592970548|FG003|Treatment Period|Participant request to discontinue treatment|5|||
164165748|NCT02477826|592970549|FG004|Treatment Period|Participant request to discontinue treatment|3|||
164165749|NCT02477826|592970550|FG005|Treatment Period|Participant request to discontinue treatment|6|||
164165750|NCT02477826|592970551|FG006|Treatment Period|Participant request to discontinue treatment|13|||
164165751|NCT02477826|592970552|FG007|Treatment Period|Participant request to discontinue treatment|15|||
164165752|NCT02477826|592970553|FG008|Treatment Period|Participant request to discontinue treatment|4|||
164165753|NCT02477826|592970554|FG009|Treatment Period|Participant request to discontinue treatment|18|||
164165754|NCT02477826|592970545|FG000|Treatment Period|Adverse event unrelated to study drug|23|||
164165755|NCT02477826|592970546|FG001|Treatment Period|Adverse event unrelated to study drug|29|||
164165756|NCT02477826|592970547|FG002|Treatment Period|Adverse event unrelated to study drug|22|||
164165757|NCT02477826|592970548|FG003|Treatment Period|Adverse event unrelated to study drug|18|||
164165758|NCT02477826|592970549|FG004|Treatment Period|Adverse event unrelated to study drug|11|||
164165759|NCT02477826|592970550|FG005|Treatment Period|Adverse event unrelated to study drug|15|||
164165760|NCT02477826|592970551|FG006|Treatment Period|Adverse event unrelated to study drug|25|||
164165761|NCT02477826|592970552|FG007|Treatment Period|Adverse event unrelated to study drug|19|||
164165762|NCT02477826|592970553|FG008|Treatment Period|Adverse event unrelated to study drug|4|||
164165763|NCT02477826|592970554|FG009|Treatment Period|Adverse event unrelated to study drug|2|||
164165764|NCT02477826|592970545|FG000|Treatment Period|Death|4|||
164165765|NCT02477826|592970546|FG001|Treatment Period|Death|7|||
164165766|NCT02477826|592970547|FG002|Treatment Period|Death|0|||
164165767|NCT02477826|592970548|FG003|Treatment Period|Death|0|||
164165768|NCT02477826|592970549|FG004|Treatment Period|Death|1|||
164165769|NCT02477826|592970550|FG005|Treatment Period|Death|2|||
164165770|NCT02477826|592970551|FG006|Treatment Period|Death|6|||
164165771|NCT02477826|592970552|FG007|Treatment Period|Death|5|||
164165772|NCT02477826|592970553|FG008|Treatment Period|Death|9|||
164165773|NCT02477826|592970554|FG009|Treatment Period|Death|0|||
164165774|NCT02477826|592970545|FG000|Treatment Period|Study Drug Toxicity|79|||
164165775|NCT02477826|592970546|FG001|Treatment Period|Study Drug Toxicity|51|||
164165776|NCT02477826|592970547|FG002|Treatment Period|Study Drug Toxicity|31|||
164165777|NCT02477826|592970548|FG003|Treatment Period|Study Drug Toxicity|39|||
164165778|NCT02477826|592970549|FG004|Treatment Period|Study Drug Toxicity|12|||
164165779|NCT02477826|592970550|FG005|Treatment Period|Study Drug Toxicity|25|||
164165780|NCT02477826|592970551|FG006|Treatment Period|Study Drug Toxicity|52|||
164165781|NCT02477826|592970552|FG007|Treatment Period|Study Drug Toxicity|30|||
164165782|NCT02477826|592970553|FG008|Treatment Period|Study Drug Toxicity|20|||
164165783|NCT02477826|592970554|FG009|Treatment Period|Study Drug Toxicity|9|||
164165784|NCT02477826|592970545|FG000|Treatment Period|Disease progression|212|||
164165785|NCT02477826|592970546|FG001|Treatment Period|Disease progression|240|||
164165786|NCT02477826|592970547|FG002|Treatment Period|Disease progression|202|||
164165787|NCT02477826|592970548|FG003|Treatment Period|Disease progression|93|||
164165788|NCT02477826|592970549|FG004|Treatment Period|Disease progression|113|||
164165789|NCT02477826|592970550|FG005|Treatment Period|Disease progression|96|||
164165790|NCT02477826|592970551|FG006|Treatment Period|Disease progression|208|||
164165791|NCT02477826|592970552|FG007|Treatment Period|Disease progression|195|||
164165792|NCT02477826|592970553|FG008|Treatment Period|Disease progression|59|||
164165793|NCT02477826|592970554|FG009|Treatment Period|Disease progression|46|||
164165794|NCT02477826|592970545|FG000|Treatment Period|Pregnancy|0|||
164165795|NCT02477826|592970546|FG001|Treatment Period|Pregnancy|0|||
164165798|NCT02477826|592970549|FG004|Treatment Period|Pregnancy|0|||
164165799|NCT02477826|592970550|FG005|Treatment Period|Pregnancy|0|||
164165800|NCT02477826|592970551|FG006|Treatment Period|Pregnancy|0|||
164165801|NCT02477826|592970552|FG007|Treatment Period|Pregnancy|0|||
164165802|NCT02477826|592970553|FG008|Treatment Period|Pregnancy|0|||
164165803|NCT02477826|592970554|FG009|Treatment Period|Pregnancy|1|||
164165804|NCT02477826|592970545|FG000|Treatment Period|Other|0|||
164165805|NCT02477826|592970546|FG001|Treatment Period|Other|0|||
164165806|NCT02477826|592970547|FG002|Treatment Period|Other|0|||
164165807|NCT02477826|592970548|FG003|Treatment Period|Other|0|||
164165808|NCT02477826|592970549|FG004|Treatment Period|Other|0|||
164165809|NCT02477826|592970550|FG005|Treatment Period|Other|0|||
164165810|NCT02477826|592970551|FG006|Treatment Period|Other|0|||
164165811|NCT02477826|592970552|FG007|Treatment Period|Other|0|||
164165812|NCT02477826|592970553|FG008|Treatment Period|Other|0|||
164165813|NCT02477826|592970554|FG009|Treatment Period|Other|1|||
164165814|NCT01218087|592970588|FG000|Overall Study|Death|2|||
164165815|NCT01218087|592970589|FG001|Overall Study|Death|1|||
164165816|NCT01218087|592970588|FG000|Overall Study|Withdrawal by Subject|5|||
164165817|NCT01218087|592970589|FG001|Overall Study|Withdrawal by Subject|0|||
164165818|NCT01218087|592970588|FG000|Overall Study|Transferred|8|||
164165819|NCT01218087|592970589|FG001|Overall Study|Transferred|5|||
164165820|NCT03170362|592970590|FG000|Overall Study|Death|2|||
164165821|NCT03170362|592970591|FG001|Overall Study|Death|2|||
164165822|NCT03170362|592970590|FG000|Overall Study|Withdrawal by Subject|23|||
164165823|NCT03170362|592970591|FG001|Overall Study|Withdrawal by Subject|22|||
164165824|NCT03170362|592970590|FG000|Overall Study|Lost to Follow-up|187|||
164165825|NCT03170362|592970591|FG001|Overall Study|Lost to Follow-up|167|||
164165826|NCT00552396|592970592|FG000|Overall Study|protocol withdrawal criteria|3|||
164165827|NCT00552396|592970593|FG001|Overall Study|protocol withdrawal criteria|3|||
164165828|NCT00552396|592970594|FG002|Overall Study|protocol withdrawal criteria|3|||
164165829|NCT00552396|592970595|FG003|Overall Study|protocol withdrawal criteria|6|||
164165830|NCT00552396|592970596|FG004|Overall Study|protocol withdrawal criteria|3|||
164165831|NCT00552396|592970597|FG005|Overall Study|protocol withdrawal criteria|3|||
164165832|NCT00552396|592970598|FG006|Overall Study|protocol withdrawal criteria|9|||
164165833|NCT03340454|592970601|FG000|Overall Study|Lost to Follow-up|0|||
164165834|NCT03340454|592970602|FG001|Overall Study|Lost to Follow-up|4|||
164165835|NCT01464164|592970604|FG000|Overall Study|Screen failure|0|||
164165836|NCT01464164|592970605|FG001|Overall Study|Screen failure|1|||
164165837|NCT01464164|592970606|FG002|Overall Study|Screen failure|2|||
164165838|NCT01464164|592970607|FG003|Overall Study|Screen failure|0|||
164165839|NCT01464164|592970608|FG004|Overall Study|Screen failure|0|||
164165840|NCT01464164|592970609|FG005|Overall Study|Screen failure|0|||
164165841|NCT01464164|592970610|FG006|Overall Study|Screen failure|0|||
164165842|NCT01464164|592970604|FG000|Overall Study|Physician Decision|0|||
164165843|NCT01464164|592970605|FG001|Overall Study|Physician Decision|1|||
164165844|NCT01464164|592970606|FG002|Overall Study|Physician Decision|0|||
164165845|NCT01464164|592970607|FG003|Overall Study|Physician Decision|0|||
164165846|NCT01464164|592970608|FG004|Overall Study|Physician Decision|0|||
164165847|NCT01464164|592970609|FG005|Overall Study|Physician Decision|0|||
164165848|NCT01464164|592970610|FG006|Overall Study|Physician Decision|2|||
164165849|NCT01972438|592970611|FG000|Baseline-Month 3 Crossover Period|Death|1|||
164165850|NCT01972438|592970612|FG001|Baseline-Month 3 Crossover Period|Death|0|||
164165851|NCT01972438|592970611|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
164165852|NCT01972438|592970612|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
164165853|NCT01972438|592970611|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
164165854|NCT01972438|592970612|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
164165855|NCT01972438|592970611|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
164165856|NCT01972438|592970612|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
164165857|NCT01972438|592970611|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
164165858|NCT01972438|592970612|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
164165859|NCT01972438|592970611|FG000|Months 6-12 Study Period|Death|1|||
164165860|NCT01972438|592970612|FG001|Months 6-12 Study Period|Death|0|||
164165861|NCT01972438|592970611|FG000|Months 6-12 Study Period|Early Study Closure|2|||
164165862|NCT01972438|592970612|FG001|Months 6-12 Study Period|Early Study Closure|2|||
164165863|NCT01972438|592970611|FG000|Post Month 12 Study Period|Early Study Closure|3|||
164165864|NCT01972438|592970612|FG001|Post Month 12 Study Period|Early Study Closure|4|||
164165865|NCT03307252|592970613|FG000|Part 2, Period 1|Treatment not received|0|||
164165866|NCT03307252|592970614|FG001|Part 2, Period 1|Treatment not received|0|||
164165867|NCT03307252|592970615|FG002|Part 2, Period 1|Treatment not received|0|||
164165868|NCT03307252|592970616|FG003|Part 2, Period 1|Treatment not received|0|||
164165869|NCT03307252|592970617|FG004|Part 2, Period 1|Treatment not received|0|||
164165870|NCT03307252|592970618|FG005|Part 2, Period 1|Treatment not received|1|||
164165871|NCT03307252|592970619|FG006|Part 2, Period 1|Treatment not received|0|||
164165872|NCT03307252|592970620|FG007|Part 2, Period 1|Treatment not received|0|||
164165873|NCT03307252|592970621|FG008|Part 2, Period 1|Treatment not received|0|||
164165874|NCT03307252|592970622|FG009|Part 2, Period 1|Treatment not received|0|||
164165875|NCT03307252|592970623|FG010|Part 2, Period 1|Treatment not received|0|||
164165876|NCT03307252|592970613|FG000|Part 2, Period 3|Other than listed|0|||
164165877|NCT03307252|592970614|FG001|Part 2, Period 3|Other than listed|0|||
164165878|NCT03307252|592970615|FG002|Part 2, Period 3|Other than listed|0|||
164165879|NCT03307252|592970616|FG003|Part 2, Period 3|Other than listed|0|||
164165880|NCT03307252|592970617|FG004|Part 2, Period 3|Other than listed|1|||
164165881|NCT03307252|592970618|FG005|Part 2, Period 3|Other than listed|0|||
164165882|NCT03307252|592970619|FG006|Part 2, Period 3|Other than listed|0|||
164165883|NCT03307252|592970620|FG007|Part 2, Period 3|Other than listed|0|||
164165884|NCT03307252|592970621|FG008|Part 2, Period 3|Other than listed|0|||
164165885|NCT03307252|592970622|FG009|Part 2, Period 3|Other than listed|0|||
164165886|NCT03307252|592970623|FG010|Part 2, Period 3|Other than listed|0|||
164165887|NCT03307252|592970613|FG000|Part 2, Period 4|Other than listed|0|||
164165888|NCT03307252|592970614|FG001|Part 2, Period 4|Other than listed|0|||
164165889|NCT03307252|592970615|FG002|Part 2, Period 4|Other than listed|0|||
164165890|NCT03307252|592970616|FG003|Part 2, Period 4|Other than listed|0|||
164165891|NCT03307252|592970617|FG004|Part 2, Period 4|Other than listed|0|||
164165892|NCT03307252|592970618|FG005|Part 2, Period 4|Other than listed|0|||
164165893|NCT03307252|592970619|FG006|Part 2, Period 4|Other than listed|1|||
164165894|NCT03307252|592970620|FG007|Part 2, Period 4|Other than listed|0|||
164165895|NCT03307252|592970621|FG008|Part 2, Period 4|Other than listed|0|||
164165896|NCT03307252|592970622|FG009|Part 2, Period 4|Other than listed|0|||
164165897|NCT03307252|592970623|FG010|Part 2, Period 4|Other than listed|0|||
164165898|NCT03307252|592970613|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
164165899|NCT03307252|592970614|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
164165900|NCT03307252|592970615|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
164165901|NCT03307252|592970616|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
164165902|NCT03307252|592970617|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
164165903|NCT03307252|592970618|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
164165904|NCT03307252|592970619|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
164165905|NCT03307252|592970620|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
164165906|NCT03307252|592970621|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
164165907|NCT03307252|592970622|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
164165908|NCT03307252|592970623|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
164165909|NCT01052480|592970624|FG000|Overall Study|Lost to Follow-up|3|||
164165910|NCT01052480|592970625|FG001|Overall Study|Lost to Follow-up|3|||
164165911|NCT01052480|592970624|FG000|Overall Study|Protocol Violation|1|||
164165912|NCT01052480|592970625|FG001|Overall Study|Protocol Violation|0|||
164165913|NCT01052480|592970624|FG000|Overall Study|Withdrawal by Subject|3|||
164165914|NCT01052480|592970625|FG001|Overall Study|Withdrawal by Subject|7|||
164165915|NCT01052480|592970624|FG000|Overall Study|Physician Decision|0|||
164165916|NCT01052480|592970625|FG001|Overall Study|Physician Decision|2|||
164165917|NCT01052480|592970624|FG000|Overall Study|Death|1|||
164165918|NCT01052480|592970625|FG001|Overall Study|Death|5|||
164165919|NCT00529373|592970626|FG000|Base Study|Adverse Event|525|||
164165920|NCT00529373|592970627|FG001|Base Study|Adverse Event|470|||
164165921|NCT00529373|592970626|FG000|Base Study|Lack of Efficacy|16|||
164165922|NCT00529373|592970627|FG001|Base Study|Lack of Efficacy|75|||
164165923|NCT00529373|592970626|FG000|Base Study|Lost to Follow-up|221|||
164165924|NCT00529373|592970627|FG001|Base Study|Lost to Follow-up|208|||
164165925|NCT00529373|592970626|FG000|Base Study|Other Protocol Specified Criteria|19|||
164165926|NCT00529373|592970627|FG001|Base Study|Other Protocol Specified Criteria|20|||
164165927|NCT00529373|592970626|FG000|Base Study|Physician Decision|60|||
164165928|NCT00529373|592970627|FG001|Base Study|Physician Decision|52|||
164165929|NCT00529373|592970626|FG000|Base Study|Protocol Violation|48|||
164165930|NCT00529373|592970627|FG001|Base Study|Protocol Violation|38|||
164165931|NCT00529373|592970626|FG000|Base Study|Withdrawal by Subject|1062|||
164165932|NCT00529373|592970627|FG001|Base Study|Withdrawal by Subject|967|||
164165933|NCT00529373|592970626|FG000|Base Study|Did not continue into Extension|1795|||
164165934|NCT00529373|592970627|FG001|Base Study|Did not continue into Extension|2238|||
164165935|NCT00529373|592970626|FG000|First Extension Study|Adverse Event|162|||
164165936|NCT00529373|592970627|FG001|First Extension Study|Adverse Event|142|||
164165937|NCT00529373|592970626|FG000|First Extension Study|Lack of Efficacy|65|||
164165938|NCT00529373|592970627|FG001|First Extension Study|Lack of Efficacy|427|||
164165939|NCT00529373|592970626|FG000|First Extension Study|Lost to Follow-up|41|||
164165940|NCT00529373|592970627|FG001|First Extension Study|Lost to Follow-up|37|||
164165941|NCT00529373|592970626|FG000|First Extension Study|Other|27|||
164165942|NCT00529373|592970627|FG001|First Extension Study|Other|47|||
164165943|NCT00529373|592970626|FG000|First Extension Study|Physician Decision|50|||
164165944|NCT00529373|592970627|FG001|First Extension Study|Physician Decision|45|||
164165945|NCT00529373|592970626|FG000|First Extension Study|Protocol Violation|16|||
164165946|NCT00529373|592970627|FG001|First Extension Study|Protocol Violation|13|||
164165947|NCT00529373|592970626|FG000|First Extension Study|Withdrawal by Subject|296|||
164166097|NCT03634033|592972597|FG005|Overall Study|Lost to Follow-up|1|||
164165948|NCT00529373|592970627|FG001|First Extension Study|Withdrawal by Subject|287|||
164165949|NCT00529373|592970626|FG000|First Extension Study|Disposition record non-existing|0|||
164165950|NCT00529373|592970627|FG001|First Extension Study|Disposition record non-existing|1|||
164165951|NCT00529373|592970626|FG000|First Extension Study|Discontinued after 5 years completion|208|||
164165952|NCT00529373|592970627|FG001|First Extension Study|Discontinued after 5 years completion|346|||
164165953|NCT00529373|592970626|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
164165954|NCT00529373|592970627|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
164165955|NCT00529373|592970626|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
164165956|NCT00529373|592970627|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
164165957|NCT00529373|592970626|FG000|Second Extension Study|Adverse Event|101|||
164165958|NCT00529373|592970627|FG001|Second Extension Study|Adverse Event|51|||
164165959|NCT00529373|592970626|FG000|Second Extension Study|Lack of Efficacy|7|||
164165960|NCT00529373|592970627|FG001|Second Extension Study|Lack of Efficacy|15|||
164165961|NCT00529373|592970626|FG000|Second Extension Study|Lost to Follow-up|18|||
164165962|NCT00529373|592970627|FG001|Second Extension Study|Lost to Follow-up|12|||
164165963|NCT00529373|592970626|FG000|Second Extension Study|Other|7|||
164165964|NCT00529373|592970627|FG001|Second Extension Study|Other|12|||
164165965|NCT00529373|592970626|FG000|Second Extension Study|Physician Decision|63|||
164165966|NCT00529373|592970627|FG001|Second Extension Study|Physician Decision|26|||
164165967|NCT00529373|592970626|FG000|Second Extension Study|Protocol Violation|2|||
164165968|NCT00529373|592970627|FG001|Second Extension Study|Protocol Violation|1|||
164165969|NCT00529373|592970626|FG000|Second Extension Study|Withdrawal by Subject|97|||
164165970|NCT00529373|592970627|FG001|Second Extension Study|Withdrawal by Subject|75|||
164165971|NCT00529373|592970626|FG000|Second Extension Study|Status Missing|5|||
164165972|NCT00529373|592970627|FG001|Second Extension Study|Status Missing|5|||
164165973|NCT01074268|592970628|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
164165974|NCT01074268|592970629|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
164165975|NCT01074268|592970628|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
164165976|NCT01074268|592970629|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
164165977|NCT01074268|592970628|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
164165978|NCT01074268|592970629|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
164165979|NCT01074268|592970628|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
164165980|NCT01074268|592970629|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
164165981|NCT01074268|592970628|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
164165982|NCT01074268|592970629|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
164165983|NCT01074268|592970628|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
164165984|NCT01074268|592970629|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
164165985|NCT01074268|592970628|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
164165986|NCT01074268|592970629|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
164165987|NCT01074268|592970628|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
164165988|NCT01074268|592970629|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
164165989|NCT01074268|592970628|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
164165990|NCT01074268|592970629|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
164165991|NCT01578239|592970630|FG000|Treatment Period|Progressive Disease|19|||
164165992|NCT01578239|592970631|FG001|Treatment Period|Progressive Disease|64|||
164165993|NCT01578239|592970630|FG000|Treatment Period|Physician Decision|17|||
164165994|NCT01578239|592970631|FG001|Treatment Period|Physician Decision|17|||
164165995|NCT01578239|592970630|FG000|Treatment Period|Adverse Event|13|||
164165996|NCT01578239|592970631|FG001|Treatment Period|Adverse Event|10|||
164165997|NCT01578239|592970630|FG000|Treatment Period|Non-compliance|2|||
164165998|NCT01578239|592970631|FG001|Treatment Period|Non-compliance|0|||
164165999|NCT01578239|592970630|FG000|Treatment Period|Withdrawal by Subject|10|||
164166000|NCT01578239|592970631|FG001|Treatment Period|Withdrawal by Subject|9|||
164166001|NCT01578239|592970630|FG000|Treatment Period|Other|6|||
164166002|NCT01578239|592970631|FG001|Treatment Period|Other|1|||
164166003|NCT01578239|592970630|FG000|Long-term Follow-Up Period|Death|69|||
164166004|NCT01578239|592970631|FG001|Long-term Follow-Up Period|Death|64|||
164166005|NCT01578239|592970630|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
164166006|NCT01578239|592970631|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
164166007|NCT01578239|592970630|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
164166008|NCT01578239|592970631|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
164166009|NCT01578239|592970630|FG000|Long-term Follow-Up Period|Other|2|||
164166010|NCT01578239|592970631|FG001|Long-term Follow-Up Period|Other|2|||
164166011|NCT02347813|592970636|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
164166012|NCT02347813|592970637|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
164166013|NCT02347813|592970636|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
164166014|NCT02347813|592970637|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
164166015|NCT01119859|592970640|FG000|Overall Study|Adverse Event|9|||
164166016|NCT01119859|592970641|FG001|Overall Study|Adverse Event|10|||
164166017|NCT01119859|592970640|FG000|Overall Study|Death|2|||
164166018|NCT01119859|592970641|FG001|Overall Study|Death|0|||
164166019|NCT01119859|592970640|FG000|Overall Study|Insufficient therapeutic response|7|||
164166020|NCT01119859|592970641|FG001|Overall Study|Insufficient therapeutic response|14|||
164166021|NCT01119859|592970640|FG000|Overall Study|Refused treatment|3|||
164166022|NCT01119859|592970641|FG001|Overall Study|Refused treatment|6|||
164166023|NCT01119859|592970640|FG000|Overall Study|Failure to return|3|||
164166024|NCT01119859|592970641|FG001|Overall Study|Failure to return|0|||
164166025|NCT01134939|592970642|FG000|Overall Study|Adverse Event|9|||
164166026|NCT01134939|592970643|FG001|Overall Study|Adverse Event|3|||
164166027|NCT01134939|592970644|FG002|Overall Study|Adverse Event|4|||
164166028|NCT01134939|592970645|FG003|Overall Study|Adverse Event|5|||
164166029|NCT01134939|592970646|FG004|Overall Study|Adverse Event|5|||
164166030|NCT01134939|592970647|FG005|Overall Study|Adverse Event|5|||
164166031|NCT01134939|592970648|FG006|Overall Study|Adverse Event|1|||
164166032|NCT01134939|592970649|FG007|Overall Study|Adverse Event|0|||
164166033|NCT01134939|592970642|FG000|Overall Study|Lack of Efficacy|2|||
164166034|NCT01134939|592970643|FG001|Overall Study|Lack of Efficacy|5|||
164166035|NCT01134939|592970644|FG002|Overall Study|Lack of Efficacy|1|||
164166036|NCT01134939|592970645|FG003|Overall Study|Lack of Efficacy|0|||
164166037|NCT01134939|592970646|FG004|Overall Study|Lack of Efficacy|3|||
164166038|NCT01134939|592970647|FG005|Overall Study|Lack of Efficacy|0|||
164166039|NCT01134939|592970648|FG006|Overall Study|Lack of Efficacy|1|||
164166040|NCT01134939|592970649|FG007|Overall Study|Lack of Efficacy|0|||
164166041|NCT01134939|592970642|FG000|Overall Study|Lost to Follow-up|2|||
164166042|NCT01134939|592970643|FG001|Overall Study|Lost to Follow-up|3|||
164166043|NCT01134939|592970644|FG002|Overall Study|Lost to Follow-up|0|||
164166044|NCT01134939|592970645|FG003|Overall Study|Lost to Follow-up|1|||
164166045|NCT01134939|592970646|FG004|Overall Study|Lost to Follow-up|2|||
164166046|NCT01134939|592970647|FG005|Overall Study|Lost to Follow-up|1|||
164166047|NCT01134939|592970648|FG006|Overall Study|Lost to Follow-up|0|||
164166048|NCT01134939|592970649|FG007|Overall Study|Lost to Follow-up|0|||
164166049|NCT01134939|592970642|FG000|Overall Study|Death|0|||
164166050|NCT01134939|592970643|FG001|Overall Study|Death|1|||
164166051|NCT01134939|592970644|FG002|Overall Study|Death|0|||
164166052|NCT01134939|592970645|FG003|Overall Study|Death|0|||
164166053|NCT01134939|592970646|FG004|Overall Study|Death|0|||
164166054|NCT01134939|592970647|FG005|Overall Study|Death|0|||
164166055|NCT01134939|592970648|FG006|Overall Study|Death|0|||
164166056|NCT01134939|592970649|FG007|Overall Study|Death|0|||
164166057|NCT01134939|592970642|FG000|Overall Study|Termination page not available|4|||
164166058|NCT01134939|592970643|FG001|Overall Study|Termination page not available|6|||
164166059|NCT01134939|592970644|FG002|Overall Study|Termination page not available|5|||
164166060|NCT01134939|592970645|FG003|Overall Study|Termination page not available|8|||
164166061|NCT01134939|592970646|FG004|Overall Study|Termination page not available|0|||
164166062|NCT01134939|592970647|FG005|Overall Study|Termination page not available|3|||
164166063|NCT01134939|592970648|FG006|Overall Study|Termination page not available|7|||
164166064|NCT01134939|592970649|FG007|Overall Study|Termination page not available|0|||
164166065|NCT02981082|592970653|FG000|Overall Study|Withdrawal by Subject|2|||
164166066|NCT02981082|592970654|FG001|Overall Study|Withdrawal by Subject|0|||
164166067|NCT02981082|592970653|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
164166068|NCT02981082|592970654|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
164166069|NCT02981082|592970653|FG000|Overall Study|Adverse Event|0|||
164166070|NCT02981082|592970654|FG001|Overall Study|Adverse Event|1|||
164166071|NCT03634033|592972592|FG000|Overall Study|Did not have a post-assessment|384|||
164166072|NCT03634033|592972593|FG001|Overall Study|Did not have a post-assessment|291|||
164166073|NCT03634033|592972594|FG002|Overall Study|Did not have a post-assessment|114|||
164166074|NCT03634033|592972595|FG003|Overall Study|Did not have a post-assessment|161|||
164166075|NCT03634033|592972596|FG004|Overall Study|Did not have a post-assessment|5|||
164166076|NCT03634033|592972597|FG005|Overall Study|Did not have a post-assessment|0|||
164166077|NCT03634033|592972598|FG006|Overall Study|Did not have a post-assessment|0|||
164166078|NCT03634033|592972592|FG000|Overall Study|Death|0|||
164166079|NCT03634033|592972593|FG001|Overall Study|Death|0|||
164166080|NCT03634033|592972594|FG002|Overall Study|Death|0|||
164166081|NCT03634033|592972595|FG003|Overall Study|Death|0|||
164166082|NCT03634033|592972596|FG004|Overall Study|Death|0|||
164166083|NCT03634033|592972597|FG005|Overall Study|Death|7|||
164166084|NCT03634033|592972598|FG006|Overall Study|Death|7|||
164166085|NCT03634033|592972592|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
164166086|NCT03634033|592972593|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
164166087|NCT03634033|592972594|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
164166088|NCT03634033|592972595|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
164166089|NCT03634033|592972596|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
164166090|NCT03634033|592972597|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
164166091|NCT03634033|592972598|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
164166092|NCT03634033|592972592|FG000|Overall Study|Lost to Follow-up|0|||
164166093|NCT03634033|592972593|FG001|Overall Study|Lost to Follow-up|0|||
164166094|NCT03634033|592972594|FG002|Overall Study|Lost to Follow-up|0|||
164166095|NCT03634033|592972595|FG003|Overall Study|Lost to Follow-up|0|||
164166096|NCT03634033|592972596|FG004|Overall Study|Lost to Follow-up|0|||
164166098|NCT03634033|592972598|FG006|Overall Study|Lost to Follow-up|2|||
164166099|NCT03634033|592972592|FG000|Overall Study|Withdrawal by Subject|0|||
164166100|NCT03634033|592972593|FG001|Overall Study|Withdrawal by Subject|0|||
164166101|NCT03634033|592972594|FG002|Overall Study|Withdrawal by Subject|0|||
164166102|NCT03634033|592972595|FG003|Overall Study|Withdrawal by Subject|0|||
164166103|NCT03634033|592972596|FG004|Overall Study|Withdrawal by Subject|0|||
164166104|NCT03634033|592972597|FG005|Overall Study|Withdrawal by Subject|0|||
164166105|NCT03634033|592972598|FG006|Overall Study|Withdrawal by Subject|1|||
164166106|NCT00956592|592972603|FG000|Overall Study|Protocol Violation|1|||
164166107|NCT00956592|592972604|FG001|Overall Study|Protocol Violation|3|||
164166108|NCT02162719|592972605|FG000|Overall Study|Death|41|||
164166109|NCT02162719|592972606|FG001|Overall Study|Death|46|||
164166110|NCT02162719|592972605|FG000|Overall Study|Lost to Follow-up|1|||
164166111|NCT02162719|592972606|FG001|Overall Study|Lost to Follow-up|3|||
164166112|NCT02162719|592972605|FG000|Overall Study|Disease Progression|2|||
164166113|NCT02162719|592972606|FG001|Overall Study|Disease Progression|1|||
164166114|NCT02162719|592972605|FG000|Overall Study|Withdrawal by Subject|8|||
164166115|NCT02162719|592972606|FG001|Overall Study|Withdrawal by Subject|2|||
164166116|NCT02162719|592972605|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
164166117|NCT02162719|592972606|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
164166118|NCT03555565|592972607|FG000|Overall Study|Case Report Forms Uncollected|2|||
164166119|NCT03555565|592972607|FG000|Overall Study|Protocol Deviation|13|||
164166120|NCT00723255|592972608|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
164166121|NCT00723255|592972608|FG000|Overall Study|Ineligible: Second primary|1|||
164166122|NCT00723255|592972608|FG000|Overall Study|Ineligible: Wrong Primary|2|||
164166123|NCT00614523|592972609|FG000|Overall Study|Adverse Event|4|||
164166124|NCT00614523|592972610|FG001|Overall Study|Adverse Event|20|||
164166125|NCT00614523|592972609|FG000|Overall Study|Death|5|||
164166126|NCT00614523|592972610|FG001|Overall Study|Death|8|||
164166127|NCT00614523|592972609|FG000|Overall Study|Lack of Efficacy|9|||
164166128|NCT00614523|592972610|FG001|Overall Study|Lack of Efficacy|11|||
164166129|NCT00614523|592972609|FG000|Overall Study|Lost to Follow-up|0|||
164166130|NCT00614523|592972610|FG001|Overall Study|Lost to Follow-up|1|||
164166131|NCT00614523|592972609|FG000|Overall Study|Protocol Violation|3|||
164166132|NCT00614523|592972610|FG001|Overall Study|Protocol Violation|2|||
164166133|NCT00614523|592972609|FG000|Overall Study|Withdrawal by Subject|12|||
164166134|NCT00614523|592972610|FG001|Overall Study|Withdrawal by Subject|22|||
164166135|NCT00614523|592972609|FG000|Overall Study|Other|6|||
164166136|NCT00614523|592972610|FG001|Overall Study|Other|11|||
164166137|NCT00614523|592972609|FG000|Overall Study|Ineligibility Determined|1|||
164166138|NCT00614523|592972610|FG001|Overall Study|Ineligibility Determined|2|||
164166139|NCT00614523|592972609|FG000|Overall Study|Disease Progression|0|||
164166140|NCT00614523|592972610|FG001|Overall Study|Disease Progression|8|||
164166141|NCT00614523|592972609|FG000|Overall Study|Administrative Decision|23|||
164166142|NCT00614523|592972610|FG001|Overall Study|Administrative Decision|46|||
164166143|NCT03854370|592972619|FG000|Overall Study|samples not collected|1|||
164166144|NCT03854370|592972620|FG001|Overall Study|samples not collected|1|||
164166145|NCT03854370|592972621|FG002|Overall Study|samples not collected|1|||
164166146|NCT03854370|592972622|FG003|Overall Study|samples not collected|1|||
164166147|NCT00452673|592972623|FG000|Dose Escalation Period|Disease Progression|6|||
164166148|NCT00452673|592972624|FG001|Dose Escalation Period|Disease Progression|6|||
164166149|NCT00452673|592972625|FG002|Dose Escalation Period|Disease Progression|2|||
164166150|NCT00452673|592972626|FG003|Dose Escalation Period|Disease Progression|6|||
164166151|NCT00452673|592972627|FG004|Dose Escalation Period|Disease Progression|0|||
164166152|NCT00452673|592972623|FG000|Dose Escalation Period|study drug toxicity|1|||
164166153|NCT00452673|592972624|FG001|Dose Escalation Period|study drug toxicity|3|||
164166154|NCT00452673|592972625|FG002|Dose Escalation Period|study drug toxicity|3|||
164166155|NCT00452673|592972626|FG003|Dose Escalation Period|study drug toxicity|1|||
164166156|NCT00452673|592972627|FG004|Dose Escalation Period|study drug toxicity|0|||
164166157|NCT00452673|592972623|FG000|Dose Escalation Period|Other|0|||
164166158|NCT00452673|592972624|FG001|Dose Escalation Period|Other|0|||
164166159|NCT00452673|592972625|FG002|Dose Escalation Period|Other|1|||
164166160|NCT00452673|592972626|FG003|Dose Escalation Period|Other|0|||
164166161|NCT00452673|592972627|FG004|Dose Escalation Period|Other|0|||
164166162|NCT00452673|592972623|FG000|Dose Escalation Period|Adverse Event|0|||
164166163|NCT00452673|592972624|FG001|Dose Escalation Period|Adverse Event|0|||
164166164|NCT00452673|592972625|FG002|Dose Escalation Period|Adverse Event|0|||
164166165|NCT00452673|592972626|FG003|Dose Escalation Period|Adverse Event|1|||
164166166|NCT00452673|592972627|FG004|Dose Escalation Period|Adverse Event|0|||
164166167|NCT00452673|592972623|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
164166168|NCT00452673|592972624|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
164166169|NCT00452673|592972625|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
164166170|NCT00452673|592972626|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
164166171|NCT00452673|592972627|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
164166172|NCT00452673|592972623|FG000|Dose Expansion Period|Disease Progression|0|||
164166173|NCT00452673|592972624|FG001|Dose Expansion Period|Disease Progression|0|||
164166174|NCT00452673|592972625|FG002|Dose Expansion Period|Disease Progression|0|||
164166175|NCT00452673|592972626|FG003|Dose Expansion Period|Disease Progression|0|||
164166176|NCT00452673|592972627|FG004|Dose Expansion Period|Disease Progression|19|||
164166177|NCT00452673|592972623|FG000|Dose Expansion Period|Other|0|||
164166178|NCT00452673|592972624|FG001|Dose Expansion Period|Other|0|||
164166179|NCT00452673|592972625|FG002|Dose Expansion Period|Other|0|||
164166180|NCT00452673|592972626|FG003|Dose Expansion Period|Other|0|||
164166181|NCT00452673|592972627|FG004|Dose Expansion Period|Other|2|||
164166182|NCT02656290|592972628|FG000|Overall Study|Lost to Follow-up|1|||
164166183|NCT02656290|592972628|FG000|Overall Study|Reintervention|3|||
164166184|NCT00394836|592972631|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
164166185|NCT00394836|592972632|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
164166186|NCT00394836|592972631|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
164166187|NCT00394836|592972632|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
164166188|NCT00394836|592972631|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
164166189|NCT00394836|592972632|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
164166190|NCT00394836|592972631|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
164166191|NCT00394836|592972632|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
164166192|NCT00394836|592972631|FG000|Teatment or Follow-up Phase|Death|0|||
164166193|NCT00394836|592972632|FG001|Teatment or Follow-up Phase|Death|1|||
164166194|NCT00394836|592972631|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
164166195|NCT00394836|592972632|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
164166196|NCT00394836|592972631|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
164166197|NCT00394836|592972632|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
164166198|NCT00394836|592972631|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
164166199|NCT00394836|592972632|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
164166200|NCT00394836|592972631|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
164166201|NCT00394836|592972632|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
164166202|NCT00394836|592972631|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
164166203|NCT00394836|592972632|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
164166204|NCT00394836|592972631|FG000|Teatment or Follow-up Phase|Non compliance|0|||
164166205|NCT00394836|592972632|FG001|Teatment or Follow-up Phase|Non compliance|1|||
164166206|NCT00394836|592972631|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
164166207|NCT00394836|592972632|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
164166208|NCT00394836|592972631|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
164166209|NCT00394836|592972632|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
164166210|NCT00394836|592972631|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
164166211|NCT00394836|592972632|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
164166212|NCT00394836|592972631|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
164166213|NCT00394836|592972632|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
164166214|NCT03692325|592972633|FG000|Overall Study|Adverse Event|2|||
164166215|NCT03692325|592972633|FG000|Overall Study|Progression/Recurrence|2|||
164166216|NCT02817516|592972634|FG000|Overall Study|Other|0|||
164166217|NCT02817516|592972635|FG001|Overall Study|Other|0|||
164166218|NCT02817516|592972636|FG002|Overall Study|Other|1|||
164166219|NCT02817516|592972637|FG003|Overall Study|Other|0|||
164166220|NCT00748189|592972638|FG000|Overall Study|Death|99|||
164166221|NCT00748189|592972639|FG001|Overall Study|Death|84|||
164166222|NCT00748189|592972638|FG000|Overall Study|Withdrawal by Subject|23|||
164166223|NCT00748189|592972639|FG001|Overall Study|Withdrawal by Subject|29|||
164166224|NCT00748189|592972638|FG000|Overall Study|Physician Decision|16|||
164166225|NCT00748189|592972639|FG001|Overall Study|Physician Decision|5|||
164166226|NCT00748189|592972638|FG000|Overall Study|Lost to Follow-up|8|||
164166227|NCT00748189|592972639|FG001|Overall Study|Lost to Follow-up|15|||
164166228|NCT00748189|592972638|FG000|Overall Study|Study terminated by Sponsor|70|||
164166229|NCT00748189|592972639|FG001|Overall Study|Study terminated by Sponsor|79|||
164166230|NCT04481191|592972646|FG000|Overall Study|Withdrawn by parent/guardian|15|||
164166231|NCT04481191|592972647|FG001|Overall Study|Withdrawn by parent/guardian|10|||
164166232|NCT00546117|592972652|FG000|Overall Study|Withdrawal by Subject|3|||
164166233|NCT00546117|592972653|FG001|Overall Study|Withdrawal by Subject|0|||
164166234|NCT00546117|592972652|FG000|Overall Study|Inability to schedule follow-up visit|1|||
164166235|NCT00546117|592972653|FG001|Overall Study|Inability to schedule follow-up visit|0|||
164166236|NCT00610155|592972657|FG000|Period 1|Withdrawal by Subject|0|||
164166237|NCT00610155|592972658|FG001|Period 1|Withdrawal by Subject|0|||
164166238|NCT00610155|592972659|FG002|Period 1|Withdrawal by Subject|1|||
164166239|NCT00610155|592972660|FG003|Period 1|Withdrawal by Subject|0|||
164166240|NCT00610155|592972661|FG004|Period 1|Withdrawal by Subject|0|||
164166241|NCT00610155|592972662|FG005|Period 1|Withdrawal by Subject|0|||
164166242|NCT00610155|592972657|FG000|Period 3|Adverse Event|1|||
164166243|NCT00610155|592972658|FG001|Period 3|Adverse Event|0|||
164166244|NCT00610155|592972659|FG002|Period 3|Adverse Event|0|||
164166245|NCT00610155|592972660|FG003|Period 3|Adverse Event|0|||
164166246|NCT00610155|592972661|FG004|Period 3|Adverse Event|0|||
164166247|NCT00610155|592972662|FG005|Period 3|Adverse Event|0|||
164166248|NCT01560234|592972663|FG000|Overall Study|Lost to Follow-up|3|||
164166249|NCT01560234|592972664|FG001|Overall Study|Lost to Follow-up|0|||
164166250|NCT01560234|592972665|FG002|Overall Study|Lost to Follow-up|1|||
164166251|NCT01560234|592972666|FG003|Overall Study|Lost to Follow-up|0|||
164166252|NCT01560234|592972667|FG004|Overall Study|Lost to Follow-up|0|||
164166253|NCT01560234|592972668|FG005|Overall Study|Lost to Follow-up|2|||
164166254|NCT01560234|592972669|FG006|Overall Study|Lost to Follow-up|0|||
164166255|NCT01560234|592972670|FG007|Overall Study|Lost to Follow-up|2|||
164166256|NCT02028767|592972671|FG000|Treatment Period 2|Non compliant with protocol|1|||
164166257|NCT02028767|592972672|FG001|Treatment Period 2|Non compliant with protocol|0|||
164166258|NCT02028767|592972671|FG000|Treatment Period 2|Reason other than those specified above|1|||
164166259|NCT02028767|592972672|FG001|Treatment Period 2|Reason other than those specified above|0|||
164166260|NCT01284348|592972673|FG000|Overall Study|Death|1|||
164166261|NCT01284348|592972674|FG001|Overall Study|Death|1|||
164166262|NCT01284348|592972673|FG000|Overall Study|Withdrew consent|0|||
164166263|NCT01284348|592972674|FG001|Overall Study|Withdrew consent|1|||
164166264|NCT01284348|592972673|FG000|Overall Study|Status not recorded|9|||
164166265|NCT01284348|592972674|FG001|Overall Study|Status not recorded|10|||
164166266|NCT00083759|592972680|FG000|Overall Study|Adverse Event|5|||
164166267|NCT00083759|592972681|FG001|Overall Study|Adverse Event|3|||
164166268|NCT00083759|592972680|FG000|Overall Study|Lost to Follow-up|1|||
164166269|NCT00083759|592972681|FG001|Overall Study|Lost to Follow-up|0|||
164166270|NCT00083759|592972680|FG000|Overall Study|Death|1|||
164166271|NCT00083759|592972681|FG001|Overall Study|Death|1|||
164166272|NCT00083759|592972680|FG000|Overall Study|Inadequate Therapeutic Response|32|||
164166273|NCT00083759|592972681|FG001|Overall Study|Inadequate Therapeutic Response|35|||
164166274|NCT00083759|592972680|FG000|Overall Study|Subject Withdrew Consent|2|||
164166275|NCT00083759|592972681|FG001|Overall Study|Subject Withdrew Consent|2|||
164166276|NCT00083759|592972680|FG000|Overall Study|Non-Compliance|1|||
164166277|NCT00083759|592972681|FG001|Overall Study|Non-Compliance|0|||
164166278|NCT00083759|592972680|FG000|Overall Study|Sponsor's Discretion|28|||
164166279|NCT00083759|592972681|FG001|Overall Study|Sponsor's Discretion|29|||
164166280|NCT00083759|592972680|FG000|Overall Study|Other|14|||
164166281|NCT00083759|592972681|FG001|Overall Study|Other|13|||
164166282|NCT02347774|592972682|FG000|Study Participation|Lost to Follow-up|3|||
164166283|NCT02347774|592972683|FG001|Study Participation|Lost to Follow-up|6|||
164166284|NCT02347774|592972684|FG002|Study Participation|Lost to Follow-up|2|||
164166285|NCT02347774|592972682|FG000|Study Participation|Withdrawal by Subject|8|||
164166286|NCT02347774|592972683|FG001|Study Participation|Withdrawal by Subject|9|||
164166287|NCT02347774|592972684|FG002|Study Participation|Withdrawal by Subject|15|||
164166288|NCT02347774|592972682|FG000|Study Participation|Adverse Event|1|||
164166289|NCT02347774|592972683|FG001|Study Participation|Adverse Event|4|||
164166290|NCT02347774|592972684|FG002|Study Participation|Adverse Event|6|||
164166291|NCT02347774|592972682|FG000|Study Participation|withdrew consent|1|||
164166292|NCT02347774|592972683|FG001|Study Participation|withdrew consent|1|||
164166293|NCT02347774|592972684|FG002|Study Participation|withdrew consent|1|||
164166294|NCT02347774|592972682|FG000|Study Participation|Met Prolonged QT criteria|1|||
164166295|NCT02347774|592972683|FG001|Study Participation|Met Prolonged QT criteria|0|||
164166296|NCT02347774|592972684|FG002|Study Participation|Met Prolonged QT criteria|0|||
164166297|NCT02347774|592972682|FG000|Study Participation|non-compliance with study drug|0|||
164166298|NCT02347774|592972683|FG001|Study Participation|non-compliance with study drug|1|||
164166299|NCT02347774|592972684|FG002|Study Participation|non-compliance with study drug|0|||
164166300|NCT02347774|592972682|FG000|Study Participation|incarceration|1|||
164166301|NCT02347774|592972683|FG001|Study Participation|incarceration|0|||
164166302|NCT02347774|592972684|FG002|Study Participation|incarceration|0|||
164166303|NCT02347774|592972682|FG000|Study Participation|randomized in error|0|||
164166304|NCT02347774|592972683|FG001|Study Participation|randomized in error|0|||
164166305|NCT02347774|592972684|FG002|Study Participation|randomized in error|1|||
164166306|NCT02347774|592972682|FG000|On Study Treatment|Adverse Event|9|||
164166307|NCT02347774|592972683|FG001|On Study Treatment|Adverse Event|15|||
164166308|NCT02347774|592972684|FG002|On Study Treatment|Adverse Event|19|||
164166309|NCT02347774|592972682|FG000|On Study Treatment|Lack of Efficacy|3|||
164166310|NCT02347774|592972683|FG001|On Study Treatment|Lack of Efficacy|0|||
164166311|NCT02347774|592972684|FG002|On Study Treatment|Lack of Efficacy|2|||
164166312|NCT02347774|592972682|FG000|On Study Treatment|non-complicance with study medication|0|||
164166313|NCT02347774|592972683|FG001|On Study Treatment|non-complicance with study medication|2|||
164166314|NCT02347774|592972684|FG002|On Study Treatment|non-complicance with study medication|0|||
164166315|NCT02347774|592972682|FG000|On Study Treatment|Protocol Violation|0|||
164166316|NCT02347774|592972683|FG001|On Study Treatment|Protocol Violation|0|||
164166317|NCT02347774|592972684|FG002|On Study Treatment|Protocol Violation|1|||
164166318|NCT02347774|592972682|FG000|On Study Treatment|withdrew consent|9|||
164166319|NCT02347774|592972683|FG001|On Study Treatment|withdrew consent|8|||
164166320|NCT02347774|592972684|FG002|On Study Treatment|withdrew consent|12|||
164166321|NCT02347774|592972682|FG000|On Study Treatment|Lost to Follow-up|2|||
164166322|NCT02347774|592972683|FG001|On Study Treatment|Lost to Follow-up|6|||
164166323|NCT02347774|592972684|FG002|On Study Treatment|Lost to Follow-up|1|||
164166324|NCT02347774|592972682|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
164166325|NCT02347774|592972683|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
164166326|NCT02347774|592972684|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
164166327|NCT02347774|592972682|FG000|On Study Treatment|ranomized in error|0|||
164166328|NCT02347774|592972683|FG001|On Study Treatment|ranomized in error|0|||
164166329|NCT02347774|592972684|FG002|On Study Treatment|ranomized in error|1|||
164166330|NCT04112043|592972686|FG000|Overall Study|Withdrawal by Subject|1|||
164166331|NCT04112043|592972687|FG001|Overall Study|Withdrawal by Subject|1|||
164166332|NCT04112043|592972688|FG002|Overall Study|Withdrawal by Subject|1|||
164166333|NCT04112043|592972686|FG000|Overall Study|Taking NR supplement|1|||
164166334|NCT04112043|592972687|FG001|Overall Study|Taking NR supplement|0|||
164166335|NCT04112043|592972688|FG002|Overall Study|Taking NR supplement|0|||
164166336|NCT04112043|592972686|FG000|Overall Study|Adverse Event|0|||
164166337|NCT04112043|592972687|FG001|Overall Study|Adverse Event|1|||
164166338|NCT04112043|592972688|FG002|Overall Study|Adverse Event|0|||
164166339|NCT05338502|592972695|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
164166340|NCT05338502|592972696|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
164166341|NCT05338502|592972697|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
164166342|NCT05338502|592972695|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
164166343|NCT05338502|592972696|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
164166344|NCT05338502|592972697|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
164166345|NCT01062113|592972705|FG000|Overall Study|Adverse Event|1|||
164166346|NCT01062113|592972706|FG001|Overall Study|Adverse Event|0|||
164166347|NCT01062113|592972707|FG002|Overall Study|Adverse Event|0|||
164166348|NCT01062113|592972705|FG000|Overall Study|Lack of Efficacy|38|||
164166349|NCT01062113|592972706|FG001|Overall Study|Lack of Efficacy|22|||
164166350|NCT01062113|592972707|FG002|Overall Study|Lack of Efficacy|31|||
164166351|NCT01062113|592972705|FG000|Overall Study|Withdrawal by Subject|1|||
164166352|NCT01062113|592972706|FG001|Overall Study|Withdrawal by Subject|0|||
164166353|NCT01062113|592972707|FG002|Overall Study|Withdrawal by Subject|0|||
164166354|NCT03499899|592972708|FG000|Overall Study|Adverse Event|2|||
164166355|NCT03499899|592972709|FG001|Overall Study|Adverse Event|3|||
164166356|NCT03499899|592972710|FG002|Overall Study|Adverse Event|3|||
164166357|NCT03499899|592972708|FG000|Overall Study|Death|0|||
164166358|NCT03499899|592972709|FG001|Overall Study|Death|0|||
164166359|NCT03499899|592972710|FG002|Overall Study|Death|1|||
164166360|NCT03499899|592972708|FG000|Overall Study|Physician Decision|3|||
164166361|NCT03499899|592972709|FG001|Overall Study|Physician Decision|6|||
164166362|NCT03499899|592972710|FG002|Overall Study|Physician Decision|6|||
164166363|NCT03499899|592972708|FG000|Overall Study|Progressive disease|15|||
164166364|NCT03499899|592972709|FG001|Overall Study|Progressive disease|23|||
164166365|NCT03499899|592972710|FG002|Overall Study|Progressive disease|23|||
164166366|NCT03499899|592972708|FG000|Overall Study|Patient decision|0|||
164166367|NCT03499899|592972709|FG001|Overall Study|Patient decision|1|||
164166368|NCT03499899|592972710|FG002|Overall Study|Patient decision|1|||
164166369|NCT03499899|592972708|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
164166370|NCT03499899|592972709|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
164166371|NCT03499899|592972710|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
164166372|NCT03655470|592972711|FG000|Overall Study|Lost to Follow-up|6|||
164166373|NCT03655470|592972712|FG001|Overall Study|Lost to Follow-up|7|||
164166374|NCT03063086|592972713|FG000|Overall Study|technical problems|1|||
164166375|NCT03063086|592972714|FG001|Overall Study|technical problems|0|||
164166376|NCT03063086|592972715|FG002|Overall Study|technical problems|0|||
164166377|NCT03063086|592972716|FG003|Overall Study|technical problems|0|||
164166378|NCT03063086|592972717|FG004|Overall Study|technical problems|0|||
164166379|NCT03063086|592972718|FG005|Overall Study|technical problems|0|||
164166380|NCT03063086|592972713|FG000|Overall Study|Adverse Event|1|||
164166381|NCT03063086|592972714|FG001|Overall Study|Adverse Event|1|||
164166382|NCT03063086|592972715|FG002|Overall Study|Adverse Event|1|||
164166383|NCT03063086|592972716|FG003|Overall Study|Adverse Event|1|||
164166384|NCT03063086|592972717|FG004|Overall Study|Adverse Event|0|||
164166385|NCT03063086|592972718|FG005|Overall Study|Adverse Event|0|||
164166386|NCT03063086|592972713|FG000|Overall Study|subject/guardian decision|1|||
164166387|NCT03063086|592972714|FG001|Overall Study|subject/guardian decision|0|||
164166388|NCT03063086|592972715|FG002|Overall Study|subject/guardian decision|0|||
164166389|NCT03063086|592972716|FG003|Overall Study|subject/guardian decision|0|||
164166390|NCT03063086|592972717|FG004|Overall Study|subject/guardian decision|0|||
164166391|NCT03063086|592972718|FG005|Overall Study|subject/guardian decision|0|||
164166392|NCT03063086|592972713|FG000|Overall Study|Non-compliance with study treatment|0|||
164166393|NCT03063086|592972714|FG001|Overall Study|Non-compliance with study treatment|0|||
164166394|NCT03063086|592972715|FG002|Overall Study|Non-compliance with study treatment|0|||
164166395|NCT03063086|592972716|FG003|Overall Study|Non-compliance with study treatment|1|||
164166396|NCT03063086|592972717|FG004|Overall Study|Non-compliance with study treatment|0|||
164166397|NCT03063086|592972718|FG005|Overall Study|Non-compliance with study treatment|1|||
164166398|NCT03063086|592972713|FG000|Overall Study|Physician Decision|0|||
164166399|NCT03063086|592972714|FG001|Overall Study|Physician Decision|0|||
164166400|NCT03063086|592972715|FG002|Overall Study|Physician Decision|0|||
164166401|NCT03063086|592972716|FG003|Overall Study|Physician Decision|1|||
164166402|NCT03063086|592972717|FG004|Overall Study|Physician Decision|0|||
164166403|NCT03063086|592972718|FG005|Overall Study|Physician Decision|0|||
164166404|NCT03702010|592972721|FG000|Follow-up (30days)|Lack of Efficacy|2|||
164166405|NCT03702010|592972722|FG001|Follow-up (30days)|Lack of Efficacy|2|||
164166406|NCT02549287|592972735|FG000|Overall Study|Lost to Follow-up|65|||
164166407|NCT02549287|592972736|FG001|Overall Study|Lost to Follow-up|26|||
164166408|NCT02549287|592972735|FG000|Overall Study|Withdrawal by Subject|15|||
164166409|NCT02549287|592972736|FG001|Overall Study|Withdrawal by Subject|6|||
164166410|NCT03793842|592972737|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
164166411|NCT03793842|592972738|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
164166412|NCT03793842|592972737|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
164166413|NCT03793842|592972738|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
164166414|NCT00427921|592972742|FG000|Overall Study|Adverse Event|26|||
164166415|NCT00427921|592972742|FG000|Overall Study|Withdrawal by Subject|4|||
164166416|NCT00427921|592972742|FG000|Overall Study|Lost to Follow-up|2|||
164166417|NCT00427921|592972742|FG000|Overall Study|Other reason not specified|10|||
164166418|NCT00427921|592972742|FG000|Overall Study|Adverse Event + Hospitalization|1|||
164166419|NCT00427921|592972742|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
164166420|NCT00427921|592972742|FG000|Overall Study|Adverse Event + No Response|1|||
164166421|NCT00427921|592972742|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
164166422|NCT00427921|592972742|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
164166423|NCT00427921|592972742|FG000|Overall Study|Adverse Event + Lost Response|1|||
164166424|NCT00427921|592972742|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
164166425|NCT00427921|592972742|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
164166426|NCT00765336|592972745|FG000|Overall Study|Protocol Violation|4|||
164166427|NCT00765336|592972746|FG001|Overall Study|Protocol Violation|2|||
164166428|NCT00765336|592972745|FG000|Overall Study|Withdrawal by Subject|6|||
164166429|NCT00765336|592972746|FG001|Overall Study|Withdrawal by Subject|4|||
164166430|NCT00765336|592972745|FG000|Overall Study|Lost to Follow-up|7|||
164166431|NCT00765336|592972746|FG001|Overall Study|Lost to Follow-up|9|||
164166432|NCT00765336|592972745|FG000|Overall Study|Adverse Event|2|||
164166433|NCT00765336|592972746|FG001|Overall Study|Adverse Event|1|||
164166434|NCT00733421|592972747|FG000|Overall Study|Withdrawal by Subject|1|||
164166435|NCT00733421|592972748|FG001|Overall Study|Withdrawal by Subject|1|||
164166436|NCT04185220|592972752|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
164166437|NCT04185220|592972753|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
164166438|NCT04185220|592972752|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
164166439|NCT04185220|592972753|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
164166440|NCT01029782|592972754|FG000|Overall Study|Lost to Follow-up|2|||
164166441|NCT01029782|592972755|FG001|Overall Study|Lost to Follow-up|2|||
164166442|NCT01029782|592972754|FG000|Overall Study|Diagnosis changed|1|||
164166443|NCT01029782|592972755|FG001|Overall Study|Diagnosis changed|1|||
164166444|NCT01029782|592972754|FG000|Overall Study|Adverse Event|0|||
164166445|NCT01029782|592972755|FG001|Overall Study|Adverse Event|1|||
164166446|NCT01029782|592972754|FG000|Overall Study|Physician Decision|0|||
164166447|NCT01029782|592972755|FG001|Overall Study|Physician Decision|1|||
164166448|NCT01029782|592972754|FG000|Overall Study|Protocol Violation|0|||
164166449|NCT01029782|592972755|FG001|Overall Study|Protocol Violation|2|||
164166450|NCT01029782|592972754|FG000|Overall Study|Withdrawal by Subject|0|||
164166451|NCT01029782|592972755|FG001|Overall Study|Withdrawal by Subject|1|||
164166452|NCT02195869|592972759|FG000|Overall Study|cGVHD Progression|5|||
164166453|NCT02195869|592972759|FG000|Overall Study|Malignancy Progression/relapse|2|||
164166454|NCT02195869|592972759|FG000|Overall Study|Adverse Event|15|||
164166455|NCT02195869|592972759|FG000|Overall Study|Withdrawal by Subject|7|||
164166456|NCT02195869|592972759|FG000|Overall Study|Physician Decision|4|||
164166457|NCT02195869|592972759|FG000|Overall Study|Study Terminated by Sponsor|7|||
164166458|NCT02195869|592972759|FG000|Overall Study|Noncompliance with study drug|2|||
164166459|NCT01314872|592972762|FG000|Treatment Period 1|Protocol Violation|2|||
164166460|NCT01314872|592972763|FG001|Treatment Period 1|Protocol Violation|1|||
164166461|NCT01314872|592972764|FG002|Treatment Period 1|Protocol Violation|1|||
164166462|NCT01314872|592972765|FG003|Treatment Period 1|Protocol Violation|0|||
164166463|NCT01314872|592972766|FG004|Treatment Period 1|Protocol Violation|1|||
164166464|NCT01314872|592972767|FG005|Treatment Period 1|Protocol Violation|0|||
164166465|NCT01314872|592972768|FG006|Treatment Period 1|Protocol Violation|0|||
164166466|NCT01314872|592972769|FG007|Treatment Period 1|Protocol Violation|0|||
164166467|NCT01314872|592972770|FG008|Treatment Period 1|Protocol Violation|0|||
164166468|NCT01314872|592972771|FG009|Treatment Period 1|Protocol Violation|1|||
164166469|NCT01314872|592972772|FG010|Treatment Period 1|Protocol Violation|1|||
164166470|NCT01314872|592972773|FG011|Treatment Period 1|Protocol Violation|0|||
164166471|NCT01314872|592972774|FG012|Treatment Period 1|Protocol Violation|0|||
164166472|NCT01314872|592972775|FG013|Treatment Period 1|Protocol Violation|0|||
164166473|NCT01314872|592972776|FG014|Treatment Period 1|Protocol Violation|0|||
164166474|NCT01314872|592972762|FG000|Treatment Period 1|Physician Decision|0|||
164166475|NCT01314872|592972763|FG001|Treatment Period 1|Physician Decision|1|||
164166476|NCT01314872|592972764|FG002|Treatment Period 1|Physician Decision|0|||
164166477|NCT01314872|592972765|FG003|Treatment Period 1|Physician Decision|1|||
164166478|NCT01314872|592972766|FG004|Treatment Period 1|Physician Decision|0|||
164166479|NCT01314872|592972767|FG005|Treatment Period 1|Physician Decision|0|||
164166480|NCT01314872|592972768|FG006|Treatment Period 1|Physician Decision|0|||
164166481|NCT01314872|592972769|FG007|Treatment Period 1|Physician Decision|0|||
164166482|NCT01314872|592972770|FG008|Treatment Period 1|Physician Decision|0|||
164166483|NCT01314872|592972771|FG009|Treatment Period 1|Physician Decision|1|||
164166484|NCT01314872|592972772|FG010|Treatment Period 1|Physician Decision|0|||
164166485|NCT01314872|592972773|FG011|Treatment Period 1|Physician Decision|0|||
164166486|NCT01314872|592972774|FG012|Treatment Period 1|Physician Decision|0|||
164166487|NCT01314872|592972775|FG013|Treatment Period 1|Physician Decision|0|||
164166488|NCT01314872|592972776|FG014|Treatment Period 1|Physician Decision|0|||
164166489|NCT01314872|592972762|FG000|Treatment Period 1|Lack of Efficacy|1|||
164166490|NCT01314872|592972763|FG001|Treatment Period 1|Lack of Efficacy|0|||
164166491|NCT01314872|592972764|FG002|Treatment Period 1|Lack of Efficacy|0|||
164166492|NCT01314872|592972765|FG003|Treatment Period 1|Lack of Efficacy|0|||
164166493|NCT01314872|592972766|FG004|Treatment Period 1|Lack of Efficacy|0|||
164166494|NCT01314872|592972767|FG005|Treatment Period 1|Lack of Efficacy|1|||
164166495|NCT01314872|592972768|FG006|Treatment Period 1|Lack of Efficacy|0|||
164166496|NCT01314872|592972769|FG007|Treatment Period 1|Lack of Efficacy|2|||
164166497|NCT01314872|592972770|FG008|Treatment Period 1|Lack of Efficacy|0|||
164166498|NCT01314872|592972771|FG009|Treatment Period 1|Lack of Efficacy|0|||
164166499|NCT01314872|592972772|FG010|Treatment Period 1|Lack of Efficacy|0|||
164166500|NCT01314872|592972773|FG011|Treatment Period 1|Lack of Efficacy|0|||
164166501|NCT01314872|592972774|FG012|Treatment Period 1|Lack of Efficacy|0|||
164166502|NCT01314872|592972775|FG013|Treatment Period 1|Lack of Efficacy|0|||
164166503|NCT01314872|592972776|FG014|Treatment Period 1|Lack of Efficacy|0|||
164166504|NCT01314872|592972762|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
164166505|NCT01314872|592972763|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
164166506|NCT01314872|592972764|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
164166507|NCT01314872|592972765|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
164166508|NCT01314872|592972766|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
164166509|NCT01314872|592972767|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
164166510|NCT01314872|592972768|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
164166511|NCT01314872|592972769|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
164166512|NCT01314872|592972770|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
164166513|NCT01314872|592972771|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
164166514|NCT01314872|592972772|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
164166515|NCT01314872|592972773|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
164166516|NCT01314872|592972774|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
164166517|NCT01314872|592972775|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
164166518|NCT01314872|592972776|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
164166519|NCT01314872|592972762|FG000|Treatment Period 1|Withdrawal by Subject|3|||
164166520|NCT01314872|592972763|FG001|Treatment Period 1|Withdrawal by Subject|1|||
164166521|NCT01314872|592972764|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164166522|NCT01314872|592972765|FG003|Treatment Period 1|Withdrawal by Subject|2|||
164166523|NCT01314872|592972766|FG004|Treatment Period 1|Withdrawal by Subject|3|||
164166524|NCT01314872|592972767|FG005|Treatment Period 1|Withdrawal by Subject|1|||
164166525|NCT01314872|592972768|FG006|Treatment Period 1|Withdrawal by Subject|3|||
164166526|NCT01314872|592972769|FG007|Treatment Period 1|Withdrawal by Subject|2|||
164166527|NCT01314872|592972770|FG008|Treatment Period 1|Withdrawal by Subject|2|||
164166528|NCT01314872|592972771|FG009|Treatment Period 1|Withdrawal by Subject|2|||
164166529|NCT01314872|592972772|FG010|Treatment Period 1|Withdrawal by Subject|1|||
164166530|NCT01314872|592972773|FG011|Treatment Period 1|Withdrawal by Subject|0|||
164166531|NCT01314872|592972774|FG012|Treatment Period 1|Withdrawal by Subject|0|||
164166532|NCT01314872|592972775|FG013|Treatment Period 1|Withdrawal by Subject|0|||
164166533|NCT01314872|592972776|FG014|Treatment Period 1|Withdrawal by Subject|0|||
164166534|NCT01314872|592972762|FG000|Treatment Period 1|Lost to Follow-up|0|||
164166535|NCT01314872|592972763|FG001|Treatment Period 1|Lost to Follow-up|1|||
164166536|NCT01314872|592972764|FG002|Treatment Period 1|Lost to Follow-up|2|||
164166537|NCT01314872|592972765|FG003|Treatment Period 1|Lost to Follow-up|2|||
164166538|NCT01314872|592972766|FG004|Treatment Period 1|Lost to Follow-up|1|||
164166539|NCT01314872|592972767|FG005|Treatment Period 1|Lost to Follow-up|1|||
164166540|NCT01314872|592972768|FG006|Treatment Period 1|Lost to Follow-up|1|||
164166541|NCT01314872|592972769|FG007|Treatment Period 1|Lost to Follow-up|1|||
164166542|NCT01314872|592972770|FG008|Treatment Period 1|Lost to Follow-up|1|||
164166543|NCT01314872|592972771|FG009|Treatment Period 1|Lost to Follow-up|0|||
164166544|NCT01314872|592972772|FG010|Treatment Period 1|Lost to Follow-up|0|||
164166545|NCT01314872|592972773|FG011|Treatment Period 1|Lost to Follow-up|0|||
164166546|NCT01314872|592972774|FG012|Treatment Period 1|Lost to Follow-up|0|||
164166547|NCT01314872|592972775|FG013|Treatment Period 1|Lost to Follow-up|0|||
164166548|NCT01314872|592972776|FG014|Treatment Period 1|Lost to Follow-up|0|||
164166549|NCT01314872|592972762|FG000|Period 2|Protocol Violation|0|||
164166550|NCT01314872|592972763|FG001|Period 2|Protocol Violation|0|||
164166551|NCT01314872|592972764|FG002|Period 2|Protocol Violation|0|||
164166552|NCT01314872|592972765|FG003|Period 2|Protocol Violation|0|||
164166553|NCT01314872|592972766|FG004|Period 2|Protocol Violation|0|||
164166554|NCT01314872|592972767|FG005|Period 2|Protocol Violation|0|||
164166555|NCT01314872|592972768|FG006|Period 2|Protocol Violation|0|||
164166556|NCT01314872|592972769|FG007|Period 2|Protocol Violation|0|||
164166557|NCT01314872|592972770|FG008|Period 2|Protocol Violation|0|||
164166558|NCT01314872|592972771|FG009|Period 2|Protocol Violation|0|||
164166559|NCT01314872|592972772|FG010|Period 2|Protocol Violation|0|||
164166560|NCT01314872|592972773|FG011|Period 2|Protocol Violation|3|||
164166561|NCT01314872|592972774|FG012|Period 2|Protocol Violation|3|||
164166562|NCT01314872|592972775|FG013|Period 2|Protocol Violation|2|||
164166563|NCT01314872|592972776|FG014|Period 2|Protocol Violation|0|||
164166564|NCT01314872|592972762|FG000|Period 2|Non-compliance with study drug|0|||
164166565|NCT01314872|592972763|FG001|Period 2|Non-compliance with study drug|0|||
164166566|NCT01314872|592972764|FG002|Period 2|Non-compliance with study drug|0|||
164166567|NCT01314872|592972765|FG003|Period 2|Non-compliance with study drug|0|||
164166568|NCT01314872|592972766|FG004|Period 2|Non-compliance with study drug|0|||
164166569|NCT01314872|592972767|FG005|Period 2|Non-compliance with study drug|0|||
164166570|NCT01314872|592972768|FG006|Period 2|Non-compliance with study drug|0|||
164166571|NCT01314872|592972769|FG007|Period 2|Non-compliance with study drug|0|||
164166572|NCT01314872|592972770|FG008|Period 2|Non-compliance with study drug|0|||
164166573|NCT01314872|592972771|FG009|Period 2|Non-compliance with study drug|0|||
164166574|NCT01314872|592972772|FG010|Period 2|Non-compliance with study drug|0|||
164166575|NCT01314872|592972773|FG011|Period 2|Non-compliance with study drug|3|||
164166576|NCT01314872|592972774|FG012|Period 2|Non-compliance with study drug|3|||
164166577|NCT01314872|592972775|FG013|Period 2|Non-compliance with study drug|1|||
164166578|NCT01314872|592972776|FG014|Period 2|Non-compliance with study drug|2|||
164166579|NCT01314872|592972762|FG000|Period 2|Lack of Efficacy|0|||
164166580|NCT01314872|592972763|FG001|Period 2|Lack of Efficacy|0|||
164166581|NCT01314872|592972764|FG002|Period 2|Lack of Efficacy|0|||
164166582|NCT01314872|592972765|FG003|Period 2|Lack of Efficacy|0|||
164166583|NCT01314872|592972766|FG004|Period 2|Lack of Efficacy|0|||
164166584|NCT01314872|592972767|FG005|Period 2|Lack of Efficacy|0|||
164166585|NCT01314872|592972768|FG006|Period 2|Lack of Efficacy|0|||
164166586|NCT01314872|592972769|FG007|Period 2|Lack of Efficacy|0|||
164166587|NCT01314872|592972770|FG008|Period 2|Lack of Efficacy|0|||
164166588|NCT01314872|592972771|FG009|Period 2|Lack of Efficacy|0|||
164166589|NCT01314872|592972772|FG010|Period 2|Lack of Efficacy|0|||
164166590|NCT01314872|592972773|FG011|Period 2|Lack of Efficacy|7|||
164166591|NCT01314872|592972774|FG012|Period 2|Lack of Efficacy|12|||
164166592|NCT01314872|592972775|FG013|Period 2|Lack of Efficacy|9|||
164166593|NCT01314872|592972776|FG014|Period 2|Lack of Efficacy|2|||
164166594|NCT01314872|592972762|FG000|Period 2|Pregnancy|0|||
164166595|NCT01314872|592972763|FG001|Period 2|Pregnancy|0|||
164166596|NCT01314872|592972764|FG002|Period 2|Pregnancy|0|||
164166597|NCT01314872|592972765|FG003|Period 2|Pregnancy|0|||
164166598|NCT01314872|592972766|FG004|Period 2|Pregnancy|0|||
164166599|NCT01314872|592972767|FG005|Period 2|Pregnancy|0|||
164166600|NCT01314872|592972768|FG006|Period 2|Pregnancy|0|||
164166601|NCT01314872|592972769|FG007|Period 2|Pregnancy|0|||
164166602|NCT01314872|592972770|FG008|Period 2|Pregnancy|0|||
164166603|NCT01314872|592972771|FG009|Period 2|Pregnancy|0|||
164166604|NCT01314872|592972772|FG010|Period 2|Pregnancy|0|||
164166605|NCT01314872|592972773|FG011|Period 2|Pregnancy|0|||
164166606|NCT01314872|592972774|FG012|Period 2|Pregnancy|0|||
164166607|NCT01314872|592972775|FG013|Period 2|Pregnancy|0|||
164166608|NCT01314872|592972776|FG014|Period 2|Pregnancy|1|||
164166609|NCT01314872|592972762|FG000|Period 2|Study terminated by Sponsor|0|||
164166610|NCT01314872|592972763|FG001|Period 2|Study terminated by Sponsor|0|||
164166611|NCT01314872|592972764|FG002|Period 2|Study terminated by Sponsor|0|||
164166612|NCT01314872|592972765|FG003|Period 2|Study terminated by Sponsor|0|||
164166613|NCT01314872|592972766|FG004|Period 2|Study terminated by Sponsor|0|||
164166614|NCT01314872|592972767|FG005|Period 2|Study terminated by Sponsor|0|||
164166615|NCT01314872|592972768|FG006|Period 2|Study terminated by Sponsor|0|||
164166616|NCT01314872|592972769|FG007|Period 2|Study terminated by Sponsor|0|||
164166617|NCT01314872|592972770|FG008|Period 2|Study terminated by Sponsor|0|||
164166618|NCT01314872|592972771|FG009|Period 2|Study terminated by Sponsor|0|||
164166619|NCT01314872|592972772|FG010|Period 2|Study terminated by Sponsor|0|||
164166620|NCT01314872|592972773|FG011|Period 2|Study terminated by Sponsor|2|||
164166621|NCT01314872|592972774|FG012|Period 2|Study terminated by Sponsor|2|||
164166622|NCT01314872|592972775|FG013|Period 2|Study terminated by Sponsor|3|||
164166623|NCT01314872|592972776|FG014|Period 2|Study terminated by Sponsor|0|||
164166624|NCT01314872|592972762|FG000|Period 2|Adverse event, non-fatal|0|||
164166625|NCT01314872|592972763|FG001|Period 2|Adverse event, non-fatal|0|||
164166626|NCT01314872|592972764|FG002|Period 2|Adverse event, non-fatal|0|||
164166627|NCT01314872|592972765|FG003|Period 2|Adverse event, non-fatal|0|||
164166628|NCT01314872|592972766|FG004|Period 2|Adverse event, non-fatal|0|||
164166629|NCT01314872|592972767|FG005|Period 2|Adverse event, non-fatal|0|||
164166630|NCT01314872|592972768|FG006|Period 2|Adverse event, non-fatal|0|||
164166631|NCT01314872|592972769|FG007|Period 2|Adverse event, non-fatal|0|||
164166632|NCT01314872|592972770|FG008|Period 2|Adverse event, non-fatal|0|||
164166633|NCT01314872|592972771|FG009|Period 2|Adverse event, non-fatal|0|||
164166634|NCT01314872|592972772|FG010|Period 2|Adverse event, non-fatal|0|||
164166635|NCT01314872|592972773|FG011|Period 2|Adverse event, non-fatal|13|||
164166636|NCT01314872|592972774|FG012|Period 2|Adverse event, non-fatal|16|||
164166637|NCT01314872|592972775|FG013|Period 2|Adverse event, non-fatal|24|||
164166638|NCT01314872|592972776|FG014|Period 2|Adverse event, non-fatal|9|||
164166639|NCT01314872|592972762|FG000|Period 2|Withdrawal by Subject|0|||
164166640|NCT01314872|592972763|FG001|Period 2|Withdrawal by Subject|0|||
164166641|NCT01314872|592972764|FG002|Period 2|Withdrawal by Subject|0|||
164166642|NCT01314872|592972765|FG003|Period 2|Withdrawal by Subject|0|||
164166643|NCT01314872|592972766|FG004|Period 2|Withdrawal by Subject|0|||
164166644|NCT01314872|592972767|FG005|Period 2|Withdrawal by Subject|0|||
164166645|NCT01314872|592972768|FG006|Period 2|Withdrawal by Subject|0|||
164166646|NCT01314872|592972769|FG007|Period 2|Withdrawal by Subject|0|||
164166647|NCT01314872|592972770|FG008|Period 2|Withdrawal by Subject|0|||
164166648|NCT01314872|592972771|FG009|Period 2|Withdrawal by Subject|0|||
164166649|NCT01314872|592972772|FG010|Period 2|Withdrawal by Subject|0|||
164166650|NCT01314872|592972773|FG011|Period 2|Withdrawal by Subject|14|||
164166651|NCT01314872|592972774|FG012|Period 2|Withdrawal by Subject|17|||
164166652|NCT01314872|592972775|FG013|Period 2|Withdrawal by Subject|12|||
164166653|NCT01314872|592972776|FG014|Period 2|Withdrawal by Subject|4|||
164166654|NCT01314872|592972762|FG000|Period 2|Lost to Follow-up|0|||
164166655|NCT01314872|592972763|FG001|Period 2|Lost to Follow-up|0|||
164166656|NCT01314872|592972764|FG002|Period 2|Lost to Follow-up|0|||
164166657|NCT01314872|592972765|FG003|Period 2|Lost to Follow-up|0|||
164166658|NCT01314872|592972766|FG004|Period 2|Lost to Follow-up|0|||
164166659|NCT01314872|592972767|FG005|Period 2|Lost to Follow-up|0|||
164166660|NCT01314872|592972768|FG006|Period 2|Lost to Follow-up|0|||
164166661|NCT01314872|592972769|FG007|Period 2|Lost to Follow-up|0|||
164166662|NCT01314872|592972770|FG008|Period 2|Lost to Follow-up|0|||
164166663|NCT01314872|592972771|FG009|Period 2|Lost to Follow-up|0|||
164166664|NCT01314872|592972772|FG010|Period 2|Lost to Follow-up|0|||
164166665|NCT01314872|592972773|FG011|Period 2|Lost to Follow-up|6|||
164166666|NCT01314872|592972774|FG012|Period 2|Lost to Follow-up|7|||
164166667|NCT01314872|592972775|FG013|Period 2|Lost to Follow-up|2|||
164166668|NCT01314872|592972776|FG014|Period 2|Lost to Follow-up|6|||
164166669|NCT06366087|592974093|FG000|Overall Study|Withdrawal by Subject|0|||
164166670|NCT06366087|592974094|FG001|Overall Study|Withdrawal by Subject|1|||
164166671|NCT00199797|592974096|FG000|Overall Study|Progressive Disease|1|||
164166672|NCT00199797|592974096|FG000|Overall Study|Adverse Event|1|||
164166673|NCT00199797|592974096|FG000|Overall Study|Physician Decision|1|||
164166674|NCT03652636|592974099|FG000|Overall Study|Withdrawal by Subject|7|||
164166675|NCT00679029|592974106|FG000|Overall Study|Adverse Event|3|||
164166676|NCT00679029|592974106|FG000|Overall Study|Withdrawal by Subject|1|||
164166677|NCT00679029|592974106|FG000|Overall Study|Lost to Follow-up|1|||
164166678|NCT00504725|592974107|FG000|Overall Study|Protocol Violation|1|||
164166679|NCT00504725|592974108|FG001|Overall Study|Protocol Violation|0|||
164166680|NCT03937908|592974109|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
164166681|NCT03937908|592974110|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
164166682|NCT03875092|592974111|FG000|Overall Study|Adverse Event|2|||
164166683|NCT03875092|592974112|FG001|Overall Study|Adverse Event|5|||
164166684|NCT03875092|592974111|FG000|Overall Study|Death|44|||
164166685|NCT03875092|592974112|FG001|Overall Study|Death|51|||
164166686|NCT03875092|592974111|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
164166687|NCT03875092|592974112|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
164166688|NCT03205761|592974113|FG000|Overall Study|Withdrawal by Subject|1|||
164166689|NCT03205761|592974113|FG000|Overall Study|Progressive Disease|10|||
164166690|NCT00636194|592974114|FG000|Overall Study|Study related symptoms and complaints|1|||
164166691|NCT00636194|592974115|FG001|Overall Study|Study related symptoms and complaints|0|||
164166692|NCT00636194|592974114|FG000|Overall Study|Protocol Violation|2|||
164166693|NCT00636194|592974115|FG001|Overall Study|Protocol Violation|0|||
164166694|NCT04114357|592974117|FG000|Baseline-Randomization|Adverse Event|2|||
164166695|NCT04114357|592974118|FG001|Baseline-Randomization|Adverse Event|1|||
164166696|NCT04114357|592974117|FG000|Baseline-Randomization|Lost to Follow-up|1|||
164166697|NCT04114357|592974118|FG001|Baseline-Randomization|Lost to Follow-up|1|||
164166698|NCT04114357|592974117|FG000|Cross-over|Adverse Event|0|||
164166699|NCT04114357|592974118|FG001|Cross-over|Adverse Event|1|||
164166700|NCT02163226|592974119|FG000|Overall Study|Death|2|||
164166701|NCT02163226|592974120|FG001|Overall Study|Death|1|||
164166702|NCT02163226|592974119|FG000|Overall Study|Withdrawal by Subject|5|||
164166703|NCT02163226|592974120|FG001|Overall Study|Withdrawal by Subject|2|||
164166704|NCT02163226|592974119|FG000|Overall Study|Returned home, local radiotherapy|3|||
164166705|NCT02163226|592974120|FG001|Overall Study|Returned home, local radiotherapy|0|||
164166706|NCT02163226|592974119|FG000|Overall Study|Repeat imaging showed no disease|2|||
164166707|NCT02163226|592974120|FG001|Overall Study|Repeat imaging showed no disease|0|||
164166708|NCT02163226|592974119|FG000|Overall Study|Incomplete radiotherapy|3|||
164166709|NCT02163226|592974120|FG001|Overall Study|Incomplete radiotherapy|0|||
164166710|NCT02163226|592974119|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
164166711|NCT02163226|592974120|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
164166712|NCT02163226|592974119|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
164166713|NCT02163226|592974120|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
164166714|NCT02163226|592974119|FG000|Overall Study|ineligible|0|||
164166715|NCT02163226|592974120|FG001|Overall Study|ineligible|3|||
164166716|NCT05318092|592974126|FG000|Overall Study|Lost to Follow-up|3|||
164166717|NCT05318092|592974126|FG000|Overall Study|Withdrawal by Subject|1|||
164166718|NCT00160706|592974128|FG000|Overall Study|Adverse Event|53|||
164166719|NCT00160706|592974128|FG000|Overall Study|Adverse Event and Other Reason|105|||
164166720|NCT00160706|592974128|FG000|Overall Study|Protocol Violation|3|||
164166721|NCT00160706|592974128|FG000|Overall Study|Withdrawal by Subject|41|||
164166722|NCT00160706|592974128|FG000|Overall Study|Withdrawal by Subject and Other|12|||
164166723|NCT00160706|592974128|FG000|Overall Study|Physician Decision|10|||
164166724|NCT00160706|592974128|FG000|Overall Study|Physician Decision and Other|3|||
164166725|NCT00160706|592974128|FG000|Overall Study|Lost to Follow-up|4|||
164166726|NCT00160706|592974128|FG000|Overall Study|Lost to Follow-up and Other|1|||
164166727|NCT00160706|592974128|FG000|Overall Study|Lack of Efficacy|42|||
164166728|NCT00160706|592974128|FG000|Overall Study|Lack of Efficacy and Other|1|||
164166729|NCT00160706|592974128|FG000|Overall Study|Other Reason|11|||
164166730|NCT03214380|592974129|FG000|Lead-in|Adverse Event|3|||
164166731|NCT03214380|592974130|FG001|Lead-in|Adverse Event|0|||
164166732|NCT03214380|592974131|FG002|Lead-in|Adverse Event|0|||
164166733|NCT03214380|592974132|FG003|Lead-in|Adverse Event|1|||
164166734|NCT03214380|592974133|FG004|Lead-in|Adverse Event|0|||
164166735|NCT03214380|592974134|FG005|Lead-in|Adverse Event|0|||
164166736|NCT03214380|592974129|FG000|Lead-in|Lost to Follow-up|4|||
164166737|NCT03214380|592974130|FG001|Lead-in|Lost to Follow-up|0|||
164166738|NCT03214380|592974131|FG002|Lead-in|Lost to Follow-up|0|||
164166739|NCT03214380|592974132|FG003|Lead-in|Lost to Follow-up|1|||
164166740|NCT03214380|592974133|FG004|Lead-in|Lost to Follow-up|0|||
164166741|NCT03214380|592974134|FG005|Lead-in|Lost to Follow-up|0|||
164166742|NCT03214380|592974129|FG000|Lead-in|Eligibility Criteria|3|||
164166743|NCT03214380|592974130|FG001|Lead-in|Eligibility Criteria|0|||
164166744|NCT03214380|592974131|FG002|Lead-in|Eligibility Criteria|0|||
164166745|NCT03214380|592974132|FG003|Lead-in|Eligibility Criteria|0|||
164166746|NCT03214380|592974133|FG004|Lead-in|Eligibility Criteria|0|||
164166747|NCT03214380|592974134|FG005|Lead-in|Eligibility Criteria|0|||
164166748|NCT03214380|592974129|FG000|Lead-in|Physician Decision|6|||
164166749|NCT03214380|592974130|FG001|Lead-in|Physician Decision|0|||
164166750|NCT03214380|592974131|FG002|Lead-in|Physician Decision|0|||
164166751|NCT03214380|592974132|FG003|Lead-in|Physician Decision|0|||
164166752|NCT03214380|592974133|FG004|Lead-in|Physician Decision|0|||
164166753|NCT03214380|592974134|FG005|Lead-in|Physician Decision|0|||
164166754|NCT03214380|592974129|FG000|Lead-in|Protocol Deviation|7|||
164166755|NCT03214380|592974130|FG001|Lead-in|Protocol Deviation|0|||
164166756|NCT03214380|592974131|FG002|Lead-in|Protocol Deviation|0|||
164166757|NCT03214380|592974132|FG003|Lead-in|Protocol Deviation|3|||
164166758|NCT03214380|592974133|FG004|Lead-in|Protocol Deviation|0|||
164166759|NCT03214380|592974134|FG005|Lead-in|Protocol Deviation|0|||
164166760|NCT03214380|592974129|FG000|Lead-in|Withdrawal by Subject|41|||
164166761|NCT03214380|592974130|FG001|Lead-in|Withdrawal by Subject|0|||
164166762|NCT03214380|592974131|FG002|Lead-in|Withdrawal by Subject|0|||
164166763|NCT03214380|592974132|FG003|Lead-in|Withdrawal by Subject|14|||
164166764|NCT03214380|592974133|FG004|Lead-in|Withdrawal by Subject|0|||
164166765|NCT03214380|592974134|FG005|Lead-in|Withdrawal by Subject|0|||
164166766|NCT03214380|592974129|FG000|Lead-in|Family Emergency|1|||
164166767|NCT03214380|592974130|FG001|Lead-in|Family Emergency|0|||
164166768|NCT03214380|592974131|FG002|Lead-in|Family Emergency|0|||
164166769|NCT03214380|592974132|FG003|Lead-in|Family Emergency|0|||
164166770|NCT03214380|592974133|FG004|Lead-in|Family Emergency|0|||
164166771|NCT03214380|592974134|FG005|Lead-in|Family Emergency|0|||
164166772|NCT03214380|592974129|FG000|Lead-in|Natural Disaster|9|||
164166773|NCT03214380|592974130|FG001|Lead-in|Natural Disaster|0|||
164166774|NCT03214380|592974131|FG002|Lead-in|Natural Disaster|0|||
164166775|NCT03214380|592974132|FG003|Lead-in|Natural Disaster|0|||
164166776|NCT03214380|592974133|FG004|Lead-in|Natural Disaster|0|||
164166777|NCT03214380|592974134|FG005|Lead-in|Natural Disaster|0|||
164166778|NCT03214380|592974129|FG000|Lead-in|Non Compliance|1|||
164166779|NCT03214380|592974130|FG001|Lead-in|Non Compliance|0|||
164166780|NCT03214380|592974131|FG002|Lead-in|Non Compliance|0|||
164166781|NCT03214380|592974132|FG003|Lead-in|Non Compliance|0|||
164166782|NCT03214380|592974133|FG004|Lead-in|Non Compliance|0|||
164166783|NCT03214380|592974134|FG005|Lead-in|Non Compliance|0|||
164166784|NCT03214380|592974129|FG000|Lead-in|Participant Schedule|2|||
164166785|NCT03214380|592974130|FG001|Lead-in|Participant Schedule|0|||
164166786|NCT03214380|592974131|FG002|Lead-in|Participant Schedule|0|||
164166787|NCT03214380|592974132|FG003|Lead-in|Participant Schedule|0|||
164166788|NCT03214380|592974133|FG004|Lead-in|Participant Schedule|0|||
164166789|NCT03214380|592974134|FG005|Lead-in|Participant Schedule|0|||
164166790|NCT03214380|592974129|FG000|Treatment Period|Adverse Event|0|||
164166791|NCT03214380|592974130|FG001|Treatment Period|Adverse Event|1|||
164166792|NCT03214380|592974131|FG002|Treatment Period|Adverse Event|1|||
164166793|NCT03214380|592974132|FG003|Treatment Period|Adverse Event|0|||
164166794|NCT03214380|592974133|FG004|Treatment Period|Adverse Event|1|||
164166795|NCT03214380|592974134|FG005|Treatment Period|Adverse Event|0|||
164166796|NCT03214380|592974129|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
164166797|NCT03214380|592974130|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
164166798|NCT03214380|592974131|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
164166799|NCT03214380|592974132|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
164166800|NCT03214380|592974133|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
164166801|NCT03214380|592974134|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
164166802|NCT03214380|592974129|FG000|Treatment Period|Withdrawal by Subject|0|||
164166803|NCT03214380|592974130|FG001|Treatment Period|Withdrawal by Subject|10|||
164166804|NCT03214380|592974131|FG002|Treatment Period|Withdrawal by Subject|8|||
164166805|NCT03214380|592974132|FG003|Treatment Period|Withdrawal by Subject|0|||
164166806|NCT03214380|592974133|FG004|Treatment Period|Withdrawal by Subject|7|||
164166807|NCT03214380|592974134|FG005|Treatment Period|Withdrawal by Subject|11|||
164166808|NCT03214380|592974129|FG000|Treatment Period|Death|0|||
164166809|NCT03214380|592974130|FG001|Treatment Period|Death|1|||
164166810|NCT03214380|592974131|FG002|Treatment Period|Death|2|||
164166811|NCT03214380|592974132|FG003|Treatment Period|Death|0|||
164166812|NCT03214380|592974133|FG004|Treatment Period|Death|0|||
164166813|NCT03214380|592974134|FG005|Treatment Period|Death|0|||
164166814|NCT03214380|592974129|FG000|Treatment Period|Lost to Follow-up|0|||
164166815|NCT03214380|592974130|FG001|Treatment Period|Lost to Follow-up|6|||
164166816|NCT03214380|592974131|FG002|Treatment Period|Lost to Follow-up|3|||
164166817|NCT03214380|592974132|FG003|Treatment Period|Lost to Follow-up|0|||
164166818|NCT03214380|592974133|FG004|Treatment Period|Lost to Follow-up|0|||
164166819|NCT03214380|592974134|FG005|Treatment Period|Lost to Follow-up|0|||
164166820|NCT03214380|592974129|FG000|Treatment Period|Participant schedule|0|||
164166821|NCT03214380|592974130|FG001|Treatment Period|Participant schedule|0|||
164166822|NCT03214380|592974131|FG002|Treatment Period|Participant schedule|1|||
164166823|NCT03214380|592974132|FG003|Treatment Period|Participant schedule|0|||
164166824|NCT03214380|592974133|FG004|Treatment Period|Participant schedule|0|||
164166825|NCT03214380|592974134|FG005|Treatment Period|Participant schedule|0|||
164166826|NCT03214380|592974129|FG000|Treatment Period|Treatment Interruption|0|||
164166827|NCT03214380|592974130|FG001|Treatment Period|Treatment Interruption|0|||
164166828|NCT03214380|592974131|FG002|Treatment Period|Treatment Interruption|1|||
164166829|NCT03214380|592974132|FG003|Treatment Period|Treatment Interruption|0|||
164166830|NCT03214380|592974133|FG004|Treatment Period|Treatment Interruption|0|||
164166831|NCT03214380|592974134|FG005|Treatment Period|Treatment Interruption|0|||
164166832|NCT04984278|592974144|FG000|Period 1|Withdrawal by Subject|1|||
164166833|NCT04984278|592974145|FG001|Period 1|Withdrawal by Subject|0|||
164166834|NCT04984278|592974144|FG000|Period 1|Other|0|||
164166835|NCT04984278|592974145|FG001|Period 1|Other|1|||
164166836|NCT04984278|592974144|FG000|Period 2|Adverse Event|1|||
164166837|NCT04984278|592974145|FG001|Period 2|Adverse Event|0|||
164166838|NCT04984278|592974144|FG000|Period 2|Other|0|||
164166839|NCT04984278|592974145|FG001|Period 2|Other|1|||
164166840|NCT04292912|592974146|FG000|Overall Study|Physician Decision|1|||
164166841|NCT04292912|592974146|FG000|Overall Study|Protocol Violation|6|||
164166842|NCT00280397|592974147|FG000|Overall Study|Adverse Event|1|||
164166843|NCT03348930|592974152|FG000|Washout (1 Week)|Lost to Follow-up|1|||
164166844|NCT03348930|592974153|FG001|Washout (1 Week)|Lost to Follow-up|1|||
164166845|NCT01598090|592974154|FG000|Treatment Period|Poor/non-compliance|0|||
164166846|NCT01598090|592974155|FG001|Treatment Period|Poor/non-compliance|2|||
164166847|NCT01598090|592974156|FG002|Treatment Period|Poor/non-compliance|0|||
164166848|NCT01598090|592974154|FG000|Treatment Period|No longer meet study criteria|0|||
164166849|NCT01598090|592974155|FG001|Treatment Period|No longer meet study criteria|1|||
164166850|NCT01598090|592974156|FG002|Treatment Period|No longer meet study criteria|0|||
164166851|NCT01598090|592974154|FG000|Treatment Period|Lack of Efficacy|5|||
164166852|NCT01598090|592974155|FG001|Treatment Period|Lack of Efficacy|14|||
164166853|NCT01598090|592974156|FG002|Treatment Period|Lack of Efficacy|6|||
164166854|NCT01598090|592974154|FG000|Treatment Period|Adverse Event|2|||
164166855|NCT01598090|592974155|FG001|Treatment Period|Adverse Event|33|||
164166856|NCT01598090|592974156|FG002|Treatment Period|Adverse Event|17|||
164166857|NCT01598090|592974154|FG000|Treatment Period|Other reasons|0|||
164166858|NCT01598090|592974155|FG001|Treatment Period|Other reasons|4|||
164166859|NCT01598090|592974156|FG002|Treatment Period|Other reasons|1|||
164166860|NCT01598090|592974154|FG000|Treatment Period|Withdrawal by Subject|3|||
164166861|NCT01598090|592974155|FG001|Treatment Period|Withdrawal by Subject|13|||
164166862|NCT01598090|592974156|FG002|Treatment Period|Withdrawal by Subject|10|||
164166863|NCT01598090|592974154|FG000|Treatment Period|Lost to Follow-up|1|||
164166864|NCT01598090|592974155|FG001|Treatment Period|Lost to Follow-up|5|||
164166865|NCT01598090|592974156|FG002|Treatment Period|Lost to Follow-up|1|||
164166866|NCT01598090|592974154|FG000|Follow-up Period|Death|0|||
164166867|NCT01598090|592974155|FG001|Follow-up Period|Death|1|||
164166868|NCT01598090|592974156|FG002|Follow-up Period|Death|0|||
164166869|NCT01598090|592974154|FG000|Follow-up Period|No longer required per protocol|1|||
164166870|NCT01598090|592974155|FG001|Follow-up Period|No longer required per protocol|3|||
164166871|NCT01598090|592974156|FG002|Follow-up Period|No longer required per protocol|2|||
164166872|NCT01598090|592974154|FG000|Follow-up Period|Not reported|0|||
164166873|NCT01598090|592974155|FG001|Follow-up Period|Not reported|10|||
164166874|NCT01598090|592974156|FG002|Follow-up Period|Not reported|4|||
164166875|NCT01598090|592974154|FG000|Follow-up Period|Withdrawal by Subject|0|||
164166876|NCT01598090|592974155|FG001|Follow-up Period|Withdrawal by Subject|3|||
164166877|NCT01598090|592974156|FG002|Follow-up Period|Withdrawal by Subject|2|||
164166878|NCT01598090|592974154|FG000|Follow-up Period|Other reasons|2|||
164166879|NCT01598090|592974155|FG001|Follow-up Period|Other reasons|8|||
164166880|NCT01598090|592974156|FG002|Follow-up Period|Other reasons|8|||
164166881|NCT01598090|592974154|FG000|Follow-up Period|Lost to Follow-up|2|||
164166882|NCT01598090|592974155|FG001|Follow-up Period|Lost to Follow-up|10|||
164166883|NCT01598090|592974156|FG002|Follow-up Period|Lost to Follow-up|12|||
164166884|NCT00355147|592974159|FG000|Overall Study|Lost to Follow-up|10|||
164166885|NCT00355147|592974160|FG001|Overall Study|Lost to Follow-up|8|||
164166886|NCT00355147|592974159|FG000|Overall Study|Withdrawal by Subject|8|||
164166887|NCT00355147|592974160|FG001|Overall Study|Withdrawal by Subject|12|||
164166888|NCT03474731|592974166|FG000|Overall Study|Withdrawal by Subject|36|||
164166889|NCT03474731|592974167|FG001|Overall Study|Withdrawal by Subject|29|||
164166890|NCT03474731|592974168|FG002|Overall Study|Withdrawal by Subject|11|||
164166891|NCT03474731|592974169|FG003|Overall Study|Withdrawal by Subject|27|||
164166892|NCT03474731|592974166|FG000|Overall Study|COVID|0|||
164166893|NCT03474731|592974167|FG001|Overall Study|COVID|23|||
164166894|NCT03474731|592974168|FG002|Overall Study|COVID|0|||
164166895|NCT03474731|592974169|FG003|Overall Study|COVID|0|||
164166896|NCT03474731|592974166|FG000|Overall Study|Participant moved from area|1|||
164166897|NCT03474731|592974167|FG001|Overall Study|Participant moved from area|0|||
164166898|NCT03474731|592974168|FG002|Overall Study|Participant moved from area|0|||
164166899|NCT03474731|592974169|FG003|Overall Study|Participant moved from area|0|||
164166900|NCT03474731|592974166|FG000|Overall Study|Lost to Follow-up|11|||
164166901|NCT03474731|592974167|FG001|Overall Study|Lost to Follow-up|3|||
164166902|NCT03474731|592974168|FG002|Overall Study|Lost to Follow-up|18|||
164166903|NCT03474731|592974169|FG003|Overall Study|Lost to Follow-up|17|||
164166904|NCT03474731|592974166|FG000|Overall Study|Death|0|||
164166905|NCT03474731|592974167|FG001|Overall Study|Death|1|||
164166906|NCT03474731|592974168|FG002|Overall Study|Death|0|||
164166907|NCT03474731|592974169|FG003|Overall Study|Death|0|||
164166908|NCT03474731|592974166|FG000|Overall Study|Participant Removed|0|||
164166909|NCT03474731|592974167|FG001|Overall Study|Participant Removed|0|||
164166910|NCT03474731|592974168|FG002|Overall Study|Participant Removed|0|||
164166911|NCT03474731|592974169|FG003|Overall Study|Participant Removed|1|||
164166912|NCT00554515|592974170|FG000|Overall Study|Withdrawal by Subject|3|||
164166913|NCT00554515|592974170|FG000|Overall Study|Disease progression|52|||
164166914|NCT00554515|592974170|FG000|Overall Study|Physician Decision|18|||
164166915|NCT00554515|592974170|FG000|Overall Study|Withdrawal by Subject|11|||
164166916|NCT00554515|592974170|FG000|Overall Study|Adverse Event|9|||
164166917|NCT00554515|592974170|FG000|Overall Study|Death|2|||
164166918|NCT00554515|592974170|FG000|Overall Study|Achieved Stable Disease|7|||
164166919|NCT00554515|592974170|FG000|Overall Study|Other|1|||
164166920|NCT00554515|592974170|FG000|Overall Study|Misc|15|||
164166921|NCT04087720|592974175|FG000|Overall Study|Withdrawal by Subject|2|||
164166922|NCT04087720|592974175|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
164166923|NCT00900159|592974178|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
164166924|NCT00900159|592974179|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
164166925|NCT01377922|592974181|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
164166926|NCT01377922|592974182|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
164166927|NCT04615403|592974183|FG000|Overall Study|Death|1|||
164166928|NCT00665431|592974184|FG000|Overall Study|Adverse Event|16|||
164166929|NCT00665431|592974185|FG001|Overall Study|Adverse Event|22|||
164166930|NCT00665431|592974186|FG002|Overall Study|Adverse Event|6|||
164166931|NCT00665431|592974184|FG000|Overall Study|Withdrawal by Subject|17|||
164166932|NCT00665431|592974185|FG001|Overall Study|Withdrawal by Subject|25|||
164166933|NCT00665431|592974186|FG002|Overall Study|Withdrawal by Subject|15|||
164166934|NCT00665431|592974184|FG000|Overall Study|Lost to Follow-up|3|||
164166935|NCT00665431|592974185|FG001|Overall Study|Lost to Follow-up|3|||
164166936|NCT00665431|592974186|FG002|Overall Study|Lost to Follow-up|1|||
164166937|NCT00665431|592974184|FG000|Overall Study|Other|4|||
164166938|NCT00665431|592974185|FG001|Overall Study|Other|7|||
164166939|NCT00665431|592974186|FG002|Overall Study|Other|2|||
164166940|NCT01726270|592974189|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
164166941|NCT01726270|592974189|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
164166942|NCT01726270|592974189|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
164166943|NCT01726270|592974189|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
164166944|NCT01726270|592974189|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
164166945|NCT01726270|592974189|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
164166946|NCT02157376|592974190|FG000|Overall Study|Death|10|||
164166947|NCT02157376|592974191|FG001|Overall Study|Death|4|||
164166948|NCT02157376|592974190|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164166949|NCT02157376|592974191|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
164166950|NCT02157376|592974190|FG000|Overall Study|Withdrawal by Subject|3|||
164166951|NCT02157376|592974191|FG001|Overall Study|Withdrawal by Subject|8|||
164166952|NCT02157376|592974190|FG000|Overall Study|Not treated|8|||
164166953|NCT02157376|592974191|FG001|Overall Study|Not treated|3|||
164166954|NCT02157376|592974190|FG000|Overall Study|Investigator's misjudgement|1|||
164166955|NCT02157376|592974191|FG001|Overall Study|Investigator's misjudgement|2|||
164166956|NCT02547220|592974192|FG000|Overall Study|Withdrawal by Subject|1|||
164166957|NCT02547220|592974193|FG001|Overall Study|Withdrawal by Subject|0|||
164166958|NCT02547220|592974192|FG000|Overall Study|Study terminated by sponsor|18|||
164166959|NCT02547220|592974193|FG001|Overall Study|Study terminated by sponsor|20|||
164166960|NCT03817229|592974194|FG000|Intervention Period-Stage 1|Withdrawal by Subject|6|||
164166961|NCT03817229|592974195|FG001|Intervention Period-Stage 1|Withdrawal by Subject|8|||
164166962|NCT03817229|592974196|FG002|Intervention Period-Stage 1|Withdrawal by Subject|0|||
164166963|NCT03817229|592974197|FG003|Intervention Period-Stage 1|Withdrawal by Subject|0|||
164166964|NCT03817229|592974194|FG000|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
164166965|NCT03817229|592974195|FG001|Intervention Period-Stage 1|Withdrawn by Study Team|1|||
164166966|NCT03817229|592974196|FG002|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
164166967|NCT03817229|592974197|FG003|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
164166968|NCT03817229|592974194|FG000|Intervention Period-Stage 1|Weaned from medication|0|||
164166969|NCT03817229|592974195|FG001|Intervention Period-Stage 1|Weaned from medication|3|||
164166970|NCT03817229|592974196|FG002|Intervention Period-Stage 1|Weaned from medication|0|||
164166971|NCT03817229|592974197|FG003|Intervention Period-Stage 1|Weaned from medication|0|||
164166972|NCT03817229|592974194|FG000|Intervention Period-Stage 2|Withdrawal by Subject|1|||
164166973|NCT03817229|592974195|FG001|Intervention Period-Stage 2|Withdrawal by Subject|0|||
164166974|NCT03817229|592974196|FG002|Intervention Period-Stage 2|Withdrawal by Subject|1|||
164166975|NCT03817229|592974197|FG003|Intervention Period-Stage 2|Withdrawal by Subject|10|||
164166976|NCT03817229|592974194|FG000|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
164166977|NCT03817229|592974195|FG001|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
164166978|NCT03817229|592974196|FG002|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
164166979|NCT03817229|592974197|FG003|Intervention Period-Stage 2|Withdrawal by Study Team|3|||
164166980|NCT03817229|592974194|FG000|Intervention Period-Stage 2|Weaned from medication|0|||
164166981|NCT03817229|592974195|FG001|Intervention Period-Stage 2|Weaned from medication|0|||
164166982|NCT03817229|592974196|FG002|Intervention Period-Stage 2|Weaned from medication|0|||
164166983|NCT03817229|592974197|FG003|Intervention Period-Stage 2|Weaned from medication|1|||
164166984|NCT03817229|592974194|FG000|Post-Intervention|Withdrawal by Subject|6|||
164166985|NCT03817229|592974195|FG001|Post-Intervention|Withdrawal by Subject|0|||
164166986|NCT03817229|592974196|FG002|Post-Intervention|Withdrawal by Subject|2|||
164166987|NCT03817229|592974197|FG003|Post-Intervention|Withdrawal by Subject|2|||
164166988|NCT03817229|592974194|FG000|Post-Intervention|Withdrawal by Study Team|3|||
164166989|NCT03817229|592974195|FG001|Post-Intervention|Withdrawal by Study Team|1|||
164166990|NCT03817229|592974196|FG002|Post-Intervention|Withdrawal by Study Team|1|||
164166991|NCT03817229|592974197|FG003|Post-Intervention|Withdrawal by Study Team|4|||
164166992|NCT03817229|592974194|FG000|Post-Intervention|Weaned from medication|3|||
164166993|NCT03817229|592974195|FG001|Post-Intervention|Weaned from medication|0|||
164166994|NCT03817229|592974196|FG002|Post-Intervention|Weaned from medication|2|||
164166995|NCT03817229|592974197|FG003|Post-Intervention|Weaned from medication|1|||
164166996|NCT03817229|592974194|FG000|Post-Intervention|Transferred care to another institution|1|||
164166997|NCT03817229|592974195|FG001|Post-Intervention|Transferred care to another institution|0|||
164166998|NCT03817229|592974196|FG002|Post-Intervention|Transferred care to another institution|0|||
164166999|NCT03817229|592974197|FG003|Post-Intervention|Transferred care to another institution|0|||
164167000|NCT03817229|592974194|FG000|Post-Intervention|Change in parental guardianship|0|||
164167001|NCT03817229|592974195|FG001|Post-Intervention|Change in parental guardianship|0|||
164167002|NCT03817229|592974196|FG002|Post-Intervention|Change in parental guardianship|1|||
164167003|NCT03817229|592974197|FG003|Post-Intervention|Change in parental guardianship|0|||
164167004|NCT03817229|592974194|FG000|Follow-up 1|Ineligible for this follow-up visit due to study timing|7|||
164167005|NCT03817229|592974195|FG001|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
164167006|NCT03817229|592974196|FG002|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
164167007|NCT03817229|592974197|FG003|Follow-up 1|Ineligible for this follow-up visit due to study timing|3|||
164167008|NCT03817229|592974194|FG000|Follow-up 1|Withdrawal by Subject|1|||
164167009|NCT03817229|592974195|FG001|Follow-up 1|Withdrawal by Subject|2|||
164167010|NCT03817229|592974196|FG002|Follow-up 1|Withdrawal by Subject|0|||
164167011|NCT03817229|592974197|FG003|Follow-up 1|Withdrawal by Subject|0|||
164167012|NCT03817229|592974194|FG000|Follow-up 1|Withdrawal by Study Team|3|||
164167013|NCT03817229|592974195|FG001|Follow-up 1|Withdrawal by Study Team|1|||
164167014|NCT03817229|592974196|FG002|Follow-up 1|Withdrawal by Study Team|0|||
164167015|NCT03817229|592974197|FG003|Follow-up 1|Withdrawal by Study Team|0|||
164167016|NCT03817229|592974194|FG000|Follow-up 1|Wean from medication|3|||
164167017|NCT03817229|592974195|FG001|Follow-up 1|Wean from medication|4|||
164167018|NCT03817229|592974196|FG002|Follow-up 1|Wean from medication|0|||
164167019|NCT03817229|592974197|FG003|Follow-up 1|Wean from medication|1|||
164167020|NCT03817229|592974194|FG000|Follow-up 1|Transferred care to another hospital|1|||
164167021|NCT03817229|592974195|FG001|Follow-up 1|Transferred care to another hospital|0|||
164167022|NCT03817229|592974196|FG002|Follow-up 1|Transferred care to another hospital|0|||
164167023|NCT03817229|592974197|FG003|Follow-up 1|Transferred care to another hospital|0|||
164167024|NCT03817229|592974194|FG000|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
164167025|NCT03817229|592974195|FG001|Follow-up 2|Ineligible for this follow-up visit due to study timing|3|||
164167026|NCT03817229|592974196|FG002|Follow-up 2|Ineligible for this follow-up visit due to study timing|1|||
164167027|NCT03817229|592974197|FG003|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
164167028|NCT03817229|592974194|FG000|Follow-up 2|Withdrawal by Subject|2|||
164167029|NCT03817229|592974195|FG001|Follow-up 2|Withdrawal by Subject|0|||
164167030|NCT03817229|592974196|FG002|Follow-up 2|Withdrawal by Subject|1|||
164167031|NCT03817229|592974197|FG003|Follow-up 2|Withdrawal by Subject|1|||
164167032|NCT03817229|592974194|FG000|Follow-up 2|Withdrawal by Study Team|2|||
164167033|NCT03817229|592974195|FG001|Follow-up 2|Withdrawal by Study Team|0|||
164167034|NCT03817229|592974196|FG002|Follow-up 2|Withdrawal by Study Team|1|||
164167035|NCT03817229|592974197|FG003|Follow-up 2|Withdrawal by Study Team|0|||
164167036|NCT03817229|592974194|FG000|Follow-up 2|Wean from medication|1|||
164167037|NCT03817229|592974195|FG001|Follow-up 2|Wean from medication|0|||
164167038|NCT03817229|592974196|FG002|Follow-up 2|Wean from medication|0|||
164167039|NCT03817229|592974197|FG003|Follow-up 2|Wean from medication|0|||
164167040|NCT03817229|592974194|FG000|Follow-up 2|Transferred care|0|||
164167041|NCT03817229|592974195|FG001|Follow-up 2|Transferred care|0|||
164167042|NCT03817229|592974196|FG002|Follow-up 2|Transferred care|1|||
164167043|NCT03817229|592974197|FG003|Follow-up 2|Transferred care|0|||
164167044|NCT02887183|592974199|FG000|Overall Study|Adverse Event|44|||
164167045|NCT02887183|592974199|FG000|Overall Study|Death|30|||
164167046|NCT02887183|592974199|FG000|Overall Study|Pregnancy|1|||
164167047|NCT02887183|592974199|FG000|Overall Study|Protocol Violation|6|||
164167048|NCT02887183|592974199|FG000|Overall Study|Technical Problems|2|||
164167049|NCT02887183|592974199|FG000|Overall Study|Lost to Follow-up|13|||
164167050|NCT02887183|592974199|FG000|Overall Study|Physician Decision|10|||
164167051|NCT02887183|592974199|FG000|Overall Study|Withdrawal by Subject|35|||
164167052|NCT02702388|592974205|FG000|Overall Study|Disease Progression|18|||
164167053|NCT02702388|592974206|FG001|Overall Study|Disease Progression|25|||
164167054|NCT02702388|592974205|FG000|Overall Study|Withdrawal by Subject|9|||
164167055|NCT02702388|592974206|FG001|Overall Study|Withdrawal by Subject|7|||
164167056|NCT02702388|592974205|FG000|Overall Study|Adverse Event|11|||
164167057|NCT02702388|592974206|FG001|Overall Study|Adverse Event|15|||
164167058|NCT02702388|592974205|FG000|Overall Study|Other|2|||
164167059|NCT02702388|592974206|FG001|Overall Study|Other|4|||
164167060|NCT02729051|592974207|FG000|Overall Study|Adverse Event|21|||
164167061|NCT02729051|592974208|FG001|Overall Study|Adverse Event|11|||
164167062|NCT02729051|592974207|FG000|Overall Study|Lack of Efficacy|1|||
164167063|NCT02729051|592974208|FG001|Overall Study|Lack of Efficacy|1|||
164167064|NCT02729051|592974207|FG000|Overall Study|Lost to Follow-up|1|||
164167065|NCT02729051|592974208|FG001|Overall Study|Lost to Follow-up|2|||
164167066|NCT02729051|592974207|FG000|Overall Study|Physician Decision|1|||
164167067|NCT02729051|592974208|FG001|Overall Study|Physician Decision|1|||
164167068|NCT02729051|592974207|FG000|Overall Study|Withdrawal by Subject|6|||
164167069|NCT02729051|592974208|FG001|Overall Study|Withdrawal by Subject|17|||
164167070|NCT01397786|592975648|FG000|Phase A|Lost to Follow-up|0|||
164167071|NCT01397786|592975649|FG001|Phase A|Lost to Follow-up|0|||
164167072|NCT01397786|592975650|FG002|Phase A|Lost to Follow-up|6|||
164167073|NCT01397786|592975648|FG000|Phase A|Adverse Event|0|||
164167074|NCT01397786|592975649|FG001|Phase A|Adverse Event|0|||
164167075|NCT01397786|592975650|FG002|Phase A|Adverse Event|8|||
164167076|NCT01397786|592975648|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
164167077|NCT01397786|592975649|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
164167078|NCT01397786|592975650|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
164167079|NCT01397786|592975648|FG000|Phase A|Physician Decision|0|||
164167080|NCT01397786|592975649|FG001|Phase A|Physician Decision|0|||
164167081|NCT01397786|592975650|FG002|Phase A|Physician Decision|1|||
164167082|NCT01397786|592975648|FG000|Phase A|Withdrawal by Subject|0|||
164167083|NCT01397786|592975649|FG001|Phase A|Withdrawal by Subject|0|||
164167084|NCT01397786|592975650|FG002|Phase A|Withdrawal by Subject|5|||
164167085|NCT01397786|592975648|FG000|Phase A|Lack of Efficacy|0|||
164167086|NCT01397786|592975649|FG001|Phase A|Lack of Efficacy|0|||
164167087|NCT01397786|592975650|FG002|Phase A|Lack of Efficacy|1|||
164167088|NCT01397786|592975648|FG000|Phase B|Lost to Follow-up|22|||
164167089|NCT01397786|592975649|FG001|Phase B|Lost to Follow-up|12|||
164167090|NCT01397786|592975650|FG002|Phase B|Lost to Follow-up|22|||
164167091|NCT01397786|592975648|FG000|Phase B|Adverse Event|109|||
164167092|NCT01397786|592975649|FG001|Phase B|Adverse Event|23|||
164167093|NCT01397786|592975650|FG002|Phase B|Adverse Event|27|||
164167094|NCT01397786|592975648|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
164167095|NCT01397786|592975649|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
164167096|NCT01397786|592975650|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
164167097|NCT01397786|592975648|FG000|Phase B|Physician Decision|9|||
164167098|NCT01397786|592975649|FG001|Phase B|Physician Decision|1|||
164167099|NCT01397786|592975650|FG002|Phase B|Physician Decision|3|||
164167100|NCT01397786|592975648|FG000|Phase B|Withdrawal by Subject|102|||
164167101|NCT01397786|592975649|FG001|Phase B|Withdrawal by Subject|45|||
164167102|NCT01397786|592975650|FG002|Phase B|Withdrawal by Subject|30|||
164167103|NCT01397786|592975648|FG000|Phase B|Protocol Deviation|1|||
164167104|NCT01397786|592975649|FG001|Phase B|Protocol Deviation|2|||
164167105|NCT01397786|592975650|FG002|Phase B|Protocol Deviation|4|||
164167106|NCT01397786|592975648|FG000|Phase B|Lack of Efficacy|22|||
164167107|NCT01397786|592975649|FG001|Phase B|Lack of Efficacy|7|||
164167108|NCT01397786|592975650|FG002|Phase B|Lack of Efficacy|14|||
164167109|NCT04250350|592975654|FG000|Overall Study|Withdrawal by Subject|13|||
164167110|NCT04250350|592975654|FG000|Overall Study|Lost to Follow-up|8|||
164167111|NCT04250350|592975654|FG000|Overall Study|Adverse Event|5|||
164167112|NCT04250350|592975654|FG000|Overall Study|Lack of Efficacy|4|||
164167113|NCT04250350|592975654|FG000|Overall Study|Physician Decision|1|||
164167114|NCT04250350|592975654|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
164167115|NCT00860249|592975655|FG000|Overall Study|trial was terminated prior to completion|21|||
164167116|NCT00860249|592975656|FG001|Overall Study|trial was terminated prior to completion|18|||
164167117|NCT00860249|592975657|FG002|Overall Study|trial was terminated prior to completion|21|||
164167118|NCT00743288|592975658|FG000|Overall Study|Adverse Event|1|||
164167119|NCT00743288|592975659|FG001|Overall Study|Adverse Event|1|||
164167120|NCT00743288|592975660|FG002|Overall Study|Adverse Event|2|||
164167121|NCT00743288|592975661|FG003|Overall Study|Adverse Event|2|||
164167122|NCT00743288|592975662|FG004|Overall Study|Adverse Event|1|||
164167123|NCT00743288|592975663|FG005|Overall Study|Adverse Event|1|||
164167124|NCT00743288|592975664|FG006|Overall Study|Adverse Event|2|||
164167125|NCT00743288|592975658|FG000|Overall Study|Withdrawal by Subject|0|||
164167126|NCT00743288|592975659|FG001|Overall Study|Withdrawal by Subject|0|||
164167127|NCT00743288|592975660|FG002|Overall Study|Withdrawal by Subject|1|||
164167128|NCT00743288|592975661|FG003|Overall Study|Withdrawal by Subject|0|||
164167129|NCT00743288|592975662|FG004|Overall Study|Withdrawal by Subject|0|||
164167130|NCT00743288|592975663|FG005|Overall Study|Withdrawal by Subject|1|||
164167131|NCT00743288|592975664|FG006|Overall Study|Withdrawal by Subject|1|||
164167132|NCT00743288|592975658|FG000|Overall Study|Progressive disease (PD)|2|||
164167133|NCT00743288|592975659|FG001|Overall Study|Progressive disease (PD)|0|||
164167134|NCT00743288|592975660|FG002|Overall Study|Progressive disease (PD)|1|||
164167135|NCT00743288|592975661|FG003|Overall Study|Progressive disease (PD)|4|||
164167136|NCT00743288|592975662|FG004|Overall Study|Progressive disease (PD)|5|||
164167137|NCT00743288|592975663|FG005|Overall Study|Progressive disease (PD)|3|||
164167138|NCT00743288|592975664|FG006|Overall Study|Progressive disease (PD)|6|||
164167139|NCT00743288|592975658|FG000|Overall Study|Worsening of condition (Not PD)|0|||
164167140|NCT00743288|592975659|FG001|Overall Study|Worsening of condition (Not PD)|2|||
164167141|NCT00743288|592975660|FG002|Overall Study|Worsening of condition (Not PD)|1|||
164167142|NCT00743288|592975661|FG003|Overall Study|Worsening of condition (Not PD)|1|||
164167143|NCT00743288|592975662|FG004|Overall Study|Worsening of condition (Not PD)|0|||
164167144|NCT00743288|592975663|FG005|Overall Study|Worsening of condition (Not PD)|0|||
164167145|NCT00743288|592975664|FG006|Overall Study|Worsening of condition (Not PD)|0|||
164167146|NCT02836236|592975668|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
164167147|NCT02836236|592975669|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
164167148|NCT02836236|592975670|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
164167149|NCT02836236|592975671|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
164167150|NCT02836236|592975668|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
164167151|NCT02836236|592975669|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
164167152|NCT02836236|592975670|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
164167153|NCT02836236|592975671|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
164167154|NCT02836236|592975668|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
164167155|NCT02836236|592975669|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
164167156|NCT02836236|592975670|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
164167157|NCT02836236|592975671|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
164167158|NCT02836236|592975668|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
164167159|NCT02836236|592975669|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
164167160|NCT02836236|592975670|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
164167161|NCT02836236|592975671|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
164167162|NCT02836236|592975668|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
164167163|NCT02836236|592975669|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
164167164|NCT02836236|592975670|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
164167165|NCT02836236|592975671|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
164167166|NCT02836236|592975668|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
164167167|NCT02836236|592975669|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
164167168|NCT02836236|592975670|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
164167169|NCT02836236|592975671|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
164167170|NCT02836236|592975668|FG000|Open-Label TAF Treatment Phase|Death|0|||
164167171|NCT02836236|592975669|FG001|Open-Label TAF Treatment Phase|Death|0|||
164167172|NCT02836236|592975670|FG002|Open-Label TAF Treatment Phase|Death|1|||
164167173|NCT02836236|592975671|FG003|Open-Label TAF Treatment Phase|Death|1|||
164167174|NCT02836236|592975668|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
164167175|NCT02836236|592975669|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
164167176|NCT02836236|592975670|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
164167177|NCT02836236|592975671|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
164167178|NCT00378508|592975672|FG000|Overall Study|Withdrawal by Subject|1|||
164167179|NCT00378508|592975673|FG001|Overall Study|Withdrawal by Subject|3|||
164167180|NCT00378508|592975672|FG000|Overall Study|Lost to Follow-up|1|||
164167181|NCT00378508|592975673|FG001|Overall Study|Lost to Follow-up|0|||
164167182|NCT01435018|592975674|FG000|Overall Study|Death|37|||
164167183|NCT01435018|592975675|FG001|Overall Study|Death|18|||
164167184|NCT01435018|592975676|FG002|Overall Study|Death|25|||
164167185|NCT01435018|592975674|FG000|Overall Study|Site is closing|4|||
164167186|NCT01435018|592975675|FG001|Overall Study|Site is closing|9|||
164167187|NCT01435018|592975676|FG002|Overall Study|Site is closing|7|||
164167188|NCT01435018|592975674|FG000|Overall Study|Withdrew consent|0|||
164167189|NCT01435018|592975675|FG001|Overall Study|Withdrew consent|3|||
164167190|NCT01435018|592975676|FG002|Overall Study|Withdrew consent|1|||
164167191|NCT01435018|592975674|FG000|Overall Study|Not willing to adhere to requirements|0|||
164167192|NCT01435018|592975675|FG001|Overall Study|Not willing to adhere to requirements|2|||
164167193|NCT01435018|592975676|FG002|Overall Study|Not willing to adhere to requirements|3|||
164167194|NCT01435018|592975674|FG000|Overall Study|Not able to get to clinic|2|||
164167195|NCT01435018|592975675|FG001|Overall Study|Not able to get to clinic|0|||
164167196|NCT01435018|592975676|FG002|Overall Study|Not able to get to clinic|2|||
164167197|NCT01435018|592975674|FG000|Overall Study|Severe debilitation, unable to continue|0|||
164167198|NCT01435018|592975675|FG001|Overall Study|Severe debilitation, unable to continue|0|||
164167199|NCT01435018|592975676|FG002|Overall Study|Severe debilitation, unable to continue|1|||
164167200|NCT01435018|592975674|FG000|Overall Study|Unable to contact participant/parent|1|||
164167201|NCT01435018|592975675|FG001|Overall Study|Unable to contact participant/parent|1|||
164167202|NCT01435018|592975676|FG002|Overall Study|Unable to contact participant/parent|1|||
164167203|NCT01435018|592975674|FG000|Overall Study|Enrollment Violation|0|||
164167204|NCT01435018|592975675|FG001|Overall Study|Enrollment Violation|1|||
164167205|NCT01435018|592975676|FG002|Overall Study|Enrollment Violation|0|||
164167206|NCT01435018|592975674|FG000|Overall Study|Never started chemotherapy|3|||
164167207|NCT01435018|592975675|FG001|Overall Study|Never started chemotherapy|0|||
164167208|NCT01435018|592975676|FG002|Overall Study|Never started chemotherapy|1|||
164167209|NCT00593684|592975677|FG000|Overall Study|Death|2|||
164167210|NCT00593684|592975678|FG001|Overall Study|Death|1|||
164167211|NCT03625466|592975679|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
164167212|NCT03625466|592975680|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
164167213|NCT03625466|592975681|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
164167214|NCT03625466|592975679|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
164167215|NCT03625466|592975680|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
164167216|NCT03625466|592975681|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
164167217|NCT03625466|592975679|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
164167218|NCT03625466|592975680|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
164167219|NCT03625466|592975681|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
164167220|NCT00809471|592975683|FG000|Overall Study|Protocol non-compliance|15|||
164167221|NCT00809471|592975684|FG001|Overall Study|Protocol non-compliance|15|||
164167222|NCT00809471|592975685|FG002|Overall Study|Protocol non-compliance|6|||
164167223|NCT00809471|592975683|FG000|Overall Study|Lost to Follow-up|4|||
164167224|NCT00809471|592975684|FG001|Overall Study|Lost to Follow-up|2|||
164167225|NCT00809471|592975685|FG002|Overall Study|Lost to Follow-up|9|||
164167226|NCT00809471|592975683|FG000|Overall Study|Adverse Event|0|||
164167227|NCT00809471|592975684|FG001|Overall Study|Adverse Event|2|||
164167228|NCT00809471|592975685|FG002|Overall Study|Adverse Event|2|||
164167229|NCT00809471|592975683|FG000|Overall Study|Requirement for restricted medication|1|||
164167230|NCT00809471|592975684|FG001|Overall Study|Requirement for restricted medication|1|||
164167231|NCT00809471|592975685|FG002|Overall Study|Requirement for restricted medication|0|||
164167232|NCT00831311|592975687|FG000|Overall Study|Definitive Contraindication|3|||
164167233|NCT00831311|592975688|FG001|Overall Study|Definitive Contraindication|3|||
164167234|NCT00831311|592975687|FG000|Overall Study|Lost to Follow-up|3|||
164167235|NCT00831311|592975688|FG001|Overall Study|Lost to Follow-up|0|||
164167236|NCT00831311|592975687|FG000|Overall Study|Physician Decision|0|||
164167237|NCT00831311|592975688|FG001|Overall Study|Physician Decision|1|||
164167238|NCT00831311|592975687|FG000|Overall Study|Withdrawal by Subject|6|||
164167239|NCT00831311|592975688|FG001|Overall Study|Withdrawal by Subject|4|||
164167240|NCT01608087|592975690|FG000|Overall Study|Lost to Follow-up|0|||
164167241|NCT01608087|592975691|FG001|Overall Study|Lost to Follow-up|1|||
164167242|NCT01608087|592975692|FG002|Overall Study|Lost to Follow-up|0|||
164167243|NCT01608087|592975690|FG000|Overall Study|Other Reason|0|||
164167244|NCT01608087|592975691|FG001|Overall Study|Other Reason|1|||
164167245|NCT01608087|592975692|FG002|Overall Study|Other Reason|0|||
164167246|NCT04696055|592975701|FG000|Overall Study|Adverse Event|10|||
164167247|NCT04696055|592975702|FG001|Overall Study|Adverse Event|2|||
164167248|NCT04696055|592975701|FG000|Overall Study|Death|4|||
164167249|NCT04696055|592975702|FG001|Overall Study|Death|0|||
164167250|NCT04696055|592975701|FG000|Overall Study|Other|7|||
164167251|NCT04696055|592975702|FG001|Overall Study|Other|2|||
164167252|NCT04696055|592975701|FG000|Overall Study|Physician Decision|3|||
164167253|NCT04696055|592975702|FG001|Overall Study|Physician Decision|0|||
164167254|NCT04696055|592975701|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
164167255|NCT04696055|592975702|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
164167256|NCT04696055|592975701|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
164167257|NCT04696055|592975702|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
164167258|NCT04696055|592975701|FG000|Overall Study|Subject Decision|1|||
164167259|NCT04696055|592975702|FG001|Overall Study|Subject Decision|2|||
164167260|NCT03969901|592975703|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164167261|NCT03969901|592975704|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164167262|NCT03969901|592975705|FG002|Overall Study|Withdrawal by parent/guardian|0|||
164167263|NCT03969901|592975706|FG003|Overall Study|Withdrawal by parent/guardian|0|||
164167264|NCT03969901|592975707|FG004|Overall Study|Withdrawal by parent/guardian|1|||
164167265|NCT03969901|592975708|FG005|Overall Study|Withdrawal by parent/guardian|0|||
164167266|NCT03969901|592975709|FG006|Overall Study|Withdrawal by parent/guardian|0|||
164167267|NCT03969901|592975710|FG007|Overall Study|Withdrawal by parent/guardian|1|||
164167268|NCT03969901|592975711|FG008|Overall Study|Withdrawal by parent/guardian|1|||
164167269|NCT03969901|592975712|FG009|Overall Study|Withdrawal by parent/guardian|0|||
164167270|NCT00348595|592975713|FG000|Overall Study|Adverse Event|5|||
164167271|NCT00348595|592975714|FG001|Overall Study|Adverse Event|8|||
164167272|NCT01920958|592975715|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
164167273|NCT03192306|592975720|FG000|Overall Study|Did not treat cold sore during study|149|||
164167274|NCT03192306|592975721|FG001|Overall Study|Did not treat cold sore during study|143|||
164167275|NCT03192306|592975720|FG000|Overall Study|Withdrawal by Subject|1|||
164167276|NCT03192306|592975721|FG001|Overall Study|Withdrawal by Subject|1|||
164167277|NCT03192306|592975720|FG000|Overall Study|Lost to Follow-up|1|||
164167278|NCT03192306|592975721|FG001|Overall Study|Lost to Follow-up|0|||
164167279|NCT03192306|592975720|FG000|Overall Study|Protocol Violation|1|||
164167280|NCT03192306|592975721|FG001|Overall Study|Protocol Violation|1|||
164167281|NCT02589626|592975726|FG000|Overall Study|Other than the reason specified|1|||
164167282|NCT02589626|592975727|FG001|Overall Study|Other than the reason specified|0|||
164167283|NCT02589626|592975726|FG000|Overall Study|Withdrawal by Subject|1|||
164167284|NCT02589626|592975727|FG001|Overall Study|Withdrawal by Subject|1|||
164167285|NCT02589626|592975726|FG000|Overall Study|Adverse Event|1|||
164167286|NCT02589626|592975727|FG001|Overall Study|Adverse Event|1|||
164167287|NCT00379080|592975728|FG000|Overall Study|Withdrawal by Subject|0|||
164167288|NCT00379080|592975729|FG001|Overall Study|Withdrawal by Subject|4|||
164167289|NCT00379080|592975730|FG002|Overall Study|Withdrawal by Subject|0|||
164167290|NCT02780713|592975731|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
164167291|NCT02780713|592975732|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
164167292|NCT02780713|592975733|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
164167293|NCT02780713|592975734|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
164167294|NCT02780713|592975735|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
164167295|NCT01931475|592975736|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
164167296|NCT01931475|592975737|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
164167297|NCT01931475|592975736|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
164167298|NCT01931475|592975737|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
164167299|NCT01931475|592975736|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
164167300|NCT01931475|592975737|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
164167301|NCT01931475|592975736|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
164167302|NCT01931475|592975737|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
164167303|NCT01931475|592975736|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
164167304|NCT01931475|592975737|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
164167305|NCT01931475|592975736|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
164167306|NCT01931475|592975737|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
164167307|NCT01931475|592975736|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
164167308|NCT01931475|592975737|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
164167309|NCT01931475|592975736|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
164167310|NCT01931475|592975737|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
164167311|NCT01931475|592975736|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
164167312|NCT01931475|592975737|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
164167313|NCT01931475|592975736|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
164167314|NCT01931475|592975737|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
164167315|NCT01931475|592975736|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
164167316|NCT01931475|592975737|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
164167317|NCT01089608|592975740|FG000|Overall Study|Adverse Event|0|||
164167318|NCT01089608|592975741|FG001|Overall Study|Adverse Event|4|||
164167319|NCT01089608|592975740|FG000|Overall Study|Lost to Follow-up|0|||
164167320|NCT01089608|592975741|FG001|Overall Study|Lost to Follow-up|2|||
164167321|NCT01028014|592975745|FG000|Overall Study|Lost to Follow-up|1|||
164167322|NCT01028014|592975746|FG001|Overall Study|Lost to Follow-up|2|||
164167323|NCT01028014|592975747|FG002|Overall Study|Lost to Follow-up|0|||
164167324|NCT01028014|592975748|FG003|Overall Study|Lost to Follow-up|1|||
164167325|NCT01028014|592975749|FG004|Overall Study|Lost to Follow-up|1|||
164167326|NCT01028014|592975750|FG005|Overall Study|Lost to Follow-up|2|||
164167327|NCT01250873|592975751|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
164167328|NCT01250873|592975751|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
164167329|NCT01127451|592975752|FG000|Overall Study|Other|2|||
164167330|NCT01127451|592975753|FG001|Overall Study|Other|1|||
164167331|NCT01127451|592975752|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
164167332|NCT01127451|592975753|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
164167333|NCT01127451|592975752|FG000|Overall Study|Death|22|||
164167334|NCT01127451|592975753|FG001|Overall Study|Death|17|||
164167335|NCT01127451|592975752|FG000|Overall Study|Lost to Follow-up|3|||
164167336|NCT01127451|592975753|FG001|Overall Study|Lost to Follow-up|0|||
164167337|NCT01127451|592975752|FG000|Overall Study|Administrative Reason by Sponsor|2|||
164167338|NCT01127451|592975753|FG001|Overall Study|Administrative Reason by Sponsor|2|||
164167339|NCT00425061|592975754|FG000|Overall Study|Adverse Event|1|||
164167340|NCT00425061|592975755|FG001|Overall Study|Adverse Event|0|||
164167341|NCT00425061|592975756|FG002|Overall Study|Adverse Event|0|||
164167342|NCT00425061|592975757|FG003|Overall Study|Adverse Event|2|||
164167343|NCT00425061|592975758|FG004|Overall Study|Adverse Event|2|||
164167344|NCT00425061|592975759|FG005|Overall Study|Adverse Event|0|||
164167345|NCT00425061|592975760|FG006|Overall Study|Adverse Event|0|||
164167346|NCT00425061|592975754|FG000|Overall Study|Lost to Follow-up|0|||
164167347|NCT00425061|592975755|FG001|Overall Study|Lost to Follow-up|1|||
164167348|NCT00425061|592975756|FG002|Overall Study|Lost to Follow-up|0|||
164167349|NCT00425061|592975757|FG003|Overall Study|Lost to Follow-up|0|||
164167350|NCT00425061|592975758|FG004|Overall Study|Lost to Follow-up|0|||
164167351|NCT00425061|592975759|FG005|Overall Study|Lost to Follow-up|0|||
164167352|NCT00425061|592975760|FG006|Overall Study|Lost to Follow-up|0|||
164167353|NCT00425061|592975754|FG000|Overall Study|Protocol Violation|1|||
164167354|NCT00425061|592975755|FG001|Overall Study|Protocol Violation|0|||
164167355|NCT00425061|592975756|FG002|Overall Study|Protocol Violation|0|||
164167356|NCT00425061|592975757|FG003|Overall Study|Protocol Violation|0|||
164167357|NCT00425061|592975758|FG004|Overall Study|Protocol Violation|0|||
164167358|NCT00425061|592975759|FG005|Overall Study|Protocol Violation|0|||
164167359|NCT00425061|592975760|FG006|Overall Study|Protocol Violation|0|||
164167360|NCT00425061|592975754|FG000|Overall Study|Withdrawal by Subject|0|||
164167361|NCT00425061|592975755|FG001|Overall Study|Withdrawal by Subject|1|||
164167362|NCT00425061|592975756|FG002|Overall Study|Withdrawal by Subject|0|||
164167363|NCT00425061|592975757|FG003|Overall Study|Withdrawal by Subject|0|||
164167364|NCT00425061|592975758|FG004|Overall Study|Withdrawal by Subject|1|||
164167365|NCT00425061|592975759|FG005|Overall Study|Withdrawal by Subject|0|||
164167366|NCT00425061|592975760|FG006|Overall Study|Withdrawal by Subject|3|||
164167367|NCT00425061|592975754|FG000|Overall Study|Sponsor's request|0|||
164167368|NCT00425061|592975755|FG001|Overall Study|Sponsor's request|0|||
164167369|NCT00425061|592975756|FG002|Overall Study|Sponsor's request|0|||
164167370|NCT00425061|592975757|FG003|Overall Study|Sponsor's request|0|||
164167371|NCT00425061|592975758|FG004|Overall Study|Sponsor's request|19|||
164167372|NCT00425061|592975759|FG005|Overall Study|Sponsor's request|4|||
164167373|NCT00425061|592975760|FG006|Overall Study|Sponsor's request|15|||
164167374|NCT00425061|592975754|FG000|Overall Study|Physician Decision|0|||
164167375|NCT00425061|592975755|FG001|Overall Study|Physician Decision|0|||
164167376|NCT00425061|592975756|FG002|Overall Study|Physician Decision|0|||
164167377|NCT00425061|592975757|FG003|Overall Study|Physician Decision|0|||
164167378|NCT00425061|592975758|FG004|Overall Study|Physician Decision|1|||
164167379|NCT00425061|592975759|FG005|Overall Study|Physician Decision|0|||
164167380|NCT00425061|592975760|FG006|Overall Study|Physician Decision|0|||
164167381|NCT00425061|592975754|FG000|Overall Study|Other|0|||
164167382|NCT00425061|592975755|FG001|Overall Study|Other|0|||
164167383|NCT00425061|592975756|FG002|Overall Study|Other|0|||
164167384|NCT00425061|592975757|FG003|Overall Study|Other|0|||
164167385|NCT00425061|592975758|FG004|Overall Study|Other|3|||
164167386|NCT00425061|592975759|FG005|Overall Study|Other|0|||
164167387|NCT00425061|592975760|FG006|Overall Study|Other|1|||
164167388|NCT02111577|592975761|FG000|Overall Study|Protocol Violation|2|||
164167389|NCT02111577|592975762|FG001|Overall Study|Protocol Violation|0|||
164167468|NCT01031680|592975790|FG001|Overall Study|Incorrect Enrolment|2|||
164167390|NCT02111577|592975761|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
164167391|NCT02111577|592975762|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
164167392|NCT02111577|592975761|FG000|Overall Study|Failure to produce study treatment|6|||
164167393|NCT02111577|592975762|FG001|Overall Study|Failure to produce study treatment|0|||
164167394|NCT02111577|592975761|FG000|Overall Study|Death|518|||
164167395|NCT02111577|592975762|FG001|Overall Study|Death|254|||
164167396|NCT02111577|592975761|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
164167397|NCT02111577|592975762|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
164167398|NCT02111577|592975761|FG000|Overall Study|Adverse Event|1|||
164167399|NCT02111577|592975762|FG001|Overall Study|Adverse Event|1|||
164167400|NCT02111577|592975761|FG000|Overall Study|Withdrawal by Subject|51|||
164167401|NCT02111577|592975762|FG001|Overall Study|Withdrawal by Subject|23|||
164167402|NCT02111577|592975761|FG000|Overall Study|Disease progression|0|||
164167403|NCT02111577|592975762|FG001|Overall Study|Disease progression|1|||
164167404|NCT02111577|592975761|FG000|Overall Study|Lost to Follow-up|19|||
164167405|NCT02111577|592975762|FG001|Overall Study|Lost to Follow-up|10|||
164167406|NCT02429778|592975764|FG000|Overall Study|Lost to Follow-up|2|||
164167407|NCT02429778|592975765|FG001|Overall Study|Lost to Follow-up|0|||
164167408|NCT02429778|592975764|FG000|Overall Study|Withdrawal by Subject|5|||
164167409|NCT02429778|592975765|FG001|Overall Study|Withdrawal by Subject|0|||
164167410|NCT03557931|592975771|FG000|Overall Study|Adverse Event|4|||
164167411|NCT03557931|592975772|FG001|Overall Study|Adverse Event|6|||
164167412|NCT03557931|592975773|FG002|Overall Study|Adverse Event|1|||
164167413|NCT03557931|592975771|FG000|Overall Study|Lost to Follow-up|4|||
164167414|NCT03557931|592975772|FG001|Overall Study|Lost to Follow-up|4|||
164167415|NCT03557931|592975773|FG002|Overall Study|Lost to Follow-up|1|||
164167416|NCT03557931|592975771|FG000|Overall Study|Protocol Violation|1|||
164167417|NCT03557931|592975772|FG001|Overall Study|Protocol Violation|4|||
164167418|NCT03557931|592975773|FG002|Overall Study|Protocol Violation|1|||
164167419|NCT03557931|592975771|FG000|Overall Study|Withdrawal by Subject|14|||
164167420|NCT03557931|592975772|FG001|Overall Study|Withdrawal by Subject|0|||
164167421|NCT03557931|592975773|FG002|Overall Study|Withdrawal by Subject|7|||
164167422|NCT03557931|592975771|FG000|Overall Study|Miscellaneous|8|||
164167423|NCT03557931|592975772|FG001|Overall Study|Miscellaneous|5|||
164167424|NCT03557931|592975773|FG002|Overall Study|Miscellaneous|3|||
164167425|NCT02394340|592975774|FG000|Overall Study|Failed drug screen test|1|||
164167426|NCT02394340|592975774|FG000|Overall Study|Adverse Event|1|||
164167427|NCT00634803|592975775|FG000|Overall Study|Lost to Follow-up|6|||
164167428|NCT00634803|592975776|FG001|Overall Study|Lost to Follow-up|7|||
164167429|NCT00634803|592975777|FG002|Overall Study|Lost to Follow-up|7|||
164167430|NCT00886743|592975779|FG000|Overall Study|Adverse Event|3|||
164167431|NCT00886743|592975779|FG000|Overall Study|Other|1|||
164167432|NCT00478777|592975780|FG000|Overall Study|Adverse Event|29|||
164167433|NCT00478777|592975780|FG000|Overall Study|Lack of Efficacy|23|||
164167434|NCT00478777|592975780|FG000|Overall Study|Withdrawal by Subject|4|||
164167435|NCT00478777|592975780|FG000|Overall Study|Death|3|||
164167436|NCT00478777|592975780|FG000|Overall Study|Protocol Violation|3|||
164167437|NCT00478777|592975780|FG000|Overall Study|Lost to Follow-up|3|||
164167438|NCT00478777|592975780|FG000|Overall Study|Physician Decision|1|||
164167439|NCT00478777|592975780|FG000|Overall Study|Intolerance of therapy|1|||
164167440|NCT00478777|592975780|FG000|Overall Study|Lack of compliance|1|||
164167441|NCT00478777|592975780|FG000|Overall Study|Lymphocytes infusion|1|||
164167442|NCT00478777|592975780|FG000|Overall Study|End of therapy|2|||
164167443|NCT00478777|592975780|FG000|Overall Study|Not treated with lenalidomide|6|||
164167444|NCT01323387|592975783|FG000|Overall Study|Withdrawal by Subject|41|||
164167445|NCT01323387|592975783|FG000|Overall Study|Radiographic Data Unavailable|1|||
164167446|NCT01323387|592975783|FG000|Overall Study|Revision|14|||
164167447|NCT01323387|592975783|FG000|Overall Study|Protocol Violation|12|||
164167448|NCT01323387|592975783|FG000|Overall Study|Randomized but Never Treated|16|||
164167449|NCT04200651|592975786|FG000|Overall Study|Moved to another country during follow-up|2|||
164167450|NCT04200651|592975787|FG001|Overall Study|Moved to another country during follow-up|2|||
164167451|NCT04200651|592975786|FG000|Overall Study|Lost to Follow-up|1|||
164167452|NCT04200651|592975787|FG001|Overall Study|Lost to Follow-up|3|||
164167453|NCT01031680|592975789|FG000|Overall Study|Adverse Event|8|||
164167454|NCT01031680|592975790|FG001|Overall Study|Adverse Event|3|||
164167455|NCT01031680|592975789|FG000|Overall Study|Lost to Follow-up|2|||
164167456|NCT01031680|592975790|FG001|Overall Study|Lost to Follow-up|10|||
164167457|NCT01031680|592975789|FG000|Overall Study|Withdrawal by Subject|12|||
164167458|NCT01031680|592975790|FG001|Overall Study|Withdrawal by Subject|16|||
164167459|NCT01031680|592975789|FG000|Overall Study|Death|2|||
164167460|NCT01031680|592975790|FG001|Overall Study|Death|1|||
164167461|NCT01031680|592975789|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
164167462|NCT01031680|592975790|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
164167463|NCT01031680|592975789|FG000|Overall Study|Poor/Non-compliance|5|||
164167464|NCT01031680|592975790|FG001|Overall Study|Poor/Non-compliance|6|||
164167465|NCT01031680|592975789|FG000|Overall Study|Safety|1|||
164167466|NCT01031680|592975790|FG001|Overall Study|Safety|0|||
164167467|NCT01031680|592975789|FG000|Overall Study|Incorrect Enrolment|1|||
164167469|NCT01031680|592975789|FG000|Overall Study|Administrative Reason by Sponsor|0|||
164167470|NCT01031680|592975790|FG001|Overall Study|Administrative Reason by Sponsor|1|||
164167471|NCT01031680|592975789|FG000|Overall Study|Various|0|||
164167472|NCT01031680|592975790|FG001|Overall Study|Various|2|||
164167473|NCT00757042|592975794|FG000|Overall Study|Lost to Follow-up|0|||
164167474|NCT00757042|592975795|FG001|Overall Study|Lost to Follow-up|0|||
164167475|NCT00757042|592975796|FG002|Overall Study|Lost to Follow-up|0|||
164167476|NCT00757042|592975797|FG003|Overall Study|Lost to Follow-up|0|||
164167477|NCT00757042|592975798|FG004|Overall Study|Lost to Follow-up|0|||
164167478|NCT00757042|592975799|FG005|Overall Study|Lost to Follow-up|0|||
164167479|NCT00757042|592975800|FG006|Overall Study|Lost to Follow-up|0|||
164167480|NCT00757042|592975801|FG007|Overall Study|Lost to Follow-up|0|||
164167481|NCT00757042|592975802|FG008|Overall Study|Lost to Follow-up|1|||
164167482|NCT00757042|592975803|FG009|Overall Study|Lost to Follow-up|0|||
164167483|NCT00757042|592975804|FG010|Overall Study|Lost to Follow-up|0|||
164167484|NCT00757042|592975794|FG000|Overall Study|Ineligibility Determined|0|||
164167485|NCT00757042|592975795|FG001|Overall Study|Ineligibility Determined|0|||
164167486|NCT00757042|592975796|FG002|Overall Study|Ineligibility Determined|0|||
164167487|NCT00757042|592975797|FG003|Overall Study|Ineligibility Determined|0|||
164167488|NCT00757042|592975798|FG004|Overall Study|Ineligibility Determined|0|||
164167489|NCT00757042|592975799|FG005|Overall Study|Ineligibility Determined|0|||
164167490|NCT00757042|592975800|FG006|Overall Study|Ineligibility Determined|0|||
164167491|NCT00757042|592975801|FG007|Overall Study|Ineligibility Determined|0|||
164167492|NCT00757042|592975802|FG008|Overall Study|Ineligibility Determined|0|||
164167493|NCT00757042|592975803|FG009|Overall Study|Ineligibility Determined|0|||
164167494|NCT00757042|592975804|FG010|Overall Study|Ineligibility Determined|1|||
164167495|NCT00757042|592975794|FG000|Overall Study|Withdrawal by Subject|0|||
164167496|NCT00757042|592975795|FG001|Overall Study|Withdrawal by Subject|0|||
164167497|NCT00757042|592975796|FG002|Overall Study|Withdrawal by Subject|0|||
164167498|NCT00757042|592975797|FG003|Overall Study|Withdrawal by Subject|0|||
164167499|NCT00757042|592975798|FG004|Overall Study|Withdrawal by Subject|0|||
164167500|NCT00757042|592975799|FG005|Overall Study|Withdrawal by Subject|0|||
164167501|NCT00757042|592975800|FG006|Overall Study|Withdrawal by Subject|0|||
164167502|NCT00757042|592975801|FG007|Overall Study|Withdrawal by Subject|0|||
164167503|NCT00757042|592975802|FG008|Overall Study|Withdrawal by Subject|0|||
164167504|NCT00757042|592975803|FG009|Overall Study|Withdrawal by Subject|1|||
164167505|NCT00757042|592975804|FG010|Overall Study|Withdrawal by Subject|0|||
164167506|NCT03319732|592975805|FG000|Overall Study|Adverse Event|40|||
164167507|NCT03319732|592975805|FG000|Overall Study|Withdrawal by Subject|50|||
164167508|NCT03319732|592975805|FG000|Overall Study|MS relapse|10|||
164167509|NCT03319732|592975805|FG000|Overall Study|reason not specified|5|||
164167510|NCT02654977|592975807|FG000|Overall Study|Death|1|||
164167511|NCT02654977|592975807|FG000|Overall Study|Lost to Follow-up|1|||
164167512|NCT02654977|592975807|FG000|Overall Study|Adverse Event|1|||
164167513|NCT02654977|592975807|FG000|Overall Study|Withdrawal by Subject|1|||
164167514|NCT02654977|592975807|FG000|Overall Study|Lack of Efficacy|3|||
164167515|NCT01266291|592975808|FG000|Overall Study|Adverse Event|1|||
164167516|NCT00596817|592975811|FG000|Open-label Period|Adverse Event|0|||
164167517|NCT00596817|592975812|FG001|Open-label Period|Adverse Event|49|||
164167518|NCT00596817|592975811|FG000|Open-label Period|Lack of Efficacy|0|||
164167519|NCT00596817|592975812|FG001|Open-label Period|Lack of Efficacy|33|||
164167520|NCT00596817|592975811|FG000|Open-label Period|Other Reasons|0|||
164167521|NCT00596817|592975812|FG001|Open-label Period|Other Reasons|65|||
164167522|NCT00596817|592975811|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
164167523|NCT00596817|592975812|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
164167524|NCT00596817|592975811|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
164167525|NCT00596817|592975812|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
164167526|NCT00596817|592975811|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
164167527|NCT00596817|592975812|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
164167528|NCT00596817|592975811|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
164167529|NCT00596817|592975812|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
164167530|NCT00596817|592975811|FG000|Double-blind Period|Adverse Event|5|||
164167531|NCT00596817|592975812|FG001|Double-blind Period|Adverse Event|16|||
164167532|NCT00596817|592975811|FG000|Double-blind Period|Lack of Efficacy|52|||
164167533|NCT00596817|592975812|FG001|Double-blind Period|Lack of Efficacy|28|||
164167534|NCT00596817|592975811|FG000|Double-blind Period|Non-compliance With Study Product|3|||
164167535|NCT00596817|592975812|FG001|Double-blind Period|Non-compliance With Study Product|4|||
164167536|NCT00596817|592975811|FG000|Double-blind Period|Protocol Violation|11|||
164167537|NCT00596817|592975812|FG001|Double-blind Period|Protocol Violation|8|||
164167538|NCT00596817|592975811|FG000|Double-blind Period|Withdrawal of Consent|7|||
164167539|NCT00596817|592975812|FG001|Double-blind Period|Withdrawal of Consent|3|||
164167540|NCT00596817|592975811|FG000|Double-blind Period|Lost to Follow-up|0|||
164167541|NCT00596817|592975812|FG001|Double-blind Period|Lost to Follow-up|2|||
164167542|NCT00596817|592975811|FG000|Double-blind Period|Other Reasons|10|||
164167543|NCT00596817|592975812|FG001|Double-blind Period|Other Reasons|18|||
164167544|NCT00519428|592978088|FG000|Overall Study|Adverse Event|5|||
164167545|NCT00519428|592978089|FG001|Overall Study|Adverse Event|2|||
164167546|NCT00519428|592978090|FG002|Overall Study|Adverse Event|10|||
164167547|NCT00519428|592978088|FG000|Overall Study|Lost to Follow-up|7|||
164167548|NCT00519428|592978089|FG001|Overall Study|Lost to Follow-up|7|||
164167549|NCT00519428|592978090|FG002|Overall Study|Lost to Follow-up|6|||
164167550|NCT00519428|592978088|FG000|Overall Study|Withdrawal by Subject|8|||
164167551|NCT00519428|592978089|FG001|Overall Study|Withdrawal by Subject|3|||
164167552|NCT00519428|592978090|FG002|Overall Study|Withdrawal by Subject|7|||
164167553|NCT00519428|592978088|FG000|Overall Study|unstated|1|||
164167554|NCT00519428|592978089|FG001|Overall Study|unstated|3|||
164167555|NCT00519428|592978090|FG002|Overall Study|unstated|2|||
164167556|NCT00688701|592978092|FG000|Overall Study|Adverse Event|1|||
164167557|NCT00688701|592978093|FG001|Overall Study|Adverse Event|0|||
164167558|NCT00688701|592978094|FG002|Overall Study|Adverse Event|5|||
164167559|NCT00688701|592978095|FG003|Overall Study|Adverse Event|3|||
164167560|NCT00688701|592978092|FG000|Overall Study|Lack of Efficacy|0|||
164167561|NCT00688701|592978093|FG001|Overall Study|Lack of Efficacy|1|||
164167562|NCT00688701|592978094|FG002|Overall Study|Lack of Efficacy|0|||
164167563|NCT00688701|592978095|FG003|Overall Study|Lack of Efficacy|0|||
164167564|NCT00688701|592978092|FG000|Overall Study|Withdrawal by Subject|3|||
164167565|NCT00688701|592978093|FG001|Overall Study|Withdrawal by Subject|3|||
164167566|NCT00688701|592978094|FG002|Overall Study|Withdrawal by Subject|4|||
164167567|NCT00688701|592978095|FG003|Overall Study|Withdrawal by Subject|8|||
164167568|NCT00688701|592978092|FG000|Overall Study|Poor compliance to protocol|0|||
164167569|NCT00688701|592978093|FG001|Overall Study|Poor compliance to protocol|1|||
164167570|NCT00688701|592978094|FG002|Overall Study|Poor compliance to protocol|1|||
164167571|NCT00688701|592978095|FG003|Overall Study|Poor compliance to protocol|0|||
164167572|NCT03962790|592978100|FG000|Period 1|Adverse Event|0|||
164167573|NCT03962790|592978101|FG001|Period 1|Adverse Event|1|||
164167574|NCT03962790|592978100|FG000|Period 1|Failed to meet all eligibility criteria|1|||
164167575|NCT03962790|592978101|FG001|Period 1|Failed to meet all eligibility criteria|1|||
164167576|NCT03962790|592978100|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
164167577|NCT03962790|592978101|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
164167578|NCT03962790|592978100|FG000|Period 1|Withdrawal by Subject|1|||
164167579|NCT03962790|592978101|FG001|Period 1|Withdrawal by Subject|0|||
164167580|NCT00664859|592978117|FG000|Overall Study|Adverse Event|2|||
164167581|NCT00664859|592978118|FG001|Overall Study|Adverse Event|1|||
164167582|NCT00664859|592978119|FG002|Overall Study|Adverse Event|3|||
164167583|NCT00664859|592978117|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
164167584|NCT00664859|592978118|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
164167585|NCT00664859|592978119|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
164167586|NCT00664859|592978117|FG000|Overall Study|Noncompliance with protocol|1|||
164167587|NCT00664859|592978118|FG001|Overall Study|Noncompliance with protocol|0|||
164167588|NCT00664859|592978119|FG002|Overall Study|Noncompliance with protocol|4|||
164167589|NCT00664859|592978117|FG000|Overall Study|Laboratory abnormality|2|||
164167590|NCT00664859|592978118|FG001|Overall Study|Laboratory abnormality|1|||
164167591|NCT00664859|592978119|FG002|Overall Study|Laboratory abnormality|4|||
164167592|NCT00664859|592978117|FG000|Overall Study|Withdrawal by Subject|4|||
164167593|NCT00664859|592978118|FG001|Overall Study|Withdrawal by Subject|1|||
164167594|NCT00664859|592978119|FG002|Overall Study|Withdrawal by Subject|3|||
164167595|NCT00664859|592978117|FG000|Overall Study|Lost to Follow-up|2|||
164167596|NCT00664859|592978118|FG001|Overall Study|Lost to Follow-up|2|||
164167597|NCT00664859|592978119|FG002|Overall Study|Lost to Follow-up|1|||
164167598|NCT00664859|592978117|FG000|Overall Study|Other|0|||
164167599|NCT00664859|592978118|FG001|Overall Study|Other|1|||
164167600|NCT00664859|592978119|FG002|Overall Study|Other|2|||
164167601|NCT01943851|592978120|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167602|NCT01943851|592978121|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167603|NCT01943851|592978122|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167604|NCT01943851|592978123|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
164167605|NCT01943851|592978124|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167606|NCT01943851|592978125|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167607|NCT01943851|592978126|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
164167608|NCT01943851|592978127|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
164167609|NCT01943851|592978128|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
164167610|NCT01943851|592978129|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167611|NCT01943851|592978130|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167612|NCT01943851|592978131|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167613|NCT01943851|592978132|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167614|NCT01943851|592978133|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167615|NCT01943851|592978134|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167616|NCT01943851|592978135|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167617|NCT01943851|592978136|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167618|NCT01943851|592978137|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167619|NCT01943851|592978120|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167620|NCT01943851|592978121|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167621|NCT01943851|592978122|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167622|NCT01943851|592978123|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167623|NCT01943851|592978124|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
164167624|NCT01943851|592978125|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167625|NCT01943851|592978126|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167626|NCT01943851|592978127|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
164167627|NCT01943851|592978128|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167628|NCT01943851|592978129|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167629|NCT01943851|592978130|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167630|NCT01943851|592978131|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167631|NCT01943851|592978132|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167632|NCT01943851|592978133|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167633|NCT01943851|592978134|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167634|NCT01943851|592978135|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167635|NCT01943851|592978136|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167636|NCT01943851|592978137|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167637|NCT01943851|592978120|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167638|NCT01943851|592978121|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167639|NCT01943851|592978122|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167640|NCT01943851|592978123|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167641|NCT01943851|592978124|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167642|NCT01943851|592978125|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167643|NCT01943851|592978126|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167644|NCT01943851|592978127|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167645|NCT01943851|592978128|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167646|NCT01943851|592978129|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167647|NCT01943851|592978130|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167648|NCT01943851|592978131|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167649|NCT01943851|592978132|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167650|NCT01943851|592978133|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
164167651|NCT01943851|592978134|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167652|NCT01943851|592978135|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167653|NCT01943851|592978136|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167654|NCT01943851|592978137|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167655|NCT01943851|592978120|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167656|NCT01943851|592978121|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167657|NCT01943851|592978122|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167658|NCT01943851|592978123|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167659|NCT01943851|592978124|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167660|NCT01943851|592978125|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167661|NCT01943851|592978126|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167662|NCT01943851|592978127|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167663|NCT01943851|592978128|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167664|NCT01943851|592978129|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167665|NCT01943851|592978130|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167666|NCT01943851|592978131|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167667|NCT01943851|592978132|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167668|NCT01943851|592978133|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167669|NCT01943851|592978134|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167670|NCT01943851|592978135|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
164167671|NCT01943851|592978136|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167672|NCT01943851|592978137|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167673|NCT01943851|592978120|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167674|NCT01943851|592978121|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167675|NCT01943851|592978122|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167676|NCT01943851|592978123|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167677|NCT01943851|592978124|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167678|NCT01943851|592978125|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167679|NCT01943851|592978126|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167680|NCT01943851|592978127|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167681|NCT01943851|592978128|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167682|NCT01943851|592978129|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167683|NCT01943851|592978130|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167684|NCT01943851|592978131|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167685|NCT01943851|592978132|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167686|NCT01943851|592978133|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167687|NCT01943851|592978134|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167688|NCT01943851|592978135|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
164167689|NCT01943851|592978136|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
164167690|NCT01943851|592978137|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
164167691|NCT00401544|592978139|FG000|Overall Study|Adverse Event|5|||
164167692|NCT00401544|592978140|FG001|Overall Study|Adverse Event|1|||
164167693|NCT00401544|592978141|FG002|Overall Study|Adverse Event|1|||
164167694|NCT00401544|592978142|FG003|Overall Study|Adverse Event|1|||
164167695|NCT00401544|592978139|FG000|Overall Study|Death|3|||
164167696|NCT00401544|592978140|FG001|Overall Study|Death|6|||
164167697|NCT00401544|592978141|FG002|Overall Study|Death|2|||
164167698|NCT00401544|592978142|FG003|Overall Study|Death|5|||
164167699|NCT00401544|592978139|FG000|Overall Study|Lost to Follow-up|2|||
164167700|NCT00401544|592978140|FG001|Overall Study|Lost to Follow-up|0|||
164167701|NCT00401544|592978141|FG002|Overall Study|Lost to Follow-up|1|||
164167702|NCT00401544|592978142|FG003|Overall Study|Lost to Follow-up|1|||
164167703|NCT00401544|592978139|FG000|Overall Study|Withdrawal by Subject|7|||
164167704|NCT00401544|592978140|FG001|Overall Study|Withdrawal by Subject|6|||
164167705|NCT00401544|592978141|FG002|Overall Study|Withdrawal by Subject|6|||
164167706|NCT00401544|592978142|FG003|Overall Study|Withdrawal by Subject|5|||
164167707|NCT00401544|592978139|FG000|Overall Study|Physician Decision|1|||
164167708|NCT00401544|592978140|FG001|Overall Study|Physician Decision|3|||
164167709|NCT00401544|592978141|FG002|Overall Study|Physician Decision|0|||
164167710|NCT00401544|592978142|FG003|Overall Study|Physician Decision|0|||
164167711|NCT00401544|592978139|FG000|Overall Study|Ineligibility determined|0|||
164167712|NCT00401544|592978140|FG001|Overall Study|Ineligibility determined|1|||
164167713|NCT00401544|592978141|FG002|Overall Study|Ineligibility determined|0|||
164167714|NCT00401544|592978142|FG003|Overall Study|Ineligibility determined|2|||
164167715|NCT00401544|592978139|FG000|Overall Study|Disease progression|0|||
164167716|NCT00401544|592978140|FG001|Overall Study|Disease progression|1|||
164167717|NCT00401544|592978141|FG002|Overall Study|Disease progression|0|||
164167718|NCT00401544|592978142|FG003|Overall Study|Disease progression|0|||
164167719|NCT00401544|592978139|FG000|Overall Study|Other|0|||
164167720|NCT00401544|592978140|FG001|Overall Study|Other|0|||
164167721|NCT00401544|592978141|FG002|Overall Study|Other|2|||
164167722|NCT00401544|592978142|FG003|Overall Study|Other|2|||
164167723|NCT03645395|592978143|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
164167724|NCT03645395|592978144|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
164167725|NCT03645395|592978145|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
164167726|NCT03645395|592978146|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
164167727|NCT03645395|592978143|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
164167728|NCT03645395|592978144|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
164167729|NCT03645395|592978145|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
164167730|NCT03645395|592978146|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
164167731|NCT03645395|592978143|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
164167732|NCT03645395|592978144|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
164167733|NCT03645395|592978145|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
164167734|NCT03645395|592978146|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
164167735|NCT03645395|592978143|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
164167736|NCT03645395|592978144|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
164167737|NCT03645395|592978145|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
164167738|NCT03645395|592978146|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
164167739|NCT01289639|592978148|FG000|Overall Study|Lost to Follow-up|1|||
164167740|NCT01289639|592978149|FG001|Overall Study|Lost to Follow-up|0|||
164167741|NCT01289639|592978150|FG002|Overall Study|Lost to Follow-up|0|||
164167742|NCT02278939|592978153|FG000|Overall Study|lack of time|1|||
164167743|NCT02278939|592978154|FG001|Overall Study|lack of time|0|||
164167744|NCT02278939|592978153|FG000|Overall Study|Lost to Follow-up|1|||
164167745|NCT02278939|592978154|FG001|Overall Study|Lost to Follow-up|1|||
164167746|NCT02278939|592978153|FG000|Overall Study|death in family|1|||
164167747|NCT02278939|592978154|FG001|Overall Study|death in family|0|||
164167748|NCT02278939|592978153|FG000|Overall Study|family emergency unable to commit|2|||
164167749|NCT02278939|592978154|FG001|Overall Study|family emergency unable to commit|0|||
164167750|NCT02423343|592978160|FG000|Overall Study|Withdrawal by Subject|0|||
164167751|NCT02423343|592978161|FG001|Overall Study|Withdrawal by Subject|1|||
164167752|NCT02423343|592978162|FG002|Overall Study|Withdrawal by Subject|0|||
164167753|NCT02423343|592978163|FG003|Overall Study|Withdrawal by Subject|0|||
164167754|NCT02423343|592978164|FG004|Overall Study|Withdrawal by Subject|0|||
164167755|NCT02423343|592978165|FG005|Overall Study|Withdrawal by Subject|0|||
164167756|NCT02423343|592978160|FG000|Overall Study|Progressive Disease|0|||
164167757|NCT02423343|592978161|FG001|Overall Study|Progressive Disease|0|||
164167758|NCT02423343|592978162|FG002|Overall Study|Progressive Disease|0|||
164167759|NCT02423343|592978163|FG003|Overall Study|Progressive Disease|0|||
164167760|NCT02423343|592978164|FG004|Overall Study|Progressive Disease|2|||
164167761|NCT02423343|592978165|FG005|Overall Study|Progressive Disease|0|||
164167762|NCT02423343|592978160|FG000|Overall Study|Adverse Event|0|||
164167763|NCT02423343|592978161|FG001|Overall Study|Adverse Event|0|||
164167764|NCT02423343|592978162|FG002|Overall Study|Adverse Event|0|||
164167765|NCT02423343|592978163|FG003|Overall Study|Adverse Event|0|||
164167766|NCT02423343|592978164|FG004|Overall Study|Adverse Event|2|||
164167767|NCT02423343|592978165|FG005|Overall Study|Adverse Event|0|||
164167768|NCT02423343|592978160|FG000|Overall Study|Death|0|||
164167769|NCT02423343|592978161|FG001|Overall Study|Death|0|||
164167770|NCT02423343|592978162|FG002|Overall Study|Death|0|||
164167771|NCT02423343|592978163|FG003|Overall Study|Death|0|||
164167772|NCT02423343|592978164|FG004|Overall Study|Death|1|||
164167773|NCT02423343|592978165|FG005|Overall Study|Death|0|||
164167774|NCT04429555|592978170|FG000|Overall Study|Death|0|||
164167775|NCT04429555|592978171|FG001|Overall Study|Death|2|||
164167776|NCT04429555|592978170|FG000|Overall Study|Other|2|||
164167777|NCT04429555|592978171|FG001|Overall Study|Other|0|||
164167778|NCT00930774|592978172|FG000|Overall Study|Withdrawal by Subject|1|||
164167779|NCT00930774|592978173|FG001|Overall Study|Withdrawal by Subject|9|||
164167780|NCT00930774|592978174|FG002|Overall Study|Withdrawal by Subject|2|||
164167781|NCT00930774|592978175|FG003|Overall Study|Withdrawal by Subject|0|||
164167782|NCT00712881|592978176|FG000|Overall Study|Adverse Event|3|||
164167783|NCT00712881|592978177|FG001|Overall Study|Adverse Event|3|||
164167784|NCT00712881|592978176|FG000|Overall Study|Withdrawal by Subject|1|||
164167785|NCT00712881|592978177|FG001|Overall Study|Withdrawal by Subject|1|||
164167786|NCT00712881|592978176|FG000|Overall Study|Disease Progression|2|||
164167787|NCT00712881|592978177|FG001|Overall Study|Disease Progression|1|||
164167788|NCT00712881|592978176|FG000|Overall Study|Lost to Follow-up|1|||
164167789|NCT00712881|592978177|FG001|Overall Study|Lost to Follow-up|1|||
164167790|NCT00712881|592978176|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
164167791|NCT00712881|592978177|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
164167792|NCT00712881|592978176|FG000|Overall Study|Protocol Violation|1|||
164167793|NCT00712881|592978177|FG001|Overall Study|Protocol Violation|1|||
164167794|NCT00712881|592978176|FG000|Overall Study|Randomized but not treated|1|||
164167795|NCT00712881|592978177|FG001|Overall Study|Randomized but not treated|0|||
164167796|NCT03200704|592978178|FG000|Overall Study|Withdrawal by Subject|1|||
164167797|NCT01680861|592978179|FG000|Early Post-transplant Period|Protocol Violation|1|||
164167798|NCT01680861|592978180|FG001|Early Post-transplant Period|Protocol Violation|1|||
164167799|NCT04590586|592978188|FG000|Overall Study|Death|7|||
164167800|NCT04590586|592978189|FG001|Overall Study|Death|1|||
164167801|NCT04590586|592978190|FG002|Overall Study|Death|37|||
164167802|NCT04590586|592978191|FG003|Overall Study|Death|34|||
164167803|NCT04590586|592978192|FG004|Overall Study|Death|19|||
164167804|NCT04590586|592978193|FG005|Overall Study|Death|3|||
164167805|NCT04590586|592978188|FG000|Overall Study|Lost to Follow-up|3|||
164167806|NCT04590586|592978189|FG001|Overall Study|Lost to Follow-up|0|||
164167807|NCT04590586|592978190|FG002|Overall Study|Lost to Follow-up|11|||
164167808|NCT04590586|592978191|FG003|Overall Study|Lost to Follow-up|11|||
164167809|NCT04590586|592978192|FG004|Overall Study|Lost to Follow-up|6|||
164167810|NCT04590586|592978193|FG005|Overall Study|Lost to Follow-up|0|||
164167811|NCT04590586|592978188|FG000|Overall Study|Withdrawal by Subject|0|||
164167812|NCT04590586|592978189|FG001|Overall Study|Withdrawal by Subject|0|||
164167813|NCT04590586|592978190|FG002|Overall Study|Withdrawal by Subject|6|||
164167814|NCT04590586|592978191|FG003|Overall Study|Withdrawal by Subject|0|||
164167815|NCT04590586|592978192|FG004|Overall Study|Withdrawal by Subject|3|||
164167816|NCT04590586|592978193|FG005|Overall Study|Withdrawal by Subject|0|||
164167817|NCT04590586|592978188|FG000|Overall Study|Other|3|||
164167818|NCT04590586|592978189|FG001|Overall Study|Other|0|||
164167819|NCT04590586|592978190|FG002|Overall Study|Other|1|||
164167820|NCT04590586|592978191|FG003|Overall Study|Other|1|||
164167821|NCT04590586|592978192|FG004|Overall Study|Other|2|||
164167822|NCT04590586|592978193|FG005|Overall Study|Other|1|||
164167823|NCT01609543|592978194|FG000|Overall Study|Disease Progression|28|||
164167824|NCT01609543|592978194|FG000|Overall Study|Adverse Event|5|||
164167825|NCT01609543|592978194|FG000|Overall Study|Withdrawal by Subject|1|||
164167826|NCT01609543|592978194|FG000|Overall Study|Protocol Violation|1|||
164167827|NCT01609543|592978194|FG000|Overall Study|Death|7|||
164167828|NCT01893281|592978195|FG000|Overall Study|Adverse Event|1|||
164167829|NCT01893281|592978195|FG000|Overall Study|Protocol Violation|1|||
164167830|NCT01893281|592978195|FG000|Overall Study|Withdrawal by Subject|1|||
164167831|NCT01254318|592978196|FG000|Overall Study|Lost to Follow-up|5|||
164167832|NCT01254318|592978196|FG000|Overall Study|Death|47|||
164167833|NCT01137110|592978206|FG000|Overall Study|Protocol Violation|1|||
164167834|NCT01137110|592978207|FG001|Overall Study|Protocol Violation|0|||
164167835|NCT02828124|592978212|FG000|Overall Study|Disease Progression|1|||
164167836|NCT02828124|592978213|FG001|Overall Study|Disease Progression|2|||
164167837|NCT02828124|592978214|FG002|Overall Study|Disease Progression|1|||
164167838|NCT02828124|592978215|FG003|Overall Study|Disease Progression|4|||
164167839|NCT02828124|592978212|FG000|Overall Study|AE Unrelated to Study Drug|0|||
164167840|NCT02828124|592978213|FG001|Overall Study|AE Unrelated to Study Drug|0|||
164167841|NCT02828124|592978214|FG002|Overall Study|AE Unrelated to Study Drug|0|||
164167842|NCT02828124|592978215|FG003|Overall Study|AE Unrelated to Study Drug|1|||
164167843|NCT02828124|592978212|FG000|Overall Study|Subject Withdrew Consent|0|||
164167844|NCT02828124|592978213|FG001|Overall Study|Subject Withdrew Consent|0|||
164167845|NCT02828124|592978214|FG002|Overall Study|Subject Withdrew Consent|0|||
164167846|NCT02828124|592978215|FG003|Overall Study|Subject Withdrew Consent|1|||
164167847|NCT03990571|592978216|FG000|Overall Study|Withdrawal by Subject|1|||
164167848|NCT03990571|592978216|FG000|Overall Study|Insurance Issues|3|||
164167849|NCT03990571|592978216|FG000|Overall Study|Covid Restrictions|2|||
164167850|NCT03605862|592978217|FG000|Overall Study|Withdrawal by Subject|12|||
164167851|NCT03605862|592978218|FG001|Overall Study|Withdrawal by Subject|9|||
164167852|NCT03605862|592978217|FG000|Overall Study|Adverse Event|2|||
164167853|NCT03605862|592978218|FG001|Overall Study|Adverse Event|1|||
164167854|NCT03605862|592978217|FG000|Overall Study|Physician Decision|3|||
164167855|NCT03605862|592978218|FG001|Overall Study|Physician Decision|1|||
164167856|NCT03605862|592978217|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
164167857|NCT03605862|592978218|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
164167858|NCT00675428|592978221|FG000|Overall Study|Disease Progression|2|||
164167859|NCT00675428|592978222|FG001|Overall Study|Disease Progression|2|||
164167860|NCT00675428|592978221|FG000|Overall Study|No Disease Response After Cycle 6|0|||
164167861|NCT00675428|592978222|FG001|Overall Study|No Disease Response After Cycle 6|1|||
164167862|NCT00675428|592978221|FG000|Overall Study|Physician Decision|1|||
164167863|NCT00675428|592978222|FG001|Overall Study|Physician Decision|0|||
164167864|NCT04105218|592978223|FG000|Overall Study|Withdrawal by Subject|3|||
164167865|NCT04105218|592978224|FG001|Overall Study|Withdrawal by Subject|2|||
164167866|NCT04105218|592978223|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
164167867|NCT04105218|592978224|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
164167868|NCT04105218|592978223|FG000|Overall Study|Failed screening tests|2|||
164167869|NCT04105218|592978224|FG001|Overall Study|Failed screening tests|1|||
164167870|NCT02553499|592978227|FG000|Overall Study|Adverse Event|0|||
164167871|NCT02553499|592978228|FG001|Overall Study|Adverse Event|0|||
164167872|NCT02553499|592978229|FG002|Overall Study|Adverse Event|0|||
164167873|NCT02553499|592978230|FG003|Overall Study|Adverse Event|0|||
164167874|NCT02553499|592978231|FG004|Overall Study|Adverse Event|0|||
164167875|NCT02553499|592978232|FG005|Overall Study|Adverse Event|0|||
164167876|NCT02553499|592978233|FG006|Overall Study|Adverse Event|1|||
164167877|NCT02553499|592978234|FG007|Overall Study|Adverse Event|1|||
164167878|NCT02553499|592978235|FG008|Overall Study|Adverse Event|0|||
164167879|NCT02553499|592978236|FG009|Overall Study|Adverse Event|0|||
164167880|NCT02553499|592978237|FG010|Overall Study|Adverse Event|0|||
164167881|NCT02553499|592978238|FG011|Overall Study|Adverse Event|0|||
164167882|NCT02553499|592978239|FG012|Overall Study|Adverse Event|0|||
164167883|NCT02553499|592978240|FG013|Overall Study|Adverse Event|1|||
164167884|NCT02553499|592978227|FG000|Overall Study|Death|0|||
164167885|NCT02553499|592978228|FG001|Overall Study|Death|1|||
164167886|NCT02553499|592978229|FG002|Overall Study|Death|1|||
164167887|NCT02553499|592978230|FG003|Overall Study|Death|0|||
164167888|NCT02553499|592978231|FG004|Overall Study|Death|1|||
164167889|NCT02553499|592978232|FG005|Overall Study|Death|2|||
164167890|NCT02553499|592978233|FG006|Overall Study|Death|0|||
164167891|NCT02553499|592978234|FG007|Overall Study|Death|0|||
164167892|NCT02553499|592978235|FG008|Overall Study|Death|0|||
164167893|NCT02553499|592978236|FG009|Overall Study|Death|0|||
164167894|NCT02553499|592978237|FG010|Overall Study|Death|1|||
164167895|NCT02553499|592978238|FG011|Overall Study|Death|0|||
164167896|NCT02553499|592978239|FG012|Overall Study|Death|0|||
164167897|NCT02553499|592978240|FG013|Overall Study|Death|0|||
164167898|NCT02553499|592978227|FG000|Overall Study|Lost to Follow-up|0|||
164167899|NCT02553499|592978228|FG001|Overall Study|Lost to Follow-up|0|||
164167900|NCT02553499|592978229|FG002|Overall Study|Lost to Follow-up|0|||
164167901|NCT02553499|592978230|FG003|Overall Study|Lost to Follow-up|0|||
164167902|NCT02553499|592978231|FG004|Overall Study|Lost to Follow-up|0|||
164167903|NCT02553499|592978232|FG005|Overall Study|Lost to Follow-up|0|||
164167904|NCT02553499|592978233|FG006|Overall Study|Lost to Follow-up|1|||
164167905|NCT02553499|592978234|FG007|Overall Study|Lost to Follow-up|0|||
164167906|NCT02553499|592978235|FG008|Overall Study|Lost to Follow-up|0|||
164167907|NCT02553499|592978236|FG009|Overall Study|Lost to Follow-up|0|||
164167908|NCT02553499|592978237|FG010|Overall Study|Lost to Follow-up|0|||
164167909|NCT02553499|592978238|FG011|Overall Study|Lost to Follow-up|0|||
164167910|NCT02553499|592978239|FG012|Overall Study|Lost to Follow-up|0|||
164167911|NCT02553499|592978240|FG013|Overall Study|Lost to Follow-up|0|||
164167912|NCT02553499|592978227|FG000|Overall Study|Physician Decision|0|||
164167913|NCT02553499|592978228|FG001|Overall Study|Physician Decision|1|||
164167914|NCT02553499|592978229|FG002|Overall Study|Physician Decision|1|||
164167915|NCT02553499|592978230|FG003|Overall Study|Physician Decision|0|||
164167916|NCT02553499|592978231|FG004|Overall Study|Physician Decision|1|||
164167917|NCT02553499|592978232|FG005|Overall Study|Physician Decision|0|||
164167918|NCT02553499|592978233|FG006|Overall Study|Physician Decision|0|||
164167919|NCT02553499|592978234|FG007|Overall Study|Physician Decision|1|||
164167920|NCT02553499|592978235|FG008|Overall Study|Physician Decision|1|||
164167921|NCT02553499|592978236|FG009|Overall Study|Physician Decision|2|||
164167922|NCT02553499|592978237|FG010|Overall Study|Physician Decision|1|||
164167923|NCT02553499|592978238|FG011|Overall Study|Physician Decision|3|||
164167924|NCT02553499|592978239|FG012|Overall Study|Physician Decision|1|||
164167925|NCT02553499|592978240|FG013|Overall Study|Physician Decision|0|||
164167926|NCT02553499|592978227|FG000|Overall Study|Progressive Disease|0|||
164167927|NCT02553499|592978228|FG001|Overall Study|Progressive Disease|0|||
164167928|NCT02553499|592978229|FG002|Overall Study|Progressive Disease|0|||
164167929|NCT02553499|592978230|FG003|Overall Study|Progressive Disease|2|||
164167930|NCT02553499|592978231|FG004|Overall Study|Progressive Disease|1|||
164167931|NCT02553499|592978232|FG005|Overall Study|Progressive Disease|1|||
164167932|NCT02553499|592978233|FG006|Overall Study|Progressive Disease|1|||
164167933|NCT02553499|592978234|FG007|Overall Study|Progressive Disease|0|||
164167934|NCT02553499|592978235|FG008|Overall Study|Progressive Disease|0|||
164167935|NCT02553499|592978236|FG009|Overall Study|Progressive Disease|1|||
164167936|NCT02553499|592978237|FG010|Overall Study|Progressive Disease|0|||
164167937|NCT02553499|592978238|FG011|Overall Study|Progressive Disease|0|||
164167938|NCT02553499|592978239|FG012|Overall Study|Progressive Disease|2|||
164167939|NCT02553499|592978240|FG013|Overall Study|Progressive Disease|1|||
164167940|NCT02553499|592978227|FG000|Overall Study|Study Terminated by Sponsor|0|||
164167941|NCT02553499|592978228|FG001|Overall Study|Study Terminated by Sponsor|0|||
164167942|NCT02553499|592978229|FG002|Overall Study|Study Terminated by Sponsor|0|||
164167943|NCT02553499|592978230|FG003|Overall Study|Study Terminated by Sponsor|0|||
164167944|NCT02553499|592978231|FG004|Overall Study|Study Terminated by Sponsor|0|||
164167945|NCT02553499|592978232|FG005|Overall Study|Study Terminated by Sponsor|0|||
164167946|NCT02553499|592978233|FG006|Overall Study|Study Terminated by Sponsor|0|||
164167947|NCT02553499|592978234|FG007|Overall Study|Study Terminated by Sponsor|0|||
164167948|NCT02553499|592978235|FG008|Overall Study|Study Terminated by Sponsor|1|||
164167949|NCT02553499|592978236|FG009|Overall Study|Study Terminated by Sponsor|0|||
164167950|NCT02553499|592978237|FG010|Overall Study|Study Terminated by Sponsor|0|||
164167951|NCT02553499|592978238|FG011|Overall Study|Study Terminated by Sponsor|0|||
164167952|NCT02553499|592978239|FG012|Overall Study|Study Terminated by Sponsor|0|||
164167953|NCT02553499|592978240|FG013|Overall Study|Study Terminated by Sponsor|0|||
164167954|NCT02553499|592978227|FG000|Overall Study|Withdrawal by Subject|2|||
164167955|NCT02553499|592978228|FG001|Overall Study|Withdrawal by Subject|0|||
164167956|NCT02553499|592978229|FG002|Overall Study|Withdrawal by Subject|0|||
164167957|NCT02553499|592978230|FG003|Overall Study|Withdrawal by Subject|0|||
164167958|NCT02553499|592978231|FG004|Overall Study|Withdrawal by Subject|0|||
164167959|NCT02553499|592978232|FG005|Overall Study|Withdrawal by Subject|0|||
164167960|NCT02553499|592978233|FG006|Overall Study|Withdrawal by Subject|0|||
164167961|NCT02553499|592978234|FG007|Overall Study|Withdrawal by Subject|1|||
164167962|NCT02553499|592978235|FG008|Overall Study|Withdrawal by Subject|1|||
164167963|NCT02553499|592978236|FG009|Overall Study|Withdrawal by Subject|0|||
164167964|NCT02553499|592978237|FG010|Overall Study|Withdrawal by Subject|1|||
164167965|NCT02553499|592978238|FG011|Overall Study|Withdrawal by Subject|0|||
164167966|NCT02553499|592978239|FG012|Overall Study|Withdrawal by Subject|0|||
164167967|NCT02553499|592978240|FG013|Overall Study|Withdrawal by Subject|0|||
164167968|NCT01582178|592978241|FG000|Overall Study|Physician Decision|6|||
164167969|NCT01582178|592978242|FG001|Overall Study|Physician Decision|5|||
164167970|NCT00570063|592978243|FG000|Overall Study|Adverse Event|4|||
164167971|NCT00570063|592978244|FG001|Overall Study|Adverse Event|1|||
164167972|NCT00570063|592978243|FG000|Overall Study|Lack of Efficacy|0|||
164167973|NCT00570063|592978244|FG001|Overall Study|Lack of Efficacy|1|||
164167974|NCT00570063|592978243|FG000|Overall Study|Withdrawal by Subject|4|||
164167975|NCT00570063|592978244|FG001|Overall Study|Withdrawal by Subject|3|||
164167976|NCT00570063|592978243|FG000|Overall Study|Sponsor's Decision|7|||
164167977|NCT00570063|592978244|FG001|Overall Study|Sponsor's Decision|3|||
164167978|NCT00550043|592978248|FG000|Overall Study|Adverse Event|0|||
164167979|NCT00550043|592978249|FG001|Overall Study|Adverse Event|0|||
164167980|NCT00550043|592978250|FG002|Overall Study|Adverse Event|0|||
164167981|NCT00550043|592978251|FG003|Overall Study|Adverse Event|1|||
164167982|NCT00550043|592978252|FG004|Overall Study|Adverse Event|1|||
164167983|NCT00550043|592978248|FG000|Overall Study|Subject Withdrew Consent|0|||
164167984|NCT00550043|592978249|FG001|Overall Study|Subject Withdrew Consent|2|||
164167985|NCT00550043|592978250|FG002|Overall Study|Subject Withdrew Consent|1|||
164167986|NCT00550043|592978251|FG003|Overall Study|Subject Withdrew Consent|0|||
164167987|NCT00550043|592978252|FG004|Overall Study|Subject Withdrew Consent|0|||
164167988|NCT00550043|592978248|FG000|Overall Study|Other Reasons- Unspecified|0|||
164167989|NCT00550043|592978249|FG001|Overall Study|Other Reasons- Unspecified|1|||
164167990|NCT00550043|592978250|FG002|Overall Study|Other Reasons- Unspecified|0|||
164167991|NCT00550043|592978251|FG003|Overall Study|Other Reasons- Unspecified|1|||
164167992|NCT00550043|592978252|FG004|Overall Study|Other Reasons- Unspecified|0|||
164167993|NCT01186692|592978256|FG000|Overall Study|Not Catheterized|11|||
164167994|NCT01186692|592978256|FG000|Overall Study|Futher testing contraindicated implant|19|||
164167995|NCT01186692|592978256|FG000|Overall Study|Adverse Event|2|||
164167996|NCT00789698|592978257|FG000|Overall Study|Lack of Efficacy|10|||
164167997|NCT00789698|592978258|FG001|Overall Study|Lack of Efficacy|4|||
164167998|NCT00789698|592978259|FG002|Overall Study|Lack of Efficacy|5|||
164167999|NCT00789698|592978260|FG003|Overall Study|Lack of Efficacy|18|||
164168000|NCT00789698|592978257|FG000|Overall Study|Adverse Event|5|||
164168001|NCT00789698|592978258|FG001|Overall Study|Adverse Event|5|||
164168002|NCT00789698|592978259|FG002|Overall Study|Adverse Event|3|||
164168003|NCT00789698|592978260|FG003|Overall Study|Adverse Event|4|||
164168004|NCT00789698|592978257|FG000|Overall Study|Lost to Follow-up|5|||
164168005|NCT00789698|592978258|FG001|Overall Study|Lost to Follow-up|5|||
164168006|NCT00789698|592978259|FG002|Overall Study|Lost to Follow-up|2|||
164168007|NCT00789698|592978260|FG003|Overall Study|Lost to Follow-up|9|||
164168008|NCT00789698|592978257|FG000|Overall Study|Protocol Violation|6|||
164168009|NCT00789698|592978258|FG001|Overall Study|Protocol Violation|1|||
164168010|NCT00789698|592978259|FG002|Overall Study|Protocol Violation|2|||
164168011|NCT00789698|592978260|FG003|Overall Study|Protocol Violation|1|||
164168012|NCT00789698|592978257|FG000|Overall Study|Withdrawal by Subject|14|||
164168013|NCT00789698|592978258|FG001|Overall Study|Withdrawal by Subject|15|||
164168014|NCT00789698|592978259|FG002|Overall Study|Withdrawal by Subject|12|||
164168015|NCT00789698|592978260|FG003|Overall Study|Withdrawal by Subject|19|||
164168016|NCT00789698|592978257|FG000|Overall Study|Administrative|0|||
164168017|NCT00789698|592978258|FG001|Overall Study|Administrative|3|||
164168018|NCT00789698|592978259|FG002|Overall Study|Administrative|3|||
164168019|NCT00789698|592978260|FG003|Overall Study|Administrative|1|||
164168020|NCT01921101|592978261|FG000|Overall Study|Death|16|||
164168021|NCT01921101|592978262|FG001|Overall Study|Death|6|||
164168022|NCT01275755|592980618|FG000|Double-blind Treatment Period|Adverse Event|0|||
164168023|NCT01275755|592980619|FG001|Double-blind Treatment Period|Adverse Event|2|||
164168024|NCT01275755|592980618|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
164168025|NCT01275755|592980619|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
164168026|NCT01275755|592980618|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
164168027|NCT01275755|592980619|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
164168028|NCT01275755|592980618|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
164168029|NCT01275755|592980619|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
164168030|NCT04420585|592980624|FG000|Overall Study|Adverse Event|1|||
164168031|NCT04420585|592980624|FG000|Overall Study|Never initiated medication|2|||
164168032|NCT03693612|592980627|FG000|Overall Study|Lost to Follow-up|0|||
164168033|NCT03693612|592980628|FG001|Overall Study|Lost to Follow-up|0|||
164168034|NCT03693612|592980629|FG002|Overall Study|Lost to Follow-up|0|||
164168035|NCT03693612|592980630|FG003|Overall Study|Lost to Follow-up|0|||
164168036|NCT03693612|592980631|FG004|Overall Study|Lost to Follow-up|1|||
164168037|NCT03693612|592980632|FG005|Overall Study|Lost to Follow-up|0|||
164168038|NCT03693612|592980633|FG006|Overall Study|Lost to Follow-up|0|||
164168039|NCT03693612|592980627|FG000|Overall Study|Withdrawal by Subject|0|||
164168040|NCT03693612|592980628|FG001|Overall Study|Withdrawal by Subject|0|||
164168041|NCT03693612|592980629|FG002|Overall Study|Withdrawal by Subject|1|||
164168042|NCT03693612|592980630|FG003|Overall Study|Withdrawal by Subject|0|||
164168043|NCT03693612|592980631|FG004|Overall Study|Withdrawal by Subject|2|||
164168044|NCT03693612|592980632|FG005|Overall Study|Withdrawal by Subject|0|||
164168045|NCT03693612|592980633|FG006|Overall Study|Withdrawal by Subject|0|||
164168046|NCT03693612|592980627|FG000|Overall Study|Study Terminated by Sponsor|0|||
164168047|NCT03693612|592980628|FG001|Overall Study|Study Terminated by Sponsor|1|||
164168048|NCT03693612|592980629|FG002|Overall Study|Study Terminated by Sponsor|0|||
164168049|NCT03693612|592980630|FG003|Overall Study|Study Terminated by Sponsor|0|||
164168050|NCT03693612|592980631|FG004|Overall Study|Study Terminated by Sponsor|3|||
164168051|NCT03693612|592980632|FG005|Overall Study|Study Terminated by Sponsor|0|||
164168052|NCT03693612|592980633|FG006|Overall Study|Study Terminated by Sponsor|0|||
164168053|NCT01669174|592980640|FG000|Overall Study|Subject withdrew consent|2|||
164168054|NCT01669174|592980641|FG001|Overall Study|Subject withdrew consent|2|||
164168055|NCT01669174|592980640|FG000|Overall Study|Lost to Follow-up|1|||
164168056|NCT01669174|592980641|FG001|Overall Study|Lost to Follow-up|0|||
164168057|NCT01669174|592980640|FG000|Overall Study|Adverse Event|2|||
164168058|NCT01669174|592980641|FG001|Overall Study|Adverse Event|2|||
164168059|NCT01669174|592980640|FG000|Overall Study|Administrative problems|1|||
164168060|NCT01669174|592980641|FG001|Overall Study|Administrative problems|2|||
164168061|NCT01953601|592980645|FG000|Part 1 (Base Study)|Adverse Event|24|||
164168062|NCT01953601|592980646|FG001|Part 1 (Base Study)|Adverse Event|37|||
164168063|NCT01953601|592980647|FG002|Part 1 (Base Study)|Adverse Event|15|||
164168064|NCT01953601|592980645|FG000|Part 1 (Base Study)|Death|2|||
164168065|NCT01953601|592980646|FG001|Part 1 (Base Study)|Death|0|||
164168066|NCT01953601|592980647|FG002|Part 1 (Base Study)|Death|3|||
164168067|NCT01953601|592980645|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
164168068|NCT01953601|592980646|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
164168069|NCT01953601|592980647|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
164168070|NCT01953601|592980645|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
164168071|NCT01953601|592980646|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
164168072|NCT01953601|592980647|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
164168073|NCT01953601|592980645|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
164168074|NCT01953601|592980646|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
164168075|NCT01953601|592980647|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
164168076|NCT01953601|592980645|FG000|Part 1 (Base Study)|Physician Decision|3|||
164168077|NCT01953601|592980646|FG001|Part 1 (Base Study)|Physician Decision|7|||
164168078|NCT01953601|592980647|FG002|Part 1 (Base Study)|Physician Decision|4|||
164168079|NCT01953601|592980645|FG000|Part 1 (Base Study)|Screen failure|1|||
164168080|NCT01953601|592980646|FG001|Part 1 (Base Study)|Screen failure|0|||
164168081|NCT01953601|592980647|FG002|Part 1 (Base Study)|Screen failure|1|||
164168082|NCT01953601|592980645|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
164168083|NCT01953601|592980646|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
164168084|NCT01953601|592980647|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
164168085|NCT01953601|592980645|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
164168086|NCT01953601|592980646|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
164168087|NCT01953601|592980647|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
164168088|NCT01953601|592980645|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
164168089|NCT01953601|592980646|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
164168090|NCT01953601|592980647|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
164168091|NCT01953601|592980645|FG000|Part 1 (Base Study)|Subject moved|2|||
164168092|NCT01953601|592980646|FG001|Part 1 (Base Study)|Subject moved|2|||
164168093|NCT01953601|592980647|FG002|Part 1 (Base Study)|Subject moved|1|||
164168094|NCT01953601|592980645|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
164168095|NCT01953601|592980646|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
164168096|NCT01953601|592980647|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
164168097|NCT01953601|592980645|FG000|Part 2 (Extension Study)|Adverse Event|1|||
164168098|NCT01953601|592980646|FG001|Part 2 (Extension Study)|Adverse Event|1|||
164168099|NCT01953601|592980647|FG002|Part 2 (Extension Study)|Adverse Event|10|||
164168100|NCT01953601|592980645|FG000|Part 2 (Extension Study)|Death|0|||
164168101|NCT01953601|592980646|FG001|Part 2 (Extension Study)|Death|3|||
164168102|NCT01953601|592980647|FG002|Part 2 (Extension Study)|Death|0|||
164168103|NCT01953601|592980645|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
164168104|NCT01953601|592980646|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
164168105|NCT01953601|592980647|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
164168106|NCT01953601|592980645|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
164168107|NCT01953601|592980646|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
164168108|NCT01953601|592980647|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
164168109|NCT01953601|592980645|FG000|Part 2 (Extension Study)|Physician Decision|2|||
164168110|NCT01953601|592980646|FG001|Part 2 (Extension Study)|Physician Decision|0|||
164168111|NCT01953601|592980647|FG002|Part 2 (Extension Study)|Physician Decision|2|||
164168112|NCT01953601|592980645|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
164168113|NCT01953601|592980646|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
164168114|NCT01953601|592980647|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
164168115|NCT01953601|592980645|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
164168116|NCT01953601|592980646|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
164168117|NCT01953601|592980647|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
164168118|NCT01953601|592980645|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
164168119|NCT01953601|592980646|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
164168120|NCT01953601|592980647|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
164168121|NCT01953601|592980645|FG000|Part 2 (Extension Study)|Subject moved|0|||
164168122|NCT01953601|592980646|FG001|Part 2 (Extension Study)|Subject moved|0|||
164168123|NCT01953601|592980647|FG002|Part 2 (Extension Study)|Subject moved|1|||
164168124|NCT01953601|592980645|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
164168125|NCT01953601|592980646|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
164168126|NCT01953601|592980647|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
164168127|NCT01905553|592980654|FG000|Period 2|Adverse Event|1|||
164168128|NCT01905553|592980655|FG001|Period 2|Adverse Event|0|||
164168129|NCT04310397|592980656|FG000|Overall Study|Lack of Efficacy|3|||
164168130|NCT04310397|592980656|FG000|Overall Study|Withdrawal by Subject|1|||
164168131|NCT02703272|592980663|FG000|Overall Study|Death|4|||
164168132|NCT02703272|592980664|FG001|Overall Study|Death|9|||
164168133|NCT02703272|592980665|FG002|Overall Study|Death|19|||
164168134|NCT02703272|592980666|FG003|Overall Study|Death|10|||
164168135|NCT02703272|592980663|FG000|Overall Study|Withdrawal by Subject|0|||
164168136|NCT02703272|592980664|FG001|Overall Study|Withdrawal by Subject|0|||
164168137|NCT02703272|592980665|FG002|Overall Study|Withdrawal by Subject|4|||
164168138|NCT02703272|592980666|FG003|Overall Study|Withdrawal by Subject|2|||
164168139|NCT02703272|592980663|FG000|Overall Study|Study Terminated by Sponsor|6|||
164168140|NCT02703272|592980664|FG001|Overall Study|Study Terminated by Sponsor|1|||
164168141|NCT02703272|592980665|FG002|Overall Study|Study Terminated by Sponsor|12|||
164168142|NCT02703272|592980666|FG003|Overall Study|Study Terminated by Sponsor|4|||
164168143|NCT02703272|592980663|FG000|Overall Study|Other|1|||
164168144|NCT02703272|592980664|FG001|Overall Study|Other|0|||
164168145|NCT02703272|592980665|FG002|Overall Study|Other|0|||
164168146|NCT02703272|592980666|FG003|Overall Study|Other|0|||
164168147|NCT00623935|592980667|FG000|Overall Study|Death|1|||
164168148|NCT00623935|592980667|FG000|Overall Study|Patient Declined Transplant|1|||
164168149|NCT03315286|592980668|FG000|Overall Study|Lost to Follow-up|0|||
164168150|NCT03315286|592980669|FG001|Overall Study|Lost to Follow-up|3|||
164168151|NCT03315286|592980668|FG000|Overall Study|Withdrawal by Subject|1|||
164168152|NCT03315286|592980669|FG001|Overall Study|Withdrawal by Subject|0|||
164168153|NCT03315286|592980668|FG000|Overall Study|Protocol Violation|0|||
164168154|NCT03315286|592980669|FG001|Overall Study|Protocol Violation|1|||
164168155|NCT00747474|592980670|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
164168156|NCT00747474|592980671|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
164168157|NCT00747474|592980672|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
164168158|NCT00747474|592980673|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
164168159|NCT00747474|592980674|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
164168160|NCT00747474|592980675|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
164168161|NCT00747474|592980676|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
164168162|NCT00747474|592980677|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
164168163|NCT00747474|592980678|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
164168164|NCT00747474|592980679|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
164168165|NCT00747474|592980680|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
164168166|NCT00747474|592980681|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
164168167|NCT02829723|592980683|FG000|Overall Study|Adverse Event|0|||
164168168|NCT02829723|592980684|FG001|Overall Study|Adverse Event|0|||
164168169|NCT02829723|592980685|FG002|Overall Study|Adverse Event|1|||
164168170|NCT02829723|592980686|FG003|Overall Study|Adverse Event|1|||
164168171|NCT02829723|592980687|FG004|Overall Study|Adverse Event|0|||
164168172|NCT02829723|592980688|FG005|Overall Study|Adverse Event|0|||
164168173|NCT02829723|592980689|FG006|Overall Study|Adverse Event|0|||
164168174|NCT02829723|592980690|FG007|Overall Study|Adverse Event|1|||
164168175|NCT02829723|592980691|FG008|Overall Study|Adverse Event|0|||
164168176|NCT02829723|592980692|FG009|Overall Study|Adverse Event|0|||
164168177|NCT02829723|592980693|FG010|Overall Study|Adverse Event|0|||
164168178|NCT02829723|592980694|FG011|Overall Study|Adverse Event|0|||
164168179|NCT02829723|592980695|FG012|Overall Study|Adverse Event|0|||
164168180|NCT02829723|592980696|FG013|Overall Study|Adverse Event|0|||
164168181|NCT02829723|592980697|FG014|Overall Study|Adverse Event|1|||
164168182|NCT02829723|592980698|FG015|Overall Study|Adverse Event|1|||
164168183|NCT02829723|592980699|FG016|Overall Study|Adverse Event|1|||
164168184|NCT02829723|592980700|FG017|Overall Study|Adverse Event|2|||
164168185|NCT02829723|592980701|FG018|Overall Study|Adverse Event|1|||
164168186|NCT02829723|592980702|FG019|Overall Study|Adverse Event|1|||
164168187|NCT02829723|592980703|FG020|Overall Study|Adverse Event|3|||
164168188|NCT02829723|592980704|FG021|Overall Study|Adverse Event|0|||
164168189|NCT02829723|592980705|FG022|Overall Study|Adverse Event|0|||
164168190|NCT02829723|592980706|FG023|Overall Study|Adverse Event|1|||
164168191|NCT02829723|592980707|FG024|Overall Study|Adverse Event|1|||
164168192|NCT02829723|592980708|FG025|Overall Study|Adverse Event|3|||
164168193|NCT02829723|592980709|FG026|Overall Study|Adverse Event|5|||
164168194|NCT02829723|592980683|FG000|Overall Study|Death|1|||
164168195|NCT02829723|592980684|FG001|Overall Study|Death|0|||
164168196|NCT02829723|592980685|FG002|Overall Study|Death|1|||
164168197|NCT02829723|592980686|FG003|Overall Study|Death|1|||
164168198|NCT02829723|592980687|FG004|Overall Study|Death|0|||
164168199|NCT02829723|592980688|FG005|Overall Study|Death|0|||
164168200|NCT02829723|592980689|FG006|Overall Study|Death|2|||
164168201|NCT02829723|592980690|FG007|Overall Study|Death|0|||
164168202|NCT02829723|592980691|FG008|Overall Study|Death|1|||
164168203|NCT02829723|592980692|FG009|Overall Study|Death|0|||
164168204|NCT02829723|592980693|FG010|Overall Study|Death|0|||
164168205|NCT02829723|592980694|FG011|Overall Study|Death|0|||
164168206|NCT02829723|592980695|FG012|Overall Study|Death|2|||
164168207|NCT02829723|592980696|FG013|Overall Study|Death|1|||
164168208|NCT02829723|592980697|FG014|Overall Study|Death|0|||
164168209|NCT02829723|592980698|FG015|Overall Study|Death|0|||
164168210|NCT02829723|592980699|FG016|Overall Study|Death|0|||
164168211|NCT02829723|592980700|FG017|Overall Study|Death|0|||
164168212|NCT02829723|592980701|FG018|Overall Study|Death|0|||
164168213|NCT02829723|592980702|FG019|Overall Study|Death|0|||
164168214|NCT02829723|592980703|FG020|Overall Study|Death|0|||
164168215|NCT02829723|592980704|FG021|Overall Study|Death|2|||
164168216|NCT02829723|592980705|FG022|Overall Study|Death|0|||
164168217|NCT02829723|592980706|FG023|Overall Study|Death|0|||
164168218|NCT02829723|592980707|FG024|Overall Study|Death|0|||
164168219|NCT02829723|592980708|FG025|Overall Study|Death|1|||
164168220|NCT02829723|592980709|FG026|Overall Study|Death|2|||
164168221|NCT02829723|592980683|FG000|Overall Study|Physician Decision|0|||
164168222|NCT02829723|592980684|FG001|Overall Study|Physician Decision|0|||
164168223|NCT02829723|592980685|FG002|Overall Study|Physician Decision|0|||
164168224|NCT02829723|592980686|FG003|Overall Study|Physician Decision|0|||
164168225|NCT02829723|592980687|FG004|Overall Study|Physician Decision|0|||
164168226|NCT02829723|592980688|FG005|Overall Study|Physician Decision|0|||
164168227|NCT02829723|592980689|FG006|Overall Study|Physician Decision|0|||
164168228|NCT02829723|592980690|FG007|Overall Study|Physician Decision|0|||
164168229|NCT02829723|592980691|FG008|Overall Study|Physician Decision|0|||
164168230|NCT02829723|592980692|FG009|Overall Study|Physician Decision|1|||
164168231|NCT02829723|592980693|FG010|Overall Study|Physician Decision|1|||
164168232|NCT02829723|592980694|FG011|Overall Study|Physician Decision|0|||
164168233|NCT02829723|592980695|FG012|Overall Study|Physician Decision|0|||
164168234|NCT02829723|592980696|FG013|Overall Study|Physician Decision|1|||
164168235|NCT02829723|592980697|FG014|Overall Study|Physician Decision|0|||
164168236|NCT02829723|592980698|FG015|Overall Study|Physician Decision|0|||
164168237|NCT02829723|592980699|FG016|Overall Study|Physician Decision|2|||
164168238|NCT02829723|592980700|FG017|Overall Study|Physician Decision|0|||
164168239|NCT02829723|592980701|FG018|Overall Study|Physician Decision|0|||
164168240|NCT02829723|592980702|FG019|Overall Study|Physician Decision|0|||
164168241|NCT02829723|592980703|FG020|Overall Study|Physician Decision|0|||
164168242|NCT02829723|592980704|FG021|Overall Study|Physician Decision|0|||
164168243|NCT02829723|592980705|FG022|Overall Study|Physician Decision|1|||
164168244|NCT02829723|592980706|FG023|Overall Study|Physician Decision|1|||
164168245|NCT02829723|592980707|FG024|Overall Study|Physician Decision|1|||
164168246|NCT02829723|592980708|FG025|Overall Study|Physician Decision|1|||
164168247|NCT02829723|592980709|FG026|Overall Study|Physician Decision|3|||
164168248|NCT02829723|592980683|FG000|Overall Study|Progressive disease|4|||
164168249|NCT02829723|592980684|FG001|Overall Study|Progressive disease|6|||
164168250|NCT02829723|592980685|FG002|Overall Study|Progressive disease|3|||
164168251|NCT02829723|592980686|FG003|Overall Study|Progressive disease|3|||
164168252|NCT02829723|592980687|FG004|Overall Study|Progressive disease|3|||
164168253|NCT02829723|592980688|FG005|Overall Study|Progressive disease|5|||
164168254|NCT02829723|592980689|FG006|Overall Study|Progressive disease|4|||
164168255|NCT02829723|592980690|FG007|Overall Study|Progressive disease|6|||
164168256|NCT02829723|592980691|FG008|Overall Study|Progressive disease|8|||
164168257|NCT02829723|592980692|FG009|Overall Study|Progressive disease|4|||
164168258|NCT02829723|592980693|FG010|Overall Study|Progressive disease|9|||
164168259|NCT02829723|592980694|FG011|Overall Study|Progressive disease|0|||
164168260|NCT02829723|592980695|FG012|Overall Study|Progressive disease|3|||
164168261|NCT02829723|592980696|FG013|Overall Study|Progressive disease|4|||
164168262|NCT02829723|592980697|FG014|Overall Study|Progressive disease|2|||
164168263|NCT02829723|592980698|FG015|Overall Study|Progressive disease|4|||
164168264|NCT02829723|592980699|FG016|Overall Study|Progressive disease|5|||
164168265|NCT02829723|592980700|FG017|Overall Study|Progressive disease|3|||
164168266|NCT02829723|592980701|FG018|Overall Study|Progressive disease|4|||
164168267|NCT02829723|592980702|FG019|Overall Study|Progressive disease|4|||
164168268|NCT02829723|592980703|FG020|Overall Study|Progressive disease|7|||
164168269|NCT02829723|592980704|FG021|Overall Study|Progressive disease|6|||
164168270|NCT02829723|592980705|FG022|Overall Study|Progressive disease|3|||
164168271|NCT02829723|592980706|FG023|Overall Study|Progressive disease|3|||
164168272|NCT02829723|592980707|FG024|Overall Study|Progressive disease|3|||
164168273|NCT02829723|592980708|FG025|Overall Study|Progressive disease|16|||
164168274|NCT02829723|592980709|FG026|Overall Study|Progressive disease|10|||
164168275|NCT02829723|592980683|FG000|Overall Study|Subject/guardian decision|0|||
164168276|NCT02829723|592980684|FG001|Overall Study|Subject/guardian decision|1|||
164168277|NCT02829723|592980685|FG002|Overall Study|Subject/guardian decision|0|||
164168278|NCT02829723|592980686|FG003|Overall Study|Subject/guardian decision|1|||
164168279|NCT02829723|592980687|FG004|Overall Study|Subject/guardian decision|0|||
164168280|NCT02829723|592980688|FG005|Overall Study|Subject/guardian decision|0|||
164168281|NCT02829723|592980689|FG006|Overall Study|Subject/guardian decision|0|||
164168282|NCT02829723|592980690|FG007|Overall Study|Subject/guardian decision|1|||
164168283|NCT02829723|592980691|FG008|Overall Study|Subject/guardian decision|0|||
164168284|NCT02829723|592980692|FG009|Overall Study|Subject/guardian decision|0|||
164168285|NCT02829723|592980693|FG010|Overall Study|Subject/guardian decision|0|||
164168286|NCT02829723|592980694|FG011|Overall Study|Subject/guardian decision|0|||
164168287|NCT02829723|592980695|FG012|Overall Study|Subject/guardian decision|0|||
164168288|NCT02829723|592980696|FG013|Overall Study|Subject/guardian decision|0|||
164168289|NCT02829723|592980697|FG014|Overall Study|Subject/guardian decision|1|||
164168290|NCT02829723|592980698|FG015|Overall Study|Subject/guardian decision|0|||
164168291|NCT02829723|592980699|FG016|Overall Study|Subject/guardian decision|1|||
164168292|NCT02829723|592980700|FG017|Overall Study|Subject/guardian decision|0|||
164168293|NCT02829723|592980701|FG018|Overall Study|Subject/guardian decision|1|||
164168294|NCT02829723|592980702|FG019|Overall Study|Subject/guardian decision|0|||
164168295|NCT02829723|592980703|FG020|Overall Study|Subject/guardian decision|1|||
164168296|NCT02829723|592980704|FG021|Overall Study|Subject/guardian decision|0|||
164168297|NCT02829723|592980705|FG022|Overall Study|Subject/guardian decision|0|||
164168298|NCT02829723|592980706|FG023|Overall Study|Subject/guardian decision|1|||
164168299|NCT02829723|592980707|FG024|Overall Study|Subject/guardian decision|0|||
164168300|NCT02829723|592980708|FG025|Overall Study|Subject/guardian decision|1|||
164168301|NCT02829723|592980709|FG026|Overall Study|Subject/guardian decision|1|||
164168302|NCT02829723|592980683|FG000|Overall Study|Study terminated by sponsor|0|||
164168303|NCT02829723|592980684|FG001|Overall Study|Study terminated by sponsor|0|||
164168304|NCT02829723|592980685|FG002|Overall Study|Study terminated by sponsor|0|||
164168305|NCT02829723|592980686|FG003|Overall Study|Study terminated by sponsor|0|||
164168306|NCT02829723|592980687|FG004|Overall Study|Study terminated by sponsor|0|||
164168307|NCT02829723|592980688|FG005|Overall Study|Study terminated by sponsor|0|||
164168308|NCT02829723|592980689|FG006|Overall Study|Study terminated by sponsor|0|||
164168309|NCT02829723|592980690|FG007|Overall Study|Study terminated by sponsor|0|||
164168310|NCT02829723|592980691|FG008|Overall Study|Study terminated by sponsor|0|||
164168311|NCT02829723|592980692|FG009|Overall Study|Study terminated by sponsor|0|||
164168312|NCT02829723|592980693|FG010|Overall Study|Study terminated by sponsor|0|||
164168313|NCT02829723|592980694|FG011|Overall Study|Study terminated by sponsor|0|||
164168314|NCT02829723|592980695|FG012|Overall Study|Study terminated by sponsor|0|||
164168315|NCT02829723|592980696|FG013|Overall Study|Study terminated by sponsor|0|||
164168316|NCT02829723|592980697|FG014|Overall Study|Study terminated by sponsor|0|||
164168317|NCT02829723|592980698|FG015|Overall Study|Study terminated by sponsor|0|||
164168318|NCT02829723|592980699|FG016|Overall Study|Study terminated by sponsor|0|||
164168319|NCT02829723|592980700|FG017|Overall Study|Study terminated by sponsor|0|||
164168320|NCT02829723|592980701|FG018|Overall Study|Study terminated by sponsor|0|||
164168321|NCT02829723|592980702|FG019|Overall Study|Study terminated by sponsor|0|||
164168322|NCT02829723|592980703|FG020|Overall Study|Study terminated by sponsor|0|||
164168323|NCT02829723|592980704|FG021|Overall Study|Study terminated by sponsor|1|||
164168324|NCT02829723|592980705|FG022|Overall Study|Study terminated by sponsor|0|||
164168325|NCT02829723|592980706|FG023|Overall Study|Study terminated by sponsor|0|||
164168326|NCT02829723|592980707|FG024|Overall Study|Study terminated by sponsor|0|||
164168327|NCT02829723|592980708|FG025|Overall Study|Study terminated by sponsor|0|||
164168328|NCT02829723|592980709|FG026|Overall Study|Study terminated by sponsor|0|||
164168329|NCT02989649|592980710|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
164168330|NCT02989649|592980710|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
164168331|NCT02989649|592980710|FG000|Overall Study|Lost For Observation During Study|3|||
164168332|NCT02989649|592980710|FG000|Overall Study|Reason Not Specified|13|||
164168333|NCT00330343|592980711|FG000|Overall Study|Lost to Follow-up|5|||
164168334|NCT00256854|592980712|FG000|Overall Study|Withdrawal by Subject|2|||
164168335|NCT00256854|592980713|FG001|Overall Study|Withdrawal by Subject|3|||
164168336|NCT00256854|592980714|FG002|Overall Study|Withdrawal by Subject|0|||
164168337|NCT00256854|592980715|FG003|Overall Study|Withdrawal by Subject|0|||
164168338|NCT00256854|592980716|FG004|Overall Study|Withdrawal by Subject|0|||
164168339|NCT00256854|592980717|FG005|Overall Study|Withdrawal by Subject|0|||
164168340|NCT00256854|592980712|FG000|Overall Study|Lack of Efficacy|1|||
164168341|NCT00256854|592980713|FG001|Overall Study|Lack of Efficacy|0|||
164168342|NCT00256854|592980714|FG002|Overall Study|Lack of Efficacy|0|||
164168343|NCT00256854|592980715|FG003|Overall Study|Lack of Efficacy|0|||
164168344|NCT00256854|592980716|FG004|Overall Study|Lack of Efficacy|0|||
164168345|NCT00256854|592980717|FG005|Overall Study|Lack of Efficacy|0|||
164168346|NCT00256854|592980712|FG000|Overall Study|Protocol Violation|0|||
164168347|NCT00256854|592980713|FG001|Overall Study|Protocol Violation|1|||
164168348|NCT00256854|592980714|FG002|Overall Study|Protocol Violation|1|||
164168349|NCT00256854|592980715|FG003|Overall Study|Protocol Violation|1|||
164168350|NCT00256854|592980716|FG004|Overall Study|Protocol Violation|0|||
164168351|NCT00256854|592980717|FG005|Overall Study|Protocol Violation|0|||
164168352|NCT00256854|592980712|FG000|Overall Study|Adverse Event|0|||
164168353|NCT00256854|592980713|FG001|Overall Study|Adverse Event|0|||
164168354|NCT00256854|592980714|FG002|Overall Study|Adverse Event|2|||
164168355|NCT00256854|592980715|FG003|Overall Study|Adverse Event|2|||
164168356|NCT00256854|592980716|FG004|Overall Study|Adverse Event|0|||
164168357|NCT00256854|592980717|FG005|Overall Study|Adverse Event|1|||
164168358|NCT00256854|592980712|FG000|Overall Study|Not compliant with the study drug|0|||
164168359|NCT00256854|592980713|FG001|Overall Study|Not compliant with the study drug|0|||
164168360|NCT00256854|592980714|FG002|Overall Study|Not compliant with the study drug|0|||
164168361|NCT00256854|592980715|FG003|Overall Study|Not compliant with the study drug|0|||
164168362|NCT00256854|592980716|FG004|Overall Study|Not compliant with the study drug|1|||
164168363|NCT00256854|592980717|FG005|Overall Study|Not compliant with the study drug|0|||
164168364|NCT00281632|592980718|FG000|Overall Study|Adverse Event|7|||
164168365|NCT00281632|592980718|FG000|Overall Study|Withdrawal by Subject|2|||
164168366|NCT00281632|592980718|FG000|Overall Study|Disease Progression|22|||
164168367|NCT00281632|592980718|FG000|Overall Study|Death|1|||
164168368|NCT00281632|592980718|FG000|Overall Study|Physician Decision|1|||
164168369|NCT00281632|592980718|FG000|Overall Study|Ongoing|3|||
164168370|NCT06586788|592980720|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
164168371|NCT03514485|592980721|FG000|Overall Study|Lost to Follow-up|5|||
164168372|NCT03514485|592980722|FG001|Overall Study|Lost to Follow-up|3|||
164168373|NCT03514485|592980723|FG002|Overall Study|Lost to Follow-up|2|||
164168374|NCT03514485|592980724|FG003|Overall Study|Lost to Follow-up|0|||
164168375|NCT03514485|592980725|FG004|Overall Study|Lost to Follow-up|1|||
164168376|NCT03514485|592980726|FG005|Overall Study|Lost to Follow-up|4|||
164168377|NCT03514485|592980721|FG000|Overall Study|Withdrawal by Subject|0|||
164168378|NCT03514485|592980722|FG001|Overall Study|Withdrawal by Subject|1|||
164168379|NCT03514485|592980723|FG002|Overall Study|Withdrawal by Subject|3|||
164168380|NCT03514485|592980724|FG003|Overall Study|Withdrawal by Subject|1|||
164168381|NCT03514485|592980725|FG004|Overall Study|Withdrawal by Subject|2|||
164168382|NCT03514485|592980726|FG005|Overall Study|Withdrawal by Subject|1|||
164168383|NCT03075891|592980727|FG000|Overall Study|Withdrawal by Subject|3|||
164168384|NCT03075891|592980728|FG001|Overall Study|Withdrawal by Subject|6|||
164168385|NCT03075891|592980727|FG000|Overall Study|Lost to Follow-up|1|||
164168386|NCT03075891|592980728|FG001|Overall Study|Lost to Follow-up|0|||
164168387|NCT03075891|592980727|FG000|Overall Study|Pregnancy|3|||
164168388|NCT03075891|592980728|FG001|Overall Study|Pregnancy|1|||
164168389|NCT03075891|592980727|FG000|Overall Study|visits not performed (no time)|1|||
164168390|NCT03075891|592980728|FG001|Overall Study|visits not performed (no time)|0|||
164168391|NCT03075891|592980727|FG000|Overall Study|Drug abuse relapse issue|0|||
164168392|NCT03075891|592980728|FG001|Overall Study|Drug abuse relapse issue|1|||
164168393|NCT03075891|592980727|FG000|Overall Study|Participant requiring study withdrawal|0|||
164168394|NCT03075891|592980728|FG001|Overall Study|Participant requiring study withdrawal|1|||
164168395|NCT03075891|592980727|FG000|Overall Study|Adverse event, non-fatal|1|||
164168396|NCT03075891|592980728|FG001|Overall Study|Adverse event, non-fatal|4|||
164168397|NCT01878084|592980731|FG000|Overall Study|Physician Decision|2|||
164168398|NCT00582608|592980761|FG000|Overall Study|Not Treated|7|||
164168399|NCT00582608|592980761|FG000|Overall Study|Patient Ineligible|1|||
164168400|NCT00582608|592980761|FG000|Overall Study|Lack of accrual|4|||
164168401|NCT03482453|592980762|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
164168402|NCT03482453|592980763|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
164168403|NCT03482453|592980764|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
164168404|NCT03482453|592980765|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
164168405|NCT03482453|592980766|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
164168406|NCT03482453|592980767|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
164168407|NCT03482453|592980768|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
164168408|NCT03482453|592980769|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
164168409|NCT03482453|592980770|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
164168410|NCT03482453|592980771|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
164168411|NCT03482453|592980772|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
164168412|NCT03482453|592980773|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
164168413|NCT03478644|592980774|FG000|Phase 2|Withdrawal by Subject|2|||
164168414|NCT03478644|592980775|FG001|Phase 2|Withdrawal by Subject|1|||
164168415|NCT03478644|592980774|FG000|Phase 2|Lost to Follow-up|1|||
164168416|NCT03478644|592980775|FG001|Phase 2|Lost to Follow-up|0|||
164168417|NCT01870973|592980776|FG000|Overall Study|Lost to Follow-up|10|||
164168418|NCT01870973|592980777|FG001|Overall Study|Lost to Follow-up|3|||
164168419|NCT02504827|592980780|FG000|Overall Study|Could not produce sputum|1|||
164168420|NCT00686829|592980781|FG000|Overall Study|Adverse Event|5|||
164168421|NCT00686829|592980781|FG000|Overall Study|Lack of Efficacy|6|||
164168422|NCT00686829|592980781|FG000|Overall Study|Lost to Follow-up|4|||
164168423|NCT00686829|592980781|FG000|Overall Study|Withdrawal by Subject|14|||
164168424|NCT00686829|592980781|FG000|Overall Study|Protocol Violation|3|||
164168425|NCT00686829|592980781|FG000|Overall Study|Sponsor discontinued VCV|47|||
164168426|NCT00712543|592980782|FG000|Day 8-14|Lost to Follow-up|0|||
164168427|NCT00712543|592980783|FG001|Day 8-14|Lost to Follow-up|2|||
164168428|NCT04740827|592980784|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
164168429|NCT04740827|592980785|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
164168430|NCT04740827|592980784|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
164168431|NCT04740827|592980785|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
164168432|NCT04740827|592980784|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
164168433|NCT04740827|592980785|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
164168434|NCT04740827|592980784|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
164168435|NCT04740827|592980785|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
164168436|NCT04740827|592980784|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
164168437|NCT04740827|592980785|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
164168438|NCT04740827|592980784|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
164168439|NCT04740827|592980785|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
164168440|NCT00940823|592980786|FG000|Overall Study|Death|8|||
164168441|NCT00940823|592980787|FG001|Overall Study|Death|12|||
164168442|NCT00940823|592980786|FG000|Overall Study|Lost to Follow-up|27|||
164168443|NCT00940823|592980787|FG001|Overall Study|Lost to Follow-up|20|||
164168444|NCT00784550|592982669|FG000|Overall Study|Adverse Event|12|||
164168445|NCT00784550|592982670|FG001|Overall Study|Adverse Event|10|||
164168446|NCT00784550|592982669|FG000|Overall Study|Lack of Efficacy|0|||
164168447|NCT00784550|592982670|FG001|Overall Study|Lack of Efficacy|1|||
164168448|NCT00784550|592982669|FG000|Overall Study|Protocol Violation|10|||
164168449|NCT00784550|592982670|FG001|Overall Study|Protocol Violation|10|||
164168450|NCT00784550|592982669|FG000|Overall Study|Lost to Follow-up|8|||
164168451|NCT00784550|592982670|FG001|Overall Study|Lost to Follow-up|5|||
164168452|NCT00784550|592982669|FG000|Overall Study|Physician Decision|2|||
164168453|NCT00784550|592982670|FG001|Overall Study|Physician Decision|3|||
164168454|NCT00784550|592982669|FG000|Overall Study|Withdrawal by Subject|4|||
164168455|NCT00784550|592982670|FG001|Overall Study|Withdrawal by Subject|13|||
164168456|NCT00477750|592982672|FG000|Overall Study|Currently Receiving Treatment|11|||
164168457|NCT03558152|592982673|FG000|Overall Study|Adverse Event|0|||
164168458|NCT03558152|592982674|FG001|Overall Study|Adverse Event|0|||
164168459|NCT03558152|592982675|FG002|Overall Study|Adverse Event|1|||
164168460|NCT03558152|592982676|FG003|Overall Study|Adverse Event|1|||
164168461|NCT03558152|592982677|FG004|Overall Study|Adverse Event|2|||
164168462|NCT03558152|592982678|FG005|Overall Study|Adverse Event|1|||
164168463|NCT03558152|592982679|FG006|Overall Study|Adverse Event|1|||
164168464|NCT03558152|592982680|FG007|Overall Study|Adverse Event|0|||
164168465|NCT03558152|592982673|FG000|Overall Study|Death|0|||
164168466|NCT03558152|592982674|FG001|Overall Study|Death|0|||
164168467|NCT03558152|592982675|FG002|Overall Study|Death|0|||
164168468|NCT03558152|592982676|FG003|Overall Study|Death|0|||
164168469|NCT03558152|592982677|FG004|Overall Study|Death|1|||
164168470|NCT03558152|592982678|FG005|Overall Study|Death|0|||
164168471|NCT03558152|592982679|FG006|Overall Study|Death|0|||
164168472|NCT03558152|592982680|FG007|Overall Study|Death|0|||
164168473|NCT03558152|592982673|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
164168474|NCT03558152|592982674|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
164168475|NCT03558152|592982675|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
164168476|NCT03558152|592982676|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
164168477|NCT03558152|592982677|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
164168478|NCT03558152|592982678|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
164168479|NCT03558152|592982679|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
164168480|NCT03558152|592982680|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
164168481|NCT03558152|592982673|FG000|Overall Study|Miscalculation in mmcs|0|||
164168482|NCT03558152|592982674|FG001|Overall Study|Miscalculation in mmcs|0|||
164168483|NCT03558152|592982675|FG002|Overall Study|Miscalculation in mmcs|0|||
164168484|NCT03558152|592982676|FG003|Overall Study|Miscalculation in mmcs|0|||
164168485|NCT03558152|592982677|FG004|Overall Study|Miscalculation in mmcs|0|||
164168486|NCT03558152|592982678|FG005|Overall Study|Miscalculation in mmcs|0|||
164168487|NCT03558152|592982679|FG006|Overall Study|Miscalculation in mmcs|1|||
164168488|NCT03558152|592982680|FG007|Overall Study|Miscalculation in mmcs|0|||
164168489|NCT03558152|592982673|FG000|Overall Study|Mistake in calculation|0|||
164168490|NCT03558152|592982674|FG001|Overall Study|Mistake in calculation|0|||
164168491|NCT03558152|592982675|FG002|Overall Study|Mistake in calculation|0|||
164168492|NCT03558152|592982676|FG003|Overall Study|Mistake in calculation|1|||
164168493|NCT03558152|592982677|FG004|Overall Study|Mistake in calculation|0|||
164168494|NCT03558152|592982678|FG005|Overall Study|Mistake in calculation|0|||
164168495|NCT03558152|592982679|FG006|Overall Study|Mistake in calculation|0|||
164168496|NCT03558152|592982680|FG007|Overall Study|Mistake in calculation|0|||
164168497|NCT03558152|592982673|FG000|Overall Study|Mistake in evaluation of disease status|0|||
164168498|NCT03558152|592982674|FG001|Overall Study|Mistake in evaluation of disease status|0|||
164168499|NCT03558152|592982675|FG002|Overall Study|Mistake in evaluation of disease status|0|||
164168500|NCT03558152|592982676|FG003|Overall Study|Mistake in evaluation of disease status|0|||
164168501|NCT03558152|592982677|FG004|Overall Study|Mistake in evaluation of disease status|0|||
164168502|NCT03558152|592982678|FG005|Overall Study|Mistake in evaluation of disease status|0|||
164168503|NCT03558152|592982679|FG006|Overall Study|Mistake in evaluation of disease status|0|||
164168504|NCT03558152|592982680|FG007|Overall Study|Mistake in evaluation of disease status|1|||
164168505|NCT03558152|592982673|FG000|Overall Study|Physician Decision|0|||
164168506|NCT03558152|592982674|FG001|Overall Study|Physician Decision|0|||
164168507|NCT03558152|592982675|FG002|Overall Study|Physician Decision|0|||
164168508|NCT03558152|592982676|FG003|Overall Study|Physician Decision|0|||
164168509|NCT03558152|592982677|FG004|Overall Study|Physician Decision|0|||
164168510|NCT03558152|592982678|FG005|Overall Study|Physician Decision|0|||
164168511|NCT03558152|592982679|FG006|Overall Study|Physician Decision|1|||
164168512|NCT03558152|592982680|FG007|Overall Study|Physician Decision|0|||
164168513|NCT03558152|592982673|FG000|Overall Study|Withdrawal by Subject|2|||
164168514|NCT03558152|592982674|FG001|Overall Study|Withdrawal by Subject|3|||
164168515|NCT03558152|592982675|FG002|Overall Study|Withdrawal by Subject|2|||
164168516|NCT03558152|592982676|FG003|Overall Study|Withdrawal by Subject|1|||
164168517|NCT03558152|592982677|FG004|Overall Study|Withdrawal by Subject|1|||
164168518|NCT03558152|592982678|FG005|Overall Study|Withdrawal by Subject|1|||
164168519|NCT03558152|592982679|FG006|Overall Study|Withdrawal by Subject|3|||
164168520|NCT03558152|592982680|FG007|Overall Study|Withdrawal by Subject|2|||
164168521|NCT03558152|592982673|FG000|Overall Study|Lack of Efficacy|11|||
164168522|NCT03558152|592982674|FG001|Overall Study|Lack of Efficacy|11|||
164168523|NCT03558152|592982675|FG002|Overall Study|Lack of Efficacy|10|||
164168524|NCT03558152|592982676|FG003|Overall Study|Lack of Efficacy|11|||
164168525|NCT03558152|592982677|FG004|Overall Study|Lack of Efficacy|14|||
164168526|NCT03558152|592982678|FG005|Overall Study|Lack of Efficacy|12|||
164168527|NCT03558152|592982679|FG006|Overall Study|Lack of Efficacy|14|||
164168528|NCT03558152|592982680|FG007|Overall Study|Lack of Efficacy|13|||
164168529|NCT03558152|592982673|FG000|Overall Study|Protocol Violation|1|||
164168530|NCT03558152|592982674|FG001|Overall Study|Protocol Violation|1|||
164168531|NCT03558152|592982675|FG002|Overall Study|Protocol Violation|0|||
164168532|NCT03558152|592982676|FG003|Overall Study|Protocol Violation|1|||
164168533|NCT03558152|592982677|FG004|Overall Study|Protocol Violation|1|||
164168534|NCT03558152|592982678|FG005|Overall Study|Protocol Violation|0|||
164168535|NCT03558152|592982679|FG006|Overall Study|Protocol Violation|2|||
164168536|NCT03558152|592982680|FG007|Overall Study|Protocol Violation|0|||
164168537|NCT04166591|592982681|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
164168538|NCT04166591|592982682|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
164168539|NCT04166591|592982683|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
164168540|NCT04166591|592982684|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
164168541|NCT04166591|592982681|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
164168542|NCT04166591|592982682|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
164168543|NCT04166591|592982683|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
164168544|NCT04166591|592982684|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
164168545|NCT03960021|592982685|FG000|Overall Study|did not undergo the 2 radiofrequency ablations.|3|||
164168546|NCT00601172|592982686|FG000|Overall Study|Adverse Event|43|||
164168547|NCT00601172|592982687|FG001|Overall Study|Adverse Event|32|||
164168548|NCT00601172|592982686|FG000|Overall Study|Lack of Efficacy|11|||
164168549|NCT00601172|592982687|FG001|Overall Study|Lack of Efficacy|12|||
164168550|NCT00601172|592982686|FG000|Overall Study|Protocol Violation|2|||
164168551|NCT00601172|592982687|FG001|Overall Study|Protocol Violation|5|||
164168552|NCT00601172|592982686|FG000|Overall Study|Lost to Follow-up|4|||
164168553|NCT00601172|592982687|FG001|Overall Study|Lost to Follow-up|3|||
164168554|NCT00601172|592982686|FG000|Overall Study|Physician Decision|27|||
164168555|NCT00601172|592982687|FG001|Overall Study|Physician Decision|28|||
164168556|NCT00601172|592982686|FG000|Overall Study|Withdrawal by Subject|35|||
164168557|NCT00601172|592982687|FG001|Overall Study|Withdrawal by Subject|27|||
164168558|NCT00601172|592982686|FG000|Overall Study|Did not meet continuation criteria|19|||
164168559|NCT00601172|592982687|FG001|Overall Study|Did not meet continuation criteria|20|||
164168560|NCT04434469|592982688|FG000|Overall Study|Death|2|||
164168561|NCT04434469|592982689|FG001|Overall Study|Death|3|||
164168562|NCT04434469|592982690|FG002|Overall Study|Death|2|||
164168563|NCT04434469|592982691|FG003|Overall Study|Death|2|||
164168564|NCT04434469|592982692|FG004|Overall Study|Death|2|||
164168565|NCT04434469|592982693|FG005|Overall Study|Death|0|||
164168566|NCT04434469|592982688|FG000|Overall Study|Lost to Follow-up|0|||
164168567|NCT04434469|592982689|FG001|Overall Study|Lost to Follow-up|0|||
164168568|NCT04434469|592982690|FG002|Overall Study|Lost to Follow-up|0|||
164168569|NCT04434469|592982691|FG003|Overall Study|Lost to Follow-up|1|||
164168570|NCT04434469|592982692|FG004|Overall Study|Lost to Follow-up|1|||
164168571|NCT04434469|592982693|FG005|Overall Study|Lost to Follow-up|0|||
164168572|NCT04434469|592982688|FG000|Overall Study|Study terminated by sponsor|1|||
164168573|NCT04434469|592982689|FG001|Overall Study|Study terminated by sponsor|1|||
164168574|NCT04434469|592982690|FG002|Overall Study|Study terminated by sponsor|1|||
164168575|NCT04434469|592982691|FG003|Overall Study|Study terminated by sponsor|2|||
164168576|NCT04434469|592982692|FG004|Overall Study|Study terminated by sponsor|3|||
164168577|NCT04434469|592982693|FG005|Overall Study|Study terminated by sponsor|3|||
164168578|NCT04434469|592982688|FG000|Overall Study|Withdrawal by Subject|0|||
164168579|NCT04434469|592982689|FG001|Overall Study|Withdrawal by Subject|0|||
164168580|NCT04434469|592982690|FG002|Overall Study|Withdrawal by Subject|1|||
164168581|NCT04434469|592982691|FG003|Overall Study|Withdrawal by Subject|0|||
164168582|NCT04434469|592982692|FG004|Overall Study|Withdrawal by Subject|0|||
164168583|NCT04434469|592982693|FG005|Overall Study|Withdrawal by Subject|0|||
164168584|NCT01300338|592982695|FG000|Overall Study|Lost to Follow-up|5|||
164168585|NCT01300338|592982696|FG001|Overall Study|Lost to Follow-up|0|||
164168586|NCT02461524|592982697|FG000|Overall Study|Death|16|||
164168587|NCT02461524|592982697|FG000|Overall Study|Withdrawal by Subject|4|||
164168588|NCT02461524|592982697|FG000|Overall Study|Device Explanted|5|||
164168589|NCT02461524|592982697|FG000|Overall Study|Missed Visit|6|||
164168590|NCT00381238|592982701|FG000|Overall Study|Adverse Event|3|||
164168591|NCT00381238|592982701|FG000|Overall Study|Protocol Violation|1|||
164168592|NCT00381238|592982701|FG000|Overall Study|Withdrawal by Subject|4|||
164168593|NCT00381238|592982701|FG000|Overall Study|Lack of Efficacy|2|||
164168594|NCT00381238|592982701|FG000|Overall Study|Withdrew by physician|1|||
164168595|NCT00381238|592982701|FG000|Overall Study|Disease progression|1|||
164168596|NCT00843037|592982704|FG000|Overall Study|Lost to Follow-up|1|||
164168597|NCT03535194|592982705|FG000|Induction Period|Adverse Event|2|||
164168598|NCT03535194|592982706|FG001|Induction Period|Adverse Event|2|||
164168599|NCT03535194|592982707|FG002|Induction Period|Adverse Event|1|||
164168600|NCT03535194|592982708|FG003|Induction Period|Adverse Event|3|||
164168601|NCT03535194|592982709|FG004|Induction Period|Adverse Event|0|||
164168602|NCT03535194|592982705|FG000|Induction Period|Death|0|||
164168603|NCT03535194|592982706|FG001|Induction Period|Death|1|||
164168604|NCT03535194|592982707|FG002|Induction Period|Death|0|||
164168605|NCT03535194|592982708|FG003|Induction Period|Death|0|||
164168606|NCT03535194|592982709|FG004|Induction Period|Death|0|||
164168607|NCT03535194|592982705|FG000|Induction Period|Lack of Efficacy|1|||
164168608|NCT03535194|592982706|FG001|Induction Period|Lack of Efficacy|3|||
164168609|NCT03535194|592982707|FG002|Induction Period|Lack of Efficacy|2|||
164168610|NCT03535194|592982708|FG003|Induction Period|Lack of Efficacy|2|||
164168611|NCT03535194|592982709|FG004|Induction Period|Lack of Efficacy|0|||
164168612|NCT03535194|592982705|FG000|Induction Period|Lost to Follow-up|3|||
164168613|NCT03535194|592982706|FG001|Induction Period|Lost to Follow-up|5|||
164168614|NCT03535194|592982707|FG002|Induction Period|Lost to Follow-up|2|||
164168615|NCT03535194|592982708|FG003|Induction Period|Lost to Follow-up|3|||
164168616|NCT03535194|592982709|FG004|Induction Period|Lost to Follow-up|0|||
164168617|NCT03535194|592982705|FG000|Induction Period|Physician Decision|1|||
164168618|NCT03535194|592982706|FG001|Induction Period|Physician Decision|1|||
164168619|NCT03535194|592982707|FG002|Induction Period|Physician Decision|0|||
164168620|NCT03535194|592982708|FG003|Induction Period|Physician Decision|0|||
164168621|NCT03535194|592982709|FG004|Induction Period|Physician Decision|0|||
164168622|NCT03535194|592982705|FG000|Induction Period|Protocol Violation|1|||
164168623|NCT03535194|592982706|FG001|Induction Period|Protocol Violation|0|||
164168624|NCT03535194|592982707|FG002|Induction Period|Protocol Violation|0|||
164168625|NCT03535194|592982708|FG003|Induction Period|Protocol Violation|1|||
164168626|NCT03535194|592982709|FG004|Induction Period|Protocol Violation|0|||
164168627|NCT03535194|592982705|FG000|Induction Period|Screen Failure|0|||
164168628|NCT03535194|592982706|FG001|Induction Period|Screen Failure|1|||
164168629|NCT03535194|592982707|FG002|Induction Period|Screen Failure|0|||
164168630|NCT03535194|592982708|FG003|Induction Period|Screen Failure|0|||
164168631|NCT03535194|592982709|FG004|Induction Period|Screen Failure|0|||
164168632|NCT03535194|592982705|FG000|Induction Period|Withdrawal by Subject|3|||
164168633|NCT03535194|592982706|FG001|Induction Period|Withdrawal by Subject|4|||
164168634|NCT03535194|592982707|FG002|Induction Period|Withdrawal by Subject|3|||
164168635|NCT03535194|592982708|FG003|Induction Period|Withdrawal by Subject|2|||
164168636|NCT03535194|592982709|FG004|Induction Period|Withdrawal by Subject|0|||
164168637|NCT03535194|592982705|FG000|Maintenance Period|Adverse Event|6|||
164168638|NCT03535194|592982706|FG001|Maintenance Period|Adverse Event|5|||
164168639|NCT03535194|592982707|FG002|Maintenance Period|Adverse Event|1|||
164168640|NCT03535194|592982708|FG003|Maintenance Period|Adverse Event|11|||
164168641|NCT03535194|592982709|FG004|Maintenance Period|Adverse Event|4|||
164168642|NCT03535194|592982705|FG000|Maintenance Period|Lack of Efficacy|3|||
164168643|NCT03535194|592982706|FG001|Maintenance Period|Lack of Efficacy|2|||
164168644|NCT03535194|592982707|FG002|Maintenance Period|Lack of Efficacy|5|||
164168645|NCT03535194|592982708|FG003|Maintenance Period|Lack of Efficacy|9|||
164168646|NCT03535194|592982709|FG004|Maintenance Period|Lack of Efficacy|0|||
164168647|NCT03535194|592982705|FG000|Maintenance Period|Lost to Follow-up|4|||
164168648|NCT03535194|592982706|FG001|Maintenance Period|Lost to Follow-up|2|||
164168649|NCT03535194|592982707|FG002|Maintenance Period|Lost to Follow-up|1|||
164168650|NCT03535194|592982708|FG003|Maintenance Period|Lost to Follow-up|5|||
164168651|NCT03535194|592982709|FG004|Maintenance Period|Lost to Follow-up|2|||
164168652|NCT03535194|592982705|FG000|Maintenance Period|Other|1|||
164168653|NCT03535194|592982706|FG001|Maintenance Period|Other|2|||
164168654|NCT03535194|592982707|FG002|Maintenance Period|Other|0|||
164168655|NCT03535194|592982708|FG003|Maintenance Period|Other|0|||
164168656|NCT03535194|592982709|FG004|Maintenance Period|Other|0|||
164168657|NCT03535194|592982705|FG000|Maintenance Period|Physician Decision|1|||
164168658|NCT03535194|592982706|FG001|Maintenance Period|Physician Decision|2|||
164168659|NCT03535194|592982707|FG002|Maintenance Period|Physician Decision|0|||
164168660|NCT03535194|592982708|FG003|Maintenance Period|Physician Decision|2|||
164168661|NCT03535194|592982709|FG004|Maintenance Period|Physician Decision|0|||
164168662|NCT03535194|592982705|FG000|Maintenance Period|Pregnancy|0|||
164168663|NCT03535194|592982706|FG001|Maintenance Period|Pregnancy|0|||
164168664|NCT03535194|592982707|FG002|Maintenance Period|Pregnancy|0|||
164168665|NCT03535194|592982708|FG003|Maintenance Period|Pregnancy|2|||
164168666|NCT03535194|592982709|FG004|Maintenance Period|Pregnancy|0|||
164168667|NCT03535194|592982705|FG000|Maintenance Period|Protocol Violation|0|||
164168668|NCT03535194|592982706|FG001|Maintenance Period|Protocol Violation|1|||
164168669|NCT03535194|592982707|FG002|Maintenance Period|Protocol Violation|0|||
164168670|NCT03535194|592982708|FG003|Maintenance Period|Protocol Violation|0|||
164168671|NCT03535194|592982709|FG004|Maintenance Period|Protocol Violation|0|||
164168672|NCT03535194|592982705|FG000|Maintenance Period|Withdrawal by Subject|7|||
164168673|NCT03535194|592982706|FG001|Maintenance Period|Withdrawal by Subject|2|||
164168674|NCT03535194|592982707|FG002|Maintenance Period|Withdrawal by Subject|1|||
164168675|NCT03535194|592982708|FG003|Maintenance Period|Withdrawal by Subject|8|||
164168676|NCT03535194|592982709|FG004|Maintenance Period|Withdrawal by Subject|0|||
164168677|NCT03535194|592982705|FG000|Post-Treatment Followup Period|Adverse Event|4|||
164168678|NCT03535194|592982706|FG001|Post-Treatment Followup Period|Adverse Event|5|||
164168679|NCT03535194|592982707|FG002|Post-Treatment Followup Period|Adverse Event|1|||
164168680|NCT03535194|592982708|FG003|Post-Treatment Followup Period|Adverse Event|8|||
164168681|NCT03535194|592982709|FG004|Post-Treatment Followup Period|Adverse Event|0|||
164168682|NCT03535194|592982705|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
164168683|NCT03535194|592982706|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
164168684|NCT03535194|592982707|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
164168685|NCT03535194|592982708|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
164168686|NCT03535194|592982709|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
164168687|NCT03535194|592982705|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
164168688|NCT03535194|592982706|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
164168689|NCT03535194|592982707|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
164168690|NCT03535194|592982708|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
164168691|NCT03535194|592982709|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
164168692|NCT03535194|592982705|FG000|Post-Treatment Followup Period|Other|1|||
164168693|NCT03535194|592982706|FG001|Post-Treatment Followup Period|Other|0|||
164168694|NCT03535194|592982707|FG002|Post-Treatment Followup Period|Other|0|||
164168695|NCT03535194|592982708|FG003|Post-Treatment Followup Period|Other|5|||
164168696|NCT03535194|592982709|FG004|Post-Treatment Followup Period|Other|0|||
164168697|NCT03535194|592982705|FG000|Post-Treatment Followup Period|Physician Decision|0|||
164168698|NCT03535194|592982706|FG001|Post-Treatment Followup Period|Physician Decision|2|||
164168699|NCT03535194|592982707|FG002|Post-Treatment Followup Period|Physician Decision|1|||
164168700|NCT03535194|592982708|FG003|Post-Treatment Followup Period|Physician Decision|1|||
164168701|NCT03535194|592982709|FG004|Post-Treatment Followup Period|Physician Decision|0|||
164168702|NCT03535194|592982705|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
164168703|NCT03535194|592982706|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
164168704|NCT03535194|592982707|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
164168705|NCT03535194|592982708|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
164168706|NCT03535194|592982709|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164168707|NCT04411810|592982710|FG000|Overall Study|Screen failure|1|||
164168708|NCT04411810|592982710|FG000|Overall Study|Withdrawal by Subject|1|||
164168709|NCT02564900|592982711|FG000|Dose Escalation|Progressive disease per RECIST|2|||
164168710|NCT02564900|592982712|FG001|Dose Escalation|Progressive disease per RECIST|3|||
164168711|NCT02564900|592982713|FG002|Dose Escalation|Progressive disease per RECIST|3|||
164168712|NCT02564900|592982714|FG003|Dose Escalation|Progressive disease per RECIST|3|||
164168713|NCT02564900|592982715|FG004|Dose Escalation|Progressive disease per RECIST|3|||
164168714|NCT02564900|592982716|FG005|Dose Escalation|Progressive disease per RECIST|1|||
164168715|NCT02564900|592982717|FG006|Dose Escalation|Progressive disease per RECIST|0|||
164168716|NCT02564900|592982718|FG007|Dose Escalation|Progressive disease per RECIST|0|||
164168717|NCT02564900|592982719|FG008|Dose Escalation|Progressive disease per RECIST|0|||
164168718|NCT02564900|592982720|FG009|Dose Escalation|Progressive disease per RECIST|0|||
164168719|NCT02564900|592982721|FG010|Dose Escalation|Progressive disease per RECIST|0|||
164168720|NCT02564900|592982722|FG011|Dose Escalation|Progressive disease per RECIST|0|||
164168721|NCT02564900|592982723|FG012|Dose Escalation|Progressive disease per RECIST|0|||
164168722|NCT02564900|592982724|FG013|Dose Escalation|Progressive disease per RECIST|0|||
164168723|NCT02564900|592982725|FG014|Dose Escalation|Progressive disease per RECIST|0|||
164168724|NCT02564900|592982711|FG000|Dose Escalation|Ongoing|1|||
164168725|NCT02564900|592982712|FG001|Dose Escalation|Ongoing|0|||
164168726|NCT02564900|592982713|FG002|Dose Escalation|Ongoing|0|||
164168727|NCT02564900|592982714|FG003|Dose Escalation|Ongoing|2|||
164168728|NCT02564900|592982715|FG004|Dose Escalation|Ongoing|2|||
164168729|NCT02564900|592982716|FG005|Dose Escalation|Ongoing|2|||
164168730|NCT02564900|592982717|FG006|Dose Escalation|Ongoing|0|||
164168731|NCT02564900|592982718|FG007|Dose Escalation|Ongoing|0|||
164168732|NCT02564900|592982719|FG008|Dose Escalation|Ongoing|0|||
164168733|NCT02564900|592982720|FG009|Dose Escalation|Ongoing|0|||
164168734|NCT02564900|592982721|FG010|Dose Escalation|Ongoing|0|||
164168735|NCT02564900|592982722|FG011|Dose Escalation|Ongoing|0|||
164168736|NCT02564900|592982723|FG012|Dose Escalation|Ongoing|0|||
164168737|NCT02564900|592982724|FG013|Dose Escalation|Ongoing|0|||
164168738|NCT02564900|592982725|FG014|Dose Escalation|Ongoing|0|||
164168739|NCT02564900|592982711|FG000|Dose Escalation|Adverse Event|0|||
164168740|NCT02564900|592982712|FG001|Dose Escalation|Adverse Event|0|||
164168741|NCT02564900|592982713|FG002|Dose Escalation|Adverse Event|0|||
164168742|NCT02564900|592982714|FG003|Dose Escalation|Adverse Event|1|||
164168743|NCT02564900|592982715|FG004|Dose Escalation|Adverse Event|1|||
164168744|NCT02564900|592982716|FG005|Dose Escalation|Adverse Event|3|||
164168745|NCT02564900|592982717|FG006|Dose Escalation|Adverse Event|0|||
164168746|NCT02564900|592982718|FG007|Dose Escalation|Adverse Event|0|||
164168747|NCT02564900|592982719|FG008|Dose Escalation|Adverse Event|0|||
164168748|NCT02564900|592982720|FG009|Dose Escalation|Adverse Event|0|||
164168749|NCT02564900|592982721|FG010|Dose Escalation|Adverse Event|0|||
164168750|NCT02564900|592982722|FG011|Dose Escalation|Adverse Event|0|||
164168751|NCT02564900|592982723|FG012|Dose Escalation|Adverse Event|0|||
164168752|NCT02564900|592982724|FG013|Dose Escalation|Adverse Event|0|||
164168753|NCT02564900|592982725|FG014|Dose Escalation|Adverse Event|0|||
164168754|NCT02564900|592982711|FG000|Dose Expansion|Progressive disease per RECIST|0|||
164168755|NCT02564900|592982712|FG001|Dose Expansion|Progressive disease per RECIST|0|||
164168756|NCT02564900|592982713|FG002|Dose Expansion|Progressive disease per RECIST|0|||
164168757|NCT02564900|592982714|FG003|Dose Expansion|Progressive disease per RECIST|0|||
164168758|NCT02564900|592982715|FG004|Dose Expansion|Progressive disease per RECIST|0|||
164168759|NCT02564900|592982716|FG005|Dose Expansion|Progressive disease per RECIST|0|||
164168760|NCT02564900|592982717|FG006|Dose Expansion|Progressive disease per RECIST|19|||
164168761|NCT02564900|592982718|FG007|Dose Expansion|Progressive disease per RECIST|17|||
164168762|NCT02564900|592982719|FG008|Dose Expansion|Progressive disease per RECIST|8|||
164168763|NCT02564900|592982720|FG009|Dose Expansion|Progressive disease per RECIST|16|||
164168764|NCT02564900|592982721|FG010|Dose Expansion|Progressive disease per RECIST|13|||
164168765|NCT02564900|592982722|FG011|Dose Expansion|Progressive disease per RECIST|19|||
164168766|NCT02564900|592982723|FG012|Dose Expansion|Progressive disease per RECIST|10|||
164168767|NCT02564900|592982724|FG013|Dose Expansion|Progressive disease per RECIST|13|||
164168768|NCT02564900|592982725|FG014|Dose Expansion|Progressive disease per RECIST|11|||
164168769|NCT02564900|592982711|FG000|Dose Expansion|Clinical progression|0|||
164168770|NCT02564900|592982712|FG001|Dose Expansion|Clinical progression|0|||
164168771|NCT02564900|592982713|FG002|Dose Expansion|Clinical progression|0|||
164168772|NCT02564900|592982714|FG003|Dose Expansion|Clinical progression|0|||
164168773|NCT02564900|592982715|FG004|Dose Expansion|Clinical progression|0|||
164168774|NCT02564900|592982716|FG005|Dose Expansion|Clinical progression|0|||
164168775|NCT02564900|592982717|FG006|Dose Expansion|Clinical progression|5|||
164168776|NCT02564900|592982718|FG007|Dose Expansion|Clinical progression|12|||
164168777|NCT02564900|592982719|FG008|Dose Expansion|Clinical progression|0|||
164168778|NCT02564900|592982720|FG009|Dose Expansion|Clinical progression|3|||
164168779|NCT02564900|592982721|FG010|Dose Expansion|Clinical progression|2|||
164168780|NCT02564900|592982722|FG011|Dose Expansion|Clinical progression|0|||
164168781|NCT02564900|592982723|FG012|Dose Expansion|Clinical progression|1|||
164168782|NCT02564900|592982724|FG013|Dose Expansion|Clinical progression|3|||
164168783|NCT02564900|592982725|FG014|Dose Expansion|Clinical progression|1|||
164168784|NCT02564900|592982711|FG000|Dose Expansion|Adverse Event|0|||
164168785|NCT02564900|592982712|FG001|Dose Expansion|Adverse Event|0|||
164168786|NCT02564900|592982713|FG002|Dose Expansion|Adverse Event|0|||
164168787|NCT02564900|592982714|FG003|Dose Expansion|Adverse Event|0|||
164168788|NCT02564900|592982715|FG004|Dose Expansion|Adverse Event|0|||
164168789|NCT02564900|592982716|FG005|Dose Expansion|Adverse Event|0|||
164168790|NCT02564900|592982717|FG006|Dose Expansion|Adverse Event|9|||
164168791|NCT02564900|592982718|FG007|Dose Expansion|Adverse Event|22|||
164168792|NCT02564900|592982719|FG008|Dose Expansion|Adverse Event|0|||
164168793|NCT02564900|592982720|FG009|Dose Expansion|Adverse Event|11|||
164168794|NCT02564900|592982721|FG010|Dose Expansion|Adverse Event|0|||
164168795|NCT02564900|592982722|FG011|Dose Expansion|Adverse Event|5|||
164168796|NCT02564900|592982723|FG012|Dose Expansion|Adverse Event|2|||
164168797|NCT02564900|592982724|FG013|Dose Expansion|Adverse Event|2|||
164168798|NCT02564900|592982725|FG014|Dose Expansion|Adverse Event|1|||
164168799|NCT02564900|592982711|FG000|Dose Expansion|Ongoing|0|||
164168800|NCT02564900|592982712|FG001|Dose Expansion|Ongoing|0|||
164168801|NCT02564900|592982713|FG002|Dose Expansion|Ongoing|0|||
164168802|NCT02564900|592982714|FG003|Dose Expansion|Ongoing|0|||
164168803|NCT02564900|592982715|FG004|Dose Expansion|Ongoing|0|||
164168804|NCT02564900|592982716|FG005|Dose Expansion|Ongoing|0|||
164168805|NCT02564900|592982717|FG006|Dose Expansion|Ongoing|9|||
164168806|NCT02564900|592982718|FG007|Dose Expansion|Ongoing|10|||
164168807|NCT02564900|592982719|FG008|Dose Expansion|Ongoing|11|||
164168808|NCT02564900|592982720|FG009|Dose Expansion|Ongoing|3|||
164168809|NCT02564900|592982721|FG010|Dose Expansion|Ongoing|0|||
164168810|NCT02564900|592982722|FG011|Dose Expansion|Ongoing|0|||
164168811|NCT02564900|592982723|FG012|Dose Expansion|Ongoing|4|||
164168812|NCT02564900|592982724|FG013|Dose Expansion|Ongoing|0|||
164168813|NCT02564900|592982725|FG014|Dose Expansion|Ongoing|6|||
164168814|NCT02564900|592982711|FG000|Dose Expansion|Death|0|||
164168815|NCT02564900|592982712|FG001|Dose Expansion|Death|0|||
164168816|NCT02564900|592982713|FG002|Dose Expansion|Death|0|||
164168817|NCT02564900|592982714|FG003|Dose Expansion|Death|0|||
164168818|NCT02564900|592982715|FG004|Dose Expansion|Death|0|||
164168819|NCT02564900|592982716|FG005|Dose Expansion|Death|0|||
164168820|NCT02564900|592982717|FG006|Dose Expansion|Death|1|||
164168821|NCT02564900|592982718|FG007|Dose Expansion|Death|0|||
164168822|NCT02564900|592982719|FG008|Dose Expansion|Death|0|||
164168823|NCT02564900|592982720|FG009|Dose Expansion|Death|0|||
164168824|NCT02564900|592982721|FG010|Dose Expansion|Death|1|||
164168825|NCT02564900|592982722|FG011|Dose Expansion|Death|0|||
164168826|NCT02564900|592982723|FG012|Dose Expansion|Death|1|||
164168827|NCT02564900|592982724|FG013|Dose Expansion|Death|1|||
164168828|NCT02564900|592982725|FG014|Dose Expansion|Death|0|||
164168829|NCT02564900|592982711|FG000|Dose Expansion|Withdrawal by Subject|0|||
164168830|NCT02564900|592982712|FG001|Dose Expansion|Withdrawal by Subject|0|||
164168831|NCT02564900|592982713|FG002|Dose Expansion|Withdrawal by Subject|0|||
164168832|NCT02564900|592982714|FG003|Dose Expansion|Withdrawal by Subject|0|||
164168833|NCT02564900|592982715|FG004|Dose Expansion|Withdrawal by Subject|0|||
164168834|NCT02564900|592982716|FG005|Dose Expansion|Withdrawal by Subject|0|||
164168835|NCT02564900|592982717|FG006|Dose Expansion|Withdrawal by Subject|4|||
164168836|NCT02564900|592982718|FG007|Dose Expansion|Withdrawal by Subject|0|||
164168837|NCT02564900|592982719|FG008|Dose Expansion|Withdrawal by Subject|0|||
164168838|NCT02564900|592982720|FG009|Dose Expansion|Withdrawal by Subject|0|||
164168839|NCT02564900|592982721|FG010|Dose Expansion|Withdrawal by Subject|1|||
164168840|NCT02564900|592982722|FG011|Dose Expansion|Withdrawal by Subject|0|||
164168841|NCT02564900|592982723|FG012|Dose Expansion|Withdrawal by Subject|0|||
164168842|NCT02564900|592982724|FG013|Dose Expansion|Withdrawal by Subject|1|||
164168843|NCT02564900|592982725|FG014|Dose Expansion|Withdrawal by Subject|1|||
164168844|NCT02564900|592982711|FG000|Dose Expansion|Other|0|||
164168845|NCT02564900|592982712|FG001|Dose Expansion|Other|0|||
164168846|NCT02564900|592982713|FG002|Dose Expansion|Other|0|||
164168847|NCT02564900|592982714|FG003|Dose Expansion|Other|0|||
164168848|NCT02564900|592982715|FG004|Dose Expansion|Other|0|||
164168849|NCT02564900|592982716|FG005|Dose Expansion|Other|0|||
164168850|NCT02564900|592982717|FG006|Dose Expansion|Other|1|||
164168851|NCT02564900|592982718|FG007|Dose Expansion|Other|0|||
164168852|NCT02564900|592982719|FG008|Dose Expansion|Other|1|||
164168853|NCT02564900|592982720|FG009|Dose Expansion|Other|0|||
164168854|NCT02564900|592982721|FG010|Dose Expansion|Other|0|||
164168855|NCT02564900|592982722|FG011|Dose Expansion|Other|0|||
164168856|NCT02564900|592982723|FG012|Dose Expansion|Other|0|||
164168857|NCT02564900|592982724|FG013|Dose Expansion|Other|0|||
164168858|NCT02564900|592982725|FG014|Dose Expansion|Other|1|||
164168859|NCT02564900|592982711|FG000|Dose Expansion|Did not receive treatment|0|||
164168860|NCT02564900|592982712|FG001|Dose Expansion|Did not receive treatment|0|||
164168861|NCT02564900|592982713|FG002|Dose Expansion|Did not receive treatment|0|||
164168862|NCT02564900|592982714|FG003|Dose Expansion|Did not receive treatment|0|||
164168863|NCT02564900|592982715|FG004|Dose Expansion|Did not receive treatment|0|||
164168864|NCT02564900|592982716|FG005|Dose Expansion|Did not receive treatment|0|||
164168865|NCT02564900|592982717|FG006|Dose Expansion|Did not receive treatment|1|||
164168866|NCT02564900|592982718|FG007|Dose Expansion|Did not receive treatment|1|||
164168867|NCT02564900|592982719|FG008|Dose Expansion|Did not receive treatment|0|||
164168868|NCT02564900|592982720|FG009|Dose Expansion|Did not receive treatment|0|||
164168869|NCT02564900|592982721|FG010|Dose Expansion|Did not receive treatment|0|||
164168870|NCT02564900|592982722|FG011|Dose Expansion|Did not receive treatment|0|||
164168871|NCT02564900|592982723|FG012|Dose Expansion|Did not receive treatment|0|||
164168872|NCT02564900|592982724|FG013|Dose Expansion|Did not receive treatment|0|||
164168873|NCT02564900|592982725|FG014|Dose Expansion|Did not receive treatment|1|||
164168874|NCT03991299|592982729|FG000|Overall Study|Study closed, sponsor decision|3|||
164168875|NCT03991299|592982729|FG000|Overall Study|Withdrawal by Subject|1|||
164168876|NCT04304235|592982730|FG000|Overall Study|incomplete triage data|0|||
164168877|NCT04304235|592982731|FG001|Overall Study|incomplete triage data|69|||
164168878|NCT04304235|592982732|FG002|Overall Study|incomplete triage data|0|||
164168879|NCT04304235|592982733|FG003|Overall Study|incomplete triage data|0|||
164168880|NCT04304235|592982734|FG004|Overall Study|incomplete triage data|289|||
164168881|NCT04304235|592982735|FG005|Overall Study|incomplete triage data|123|||
164168882|NCT04304235|592982736|FG006|Overall Study|incomplete triage data|65|||
164168883|NCT04470544|592982737|FG000|Overall Study|Withdrawal by Subject|4|||
164168884|NCT04470544|592982738|FG001|Overall Study|Withdrawal by Subject|6|||
164168885|NCT02005692|592982739|FG000|Overall Study|Protocol Violation|1|||
164168886|NCT02005692|592982739|FG000|Overall Study|Withdrawal by Subject|1|||
164168887|NCT02005692|592982739|FG000|Overall Study|Discharged earlier than anticipated|5|||
164168888|NCT04967885|592982740|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
164168889|NCT04967885|592982741|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
164168890|NCT04967885|592982740|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
164168891|NCT04967885|592982741|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
164168892|NCT04967885|592982740|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
164168893|NCT04967885|592982741|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
164168894|NCT04967885|592982740|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
164168895|NCT04967885|592982741|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
164168896|NCT04967885|592982740|FG000|EMI-II Intervention|Lost to Follow-up|14|||
164168897|NCT04967885|592982741|FG001|EMI-II Intervention|Lost to Follow-up|10|||
164168898|NCT01011465|592982742|FG000|Overall Study|Withdrawal by Subject|2|||
164168899|NCT01011465|592982743|FG001|Overall Study|Withdrawal by Subject|1|||
164168900|NCT01011465|592982744|FG002|Overall Study|Withdrawal by Subject|0|||
164168901|NCT01011465|592982745|FG003|Overall Study|Withdrawal by Subject|0|||
164168902|NCT01011465|592982746|FG004|Overall Study|Withdrawal by Subject|1|||
164168903|NCT01011465|592982747|FG005|Overall Study|Withdrawal by Subject|0|||
164168904|NCT01011465|592982748|FG006|Overall Study|Withdrawal by Subject|1|||
164168905|NCT01011465|592982749|FG007|Overall Study|Withdrawal by Subject|0|||
164168906|NCT02042950|592982752|FG000|Overall Study|Progressive Disease|4|||
164168907|NCT00723008|592982753|FG000|Enrollment|Lost to Follow-up|1|||
164168908|NCT00723008|592982754|FG001|Enrollment|Lost to Follow-up|0|||
164168909|NCT00723008|592982753|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
164168910|NCT00723008|592982754|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
164168911|NCT00723008|592982753|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
164168912|NCT00723008|592982754|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
164168913|NCT00723008|592982753|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
164168914|NCT00723008|592982754|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
164168915|NCT00723008|592982753|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
164168916|NCT00723008|592982754|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
164168917|NCT00723008|592982753|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
164168918|NCT00723008|592982754|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
164168919|NCT05896527|592982755|FG000|Overall Study|Withdrawal by Subject|11|||
164168920|NCT05896527|592982756|FG001|Overall Study|Withdrawal by Subject|10|||
164168921|NCT05896527|592982757|FG002|Overall Study|Withdrawal by Subject|4|||
164168922|NCT05896527|592982758|FG003|Overall Study|Withdrawal by Subject|3|||
164168923|NCT05896527|592982759|FG004|Overall Study|Withdrawal by Subject|2|||
164168924|NCT05896527|592982755|FG000|Overall Study|Lost to Follow-up|0|||
164168925|NCT05896527|592982756|FG001|Overall Study|Lost to Follow-up|2|||
164168926|NCT05896527|592982757|FG002|Overall Study|Lost to Follow-up|2|||
164168927|NCT05896527|592982758|FG003|Overall Study|Lost to Follow-up|2|||
164168928|NCT05896527|592982759|FG004|Overall Study|Lost to Follow-up|1|||
164168929|NCT05896527|592982755|FG000|Overall Study|Significant protocol noncompliance|0|||
164168930|NCT05896527|592982756|FG001|Overall Study|Significant protocol noncompliance|1|||
164168931|NCT05896527|592982757|FG002|Overall Study|Significant protocol noncompliance|0|||
164168932|NCT05896527|592982758|FG003|Overall Study|Significant protocol noncompliance|0|||
164168933|NCT05896527|592982759|FG004|Overall Study|Significant protocol noncompliance|0|||
164168934|NCT05896527|592982755|FG000|Overall Study|Eligibility criteria not met|1|||
164168935|NCT05896527|592982756|FG001|Overall Study|Eligibility criteria not met|0|||
164168936|NCT05896527|592982757|FG002|Overall Study|Eligibility criteria not met|0|||
164168937|NCT05896527|592982758|FG003|Overall Study|Eligibility criteria not met|0|||
164168938|NCT05896527|592982759|FG004|Overall Study|Eligibility criteria not met|0|||
164168939|NCT05896527|592982755|FG000|Overall Study|Sponsor's decision|0|||
164168940|NCT05896527|592982756|FG001|Overall Study|Sponsor's decision|0|||
164168941|NCT05896527|592982757|FG002|Overall Study|Sponsor's decision|0|||
164168942|NCT05896527|592982758|FG003|Overall Study|Sponsor's decision|1|||
164168943|NCT05896527|592982759|FG004|Overall Study|Sponsor's decision|0|||
164168944|NCT05896527|592982755|FG000|Overall Study|Investigator's decision|0|||
164168945|NCT05896527|592982756|FG001|Overall Study|Investigator's decision|1|||
164168946|NCT05896527|592982757|FG002|Overall Study|Investigator's decision|0|||
164168947|NCT05896527|592982758|FG003|Overall Study|Investigator's decision|0|||
164168948|NCT05896527|592982759|FG004|Overall Study|Investigator's decision|0|||
164168949|NCT05896527|592982755|FG000|Overall Study|Pregnancy of his partner|0|||
164168950|NCT05896527|592982756|FG001|Overall Study|Pregnancy of his partner|0|||
164168951|NCT05896527|592982757|FG002|Overall Study|Pregnancy of his partner|0|||
164168952|NCT05896527|592982758|FG003|Overall Study|Pregnancy of his partner|1|||
164168953|NCT05896527|592982759|FG004|Overall Study|Pregnancy of his partner|0|||
164168954|NCT01279070|592982760|FG000|Overall Study|Withdrawal by Subject|2|||
164168955|NCT01279070|592982761|FG001|Overall Study|Withdrawal by Subject|3|||
164168956|NCT01279070|592982760|FG000|Overall Study|Acute exacerbation|3|||
164168957|NCT01279070|592982761|FG001|Overall Study|Acute exacerbation|1|||
164168958|NCT02217410|592982768|FG000|Overall Study|Graft Loss|0|||
164168959|NCT02217410|592982769|FG001|Overall Study|Graft Loss|0|||
164168960|NCT02217410|592982770|FG002|Overall Study|Graft Loss|2|||
164168961|NCT02217410|592982768|FG000|Overall Study|Withdrawal by Subject|0|||
164168962|NCT02217410|592982769|FG001|Overall Study|Withdrawal by Subject|0|||
164168963|NCT02217410|592982770|FG002|Overall Study|Withdrawal by Subject|2|||
164168964|NCT02217410|592982768|FG000|Overall Study|Lost to Follow-up|0|||
164168965|NCT02217410|592982769|FG001|Overall Study|Lost to Follow-up|0|||
164168966|NCT02217410|592982770|FG002|Overall Study|Lost to Follow-up|1|||
164168967|NCT02217410|592982768|FG000|Overall Study|Lack of Efficacy|0|||
164168968|NCT02217410|592982769|FG001|Overall Study|Lack of Efficacy|1|||
164168969|NCT02217410|592982770|FG002|Overall Study|Lack of Efficacy|0|||
164168970|NCT02217410|592982768|FG000|Overall Study|Physician Decision|1|||
164168971|NCT02217410|592982769|FG001|Overall Study|Physician Decision|3|||
164168972|NCT02217410|592982770|FG002|Overall Study|Physician Decision|0|||
164168973|NCT00626821|592982773|FG000|Overall Study|Adverse Event|44|||
164168974|NCT00626821|592982773|FG000|Overall Study|Protocol Violation|33|||
164168975|NCT00626821|592982773|FG000|Overall Study|Withdrawal by Subject|10|||
164168976|NCT00626821|592982773|FG000|Overall Study|Physician Decision|9|||
164168977|NCT00626821|592982773|FG000|Overall Study|Product dysfunction|21|||
164168978|NCT00626821|592982773|FG000|Overall Study|other/unknown reason|104|||
164168979|NCT01940887|592982774|FG000|Year 1|Protocol Violation|0|||
164168980|NCT01940887|592982775|FG001|Year 1|Protocol Violation|1|||
164168981|NCT01940887|592982774|FG000|Year 1|Physician Decision|7|||
164168982|NCT01940887|592982775|FG001|Year 1|Physician Decision|3|||
164168983|NCT01940887|592982774|FG000|Year 1|Death|5|||
164168984|NCT01940887|592982775|FG001|Year 1|Death|3|||
164168985|NCT01940887|592982774|FG000|Year 1|Adverse Event|7|||
164168986|NCT01940887|592982775|FG001|Year 1|Adverse Event|6|||
164168987|NCT01940887|592982774|FG000|Year 1|Withdrawal by Subject|18|||
164168988|NCT01940887|592982775|FG001|Year 1|Withdrawal by Subject|9|||
164168989|NCT01940887|592982774|FG000|Year 1|Lost to Follow-up|2|||
164168990|NCT01940887|592982775|FG001|Year 1|Lost to Follow-up|1|||
164168991|NCT01940887|592982774|FG000|Year 2|Physician Decision|8|||
164168992|NCT01940887|592982775|FG001|Year 2|Physician Decision|1|||
164168993|NCT01940887|592982774|FG000|Year 2|Death|0|||
164168994|NCT01940887|592982775|FG001|Year 2|Death|2|||
164168995|NCT01940887|592982774|FG000|Year 2|Sponsor Decision, early termination|192|||
164168996|NCT01940887|592982775|FG001|Year 2|Sponsor Decision, early termination|203|||
164168997|NCT01940887|592982774|FG000|Year 2|Adverse Event|8|||
164168998|NCT01940887|592982775|FG001|Year 2|Adverse Event|2|||
164168999|NCT01940887|592982774|FG000|Year 2|Withdrawal by Subject|8|||
164169000|NCT01940887|592982775|FG001|Year 2|Withdrawal by Subject|8|||
164169001|NCT01940887|592982774|FG000|Year 2|Lost to Follow-up|1|||
164169002|NCT01940887|592982775|FG001|Year 2|Lost to Follow-up|6|||
164169003|NCT01471340|592982779|FG000|Overall Study|Death|5|||
164169004|NCT01471340|592982780|FG001|Overall Study|Death|4|||
164169005|NCT01471340|592982779|FG000|Overall Study|Lost to Follow-up|0|||
164169006|NCT01471340|592982780|FG001|Overall Study|Lost to Follow-up|1|||
164169007|NCT01471340|592982779|FG000|Overall Study|Investigational site closure|0|||
164169008|NCT01471340|592982780|FG001|Overall Study|Investigational site closure|1|||
164169009|NCT01471340|592982779|FG000|Overall Study|Invalid informed consent|1|||
164169010|NCT01471340|592982780|FG001|Overall Study|Invalid informed consent|0|||
164169011|NCT02475265|592982781|FG000|Overall Study|Physician Decision|1|||
164169012|NCT02475265|592982781|FG000|Overall Study|Withdrawal by Subject|2|||
164169013|NCT02218736|592982785|FG000|Overall Study|Withdrawal by Subject|10|||
164169014|NCT02218736|592982786|FG001|Overall Study|Withdrawal by Subject|9|||
164169015|NCT02218736|592982785|FG000|Overall Study|Protocol Violation|2|||
164169016|NCT02218736|592982786|FG001|Overall Study|Protocol Violation|0|||
164169017|NCT03452488|592982787|FG000|Overall Study|Adverse Event|4|||
164169018|NCT03452488|592982788|FG001|Overall Study|Adverse Event|6|||
164169019|NCT03452488|592982789|FG002|Overall Study|Adverse Event|1|||
164169020|NCT03452488|592982787|FG000|Overall Study|Death|0|||
164169021|NCT03452488|592982788|FG001|Overall Study|Death|0|||
164169022|NCT03452488|592982789|FG002|Overall Study|Death|1|||
164169023|NCT03452488|592982787|FG000|Overall Study|Lost to Follow-up|1|||
164169024|NCT03452488|592982788|FG001|Overall Study|Lost to Follow-up|2|||
164169025|NCT03452488|592982789|FG002|Overall Study|Lost to Follow-up|0|||
164169026|NCT03452488|592982787|FG000|Overall Study|PI Decision|1|||
164169027|NCT03452488|592982788|FG001|Overall Study|PI Decision|0|||
164169028|NCT03452488|592982789|FG002|Overall Study|PI Decision|0|||
164169029|NCT03452488|592982787|FG000|Overall Study|Withdrew consent|4|||
164169030|NCT03452488|592982788|FG001|Overall Study|Withdrew consent|2|||
164169031|NCT03452488|592982789|FG002|Overall Study|Withdrew consent|2|||
164169032|NCT03452488|592982787|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
164169033|NCT03452488|592982788|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
164169034|NCT03452488|592982789|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
164169035|NCT03452488|592982787|FG000|Overall Study|Other|0|||
164169036|NCT03452488|592982788|FG001|Overall Study|Other|2|||
164169037|NCT03452488|592982789|FG002|Overall Study|Other|2|||
164169038|NCT01876784|592982792|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
164169039|NCT01876784|592982793|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
164169040|NCT01876784|592982792|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
164169041|NCT01876784|592982793|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
164169042|NCT01876784|592982792|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
164169043|NCT01876784|592982793|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
164169044|NCT01876784|592982792|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
164169045|NCT01876784|592982793|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
164169046|NCT01876784|592982792|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
164169047|NCT01876784|592982793|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
164169048|NCT01876784|592982792|FG000|Randomized Treatment Period (40 Months)|Death|1|||
164169049|NCT01876784|592982793|FG001|Randomized Treatment Period (40 Months)|Death|0|||
164169050|NCT01876784|592982792|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
164169051|NCT01876784|592982793|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
164169052|NCT01876784|592982792|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
164169053|NCT01876784|592982793|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
164169054|NCT01876784|592982792|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
164169055|NCT01876784|592982793|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
164169056|NCT01876784|592982792|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
164169057|NCT01876784|592982793|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
164169058|NCT01876784|592982792|FG000|Open-label Period (31 Months)|Adverse Event|2|||
164169059|NCT01876784|592982793|FG001|Open-label Period (31 Months)|Adverse Event|6|||
164169060|NCT01876784|592982792|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
164169061|NCT01876784|592982793|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
164169062|NCT01876784|592982792|FG000|Open-label Period (31 Months)|Progressive disease|4|||
164169063|NCT01876784|592982793|FG001|Open-label Period (31 Months)|Progressive disease|35|||
164169064|NCT01876784|592982792|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
164169065|NCT01876784|592982793|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
164169066|NCT01876784|592982792|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
164169067|NCT01876784|592982793|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
164169068|NCT01876784|592982792|FG000|Open-label Period (31 Months)|Death|0|||
164169069|NCT01876784|592982793|FG001|Open-label Period (31 Months)|Death|1|||
164169070|NCT01876784|592982792|FG000|Open-label Period (31 Months)|Other than specified above|9|||
164169071|NCT01876784|592982793|FG001|Open-label Period (31 Months)|Other than specified above|18|||
164169072|NCT03047720|592982794|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
164169073|NCT03047720|592982795|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
164169074|NCT01475851|592982796|FG000|Overall Study|Protocol defined stopping criteria|1|||
164169075|NCT01475851|592982797|FG001|Overall Study|Protocol defined stopping criteria|0|||
164169076|NCT04603482|592982798|FG000|Overall Study|Lost to Follow-up|15|||
164169077|NCT04603482|592982799|FG001|Overall Study|Lost to Follow-up|15|||
164169078|NCT04603482|592982800|FG002|Overall Study|Lost to Follow-up|15|||
164169079|NCT00732758|592982801|FG000|Overall Study|Lost to Follow-up|8|||
164169080|NCT00732758|592982802|FG001|Overall Study|Lost to Follow-up|16|||
164169081|NCT00373958|592982803|FG000|Infant Series|Withdrawal by Subject|13|||
164169082|NCT00373958|592982804|FG001|Infant Series|Withdrawal by Subject|15|||
164169083|NCT00373958|592982803|FG000|Infant Series|Failed to return|8|||
164169084|NCT00373958|592982804|FG001|Infant Series|Failed to return|13|||
164169085|NCT00373958|592982803|FG000|Infant Series|Lost to Follow-up|6|||
164169086|NCT00373958|592982804|FG001|Infant Series|Lost to Follow-up|5|||
164169087|NCT00373958|592982803|FG000|Infant Series|Protocol Violation|3|||
164169088|NCT00373958|592982804|FG001|Infant Series|Protocol Violation|7|||
164169089|NCT00373958|592982803|FG000|Infant Series|Lost Kaiser coverage|4|||
164169090|NCT00373958|592982804|FG001|Infant Series|Lost Kaiser coverage|0|||
164169091|NCT00373958|592982803|FG000|Infant Series|Child relocated|1|||
164169092|NCT00373958|592982804|FG001|Infant Series|Child relocated|0|||
164169093|NCT00373958|592982803|FG000|Infant Series|Consent was not received|1|||
164169094|NCT00373958|592982804|FG001|Infant Series|Consent was not received|0|||
164169095|NCT00373958|592982803|FG000|Infant Series|Adverse Event|3|||
164169096|NCT00373958|592982804|FG001|Infant Series|Adverse Event|1|||
164169097|NCT00373958|592982803|FG000|Infant Series|Physician Decision|1|||
164169098|NCT00373958|592982804|FG001|Infant Series|Physician Decision|1|||
164169099|NCT00373958|592982803|FG000|Toddler Dose|Lost to Follow-up|5|||
164169100|NCT00373958|592982804|FG001|Toddler Dose|Lost to Follow-up|8|||
164169101|NCT00373958|592982803|FG000|Toddler Dose|Withdrawal by Subject|2|||
164169102|NCT00373958|592982804|FG001|Toddler Dose|Withdrawal by Subject|2|||
164169103|NCT00373958|592982803|FG000|Toddler Dose|Failed to return|1|||
164169104|NCT00373958|592982804|FG001|Toddler Dose|Failed to return|2|||
164169105|NCT00373958|592982803|FG000|Toddler Dose|Protocol Violation|0|||
164169106|NCT00373958|592982804|FG001|Toddler Dose|Protocol Violation|1|||
164169107|NCT00373958|592982803|FG000|Toddler Dose|Withdrawn after infant series|22|||
164169108|NCT00373958|592982804|FG001|Toddler Dose|Withdrawn after infant series|25|||
164169109|NCT01552915|592982805|FG000|Overall Study|Adverse Event|3|||
164169110|NCT01552915|592982806|FG001|Overall Study|Adverse Event|14|||
164169111|NCT01552915|592982807|FG002|Overall Study|Adverse Event|3|||
164169112|NCT01552915|592982805|FG000|Overall Study|Lost to Follow-up|4|||
164169113|NCT01552915|592982806|FG001|Overall Study|Lost to Follow-up|6|||
164169114|NCT01552915|592982807|FG002|Overall Study|Lost to Follow-up|5|||
164169115|NCT01552915|592982805|FG000|Overall Study|Withdrawal by Subject|6|||
164169116|NCT01552915|592982806|FG001|Overall Study|Withdrawal by Subject|4|||
164169117|NCT01552915|592982807|FG002|Overall Study|Withdrawal by Subject|5|||
164169118|NCT01552915|592982805|FG000|Overall Study|Protocol Violation|0|||
164169119|NCT01552915|592982806|FG001|Overall Study|Protocol Violation|4|||
164169120|NCT01552915|592982807|FG002|Overall Study|Protocol Violation|4|||
164169121|NCT01552915|592982805|FG000|Overall Study|Lack of Efficacy|8|||
164169122|NCT01552915|592982806|FG001|Overall Study|Lack of Efficacy|1|||
164169123|NCT01552915|592982807|FG002|Overall Study|Lack of Efficacy|4|||
164169124|NCT01552915|592982805|FG000|Overall Study|Other|2|||
164169125|NCT01552915|592982806|FG001|Overall Study|Other|0|||
164169126|NCT01552915|592982807|FG002|Overall Study|Other|6|||
164169127|NCT00179673|592982810|FG000|Overall Study|Adverse Event|7|||
164169128|NCT00179673|592982810|FG000|Overall Study|Lack of Efficacy|15|||
164169129|NCT00179673|592982810|FG000|Overall Study|Withdrawal by Subject|3|||
164169130|NCT00179673|592982810|FG000|Overall Study|Death|4|||
164169131|NCT00179673|592982810|FG000|Overall Study|Other Observations and options|14|||
164169132|NCT00492648|592982811|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
164169133|NCT00492648|592982812|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
164169134|NCT02387957|592982813|FG000|Overall Study|The study was discontinued|21|||
164169135|NCT02387957|592982814|FG001|Overall Study|The study was discontinued|21|||
164169136|NCT02387957|592982815|FG002|Overall Study|The study was discontinued|20|||
164169137|NCT02887248|592982816|FG000|Overall Study|Withdrawal by Subject|1|||
164169138|NCT02887248|592982816|FG000|Overall Study|Adverse Event|1|||
164169139|NCT02887248|592982816|FG000|Overall Study|Progressive Disease|1|||
164169140|NCT02294396|592982817|FG000|Overall Study|Adverse Event|26|||
164169141|NCT02294396|592982818|FG001|Overall Study|Adverse Event|25|||
164169142|NCT02294396|592982819|FG002|Overall Study|Adverse Event|21|||
164169143|NCT02294396|592982820|FG003|Overall Study|Adverse Event|24|||
164169144|NCT02294396|592982817|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
164169145|NCT02294396|592982818|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
164169146|NCT02294396|592982819|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
164169147|NCT02294396|592982820|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
164169148|NCT02294396|592982817|FG000|Overall Study|Withdrawal by Subject|8|||
164169149|NCT02294396|592982818|FG001|Overall Study|Withdrawal by Subject|6|||
164169150|NCT02294396|592982819|FG002|Overall Study|Withdrawal by Subject|6|||
164169151|NCT02294396|592982820|FG003|Overall Study|Withdrawal by Subject|8|||
164169152|NCT02294396|592982817|FG000|Overall Study|Lost to Follow-up|0|||
164169153|NCT02294396|592982818|FG001|Overall Study|Lost to Follow-up|0|||
164169154|NCT02294396|592982819|FG002|Overall Study|Lost to Follow-up|1|||
164169155|NCT02294396|592982820|FG003|Overall Study|Lost to Follow-up|1|||
164169156|NCT02294396|592982817|FG000|Overall Study|Protocol Deviation|3|||
164169157|NCT02294396|592982818|FG001|Overall Study|Protocol Deviation|2|||
164169158|NCT02294396|592982819|FG002|Overall Study|Protocol Deviation|2|||
164169159|NCT02294396|592982820|FG003|Overall Study|Protocol Deviation|1|||
164169160|NCT02294396|592982817|FG000|Overall Study|Miscellaneous|2|||
164169161|NCT02294396|592982818|FG001|Overall Study|Miscellaneous|0|||
164169162|NCT02294396|592982819|FG002|Overall Study|Miscellaneous|5|||
164169163|NCT02294396|592982820|FG003|Overall Study|Miscellaneous|2|||
164169164|NCT02120833|592982821|FG000|Overall Study|Adverse Event|1|||
164169165|NCT02120833|592982822|FG001|Overall Study|Adverse Event|0|||
164169166|NCT02120833|592982821|FG000|Overall Study|Withdrawal by Subject|2|||
164169167|NCT02120833|592982822|FG001|Overall Study|Withdrawal by Subject|0|||
164169168|NCT02120833|592982821|FG000|Overall Study|Lost to Follow-up|1|||
164169169|NCT02120833|592982822|FG001|Overall Study|Lost to Follow-up|1|||
164169170|NCT02438826|592982823|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
164169171|NCT02438826|592982824|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
164169172|NCT02438826|592982825|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
164169173|NCT02438826|592982826|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
164169174|NCT02438826|592982823|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
164169175|NCT02438826|592982824|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
164169176|NCT02438826|592982825|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
164169177|NCT02438826|592982826|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
164169178|NCT02438826|592982823|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
164169179|NCT02438826|592982824|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
164169180|NCT02438826|592982825|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
164169181|NCT02438826|592982826|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
164169182|NCT02438826|592982823|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
164169183|NCT02438826|592982824|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
164169184|NCT02438826|592982825|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
164169185|NCT02438826|592982826|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
164169186|NCT02438826|592982823|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
164169187|NCT02438826|592982824|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
164169188|NCT02438826|592982825|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
164169189|NCT02438826|592982826|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
164169190|NCT02438826|592982823|FG000|Open-Label Treatment Phase|Adverse Event|11|||
164169191|NCT02438826|592982824|FG001|Open-Label Treatment Phase|Adverse Event|6|||
164169192|NCT02438826|592982825|FG002|Open-Label Treatment Phase|Adverse Event|0|||
164169193|NCT02438826|592982826|FG003|Open-Label Treatment Phase|Adverse Event|0|||
164169194|NCT02438826|592982823|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
164169195|NCT02438826|592982824|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
164169196|NCT02438826|592982825|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
164169197|NCT02438826|592982826|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
164169198|NCT02438826|592982823|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
164169199|NCT02438826|592982824|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
164169200|NCT02438826|592982825|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
164169201|NCT02438826|592982826|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
164169202|NCT02438826|592982823|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
164169203|NCT02438826|592982824|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
164169204|NCT02438826|592982825|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
164169205|NCT02438826|592982826|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
164169206|NCT02438826|592982823|FG000|Post-Treatment Phase|Adverse Event|3|||
164169207|NCT02438826|592982824|FG001|Post-Treatment Phase|Adverse Event|0|||
164169208|NCT02438826|592982825|FG002|Post-Treatment Phase|Adverse Event|0|||
164169209|NCT02438826|592982826|FG003|Post-Treatment Phase|Adverse Event|0|||
164169210|NCT02438826|592982823|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
164169211|NCT02438826|592982824|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
164169212|NCT02438826|592982825|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
164169213|NCT02438826|592982826|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
164169214|NCT02438826|592982823|FG000|Post-Treatment Phase|Physician Decision|1|||
164169215|NCT02438826|592982824|FG001|Post-Treatment Phase|Physician Decision|0|||
164169216|NCT02438826|592982825|FG002|Post-Treatment Phase|Physician Decision|0|||
164169217|NCT02438826|592982826|FG003|Post-Treatment Phase|Physician Decision|0|||
164169218|NCT02438826|592982823|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
164169219|NCT02438826|592982824|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
164169220|NCT02438826|592982825|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
164169221|NCT02438826|592982826|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
164169222|NCT03613649|592982829|FG000|Second Treatment|Lost to Follow-up|0|||
164169223|NCT03613649|592982830|FG001|Second Treatment|Lost to Follow-up|0|||
164169224|NCT03613649|592982831|FG002|Second Treatment|Lost to Follow-up|1|||
164169225|NCT03613649|592982832|FG003|Second Treatment|Lost to Follow-up|0|||
164169226|NCT03613649|592982833|FG004|Second Treatment|Lost to Follow-up|0|||
164169227|NCT03613649|592982834|FG005|Second Treatment|Lost to Follow-up|0|||
164169228|NCT03613649|592982835|FG006|Second Treatment|Lost to Follow-up|0|||
164169229|NCT03613649|592982836|FG007|Second Treatment|Lost to Follow-up|0|||
164169230|NCT03613649|592982837|FG008|Second Treatment|Lost to Follow-up|0|||
164169231|NCT03613649|592982838|FG009|Second Treatment|Lost to Follow-up|0|||
164169232|NCT03613649|592982839|FG010|Second Treatment|Lost to Follow-up|0|||
164169233|NCT03613649|592982840|FG011|Second Treatment|Lost to Follow-up|0|||
164169234|NCT03613649|592982829|FG000|Second Treatment|Withdrawal by Subject|0|||
164169235|NCT03613649|592982830|FG001|Second Treatment|Withdrawal by Subject|0|||
164169236|NCT03613649|592982831|FG002|Second Treatment|Withdrawal by Subject|0|||
164169237|NCT03613649|592982832|FG003|Second Treatment|Withdrawal by Subject|0|||
164169238|NCT03613649|592982833|FG004|Second Treatment|Withdrawal by Subject|1|||
164169239|NCT03613649|592982834|FG005|Second Treatment|Withdrawal by Subject|0|||
164169240|NCT03613649|592982835|FG006|Second Treatment|Withdrawal by Subject|0|||
164169241|NCT03613649|592982836|FG007|Second Treatment|Withdrawal by Subject|0|||
164169242|NCT03613649|592982837|FG008|Second Treatment|Withdrawal by Subject|0|||
164169243|NCT03613649|592982838|FG009|Second Treatment|Withdrawal by Subject|0|||
164169244|NCT03613649|592982839|FG010|Second Treatment|Withdrawal by Subject|0|||
164169245|NCT03613649|592982840|FG011|Second Treatment|Withdrawal by Subject|0|||
164169246|NCT03613649|592982829|FG000|Third Treatment|Lost to Follow-up|0|||
164169247|NCT03613649|592982830|FG001|Third Treatment|Lost to Follow-up|0|||
164169248|NCT03613649|592982831|FG002|Third Treatment|Lost to Follow-up|0|||
164169249|NCT03613649|592982832|FG003|Third Treatment|Lost to Follow-up|0|||
164169250|NCT03613649|592982833|FG004|Third Treatment|Lost to Follow-up|1|||
164169251|NCT03613649|592982834|FG005|Third Treatment|Lost to Follow-up|0|||
164169252|NCT03613649|592982835|FG006|Third Treatment|Lost to Follow-up|0|||
164169253|NCT03613649|592982836|FG007|Third Treatment|Lost to Follow-up|0|||
164169254|NCT03613649|592982837|FG008|Third Treatment|Lost to Follow-up|0|||
164169255|NCT03613649|592982838|FG009|Third Treatment|Lost to Follow-up|0|||
164169256|NCT03613649|592982839|FG010|Third Treatment|Lost to Follow-up|0|||
164169257|NCT03613649|592982840|FG011|Third Treatment|Lost to Follow-up|1|||
164169258|NCT03613649|592982829|FG000|Third Treatment|Protocol Violation|0|||
164169259|NCT03613649|592982830|FG001|Third Treatment|Protocol Violation|0|||
164169260|NCT03613649|592982831|FG002|Third Treatment|Protocol Violation|0|||
164169261|NCT03613649|592982832|FG003|Third Treatment|Protocol Violation|0|||
164169262|NCT03613649|592982833|FG004|Third Treatment|Protocol Violation|0|||
164169263|NCT03613649|592982834|FG005|Third Treatment|Protocol Violation|0|||
164169264|NCT03613649|592982835|FG006|Third Treatment|Protocol Violation|1|||
164169265|NCT03613649|592982836|FG007|Third Treatment|Protocol Violation|0|||
164169266|NCT03613649|592982837|FG008|Third Treatment|Protocol Violation|0|||
164169267|NCT03613649|592982838|FG009|Third Treatment|Protocol Violation|0|||
164169268|NCT03613649|592982839|FG010|Third Treatment|Protocol Violation|0|||
164169269|NCT03613649|592982840|FG011|Third Treatment|Protocol Violation|1|||
164169270|NCT03613649|592982829|FG000|Fourth Treatment|Protocol Violation|1|||
164169271|NCT03613649|592982830|FG001|Fourth Treatment|Protocol Violation|0|||
164169272|NCT03613649|592982831|FG002|Fourth Treatment|Protocol Violation|0|||
164169273|NCT03613649|592982832|FG003|Fourth Treatment|Protocol Violation|0|||
164169274|NCT03613649|592982833|FG004|Fourth Treatment|Protocol Violation|1|||
164169275|NCT03613649|592982834|FG005|Fourth Treatment|Protocol Violation|0|||
164169276|NCT03613649|592982835|FG006|Fourth Treatment|Protocol Violation|0|||
164169277|NCT03613649|592982836|FG007|Fourth Treatment|Protocol Violation|0|||
164169278|NCT03613649|592982837|FG008|Fourth Treatment|Protocol Violation|0|||
164169279|NCT03613649|592982838|FG009|Fourth Treatment|Protocol Violation|0|||
164169280|NCT03613649|592982839|FG010|Fourth Treatment|Protocol Violation|0|||
164169281|NCT03613649|592982840|FG011|Fourth Treatment|Protocol Violation|0|||
164169282|NCT03613649|592982829|FG000|Fourth Treatment|Physician Decision|0|||
164169283|NCT03613649|592982830|FG001|Fourth Treatment|Physician Decision|0|||
164169284|NCT03613649|592982831|FG002|Fourth Treatment|Physician Decision|0|||
164169285|NCT03613649|592982832|FG003|Fourth Treatment|Physician Decision|0|||
164169286|NCT03613649|592982833|FG004|Fourth Treatment|Physician Decision|0|||
164169287|NCT03613649|592982834|FG005|Fourth Treatment|Physician Decision|0|||
164169288|NCT03613649|592982835|FG006|Fourth Treatment|Physician Decision|1|||
164169289|NCT03613649|592982836|FG007|Fourth Treatment|Physician Decision|0|||
164169290|NCT03613649|592982837|FG008|Fourth Treatment|Physician Decision|0|||
164169291|NCT03613649|592982838|FG009|Fourth Treatment|Physician Decision|0|||
164169292|NCT03613649|592982839|FG010|Fourth Treatment|Physician Decision|0|||
164169293|NCT03613649|592982840|FG011|Fourth Treatment|Physician Decision|0|||
164169294|NCT03429244|592982841|FG000|Overall Study|Withdrawal by Subject|2|||
164169295|NCT03429244|592982842|FG001|Overall Study|Withdrawal by Subject|1|||
164169296|NCT03429244|592982843|FG002|Overall Study|Withdrawal by Subject|1|||
164169297|NCT01500187|592982849|FG000|Overall Study|Lost to Follow-up|6|||
164169298|NCT01500187|592982850|FG001|Overall Study|Lost to Follow-up|0|||
164169299|NCT00750139|592982852|FG000|Overall Study|Adverse Event|1|||
164169300|NCT00750139|592982853|FG001|Overall Study|Adverse Event|2|||
164169301|NCT00750139|592982854|FG002|Overall Study|Adverse Event|0|||
164169302|NCT00750139|592982855|FG003|Overall Study|Adverse Event|1|||
164169303|NCT00750139|592982852|FG000|Overall Study|Lost to Follow-up|17|||
164169304|NCT00750139|592982853|FG001|Overall Study|Lost to Follow-up|12|||
164169305|NCT00750139|592982854|FG002|Overall Study|Lost to Follow-up|15|||
164169306|NCT00750139|592982855|FG003|Overall Study|Lost to Follow-up|6|||
164169307|NCT00750139|592982852|FG000|Overall Study|Withdrawal by Subject|3|||
164169308|NCT00750139|592982853|FG001|Overall Study|Withdrawal by Subject|2|||
164169309|NCT00750139|592982854|FG002|Overall Study|Withdrawal by Subject|6|||
164169310|NCT00750139|592982855|FG003|Overall Study|Withdrawal by Subject|2|||
164169311|NCT00750139|592982852|FG000|Overall Study|Physician Decision|1|||
164169312|NCT00750139|592982853|FG001|Overall Study|Physician Decision|1|||
164169313|NCT00750139|592982854|FG002|Overall Study|Physician Decision|0|||
164169314|NCT00750139|592982855|FG003|Overall Study|Physician Decision|0|||
164169315|NCT00750139|592982852|FG000|Overall Study|Non-compliance|1|||
164169316|NCT00750139|592982853|FG001|Overall Study|Non-compliance|0|||
164169317|NCT00750139|592982854|FG002|Overall Study|Non-compliance|1|||
164169318|NCT00750139|592982855|FG003|Overall Study|Non-compliance|3|||
164169319|NCT00750139|592982852|FG000|Overall Study|Termination by sponsor|4|||
164169320|NCT00750139|592982853|FG001|Overall Study|Termination by sponsor|0|||
164169321|NCT00750139|592982854|FG002|Overall Study|Termination by sponsor|0|||
164169322|NCT00750139|592982855|FG003|Overall Study|Termination by sponsor|1|||
164169323|NCT00750139|592982852|FG000|Overall Study|Non-specific|62|||
164169324|NCT00750139|592982853|FG001|Overall Study|Non-specific|42|||
164169325|NCT00750139|592982854|FG002|Overall Study|Non-specific|79|||
164169326|NCT00750139|592982855|FG003|Overall Study|Non-specific|33|||
164169327|NCT00586820|592982861|FG000|Overall Study|Unsuccessful PCI|1|||
164169328|NCT00586820|592982862|FG001|Overall Study|Unsuccessful PCI|0|||
164169329|NCT02073929|592982863|FG000|Overall Study|Lost to Follow-up|2|||
164169330|NCT02073929|592982864|FG001|Overall Study|Lost to Follow-up|1|||
164169331|NCT02073929|592982863|FG000|Overall Study|Adverse Event|2|||
164169332|NCT02073929|592982864|FG001|Overall Study|Adverse Event|1|||
164169333|NCT02073929|592982863|FG000|Overall Study|Withdrawal by Subject|0|||
164169334|NCT02073929|592982864|FG001|Overall Study|Withdrawal by Subject|1|||
164169335|NCT00430573|592982865|FG000|Overall Study|Withdrawal by Subject|5|||
164169336|NCT01483027|592982866|FG000|Overall Study|Administrative Reasons|2|||
164169337|NCT01483027|592982867|FG001|Overall Study|Administrative Reasons|1|||
164169338|NCT01483027|592982866|FG000|Overall Study|Withdrawal by Subject|21|||
164169339|NCT01483027|592982867|FG001|Overall Study|Withdrawal by Subject|32|||
164169340|NCT01483027|592982866|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
164169341|NCT01483027|592982867|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
164169342|NCT01483027|592982866|FG000|Overall Study|Lost to Follow-up|1|||
164169343|NCT01483027|592982867|FG001|Overall Study|Lost to Follow-up|1|||
164169344|NCT01483027|592982866|FG000|Overall Study|Adverse Event|0|||
164169345|NCT01483027|592982867|FG001|Overall Study|Adverse Event|1|||
164169346|NCT01483027|592982866|FG000|Overall Study|Withdrawal by Subject|0|||
164169347|NCT01483027|592982867|FG001|Overall Study|Withdrawal by Subject|1|||
164169348|NCT01936181|592984971|FG000|Randomised, Double-blind|Adverse Event|27|||
164169349|NCT01936181|592984972|FG001|Randomised, Double-blind|Adverse Event|21|||
164169350|NCT01936181|592984973|FG002|Randomised, Double-blind|Adverse Event|0|||
164169351|NCT01936181|592984974|FG003|Randomised, Double-blind|Adverse Event|0|||
164169352|NCT01936181|592984971|FG000|Randomised, Double-blind|Protocol Violation|1|||
164169353|NCT01936181|592984972|FG001|Randomised, Double-blind|Protocol Violation|5|||
164169354|NCT01936181|592984973|FG002|Randomised, Double-blind|Protocol Violation|0|||
164169355|NCT01936181|592984974|FG003|Randomised, Double-blind|Protocol Violation|0|||
164169356|NCT01936181|592984971|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
164169357|NCT01936181|592984972|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
164169358|NCT01936181|592984973|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
164169359|NCT01936181|592984974|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
164169360|NCT01936181|592984971|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
164169361|NCT01936181|592984972|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
164169362|NCT01936181|592984973|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
164169363|NCT01936181|592984974|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
164169364|NCT01936181|592984971|FG000|Randomised, Double-blind|Pregnancy|0|||
164169365|NCT01936181|592984972|FG001|Randomised, Double-blind|Pregnancy|1|||
164169366|NCT01936181|592984973|FG002|Randomised, Double-blind|Pregnancy|0|||
164169367|NCT01936181|592984974|FG003|Randomised, Double-blind|Pregnancy|0|||
164169368|NCT01936181|592984971|FG000|Randomised, Double-blind|Physician Decision|4|||
164169369|NCT01936181|592984972|FG001|Randomised, Double-blind|Physician Decision|4|||
164169370|NCT01936181|592984973|FG002|Randomised, Double-blind|Physician Decision|0|||
164169371|NCT01936181|592984974|FG003|Randomised, Double-blind|Physician Decision|0|||
164169372|NCT01936181|592984971|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
164169373|NCT01936181|592984972|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
164169374|NCT01936181|592984973|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
164169375|NCT01936181|592984974|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
164169376|NCT01936181|592984971|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
164169377|NCT01936181|592984972|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
164169378|NCT01936181|592984973|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
164169379|NCT01936181|592984974|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
164169380|NCT01936181|592984971|FG000|Transition-extension|Adverse Event|3|||
164169381|NCT01936181|592984972|FG001|Transition-extension|Adverse Event|0|||
164169382|NCT01936181|592984973|FG002|Transition-extension|Adverse Event|3|||
164169383|NCT01936181|592984974|FG003|Transition-extension|Adverse Event|1|||
164169384|NCT01936181|592984971|FG000|Transition-extension|Lost to Follow-up|3|||
164169385|NCT01936181|592984972|FG001|Transition-extension|Lost to Follow-up|0|||
164169386|NCT01936181|592984973|FG002|Transition-extension|Lost to Follow-up|1|||
164169387|NCT01936181|592984974|FG003|Transition-extension|Lost to Follow-up|2|||
164169388|NCT01936181|592984971|FG000|Transition-extension|Physician Decision|2|||
164169389|NCT01936181|592984972|FG001|Transition-extension|Physician Decision|0|||
164169390|NCT01936181|592984973|FG002|Transition-extension|Physician Decision|0|||
164169391|NCT01936181|592984974|FG003|Transition-extension|Physician Decision|1|||
164169392|NCT01936181|592984971|FG000|Transition-extension|Withdrawal by Subject|7|||
164169393|NCT01936181|592984972|FG001|Transition-extension|Withdrawal by Subject|0|||
164169394|NCT01936181|592984973|FG002|Transition-extension|Withdrawal by Subject|2|||
164169395|NCT01936181|592984974|FG003|Transition-extension|Withdrawal by Subject|1|||
164169396|NCT01346189|592984975|FG000|Overall Study|Withdrawal by Subject|7|||
164169397|NCT01346189|592984976|FG001|Overall Study|Withdrawal by Subject|5|||
164169398|NCT01346189|592984977|FG002|Overall Study|Withdrawal by Subject|3|||
164169399|NCT01346189|592984978|FG003|Overall Study|Withdrawal by Subject|5|||
164169400|NCT01346189|592984975|FG000|Overall Study|Physician Decision|4|||
164169401|NCT01346189|592984976|FG001|Overall Study|Physician Decision|0|||
164169402|NCT01346189|592984977|FG002|Overall Study|Physician Decision|0|||
164169403|NCT01346189|592984978|FG003|Overall Study|Physician Decision|0|||
164169404|NCT01346189|592984975|FG000|Overall Study|Moved|3|||
164169405|NCT01346189|592984976|FG001|Overall Study|Moved|0|||
164169406|NCT01346189|592984977|FG002|Overall Study|Moved|4|||
164169407|NCT01346189|592984978|FG003|Overall Study|Moved|0|||
164169408|NCT01346189|592984975|FG000|Overall Study|Other|2|||
164169409|NCT01346189|592984976|FG001|Overall Study|Other|4|||
164169410|NCT01346189|592984977|FG002|Overall Study|Other|7|||
164169411|NCT01346189|592984978|FG003|Overall Study|Other|3|||
164169412|NCT01346189|592984975|FG000|Overall Study|Death|0|||
164169413|NCT01346189|592984976|FG001|Overall Study|Death|3|||
164169414|NCT01346189|592984977|FG002|Overall Study|Death|0|||
164169415|NCT01346189|592984978|FG003|Overall Study|Death|0|||
164169416|NCT01346189|592984975|FG000|Overall Study|Non-health system primary care physician|0|||
164169417|NCT01346189|592984976|FG001|Overall Study|Non-health system primary care physician|5|||
164169418|NCT01346189|592984977|FG002|Overall Study|Non-health system primary care physician|0|||
164169419|NCT01346189|592984978|FG003|Overall Study|Non-health system primary care physician|0|||
164169420|NCT01346189|592984975|FG000|Overall Study|Travel|0|||
164169421|NCT01346189|592984976|FG001|Overall Study|Travel|0|||
164169422|NCT01346189|592984977|FG002|Overall Study|Travel|0|||
164169423|NCT01346189|592984978|FG003|Overall Study|Travel|3|||
164169424|NCT00900757|592984979|FG000|Overall Study|screen failure|19|||
164169425|NCT01014988|592984984|FG000|Overall Study|Adverse Event|20|||
164169426|NCT01014988|592984985|FG001|Overall Study|Adverse Event|0|||
164169427|NCT01014988|592984986|FG002|Overall Study|Adverse Event|1|||
164169428|NCT01014988|592984987|FG003|Overall Study|Adverse Event|0|||
164169429|NCT01014988|592984988|FG004|Overall Study|Adverse Event|1|||
164169430|NCT01014988|592984989|FG005|Overall Study|Adverse Event|3|||
164169431|NCT01014988|592984984|FG000|Overall Study|Lost to Follow-up|1|||
164169432|NCT01014988|592984985|FG001|Overall Study|Lost to Follow-up|0|||
164169433|NCT01014988|592984986|FG002|Overall Study|Lost to Follow-up|1|||
164169434|NCT01014988|592984987|FG003|Overall Study|Lost to Follow-up|0|||
164169435|NCT01014988|592984988|FG004|Overall Study|Lost to Follow-up|0|||
164169436|NCT01014988|592984989|FG005|Overall Study|Lost to Follow-up|0|||
164169437|NCT01014988|592984984|FG000|Overall Study|Physician Decision|1|||
164169438|NCT01014988|592984985|FG001|Overall Study|Physician Decision|0|||
164169439|NCT01014988|592984986|FG002|Overall Study|Physician Decision|0|||
164169440|NCT01014988|592984987|FG003|Overall Study|Physician Decision|0|||
164169441|NCT01014988|592984988|FG004|Overall Study|Physician Decision|0|||
164169442|NCT01014988|592984989|FG005|Overall Study|Physician Decision|0|||
164169443|NCT01014988|592984984|FG000|Overall Study|Withdrawal by Subject|1|||
164169444|NCT01014988|592984985|FG001|Overall Study|Withdrawal by Subject|0|||
164169445|NCT01014988|592984986|FG002|Overall Study|Withdrawal by Subject|0|||
164169446|NCT01014988|592984987|FG003|Overall Study|Withdrawal by Subject|0|||
164169447|NCT01014988|592984988|FG004|Overall Study|Withdrawal by Subject|0|||
164169448|NCT01014988|592984989|FG005|Overall Study|Withdrawal by Subject|0|||
164169449|NCT05835011|592984990|FG000|Overall Study|Study Terminated by the Sponsor|1|||
164169450|NCT05835011|592984990|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
164169451|NCT01683266|592984991|FG000|Overall Study|Adverse Event|5|||
164169452|NCT01683266|592984992|FG001|Overall Study|Adverse Event|4|||
164169453|NCT01683266|592984991|FG000|Overall Study|Lack of Efficacy|5|||
164169454|NCT01683266|592984992|FG001|Overall Study|Lack of Efficacy|2|||
164169455|NCT01683266|592984991|FG000|Overall Study|Protocol Violation|13|||
164169456|NCT01683266|592984992|FG001|Overall Study|Protocol Violation|6|||
164169457|NCT01683266|592984991|FG000|Overall Study|Personal Reason|17|||
164169458|NCT01683266|592984992|FG001|Overall Study|Personal Reason|25|||
164169679|NCT02738879|592985026|FG000|Overall Study|Screen Failure|1|||
164169459|NCT01683266|592984991|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
164169460|NCT01683266|592984992|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
164169461|NCT01683266|592984991|FG000|Overall Study|Lost to Follow-up|5|||
164169462|NCT01683266|592984992|FG001|Overall Study|Lost to Follow-up|0|||
164169463|NCT01683266|592984991|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
164169464|NCT01683266|592984992|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
164169465|NCT01683266|592984991|FG000|Overall Study|Nonserious Hypoglycemia|0|||
164169466|NCT01683266|592984992|FG001|Overall Study|Nonserious Hypoglycemia|3|||
164169467|NCT01683266|592984991|FG000|Overall Study|Perceived Lack of Efficacy|1|||
164169468|NCT01683266|592984992|FG001|Overall Study|Perceived Lack of Efficacy|1|||
164169469|NCT01683266|592984991|FG000|Overall Study|Possibly Hypoglycemia|1|||
164169470|NCT01683266|592984992|FG001|Overall Study|Possibly Hypoglycemia|0|||
164169471|NCT01683266|592984991|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
164169472|NCT01683266|592984992|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
164169473|NCT02222545|592984993|FG000|Overall Study|Adverse Event|1|||
164169474|NCT02222545|592984994|FG001|Overall Study|Adverse Event|0|||
164169475|NCT02222545|592984995|FG002|Overall Study|Adverse Event|2|||
164169476|NCT02222545|592984993|FG000|Overall Study|Death|0|||
164169477|NCT02222545|592984994|FG001|Overall Study|Death|0|||
164169478|NCT02222545|592984995|FG002|Overall Study|Death|9|||
164169479|NCT02222545|592984993|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
164169480|NCT02222545|592984994|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
164169481|NCT02222545|592984995|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
164169482|NCT02222545|592984993|FG000|Overall Study|Withdrawal by Subject|0|||
164169483|NCT02222545|592984994|FG001|Overall Study|Withdrawal by Subject|0|||
164169484|NCT02222545|592984995|FG002|Overall Study|Withdrawal by Subject|3|||
164169485|NCT02222545|592984993|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
164169486|NCT02222545|592984994|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
164169487|NCT02222545|592984995|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
164169488|NCT00090220|592984996|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
164169489|NCT00090220|592984997|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
164169490|NCT00090220|592984998|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
164169491|NCT00090220|592984999|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
164169492|NCT00090220|592985000|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
164169493|NCT00090220|592985001|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
164169494|NCT00090220|592984996|FG000|Base Study Vaccination Period|Adverse Event|6|||
164169495|NCT00090220|592984997|FG001|Base Study Vaccination Period|Adverse Event|1|||
164169496|NCT00090220|592984998|FG002|Base Study Vaccination Period|Adverse Event|0|||
164169497|NCT00090220|592984999|FG003|Base Study Vaccination Period|Adverse Event|0|||
164169498|NCT00090220|592985000|FG004|Base Study Vaccination Period|Adverse Event|0|||
164169499|NCT00090220|592985001|FG005|Base Study Vaccination Period|Adverse Event|0|||
164169500|NCT00090220|592984996|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
164169501|NCT00090220|592984997|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
164169502|NCT00090220|592984998|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
164169503|NCT00090220|592984999|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
164169504|NCT00090220|592985000|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
164169505|NCT00090220|592985001|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
164169506|NCT00090220|592984996|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
164169507|NCT00090220|592984997|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
164169508|NCT00090220|592984998|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
164169509|NCT00090220|592984999|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
164169510|NCT00090220|592985000|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
164169511|NCT00090220|592985001|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
164169512|NCT00090220|592984996|FG000|Base Study Vaccination Period|Patient Moved|6|||
164169513|NCT00090220|592984997|FG001|Base Study Vaccination Period|Patient Moved|2|||
164169514|NCT00090220|592984998|FG002|Base Study Vaccination Period|Patient Moved|0|||
164169515|NCT00090220|592984999|FG003|Base Study Vaccination Period|Patient Moved|0|||
164169516|NCT00090220|592985000|FG004|Base Study Vaccination Period|Patient Moved|0|||
164169517|NCT00090220|592985001|FG005|Base Study Vaccination Period|Patient Moved|0|||
164169518|NCT00090220|592984996|FG000|Base Study Vaccination Period|Other|4|||
164169519|NCT00090220|592984997|FG001|Base Study Vaccination Period|Other|4|||
164169520|NCT00090220|592984998|FG002|Base Study Vaccination Period|Other|0|||
164169521|NCT00090220|592984999|FG003|Base Study Vaccination Period|Other|0|||
164169522|NCT00090220|592985000|FG004|Base Study Vaccination Period|Other|0|||
164169523|NCT00090220|592985001|FG005|Base Study Vaccination Period|Other|0|||
164169524|NCT00090220|592984996|FG000|Base Study Follow-up Period|Adverse Event|6|||
164169525|NCT00090220|592984997|FG001|Base Study Follow-up Period|Adverse Event|1|||
164169526|NCT00090220|592984998|FG002|Base Study Follow-up Period|Adverse Event|0|||
164169527|NCT00090220|592984999|FG003|Base Study Follow-up Period|Adverse Event|0|||
164169528|NCT00090220|592985000|FG004|Base Study Follow-up Period|Adverse Event|0|||
164169529|NCT00090220|592985001|FG005|Base Study Follow-up Period|Adverse Event|0|||
164169530|NCT00090220|592984996|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
164169531|NCT00090220|592984997|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
164169532|NCT00090220|592984998|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
164169533|NCT00090220|592984999|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
164169534|NCT00090220|592985000|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
164169535|NCT00090220|592985001|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
164169536|NCT00090220|592984996|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
164169537|NCT00090220|592984997|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
164169538|NCT00090220|592984998|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
164169539|NCT00090220|592984999|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
164169540|NCT00090220|592985000|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
164169541|NCT00090220|592985001|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
164169542|NCT00090220|592984996|FG000|Base Study Follow-up Period|Patient Moved|20|||
164169543|NCT00090220|592984997|FG001|Base Study Follow-up Period|Patient Moved|28|||
164169544|NCT00090220|592984998|FG002|Base Study Follow-up Period|Patient Moved|0|||
164169545|NCT00090220|592984999|FG003|Base Study Follow-up Period|Patient Moved|0|||
164169546|NCT00090220|592985000|FG004|Base Study Follow-up Period|Patient Moved|0|||
164169547|NCT00090220|592985001|FG005|Base Study Follow-up Period|Patient Moved|0|||
164169548|NCT00090220|592984996|FG000|Base Study Follow-up Period|Other|19|||
164169549|NCT00090220|592984997|FG001|Base Study Follow-up Period|Other|21|||
164169550|NCT00090220|592984998|FG002|Base Study Follow-up Period|Other|0|||
164169551|NCT00090220|592984999|FG003|Base Study Follow-up Period|Other|0|||
164169552|NCT00090220|592985000|FG004|Base Study Follow-up Period|Other|0|||
164169553|NCT00090220|592985001|FG005|Base Study Follow-up Period|Other|0|||
164169554|NCT00090220|592984996|FG000|Extension 1 (EXT1)|Adverse Event|0|||
164169555|NCT00090220|592984997|FG001|Extension 1 (EXT1)|Adverse Event|0|||
164169556|NCT00090220|592984998|FG002|Extension 1 (EXT1)|Adverse Event|4|||
164169557|NCT00090220|592984999|FG003|Extension 1 (EXT1)|Adverse Event|0|||
164169558|NCT00090220|592985000|FG004|Extension 1 (EXT1)|Adverse Event|0|||
164169559|NCT00090220|592985001|FG005|Extension 1 (EXT1)|Adverse Event|0|||
164169560|NCT00090220|592984996|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
164169561|NCT00090220|592984997|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
164169562|NCT00090220|592984998|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
164169563|NCT00090220|592984999|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
164169564|NCT00090220|592985000|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
164169565|NCT00090220|592985001|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
164169566|NCT00090220|592984996|FG000|Extension 1 (EXT1)|Moved|0|||
164169567|NCT00090220|592984997|FG001|Extension 1 (EXT1)|Moved|0|||
164169568|NCT00090220|592984998|FG002|Extension 1 (EXT1)|Moved|2|||
164169569|NCT00090220|592984999|FG003|Extension 1 (EXT1)|Moved|1|||
164169570|NCT00090220|592985000|FG004|Extension 1 (EXT1)|Moved|0|||
164169571|NCT00090220|592985001|FG005|Extension 1 (EXT1)|Moved|0|||
164169572|NCT00090220|592984996|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
164169573|NCT00090220|592984997|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
164169574|NCT00090220|592984998|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
164169575|NCT00090220|592984999|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
164169576|NCT00090220|592985000|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
164169577|NCT00090220|592985001|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
164169578|NCT00090220|592984996|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
164169579|NCT00090220|592984997|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
164169580|NCT00090220|592984998|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
164169581|NCT00090220|592984999|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
164169582|NCT00090220|592985000|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
164169583|NCT00090220|592985001|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
164169584|NCT00090220|592984996|FG000|Extension 1 (EXT1)|Other reason|0|||
164169585|NCT00090220|592984997|FG001|Extension 1 (EXT1)|Other reason|0|||
164169586|NCT00090220|592984998|FG002|Extension 1 (EXT1)|Other reason|2|||
164169587|NCT00090220|592984999|FG003|Extension 1 (EXT1)|Other reason|0|||
164169588|NCT00090220|592985000|FG004|Extension 1 (EXT1)|Other reason|0|||
164169589|NCT00090220|592985001|FG005|Extension 1 (EXT1)|Other reason|0|||
164169590|NCT00090220|592984996|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
164169591|NCT00090220|592984997|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
164169592|NCT00090220|592984998|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
164169593|NCT00090220|592984999|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
164169594|NCT00090220|592985000|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
164169595|NCT00090220|592985001|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
164169596|NCT00090220|592984996|FG000|Long-term Follow-up (EXT2)|Death|0|||
164169597|NCT00090220|592984997|FG001|Long-term Follow-up (EXT2)|Death|0|||
164169598|NCT00090220|592984998|FG002|Long-term Follow-up (EXT2)|Death|0|||
164169599|NCT00090220|592984999|FG003|Long-term Follow-up (EXT2)|Death|0|||
164169600|NCT00090220|592985000|FG004|Long-term Follow-up (EXT2)|Death|1|||
164169601|NCT00090220|592985001|FG005|Long-term Follow-up (EXT2)|Death|1|||
164169602|NCT00090220|592984996|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
164169603|NCT00090220|592984997|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
164169604|NCT00090220|592984998|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
164169605|NCT00090220|592984999|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
164169606|NCT00090220|592985000|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
164169607|NCT00090220|592985001|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
164169608|NCT00090220|592984996|FG000|Long-term Follow-up (EXT2)|Other|0|||
164169609|NCT00090220|592984997|FG001|Long-term Follow-up (EXT2)|Other|0|||
164169610|NCT00090220|592984998|FG002|Long-term Follow-up (EXT2)|Other|0|||
164169611|NCT00090220|592984999|FG003|Long-term Follow-up (EXT2)|Other|0|||
164169612|NCT00090220|592985000|FG004|Long-term Follow-up (EXT2)|Other|1|||
164169613|NCT00090220|592985001|FG005|Long-term Follow-up (EXT2)|Other|0|||
164169614|NCT00941863|592985002|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
164169615|NCT00941863|592985003|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
164169616|NCT00941863|592985004|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
164169617|NCT00941863|592985005|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
164169618|NCT00941863|592985006|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
164169619|NCT00941863|592985002|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
164169620|NCT00941863|592985003|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
164169621|NCT00941863|592985004|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
164169622|NCT00941863|592985005|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
164169623|NCT00941863|592985006|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
164169624|NCT00941863|592985002|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
164169625|NCT00941863|592985003|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
164169626|NCT00941863|592985004|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
164169627|NCT00941863|592985005|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
164169628|NCT00941863|592985006|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
164169629|NCT00941863|592985002|FG000|Until Primary Completion Date (PCD)|Death|0|||
164169630|NCT00941863|592985003|FG001|Until Primary Completion Date (PCD)|Death|0|||
164169631|NCT00941863|592985004|FG002|Until Primary Completion Date (PCD)|Death|1|||
164169632|NCT00941863|592985005|FG003|Until Primary Completion Date (PCD)|Death|2|||
164169633|NCT00941863|592985006|FG004|Until Primary Completion Date (PCD)|Death|7|||
164169634|NCT00941863|592985002|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
164169635|NCT00941863|592985003|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
164169636|NCT00941863|592985004|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
164169637|NCT00941863|592985005|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
164169638|NCT00941863|592985006|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
164169639|NCT00941863|592985002|FG000|Continued After PCD|Withdrawal by Subject|0|||
164169640|NCT00941863|592985003|FG001|Continued After PCD|Withdrawal by Subject|0|||
164169641|NCT00941863|592985004|FG002|Continued After PCD|Withdrawal by Subject|0|||
164169642|NCT00941863|592985005|FG003|Continued After PCD|Withdrawal by Subject|0|||
164169643|NCT00941863|592985006|FG004|Continued After PCD|Withdrawal by Subject|1|||
164169644|NCT00941863|592985002|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
164169645|NCT00941863|592985003|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
164169646|NCT00941863|592985004|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
164169647|NCT00941863|592985005|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
164169648|NCT00941863|592985006|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
164169649|NCT02651155|592985007|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
164169650|NCT02651155|592985008|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
164169651|NCT02651155|592985007|FG000|Overall Study|Voluntary Withdrawal|5|||
164169652|NCT02651155|592985008|FG001|Overall Study|Voluntary Withdrawal|0|||
164169653|NCT04016779|592985012|FG000|Overall Study|Adverse Event|9|||
164169654|NCT04016779|592985013|FG001|Overall Study|Adverse Event|17|||
164169655|NCT04016779|592985012|FG000|Overall Study|Lack of Efficacy|4|||
164169656|NCT04016779|592985013|FG001|Overall Study|Lack of Efficacy|1|||
164169657|NCT04016779|592985012|FG000|Overall Study|Lost to Follow-up|5|||
164169658|NCT04016779|592985013|FG001|Overall Study|Lost to Follow-up|14|||
164169659|NCT04016779|592985012|FG000|Overall Study|Physician Decision|1|||
164169660|NCT04016779|592985013|FG001|Overall Study|Physician Decision|3|||
164169661|NCT04016779|592985012|FG000|Overall Study|Withdrawal by Subject|6|||
164169662|NCT04016779|592985013|FG001|Overall Study|Withdrawal by Subject|8|||
164169663|NCT04016779|592985012|FG000|Overall Study|Non-compliance with Study Drug|2|||
164169664|NCT04016779|592985013|FG001|Overall Study|Non-compliance with Study Drug|3|||
164169665|NCT04016779|592985012|FG000|Overall Study|Other, Multiple categories|17|||
164169666|NCT04016779|592985013|FG001|Overall Study|Other, Multiple categories|17|||
164169667|NCT02738879|592985026|FG000|Overall Study|Adverse Event|1|||
164169668|NCT02738879|592985027|FG001|Overall Study|Adverse Event|1|||
164169669|NCT02738879|592985026|FG000|Overall Study|Death|0|||
164169670|NCT02738879|592985027|FG001|Overall Study|Death|2|||
164169671|NCT02738879|592985026|FG000|Overall Study|Lost to Follow-up|1|||
164169672|NCT02738879|592985027|FG001|Overall Study|Lost to Follow-up|5|||
164169673|NCT02738879|592985026|FG000|Overall Study|Protocol Violation|1|||
164169674|NCT02738879|592985027|FG001|Overall Study|Protocol Violation|3|||
164169675|NCT02738879|592985026|FG000|Overall Study|Physician Decision|3|||
164169676|NCT02738879|592985027|FG001|Overall Study|Physician Decision|4|||
164169677|NCT02738879|592985026|FG000|Overall Study|Pregnancy|0|||
164169678|NCT02738879|592985027|FG001|Overall Study|Pregnancy|1|||
164169680|NCT02738879|592985027|FG001|Overall Study|Screen Failure|2|||
164169681|NCT02738879|592985026|FG000|Overall Study|Site Discontinued Study Participation|1|||
164169682|NCT02738879|592985027|FG001|Overall Study|Site Discontinued Study Participation|0|||
164169683|NCT02738879|592985026|FG000|Overall Study|Withdrawal by Subject|5|||
164169684|NCT02738879|592985027|FG001|Overall Study|Withdrawal by Subject|7|||
164169685|NCT00890084|592985028|FG000|Overall Study|Adverse Event|16|||
164169686|NCT00890084|592985028|FG000|Overall Study|Lost to Follow-up|126|||
164169687|NCT04143594|592985033|FG000|Overall Study|Withdrew consent|3|||
164169688|NCT04143594|592985034|FG001|Overall Study|Withdrew consent|10|||
164169689|NCT04143594|592985035|FG002|Overall Study|Withdrew consent|3|||
164169690|NCT04143594|592985036|FG003|Overall Study|Withdrew consent|1|||
164169691|NCT04143594|592985033|FG000|Overall Study|Lost to Follow-up|3|||
164169692|NCT04143594|592985034|FG001|Overall Study|Lost to Follow-up|5|||
164169693|NCT04143594|592985035|FG002|Overall Study|Lost to Follow-up|11|||
164169694|NCT04143594|592985036|FG003|Overall Study|Lost to Follow-up|0|||
164169695|NCT04143594|592985033|FG000|Overall Study|Investigator's discretion|2|||
164169696|NCT04143594|592985034|FG001|Overall Study|Investigator's discretion|2|||
164169697|NCT04143594|592985035|FG002|Overall Study|Investigator's discretion|0|||
164169698|NCT04143594|592985036|FG003|Overall Study|Investigator's discretion|0|||
164169699|NCT04143594|592985033|FG000|Overall Study|Randomized but never treated|0|||
164169700|NCT04143594|592985034|FG001|Overall Study|Randomized but never treated|0|||
164169701|NCT04143594|592985035|FG002|Overall Study|Randomized but never treated|0|||
164169702|NCT04143594|592985036|FG003|Overall Study|Randomized but never treated|1|||
164169703|NCT04143594|592985033|FG000|Overall Study|Death|1|||
164169704|NCT04143594|592985034|FG001|Overall Study|Death|0|||
164169705|NCT04143594|592985035|FG002|Overall Study|Death|1|||
164169706|NCT04143594|592985036|FG003|Overall Study|Death|0|||
164169707|NCT04143594|592985033|FG000|Overall Study|Adverse Event|1|||
164169708|NCT04143594|592985034|FG001|Overall Study|Adverse Event|0|||
164169709|NCT04143594|592985035|FG002|Overall Study|Adverse Event|0|||
164169710|NCT04143594|592985036|FG003|Overall Study|Adverse Event|0|||
164169711|NCT04143594|592985033|FG000|Overall Study|Pregnancy|0|||
164169712|NCT04143594|592985034|FG001|Overall Study|Pregnancy|0|||
164169713|NCT04143594|592985035|FG002|Overall Study|Pregnancy|1|||
164169714|NCT04143594|592985036|FG003|Overall Study|Pregnancy|0|||
164169715|NCT04143594|592985033|FG000|Overall Study|Lack of Efficacy|1|||
164169716|NCT04143594|592985034|FG001|Overall Study|Lack of Efficacy|1|||
164169717|NCT04143594|592985035|FG002|Overall Study|Lack of Efficacy|0|||
164169718|NCT04143594|592985036|FG003|Overall Study|Lack of Efficacy|0|||
164169719|NCT01023256|592985039|FG000|Overall Study|Protocol Violation|2|||
164169720|NCT01023256|592985040|FG001|Overall Study|Protocol Violation|3|||
164169721|NCT01023256|592985041|FG002|Overall Study|Protocol Violation|0|||
164169722|NCT01023256|592985042|FG003|Overall Study|Protocol Violation|0|||
164169723|NCT01023256|592985039|FG000|Overall Study|Randomized but not treated|1|||
164169724|NCT01023256|592985040|FG001|Overall Study|Randomized but not treated|0|||
164169725|NCT01023256|592985041|FG002|Overall Study|Randomized but not treated|1|||
164169726|NCT01023256|592985042|FG003|Overall Study|Randomized but not treated|0|||
164169727|NCT01023256|592985039|FG000|Overall Study|Other|1|||
164169728|NCT01023256|592985040|FG001|Overall Study|Other|0|||
164169729|NCT01023256|592985041|FG002|Overall Study|Other|0|||
164169730|NCT01023256|592985042|FG003|Overall Study|Other|2|||
164169731|NCT01023256|592985039|FG000|Overall Study|Adverse Event|0|||
164169732|NCT01023256|592985040|FG001|Overall Study|Adverse Event|0|||
164169733|NCT01023256|592985041|FG002|Overall Study|Adverse Event|0|||
164169734|NCT01023256|592985042|FG003|Overall Study|Adverse Event|1|||
164169735|NCT01023256|592985039|FG000|Overall Study|Withdrawal by Subject|0|||
164169736|NCT01023256|592985040|FG001|Overall Study|Withdrawal by Subject|0|||
164169737|NCT01023256|592985041|FG002|Overall Study|Withdrawal by Subject|0|||
164169738|NCT01023256|592985042|FG003|Overall Study|Withdrawal by Subject|2|||
164169739|NCT03089697|592985043|FG000|Overall Study|Adverse Event|1|||
164169740|NCT03089697|592985044|FG001|Overall Study|Adverse Event|2|||
164169741|NCT03089697|592985043|FG000|Overall Study|Withdrawal by Subject|1|||
164169742|NCT03089697|592985044|FG001|Overall Study|Withdrawal by Subject|0|||
164169743|NCT00638443|592985045|FG000|First Intervention|Adverse Event|2|||
164169744|NCT00638443|592985046|FG001|First Intervention|Adverse Event|1|||
164169745|NCT01044290|592985047|FG000|Follow-up 1|Death|3|||
164169746|NCT01044290|592985048|FG001|Follow-up 1|Death|3|||
164169747|NCT01044290|592985049|FG002|Follow-up 1|Death|1|||
164169748|NCT01044290|592985047|FG000|Follow-up 1|Withdrawal by Subject|2|||
164169749|NCT01044290|592985048|FG001|Follow-up 1|Withdrawal by Subject|2|||
164169750|NCT01044290|592985049|FG002|Follow-up 1|Withdrawal by Subject|0|||
164169751|NCT01044290|592985047|FG000|Follow-Up 2|Death|0|||
164169752|NCT01044290|592985048|FG001|Follow-Up 2|Death|1|||
164169753|NCT01044290|592985049|FG002|Follow-Up 2|Death|1|||
164169754|NCT01044290|592985047|FG000|Follow-Up 2|Withdrawal by Subject|0|||
164169755|NCT01044290|592985048|FG001|Follow-Up 2|Withdrawal by Subject|1|||
164169756|NCT01044290|592985049|FG002|Follow-Up 2|Withdrawal by Subject|1|||
164169757|NCT01967706|592985052|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
164169758|NCT01967706|592985053|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
164169759|NCT01967706|592985054|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
164169760|NCT01967706|592985055|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
164169761|NCT01154088|592985056|FG000|Overall Study|Lost to Follow-up|4|||
164169762|NCT01154088|592985057|FG001|Overall Study|Lost to Follow-up|6|||
164169763|NCT01154088|592985058|FG002|Overall Study|Lost to Follow-up|7|||
164169764|NCT00282113|592985062|FG000|Overall Study|Removed at parents request|1|||
164169765|NCT00282113|592985063|FG001|Overall Study|Removed at parents request|0|||
164169766|NCT00282113|592985064|FG002|Overall Study|Removed at parents request|0|||
164169767|NCT03382834|592985065|FG000|Step 1|Lost to Follow-up|0|||
164169768|NCT03382834|592985066|FG001|Step 1|Lost to Follow-up|1|||
164169769|NCT03382834|592985065|FG000|Step 2|Death|1|||
164169770|NCT03382834|592985066|FG001|Step 2|Death|0|||
164169771|NCT03382834|592985065|FG000|Step 2|Lost to Follow-up|2|||
164169772|NCT03382834|592985066|FG001|Step 2|Lost to Follow-up|2|||
164169773|NCT03382834|592985065|FG000|Step 2|Site Terminated by Sponsor|1|||
164169774|NCT03382834|592985066|FG001|Step 2|Site Terminated by Sponsor|0|||
164169775|NCT02949843|592985067|FG000|Overall Study|Withdrawal by Subject|0|||
164169776|NCT02949843|592985068|FG001|Overall Study|Withdrawal by Subject|1|||
164169777|NCT02949843|592985069|FG002|Overall Study|Withdrawal by Subject|1|||
164169778|NCT02783729|592985073|FG000|Overall Study|Lack of Efficacy|1|||
164169779|NCT02783729|592985074|FG001|Overall Study|Lack of Efficacy|0|||
164169780|NCT02783729|592985075|FG002|Overall Study|Lack of Efficacy|0|||
164169781|NCT02783729|592985076|FG003|Overall Study|Lack of Efficacy|0|||
164169782|NCT02783729|592985073|FG000|Overall Study|Adverse Event|2|||
164169783|NCT02783729|592985074|FG001|Overall Study|Adverse Event|6|||
164169784|NCT02783729|592985075|FG002|Overall Study|Adverse Event|2|||
164169785|NCT02783729|592985076|FG003|Overall Study|Adverse Event|3|||
164169786|NCT02783729|592985073|FG000|Overall Study|Other|1|||
164169787|NCT02783729|592985074|FG001|Overall Study|Other|6|||
164169788|NCT02783729|592985075|FG002|Overall Study|Other|2|||
164169789|NCT02783729|592985076|FG003|Overall Study|Other|3|||
164169790|NCT02783729|592985073|FG000|Overall Study|Withdrawal by Subject|2|||
164169791|NCT02783729|592985074|FG001|Overall Study|Withdrawal by Subject|3|||
164169792|NCT02783729|592985075|FG002|Overall Study|Withdrawal by Subject|1|||
164169793|NCT02783729|592985076|FG003|Overall Study|Withdrawal by Subject|2|||
164169794|NCT02783729|592985073|FG000|Overall Study|Participant's choice|2|||
164169795|NCT02783729|592985074|FG001|Overall Study|Participant's choice|1|||
164169796|NCT02783729|592985075|FG002|Overall Study|Participant's choice|2|||
164169797|NCT02783729|592985076|FG003|Overall Study|Participant's choice|1|||
164169798|NCT02783729|592985073|FG000|Overall Study|Lost to Follow-up|2|||
164169799|NCT02783729|592985074|FG001|Overall Study|Lost to Follow-up|1|||
164169800|NCT02783729|592985075|FG002|Overall Study|Lost to Follow-up|1|||
164169801|NCT02783729|592985076|FG003|Overall Study|Lost to Follow-up|0|||
164169802|NCT02693171|592985078|FG000|Overall Study|Adverse Event|1|||
164169803|NCT02693171|592985078|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
164169804|NCT00319592|592985079|FG000|Overall Study|Protocol Violation|1|||
164169805|NCT00319592|592985080|FG001|Overall Study|Protocol Violation|0|||
164169806|NCT00319592|592985079|FG000|Overall Study|Physician Decision|0|||
164169807|NCT00319592|592985080|FG001|Overall Study|Physician Decision|1|||
164169808|NCT00658775|592985083|FG000|Overall Study|Adverse Event|4|||
164169809|NCT00658775|592985084|FG001|Overall Study|Adverse Event|6|||
164169810|NCT00658775|592985083|FG000|Overall Study|Lost to Follow-up|17|||
164169811|NCT00658775|592985084|FG001|Overall Study|Lost to Follow-up|18|||
164169812|NCT00658775|592985083|FG000|Overall Study|Withdrawal by Subject|6|||
164169813|NCT00658775|592985084|FG001|Overall Study|Withdrawal by Subject|4|||
164169814|NCT00658775|592985083|FG000|Overall Study|Withdrawal of consent|8|||
164169815|NCT00658775|592985084|FG001|Overall Study|Withdrawal of consent|7|||
164169816|NCT00658775|592985083|FG000|Overall Study|Other|7|||
164169817|NCT00658775|592985084|FG001|Overall Study|Other|8|||
164169818|NCT03085238|592985085|FG000|Overall Study|Adverse Event|2|||
164169819|NCT03085238|592985085|FG000|Overall Study|Death|2|||
164169820|NCT01992653|592985088|FG000|Overall Study|Death|0|||
164169821|NCT01992653|592985089|FG001|Overall Study|Death|0|||
164169822|NCT01992653|592985090|FG002|Overall Study|Death|1|||
164169823|NCT01992653|592985091|FG003|Overall Study|Death|0|||
164169824|NCT01992653|592985092|FG004|Overall Study|Death|1|||
164169825|NCT01992653|592985093|FG005|Overall Study|Death|0|||
164169826|NCT01992653|592985094|FG006|Overall Study|Death|4|||
164169827|NCT01992653|592985095|FG007|Overall Study|Death|2|||
164169828|NCT01992653|592985088|FG000|Overall Study|Lost to Follow-up|0|||
164169829|NCT01992653|592985089|FG001|Overall Study|Lost to Follow-up|0|||
164169830|NCT01992653|592985090|FG002|Overall Study|Lost to Follow-up|0|||
164169831|NCT01992653|592985091|FG003|Overall Study|Lost to Follow-up|0|||
164169832|NCT01992653|592985092|FG004|Overall Study|Lost to Follow-up|0|||
164169833|NCT01992653|592985093|FG005|Overall Study|Lost to Follow-up|0|||
164169834|NCT01992653|592985094|FG006|Overall Study|Lost to Follow-up|0|||
164169835|NCT01992653|592985095|FG007|Overall Study|Lost to Follow-up|1|||
164169836|NCT01992653|592985088|FG000|Overall Study|Study Completed|0|||
164169837|NCT01992653|592985089|FG001|Overall Study|Study Completed|0|||
164169838|NCT01992653|592985090|FG002|Overall Study|Study Completed|0|||
164169839|NCT01992653|592985091|FG003|Overall Study|Study Completed|0|||
164169840|NCT01992653|592985092|FG004|Overall Study|Study Completed|0|||
164169841|NCT01992653|592985093|FG005|Overall Study|Study Completed|0|||
164169842|NCT01992653|592985094|FG006|Overall Study|Study Completed|0|||
164169843|NCT01992653|592985095|FG007|Overall Study|Study Completed|1|||
164169844|NCT01992653|592985088|FG000|Overall Study|Disease Progression|0|||
164169845|NCT01992653|592985089|FG001|Overall Study|Disease Progression|0|||
164169846|NCT01992653|592985090|FG002|Overall Study|Disease Progression|0|||
164169847|NCT01992653|592985091|FG003|Overall Study|Disease Progression|0|||
164169848|NCT01992653|592985092|FG004|Overall Study|Disease Progression|0|||
164169849|NCT01992653|592985093|FG005|Overall Study|Disease Progression|0|||
164169850|NCT01992653|592985094|FG006|Overall Study|Disease Progression|4|||
164169851|NCT01992653|592985095|FG007|Overall Study|Disease Progression|0|||
164169852|NCT01435460|592985096|FG000|Overall Study|Adverse Event|2|||
164169853|NCT01435460|592985097|FG001|Overall Study|Adverse Event|1|||
164169854|NCT01435460|592985096|FG000|Overall Study|Lost to Follow-up|6|||
164169855|NCT01435460|592985097|FG001|Overall Study|Lost to Follow-up|1|||
164169856|NCT01435460|592985096|FG000|Overall Study|Withdrawal by Subject|1|||
164169857|NCT01435460|592985097|FG001|Overall Study|Withdrawal by Subject|3|||
164169858|NCT01435460|592985096|FG000|Overall Study|Protocol Violation|0|||
164169859|NCT01435460|592985097|FG001|Overall Study|Protocol Violation|1|||
164169860|NCT01435460|592985096|FG000|Overall Study|Did not meet eligibility criteria|2|||
164169861|NCT01435460|592985097|FG001|Overall Study|Did not meet eligibility criteria|0|||
164169862|NCT01706939|592985098|FG000|Pre Randomization|Screen Failure|1|||
164169863|NCT01706939|592985099|FG001|Pre Randomization|Screen Failure|0|||
164169864|NCT01706939|592985100|FG002|Pre Randomization|Screen Failure|0|||
164169865|NCT01706939|592985098|FG000|Pre Randomization|Ineligible for Randomization|1|||
164169866|NCT01706939|592985099|FG001|Pre Randomization|Ineligible for Randomization|0|||
164169867|NCT01706939|592985100|FG002|Pre Randomization|Ineligible for Randomization|0|||
164169868|NCT01706939|592985098|FG000|Pre Randomization|Withdrawal by Subject|1|||
164169869|NCT01706939|592985099|FG001|Pre Randomization|Withdrawal by Subject|0|||
164169870|NCT01706939|592985100|FG002|Pre Randomization|Withdrawal by Subject|0|||
164169871|NCT01706939|592985098|FG000|Randomization|Insufficient QoL survey compliance|0|||
164169872|NCT01706939|592985099|FG001|Randomization|Insufficient QoL survey compliance|1|||
164169873|NCT01706939|592985100|FG002|Randomization|Insufficient QoL survey compliance|1|||
164169874|NCT01706939|592985098|FG000|Randomization|Progression of disease|0|||
164169875|NCT01706939|592985099|FG001|Randomization|Progression of disease|2|||
164169876|NCT01706939|592985100|FG002|Randomization|Progression of disease|1|||
164169877|NCT01046903|592985101|FG000|Overall Study|Lost to Follow-up|16|||
164169878|NCT01046903|592985101|FG000|Overall Study|Adverse Event|4|||
164169879|NCT01046903|592985101|FG000|Overall Study|Withdrawal by Subject|3|||
164169880|NCT01046903|592985101|FG000|Overall Study|Other|5|||
164169881|NCT00977314|592985102|FG000|Overall Study|Withdrawal by Subject|1|||
164169882|NCT00977314|592985103|FG001|Overall Study|Withdrawal by Subject|0|||
164169883|NCT00977314|592985102|FG000|Overall Study|Physician Decision|1|||
164169884|NCT00977314|592985103|FG001|Overall Study|Physician Decision|0|||
164169885|NCT04463251|592985112|FG000|Overall Study|Death|1|||
164169886|NCT04463251|592985113|FG001|Overall Study|Death|0|||
164169887|NCT04463251|592985114|FG002|Overall Study|Death|1|||
164169888|NCT04463251|592985112|FG000|Overall Study|Adverse Event|0|||
164169889|NCT04463251|592985113|FG001|Overall Study|Adverse Event|1|||
164169890|NCT04463251|592985114|FG002|Overall Study|Adverse Event|0|||
164169891|NCT04463251|592985112|FG000|Overall Study|Lost to Follow-up|0|||
164169892|NCT04463251|592985113|FG001|Overall Study|Lost to Follow-up|1|||
164169893|NCT04463251|592985114|FG002|Overall Study|Lost to Follow-up|0|||
164169894|NCT04463251|592985112|FG000|Overall Study|Withdrawal by Subject|0|||
164169895|NCT04463251|592985113|FG001|Overall Study|Withdrawal by Subject|2|||
164169896|NCT04463251|592985114|FG002|Overall Study|Withdrawal by Subject|2|||
164169897|NCT05020665|592985115|FG000|Overall Study|Study terminated by Sponsor|5|||
164169898|NCT05020665|592985116|FG001|Overall Study|Study terminated by Sponsor|4|||
164169899|NCT05020665|592985115|FG000|Overall Study|Death|2|||
164169900|NCT05020665|592985116|FG001|Overall Study|Death|1|||
164169901|NCT05020665|592985115|FG000|Overall Study|Physician Decision|0|||
164169902|NCT05020665|592985116|FG001|Overall Study|Physician Decision|1|||
164169903|NCT05020665|592985115|FG000|Overall Study|Withdrawal by Subject|0|||
164169904|NCT05020665|592985116|FG001|Overall Study|Withdrawal by Subject|1|||
164169905|NCT05020665|592985115|FG000|Overall Study|Reason not specified|1|||
164169906|NCT05020665|592985116|FG001|Overall Study|Reason not specified|0|||
164169907|NCT01743560|592985121|FG000|Overall Study|Disease progression|26|||
164169908|NCT01743560|592985121|FG000|Overall Study|Adverse Event|8|||
164169909|NCT01743560|592985121|FG000|Overall Study|Death|3|||
164169910|NCT01743560|592985121|FG000|Overall Study|Withdrawal by Subject|2|||
164169911|NCT01743560|592985121|FG000|Overall Study|Protocol Violation|1|||
164169912|NCT01743560|592985121|FG000|Overall Study|>1 dose of study drug|3|||
164169913|NCT01732640|592985127|FG000|Overall Study|Adverse Event|0|||
164169914|NCT01732640|592985128|FG001|Overall Study|Adverse Event|1|||
164169915|NCT01732640|592985127|FG000|Overall Study|Death|0|||
164169916|NCT01732640|592985128|FG001|Overall Study|Death|1|||
164169917|NCT00877487|592985131|FG000|Open-label Treatment Phase|Adverse Event|1|||
164169918|NCT00877487|592985132|FG001|Open-label Treatment Phase|Adverse Event|0|||
164169919|NCT00877487|592985131|FG000|Open-label Treatment Phase|Protocol Violation|3|||
164169920|NCT00877487|592985132|FG001|Open-label Treatment Phase|Protocol Violation|0|||
164169921|NCT00877487|592985131|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
164169922|NCT00877487|592985132|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
164169923|NCT00877487|592985131|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
164169924|NCT00877487|592985132|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
164169925|NCT00877487|592985131|FG000|Open-label Treatment Phase|Out of country for business|1|||
164169926|NCT00877487|592985132|FG001|Open-label Treatment Phase|Out of country for business|0|||
164169927|NCT00877487|592985131|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
164169928|NCT00877487|592985132|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
164169929|NCT00877487|592985131|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
164169930|NCT00877487|592985132|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
164169931|NCT00877487|592985131|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
164169932|NCT00877487|592985132|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
164169933|NCT00877487|592985131|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
164169934|NCT00877487|592985132|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
164169935|NCT03070002|592985133|FG000|Follow up for 2 Years|Death|1|||
164169936|NCT03425396|592985145|FG000|Overall Study|Lost to Follow-up|2|||
164169937|NCT03425396|592985146|FG001|Overall Study|Lost to Follow-up|5|||
164169938|NCT03425396|592985147|FG002|Overall Study|Lost to Follow-up|2|||
164169939|NCT03425396|592985148|FG003|Overall Study|Lost to Follow-up|0|||
164169940|NCT03425396|592985149|FG004|Overall Study|Lost to Follow-up|0|||
164169941|NCT03425396|592985145|FG000|Overall Study|Withdrawal by Subject|0|||
164169942|NCT03425396|592985146|FG001|Overall Study|Withdrawal by Subject|1|||
164169943|NCT03425396|592985147|FG002|Overall Study|Withdrawal by Subject|0|||
164169944|NCT03425396|592985148|FG003|Overall Study|Withdrawal by Subject|1|||
164169945|NCT03425396|592985149|FG004|Overall Study|Withdrawal by Subject|0|||
164169946|NCT03425396|592985145|FG000|Overall Study|Other|0|||
164169947|NCT03425396|592985146|FG001|Overall Study|Other|1|||
164169948|NCT03425396|592985147|FG002|Overall Study|Other|1|||
164169949|NCT03425396|592985148|FG003|Overall Study|Other|0|||
164169950|NCT03425396|592985149|FG004|Overall Study|Other|1|||
164169951|NCT01082211|592985152|FG000|Overall Study|Protocol Violation|4|||
164169952|NCT01082211|592985152|FG000|Overall Study|No protocol treatment received|3|||
164169953|NCT04999163|592985153|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
164169954|NCT04999163|592985154|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
164169955|NCT04999163|592985153|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
164169956|NCT04999163|592985154|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
164169957|NCT04999163|592985153|FG000|Overall Study|Withdrawal by Subject|1|||
164169958|NCT04999163|592985154|FG001|Overall Study|Withdrawal by Subject|0|||
164169959|NCT05903924|592987323|FG000|Overall Study|Lost to Follow-up|1|||
164169960|NCT05903924|592987324|FG001|Overall Study|Lost to Follow-up|0|||
164169961|NCT05903924|592987325|FG002|Overall Study|Lost to Follow-up|0|||
164169962|NCT04338269|592987326|FG000|Overall Study|Death|86|||
164169963|NCT04338269|592987327|FG001|Overall Study|Death|89|||
164169964|NCT04338269|592987326|FG000|Overall Study|Lost to Follow-up|1|||
164169965|NCT04338269|592987327|FG001|Overall Study|Lost to Follow-up|2|||
164169966|NCT04338269|592987326|FG000|Overall Study|Physician Decision|1|||
164169967|NCT04338269|592987327|FG001|Overall Study|Physician Decision|0|||
164169968|NCT04338269|592987326|FG000|Overall Study|Withdrawal by Subject|14|||
164169969|NCT04338269|592987327|FG001|Overall Study|Withdrawal by Subject|11|||
164169970|NCT00174967|592987328|FG000|Overall Study|Adverse Event|1|||
164169971|NCT00174967|592987329|FG001|Overall Study|Adverse Event|2|||
164169972|NCT00174967|592987330|FG002|Overall Study|Adverse Event|2|||
164169973|NCT00174967|592987331|FG003|Overall Study|Adverse Event|1|||
164169974|NCT00174967|592987328|FG000|Overall Study|Gout Flare|0|||
164169975|NCT00174967|592987329|FG001|Overall Study|Gout Flare|0|||
164169976|NCT00174967|592987330|FG002|Overall Study|Gout Flare|0|||
164169977|NCT00174967|592987331|FG003|Overall Study|Gout Flare|1|||
164169978|NCT00174967|592987328|FG000|Overall Study|Other|0|||
164169979|NCT00174967|592987329|FG001|Overall Study|Other|1|||
164169980|NCT00174967|592987330|FG002|Overall Study|Other|0|||
164169981|NCT00174967|592987331|FG003|Overall Study|Other|0|||
164169982|NCT03030989|592987332|FG000|Overall Study|Fever|2|||
164169983|NCT03030989|592987333|FG001|Overall Study|Fever|2|||
164169984|NCT03030989|592987332|FG000|Overall Study|Rash|2|||
164169985|NCT03030989|592987333|FG001|Overall Study|Rash|1|||
164169986|NCT03030989|592987332|FG000|Overall Study|Fatigue/Overwhelmed|1|||
164169987|NCT03030989|592987333|FG001|Overall Study|Fatigue/Overwhelmed|5|||
164169988|NCT03030989|592987332|FG000|Overall Study|Positive Blood Cultures|2|||
164169989|NCT03030989|592987333|FG001|Overall Study|Positive Blood Cultures|1|||
164169990|NCT03030989|592987332|FG000|Overall Study|Line Removed|0|||
164169991|NCT03030989|592987333|FG001|Overall Study|Line Removed|2|||
164169992|NCT03030989|592987332|FG000|Overall Study|No longer interested|5|||
164169993|NCT03030989|592987333|FG001|Overall Study|No longer interested|3|||
164169994|NCT02730377|592987334|FG000|Overall Study|Other|5|||
164169995|NCT02730377|592987335|FG001|Overall Study|Other|4|||
164169996|NCT02730377|592987334|FG000|Overall Study|Death|1|||
164169997|NCT02730377|592987335|FG001|Overall Study|Death|8|||
164169998|NCT02730377|592987334|FG000|Overall Study|Inadequate glycaemic control|368|||
164169999|NCT02730377|592987335|FG001|Overall Study|Inadequate glycaemic control|473|||
164170000|NCT02730377|592987334|FG000|Overall Study|Adverse Event|79|||
164170001|NCT02730377|592987335|FG001|Overall Study|Adverse Event|41|||
164170002|NCT02730377|592987334|FG000|Overall Study|Protocol Violation|23|||
164170003|NCT02730377|592987335|FG001|Overall Study|Protocol Violation|30|||
164170004|NCT02730377|592987334|FG000|Overall Study|Lack of Efficacy|4|||
164170005|NCT02730377|592987335|FG001|Overall Study|Lack of Efficacy|13|||
164170006|NCT02730377|592987334|FG000|Overall Study|Pregnancy|0|||
164170007|NCT02730377|592987335|FG001|Overall Study|Pregnancy|1|||
164170008|NCT02730377|592987334|FG000|Overall Study|Withdrawal by Subject|45|||
164170009|NCT02730377|592987335|FG001|Overall Study|Withdrawal by Subject|42|||
164170010|NCT02730377|592987334|FG000|Overall Study|Lost to Follow-up|25|||
164170011|NCT02730377|592987335|FG001|Overall Study|Lost to Follow-up|21|||
164170012|NCT03917472|592987336|FG000|Overall Study|Physician Decision|4|||
164170013|NCT03917472|592987337|FG001|Overall Study|Physician Decision|0|||
164170014|NCT03917472|592987336|FG000|Overall Study|Adverse Event|3|||
164170015|NCT03917472|592987337|FG001|Overall Study|Adverse Event|1|||
164170016|NCT03917472|592987336|FG000|Overall Study|Death|7|||
164170017|NCT03917472|592987337|FG001|Overall Study|Death|5|||
164170018|NCT03917472|592987336|FG000|Overall Study|Withdrawal by Subject|11|||
164170019|NCT03917472|592987337|FG001|Overall Study|Withdrawal by Subject|4|||
164170020|NCT03917472|592987336|FG000|Overall Study|Lost to Follow-up|10|||
164170021|NCT03917472|592987337|FG001|Overall Study|Lost to Follow-up|5|||
164170022|NCT02706886|592987338|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
164170023|NCT02706886|592987339|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
164170024|NCT02706886|592987340|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
164170025|NCT02706886|592987341|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
164170026|NCT02706886|592987342|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
164170027|NCT02706886|592987343|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
164170028|NCT02706886|592987344|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
164170029|NCT02706886|592987345|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
164170030|NCT02706886|592987346|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
164170031|NCT01154296|592987347|FG000|Randomization and Intervention|Decided to decline|1|||
164170032|NCT01154296|592987348|FG001|Randomization and Intervention|Decided to decline|1|||
164170033|NCT01154296|592987347|FG000|Randomization and Intervention|Declined by staff|1|||
164170034|NCT01154296|592987348|FG001|Randomization and Intervention|Declined by staff|0|||
164170035|NCT01154296|592987347|FG000|Randomization and Intervention|Did not return|1|||
164170036|NCT01154296|592987348|FG001|Randomization and Intervention|Did not return|0|||
164170037|NCT01154296|592987347|FG000|Randomization and Intervention|Left before test|0|||
164170038|NCT01154296|592987348|FG001|Randomization and Intervention|Left before test|1|||
164170039|NCT01154296|592987347|FG000|Randomization and Intervention|Left clinic early|2|||
164170040|NCT01154296|592987348|FG001|Randomization and Intervention|Left clinic early|0|||
164170041|NCT01154296|592987347|FG000|6-month Follow-up|Lost contact|269|||
164170042|NCT01154296|592987348|FG001|6-month Follow-up|Lost contact|275|||
164170043|NCT01154296|592987347|FG000|6-month Follow-up|Incarcerated|37|||
164170044|NCT01154296|592987348|FG001|6-month Follow-up|Incarcerated|32|||
164170045|NCT01154296|592987347|FG000|6-month Follow-up|Withdrew consent|14|||
164170046|NCT01154296|592987348|FG001|6-month Follow-up|Withdrew consent|15|||
164170047|NCT01154296|592987347|FG000|6-month Follow-up|Death|3|||
164170048|NCT01154296|592987348|FG001|6-month Follow-up|Death|2|||
164170049|NCT01154296|592987347|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
164170050|NCT01154296|592987348|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
164170051|NCT02203851|592987349|FG000|Overall Study|Lost to Follow-up|4|||
164170052|NCT02203851|592987349|FG000|Overall Study|Withdrawal by Subject|6|||
164170053|NCT02203851|592987349|FG000|Overall Study|Other|1|||
164170054|NCT02086448|592987350|FG000|Overall Study|Withdrawal by Subject|1|||
164170055|NCT02086448|592987351|FG001|Overall Study|Withdrawal by Subject|0|||
164170056|NCT02086448|592987352|FG002|Overall Study|Withdrawal by Subject|0|||
164170057|NCT02086448|592987353|FG003|Overall Study|Withdrawal by Subject|2|||
164170058|NCT02031640|592987364|FG000|Screening Period|Adverse Event|1|||
164170059|NCT02031640|592987365|FG001|Screening Period|Adverse Event|0|||
164170060|NCT02031640|592987366|FG002|Screening Period|Adverse Event|0|||
164170061|NCT02031640|592987367|FG003|Screening Period|Adverse Event|0|||
164170062|NCT02031640|592987368|FG004|Screening Period|Adverse Event|0|||
164170063|NCT02031640|592987369|FG005|Screening Period|Adverse Event|0|||
164170064|NCT02031640|592987364|FG000|Screening Period|Withdrawal by Subject|29|||
164170065|NCT02031640|592987365|FG001|Screening Period|Withdrawal by Subject|0|||
164170066|NCT02031640|592987366|FG002|Screening Period|Withdrawal by Subject|0|||
164170067|NCT02031640|592987367|FG003|Screening Period|Withdrawal by Subject|0|||
164170068|NCT02031640|592987368|FG004|Screening Period|Withdrawal by Subject|0|||
164170069|NCT02031640|592987369|FG005|Screening Period|Withdrawal by Subject|0|||
164170070|NCT02031640|592987364|FG000|Screening Period|Inclusion criteria not met|312|||
164170071|NCT02031640|592987365|FG001|Screening Period|Inclusion criteria not met|0|||
164170072|NCT02031640|592987366|FG002|Screening Period|Inclusion criteria not met|0|||
164170073|NCT02031640|592987367|FG003|Screening Period|Inclusion criteria not met|0|||
164170074|NCT02031640|592987368|FG004|Screening Period|Inclusion criteria not met|0|||
164170075|NCT02031640|592987369|FG005|Screening Period|Inclusion criteria not met|0|||
164170076|NCT02031640|592987364|FG000|Screening Period|Exclusion criteria met|30|||
164170077|NCT02031640|592987365|FG001|Screening Period|Exclusion criteria met|0|||
164170078|NCT02031640|592987366|FG002|Screening Period|Exclusion criteria met|0|||
164170079|NCT02031640|592987367|FG003|Screening Period|Exclusion criteria met|0|||
164170080|NCT02031640|592987368|FG004|Screening Period|Exclusion criteria met|0|||
164170081|NCT02031640|592987369|FG005|Screening Period|Exclusion criteria met|0|||
164170082|NCT02031640|592987364|FG000|Screening Period|Lost to Follow-up|14|||
164170083|NCT02031640|592987365|FG001|Screening Period|Lost to Follow-up|0|||
164170084|NCT02031640|592987366|FG002|Screening Period|Lost to Follow-up|0|||
164170085|NCT02031640|592987367|FG003|Screening Period|Lost to Follow-up|0|||
164170086|NCT02031640|592987368|FG004|Screening Period|Lost to Follow-up|0|||
164170087|NCT02031640|592987369|FG005|Screening Period|Lost to Follow-up|0|||
164170088|NCT02031640|592987364|FG000|Screening Period|Enrollment closed|26|||
164170089|NCT02031640|592987365|FG001|Screening Period|Enrollment closed|0|||
164170090|NCT02031640|592987366|FG002|Screening Period|Enrollment closed|0|||
164170091|NCT02031640|592987367|FG003|Screening Period|Enrollment closed|0|||
164170092|NCT02031640|592987368|FG004|Screening Period|Enrollment closed|0|||
164170093|NCT02031640|592987369|FG005|Screening Period|Enrollment closed|0|||
164170094|NCT02031640|592987364|FG000|Run-In Period|Adverse Event|4|||
164170095|NCT02031640|592987365|FG001|Run-In Period|Adverse Event|0|||
164170096|NCT02031640|592987366|FG002|Run-In Period|Adverse Event|0|||
164170097|NCT02031640|592987367|FG003|Run-In Period|Adverse Event|0|||
164170098|NCT02031640|592987368|FG004|Run-In Period|Adverse Event|0|||
164170099|NCT02031640|592987369|FG005|Run-In Period|Adverse Event|0|||
164170100|NCT02031640|592987364|FG000|Run-In Period|Withdrawal by Subject|17|||
164170101|NCT02031640|592987365|FG001|Run-In Period|Withdrawal by Subject|0|||
164170102|NCT02031640|592987366|FG002|Run-In Period|Withdrawal by Subject|0|||
164170103|NCT02031640|592987367|FG003|Run-In Period|Withdrawal by Subject|0|||
164170104|NCT02031640|592987368|FG004|Run-In Period|Withdrawal by Subject|0|||
164170105|NCT02031640|592987369|FG005|Run-In Period|Withdrawal by Subject|0|||
164170106|NCT02031640|592987364|FG000|Run-In Period|Inclusion criteria not met|38|||
164170107|NCT02031640|592987365|FG001|Run-In Period|Inclusion criteria not met|0|||
164170108|NCT02031640|592987366|FG002|Run-In Period|Inclusion criteria not met|0|||
164170109|NCT02031640|592987367|FG003|Run-In Period|Inclusion criteria not met|0|||
164170110|NCT02031640|592987368|FG004|Run-In Period|Inclusion criteria not met|0|||
164170111|NCT02031640|592987369|FG005|Run-In Period|Inclusion criteria not met|0|||
164170112|NCT02031640|592987364|FG000|Run-In Period|Exclusion criteria met|8|||
164170113|NCT02031640|592987365|FG001|Run-In Period|Exclusion criteria met|0|||
164170114|NCT02031640|592987366|FG002|Run-In Period|Exclusion criteria met|0|||
164170115|NCT02031640|592987367|FG003|Run-In Period|Exclusion criteria met|0|||
164170116|NCT02031640|592987368|FG004|Run-In Period|Exclusion criteria met|0|||
164170117|NCT02031640|592987369|FG005|Run-In Period|Exclusion criteria met|0|||
164170118|NCT02031640|592987364|FG000|Run-In Period|Randomization criteria not met|85|||
164170119|NCT02031640|592987365|FG001|Run-In Period|Randomization criteria not met|0|||
164170120|NCT02031640|592987366|FG002|Run-In Period|Randomization criteria not met|0|||
164170121|NCT02031640|592987367|FG003|Run-In Period|Randomization criteria not met|0|||
164170122|NCT02031640|592987368|FG004|Run-In Period|Randomization criteria not met|0|||
164170123|NCT02031640|592987369|FG005|Run-In Period|Randomization criteria not met|0|||
164170124|NCT02031640|592987364|FG000|Run-In Period|Various administrative reasons|17|||
164170125|NCT02031640|592987365|FG001|Run-In Period|Various administrative reasons|0|||
164170126|NCT02031640|592987366|FG002|Run-In Period|Various administrative reasons|0|||
164170127|NCT02031640|592987367|FG003|Run-In Period|Various administrative reasons|0|||
164170128|NCT02031640|592987368|FG004|Run-In Period|Various administrative reasons|0|||
164170129|NCT02031640|592987369|FG005|Run-In Period|Various administrative reasons|0|||
164170130|NCT02031640|592987364|FG000|Double-blind Treatment Period|Protocol deviation|0|||
164170131|NCT02031640|592987365|FG001|Double-blind Treatment Period|Protocol deviation|2|||
164170132|NCT02031640|592987366|FG002|Double-blind Treatment Period|Protocol deviation|0|||
164170133|NCT02031640|592987367|FG003|Double-blind Treatment Period|Protocol deviation|1|||
164170134|NCT02031640|592987368|FG004|Double-blind Treatment Period|Protocol deviation|3|||
164170135|NCT02031640|592987369|FG005|Double-blind Treatment Period|Protocol deviation|1|||
164170136|NCT02031640|592987364|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
164170137|NCT02031640|592987365|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
164170138|NCT02031640|592987366|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
164170139|NCT02031640|592987367|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
164170140|NCT02031640|592987368|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
164170141|NCT02031640|592987369|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
164170142|NCT02031640|592987364|FG000|Double-blind Treatment Period|Non-compliance|0|||
164170143|NCT02031640|592987365|FG001|Double-blind Treatment Period|Non-compliance|1|||
164170144|NCT02031640|592987366|FG002|Double-blind Treatment Period|Non-compliance|0|||
164170145|NCT02031640|592987367|FG003|Double-blind Treatment Period|Non-compliance|1|||
164170146|NCT02031640|592987368|FG004|Double-blind Treatment Period|Non-compliance|1|||
164170147|NCT02031640|592987369|FG005|Double-blind Treatment Period|Non-compliance|0|||
164170148|NCT02031640|592987364|FG000|Double-blind Treatment Period|Adverse Event|0|||
164170149|NCT02031640|592987365|FG001|Double-blind Treatment Period|Adverse Event|0|||
164170150|NCT02031640|592987366|FG002|Double-blind Treatment Period|Adverse Event|0|||
164170151|NCT02031640|592987367|FG003|Double-blind Treatment Period|Adverse Event|2|||
164170152|NCT02031640|592987368|FG004|Double-blind Treatment Period|Adverse Event|0|||
164170153|NCT02031640|592987369|FG005|Double-blind Treatment Period|Adverse Event|0|||
164170154|NCT02031640|592987364|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
164170155|NCT02031640|592987365|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
164170156|NCT02031640|592987366|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
164170157|NCT02031640|592987367|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
164170158|NCT02031640|592987368|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
164170159|NCT02031640|592987369|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
164170160|NCT02031640|592987364|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
164170161|NCT02031640|592987365|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
164170162|NCT02031640|592987366|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
164170163|NCT02031640|592987367|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
164170164|NCT02031640|592987368|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
164170165|NCT02031640|592987369|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
164170166|NCT00654875|592987370|FG000|Overall Study|Adverse Event|5|||
164170167|NCT00654875|592987371|FG001|Overall Study|Adverse Event|5|||
164170168|NCT00654875|592987370|FG000|Overall Study|Withdrawal by Subject|4|||
164170169|NCT00654875|592987371|FG001|Overall Study|Withdrawal by Subject|4|||
164170170|NCT00654875|592987370|FG000|Overall Study|Protocol Violation|3|||
164170171|NCT00654875|592987371|FG001|Overall Study|Protocol Violation|3|||
164170172|NCT00654875|592987370|FG000|Overall Study|Lack of Efficacy|2|||
164170173|NCT00654875|592987371|FG001|Overall Study|Lack of Efficacy|2|||
164170174|NCT00654875|592987370|FG000|Overall Study|Lost to Follow-up|1|||
164170175|NCT00654875|592987371|FG001|Overall Study|Lost to Follow-up|3|||
164170176|NCT00654875|592987370|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
164170177|NCT00654875|592987371|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
164170178|NCT00654875|592987370|FG000|Overall Study|Administrative Problems|1|||
164170179|NCT00654875|592987371|FG001|Overall Study|Administrative Problems|0|||
164170180|NCT01867710|592987373|FG000|Overall Study|Death|25|||
164170181|NCT01867710|592987374|FG001|Overall Study|Death|15|||
164170182|NCT01867710|592987375|FG002|Overall Study|Death|27|||
164170183|NCT01867710|592987376|FG003|Overall Study|Death|20|||
164170184|NCT01867710|592987373|FG000|Overall Study|Lost to Follow-up|3|||
164170185|NCT01867710|592987374|FG001|Overall Study|Lost to Follow-up|4|||
164170186|NCT01867710|592987375|FG002|Overall Study|Lost to Follow-up|3|||
164170187|NCT01867710|592987376|FG003|Overall Study|Lost to Follow-up|2|||
164170188|NCT01867710|592987373|FG000|Overall Study|Withdrawal of consent|2|||
164170189|NCT01867710|592987374|FG001|Overall Study|Withdrawal of consent|5|||
164170190|NCT01867710|592987375|FG002|Overall Study|Withdrawal of consent|1|||
164170191|NCT01867710|592987376|FG003|Overall Study|Withdrawal of consent|2|||
164170192|NCT01867710|592987373|FG000|Overall Study|Study Terminated by Sponsor|9|||
164170193|NCT01867710|592987374|FG001|Overall Study|Study Terminated by Sponsor|13|||
164170194|NCT01867710|592987375|FG002|Overall Study|Study Terminated by Sponsor|8|||
164170195|NCT01867710|592987376|FG003|Overall Study|Study Terminated by Sponsor|16|||
164170196|NCT01867710|592987373|FG000|Overall Study|Biochemical progression|0|||
164170197|NCT01867710|592987374|FG001|Overall Study|Biochemical progression|1|||
164170198|NCT01867710|592987375|FG002|Overall Study|Biochemical progression|0|||
164170199|NCT01867710|592987376|FG003|Overall Study|Biochemical progression|0|||
164170200|NCT01867710|592987373|FG000|Overall Study|Clinical progression|0|||
164170201|NCT01867710|592987374|FG001|Overall Study|Clinical progression|0|||
164170202|NCT01867710|592987375|FG002|Overall Study|Clinical progression|1|||
164170203|NCT01867710|592987376|FG003|Overall Study|Clinical progression|0|||
164170204|NCT01867710|592987373|FG000|Overall Study|Disease progression|1|||
164170205|NCT01867710|592987374|FG001|Overall Study|Disease progression|0|||
164170206|NCT01867710|592987375|FG002|Overall Study|Disease progression|0|||
164170207|NCT01867710|592987376|FG003|Overall Study|Disease progression|0|||
164170208|NCT01867710|592987373|FG000|Overall Study|Patient decision|0|||
164170209|NCT01867710|592987374|FG001|Overall Study|Patient decision|0|||
164170210|NCT01867710|592987375|FG002|Overall Study|Patient decision|0|||
164170211|NCT01867710|592987376|FG003|Overall Study|Patient decision|1|||
164170212|NCT01867710|592987373|FG000|Overall Study|Patient to follow subsequent treatment|0|||
164170213|NCT01867710|592987374|FG001|Overall Study|Patient to follow subsequent treatment|1|||
164170214|NCT01867710|592987375|FG002|Overall Study|Patient to follow subsequent treatment|0|||
164170215|NCT01867710|592987376|FG003|Overall Study|Patient to follow subsequent treatment|0|||
164170216|NCT01867710|592987373|FG000|Overall Study|Progressive disease|1|||
164170217|NCT01867710|592987374|FG001|Overall Study|Progressive disease|0|||
164170218|NCT01867710|592987375|FG002|Overall Study|Progressive disease|0|||
164170219|NCT01867710|592987376|FG003|Overall Study|Progressive disease|0|||
164170220|NCT01867710|592987373|FG000|Overall Study|Protocol Violation|0|||
164170221|NCT01867710|592987374|FG001|Overall Study|Protocol Violation|0|||
164170222|NCT01867710|592987375|FG002|Overall Study|Protocol Violation|0|||
164170223|NCT01867710|592987376|FG003|Overall Study|Protocol Violation|1|||
164170224|NCT01867710|592987373|FG000|Overall Study|PSA-progression|0|||
164170225|NCT01867710|592987374|FG001|Overall Study|PSA-progression|1|||
164170226|NCT01867710|592987375|FG002|Overall Study|PSA-progression|0|||
164170227|NCT01867710|592987376|FG003|Overall Study|PSA-progression|0|||
164170228|NCT01867710|592987373|FG000|Overall Study|Study medication no longer effective|0|||
164170229|NCT01867710|592987374|FG001|Overall Study|Study medication no longer effective|1|||
164170230|NCT01867710|592987375|FG002|Overall Study|Study medication no longer effective|0|||
164170231|NCT01867710|592987376|FG003|Overall Study|Study medication no longer effective|0|||
164170232|NCT05113979|592987377|FG000|Overall Study|Death|2|||
164170233|NCT05113979|592987377|FG000|Overall Study|Lost to Follow-up|1|||
164170234|NCT02048826|592987378|FG000|Overall Study|Withdrawal by Subject|1|||
164170235|NCT02048826|592987379|FG001|Overall Study|Withdrawal by Subject|0|||
164170236|NCT00976820|592987380|FG000|Overall Study|Lost to Follow-up|5|||
164170237|NCT00976820|592987381|FG001|Overall Study|Lost to Follow-up|16|||
164170238|NCT00976820|592987382|FG002|Overall Study|Lost to Follow-up|2|||
164170239|NCT00976820|592987383|FG003|Overall Study|Lost to Follow-up|3|||
164170240|NCT00976820|592987380|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
164170241|NCT00976820|592987381|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
164170242|NCT00976820|592987382|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
164170243|NCT00976820|592987383|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
164170244|NCT00976820|592987380|FG000|Overall Study|Withdrawal by Subject|2|||
164170245|NCT00976820|592987381|FG001|Overall Study|Withdrawal by Subject|4|||
164170246|NCT00976820|592987382|FG002|Overall Study|Withdrawal by Subject|1|||
164170247|NCT00976820|592987383|FG003|Overall Study|Withdrawal by Subject|4|||
164170248|NCT00526669|592987384|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
164170249|NCT00526669|592987385|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
164170250|NCT00526669|592987384|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
164170251|NCT00526669|592987385|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
164170252|NCT00526669|592987384|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
164170253|NCT00526669|592987385|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
164170254|NCT00526669|592987384|FG000|Combined Treatment Phase|Death|0|||
164170255|NCT00526669|592987385|FG001|Combined Treatment Phase|Death|2|||
164170256|NCT00968981|592987386|FG000|Overall Study|Adverse Event|2|||
164170257|NCT00968981|592987387|FG001|Overall Study|Adverse Event|0|||
164170258|NCT00968981|592987388|FG002|Overall Study|Adverse Event|0|||
164170259|NCT00968981|592987386|FG000|Overall Study|Disease Progression|14|||
164170260|NCT00968981|592987387|FG001|Overall Study|Disease Progression|16|||
164170261|NCT00968981|592987388|FG002|Overall Study|Disease Progression|13|||
164170262|NCT00968981|592987386|FG000|Overall Study|Lost to Follow-up|0|||
164170263|NCT00968981|592987387|FG001|Overall Study|Lost to Follow-up|0|||
164170264|NCT00968981|592987388|FG002|Overall Study|Lost to Follow-up|1|||
164170265|NCT00968981|592987386|FG000|Overall Study|Physician Decision|5|||
164170266|NCT00968981|592987387|FG001|Overall Study|Physician Decision|3|||
164170267|NCT00968981|592987388|FG002|Overall Study|Physician Decision|5|||
164170268|NCT00968981|592987386|FG000|Overall Study|Withdrawal by Subject|1|||
164170269|NCT00968981|592987387|FG001|Overall Study|Withdrawal by Subject|3|||
164170270|NCT00968981|592987388|FG002|Overall Study|Withdrawal by Subject|3|||
164170271|NCT01981954|592987399|FG000|Titration Period|Protocol Deviation|1|||
164170272|NCT01981954|592987399|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
164170273|NCT01489254|592987400|FG000|Double-blind Part|Adverse Event|7|||
164170274|NCT01489254|592987401|FG001|Double-blind Part|Adverse Event|2|||
164170275|NCT01489254|592987402|FG002|Double-blind Part|Adverse Event|2|||
164170276|NCT01489254|592987403|FG003|Double-blind Part|Adverse Event|0|||
164170277|NCT01489254|592987400|FG000|Double-blind Part|Pregnancy|1|||
164170278|NCT01489254|592987401|FG001|Double-blind Part|Pregnancy|3|||
164170279|NCT01489254|592987402|FG002|Double-blind Part|Pregnancy|0|||
164170280|NCT01489254|592987403|FG003|Double-blind Part|Pregnancy|0|||
164170281|NCT01489254|592987400|FG000|Double-blind Part|Withdrawal by Subject|12|||
164170282|NCT01489254|592987401|FG001|Double-blind Part|Withdrawal by Subject|20|||
164170283|NCT01489254|592987402|FG002|Double-blind Part|Withdrawal by Subject|1|||
164170284|NCT01489254|592987403|FG003|Double-blind Part|Withdrawal by Subject|0|||
164170285|NCT01489254|592987400|FG000|Double-blind Part|Lost to Follow-up|1|||
164170286|NCT01489254|592987401|FG001|Double-blind Part|Lost to Follow-up|2|||
164170287|NCT01489254|592987402|FG002|Double-blind Part|Lost to Follow-up|0|||
164170288|NCT01489254|592987403|FG003|Double-blind Part|Lost to Follow-up|0|||
164170289|NCT01489254|592987400|FG000|Double-blind Part|Other reasons for not completing study|4|||
164170290|NCT01489254|592987401|FG001|Double-blind Part|Other reasons for not completing study|6|||
164170291|NCT01489254|592987402|FG002|Double-blind Part|Other reasons for not completing study|0|||
164170292|NCT01489254|592987403|FG003|Double-blind Part|Other reasons for not completing study|0|||
164170293|NCT01489254|592987400|FG000|Open-label Extension Part|Adverse Event|0|||
164170294|NCT01489254|592987401|FG001|Open-label Extension Part|Adverse Event|0|||
164170295|NCT01489254|592987402|FG002|Open-label Extension Part|Adverse Event|0|||
164170296|NCT01489254|592987403|FG003|Open-label Extension Part|Adverse Event|10|||
164170725|NCT02147158|592987475|FG002|Treatment Course 1|Adverse Event|3|||
164170297|NCT01489254|592987400|FG000|Open-label Extension Part|Pregnancy|0|||
164170298|NCT01489254|592987401|FG001|Open-label Extension Part|Pregnancy|0|||
164170299|NCT01489254|592987402|FG002|Open-label Extension Part|Pregnancy|0|||
164170300|NCT01489254|592987403|FG003|Open-label Extension Part|Pregnancy|3|||
164170301|NCT01489254|592987400|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
164170302|NCT01489254|592987401|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
164170303|NCT01489254|592987402|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
164170304|NCT01489254|592987403|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
164170305|NCT01489254|592987400|FG000|Open-label Extension Part|Protocol Violation|0|||
164170306|NCT01489254|592987401|FG001|Open-label Extension Part|Protocol Violation|0|||
164170307|NCT01489254|592987402|FG002|Open-label Extension Part|Protocol Violation|0|||
164170308|NCT01489254|592987403|FG003|Open-label Extension Part|Protocol Violation|1|||
164170309|NCT01489254|592987400|FG000|Open-label Extension Part|Lost to Follow-up|0|||
164170310|NCT01489254|592987401|FG001|Open-label Extension Part|Lost to Follow-up|0|||
164170311|NCT01489254|592987402|FG002|Open-label Extension Part|Lost to Follow-up|0|||
164170312|NCT01489254|592987403|FG003|Open-label Extension Part|Lost to Follow-up|9|||
164170313|NCT01489254|592987400|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
164170314|NCT01489254|592987401|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
164170315|NCT01489254|592987402|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
164170316|NCT01489254|592987403|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
164170317|NCT01730534|592987404|FG000|Overall Study|Withdrawal by Subject|97|||
164170318|NCT01730534|592987405|FG001|Overall Study|Withdrawal by Subject|127|||
164170319|NCT01730534|592987404|FG000|Overall Study|Lost to Follow-up|12|||
164170320|NCT01730534|592987405|FG001|Overall Study|Lost to Follow-up|18|||
164170321|NCT02980341|592987406|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
164170322|NCT02980341|592987407|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
164170323|NCT02980341|592987408|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
164170324|NCT02980341|592987409|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
164170325|NCT02980341|592987410|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
164170326|NCT02980341|592987411|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
164170327|NCT02980341|592987412|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
164170328|NCT02980341|592987413|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
164170329|NCT02980341|592987414|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
164170330|NCT02980341|592987415|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
164170331|NCT02980341|592987416|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
164170332|NCT02980341|592987406|FG000|Dose Escalation|Clinical progression|0|||
164170333|NCT02980341|592987407|FG001|Dose Escalation|Clinical progression|0|||
164170334|NCT02980341|592987408|FG002|Dose Escalation|Clinical progression|2|||
164170335|NCT02980341|592987409|FG003|Dose Escalation|Clinical progression|1|||
164170336|NCT02980341|592987410|FG004|Dose Escalation|Clinical progression|0|||
164170337|NCT02980341|592987411|FG005|Dose Escalation|Clinical progression|0|||
164170338|NCT02980341|592987412|FG006|Dose Escalation|Clinical progression|0|||
164170339|NCT02980341|592987413|FG007|Dose Escalation|Clinical progression|0|||
164170340|NCT02980341|592987414|FG008|Dose Escalation|Clinical progression|0|||
164170341|NCT02980341|592987415|FG009|Dose Escalation|Clinical progression|0|||
164170342|NCT02980341|592987416|FG010|Dose Escalation|Clinical progression|0|||
164170343|NCT02980341|592987406|FG000|Dose Escalation|Adverse Event|0|||
164170344|NCT02980341|592987407|FG001|Dose Escalation|Adverse Event|0|||
164170345|NCT02980341|592987408|FG002|Dose Escalation|Adverse Event|1|||
164170346|NCT02980341|592987409|FG003|Dose Escalation|Adverse Event|2|||
164170347|NCT02980341|592987410|FG004|Dose Escalation|Adverse Event|2|||
164170348|NCT02980341|592987411|FG005|Dose Escalation|Adverse Event|0|||
164170349|NCT02980341|592987412|FG006|Dose Escalation|Adverse Event|0|||
164170350|NCT02980341|592987413|FG007|Dose Escalation|Adverse Event|0|||
164170351|NCT02980341|592987414|FG008|Dose Escalation|Adverse Event|0|||
164170352|NCT02980341|592987415|FG009|Dose Escalation|Adverse Event|0|||
164170353|NCT02980341|592987416|FG010|Dose Escalation|Adverse Event|0|||
164170354|NCT02980341|592987406|FG000|Dose Escalation|Withdrawal by Subject|0|||
164170355|NCT02980341|592987407|FG001|Dose Escalation|Withdrawal by Subject|0|||
164170356|NCT02980341|592987408|FG002|Dose Escalation|Withdrawal by Subject|1|||
164170357|NCT02980341|592987409|FG003|Dose Escalation|Withdrawal by Subject|0|||
164170358|NCT02980341|592987410|FG004|Dose Escalation|Withdrawal by Subject|0|||
164170359|NCT02980341|592987411|FG005|Dose Escalation|Withdrawal by Subject|0|||
164170360|NCT02980341|592987412|FG006|Dose Escalation|Withdrawal by Subject|0|||
164170361|NCT02980341|592987413|FG007|Dose Escalation|Withdrawal by Subject|0|||
164170362|NCT02980341|592987414|FG008|Dose Escalation|Withdrawal by Subject|0|||
164170363|NCT02980341|592987415|FG009|Dose Escalation|Withdrawal by Subject|0|||
164170364|NCT02980341|592987416|FG010|Dose Escalation|Withdrawal by Subject|0|||
164170365|NCT02980341|592987406|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
164170366|NCT02980341|592987407|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
164170367|NCT02980341|592987408|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
164170368|NCT02980341|592987409|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
164170369|NCT02980341|592987410|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
164170370|NCT02980341|592987411|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
164170371|NCT02980341|592987412|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
164170372|NCT02980341|592987413|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
164170373|NCT02980341|592987414|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
164170374|NCT02980341|592987415|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
164170375|NCT02980341|592987416|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
164170376|NCT02980341|592987406|FG000|Dose Escalation|Due to investigator's decision|0|||
164170377|NCT02980341|592987407|FG001|Dose Escalation|Due to investigator's decision|0|||
164170378|NCT02980341|592987408|FG002|Dose Escalation|Due to investigator's decision|0|||
164170379|NCT02980341|592987409|FG003|Dose Escalation|Due to investigator's decision|0|||
164170380|NCT02980341|592987410|FG004|Dose Escalation|Due to investigator's decision|1|||
164170381|NCT02980341|592987411|FG005|Dose Escalation|Due to investigator's decision|0|||
164170382|NCT02980341|592987412|FG006|Dose Escalation|Due to investigator's decision|0|||
164170383|NCT02980341|592987413|FG007|Dose Escalation|Due to investigator's decision|0|||
164170384|NCT02980341|592987414|FG008|Dose Escalation|Due to investigator's decision|0|||
164170385|NCT02980341|592987415|FG009|Dose Escalation|Due to investigator's decision|0|||
164170386|NCT02980341|592987416|FG010|Dose Escalation|Due to investigator's decision|0|||
164170387|NCT02980341|592987406|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
164170388|NCT02980341|592987407|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
164170389|NCT02980341|592987408|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
164170390|NCT02980341|592987409|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
164170391|NCT02980341|592987410|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
164170392|NCT02980341|592987411|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
164170393|NCT02980341|592987412|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
164170394|NCT02980341|592987413|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
164170395|NCT02980341|592987414|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
164170396|NCT02980341|592987415|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
164170397|NCT02980341|592987416|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
164170398|NCT02980341|592987406|FG000|Dose Finding|Adverse Event|0|||
164170399|NCT02980341|592987407|FG001|Dose Finding|Adverse Event|0|||
164170400|NCT02980341|592987408|FG002|Dose Finding|Adverse Event|0|||
164170401|NCT02980341|592987409|FG003|Dose Finding|Adverse Event|0|||
164170402|NCT02980341|592987410|FG004|Dose Finding|Adverse Event|0|||
164170403|NCT02980341|592987411|FG005|Dose Finding|Adverse Event|3|||
164170404|NCT02980341|592987412|FG006|Dose Finding|Adverse Event|0|||
164170405|NCT02980341|592987413|FG007|Dose Finding|Adverse Event|0|||
164170406|NCT02980341|592987414|FG008|Dose Finding|Adverse Event|0|||
164170407|NCT02980341|592987415|FG009|Dose Finding|Adverse Event|0|||
164170408|NCT02980341|592987416|FG010|Dose Finding|Adverse Event|0|||
164170409|NCT02980341|592987406|FG000|Dose Finding|Withdrawal by Subject|0|||
164170410|NCT02980341|592987407|FG001|Dose Finding|Withdrawal by Subject|0|||
164170411|NCT02980341|592987408|FG002|Dose Finding|Withdrawal by Subject|0|||
164170412|NCT02980341|592987409|FG003|Dose Finding|Withdrawal by Subject|0|||
164170413|NCT02980341|592987410|FG004|Dose Finding|Withdrawal by Subject|0|||
164170414|NCT02980341|592987411|FG005|Dose Finding|Withdrawal by Subject|1|||
164170415|NCT02980341|592987412|FG006|Dose Finding|Withdrawal by Subject|1|||
164170416|NCT02980341|592987413|FG007|Dose Finding|Withdrawal by Subject|0|||
164170417|NCT02980341|592987414|FG008|Dose Finding|Withdrawal by Subject|0|||
164170418|NCT02980341|592987415|FG009|Dose Finding|Withdrawal by Subject|0|||
164170419|NCT02980341|592987416|FG010|Dose Finding|Withdrawal by Subject|0|||
164170420|NCT02980341|592987406|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
164170421|NCT02980341|592987407|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
164170422|NCT02980341|592987408|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
164170423|NCT02980341|592987409|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
164170424|NCT02980341|592987410|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
164170425|NCT02980341|592987411|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
164170426|NCT02980341|592987412|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
164170427|NCT02980341|592987413|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
164170428|NCT02980341|592987414|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
164170429|NCT02980341|592987415|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
164170430|NCT02980341|592987416|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
164170431|NCT02980341|592987406|FG000|Dose Expansion|Clinical progression|0|||
164170432|NCT02980341|592987407|FG001|Dose Expansion|Clinical progression|0|||
164170433|NCT02980341|592987408|FG002|Dose Expansion|Clinical progression|0|||
164170434|NCT02980341|592987409|FG003|Dose Expansion|Clinical progression|0|||
164170435|NCT02980341|592987410|FG004|Dose Expansion|Clinical progression|0|||
164170436|NCT02980341|592987411|FG005|Dose Expansion|Clinical progression|0|||
164170437|NCT02980341|592987412|FG006|Dose Expansion|Clinical progression|0|||
164170438|NCT02980341|592987413|FG007|Dose Expansion|Clinical progression|4|||
164170439|NCT02980341|592987414|FG008|Dose Expansion|Clinical progression|3|||
164170440|NCT02980341|592987415|FG009|Dose Expansion|Clinical progression|1|||
164170441|NCT02980341|592987416|FG010|Dose Expansion|Clinical progression|4|||
164170442|NCT02980341|592987406|FG000|Dose Expansion|Adverse Event|0|||
164170443|NCT02980341|592987407|FG001|Dose Expansion|Adverse Event|0|||
164170444|NCT02980341|592987408|FG002|Dose Expansion|Adverse Event|0|||
164170445|NCT02980341|592987409|FG003|Dose Expansion|Adverse Event|0|||
164170446|NCT02980341|592987410|FG004|Dose Expansion|Adverse Event|0|||
164170447|NCT02980341|592987411|FG005|Dose Expansion|Adverse Event|0|||
164170448|NCT02980341|592987412|FG006|Dose Expansion|Adverse Event|0|||
164170449|NCT02980341|592987413|FG007|Dose Expansion|Adverse Event|3|||
164170450|NCT02980341|592987414|FG008|Dose Expansion|Adverse Event|0|||
164170451|NCT02980341|592987415|FG009|Dose Expansion|Adverse Event|1|||
164170452|NCT02980341|592987416|FG010|Dose Expansion|Adverse Event|3|||
164170453|NCT02980341|592987406|FG000|Dose Expansion|Death|0|||
164170454|NCT02980341|592987407|FG001|Dose Expansion|Death|0|||
164170455|NCT02980341|592987408|FG002|Dose Expansion|Death|0|||
164170456|NCT02980341|592987409|FG003|Dose Expansion|Death|0|||
164170457|NCT02980341|592987410|FG004|Dose Expansion|Death|0|||
164170458|NCT02980341|592987411|FG005|Dose Expansion|Death|0|||
164170459|NCT02980341|592987412|FG006|Dose Expansion|Death|0|||
164170460|NCT02980341|592987413|FG007|Dose Expansion|Death|0|||
164170461|NCT02980341|592987414|FG008|Dose Expansion|Death|2|||
164170462|NCT02980341|592987415|FG009|Dose Expansion|Death|1|||
164170463|NCT02980341|592987416|FG010|Dose Expansion|Death|0|||
164170464|NCT02980341|592987406|FG000|Dose Expansion|Withdrawal by Subject|0|||
164170465|NCT02980341|592987407|FG001|Dose Expansion|Withdrawal by Subject|0|||
164170466|NCT02980341|592987408|FG002|Dose Expansion|Withdrawal by Subject|0|||
164170467|NCT02980341|592987409|FG003|Dose Expansion|Withdrawal by Subject|0|||
164170468|NCT02980341|592987410|FG004|Dose Expansion|Withdrawal by Subject|0|||
164170469|NCT02980341|592987411|FG005|Dose Expansion|Withdrawal by Subject|0|||
164170470|NCT02980341|592987412|FG006|Dose Expansion|Withdrawal by Subject|0|||
164170471|NCT02980341|592987413|FG007|Dose Expansion|Withdrawal by Subject|2|||
164170472|NCT02980341|592987414|FG008|Dose Expansion|Withdrawal by Subject|0|||
164170473|NCT02980341|592987415|FG009|Dose Expansion|Withdrawal by Subject|1|||
164170474|NCT02980341|592987416|FG010|Dose Expansion|Withdrawal by Subject|0|||
164170475|NCT02980341|592987406|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
164170476|NCT02980341|592987407|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
164170477|NCT02980341|592987408|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
164170478|NCT02980341|592987409|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
164170479|NCT02980341|592987410|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
164170480|NCT02980341|592987411|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
164170481|NCT02980341|592987412|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
164170482|NCT02980341|592987413|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
164170483|NCT02980341|592987414|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
164170484|NCT02980341|592987415|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
164170485|NCT02980341|592987416|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
164170486|NCT02980341|592987406|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
164170487|NCT02980341|592987407|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
164170488|NCT02980341|592987408|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
164170489|NCT02980341|592987409|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
164170490|NCT02980341|592987410|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
164170491|NCT02980341|592987411|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
164170492|NCT02980341|592987412|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
164170493|NCT02980341|592987413|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
164170494|NCT02980341|592987414|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
164170495|NCT02980341|592987415|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
164170496|NCT02980341|592987416|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
164170497|NCT02980341|592987406|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
164170498|NCT02980341|592987407|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
164170499|NCT02980341|592987408|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
164170500|NCT02980341|592987409|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
164170501|NCT02980341|592987410|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
164170502|NCT02980341|592987411|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
164170503|NCT02980341|592987412|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
164170504|NCT02980341|592987413|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
164170505|NCT02980341|592987414|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
164170506|NCT02980341|592987415|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
164170507|NCT02980341|592987416|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
164170508|NCT02980341|592987406|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
164170509|NCT02980341|592987407|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
164170510|NCT02980341|592987408|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
164170511|NCT02980341|592987409|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
164170512|NCT02980341|592987410|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
164170513|NCT02980341|592987411|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
164170514|NCT02980341|592987412|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
164170515|NCT02980341|592987413|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
164170516|NCT02980341|592987414|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
164170517|NCT02980341|592987415|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
164170518|NCT02980341|592987416|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
164170519|NCT01647516|592987417|FG000|Induction Period (IP)|Physician Decision|2|||
164170520|NCT01647516|592987418|FG001|Induction Period (IP)|Physician Decision|0|||
164170521|NCT01647516|592987419|FG002|Induction Period (IP)|Physician Decision|0|||
164170522|NCT01647516|592987420|FG003|Induction Period (IP)|Physician Decision|0|||
164170523|NCT01647516|592987421|FG004|Induction Period (IP)|Physician Decision|0|||
164170524|NCT01647516|592987422|FG005|Induction Period (IP)|Physician Decision|0|||
164170525|NCT01647516|592987417|FG000|Induction Period (IP)|Adverse Event|1|||
164170526|NCT01647516|592987418|FG001|Induction Period (IP)|Adverse Event|2|||
164170527|NCT01647516|592987419|FG002|Induction Period (IP)|Adverse Event|0|||
164170528|NCT01647516|592987420|FG003|Induction Period (IP)|Adverse Event|0|||
164170529|NCT01647516|592987421|FG004|Induction Period (IP)|Adverse Event|0|||
164170530|NCT01647516|592987422|FG005|Induction Period (IP)|Adverse Event|0|||
164170531|NCT01647516|592987417|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
164170532|NCT01647516|592987418|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
164170533|NCT01647516|592987419|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
164170534|NCT01647516|592987420|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
164170535|NCT01647516|592987421|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
164170536|NCT01647516|592987422|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
164170537|NCT01647516|592987417|FG000|Induction Period (IP)|Participant Choice|0|||
164170538|NCT01647516|592987418|FG001|Induction Period (IP)|Participant Choice|0|||
164170539|NCT01647516|592987419|FG002|Induction Period (IP)|Participant Choice|1|||
164170540|NCT01647516|592987420|FG003|Induction Period (IP)|Participant Choice|0|||
164170541|NCT01647516|592987421|FG004|Induction Period (IP)|Participant Choice|0|||
164170542|NCT01647516|592987422|FG005|Induction Period (IP)|Participant Choice|0|||
164170543|NCT01647516|592987417|FG000|Induction Period (IP)|Lack of Efficacy|1|||
164170544|NCT01647516|592987418|FG001|Induction Period (IP)|Lack of Efficacy|0|||
164170545|NCT01647516|592987419|FG002|Induction Period (IP)|Lack of Efficacy|0|||
164170546|NCT01647516|592987420|FG003|Induction Period (IP)|Lack of Efficacy|0|||
164170547|NCT01647516|592987421|FG004|Induction Period (IP)|Lack of Efficacy|0|||
164170548|NCT01647516|592987422|FG005|Induction Period (IP)|Lack of Efficacy|0|||
164170549|NCT01647516|592987417|FG000|Induction Period (IP)|No study drug received|1|||
164170550|NCT01647516|592987418|FG001|Induction Period (IP)|No study drug received|1|||
164170551|NCT01647516|592987419|FG002|Induction Period (IP)|No study drug received|0|||
164170552|NCT01647516|592987420|FG003|Induction Period (IP)|No study drug received|0|||
164170553|NCT01647516|592987421|FG004|Induction Period (IP)|No study drug received|0|||
164170554|NCT01647516|592987422|FG005|Induction Period (IP)|No study drug received|0|||
164170555|NCT01647516|592987417|FG000|Maintenance Period (MP)|Adverse Event|2|||
164170556|NCT01647516|592987418|FG001|Maintenance Period (MP)|Adverse Event|1|||
164170557|NCT01647516|592987419|FG002|Maintenance Period (MP)|Adverse Event|0|||
164170558|NCT01647516|592987420|FG003|Maintenance Period (MP)|Adverse Event|0|||
164170559|NCT01647516|592987421|FG004|Maintenance Period (MP)|Adverse Event|0|||
164170560|NCT01647516|592987422|FG005|Maintenance Period (MP)|Adverse Event|0|||
164170561|NCT01647516|592987417|FG000|Maintenance Period (MP)|Non-compliance|1|||
164170562|NCT01647516|592987418|FG001|Maintenance Period (MP)|Non-compliance|0|||
164170563|NCT01647516|592987419|FG002|Maintenance Period (MP)|Non-compliance|0|||
164170564|NCT01647516|592987420|FG003|Maintenance Period (MP)|Non-compliance|0|||
164170565|NCT01647516|592987421|FG004|Maintenance Period (MP)|Non-compliance|0|||
164170566|NCT01647516|592987422|FG005|Maintenance Period (MP)|Non-compliance|0|||
164170567|NCT01647516|592987417|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
164170568|NCT01647516|592987418|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
164170569|NCT01647516|592987419|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
164170570|NCT01647516|592987420|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
164170571|NCT01647516|592987421|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
164170572|NCT01647516|592987422|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
164170573|NCT01647516|592987417|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
164170574|NCT01647516|592987418|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
164170575|NCT01647516|592987419|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
164170576|NCT01647516|592987420|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
164170577|NCT01647516|592987421|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
164170578|NCT01647516|592987422|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
164170579|NCT01647516|592987417|FG000|Open-Label Period|Adverse Event|0|||
164170580|NCT01647516|592987418|FG001|Open-Label Period|Adverse Event|0|||
164170581|NCT01647516|592987419|FG002|Open-Label Period|Adverse Event|0|||
164170582|NCT01647516|592987420|FG003|Open-Label Period|Adverse Event|5|||
164170583|NCT01647516|592987421|FG004|Open-Label Period|Adverse Event|6|||
164170584|NCT01647516|592987422|FG005|Open-Label Period|Adverse Event|3|||
164170585|NCT01647516|592987417|FG000|Open-Label Period|Pregnancy|0|||
164170586|NCT01647516|592987418|FG001|Open-Label Period|Pregnancy|0|||
164170587|NCT01647516|592987419|FG002|Open-Label Period|Pregnancy|0|||
164170588|NCT01647516|592987420|FG003|Open-Label Period|Pregnancy|0|||
164170589|NCT01647516|592987421|FG004|Open-Label Period|Pregnancy|0|||
164170590|NCT01647516|592987422|FG005|Open-Label Period|Pregnancy|1|||
164170591|NCT01647516|592987417|FG000|Open-Label Period|Non-compliance|0|||
164170592|NCT01647516|592987418|FG001|Open-Label Period|Non-compliance|0|||
164170593|NCT01647516|592987419|FG002|Open-Label Period|Non-compliance|0|||
164170594|NCT01647516|592987420|FG003|Open-Label Period|Non-compliance|1|||
164170595|NCT01647516|592987421|FG004|Open-Label Period|Non-compliance|0|||
164170596|NCT01647516|592987422|FG005|Open-Label Period|Non-compliance|1|||
164170597|NCT01647516|592987417|FG000|Open-Label Period|Physician Decision|0|||
164170598|NCT01647516|592987418|FG001|Open-Label Period|Physician Decision|0|||
164170599|NCT01647516|592987419|FG002|Open-Label Period|Physician Decision|0|||
164170600|NCT01647516|592987420|FG003|Open-Label Period|Physician Decision|1|||
164170601|NCT01647516|592987421|FG004|Open-Label Period|Physician Decision|1|||
164170602|NCT01647516|592987422|FG005|Open-Label Period|Physician Decision|0|||
164170603|NCT01647516|592987417|FG000|Open-Label Period|Withdrawal by Subject|0|||
164170604|NCT01647516|592987418|FG001|Open-Label Period|Withdrawal by Subject|0|||
164170605|NCT01647516|592987419|FG002|Open-Label Period|Withdrawal by Subject|0|||
164170606|NCT01647516|592987420|FG003|Open-Label Period|Withdrawal by Subject|9|||
164170607|NCT01647516|592987421|FG004|Open-Label Period|Withdrawal by Subject|11|||
164170608|NCT01647516|592987422|FG005|Open-Label Period|Withdrawal by Subject|6|||
164170609|NCT01647516|592987417|FG000|Open-Label Period|Lost to Follow-up|0|||
164170610|NCT01647516|592987418|FG001|Open-Label Period|Lost to Follow-up|0|||
164170611|NCT01647516|592987419|FG002|Open-Label Period|Lost to Follow-up|0|||
164170612|NCT01647516|592987420|FG003|Open-Label Period|Lost to Follow-up|1|||
164170613|NCT01647516|592987421|FG004|Open-Label Period|Lost to Follow-up|0|||
164170614|NCT01647516|592987422|FG005|Open-Label Period|Lost to Follow-up|1|||
164170615|NCT01647516|592987417|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
164170616|NCT01647516|592987418|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
164170617|NCT01647516|592987419|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
164170618|NCT01647516|592987420|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
164170619|NCT01647516|592987421|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
164170620|NCT01647516|592987422|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
164170621|NCT01647516|592987417|FG000|Open-Label Period|Lack of Efficacy|0|||
164170622|NCT01647516|592987418|FG001|Open-Label Period|Lack of Efficacy|0|||
164170623|NCT01647516|592987419|FG002|Open-Label Period|Lack of Efficacy|0|||
164170624|NCT01647516|592987420|FG003|Open-Label Period|Lack of Efficacy|7|||
164170625|NCT01647516|592987421|FG004|Open-Label Period|Lack of Efficacy|9|||
164170626|NCT01647516|592987422|FG005|Open-Label Period|Lack of Efficacy|10|||
164170627|NCT01647516|592987417|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
164170628|NCT01647516|592987418|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
164170629|NCT01647516|592987419|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
164170630|NCT01647516|592987420|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
164170631|NCT01647516|592987421|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
164170632|NCT01647516|592987422|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
164170633|NCT01647516|592987417|FG000|Open-Label Period|No completion / discontinuation visit|0|||
164170634|NCT01647516|592987418|FG001|Open-Label Period|No completion / discontinuation visit|0|||
164170635|NCT01647516|592987419|FG002|Open-Label Period|No completion / discontinuation visit|0|||
164170636|NCT01647516|592987420|FG003|Open-Label Period|No completion / discontinuation visit|0|||
164170637|NCT01647516|592987421|FG004|Open-Label Period|No completion / discontinuation visit|2|||
164170638|NCT01647516|592987422|FG005|Open-Label Period|No completion / discontinuation visit|1|||
164170639|NCT01676896|592987423|FG000|Overall Study|Withdrawal by Subject|12|||
164170640|NCT01676896|592987424|FG001|Overall Study|Withdrawal by Subject|7|||
164170641|NCT01676896|592987425|FG002|Overall Study|Withdrawal by Subject|19|||
164170642|NCT03614078|592987426|FG000|Overall Study|Withdrawal by Subject|2|||
164170643|NCT03614078|592987427|FG001|Overall Study|Withdrawal by Subject|2|||
164170644|NCT03614078|592987428|FG002|Overall Study|Withdrawal by Subject|3|||
164170645|NCT03614078|592987426|FG000|Overall Study|Participant Did Not Return for Visit|0|||
164170646|NCT03614078|592987427|FG001|Overall Study|Participant Did Not Return for Visit|1|||
164170647|NCT03614078|592987428|FG002|Overall Study|Participant Did Not Return for Visit|0|||
164170648|NCT03614078|592987426|FG000|Overall Study|High Neutrophils|0|||
164170649|NCT03614078|592987427|FG001|Overall Study|High Neutrophils|0|||
164170650|NCT03614078|592987428|FG002|Overall Study|High Neutrophils|2|||
164170651|NCT03614078|592987426|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
164170652|NCT03614078|592987427|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
164170653|NCT03614078|592987428|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
164170654|NCT03614078|592987426|FG000|Overall Study|Exacerbation of Psoriasis|0|||
164170655|NCT03614078|592987427|FG001|Overall Study|Exacerbation of Psoriasis|1|||
164170656|NCT03614078|592987428|FG002|Overall Study|Exacerbation of Psoriasis|0|||
164170657|NCT03614078|592987426|FG000|Overall Study|Adverse Event|0|||
164170658|NCT03614078|592987427|FG001|Overall Study|Adverse Event|2|||
164170659|NCT03614078|592987428|FG002|Overall Study|Adverse Event|0|||
164170660|NCT03614078|592987426|FG000|Overall Study|Dizziness and Rash|0|||
164170661|NCT03614078|592987427|FG001|Overall Study|Dizziness and Rash|1|||
164170662|NCT03614078|592987428|FG002|Overall Study|Dizziness and Rash|0|||
164170663|NCT04964544|592987431|FG000|Overall Study|Screen failure or other uncategorised|10|||
164170664|NCT04964544|592987431|FG000|Overall Study|Physician Decision|4|||
164170665|NCT04964544|592987431|FG000|Overall Study|Lost to Follow-up|9|||
164170666|NCT04964544|592987431|FG000|Overall Study|Withdrawal by Subject|18|||
164170667|NCT04964544|592987431|FG000|Overall Study|Death|1|||
164170668|NCT01613222|592987434|FG000|Overall Study|Physician Decision|1|||
164170669|NCT01613222|592987434|FG000|Overall Study|Unable to place arterial line|1|||
164170670|NCT01613222|592987434|FG000|Overall Study|Reused disposable sensors|10|||
164170671|NCT02691936|592987436|FG000|Overall Study|Withdrawal by Subject|2|||
164170672|NCT02691936|592987437|FG001|Overall Study|Withdrawal by Subject|5|||
164170673|NCT00749684|592987441|FG000|Overall Study|Death|1|||
164170674|NCT00749684|592987441|FG000|Overall Study|Adverse Event|27|||
164170675|NCT00749684|592987441|FG000|Overall Study|Participant's Wish|10|||
164170676|NCT00749684|592987441|FG000|Overall Study|Not Documented|1|||
164170677|NCT00749684|592987441|FG000|Overall Study|Progressive Desease|31|||
164170678|NCT00749684|592987441|FG000|Overall Study|Therapy according to protocol + AE|2|||
164170679|NCT00749684|592987441|FG000|Overall Study|AE+discontinuation on participants wish|1|||
164170680|NCT00749684|592987441|FG000|Overall Study|Missing|9|||
164170681|NCT01194531|592987442|FG000|Overall Study|Withdrawal by Subject|1|||
164170682|NCT01194531|592987443|FG001|Overall Study|Withdrawal by Subject|0|||
164170683|NCT01194531|592987442|FG000|Overall Study|Protocol Violation|4|||
164170684|NCT01194531|592987443|FG001|Overall Study|Protocol Violation|1|||
164170685|NCT01194531|592987442|FG000|Overall Study|Physician Decision|0|||
164170686|NCT01194531|592987443|FG001|Overall Study|Physician Decision|2|||
164170687|NCT01343277|592987446|FG000|Overall Study|Other|3|||
164170688|NCT01343277|592987447|FG001|Overall Study|Other|3|||
164170689|NCT01343277|592987446|FG000|Overall Study|Withdrawal by Subject|18|||
164170690|NCT01343277|592987447|FG001|Overall Study|Withdrawal by Subject|13|||
164170691|NCT01343277|592987446|FG000|Overall Study|Physician Decision|1|||
164170692|NCT01343277|592987447|FG001|Overall Study|Physician Decision|2|||
164170693|NCT01343277|592987446|FG000|Overall Study|Death|10|||
164170694|NCT01343277|592987447|FG001|Overall Study|Death|1|||
164170695|NCT01343277|592987446|FG000|Overall Study|Adverse Event|67|||
164170696|NCT01343277|592987447|FG001|Overall Study|Adverse Event|13|||
164170697|NCT01343277|592987446|FG000|Overall Study|Disease progression|270|||
164170698|NCT01343277|592987447|FG001|Overall Study|Disease progression|138|||
164170699|NCT01343277|592987446|FG000|Overall Study|Randomized not treated|6|||
164170700|NCT01343277|592987447|FG001|Overall Study|Randomized not treated|21|||
164170701|NCT01343277|592987446|FG000|Overall Study|Treatment ongoing|8|||
164170702|NCT01343277|592987447|FG001|Overall Study|Treatment ongoing|2|||
164170703|NCT01343277|592987446|FG000|Overall Study|Subsequent anticancer therapy|1|||
164170704|NCT01343277|592987447|FG001|Overall Study|Subsequent anticancer therapy|0|||
164170705|NCT01894100|592987450|FG000|Overall Study|Lost to Follow-up|0|||
164170706|NCT01894100|592987451|FG001|Overall Study|Lost to Follow-up|1|||
164170707|NCT01894100|592987450|FG000|Overall Study|Withdrawal by Subject|3|||
164170708|NCT01894100|592987451|FG001|Overall Study|Withdrawal by Subject|0|||
164170709|NCT00135512|592987454|FG000|Overall Study|Adverse Event|56|||
164170710|NCT00135512|592987454|FG000|Overall Study|Lack of Efficacy|25|||
164170711|NCT00135512|592987454|FG000|Overall Study|Other|42|||
164170712|NCT01094301|592987455|FG000|Trial Stage|Withdrawal by Subject|1|||
164170713|NCT01094301|592987455|FG000|Implant Stage|Adverse Event|1|||
164170714|NCT01094301|592987455|FG000|Implant Stage|Protocol Violation|1|||
164170715|NCT01094301|592987455|FG000|Implant Stage|Withdrawal by Subject|2|||
164170716|NCT01094301|592987455|FG000|Implant Stage|No return of pain|4|||
164170717|NCT04152837|592987465|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
164170718|NCT04152837|592987465|FG000|Maintenance Period|Adverse Event|1|||
164170719|NCT04152837|592987465|FG000|Maintenance Period|Withdrawal by Subject|1|||
164170720|NCT04152837|592987465|FG000|Maintenance Period|Sponsor Termination of Study|2|||
164170721|NCT04553471|592987472|FG000|Overall Study|Did not start treatment on protocol|3|||
164170722|NCT04553471|592987472|FG000|Overall Study|Death|1|||
164170723|NCT02147158|592987473|FG000|Treatment Course 1|Adverse Event|1|||
164170724|NCT02147158|592987474|FG001|Treatment Course 1|Adverse Event|4|||
164170726|NCT02147158|592987476|FG003|Treatment Course 1|Adverse Event|4|||
164170727|NCT02147158|592987477|FG004|Treatment Course 1|Adverse Event|1|||
164170728|NCT02147158|592987478|FG005|Treatment Course 1|Adverse Event|2|||
164170729|NCT02147158|592987473|FG000|Treatment Course 1|Lost to Follow-up|2|||
164170730|NCT02147158|592987474|FG001|Treatment Course 1|Lost to Follow-up|4|||
164170731|NCT02147158|592987475|FG002|Treatment Course 1|Lost to Follow-up|3|||
164170732|NCT02147158|592987476|FG003|Treatment Course 1|Lost to Follow-up|3|||
164170733|NCT02147158|592987477|FG004|Treatment Course 1|Lost to Follow-up|2|||
164170734|NCT02147158|592987478|FG005|Treatment Course 1|Lost to Follow-up|4|||
164170735|NCT02147158|592987473|FG000|Treatment Course 1|Protocol Violation|0|||
164170736|NCT02147158|592987474|FG001|Treatment Course 1|Protocol Violation|0|||
164170737|NCT02147158|592987475|FG002|Treatment Course 1|Protocol Violation|1|||
164170738|NCT02147158|592987476|FG003|Treatment Course 1|Protocol Violation|1|||
164170739|NCT02147158|592987477|FG004|Treatment Course 1|Protocol Violation|0|||
164170740|NCT02147158|592987478|FG005|Treatment Course 1|Protocol Violation|0|||
164170741|NCT02147158|592987473|FG000|Treatment Course 1|Withdrawal of Consent|1|||
164170742|NCT02147158|592987474|FG001|Treatment Course 1|Withdrawal of Consent|1|||
164170743|NCT02147158|592987475|FG002|Treatment Course 1|Withdrawal of Consent|1|||
164170744|NCT02147158|592987476|FG003|Treatment Course 1|Withdrawal of Consent|5|||
164170745|NCT02147158|592987477|FG004|Treatment Course 1|Withdrawal of Consent|3|||
164170746|NCT02147158|592987478|FG005|Treatment Course 1|Withdrawal of Consent|2|||
164170747|NCT02147158|592987473|FG000|Off-Treatment Interval 1|Adverse Event|1|||
164170748|NCT02147158|592987474|FG001|Off-Treatment Interval 1|Adverse Event|0|||
164170749|NCT02147158|592987475|FG002|Off-Treatment Interval 1|Adverse Event|0|||
164170750|NCT02147158|592987476|FG003|Off-Treatment Interval 1|Adverse Event|1|||
164170751|NCT02147158|592987477|FG004|Off-Treatment Interval 1|Adverse Event|0|||
164170752|NCT02147158|592987478|FG005|Off-Treatment Interval 1|Adverse Event|0|||
164170753|NCT02147158|592987473|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
164170754|NCT02147158|592987474|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
164170755|NCT02147158|592987475|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
164170756|NCT02147158|592987476|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
164170757|NCT02147158|592987477|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
164170758|NCT02147158|592987478|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
164170759|NCT02147158|592987473|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
164170760|NCT02147158|592987474|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
164170761|NCT02147158|592987475|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
164170762|NCT02147158|592987476|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
164170763|NCT02147158|592987477|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
164170764|NCT02147158|592987478|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
164170765|NCT02147158|592987473|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
164170766|NCT02147158|592987474|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
164170767|NCT02147158|592987475|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
164170768|NCT02147158|592987476|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
164170769|NCT02147158|592987477|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
164170770|NCT02147158|592987478|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
164170771|NCT02147158|592987473|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
164170772|NCT02147158|592987474|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
164170773|NCT02147158|592987475|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
164170774|NCT02147158|592987476|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
164170775|NCT02147158|592987477|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
164170776|NCT02147158|592987478|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
164170777|NCT02147158|592987473|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
164170778|NCT02147158|592987474|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
164170779|NCT02147158|592987475|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
164170780|NCT02147158|592987476|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
164170781|NCT02147158|592987477|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
164170782|NCT02147158|592987478|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
164170783|NCT02147158|592987473|FG000|Treatment Course 2|Adverse Event|0|||
164170784|NCT02147158|592987474|FG001|Treatment Course 2|Adverse Event|4|||
164170785|NCT02147158|592987475|FG002|Treatment Course 2|Adverse Event|2|||
164170786|NCT02147158|592987476|FG003|Treatment Course 2|Adverse Event|1|||
164170787|NCT02147158|592987477|FG004|Treatment Course 2|Adverse Event|0|||
164170788|NCT02147158|592987478|FG005|Treatment Course 2|Adverse Event|1|||
164170789|NCT02147158|592987473|FG000|Treatment Course 2|Withdrawal of Consent|0|||
164170790|NCT02147158|592987474|FG001|Treatment Course 2|Withdrawal of Consent|1|||
164170791|NCT02147158|592987475|FG002|Treatment Course 2|Withdrawal of Consent|2|||
164170792|NCT02147158|592987476|FG003|Treatment Course 2|Withdrawal of Consent|3|||
164170793|NCT02147158|592987477|FG004|Treatment Course 2|Withdrawal of Consent|0|||
164170794|NCT02147158|592987478|FG005|Treatment Course 2|Withdrawal of Consent|0|||
164170795|NCT02147158|592987473|FG000|Treatment Course 2|Lost to Follow-up|1|||
164170796|NCT02147158|592987474|FG001|Treatment Course 2|Lost to Follow-up|0|||
164170797|NCT02147158|592987475|FG002|Treatment Course 2|Lost to Follow-up|1|||
164170798|NCT02147158|592987476|FG003|Treatment Course 2|Lost to Follow-up|1|||
164170799|NCT02147158|592987477|FG004|Treatment Course 2|Lost to Follow-up|0|||
164170800|NCT02147158|592987478|FG005|Treatment Course 2|Lost to Follow-up|1|||
164170801|NCT02147158|592987473|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
164170802|NCT02147158|592987474|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
164170803|NCT02147158|592987475|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
164170804|NCT02147158|592987476|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
164170805|NCT02147158|592987477|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
164170806|NCT02147158|592987478|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
164170807|NCT02147158|592987473|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
164170808|NCT02147158|592987474|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
164170809|NCT02147158|592987475|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
164170810|NCT02147158|592987476|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
164170811|NCT02147158|592987477|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
164170812|NCT02147158|592987478|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
164170813|NCT02147158|592987473|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
164170814|NCT02147158|592987474|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
164170815|NCT02147158|592987475|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
164170816|NCT02147158|592987476|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
164170817|NCT02147158|592987477|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
164170818|NCT02147158|592987478|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
164170819|NCT02147158|592987473|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
164170820|NCT02147158|592987474|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
164170821|NCT02147158|592987475|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
164170822|NCT02147158|592987476|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
164170823|NCT02147158|592987477|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
164170824|NCT02147158|592987478|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
164170825|NCT02147158|592987473|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
164170826|NCT02147158|592987474|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
164170827|NCT02147158|592987475|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
164170828|NCT02147158|592987476|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
164170829|NCT02147158|592987477|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
164170830|NCT02147158|592987478|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
164170831|NCT01441765|592987479|FG000|Overall Study|Death|1|||
164170832|NCT01441765|592987480|FG001|Overall Study|Death|0|||
164170833|NCT04520997|592987481|FG000|Overall Study|Lost to Follow-up|1|||
164170834|NCT04520997|592987482|FG001|Overall Study|Lost to Follow-up|1|||
164170835|NCT04520997|592987481|FG000|Overall Study|Withdrawal by Subject|1|||
164170836|NCT04520997|592987482|FG001|Overall Study|Withdrawal by Subject|0|||
164170837|NCT04520997|592987481|FG000|Overall Study|Not Treated|0|||
164170838|NCT04520997|592987482|FG001|Overall Study|Not Treated|1|||
164170839|NCT03689374|592987483|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
164170840|NCT03689374|592987484|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
164170841|NCT03689374|592987485|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
164170842|NCT03689374|592987483|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
164170843|NCT03689374|592987484|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
164170844|NCT03689374|592987485|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
164170845|NCT03689374|592987483|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
164170846|NCT03689374|592987484|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
164170847|NCT03689374|592987485|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
164170848|NCT03689374|592987483|FG000|Treatment Period (Week 0 to 52)|Death|0|||
164170849|NCT03689374|592987484|FG001|Treatment Period (Week 0 to 52)|Death|11|||
164170850|NCT03689374|592987485|FG002|Treatment Period (Week 0 to 52)|Death|1|||
164170851|NCT05367973|592987486|FG000|Overall Study|Adverse Event|0|||
164170852|NCT05367973|592987487|FG001|Overall Study|Adverse Event|2|||
164170853|NCT00986921|592987488|FG000|Overall Study|Physician Decision|1|||
164170854|NCT00986921|592987489|FG001|Overall Study|Physician Decision|0|||
164170855|NCT00813813|592987490|FG000|Overall Study|Withdrawal by Subject|1|||
164170856|NCT00813813|592987491|FG001|Overall Study|Withdrawal by Subject|1|||
164170857|NCT00813813|592987490|FG000|Overall Study|Lost to Follow-up|2|||
164170858|NCT00813813|592987491|FG001|Overall Study|Lost to Follow-up|7|||
164170859|NCT00813813|592987490|FG000|Overall Study|Other|0|||
164170860|NCT00813813|592987491|FG001|Overall Study|Other|1|||
164170861|NCT01758731|592987492|FG000|Overall Study|Physician Decision|1|||
164170862|NCT04445714|592987493|FG000|Overall Study|Discontinuation of the study|14|||
164170863|NCT04445714|592987493|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
164170864|NCT04445714|592987493|FG000|Overall Study|Withdrawal of Informed Consent|8|||
164170865|NCT02396420|592987494|FG000|Overall Study|Death|1|||
164170866|NCT01273623|592987500|FG000|Overall Study|did not meet IVUS criteria|29|||
164170867|NCT04934189|592989092|FG000|Overall Study|Lost to Follow-up|4|||
164170868|NCT04934189|592989092|FG000|Overall Study|Withdrawal by Subject|17|||
164170869|NCT03320850|592989095|FG000|Overall Study|Lost to Follow-up|0|||
164170870|NCT03320850|592989096|FG001|Overall Study|Lost to Follow-up|0|||
164170871|NCT03320850|592989097|FG002|Overall Study|Lost to Follow-up|0|||
164170872|NCT03320850|592989098|FG003|Overall Study|Lost to Follow-up|0|||
164170873|NCT03320850|592989099|FG004|Overall Study|Lost to Follow-up|1|||
164170874|NCT03320850|592989100|FG005|Overall Study|Lost to Follow-up|2|||
164170875|NCT03320850|592989101|FG006|Overall Study|Lost to Follow-up|2|||
164170876|NCT03320850|592989102|FG007|Overall Study|Lost to Follow-up|0|||
164170877|NCT03320850|592989103|FG008|Overall Study|Lost to Follow-up|6|||
164170878|NCT03320850|592989104|FG009|Overall Study|Lost to Follow-up|4|||
164170879|NCT03320850|592989095|FG000|Overall Study|Withdrawal by Subject|0|||
164170880|NCT03320850|592989096|FG001|Overall Study|Withdrawal by Subject|0|||
164170881|NCT03320850|592989097|FG002|Overall Study|Withdrawal by Subject|0|||
164170882|NCT03320850|592989098|FG003|Overall Study|Withdrawal by Subject|0|||
164170883|NCT03320850|592989099|FG004|Overall Study|Withdrawal by Subject|1|||
164170884|NCT03320850|592989100|FG005|Overall Study|Withdrawal by Subject|2|||
164170885|NCT03320850|592989101|FG006|Overall Study|Withdrawal by Subject|4|||
164170886|NCT03320850|592989102|FG007|Overall Study|Withdrawal by Subject|5|||
164170887|NCT03320850|592989103|FG008|Overall Study|Withdrawal by Subject|2|||
164170888|NCT03320850|592989104|FG009|Overall Study|Withdrawal by Subject|1|||
164170889|NCT03320850|592989095|FG000|Overall Study|Lack of Efficacy|0|||
164170890|NCT03320850|592989096|FG001|Overall Study|Lack of Efficacy|0|||
164170891|NCT03320850|592989097|FG002|Overall Study|Lack of Efficacy|0|||
164170892|NCT03320850|592989098|FG003|Overall Study|Lack of Efficacy|1|||
164170893|NCT03320850|592989099|FG004|Overall Study|Lack of Efficacy|0|||
164170894|NCT03320850|592989100|FG005|Overall Study|Lack of Efficacy|1|||
164170895|NCT03320850|592989101|FG006|Overall Study|Lack of Efficacy|0|||
164170896|NCT03320850|592989102|FG007|Overall Study|Lack of Efficacy|2|||
164170897|NCT03320850|592989103|FG008|Overall Study|Lack of Efficacy|0|||
164170898|NCT03320850|592989104|FG009|Overall Study|Lack of Efficacy|3|||
164170899|NCT03320850|592989095|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
164170900|NCT03320850|592989096|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
164170901|NCT03320850|592989097|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
164170902|NCT03320850|592989098|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
164170903|NCT03320850|592989099|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
164170904|NCT03320850|592989100|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
164170905|NCT03320850|592989101|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
164170906|NCT03320850|592989102|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
164170907|NCT03320850|592989103|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
164170908|NCT03320850|592989104|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
164170909|NCT03320850|592989095|FG000|Overall Study|Adverse Event|0|||
164170910|NCT03320850|592989096|FG001|Overall Study|Adverse Event|0|||
164170911|NCT03320850|592989097|FG002|Overall Study|Adverse Event|0|||
164170912|NCT03320850|592989098|FG003|Overall Study|Adverse Event|0|||
164170913|NCT03320850|592989099|FG004|Overall Study|Adverse Event|0|||
164170914|NCT03320850|592989100|FG005|Overall Study|Adverse Event|2|||
164170915|NCT03320850|592989101|FG006|Overall Study|Adverse Event|1|||
164170916|NCT03320850|592989102|FG007|Overall Study|Adverse Event|0|||
164170917|NCT03320850|592989103|FG008|Overall Study|Adverse Event|2|||
164170918|NCT03320850|592989104|FG009|Overall Study|Adverse Event|0|||
164170919|NCT03320850|592989095|FG000|Overall Study|Reason Not Specified|0|||
164170920|NCT03320850|592989096|FG001|Overall Study|Reason Not Specified|0|||
164170921|NCT03320850|592989097|FG002|Overall Study|Reason Not Specified|0|||
164170922|NCT03320850|592989098|FG003|Overall Study|Reason Not Specified|0|||
164170923|NCT03320850|592989099|FG004|Overall Study|Reason Not Specified|0|||
164170924|NCT03320850|592989100|FG005|Overall Study|Reason Not Specified|1|||
164170925|NCT03320850|592989101|FG006|Overall Study|Reason Not Specified|0|||
164170926|NCT03320850|592989102|FG007|Overall Study|Reason Not Specified|0|||
164170927|NCT03320850|592989103|FG008|Overall Study|Reason Not Specified|0|||
164170928|NCT03320850|592989104|FG009|Overall Study|Reason Not Specified|1|||
164170929|NCT02002533|592989108|FG000|Overall Study|Withdrawal by Subject|6|||
164170930|NCT02002533|592989109|FG001|Overall Study|Withdrawal by Subject|13|||
164170931|NCT02002533|592989108|FG000|Overall Study|Protocol Violation|0|||
164170932|NCT02002533|592989109|FG001|Overall Study|Protocol Violation|1|||
164170933|NCT02002533|592989108|FG000|Overall Study|Adverse Event|0|||
164170934|NCT02002533|592989109|FG001|Overall Study|Adverse Event|3|||
164170935|NCT02002533|592989108|FG000|Overall Study|Lost to Follow-up|0|||
164170936|NCT02002533|592989109|FG001|Overall Study|Lost to Follow-up|1|||
164170937|NCT03408444|592989121|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
164170938|NCT03408444|592989122|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
164170939|NCT03408444|592989123|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
164170940|NCT03408444|592989124|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
164170941|NCT03408444|592989121|FG000|Overall Study|Lens Discomfort|0|||
164170942|NCT03408444|592989122|FG001|Overall Study|Lens Discomfort|1|||
164170943|NCT03408444|592989123|FG002|Overall Study|Lens Discomfort|0|||
164170944|NCT03408444|592989124|FG003|Overall Study|Lens Discomfort|0|||
164170945|NCT03408444|592989121|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
164170946|NCT03408444|592989122|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
164170947|NCT03408444|592989123|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
164171093|NCT01938430|592989154|FG004|Overall Study|Lack of Efficacy|0|||
164170948|NCT03408444|592989124|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
164170949|NCT03408444|592989121|FG000|Overall Study|Withdrawal by Subject|0|||
164170950|NCT03408444|592989122|FG001|Overall Study|Withdrawal by Subject|2|||
164170951|NCT03408444|592989123|FG002|Overall Study|Withdrawal by Subject|3|||
164170952|NCT03408444|592989124|FG003|Overall Study|Withdrawal by Subject|0|||
164170953|NCT03408444|592989121|FG000|Overall Study|Lost to Follow-up|0|||
164170954|NCT03408444|592989122|FG001|Overall Study|Lost to Follow-up|0|||
164170955|NCT03408444|592989123|FG002|Overall Study|Lost to Follow-up|1|||
164170956|NCT03408444|592989124|FG003|Overall Study|Lost to Follow-up|0|||
164170957|NCT03408444|592989121|FG000|Overall Study|Adverse Event|0|||
164170958|NCT03408444|592989122|FG001|Overall Study|Adverse Event|0|||
164170959|NCT03408444|592989123|FG002|Overall Study|Adverse Event|0|||
164170960|NCT03408444|592989124|FG003|Overall Study|Adverse Event|1|||
164170961|NCT03408444|592989121|FG000|Overall Study|Lens Handling Difficulties|0|||
164170962|NCT03408444|592989122|FG001|Overall Study|Lens Handling Difficulties|0|||
164170963|NCT03408444|592989123|FG002|Overall Study|Lens Handling Difficulties|1|||
164170964|NCT03408444|592989124|FG003|Overall Study|Lens Handling Difficulties|0|||
164170965|NCT03408444|592989121|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
164170966|NCT03408444|592989122|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
164170967|NCT03408444|592989123|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
164170968|NCT03408444|592989124|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
164170969|NCT00231114|592989125|FG000|Randomized|Withdrawal by Subject|6|||
164170970|NCT00231114|592989126|FG001|Randomized|Withdrawal by Subject|3|||
164170971|NCT00231114|592989125|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
164170972|NCT00231114|592989126|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
164170973|NCT00231114|592989125|FG000|Post-Treatment Period|Lost to Follow-up|6|||
164170974|NCT00231114|592989126|FG001|Post-Treatment Period|Lost to Follow-up|1|||
164170975|NCT00231114|592989125|FG000|Post-Treatment Period|Physician Decision|1|||
164170976|NCT00231114|592989126|FG001|Post-Treatment Period|Physician Decision|0|||
164170977|NCT00231114|592989125|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
164170978|NCT00231114|592989126|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
164170979|NCT01194999|592989130|FG000|Overall Study|Lost to Follow-up|17|||
164170980|NCT01895270|592989131|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
164170981|NCT01895270|592989132|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
164170982|NCT01895270|592989131|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
164170983|NCT01895270|592989132|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
164170984|NCT01895270|592989131|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
164170985|NCT01895270|592989132|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
164170986|NCT01895270|592989131|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
164170987|NCT01895270|592989132|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
164170988|NCT01895270|592989131|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
164170989|NCT01895270|592989132|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
164170990|NCT01895270|592989131|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
164170991|NCT01895270|592989132|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
164170992|NCT01895270|592989131|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
164170993|NCT01895270|592989132|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
164170994|NCT02091375|592989135|FG000|Overall Study|Adverse Event|8|||
164170995|NCT02091375|592989136|FG001|Overall Study|Adverse Event|1|||
164170996|NCT02091375|592989135|FG000|Overall Study|Lost to Follow-up|0|||
164170997|NCT02091375|592989136|FG001|Overall Study|Lost to Follow-up|1|||
164170998|NCT02091375|592989135|FG000|Overall Study|Withdrawal by Subject|0|||
164170999|NCT02091375|592989136|FG001|Overall Study|Withdrawal by Subject|1|||
164171000|NCT02091375|592989135|FG000|Overall Study|Withdrawn by the investigator|1|||
164171001|NCT02091375|592989136|FG001|Overall Study|Withdrawn by the investigator|0|||
164171002|NCT02682823|592989138|FG000|Overall Study|Withdrawal by Subject|0|||
164171003|NCT02682823|592989139|FG001|Overall Study|Withdrawal by Subject|0|||
164171004|NCT02682823|592989140|FG002|Overall Study|Withdrawal by Subject|1|||
164171005|NCT02682823|592989141|FG003|Overall Study|Withdrawal by Subject|0|||
164171006|NCT02682823|592989142|FG004|Overall Study|Withdrawal by Subject|1|||
164171007|NCT02682823|592989138|FG000|Overall Study|Protocol Deviation|0|||
164171008|NCT02682823|592989139|FG001|Overall Study|Protocol Deviation|1|||
164171009|NCT02682823|592989140|FG002|Overall Study|Protocol Deviation|0|||
164171010|NCT02682823|592989141|FG003|Overall Study|Protocol Deviation|0|||
164171011|NCT02682823|592989142|FG004|Overall Study|Protocol Deviation|0|||
164171012|NCT02682823|592989138|FG000|Overall Study|Adverse Event|0|||
164171013|NCT02682823|592989139|FG001|Overall Study|Adverse Event|0|||
164171014|NCT02682823|592989140|FG002|Overall Study|Adverse Event|0|||
164171015|NCT02682823|592989141|FG003|Overall Study|Adverse Event|1|||
164171016|NCT02682823|592989142|FG004|Overall Study|Adverse Event|0|||
164171017|NCT03781583|592989145|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
164171018|NCT03781583|592989146|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
164171019|NCT03781583|592989147|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
164171020|NCT03781583|592989148|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
164171021|NCT03781583|592989145|FG000|Overall Study|Technology did not work for that person in that environment|1|||
164171022|NCT03781583|592989146|FG001|Overall Study|Technology did not work for that person in that environment|0|||
164171023|NCT03781583|592989147|FG002|Overall Study|Technology did not work for that person in that environment|0|||
164171024|NCT03781583|592989148|FG003|Overall Study|Technology did not work for that person in that environment|0|||
164171025|NCT03781583|592989145|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
164171026|NCT03781583|592989146|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
164171027|NCT03781583|592989147|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
164171028|NCT03781583|592989148|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
164171029|NCT03781583|592989145|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
164171030|NCT03781583|592989146|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
164171031|NCT03781583|592989147|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
164171032|NCT03781583|592989148|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
164171033|NCT01938430|592989150|FG000|Overall Study|Randomized but Not Treated|0|||
164171034|NCT01938430|592989151|FG001|Overall Study|Randomized but Not Treated|0|||
164171035|NCT01938430|592989152|FG002|Overall Study|Randomized but Not Treated|0|||
164171036|NCT01938430|592989153|FG003|Overall Study|Randomized but Not Treated|0|||
164171037|NCT01938430|592989154|FG004|Overall Study|Randomized but Not Treated|0|||
164171038|NCT01938430|592989155|FG005|Overall Study|Randomized but Not Treated|0|||
164171039|NCT01938430|592989156|FG006|Overall Study|Randomized but Not Treated|0|||
164171040|NCT01938430|592989157|FG007|Overall Study|Randomized but Not Treated|0|||
164171041|NCT01938430|592989158|FG008|Overall Study|Randomized but Not Treated|0|||
164171042|NCT01938430|592989159|FG009|Overall Study|Randomized but Not Treated|0|||
164171043|NCT01938430|592989160|FG010|Overall Study|Randomized but Not Treated|1|||
164171044|NCT01938430|592989161|FG011|Overall Study|Randomized but Not Treated|0|||
164171045|NCT01938430|592989162|FG012|Overall Study|Randomized but Not Treated|0|||
164171046|NCT01938430|592989163|FG013|Overall Study|Randomized but Not Treated|1|||
164171047|NCT01938430|592989150|FG000|Overall Study|Adverse Event|0|||
164171048|NCT01938430|592989151|FG001|Overall Study|Adverse Event|0|||
164171049|NCT01938430|592989152|FG002|Overall Study|Adverse Event|0|||
164171050|NCT01938430|592989153|FG003|Overall Study|Adverse Event|0|||
164171051|NCT01938430|592989154|FG004|Overall Study|Adverse Event|0|||
164171052|NCT01938430|592989155|FG005|Overall Study|Adverse Event|0|||
164171053|NCT01938430|592989156|FG006|Overall Study|Adverse Event|1|||
164171054|NCT01938430|592989157|FG007|Overall Study|Adverse Event|0|||
164171055|NCT01938430|592989158|FG008|Overall Study|Adverse Event|0|||
164171056|NCT01938430|592989159|FG009|Overall Study|Adverse Event|0|||
164171057|NCT01938430|592989160|FG010|Overall Study|Adverse Event|0|||
164171058|NCT01938430|592989161|FG011|Overall Study|Adverse Event|0|||
164171059|NCT01938430|592989162|FG012|Overall Study|Adverse Event|0|||
164171060|NCT01938430|592989163|FG013|Overall Study|Adverse Event|0|||
164171061|NCT01938430|592989150|FG000|Overall Study|Death|1|||
164171062|NCT01938430|592989151|FG001|Overall Study|Death|2|||
164171063|NCT01938430|592989152|FG002|Overall Study|Death|2|||
164171064|NCT01938430|592989153|FG003|Overall Study|Death|1|||
164171065|NCT01938430|592989154|FG004|Overall Study|Death|0|||
164171066|NCT01938430|592989155|FG005|Overall Study|Death|0|||
164171067|NCT01938430|592989156|FG006|Overall Study|Death|1|||
164171068|NCT01938430|592989157|FG007|Overall Study|Death|1|||
164171069|NCT01938430|592989158|FG008|Overall Study|Death|2|||
164171070|NCT01938430|592989159|FG009|Overall Study|Death|3|||
164171071|NCT01938430|592989160|FG010|Overall Study|Death|0|||
164171072|NCT01938430|592989161|FG011|Overall Study|Death|0|||
164171073|NCT01938430|592989162|FG012|Overall Study|Death|0|||
164171074|NCT01938430|592989163|FG013|Overall Study|Death|0|||
164171075|NCT01938430|592989150|FG000|Overall Study|Investigator's Discretion|0|||
164171076|NCT01938430|592989151|FG001|Overall Study|Investigator's Discretion|0|||
164171077|NCT01938430|592989152|FG002|Overall Study|Investigator's Discretion|1|||
164171078|NCT01938430|592989153|FG003|Overall Study|Investigator's Discretion|0|||
164171079|NCT01938430|592989154|FG004|Overall Study|Investigator's Discretion|0|||
164171080|NCT01938430|592989155|FG005|Overall Study|Investigator's Discretion|0|||
164171081|NCT01938430|592989156|FG006|Overall Study|Investigator's Discretion|0|||
164171082|NCT01938430|592989157|FG007|Overall Study|Investigator's Discretion|0|||
164171083|NCT01938430|592989158|FG008|Overall Study|Investigator's Discretion|0|||
164171084|NCT01938430|592989159|FG009|Overall Study|Investigator's Discretion|0|||
164171085|NCT01938430|592989160|FG010|Overall Study|Investigator's Discretion|0|||
164171086|NCT01938430|592989161|FG011|Overall Study|Investigator's Discretion|0|||
164171087|NCT01938430|592989162|FG012|Overall Study|Investigator's Discretion|0|||
164171088|NCT01938430|592989163|FG013|Overall Study|Investigator's Discretion|0|||
164171089|NCT01938430|592989150|FG000|Overall Study|Lack of Efficacy|3|||
164171090|NCT01938430|592989151|FG001|Overall Study|Lack of Efficacy|1|||
164171091|NCT01938430|592989152|FG002|Overall Study|Lack of Efficacy|1|||
164171092|NCT01938430|592989153|FG003|Overall Study|Lack of Efficacy|1|||
164171094|NCT01938430|592989155|FG005|Overall Study|Lack of Efficacy|0|||
164171095|NCT01938430|592989156|FG006|Overall Study|Lack of Efficacy|0|||
164171096|NCT01938430|592989157|FG007|Overall Study|Lack of Efficacy|0|||
164171097|NCT01938430|592989158|FG008|Overall Study|Lack of Efficacy|1|||
164171098|NCT01938430|592989159|FG009|Overall Study|Lack of Efficacy|0|||
164171099|NCT01938430|592989160|FG010|Overall Study|Lack of Efficacy|2|||
164171100|NCT01938430|592989161|FG011|Overall Study|Lack of Efficacy|1|||
164171101|NCT01938430|592989162|FG012|Overall Study|Lack of Efficacy|0|||
164171102|NCT01938430|592989163|FG013|Overall Study|Lack of Efficacy|0|||
164171103|NCT01938430|592989150|FG000|Overall Study|Lost to Follow-up|0|||
164171104|NCT01938430|592989151|FG001|Overall Study|Lost to Follow-up|0|||
164171105|NCT01938430|592989152|FG002|Overall Study|Lost to Follow-up|1|||
164171106|NCT01938430|592989153|FG003|Overall Study|Lost to Follow-up|0|||
164171107|NCT01938430|592989154|FG004|Overall Study|Lost to Follow-up|0|||
164171108|NCT01938430|592989155|FG005|Overall Study|Lost to Follow-up|1|||
164171109|NCT01938430|592989156|FG006|Overall Study|Lost to Follow-up|0|||
164171110|NCT01938430|592989157|FG007|Overall Study|Lost to Follow-up|0|||
164171111|NCT01938430|592989158|FG008|Overall Study|Lost to Follow-up|0|||
164171112|NCT01938430|592989159|FG009|Overall Study|Lost to Follow-up|0|||
164171113|NCT01938430|592989160|FG010|Overall Study|Lost to Follow-up|0|||
164171114|NCT01938430|592989161|FG011|Overall Study|Lost to Follow-up|0|||
164171115|NCT01938430|592989162|FG012|Overall Study|Lost to Follow-up|0|||
164171116|NCT01938430|592989163|FG013|Overall Study|Lost to Follow-up|0|||
164171117|NCT01938430|592989150|FG000|Overall Study|Withdrew Consent|0|||
164171118|NCT01938430|592989151|FG001|Overall Study|Withdrew Consent|0|||
164171119|NCT01938430|592989152|FG002|Overall Study|Withdrew Consent|0|||
164171120|NCT01938430|592989153|FG003|Overall Study|Withdrew Consent|0|||
164171121|NCT01938430|592989154|FG004|Overall Study|Withdrew Consent|0|||
164171122|NCT01938430|592989155|FG005|Overall Study|Withdrew Consent|0|||
164171123|NCT01938430|592989156|FG006|Overall Study|Withdrew Consent|0|||
164171124|NCT01938430|592989157|FG007|Overall Study|Withdrew Consent|0|||
164171125|NCT01938430|592989158|FG008|Overall Study|Withdrew Consent|1|||
164171126|NCT01938430|592989159|FG009|Overall Study|Withdrew Consent|0|||
164171127|NCT01938430|592989160|FG010|Overall Study|Withdrew Consent|0|||
164171128|NCT01938430|592989161|FG011|Overall Study|Withdrew Consent|0|||
164171129|NCT01938430|592989162|FG012|Overall Study|Withdrew Consent|0|||
164171130|NCT01938430|592989163|FG013|Overall Study|Withdrew Consent|0|||
164171131|NCT00537316|592989165|FG000|Part 1|Adverse Event|7|||
164171132|NCT00537316|592989166|FG001|Part 1|Adverse Event|11|||
164171133|NCT00537316|592989167|FG002|Part 1|Adverse Event|8|||
164171134|NCT00537316|592989168|FG003|Part 1|Adverse Event|0|||
164171135|NCT00537316|592989169|FG004|Part 1|Adverse Event|0|||
164171136|NCT00537316|592989170|FG005|Part 1|Adverse Event|0|||
164171137|NCT00537316|592989171|FG006|Part 1|Adverse Event|0|||
164171138|NCT00537316|592989165|FG000|Part 1|Protocol defined clinical event|1|||
164171139|NCT00537316|592989166|FG001|Part 1|Protocol defined clinical event|0|||
164171140|NCT00537316|592989167|FG002|Part 1|Protocol defined clinical event|0|||
164171141|NCT00537316|592989168|FG003|Part 1|Protocol defined clinical event|0|||
164171142|NCT00537316|592989169|FG004|Part 1|Protocol defined clinical event|0|||
164171143|NCT00537316|592989170|FG005|Part 1|Protocol defined clinical event|0|||
164171144|NCT00537316|592989171|FG006|Part 1|Protocol defined clinical event|0|||
164171145|NCT00537316|592989165|FG000|Part 1|Lost to Follow-up|1|||
164171146|NCT00537316|592989166|FG001|Part 1|Lost to Follow-up|0|||
164171147|NCT00537316|592989167|FG002|Part 1|Lost to Follow-up|0|||
164171148|NCT00537316|592989168|FG003|Part 1|Lost to Follow-up|0|||
164171149|NCT00537316|592989169|FG004|Part 1|Lost to Follow-up|0|||
164171150|NCT00537316|592989170|FG005|Part 1|Lost to Follow-up|0|||
164171151|NCT00537316|592989171|FG006|Part 1|Lost to Follow-up|0|||
164171152|NCT00537316|592989165|FG000|Part 1|Withdrawal by Subject|3|||
164171153|NCT00537316|592989166|FG001|Part 1|Withdrawal by Subject|8|||
164171154|NCT00537316|592989167|FG002|Part 1|Withdrawal by Subject|4|||
164171155|NCT00537316|592989168|FG003|Part 1|Withdrawal by Subject|0|||
164171156|NCT00537316|592989169|FG004|Part 1|Withdrawal by Subject|0|||
164171157|NCT00537316|592989170|FG005|Part 1|Withdrawal by Subject|0|||
164171158|NCT00537316|592989171|FG006|Part 1|Withdrawal by Subject|0|||
164171159|NCT00537316|592989165|FG000|Part 1|Protocol Violation|1|||
164171160|NCT00537316|592989166|FG001|Part 1|Protocol Violation|5|||
164171161|NCT00537316|592989167|FG002|Part 1|Protocol Violation|1|||
164171162|NCT00537316|592989168|FG003|Part 1|Protocol Violation|0|||
164171163|NCT00537316|592989169|FG004|Part 1|Protocol Violation|0|||
164171164|NCT00537316|592989170|FG005|Part 1|Protocol Violation|0|||
164171165|NCT00537316|592989171|FG006|Part 1|Protocol Violation|0|||
164171166|NCT00537316|592989165|FG000|Part 1|Did not meet protocol eligibility|1|||
164171167|NCT00537316|592989166|FG001|Part 1|Did not meet protocol eligibility|3|||
164171168|NCT00537316|592989167|FG002|Part 1|Did not meet protocol eligibility|2|||
164171169|NCT00537316|592989168|FG003|Part 1|Did not meet protocol eligibility|0|||
164171170|NCT00537316|592989169|FG004|Part 1|Did not meet protocol eligibility|0|||
164171171|NCT00537316|592989170|FG005|Part 1|Did not meet protocol eligibility|0|||
164171172|NCT00537316|592989171|FG006|Part 1|Did not meet protocol eligibility|0|||
164171173|NCT00537316|592989165|FG000|Part 1|Administrative|0|||
164171174|NCT00537316|592989166|FG001|Part 1|Administrative|0|||
164171175|NCT00537316|592989167|FG002|Part 1|Administrative|2|||
164171176|NCT00537316|592989168|FG003|Part 1|Administrative|0|||
164171177|NCT00537316|592989169|FG004|Part 1|Administrative|0|||
164171178|NCT00537316|592989170|FG005|Part 1|Administrative|0|||
164171179|NCT00537316|592989171|FG006|Part 1|Administrative|0|||
164171180|NCT00537316|592989165|FG000|Part 2|Never entered follow-up|0|||
164171181|NCT00537316|592989166|FG001|Part 2|Never entered follow-up|0|||
164171182|NCT00537316|592989167|FG002|Part 2|Never entered follow-up|0|||
164171183|NCT00537316|592989168|FG003|Part 2|Never entered follow-up|0|||
164171184|NCT00537316|592989169|FG004|Part 2|Never entered follow-up|0|||
164171185|NCT00537316|592989170|FG005|Part 2|Never entered follow-up|0|||
164171186|NCT00537316|592989171|FG006|Part 2|Never entered follow-up|1|||
164171187|NCT00537316|592989165|FG000|Part 2|Adverse Event|4|||
164171188|NCT00537316|592989166|FG001|Part 2|Adverse Event|0|||
164171189|NCT00537316|592989167|FG002|Part 2|Adverse Event|2|||
164171190|NCT00537316|592989168|FG003|Part 2|Adverse Event|0|||
164171191|NCT00537316|592989169|FG004|Part 2|Adverse Event|0|||
164171192|NCT00537316|592989170|FG005|Part 2|Adverse Event|0|||
164171193|NCT00537316|592989171|FG006|Part 2|Adverse Event|0|||
164171194|NCT00537316|592989165|FG000|Part 2|Lost to Follow-up|1|||
164171195|NCT00537316|592989166|FG001|Part 2|Lost to Follow-up|0|||
164171196|NCT00537316|592989167|FG002|Part 2|Lost to Follow-up|2|||
164171197|NCT00537316|592989168|FG003|Part 2|Lost to Follow-up|0|||
164171198|NCT00537316|592989169|FG004|Part 2|Lost to Follow-up|0|||
164171199|NCT00537316|592989170|FG005|Part 2|Lost to Follow-up|0|||
164171200|NCT00537316|592989171|FG006|Part 2|Lost to Follow-up|0|||
164171201|NCT00537316|592989165|FG000|Part 2|Withdrawal by Subject|5|||
164171202|NCT00537316|592989166|FG001|Part 2|Withdrawal by Subject|1|||
164171203|NCT00537316|592989167|FG002|Part 2|Withdrawal by Subject|4|||
164171204|NCT00537316|592989168|FG003|Part 2|Withdrawal by Subject|0|||
164171205|NCT00537316|592989169|FG004|Part 2|Withdrawal by Subject|0|||
164171206|NCT00537316|592989170|FG005|Part 2|Withdrawal by Subject|0|||
164171207|NCT00537316|592989171|FG006|Part 2|Withdrawal by Subject|0|||
164171208|NCT00537316|592989165|FG000|Part 2|Administrative|16|||
164171209|NCT00537316|592989166|FG001|Part 2|Administrative|8|||
164171210|NCT00537316|592989167|FG002|Part 2|Administrative|24|||
164171211|NCT00537316|592989168|FG003|Part 2|Administrative|3|||
164171212|NCT00537316|592989169|FG004|Part 2|Administrative|1|||
164171213|NCT00537316|592989170|FG005|Part 2|Administrative|4|||
164171214|NCT00537316|592989171|FG006|Part 2|Administrative|1|||
164171215|NCT00782184|592989174|FG000|Overall Study|Adverse Event|1|||
164171216|NCT00782184|592989175|FG001|Overall Study|Adverse Event|2|||
164171217|NCT00782184|592989174|FG000|Overall Study|Protocol Violation|0|||
164171218|NCT00782184|592989175|FG001|Overall Study|Protocol Violation|1|||
164171219|NCT00782184|592989174|FG000|Overall Study|Withdrawal by Subject|3|||
164171220|NCT00782184|592989175|FG001|Overall Study|Withdrawal by Subject|2|||
164171221|NCT01438294|592989176|FG000|Overall Study|Lost to Follow-up|3|||
164171222|NCT01438294|592989177|FG001|Overall Study|Lost to Follow-up|7|||
164171223|NCT03696108|592989185|FG000|Overall Study|Physician Decision|1|||
164171224|NCT03696108|592989186|FG001|Overall Study|Physician Decision|0|||
164171225|NCT03696108|592989185|FG000|Overall Study|Withdrawal by Subject|3|||
164171226|NCT03696108|592989186|FG001|Overall Study|Withdrawal by Subject|6|||
164171227|NCT03505593|592989187|FG000|Overall Study|Withdrawal by Subject|1|||
164171228|NCT03505593|592989187|FG000|Overall Study|Died before procedure|1|||
164171229|NCT03505593|592989187|FG000|Overall Study|Anatomical abnormality|1|||
164171230|NCT03505593|592989187|FG000|Overall Study|Unable to pass through esophagus|1|||
164171231|NCT03505593|592989187|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
164171232|NCT02822573|592989189|FG000|Overall Study|Lost to Follow-up|5|||
164171233|NCT02822573|592989190|FG001|Overall Study|Lost to Follow-up|3|||
164171234|NCT02822573|592989189|FG000|Overall Study|Physician Decision|1|||
164171235|NCT02822573|592989190|FG001|Overall Study|Physician Decision|1|||
164171236|NCT02822573|592989189|FG000|Overall Study|Withdrawal by Subject|9|||
164171237|NCT02822573|592989190|FG001|Overall Study|Withdrawal by Subject|5|||
164171238|NCT02822573|592989189|FG000|Overall Study|Protocol Violation|6|||
164171239|NCT02822573|592989190|FG001|Overall Study|Protocol Violation|4|||
164171240|NCT02822573|592989189|FG000|Overall Study|Too sick or ill|2|||
164171241|NCT02822573|592989190|FG001|Overall Study|Too sick or ill|1|||
164171242|NCT02822573|592989189|FG000|Overall Study|Disease Progression|1|||
164171243|NCT02822573|592989190|FG001|Overall Study|Disease Progression|1|||
164171244|NCT02822573|592989189|FG000|Overall Study|No reason given|6|||
164171245|NCT02822573|592989190|FG001|Overall Study|No reason given|4|||
164171246|NCT03891862|592989191|FG000|Open-label Period|Adverse Event|2|||
164171247|NCT03891862|592989192|FG001|Open-label Period|Adverse Event|0|||
164171248|NCT03891862|592989193|FG002|Open-label Period|Adverse Event|0|||
164171249|NCT03891862|592989191|FG000|Open-label Period|Protocol Violation|5|||
164171250|NCT03891862|592989192|FG001|Open-label Period|Protocol Violation|0|||
164171251|NCT03891862|592989193|FG002|Open-label Period|Protocol Violation|0|||
164171252|NCT03891862|592989191|FG000|Open-label Period|Withdrawal by Subject|6|||
164171253|NCT03891862|592989192|FG001|Open-label Period|Withdrawal by Subject|0|||
164171254|NCT03891862|592989193|FG002|Open-label Period|Withdrawal by Subject|0|||
164171255|NCT03891862|592989191|FG000|Open-label Period|Death|1|||
164171256|NCT03891862|592989192|FG001|Open-label Period|Death|0|||
164171257|NCT03891862|592989193|FG002|Open-label Period|Death|0|||
164171258|NCT03891862|592989191|FG000|Open-label Period|Lost to Follow-up|2|||
164171259|NCT03891862|592989192|FG001|Open-label Period|Lost to Follow-up|0|||
164171260|NCT03891862|592989193|FG002|Open-label Period|Lost to Follow-up|0|||
164171261|NCT03891862|592989191|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
164171262|NCT03891862|592989192|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
164171263|NCT03891862|592989193|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
164171264|NCT03891862|592989191|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
164171265|NCT03891862|592989192|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
164171266|NCT03891862|592989193|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
164171267|NCT03891862|592989191|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
164171268|NCT03891862|592989192|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
164171269|NCT03891862|592989193|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
164171270|NCT03891862|592989191|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
164171271|NCT03891862|592989192|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
164171272|NCT03891862|592989193|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
164171273|NCT01053962|592989194|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
164171274|NCT01053962|592989195|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
164171275|NCT01053962|592989196|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
164171276|NCT01053962|592989197|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
164171277|NCT01053962|592989198|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
164171278|NCT01053962|592989194|FG000|Pretreatment Period|Venipuncture Failure|0|||
164171279|NCT01053962|592989195|FG001|Pretreatment Period|Venipuncture Failure|0|||
164171280|NCT01053962|592989196|FG002|Pretreatment Period|Venipuncture Failure|1|||
164171281|NCT01053962|592989197|FG003|Pretreatment Period|Venipuncture Failure|0|||
164171282|NCT01053962|592989198|FG004|Pretreatment Period|Venipuncture Failure|0|||
164171283|NCT01053962|592989194|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
164171284|NCT01053962|592989195|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
164171285|NCT01053962|592989196|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
164171286|NCT01053962|592989197|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
164171287|NCT01053962|592989198|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
164171288|NCT01053962|592989194|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
164171289|NCT01053962|592989195|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
164171290|NCT01053962|592989196|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
164171291|NCT01053962|592989197|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
164171292|NCT01053962|592989198|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
164171293|NCT01053962|592989194|FG000|Treatment Period|Lack of Efficacy|0|||
164171294|NCT01053962|592989195|FG001|Treatment Period|Lack of Efficacy|0|||
164171295|NCT01053962|592989196|FG002|Treatment Period|Lack of Efficacy|0|||
164171296|NCT01053962|592989197|FG003|Treatment Period|Lack of Efficacy|0|||
164171297|NCT01053962|592989198|FG004|Treatment Period|Lack of Efficacy|1|||
164171298|NCT01053962|592989194|FG000|Treatment Period|Adverse Event|0|||
164171299|NCT01053962|592989195|FG001|Treatment Period|Adverse Event|0|||
164171300|NCT01053962|592989196|FG002|Treatment Period|Adverse Event|0|||
164171301|NCT01053962|592989197|FG003|Treatment Period|Adverse Event|0|||
164171302|NCT01053962|592989198|FG004|Treatment Period|Adverse Event|1|||
164171303|NCT01053962|592989194|FG000|Treatment Period|Withdrawal by Subject|0|||
164171304|NCT01053962|592989195|FG001|Treatment Period|Withdrawal by Subject|0|||
164171305|NCT01053962|592989196|FG002|Treatment Period|Withdrawal by Subject|0|||
164171306|NCT01053962|592989197|FG003|Treatment Period|Withdrawal by Subject|0|||
164171307|NCT01053962|592989198|FG004|Treatment Period|Withdrawal by Subject|1|||
164171308|NCT01053962|592989194|FG000|Treatment Period|Noncompliance with protocol|1|||
164171309|NCT01053962|592989195|FG001|Treatment Period|Noncompliance with protocol|0|||
164171310|NCT01053962|592989196|FG002|Treatment Period|Noncompliance with protocol|0|||
164171311|NCT01053962|592989197|FG003|Treatment Period|Noncompliance with protocol|0|||
164171312|NCT01053962|592989198|FG004|Treatment Period|Noncompliance with protocol|0|||
164171313|NCT02833844|592989199|FG000|Double-Blind Period|Withdrawal by Subject|2|||
164171314|NCT02833844|592989200|FG001|Double-Blind Period|Withdrawal by Subject|3|||
164171315|NCT02833844|592989199|FG000|Double-Blind Period|Protocol Violation|0|||
164171316|NCT02833844|592989200|FG001|Double-Blind Period|Protocol Violation|4|||
164171317|NCT02833844|592989199|FG000|Open-Label Period|Death|0|||
164171318|NCT02833844|592989200|FG001|Open-Label Period|Death|2|||
164171319|NCT02833844|592989199|FG000|Open-Label Period|Lost to Follow-up|1|||
164171320|NCT02833844|592989200|FG001|Open-Label Period|Lost to Follow-up|0|||
164171321|NCT02833844|592989199|FG000|Open-Label Period|Withdrawal by Subject|1|||
164171322|NCT02833844|592989200|FG001|Open-Label Period|Withdrawal by Subject|0|||
164171323|NCT00308087|592989201|FG000|Overall Study|Progressive Disease|19|||
164171324|NCT00308087|592989202|FG001|Overall Study|Progressive Disease|21|||
164171325|NCT00308087|592989201|FG000|Overall Study|Study Closure|11|||
164171326|NCT00308087|592989202|FG001|Overall Study|Study Closure|12|||
164171327|NCT00308087|592989201|FG000|Overall Study|Withdrawal by Subject|2|||
164171328|NCT00308087|592989202|FG001|Overall Study|Withdrawal by Subject|1|||
164171329|NCT00308087|592989201|FG000|Overall Study|Other|4|||
164171330|NCT00308087|592989202|FG001|Overall Study|Other|3|||
164171331|NCT01646021|592989204|FG000|Overall Study|Death|77|||
164171332|NCT01646021|592989205|FG001|Overall Study|Death|83|||
164171333|NCT01646021|592989204|FG000|Overall Study|Study Terminated by Sponsor|50|||
164171334|NCT01646021|592989205|FG001|Overall Study|Study Terminated by Sponsor|41|||
164171335|NCT01646021|592989204|FG000|Overall Study|Lost to Follow-up|2|||
164171336|NCT01646021|592989205|FG001|Overall Study|Lost to Follow-up|2|||
164171337|NCT01646021|592989204|FG000|Overall Study|Withdrawal by Subject|10|||
164171338|NCT01646021|592989205|FG001|Overall Study|Withdrawal by Subject|15|||
164171339|NCT02347891|592989206|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
164171340|NCT02347891|592989207|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
164171341|NCT02347891|592989206|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
164171342|NCT02347891|592989207|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
164171343|NCT05129137|592989208|FG000|Second Period|Adverse Event|1|||
164171344|NCT05129137|592989209|FG001|Second Period|Adverse Event|0|||
164171345|NCT05129137|592989210|FG002|Second Period|Adverse Event|0|||
164171346|NCT05129137|592989211|FG003|Second Period|Adverse Event|0|||
164171347|NCT05129137|592989208|FG000|Second Period|Protocol Violation|0|||
164171348|NCT05129137|592989209|FG001|Second Period|Protocol Violation|0|||
164171349|NCT05129137|592989210|FG002|Second Period|Protocol Violation|0|||
164171350|NCT05129137|592989211|FG003|Second Period|Protocol Violation|1|||
164171351|NCT05129137|592989208|FG000|Third Period|Protocol Violation|0|||
164171352|NCT05129137|592989209|FG001|Third Period|Protocol Violation|0|||
164171353|NCT05129137|592989210|FG002|Third Period|Protocol Violation|0|||
164171354|NCT05129137|592989211|FG003|Third Period|Protocol Violation|1|||
164171355|NCT05129137|592989208|FG000|Forth Period|Protocol Violation|0|||
164171356|NCT05129137|592989209|FG001|Forth Period|Protocol Violation|1|||
164171357|NCT05129137|592989210|FG002|Forth Period|Protocol Violation|0|||
164171358|NCT05129137|592989211|FG003|Forth Period|Protocol Violation|0|||
164171359|NCT05129137|592989208|FG000|Forth Period|Withdrawal by Subject|0|||
164171360|NCT05129137|592989209|FG001|Forth Period|Withdrawal by Subject|0|||
164171361|NCT05129137|592989210|FG002|Forth Period|Withdrawal by Subject|1|||
164171362|NCT05129137|592989211|FG003|Forth Period|Withdrawal by Subject|0|||
164171363|NCT00727844|592989213|FG000|Initial Randomization|Physician Decision|2|||
164171364|NCT00727844|592989214|FG001|Initial Randomization|Physician Decision|0|||
164171365|NCT00727844|592989215|FG002|Initial Randomization|Physician Decision|0|||
164171366|NCT00727844|592989216|FG003|Initial Randomization|Physician Decision|0|||
164171367|NCT04439214|592989217|FG000|Overall Study|Adverse Event|13|||
164171368|NCT04439214|592989217|FG000|Overall Study|Disease progression|16|||
164171369|NCT04439214|592989217|FG000|Overall Study|Death|1|||
164171370|NCT04439214|592989217|FG000|Overall Study|Withdrawal by Subject|2|||
164171371|NCT04439214|592989217|FG000|Overall Study|Declining health|1|||
164171372|NCT04439214|592989217|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
164171373|NCT04439214|592989217|FG000|Overall Study|Ineligible|5|||
164171374|NCT04013672|592989222|FG000|Overall Study|Withdrawal by Subject|3|||
164171375|NCT04013672|592989223|FG001|Overall Study|Withdrawal by Subject|0|||
164171376|NCT04013672|592989222|FG000|Overall Study|Death|1|||
164171377|NCT04013672|592989223|FG001|Overall Study|Death|0|||
164171378|NCT04013672|592989222|FG000|Overall Study|Physician Decision|5|||
164171379|NCT04013672|592989223|FG001|Overall Study|Physician Decision|0|||
164171380|NCT02847494|592989228|FG000|Overall Study|Lost to Follow-up|8|||
164171381|NCT02847494|592989229|FG001|Overall Study|Lost to Follow-up|5|||
164171382|NCT00556933|592989230|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
164171383|NCT00556933|592989231|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
164171384|NCT00556933|592989232|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
164171385|NCT00556933|592989233|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
164171386|NCT00556933|592989230|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
164171387|NCT00556933|592989231|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
164171388|NCT00556933|592989232|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
164171389|NCT00556933|592989233|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
164171390|NCT00556933|592989230|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
164171391|NCT00556933|592989231|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
164171392|NCT00556933|592989232|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
164171393|NCT00556933|592989233|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
164171394|NCT00556933|592989230|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
164171395|NCT00556933|592989231|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
164171396|NCT00556933|592989232|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
164171397|NCT00556933|592989233|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
164171398|NCT00556933|592989230|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
164171399|NCT00556933|592989231|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
164171400|NCT00556933|592989232|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
164171401|NCT00556933|592989233|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
164171402|NCT00556933|592989230|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
164171403|NCT00556933|592989231|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
164171404|NCT00556933|592989232|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
164171405|NCT00556933|592989233|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
164171406|NCT00556933|592989230|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
164171407|NCT00556933|592989231|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
164171408|NCT00556933|592989232|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
164171409|NCT00556933|592989233|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
164171410|NCT00556933|592989230|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
164171411|NCT00556933|592989231|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
164171412|NCT00556933|592989232|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
164171413|NCT00556933|592989233|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
164171414|NCT00556933|592989230|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
164171415|NCT00556933|592989231|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
164171416|NCT00556933|592989232|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
164171417|NCT00556933|592989233|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
164171418|NCT00556933|592989230|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
164171419|NCT00556933|592989231|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
164171420|NCT00556933|592989232|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
164171421|NCT00556933|592989233|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
164171422|NCT00556933|592989230|FG000|CNI Withdrawal vs. Minimization|Death|0|||
164171423|NCT00556933|592989231|FG001|CNI Withdrawal vs. Minimization|Death|0|||
164171424|NCT00556933|592989232|FG002|CNI Withdrawal vs. Minimization|Death|0|||
164171425|NCT00556933|592989233|FG003|CNI Withdrawal vs. Minimization|Death|1|||
164171426|NCT00767455|592989234|FG000|Overall Study|Investigator error|19|||
164171427|NCT00746564|592989235|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
164171428|NCT00022698|592989236|FG000|Overall Study|Adverse Event|5|||
164171429|NCT00022698|592989237|FG001|Overall Study|Adverse Event|9|||
164171430|NCT00022698|592989236|FG000|Overall Study|Death|0|||
164171431|NCT00022698|592989237|FG001|Overall Study|Death|2|||
164171432|NCT00022698|592989236|FG000|Overall Study|Failure to return|0|||
164171433|NCT00022698|592989237|FG001|Overall Study|Failure to return|1|||
164171434|NCT00022698|592989236|FG000|Overall Study|Refused treatment|0|||
164171435|NCT00022698|592989237|FG001|Overall Study|Refused treatment|2|||
164171436|NCT00022698|592989236|FG000|Overall Study|Insufficient therapeutic response|2|||
164171437|NCT00022698|592989237|FG001|Overall Study|Insufficient therapeutic response|14|||
164171438|NCT00022698|592989236|FG000|Overall Study|Administrative /other|1|||
164171439|NCT00022698|592989237|FG001|Overall Study|Administrative /other|7|||
164171440|NCT01827267|592989238|FG000|Overall Study|Did not receive study drug|1|||
164171441|NCT01827267|592989239|FG001|Overall Study|Did not receive study drug|1|||
164171442|NCT01827267|592989238|FG000|Overall Study|Physician Decision|1|||
164171443|NCT01827267|592989239|FG001|Overall Study|Physician Decision|0|||
164171444|NCT01827267|592989238|FG000|Overall Study|Disease Progression|1|||
164171445|NCT01827267|592989239|FG001|Overall Study|Disease Progression|1|||
164171446|NCT01827267|592989238|FG000|Overall Study|Sponsor Discontinued Study|2|||
164171447|NCT01827267|592989239|FG001|Overall Study|Sponsor Discontinued Study|8|||
164171448|NCT01827267|592989238|FG000|Overall Study|Still on study|0|||
164171449|NCT01827267|592989239|FG001|Overall Study|Still on study|2|||
164171450|NCT01684943|592989243|FG000|Overall Study|Inadequate Venous Access|3|||
164171451|NCT01684943|592989244|FG001|Overall Study|Inadequate Venous Access|0|||
164171452|NCT01684943|592989245|FG002|Overall Study|Inadequate Venous Access|0|||
164171453|NCT01684943|592989243|FG000|Overall Study|Principal Investigator Determination|1|||
164171454|NCT01684943|592989244|FG001|Overall Study|Principal Investigator Determination|0|||
164171455|NCT01684943|592989245|FG002|Overall Study|Principal Investigator Determination|0|||
164171456|NCT01684943|592989243|FG000|Overall Study|Excluded from Analysis|1|||
164171457|NCT01684943|592989244|FG001|Overall Study|Excluded from Analysis|1|||
164171458|NCT01684943|592989245|FG002|Overall Study|Excluded from Analysis|1|||
164171459|NCT01684943|592989243|FG000|Overall Study|Lost to Follow-up|3|||
164171460|NCT01684943|592989244|FG001|Overall Study|Lost to Follow-up|0|||
164171461|NCT01684943|592989245|FG002|Overall Study|Lost to Follow-up|0|||
164171462|NCT01684943|592989243|FG000|Overall Study|Planning Pregnancy|1|||
164171463|NCT01684943|592989244|FG001|Overall Study|Planning Pregnancy|0|||
164171464|NCT01684943|592989245|FG002|Overall Study|Planning Pregnancy|0|||
164171465|NCT03395184|592989246|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
164171466|NCT03395184|592989247|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
164171467|NCT03395184|592989248|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
164171468|NCT03395184|592989249|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
164171469|NCT03395184|592989250|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
164171470|NCT03395184|592989251|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
164171471|NCT03395184|592989252|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
164171472|NCT03395184|592989246|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
164171473|NCT03395184|592989247|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
164171474|NCT03395184|592989248|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
164171475|NCT03395184|592989249|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
164171476|NCT03395184|592989250|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
164171477|NCT03395184|592989251|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
164171478|NCT03395184|592989252|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
164171479|NCT03395184|592989246|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
164171480|NCT03395184|592989247|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
164171481|NCT03395184|592989248|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
164171482|NCT03395184|592989249|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
164171483|NCT03395184|592989250|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
164171484|NCT03395184|592989251|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
164171485|NCT03395184|592989252|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
164171486|NCT03395184|592989246|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
164171487|NCT03395184|592989247|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
164171488|NCT03395184|592989248|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
164171489|NCT03395184|592989249|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
164171490|NCT03395184|592989250|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
164171491|NCT03395184|592989251|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
164171492|NCT03395184|592989252|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
164171493|NCT03395184|592989246|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
164171494|NCT03395184|592989247|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
164171495|NCT03395184|592989248|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
164171496|NCT03395184|592989249|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
164171497|NCT03395184|592989250|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
164171498|NCT03395184|592989251|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
164171499|NCT03395184|592989252|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
164171500|NCT03395184|592989246|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
164171501|NCT03395184|592989247|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
164171502|NCT03395184|592989248|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
164171503|NCT03395184|592989249|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
164171504|NCT03395184|592989250|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
164171505|NCT03395184|592989251|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
164171506|NCT03395184|592989252|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
164171507|NCT03395184|592989246|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
164171508|NCT03395184|592989247|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
164171509|NCT03395184|592989248|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
164171510|NCT03395184|592989249|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
164171511|NCT03395184|592989250|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
164171512|NCT03395184|592989251|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
164171513|NCT03395184|592989252|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
164171514|NCT03395184|592989246|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
164171515|NCT03395184|592989247|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
164171516|NCT03395184|592989248|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
164171517|NCT03395184|592989249|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
164171518|NCT03395184|592989250|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
164171519|NCT03395184|592989251|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
164171520|NCT03395184|592989252|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
164171521|NCT03395184|592989246|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
164171522|NCT03395184|592989247|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
164171523|NCT03395184|592989248|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
164171524|NCT03395184|592989249|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
164171525|NCT03395184|592989250|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
164171526|NCT03395184|592989251|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
164171527|NCT03395184|592989252|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
164171528|NCT03395184|592989246|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
164171529|NCT03395184|592989247|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
164171530|NCT03395184|592989248|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
164171531|NCT03395184|592989249|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
164171532|NCT03395184|592989250|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
164171533|NCT03395184|592989251|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
164171534|NCT03395184|592989252|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
164171535|NCT03395184|592989246|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
164171536|NCT03395184|592989247|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
164171537|NCT03395184|592989248|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
164171538|NCT03395184|592989249|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
164171539|NCT03395184|592989250|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
164171540|NCT03395184|592989251|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
164171541|NCT03395184|592989252|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
164171542|NCT03395184|592989246|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
164171543|NCT03395184|592989247|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
164171544|NCT03395184|592989248|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
164171545|NCT03395184|592989249|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
164171546|NCT03395184|592989250|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
164171547|NCT03395184|592989251|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
164171548|NCT03395184|592989252|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
164171549|NCT02122887|592989261|FG000|Overall Study|Withdrawal by Subject|20|||
164171550|NCT02122887|592989262|FG001|Overall Study|Withdrawal by Subject|2|||
164171551|NCT05033262|592989263|FG000|Overall Study|Lost to Follow-up|1|||
164171552|NCT05033262|592989264|FG001|Overall Study|Lost to Follow-up|0|||
164171553|NCT05033262|592989265|FG002|Overall Study|Lost to Follow-up|0|||
164171554|NCT05033262|592989266|FG003|Overall Study|Lost to Follow-up|1|||
164171555|NCT01482065|592990763|FG000|Overall Study|Withdrawal by Subject|0|||
164171556|NCT01482065|592990764|FG001|Overall Study|Withdrawal by Subject|1|||
164171557|NCT04720911|592990765|FG000|Overall Study|Withdrawal by Subject|0|||
164171558|NCT04720911|592990766|FG001|Overall Study|Withdrawal by Subject|1|||
164171559|NCT04720911|592990767|FG002|Overall Study|Withdrawal by Subject|0|||
164171560|NCT04533412|592990768|FG000|Overall Study|Withdrawal by Subject|1|||
164171561|NCT04533412|592990769|FG001|Overall Study|Withdrawal by Subject|1|||
164171562|NCT04533412|592990768|FG000|Overall Study|Lost to Follow-up|1|||
164171563|NCT04533412|592990769|FG001|Overall Study|Lost to Follow-up|4|||
164171564|NCT03261674|592990770|FG000|Overall Study|Lost to Follow-up|6|||
164171565|NCT03261674|592990771|FG001|Overall Study|Lost to Follow-up|7|||
164171566|NCT03261674|592990770|FG000|Overall Study|Protocol Violation|1|||
164171567|NCT03261674|592990771|FG001|Overall Study|Protocol Violation|4|||
164171568|NCT03261674|592990770|FG000|Overall Study|Withdrawal by Subject|1|||
164171569|NCT03261674|592990771|FG001|Overall Study|Withdrawal by Subject|4|||
164171570|NCT03261674|592990770|FG000|Overall Study|Physician Decision|1|||
164171571|NCT03261674|592990771|FG001|Overall Study|Physician Decision|0|||
164171572|NCT02004886|592990772|FG000|Overall Study|Adverse Event|0|||
164171573|NCT02004886|592990773|FG001|Overall Study|Adverse Event|1|||
164171574|NCT02004886|592990774|FG002|Overall Study|Adverse Event|0|||
164171575|NCT02004886|592990775|FG003|Overall Study|Adverse Event|0|||
164171576|NCT02004886|592990772|FG000|Overall Study|Unable to attend future visits|1|||
164171577|NCT02004886|592990773|FG001|Overall Study|Unable to attend future visits|0|||
164171578|NCT02004886|592990774|FG002|Overall Study|Unable to attend future visits|0|||
164171579|NCT02004886|592990775|FG003|Overall Study|Unable to attend future visits|0|||
164171580|NCT01895608|592990777|FG000|Overall Study|change in health status|0|||
164171581|NCT01895608|592990778|FG001|Overall Study|change in health status|1|||
164171582|NCT01895608|592990779|FG002|Overall Study|change in health status|1|||
164171583|NCT01895608|592990780|FG003|Overall Study|change in health status|0|||
164171584|NCT01895608|592990777|FG000|Overall Study|Withdrawal by Subject|0|||
164171585|NCT01895608|592990778|FG001|Overall Study|Withdrawal by Subject|0|||
164171586|NCT01895608|592990779|FG002|Overall Study|Withdrawal by Subject|2|||
164171587|NCT01895608|592990780|FG003|Overall Study|Withdrawal by Subject|0|||
164171588|NCT02892422|592990782|FG000|Overall Study|Enrolled not treated|4|||
164171589|NCT02892422|592990782|FG000|Overall Study|Adverse Event|38|||
164171590|NCT02892422|592990782|FG000|Overall Study|Lack of Efficacy|32|||
164171591|NCT02892422|592990782|FG000|Overall Study|Non-compliance with study drug|11|||
164171592|NCT02892422|592990782|FG000|Overall Study|Protocol Violation|4|||
164171593|NCT02892422|592990782|FG000|Overall Study|Withdrawal by Subject|56|||
164171594|NCT02892422|592990782|FG000|Overall Study|Lost to Follow-up|5|||
164171595|NCT02892422|592990782|FG000|Overall Study|sponsor information 16159A results|21|||
164171596|NCT02892422|592990782|FG000|Overall Study|withdrawal of consent|13|||
164171597|NCT02892422|592990782|FG000|Overall Study|exclusion criteria met|3|||
164171598|NCT02892422|592990782|FG000|Overall Study|moving elsewhere|4|||
164171599|NCT02892422|592990782|FG000|Overall Study|non-compliance|10|||
164171600|NCT02892422|592990782|FG000|Overall Study|patient legally incapable|1|||
164171601|NCT02892422|592990782|FG000|Overall Study|patient decision|7|||
164171602|NCT02892422|592990782|FG000|Overall Study|Investigator decision|1|||
164171603|NCT04323306|592990783|FG000|Overall Study|Physician Decision|1|||
164171604|NCT04323306|592990784|FG001|Overall Study|Physician Decision|0|||
164171605|NCT04323306|592990785|FG002|Overall Study|Physician Decision|0|||
164171606|NCT04323306|592990786|FG003|Overall Study|Physician Decision|0|||
164171607|NCT04323306|592990787|FG004|Overall Study|Physician Decision|0|||
164171608|NCT04323306|592990788|FG005|Overall Study|Physician Decision|0|||
164171609|NCT04323306|592990789|FG006|Overall Study|Physician Decision|0|||
164171610|NCT04323306|592990790|FG007|Overall Study|Physician Decision|0|||
164171611|NCT04323306|592990791|FG008|Overall Study|Physician Decision|0|||
164171612|NCT04323306|592990783|FG000|Overall Study|Withdrawal by Subject|0|||
164171613|NCT04323306|592990784|FG001|Overall Study|Withdrawal by Subject|0|||
164171614|NCT04323306|592990785|FG002|Overall Study|Withdrawal by Subject|0|||
164171615|NCT04323306|592990786|FG003|Overall Study|Withdrawal by Subject|0|||
164171616|NCT04323306|592990787|FG004|Overall Study|Withdrawal by Subject|0|||
164171617|NCT04323306|592990788|FG005|Overall Study|Withdrawal by Subject|1|||
164171618|NCT04323306|592990789|FG006|Overall Study|Withdrawal by Subject|3|||
164171619|NCT04323306|592990790|FG007|Overall Study|Withdrawal by Subject|0|||
164171620|NCT04323306|592990791|FG008|Overall Study|Withdrawal by Subject|1|||
164171621|NCT00759785|592990792|FG000|Overall Study|Participant sample not evaluable|11|||
164171622|NCT00759785|592990793|FG001|Overall Study|Participant sample not evaluable|2|||
164171623|NCT00759785|592990792|FG000|Overall Study|Participant sample lost|0|||
164171624|NCT00759785|592990793|FG001|Overall Study|Participant sample lost|1|||
164171625|NCT00759785|592990792|FG000|Overall Study|Protocol Violation|1|||
164171626|NCT00759785|592990793|FG001|Overall Study|Protocol Violation|0|||
164171627|NCT00759785|592990792|FG000|Overall Study|Physician Decision|0|||
164171628|NCT00759785|592990793|FG001|Overall Study|Physician Decision|1|||
164171629|NCT00759785|592990792|FG000|Overall Study|Withdrawal by Subject|0|||
164171630|NCT00759785|592990793|FG001|Overall Study|Withdrawal by Subject|1|||
164171631|NCT00089778|592990794|FG000|Overall Study|Protocol Violation|0|||
164171632|NCT00089778|592990795|FG001|Overall Study|Protocol Violation|0|||
164171633|NCT00089778|592990796|FG002|Overall Study|Protocol Violation|1|||
164171634|NCT04712019|592990797|FG000|Overall Study|Withdrawal by Subject|2|||
164171635|NCT04712019|592990798|FG001|Overall Study|Withdrawal by Subject|2|||
164171636|NCT04712019|592990797|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
164171637|NCT04712019|592990798|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
164171638|NCT00725608|592990806|FG000|Overall Study|Lost to Follow-up|60|||
164171639|NCT00725608|592990806|FG000|Overall Study|Adverse Event|14|||
164171640|NCT00725608|592990806|FG000|Overall Study|Individual reasons|86|||
164171641|NCT00725608|592990806|FG000|Overall Study|Other|7|||
164171642|NCT00614120|592990810|FG000|Overall Study|Adverse Event|9|||
164171643|NCT00614120|592990811|FG001|Overall Study|Adverse Event|22|||
164171644|NCT00614120|592990812|FG002|Overall Study|Adverse Event|30|||
164171645|NCT00614120|592990813|FG003|Overall Study|Adverse Event|3|||
164171646|NCT00614120|592990810|FG000|Overall Study|Lack of Efficacy|3|||
164171647|NCT00614120|592990811|FG001|Overall Study|Lack of Efficacy|3|||
164171648|NCT00614120|592990812|FG002|Overall Study|Lack of Efficacy|2|||
164171649|NCT00614120|592990813|FG003|Overall Study|Lack of Efficacy|2|||
164171650|NCT00614120|592990810|FG000|Overall Study|Protocol Violation|2|||
164171651|NCT00614120|592990811|FG001|Overall Study|Protocol Violation|5|||
164171652|NCT00614120|592990812|FG002|Overall Study|Protocol Violation|3|||
164171653|NCT00614120|592990813|FG003|Overall Study|Protocol Violation|1|||
164171654|NCT00614120|592990810|FG000|Overall Study|Withdrawal criteria|1|||
164171655|NCT00614120|592990811|FG001|Overall Study|Withdrawal criteria|0|||
164171656|NCT00614120|592990812|FG002|Overall Study|Withdrawal criteria|0|||
164171657|NCT00614120|592990813|FG003|Overall Study|Withdrawal criteria|0|||
164171658|NCT00614120|592990810|FG000|Overall Study|Withdrawal by Subject|9|||
164171659|NCT00614120|592990811|FG001|Overall Study|Withdrawal by Subject|10|||
164171660|NCT00614120|592990812|FG002|Overall Study|Withdrawal by Subject|16|||
164171661|NCT00614120|592990813|FG003|Overall Study|Withdrawal by Subject|3|||
164171662|NCT00614120|592990810|FG000|Overall Study|Did not meet trial criteria|0|||
164171663|NCT00614120|592990811|FG001|Overall Study|Did not meet trial criteria|1|||
164171664|NCT00614120|592990812|FG002|Overall Study|Did not meet trial criteria|1|||
164171665|NCT00614120|592990813|FG003|Overall Study|Did not meet trial criteria|1|||
164171666|NCT00614120|592990810|FG000|Overall Study|hCG positive (not pregnant)|0|||
164171667|NCT00614120|592990811|FG001|Overall Study|hCG positive (not pregnant)|0|||
164171668|NCT00614120|592990812|FG002|Overall Study|hCG positive (not pregnant)|1|||
164171669|NCT00614120|592990813|FG003|Overall Study|hCG positive (not pregnant)|0|||
164171670|NCT00614120|592990810|FG000|Overall Study|Hypoglycaemia|0|||
164171671|NCT00614120|592990811|FG001|Overall Study|Hypoglycaemia|0|||
164171672|NCT00614120|592990812|FG002|Overall Study|Hypoglycaemia|0|||
164171673|NCT00614120|592990813|FG003|Overall Study|Hypoglycaemia|1|||
164171674|NCT00614120|592990810|FG000|Overall Study|Lack of trial product|3|||
164171675|NCT00614120|592990811|FG001|Overall Study|Lack of trial product|3|||
164171676|NCT00614120|592990812|FG002|Overall Study|Lack of trial product|2|||
164171677|NCT00614120|592990813|FG003|Overall Study|Lack of trial product|0|||
164171678|NCT00614120|592990810|FG000|Overall Study|Late syphilis, latent|1|||
164171679|NCT00614120|592990811|FG001|Overall Study|Late syphilis, latent|0|||
164171680|NCT00614120|592990812|FG002|Overall Study|Late syphilis, latent|0|||
164171681|NCT00614120|592990813|FG003|Overall Study|Late syphilis, latent|0|||
164171682|NCT00614120|592990810|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
164171683|NCT00614120|592990811|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
164171684|NCT00614120|592990812|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
164171685|NCT00614120|592990813|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
164171686|NCT00614120|592990810|FG000|Overall Study|Lost to Follow-up|1|||
164171687|NCT00614120|592990811|FG001|Overall Study|Lost to Follow-up|2|||
164171688|NCT00614120|592990812|FG002|Overall Study|Lost to Follow-up|3|||
164171689|NCT00614120|592990813|FG003|Overall Study|Lost to Follow-up|4|||
164171690|NCT01968707|592990814|FG000|Overall Study|Did not meet treatment day baseline|49|||
164171691|NCT01968707|592990815|FG001|Overall Study|Did not meet treatment day baseline|12|||
164171692|NCT01968707|592990816|FG002|Overall Study|Did not meet treatment day baseline|41|||
164171693|NCT01968707|592990817|FG003|Overall Study|Did not meet treatment day baseline|44|||
164171694|NCT01968707|592990818|FG004|Overall Study|Did not meet treatment day baseline|36|||
164171695|NCT01968707|592990819|FG005|Overall Study|Did not meet treatment day baseline|11|||
164171696|NCT01968707|592990820|FG006|Overall Study|Did not meet treatment day baseline|34|||
164171697|NCT01968707|592990821|FG007|Overall Study|Did not meet treatment day baseline|35|||
164171698|NCT01084668|592990822|FG000|Overall Study|Lack of Efficacy|5|||
164171699|NCT01084668|592990822|FG000|Overall Study|Withdrawal by Subject|2|||
164171700|NCT01084668|592990822|FG000|Overall Study|Pregnancy|1|||
164171701|NCT01084668|592990822|FG000|Overall Study|Non-compliance|1|||
164171702|NCT03729570|592990826|FG000|Overall Study|Lost to Follow-up|16|||
164171703|NCT03729570|592990827|FG001|Overall Study|Lost to Follow-up|20|||
164171704|NCT03729570|592990826|FG000|Overall Study|Seroconversion|5|||
164171705|NCT03729570|592990827|FG001|Overall Study|Seroconversion|0|||
164171706|NCT03729570|592990826|FG000|Overall Study|Moved out of the city|1|||
164171707|NCT03729570|592990827|FG001|Overall Study|Moved out of the city|0|||
164171708|NCT03729570|592990826|FG000|Overall Study|Time Conflict|1|||
164171709|NCT03729570|592990827|FG001|Overall Study|Time Conflict|0|||
164171710|NCT03729570|592990826|FG000|Overall Study|Time Commitment|2|||
164171711|NCT03729570|592990827|FG001|Overall Study|Time Commitment|0|||
164171712|NCT03729570|592990826|FG000|Overall Study|Bad Experience|0|||
164171713|NCT03729570|592990827|FG001|Overall Study|Bad Experience|1|||
164171714|NCT03729570|592990826|FG000|Overall Study|No reason provided|2|||
164171715|NCT03729570|592990827|FG001|Overall Study|No reason provided|1|||
164171716|NCT03729570|592990826|FG000|Overall Study|Family Conflict|0|||
164171717|NCT03729570|592990827|FG001|Overall Study|Family Conflict|1|||
164171718|NCT03729570|592990826|FG000|Overall Study|Did not want to continue taking medications|0|||
164171719|NCT03729570|592990827|FG001|Overall Study|Did not want to continue taking medications|1|||
164171720|NCT03729570|592990826|FG000|Overall Study|Found another PrEP provider|1|||
164171721|NCT03729570|592990827|FG001|Overall Study|Found another PrEP provider|0|||
164171722|NCT03729570|592990826|FG000|Overall Study|Did not enjoy being in the control group|0|||
164171723|NCT03729570|592990827|FG001|Overall Study|Did not enjoy being in the control group|1|||
164171724|NCT02474589|592990828|FG000|Overall Study|Adverse Event|6|||
164171725|NCT02474589|592990829|FG001|Overall Study|Adverse Event|2|||
164171726|NCT02474589|592990828|FG000|Overall Study|Lost to Follow-up|6|||
164171727|NCT02474589|592990829|FG001|Overall Study|Lost to Follow-up|1|||
164171728|NCT02474589|592990828|FG000|Overall Study|Protocol Violation|4|||
164171729|NCT02474589|592990829|FG001|Overall Study|Protocol Violation|1|||
164171730|NCT02474589|592990828|FG000|Overall Study|Withdrawal by Subject|4|||
164171731|NCT02474589|592990829|FG001|Overall Study|Withdrawal by Subject|0|||
164171732|NCT02474589|592990828|FG000|Overall Study|Inability to complete study procedures|5|||
164171733|NCT02474589|592990829|FG001|Overall Study|Inability to complete study procedures|1|||
164171734|NCT00459706|592990830|FG000|Overall Study|Adverse Event|19|||
164171735|NCT00459706|592990831|FG001|Overall Study|Adverse Event|13|||
164171736|NCT00459706|592990830|FG000|Overall Study|Withdrawal by Subject|1|||
164171737|NCT00459706|592990831|FG001|Overall Study|Withdrawal by Subject|6|||
164171738|NCT00459706|592990830|FG000|Overall Study|Physician Decision|2|||
164171739|NCT00459706|592990831|FG001|Overall Study|Physician Decision|0|||
164171740|NCT00459706|592990830|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
164171741|NCT00459706|592990831|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
164171742|NCT00459706|592990830|FG000|Overall Study|Protocol Violation|2|||
164171743|NCT00459706|592990831|FG001|Overall Study|Protocol Violation|1|||
164171744|NCT00459706|592990830|FG000|Overall Study|Failed to Return|1|||
164171745|NCT00459706|592990831|FG001|Overall Study|Failed to Return|0|||
164171746|NCT00459706|592990830|FG000|Overall Study|Other|0|||
164171747|NCT00459706|592990831|FG001|Overall Study|Other|1|||
164171748|NCT02447497|592990832|FG000|Overall Study|Did not meet treatment day baseline.|6|||
164171749|NCT02447497|592990833|FG001|Overall Study|Did not meet treatment day baseline.|5|||
164171750|NCT02447497|592990834|FG002|Overall Study|Did not meet treatment day baseline.|2|||
164171751|NCT02447497|592990835|FG003|Overall Study|Did not meet treatment day baseline.|2|||
164171752|NCT02447497|592990832|FG000|Overall Study|Dressing was compromised|0|||
164171753|NCT02447497|592990833|FG001|Overall Study|Dressing was compromised|1|||
164171754|NCT02447497|592990834|FG002|Overall Study|Dressing was compromised|0|||
164171755|NCT02447497|592990835|FG003|Overall Study|Dressing was compromised|0|||
164171756|NCT02017912|592990836|FG000|Overall Study|Withdrawal by Subject|2|||
164171757|NCT02017912|592990837|FG001|Overall Study|Withdrawal by Subject|1|||
164171758|NCT02017912|592990836|FG000|Overall Study|miscellaneous|1|||
164171759|NCT02017912|592990837|FG001|Overall Study|miscellaneous|1|||
164171760|NCT04569968|592990838|FG000|Overall Study|Lost to Follow-up|2|||
164171761|NCT04569968|592990839|FG001|Overall Study|Lost to Follow-up|5|||
164171762|NCT04569968|592990838|FG000|Overall Study|Story of head and/or neck surgery|2|||
164171763|NCT04569968|592990839|FG001|Overall Study|Story of head and/or neck surgery|2|||
164171764|NCT04569968|592990838|FG000|Overall Study|Time of stroke onset|8|||
164171765|NCT04569968|592990839|FG001|Overall Study|Time of stroke onset|7|||
164171766|NCT04569968|592990838|FG000|Overall Study|Type of strokr|12|||
164171767|NCT04569968|592990839|FG001|Overall Study|Type of strokr|8|||
164171768|NCT04569968|592990838|FG000|Overall Study|Cooperation|8|||
164171769|NCT04569968|592990839|FG001|Overall Study|Cooperation|8|||
164171770|NCT04569968|592990838|FG000|Overall Study|Age interval|17|||
164171771|NCT04569968|592990839|FG001|Overall Study|Age interval|6|||
164171772|NCT04569968|592990838|FG000|Overall Study|Denial of participation to the study|0|||
164171773|NCT04569968|592990839|FG001|Overall Study|Denial of participation to the study|3|||
164172293|NCT02083185|592993194|FG000|Overall Study|Death|2|||
164171774|NCT04569968|592990838|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
164171775|NCT04569968|592990839|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
164171776|NCT04569968|592990838|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
164171777|NCT04569968|592990839|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
164171778|NCT04569968|592990838|FG000|Overall Study|Quarantine|1|||
164171779|NCT04569968|592990839|FG001|Overall Study|Quarantine|0|||
164171780|NCT04569968|592990838|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
164171781|NCT04569968|592990839|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
164171782|NCT04569968|592990838|FG000|Overall Study|Repetitive stroke|8|||
164171783|NCT04569968|592990839|FG001|Overall Study|Repetitive stroke|0|||
164171784|NCT04569968|592990838|FG000|Overall Study|Insufficient mastication|1|||
164171785|NCT04569968|592990839|FG001|Overall Study|Insufficient mastication|0|||
164171786|NCT04569968|592990838|FG000|Overall Study|Infection|1|||
164171787|NCT04569968|592990839|FG001|Overall Study|Infection|0|||
164171788|NCT00985959|592990844|FG000|Overall Study|Adverse Event|0|||
164171789|NCT00985959|592990845|FG001|Overall Study|Adverse Event|0|||
164171790|NCT00985959|592990846|FG002|Overall Study|Adverse Event|19|||
164171791|NCT00985959|592990844|FG000|Overall Study|Withdrawal by Subject|0|||
164171792|NCT00985959|592990845|FG001|Overall Study|Withdrawal by Subject|0|||
164171793|NCT00985959|592990846|FG002|Overall Study|Withdrawal by Subject|8|||
164171794|NCT00985959|592990844|FG000|Overall Study|Progressive disease|1|||
164171795|NCT00985959|592990845|FG001|Overall Study|Progressive disease|2|||
164171796|NCT00985959|592990846|FG002|Overall Study|Progressive disease|8|||
164171797|NCT00985959|592990844|FG000|Overall Study|Unrecovered toxicity|0|||
164171798|NCT00985959|592990845|FG001|Overall Study|Unrecovered toxicity|0|||
164171799|NCT00985959|592990846|FG002|Overall Study|Unrecovered toxicity|7|||
164171800|NCT00985959|592990844|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
164171801|NCT00985959|592990845|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
164171802|NCT00985959|592990846|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
164171803|NCT00985959|592990844|FG000|Overall Study|Complete response observed over 2 cycles|0|||
164171804|NCT00985959|592990845|FG001|Overall Study|Complete response observed over 2 cycles|1|||
164171805|NCT00985959|592990846|FG002|Overall Study|Complete response observed over 2 cycles|4|||
164171806|NCT00985959|592990844|FG000|Overall Study|Other|0|||
164171807|NCT00985959|592990845|FG001|Overall Study|Other|0|||
164171808|NCT00985959|592990846|FG002|Overall Study|Other|11|||
164171809|NCT00979420|592990847|FG000|Overall Study|Adverse Event|1|||
164171810|NCT00979420|592990848|FG001|Overall Study|Adverse Event|0|||
164171811|NCT00979420|592990849|FG002|Overall Study|Adverse Event|0|||
164171812|NCT00979420|592990850|FG003|Overall Study|Adverse Event|0|||
164171813|NCT00979420|592990847|FG000|Overall Study|Lack of Efficacy|3|||
164171814|NCT00979420|592990848|FG001|Overall Study|Lack of Efficacy|0|||
164171815|NCT00979420|592990849|FG002|Overall Study|Lack of Efficacy|1|||
164171816|NCT00979420|592990850|FG003|Overall Study|Lack of Efficacy|1|||
164171817|NCT00979420|592990847|FG000|Overall Study|Other reasons not related to Viramune|3|||
164171818|NCT00979420|592990848|FG001|Overall Study|Other reasons not related to Viramune|0|||
164171819|NCT00979420|592990849|FG002|Overall Study|Other reasons not related to Viramune|0|||
164171820|NCT00979420|592990850|FG003|Overall Study|Other reasons not related to Viramune|1|||
164171821|NCT02107859|592990851|FG000|Overall Study|Withdrawal by Subject|14|||
164171822|NCT02107859|592990851|FG000|Overall Study|Adverse Event|3|||
164171823|NCT02107859|592990851|FG000|Overall Study|Study closure|41|||
164171824|NCT02107859|592990851|FG000|Overall Study|Other than specified|3|||
164171825|NCT02235077|592990852|FG000|Overall Study|Death|5|||
164171826|NCT02235077|592990853|FG001|Overall Study|Death|7|||
164171827|NCT02235077|592990852|FG000|Overall Study|Lost to Follow-up|5|||
164171828|NCT02235077|592990853|FG001|Overall Study|Lost to Follow-up|6|||
164171829|NCT02235077|592990852|FG000|Overall Study|Withdrawal by Subject|8|||
164171830|NCT02235077|592990853|FG001|Overall Study|Withdrawal by Subject|5|||
164171831|NCT02235077|592990852|FG000|Overall Study|Physician Decision|0|||
164171832|NCT02235077|592990853|FG001|Overall Study|Physician Decision|1|||
164171833|NCT02964208|592990854|FG000|Overall Study|Death|103|||
164171834|NCT02964208|592990854|FG000|Overall Study|Withdrawal by Subject|6|||
164171835|NCT02964208|592990854|FG000|Overall Study|Lost to Follow-up|6|||
164171836|NCT02964208|592990854|FG000|Overall Study|Unsuccessful Procedure|5|||
164171837|NCT02964208|592990854|FG000|Overall Study|Device Explant|1|||
164171838|NCT02964208|592990854|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
164171839|NCT03887442|592990860|FG000|Overall Study|Adverse Event|1|||
164171840|NCT03887442|592990861|FG001|Overall Study|Adverse Event|0|||
164171841|NCT00101166|592990864|FG000|Overall Study|progressive disease|10|||
164171842|NCT01868022|592990865|FG000|Overall Study|Withdrawal by Subject|0|||
164171843|NCT01868022|592990866|FG001|Overall Study|Withdrawal by Subject|0|||
164171844|NCT01868022|592990867|FG002|Overall Study|Withdrawal by Subject|1|||
164171845|NCT01868022|592990868|FG003|Overall Study|Withdrawal by Subject|1|||
164171846|NCT01868022|592990869|FG004|Overall Study|Withdrawal by Subject|0|||
164171847|NCT01868022|592990870|FG005|Overall Study|Withdrawal by Subject|0|||
164171848|NCT01868022|592990871|FG006|Overall Study|Withdrawal by Subject|0|||
164171849|NCT01868022|592990872|FG007|Overall Study|Withdrawal by Subject|1|||
164171850|NCT01868022|592990873|FG008|Overall Study|Withdrawal by Subject|0|||
164171851|NCT01868022|592990865|FG000|Overall Study|Adverse Event|0|||
164171852|NCT01868022|592990866|FG001|Overall Study|Adverse Event|0|||
164171853|NCT01868022|592990867|FG002|Overall Study|Adverse Event|0|||
164171854|NCT01868022|592990868|FG003|Overall Study|Adverse Event|0|||
164171855|NCT01868022|592990869|FG004|Overall Study|Adverse Event|2|||
164171856|NCT01868022|592990870|FG005|Overall Study|Adverse Event|0|||
164171857|NCT01868022|592990871|FG006|Overall Study|Adverse Event|0|||
164171858|NCT01868022|592990872|FG007|Overall Study|Adverse Event|2|||
164171859|NCT01868022|592990873|FG008|Overall Study|Adverse Event|2|||
164171860|NCT01868022|592990865|FG000|Overall Study|Physician Decision|0|||
164171861|NCT01868022|592990866|FG001|Overall Study|Physician Decision|0|||
164171862|NCT01868022|592990867|FG002|Overall Study|Physician Decision|0|||
164171863|NCT01868022|592990868|FG003|Overall Study|Physician Decision|0|||
164171864|NCT01868022|592990869|FG004|Overall Study|Physician Decision|0|||
164171865|NCT01868022|592990870|FG005|Overall Study|Physician Decision|1|||
164171866|NCT01868022|592990871|FG006|Overall Study|Physician Decision|0|||
164171867|NCT01868022|592990872|FG007|Overall Study|Physician Decision|2|||
164171868|NCT01868022|592990873|FG008|Overall Study|Physician Decision|0|||
164171869|NCT01868022|592990865|FG000|Overall Study|Study closed/terminated|0|||
164171870|NCT01868022|592990866|FG001|Overall Study|Study closed/terminated|0|||
164171871|NCT01868022|592990867|FG002|Overall Study|Study closed/terminated|0|||
164171872|NCT01868022|592990868|FG003|Overall Study|Study closed/terminated|0|||
164171873|NCT01868022|592990869|FG004|Overall Study|Study closed/terminated|0|||
164171874|NCT01868022|592990870|FG005|Overall Study|Study closed/terminated|0|||
164171875|NCT01868022|592990871|FG006|Overall Study|Study closed/terminated|0|||
164171876|NCT01868022|592990872|FG007|Overall Study|Study closed/terminated|1|||
164171877|NCT01868022|592990873|FG008|Overall Study|Study closed/terminated|0|||
164171878|NCT01868022|592990865|FG000|Overall Study|Ongoing|0|||
164171879|NCT01868022|592990866|FG001|Overall Study|Ongoing|0|||
164171880|NCT01868022|592990867|FG002|Overall Study|Ongoing|0|||
164171881|NCT01868022|592990868|FG003|Overall Study|Ongoing|0|||
164171882|NCT01868022|592990869|FG004|Overall Study|Ongoing|0|||
164171883|NCT01868022|592990870|FG005|Overall Study|Ongoing|0|||
164171884|NCT01868022|592990871|FG006|Overall Study|Ongoing|0|||
164171885|NCT01868022|592990872|FG007|Overall Study|Ongoing|3|||
164171886|NCT01868022|592990873|FG008|Overall Study|Ongoing|0|||
164171887|NCT01628198|592990874|FG000|Overall Study|Lost to Follow-up|7|||
164171888|NCT01628198|592990874|FG000|Overall Study|Withdrawal by Subject|10|||
164171889|NCT01628198|592990874|FG000|Overall Study|Screen failure|1|||
164171890|NCT03386994|592990875|FG000|Overall Study|Lung transplant|1|||
164171891|NCT03386994|592990875|FG000|Overall Study|Adverse Event|14|||
164171892|NCT03386994|592990875|FG000|Overall Study|Lost to Follow-up|4|||
164171893|NCT03386994|592990875|FG000|Overall Study|Withdrawal by Subject|3|||
164171894|NCT03386994|592990875|FG000|Overall Study|Death|16|||
164171895|NCT03226769|592990878|FG000|Overall Study|Withdrawal by Subject|0|||
164171896|NCT03226769|592990879|FG001|Overall Study|Withdrawal by Subject|1|||
164171897|NCT01516008|592990880|FG000|Overall Study|Adverse Event|0|||
164171898|NCT01516008|592990881|FG001|Overall Study|Adverse Event|2|||
164171899|NCT01516008|592990882|FG002|Overall Study|Adverse Event|7|||
164171900|NCT01516008|592990880|FG000|Overall Study|Lack of Efficacy|44|||
164171901|NCT01516008|592990881|FG001|Overall Study|Lack of Efficacy|14|||
164171902|NCT01516008|592990882|FG002|Overall Study|Lack of Efficacy|10|||
164171903|NCT01516008|592990880|FG000|Overall Study|Protocol Violation|1|||
164171904|NCT01516008|592990881|FG001|Overall Study|Protocol Violation|0|||
164171905|NCT01516008|592990882|FG002|Overall Study|Protocol Violation|0|||
164171906|NCT01516008|592990880|FG000|Overall Study|Reason not specified|0|||
164171907|NCT01516008|592990881|FG001|Overall Study|Reason not specified|0|||
164171908|NCT01516008|592990882|FG002|Overall Study|Reason not specified|1|||
164171909|NCT01217476|592990885|FG000|Overall Study|Adverse Event|6|||
164171910|NCT01217476|592990886|FG001|Overall Study|Adverse Event|1|||
164171911|NCT01217476|592990885|FG000|Overall Study|Physician Decision|0|||
164171912|NCT01217476|592990886|FG001|Overall Study|Physician Decision|1|||
164171913|NCT01217476|592990885|FG000|Overall Study|Withdrawal by Subject|3|||
164171914|NCT01217476|592990886|FG001|Overall Study|Withdrawal by Subject|3|||
164171915|NCT01217476|592990885|FG000|Overall Study|Surgery on the Target Limb|0|||
164171916|NCT01217476|592990886|FG001|Overall Study|Surgery on the Target Limb|2|||
164171917|NCT01217476|592990885|FG000|Overall Study|Protocol Deviation|1|||
164171918|NCT01217476|592990886|FG001|Overall Study|Protocol Deviation|0|||
164171919|NCT01217476|592990885|FG000|Overall Study|Other|2|||
164171920|NCT01217476|592990886|FG001|Overall Study|Other|0|||
164171921|NCT03033602|592990887|FG000|Overall Study|Withdrawal by Subject|11|||
164171922|NCT03033602|592990888|FG001|Overall Study|Withdrawal by Subject|21|||
164171923|NCT03033602|592990887|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
164171924|NCT03033602|592990888|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
164171925|NCT01493284|592990893|FG000|Overall Study|Death|29|||
164171926|NCT01493284|592990893|FG000|Overall Study|Withdrawal by Subject|32|||
164171927|NCT00325156|592990894|FG000|Overall Study|Protocol Violation|8|||
164171928|NCT00325156|592990894|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
164171929|NCT00325156|592990894|FG000|Overall Study|Migrated/moved from study area|12|||
164171930|NCT00325156|592990894|FG000|Overall Study|Adverse event, non-fatal|3|||
164171931|NCT00325156|592990894|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
164171932|NCT00325156|592990894|FG000|Overall Study|Other|1|||
164171933|NCT00325156|592990894|FG000|Overall Study|Withdrawal by Subject|31|||
164171934|NCT04064411|592990895|FG000|Overall Study|Adverse Event|29|||
164171935|NCT04064411|592990896|FG001|Overall Study|Adverse Event|19|||
164171936|NCT04064411|592990895|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
164171937|NCT04064411|592990896|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
164171938|NCT04064411|592990895|FG000|Overall Study|Protocol Deviation|0|||
164171939|NCT04064411|592990896|FG001|Overall Study|Protocol Deviation|2|||
164171940|NCT04064411|592990895|FG000|Overall Study|Withdrawal by Subject|25|||
164171941|NCT04064411|592990896|FG001|Overall Study|Withdrawal by Subject|29|||
164171942|NCT04064411|592990895|FG000|Overall Study|Lost to Follow-up|5|||
164171943|NCT04064411|592990896|FG001|Overall Study|Lost to Follow-up|2|||
164171944|NCT04064411|592990895|FG000|Overall Study|Other than Specified|4|||
164171945|NCT04064411|592990896|FG001|Overall Study|Other than Specified|1|||
164171946|NCT04064411|592990895|FG000|Overall Study|Death|1|||
164171947|NCT04064411|592990896|FG001|Overall Study|Death|0|||
164171948|NCT03512210|592990898|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
164171949|NCT03512210|592990898|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
164171950|NCT03512210|592990898|FG000|Step 2:Post-MINMON|Death|2|||
164171951|NCT03512210|592990898|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
164171952|NCT03512210|592990898|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
164171953|NCT01672710|592990899|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
164171954|NCT01672710|592990900|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
164171955|NCT01672710|592990899|FG000|3 Month Follow up|Lost to Follow-up|2|||
164171956|NCT01672710|592990900|FG001|3 Month Follow up|Lost to Follow-up|3|||
164171957|NCT01672710|592990899|FG000|3 Month Follow up|follow up due after termination date|4|||
164171958|NCT01672710|592990900|FG001|3 Month Follow up|follow up due after termination date|1|||
164171959|NCT03725761|592990901|FG000|Overall Study|still on study|1|||
164171960|NCT03197467|592993064|FG000|Overall Study|Withdrawal by Subject|1|||
164171961|NCT03666533|592993065|FG000|Overall Study|Lost to Follow-up|2|||
164171962|NCT03666533|592993066|FG001|Overall Study|Lost to Follow-up|2|||
164171963|NCT02017717|592993067|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
164171964|NCT02017717|592993068|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
164171965|NCT02017717|592993069|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
164171966|NCT02017717|592993070|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
164171967|NCT02017717|592993071|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
164171968|NCT02017717|592993072|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
164171969|NCT02017717|592993073|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
164171970|NCT02017717|592993074|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
164171971|NCT02017717|592993075|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
164171972|NCT02017717|592993067|FG000|Before Treatment Period|Participant request to stop therapy|0|||
164171973|NCT02017717|592993068|FG001|Before Treatment Period|Participant request to stop therapy|0|||
164171974|NCT02017717|592993069|FG002|Before Treatment Period|Participant request to stop therapy|0|||
164171975|NCT02017717|592993070|FG003|Before Treatment Period|Participant request to stop therapy|0|||
164171976|NCT02017717|592993071|FG004|Before Treatment Period|Participant request to stop therapy|0|||
164171977|NCT02017717|592993072|FG005|Before Treatment Period|Participant request to stop therapy|0|||
164171978|NCT02017717|592993073|FG006|Before Treatment Period|Participant request to stop therapy|0|||
164171979|NCT02017717|592993074|FG007|Before Treatment Period|Participant request to stop therapy|0|||
164171980|NCT02017717|592993075|FG008|Before Treatment Period|Participant request to stop therapy|5|||
164171981|NCT02017717|592993067|FG000|Before Treatment Period|Participant withdrew consent|0|||
164171982|NCT02017717|592993068|FG001|Before Treatment Period|Participant withdrew consent|0|||
164171983|NCT02017717|592993069|FG002|Before Treatment Period|Participant withdrew consent|0|||
164171984|NCT02017717|592993070|FG003|Before Treatment Period|Participant withdrew consent|0|||
164171985|NCT02017717|592993071|FG004|Before Treatment Period|Participant withdrew consent|0|||
164171986|NCT02017717|592993072|FG005|Before Treatment Period|Participant withdrew consent|0|||
164171987|NCT02017717|592993073|FG006|Before Treatment Period|Participant withdrew consent|2|||
164171988|NCT02017717|592993074|FG007|Before Treatment Period|Participant withdrew consent|0|||
164171989|NCT02017717|592993075|FG008|Before Treatment Period|Participant withdrew consent|11|||
164171990|NCT02017717|592993067|FG000|Before Treatment Period|Lost to Follow-up|0|||
164171991|NCT02017717|592993068|FG001|Before Treatment Period|Lost to Follow-up|0|||
164171992|NCT02017717|592993069|FG002|Before Treatment Period|Lost to Follow-up|0|||
164171993|NCT02017717|592993070|FG003|Before Treatment Period|Lost to Follow-up|0|||
164171994|NCT02017717|592993071|FG004|Before Treatment Period|Lost to Follow-up|0|||
164171995|NCT02017717|592993072|FG005|Before Treatment Period|Lost to Follow-up|0|||
164171996|NCT02017717|592993073|FG006|Before Treatment Period|Lost to Follow-up|0|||
164171997|NCT02017717|592993074|FG007|Before Treatment Period|Lost to Follow-up|0|||
164171998|NCT02017717|592993075|FG008|Before Treatment Period|Lost to Follow-up|1|||
164171999|NCT02017717|592993067|FG000|Before Treatment Period|Participant no longer met criteria|0|||
164172000|NCT02017717|592993068|FG001|Before Treatment Period|Participant no longer met criteria|0|||
164172001|NCT02017717|592993069|FG002|Before Treatment Period|Participant no longer met criteria|0|||
164172002|NCT02017717|592993070|FG003|Before Treatment Period|Participant no longer met criteria|0|||
164172003|NCT02017717|592993071|FG004|Before Treatment Period|Participant no longer met criteria|0|||
164172004|NCT02017717|592993072|FG005|Before Treatment Period|Participant no longer met criteria|1|||
164172005|NCT02017717|592993073|FG006|Before Treatment Period|Participant no longer met criteria|0|||
164172006|NCT02017717|592993074|FG007|Before Treatment Period|Participant no longer met criteria|1|||
164172007|NCT02017717|592993075|FG008|Before Treatment Period|Participant no longer met criteria|2|||
164172008|NCT02017717|592993067|FG000|Before Treatment Period|other reason|0|||
164172009|NCT02017717|592993068|FG001|Before Treatment Period|other reason|0|||
164172010|NCT02017717|592993069|FG002|Before Treatment Period|other reason|0|||
164172011|NCT02017717|592993070|FG003|Before Treatment Period|other reason|0|||
164172012|NCT02017717|592993071|FG004|Before Treatment Period|other reason|0|||
164172013|NCT02017717|592993072|FG005|Before Treatment Period|other reason|0|||
164172014|NCT02017717|592993073|FG006|Before Treatment Period|other reason|0|||
164172015|NCT02017717|592993074|FG007|Before Treatment Period|other reason|0|||
164172016|NCT02017717|592993075|FG008|Before Treatment Period|other reason|1|||
164172017|NCT02017717|592993067|FG000|Treatment Period|Disease progression|7|||
164172018|NCT02017717|592993068|FG001|Treatment Period|Disease progression|9|||
164172019|NCT02017717|592993069|FG002|Treatment Period|Disease progression|12|||
164172020|NCT02017717|592993070|FG003|Treatment Period|Disease progression|20|||
164172021|NCT02017717|592993071|FG004|Treatment Period|Disease progression|26|||
164172022|NCT02017717|592993072|FG005|Treatment Period|Disease progression|16|||
164172023|NCT02017717|592993073|FG006|Treatment Period|Disease progression|22|||
164172024|NCT02017717|592993074|FG007|Treatment Period|Disease progression|165|||
164172025|NCT02017717|592993075|FG008|Treatment Period|Disease progression|135|||
164172026|NCT02017717|592993067|FG000|Treatment Period|Study drug toxicity|3|||
164172027|NCT02017717|592993068|FG001|Treatment Period|Study drug toxicity|0|||
164172028|NCT02017717|592993069|FG002|Treatment Period|Study drug toxicity|1|||
164172029|NCT02017717|592993070|FG003|Treatment Period|Study drug toxicity|4|||
164172030|NCT02017717|592993071|FG004|Treatment Period|Study drug toxicity|4|||
164172031|NCT02017717|592993072|FG005|Treatment Period|Study drug toxicity|5|||
164172032|NCT02017717|592993073|FG006|Treatment Period|Study drug toxicity|3|||
164172033|NCT02017717|592993074|FG007|Treatment Period|Study drug toxicity|7|||
164172034|NCT02017717|592993075|FG008|Treatment Period|Study drug toxicity|11|||
164172035|NCT02017717|592993067|FG000|Treatment Period|Death|0|||
164172036|NCT02017717|592993068|FG001|Treatment Period|Death|0|||
164172037|NCT02017717|592993069|FG002|Treatment Period|Death|1|||
164172038|NCT02017717|592993070|FG003|Treatment Period|Death|0|||
164172039|NCT02017717|592993071|FG004|Treatment Period|Death|0|||
164172040|NCT02017717|592993072|FG005|Treatment Period|Death|2|||
164172041|NCT02017717|592993073|FG006|Treatment Period|Death|0|||
164172042|NCT02017717|592993074|FG007|Treatment Period|Death|0|||
164172043|NCT02017717|592993075|FG008|Treatment Period|Death|0|||
164172044|NCT02017717|592993067|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
164172045|NCT02017717|592993068|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
164172046|NCT02017717|592993069|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
164172047|NCT02017717|592993070|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
164172048|NCT02017717|592993071|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
164172049|NCT02017717|592993072|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
164172050|NCT02017717|592993073|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
164172051|NCT02017717|592993074|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
164172052|NCT02017717|592993075|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
164172053|NCT02017717|592993067|FG000|Treatment Period|Participant request to stop therapy|0|||
164172054|NCT02017717|592993068|FG001|Treatment Period|Participant request to stop therapy|0|||
164172055|NCT02017717|592993069|FG002|Treatment Period|Participant request to stop therapy|3|||
164172056|NCT02017717|592993070|FG003|Treatment Period|Participant request to stop therapy|6|||
164172057|NCT02017717|592993071|FG004|Treatment Period|Participant request to stop therapy|0|||
164172058|NCT02017717|592993072|FG005|Treatment Period|Participant request to stop therapy|2|||
164172059|NCT02017717|592993073|FG006|Treatment Period|Participant request to stop therapy|1|||
164172060|NCT02017717|592993074|FG007|Treatment Period|Participant request to stop therapy|4|||
164172061|NCT02017717|592993075|FG008|Treatment Period|Participant request to stop therapy|7|||
164172062|NCT02017717|592993067|FG000|Treatment Period|Participant withdrew consent|0|||
164172063|NCT02017717|592993068|FG001|Treatment Period|Participant withdrew consent|0|||
164172064|NCT02017717|592993069|FG002|Treatment Period|Participant withdrew consent|1|||
164172065|NCT02017717|592993070|FG003|Treatment Period|Participant withdrew consent|0|||
164172066|NCT02017717|592993071|FG004|Treatment Period|Participant withdrew consent|0|||
164172067|NCT02017717|592993072|FG005|Treatment Period|Participant withdrew consent|2|||
164172068|NCT02017717|592993073|FG006|Treatment Period|Participant withdrew consent|0|||
164172069|NCT02017717|592993074|FG007|Treatment Period|Participant withdrew consent|1|||
164172070|NCT02017717|592993075|FG008|Treatment Period|Participant withdrew consent|4|||
164172071|NCT02017717|592993067|FG000|Treatment Period|Participant no longer met criteria|0|||
164172072|NCT02017717|592993068|FG001|Treatment Period|Participant no longer met criteria|0|||
164172073|NCT02017717|592993069|FG002|Treatment Period|Participant no longer met criteria|0|||
164172074|NCT02017717|592993070|FG003|Treatment Period|Participant no longer met criteria|0|||
164172075|NCT02017717|592993071|FG004|Treatment Period|Participant no longer met criteria|0|||
164172076|NCT02017717|592993072|FG005|Treatment Period|Participant no longer met criteria|0|||
164172077|NCT02017717|592993073|FG006|Treatment Period|Participant no longer met criteria|0|||
164172078|NCT02017717|592993074|FG007|Treatment Period|Participant no longer met criteria|0|||
164172079|NCT02017717|592993075|FG008|Treatment Period|Participant no longer met criteria|1|||
164172080|NCT02017717|592993067|FG000|Treatment Period|Other reasons|0|||
164172081|NCT02017717|592993068|FG001|Treatment Period|Other reasons|0|||
164172082|NCT02017717|592993069|FG002|Treatment Period|Other reasons|0|||
164172083|NCT02017717|592993070|FG003|Treatment Period|Other reasons|1|||
164172084|NCT02017717|592993071|FG004|Treatment Period|Other reasons|0|||
164172085|NCT02017717|592993072|FG005|Treatment Period|Other reasons|1|||
164172086|NCT02017717|592993073|FG006|Treatment Period|Other reasons|1|||
164172087|NCT02017717|592993074|FG007|Treatment Period|Other reasons|1|||
164172088|NCT02017717|592993075|FG008|Treatment Period|Other reasons|1|||
164172089|NCT02017717|592993067|FG000|Treatment Period|Maximum clinical benefit|0|||
164172090|NCT02017717|592993068|FG001|Treatment Period|Maximum clinical benefit|0|||
164172091|NCT02017717|592993069|FG002|Treatment Period|Maximum clinical benefit|0|||
164172092|NCT02017717|592993070|FG003|Treatment Period|Maximum clinical benefit|0|||
164172093|NCT02017717|592993071|FG004|Treatment Period|Maximum clinical benefit|0|||
164172094|NCT02017717|592993072|FG005|Treatment Period|Maximum clinical benefit|0|||
164172095|NCT02017717|592993073|FG006|Treatment Period|Maximum clinical benefit|0|||
164172096|NCT02017717|592993074|FG007|Treatment Period|Maximum clinical benefit|0|||
164172097|NCT02017717|592993075|FG008|Treatment Period|Maximum clinical benefit|1|||
164172098|NCT02017717|592993067|FG000|Treatment Period|Not reported|0|||
164172099|NCT02017717|592993068|FG001|Treatment Period|Not reported|1|||
164172100|NCT02017717|592993069|FG002|Treatment Period|Not reported|0|||
164172101|NCT02017717|592993070|FG003|Treatment Period|Not reported|0|||
164172102|NCT02017717|592993071|FG004|Treatment Period|Not reported|0|||
164172103|NCT02017717|592993072|FG005|Treatment Period|Not reported|0|||
164172104|NCT02017717|592993073|FG006|Treatment Period|Not reported|0|||
164172105|NCT02017717|592993074|FG007|Treatment Period|Not reported|0|||
164172106|NCT02017717|592993075|FG008|Treatment Period|Not reported|0|||
164172107|NCT04488419|592993077|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
164172108|NCT04488419|592993078|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
164172109|NCT04488419|592993079|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
164172110|NCT04488419|592993077|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
164172111|NCT04488419|592993078|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
164172112|NCT04488419|592993079|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
164172113|NCT04488419|592993077|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
164172114|NCT04488419|592993078|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
164172115|NCT04488419|592993079|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
164172116|NCT04488419|592993077|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
164172117|NCT04488419|592993078|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
164172118|NCT04488419|592993079|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
164172119|NCT04488419|592993077|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
164172120|NCT04488419|592993078|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
164172121|NCT04488419|592993079|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
164172122|NCT04488419|592993077|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
164172123|NCT04488419|592993078|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
164172124|NCT04488419|592993079|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
164172125|NCT04488419|592993077|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
164172126|NCT04488419|592993078|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
164172127|NCT04488419|592993079|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
164172128|NCT04488419|592993077|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
164172129|NCT04488419|592993078|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
164172130|NCT04488419|592993079|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
164172131|NCT04488419|592993077|FG000|Primary Analysis Population|Adverse Event|6|||
164172132|NCT04488419|592993078|FG001|Primary Analysis Population|Adverse Event|9|||
164172133|NCT04488419|592993079|FG002|Primary Analysis Population|Adverse Event|0|||
164172134|NCT04488419|592993077|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
164172135|NCT04488419|592993078|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
164172136|NCT04488419|592993079|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
164172137|NCT04488419|592993077|FG000|Primary Analysis Population|Protocol Violation|1|||
164172138|NCT04488419|592993078|FG001|Primary Analysis Population|Protocol Violation|1|||
164172139|NCT04488419|592993079|FG002|Primary Analysis Population|Protocol Violation|0|||
164172140|NCT04488419|592993077|FG000|Primary Analysis Population|Undetermined|7|||
164172141|NCT04488419|592993078|FG001|Primary Analysis Population|Undetermined|3|||
164172142|NCT04488419|592993079|FG002|Primary Analysis Population|Undetermined|0|||
164172143|NCT04488419|592993077|FG000|Primary Analysis Population|>1 Reason|2|||
164172144|NCT04488419|592993078|FG001|Primary Analysis Population|>1 Reason|4|||
164172145|NCT04488419|592993079|FG002|Primary Analysis Population|>1 Reason|0|||
164172146|NCT00970632|592993081|FG000|Overall Study|Adverse Event|2|||
164172147|NCT00970632|592993082|FG001|Overall Study|Adverse Event|2|||
164172148|NCT00970632|592993083|FG002|Overall Study|Adverse Event|1|||
164172149|NCT00970632|592993081|FG000|Overall Study|Lack of Efficacy|3|||
164172150|NCT00970632|592993082|FG001|Overall Study|Lack of Efficacy|0|||
164172151|NCT00970632|592993083|FG002|Overall Study|Lack of Efficacy|0|||
164172152|NCT00970632|592993081|FG000|Overall Study|Lost to Follow-up|3|||
164172153|NCT00970632|592993082|FG001|Overall Study|Lost to Follow-up|0|||
164172154|NCT00970632|592993083|FG002|Overall Study|Lost to Follow-up|2|||
164172155|NCT00970632|592993081|FG000|Overall Study|Protocol Violation|8|||
164172156|NCT00970632|592993082|FG001|Overall Study|Protocol Violation|5|||
164172157|NCT00970632|592993083|FG002|Overall Study|Protocol Violation|8|||
164172158|NCT00970632|592993081|FG000|Overall Study|Withdrawal by Subject|7|||
164172159|NCT00970632|592993082|FG001|Overall Study|Withdrawal by Subject|6|||
164172160|NCT00970632|592993083|FG002|Overall Study|Withdrawal by Subject|4|||
164172161|NCT00970632|592993081|FG000|Overall Study|Entry criteria not met|0|||
164172162|NCT00970632|592993082|FG001|Overall Study|Entry criteria not met|2|||
164172163|NCT00970632|592993083|FG002|Overall Study|Entry criteria not met|2|||
164172164|NCT00970632|592993081|FG000|Overall Study|Sponsor decision|1|||
164172165|NCT00970632|592993082|FG001|Overall Study|Sponsor decision|0|||
164172166|NCT00970632|592993083|FG002|Overall Study|Sponsor decision|1|||
164172167|NCT01286168|592993089|FG000|Overall Study|Withdrawal by Subject|1|||
164172168|NCT01286168|592993089|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
164172169|NCT02487771|592993090|FG000|Overall Study|Lost to Follow-up|2|||
164172170|NCT02487771|592993091|FG001|Overall Study|Lost to Follow-up|3|||
164172171|NCT02487771|592993090|FG000|Overall Study|Moved out of area|5|||
164172172|NCT02487771|592993091|FG001|Overall Study|Moved out of area|6|||
164172173|NCT02487771|592993090|FG000|Overall Study|Withdrawal by Subject|3|||
164172174|NCT02487771|592993091|FG001|Overall Study|Withdrawal by Subject|5|||
164172175|NCT01871402|592993092|FG000|Overall Study|Lost to Follow-up|1|||
164172176|NCT01871402|592993093|FG001|Overall Study|Lost to Follow-up|0|||
164172177|NCT01871402|592993092|FG000|Overall Study|Withdrawal by Subject|0|||
164172178|NCT01871402|592993093|FG001|Overall Study|Withdrawal by Subject|2|||
164172179|NCT01871402|592993092|FG000|Overall Study|Non-compliance|0|||
164172180|NCT01871402|592993093|FG001|Overall Study|Non-compliance|1|||
164172181|NCT04594941|592993094|FG000|Overall Study|Other|0|||
164172182|NCT04594941|592993095|FG001|Overall Study|Other|3|||
164172183|NCT04594941|592993096|FG002|Overall Study|Other|1|||
164172184|NCT04594941|592993097|FG003|Overall Study|Other|0|||
164172185|NCT04984681|592993098|FG000|Overall Study|Lost to Follow-up|3|||
164172186|NCT04984681|592993099|FG001|Overall Study|Lost to Follow-up|1|||
164172187|NCT04327661|592993100|FG000|Overall Study|Withdrawal by Subject|1|||
164172188|NCT04327661|592993101|FG001|Overall Study|Withdrawal by Subject|0|||
164172189|NCT04327661|592993102|FG002|Overall Study|Withdrawal by Subject|0|||
164172190|NCT02091960|592993103|FG000|Overall Study|Death|7|||
164172191|NCT02091960|592993103|FG000|Overall Study|Withdrawal by Subject|1|||
164172192|NCT02091960|592993103|FG000|Overall Study|Miscellaneous Reasons|37|||
164172193|NCT01942486|592993114|FG000|Overall Study|Lost to Follow-up|27|||
164172194|NCT03728426|592993115|FG000|Overall Study|Death|3|||
164172195|NCT02424630|592993118|FG000|Overall Study|No rotator cuff tear|1|||
164172196|NCT02424630|592993119|FG001|Overall Study|No rotator cuff tear|2|||
164172197|NCT02424630|592993118|FG000|Overall Study|Open procedure|0|||
164172198|NCT02424630|592993119|FG001|Overall Study|Open procedure|1|||
164172199|NCT02637895|592993120|FG000|Overall Study|Lost to Follow-up|4|||
164172200|NCT02637895|592993121|FG001|Overall Study|Lost to Follow-up|0|||
164172201|NCT02637895|592993120|FG000|Overall Study|Protocol Violation|0|||
164172202|NCT02637895|592993121|FG001|Overall Study|Protocol Violation|1|||
164172203|NCT02637895|592993120|FG000|Overall Study|Lack of Efficacy|1|||
164172204|NCT02637895|592993121|FG001|Overall Study|Lack of Efficacy|0|||
164172205|NCT02637895|592993120|FG000|Overall Study|Withdrawal by Subject|1|||
164172206|NCT02637895|592993121|FG001|Overall Study|Withdrawal by Subject|1|||
164172207|NCT02637895|592993120|FG000|Overall Study|Abnormal baseline lab|0|||
164172208|NCT02637895|592993121|FG001|Overall Study|Abnormal baseline lab|1|||
164172209|NCT01741792|592993124|FG000|Overall Study|Death|6|||
164172210|NCT01741792|592993125|FG001|Overall Study|Death|1|||
164172211|NCT01741792|592993126|FG002|Overall Study|Death|12|||
164172212|NCT01995175|592993127|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
164172213|NCT01995175|592993127|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
164172214|NCT01995175|592993127|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
164172215|NCT01995175|592993127|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
164172216|NCT01995175|592993127|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
164172217|NCT01995175|592993127|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
164172218|NCT01995175|592993127|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
164172219|NCT01995175|592993127|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
164172220|NCT01995175|592993127|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
164172221|NCT00984061|592993128|FG000|Clarithromycin Alone|Protocol Violation|1|||
164172222|NCT05139303|592993129|FG000|Overall Study|Lost to Follow-up|3|||
164172223|NCT05139303|592993130|FG001|Overall Study|Lost to Follow-up|0|||
164172224|NCT05139303|592993129|FG000|Overall Study|Adverse Event|1|||
164172225|NCT05139303|592993130|FG001|Overall Study|Adverse Event|0|||
164172226|NCT02045862|592993131|FG000|Overall Study|Death|0|||
164172227|NCT02045862|592993132|FG001|Overall Study|Death|0|||
164172228|NCT02045862|592993133|FG002|Overall Study|Death|1|||
164172229|NCT02045862|592993131|FG000|Overall Study|Miscellaneous|5|||
164172230|NCT02045862|592993132|FG001|Overall Study|Miscellaneous|0|||
164172231|NCT02045862|592993133|FG002|Overall Study|Miscellaneous|8|||
164172232|NCT02045862|592993131|FG000|Overall Study|Withdrawal by Patient|18|||
164172233|NCT02045862|592993132|FG001|Overall Study|Withdrawal by Patient|27|||
164172234|NCT02045862|592993133|FG002|Overall Study|Withdrawal by Patient|57|||
164172235|NCT02045862|592993131|FG000|Overall Study|Protocol Violation|0|||
164172236|NCT02045862|592993132|FG001|Overall Study|Protocol Violation|0|||
164172237|NCT02045862|592993133|FG002|Overall Study|Protocol Violation|6|||
164172238|NCT02045862|592993131|FG000|Overall Study|Lack of Efficacy|8|||
164172239|NCT02045862|592993132|FG001|Overall Study|Lack of Efficacy|4|||
164172240|NCT02045862|592993133|FG002|Overall Study|Lack of Efficacy|13|||
164172241|NCT02045862|592993131|FG000|Overall Study|Randomized but not Received Study Drug|0|||
164172242|NCT02045862|592993132|FG001|Overall Study|Randomized but not Received Study Drug|2|||
164172243|NCT02045862|592993133|FG002|Overall Study|Randomized but not Received Study Drug|8|||
164172244|NCT02045862|592993131|FG000|Overall Study|Adverse Event|7|||
164172245|NCT02045862|592993132|FG001|Overall Study|Adverse Event|5|||
164172246|NCT02045862|592993133|FG002|Overall Study|Adverse Event|27|||
164172247|NCT02045862|592993131|FG000|Overall Study|Lost to Follow-up|1|||
164172248|NCT02045862|592993132|FG001|Overall Study|Lost to Follow-up|2|||
164172249|NCT02045862|592993133|FG002|Overall Study|Lost to Follow-up|6|||
164172250|NCT02353442|592993138|FG000|Overall Study|Withdrawal by Subject|3|||
164172251|NCT02353442|592993139|FG001|Overall Study|Withdrawal by Subject|4|||
164172252|NCT01075646|592993142|FG000|Overall Study|Lost to Follow-up|4|||
164172253|NCT01075646|592993143|FG001|Overall Study|Lost to Follow-up|3|||
164172254|NCT01075646|592993144|FG002|Overall Study|Lost to Follow-up|1|||
164172255|NCT01075646|592993145|FG003|Overall Study|Lost to Follow-up|2|||
164172256|NCT05239494|592993149|FG000|Overall Study|Lost to Follow-up|1|||
164172257|NCT02855359|592993150|FG000|Overall Study|Death|2|||
164172258|NCT02855359|592993151|FG001|Overall Study|Death|2|||
164172259|NCT02855359|592993152|FG002|Overall Study|Death|0|||
164172260|NCT02855359|592993153|FG003|Overall Study|Death|0|||
164172261|NCT02855359|592993150|FG000|Overall Study|Study Termination by Sponsor|9|||
164172262|NCT02855359|592993151|FG001|Overall Study|Study Termination by Sponsor|11|||
164172263|NCT02855359|592993152|FG002|Overall Study|Study Termination by Sponsor|0|||
164172264|NCT02855359|592993153|FG003|Overall Study|Study Termination by Sponsor|0|||
164172265|NCT03155178|592993154|FG000|Overall Study|Did not meet treatment day baseline|7|||
164172266|NCT03155178|592993155|FG001|Overall Study|Did not meet treatment day baseline|7|||
164172267|NCT03155178|592993156|FG002|Overall Study|Did not meet treatment day baseline|7|||
164172268|NCT03155178|592993157|FG003|Overall Study|Did not meet treatment day baseline|7|||
164172269|NCT02677038|592993163|FG000|Overall Study|Physician Decision|1|||
164172270|NCT02677038|592993163|FG000|Overall Study|Withdrawal by Subject|1|||
164172271|NCT02777970|592993167|FG000|Overall Study|Lost to Follow-up|0|||
164172272|NCT02777970|592993168|FG001|Overall Study|Lost to Follow-up|1|||
164172273|NCT02777970|592993169|FG002|Overall Study|Lost to Follow-up|0|||
164172274|NCT02777970|592993167|FG000|Overall Study|Protocol Violation|1|||
164172275|NCT02777970|592993168|FG001|Overall Study|Protocol Violation|0|||
164172276|NCT02777970|592993169|FG002|Overall Study|Protocol Violation|0|||
164172277|NCT02541669|592993177|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
164172278|NCT02541669|592993178|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
164172279|NCT02541669|592993179|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
164172280|NCT02541669|592993180|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
164172281|NCT02541669|592993181|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
164172282|NCT00834639|592993182|FG000|Second Intervention|Physician Decision|0|||
164172283|NCT00834639|592993183|FG001|Second Intervention|Physician Decision|2|||
164172284|NCT04739722|592993187|FG000|Overall Study|Lost to Follow-up|5301|||
164172285|NCT04739722|592993187|FG000|Overall Study|Withdrawal by Subject|42|||
164172286|NCT04739722|592993187|FG000|Overall Study|Non Average-risk|1157|||
164172287|NCT02083185|592993194|FG000|Overall Study|Lost to Follow-up|0|||
164172288|NCT02083185|592993195|FG001|Overall Study|Lost to Follow-up|3|||
164172289|NCT02083185|592993196|FG002|Overall Study|Lost to Follow-up|0|||
164172290|NCT02083185|592993194|FG000|Overall Study|Withdrawal by Subject|9|||
164172291|NCT02083185|592993195|FG001|Overall Study|Withdrawal by Subject|15|||
164172292|NCT02083185|592993196|FG002|Overall Study|Withdrawal by Subject|1|||
164172294|NCT02083185|592993195|FG001|Overall Study|Death|2|||
164172295|NCT02083185|592993196|FG002|Overall Study|Death|1|||
164172296|NCT02083185|592993194|FG000|Overall Study|Reason not Specified|9|||
164172297|NCT02083185|592993195|FG001|Overall Study|Reason not Specified|6|||
164172298|NCT02083185|592993196|FG002|Overall Study|Reason not Specified|5|||
164172299|NCT02083185|592993194|FG000|Overall Study|Study Terminated by Sponsor|0|||
164172300|NCT02083185|592993195|FG001|Overall Study|Study Terminated by Sponsor|1|||
164172301|NCT02083185|592993196|FG002|Overall Study|Study Terminated by Sponsor|0|||
164172302|NCT02083185|592993194|FG000|Overall Study|Did not Receive Study Drug|0|||
164172303|NCT02083185|592993195|FG001|Overall Study|Did not Receive Study Drug|2|||
164172304|NCT02083185|592993196|FG002|Overall Study|Did not Receive Study Drug|0|||
164172305|NCT01322035|592993197|FG000|Overall Study|Lost to Follow-up|8|||
164172306|NCT01322035|592993198|FG001|Overall Study|Lost to Follow-up|3|||
164172307|NCT00535847|592993199|FG000|Overall Study|Adverse Event|5|||
164172308|NCT00535847|592993200|FG001|Overall Study|Adverse Event|3|||
164172309|NCT00535847|592993201|FG002|Overall Study|Adverse Event|2|||
164172310|NCT00535847|592993199|FG000|Overall Study|Non compliance|1|||
164172311|NCT00535847|592993200|FG001|Overall Study|Non compliance|1|||
164172312|NCT00535847|592993201|FG002|Overall Study|Non compliance|0|||
164172313|NCT00535847|592993199|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
164172314|NCT00535847|592993200|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
164172315|NCT00535847|592993201|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
164172316|NCT01546168|592993202|FG000|Overall Study|Lost to Follow-up|1|||
164172317|NCT01546168|592993203|FG001|Overall Study|Lost to Follow-up|0|||
164172318|NCT01546168|592993202|FG000|Overall Study|Withdrawal by Subject|1|||
164172319|NCT01546168|592993203|FG001|Overall Study|Withdrawal by Subject|0|||
164172320|NCT01546168|592993202|FG000|Overall Study|ineligible after signing consent|2|||
164172321|NCT01546168|592993203|FG001|Overall Study|ineligible after signing consent|0|||
164172322|NCT02850016|592993204|FG000|Overall Study|Withdrawal by Subject|1|||
164172323|NCT02850016|592993205|FG001|Overall Study|Withdrawal by Subject|2|||
164172324|NCT01054196|592993213|FG000|Overall Study|Physician Decision|0|||
164172325|NCT01054196|592993214|FG001|Overall Study|Physician Decision|0|||
164172326|NCT01054196|592993215|FG002|Overall Study|Physician Decision|0|||
164172327|NCT01054196|592993216|FG003|Overall Study|Physician Decision|1|||
164172328|NCT01054196|592993217|FG004|Overall Study|Physician Decision|0|||
164172329|NCT01054196|592993218|FG005|Overall Study|Physician Decision|0|||
164172330|NCT01054196|592993219|FG006|Overall Study|Physician Decision|1|||
164172331|NCT00478699|592993226|FG000|Overall Study|Inclusion Error|1|||
164172332|NCT00478699|592993227|FG001|Overall Study|Inclusion Error|7|||
164172333|NCT00478699|592993226|FG000|Overall Study|Not receive study treatment|6|||
164172334|NCT00478699|592993227|FG001|Overall Study|Not receive study treatment|30|||
164172335|NCT01508130|592993228|FG000|Overall Study|Adverse Event|81|||
164172336|NCT01508130|592993229|FG001|Overall Study|Adverse Event|28|||
164172337|NCT01508130|592993228|FG000|Overall Study|Death|3|||
164172338|NCT01508130|592993229|FG001|Overall Study|Death|1|||
164172339|NCT01508130|592993228|FG000|Overall Study|Protocol Violation|2|||
164172340|NCT01508130|592993229|FG001|Overall Study|Protocol Violation|0|||
164172341|NCT01508130|592993228|FG000|Overall Study|Lost to Follow-up|25|||
164172342|NCT01508130|592993229|FG001|Overall Study|Lost to Follow-up|2|||
164172343|NCT01508130|592993228|FG000|Overall Study|Withdrawal by Subject|3|||
164172344|NCT01508130|592993229|FG001|Overall Study|Withdrawal by Subject|3|||
164172345|NCT01508130|592993228|FG000|Overall Study|Subject's substantial non-compliance|25|||
164172346|NCT01508130|592993229|FG001|Overall Study|Subject's substantial non-compliance|9|||
164172347|NCT01508130|592993228|FG000|Overall Study|Insufficient therapeutic response|74|||
164172348|NCT01508130|592993229|FG001|Overall Study|Insufficient therapeutic response|23|||
164172349|NCT01508130|592993228|FG000|Overall Study|Administrative|14|||
164172350|NCT01508130|592993229|FG001|Overall Study|Administrative|3|||
164172351|NCT01880086|592993235|FG000|Overall Study|Lost to Follow-up|1|||
164172352|NCT01880086|592993236|FG001|Overall Study|Lost to Follow-up|1|||
164172353|NCT02288091|592993240|FG000|Overall Study|Lost to Follow-up|1|||
164172354|NCT02288091|592993240|FG000|Overall Study|Screen fail|7|||
164172355|NCT03843632|592993246|FG000|Overall Study|Withdrawal by Subject|1|||
164172356|NCT03843632|592993247|FG001|Overall Study|Withdrawal by Subject|0|||
164172357|NCT03843632|592993248|FG002|Overall Study|Withdrawal by Subject|0|||
164172358|NCT03843632|592993249|FG003|Overall Study|Withdrawal by Subject|0|||
164172359|NCT01820572|592993250|FG000|Randomization|Not Treated|2|||
164172360|NCT01820572|592993251|FG001|Randomization|Not Treated|1|||
164172361|NCT01820572|592993250|FG000|Treatment Period|Adverse Event|12|||
164172362|NCT01820572|592993251|FG001|Treatment Period|Adverse Event|7|||
164172363|NCT01820572|592993250|FG000|Treatment Period|Death|3|||
164172364|NCT01820572|592993251|FG001|Treatment Period|Death|3|||
164172365|NCT01820572|592993250|FG000|Treatment Period|Lack of Efficacy|1|||
164172366|NCT01820572|592993251|FG001|Treatment Period|Lack of Efficacy|0|||
164172367|NCT01820572|592993250|FG000|Treatment Period|poor/non compliance|0|||
164172368|NCT01820572|592993251|FG001|Treatment Period|poor/non compliance|3|||
164172369|NCT01820572|592993250|FG000|Treatment Period|request to discontinue|6|||
164172370|NCT01820572|592993251|FG001|Treatment Period|request to discontinue|11|||
164172371|NCT01820572|592993250|FG000|Treatment Period|No longer meets study criteria|3|||
164172372|NCT01820572|592993251|FG001|Treatment Period|No longer meets study criteria|10|||
164172373|NCT01820572|592993250|FG000|Treatment Period|withdrew consent|1|||
164172374|NCT01820572|592993251|FG001|Treatment Period|withdrew consent|2|||
164172375|NCT00595517|592993252|FG000|Overall Study|Adverse Event|6|||
164172376|NCT00595517|592993252|FG000|Overall Study|Withdrawal by Subject|4|||
164172377|NCT00595517|592993252|FG000|Overall Study|Protocol Violation|2|||
164172378|NCT00595517|592993252|FG000|Overall Study|Recurrence of ulcer|5|||
164172379|NCT00595517|592993252|FG000|Overall Study|usage of prohibited treatment|1|||
164172380|NCT00595517|592993252|FG000|Overall Study|No intention to attend regularly|1|||
164172381|NCT03852628|592993255|FG000|Overall Study|Lost to Follow-up|7|||
164172382|NCT03852628|592993256|FG001|Overall Study|Lost to Follow-up|6|||
164172383|NCT03852628|592993255|FG000|Overall Study|Lack of Efficacy|6|||
164172384|NCT03852628|592993256|FG001|Overall Study|Lack of Efficacy|6|||
164172385|NCT01931956|592993257|FG000|Overall Study|Death|42|||
164172386|NCT01931956|592993258|FG001|Overall Study|Death|7|||
164172387|NCT01931956|592993259|FG002|Overall Study|Death|379|||
164172388|NCT01931956|592993260|FG003|Overall Study|Death|96|||
164172389|NCT01931956|592993257|FG000|Overall Study|Withdrawal by Subject|5|||
164172390|NCT01931956|592993258|FG001|Overall Study|Withdrawal by Subject|0|||
164172391|NCT01931956|592993259|FG002|Overall Study|Withdrawal by Subject|70|||
164172392|NCT01931956|592993260|FG003|Overall Study|Withdrawal by Subject|30|||
164172393|NCT01931956|592993257|FG000|Overall Study|Lost to Follow-up|2|||
164172394|NCT01931956|592993258|FG001|Overall Study|Lost to Follow-up|0|||
164172395|NCT01931956|592993259|FG002|Overall Study|Lost to Follow-up|11|||
164172396|NCT01931956|592993260|FG003|Overall Study|Lost to Follow-up|7|||
164172397|NCT01931956|592993257|FG000|Overall Study|Expected|2|||
164172398|NCT01931956|592993258|FG001|Overall Study|Expected|0|||
164172399|NCT01931956|592993259|FG002|Overall Study|Expected|6|||
164172400|NCT01931956|592993260|FG003|Overall Study|Expected|0|||
164172401|NCT01931956|592993257|FG000|Overall Study|Not due|0|||
164172402|NCT01931956|592993258|FG001|Overall Study|Not due|0|||
164172403|NCT01931956|592993259|FG002|Overall Study|Not due|21|||
164172404|NCT01931956|592993260|FG003|Overall Study|Not due|0|||
164172405|NCT02600845|592993270|FG000|Overall Study|Reason Not Specified|3|||
164172406|NCT02600845|592993270|FG000|Overall Study|Non-compliance with Study Procedures|10|||
164172407|NCT02600845|592993270|FG000|Overall Study|Consent Withdrawal|5|||
164172408|NCT00197002|592995423|FG000|Overall Study|Adverse Event|0|||
164172409|NCT00197002|592995424|FG001|Overall Study|Adverse Event|1|||
164172410|NCT00197002|592995425|FG002|Overall Study|Adverse Event|0|||
164172411|NCT00197002|592995423|FG000|Overall Study|Protocol Violation|1|||
164172412|NCT00197002|592995424|FG001|Overall Study|Protocol Violation|0|||
164172413|NCT00197002|592995425|FG002|Overall Study|Protocol Violation|2|||
164172414|NCT00197002|592995423|FG000|Overall Study|Withdrawal by Subject|9|||
164172415|NCT00197002|592995424|FG001|Overall Study|Withdrawal by Subject|5|||
164172416|NCT00197002|592995425|FG002|Overall Study|Withdrawal by Subject|7|||
164172417|NCT00197002|592995423|FG000|Overall Study|Migrated/moved from study area|3|||
164172418|NCT00197002|592995424|FG001|Overall Study|Migrated/moved from study area|5|||
164172419|NCT00197002|592995425|FG002|Overall Study|Migrated/moved from study area|1|||
164172420|NCT00197002|592995423|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
164172421|NCT00197002|592995424|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
164172422|NCT00197002|592995425|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
164172423|NCT00197002|592995423|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
164172424|NCT00197002|592995424|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
164172425|NCT00197002|592995425|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
164172426|NCT00197002|592995423|FG000|Overall Study|Others|3|||
164172427|NCT00197002|592995424|FG001|Overall Study|Others|1|||
164172428|NCT00197002|592995425|FG002|Overall Study|Others|1|||
164172429|NCT05072106|592995428|FG000|Overall Study|Progressive disease|3|||
164172430|NCT05072106|592995429|FG001|Overall Study|Progressive disease|3|||
164172431|NCT05072106|592995428|FG000|Overall Study|Compassionate use|3|||
164172432|NCT05072106|592995429|FG001|Overall Study|Compassionate use|1|||
164172433|NCT05072106|592995428|FG000|Overall Study|Withdrawal by Subject|1|||
164172434|NCT05072106|592995429|FG001|Overall Study|Withdrawal by Subject|0|||
164172435|NCT03839459|592995430|FG000|Overall Study|Withdrawal by Subject|2|||
164172436|NCT03839459|592995430|FG000|Overall Study|progression of disease|3|||
164172437|NCT05376241|592995431|FG000|Overall Study|did not meet eligibility criteria after consenting|22|||
164172438|NCT05376241|592995431|FG000|Overall Study|103 did not complete the survey|103|||
164172439|NCT05376241|592995431|FG000|Overall Study|17 failed 2 attention check questions|17|||
164172440|NCT01632150|592995432|FG000|Overall Study|Disease progression|27|||
164172441|NCT01632150|592995432|FG000|Overall Study|Study drug toxicity|1|||
164172442|NCT01632150|592995432|FG000|Overall Study|Unrelated adverse event|7|||
164172443|NCT01632150|592995432|FG000|Overall Study|Withdrawal by Subject|2|||
164172444|NCT01632150|592995432|FG000|Overall Study|Patient underwent autologous transplant|1|||
164172445|NCT01632150|592995432|FG000|Overall Study|Moved to compassionate program|2|||
164172446|NCT02879994|592995435|FG000|Overall Study|off treatment early|7|||
164172447|NCT02879994|592995435|FG000|Overall Study|Adverse Event|2|||
164172448|NCT02879994|592995435|FG000|Overall Study|Death|2|||
164172449|NCT02143791|592995436|FG000|Enrolled|Withdrawal by Subject|4|||
164172450|NCT02143791|592995436|FG000|Trial Stimulation|Lack of Efficacy|21|||
164172451|NCT02143791|592995436|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
164172452|NCT02143791|592995436|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
164172453|NCT02143791|592995436|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
164172454|NCT02143791|592995436|FG000|Any Programming (3-6 Months)|Missing Data|1|||
164172455|NCT02143791|592995436|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
164172456|NCT00507819|592995444|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
164172457|NCT00507819|592995445|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
164172458|NCT02691013|592995448|FG000|Overall Study|Withdrawal by Subject|3|||
164172459|NCT02691013|592995449|FG001|Overall Study|Withdrawal by Subject|0|||
164172460|NCT02275780|592995452|FG000|Base Study: 96 Weeks|Adverse Event|6|||
164172461|NCT02275780|592995453|FG001|Base Study: 96 Weeks|Adverse Event|14|||
164172462|NCT02275780|592995452|FG000|Base Study: 96 Weeks|Death|3|||
164172463|NCT02275780|592995453|FG001|Base Study: 96 Weeks|Death|1|||
164172464|NCT02275780|592995452|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
164172465|NCT02275780|592995453|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
164172466|NCT02275780|592995452|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
164172467|NCT02275780|592995453|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
164172468|NCT02275780|592995452|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
164172469|NCT02275780|592995453|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
164172470|NCT02275780|592995452|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
164172471|NCT02275780|592995453|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
164172472|NCT02275780|592995452|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
164172473|NCT02275780|592995453|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
164172474|NCT02275780|592995452|FG000|Base Study: 96 Weeks|Physician Decision|2|||
164172475|NCT02275780|592995453|FG001|Base Study: 96 Weeks|Physician Decision|4|||
164172476|NCT02275780|592995452|FG000|Base Study: 96 Weeks|Pregnancy|2|||
164172477|NCT02275780|592995453|FG001|Base Study: 96 Weeks|Pregnancy|1|||
164172478|NCT02275780|592995452|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
164172479|NCT02275780|592995453|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
164172480|NCT02275780|592995452|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
164172481|NCT02275780|592995453|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
164172482|NCT02275780|592995452|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
164172483|NCT02275780|592995453|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
164172484|NCT02275780|592995452|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
164172485|NCT02275780|592995453|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
164172486|NCT02275780|592995452|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
164172487|NCT02275780|592995453|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
164172488|NCT02275780|592995452|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
164172489|NCT02275780|592995453|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
164172490|NCT02275780|592995452|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
164172491|NCT02275780|592995453|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
164172492|NCT02275780|592995452|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
164172493|NCT02275780|592995453|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
164172494|NCT02275780|592995452|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
164172495|NCT02275780|592995453|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
164172496|NCT02275780|592995452|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
164172497|NCT02275780|592995453|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
164172498|NCT02275780|592995452|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
164172499|NCT02275780|592995453|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
164172500|NCT02275780|592995452|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
164172501|NCT02275780|592995453|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
164172502|NCT02275780|592995452|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
164172503|NCT02275780|592995453|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
164172504|NCT02275780|592995452|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
164172505|NCT02275780|592995453|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
164172506|NCT02275780|592995452|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
164172507|NCT02275780|592995453|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
164172508|NCT02275780|592995452|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
164172509|NCT02275780|592995453|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
164172510|NCT02275780|592995452|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
164172511|NCT02275780|592995453|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
164172512|NCT02275780|592995452|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
164172513|NCT02275780|592995453|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
164172514|NCT02275780|592995452|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
164172515|NCT02275780|592995453|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
164172516|NCT02275780|592995452|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
164172517|NCT02275780|592995453|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
164172518|NCT02275780|592995452|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
164172519|NCT02275780|592995453|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
164172520|NCT02275780|592995452|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
164172521|NCT02275780|592995453|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
164172522|NCT00631410|592995456|FG000|Overall Study|Adverse Event|1|||
164172523|NCT00631410|592995457|FG001|Overall Study|Adverse Event|3|||
164172524|NCT00631410|592995456|FG000|Overall Study|Objective Progression or Relapse|4|||
164172525|NCT00631410|592995457|FG001|Overall Study|Objective Progression or Relapse|3|||
164172526|NCT00631410|592995456|FG000|Overall Study|Surgery|1|||
164172527|NCT00631410|592995457|FG001|Overall Study|Surgery|0|||
164172528|NCT03419598|592995459|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
164172529|NCT00380081|592995462|FG000|Overall Study|Withdrawal by Subject|0|||
164172530|NCT00380081|592995463|FG001|Overall Study|Withdrawal by Subject|0|||
164172531|NCT00380081|592995464|FG002|Overall Study|Withdrawal by Subject|0|||
164172532|NCT00380081|592995465|FG003|Overall Study|Withdrawal by Subject|0|||
164172533|NCT00380081|592995466|FG004|Overall Study|Withdrawal by Subject|1|||
164172534|NCT00380081|592995467|FG005|Overall Study|Withdrawal by Subject|0|||
164172535|NCT00380081|592995462|FG000|Overall Study|Family Emergency|0|||
164172536|NCT00380081|592995463|FG001|Overall Study|Family Emergency|0|||
164172537|NCT00380081|592995464|FG002|Overall Study|Family Emergency|0|||
164172538|NCT00380081|592995465|FG003|Overall Study|Family Emergency|0|||
164172539|NCT00380081|592995466|FG004|Overall Study|Family Emergency|0|||
164172540|NCT00380081|592995467|FG005|Overall Study|Family Emergency|1|||
164172541|NCT02231879|592995468|FG000|Overall Study|Adverse Event|2|||
164172542|NCT02231879|592995469|FG001|Overall Study|Adverse Event|1|||
164172543|NCT02231879|592995468|FG000|Overall Study|Lack of Efficacy|0|||
164172544|NCT02231879|592995469|FG001|Overall Study|Lack of Efficacy|1|||
164172545|NCT00189306|592995470|FG000|Treatment Period|Withdrawal by Subject|2|||
164172546|NCT00189306|592995470|FG000|Treatment Period|Adverse Event|2|||
164172547|NCT00189306|592995470|FG000|Treatment Period|Protocol Violation|1|||
164172548|NCT00189306|592995470|FG000|Posttreatment Period|Death|1|||
164172549|NCT00189306|592995470|FG000|Posttreatment Period|Withdrawal by Subject|2|||
164172550|NCT00189306|592995470|FG000|Posttreatment Period|Noncompliance|1|||
164172551|NCT00189306|592995470|FG000|Posttreatment Period|Target lesion excised|1|||
164172552|NCT00189306|592995470|FG000|Posttreatment Period|Protocol Violation|1|||
164172553|NCT00189306|592995470|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
164172554|NCT00189306|592995470|FG000|Posttreatment Period|Local skin reaction/sign|1|||
164172555|NCT00189306|592995470|FG000|Long-Term Follow-up|Adverse Event|2|||
164172556|NCT00189306|592995470|FG000|Long-Term Follow-up|Death|4|||
164172557|NCT00189306|592995470|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
164172558|NCT00189306|592995470|FG000|Long-Term Follow-up|Intercurrent disease|2|||
164172559|NCT00189306|592995470|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
164172560|NCT00189306|592995470|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
164172561|NCT03640481|592995471|FG000|Overall Study|Death|14|||
164172562|NCT03640481|592995472|FG001|Overall Study|Death|14|||
164172563|NCT03640481|592995473|FG002|Overall Study|Death|0|||
164172564|NCT03640481|592995474|FG003|Overall Study|Death|0|||
164172565|NCT03640481|592995471|FG000|Overall Study|Lost to Follow-up|2|||
164172566|NCT03640481|592995472|FG001|Overall Study|Lost to Follow-up|0|||
164172567|NCT03640481|592995473|FG002|Overall Study|Lost to Follow-up|0|||
164172568|NCT03640481|592995474|FG003|Overall Study|Lost to Follow-up|0|||
164172569|NCT03640481|592995471|FG000|Overall Study|Site terminated by sponsor|1|||
164172570|NCT03640481|592995472|FG001|Overall Study|Site terminated by sponsor|3|||
164172571|NCT03640481|592995473|FG002|Overall Study|Site terminated by sponsor|0|||
164172572|NCT03640481|592995474|FG003|Overall Study|Site terminated by sponsor|0|||
164172573|NCT03640481|592995471|FG000|Overall Study|Study terminated by sponsor|29|||
164172574|NCT03640481|592995472|FG001|Overall Study|Study terminated by sponsor|42|||
164172575|NCT03640481|592995473|FG002|Overall Study|Study terminated by sponsor|1|||
164172576|NCT03640481|592995474|FG003|Overall Study|Study terminated by sponsor|0|||
164172577|NCT03640481|592995471|FG000|Overall Study|Withdrawal by Subject|5|||
164172578|NCT03640481|592995472|FG001|Overall Study|Withdrawal by Subject|4|||
164172579|NCT03640481|592995473|FG002|Overall Study|Withdrawal by Subject|0|||
164172580|NCT03640481|592995474|FG003|Overall Study|Withdrawal by Subject|1|||
164172581|NCT03640481|592995471|FG000|Overall Study|Other|26|||
164172582|NCT03640481|592995472|FG001|Overall Study|Other|12|||
164172583|NCT03640481|592995473|FG002|Overall Study|Other|1|||
164172584|NCT03640481|592995474|FG003|Overall Study|Other|0|||
164172585|NCT03640481|592995471|FG000|Overall Study|Randomized, but not treated|1|||
164172586|NCT03640481|592995472|FG001|Overall Study|Randomized, but not treated|3|||
164172587|NCT03640481|592995473|FG002|Overall Study|Randomized, but not treated|0|||
164172588|NCT03640481|592995474|FG003|Overall Study|Randomized, but not treated|0|||
164172589|NCT00070018|592995477|FG000|Overall Study|Adverse Event|2|||
164172590|NCT00070018|592995477|FG000|Overall Study|Lack of Efficacy|1|||
164172591|NCT00070018|592995477|FG000|Overall Study|Withdrawal by Subject|1|||
164172592|NCT02939716|592995478|FG000|Overall Study|scanner failure|0|||
164172593|NCT02939716|592995479|FG001|Overall Study|scanner failure|0|||
164172594|NCT02939716|592995480|FG002|Overall Study|scanner failure|0|||
164172595|NCT02939716|592995481|FG003|Overall Study|scanner failure|1|||
164172596|NCT02939716|592995482|FG004|Overall Study|scanner failure|1|||
164172597|NCT02939716|592995483|FG005|Overall Study|scanner failure|1|||
164172598|NCT00574249|592995486|FG000|Overall Study|Adverse Event|6|||
164172599|NCT00574249|592995487|FG001|Overall Study|Adverse Event|18|||
164172600|NCT00574249|592995486|FG000|Overall Study|Lack of Efficacy|5|||
164172601|NCT00574249|592995487|FG001|Overall Study|Lack of Efficacy|3|||
164172602|NCT00574249|592995486|FG000|Overall Study|Lost to Follow-up|4|||
164172603|NCT00574249|592995487|FG001|Overall Study|Lost to Follow-up|3|||
164172604|NCT00574249|592995486|FG000|Overall Study|Protocol Violation|5|||
164172605|NCT00574249|592995487|FG001|Overall Study|Protocol Violation|2|||
164172606|NCT00574249|592995486|FG000|Overall Study|History of carcinoma|1|||
164172607|NCT00574249|592995487|FG001|Overall Study|History of carcinoma|0|||
164172608|NCT00574249|592995486|FG000|Overall Study|Withdrawal by Subject|3|||
164172609|NCT00574249|592995487|FG001|Overall Study|Withdrawal by Subject|0|||
164172610|NCT00574249|592995486|FG000|Overall Study|Physician Decision|1|||
164172611|NCT00574249|592995487|FG001|Overall Study|Physician Decision|0|||
164172612|NCT00574249|592995486|FG000|Overall Study|Pregnancy|1|||
164172613|NCT00574249|592995487|FG001|Overall Study|Pregnancy|0|||
164172614|NCT00574249|592995486|FG000|Overall Study|Excluded by company|0|||
164172615|NCT00574249|592995487|FG001|Overall Study|Excluded by company|1|||
164172616|NCT00574249|592995486|FG000|Overall Study|PPD test taken twice|0|||
164172617|NCT00574249|592995487|FG001|Overall Study|PPD test taken twice|1|||
164172618|NCT03197870|592995488|FG000|Overall Study|Adverse Event|9|||
164172619|NCT03197870|592995489|FG001|Overall Study|Adverse Event|4|||
164172620|NCT03197870|592995490|FG002|Overall Study|Adverse Event|6|||
164172621|NCT03197870|592995488|FG000|Overall Study|Withdrawal by Subject|2|||
164172622|NCT03197870|592995489|FG001|Overall Study|Withdrawal by Subject|3|||
164172623|NCT03197870|592995490|FG002|Overall Study|Withdrawal by Subject|0|||
164172624|NCT03197870|592995488|FG000|Overall Study|Lost to Follow-up|2|||
164172625|NCT03197870|592995489|FG001|Overall Study|Lost to Follow-up|2|||
164172626|NCT03197870|592995490|FG002|Overall Study|Lost to Follow-up|0|||
164172627|NCT03197870|592995488|FG000|Overall Study|data not available|1|||
164172628|NCT03197870|592995489|FG001|Overall Study|data not available|1|||
164172629|NCT03197870|592995490|FG002|Overall Study|data not available|0|||
164172630|NCT01618019|592995492|FG000|Overall Study|Withdrawal by Subject|14|||
164172631|NCT01618019|592995493|FG001|Overall Study|Withdrawal by Subject|14|||
164172632|NCT01542034|592995494|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
164172633|NCT01542034|592995495|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
164172634|NCT01542034|592995494|FG000|Overall Study|Administrative decision|0|||
164172635|NCT01542034|592995495|FG001|Overall Study|Administrative decision|3|||
164172636|NCT01542034|592995494|FG000|Overall Study|Subject Noncompliance|1|||
164172637|NCT01542034|592995495|FG001|Overall Study|Subject Noncompliance|0|||
164172638|NCT01542034|592995494|FG000|Overall Study|Adverse Event|2|||
164172639|NCT01542034|592995495|FG001|Overall Study|Adverse Event|2|||
164172640|NCT01542034|592995494|FG000|Overall Study|Lost to Follow-up|7|||
164172641|NCT01542034|592995495|FG001|Overall Study|Lost to Follow-up|6|||
164172642|NCT02612610|592995496|FG000|Overall Study|Withdrawal by Subject|1|||
164172643|NCT02612610|592995497|FG001|Overall Study|Withdrawal by Subject|1|||
164172644|NCT02612610|592995498|FG002|Overall Study|Withdrawal by Subject|0|||
164172645|NCT02612610|592995499|FG003|Overall Study|Withdrawal by Subject|2|||
164172646|NCT02612610|592995496|FG000|Overall Study|Adverse Event|2|||
164172647|NCT02612610|592995497|FG001|Overall Study|Adverse Event|2|||
164172648|NCT02612610|592995498|FG002|Overall Study|Adverse Event|3|||
164172649|NCT02612610|592995499|FG003|Overall Study|Adverse Event|10|||
164172650|NCT02612610|592995496|FG000|Overall Study|Lost to Follow-up|0|||
164172651|NCT02612610|592995497|FG001|Overall Study|Lost to Follow-up|1|||
164172652|NCT02612610|592995498|FG002|Overall Study|Lost to Follow-up|0|||
164172653|NCT02612610|592995499|FG003|Overall Study|Lost to Follow-up|0|||
164172654|NCT02612610|592995496|FG000|Overall Study|Protocol Violation|0|||
164172655|NCT02612610|592995497|FG001|Overall Study|Protocol Violation|1|||
164172656|NCT02612610|592995498|FG002|Overall Study|Protocol Violation|1|||
164172657|NCT02612610|592995499|FG003|Overall Study|Protocol Violation|0|||
164172658|NCT02612610|592995496|FG000|Overall Study|Lack of Efficacy|1|||
164172659|NCT02612610|592995497|FG001|Overall Study|Lack of Efficacy|2|||
164172660|NCT02612610|592995498|FG002|Overall Study|Lack of Efficacy|0|||
164172661|NCT02612610|592995499|FG003|Overall Study|Lack of Efficacy|1|||
164172662|NCT02612610|592995496|FG000|Overall Study|Physician Decision|0|||
164172663|NCT02612610|592995497|FG001|Overall Study|Physician Decision|1|||
164172664|NCT02612610|592995498|FG002|Overall Study|Physician Decision|0|||
164172665|NCT02612610|592995499|FG003|Overall Study|Physician Decision|0|||
164172666|NCT02612610|592995496|FG000|Overall Study|Noncompliance|1|||
164172667|NCT02612610|592995497|FG001|Overall Study|Noncompliance|0|||
164172668|NCT02612610|592995498|FG002|Overall Study|Noncompliance|0|||
164172669|NCT02612610|592995499|FG003|Overall Study|Noncompliance|0|||
164172670|NCT02612610|592995496|FG000|Overall Study|Cough Improvement|0|||
164172671|NCT02612610|592995497|FG001|Overall Study|Cough Improvement|0|||
164172672|NCT02612610|592995498|FG002|Overall Study|Cough Improvement|1|||
164172673|NCT02612610|592995499|FG003|Overall Study|Cough Improvement|0|||
164172674|NCT01546571|592995502|FG000|Overall Study|Adverse Event|1|||
164172675|NCT01546571|592995503|FG001|Overall Study|Adverse Event|0|||
164172676|NCT01546571|592995504|FG002|Overall Study|Adverse Event|0|||
164172677|NCT01546571|592995505|FG003|Overall Study|Adverse Event|1|||
164172678|NCT01546571|592995506|FG004|Overall Study|Adverse Event|0|||
164172679|NCT01546571|592995502|FG000|Overall Study|assigned placebo in Part A|0|||
164172680|NCT01546571|592995503|FG001|Overall Study|assigned placebo in Part A|0|||
164172681|NCT01546571|592995504|FG002|Overall Study|assigned placebo in Part A|22|||
164172682|NCT01546571|592995505|FG003|Overall Study|assigned placebo in Part A|0|||
164172683|NCT01546571|592995506|FG004|Overall Study|assigned placebo in Part A|0|||
164172684|NCT01546571|592995502|FG000|Overall Study|Death|0|||
164172685|NCT01546571|592995503|FG001|Overall Study|Death|1|||
164172686|NCT01546571|592995504|FG002|Overall Study|Death|0|||
164172687|NCT01546571|592995505|FG003|Overall Study|Death|0|||
164172688|NCT01546571|592995506|FG004|Overall Study|Death|0|||
164172689|NCT01546571|592995502|FG000|Overall Study|Lost to Follow-up|0|||
164172690|NCT01546571|592995503|FG001|Overall Study|Lost to Follow-up|0|||
164172691|NCT01546571|592995504|FG002|Overall Study|Lost to Follow-up|2|||
164172692|NCT01546571|592995505|FG003|Overall Study|Lost to Follow-up|2|||
164172693|NCT01546571|592995506|FG004|Overall Study|Lost to Follow-up|3|||
164172694|NCT01546571|592995502|FG000|Overall Study|Pregnancy|0|||
164172695|NCT01546571|592995503|FG001|Overall Study|Pregnancy|0|||
164172696|NCT01546571|592995504|FG002|Overall Study|Pregnancy|0|||
164172697|NCT01546571|592995505|FG003|Overall Study|Pregnancy|1|||
164172698|NCT01546571|592995506|FG004|Overall Study|Pregnancy|0|||
164172699|NCT01546571|592995502|FG000|Overall Study|Disease Progression|20|||
164172700|NCT01546571|592995503|FG001|Overall Study|Disease Progression|18|||
164172701|NCT01546571|592995504|FG002|Overall Study|Disease Progression|15|||
164172702|NCT01546571|592995505|FG003|Overall Study|Disease Progression|73|||
164172703|NCT01546571|592995506|FG004|Overall Study|Disease Progression|37|||
164172704|NCT01546571|592995502|FG000|Overall Study|Withdrawal by Subject|1|||
164172705|NCT01546571|592995503|FG001|Overall Study|Withdrawal by Subject|2|||
164172706|NCT01546571|592995504|FG002|Overall Study|Withdrawal by Subject|4|||
164172707|NCT01546571|592995505|FG003|Overall Study|Withdrawal by Subject|9|||
164172708|NCT01546571|592995506|FG004|Overall Study|Withdrawal by Subject|2|||
164172709|NCT01546571|592995502|FG000|Overall Study|Intercurrent Illness|1|||
164172710|NCT01546571|592995503|FG001|Overall Study|Intercurrent Illness|2|||
164172711|NCT01546571|592995504|FG002|Overall Study|Intercurrent Illness|0|||
164172712|NCT01546571|592995505|FG003|Overall Study|Intercurrent Illness|0|||
164172713|NCT01546571|592995506|FG004|Overall Study|Intercurrent Illness|0|||
164172714|NCT01546571|592995502|FG000|Overall Study|Other Cancers|0|||
164172715|NCT01546571|592995503|FG001|Overall Study|Other Cancers|0|||
164172716|NCT01546571|592995504|FG002|Overall Study|Other Cancers|0|||
164172717|NCT01546571|592995505|FG003|Overall Study|Other Cancers|3|||
164172718|NCT01546571|592995506|FG004|Overall Study|Other Cancers|1|||
164172719|NCT01546571|592995502|FG000|Overall Study|Other|0|||
164172720|NCT01546571|592995503|FG001|Overall Study|Other|0|||
164172721|NCT01546571|592995504|FG002|Overall Study|Other|3|||
164172722|NCT01546571|592995505|FG003|Overall Study|Other|0|||
164172723|NCT01546571|592995506|FG004|Overall Study|Other|0|||
164172724|NCT00387010|592995509|FG000|Dose Titration Period|Adverse Event|12|||
164172725|NCT00387010|592995509|FG000|Dose Titration Period|Lack of Efficacy|5|||
164172726|NCT00387010|592995509|FG000|Dose Titration Period|Withdrawal by Subject|3|||
164172727|NCT00387010|592995509|FG000|Dose Titration Period|Protocol Violation|1|||
164172728|NCT00387010|592995509|FG000|Dose Titration Period|Lost to Follow-up|2|||
164172729|NCT00387010|592995509|FG000|Dose Titration Period|Noncompliance with study medication|8|||
164172730|NCT00387010|592995509|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
164172731|NCT00387010|592995509|FG000|Treatment Period|Adverse Event|4|||
164172732|NCT00387010|592995509|FG000|Treatment Period|Withdrawal by Subject|1|||
164172733|NCT00387010|592995509|FG000|Treatment Period|Noncompliance with study medication|2|||
164172734|NCT00387010|592995509|FG000|Treatment Period|Noncompliance with study procedures|3|||
164172735|NCT00387010|592995509|FG000|Treatment Period|Participant reported study drug stolen|1|||
164172736|NCT00430352|592995510|FG000|Overall Study|Disease progression|58|||
164172737|NCT00430352|592995510|FG000|Overall Study|Withdrawal by Subject|11|||
164172738|NCT00430352|592995510|FG000|Overall Study|Adverse Event|16|||
164172739|NCT00430352|592995510|FG000|Overall Study|Death|5|||
164172740|NCT00430352|592995510|FG000|Overall Study|Other|48|||
164172741|NCT03099694|592995511|FG000|Overall Study|Withdrawal by Subject|11|||
164172742|NCT03099694|592995512|FG001|Overall Study|Withdrawal by Subject|13|||
164172743|NCT03099694|592995511|FG000|Overall Study|Lost to Follow-up|9|||
164172744|NCT03099694|592995512|FG001|Overall Study|Lost to Follow-up|5|||
164172745|NCT04326439|592995513|FG000|Overall Study|Withdrawal by Subject|1|||
164172746|NCT04326439|592995514|FG001|Overall Study|Withdrawal by Subject|0|||
164172747|NCT04326439|592995513|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
164172748|NCT04326439|592995514|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
164172749|NCT04326439|592995513|FG000|Overall Study|Relapse after Induction 2|0|||
164172750|NCT04326439|592995514|FG001|Overall Study|Relapse after Induction 2|1|||
164172751|NCT04326439|592995513|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
164172752|NCT04326439|592995514|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
164172753|NCT01167881|592995516|FG000|Overall Study|Adverse Event|47|||
164172754|NCT01167881|592995517|FG001|Overall Study|Adverse Event|51|||
164172755|NCT01167881|592995516|FG000|Overall Study|Lack of Efficacy|4|||
164172756|NCT01167881|592995517|FG001|Overall Study|Lack of Efficacy|7|||
164172757|NCT01167881|592995516|FG000|Overall Study|Non compliant with protocol|9|||
164172758|NCT01167881|592995517|FG001|Overall Study|Non compliant with protocol|18|||
164172759|NCT01167881|592995516|FG000|Overall Study|Lost to Follow-up|19|||
164172760|NCT01167881|592995517|FG001|Overall Study|Lost to Follow-up|20|||
164172761|NCT01167881|592995516|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
164172762|NCT01167881|592995517|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
164172763|NCT01167881|592995516|FG000|Overall Study|Not treated|4|||
164172764|NCT01167881|592995517|FG001|Overall Study|Not treated|0|||
164172765|NCT01167881|592995516|FG000|Overall Study|Other not defined above|31|||
164172766|NCT01167881|592995517|FG001|Overall Study|Other not defined above|55|||
164172767|NCT00471718|592995520|FG000|Overall Study|Adverse Event|3|||
164172768|NCT00471718|592995520|FG000|Overall Study|other complicating disease|1|||
164172769|NCT00471718|592995520|FG000|Overall Study|disease progression|22|||
164172770|NCT00471718|592995520|FG000|Overall Study|Withdrawal by Subject|1|||
164172771|NCT01446237|592995521|FG000|Overall Study|Adverse Event|1|||
164172772|NCT01446237|592995521|FG000|Overall Study|Lost to Follow-up|2|||
164172773|NCT01446237|592995521|FG000|Overall Study|Withdrawal by Subject|7|||
164172774|NCT02294175|592995533|FG000|Overall Study|Withdrawal by Subject|1|||
164172775|NCT02294175|592995534|FG001|Overall Study|Withdrawal by Subject|2|||
164172776|NCT02294175|592995533|FG000|Overall Study|pt taking excluded medication|3|||
164172777|NCT02294175|592995534|FG001|Overall Study|pt taking excluded medication|1|||
164172778|NCT02294175|592995533|FG000|Overall Study|Protocol Violation|1|||
164172779|NCT02294175|592995534|FG001|Overall Study|Protocol Violation|0|||
164172780|NCT02294175|592995533|FG000|Overall Study|Lost to Follow-up|0|||
164172781|NCT02294175|592995534|FG001|Overall Study|Lost to Follow-up|1|||
164172782|NCT02294175|592995533|FG000|Overall Study|wound healed|0|||
164172783|NCT02294175|592995534|FG001|Overall Study|wound healed|2|||
164172784|NCT01901653|592995535|FG000|Overall Study|Death|2|||
164172785|NCT01901653|592995536|FG001|Overall Study|Death|1|||
164172786|NCT01901653|592995537|FG002|Overall Study|Death|8|||
164172787|NCT01901653|592995538|FG003|Overall Study|Death|3|||
164172788|NCT01901653|592995539|FG004|Overall Study|Death|2|||
164172789|NCT01901653|592995540|FG005|Overall Study|Death|2|||
164172790|NCT01901653|592995541|FG006|Overall Study|Death|6|||
164172791|NCT01901653|592995542|FG007|Overall Study|Death|9|||
164172792|NCT01901653|592995543|FG008|Overall Study|Death|1|||
164172793|NCT01901653|592995544|FG009|Overall Study|Death|16|||
164172794|NCT01901653|592995545|FG010|Overall Study|Death|2|||
164172795|NCT01901653|592995546|FG011|Overall Study|Death|15|||
164172796|NCT01901653|592995547|FG012|Overall Study|Death|4|||
164172797|NCT01901653|592995535|FG000|Overall Study|Lost to Follow-up|1|||
164172798|NCT01901653|592995536|FG001|Overall Study|Lost to Follow-up|0|||
164172799|NCT01901653|592995537|FG002|Overall Study|Lost to Follow-up|2|||
164172800|NCT01901653|592995538|FG003|Overall Study|Lost to Follow-up|0|||
164172801|NCT01901653|592995539|FG004|Overall Study|Lost to Follow-up|0|||
164172802|NCT01901653|592995540|FG005|Overall Study|Lost to Follow-up|1|||
164172803|NCT01901653|592995541|FG006|Overall Study|Lost to Follow-up|0|||
164172804|NCT01901653|592995542|FG007|Overall Study|Lost to Follow-up|1|||
164172805|NCT01901653|592995543|FG008|Overall Study|Lost to Follow-up|0|||
164172806|NCT01901653|592995544|FG009|Overall Study|Lost to Follow-up|0|||
164172807|NCT01901653|592995545|FG010|Overall Study|Lost to Follow-up|0|||
164172808|NCT01901653|592995546|FG011|Overall Study|Lost to Follow-up|0|||
164172809|NCT01901653|592995547|FG012|Overall Study|Lost to Follow-up|0|||
164172810|NCT01901653|592995535|FG000|Overall Study|Withdrawal by Subject|0|||
164172811|NCT01901653|592995536|FG001|Overall Study|Withdrawal by Subject|0|||
164172812|NCT01901653|592995537|FG002|Overall Study|Withdrawal by Subject|0|||
164172813|NCT01901653|592995538|FG003|Overall Study|Withdrawal by Subject|0|||
164172814|NCT01901653|592995539|FG004|Overall Study|Withdrawal by Subject|0|||
164172815|NCT01901653|592995540|FG005|Overall Study|Withdrawal by Subject|0|||
164172816|NCT01901653|592995541|FG006|Overall Study|Withdrawal by Subject|1|||
164172817|NCT01901653|592995542|FG007|Overall Study|Withdrawal by Subject|0|||
164172818|NCT01901653|592995543|FG008|Overall Study|Withdrawal by Subject|0|||
164172819|NCT01901653|592995544|FG009|Overall Study|Withdrawal by Subject|0|||
164172820|NCT01901653|592995545|FG010|Overall Study|Withdrawal by Subject|0|||
164172821|NCT01901653|592995546|FG011|Overall Study|Withdrawal by Subject|0|||
164172822|NCT01901653|592995547|FG012|Overall Study|Withdrawal by Subject|0|||
164172823|NCT01901653|592995535|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
164172824|NCT01901653|592995536|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
164172825|NCT01901653|592995537|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
164172826|NCT01901653|592995538|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
164172827|NCT01901653|592995539|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
164172828|NCT01901653|592995540|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
164172829|NCT01901653|592995541|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
164172830|NCT01901653|592995542|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
164172831|NCT01901653|592995543|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
164172832|NCT01901653|592995544|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
164172833|NCT01901653|592995545|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
164172834|NCT01901653|592995546|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
164172835|NCT01901653|592995547|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
164172836|NCT02548351|592995548|FG000|Overall Study|Withdrawal by Subject|149|||
164172837|NCT02548351|592995549|FG001|Overall Study|Withdrawal by Subject|154|||
164172838|NCT02548351|592995550|FG002|Overall Study|Withdrawal by Subject|152|||
164172839|NCT02548351|592995548|FG000|Overall Study|Death|11|||
164172840|NCT02548351|592995549|FG001|Overall Study|Death|15|||
164172841|NCT02548351|592995550|FG002|Overall Study|Death|12|||
164172842|NCT02548351|592995548|FG000|Overall Study|Adverse Event|22|||
164172843|NCT02548351|592995549|FG001|Overall Study|Adverse Event|56|||
164172844|NCT02548351|592995550|FG002|Overall Study|Adverse Event|36|||
164172845|NCT02548351|592995548|FG000|Overall Study|Study Terminated by Sponsor|549|||
164172846|NCT02548351|592995549|FG001|Overall Study|Study Terminated by Sponsor|509|||
164172847|NCT02548351|592995550|FG002|Overall Study|Study Terminated by Sponsor|528|||
164172848|NCT02548351|592995548|FG000|Overall Study|Site Closure|14|||
164172849|NCT02548351|592995549|FG001|Overall Study|Site Closure|5|||
164172850|NCT02548351|592995550|FG002|Overall Study|Site Closure|7|||
164172851|NCT02548351|592995548|FG000|Overall Study|Non-compliance with Study Drug|4|||
164172852|NCT02548351|592995549|FG001|Overall Study|Non-compliance with Study Drug|2|||
164172853|NCT02548351|592995550|FG002|Overall Study|Non-compliance with Study Drug|0|||
164172854|NCT02548351|592995548|FG000|Overall Study|Protocol Violation|2|||
164172855|NCT02548351|592995549|FG001|Overall Study|Protocol Violation|1|||
164172856|NCT02548351|592995550|FG002|Overall Study|Protocol Violation|2|||
164172857|NCT02548351|592995548|FG000|Overall Study|Physician Decision|11|||
164172858|NCT02548351|592995549|FG001|Overall Study|Physician Decision|18|||
164172859|NCT02548351|592995550|FG002|Overall Study|Physician Decision|11|||
164172860|NCT02548351|592995548|FG000|Overall Study|Lost to Follow-up|43|||
164172861|NCT02548351|592995549|FG001|Overall Study|Lost to Follow-up|50|||
164172862|NCT02548351|592995550|FG002|Overall Study|Lost to Follow-up|57|||
164172863|NCT02548351|592995548|FG000|Overall Study|Other|19|||
164172864|NCT02548351|592995549|FG001|Overall Study|Other|16|||
164172865|NCT02548351|592995550|FG002|Overall Study|Other|20|||
164172866|NCT02548351|592995548|FG000|Overall Study|Missing|1|||
164172867|NCT02548351|592995549|FG001|Overall Study|Missing|1|||
164172868|NCT02548351|592995550|FG002|Overall Study|Missing|0|||
164172869|NCT01668173|592995551|FG000|Overall Study|Adverse Event|3|||
164172870|NCT01668173|592995551|FG000|Overall Study|Trial suspension|4|||
164172871|NCT01295827|592995552|FG000|Overall Study|Adverse Event|1|||
164172872|NCT01295827|592995553|FG001|Overall Study|Adverse Event|2|||
164172873|NCT01295827|592995554|FG002|Overall Study|Adverse Event|2|||
164172874|NCT01295827|592995555|FG003|Overall Study|Adverse Event|1|||
164172875|NCT01295827|592995556|FG004|Overall Study|Adverse Event|1|||
164172876|NCT01295827|592995557|FG005|Overall Study|Adverse Event|4|||
164172877|NCT01295827|592995558|FG006|Overall Study|Adverse Event|15|||
164172878|NCT01295827|592995559|FG007|Overall Study|Adverse Event|49|||
164172879|NCT01295827|592995560|FG008|Overall Study|Adverse Event|22|||
164172880|NCT01295827|592995561|FG009|Overall Study|Adverse Event|7|||
164172881|NCT01295827|592995562|FG010|Overall Study|Adverse Event|50|||
164172882|NCT01295827|592995563|FG011|Overall Study|Adverse Event|21|||
164172883|NCT01295827|592995564|FG012|Overall Study|Adverse Event|0|||
164172884|NCT01295827|592995565|FG013|Overall Study|Adverse Event|0|||
164172885|NCT01295827|592995566|FG014|Overall Study|Adverse Event|0|||
164172886|NCT01295827|592995552|FG000|Overall Study|Lost to Follow-up|0|||
164172887|NCT01295827|592995553|FG001|Overall Study|Lost to Follow-up|0|||
164172888|NCT01295827|592995554|FG002|Overall Study|Lost to Follow-up|3|||
164172889|NCT01295827|592995555|FG003|Overall Study|Lost to Follow-up|0|||
164172890|NCT01295827|592995556|FG004|Overall Study|Lost to Follow-up|1|||
164172891|NCT01295827|592995557|FG005|Overall Study|Lost to Follow-up|0|||
164172892|NCT01295827|592995558|FG006|Overall Study|Lost to Follow-up|4|||
164172893|NCT01295827|592995559|FG007|Overall Study|Lost to Follow-up|8|||
164172894|NCT01295827|592995560|FG008|Overall Study|Lost to Follow-up|7|||
164172895|NCT01295827|592995561|FG009|Overall Study|Lost to Follow-up|4|||
164172896|NCT01295827|592995562|FG010|Overall Study|Lost to Follow-up|7|||
164172897|NCT01295827|592995563|FG011|Overall Study|Lost to Follow-up|3|||
164172898|NCT01295827|592995564|FG012|Overall Study|Lost to Follow-up|0|||
164172899|NCT01295827|592995565|FG013|Overall Study|Lost to Follow-up|0|||
164172900|NCT01295827|592995566|FG014|Overall Study|Lost to Follow-up|0|||
164172901|NCT01295827|592995552|FG000|Overall Study|Not Reported|0|||
164172902|NCT01295827|592995553|FG001|Overall Study|Not Reported|0|||
164172903|NCT01295827|592995554|FG002|Overall Study|Not Reported|0|||
164172904|NCT01295827|592995555|FG003|Overall Study|Not Reported|1|||
164172905|NCT01295827|592995556|FG004|Overall Study|Not Reported|0|||
164172906|NCT01295827|592995557|FG005|Overall Study|Not Reported|0|||
164172907|NCT01295827|592995558|FG006|Overall Study|Not Reported|24|||
164172908|NCT01295827|592995559|FG007|Overall Study|Not Reported|58|||
164172909|NCT01295827|592995560|FG008|Overall Study|Not Reported|41|||
164172910|NCT01295827|592995561|FG009|Overall Study|Not Reported|2|||
164172911|NCT01295827|592995562|FG010|Overall Study|Not Reported|23|||
164172912|NCT01295827|592995563|FG011|Overall Study|Not Reported|13|||
164172913|NCT01295827|592995564|FG012|Overall Study|Not Reported|0|||
164172914|NCT01295827|592995565|FG013|Overall Study|Not Reported|0|||
164172915|NCT01295827|592995566|FG014|Overall Study|Not Reported|0|||
164172916|NCT01295827|592995552|FG000|Overall Study|Progressive Disease|2|||
164172917|NCT01295827|592995553|FG001|Overall Study|Progressive Disease|1|||
164172918|NCT01295827|592995554|FG002|Overall Study|Progressive Disease|5|||
164172919|NCT01295827|592995555|FG003|Overall Study|Progressive Disease|2|||
164172920|NCT01295827|592995556|FG004|Overall Study|Progressive Disease|0|||
164172921|NCT01295827|592995557|FG005|Overall Study|Progressive Disease|1|||
164172922|NCT01295827|592995558|FG006|Overall Study|Progressive Disease|87|||
164172923|NCT01295827|592995559|FG007|Overall Study|Progressive Disease|144|||
164172924|NCT01295827|592995560|FG008|Overall Study|Progressive Disease|85|||
164172925|NCT01295827|592995561|FG009|Overall Study|Progressive Disease|40|||
164172926|NCT01295827|592995562|FG010|Overall Study|Progressive Disease|175|||
164172927|NCT01295827|592995563|FG011|Overall Study|Progressive Disease|136|||
164172928|NCT01295827|592995564|FG012|Overall Study|Progressive Disease|0|||
164172929|NCT01295827|592995565|FG013|Overall Study|Progressive Disease|0|||
164172930|NCT01295827|592995566|FG014|Overall Study|Progressive Disease|0|||
164172931|NCT01295827|592995552|FG000|Overall Study|Screen Failure|0|||
164172932|NCT01295827|592995553|FG001|Overall Study|Screen Failure|0|||
164172933|NCT01295827|592995554|FG002|Overall Study|Screen Failure|0|||
164172934|NCT01295827|592995555|FG003|Overall Study|Screen Failure|0|||
164172935|NCT01295827|592995556|FG004|Overall Study|Screen Failure|0|||
164172936|NCT01295827|592995557|FG005|Overall Study|Screen Failure|0|||
164172937|NCT01295827|592995558|FG006|Overall Study|Screen Failure|2|||
164172938|NCT01295827|592995559|FG007|Overall Study|Screen Failure|2|||
164172939|NCT01295827|592995560|FG008|Overall Study|Screen Failure|2|||
164172940|NCT01295827|592995561|FG009|Overall Study|Screen Failure|0|||
164172941|NCT01295827|592995562|FG010|Overall Study|Screen Failure|1|||
164172942|NCT01295827|592995563|FG011|Overall Study|Screen Failure|0|||
164172943|NCT01295827|592995564|FG012|Overall Study|Screen Failure|0|||
164172944|NCT01295827|592995565|FG013|Overall Study|Screen Failure|0|||
164172945|NCT01295827|592995566|FG014|Overall Study|Screen Failure|0|||
164172946|NCT01295827|592995552|FG000|Overall Study|Withdrawal by Subject|1|||
164172947|NCT01295827|592995553|FG001|Overall Study|Withdrawal by Subject|0|||
164172948|NCT01295827|592995554|FG002|Overall Study|Withdrawal by Subject|2|||
164172949|NCT01295827|592995555|FG003|Overall Study|Withdrawal by Subject|0|||
164172950|NCT01295827|592995556|FG004|Overall Study|Withdrawal by Subject|0|||
164172951|NCT01295827|592995557|FG005|Overall Study|Withdrawal by Subject|1|||
164172952|NCT01295827|592995558|FG006|Overall Study|Withdrawal by Subject|13|||
164172953|NCT01295827|592995559|FG007|Overall Study|Withdrawal by Subject|35|||
164172954|NCT01295827|592995560|FG008|Overall Study|Withdrawal by Subject|11|||
164172955|NCT01295827|592995561|FG009|Overall Study|Withdrawal by Subject|2|||
164172956|NCT01295827|592995562|FG010|Overall Study|Withdrawal by Subject|18|||
164172957|NCT01295827|592995563|FG011|Overall Study|Withdrawal by Subject|13|||
164172958|NCT01295827|592995564|FG012|Overall Study|Withdrawal by Subject|0|||
164172959|NCT01295827|592995565|FG013|Overall Study|Withdrawal by Subject|0|||
164172960|NCT01295827|592995566|FG014|Overall Study|Withdrawal by Subject|0|||
164172961|NCT01295827|592995552|FG000|Overall Study|Other|0|||
164172962|NCT01295827|592995553|FG001|Overall Study|Other|0|||
164172963|NCT01295827|592995554|FG002|Overall Study|Other|0|||
164172964|NCT01295827|592995555|FG003|Overall Study|Other|0|||
164172965|NCT01295827|592995556|FG004|Overall Study|Other|0|||
164172966|NCT01295827|592995557|FG005|Overall Study|Other|0|||
164172967|NCT01295827|592995558|FG006|Overall Study|Other|1|||
164172968|NCT01295827|592995559|FG007|Overall Study|Other|1|||
164172969|NCT01295827|592995560|FG008|Overall Study|Other|1|||
164172970|NCT01295827|592995561|FG009|Overall Study|Other|0|||
164172971|NCT01295827|592995562|FG010|Overall Study|Other|2|||
164172972|NCT01295827|592995563|FG011|Overall Study|Other|0|||
164172973|NCT01295827|592995564|FG012|Overall Study|Other|0|||
164172974|NCT01295827|592995565|FG013|Overall Study|Other|0|||
164172975|NCT01295827|592995566|FG014|Overall Study|Other|0|||
164172976|NCT02640677|592995567|FG000|Overall Study|Lost to Follow-up|1|||
164172977|NCT02640677|592995567|FG000|Overall Study|Withdrawal by Subject|1|||
164172978|NCT02805660|592995574|FG000|Overall Study|Death|5|||
164172979|NCT02805660|592995575|FG001|Overall Study|Death|2|||
164172980|NCT02805660|592995576|FG002|Overall Study|Death|9|||
164172981|NCT02805660|592995577|FG003|Overall Study|Death|5|||
164172982|NCT02805660|592995578|FG004|Overall Study|Death|0|||
164172983|NCT02805660|592995579|FG005|Overall Study|Death|14|||
164172984|NCT02805660|592995580|FG006|Overall Study|Death|12|||
164172985|NCT02805660|592995574|FG000|Overall Study|Lost to Follow-up|0|||
164172986|NCT02805660|592995575|FG001|Overall Study|Lost to Follow-up|1|||
164172987|NCT02805660|592995576|FG002|Overall Study|Lost to Follow-up|1|||
164172988|NCT02805660|592995577|FG003|Overall Study|Lost to Follow-up|2|||
164172989|NCT02805660|592995578|FG004|Overall Study|Lost to Follow-up|0|||
164172990|NCT02805660|592995579|FG005|Overall Study|Lost to Follow-up|0|||
164172991|NCT02805660|592995580|FG006|Overall Study|Lost to Follow-up|0|||
164172992|NCT02805660|592995574|FG000|Overall Study|Withdrawal by Subject|0|||
164172993|NCT02805660|592995575|FG001|Overall Study|Withdrawal by Subject|0|||
164172994|NCT02805660|592995576|FG002|Overall Study|Withdrawal by Subject|0|||
164172995|NCT02805660|592995577|FG003|Overall Study|Withdrawal by Subject|3|||
164172996|NCT02805660|592995578|FG004|Overall Study|Withdrawal by Subject|1|||
164172997|NCT02805660|592995579|FG005|Overall Study|Withdrawal by Subject|0|||
164172998|NCT02805660|592995580|FG006|Overall Study|Withdrawal by Subject|2|||
164172999|NCT02805660|592995574|FG000|Overall Study|Study terminated by Sponsor|0|||
164173000|NCT02805660|592995575|FG001|Overall Study|Study terminated by Sponsor|0|||
164173001|NCT02805660|592995576|FG002|Overall Study|Study terminated by Sponsor|1|||
164173002|NCT02805660|592995577|FG003|Overall Study|Study terminated by Sponsor|4|||
164173003|NCT02805660|592995578|FG004|Overall Study|Study terminated by Sponsor|2|||
164173004|NCT02805660|592995579|FG005|Overall Study|Study terminated by Sponsor|3|||
164173005|NCT02805660|592995580|FG006|Overall Study|Study terminated by Sponsor|1|||
164173006|NCT02805660|592995574|FG000|Overall Study|Miscellaneous|0|||
164173007|NCT02805660|592995575|FG001|Overall Study|Miscellaneous|1|||
164173008|NCT02805660|592995576|FG002|Overall Study|Miscellaneous|0|||
164173009|NCT02805660|592995577|FG003|Overall Study|Miscellaneous|4|||
164173010|NCT02805660|592995578|FG004|Overall Study|Miscellaneous|0|||
164173011|NCT02805660|592995579|FG005|Overall Study|Miscellaneous|6|||
164173012|NCT02805660|592995580|FG006|Overall Study|Miscellaneous|4|||
164173013|NCT02572076|592995581|FG000|Overall Study|Protocol Violation|1|||
164173014|NCT02778074|592995582|FG000|Overall Study|Lost to Follow-up|7|||
164173015|NCT02778074|592995583|FG001|Overall Study|Lost to Follow-up|10|||
164173016|NCT03489707|592995586|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
164173017|NCT03489707|592995587|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
164173018|NCT03489707|592995586|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
164173019|NCT03489707|592995587|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
164173020|NCT01817582|592995593|FG000|Overall Study|Withdrawal by Subject|0|||
164173021|NCT01817582|592995594|FG001|Overall Study|Withdrawal by Subject|1|||
164173022|NCT01817582|592995595|FG002|Overall Study|Withdrawal by Subject|0|||
164173023|NCT01817582|592995593|FG000|Overall Study|Participant revealed masked treatment|1|||
164173024|NCT01817582|592995594|FG001|Overall Study|Participant revealed masked treatment|0|||
164173025|NCT01817582|592995595|FG002|Overall Study|Participant revealed masked treatment|0|||
164173026|NCT01817582|592995593|FG000|Overall Study|Randomized but exclusion criteria met|1|||
164173027|NCT01817582|592995594|FG001|Overall Study|Randomized but exclusion criteria met|0|||
164173028|NCT01817582|592995595|FG002|Overall Study|Randomized but exclusion criteria met|0|||
164173029|NCT03053063|592995596|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
164173030|NCT03053063|592995597|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
164173031|NCT03053063|592995598|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
164173032|NCT03053063|592995599|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
164173033|NCT03053063|592995596|FG000|Randomized Phase|Withdrew consent|8|||
164173034|NCT03053063|592995597|FG001|Randomized Phase|Withdrew consent|11|||
164173035|NCT03053063|592995598|FG002|Randomized Phase|Withdrew consent|5|||
164173036|NCT03053063|592995599|FG003|Randomized Phase|Withdrew consent|0|||
164173037|NCT03053063|592995596|FG000|Randomized Phase|Investigator's Discretion|8|||
164173038|NCT03053063|592995597|FG001|Randomized Phase|Investigator's Discretion|6|||
164173039|NCT03053063|592995598|FG002|Randomized Phase|Investigator's Discretion|2|||
164173040|NCT03053063|592995599|FG003|Randomized Phase|Investigator's Discretion|0|||
164173041|NCT03053063|592995596|FG000|Randomized Phase|Lost to Follow-up|3|||
164173042|NCT03053063|592995597|FG001|Randomized Phase|Lost to Follow-up|5|||
164173043|NCT03053063|592995598|FG002|Randomized Phase|Lost to Follow-up|1|||
164173044|NCT03053063|592995599|FG003|Randomized Phase|Lost to Follow-up|0|||
164173045|NCT03053063|592995596|FG000|Randomized Phase|Adverse Event|0|||
164173046|NCT03053063|592995597|FG001|Randomized Phase|Adverse Event|1|||
164173047|NCT03053063|592995598|FG002|Randomized Phase|Adverse Event|0|||
164173048|NCT03053063|592995599|FG003|Randomized Phase|Adverse Event|0|||
164173049|NCT03053063|592995596|FG000|Randomized Phase|Randomized but Never Treated|1|||
164173050|NCT03053063|592995597|FG001|Randomized Phase|Randomized but Never Treated|3|||
164173051|NCT03053063|592995598|FG002|Randomized Phase|Randomized but Never Treated|2|||
164173052|NCT03053063|592995599|FG003|Randomized Phase|Randomized but Never Treated|0|||
164173053|NCT03053063|592995596|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
164173054|NCT03053063|592995597|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
164173055|NCT03053063|592995598|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
164173056|NCT03053063|592995599|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
164173057|NCT03053063|592995596|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
164173058|NCT03053063|592995597|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
164173059|NCT03053063|592995598|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
164173060|NCT03053063|592995599|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
164173061|NCT03053063|592995596|FG000|Open-Label Phase|Death|0|||
164173062|NCT03053063|592995597|FG001|Open-Label Phase|Death|0|||
164173063|NCT03053063|592995598|FG002|Open-Label Phase|Death|0|||
164173064|NCT03053063|592995599|FG003|Open-Label Phase|Death|2|||
164173065|NCT03053063|592995596|FG000|Open-Label Phase|Investigator's discretion|0|||
164173066|NCT03053063|592995597|FG001|Open-Label Phase|Investigator's discretion|0|||
164173067|NCT03053063|592995598|FG002|Open-Label Phase|Investigator's discretion|0|||
164173068|NCT03053063|592995599|FG003|Open-Label Phase|Investigator's discretion|2|||
164173069|NCT03963232|592995601|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
164173070|NCT03963232|592995602|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
164173071|NCT03963232|592995601|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
164173072|NCT03963232|592995602|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
164173073|NCT03963232|592995601|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
164173074|NCT03963232|592995602|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
164173075|NCT03963232|592995601|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
164173076|NCT03963232|592995602|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
164173077|NCT03963232|592995601|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
164173078|NCT03963232|592995602|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
164173079|NCT03963232|592995601|FG000|Open-Label Treatment Phase|Adverse Event|1|||
164173080|NCT03963232|592995602|FG001|Open-Label Treatment Phase|Adverse Event|2|||
164173081|NCT03963232|592995601|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
164173082|NCT03963232|592995602|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
164173083|NCT03963232|592995601|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
164173084|NCT03963232|592995602|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
164173085|NCT03963232|592995601|FG000|Open-Label Treatment Phase|Pregnancy|1|||
164173086|NCT03963232|592995602|FG001|Open-Label Treatment Phase|Pregnancy|0|||
164173087|NCT03963232|592995601|FG000|Follow-up Phase|Withdrawal by Subject|7|||
164173088|NCT03963232|592995602|FG001|Follow-up Phase|Withdrawal by Subject|5|||
164173089|NCT03963232|592995601|FG000|Follow-up Phase|Protocol Violation|0|||
164173090|NCT03963232|592995602|FG001|Follow-up Phase|Protocol Violation|2|||
164173091|NCT03963232|592995601|FG000|Follow-up Phase|Adverse Event|0|||
164173092|NCT03963232|592995602|FG001|Follow-up Phase|Adverse Event|1|||
164173093|NCT03963232|592995601|FG000|Follow-up Phase|Lost to Follow-up|0|||
164173094|NCT03963232|592995602|FG001|Follow-up Phase|Lost to Follow-up|1|||
164173095|NCT00356135|592995603|FG000|Overall Study|Protocol Violation|1|||
164173096|NCT00356135|592995604|FG001|Overall Study|Protocol Violation|0|||
164173097|NCT00356135|592995605|FG002|Overall Study|Protocol Violation|0|||
164173098|NCT00356135|592995603|FG000|Overall Study|Adverse Event|1|||
164173099|NCT00356135|592995604|FG001|Overall Study|Adverse Event|0|||
164173100|NCT00356135|592995605|FG002|Overall Study|Adverse Event|0|||
164173101|NCT00356135|592995603|FG000|Overall Study|Lost to Follow-up|0|||
164173102|NCT00356135|592995604|FG001|Overall Study|Lost to Follow-up|0|||
164173103|NCT00356135|592995605|FG002|Overall Study|Lost to Follow-up|1|||
164173104|NCT00356135|592995603|FG000|Overall Study|Physician Decision|1|||
164173105|NCT00356135|592995604|FG001|Overall Study|Physician Decision|1|||
164173106|NCT00356135|592995605|FG002|Overall Study|Physician Decision|1|||
164173107|NCT00356135|592995603|FG000|Overall Study|Subject non-compliance|1|||
164173108|NCT00356135|592995604|FG001|Overall Study|Subject non-compliance|1|||
164173109|NCT00356135|592995605|FG002|Overall Study|Subject non-compliance|3|||
164173110|NCT03617770|592995606|FG000|Overall Study|Lost to Follow-up|1|||
164173111|NCT03617770|592995607|FG001|Overall Study|Lost to Follow-up|0|||
164173112|NCT05270395|592995613|FG000|Overall Study|Lost to Follow-up|2|||
164173113|NCT05270395|592995614|FG001|Overall Study|Lost to Follow-up|2|||
164173114|NCT05270395|592995613|FG000|Overall Study|Death|1|||
164173115|NCT05270395|592995614|FG001|Overall Study|Death|2|||
164173116|NCT05270395|592995613|FG000|Overall Study|Study Team Withdrew|1|||
164173117|NCT05270395|592995614|FG001|Overall Study|Study Team Withdrew|0|||
164173118|NCT03055494|592997456|FG000|Overall Study|Lost to Follow-up|6|||
164173119|NCT03055494|592997457|FG001|Overall Study|Lost to Follow-up|0|||
164173120|NCT03055494|592997456|FG000|Overall Study|Physician Decision|2|||
164173121|NCT03055494|592997457|FG001|Overall Study|Physician Decision|0|||
164173122|NCT03055494|592997456|FG000|Overall Study|Withdrawal by Subject|1|||
164173123|NCT03055494|592997457|FG001|Overall Study|Withdrawal by Subject|0|||
164173124|NCT03055494|592997456|FG000|Overall Study|Adverse Event|0|||
164173125|NCT03055494|592997457|FG001|Overall Study|Adverse Event|1|||
164173126|NCT03055494|592997456|FG000|Overall Study|Non-compliance with study treatment|1|||
164173127|NCT03055494|592997457|FG001|Overall Study|Non-compliance with study treatment|0|||
164173128|NCT03569293|592997461|FG000|Overall Study|Adverse Event|4|||
164173129|NCT03569293|592997462|FG001|Overall Study|Adverse Event|1|||
164173130|NCT03569293|592997463|FG002|Overall Study|Adverse Event|5|||
164173131|NCT03569293|592997464|FG003|Overall Study|Adverse Event|1|||
164173132|NCT03569293|592997465|FG004|Overall Study|Adverse Event|0|||
164173133|NCT03569293|592997466|FG005|Overall Study|Adverse Event|0|||
164173134|NCT03569293|592997461|FG000|Overall Study|Withdrawal by Subject|16|||
164173135|NCT03569293|592997462|FG001|Overall Study|Withdrawal by Subject|2|||
164173136|NCT03569293|592997463|FG002|Overall Study|Withdrawal by Subject|4|||
164173137|NCT03569293|592997464|FG003|Overall Study|Withdrawal by Subject|1|||
164173138|NCT03569293|592997465|FG004|Overall Study|Withdrawal by Subject|0|||
164173139|NCT03569293|592997466|FG005|Overall Study|Withdrawal by Subject|0|||
164173140|NCT03569293|592997461|FG000|Overall Study|Lost to Follow-up|1|||
164173141|NCT03569293|592997462|FG001|Overall Study|Lost to Follow-up|3|||
164173142|NCT03569293|592997463|FG002|Overall Study|Lost to Follow-up|1|||
164173143|NCT03569293|592997464|FG003|Overall Study|Lost to Follow-up|1|||
164173144|NCT03569293|592997465|FG004|Overall Study|Lost to Follow-up|0|||
164173145|NCT03569293|592997466|FG005|Overall Study|Lost to Follow-up|0|||
164173146|NCT03569293|592997461|FG000|Overall Study|Other|8|||
164173147|NCT03569293|592997462|FG001|Overall Study|Other|2|||
164173148|NCT03569293|592997463|FG002|Overall Study|Other|1|||
164173149|NCT03569293|592997464|FG003|Overall Study|Other|1|||
164173150|NCT03569293|592997465|FG004|Overall Study|Other|0|||
164173151|NCT03569293|592997466|FG005|Overall Study|Other|0|||
164173152|NCT03569293|592997461|FG000|Overall Study|Ongoing at Time of Analysis|8|||
164173153|NCT03569293|592997462|FG001|Overall Study|Ongoing at Time of Analysis|1|||
164173154|NCT03569293|592997463|FG002|Overall Study|Ongoing at Time of Analysis|3|||
164173155|NCT03569293|592997464|FG003|Overall Study|Ongoing at Time of Analysis|0|||
164173156|NCT03569293|592997465|FG004|Overall Study|Ongoing at Time of Analysis|0|||
164173157|NCT03569293|592997466|FG005|Overall Study|Ongoing at Time of Analysis|0|||
164173158|NCT03036098|592997477|FG000|Pre-Treatment|Other Reasons|1|||
164173159|NCT03036098|592997478|FG001|Pre-Treatment|Other Reasons|2|||
164173160|NCT03036098|592997479|FG002|Pre-Treatment|Other Reasons|0|||
164173161|NCT03036098|592997480|FG003|Pre-Treatment|Other Reasons|5|||
164173162|NCT03036098|592997477|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
164173163|NCT03036098|592997478|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
164173164|NCT03036098|592997479|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
164173165|NCT03036098|592997480|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
164173166|NCT03036098|592997477|FG000|Pre-Treatment|Withdrawal by Subject|1|||
164173167|NCT03036098|592997478|FG001|Pre-Treatment|Withdrawal by Subject|14|||
164173168|NCT03036098|592997479|FG002|Pre-Treatment|Withdrawal by Subject|0|||
164173169|NCT03036098|592997480|FG003|Pre-Treatment|Withdrawal by Subject|5|||
164173170|NCT03036098|592997477|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
164173171|NCT03036098|592997478|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
164173172|NCT03036098|592997479|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
164173173|NCT03036098|592997480|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
164173174|NCT03036098|592997477|FG000|Treatment|Disease Progression|130|||
164173175|NCT03036098|592997478|FG001|Treatment|Disease Progression|77|||
164173176|NCT03036098|592997479|FG002|Treatment|Disease Progression|168|||
164173177|NCT03036098|592997480|FG003|Treatment|Disease Progression|50|||
164173178|NCT03036098|592997477|FG000|Treatment|Study Drug Toxicity|95|||
164173179|NCT03036098|592997478|FG001|Treatment|Study Drug Toxicity|45|||
164173180|NCT03036098|592997479|FG002|Treatment|Study Drug Toxicity|26|||
164173181|NCT03036098|592997480|FG003|Treatment|Study Drug Toxicity|22|||
164173182|NCT03036098|592997477|FG000|Treatment|Death|9|||
164173183|NCT03036098|592997478|FG001|Treatment|Death|3|||
164173184|NCT03036098|592997479|FG002|Treatment|Death|1|||
164173185|NCT03036098|592997480|FG003|Treatment|Death|2|||
164173186|NCT03036098|592997477|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
164173187|NCT03036098|592997478|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
164173188|NCT03036098|592997479|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
164173189|NCT03036098|592997480|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
164173190|NCT03036098|592997477|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
164173191|NCT03036098|592997478|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
164173192|NCT03036098|592997479|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
164173193|NCT03036098|592997480|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
164173194|NCT03036098|592997477|FG000|Treatment|Withdrawal by Subject|2|||
164173195|NCT03036098|592997478|FG001|Treatment|Withdrawal by Subject|9|||
164173196|NCT03036098|592997479|FG002|Treatment|Withdrawal by Subject|2|||
164173197|NCT03036098|592997480|FG003|Treatment|Withdrawal by Subject|4|||
164173198|NCT03036098|592997477|FG000|Treatment|Maximum Clinical Benefit|6|||
164173199|NCT03036098|592997478|FG001|Treatment|Maximum Clinical Benefit|1|||
164173200|NCT03036098|592997479|FG002|Treatment|Maximum Clinical Benefit|6|||
164173201|NCT03036098|592997480|FG003|Treatment|Maximum Clinical Benefit|10|||
164173202|NCT03036098|592997477|FG000|Treatment|Poor/Non Compliance|1|||
164173203|NCT03036098|592997478|FG001|Treatment|Poor/Non Compliance|2|||
164173204|NCT03036098|592997479|FG002|Treatment|Poor/Non Compliance|0|||
164173205|NCT03036098|592997480|FG003|Treatment|Poor/Non Compliance|1|||
164173206|NCT03036098|592997477|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
164173207|NCT03036098|592997478|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
164173208|NCT03036098|592997479|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
164173209|NCT03036098|592997480|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
164173210|NCT03036098|592997477|FG000|Treatment|Administrative Reason by Sponsor|1|||
164173211|NCT03036098|592997478|FG001|Treatment|Administrative Reason by Sponsor|0|||
164173212|NCT03036098|592997479|FG002|Treatment|Administrative Reason by Sponsor|2|||
164173213|NCT03036098|592997480|FG003|Treatment|Administrative Reason by Sponsor|1|||
164173214|NCT03036098|592997477|FG000|Treatment|Other Reasons|31|||
164173215|NCT03036098|592997478|FG001|Treatment|Other Reasons|5|||
164173216|NCT03036098|592997479|FG002|Treatment|Other Reasons|21|||
164173217|NCT03036098|592997480|FG003|Treatment|Other Reasons|8|||
164173218|NCT03036098|592997477|FG000|Treatment|Ongoing Treatment|0|||
164173219|NCT03036098|592997478|FG001|Treatment|Ongoing Treatment|0|||
164173220|NCT03036098|592997479|FG002|Treatment|Ongoing Treatment|23|||
164173221|NCT03036098|592997480|FG003|Treatment|Ongoing Treatment|0|||
164173222|NCT04240886|592997483|FG000|Treatment Phase|Death|4|||
164173223|NCT04240886|592997483|FG000|Treatment Phase|Discontinuation by Subject|1|||
164173224|NCT04240886|592997483|FG000|Treatment Phase|Adverse Event|5|||
164173225|NCT04240886|592997483|FG000|Follow-up Phase|Withdrawal by Subject|1|||
164173226|NCT04240886|592997483|FG000|Follow-up Phase|Discontinuation by Subject|1|||
164173227|NCT04240886|592997483|FG000|Follow-up Phase|Death|2|||
164173228|NCT02276053|592997484|FG000|Overall Study|Death|2|||
164173229|NCT02276053|592997484|FG000|Overall Study|Adverse Event|5|||
164173230|NCT02276053|592997484|FG000|Overall Study|Lack of Efficacy|2|||
164173231|NCT02276053|592997484|FG000|Overall Study|Withdrawal by Subject|1|||
164173232|NCT02276053|592997484|FG000|Overall Study|Patient does not meet selection criteria|3|||
164173233|NCT02276053|592997484|FG000|Overall Study|Patient needs to increase baseline AED|1|||
164173234|NCT04743804|592997487|FG000|Overall Study|Other|1|||
164173235|NCT04743804|592997488|FG001|Overall Study|Other|0|||
164173236|NCT04743804|592997487|FG000|Overall Study|Withdrawal by Subject|0|||
164173237|NCT04743804|592997488|FG001|Overall Study|Withdrawal by Subject|1|||
164173238|NCT04743804|592997487|FG000|Overall Study|Study Terminated by Sponsor|1|||
164173239|NCT04743804|592997488|FG001|Overall Study|Study Terminated by Sponsor|4|||
164173240|NCT04743804|592997487|FG000|Overall Study|Physician Decision|0|||
164173241|NCT04743804|592997488|FG001|Overall Study|Physician Decision|1|||
164173242|NCT04743804|592997487|FG000|Overall Study|Death|3|||
164173243|NCT04743804|592997488|FG001|Overall Study|Death|0|||
164173244|NCT02059434|592997489|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
164173245|NCT02059434|592997490|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
164173246|NCT02059434|592997491|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
164173247|NCT02059434|592997492|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
164173248|NCT02059434|592997493|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
164173249|NCT02059434|592997494|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
164173250|NCT02059434|592997495|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
164173251|NCT02059434|592997496|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
164173252|NCT02059434|592997497|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
164173253|NCT02059434|592997489|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
164173254|NCT02059434|592997490|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
164173255|NCT02059434|592997491|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
164173256|NCT02059434|592997492|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
164173257|NCT02059434|592997493|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
164173258|NCT02059434|592997494|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
164173259|NCT02059434|592997495|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
164173260|NCT02059434|592997496|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
164173261|NCT02059434|592997497|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
164173262|NCT02059434|592997489|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
164173263|NCT02059434|592997490|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
164173264|NCT02059434|592997491|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
164173265|NCT02059434|592997492|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
164173266|NCT02059434|592997493|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
164173267|NCT02059434|592997494|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
164173268|NCT02059434|592997495|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
164173269|NCT02059434|592997496|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
164173270|NCT02059434|592997497|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
164173271|NCT02059434|592997489|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
164173272|NCT02059434|592997490|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
164173273|NCT02059434|592997491|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
164173274|NCT02059434|592997492|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
164173275|NCT02059434|592997493|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
164173276|NCT02059434|592997494|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
164173277|NCT02059434|592997495|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
164173278|NCT02059434|592997496|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
164173279|NCT02059434|592997497|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
164173280|NCT02059434|592997489|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
164173281|NCT02059434|592997490|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
164173282|NCT02059434|592997491|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
164173283|NCT02059434|592997492|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
164173284|NCT02059434|592997493|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
164173285|NCT02059434|592997494|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
164173286|NCT02059434|592997495|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
164173287|NCT02059434|592997496|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
164173288|NCT02059434|592997497|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
164173289|NCT02928770|592997502|FG000|Overall Study|Withdrawal by Subject|2|||
164173290|NCT03201874|592997503|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
164173291|NCT03201874|592997504|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
164173292|NCT03201874|592997503|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
164173293|NCT03201874|592997504|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
164173294|NCT02515994|592997510|FG000|Overall Study|Protocol Violation|3|||
164173295|NCT02515994|592997511|FG001|Overall Study|Protocol Violation|5|||
164173296|NCT02515994|592997510|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
164173297|NCT02515994|592997511|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
164173298|NCT02515994|592997510|FG000|Overall Study|Adverse Event|3|||
164173299|NCT02515994|592997511|FG001|Overall Study|Adverse Event|1|||
164173300|NCT02515994|592997510|FG000|Overall Study|Withdrawal by Subject|2|||
164173301|NCT02515994|592997511|FG001|Overall Study|Withdrawal by Subject|0|||
164173302|NCT01424514|592997512|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
164173303|NCT01424514|592997513|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
164173304|NCT01424514|592997512|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
164173305|NCT01424514|592997513|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
164173306|NCT04598451|592997514|FG000|Overall Study|Adverse Event|3|||
164173307|NCT04598451|592997515|FG001|Overall Study|Adverse Event|2|||
164173308|NCT04598451|592997514|FG000|Overall Study|Withdrawal by Subject|3|||
164173309|NCT04598451|592997515|FG001|Overall Study|Withdrawal by Subject|7|||
164173310|NCT04598451|592997514|FG000|Overall Study|Lost to Follow-up|2|||
164173311|NCT04598451|592997515|FG001|Overall Study|Lost to Follow-up|0|||
164173312|NCT04598451|592997514|FG000|Overall Study|Physician Decision|4|||
164173313|NCT04598451|592997515|FG001|Overall Study|Physician Decision|1|||
164173314|NCT04598451|592997514|FG000|Overall Study|Requires Prohibited Medication|1|||
164173315|NCT04598451|592997515|FG001|Overall Study|Requires Prohibited Medication|0|||
164173316|NCT04598451|592997514|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
164173317|NCT04598451|592997515|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
164173318|NCT02653170|592997516|FG000|Overall Study|Withdrawal by Subject|3|||
164173319|NCT02653170|592997517|FG001|Overall Study|Withdrawal by Subject|8|||
164173320|NCT02653170|592997518|FG002|Overall Study|Withdrawal by Subject|3|||
164173321|NCT02653170|592997516|FG000|Overall Study|withdrawn by study team|2|||
164173322|NCT02653170|592997517|FG001|Overall Study|withdrawn by study team|4|||
164173323|NCT02653170|592997518|FG002|Overall Study|withdrawn by study team|5|||
164173324|NCT02653170|592997516|FG000|Overall Study|Lost to Follow-up|12|||
164173325|NCT02653170|592997517|FG001|Overall Study|Lost to Follow-up|4|||
164173326|NCT02653170|592997518|FG002|Overall Study|Lost to Follow-up|10|||
164173327|NCT02963558|592997519|FG000|Overall Study|Withdrawn by investigator|1|||
164173328|NCT02963558|592997520|FG001|Overall Study|Withdrawn by investigator|0|||
164173329|NCT02963558|592997519|FG000|Overall Study|Withdrawal by Subject|0|||
164173330|NCT02963558|592997520|FG001|Overall Study|Withdrawal by Subject|1|||
164173331|NCT04063657|592997524|FG000|Overall Study|Lost to Follow-up|1|||
164173332|NCT04063657|592997525|FG001|Overall Study|Lost to Follow-up|0|||
164173333|NCT01214252|592997526|FG000|Overall Study|Not eligible per protocol|82|||
164173334|NCT01371877|592997528|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
164173335|NCT01371877|592997529|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
164173336|NCT05932225|592997530|FG000|Overall Study|Lost to Follow-up|0|||
164173337|NCT05932225|592997531|FG001|Overall Study|Lost to Follow-up|1|||
164173338|NCT05932225|592997532|FG002|Overall Study|Lost to Follow-up|0|||
164173339|NCT05932225|592997530|FG000|Overall Study|Withdrawal by Subject|1|||
164173340|NCT05932225|592997531|FG001|Overall Study|Withdrawal by Subject|0|||
164173341|NCT05932225|592997532|FG002|Overall Study|Withdrawal by Subject|0|||
164173342|NCT05932225|592997530|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
164173343|NCT05932225|592997531|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
164173344|NCT05932225|592997532|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
164173345|NCT01473394|592997533|FG000|Overall Study|Adverse Event|13|||
164173346|NCT01473394|592997534|FG001|Overall Study|Adverse Event|16|||
164173347|NCT01473394|592997533|FG000|Overall Study|Insufficient Therapeutic Response|4|||
164173348|NCT01473394|592997534|FG001|Overall Study|Insufficient Therapeutic Response|1|||
164173349|NCT01473394|592997533|FG000|Overall Study|Protocol Violation|7|||
164173350|NCT01473394|592997534|FG001|Overall Study|Protocol Violation|5|||
164173351|NCT01473394|592997533|FG000|Overall Study|Withdrew Consent|12|||
164173352|NCT01473394|592997534|FG001|Overall Study|Withdrew Consent|10|||
164173353|NCT01473394|592997533|FG000|Overall Study|Lost to Follow-up|9|||
164173354|NCT01473394|592997534|FG001|Overall Study|Lost to Follow-up|11|||
164173355|NCT01877551|592997535|FG000|Overall Study|Physician Decision|0|||
164173356|NCT01877551|592997536|FG001|Overall Study|Physician Decision|1|||
164173514|NCT03802565|592997623|FG001|Overall Study|Lost to Follow-up|0|||
164173357|NCT00761280|592997537|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
164173358|NCT00761280|592997538|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
164173359|NCT00761280|592997537|FG000|Randomization to First Dose|Sponsor decision|1|||
164173360|NCT00761280|592997538|FG001|Randomization to First Dose|Sponsor decision|0|||
164173361|NCT00761280|592997537|FG000|Randomization to First Dose|Other|1|||
164173362|NCT00761280|592997538|FG001|Randomization to First Dose|Other|0|||
164173363|NCT00761280|592997537|FG000|First Dose to End of Study|End of trial|5|||
164173364|NCT00761280|592997538|FG001|First Dose to End of Study|End of trial|5|||
164173365|NCT00761280|592997537|FG000|First Dose to End of Study|Progressive disease|5|||
164173366|NCT00761280|592997538|FG001|First Dose to End of Study|Progressive disease|3|||
164173367|NCT00761280|592997537|FG000|First Dose to End of Study|Sponsor decision|1|||
164173368|NCT00761280|592997538|FG001|First Dose to End of Study|Sponsor decision|2|||
164173369|NCT00761280|592997537|FG000|First Dose to End of Study|Death|1|||
164173370|NCT00761280|592997538|FG001|First Dose to End of Study|Death|0|||
164173371|NCT00761280|592997537|FG000|First Dose to End of Study|Lost to Follow-up|0|||
164173372|NCT00761280|592997538|FG001|First Dose to End of Study|Lost to Follow-up|1|||
164173373|NCT03875482|592997539|FG000|Overall Study|Adverse Event|0|||
164173374|NCT03875482|592997540|FG001|Overall Study|Adverse Event|1|||
164173375|NCT03875482|592997539|FG000|Overall Study|Withdrew consent|5|||
164173376|NCT03875482|592997540|FG001|Overall Study|Withdrew consent|6|||
164173377|NCT03875482|592997539|FG000|Overall Study|Lost to Follow-up|8|||
164173378|NCT03875482|592997540|FG001|Overall Study|Lost to Follow-up|2|||
164173379|NCT03875482|592997539|FG000|Overall Study|Lack of Efficacy|0|||
164173380|NCT03875482|592997540|FG001|Overall Study|Lack of Efficacy|11|||
164173381|NCT04507256|592997541|FG000|Overall Study|Withdrawal by Subject|1|||
164173382|NCT04507256|592997542|FG001|Overall Study|Withdrawal by Subject|0|||
164173383|NCT04507256|592997543|FG002|Overall Study|Withdrawal by Subject|0|||
164173384|NCT04507256|592997544|FG003|Overall Study|Withdrawal by Subject|1|||
164173385|NCT04507256|592997545|FG004|Overall Study|Withdrawal by Subject|0|||
164173386|NCT04507256|592997546|FG005|Overall Study|Withdrawal by Subject|0|||
164173387|NCT02111785|592997547|FG000|Overall Study|Death|0|||
164173388|NCT02111785|592997548|FG001|Overall Study|Death|1|||
164173389|NCT02111785|592997549|FG002|Overall Study|Death|0|||
164173390|NCT02111785|592997550|FG003|Overall Study|Death|0|||
164173391|NCT02256982|592997552|FG000|Overall Study|Disease Progression|0|||
164173392|NCT02256982|592997553|FG001|Overall Study|Disease Progression|1|||
164173393|NCT01054300|592997558|FG000|Period 1|Adverse Event|1|||
164173394|NCT01054300|592997559|FG001|Period 1|Adverse Event|0|||
164173395|NCT01054300|592997560|FG002|Period 1|Adverse Event|0|||
164173396|NCT01054300|592997561|FG003|Period 1|Adverse Event|0|||
164173397|NCT01054300|592997558|FG000|Period 2|Withdrawal by Subject|0|||
164173398|NCT01054300|592997559|FG001|Period 2|Withdrawal by Subject|0|||
164173399|NCT01054300|592997560|FG002|Period 2|Withdrawal by Subject|1|||
164173400|NCT01054300|592997561|FG003|Period 2|Withdrawal by Subject|0|||
164173401|NCT01899742|592997564|FG000|Overall Study|Adverse Event|5|||
164173402|NCT01899742|592997565|FG001|Overall Study|Adverse Event|4|||
164173403|NCT01899742|592997564|FG000|Overall Study|Lack of Efficacy|1|||
164173404|NCT01899742|592997565|FG001|Overall Study|Lack of Efficacy|5|||
164173405|NCT01899742|592997564|FG000|Overall Study|Protocol Violation|2|||
164173406|NCT01899742|592997565|FG001|Overall Study|Protocol Violation|2|||
164173407|NCT01899742|592997564|FG000|Overall Study|Withdrawal by Subject|9|||
164173408|NCT01899742|592997565|FG001|Overall Study|Withdrawal by Subject|5|||
164173409|NCT00738881|592997569|FG000|Overall Study|Withdrawal by Subject|0|||
164173410|NCT00738881|592997570|FG001|Overall Study|Withdrawal by Subject|2|||
164173411|NCT02662764|592997571|FG000|Overall Study|Adverse Event|6|||
164173412|NCT02662764|592997571|FG000|Overall Study|Lack of Efficacy|8|||
164173413|NCT02662764|592997571|FG000|Overall Study|Protocol Violation|1|||
164173414|NCT02662764|592997571|FG000|Overall Study|Withdrawal by Subject|5|||
164173415|NCT02662764|592997571|FG000|Overall Study|Device failure|4|||
164173416|NCT02662764|592997571|FG000|Overall Study|Patient changed treatment|1|||
164173417|NCT02662764|592997571|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
164173418|NCT02035748|592997575|FG000|Overall Study|Adverse Event|5|||
164173419|NCT02035748|592997575|FG000|Overall Study|Death|3|||
164173420|NCT02035748|592997575|FG000|Overall Study|Lost to Follow-up|2|||
164173421|NCT02035748|592997575|FG000|Overall Study|Physician Decision|3|||
164173422|NCT02035748|592997575|FG000|Overall Study|Withdrawal by Subject|6|||
164173423|NCT02035748|592997575|FG000|Overall Study|Progressive Disease|1|||
164173424|NCT01740128|592997576|FG000|Overall Study|Pregnancy|0|||
164173425|NCT01740128|592997577|FG001|Overall Study|Pregnancy|1|||
164173426|NCT01740128|592997576|FG000|Overall Study|Protocol Violation|1|||
164173427|NCT01740128|592997577|FG001|Overall Study|Protocol Violation|2|||
164173428|NCT01740128|592997576|FG000|Overall Study|Lost to Follow-up|2|||
164173429|NCT01740128|592997577|FG001|Overall Study|Lost to Follow-up|2|||
164173430|NCT01740128|592997576|FG000|Overall Study|Withdrawal by Subject|1|||
164173431|NCT01740128|592997577|FG001|Overall Study|Withdrawal by Subject|0|||
164173432|NCT01740128|592997576|FG000|Overall Study|Insufficient protocol compliance|2|||
164173433|NCT01740128|592997577|FG001|Overall Study|Insufficient protocol compliance|2|||
164173434|NCT01041976|592997578|FG000|Overall Study|Withdrawal by Subject|3|||
164173515|NCT03802565|592997624|FG002|Overall Study|Lost to Follow-up|1|||
164173435|NCT01041976|592997579|FG001|Overall Study|Withdrawal by Subject|0|||
164173436|NCT01041976|592997578|FG000|Overall Study|Incarceration|2|||
164173437|NCT01041976|592997579|FG001|Overall Study|Incarceration|0|||
164173438|NCT01041976|592997578|FG000|Overall Study|Death|0|||
164173439|NCT01041976|592997579|FG001|Overall Study|Death|4|||
164173440|NCT02658734|592997580|FG000|Overall Study|Adverse Event|2|||
164173441|NCT02658734|592997580|FG000|Overall Study|Death|4|||
164173442|NCT02658734|592997580|FG000|Overall Study|Lost to Follow-up|7|||
164173443|NCT02658734|592997580|FG000|Overall Study|Withdrawal of Consent|16|||
164173444|NCT02658734|592997580|FG000|Overall Study|Disease Progression|28|||
164173445|NCT04240457|592997583|FG000|Overall Study|Lost to Follow-up|5|||
164173446|NCT04240457|592997584|FG001|Overall Study|Lost to Follow-up|1|||
164173447|NCT00976209|592997585|FG000|Treatment Period 1|Protocol Violation|1|||
164173448|NCT00976209|592997586|FG001|Treatment Period 1|Protocol Violation|0|||
164173449|NCT00976209|592997585|FG000|Treatment Period 1|Lost to Follow-up|2|||
164173450|NCT00976209|592997586|FG001|Treatment Period 1|Lost to Follow-up|0|||
164173451|NCT00976209|592997585|FG000|Treatment Period 1|Other|0|||
164173452|NCT00976209|592997586|FG001|Treatment Period 1|Other|1|||
164173453|NCT00976209|592997585|FG000|Wash-out Period|Adverse Event|1|||
164173454|NCT00976209|592997586|FG001|Wash-out Period|Adverse Event|2|||
164173455|NCT00976209|592997585|FG000|Wash-out Period|Lost to Follow-up|1|||
164173456|NCT00976209|592997586|FG001|Wash-out Period|Lost to Follow-up|0|||
164173457|NCT00976209|592997585|FG000|Wash-out Period|Protocol Violation|1|||
164173458|NCT00976209|592997586|FG001|Wash-out Period|Protocol Violation|0|||
164173459|NCT00976209|592997585|FG000|Wash-out Period|Other|1|||
164173460|NCT00976209|592997586|FG001|Wash-out Period|Other|0|||
164173461|NCT00976209|592997585|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164173462|NCT00976209|592997586|FG001|Treatment Period 2|Withdrawal by Subject|1|||
164173463|NCT00976209|592997585|FG000|Treatment Period 2|Lost to Follow-up|0|||
164173464|NCT00976209|592997586|FG001|Treatment Period 2|Lost to Follow-up|1|||
164173465|NCT00844480|592997591|FG000|Overall Study|Withdrawal by Subject|2|||
164173466|NCT00844480|592997592|FG001|Overall Study|Withdrawal by Subject|3|||
164173467|NCT02858180|592997593|FG000|Overall Study|Lost to Follow-up|0|||
164173468|NCT02858180|592997594|FG001|Overall Study|Lost to Follow-up|2|||
164173469|NCT01252563|592997599|FG000|Overall Study|Contract Deviation|41|||
164173470|NCT01252563|592997599|FG000|Overall Study|Centralized Registration Deviation|30|||
164173471|NCT01252563|592997599|FG000|Overall Study|Lost to Follow-up|161|||
164173472|NCT01252563|592997599|FG000|Overall Study|No visit after first day of treatment|194|||
164173473|NCT01252563|592997599|FG000|Overall Study|No drug administration|6|||
164173474|NCT01866657|592997605|FG000|Overall Study|Surgery canceled|2|||
164173475|NCT01866657|592997606|FG001|Overall Study|Surgery canceled|0|||
164173476|NCT03403751|592997608|FG000|Overall Study|Death|5|||
164173477|NCT03403751|592997609|FG001|Overall Study|Death|6|||
164173478|NCT03403751|592997608|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
164173479|NCT03403751|592997609|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
164173480|NCT00520481|592997616|FG000|Overall Study|Adverse Event|4|||
164173481|NCT00520481|592997617|FG001|Overall Study|Adverse Event|1|||
164173482|NCT00520481|592997616|FG000|Overall Study|Withdrawal by Subject|3|||
164173483|NCT00520481|592997617|FG001|Overall Study|Withdrawal by Subject|0|||
164173484|NCT04442269|592997620|FG000|Overall Study|Adverse Event|1|||
164173485|NCT04442269|592997621|FG001|Overall Study|Adverse Event|0|||
164173486|NCT04442269|592997620|FG000|Overall Study|Death|0|||
164173487|NCT04442269|592997621|FG001|Overall Study|Death|1|||
164173488|NCT04442269|592997620|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
164173489|NCT04442269|592997621|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
164173490|NCT04442269|592997620|FG000|Overall Study|Lost to Follow-up|1|||
164173491|NCT04442269|592997621|FG001|Overall Study|Lost to Follow-up|0|||
164173492|NCT04442269|592997620|FG000|Overall Study|Withdrawal by Subject|3|||
164173493|NCT04442269|592997621|FG001|Overall Study|Withdrawal by Subject|2|||
164173494|NCT04442269|592997620|FG000|Overall Study|Protocol Deviation|0|||
164173495|NCT04442269|592997621|FG001|Overall Study|Protocol Deviation|1|||
164173496|NCT04442269|592997620|FG000|Overall Study|Travel Limitations|1|||
164173497|NCT04442269|592997621|FG001|Overall Study|Travel Limitations|1|||
164173498|NCT03802565|592997622|FG000|Overall Study|Adverse Event|0|||
164173499|NCT03802565|592997623|FG001|Overall Study|Adverse Event|1|||
164173500|NCT03802565|592997624|FG002|Overall Study|Adverse Event|2|||
164173501|NCT03802565|592997625|FG003|Overall Study|Adverse Event|1|||
164173502|NCT03802565|592997626|FG004|Overall Study|Adverse Event|1|||
164173503|NCT03802565|592997622|FG000|Overall Study|Withdrawal by Subject|2|||
164173504|NCT03802565|592997623|FG001|Overall Study|Withdrawal by Subject|2|||
164173505|NCT03802565|592997624|FG002|Overall Study|Withdrawal by Subject|2|||
164173506|NCT03802565|592997625|FG003|Overall Study|Withdrawal by Subject|0|||
164173507|NCT03802565|592997626|FG004|Overall Study|Withdrawal by Subject|1|||
164173508|NCT03802565|592997622|FG000|Overall Study|Protocol Violation|2|||
164173509|NCT03802565|592997623|FG001|Overall Study|Protocol Violation|1|||
164173510|NCT03802565|592997624|FG002|Overall Study|Protocol Violation|4|||
164173511|NCT03802565|592997625|FG003|Overall Study|Protocol Violation|5|||
164173512|NCT03802565|592997626|FG004|Overall Study|Protocol Violation|1|||
164173513|NCT03802565|592997622|FG000|Overall Study|Lost to Follow-up|0|||
164173516|NCT03802565|592997625|FG003|Overall Study|Lost to Follow-up|0|||
164173517|NCT03802565|592997626|FG004|Overall Study|Lost to Follow-up|0|||
164173518|NCT03802565|592997622|FG000|Overall Study|Subjects Related to Each Other|1|||
164173519|NCT03802565|592997623|FG001|Overall Study|Subjects Related to Each Other|0|||
164173520|NCT03802565|592997624|FG002|Overall Study|Subjects Related to Each Other|0|||
164173521|NCT03802565|592997625|FG003|Overall Study|Subjects Related to Each Other|2|||
164173522|NCT03802565|592997626|FG004|Overall Study|Subjects Related to Each Other|1|||
164173523|NCT03802565|592997622|FG000|Overall Study|Elevated Enzymes|0|||
164173524|NCT03802565|592997623|FG001|Overall Study|Elevated Enzymes|0|||
164173525|NCT03802565|592997624|FG002|Overall Study|Elevated Enzymes|0|||
164173526|NCT03802565|592997625|FG003|Overall Study|Elevated Enzymes|0|||
164173527|NCT03802565|592997626|FG004|Overall Study|Elevated Enzymes|2|||
164173528|NCT01004406|592999977|FG000|Overall Study|Withdrawal by Subject|2|||
164173529|NCT01004406|592999978|FG001|Overall Study|Withdrawal by Subject|0|||
164173530|NCT01004406|592999977|FG000|Overall Study|Lost to Follow-up|1|||
164173531|NCT01004406|592999978|FG001|Overall Study|Lost to Follow-up|0|||
164173532|NCT02907593|592999981|FG000|Overall Study|Withdrawal by Subject|0|||
164173533|NCT02907593|592999982|FG001|Overall Study|Withdrawal by Subject|0|||
164173534|NCT02907593|592999983|FG002|Overall Study|Withdrawal by Subject|1|||
164173535|NCT02907593|592999984|FG003|Overall Study|Withdrawal by Subject|0|||
164173536|NCT01944670|592999985|FG000|Overall Study|Lost to Follow-up|2|||
164173537|NCT05128773|592999986|FG000|Overall Study|Sponsor decision to terminate study|3|||
164173538|NCT04250714|592999987|FG000|Overall Study|Treatment - withdrawal by subject|14|||
164173539|NCT04250714|592999987|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
164173540|NCT04250714|592999987|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
164173541|NCT04250714|592999987|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
164173542|NCT04250714|592999987|FG000|Overall Study|Treatment - Death|1|||
164173543|NCT04250714|592999987|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
164173544|NCT04250714|592999987|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
164173545|NCT04250714|592999987|FG000|Overall Study|Attempt|2|||
164173546|NCT04250714|592999987|FG000|Overall Study|Intent|7|||
164173547|NCT02759055|592999990|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
164173548|NCT02759055|592999991|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
164173549|NCT00623597|592999992|FG000|Overall Study|Failed to return|1|||
164173550|NCT00623597|592999993|FG001|Overall Study|Failed to return|0|||
164173551|NCT04045132|592999997|FG000|Overall Study|Lost to Follow-up|3|||
164173552|NCT04045132|592999998|FG001|Overall Study|Lost to Follow-up|6|||
164173553|NCT00552032|592999999|FG000|Overall Study|Withdrawal by Subject|2|||
164173554|NCT00552032|593000000|FG001|Overall Study|Withdrawal by Subject|2|||
164173555|NCT00552032|592999999|FG000|Overall Study|Protocol Violation|7|||
164173556|NCT00552032|593000000|FG001|Overall Study|Protocol Violation|12|||
164173557|NCT00552032|592999999|FG000|Overall Study|Lost to Follow-up|8|||
164173558|NCT00552032|593000000|FG001|Overall Study|Lost to Follow-up|5|||
164173559|NCT03391232|593000001|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
164173560|NCT03391232|593000002|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
164173561|NCT03391232|593000001|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
164173562|NCT03391232|593000002|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
164173563|NCT00345878|593000003|FG000|Overall Study|Adverse Event|1|||
164173564|NCT00345878|593000004|FG001|Overall Study|Adverse Event|0|||
164173565|NCT00345878|593000003|FG000|Overall Study|Lost to Follow-up|2|||
164173566|NCT00345878|593000004|FG001|Overall Study|Lost to Follow-up|1|||
164173567|NCT00345878|593000003|FG000|Overall Study|Other|1|||
164173568|NCT00345878|593000004|FG001|Overall Study|Other|0|||
164173569|NCT02045732|593000005|FG000|Overall Study|At the discretion of the investigator|1|||
164173570|NCT02045732|593000006|FG001|Overall Study|At the discretion of the investigator|1|||
164173571|NCT04777201|593000010|FG000|Main Study|Withdrawal by Subject|19|||
164173572|NCT04777201|593000011|FG001|Main Study|Withdrawal by Subject|27|||
164173573|NCT04777201|593000012|FG002|Main Study|Withdrawal by Subject|0|||
164173574|NCT04777201|593000010|FG000|Main Study|Death|13|||
164173575|NCT04777201|593000011|FG001|Main Study|Death|27|||
164173576|NCT04777201|593000012|FG002|Main Study|Death|0|||
164173577|NCT04777201|593000010|FG000|Main Study|Subject missed the safety follow-up visit|9|||
164173578|NCT04777201|593000011|FG001|Main Study|Subject missed the safety follow-up visit|10|||
164173579|NCT04777201|593000012|FG002|Main Study|Subject missed the safety follow-up visit|0|||
164173580|NCT04777201|593000010|FG000|Main Study|Physician Decision|8|||
164173581|NCT04777201|593000011|FG001|Main Study|Physician Decision|10|||
164173582|NCT04777201|593000012|FG002|Main Study|Physician Decision|0|||
164173583|NCT04777201|593000010|FG000|Main Study|Adverse Event|8|||
164173584|NCT04777201|593000011|FG001|Main Study|Adverse Event|8|||
164173585|NCT04777201|593000012|FG002|Main Study|Adverse Event|0|||
164173586|NCT04777201|593000010|FG000|Main Study|Lost to Follow-up|9|||
164173587|NCT04777201|593000011|FG001|Main Study|Lost to Follow-up|4|||
164173588|NCT04777201|593000012|FG002|Main Study|Lost to Follow-up|0|||
164173589|NCT04777201|593000010|FG000|Main Study|Reason not specified|3|||
164173590|NCT04777201|593000011|FG001|Main Study|Reason not specified|3|||
164173591|NCT04777201|593000012|FG002|Main Study|Reason not specified|0|||
164173592|NCT04777201|593000010|FG000|Main Study|Lack of Efficacy|1|||
164173593|NCT04777201|593000011|FG001|Main Study|Lack of Efficacy|1|||
164173594|NCT04777201|593000012|FG002|Main Study|Lack of Efficacy|0|||
164173595|NCT04777201|593000010|FG000|Main Study|Protocol Violation|1|||
164173596|NCT04777201|593000011|FG001|Main Study|Protocol Violation|0|||
164173597|NCT04777201|593000012|FG002|Main Study|Protocol Violation|0|||
164173598|NCT04777201|593000010|FG000|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
164173599|NCT04777201|593000011|FG001|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
164173600|NCT04777201|593000012|FG002|Substudy (Concurrent With Main Study)|Withdrawal by Subject|4|||
164173601|NCT04777201|593000010|FG000|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
164173602|NCT04777201|593000011|FG001|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
164173603|NCT04777201|593000012|FG002|Substudy (Concurrent With Main Study)|Prohibited Medication|2|||
164173604|NCT04777201|593000010|FG000|Substudy (Concurrent With Main Study)|Adverse Event|0|||
164173605|NCT04777201|593000011|FG001|Substudy (Concurrent With Main Study)|Adverse Event|0|||
164173606|NCT04777201|593000012|FG002|Substudy (Concurrent With Main Study)|Adverse Event|1|||
164173607|NCT04777201|593000010|FG000|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
164173608|NCT04777201|593000011|FG001|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
164173609|NCT04777201|593000012|FG002|Substudy (Concurrent With Main Study)|Cataract Surgery|1|||
164173610|NCT04777201|593000010|FG000|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
164173611|NCT04777201|593000011|FG001|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
164173612|NCT04777201|593000012|FG002|Substudy (Concurrent With Main Study)|Lost to Follow-up|1|||
164173613|NCT04777201|593000010|FG000|Substudy (Concurrent With Main Study)|Physician Decision|0|||
164173614|NCT04777201|593000011|FG001|Substudy (Concurrent With Main Study)|Physician Decision|0|||
164173615|NCT04777201|593000012|FG002|Substudy (Concurrent With Main Study)|Physician Decision|1|||
164173616|NCT00177307|593000017|FG000|Overall Study|Withdrawal by Subject|1|||
164173617|NCT01282164|593000020|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
164173618|NCT01282164|593000021|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
164173619|NCT04521621|593000022|FG000|Overall Study|Death|17|||
164173620|NCT04521621|593000023|FG001|Overall Study|Death|8|||
164173621|NCT04521621|593000024|FG002|Overall Study|Death|8|||
164173622|NCT04521621|593000025|FG003|Overall Study|Death|5|||
164173623|NCT04521621|593000026|FG004|Overall Study|Death|2|||
164173624|NCT04521621|593000027|FG005|Overall Study|Death|7|||
164173625|NCT04521621|593000028|FG006|Overall Study|Death|0|||
164173626|NCT04521621|593000029|FG007|Overall Study|Death|0|||
164173627|NCT04521621|593000022|FG000|Overall Study|Study Terminated by Sponsor|4|||
164173628|NCT04521621|593000023|FG001|Overall Study|Study Terminated by Sponsor|6|||
164173629|NCT04521621|593000024|FG002|Overall Study|Study Terminated by Sponsor|8|||
164173630|NCT04521621|593000025|FG003|Overall Study|Study Terminated by Sponsor|0|||
164173631|NCT04521621|593000026|FG004|Overall Study|Study Terminated by Sponsor|1|||
164173632|NCT04521621|593000027|FG005|Overall Study|Study Terminated by Sponsor|7|||
164173633|NCT04521621|593000028|FG006|Overall Study|Study Terminated by Sponsor|0|||
164173634|NCT04521621|593000029|FG007|Overall Study|Study Terminated by Sponsor|0|||
164173635|NCT04521621|593000022|FG000|Overall Study|Withdrawal by Subject|0|||
164173636|NCT04521621|593000023|FG001|Overall Study|Withdrawal by Subject|0|||
164173637|NCT04521621|593000024|FG002|Overall Study|Withdrawal by Subject|1|||
164173638|NCT04521621|593000025|FG003|Overall Study|Withdrawal by Subject|1|||
164173639|NCT04521621|593000026|FG004|Overall Study|Withdrawal by Subject|0|||
164173640|NCT04521621|593000027|FG005|Overall Study|Withdrawal by Subject|0|||
164173641|NCT04521621|593000028|FG006|Overall Study|Withdrawal by Subject|0|||
164173642|NCT04521621|593000029|FG007|Overall Study|Withdrawal by Subject|0|||
164173643|NCT04521621|593000022|FG000|Overall Study|Allocated in error without study intervention|1|||
164173644|NCT04521621|593000023|FG001|Overall Study|Allocated in error without study intervention|0|||
164173645|NCT04521621|593000024|FG002|Overall Study|Allocated in error without study intervention|0|||
164173646|NCT04521621|593000025|FG003|Overall Study|Allocated in error without study intervention|0|||
164173647|NCT04521621|593000026|FG004|Overall Study|Allocated in error without study intervention|0|||
164173648|NCT04521621|593000027|FG005|Overall Study|Allocated in error without study intervention|0|||
164173649|NCT04521621|593000028|FG006|Overall Study|Allocated in error without study intervention|0|||
164173650|NCT04521621|593000029|FG007|Overall Study|Allocated in error without study intervention|0|||
164173651|NCT03671564|593000030|FG000|Overall Study|Progressive Disease|3|||
164173652|NCT03671564|593000031|FG001|Overall Study|Progressive Disease|5|||
164173653|NCT03671564|593000032|FG002|Overall Study|Progressive Disease|3|||
164173654|NCT03671564|593000030|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
164173655|NCT03671564|593000031|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
164173656|NCT03671564|593000032|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
164173657|NCT03671564|593000030|FG000|Overall Study|Withdrawal by Subject|1|||
164173658|NCT03671564|593000031|FG001|Overall Study|Withdrawal by Subject|1|||
164173659|NCT03671564|593000032|FG002|Overall Study|Withdrawal by Subject|0|||
164173660|NCT05845567|593000037|FG000|Overall Study|Withdrawal by Subject|1|||
164173661|NCT01104246|593000042|FG000|Overall Study|Withdrawal by Subject|1|||
164173662|NCT01104246|593000042|FG000|Overall Study|did not meet inclusion criteria|4|||
164173663|NCT05178641|593000045|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
164173664|NCT05178641|593000046|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
164173665|NCT05178641|593000045|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
164173666|NCT05178641|593000046|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
164173667|NCT01869699|593000047|FG000|Overall Study|Withdrawal by Subject|1|||
164173668|NCT01869699|593000048|FG001|Overall Study|Withdrawal by Subject|0|||
164173669|NCT01083186|593000050|FG000|Overall Study|Lost to Follow-up|48|||
164173670|NCT01083186|593000050|FG000|Overall Study|Consent Withdrawal|7|||
164173671|NCT01083186|593000050|FG000|Overall Study|Death|3|||
164173672|NCT01083186|593000050|FG000|Overall Study|Adverse Event|3|||
164173673|NCT01083186|593000050|FG000|Overall Study|Lack of Efficacy|2|||
164173674|NCT01083186|593000050|FG000|Overall Study|Hemodialysis Initiation|28|||
164173675|NCT01083186|593000050|FG000|Overall Study|Administrative Reasons|2|||
164173676|NCT01083186|593000050|FG000|Overall Study|Non-compliance to Study Treatment|1|||
164173677|NCT01867294|593000056|FG000|Overall Study|Withdrawal by Subject|1|||
164173678|NCT01867294|593000057|FG001|Overall Study|Withdrawal by Subject|1|||
164173679|NCT01867294|593000058|FG002|Overall Study|Withdrawal by Subject|0|||
164173680|NCT01867294|593000059|FG003|Overall Study|Withdrawal by Subject|0|||
164173681|NCT00978250|593000060|FG000|Overall Study|Late determination of ineligibility|0|||
164173682|NCT00978250|593000061|FG001|Overall Study|Late determination of ineligibility|1|||
164173683|NCT00978250|593000062|FG002|Overall Study|Late determination of ineligibility|0|||
164173684|NCT00978250|593000063|FG003|Overall Study|Late determination of ineligibility|1|||
164173685|NCT05174949|593000064|FG000|Overall Study|Physician Decision|1|||
164173686|NCT05174949|593000065|FG001|Overall Study|Physician Decision|2|||
164173687|NCT05174949|593000066|FG002|Overall Study|Physician Decision|0|||
164173688|NCT05174949|593000067|FG003|Overall Study|Physician Decision|1|||
164173689|NCT05174949|593000068|FG004|Overall Study|Physician Decision|0|||
164173690|NCT05174949|593000069|FG005|Overall Study|Physician Decision|0|||
164173691|NCT05174949|593000064|FG000|Overall Study|Withdrawal by Subject|0|||
164173692|NCT05174949|593000065|FG001|Overall Study|Withdrawal by Subject|1|||
164173693|NCT05174949|593000066|FG002|Overall Study|Withdrawal by Subject|0|||
164173694|NCT05174949|593000067|FG003|Overall Study|Withdrawal by Subject|0|||
164173695|NCT05174949|593000068|FG004|Overall Study|Withdrawal by Subject|0|||
164173696|NCT05174949|593000069|FG005|Overall Study|Withdrawal by Subject|0|||
164173697|NCT05174949|593000064|FG000|Overall Study|Lost to Follow-up|0|||
164173698|NCT05174949|593000065|FG001|Overall Study|Lost to Follow-up|0|||
164173699|NCT05174949|593000066|FG002|Overall Study|Lost to Follow-up|0|||
164173700|NCT05174949|593000067|FG003|Overall Study|Lost to Follow-up|1|||
164173701|NCT05174949|593000068|FG004|Overall Study|Lost to Follow-up|0|||
164173702|NCT05174949|593000069|FG005|Overall Study|Lost to Follow-up|0|||
164173703|NCT02029989|593000070|FG000|Overall Study|Withdrawal by Subject|1|||
164173704|NCT02029989|593000071|FG001|Overall Study|Withdrawal by Subject|0|||
164173705|NCT02029989|593000070|FG000|Overall Study|Withdrawal: Fear of needles|1|||
164173706|NCT02029989|593000071|FG001|Overall Study|Withdrawal: Fear of needles|0|||
164173707|NCT02029989|593000070|FG000|Overall Study|Change of location|2|||
164173708|NCT02029989|593000071|FG001|Overall Study|Change of location|3|||
164173709|NCT02029989|593000070|FG000|Overall Study|Physician Decision|2|||
164173710|NCT02029989|593000071|FG001|Overall Study|Physician Decision|0|||
164173711|NCT02029989|593000070|FG000|Overall Study|Lost to Follow-up|9|||
164173712|NCT02029989|593000071|FG001|Overall Study|Lost to Follow-up|7|||
164173713|NCT02029989|593000070|FG000|Overall Study|Death|0|||
164173714|NCT02029989|593000071|FG001|Overall Study|Death|1|||
164173715|NCT02029989|593000070|FG000|Overall Study|Protocol Violation|1|||
164173716|NCT02029989|593000071|FG001|Overall Study|Protocol Violation|0|||
164173717|NCT04351373|593000072|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
164173718|NCT01123941|593000078|FG000|Overall Study|Lost to Follow-up|2|||
164173719|NCT01123941|593000079|FG001|Overall Study|Lost to Follow-up|1|||
164173720|NCT05036668|593000080|FG000|Overall Study|lost to follow Up|0|||
164173721|NCT05036668|593000081|FG001|Overall Study|lost to follow Up|0|||
164173722|NCT05036668|593000082|FG002|Overall Study|lost to follow Up|1|||
164173723|NCT01537068|593000083|FG000|Overall Study|Lost to Follow-up|2|||
164173724|NCT01537068|593000084|FG001|Overall Study|Lost to Follow-up|1|||
164173725|NCT01537068|593000083|FG000|Overall Study|Adverse Event|0|||
164173726|NCT01537068|593000084|FG001|Overall Study|Adverse Event|1|||
164173727|NCT01537068|593000083|FG000|Overall Study|Withdrawal by Subject|1|||
164173728|NCT01537068|593000084|FG001|Overall Study|Withdrawal by Subject|1|||
164173729|NCT01537068|593000083|FG000|Overall Study|Lack of Efficacy|1|||
164173730|NCT01537068|593000084|FG001|Overall Study|Lack of Efficacy|0|||
164173731|NCT06011161|593000085|FG000|Overall Study|Withdrawal by Subject|2|||
164173732|NCT06011161|593000085|FG000|Overall Study|Lost to Follow-up|5|||
164173733|NCT02291601|593000086|FG000|Abdomen|Did not qualify|333|||
164173734|NCT02291601|593000087|FG001|Abdomen|Did not qualify|54|||
164173735|NCT02291601|593000088|FG002|Abdomen|Did not qualify|339|||
164173736|NCT02291601|593000086|FG000|Groin|Did not qualify|183|||
164173737|NCT02291601|593000087|FG001|Groin|Did not qualify|30|||
164173738|NCT02291601|593000088|FG002|Groin|Did not qualify|177|||
164173739|NCT04017832|593000096|FG000|Overall Study|Withdrawal by Subject|13|||
164173740|NCT04017832|593000097|FG001|Overall Study|Withdrawal by Subject|12|||
164173741|NCT04017832|593000098|FG002|Overall Study|Withdrawal by Subject|21|||
164173742|NCT04017832|593000099|FG003|Overall Study|Withdrawal by Subject|7|||
164173743|NCT04017832|593000096|FG000|Overall Study|Lost to Follow-up|0|||
164173744|NCT04017832|593000097|FG001|Overall Study|Lost to Follow-up|3|||
164173745|NCT04017832|593000098|FG002|Overall Study|Lost to Follow-up|3|||
164173746|NCT04017832|593000099|FG003|Overall Study|Lost to Follow-up|1|||
164173747|NCT04017832|593000096|FG000|Overall Study|Physician Decision|1|||
164173748|NCT04017832|593000097|FG001|Overall Study|Physician Decision|1|||
164173749|NCT04017832|593000098|FG002|Overall Study|Physician Decision|1|||
164173750|NCT04017832|593000099|FG003|Overall Study|Physician Decision|1|||
164173751|NCT04017832|593000096|FG000|Overall Study|Death|2|||
164173752|NCT04017832|593000097|FG001|Overall Study|Death|2|||
164173753|NCT04017832|593000098|FG002|Overall Study|Death|1|||
164173754|NCT04017832|593000099|FG003|Overall Study|Death|0|||
164173755|NCT01744184|593000103|FG000|Overall Study|Adverse Event|1|||
164173756|NCT01744184|593000104|FG001|Overall Study|Adverse Event|0|||
164173757|NCT01744184|593000103|FG000|Overall Study|Withdrawal by Subject|0|||
164173758|NCT01744184|593000104|FG001|Overall Study|Withdrawal by Subject|1|||
164173759|NCT00072280|593000105|FG000|Treatment|Found ineligible|1|||
164173760|NCT00072280|593000106|FG001|Treatment|Found ineligible|2|||
164173761|NCT00072280|593000105|FG000|Follow-up|Early termination of study|2|||
164173762|NCT00072280|593000106|FG001|Follow-up|Early termination of study|2|||
164173763|NCT02091986|593000107|FG000|Overall Study|7 rand in error 1 patient decision|2|||
164173764|NCT02091986|593000108|FG001|Overall Study|7 rand in error 1 patient decision|3|||
164173765|NCT02091986|593000109|FG002|Overall Study|7 rand in error 1 patient decision|3|||
164173766|NCT02091986|593000107|FG000|Overall Study|Lost to Follow-up|1|||
164173767|NCT02091986|593000108|FG001|Overall Study|Lost to Follow-up|0|||
164173768|NCT02091986|593000109|FG002|Overall Study|Lost to Follow-up|0|||
164173769|NCT02091986|593000107|FG000|Overall Study|Withdrawal by Subject|4|||
164173770|NCT02091986|593000108|FG001|Overall Study|Withdrawal by Subject|8|||
164173771|NCT02091986|593000109|FG002|Overall Study|Withdrawal by Subject|3|||
164173772|NCT02091986|593000107|FG000|Overall Study|Adverse Event|0|||
164173773|NCT02091986|593000108|FG001|Overall Study|Adverse Event|0|||
164173774|NCT02091986|593000109|FG002|Overall Study|Adverse Event|2|||
164173775|NCT02841280|593000110|FG000|Overall Study|Adverse Event|2|||
164173776|NCT02841280|593000111|FG001|Overall Study|Adverse Event|1|||
164173777|NCT02841280|593000110|FG000|Overall Study|Death|1|||
164173778|NCT02841280|593000111|FG001|Overall Study|Death|0|||
164173779|NCT02841280|593000110|FG000|Overall Study|Lost to Follow-up|2|||
164173780|NCT02841280|593000111|FG001|Overall Study|Lost to Follow-up|2|||
164173781|NCT02841280|593000110|FG000|Overall Study|Withdrawal by Subject|7|||
164173782|NCT02841280|593000111|FG001|Overall Study|Withdrawal by Subject|3|||
164173783|NCT02841280|593000110|FG000|Overall Study|Stop Point: BP above threshold|2|||
164173784|NCT02841280|593000111|FG001|Overall Study|Stop Point: BP above threshold|0|||
164173785|NCT00125242|593000112|FG000|Overall Study|did not qualify|7|||
164173786|NCT00125242|593000113|FG001|Overall Study|did not qualify|2|||
164173787|NCT01664949|593000114|FG000|Overall Study|Adverse Event|11|||
164173788|NCT01664949|593000115|FG001|Overall Study|Adverse Event|12|||
164173789|NCT01664949|593000114|FG000|Overall Study|Lack of Efficacy|1|||
164173790|NCT01664949|593000115|FG001|Overall Study|Lack of Efficacy|1|||
164173791|NCT01664949|593000114|FG000|Overall Study|Lost to Follow-up|1|||
164173792|NCT01664949|593000115|FG001|Overall Study|Lost to Follow-up|2|||
164173793|NCT01664949|593000114|FG000|Overall Study|Personal Reasons|3|||
164173794|NCT01664949|593000115|FG001|Overall Study|Personal Reasons|4|||
164173795|NCT01664949|593000114|FG000|Overall Study|Protocol Violation|5|||
164173796|NCT01664949|593000115|FG001|Overall Study|Protocol Violation|5|||
164173797|NCT01664949|593000114|FG000|Overall Study|Other Miscellaneous Reasons|3|||
164173798|NCT01664949|593000115|FG001|Overall Study|Other Miscellaneous Reasons|1|||
164173799|NCT02727777|593000122|FG000|Overall Study|Screen Failure|2|||
164173800|NCT02727777|593000123|FG001|Overall Study|Screen Failure|0|||
164173801|NCT02727777|593000124|FG002|Overall Study|Screen Failure|0|||
164173802|NCT02727777|593000122|FG000|Overall Study|Progressive disease|2|||
164173803|NCT02727777|593000123|FG001|Overall Study|Progressive disease|0|||
164173804|NCT02727777|593000124|FG002|Overall Study|Progressive disease|0|||
164173805|NCT03003494|593000125|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
164173806|NCT00957268|593000126|FG000|Overall Study|Voluntary Withdrawal|0|||
164173807|NCT00957268|593000127|FG001|Overall Study|Voluntary Withdrawal|0|||
164173808|NCT00957268|593000128|FG002|Overall Study|Voluntary Withdrawal|1|||
164173809|NCT00957268|593000129|FG003|Overall Study|Voluntary Withdrawal|0|||
164173810|NCT00957268|593000130|FG004|Overall Study|Voluntary Withdrawal|0|||
164173811|NCT01738503|593000132|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
164173812|NCT01738503|593000133|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
164173813|NCT01738503|593000134|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
164173814|NCT01738503|593000135|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
164173815|NCT01738503|593000136|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
164173816|NCT01738503|593000137|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
164173817|NCT01738503|593000138|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
164173818|NCT01738503|593000132|FG000|Treatment Period|Adverse Event|0|||
164173819|NCT01738503|593000133|FG001|Treatment Period|Adverse Event|1|||
164173820|NCT01738503|593000134|FG002|Treatment Period|Adverse Event|0|||
164173821|NCT01738503|593000135|FG003|Treatment Period|Adverse Event|1|||
164173822|NCT01738503|593000136|FG004|Treatment Period|Adverse Event|2|||
164173823|NCT01738503|593000137|FG005|Treatment Period|Adverse Event|2|||
164173824|NCT01738503|593000138|FG006|Treatment Period|Adverse Event|2|||
164173825|NCT01738503|593000132|FG000|Treatment Period|Lost to Follow-up|0|||
164173826|NCT01738503|593000133|FG001|Treatment Period|Lost to Follow-up|0|||
164173827|NCT01738503|593000134|FG002|Treatment Period|Lost to Follow-up|3|||
164173828|NCT01738503|593000135|FG003|Treatment Period|Lost to Follow-up|4|||
164173829|NCT01738503|593000136|FG004|Treatment Period|Lost to Follow-up|1|||
164173830|NCT01738503|593000137|FG005|Treatment Period|Lost to Follow-up|1|||
164173831|NCT01738503|593000138|FG006|Treatment Period|Lost to Follow-up|5|||
164173832|NCT01738503|593000132|FG000|Treatment Period|Withdrawal by Subject|0|||
164173833|NCT01738503|593000133|FG001|Treatment Period|Withdrawal by Subject|1|||
164173834|NCT01738503|593000134|FG002|Treatment Period|Withdrawal by Subject|0|||
164173835|NCT01738503|593000135|FG003|Treatment Period|Withdrawal by Subject|1|||
164173836|NCT01738503|593000136|FG004|Treatment Period|Withdrawal by Subject|1|||
164173837|NCT01738503|593000137|FG005|Treatment Period|Withdrawal by Subject|1|||
164173838|NCT01738503|593000138|FG006|Treatment Period|Withdrawal by Subject|1|||
164173839|NCT01738503|593000132|FG000|Treatment Period|Protocol Violation|0|||
164173840|NCT01738503|593000133|FG001|Treatment Period|Protocol Violation|3|||
164173841|NCT01738503|593000134|FG002|Treatment Period|Protocol Violation|1|||
164173842|NCT01738503|593000135|FG003|Treatment Period|Protocol Violation|0|||
164173843|NCT01738503|593000136|FG004|Treatment Period|Protocol Violation|4|||
164173844|NCT01738503|593000137|FG005|Treatment Period|Protocol Violation|2|||
164173845|NCT01738503|593000138|FG006|Treatment Period|Protocol Violation|0|||
164173846|NCT01738503|593000132|FG000|Treatment Period|Other|0|||
164173847|NCT01738503|593000133|FG001|Treatment Period|Other|0|||
164173848|NCT01738503|593000134|FG002|Treatment Period|Other|1|||
164173849|NCT01738503|593000135|FG003|Treatment Period|Other|0|||
164173850|NCT01738503|593000136|FG004|Treatment Period|Other|0|||
164173851|NCT01738503|593000137|FG005|Treatment Period|Other|0|||
164173852|NCT01738503|593000138|FG006|Treatment Period|Other|0|||
164173853|NCT01738503|593000132|FG000|PET Imaging Sub-study|Adverse Event|0|||
164173854|NCT01738503|593000133|FG001|PET Imaging Sub-study|Adverse Event|0|||
164173855|NCT01738503|593000134|FG002|PET Imaging Sub-study|Adverse Event|0|||
164173856|NCT01738503|593000135|FG003|PET Imaging Sub-study|Adverse Event|0|||
164173857|NCT01738503|593000136|FG004|PET Imaging Sub-study|Adverse Event|0|||
164173858|NCT01738503|593000137|FG005|PET Imaging Sub-study|Adverse Event|1|||
164173859|NCT01738503|593000138|FG006|PET Imaging Sub-study|Adverse Event|0|||
164173860|NCT01738503|593000132|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
164173861|NCT01738503|593000133|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
164173862|NCT01738503|593000134|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
164173863|NCT01738503|593000135|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
164173864|NCT01738503|593000136|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
164173865|NCT01738503|593000137|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
164173866|NCT01738503|593000138|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
164173867|NCT03005327|593000139|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
164173868|NCT03005327|593000140|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
164173869|NCT03005327|593000141|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
164173870|NCT03005327|593000142|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
164173871|NCT03005327|593000139|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164173872|NCT03005327|593000140|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
164173873|NCT03005327|593000141|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164173874|NCT03005327|593000142|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164173875|NCT01340027|593000143|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
164173876|NCT01340027|593000144|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
164173877|NCT01340027|593000145|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
164173878|NCT01340027|593000146|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
164173879|NCT01340027|593000147|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
164173880|NCT01340027|593000148|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
164173881|NCT01340027|593000149|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
164173882|NCT01340027|593000150|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
164173883|NCT01340027|593000151|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
164173884|NCT01340027|593000152|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
164173885|NCT01340027|593000153|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
164173886|NCT01340027|593000154|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
164173887|NCT01340027|593000143|FG000|Overall Study|Adverse Event|0|||
164173888|NCT01340027|593000144|FG001|Overall Study|Adverse Event|1|||
164173889|NCT01340027|593000145|FG002|Overall Study|Adverse Event|2|||
164173890|NCT01340027|593000146|FG003|Overall Study|Adverse Event|0|||
164173891|NCT01340027|593000147|FG004|Overall Study|Adverse Event|1|||
164173892|NCT01340027|593000148|FG005|Overall Study|Adverse Event|2|||
164173893|NCT01340027|593000149|FG006|Overall Study|Adverse Event|2|||
164173894|NCT01340027|593000150|FG007|Overall Study|Adverse Event|1|||
164173895|NCT01340027|593000151|FG008|Overall Study|Adverse Event|4|||
164173896|NCT01340027|593000152|FG009|Overall Study|Adverse Event|1|||
164173897|NCT01340027|593000153|FG010|Overall Study|Adverse Event|1|||
164173898|NCT01340027|593000154|FG011|Overall Study|Adverse Event|3|||
164173899|NCT01340027|593000143|FG000|Overall Study|Lack of Efficacy|0|||
164173900|NCT01340027|593000144|FG001|Overall Study|Lack of Efficacy|0|||
164173901|NCT01340027|593000145|FG002|Overall Study|Lack of Efficacy|0|||
164173902|NCT01340027|593000146|FG003|Overall Study|Lack of Efficacy|0|||
164173903|NCT01340027|593000147|FG004|Overall Study|Lack of Efficacy|0|||
164173904|NCT01340027|593000148|FG005|Overall Study|Lack of Efficacy|0|||
164173905|NCT01340027|593000149|FG006|Overall Study|Lack of Efficacy|1|||
164173906|NCT01340027|593000150|FG007|Overall Study|Lack of Efficacy|1|||
164173907|NCT01340027|593000151|FG008|Overall Study|Lack of Efficacy|1|||
164173908|NCT01340027|593000152|FG009|Overall Study|Lack of Efficacy|0|||
164173909|NCT01340027|593000153|FG010|Overall Study|Lack of Efficacy|0|||
164173910|NCT01340027|593000154|FG011|Overall Study|Lack of Efficacy|0|||
164173911|NCT01340027|593000143|FG000|Overall Study|Lost to Follow-up|0|||
164173912|NCT01340027|593000144|FG001|Overall Study|Lost to Follow-up|1|||
164173913|NCT01340027|593000145|FG002|Overall Study|Lost to Follow-up|0|||
164173914|NCT01340027|593000146|FG003|Overall Study|Lost to Follow-up|0|||
164173915|NCT01340027|593000147|FG004|Overall Study|Lost to Follow-up|0|||
164173916|NCT01340027|593000148|FG005|Overall Study|Lost to Follow-up|0|||
164173917|NCT01340027|593000149|FG006|Overall Study|Lost to Follow-up|1|||
164173918|NCT01340027|593000150|FG007|Overall Study|Lost to Follow-up|0|||
164173919|NCT01340027|593000151|FG008|Overall Study|Lost to Follow-up|0|||
164173920|NCT01340027|593000152|FG009|Overall Study|Lost to Follow-up|1|||
164173921|NCT01340027|593000153|FG010|Overall Study|Lost to Follow-up|0|||
164173922|NCT01340027|593000154|FG011|Overall Study|Lost to Follow-up|0|||
164173923|NCT01340027|593000143|FG000|Overall Study|Protocol Violation|1|||
164173924|NCT01340027|593000144|FG001|Overall Study|Protocol Violation|2|||
164173925|NCT01340027|593000145|FG002|Overall Study|Protocol Violation|0|||
164173926|NCT01340027|593000146|FG003|Overall Study|Protocol Violation|0|||
164173927|NCT01340027|593000147|FG004|Overall Study|Protocol Violation|6|||
164173928|NCT01340027|593000148|FG005|Overall Study|Protocol Violation|0|||
164173929|NCT01340027|593000149|FG006|Overall Study|Protocol Violation|0|||
164173930|NCT01340027|593000150|FG007|Overall Study|Protocol Violation|1|||
164173931|NCT01340027|593000151|FG008|Overall Study|Protocol Violation|2|||
164173932|NCT01340027|593000152|FG009|Overall Study|Protocol Violation|2|||
164173933|NCT01340027|593000153|FG010|Overall Study|Protocol Violation|0|||
164173934|NCT01340027|593000154|FG011|Overall Study|Protocol Violation|0|||
164173935|NCT01340027|593000143|FG000|Overall Study|Withdrawal by Subject|4|||
164173936|NCT01340027|593000144|FG001|Overall Study|Withdrawal by Subject|3|||
164173937|NCT01340027|593000145|FG002|Overall Study|Withdrawal by Subject|1|||
164173938|NCT01340027|593000146|FG003|Overall Study|Withdrawal by Subject|3|||
164173939|NCT01340027|593000147|FG004|Overall Study|Withdrawal by Subject|3|||
164173940|NCT01340027|593000148|FG005|Overall Study|Withdrawal by Subject|2|||
164173941|NCT01340027|593000149|FG006|Overall Study|Withdrawal by Subject|3|||
164173942|NCT01340027|593000150|FG007|Overall Study|Withdrawal by Subject|4|||
164173943|NCT01340027|593000151|FG008|Overall Study|Withdrawal by Subject|1|||
164173944|NCT01340027|593000152|FG009|Overall Study|Withdrawal by Subject|2|||
164173945|NCT01340027|593000153|FG010|Overall Study|Withdrawal by Subject|0|||
164173946|NCT01340027|593000154|FG011|Overall Study|Withdrawal by Subject|1|||
164173947|NCT01340027|593000143|FG000|Overall Study|Miscellaneous|0|||
164173948|NCT01340027|593000144|FG001|Overall Study|Miscellaneous|0|||
164173949|NCT01340027|593000145|FG002|Overall Study|Miscellaneous|0|||
164173950|NCT01340027|593000146|FG003|Overall Study|Miscellaneous|1|||
164173951|NCT01340027|593000147|FG004|Overall Study|Miscellaneous|0|||
164173952|NCT01340027|593000148|FG005|Overall Study|Miscellaneous|0|||
164173953|NCT01340027|593000149|FG006|Overall Study|Miscellaneous|0|||
164173954|NCT01340027|593000150|FG007|Overall Study|Miscellaneous|0|||
164173955|NCT01340027|593000151|FG008|Overall Study|Miscellaneous|0|||
164173956|NCT01340027|593000152|FG009|Overall Study|Miscellaneous|0|||
164173957|NCT01340027|593000153|FG010|Overall Study|Miscellaneous|1|||
164173958|NCT01340027|593000154|FG011|Overall Study|Miscellaneous|0|||
164173959|NCT00833482|593000155|FG000|Days 11-20|Adverse Event|0|||
164173960|NCT00833482|593000156|FG001|Days 11-20|Adverse Event|2|||
164173961|NCT00833482|593000157|FG002|Days 11-20|Adverse Event|0|||
164173962|NCT00833482|593000158|FG003|Days 11-20|Adverse Event|0|||
164173963|NCT00833482|593000159|FG004|Days 11-20|Adverse Event|0|||
164173964|NCT00833482|593000160|FG005|Days 11-20|Adverse Event|0|||
164173965|NCT00833482|593000155|FG000|Days 11-20|Withdrawal by Subject|0|||
164173966|NCT00833482|593000156|FG001|Days 11-20|Withdrawal by Subject|1|||
164173967|NCT00833482|593000157|FG002|Days 11-20|Withdrawal by Subject|0|||
164173968|NCT00833482|593000158|FG003|Days 11-20|Withdrawal by Subject|0|||
164173969|NCT00833482|593000159|FG004|Days 11-20|Withdrawal by Subject|0|||
164173970|NCT00833482|593000160|FG005|Days 11-20|Withdrawal by Subject|0|||
164173971|NCT00833482|593000155|FG000|Days 21-30|Adverse Event|0|||
164173972|NCT00833482|593000156|FG001|Days 21-30|Adverse Event|0|||
164173973|NCT00833482|593000157|FG002|Days 21-30|Adverse Event|1|||
164173974|NCT00833482|593000158|FG003|Days 21-30|Adverse Event|0|||
164173975|NCT00833482|593000159|FG004|Days 21-30|Adverse Event|0|||
164173976|NCT00833482|593000160|FG005|Days 21-30|Adverse Event|0|||
164173977|NCT00833482|593000155|FG000|Days 21-30|Withdrawal by Subject|0|||
164173978|NCT00833482|593000156|FG001|Days 21-30|Withdrawal by Subject|0|||
164173979|NCT00833482|593000157|FG002|Days 21-30|Withdrawal by Subject|0|||
164173980|NCT00833482|593000158|FG003|Days 21-30|Withdrawal by Subject|0|||
164173981|NCT00833482|593000159|FG004|Days 21-30|Withdrawal by Subject|1|||
164173982|NCT00833482|593000160|FG005|Days 21-30|Withdrawal by Subject|0|||
164173983|NCT00915876|593000161|FG000|Overall Study|Adverse Event|0|||
164173984|NCT00915876|593000162|FG001|Overall Study|Adverse Event|1|||
164173985|NCT02496091|593000168|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
164173986|NCT02272842|593000169|FG000|Overall Study|Lost to Follow-up|8|||
164173987|NCT02272842|593000170|FG001|Overall Study|Lost to Follow-up|8|||
164173988|NCT02272842|593000169|FG000|Overall Study|Withdrawal by Subject|8|||
164173989|NCT02272842|593000170|FG001|Overall Study|Withdrawal by Subject|2|||
164173990|NCT01794793|593000172|FG000|Treatment Period|Withdrawal by Subject|24|||
164173991|NCT01794793|593000172|FG000|Treatment Period|Lack of Efficacy|22|||
164173992|NCT01794793|593000172|FG000|Treatment Period|Adverse Event|17|||
164173993|NCT01794793|593000172|FG000|Treatment Period|Physician Decision|14|||
164173994|NCT01794793|593000172|FG000|Treatment Period|Lost to Follow-up|7|||
164173995|NCT01794793|593000172|FG000|Treatment Period|Death|6|||
164173996|NCT01794793|593000172|FG000|Treatment Period|Protocol Violation|5|||
164173997|NCT01794793|593000172|FG000|Treatment Period|administrative problem|3|||
164173998|NCT01794793|593000172|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
164173999|NCT01794793|593000172|FG000|Post-treatment Follow-up|Adverse Event|8|||
164174000|NCT01794793|593000172|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
164174001|NCT01794793|593000172|FG000|Post-treatment Follow-up|administrative problem|5|||
164174002|NCT01794793|593000172|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
164174003|NCT01794793|593000172|FG000|Post-treatment Follow-up|Protocol Violation|3|||
164174004|NCT02234596|593000173|FG000|Overall Study|Participant not treated|2|||
164174005|NCT04852679|593000174|FG000|Main Intervention Period|Withdrawal by Subject|3|||
164174006|NCT04852679|593000174|FG000|Main Intervention Period|Adverse Event|1|||
164174007|NCT04852679|593000174|FG000|Main Intervention Period|Progressive Disease|16|||
164174008|NCT04852679|593000174|FG000|Main Intervention Period|Refused study visit|1|||
164174009|NCT04852679|593000174|FG000|Independent Injection Period|Missed study visit|1|||
164174010|NCT01632904|593001636|FG000|Overall Study|Adverse Event|4|||
164174011|NCT01632904|593001637|FG001|Overall Study|Adverse Event|1|||
164174012|NCT01632904|593001636|FG000|Overall Study|Physician Decision|0|||
164174013|NCT01632904|593001637|FG001|Overall Study|Physician Decision|1|||
164174014|NCT01632904|593001636|FG000|Overall Study|Subject decision|3|||
164174015|NCT01632904|593001637|FG001|Overall Study|Subject decision|2|||
164174016|NCT01632904|593001636|FG000|Overall Study|Disease Progression|0|||
164174017|NCT01632904|593001637|FG001|Overall Study|Disease Progression|1|||
164174018|NCT01632904|593001636|FG000|Overall Study|Reason for discontinuation not available|0|||
164174019|NCT01632904|593001637|FG001|Overall Study|Reason for discontinuation not available|1|||
164174020|NCT01752634|593001641|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
164174021|NCT01752634|593001642|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
164174022|NCT01752634|593001643|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
164174023|NCT01752634|593001644|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
164174024|NCT01752634|593001645|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
164174025|NCT01752634|593001646|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
164174026|NCT01752634|593001641|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
164174027|NCT01752634|593001642|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
164174028|NCT01752634|593001643|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
164174029|NCT01752634|593001644|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
164174030|NCT01752634|593001645|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
164174031|NCT01752634|593001646|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
164174032|NCT01752634|593001641|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
164174033|NCT01752634|593001642|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
164174034|NCT01752634|593001643|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
164174035|NCT01752634|593001644|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
164174036|NCT01752634|593001645|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
164174037|NCT01752634|593001646|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
164174038|NCT01752634|593001641|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
164174039|NCT01752634|593001642|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
164174040|NCT01752634|593001643|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
164174041|NCT01752634|593001644|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
164174042|NCT01752634|593001645|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
164174043|NCT01752634|593001646|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
164174044|NCT01752634|593001641|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
164174045|NCT01752634|593001642|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
164174046|NCT01752634|593001643|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
164174047|NCT01752634|593001644|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
164174048|NCT01752634|593001645|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
164174049|NCT01752634|593001646|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
164174050|NCT01752634|593001641|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
164174051|NCT01752634|593001642|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
164174052|NCT01752634|593001643|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
164174053|NCT01752634|593001644|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
164174054|NCT01752634|593001645|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
164174055|NCT01752634|593001646|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
164174056|NCT01752634|593001641|FG000|Week 24 to Week 260|Physician Decision|1|||
164174057|NCT01752634|593001642|FG001|Week 24 to Week 260|Physician Decision|2|||
164174058|NCT01752634|593001643|FG002|Week 24 to Week 260|Physician Decision|4|||
164174059|NCT01752634|593001644|FG003|Week 24 to Week 260|Physician Decision|2|||
164174060|NCT01752634|593001645|FG004|Week 24 to Week 260|Physician Decision|1|||
164174061|NCT01752634|593001646|FG005|Week 24 to Week 260|Physician Decision|0|||
164174062|NCT01752634|593001641|FG000|Week 24 to Week 260|Death|0|||
164174063|NCT01752634|593001642|FG001|Week 24 to Week 260|Death|1|||
164174064|NCT01752634|593001643|FG002|Week 24 to Week 260|Death|0|||
164174065|NCT01752634|593001644|FG003|Week 24 to Week 260|Death|0|||
164174066|NCT01752634|593001645|FG004|Week 24 to Week 260|Death|0|||
164174067|NCT01752634|593001646|FG005|Week 24 to Week 260|Death|0|||
164174068|NCT01752634|593001641|FG000|Week 24 to Week 260|Pregnancy|0|||
164174069|NCT01752634|593001642|FG001|Week 24 to Week 260|Pregnancy|0|||
164174070|NCT01752634|593001643|FG002|Week 24 to Week 260|Pregnancy|1|||
164174071|NCT01752634|593001644|FG003|Week 24 to Week 260|Pregnancy|0|||
164174072|NCT01752634|593001645|FG004|Week 24 to Week 260|Pregnancy|0|||
164174073|NCT01752634|593001646|FG005|Week 24 to Week 260|Pregnancy|0|||
164174074|NCT01752634|593001641|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
164174075|NCT01752634|593001642|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
164174076|NCT01752634|593001643|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
164174077|NCT01752634|593001644|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
164174078|NCT01752634|593001645|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
164174079|NCT01752634|593001646|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
164174080|NCT01752634|593001641|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
164174081|NCT01752634|593001642|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
164174082|NCT01752634|593001643|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
164174083|NCT01752634|593001644|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
164174084|NCT01752634|593001645|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
164174085|NCT01752634|593001646|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
164174086|NCT01752634|593001641|FG000|Week 24 to Week 260|Adverse Event|4|||
164174087|NCT01752634|593001642|FG001|Week 24 to Week 260|Adverse Event|8|||
164174088|NCT01752634|593001643|FG002|Week 24 to Week 260|Adverse Event|8|||
164174089|NCT01752634|593001644|FG003|Week 24 to Week 260|Adverse Event|4|||
164174090|NCT01752634|593001645|FG004|Week 24 to Week 260|Adverse Event|2|||
164174091|NCT01752634|593001646|FG005|Week 24 to Week 260|Adverse Event|0|||
164174092|NCT04697056|593001655|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
164174093|NCT04697056|593001656|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
164174094|NCT04542499|593001657|FG000|Overall Study|Adverse Event|23|||
164174095|NCT04542499|593001658|FG001|Overall Study|Adverse Event|43|||
164174096|NCT04542499|593001657|FG000|Overall Study|Lack of Efficacy|5|||
164174097|NCT04542499|593001658|FG001|Overall Study|Lack of Efficacy|2|||
164174098|NCT04542499|593001657|FG000|Overall Study|Lost to Follow-up|3|||
164174099|NCT04542499|593001658|FG001|Overall Study|Lost to Follow-up|4|||
164174100|NCT04542499|593001657|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
164174101|NCT04542499|593001658|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
164174102|NCT04542499|593001657|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
164174103|NCT04542499|593001658|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
164174104|NCT04542499|593001657|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164174105|NCT04542499|593001658|FG001|Overall Study|Non-Compliance with Study Drug|2|||
164174106|NCT04542499|593001657|FG000|Overall Study|Physician Decision|0|||
164174107|NCT04542499|593001658|FG001|Overall Study|Physician Decision|1|||
164174108|NCT04542499|593001657|FG000|Overall Study|Site Terminated by Sponsor|3|||
164174109|NCT04542499|593001658|FG001|Overall Study|Site Terminated by Sponsor|5|||
164174110|NCT04542499|593001657|FG000|Overall Study|Withdrawal by Subject|12|||
164174111|NCT04542499|593001658|FG001|Overall Study|Withdrawal by Subject|33|||
164174112|NCT04542499|593001657|FG000|Overall Study|Other|2|||
164174113|NCT04542499|593001658|FG001|Overall Study|Other|2|||
164174114|NCT05906836|593001662|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
164174115|NCT05906836|593001662|FG000|Overall Study|Lost to Follow-up|1|||
164174116|NCT04035434|593001665|FG000|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174117|NCT04035434|593001666|FG001|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
164174118|NCT04035434|593001667|FG002|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174119|NCT04035434|593001668|FG003|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|2|||
164174120|NCT04035434|593001669|FG004|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
164174121|NCT04035434|593001670|FG005|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174122|NCT04035434|593001671|FG006|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174123|NCT04035434|593001672|FG007|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174124|NCT04035434|593001673|FG008|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174125|NCT04035434|593001674|FG009|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174126|NCT04035434|593001675|FG010|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
164174127|NCT04035434|593001676|FG011|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
164174128|NCT04035434|593001677|FG012|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174129|NCT04035434|593001665|FG000|Dose Escalation Phase (Up to 5 Years)|Death|3|||
164174130|NCT04035434|593001666|FG001|Dose Escalation Phase (Up to 5 Years)|Death|1|||
164174131|NCT04035434|593001667|FG002|Dose Escalation Phase (Up to 5 Years)|Death|4|||
164174132|NCT04035434|593001668|FG003|Dose Escalation Phase (Up to 5 Years)|Death|3|||
164174133|NCT04035434|593001669|FG004|Dose Escalation Phase (Up to 5 Years)|Death|8|||
164174134|NCT04035434|593001670|FG005|Dose Escalation Phase (Up to 5 Years)|Death|3|||
164174135|NCT04035434|593001671|FG006|Dose Escalation Phase (Up to 5 Years)|Death|0|||
164174136|NCT04035434|593001672|FG007|Dose Escalation Phase (Up to 5 Years)|Death|1|||
164174137|NCT04035434|593001673|FG008|Dose Escalation Phase (Up to 5 Years)|Death|3|||
164174138|NCT04035434|593001674|FG009|Dose Escalation Phase (Up to 5 Years)|Death|4|||
164174139|NCT04035434|593001675|FG010|Dose Escalation Phase (Up to 5 Years)|Death|3|||
164174140|NCT04035434|593001676|FG011|Dose Escalation Phase (Up to 5 Years)|Death|2|||
164174141|NCT04035434|593001677|FG012|Dose Escalation Phase (Up to 5 Years)|Death|1|||
164174142|NCT04035434|593001665|FG000|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174143|NCT04035434|593001666|FG001|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
164174144|NCT04035434|593001667|FG002|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
164174145|NCT04035434|593001668|FG003|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174146|NCT04035434|593001669|FG004|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
164174147|NCT04035434|593001670|FG005|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
164174148|NCT04035434|593001671|FG006|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174149|NCT04035434|593001672|FG007|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174150|NCT04035434|593001673|FG008|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
164174151|NCT04035434|593001674|FG009|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
164174152|NCT04035434|593001675|FG010|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174153|NCT04035434|593001676|FG011|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
164174154|NCT04035434|593001677|FG012|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|6|||
164174155|NCT04035434|593001665|FG000|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
164174156|NCT04035434|593001666|FG001|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
164174157|NCT04035434|593001667|FG002|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
164174158|NCT04035434|593001668|FG003|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|1|||
164174159|NCT04035434|593001669|FG004|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
164174160|NCT04035434|593001670|FG005|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
164174161|NCT04035434|593001671|FG006|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
164174162|NCT04035434|593001672|FG007|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
164174163|NCT04035434|593001673|FG008|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
164174164|NCT04035434|593001674|FG009|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
164174165|NCT04035434|593001675|FG010|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
164174166|NCT04035434|593001676|FG011|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
164174167|NCT04035434|593001677|FG012|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
164174168|NCT04035434|593001665|FG000|Dose Expansion Phase (Up to 5 Years)|Death|0|||
164174169|NCT04035434|593001666|FG001|Dose Expansion Phase (Up to 5 Years)|Death|0|||
164174170|NCT04035434|593001667|FG002|Dose Expansion Phase (Up to 5 Years)|Death|0|||
164174171|NCT04035434|593001668|FG003|Dose Expansion Phase (Up to 5 Years)|Death|0|||
164174172|NCT04035434|593001669|FG004|Dose Expansion Phase (Up to 5 Years)|Death|0|||
164174173|NCT04035434|593001670|FG005|Dose Expansion Phase (Up to 5 Years)|Death|14|||
164174174|NCT04035434|593001671|FG006|Dose Expansion Phase (Up to 5 Years)|Death|3|||
164174175|NCT04035434|593001672|FG007|Dose Expansion Phase (Up to 5 Years)|Death|0|||
164174176|NCT04035434|593001673|FG008|Dose Expansion Phase (Up to 5 Years)|Death|0|||
164174177|NCT04035434|593001674|FG009|Dose Expansion Phase (Up to 5 Years)|Death|0|||
164174178|NCT04035434|593001675|FG010|Dose Expansion Phase (Up to 5 Years)|Death|0|||
164174179|NCT04035434|593001676|FG011|Dose Expansion Phase (Up to 5 Years)|Death|0|||
164174180|NCT04035434|593001677|FG012|Dose Expansion Phase (Up to 5 Years)|Death|0|||
164174181|NCT04035434|593001665|FG000|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174182|NCT04035434|593001666|FG001|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174183|NCT04035434|593001667|FG002|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174184|NCT04035434|593001668|FG003|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174185|NCT04035434|593001669|FG004|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174186|NCT04035434|593001670|FG005|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
164174187|NCT04035434|593001671|FG006|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
164174188|NCT04035434|593001672|FG007|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174189|NCT04035434|593001673|FG008|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174190|NCT04035434|593001674|FG009|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174191|NCT04035434|593001675|FG010|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174192|NCT04035434|593001676|FG011|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174193|NCT04035434|593001677|FG012|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174194|NCT04035434|593001665|FG000|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174195|NCT04035434|593001666|FG001|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174196|NCT04035434|593001667|FG002|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174197|NCT04035434|593001668|FG003|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174198|NCT04035434|593001669|FG004|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174199|NCT04035434|593001670|FG005|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|8|||
164174200|NCT04035434|593001671|FG006|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|4|||
164174201|NCT04035434|593001672|FG007|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174202|NCT04035434|593001673|FG008|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174203|NCT04035434|593001674|FG009|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174204|NCT04035434|593001675|FG010|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174205|NCT04035434|593001676|FG011|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174206|NCT04035434|593001677|FG012|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174207|NCT04488497|593001678|FG000|Randomization/Baseline Assessment|Lost to Follow-up|2|||
164174208|NCT04488497|593001679|FG001|Randomization/Baseline Assessment|Lost to Follow-up|3|||
164174209|NCT04488497|593001678|FG000|Intervention|Physician Decision|2|||
164174210|NCT04488497|593001679|FG001|Intervention|Physician Decision|1|||
164174211|NCT04488497|593001678|FG000|Intervention|Withdrawal by Subject|5|||
164174212|NCT04488497|593001679|FG001|Intervention|Withdrawal by Subject|6|||
164174213|NCT04488497|593001678|FG000|Intervention|Lost to Follow-up|2|||
164174214|NCT04488497|593001679|FG001|Intervention|Lost to Follow-up|0|||
164174215|NCT04488497|593001678|FG000|1-Week Post-Intervention Data Collection|Lost to Follow-up|0|||
164174216|NCT04488497|593001679|FG001|1-Week Post-Intervention Data Collection|Lost to Follow-up|2|||
164174217|NCT04488497|593001678|FG000|3-Months Post-Intervention|Lost to Follow-up|0|||
164174218|NCT04488497|593001679|FG001|3-Months Post-Intervention|Lost to Follow-up|2|||
164174219|NCT04322539|593001680|FG000|Overall Study|Adverse Event|2|||
164174220|NCT04322539|593001681|FG001|Overall Study|Adverse Event|0|||
164174221|NCT04322539|593001680|FG000|Overall Study|Death|411|||
164174222|NCT04322539|593001681|FG001|Overall Study|Death|203|||
164174223|NCT04322539|593001680|FG000|Overall Study|Lost to Follow-up|3|||
164174224|NCT04322539|593001681|FG001|Overall Study|Lost to Follow-up|1|||
164174225|NCT04322539|593001680|FG000|Overall Study|Withdrawal of consent|14|||
164174226|NCT04322539|593001681|FG001|Overall Study|Withdrawal of consent|8|||
164174227|NCT04322539|593001680|FG000|Overall Study|Radiological Disease Progression|6|||
164174228|NCT04322539|593001681|FG001|Overall Study|Radiological Disease Progression|0|||
164174229|NCT04322539|593001680|FG000|Overall Study|Sponsor Decision|19|||
164174230|NCT04322539|593001681|FG001|Overall Study|Sponsor Decision|14|||
164174231|NCT04322539|593001680|FG000|Overall Study|Other|6|||
164174232|NCT04322539|593001681|FG001|Overall Study|Other|4|||
164174233|NCT04161079|593001684|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
164174234|NCT01702532|593001685|FG000|Overall Study|Adverse Event|0|||
164174235|NCT01702532|593001686|FG001|Overall Study|Adverse Event|1|||
164174236|NCT03617861|593001687|FG000|Second Intervention (1 Day)|Adverse Event|0|||
164174237|NCT03617861|593001688|FG001|Second Intervention (1 Day)|Adverse Event|0|||
164174238|NCT03617861|593001689|FG002|Second Intervention (1 Day)|Adverse Event|1|||
164174239|NCT03617861|593001690|FG003|Second Intervention (1 Day)|Adverse Event|0|||
164174240|NCT01451164|593001691|FG000|Overall Study|Adverse Event|19|||
164174241|NCT01451164|593001692|FG001|Overall Study|Adverse Event|12|||
164174242|NCT01451164|593001693|FG002|Overall Study|Adverse Event|18|||
164174243|NCT01451164|593001694|FG003|Overall Study|Adverse Event|21|||
164174244|NCT01451164|593001691|FG000|Overall Study|Withdrawal Criteria|1|||
164174245|NCT01451164|593001692|FG001|Overall Study|Withdrawal Criteria|1|||
164174246|NCT01451164|593001693|FG002|Overall Study|Withdrawal Criteria|1|||
164174247|NCT01451164|593001694|FG003|Overall Study|Withdrawal Criteria|1|||
164174248|NCT01451164|593001691|FG000|Overall Study|Physician Decision|2|||
164174249|NCT01451164|593001692|FG001|Overall Study|Physician Decision|0|||
164174250|NCT01451164|593001693|FG002|Overall Study|Physician Decision|1|||
164174251|NCT01451164|593001694|FG003|Overall Study|Physician Decision|0|||
164174252|NCT01451164|593001691|FG000|Overall Study|Withdrawal by Subject|14|||
164174253|NCT01451164|593001692|FG001|Overall Study|Withdrawal by Subject|11|||
164174254|NCT01451164|593001693|FG002|Overall Study|Withdrawal by Subject|16|||
164174255|NCT01451164|593001694|FG003|Overall Study|Withdrawal by Subject|17|||
164174256|NCT01451164|593001691|FG000|Overall Study|Protocol Violation|0|||
164174257|NCT01451164|593001692|FG001|Overall Study|Protocol Violation|1|||
164174258|NCT01451164|593001693|FG002|Overall Study|Protocol Violation|0|||
164174259|NCT01451164|593001694|FG003|Overall Study|Protocol Violation|0|||
164174260|NCT01451164|593001691|FG000|Overall Study|Lack of Efficacy|7|||
164174261|NCT01451164|593001692|FG001|Overall Study|Lack of Efficacy|9|||
164174262|NCT01451164|593001693|FG002|Overall Study|Lack of Efficacy|9|||
164174263|NCT01451164|593001694|FG003|Overall Study|Lack of Efficacy|7|||
164174264|NCT00308750|593001697|FG000|Overall Study|Adverse Event|9|||
164174265|NCT00308750|593001698|FG001|Overall Study|Adverse Event|9|||
164174266|NCT00308750|593001699|FG002|Overall Study|Adverse Event|13|||
164174267|NCT00308750|593001697|FG000|Overall Study|Withdrawal by Subject|6|||
164174268|NCT00308750|593001698|FG001|Overall Study|Withdrawal by Subject|2|||
164174269|NCT00308750|593001699|FG002|Overall Study|Withdrawal by Subject|3|||
164174270|NCT00308750|593001697|FG000|Overall Study|Physician Decision|3|||
164174271|NCT00308750|593001698|FG001|Overall Study|Physician Decision|4|||
164174272|NCT00308750|593001699|FG002|Overall Study|Physician Decision|3|||
164174273|NCT00308750|593001697|FG000|Overall Study|Sponsor Decision|1|||
164174274|NCT00308750|593001698|FG001|Overall Study|Sponsor Decision|0|||
164174275|NCT00308750|593001699|FG002|Overall Study|Sponsor Decision|0|||
164174276|NCT00308750|593001697|FG000|Overall Study|Disease Progression|47|||
164174277|NCT00308750|593001698|FG001|Overall Study|Disease Progression|24|||
164174278|NCT00308750|593001699|FG002|Overall Study|Disease Progression|28|||
164174279|NCT00308750|593001697|FG000|Overall Study|Unrelated Complication|3|||
164174280|NCT00308750|593001698|FG001|Overall Study|Unrelated Complication|0|||
164174281|NCT00308750|593001699|FG002|Overall Study|Unrelated Complication|1|||
164174282|NCT00308750|593001697|FG000|Overall Study|Death|1|||
164174283|NCT00308750|593001698|FG001|Overall Study|Death|0|||
164174284|NCT00308750|593001699|FG002|Overall Study|Death|1|||
164174285|NCT00308750|593001697|FG000|Overall Study|Protocol Violation|1|||
164174286|NCT00308750|593001698|FG001|Overall Study|Protocol Violation|0|||
164174287|NCT00308750|593001699|FG002|Overall Study|Protocol Violation|0|||
164174288|NCT00308750|593001697|FG000|Overall Study|New Primary Disease Identified|1|||
164174289|NCT00308750|593001698|FG001|Overall Study|New Primary Disease Identified|1|||
164174290|NCT00308750|593001699|FG002|Overall Study|New Primary Disease Identified|0|||
164174291|NCT01358578|593001700|FG000|Induction Period|Adverse Event|2|||
164174292|NCT01358578|593001701|FG001|Induction Period|Adverse Event|4|||
164174293|NCT01358578|593001702|FG002|Induction Period|Adverse Event|2|||
164174294|NCT01358578|593001703|FG003|Induction Period|Adverse Event|6|||
164174295|NCT01358578|593001704|FG004|Induction Period|Adverse Event|0|||
164174296|NCT01358578|593001705|FG005|Induction Period|Adverse Event|0|||
164174297|NCT01358578|593001700|FG000|Induction Period|Lack of Efficacy|0|||
164174298|NCT01358578|593001701|FG001|Induction Period|Lack of Efficacy|0|||
164174299|NCT01358578|593001702|FG002|Induction Period|Lack of Efficacy|9|||
164174300|NCT01358578|593001703|FG003|Induction Period|Lack of Efficacy|1|||
164174301|NCT01358578|593001704|FG004|Induction Period|Lack of Efficacy|0|||
164174302|NCT01358578|593001705|FG005|Induction Period|Lack of Efficacy|0|||
164174303|NCT01358578|593001700|FG000|Induction Period|Lost to Follow-up|0|||
164174304|NCT01358578|593001701|FG001|Induction Period|Lost to Follow-up|0|||
164174305|NCT01358578|593001702|FG002|Induction Period|Lost to Follow-up|1|||
164174306|NCT01358578|593001703|FG003|Induction Period|Lost to Follow-up|4|||
164174307|NCT01358578|593001704|FG004|Induction Period|Lost to Follow-up|0|||
164174308|NCT01358578|593001705|FG005|Induction Period|Lost to Follow-up|0|||
164174309|NCT01358578|593001700|FG000|Induction Period|Physician Decision|2|||
164174310|NCT01358578|593001701|FG001|Induction Period|Physician Decision|1|||
164174311|NCT01358578|593001702|FG002|Induction Period|Physician Decision|2|||
164174312|NCT01358578|593001703|FG003|Induction Period|Physician Decision|0|||
164174313|NCT01358578|593001704|FG004|Induction Period|Physician Decision|0|||
164174314|NCT01358578|593001705|FG005|Induction Period|Physician Decision|0|||
164174315|NCT01358578|593001700|FG000|Induction Period|Protocol Deviation|3|||
164174316|NCT01358578|593001701|FG001|Induction Period|Protocol Deviation|5|||
164174317|NCT01358578|593001702|FG002|Induction Period|Protocol Deviation|0|||
164174318|NCT01358578|593001703|FG003|Induction Period|Protocol Deviation|3|||
164174319|NCT01358578|593001704|FG004|Induction Period|Protocol Deviation|0|||
164174320|NCT01358578|593001705|FG005|Induction Period|Protocol Deviation|0|||
164174321|NCT01358578|593001700|FG000|Induction Period|technical problems|0|||
164174322|NCT01358578|593001701|FG001|Induction Period|technical problems|0|||
164174323|NCT01358578|593001702|FG002|Induction Period|technical problems|1|||
164174324|NCT01358578|593001703|FG003|Induction Period|technical problems|1|||
164174325|NCT01358578|593001704|FG004|Induction Period|technical problems|0|||
164174326|NCT01358578|593001705|FG005|Induction Period|technical problems|0|||
164174327|NCT01358578|593001700|FG000|Induction Period|Withdrawal by Subject|5|||
164174328|NCT01358578|593001701|FG001|Induction Period|Withdrawal by Subject|5|||
164174329|NCT01358578|593001702|FG002|Induction Period|Withdrawal by Subject|10|||
164174330|NCT01358578|593001703|FG003|Induction Period|Withdrawal by Subject|6|||
164174331|NCT01358578|593001704|FG004|Induction Period|Withdrawal by Subject|0|||
164174332|NCT01358578|593001705|FG005|Induction Period|Withdrawal by Subject|0|||
164174333|NCT01358578|593001700|FG000|Maintenance Period|Adverse Event|2|||
164174334|NCT01358578|593001701|FG001|Maintenance Period|Adverse Event|7|||
164174335|NCT01358578|593001702|FG002|Maintenance Period|Adverse Event|0|||
164174336|NCT01358578|593001703|FG003|Maintenance Period|Adverse Event|6|||
164174337|NCT01358578|593001704|FG004|Maintenance Period|Adverse Event|4|||
164174338|NCT01358578|593001705|FG005|Maintenance Period|Adverse Event|3|||
164174339|NCT01358578|593001700|FG000|Maintenance Period|Lack of Efficacy|10|||
164174340|NCT01358578|593001701|FG001|Maintenance Period|Lack of Efficacy|2|||
164174341|NCT01358578|593001702|FG002|Maintenance Period|Lack of Efficacy|0|||
164174342|NCT01358578|593001703|FG003|Maintenance Period|Lack of Efficacy|11|||
164174343|NCT01358578|593001704|FG004|Maintenance Period|Lack of Efficacy|3|||
164174344|NCT01358578|593001705|FG005|Maintenance Period|Lack of Efficacy|0|||
164174345|NCT01358578|593001700|FG000|Maintenance Period|Lost to Follow-up|4|||
164174346|NCT01358578|593001701|FG001|Maintenance Period|Lost to Follow-up|0|||
164174347|NCT01358578|593001702|FG002|Maintenance Period|Lost to Follow-up|0|||
164174348|NCT01358578|593001703|FG003|Maintenance Period|Lost to Follow-up|5|||
164174349|NCT01358578|593001704|FG004|Maintenance Period|Lost to Follow-up|1|||
164174350|NCT01358578|593001705|FG005|Maintenance Period|Lost to Follow-up|1|||
164174351|NCT01358578|593001700|FG000|Maintenance Period|Non-compliance with study treatment|3|||
164174352|NCT01358578|593001701|FG001|Maintenance Period|Non-compliance with study treatment|1|||
164174353|NCT01358578|593001702|FG002|Maintenance Period|Non-compliance with study treatment|0|||
164174354|NCT01358578|593001703|FG003|Maintenance Period|Non-compliance with study treatment|2|||
164174355|NCT01358578|593001704|FG004|Maintenance Period|Non-compliance with study treatment|1|||
164174356|NCT01358578|593001705|FG005|Maintenance Period|Non-compliance with study treatment|2|||
164174357|NCT01358578|593001700|FG000|Maintenance Period|Physician Decision|0|||
164174358|NCT01358578|593001701|FG001|Maintenance Period|Physician Decision|1|||
164174359|NCT01358578|593001702|FG002|Maintenance Period|Physician Decision|0|||
164174360|NCT01358578|593001703|FG003|Maintenance Period|Physician Decision|1|||
164174361|NCT01358578|593001704|FG004|Maintenance Period|Physician Decision|0|||
164174362|NCT01358578|593001705|FG005|Maintenance Period|Physician Decision|0|||
164174363|NCT01358578|593001700|FG000|Maintenance Period|Pregnancy|1|||
164174364|NCT01358578|593001701|FG001|Maintenance Period|Pregnancy|0|||
164174365|NCT01358578|593001702|FG002|Maintenance Period|Pregnancy|0|||
164174366|NCT01358578|593001703|FG003|Maintenance Period|Pregnancy|0|||
164174367|NCT01358578|593001704|FG004|Maintenance Period|Pregnancy|0|||
164174368|NCT01358578|593001705|FG005|Maintenance Period|Pregnancy|0|||
164174369|NCT01358578|593001700|FG000|Maintenance Period|Protocol deviation|7|||
164174370|NCT01358578|593001701|FG001|Maintenance Period|Protocol deviation|4|||
164174371|NCT01358578|593001702|FG002|Maintenance Period|Protocol deviation|0|||
164174372|NCT01358578|593001703|FG003|Maintenance Period|Protocol deviation|2|||
164174373|NCT01358578|593001704|FG004|Maintenance Period|Protocol deviation|2|||
164174374|NCT01358578|593001705|FG005|Maintenance Period|Protocol deviation|2|||
164174375|NCT01358578|593001700|FG000|Maintenance Period|Withdrawal by Subject|12|||
164174376|NCT01358578|593001701|FG001|Maintenance Period|Withdrawal by Subject|7|||
164174377|NCT01358578|593001702|FG002|Maintenance Period|Withdrawal by Subject|2|||
164174378|NCT01358578|593001703|FG003|Maintenance Period|Withdrawal by Subject|15|||
164174379|NCT01358578|593001704|FG004|Maintenance Period|Withdrawal by Subject|6|||
164174380|NCT01358578|593001705|FG005|Maintenance Period|Withdrawal by Subject|3|||
164174381|NCT01358578|593001700|FG000|Follow-up Period|Adverse Event|1|||
164174382|NCT01358578|593001701|FG001|Follow-up Period|Adverse Event|1|||
164174383|NCT01358578|593001702|FG002|Follow-up Period|Adverse Event|0|||
164174384|NCT01358578|593001703|FG003|Follow-up Period|Adverse Event|0|||
164174385|NCT01358578|593001704|FG004|Follow-up Period|Adverse Event|0|||
164174386|NCT01358578|593001705|FG005|Follow-up Period|Adverse Event|0|||
164174387|NCT01358578|593001700|FG000|Follow-up Period|Lack of Efficacy|3|||
164174388|NCT01358578|593001701|FG001|Follow-up Period|Lack of Efficacy|0|||
164174389|NCT01358578|593001702|FG002|Follow-up Period|Lack of Efficacy|4|||
164174390|NCT01358578|593001703|FG003|Follow-up Period|Lack of Efficacy|1|||
164174391|NCT01358578|593001704|FG004|Follow-up Period|Lack of Efficacy|0|||
164174392|NCT01358578|593001705|FG005|Follow-up Period|Lack of Efficacy|0|||
164174393|NCT01358578|593001700|FG000|Follow-up Period|Lost to Follow-up|0|||
164174394|NCT01358578|593001701|FG001|Follow-up Period|Lost to Follow-up|1|||
164174395|NCT01358578|593001702|FG002|Follow-up Period|Lost to Follow-up|0|||
164174396|NCT01358578|593001703|FG003|Follow-up Period|Lost to Follow-up|4|||
164174397|NCT01358578|593001704|FG004|Follow-up Period|Lost to Follow-up|0|||
164174398|NCT01358578|593001705|FG005|Follow-up Period|Lost to Follow-up|0|||
164174399|NCT01358578|593001700|FG000|Follow-up Period|non- compliance with study treatment|1|||
164174400|NCT01358578|593001701|FG001|Follow-up Period|non- compliance with study treatment|0|||
164174401|NCT01358578|593001702|FG002|Follow-up Period|non- compliance with study treatment|0|||
164174402|NCT01358578|593001703|FG003|Follow-up Period|non- compliance with study treatment|0|||
164174403|NCT01358578|593001704|FG004|Follow-up Period|non- compliance with study treatment|0|||
164174404|NCT01358578|593001705|FG005|Follow-up Period|non- compliance with study treatment|0|||
164174405|NCT01358578|593001700|FG000|Follow-up Period|Pregnancy|1|||
164174406|NCT01358578|593001701|FG001|Follow-up Period|Pregnancy|0|||
164174407|NCT01358578|593001702|FG002|Follow-up Period|Pregnancy|0|||
164174408|NCT01358578|593001703|FG003|Follow-up Period|Pregnancy|0|||
164174409|NCT01358578|593001704|FG004|Follow-up Period|Pregnancy|0|||
164174410|NCT01358578|593001705|FG005|Follow-up Period|Pregnancy|0|||
164174411|NCT01358578|593001700|FG000|Follow-up Period|Withdrawal by Subject|3|||
164174412|NCT01358578|593001701|FG001|Follow-up Period|Withdrawal by Subject|3|||
164174413|NCT01358578|593001702|FG002|Follow-up Period|Withdrawal by Subject|1|||
164174414|NCT01358578|593001703|FG003|Follow-up Period|Withdrawal by Subject|12|||
164174415|NCT01358578|593001704|FG004|Follow-up Period|Withdrawal by Subject|0|||
164174416|NCT01358578|593001705|FG005|Follow-up Period|Withdrawal by Subject|0|||
164174417|NCT01358578|593001700|FG000|Follow-up Period|Physician Decision|1|||
164174418|NCT01358578|593001701|FG001|Follow-up Period|Physician Decision|1|||
164174419|NCT01358578|593001702|FG002|Follow-up Period|Physician Decision|0|||
164174420|NCT01358578|593001703|FG003|Follow-up Period|Physician Decision|2|||
164174421|NCT01358578|593001704|FG004|Follow-up Period|Physician Decision|0|||
164174422|NCT01358578|593001705|FG005|Follow-up Period|Physician Decision|0|||
164174423|NCT01643798|593001706|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
164174424|NCT01643798|593001707|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
164174425|NCT03605849|593001708|FG000|Overall Study|Adverse Event|20|||
164174426|NCT03605849|593001709|FG001|Overall Study|Adverse Event|21|||
164174427|NCT03605849|593001710|FG002|Overall Study|Adverse Event|29|||
164174428|NCT03605849|593001711|FG003|Overall Study|Adverse Event|11|||
164174429|NCT03605849|593001708|FG000|Overall Study|Lack of Efficacy|4|||
164174430|NCT03605849|593001709|FG001|Overall Study|Lack of Efficacy|7|||
164174431|NCT03605849|593001710|FG002|Overall Study|Lack of Efficacy|9|||
164174432|NCT03605849|593001711|FG003|Overall Study|Lack of Efficacy|2|||
164174433|NCT03605849|593001708|FG000|Overall Study|Lost to Follow-up|8|||
164174434|NCT03605849|593001709|FG001|Overall Study|Lost to Follow-up|8|||
164174435|NCT03605849|593001710|FG002|Overall Study|Lost to Follow-up|14|||
164174436|NCT03605849|593001711|FG003|Overall Study|Lost to Follow-up|11|||
164174437|NCT03605849|593001708|FG000|Overall Study|Non-compliance With IMP|6|||
164174438|NCT03605849|593001709|FG001|Overall Study|Non-compliance With IMP|5|||
164174439|NCT03605849|593001710|FG002|Overall Study|Non-compliance With IMP|2|||
164174440|NCT03605849|593001711|FG003|Overall Study|Non-compliance With IMP|1|||
164174441|NCT03605849|593001708|FG000|Overall Study|Protocol Deviation|1|||
164174442|NCT03605849|593001709|FG001|Overall Study|Protocol Deviation|2|||
164174443|NCT03605849|593001710|FG002|Overall Study|Protocol Deviation|1|||
164174444|NCT03605849|593001711|FG003|Overall Study|Protocol Deviation|3|||
164174445|NCT03605849|593001708|FG000|Overall Study|Withdrawal by Subject|33|||
164174446|NCT03605849|593001709|FG001|Overall Study|Withdrawal by Subject|28|||
164174447|NCT03605849|593001710|FG002|Overall Study|Withdrawal by Subject|30|||
164174448|NCT03605849|593001711|FG003|Overall Study|Withdrawal by Subject|28|||
164174449|NCT03605849|593001708|FG000|Overall Study|Site Terminated by Sponsor|0|||
164174450|NCT03605849|593001709|FG001|Overall Study|Site Terminated by Sponsor|0|||
164174451|NCT03605849|593001710|FG002|Overall Study|Site Terminated by Sponsor|0|||
164174452|NCT03605849|593001711|FG003|Overall Study|Site Terminated by Sponsor|1|||
164174453|NCT03605849|593001708|FG000|Overall Study|Physician Decision|2|||
164174454|NCT03605849|593001709|FG001|Overall Study|Physician Decision|1|||
164174455|NCT03605849|593001710|FG002|Overall Study|Physician Decision|2|||
164174456|NCT03605849|593001711|FG003|Overall Study|Physician Decision|1|||
164174457|NCT03605849|593001708|FG000|Overall Study|Enrolled, but not Treated|2|||
164174458|NCT03605849|593001709|FG001|Overall Study|Enrolled, but not Treated|2|||
164174459|NCT03605849|593001710|FG002|Overall Study|Enrolled, but not Treated|3|||
164174460|NCT03605849|593001711|FG003|Overall Study|Enrolled, but not Treated|2|||
164174461|NCT03605849|593001708|FG000|Overall Study|Other (COVID-19 Related)|0|||
164174462|NCT03605849|593001709|FG001|Overall Study|Other (COVID-19 Related)|1|||
164174463|NCT03605849|593001710|FG002|Overall Study|Other (COVID-19 Related)|1|||
164174464|NCT03605849|593001711|FG003|Overall Study|Other (COVID-19 Related)|0|||
164174465|NCT03605849|593001708|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
164174466|NCT03605849|593001709|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
164174467|NCT03605849|593001710|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
164174468|NCT03605849|593001711|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
164174469|NCT02659514|593001712|FG000|Overall Study|Adverse Event|3|||
164174470|NCT02659514|593001713|FG001|Overall Study|Adverse Event|12|||
164174471|NCT02659514|593001712|FG000|Overall Study|Disease Progression|23|||
164174472|NCT02659514|593001713|FG001|Overall Study|Disease Progression|13|||
164174473|NCT02659514|593001712|FG000|Overall Study|Withdrawal by Subject|0|||
164174474|NCT02659514|593001713|FG001|Overall Study|Withdrawal by Subject|4|||
164174475|NCT02659514|593001712|FG000|Overall Study|Lost to Follow-up|0|||
164174476|NCT02659514|593001713|FG001|Overall Study|Lost to Follow-up|1|||
164174477|NCT02659514|593001712|FG000|Overall Study|Death|6|||
164174478|NCT02659514|593001713|FG001|Overall Study|Death|1|||
164174479|NCT02659514|593001712|FG000|Overall Study|Reason Unspecified|0|||
164174480|NCT02659514|593001713|FG001|Overall Study|Reason Unspecified|3|||
164174481|NCT03409107|593001714|FG000|Overall Study|Withdrawal by Subject|4|||
164174482|NCT03409107|593001715|FG001|Overall Study|Withdrawal by Subject|2|||
164174483|NCT03409107|593001714|FG000|Overall Study|Physician Decision|1|||
164174484|NCT03409107|593001715|FG001|Overall Study|Physician Decision|0|||
164174485|NCT03409107|593001714|FG000|Overall Study|Lost to Follow-up|7|||
164174486|NCT03409107|593001715|FG001|Overall Study|Lost to Follow-up|2|||
164174487|NCT03409107|593001714|FG000|Overall Study|Adverse Event|5|||
164174488|NCT03409107|593001715|FG001|Overall Study|Adverse Event|3|||
164174489|NCT02062944|593001722|FG000|Overall Study|Lost to Follow-up|1|||
164174490|NCT02062944|593001722|FG000|Overall Study|New hemotological disorder identified|1|||
164174491|NCT02062944|593001722|FG000|Overall Study|Uncontrolled Hypertension|1|||
164174492|NCT02062944|593001722|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
164174493|NCT01482962|593001723|FG000|Overall Study|Progressive Disease|65|||
164174494|NCT01482962|593001724|FG001|Overall Study|Progressive Disease|53|||
164174495|NCT01482962|593001723|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
164174496|NCT01482962|593001724|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
164174497|NCT01482962|593001723|FG000|Overall Study|Adverse Event|18|||
164174498|NCT01482962|593001724|FG001|Overall Study|Adverse Event|22|||
164174499|NCT01482962|593001723|FG000|Overall Study|Withdrawal by Participant|8|||
164174500|NCT01482962|593001724|FG001|Overall Study|Withdrawal by Participant|13|||
164174501|NCT01482962|593001723|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
164174502|NCT01482962|593001724|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
164174503|NCT01482962|593001723|FG000|Overall Study|Other Reason|1|||
164174504|NCT01482962|593001724|FG001|Overall Study|Other Reason|5|||
164174505|NCT01482962|593001723|FG000|Overall Study|Study Terminated by Sponsor|5|||
164174506|NCT01482962|593001724|FG001|Overall Study|Study Terminated by Sponsor|2|||
164174507|NCT01482962|593001723|FG000|Overall Study|Did not Receive Study Drug|1|||
164174508|NCT01482962|593001724|FG001|Overall Study|Did not Receive Study Drug|6|||
164174509|NCT00278148|593001725|FG000|Phase II - Expansion Phase|Disease progression|0|||
164174510|NCT00278148|593001726|FG001|Phase II - Expansion Phase|Disease progression|0|||
164174511|NCT00278148|593001727|FG002|Phase II - Expansion Phase|Disease progression|4|||
164174512|NCT00278148|593001725|FG000|Phase II - Expansion Phase|Adverse Event|0|||
164174513|NCT00278148|593001726|FG001|Phase II - Expansion Phase|Adverse Event|0|||
164174514|NCT00278148|593001727|FG002|Phase II - Expansion Phase|Adverse Event|2|||
164174515|NCT02407457|593001728|FG000|1 Month|Death|3|||
164174516|NCT02407457|593001729|FG001|1 Month|Death|0|||
164174517|NCT02407457|593001728|FG000|1 Month|Lost to Follow-up|1|||
164174518|NCT02407457|593001729|FG001|1 Month|Lost to Follow-up|1|||
164174519|NCT02407457|593001728|FG000|1 Month|missed visit|2|||
164174520|NCT02407457|593001729|FG001|1 Month|missed visit|5|||
164174521|NCT02407457|593001728|FG000|6-Month|Death|2|||
164174522|NCT02407457|593001729|FG001|6-Month|Death|8|||
164174523|NCT02407457|593001728|FG000|6-Month|Lost to Follow-up|2|||
164174524|NCT02407457|593001729|FG001|6-Month|Lost to Follow-up|2|||
164174525|NCT02407457|593001728|FG000|6-Month|missed visit|16|||
164174526|NCT02407457|593001729|FG001|6-Month|missed visit|14|||
164174527|NCT02407457|593001728|FG000|6-Month|Open Repair|0|||
164174528|NCT02407457|593001729|FG001|6-Month|Open Repair|1|||
164174529|NCT02407457|593001728|FG000|1 Year|Death|6|||
164174530|NCT02407457|593001729|FG001|1 Year|Death|11|||
164174531|NCT02407457|593001728|FG000|1 Year|Lost to Follow-up|3|||
164174532|NCT02407457|593001729|FG001|1 Year|Lost to Follow-up|2|||
164174533|NCT02407457|593001728|FG000|1 Year|Missed Visit|24|||
164174534|NCT02407457|593001729|FG001|1 Year|Missed Visit|14|||
164174535|NCT02407457|593001728|FG000|1 Year|Open Repair|0|||
164174536|NCT02407457|593001729|FG001|1 Year|Open Repair|1|||
164174537|NCT02407457|593001728|FG000|2-year|Death|14|||
164174538|NCT02407457|593001729|FG001|2-year|Death|8|||
164174539|NCT02407457|593001728|FG000|2-year|Lost to Follow-up|7|||
164174540|NCT02407457|593001729|FG001|2-year|Lost to Follow-up|10|||
164174541|NCT02407457|593001728|FG000|2-year|Missed Visit|13|||
164174542|NCT02407457|593001729|FG001|2-year|Missed Visit|15|||
164174543|NCT02407457|593001728|FG000|2-year|Open Repair|0|||
164174544|NCT02407457|593001729|FG001|2-year|Open Repair|2|||
164174545|NCT02407457|593001728|FG000|3-year|Death|11|||
164174546|NCT02407457|593001729|FG001|3-year|Death|10|||
164174547|NCT02407457|593001728|FG000|3-year|Lost to Follow-up|9|||
164174548|NCT02407457|593001729|FG001|3-year|Lost to Follow-up|10|||
164174549|NCT02407457|593001728|FG000|3-year|Missed Visit|19|||
164174550|NCT02407457|593001729|FG001|3-year|Missed Visit|16|||
164174551|NCT02407457|593001728|FG000|4-year|Death|18|||
164174552|NCT02407457|593001729|FG001|4-year|Death|10|||
164174553|NCT02407457|593001728|FG000|4-year|Lost to Follow-up|10|||
164174554|NCT02407457|593001729|FG001|4-year|Lost to Follow-up|12|||
164174555|NCT02407457|593001728|FG000|4-year|Missed Visit|18|||
164174556|NCT02407457|593001729|FG001|4-year|Missed Visit|16|||
164174557|NCT02407457|593001728|FG000|5-year|Death|10|||
164174558|NCT02407457|593001729|FG001|5-year|Death|3|||
164174559|NCT02407457|593001728|FG000|5-year|Lost to Follow-up|22|||
164174560|NCT02407457|593001729|FG001|5-year|Lost to Follow-up|13|||
164174561|NCT02407457|593001728|FG000|5-year|Missed Visit|9|||
164174562|NCT02407457|593001729|FG001|5-year|Missed Visit|1|||
164174563|NCT01088243|593001731|FG000|Overall Study|Adverse Event|1|||
164174564|NCT01088243|593001732|FG001|Overall Study|Adverse Event|0|||
164174565|NCT05007041|593001752|FG000|Overall Study|Missing Diary Entries|0|||
164174566|NCT05007041|593001753|FG001|Overall Study|Missing Diary Entries|1|||
164174567|NCT04495816|593001754|FG000|Overall Study|Lost to Follow-up|10|||
164174568|NCT04495816|593001755|FG001|Overall Study|Lost to Follow-up|4|||
164174569|NCT04495816|593001754|FG000|Overall Study|Withdrawal by Subject|3|||
164174570|NCT04495816|593001755|FG001|Overall Study|Withdrawal by Subject|5|||
164174571|NCT01459718|593001757|FG000|Overall Study|Physician Decision|1|||
164174572|NCT01459718|593001757|FG000|Overall Study|Lost to Follow-up|1|||
164174573|NCT01459718|593001757|FG000|Overall Study|Adverse Event|1|||
164174574|NCT01258075|593001758|FG000|Overall Study|Adverse Event|8|||
164174575|NCT01258075|593001759|FG001|Overall Study|Adverse Event|3|||
164174576|NCT01258075|593001758|FG000|Overall Study|Lost to Follow-up|11|||
164174577|NCT01258075|593001759|FG001|Overall Study|Lost to Follow-up|6|||
164174578|NCT01258075|593001758|FG000|Overall Study|Withdrawal by Subject|10|||
164174579|NCT01258075|593001759|FG001|Overall Study|Withdrawal by Subject|7|||
164174580|NCT01258075|593001758|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
164174581|NCT01258075|593001759|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
164174582|NCT01258075|593001758|FG000|Overall Study|Other|12|||
164174583|NCT01258075|593001759|FG001|Overall Study|Other|5|||
164174584|NCT02951533|593001769|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
164174585|NCT02951533|593001770|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
164174586|NCT02951533|593001771|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
164174587|NCT02951533|593001769|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
164174588|NCT02951533|593001770|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
164174589|NCT02951533|593001771|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
164174590|NCT02951533|593001769|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
164174591|NCT02951533|593001770|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
164174592|NCT02951533|593001771|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
164174593|NCT02951533|593001769|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
164174594|NCT02951533|593001770|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
164174595|NCT02951533|593001771|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
164174596|NCT02951533|593001769|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
164174597|NCT02951533|593001770|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
164174598|NCT02951533|593001771|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
164174599|NCT02951533|593001769|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
164174600|NCT02951533|593001770|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
164174601|NCT02951533|593001771|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
164174602|NCT02951533|593001769|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
164174603|NCT02951533|593001770|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
164174604|NCT02951533|593001771|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
164174605|NCT02951533|593001769|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
164174606|NCT02951533|593001770|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
164174607|NCT02951533|593001771|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
164174608|NCT02951533|593001769|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
164174609|NCT02951533|593001770|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
164174610|NCT02951533|593001771|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
164174611|NCT02951533|593001769|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
164174612|NCT02951533|593001770|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
164174613|NCT02951533|593001771|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
164174614|NCT02951533|593001769|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
164174615|NCT02951533|593001770|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
164174616|NCT02951533|593001771|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
164174617|NCT01597375|593001772|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
164174618|NCT01597375|593001773|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
164174619|NCT01597375|593001772|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
164174620|NCT01597375|593001773|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
164174621|NCT01597375|593001772|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
164174622|NCT01597375|593001773|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
164174623|NCT01597375|593001772|FG000|Washout (2 Weeks)|Adverse Event|1|||
164174624|NCT01597375|593001773|FG001|Washout (2 Weeks)|Adverse Event|0|||
164174625|NCT01597375|593001772|FG000|Second Intervention|Failed to react at both Aspirin|1|||
164174626|NCT01597375|593001773|FG001|Second Intervention|Failed to react at both Aspirin|1|||
164174627|NCT02375555|593001774|FG000|Induction Period|Adverse Event|7|||
164174628|NCT02375555|593001774|FG000|Induction Period|Withdrawal by Subject|2|||
164174629|NCT02375555|593001774|FG000|Induction Period|Other|1|||
164174630|NCT02375555|593001774|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
164174631|NCT02375555|593001774|FG000|Maintenance Period|Adverse Event|2|||
164174632|NCT02375555|593001774|FG000|Maintenance Period|Withdrawal by Subject|4|||
164174633|NCT02375555|593001774|FG000|Maintenance Period|Death|1|||
164174634|NCT02375555|593001774|FG000|Maintenance Period|Disease Progression|5|||
164174635|NCT02375555|593001774|FG000|Maintenance Period|Patient Non-compliance|1|||
164174636|NCT02375555|593001774|FG000|Maintenance Period|Still on maintenance|16|||
164174637|NCT01984892|593001780|FG000|Overall Study|Progressive disease|7|||
164174638|NCT04464720|593001781|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
164174639|NCT05723328|593001783|FG000|Overall Study|Investigator's Decision|5|||
164174640|NCT05723328|593001784|FG001|Overall Study|Investigator's Decision|2|||
164174641|NCT02000882|593003298|FG000|Overall Study|Adverse Event|3|||
164174642|NCT02000882|593003298|FG000|Overall Study|Physician Decision|2|||
164174643|NCT02000882|593003298|FG000|Overall Study|Withdrawal by Subject|1|||
164174644|NCT02417961|593003299|FG000|Overall Study|Adverse Event|1|||
164174645|NCT02417961|593003299|FG000|Overall Study|Lost to Follow-up|1|||
164174646|NCT02417961|593003299|FG000|Overall Study|Withdrawal by Subject|2|||
164174647|NCT01390428|593003300|FG000|Overall Study|Elective Surgery|0|||
164174648|NCT01390428|593003301|FG001|Overall Study|Elective Surgery|0|||
164174649|NCT01390428|593003302|FG002|Overall Study|Elective Surgery|0|||
164174650|NCT01390428|593003303|FG003|Overall Study|Elective Surgery|0|||
164174651|NCT01390428|593003304|FG004|Overall Study|Elective Surgery|1|||
164174652|NCT01390428|593003305|FG005|Overall Study|Elective Surgery|0|||
164174653|NCT01390428|593003300|FG000|Overall Study|Withdrawal by Subject|0|||
164174654|NCT01390428|593003301|FG001|Overall Study|Withdrawal by Subject|0|||
164174655|NCT01390428|593003302|FG002|Overall Study|Withdrawal by Subject|1|||
164174656|NCT01390428|593003303|FG003|Overall Study|Withdrawal by Subject|0|||
164174657|NCT01390428|593003304|FG004|Overall Study|Withdrawal by Subject|0|||
164174658|NCT01390428|593003305|FG005|Overall Study|Withdrawal by Subject|0|||
164174659|NCT05897827|593003306|FG000|Overall Study|Lost to Follow-up|33|||
164174660|NCT05897827|593003307|FG001|Overall Study|Lost to Follow-up|14|||
164174661|NCT05897827|593003306|FG000|Overall Study|Withdrawal by Subject|1|||
164174662|NCT05897827|593003307|FG001|Overall Study|Withdrawal by Subject|1|||
164174663|NCT03339726|593003308|FG000|Overall Study|Withdrawal by Subject|1|||
164174664|NCT03339726|593003309|FG001|Overall Study|Withdrawal by Subject|0|||
164174665|NCT03339726|593003310|FG002|Overall Study|Withdrawal by Subject|0|||
164174666|NCT03339726|593003308|FG000|Overall Study|Lost to Follow-up|0|||
164174667|NCT03339726|593003309|FG001|Overall Study|Lost to Follow-up|1|||
164174668|NCT03339726|593003310|FG002|Overall Study|Lost to Follow-up|0|||
164174669|NCT04599933|593003312|FG000|Overall Study|Adverse Event|4|||
164174670|NCT04599933|593003313|FG001|Overall Study|Adverse Event|1|||
164174671|NCT04599933|593003312|FG000|Overall Study|Withdrawal by Subject|4|||
164174672|NCT04599933|593003313|FG001|Overall Study|Withdrawal by Subject|2|||
164174673|NCT04599933|593003312|FG000|Overall Study|Lost to Follow-up|0|||
164174674|NCT04599933|593003313|FG001|Overall Study|Lost to Follow-up|1|||
164174675|NCT04599933|593003312|FG000|Overall Study|Physician Decision|0|||
164174676|NCT04599933|593003313|FG001|Overall Study|Physician Decision|1|||
164174677|NCT04599933|593003312|FG000|Overall Study|Screen Failure|1|||
164174678|NCT04599933|593003313|FG001|Overall Study|Screen Failure|2|||
164174679|NCT01911780|593003325|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
164174680|NCT01911780|593003326|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
164174681|NCT01911780|593003325|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
164174682|NCT01911780|593003326|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
164174683|NCT01911780|593003325|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
164174684|NCT01911780|593003326|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
164174685|NCT01911780|593003325|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
164174686|NCT01911780|593003326|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
164174687|NCT01911780|593003325|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
164174688|NCT01911780|593003326|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
164174689|NCT01911780|593003325|FG000|Extension Period (52 Weeks)|Personal reason|1|||
164174690|NCT01911780|593003326|FG001|Extension Period (52 Weeks)|Personal reason|1|||
164174691|NCT06303167|593003333|FG000|Overall Study|Ineligible|1|||
164174692|NCT06303167|593003333|FG000|Overall Study|Never start protocol therapy|2|||
164174693|NCT06303167|593003333|FG000|Overall Study|Disease progression|16|||
164174694|NCT02677896|593003334|FG000|Double Blind Period (up to 35 Months)|Death|117|||
164174695|NCT02677896|593003335|FG001|Double Blind Period (up to 35 Months)|Death|197|||
164174696|NCT02677896|593003334|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
164174697|NCT02677896|593003335|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
164174698|NCT02677896|593003334|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
164174699|NCT02677896|593003335|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
164174700|NCT02677896|593003334|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
164174701|NCT02677896|593003335|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
164174702|NCT02677896|593003334|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
164174703|NCT02677896|593003335|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
164174704|NCT02677896|593003334|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
164174705|NCT02677896|593003335|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
164174706|NCT02677896|593003334|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
164174707|NCT02677896|593003335|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
164174708|NCT02677896|593003334|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
164174709|NCT02677896|593003335|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
164174710|NCT02677896|593003334|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
164174711|NCT02677896|593003335|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
164174712|NCT02677896|593003334|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
164174713|NCT02677896|593003335|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
164174714|NCT02677896|593003334|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
164174715|NCT02677896|593003335|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
164174716|NCT02677896|593003334|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
164174717|NCT02677896|593003335|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
164174718|NCT02677896|593003334|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
164174719|NCT02677896|593003335|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
164174720|NCT02677896|593003334|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
164174721|NCT02677896|593003335|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
164174722|NCT00348790|593003341|FG000|Completed Treatment|Withdrawal by Subject|4|||
164174723|NCT00348790|593003341|FG000|Completed Treatment|Disease progression|14|||
164174724|NCT00348790|593003341|FG000|Completed Treatment|Adverse Event|4|||
164174725|NCT00348790|593003341|FG000|Completed Treatment|Required surgery|2|||
164174726|NCT00348790|593003341|FG000|Completed Treatment|Unable to travel to study site|1|||
164174727|NCT01185509|593003345|FG000|Overall Study|Progression/Relapse|9|||
164174728|NCT01185509|593003346|FG001|Overall Study|Progression/Relapse|15|||
164174729|NCT01185509|593003345|FG000|Overall Study|Physician Decision|2|||
164174730|NCT01185509|593003346|FG001|Overall Study|Physician Decision|2|||
164174731|NCT01185509|593003345|FG000|Overall Study|Withdrawal by Subject|0|||
164174732|NCT01185509|593003346|FG001|Overall Study|Withdrawal by Subject|1|||
164174733|NCT01185509|593003345|FG000|Overall Study|Death|0|||
164174734|NCT01185509|593003346|FG001|Overall Study|Death|1|||
164174735|NCT01185509|593003345|FG000|Overall Study|Intercurrent Illness|0|||
164174736|NCT01185509|593003346|FG001|Overall Study|Intercurrent Illness|1|||
164174737|NCT03687372|593003347|FG000|Overall Study|Lost to Follow-up|12|||
164174738|NCT03687372|593003348|FG001|Overall Study|Lost to Follow-up|21|||
164174739|NCT03687372|593003347|FG000|Overall Study|Withdrawal by Subject|4|||
164174740|NCT03687372|593003348|FG001|Overall Study|Withdrawal by Subject|17|||
164174741|NCT03687372|593003347|FG000|Overall Study|Investigator Decision|1|||
164174742|NCT03687372|593003348|FG001|Overall Study|Investigator Decision|1|||
164174743|NCT00655733|593003351|FG000|Overall Study|Lost to Follow-up|2|||
164174744|NCT00655733|593003352|FG001|Overall Study|Lost to Follow-up|2|||
164174745|NCT00655733|593003351|FG000|Overall Study|Adverse Event|2|||
164174746|NCT00655733|593003352|FG001|Overall Study|Adverse Event|2|||
164174747|NCT00655733|593003351|FG000|Overall Study|Withdrawal by Subject|3|||
164174748|NCT00655733|593003352|FG001|Overall Study|Withdrawal by Subject|3|||
164174749|NCT00655733|593003351|FG000|Overall Study|Physician Decision|0|||
164174750|NCT00655733|593003352|FG001|Overall Study|Physician Decision|1|||
164174751|NCT02370667|593003356|FG000|Overall Study|Lost to Follow-up|0|||
164174752|NCT02370667|593003357|FG001|Overall Study|Lost to Follow-up|1|||
164174753|NCT02370667|593003358|FG002|Overall Study|Lost to Follow-up|0|||
164174754|NCT03536949|593003359|FG000|Overall Study|Adverse Event|4|||
164174755|NCT03536949|593003360|FG001|Overall Study|Adverse Event|0|||
164174756|NCT03536949|593003359|FG000|Overall Study|Lost to Follow-up|2|||
164174757|NCT03536949|593003360|FG001|Overall Study|Lost to Follow-up|1|||
164174758|NCT03536949|593003359|FG000|Overall Study|Withdrawal by Subject|6|||
164174759|NCT03536949|593003360|FG001|Overall Study|Withdrawal by Subject|0|||
164174760|NCT03536949|593003359|FG000|Overall Study|Non-compliance|2|||
164174761|NCT03536949|593003360|FG001|Overall Study|Non-compliance|1|||
164174762|NCT00705718|593003361|FG000|Overall Study|Death|6|||
164174763|NCT00705718|593003362|FG001|Overall Study|Death|6|||
164174764|NCT00705718|593003361|FG000|Overall Study|Not due for Visit|0|||
164174765|NCT00705718|593003362|FG001|Overall Study|Not due for Visit|12|||
164174766|NCT00705718|593003361|FG000|Overall Study|Follow up not done|1|||
164174767|NCT00705718|593003362|FG001|Overall Study|Follow up not done|4|||
164174768|NCT02954653|593003363|FG000|Overall Study|Death|3|||
164174769|NCT02954653|593003364|FG001|Overall Study|Death|1|||
164174770|NCT02954653|593003365|FG002|Overall Study|Death|0|||
164174771|NCT02954653|593003366|FG003|Overall Study|Death|0|||
164174772|NCT02954653|593003367|FG004|Overall Study|Death|0|||
164174773|NCT02954653|593003368|FG005|Overall Study|Death|0|||
164174774|NCT02954653|593003369|FG006|Overall Study|Death|0|||
164174775|NCT02954653|593003370|FG007|Overall Study|Death|0|||
164174776|NCT02954653|593003371|FG008|Overall Study|Death|0|||
164174777|NCT02954653|593003363|FG000|Overall Study|Randomized but did not receive treatment|1|||
164174778|NCT02954653|593003364|FG001|Overall Study|Randomized but did not receive treatment|0|||
164174779|NCT02954653|593003365|FG002|Overall Study|Randomized but did not receive treatment|0|||
164174780|NCT02954653|593003366|FG003|Overall Study|Randomized but did not receive treatment|0|||
164174781|NCT02954653|593003367|FG004|Overall Study|Randomized but did not receive treatment|0|||
164174782|NCT02954653|593003368|FG005|Overall Study|Randomized but did not receive treatment|0|||
164174783|NCT02954653|593003369|FG006|Overall Study|Randomized but did not receive treatment|0|||
164174784|NCT02954653|593003370|FG007|Overall Study|Randomized but did not receive treatment|0|||
164174785|NCT02954653|593003371|FG008|Overall Study|Randomized but did not receive treatment|0|||
164174786|NCT02954653|593003363|FG000|Overall Study|Started another anti-cancer therapy|0|||
164174787|NCT02954653|593003364|FG001|Overall Study|Started another anti-cancer therapy|1|||
164174788|NCT02954653|593003365|FG002|Overall Study|Started another anti-cancer therapy|0|||
164174789|NCT02954653|593003366|FG003|Overall Study|Started another anti-cancer therapy|0|||
164174790|NCT02954653|593003367|FG004|Overall Study|Started another anti-cancer therapy|0|||
164174791|NCT02954653|593003368|FG005|Overall Study|Started another anti-cancer therapy|0|||
164174792|NCT02954653|593003369|FG006|Overall Study|Started another anti-cancer therapy|0|||
164174793|NCT02954653|593003370|FG007|Overall Study|Started another anti-cancer therapy|0|||
164174794|NCT02954653|593003371|FG008|Overall Study|Started another anti-cancer therapy|0|||
164174795|NCT02954653|593003363|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
164174796|NCT02954653|593003364|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
164174797|NCT02954653|593003365|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
164174798|NCT02954653|593003366|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
164174799|NCT02954653|593003367|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
164174800|NCT02954653|593003368|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
164174801|NCT02954653|593003369|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
164174802|NCT02954653|593003370|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
164174803|NCT02954653|593003371|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
164174804|NCT04329091|593003375|FG000|Overall Study|Physician Decision|5|||
164174805|NCT00423189|593003376|FG000|Overall Study|Death|0|||
164174806|NCT00423189|593003377|FG001|Overall Study|Death|1|||
164174807|NCT00423189|593003378|FG002|Overall Study|Death|0|||
164174808|NCT03787303|593003381|FG000|Overall Study|Death|1|||
164174809|NCT03787303|593003381|FG000|Overall Study|Premature Termination of Study|1|||
164174810|NCT01210495|593003388|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
164174811|NCT01210495|593003389|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
164174812|NCT01210495|593003390|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
164174813|NCT01210495|593003391|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
164174814|NCT01210495|593003388|FG000|Overall Study|Death|14|||
164174815|NCT01210495|593003389|FG001|Overall Study|Death|7|||
164174816|NCT01210495|593003390|FG002|Overall Study|Death|112|||
164174817|NCT01210495|593003391|FG003|Overall Study|Death|54|||
164174818|NCT01210495|593003388|FG000|Overall Study|Study Terminated by Sponsor|0|||
164174819|NCT01210495|593003389|FG001|Overall Study|Study Terminated by Sponsor|0|||
164174820|NCT01210495|593003390|FG002|Overall Study|Study Terminated by Sponsor|4|||
164174821|NCT01210495|593003391|FG003|Overall Study|Study Terminated by Sponsor|11|||
164174822|NCT01210495|593003388|FG000|Overall Study|Lost to Follow-up|0|||
164174823|NCT01210495|593003389|FG001|Overall Study|Lost to Follow-up|0|||
164174824|NCT01210495|593003390|FG002|Overall Study|Lost to Follow-up|1|||
164174825|NCT01210495|593003391|FG003|Overall Study|Lost to Follow-up|1|||
164174826|NCT01210495|593003388|FG000|Overall Study|Other unspecified|0|||
164174827|NCT01210495|593003389|FG001|Overall Study|Other unspecified|0|||
164174828|NCT01210495|593003390|FG002|Overall Study|Other unspecified|6|||
164174829|NCT01210495|593003391|FG003|Overall Study|Other unspecified|0|||
164174830|NCT01826370|593003396|FG000|Overall Study|Protocol Violation|6|||
164174831|NCT01826370|593003396|FG000|Overall Study|Lost to Follow-up|12|||
164174832|NCT01826370|593003396|FG000|Overall Study|Other reason not defined above|2|||
164174833|NCT04416737|593003397|FG000|Week 1 (First Injection)|Physician Decision|0|||
164174834|NCT04416737|593003398|FG001|Week 1 (First Injection)|Physician Decision|1|||
164174835|NCT03332628|593003399|FG000|Overall Study|Physician Decision|2|||
164174836|NCT02543892|593003407|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
164174837|NCT02543892|593003408|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
164174838|NCT02543892|593003409|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
164174839|NCT02543892|593003410|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
164174840|NCT02543892|593003411|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
164174841|NCT02543892|593003412|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
164174842|NCT02543892|593003413|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
164174843|NCT02543892|593003414|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
164174844|NCT02543892|593003407|FG000|Received Vaccination 2|Physician Decision|0|||
164174845|NCT02543892|593003408|FG001|Received Vaccination 2|Physician Decision|0|||
164174846|NCT02543892|593003409|FG002|Received Vaccination 2|Physician Decision|0|||
164174847|NCT02543892|593003410|FG003|Received Vaccination 2|Physician Decision|0|||
164174848|NCT02543892|593003411|FG004|Received Vaccination 2|Physician Decision|0|||
164174849|NCT02543892|593003412|FG005|Received Vaccination 2|Physician Decision|1|||
164174850|NCT02543892|593003413|FG006|Received Vaccination 2|Physician Decision|0|||
164174851|NCT02543892|593003414|FG007|Received Vaccination 2|Physician Decision|0|||
164174852|NCT02543892|593003407|FG000|Received Vaccination 2|Adverse Event|0|||
164174853|NCT02543892|593003408|FG001|Received Vaccination 2|Adverse Event|1|||
164174854|NCT02543892|593003409|FG002|Received Vaccination 2|Adverse Event|0|||
164174855|NCT02543892|593003410|FG003|Received Vaccination 2|Adverse Event|0|||
164174856|NCT02543892|593003411|FG004|Received Vaccination 2|Adverse Event|0|||
164174857|NCT02543892|593003412|FG005|Received Vaccination 2|Adverse Event|0|||
164174858|NCT02543892|593003413|FG006|Received Vaccination 2|Adverse Event|0|||
164174859|NCT02543892|593003414|FG007|Received Vaccination 2|Adverse Event|0|||
164174860|NCT02543892|593003407|FG000|Had Immunology Data|Withdrawal by Subject|0|||
164174861|NCT02543892|593003408|FG001|Had Immunology Data|Withdrawal by Subject|0|||
164174862|NCT02543892|593003409|FG002|Had Immunology Data|Withdrawal by Subject|0|||
164174863|NCT02543892|593003410|FG003|Had Immunology Data|Withdrawal by Subject|0|||
164174864|NCT02543892|593003411|FG004|Had Immunology Data|Withdrawal by Subject|0|||
164174865|NCT02543892|593003412|FG005|Had Immunology Data|Withdrawal by Subject|0|||
164174866|NCT02543892|593003413|FG006|Had Immunology Data|Withdrawal by Subject|1|||
164174867|NCT02543892|593003414|FG007|Had Immunology Data|Withdrawal by Subject|0|||
164174868|NCT01801280|593003415|FG000|Period 1|Withdrawal by Subject|0|||
164174869|NCT01801280|593003416|FG001|Period 1|Withdrawal by Subject|1|||
164174870|NCT01801280|593003417|FG002|Period 1|Withdrawal by Subject|0|||
164174871|NCT01801280|593003418|FG003|Period 1|Withdrawal by Subject|0|||
164174872|NCT01801280|593003415|FG000|Period 2|Withdrawal by Subject|1|||
164174873|NCT01801280|593003416|FG001|Period 2|Withdrawal by Subject|0|||
164174874|NCT01801280|593003417|FG002|Period 2|Withdrawal by Subject|0|||
164174875|NCT01801280|593003418|FG003|Period 2|Withdrawal by Subject|0|||
164174876|NCT01801280|593003415|FG000|Period 4|Protocol Violation|0|||
164174877|NCT01801280|593003416|FG001|Period 4|Protocol Violation|0|||
164174878|NCT01801280|593003417|FG002|Period 4|Protocol Violation|1|||
164174879|NCT01801280|593003418|FG003|Period 4|Protocol Violation|0|||
164174880|NCT04021121|593003421|FG000|Overall Study|Death|3|||
164174881|NCT04021121|593003422|FG001|Overall Study|Death|3|||
164174882|NCT04021121|593003423|FG002|Overall Study|Death|5|||
164174883|NCT04021121|593003424|FG003|Overall Study|Death|4|||
164174884|NCT04050124|593003430|FG000|Overall Study|Death|1|||
164174885|NCT04050124|593003431|FG001|Overall Study|Death|0|||
164174886|NCT05083923|593003436|FG000|Overall Study|Adverse Event|2|||
164174887|NCT05083923|593003437|FG001|Overall Study|Adverse Event|0|||
164174888|NCT05083923|593003436|FG000|Overall Study|Lack of Efficacy|1|||
164174889|NCT05083923|593003437|FG001|Overall Study|Lack of Efficacy|3|||
164174890|NCT05083923|593003436|FG000|Overall Study|Withdrawal by Subject|2|||
164174891|NCT05083923|593003437|FG001|Overall Study|Withdrawal by Subject|6|||
164174892|NCT05083923|593003436|FG000|Overall Study|Reason Not Specified|0|||
164174893|NCT05083923|593003437|FG001|Overall Study|Reason Not Specified|1|||
164174894|NCT01785849|593003448|FG000|Overall Study|Death|7|||
164174895|NCT01785849|593003449|FG001|Overall Study|Death|9|||
164174896|NCT01785849|593003448|FG000|Overall Study|Protocol Specified Criteria|29|||
164174897|NCT01785849|593003449|FG001|Overall Study|Protocol Specified Criteria|1|||
164174898|NCT01785849|593003448|FG000|Overall Study|Withdrawal by Subject|15|||
164174899|NCT01785849|593003449|FG001|Overall Study|Withdrawal by Subject|12|||
164174900|NCT01785849|593003448|FG000|Overall Study|Sponsor Decision|0|||
164174901|NCT01785849|593003449|FG001|Overall Study|Sponsor Decision|1|||
164174902|NCT01785849|593003448|FG000|Overall Study|Lost to Follow-up|10|||
164174903|NCT01785849|593003449|FG001|Overall Study|Lost to Follow-up|11|||
164174904|NCT00381043|593003450|FG000|Overall Study|Lost to Follow-up|8|||
164174905|NCT00381043|593003451|FG001|Overall Study|Lost to Follow-up|6|||
164174906|NCT00381043|593003450|FG000|Overall Study|Withdrawal by Subject|3|||
164174907|NCT00381043|593003451|FG001|Overall Study|Withdrawal by Subject|1|||
164174908|NCT00381043|593003450|FG000|Overall Study|wanted more care|0|||
164174909|NCT00381043|593003451|FG001|Overall Study|wanted more care|1|||
164174910|NCT00381043|593003450|FG000|Overall Study|incarcerated|1|||
164174911|NCT00381043|593003451|FG001|Overall Study|incarcerated|0|||
164174912|NCT02880865|593003454|FG000|Overall Study|Adverse Event|1|||
164174913|NCT02880865|593003455|FG001|Overall Study|Adverse Event|0|||
164174914|NCT02880865|593003454|FG000|Overall Study|Withdrawal by Subject|0|||
164174915|NCT02880865|593003455|FG001|Overall Study|Withdrawal by Subject|2|||
164174916|NCT02880865|593003454|FG000|Overall Study|Physician Decision|0|||
164174917|NCT02880865|593003455|FG001|Overall Study|Physician Decision|1|||
164174918|NCT03379753|593003456|FG000|Overall Study|Withdrawal by Subject|2|||
164174919|NCT03379753|593003457|FG001|Overall Study|Withdrawal by Subject|1|||
164174920|NCT03379753|593003456|FG000|Overall Study|not having correct procedure|1|||
164174921|NCT03379753|593003457|FG001|Overall Study|not having correct procedure|2|||
164174922|NCT03379753|593003456|FG000|Overall Study|No primary outcome|12|||
164174923|NCT03379753|593003457|FG001|Overall Study|No primary outcome|22|||
164174924|NCT05079750|593005167|FG000|Overall Study|Lost to Follow-up|0|||
164174925|NCT05079750|593005168|FG001|Overall Study|Lost to Follow-up|0|||
164174926|NCT05079750|593005169|FG002|Overall Study|Lost to Follow-up|1|||
164174927|NCT05091346|593005172|FG000|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
164174928|NCT05091346|593005173|FG001|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
164174929|NCT05091346|593005174|FG002|Overall Study|Survival follow-up ceased/discontinued by sponsor|7|||
164174930|NCT05091346|593005175|FG003|Overall Study|Survival follow-up ceased/discontinued by sponsor|10|||
164174931|NCT05091346|593005176|FG004|Overall Study|Survival follow-up ceased/discontinued by sponsor|4|||
164174932|NCT05091346|593005172|FG000|Overall Study|Death|6|||
164174933|NCT05091346|593005173|FG001|Overall Study|Death|5|||
164174934|NCT05091346|593005174|FG002|Overall Study|Death|8|||
164174935|NCT05091346|593005175|FG003|Overall Study|Death|16|||
164174936|NCT05091346|593005176|FG004|Overall Study|Death|26|||
164174937|NCT05091346|593005172|FG000|Overall Study|Lost to Follow-up|0|||
164174938|NCT05091346|593005173|FG001|Overall Study|Lost to Follow-up|0|||
164174939|NCT05091346|593005174|FG002|Overall Study|Lost to Follow-up|0|||
164174940|NCT05091346|593005175|FG003|Overall Study|Lost to Follow-up|1|||
164174941|NCT05091346|593005176|FG004|Overall Study|Lost to Follow-up|0|||
164174942|NCT05091346|593005172|FG000|Overall Study|Withdrawal by Subject|0|||
164174943|NCT05091346|593005173|FG001|Overall Study|Withdrawal by Subject|1|||
164174944|NCT05091346|593005174|FG002|Overall Study|Withdrawal by Subject|2|||
164174945|NCT05091346|593005175|FG003|Overall Study|Withdrawal by Subject|2|||
164174946|NCT05091346|593005176|FG004|Overall Study|Withdrawal by Subject|1|||
164174947|NCT01573767|593005182|FG000|Overall Study|Adverse Event|0|||
164174948|NCT01573767|593005183|FG001|Overall Study|Adverse Event|1|||
164174949|NCT01573767|593005184|FG002|Overall Study|Adverse Event|0|||
164174950|NCT01573767|593005185|FG003|Overall Study|Adverse Event|1|||
164174951|NCT01573767|593005182|FG000|Overall Study|Lack of Efficacy|18|||
164174952|NCT01573767|593005183|FG001|Overall Study|Lack of Efficacy|15|||
164174953|NCT01573767|593005184|FG002|Overall Study|Lack of Efficacy|12|||
164174954|NCT01573767|593005185|FG003|Overall Study|Lack of Efficacy|17|||
164174955|NCT01573767|593005182|FG000|Overall Study|Protocol Violation|3|||
164174956|NCT01573767|593005183|FG001|Overall Study|Protocol Violation|1|||
164174957|NCT01573767|593005184|FG002|Overall Study|Protocol Violation|1|||
164174958|NCT01573767|593005185|FG003|Overall Study|Protocol Violation|3|||
164174959|NCT01573767|593005182|FG000|Overall Study|Lost to Follow-up|0|||
164174960|NCT01573767|593005183|FG001|Overall Study|Lost to Follow-up|1|||
164174961|NCT01573767|593005184|FG002|Overall Study|Lost to Follow-up|1|||
164174962|NCT01573767|593005185|FG003|Overall Study|Lost to Follow-up|1|||
164174963|NCT01573767|593005182|FG000|Overall Study|Physician Decision|1|||
164174964|NCT01573767|593005183|FG001|Overall Study|Physician Decision|2|||
164174965|NCT01573767|593005184|FG002|Overall Study|Physician Decision|0|||
164174966|NCT01573767|593005185|FG003|Overall Study|Physician Decision|2|||
164174967|NCT01573767|593005182|FG000|Overall Study|Withdrawal by Subject|0|||
164174968|NCT01573767|593005183|FG001|Overall Study|Withdrawal by Subject|1|||
164174969|NCT01573767|593005184|FG002|Overall Study|Withdrawal by Subject|0|||
164174970|NCT01573767|593005185|FG003|Overall Study|Withdrawal by Subject|0|||
164174971|NCT02339155|593005186|FG000|Overall Study|Adverse Event|0|||
164174972|NCT02339155|593005187|FG001|Overall Study|Adverse Event|6|||
164174973|NCT02339155|593005186|FG000|Overall Study|Death|1|||
164174974|NCT02339155|593005187|FG001|Overall Study|Death|1|||
164174975|NCT02339155|593005186|FG000|Overall Study|Lost to Follow-up|8|||
164174976|NCT02339155|593005187|FG001|Overall Study|Lost to Follow-up|9|||
164174977|NCT02339155|593005186|FG000|Overall Study|Physician Decision|2|||
164174978|NCT02339155|593005187|FG001|Overall Study|Physician Decision|1|||
164174979|NCT02339155|593005186|FG000|Overall Study|Withdrawal by Subject|4|||
164174980|NCT02339155|593005187|FG001|Overall Study|Withdrawal by Subject|4|||
164174981|NCT03226678|593005192|FG000|Part A (Core Study Phase)|Adverse Event|0|||
164174982|NCT03226678|593005193|FG001|Part A (Core Study Phase)|Adverse Event|1|||
164174983|NCT03226678|593005194|FG002|Part A (Core Study Phase)|Adverse Event|0|||
164174984|NCT03226678|593005195|FG003|Part A (Core Study Phase)|Adverse Event|0|||
164174985|NCT03226678|593005196|FG004|Part A (Core Study Phase)|Adverse Event|0|||
164174986|NCT03226678|593005197|FG005|Part A (Core Study Phase)|Adverse Event|0|||
164174987|NCT03226678|593005192|FG000|Part A (Core Study Phase)|Death|0|||
164174988|NCT03226678|593005193|FG001|Part A (Core Study Phase)|Death|0|||
164174989|NCT03226678|593005194|FG002|Part A (Core Study Phase)|Death|1|||
164174990|NCT03226678|593005195|FG003|Part A (Core Study Phase)|Death|0|||
164174991|NCT03226678|593005196|FG004|Part A (Core Study Phase)|Death|0|||
164174992|NCT03226678|593005197|FG005|Part A (Core Study Phase)|Death|0|||
164174993|NCT03226678|593005192|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
164174994|NCT03226678|593005193|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
164174995|NCT03226678|593005194|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
164174996|NCT03226678|593005195|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
164174997|NCT03226678|593005196|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
164174998|NCT03226678|593005197|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
164174999|NCT03226678|593005192|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
164175000|NCT03226678|593005193|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
164175001|NCT03226678|593005194|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
164175002|NCT03226678|593005195|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
164175003|NCT03226678|593005196|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
164175004|NCT03226678|593005197|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
164175005|NCT03226678|593005192|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
164175006|NCT03226678|593005193|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
164175007|NCT03226678|593005194|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
164175008|NCT03226678|593005195|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
164175009|NCT03226678|593005196|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
164175010|NCT03226678|593005197|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
164175011|NCT03226678|593005192|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
164175012|NCT03226678|593005193|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
164175013|NCT03226678|593005194|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
164175014|NCT03226678|593005195|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
164175089|NCT00878969|593005229|FG002|Overall Study|Pregnancy|0|||
164175015|NCT03226678|593005196|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
164175016|NCT03226678|593005197|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
164175017|NCT03226678|593005192|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
164175018|NCT03226678|593005193|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
164175019|NCT03226678|593005194|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
164175020|NCT03226678|593005195|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
164175021|NCT03226678|593005196|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
164175022|NCT03226678|593005197|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
164175023|NCT03226678|593005192|FG000|Part B (Long-Term Extension Phase)|Death|0|||
164175024|NCT03226678|593005193|FG001|Part B (Long-Term Extension Phase)|Death|0|||
164175025|NCT03226678|593005194|FG002|Part B (Long-Term Extension Phase)|Death|0|||
164175026|NCT03226678|593005195|FG003|Part B (Long-Term Extension Phase)|Death|0|||
164175027|NCT03226678|593005196|FG004|Part B (Long-Term Extension Phase)|Death|0|||
164175028|NCT03226678|593005197|FG005|Part B (Long-Term Extension Phase)|Death|1|||
164175029|NCT03226678|593005192|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
164175030|NCT03226678|593005193|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
164175031|NCT03226678|593005194|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
164175032|NCT03226678|593005195|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
164175033|NCT03226678|593005196|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
164175034|NCT03226678|593005197|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
164175035|NCT03226678|593005192|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
164175036|NCT03226678|593005193|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
164175037|NCT03226678|593005194|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
164175038|NCT03226678|593005195|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
164175039|NCT03226678|593005196|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
164175040|NCT03226678|593005197|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
164175041|NCT03226678|593005192|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
164175042|NCT03226678|593005193|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
164175043|NCT03226678|593005194|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
164175044|NCT03226678|593005195|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
164175045|NCT03226678|593005196|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
164175046|NCT03226678|593005197|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
164175047|NCT05014815|593005204|FG000|Overall Study|Death|63|||
164175048|NCT05014815|593005205|FG001|Overall Study|Death|70|||
164175049|NCT05014815|593005204|FG000|Overall Study|Withdrawal by Subject|10|||
164175050|NCT05014815|593005205|FG001|Overall Study|Withdrawal by Subject|10|||
164175051|NCT05014815|593005204|FG000|Overall Study|Lost to Follow-up|4|||
164175052|NCT05014815|593005205|FG001|Overall Study|Lost to Follow-up|2|||
164175053|NCT05014815|593005204|FG000|Overall Study|Physician Decision|2|||
164175054|NCT05014815|593005205|FG001|Overall Study|Physician Decision|4|||
164175055|NCT04247880|593005206|FG000|Overall Study|Lost to Follow-up|24|||
164175056|NCT04247880|593005207|FG001|Overall Study|Lost to Follow-up|17|||
164175057|NCT04247880|593005206|FG000|Overall Study|Withdrawal by Subject|3|||
164175058|NCT04247880|593005207|FG001|Overall Study|Withdrawal by Subject|0|||
164175059|NCT00916344|593005216|FG000|Overall Study|Death|2|||
164175060|NCT00916344|593005216|FG000|Overall Study|ICD upgrade|1|||
164175061|NCT00916344|593005216|FG000|Overall Study|Drop-out|5|||
164175062|NCT00108485|593005221|FG000|Overall Study|Withdrawal by Subject|3|||
164175063|NCT00108485|593005222|FG001|Overall Study|Withdrawal by Subject|0|||
164175064|NCT00108485|593005221|FG000|Overall Study|Lost to Follow-up|0|||
164175065|NCT00108485|593005222|FG001|Overall Study|Lost to Follow-up|2|||
164175066|NCT00878969|593005227|FG000|Overall Study|Physician Decision|5|||
164175067|NCT00878969|593005228|FG001|Overall Study|Physician Decision|3|||
164175068|NCT00878969|593005229|FG002|Overall Study|Physician Decision|2|||
164175069|NCT00878969|593005227|FG000|Overall Study|Withdrawal by Subject|1|||
164175070|NCT00878969|593005228|FG001|Overall Study|Withdrawal by Subject|6|||
164175071|NCT00878969|593005229|FG002|Overall Study|Withdrawal by Subject|3|||
164175072|NCT00878969|593005227|FG000|Overall Study|kidney transplant|2|||
164175073|NCT00878969|593005228|FG001|Overall Study|kidney transplant|3|||
164175074|NCT00878969|593005229|FG002|Overall Study|kidney transplant|2|||
164175075|NCT00878969|593005227|FG000|Overall Study|Adverse Event|3|||
164175076|NCT00878969|593005228|FG001|Overall Study|Adverse Event|1|||
164175077|NCT00878969|593005229|FG002|Overall Study|Adverse Event|2|||
164175078|NCT00878969|593005227|FG000|Overall Study|Lost to Follow-up|2|||
164175079|NCT00878969|593005228|FG001|Overall Study|Lost to Follow-up|1|||
164175080|NCT00878969|593005229|FG002|Overall Study|Lost to Follow-up|0|||
164175081|NCT00878969|593005227|FG000|Overall Study|Protocol Violation|2|||
164175082|NCT00878969|593005228|FG001|Overall Study|Protocol Violation|0|||
164175083|NCT00878969|593005229|FG002|Overall Study|Protocol Violation|0|||
164175084|NCT00878969|593005227|FG000|Overall Study|Death|0|||
164175085|NCT00878969|593005228|FG001|Overall Study|Death|0|||
164175086|NCT00878969|593005229|FG002|Overall Study|Death|2|||
164175087|NCT00878969|593005227|FG000|Overall Study|Pregnancy|0|||
164175088|NCT00878969|593005228|FG001|Overall Study|Pregnancy|1|||
164175090|NCT01701193|593005232|FG000|Overall Study|Withdrawal by Subject|2|||
164175091|NCT01701193|593005233|FG001|Overall Study|Withdrawal by Subject|2|||
164175092|NCT01701193|593005234|FG002|Overall Study|Withdrawal by Subject|1|||
164175093|NCT01701193|593005235|FG003|Overall Study|Withdrawal by Subject|2|||
164175094|NCT01701193|593005232|FG000|Overall Study|Adverse Event|1|||
164175095|NCT01701193|593005233|FG001|Overall Study|Adverse Event|0|||
164175096|NCT01701193|593005234|FG002|Overall Study|Adverse Event|0|||
164175097|NCT01701193|593005235|FG003|Overall Study|Adverse Event|0|||
164175098|NCT03054064|593005236|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
164175099|NCT03054064|593005236|FG000|Overall Study|Investigator Decision|2|||
164175100|NCT03054064|593005236|FG000|Overall Study|Bladder Issue|1|||
164175101|NCT03054064|593005236|FG000|Overall Study|High Blood Pressure|1|||
164175102|NCT03054064|593005236|FG000|Overall Study|Change in Status|1|||
164175103|NCT01384019|593005237|FG000|Overall Study|Withdrawal by Subject|3|||
164175104|NCT01384019|593005238|FG001|Overall Study|Withdrawal by Subject|0|||
164175105|NCT01384019|593005237|FG000|Overall Study|Death|1|||
164175106|NCT01384019|593005238|FG001|Overall Study|Death|0|||
164175107|NCT01384019|593005237|FG000|Overall Study|MRI refusal|6|||
164175108|NCT01384019|593005238|FG001|Overall Study|MRI refusal|6|||
164175109|NCT04489381|593005244|FG000|Overall Study|Lost to Follow-up|2|||
164175110|NCT04489381|593005245|FG001|Overall Study|Lost to Follow-up|3|||
164175111|NCT04489381|593005244|FG000|Overall Study|Withdrawal by Subject|1|||
164175112|NCT04489381|593005245|FG001|Overall Study|Withdrawal by Subject|0|||
164175113|NCT03199612|593005248|FG000|Overall Study|Adverse Event|1|||
164175114|NCT03199612|593005249|FG001|Overall Study|Adverse Event|0|||
164175115|NCT01199822|593005250|FG000|Overall Study|Investigator discontinued therapy|0|||
164175116|NCT01199822|593005251|FG001|Overall Study|Investigator discontinued therapy|1|||
164175117|NCT01199822|593005252|FG002|Overall Study|Investigator discontinued therapy|0|||
164175118|NCT01500213|593005253|FG000|Overall Study|Adverse Event|35|||
164175119|NCT01500213|593005254|FG001|Overall Study|Adverse Event|35|||
164175120|NCT01500213|593005253|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
164175121|NCT01500213|593005254|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
164175122|NCT01500213|593005253|FG000|Overall Study|Withdrawal by Subject|28|||
164175123|NCT01500213|593005254|FG001|Overall Study|Withdrawal by Subject|37|||
164175124|NCT01500213|593005253|FG000|Overall Study|Death|7|||
164175125|NCT01500213|593005254|FG001|Overall Study|Death|3|||
164175126|NCT01500213|593005253|FG000|Overall Study|Disease Progression|13|||
164175127|NCT01500213|593005254|FG001|Overall Study|Disease Progression|21|||
164175128|NCT01500213|593005253|FG000|Overall Study|Protocol Violation|19|||
164175129|NCT01500213|593005254|FG001|Overall Study|Protocol Violation|19|||
164175130|NCT01500213|593005253|FG000|Overall Study|Physician Decision|12|||
164175131|NCT01500213|593005254|FG001|Overall Study|Physician Decision|10|||
164175132|NCT01500213|593005253|FG000|Overall Study|Lack of Efficacy|9|||
164175133|NCT01500213|593005254|FG001|Overall Study|Lack of Efficacy|7|||
164175134|NCT01500213|593005253|FG000|Overall Study|Lost to Follow-up|3|||
164175135|NCT01500213|593005254|FG001|Overall Study|Lost to Follow-up|6|||
164175136|NCT01500213|593005253|FG000|Overall Study|Other Reasons|7|||
164175137|NCT01500213|593005254|FG001|Overall Study|Other Reasons|5|||
164175138|NCT04027075|593005255|FG000|Overall Study|Lost to Follow-up|41|||
164175139|NCT04027075|593005256|FG001|Overall Study|Lost to Follow-up|22|||
164175140|NCT01043705|593005258|FG000|Overall Study|Death|28|||
164175141|NCT01043705|593005259|FG001|Overall Study|Death|60|||
164175142|NCT01043705|593005260|FG002|Overall Study|Death|26|||
164175143|NCT01043705|593005258|FG000|Overall Study|Lost to Follow-up|27|||
164175144|NCT01043705|593005259|FG001|Overall Study|Lost to Follow-up|12|||
164175145|NCT01043705|593005260|FG002|Overall Study|Lost to Follow-up|0|||
164175146|NCT01043705|593005258|FG000|Overall Study|Multiple Reasons|4|||
164175147|NCT01043705|593005259|FG001|Overall Study|Multiple Reasons|7|||
164175148|NCT01043705|593005260|FG002|Overall Study|Multiple Reasons|0|||
164175149|NCT01043705|593005258|FG000|Overall Study|Protocol Violation|2|||
164175150|NCT01043705|593005259|FG001|Overall Study|Protocol Violation|1|||
164175151|NCT01043705|593005260|FG002|Overall Study|Protocol Violation|0|||
164175152|NCT01043705|593005258|FG000|Overall Study|Withdrawal by Subject|8|||
164175153|NCT01043705|593005259|FG001|Overall Study|Withdrawal by Subject|6|||
164175154|NCT01043705|593005260|FG002|Overall Study|Withdrawal by Subject|0|||
164175155|NCT01043705|593005258|FG000|Overall Study|Site Closure|8|||
164175156|NCT01043705|593005259|FG001|Overall Study|Site Closure|0|||
164175157|NCT01043705|593005260|FG002|Overall Study|Site Closure|0|||
164175158|NCT01043705|593005258|FG000|Overall Study|Subsequent Procedure|9|||
164175159|NCT01043705|593005259|FG001|Overall Study|Subsequent Procedure|24|||
164175160|NCT01043705|593005260|FG002|Overall Study|Subsequent Procedure|29|||
164175161|NCT01043705|593005258|FG000|Overall Study|Adverse Event|0|||
164175162|NCT01043705|593005259|FG001|Overall Study|Adverse Event|2|||
164175163|NCT01043705|593005260|FG002|Overall Study|Adverse Event|0|||
164175164|NCT01043705|593005258|FG000|Overall Study|Screen Fail|21|||
164175165|NCT01043705|593005259|FG001|Overall Study|Screen Fail|0|||
164175166|NCT01043705|593005260|FG002|Overall Study|Screen Fail|0|||
164175167|NCT01043705|593005258|FG000|Overall Study|Other|0|||
164175168|NCT01043705|593005259|FG001|Overall Study|Other|19|||
164175169|NCT01043705|593005260|FG002|Overall Study|Other|25|||
164175170|NCT02003963|593005264|FG000|Overall Study|Lost to Follow-up|2|||
164175171|NCT02003963|593005265|FG001|Overall Study|Lost to Follow-up|1|||
164175172|NCT01195844|593005266|FG000|Overall Study|Fecal sample not collected|40|||
164175173|NCT00176644|593005267|FG000|Overall Study|Withdrawal by Subject|1|||
164175174|NCT00581542|593005268|FG000|Overall Study|they met an exclusion criteria|2|||
164175175|NCT00581542|593005269|FG001|Overall Study|they met an exclusion criteria|2|||
164175176|NCT00581542|593005268|FG000|Overall Study|Lost to Follow-up|9|||
164175177|NCT00581542|593005269|FG001|Overall Study|Lost to Follow-up|21|||
164175178|NCT05020366|593005270|FG000|Overall Study|Lost to Follow-up|2|||
164175179|NCT05020366|593005271|FG001|Overall Study|Lost to Follow-up|0|||
164175180|NCT05020366|593005270|FG000|Overall Study|Withdrawal by Subject|2|||
164175181|NCT05020366|593005271|FG001|Overall Study|Withdrawal by Subject|0|||
164175182|NCT00195494|593005274|FG000|Year 1|Adverse Event|0|||
164175183|NCT00195494|593005275|FG001|Year 1|Adverse Event|0|||
164175184|NCT00195494|593005276|FG002|Year 1|Adverse Event|0|||
164175185|NCT00195494|593005277|FG003|Year 1|Adverse Event|0|||
164175186|NCT00195494|593005278|FG004|Year 1|Adverse Event|34|||
164175187|NCT00195494|593005279|FG005|Year 1|Adverse Event|27|||
164175188|NCT00195494|593005274|FG000|Year 1|System Toxicity|0|||
164175189|NCT00195494|593005275|FG001|Year 1|System Toxicity|0|||
164175190|NCT00195494|593005276|FG002|Year 1|System Toxicity|0|||
164175191|NCT00195494|593005277|FG003|Year 1|System Toxicity|0|||
164175192|NCT00195494|593005278|FG004|Year 1|System Toxicity|0|||
164175193|NCT00195494|593005279|FG005|Year 1|System Toxicity|1|||
164175194|NCT00195494|593005274|FG000|Year 1|Lack of Efficacy|0|||
164175195|NCT00195494|593005275|FG001|Year 1|Lack of Efficacy|0|||
164175196|NCT00195494|593005276|FG002|Year 1|Lack of Efficacy|0|||
164175197|NCT00195494|593005277|FG003|Year 1|Lack of Efficacy|0|||
164175198|NCT00195494|593005278|FG004|Year 1|Lack of Efficacy|24|||
164175199|NCT00195494|593005279|FG005|Year 1|Lack of Efficacy|9|||
164175200|NCT00195494|593005274|FG000|Year 1|Compliance|0|||
164175201|NCT00195494|593005275|FG001|Year 1|Compliance|0|||
164175202|NCT00195494|593005276|FG002|Year 1|Compliance|0|||
164175203|NCT00195494|593005277|FG003|Year 1|Compliance|0|||
164175204|NCT00195494|593005278|FG004|Year 1|Compliance|5|||
164175205|NCT00195494|593005279|FG005|Year 1|Compliance|1|||
164175206|NCT00195494|593005274|FG000|Year 1|Lost to Follow-up|0|||
164175207|NCT00195494|593005275|FG001|Year 1|Lost to Follow-up|0|||
164175208|NCT00195494|593005276|FG002|Year 1|Lost to Follow-up|0|||
164175209|NCT00195494|593005277|FG003|Year 1|Lost to Follow-up|0|||
164175210|NCT00195494|593005278|FG004|Year 1|Lost to Follow-up|1|||
164175211|NCT00195494|593005279|FG005|Year 1|Lost to Follow-up|0|||
164175212|NCT00195494|593005274|FG000|Year 1|Missed >4 consecutive doses|0|||
164175213|NCT00195494|593005275|FG001|Year 1|Missed >4 consecutive doses|0|||
164175214|NCT00195494|593005276|FG002|Year 1|Missed >4 consecutive doses|0|||
164175215|NCT00195494|593005277|FG003|Year 1|Missed >4 consecutive doses|0|||
164175216|NCT00195494|593005278|FG004|Year 1|Missed >4 consecutive doses|3|||
164175217|NCT00195494|593005279|FG005|Year 1|Missed >4 consecutive doses|2|||
164175218|NCT00195494|593005274|FG000|Year 1|Protocol deviation|0|||
164175219|NCT00195494|593005275|FG001|Year 1|Protocol deviation|0|||
164175220|NCT00195494|593005276|FG002|Year 1|Protocol deviation|0|||
164175221|NCT00195494|593005277|FG003|Year 1|Protocol deviation|0|||
164175222|NCT00195494|593005278|FG004|Year 1|Protocol deviation|2|||
164175223|NCT00195494|593005279|FG005|Year 1|Protocol deviation|3|||
164175224|NCT00195494|593005274|FG000|Year 1|Physician Decision|0|||
164175225|NCT00195494|593005275|FG001|Year 1|Physician Decision|0|||
164175226|NCT00195494|593005276|FG002|Year 1|Physician Decision|0|||
164175227|NCT00195494|593005277|FG003|Year 1|Physician Decision|0|||
164175228|NCT00195494|593005278|FG004|Year 1|Physician Decision|1|||
164175229|NCT00195494|593005279|FG005|Year 1|Physician Decision|0|||
164175230|NCT00195494|593005274|FG000|Year 1|Withdrawal by Subject|0|||
164175231|NCT00195494|593005275|FG001|Year 1|Withdrawal by Subject|0|||
164175232|NCT00195494|593005276|FG002|Year 1|Withdrawal by Subject|0|||
164175233|NCT00195494|593005277|FG003|Year 1|Withdrawal by Subject|0|||
164175234|NCT00195494|593005278|FG004|Year 1|Withdrawal by Subject|8|||
164175235|NCT00195494|593005279|FG005|Year 1|Withdrawal by Subject|9|||
164175236|NCT00195494|593005274|FG000|Year 1|Protocol Violation|0|||
164175237|NCT00195494|593005275|FG001|Year 1|Protocol Violation|0|||
164175238|NCT00195494|593005276|FG002|Year 1|Protocol Violation|0|||
164175239|NCT00195494|593005277|FG003|Year 1|Protocol Violation|0|||
164175240|NCT00195494|593005278|FG004|Year 1|Protocol Violation|1|||
164175241|NCT00195494|593005279|FG005|Year 1|Protocol Violation|1|||
164175242|NCT00195494|593005274|FG000|Year 2|Adverse Event|3|||
164175243|NCT00195494|593005275|FG001|Year 2|Adverse Event|7|||
164175244|NCT00195494|593005276|FG002|Year 2|Adverse Event|5|||
164175245|NCT00195494|593005277|FG003|Year 2|Adverse Event|9|||
164175246|NCT00195494|593005278|FG004|Year 2|Adverse Event|0|||
164175247|NCT00195494|593005279|FG005|Year 2|Adverse Event|0|||
164175248|NCT00195494|593005274|FG000|Year 2|Lack of Efficacy|0|||
164175249|NCT00195494|593005275|FG001|Year 2|Lack of Efficacy|1|||
164175250|NCT00195494|593005276|FG002|Year 2|Lack of Efficacy|7|||
164175251|NCT00195494|593005277|FG003|Year 2|Lack of Efficacy|7|||
164175252|NCT00195494|593005278|FG004|Year 2|Lack of Efficacy|0|||
164175253|NCT00195494|593005279|FG005|Year 2|Lack of Efficacy|0|||
164175254|NCT00195494|593005274|FG000|Year 2|Compliance|1|||
164175255|NCT00195494|593005275|FG001|Year 2|Compliance|0|||
164175256|NCT00195494|593005276|FG002|Year 2|Compliance|0|||
164175257|NCT00195494|593005277|FG003|Year 2|Compliance|2|||
164175258|NCT00195494|593005278|FG004|Year 2|Compliance|0|||
164175259|NCT00195494|593005279|FG005|Year 2|Compliance|0|||
164175260|NCT00195494|593005274|FG000|Year 2|Lost to Follow-up|0|||
164175261|NCT00195494|593005275|FG001|Year 2|Lost to Follow-up|0|||
164175262|NCT00195494|593005276|FG002|Year 2|Lost to Follow-up|1|||
164175263|NCT00195494|593005277|FG003|Year 2|Lost to Follow-up|1|||
164175264|NCT00195494|593005278|FG004|Year 2|Lost to Follow-up|0|||
164175265|NCT00195494|593005279|FG005|Year 2|Lost to Follow-up|0|||
164175266|NCT00195494|593005274|FG000|Year 2|Missed >4 consecutive doses|1|||
164175267|NCT00195494|593005275|FG001|Year 2|Missed >4 consecutive doses|1|||
164175268|NCT00195494|593005276|FG002|Year 2|Missed >4 consecutive doses|1|||
164175269|NCT00195494|593005277|FG003|Year 2|Missed >4 consecutive doses|0|||
164175270|NCT00195494|593005278|FG004|Year 2|Missed >4 consecutive doses|0|||
164175271|NCT00195494|593005279|FG005|Year 2|Missed >4 consecutive doses|0|||
164175272|NCT00195494|593005274|FG000|Year 2|Protocol deviation|0|||
164175273|NCT00195494|593005275|FG001|Year 2|Protocol deviation|1|||
164175274|NCT00195494|593005276|FG002|Year 2|Protocol deviation|0|||
164175275|NCT00195494|593005277|FG003|Year 2|Protocol deviation|0|||
164175276|NCT00195494|593005278|FG004|Year 2|Protocol deviation|0|||
164175277|NCT00195494|593005279|FG005|Year 2|Protocol deviation|0|||
164175278|NCT00195494|593005274|FG000|Year 2|Physician Decision|1|||
164175279|NCT00195494|593005275|FG001|Year 2|Physician Decision|1|||
164175280|NCT00195494|593005276|FG002|Year 2|Physician Decision|0|||
164175281|NCT00195494|593005277|FG003|Year 2|Physician Decision|0|||
164175282|NCT00195494|593005278|FG004|Year 2|Physician Decision|0|||
164175283|NCT00195494|593005279|FG005|Year 2|Physician Decision|0|||
164175284|NCT00195494|593005274|FG000|Year 2|Withdrawal by Subject|1|||
164175285|NCT00195494|593005275|FG001|Year 2|Withdrawal by Subject|5|||
164175286|NCT00195494|593005276|FG002|Year 2|Withdrawal by Subject|4|||
164175287|NCT00195494|593005277|FG003|Year 2|Withdrawal by Subject|3|||
164175288|NCT00195494|593005278|FG004|Year 2|Withdrawal by Subject|0|||
164175289|NCT00195494|593005279|FG005|Year 2|Withdrawal by Subject|0|||
164175290|NCT00195494|593005274|FG000|Year 2|System toxicity|0|||
164175291|NCT00195494|593005275|FG001|Year 2|System toxicity|0|||
164175292|NCT00195494|593005276|FG002|Year 2|System toxicity|0|||
164175293|NCT00195494|593005277|FG003|Year 2|System toxicity|1|||
164175294|NCT00195494|593005278|FG004|Year 2|System toxicity|0|||
164175295|NCT00195494|593005279|FG005|Year 2|System toxicity|0|||
164175296|NCT03045276|593005283|FG000|Intervention Phase|Withdrawal by Subject|7|||
164175297|NCT03045276|593005284|FG001|Intervention Phase|Withdrawal by Subject|2|||
164175298|NCT03045276|593005285|FG002|Intervention Phase|Withdrawal by Subject|3|||
164175299|NCT03045276|593005286|FG003|Intervention Phase|Withdrawal by Subject|7|||
164175300|NCT03045276|593005283|FG000|Intervention Phase|Developed exclusionary criteria|3|||
164175301|NCT03045276|593005284|FG001|Intervention Phase|Developed exclusionary criteria|3|||
164175302|NCT03045276|593005285|FG002|Intervention Phase|Developed exclusionary criteria|0|||
164175303|NCT03045276|593005286|FG003|Intervention Phase|Developed exclusionary criteria|0|||
164175304|NCT03045276|593005283|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
164175305|NCT03045276|593005284|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
164175306|NCT03045276|593005285|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
164175307|NCT03045276|593005286|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
164175308|NCT03045276|593005283|FG000|Follow-Up Phase|Lost to Follow-up|0|||
164175309|NCT03045276|593005284|FG001|Follow-Up Phase|Lost to Follow-up|1|||
164175310|NCT03045276|593005285|FG002|Follow-Up Phase|Lost to Follow-up|0|||
164175311|NCT03045276|593005286|FG003|Follow-Up Phase|Lost to Follow-up|1|||
164175312|NCT03045276|593005283|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
164175313|NCT03045276|593005284|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
164175314|NCT03045276|593005285|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
164175315|NCT03045276|593005286|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
164175316|NCT00347919|593005288|FG000|Overall Study|Lost to Follow-up|11|||
164175317|NCT00347919|593005289|FG001|Overall Study|Lost to Follow-up|13|||
164175318|NCT00347919|593005290|FG002|Overall Study|Lost to Follow-up|0|||
164175319|NCT00347919|593005288|FG000|Overall Study|Withdrawal by Subject|6|||
164175320|NCT00347919|593005289|FG001|Overall Study|Withdrawal by Subject|8|||
164175321|NCT00347919|593005290|FG002|Overall Study|Withdrawal by Subject|0|||
164175322|NCT00347919|593005288|FG000|Overall Study|Physician Decision|1|||
164175323|NCT00347919|593005289|FG001|Overall Study|Physician Decision|1|||
164175324|NCT00347919|593005290|FG002|Overall Study|Physician Decision|0|||
164175325|NCT00347919|593005288|FG000|Overall Study|Sponsor terminated study|15|||
164175326|NCT00347919|593005289|FG001|Overall Study|Sponsor terminated study|10|||
164175327|NCT00347919|593005290|FG002|Overall Study|Sponsor terminated study|16|||
164175328|NCT00347919|593005288|FG000|Overall Study|Death|35|||
164175329|NCT00347919|593005289|FG001|Overall Study|Death|42|||
164175330|NCT00347919|593005290|FG002|Overall Study|Death|19|||
164175331|NCT00347919|593005288|FG000|Overall Study|Par. Started Other Treatment|1|||
164175332|NCT00347919|593005289|FG001|Overall Study|Par. Started Other Treatment|1|||
164175333|NCT00347919|593005290|FG002|Overall Study|Par. Started Other Treatment|1|||
164175334|NCT00347919|593005288|FG000|Overall Study|Missing|2|||
164175335|NCT00347919|593005289|FG001|Overall Study|Missing|1|||
164175336|NCT00347919|593005290|FG002|Overall Study|Missing|2|||
164175337|NCT01190267|593005295|FG000|Overall Study|Adverse Event|10|||
164175338|NCT01190267|593005296|FG001|Overall Study|Adverse Event|0|||
164175339|NCT01190267|593005295|FG000|Overall Study|Treatment Failure|8|||
164175340|NCT01190267|593005296|FG001|Overall Study|Treatment Failure|2|||
164175341|NCT01190267|593005295|FG000|Overall Study|Lost to Follow-up|2|||
164175342|NCT01190267|593005296|FG001|Overall Study|Lost to Follow-up|0|||
164175343|NCT01190267|593005295|FG000|Overall Study|Withdrawal by Subject|13|||
164175344|NCT01190267|593005296|FG001|Overall Study|Withdrawal by Subject|1|||
164175345|NCT01190267|593005295|FG000|Overall Study|Protocol Violation|8|||
164175346|NCT01190267|593005296|FG001|Overall Study|Protocol Violation|1|||
164175347|NCT05513703|593005300|FG000|Overall Study|Death|4|||
164175348|NCT05513703|593005300|FG000|Overall Study|Study terminated by sponsor|5|||
164175349|NCT04450407|593005313|FG000|Overall Study|Withdrawal by Subject|10|||
164175350|NCT04450407|593005314|FG001|Overall Study|Withdrawal by Subject|1|||
164175351|NCT04450407|593005315|FG002|Overall Study|Withdrawal by Subject|4|||
164175352|NCT04450407|593005313|FG000|Overall Study|Adverse Event|0|||
164175353|NCT04450407|593005314|FG001|Overall Study|Adverse Event|0|||
164175354|NCT04450407|593005315|FG002|Overall Study|Adverse Event|1|||
164175355|NCT04450407|593005313|FG000|Overall Study|Lost to Follow-up|1|||
164175356|NCT04450407|593005314|FG001|Overall Study|Lost to Follow-up|0|||
164175357|NCT04450407|593005315|FG002|Overall Study|Lost to Follow-up|0|||
164175358|NCT04450407|593005313|FG000|Overall Study|Physician Decision|0|||
164175359|NCT04450407|593005314|FG001|Overall Study|Physician Decision|0|||
164175360|NCT04450407|593005315|FG002|Overall Study|Physician Decision|1|||
164175361|NCT04450407|593005313|FG000|Overall Study|Pregnancy|1|||
164175362|NCT04450407|593005314|FG001|Overall Study|Pregnancy|0|||
164175363|NCT04450407|593005315|FG002|Overall Study|Pregnancy|0|||
164175364|NCT04450407|593005313|FG000|Overall Study|Protocol Violation|2|||
164175365|NCT04450407|593005314|FG001|Overall Study|Protocol Violation|0|||
164175366|NCT04450407|593005315|FG002|Overall Study|Protocol Violation|0|||
164175367|NCT04450407|593005313|FG000|Overall Study|Investigational site terminated by sponsor|3|||
164175368|NCT04450407|593005314|FG001|Overall Study|Investigational site terminated by sponsor|0|||
164175369|NCT04450407|593005315|FG002|Overall Study|Investigational site terminated by sponsor|2|||
164175370|NCT04696354|593005318|FG000|Overall Study|Study termination|6|||
164175371|NCT04696354|593005319|FG001|Overall Study|Study termination|6|||
164175372|NCT00533702|593005321|FG000|Overall Study|Withdrawal by Subject|3|||
164175373|NCT00533702|593005322|FG001|Overall Study|Withdrawal by Subject|1|||
164175374|NCT00533702|593005321|FG000|Overall Study|Found ineligible after randomization|2|||
164175375|NCT00533702|593005322|FG001|Overall Study|Found ineligible after randomization|1|||
164175376|NCT01970475|593005325|FG000|Overall Study|Withdrawal by Subject|11|||
164175377|NCT01970475|593005326|FG001|Overall Study|Withdrawal by Subject|6|||
164175378|NCT01970475|593005325|FG000|Overall Study|Adverse Event|7|||
164175379|NCT01970475|593005326|FG001|Overall Study|Adverse Event|3|||
164175380|NCT01970475|593005325|FG000|Overall Study|Lost to Follow-up|2|||
164175381|NCT01970475|593005326|FG001|Overall Study|Lost to Follow-up|2|||
164175382|NCT01970475|593005325|FG000|Overall Study|Protocol Violation|1|||
164175383|NCT01970475|593005326|FG001|Overall Study|Protocol Violation|0|||
164175384|NCT04413552|593005331|FG000|Overall Study|Adverse Event|0|||
164175385|NCT04413552|593005332|FG001|Overall Study|Adverse Event|0|||
164175386|NCT04413552|593005333|FG002|Overall Study|Adverse Event|0|||
164175387|NCT04413552|593005334|FG003|Overall Study|Adverse Event|0|||
164175388|NCT04413552|593005335|FG004|Overall Study|Adverse Event|0|||
164175389|NCT04413552|593005336|FG005|Overall Study|Adverse Event|0|||
164175390|NCT04413552|593005337|FG006|Overall Study|Adverse Event|1|||
164175391|NCT04413552|593005338|FG007|Overall Study|Adverse Event|0|||
164175392|NCT04413552|593005339|FG008|Overall Study|Adverse Event|0|||
164175393|NCT04413552|593005340|FG009|Overall Study|Adverse Event|0|||
164175394|NCT01317797|593005341|FG000|Overall Study|Other|0|||
164175395|NCT01317797|593005342|FG001|Overall Study|Other|1|||
164175396|NCT01317797|593005343|FG002|Overall Study|Other|0|||
164175397|NCT01317797|593005341|FG000|Overall Study|Withdrawal of Patient|0|||
164175398|NCT01317797|593005342|FG001|Overall Study|Withdrawal of Patient|0|||
164175399|NCT01317797|593005343|FG002|Overall Study|Withdrawal of Patient|1|||
164175400|NCT03026530|593005344|FG000|Overall Study|Lost to Follow-up|19|||
164175401|NCT03026530|593005345|FG001|Overall Study|Lost to Follow-up|24|||
164175402|NCT03026530|593005344|FG000|Overall Study|Protocol Violation|2|||
164175403|NCT03026530|593005345|FG001|Overall Study|Protocol Violation|5|||
164175404|NCT03721835|593005347|FG000|Overall Study|Participant not able to return|1|||
164175405|NCT03721835|593005347|FG000|Overall Study|Lost to Follow-up|1|||
164175406|NCT03721835|593005347|FG000|Overall Study|Revision of the components of the study device|2|||
164175407|NCT03721835|593005347|FG000|Overall Study|Sponsor terminated study|6|||
164175408|NCT03721835|593005347|FG000|Overall Study|Death|1|||
164175409|NCT03721835|593005347|FG000|Overall Study|Sponsor decision|1|||
164175410|NCT03495154|593005348|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
164175411|NCT03495154|593005348|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
164175412|NCT03495154|593005348|FG000|Overall Study|Screen Failures During Surgery|6|||
164175413|NCT03495154|593005348|FG000|Overall Study|Death|2|||
164175414|NCT03495154|593005348|FG000|Overall Study|Lost to Follow-up|16|||
164175415|NCT03495154|593005348|FG000|Overall Study|Withdrawal by Subject|2|||
164175416|NCT03495154|593005348|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
164175417|NCT01294696|593005352|FG000|Overall Study|Screening failures|7|||
164175418|NCT01294696|593005352|FG000|Overall Study|Protocol Violation|8|||
164175419|NCT01294696|593005352|FG000|Overall Study|Missing BPI Response|7|||
164175420|NCT01294696|593005352|FG000|Overall Study|Site closure|52|||
164175421|NCT05741346|593006552|FG000|Overall Study|Withdrawn due to termination of study|28|||
164175422|NCT04439357|593006553|FG000|Overall Study|Disease Progression|4|||
164175423|NCT01668966|593006558|FG000|Overall Study|Withdrawal by Subject|1|||
164175424|NCT01668966|593006558|FG000|Overall Study|Death|1|||
164175425|NCT01668966|593006558|FG000|Overall Study|Not treated|2|||
164175426|NCT03602391|593006560|FG000|Overall Study|COVID-19|7|||
164175427|NCT03602391|593006561|FG001|Overall Study|COVID-19|6|||
164175428|NCT01527487|593006562|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
164175429|NCT01527487|593006563|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
164175430|NCT01527487|593006562|FG000|Overall Study|Disease Progression|4|||
164175431|NCT01527487|593006563|FG001|Overall Study|Disease Progression|1|||
164175432|NCT01527487|593006562|FG000|Overall Study|Adverse Event|1|||
164175433|NCT01527487|593006563|FG001|Overall Study|Adverse Event|1|||
164175434|NCT01527487|593006562|FG000|Overall Study|Death|0|||
164175435|NCT01527487|593006563|FG001|Overall Study|Death|1|||
164175436|NCT01892085|593006564|FG000|Overall Study|Death|4|||
164175437|NCT01892085|593006565|FG001|Overall Study|Death|1|||
164175438|NCT01892085|593006566|FG002|Overall Study|Death|3|||
164175439|NCT01892085|593006564|FG000|Overall Study|Withdrawal by Subject|2|||
164175440|NCT01892085|593006565|FG001|Overall Study|Withdrawal by Subject|0|||
164175441|NCT01892085|593006566|FG002|Overall Study|Withdrawal by Subject|2|||
164175442|NCT01472757|593006567|FG000|Overall Study|Withdrawal by Subject|1|||
164175443|NCT01472757|593006568|FG001|Overall Study|Withdrawal by Subject|2|||
164175444|NCT01472757|593006569|FG002|Overall Study|Withdrawal by Subject|2|||
164175445|NCT01472757|593006570|FG003|Overall Study|Withdrawal by Subject|0|||
164175446|NCT01472757|593006567|FG000|Overall Study|Asthma exacerbation|4|||
164175447|NCT01472757|593006568|FG001|Overall Study|Asthma exacerbation|1|||
164175448|NCT01472757|593006569|FG002|Overall Study|Asthma exacerbation|2|||
164175449|NCT01472757|593006570|FG003|Overall Study|Asthma exacerbation|1|||
164175450|NCT01472757|593006567|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
164175451|NCT01472757|593006568|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
164175452|NCT01472757|593006569|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
164175453|NCT01472757|593006570|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
164175454|NCT01472757|593006567|FG000|Overall Study|Protocol Violation|3|||
164175455|NCT01472757|593006568|FG001|Overall Study|Protocol Violation|2|||
164175456|NCT01472757|593006569|FG002|Overall Study|Protocol Violation|4|||
164175457|NCT01472757|593006570|FG003|Overall Study|Protocol Violation|4|||
164175458|NCT01472757|593006567|FG000|Overall Study|Other reasons|1|||
164175459|NCT01472757|593006568|FG001|Overall Study|Other reasons|0|||
164175460|NCT01472757|593006569|FG002|Overall Study|Other reasons|2|||
164175461|NCT01472757|593006570|FG003|Overall Study|Other reasons|2|||
164175462|NCT00597506|593006571|FG000|Overall Study|Subject is being followed for survival|1|||
164175463|NCT00081731|593006576|FG000|Overall Study|scientific integrity issue|8|||
164175464|NCT00081731|593006577|FG001|Overall Study|scientific integrity issue|8|||
164175465|NCT01629823|593006582|FG000|Trial Period|Missed visit|11|||
164175466|NCT01629823|593006583|FG001|Trial Period|Missed visit|9|||
164175467|NCT01629823|593006584|FG002|Trial Period|Missed visit|8|||
164175468|NCT01629823|593006582|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
164175469|NCT01629823|593006583|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
164175470|NCT01629823|593006584|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
164175471|NCT01629823|593006582|FG000|Trial Period|Pregnancy|1|||
164175472|NCT01629823|593006583|FG001|Trial Period|Pregnancy|0|||
164175473|NCT01629823|593006584|FG002|Trial Period|Pregnancy|0|||
164175474|NCT01629823|593006582|FG000|Trial Period|Adverse Event|0|||
164175475|NCT01629823|593006583|FG001|Trial Period|Adverse Event|1|||
164175476|NCT01629823|593006584|FG002|Trial Period|Adverse Event|0|||
164175477|NCT01629823|593006582|FG000|Trial Period|Out-of-window visit|0|||
164175478|NCT01629823|593006583|FG001|Trial Period|Out-of-window visit|2|||
164175479|NCT01629823|593006584|FG002|Trial Period|Out-of-window visit|0|||
164175480|NCT01629823|593006582|FG000|Trial Period|Failed to hold medication|0|||
164175481|NCT01629823|593006583|FG001|Trial Period|Failed to hold medication|0|||
164175482|NCT01629823|593006584|FG002|Trial Period|Failed to hold medication|1|||
164175483|NCT01629823|593006582|FG000|Washout Period|Safety|2|||
164175484|NCT01629823|593006583|FG001|Washout Period|Safety|5|||
164175485|NCT01629823|593006584|FG002|Washout Period|Safety|0|||
164175486|NCT01629823|593006582|FG000|Washout Period|Pregnancy|1|||
164175487|NCT01629823|593006583|FG001|Washout Period|Pregnancy|0|||
164175488|NCT01629823|593006584|FG002|Washout Period|Pregnancy|0|||
164175489|NCT01629823|593006582|FG000|Washout Period|Protocol Violation|0|||
164175490|NCT01629823|593006583|FG001|Washout Period|Protocol Violation|1|||
164175491|NCT01629823|593006584|FG002|Washout Period|Protocol Violation|0|||
164175492|NCT00785213|593006585|FG000|Quinine Sulfate Alone|Adverse Event|4|||
164175493|NCT00785213|593006585|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
164175494|NCT02386345|593006586|FG000|Overall Study|Not treated|14|||
164175495|NCT02386345|593006586|FG000|Overall Study|Lost to Follow-up|1|||
164175496|NCT02386345|593006586|FG000|Overall Study|Adverse Event|5|||
164175497|NCT02386345|593006586|FG000|Overall Study|Repeat Procedure|10|||
164175498|NCT02386345|593006586|FG000|Overall Study|Did not complete 12-month follow-up|72|||
164175499|NCT00526331|593006588|FG000|Overall Study|Sponsor Termination|55|||
164175500|NCT00455520|593006589|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
164175501|NCT00455520|593006590|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
164175502|NCT00455520|593006589|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
164175503|NCT00455520|593006590|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
164175504|NCT00455520|593006589|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
164175505|NCT00455520|593006590|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
164175506|NCT00455520|593006589|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
164175507|NCT00455520|593006590|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
164175508|NCT00455520|593006589|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
164175509|NCT00455520|593006590|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
164175510|NCT00455520|593006589|FG000|Open Label Tapentadol Extended Release|All other|33|||
164175511|NCT00455520|593006590|FG001|Open Label Tapentadol Extended Release|All other|0|||
164175512|NCT00455520|593006589|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
164175513|NCT00455520|593006590|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
164175514|NCT00455520|593006589|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
164175515|NCT00455520|593006590|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
164175516|NCT00455520|593006589|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
164175517|NCT00455520|593006590|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
164175518|NCT00455520|593006589|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
164175519|NCT00455520|593006590|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
164175520|NCT00455520|593006589|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
164175521|NCT00455520|593006590|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
164175522|NCT00455520|593006589|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
164175523|NCT00455520|593006590|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
164175524|NCT00033657|593006594|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
164175525|NCT00033657|593006595|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
164175526|NCT00033657|593006594|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
164175527|NCT00033657|593006595|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
164175528|NCT00033657|593006594|FG000|Neoadjuvant Chemotherapy|Death|1|||
164175529|NCT00033657|593006595|FG001|Neoadjuvant Chemotherapy|Death|1|||
164175530|NCT00033657|593006594|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
164175531|NCT00033657|593006595|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
164175532|NCT00033657|593006594|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
164175533|NCT00033657|593006595|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
164175534|NCT00033657|593006594|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
164175535|NCT00033657|593006595|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
164175536|NCT00033657|593006594|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
164175537|NCT00033657|593006595|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
164175538|NCT00033657|593006594|FG000|Surgical Resection|not complete resection|0|||
164175539|NCT00033657|593006595|FG001|Surgical Resection|not complete resection|3|||
164175540|NCT00033657|593006594|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
164175541|NCT00033657|593006595|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
164175542|NCT00033657|593006594|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
164175543|NCT00033657|593006595|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
164175544|NCT00033657|593006594|FG000|Adjuvant Chemotherapy|Death|2|||
164175545|NCT00033657|593006595|FG001|Adjuvant Chemotherapy|Death|1|||
164175546|NCT00033657|593006594|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
164175547|NCT00033657|593006595|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
164175548|NCT00033657|593006594|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
164175549|NCT00033657|593006595|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
164175550|NCT00033657|593006594|FG000|Adjuvant Chemotherapy|Other|0|||
164175551|NCT00033657|593006595|FG001|Adjuvant Chemotherapy|Other|2|||
164175552|NCT03448939|593006597|FG000|Overall Study|Adverse Event|5|||
164175553|NCT03448939|593006598|FG001|Overall Study|Adverse Event|1|||
164175554|NCT03448939|593006597|FG000|Overall Study|Lost to Follow-up|6|||
164175555|NCT03448939|593006598|FG001|Overall Study|Lost to Follow-up|6|||
164175556|NCT03448939|593006597|FG000|Overall Study|Pregnancy|1|||
164175557|NCT03448939|593006598|FG001|Overall Study|Pregnancy|1|||
164175558|NCT03448939|593006597|FG000|Overall Study|Withdrawal by Subject|9|||
164175559|NCT03448939|593006598|FG001|Overall Study|Withdrawal by Subject|3|||
164175560|NCT01259375|593006599|FG000|Overall Study|Adverse Event|1|||
164175561|NCT00986986|593006600|FG000|Overall Study|Lost to Follow-up|0|||
164175562|NCT00986986|593006601|FG001|Overall Study|Lost to Follow-up|1|||
164175563|NCT00628095|593006602|FG000|Overall Study|Adverse Event|5|||
164175564|NCT00628095|593006603|FG001|Overall Study|Adverse Event|3|||
164175565|NCT00628095|593006602|FG000|Overall Study|Lack of Efficacy|0|||
164175566|NCT00628095|593006603|FG001|Overall Study|Lack of Efficacy|3|||
164175567|NCT00628095|593006602|FG000|Overall Study|Withdrawal by Subject|2|||
164175568|NCT00628095|593006603|FG001|Overall Study|Withdrawal by Subject|0|||
164175569|NCT00628095|593006602|FG000|Overall Study|Other|0|||
164175570|NCT00628095|593006603|FG001|Overall Study|Other|1|||
164175571|NCT03235115|593006606|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
164175572|NCT03235115|593006607|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
164175573|NCT03235115|593006608|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
164175574|NCT03235115|593006609|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
164175575|NCT03235115|593006610|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
164175576|NCT03235115|593006611|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
164175577|NCT00503997|593006615|FG000|Overall Study|disease progression|1|||
164175578|NCT00503997|593006615|FG000|Overall Study|Adverse Event|5|||
164175579|NCT00503997|593006615|FG000|Overall Study|Death|1|||
164175580|NCT00503997|593006615|FG000|Overall Study|Withdrawal by Subject|1|||
164175581|NCT03973918|593006617|FG000|Overall Study|Adverse Event|0|||
164175582|NCT03973918|593006618|FG001|Overall Study|Adverse Event|0|||
164175583|NCT03973918|593006619|FG002|Overall Study|Adverse Event|0|||
164175584|NCT03973918|593006620|FG003|Overall Study|Adverse Event|1|||
164175585|NCT03973918|593006617|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
164175586|NCT03973918|593006618|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
164175587|NCT03973918|593006619|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
164175588|NCT03973918|593006620|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
164175589|NCT00955968|593006628|FG000|Overall Study|Death|2|||
164175590|NCT00955968|593006629|FG001|Overall Study|Death|4|||
164175591|NCT00955968|593006628|FG000|Overall Study|Withdrawal by Subject|35|||
164175592|NCT00955968|593006629|FG001|Overall Study|Withdrawal by Subject|31|||
164175593|NCT00955968|593006628|FG000|Overall Study|Lost to Follow-up|45|||
164175594|NCT00955968|593006629|FG001|Overall Study|Lost to Follow-up|39|||
164175595|NCT00955968|593006628|FG000|Overall Study|Site closed|55|||
164175596|NCT00955968|593006629|FG001|Overall Study|Site closed|52|||
164175597|NCT02484651|593006638|FG000|Overall Study|Patients' data files were corrupted.|1|||
164175598|NCT02484651|593006639|FG001|Overall Study|Patients' data files were corrupted.|1|||
164175599|NCT02484651|593006638|FG000|Overall Study|BIS monitoring failed.|1|||
164175600|NCT02484651|593006639|FG001|Overall Study|BIS monitoring failed.|1|||
164175601|NCT02484651|593006638|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
164175602|NCT02484651|593006639|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
164175603|NCT04972968|593006640|FG000|Overall Study|Adverse Event|3|||
164175604|NCT04972968|593006641|FG001|Overall Study|Adverse Event|1|||
164175605|NCT04972968|593006642|FG002|Overall Study|Adverse Event|1|||
164175606|NCT04972968|593006643|FG003|Overall Study|Adverse Event|7|||
164175607|NCT04972968|593006640|FG000|Overall Study|Lack of Efficacy|2|||
164175608|NCT04972968|593006641|FG001|Overall Study|Lack of Efficacy|1|||
164175609|NCT04972968|593006642|FG002|Overall Study|Lack of Efficacy|0|||
164175610|NCT04972968|593006643|FG003|Overall Study|Lack of Efficacy|0|||
164175611|NCT04972968|593006640|FG000|Overall Study|Withdrawal by Subject|7|||
164175612|NCT04972968|593006641|FG001|Overall Study|Withdrawal by Subject|4|||
164175613|NCT04972968|593006642|FG002|Overall Study|Withdrawal by Subject|3|||
164175614|NCT04972968|593006643|FG003|Overall Study|Withdrawal by Subject|2|||
164175615|NCT04972968|593006640|FG000|Overall Study|Study Terminated by Sponsor|25|||
164175616|NCT04972968|593006641|FG001|Overall Study|Study Terminated by Sponsor|28|||
164175617|NCT04972968|593006642|FG002|Overall Study|Study Terminated by Sponsor|32|||
164175618|NCT04972968|593006643|FG003|Overall Study|Study Terminated by Sponsor|27|||
164175619|NCT04972968|593006640|FG000|Overall Study|Other|1|||
164175620|NCT04972968|593006641|FG001|Overall Study|Other|0|||
164175621|NCT04972968|593006642|FG002|Overall Study|Other|1|||
164175622|NCT04972968|593006643|FG003|Overall Study|Other|1|||
164175623|NCT00150800|593006644|FG000|Overall Study|Adverse Event|89|||
164175624|NCT00150800|593006644|FG000|Overall Study|Death|18|||
164175625|NCT00150800|593006644|FG000|Overall Study|Lack of Efficacy|166|||
164175626|NCT00150800|593006644|FG000|Overall Study|Lost to Follow-up|58|||
164175627|NCT00150800|593006644|FG000|Overall Study|Subject's choice|90|||
164175628|NCT00150800|593006644|FG000|Overall Study|No compliance|18|||
164175629|NCT00150800|593006644|FG000|Overall Study|IP misshandling|1|||
164175630|NCT00150800|593006644|FG000|Overall Study|Site closure|24|||
164175631|NCT00150800|593006644|FG000|Overall Study|Protocol non-adherence|2|||
164175632|NCT00150800|593006644|FG000|Overall Study|Nobody to accompany patient|1|||
164175633|NCT00150800|593006644|FG000|Overall Study|Distance too long for patient|1|||
164175634|NCT00150800|593006644|FG000|Overall Study|Neurosurgery|2|||
164175635|NCT00150800|593006644|FG000|Overall Study|BRV monotherapy|1|||
164175636|NCT00150800|593006644|FG000|Overall Study|Visit refusal|3|||
164175637|NCT00150800|593006644|FG000|Overall Study|Sponsor's request|2|||
164175638|NCT00150800|593006644|FG000|Overall Study|Generalized Epilepsy|1|||
164175639|NCT00150800|593006644|FG000|Overall Study|Moved from area/country|8|||
164175640|NCT00150800|593006644|FG000|Overall Study|PI retiring|2|||
164175641|NCT00150800|593006644|FG000|Overall Study|PI leaving site|2|||
164175642|NCT00150800|593006644|FG000|Overall Study|Patient insurance|1|||
164175643|NCT00150800|593006644|FG000|Overall Study|Surgical intervention|4|||
164175644|NCT00150800|593006644|FG000|Overall Study|Pregnancy planned|1|||
164175645|NCT00150800|593006644|FG000|Overall Study|PI discontinuation request|1|||
164175646|NCT01698879|593006645|FG000|Overall Study|Withdrawal by Subject|1|||
164175647|NCT01698879|593006646|FG001|Overall Study|Withdrawal by Subject|0|||
164175648|NCT01698879|593006647|FG002|Overall Study|Withdrawal by Subject|0|||
164175649|NCT03649178|593006648|FG000|Overall Study|Adverse Event|1|||
164175650|NCT03649178|593006649|FG001|Overall Study|Adverse Event|2|||
164175651|NCT03649178|593006648|FG000|Overall Study|Withdrawal by Subject|0|||
164175652|NCT03649178|593006649|FG001|Overall Study|Withdrawal by Subject|2|||
164175653|NCT03649178|593006648|FG000|Overall Study|COVID regulation required halt in protocol|1|||
164175654|NCT03649178|593006649|FG001|Overall Study|COVID regulation required halt in protocol|0|||
164175655|NCT03619902|593006651|FG000|Overall Study|Termination of Study by Investigator|1|||
164175656|NCT03619902|593006651|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
164175657|NCT00794040|593006655|FG000|Overall Study|Withdrawal by Subject|3|||
164175658|NCT00794040|593006656|FG001|Overall Study|Withdrawal by Subject|4|||
164175659|NCT00794040|593006655|FG000|Overall Study|Physician Decision|0|||
164175660|NCT00794040|593006656|FG001|Overall Study|Physician Decision|1|||
164175661|NCT04687072|593006657|FG000|Overall Study|Adverse Event|2|||
164175662|NCT04687072|593006658|FG001|Overall Study|Adverse Event|0|||
164175663|NCT04687072|593006657|FG000|Overall Study|Death|1|||
164175664|NCT04687072|593006658|FG001|Overall Study|Death|0|||
164175665|NCT04687072|593006657|FG000|Overall Study|Lack of Efficacy|2|||
164175666|NCT04687072|593006658|FG001|Overall Study|Lack of Efficacy|1|||
164175667|NCT04687072|593006657|FG000|Overall Study|Physician Decision|1|||
164175668|NCT04687072|593006658|FG001|Overall Study|Physician Decision|0|||
164175669|NCT04687072|593006657|FG000|Overall Study|Pregnancy|1|||
164175670|NCT04687072|593006658|FG001|Overall Study|Pregnancy|0|||
164175671|NCT04687072|593006657|FG000|Overall Study|Requires Prohibited Medication|2|||
164175672|NCT04687072|593006658|FG001|Overall Study|Requires Prohibited Medication|0|||
164175673|NCT04687072|593006657|FG000|Overall Study|Withdrawal of Consent|11|||
164175674|NCT04687072|593006658|FG001|Overall Study|Withdrawal of Consent|6|||
164175675|NCT04687072|593006657|FG000|Overall Study|Miscellaneous|4|||
164175676|NCT04687072|593006658|FG001|Overall Study|Miscellaneous|1|||
164175677|NCT01263782|593006659|FG000|Overall Study|Death|0|||
164175678|NCT01263782|593006660|FG001|Overall Study|Death|0|||
164175679|NCT01263782|593006661|FG002|Overall Study|Death|1|||
164175680|NCT01263782|593006662|FG003|Overall Study|Death|0|||
164175681|NCT01263782|593006659|FG000|Overall Study|Progressive disease|0|||
164175682|NCT01263782|593006660|FG001|Overall Study|Progressive disease|0|||
164175683|NCT01263782|593006661|FG002|Overall Study|Progressive disease|0|||
164175684|NCT01263782|593006662|FG003|Overall Study|Progressive disease|1|||
164175685|NCT01263782|593006659|FG000|Overall Study|Too early|0|||
164175686|NCT01263782|593006660|FG001|Overall Study|Too early|0|||
164175687|NCT01263782|593006661|FG002|Overall Study|Too early|1|||
164175688|NCT01263782|593006662|FG003|Overall Study|Too early|0|||
164175689|NCT01263782|593006659|FG000|Overall Study|Inevaluable|0|||
164175690|NCT01263782|593006660|FG001|Overall Study|Inevaluable|0|||
164175691|NCT01263782|593006661|FG002|Overall Study|Inevaluable|1|||
164175692|NCT01263782|593006662|FG003|Overall Study|Inevaluable|0|||
164175693|NCT04545567|593006664|FG000|Overall Study|tested positive for SARS-co-V2|1|||
164175694|NCT04545567|593006665|FG001|Overall Study|tested positive for SARS-co-V2|1|||
164175695|NCT04545567|593006664|FG000|Overall Study|Withdrawal by Subject|0|||
164175696|NCT04545567|593006665|FG001|Overall Study|Withdrawal by Subject|1|||
164175697|NCT03626363|593006671|FG000|Overall Study|Protocol Violation|4|||
164175698|NCT03626363|593006672|FG001|Overall Study|Protocol Violation|0|||
164175699|NCT03626363|593006671|FG000|Overall Study|Lost to Follow-up|5|||
164175700|NCT03626363|593006672|FG001|Overall Study|Lost to Follow-up|7|||
164175701|NCT00965341|593006673|FG000|Overall Study|Withdrew consent|1|||
164175702|NCT00965341|593006674|FG001|Overall Study|Withdrew consent|5|||
164175703|NCT00965341|593006673|FG000|Overall Study|Lost to Follow-up|1|||
164175704|NCT00965341|593006674|FG001|Overall Study|Lost to Follow-up|0|||
164175705|NCT00965341|593006673|FG000|Overall Study|Transportation issues|4|||
164175706|NCT00965341|593006674|FG001|Overall Study|Transportation issues|3|||
164175707|NCT01077739|593006675|FG000|Overall Study|Premature withdrawal|1|||
164175708|NCT01077739|593006676|FG001|Overall Study|Premature withdrawal|3|||
164175709|NCT01077739|593006675|FG000|Overall Study|Withdrawal by Subject|1|||
164175710|NCT01077739|593006676|FG001|Overall Study|Withdrawal by Subject|0|||
164175711|NCT01077739|593006675|FG000|Overall Study|Death|0|||
164175712|NCT01077739|593006676|FG001|Overall Study|Death|3|||
164175713|NCT01077739|593006675|FG000|Overall Study|Unacceptable toxicity|1|||
164175714|NCT01077739|593006676|FG001|Overall Study|Unacceptable toxicity|2|||
164175715|NCT01077739|593006675|FG000|Overall Study|Other|2|||
164175716|NCT01077739|593006676|FG001|Overall Study|Other|2|||
164175717|NCT00960986|593006677|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
164175718|NCT00960986|593006678|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
164175719|NCT00960986|593006679|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
164175720|NCT00960986|593006680|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
164175721|NCT00960986|593006677|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
164175722|NCT00960986|593006678|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
164175723|NCT00960986|593006679|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
164175724|NCT00960986|593006680|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
164175725|NCT00960986|593006677|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
164175726|NCT00960986|593006678|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
164175727|NCT00960986|593006679|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
164175728|NCT00960986|593006680|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
164175729|NCT00960986|593006677|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
164175730|NCT00960986|593006678|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
164175731|NCT00960986|593006679|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
164175732|NCT00960986|593006680|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
164175733|NCT00960986|593006677|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
164175734|NCT00960986|593006678|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
164175735|NCT00960986|593006679|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
164175736|NCT00960986|593006680|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
164175737|NCT00960986|593006677|FG000|Period 3 (7-week Therapy Period)|Death|0|||
164175738|NCT00960986|593006678|FG001|Period 3 (7-week Therapy Period)|Death|0|||
164175739|NCT00960986|593006679|FG002|Period 3 (7-week Therapy Period)|Death|1|||
164175740|NCT00960986|593006680|FG003|Period 3 (7-week Therapy Period)|Death|0|||
164175741|NCT00960986|593006677|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
164175742|NCT00960986|593006678|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
164175743|NCT00960986|593006679|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
164175744|NCT00960986|593006680|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
164175745|NCT00960986|593006677|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
164175746|NCT00960986|593006678|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
164175747|NCT00960986|593006679|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
164175748|NCT00960986|593006680|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
164175749|NCT00960986|593006677|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
164175750|NCT00960986|593006678|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
164175751|NCT00960986|593006679|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
164175752|NCT00960986|593006680|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
164175753|NCT00960986|593006677|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
164175754|NCT00960986|593006678|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
164175755|NCT00960986|593006679|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
164175756|NCT00960986|593006680|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
164175757|NCT00877071|593006681|FG000|Overall Study|disease progression|2|||
164175758|NCT01556997|593008051|FG000|Overall Study|Adverse Event|10|||
164175759|NCT01556997|593008052|FG001|Overall Study|Adverse Event|12|||
164175760|NCT01556997|593008053|FG002|Overall Study|Adverse Event|12|||
164175761|NCT01556997|593008051|FG000|Overall Study|Lost to Follow-up|6|||
164175762|NCT01556997|593008052|FG001|Overall Study|Lost to Follow-up|6|||
164175763|NCT01556997|593008053|FG002|Overall Study|Lost to Follow-up|4|||
164175764|NCT01556997|593008051|FG000|Overall Study|Physician Decision|1|||
164175765|NCT01556997|593008052|FG001|Overall Study|Physician Decision|1|||
164175766|NCT01556997|593008053|FG002|Overall Study|Physician Decision|1|||
164175767|NCT01556997|593008051|FG000|Overall Study|Withdrawal by Subject|7|||
164175768|NCT01556997|593008052|FG001|Overall Study|Withdrawal by Subject|6|||
164175769|NCT01556997|593008053|FG002|Overall Study|Withdrawal by Subject|8|||
164175770|NCT01556997|593008051|FG000|Overall Study|Other|2|||
164175771|NCT01556997|593008052|FG001|Overall Study|Other|3|||
164175772|NCT01556997|593008053|FG002|Overall Study|Other|7|||
164175773|NCT05459558|593008054|FG000|Overall Study|Adverse Event|1|||
164175774|NCT05459558|593008055|FG001|Overall Study|Adverse Event|0|||
164175775|NCT05459558|593008056|FG002|Overall Study|Adverse Event|0|||
164175776|NCT05459558|593008054|FG000|Overall Study|Scheduling issue|0|||
164175777|NCT05459558|593008055|FG001|Overall Study|Scheduling issue|1|||
164175778|NCT05459558|593008056|FG002|Overall Study|Scheduling issue|3|||
164175779|NCT05459558|593008054|FG000|Overall Study|Withdrawal by Subject|0|||
164175780|NCT05459558|593008055|FG001|Overall Study|Withdrawal by Subject|0|||
164175781|NCT05459558|593008056|FG002|Overall Study|Withdrawal by Subject|2|||
164175782|NCT00250458|593008069|FG000|Overall Study|Lost to Follow-up|4|||
164175783|NCT00250458|593008070|FG001|Overall Study|Lost to Follow-up|2|||
164175784|NCT00250458|593008069|FG000|Overall Study|Protocol Violation|0|||
164175785|NCT00250458|593008070|FG001|Overall Study|Protocol Violation|1|||
164175786|NCT00250458|593008069|FG000|Overall Study|Withdrawal by Subject|4|||
164175787|NCT00250458|593008070|FG001|Overall Study|Withdrawal by Subject|2|||
164175788|NCT00250458|593008069|FG000|Overall Study|Lack of Migraine Attack|20|||
164175789|NCT00250458|593008070|FG001|Overall Study|Lack of Migraine Attack|9|||
164175790|NCT00250458|593008069|FG000|Overall Study|Qualifying migraine but did not treat|3|||
164175791|NCT00250458|593008070|FG001|Overall Study|Qualifying migraine but did not treat|3|||
164175792|NCT00250458|593008069|FG000|Overall Study|Other|1|||
164175793|NCT00250458|593008070|FG001|Overall Study|Other|0|||
164175794|NCT00741091|593008071|FG000|Overall Study|Death|13|||
164175795|NCT00741091|593008071|FG000|Overall Study|Lost to Follow-up|16|||
164175796|NCT00741091|593008071|FG000|Overall Study|Withdrawal by Subject|6|||
164175797|NCT00741091|593008071|FG000|Overall Study|Missed Visit|22|||
164175798|NCT00525902|593008075|FG000|Overall Study|Lack of Efficacy|1|||
164175799|NCT00480493|593008076|FG000|Overall Study|moved|2|||
164175800|NCT00480493|593008077|FG001|Overall Study|moved|7|||
164175801|NCT03747302|593008078|FG000|Overall Study|Withdrawal by Subject|1|||
164175802|NCT03747302|593008079|FG001|Overall Study|Withdrawal by Subject|2|||
164175803|NCT03769675|593008082|FG000|Overall Study|Lost to Follow-up|1|||
164175804|NCT02844907|593008083|FG000|With Dexamethasone|No IV access|1|||
164175805|NCT00738062|593008084|FG000|Open Label Treatment|Lack of Efficacy|5|||
164175806|NCT00738062|593008085|FG001|Open Label Treatment|Lack of Efficacy|0|||
164175807|NCT00738062|593008086|FG002|Open Label Treatment|Lack of Efficacy|0|||
164175808|NCT00738062|593008084|FG000|Open Label Treatment|Adverse Event|11|||
164175809|NCT00738062|593008085|FG001|Open Label Treatment|Adverse Event|0|||
164175810|NCT00738062|593008086|FG002|Open Label Treatment|Adverse Event|0|||
164175811|NCT00738062|593008084|FG000|Open Label Treatment|Protocol Violation|2|||
164175812|NCT00738062|593008085|FG001|Open Label Treatment|Protocol Violation|0|||
164175813|NCT00738062|593008086|FG002|Open Label Treatment|Protocol Violation|0|||
164175814|NCT00738062|593008084|FG000|Open Label Treatment|Withdrawal by Subject|9|||
164175815|NCT00738062|593008085|FG001|Open Label Treatment|Withdrawal by Subject|0|||
164175816|NCT00738062|593008086|FG002|Open Label Treatment|Withdrawal by Subject|0|||
164175817|NCT00738062|593008084|FG000|Open Label Treatment|Investigator Decision|1|||
164175818|NCT00738062|593008085|FG001|Open Label Treatment|Investigator Decision|0|||
164175819|NCT00738062|593008086|FG002|Open Label Treatment|Investigator Decision|0|||
164175820|NCT00738062|593008084|FG000|Open-Label Extension|Adverse Event|5|||
164175821|NCT00738062|593008085|FG001|Open-Label Extension|Adverse Event|0|||
164175822|NCT00738062|593008086|FG002|Open-Label Extension|Adverse Event|0|||
164175823|NCT00738062|593008084|FG000|Open-Label Extension|Physician Decision|1|||
164175824|NCT00738062|593008085|FG001|Open-Label Extension|Physician Decision|0|||
164175825|NCT00738062|593008086|FG002|Open-Label Extension|Physician Decision|0|||
164175826|NCT00738062|593008084|FG000|Open-Label Extension|Lack of Efficacy|2|||
164175827|NCT00738062|593008085|FG001|Open-Label Extension|Lack of Efficacy|0|||
164175828|NCT00738062|593008086|FG002|Open-Label Extension|Lack of Efficacy|0|||
164175829|NCT00738062|593008084|FG000|Open-Label Extension|Withdrawal by Subject|6|||
164175830|NCT00738062|593008085|FG001|Open-Label Extension|Withdrawal by Subject|0|||
164175831|NCT00738062|593008086|FG002|Open-Label Extension|Withdrawal by Subject|0|||
164175832|NCT00738062|593008084|FG000|Open-Label Extension|Protocol Violation|1|||
164175833|NCT00738062|593008085|FG001|Open-Label Extension|Protocol Violation|0|||
164175834|NCT00738062|593008086|FG002|Open-Label Extension|Protocol Violation|0|||
164175835|NCT00738062|593008084|FG000|Open-Label Extension|Study Terminated|2|||
164175836|NCT00738062|593008085|FG001|Open-Label Extension|Study Terminated|0|||
164175837|NCT00738062|593008086|FG002|Open-Label Extension|Study Terminated|0|||
164175838|NCT02945254|593008087|FG000|Overall Study|Lost to Follow-up|1|||
164175839|NCT02945254|593008088|FG001|Overall Study|Lost to Follow-up|0|||
164175840|NCT02945254|593008087|FG000|Overall Study|Withdrawal by Subject|1|||
164175841|NCT02945254|593008088|FG001|Overall Study|Withdrawal by Subject|0|||
164175842|NCT00783224|593008089|FG000|Overall Study|Adverse Event|0|||
164175843|NCT00783224|593008090|FG001|Overall Study|Adverse Event|0|||
164175844|NCT00783224|593008091|FG002|Overall Study|Adverse Event|1|||
164175845|NCT00783224|593008092|FG003|Overall Study|Adverse Event|0|||
164175846|NCT00783224|593008089|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
164175847|NCT00783224|593008090|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
164175848|NCT00783224|593008091|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
164175849|NCT00783224|593008092|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
164175850|NCT00783224|593008089|FG000|Overall Study|Inappropriate as a study subject|0|||
164175851|NCT00783224|593008090|FG001|Overall Study|Inappropriate as a study subject|0|||
164175852|NCT00783224|593008091|FG002|Overall Study|Inappropriate as a study subject|0|||
164175853|NCT00783224|593008092|FG003|Overall Study|Inappropriate as a study subject|1|||
164175854|NCT01711619|593008093|FG000|Overall Study|Early study termination|10|||
164175855|NCT01711619|593008094|FG001|Overall Study|Early study termination|14|||
164175856|NCT01711619|593008093|FG000|Overall Study|Withdrawal by Subject|3|||
164175857|NCT01711619|593008094|FG001|Overall Study|Withdrawal by Subject|7|||
164175858|NCT01711619|593008093|FG000|Overall Study|Protocol Violation|2|||
164175859|NCT01711619|593008094|FG001|Overall Study|Protocol Violation|3|||
164175860|NCT01711619|593008093|FG000|Overall Study|Adverse Event|2|||
164175861|NCT01711619|593008094|FG001|Overall Study|Adverse Event|0|||
164175862|NCT01711619|593008093|FG000|Overall Study|Lost to Follow-up|1|||
164175863|NCT01711619|593008094|FG001|Overall Study|Lost to Follow-up|0|||
164175864|NCT03422159|593008095|FG000|Overall Study|Exclusion due to terminal disease|2|||
164175865|NCT03422159|593008096|FG001|Overall Study|Exclusion due to terminal disease|1|||
164175866|NCT04631107|593008097|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
164175867|NCT04631107|593008097|FG000|Second Intervention (1 Night)|Adverse Event|1|||
164175868|NCT04631107|593008097|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
164175869|NCT04631107|593008097|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
164175870|NCT04601103|593008098|FG000|Overall Study|Needed crown & cleaning|0|||
164175871|NCT04601103|593008099|FG001|Overall Study|Needed crown & cleaning|0|||
164175872|NCT04601103|593008100|FG002|Overall Study|Needed crown & cleaning|1|||
164175873|NCT04601103|593008098|FG000|Overall Study|study was terminated|18|||
164175874|NCT04601103|593008099|FG001|Overall Study|study was terminated|18|||
164175875|NCT04601103|593008100|FG002|Overall Study|study was terminated|16|||
164175876|NCT01068626|593008101|FG000|Overall Study|Adverse Event|3|||
164175877|NCT01068626|593008102|FG001|Overall Study|Adverse Event|0|||
164175878|NCT01068626|593008101|FG000|Overall Study|Withdrawal by Subject|0|||
164175879|NCT01068626|593008102|FG001|Overall Study|Withdrawal by Subject|2|||
164175880|NCT03932331|593008104|FG000|Overall Study|Death|0|||
164175881|NCT03932331|593008105|FG001|Overall Study|Death|7|||
164175882|NCT03932331|593008106|FG002|Overall Study|Death|2|||
164175883|NCT03932331|593008104|FG000|Overall Study|Withdrawal by Subject|0|||
164175884|NCT03932331|593008105|FG001|Overall Study|Withdrawal by Subject|3|||
164175885|NCT03932331|593008106|FG002|Overall Study|Withdrawal by Subject|0|||
164175886|NCT03932331|593008104|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
164175887|NCT03932331|593008105|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
164175888|NCT03932331|593008106|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
164175889|NCT03932331|593008104|FG000|Overall Study|Progressive disease|3|||
164175890|NCT03932331|593008105|FG001|Overall Study|Progressive disease|0|||
164175891|NCT03932331|593008106|FG002|Overall Study|Progressive disease|0|||
164175892|NCT03932331|593008104|FG000|Overall Study|Lung infection|1|||
164175893|NCT03932331|593008105|FG001|Overall Study|Lung infection|0|||
164175894|NCT03932331|593008106|FG002|Overall Study|Lung infection|0|||
164175895|NCT03932331|593008104|FG000|Overall Study|Other|0|||
164175896|NCT03932331|593008105|FG001|Overall Study|Other|0|||
164175897|NCT03932331|593008106|FG002|Overall Study|Other|58|||
164175898|NCT01032239|593008107|FG000|Overall Study|Lost to Follow-up|3|||
164175899|NCT01032239|593008108|FG001|Overall Study|Lost to Follow-up|2|||
164175900|NCT01032239|593008107|FG000|Overall Study|Withdrawal by Subject|2|||
164175901|NCT01032239|593008108|FG001|Overall Study|Withdrawal by Subject|3|||
164175902|NCT01032239|593008107|FG000|Overall Study|Death|1|||
164175903|NCT01032239|593008108|FG001|Overall Study|Death|0|||
164175904|NCT01032239|593008107|FG000|Overall Study|Protocol Violation|1|||
164175905|NCT01032239|593008108|FG001|Overall Study|Protocol Violation|0|||
164175906|NCT01940900|593008109|FG000|Overall Study|Physician Decision|4|||
164175907|NCT01940900|593008110|FG001|Overall Study|Physician Decision|0|||
164175908|NCT01940900|593008109|FG000|Overall Study|Adverse Event|10|||
164175909|NCT01940900|593008110|FG001|Overall Study|Adverse Event|15|||
164175910|NCT01940900|593008109|FG000|Overall Study|Withdrawal by Subject|11|||
164175911|NCT01940900|593008110|FG001|Overall Study|Withdrawal by Subject|15|||
164175912|NCT01940900|593008109|FG000|Overall Study|Lost to Follow-up|1|||
164175913|NCT01940900|593008110|FG001|Overall Study|Lost to Follow-up|0|||
164175914|NCT01940900|593008109|FG000|Overall Study|Sponsor Decision|1|||
164175915|NCT01940900|593008110|FG001|Overall Study|Sponsor Decision|0|||
164175916|NCT01940900|593008109|FG000|Overall Study|subject non-compliance|1|||
164175917|NCT01940900|593008110|FG001|Overall Study|subject non-compliance|1|||
164175918|NCT01940900|593008109|FG000|Overall Study|other|1|||
164175919|NCT01940900|593008110|FG001|Overall Study|other|0|||
164175920|NCT00204477|593008113|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
164175921|NCT00204477|593008114|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
164175922|NCT00204477|593008113|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
164175923|NCT00204477|593008114|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
164175924|NCT04713592|593008115|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
164175925|NCT04713592|593008116|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
164175926|NCT04713592|593008117|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
164175927|NCT04713592|593008118|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
164175928|NCT04713592|593008115|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
164175929|NCT04713592|593008116|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
164175930|NCT04713592|593008117|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
164175931|NCT04713592|593008118|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
164175932|NCT04713592|593008115|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
164175933|NCT04713592|593008116|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
164175934|NCT04713592|593008117|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
164175935|NCT04713592|593008118|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
164175936|NCT04713592|593008115|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164175937|NCT04713592|593008116|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164175938|NCT04713592|593008117|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
164175939|NCT04713592|593008118|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
164175940|NCT04713592|593008115|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
164175941|NCT04713592|593008116|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
164175942|NCT04713592|593008117|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
164175943|NCT04713592|593008118|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
164175944|NCT04713592|593008115|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164175945|NCT04713592|593008116|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164175946|NCT04713592|593008117|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
164175947|NCT04713592|593008118|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
164175948|NCT04713592|593008115|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
164175949|NCT04713592|593008116|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
164175950|NCT04713592|593008117|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
164175951|NCT04713592|593008118|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
164175952|NCT02225366|593008121|FG000|Overall Study|Lack of Efficacy|1|||
164175953|NCT02225366|593008122|FG001|Overall Study|Lack of Efficacy|0|||
164175954|NCT03782298|593008127|FG000|Overall Study|Protocol Deviation|4|||
164175955|NCT00742508|593008128|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
164175956|NCT00742508|593008129|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
164175957|NCT00742508|593008128|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
164175958|NCT00742508|593008129|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
164175959|NCT00742508|593008128|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
164175960|NCT00742508|593008129|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
164175961|NCT00742508|593008128|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
164175962|NCT00742508|593008129|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
164175963|NCT00742508|593008128|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
164175964|NCT00742508|593008129|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
164175965|NCT02431806|593008130|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
164175966|NCT02431806|593008131|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
164175967|NCT02431806|593008132|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
164175968|NCT02431806|593008133|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
164175969|NCT02431806|593008130|FG000|Double-blind Treatment Period|Adverse Event|4|||
164175970|NCT02431806|593008131|FG001|Double-blind Treatment Period|Adverse Event|7|||
164175971|NCT02431806|593008132|FG002|Double-blind Treatment Period|Adverse Event|11|||
164175972|NCT02431806|593008133|FG003|Double-blind Treatment Period|Adverse Event|7|||
164175973|NCT02431806|593008130|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
164175974|NCT02431806|593008131|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
164175975|NCT02431806|593008132|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
164175976|NCT02431806|593008133|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
164175977|NCT02431806|593008130|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
164175978|NCT02431806|593008131|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
164175979|NCT02431806|593008132|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
164175980|NCT02431806|593008133|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
164175981|NCT02431806|593008130|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
164175982|NCT02431806|593008131|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
164175983|NCT02431806|593008132|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
164175984|NCT02431806|593008133|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
164175985|NCT02431806|593008130|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
164175986|NCT02431806|593008131|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
164175987|NCT02431806|593008132|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
164175988|NCT02431806|593008133|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
164175989|NCT02431806|593008130|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
164175990|NCT02431806|593008131|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
164175991|NCT02431806|593008132|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
164175992|NCT02431806|593008133|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
164175993|NCT01382225|593008134|FG000|Overall Study|Adverse Event|3|||
164175994|NCT01382225|593008135|FG001|Overall Study|Adverse Event|2|||
164175995|NCT01382225|593008134|FG000|Overall Study|Protocol Violation|2|||
164175996|NCT01382225|593008135|FG001|Overall Study|Protocol Violation|1|||
164175997|NCT01382225|593008134|FG000|Overall Study|Subject Withdrew Consent|5|||
164175998|NCT01382225|593008135|FG001|Overall Study|Subject Withdrew Consent|2|||
164175999|NCT01382225|593008134|FG000|Overall Study|Other|4|||
164176000|NCT01382225|593008135|FG001|Overall Study|Other|2|||
164176001|NCT01797081|593008138|FG000|Overall Study|Adverse Event|1|||
164176002|NCT01797081|593008139|FG001|Overall Study|Adverse Event|0|||
164176003|NCT01797081|593008140|FG002|Overall Study|Adverse Event|1|||
164176004|NCT01797081|593008141|FG003|Overall Study|Adverse Event|0|||
164176005|NCT01797081|593008138|FG000|Overall Study|Pregnancy|1|||
164176006|NCT01797081|593008139|FG001|Overall Study|Pregnancy|0|||
164176007|NCT01797081|593008140|FG002|Overall Study|Pregnancy|0|||
164176008|NCT01797081|593008141|FG003|Overall Study|Pregnancy|0|||
164176009|NCT01797081|593008138|FG000|Overall Study|Personal Reasons|12|||
164176010|NCT01797081|593008139|FG001|Overall Study|Personal Reasons|4|||
164176011|NCT01797081|593008140|FG002|Overall Study|Personal Reasons|4|||
164176012|NCT01797081|593008141|FG003|Overall Study|Personal Reasons|8|||
164176013|NCT01797081|593008138|FG000|Overall Study|Protocol Violation|0|||
164176014|NCT01797081|593008139|FG001|Overall Study|Protocol Violation|0|||
164176015|NCT01797081|593008140|FG002|Overall Study|Protocol Violation|0|||
164176016|NCT01797081|593008141|FG003|Overall Study|Protocol Violation|1|||
164176017|NCT01793688|593008142|FG000|Overall Study|Protocol Violation|2|||
164176018|NCT01419080|593008143|FG000|Overall Study|Withdrawal by Subject|75|||
164176019|NCT01419080|593008143|FG000|Overall Study|Death|30|||
164176020|NCT01419080|593008143|FG000|Overall Study|Lost to Follow-up|23|||
164176021|NCT01419080|593008143|FG000|Overall Study|Too Ill|3|||
164176022|NCT05238025|593008144|FG000|Overall Study|Adverse Event|2|||
164176023|NCT05238025|593008145|FG001|Overall Study|Adverse Event|2|||
164176024|NCT05238025|593008144|FG000|Overall Study|Lost to Follow-up|334|||
164176025|NCT05238025|593008145|FG001|Overall Study|Lost to Follow-up|339|||
164176026|NCT05238025|593008144|FG000|Overall Study|Withdrawal by Subject|203|||
164176027|NCT05238025|593008145|FG001|Overall Study|Withdrawal by Subject|222|||
164176028|NCT05238025|593008144|FG000|Overall Study|Physician Decision|20|||
164176029|NCT05238025|593008145|FG001|Overall Study|Physician Decision|8|||
164176030|NCT05238025|593008144|FG000|Overall Study|Protocol Violation|6|||
164176031|NCT05238025|593008145|FG001|Overall Study|Protocol Violation|2|||
164176032|NCT05238025|593008144|FG000|Overall Study|Death|38|||
164176033|NCT05238025|593008145|FG001|Overall Study|Death|32|||
164176034|NCT05238025|593008144|FG000|Overall Study|Study terminated by Sponsor|6358|||
164176035|NCT05238025|593008145|FG001|Overall Study|Study terminated by Sponsor|6358|||
164176036|NCT05238025|593008144|FG000|Overall Study|Other Reason|669|||
164176037|NCT05238025|593008145|FG001|Overall Study|Other Reason|690|||
164176038|NCT03814720|593008148|FG000|Overall Study|Lost to Follow-up|0|||
164176039|NCT03814720|593008149|FG001|Overall Study|Lost to Follow-up|1|||
164176040|NCT03814720|593008150|FG002|Overall Study|Lost to Follow-up|0|||
164176041|NCT03814720|593008151|FG003|Overall Study|Lost to Follow-up|0|||
164176042|NCT03814720|593008152|FG004|Overall Study|Lost to Follow-up|0|||
164176043|NCT02135107|593008153|FG000|Treatment Period|Withdrawal by Subject|11|||
164176044|NCT02135107|593008154|FG001|Treatment Period|Withdrawal by Subject|0|||
164176045|NCT02135107|593008155|FG002|Treatment Period|Withdrawal by Subject|0|||
164176046|NCT02135107|593008156|FG003|Treatment Period|Withdrawal by Subject|0|||
164176047|NCT02135107|593008153|FG000|Treatment Period|Adverse Event|5|||
164176048|NCT02135107|593008154|FG001|Treatment Period|Adverse Event|2|||
164176049|NCT02135107|593008155|FG002|Treatment Period|Adverse Event|0|||
164176050|NCT02135107|593008156|FG003|Treatment Period|Adverse Event|0|||
164176051|NCT02135107|593008153|FG000|Treatment Period|Pregnancy|1|||
164176052|NCT02135107|593008154|FG001|Treatment Period|Pregnancy|0|||
164176053|NCT02135107|593008155|FG002|Treatment Period|Pregnancy|0|||
164176054|NCT02135107|593008156|FG003|Treatment Period|Pregnancy|0|||
164176055|NCT02135107|593008153|FG000|Treatment Period|Other|115|||
164176056|NCT02135107|593008154|FG001|Treatment Period|Other|24|||
164176057|NCT02135107|593008155|FG002|Treatment Period|Other|0|||
164176058|NCT02135107|593008156|FG003|Treatment Period|Other|0|||
164176059|NCT02135107|593008153|FG000|Maintenance Therapy Period|Adverse Event|0|||
164176060|NCT02135107|593008154|FG001|Maintenance Therapy Period|Adverse Event|0|||
164176061|NCT02135107|593008155|FG002|Maintenance Therapy Period|Adverse Event|3|||
164176062|NCT02135107|593008156|FG003|Maintenance Therapy Period|Adverse Event|7|||
164176063|NCT02135107|593008153|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
164176064|NCT02135107|593008154|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
164176065|NCT02135107|593008155|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
164176066|NCT02135107|593008156|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
164176067|NCT02135107|593008153|FG000|Maintenance Therapy Period|Pregnancy|0|||
164176068|NCT02135107|593008154|FG001|Maintenance Therapy Period|Pregnancy|0|||
164176069|NCT02135107|593008155|FG002|Maintenance Therapy Period|Pregnancy|0|||
164176070|NCT02135107|593008156|FG003|Maintenance Therapy Period|Pregnancy|1|||
164176071|NCT02135107|593008153|FG000|Maintenance Therapy Period|Other|0|||
164176072|NCT02135107|593008154|FG001|Maintenance Therapy Period|Other|0|||
164176073|NCT02135107|593008155|FG002|Maintenance Therapy Period|Other|7|||
164176074|NCT02135107|593008156|FG003|Maintenance Therapy Period|Other|8|||
164176075|NCT00474045|593008163|FG000|Overall Study|Adverse Event|18|||
164176076|NCT00474045|593008164|FG001|Overall Study|Adverse Event|8|||
164176077|NCT00474045|593008163|FG000|Overall Study|Unclassified|1|||
164176078|NCT00474045|593008164|FG001|Overall Study|Unclassified|3|||
164176079|NCT00474045|593008163|FG000|Overall Study|Lack of Efficacy|0|||
164176080|NCT00474045|593008164|FG001|Overall Study|Lack of Efficacy|9|||
164176081|NCT00474045|593008163|FG000|Overall Study|Lost to Follow-up|1|||
164176082|NCT00474045|593008164|FG001|Overall Study|Lost to Follow-up|1|||
164176083|NCT00474045|593008163|FG000|Overall Study|Protocol Violation|10|||
164176084|NCT00474045|593008164|FG001|Overall Study|Protocol Violation|12|||
164176085|NCT00474045|593008163|FG000|Overall Study|Withdrawal by Subject|16|||
164176086|NCT00474045|593008164|FG001|Overall Study|Withdrawal by Subject|18|||
164176087|NCT00474045|593008163|FG000|Overall Study|Withdrawal criteria|60|||
164176088|NCT00474045|593008164|FG001|Overall Study|Withdrawal criteria|50|||
164176089|NCT01095978|593008165|FG000|Overall Study|Did not take Klacid SR|2|||
164176090|NCT01095978|593008165|FG000|Overall Study|Adverse Event|1|||
164176091|NCT02009397|593008166|FG000|Overall Study|Protocol Violation|6|||
164176092|NCT02009397|593008166|FG000|Overall Study|Death|8|||
164176093|NCT02009397|593008166|FG000|Overall Study|Lost to Follow-up|6|||
164176094|NCT02278120|593008171|FG000|Treatment Period|Progressive disease|234|||
164176095|NCT02278120|593008172|FG001|Treatment Period|Progressive disease|260|||
164176096|NCT02278120|593008171|FG000|Treatment Period|Subject/guardian decision|23|||
164176097|NCT02278120|593008172|FG001|Treatment Period|Subject/guardian decision|20|||
164176098|NCT02278120|593008171|FG000|Treatment Period|Adverse Event|16|||
164176099|NCT02278120|593008172|FG001|Treatment Period|Adverse Event|14|||
164176100|NCT02278120|593008171|FG000|Treatment Period|Physician Decision|14|||
164176101|NCT02278120|593008172|FG001|Treatment Period|Physician Decision|27|||
164176102|NCT02278120|593008171|FG000|Treatment Period|Death|3|||
164176103|NCT02278120|593008172|FG001|Treatment Period|Death|3|||
164176104|NCT02278120|593008171|FG000|Treatment Period|Lost to Follow-up|2|||
164176105|NCT02278120|593008172|FG001|Treatment Period|Lost to Follow-up|0|||
164176106|NCT02278120|593008171|FG000|Treatment Period|Protocol deviation|0|||
164176107|NCT02278120|593008172|FG001|Treatment Period|Protocol deviation|2|||
164176108|NCT02278120|593008171|FG000|Treatment Period|Study terminated as per protocol|43|||
164176109|NCT02278120|593008172|FG001|Treatment Period|Study terminated as per protocol|11|||
164176110|NCT02278120|593008171|FG000|Post-treatment Efficacy Follow-up|Death|0|||
164176111|NCT02278120|593008172|FG001|Post-treatment Efficacy Follow-up|Death|1|||
164176112|NCT02278120|593008171|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
164176113|NCT02278120|593008172|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
164176114|NCT02278120|593008171|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
164176115|NCT02278120|593008172|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
164176116|NCT02278120|593008171|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
164176117|NCT02278120|593008172|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
164176118|NCT02278120|593008171|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
164176119|NCT02278120|593008172|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
164176120|NCT00808639|593008176|FG000|Overall Study|Disease progression before surgery.|1|||
164176121|NCT01966068|593008177|FG000|Overall Study|Withdrawal by Subject|57|||
164176122|NCT01966068|593008177|FG000|Overall Study|Lost to Follow-up|81|||
164176123|NCT03197324|593008180|FG000|Overall Study|Adverse Event|0|||
164176124|NCT03197324|593008181|FG001|Overall Study|Adverse Event|1|||
164176125|NCT03589976|593008183|FG000|Overall Study|Death|5|||
164176126|NCT03589976|593008184|FG001|Overall Study|Death|1|||
164176127|NCT03589976|593008183|FG000|Overall Study|Adverse Event|5|||
164176128|NCT03589976|593008184|FG001|Overall Study|Adverse Event|1|||
164176129|NCT03589976|593008183|FG000|Overall Study|Withdrawal by Subject|4|||
164176130|NCT03589976|593008184|FG001|Overall Study|Withdrawal by Subject|1|||
164176131|NCT03589976|593008183|FG000|Overall Study|Lost to Follow-up|1|||
164176132|NCT03589976|593008184|FG001|Overall Study|Lost to Follow-up|0|||
164176133|NCT03589976|593008183|FG000|Overall Study|Other|4|||
164176134|NCT03589976|593008184|FG001|Overall Study|Other|3|||
164176135|NCT02089334|593008187|FG000|Overall Study|Withdrawal by Subject|0|||
164176136|NCT02089334|593008188|FG001|Overall Study|Withdrawal by Subject|0|||
164176137|NCT02089334|593008189|FG002|Overall Study|Withdrawal by Subject|0|||
164176138|NCT02089334|593008190|FG003|Overall Study|Withdrawal by Subject|2|||
164176139|NCT02089334|593008187|FG000|Overall Study|Adverse Event|0|||
164176140|NCT02089334|593008188|FG001|Overall Study|Adverse Event|0|||
164176141|NCT02089334|593008189|FG002|Overall Study|Adverse Event|0|||
164176142|NCT02089334|593008190|FG003|Overall Study|Adverse Event|2|||
164176143|NCT02089334|593008187|FG000|Overall Study|Progressive disease|0|||
164176144|NCT02089334|593008188|FG001|Overall Study|Progressive disease|0|||
164176145|NCT02089334|593008189|FG002|Overall Study|Progressive disease|0|||
164176146|NCT02089334|593008190|FG003|Overall Study|Progressive disease|2|||
164176147|NCT02089334|593008187|FG000|Overall Study|Physician Decision|0|||
164176148|NCT02089334|593008188|FG001|Overall Study|Physician Decision|0|||
164176149|NCT02089334|593008189|FG002|Overall Study|Physician Decision|1|||
164176150|NCT02089334|593008190|FG003|Overall Study|Physician Decision|1|||
164176151|NCT04778059|593008191|FG000|Overall Study|Death|2|||
164176152|NCT04778059|593008192|FG001|Overall Study|Death|2|||
164176153|NCT04778059|593008193|FG002|Overall Study|Death|1|||
164176154|NCT04778059|593008194|FG003|Overall Study|Death|1|||
164176155|NCT04778059|593008195|FG004|Overall Study|Death|1|||
164176156|NCT04778059|593008191|FG000|Overall Study|Lost to Follow-up|0|||
164176157|NCT04778059|593008192|FG001|Overall Study|Lost to Follow-up|0|||
164176158|NCT04778059|593008193|FG002|Overall Study|Lost to Follow-up|0|||
164176159|NCT04778059|593008194|FG003|Overall Study|Lost to Follow-up|0|||
164176160|NCT04778059|593008195|FG004|Overall Study|Lost to Follow-up|1|||
164176161|NCT04778059|593008191|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
164176162|NCT04778059|593008192|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
164176163|NCT04778059|593008193|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
164176164|NCT04778059|593008194|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
164176165|NCT04778059|593008195|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
164176166|NCT02832375|593008196|FG000|Overall Study|Lost to Follow-up|1|||
164176167|NCT02832375|593008197|FG001|Overall Study|Lost to Follow-up|0|||
164176168|NCT02832375|593008196|FG000|Overall Study|Withdrawal of Consent|1|||
164176169|NCT02832375|593008197|FG001|Overall Study|Withdrawal of Consent|0|||
164176170|NCT02100670|593008202|FG000|Overall Study|Adverse Event|10|||
164176171|NCT02100670|593008203|FG001|Overall Study|Adverse Event|3|||
164176172|NCT02100670|593008204|FG002|Overall Study|Adverse Event|3|||
164176173|NCT02100670|593008205|FG003|Overall Study|Adverse Event|0|||
164176174|NCT02100670|593008202|FG000|Overall Study|Lost to Follow-up|1|||
164176175|NCT02100670|593008203|FG001|Overall Study|Lost to Follow-up|0|||
164176176|NCT02100670|593008204|FG002|Overall Study|Lost to Follow-up|0|||
164176177|NCT02100670|593008205|FG003|Overall Study|Lost to Follow-up|0|||
164176178|NCT02100670|593008202|FG000|Overall Study|Protocol Violation|0|||
164176179|NCT02100670|593008203|FG001|Overall Study|Protocol Violation|1|||
164176180|NCT02100670|593008204|FG002|Overall Study|Protocol Violation|0|||
164176181|NCT02100670|593008205|FG003|Overall Study|Protocol Violation|1|||
164176182|NCT02100670|593008202|FG000|Overall Study|Withdrawal of Consent|0|||
164176183|NCT02100670|593008203|FG001|Overall Study|Withdrawal of Consent|1|||
164176184|NCT02100670|593008204|FG002|Overall Study|Withdrawal of Consent|1|||
164176185|NCT02100670|593008205|FG003|Overall Study|Withdrawal of Consent|0|||
164176186|NCT02100670|593008202|FG000|Overall Study|No swelling no pain|1|||
164176187|NCT02100670|593008203|FG001|Overall Study|No swelling no pain|0|||
164176188|NCT02100670|593008204|FG002|Overall Study|No swelling no pain|0|||
164176189|NCT02100670|593008205|FG003|Overall Study|No swelling no pain|0|||
164176190|NCT02100670|593008202|FG000|Overall Study|Poor Efficacy|0|||
164176191|NCT02100670|593008203|FG001|Overall Study|Poor Efficacy|1|||
164176192|NCT02100670|593008204|FG002|Overall Study|Poor Efficacy|0|||
164176193|NCT02100670|593008205|FG003|Overall Study|Poor Efficacy|0|||
164176194|NCT02100670|593008202|FG000|Overall Study|Physician Decision|0|||
164176195|NCT02100670|593008203|FG001|Overall Study|Physician Decision|1|||
164176196|NCT02100670|593008204|FG002|Overall Study|Physician Decision|0|||
164176197|NCT02100670|593008205|FG003|Overall Study|Physician Decision|0|||
164176198|NCT02100670|593008202|FG000|Overall Study|Withdrawal by Subject|1|||
164176199|NCT02100670|593008203|FG001|Overall Study|Withdrawal by Subject|0|||
164176200|NCT02100670|593008204|FG002|Overall Study|Withdrawal by Subject|0|||
164176201|NCT02100670|593008205|FG003|Overall Study|Withdrawal by Subject|0|||
164176202|NCT00549601|593009716|FG000|Randomized|Protocol Violation|0|||
164176203|NCT00549601|593009717|FG001|Randomized|Protocol Violation|0|||
164176204|NCT00549601|593009718|FG002|Randomized|Protocol Violation|1|||
164176205|NCT00549601|593009716|FG000|Randomized|Withdrawal by Subject|0|||
164176206|NCT00549601|593009717|FG001|Randomized|Withdrawal by Subject|1|||
164176207|NCT00549601|593009718|FG002|Randomized|Withdrawal by Subject|1|||
164176208|NCT00549601|593009716|FG000|Received Study Drug|Adverse Event|2|||
164176209|NCT00549601|593009717|FG001|Received Study Drug|Adverse Event|5|||
164176210|NCT00549601|593009718|FG002|Received Study Drug|Adverse Event|1|||
164176211|NCT00549601|593009716|FG000|Received Study Drug|Death|0|||
164176212|NCT00549601|593009717|FG001|Received Study Drug|Death|1|||
164176213|NCT00549601|593009718|FG002|Received Study Drug|Death|0|||
164176214|NCT00549601|593009716|FG000|Received Study Drug|Lost to Follow-up|0|||
164176215|NCT00549601|593009717|FG001|Received Study Drug|Lost to Follow-up|1|||
164176216|NCT00549601|593009718|FG002|Received Study Drug|Lost to Follow-up|1|||
164176217|NCT00549601|593009716|FG000|Received Study Drug|Protocol Violation|3|||
164176218|NCT00549601|593009717|FG001|Received Study Drug|Protocol Violation|4|||
164176219|NCT00549601|593009718|FG002|Received Study Drug|Protocol Violation|1|||
164176220|NCT00549601|593009716|FG000|Received Study Drug|Withdrawal by Subject|2|||
164176221|NCT00549601|593009717|FG001|Received Study Drug|Withdrawal by Subject|0|||
164176222|NCT00549601|593009718|FG002|Received Study Drug|Withdrawal by Subject|1|||
164176223|NCT02824562|593009719|FG000|Overall Study|Lost to Follow-up|3|||
164176224|NCT02824562|593009720|FG001|Overall Study|Lost to Follow-up|4|||
164176225|NCT02824562|593009719|FG000|Overall Study|Death|0|||
164176226|NCT02824562|593009720|FG001|Overall Study|Death|1|||
164176227|NCT00908596|593009724|FG000|Overall Study|Other reasons|46|||
164176228|NCT00908596|593009725|FG001|Overall Study|Other reasons|6|||
164176229|NCT00908596|593009726|FG002|Overall Study|Other reasons|2|||
164176230|NCT00908596|593009727|FG003|Overall Study|Other reasons|0|||
164176231|NCT00908596|593009724|FG000|Overall Study|Lost to Follow-up|0|||
164176232|NCT00908596|593009725|FG001|Overall Study|Lost to Follow-up|1|||
164176233|NCT00908596|593009726|FG002|Overall Study|Lost to Follow-up|12|||
164176234|NCT00908596|593009727|FG003|Overall Study|Lost to Follow-up|4|||
164176235|NCT00908596|593009724|FG000|Overall Study|Death|0|||
164176236|NCT00908596|593009725|FG001|Overall Study|Death|5|||
164176237|NCT00908596|593009726|FG002|Overall Study|Death|57|||
164176238|NCT00908596|593009727|FG003|Overall Study|Death|32|||
164176239|NCT00908596|593009724|FG000|Overall Study|Protocol Violation|1|||
164176240|NCT00908596|593009725|FG001|Overall Study|Protocol Violation|0|||
164176241|NCT00908596|593009726|FG002|Overall Study|Protocol Violation|0|||
164176242|NCT00908596|593009727|FG003|Overall Study|Protocol Violation|0|||
164176243|NCT00908596|593009724|FG000|Overall Study|Withdrawal by Subject|0|||
164176244|NCT00908596|593009725|FG001|Overall Study|Withdrawal by Subject|1|||
164176245|NCT00908596|593009726|FG002|Overall Study|Withdrawal by Subject|3|||
164176246|NCT00908596|593009727|FG003|Overall Study|Withdrawal by Subject|1|||
164176247|NCT00224406|593009728|FG000|Overall Study|Re-transplant|0|||
164176248|NCT00224406|593009729|FG001|Overall Study|Re-transplant|2|||
164176249|NCT00224406|593009728|FG000|Overall Study|Death|0|||
164176250|NCT00224406|593009729|FG001|Overall Study|Death|1|||
164176251|NCT00224406|593009728|FG000|Overall Study|Transplant cancelled|0|||
164176252|NCT00224406|593009729|FG001|Overall Study|Transplant cancelled|4|||
164176253|NCT00224406|593009728|FG000|Overall Study|Drug not delivered|2|||
164176254|NCT00224406|593009729|FG001|Overall Study|Drug not delivered|0|||
164176255|NCT00224406|593009728|FG000|Overall Study|Other|4|||
164176256|NCT00224406|593009729|FG001|Overall Study|Other|0|||
164176257|NCT00224406|593009728|FG000|Overall Study|Transplant cancelled|3|||
164176258|NCT00224406|593009729|FG001|Overall Study|Transplant cancelled|0|||
164176259|NCT01250171|593009734|FG000|Overall Study|Administrative reasons|1|||
164176260|NCT01250171|593009735|FG001|Overall Study|Administrative reasons|0|||
164176261|NCT01250171|593009736|FG002|Overall Study|Administrative reasons|0|||
164176262|NCT03427268|593009745|FG000|Overall Study|Progressive disease|25|||
164176263|NCT03427268|593009745|FG000|Overall Study|Never treated|2|||
164176264|NCT03427268|593009745|FG000|Overall Study|Compassionate use|1|||
164176265|NCT03427268|593009745|FG000|Overall Study|Withdrawal by Subject|1|||
164176266|NCT03427268|593009745|FG000|Overall Study|Adverse Event|3|||
164176267|NCT02638129|593009746|FG000|Overall Study|Study terminated|28|||
164176268|NCT02638129|593009747|FG001|Overall Study|Study terminated|30|||
164176269|NCT03117881|593009748|FG000|Baseline|Withdrawal by Subject|21|||
164176270|NCT03117881|593009749|FG001|Baseline|Withdrawal by Subject|10|||
164176271|NCT03117881|593009750|FG002|Baseline|Withdrawal by Subject|0|||
164176272|NCT03117881|593009748|FG000|Baseline|Lost to Follow-up|22|||
164176273|NCT03117881|593009749|FG001|Baseline|Lost to Follow-up|25|||
164176274|NCT03117881|593009750|FG002|Baseline|Lost to Follow-up|0|||
164176275|NCT03117881|593009748|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
164176276|NCT03117881|593009749|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
164176277|NCT03117881|593009750|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
164176278|NCT03117881|593009748|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
164176279|NCT03117881|593009749|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
164176280|NCT03117881|593009750|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
164176281|NCT03117881|593009748|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
164176282|NCT03117881|593009749|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
164176283|NCT03117881|593009750|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
164176284|NCT03117881|593009748|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
164176285|NCT03117881|593009749|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
164176286|NCT03117881|593009750|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
164176287|NCT03117881|593009748|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
164176288|NCT03117881|593009749|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
164176289|NCT03117881|593009750|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
164176290|NCT03117881|593009748|FG000|6-Month Follow-Up|Did not complete test|53|||
164176291|NCT03117881|593009749|FG001|6-Month Follow-Up|Did not complete test|25|||
164176292|NCT03117881|593009750|FG002|6-Month Follow-Up|Did not complete test|7|||
164176293|NCT03117881|593009748|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
164176294|NCT03117881|593009749|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
164176295|NCT03117881|593009750|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
164176296|NCT03117881|593009748|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
164176297|NCT03117881|593009749|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
164176298|NCT03117881|593009750|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
164176299|NCT03117881|593009748|FG000|12-Month Follow-Up|Did not complete test|40|||
164176300|NCT03117881|593009749|FG001|12-Month Follow-Up|Did not complete test|0|||
164176301|NCT03117881|593009750|FG002|12-Month Follow-Up|Did not complete test|0|||
164176302|NCT02309723|593009753|FG000|Overall Study|Withdrawal by Subject|24|||
164176303|NCT02309723|593009754|FG001|Overall Study|Withdrawal by Subject|23|||
164176304|NCT02309723|593009755|FG002|Overall Study|Withdrawal by Subject|24|||
164176305|NCT02560623|593009756|FG000|Overall Study|Unable to swallow sponge|0|||
164176306|NCT02560623|593009757|FG001|Overall Study|Unable to swallow sponge|1|||
164176307|NCT02560623|593009758|FG002|Overall Study|Unable to swallow sponge|0|||
164176308|NCT02560623|593009759|FG003|Overall Study|Unable to swallow sponge|0|||
164176309|NCT02560623|593009756|FG000|Overall Study|Intervention prior to sponge administration|0|||
164176310|NCT02560623|593009757|FG001|Overall Study|Intervention prior to sponge administration|1|||
164176311|NCT02560623|593009758|FG002|Overall Study|Intervention prior to sponge administration|0|||
164176312|NCT02560623|593009759|FG003|Overall Study|Intervention prior to sponge administration|0|||
164176313|NCT01349322|593009760|FG000|Overall Study|Protocol Violation|45|||
164176314|NCT01349322|593009761|FG001|Overall Study|Protocol Violation|47|||
164176315|NCT01565668|593009765|FG000|Overall Study|Death|2|||
164176316|NCT01565668|593009766|FG001|Overall Study|Death|1|||
164176317|NCT01565668|593009765|FG000|Overall Study|Lack of Efficacy|4|||
164176318|NCT01565668|593009766|FG001|Overall Study|Lack of Efficacy|2|||
164176319|NCT01565668|593009765|FG000|Overall Study|Participant went on Hospice Care|1|||
164176320|NCT01565668|593009766|FG001|Overall Study|Participant went on Hospice Care|0|||
164176321|NCT01565668|593009765|FG000|Overall Study|Adverse Event|6|||
164176322|NCT01565668|593009766|FG001|Overall Study|Adverse Event|1|||
164176323|NCT01565668|593009765|FG000|Overall Study|Randomized, but never received drug|0|||
164176324|NCT01565668|593009766|FG001|Overall Study|Randomized, but never received drug|2|||
164176325|NCT01565668|593009765|FG000|Overall Study|Progressive disease|13|||
164176326|NCT01565668|593009766|FG001|Overall Study|Progressive disease|14|||
164176327|NCT01565668|593009765|FG000|Overall Study|Withdrawal by Subject|1|||
164176328|NCT01565668|593009766|FG001|Overall Study|Withdrawal by Subject|3|||
164176329|NCT01565668|593009765|FG000|Overall Study|HSCT Transplant|11|||
164176330|NCT01565668|593009766|FG001|Overall Study|HSCT Transplant|15|||
164176331|NCT01097421|593009767|FG000|Overall Study|Adverse Event|8|||
164176332|NCT01097421|593009767|FG000|Overall Study|Protocol Violation|2|||
164176333|NCT01097421|593009767|FG000|Overall Study|Lost to Follow-up|1|||
164176334|NCT01097421|593009767|FG000|Overall Study|Withdrawal by Subject|3|||
164176335|NCT06137703|593009770|FG000|Overall Study|Other|0|||
164176336|NCT06137703|593009771|FG001|Overall Study|Other|1|||
164176337|NCT06137703|593009772|FG002|Overall Study|Other|0|||
164176338|NCT06137703|593009773|FG003|Overall Study|Other|0|||
164176339|NCT06137703|593009770|FG000|Overall Study|Adverse Event|0|||
164176340|NCT06137703|593009771|FG001|Overall Study|Adverse Event|0|||
164176341|NCT06137703|593009772|FG002|Overall Study|Adverse Event|1|||
164176342|NCT06137703|593009773|FG003|Overall Study|Adverse Event|0|||
164176343|NCT01801358|593009774|FG000|Overall Study|Adverse Event|0|||
164176344|NCT01801358|593009775|FG001|Overall Study|Adverse Event|2|||
164176345|NCT01801358|593009776|FG002|Overall Study|Adverse Event|1|||
164176346|NCT01801358|593009777|FG003|Overall Study|Adverse Event|0|||
164176347|NCT01801358|593009778|FG004|Overall Study|Adverse Event|0|||
164176348|NCT01801358|593009779|FG005|Overall Study|Adverse Event|1|||
164176349|NCT01801358|593009774|FG000|Overall Study|Physician Decision|0|||
164176350|NCT01801358|593009775|FG001|Overall Study|Physician Decision|0|||
164176351|NCT01801358|593009776|FG002|Overall Study|Physician Decision|1|||
164176352|NCT01801358|593009777|FG003|Overall Study|Physician Decision|0|||
164176353|NCT01801358|593009778|FG004|Overall Study|Physician Decision|0|||
164176354|NCT01801358|593009779|FG005|Overall Study|Physician Decision|0|||
164176355|NCT01801358|593009774|FG000|Overall Study|Progressive Disease|6|||
164176356|NCT01801358|593009775|FG001|Overall Study|Progressive Disease|4|||
164176357|NCT01801358|593009776|FG002|Overall Study|Progressive Disease|4|||
164176358|NCT01801358|593009777|FG003|Overall Study|Progressive Disease|5|||
164176359|NCT01801358|593009778|FG004|Overall Study|Progressive Disease|6|||
164176360|NCT01801358|593009779|FG005|Overall Study|Progressive Disease|5|||
164176361|NCT01801358|593009774|FG000|Overall Study|Withdrawal by Subject|0|||
164176362|NCT01801358|593009775|FG001|Overall Study|Withdrawal by Subject|0|||
164176363|NCT01801358|593009776|FG002|Overall Study|Withdrawal by Subject|0|||
164176364|NCT01801358|593009777|FG003|Overall Study|Withdrawal by Subject|1|||
164176365|NCT01801358|593009778|FG004|Overall Study|Withdrawal by Subject|0|||
164176366|NCT01801358|593009779|FG005|Overall Study|Withdrawal by Subject|2|||
164176367|NCT04093492|593009782|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
164176368|NCT04093492|593009783|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
164176369|NCT04093492|593009784|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
164176370|NCT04093492|593009785|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
164176371|NCT04093492|593009782|FG000|25 Weeks Gestational Age (GA)|No response|5|||
164176372|NCT04093492|593009783|FG001|25 Weeks Gestational Age (GA)|No response|5|||
164176373|NCT04093492|593009784|FG002|25 Weeks Gestational Age (GA)|No response|5|||
164176374|NCT04093492|593009785|FG003|25 Weeks Gestational Age (GA)|No response|2|||
164176375|NCT04093492|593009782|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
164176376|NCT04093492|593009783|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
164176377|NCT04093492|593009784|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
164176378|NCT04093492|593009785|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
164176379|NCT04093492|593009782|FG000|30 Weeks GA|Delivered before assessment|1|||
164176380|NCT04093492|593009783|FG001|30 Weeks GA|Delivered before assessment|2|||
164176381|NCT04093492|593009784|FG002|30 Weeks GA|Delivered before assessment|0|||
164176382|NCT04093492|593009785|FG003|30 Weeks GA|Delivered before assessment|0|||
164176383|NCT04093492|593009782|FG000|30 Weeks GA|No response|7|||
164176384|NCT04093492|593009783|FG001|30 Weeks GA|No response|5|||
164176385|NCT04093492|593009784|FG002|30 Weeks GA|No response|5|||
164176386|NCT04093492|593009785|FG003|30 Weeks GA|No response|2|||
164176387|NCT04093492|593009782|FG000|30 Weeks GA|Lost to Follow-up|0|||
164176388|NCT04093492|593009783|FG001|30 Weeks GA|Lost to Follow-up|1|||
164176389|NCT04093492|593009784|FG002|30 Weeks GA|Lost to Follow-up|0|||
164176390|NCT04093492|593009785|FG003|30 Weeks GA|Lost to Follow-up|0|||
164176391|NCT04093492|593009782|FG000|34 Weeks GA|Delivered before assessment|6|||
164176392|NCT04093492|593009783|FG001|34 Weeks GA|Delivered before assessment|3|||
164176393|NCT04093492|593009784|FG002|34 Weeks GA|Delivered before assessment|0|||
164176394|NCT04093492|593009785|FG003|34 Weeks GA|Delivered before assessment|0|||
164176395|NCT04093492|593009782|FG000|34 Weeks GA|No response|0|||
164176396|NCT04093492|593009783|FG001|34 Weeks GA|No response|7|||
164176397|NCT04093492|593009784|FG002|34 Weeks GA|No response|5|||
164176398|NCT04093492|593009785|FG003|34 Weeks GA|No response|3|||
164176399|NCT04093492|593009782|FG000|34 Weeks GA|Lost to Follow-up|0|||
164176400|NCT04093492|593009783|FG001|34 Weeks GA|Lost to Follow-up|1|||
164176401|NCT04093492|593009784|FG002|34 Weeks GA|Lost to Follow-up|0|||
164176402|NCT04093492|593009785|FG003|34 Weeks GA|Lost to Follow-up|0|||
164176403|NCT03436199|593009792|FG000|Overall Study|Adverse Event|15|||
164176404|NCT03436199|593009793|FG001|Overall Study|Adverse Event|40|||
164176405|NCT03436199|593009794|FG002|Overall Study|Adverse Event|7|||
164176406|NCT03436199|593009792|FG000|Overall Study|Withdrawal by Subject|4|||
164176407|NCT03436199|593009793|FG001|Overall Study|Withdrawal by Subject|10|||
164176408|NCT03436199|593009794|FG002|Overall Study|Withdrawal by Subject|3|||
164176409|NCT03436199|593009792|FG000|Overall Study|Lost to Follow-up|1|||
164176410|NCT03436199|593009793|FG001|Overall Study|Lost to Follow-up|0|||
164176411|NCT03436199|593009794|FG002|Overall Study|Lost to Follow-up|2|||
164176412|NCT03436199|593009792|FG000|Overall Study|Protocol Violation|1|||
164176413|NCT03436199|593009793|FG001|Overall Study|Protocol Violation|1|||
164176414|NCT03436199|593009794|FG002|Overall Study|Protocol Violation|0|||
164176415|NCT03436199|593009792|FG000|Overall Study|Physician Decision|0|||
164176416|NCT03436199|593009793|FG001|Overall Study|Physician Decision|1|||
164176417|NCT03436199|593009794|FG002|Overall Study|Physician Decision|0|||
164176418|NCT03436199|593009792|FG000|Overall Study|Could not return to clinic|1|||
164176419|NCT03436199|593009793|FG001|Overall Study|Could not return to clinic|0|||
164176420|NCT03436199|593009794|FG002|Overall Study|Could not return to clinic|0|||
164176421|NCT03436199|593009792|FG000|Overall Study|Withdrawn per physician|0|||
164176422|NCT03436199|593009793|FG001|Overall Study|Withdrawn per physician|1|||
164176423|NCT03436199|593009794|FG002|Overall Study|Withdrawn per physician|0|||
164176424|NCT00087126|593009798|FG000|Overall Study|Ineligible - second primary|1|||
164176425|NCT00087126|593009798|FG000|Overall Study|Never treated|1|||
164176426|NCT01432275|593009799|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
164176427|NCT01432275|593009800|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
164176428|NCT01432275|593009799|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
164176429|NCT01432275|593009800|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
164176430|NCT01432275|593009799|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
164176431|NCT01432275|593009800|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
164176432|NCT01432275|593009799|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
164176433|NCT01432275|593009800|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
164176434|NCT01432275|593009799|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
164176435|NCT01432275|593009800|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
164176436|NCT01432275|593009799|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
164176437|NCT01432275|593009800|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
164176438|NCT01432275|593009799|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
164176439|NCT01432275|593009800|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
164176440|NCT01432275|593009799|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
164176441|NCT01432275|593009800|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
164176442|NCT01432275|593009799|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
164176443|NCT01432275|593009800|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
164176444|NCT01935128|593009807|FG000|Overall Study|Death|1|||
164176445|NCT01935128|593009807|FG000|Overall Study|Adverse Event|6|||
164176446|NCT00096993|593009808|FG000|Overall Study|Death|1|||
164176447|NCT00096993|593009809|FG001|Overall Study|Death|0|||
164176448|NCT00096993|593009808|FG000|Overall Study|Disease progression|56|||
164176449|NCT00096993|593009809|FG001|Overall Study|Disease progression|53|||
164176450|NCT00096993|593009808|FG000|Overall Study|Adverse Event|2|||
164176451|NCT00096993|593009809|FG001|Overall Study|Adverse Event|8|||
164176452|NCT00096993|593009808|FG000|Overall Study|Subject's decision|3|||
164176453|NCT00096993|593009809|FG001|Overall Study|Subject's decision|1|||
164176454|NCT00096993|593009808|FG000|Overall Study|Physician Decision|2|||
164176455|NCT00096993|593009809|FG001|Overall Study|Physician Decision|1|||
164176456|NCT00096993|593009808|FG000|Overall Study|Non-compliance|0|||
164176457|NCT00096993|593009809|FG001|Overall Study|Non-compliance|1|||
164176458|NCT00096993|593009808|FG000|Overall Study|Other unspecified|1|||
164176459|NCT00096993|593009809|FG001|Overall Study|Other unspecified|1|||
164176460|NCT01438814|593009815|FG000|Overall Study|Adverse Event|3|||
164176461|NCT01438814|593009816|FG001|Overall Study|Adverse Event|3|||
164176462|NCT01438814|593009815|FG000|Overall Study|Protocol Violation|1|||
164176463|NCT01438814|593009816|FG001|Overall Study|Protocol Violation|2|||
164176464|NCT01438814|593009815|FG000|Overall Study|Lost to Follow-up|4|||
164176465|NCT01438814|593009816|FG001|Overall Study|Lost to Follow-up|3|||
164176466|NCT01438814|593009815|FG000|Overall Study|Withdrawal by Subject|4|||
164176467|NCT01438814|593009816|FG001|Overall Study|Withdrawal by Subject|2|||
164176468|NCT01438814|593009815|FG000|Overall Study|Other|2|||
164176469|NCT01438814|593009816|FG001|Overall Study|Other|4|||
164176470|NCT01739764|593009817|FG000|Overall Study|Adverse Event|0|||
164176471|NCT01739764|593009818|FG001|Overall Study|Adverse Event|3|||
164176472|NCT01739764|593009819|FG002|Overall Study|Adverse Event|4|||
164176473|NCT01739764|593009817|FG000|Overall Study|Death|4|||
164176474|NCT01739764|593009818|FG001|Overall Study|Death|6|||
164176475|NCT01739764|593009819|FG002|Overall Study|Death|38|||
164176476|NCT01739764|593009817|FG000|Overall Study|Lost to Follow-up|0|||
164176477|NCT01739764|593009818|FG001|Overall Study|Lost to Follow-up|0|||
164176478|NCT01739764|593009819|FG002|Overall Study|Lost to Follow-up|5|||
164176479|NCT01739764|593009817|FG000|Overall Study|Non-Compliance|0|||
164176480|NCT01739764|593009818|FG001|Overall Study|Non-Compliance|0|||
164176481|NCT01739764|593009819|FG002|Overall Study|Non-Compliance|1|||
164176482|NCT01739764|593009817|FG000|Overall Study|Multiple Reasons|3|||
164176483|NCT01739764|593009818|FG001|Overall Study|Multiple Reasons|2|||
164176484|NCT01739764|593009819|FG002|Overall Study|Multiple Reasons|3|||
164176485|NCT01739764|593009817|FG000|Overall Study|Physician Decision|2|||
164176486|NCT01739764|593009818|FG001|Overall Study|Physician Decision|2|||
164176487|NCT01739764|593009819|FG002|Overall Study|Physician Decision|4|||
164176488|NCT01739764|593009817|FG000|Overall Study|Progressive Disease|3|||
164176489|NCT01739764|593009818|FG001|Overall Study|Progressive Disease|5|||
164176490|NCT01739764|593009819|FG002|Overall Study|Progressive Disease|16|||
164176491|NCT01739764|593009817|FG000|Overall Study|Protocol Violation|0|||
164176492|NCT01739764|593009818|FG001|Overall Study|Protocol Violation|0|||
164176493|NCT01739764|593009819|FG002|Overall Study|Protocol Violation|2|||
164176494|NCT01739764|593009817|FG000|Overall Study|Study Terminated by Sponsor|8|||
164176495|NCT01739764|593009818|FG001|Overall Study|Study Terminated by Sponsor|13|||
164176496|NCT01739764|593009819|FG002|Overall Study|Study Terminated by Sponsor|26|||
164176497|NCT01739764|593009817|FG000|Overall Study|Withdrawal by Subject|6|||
164176498|NCT01739764|593009818|FG001|Overall Study|Withdrawal by Subject|5|||
164176499|NCT01739764|593009819|FG002|Overall Study|Withdrawal by Subject|27|||
164176500|NCT00404924|593009820|FG000|Overall Study|Adverse Event|75|||
164176501|NCT00404924|593009821|FG001|Overall Study|Adverse Event|16|||
164176502|NCT00404924|593009820|FG000|Overall Study|Condition under investigation worsened|475|||
164176503|NCT00404924|593009821|FG001|Overall Study|Condition under investigation worsened|264|||
164176504|NCT00404924|593009820|FG000|Overall Study|Lost to Follow-up|1|||
164176505|NCT00404924|593009821|FG001|Overall Study|Lost to Follow-up|1|||
164176506|NCT00404924|593009820|FG000|Overall Study|Withdrawal by Subject|26|||
164176507|NCT00404924|593009821|FG001|Overall Study|Withdrawal by Subject|13|||
164176508|NCT00404924|593009820|FG000|Overall Study|Other|25|||
164176509|NCT00404924|593009821|FG001|Overall Study|Other|11|||
164176510|NCT00404924|593009820|FG000|Overall Study|Randomised but not received treatment|1|||
164176511|NCT00404924|593009821|FG001|Overall Study|Randomised but not received treatment|1|||
164176512|NCT00513357|593009826|FG000|Overall Study|did not receive allocated placebo|2|||
164176513|NCT00513357|593009827|FG001|Overall Study|did not receive allocated placebo|3|||
164176514|NCT00513357|593009826|FG000|Overall Study|Adverse Event|4|||
164176515|NCT00513357|593009827|FG001|Overall Study|Adverse Event|2|||
164176516|NCT00513357|593009826|FG000|Overall Study|Death|2|||
164176517|NCT00513357|593009827|FG001|Overall Study|Death|0|||
164176518|NCT00513357|593009826|FG000|Overall Study|Withdrawal by Subject|5|||
164176519|NCT00513357|593009827|FG001|Overall Study|Withdrawal by Subject|4|||
164176520|NCT00513357|593009826|FG000|Overall Study|Disease Progression|2|||
164176521|NCT00513357|593009827|FG001|Overall Study|Disease Progression|1|||
164176522|NCT01162122|593009828|FG000|Overall Study|Withdrawal by Subject|52|||
164176523|NCT01162122|593009829|FG001|Overall Study|Withdrawal by Subject|43|||
164176524|NCT01162122|593009828|FG000|Overall Study|Lost to Follow-up|73|||
164176525|NCT01162122|593009829|FG001|Overall Study|Lost to Follow-up|91|||
164176526|NCT01162122|593009828|FG000|Overall Study|Adverse Event|3|||
164176527|NCT01162122|593009829|FG001|Overall Study|Adverse Event|2|||
164176528|NCT01162122|593009828|FG000|Overall Study|Death|51|||
164176529|NCT01162122|593009829|FG001|Overall Study|Death|46|||
164176530|NCT01162122|593009828|FG000|Overall Study|Protocol Violation|2|||
164176531|NCT01162122|593009829|FG001|Overall Study|Protocol Violation|2|||
164176532|NCT01162122|593009828|FG000|Overall Study|Inappropriate enrollment|5|||
164176533|NCT01162122|593009829|FG001|Overall Study|Inappropriate enrollment|4|||
164176534|NCT01162122|593009828|FG000|Overall Study|Administrative reason|1|||
164176535|NCT01162122|593009829|FG001|Overall Study|Administrative reason|1|||
164176536|NCT01162122|593009828|FG000|Overall Study|Unable to classify|3|||
164176537|NCT01162122|593009829|FG001|Overall Study|Unable to classify|7|||
164176538|NCT01162122|593009828|FG000|Overall Study|Missing primary reason|1|||
164176539|NCT01162122|593009829|FG001|Overall Study|Missing primary reason|0|||
164176540|NCT02020512|593009830|FG000|Overall Study|Adverse Event|1|||
164176541|NCT02020512|593009830|FG000|Overall Study|Lost to Follow-up|3|||
164176542|NCT02020512|593009830|FG000|Overall Study|Protocol Violation|4|||
164176543|NCT00656851|593009836|FG000|Overall Study|Withdrawal by Subject|0|||
164176544|NCT00656851|593009837|FG001|Overall Study|Withdrawal by Subject|4|||
164176545|NCT00835679|593009838|FG000|Overall Study|Withdrawal by Subject|1|||
164176546|NCT00835679|593009839|FG001|Overall Study|Withdrawal by Subject|0|||
164176547|NCT00835679|593009840|FG002|Overall Study|Withdrawal by Subject|0|||
164176548|NCT00835679|593009841|FG003|Overall Study|Withdrawal by Subject|0|||
164176549|NCT05020899|593009842|FG000|8 Week Follow-up|Lost to Follow-up|3|||
164176550|NCT05020899|593009843|FG001|8 Week Follow-up|Lost to Follow-up|6|||
164176551|NCT05020899|593009842|FG000|12 Week Follow-up|Lost to Follow-up|1|||
164176552|NCT05020899|593009843|FG001|12 Week Follow-up|Lost to Follow-up|0|||
164176553|NCT05020899|593009842|FG000|12 Week Follow-up|Death|0|||
164176554|NCT05020899|593009843|FG001|12 Week Follow-up|Death|1|||
164176555|NCT00191282|593009848|FG000|Overall Study|Adverse Event|5|||
164176556|NCT00191282|593009849|FG001|Overall Study|Adverse Event|6|||
164176557|NCT00191282|593009848|FG000|Overall Study|Death|51|||
164176558|NCT00191282|593009849|FG001|Overall Study|Death|51|||
164176559|NCT00191282|593009848|FG000|Overall Study|Lack of Efficacy|11|||
164176560|NCT00191282|593009849|FG001|Overall Study|Lack of Efficacy|6|||
164176561|NCT00191282|593009848|FG000|Overall Study|Noncompliance|14|||
164176562|NCT00191282|593009849|FG001|Overall Study|Noncompliance|17|||
164176563|NCT00191282|593009848|FG000|Overall Study|Patient moved|11|||
164176564|NCT00191282|593009849|FG001|Overall Study|Patient moved|14|||
164176565|NCT00191282|593009848|FG000|Overall Study|Withdrawal by Subject|59|||
164176566|NCT00191282|593009849|FG001|Overall Study|Withdrawal by Subject|44|||
164176567|NCT00191282|593009848|FG000|Overall Study|Physician Decision|18|||
164176568|NCT00191282|593009849|FG001|Overall Study|Physician Decision|15|||
164176569|NCT00191282|593009848|FG000|Overall Study|Protocol entry criteria not met|14|||
164176570|NCT00191282|593009849|FG001|Overall Study|Protocol entry criteria not met|9|||
164176571|NCT00191282|593009848|FG000|Overall Study|Protocol Violation|9|||
164176572|NCT00191282|593009849|FG001|Overall Study|Protocol Violation|12|||
164176573|NCT00191282|593009848|FG000|Overall Study|Severity of outcome|2|||
164176574|NCT00191282|593009849|FG001|Overall Study|Severity of outcome|5|||
164176575|NCT00191282|593009848|FG000|Overall Study|Sponsor's decision|2|||
164176576|NCT00191282|593009849|FG001|Overall Study|Sponsor's decision|2|||
164176577|NCT00191282|593009848|FG000|Overall Study|Lost to Follow-up|24|||
164176578|NCT00191282|593009849|FG001|Overall Study|Lost to Follow-up|31|||
164176579|NCT00102531|593009850|FG000|Overall Study|Adverse Event|0|||
164176580|NCT00102531|593009851|FG001|Overall Study|Adverse Event|1|||
164176581|NCT00102531|593009850|FG000|Overall Study|Disease Progression|5|||
164176582|NCT00102531|593009851|FG001|Overall Study|Disease Progression|9|||
164176583|NCT00102531|593009850|FG000|Overall Study|Physician Decision|0|||
164176584|NCT00102531|593009851|FG001|Overall Study|Physician Decision|1|||
164176585|NCT04756154|593009858|FG000|Overall Study|Did not meet treatment day baseline|30|||
164176586|NCT04756154|593009859|FG001|Overall Study|Did not meet treatment day baseline|28|||
164176587|NCT04756154|593009860|FG002|Overall Study|Did not meet treatment day baseline|7|||
164176588|NCT04756154|593009858|FG000|Overall Study|Did not return for final sample collection|1|||
164176589|NCT04756154|593009859|FG001|Overall Study|Did not return for final sample collection|1|||
164176590|NCT04756154|593009860|FG002|Overall Study|Did not return for final sample collection|0|||
164176591|NCT01790828|593009861|FG000|Overall Study|Other|34|||
164176592|NCT00710684|593009862|FG000|Overall Study|Adverse Event|11|||
164176593|NCT00710684|593009863|FG001|Overall Study|Adverse Event|19|||
164176594|NCT00710684|593009864|FG002|Overall Study|Adverse Event|16|||
164176595|NCT00710684|593009862|FG000|Overall Study|Lack of Efficacy|4|||
164176596|NCT00710684|593009863|FG001|Overall Study|Lack of Efficacy|3|||
164176597|NCT00710684|593009864|FG002|Overall Study|Lack of Efficacy|5|||
164176598|NCT00710684|593009862|FG000|Overall Study|Protocol Violation|5|||
164176599|NCT00710684|593009863|FG001|Overall Study|Protocol Violation|5|||
164176600|NCT00710684|593009864|FG002|Overall Study|Protocol Violation|5|||
164176601|NCT00710684|593009862|FG000|Overall Study|Lost to Follow-up|4|||
164176602|NCT00710684|593009863|FG001|Overall Study|Lost to Follow-up|6|||
164176603|NCT00710684|593009864|FG002|Overall Study|Lost to Follow-up|7|||
164176604|NCT00710684|593009862|FG000|Overall Study|Physician Decision|0|||
164176605|NCT00710684|593009863|FG001|Overall Study|Physician Decision|2|||
164176606|NCT00710684|593009864|FG002|Overall Study|Physician Decision|4|||
164176607|NCT00710684|593009862|FG000|Overall Study|Withdrawal by Subject|24|||
164176608|NCT00710684|593009863|FG001|Overall Study|Withdrawal by Subject|18|||
164176609|NCT00710684|593009864|FG002|Overall Study|Withdrawal by Subject|11|||
164176610|NCT00710684|593009862|FG000|Overall Study|Missing|1|||
164176611|NCT00710684|593009863|FG001|Overall Study|Missing|0|||
164176612|NCT00710684|593009864|FG002|Overall Study|Missing|0|||
164176613|NCT00710684|593009862|FG000|Overall Study|Did not continue after week 24|25|||
164176614|NCT00710684|593009863|FG001|Overall Study|Did not continue after week 24|21|||
164176615|NCT00710684|593009864|FG002|Overall Study|Did not continue after week 24|16|||
164176616|NCT00514904|593009865|FG000|Overall Study|Withdrawal by Subject|3|||
164176617|NCT00514904|593009866|FG001|Overall Study|Withdrawal by Subject|2|||
164176618|NCT00514904|593009865|FG000|Overall Study|Lost to Follow-up|21|||
164176619|NCT00514904|593009866|FG001|Overall Study|Lost to Follow-up|3|||
164176620|NCT00084318|593009867|FG000|Overall Study|Withdrawal by Subject|5|||
164176621|NCT00084318|593009868|FG001|Overall Study|Withdrawal by Subject|2|||
164176622|NCT00084318|593009867|FG000|Overall Study|Protocol Violation|15|||
164176623|NCT00084318|593009868|FG001|Overall Study|Protocol Violation|11|||
164176624|NCT00084318|593009867|FG000|Overall Study|No protocol treatment|2|||
164176625|NCT00084318|593009868|FG001|Overall Study|No protocol treatment|0|||
164176626|NCT02921750|593012487|FG000|Overall Study|Adverse Event|1|||
164176627|NCT02921750|593012488|FG001|Overall Study|Adverse Event|2|||
164176628|NCT02921750|593012487|FG000|Overall Study|Withdrawal by Subject|1|||
164176629|NCT02921750|593012488|FG001|Overall Study|Withdrawal by Subject|1|||
164176630|NCT02921750|593012487|FG000|Overall Study|Lost to Follow-up|3|||
164176631|NCT02921750|593012488|FG001|Overall Study|Lost to Follow-up|3|||
164176632|NCT02921750|593012487|FG000|Overall Study|Wound healed|3|||
164176633|NCT02921750|593012488|FG001|Overall Study|Wound healed|3|||
164176634|NCT02921750|593012487|FG000|Overall Study|Serious Adverse Event|1|||
164176635|NCT02921750|593012488|FG001|Overall Study|Serious Adverse Event|2|||
164176636|NCT04676412|593012490|FG000|Overall Study|Death|28|||
164176637|NCT04676412|593012491|FG001|Overall Study|Death|31|||
164176638|NCT04676412|593012490|FG000|Overall Study|Lost to Follow-up|1|||
164176639|NCT04676412|593012491|FG001|Overall Study|Lost to Follow-up|2|||
164176640|NCT04676412|593012490|FG000|Overall Study|Sponsor Decision|20|||
164176641|NCT04676412|593012491|FG001|Overall Study|Sponsor Decision|23|||
164176642|NCT04676412|593012490|FG000|Overall Study|Withdrawal by Subject|0|||
164176643|NCT04676412|593012491|FG001|Overall Study|Withdrawal by Subject|2|||
164176644|NCT04550832|593012492|FG000|Overall Study|Adverse Event|0|||
164176645|NCT04550832|593012493|FG001|Overall Study|Adverse Event|0|||
164176646|NCT04550832|593012494|FG002|Overall Study|Adverse Event|2|||
164176647|NCT04550832|593012495|FG003|Overall Study|Adverse Event|0|||
164176648|NCT04550832|593012496|FG004|Overall Study|Adverse Event|1|||
164176649|NCT04823130|593012497|FG000|Overall Study|Withdrawal by Subject|2|||
164176650|NCT04823130|593012498|FG001|Overall Study|Withdrawal by Subject|3|||
164176651|NCT04823130|593012497|FG000|Overall Study|Failure to meet inclusion criteria|6|||
164176652|NCT04823130|593012498|FG001|Overall Study|Failure to meet inclusion criteria|4|||
164176653|NCT04823130|593012497|FG000|Overall Study|Other-unspecified|1|||
164176654|NCT04823130|593012498|FG001|Overall Study|Other-unspecified|0|||
164176655|NCT03315455|593012500|FG000|Overall Study|Ongoing in the Study|13|||
164176656|NCT03315455|593012501|FG001|Overall Study|Ongoing in the Study|24|||
164176657|NCT03315455|593012502|FG002|Overall Study|Ongoing in the Study|17|||
164176658|NCT03315455|593012503|FG003|Overall Study|Ongoing in the Study|15|||
164176659|NCT03315455|593012500|FG000|Overall Study|Withdrawal by Subject|0|||
164176660|NCT03315455|593012501|FG001|Overall Study|Withdrawal by Subject|1|||
164176661|NCT03315455|593012502|FG002|Overall Study|Withdrawal by Subject|0|||
164176662|NCT03315455|593012503|FG003|Overall Study|Withdrawal by Subject|0|||
164176663|NCT01458951|593012509|FG000|Overall Study|Other|1|||
164176664|NCT01458951|593012510|FG001|Overall Study|Other|0|||
164176665|NCT01458951|593012511|FG002|Overall Study|Other|0|||
164176666|NCT01458951|593012509|FG000|Overall Study|Protocol Violation|5|||
164176667|NCT01458951|593012510|FG001|Overall Study|Protocol Violation|1|||
164176668|NCT01458951|593012511|FG002|Overall Study|Protocol Violation|0|||
164176669|NCT01458951|593012509|FG000|Overall Study|Withdrawal by Subject|2|||
164176670|NCT01458951|593012510|FG001|Overall Study|Withdrawal by Subject|0|||
164176671|NCT01458951|593012511|FG002|Overall Study|Withdrawal by Subject|2|||
164176672|NCT01458951|593012509|FG000|Overall Study|Adverse Event|7|||
164176673|NCT01458951|593012510|FG001|Overall Study|Adverse Event|0|||
164176674|NCT01458951|593012511|FG002|Overall Study|Adverse Event|2|||
164176675|NCT01458951|593012509|FG000|Overall Study|Insufficient Clinical Response|17|||
164176676|NCT01458951|593012510|FG001|Overall Study|Insufficient Clinical Response|0|||
164176677|NCT01458951|593012511|FG002|Overall Study|Insufficient Clinical Response|11|||
164176678|NCT01846221|593012514|FG000|Overall Study|Catheter Failure|2|||
164176679|NCT01846221|593012515|FG001|Overall Study|Catheter Failure|0|||
164176680|NCT01846221|593012514|FG000|Overall Study|Age Exclusion|1|||
164176681|NCT01846221|593012515|FG001|Overall Study|Age Exclusion|0|||
164176682|NCT04392167|593012516|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
164176683|NCT03309696|593012517|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
164176684|NCT03309696|593012518|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
164176685|NCT03309696|593012519|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
164176686|NCT03309696|593012520|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
164176687|NCT02304380|593012522|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
164176688|NCT02304380|593012523|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
164176689|NCT02304380|593012524|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
164176690|NCT02304380|593012525|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
164176691|NCT02304380|593012526|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
164176692|NCT02304380|593012527|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
164176693|NCT01027897|593012528|FG000|Overall Study|Protocol Violation|1|||
164176694|NCT01027897|593012528|FG000|Overall Study|Withdrawal by Subject|1|||
164176695|NCT00328094|593012529|FG000|Overall Study|Physician Decision|3|||
164176696|NCT00328094|593012530|FG001|Overall Study|Physician Decision|3|||
164176697|NCT00577005|593012531|FG000|Overall Study|Lost to Follow-up|3|||
164176698|NCT00577005|593012532|FG001|Overall Study|Lost to Follow-up|2|||
164176699|NCT00577005|593012531|FG000|Overall Study|Withdrawal by Subject|2|||
164176700|NCT00577005|593012532|FG001|Overall Study|Withdrawal by Subject|1|||
164176701|NCT02667626|593012533|FG000|Overall Study|Withdrawal by Subject|0|||
164176702|NCT02667626|593012534|FG001|Overall Study|Withdrawal by Subject|1|||
164176703|NCT00473824|593012535|FG000|Overall Study|Virologic Breakthrough|1|||
164176704|NCT00473824|593012536|FG001|Overall Study|Virologic Breakthrough|0|||
164176705|NCT00473824|593012535|FG000|Overall Study|Adverse Event|1|||
164176706|NCT00473824|593012536|FG001|Overall Study|Adverse Event|0|||
164176707|NCT00473824|593012535|FG000|Overall Study|Death|1|||
164176708|NCT00473824|593012536|FG001|Overall Study|Death|0|||
164176709|NCT00473824|593012535|FG000|Overall Study|Lost to Follow-up|1|||
164176710|NCT00473824|593012536|FG001|Overall Study|Lost to Follow-up|0|||
164176711|NCT00473824|593012535|FG000|Overall Study|Withdrawal by physician|1|||
164176712|NCT00473824|593012536|FG001|Overall Study|Withdrawal by physician|0|||
164176713|NCT02539134|593012539|FG000|Overall Study|Lost to Follow-up|1|||
164176714|NCT02539134|593012540|FG001|Overall Study|Lost to Follow-up|0|||
164176715|NCT02539134|593012541|FG002|Overall Study|Lost to Follow-up|0|||
164176716|NCT02539134|593012542|FG003|Overall Study|Lost to Follow-up|0|||
164176717|NCT02539134|593012543|FG004|Overall Study|Lost to Follow-up|0|||
164176718|NCT02539134|593012544|FG005|Overall Study|Lost to Follow-up|0|||
164176719|NCT01143064|593012545|FG000|Overall Study|Death|109|||
164176720|NCT01143064|593012546|FG001|Overall Study|Death|91|||
164176721|NCT01143064|593012545|FG000|Overall Study|Adverse Event|0|||
164176722|NCT01143064|593012546|FG001|Overall Study|Adverse Event|1|||
164176723|NCT01143064|593012545|FG000|Overall Study|Withdrawal by Subject|7|||
164176724|NCT01143064|593012546|FG001|Overall Study|Withdrawal by Subject|5|||
164176725|NCT01143064|593012545|FG000|Overall Study|Lost to Follow-up|17|||
164176726|NCT01143064|593012546|FG001|Overall Study|Lost to Follow-up|14|||
164176727|NCT01143064|593012545|FG000|Overall Study|Physician Decision|0|||
164176728|NCT01143064|593012546|FG001|Overall Study|Physician Decision|4|||
164176729|NCT02453282|593012547|FG000|Overall Study|Death|275|||
164176730|NCT02453282|593012548|FG001|Overall Study|Death|277|||
164176731|NCT02453282|593012549|FG002|Overall Study|Death|296|||
164176732|NCT02453282|593012547|FG000|Overall Study|Lost to Follow-up|1|||
164176733|NCT02453282|593012548|FG001|Overall Study|Lost to Follow-up|0|||
164176734|NCT02453282|593012549|FG002|Overall Study|Lost to Follow-up|2|||
164176735|NCT02453282|593012547|FG000|Overall Study|Withdrawal by Subject|12|||
164176736|NCT02453282|593012548|FG001|Overall Study|Withdrawal by Subject|10|||
164176737|NCT02453282|593012549|FG002|Overall Study|Withdrawal by Subject|11|||
164176738|NCT02453282|593012547|FG000|Overall Study|Participants ongoing at data cut-off|85|||
164176739|NCT02453282|593012548|FG001|Overall Study|Participants ongoing at data cut-off|84|||
164176740|NCT02453282|593012549|FG002|Overall Study|Participants ongoing at data cut-off|62|||
164176741|NCT02453282|593012547|FG000|Overall Study|Other|1|||
164176742|NCT02453282|593012548|FG001|Overall Study|Other|1|||
164176743|NCT02453282|593012549|FG002|Overall Study|Other|1|||
164176744|NCT00985426|593012550|FG000|Overall Study|Adverse Event|0|||
164176745|NCT00985426|593012551|FG001|Overall Study|Adverse Event|1|||
164176746|NCT00985426|593012550|FG000|Overall Study|Subject Non-Compliance|3|||
164176747|NCT00985426|593012551|FG001|Overall Study|Subject Non-Compliance|3|||
164176748|NCT00985426|593012550|FG000|Overall Study|Withdrawal by Subject|12|||
164176749|NCT00985426|593012551|FG001|Overall Study|Withdrawal by Subject|16|||
164176750|NCT00985426|593012550|FG000|Overall Study|Lost to Follow-up|8|||
164176751|NCT00985426|593012551|FG001|Overall Study|Lost to Follow-up|10|||
164176752|NCT00985426|593012550|FG000|Overall Study|Death|7|||
164176753|NCT00985426|593012551|FG001|Overall Study|Death|3|||
164176754|NCT00985426|593012550|FG000|Overall Study|Protocol Violation|2|||
164176755|NCT00985426|593012551|FG001|Overall Study|Protocol Violation|0|||
164176756|NCT00985426|593012550|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
164176757|NCT00985426|593012551|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
164176758|NCT02327013|593012554|FG000|Overall Study|Adverse Event|4|||
164176759|NCT02327013|593012555|FG001|Overall Study|Adverse Event|4|||
164176760|NCT02327013|593012556|FG002|Overall Study|Adverse Event|3|||
164176761|NCT02327013|593012557|FG003|Overall Study|Adverse Event|0|||
164176762|NCT02327013|593012558|FG004|Overall Study|Adverse Event|1|||
164176763|NCT02327013|593012554|FG000|Overall Study|Lack of Efficacy|2|||
164176764|NCT02327013|593012555|FG001|Overall Study|Lack of Efficacy|0|||
164176765|NCT02327013|593012556|FG002|Overall Study|Lack of Efficacy|5|||
164176766|NCT02327013|593012557|FG003|Overall Study|Lack of Efficacy|0|||
164176767|NCT02327013|593012558|FG004|Overall Study|Lack of Efficacy|1|||
164176768|NCT02327013|593012554|FG000|Overall Study|Non-compliance with IMP|1|||
164176769|NCT02327013|593012555|FG001|Overall Study|Non-compliance with IMP|2|||
164176770|NCT02327013|593012556|FG002|Overall Study|Non-compliance with IMP|7|||
164176771|NCT02327013|593012557|FG003|Overall Study|Non-compliance with IMP|0|||
164176772|NCT02327013|593012558|FG004|Overall Study|Non-compliance with IMP|0|||
164176773|NCT02327013|593012554|FG000|Overall Study|Withdrawal of Consent|1|||
164176774|NCT02327013|593012555|FG001|Overall Study|Withdrawal of Consent|0|||
164176775|NCT02327013|593012556|FG002|Overall Study|Withdrawal of Consent|3|||
164176776|NCT02327013|593012557|FG003|Overall Study|Withdrawal of Consent|0|||
164176777|NCT02327013|593012558|FG004|Overall Study|Withdrawal of Consent|0|||
164176778|NCT02327013|593012554|FG000|Overall Study|Lost to Follow-up|2|||
164176779|NCT02327013|593012555|FG001|Overall Study|Lost to Follow-up|4|||
164176780|NCT02327013|593012556|FG002|Overall Study|Lost to Follow-up|5|||
164176781|NCT02327013|593012557|FG003|Overall Study|Lost to Follow-up|0|||
164176782|NCT02327013|593012558|FG004|Overall Study|Lost to Follow-up|0|||
164176783|NCT02327013|593012554|FG000|Overall Study|Administrative or other reason(s)|1|||
164176784|NCT02327013|593012555|FG001|Overall Study|Administrative or other reason(s)|5|||
164176785|NCT02327013|593012556|FG002|Overall Study|Administrative or other reason(s)|11|||
164176786|NCT02327013|593012557|FG003|Overall Study|Administrative or other reason(s)|1|||
164176787|NCT02327013|593012558|FG004|Overall Study|Administrative or other reason(s)|1|||
164176788|NCT02327013|593012554|FG000|Overall Study|Protocol Violation|0|||
164176789|NCT02327013|593012555|FG001|Overall Study|Protocol Violation|0|||
164176790|NCT02327013|593012556|FG002|Overall Study|Protocol Violation|3|||
164176791|NCT02327013|593012557|FG003|Overall Study|Protocol Violation|0|||
164176792|NCT02327013|593012558|FG004|Overall Study|Protocol Violation|1|||
164176793|NCT02327013|593012554|FG000|Overall Study|Withdrawal before treatment|2|||
164176794|NCT02327013|593012555|FG001|Overall Study|Withdrawal before treatment|1|||
164176795|NCT02327013|593012556|FG002|Overall Study|Withdrawal before treatment|5|||
164176796|NCT02327013|593012557|FG003|Overall Study|Withdrawal before treatment|0|||
164176797|NCT02327013|593012558|FG004|Overall Study|Withdrawal before treatment|0|||
164176798|NCT02380859|593012559|FG000|Overall Study|Withdrawal by Subject|2|||
164176799|NCT02380859|593012560|FG001|Overall Study|Withdrawal by Subject|0|||
164176800|NCT04076059|593012563|FG000|Double Blind Phase|Progressive disease|22|||
164176801|NCT04076059|593012564|FG001|Double Blind Phase|Progressive disease|26|||
164176802|NCT04076059|593012565|FG002|Double Blind Phase|Progressive disease|0|||
164176803|NCT04076059|593012563|FG000|Double Blind Phase|Withdrawal by Subject|4|||
164176804|NCT04076059|593012564|FG001|Double Blind Phase|Withdrawal by Subject|11|||
164176805|NCT04076059|593012565|FG002|Double Blind Phase|Withdrawal by Subject|0|||
164176806|NCT04076059|593012563|FG000|Double Blind Phase|Death|1|||
164176807|NCT04076059|593012564|FG001|Double Blind Phase|Death|1|||
164176808|NCT04076059|593012565|FG002|Double Blind Phase|Death|0|||
164176809|NCT04076059|593012563|FG000|Double Blind Phase|Lost to Follow-up|1|||
164176810|NCT04076059|593012564|FG001|Double Blind Phase|Lost to Follow-up|0|||
164176811|NCT04076059|593012565|FG002|Double Blind Phase|Lost to Follow-up|0|||
164176812|NCT04076059|593012563|FG000|Double Blind Phase|Adverse Event|5|||
164176813|NCT04076059|593012564|FG001|Double Blind Phase|Adverse Event|1|||
164176814|NCT04076059|593012565|FG002|Double Blind Phase|Adverse Event|0|||
164176815|NCT04076059|593012563|FG000|Double Blind Phase|Ongoing Participants|82|||
164176816|NCT04076059|593012564|FG001|Double Blind Phase|Ongoing Participants|18|||
164176817|NCT04076059|593012565|FG002|Double Blind Phase|Ongoing Participants|0|||
164176818|NCT04076059|593012563|FG000|Double Blind Phase|Miscellaneous|3|||
164176819|NCT04076059|593012564|FG001|Double Blind Phase|Miscellaneous|1|||
164176820|NCT04076059|593012565|FG002|Double Blind Phase|Miscellaneous|0|||
164176821|NCT04076059|593012563|FG000|Double Blind Phase|Protocol Deviation|1|||
164176822|NCT04076059|593012564|FG001|Double Blind Phase|Protocol Deviation|1|||
164176823|NCT04076059|593012565|FG002|Double Blind Phase|Protocol Deviation|0|||
164176824|NCT04076059|593012563|FG000|Double Blind Phase|Did not take study drug|1|||
164176825|NCT04076059|593012564|FG001|Double Blind Phase|Did not take study drug|1|||
164176826|NCT04076059|593012565|FG002|Double Blind Phase|Did not take study drug|0|||
164176827|NCT04076059|593012563|FG000|Open Label Phase|Progressive disease|0|||
164176828|NCT04076059|593012564|FG001|Open Label Phase|Progressive disease|0|||
164176829|NCT04076059|593012565|FG002|Open Label Phase|Progressive disease|7|||
164176830|NCT04076059|593012563|FG000|Open Label Phase|Withdrawal by Subject|0|||
164176831|NCT04076059|593012564|FG001|Open Label Phase|Withdrawal by Subject|0|||
164176832|NCT04076059|593012565|FG002|Open Label Phase|Withdrawal by Subject|3|||
164176833|NCT04076059|593012563|FG000|Open Label Phase|Death|0|||
164176834|NCT04076059|593012564|FG001|Open Label Phase|Death|0|||
164176835|NCT04076059|593012565|FG002|Open Label Phase|Death|2|||
164176836|NCT04076059|593012563|FG000|Open Label Phase|Ongoing Participants|0|||
164176837|NCT04076059|593012564|FG001|Open Label Phase|Ongoing Participants|0|||
164176838|NCT04076059|593012565|FG002|Open Label Phase|Ongoing Participants|11|||
164176839|NCT04186806|593012566|FG000|Period 1: 7 Days|Adverse Event|1|||
164176840|NCT04186806|593012567|FG001|Period 1: 7 Days|Adverse Event|0|||
164176841|NCT01661933|593012569|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
164176842|NCT01661933|593012569|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
164176843|NCT03385304|593012570|FG000|Overall Study|Death|19|||
164176844|NCT03385304|593012571|FG001|Overall Study|Death|7|||
164176845|NCT03385304|593012570|FG000|Overall Study|Lost to Follow-up|17|||
164176846|NCT03385304|593012571|FG001|Overall Study|Lost to Follow-up|14|||
164176847|NCT03385304|593012570|FG000|Overall Study|Withdrawal by Subject|3|||
164176848|NCT03385304|593012571|FG001|Overall Study|Withdrawal by Subject|2|||
164176849|NCT03385304|593012570|FG000|Overall Study|Incarceration|2|||
164176850|NCT03385304|593012571|FG001|Overall Study|Incarceration|3|||
164176851|NCT01120249|593012572|FG000|Overall Study|No protocol treatment received|21|||
164176852|NCT01120249|593012573|FG001|Overall Study|No protocol treatment received|15|||
164176853|NCT01120249|593012572|FG000|Overall Study|Disease recurrence|107|||
164176854|NCT01120249|593012573|FG001|Overall Study|Disease recurrence|57|||
164176855|NCT01120249|593012572|FG000|Overall Study|Death|1|||
164176856|NCT01120249|593012573|FG001|Overall Study|Death|0|||
164176857|NCT01120249|593012572|FG000|Overall Study|Adverse Event|40|||
164176858|NCT01120249|593012573|FG001|Overall Study|Adverse Event|276|||
164176859|NCT01120249|593012572|FG000|Overall Study|Participant refusal|34|||
164176860|NCT01120249|593012573|FG001|Overall Study|Participant refusal|42|||
164176861|NCT01120249|593012572|FG000|Overall Study|Other reasons, not protocol specified|29|||
164176862|NCT01120249|593012573|FG001|Overall Study|Other reasons, not protocol specified|22|||
164176863|NCT04258254|593012574|FG000|Overall Study|Withdrawal by Subject|0|||
164176864|NCT04258254|593012575|FG001|Overall Study|Withdrawal by Subject|1|||
164176865|NCT04258254|593012576|FG002|Overall Study|Withdrawal by Subject|0|||
164176866|NCT02720744|593012577|FG000|Overall Study|Protocol Violation|0|||
164176867|NCT02720744|593012578|FG001|Overall Study|Protocol Violation|2|||
164176868|NCT02720744|593012577|FG000|Overall Study|Pregnancy|2|||
164176869|NCT02720744|593012578|FG001|Overall Study|Pregnancy|0|||
164176870|NCT02720744|593012577|FG000|Overall Study|Lack of Efficacy|2|||
164176871|NCT02720744|593012578|FG001|Overall Study|Lack of Efficacy|8|||
164176872|NCT02720744|593012577|FG000|Overall Study|Adverse Event|21|||
164176873|NCT02720744|593012578|FG001|Overall Study|Adverse Event|3|||
164176874|NCT02720744|593012577|FG000|Overall Study|Withdrawal by Subject|11|||
164176875|NCT02720744|593012578|FG001|Overall Study|Withdrawal by Subject|11|||
164176876|NCT02720744|593012577|FG000|Overall Study|Lost to follow up|2|||
164176877|NCT02720744|593012578|FG001|Overall Study|Lost to follow up|0|||
164176878|NCT02720744|593012577|FG000|Overall Study|Non Compliance with Investigational Product|0|||
164176879|NCT02720744|593012578|FG001|Overall Study|Non Compliance with Investigational Product|1|||
164176880|NCT02720744|593012577|FG000|Overall Study|Excluded Concomitant Medication|0|||
164176881|NCT02720744|593012578|FG001|Overall Study|Excluded Concomitant Medication|1|||
164176882|NCT02255552|593012579|FG000|Overall Study|Participants enrolled into another study|0|||
164176883|NCT02255552|593012580|FG001|Overall Study|Participants enrolled into another study|11|||
164176884|NCT02255552|593012579|FG000|Overall Study|Withdrawal by Subject|1|||
164176885|NCT02255552|593012580|FG001|Overall Study|Withdrawal by Subject|4|||
164176886|NCT02122770|593012581|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
164176887|NCT02122770|593012582|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
164176888|NCT02122770|593012583|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
164176889|NCT02122770|593012584|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
164176890|NCT02122770|593012585|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
164176891|NCT02122770|593012586|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
164176892|NCT02122770|593012581|FG000|Part A: Drug-drug Interaction 2|Other|0|||
164176893|NCT02122770|593012582|FG001|Part A: Drug-drug Interaction 2|Other|0|||
164176894|NCT02122770|593012583|FG002|Part A: Drug-drug Interaction 2|Other|1|||
164176895|NCT02122770|593012584|FG003|Part A: Drug-drug Interaction 2|Other|0|||
164176896|NCT02122770|593012585|FG004|Part A: Drug-drug Interaction 2|Other|0|||
164176897|NCT02122770|593012586|FG005|Part A: Drug-drug Interaction 2|Other|0|||
164176898|NCT02122770|593012581|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
164176899|NCT02122770|593012582|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
164176900|NCT02122770|593012583|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
164176901|NCT02122770|593012584|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
164176902|NCT02122770|593012585|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
164176903|NCT02122770|593012586|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
164176904|NCT02122770|593012581|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
164176905|NCT02122770|593012582|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
164176906|NCT02122770|593012583|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
164176907|NCT02122770|593012584|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
164176908|NCT02122770|593012585|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
164176909|NCT02122770|593012586|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
164176910|NCT02122770|593012581|FG000|Part B: Standard of Care|Adverse Event|0|||
164176911|NCT02122770|593012582|FG001|Part B: Standard of Care|Adverse Event|0|||
164176912|NCT02122770|593012583|FG002|Part B: Standard of Care|Adverse Event|0|||
164176913|NCT02122770|593012584|FG003|Part B: Standard of Care|Adverse Event|0|||
164176914|NCT02122770|593012585|FG004|Part B: Standard of Care|Adverse Event|4|||
164176915|NCT02122770|593012586|FG005|Part B: Standard of Care|Adverse Event|1|||
164176916|NCT02122770|593012581|FG000|Part B: Standard of Care|Other|0|||
164176917|NCT02122770|593012582|FG001|Part B: Standard of Care|Other|0|||
164176918|NCT02122770|593012583|FG002|Part B: Standard of Care|Other|0|||
164176919|NCT02122770|593012584|FG003|Part B: Standard of Care|Other|0|||
164176920|NCT02122770|593012585|FG004|Part B: Standard of Care|Other|0|||
164176921|NCT02122770|593012586|FG005|Part B: Standard of Care|Other|2|||
164176922|NCT02122770|593012581|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
164176923|NCT02122770|593012582|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
164176924|NCT02122770|593012583|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
164176925|NCT02122770|593012584|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
164176926|NCT02122770|593012585|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
164176927|NCT02122770|593012586|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
164176928|NCT02122770|593012581|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
164176929|NCT02122770|593012582|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
164176930|NCT02122770|593012583|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
164176931|NCT02122770|593012584|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
164176932|NCT02122770|593012585|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
164176933|NCT02122770|593012586|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
164176934|NCT02122770|593012581|FG000|Part B: Standard of Care|Progressive Disease|0|||
164176935|NCT02122770|593012582|FG001|Part B: Standard of Care|Progressive Disease|0|||
164176936|NCT02122770|593012583|FG002|Part B: Standard of Care|Progressive Disease|0|||
164176937|NCT02122770|593012584|FG003|Part B: Standard of Care|Progressive Disease|0|||
164176938|NCT02122770|593012585|FG004|Part B: Standard of Care|Progressive Disease|10|||
164176939|NCT02122770|593012586|FG005|Part B: Standard of Care|Progressive Disease|8|||
164176940|NCT00558896|593012587|FG000|Overall Study|Adverse Event|1|||
164176941|NCT00558896|593012588|FG001|Overall Study|Adverse Event|1|||
164176942|NCT00558896|593012589|FG002|Overall Study|Adverse Event|1|||
164176943|NCT00558896|593012590|FG003|Overall Study|Adverse Event|3|||
164176944|NCT00558896|593012591|FG004|Overall Study|Adverse Event|4|||
164176945|NCT00558896|593012592|FG005|Overall Study|Adverse Event|10|||
164176946|NCT00558896|593012593|FG006|Overall Study|Adverse Event|3|||
164176947|NCT00558896|593012587|FG000|Overall Study|Death|3|||
164176948|NCT00558896|593012588|FG001|Overall Study|Death|0|||
164176949|NCT00558896|593012589|FG002|Overall Study|Death|2|||
164176950|NCT00558896|593012590|FG003|Overall Study|Death|3|||
164176951|NCT00558896|593012591|FG004|Overall Study|Death|2|||
164176952|NCT00558896|593012592|FG005|Overall Study|Death|2|||
164176953|NCT00558896|593012593|FG006|Overall Study|Death|6|||
164176954|NCT00558896|593012587|FG000|Overall Study|Withdrawal by Subject|2|||
164176955|NCT00558896|593012588|FG001|Overall Study|Withdrawal by Subject|1|||
164176956|NCT00558896|593012589|FG002|Overall Study|Withdrawal by Subject|1|||
164176957|NCT00558896|593012590|FG003|Overall Study|Withdrawal by Subject|1|||
164176958|NCT00558896|593012591|FG004|Overall Study|Withdrawal by Subject|1|||
164176959|NCT00558896|593012592|FG005|Overall Study|Withdrawal by Subject|5|||
164176960|NCT00558896|593012593|FG006|Overall Study|Withdrawal by Subject|5|||
164176961|NCT00558896|593012587|FG000|Overall Study|Alternative Treatment|2|||
164176962|NCT00558896|593012588|FG001|Overall Study|Alternative Treatment|2|||
164176963|NCT00558896|593012589|FG002|Overall Study|Alternative Treatment|0|||
164176964|NCT00558896|593012590|FG003|Overall Study|Alternative Treatment|2|||
164176965|NCT00558896|593012591|FG004|Overall Study|Alternative Treatment|6|||
164176966|NCT00558896|593012592|FG005|Overall Study|Alternative Treatment|7|||
164176967|NCT00558896|593012593|FG006|Overall Study|Alternative Treatment|1|||
164176968|NCT00558896|593012587|FG000|Overall Study|Physician discretion|3|||
164176969|NCT00558896|593012588|FG001|Overall Study|Physician discretion|2|||
164176970|NCT00558896|593012589|FG002|Overall Study|Physician discretion|1|||
164176971|NCT00558896|593012590|FG003|Overall Study|Physician discretion|2|||
164176972|NCT00558896|593012591|FG004|Overall Study|Physician discretion|1|||
164176973|NCT00558896|593012592|FG005|Overall Study|Physician discretion|3|||
164176974|NCT00558896|593012593|FG006|Overall Study|Physician discretion|3|||
164176975|NCT00558896|593012587|FG000|Overall Study|Continues on treatment|10|||
164176976|NCT00558896|593012588|FG001|Overall Study|Continues on treatment|1|||
164176977|NCT00558896|593012589|FG002|Overall Study|Continues on treatment|0|||
164176978|NCT00558896|593012590|FG003|Overall Study|Continues on treatment|1|||
164176979|NCT00558896|593012591|FG004|Overall Study|Continues on treatment|9|||
164176980|NCT00558896|593012592|FG005|Overall Study|Continues on treatment|25|||
164176981|NCT00558896|593012593|FG006|Overall Study|Continues on treatment|6|||
164176982|NCT00723190|593012596|FG000|Overall Study|Withdrawal by Subject|45|||
164176983|NCT00723190|593012596|FG000|Overall Study|Lost to Follow-up|37|||
164176984|NCT00723190|593012596|FG000|Overall Study|Adverse Event|18|||
164176985|NCT00723190|593012596|FG000|Overall Study|Lack of Efficacy|16|||
164176986|NCT00723190|593012596|FG000|Overall Study|Protocol Violation|15|||
164176987|NCT00723190|593012596|FG000|Overall Study|Other-Premature Discontinuation|9|||
164176988|NCT00723190|593012596|FG000|Overall Study|Other-Not included in safety population|2|||
164176989|NCT03181503|593012597|FG000|Overall Study|Adverse Event|2|||
164176990|NCT03181503|593012598|FG001|Overall Study|Adverse Event|2|||
164176991|NCT03181503|593012597|FG000|Overall Study|Protocol Violation|1|||
164176992|NCT03181503|593012598|FG001|Overall Study|Protocol Violation|0|||
164176993|NCT03181503|593012597|FG000|Overall Study|Withdrawal by Subject|3|||
164176994|NCT03181503|593012598|FG001|Overall Study|Withdrawal by Subject|0|||
164176995|NCT03181503|593012597|FG000|Overall Study|Lost to Follow-up|1|||
164176996|NCT03181503|593012598|FG001|Overall Study|Lost to Follow-up|1|||
164176997|NCT00767039|593012602|FG000|Overall Study|Death|5|||
164176998|NCT00767039|593012603|FG001|Overall Study|Death|2|||
164176999|NCT02505334|593012604|FG000|Main Treatment Period|Adverse Event|3|||
164177000|NCT02505334|593012605|FG001|Main Treatment Period|Adverse Event|3|||
164177001|NCT02505334|593012604|FG000|Main Treatment Period|Lack of Efficacy|7|||
164177002|NCT02505334|593012605|FG001|Main Treatment Period|Lack of Efficacy|17|||
164177003|NCT02505334|593012604|FG000|Main Treatment Period|Protocol Violation|0|||
164177004|NCT02505334|593012605|FG001|Main Treatment Period|Protocol Violation|1|||
164177005|NCT02505334|593012604|FG000|Main Treatment Period|Withdrawal by Subject|1|||
164177006|NCT02505334|593012605|FG001|Main Treatment Period|Withdrawal by Subject|8|||
164177007|NCT02505334|593012604|FG000|Main Treatment Period|Unclassified|4|||
164177008|NCT02505334|593012605|FG001|Main Treatment Period|Unclassified|10|||
164177009|NCT02505334|593012604|FG000|Extension Treatment Period|Adverse Event|5|||
164177010|NCT02505334|593012605|FG001|Extension Treatment Period|Adverse Event|0|||
164177011|NCT02505334|593012604|FG000|Extension Treatment Period|Lack of Efficacy|4|||
164177012|NCT02505334|593012605|FG001|Extension Treatment Period|Lack of Efficacy|0|||
164177013|NCT02505334|593012604|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
164177014|NCT02505334|593012605|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
164177015|NCT02505334|593012604|FG000|Extension Treatment Period|Unclassified|3|||
164177016|NCT02505334|593012605|FG001|Extension Treatment Period|Unclassified|0|||
164177017|NCT01549041|593012610|FG000|Overall Study|Lack of Efficacy|2|||
164177018|NCT01549041|593012611|FG001|Overall Study|Lack of Efficacy|4|||
164177019|NCT01549041|593012610|FG000|Overall Study|Adverse Event|0|||
164177020|NCT01549041|593012611|FG001|Overall Study|Adverse Event|4|||
164177021|NCT04472026|593012616|FG000|Overall Study|Lost to Follow-up|5|||
164177022|NCT01404208|593012617|FG000|Overall Study|Discontinued|3|||
164177023|NCT01404208|593012618|FG001|Overall Study|Discontinued|0|||
164177024|NCT02382796|593012619|FG000|Overall Study|Global deterioration of health status|1|||
164177025|NCT02382796|593012619|FG000|Overall Study|Objective progression or relapse|3|||
164177026|NCT02382796|593012619|FG000|Overall Study|Commercial dacomitinib became available|3|||
164177027|NCT03077659|593012620|FG000|Overall Study|Withdrawal by Subject|0|||
164177028|NCT03077659|593012621|FG001|Overall Study|Withdrawal by Subject|0|||
164177029|NCT03077659|593012622|FG002|Overall Study|Withdrawal by Subject|1|||
164177030|NCT02258542|593012629|FG000|Overall Study|eg. not made to the visit|7|||
164177031|NCT02258542|593012630|FG001|Overall Study|eg. not made to the visit|4|||
164177032|NCT02258542|593012631|FG002|Overall Study|eg. not made to the visit|0|||
164177033|NCT02258542|593012632|FG003|Overall Study|eg. not made to the visit|1|||
164177034|NCT02258542|593012629|FG000|Overall Study|study specific discount. criteria|1|||
164177035|NCT02258542|593012630|FG001|Overall Study|study specific discount. criteria|1|||
164177036|NCT02258542|593012631|FG002|Overall Study|study specific discount. criteria|0|||
164177037|NCT02258542|593012632|FG003|Overall Study|study specific discount. criteria|0|||
164177038|NCT02258542|593012629|FG000|Overall Study|Withdrawal by Subject|20|||
164177039|NCT02258542|593012630|FG001|Overall Study|Withdrawal by Subject|20|||
164177040|NCT02258542|593012631|FG002|Overall Study|Withdrawal by Subject|7|||
164177041|NCT02258542|593012632|FG003|Overall Study|Withdrawal by Subject|1|||
164177042|NCT02258542|593012629|FG000|Overall Study|Lost to Follow-up|5|||
164177043|NCT02258542|593012630|FG001|Overall Study|Lost to Follow-up|12|||
164177044|NCT02258542|593012631|FG002|Overall Study|Lost to Follow-up|1|||
164177045|NCT02258542|593012632|FG003|Overall Study|Lost to Follow-up|2|||
164177046|NCT02258542|593012629|FG000|Overall Study|Death|5|||
164177047|NCT02258542|593012630|FG001|Overall Study|Death|4|||
164177048|NCT02258542|593012631|FG002|Overall Study|Death|0|||
164177049|NCT02258542|593012632|FG003|Overall Study|Death|1|||
164177050|NCT02258542|593012629|FG000|Overall Study|Adverse Event|3|||
164177051|NCT02258542|593012630|FG001|Overall Study|Adverse Event|4|||
164177052|NCT02258542|593012631|FG002|Overall Study|Adverse Event|0|||
164177053|NCT02258542|593012632|FG003|Overall Study|Adverse Event|0|||
164177054|NCT02258542|593012629|FG000|Overall Study|Protocol Violation|1|||
164177055|NCT02258542|593012630|FG001|Overall Study|Protocol Violation|2|||
164177056|NCT02258542|593012631|FG002|Overall Study|Protocol Violation|0|||
164177057|NCT02258542|593012632|FG003|Overall Study|Protocol Violation|0|||
164177058|NCT02258542|593012629|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164177059|NCT02258542|593012630|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
164177060|NCT02258542|593012631|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
164177061|NCT02258542|593012632|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
164177062|NCT04068688|593012633|FG000|Overall Study|Lost to Follow-up|1|||
164177063|NCT04068688|593012634|FG001|Overall Study|Lost to Follow-up|1|||
164177064|NCT04068688|593012635|FG002|Overall Study|Lost to Follow-up|0|||
164177065|NCT04068688|593012636|FG003|Overall Study|Lost to Follow-up|0|||
164177066|NCT04068688|593012637|FG004|Overall Study|Lost to Follow-up|5|||
164177067|NCT04068688|593012638|FG005|Overall Study|Lost to Follow-up|5|||
164177068|NCT04068688|593012639|FG006|Overall Study|Lost to Follow-up|0|||
164177069|NCT04068688|593012640|FG007|Overall Study|Lost to Follow-up|0|||
164177070|NCT04068688|593012641|FG008|Overall Study|Lost to Follow-up|1|||
164177071|NCT04068688|593012642|FG009|Overall Study|Lost to Follow-up|0|||
164177072|NCT04068688|593012633|FG000|Overall Study|Withdrawal by Subject|1|||
164177073|NCT04068688|593012634|FG001|Overall Study|Withdrawal by Subject|1|||
164177074|NCT04068688|593012635|FG002|Overall Study|Withdrawal by Subject|0|||
164177075|NCT04068688|593012636|FG003|Overall Study|Withdrawal by Subject|0|||
164177076|NCT04068688|593012637|FG004|Overall Study|Withdrawal by Subject|0|||
164177077|NCT04068688|593012638|FG005|Overall Study|Withdrawal by Subject|0|||
164177078|NCT04068688|593012639|FG006|Overall Study|Withdrawal by Subject|0|||
164177079|NCT04068688|593012640|FG007|Overall Study|Withdrawal by Subject|0|||
164177080|NCT04068688|593012641|FG008|Overall Study|Withdrawal by Subject|0|||
164177081|NCT04068688|593012642|FG009|Overall Study|Withdrawal by Subject|0|||
164177082|NCT04068688|593012633|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
164177083|NCT04068688|593012634|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
164177084|NCT04068688|593012635|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
164177085|NCT04068688|593012636|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
164177086|NCT04068688|593012637|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
164177087|NCT04068688|593012638|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
164177088|NCT04068688|593012639|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
164177089|NCT04068688|593012640|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
164177090|NCT04068688|593012641|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
164177091|NCT04068688|593012642|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
164177092|NCT04679051|593012643|FG000|Overall Study|felt tired after restricted time in bed|3|||
164177093|NCT04679051|593012644|FG001|Overall Study|felt tired after restricted time in bed|0|||
164177094|NCT04679051|593012643|FG000|Overall Study|discomfort with blood pressure cuff|2|||
164177095|NCT04679051|593012644|FG001|Overall Study|discomfort with blood pressure cuff|0|||
164177096|NCT04679051|593012643|FG000|Overall Study|scheduling conflict|1|||
164177097|NCT04679051|593012644|FG001|Overall Study|scheduling conflict|1|||
164177098|NCT04679051|593012643|FG000|Overall Study|Protocol Violation|0|||
164177099|NCT04679051|593012644|FG001|Overall Study|Protocol Violation|4|||
164177100|NCT02772276|593012645|FG000|Overall Study|Lost to Follow-up|0|||
164177101|NCT02772276|593012646|FG001|Overall Study|Lost to Follow-up|0|||
164177102|NCT02772276|593012647|FG002|Overall Study|Lost to Follow-up|0|||
164177103|NCT02772276|593012648|FG003|Overall Study|Lost to Follow-up|0|||
164177104|NCT02772276|593012649|FG004|Overall Study|Lost to Follow-up|0|||
164177105|NCT02772276|593012650|FG005|Overall Study|Lost to Follow-up|0|||
164177106|NCT02772276|593012651|FG006|Overall Study|Lost to Follow-up|1|||
164177107|NCT02772276|593012652|FG007|Overall Study|Lost to Follow-up|0|||
164177108|NCT02772276|593012653|FG008|Overall Study|Lost to Follow-up|0|||
164177109|NCT02772276|593012654|FG009|Overall Study|Lost to Follow-up|0|||
164177110|NCT02772276|593012655|FG010|Overall Study|Lost to Follow-up|0|||
164177111|NCT02772276|593012656|FG011|Overall Study|Lost to Follow-up|0|||
164177112|NCT02772276|593012657|FG012|Overall Study|Lost to Follow-up|0|||
164177113|NCT02772276|593012645|FG000|Overall Study|Withdrew consent|0|||
164177114|NCT02772276|593012646|FG001|Overall Study|Withdrew consent|0|||
164177115|NCT02772276|593012647|FG002|Overall Study|Withdrew consent|0|||
164177116|NCT02772276|593012648|FG003|Overall Study|Withdrew consent|0|||
164177117|NCT02772276|593012649|FG004|Overall Study|Withdrew consent|0|||
164177118|NCT02772276|593012650|FG005|Overall Study|Withdrew consent|0|||
164177119|NCT02772276|593012651|FG006|Overall Study|Withdrew consent|0|||
164177120|NCT02772276|593012652|FG007|Overall Study|Withdrew consent|1|||
164177121|NCT02772276|593012653|FG008|Overall Study|Withdrew consent|0|||
164177122|NCT02772276|593012654|FG009|Overall Study|Withdrew consent|0|||
164177123|NCT02772276|593012655|FG010|Overall Study|Withdrew consent|0|||
164177124|NCT02772276|593012656|FG011|Overall Study|Withdrew consent|0|||
164177125|NCT02772276|593012657|FG012|Overall Study|Withdrew consent|0|||
164177126|NCT00550862|593012658|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
164177127|NCT00550862|593012659|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
164177128|NCT00550862|593012660|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
164177129|NCT00550862|593012661|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
164177130|NCT00550862|593012662|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
164177131|NCT00550862|593012658|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
164177132|NCT00550862|593012659|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
164177133|NCT00550862|593012660|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
164177134|NCT00550862|593012661|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
164177135|NCT00550862|593012662|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
164177136|NCT00550862|593012658|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
164177137|NCT00550862|593012659|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
164177138|NCT00550862|593012660|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
164177139|NCT00550862|593012661|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
164177140|NCT00550862|593012662|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
164177141|NCT00550862|593012658|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
164177142|NCT00550862|593012659|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
164177143|NCT00550862|593012660|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
164177144|NCT00550862|593012661|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
164177145|NCT00550862|593012662|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
164177146|NCT00550862|593012658|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
164177147|NCT00550862|593012659|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
164177148|NCT00550862|593012660|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
164177149|NCT00550862|593012661|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
164177150|NCT00550862|593012662|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
164177151|NCT00550862|593012658|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
164177152|NCT00550862|593012659|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
164177153|NCT00550862|593012660|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
164177154|NCT00550862|593012661|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
164177155|NCT00550862|593012662|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
164177156|NCT00550862|593012658|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
164177157|NCT00550862|593012659|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
164177158|NCT00550862|593012660|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
164177159|NCT00550862|593012661|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
164177160|NCT00550862|593012662|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
164177161|NCT00550862|593012658|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
164177162|NCT00550862|593012659|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
164177163|NCT00550862|593012660|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
164177164|NCT00550862|593012661|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
164177165|NCT00550862|593012662|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
164177166|NCT00550862|593012658|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
164177167|NCT00550862|593012659|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
164177168|NCT00550862|593012660|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
164177169|NCT00550862|593012661|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
164177170|NCT00550862|593012662|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
164177171|NCT00550862|593012658|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
164177172|NCT00550862|593012659|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
164177173|NCT00550862|593012660|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
164177174|NCT00550862|593012661|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
164177175|NCT00550862|593012662|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
164177176|NCT02248974|593012663|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
164177177|NCT02248974|593012664|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
164177178|NCT02248974|593012663|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
164177179|NCT02248974|593012664|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
164177180|NCT02248974|593012663|FG000|1-Day Follow-Up|Enrolled in another study|1|||
164177181|NCT02248974|593012664|FG001|1-Day Follow-Up|Enrolled in another study|0|||
164177182|NCT02248974|593012663|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
164177183|NCT02248974|593012664|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
164177184|NCT02248974|593012663|FG000|1-Week Follow-Up|Enrolled in another study|1|||
164177185|NCT02248974|593012664|FG001|1-Week Follow-Up|Enrolled in another study|1|||
164177186|NCT02248974|593012663|FG000|1-Week Follow-Up|Transferred to another facility|1|||
164177187|NCT02248974|593012664|FG001|1-Week Follow-Up|Transferred to another facility|0|||
164177188|NCT02248974|593012663|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
164177189|NCT02248974|593012664|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
164177190|NCT02248974|593012663|FG000|1-Week Follow-Up|Death|1|||
164177191|NCT02248974|593012664|FG001|1-Week Follow-Up|Death|1|||
164177192|NCT02248974|593012663|FG000|1-Week Follow-Up|Excluded because of age|0|||
164177193|NCT02248974|593012664|FG001|1-Week Follow-Up|Excluded because of age|1|||
164177194|NCT02248974|593012663|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
164177195|NCT02248974|593012664|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
164177196|NCT02248974|593012663|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
164177197|NCT02248974|593012664|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
164177198|NCT02248974|593012663|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
164177199|NCT02248974|593012664|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
164177200|NCT02248974|593012663|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
164177201|NCT02248974|593012664|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
164177202|NCT02248974|593012663|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
164177203|NCT02248974|593012664|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
164177204|NCT03488225|593012665|FG000|Overall Study|Off Protocol Therapy|2|||
164177205|NCT03488225|593012665|FG000|Overall Study|Stem Cell Transplant|2|||
164177206|NCT00085098|593012668|FG000|Overall Study|Withdrawal by Subject|0|||
164177207|NCT00085098|593012669|FG001|Overall Study|Withdrawal by Subject|1|||
164177208|NCT00085098|593012668|FG000|Overall Study|Ineligible|1|||
164177209|NCT00085098|593012669|FG001|Overall Study|Ineligible|1|||
164177210|NCT01935700|593012670|FG000|Overall Study|Withdrawal by Subject|1|||
164177211|NCT01935700|593012671|FG001|Overall Study|Withdrawal by Subject|0|||
164177212|NCT01935700|593012670|FG000|Overall Study|Physician Decision|4|||
164177213|NCT01935700|593012671|FG001|Overall Study|Physician Decision|0|||
164177214|NCT01273155|593012674|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
164177215|NCT01273155|593012675|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
164177216|NCT01273155|593012676|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
164177217|NCT01273155|593012677|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
164177218|NCT01273155|593012678|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
164177219|NCT01273155|593012679|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
164177220|NCT01273155|593012680|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
164177221|NCT01273155|593012674|FG000|Overall Study|Change in liver function/no longer eval.|0|||
164177222|NCT01273155|593012675|FG001|Overall Study|Change in liver function/no longer eval.|1|||
164177223|NCT01273155|593012676|FG002|Overall Study|Change in liver function/no longer eval.|0|||
164177224|NCT01273155|593012677|FG003|Overall Study|Change in liver function/no longer eval.|0|||
164177225|NCT01273155|593012678|FG004|Overall Study|Change in liver function/no longer eval.|1|||
164177226|NCT01273155|593012679|FG005|Overall Study|Change in liver function/no longer eval.|0|||
164177227|NCT01273155|593012680|FG006|Overall Study|Change in liver function/no longer eval.|0|||
164177228|NCT01273155|593012674|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
164177229|NCT01273155|593012675|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
164177230|NCT01273155|593012676|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
164177231|NCT01273155|593012677|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
164177232|NCT01273155|593012678|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
164177233|NCT01273155|593012679|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
164177234|NCT01273155|593012680|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
164177235|NCT01273155|593012674|FG000|Overall Study|Died during Cycle 1|0|||
164177236|NCT01273155|593012675|FG001|Overall Study|Died during Cycle 1|0|||
164177237|NCT01273155|593012676|FG002|Overall Study|Died during Cycle 1|1|||
164177238|NCT01273155|593012677|FG003|Overall Study|Died during Cycle 1|1|||
164177239|NCT01273155|593012678|FG004|Overall Study|Died during Cycle 1|0|||
164177240|NCT01273155|593012679|FG005|Overall Study|Died during Cycle 1|2|||
164177241|NCT01273155|593012680|FG006|Overall Study|Died during Cycle 1|2|||
164177242|NCT01273155|593012674|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
164177243|NCT01273155|593012675|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
164177244|NCT01273155|593012676|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
164177245|NCT01273155|593012677|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
164177246|NCT01273155|593012678|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
164177247|NCT01273155|593012679|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
164177248|NCT01273155|593012680|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
164177249|NCT02419612|593012681|FG000|Short-term Treatment Period|Adverse Event|1|||
164177250|NCT02419612|593012682|FG001|Short-term Treatment Period|Adverse Event|1|||
164177251|NCT02419612|593012681|FG000|Short-term Treatment Period|Death|0|||
164177252|NCT02419612|593012682|FG001|Short-term Treatment Period|Death|2|||
164177253|NCT02419612|593012681|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
164177254|NCT02419612|593012682|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
164177255|NCT02419612|593012681|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
164177256|NCT02419612|593012682|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
164177257|NCT02419612|593012681|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
164177258|NCT02419612|593012682|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
164177259|NCT02419612|593012681|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
164177260|NCT02419612|593012682|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
164177261|NCT02419612|593012681|FG000|Short-term Treatment Period|Worsening of liver function|0|||
164177262|NCT02419612|593012682|FG001|Short-term Treatment Period|Worsening of liver function|1|||
164177263|NCT02419612|593012681|FG000|Short-term Treatment Period|Subject moved out of state|0|||
164177264|NCT02419612|593012682|FG001|Short-term Treatment Period|Subject moved out of state|1|||
164177265|NCT02419612|593012681|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
164177266|NCT02419612|593012682|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
164177267|NCT02419612|593012681|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
164177268|NCT02419612|593012682|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
164177269|NCT02419612|593012681|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
164177270|NCT02419612|593012682|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
164177271|NCT02419612|593012681|FG000|Long-term Treatment Period|Death|0|||
164177272|NCT02419612|593012682|FG001|Long-term Treatment Period|Death|1|||
164177273|NCT02419612|593012681|FG000|Long-term Treatment Period|Adverse Event|0|||
164177274|NCT02419612|593012682|FG001|Long-term Treatment Period|Adverse Event|5|||
164177275|NCT02419612|593012681|FG000|Long-term Treatment Period|Other|4|||
164177276|NCT02419612|593012682|FG001|Long-term Treatment Period|Other|4|||
164177277|NCT02419612|593012681|FG000|Long-term Treatment Period|Subject Decision|2|||
164177278|NCT02419612|593012682|FG001|Long-term Treatment Period|Subject Decision|4|||
164177279|NCT02419612|593012681|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
164177280|NCT02419612|593012682|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
164177281|NCT00078949|593013972|FG000|Overall Study|No treated|4|||
164177282|NCT00078949|593013973|FG001|Overall Study|No treated|5|||
164177283|NCT00078949|593013974|FG002|Overall Study|No treated|3|||
164177284|NCT00078949|593013975|FG003|Overall Study|No treated|3|||
164177285|NCT00396877|593013976|FG000|Overall Study|Lost to Follow-up|2|||
164177286|NCT00396877|593013977|FG001|Overall Study|Lost to Follow-up|1|||
164177287|NCT00396877|593013976|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
164177288|NCT00396877|593013977|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
164177289|NCT02584959|593013978|FG000|Period 1|Withdrawn from study|3|||
164177290|NCT02584959|593013979|FG001|Period 1|Withdrawn from study|4|||
164177291|NCT02584959|593013980|FG002|Period 1|Withdrawn from study|0|||
164177292|NCT02584959|593013978|FG000|Period 2|Withdrawn from study|6|||
164177293|NCT02584959|593013979|FG001|Period 2|Withdrawn from study|1|||
164177294|NCT02584959|593013980|FG002|Period 2|Withdrawn from study|2|||
164177295|NCT00422422|593013981|FG000|Overall Study|Lack of Efficacy|1|||
164177296|NCT00422422|593013981|FG000|Overall Study|Protocol Violation|1|||
164177297|NCT00422422|593013981|FG000|Overall Study|Withdrawal by Subject|2|||
164177298|NCT00422422|593013981|FG000|Overall Study|SAE, non-fatal|1|||
164177299|NCT00422422|593013981|FG000|Overall Study|AE, non-serious non-fatal|5|||
164177300|NCT00926536|593013983|FG000|Overall Study|Physician Decision|1|||
164177301|NCT00926536|593013984|FG001|Overall Study|Physician Decision|2|||
164177302|NCT00435487|593013985|FG000|Overall Study|Death|3|||
164177303|NCT00435487|593013986|FG001|Overall Study|Death|4|||
164177304|NCT00435487|593013985|FG000|Overall Study|Adverse Event|0|||
164177305|NCT00435487|593013986|FG001|Overall Study|Adverse Event|3|||
164177306|NCT00435487|593013985|FG000|Overall Study|Lost to Follow-up|2|||
164177307|NCT00435487|593013986|FG001|Overall Study|Lost to Follow-up|2|||
164177308|NCT00435487|593013985|FG000|Overall Study|Other|5|||
164177309|NCT00435487|593013986|FG001|Overall Study|Other|2|||
164177310|NCT00435487|593013985|FG000|Overall Study|Withdrawal by Subject|2|||
164177311|NCT00435487|593013986|FG001|Overall Study|Withdrawal by Subject|1|||
164177312|NCT00435487|593013985|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
164177313|NCT00435487|593013986|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
164177314|NCT00435487|593013985|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
164177315|NCT00435487|593013986|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
164177316|NCT03301844|593013988|FG000|Overall Study|suspected colon cancer|1|||
164177317|NCT03301844|593013989|FG001|Overall Study|suspected colon cancer|1|||
164177318|NCT05087966|593013990|FG000|Overall Study|Lost to Follow-up|1|||
164177319|NCT05087966|593013990|FG000|Overall Study|Withdrawal by Subject|5|||
164177320|NCT01267201|593013992|FG000|First Intervention Period|Withdrawal by Subject|1|||
164177321|NCT01267201|593013993|FG001|First Intervention Period|Withdrawal by Subject|0|||
164177322|NCT01267201|593013994|FG002|First Intervention Period|Withdrawal by Subject|0|||
164177323|NCT01267201|593013995|FG003|First Intervention Period|Withdrawal by Subject|0|||
164177324|NCT01267201|593013996|FG004|First Intervention Period|Withdrawal by Subject|0|||
164177325|NCT01267201|593013997|FG005|First Intervention Period|Withdrawal by Subject|0|||
164177326|NCT01267201|593013992|FG000|Second Intervention Period|Withdrawal by Subject|0|||
164177327|NCT01267201|593013993|FG001|Second Intervention Period|Withdrawal by Subject|1|||
164177328|NCT01267201|593013994|FG002|Second Intervention Period|Withdrawal by Subject|0|||
164177329|NCT01267201|593013995|FG003|Second Intervention Period|Withdrawal by Subject|0|||
164177330|NCT01267201|593013996|FG004|Second Intervention Period|Withdrawal by Subject|0|||
164177331|NCT01267201|593013997|FG005|Second Intervention Period|Withdrawal by Subject|0|||
164177332|NCT00501059|593013998|FG000|Overall Study|Protocol Violation|80|||
164177333|NCT00501059|593013999|FG001|Overall Study|Protocol Violation|69|||
164177334|NCT00501059|593013998|FG000|Overall Study|Death|140|||
164177335|NCT00501059|593013999|FG001|Overall Study|Death|137|||
164177336|NCT00501059|593013998|FG000|Overall Study|Other|236|||
164177337|NCT00501059|593013999|FG001|Overall Study|Other|239|||
164177338|NCT00501059|593013998|FG000|Overall Study|Missing end-of-study page|91|||
164177339|NCT00501059|593013999|FG001|Overall Study|Missing end-of-study page|92|||
164177340|NCT00501059|593013998|FG000|Overall Study|Clinical endpoint reached|110|||
164177341|NCT00501059|593013999|FG001|Overall Study|Clinical endpoint reached|123|||
164177342|NCT00501059|593013998|FG000|Overall Study|Insufficient therapeutic effect|4|||
164177343|NCT00501059|593013999|FG001|Overall Study|Insufficient therapeutic effect|5|||
164177344|NCT00501059|593013998|FG000|Overall Study|Consent withdrawn by subject|817|||
164177345|NCT00501059|593013999|FG001|Overall Study|Consent withdrawn by subject|873|||
164177346|NCT00501059|593013998|FG000|Overall Study|Non-compliant with study treatment|23|||
164177347|NCT00501059|593013999|FG001|Overall Study|Non-compliant with study treatment|16|||
164177348|NCT00501059|593013998|FG000|Overall Study|Reason not given|3|||
164177349|NCT00501059|593013999|FG001|Overall Study|Reason not given|1|||
164177350|NCT00501059|593013998|FG000|Overall Study|Adverse Event|129|||
164177351|NCT00501059|593013999|FG001|Overall Study|Adverse Event|122|||
164177352|NCT00501059|593013998|FG000|Overall Study|Lost to Follow-up|210|||
164177353|NCT00501059|593013999|FG001|Overall Study|Lost to Follow-up|198|||
164177354|NCT00501059|593013998|FG000|Overall Study|Not treated|25|||
164177355|NCT00501059|593013999|FG001|Overall Study|Not treated|17|||
164177356|NCT00483704|593014000|FG000|Randomization|Withdrawal by Subject|19|||
164177357|NCT00483704|593014001|FG001|Randomization|Withdrawal by Subject|28|||
164177358|NCT00483704|593014002|FG002|Randomization|Withdrawal by Subject|18|||
164177359|NCT00483704|593014000|FG000|Randomization|Protocol Violation|14|||
164177360|NCT00483704|593014001|FG001|Randomization|Protocol Violation|25|||
164177361|NCT00483704|593014002|FG002|Randomization|Protocol Violation|22|||
164177362|NCT00483704|593014000|FG000|Randomization|Lost to Follow-up|14|||
164177363|NCT00483704|593014001|FG001|Randomization|Lost to Follow-up|14|||
164177364|NCT00483704|593014002|FG002|Randomization|Lost to Follow-up|19|||
164177365|NCT00483704|593014000|FG000|Randomization|Pregnancy|1|||
164177366|NCT00483704|593014001|FG001|Randomization|Pregnancy|0|||
164177367|NCT00483704|593014002|FG002|Randomization|Pregnancy|0|||
164177368|NCT00483704|593014000|FG000|Randomization|Physician Decision|2|||
164177369|NCT00483704|593014001|FG001|Randomization|Physician Decision|4|||
164177370|NCT00483704|593014002|FG002|Randomization|Physician Decision|0|||
164177371|NCT00483704|593014000|FG000|Randomization|Progressive disease|0|||
164177372|NCT00483704|593014001|FG001|Randomization|Progressive disease|0|||
164177373|NCT00483704|593014002|FG002|Randomization|Progressive disease|1|||
164177374|NCT00483704|593014000|FG000|Randomization|Lack of qualifying migraines|21|||
164177375|NCT00483704|593014001|FG001|Randomization|Lack of qualifying migraines|25|||
164177376|NCT00483704|593014002|FG002|Randomization|Lack of qualifying migraines|31|||
164177377|NCT00483704|593014000|FG000|Treatment|Lack of qualifying migraines|101|||
164177378|NCT00483704|593014001|FG001|Treatment|Lack of qualifying migraines|99|||
164177379|NCT00483704|593014002|FG002|Treatment|Lack of qualifying migraines|116|||
164177380|NCT00483704|593014000|FG000|Treatment|Adverse Event|3|||
164177381|NCT00483704|593014001|FG001|Treatment|Adverse Event|5|||
164177382|NCT00483704|593014002|FG002|Treatment|Adverse Event|4|||
164177383|NCT00483704|593014000|FG000|Treatment|Withdrawal by Subject|16|||
164177384|NCT00483704|593014001|FG001|Treatment|Withdrawal by Subject|12|||
164177385|NCT00483704|593014002|FG002|Treatment|Withdrawal by Subject|21|||
164177386|NCT00483704|593014000|FG000|Treatment|Protocol Violation|6|||
164177387|NCT00483704|593014001|FG001|Treatment|Protocol Violation|3|||
164177388|NCT00483704|593014002|FG002|Treatment|Protocol Violation|5|||
164177389|NCT00483704|593014000|FG000|Treatment|Lost to Follow-up|2|||
164177390|NCT00483704|593014001|FG001|Treatment|Lost to Follow-up|7|||
164177391|NCT00483704|593014002|FG002|Treatment|Lost to Follow-up|5|||
164177392|NCT00483704|593014000|FG000|Treatment|Lack of Efficacy|1|||
164177393|NCT00483704|593014001|FG001|Treatment|Lack of Efficacy|1|||
164177394|NCT00483704|593014002|FG002|Treatment|Lack of Efficacy|1|||
164177395|NCT00483704|593014000|FG000|Treatment|Pregnancy|0|||
164177396|NCT00483704|593014001|FG001|Treatment|Pregnancy|1|||
164177397|NCT00483704|593014002|FG002|Treatment|Pregnancy|0|||
164177398|NCT00483704|593014000|FG000|Treatment|Physician Decision|0|||
164177399|NCT00483704|593014001|FG001|Treatment|Physician Decision|1|||
164177400|NCT00483704|593014002|FG002|Treatment|Physician Decision|4|||
164177401|NCT02968433|593014004|FG000|Overall Study|Withdrawal by Subject|1|||
164177402|NCT00875433|593014005|FG000|Overall Study|Progressive disease|41|||
164177403|NCT00875433|593014005|FG000|Overall Study|Other Adverse Event|14|||
164177404|NCT00875433|593014005|FG000|Overall Study|Withdrawal by Subject|2|||
164177405|NCT00875433|593014005|FG000|Overall Study|Other|3|||
164177406|NCT04272606|593014006|FG000|Overall Study|Protocol Violation|1|||
164177407|NCT04272606|593014007|FG001|Overall Study|Protocol Violation|1|||
164177408|NCT04272606|593014006|FG000|Overall Study|Physician Decision|0|||
164177409|NCT04272606|593014007|FG001|Overall Study|Physician Decision|1|||
164177410|NCT00725101|593014008|FG000|Overall Study|Death|3|||
164177411|NCT00725101|593014008|FG000|Overall Study|Lost to Follow-up|353|||
164177412|NCT00725101|593014008|FG000|Overall Study|Protocol Violation|1|||
164177413|NCT00725101|593014008|FG000|Overall Study|Withdrawal by Subject|127|||
164177414|NCT00725101|593014008|FG000|Overall Study|not specified/no reason given|11|||
164177415|NCT03912428|593014018|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
164177416|NCT03912428|593014019|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
164177417|NCT03912428|593014020|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
164177418|NCT03912428|593014021|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
164177419|NCT03912428|593014018|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
164177420|NCT03912428|593014019|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
164177421|NCT03912428|593014020|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
164177422|NCT03912428|593014021|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
164177423|NCT03912428|593014018|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
164177424|NCT03912428|593014019|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
164177425|NCT03912428|593014020|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
164177426|NCT03912428|593014021|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
164177427|NCT02537431|593014022|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
164177428|NCT03430895|593014033|FG000|Overall Study|Not Treated|2|||
164177429|NCT01037127|593014037|FG000|Overall Study|Lost to Follow-up|2|||
164177430|NCT01037127|593014038|FG001|Overall Study|Lost to Follow-up|4|||
164177431|NCT01037127|593014037|FG000|Overall Study|Physician Decision|1|||
164177432|NCT01037127|593014038|FG001|Overall Study|Physician Decision|0|||
164177433|NCT01037127|593014037|FG000|Overall Study|Study Closed Terminated|2|||
164177434|NCT01037127|593014038|FG001|Overall Study|Study Closed Terminated|17|||
164177435|NCT00954512|593014042|FG000|Overall Study|Withdrawal by Subject|0|||
164177436|NCT00954512|593014043|FG001|Overall Study|Withdrawal by Subject|0|||
164177437|NCT00954512|593014044|FG002|Overall Study|Withdrawal by Subject|0|||
164177438|NCT00954512|593014045|FG003|Overall Study|Withdrawal by Subject|0|||
164177439|NCT00954512|593014046|FG004|Overall Study|Withdrawal by Subject|0|||
164177440|NCT00954512|593014047|FG005|Overall Study|Withdrawal by Subject|1|||
164177441|NCT00954512|593014042|FG000|Overall Study|Adverse Event|0|||
164177442|NCT00954512|593014043|FG001|Overall Study|Adverse Event|0|||
164177443|NCT00954512|593014044|FG002|Overall Study|Adverse Event|0|||
164177444|NCT00954512|593014045|FG003|Overall Study|Adverse Event|0|||
164177445|NCT00954512|593014046|FG004|Overall Study|Adverse Event|1|||
164177446|NCT00954512|593014047|FG005|Overall Study|Adverse Event|2|||
164177447|NCT00954512|593014042|FG000|Overall Study|Physician Decision|0|||
164177448|NCT00954512|593014043|FG001|Overall Study|Physician Decision|1|||
164177449|NCT00954512|593014044|FG002|Overall Study|Physician Decision|0|||
164177450|NCT00954512|593014045|FG003|Overall Study|Physician Decision|1|||
164177451|NCT00954512|593014046|FG004|Overall Study|Physician Decision|0|||
164177452|NCT00954512|593014047|FG005|Overall Study|Physician Decision|0|||
164177453|NCT00954512|593014042|FG000|Overall Study|Symptomatic Deterioration|0|||
164177454|NCT00954512|593014043|FG001|Overall Study|Symptomatic Deterioration|1|||
164177455|NCT00954512|593014044|FG002|Overall Study|Symptomatic Deterioration|0|||
164177456|NCT00954512|593014045|FG003|Overall Study|Symptomatic Deterioration|0|||
164177457|NCT00954512|593014046|FG004|Overall Study|Symptomatic Deterioration|2|||
164177458|NCT00954512|593014047|FG005|Overall Study|Symptomatic Deterioration|0|||
164177459|NCT00954512|593014042|FG000|Overall Study|Progression of Disease|2|||
164177460|NCT00954512|593014043|FG001|Overall Study|Progression of Disease|1|||
164177461|NCT00954512|593014044|FG002|Overall Study|Progression of Disease|0|||
164177462|NCT00954512|593014045|FG003|Overall Study|Progression of Disease|1|||
164177463|NCT00954512|593014046|FG004|Overall Study|Progression of Disease|1|||
164177464|NCT00954512|593014047|FG005|Overall Study|Progression of Disease|1|||
164177465|NCT04814368|593014048|FG000|Overall Study|Study Terminated by Sponsor|0|||
164177466|NCT04814368|593014049|FG001|Overall Study|Study Terminated by Sponsor|3|||
164177467|NCT04814368|593014050|FG002|Overall Study|Study Terminated by Sponsor|0|||
164177468|NCT04814368|593014051|FG003|Overall Study|Study Terminated by Sponsor|2|||
164177469|NCT04814368|593014048|FG000|Overall Study|Subject Decision|1|||
164177470|NCT04814368|593014049|FG001|Overall Study|Subject Decision|2|||
164177471|NCT04814368|593014050|FG002|Overall Study|Subject Decision|0|||
164177472|NCT04814368|593014051|FG003|Overall Study|Subject Decision|0|||
164177473|NCT01173055|593014053|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
164177474|NCT01173055|593014054|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
164177475|NCT01173055|593014053|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
164177476|NCT01173055|593014054|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
164177477|NCT04325698|593014055|FG000|Overall Study|Study Terminated By Sponsor|1|||
164177478|NCT04325698|593014056|FG001|Overall Study|Study Terminated By Sponsor|1|||
164177479|NCT04325698|593014055|FG000|Overall Study|Withdrawal by Subject|0|||
164177480|NCT04325698|593014056|FG001|Overall Study|Withdrawal by Subject|2|||
164177481|NCT04253782|593014057|FG000|Overall Study|Death|2|||
164177482|NCT04253782|593014058|FG001|Overall Study|Death|0|||
164177483|NCT04216589|593014060|FG000|Overall Study|Withdrawal by Subject|2|||
164177484|NCT04216589|593014060|FG000|Overall Study|Protocol Violation|1|||
164177485|NCT04216589|593014060|FG000|Overall Study|Incarceration|1|||
164177486|NCT02326298|593014065|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177487|NCT02326298|593014066|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177488|NCT02326298|593014067|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
164177489|NCT02326298|593014068|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177490|NCT02326298|593014069|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177491|NCT02326298|593014070|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177492|NCT02326298|593014071|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177493|NCT02326298|593014072|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177494|NCT02326298|593014073|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177495|NCT02326298|593014074|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177496|NCT02326298|593014075|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177497|NCT02326298|593014076|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177498|NCT02326298|593014077|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177499|NCT02326298|593014078|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177500|NCT02326298|593014065|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
164177501|NCT02326298|593014066|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177502|NCT02326298|593014067|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177503|NCT02326298|593014068|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177504|NCT02326298|593014069|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177505|NCT02326298|593014070|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177506|NCT02326298|593014071|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177507|NCT02326298|593014072|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177508|NCT02326298|593014073|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177509|NCT02326298|593014074|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177510|NCT02326298|593014075|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177511|NCT02326298|593014076|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177512|NCT02326298|593014077|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177513|NCT02326298|593014078|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177514|NCT02326298|593014065|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
164177515|NCT02326298|593014066|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
164177516|NCT02326298|593014067|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164177517|NCT02326298|593014068|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164177518|NCT02326298|593014069|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164177519|NCT02326298|593014070|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164177520|NCT02326298|593014071|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164177521|NCT02326298|593014072|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164177522|NCT02326298|593014073|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164177523|NCT02326298|593014074|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164177524|NCT02326298|593014075|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164177525|NCT02326298|593014076|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164177526|NCT02326298|593014077|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164177527|NCT02326298|593014078|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164177528|NCT02326298|593014065|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
164177529|NCT02326298|593014066|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
164177530|NCT02326298|593014067|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164177531|NCT02326298|593014068|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164177532|NCT02326298|593014069|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164177533|NCT02326298|593014070|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164177534|NCT02326298|593014071|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164177535|NCT02326298|593014072|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164177536|NCT02326298|593014073|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164177537|NCT02326298|593014074|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164177538|NCT02326298|593014075|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164177539|NCT02326298|593014076|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164177540|NCT02326298|593014077|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164177541|NCT02326298|593014078|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164177542|NCT02326298|593014065|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177543|NCT02326298|593014066|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177544|NCT02326298|593014067|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
164177545|NCT02326298|593014068|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177546|NCT02326298|593014069|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177547|NCT02326298|593014070|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177548|NCT02326298|593014071|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177549|NCT02326298|593014072|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177550|NCT02326298|593014073|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177551|NCT02326298|593014074|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177552|NCT02326298|593014075|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177553|NCT02326298|593014076|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177554|NCT02326298|593014077|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177555|NCT02326298|593014078|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177556|NCT02326298|593014065|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164177557|NCT02326298|593014066|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164177558|NCT02326298|593014067|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164177559|NCT02326298|593014068|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164177560|NCT02326298|593014069|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164177561|NCT02326298|593014070|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164177562|NCT02326298|593014071|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
164177563|NCT02326298|593014072|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164177564|NCT02326298|593014073|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164177565|NCT02326298|593014074|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164177566|NCT02326298|593014075|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164177567|NCT02326298|593014076|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164177568|NCT02326298|593014077|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164177569|NCT02326298|593014078|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164177570|NCT02326298|593014065|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
164177571|NCT02326298|593014066|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
164177572|NCT02326298|593014067|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
164177573|NCT02326298|593014068|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
164177574|NCT02326298|593014069|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
164177575|NCT02326298|593014070|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
164177576|NCT02326298|593014071|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
164177577|NCT02326298|593014072|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
164177578|NCT02326298|593014073|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
164177579|NCT02326298|593014074|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
164177580|NCT02326298|593014075|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
164177581|NCT02326298|593014076|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
164177582|NCT02326298|593014077|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
164177583|NCT02326298|593014078|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
164177584|NCT02326298|593014065|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177585|NCT02326298|593014066|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177586|NCT02326298|593014067|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177587|NCT02326298|593014068|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177588|NCT02326298|593014069|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177589|NCT02326298|593014070|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
164177590|NCT02326298|593014071|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177591|NCT02326298|593014072|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177592|NCT02326298|593014073|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177593|NCT02326298|593014074|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177594|NCT02326298|593014075|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177595|NCT02326298|593014076|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177596|NCT02326298|593014077|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177597|NCT02326298|593014078|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177598|NCT02326298|593014065|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177599|NCT02326298|593014066|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177600|NCT02326298|593014067|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177601|NCT02326298|593014068|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177602|NCT02326298|593014069|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177603|NCT02326298|593014070|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177604|NCT02326298|593014071|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
164177605|NCT02326298|593014072|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177606|NCT02326298|593014073|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177607|NCT02326298|593014074|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177608|NCT02326298|593014075|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177609|NCT02326298|593014076|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177610|NCT02326298|593014077|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177611|NCT02326298|593014078|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177612|NCT02326298|593014065|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177613|NCT02326298|593014066|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177614|NCT02326298|593014067|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177615|NCT02326298|593014068|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177616|NCT02326298|593014069|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177617|NCT02326298|593014070|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177618|NCT02326298|593014071|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177619|NCT02326298|593014072|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
164177620|NCT02326298|593014073|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177621|NCT02326298|593014074|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177622|NCT02326298|593014075|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177623|NCT02326298|593014076|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177624|NCT02326298|593014077|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177625|NCT02326298|593014078|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177626|NCT02326298|593014065|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164177627|NCT02326298|593014066|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164177628|NCT02326298|593014067|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164177629|NCT02326298|593014068|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164177630|NCT02326298|593014069|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164177631|NCT02326298|593014070|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164177632|NCT02326298|593014071|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
164177633|NCT02326298|593014072|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
164177634|NCT02326298|593014073|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164177635|NCT02326298|593014074|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164177636|NCT02326298|593014075|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164177637|NCT02326298|593014076|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164177638|NCT02326298|593014077|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164177639|NCT02326298|593014078|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164177640|NCT02326298|593014065|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177641|NCT02326298|593014066|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177642|NCT02326298|593014067|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177643|NCT02326298|593014068|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177644|NCT02326298|593014069|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177645|NCT02326298|593014070|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177646|NCT02326298|593014071|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177647|NCT02326298|593014072|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
164177648|NCT02326298|593014073|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177649|NCT02326298|593014074|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177650|NCT02326298|593014075|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177651|NCT02326298|593014076|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177652|NCT02326298|593014077|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177653|NCT02326298|593014078|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177654|NCT02326298|593014065|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177655|NCT02326298|593014066|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177656|NCT02326298|593014067|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177657|NCT02326298|593014068|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177658|NCT02326298|593014069|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177659|NCT02326298|593014070|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
164177660|NCT02326298|593014071|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177661|NCT02326298|593014072|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177662|NCT02326298|593014073|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177663|NCT02326298|593014074|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177664|NCT02326298|593014075|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177665|NCT02326298|593014076|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177666|NCT02326298|593014077|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177667|NCT02326298|593014078|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177668|NCT02326298|593014065|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
164177669|NCT02326298|593014066|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
164177670|NCT02326298|593014067|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
164177671|NCT02326298|593014068|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
164177672|NCT02326298|593014069|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
164177673|NCT02326298|593014070|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
164177674|NCT02326298|593014071|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
164177675|NCT02326298|593014072|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
164177676|NCT02326298|593014073|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
164177677|NCT02326298|593014074|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
164177678|NCT02326298|593014075|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
164177679|NCT02326298|593014076|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
164177680|NCT02326298|593014077|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
164177681|NCT02326298|593014078|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
164177682|NCT02326298|593014065|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164177683|NCT02326298|593014066|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164177684|NCT02326298|593014067|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164177685|NCT02326298|593014068|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164177686|NCT02326298|593014069|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164177687|NCT02326298|593014070|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164177688|NCT02326298|593014071|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164177689|NCT02326298|593014072|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164177690|NCT02326298|593014073|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164177691|NCT02326298|593014074|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164177692|NCT02326298|593014075|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164177693|NCT02326298|593014076|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
164177694|NCT02326298|593014077|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
164177695|NCT02326298|593014078|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164177696|NCT02326298|593014065|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164177697|NCT02326298|593014066|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164177698|NCT02326298|593014067|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164177699|NCT02326298|593014068|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164177700|NCT02326298|593014069|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164177701|NCT02326298|593014070|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164177702|NCT02326298|593014071|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164177703|NCT02326298|593014072|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164177704|NCT02326298|593014073|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164177705|NCT02326298|593014074|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164177706|NCT02326298|593014075|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164177707|NCT02326298|593014076|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
164177708|NCT02326298|593014077|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
164177709|NCT02326298|593014078|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164177710|NCT02326298|593014065|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177854|NCT05685732|593014101|FG000|Overall Study|Physician Decision|1|||
164177711|NCT02326298|593014066|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177712|NCT02326298|593014067|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177713|NCT02326298|593014068|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177714|NCT02326298|593014069|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177715|NCT02326298|593014070|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177716|NCT02326298|593014071|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177717|NCT02326298|593014072|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177718|NCT02326298|593014073|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177719|NCT02326298|593014074|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177720|NCT02326298|593014075|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177721|NCT02326298|593014076|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177722|NCT02326298|593014077|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177723|NCT02326298|593014078|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
164177724|NCT02326298|593014065|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164177725|NCT02326298|593014066|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164177726|NCT02326298|593014067|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164177727|NCT02326298|593014068|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164177728|NCT02326298|593014069|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164177729|NCT02326298|593014070|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164177730|NCT02326298|593014071|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164177731|NCT02326298|593014072|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164177732|NCT02326298|593014073|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164177733|NCT02326298|593014074|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164177734|NCT02326298|593014075|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164177735|NCT02326298|593014076|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
164177736|NCT02326298|593014077|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
164177737|NCT02326298|593014078|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
164177738|NCT02326298|593014065|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164177739|NCT02326298|593014066|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164177740|NCT02326298|593014067|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164177741|NCT02326298|593014068|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164177742|NCT02326298|593014069|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164177743|NCT02326298|593014070|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164177744|NCT02326298|593014071|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164177745|NCT02326298|593014072|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164177746|NCT02326298|593014073|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164177747|NCT02326298|593014074|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164177748|NCT02326298|593014075|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164177749|NCT02326298|593014076|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
164177750|NCT02326298|593014077|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
164177751|NCT02326298|593014078|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
164177752|NCT02326298|593014065|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164177753|NCT02326298|593014066|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164177754|NCT02326298|593014067|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164177755|NCT02326298|593014068|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164177756|NCT02326298|593014069|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164177757|NCT02326298|593014070|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164177758|NCT02326298|593014071|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164177759|NCT02326298|593014072|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164177760|NCT02326298|593014073|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164177761|NCT02326298|593014074|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164177762|NCT02326298|593014075|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164177763|NCT02326298|593014076|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
164177764|NCT02326298|593014077|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
164177765|NCT02326298|593014078|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
164177766|NCT02889835|593014081|FG000|Overall Study|Lost to Follow-up|13|||
164177767|NCT02889835|593014082|FG001|Overall Study|Lost to Follow-up|13|||
164177768|NCT02889835|593014083|FG002|Overall Study|Lost to Follow-up|13|||
164177769|NCT02889835|593014081|FG000|Overall Study|Withdrawal by Subject|2|||
164177770|NCT02889835|593014082|FG001|Overall Study|Withdrawal by Subject|2|||
164177771|NCT02889835|593014083|FG002|Overall Study|Withdrawal by Subject|2|||
164177772|NCT02889835|593014081|FG000|Overall Study|Protocol Violation|1|||
164177773|NCT02889835|593014082|FG001|Overall Study|Protocol Violation|1|||
164177774|NCT02889835|593014083|FG002|Overall Study|Protocol Violation|1|||
164177775|NCT02889835|593014081|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
164177776|NCT02889835|593014082|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
164177777|NCT02889835|593014083|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
164177778|NCT02889835|593014081|FG000|Overall Study|Death|1|||
164177779|NCT02889835|593014082|FG001|Overall Study|Death|1|||
164177780|NCT02889835|593014083|FG002|Overall Study|Death|1|||
164177781|NCT02342548|593014086|FG000|Overall Study|Adverse Event|12|||
164177782|NCT02342548|593014087|FG001|Overall Study|Adverse Event|17|||
164177783|NCT02342548|593014088|FG002|Overall Study|Adverse Event|13|||
164177784|NCT02342548|593014086|FG000|Overall Study|Lost to Follow-up|0|||
164177785|NCT02342548|593014087|FG001|Overall Study|Lost to Follow-up|1|||
164177786|NCT02342548|593014088|FG002|Overall Study|Lost to Follow-up|0|||
164177787|NCT02342548|593014086|FG000|Overall Study|Study terminated by sponsor|20|||
164177788|NCT02342548|593014087|FG001|Overall Study|Study terminated by sponsor|39|||
164177789|NCT02342548|593014088|FG002|Overall Study|Study terminated by sponsor|25|||
164177790|NCT02342548|593014086|FG000|Overall Study|Protocol Violation|0|||
164177791|NCT02342548|593014087|FG001|Overall Study|Protocol Violation|1|||
164177792|NCT02342548|593014088|FG002|Overall Study|Protocol Violation|0|||
164177793|NCT02342548|593014086|FG000|Overall Study|Withdrawal by Subject|1|||
164177794|NCT02342548|593014087|FG001|Overall Study|Withdrawal by Subject|3|||
164177795|NCT02342548|593014088|FG002|Overall Study|Withdrawal by Subject|4|||
164177796|NCT02342548|593014086|FG000|Overall Study|Other|1|||
164177797|NCT02342548|593014087|FG001|Overall Study|Other|1|||
164177798|NCT02342548|593014088|FG002|Overall Study|Other|1|||
164177799|NCT02987972|593014089|FG000|Overall Study|Adverse Event|1|||
164177800|NCT02987972|593014090|FG001|Overall Study|Adverse Event|1|||
164177801|NCT02987972|593014091|FG002|Overall Study|Adverse Event|0|||
164177802|NCT02987972|593014089|FG000|Overall Study|Death|1|||
164177803|NCT02987972|593014090|FG001|Overall Study|Death|0|||
164177804|NCT02987972|593014091|FG002|Overall Study|Death|0|||
164177805|NCT02987972|593014089|FG000|Overall Study|Lack of Efficacy|9|||
164177806|NCT02987972|593014090|FG001|Overall Study|Lack of Efficacy|12|||
164177807|NCT02987972|593014091|FG002|Overall Study|Lack of Efficacy|12|||
164177808|NCT02987972|593014089|FG000|Overall Study|Lost to Follow-up|7|||
164177809|NCT02987972|593014090|FG001|Overall Study|Lost to Follow-up|8|||
164177810|NCT02987972|593014091|FG002|Overall Study|Lost to Follow-up|4|||
164177811|NCT02987972|593014089|FG000|Overall Study|Physician Decision|1|||
164177812|NCT02987972|593014090|FG001|Overall Study|Physician Decision|6|||
164177813|NCT02987972|593014091|FG002|Overall Study|Physician Decision|0|||
164177814|NCT02987972|593014089|FG000|Overall Study|Protocol Violation|2|||
164177815|NCT02987972|593014090|FG001|Overall Study|Protocol Violation|1|||
164177816|NCT02987972|593014091|FG002|Overall Study|Protocol Violation|5|||
164177817|NCT02987972|593014089|FG000|Overall Study|Withdrawal by Subject|22|||
164177818|NCT02987972|593014090|FG001|Overall Study|Withdrawal by Subject|17|||
164177819|NCT02987972|593014091|FG002|Overall Study|Withdrawal by Subject|21|||
164177820|NCT01047332|593014094|FG000|Overall Study|SEMS Obstruction|11|||
164177821|NCT01047332|593014095|FG001|Overall Study|SEMS Obstruction|20|||
164177822|NCT01047332|593014094|FG000|Overall Study|Died Unobstructed|38|||
164177823|NCT01047332|593014095|FG001|Overall Study|Died Unobstructed|41|||
164177824|NCT01047332|593014094|FG000|Overall Study|Lost to Follow-up|8|||
164177825|NCT01047332|593014095|FG001|Overall Study|Lost to Follow-up|3|||
164177826|NCT03521817|593014096|FG000|Overall Study|Protocol Violation|0|||
164177827|NCT03521817|593014097|FG001|Overall Study|Protocol Violation|1|||
164177828|NCT00787917|593014098|FG000|Blinded Treatment|Adverse Event|1|||
164177829|NCT00787917|593014099|FG001|Blinded Treatment|Adverse Event|0|||
164177830|NCT00787917|593014098|FG000|Blinded Treatment|Lack of Efficacy|1|||
164177831|NCT00787917|593014099|FG001|Blinded Treatment|Lack of Efficacy|0|||
164177832|NCT00787917|593014098|FG000|Blinded Treatment|Administrative problems|3|||
164177833|NCT00787917|593014099|FG001|Blinded Treatment|Administrative problems|2|||
164177834|NCT00787917|593014098|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
164177835|NCT00787917|593014099|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
164177836|NCT00787917|593014098|FG000|Open Label|Administrative problems|3|||
164177837|NCT00787917|593014099|FG001|Open Label|Administrative problems|0|||
164177838|NCT05685732|593014101|FG000|Overall Study|Withdrawal by Subject|2|||
164177839|NCT05685732|593014102|FG001|Overall Study|Withdrawal by Subject|0|||
164177840|NCT05685732|593014103|FG002|Overall Study|Withdrawal by Subject|2|||
164177841|NCT05685732|593014104|FG003|Overall Study|Withdrawal by Subject|3|||
164177842|NCT05685732|593014101|FG000|Overall Study|Protocol Violation|1|||
164177843|NCT05685732|593014102|FG001|Overall Study|Protocol Violation|2|||
164177844|NCT05685732|593014103|FG002|Overall Study|Protocol Violation|4|||
164177845|NCT05685732|593014104|FG003|Overall Study|Protocol Violation|1|||
164177846|NCT05685732|593014101|FG000|Overall Study|Lost to Follow-up|5|||
164177847|NCT05685732|593014102|FG001|Overall Study|Lost to Follow-up|1|||
164177848|NCT05685732|593014103|FG002|Overall Study|Lost to Follow-up|3|||
164177849|NCT05685732|593014104|FG003|Overall Study|Lost to Follow-up|1|||
164177850|NCT05685732|593014101|FG000|Overall Study|Adverse Event|2|||
164177851|NCT05685732|593014102|FG001|Overall Study|Adverse Event|1|||
164177852|NCT05685732|593014103|FG002|Overall Study|Adverse Event|0|||
164177853|NCT05685732|593014104|FG003|Overall Study|Adverse Event|0|||
164177855|NCT05685732|593014102|FG001|Overall Study|Physician Decision|0|||
164177856|NCT05685732|593014103|FG002|Overall Study|Physician Decision|0|||
164177857|NCT05685732|593014104|FG003|Overall Study|Physician Decision|0|||
164177858|NCT02640404|593014105|FG000|Overall Study|Protocol Violation|1|||
164177859|NCT02640404|593014106|FG001|Overall Study|Protocol Violation|0|||
164177860|NCT02640404|593014105|FG000|Overall Study|Withdrawal by Subject|1|||
164177861|NCT02640404|593014106|FG001|Overall Study|Withdrawal by Subject|0|||
164177862|NCT00778102|593014107|FG000|Overall Study|Adverse Event|8|||
164177863|NCT00778102|593014108|FG001|Overall Study|Adverse Event|5|||
164177864|NCT00778102|593014107|FG000|Overall Study|Death|1|||
164177865|NCT00778102|593014108|FG001|Overall Study|Death|1|||
164177866|NCT00778102|593014107|FG000|Overall Study|Lost to Follow-up|1|||
164177867|NCT00778102|593014108|FG001|Overall Study|Lost to Follow-up|0|||
164177868|NCT00778102|593014107|FG000|Overall Study|Violation of Selection Criteria|1|||
164177869|NCT00778102|593014108|FG001|Overall Study|Violation of Selection Criteria|1|||
164177870|NCT00778102|593014107|FG000|Overall Study|Protocol Violation|0|||
164177871|NCT00778102|593014108|FG001|Overall Study|Protocol Violation|1|||
164177872|NCT00778102|593014107|FG000|Overall Study|Refused Treatment|2|||
164177873|NCT00778102|593014108|FG001|Overall Study|Refused Treatment|3|||
164177874|NCT00778102|593014107|FG000|Overall Study|Withdrawal by Subject|1|||
164177875|NCT00778102|593014108|FG001|Overall Study|Withdrawal by Subject|1|||
164177876|NCT00778102|593014107|FG000|Overall Study|Administrative Reason|7|||
164177877|NCT00778102|593014108|FG001|Overall Study|Administrative Reason|10|||
164177878|NCT05397171|593014109|FG000|Overall Study|Death|2|||
164177879|NCT05397171|593014110|FG001|Overall Study|Death|3|||
164177880|NCT05397171|593014111|FG002|Overall Study|Death|3|||
164177881|NCT05397171|593014109|FG000|Overall Study|Study Terminated By Sponsor|1|||
164177882|NCT05397171|593014110|FG001|Overall Study|Study Terminated By Sponsor|2|||
164177883|NCT05397171|593014111|FG002|Overall Study|Study Terminated By Sponsor|3|||
164177884|NCT05397171|593014109|FG000|Overall Study|Withdrawal by Subject|0|||
164177885|NCT05397171|593014110|FG001|Overall Study|Withdrawal by Subject|1|||
164177886|NCT05397171|593014111|FG002|Overall Study|Withdrawal by Subject|1|||
164177887|NCT01328548|593014112|FG000|Overall Study|Death|3|||
164177888|NCT01328548|593014113|FG001|Overall Study|Death|0|||
164177889|NCT01328548|593014112|FG000|Overall Study|Protocol Violation|1|||
164177890|NCT01328548|593014113|FG001|Overall Study|Protocol Violation|0|||
164177891|NCT01066793|593016445|FG000|Overall Study|Death|4|||
164177892|NCT01066793|593016446|FG001|Overall Study|Death|1|||
164177893|NCT01066793|593016447|FG002|Overall Study|Death|1|||
164177894|NCT01066793|593016448|FG003|Overall Study|Death|0|||
164177895|NCT01066793|593016449|FG004|Overall Study|Death|0|||
164177896|NCT01066793|593016450|FG005|Overall Study|Death|0|||
164177897|NCT01066793|593016445|FG000|Overall Study|Lack of Efficacy|2|||
164177898|NCT01066793|593016446|FG001|Overall Study|Lack of Efficacy|1|||
164177899|NCT01066793|593016447|FG002|Overall Study|Lack of Efficacy|0|||
164177900|NCT01066793|593016448|FG003|Overall Study|Lack of Efficacy|0|||
164177901|NCT01066793|593016449|FG004|Overall Study|Lack of Efficacy|0|||
164177902|NCT01066793|593016450|FG005|Overall Study|Lack of Efficacy|0|||
164177903|NCT01066793|593016445|FG000|Overall Study|Lost to Follow-up|180|||
164177904|NCT01066793|593016446|FG001|Overall Study|Lost to Follow-up|39|||
164177905|NCT01066793|593016447|FG002|Overall Study|Lost to Follow-up|82|||
164177906|NCT01066793|593016448|FG003|Overall Study|Lost to Follow-up|16|||
164177907|NCT01066793|593016449|FG004|Overall Study|Lost to Follow-up|0|||
164177908|NCT01066793|593016450|FG005|Overall Study|Lost to Follow-up|1|||
164177909|NCT01066793|593016445|FG000|Overall Study|Physician Decision|3|||
164177910|NCT01066793|593016446|FG001|Overall Study|Physician Decision|0|||
164177911|NCT01066793|593016447|FG002|Overall Study|Physician Decision|0|||
164177912|NCT01066793|593016448|FG003|Overall Study|Physician Decision|0|||
164177913|NCT01066793|593016449|FG004|Overall Study|Physician Decision|0|||
164177914|NCT01066793|593016450|FG005|Overall Study|Physician Decision|0|||
164177915|NCT01066793|593016445|FG000|Overall Study|Protocol Violation|3|||
164177916|NCT01066793|593016446|FG001|Overall Study|Protocol Violation|2|||
164177917|NCT01066793|593016447|FG002|Overall Study|Protocol Violation|2|||
164177918|NCT01066793|593016448|FG003|Overall Study|Protocol Violation|0|||
164177919|NCT01066793|593016449|FG004|Overall Study|Protocol Violation|0|||
164177920|NCT01066793|593016450|FG005|Overall Study|Protocol Violation|0|||
164177921|NCT01066793|593016445|FG000|Overall Study|Withdrawal by Subject|7|||
164177922|NCT01066793|593016446|FG001|Overall Study|Withdrawal by Subject|4|||
164177923|NCT01066793|593016447|FG002|Overall Study|Withdrawal by Subject|1|||
164177924|NCT01066793|593016448|FG003|Overall Study|Withdrawal by Subject|0|||
164177925|NCT01066793|593016449|FG004|Overall Study|Withdrawal by Subject|0|||
164177926|NCT01066793|593016450|FG005|Overall Study|Withdrawal by Subject|0|||
164177927|NCT01066793|593016445|FG000|Overall Study|Early Termination|3|||
164177928|NCT01066793|593016446|FG001|Overall Study|Early Termination|0|||
164177929|NCT01066793|593016447|FG002|Overall Study|Early Termination|0|||
164177930|NCT01066793|593016448|FG003|Overall Study|Early Termination|0|||
164177931|NCT01066793|593016449|FG004|Overall Study|Early Termination|0|||
164177932|NCT01066793|593016450|FG005|Overall Study|Early Termination|0|||
164177933|NCT01066793|593016445|FG000|Overall Study|Lab test not done|7|||
164177934|NCT01066793|593016446|FG001|Overall Study|Lab test not done|0|||
164177935|NCT01066793|593016447|FG002|Overall Study|Lab test not done|0|||
164177936|NCT01066793|593016448|FG003|Overall Study|Lab test not done|1|||
164177937|NCT01066793|593016449|FG004|Overall Study|Lab test not done|0|||
164177938|NCT01066793|593016450|FG005|Overall Study|Lab test not done|0|||
164177939|NCT01066793|593016445|FG000|Overall Study|Miscellaneous|4|||
164177940|NCT01066793|593016446|FG001|Overall Study|Miscellaneous|5|||
164177941|NCT01066793|593016447|FG002|Overall Study|Miscellaneous|6|||
164177942|NCT01066793|593016448|FG003|Overall Study|Miscellaneous|0|||
164177943|NCT01066793|593016449|FG004|Overall Study|Miscellaneous|0|||
164177944|NCT01066793|593016450|FG005|Overall Study|Miscellaneous|0|||
164177945|NCT01066793|593016445|FG000|Overall Study|Non-responders|104|||
164177946|NCT01066793|593016446|FG001|Overall Study|Non-responders|5|||
164177947|NCT01066793|593016447|FG002|Overall Study|Non-responders|11|||
164177948|NCT01066793|593016448|FG003|Overall Study|Non-responders|25|||
164177949|NCT01066793|593016449|FG004|Overall Study|Non-responders|0|||
164177950|NCT01066793|593016450|FG005|Overall Study|Non-responders|0|||
164177951|NCT01066793|593016445|FG000|Overall Study|Other|15|||
164177952|NCT01066793|593016446|FG001|Overall Study|Other|5|||
164177953|NCT01066793|593016447|FG002|Overall Study|Other|6|||
164177954|NCT01066793|593016448|FG003|Overall Study|Other|2|||
164177955|NCT01066793|593016449|FG004|Overall Study|Other|0|||
164177956|NCT01066793|593016450|FG005|Overall Study|Other|0|||
164177957|NCT01066793|593016445|FG000|Overall Study|Relapse|20|||
164177958|NCT01066793|593016446|FG001|Overall Study|Relapse|8|||
164177959|NCT01066793|593016447|FG002|Overall Study|Relapse|2|||
164177960|NCT01066793|593016448|FG003|Overall Study|Relapse|3|||
164177961|NCT01066793|593016449|FG004|Overall Study|Relapse|0|||
164177962|NCT01066793|593016450|FG005|Overall Study|Relapse|0|||
164177963|NCT01066793|593016445|FG000|Overall Study|Result Not Available|1|||
164177964|NCT01066793|593016446|FG001|Overall Study|Result Not Available|0|||
164177965|NCT01066793|593016447|FG002|Overall Study|Result Not Available|0|||
164177966|NCT01066793|593016448|FG003|Overall Study|Result Not Available|0|||
164177967|NCT01066793|593016449|FG004|Overall Study|Result Not Available|0|||
164177968|NCT01066793|593016450|FG005|Overall Study|Result Not Available|0|||
164177969|NCT01066793|593016445|FG000|Overall Study|Treatment Interrupted|1|||
164177970|NCT01066793|593016446|FG001|Overall Study|Treatment Interrupted|1|||
164177971|NCT01066793|593016447|FG002|Overall Study|Treatment Interrupted|0|||
164177972|NCT01066793|593016448|FG003|Overall Study|Treatment Interrupted|0|||
164177973|NCT01066793|593016449|FG004|Overall Study|Treatment Interrupted|0|||
164177974|NCT01066793|593016450|FG005|Overall Study|Treatment Interrupted|0|||
164177975|NCT01066793|593016445|FG000|Overall Study|Treatment Never Started|18|||
164177976|NCT01066793|593016446|FG001|Overall Study|Treatment Never Started|5|||
164177977|NCT01066793|593016447|FG002|Overall Study|Treatment Never Started|4|||
164177978|NCT01066793|593016448|FG003|Overall Study|Treatment Never Started|1|||
164177979|NCT01066793|593016449|FG004|Overall Study|Treatment Never Started|0|||
164177980|NCT01066793|593016450|FG005|Overall Study|Treatment Never Started|0|||
164177981|NCT01066793|593016445|FG000|Overall Study|Treatment Stopped|2|||
164177982|NCT01066793|593016446|FG001|Overall Study|Treatment Stopped|1|||
164177983|NCT01066793|593016447|FG002|Overall Study|Treatment Stopped|0|||
164177984|NCT01066793|593016448|FG003|Overall Study|Treatment Stopped|1|||
164177985|NCT01066793|593016449|FG004|Overall Study|Treatment Stopped|0|||
164177986|NCT01066793|593016450|FG005|Overall Study|Treatment Stopped|0|||
164177987|NCT04643964|593016452|FG000|Overall Study|Lost to Follow-up|55|||
164177988|NCT04643964|593016453|FG001|Overall Study|Lost to Follow-up|59|||
164177989|NCT04643964|593016454|FG002|Overall Study|Lost to Follow-up|54|||
164177990|NCT04643964|593016455|FG003|Overall Study|Lost to Follow-up|129|||
164177991|NCT04643964|593016456|FG004|Overall Study|Lost to Follow-up|48|||
164177992|NCT04643964|593016452|FG000|Overall Study|Failed attention check|1|||
164177993|NCT04643964|593016453|FG001|Overall Study|Failed attention check|8|||
164177994|NCT04643964|593016454|FG002|Overall Study|Failed attention check|2|||
164177995|NCT04643964|593016455|FG003|Overall Study|Failed attention check|14|||
164177996|NCT04643964|593016456|FG004|Overall Study|Failed attention check|11|||
164177997|NCT02607280|593016458|FG000|Overall Study|Adverse Event|4|||
164177998|NCT02607280|593016459|FG001|Overall Study|Adverse Event|0|||
164177999|NCT02607280|593016458|FG000|Overall Study|Decrease in CrCl <15|0|||
164178000|NCT02607280|593016459|FG001|Overall Study|Decrease in CrCl <15|1|||
164178001|NCT02368210|593016460|FG000|Overall Study|Withdrawal by Subject|1|||
164178002|NCT02368210|593016461|FG001|Overall Study|Withdrawal by Subject|0|||
164178003|NCT02368210|593016460|FG000|Overall Study|Adverse Event|0|||
164178004|NCT02368210|593016461|FG001|Overall Study|Adverse Event|1|||
164178005|NCT00590538|593016462|FG000|Overall Study|Study terminated before completed|2|||
164178006|NCT01125813|593016463|FG000|Overall Study|Death|1|||
164178007|NCT01125813|593016463|FG000|Overall Study|Withdrawal by Subject|1|||
164178008|NCT01125813|593016463|FG000|Overall Study|Screen Failures|4|||
164178009|NCT00766467|593016465|FG000|Overall Study|Withdrawal by Subject|7|||
164178010|NCT00766467|593016466|FG001|Overall Study|Withdrawal by Subject|2|||
164178011|NCT00766467|593016465|FG000|Overall Study|Adverse Event|1|||
164178012|NCT00766467|593016466|FG001|Overall Study|Adverse Event|1|||
164178013|NCT00766467|593016465|FG000|Overall Study|Protocol Violation|2|||
164178014|NCT00766467|593016466|FG001|Overall Study|Protocol Violation|4|||
164178015|NCT00766467|593016465|FG000|Overall Study|Tumor Progression on Study|0|||
164178016|NCT00766467|593016466|FG001|Overall Study|Tumor Progression on Study|1|||
164178017|NCT00766467|593016465|FG000|Overall Study|Physician Decision|1|||
164178018|NCT00766467|593016466|FG001|Overall Study|Physician Decision|0|||
164178019|NCT00980018|593016473|FG000|Overall Study|Adverse Event|8|||
164178020|NCT00980018|593016473|FG000|Overall Study|Patient withdrew consent|3|||
164178021|NCT00980018|593016473|FG000|Overall Study|Lost to Follow-up|1|||
164178022|NCT00551161|593016475|FG000|Overall Study|Withdrawal by Subject|1|||
164178023|NCT00934856|593016476|FG000|Feasibility Part|Progressive disease|4|||
164178024|NCT00934856|593016477|FG001|Feasibility Part|Progressive disease|4|||
164178025|NCT00934856|593016478|FG002|Feasibility Part|Progressive disease|2|||
164178026|NCT00934856|593016479|FG003|Feasibility Part|Progressive disease|3|||
164178027|NCT00934856|593016480|FG004|Feasibility Part|Progressive disease|0|||
164178028|NCT00934856|593016481|FG005|Feasibility Part|Progressive disease|0|||
164178029|NCT00934856|593016476|FG000|Feasibility Part|Physician Decision|0|||
164178030|NCT00934856|593016477|FG001|Feasibility Part|Physician Decision|0|||
164178031|NCT00934856|593016478|FG002|Feasibility Part|Physician Decision|1|||
164178032|NCT00934856|593016479|FG003|Feasibility Part|Physician Decision|0|||
164178033|NCT00934856|593016480|FG004|Feasibility Part|Physician Decision|0|||
164178034|NCT00934856|593016481|FG005|Feasibility Part|Physician Decision|0|||
164178035|NCT00934856|593016476|FG000|Feasibility Part|Adverse Event|1|||
164178036|NCT00934856|593016477|FG001|Feasibility Part|Adverse Event|1|||
164178037|NCT00934856|593016478|FG002|Feasibility Part|Adverse Event|0|||
164178038|NCT00934856|593016479|FG003|Feasibility Part|Adverse Event|1|||
164178039|NCT00934856|593016480|FG004|Feasibility Part|Adverse Event|0|||
164178040|NCT00934856|593016481|FG005|Feasibility Part|Adverse Event|2|||
164178041|NCT00934856|593016476|FG000|Feasibility Part|Withdrawal by Subject|0|||
164178042|NCT00934856|593016477|FG001|Feasibility Part|Withdrawal by Subject|0|||
164178043|NCT00934856|593016478|FG002|Feasibility Part|Withdrawal by Subject|0|||
164178044|NCT00934856|593016479|FG003|Feasibility Part|Withdrawal by Subject|1|||
164178045|NCT00934856|593016480|FG004|Feasibility Part|Withdrawal by Subject|0|||
164178046|NCT00934856|593016481|FG005|Feasibility Part|Withdrawal by Subject|1|||
164178047|NCT00934856|593016476|FG000|Extension Part|Adverse Event|0|||
164178048|NCT00934856|593016477|FG001|Extension Part|Adverse Event|0|||
164178049|NCT00934856|593016478|FG002|Extension Part|Adverse Event|0|||
164178050|NCT00934856|593016479|FG003|Extension Part|Adverse Event|1|||
164178051|NCT00934856|593016480|FG004|Extension Part|Adverse Event|4|||
164178052|NCT00934856|593016481|FG005|Extension Part|Adverse Event|4|||
164178053|NCT00934856|593016476|FG000|Extension Part|Progressive disease|0|||
164178054|NCT00934856|593016477|FG001|Extension Part|Progressive disease|0|||
164178055|NCT00934856|593016478|FG002|Extension Part|Progressive disease|0|||
164178056|NCT00934856|593016479|FG003|Extension Part|Progressive disease|1|||
164178057|NCT00934856|593016480|FG004|Extension Part|Progressive disease|0|||
164178058|NCT00934856|593016481|FG005|Extension Part|Progressive disease|0|||
164178059|NCT00934856|593016476|FG000|Extension Part|Non-compliance with drug|0|||
164178060|NCT00934856|593016477|FG001|Extension Part|Non-compliance with drug|0|||
164178061|NCT00934856|593016478|FG002|Extension Part|Non-compliance with drug|0|||
164178062|NCT00934856|593016479|FG003|Extension Part|Non-compliance with drug|0|||
164178063|NCT00934856|593016480|FG004|Extension Part|Non-compliance with drug|0|||
164178064|NCT00934856|593016481|FG005|Extension Part|Non-compliance with drug|1|||
164178065|NCT00772005|593016482|FG000|Overall Study|Adverse Event|9|||
164178066|NCT00772005|593016483|FG001|Overall Study|Adverse Event|14|||
164178067|NCT00772005|593016484|FG002|Overall Study|Adverse Event|10|||
164178068|NCT00772005|593016485|FG003|Overall Study|Adverse Event|13|||
164178069|NCT00772005|593016482|FG000|Overall Study|Lack of Efficacy|0|||
164178070|NCT00772005|593016483|FG001|Overall Study|Lack of Efficacy|1|||
164178071|NCT00772005|593016484|FG002|Overall Study|Lack of Efficacy|0|||
164178072|NCT00772005|593016485|FG003|Overall Study|Lack of Efficacy|0|||
164178073|NCT00772005|593016482|FG000|Overall Study|Withdrawal by Subject|3|||
164178074|NCT00772005|593016483|FG001|Overall Study|Withdrawal by Subject|7|||
164178075|NCT00772005|593016484|FG002|Overall Study|Withdrawal by Subject|10|||
164178076|NCT00772005|593016485|FG003|Overall Study|Withdrawal by Subject|2|||
164178077|NCT00772005|593016482|FG000|Overall Study|Protocol Violation|2|||
164178078|NCT00772005|593016483|FG001|Overall Study|Protocol Violation|4|||
164178079|NCT00772005|593016484|FG002|Overall Study|Protocol Violation|1|||
164178080|NCT00772005|593016485|FG003|Overall Study|Protocol Violation|6|||
164178081|NCT00772005|593016482|FG000|Overall Study|Lost to Follow-up|7|||
164178082|NCT00772005|593016483|FG001|Overall Study|Lost to Follow-up|3|||
164178083|NCT00772005|593016484|FG002|Overall Study|Lost to Follow-up|6|||
164178084|NCT00772005|593016485|FG003|Overall Study|Lost to Follow-up|3|||
164178085|NCT00772005|593016482|FG000|Overall Study|Non-compliance with study procedures|1|||
164178086|NCT00772005|593016483|FG001|Overall Study|Non-compliance with study procedures|1|||
164178087|NCT00772005|593016484|FG002|Overall Study|Non-compliance with study procedures|0|||
164178088|NCT00772005|593016485|FG003|Overall Study|Non-compliance with study procedures|1|||
164178089|NCT00772005|593016482|FG000|Overall Study|Non-compliance with drug administration|3|||
164178090|NCT00772005|593016483|FG001|Overall Study|Non-compliance with drug administration|0|||
164178383|NCT01709864|593018541|FG001|Overall Study|Physician Decision|1|||
164178091|NCT00772005|593016484|FG002|Overall Study|Non-compliance with drug administration|1|||
164178092|NCT00772005|593016485|FG003|Overall Study|Non-compliance with drug administration|1|||
164178093|NCT01256385|593016488|FG000|Overall Study|Physician Decision|1|||
164178094|NCT01256385|593016489|FG001|Overall Study|Physician Decision|1|||
164178095|NCT01256385|593016488|FG000|Overall Study|Withdrawal by Subject|2|||
164178096|NCT01256385|593016489|FG001|Overall Study|Withdrawal by Subject|2|||
164178097|NCT01440569|593016490|FG000|Main Study|Enrolled but not treated|1|||
164178098|NCT01440569|593016491|FG001|Main Study|Enrolled but not treated|0|||
164178099|NCT01440569|593016490|FG000|Main Study|Adverse Event|9|||
164178100|NCT01440569|593016491|FG001|Main Study|Adverse Event|0|||
164178101|NCT01440569|593016490|FG000|Main Study|Pregnancy|1|||
164178102|NCT01440569|593016491|FG001|Main Study|Pregnancy|0|||
164178103|NCT01440569|593016490|FG000|Main Study|Investigator's Discretion|1|||
164178104|NCT01440569|593016491|FG001|Main Study|Investigator's Discretion|1|||
164178105|NCT01440569|593016490|FG000|Main Study|Withdrew Consent|7|||
164178106|NCT01440569|593016491|FG001|Main Study|Withdrew Consent|1|||
164178107|NCT01440569|593016490|FG000|Main Study|Lost to Follow-up|13|||
164178108|NCT01440569|593016491|FG001|Main Study|Lost to Follow-up|2|||
164178109|NCT01440569|593016490|FG000|Main Study|Subject Non-Compliance|3|||
164178110|NCT01440569|593016491|FG001|Main Study|Subject Non-Compliance|0|||
164178111|NCT01440569|593016490|FG000|Main Study|Protocol Violation|1|||
164178112|NCT01440569|593016491|FG001|Main Study|Protocol Violation|0|||
164178113|NCT01440569|593016490|FG000|Open-Label Rollover Phase|Adverse Event|3|||
164178114|NCT01440569|593016491|FG001|Open-Label Rollover Phase|Adverse Event|0|||
164178115|NCT01440569|593016490|FG000|Open-Label Rollover Phase|Pregnancy|1|||
164178116|NCT01440569|593016491|FG001|Open-Label Rollover Phase|Pregnancy|0|||
164178117|NCT01440569|593016490|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
164178118|NCT01440569|593016491|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
164178119|NCT01440569|593016490|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
164178120|NCT01440569|593016491|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
164178121|NCT01440569|593016490|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
164178122|NCT01440569|593016491|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
164178123|NCT01440569|593016490|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
164178124|NCT01440569|593016491|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
164178125|NCT01440569|593016490|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
164178126|NCT01440569|593016491|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
164178127|NCT02273908|593016501|FG000|Overall Study|Adverse Event|16|||
164178128|NCT02273908|593016502|FG001|Overall Study|Adverse Event|0|||
164178129|NCT02273908|593016501|FG000|Overall Study|Lost to Follow-up|10|||
164178130|NCT02273908|593016502|FG001|Overall Study|Lost to Follow-up|1|||
164178131|NCT02273908|593016501|FG000|Overall Study|Did not meet entrance criteria|3|||
164178132|NCT02273908|593016502|FG001|Overall Study|Did not meet entrance criteria|2|||
164178133|NCT02273908|593016501|FG000|Overall Study|Withdrawal by Subject|4|||
164178134|NCT02273908|593016502|FG001|Overall Study|Withdrawal by Subject|2|||
164178135|NCT03887117|593016503|FG000|Overall Study|Discontinued prematurely|0|||
164178136|NCT03887117|593016504|FG001|Overall Study|Discontinued prematurely|1|||
164178137|NCT03887117|593016505|FG002|Overall Study|Discontinued prematurely|1|||
164178138|NCT03887117|593016506|FG003|Overall Study|Discontinued prematurely|2|||
164178139|NCT04908475|593016507|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
164178140|NCT04908475|593016508|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164178141|NCT04908475|593016509|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164178142|NCT04908475|593016510|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164178143|NCT04908475|593016511|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164178144|NCT04908475|593016512|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164178145|NCT04908475|593016507|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
164178146|NCT04908475|593016508|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
164178147|NCT04908475|593016509|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
164178148|NCT04908475|593016510|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
164178149|NCT04908475|593016511|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
164178150|NCT04908475|593016512|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
164178151|NCT04908475|593016507|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
164178152|NCT04908475|593016508|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
164178153|NCT04908475|593016509|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
164178154|NCT04908475|593016510|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
164178155|NCT04908475|593016511|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
164178156|NCT04908475|593016512|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
164178157|NCT04908475|593016507|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
164178158|NCT04908475|593016508|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
164178159|NCT04908475|593016509|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
164178160|NCT04908475|593016510|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
164178161|NCT04908475|593016511|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
164178162|NCT04908475|593016512|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
164178163|NCT04908475|593016507|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
164178164|NCT04908475|593016508|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
164178165|NCT04908475|593016509|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
164178166|NCT04908475|593016510|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
164178167|NCT04908475|593016511|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
164178168|NCT04908475|593016512|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
164178169|NCT04908475|593016507|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
164178170|NCT04908475|593016508|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
164178171|NCT04908475|593016509|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
164178172|NCT04908475|593016510|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
164178173|NCT04908475|593016511|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
164178174|NCT04908475|593016512|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
164178175|NCT02124759|593016517|FG000|Overall Study|Withdrawal by Subject|3|||
164178176|NCT02124759|593016518|FG001|Overall Study|Withdrawal by Subject|1|||
164178177|NCT02124759|593016519|FG002|Overall Study|Withdrawal by Subject|1|||
164178178|NCT02124759|593016517|FG000|Overall Study|Screen Fail|2|||
164178179|NCT02124759|593016518|FG001|Overall Study|Screen Fail|2|||
164178180|NCT02124759|593016519|FG002|Overall Study|Screen Fail|3|||
164178181|NCT01294371|593016520|FG000|Overall Study|Adverse Event|1|||
164178182|NCT01294371|593016520|FG000|Overall Study|Withdrawal by Subject|12|||
164178183|NCT01294371|593016520|FG000|Overall Study|Lost to Follow-up|6|||
164178184|NCT01294371|593016520|FG000|Overall Study|Administrative Reason|1|||
164178185|NCT01294371|593016520|FG000|Overall Study|Other|14|||
164178186|NCT03325894|593016521|FG000|Overall Study|Adverse Event|2|||
164178187|NCT03325894|593016522|FG001|Overall Study|Adverse Event|3|||
164178188|NCT03325894|593016521|FG000|Overall Study|Protocol Violation|1|||
164178189|NCT03325894|593016522|FG001|Overall Study|Protocol Violation|2|||
164178190|NCT03325894|593016521|FG000|Overall Study|Withdrawal by Subject|10|||
164178191|NCT03325894|593016522|FG001|Overall Study|Withdrawal by Subject|6|||
164178192|NCT03325894|593016521|FG000|Overall Study|Lost to Follow-up|4|||
164178193|NCT03325894|593016522|FG001|Overall Study|Lost to Follow-up|9|||
164178194|NCT03325894|593016521|FG000|Overall Study|Lack of Efficacy|8|||
164178195|NCT03325894|593016522|FG001|Overall Study|Lack of Efficacy|14|||
164178196|NCT03325894|593016521|FG000|Overall Study|Study Terminated by Sponsor|38|||
164178197|NCT03325894|593016522|FG001|Overall Study|Study Terminated by Sponsor|43|||
164178198|NCT03325894|593016521|FG000|Overall Study|Other (Not received Treatment)|1|||
164178199|NCT03325894|593016522|FG001|Overall Study|Other (Not received Treatment)|0|||
164178200|NCT03482167|593016525|FG000|Allocated to Intervention|Physician Decision|1|||
164178201|NCT03482167|593016526|FG001|Allocated to Intervention|Physician Decision|2|||
164178202|NCT03482167|593016525|FG000|Received Intervention|Adverse Event|3|||
164178203|NCT03482167|593016526|FG001|Received Intervention|Adverse Event|1|||
164178204|NCT03482167|593016525|FG000|Received Intervention|Physician Decision|1|||
164178205|NCT03482167|593016526|FG001|Received Intervention|Physician Decision|1|||
164178206|NCT03482167|593016525|FG000|Received Intervention|Withdrawal by Subject|1|||
164178207|NCT03482167|593016526|FG001|Received Intervention|Withdrawal by Subject|0|||
164178208|NCT00622336|593016528|FG000|Treatment Phase|Progression of Disease|181|||
164178209|NCT00622336|593016528|FG000|Treatment Phase|Adverse Event|46|||
164178210|NCT00622336|593016528|FG000|Treatment Phase|Other|40|||
164178211|NCT00622336|593016528|FG000|Treatment Phase|Death|14|||
164178212|NCT00622336|593016528|FG000|Treatment Phase|Lack of therapeutic effect|13|||
164178213|NCT00622336|593016528|FG000|Treatment Phase|Withdrawal by Subject|13|||
164178214|NCT00622336|593016528|FG000|Treatment Phase|Lost to Follow-up|2|||
164178215|NCT00622336|593016528|FG000|Extension Phase|Adverse Event|2|||
164178216|NCT00622336|593016528|FG000|Extension Phase|Progressive Disease|6|||
164178217|NCT00622336|593016528|FG000|Extension Phase|Lack of therapeutic effect|2|||
164178218|NCT00622336|593016528|FG000|Extension Phase|Withdrawal by Subject|1|||
164178219|NCT00622336|593016528|FG000|Extension Phase|Lost to Follow-up|1|||
164178220|NCT00622336|593016528|FG000|Extension Phase|Other|9|||
164178221|NCT00819780|593016529|FG000|Overall Study|Did not receive study drug|3|||
164178222|NCT00819780|593016530|FG001|Overall Study|Did not receive study drug|4|||
164178223|NCT00819780|593016529|FG000|Overall Study|Still in treatment|25|||
164178224|NCT00819780|593016530|FG001|Overall Study|Still in treatment|17|||
164178225|NCT04148287|593016535|FG000|Overall Study|Death|2|||
164178226|NCT00106639|593016536|FG000|Overall Study|Adverse Event|3|||
164178227|NCT00106639|593016537|FG001|Overall Study|Adverse Event|4|||
164178228|NCT00106639|593016538|FG002|Overall Study|Adverse Event|1|||
164178229|NCT00106639|593016536|FG000|Overall Study|Protocol Violation|0|||
164178230|NCT00106639|593016537|FG001|Overall Study|Protocol Violation|1|||
164178231|NCT00106639|593016538|FG002|Overall Study|Protocol Violation|0|||
164178232|NCT00106639|593016536|FG000|Overall Study|Withdrawal by Subject|0|||
164178233|NCT00106639|593016537|FG001|Overall Study|Withdrawal by Subject|1|||
164178234|NCT00106639|593016538|FG002|Overall Study|Withdrawal by Subject|0|||
164178235|NCT00106639|593016536|FG000|Overall Study|Participant defaulted|0|||
164178236|NCT00106639|593016537|FG001|Overall Study|Participant defaulted|1|||
164178237|NCT00106639|593016538|FG002|Overall Study|Participant defaulted|1|||
164178238|NCT01645891|593016543|FG000|Overall Study|Adverse Event|6|||
164178239|NCT01645891|593016544|FG001|Overall Study|Adverse Event|10|||
164178240|NCT01645891|593016543|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
164178241|NCT01645891|593016544|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
164178242|NCT01645891|593016543|FG000|Overall Study|Withdrawal by Subject|3|||
164178243|NCT01645891|593016544|FG001|Overall Study|Withdrawal by Subject|3|||
164178244|NCT01645891|593016543|FG000|Overall Study|Protocol Violation|4|||
164178245|NCT01645891|593016544|FG001|Overall Study|Protocol Violation|0|||
164178246|NCT01645891|593016543|FG000|Overall Study|Lost to Follow-up|4|||
164178247|NCT01645891|593016544|FG001|Overall Study|Lost to Follow-up|1|||
164178248|NCT01645891|593016543|FG000|Overall Study|Death|0|||
164178249|NCT01645891|593016544|FG001|Overall Study|Death|2|||
164178250|NCT00138073|593016545|FG000|Overall Study|lack of resources|55|||
164178251|NCT02847182|593016546|FG000|Overall Study|Withdrawal by Subject|0|||
164178252|NCT02847182|593016547|FG001|Overall Study|Withdrawal by Subject|1|||
164178253|NCT00962091|593016548|FG000|Overall Study|Withdrawal by Subject|1|||
164178254|NCT00962091|593016549|FG001|Overall Study|Withdrawal by Subject|2|||
164178255|NCT00962091|593016550|FG002|Overall Study|Withdrawal by Subject|1|||
164178256|NCT00962091|593016551|FG003|Overall Study|Withdrawal by Subject|1|||
164178257|NCT00962091|593016552|FG004|Overall Study|Withdrawal by Subject|0|||
164178258|NCT00962091|593016553|FG005|Overall Study|Withdrawal by Subject|1|||
164178259|NCT00962091|593016554|FG006|Overall Study|Withdrawal by Subject|0|||
164178260|NCT00962091|593016548|FG000|Overall Study|Adverse Event|0|||
164178261|NCT00962091|593016549|FG001|Overall Study|Adverse Event|0|||
164178262|NCT00962091|593016550|FG002|Overall Study|Adverse Event|0|||
164178263|NCT00962091|593016551|FG003|Overall Study|Adverse Event|0|||
164178264|NCT00962091|593016552|FG004|Overall Study|Adverse Event|0|||
164178265|NCT00962091|593016553|FG005|Overall Study|Adverse Event|0|||
164178266|NCT00962091|593016554|FG006|Overall Study|Adverse Event|1|||
164178267|NCT01306045|593016557|FG000|Met General Eligibility Criteria|Screen failures|193|||
164178268|NCT01306045|593016558|FG001|Met General Eligibility Criteria|Screen failures|11|||
164178269|NCT01306045|593016559|FG002|Met General Eligibility Criteria|Screen failures|8|||
164178270|NCT05072964|593016560|FG000|Overall Study|Withdrawal by Subject|4|||
164178271|NCT05072964|593016560|FG000|Overall Study|Death|1|||
164178272|NCT02172040|593016563|FG000|Overall Study|Adverse Event|0|||
164178273|NCT02172040|593016564|FG001|Overall Study|Adverse Event|2|||
164178274|NCT02172040|593016565|FG002|Overall Study|Adverse Event|0|||
164178275|NCT02172040|593016566|FG003|Overall Study|Adverse Event|0|||
164178276|NCT02172040|593016563|FG000|Overall Study|Protocol Violation|0|||
164178277|NCT02172040|593016564|FG001|Overall Study|Protocol Violation|1|||
164178278|NCT02172040|593016565|FG002|Overall Study|Protocol Violation|0|||
164178279|NCT02172040|593016566|FG003|Overall Study|Protocol Violation|0|||
164178280|NCT02172040|593016563|FG000|Overall Study|Withdrawal by Subject|0|||
164178281|NCT02172040|593016564|FG001|Overall Study|Withdrawal by Subject|0|||
164178282|NCT02172040|593016565|FG002|Overall Study|Withdrawal by Subject|1|||
164178283|NCT02172040|593016566|FG003|Overall Study|Withdrawal by Subject|0|||
164178284|NCT02172040|593016563|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
164178285|NCT02172040|593016564|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
164178286|NCT02172040|593016565|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
164178287|NCT02172040|593016566|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
164178288|NCT02172040|593016563|FG000|Overall Study|Family emergency abroad|0|||
164178289|NCT02172040|593016564|FG001|Overall Study|Family emergency abroad|0|||
164178290|NCT02172040|593016565|FG002|Overall Study|Family emergency abroad|0|||
164178291|NCT02172040|593016566|FG003|Overall Study|Family emergency abroad|1|||
164178292|NCT04908202|593016572|FG000|Pre-Treatment Period|OTHER REASONS|3|||
164178293|NCT04908202|593016573|FG001|Pre-Treatment Period|OTHER REASONS|1|||
164178294|NCT04908202|593016574|FG002|Pre-Treatment Period|OTHER REASONS|0|||
164178295|NCT04908202|593016575|FG003|Pre-Treatment Period|OTHER REASONS|0|||
164178296|NCT04908202|593016572|FG000|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|1|||
164178297|NCT04908202|593016573|FG001|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
164178298|NCT04908202|593016574|FG002|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
164178299|NCT04908202|593016575|FG003|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
164178300|NCT04908202|593016572|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|1|||
164178301|NCT04908202|593016573|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
164178302|NCT04908202|593016574|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
164178303|NCT04908202|593016575|FG003|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
164178304|NCT04908202|593016572|FG000|Placebo-Controlled Treatment Period|Adverse Event|8|||
164178305|NCT04908202|593016573|FG001|Placebo-Controlled Treatment Period|Adverse Event|6|||
164178306|NCT04908202|593016574|FG002|Placebo-Controlled Treatment Period|Adverse Event|0|||
164178307|NCT04908202|593016575|FG003|Placebo-Controlled Treatment Period|Adverse Event|0|||
164178308|NCT04908202|593016572|FG000|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
164178309|NCT04908202|593016573|FG001|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
164178310|NCT04908202|593016574|FG002|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
164178311|NCT04908202|593016575|FG003|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
164178312|NCT04908202|593016572|FG000|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|4|||
164178313|NCT04908202|593016573|FG001|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|10|||
164178314|NCT04908202|593016574|FG002|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
164178315|NCT04908202|593016575|FG003|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
164178316|NCT04908202|593016572|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
164178317|NCT04908202|593016573|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
164178318|NCT04908202|593016574|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
164178319|NCT04908202|593016575|FG003|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
164178320|NCT04908202|593016572|FG000|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
164178321|NCT04908202|593016573|FG001|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
164178322|NCT04908202|593016574|FG002|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
164178323|NCT04908202|593016575|FG003|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
164178324|NCT04908202|593016572|FG000|Placebo-Controlled Treatment Period|Other reasons|8|||
164178325|NCT04908202|593016573|FG001|Placebo-Controlled Treatment Period|Other reasons|4|||
164178326|NCT04908202|593016574|FG002|Placebo-Controlled Treatment Period|Other reasons|0|||
164178327|NCT04908202|593016575|FG003|Placebo-Controlled Treatment Period|Other reasons|0|||
164178328|NCT04908202|593016572|FG000|Active Treatment Period|OTHER REASONS|0|||
164178329|NCT04908202|593016573|FG001|Active Treatment Period|OTHER REASONS|0|||
164178330|NCT04908202|593016574|FG002|Active Treatment Period|OTHER REASONS|1|||
164178331|NCT04908202|593016575|FG003|Active Treatment Period|OTHER REASONS|3|||
164178332|NCT04908202|593016572|FG000|Active Treatment Period|Lack of Efficacy|0|||
164178333|NCT04908202|593016573|FG001|Active Treatment Period|Lack of Efficacy|0|||
164178334|NCT04908202|593016574|FG002|Active Treatment Period|Lack of Efficacy|4|||
164178335|NCT04908202|593016575|FG003|Active Treatment Period|Lack of Efficacy|5|||
164178336|NCT04908202|593016572|FG000|Active Treatment Period|Adverse Event|0|||
164178337|NCT04908202|593016573|FG001|Active Treatment Period|Adverse Event|0|||
164178338|NCT04908202|593016574|FG002|Active Treatment Period|Adverse Event|5|||
164178339|NCT04908202|593016575|FG003|Active Treatment Period|Adverse Event|8|||
164178340|NCT04908202|593016572|FG000|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
164178341|NCT04908202|593016573|FG001|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
164178342|NCT04908202|593016574|FG002|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
164178343|NCT04908202|593016575|FG003|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
164178344|NCT04908202|593016572|FG000|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
164178345|NCT04908202|593016573|FG001|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
164178346|NCT04908202|593016574|FG002|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|8|||
164178347|NCT04908202|593016575|FG003|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|11|||
164178348|NCT04908202|593016572|FG000|Active Treatment Period|Lost to Follow-up|0|||
164178349|NCT04908202|593016573|FG001|Active Treatment Period|Lost to Follow-up|0|||
164178350|NCT04908202|593016574|FG002|Active Treatment Period|Lost to Follow-up|2|||
164178351|NCT04908202|593016575|FG003|Active Treatment Period|Lost to Follow-up|2|||
164178352|NCT04908202|593016572|FG000|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
164178353|NCT04908202|593016573|FG001|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
164178354|NCT04908202|593016574|FG002|Active Treatment Period|POOR/NON-COMPLIANCE|1|||
164178355|NCT04908202|593016575|FG003|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
164178356|NCT04908202|593016572|FG000|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
164178357|NCT04908202|593016573|FG001|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
164178358|NCT04908202|593016574|FG002|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
164178359|NCT04908202|593016575|FG003|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
164178360|NCT04908202|593016572|FG000|Active Treatment Period|ONGOING Treatment|0|||
164178361|NCT04908202|593016573|FG001|Active Treatment Period|ONGOING Treatment|0|||
164178362|NCT04908202|593016574|FG002|Active Treatment Period|ONGOING Treatment|117|||
164178363|NCT04908202|593016575|FG003|Active Treatment Period|ONGOING Treatment|114|||
164178364|NCT04506905|593016578|FG000|Overall Study|Lost to Follow-up|1|||
164178365|NCT04506905|593016579|FG001|Overall Study|Lost to Follow-up|0|||
164178366|NCT04506905|593016580|FG002|Overall Study|Lost to Follow-up|0|||
164178367|NCT04506905|593016581|FG003|Overall Study|Lost to Follow-up|1|||
164178368|NCT04506905|593016582|FG004|Overall Study|Lost to Follow-up|0|||
164178369|NCT04506905|593016583|FG005|Overall Study|Lost to Follow-up|0|||
164178370|NCT04506905|593016584|FG006|Overall Study|Lost to Follow-up|0|||
164178371|NCT04506905|593016585|FG007|Overall Study|Lost to Follow-up|0|||
164178372|NCT04506905|593016586|FG008|Overall Study|Lost to Follow-up|0|||
164178373|NCT04506905|593016578|FG000|Overall Study|Withdrawal by Subject|0|||
164178374|NCT04506905|593016579|FG001|Overall Study|Withdrawal by Subject|0|||
164178375|NCT04506905|593016580|FG002|Overall Study|Withdrawal by Subject|0|||
164178376|NCT04506905|593016581|FG003|Overall Study|Withdrawal by Subject|2|||
164178377|NCT04506905|593016582|FG004|Overall Study|Withdrawal by Subject|0|||
164178378|NCT04506905|593016583|FG005|Overall Study|Withdrawal by Subject|0|||
164178379|NCT04506905|593016584|FG006|Overall Study|Withdrawal by Subject|0|||
164178380|NCT04506905|593016585|FG007|Overall Study|Withdrawal by Subject|0|||
164178381|NCT04506905|593016586|FG008|Overall Study|Withdrawal by Subject|0|||
164178382|NCT01709864|593018540|FG000|Overall Study|Physician Decision|0|||
164178384|NCT01709864|593018540|FG000|Overall Study|subject/guardian decision|5|||
164178385|NCT01709864|593018541|FG001|Overall Study|subject/guardian decision|6|||
164178386|NCT01709864|593018540|FG000|Overall Study|Lost to Follow-up|1|||
164178387|NCT01709864|593018541|FG001|Overall Study|Lost to Follow-up|0|||
164178388|NCT01709864|593018540|FG000|Overall Study|non-compliance with study treatment|1|||
164178389|NCT01709864|593018541|FG001|Overall Study|non-compliance with study treatment|1|||
164178390|NCT01709864|593018540|FG000|Overall Study|Adverse Event|0|||
164178391|NCT01709864|593018541|FG001|Overall Study|Adverse Event|2|||
164178392|NCT01709864|593018540|FG000|Overall Study|Death|0|||
164178393|NCT01709864|593018541|FG001|Overall Study|Death|1|||
164178394|NCT03774394|593018542|FG000|Overall Study|Withdrawal by Subject|2|||
164178395|NCT03774394|593018543|FG001|Overall Study|Withdrawal by Subject|0|||
164178396|NCT02697916|593018544|FG000|Overall Study|Death|357|||
164178397|NCT02697916|593018545|FG001|Overall Study|Death|315|||
164178398|NCT02697916|593018544|FG000|Overall Study|Withdrawal by Subject|221|||
164178399|NCT02697916|593018545|FG001|Overall Study|Withdrawal by Subject|393|||
164178400|NCT01313221|593018546|FG000|Overall Study|Protocol Violation|0|||
164178401|NCT01313221|593018547|FG001|Overall Study|Protocol Violation|1|||
164178402|NCT01313221|593018548|FG002|Overall Study|Protocol Violation|1|||
164178403|NCT01313221|593018546|FG000|Overall Study|Non-compliance|3|||
164178404|NCT01313221|593018547|FG001|Overall Study|Non-compliance|0|||
164178405|NCT01313221|593018548|FG002|Overall Study|Non-compliance|2|||
164178406|NCT01313221|593018546|FG000|Overall Study|Withdrawal by Subject|2|||
164178407|NCT01313221|593018547|FG001|Overall Study|Withdrawal by Subject|3|||
164178408|NCT01313221|593018548|FG002|Overall Study|Withdrawal by Subject|5|||
164178409|NCT01313221|593018546|FG000|Overall Study|Requirement for alternative therapy|0|||
164178410|NCT01313221|593018547|FG001|Overall Study|Requirement for alternative therapy|1|||
164178411|NCT01313221|593018548|FG002|Overall Study|Requirement for alternative therapy|1|||
164178412|NCT01313221|593018546|FG000|Overall Study|Lost to Follow-up|6|||
164178413|NCT01313221|593018547|FG001|Overall Study|Lost to Follow-up|3|||
164178414|NCT01313221|593018548|FG002|Overall Study|Lost to Follow-up|1|||
164178415|NCT01313221|593018546|FG000|Overall Study|Other|1|||
164178416|NCT01313221|593018547|FG001|Overall Study|Other|0|||
164178417|NCT01313221|593018548|FG002|Overall Study|Other|0|||
164178418|NCT01313221|593018546|FG000|Overall Study|Adverse Event|0|||
164178419|NCT01313221|593018547|FG001|Overall Study|Adverse Event|0|||
164178420|NCT01313221|593018548|FG002|Overall Study|Adverse Event|7|||
164178421|NCT01313221|593018546|FG000|Overall Study|Disease progression|0|||
164178422|NCT01313221|593018547|FG001|Overall Study|Disease progression|0|||
164178423|NCT01313221|593018548|FG002|Overall Study|Disease progression|2|||
164178424|NCT01313221|593018546|FG000|Overall Study|Physician Decision|0|||
164178425|NCT01313221|593018547|FG001|Overall Study|Physician Decision|0|||
164178426|NCT01313221|593018548|FG002|Overall Study|Physician Decision|2|||
164178427|NCT01313221|593018546|FG000|Overall Study|Pregnancy|0|||
164178428|NCT01313221|593018547|FG001|Overall Study|Pregnancy|0|||
164178429|NCT01313221|593018548|FG002|Overall Study|Pregnancy|2|||
164178430|NCT03246061|593018549|FG000|Overall Study|Still in follow-up|15|||
164178431|NCT03246061|593018550|FG001|Overall Study|Still in follow-up|21|||
164178432|NCT02864316|593018551|FG000|Overall Study|Progressive Disease|2|||
164178433|NCT02864316|593018552|FG001|Overall Study|Progressive Disease|1|||
164178434|NCT02864316|593018551|FG000|Overall Study|Adverse Event|0|||
164178435|NCT02864316|593018552|FG001|Overall Study|Adverse Event|1|||
164178436|NCT00290693|593018553|FG000|Overall Study|Withdrawal by Subject|2|||
164178437|NCT05625477|593018554|FG000|Overall Study|Lost to Follow-up|2|||
164178438|NCT05625477|593018555|FG001|Overall Study|Lost to Follow-up|2|||
164178439|NCT05625477|593018556|FG002|Overall Study|Lost to Follow-up|1|||
164178440|NCT05625477|593018557|FG003|Overall Study|Lost to Follow-up|1|||
164178441|NCT05625477|593018558|FG004|Overall Study|Lost to Follow-up|0|||
164178442|NCT05625477|593018554|FG000|Overall Study|Covid quarantine|1|||
164178443|NCT05625477|593018555|FG001|Overall Study|Covid quarantine|0|||
164178444|NCT05625477|593018556|FG002|Overall Study|Covid quarantine|0|||
164178445|NCT05625477|593018557|FG003|Overall Study|Covid quarantine|0|||
164178446|NCT05625477|593018558|FG004|Overall Study|Covid quarantine|0|||
164178447|NCT01092637|593018561|FG000|Overall Study|Death|47|||
164178448|NCT01092637|593018562|FG001|Overall Study|Death|49|||
164178449|NCT01716520|593018567|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
164178450|NCT01716520|593018568|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
164178451|NCT01716520|593018569|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
164178452|NCT01716520|593018570|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
164178453|NCT01716520|593018571|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
164178454|NCT01716520|593018572|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
164178455|NCT01716520|593018567|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
164178456|NCT01716520|593018568|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
164178457|NCT01716520|593018569|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
164178458|NCT01716520|593018570|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
164178459|NCT01716520|593018571|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
164178460|NCT01716520|593018572|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
164178750|NCT00115037|593018637|FG003|Phase1|Withdrawal by Subject|0|||
164178461|NCT01716520|593018567|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164178462|NCT01716520|593018568|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
164178463|NCT01716520|593018569|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164178464|NCT01716520|593018570|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164178465|NCT01716520|593018571|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164178466|NCT01716520|593018572|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164178467|NCT01716520|593018567|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
164178468|NCT01716520|593018568|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
164178469|NCT01716520|593018569|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
164178470|NCT01716520|593018570|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
164178471|NCT01716520|593018571|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
164178472|NCT01716520|593018572|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
164178473|NCT01716520|593018567|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
164178474|NCT01716520|593018568|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
164178475|NCT01716520|593018569|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
164178476|NCT01716520|593018570|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
164178477|NCT01716520|593018571|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
164178478|NCT01716520|593018572|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
164178479|NCT01716520|593018567|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
164178480|NCT01716520|593018568|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
164178481|NCT01716520|593018569|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
164178482|NCT01716520|593018570|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
164178483|NCT01716520|593018571|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
164178484|NCT01716520|593018572|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
164178485|NCT01716520|593018567|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
164178486|NCT01716520|593018568|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
164178487|NCT01716520|593018569|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
164178488|NCT01716520|593018570|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
164178489|NCT01716520|593018571|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
164178490|NCT01716520|593018572|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
164178491|NCT01716520|593018567|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
164178492|NCT01716520|593018568|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
164178493|NCT01716520|593018569|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
164178494|NCT01716520|593018570|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
164178495|NCT01716520|593018571|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
164178496|NCT01716520|593018572|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
164178497|NCT01716520|593018567|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
164178498|NCT01716520|593018568|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
164178499|NCT01716520|593018569|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
164178500|NCT01716520|593018570|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
164178501|NCT01716520|593018571|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
164178502|NCT01716520|593018572|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
164178503|NCT01716520|593018567|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
164178504|NCT01716520|593018568|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
164178505|NCT01716520|593018569|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
164178506|NCT01716520|593018570|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
164178507|NCT01716520|593018571|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
164178508|NCT01716520|593018572|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
164178509|NCT01716520|593018567|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
164178510|NCT01716520|593018568|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
164178511|NCT01716520|593018569|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
164178512|NCT01716520|593018570|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
164178513|NCT01716520|593018571|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
164178514|NCT01716520|593018572|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
164178515|NCT01716520|593018567|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
164178516|NCT01716520|593018568|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
164178517|NCT01716520|593018569|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
164178518|NCT01716520|593018570|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
164178519|NCT01716520|593018571|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
164178520|NCT01716520|593018572|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
164178521|NCT01716520|593018567|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
164178522|NCT01716520|593018568|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
164178523|NCT01716520|593018569|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
164178524|NCT01716520|593018570|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
164178525|NCT01716520|593018571|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
164178526|NCT01716520|593018572|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
164178527|NCT01716520|593018567|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164178528|NCT01716520|593018568|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164178529|NCT01716520|593018569|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164178530|NCT01716520|593018570|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164178531|NCT01716520|593018571|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164178532|NCT01716520|593018572|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
164178533|NCT01716520|593018567|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
164178534|NCT01716520|593018568|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
164178535|NCT01716520|593018569|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
164178536|NCT01716520|593018570|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
164178537|NCT01716520|593018571|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
164178538|NCT01716520|593018572|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
164178539|NCT05916131|593018575|FG000|Overall Study|Lost to Follow-up|0|||
164178540|NCT05916131|593018576|FG001|Overall Study|Lost to Follow-up|0|||
164178541|NCT05916131|593018577|FG002|Overall Study|Lost to Follow-up|1|||
164178542|NCT05916131|593018578|FG003|Overall Study|Lost to Follow-up|0|||
164178543|NCT03030118|593018579|FG000|Overall Study|Achieved SLE Diagnosis|11|||
164178544|NCT03030118|593018580|FG001|Overall Study|Achieved SLE Diagnosis|10|||
164178545|NCT03030118|593018579|FG000|Overall Study|Adverse Event|1|||
164178546|NCT03030118|593018580|FG001|Overall Study|Adverse Event|1|||
164178547|NCT03030118|593018579|FG000|Overall Study|Pregnancy|2|||
164178548|NCT03030118|593018580|FG001|Overall Study|Pregnancy|2|||
164178549|NCT03030118|593018579|FG000|Overall Study|Lost to Follow-up|5|||
164178550|NCT03030118|593018580|FG001|Overall Study|Lost to Follow-up|6|||
164178551|NCT03030118|593018579|FG000|Overall Study|Concomitant Medications|1|||
164178552|NCT03030118|593018580|FG001|Overall Study|Concomitant Medications|1|||
164178553|NCT03030118|593018579|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
164178554|NCT03030118|593018580|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
164178555|NCT03030118|593018579|FG000|Overall Study|Other|2|||
164178556|NCT03030118|593018580|FG001|Overall Study|Other|0|||
164178557|NCT03030118|593018579|FG000|Overall Study|Withdrawal by Subject|26|||
164178558|NCT03030118|593018580|FG001|Overall Study|Withdrawal by Subject|21|||
164178559|NCT03030118|593018579|FG000|Overall Study|Protocol Violation|1|||
164178560|NCT03030118|593018580|FG001|Overall Study|Protocol Violation|6|||
164178561|NCT01447446|593018581|FG000|Overall Study|Death|6|||
164178562|NCT01447446|593018582|FG001|Overall Study|Death|3|||
164178563|NCT01447446|593018583|FG002|Overall Study|Death|2|||
164178564|NCT01447446|593018584|FG003|Overall Study|Death|1|||
164178565|NCT01447446|593018585|FG004|Overall Study|Death|7|||
164178566|NCT01447446|593018586|FG005|Overall Study|Death|0|||
164178567|NCT01447446|593018581|FG000|Overall Study|Adverse Event|3|||
164178568|NCT01447446|593018582|FG001|Overall Study|Adverse Event|0|||
164178569|NCT01447446|593018583|FG002|Overall Study|Adverse Event|1|||
164178570|NCT01447446|593018584|FG003|Overall Study|Adverse Event|0|||
164178571|NCT01447446|593018585|FG004|Overall Study|Adverse Event|2|||
164178572|NCT01447446|593018586|FG005|Overall Study|Adverse Event|0|||
164178573|NCT01447446|593018581|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
164178574|NCT01447446|593018582|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
164178575|NCT01447446|593018583|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
164178576|NCT01447446|593018584|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
164178577|NCT01447446|593018585|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
164178578|NCT01447446|593018586|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
164178579|NCT01447446|593018581|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
164178580|NCT01447446|593018582|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
164178581|NCT01447446|593018583|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
164178582|NCT01447446|593018584|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
164178583|NCT01447446|593018585|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
164178584|NCT01447446|593018586|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
164178585|NCT01447446|593018581|FG000|Overall Study|Administrative/Other|34|||
164178586|NCT01447446|593018582|FG001|Overall Study|Administrative/Other|9|||
164178587|NCT01447446|593018583|FG002|Overall Study|Administrative/Other|10|||
164178588|NCT01447446|593018584|FG003|Overall Study|Administrative/Other|2|||
164178589|NCT01447446|593018585|FG004|Overall Study|Administrative/Other|33|||
164178590|NCT01447446|593018586|FG005|Overall Study|Administrative/Other|4|||
164178591|NCT01447446|593018581|FG000|Overall Study|SVR12 Assessment|13|||
164178592|NCT01447446|593018582|FG001|Overall Study|SVR12 Assessment|1|||
164178593|NCT01447446|593018583|FG002|Overall Study|SVR12 Assessment|2|||
164178594|NCT01447446|593018584|FG003|Overall Study|SVR12 Assessment|1|||
164178595|NCT01447446|593018585|FG004|Overall Study|SVR12 Assessment|5|||
164178596|NCT01447446|593018586|FG005|Overall Study|SVR12 Assessment|5|||
164178597|NCT01447446|593018581|FG000|Overall Study|New Treatment Started|8|||
164178598|NCT01447446|593018582|FG001|Overall Study|New Treatment Started|2|||
164178599|NCT01447446|593018583|FG002|Overall Study|New Treatment Started|1|||
164178600|NCT01447446|593018584|FG003|Overall Study|New Treatment Started|0|||
164178601|NCT01447446|593018585|FG004|Overall Study|New Treatment Started|2|||
164178602|NCT01447446|593018586|FG005|Overall Study|New Treatment Started|0|||
164178603|NCT01447446|593018581|FG000|Overall Study|Reason not Specified|1|||
164178604|NCT01447446|593018582|FG001|Overall Study|Reason not Specified|1|||
164178605|NCT01447446|593018583|FG002|Overall Study|Reason not Specified|1|||
164178606|NCT01447446|593018584|FG003|Overall Study|Reason not Specified|1|||
164178607|NCT01447446|593018585|FG004|Overall Study|Reason not Specified|1|||
164178608|NCT01447446|593018586|FG005|Overall Study|Reason not Specified|0|||
164178609|NCT02052596|593018587|FG000|Active Phase|Adverse Event|3|||
164178610|NCT02052596|593018588|FG001|Active Phase|Adverse Event|2|||
164178611|NCT02052596|593018587|FG000|Active Phase|Lost to Follow-up|8|||
164178612|NCT02052596|593018588|FG001|Active Phase|Lost to Follow-up|11|||
164178613|NCT02052596|593018587|FG000|Active Phase|Protocol Violation|1|||
164178614|NCT02052596|593018588|FG001|Active Phase|Protocol Violation|2|||
164178615|NCT02052596|593018587|FG000|Active Phase|Withdrawal by Subject|3|||
164178616|NCT02052596|593018588|FG001|Active Phase|Withdrawal by Subject|4|||
164178617|NCT02052596|593018587|FG000|Active Phase|Enrolled in error|1|||
164178618|NCT02052596|593018588|FG001|Active Phase|Enrolled in error|0|||
164178619|NCT02052596|593018587|FG000|Active Phase|Lost due to Crohn's disease|0|||
164178620|NCT02052596|593018588|FG001|Active Phase|Lost due to Crohn's disease|1|||
164178621|NCT02052596|593018587|FG000|Safety Phase|Adverse Event|6|||
164178622|NCT02052596|593018588|FG001|Safety Phase|Adverse Event|3|||
164178623|NCT02052596|593018587|FG000|Safety Phase|Lost to Follow-up|11|||
164178624|NCT02052596|593018588|FG001|Safety Phase|Lost to Follow-up|18|||
164178625|NCT02052596|593018587|FG000|Safety Phase|Protocol Violation|1|||
164178626|NCT02052596|593018588|FG001|Safety Phase|Protocol Violation|2|||
164178627|NCT02052596|593018587|FG000|Safety Phase|Withdrawal by Subject|8|||
164178628|NCT02052596|593018588|FG001|Safety Phase|Withdrawal by Subject|11|||
164178629|NCT02052596|593018587|FG000|Safety Phase|Enrolled in error|1|||
164178630|NCT02052596|593018588|FG001|Safety Phase|Enrolled in error|0|||
164178631|NCT02052596|593018587|FG000|Safety Phase|Lost due to Crohn's disease|0|||
164178632|NCT02052596|593018588|FG001|Safety Phase|Lost due to Crohn's disease|1|||
164178633|NCT04829331|593018591|FG000|Overall Study|Lost to Follow-up|1|||
164178634|NCT04829331|593018592|FG001|Overall Study|Lost to Follow-up|0|||
164178635|NCT05323994|593018593|FG000|Overall Study|Protocol Violation|1|||
164178636|NCT00454818|593018595|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
164178637|NCT00454818|593018596|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
164178638|NCT00454818|593018597|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
164178639|NCT00454818|593018598|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
164178640|NCT00454818|593018599|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
164178641|NCT00454818|593018595|FG000|Phase I: Open-label Dose-escalation|Death|0|||
164178642|NCT00454818|593018596|FG001|Phase I: Open-label Dose-escalation|Death|1|||
164178643|NCT00454818|593018597|FG002|Phase I: Open-label Dose-escalation|Death|0|||
164178644|NCT00454818|593018598|FG003|Phase I: Open-label Dose-escalation|Death|0|||
164178645|NCT00454818|593018599|FG004|Phase I: Open-label Dose-escalation|Death|0|||
164178646|NCT00454818|593018595|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
164178647|NCT00454818|593018596|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
164178648|NCT00454818|593018597|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
164178649|NCT00454818|593018598|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
164178650|NCT00454818|593018599|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
164178651|NCT00454818|593018595|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
164178652|NCT00454818|593018596|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
164178653|NCT00454818|593018597|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
164178654|NCT00454818|593018598|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
164178655|NCT00454818|593018599|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
164178656|NCT00454818|593018595|FG000|Phase 2: Randomized Double-blind|Death|0|||
164178657|NCT00454818|593018596|FG001|Phase 2: Randomized Double-blind|Death|1|||
164178658|NCT00454818|593018597|FG002|Phase 2: Randomized Double-blind|Death|0|||
164178659|NCT00454818|593018598|FG003|Phase 2: Randomized Double-blind|Death|0|||
164178660|NCT00454818|593018599|FG004|Phase 2: Randomized Double-blind|Death|1|||
164178661|NCT00454818|593018595|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
164178662|NCT00454818|593018596|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
164178663|NCT00454818|593018597|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
164178664|NCT00454818|593018598|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
164178665|NCT00454818|593018599|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
164178666|NCT00454818|593018595|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
164178667|NCT00454818|593018596|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
164178668|NCT00454818|593018597|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
164178669|NCT00454818|593018598|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
164178670|NCT00454818|593018599|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
164178671|NCT00943670|593018605|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
164178672|NCT00943670|593018605|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
164178751|NCT00115037|593018638|FG004|Phase1|Withdrawal by Subject|0|||
164178673|NCT00943670|593018605|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
164178674|NCT00943670|593018605|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
164178675|NCT00943670|593018605|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
164178676|NCT00943670|593018605|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
164178677|NCT00943670|593018605|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
164178678|NCT00943670|593018605|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
164178679|NCT00943670|593018605|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
164178680|NCT00943670|593018605|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
164178681|NCT02604550|593018606|FG000|Overall Study|Lost to Follow-up|7|||
164178682|NCT02604550|593018607|FG001|Overall Study|Lost to Follow-up|6|||
164178683|NCT02604550|593018606|FG000|Overall Study|Withdrawal by Subject|0|||
164178684|NCT02604550|593018607|FG001|Overall Study|Withdrawal by Subject|1|||
164178685|NCT02604550|593018606|FG000|Overall Study|Incomplete data using paper journal|18|||
164178686|NCT02604550|593018607|FG001|Overall Study|Incomplete data using paper journal|19|||
164178687|NCT00908076|593018608|FG000|Overall Study|Lack of Efficacy|1|||
164178688|NCT00908076|593018609|FG001|Overall Study|Lack of Efficacy|1|||
164178689|NCT04526574|593018610|FG000|Overall Study|Protocol Violation|3|||
164178690|NCT04526574|593018611|FG001|Overall Study|Protocol Violation|1|||
164178691|NCT04526574|593018610|FG000|Overall Study|Withdrawal by Subject|12|||
164178692|NCT04526574|593018611|FG001|Overall Study|Withdrawal by Subject|9|||
164178693|NCT04526574|593018610|FG000|Overall Study|Other|1|||
164178694|NCT04526574|593018611|FG001|Overall Study|Other|2|||
164178695|NCT04526574|593018610|FG000|Overall Study|Adverse Event|1|||
164178696|NCT04526574|593018611|FG001|Overall Study|Adverse Event|1|||
164178697|NCT04526574|593018610|FG000|Overall Study|Death|2|||
164178698|NCT04526574|593018611|FG001|Overall Study|Death|3|||
164178699|NCT04526574|593018610|FG000|Overall Study|Lost to Follow-up|9|||
164178700|NCT04526574|593018611|FG001|Overall Study|Lost to Follow-up|9|||
164178701|NCT04526574|593018610|FG000|Overall Study|No longer meets eligibility criteria|8|||
164178702|NCT04526574|593018611|FG001|Overall Study|No longer meets eligibility criteria|8|||
164178703|NCT01032070|593018612|FG000|Overall Study|Disease progression|13|||
164178704|NCT01032070|593018613|FG001|Overall Study|Disease progression|8|||
164178705|NCT01032070|593018612|FG000|Overall Study|Medical or ethical reasons|0|||
164178706|NCT01032070|593018613|FG001|Overall Study|Medical or ethical reasons|2|||
164178707|NCT01032070|593018612|FG000|Overall Study|Withdrawal by Subject|0|||
164178708|NCT01032070|593018613|FG001|Overall Study|Withdrawal by Subject|2|||
164178709|NCT02554318|593018614|FG000|Overall Study|Withdrawal by Subject|10|||
164178710|NCT02554318|593018615|FG001|Overall Study|Withdrawal by Subject|8|||
164178711|NCT02332239|593018618|FG000|Overall Study|Lost to Follow-up|4|||
164178712|NCT02332239|593018619|FG001|Overall Study|Lost to Follow-up|6|||
164178713|NCT00894790|593018620|FG000|Overall Study|Protocol Violation|0|||
164178714|NCT00894790|593018621|FG001|Overall Study|Protocol Violation|1|||
164178715|NCT00894790|593018620|FG000|Overall Study|Lost to Follow-up|0|||
164178716|NCT00894790|593018621|FG001|Overall Study|Lost to Follow-up|1|||
164178717|NCT00894790|593018620|FG000|Overall Study|Did not meet entrance criteria|1|||
164178718|NCT00894790|593018621|FG001|Overall Study|Did not meet entrance criteria|0|||
164178719|NCT01472965|593018622|FG000|Overall Study|Withdrawal by Subject|1|||
164178720|NCT01472965|593018623|FG001|Overall Study|Withdrawal by Subject|0|||
164178721|NCT00006305|593018624|FG000|Overall Study|Withdrawal by Subject|17|||
164178722|NCT00006305|593018625|FG001|Overall Study|Withdrawal by Subject|10|||
164178723|NCT00006305|593018626|FG002|Overall Study|Withdrawal by Subject|15|||
164178724|NCT00006305|593018627|FG003|Overall Study|Withdrawal by Subject|14|||
164178725|NCT00662558|593018628|FG000|Overall Study|Adverse Event|21|||
164178726|NCT00662558|593018629|FG001|Overall Study|Adverse Event|59|||
164178727|NCT00662558|593018628|FG000|Overall Study|Lack of Efficacy|4|||
164178728|NCT00662558|593018629|FG001|Overall Study|Lack of Efficacy|7|||
164178729|NCT00662558|593018628|FG000|Overall Study|Lost to Follow-up|13|||
164178730|NCT00662558|593018629|FG001|Overall Study|Lost to Follow-up|10|||
164178731|NCT00662558|593018628|FG000|Overall Study|Other|9|||
164178732|NCT00662558|593018629|FG001|Overall Study|Other|14|||
164178733|NCT00662558|593018628|FG000|Overall Study|Withdrawal by Subject|7|||
164178734|NCT00662558|593018629|FG001|Overall Study|Withdrawal by Subject|12|||
164178735|NCT00662558|593018628|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
164178736|NCT00662558|593018629|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
164178737|NCT00329641|593018630|FG000|Overall Study|Did not start treatment|1|||
164178738|NCT00329641|593018630|FG000|Overall Study|Not eligible|1|||
164178739|NCT00329641|593018630|FG000|Overall Study|Adverse Event|3|||
164178740|NCT00329641|593018630|FG000|Overall Study|Other reason, not protocol specified|1|||
164178741|NCT00115037|593018634|FG000|Phase1|Lost to Follow-up|16|||
164178742|NCT00115037|593018635|FG001|Phase1|Lost to Follow-up|23|||
164178743|NCT00115037|593018636|FG002|Phase1|Lost to Follow-up|0|||
164178744|NCT00115037|593018637|FG003|Phase1|Lost to Follow-up|0|||
164178745|NCT00115037|593018638|FG004|Phase1|Lost to Follow-up|0|||
164178746|NCT00115037|593018639|FG005|Phase1|Lost to Follow-up|0|||
164178747|NCT00115037|593018634|FG000|Phase1|Withdrawal by Subject|9|||
164178748|NCT00115037|593018635|FG001|Phase1|Withdrawal by Subject|4|||
164178749|NCT00115037|593018636|FG002|Phase1|Withdrawal by Subject|0|||
164178752|NCT00115037|593018639|FG005|Phase1|Withdrawal by Subject|0|||
164178753|NCT00115037|593018634|FG000|Phase2|Death|0|||
164178754|NCT00115037|593018635|FG001|Phase2|Death|0|||
164178755|NCT00115037|593018636|FG002|Phase2|Death|1|||
164178756|NCT00115037|593018637|FG003|Phase2|Death|0|||
164178757|NCT00115037|593018638|FG004|Phase2|Death|0|||
164178758|NCT00115037|593018639|FG005|Phase2|Death|1|||
164178759|NCT00115037|593018634|FG000|Phase2|Withdrawal by Subject|0|||
164178760|NCT00115037|593018635|FG001|Phase2|Withdrawal by Subject|0|||
164178761|NCT00115037|593018636|FG002|Phase2|Withdrawal by Subject|2|||
164178762|NCT00115037|593018637|FG003|Phase2|Withdrawal by Subject|1|||
164178763|NCT00115037|593018638|FG004|Phase2|Withdrawal by Subject|2|||
164178764|NCT00115037|593018639|FG005|Phase2|Withdrawal by Subject|1|||
164178765|NCT00115037|593018634|FG000|Phase2|Lost to Follow-up|0|||
164178766|NCT00115037|593018635|FG001|Phase2|Lost to Follow-up|0|||
164178767|NCT00115037|593018636|FG002|Phase2|Lost to Follow-up|12|||
164178768|NCT00115037|593018637|FG003|Phase2|Lost to Follow-up|14|||
164178769|NCT00115037|593018638|FG004|Phase2|Lost to Follow-up|4|||
164178770|NCT00115037|593018639|FG005|Phase2|Lost to Follow-up|10|||
164178771|NCT01398410|593018640|FG000|Overall Study|Adverse Event|12|||
164178772|NCT01398410|593018641|FG001|Overall Study|Adverse Event|16|||
164178773|NCT01398410|593018640|FG000|Overall Study|Participants Choice|8|||
164178774|NCT01398410|593018641|FG001|Overall Study|Participants Choice|11|||
164178775|NCT01398410|593018640|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
164178776|NCT01398410|593018641|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
164178777|NCT01398410|593018640|FG000|Overall Study|Other|36|||
164178778|NCT01398410|593018641|FG001|Overall Study|Other|29|||
164178779|NCT00334802|593018642|FG000|Overall Study|Progressive Disease|2|||
164178780|NCT00334802|593018643|FG001|Overall Study|Progressive Disease|24|||
164178781|NCT00334802|593018642|FG000|Overall Study|Toxicity|1|||
164178782|NCT00334802|593018643|FG001|Overall Study|Toxicity|5|||
164178783|NCT00334802|593018642|FG000|Overall Study|Lack of Efficacy|1|||
164178784|NCT00334802|593018643|FG001|Overall Study|Lack of Efficacy|3|||
164178785|NCT00334802|593018642|FG000|Overall Study|Patient Condition Aggrevated|1|||
164178786|NCT00334802|593018643|FG001|Overall Study|Patient Condition Aggrevated|0|||
164178787|NCT00334802|593018642|FG000|Overall Study|Physician Decision|1|||
164178788|NCT00334802|593018643|FG001|Overall Study|Physician Decision|0|||
164178789|NCT00334802|593018642|FG000|Overall Study|Withdrawal by Subject|0|||
164178790|NCT00334802|593018643|FG001|Overall Study|Withdrawal by Subject|4|||
164178791|NCT00334802|593018642|FG000|Overall Study|Adverse Event|0|||
164178792|NCT00334802|593018643|FG001|Overall Study|Adverse Event|3|||
164178793|NCT00334802|593018642|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
164178794|NCT00334802|593018643|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
164178795|NCT03515629|593018654|FG000|Overall Study|Death|0|||
164178796|NCT03515629|593018655|FG001|Overall Study|Death|1|||
164178797|NCT03515629|593018656|FG002|Overall Study|Death|1|||
164178798|NCT03515629|593018654|FG000|Overall Study|Progressive disease|0|||
164178799|NCT03515629|593018655|FG001|Overall Study|Progressive disease|1|||
164178800|NCT03515629|593018656|FG002|Overall Study|Progressive disease|0|||
164178801|NCT03329248|593018657|FG000|Overall Study|Progressive Disease|6|||
164178802|NCT01886781|593018658|FG000|Overall Study|Protocol Violation|5|||
164178803|NCT01886781|593018659|FG001|Overall Study|Protocol Violation|0|||
164178804|NCT01886781|593018658|FG000|Overall Study|Adverse Event|1|||
164178805|NCT01886781|593018659|FG001|Overall Study|Adverse Event|0|||
164178806|NCT01886781|593018658|FG000|Overall Study|Lost to Follow-up|5|||
164178807|NCT01886781|593018659|FG001|Overall Study|Lost to Follow-up|0|||
164178808|NCT01886781|593018658|FG000|Overall Study|Withdrawal by Subject|2|||
164178809|NCT01886781|593018659|FG001|Overall Study|Withdrawal by Subject|1|||
164178810|NCT01886781|593018658|FG000|Overall Study|Worsening of symptoms|1|||
164178811|NCT01886781|593018659|FG001|Overall Study|Worsening of symptoms|1|||
164178812|NCT00987402|593018660|FG000|Overall Study|Insufficient data entry|86|||
164178813|NCT00987402|593018661|FG001|Overall Study|Insufficient data entry|98|||
164178814|NCT03000530|593018665|FG000|Overall Study|Adverse Event|0|||
164178815|NCT03000530|593018666|FG001|Overall Study|Adverse Event|0|||
164178816|NCT03000530|593018667|FG002|Overall Study|Adverse Event|2|||
164178817|NCT03000530|593018665|FG000|Overall Study|Lost to Follow-up|0|||
164178818|NCT03000530|593018666|FG001|Overall Study|Lost to Follow-up|3|||
164178819|NCT03000530|593018667|FG002|Overall Study|Lost to Follow-up|1|||
164178820|NCT03000530|593018665|FG000|Overall Study|Withdrawal by Subject|0|||
164178821|NCT03000530|593018666|FG001|Overall Study|Withdrawal by Subject|2|||
164178822|NCT03000530|593018667|FG002|Overall Study|Withdrawal by Subject|1|||
164178823|NCT03597022|593018670|FG000|Overall Study|Premature termination of the study|7|||
164178824|NCT03597022|593018671|FG001|Overall Study|Premature termination of the study|7|||
164178825|NCT03597022|593018672|FG002|Overall Study|Premature termination of the study|8|||
164178826|NCT03597022|593018670|FG000|Overall Study|Serious adverse event|1|||
164178827|NCT03597022|593018671|FG001|Overall Study|Serious adverse event|1|||
164178828|NCT03597022|593018672|FG002|Overall Study|Serious adverse event|0|||
164178829|NCT01430624|593018673|FG000|Overall Study|Lost to Follow-up|23|||
164178830|NCT01430624|593018674|FG001|Overall Study|Lost to Follow-up|29|||
164178831|NCT01430624|593018675|FG002|Overall Study|Lost to Follow-up|27|||
164178832|NCT01430624|593018673|FG000|Overall Study|technical or eligibility|5|||
164178833|NCT01430624|593018674|FG001|Overall Study|technical or eligibility|5|||
164178834|NCT01430624|593018675|FG002|Overall Study|technical or eligibility|2|||
164178835|NCT01672294|593018680|FG000|Overall Study|Withdrawal by Subject|4|||
164178836|NCT01672294|593018681|FG001|Overall Study|Withdrawal by Subject|4|||
164178837|NCT01672294|593018682|FG002|Overall Study|Withdrawal by Subject|4|||
164178838|NCT01672294|593018683|FG003|Overall Study|Withdrawal by Subject|4|||
164178839|NCT01672294|593018680|FG000|Overall Study|Excluded by study|1|||
164178840|NCT01672294|593018681|FG001|Overall Study|Excluded by study|1|||
164178841|NCT01672294|593018682|FG002|Overall Study|Excluded by study|0|||
164178842|NCT01672294|593018683|FG003|Overall Study|Excluded by study|0|||
164178843|NCT01672294|593018680|FG000|Overall Study|Lost to Follow-up|1|||
164178844|NCT01672294|593018681|FG001|Overall Study|Lost to Follow-up|16|||
164178845|NCT01672294|593018682|FG002|Overall Study|Lost to Follow-up|7|||
164178846|NCT01672294|593018683|FG003|Overall Study|Lost to Follow-up|9|||
164178847|NCT03379792|593018684|FG000|Overall Study|Physician Decision|0|||
164178848|NCT03379792|593018685|FG001|Overall Study|Physician Decision|0|||
164178849|NCT03379792|593018686|FG002|Overall Study|Physician Decision|0|||
164178850|NCT03379792|593018687|FG003|Overall Study|Physician Decision|1|||
164178851|NCT03379792|593018688|FG004|Overall Study|Physician Decision|0|||
164178852|NCT03379792|593018689|FG005|Overall Study|Physician Decision|0|||
164178853|NCT03379792|593018684|FG000|Overall Study|Withdrawal by Subject|0|||
164178854|NCT03379792|593018685|FG001|Overall Study|Withdrawal by Subject|0|||
164178855|NCT03379792|593018686|FG002|Overall Study|Withdrawal by Subject|0|||
164178856|NCT03379792|593018687|FG003|Overall Study|Withdrawal by Subject|0|||
164178857|NCT03379792|593018688|FG004|Overall Study|Withdrawal by Subject|1|||
164178858|NCT03379792|593018689|FG005|Overall Study|Withdrawal by Subject|1|||
164178859|NCT00306787|593018690|FG000|Overall Study|Discontinued without taking study drug|208|||
164178860|NCT00306787|593018691|FG001|Overall Study|Discontinued without taking study drug|215|||
164178861|NCT00306787|593018690|FG000|Overall Study|Adverse Event|1|||
164178862|NCT00306787|593018691|FG001|Overall Study|Adverse Event|1|||
164178863|NCT00306787|593018690|FG000|Overall Study|Lack of Efficacy|1|||
164178864|NCT00306787|593018691|FG001|Overall Study|Lack of Efficacy|0|||
164178865|NCT00306787|593018690|FG000|Overall Study|Protocol Violation|8|||
164178866|NCT00306787|593018691|FG001|Overall Study|Protocol Violation|10|||
164178867|NCT00306787|593018690|FG000|Overall Study|Withdrawal by Subject|2|||
164178868|NCT00306787|593018691|FG001|Overall Study|Withdrawal by Subject|9|||
164178869|NCT00306787|593018690|FG000|Overall Study|Lost to Follow-up|9|||
164178870|NCT00306787|593018691|FG001|Overall Study|Lost to Follow-up|6|||
164178871|NCT00306787|593018690|FG000|Overall Study|Administrative problems|4|||
164178872|NCT00306787|593018691|FG001|Overall Study|Administrative problems|0|||
164178873|NCT00306787|593018690|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164178874|NCT00306787|593018691|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164178875|NCT00369161|593018697|FG000|Overall Study|Adverse Event|15|||
164178876|NCT00369161|593018698|FG001|Overall Study|Adverse Event|13|||
164178877|NCT00369161|593018697|FG000|Overall Study|Abnormal laboratory value|0|||
164178878|NCT00369161|593018698|FG001|Overall Study|Abnormal laboratory value|1|||
164178879|NCT00369161|593018697|FG000|Overall Study|Lack of Efficacy|3|||
164178880|NCT00369161|593018698|FG001|Overall Study|Lack of Efficacy|1|||
164178881|NCT00369161|593018697|FG000|Overall Study|Protocol Violation|0|||
164178882|NCT00369161|593018698|FG001|Overall Study|Protocol Violation|2|||
164178883|NCT00369161|593018697|FG000|Overall Study|Withdrawal by Subject|2|||
164178884|NCT00369161|593018698|FG001|Overall Study|Withdrawal by Subject|3|||
164178885|NCT00369161|593018697|FG000|Overall Study|Death|1|||
164178886|NCT00369161|593018698|FG001|Overall Study|Death|2|||
164178887|NCT00369161|593018697|FG000|Overall Study|Graft loss|4|||
164178888|NCT00369161|593018698|FG001|Overall Study|Graft loss|0|||
164178889|NCT00369161|593018697|FG000|Overall Study|Administrative Problem|2|||
164178890|NCT00369161|593018698|FG001|Overall Study|Administrative Problem|2|||
164178891|NCT01870297|593018701|FG000|Overall Study|Adverse Event|0|||
164178892|NCT01870297|593018702|FG001|Overall Study|Adverse Event|0|||
164178893|NCT01870297|593018703|FG002|Overall Study|Adverse Event|0|||
164178894|NCT01870297|593018704|FG003|Overall Study|Adverse Event|0|||
164178895|NCT01870297|593018705|FG004|Overall Study|Adverse Event|2|||
164178896|NCT01870297|593018706|FG005|Overall Study|Adverse Event|0|||
164178897|NCT01870297|593018707|FG006|Overall Study|Adverse Event|0|||
164178898|NCT01870297|593018701|FG000|Overall Study|Lost to Follow-up|0|||
164178899|NCT01870297|593018702|FG001|Overall Study|Lost to Follow-up|1|||
164178900|NCT01870297|593018703|FG002|Overall Study|Lost to Follow-up|1|||
164178901|NCT01870297|593018704|FG003|Overall Study|Lost to Follow-up|0|||
164178902|NCT01870297|593018705|FG004|Overall Study|Lost to Follow-up|0|||
164178903|NCT01870297|593018706|FG005|Overall Study|Lost to Follow-up|0|||
164178904|NCT01870297|593018707|FG006|Overall Study|Lost to Follow-up|0|||
164178905|NCT01870297|593018701|FG000|Overall Study|Withdrawal by Subject|0|||
164178906|NCT01870297|593018702|FG001|Overall Study|Withdrawal by Subject|0|||
164178907|NCT01870297|593018703|FG002|Overall Study|Withdrawal by Subject|0|||
164178908|NCT01870297|593018704|FG003|Overall Study|Withdrawal by Subject|0|||
164178909|NCT01870297|593018705|FG004|Overall Study|Withdrawal by Subject|1|||
164178910|NCT01870297|593018706|FG005|Overall Study|Withdrawal by Subject|1|||
164178911|NCT01870297|593018707|FG006|Overall Study|Withdrawal by Subject|1|||
164178912|NCT01870297|593018701|FG000|Overall Study|Sponsor Decision|0|||
164178913|NCT01870297|593018702|FG001|Overall Study|Sponsor Decision|6|||
164178914|NCT01870297|593018703|FG002|Overall Study|Sponsor Decision|0|||
164178915|NCT01870297|593018704|FG003|Overall Study|Sponsor Decision|0|||
164178916|NCT01870297|593018705|FG004|Overall Study|Sponsor Decision|0|||
164178917|NCT01870297|593018706|FG005|Overall Study|Sponsor Decision|0|||
164178918|NCT01870297|593018707|FG006|Overall Study|Sponsor Decision|1|||
164178919|NCT04249622|593018710|FG000|Overall Study|Withdrawal by Subject|1|||
164178920|NCT04249622|593018711|FG001|Overall Study|Withdrawal by Subject|1|||
164178921|NCT04249622|593018710|FG000|Overall Study|Alternative therapy|1|||
164178922|NCT04249622|593018711|FG001|Overall Study|Alternative therapy|0|||
164178923|NCT04249622|593018710|FG000|Overall Study|Discontinuation of pertuzumab|1|||
164178924|NCT04249622|593018711|FG001|Overall Study|Discontinuation of pertuzumab|0|||
164178925|NCT03689543|593018713|FG000|Overall Study|Adverse Event|0|||
164178926|NCT03689543|593018714|FG001|Overall Study|Adverse Event|0|||
164178927|NCT03689543|593018715|FG002|Overall Study|Adverse Event|1|||
164178928|NCT00586508|593018716|FG000|Overall Study|Progressive disease|52|||
164178929|NCT00586508|593018717|FG001|Overall Study|Progressive disease|8|||
164178930|NCT00586508|593018716|FG000|Overall Study|Death|0|||
164178931|NCT00586508|593018717|FG001|Overall Study|Death|1|||
164178932|NCT00586508|593018716|FG000|Overall Study|Adverse Event|12|||
164178933|NCT00586508|593018717|FG001|Overall Study|Adverse Event|4|||
164178934|NCT00586508|593018716|FG000|Overall Study|Withdrawal by Subject|4|||
164178935|NCT00586508|593018717|FG001|Overall Study|Withdrawal by Subject|0|||
164178936|NCT05619536|593018718|FG000|Overall Study|Withdrawal by Subject|0|||
164178937|NCT05619536|593018719|FG001|Overall Study|Withdrawal by Subject|1|||
164178938|NCT05619536|593018720|FG002|Overall Study|Withdrawal by Subject|0|||
164178939|NCT05619536|593018721|FG003|Overall Study|Withdrawal by Subject|1|||
164178940|NCT05619536|593018718|FG000|Overall Study|Lost to Follow-up|0|||
164178941|NCT05619536|593018719|FG001|Overall Study|Lost to Follow-up|1|||
164178942|NCT05619536|593018720|FG002|Overall Study|Lost to Follow-up|1|||
164178943|NCT05619536|593018721|FG003|Overall Study|Lost to Follow-up|0|||
164178944|NCT03301740|593018722|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
164178945|NCT03301740|593018723|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
164178946|NCT03301740|593018722|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
164178947|NCT03301740|593018723|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
164178948|NCT02345889|593018727|FG000|Overall Study|Inadequate Bowel Prep|17|||
164178949|NCT02345889|593018728|FG001|Overall Study|Inadequate Bowel Prep|16|||
164178950|NCT02345889|593018729|FG002|Overall Study|Inadequate Bowel Prep|18|||
164178951|NCT02345889|593018730|FG003|Overall Study|Inadequate Bowel Prep|14|||
164178952|NCT02345889|593018727|FG000|Overall Study|Polyposis identified during procedure|1|||
164178953|NCT02345889|593018728|FG001|Overall Study|Polyposis identified during procedure|1|||
164178954|NCT02345889|593018729|FG002|Overall Study|Polyposis identified during procedure|0|||
164178955|NCT02345889|593018730|FG003|Overall Study|Polyposis identified during procedure|1|||
164178956|NCT02345889|593018727|FG000|Overall Study|Recognized ineligible post-randomization|1|||
164178957|NCT02345889|593018728|FG001|Overall Study|Recognized ineligible post-randomization|0|||
164178958|NCT02345889|593018729|FG002|Overall Study|Recognized ineligible post-randomization|2|||
164178959|NCT02345889|593018730|FG003|Overall Study|Recognized ineligible post-randomization|1|||
164178960|NCT02345889|593018727|FG000|Overall Study|Ulcerative Colitis identified|1|||
164178961|NCT02345889|593018728|FG001|Overall Study|Ulcerative Colitis identified|0|||
164178962|NCT02345889|593018729|FG002|Overall Study|Ulcerative Colitis identified|0|||
164178963|NCT02345889|593018730|FG003|Overall Study|Ulcerative Colitis identified|0|||
164178964|NCT02345889|593018727|FG000|Overall Study|Cecum not intubated|1|||
164178965|NCT02345889|593018728|FG001|Overall Study|Cecum not intubated|0|||
164178966|NCT02345889|593018729|FG002|Overall Study|Cecum not intubated|0|||
164178967|NCT02345889|593018730|FG003|Overall Study|Cecum not intubated|0|||
164178968|NCT03191864|593018732|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
164178969|NCT03191864|593018733|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
164178970|NCT03191864|593018734|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
164178971|NCT03191864|593018735|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
164178972|NCT03191864|593018736|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
164178973|NCT03191864|593018737|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
164178974|NCT03191864|593018732|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
164178975|NCT03191864|593018733|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
164178976|NCT03191864|593018734|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
164178977|NCT03191864|593018735|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
164178978|NCT03191864|593018736|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
164178979|NCT03191864|593018737|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
164178980|NCT03191864|593018732|FG000|Baseline Symptom Assessment|Adverse Event|0|||
164178981|NCT03191864|593018733|FG001|Baseline Symptom Assessment|Adverse Event|0|||
164178982|NCT03191864|593018734|FG002|Baseline Symptom Assessment|Adverse Event|0|||
164178983|NCT03191864|593018735|FG003|Baseline Symptom Assessment|Adverse Event|0|||
164178984|NCT03191864|593018736|FG004|Baseline Symptom Assessment|Adverse Event|0|||
164178985|NCT03191864|593018737|FG005|Baseline Symptom Assessment|Adverse Event|2|||
164178986|NCT03191864|593018732|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
164178987|NCT03191864|593018733|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
164178988|NCT03191864|593018734|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
164178989|NCT03191864|593018735|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
164178990|NCT03191864|593018736|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
164178991|NCT03191864|593018737|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
164178992|NCT03191864|593018732|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
164178993|NCT03191864|593018733|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
164178994|NCT03191864|593018734|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
164178995|NCT03191864|593018735|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
164178996|NCT03191864|593018736|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
164178997|NCT03191864|593018737|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
164178998|NCT03191864|593018732|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
164178999|NCT03191864|593018733|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
164179000|NCT03191864|593018734|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
164179001|NCT03191864|593018735|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
164179002|NCT03191864|593018736|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
164179003|NCT03191864|593018737|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
164179004|NCT03191864|593018732|FG000|Part 1 - Induction|Adverse Event|0|||
164179005|NCT03191864|593018733|FG001|Part 1 - Induction|Adverse Event|2|||
164179006|NCT03191864|593018734|FG002|Part 1 - Induction|Adverse Event|0|||
164179007|NCT03191864|593018735|FG003|Part 1 - Induction|Adverse Event|1|||
164179008|NCT03191864|593018736|FG004|Part 1 - Induction|Adverse Event|0|||
164179009|NCT03191864|593018737|FG005|Part 1 - Induction|Adverse Event|2|||
164179010|NCT03191864|593018732|FG000|Part 1 - Induction|Randomized but never dosed|0|||
164179011|NCT03191864|593018733|FG001|Part 1 - Induction|Randomized but never dosed|0|||
164179012|NCT03191864|593018734|FG002|Part 1 - Induction|Randomized but never dosed|1|||
164179013|NCT03191864|593018735|FG003|Part 1 - Induction|Randomized but never dosed|0|||
164179014|NCT03191864|593018736|FG004|Part 1 - Induction|Randomized but never dosed|0|||
164179015|NCT03191864|593018737|FG005|Part 1 - Induction|Randomized but never dosed|0|||
164179016|NCT03191864|593018732|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
164179017|NCT03191864|593018733|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
164179018|NCT03191864|593018734|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
164179019|NCT03191864|593018735|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
164179020|NCT03191864|593018736|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
164179021|NCT03191864|593018737|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
164179022|NCT03191864|593018732|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
164179023|NCT03191864|593018733|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
164179024|NCT03191864|593018734|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
164179025|NCT03191864|593018735|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
164179026|NCT03191864|593018736|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
164179027|NCT03191864|593018737|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
164179028|NCT03191864|593018732|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
164179029|NCT03191864|593018733|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
164179030|NCT03191864|593018734|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
164179031|NCT03191864|593018735|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
164179032|NCT03191864|593018736|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
164179033|NCT03191864|593018737|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
164179034|NCT03191864|593018732|FG000|Part 2 - Maintenance|Physician Decision|1|||
164179035|NCT03191864|593018733|FG001|Part 2 - Maintenance|Physician Decision|0|||
164179036|NCT03191864|593018734|FG002|Part 2 - Maintenance|Physician Decision|0|||
164179037|NCT03191864|593018735|FG003|Part 2 - Maintenance|Physician Decision|0|||
164179038|NCT03191864|593018736|FG004|Part 2 - Maintenance|Physician Decision|0|||
164179039|NCT03191864|593018737|FG005|Part 2 - Maintenance|Physician Decision|0|||
164179040|NCT03191864|593018732|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
164179041|NCT03191864|593018733|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
164179042|NCT03191864|593018734|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
164179043|NCT03191864|593018735|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
164179044|NCT03191864|593018736|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
164179045|NCT03191864|593018737|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
164179046|NCT03191864|593018732|FG000|Part 2 - Maintenance|Adverse Event|0|||
164179047|NCT03191864|593018733|FG001|Part 2 - Maintenance|Adverse Event|0|||
164179048|NCT03191864|593018734|FG002|Part 2 - Maintenance|Adverse Event|0|||
164179049|NCT03191864|593018735|FG003|Part 2 - Maintenance|Adverse Event|0|||
164179050|NCT03191864|593018736|FG004|Part 2 - Maintenance|Adverse Event|1|||
164179051|NCT03191864|593018737|FG005|Part 2 - Maintenance|Adverse Event|0|||
164179052|NCT03191864|593018732|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
164179053|NCT03191864|593018733|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
164179054|NCT03191864|593018734|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
164179055|NCT03191864|593018735|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
164179056|NCT03191864|593018736|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
164179057|NCT03191864|593018737|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
164179058|NCT03191864|593018732|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
164179059|NCT03191864|593018733|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
164179060|NCT03191864|593018734|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
164179061|NCT03191864|593018735|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
164179062|NCT03191864|593018736|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
164179063|NCT03191864|593018737|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
164179064|NCT02044874|593018740|FG000|Overall Study|Adverse Event|5|||
164179065|NCT02044874|593018741|FG001|Overall Study|Adverse Event|6|||
164179066|NCT02044874|593018742|FG002|Overall Study|Adverse Event|6|||
164179067|NCT02044874|593018740|FG000|Overall Study|Withdrawal by Subject|8|||
164179068|NCT02044874|593018741|FG001|Overall Study|Withdrawal by Subject|16|||
164179069|NCT02044874|593018742|FG002|Overall Study|Withdrawal by Subject|23|||
164179070|NCT02044874|593018740|FG000|Overall Study|Physician Decision|0|||
164179071|NCT02044874|593018741|FG001|Overall Study|Physician Decision|2|||
164179072|NCT02044874|593018742|FG002|Overall Study|Physician Decision|1|||
164179073|NCT02044874|593018740|FG000|Overall Study|Lost to Follow-up|10|||
164179074|NCT02044874|593018741|FG001|Overall Study|Lost to Follow-up|27|||
164179075|NCT02044874|593018742|FG002|Overall Study|Lost to Follow-up|21|||
164179076|NCT02044874|593018740|FG000|Overall Study|Sponsor Decision|0|||
164179077|NCT02044874|593018741|FG001|Overall Study|Sponsor Decision|1|||
164179078|NCT02044874|593018742|FG002|Overall Study|Sponsor Decision|1|||
164179079|NCT02044874|593018740|FG000|Overall Study|Other|7|||
164179080|NCT02044874|593018741|FG001|Overall Study|Other|3|||
164179081|NCT02044874|593018742|FG002|Overall Study|Other|8|||
164179082|NCT00415597|593018743|FG000|Enrollment|Withdrawal by Subject|1|||
164179083|NCT00415597|593018743|FG000|Enrollment|Protocol Violation|1|||
164179084|NCT00415597|593018743|FG000|Treatment|Adverse Event|110|||
164179085|NCT00415597|593018743|FG000|Treatment|Lack of Efficacy|39|||
164179086|NCT00415597|593018743|FG000|Treatment|Protocol Violation|67|||
164179087|NCT00415597|593018743|FG000|Treatment|Physician Decision|3|||
164179088|NCT00415597|593018743|FG000|Treatment|Withdrawal by Subject|51|||
164179089|NCT00415597|593018743|FG000|Treatment|Lost to Follow-up|28|||
164179090|NCT00415597|593018743|FG000|Treatment|Drug Screen|2|||
164179091|NCT00415597|593018743|FG000|Treatment|Administrative|3|||
164179092|NCT00415597|593018743|FG000|Treatment|Sponsor Decision|1|||
164179093|NCT00415597|593018743|FG000|Treatment|Multiple Reasons|1|||
164179094|NCT03976323|593018744|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
164179095|NCT03976323|593018745|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
164179096|NCT03976323|593018746|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
164179097|NCT03976323|593018744|FG000|Induction Phase|Death|80|||
164179098|NCT03976323|593018745|FG001|Induction Phase|Death|0|||
164179099|NCT03976323|593018746|FG002|Induction Phase|Death|0|||
164179100|NCT03976323|593018744|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
164179101|NCT03976323|593018745|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
164179102|NCT03976323|593018746|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
164179103|NCT03976323|593018744|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164179104|NCT03976323|593018745|FG001|Maintenance Phase|Withdrawal by Subject|9|||
164179105|NCT03976323|593018746|FG002|Maintenance Phase|Withdrawal by Subject|3|||
164179106|NCT03976323|593018744|FG000|Maintenance Phase|Physician Decision|0|||
164179107|NCT03976323|593018745|FG001|Maintenance Phase|Physician Decision|0|||
164179108|NCT03976323|593018746|FG002|Maintenance Phase|Physician Decision|1|||
164179109|NCT03976323|593018744|FG000|Maintenance Phase|Death|0|||
164179110|NCT03976323|593018745|FG001|Maintenance Phase|Death|228|||
164179111|NCT03976323|593018746|FG002|Maintenance Phase|Death|234|||
164179112|NCT02913105|593020441|FG000|Overall Study|Adverse Event|11|||
164179113|NCT02913105|593020442|FG001|Overall Study|Adverse Event|0|||
164179114|NCT02913105|593020443|FG002|Overall Study|Adverse Event|4|||
164179115|NCT02913105|593020441|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164179116|NCT02913105|593020442|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164179117|NCT02913105|593020443|FG002|Overall Study|Non-Compliance With Study Drug|1|||
164179118|NCT02913105|593020441|FG000|Overall Study|Reason Not Specified|3|||
164179119|NCT02913105|593020442|FG001|Overall Study|Reason Not Specified|1|||
164179120|NCT02913105|593020443|FG002|Overall Study|Reason Not Specified|1|||
164179121|NCT02913105|593020441|FG000|Overall Study|Physician Decision|1|||
164179122|NCT02913105|593020442|FG001|Overall Study|Physician Decision|1|||
164179123|NCT02913105|593020443|FG002|Overall Study|Physician Decision|0|||
164179124|NCT02913105|593020441|FG000|Overall Study|Withdrawal by Subject|0|||
164179125|NCT02913105|593020442|FG001|Overall Study|Withdrawal by Subject|3|||
164179126|NCT02913105|593020443|FG002|Overall Study|Withdrawal by Subject|1|||
164179127|NCT02168777|593020444|FG000|Overall Study|Withdrawal by Subject|1|||
164179128|NCT02168777|593020445|FG001|Overall Study|Withdrawal by Subject|0|||
164179129|NCT02168777|593020446|FG002|Overall Study|Withdrawal by Subject|2|||
164179130|NCT02168777|593020444|FG000|Overall Study|Adverse Event|1|||
164179131|NCT02168777|593020445|FG001|Overall Study|Adverse Event|0|||
164179132|NCT02168777|593020446|FG002|Overall Study|Adverse Event|1|||
164179133|NCT02168777|593020444|FG000|Overall Study|Disease recurrence|0|||
164179134|NCT02168777|593020445|FG001|Overall Study|Disease recurrence|0|||
164179135|NCT02168777|593020446|FG002|Overall Study|Disease recurrence|1|||
164179136|NCT02168777|593020444|FG000|Overall Study|Radiological disease progression|0|||
164179137|NCT02168777|593020445|FG001|Overall Study|Radiological disease progression|5|||
164179138|NCT02168777|593020446|FG002|Overall Study|Radiological disease progression|5|||
164179139|NCT02168777|593020444|FG000|Overall Study|Clinical disease progression|0|||
164179140|NCT02168777|593020445|FG001|Overall Study|Clinical disease progression|1|||
164179141|NCT02168777|593020446|FG002|Overall Study|Clinical disease progression|2|||
164179142|NCT02168777|593020444|FG000|Overall Study|Other reason|0|||
164179143|NCT02168777|593020445|FG001|Overall Study|Other reason|1|||
164179144|NCT02168777|593020446|FG002|Overall Study|Other reason|0|||
164179145|NCT05243563|593020447|FG000|Overall Study|Withdrawal by Subject|1|||
164179146|NCT05243563|593020448|FG001|Overall Study|Withdrawal by Subject|0|||
164179147|NCT05243563|593020447|FG000|Overall Study|Physician Decision|1|||
164179148|NCT05243563|593020448|FG001|Overall Study|Physician Decision|0|||
164179149|NCT00441363|593020449|FG000|Overall Study|Adverse Event|4|||
164179150|NCT00441363|593020450|FG001|Overall Study|Adverse Event|2|||
164179151|NCT00441363|593020449|FG000|Overall Study|Withdrawal by Subject|3|||
164179152|NCT00441363|593020450|FG001|Overall Study|Withdrawal by Subject|4|||
164179153|NCT00441363|593020449|FG000|Overall Study|Physician Decision|6|||
164179154|NCT00441363|593020450|FG001|Overall Study|Physician Decision|7|||
164179155|NCT00441363|593020449|FG000|Overall Study|Lost to Follow-up|2|||
164179156|NCT00441363|593020450|FG001|Overall Study|Lost to Follow-up|2|||
164179157|NCT00441363|593020449|FG000|Overall Study|Other|2|||
164179158|NCT00441363|593020450|FG001|Overall Study|Other|0|||
164179159|NCT02437188|593020453|FG000|Overall Study|Randomized but did not receive surgery|4|||
164179160|NCT02437188|593020454|FG001|Overall Study|Randomized but did not receive surgery|8|||
164179161|NCT02437188|593020453|FG000|Overall Study|Adverse Event|0|||
164179162|NCT02437188|593020454|FG001|Overall Study|Adverse Event|1|||
164179163|NCT01663857|593020455|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
164179164|NCT01663857|593020456|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
164179165|NCT01663857|593020457|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
164179166|NCT01663857|593020458|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
164179167|NCT01663857|593020455|FG000|Overall Study|Lost to Follow-up|0|||
164179168|NCT01663857|593020456|FG001|Overall Study|Lost to Follow-up|0|||
164179169|NCT01663857|593020457|FG002|Overall Study|Lost to Follow-up|3|||
164179170|NCT01663857|593020458|FG003|Overall Study|Lost to Follow-up|1|||
164179171|NCT02578940|593020467|FG000|Overall Study|Screening failure|5|||
164179172|NCT02578940|593020467|FG000|Overall Study|Lost to Follow-up|1|||
164179173|NCT01911793|593020468|FG000|Overall Study|Physician Decision|1|||
164179174|NCT01911793|593020469|FG001|Overall Study|Physician Decision|5|||
164179175|NCT03334422|593020470|FG000|Overall Study|Adverse Event|1|||
164179176|NCT03334422|593020471|FG001|Overall Study|Adverse Event|3|||
164179177|NCT03334422|593020472|FG002|Overall Study|Adverse Event|2|||
164179178|NCT03334422|593020473|FG003|Overall Study|Adverse Event|2|||
164179179|NCT03334422|593020470|FG000|Overall Study|Lack of Efficacy|10|||
164179180|NCT03334422|593020471|FG001|Overall Study|Lack of Efficacy|2|||
164179181|NCT03334422|593020472|FG002|Overall Study|Lack of Efficacy|7|||
164179182|NCT03334422|593020473|FG003|Overall Study|Lack of Efficacy|3|||
164179183|NCT03334422|593020470|FG000|Overall Study|Withdrawal by Subject|8|||
164179184|NCT03334422|593020471|FG001|Overall Study|Withdrawal by Subject|3|||
164179185|NCT03334422|593020472|FG002|Overall Study|Withdrawal by Subject|1|||
164179186|NCT03334422|593020473|FG003|Overall Study|Withdrawal by Subject|0|||
164179187|NCT03334422|593020470|FG000|Overall Study|Lost to Follow-up|0|||
164179188|NCT03334422|593020471|FG001|Overall Study|Lost to Follow-up|0|||
164179189|NCT03334422|593020472|FG002|Overall Study|Lost to Follow-up|0|||
164179190|NCT03334422|593020473|FG003|Overall Study|Lost to Follow-up|1|||
164179191|NCT03334422|593020470|FG000|Overall Study|Inability to obtain laboratory samples|0|||
164179192|NCT03334422|593020471|FG001|Overall Study|Inability to obtain laboratory samples|1|||
164179193|NCT03334422|593020472|FG002|Overall Study|Inability to obtain laboratory samples|0|||
164179194|NCT03334422|593020473|FG003|Overall Study|Inability to obtain laboratory samples|0|||
164179195|NCT03334422|593020470|FG000|Overall Study|Pregnancy|0|||
164179196|NCT03334422|593020471|FG001|Overall Study|Pregnancy|1|||
164179197|NCT03334422|593020472|FG002|Overall Study|Pregnancy|0|||
164179198|NCT03334422|593020473|FG003|Overall Study|Pregnancy|0|||
164179199|NCT00994214|593020474|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
164179200|NCT00994214|593020475|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
164179201|NCT00994214|593020476|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
164179202|NCT00994214|593020477|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
164179203|NCT00994214|593020474|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
164179204|NCT00994214|593020475|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
164179205|NCT00994214|593020476|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
164179206|NCT00994214|593020477|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
164179207|NCT00994214|593020474|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
164179208|NCT00994214|593020475|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
164179209|NCT00994214|593020476|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
164179210|NCT00994214|593020477|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
164179211|NCT00994214|593020474|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
164179212|NCT00994214|593020475|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
164179213|NCT00994214|593020476|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
164179214|NCT00994214|593020477|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
164179215|NCT00994214|593020474|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
164179216|NCT00994214|593020475|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
164179217|NCT00994214|593020476|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
164179218|NCT00994214|593020477|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
164179219|NCT00994214|593020474|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
164179220|NCT00994214|593020475|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
164179221|NCT00994214|593020476|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
164179222|NCT00994214|593020477|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
164179223|NCT04710368|593020483|FG000|Overall Study|Withdrawal by Subject|9|||
164179224|NCT04710368|593020483|FG000|Overall Study|Lost to Follow-up|4|||
164179225|NCT04710368|593020483|FG000|Overall Study|Death|2|||
164179226|NCT04710368|593020483|FG000|Overall Study|Patient preference|11|||
164179227|NCT04710368|593020483|FG000|Overall Study|Treatment discontinuation|1|||
164179228|NCT01777139|593020486|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
164179229|NCT01777139|593020487|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
164179230|NCT01777139|593020486|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
164179231|NCT01777139|593020487|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
164179232|NCT01777139|593020486|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
164179233|NCT01777139|593020487|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
164179234|NCT01777139|593020486|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
164179235|NCT01777139|593020487|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
164179236|NCT01777139|593020486|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
164179237|NCT01777139|593020487|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
164179238|NCT01777139|593020486|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
164179239|NCT01777139|593020487|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
164179240|NCT01777139|593020486|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
164179241|NCT01777139|593020487|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
164179242|NCT01777139|593020486|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
164179243|NCT01777139|593020487|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
164179244|NCT03959488|593020488|FG000|Season 1|Other|6|||
164179245|NCT03959488|593020489|FG001|Season 1|Other|7|||
164179246|NCT03959488|593020490|FG002|Season 1|Other|0|||
164179247|NCT03959488|593020491|FG003|Season 1|Other|0|||
164179248|NCT03959488|593020492|FG004|Season 1|Other|0|||
164179249|NCT03959488|593020488|FG000|Season 1|Withdrawal by parent/guardian|43|||
164179250|NCT03959488|593020489|FG001|Season 1|Withdrawal by parent/guardian|28|||
164179251|NCT03959488|593020490|FG002|Season 1|Withdrawal by parent/guardian|0|||
164179252|NCT03959488|593020491|FG003|Season 1|Withdrawal by parent/guardian|0|||
164179253|NCT03959488|593020492|FG004|Season 1|Withdrawal by parent/guardian|0|||
164179254|NCT03959488|593020488|FG000|Season 1|Due to COVID-19 pandemic|2|||
164179255|NCT03959488|593020489|FG001|Season 1|Due to COVID-19 pandemic|3|||
164179256|NCT03959488|593020490|FG002|Season 1|Due to COVID-19 pandemic|0|||
164179257|NCT03959488|593020491|FG003|Season 1|Due to COVID-19 pandemic|0|||
164179258|NCT03959488|593020492|FG004|Season 1|Due to COVID-19 pandemic|0|||
164179259|NCT03959488|593020488|FG000|Season 1|Lost to Follow-up|17|||
164179260|NCT03959488|593020489|FG001|Season 1|Lost to Follow-up|7|||
164179261|NCT03959488|593020490|FG002|Season 1|Lost to Follow-up|0|||
164179262|NCT03959488|593020491|FG003|Season 1|Lost to Follow-up|0|||
164179263|NCT03959488|593020492|FG004|Season 1|Lost to Follow-up|0|||
164179264|NCT03959488|593020488|FG000|Season 1|Death|5|||
164179265|NCT03959488|593020489|FG001|Season 1|Death|1|||
164179266|NCT03959488|593020490|FG002|Season 1|Death|0|||
164179267|NCT03959488|593020491|FG003|Season 1|Death|0|||
164179268|NCT03959488|593020492|FG004|Season 1|Death|0|||
164179269|NCT03959488|593020488|FG000|Season 2|Other|0|||
164179270|NCT03959488|593020489|FG001|Season 2|Other|0|||
164179271|NCT03959488|593020490|FG002|Season 2|Other|2|||
164179272|NCT03959488|593020491|FG003|Season 2|Other|0|||
164179273|NCT03959488|593020492|FG004|Season 2|Other|0|||
164179274|NCT03959488|593020488|FG000|Season 2|Withdrawal by parent/guardian|0|||
164179275|NCT03959488|593020489|FG001|Season 2|Withdrawal by parent/guardian|0|||
164179276|NCT03959488|593020490|FG002|Season 2|Withdrawal by parent/guardian|3|||
164179277|NCT03959488|593020491|FG003|Season 2|Withdrawal by parent/guardian|1|||
164179278|NCT03959488|593020492|FG004|Season 2|Withdrawal by parent/guardian|1|||
164179279|NCT03959488|593020488|FG000|Season 2|Lost to Follow-up|0|||
164179280|NCT03959488|593020489|FG001|Season 2|Lost to Follow-up|0|||
164179281|NCT03959488|593020490|FG002|Season 2|Lost to Follow-up|1|||
164179282|NCT03959488|593020491|FG003|Season 2|Lost to Follow-up|0|||
164179283|NCT03959488|593020492|FG004|Season 2|Lost to Follow-up|1|||
164179284|NCT01887288|593020494|FG000|Overall Study|The study was terminated and the PI has|16|||
164179285|NCT02278367|593020497|FG000|Overall Study|Physician Decision|5|||
164179286|NCT02278367|593020498|FG001|Overall Study|Physician Decision|0|||
164179287|NCT02278367|593020497|FG000|Overall Study|Withdrawal by Subject|5|||
164179288|NCT02278367|593020498|FG001|Overall Study|Withdrawal by Subject|0|||
164179289|NCT02949908|593020499|FG000|Overall Study|Study termination|2|||
164179290|NCT04105010|593020500|FG000|Overall Study|Death|3|||
164179291|NCT04105010|593020501|FG001|Overall Study|Death|1|||
164179292|NCT04105010|593020502|FG002|Overall Study|Death|1|||
164179293|NCT04105010|593020503|FG003|Overall Study|Death|54|||
164179294|NCT04105010|593020500|FG000|Overall Study|Lost to Follow-up|0|||
164179295|NCT04105010|593020501|FG001|Overall Study|Lost to Follow-up|0|||
164179296|NCT04105010|593020502|FG002|Overall Study|Lost to Follow-up|0|||
164179297|NCT04105010|593020503|FG003|Overall Study|Lost to Follow-up|4|||
164179298|NCT04105010|593020500|FG000|Overall Study|Withdrawal by Subject|8|||
164179299|NCT04105010|593020501|FG001|Overall Study|Withdrawal by Subject|1|||
164179300|NCT04105010|593020502|FG002|Overall Study|Withdrawal by Subject|1|||
164179301|NCT04105010|593020503|FG003|Overall Study|Withdrawal by Subject|4|||
164179302|NCT04105010|593020500|FG000|Overall Study|Other reason|4|||
164179303|NCT04105010|593020501|FG001|Overall Study|Other reason|7|||
164179304|NCT04105010|593020502|FG002|Overall Study|Other reason|0|||
164179305|NCT04105010|593020503|FG003|Overall Study|Other reason|19|||
164179306|NCT01211483|593020504|FG000|Phase 1b|Death|6|||
164179307|NCT01211483|593020505|FG001|Phase 1b|Death|0|||
164179308|NCT01211483|593020506|FG002|Phase 1b|Death|0|||
164179309|NCT01211483|593020507|FG003|Phase 1b|Death|0|||
164179310|NCT01211483|593020504|FG000|Phase 1b|Withdrawal by Subject|1|||
164179311|NCT01211483|593020505|FG001|Phase 1b|Withdrawal by Subject|0|||
164179312|NCT01211483|593020506|FG002|Phase 1b|Withdrawal by Subject|0|||
164179313|NCT01211483|593020507|FG003|Phase 1b|Withdrawal by Subject|0|||
164179314|NCT01211483|593020504|FG000|Phase 2|Lost to Follow-up|0|||
164179315|NCT01211483|593020505|FG001|Phase 2|Lost to Follow-up|1|||
164179316|NCT01211483|593020506|FG002|Phase 2|Lost to Follow-up|1|||
164179317|NCT01211483|593020507|FG003|Phase 2|Lost to Follow-up|2|||
164179318|NCT01211483|593020504|FG000|Phase 2|Death|0|||
164179319|NCT01211483|593020505|FG001|Phase 2|Death|64|||
164179320|NCT01211483|593020506|FG002|Phase 2|Death|53|||
164179321|NCT01211483|593020507|FG003|Phase 2|Death|53|||
164179322|NCT01211483|593020504|FG000|Phase 2|Withdrawal by Subject|0|||
164179323|NCT01211483|593020505|FG001|Phase 2|Withdrawal by Subject|1|||
164179324|NCT01211483|593020506|FG002|Phase 2|Withdrawal by Subject|10|||
164179325|NCT01211483|593020507|FG003|Phase 2|Withdrawal by Subject|5|||
164179326|NCT01211483|593020504|FG000|Phase 2|Study terminated by Sponsor|0|||
164179327|NCT01211483|593020505|FG001|Phase 2|Study terminated by Sponsor|6|||
164179328|NCT01211483|593020506|FG002|Phase 2|Study terminated by Sponsor|8|||
164179329|NCT01211483|593020507|FG003|Phase 2|Study terminated by Sponsor|11|||
164179330|NCT01675154|593020508|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
164179331|NCT01675154|593020509|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
164179332|NCT01675154|593020510|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
164179333|NCT01675154|593020511|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
164179334|NCT02971800|593020514|FG000|Overall Study|Protocol Violation|1|||
164179335|NCT02971800|593020514|FG000|Overall Study|Withdrawal by Subject|1|||
164179336|NCT02971800|593020514|FG000|Overall Study|Exclusion criteria prior intervention|1|||
164179337|NCT02971800|593020514|FG000|Overall Study|Number evaluable participant already reached|4|||
164179338|NCT00616603|593020517|FG000|Overall Study|Physician Decision|2|||
164179339|NCT00616603|593020518|FG001|Overall Study|Physician Decision|0|||
164179340|NCT00616603|593020519|FG002|Overall Study|Physician Decision|2|||
164179341|NCT01285492|593020522|FG000|Overall Study|Adverse Event|11|||
164179342|NCT01285492|593020523|FG001|Overall Study|Adverse Event|0|||
164179343|NCT01285492|593020522|FG000|Overall Study|Protocol Violation|3|||
164179344|NCT01285492|593020523|FG001|Overall Study|Protocol Violation|0|||
164179345|NCT01285492|593020522|FG000|Overall Study|Withdrawal by Subject|2|||
164179346|NCT01285492|593020523|FG001|Overall Study|Withdrawal by Subject|1|||
164179347|NCT01285492|593020522|FG000|Overall Study|Death|1|||
164179348|NCT01285492|593020523|FG001|Overall Study|Death|0|||
164179349|NCT01121536|593020524|FG000|Overall Study|Adverse Event|63|||
164179350|NCT01121536|593020524|FG000|Overall Study|Lack of Efficacy|35|||
164179351|NCT01121536|593020524|FG000|Overall Study|Withdrawal by Subject|65|||
164179352|NCT01121536|593020524|FG000|Overall Study|Protocol Violation|20|||
164179353|NCT01121536|593020524|FG000|Overall Study|Noncompliance with study medication|12|||
164179354|NCT01121536|593020524|FG000|Overall Study|Noncompliance with study procedures|9|||
164179355|NCT01121536|593020524|FG000|Overall Study|Lost to Follow-up|39|||
164179356|NCT01121536|593020524|FG000|Overall Study|Other|118|||
164179357|NCT02649426|593020526|FG000|Overall Study|Follow-up on going|1|||
164179358|NCT02649426|593020527|FG001|Overall Study|Follow-up on going|26|||
164179359|NCT02649426|593020528|FG002|Overall Study|Follow-up on going|28|||
164179360|NCT02649426|593020529|FG003|Overall Study|Follow-up on going|31|||
164179361|NCT01593254|593020532|FG000|Overall Study|Disease progression|2|||
164179362|NCT01593254|593020533|FG001|Overall Study|Disease progression|7|||
164179363|NCT01593254|593020532|FG000|Overall Study|Study drug toxicity|6|||
164179364|NCT01593254|593020533|FG001|Overall Study|Study drug toxicity|20|||
164179365|NCT01593254|593020532|FG000|Overall Study|Death|3|||
164179366|NCT01593254|593020533|FG001|Overall Study|Death|3|||
164179367|NCT01593254|593020532|FG000|Overall Study|AE unrelated to study drug|0|||
164179368|NCT01593254|593020533|FG001|Overall Study|AE unrelated to study drug|1|||
164179369|NCT01593254|593020532|FG000|Overall Study|participant request to discontinue study treatment|1|||
164179370|NCT01593254|593020533|FG001|Overall Study|participant request to discontinue study treatment|3|||
164179371|NCT01593254|593020532|FG000|Overall Study|participant withdrew consent|0|||
164179372|NCT01593254|593020533|FG001|Overall Study|participant withdrew consent|9|||
164179373|NCT01593254|593020532|FG000|Overall Study|lost to follow up|1|||
164179374|NCT01593254|593020533|FG001|Overall Study|lost to follow up|6|||
164179375|NCT01593254|593020532|FG000|Overall Study|maximum clinical benefit|1|||
164179376|NCT01593254|593020533|FG001|Overall Study|maximum clinical benefit|2|||
164179377|NCT01593254|593020532|FG000|Overall Study|Poor/non compliance|1|||
164179378|NCT01593254|593020533|FG001|Overall Study|Poor/non compliance|1|||
164179379|NCT01593254|593020532|FG000|Overall Study|Pregnancy|0|||
164179380|NCT01593254|593020533|FG001|Overall Study|Pregnancy|3|||
164179381|NCT01593254|593020532|FG000|Overall Study|participant no longer meets study criteria|1|||
164179382|NCT01593254|593020533|FG001|Overall Study|participant no longer meets study criteria|1|||
164179383|NCT01593254|593020532|FG000|Overall Study|Admin reason by sponsor|7|||
164179384|NCT01593254|593020533|FG001|Overall Study|Admin reason by sponsor|3|||
164179385|NCT01593254|593020532|FG000|Overall Study|Imatinib treatment failure|2|||
164179386|NCT01593254|593020533|FG001|Overall Study|Imatinib treatment failure|0|||
164179387|NCT01593254|593020532|FG000|Overall Study|Other Reasons|61|||
164179388|NCT01593254|593020533|FG001|Overall Study|Other Reasons|115|||
164179389|NCT02079636|593020534|FG000|Overall Study|Death|2|||
164179390|NCT02079636|593020535|FG001|Overall Study|Death|1|||
164179391|NCT02079636|593020536|FG002|Overall Study|Death|0|||
164179392|NCT02079636|593020537|FG003|Overall Study|Death|5|||
164179393|NCT02079636|593020538|FG004|Overall Study|Death|1|||
164179394|NCT02079636|593020539|FG005|Overall Study|Death|2|||
164179395|NCT02079636|593020540|FG006|Overall Study|Death|1|||
164179396|NCT02079636|593020541|FG007|Overall Study|Death|0|||
164179397|NCT02079636|593020542|FG008|Overall Study|Death|0|||
164179398|NCT02079636|593020543|FG009|Overall Study|Death|0|||
164179399|NCT02079636|593020544|FG010|Overall Study|Death|0|||
164179400|NCT02079636|593020545|FG011|Overall Study|Death|1|||
164179401|NCT02079636|593020546|FG012|Overall Study|Death|1|||
164179402|NCT02079636|593020547|FG013|Overall Study|Death|0|||
164179403|NCT02079636|593020548|FG014|Overall Study|Death|2|||
164179404|NCT02079636|593020534|FG000|Overall Study|Adverse Event|1|||
164179405|NCT02079636|593020535|FG001|Overall Study|Adverse Event|1|||
164179406|NCT02079636|593020536|FG002|Overall Study|Adverse Event|0|||
164179407|NCT02079636|593020537|FG003|Overall Study|Adverse Event|1|||
164179408|NCT02079636|593020538|FG004|Overall Study|Adverse Event|1|||
164179409|NCT02079636|593020539|FG005|Overall Study|Adverse Event|2|||
164179410|NCT02079636|593020540|FG006|Overall Study|Adverse Event|0|||
164179411|NCT02079636|593020541|FG007|Overall Study|Adverse Event|0|||
164179412|NCT02079636|593020542|FG008|Overall Study|Adverse Event|0|||
164179413|NCT02079636|593020543|FG009|Overall Study|Adverse Event|0|||
164179414|NCT02079636|593020544|FG010|Overall Study|Adverse Event|0|||
164179415|NCT02079636|593020545|FG011|Overall Study|Adverse Event|0|||
164179416|NCT02079636|593020546|FG012|Overall Study|Adverse Event|0|||
164179417|NCT02079636|593020547|FG013|Overall Study|Adverse Event|0|||
164179418|NCT02079636|593020548|FG014|Overall Study|Adverse Event|0|||
164179419|NCT02079636|593020534|FG000|Overall Study|Progressive disease|0|||
164179420|NCT02079636|593020535|FG001|Overall Study|Progressive disease|0|||
164179421|NCT02079636|593020536|FG002|Overall Study|Progressive disease|0|||
164179422|NCT02079636|593020537|FG003|Overall Study|Progressive disease|2|||
164179423|NCT02079636|593020538|FG004|Overall Study|Progressive disease|0|||
164179424|NCT02079636|593020539|FG005|Overall Study|Progressive disease|0|||
164179425|NCT02079636|593020540|FG006|Overall Study|Progressive disease|0|||
164179426|NCT02079636|593020541|FG007|Overall Study|Progressive disease|0|||
164179427|NCT02079636|593020542|FG008|Overall Study|Progressive disease|0|||
164179428|NCT02079636|593020543|FG009|Overall Study|Progressive disease|0|||
164179429|NCT02079636|593020544|FG010|Overall Study|Progressive disease|0|||
164179430|NCT02079636|593020545|FG011|Overall Study|Progressive disease|0|||
164179431|NCT02079636|593020546|FG012|Overall Study|Progressive disease|1|||
164179432|NCT02079636|593020547|FG013|Overall Study|Progressive disease|0|||
164179433|NCT02079636|593020548|FG014|Overall Study|Progressive disease|0|||
164179434|NCT02079636|593020534|FG000|Overall Study|Withdrawal by Subject|0|||
164179435|NCT02079636|593020535|FG001|Overall Study|Withdrawal by Subject|0|||
164179515|NCT01592292|593020559|FG002|Overall Study|Follow-up loss|1|||
164179436|NCT02079636|593020536|FG002|Overall Study|Withdrawal by Subject|0|||
164179437|NCT02079636|593020537|FG003|Overall Study|Withdrawal by Subject|4|||
164179438|NCT02079636|593020538|FG004|Overall Study|Withdrawal by Subject|0|||
164179439|NCT02079636|593020539|FG005|Overall Study|Withdrawal by Subject|1|||
164179440|NCT02079636|593020540|FG006|Overall Study|Withdrawal by Subject|0|||
164179441|NCT02079636|593020541|FG007|Overall Study|Withdrawal by Subject|0|||
164179442|NCT02079636|593020542|FG008|Overall Study|Withdrawal by Subject|0|||
164179443|NCT02079636|593020543|FG009|Overall Study|Withdrawal by Subject|2|||
164179444|NCT02079636|593020544|FG010|Overall Study|Withdrawal by Subject|1|||
164179445|NCT02079636|593020545|FG011|Overall Study|Withdrawal by Subject|1|||
164179446|NCT02079636|593020546|FG012|Overall Study|Withdrawal by Subject|1|||
164179447|NCT02079636|593020547|FG013|Overall Study|Withdrawal by Subject|0|||
164179448|NCT02079636|593020548|FG014|Overall Study|Withdrawal by Subject|2|||
164179449|NCT02079636|593020534|FG000|Overall Study|Physician Decision|0|||
164179450|NCT02079636|593020535|FG001|Overall Study|Physician Decision|0|||
164179451|NCT02079636|593020536|FG002|Overall Study|Physician Decision|0|||
164179452|NCT02079636|593020537|FG003|Overall Study|Physician Decision|0|||
164179453|NCT02079636|593020538|FG004|Overall Study|Physician Decision|0|||
164179454|NCT02079636|593020539|FG005|Overall Study|Physician Decision|1|||
164179455|NCT02079636|593020540|FG006|Overall Study|Physician Decision|0|||
164179456|NCT02079636|593020541|FG007|Overall Study|Physician Decision|0|||
164179457|NCT02079636|593020542|FG008|Overall Study|Physician Decision|0|||
164179458|NCT02079636|593020543|FG009|Overall Study|Physician Decision|1|||
164179459|NCT02079636|593020544|FG010|Overall Study|Physician Decision|1|||
164179460|NCT02079636|593020545|FG011|Overall Study|Physician Decision|0|||
164179461|NCT02079636|593020546|FG012|Overall Study|Physician Decision|0|||
164179462|NCT02079636|593020547|FG013|Overall Study|Physician Decision|0|||
164179463|NCT02079636|593020548|FG014|Overall Study|Physician Decision|1|||
164179464|NCT02079636|593020534|FG000|Overall Study|Lost to Follow-up|0|||
164179465|NCT02079636|593020535|FG001|Overall Study|Lost to Follow-up|0|||
164179466|NCT02079636|593020536|FG002|Overall Study|Lost to Follow-up|0|||
164179467|NCT02079636|593020537|FG003|Overall Study|Lost to Follow-up|0|||
164179468|NCT02079636|593020538|FG004|Overall Study|Lost to Follow-up|0|||
164179469|NCT02079636|593020539|FG005|Overall Study|Lost to Follow-up|0|||
164179470|NCT02079636|593020540|FG006|Overall Study|Lost to Follow-up|0|||
164179471|NCT02079636|593020541|FG007|Overall Study|Lost to Follow-up|1|||
164179472|NCT02079636|593020542|FG008|Overall Study|Lost to Follow-up|0|||
164179473|NCT02079636|593020543|FG009|Overall Study|Lost to Follow-up|0|||
164179474|NCT02079636|593020544|FG010|Overall Study|Lost to Follow-up|0|||
164179475|NCT02079636|593020545|FG011|Overall Study|Lost to Follow-up|0|||
164179476|NCT02079636|593020546|FG012|Overall Study|Lost to Follow-up|0|||
164179477|NCT02079636|593020547|FG013|Overall Study|Lost to Follow-up|0|||
164179478|NCT02079636|593020548|FG014|Overall Study|Lost to Follow-up|0|||
164179479|NCT00561470|593020549|FG000|Overall Study|Adverse Event|74|||
164179480|NCT00561470|593020550|FG001|Overall Study|Adverse Event|163|||
164179481|NCT00561470|593020549|FG000|Overall Study|Disease progression|437|||
164179482|NCT00561470|593020550|FG001|Overall Study|Disease progression|305|||
164179483|NCT00561470|593020549|FG000|Overall Study|poor compliance to protocol|4|||
164179484|NCT00561470|593020550|FG001|Overall Study|poor compliance to protocol|4|||
164179485|NCT00561470|593020549|FG000|Overall Study|Lost to Follow-up|2|||
164179486|NCT00561470|593020550|FG001|Overall Study|Lost to Follow-up|0|||
164179487|NCT00561470|593020549|FG000|Overall Study|Physician Decision|21|||
164179488|NCT00561470|593020550|FG001|Overall Study|Physician Decision|20|||
164179489|NCT00561470|593020549|FG000|Overall Study|Consent Withdrawn|2|||
164179490|NCT00561470|593020550|FG001|Overall Study|Consent Withdrawn|6|||
164179491|NCT00561470|593020549|FG000|Overall Study|Subject request|43|||
164179492|NCT00561470|593020550|FG001|Overall Study|Subject request|77|||
164179493|NCT00561470|593020549|FG000|Overall Study|Metastatic surgery|10|||
164179494|NCT00561470|593020550|FG001|Overall Study|Metastatic surgery|12|||
164179495|NCT00561470|593020549|FG000|Overall Study|Unauthorized procedure|3|||
164179496|NCT00561470|593020550|FG001|Overall Study|Unauthorized procedure|1|||
164179497|NCT00561470|593020549|FG000|Overall Study|Randomized but not treated|5|||
164179498|NCT00561470|593020550|FG001|Overall Study|Randomized but not treated|5|||
164179499|NCT00561470|593020549|FG000|Overall Study|Missed visit window|1|||
164179500|NCT00561470|593020550|FG001|Overall Study|Missed visit window|4|||
164179501|NCT00561470|593020549|FG000|Overall Study|Planning surgery|1|||
164179502|NCT00561470|593020550|FG001|Overall Study|Planning surgery|1|||
164179503|NCT00561470|593020549|FG000|Overall Study|Ongoing Treatment|11|||
164179504|NCT00561470|593020550|FG001|Overall Study|Ongoing Treatment|14|||
164179505|NCT00637806|593020551|FG000|Double-blind Phase|Study Discontinued|2|||
164179506|NCT00637806|593020552|FG001|Double-blind Phase|Study Discontinued|0|||
164179507|NCT00637806|593020553|FG002|Double-blind Phase|Study Discontinued|1|||
164179508|NCT00637806|593020554|FG003|Double-blind Phase|Study Discontinued|0|||
164179509|NCT00637806|593020551|FG000|Extension Phase|Study Discontinued|0|||
164179510|NCT00637806|593020552|FG001|Extension Phase|Study Discontinued|0|||
164179511|NCT00637806|593020553|FG002|Extension Phase|Study Discontinued|0|||
164179512|NCT00637806|593020554|FG003|Extension Phase|Study Discontinued|1|||
164179513|NCT01592292|593020557|FG000|Overall Study|Follow-up loss|3|||
164179514|NCT01592292|593020558|FG001|Overall Study|Follow-up loss|3|||
164179516|NCT01592292|593020560|FG003|Overall Study|Follow-up loss|0|||
164179517|NCT01592292|593020557|FG000|Overall Study|Withdrew consent|2|||
164179518|NCT01592292|593020558|FG001|Overall Study|Withdrew consent|1|||
164179519|NCT01592292|593020559|FG002|Overall Study|Withdrew consent|0|||
164179520|NCT01592292|593020560|FG003|Overall Study|Withdrew consent|0|||
164179521|NCT01592292|593020557|FG000|Overall Study|Other|1|||
164179522|NCT01592292|593020558|FG001|Overall Study|Other|1|||
164179523|NCT01592292|593020559|FG002|Overall Study|Other|2|||
164179524|NCT01592292|593020560|FG003|Overall Study|Other|1|||
164179525|NCT02923245|593020562|FG000|Overall Study|ultrasound order was cancelled|2|||
164179526|NCT02923245|593020563|FG001|Overall Study|ultrasound order was cancelled|1|||
164179527|NCT02680834|593020564|FG000|Overall Study|Physician Decision|5|||
164179528|NCT02680834|593020565|FG001|Overall Study|Physician Decision|2|||
164179529|NCT02680834|593020564|FG000|Overall Study|Withdrawal by Subject|6|||
164179530|NCT02680834|593020565|FG001|Overall Study|Withdrawal by Subject|0|||
164179531|NCT02680834|593020564|FG000|Overall Study|Lost to Follow-up|0|||
164179532|NCT02680834|593020565|FG001|Overall Study|Lost to Follow-up|1|||
164179533|NCT01712334|593020569|FG000|Treatment Period 1|Randomized in Error|0|||
164179534|NCT01712334|593020570|FG001|Treatment Period 1|Randomized in Error|2|||
164179535|NCT00232596|593020571|FG000|6-Week Titration Phase|Adverse Event|6|||
164179536|NCT00232596|593020572|FG001|6-Week Titration Phase|Adverse Event|19|||
164179537|NCT00232596|593020571|FG000|6-Week Titration Phase|Failed to Return|2|||
164179538|NCT00232596|593020572|FG001|6-Week Titration Phase|Failed to Return|1|||
164179539|NCT00232596|593020571|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
164179540|NCT00232596|593020572|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
164179541|NCT00232596|593020571|FG000|6-Week Titration Phase|Protocol Violation|1|||
164179542|NCT00232596|593020572|FG001|6-Week Titration Phase|Protocol Violation|3|||
164179543|NCT00232596|593020571|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
164179544|NCT00232596|593020572|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
164179545|NCT00232596|593020571|FG000|6-Week Titration Phase|Other|3|||
164179546|NCT00232596|593020572|FG001|6-Week Titration Phase|Other|3|||
164179547|NCT00232596|593020571|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
164179548|NCT00232596|593020572|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
164179549|NCT00232596|593020571|FG000|12-Week Maintenance Phase|Adverse Event|7|||
164179550|NCT00232596|593020572|FG001|12-Week Maintenance Phase|Adverse Event|22|||
164179551|NCT00232596|593020571|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
164179552|NCT00232596|593020572|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
164179553|NCT00232596|593020571|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
164179554|NCT00232596|593020572|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
164179555|NCT00232596|593020571|FG000|12-Week Maintenance Phase|Other|1|||
164179556|NCT00232596|593020572|FG001|12-Week Maintenance Phase|Other|3|||
164179557|NCT02637713|593020573|FG000|Overall Study|Screen Failure|2|||
164179558|NCT04102865|593020576|FG000|Overall Study|Adverse Event|4|||
164179559|NCT04102865|593020577|FG001|Overall Study|Adverse Event|0|||
164179560|NCT04102865|593020576|FG000|Overall Study|Lost to Follow-up|1|||
164179561|NCT04102865|593020577|FG001|Overall Study|Lost to Follow-up|0|||
164179562|NCT04102865|593020576|FG000|Overall Study|Withdrawal by Subject|2|||
164179563|NCT04102865|593020577|FG001|Overall Study|Withdrawal by Subject|0|||
164179564|NCT01764997|593020582|FG000|Run-in Period|Adverse Event|15|||
164179565|NCT01764997|593020583|FG001|Run-in Period|Adverse Event|0|||
164179566|NCT01764997|593020584|FG002|Run-in Period|Adverse Event|0|||
164179567|NCT01764997|593020585|FG003|Run-in Period|Adverse Event|0|||
164179568|NCT01764997|593020586|FG004|Run-in Period|Adverse Event|0|||
164179569|NCT01764997|593020582|FG000|Run-in Period|Lack of Efficacy|5|||
164179570|NCT01764997|593020583|FG001|Run-in Period|Lack of Efficacy|0|||
164179571|NCT01764997|593020584|FG002|Run-in Period|Lack of Efficacy|0|||
164179572|NCT01764997|593020585|FG003|Run-in Period|Lack of Efficacy|0|||
164179573|NCT01764997|593020586|FG004|Run-in Period|Lack of Efficacy|0|||
164179574|NCT01764997|593020582|FG000|Run-in Period|Poor compliance to protocol|1|||
164179575|NCT01764997|593020583|FG001|Run-in Period|Poor compliance to protocol|0|||
164179576|NCT01764997|593020584|FG002|Run-in Period|Poor compliance to protocol|0|||
164179577|NCT01764997|593020585|FG003|Run-in Period|Poor compliance to protocol|0|||
164179578|NCT01764997|593020586|FG004|Run-in Period|Poor compliance to protocol|0|||
164179579|NCT01764997|593020582|FG000|Run-in Period|Other than specified above|17|||
164179580|NCT01764997|593020583|FG001|Run-in Period|Other than specified above|0|||
164179581|NCT01764997|593020584|FG002|Run-in Period|Other than specified above|0|||
164179582|NCT01764997|593020585|FG003|Run-in Period|Other than specified above|0|||
164179583|NCT01764997|593020586|FG004|Run-in Period|Other than specified above|0|||
164179584|NCT01764997|593020582|FG000|Study Drug Treatment Period|Adverse Event|0|||
164179585|NCT01764997|593020583|FG001|Study Drug Treatment Period|Adverse Event|1|||
164179586|NCT01764997|593020584|FG002|Study Drug Treatment Period|Adverse Event|0|||
164179587|NCT01764997|593020585|FG003|Study Drug Treatment Period|Adverse Event|0|||
164179588|NCT01764997|593020586|FG004|Study Drug Treatment Period|Adverse Event|24|||
164179589|NCT01764997|593020582|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
164179590|NCT01764997|593020583|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
164179591|NCT01764997|593020584|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
164179592|NCT01764997|593020585|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
164179593|NCT01764997|593020586|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
164179594|NCT01764997|593020582|FG000|Study Drug Treatment Period|Other than specified above|0|||
164179595|NCT01764997|593020583|FG001|Study Drug Treatment Period|Other than specified above|0|||
164179596|NCT01764997|593020584|FG002|Study Drug Treatment Period|Other than specified above|0|||
164179597|NCT01764997|593020585|FG003|Study Drug Treatment Period|Other than specified above|0|||
164179598|NCT01764997|593020586|FG004|Study Drug Treatment Period|Other than specified above|10|||
164179599|NCT02093390|593020589|FG000|Overall Study|Withdrawal by Subject|0|||
164179600|NCT02093390|593020590|FG001|Overall Study|Withdrawal by Subject|1|||
164179601|NCT00073983|593020591|FG000|Overall Study|not evaluable|1|||
164179602|NCT02294461|593020594|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
164179603|NCT02294461|593020595|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
164179604|NCT02294461|593020596|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
164179605|NCT02294461|593020594|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
164179606|NCT02294461|593020595|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
164179607|NCT02294461|593020596|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
164179608|NCT02294461|593020594|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
164179609|NCT02294461|593020595|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
164179610|NCT02294461|593020596|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
164179611|NCT02294461|593020594|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
164179612|NCT02294461|593020595|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
164179613|NCT02294461|593020596|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
164179614|NCT02294461|593020594|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
164179615|NCT02294461|593020595|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
164179616|NCT02294461|593020596|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
164179617|NCT02294461|593020594|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
164179618|NCT02294461|593020595|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
164179619|NCT02294461|593020596|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
164179620|NCT02294461|593020594|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
164179621|NCT02294461|593020595|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
164179622|NCT02294461|593020596|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
164179623|NCT02294461|593020594|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
164179624|NCT02294461|593020595|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
164179625|NCT02294461|593020596|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
164179626|NCT02294461|593020594|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
164179627|NCT02294461|593020595|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
164179628|NCT02294461|593020596|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
164179629|NCT02294461|593020594|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
164179630|NCT02294461|593020595|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
164179631|NCT02294461|593020596|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
164179632|NCT02294461|593020594|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
164179633|NCT02294461|593020595|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
164179634|NCT02294461|593020596|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
164179635|NCT02294461|593020594|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
164179636|NCT02294461|593020595|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
164179637|NCT02294461|593020596|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
164179638|NCT02294461|593020594|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
164179639|NCT02294461|593020595|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
164179640|NCT02294461|593020596|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
164179641|NCT02294461|593020594|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
164179642|NCT02294461|593020595|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
164179643|NCT02294461|593020596|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
164179644|NCT03800836|593020597|FG000|Overall Study|Other|2|||
164179645|NCT03800836|593020598|FG001|Overall Study|Other|1|||
164179646|NCT03800836|593020599|FG002|Overall Study|Other|0|||
164179647|NCT03800836|593020600|FG003|Overall Study|Other|2|||
164179648|NCT03800836|593020601|FG004|Overall Study|Other|0|||
164179649|NCT03800836|593020602|FG005|Overall Study|Other|1|||
164179650|NCT03800836|593020597|FG000|Overall Study|Lost to Follow-up|2|||
164179651|NCT03800836|593020598|FG001|Overall Study|Lost to Follow-up|0|||
164179652|NCT03800836|593020599|FG002|Overall Study|Lost to Follow-up|1|||
164179653|NCT03800836|593020600|FG003|Overall Study|Lost to Follow-up|1|||
164179654|NCT03800836|593020601|FG004|Overall Study|Lost to Follow-up|3|||
164179655|NCT03800836|593020602|FG005|Overall Study|Lost to Follow-up|0|||
164179656|NCT03800836|593020597|FG000|Overall Study|Withdrawal by Subject|1|||
164179657|NCT03800836|593020598|FG001|Overall Study|Withdrawal by Subject|0|||
164179658|NCT03800836|593020599|FG002|Overall Study|Withdrawal by Subject|0|||
164179659|NCT03800836|593020600|FG003|Overall Study|Withdrawal by Subject|0|||
164179660|NCT03800836|593020601|FG004|Overall Study|Withdrawal by Subject|0|||
164179661|NCT03800836|593020602|FG005|Overall Study|Withdrawal by Subject|0|||
164179662|NCT03800836|593020597|FG000|Overall Study|Physician Decision|31|||
164179663|NCT03800836|593020598|FG001|Overall Study|Physician Decision|3|||
164179664|NCT03800836|593020599|FG002|Overall Study|Physician Decision|6|||
164179665|NCT03800836|593020600|FG003|Overall Study|Physician Decision|4|||
164179666|NCT03800836|593020601|FG004|Overall Study|Physician Decision|4|||
164179667|NCT03800836|593020602|FG005|Overall Study|Physician Decision|5|||
164179668|NCT03800836|593020597|FG000|Overall Study|Death|34|||
164179669|NCT03800836|593020598|FG001|Overall Study|Death|16|||
164179670|NCT03800836|593020599|FG002|Overall Study|Death|5|||
164179671|NCT03800836|593020600|FG003|Overall Study|Death|5|||
164179672|NCT03800836|593020601|FG004|Overall Study|Death|10|||
164179673|NCT03800836|593020602|FG005|Overall Study|Death|0|||
164179674|NCT03800836|593020597|FG000|Overall Study|Symptomatic Deterioration|1|||
164179675|NCT03800836|593020598|FG001|Overall Study|Symptomatic Deterioration|0|||
164179676|NCT03800836|593020599|FG002|Overall Study|Symptomatic Deterioration|1|||
164179677|NCT03800836|593020600|FG003|Overall Study|Symptomatic Deterioration|0|||
164179678|NCT03800836|593020601|FG004|Overall Study|Symptomatic Deterioration|0|||
164179679|NCT03800836|593020602|FG005|Overall Study|Symptomatic Deterioration|0|||
164179680|NCT03341936|593023028|FG000|Overall Study|Ineligible|1|||
164179681|NCT03341936|593023028|FG000|Overall Study|Disease Progression|2|||
164179682|NCT03341936|593023028|FG000|Overall Study|Withdrew Consent|4|||
164179683|NCT03341936|593023028|FG000|Overall Study|Non-Compliance|1|||
164179684|NCT03341936|593023028|FG000|Overall Study|Physician Decision|1|||
164179685|NCT03341936|593023028|FG000|Overall Study|Withdrawal by Subject|1|||
164179686|NCT03341936|593023028|FG000|Overall Study|Other|1|||
164179687|NCT04849416|593023029|FG000|Overall Study|Ongoing Treatment|12|||
164179688|NCT04849416|593023030|FG001|Overall Study|Ongoing Treatment|5|||
164179689|NCT04849416|593023031|FG002|Overall Study|Ongoing Treatment|3|||
164179690|NCT04849416|593023029|FG000|Overall Study|On Post-Treatment Follow-up|8|||
164179691|NCT04849416|593023030|FG001|Overall Study|On Post-Treatment Follow-up|9|||
164179692|NCT04849416|593023031|FG002|Overall Study|On Post-Treatment Follow-up|10|||
164179693|NCT04849416|593023029|FG000|Overall Study|Withdrawal by Subject|0|||
164179694|NCT04849416|593023030|FG001|Overall Study|Withdrawal by Subject|0|||
164179695|NCT04849416|593023031|FG002|Overall Study|Withdrawal by Subject|1|||
164179696|NCT04849416|593023029|FG000|Overall Study|Lost to Follow-up|1|||
164179697|NCT04849416|593023030|FG001|Overall Study|Lost to Follow-up|0|||
164179698|NCT04849416|593023031|FG002|Overall Study|Lost to Follow-up|0|||
164179699|NCT04529850|593023032|FG000|Overall Study|Death|2|||
164179700|NCT04529850|593023032|FG000|Overall Study|Physician Decision|1|||
164179701|NCT04529850|593023032|FG000|Overall Study|Withdrawal by Subject|2|||
164179702|NCT00593606|593023033|FG000|Overall Study|Adverse Event|13|||
164179703|NCT00593606|593023033|FG000|Overall Study|Withdrawal by Subject|1|||
164179704|NCT00593606|593023033|FG000|Overall Study|Protocol Violation|3|||
164179705|NCT00593606|593023033|FG000|Overall Study|Lost to Follow-up|2|||
164179706|NCT00593606|593023033|FG000|Overall Study|Run-In Failure|5|||
164179707|NCT00593606|593023033|FG000|Overall Study|Screen Failure|3|||
164179708|NCT00869557|593023036|FG000|Randomized Phase|Lost to Follow-up|2|||
164179709|NCT00869557|593023037|FG001|Randomized Phase|Lost to Follow-up|1|||
164179710|NCT00869557|593023036|FG000|Randomized Phase|Investigator's Discretion|1|||
164179711|NCT00869557|593023037|FG001|Randomized Phase|Investigator's Discretion|0|||
164179712|NCT00869557|593023036|FG000|Randomized Phase|Withdrew Consent|0|||
164179713|NCT00869557|593023037|FG001|Randomized Phase|Withdrew Consent|1|||
164179714|NCT00869557|593023036|FG000|Extension Phase|Adverse Event|2|||
164179715|NCT00869557|593023037|FG001|Extension Phase|Adverse Event|2|||
164179716|NCT00869557|593023036|FG000|Extension Phase|Lack of Efficacy|1|||
164179717|NCT00869557|593023037|FG001|Extension Phase|Lack of Efficacy|0|||
164179718|NCT00869557|593023036|FG000|Extension Phase|Lost to Follow-up|3|||
164179719|NCT00869557|593023037|FG001|Extension Phase|Lost to Follow-up|1|||
164179720|NCT00869557|593023036|FG000|Extension Phase|Investigator's Discretion|2|||
164179721|NCT00869557|593023037|FG001|Extension Phase|Investigator's Discretion|0|||
164179722|NCT00869557|593023036|FG000|Extension Phase|Withdrew Consent|2|||
164179723|NCT00869557|593023037|FG001|Extension Phase|Withdrew Consent|0|||
164179724|NCT01472939|593023038|FG000|Overall Study|Adverse Event|3|||
164179725|NCT01472939|593023039|FG001|Overall Study|Adverse Event|7|||
164179726|NCT01472939|593023040|FG002|Overall Study|Adverse Event|7|||
164179727|NCT01472939|593023041|FG003|Overall Study|Adverse Event|14|||
164179728|NCT01472939|593023038|FG000|Overall Study|Lack of Efficacy|1|||
164179729|NCT01472939|593023039|FG001|Overall Study|Lack of Efficacy|0|||
164179730|NCT01472939|593023040|FG002|Overall Study|Lack of Efficacy|0|||
164179731|NCT01472939|593023041|FG003|Overall Study|Lack of Efficacy|1|||
164179732|NCT01472939|593023038|FG000|Overall Study|Lost to Follow-up|3|||
164179733|NCT01472939|593023039|FG001|Overall Study|Lost to Follow-up|0|||
164179734|NCT01472939|593023040|FG002|Overall Study|Lost to Follow-up|2|||
164179735|NCT01472939|593023041|FG003|Overall Study|Lost to Follow-up|0|||
164179736|NCT01472939|593023038|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
164179737|NCT01472939|593023039|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
164179738|NCT01472939|593023040|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
164179739|NCT01472939|593023041|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
164179740|NCT01472939|593023038|FG000|Overall Study|Prohibited Medication|0|||
164179741|NCT01472939|593023039|FG001|Overall Study|Prohibited Medication|1|||
164179742|NCT01472939|593023040|FG002|Overall Study|Prohibited Medication|0|||
164179743|NCT01472939|593023041|FG003|Overall Study|Prohibited Medication|0|||
164179744|NCT01472939|593023038|FG000|Overall Study|Withdrawal By PI|1|||
164179745|NCT01472939|593023039|FG001|Overall Study|Withdrawal By PI|0|||
164179746|NCT01472939|593023040|FG002|Overall Study|Withdrawal By PI|0|||
164179747|NCT01472939|593023041|FG003|Overall Study|Withdrawal By PI|0|||
164179748|NCT01472939|593023038|FG000|Overall Study|Protocol Violation|3|||
164179749|NCT01472939|593023039|FG001|Overall Study|Protocol Violation|3|||
164179750|NCT01472939|593023040|FG002|Overall Study|Protocol Violation|0|||
164179751|NCT01472939|593023041|FG003|Overall Study|Protocol Violation|1|||
164179752|NCT01472939|593023038|FG000|Overall Study|Withdrawal by Subject|9|||
164179753|NCT01472939|593023039|FG001|Overall Study|Withdrawal by Subject|3|||
164179754|NCT01472939|593023040|FG002|Overall Study|Withdrawal by Subject|1|||
164179755|NCT01472939|593023041|FG003|Overall Study|Withdrawal by Subject|4|||
164179756|NCT00114738|593023042|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
164179757|NCT00114738|593023043|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
164179758|NCT00114738|593023044|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
164179759|NCT00114738|593023042|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
164179760|NCT00114738|593023043|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
164179761|NCT00114738|593023044|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
164179762|NCT00114738|593023042|FG000|Screening for Randomization|Neuropathy|17|||
164179763|NCT00114738|593023043|FG001|Screening for Randomization|Neuropathy|0|||
164179764|NCT00114738|593023044|FG002|Screening for Randomization|Neuropathy|0|||
164179765|NCT00114738|593023042|FG000|Screening for Randomization|Progressive disease|2|||
164179766|NCT00114738|593023043|FG001|Screening for Randomization|Progressive disease|0|||
164179767|NCT00114738|593023044|FG002|Screening for Randomization|Progressive disease|0|||
164179768|NCT00114738|593023042|FG000|Screening for Randomization|CNS Hemorrhage|1|||
164179769|NCT00114738|593023043|FG001|Screening for Randomization|CNS Hemorrhage|0|||
164179770|NCT00114738|593023044|FG002|Screening for Randomization|CNS Hemorrhage|0|||
164179771|NCT00114738|593023042|FG000|Screening for Randomization|Other|1|||
164179772|NCT00114738|593023043|FG001|Screening for Randomization|Other|0|||
164179773|NCT00114738|593023044|FG002|Screening for Randomization|Other|0|||
164179774|NCT05940077|593023045|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
164179775|NCT01492101|593023046|FG000|Overall Study|Death|323|||
164179776|NCT01492101|593023047|FG001|Overall Study|Death|322|||
164179777|NCT01492101|593023046|FG000|Overall Study|Withdrawal by Subject|14|||
164179778|NCT01492101|593023047|FG001|Overall Study|Withdrawal by Subject|18|||
164179779|NCT01492101|593023046|FG000|Overall Study|Lost to Follow-up|0|||
164179780|NCT01492101|593023047|FG001|Overall Study|Lost to Follow-up|2|||
164179781|NCT01004432|593023048|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
164179782|NCT01004432|593023049|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
164179783|NCT01004432|593023050|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
164179784|NCT01004432|593023051|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
164179785|NCT01004432|593023052|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
164179786|NCT01004432|593023048|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
164179787|NCT01004432|593023049|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
164179788|NCT01004432|593023050|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
164179789|NCT01004432|593023051|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
164179790|NCT01004432|593023052|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
164179791|NCT01004432|593023048|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
164179792|NCT01004432|593023049|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
164179793|NCT01004432|593023050|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
164179794|NCT01004432|593023051|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
164179795|NCT01004432|593023052|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
164179796|NCT01004432|593023048|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
164179797|NCT01004432|593023049|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
164179798|NCT01004432|593023050|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
164179799|NCT01004432|593023051|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
164179800|NCT01004432|593023052|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
164179801|NCT01004432|593023048|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
164179802|NCT01004432|593023049|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
164179803|NCT01004432|593023050|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
164179804|NCT01004432|593023051|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
164179805|NCT01004432|593023052|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
164179806|NCT01004432|593023048|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
164179807|NCT01004432|593023049|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
164179808|NCT01004432|593023050|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
164179955|NCT03114657|593023095|FG000|Overall Study|Death|4|||
164179809|NCT01004432|593023051|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
164179810|NCT01004432|593023052|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
164179811|NCT01004432|593023048|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
164179812|NCT01004432|593023049|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
164179813|NCT01004432|593023050|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
164179814|NCT01004432|593023051|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
164179815|NCT01004432|593023052|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
164179816|NCT01004432|593023048|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
164179817|NCT01004432|593023049|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
164179818|NCT01004432|593023050|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
164179819|NCT01004432|593023051|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
164179820|NCT01004432|593023052|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
164179821|NCT01004432|593023048|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
164179822|NCT01004432|593023049|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
164179823|NCT01004432|593023050|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
164179824|NCT01004432|593023051|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
164179825|NCT01004432|593023052|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
164179826|NCT01004432|593023048|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
164179827|NCT01004432|593023049|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
164179828|NCT01004432|593023050|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
164179829|NCT01004432|593023051|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
164179830|NCT01004432|593023052|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
164179831|NCT01004432|593023048|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
164179832|NCT01004432|593023049|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
164179833|NCT01004432|593023050|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
164179834|NCT01004432|593023051|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
164179835|NCT01004432|593023052|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
164179836|NCT01004432|593023048|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
164179837|NCT01004432|593023049|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
164179838|NCT01004432|593023050|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
164179839|NCT01004432|593023051|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
164179840|NCT01004432|593023052|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
164179841|NCT01004432|593023048|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
164179842|NCT01004432|593023049|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
164179843|NCT01004432|593023050|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
164179844|NCT01004432|593023051|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
164179845|NCT01004432|593023052|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
164179846|NCT01004432|593023048|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
164179847|NCT01004432|593023049|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
164179848|NCT01004432|593023050|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
164179849|NCT01004432|593023051|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
164179850|NCT01004432|593023052|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
164179851|NCT01004432|593023048|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
164179852|NCT01004432|593023049|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
164179853|NCT01004432|593023050|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
164179854|NCT01004432|593023051|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
164179855|NCT01004432|593023052|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
164179856|NCT01149421|593023054|FG000|Overall Study|Adverse Event|22|||
164179857|NCT01149421|593023055|FG001|Overall Study|Adverse Event|6|||
164179858|NCT01149421|593023056|FG002|Overall Study|Adverse Event|11|||
164179859|NCT01149421|593023054|FG000|Overall Study|Withdrawal by Subject|20|||
164179860|NCT01149421|593023055|FG001|Overall Study|Withdrawal by Subject|12|||
164179861|NCT01149421|593023056|FG002|Overall Study|Withdrawal by Subject|13|||
164179862|NCT01149421|593023054|FG000|Overall Study|Sponsor Decision|0|||
164179863|NCT01149421|593023055|FG001|Overall Study|Sponsor Decision|1|||
164179864|NCT01149421|593023056|FG002|Overall Study|Sponsor Decision|1|||
164179865|NCT01149421|593023054|FG000|Overall Study|Lost to Follow-up|2|||
164179866|NCT01149421|593023055|FG001|Overall Study|Lost to Follow-up|4|||
164179867|NCT01149421|593023056|FG002|Overall Study|Lost to Follow-up|5|||
164179868|NCT01149421|593023054|FG000|Overall Study|Physician Decision|5|||
164179869|NCT01149421|593023055|FG001|Overall Study|Physician Decision|3|||
164179870|NCT01149421|593023056|FG002|Overall Study|Physician Decision|6|||
164179871|NCT01149421|593023054|FG000|Overall Study|Entry Criteria Not Met|1|||
164179872|NCT01149421|593023055|FG001|Overall Study|Entry Criteria Not Met|1|||
164179873|NCT01149421|593023056|FG002|Overall Study|Entry Criteria Not Met|2|||
164179874|NCT01149421|593023054|FG000|Overall Study|Protocol Violation|2|||
164179875|NCT01149421|593023055|FG001|Overall Study|Protocol Violation|2|||
164179876|NCT01149421|593023056|FG002|Overall Study|Protocol Violation|6|||
164179877|NCT03738800|593023059|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
164179878|NCT03738800|593023060|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
164179879|NCT03738800|593023061|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
164179880|NCT03738800|593023059|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
164179881|NCT03738800|593023060|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
164179882|NCT03738800|593023061|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
164179883|NCT03738800|593023059|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
164179884|NCT03738800|593023060|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
164179885|NCT03738800|593023061|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
164179886|NCT02719353|593023062|FG000|First Intervention|Physician Decision|0|||
164179887|NCT02719353|593023063|FG001|First Intervention|Physician Decision|1|||
164179888|NCT02223819|593023067|FG000|Overall Study|Lost to Follow-up|2|||
164179889|NCT01917344|593023069|FG000|Overall Study|Withdrawal by Subject|1|||
164179890|NCT03435224|593023070|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
164179891|NCT00367484|593023071|FG000|Overall Study|Adverse Event|7|||
164179892|NCT00367484|593023071|FG000|Overall Study|Withdrew informed consent|5|||
164179893|NCT00367484|593023071|FG000|Overall Study|Travel to USA|1|||
164179894|NCT00367484|593023071|FG000|Overall Study|Lost to Follow-up|1|||
164179895|NCT00367484|593023071|FG000|Overall Study|Protocol Violation|1|||
164179896|NCT00367484|593023071|FG000|Overall Study|The choice of the patient|1|||
164179897|NCT00367484|593023071|FG000|Overall Study|Lack of Efficacy|1|||
164179898|NCT00412217|593023072|FG000|Overall Study|Insufficient Data Available|8|||
164179899|NCT00412217|593023073|FG001|Overall Study|Insufficient Data Available|3|||
164179900|NCT00412217|593023072|FG000|Overall Study|Death|5|||
164179901|NCT00412217|593023073|FG001|Overall Study|Death|4|||
164179902|NCT00412217|593023072|FG000|Overall Study|Disease Progression|2|||
164179903|NCT00412217|593023073|FG001|Overall Study|Disease Progression|3|||
164179904|NCT00412217|593023072|FG000|Overall Study|Investigator Decision|1|||
164179905|NCT00412217|593023073|FG001|Overall Study|Investigator Decision|0|||
164179906|NCT00412217|593023072|FG000|Overall Study|Withdrawal by Subject|2|||
164179907|NCT00412217|593023073|FG001|Overall Study|Withdrawal by Subject|0|||
164179908|NCT00412217|593023072|FG000|Overall Study|Lost to Follow-up|1|||
164179909|NCT00412217|593023073|FG001|Overall Study|Lost to Follow-up|4|||
164179910|NCT00412217|593023072|FG000|Overall Study|Study Terminated by Sponsor|26|||
164179911|NCT00412217|593023073|FG001|Overall Study|Study Terminated by Sponsor|33|||
164179912|NCT00412217|593023072|FG000|Overall Study|Other|1|||
164179913|NCT00412217|593023073|FG001|Overall Study|Other|1|||
164179914|NCT01777295|593023074|FG000|Overall Study|Withdrawal by Subject|2|||
164179915|NCT01777295|593023075|FG001|Overall Study|Withdrawal by Subject|2|||
164179916|NCT01777295|593023074|FG000|Overall Study|Pregnancy|0|||
164179917|NCT01777295|593023075|FG001|Overall Study|Pregnancy|1|||
164179918|NCT01777295|593023074|FG000|Overall Study|Personal problem|1|||
164179919|NCT01777295|593023075|FG001|Overall Study|Personal problem|0|||
164179920|NCT01777295|593023074|FG000|Overall Study|Investigator call for AEs check|1|||
164179921|NCT01777295|593023075|FG001|Overall Study|Investigator call for AEs check|0|||
164179922|NCT02609724|593023076|FG000|Overall Study|Death|2|||
164179923|NCT02609724|593023077|FG001|Overall Study|Death|0|||
164179924|NCT02609724|593023078|FG002|Overall Study|Death|1|||
164179925|NCT02609724|593023076|FG000|Overall Study|Withdrawal by Subject|1|||
164179926|NCT02609724|593023077|FG001|Overall Study|Withdrawal by Subject|2|||
164179927|NCT02609724|593023078|FG002|Overall Study|Withdrawal by Subject|3|||
164179928|NCT02609724|593023076|FG000|Overall Study|Illness|2|||
164179929|NCT02609724|593023077|FG001|Overall Study|Illness|1|||
164179930|NCT02609724|593023078|FG002|Overall Study|Illness|0|||
164179931|NCT04007107|593023083|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
164179932|NCT04007107|593023084|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
164179933|NCT04007107|593023085|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
164179934|NCT04007107|593023086|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
164179935|NCT00426660|593023092|FG000|Overall Study|Death|14|||
164179936|NCT00426660|593023092|FG000|Overall Study|Adverse Event|23|||
164179937|NCT00426660|593023092|FG000|Overall Study|Insufficient Clinical Response|22|||
164179938|NCT00426660|593023092|FG000|Overall Study|Lost to Follow-up|15|||
164179939|NCT00426660|593023092|FG000|Overall Study|Other|23|||
164179940|NCT00426660|593023092|FG000|Overall Study|Withdrawal by Subject|18|||
164179941|NCT00426660|593023092|FG000|Overall Study|Protocol Violation|1|||
164179942|NCT00426660|593023092|FG000|Overall Study|Enrolled Not Treated|15|||
164179943|NCT00980174|593023093|FG000|Overall Study|Withdrawal by Subject|1|||
164179944|NCT00980174|593023094|FG001|Overall Study|Withdrawal by Subject|4|||
164179945|NCT00980174|593023093|FG000|Overall Study|Adverse Event|0|||
164179946|NCT00980174|593023094|FG001|Overall Study|Adverse Event|3|||
164179947|NCT00980174|593023093|FG000|Overall Study|Ineligibility determined|2|||
164179948|NCT00980174|593023094|FG001|Overall Study|Ineligibility determined|1|||
164179949|NCT00980174|593023093|FG000|Overall Study|Death|1|||
164179950|NCT00980174|593023094|FG001|Overall Study|Death|1|||
164179951|NCT00980174|593023093|FG000|Overall Study|Other|0|||
164179952|NCT00980174|593023094|FG001|Overall Study|Other|1|||
164179953|NCT03114657|593023095|FG000|Overall Study|Adverse Event|9|||
164179954|NCT03114657|593023096|FG001|Overall Study|Adverse Event|6|||
164179956|NCT03114657|593023096|FG001|Overall Study|Death|0|||
164179957|NCT03114657|593023095|FG000|Overall Study|Multiple Reasons|1|||
164179958|NCT03114657|593023096|FG001|Overall Study|Multiple Reasons|2|||
164179959|NCT03114657|593023095|FG000|Overall Study|Physician Decision|2|||
164179960|NCT03114657|593023096|FG001|Overall Study|Physician Decision|2|||
164179961|NCT03114657|593023095|FG000|Overall Study|Study Terminated By Sponsor|355|||
164179962|NCT03114657|593023096|FG001|Overall Study|Study Terminated By Sponsor|374|||
164179963|NCT03114657|593023095|FG000|Overall Study|Symptomatic Deterioration|0|||
164179964|NCT03114657|593023096|FG001|Overall Study|Symptomatic Deterioration|1|||
164179965|NCT03114657|593023095|FG000|Overall Study|Withdrawal by Subject|28|||
164179966|NCT03114657|593023096|FG001|Overall Study|Withdrawal by Subject|22|||
164179967|NCT01546038|593023097|FG000|Overall Study|Death|15|||
164179968|NCT01546038|593023098|FG001|Overall Study|Death|6|||
164179969|NCT01546038|593023099|FG002|Overall Study|Death|4|||
164179970|NCT01546038|593023100|FG003|Overall Study|Death|2|||
164179971|NCT01546038|593023101|FG004|Overall Study|Death|9|||
164179972|NCT01546038|593023102|FG005|Overall Study|Death|3|||
164179973|NCT01546038|593023103|FG006|Overall Study|Death|46|||
164179974|NCT01546038|593023104|FG007|Overall Study|Death|76|||
164179975|NCT01546038|593023105|FG008|Overall Study|Death|39|||
164179976|NCT01546038|593023097|FG000|Overall Study|Lost to Follow-up|0|||
164179977|NCT01546038|593023098|FG001|Overall Study|Lost to Follow-up|0|||
164179978|NCT01546038|593023099|FG002|Overall Study|Lost to Follow-up|0|||
164179979|NCT01546038|593023100|FG003|Overall Study|Lost to Follow-up|0|||
164179980|NCT01546038|593023101|FG004|Overall Study|Lost to Follow-up|1|||
164179981|NCT01546038|593023102|FG005|Overall Study|Lost to Follow-up|0|||
164179982|NCT01546038|593023103|FG006|Overall Study|Lost to Follow-up|2|||
164179983|NCT01546038|593023104|FG007|Overall Study|Lost to Follow-up|1|||
164179984|NCT01546038|593023105|FG008|Overall Study|Lost to Follow-up|0|||
164179985|NCT01546038|593023097|FG000|Overall Study|Withdrawal by Subject|1|||
164179986|NCT01546038|593023098|FG001|Overall Study|Withdrawal by Subject|0|||
164179987|NCT01546038|593023099|FG002|Overall Study|Withdrawal by Subject|0|||
164179988|NCT01546038|593023100|FG003|Overall Study|Withdrawal by Subject|1|||
164179989|NCT01546038|593023101|FG004|Overall Study|Withdrawal by Subject|0|||
164179990|NCT01546038|593023102|FG005|Overall Study|Withdrawal by Subject|1|||
164179991|NCT01546038|593023103|FG006|Overall Study|Withdrawal by Subject|3|||
164179992|NCT01546038|593023104|FG007|Overall Study|Withdrawal by Subject|3|||
164179993|NCT01546038|593023105|FG008|Overall Study|Withdrawal by Subject|1|||
164179994|NCT01546038|593023097|FG000|Overall Study|: Randomized, not treated|0|||
164179995|NCT01546038|593023098|FG001|Overall Study|: Randomized, not treated|0|||
164179996|NCT01546038|593023099|FG002|Overall Study|: Randomized, not treated|0|||
164179997|NCT01546038|593023100|FG003|Overall Study|: Randomized, not treated|0|||
164179998|NCT01546038|593023101|FG004|Overall Study|: Randomized, not treated|0|||
164179999|NCT01546038|593023102|FG005|Overall Study|: Randomized, not treated|0|||
164180000|NCT01546038|593023103|FG006|Overall Study|: Randomized, not treated|2|||
164180001|NCT01546038|593023104|FG007|Overall Study|: Randomized, not treated|4|||
164180002|NCT01546038|593023105|FG008|Overall Study|: Randomized, not treated|3|||
164180003|NCT04245202|593023106|FG000|Overall Study|Lack of Efficacy|10|||
164180004|NCT04245202|593023107|FG001|Overall Study|Lack of Efficacy|1|||
164180005|NCT02470403|593023108|FG000|Overall Study|Adverse Event|1|||
164180006|NCT02470403|593023109|FG001|Overall Study|Adverse Event|0|||
164180007|NCT02470403|593023110|FG002|Overall Study|Adverse Event|0|||
164180008|NCT02470403|593023111|FG003|Overall Study|Adverse Event|0|||
164180009|NCT02470403|593023112|FG004|Overall Study|Adverse Event|0|||
164180010|NCT02470403|593023108|FG000|Overall Study|Lost to Follow-up|0|||
164180011|NCT02470403|593023109|FG001|Overall Study|Lost to Follow-up|1|||
164180012|NCT02470403|593023110|FG002|Overall Study|Lost to Follow-up|0|||
164180013|NCT02470403|593023111|FG003|Overall Study|Lost to Follow-up|0|||
164180014|NCT02470403|593023112|FG004|Overall Study|Lost to Follow-up|0|||
164180015|NCT02470403|593023108|FG000|Overall Study|Subject/guardian decision|1|||
164180016|NCT02470403|593023109|FG001|Overall Study|Subject/guardian decision|0|||
164180017|NCT02470403|593023110|FG002|Overall Study|Subject/guardian decision|0|||
164180018|NCT02470403|593023111|FG003|Overall Study|Subject/guardian decision|4|||
164180019|NCT02470403|593023112|FG004|Overall Study|Subject/guardian decision|0|||
164180020|NCT02631070|593023113|FG000|Overall Study|Withdrawal by Subject|35|||
164180021|NCT02631070|593023114|FG001|Overall Study|Withdrawal by Subject|13|||
164180022|NCT02631070|593023113|FG000|Overall Study|Death|45|||
164180023|NCT02631070|593023114|FG001|Overall Study|Death|24|||
164180024|NCT02631070|593023113|FG000|Overall Study|Lost to Follow-up|5|||
164180025|NCT02631070|593023114|FG001|Overall Study|Lost to Follow-up|1|||
164180026|NCT02631070|593023113|FG000|Overall Study|Transition to rollover protocol|52|||
164180027|NCT02631070|593023114|FG001|Overall Study|Transition to rollover protocol|21|||
164180028|NCT02631070|593023113|FG000|Overall Study|Other reasons|12|||
164180029|NCT02631070|593023114|FG001|Overall Study|Other reasons|5|||
164180030|NCT01522235|593023117|FG000|Overall Study|Physician Decision|1|||
164180031|NCT01522235|593023118|FG001|Overall Study|Physician Decision|1|||
164180032|NCT00312572|593023119|FG000|Overall Study|Adverse Event|10|||
164180033|NCT00312572|593023120|FG001|Overall Study|Adverse Event|16|||
164180034|NCT00312572|593023119|FG000|Overall Study|Lost to Follow-up|1|||
164180035|NCT00312572|593023120|FG001|Overall Study|Lost to Follow-up|1|||
164180036|NCT00312572|593023119|FG000|Overall Study|Administrative|4|||
164180037|NCT00312572|593023120|FG001|Overall Study|Administrative|2|||
164180038|NCT00312572|593023119|FG000|Overall Study|Lack of Efficacy|1|||
164180039|NCT00312572|593023120|FG001|Overall Study|Lack of Efficacy|2|||
164180040|NCT05385224|593023121|FG000|Overall Study|Unable to swallow capsule|2|||
164180041|NCT05385224|593023121|FG000|Overall Study|Withdrawal by Subject|2|||
164180042|NCT05385224|593023121|FG000|Overall Study|Did not meet study criteria|1|||
164180043|NCT04521114|593023124|FG000|Overall Study|Lost to Follow-up|1|||
164180044|NCT04521114|593023125|FG001|Overall Study|Lost to Follow-up|2|||
164180045|NCT04521114|593023126|FG002|Overall Study|Lost to Follow-up|0|||
164180046|NCT04521114|593023124|FG000|Overall Study|Withdrawal by Subject|1|||
164180047|NCT04521114|593023125|FG001|Overall Study|Withdrawal by Subject|2|||
164180048|NCT04521114|593023126|FG002|Overall Study|Withdrawal by Subject|2|||
164180049|NCT04521114|593023124|FG000|Overall Study|Adverse Event|1|||
164180050|NCT04521114|593023125|FG001|Overall Study|Adverse Event|0|||
164180051|NCT04521114|593023126|FG002|Overall Study|Adverse Event|0|||
164180052|NCT04521114|593023124|FG000|Overall Study|Sponsor Wish|1|||
164180053|NCT04521114|593023125|FG001|Overall Study|Sponsor Wish|0|||
164180054|NCT04521114|593023126|FG002|Overall Study|Sponsor Wish|0|||
164180055|NCT04521114|593023124|FG000|Overall Study|Withdrawal of Consent|2|||
164180056|NCT04521114|593023125|FG001|Overall Study|Withdrawal of Consent|2|||
164180057|NCT04521114|593023126|FG002|Overall Study|Withdrawal of Consent|0|||
164180058|NCT01362517|593023127|FG000|Overall Study|Protocol Violation|1|||
164180059|NCT01362517|593023127|FG000|Overall Study|Lost to Follow-up|1|||
164180060|NCT01133288|593023130|FG000|Eligibility Assessment|met exclusion criteria|5|||
164180061|NCT01133288|593023130|FG000|Intervention Allocation|study terminated|2|||
164180062|NCT02614131|593023131|FG000|Overall Study|Withdrawal by Subject|1|||
164180063|NCT02614131|593023132|FG001|Overall Study|Withdrawal by Subject|0|||
164180064|NCT02614131|593023133|FG002|Overall Study|Withdrawal by Subject|0|||
164180065|NCT02614131|593023134|FG003|Overall Study|Withdrawal by Subject|0|||
164180066|NCT02614131|593023135|FG004|Overall Study|Withdrawal by Subject|0|||
164180067|NCT02614131|593023136|FG005|Overall Study|Withdrawal by Subject|0|||
164180068|NCT02614131|593023137|FG006|Overall Study|Withdrawal by Subject|0|||
164180069|NCT02614131|593023131|FG000|Overall Study|Adverse Event|0|||
164180070|NCT02614131|593023132|FG001|Overall Study|Adverse Event|0|||
164180071|NCT02614131|593023133|FG002|Overall Study|Adverse Event|0|||
164180072|NCT02614131|593023134|FG003|Overall Study|Adverse Event|0|||
164180073|NCT02614131|593023135|FG004|Overall Study|Adverse Event|0|||
164180074|NCT02614131|593023136|FG005|Overall Study|Adverse Event|0|||
164180075|NCT02614131|593023137|FG006|Overall Study|Adverse Event|1|||
164180076|NCT01832818|593023138|FG000|Overall Study|Lost to Follow-up|6|||
164180077|NCT03209518|593023139|FG000|Overall Study|Case Report Forms Uncollected|1|||
164180078|NCT03209518|593023139|FG000|Overall Study|Protocol Deviation|1|||
164180079|NCT00568334|593023144|FG000|Overall Study|Withdrawal by Subject|0|||
164180080|NCT00568334|593023145|FG001|Overall Study|Withdrawal by Subject|1|||
164180081|NCT00568334|593023144|FG000|Overall Study|Lost to Follow-up|1|||
164180082|NCT00568334|593023145|FG001|Overall Study|Lost to Follow-up|0|||
164180083|NCT01897571|593023146|FG000|Overall Study|Lost to Follow-up|3|||
164180084|NCT01897571|593023147|FG001|Overall Study|Lost to Follow-up|0|||
164180085|NCT01897571|593023148|FG002|Overall Study|Lost to Follow-up|0|||
164180086|NCT01897571|593023149|FG003|Overall Study|Lost to Follow-up|0|||
164180087|NCT01897571|593023150|FG004|Overall Study|Lost to Follow-up|2|||
164180088|NCT01897571|593023151|FG005|Overall Study|Lost to Follow-up|0|||
164180089|NCT01897571|593023152|FG006|Overall Study|Lost to Follow-up|0|||
164180090|NCT01897571|593023153|FG007|Overall Study|Lost to Follow-up|0|||
164180091|NCT01897571|593023154|FG008|Overall Study|Lost to Follow-up|1|||
164180092|NCT01897571|593023155|FG009|Overall Study|Lost to Follow-up|2|||
164180093|NCT01897571|593023156|FG010|Overall Study|Lost to Follow-up|4|||
164180094|NCT01897571|593023146|FG000|Overall Study|Withdrawal by Subject|0|||
164180095|NCT01897571|593023147|FG001|Overall Study|Withdrawal by Subject|0|||
164180096|NCT01897571|593023148|FG002|Overall Study|Withdrawal by Subject|0|||
164180097|NCT01897571|593023149|FG003|Overall Study|Withdrawal by Subject|0|||
164180098|NCT01897571|593023150|FG004|Overall Study|Withdrawal by Subject|0|||
164180099|NCT01897571|593023151|FG005|Overall Study|Withdrawal by Subject|0|||
164180100|NCT01897571|593023152|FG006|Overall Study|Withdrawal by Subject|0|||
164180101|NCT01897571|593023153|FG007|Overall Study|Withdrawal by Subject|1|||
164180102|NCT01897571|593023154|FG008|Overall Study|Withdrawal by Subject|4|||
164180103|NCT01897571|593023155|FG009|Overall Study|Withdrawal by Subject|3|||
164180104|NCT01897571|593023156|FG010|Overall Study|Withdrawal by Subject|1|||
164180105|NCT01897571|593023146|FG000|Overall Study|Other|1|||
164180106|NCT01897571|593023147|FG001|Overall Study|Other|0|||
164180107|NCT01897571|593023148|FG002|Overall Study|Other|0|||
164180108|NCT01897571|593023149|FG003|Overall Study|Other|3|||
164180109|NCT01897571|593023150|FG004|Overall Study|Other|3|||
164180110|NCT01897571|593023151|FG005|Overall Study|Other|4|||
164180111|NCT01897571|593023152|FG006|Overall Study|Other|7|||
164180112|NCT01897571|593023153|FG007|Overall Study|Other|0|||
164180113|NCT01897571|593023154|FG008|Overall Study|Other|0|||
164180114|NCT01897571|593023155|FG009|Overall Study|Other|0|||
164180115|NCT01897571|593023156|FG010|Overall Study|Other|0|||
164180116|NCT01897571|593023146|FG000|Overall Study|Enrolled in rollover study|0|||
164180117|NCT01897571|593023147|FG001|Overall Study|Enrolled in rollover study|0|||
164180118|NCT01897571|593023148|FG002|Overall Study|Enrolled in rollover study|0|||
164180119|NCT01897571|593023149|FG003|Overall Study|Enrolled in rollover study|0|||
164180120|NCT01897571|593023150|FG004|Overall Study|Enrolled in rollover study|0|||
164180121|NCT01897571|593023151|FG005|Overall Study|Enrolled in rollover study|0|||
164180122|NCT01897571|593023152|FG006|Overall Study|Enrolled in rollover study|0|||
164180123|NCT01897571|593023153|FG007|Overall Study|Enrolled in rollover study|9|||
164180124|NCT01897571|593023154|FG008|Overall Study|Enrolled in rollover study|7|||
164180125|NCT01897571|593023155|FG009|Overall Study|Enrolled in rollover study|9|||
164180126|NCT01897571|593023156|FG010|Overall Study|Enrolled in rollover study|1|||
164180127|NCT01897571|593023146|FG000|Overall Study|Death|2|||
164180128|NCT01897571|593023147|FG001|Overall Study|Death|2|||
164180129|NCT01897571|593023148|FG002|Overall Study|Death|3|||
164180130|NCT01897571|593023149|FG003|Overall Study|Death|6|||
164180131|NCT01897571|593023150|FG004|Overall Study|Death|7|||
164180132|NCT01897571|593023151|FG005|Overall Study|Death|9|||
164180133|NCT01897571|593023152|FG006|Overall Study|Death|5|||
164180134|NCT01897571|593023153|FG007|Overall Study|Death|22|||
164180135|NCT01897571|593023154|FG008|Overall Study|Death|23|||
164180136|NCT01897571|593023155|FG009|Overall Study|Death|129|||
164180137|NCT01897571|593023156|FG010|Overall Study|Death|59|||
164180138|NCT00401960|593023157|FG000|Overall Study|Lost to Follow-up|3|||
164180139|NCT00401960|593023158|FG001|Overall Study|Lost to Follow-up|0|||
164180140|NCT00401960|593023157|FG000|Overall Study|Death|2|||
164180141|NCT00401960|593023158|FG001|Overall Study|Death|0|||
164180142|NCT01606202|593023159|FG000|Overall Study|Adverse Event|5|||
164180143|NCT01606202|593023160|FG001|Overall Study|Adverse Event|0|||
164180144|NCT01606202|593023159|FG000|Overall Study|Withdrawal by Subject|2|||
164180145|NCT01606202|593023160|FG001|Overall Study|Withdrawal by Subject|1|||
164180146|NCT01606202|593023159|FG000|Overall Study|Personal problems|0|||
164180147|NCT01606202|593023160|FG001|Overall Study|Personal problems|1|||
164180148|NCT01606202|593023159|FG000|Overall Study|Problems with administration|0|||
164180149|NCT01606202|593023160|FG001|Overall Study|Problems with administration|1|||
164180150|NCT03217968|593023163|FG000|Overall Study|Withdrawal by Subject|4|||
164180151|NCT03217968|593023163|FG000|Overall Study|Lost to Follow-up|1|||
164180152|NCT03217968|593023163|FG000|Overall Study|Protocol Violation|6|||
164180153|NCT00337779|593023164|FG000|Overall Study|Withdrawal by Subject|10|||
164180154|NCT00337779|593023165|FG001|Overall Study|Withdrawal by Subject|12|||
164180155|NCT00337779|593023164|FG000|Overall Study|Sponsor decision|1|||
164180156|NCT00337779|593023165|FG001|Overall Study|Sponsor decision|1|||
164180157|NCT00337779|593023164|FG000|Overall Study|Physician Decision|3|||
164180158|NCT00337779|593023165|FG001|Overall Study|Physician Decision|6|||
164180159|NCT00337779|593023164|FG000|Overall Study|Protocol Violation|1|||
164180160|NCT00337779|593023165|FG001|Overall Study|Protocol Violation|1|||
164180161|NCT00337779|593023164|FG000|Overall Study|Lost to Follow-up|6|||
164180162|NCT00337779|593023165|FG001|Overall Study|Lost to Follow-up|5|||
164180163|NCT00337779|593023164|FG000|Overall Study|Adverse Event|28|||
164180164|NCT00337779|593023165|FG001|Overall Study|Adverse Event|51|||
164180165|NCT00337779|593023164|FG000|Overall Study|Pregnancy|3|||
164180166|NCT00337779|593023165|FG001|Overall Study|Pregnancy|2|||
164180167|NCT00337779|593023164|FG000|Overall Study|Death|0|||
164180168|NCT00337779|593023165|FG001|Overall Study|Death|1|||
164180169|NCT03008278|593023166|FG000|Overall Study|Progressive Disease|0|||
164180170|NCT03008278|593023167|FG001|Overall Study|Progressive Disease|0|||
164180171|NCT03008278|593023168|FG002|Overall Study|Progressive Disease|32|||
164180172|NCT03008278|593023166|FG000|Overall Study|Adverse Event|0|||
164180173|NCT03008278|593023167|FG001|Overall Study|Adverse Event|0|||
164180174|NCT03008278|593023168|FG002|Overall Study|Adverse Event|4|||
164180175|NCT03008278|593023166|FG000|Overall Study|Withdrawal by Subject|0|||
164180176|NCT03008278|593023167|FG001|Overall Study|Withdrawal by Subject|0|||
164180177|NCT03008278|593023168|FG002|Overall Study|Withdrawal by Subject|3|||
164180178|NCT03008278|593023166|FG000|Overall Study|Physician Decision|0|||
164180179|NCT03008278|593023167|FG001|Overall Study|Physician Decision|2|||
164180180|NCT03008278|593023168|FG002|Overall Study|Physician Decision|0|||
164180181|NCT01074255|593023169|FG000|Overall Study|Did not receive EMEND|2|||
164180182|NCT01389258|593023170|FG000|Overall Study|Lost to Follow-up|5|||
164180183|NCT03313310|593023171|FG000|Phase 2|Lost to Follow-up|4|||
164180184|NCT03313310|593023172|FG001|Phase 2|Lost to Follow-up|0|||
164180185|NCT03313310|593023171|FG000|Phase 3|Lost to Follow-up|0|||
164180186|NCT03313310|593023172|FG001|Phase 3|Lost to Follow-up|1|||
164180187|NCT00932451|593023183|FG000|Overall Study|Withdrawal by Subject|69|||
164180188|NCT00932451|593023183|FG000|Overall Study|Lost to Follow-up|22|||
164180189|NCT00932451|593023183|FG000|Overall Study|Death|726|||
164180190|NCT00932451|593023183|FG000|Overall Study|Other reasons|5|||
164180191|NCT03627416|593023184|FG000|Overall Study|Adverse Event|0|||
164180192|NCT03627416|593023185|FG001|Overall Study|Adverse Event|1|||
164180193|NCT01096589|593023188|FG000|Overall Study|Adverse Event|2|||
164180194|NCT01096589|593023189|FG001|Overall Study|Adverse Event|1|||
164180195|NCT01096589|593023190|FG002|Overall Study|Adverse Event|2|||
164180196|NCT01096589|593023191|FG003|Overall Study|Adverse Event|1|||
164180197|NCT01096589|593023188|FG000|Overall Study|Withdrawal by Subject|2|||
164180198|NCT01096589|593023189|FG001|Overall Study|Withdrawal by Subject|1|||
164180199|NCT01096589|593023190|FG002|Overall Study|Withdrawal by Subject|1|||
164180200|NCT01096589|593023191|FG003|Overall Study|Withdrawal by Subject|1|||
164180201|NCT01096589|593023188|FG000|Overall Study|Compliance with protocol|0|||
164180202|NCT01096589|593023189|FG001|Overall Study|Compliance with protocol|0|||
164180203|NCT01096589|593023190|FG002|Overall Study|Compliance with protocol|1|||
164180204|NCT01096589|593023191|FG003|Overall Study|Compliance with protocol|0|||
164180205|NCT01096589|593023188|FG000|Overall Study|found treatment exhausting|0|||
164180206|NCT01096589|593023189|FG001|Overall Study|found treatment exhausting|0|||
164180207|NCT01096589|593023190|FG002|Overall Study|found treatment exhausting|0|||
164180208|NCT01096589|593023191|FG003|Overall Study|found treatment exhausting|1|||
164180209|NCT02520427|593023192|FG000|Overall Study|Decision by sponsor|0|||
164180210|NCT02520427|593023193|FG001|Overall Study|Decision by sponsor|0|||
164180211|NCT02520427|593023194|FG002|Overall Study|Decision by sponsor|0|||
164180212|NCT02520427|593023195|FG003|Overall Study|Decision by sponsor|0|||
164180213|NCT02520427|593023196|FG004|Overall Study|Decision by sponsor|0|||
164180214|NCT02520427|593023197|FG005|Overall Study|Decision by sponsor|0|||
164180215|NCT02520427|593023198|FG006|Overall Study|Decision by sponsor|0|||
164180216|NCT02520427|593023199|FG007|Overall Study|Decision by sponsor|0|||
164180217|NCT02520427|593023200|FG008|Overall Study|Decision by sponsor|1|||
164180218|NCT02520427|593023201|FG009|Overall Study|Decision by sponsor|1|||
164180219|NCT02520427|593023202|FG010|Overall Study|Decision by sponsor|0|||
164180220|NCT02520427|593023203|FG011|Overall Study|Decision by sponsor|0|||
164180221|NCT02520427|593023204|FG012|Overall Study|Decision by sponsor|0|||
164180222|NCT02520427|593023205|FG013|Overall Study|Decision by sponsor|0|||
164180223|NCT02520427|593023206|FG014|Overall Study|Decision by sponsor|0|||
164180224|NCT02520427|593023207|FG015|Overall Study|Decision by sponsor|0|||
164180225|NCT02520427|593023208|FG016|Overall Study|Decision by sponsor|0|||
164180226|NCT02520427|593023209|FG017|Overall Study|Decision by sponsor|0|||
164180227|NCT02520427|593023210|FG018|Overall Study|Decision by sponsor|0|||
164180228|NCT02520427|593023211|FG019|Overall Study|Decision by sponsor|0|||
164180229|NCT02520427|593023212|FG020|Overall Study|Decision by sponsor|0|||
164180230|NCT02520427|593023213|FG021|Overall Study|Decision by sponsor|0|||
164180231|NCT02520427|593023214|FG022|Overall Study|Decision by sponsor|0|||
164180232|NCT02520427|593023215|FG023|Overall Study|Decision by sponsor|0|||
164180233|NCT02520427|593023216|FG024|Overall Study|Decision by sponsor|0|||
164180234|NCT02520427|593023217|FG025|Overall Study|Decision by sponsor|0|||
164180235|NCT02520427|593023192|FG000|Overall Study|Withdrawal by Subject|0|||
164180236|NCT02520427|593023193|FG001|Overall Study|Withdrawal by Subject|0|||
164180237|NCT02520427|593023194|FG002|Overall Study|Withdrawal by Subject|1|||
164180238|NCT02520427|593023195|FG003|Overall Study|Withdrawal by Subject|0|||
164180239|NCT02520427|593023196|FG004|Overall Study|Withdrawal by Subject|0|||
164180240|NCT02520427|593023197|FG005|Overall Study|Withdrawal by Subject|0|||
164180241|NCT02520427|593023198|FG006|Overall Study|Withdrawal by Subject|0|||
164180242|NCT02520427|593023199|FG007|Overall Study|Withdrawal by Subject|0|||
164180243|NCT02520427|593023200|FG008|Overall Study|Withdrawal by Subject|0|||
164180244|NCT02520427|593023201|FG009|Overall Study|Withdrawal by Subject|0|||
164180245|NCT02520427|593023202|FG010|Overall Study|Withdrawal by Subject|0|||
164180246|NCT02520427|593023203|FG011|Overall Study|Withdrawal by Subject|0|||
164180247|NCT02520427|593023204|FG012|Overall Study|Withdrawal by Subject|1|||
164180248|NCT02520427|593023205|FG013|Overall Study|Withdrawal by Subject|1|||
164180249|NCT02520427|593023206|FG014|Overall Study|Withdrawal by Subject|1|||
164180250|NCT02520427|593023207|FG015|Overall Study|Withdrawal by Subject|0|||
164180251|NCT02520427|593023208|FG016|Overall Study|Withdrawal by Subject|1|||
164180252|NCT02520427|593023209|FG017|Overall Study|Withdrawal by Subject|0|||
164180253|NCT02520427|593023210|FG018|Overall Study|Withdrawal by Subject|0|||
164180254|NCT02520427|593023211|FG019|Overall Study|Withdrawal by Subject|3|||
164180255|NCT02520427|593023212|FG020|Overall Study|Withdrawal by Subject|2|||
164180256|NCT02520427|593023213|FG021|Overall Study|Withdrawal by Subject|0|||
164180257|NCT02520427|593023214|FG022|Overall Study|Withdrawal by Subject|0|||
164180258|NCT02520427|593023215|FG023|Overall Study|Withdrawal by Subject|0|||
164180259|NCT02520427|593023216|FG024|Overall Study|Withdrawal by Subject|0|||
164180260|NCT02520427|593023217|FG025|Overall Study|Withdrawal by Subject|0|||
164180261|NCT02520427|593023192|FG000|Overall Study|Death|1|||
164180262|NCT02520427|593023193|FG001|Overall Study|Death|0|||
164180263|NCT02520427|593023194|FG002|Overall Study|Death|0|||
164180264|NCT02520427|593023195|FG003|Overall Study|Death|0|||
164180265|NCT02520427|593023196|FG004|Overall Study|Death|0|||
164180266|NCT02520427|593023197|FG005|Overall Study|Death|0|||
164180267|NCT02520427|593023198|FG006|Overall Study|Death|0|||
164180268|NCT02520427|593023199|FG007|Overall Study|Death|0|||
164180269|NCT02520427|593023200|FG008|Overall Study|Death|0|||
164180270|NCT02520427|593023201|FG009|Overall Study|Death|0|||
164180271|NCT02520427|593023202|FG010|Overall Study|Death|0|||
164180272|NCT02520427|593023203|FG011|Overall Study|Death|0|||
164180273|NCT02520427|593023204|FG012|Overall Study|Death|0|||
164180274|NCT02520427|593023205|FG013|Overall Study|Death|0|||
164180275|NCT02520427|593023206|FG014|Overall Study|Death|0|||
164180276|NCT02520427|593023207|FG015|Overall Study|Death|0|||
164180277|NCT02520427|593023208|FG016|Overall Study|Death|2|||
164180278|NCT02520427|593023209|FG017|Overall Study|Death|1|||
164180279|NCT02520427|593023210|FG018|Overall Study|Death|3|||
164180280|NCT02520427|593023211|FG019|Overall Study|Death|2|||
164180281|NCT02520427|593023212|FG020|Overall Study|Death|0|||
164180282|NCT02520427|593023213|FG021|Overall Study|Death|0|||
164180283|NCT02520427|593023214|FG022|Overall Study|Death|1|||
164180284|NCT02520427|593023215|FG023|Overall Study|Death|0|||
164180285|NCT02520427|593023216|FG024|Overall Study|Death|1|||
164180286|NCT02520427|593023217|FG025|Overall Study|Death|0|||
164180287|NCT00793624|593023218|FG000|Overall Study|Adverse Event|18|||
164180288|NCT00793624|593023219|FG001|Overall Study|Adverse Event|16|||
164180289|NCT00793624|593023220|FG002|Overall Study|Adverse Event|15|||
164180290|NCT00793624|593023221|FG003|Overall Study|Adverse Event|20|||
164180291|NCT00793624|593023218|FG000|Overall Study|Lost to Follow-up|2|||
164180292|NCT00793624|593023219|FG001|Overall Study|Lost to Follow-up|2|||
164180293|NCT00793624|593023220|FG002|Overall Study|Lost to Follow-up|4|||
164180294|NCT00793624|593023221|FG003|Overall Study|Lost to Follow-up|0|||
164180295|NCT00793624|593023218|FG000|Overall Study|Withdrawal by Subject|20|||
164180296|NCT00793624|593023219|FG001|Overall Study|Withdrawal by Subject|9|||
164180297|NCT00793624|593023220|FG002|Overall Study|Withdrawal by Subject|11|||
164180298|NCT00793624|593023221|FG003|Overall Study|Withdrawal by Subject|14|||
164180299|NCT00793624|593023218|FG000|Overall Study|Lack of Efficacy|9|||
164180300|NCT00793624|593023219|FG001|Overall Study|Lack of Efficacy|2|||
164180301|NCT00793624|593023220|FG002|Overall Study|Lack of Efficacy|1|||
164180302|NCT00793624|593023221|FG003|Overall Study|Lack of Efficacy|3|||
164180303|NCT00793624|593023218|FG000|Overall Study|Non compliance with protocol|2|||
164180304|NCT00793624|593023219|FG001|Overall Study|Non compliance with protocol|3|||
164180305|NCT00793624|593023220|FG002|Overall Study|Non compliance with protocol|2|||
164180306|NCT00793624|593023221|FG003|Overall Study|Non compliance with protocol|3|||
164180307|NCT00793624|593023218|FG000|Overall Study|Other reason not described above|6|||
164180308|NCT00793624|593023219|FG001|Overall Study|Other reason not described above|4|||
164180309|NCT00793624|593023220|FG002|Overall Study|Other reason not described above|6|||
164180310|NCT00793624|593023221|FG003|Overall Study|Other reason not described above|3|||
164180311|NCT00157248|593023222|FG000|Overall Study|Adverse Event|36|||
164180312|NCT00157248|593023223|FG001|Overall Study|Adverse Event|25|||
164180313|NCT00157248|593023224|FG002|Overall Study|Adverse Event|13|||
164180314|NCT00157248|593023225|FG003|Overall Study|Adverse Event|33|||
164180315|NCT00157248|593023222|FG000|Overall Study|Protocol Violation|4|||
164180316|NCT00157248|593023223|FG001|Overall Study|Protocol Violation|0|||
164180317|NCT00157248|593023224|FG002|Overall Study|Protocol Violation|2|||
164180318|NCT00157248|593023225|FG003|Overall Study|Protocol Violation|2|||
164180319|NCT00157248|593023222|FG000|Overall Study|Lost to Follow-up|0|||
164180320|NCT00157248|593023223|FG001|Overall Study|Lost to Follow-up|1|||
164180321|NCT00157248|593023224|FG002|Overall Study|Lost to Follow-up|0|||
164180322|NCT00157248|593023225|FG003|Overall Study|Lost to Follow-up|0|||
164180323|NCT00157248|593023222|FG000|Overall Study|Withdrawal by Subject|1|||
164180324|NCT00157248|593023223|FG001|Overall Study|Withdrawal by Subject|4|||
164180325|NCT00157248|593023224|FG002|Overall Study|Withdrawal by Subject|3|||
164180326|NCT00157248|593023225|FG003|Overall Study|Withdrawal by Subject|3|||
164180327|NCT00157248|593023222|FG000|Overall Study|site closures, subject moving|7|||
164180328|NCT00157248|593023223|FG001|Overall Study|site closures, subject moving|7|||
164180329|NCT00157248|593023224|FG002|Overall Study|site closures, subject moving|3|||
164180330|NCT00157248|593023225|FG003|Overall Study|site closures, subject moving|9|||
164180331|NCT03467763|593023226|FG000|Overall Study|Lost to Follow-up|1|||
164180332|NCT03467763|593023226|FG000|Overall Study|Protocol Violation|2|||
164180333|NCT02073565|593023227|FG000|Cohort A|Withdrawal by Subject|1|||
164180334|NCT02073565|593023228|FG001|Cohort A|Withdrawal by Subject|0|||
164180335|NCT02073565|593023227|FG000|Cohort B|Withdrawal by Subject|1|||
164180336|NCT02073565|593023228|FG001|Cohort B|Withdrawal by Subject|2|||
164180337|NCT02073565|593023227|FG000|Cohort C|Withdrawal by Subject|0|||
164180338|NCT02073565|593023228|FG001|Cohort C|Withdrawal by Subject|2|||
164180339|NCT02073565|593023227|FG000|Cohort C|Lost to Follow-up|0|||
164180340|NCT02073565|593023228|FG001|Cohort C|Lost to Follow-up|2|||
164180341|NCT02227368|593025204|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
164180342|NCT02227368|593025205|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
164180343|NCT02227368|593025204|FG000|Overall Study|Lost to Follow-up|1|||
164180344|NCT02227368|593025205|FG001|Overall Study|Lost to Follow-up|0|||
164180345|NCT02227368|593025204|FG000|Overall Study|Adverse Event|1|||
164180346|NCT02227368|593025205|FG001|Overall Study|Adverse Event|0|||
164180347|NCT03046056|593025207|FG000|Overall Study|Non-responder at Week 10|6|||
164180348|NCT03046056|593025208|FG001|Overall Study|Non-responder at Week 10|6|||
164180349|NCT03046056|593025209|FG002|Overall Study|Non-responder at Week 10|4|||
164180350|NCT03046056|593025207|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
164180351|NCT03046056|593025208|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
164180352|NCT03046056|593025209|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
164180353|NCT03046056|593025207|FG000|Overall Study|Adverse Event|1|||
164180354|NCT03046056|593025208|FG001|Overall Study|Adverse Event|5|||
164180355|NCT03046056|593025209|FG002|Overall Study|Adverse Event|0|||
164180356|NCT03046056|593025207|FG000|Overall Study|Non-compliance With Study Drug|0|||
164180357|NCT03046056|593025208|FG001|Overall Study|Non-compliance With Study Drug|0|||
164180358|NCT03046056|593025209|FG002|Overall Study|Non-compliance With Study Drug|2|||
164180359|NCT03046056|593025207|FG000|Overall Study|Protocol Violation|1|||
164180360|NCT03046056|593025208|FG001|Overall Study|Protocol Violation|1|||
164180361|NCT03046056|593025209|FG002|Overall Study|Protocol Violation|0|||
164180362|NCT03046056|593025207|FG000|Overall Study|Investigator's Discretion|0|||
164180363|NCT03046056|593025208|FG001|Overall Study|Investigator's Discretion|1|||
164180364|NCT03046056|593025209|FG002|Overall Study|Investigator's Discretion|0|||
164180365|NCT03046056|593025207|FG000|Overall Study|Withdrew Consent|1|||
164180366|NCT03046056|593025208|FG001|Overall Study|Withdrew Consent|0|||
164180367|NCT03046056|593025209|FG002|Overall Study|Withdrew Consent|0|||
164180368|NCT03089853|593025210|FG000|Overall Study|Lost to Follow-up|2|||
164180369|NCT03089853|593025211|FG001|Overall Study|Lost to Follow-up|1|||
164180370|NCT01172808|593025212|FG000|Overall Study|Adverse Event|8|||
164180371|NCT01172808|593025213|FG001|Overall Study|Adverse Event|4|||
164180372|NCT01172808|593025214|FG002|Overall Study|Adverse Event|8|||
164180373|NCT01172808|593025215|FG003|Overall Study|Adverse Event|3|||
164180374|NCT01172808|593025212|FG000|Overall Study|Lack of Efficacy|1|||
164180375|NCT01172808|593025213|FG001|Overall Study|Lack of Efficacy|0|||
164180376|NCT01172808|593025214|FG002|Overall Study|Lack of Efficacy|0|||
164180377|NCT01172808|593025215|FG003|Overall Study|Lack of Efficacy|0|||
164180378|NCT01172808|593025212|FG000|Overall Study|Protocol Violation|2|||
164180379|NCT01172808|593025213|FG001|Overall Study|Protocol Violation|2|||
164180380|NCT01172808|593025214|FG002|Overall Study|Protocol Violation|2|||
164180381|NCT01172808|593025215|FG003|Overall Study|Protocol Violation|0|||
164180382|NCT01172808|593025212|FG000|Overall Study|Lost to Follow-up|0|||
164180383|NCT01172808|593025213|FG001|Overall Study|Lost to Follow-up|1|||
164180384|NCT01172808|593025214|FG002|Overall Study|Lost to Follow-up|1|||
164180385|NCT01172808|593025215|FG003|Overall Study|Lost to Follow-up|3|||
164180386|NCT01172808|593025212|FG000|Overall Study|Withdrawal by Subject|4|||
164180387|NCT01172808|593025213|FG001|Overall Study|Withdrawal by Subject|1|||
164180388|NCT01172808|593025214|FG002|Overall Study|Withdrawal by Subject|3|||
164180389|NCT01172808|593025215|FG003|Overall Study|Withdrawal by Subject|2|||
164180390|NCT01172808|593025212|FG000|Overall Study|Other|6|||
164180391|NCT01172808|593025213|FG001|Overall Study|Other|5|||
164180392|NCT01172808|593025214|FG002|Overall Study|Other|9|||
164180393|NCT01172808|593025215|FG003|Overall Study|Other|7|||
164180394|NCT03539484|593025223|FG000|Overall Study|Death|1|||
164180395|NCT03539484|593025224|FG001|Overall Study|Death|0|||
164180396|NCT03539484|593025225|FG002|Overall Study|Death|0|||
164180397|NCT03539484|593025226|FG003|Overall Study|Death|2|||
164180398|NCT03539484|593025227|FG004|Overall Study|Death|8|||
164180399|NCT03539484|593025228|FG005|Overall Study|Death|3|||
164180400|NCT03539484|593025229|FG006|Overall Study|Death|0|||
164180401|NCT03539484|593025223|FG000|Overall Study|Lost to Follow-up|0|||
164180402|NCT03539484|593025224|FG001|Overall Study|Lost to Follow-up|1|||
164180403|NCT03539484|593025225|FG002|Overall Study|Lost to Follow-up|0|||
164180404|NCT03539484|593025226|FG003|Overall Study|Lost to Follow-up|0|||
164180405|NCT03539484|593025227|FG004|Overall Study|Lost to Follow-up|1|||
164180406|NCT03539484|593025228|FG005|Overall Study|Lost to Follow-up|0|||
164180407|NCT03539484|593025229|FG006|Overall Study|Lost to Follow-up|0|||
164180408|NCT03539484|593025223|FG000|Overall Study|Withdrawal by Subject|0|||
164180409|NCT03539484|593025224|FG001|Overall Study|Withdrawal by Subject|0|||
164180410|NCT03539484|593025225|FG002|Overall Study|Withdrawal by Subject|0|||
164180411|NCT03539484|593025226|FG003|Overall Study|Withdrawal by Subject|0|||
164180412|NCT03539484|593025227|FG004|Overall Study|Withdrawal by Subject|2|||
164180413|NCT03539484|593025228|FG005|Overall Study|Withdrawal by Subject|0|||
164180414|NCT03539484|593025229|FG006|Overall Study|Withdrawal by Subject|1|||
164180415|NCT03539484|593025223|FG000|Overall Study|Study Terminated by Sponsor|0|||
164180416|NCT03539484|593025224|FG001|Overall Study|Study Terminated by Sponsor|0|||
164180417|NCT03539484|593025225|FG002|Overall Study|Study Terminated by Sponsor|1|||
164180418|NCT03539484|593025226|FG003|Overall Study|Study Terminated by Sponsor|1|||
164180419|NCT03539484|593025227|FG004|Overall Study|Study Terminated by Sponsor|2|||
164180420|NCT03539484|593025228|FG005|Overall Study|Study Terminated by Sponsor|2|||
164180421|NCT03539484|593025229|FG006|Overall Study|Study Terminated by Sponsor|1|||
164180422|NCT02131636|593025233|FG000|Overall Study|Personal Reasons|4|||
164180423|NCT02131636|593025234|FG001|Overall Study|Personal Reasons|4|||
164180424|NCT02131636|593025233|FG000|Overall Study|Lost to Follow-up|4|||
164180425|NCT02131636|593025234|FG001|Overall Study|Lost to Follow-up|0|||
164180426|NCT02131636|593025233|FG000|Overall Study|Adverse Event|4|||
164180427|NCT02131636|593025234|FG001|Overall Study|Adverse Event|1|||
164180428|NCT02173379|593025235|FG000|Overall Study|Lost to Follow-up|89|||
164180429|NCT02173379|593025236|FG001|Overall Study|Lost to Follow-up|81|||
164180430|NCT02173379|593025235|FG000|Overall Study|Withdrawal by Subject|24|||
164180431|NCT02173379|593025236|FG001|Overall Study|Withdrawal by Subject|29|||
164180432|NCT02173379|593025235|FG000|Overall Study|Physician Decision|8|||
164180433|NCT02173379|593025236|FG001|Overall Study|Physician Decision|8|||
164180434|NCT02173379|593025235|FG000|Overall Study|Death|75|||
164180435|NCT02173379|593025236|FG001|Overall Study|Death|72|||
164180436|NCT02173379|593025235|FG000|Overall Study|Other Reason|1|||
164180437|NCT02173379|593025236|FG001|Overall Study|Other Reason|0|||
164180438|NCT06226649|593025237|FG000|Overall Study|Withdrawal by Subject|4|||
164180439|NCT06226649|593025238|FG001|Overall Study|Withdrawal by Subject|1|||
164180440|NCT00981058|593025250|FG000|Overall Study|Progressive Disease|38|||
164180441|NCT00981058|593025251|FG001|Overall Study|Progressive Disease|31|||
164180442|NCT00981058|593025250|FG000|Overall Study|Lost to Follow-up|3|||
164180443|NCT00981058|593025251|FG001|Overall Study|Lost to Follow-up|2|||
164180444|NCT00981058|593025250|FG000|Overall Study|Physician Decision|4|||
164180445|NCT00981058|593025251|FG001|Overall Study|Physician Decision|5|||
164180446|NCT00981058|593025250|FG000|Overall Study|Randomization Error|0|||
164180447|NCT00981058|593025251|FG001|Overall Study|Randomization Error|1|||
164180448|NCT00981058|593025250|FG000|Overall Study|Withdrawal by Subject|24|||
164180449|NCT00981058|593025251|FG001|Overall Study|Withdrawal by Subject|22|||
164180450|NCT02667587|593025252|FG000|Pre-Treatment|Not reported|1|||
164180451|NCT02667587|593025253|FG001|Pre-Treatment|Not reported|0|||
164180452|NCT02667587|593025252|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
164180453|NCT02667587|593025253|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
164180454|NCT02667587|593025252|FG000|Pre-Treatment|Participant withdrew consent|0|||
164180455|NCT02667587|593025253|FG001|Pre-Treatment|Participant withdrew consent|1|||
164180456|NCT02667587|593025252|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
164180457|NCT02667587|593025253|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
164180458|NCT02667587|593025252|FG000|End of Treatment|Disease Progression|193|||
164180459|NCT02667587|593025253|FG001|End of Treatment|Disease Progression|226|||
164180460|NCT02667587|593025252|FG000|End of Treatment|Study Drug Toxicity|75|||
164180461|NCT02667587|593025253|FG001|End of Treatment|Study Drug Toxicity|19|||
164180462|NCT02667587|593025252|FG000|End of Treatment|Death|2|||
164180463|NCT02667587|593025253|FG001|End of Treatment|Death|1|||
164180464|NCT02667587|593025252|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
164180465|NCT02667587|593025253|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
164180466|NCT02667587|593025252|FG000|End of Treatment|participant request to discontinue treatment|33|||
164180467|NCT02667587|593025253|FG001|End of Treatment|participant request to discontinue treatment|35|||
164180468|NCT02667587|593025252|FG000|End of Treatment|participant withdrew consent|5|||
164180469|NCT02667587|593025253|FG001|End of Treatment|participant withdrew consent|6|||
164180470|NCT02667587|593025252|FG000|End of Treatment|Lost to Follow-up|1|||
164180471|NCT02667587|593025253|FG001|End of Treatment|Lost to Follow-up|2|||
164180472|NCT02667587|593025252|FG000|End of Treatment|maximum clinical benefit|4|||
164180473|NCT02667587|593025253|FG001|End of Treatment|maximum clinical benefit|4|||
164180474|NCT02667587|593025252|FG000|End of Treatment|poor or non compliant|0|||
164180475|NCT02667587|593025253|FG001|End of Treatment|poor or non compliant|1|||
164180476|NCT02667587|593025252|FG000|End of Treatment|participant no longer meets study criteria|1|||
164180477|NCT02667587|593025253|FG001|End of Treatment|participant no longer meets study criteria|1|||
164180478|NCT02667587|593025252|FG000|End of Treatment|administrative reason by sponsor|1|||
164180479|NCT02667587|593025253|FG001|End of Treatment|administrative reason by sponsor|29|||
164180480|NCT02667587|593025252|FG000|End of Treatment|other reasonse|21|||
164180481|NCT02667587|593025253|FG001|End of Treatment|other reasonse|10|||
164180482|NCT02542293|593025254|FG000|Overall Study|Death|367|||
164180483|NCT02542293|593025255|FG001|Overall Study|Death|377|||
164180484|NCT02542293|593025254|FG000|Overall Study|Withdrawal by Subject|8|||
164180485|NCT02542293|593025255|FG001|Overall Study|Withdrawal by Subject|19|||
164180486|NCT02305446|593025259|FG000|Overall Study|Adverse Event|1|||
164180487|NCT01636947|593025260|FG000|Overall Study|Not Treated|2|||
164180488|NCT01636947|593025261|FG001|Overall Study|Not Treated|2|||
164180489|NCT01636947|593025260|FG000|Overall Study|Lost to Follow-up|4|||
164180490|NCT01636947|593025261|FG001|Overall Study|Lost to Follow-up|0|||
164180491|NCT01636947|593025260|FG000|Overall Study|Protocol Violation|1|||
164180492|NCT01636947|593025261|FG001|Overall Study|Protocol Violation|1|||
164180493|NCT01636947|593025260|FG000|Overall Study|Withdrawal by Subject|3|||
164180494|NCT01636947|593025261|FG001|Overall Study|Withdrawal by Subject|3|||
164180495|NCT01636947|593025260|FG000|Overall Study|Adverse Event|1|||
164180496|NCT01636947|593025261|FG001|Overall Study|Adverse Event|1|||
164180497|NCT01636947|593025260|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
164180498|NCT01636947|593025261|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
164180499|NCT02696434|593025267|FG000|Overall Study|Adverse Event|3|||
164180500|NCT02696434|593025268|FG001|Overall Study|Adverse Event|1|||
164180501|NCT02696434|593025267|FG000|Overall Study|Lost to Follow-up|5|||
164180502|NCT02696434|593025268|FG001|Overall Study|Lost to Follow-up|4|||
164180503|NCT02696434|593025267|FG000|Overall Study|Withdrawal by Subject|14|||
164180504|NCT02696434|593025268|FG001|Overall Study|Withdrawal by Subject|12|||
164180505|NCT02696434|593025267|FG000|Overall Study|Physician Decision|0|||
164180506|NCT02696434|593025268|FG001|Overall Study|Physician Decision|1|||
164180507|NCT00316914|593025273|FG000|Overall Study|Withdrawal by Subject|5|||
164180508|NCT00316914|593025274|FG001|Overall Study|Withdrawal by Subject|3|||
164180509|NCT00316914|593025273|FG000|Overall Study|Adverse Event|8|||
164180510|NCT00316914|593025274|FG001|Overall Study|Adverse Event|7|||
164180511|NCT00316914|593025273|FG000|Overall Study|Other Problems|6|||
164180512|NCT00316914|593025274|FG001|Overall Study|Other Problems|11|||
164180513|NCT00316914|593025273|FG000|Overall Study|Missing end of treatment documentation|14|||
164180514|NCT00316914|593025274|FG001|Overall Study|Missing end of treatment documentation|15|||
164180515|NCT00717275|593025279|FG000|Overall Study|Premature study termination.|3|||
164180516|NCT00424021|593025281|FG000|NCT00046319 Study Period|Adverse Event|1|||
164180517|NCT00424021|593025282|FG001|NCT00046319 Study Period|Adverse Event|0|||
164180518|NCT00424021|593025283|FG002|NCT00046319 Study Period|Adverse Event|1|||
164180519|NCT00424021|593025284|FG003|NCT00046319 Study Period|Adverse Event|1|||
164180520|NCT00424021|593025281|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
164180521|NCT00424021|593025282|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
164180522|NCT00424021|593025283|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
164180523|NCT00424021|593025284|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
164180524|NCT00424021|593025281|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
164180525|NCT00424021|593025282|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
164180526|NCT00424021|593025283|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
164180527|NCT00424021|593025284|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
164180528|NCT00424021|593025281|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
164180529|NCT00424021|593025282|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
164180530|NCT00424021|593025283|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
164180531|NCT00424021|593025284|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
164180532|NCT00424021|593025281|FG000|AMB-220-E Study Period|Adverse Event|1|||
164180533|NCT00424021|593025282|FG001|AMB-220-E Study Period|Adverse Event|1|||
164180534|NCT00424021|593025283|FG002|AMB-220-E Study Period|Adverse Event|3|||
164180535|NCT00424021|593025284|FG003|AMB-220-E Study Period|Adverse Event|7|||
164180536|NCT00424021|593025281|FG000|AMB-220-E Study Period|Death|0|||
164180537|NCT00424021|593025282|FG001|AMB-220-E Study Period|Death|0|||
164180538|NCT00424021|593025283|FG002|AMB-220-E Study Period|Death|1|||
164180539|NCT00424021|593025284|FG003|AMB-220-E Study Period|Death|1|||
164180540|NCT00424021|593025281|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
164180541|NCT00424021|593025282|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
164180542|NCT00424021|593025283|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
164180543|NCT00424021|593025284|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
164180544|NCT00424021|593025281|FG000|AMB-220-E Study Period|Physician Decision|0|||
164180545|NCT00424021|593025282|FG001|AMB-220-E Study Period|Physician Decision|0|||
164180546|NCT00424021|593025283|FG002|AMB-220-E Study Period|Physician Decision|0|||
164180547|NCT00424021|593025284|FG003|AMB-220-E Study Period|Physician Decision|1|||
164180548|NCT03769194|593025285|FG000|Overall Study|Withdrawal by Subject|0|||
164180549|NCT03769194|593025286|FG001|Overall Study|Withdrawal by Subject|7|||
164180550|NCT03769194|593025287|FG002|Overall Study|Withdrawal by Subject|4|||
164180551|NCT03769194|593025288|FG003|Overall Study|Withdrawal by Subject|1|||
164180552|NCT03769194|593025285|FG000|Overall Study|moved from study area|0|||
164180553|NCT03769194|593025286|FG001|Overall Study|moved from study area|2|||
164180554|NCT03769194|593025287|FG002|Overall Study|moved from study area|1|||
164180555|NCT03769194|593025288|FG003|Overall Study|moved from study area|1|||
164180556|NCT03769194|593025285|FG000|Overall Study|Lost to Follow-up|3|||
164180557|NCT03769194|593025286|FG001|Overall Study|Lost to Follow-up|6|||
164180558|NCT03769194|593025287|FG002|Overall Study|Lost to Follow-up|3|||
164180559|NCT03769194|593025288|FG003|Overall Study|Lost to Follow-up|6|||
164180560|NCT03769194|593025285|FG000|Overall Study|other|1|||
164180561|NCT03769194|593025286|FG001|Overall Study|other|3|||
164180562|NCT03769194|593025287|FG002|Overall Study|other|0|||
164180563|NCT03769194|593025288|FG003|Overall Study|other|1|||
164180564|NCT01797094|593025294|FG000|Overall Study|Adverse Event|1|||
164180565|NCT01797094|593025295|FG001|Overall Study|Adverse Event|1|||
164180566|NCT01797094|593025294|FG000|Overall Study|Personal Reasons|4|||
164180567|NCT01797094|593025295|FG001|Overall Study|Personal Reasons|0|||
164180568|NCT01797094|593025294|FG000|Overall Study|Protocol Violation|0|||
164180569|NCT01797094|593025295|FG001|Overall Study|Protocol Violation|1|||
164180570|NCT01797094|593025294|FG000|Overall Study|Other Miscellaneous Reasons|1|||
164180571|NCT01797094|593025295|FG001|Overall Study|Other Miscellaneous Reasons|0|||
164180572|NCT03677934|593025305|FG000|Overall Study|Adverse Event|1|||
164180573|NCT03677934|593025306|FG001|Overall Study|Adverse Event|1|||
164180574|NCT03677934|593025305|FG000|Overall Study|Death|8|||
164180575|NCT03677934|593025306|FG001|Overall Study|Death|4|||
164180576|NCT03677934|593025305|FG000|Overall Study|Lost to Follow-up|3|||
164180577|NCT03677934|593025306|FG001|Overall Study|Lost to Follow-up|0|||
164180578|NCT03677934|593025305|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164180579|NCT03677934|593025306|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164180580|NCT03677934|593025305|FG000|Overall Study|Physician Decision|0|||
164180581|NCT03677934|593025306|FG001|Overall Study|Physician Decision|1|||
164180582|NCT03677934|593025305|FG000|Overall Study|Withdrawal by Subject|1|||
164180583|NCT03677934|593025306|FG001|Overall Study|Withdrawal by Subject|7|||
164180584|NCT04769739|593025307|FG000|Overall Study|Colorectal cancer obstruction|2|||
164180585|NCT04769739|593025308|FG001|Overall Study|Colorectal cancer obstruction|0|||
164180586|NCT04769739|593025309|FG002|Overall Study|Colorectal cancer obstruction|0|||
164180587|NCT04769739|593025310|FG003|Overall Study|Colorectal cancer obstruction|0|||
164180588|NCT04769739|593025307|FG000|Overall Study|Failed cecal intubation|1|||
164180589|NCT04769739|593025308|FG001|Overall Study|Failed cecal intubation|0|||
164180590|NCT04769739|593025309|FG002|Overall Study|Failed cecal intubation|0|||
164180591|NCT04769739|593025310|FG003|Overall Study|Failed cecal intubation|1|||
164180592|NCT04769739|593025307|FG000|Overall Study|Poor bowel preparation|0|||
164180593|NCT04769739|593025308|FG001|Overall Study|Poor bowel preparation|0|||
164180594|NCT04769739|593025309|FG002|Overall Study|Poor bowel preparation|0|||
164180595|NCT04769739|593025310|FG003|Overall Study|Poor bowel preparation|1|||
164180596|NCT04395274|593025330|FG000|Overall Study|Lost to Follow-up|20|||
164180597|NCT04395274|593025331|FG001|Overall Study|Lost to Follow-up|11|||
164180598|NCT04395274|593025330|FG000|Overall Study|Withdrawal by Subject|13|||
164180599|NCT04395274|593025331|FG001|Overall Study|Withdrawal by Subject|10|||
164180600|NCT04395274|593025330|FG000|Overall Study|Moved Abroad|0|||
164180601|NCT04395274|593025331|FG001|Overall Study|Moved Abroad|1|||
164180602|NCT02028169|593025332|FG000|Overall Study|Lost to Follow-up|21|||
164180603|NCT02028169|593025332|FG000|Overall Study|Lack of Efficacy|2|||
164180604|NCT02028169|593025332|FG000|Overall Study|Withdrawal by Subject|2|||
164180605|NCT02028169|593025332|FG000|Overall Study|Adverse Event|1|||
164180606|NCT02028169|593025332|FG000|Overall Study|Cessation of Drug|1|||
164180607|NCT02028169|593025332|FG000|Overall Study|Concomitant Medication Usage|1|||
164180608|NCT01876979|593025335|FG000|Overall Study|Physician Decision|2|||
164180609|NCT01876979|593025336|FG001|Overall Study|Physician Decision|3|||
164180610|NCT02240069|593025337|FG000|Overall Study|Withdrawal by Subject|5|||
164180611|NCT02240069|593025338|FG001|Overall Study|Withdrawal by Subject|5|||
164180612|NCT02240069|593025339|FG002|Overall Study|Withdrawal by Subject|2|||
164180613|NCT00948506|593025340|FG000|Overall Study|Withdrawal by Subject|3|||
164180614|NCT00948506|593025341|FG001|Overall Study|Withdrawal by Subject|1|||
164180615|NCT03233204|593025343|FG000|Overall Study|Adverse Event|1|||
164180616|NCT03233204|593025343|FG000|Overall Study|Death|1|||
164180617|NCT03233204|593025343|FG000|Overall Study|Withdrawal by Subject|1|||
164180618|NCT03233204|593025343|FG000|Overall Study|Progressive Disease|3|||
164180619|NCT02407054|593025346|FG000|Overall Study|Adverse Event|1|||
164180620|NCT02407054|593025347|FG001|Overall Study|Adverse Event|4|||
164180621|NCT02407054|593025348|FG002|Overall Study|Adverse Event|1|||
164180622|NCT02407054|593025346|FG000|Overall Study|Non-compliance with Study|0|||
164180623|NCT02407054|593025347|FG001|Overall Study|Non-compliance with Study|2|||
164180624|NCT02407054|593025348|FG002|Overall Study|Non-compliance with Study|1|||
164180625|NCT02407054|593025346|FG000|Overall Study|Physician Decision|1|||
164180626|NCT02407054|593025347|FG001|Overall Study|Physician Decision|3|||
164180627|NCT02407054|593025348|FG002|Overall Study|Physician Decision|3|||
164180628|NCT02407054|593025346|FG000|Overall Study|Withdrawal by Subject|5|||
164180629|NCT02407054|593025347|FG001|Overall Study|Withdrawal by Subject|9|||
164180630|NCT02407054|593025348|FG002|Overall Study|Withdrawal by Subject|2|||
164180631|NCT00932698|593025349|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
164180632|NCT00932698|593025350|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
164180633|NCT00932698|593025351|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
164180634|NCT00932698|593025352|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
164180635|NCT00932698|593025353|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
164180636|NCT00932698|593025354|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
164180637|NCT00932698|593025355|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
164180638|NCT00932698|593025356|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
164180639|NCT00932698|593025357|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
164180640|NCT00932698|593025358|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
164180641|NCT00932698|593025359|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
164180642|NCT00932698|593025349|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
164180643|NCT00932698|593025350|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
164180644|NCT00932698|593025351|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
164180645|NCT00932698|593025352|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
164180646|NCT00932698|593025353|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
164180647|NCT00932698|593025354|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
164180648|NCT00932698|593025355|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
164180649|NCT00932698|593025356|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
164180650|NCT00932698|593025357|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
164180651|NCT00932698|593025358|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
164180652|NCT00932698|593025359|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
164180653|NCT00932698|593025349|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
164180654|NCT00932698|593025350|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
164180655|NCT00932698|593025351|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
164180656|NCT00932698|593025352|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
164180657|NCT00932698|593025353|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
164180658|NCT00932698|593025354|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
164180659|NCT00932698|593025355|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
164180660|NCT00932698|593025356|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
164180661|NCT00932698|593025357|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
164180662|NCT00932698|593025358|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
164180663|NCT00932698|593025359|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
164180664|NCT00932698|593025349|FG000|Part 1 (Dose Escalation)|Other|0|||
164180665|NCT00932698|593025350|FG001|Part 1 (Dose Escalation)|Other|0|||
164180666|NCT00932698|593025351|FG002|Part 1 (Dose Escalation)|Other|1|||
164180667|NCT00932698|593025352|FG003|Part 1 (Dose Escalation)|Other|0|||
164180668|NCT00932698|593025353|FG004|Part 1 (Dose Escalation)|Other|0|||
164180669|NCT00932698|593025354|FG005|Part 1 (Dose Escalation)|Other|0|||
164180670|NCT00932698|593025355|FG006|Part 1 (Dose Escalation)|Other|1|||
164180671|NCT00932698|593025356|FG007|Part 1 (Dose Escalation)|Other|0|||
164180672|NCT00932698|593025357|FG008|Part 1 (Dose Escalation)|Other|0|||
164180673|NCT00932698|593025358|FG009|Part 1 (Dose Escalation)|Other|0|||
164180674|NCT00932698|593025359|FG010|Part 1 (Dose Escalation)|Other|0|||
164180675|NCT00932698|593025349|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
164180676|NCT00932698|593025350|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
164180677|NCT00932698|593025351|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
164180678|NCT00932698|593025352|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
164180679|NCT00932698|593025353|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
164180680|NCT00932698|593025354|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
164180681|NCT00932698|593025355|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
164180682|NCT00932698|593025356|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
164180683|NCT00932698|593025357|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
164180684|NCT00932698|593025358|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
164180685|NCT00932698|593025359|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
164180686|NCT00932698|593025349|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
164180687|NCT00932698|593025350|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
164180688|NCT00932698|593025351|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
164180689|NCT00932698|593025352|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
164180690|NCT00932698|593025353|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
164180691|NCT00932698|593025354|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
164180692|NCT00932698|593025355|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
164180693|NCT00932698|593025356|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
164180694|NCT00932698|593025357|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
164180695|NCT00932698|593025358|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
164180696|NCT00932698|593025359|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
164180697|NCT00932698|593025349|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
164180698|NCT00932698|593025350|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
164180699|NCT00932698|593025351|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
164180700|NCT00932698|593025352|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
164180701|NCT00932698|593025353|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
164180702|NCT00932698|593025354|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
164180703|NCT00932698|593025355|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
164180704|NCT00932698|593025356|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
164180705|NCT00932698|593025357|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
164180706|NCT00932698|593025358|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
164180707|NCT00932698|593025359|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
164180708|NCT00642954|593026698|FG000|Overall Study|Progressive Disease|3|||
164180709|NCT00642954|593026699|FG001|Overall Study|Progressive Disease|3|||
164180710|NCT00642954|593026700|FG002|Overall Study|Progressive Disease|3|||
164180711|NCT00642954|593026701|FG003|Overall Study|Progressive Disease|3|||
164180712|NCT00642954|593026702|FG004|Overall Study|Progressive Disease|9|||
164180713|NCT00642954|593026698|FG000|Overall Study|Withdrawal by Subject|0|||
164180714|NCT00642954|593026699|FG001|Overall Study|Withdrawal by Subject|0|||
164180715|NCT00642954|593026700|FG002|Overall Study|Withdrawal by Subject|0|||
164180716|NCT00642954|593026701|FG003|Overall Study|Withdrawal by Subject|0|||
164180717|NCT00642954|593026702|FG004|Overall Study|Withdrawal by Subject|1|||
164180718|NCT00642954|593026698|FG000|Overall Study|Adverse Event|1|||
164180719|NCT00642954|593026699|FG001|Overall Study|Adverse Event|1|||
164180720|NCT00642954|593026700|FG002|Overall Study|Adverse Event|0|||
164180721|NCT00642954|593026701|FG003|Overall Study|Adverse Event|0|||
164180722|NCT00642954|593026702|FG004|Overall Study|Adverse Event|6|||
164180723|NCT01317004|593026703|FG000|Overall Study|Withdrawal by Subject|1|||
164180724|NCT01317004|593026704|FG001|Overall Study|Withdrawal by Subject|4|||
164180725|NCT01317004|593026703|FG000|Overall Study|Protocol Violation|0|||
164180726|NCT01317004|593026704|FG001|Overall Study|Protocol Violation|2|||
164180727|NCT01317004|593026703|FG000|Overall Study|Adverse Event|3|||
164180728|NCT01317004|593026704|FG001|Overall Study|Adverse Event|3|||
164180729|NCT01890759|593026707|FG000|Overall Study|Protocol Violation|0|||
164180730|NCT01890759|593026708|FG001|Overall Study|Protocol Violation|2|||
164180731|NCT01890759|593026707|FG000|Overall Study|Lost to Follow-up|0|||
164180732|NCT01890759|593026708|FG001|Overall Study|Lost to Follow-up|2|||
164180733|NCT01890759|593026707|FG000|Overall Study|Withdrawal by Subject|2|||
164180734|NCT01890759|593026708|FG001|Overall Study|Withdrawal by Subject|8|||
164180735|NCT01344759|593026709|FG000|Overall Study|Patients failed to reach sedation level|0|||
164180736|NCT01344759|593026710|FG001|Overall Study|Patients failed to reach sedation level|2|||
164180737|NCT04114656|593026713|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
164180738|NCT04114656|593026714|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
164180739|NCT04114656|593026713|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
164180740|NCT04114656|593026714|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
164180741|NCT04114656|593026713|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
164180742|NCT04114656|593026714|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
164180743|NCT04114656|593026713|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
164180744|NCT04114656|593026714|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
164180745|NCT04114656|593026713|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
164180746|NCT04114656|593026714|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
164180747|NCT00703326|593026715|FG000|Overall Study|Lost to Follow-up|47|||
164180748|NCT00703326|593026716|FG001|Overall Study|Lost to Follow-up|18|||
164180749|NCT00703326|593026715|FG000|Overall Study|Withdrawal by Subject|54|||
164180750|NCT00703326|593026716|FG001|Overall Study|Withdrawal by Subject|20|||
164180751|NCT00703326|593026715|FG000|Overall Study|Adverse Event|1|||
164180752|NCT00703326|593026716|FG001|Overall Study|Adverse Event|0|||
164180753|NCT02661061|593026718|FG000|Overall Study|Lack of Efficacy|1|||
164180754|NCT02661061|593026719|FG001|Overall Study|Lack of Efficacy|1|||
164180755|NCT02661061|593026718|FG000|Overall Study|Withdrawal by Subject|1|||
164180756|NCT02661061|593026719|FG001|Overall Study|Withdrawal by Subject|1|||
164180757|NCT01393106|593026720|FG000|Overall Study|Adverse Event|3|||
164180758|NCT01393106|593026720|FG000|Overall Study|Withdrawal by Subject|1|||
164180759|NCT01393106|593026720|FG000|Overall Study|Lack of Efficacy|1|||
164180760|NCT02732015|593026721|FG000|Overall Study|Lost to Follow-up|0|||
164180761|NCT02732015|593026722|FG001|Overall Study|Lost to Follow-up|1|||
164180762|NCT03052920|593026723|FG000|Overall Study|Withdrawal by Subject|1|||
164180763|NCT01980628|593026724|FG000|Overall Study|Adverse Event|12|||
164180764|NCT01980628|593026724|FG000|Overall Study|Physician Decision|5|||
164180765|NCT01980628|593026724|FG000|Overall Study|Withdrawal by Subject|4|||
164180766|NCT01980628|593026724|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
164180767|NCT05437640|593026725|FG000|Washout (1 Week)|Adverse Event|1|||
164180768|NCT05437640|593026726|FG001|Washout (1 Week)|Adverse Event|0|||
164180769|NCT02474355|593026727|FG000|Overall Study|Other|43|||
164180770|NCT02474355|593026727|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
164180771|NCT02474355|593026727|FG000|Overall Study|Lost to Follow-up|98|||
164180772|NCT02474355|593026727|FG000|Overall Study|Withdrawal by Subject|124|||
164180773|NCT02474355|593026727|FG000|Overall Study|Death|1361|||
164180774|NCT03015194|593026729|FG000|Overall Study|Death|10|||
164180775|NCT03015194|593026729|FG000|Overall Study|Withdrawal by Subject|2|||
164180776|NCT01937715|593026733|FG000|Overall Study|Death|0|||
164180777|NCT01937715|593026734|FG001|Overall Study|Death|0|||
164180778|NCT01937715|593026735|FG002|Overall Study|Death|0|||
164180779|NCT01937715|593026736|FG003|Overall Study|Death|1|||
164180780|NCT01937715|593026737|FG004|Overall Study|Death|0|||
164180781|NCT01937715|593026733|FG000|Overall Study|Withdrawal by Subject|0|||
164180782|NCT01937715|593026734|FG001|Overall Study|Withdrawal by Subject|1|||
164180783|NCT01937715|593026735|FG002|Overall Study|Withdrawal by Subject|0|||
164180784|NCT01937715|593026736|FG003|Overall Study|Withdrawal by Subject|0|||
164180785|NCT01937715|593026737|FG004|Overall Study|Withdrawal by Subject|2|||
164180786|NCT01937715|593026733|FG000|Overall Study|Other|0|||
164180787|NCT01937715|593026734|FG001|Overall Study|Other|0|||
164180788|NCT01937715|593026735|FG002|Overall Study|Other|0|||
164180789|NCT01937715|593026736|FG003|Overall Study|Other|3|||
164180790|NCT01937715|593026737|FG004|Overall Study|Other|0|||
164180791|NCT01698268|593026740|FG000|Overall Study|Physician Decision|2|||
164180792|NCT01698268|593026741|FG001|Overall Study|Physician Decision|1|||
164180793|NCT00433017|593026742|FG000|Overall Study|Adverse Event|5|||
164180794|NCT00433017|593026743|FG001|Overall Study|Adverse Event|3|||
164180795|NCT00433017|593026742|FG000|Overall Study|Withdrawal by Subject|4|||
164180796|NCT00433017|593026743|FG001|Overall Study|Withdrawal by Subject|5|||
164180797|NCT00433017|593026742|FG000|Overall Study|Lost to Follow-up|3|||
164180798|NCT00433017|593026743|FG001|Overall Study|Lost to Follow-up|4|||
164180799|NCT00433017|593026742|FG000|Overall Study|Administrative problems|80|||
164180800|NCT00433017|593026743|FG001|Overall Study|Administrative problems|86|||
164180801|NCT00433017|593026742|FG000|Overall Study|Protocol Violation|1|||
164180802|NCT00433017|593026743|FG001|Overall Study|Protocol Violation|0|||
164180803|NCT00433017|593026742|FG000|Overall Study|Death|2|||
164180804|NCT00433017|593026743|FG001|Overall Study|Death|2|||
164180805|NCT00433017|593026742|FG000|Overall Study|Subject no longer requires study drug|1|||
164180806|NCT00433017|593026743|FG001|Overall Study|Subject no longer requires study drug|1|||
164180807|NCT00153816|593026744|FG000|Overall Study|Death|6|||
164180808|NCT00153816|593026745|FG001|Overall Study|Death|5|||
164180809|NCT00153816|593026746|FG002|Overall Study|Death|4|||
164180810|NCT00153816|593026747|FG003|Overall Study|Death|6|||
164180811|NCT00153816|593026748|FG004|Overall Study|Death|0|||
164180812|NCT00153816|593026749|FG005|Overall Study|Death|2|||
164180813|NCT00153816|593026744|FG000|Overall Study|Lost to Follow-up|7|||
164180814|NCT00153816|593026745|FG001|Overall Study|Lost to Follow-up|8|||
164180815|NCT00153816|593026746|FG002|Overall Study|Lost to Follow-up|5|||
164180816|NCT00153816|593026747|FG003|Overall Study|Lost to Follow-up|8|||
164180817|NCT00153816|593026748|FG004|Overall Study|Lost to Follow-up|7|||
164180818|NCT00153816|593026749|FG005|Overall Study|Lost to Follow-up|9|||
164180819|NCT00153816|593026744|FG000|Overall Study|Withdrawal by Subject|9|||
164180820|NCT00153816|593026745|FG001|Overall Study|Withdrawal by Subject|9|||
164180821|NCT00153816|593026746|FG002|Overall Study|Withdrawal by Subject|9|||
164180822|NCT00153816|593026747|FG003|Overall Study|Withdrawal by Subject|4|||
164180823|NCT00153816|593026748|FG004|Overall Study|Withdrawal by Subject|1|||
164180824|NCT00153816|593026749|FG005|Overall Study|Withdrawal by Subject|5|||
164180825|NCT00153816|593026744|FG000|Overall Study|Follow-up exam not done|8|||
164180826|NCT00153816|593026745|FG001|Overall Study|Follow-up exam not done|7|||
164180827|NCT00153816|593026746|FG002|Overall Study|Follow-up exam not done|11|||
164180828|NCT00153816|593026747|FG003|Overall Study|Follow-up exam not done|10|||
164180829|NCT00153816|593026748|FG004|Overall Study|Follow-up exam not done|8|||
164180830|NCT00153816|593026749|FG005|Overall Study|Follow-up exam not done|9|||
164180831|NCT00153816|593026744|FG000|Overall Study|Follow-up exam done, histology missing|2|||
164180832|NCT00153816|593026745|FG001|Overall Study|Follow-up exam done, histology missing|3|||
164180833|NCT00153816|593026746|FG002|Overall Study|Follow-up exam done, histology missing|3|||
164180834|NCT00153816|593026747|FG003|Overall Study|Follow-up exam done, histology missing|3|||
164180835|NCT00153816|593026748|FG004|Overall Study|Follow-up exam done, histology missing|1|||
164180836|NCT00153816|593026749|FG005|Overall Study|Follow-up exam done, histology missing|2|||
164180837|NCT02263729|593026750|FG000|Overall Study|Lost to Follow-up|1|||
164180838|NCT02263729|593026751|FG001|Overall Study|Lost to Follow-up|1|||
164180839|NCT04591015|593026752|FG000|Overall Study|Death|6|||
164180840|NCT04591015|593026753|FG001|Overall Study|Death|4|||
164180841|NCT04591015|593026752|FG000|Overall Study|Withdrawal by Subject|6|||
164180842|NCT04591015|593026753|FG001|Overall Study|Withdrawal by Subject|3|||
164180843|NCT04591015|593026752|FG000|Overall Study|Lost to Follow-up|16|||
164180844|NCT04591015|593026753|FG001|Overall Study|Lost to Follow-up|11|||
164180845|NCT02509078|593026754|FG000|Overall Study|Protocol Violation|1|||
164180846|NCT02509078|593026755|FG001|Overall Study|Protocol Violation|1|||
164180847|NCT03594955|593026759|FG000|Overall Study|Adverse Event|1|||
164180848|NCT03594955|593026759|FG000|Overall Study|Progressive disease|5|||
164180849|NCT03594955|593026759|FG000|Overall Study|Sponsor's decision|1|||
164180850|NCT00631163|593026768|FG000|Number of Participants in Year 1|Adverse Event|12|||
164180851|NCT00631163|593026768|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
164180852|NCT00631163|593026768|FG000|Number of Participants in Year 1|Death|6|||
164180853|NCT00631163|593026768|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
164180854|NCT00631163|593026768|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
164180855|NCT00631163|593026768|FG000|Number of Participants in Year 1|Administrative problems|6|||
164180856|NCT00631163|593026768|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
164180857|NCT00631163|593026768|FG000|Number of Participants in Year 2|Adverse Event|1|||
164180858|NCT00631163|593026768|FG000|Number of Participants in Year 2|Protocol Violation|1|||
164180859|NCT00631163|593026768|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
164180860|NCT02290925|593026770|FG000|First Period of Three Months|Lost to Follow-up|2|||
164180861|NCT02290925|593026771|FG001|First Period of Three Months|Lost to Follow-up|1|||
164180862|NCT02290925|593026770|FG000|First Period of Three Months|Death|1|||
164180863|NCT02290925|593026771|FG001|First Period of Three Months|Death|0|||
164180864|NCT02290925|593026770|FG000|First Period of Three Months|Insulin Started|1|||
164180865|NCT02290925|593026771|FG001|First Period of Three Months|Insulin Started|1|||
164180866|NCT02290925|593026770|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
164180867|NCT02290925|593026771|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
164180868|NCT02290925|593026770|FG000|Second Period of 3 Months|insulin started|0|||
164180869|NCT02290925|593026771|FG001|Second Period of 3 Months|insulin started|1|||
164180870|NCT00388297|593026779|FG000|Overall Study|Lost to Follow-up|16|||
164180871|NCT00388297|593026780|FG001|Overall Study|Lost to Follow-up|12|||
164180872|NCT00388297|593026781|FG002|Overall Study|Lost to Follow-up|11|||
164180873|NCT00388297|593026782|FG003|Overall Study|Lost to Follow-up|8|||
164180874|NCT00427999|593026788|FG000|Overall Study|Adverse Event|6|||
164180875|NCT00427999|593026788|FG000|Overall Study|Abnormal laboratory values|1|||
164180876|NCT00427999|593026788|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
164180877|NCT00427999|593026788|FG000|Overall Study|Protocol Violation|2|||
164180878|NCT00427999|593026788|FG000|Overall Study|Withdrawal by Subject|9|||
164180879|NCT00427999|593026788|FG000|Overall Study|Death|1|||
164180880|NCT02284568|593026789|FG000|Overall Study|Adverse Event|2|||
164180881|NCT02284568|593026790|FG001|Overall Study|Adverse Event|9|||
164180882|NCT02284568|593026791|FG002|Overall Study|Adverse Event|4|||
164180883|NCT02284568|593026789|FG000|Overall Study|Withdrawal by Subject|22|||
164180884|NCT02284568|593026790|FG001|Overall Study|Withdrawal by Subject|21|||
164180885|NCT02284568|593026791|FG002|Overall Study|Withdrawal by Subject|1|||
164180886|NCT02284568|593026789|FG000|Overall Study|Noncompliance with study drug admin|1|||
164180887|NCT02284568|593026790|FG001|Overall Study|Noncompliance with study drug admin|2|||
164180888|NCT02284568|593026791|FG002|Overall Study|Noncompliance with study drug admin|0|||
164180889|NCT02284568|593026789|FG000|Overall Study|Noncompliance|1|||
164180890|NCT02284568|593026790|FG001|Overall Study|Noncompliance|0|||
164180891|NCT02284568|593026791|FG002|Overall Study|Noncompliance|0|||
164180892|NCT02284568|593026789|FG000|Overall Study|Protocol Violation|0|||
164180893|NCT02284568|593026790|FG001|Overall Study|Protocol Violation|1|||
164180894|NCT02284568|593026791|FG002|Overall Study|Protocol Violation|0|||
164180895|NCT02284568|593026789|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
164180896|NCT02284568|593026790|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
164180897|NCT02284568|593026791|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
164180898|NCT02284568|593026789|FG000|Overall Study|Lost to Follow-up|0|||
164180899|NCT02284568|593026790|FG001|Overall Study|Lost to Follow-up|3|||
164180900|NCT02284568|593026791|FG002|Overall Study|Lost to Follow-up|0|||
164180901|NCT02284568|593026789|FG000|Overall Study|Lack of Efficacy|4|||
164180902|NCT02284568|593026790|FG001|Overall Study|Lack of Efficacy|7|||
164180903|NCT02284568|593026791|FG002|Overall Study|Lack of Efficacy|0|||
164180904|NCT02284568|593026789|FG000|Overall Study|Other|1|||
164180905|NCT02284568|593026790|FG001|Overall Study|Other|2|||
164180906|NCT02284568|593026791|FG002|Overall Study|Other|0|||
164180907|NCT02284568|593026789|FG000|Overall Study|Withdrew before taking study drug|0|||
164180908|NCT02284568|593026790|FG001|Overall Study|Withdrew before taking study drug|1|||
164180909|NCT02284568|593026791|FG002|Overall Study|Withdrew before taking study drug|0|||
164180910|NCT00460265|593026792|FG000|Overall Study|Lost to Follow-up|14|||
164180911|NCT00460265|593026793|FG001|Overall Study|Lost to Follow-up|15|||
164180912|NCT00460265|593026792|FG000|Overall Study|Physician Decision|1|||
164180913|NCT00460265|593026793|FG001|Overall Study|Physician Decision|2|||
164180914|NCT00460265|593026792|FG000|Overall Study|Withdrawal by Subject|10|||
164180915|NCT00460265|593026793|FG001|Overall Study|Withdrawal by Subject|25|||
164180916|NCT00460265|593026792|FG000|Overall Study|Ongoing|60|||
164180917|NCT00460265|593026793|FG001|Overall Study|Ongoing|47|||
164180918|NCT03570554|593026796|FG000|Overall Study|Non-compliance with study drug|0|||
164180919|NCT03570554|593026797|FG001|Overall Study|Non-compliance with study drug|0|||
164180920|NCT03570554|593026798|FG002|Overall Study|Non-compliance with study drug|1|||
164180921|NCT03570554|593026799|FG003|Overall Study|Non-compliance with study drug|0|||
164180922|NCT03570554|593026796|FG000|Overall Study|Adverse Event|0|||
164180923|NCT03570554|593026797|FG001|Overall Study|Adverse Event|0|||
164180924|NCT03570554|593026798|FG002|Overall Study|Adverse Event|0|||
164180925|NCT03570554|593026799|FG003|Overall Study|Adverse Event|1|||
164180926|NCT02956057|593026811|FG000|Overall Study|Discontinued intervention|14|||
164180927|NCT02956057|593026812|FG001|Overall Study|Discontinued intervention|10|||
164180928|NCT02956057|593026813|FG002|Overall Study|Discontinued intervention|7|||
164180929|NCT02956057|593026814|FG003|Overall Study|Discontinued intervention|14|||
164180930|NCT02956057|593026815|FG004|Overall Study|Discontinued intervention|4|||
164180931|NCT02956057|593026816|FG005|Overall Study|Discontinued intervention|17|||
164180932|NCT02956057|593026811|FG000|Overall Study|Lost to Follow-up|0|||
164180933|NCT02956057|593026812|FG001|Overall Study|Lost to Follow-up|2|||
164180934|NCT02956057|593026813|FG002|Overall Study|Lost to Follow-up|1|||
164180935|NCT02956057|593026814|FG003|Overall Study|Lost to Follow-up|1|||
164180936|NCT02956057|593026815|FG004|Overall Study|Lost to Follow-up|1|||
164180937|NCT02956057|593026816|FG005|Overall Study|Lost to Follow-up|0|||
164180938|NCT01420679|593026821|FG000|Overall Study|Disease Progression|3|||
164180939|NCT01420679|593026822|FG001|Overall Study|Disease Progression|2|||
164180940|NCT01420679|593026821|FG000|Overall Study|Adverse Event|4|||
164180941|NCT01420679|593026822|FG001|Overall Study|Adverse Event|0|||
164180942|NCT01420679|593026821|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
164180943|NCT01420679|593026822|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
164180944|NCT01420679|593026821|FG000|Overall Study|Patient Decision|1|||
164180945|NCT01420679|593026822|FG001|Overall Study|Patient Decision|0|||
164180946|NCT01420679|593026821|FG000|Overall Study|Investigator Decision|1|||
164180947|NCT01420679|593026822|FG001|Overall Study|Investigator Decision|2|||
164180948|NCT01420679|593026821|FG000|Overall Study|Sponsor Decision|3|||
164180949|NCT01420679|593026822|FG001|Overall Study|Sponsor Decision|3|||
164180950|NCT01420679|593026821|FG000|Overall Study|Other|1|||
164180951|NCT01420679|593026822|FG001|Overall Study|Other|0|||
164180952|NCT03956615|593026823|FG000|Overall Study|No multiple myeloma confirmed|2|||
164180953|NCT03956615|593026823|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
164180954|NCT03956615|593026823|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
164180955|NCT03956615|593026823|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
164180956|NCT01069419|593026824|FG000|Overall Study|Adverse Event|233|||
164180957|NCT01069419|593026824|FG000|Overall Study|Lack of Efficacy|332|||
164180958|NCT01069419|593026824|FG000|Overall Study|Lost to Follow-up|49|||
164180959|NCT01069419|593026824|FG000|Overall Study|Remission of disease|11|||
164180960|NCT01069419|593026824|FG000|Overall Study|Withdrawal by Subject|34|||
164180961|NCT01069419|593026824|FG000|Overall Study|Other Reason|43|||
164180962|NCT01069419|593026824|FG000|Overall Study|Missing termination information|13|||
164180963|NCT00236899|593026827|FG000|Overall Study|Adverse Event (Study Related)|1|||
164180964|NCT00236899|593026828|FG001|Overall Study|Adverse Event (Study Related)|1|||
164180965|NCT00236899|593026829|FG002|Overall Study|Adverse Event (Study Related)|2|||
164180966|NCT00236899|593026830|FG003|Overall Study|Adverse Event (Study Related)|1|||
164180967|NCT00236899|593026827|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
164180968|NCT00236899|593026828|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
164180969|NCT00236899|593026829|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
164180970|NCT00236899|593026830|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
164180971|NCT00236899|593026827|FG000|Overall Study|Death (Study Disease)|1|||
164180972|NCT00236899|593026828|FG001|Overall Study|Death (Study Disease)|4|||
164180973|NCT00236899|593026829|FG002|Overall Study|Death (Study Disease)|0|||
164180974|NCT00236899|593026830|FG003|Overall Study|Death (Study Disease)|0|||
164180975|NCT00236899|593026827|FG000|Overall Study|Death (Not Study Related)|2|||
164180976|NCT00236899|593026828|FG001|Overall Study|Death (Not Study Related)|0|||
164180977|NCT00236899|593026829|FG002|Overall Study|Death (Not Study Related)|0|||
164180978|NCT00236899|593026830|FG003|Overall Study|Death (Not Study Related)|0|||
164180979|NCT00236899|593026827|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
164180980|NCT00236899|593026828|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
164180981|NCT00236899|593026829|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
164180982|NCT00236899|593026830|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
164180983|NCT00236899|593026827|FG000|Overall Study|Lost to Follow-up|0|||
164180984|NCT00236899|593026828|FG001|Overall Study|Lost to Follow-up|1|||
164180985|NCT00236899|593026829|FG002|Overall Study|Lost to Follow-up|0|||
164180986|NCT00236899|593026830|FG003|Overall Study|Lost to Follow-up|0|||
164180987|NCT00236899|593026827|FG000|Overall Study|Entry Criteria Exclusion|0|||
164180988|NCT00236899|593026828|FG001|Overall Study|Entry Criteria Exclusion|1|||
164180989|NCT00236899|593026829|FG002|Overall Study|Entry Criteria Exclusion|1|||
164180990|NCT00236899|593026830|FG003|Overall Study|Entry Criteria Exclusion|0|||
164180991|NCT00236899|593026827|FG000|Overall Study|Protocol Violation|1|||
164180992|NCT00236899|593026828|FG001|Overall Study|Protocol Violation|0|||
164180993|NCT00236899|593026829|FG002|Overall Study|Protocol Violation|0|||
164180994|NCT00236899|593026830|FG003|Overall Study|Protocol Violation|0|||
164180995|NCT00236899|593026827|FG000|Overall Study|Withdrawal by Subject|6|||
164180996|NCT00236899|593026828|FG001|Overall Study|Withdrawal by Subject|4|||
164180997|NCT00236899|593026829|FG002|Overall Study|Withdrawal by Subject|5|||
164180998|NCT00236899|593026830|FG003|Overall Study|Withdrawal by Subject|2|||
164180999|NCT00236899|593026827|FG000|Overall Study|Physician Decision|7|||
164181000|NCT00236899|593026828|FG001|Overall Study|Physician Decision|8|||
164181001|NCT00236899|593026829|FG002|Overall Study|Physician Decision|7|||
164181002|NCT00236899|593026830|FG003|Overall Study|Physician Decision|6|||
164181003|NCT00236899|593026827|FG000|Overall Study|Satisfactory Response|2|||
164181004|NCT00236899|593026828|FG001|Overall Study|Satisfactory Response|0|||
164181005|NCT00236899|593026829|FG002|Overall Study|Satisfactory Response|0|||
164181006|NCT00236899|593026830|FG003|Overall Study|Satisfactory Response|1|||
164181007|NCT00236899|593026827|FG000|Overall Study|Lack of Efficacy|18|||
164181008|NCT00236899|593026828|FG001|Overall Study|Lack of Efficacy|18|||
164181009|NCT00236899|593026829|FG002|Overall Study|Lack of Efficacy|25|||
164181010|NCT00236899|593026830|FG003|Overall Study|Lack of Efficacy|23|||
164181011|NCT02565706|593026831|FG000|Overall Study|Withdrawal by Subject|5|||
164181012|NCT02565706|593026832|FG001|Overall Study|Withdrawal by Subject|7|||
164181013|NCT02565706|593026833|FG002|Overall Study|Withdrawal by Subject|7|||
164181014|NCT02565706|593026834|FG003|Overall Study|Withdrawal by Subject|11|||
164181015|NCT02565706|593026831|FG000|Overall Study|Lost to Follow-up|72|||
164181016|NCT02565706|593026832|FG001|Overall Study|Lost to Follow-up|75|||
164181017|NCT02565706|593026833|FG002|Overall Study|Lost to Follow-up|82|||
164181018|NCT02565706|593026834|FG003|Overall Study|Lost to Follow-up|74|||
164181019|NCT01281956|593026837|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
164181020|NCT01281956|593026838|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
164181021|NCT01904903|593026839|FG000|Overall Study|Withdrawal by Subject|1|||
164181022|NCT01634659|593026841|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
164181023|NCT01634659|593026842|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
164181024|NCT01634659|593026841|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
164181025|NCT01634659|593026842|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
164181026|NCT00335959|593026843|FG000|Overall Study|Adverse Event|2|||
164181027|NCT00335959|593026843|FG000|Overall Study|Ineligible|1|||
164181028|NCT01447927|593026846|FG000|Overall Study|Adverse Event|4|||
164181029|NCT01447927|593026847|FG001|Overall Study|Adverse Event|3|||
164181030|NCT01447927|593026846|FG000|Overall Study|Withdrawal by Subject|1|||
164181031|NCT01447927|593026847|FG001|Overall Study|Withdrawal by Subject|0|||
164181032|NCT02190721|593028774|FG000|Overall Study|Patient was out of the city|0|||
164181033|NCT02190721|593028775|FG001|Overall Study|Patient was out of the city|1|||
164181034|NCT02190721|593028776|FG002|Overall Study|Patient was out of the city|0|||
164181035|NCT01760447|593028777|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
164181036|NCT01760447|593028778|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
164181037|NCT01760447|593028779|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
164181038|NCT01760447|593028780|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
164181039|NCT01760447|593028777|FG000|Weeks 0-20|Withdrawal by Subject|2|||
164181040|NCT01760447|593028778|FG001|Weeks 0-20|Withdrawal by Subject|0|||
164181041|NCT01760447|593028779|FG002|Weeks 0-20|Withdrawal by Subject|1|||
164181042|NCT01760447|593028780|FG003|Weeks 0-20|Withdrawal by Subject|0|||
164181043|NCT01760447|593028777|FG000|Weeks 0-20|Lost to Follow-up|1|||
164181044|NCT01760447|593028778|FG001|Weeks 0-20|Lost to Follow-up|0|||
164181045|NCT01760447|593028779|FG002|Weeks 0-20|Lost to Follow-up|1|||
164181046|NCT01760447|593028780|FG003|Weeks 0-20|Lost to Follow-up|1|||
164181047|NCT01760447|593028777|FG000|Weeks 0-20|Randomized but not treated|0|||
164181048|NCT01760447|593028778|FG001|Weeks 0-20|Randomized but not treated|0|||
164181049|NCT01760447|593028779|FG002|Weeks 0-20|Randomized but not treated|2|||
164181050|NCT01760447|593028780|FG003|Weeks 0-20|Randomized but not treated|0|||
164181051|NCT01760447|593028777|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
164181052|NCT01760447|593028778|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
164181053|NCT01760447|593028779|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
164181054|NCT01760447|593028780|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
164181055|NCT01760447|593028777|FG000|Weeks 20-54|Withdrawal by Subject|2|||
164181056|NCT01760447|593028778|FG001|Weeks 20-54|Withdrawal by Subject|1|||
164181057|NCT01760447|593028779|FG002|Weeks 20-54|Withdrawal by Subject|1|||
164181058|NCT01760447|593028780|FG003|Weeks 20-54|Withdrawal by Subject|2|||
164181059|NCT01760447|593028777|FG000|Weeks 20-54|Lost to Follow-up|0|||
164181060|NCT01760447|593028778|FG001|Weeks 20-54|Lost to Follow-up|0|||
164181061|NCT01760447|593028779|FG002|Weeks 20-54|Lost to Follow-up|1|||
164181062|NCT01760447|593028780|FG003|Weeks 20-54|Lost to Follow-up|2|||
164181063|NCT01214668|593028781|FG000|Overall Study|Adverse Event|0|||
164181064|NCT01214668|593028782|FG001|Overall Study|Adverse Event|1|||
164181065|NCT01214668|593028783|FG002|Overall Study|Adverse Event|0|||
164181066|NCT01214668|593028784|FG003|Overall Study|Adverse Event|2|||
164181067|NCT01214668|593028785|FG004|Overall Study|Adverse Event|1|||
164181068|NCT01214668|593028786|FG005|Overall Study|Adverse Event|1|||
164181069|NCT01214668|593028781|FG000|Overall Study|Death|0|||
164181070|NCT01214668|593028782|FG001|Overall Study|Death|0|||
164181071|NCT01214668|593028783|FG002|Overall Study|Death|1|||
164181072|NCT01214668|593028784|FG003|Overall Study|Death|0|||
164181073|NCT01214668|593028785|FG004|Overall Study|Death|0|||
164181074|NCT01214668|593028786|FG005|Overall Study|Death|0|||
164181075|NCT01214668|593028781|FG000|Overall Study|Progressive Disease|4|||
164181076|NCT01214668|593028782|FG001|Overall Study|Progressive Disease|2|||
164181077|NCT01214668|593028783|FG002|Overall Study|Progressive Disease|5|||
164181078|NCT01214668|593028784|FG003|Overall Study|Progressive Disease|4|||
164181079|NCT01214668|593028785|FG004|Overall Study|Progressive Disease|4|||
164181080|NCT01214668|593028786|FG005|Overall Study|Progressive Disease|5|||
164181081|NCT01214668|593028781|FG000|Overall Study|Withdrawal by Subject|0|||
164181082|NCT01214668|593028782|FG001|Overall Study|Withdrawal by Subject|0|||
164181083|NCT01214668|593028783|FG002|Overall Study|Withdrawal by Subject|0|||
164181084|NCT01214668|593028784|FG003|Overall Study|Withdrawal by Subject|0|||
164181085|NCT01214668|593028785|FG004|Overall Study|Withdrawal by Subject|1|||
164181086|NCT01214668|593028786|FG005|Overall Study|Withdrawal by Subject|0|||
164181087|NCT02907619|593028787|FG000|Overall Study|Study terminated by sponsor|18|||
164181088|NCT02907619|593028788|FG001|Overall Study|Study terminated by sponsor|18|||
164181089|NCT02907619|593028789|FG002|Overall Study|Study terminated by sponsor|19|||
164181090|NCT02907619|593028787|FG000|Overall Study|Death|0|||
164181091|NCT02907619|593028788|FG001|Overall Study|Death|0|||
164181092|NCT02907619|593028789|FG002|Overall Study|Death|1|||
164181093|NCT02907619|593028787|FG000|Overall Study|Withdrawal by Subject|1|||
164181094|NCT02907619|593028788|FG001|Overall Study|Withdrawal by Subject|1|||
164181095|NCT02907619|593028789|FG002|Overall Study|Withdrawal by Subject|0|||
164181096|NCT02907619|593028787|FG000|Overall Study|Other|0|||
164181097|NCT02907619|593028788|FG001|Overall Study|Other|1|||
164181098|NCT02907619|593028789|FG002|Overall Study|Other|0|||
164181099|NCT03326518|593028790|FG000|Overall Study|Protocol Violation|1|||
164181100|NCT03326518|593028791|FG001|Overall Study|Protocol Violation|0|||
164181101|NCT03326518|593028792|FG002|Overall Study|Protocol Violation|0|||
164181102|NCT03326518|593028790|FG000|Overall Study|Withdrawal by Subject|1|||
164181103|NCT03326518|593028791|FG001|Overall Study|Withdrawal by Subject|0|||
164181104|NCT03326518|593028792|FG002|Overall Study|Withdrawal by Subject|0|||
164181105|NCT03326518|593028790|FG000|Overall Study|Lost to Follow-up|1|||
164181106|NCT03326518|593028791|FG001|Overall Study|Lost to Follow-up|0|||
164181107|NCT03326518|593028792|FG002|Overall Study|Lost to Follow-up|1|||
164181108|NCT06439095|593028793|FG000|Overall Study|Lost to Follow-up|2|||
164181109|NCT03484403|593028795|FG000|Overall Study|Withdrawal by Subject|6|||
164181110|NCT03484403|593028796|FG001|Overall Study|Withdrawal by Subject|4|||
164181111|NCT01937884|593028797|FG000|Overall Study|Withdrawal by Subject|1|||
164181112|NCT01937884|593028798|FG001|Overall Study|Withdrawal by Subject|0|||
164181113|NCT01179737|593028803|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
164181114|NCT01179737|593028804|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
164181115|NCT01179737|593028805|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
164181116|NCT01179737|593028806|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
164181117|NCT01179737|593028803|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
164181118|NCT01179737|593028804|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
164181119|NCT01179737|593028805|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
164181120|NCT01179737|593028806|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
164181121|NCT01179737|593028803|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
164181122|NCT01179737|593028804|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
164181123|NCT01179737|593028805|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
164181124|NCT01179737|593028806|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
164181125|NCT01179737|593028803|FG000|Cohort 1 & Cohort 2|Death|0|||
164181126|NCT01179737|593028804|FG001|Cohort 1 & Cohort 2|Death|0|||
164181127|NCT01179737|593028805|FG002|Cohort 1 & Cohort 2|Death|1|||
164181128|NCT01179737|593028806|FG003|Cohort 1 & Cohort 2|Death|0|||
164181129|NCT01179737|593028803|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
164181130|NCT01179737|593028804|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
164181131|NCT01179737|593028805|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
164181132|NCT01179737|593028806|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
164181133|NCT01179737|593028803|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
164181134|NCT01179737|593028804|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
164181135|NCT01179737|593028805|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
164181136|NCT01179737|593028806|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
164181137|NCT01179737|593028803|FG000|Extension|The study was terminated|3|||
164181138|NCT01179737|593028804|FG001|Extension|The study was terminated|0|||
164181139|NCT01179737|593028805|FG002|Extension|The study was terminated|0|||
164181140|NCT01179737|593028806|FG003|Extension|The study was terminated|0|||
164181141|NCT01254721|593028807|FG000|Overall Study|Lost to Follow-up|0|||
164181142|NCT01254721|593028808|FG001|Overall Study|Lost to Follow-up|4|||
164181143|NCT01254721|593028807|FG000|Overall Study|Lack of Efficacy|4|||
164181144|NCT01254721|593028808|FG001|Overall Study|Lack of Efficacy|2|||
164181145|NCT01254721|593028807|FG000|Overall Study|Death|0|||
164181146|NCT01254721|593028808|FG001|Overall Study|Death|1|||
164181147|NCT01254721|593028807|FG000|Overall Study|technical problum|1|||
164181148|NCT01254721|593028808|FG001|Overall Study|technical problum|0|||
164181149|NCT01254721|593028807|FG000|Overall Study|Adverse Event|2|||
164181150|NCT01254721|593028808|FG001|Overall Study|Adverse Event|3|||
164181151|NCT01254721|593028807|FG000|Overall Study|Withdrawal by Subject|8|||
164181152|NCT01254721|593028808|FG001|Overall Study|Withdrawal by Subject|11|||
164181153|NCT01254721|593028807|FG000|Overall Study|Wrongly randomization|0|||
164181154|NCT01254721|593028808|FG001|Overall Study|Wrongly randomization|1|||
164181155|NCT01955109|593028809|FG000|Overall Study|Adverse Event|2|||
164181156|NCT01955109|593028810|FG001|Overall Study|Adverse Event|0|||
164181157|NCT01955109|593028809|FG000|Overall Study|Participant unwilling to continue|35|||
164181158|NCT01955109|593028810|FG001|Overall Study|Participant unwilling to continue|7|||
164181159|NCT01955109|593028809|FG000|Overall Study|Physician Decision|2|||
164181160|NCT01955109|593028810|FG001|Overall Study|Physician Decision|0|||
164181161|NCT01955109|593028809|FG000|Overall Study|Lost to Follow-up|3|||
164181162|NCT01955109|593028810|FG001|Overall Study|Lost to Follow-up|1|||
164181163|NCT01955109|593028809|FG000|Overall Study|Non-compliance|3|||
164181164|NCT01955109|593028810|FG001|Overall Study|Non-compliance|1|||
164181165|NCT00904839|593028811|FG000|Overall Study|Adverse Event|0|||
164181166|NCT00904839|593028812|FG001|Overall Study|Adverse Event|5|||
164181167|NCT00904839|593028813|FG002|Overall Study|Adverse Event|4|||
164181168|NCT00904839|593028811|FG000|Overall Study|Protocol Violation|0|||
164181169|NCT00904839|593028812|FG001|Overall Study|Protocol Violation|1|||
164181170|NCT00904839|593028813|FG002|Overall Study|Protocol Violation|1|||
164181171|NCT00904839|593028811|FG000|Overall Study|Lost to Follow-up|0|||
164181172|NCT00904839|593028812|FG001|Overall Study|Lost to Follow-up|1|||
164181173|NCT00904839|593028813|FG002|Overall Study|Lost to Follow-up|2|||
164181174|NCT00904839|593028811|FG000|Overall Study|Withdrawal by Subject|0|||
164181175|NCT00904839|593028812|FG001|Overall Study|Withdrawal by Subject|2|||
164181176|NCT00904839|593028813|FG002|Overall Study|Withdrawal by Subject|0|||
164181177|NCT00904839|593028811|FG000|Overall Study|Not treated|1|||
164181178|NCT00904839|593028812|FG001|Overall Study|Not treated|0|||
164181179|NCT00904839|593028813|FG002|Overall Study|Not treated|1|||
164181180|NCT00904839|593028811|FG000|Overall Study|Other than above|0|||
164181181|NCT00904839|593028812|FG001|Overall Study|Other than above|9|||
164181182|NCT00904839|593028813|FG002|Overall Study|Other than above|7|||
164181183|NCT01853696|593028816|FG000|Overall Study|Withdrawal by Subject|1|||
164181184|NCT01853696|593028817|FG001|Overall Study|Withdrawal by Subject|1|||
164181185|NCT01853696|593028816|FG000|Overall Study|Lost to Follow-up|5|||
164181186|NCT01853696|593028817|FG001|Overall Study|Lost to Follow-up|4|||
164181187|NCT01167634|593028818|FG000|Overall Study|Lost to Follow-up|1|||
164181188|NCT01167634|593028819|FG001|Overall Study|Lost to Follow-up|3|||
164181189|NCT01167634|593028820|FG002|Overall Study|Lost to Follow-up|3|||
164181190|NCT01167634|593028821|FG003|Overall Study|Lost to Follow-up|4|||
164181191|NCT01167634|593028818|FG000|Overall Study|Withdrawal by Subject|1|||
164181192|NCT01167634|593028819|FG001|Overall Study|Withdrawal by Subject|1|||
164181193|NCT01167634|593028820|FG002|Overall Study|Withdrawal by Subject|0|||
164181194|NCT01167634|593028821|FG003|Overall Study|Withdrawal by Subject|0|||
164181195|NCT00553358|593028822|FG000|Overall Study|Randomized but did not receive treatment|3|||
164181196|NCT00553358|593028823|FG001|Overall Study|Randomized but did not receive treatment|3|||
164181197|NCT00553358|593028824|FG002|Overall Study|Randomized but did not receive treatment|1|||
164181198|NCT00553358|593028822|FG000|Overall Study|Lost to Follow-up|22|||
164181199|NCT00553358|593028823|FG001|Overall Study|Lost to Follow-up|26|||
164181200|NCT00553358|593028824|FG002|Overall Study|Lost to Follow-up|18|||
164181201|NCT00553358|593028822|FG000|Overall Study|Withdrew completely|23|||
164181202|NCT00553358|593028823|FG001|Overall Study|Withdrew completely|33|||
164181203|NCT00553358|593028824|FG002|Overall Study|Withdrew completely|34|||
164181204|NCT00553358|593028822|FG000|Overall Study|Died during clinical follow-up|25|||
164181205|NCT00553358|593028823|FG001|Overall Study|Died during clinical follow-up|29|||
164181206|NCT00553358|593028824|FG002|Overall Study|Died during clinical follow-up|32|||
164181207|NCT00553358|593028822|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
164181208|NCT00553358|593028823|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
164181209|NCT00553358|593028824|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
164181210|NCT00553358|593028822|FG000|Overall Study|Died after clinical follow-up ended|1|||
164181211|NCT00553358|593028823|FG001|Overall Study|Died after clinical follow-up ended|2|||
164181212|NCT00553358|593028824|FG002|Overall Study|Died after clinical follow-up ended|0|||
164181213|NCT00553358|593028822|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
164181214|NCT00553358|593028823|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
164181215|NCT00553358|593028824|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
164181216|NCT02854605|593028829|FG000|Overall Study|Adverse Event|1|||
164181217|NCT02854605|593028830|FG001|Overall Study|Adverse Event|5|||
164181218|NCT02854605|593028831|FG002|Overall Study|Adverse Event|2|||
164181219|NCT02854605|593028829|FG000|Overall Study|Lost to Follow-up|0|||
164181220|NCT02854605|593028830|FG001|Overall Study|Lost to Follow-up|2|||
164181221|NCT02854605|593028831|FG002|Overall Study|Lost to Follow-up|0|||
164181222|NCT02854605|593028829|FG000|Overall Study|Withdrew Consent|1|||
164181223|NCT02854605|593028830|FG001|Overall Study|Withdrew Consent|0|||
164181224|NCT02854605|593028831|FG002|Overall Study|Withdrew Consent|1|||
164181225|NCT02854605|593028829|FG000|Overall Study|Investigator's Discretion|1|||
164181226|NCT02854605|593028830|FG001|Overall Study|Investigator's Discretion|0|||
164181227|NCT02854605|593028831|FG002|Overall Study|Investigator's Discretion|0|||
164181228|NCT02854605|593028829|FG000|Overall Study|Protocol Violation|0|||
164181229|NCT02854605|593028830|FG001|Overall Study|Protocol Violation|0|||
164181230|NCT02854605|593028831|FG002|Overall Study|Protocol Violation|1|||
164181231|NCT03003000|593028832|FG000|Overall Study|Adverse Event|1|||
164181232|NCT03003000|593028833|FG001|Overall Study|Adverse Event|2|||
164181233|NCT03003000|593028834|FG002|Overall Study|Adverse Event|3|||
164181234|NCT03003000|593028832|FG000|Overall Study|Lack of Efficacy|1|||
164181235|NCT03003000|593028833|FG001|Overall Study|Lack of Efficacy|0|||
164181236|NCT03003000|593028834|FG002|Overall Study|Lack of Efficacy|0|||
164181237|NCT03003000|593028832|FG000|Overall Study|Non-compliant with protocol|0|||
164181238|NCT03003000|593028833|FG001|Overall Study|Non-compliant with protocol|1|||
164181239|NCT03003000|593028834|FG002|Overall Study|Non-compliant with protocol|1|||
164181240|NCT03003000|593028832|FG000|Overall Study|Refused to continue medication|2|||
164181241|NCT03003000|593028833|FG001|Overall Study|Refused to continue medication|0|||
164181242|NCT03003000|593028834|FG002|Overall Study|Refused to continue medication|0|||
164181243|NCT03003000|593028832|FG000|Overall Study|Other than listed|1|||
164181244|NCT03003000|593028833|FG001|Overall Study|Other than listed|1|||
164181245|NCT03003000|593028834|FG002|Overall Study|Other than listed|1|||
164181246|NCT04933617|593028835|FG000|Dose Escalation|Early closure of study|0|||
164181247|NCT04933617|593028836|FG001|Dose Escalation|Early closure of study|3|||
164181248|NCT04933617|593028837|FG002|Dose Escalation|Early closure of study|0|||
164181249|NCT04933617|593028838|FG003|Dose Escalation|Early closure of study|0|||
164181250|NCT04933617|593028839|FG004|Dose Escalation|Early closure of study|0|||
164181251|NCT05268016|593028840|FG000|Overall Study|Unacceptable toxicity or AE|2|||
164181252|NCT05268016|593028841|FG001|Overall Study|Unacceptable toxicity or AE|2|||
164181253|NCT05268016|593028842|FG002|Overall Study|Unacceptable toxicity or AE|4|||
164181254|NCT05268016|593028843|FG003|Overall Study|Unacceptable toxicity or AE|3|||
164181255|NCT05268016|593028844|FG004|Overall Study|Unacceptable toxicity or AE|1|||
164181256|NCT05268016|593028840|FG000|Overall Study|Withdrawal by Subject|1|||
164181257|NCT05268016|593028841|FG001|Overall Study|Withdrawal by Subject|3|||
164181258|NCT05268016|593028842|FG002|Overall Study|Withdrawal by Subject|2|||
164181259|NCT05268016|593028843|FG003|Overall Study|Withdrawal by Subject|2|||
164181260|NCT05268016|593028844|FG004|Overall Study|Withdrawal by Subject|1|||
164181261|NCT05268016|593028840|FG000|Overall Study|Lost to Follow-up|4|||
164181262|NCT05268016|593028841|FG001|Overall Study|Lost to Follow-up|7|||
164181263|NCT05268016|593028842|FG002|Overall Study|Lost to Follow-up|1|||
164181264|NCT05268016|593028843|FG003|Overall Study|Lost to Follow-up|3|||
164181265|NCT05268016|593028844|FG004|Overall Study|Lost to Follow-up|5|||
164181345|NCT01260584|593028870|FG002|Period 1|Protocol Violation|1|||
164181266|NCT05268016|593028840|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
164181267|NCT05268016|593028841|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
164181268|NCT05268016|593028842|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
164181269|NCT05268016|593028843|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
164181270|NCT05268016|593028844|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
164181271|NCT05268016|593028840|FG000|Overall Study|Lack of Efficacy|0|||
164181272|NCT05268016|593028841|FG001|Overall Study|Lack of Efficacy|0|||
164181273|NCT05268016|593028842|FG002|Overall Study|Lack of Efficacy|0|||
164181274|NCT05268016|593028843|FG003|Overall Study|Lack of Efficacy|0|||
164181275|NCT05268016|593028844|FG004|Overall Study|Lack of Efficacy|4|||
164181276|NCT05268016|593028840|FG000|Overall Study|Physician Decision|0|||
164181277|NCT05268016|593028841|FG001|Overall Study|Physician Decision|0|||
164181278|NCT05268016|593028842|FG002|Overall Study|Physician Decision|0|||
164181279|NCT05268016|593028843|FG003|Overall Study|Physician Decision|1|||
164181280|NCT05268016|593028844|FG004|Overall Study|Physician Decision|0|||
164181281|NCT05268016|593028840|FG000|Overall Study|Other|1|||
164181282|NCT05268016|593028841|FG001|Overall Study|Other|0|||
164181283|NCT05268016|593028842|FG002|Overall Study|Other|1|||
164181284|NCT05268016|593028843|FG003|Overall Study|Other|2|||
164181285|NCT05268016|593028844|FG004|Overall Study|Other|0|||
164181286|NCT02191046|593028845|FG000|Overall Study|low compliance|5|||
164181287|NCT02191046|593028846|FG001|Overall Study|low compliance|1|||
164181288|NCT01964716|593028847|FG000|Overall Study|Withdrawal by Subject|2|||
164181289|NCT01964716|593028848|FG001|Overall Study|Withdrawal by Subject|3|||
164181290|NCT01964716|593028847|FG000|Overall Study|Lost to Follow-up|1|||
164181291|NCT01964716|593028848|FG001|Overall Study|Lost to Follow-up|2|||
164181292|NCT01964716|593028847|FG000|Overall Study|No longer met eligibility criteria|1|||
164181293|NCT01964716|593028848|FG001|Overall Study|No longer met eligibility criteria|1|||
164181294|NCT01964716|593028847|FG000|Overall Study|Death|1|||
164181295|NCT01964716|593028848|FG001|Overall Study|Death|0|||
164181296|NCT02147067|593028849|FG000|Overall Study|Withdrawal by Subject|2|||
164181297|NCT02147067|593028850|FG001|Overall Study|Withdrawal by Subject|2|||
164181298|NCT00791492|593028851|FG000|Overall Study|Withdrawal by Subject|1|||
164181299|NCT00791492|593028852|FG001|Overall Study|Withdrawal by Subject|2|||
164181300|NCT00791492|593028851|FG000|Overall Study|Liver transplantation|5|||
164181301|NCT00791492|593028852|FG001|Overall Study|Liver transplantation|1|||
164181302|NCT00090987|593028853|FG000|Overall Study|Adverse Event|5|||
164181303|NCT00090987|593028853|FG000|Overall Study|Lack of Efficacy|7|||
164181304|NCT00090987|593028853|FG000|Overall Study|Withdrawal by Subject|3|||
164181305|NCT00090987|593028853|FG000|Overall Study|alternative therapy|1|||
164181306|NCT00090987|593028853|FG000|Overall Study|Non-compliance|4|||
164181307|NCT00090987|593028853|FG000|Overall Study|Incarcerated|1|||
164181308|NCT00990665|593028858|FG000|Overall Study|Unsuccessful Implant|8|||
164181309|NCT00990665|593028858|FG000|Overall Study|Death|29|||
164181310|NCT00990665|593028858|FG000|Overall Study|Heart Transplant|1|||
164181311|NCT00990665|593028858|FG000|Overall Study|Withdrawal by Subject|6|||
164181312|NCT00990665|593028858|FG000|Overall Study|Lost to Follow-up|1|||
164181313|NCT00990665|593028858|FG000|Overall Study|System Explant|3|||
164181314|NCT00270231|593028859|FG000|First Intervention|Lost to Follow-up|1|||
164181315|NCT00270231|593028860|FG001|First Intervention|Lost to Follow-up|1|||
164181316|NCT00270231|593028859|FG000|Washout Period|Lost to Follow-up|1|||
164181317|NCT00270231|593028860|FG001|Washout Period|Lost to Follow-up|0|||
164181318|NCT00270231|593028859|FG000|Second Intervention|Lost to Follow-up|0|||
164181319|NCT00270231|593028860|FG001|Second Intervention|Lost to Follow-up|1|||
164181320|NCT02603562|593028861|FG000|Overall Study|Lost to Follow-up|1|||
164181321|NCT00574795|593028863|FG000|Infant Series|Withdrawal by Subject|2|||
164181322|NCT00574795|593028863|FG000|Infant Series|Protocol Violation|2|||
164181323|NCT00574795|593028863|FG000|Infant Series|Adverse Event|1|||
164181324|NCT00574795|593028863|FG000|After Infant Series|Withdrawal by Subject|1|||
164181325|NCT00574795|593028863|FG000|After Infant Series|Adverse Event|2|||
164181326|NCT00574795|593028863|FG000|Toddler Dose|Withdrawal by Subject|1|||
164181327|NCT00314132|593028864|FG000|Overall Study|Lost to Follow-up|3|||
164181328|NCT00314132|593028865|FG001|Overall Study|Lost to Follow-up|13|||
164181329|NCT00314132|593028864|FG000|Overall Study|Withdrawal by Subject|3|||
164181330|NCT00314132|593028865|FG001|Overall Study|Withdrawal by Subject|5|||
164181331|NCT00314132|593028864|FG000|Overall Study|Adverse Event|1|||
164181332|NCT00314132|593028865|FG001|Overall Study|Adverse Event|0|||
164181333|NCT00314132|593028864|FG000|Overall Study|Physician Decision|1|||
164181334|NCT00314132|593028865|FG001|Overall Study|Physician Decision|0|||
164181335|NCT00957905|593028866|FG000|Part B|Not Treated|0|||
164181336|NCT00957905|593028867|FG001|Part B|Not Treated|1|||
164181337|NCT00957905|593028866|FG000|Part B|Physician Decision|0|||
164181338|NCT00957905|593028867|FG001|Part B|Physician Decision|1|||
164181339|NCT00957905|593028866|FG000|Part B|Death|0|||
164181340|NCT00957905|593028867|FG001|Part B|Death|1|||
164181341|NCT00957905|593028866|FG000|Part B|Protocol Violation|0|||
164181342|NCT00957905|593028867|FG001|Part B|Protocol Violation|1|||
164181343|NCT01260584|593028868|FG000|Period 1|Protocol Violation|0|||
164181344|NCT01260584|593028869|FG001|Period 1|Protocol Violation|0|||
164181346|NCT01260584|593028871|FG003|Period 1|Protocol Violation|1|||
164181347|NCT01260584|593028868|FG000|Period 1|Adverse Event|0|||
164181348|NCT01260584|593028869|FG001|Period 1|Adverse Event|0|||
164181349|NCT01260584|593028870|FG002|Period 1|Adverse Event|1|||
164181350|NCT01260584|593028871|FG003|Period 1|Adverse Event|0|||
164181351|NCT01260584|593028868|FG000|Period 2|Protocol Violation|0|||
164181352|NCT01260584|593028869|FG001|Period 2|Protocol Violation|2|||
164181353|NCT01260584|593028870|FG002|Period 2|Protocol Violation|3|||
164181354|NCT01260584|593028871|FG003|Period 2|Protocol Violation|1|||
164181355|NCT01260584|593028868|FG000|Period 2|Adverse Event|1|||
164181356|NCT01260584|593028869|FG001|Period 2|Adverse Event|0|||
164181357|NCT01260584|593028870|FG002|Period 2|Adverse Event|2|||
164181358|NCT01260584|593028871|FG003|Period 2|Adverse Event|0|||
164181359|NCT01260584|593028868|FG000|Period 2|Withdrawal by Subject|0|||
164181360|NCT01260584|593028869|FG001|Period 2|Withdrawal by Subject|1|||
164181361|NCT01260584|593028870|FG002|Period 2|Withdrawal by Subject|0|||
164181362|NCT01260584|593028871|FG003|Period 2|Withdrawal by Subject|0|||
164181363|NCT03434249|593028872|FG000|Overall Study|Adverse Event|1|||
164181364|NCT03434249|593028873|FG001|Overall Study|Adverse Event|0|||
164181365|NCT03434249|593028872|FG000|Overall Study|Lost to Follow-up|0|||
164181366|NCT03434249|593028873|FG001|Overall Study|Lost to Follow-up|1|||
164181367|NCT03434249|593028872|FG000|Overall Study|Non-compliance of family|2|||
164181368|NCT03434249|593028873|FG001|Overall Study|Non-compliance of family|1|||
164181369|NCT03434249|593028872|FG000|Overall Study|Difficulties in completing daily diary|2|||
164181370|NCT03434249|593028873|FG001|Overall Study|Difficulties in completing daily diary|1|||
164181371|NCT02918552|593028874|FG000|Overall Study|Failed Pharmacokinetics|1|||
164181372|NCT02918552|593028875|FG001|Overall Study|Failed Pharmacokinetics|0|||
164181373|NCT02918552|593028874|FG000|Overall Study|Withdrawal by Subject|0|||
164181374|NCT02918552|593028875|FG001|Overall Study|Withdrawal by Subject|1|||
164181375|NCT02918552|593028874|FG000|Overall Study|Lost to Follow-up|0|||
164181376|NCT02918552|593028875|FG001|Overall Study|Lost to Follow-up|1|||
164181377|NCT01001598|593028876|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
164181378|NCT01001598|593028876|FG000|Overall Study|Adverse Event|1|||
164181379|NCT01969084|593028881|FG000|Overall Study|Adverse Event|0|||
164181380|NCT01969084|593028882|FG001|Overall Study|Adverse Event|1|||
164181381|NCT02920177|593028883|FG000|Overall Study|Withdrawal by Subject|1|||
164181382|NCT02920177|593028884|FG001|Overall Study|Withdrawal by Subject|1|||
164181383|NCT02920177|593028883|FG000|Overall Study|Physician Decision|1|||
164181384|NCT02920177|593028884|FG001|Overall Study|Physician Decision|0|||
164181385|NCT02920177|593028883|FG000|Overall Study|Lost to Follow-up|0|||
164181386|NCT02920177|593028884|FG001|Overall Study|Lost to Follow-up|1|||
164181387|NCT03164265|593028885|FG000|Overall Study|Physician Decision|3|||
164181388|NCT04907227|593028886|FG000|Overall Study|Death|12|||
164181389|NCT04907227|593028887|FG001|Overall Study|Death|8|||
164181390|NCT04907227|593028886|FG000|Overall Study|Withdrawal by Subject|2|||
164181391|NCT04907227|593028887|FG001|Overall Study|Withdrawal by Subject|2|||
164181392|NCT04907227|593028886|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
164181393|NCT04907227|593028887|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
164181394|NCT04907227|593028886|FG000|Overall Study|Sponsor Decision|25|||
164181395|NCT04907227|593028887|FG001|Overall Study|Sponsor Decision|30|||
164181396|NCT04907227|593028886|FG000|Overall Study|Physician Decision|1|||
164181397|NCT04907227|593028887|FG001|Overall Study|Physician Decision|0|||
164181398|NCT00824382|593028888|FG000|Overall Study|Adverse Event|4|||
164181399|NCT00824382|593028889|FG001|Overall Study|Adverse Event|1|||
164181400|NCT00824382|593028890|FG002|Overall Study|Adverse Event|1|||
164181401|NCT00824382|593028891|FG003|Overall Study|Adverse Event|4|||
164181402|NCT00824382|593028888|FG000|Overall Study|Protocol Violation|1|||
164181403|NCT00824382|593028889|FG001|Overall Study|Protocol Violation|0|||
164181404|NCT00824382|593028890|FG002|Overall Study|Protocol Violation|0|||
164181405|NCT00824382|593028891|FG003|Overall Study|Protocol Violation|1|||
164181406|NCT00824382|593028888|FG000|Overall Study|Investigator's decision|0|||
164181407|NCT00824382|593028889|FG001|Overall Study|Investigator's decision|1|||
164181408|NCT00824382|593028890|FG002|Overall Study|Investigator's decision|2|||
164181409|NCT00824382|593028891|FG003|Overall Study|Investigator's decision|0|||
164181410|NCT03673345|593028892|FG000|Overall Study|Lost to Follow-up|1|||
164181411|NCT03673345|593028893|FG001|Overall Study|Lost to Follow-up|0|||
164181412|NCT03673345|593028894|FG002|Overall Study|Lost to Follow-up|3|||
164181413|NCT03673345|593028895|FG003|Overall Study|Lost to Follow-up|3|||
164181414|NCT03673345|593028896|FG004|Overall Study|Lost to Follow-up|2|||
164181415|NCT03673345|593028897|FG005|Overall Study|Lost to Follow-up|1|||
164181416|NCT03673345|593028898|FG006|Overall Study|Lost to Follow-up|0|||
164181417|NCT03673345|593028899|FG007|Overall Study|Lost to Follow-up|0|||
164181418|NCT03673345|593028892|FG000|Overall Study|Withdrawal by Subject|1|||
164181419|NCT03673345|593028893|FG001|Overall Study|Withdrawal by Subject|0|||
164181420|NCT03673345|593028894|FG002|Overall Study|Withdrawal by Subject|4|||
164181421|NCT03673345|593028895|FG003|Overall Study|Withdrawal by Subject|2|||
164181422|NCT03673345|593028896|FG004|Overall Study|Withdrawal by Subject|0|||
164181423|NCT03673345|593028897|FG005|Overall Study|Withdrawal by Subject|0|||
164181424|NCT03673345|593028898|FG006|Overall Study|Withdrawal by Subject|0|||
164181425|NCT03673345|593028899|FG007|Overall Study|Withdrawal by Subject|0|||
164181426|NCT03673345|593028892|FG000|Overall Study|Physician Decision|0|||
164181427|NCT03673345|593028893|FG001|Overall Study|Physician Decision|0|||
164181428|NCT03673345|593028894|FG002|Overall Study|Physician Decision|2|||
164181429|NCT03673345|593028895|FG003|Overall Study|Physician Decision|0|||
164181430|NCT03673345|593028896|FG004|Overall Study|Physician Decision|0|||
164181431|NCT03673345|593028897|FG005|Overall Study|Physician Decision|0|||
164181432|NCT03673345|593028898|FG006|Overall Study|Physician Decision|0|||
164181433|NCT03673345|593028899|FG007|Overall Study|Physician Decision|0|||
164181434|NCT01362244|593028900|FG000|Overall Study|Adverse Event|3|||
164181435|NCT01362244|593028901|FG001|Overall Study|Adverse Event|5|||
164181436|NCT01362244|593028900|FG000|Overall Study|Lack of Efficacy|5|||
164181437|NCT01362244|593028901|FG001|Overall Study|Lack of Efficacy|11|||
164181438|NCT01362244|593028900|FG000|Overall Study|Lost to Follow-up|0|||
164181439|NCT01362244|593028901|FG001|Overall Study|Lost to Follow-up|2|||
164181440|NCT01362244|593028900|FG000|Overall Study|Protocol Violation|5|||
164181441|NCT01362244|593028901|FG001|Overall Study|Protocol Violation|1|||
164181442|NCT01362244|593028900|FG000|Overall Study|Withdrawal by Subject|2|||
164181443|NCT01362244|593028901|FG001|Overall Study|Withdrawal by Subject|1|||
164181444|NCT01362244|593028900|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
164181445|NCT01362244|593028901|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
164181446|NCT01362244|593028900|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
164181447|NCT01362244|593028901|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
164181448|NCT01253174|593028902|FG000|Period 1|Randomized but not treated|0|||
164181449|NCT01253174|593028903|FG001|Period 1|Randomized but not treated|1|||
164181450|NCT01253174|593028904|FG002|Period 1|Randomized but not treated|1|||
164181451|NCT01253174|593028905|FG003|Period 1|Randomized but not treated|0|||
164181452|NCT01253174|593028906|FG004|Period 1|Randomized but not treated|1|||
164181453|NCT01253174|593028907|FG005|Period 1|Randomized but not treated|0|||
164181454|NCT01253174|593028902|FG000|Period 2|Adverse Event|0|||
164181455|NCT01253174|593028903|FG001|Period 2|Adverse Event|0|||
164181456|NCT01253174|593028904|FG002|Period 2|Adverse Event|1|||
164181457|NCT01253174|593028905|FG003|Period 2|Adverse Event|0|||
164181458|NCT01253174|593028906|FG004|Period 2|Adverse Event|0|||
164181459|NCT01253174|593028907|FG005|Period 2|Adverse Event|0|||
164181460|NCT01253174|593028902|FG000|Period 3|Withdrawal by Subject|0|||
164181461|NCT01253174|593028903|FG001|Period 3|Withdrawal by Subject|1|||
164181462|NCT01253174|593028904|FG002|Period 3|Withdrawal by Subject|0|||
164181463|NCT01253174|593028905|FG003|Period 3|Withdrawal by Subject|0|||
164181464|NCT01253174|593028906|FG004|Period 3|Withdrawal by Subject|1|||
164181465|NCT01253174|593028907|FG005|Period 3|Withdrawal by Subject|0|||
164181466|NCT01253174|593028902|FG000|Period 3|Pregnancy|0|||
164181467|NCT01253174|593028903|FG001|Period 3|Pregnancy|0|||
164181468|NCT01253174|593028904|FG002|Period 3|Pregnancy|1|||
164181469|NCT01253174|593028905|FG003|Period 3|Pregnancy|0|||
164181470|NCT01253174|593028906|FG004|Period 3|Pregnancy|0|||
164181471|NCT01253174|593028907|FG005|Period 3|Pregnancy|0|||
164181472|NCT02267135|593028908|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
164181473|NCT02267135|593028909|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
164181474|NCT02267135|593028908|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
164181475|NCT02267135|593028909|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
164181476|NCT02267135|593028908|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
164181477|NCT02267135|593028909|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
164181478|NCT02267135|593028908|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
164181479|NCT02267135|593028909|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
164181480|NCT02267135|593028908|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
164181481|NCT02267135|593028909|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
164181482|NCT03806231|593028910|FG000|Overall Study|Physician Decision|1|||
164181483|NCT03806231|593028911|FG001|Overall Study|Physician Decision|0|||
164181484|NCT03806231|593028910|FG000|Overall Study|Withdrawal by Subject|1|||
164181485|NCT03806231|593028911|FG001|Overall Study|Withdrawal by Subject|0|||
164181486|NCT02919267|593028912|FG000|Overall Study|Protocol Violation|0|||
164181487|NCT02919267|593028913|FG001|Overall Study|Protocol Violation|3|||
164181488|NCT02919267|593028914|FG002|Overall Study|Protocol Violation|3|||
164181489|NCT02919267|593028915|FG003|Overall Study|Protocol Violation|4|||
164181490|NCT04608344|593028916|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
164181491|NCT04608344|593028917|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
164181492|NCT04608344|593028916|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
164181493|NCT04608344|593028917|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
164181494|NCT00467961|593028918|FG000|Overall Study|Technical Failures|5|||
164181495|NCT00467961|593028918|FG000|Overall Study|Disease Progression|2|||
164181496|NCT02908074|593028920|FG000|Overall Study|sponsor/ICON decision|0|||
164181497|NCT02908074|593028921|FG001|Overall Study|sponsor/ICON decision|0|||
164181498|NCT02908074|593028922|FG002|Overall Study|sponsor/ICON decision|1|||
164181499|NCT02908074|593028923|FG003|Overall Study|sponsor/ICON decision|0|||
164181500|NCT02908074|593028924|FG004|Overall Study|sponsor/ICON decision|0|||
164181501|NCT02908074|593028925|FG005|Overall Study|sponsor/ICON decision|0|||
164181502|NCT02908074|593028920|FG000|Overall Study|Protocol Violation|0|||
164181503|NCT02908074|593028921|FG001|Overall Study|Protocol Violation|1|||
164181504|NCT02908074|593028922|FG002|Overall Study|Protocol Violation|0|||
164181505|NCT02908074|593028923|FG003|Overall Study|Protocol Violation|0|||
164181506|NCT02908074|593028924|FG004|Overall Study|Protocol Violation|0|||
164181507|NCT02908074|593028925|FG005|Overall Study|Protocol Violation|0|||
164181508|NCT02908074|593028920|FG000|Overall Study|Adverse Event|5|||
164181509|NCT02908074|593028921|FG001|Overall Study|Adverse Event|2|||
164181510|NCT02908074|593028922|FG002|Overall Study|Adverse Event|0|||
164181511|NCT02908074|593028923|FG003|Overall Study|Adverse Event|0|||
164181512|NCT02908074|593028924|FG004|Overall Study|Adverse Event|1|||
164181513|NCT02908074|593028925|FG005|Overall Study|Adverse Event|0|||
164181514|NCT02908074|593028920|FG000|Overall Study|AESI|1|||
164181515|NCT02908074|593028921|FG001|Overall Study|AESI|0|||
164181516|NCT02908074|593028922|FG002|Overall Study|AESI|1|||
164181517|NCT02908074|593028923|FG003|Overall Study|AESI|0|||
164181518|NCT02908074|593028924|FG004|Overall Study|AESI|1|||
164181519|NCT02908074|593028925|FG005|Overall Study|AESI|0|||
164181520|NCT02908074|593028920|FG000|Overall Study|Discontinuation criteria per protocol|0|||
164181521|NCT02908074|593028921|FG001|Overall Study|Discontinuation criteria per protocol|0|||
164181522|NCT02908074|593028922|FG002|Overall Study|Discontinuation criteria per protocol|1|||
164181523|NCT02908074|593028923|FG003|Overall Study|Discontinuation criteria per protocol|0|||
164181524|NCT02908074|593028924|FG004|Overall Study|Discontinuation criteria per protocol|0|||
164181525|NCT02908074|593028925|FG005|Overall Study|Discontinuation criteria per protocol|1|||
164181526|NCT02908074|593028920|FG000|Overall Study|Withdrawal by Subject|3|||
164181527|NCT02908074|593028921|FG001|Overall Study|Withdrawal by Subject|2|||
164181528|NCT02908074|593028922|FG002|Overall Study|Withdrawal by Subject|2|||
164181529|NCT02908074|593028923|FG003|Overall Study|Withdrawal by Subject|2|||
164181530|NCT02908074|593028924|FG004|Overall Study|Withdrawal by Subject|2|||
164181531|NCT02908074|593028925|FG005|Overall Study|Withdrawal by Subject|2|||
164181532|NCT02908074|593028920|FG000|Overall Study|Lost to Follow-up|0|||
164181533|NCT02908074|593028921|FG001|Overall Study|Lost to Follow-up|1|||
164181534|NCT02908074|593028922|FG002|Overall Study|Lost to Follow-up|1|||
164181535|NCT02908074|593028923|FG003|Overall Study|Lost to Follow-up|1|||
164181536|NCT02908074|593028924|FG004|Overall Study|Lost to Follow-up|0|||
164181537|NCT02908074|593028925|FG005|Overall Study|Lost to Follow-up|1|||
164181538|NCT02429310|593028927|FG000|Overall Study|Lost to Follow-up|1|||
164181539|NCT02429310|593028928|FG001|Overall Study|Lost to Follow-up|2|||
164181540|NCT02429310|593028927|FG000|Overall Study|Protocol Violation|1|||
164181541|NCT02429310|593028928|FG001|Overall Study|Protocol Violation|1|||
164181542|NCT00394433|593028929|FG000|Overall Study|Adverse Event|2|||
164181543|NCT00394433|593028929|FG000|Overall Study|Alternative Therapy|1|||
164181544|NCT03646305|593028930|FG000|Overall Study|Lost to Follow-up|4|||
164181545|NCT03646305|593028931|FG001|Overall Study|Lost to Follow-up|2|||
164181546|NCT03646305|593028932|FG002|Overall Study|Lost to Follow-up|2|||
164181547|NCT03646305|593028933|FG003|Overall Study|Lost to Follow-up|1|||
164181548|NCT03646305|593028930|FG000|Overall Study|Withdrawal by Subject|1|||
164181549|NCT03646305|593028931|FG001|Overall Study|Withdrawal by Subject|0|||
164181550|NCT03646305|593028932|FG002|Overall Study|Withdrawal by Subject|0|||
164181551|NCT03646305|593028933|FG003|Overall Study|Withdrawal by Subject|1|||
164181552|NCT01554176|593028934|FG000|Treatment Phase|Protocol Violation|1|||
164181553|NCT01554176|593028935|FG001|Treatment Phase|Protocol Violation|2|||
164181554|NCT01554176|593028936|FG002|Treatment Phase|Protocol Violation|0|||
164181555|NCT01554176|593028937|FG003|Treatment Phase|Protocol Violation|0|||
164181556|NCT01554176|593028938|FG004|Treatment Phase|Protocol Violation|0|||
164181557|NCT01554176|593028934|FG000|Treatment Phase|Physician Decision|1|||
164181558|NCT01554176|593028935|FG001|Treatment Phase|Physician Decision|1|||
164181559|NCT01554176|593028936|FG002|Treatment Phase|Physician Decision|0|||
164181560|NCT01554176|593028937|FG003|Treatment Phase|Physician Decision|0|||
164181561|NCT01554176|593028938|FG004|Treatment Phase|Physician Decision|0|||
164181562|NCT01554176|593028934|FG000|Treatment Phase|Lack of Efficacy|0|||
164181563|NCT01554176|593028935|FG001|Treatment Phase|Lack of Efficacy|1|||
164181564|NCT01554176|593028936|FG002|Treatment Phase|Lack of Efficacy|0|||
164181565|NCT01554176|593028937|FG003|Treatment Phase|Lack of Efficacy|0|||
164181566|NCT01554176|593028938|FG004|Treatment Phase|Lack of Efficacy|0|||
164181567|NCT01554176|593028934|FG000|Treatment Phase|Adverse event, non-fatal|1|||
164181568|NCT01554176|593028935|FG001|Treatment Phase|Adverse event, non-fatal|1|||
164181569|NCT01554176|593028936|FG002|Treatment Phase|Adverse event, non-fatal|0|||
164181570|NCT01554176|593028937|FG003|Treatment Phase|Adverse event, non-fatal|0|||
164181571|NCT01554176|593028938|FG004|Treatment Phase|Adverse event, non-fatal|0|||
164181572|NCT01554176|593028934|FG000|Treatment Phase|Non-compliance with study drug|1|||
164181573|NCT01554176|593028935|FG001|Treatment Phase|Non-compliance with study drug|0|||
164181574|NCT01554176|593028936|FG002|Treatment Phase|Non-compliance with study drug|0|||
164181575|NCT01554176|593028937|FG003|Treatment Phase|Non-compliance with study drug|0|||
164181576|NCT01554176|593028938|FG004|Treatment Phase|Non-compliance with study drug|0|||
164181577|NCT01554176|593028934|FG000|Treatment Phase|Withdrawal by Subject|1|||
164181578|NCT01554176|593028935|FG001|Treatment Phase|Withdrawal by Subject|0|||
164181579|NCT01554176|593028936|FG002|Treatment Phase|Withdrawal by Subject|0|||
164181580|NCT01554176|593028937|FG003|Treatment Phase|Withdrawal by Subject|0|||
164181581|NCT01554176|593028938|FG004|Treatment Phase|Withdrawal by Subject|0|||
164181582|NCT01554176|593028934|FG000|Treatment Phase|Lost to Follow-up|3|||
164181583|NCT01554176|593028935|FG001|Treatment Phase|Lost to Follow-up|0|||
164181584|NCT01554176|593028936|FG002|Treatment Phase|Lost to Follow-up|0|||
164181585|NCT01554176|593028937|FG003|Treatment Phase|Lost to Follow-up|0|||
164181586|NCT01554176|593028938|FG004|Treatment Phase|Lost to Follow-up|0|||
164181587|NCT01554176|593028934|FG000|Run-out Phase|Protocol Violation|0|||
164181588|NCT01554176|593028935|FG001|Run-out Phase|Protocol Violation|0|||
164181589|NCT01554176|593028936|FG002|Run-out Phase|Protocol Violation|0|||
164181590|NCT01554176|593028937|FG003|Run-out Phase|Protocol Violation|1|||
164181591|NCT01554176|593028938|FG004|Run-out Phase|Protocol Violation|0|||
164181592|NCT02678000|593028939|FG000|PART 2|Adverse Event|0|||
164181593|NCT02678000|593028940|FG001|PART 2|Adverse Event|0|||
164181594|NCT02678000|593028941|FG002|PART 2|Adverse Event|2|||
164181595|NCT02678000|593028942|FG003|PART 2|Adverse Event|1|||
164181596|NCT02678000|593028943|FG004|PART 2|Adverse Event|0|||
164181597|NCT02678000|593028939|FG000|PART 2|Withdrawal by Subject|0|||
164181598|NCT02678000|593028940|FG001|PART 2|Withdrawal by Subject|0|||
164181599|NCT02678000|593028941|FG002|PART 2|Withdrawal by Subject|1|||
164181600|NCT02678000|593028942|FG003|PART 2|Withdrawal by Subject|0|||
164181601|NCT02678000|593028943|FG004|PART 2|Withdrawal by Subject|0|||
164181602|NCT00004088|593030693|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
164181603|NCT00004088|593030693|FG000|Overall Study|Withdrawal by Subject|1|||
164181604|NCT00004088|593030693|FG000|Overall Study|Protocol Violation|3|||
164181605|NCT00004088|593030693|FG000|Overall Study|Physician Decision|1|||
164181606|NCT03004924|593030694|FG000|Overall Study|Adverse Event|6|||
164181607|NCT03004924|593030695|FG001|Overall Study|Adverse Event|5|||
164181608|NCT03004924|593030696|FG002|Overall Study|Adverse Event|10|||
164181609|NCT03004924|593030694|FG000|Overall Study|Protocol Violation|4|||
164181610|NCT03004924|593030695|FG001|Overall Study|Protocol Violation|0|||
164181611|NCT03004924|593030696|FG002|Overall Study|Protocol Violation|1|||
164181612|NCT03004924|593030694|FG000|Overall Study|Withdrawal by Subject|5|||
164181613|NCT03004924|593030695|FG001|Overall Study|Withdrawal by Subject|3|||
164181614|NCT03004924|593030696|FG002|Overall Study|Withdrawal by Subject|5|||
164181615|NCT03004924|593030694|FG000|Overall Study|Lost to Follow-up|6|||
164181616|NCT03004924|593030695|FG001|Overall Study|Lost to Follow-up|1|||
164181617|NCT03004924|593030696|FG002|Overall Study|Lost to Follow-up|4|||
164181618|NCT03004924|593030694|FG000|Overall Study|Lack of Efficacy|2|||
164181619|NCT03004924|593030695|FG001|Overall Study|Lack of Efficacy|4|||
164181620|NCT03004924|593030696|FG002|Overall Study|Lack of Efficacy|2|||
164181621|NCT03004924|593030694|FG000|Overall Study|Physician Decision|1|||
164181622|NCT03004924|593030695|FG001|Overall Study|Physician Decision|0|||
164181623|NCT03004924|593030696|FG002|Overall Study|Physician Decision|1|||
164181624|NCT03004924|593030694|FG000|Overall Study|Withdrawal by parent/guardian|1|||
164181625|NCT03004924|593030695|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164181626|NCT03004924|593030696|FG002|Overall Study|Withdrawal by parent/guardian|2|||
164181627|NCT03004924|593030694|FG000|Overall Study|Screen Failure|1|||
164181628|NCT03004924|593030695|FG001|Overall Study|Screen Failure|0|||
164181629|NCT03004924|593030696|FG002|Overall Study|Screen Failure|0|||
164181630|NCT03004924|593030694|FG000|Overall Study|Pregnancy|0|||
164181631|NCT03004924|593030695|FG001|Overall Study|Pregnancy|1|||
164181632|NCT03004924|593030696|FG002|Overall Study|Pregnancy|0|||
164181633|NCT03004924|593030694|FG000|Overall Study|Terminated by Sponsor|0|||
164181634|NCT03004924|593030695|FG001|Overall Study|Terminated by Sponsor|0|||
164181635|NCT03004924|593030696|FG002|Overall Study|Terminated by Sponsor|1|||
164181636|NCT03004924|593030694|FG000|Overall Study|Missed Study Visit|0|||
164181637|NCT03004924|593030695|FG001|Overall Study|Missed Study Visit|0|||
164181638|NCT03004924|593030696|FG002|Overall Study|Missed Study Visit|2|||
164181639|NCT03004924|593030694|FG000|Overall Study|HSV1 Positive|1|||
164181640|NCT03004924|593030695|FG001|Overall Study|HSV1 Positive|0|||
164181641|NCT03004924|593030696|FG002|Overall Study|HSV1 Positive|0|||
164181642|NCT00089635|593030702|FG000|Overall Study|Adverse Event|2|||
164181643|NCT00089635|593030702|FG000|Overall Study|Death|17|||
164181644|NCT00089635|593030702|FG000|Overall Study|Disease Progression|12|||
164181645|NCT00089635|593030702|FG000|Overall Study|Lost to Follow-up|3|||
164181646|NCT00089635|593030702|FG000|Overall Study|Withdrawal by Subject|6|||
164181647|NCT00089635|593030702|FG000|Overall Study|Ineligibility determined|1|||
164181648|NCT00089635|593030702|FG000|Overall Study|Other|2|||
164181649|NCT02943785|593030703|FG000|Overall Study|Adverse Event|112|||
164181650|NCT02943785|593030704|FG001|Overall Study|Adverse Event|97|||
164181651|NCT02943785|593030703|FG000|Overall Study|Withdrawal by Subject|63|||
164181652|NCT02943785|593030704|FG001|Overall Study|Withdrawal by Subject|126|||
164181653|NCT02943785|593030703|FG000|Overall Study|Physician Decision|23|||
164181654|NCT02943785|593030704|FG001|Overall Study|Physician Decision|47|||
164181655|NCT02943785|593030703|FG000|Overall Study|Death|46|||
164181656|NCT02943785|593030704|FG001|Overall Study|Death|46|||
164181657|NCT02943785|593030703|FG000|Overall Study|Lost to Follow-up|1|||
164181658|NCT02943785|593030704|FG001|Overall Study|Lost to Follow-up|0|||
164181659|NCT02943785|593030703|FG000|Overall Study|Other|16|||
164181660|NCT02943785|593030704|FG001|Overall Study|Other|19|||
164181661|NCT02943785|593030703|FG000|Overall Study|Did not receive any study medication|21|||
164181662|NCT02943785|593030704|FG001|Overall Study|Did not receive any study medication|28|||
164181663|NCT02603107|593030705|FG000|Randomized Phase|Withdrew consent|8|||
164181664|NCT02603107|593030706|FG001|Randomized Phase|Withdrew consent|15|||
164181665|NCT02603107|593030705|FG000|Randomized Phase|Lost to Follow-up|1|||
164181666|NCT02603107|593030706|FG001|Randomized Phase|Lost to Follow-up|3|||
164181667|NCT02603107|593030705|FG000|Randomized Phase|Adverse Event|2|||
164181668|NCT02603107|593030706|FG001|Randomized Phase|Adverse Event|0|||
164181669|NCT02603107|593030705|FG000|Randomized Phase|Death|1|||
164181670|NCT02603107|593030706|FG001|Randomized Phase|Death|1|||
164181671|NCT02603107|593030705|FG000|Randomized Phase|Non-compliance with study drug|1|||
164181672|NCT02603107|593030706|FG001|Randomized Phase|Non-compliance with study drug|1|||
164181673|NCT02603107|593030705|FG000|Randomized Phase|Investigator's discretion|0|||
164181674|NCT02603107|593030706|FG001|Randomized Phase|Investigator's discretion|1|||
164181675|NCT02603107|593030705|FG000|Randomized Phase|Lack of Efficacy|1|||
164181676|NCT02603107|593030706|FG001|Randomized Phase|Lack of Efficacy|0|||
164181677|NCT02603107|593030705|FG000|Randomized Phase|Protocol Violation|1|||
164181678|NCT02603107|593030706|FG001|Randomized Phase|Protocol Violation|0|||
164181679|NCT02603107|593030705|FG000|Optional Extension Phase|Lost to Follow-up|3|||
164181680|NCT02603107|593030706|FG001|Optional Extension Phase|Lost to Follow-up|3|||
164181681|NCT02603107|593030705|FG000|Optional Extension Phase|Withdrew consent|3|||
164181682|NCT02603107|593030706|FG001|Optional Extension Phase|Withdrew consent|2|||
164181683|NCT02603107|593030705|FG000|Optional Extension Phase|Investigator's discretion|2|||
164181684|NCT02603107|593030706|FG001|Optional Extension Phase|Investigator's discretion|2|||
164181685|NCT02603107|593030705|FG000|Optional Extension Phase|Pregnancy|0|||
164181686|NCT02603107|593030706|FG001|Optional Extension Phase|Pregnancy|3|||
164181687|NCT02603107|593030705|FG000|Optional Extension Phase|Adverse Event|0|||
164181688|NCT02603107|593030706|FG001|Optional Extension Phase|Adverse Event|2|||
164181689|NCT02603107|593030705|FG000|Optional Extension Phase|Not treated in extension phase|0|||
164181690|NCT02603107|593030706|FG001|Optional Extension Phase|Not treated in extension phase|1|||
164181691|NCT02603107|593030705|FG000|Optional Extension Phase|Protocol Violation|1|||
164181692|NCT02603107|593030706|FG001|Optional Extension Phase|Protocol Violation|0|||
164181693|NCT00821015|593030707|FG000|Overall Study|Lost to Follow-up|12|||
164181694|NCT03170609|593030710|FG000|Overall Study|Death|0|||
164181695|NCT03170609|593030711|FG001|Overall Study|Death|0|||
164181696|NCT03170609|593030712|FG002|Overall Study|Death|1|||
164181697|NCT03170609|593030713|FG003|Overall Study|Death|0|||
164181698|NCT03170609|593030714|FG004|Overall Study|Death|0|||
164181699|NCT03170609|593030715|FG005|Overall Study|Death|0|||
164181700|NCT03170609|593030716|FG006|Overall Study|Death|0|||
164181701|NCT03170609|593030710|FG000|Overall Study|Withdrawal by Subject|1|||
164181702|NCT03170609|593030711|FG001|Overall Study|Withdrawal by Subject|2|||
164181703|NCT03170609|593030712|FG002|Overall Study|Withdrawal by Subject|0|||
164181704|NCT03170609|593030713|FG003|Overall Study|Withdrawal by Subject|0|||
164181705|NCT03170609|593030714|FG004|Overall Study|Withdrawal by Subject|0|||
164181706|NCT03170609|593030715|FG005|Overall Study|Withdrawal by Subject|0|||
164181707|NCT03170609|593030716|FG006|Overall Study|Withdrawal by Subject|1|||
164181708|NCT03170609|593030710|FG000|Overall Study|Lost to Follow-up|1|||
164181709|NCT03170609|593030711|FG001|Overall Study|Lost to Follow-up|0|||
164181710|NCT03170609|593030712|FG002|Overall Study|Lost to Follow-up|5|||
164181711|NCT03170609|593030713|FG003|Overall Study|Lost to Follow-up|2|||
164181712|NCT03170609|593030714|FG004|Overall Study|Lost to Follow-up|1|||
164181713|NCT03170609|593030715|FG005|Overall Study|Lost to Follow-up|1|||
164181714|NCT03170609|593030716|FG006|Overall Study|Lost to Follow-up|0|||
164181715|NCT03170609|593030710|FG000|Overall Study|Other|1|||
164181716|NCT03170609|593030711|FG001|Overall Study|Other|0|||
164181717|NCT03170609|593030712|FG002|Overall Study|Other|0|||
164181718|NCT03170609|593030713|FG003|Overall Study|Other|0|||
164181719|NCT03170609|593030714|FG004|Overall Study|Other|0|||
164181720|NCT03170609|593030715|FG005|Overall Study|Other|1|||
164181721|NCT03170609|593030716|FG006|Overall Study|Other|0|||
164181722|NCT01887678|593030722|FG000|Overall Study|Adverse Event|4|||
164181723|NCT01887678|593030723|FG001|Overall Study|Adverse Event|6|||
164181724|NCT01887678|593030722|FG000|Overall Study|Exceeded rescue medication dosage|4|||
164181725|NCT01887678|593030723|FG001|Overall Study|Exceeded rescue medication dosage|5|||
164181726|NCT01887678|593030722|FG000|Overall Study|Withdrawal of consent|3|||
164181727|NCT01887678|593030723|FG001|Overall Study|Withdrawal of consent|4|||
164181728|NCT01887678|593030722|FG000|Overall Study|Lost to Follow-up|4|||
164181729|NCT01887678|593030723|FG001|Overall Study|Lost to Follow-up|2|||
164181730|NCT01887678|593030722|FG000|Overall Study|Deterioration of clinical condition|0|||
164181731|NCT01887678|593030723|FG001|Overall Study|Deterioration of clinical condition|4|||
164181732|NCT01887678|593030722|FG000|Overall Study|Lack of Efficacy|1|||
164181733|NCT01887678|593030723|FG001|Overall Study|Lack of Efficacy|2|||
164181734|NCT01887678|593030722|FG000|Overall Study|Non-compliance|0|||
164181735|NCT01887678|593030723|FG001|Overall Study|Non-compliance|3|||
164181736|NCT01887678|593030722|FG000|Overall Study|Specified|1|||
164181737|NCT01887678|593030723|FG001|Overall Study|Specified|2|||
164181738|NCT03013985|593030725|FG000|Overall Study|Protocol Violation|2|||
164181739|NCT03013985|593030726|FG001|Overall Study|Protocol Violation|2|||
164181740|NCT03013985|593030725|FG000|Overall Study|Withdrawal by Subject|14|||
164181741|NCT03013985|593030726|FG001|Overall Study|Withdrawal by Subject|17|||
164181742|NCT01370616|593030729|FG000|Overall Study|Adverse Event|11|||
164181743|NCT01370616|593030730|FG001|Overall Study|Adverse Event|16|||
164181744|NCT01370616|593030729|FG000|Overall Study|Death|1|||
164181745|NCT01370616|593030730|FG001|Overall Study|Death|0|||
164181746|NCT01370616|593030729|FG000|Overall Study|Lack of Efficacy|6|||
164181747|NCT01370616|593030730|FG001|Overall Study|Lack of Efficacy|2|||
164181748|NCT01370616|593030729|FG000|Overall Study|Lost to Follow-up|0|||
164181749|NCT01370616|593030730|FG001|Overall Study|Lost to Follow-up|3|||
164181750|NCT01370616|593030729|FG000|Overall Study|Physician Decision|6|||
164181751|NCT01370616|593030730|FG001|Overall Study|Physician Decision|6|||
164181752|NCT01370616|593030729|FG000|Overall Study|Progressive Disease|0|||
164181753|NCT01370616|593030730|FG001|Overall Study|Progressive Disease|1|||
164181754|NCT01370616|593030729|FG000|Overall Study|Recovery|1|||
164181755|NCT01370616|593030730|FG001|Overall Study|Recovery|0|||
164181756|NCT01370616|593030729|FG000|Overall Study|Technical Problems|3|||
164181757|NCT01370616|593030730|FG001|Overall Study|Technical Problems|5|||
164181758|NCT01370616|593030729|FG000|Overall Study|Withdrawal by Subject|34|||
164181759|NCT01370616|593030730|FG001|Overall Study|Withdrawal by Subject|34|||
164181760|NCT00076999|593030735|FG000|Overall Study|Adverse Event|2|||
164181761|NCT00076999|593030736|FG001|Overall Study|Adverse Event|8|||
164181762|NCT00076999|593030737|FG002|Overall Study|Adverse Event|6|||
164181763|NCT00076999|593030738|FG003|Overall Study|Adverse Event|0|||
164181764|NCT00076999|593030739|FG004|Overall Study|Adverse Event|2|||
164181765|NCT00076999|593030735|FG000|Overall Study|Protocol Violation|0|||
164181766|NCT00076999|593030736|FG001|Overall Study|Protocol Violation|3|||
164181767|NCT00076999|593030737|FG002|Overall Study|Protocol Violation|4|||
164181768|NCT00076999|593030738|FG003|Overall Study|Protocol Violation|0|||
164181769|NCT00076999|593030739|FG004|Overall Study|Protocol Violation|9|||
164181770|NCT00076999|593030735|FG000|Overall Study|Lost to Follow-up|2|||
164181771|NCT00076999|593030736|FG001|Overall Study|Lost to Follow-up|1|||
164181772|NCT00076999|593030737|FG002|Overall Study|Lost to Follow-up|0|||
164181773|NCT00076999|593030738|FG003|Overall Study|Lost to Follow-up|0|||
164181774|NCT00076999|593030739|FG004|Overall Study|Lost to Follow-up|0|||
164181775|NCT00076999|593030735|FG000|Overall Study|Withdrawal by Subject|0|||
164181776|NCT00076999|593030736|FG001|Overall Study|Withdrawal by Subject|4|||
164181777|NCT00076999|593030737|FG002|Overall Study|Withdrawal by Subject|3|||
164181778|NCT00076999|593030738|FG003|Overall Study|Withdrawal by Subject|0|||
164181779|NCT00076999|593030739|FG004|Overall Study|Withdrawal by Subject|1|||
164181780|NCT00076999|593030735|FG000|Overall Study|Other reason (not specified)|8|||
164181781|NCT00076999|593030736|FG001|Overall Study|Other reason (not specified)|8|||
164181782|NCT00076999|593030737|FG002|Overall Study|Other reason (not specified)|4|||
164181783|NCT00076999|593030738|FG003|Overall Study|Other reason (not specified)|1|||
164181784|NCT00076999|593030739|FG004|Overall Study|Other reason (not specified)|13|||
164181785|NCT00803205|593030740|FG000|Overall Study|Adverse Event|7|||
164181786|NCT00803205|593030741|FG001|Overall Study|Adverse Event|2|||
164181787|NCT00803205|593030740|FG000|Overall Study|Lost to Follow-up|1|||
164181788|NCT00803205|593030741|FG001|Overall Study|Lost to Follow-up|0|||
164181789|NCT00803205|593030740|FG000|Overall Study|Withdrawal by Subject|9|||
164181790|NCT00803205|593030741|FG001|Overall Study|Withdrawal by Subject|9|||
164181791|NCT00803205|593030740|FG000|Overall Study|Physician Decision|1|||
164181792|NCT00803205|593030741|FG001|Overall Study|Physician Decision|0|||
164181793|NCT00803205|593030740|FG000|Overall Study|Protocol Violation|1|||
164181794|NCT00803205|593030741|FG001|Overall Study|Protocol Violation|1|||
164181795|NCT00803205|593030740|FG000|Overall Study|Medical Monitor Decision|1|||
164181796|NCT00803205|593030741|FG001|Overall Study|Medical Monitor Decision|0|||
164181797|NCT00803205|593030740|FG000|Overall Study|Acquired a Lung Infection|0|||
164181798|NCT00803205|593030741|FG001|Overall Study|Acquired a Lung Infection|1|||
164181799|NCT00803205|593030740|FG000|Overall Study|Sponsor Decision|0|||
164181800|NCT00803205|593030741|FG001|Overall Study|Sponsor Decision|1|||
164181801|NCT01217385|593030743|FG000|Overall Study|Withdrawal by Subject|3|||
164181802|NCT01217385|593030743|FG000|Overall Study|DOSI not performed/not eval|12|||
164181803|NCT01217385|593030743|FG000|Overall Study|Central Path not Available|1|||
164181804|NCT01217385|593030743|FG000|Overall Study|Normal Breast TOI not available|10|||
164181805|NCT01534208|593030745|FG000|Overall Study|Lost to Follow-up|19|||
164181806|NCT01534208|593030746|FG001|Overall Study|Lost to Follow-up|14|||
164181807|NCT01534208|593030745|FG000|Overall Study|Withdrawal by Subject|6|||
164181808|NCT01534208|593030746|FG001|Overall Study|Withdrawal by Subject|20|||
164181809|NCT01534208|593030745|FG000|Overall Study|Adverse Event|15|||
164181810|NCT01534208|593030746|FG001|Overall Study|Adverse Event|8|||
164181811|NCT01534208|593030745|FG000|Overall Study|Physician Decision|2|||
164181812|NCT01534208|593030746|FG001|Overall Study|Physician Decision|0|||
164181813|NCT01534208|593030745|FG000|Overall Study|Lack of Efficacy|0|||
164181814|NCT01534208|593030746|FG001|Overall Study|Lack of Efficacy|3|||
164181815|NCT01534208|593030745|FG000|Overall Study|Protocol Violation|2|||
164181816|NCT01534208|593030746|FG001|Overall Study|Protocol Violation|2|||
164181817|NCT01534208|593030745|FG000|Overall Study|Sponsor decision|4|||
164181818|NCT01534208|593030746|FG001|Overall Study|Sponsor decision|1|||
164181819|NCT01534208|593030745|FG000|Overall Study|Subject relocation|2|||
164181820|NCT01534208|593030746|FG001|Overall Study|Subject relocation|0|||
164181821|NCT01534208|593030745|FG000|Overall Study|Lab assessment|2|||
164181822|NCT01534208|593030746|FG001|Overall Study|Lab assessment|1|||
164181823|NCT01534208|593030745|FG000|Overall Study|Eligibility error|3|||
164181824|NCT01534208|593030746|FG001|Overall Study|Eligibility error|0|||
164181825|NCT01534208|593030745|FG000|Overall Study|PCP decision|1|||
164181826|NCT01534208|593030746|FG001|Overall Study|PCP decision|0|||
164181827|NCT01534208|593030745|FG000|Overall Study|Needed prohibited meds|1|||
164181828|NCT01534208|593030746|FG001|Overall Study|Needed prohibited meds|0|||
164181829|NCT02117713|593030757|FG000|Week 48|Adverse Event|4|||
164181830|NCT02117713|593030757|FG000|Week 48|Withdrawal by caregiver|2|||
164181831|NCT02117713|593030757|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
164181832|NCT02117713|593030757|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
164181833|NCT02117713|593030757|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
164181834|NCT02117713|593030757|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
164181835|NCT00672841|593030758|FG000|Overall Study|Comfort care|1|||
164181836|NCT00672841|593030759|FG001|Overall Study|Comfort care|4|||
164181837|NCT00672841|593030758|FG000|Overall Study|icteric specimens|0|||
164181838|NCT00672841|593030759|FG001|Overall Study|icteric specimens|3|||
164181839|NCT00672841|593030758|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
164181840|NCT00672841|593030759|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
164181841|NCT00672841|593030758|FG000|Overall Study|Adverse Event|0|||
164181842|NCT00672841|593030759|FG001|Overall Study|Adverse Event|3|||
164181843|NCT00672841|593030758|FG000|Overall Study|Pregnancy|0|||
164181844|NCT00672841|593030759|FG001|Overall Study|Pregnancy|1|||
164181845|NCT02638259|593030760|FG000|Treatment Period 1|Adverse Event|1|||
164181846|NCT02638259|593030761|FG001|Treatment Period 1|Adverse Event|5|||
164181847|NCT02638259|593030760|FG000|Treatment Period 1|Death|0|||
164181848|NCT02638259|593030761|FG001|Treatment Period 1|Death|1|||
164181849|NCT02638259|593030760|FG000|Treatment Period 1|Lack of Efficacy|0|||
164181850|NCT02638259|593030761|FG001|Treatment Period 1|Lack of Efficacy|1|||
164181851|NCT02638259|593030760|FG000|Treatment Period 1|Protocol Violation|0|||
164181852|NCT02638259|593030761|FG001|Treatment Period 1|Protocol Violation|3|||
164181853|NCT02638259|593030760|FG000|Treatment Period 1|Withdrawal by Subject|4|||
164181854|NCT02638259|593030761|FG001|Treatment Period 1|Withdrawal by Subject|6|||
164181855|NCT02638259|593030760|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
164181856|NCT02638259|593030761|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
164181857|NCT02638259|593030760|FG000|Treatment Period 2|Adverse Event|5|||
164181858|NCT02638259|593030761|FG001|Treatment Period 2|Adverse Event|4|||
164181859|NCT02638259|593030760|FG000|Treatment Period 2|Withdrawal by Subject|1|||
164181860|NCT02638259|593030761|FG001|Treatment Period 2|Withdrawal by Subject|7|||
164181861|NCT04299048|593030762|FG000|Overall Study|Death|1|||
164181862|NCT04299048|593030762|FG000|Overall Study|Global deterioration of health status|2|||
164181863|NCT04299048|593030762|FG000|Overall Study|Enrolled and not treated|1|||
164181864|NCT03578146|593030764|FG000|Overall Study|Did Not Receive Treatment|1|||
164181865|NCT03578146|593030765|FG001|Overall Study|Did Not Receive Treatment|0|||
164181866|NCT03578146|593030766|FG002|Overall Study|Did Not Receive Treatment|0|||
164181867|NCT03578146|593030767|FG003|Overall Study|Did Not Receive Treatment|0|||
164181868|NCT03578146|593030768|FG004|Overall Study|Did Not Receive Treatment|0|||
164181869|NCT03578146|593030769|FG005|Overall Study|Did Not Receive Treatment|2|||
164181870|NCT03578146|593030764|FG000|Overall Study|Lost to Follow-up|0|||
164181871|NCT03578146|593030765|FG001|Overall Study|Lost to Follow-up|1|||
164181872|NCT03578146|593030766|FG002|Overall Study|Lost to Follow-up|1|||
164181873|NCT03578146|593030767|FG003|Overall Study|Lost to Follow-up|0|||
164181874|NCT03578146|593030768|FG004|Overall Study|Lost to Follow-up|0|||
164181875|NCT03578146|593030769|FG005|Overall Study|Lost to Follow-up|1|||
164181876|NCT01094782|593030770|FG000|Overall Study|Withdrawal by Subject|5|||
164181877|NCT01094782|593030771|FG001|Overall Study|Withdrawal by Subject|5|||
164181878|NCT01094782|593030772|FG002|Overall Study|Withdrawal by Subject|1|||
164181879|NCT01094782|593030773|FG003|Overall Study|Withdrawal by Subject|5|||
164181880|NCT01094782|593030774|FG004|Overall Study|Withdrawal by Subject|5|||
164181881|NCT01094782|593030775|FG005|Overall Study|Withdrawal by Subject|0|||
164181882|NCT01094782|593030770|FG000|Overall Study|Lost to Follow-up|1|||
164181883|NCT01094782|593030771|FG001|Overall Study|Lost to Follow-up|0|||
164181884|NCT01094782|593030772|FG002|Overall Study|Lost to Follow-up|0|||
164181885|NCT01094782|593030773|FG003|Overall Study|Lost to Follow-up|2|||
164181886|NCT01094782|593030774|FG004|Overall Study|Lost to Follow-up|1|||
164181887|NCT01094782|593030775|FG005|Overall Study|Lost to Follow-up|4|||
164181888|NCT01094782|593030770|FG000|Overall Study|Positive Drug Screen|2|||
164181889|NCT01094782|593030771|FG001|Overall Study|Positive Drug Screen|2|||
164181890|NCT01094782|593030772|FG002|Overall Study|Positive Drug Screen|1|||
164181891|NCT01094782|593030773|FG003|Overall Study|Positive Drug Screen|1|||
164181892|NCT01094782|593030774|FG004|Overall Study|Positive Drug Screen|3|||
164181893|NCT01094782|593030775|FG005|Overall Study|Positive Drug Screen|2|||
164181894|NCT01094782|593030770|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
164182126|NCT03041467|593032491|FG001|Overall Study|Lost to Follow-up|8|||
164181895|NCT01094782|593030771|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
164181896|NCT01094782|593030772|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
164181897|NCT01094782|593030773|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
164181898|NCT01094782|593030774|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
164181899|NCT01094782|593030775|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
164181900|NCT01094782|593030770|FG000|Overall Study|Unable to Complete Questionnaires|0|||
164181901|NCT01094782|593030771|FG001|Overall Study|Unable to Complete Questionnaires|1|||
164181902|NCT01094782|593030772|FG002|Overall Study|Unable to Complete Questionnaires|0|||
164181903|NCT01094782|593030773|FG003|Overall Study|Unable to Complete Questionnaires|0|||
164181904|NCT01094782|593030774|FG004|Overall Study|Unable to Complete Questionnaires|0|||
164181905|NCT01094782|593030775|FG005|Overall Study|Unable to Complete Questionnaires|0|||
164181906|NCT01094782|593030770|FG000|Overall Study|Healthy Subject Had Pain|0|||
164181907|NCT01094782|593030771|FG001|Overall Study|Healthy Subject Had Pain|1|||
164181908|NCT01094782|593030772|FG002|Overall Study|Healthy Subject Had Pain|0|||
164181909|NCT01094782|593030773|FG003|Overall Study|Healthy Subject Had Pain|0|||
164181910|NCT01094782|593030774|FG004|Overall Study|Healthy Subject Had Pain|0|||
164181911|NCT01094782|593030775|FG005|Overall Study|Healthy Subject Had Pain|0|||
164181912|NCT01094782|593030770|FG000|Overall Study|Hypertension|0|||
164181913|NCT01094782|593030771|FG001|Overall Study|Hypertension|0|||
164181914|NCT01094782|593030772|FG002|Overall Study|Hypertension|1|||
164181915|NCT01094782|593030773|FG003|Overall Study|Hypertension|0|||
164181916|NCT01094782|593030774|FG004|Overall Study|Hypertension|0|||
164181917|NCT01094782|593030775|FG005|Overall Study|Hypertension|0|||
164181918|NCT01094782|593030770|FG000|Overall Study|Wrong Pain Condition|0|||
164181919|NCT01094782|593030771|FG001|Overall Study|Wrong Pain Condition|0|||
164181920|NCT01094782|593030772|FG002|Overall Study|Wrong Pain Condition|0|||
164181921|NCT01094782|593030773|FG003|Overall Study|Wrong Pain Condition|2|||
164181922|NCT01094782|593030774|FG004|Overall Study|Wrong Pain Condition|1|||
164181923|NCT01094782|593030775|FG005|Overall Study|Wrong Pain Condition|1|||
164181924|NCT01094782|593030770|FG000|Overall Study|Recent Interventional Injection|0|||
164181925|NCT01094782|593030771|FG001|Overall Study|Recent Interventional Injection|0|||
164181926|NCT01094782|593030772|FG002|Overall Study|Recent Interventional Injection|0|||
164181927|NCT01094782|593030773|FG003|Overall Study|Recent Interventional Injection|0|||
164181928|NCT01094782|593030774|FG004|Overall Study|Recent Interventional Injection|0|||
164181929|NCT01094782|593030775|FG005|Overall Study|Recent Interventional Injection|1|||
164181930|NCT01094782|593030770|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
164181931|NCT01094782|593030771|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
164181932|NCT01094782|593030772|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
164181933|NCT01094782|593030773|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
164181934|NCT01094782|593030774|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
164181935|NCT01094782|593030775|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
164181936|NCT01094782|593030770|FG000|Overall Study|Noncompliance With Study Schedule|0|||
164181937|NCT01094782|593030771|FG001|Overall Study|Noncompliance With Study Schedule|0|||
164181938|NCT01094782|593030772|FG002|Overall Study|Noncompliance With Study Schedule|0|||
164181939|NCT01094782|593030773|FG003|Overall Study|Noncompliance With Study Schedule|1|||
164181940|NCT01094782|593030774|FG004|Overall Study|Noncompliance With Study Schedule|0|||
164181941|NCT01094782|593030775|FG005|Overall Study|Noncompliance With Study Schedule|0|||
164181942|NCT00634049|593030776|FG000|Overall Study|Never received study drug|1|||
164181943|NCT00634049|593030776|FG000|Overall Study|Died prior to receiving study drug|1|||
164181944|NCT00634049|593030776|FG000|Overall Study|Screening failure|1|||
164181945|NCT01717391|593030777|FG000|Overall Study|Withdrawal by Subject|5|||
164181946|NCT01717391|593030777|FG000|Overall Study|Physician Decision|1|||
164181947|NCT01717391|593030777|FG000|Overall Study|FLT technical failure|3|||
164181948|NCT00045734|593030797|FG000|Overall Study|Protocol Violation|1|||
164181949|NCT02069093|593030798|FG000|Overall Study|Disease progression|14|||
164181950|NCT02069093|593030798|FG000|Overall Study|New cancer therapy|1|||
164181951|NCT02069093|593030798|FG000|Overall Study|Death|1|||
164181952|NCT02069093|593030798|FG000|Overall Study|Administrative problems|1|||
164181953|NCT02069093|593030798|FG000|Overall Study|Withdrawal by Subject|2|||
164181954|NCT02069093|593030798|FG000|Overall Study|Abnormal laboratory values|1|||
164181955|NCT02069093|593030798|FG000|Overall Study|Adverse Event|10|||
164181956|NCT00474786|593030801|FG000|Overall Study|Not Meeting Study Criteria|0|||
164181957|NCT00474786|593030802|FG001|Overall Study|Not Meeting Study Criteria|1|||
164181958|NCT00474786|593030801|FG000|Overall Study|Investigator Request|2|||
164181959|NCT00474786|593030802|FG001|Overall Study|Investigator Request|1|||
164181960|NCT00474786|593030801|FG000|Overall Study|Death|189|||
164181961|NCT00474786|593030802|FG001|Overall Study|Death|170|||
164181962|NCT00474786|593030801|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
164181963|NCT00474786|593030802|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
164181964|NCT00474786|593030801|FG000|Overall Study|Lost to Follow-up|4|||
164181965|NCT00474786|593030802|FG001|Overall Study|Lost to Follow-up|7|||
164181966|NCT00474786|593030801|FG000|Overall Study|Protocol Violation|2|||
164181967|NCT00474786|593030802|FG001|Overall Study|Protocol Violation|0|||
164181968|NCT00474786|593030801|FG000|Overall Study|Withdrawal by Subject|15|||
164181969|NCT00474786|593030802|FG001|Overall Study|Withdrawal by Subject|15|||
164181970|NCT00474786|593030801|FG000|Overall Study|Other|5|||
164181971|NCT00474786|593030802|FG001|Overall Study|Other|0|||
164181972|NCT02892513|593030803|FG000|Overall Study|Withdrawal by Subject|0|||
164181973|NCT02892513|593030804|FG001|Overall Study|Withdrawal by Subject|1|||
164181974|NCT00900731|593030805|FG000|Overall Study|Adverse Event|31|||
164181975|NCT00900731|593030806|FG001|Overall Study|Adverse Event|27|||
164181976|NCT00900731|593030805|FG000|Overall Study|Withdrawal by Subject|8|||
164181977|NCT00900731|593030806|FG001|Overall Study|Withdrawal by Subject|7|||
164181978|NCT00900731|593030805|FG000|Overall Study|Protocol Deviation|8|||
164181979|NCT00900731|593030806|FG001|Overall Study|Protocol Deviation|11|||
164181980|NCT00900731|593030805|FG000|Overall Study|Administrative Problems|5|||
164181981|NCT00900731|593030806|FG001|Overall Study|Administrative Problems|4|||
164181982|NCT00900731|593030805|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
164181983|NCT00900731|593030806|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
164181984|NCT00900731|593030805|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
164181985|NCT00900731|593030806|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
164181986|NCT00900731|593030805|FG000|Overall Study|Lost to Follow-up|2|||
164181987|NCT00900731|593030806|FG001|Overall Study|Lost to Follow-up|3|||
164181988|NCT00900731|593030805|FG000|Overall Study|Lack of Efficacy|1|||
164181989|NCT00900731|593030806|FG001|Overall Study|Lack of Efficacy|3|||
164181990|NCT00900731|593030805|FG000|Overall Study|Death|0|||
164181991|NCT00900731|593030806|FG001|Overall Study|Death|2|||
164181992|NCT00131365|593030807|FG000|Overall Study|Withdrawal by Subject|1|||
164181993|NCT00131365|593030807|FG000|Overall Study|Alternative treatment|3|||
164181994|NCT05249127|593030808|FG000|Overall Study|Protocol Violation|13|||
164181995|NCT05249127|593030808|FG000|Overall Study|Physician Decision|4|||
164181996|NCT05249127|593030808|FG000|Overall Study|Withdrawal by Subject|2|||
164181997|NCT05249127|593030808|FG000|Overall Study|Participant Non-compliance|1|||
164181998|NCT03053427|593030811|FG000|Overall Study|Adverse Event|4|||
164181999|NCT03053427|593030812|FG001|Overall Study|Adverse Event|4|||
164182000|NCT03053427|593030811|FG000|Overall Study|Lack of Efficacy|1|||
164182001|NCT03053427|593030812|FG001|Overall Study|Lack of Efficacy|3|||
164182002|NCT03053427|593030811|FG000|Overall Study|Lost to Follow-up|2|||
164182003|NCT03053427|593030812|FG001|Overall Study|Lost to Follow-up|2|||
164182004|NCT03053427|593030811|FG000|Overall Study|Worsening of the target disease|0|||
164182005|NCT03053427|593030812|FG001|Overall Study|Worsening of the target disease|1|||
164182006|NCT03053427|593030811|FG000|Overall Study|Protocol Deviation|3|||
164182007|NCT03053427|593030812|FG001|Overall Study|Protocol Deviation|3|||
164182008|NCT03053427|593030811|FG000|Overall Study|Withdrawal by Subject|3|||
164182009|NCT03053427|593030812|FG001|Overall Study|Withdrawal by Subject|2|||
164182010|NCT03053427|593030811|FG000|Overall Study|Miscellaneous|0|||
164182011|NCT03053427|593030812|FG001|Overall Study|Miscellaneous|1|||
164182012|NCT02607306|593030817|FG000|Overall Study|Adverse Event|8|||
164182013|NCT02607306|593030818|FG001|Overall Study|Adverse Event|6|||
164182014|NCT02607306|593030819|FG002|Overall Study|Adverse Event|6|||
164182015|NCT02607306|593030817|FG000|Overall Study|Unclassified|1|||
164182016|NCT02607306|593030818|FG001|Overall Study|Unclassified|4|||
164182017|NCT02607306|593030819|FG002|Overall Study|Unclassified|0|||
164182018|NCT02607306|593030817|FG000|Overall Study|Withdrawal by Subject|8|||
164182019|NCT02607306|593030818|FG001|Overall Study|Withdrawal by Subject|10|||
164182020|NCT02607306|593030819|FG002|Overall Study|Withdrawal by Subject|2|||
164182021|NCT02607306|593030817|FG000|Overall Study|Lack of Efficacy|0|||
164182022|NCT02607306|593030818|FG001|Overall Study|Lack of Efficacy|1|||
164182023|NCT02607306|593030819|FG002|Overall Study|Lack of Efficacy|1|||
164182024|NCT02607306|593030817|FG000|Overall Study|Protocol Violation|4|||
164182025|NCT02607306|593030818|FG001|Overall Study|Protocol Violation|2|||
164182026|NCT02607306|593030819|FG002|Overall Study|Protocol Violation|1|||
164182027|NCT01324570|593030820|FG000|Overall Study|Adverse Event|4|||
164182028|NCT01324570|593030821|FG001|Overall Study|Adverse Event|7|||
164182029|NCT01324570|593030820|FG000|Overall Study|Withdrawal by Subject|0|||
164182030|NCT01324570|593030821|FG001|Overall Study|Withdrawal by Subject|3|||
164182031|NCT01324570|593030820|FG000|Overall Study|Lack of Efficacy|0|||
164182032|NCT01324570|593030821|FG001|Overall Study|Lack of Efficacy|1|||
164182033|NCT01324570|593030820|FG000|Overall Study|Confirmed or suspected diversion|0|||
164182034|NCT01324570|593030821|FG001|Overall Study|Confirmed or suspected diversion|1|||
164182035|NCT01324570|593030820|FG000|Overall Study|Administrative|0|||
164182036|NCT01324570|593030821|FG001|Overall Study|Administrative|2|||
164182037|NCT02360475|593030822|FG000|Overall Study|Lost to Follow-up|4|||
164182038|NCT02360475|593030823|FG001|Overall Study|Lost to Follow-up|12|||
164182039|NCT02360475|593030824|FG002|Overall Study|Lost to Follow-up|6|||
164182040|NCT02360475|593030825|FG003|Overall Study|Lost to Follow-up|4|||
164182041|NCT02360475|593030822|FG000|Overall Study|Withdrawal by Subject|0|||
164182042|NCT02360475|593030823|FG001|Overall Study|Withdrawal by Subject|1|||
164182043|NCT02360475|593030824|FG002|Overall Study|Withdrawal by Subject|2|||
164182044|NCT02360475|593030825|FG003|Overall Study|Withdrawal by Subject|0|||
164182045|NCT02360475|593030822|FG000|Overall Study|Migrated/moved from study area|0|||
164182046|NCT02360475|593030823|FG001|Overall Study|Migrated/moved from study area|0|||
164182047|NCT02360475|593030824|FG002|Overall Study|Migrated/moved from study area|0|||
164182048|NCT02360475|593030825|FG003|Overall Study|Migrated/moved from study area|1|||
164182049|NCT02510820|593032469|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
164182050|NCT02510820|593032470|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
164182051|NCT02510820|593032469|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
164182052|NCT02510820|593032470|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
164182053|NCT01859949|593032471|FG000|Overall Study|Family Matters|0|||
164182054|NCT01859949|593032472|FG001|Overall Study|Family Matters|1|||
164182055|NCT01859949|593032471|FG000|Overall Study|Physician Decision|2|||
164182056|NCT01859949|593032472|FG001|Overall Study|Physician Decision|4|||
164182057|NCT01859949|593032471|FG000|Overall Study|Withdrawal by Subject|11|||
164182058|NCT01859949|593032472|FG001|Overall Study|Withdrawal by Subject|10|||
164182059|NCT01859949|593032471|FG000|Overall Study|Protocol Violation|1|||
164182060|NCT01859949|593032472|FG001|Overall Study|Protocol Violation|1|||
164182061|NCT01859949|593032471|FG000|Overall Study|Adverse Event|0|||
164182062|NCT01859949|593032472|FG001|Overall Study|Adverse Event|1|||
164182063|NCT01153009|593032473|FG000|Overall Study|Adverse Event|4|||
164182064|NCT01153009|593032474|FG001|Overall Study|Adverse Event|14|||
164182065|NCT01153009|593032475|FG002|Overall Study|Adverse Event|14|||
164182066|NCT01153009|593032476|FG003|Overall Study|Adverse Event|10|||
164182067|NCT01153009|593032473|FG000|Overall Study|Lack of Efficacy|9|||
164182068|NCT01153009|593032474|FG001|Overall Study|Lack of Efficacy|0|||
164182069|NCT01153009|593032475|FG002|Overall Study|Lack of Efficacy|2|||
164182070|NCT01153009|593032476|FG003|Overall Study|Lack of Efficacy|1|||
164182071|NCT01153009|593032473|FG000|Overall Study|Noncompliance with Study Medication|1|||
164182072|NCT01153009|593032474|FG001|Overall Study|Noncompliance with Study Medication|3|||
164182073|NCT01153009|593032475|FG002|Overall Study|Noncompliance with Study Medication|4|||
164182074|NCT01153009|593032476|FG003|Overall Study|Noncompliance with Study Medication|1|||
164182075|NCT01153009|593032473|FG000|Overall Study|Protocol Deviations|4|||
164182076|NCT01153009|593032474|FG001|Overall Study|Protocol Deviations|3|||
164182077|NCT01153009|593032475|FG002|Overall Study|Protocol Deviations|3|||
164182078|NCT01153009|593032476|FG003|Overall Study|Protocol Deviations|2|||
164182079|NCT01153009|593032473|FG000|Overall Study|Withdrawal of Consent|5|||
164182080|NCT01153009|593032474|FG001|Overall Study|Withdrawal of Consent|5|||
164182081|NCT01153009|593032475|FG002|Overall Study|Withdrawal of Consent|4|||
164182082|NCT01153009|593032476|FG003|Overall Study|Withdrawal of Consent|6|||
164182083|NCT01153009|593032473|FG000|Overall Study|Lost to Follow-up|8|||
164182084|NCT01153009|593032474|FG001|Overall Study|Lost to Follow-up|8|||
164182085|NCT01153009|593032475|FG002|Overall Study|Lost to Follow-up|11|||
164182086|NCT01153009|593032476|FG003|Overall Study|Lost to Follow-up|15|||
164182087|NCT01153009|593032473|FG000|Overall Study|Other|1|||
164182088|NCT01153009|593032474|FG001|Overall Study|Other|1|||
164182089|NCT01153009|593032475|FG002|Overall Study|Other|3|||
164182090|NCT01153009|593032476|FG003|Overall Study|Other|2|||
164182091|NCT03307837|593032481|FG000|Overall Study|Withdrawal by Subject|0|||
164182092|NCT03307837|593032482|FG001|Overall Study|Withdrawal by Subject|0|||
164182093|NCT03307837|593032483|FG002|Overall Study|Withdrawal by Subject|1|||
164182094|NCT03307837|593032484|FG003|Overall Study|Withdrawal by Subject|0|||
164182095|NCT03307837|593032485|FG004|Overall Study|Withdrawal by Subject|0|||
164182096|NCT03307837|593032486|FG005|Overall Study|Withdrawal by Subject|1|||
164182097|NCT03307837|593032481|FG000|Overall Study|Lost to Follow-up|1|||
164182098|NCT03307837|593032482|FG001|Overall Study|Lost to Follow-up|1|||
164182099|NCT03307837|593032483|FG002|Overall Study|Lost to Follow-up|0|||
164182100|NCT03307837|593032484|FG003|Overall Study|Lost to Follow-up|0|||
164182101|NCT03307837|593032485|FG004|Overall Study|Lost to Follow-up|0|||
164182102|NCT03307837|593032486|FG005|Overall Study|Lost to Follow-up|1|||
164182103|NCT01744483|593032487|FG000|Overall Study|Death|9|||
164182104|NCT01744483|593032488|FG001|Overall Study|Death|4|||
164182105|NCT01744483|593032489|FG002|Overall Study|Death|11|||
164182106|NCT01744483|593032487|FG000|Overall Study|Lost to Follow-up|8|||
164182107|NCT01744483|593032488|FG001|Overall Study|Lost to Follow-up|9|||
164182108|NCT01744483|593032489|FG002|Overall Study|Lost to Follow-up|11|||
164182109|NCT01744483|593032487|FG000|Overall Study|Protocol Violation|1|||
164182110|NCT01744483|593032488|FG001|Overall Study|Protocol Violation|2|||
164182111|NCT01744483|593032489|FG002|Overall Study|Protocol Violation|1|||
164182112|NCT01744483|593032487|FG000|Overall Study|Withdrawal by Subject|4|||
164182113|NCT01744483|593032488|FG001|Overall Study|Withdrawal by Subject|6|||
164182114|NCT01744483|593032489|FG002|Overall Study|Withdrawal by Subject|2|||
164182115|NCT01744483|593032487|FG000|Overall Study|No ICU Admit|5|||
164182116|NCT01744483|593032488|FG001|Overall Study|No ICU Admit|1|||
164182117|NCT01744483|593032489|FG002|Overall Study|No ICU Admit|2|||
164182118|NCT01744483|593032487|FG000|Overall Study|Routed to OSH|2|||
164182119|NCT01744483|593032488|FG001|Overall Study|Routed to OSH|0|||
164182120|NCT01744483|593032489|FG002|Overall Study|Routed to OSH|1|||
164182121|NCT03041467|593032490|FG000|Overall Study|Death|46|||
164182122|NCT03041467|593032491|FG001|Overall Study|Death|39|||
164182123|NCT03041467|593032490|FG000|Overall Study|Withdrawal by Subject|36|||
164182124|NCT03041467|593032491|FG001|Overall Study|Withdrawal by Subject|37|||
164182125|NCT03041467|593032490|FG000|Overall Study|Lost to Follow-up|6|||
164182127|NCT03041467|593032490|FG000|Overall Study|Declined consent for study extension|21|||
164182128|NCT03041467|593032491|FG001|Overall Study|Declined consent for study extension|33|||
164182129|NCT03041467|593032490|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
164182130|NCT03041467|593032491|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
164182131|NCT02469168|593032496|FG000|Overall Study|Trial closed|1|||
164182132|NCT02469168|593032497|FG001|Overall Study|Trial closed|0|||
164182133|NCT00298363|593032498|FG000|Overall Study|Lost to Follow-up|0|||
164182134|NCT00298363|593032499|FG001|Overall Study|Lost to Follow-up|0|||
164182135|NCT00298363|593032500|FG002|Overall Study|Lost to Follow-up|1|||
164182136|NCT00298363|593032498|FG000|Overall Study|Physician Decision|4|||
164182137|NCT00298363|593032499|FG001|Overall Study|Physician Decision|1|||
164182138|NCT00298363|593032500|FG002|Overall Study|Physician Decision|0|||
164182139|NCT00298363|593032498|FG000|Overall Study|Protocol Violation|1|||
164182140|NCT00298363|593032499|FG001|Overall Study|Protocol Violation|1|||
164182141|NCT00298363|593032500|FG002|Overall Study|Protocol Violation|0|||
164182142|NCT00298363|593032498|FG000|Overall Study|Withdrawal by Subject|5|||
164182143|NCT00298363|593032499|FG001|Overall Study|Withdrawal by Subject|1|||
164182144|NCT00298363|593032500|FG002|Overall Study|Withdrawal by Subject|3|||
164182145|NCT00298363|593032498|FG000|Overall Study|Adverse Event|5|||
164182146|NCT00298363|593032499|FG001|Overall Study|Adverse Event|2|||
164182147|NCT00298363|593032500|FG002|Overall Study|Adverse Event|2|||
164182148|NCT00298363|593032498|FG000|Overall Study|Lack of Efficacy|2|||
164182149|NCT00298363|593032499|FG001|Overall Study|Lack of Efficacy|3|||
164182150|NCT00298363|593032500|FG002|Overall Study|Lack of Efficacy|0|||
164182151|NCT00135356|593032501|FG000|Overall Study|Adverse Event|6|||
164182152|NCT00135356|593032502|FG001|Overall Study|Adverse Event|2|||
164182153|NCT00135356|593032501|FG000|Overall Study|Lack of Efficacy|2|||
164182154|NCT00135356|593032502|FG001|Overall Study|Lack of Efficacy|0|||
164182155|NCT00135356|593032501|FG000|Overall Study|Lost to Follow-up|3|||
164182156|NCT00135356|593032502|FG001|Overall Study|Lost to Follow-up|1|||
164182157|NCT00135356|593032501|FG000|Overall Study|Surgery for abdominal fat|1|||
164182158|NCT00135356|593032502|FG001|Overall Study|Surgery for abdominal fat|0|||
164182159|NCT00135356|593032501|FG000|Overall Study|Change in antiviral regimen|0|||
164182160|NCT00135356|593032502|FG001|Overall Study|Change in antiviral regimen|1|||
164182161|NCT00135356|593032501|FG000|Overall Study|Poor/noncompliance|1|||
164182162|NCT00135356|593032502|FG001|Overall Study|Poor/noncompliance|1|||
164182163|NCT00135356|593032501|FG000|Overall Study|No longer meets study criteria|2|||
164182164|NCT00135356|593032502|FG001|Overall Study|No longer meets study criteria|0|||
164182165|NCT00135356|593032501|FG000|Overall Study|Withdrawal by Subject|2|||
164182166|NCT00135356|593032502|FG001|Overall Study|Withdrawal by Subject|4|||
164182167|NCT01533688|593032503|FG000|Overall Study|Withdrawal by Subject|5|||
164182168|NCT01533688|593032504|FG001|Overall Study|Withdrawal by Subject|4|||
164182169|NCT01533688|593032505|FG002|Overall Study|Withdrawal by Subject|3|||
164182170|NCT01533688|593032503|FG000|Overall Study|Medically unstable|1|||
164182171|NCT01533688|593032504|FG001|Overall Study|Medically unstable|3|||
164182172|NCT01533688|593032505|FG002|Overall Study|Medically unstable|3|||
164182173|NCT01533688|593032503|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
164182174|NCT01533688|593032504|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
164182175|NCT01533688|593032505|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
164182176|NCT01306214|593032507|FG000|Overall Study|Death|0|||
164182177|NCT01306214|593032508|FG001|Overall Study|Death|0|||
164182178|NCT01306214|593032509|FG002|Overall Study|Death|1|||
164182179|NCT01306214|593032507|FG000|Overall Study|Lost to Follow-up|3|||
164182180|NCT01306214|593032508|FG001|Overall Study|Lost to Follow-up|5|||
164182181|NCT01306214|593032509|FG002|Overall Study|Lost to Follow-up|4|||
164182182|NCT01306214|593032507|FG000|Overall Study|Withdrawal by Subject|24|||
164182183|NCT01306214|593032508|FG001|Overall Study|Withdrawal by Subject|22|||
164182184|NCT01306214|593032509|FG002|Overall Study|Withdrawal by Subject|16|||
164182185|NCT01306214|593032507|FG000|Overall Study|Not treated|1|||
164182186|NCT01306214|593032508|FG001|Overall Study|Not treated|1|||
164182187|NCT01306214|593032509|FG002|Overall Study|Not treated|1|||
164182188|NCT02686814|593032510|FG000|Overall Study|Physician Decision|14|||
164182189|NCT02686814|593032510|FG000|Overall Study|Withdrawal by Subject|4|||
164182190|NCT02686814|593032510|FG000|Overall Study|Death|1|||
164182191|NCT02065518|593032511|FG000|Overall Study|Lost to Follow-up|3|||
164182192|NCT02065518|593032512|FG001|Overall Study|Lost to Follow-up|4|||
164182193|NCT02065518|593032513|FG002|Overall Study|Lost to Follow-up|0|||
164182194|NCT02065518|593032514|FG003|Overall Study|Lost to Follow-up|3|||
164182195|NCT02065518|593032511|FG000|Overall Study|Withdrawal by Subject|3|||
164182196|NCT02065518|593032512|FG001|Overall Study|Withdrawal by Subject|4|||
164182197|NCT02065518|593032513|FG002|Overall Study|Withdrawal by Subject|9|||
164182198|NCT02065518|593032514|FG003|Overall Study|Withdrawal by Subject|2|||
164182199|NCT01090050|593032516|FG000|Overall Study|Lost to Follow-up|0|||
164182200|NCT01090050|593032517|FG001|Overall Study|Lost to Follow-up|1|||
164182201|NCT01090050|593032516|FG000|Overall Study|Lack of Efficacy|1|||
164182202|NCT01090050|593032517|FG001|Overall Study|Lack of Efficacy|5|||
164182203|NCT01090050|593032516|FG000|Overall Study|Physician Decision|0|||
164182204|NCT01090050|593032517|FG001|Overall Study|Physician Decision|1|||
164182205|NCT03624569|593032519|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
164182206|NCT03624569|593032520|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
164182207|NCT03624569|593032519|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
164182208|NCT03624569|593032520|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
164182209|NCT01464619|593032559|FG000|Overall Study|Lost to Follow-up|3|||
164182210|NCT01464619|593032560|FG001|Overall Study|Lost to Follow-up|4|||
164182211|NCT03411902|593032561|FG000|Overall Study|Lost to Follow-up|3|||
164182212|NCT03411902|593032562|FG001|Overall Study|Lost to Follow-up|0|||
164182213|NCT01693185|593032565|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
164182214|NCT01693185|593032566|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
164182215|NCT00419159|593032567|FG000|Overall Study|Adverse Event|7|||
164182216|NCT00419159|593032568|FG001|Overall Study|Adverse Event|15|||
164182217|NCT00419159|593032567|FG000|Overall Study|Abnormal laboratory value(s)|0|||
164182218|NCT00419159|593032568|FG001|Overall Study|Abnormal laboratory value(s)|2|||
164182219|NCT00419159|593032567|FG000|Overall Study|Subject's no longer requires study drug|0|||
164182220|NCT00419159|593032568|FG001|Overall Study|Subject's no longer requires study drug|1|||
164182221|NCT00419159|593032567|FG000|Overall Study|Protocol Violation|1|||
164182222|NCT00419159|593032568|FG001|Overall Study|Protocol Violation|0|||
164182223|NCT00419159|593032567|FG000|Overall Study|Withdrawal by Subject|10|||
164182224|NCT00419159|593032568|FG001|Overall Study|Withdrawal by Subject|3|||
164182225|NCT00419159|593032567|FG000|Overall Study|Lost to Follow-up|0|||
164182226|NCT00419159|593032568|FG001|Overall Study|Lost to Follow-up|1|||
164182227|NCT00419159|593032567|FG000|Overall Study|Death|2|||
164182228|NCT00419159|593032568|FG001|Overall Study|Death|2|||
164182229|NCT00419159|593032567|FG000|Overall Study|Disease progression|79|||
164182230|NCT00419159|593032568|FG001|Overall Study|Disease progression|76|||
164182231|NCT01017601|593032569|FG000|Overall Study|Disease Progression|12|||
164182232|NCT01017601|593032570|FG001|Overall Study|Disease Progression|12|||
164182233|NCT01017601|593032569|FG000|Overall Study|Withdrawal by Subject|0|||
164182234|NCT01017601|593032570|FG001|Overall Study|Withdrawal by Subject|1|||
164182235|NCT01857102|593032572|FG000|Period 1|No longer meets Eligibility Criteria|0|||
164182236|NCT01857102|593032573|FG001|Period 1|No longer meets Eligibility Criteria|2|||
164182237|NCT01857102|593032572|FG000|Period 1|Lost to Follow-up|0|||
164182238|NCT01857102|593032573|FG001|Period 1|Lost to Follow-up|3|||
164182239|NCT01857102|593032572|FG000|Period 1|Unsatisfactory Lens Fit|1|||
164182240|NCT01857102|593032573|FG001|Period 1|Unsatisfactory Lens Fit|0|||
164182241|NCT01857102|593032572|FG000|Period 1|Unsatisfactory Visual Response|1|||
164182242|NCT01857102|593032573|FG001|Period 1|Unsatisfactory Visual Response|0|||
164182243|NCT01857102|593032572|FG000|Period 1|Physician Decision|1|||
164182244|NCT01857102|593032573|FG001|Period 1|Physician Decision|0|||
164182245|NCT01857102|593032572|FG000|Period 2|Lens Discomfort|1|||
164182246|NCT01857102|593032573|FG001|Period 2|Lens Discomfort|0|||
164182247|NCT01857102|593032572|FG000|Period 2|Unsatisfactory Lens Fit|1|||
164182248|NCT01857102|593032573|FG001|Period 2|Unsatisfactory Lens Fit|0|||
164182249|NCT02735096|593032578|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
164182250|NCT01080391|593032589|FG000|Overall Study|Randomized but not treated|7|||
164182251|NCT01080391|593032590|FG001|Overall Study|Randomized but not treated|4|||
164182252|NCT02083653|593032598|FG000|Overall Study|Randomized but not Treated|0|||
164182253|NCT02083653|593032599|FG001|Overall Study|Randomized but not Treated|2|||
164182254|NCT02083653|593032600|FG002|Overall Study|Randomized but not Treated|7|||
164182255|NCT02083653|593032598|FG000|Overall Study|Adverse Event|12|||
164182256|NCT02083653|593032599|FG001|Overall Study|Adverse Event|5|||
164182257|NCT02083653|593032600|FG002|Overall Study|Adverse Event|4|||
164182258|NCT02083653|593032598|FG000|Overall Study|Lost to Follow-up|1|||
164182259|NCT02083653|593032599|FG001|Overall Study|Lost to Follow-up|0|||
164182260|NCT02083653|593032600|FG002|Overall Study|Lost to Follow-up|0|||
164182261|NCT02083653|593032598|FG000|Overall Study|Death|2|||
164182262|NCT02083653|593032599|FG001|Overall Study|Death|2|||
164182263|NCT02083653|593032600|FG002|Overall Study|Death|2|||
164182264|NCT02083653|593032598|FG000|Overall Study|Progressive Disease|65|||
164182265|NCT02083653|593032599|FG001|Overall Study|Progressive Disease|73|||
164182266|NCT02083653|593032600|FG002|Overall Study|Progressive Disease|63|||
164182267|NCT02083653|593032598|FG000|Overall Study|Withdrawal by Subject|2|||
164182268|NCT02083653|593032599|FG001|Overall Study|Withdrawal by Subject|1|||
164182269|NCT02083653|593032600|FG002|Overall Study|Withdrawal by Subject|2|||
164182270|NCT02083653|593032598|FG000|Overall Study|Other Events|0|||
164182271|NCT02083653|593032599|FG001|Overall Study|Other Events|2|||
164182272|NCT02083653|593032600|FG002|Overall Study|Other Events|2|||
164182273|NCT02083653|593032598|FG000|Overall Study|Reason Missing|0|||
164182274|NCT02083653|593032599|FG001|Overall Study|Reason Missing|0|||
164182275|NCT02083653|593032600|FG002|Overall Study|Reason Missing|4|||
164182276|NCT02073656|593032601|FG000|Primary Study|Lost to Follow-up|6|||
164182277|NCT02073656|593032601|FG000|Primary Study|Death|1|||
164182278|NCT02073656|593032601|FG000|Primary Study|Withdrew Consent|1|||
164182279|NCT02536781|593032605|FG000|Overall Study|Lost to Follow-up|2|||
164182280|NCT02536781|593032606|FG001|Overall Study|Lost to Follow-up|0|||
164182281|NCT03423147|593032607|FG000|Overall Study|Lost to Follow-up|5|||
164182282|NCT03423147|593032608|FG001|Overall Study|Lost to Follow-up|8|||
164182283|NCT03423147|593032607|FG000|Overall Study|Withdrawal by Subject|1|||
164182284|NCT03423147|593032608|FG001|Overall Study|Withdrawal by Subject|0|||
164182285|NCT03423147|593032607|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
164182286|NCT03423147|593032608|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
164182287|NCT03423147|593032607|FG000|Overall Study|Age < 18|1|||
164182288|NCT03423147|593032608|FG001|Overall Study|Age < 18|0|||
164182289|NCT03423147|593032607|FG000|Overall Study|No Trial of Labor|0|||
164182290|NCT03423147|593032608|FG001|Overall Study|No Trial of Labor|1|||
164182291|NCT01048099|593032609|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
164182292|NCT01048099|593032609|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
164182293|NCT01731470|593032611|FG000|Overall Study|Withdrawal by Subject|1|||
164182294|NCT01731470|593032611|FG000|Overall Study|Did not meet study criteria|1|||
164182295|NCT02450552|593032615|FG000|Overall Study|Withdrawal by Subject|4|||
164182296|NCT02450552|593032616|FG001|Overall Study|Withdrawal by Subject|0|||
164182297|NCT02450552|593032617|FG002|Overall Study|Withdrawal by Subject|4|||
164182298|NCT02450552|593032615|FG000|Overall Study|Physician Decision|1|||
164182299|NCT02450552|593032616|FG001|Overall Study|Physician Decision|0|||
164182300|NCT02450552|593032617|FG002|Overall Study|Physician Decision|1|||
164182301|NCT01524783|593032618|FG000|Blinded Period|Adverse Event|64|||
164182302|NCT01524783|593032619|FG001|Blinded Period|Adverse Event|7|||
164182303|NCT01524783|593032620|FG002|Blinded Period|Adverse Event|0|||
164182304|NCT01524783|593032618|FG000|Blinded Period|Disease Progression|89|||
164182305|NCT01524783|593032619|FG001|Blinded Period|Disease Progression|75|||
164182306|NCT01524783|593032620|FG002|Blinded Period|Disease Progression|0|||
164182307|NCT01524783|593032618|FG000|Blinded Period|Withdrawal by Subject|19|||
164182308|NCT01524783|593032619|FG001|Blinded Period|Withdrawal by Subject|6|||
164182309|NCT01524783|593032620|FG002|Blinded Period|Withdrawal by Subject|0|||
164182310|NCT01524783|593032618|FG000|Blinded Period|Protocol deviation|2|||
164182311|NCT01524783|593032619|FG001|Blinded Period|Protocol deviation|1|||
164182312|NCT01524783|593032620|FG002|Blinded Period|Protocol deviation|0|||
164182313|NCT01524783|593032618|FG000|Blinded Period|Death|5|||
164182314|NCT01524783|593032619|FG001|Blinded Period|Death|2|||
164182315|NCT01524783|593032620|FG002|Blinded Period|Death|0|||
164182316|NCT01524783|593032618|FG000|Open-label Period|Disease progression|13|||
164182317|NCT01524783|593032619|FG001|Open-label Period|Disease progression|0|||
164182318|NCT01524783|593032620|FG002|Open-label Period|Disease progression|2|||
164182319|NCT01524783|593032618|FG000|Open-label Period|Administrative problems|5|||
164182320|NCT01524783|593032619|FG001|Open-label Period|Administrative problems|0|||
164182321|NCT01524783|593032620|FG002|Open-label Period|Administrative problems|2|||
164182322|NCT01524783|593032618|FG000|Open-label Period|Adverse Event|5|||
164182323|NCT01524783|593032619|FG001|Open-label Period|Adverse Event|0|||
164182324|NCT01524783|593032620|FG002|Open-label Period|Adverse Event|1|||
164182325|NCT01524783|593032618|FG000|Open-label Period|Withdrawal by Subject|2|||
164182326|NCT01524783|593032619|FG001|Open-label Period|Withdrawal by Subject|0|||
164182327|NCT01524783|593032620|FG002|Open-label Period|Withdrawal by Subject|1|||
164182328|NCT01524783|593032618|FG000|Open-label Period|Protocol deviation|1|||
164182329|NCT01524783|593032619|FG001|Open-label Period|Protocol deviation|0|||
164182330|NCT01524783|593032620|FG002|Open-label Period|Protocol deviation|0|||
164182331|NCT01625689|593032621|FG000|Overall Study|Migration|2|||
164182332|NCT01625689|593032622|FG001|Overall Study|Migration|1|||
164182333|NCT03723070|593032627|FG000|Overall Study|Lost to Follow-up|2|||
164182334|NCT03723070|593032627|FG000|Overall Study|Physician Decision|1|||
164182335|NCT03723070|593032627|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
164182336|NCT02208050|593032628|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
164182337|NCT02208050|593032629|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
164182338|NCT00721279|593032633|FG000|Overall Study|Lack of Efficacy|6|||
164182339|NCT00721279|593032634|FG001|Overall Study|Lack of Efficacy|3|||
164182340|NCT00721279|593032633|FG000|Overall Study|Tolerability insufficient|5|||
164182341|NCT00721279|593032634|FG001|Overall Study|Tolerability insufficient|2|||
164182342|NCT00721279|593032633|FG000|Overall Study|Withdrawal by Subject|13|||
164182343|NCT00721279|593032634|FG001|Overall Study|Withdrawal by Subject|3|||
164182344|NCT00721279|593032633|FG000|Overall Study|Other|12|||
164182345|NCT00721279|593032634|FG001|Overall Study|Other|16|||
164182346|NCT05153148|593032635|FG000|Overall Study|Adverse Event|1|||
164182347|NCT05153148|593032636|FG001|Overall Study|Adverse Event|0|||
164182348|NCT05153148|593032637|FG002|Overall Study|Adverse Event|3|||
164182349|NCT05153148|593032638|FG003|Overall Study|Adverse Event|5|||
164182350|NCT05153148|593032635|FG000|Overall Study|Lost to Follow-up|1|||
164182351|NCT05153148|593032636|FG001|Overall Study|Lost to Follow-up|1|||
164182352|NCT05153148|593032637|FG002|Overall Study|Lost to Follow-up|2|||
164182353|NCT05153148|593032638|FG003|Overall Study|Lost to Follow-up|0|||
164182354|NCT05153148|593032635|FG000|Overall Study|Withdrawal by Subject|6|||
164182355|NCT05153148|593032636|FG001|Overall Study|Withdrawal by Subject|8|||
164182356|NCT05153148|593032637|FG002|Overall Study|Withdrawal by Subject|6|||
164182357|NCT05153148|593032638|FG003|Overall Study|Withdrawal by Subject|8|||
164182358|NCT05153148|593032635|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
164182359|NCT05153148|593032636|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
164182360|NCT05153148|593032637|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
164182361|NCT05153148|593032638|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
164182362|NCT05153148|593032635|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
164182363|NCT05153148|593032636|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
164182364|NCT05153148|593032637|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
164182365|NCT05153148|593032638|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
164182366|NCT05153148|593032635|FG000|Overall Study|Reason not Specified|1|||
164182367|NCT05153148|593032636|FG001|Overall Study|Reason not Specified|1|||
164182368|NCT05153148|593032637|FG002|Overall Study|Reason not Specified|1|||
164182369|NCT05153148|593032638|FG003|Overall Study|Reason not Specified|1|||
164182370|NCT01732471|593032639|FG000|Overall Study|Withdrawal by Subject|1|||
164182371|NCT04494425|593034190|FG000|Overall Study|Death|160|||
164182372|NCT04494425|593034191|FG001|Overall Study|Death|166|||
164182373|NCT04494425|593034190|FG000|Overall Study|Withdrawal by Subject|10|||
164182374|NCT04494425|593034191|FG001|Overall Study|Withdrawal by Subject|40|||
164182375|NCT04494425|593034190|FG000|Overall Study|Other|1|||
164182376|NCT04494425|593034191|FG001|Overall Study|Other|1|||
164182377|NCT04494425|593034190|FG000|Overall Study|Ongoing at the time of PCD|265|||
164182378|NCT04494425|593034191|FG001|Overall Study|Ongoing at the time of PCD|223|||
164182379|NCT01270321|593034193|FG000|Overall Study|Death|3|||
164182380|NCT01270321|593034194|FG001|Overall Study|Death|1|||
164182381|NCT01270321|593034195|FG002|Overall Study|Death|4|||
164182382|NCT01270321|593034193|FG000|Overall Study|Adverse Event|7|||
164182383|NCT01270321|593034194|FG001|Overall Study|Adverse Event|9|||
164182384|NCT01270321|593034195|FG002|Overall Study|Adverse Event|5|||
164182385|NCT04003623|593034199|FG000|Overall Study|Withdrawal by Subject|1|||
164182386|NCT04003623|593034200|FG001|Overall Study|Withdrawal by Subject|0|||
164182387|NCT01190189|593034204|FG000|Overall Study|Lost to Follow-up|4|||
164182388|NCT01190189|593034204|FG000|Overall Study|Withdrawal by Subject|1|||
164182389|NCT01190189|593034204|FG000|Overall Study|Migrated/moved from study area|1|||
164182390|NCT00762034|593034208|FG000|Induction Period|Protocol Violation|1|||
164182391|NCT00762034|593034209|FG001|Induction Period|Protocol Violation|2|||
164182392|NCT00762034|593034208|FG000|Induction Period|Entry Criterion Not Met|12|||
164182393|NCT00762034|593034209|FG001|Induction Period|Entry Criterion Not Met|11|||
164182394|NCT00762034|593034208|FG000|Induction Period|Adverse Event|27|||
164182395|NCT00762034|593034209|FG001|Induction Period|Adverse Event|38|||
164182396|NCT00762034|593034208|FG000|Induction Period|Lost to Follow-up|1|||
164182397|NCT00762034|593034209|FG001|Induction Period|Lost to Follow-up|1|||
164182398|NCT00762034|593034208|FG000|Induction Period|Progressive Disease|73|||
164182399|NCT00762034|593034209|FG001|Induction Period|Progressive Disease|55|||
164182400|NCT00762034|593034208|FG000|Induction Period|Physician Decision|21|||
164182401|NCT00762034|593034209|FG001|Induction Period|Physician Decision|20|||
164182402|NCT00762034|593034208|FG000|Induction Period|Withdrawal by Subject|15|||
164182403|NCT00762034|593034209|FG001|Induction Period|Withdrawal by Subject|19|||
164182404|NCT00762034|593034208|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
164182405|NCT00762034|593034209|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
164182406|NCT00762034|593034208|FG000|Induction Period|Deaths Due to Study Disease|9|||
164182407|NCT00762034|593034209|FG001|Induction Period|Deaths Due to Study Disease|9|||
164182408|NCT00762034|593034208|FG000|Maintenance Period|Protocol Violation|1|||
164182409|NCT00762034|593034209|FG001|Maintenance Period|Protocol Violation|3|||
164182410|NCT00762034|593034208|FG000|Maintenance Period|Entry Criterion Not Met|0|||
164182411|NCT00762034|593034209|FG001|Maintenance Period|Entry Criterion Not Met|2|||
164182412|NCT00762034|593034208|FG000|Maintenance Period|Adverse Event|42|||
164182413|NCT00762034|593034209|FG001|Maintenance Period|Adverse Event|26|||
164182414|NCT00762034|593034208|FG000|Maintenance Period|Progressive Disease|186|||
164182415|NCT00762034|593034209|FG001|Maintenance Period|Progressive Disease|224|||
164182416|NCT00762034|593034208|FG000|Maintenance Period|Physician Decision|25|||
164182417|NCT00762034|593034209|FG001|Maintenance Period|Physician Decision|20|||
164182418|NCT00762034|593034208|FG000|Maintenance Period|Withdrawal by Subject|34|||
164182419|NCT00762034|593034209|FG001|Maintenance Period|Withdrawal by Subject|14|||
164182420|NCT00762034|593034208|FG000|Maintenance Period|Death not due to study disease|2|||
164182421|NCT00762034|593034209|FG001|Maintenance Period|Death not due to study disease|5|||
164182422|NCT00762034|593034208|FG000|Maintenance Period|Death due to study disease|3|||
164182423|NCT00762034|593034209|FG001|Maintenance Period|Death due to study disease|3|||
164182424|NCT00762034|593034208|FG000|Maintenance Period|Other|1|||
164182425|NCT00762034|593034209|FG001|Maintenance Period|Other|1|||
164182426|NCT00734656|593034210|FG000|Lab Session 1|Withdrawal by Subject|2|||
164182427|NCT00734656|593034211|FG001|Lab Session 1|Withdrawal by Subject|0|||
164182428|NCT00734656|593034212|FG002|Lab Session 1|Withdrawal by Subject|0|||
164182429|NCT00734656|593034213|FG003|Lab Session 1|Withdrawal by Subject|0|||
164182430|NCT00734656|593034210|FG000|Washout 1|Withdrawal by Subject|1|||
164182431|NCT00734656|593034211|FG001|Washout 1|Withdrawal by Subject|5|||
164182432|NCT00734656|593034212|FG002|Washout 1|Withdrawal by Subject|2|||
164182433|NCT00734656|593034213|FG003|Washout 1|Withdrawal by Subject|3|||
164182434|NCT00734656|593034210|FG000|Lab Session 2|Withdrawal by Subject|1|||
164182435|NCT00734656|593034211|FG001|Lab Session 2|Withdrawal by Subject|0|||
164182436|NCT00734656|593034212|FG002|Lab Session 2|Withdrawal by Subject|0|||
164182437|NCT00734656|593034213|FG003|Lab Session 2|Withdrawal by Subject|1|||
164182438|NCT00734656|593034210|FG000|Washout 2|Withdrawal by Subject|1|||
164182439|NCT00734656|593034211|FG001|Washout 2|Withdrawal by Subject|1|||
164182440|NCT00734656|593034212|FG002|Washout 2|Withdrawal by Subject|1|||
164182441|NCT00734656|593034213|FG003|Washout 2|Withdrawal by Subject|0|||
164182442|NCT00734656|593034210|FG000|Washout 3|Withdrawal by Subject|1|||
164182443|NCT00734656|593034211|FG001|Washout 3|Withdrawal by Subject|0|||
164182444|NCT00734656|593034212|FG002|Washout 3|Withdrawal by Subject|0|||
164182445|NCT00734656|593034213|FG003|Washout 3|Withdrawal by Subject|1|||
164182446|NCT00734656|593034210|FG000|Lab Session 4|Withdrawal by Subject|0|||
164182447|NCT00734656|593034211|FG001|Lab Session 4|Withdrawal by Subject|0|||
164182448|NCT00734656|593034212|FG002|Lab Session 4|Withdrawal by Subject|0|||
164182449|NCT00734656|593034213|FG003|Lab Session 4|Withdrawal by Subject|1|||
164182450|NCT03214679|593034216|FG000|Overall Study|Lost to Follow-up|12|||
164182451|NCT03214679|593034217|FG001|Overall Study|Lost to Follow-up|14|||
164182452|NCT03214679|593034216|FG000|Overall Study|not eligible|2|||
164182453|NCT03214679|593034217|FG001|Overall Study|not eligible|0|||
164182454|NCT01754766|593034225|FG000|Overall Study|Personal reasons|1|||
164182455|NCT01754766|593034226|FG001|Overall Study|Personal reasons|1|||
164182456|NCT01754766|593034227|FG002|Overall Study|Personal reasons|0|||
164182457|NCT01709409|593034230|FG000|Overall Study|Protocol Violation|1|||
164182458|NCT01709409|593034231|FG001|Overall Study|Protocol Violation|0|||
164182459|NCT02412878|593034232|FG000|Overall Study|Withdrawal by Subject|19|||
164182460|NCT02412878|593034233|FG001|Overall Study|Withdrawal by Subject|10|||
164182461|NCT02412878|593034232|FG000|Overall Study|Lost to Follow-up|2|||
164182462|NCT02412878|593034233|FG001|Overall Study|Lost to Follow-up|3|||
164182463|NCT04571385|593034234|FG000|Overall Study|Participant non-compliance|1|||
164182464|NCT04571385|593034235|FG001|Overall Study|Participant non-compliance|0|||
164182465|NCT04571385|593034236|FG002|Overall Study|Participant non-compliance|0|||
164182466|NCT04571385|593034234|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
164182467|NCT04571385|593034235|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
164182468|NCT04571385|593034236|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
164182469|NCT04571385|593034234|FG000|Overall Study|Screen failure|0|||
164182470|NCT04571385|593034235|FG001|Overall Study|Screen failure|0|||
164182471|NCT04571385|593034236|FG002|Overall Study|Screen failure|1|||
164182472|NCT04676152|593034237|FG000|Overall Study|screen fail|9|||
164182473|NCT01928199|593034240|FG000|Overall Study|Lost to Follow-up|2|||
164182474|NCT01928199|593034241|FG001|Overall Study|Lost to Follow-up|1|||
164182475|NCT01928199|593034240|FG000|Overall Study|Withdrawal by Subject|3|||
164182476|NCT01928199|593034241|FG001|Overall Study|Withdrawal by Subject|5|||
164182477|NCT00571103|593034243|FG000|Overall Study|Withdrawal by Subject|1|||
164182478|NCT00571103|593034243|FG000|Overall Study|Lost to Follow-up|1|||
164182479|NCT02368886|593034244|FG000|Overall Study|Cancel|1|||
164182480|NCT02368886|593034245|FG001|Overall Study|Cancel|1|||
164182481|NCT02368886|593034246|FG002|Overall Study|Cancel|1|||
164182482|NCT02368886|593034247|FG003|Overall Study|Cancel|3|||
164182483|NCT02368886|593034244|FG000|Overall Study|Ineligible|0|||
164182484|NCT02368886|593034245|FG001|Overall Study|Ineligible|0|||
164182485|NCT02368886|593034246|FG002|Overall Study|Ineligible|0|||
164182486|NCT02368886|593034247|FG003|Overall Study|Ineligible|1|||
164182487|NCT04278924|593034249|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
164182488|NCT04278924|593034250|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
164182489|NCT04278924|593034251|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
164182490|NCT04278924|593034252|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
164182491|NCT04278924|593034253|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
164182492|NCT04278924|593034254|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
164182493|NCT04278924|593034255|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
164182494|NCT04278924|593034249|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
164182495|NCT04278924|593034250|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
164182496|NCT04278924|593034251|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
164182497|NCT04278924|593034252|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
164182498|NCT04278924|593034253|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
164182499|NCT04278924|593034254|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
164182500|NCT04278924|593034255|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
164182501|NCT04767529|593034256|FG000|Overall Study|Adverse Event|0|||
164182502|NCT04767529|593034257|FG001|Overall Study|Adverse Event|4|||
164182503|NCT04767529|593034258|FG002|Overall Study|Adverse Event|3|||
164182504|NCT04767529|593034256|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
164182505|NCT04767529|593034257|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
164182506|NCT04767529|593034258|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
164182507|NCT04767529|593034256|FG000|Overall Study|Required use of a prohibited medication|0|||
164182508|NCT04767529|593034257|FG001|Overall Study|Required use of a prohibited medication|1|||
164182509|NCT04767529|593034258|FG002|Overall Study|Required use of a prohibited medication|0|||
164182510|NCT04767529|593034256|FG000|Overall Study|Withdrawal by Subject|7|||
164182511|NCT04767529|593034257|FG001|Overall Study|Withdrawal by Subject|5|||
164182512|NCT04767529|593034258|FG002|Overall Study|Withdrawal by Subject|4|||
164182513|NCT04767529|593034256|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
164182514|NCT04767529|593034257|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
164182515|NCT04767529|593034258|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
164182516|NCT04767529|593034256|FG000|Overall Study|Lost to Follow-up|0|||
164182517|NCT04767529|593034257|FG001|Overall Study|Lost to Follow-up|2|||
164182518|NCT04767529|593034258|FG002|Overall Study|Lost to Follow-up|3|||
164182519|NCT04847232|593034259|FG000|Overall Study|Death|123|||
164182520|NCT04847232|593034260|FG001|Overall Study|Death|115|||
164182521|NCT04847232|593034259|FG000|Overall Study|Lost to Follow-up|3|||
164182522|NCT04847232|593034260|FG001|Overall Study|Lost to Follow-up|10|||
164182523|NCT04847232|593034259|FG000|Overall Study|Withdrawal by Subject|73|||
164182524|NCT04847232|593034260|FG001|Overall Study|Withdrawal by Subject|101|||
164182525|NCT04847232|593034259|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
164182526|NCT04847232|593034260|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
164182527|NCT02476916|593034261|FG000|Core Period|Adverse Event|2|||
164182528|NCT02476916|593034262|FG001|Core Period|Adverse Event|2|||
164182529|NCT02476916|593034261|FG000|Core Period|Investigator decision|1|||
164182530|NCT02476916|593034262|FG001|Core Period|Investigator decision|1|||
164182531|NCT02476916|593034261|FG000|Core Period|Withdrawal by Subject|3|||
164182532|NCT02476916|593034262|FG001|Core Period|Withdrawal by Subject|0|||
164182533|NCT02476916|593034261|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
164182534|NCT02476916|593034262|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
164182535|NCT02476916|593034261|FG000|Extension Period|On Treatment|12|||
164182536|NCT02476916|593034262|FG001|Extension Period|On Treatment|17|||
164182537|NCT06010732|593034263|FG000|Crossover Period 1|Protocol Violation|0|||
164182538|NCT06010732|593034264|FG001|Crossover Period 1|Protocol Violation|0|||
164182539|NCT06010732|593034265|FG002|Crossover Period 1|Protocol Violation|1|||
164182540|NCT06010732|593034266|FG003|Crossover Period 1|Protocol Violation|0|||
164182541|NCT06010732|593034267|FG004|Crossover Period 1|Protocol Violation|1|||
164182542|NCT06010732|593034268|FG005|Crossover Period 1|Protocol Violation|0|||
164182543|NCT06010732|593034263|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
164182544|NCT06010732|593034264|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
164182545|NCT06010732|593034265|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
164182546|NCT06010732|593034266|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
164182547|NCT06010732|593034267|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
164182548|NCT06010732|593034268|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
164182549|NCT06010732|593034263|FG000|Crossover Period 2|Adverse Event|0|||
164182550|NCT06010732|593034264|FG001|Crossover Period 2|Adverse Event|1|||
164182551|NCT06010732|593034265|FG002|Crossover Period 2|Adverse Event|0|||
164182552|NCT06010732|593034266|FG003|Crossover Period 2|Adverse Event|0|||
164182553|NCT06010732|593034267|FG004|Crossover Period 2|Adverse Event|0|||
164182554|NCT06010732|593034268|FG005|Crossover Period 2|Adverse Event|0|||
164182555|NCT06010732|593034263|FG000|Crossover Period 2|broken denture|0|||
164182556|NCT06010732|593034264|FG001|Crossover Period 2|broken denture|0|||
164182557|NCT06010732|593034265|FG002|Crossover Period 2|broken denture|1|||
164182558|NCT06010732|593034266|FG003|Crossover Period 2|broken denture|0|||
164182559|NCT06010732|593034267|FG004|Crossover Period 2|broken denture|0|||
164182560|NCT06010732|593034268|FG005|Crossover Period 2|broken denture|0|||
164182561|NCT00253370|593034270|FG000|Overall Study|Adverse Event|18|||
164182562|NCT00253370|593034270|FG000|Overall Study|Disease progression|13|||
164182563|NCT00253370|593034270|FG000|Overall Study|Death|2|||
164182564|NCT00253370|593034270|FG000|Overall Study|Withdrawal by Subject|6|||
164182565|NCT00253370|593034270|FG000|Overall Study|Non-protocol therapy|1|||
164182566|NCT00253370|593034270|FG000|Overall Study|Physician Decision|1|||
164182567|NCT00253370|593034270|FG000|Overall Study|Protocol Violation|1|||
164182568|NCT00253370|593034270|FG000|Overall Study|Abdominal pain due to disease|1|||
164182569|NCT03699540|593034271|FG000|Overall Study|Lost to Follow-up|1|||
164182570|NCT02697591|593034272|FG000|Overall Study|Lost to Follow-up|0|||
164182571|NCT02697591|593034273|FG001|Overall Study|Lost to Follow-up|0|||
164182572|NCT02697591|593034274|FG002|Overall Study|Lost to Follow-up|0|||
164182573|NCT02697591|593034275|FG003|Overall Study|Lost to Follow-up|0|||
164182574|NCT02697591|593034276|FG004|Overall Study|Lost to Follow-up|0|||
164182575|NCT02697591|593034277|FG005|Overall Study|Lost to Follow-up|1|||
164182576|NCT02697591|593034278|FG006|Overall Study|Lost to Follow-up|1|||
164182577|NCT02697591|593034279|FG007|Overall Study|Lost to Follow-up|0|||
164182578|NCT02697591|593034280|FG008|Overall Study|Lost to Follow-up|0|||
164182579|NCT02697591|593034281|FG009|Overall Study|Lost to Follow-up|1|||
164182580|NCT02697591|593034272|FG000|Overall Study|Withdrawal by Subject|1|||
164182581|NCT02697591|593034273|FG001|Overall Study|Withdrawal by Subject|1|||
164182582|NCT02697591|593034274|FG002|Overall Study|Withdrawal by Subject|2|||
164182583|NCT02697591|593034275|FG003|Overall Study|Withdrawal by Subject|1|||
164182584|NCT02697591|593034276|FG004|Overall Study|Withdrawal by Subject|7|||
164182585|NCT02697591|593034277|FG005|Overall Study|Withdrawal by Subject|6|||
164182586|NCT02697591|593034278|FG006|Overall Study|Withdrawal by Subject|9|||
164182587|NCT02697591|593034279|FG007|Overall Study|Withdrawal by Subject|1|||
164182588|NCT02697591|593034280|FG008|Overall Study|Withdrawal by Subject|6|||
164182589|NCT02697591|593034281|FG009|Overall Study|Withdrawal by Subject|10|||
164182590|NCT02697591|593034272|FG000|Overall Study|Physician Decision|1|||
164182591|NCT02697591|593034273|FG001|Overall Study|Physician Decision|0|||
164182592|NCT02697591|593034274|FG002|Overall Study|Physician Decision|0|||
164182593|NCT02697591|593034275|FG003|Overall Study|Physician Decision|0|||
164182594|NCT02697591|593034276|FG004|Overall Study|Physician Decision|1|||
164182595|NCT02697591|593034277|FG005|Overall Study|Physician Decision|2|||
164182596|NCT02697591|593034278|FG006|Overall Study|Physician Decision|0|||
164182597|NCT02697591|593034279|FG007|Overall Study|Physician Decision|0|||
164182598|NCT02697591|593034280|FG008|Overall Study|Physician Decision|1|||
164182599|NCT02697591|593034281|FG009|Overall Study|Physician Decision|1|||
164182600|NCT02697591|593034272|FG000|Overall Study|Death|2|||
164182601|NCT02697591|593034273|FG001|Overall Study|Death|3|||
164182602|NCT02697591|593034274|FG002|Overall Study|Death|1|||
164182603|NCT02697591|593034275|FG003|Overall Study|Death|1|||
164182604|NCT02697591|593034276|FG004|Overall Study|Death|4|||
164182605|NCT02697591|593034277|FG005|Overall Study|Death|5|||
164182606|NCT02697591|593034278|FG006|Overall Study|Death|3|||
164182607|NCT02697591|593034279|FG007|Overall Study|Death|1|||
164182608|NCT02697591|593034280|FG008|Overall Study|Death|1|||
164182609|NCT02697591|593034281|FG009|Overall Study|Death|5|||
164182610|NCT02697591|593034272|FG000|Overall Study|Reason not Specified|0|||
164182611|NCT02697591|593034273|FG001|Overall Study|Reason not Specified|0|||
164182612|NCT02697591|593034274|FG002|Overall Study|Reason not Specified|0|||
164182613|NCT02697591|593034275|FG003|Overall Study|Reason not Specified|1|||
164182614|NCT02697591|593034276|FG004|Overall Study|Reason not Specified|1|||
164182615|NCT02697591|593034277|FG005|Overall Study|Reason not Specified|2|||
164182616|NCT02697591|593034278|FG006|Overall Study|Reason not Specified|3|||
164182617|NCT02697591|593034279|FG007|Overall Study|Reason not Specified|1|||
164182618|NCT02697591|593034280|FG008|Overall Study|Reason not Specified|1|||
164182619|NCT02697591|593034281|FG009|Overall Study|Reason not Specified|3|||
164182620|NCT02636699|593034282|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
164182621|NCT02636699|593034283|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
164182622|NCT02636699|593034284|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
164182623|NCT02636699|593034282|FG000|Screening Period|Withdrawal by Subject|0|||
164182624|NCT02636699|593034283|FG001|Screening Period|Withdrawal by Subject|0|||
164182625|NCT02636699|593034284|FG002|Screening Period|Withdrawal by Subject|23|||
164182626|NCT02636699|593034282|FG000|Screening Period|Adverse Event|0|||
164182627|NCT02636699|593034283|FG001|Screening Period|Adverse Event|0|||
164182628|NCT02636699|593034284|FG002|Screening Period|Adverse Event|1|||
164182629|NCT02636699|593034282|FG000|Screening Period|Other not specified|0|||
164182630|NCT02636699|593034283|FG001|Screening Period|Other not specified|0|||
164182631|NCT02636699|593034284|FG002|Screening Period|Other not specified|3|||
164182632|NCT02636699|593034282|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
164182633|NCT02636699|593034283|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
164182634|NCT02636699|593034284|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
164182635|NCT02636699|593034282|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
164182636|NCT02636699|593034283|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
164182637|NCT02636699|593034284|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
164182638|NCT02636699|593034282|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
164182639|NCT02636699|593034283|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
164182640|NCT02636699|593034284|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
164182641|NCT02636699|593034282|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
164182642|NCT02636699|593034283|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
164182643|NCT02636699|593034284|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
164182644|NCT02636699|593034282|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
164182645|NCT02636699|593034283|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
164182646|NCT02636699|593034284|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
164182647|NCT02636699|593034282|FG000|Treatment and Follow-up Periods|Other|3|||
164182648|NCT02636699|593034283|FG001|Treatment and Follow-up Periods|Other|1|||
164182649|NCT02636699|593034284|FG002|Treatment and Follow-up Periods|Other|0|||
164182650|NCT00624832|593034285|FG000|Overall Study|Adverse Event|0|||
164182651|NCT00624832|593034286|FG001|Overall Study|Adverse Event|1|||
164182652|NCT00624832|593034287|FG002|Overall Study|Adverse Event|0|||
164182653|NCT00624832|593034288|FG003|Overall Study|Adverse Event|1|||
164182654|NCT00624832|593034285|FG000|Overall Study|Abnormal Laboratory Value|2|||
164182655|NCT00624832|593034286|FG001|Overall Study|Abnormal Laboratory Value|0|||
164182656|NCT00624832|593034287|FG002|Overall Study|Abnormal Laboratory Value|0|||
164182657|NCT00624832|593034288|FG003|Overall Study|Abnormal Laboratory Value|0|||
164182658|NCT01939223|593034289|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
164182659|NCT01939223|593034290|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
164182660|NCT01939223|593034289|FG000|Overall Study|Disease recurrence (radiological)|1|||
164182661|NCT01939223|593034290|FG001|Overall Study|Disease recurrence (radiological)|3|||
164182662|NCT01939223|593034289|FG000|Overall Study|Study stopped by Sponsor|5|||
164182663|NCT01939223|593034290|FG001|Overall Study|Study stopped by Sponsor|7|||
164182664|NCT01939223|593034289|FG000|Overall Study|Withdrawal by Subject|6|||
164182665|NCT01939223|593034290|FG001|Overall Study|Withdrawal by Subject|0|||
164182666|NCT04379700|593034291|FG000|Overall Study|Withdrawal by Subject|10|||
164182667|NCT04379700|593034291|FG000|Overall Study|Screen Fail|4|||
164182668|NCT04379700|593034291|FG000|Overall Study|Lost to Follow-up|3|||
164182669|NCT02258334|593034293|FG000|Overall Study|Adverse Event|1|||
164182670|NCT02258334|593034294|FG001|Overall Study|Adverse Event|0|||
164182671|NCT02258334|593034295|FG002|Overall Study|Adverse Event|0|||
164182672|NCT02258334|593034296|FG003|Overall Study|Adverse Event|0|||
164182673|NCT03564795|593034303|FG000|Overall Study|Withdrawal by Subject|3|||
164182674|NCT03564795|593034303|FG000|Overall Study|Lost to Follow-up|6|||
164182675|NCT03564795|593034303|FG000|Overall Study|Physician Decision|2|||
164182676|NCT05079230|593034304|FG000|Overall Study|Study Terminated by Sponsor|101|||
164182677|NCT05079230|593034305|FG001|Overall Study|Study Terminated by Sponsor|102|||
164182678|NCT05079230|593034304|FG000|Overall Study|Death|72|||
164182679|NCT05079230|593034305|FG001|Overall Study|Death|66|||
164182680|NCT05079230|593034304|FG000|Overall Study|Withdrew Consent|16|||
164182681|NCT05079230|593034305|FG001|Overall Study|Withdrew Consent|18|||
164182682|NCT05079230|593034304|FG000|Overall Study|Lost to Follow-up|0|||
164182683|NCT05079230|593034305|FG001|Overall Study|Lost to Follow-up|3|||
164182684|NCT00564395|593034310|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
164182685|NCT00564395|593034311|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
164182686|NCT00564395|593034310|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
164182687|NCT00564395|593034311|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
164182688|NCT02054910|593034313|FG000|Overall Study|Lost to Follow-up|4|||
164182689|NCT02054910|593034314|FG001|Overall Study|Lost to Follow-up|1|||
164182690|NCT00477607|593034319|FG000|Overall Study|Lost to Follow-up|7|||
164182691|NCT00477607|593034320|FG001|Overall Study|Lost to Follow-up|7|||
164182692|NCT00432276|593034321|FG000|Overall Study|Hyperglycemic Rescue|44|||
164182693|NCT00432276|593034322|FG001|Overall Study|Hyperglycemic Rescue|87|||
164182694|NCT00432276|593034321|FG000|Overall Study|Adverse Event|13|||
164182695|NCT00432276|593034322|FG001|Overall Study|Adverse Event|16|||
164182696|NCT00432276|593034321|FG000|Overall Study|Protocol Violation|25|||
164182697|NCT00432276|593034322|FG001|Overall Study|Protocol Violation|20|||
164182698|NCT00432276|593034321|FG000|Overall Study|Lost to Follow-up|6|||
164182699|NCT00432276|593034322|FG001|Overall Study|Lost to Follow-up|2|||
164182700|NCT00432276|593034321|FG000|Overall Study|Withdrawal by Subject|25|||
164182701|NCT00432276|593034322|FG001|Overall Study|Withdrawal by Subject|20|||
164182702|NCT00432276|593034321|FG000|Overall Study|Physician Decision|6|||
164182703|NCT00432276|593034322|FG001|Overall Study|Physician Decision|8|||
164182704|NCT00432276|593034321|FG000|Overall Study|Other|2|||
164182705|NCT00432276|593034322|FG001|Overall Study|Other|3|||
164182706|NCT00594386|593034323|FG000|Overall Study|Major protocol violation|2|||
164182707|NCT00594386|593034323|FG000|Overall Study|Lack of Efficacy|12|||
164182708|NCT00594386|593034323|FG000|Overall Study|Adverse Event|68|||
164182709|NCT00594386|593034323|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
164182710|NCT00594386|593034323|FG000|Overall Study|Subject withdrew consent|35|||
164182711|NCT00594386|593034323|FG000|Overall Study|Study ended per sponsor|115|||
164182712|NCT00594386|593034323|FG000|Overall Study|Lost to Follow-up|6|||
164182713|NCT00594386|593034323|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
164182714|NCT00594386|593034323|FG000|Overall Study|Other: Subject moved to Seattle|1|||
164182715|NCT00594386|593034323|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
164182716|NCT00594386|593034323|FG000|Overall Study|Other: Study terminated per investigator|2|||
164182717|NCT00594386|593034323|FG000|Overall Study|Other: Sponsor closure of study|1|||
164182718|NCT00594386|593034323|FG000|Overall Study|Other: Site terminated participation|1|||
164182719|NCT00594386|593034323|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
164182720|NCT00594386|593034323|FG000|Overall Study|Other: Loss of drivers license|1|||
164182721|NCT01210144|593034324|FG000|Overall Study|Lack of ovarian response|1|||
164182722|NCT01210144|593034325|FG001|Overall Study|Lack of ovarian response|0|||
164182723|NCT01210144|593034324|FG000|Overall Study|No fertilization|1|||
164182724|NCT01210144|593034325|FG001|Overall Study|No fertilization|0|||
164182725|NCT01210144|593034324|FG000|Overall Study|No transfer|1|||
164182726|NCT01210144|593034325|FG001|Overall Study|No transfer|0|||
164182727|NCT00207727|593034333|FG000|Overall Study|Withdrawal by Subject|0|||
164182728|NCT00207727|593034334|FG001|Overall Study|Withdrawal by Subject|0|||
164182729|NCT00207727|593034335|FG002|Overall Study|Withdrawal by Subject|0|||
164182730|NCT00207727|593034336|FG003|Overall Study|Withdrawal by Subject|0|||
164182731|NCT00207727|593034337|FG004|Overall Study|Withdrawal by Subject|1|||
164182732|NCT00207727|593034333|FG000|Overall Study|Lost to Follow-up|0|||
164182733|NCT00207727|593034334|FG001|Overall Study|Lost to Follow-up|1|||
164182734|NCT00207727|593034335|FG002|Overall Study|Lost to Follow-up|0|||
164182735|NCT00207727|593034336|FG003|Overall Study|Lost to Follow-up|0|||
164182736|NCT00207727|593034337|FG004|Overall Study|Lost to Follow-up|0|||
164182737|NCT00207727|593034333|FG000|Overall Study|Other|38|||
164182738|NCT00207727|593034334|FG001|Overall Study|Other|41|||
164182739|NCT00207727|593034335|FG002|Overall Study|Other|41|||
164182740|NCT00207727|593034336|FG003|Overall Study|Other|37|||
164182741|NCT00207727|593034337|FG004|Overall Study|Other|33|||
164182742|NCT03759366|593034338|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
164182743|NCT03759366|593034338|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
164182744|NCT03759366|593034338|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
164182745|NCT03759366|593034338|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
164182746|NCT03759366|593034338|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
164182747|NCT03759366|593034338|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
164182748|NCT03759366|593034338|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
164182749|NCT00539032|593034339|FG000|Overall Study|Withdrawal by Subject|2|||
164182750|NCT00539032|593034340|FG001|Overall Study|Withdrawal by Subject|1|||
164182751|NCT00505661|593034346|FG000|Overall Study|Not Eligible|4|||
164182752|NCT03611582|593034349|FG000|Overall Study|Adverse Event|26|||
164182753|NCT03611582|593034350|FG001|Overall Study|Adverse Event|6|||
164182754|NCT03611582|593034349|FG000|Overall Study|Protocol Violation|0|||
164182755|NCT03611582|593034350|FG001|Overall Study|Protocol Violation|1|||
164182756|NCT03611582|593034349|FG000|Overall Study|Pregnancy|1|||
164182757|NCT03611582|593034350|FG001|Overall Study|Pregnancy|2|||
164182758|NCT03611582|593034349|FG000|Overall Study|Lack of Efficacy|0|||
164182759|NCT03611582|593034350|FG001|Overall Study|Lack of Efficacy|1|||
164182760|NCT03611582|593034349|FG000|Overall Study|At the discretion of the investigator|1|||
164182761|NCT03611582|593034350|FG001|Overall Study|At the discretion of the investigator|0|||
164182762|NCT03611582|593034349|FG000|Overall Study|Safety concern as judged by the investigator|1|||
164182763|NCT03611582|593034350|FG001|Overall Study|Safety concern as judged by the investigator|2|||
164182764|NCT03611582|593034349|FG000|Overall Study|Withdrawal by Subject|4|||
164182765|NCT03611582|593034350|FG001|Overall Study|Withdrawal by Subject|3|||
164182766|NCT03611582|593034349|FG000|Overall Study|Lost to Follow-up|18|||
164182767|NCT03611582|593034350|FG001|Overall Study|Lost to Follow-up|7|||
164182768|NCT03611582|593034349|FG000|Overall Study|other|17|||
164182769|NCT03611582|593034350|FG001|Overall Study|other|16|||
164182770|NCT01573754|593034351|FG000|Overall Study|Noncompliance or remission not achieved|3|||
164182771|NCT01573754|593034352|FG001|Overall Study|Noncompliance or remission not achieved|15|||
164182772|NCT00463840|593034354|FG000|Overall Study|Disease progression|7|||
164182773|NCT00463840|593034354|FG000|Overall Study|Withdrawal by Subject|2|||
164182774|NCT00463840|593034354|FG000|Overall Study|Adverse Event|3|||
164182775|NCT04438499|593034355|FG000|Overall Study|Lack of Efficacy|3|||
164182776|NCT04228965|593036752|FG000|Overall Study|Lost to Follow-up|26|||
164182777|NCT04228965|593036753|FG001|Overall Study|Lost to Follow-up|11|||
164182778|NCT04228965|593036752|FG000|Overall Study|Withdrawal by Subject|18|||
164182779|NCT04228965|593036753|FG001|Overall Study|Withdrawal by Subject|5|||
164182780|NCT01026818|593036760|FG000|Screening Period|Entry Criteria Not Met|105|||
164182781|NCT01026818|593036761|FG001|Screening Period|Entry Criteria Not Met|0|||
164182782|NCT01026818|593036762|FG002|Screening Period|Entry Criteria Not Met|0|||
164182783|NCT01026818|593036763|FG003|Screening Period|Entry Criteria Not Met|0|||
164182784|NCT01026818|593036760|FG000|Screening Period|Withdrawal by Subject|49|||
164182785|NCT01026818|593036761|FG001|Screening Period|Withdrawal by Subject|0|||
164182786|NCT01026818|593036762|FG002|Screening Period|Withdrawal by Subject|0|||
164182787|NCT01026818|593036763|FG003|Screening Period|Withdrawal by Subject|0|||
164182788|NCT01026818|593036760|FG000|Screening Period|Protocol Deviation|3|||
164182789|NCT01026818|593036761|FG001|Screening Period|Protocol Deviation|0|||
164182790|NCT01026818|593036762|FG002|Screening Period|Protocol Deviation|0|||
164182791|NCT01026818|593036763|FG003|Screening Period|Protocol Deviation|0|||
164182792|NCT01026818|593036760|FG000|Screening Period|Adverse Event|2|||
164182793|NCT01026818|593036761|FG001|Screening Period|Adverse Event|0|||
164182794|NCT01026818|593036762|FG002|Screening Period|Adverse Event|0|||
164182795|NCT01026818|593036763|FG003|Screening Period|Adverse Event|0|||
164182796|NCT01026818|593036760|FG000|Screening Period|Physician Decision|1|||
164182797|NCT01026818|593036761|FG001|Screening Period|Physician Decision|0|||
164182798|NCT01026818|593036762|FG002|Screening Period|Physician Decision|0|||
164182799|NCT01026818|593036763|FG003|Screening Period|Physician Decision|0|||
164182800|NCT01026818|593036760|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
164182801|NCT01026818|593036761|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
164182802|NCT01026818|593036762|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
164182803|NCT01026818|593036763|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
164182804|NCT01026818|593036760|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
164182805|NCT01026818|593036761|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
164182806|NCT01026818|593036762|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
164182807|NCT01026818|593036763|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
164182808|NCT01026818|593036760|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
164182809|NCT01026818|593036761|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
164182810|NCT01026818|593036762|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
164182811|NCT01026818|593036763|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
164182878|NCT01641471|593036764|FG000|Overall Study|Lost to Follow-up|2|||
164182812|NCT01026818|593036760|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
164182813|NCT01026818|593036761|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
164182814|NCT01026818|593036762|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
164182815|NCT01026818|593036763|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
164182816|NCT01026818|593036760|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
164182817|NCT01026818|593036761|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
164182818|NCT01026818|593036762|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
164182819|NCT01026818|593036763|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
164182820|NCT01026818|593036760|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
164182821|NCT01026818|593036761|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
164182822|NCT01026818|593036762|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
164182823|NCT01026818|593036763|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
164182824|NCT01026818|593036760|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
164182825|NCT01026818|593036761|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
164182826|NCT01026818|593036762|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
164182827|NCT01026818|593036763|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
164182828|NCT01026818|593036760|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
164182829|NCT01026818|593036761|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
164182830|NCT01026818|593036762|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
164182831|NCT01026818|593036763|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
164182832|NCT01026818|593036760|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
164182833|NCT01026818|593036761|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
164182834|NCT01026818|593036762|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
164182835|NCT01026818|593036763|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
164182836|NCT01026818|593036760|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
164182837|NCT01026818|593036761|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
164182838|NCT01026818|593036762|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
164182839|NCT01026818|593036763|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
164182840|NCT01026818|593036760|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
164182841|NCT01026818|593036761|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
164182842|NCT01026818|593036762|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
164182843|NCT01026818|593036763|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
164182844|NCT01026818|593036760|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
164182845|NCT01026818|593036761|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
164182846|NCT01026818|593036762|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
164182847|NCT01026818|593036763|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
164182848|NCT01026818|593036760|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
164182849|NCT01026818|593036761|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
164182850|NCT01026818|593036762|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
164182851|NCT01026818|593036763|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
164182852|NCT01026818|593036760|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
164182853|NCT01026818|593036761|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
164182854|NCT01026818|593036762|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
164182855|NCT01026818|593036763|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
164182856|NCT01026818|593036760|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
164182857|NCT01026818|593036761|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
164182858|NCT01026818|593036762|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
164182859|NCT01026818|593036763|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
164182860|NCT01026818|593036760|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
164182861|NCT01026818|593036761|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
164182862|NCT01026818|593036762|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
164182863|NCT01026818|593036763|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
164182864|NCT01026818|593036760|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
164182865|NCT01026818|593036761|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
164182866|NCT01026818|593036762|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
164182867|NCT01026818|593036763|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
164182868|NCT01026818|593036760|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
164182869|NCT01026818|593036761|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
164182870|NCT01026818|593036762|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
164182871|NCT01026818|593036763|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
164182872|NCT01026818|593036760|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
164182873|NCT01026818|593036761|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
164182874|NCT01026818|593036762|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
164182875|NCT01026818|593036763|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
164182876|NCT01641471|593036764|FG000|Overall Study|Withdrawal by Subject|19|||
164182877|NCT01641471|593036765|FG001|Overall Study|Withdrawal by Subject|19|||
164182879|NCT01641471|593036765|FG001|Overall Study|Lost to Follow-up|4|||
164182880|NCT01641471|593036764|FG000|Overall Study|Protocol Violation|2|||
164182881|NCT01641471|593036765|FG001|Overall Study|Protocol Violation|4|||
164182882|NCT04575584|593036766|FG000|Overall Study|Death|6|||
164182883|NCT04575584|593036767|FG001|Overall Study|Death|4|||
164182884|NCT04575584|593036768|FG002|Overall Study|Death|6|||
164182885|NCT04575584|593036769|FG003|Overall Study|Death|2|||
164182886|NCT04575584|593036770|FG004|Overall Study|Death|0|||
164182887|NCT04575584|593036771|FG005|Overall Study|Death|0|||
164182888|NCT04575584|593036766|FG000|Overall Study|Lost to Follow-up|1|||
164182889|NCT04575584|593036767|FG001|Overall Study|Lost to Follow-up|1|||
164182890|NCT04575584|593036768|FG002|Overall Study|Lost to Follow-up|1|||
164182891|NCT04575584|593036769|FG003|Overall Study|Lost to Follow-up|1|||
164182892|NCT04575584|593036770|FG004|Overall Study|Lost to Follow-up|0|||
164182893|NCT04575584|593036771|FG005|Overall Study|Lost to Follow-up|0|||
164182894|NCT04575584|593036766|FG000|Overall Study|Physician Decision|0|||
164182895|NCT04575584|593036767|FG001|Overall Study|Physician Decision|1|||
164182896|NCT04575584|593036768|FG002|Overall Study|Physician Decision|1|||
164182897|NCT04575584|593036769|FG003|Overall Study|Physician Decision|1|||
164182898|NCT04575584|593036770|FG004|Overall Study|Physician Decision|0|||
164182899|NCT04575584|593036771|FG005|Overall Study|Physician Decision|0|||
164182900|NCT04575584|593036766|FG000|Overall Study|Withdrawal by Subject|7|||
164182901|NCT04575584|593036767|FG001|Overall Study|Withdrawal by Subject|9|||
164182902|NCT04575584|593036768|FG002|Overall Study|Withdrawal by Subject|5|||
164182903|NCT04575584|593036769|FG003|Overall Study|Withdrawal by Subject|3|||
164182904|NCT04575584|593036770|FG004|Overall Study|Withdrawal by Subject|0|||
164182905|NCT04575584|593036771|FG005|Overall Study|Withdrawal by Subject|0|||
164182906|NCT04575584|593036766|FG000|Overall Study|Not recorded|0|||
164182907|NCT04575584|593036767|FG001|Overall Study|Not recorded|0|||
164182908|NCT04575584|593036768|FG002|Overall Study|Not recorded|0|||
164182909|NCT04575584|593036769|FG003|Overall Study|Not recorded|1|||
164182910|NCT04575584|593036770|FG004|Overall Study|Not recorded|0|||
164182911|NCT04575584|593036771|FG005|Overall Study|Not recorded|0|||
164182912|NCT02634801|593036772|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
164182913|NCT02634801|593036773|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
164182914|NCT02634801|593036774|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
164182915|NCT02634801|593036772|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
164182916|NCT02634801|593036773|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
164182917|NCT02634801|593036774|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
164182918|NCT02634801|593036772|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
164182919|NCT02634801|593036773|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
164182920|NCT02634801|593036774|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
164182921|NCT02634801|593036772|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
164182922|NCT02634801|593036773|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
164182923|NCT02634801|593036774|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
164182924|NCT02634801|593036772|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
164182925|NCT02634801|593036773|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
164182926|NCT02634801|593036774|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
164182927|NCT02634801|593036772|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
164182928|NCT02634801|593036773|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
164182929|NCT02634801|593036774|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
164182930|NCT02634801|593036772|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
164182931|NCT02634801|593036773|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
164182932|NCT02634801|593036774|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
164182933|NCT02634801|593036772|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
164182934|NCT02634801|593036773|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
164182935|NCT02634801|593036774|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
164182936|NCT02634801|593036772|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
164182937|NCT02634801|593036773|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
164182938|NCT02634801|593036774|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
164182939|NCT02634801|593036772|FG000|Follow-up Period|Lost to Follow-up|3|||
164182940|NCT02634801|593036773|FG001|Follow-up Period|Lost to Follow-up|1|||
164182941|NCT02634801|593036774|FG002|Follow-up Period|Lost to Follow-up|2|||
164182942|NCT02634801|593036772|FG000|Follow-up Period|Physician Decision|0|||
164182943|NCT02634801|593036773|FG001|Follow-up Period|Physician Decision|0|||
164182944|NCT02634801|593036774|FG002|Follow-up Period|Physician Decision|1|||
164182945|NCT02634801|593036772|FG000|Follow-up Period|Withdrawal by Subject|1|||
164182946|NCT02634801|593036773|FG001|Follow-up Period|Withdrawal by Subject|2|||
164182947|NCT02634801|593036774|FG002|Follow-up Period|Withdrawal by Subject|5|||
164182948|NCT02634801|593036772|FG000|Follow-up Period|Adverse Event|1|||
164182949|NCT02634801|593036773|FG001|Follow-up Period|Adverse Event|5|||
164182950|NCT02634801|593036774|FG002|Follow-up Period|Adverse Event|0|||
164182951|NCT00199849|593036777|FG000|Overall Study|Unrelated illness or complication|0|||
164182952|NCT00199849|593036778|FG001|Overall Study|Unrelated illness or complication|1|||
164182953|NCT00199849|593036779|FG002|Overall Study|Unrelated illness or complication|0|||
164182954|NCT00199849|593036777|FG000|Overall Study|Progressive disease requiring intervention|0|||
164182955|NCT00199849|593036778|FG001|Overall Study|Progressive disease requiring intervention|0|||
164182956|NCT00199849|593036779|FG002|Overall Study|Progressive disease requiring intervention|1|||
164182957|NCT00199849|593036777|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
164182958|NCT00199849|593036778|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
164182959|NCT00199849|593036779|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
164182960|NCT01548768|593036780|FG000|Overall Study|Withdrawal by Subject|0|||
164182961|NCT01548768|593036781|FG001|Overall Study|Withdrawal by Subject|2|||
164182962|NCT01548768|593036782|FG002|Overall Study|Withdrawal by Subject|1|||
164182963|NCT01548768|593036783|FG003|Overall Study|Withdrawal by Subject|0|||
164182964|NCT01548768|593036780|FG000|Overall Study|Physician Decision|1|||
164182965|NCT01548768|593036781|FG001|Overall Study|Physician Decision|0|||
164182966|NCT01548768|593036782|FG002|Overall Study|Physician Decision|0|||
164182967|NCT01548768|593036783|FG003|Overall Study|Physician Decision|0|||
164182968|NCT01548768|593036780|FG000|Overall Study|Adverse Event|0|||
164182969|NCT01548768|593036781|FG001|Overall Study|Adverse Event|0|||
164182970|NCT01548768|593036782|FG002|Overall Study|Adverse Event|0|||
164182971|NCT01548768|593036783|FG003|Overall Study|Adverse Event|1|||
164182972|NCT01548768|593036780|FG000|Overall Study|Non-Compliance|0|||
164182973|NCT01548768|593036781|FG001|Overall Study|Non-Compliance|0|||
164182974|NCT01548768|593036782|FG002|Overall Study|Non-Compliance|0|||
164182975|NCT01548768|593036783|FG003|Overall Study|Non-Compliance|3|||
164182976|NCT03300050|593036784|FG000|Overall Study|Lost to Follow-up|2|||
164182977|NCT03300050|593036785|FG001|Overall Study|Lost to Follow-up|1|||
164182978|NCT03300050|593036786|FG002|Overall Study|Lost to Follow-up|0|||
164182979|NCT03300050|593036787|FG003|Overall Study|Lost to Follow-up|0|||
164182980|NCT03300050|593036788|FG004|Overall Study|Lost to Follow-up|1|||
164182981|NCT03300050|593036784|FG000|Overall Study|Withdrawal by Subject|1|||
164182982|NCT03300050|593036785|FG001|Overall Study|Withdrawal by Subject|1|||
164182983|NCT03300050|593036786|FG002|Overall Study|Withdrawal by Subject|1|||
164182984|NCT03300050|593036787|FG003|Overall Study|Withdrawal by Subject|0|||
164182985|NCT03300050|593036788|FG004|Overall Study|Withdrawal by Subject|0|||
164182986|NCT03300050|593036784|FG000|Overall Study|Death|0|||
164182987|NCT03300050|593036785|FG001|Overall Study|Death|0|||
164182988|NCT03300050|593036786|FG002|Overall Study|Death|1|||
164182989|NCT03300050|593036787|FG003|Overall Study|Death|0|||
164182990|NCT03300050|593036788|FG004|Overall Study|Death|0|||
164182991|NCT03300050|593036784|FG000|Overall Study|Not Eligible at Randomization|0|||
164182992|NCT03300050|593036785|FG001|Overall Study|Not Eligible at Randomization|0|||
164182993|NCT03300050|593036786|FG002|Overall Study|Not Eligible at Randomization|1|||
164182994|NCT03300050|593036787|FG003|Overall Study|Not Eligible at Randomization|1|||
164182995|NCT03300050|593036788|FG004|Overall Study|Not Eligible at Randomization|0|||
164182996|NCT02499263|593036789|FG000|Overall Study|Lost to Follow-up|9|||
164182997|NCT02499263|593036789|FG000|Overall Study|Participant's withdrawal of consent|4|||
164182998|NCT02499263|593036789|FG000|Overall Study|Lack of Efficacy|22|||
164182999|NCT02499263|593036789|FG000|Overall Study|investigator's judgment|12|||
164183000|NCT02499263|593036789|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
164183001|NCT02499263|593036789|FG000|Overall Study|Participant's decision|3|||
164183002|NCT02499263|593036789|FG000|Overall Study|Pregnancy|1|||
164183003|NCT01375374|593036790|FG000|Overall Study|Adverse Event|1|||
164183004|NCT01908582|593036791|FG000|Period 2|Physician Decision|1|||
164183005|NCT01908582|593036791|FG000|Period 2|Withdrawal by Subject|1|||
164183006|NCT00424593|593036792|FG000|Acute Double-Blind Period|Adverse Event|16|||
164183007|NCT00424593|593036793|FG001|Acute Double-Blind Period|Adverse Event|7|||
164183008|NCT00424593|593036792|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
164183009|NCT00424593|593036793|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
164183010|NCT00424593|593036792|FG000|Acute Double-Blind Period|Protocol Violation|2|||
164183011|NCT00424593|593036793|FG001|Acute Double-Blind Period|Protocol Violation|2|||
164183012|NCT00424593|593036792|FG000|Acute Double-Blind Period|Physician Decision|1|||
164183013|NCT00424593|593036793|FG001|Acute Double-Blind Period|Physician Decision|2|||
164183014|NCT00424593|593036792|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
164183015|NCT00424593|593036793|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
164183016|NCT00424593|593036792|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
164183017|NCT00424593|593036793|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
164183018|NCT00424593|593036792|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
164183019|NCT00424593|593036793|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
164183020|NCT00424593|593036792|FG000|Dose-Blind Extension Period|Adverse Event|18|||
164183021|NCT00424593|593036793|FG001|Dose-Blind Extension Period|Adverse Event|0|||
164183022|NCT00424593|593036792|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
164183023|NCT00424593|593036793|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
164183024|NCT00424593|593036792|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
164183025|NCT00424593|593036793|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
164183026|NCT00424593|593036792|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
164183027|NCT00424593|593036793|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
164183028|NCT00424593|593036792|FG000|Dose-Blind Extension Period|Physician Decision|3|||
164183029|NCT00424593|593036793|FG001|Dose-Blind Extension Period|Physician Decision|0|||
164183030|NCT01108237|593036794|FG000|Overall Study|No alignment data|2|||
164183031|NCT01108237|593036795|FG001|Overall Study|No alignment data|15|||
164183032|NCT01108237|593036794|FG000|Overall Study|Did not meet criteria for analysis|7|||
164183033|NCT01108237|593036795|FG001|Overall Study|Did not meet criteria for analysis|0|||
164183034|NCT02178358|593036798|FG000|Overall Study|Withdrawal by Subject|0|||
164183035|NCT02178358|593036799|FG001|Overall Study|Withdrawal by Subject|2|||
164183036|NCT02178358|593036800|FG002|Overall Study|Withdrawal by Subject|2|||
164183037|NCT02178358|593036798|FG000|Overall Study|Lost to Follow-up|1|||
164183038|NCT02178358|593036799|FG001|Overall Study|Lost to Follow-up|0|||
164183039|NCT02178358|593036800|FG002|Overall Study|Lost to Follow-up|0|||
164183040|NCT01066663|593036801|FG000|Overall Study|Adverse Event|0|||
164183041|NCT01066663|593036802|FG001|Overall Study|Adverse Event|0|||
164183042|NCT01066663|593036803|FG002|Overall Study|Adverse Event|1|||
164183043|NCT02232061|593036804|FG000|Overall Study|Administrative problems|1|||
164183044|NCT02232061|593036804|FG000|Overall Study|Withdrawal by Subject|1|||
164183045|NCT03297021|593036806|FG000|Overall Study|Incomplete/illegible data sheet|4|||
164183046|NCT03297021|593036807|FG001|Overall Study|Incomplete/illegible data sheet|2|||
164183047|NCT03297021|593036808|FG002|Overall Study|Incomplete/illegible data sheet|3|||
164183048|NCT03297021|593036806|FG000|Overall Study|Missing Post-Op Data|1|||
164183049|NCT03297021|593036807|FG001|Overall Study|Missing Post-Op Data|2|||
164183050|NCT03297021|593036808|FG002|Overall Study|Missing Post-Op Data|1|||
164183051|NCT02784288|593036810|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
164183052|NCT02734862|593036811|FG000|Part A|Death|3|||
164183053|NCT02734862|593036812|FG001|Part A|Death|4|||
164183054|NCT02734862|593036813|FG002|Part A|Death|6|||
164183055|NCT02734862|593036811|FG000|Part A|Lost to Follow-up|2|||
164183056|NCT02734862|593036812|FG001|Part A|Lost to Follow-up|1|||
164183057|NCT02734862|593036813|FG002|Part A|Lost to Follow-up|1|||
164183058|NCT02734862|593036811|FG000|Part A|Withdrawal by Subject|1|||
164183059|NCT02734862|593036812|FG001|Part A|Withdrawal by Subject|1|||
164183060|NCT02734862|593036813|FG002|Part A|Withdrawal by Subject|2|||
164183061|NCT02734862|593036811|FG000|Part A|Physician Decision|2|||
164183062|NCT02734862|593036812|FG001|Part A|Physician Decision|0|||
164183063|NCT02734862|593036813|FG002|Part A|Physician Decision|1|||
164183064|NCT02734862|593036811|FG000|Part A|Adverse Event|2|||
164183065|NCT02734862|593036812|FG001|Part A|Adverse Event|0|||
164183066|NCT02734862|593036813|FG002|Part A|Adverse Event|1|||
164183067|NCT02734862|593036811|FG000|Part A|Noncompliance|1|||
164183068|NCT02734862|593036812|FG001|Part A|Noncompliance|1|||
164183069|NCT02734862|593036813|FG002|Part A|Noncompliance|0|||
164183070|NCT02734862|593036811|FG000|Part A|Other|1|||
164183071|NCT02734862|593036812|FG001|Part A|Other|1|||
164183072|NCT02734862|593036813|FG002|Part A|Other|3|||
164183073|NCT02734862|593036811|FG000|Part B|Death|8|||
164183074|NCT02734862|593036812|FG001|Part B|Death|3|||
164183075|NCT02734862|593036813|FG002|Part B|Death|5|||
164183076|NCT02734862|593036811|FG000|Part B|Lost to Follow-up|2|||
164183077|NCT02734862|593036812|FG001|Part B|Lost to Follow-up|2|||
164183078|NCT02734862|593036813|FG002|Part B|Lost to Follow-up|0|||
164183079|NCT02734862|593036811|FG000|Part B|Withdrawal by Subject|3|||
164183080|NCT02734862|593036812|FG001|Part B|Withdrawal by Subject|1|||
164183081|NCT02734862|593036813|FG002|Part B|Withdrawal by Subject|0|||
164183082|NCT02734862|593036811|FG000|Part B|Other|0|||
164183083|NCT02734862|593036812|FG001|Part B|Other|1|||
164183084|NCT02734862|593036813|FG002|Part B|Other|0|||
164183085|NCT02757625|593036814|FG000|Overall Study|Investigator's discretion|0|||
164183086|NCT02757625|593036815|FG001|Overall Study|Investigator's discretion|0|||
164183087|NCT02757625|593036816|FG002|Overall Study|Investigator's discretion|1|||
164183088|NCT02757625|593036817|FG003|Overall Study|Investigator's discretion|0|||
164183089|NCT02757625|593036814|FG000|Overall Study|Adverse Event|0|||
164183090|NCT02757625|593036815|FG001|Overall Study|Adverse Event|0|||
164183091|NCT02757625|593036816|FG002|Overall Study|Adverse Event|1|||
164183092|NCT02757625|593036817|FG003|Overall Study|Adverse Event|0|||
164183093|NCT00564278|593036818|FG000|Overall Study|Lost to Follow-up|35|||
164183094|NCT00564278|593036819|FG001|Overall Study|Lost to Follow-up|33|||
164183095|NCT00564278|593036818|FG000|Overall Study|Physician Decision|1|||
164183096|NCT00564278|593036819|FG001|Overall Study|Physician Decision|2|||
164183097|NCT00564278|593036818|FG000|Overall Study|Withdrawal by Subject|11|||
164183098|NCT00564278|593036819|FG001|Overall Study|Withdrawal by Subject|7|||
164183099|NCT00645671|593036820|FG000|Overall Study|Protocol Violation|1|||
164183100|NCT00645671|593036821|FG001|Overall Study|Protocol Violation|0|||
164183101|NCT00645671|593036820|FG000|Overall Study|Withdrawal by Subject|0|||
164183102|NCT00645671|593036821|FG001|Overall Study|Withdrawal by Subject|4|||
164183103|NCT00645671|593036820|FG000|Overall Study|Adverse Event|0|||
164183104|NCT00645671|593036821|FG001|Overall Study|Adverse Event|1|||
164183105|NCT00645671|593036820|FG000|Overall Study|Physician Decision|0|||
164183106|NCT00645671|593036821|FG001|Overall Study|Physician Decision|1|||
164183107|NCT00560703|593036822|FG000|Overall Study|Adverse Event|0|||
164183108|NCT00560703|593036823|FG001|Overall Study|Adverse Event|2|||
164183109|NCT00560703|593036822|FG000|Overall Study|Protocol Violation|0|||
164183110|NCT00560703|593036823|FG001|Overall Study|Protocol Violation|2|||
164183111|NCT00560703|593036822|FG000|Overall Study|Withdrawal by Subject|0|||
164183112|NCT00560703|593036823|FG001|Overall Study|Withdrawal by Subject|1|||
164183113|NCT00560703|593036822|FG000|Overall Study|non-compliance|0|||
164183114|NCT00560703|593036823|FG001|Overall Study|non-compliance|1|||
164183115|NCT02095197|593036824|FG000|Overall Study|Lost to Follow-up|0|||
164183116|NCT02095197|593036825|FG001|Overall Study|Lost to Follow-up|3|||
164183117|NCT00493311|593036826|FG000|Overall Study|Need for rescue medication|2|||
164183118|NCT00493311|593036827|FG001|Overall Study|Need for rescue medication|2|||
164183119|NCT02779075|593036828|FG000|Overall Study|Withdrawal by Subject|1|||
164183120|NCT02779075|593036829|FG001|Overall Study|Withdrawal by Subject|3|||
164183121|NCT02779075|593036828|FG000|Overall Study|IV lost during 2nd study|1|||
164183122|NCT02779075|593036829|FG001|Overall Study|IV lost during 2nd study|0|||
164183123|NCT00790556|593036830|FG000|Treatment Period 1|Physician Decision|1|||
164183124|NCT00790556|593036831|FG001|Treatment Period 1|Physician Decision|0|||
164183125|NCT00790556|593036830|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164183126|NCT00790556|593036831|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164183127|NCT03077607|593036832|FG000|Period 1 (15 Days)|Adverse Event|1|||
164183128|NCT03077607|593036833|FG001|Period 1 (15 Days)|Adverse Event|0|||
164183129|NCT03077607|593036832|FG000|Period 1 (15 Days)|Death|1|||
164183130|NCT03077607|593036833|FG001|Period 1 (15 Days)|Death|0|||
164183131|NCT03077607|593036832|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
164183132|NCT03077607|593036833|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
164183133|NCT03077607|593036832|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
164183134|NCT03077607|593036833|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
164183135|NCT05600036|593036835|FG000|Overall Study|Adverse Event|0|||
164183136|NCT05600036|593036836|FG001|Overall Study|Adverse Event|2|||
164183137|NCT05600036|593036837|FG002|Overall Study|Adverse Event|1|||
164183138|NCT05600036|593036838|FG003|Overall Study|Adverse Event|0|||
164183139|NCT05600036|593036839|FG004|Overall Study|Adverse Event|1|||
164183140|NCT05600036|593036840|FG005|Overall Study|Adverse Event|0|||
164183141|NCT05600036|593036835|FG000|Overall Study|Lost to Follow-up|0|||
164183142|NCT05600036|593036836|FG001|Overall Study|Lost to Follow-up|2|||
164183143|NCT05600036|593036837|FG002|Overall Study|Lost to Follow-up|1|||
164183144|NCT05600036|593036838|FG003|Overall Study|Lost to Follow-up|1|||
164183145|NCT05600036|593036839|FG004|Overall Study|Lost to Follow-up|0|||
164183146|NCT05600036|593036840|FG005|Overall Study|Lost to Follow-up|0|||
164183147|NCT05600036|593036835|FG000|Overall Study|Protocol Violation|0|||
164183148|NCT05600036|593036836|FG001|Overall Study|Protocol Violation|0|||
164183149|NCT05600036|593036837|FG002|Overall Study|Protocol Violation|2|||
164183150|NCT05600036|593036838|FG003|Overall Study|Protocol Violation|0|||
164183151|NCT05600036|593036839|FG004|Overall Study|Protocol Violation|0|||
164183152|NCT05600036|593036840|FG005|Overall Study|Protocol Violation|0|||
164183153|NCT05600036|593036835|FG000|Overall Study|Withdrawal by Subject|0|||
164183154|NCT05600036|593036836|FG001|Overall Study|Withdrawal by Subject|1|||
164183155|NCT05600036|593036837|FG002|Overall Study|Withdrawal by Subject|2|||
164183156|NCT05600036|593036838|FG003|Overall Study|Withdrawal by Subject|0|||
164183157|NCT05600036|593036839|FG004|Overall Study|Withdrawal by Subject|3|||
164183158|NCT05600036|593036840|FG005|Overall Study|Withdrawal by Subject|5|||
164183159|NCT05600036|593036835|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
164183160|NCT05600036|593036836|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
164183161|NCT05600036|593036837|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
164183162|NCT05600036|593036838|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
164183163|NCT05600036|593036839|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
164183164|NCT05600036|593036840|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
164183165|NCT05600036|593036835|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
164183166|NCT05600036|593036836|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
164183167|NCT05600036|593036837|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
164183168|NCT05600036|593036838|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
164183169|NCT05600036|593036839|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
164183170|NCT05600036|593036840|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
164183171|NCT05600036|593036835|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
164183172|NCT05600036|593036836|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
164183173|NCT05600036|593036837|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
164183174|NCT05600036|593036838|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
164183175|NCT05600036|593036839|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
164183176|NCT05600036|593036840|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
164183177|NCT04401202|593036841|FG000|Overall Study|Lost to Follow-up|2|||
164183178|NCT04401202|593036842|FG001|Overall Study|Lost to Follow-up|2|||
164183179|NCT04401202|593036841|FG000|Overall Study|Adverse Event|0|||
164183180|NCT04401202|593036842|FG001|Overall Study|Adverse Event|1|||
164183181|NCT04401202|593036841|FG000|Overall Study|Hospitalized|4|||
164183182|NCT04401202|593036842|FG001|Overall Study|Hospitalized|1|||
164183183|NCT02714036|593036843|FG000|Overall Study|Adverse Event|9|||
164183184|NCT02714036|593036844|FG001|Overall Study|Adverse Event|2|||
164183185|NCT02714036|593036843|FG000|Overall Study|Withdrawal by Subject|3|||
164183186|NCT02714036|593036844|FG001|Overall Study|Withdrawal by Subject|2|||
164183187|NCT05697627|593036848|FG000|Overall Study|Adverse Event|1|||
164183188|NCT04122625|593036849|FG000|Part A (up to 2.92 Years)|Death|2|||
164183189|NCT04122625|593036850|FG001|Part A (up to 2.92 Years)|Death|4|||
164183190|NCT04122625|593036851|FG002|Part A (up to 2.92 Years)|Death|0|||
164183191|NCT04122625|593036852|FG003|Part A (up to 2.92 Years)|Death|0|||
164183192|NCT04122625|593036853|FG004|Part A (up to 2.92 Years)|Death|0|||
164183193|NCT04122625|593036854|FG005|Part A (up to 2.92 Years)|Death|0|||
164183194|NCT04122625|593036849|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
164183195|NCT04122625|593036850|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
164183196|NCT04122625|593036851|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
164183197|NCT04122625|593036852|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
164183198|NCT04122625|593036853|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
164183199|NCT04122625|593036854|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
164183200|NCT04122625|593036849|FG000|Part B (up to 2.33 Years)|Death|0|||
164183201|NCT04122625|593036850|FG001|Part B (up to 2.33 Years)|Death|0|||
164183202|NCT04122625|593036851|FG002|Part B (up to 2.33 Years)|Death|5|||
164183203|NCT04122625|593036852|FG003|Part B (up to 2.33 Years)|Death|7|||
164183204|NCT04122625|593036853|FG004|Part B (up to 2.33 Years)|Death|6|||
164183205|NCT04122625|593036854|FG005|Part B (up to 2.33 Years)|Death|7|||
164183206|NCT04348500|593036855|FG000|Overall Study|Death|2|||
164183207|NCT04348500|593036856|FG001|Overall Study|Death|2|||
164183208|NCT04348500|593036855|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
164183209|NCT04348500|593036856|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
164183210|NCT02722746|593036857|FG000|Overall Study|Withdrawal by Subject|0|||
164183211|NCT02722746|593036858|FG001|Overall Study|Withdrawal by Subject|1|||
164183212|NCT02722746|593036859|FG002|Overall Study|Withdrawal by Subject|0|||
164183213|NCT02722746|593036857|FG000|Overall Study|Protocol Violation|8|||
164183214|NCT02722746|593036858|FG001|Overall Study|Protocol Violation|4|||
164183215|NCT02722746|593036859|FG002|Overall Study|Protocol Violation|6|||
164183216|NCT04165135|593036872|FG000|Overall Study|Protocol Violation|10|||
164183217|NCT04165135|593036872|FG000|Overall Study|Participants withdrawal of consent|5|||
164183218|NCT00530790|593036873|FG000|Overall Study|Adverse Event|2|||
164183219|NCT00530790|593036873|FG000|Overall Study|Withdrawal by Subject|2|||
164183220|NCT00530790|593036873|FG000|Overall Study|Physician Decision|1|||
164183221|NCT01618916|593036878|FG000|Overall Study|Adverse Event|1|||
164183222|NCT01618916|593036879|FG001|Overall Study|Adverse Event|0|||
164183223|NCT01618916|593036880|FG002|Overall Study|Adverse Event|0|||
164183224|NCT01618916|593036881|FG003|Overall Study|Adverse Event|0|||
164183225|NCT01618916|593036882|FG004|Overall Study|Adverse Event|0|||
164183226|NCT01618916|593036883|FG005|Overall Study|Adverse Event|0|||
164183227|NCT01618916|593036878|FG000|Overall Study|Withdrawal by Subject|0|||
164183228|NCT01618916|593036879|FG001|Overall Study|Withdrawal by Subject|1|||
164183229|NCT01618916|593036880|FG002|Overall Study|Withdrawal by Subject|1|||
164183230|NCT01618916|593036881|FG003|Overall Study|Withdrawal by Subject|0|||
164183231|NCT01618916|593036882|FG004|Overall Study|Withdrawal by Subject|1|||
164183232|NCT01618916|593036883|FG005|Overall Study|Withdrawal by Subject|0|||
164183233|NCT01618916|593036878|FG000|Overall Study|Lost to Follow-up|1|||
164183234|NCT01618916|593036879|FG001|Overall Study|Lost to Follow-up|0|||
164183235|NCT01618916|593036880|FG002|Overall Study|Lost to Follow-up|0|||
164183236|NCT01618916|593036881|FG003|Overall Study|Lost to Follow-up|2|||
164183237|NCT01618916|593036882|FG004|Overall Study|Lost to Follow-up|0|||
164183238|NCT01618916|593036883|FG005|Overall Study|Lost to Follow-up|0|||
164183239|NCT00438256|593036884|FG000|Overall Study|Ineligible for Resection|2|||
164183240|NCT00438256|593036885|FG001|Overall Study|Ineligible for Resection|1|||
164183241|NCT00438256|593036886|FG002|Overall Study|Ineligible for Resection|1|||
164183242|NCT00438256|593036887|FG003|Overall Study|Ineligible for Resection|7|||
164183243|NCT00438256|593036884|FG000|Overall Study|Excluded final Diagnosis|0|||
164183244|NCT00438256|593036885|FG001|Overall Study|Excluded final Diagnosis|0|||
164183245|NCT00438256|593036886|FG002|Overall Study|Excluded final Diagnosis|0|||
164183246|NCT00438256|593036887|FG003|Overall Study|Excluded final Diagnosis|2|||
164183247|NCT00849290|593036896|FG000|Overall Study|Adverse Event|3|||
164183248|NCT00849290|593036896|FG000|Overall Study|Death|14|||
164183249|NCT00849290|593036896|FG000|Overall Study|Withdrawal by Subject|11|||
164183250|NCT00849290|593036896|FG000|Overall Study|Lost to Follow-up|2|||
164183251|NCT00849290|593036896|FG000|Overall Study|Protocol Violation|5|||
164183252|NCT00849290|593036896|FG000|Overall Study|Disease Progression|20|||
164183253|NCT00938587|593036897|FG000|Overall Study|Adverse Event|2|||
164183254|NCT00938587|593036898|FG001|Overall Study|Adverse Event|0|||
164183255|NCT00938587|593036899|FG002|Overall Study|Adverse Event|0|||
164183256|NCT00938587|593036900|FG003|Overall Study|Adverse Event|2|||
164183257|NCT00938587|593036897|FG000|Overall Study|Did not meet entrance criteria|0|||
164183409|NCT00582426|593038925|FG001|Overall Study|Adverse Event|2|||
164183258|NCT00938587|593036898|FG001|Overall Study|Did not meet entrance criteria|0|||
164183259|NCT00938587|593036899|FG002|Overall Study|Did not meet entrance criteria|1|||
164183260|NCT00938587|593036900|FG003|Overall Study|Did not meet entrance criteria|0|||
164183261|NCT00938587|593036897|FG000|Overall Study|Withdrawal by Subject|1|||
164183262|NCT00938587|593036898|FG001|Overall Study|Withdrawal by Subject|1|||
164183263|NCT00938587|593036899|FG002|Overall Study|Withdrawal by Subject|0|||
164183264|NCT00938587|593036900|FG003|Overall Study|Withdrawal by Subject|0|||
164183265|NCT02819440|593036905|FG000|Overall Study|Adverse Event|3|||
164183266|NCT02819440|593036906|FG001|Overall Study|Adverse Event|1|||
164183267|NCT02819440|593036905|FG000|Overall Study|Lost to Follow-up|1|||
164183268|NCT02819440|593036906|FG001|Overall Study|Lost to Follow-up|3|||
164183269|NCT02819440|593036905|FG000|Overall Study|Withdrawal by Subject|9|||
164183270|NCT02819440|593036906|FG001|Overall Study|Withdrawal by Subject|8|||
164183271|NCT02334384|593036914|FG000|Overall Study|Lost to Follow-up|1|||
164183272|NCT02334384|593036915|FG001|Overall Study|Lost to Follow-up|1|||
164183273|NCT00055497|593036916|FG000|Overall Study|Adverse Event|1|||
164183274|NCT00055497|593036917|FG001|Overall Study|Adverse Event|1|||
164183275|NCT00055497|593036918|FG002|Overall Study|Adverse Event|1|||
164183276|NCT00055497|593036919|FG003|Overall Study|Adverse Event|28|||
164183277|NCT00055497|593036916|FG000|Overall Study|Withdrawal by Subject|3|||
164183278|NCT00055497|593036917|FG001|Overall Study|Withdrawal by Subject|1|||
164183279|NCT00055497|593036918|FG002|Overall Study|Withdrawal by Subject|1|||
164183280|NCT00055497|593036919|FG003|Overall Study|Withdrawal by Subject|15|||
164183281|NCT00055497|593036916|FG000|Overall Study|Lost to Follow-up|0|||
164183282|NCT00055497|593036917|FG001|Overall Study|Lost to Follow-up|1|||
164183283|NCT00055497|593036918|FG002|Overall Study|Lost to Follow-up|0|||
164183284|NCT00055497|593036919|FG003|Overall Study|Lost to Follow-up|5|||
164183285|NCT00055497|593036916|FG000|Overall Study|Protocol Violation|0|||
164183286|NCT00055497|593036917|FG001|Overall Study|Protocol Violation|0|||
164183287|NCT00055497|593036918|FG002|Overall Study|Protocol Violation|0|||
164183288|NCT00055497|593036919|FG003|Overall Study|Protocol Violation|3|||
164183289|NCT00055497|593036916|FG000|Overall Study|Lack of Efficacy|1|||
164183290|NCT00055497|593036917|FG001|Overall Study|Lack of Efficacy|0|||
164183291|NCT00055497|593036918|FG002|Overall Study|Lack of Efficacy|0|||
164183292|NCT00055497|593036919|FG003|Overall Study|Lack of Efficacy|27|||
164183293|NCT00055497|593036916|FG000|Overall Study|Administrative Reasons|0|||
164183294|NCT00055497|593036917|FG001|Overall Study|Administrative Reasons|0|||
164183295|NCT00055497|593036918|FG002|Overall Study|Administrative Reasons|0|||
164183296|NCT00055497|593036919|FG003|Overall Study|Administrative Reasons|1|||
164183297|NCT00055497|593036916|FG000|Overall Study|Other|0|||
164183298|NCT00055497|593036917|FG001|Overall Study|Other|0|||
164183299|NCT00055497|593036918|FG002|Overall Study|Other|0|||
164183300|NCT00055497|593036919|FG003|Overall Study|Other|11|||
164183301|NCT00048165|593036920|FG000|Completed 6 Months Study|Administration/Other|8|||
164183302|NCT00048165|593036921|FG001|Completed 6 Months Study|Administration/Other|8|||
164183303|NCT00048165|593036920|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
164183304|NCT00048165|593036921|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
164183305|NCT00048165|593036920|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
164183306|NCT00048165|593036921|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
164183307|NCT00048165|593036920|FG000|Completed 6 Months Study|Death|12|||
164183308|NCT00048165|593036921|FG001|Completed 6 Months Study|Death|6|||
164183309|NCT00048165|593036920|FG000|Completed 6 Months Study|Insufficient therapy|1|||
164183310|NCT00048165|593036921|FG001|Completed 6 Months Study|Insufficient therapy|4|||
164183311|NCT00048165|593036920|FG000|Completed 6 Months Study|Other violation|4|||
164183312|NCT00048165|593036921|FG001|Completed 6 Months Study|Other violation|6|||
164183313|NCT00048165|593036920|FG000|Completed 6 Months Study|Refused treatment|5|||
164183314|NCT00048165|593036921|FG001|Completed 6 Months Study|Refused treatment|5|||
164183315|NCT00048165|593036920|FG000|Completed 6 Months Study|Violation criteria|0|||
164183316|NCT00048165|593036921|FG001|Completed 6 Months Study|Violation criteria|2|||
164183317|NCT00048165|593036920|FG000|Completed 6 Months Study|Did not receive study drug|6|||
164183318|NCT00048165|593036921|FG001|Completed 6 Months Study|Did not receive study drug|6|||
164183319|NCT00048165|593036920|FG000|Completed 12 Months Study|Administration/Other|0|||
164183320|NCT00048165|593036921|FG001|Completed 12 Months Study|Administration/Other|2|||
164183321|NCT00048165|593036920|FG000|Completed 12 Months Study|Death|2|||
164183322|NCT00048165|593036921|FG001|Completed 12 Months Study|Death|1|||
164183323|NCT00048165|593036920|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
164183324|NCT00048165|593036921|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
164183325|NCT00731731|593036922|FG000|Overall Study|Protocol Violation|0|||
164183326|NCT00731731|593036923|FG001|Overall Study|Protocol Violation|0|||
164183327|NCT00731731|593036924|FG002|Overall Study|Protocol Violation|1|||
164183328|NCT00731731|593036922|FG000|Overall Study|Cancel prior to treatment|0|||
164183329|NCT00731731|593036923|FG001|Overall Study|Cancel prior to treatment|0|||
164183330|NCT00731731|593036924|FG002|Overall Study|Cancel prior to treatment|2|||
164183331|NCT01084538|593036925|FG000|Overall Study|Drug not available|30|||
164183332|NCT01084538|593036925|FG000|Overall Study|Adverse Event|9|||
164183333|NCT01084538|593036925|FG000|Overall Study|Kidney transplant|6|||
164183334|NCT01084538|593036925|FG000|Overall Study|Serious Adverse Event|3|||
164183335|NCT01084538|593036925|FG000|Overall Study|Lack of effectiveness|2|||
164183336|NCT01084538|593036925|FG000|Overall Study|Patient noncompliance|2|||
164183337|NCT01084538|593036925|FG000|Overall Study|Hyperphosphatemia|2|||
164183338|NCT01084538|593036925|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
164183339|NCT01084538|593036925|FG000|Overall Study|Change of residence|2|||
164183340|NCT01084538|593036925|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
164183341|NCT01084538|593036925|FG000|Overall Study|Reason unknown|8|||
164183342|NCT03742258|593036926|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
164183343|NCT03742258|593036927|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
164183344|NCT03742258|593036928|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
164183345|NCT03742258|593036926|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
164183346|NCT03742258|593036927|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
164183347|NCT03742258|593036928|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
164183348|NCT03742258|593036926|FG000|Survival Follow-Up|Still in Follow-up|0|||
164183349|NCT03742258|593036927|FG001|Survival Follow-Up|Still in Follow-up|0|||
164183350|NCT03742258|593036928|FG002|Survival Follow-Up|Still in Follow-up|2|||
164183351|NCT01687283|593038900|FG000|Overall Study|Adverse Event|11|||
164183352|NCT01687283|593038901|FG001|Overall Study|Adverse Event|4|||
164183353|NCT01687283|593038900|FG000|Overall Study|Lack of Efficacy|3|||
164183354|NCT01687283|593038901|FG001|Overall Study|Lack of Efficacy|1|||
164183355|NCT01687283|593038900|FG000|Overall Study|Protocol Violation|1|||
164183356|NCT01687283|593038901|FG001|Overall Study|Protocol Violation|3|||
164183357|NCT01687283|593038900|FG000|Overall Study|protocol defined stopping criteria|8|||
164183358|NCT01687283|593038901|FG001|Overall Study|protocol defined stopping criteria|10|||
164183359|NCT01687283|593038900|FG000|Overall Study|Lost to Follow-up|1|||
164183360|NCT01687283|593038901|FG001|Overall Study|Lost to Follow-up|1|||
164183361|NCT01687283|593038900|FG000|Overall Study|Investigator discretion|2|||
164183362|NCT01687283|593038901|FG001|Overall Study|Investigator discretion|0|||
164183363|NCT01687283|593038900|FG000|Overall Study|Withdrawal by Subject|9|||
164183364|NCT01687283|593038901|FG001|Overall Study|Withdrawal by Subject|8|||
164183365|NCT02442206|593038902|FG000|Period 1|Adverse Event|1|||
164183366|NCT02442206|593038903|FG001|Period 1|Adverse Event|1|||
164183367|NCT02442206|593038902|FG000|Period 1|withdrew consent|0|||
164183368|NCT02442206|593038903|FG001|Period 1|withdrew consent|1|||
164183369|NCT02442206|593038902|FG000|Period 1|COPD exacerbation|0|||
164183370|NCT02442206|593038903|FG001|Period 1|COPD exacerbation|1|||
164183371|NCT02442206|593038902|FG000|Period 2|Adverse Event|1|||
164183372|NCT02442206|593038903|FG001|Period 2|Adverse Event|0|||
164183373|NCT00497146|593038904|FG000|Treatment Period|Adverse Event|6|||
164183374|NCT00497146|593038905|FG001|Treatment Period|Adverse Event|2|||
164183375|NCT00497146|593038904|FG000|Treatment Period|Withdrawal by Subject|5|||
164183376|NCT00497146|593038905|FG001|Treatment Period|Withdrawal by Subject|9|||
164183377|NCT00497146|593038904|FG000|Treatment Period|Lost to Follow-up|1|||
164183378|NCT00497146|593038905|FG001|Treatment Period|Lost to Follow-up|3|||
164183379|NCT00497146|593038904|FG000|Treatment Period|Required dialysis|4|||
164183380|NCT00497146|593038905|FG001|Treatment Period|Required dialysis|1|||
164183381|NCT00497146|593038904|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
164183382|NCT00497146|593038905|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
164183383|NCT00497146|593038904|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
164183384|NCT00497146|593038905|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
164183385|NCT00497146|593038904|FG000|Treatment Period|Other Reason|2|||
164183386|NCT00497146|593038905|FG001|Treatment Period|Other Reason|3|||
164183387|NCT00497146|593038904|FG000|Long-term Follow-up Period|Adverse Event|2|||
164183388|NCT00497146|593038905|FG001|Long-term Follow-up Period|Adverse Event|2|||
164183389|NCT00497146|593038904|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
164183390|NCT00497146|593038905|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
164183391|NCT00497146|593038904|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
164183392|NCT00497146|593038905|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
164183393|NCT00497146|593038904|FG000|Long-term Follow-up Period|Other|0|||
164183394|NCT00497146|593038905|FG001|Long-term Follow-up Period|Other|1|||
164183395|NCT01471444|593038906|FG000|Overall Study|Physician Decision|3|||
164183396|NCT01471444|593038907|FG001|Overall Study|Physician Decision|2|||
164183397|NCT01471444|593038906|FG000|Overall Study|Withdrawal by Subject|0|||
164183398|NCT01471444|593038907|FG001|Overall Study|Withdrawal by Subject|1|||
164183399|NCT03915626|593038908|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
164183400|NCT02107313|593038911|FG000|Overall Study|One participant did not do the FED cohor|0|||
164183401|NCT02107313|593038912|FG001|Overall Study|One participant did not do the FED cohor|1|||
164183402|NCT01031004|593038915|FG000|Overall Study|Protocol Violation|0|||
164183403|NCT01031004|593038916|FG001|Overall Study|Protocol Violation|1|||
164183404|NCT01031004|593038915|FG000|Overall Study|Lost to Follow-up|1|||
164183405|NCT01031004|593038916|FG001|Overall Study|Lost to Follow-up|0|||
164183406|NCT00582426|593038924|FG000|Overall Study|Lost to Follow-up|0|||
164183407|NCT00582426|593038925|FG001|Overall Study|Lost to Follow-up|2|||
164183408|NCT00582426|593038924|FG000|Overall Study|Adverse Event|4|||
164183410|NCT00582426|593038924|FG000|Overall Study|Protocol Violation|6|||
164183411|NCT00582426|593038925|FG001|Overall Study|Protocol Violation|2|||
164183412|NCT00582426|593038924|FG000|Overall Study|Death|4|||
164183413|NCT00582426|593038925|FG001|Overall Study|Death|3|||
164183414|NCT00582426|593038924|FG000|Overall Study|Withdrawal by Subject|3|||
164183415|NCT00582426|593038925|FG001|Overall Study|Withdrawal by Subject|2|||
164183416|NCT00582426|593038924|FG000|Overall Study|Disease Progression|2|||
164183417|NCT00582426|593038925|FG001|Overall Study|Disease Progression|2|||
164183418|NCT00582426|593038924|FG000|Overall Study|Use of illicit drugs|1|||
164183419|NCT00582426|593038925|FG001|Overall Study|Use of illicit drugs|0|||
164183420|NCT00662311|593038928|FG000|Overall Study|Respiratory Infection|1|||
164183421|NCT00662311|593038929|FG001|Overall Study|Respiratory Infection|0|||
164183422|NCT00662311|593038930|FG002|Overall Study|Respiratory Infection|0|||
164183423|NCT02164318|593038931|FG000|Overall Study|Withdrawal by Subject|0|||
164183424|NCT02164318|593038932|FG001|Overall Study|Withdrawal by Subject|1|||
164183425|NCT02164318|593038933|FG002|Overall Study|Withdrawal by Subject|0|||
164183426|NCT02164318|593038934|FG003|Overall Study|Withdrawal by Subject|1|||
164183427|NCT04727528|593038935|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
164183428|NCT04727528|593038936|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
164183429|NCT04727528|593038935|FG000|Open-label Period|Randomized who did not receive treatment|1|||
164183430|NCT04727528|593038936|FG001|Open-label Period|Randomized who did not receive treatment|0|||
164183431|NCT04727528|593038935|FG000|Double-blind Treatment Phase|Adverse Event|0|||
164183432|NCT04727528|593038936|FG001|Double-blind Treatment Phase|Adverse Event|1|||
164183433|NCT04727528|593038935|FG000|Double-blind Treatment Phase|Death|0|||
164183434|NCT04727528|593038936|FG001|Double-blind Treatment Phase|Death|1|||
164183435|NCT04727528|593038935|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
164183436|NCT04727528|593038936|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
164183437|NCT04727528|593038935|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
164183438|NCT04727528|593038936|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
164183439|NCT04727528|593038935|FG000|Double-blind Treatment Phase|Physician Decision|0|||
164183440|NCT04727528|593038936|FG001|Double-blind Treatment Phase|Physician Decision|1|||
164183441|NCT04727528|593038935|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
164183442|NCT04727528|593038936|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
164183443|NCT02335346|593038940|FG000|Overall Study|Adverse Event|11|||
164183444|NCT02335346|593038940|FG000|Overall Study|Withdrawal by Subject|1|||
164183445|NCT01964989|593038941|FG000|Overall Study|Protocol Violation|3|||
164183446|NCT01964989|593038942|FG001|Overall Study|Protocol Violation|4|||
164183447|NCT01964989|593038941|FG000|Overall Study|Administrative Reason|103|||
164183448|NCT01964989|593038942|FG001|Overall Study|Administrative Reason|95|||
164183449|NCT01964989|593038941|FG000|Overall Study|Adverse Event|0|||
164183450|NCT01964989|593038942|FG001|Overall Study|Adverse Event|1|||
164183451|NCT01964989|593038941|FG000|Overall Study|Death|1|||
164183452|NCT01964989|593038942|FG001|Overall Study|Death|3|||
164183453|NCT01964989|593038941|FG000|Overall Study|Withdrawal by Subject|156|||
164183454|NCT01964989|593038942|FG001|Overall Study|Withdrawal by Subject|160|||
164183455|NCT01964989|593038941|FG000|Overall Study|Lost to Follow-up|254|||
164183456|NCT01964989|593038942|FG001|Overall Study|Lost to Follow-up|232|||
164183457|NCT01964989|593038941|FG000|Overall Study|Other|267|||
164183458|NCT01964989|593038942|FG001|Overall Study|Other|252|||
164183459|NCT02769312|593038943|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
164183460|NCT02769312|593038944|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
164183461|NCT02769312|593038943|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
164183462|NCT02769312|593038944|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
164183463|NCT02769312|593038943|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
164183464|NCT02769312|593038944|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
164183465|NCT02769312|593038943|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
164183466|NCT02769312|593038944|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
164183467|NCT02769312|593038943|FG000|Follow-up|Lost to Follow-up|1|||
164183468|NCT02769312|593038944|FG001|Follow-up|Lost to Follow-up|1|||
164183469|NCT01148459|593038947|FG000|Overall Study|Serious Adverse Event|5|||
164183470|NCT01148459|593038948|FG001|Overall Study|Serious Adverse Event|4|||
164183471|NCT01148459|593038947|FG000|Overall Study|Withdrawal by Subject|1|||
164183472|NCT01148459|593038948|FG001|Overall Study|Withdrawal by Subject|0|||
164183473|NCT01148459|593038947|FG000|Overall Study|Migrated/moved from study area|3|||
164183474|NCT01148459|593038948|FG001|Overall Study|Migrated/moved from study area|6|||
164183475|NCT01148459|593038947|FG000|Overall Study|Lost to Follow-up|2|||
164183476|NCT01148459|593038948|FG001|Overall Study|Lost to Follow-up|0|||
164183477|NCT01148459|593038947|FG000|Overall Study|Refusal|1|||
164183478|NCT01148459|593038948|FG001|Overall Study|Refusal|0|||
164183479|NCT01148459|593038947|FG000|Overall Study|Failure to comply with study procedures|0|||
164183480|NCT01148459|593038948|FG001|Overall Study|Failure to comply with study procedures|1|||
164183481|NCT02496039|593038949|FG000|Overall Study|Adverse Event|3|||
164183482|NCT02496039|593038949|FG000|Overall Study|Protocol Violation|1|||
164183483|NCT01038752|593038950|FG000|Overall Study|Tumor Progression|2|||
164183484|NCT01038752|593038951|FG001|Overall Study|Tumor Progression|2|||
164183485|NCT01038752|593038950|FG000|Overall Study|Lost to Follow-up|3|||
164183486|NCT01038752|593038951|FG001|Overall Study|Lost to Follow-up|3|||
164183487|NCT02700698|593038952|FG000|Overall Study|Withdrawal by Subject|1|||
164183488|NCT02700698|593038953|FG001|Overall Study|Withdrawal by Subject|0|||
164183489|NCT00703118|593038954|FG000|Overall Study|Adverse Event|1|||
164183490|NCT00703118|593038955|FG001|Overall Study|Adverse Event|2|||
164183491|NCT00703118|593038956|FG002|Overall Study|Adverse Event|2|||
164183492|NCT00703118|593038954|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
164183493|NCT00703118|593038955|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
164183494|NCT00703118|593038956|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
164183495|NCT00703118|593038954|FG000|Overall Study|Lost to Follow-up|6|||
164183496|NCT00703118|593038955|FG001|Overall Study|Lost to Follow-up|4|||
164183497|NCT00703118|593038956|FG002|Overall Study|Lost to Follow-up|4|||
164183498|NCT00703118|593038954|FG000|Overall Study|Withdrawal by Subject|8|||
164183499|NCT00703118|593038955|FG001|Overall Study|Withdrawal by Subject|7|||
164183500|NCT00703118|593038956|FG002|Overall Study|Withdrawal by Subject|13|||
164183501|NCT00703118|593038954|FG000|Overall Study|Other|0|||
164183502|NCT00703118|593038955|FG001|Overall Study|Other|0|||
164183503|NCT00703118|593038956|FG002|Overall Study|Other|1|||
164183504|NCT05053035|593038959|FG000|Overall Study|Withdrawal by Subject|1|||
164183505|NCT05053035|593038960|FG001|Overall Study|Withdrawal by Subject|0|||
164183506|NCT02005627|593038964|FG000|Overall Study|Lost to Follow-up|1|||
164183507|NCT02005627|593038965|FG001|Overall Study|Lost to Follow-up|2|||
164183508|NCT02005627|593038964|FG000|Overall Study|Withdrawal by Subject|1|||
164183509|NCT02005627|593038965|FG001|Overall Study|Withdrawal by Subject|2|||
164183510|NCT03760458|593038966|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
164183511|NCT03760458|593038967|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
164183512|NCT03760458|593038968|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
164183513|NCT03760458|593038969|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
164183514|NCT03760458|593038970|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
164183515|NCT00750919|593038971|FG000|Overall Study|Adverse Event|9|||
164183516|NCT00750919|593038971|FG000|Overall Study|Withdrawal by Subject|1|||
164183517|NCT00750919|593038971|FG000|Overall Study|Lack of Efficacy|8|||
164183518|NCT00750919|593038971|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
164183519|NCT00750919|593038971|FG000|Overall Study|Other|36|||
164183520|NCT00048997|593038976|FG000|Overall Study|Protocol Violation|7|||
164183521|NCT00048997|593038977|FG001|Overall Study|Protocol Violation|2|||
164183522|NCT00048997|593038976|FG000|Overall Study|Withdrawal by Subject|6|||
164183523|NCT00048997|593038977|FG001|Overall Study|Withdrawal by Subject|1|||
164183524|NCT00002525|593038984|FG000|Overall Study|Adverse Event|36|||
164183525|NCT00002525|593038985|FG001|Overall Study|Adverse Event|0|||
164183526|NCT00002525|593038984|FG000|Overall Study|Death|5|||
164183527|NCT00002525|593038985|FG001|Overall Study|Death|0|||
164183528|NCT00002525|593038984|FG000|Overall Study|Withdrawal by Subject|11|||
164183529|NCT00002525|593038985|FG001|Overall Study|Withdrawal by Subject|0|||
164183530|NCT00002525|593038984|FG000|Overall Study|Start non-protocol therapy|1|||
164183531|NCT00002525|593038985|FG001|Overall Study|Start non-protocol therapy|0|||
164183532|NCT00002525|593038984|FG000|Overall Study|Other complicating disease|1|||
164183533|NCT00002525|593038985|FG001|Overall Study|Other complicating disease|0|||
164183534|NCT00002525|593038984|FG000|Overall Study|Duke's A, B1, D disease|92|||
164183535|NCT00002525|593038985|FG001|Overall Study|Duke's A, B1, D disease|0|||
164183536|NCT00002525|593038984|FG000|Overall Study|Error|6|||
164183537|NCT00002525|593038985|FG001|Overall Study|Error|0|||
164183538|NCT00002525|593038984|FG000|Overall Study|Other|26|||
164183539|NCT00002525|593038985|FG001|Overall Study|Other|0|||
164183540|NCT00002525|593038984|FG000|Overall Study|Never start protocol therapy|8|||
164183541|NCT00002525|593038985|FG001|Overall Study|Never start protocol therapy|0|||
164183542|NCT03304184|593038986|FG000|Overall Study|Withdrawal by Subject|1|||
164183543|NCT03304184|593038987|FG001|Overall Study|Withdrawal by Subject|2|||
164183544|NCT04527978|593038991|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
164183545|NCT04527978|593038992|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
164183546|NCT02112877|593038994|FG000|Overall Study|Withdrawal by Subject|1|||
164183547|NCT02112877|593038995|FG001|Overall Study|Withdrawal by Subject|7|||
164183548|NCT02112877|593038994|FG000|Overall Study|Visit Missed|1|||
164183549|NCT02112877|593038995|FG001|Overall Study|Visit Missed|6|||
164183550|NCT01490697|593039006|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
164183551|NCT01490697|593039007|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
164183552|NCT00090584|593039008|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
164183553|NCT00090584|593039009|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
164183554|NCT00090584|593039008|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
164183555|NCT00090584|593039009|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
164183556|NCT00379808|593039010|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
164183557|NCT00379808|593039011|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
164183558|NCT01578499|593039012|FG000|Overall Study|Reason not Specified|0|||
164183559|NCT01578499|593039013|FG001|Overall Study|Reason not Specified|1|||
164183560|NCT01578499|593039012|FG000|Overall Study|Lost to Follow-up|2|||
164183561|NCT01578499|593039013|FG001|Overall Study|Lost to Follow-up|1|||
164183562|NCT01578499|593039012|FG000|Overall Study|Withdrawal by Subject|10|||
164183563|NCT01578499|593039013|FG001|Overall Study|Withdrawal by Subject|16|||
164183564|NCT01578499|593039012|FG000|Overall Study|Death|20|||
164183565|NCT01578499|593039013|FG001|Overall Study|Death|25|||
164183566|NCT01578499|593039012|FG000|Overall Study|Died and End of Study Page not Completed|2|||
164183567|NCT01578499|593039013|FG001|Overall Study|Died and End of Study Page not Completed|0|||
164183568|NCT00508157|593039014|FG000|Overall Study|Adverse Event|0|||
164183569|NCT00508157|593039015|FG001|Overall Study|Adverse Event|1|||
164183570|NCT00508157|593039014|FG000|Overall Study|Subject Withdrew Consent|1|||
164183571|NCT00508157|593039015|FG001|Overall Study|Subject Withdrew Consent|0|||
164183572|NCT00508157|593039014|FG000|Overall Study|Lost to Follow-up|1|||
164183573|NCT00508157|593039015|FG001|Overall Study|Lost to Follow-up|0|||
164183574|NCT00508157|593039014|FG000|Overall Study|Subject no longer met study criteria|0|||
164183575|NCT00508157|593039015|FG001|Overall Study|Subject no longer met study criteria|1|||
164183576|NCT00508157|593039014|FG000|Overall Study|Other known cause|0|||
164183577|NCT00508157|593039015|FG001|Overall Study|Other known cause|1|||
164183578|NCT01987232|593039016|FG000|Overall Study|Ongoing in Study|0|||
164183579|NCT01987232|593039017|FG001|Overall Study|Ongoing in Study|0|||
164183580|NCT01987232|593039018|FG002|Overall Study|Ongoing in Study|0|||
164183581|NCT01987232|593039019|FG003|Overall Study|Ongoing in Study|1|||
164183582|NCT01987232|593039020|FG004|Overall Study|Ongoing in Study|0|||
164183583|NCT01952080|593039022|FG000|Overall Study|Withdrawal by Subject|0|||
164183584|NCT01952080|593039023|FG001|Overall Study|Withdrawal by Subject|0|||
164183585|NCT01952080|593039024|FG002|Overall Study|Withdrawal by Subject|0|||
164183586|NCT01952080|593039025|FG003|Overall Study|Withdrawal by Subject|1|||
164183587|NCT01952080|593039022|FG000|Overall Study|Protocol Non-compliance|0|||
164183588|NCT01952080|593039023|FG001|Overall Study|Protocol Non-compliance|1|||
164183589|NCT01952080|593039024|FG002|Overall Study|Protocol Non-compliance|0|||
164183590|NCT01952080|593039025|FG003|Overall Study|Protocol Non-compliance|0|||
164183591|NCT01333956|593039036|FG000|Overall Study|Lost to Follow-up|1|||
164183592|NCT01333956|593039037|FG001|Overall Study|Lost to Follow-up|2|||
164183593|NCT01333956|593039038|FG002|Overall Study|Lost to Follow-up|0|||
164183594|NCT01333956|593039039|FG003|Overall Study|Lost to Follow-up|1|||
164183595|NCT01333956|593039036|FG000|Overall Study|Unable to complete study procedure|1|||
164183596|NCT01333956|593039037|FG001|Overall Study|Unable to complete study procedure|0|||
164183597|NCT01333956|593039038|FG002|Overall Study|Unable to complete study procedure|0|||
164183598|NCT01333956|593039039|FG003|Overall Study|Unable to complete study procedure|1|||
164183599|NCT01333956|593039036|FG000|Overall Study|Withdrawal by Subject|0|||
164183600|NCT01333956|593039037|FG001|Overall Study|Withdrawal by Subject|2|||
164183601|NCT01333956|593039038|FG002|Overall Study|Withdrawal by Subject|1|||
164183602|NCT01333956|593039039|FG003|Overall Study|Withdrawal by Subject|0|||
164183603|NCT02134353|593039040|FG000|Overall Study|Adverse Event|10|||
164183604|NCT02134353|593039041|FG001|Overall Study|Adverse Event|6|||
164183605|NCT02134353|593039040|FG000|Overall Study|Lost to Follow-up|1|||
164183606|NCT02134353|593039041|FG001|Overall Study|Lost to Follow-up|1|||
164183607|NCT02134353|593039040|FG000|Overall Study|Lack of Efficacy|2|||
164183608|NCT02134353|593039041|FG001|Overall Study|Lack of Efficacy|1|||
164183609|NCT02134353|593039040|FG000|Overall Study|Withdrawal by Subject|12|||
164183610|NCT02134353|593039041|FG001|Overall Study|Withdrawal by Subject|13|||
164183611|NCT02134353|593039040|FG000|Overall Study|Death|0|||
164183612|NCT02134353|593039041|FG001|Overall Study|Death|1|||
164183613|NCT02134353|593039040|FG000|Overall Study|Pregnancy|0|||
164183614|NCT02134353|593039041|FG001|Overall Study|Pregnancy|1|||
164183615|NCT02134353|593039040|FG000|Overall Study|Relocation|1|||
164183616|NCT02134353|593039041|FG001|Overall Study|Relocation|0|||
164183617|NCT02134353|593039040|FG000|Overall Study|Other - Patient's Choice|0|||
164183618|NCT02134353|593039041|FG001|Overall Study|Other - Patient's Choice|1|||
164183619|NCT00655681|593039044|FG000|Overall Study|Lost to Follow-up|1|||
164183620|NCT00655681|593039045|FG001|Overall Study|Lost to Follow-up|1|||
164183621|NCT01783821|593039049|FG000|Overall Study|Screen Failure|1|||
164183622|NCT01783821|593039050|FG001|Overall Study|Screen Failure|1|||
164183623|NCT01653327|593039057|FG000|Overall Study|Withdrawal by Subject|1|||
164183624|NCT00422292|593039058|FG000|Overall Study|Serious adverse events|1|||
164183625|NCT00422292|593039059|FG001|Overall Study|Serious adverse events|4|||
164183626|NCT00422292|593039060|FG002|Overall Study|Serious adverse events|0|||
164183627|NCT00422292|593039061|FG003|Overall Study|Serious adverse events|0|||
164183628|NCT00422292|593039058|FG000|Overall Study|Adverse Event|1|||
164183629|NCT00422292|593039059|FG001|Overall Study|Adverse Event|0|||
164183630|NCT00422292|593039060|FG002|Overall Study|Adverse Event|1|||
164183631|NCT00422292|593039061|FG003|Overall Study|Adverse Event|0|||
164183632|NCT00422292|593039058|FG000|Overall Study|Protocol Violation|4|||
164183633|NCT00422292|593039059|FG001|Overall Study|Protocol Violation|25|||
164183634|NCT00422292|593039060|FG002|Overall Study|Protocol Violation|8|||
164183635|NCT00422292|593039061|FG003|Overall Study|Protocol Violation|5|||
164183636|NCT00422292|593039058|FG000|Overall Study|Lost to Follow-up|6|||
164183637|NCT00422292|593039059|FG001|Overall Study|Lost to Follow-up|12|||
164183638|NCT00422292|593039060|FG002|Overall Study|Lost to Follow-up|6|||
164183639|NCT00422292|593039061|FG003|Overall Study|Lost to Follow-up|6|||
164183640|NCT00422292|593039058|FG000|Overall Study|Withdrawal by Subject|6|||
164183641|NCT00422292|593039059|FG001|Overall Study|Withdrawal by Subject|25|||
164183642|NCT00422292|593039060|FG002|Overall Study|Withdrawal by Subject|7|||
164183643|NCT00422292|593039061|FG003|Overall Study|Withdrawal by Subject|13|||
164183644|NCT02440854|593039062|FG000|Overall Study|Relocation of patient|1|||
164183645|NCT02440854|593039062|FG000|Overall Study|Death|6|||
164183646|NCT02440854|593039062|FG000|Overall Study|Lost to Follow-up|10|||
164183647|NCT02440854|593039062|FG000|Overall Study|Afatinib discontinuation|46|||
164183648|NCT02440854|593039062|FG000|Overall Study|stopped study at earlier timepoint|14|||
164183649|NCT02440854|593039062|FG000|Overall Study|Study medication not received|1|||
164183650|NCT02440854|593039062|FG000|Overall Study|Violation of inclusion criteria|2|||
164183651|NCT02243046|593039063|FG000|Overall Study|Lost to Follow-up|1|||
164183652|NCT02243046|593039064|FG001|Overall Study|Lost to Follow-up|1|||
164183653|NCT02243046|593039065|FG002|Overall Study|Lost to Follow-up|4|||
164183654|NCT02669082|593039066|FG000|Overall Study|Adverse Event|1|||
164183655|NCT04918355|593039067|FG000|Overall Study|no qualifying health encounter|497|||
164183656|NCT04918355|593039068|FG001|Overall Study|no qualifying health encounter|192|||
164183657|NCT04918355|593039069|FG002|Overall Study|no qualifying health encounter|438|||
164183658|NCT04918355|593039070|FG003|Overall Study|no qualifying health encounter|424|||
164183659|NCT04683939|593039074|FG000|Overall Study|Study termination by the sponsor|0|||
164183660|NCT04683939|593039075|FG001|Overall Study|Study termination by the sponsor|1|||
164183661|NCT04683939|593039076|FG002|Overall Study|Study termination by the sponsor|2|||
164183662|NCT04683939|593039077|FG003|Overall Study|Study termination by the sponsor|2|||
164183663|NCT04683939|593039074|FG000|Overall Study|Death|1|||
164183664|NCT04683939|593039075|FG001|Overall Study|Death|1|||
164183665|NCT04683939|593039076|FG002|Overall Study|Death|2|||
164183666|NCT04683939|593039077|FG003|Overall Study|Death|1|||
164183667|NCT04683939|593039074|FG000|Overall Study|Withdrawal by Subject|1|||
164183668|NCT04683939|593039075|FG001|Overall Study|Withdrawal by Subject|0|||
164183669|NCT04683939|593039076|FG002|Overall Study|Withdrawal by Subject|0|||
164183670|NCT04683939|593039077|FG003|Overall Study|Withdrawal by Subject|0|||
164183671|NCT04683939|593039074|FG000|Overall Study|Physician Decision|1|||
164183672|NCT04683939|593039075|FG001|Overall Study|Physician Decision|0|||
164183673|NCT04683939|593039076|FG002|Overall Study|Physician Decision|0|||
164183674|NCT04683939|593039077|FG003|Overall Study|Physician Decision|0|||
164183675|NCT04683939|593039074|FG000|Overall Study|Lost to Follow-up|0|||
164183676|NCT04683939|593039075|FG001|Overall Study|Lost to Follow-up|1|||
164183677|NCT04683939|593039076|FG002|Overall Study|Lost to Follow-up|0|||
164183678|NCT04683939|593039077|FG003|Overall Study|Lost to Follow-up|0|||
164183679|NCT04852276|593039078|FG000|Overall Study|Death|2|||
164183680|NCT04852276|593039079|FG001|Overall Study|Death|0|||
164183681|NCT04852276|593039078|FG000|Overall Study|Lost to Follow-up|15|||
164183682|NCT04852276|593039079|FG001|Overall Study|Lost to Follow-up|9|||
164183683|NCT04852276|593039078|FG000|Overall Study|Withdrawal by Subject|26|||
164183684|NCT04852276|593039079|FG001|Overall Study|Withdrawal by Subject|6|||
164183685|NCT00385827|593040491|FG000|Part 1|Adverse Event|1|||
164183686|NCT00385827|593040492|FG001|Part 1|Adverse Event|0|||
164183687|NCT00385827|593040493|FG002|Part 1|Adverse Event|0|||
164183688|NCT00385827|593040491|FG000|Part 1|Death|2|||
164183689|NCT00385827|593040492|FG001|Part 1|Death|0|||
164183690|NCT00385827|593040493|FG002|Part 1|Death|0|||
164183691|NCT00385827|593040491|FG000|Part 1|Lack of Efficacy|5|||
164183692|NCT00385827|593040492|FG001|Part 1|Lack of Efficacy|0|||
164183693|NCT00385827|593040493|FG002|Part 1|Lack of Efficacy|0|||
164183694|NCT00385827|593040491|FG000|Part 1|Other|1|||
164183695|NCT00385827|593040492|FG001|Part 1|Other|0|||
164183696|NCT00385827|593040493|FG002|Part 1|Other|0|||
164183697|NCT00385827|593040491|FG000|Part 2|Adverse Event|0|||
164183698|NCT00385827|593040492|FG001|Part 2|Adverse Event|6|||
164183699|NCT00385827|593040493|FG002|Part 2|Adverse Event|10|||
164183700|NCT00385827|593040491|FG000|Part 2|Death|0|||
164183701|NCT00385827|593040492|FG001|Part 2|Death|0|||
164183702|NCT00385827|593040493|FG002|Part 2|Death|2|||
164183703|NCT00385827|593040491|FG000|Part 2|Lack of Efficacy|0|||
164183704|NCT00385827|593040492|FG001|Part 2|Lack of Efficacy|14|||
164183705|NCT00385827|593040493|FG002|Part 2|Lack of Efficacy|13|||
164183706|NCT00385827|593040491|FG000|Part 2|Randomized but not treated|0|||
164183707|NCT00385827|593040492|FG001|Part 2|Randomized but not treated|2|||
164183708|NCT00385827|593040493|FG002|Part 2|Randomized but not treated|2|||
164183709|NCT00385827|593040491|FG000|Part 2|Other|0|||
164183710|NCT00385827|593040492|FG001|Part 2|Other|11|||
164183711|NCT00385827|593040493|FG002|Part 2|Other|21|||
164183712|NCT00410072|593040494|FG000|Day 1 to Week 48|Adverse Event|1|||
164183713|NCT00410072|593040495|FG001|Day 1 to Week 48|Adverse Event|2|||
164183714|NCT00410072|593040494|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
164183715|NCT00410072|593040495|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
164183716|NCT00410072|593040494|FG000|Day 1 to Week 48|Other|0|||
164183717|NCT00410072|593040495|FG001|Day 1 to Week 48|Other|1|||
164183718|NCT00410072|593040494|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
164183719|NCT00410072|593040495|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
164183720|NCT00410072|593040494|FG000|Day 1 to Week 48|Pregnancy|0|||
164183721|NCT00410072|593040495|FG001|Day 1 to Week 48|Pregnancy|2|||
164183722|NCT00410072|593040494|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
164183723|NCT00410072|593040495|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
164183724|NCT00410072|593040494|FG000|After Week 48 to Week 96|Adverse Event|1|||
164183725|NCT00410072|593040495|FG001|After Week 48 to Week 96|Adverse Event|2|||
164183726|NCT00410072|593040494|FG000|After Week 48 to Week 96|Death|0|||
164183727|NCT00410072|593040495|FG001|After Week 48 to Week 96|Death|1|||
164183728|NCT00410072|593040494|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
164183729|NCT00410072|593040495|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
164183730|NCT00410072|593040494|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
164183731|NCT00410072|593040495|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
164183732|NCT00410072|593040494|FG000|After Week 48 to Week 96|Other|2|||
164183733|NCT00410072|593040495|FG001|After Week 48 to Week 96|Other|0|||
164183734|NCT00410072|593040494|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
164183735|NCT00410072|593040495|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
164183736|NCT00410072|593040494|FG000|After Week 48 to Week 96|Pregnancy|0|||
164183737|NCT00410072|593040495|FG001|After Week 48 to Week 96|Pregnancy|2|||
164183738|NCT00410072|593040494|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
164183739|NCT00410072|593040495|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
164183740|NCT01421147|593040496|FG000|Treatment Period|Adverse Event|2|||
164183741|NCT01421147|593040497|FG001|Treatment Period|Adverse Event|3|||
164183742|NCT01421147|593040496|FG000|Treatment Period|Lost to Follow-up|2|||
164183743|NCT01421147|593040497|FG001|Treatment Period|Lost to Follow-up|1|||
164183744|NCT01421147|593040496|FG000|Treatment Period|Physician Decision|2|||
164183745|NCT01421147|593040497|FG001|Treatment Period|Physician Decision|2|||
164183746|NCT01421147|593040496|FG000|Treatment Period|Withdrawal by Subject|10|||
164183747|NCT01421147|593040497|FG001|Treatment Period|Withdrawal by Subject|5|||
164183748|NCT01421147|593040496|FG000|Extension Period|Adverse Event|0|||
164183749|NCT01421147|593040497|FG001|Extension Period|Adverse Event|2|||
164183750|NCT01421147|593040496|FG000|Extension Period|Death|0|||
164183751|NCT01421147|593040497|FG001|Extension Period|Death|1|||
164183752|NCT01421147|593040496|FG000|Extension Period|Lost to Follow-up|2|||
164183753|NCT01421147|593040497|FG001|Extension Period|Lost to Follow-up|5|||
164183754|NCT01421147|593040496|FG000|Extension Period|Physician Decision|1|||
164183755|NCT01421147|593040497|FG001|Extension Period|Physician Decision|0|||
164183756|NCT01421147|593040496|FG000|Extension Period|Withdrawal by Subject|5|||
164183757|NCT01421147|593040497|FG001|Extension Period|Withdrawal by Subject|3|||
164183758|NCT00904917|593040500|FG000|Overall Study|Lost to Follow-up|2|||
164183759|NCT00904917|593040501|FG001|Overall Study|Lost to Follow-up|2|||
164183760|NCT00904917|593040502|FG002|Overall Study|Lost to Follow-up|2|||
164183761|NCT00904917|593040503|FG003|Overall Study|Lost to Follow-up|2|||
164183762|NCT05025332|593040504|FG000|Screening|Screen failure|12|||
164183763|NCT05025332|593040504|FG000|Treatment & Follow Up|Protocol Violation|1|||
164183764|NCT05025332|593040504|FG000|Treatment & Follow Up|Adverse Event|4|||
164183765|NCT01299896|593040505|FG000|Overall Study|Withdrawal by Subject|1|||
164183766|NCT01299896|593040506|FG001|Overall Study|Withdrawal by Subject|7|||
164183767|NCT01299896|593040505|FG000|Overall Study|Lost to Follow-up|0|||
164183768|NCT01299896|593040506|FG001|Overall Study|Lost to Follow-up|11|||
164183769|NCT01467271|593040507|FG000|Overall Study|Death|84|||
164183770|NCT01467271|593040507|FG000|Overall Study|Lost to Follow-up|83|||
164183771|NCT01467271|593040507|FG000|Overall Study|Retraction of patient's consent|21|||
164183772|NCT01467271|593040507|FG000|Overall Study|Other reason|14|||
164183773|NCT01411319|593040512|FG000|Overall Study|Lost to Follow-up|1|||
164183774|NCT02815267|593040513|FG000|Double-Blind Phase|Adverse Event|0|||
164183775|NCT02815267|593040514|FG001|Double-Blind Phase|Adverse Event|3|||
164183776|NCT02815267|593040513|FG000|Double-Blind Phase|Lost to Follow-up|17|||
164183777|NCT02815267|593040514|FG001|Double-Blind Phase|Lost to Follow-up|9|||
164183778|NCT02815267|593040513|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
164183779|NCT02815267|593040514|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
164183780|NCT02815267|593040513|FG000|Double-Blind Phase|Protocol Violation|3|||
164183781|NCT02815267|593040514|FG001|Double-Blind Phase|Protocol Violation|2|||
164183782|NCT02815267|593040513|FG000|Double-Blind Phase|Site withdrawal|1|||
164183783|NCT02815267|593040514|FG001|Double-Blind Phase|Site withdrawal|6|||
164183784|NCT02815267|593040513|FG000|Double-Blind Phase|Received a disallowed medication|1|||
164183785|NCT02815267|593040514|FG001|Double-Blind Phase|Received a disallowed medication|1|||
164183786|NCT02815267|593040513|FG000|Open-Label Phase|Adverse Event|1|||
164183787|NCT02815267|593040514|FG001|Open-Label Phase|Adverse Event|1|||
164183788|NCT02815267|593040513|FG000|Open-Label Phase|Lost to Follow-up|23|||
164183789|NCT02815267|593040514|FG001|Open-Label Phase|Lost to Follow-up|9|||
164183790|NCT02815267|593040513|FG000|Open-Label Phase|Withdrawal by Subject|24|||
164183791|NCT02815267|593040514|FG001|Open-Label Phase|Withdrawal by Subject|13|||
164183792|NCT02815267|593040513|FG000|Open-Label Phase|Protocol Violation|0|||
164183793|NCT02815267|593040514|FG001|Open-Label Phase|Protocol Violation|1|||
164183794|NCT02815267|593040513|FG000|Open-Label Phase|Administrative|21|||
164183795|NCT02815267|593040514|FG001|Open-Label Phase|Administrative|12|||
164183796|NCT02815267|593040513|FG000|Open-Label Phase|Other|2|||
164183797|NCT02815267|593040514|FG001|Open-Label Phase|Other|5|||
164183798|NCT04126317|593040528|FG000|Overall Study|Adverse Event|0|||
164183799|NCT04126317|593040529|FG001|Overall Study|Adverse Event|1|||
164183800|NCT04126317|593040528|FG000|Overall Study|Withdrawal by Subject|4|||
164183801|NCT04126317|593040529|FG001|Overall Study|Withdrawal by Subject|1|||
164183802|NCT00660595|593040532|FG000|Overall Study|Lost to Follow-up|0|||
164183803|NCT00660595|593040533|FG001|Overall Study|Lost to Follow-up|1|||
164183804|NCT00660595|593040532|FG000|Overall Study|Did not consent to participate in study|12|||
164183805|NCT00660595|593040533|FG001|Overall Study|Did not consent to participate in study|8|||
164183806|NCT00660595|593040532|FG000|Overall Study|Participant left hospital|1|||
164183807|NCT00660595|593040533|FG001|Overall Study|Participant left hospital|0|||
164183808|NCT00660595|593040532|FG000|Overall Study|Non Specified reasons|5|||
164183809|NCT00660595|593040533|FG001|Overall Study|Non Specified reasons|0|||
164183810|NCT00948922|593040536|FG000|Overall Study|Did not start study treatment|2|||
164183811|NCT00948922|593040537|FG001|Overall Study|Did not start study treatment|5|||
164183812|NCT00948922|593040538|FG002|Overall Study|Did not start study treatment|0|||
164183813|NCT00948922|593040536|FG000|Overall Study|Withdrawal by Subject|0|||
164183814|NCT00948922|593040537|FG001|Overall Study|Withdrawal by Subject|2|||
164183815|NCT00948922|593040538|FG002|Overall Study|Withdrawal by Subject|1|||
164183816|NCT00948922|593040536|FG000|Overall Study|Death|3|||
164183817|NCT00948922|593040537|FG001|Overall Study|Death|0|||
164183818|NCT00948922|593040538|FG002|Overall Study|Death|0|||
164183819|NCT00948922|593040536|FG000|Overall Study|Disease progression|0|||
164183820|NCT00948922|593040537|FG001|Overall Study|Disease progression|1|||
164183821|NCT00948922|593040538|FG002|Overall Study|Disease progression|0|||
164183822|NCT00948922|593040536|FG000|Overall Study|Insurance issues|1|||
164183823|NCT00948922|593040537|FG001|Overall Study|Insurance issues|0|||
164183824|NCT00948922|593040538|FG002|Overall Study|Insurance issues|0|||
164183825|NCT00948922|593040536|FG000|Overall Study|Transplant eligibility issues|2|||
164183826|NCT00948922|593040537|FG001|Overall Study|Transplant eligibility issues|3|||
164183827|NCT00948922|593040538|FG002|Overall Study|Transplant eligibility issues|0|||
164183828|NCT00948922|593040536|FG000|Overall Study|Not evaluable at time of analysis|0|||
164183829|NCT00948922|593040537|FG001|Overall Study|Not evaluable at time of analysis|3|||
164183830|NCT00948922|593040538|FG002|Overall Study|Not evaluable at time of analysis|0|||
164183831|NCT04854057|593040539|FG000|Overall Study|Adverse Event|0|||
164183832|NCT04854057|593040540|FG001|Overall Study|Adverse Event|1|||
164183833|NCT02131233|593040541|FG000|Overall Study|Not Treated|2|||
164183834|NCT02131233|593040542|FG001|Overall Study|Not Treated|3|||
164183835|NCT02131233|593040541|FG000|Overall Study|Adverse Event|7|||
164183836|NCT02131233|593040542|FG001|Overall Study|Adverse Event|6|||
164183837|NCT02131233|593040541|FG000|Overall Study|Death|0|||
164183838|NCT02131233|593040542|FG001|Overall Study|Death|1|||
164183839|NCT02131233|593040541|FG000|Overall Study|Lack of Efficacy|6|||
164183840|NCT02131233|593040542|FG001|Overall Study|Lack of Efficacy|3|||
164183841|NCT02131233|593040541|FG000|Overall Study|Lost to Follow-up|14|||
164183842|NCT02131233|593040542|FG001|Overall Study|Lost to Follow-up|13|||
164183843|NCT02131233|593040541|FG000|Overall Study|Non-Compliance With Study Drug|8|||
164183844|NCT02131233|593040542|FG001|Overall Study|Non-Compliance With Study Drug|5|||
164183845|NCT02131233|593040541|FG000|Overall Study|Physician Decision|7|||
164183846|NCT02131233|593040542|FG001|Overall Study|Physician Decision|0|||
164183847|NCT02131233|593040541|FG000|Overall Study|Pregnancy|4|||
164183848|NCT02131233|593040542|FG001|Overall Study|Pregnancy|0|||
164183849|NCT02131233|593040541|FG000|Overall Study|Withdrawal by Subject|18|||
164183850|NCT02131233|593040542|FG001|Overall Study|Withdrawal by Subject|11|||
164183851|NCT05114564|593040544|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
164183852|NCT05114564|593040545|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
164183853|NCT05114564|593040544|FG000|First Intervention|Adverse Event|0|||
164183854|NCT05114564|593040545|FG001|First Intervention|Adverse Event|1|||
164183855|NCT00255840|593040546|FG000|Overall Study|Lost to Follow-up|10|||
164183856|NCT00255840|593040547|FG001|Overall Study|Lost to Follow-up|14|||
164183857|NCT00255840|593040546|FG000|Overall Study|Discontinued intervention|53|||
164183858|NCT00255840|593040547|FG001|Overall Study|Discontinued intervention|56|||
164183859|NCT01005901|593040552|FG000|Overall Study|Withdrawal by Subject|38|||
164183860|NCT01005901|593040553|FG001|Overall Study|Withdrawal by Subject|14|||
164183861|NCT01005901|593040552|FG000|Overall Study|Adverse Event|30|||
164183862|NCT01005901|593040553|FG001|Overall Study|Adverse Event|16|||
164183863|NCT01005901|593040552|FG000|Overall Study|Administrative problems|21|||
164183864|NCT01005901|593040553|FG001|Overall Study|Administrative problems|13|||
164183865|NCT01005901|593040552|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
164183866|NCT01005901|593040553|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
164183867|NCT01005901|593040552|FG000|Overall Study|Protocol Violation|4|||
164183868|NCT01005901|593040553|FG001|Overall Study|Protocol Violation|3|||
164183869|NCT01005901|593040552|FG000|Overall Study|Death|2|||
164183870|NCT01005901|593040553|FG001|Overall Study|Death|3|||
164183871|NCT01005901|593040552|FG000|Overall Study|Lost to Follow-up|1|||
164183872|NCT01005901|593040553|FG001|Overall Study|Lost to Follow-up|2|||
164183873|NCT01005901|593040552|FG000|Overall Study|Patient's inability to use the device|1|||
164183874|NCT01005901|593040553|FG001|Overall Study|Patient's inability to use the device|1|||
164183875|NCT01005901|593040552|FG000|Overall Study|No longer requires study drug|0|||
164183876|NCT01005901|593040553|FG001|Overall Study|No longer requires study drug|1|||
164183877|NCT00715520|593040558|FG000|Overall Study|Screen failure|8|||
164183878|NCT00715520|593040559|FG001|Overall Study|Screen failure|1|||
164183879|NCT00715520|593040560|FG002|Overall Study|Screen failure|1|||
164183880|NCT00715520|593040558|FG000|Overall Study|Withdrawal by Subject|2|||
164183881|NCT00715520|593040559|FG001|Overall Study|Withdrawal by Subject|0|||
164183882|NCT00715520|593040560|FG002|Overall Study|Withdrawal by Subject|1|||
164183883|NCT01006590|593040561|FG000|Overall Study|Adverse Event|2|||
164183884|NCT01006590|593040562|FG001|Overall Study|Adverse Event|3|||
164183885|NCT01006590|593040561|FG000|Overall Study|Death|1|||
164183886|NCT01006590|593040562|FG001|Overall Study|Death|1|||
164183887|NCT01006590|593040561|FG000|Overall Study|Lost to Follow-up|1|||
164183888|NCT01006590|593040562|FG001|Overall Study|Lost to Follow-up|1|||
164183889|NCT01006590|593040561|FG000|Overall Study|Protocol Violation|1|||
164183890|NCT01006590|593040562|FG001|Overall Study|Protocol Violation|0|||
164183891|NCT01006590|593040561|FG000|Overall Study|Withdrawal by Subject|4|||
164183892|NCT01006590|593040562|FG001|Overall Study|Withdrawal by Subject|2|||
164183893|NCT01006590|593040561|FG000|Overall Study|Study specific discontinuation criteria|16|||
164183894|NCT01006590|593040562|FG001|Overall Study|Study specific discontinuation criteria|23|||
164183895|NCT01006590|593040561|FG000|Overall Study|Other|3|||
164183896|NCT01006590|593040562|FG001|Overall Study|Other|2|||
164183897|NCT03332095|593040563|FG000|Overall Study|Lost to Follow-up|1|||
164183898|NCT03332095|593040564|FG001|Overall Study|Lost to Follow-up|0|||
164183899|NCT03332095|593040563|FG000|Overall Study|Pregnancy|0|||
164183900|NCT03332095|593040564|FG001|Overall Study|Pregnancy|1|||
164183901|NCT04942210|593040568|FG000|Overall Study|Adverse Event|0|||
164183902|NCT04942210|593040569|FG001|Overall Study|Adverse Event|1|||
164183903|NCT04942210|593040568|FG000|Overall Study|Protocol Deviation|4|||
164183904|NCT04942210|593040569|FG001|Overall Study|Protocol Deviation|1|||
164183905|NCT04942210|593040568|FG000|Overall Study|Withdrawal by Subject|5|||
164183906|NCT04942210|593040569|FG001|Overall Study|Withdrawal by Subject|2|||
164183907|NCT04942210|593040568|FG000|Overall Study|Lost to Follow-up|16|||
164183908|NCT04942210|593040569|FG001|Overall Study|Lost to Follow-up|7|||
164183909|NCT04942210|593040568|FG000|Overall Study|Ongoing at the time of DBL date|60|||
164183910|NCT04942210|593040569|FG001|Overall Study|Ongoing at the time of DBL date|25|||
164183911|NCT04942210|593040568|FG000|Overall Study|Randomized but did not receive vaccination|3|||
164183912|NCT04942210|593040569|FG001|Overall Study|Randomized but did not receive vaccination|0|||
164183913|NCT03420222|593040570|FG000|Overall Study|Withdrawal by Subject|5|||
164183914|NCT03420222|593040571|FG001|Overall Study|Withdrawal by Subject|0|||
164183915|NCT03420222|593040570|FG000|Overall Study|Physician Decision|0|||
164183916|NCT03420222|593040571|FG001|Overall Study|Physician Decision|1|||
164183917|NCT02651688|593040572|FG000|Overall Study|Non-compliance|0|||
164183918|NCT02651688|593040573|FG001|Overall Study|Non-compliance|0|||
164183919|NCT02651688|593040574|FG002|Overall Study|Non-compliance|1|||
164183920|NCT02651688|593040572|FG000|Overall Study|Principal Investigator (PI) decision|0|||
164183921|NCT02651688|593040573|FG001|Overall Study|Principal Investigator (PI) decision|2|||
164183922|NCT02651688|593040574|FG002|Overall Study|Principal Investigator (PI) decision|0|||
164183923|NCT02651688|593040572|FG000|Overall Study|Lost to Follow-up|1|||
164183924|NCT02651688|593040573|FG001|Overall Study|Lost to Follow-up|3|||
164183925|NCT02651688|593040574|FG002|Overall Study|Lost to Follow-up|0|||
164183926|NCT02651688|593040572|FG000|Overall Study|Withdrawal by Subject|1|||
164183927|NCT02651688|593040573|FG001|Overall Study|Withdrawal by Subject|0|||
164183928|NCT02651688|593040574|FG002|Overall Study|Withdrawal by Subject|2|||
164183929|NCT00187278|593040579|FG000|Overall Study|Protocol Violation|10|||
164183930|NCT00187278|593040580|FG001|Overall Study|Protocol Violation|13|||
164183931|NCT01380691|593040585|FG000|Washout (7 Days)|Protocol Violation|0|||
164183932|NCT01380691|593040586|FG001|Washout (7 Days)|Protocol Violation|0|||
164183933|NCT01380691|593040587|FG002|Washout (7 Days)|Protocol Violation|0|||
164183934|NCT01380691|593040588|FG003|Washout (7 Days)|Protocol Violation|1|||
164183935|NCT01380691|593040585|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
164183936|NCT01380691|593040586|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
164183937|NCT01380691|593040587|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
164183938|NCT01380691|593040588|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
164183939|NCT00460746|593040593|FG000|Overall Study|Adverse Event|1|||
164183940|NCT00460746|593040593|FG000|Overall Study|Lost to Follow-up|1|||
164183941|NCT02791438|593040596|FG000|Treatment Period|Adverse Event|1|||
164183942|NCT02791438|593040597|FG001|Treatment Period|Adverse Event|0|||
164183943|NCT02791438|593040596|FG000|Treatment Period|Withdrawal by Subject|0|||
164183944|NCT02791438|593040597|FG001|Treatment Period|Withdrawal by Subject|1|||
164183945|NCT02791438|593040596|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
164183946|NCT02791438|593040597|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
164183947|NCT01603394|593040598|FG000|Overall Study|Adverse Event|1|||
164183948|NCT00862459|593040599|FG000|Overall Study|Lost to Follow-up|1|||
164183949|NCT00862459|593040600|FG001|Overall Study|Lost to Follow-up|2|||
164183950|NCT00862459|593040601|FG002|Overall Study|Lost to Follow-up|2|||
164183951|NCT00862459|593040599|FG000|Overall Study|Protocol Violation|1|||
164183952|NCT00862459|593040600|FG001|Overall Study|Protocol Violation|0|||
164183953|NCT00862459|593040601|FG002|Overall Study|Protocol Violation|0|||
164183954|NCT00862459|593040599|FG000|Overall Study|Withdrawal by Subject|1|||
164183955|NCT00862459|593040600|FG001|Overall Study|Withdrawal by Subject|1|||
164183956|NCT00862459|593040601|FG002|Overall Study|Withdrawal by Subject|3|||
164183957|NCT00862459|593040599|FG000|Overall Study|Adverse Event|0|||
164183958|NCT00862459|593040600|FG001|Overall Study|Adverse Event|1|||
164183959|NCT00862459|593040601|FG002|Overall Study|Adverse Event|0|||
164183960|NCT00862459|593040599|FG000|Overall Study|Personal reasons|1|||
164183961|NCT00862459|593040600|FG001|Overall Study|Personal reasons|0|||
164183962|NCT00862459|593040601|FG002|Overall Study|Personal reasons|0|||
164183963|NCT00862459|593040599|FG000|Overall Study|Operation|1|||
164183964|NCT00862459|593040600|FG001|Overall Study|Operation|1|||
164183965|NCT00862459|593040601|FG002|Overall Study|Operation|0|||
164183966|NCT00862459|593040599|FG000|Overall Study|Intravenous (IV) site problems|1|||
164183967|NCT00862459|593040600|FG001|Overall Study|Intravenous (IV) site problems|0|||
164183968|NCT00862459|593040601|FG002|Overall Study|Intravenous (IV) site problems|1|||
164183969|NCT00862459|593040599|FG000|Overall Study|Unable to hold still for imaging|0|||
164183970|NCT00862459|593040600|FG001|Overall Study|Unable to hold still for imaging|1|||
164183971|NCT00862459|593040601|FG002|Overall Study|Unable to hold still for imaging|0|||
164183972|NCT00862459|593040599|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
164183973|NCT00862459|593040600|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
164183974|NCT00862459|593040601|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
164183975|NCT00862459|593040599|FG000|Overall Study|Administrative problems|0|||
164183976|NCT00862459|593040600|FG001|Overall Study|Administrative problems|1|||
164183977|NCT00862459|593040601|FG002|Overall Study|Administrative problems|0|||
164183978|NCT03426436|593040602|FG000|Overall Study|Incorrect lead placement|12|||
164183979|NCT03426436|593040602|FG000|Overall Study|Withdrawal by Subject|2|||
164183980|NCT03426436|593040602|FG000|Overall Study|Consent issue|1|||
164183981|NCT03426436|593040602|FG000|Overall Study|ECGs not saved|4|||
164183982|NCT03168919|593040603|FG000|Overall Study|Withdrawal by Subject|2|||
164183983|NCT01085136|593040604|FG000|Part A|Other Adverse event|223|||
164183984|NCT01085136|593040605|FG001|Part A|Other Adverse event|0|||
164183985|NCT01085136|593040606|FG002|Part A|Other Adverse event|0|||
164183986|NCT01085136|593040604|FG000|Part A|Protocol Violation|3|||
164183987|NCT01085136|593040605|FG001|Part A|Protocol Violation|0|||
164183988|NCT01085136|593040606|FG002|Part A|Protocol Violation|0|||
164183989|NCT01085136|593040604|FG000|Part A|Lost to Follow-up|3|||
164183990|NCT01085136|593040605|FG001|Part A|Lost to Follow-up|0|||
164183991|NCT01085136|593040606|FG002|Part A|Lost to Follow-up|0|||
164183992|NCT01085136|593040604|FG000|Part A|Refusal to continue trial medication|64|||
164183993|NCT01085136|593040605|FG001|Part A|Refusal to continue trial medication|0|||
164183994|NCT01085136|593040606|FG002|Part A|Refusal to continue trial medication|0|||
164183995|NCT01085136|593040604|FG000|Part A|Other reason not defined above|30|||
164183996|NCT01085136|593040605|FG001|Part A|Other reason not defined above|0|||
164183997|NCT01085136|593040606|FG002|Part A|Other reason not defined above|0|||
164183998|NCT01085136|593040604|FG000|Part B|Other AE|0|||
164183999|NCT01085136|593040605|FG001|Part B|Other AE|29|||
164184000|NCT01085136|593040606|FG002|Part B|Other AE|8|||
164184001|NCT01085136|593040604|FG000|Part B|Refusal to continue trial medication|0|||
164184002|NCT01085136|593040605|FG001|Part B|Refusal to continue trial medication|12|||
164184003|NCT01085136|593040606|FG002|Part B|Refusal to continue trial medication|7|||
164184004|NCT01085136|593040604|FG000|Part B|Not treated|0|||
164184005|NCT01085136|593040605|FG001|Part B|Not treated|4|||
164184006|NCT01085136|593040606|FG002|Part B|Not treated|8|||
164184007|NCT01085136|593040604|FG000|Part B|Other reason not defined above|0|||
164184008|NCT01085136|593040605|FG001|Part B|Other reason not defined above|6|||
164184009|NCT01085136|593040606|FG002|Part B|Other reason not defined above|3|||
164184010|NCT02655419|593040607|FG000|Overall Study|Enrolled but not treated|1|||
164184011|NCT02655419|593040608|FG001|Overall Study|Enrolled but not treated|5|||
164184012|NCT02655419|593040607|FG000|Overall Study|Withdrawal by Subject|4|||
164184013|NCT02655419|593040608|FG001|Overall Study|Withdrawal by Subject|1|||
164184014|NCT02655419|593040607|FG000|Overall Study|Other|0|||
164184015|NCT02655419|593040608|FG001|Overall Study|Other|1|||
164184016|NCT04226495|593040612|FG000|Overall Study|Withdrawal by Subject|3|||
164184017|NCT04226495|593040613|FG001|Overall Study|Withdrawal by Subject|3|||
164184018|NCT04226495|593040612|FG000|Overall Study|PI discretion|3|||
164184019|NCT04226495|593040613|FG001|Overall Study|PI discretion|4|||
164184020|NCT02333383|593040615|FG000|Overall Study|Adalimumab discontinuation|21|||
164184021|NCT02333383|593040615|FG000|Overall Study|Lost to Follow-up|15|||
164184022|NCT02333383|593040615|FG000|Overall Study|Withdrawal by Subject|3|||
164184023|NCT02333383|593040615|FG000|Overall Study|Transfer to another hospital|2|||
164184024|NCT04459598|593040616|FG000|Overall Study|Adverse Event|1|||
164184025|NCT04459598|593040617|FG001|Overall Study|Adverse Event|1|||
164184026|NCT00866333|593040618|FG000|Overall Study|Withdrawal of consent|0|||
164184027|NCT00866333|593040619|FG001|Overall Study|Withdrawal of consent|1|||
164184028|NCT00866333|593040620|FG002|Overall Study|Withdrawal of consent|2|||
164184029|NCT00866333|593040618|FG000|Overall Study|Reason not Specified|3|||
164184030|NCT00866333|593040619|FG001|Overall Study|Reason not Specified|1|||
164184031|NCT00866333|593040620|FG002|Overall Study|Reason not Specified|1|||
164184032|NCT00866333|593040618|FG000|Overall Study|Study Terminated by Sponsor|2|||
164184033|NCT00866333|593040619|FG001|Overall Study|Study Terminated by Sponsor|5|||
164184034|NCT00866333|593040620|FG002|Overall Study|Study Terminated by Sponsor|9|||
164184035|NCT01854879|593040621|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
164184036|NCT01854879|593040621|FG000|Overall Study|screen fail|3|||
164184037|NCT01854879|593040621|FG000|Overall Study|incomplete data set|1|||
164184038|NCT04985942|593042126|FG000|Overall Study|Adverse Event|14|||
164184039|NCT04985942|593042127|FG001|Overall Study|Adverse Event|2|||
164184040|NCT04985942|593042126|FG000|Overall Study|Lack of Efficacy|0|||
164184041|NCT04985942|593042127|FG001|Overall Study|Lack of Efficacy|3|||
164184042|NCT04985942|593042126|FG000|Overall Study|Lost to Follow-up|1|||
164184043|NCT04985942|593042127|FG001|Overall Study|Lost to Follow-up|1|||
164184044|NCT04985942|593042126|FG000|Overall Study|Protocol Violation|1|||
164184045|NCT04985942|593042127|FG001|Overall Study|Protocol Violation|1|||
164184046|NCT04985942|593042126|FG000|Overall Study|Withdrawal by Subject|5|||
164184047|NCT04985942|593042127|FG001|Overall Study|Withdrawal by Subject|4|||
164184048|NCT00171158|593042128|FG000|Core Study|Death|27|||
164184049|NCT00171158|593042128|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
164184050|NCT00171158|593042128|FG000|Core Study|Protocol Violation|4|||
164184051|NCT00171158|593042128|FG000|Core Study|Administrative problems|1|||
164184052|NCT00171158|593042128|FG000|Core Study|Adverse event, non-fatal|21|||
164184053|NCT00171158|593042128|FG000|Core Study|Consent withdrawn by subject|6|||
164184054|NCT00171158|593042128|FG000|Core Study|No longer required drug (BMT)|14|||
164184055|NCT00171158|593042128|FG000|Core Study|Abnormal Laboratory Values|2|||
164184056|NCT00171158|593042128|FG000|Core Study|Lost to Follow-up|1|||
164184057|NCT00171158|593042128|FG000|E2 Extension|Other|7|||
164184058|NCT02757352|593042129|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
164184059|NCT02757352|593042130|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
164184060|NCT02757352|593042131|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
164184061|NCT02757352|593042132|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
164184062|NCT02757352|593042133|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
164184063|NCT02757352|593042134|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
164184064|NCT02757352|593042135|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
164184065|NCT02757352|593042136|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
164184066|NCT02757352|593042137|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
164184067|NCT02757352|593042138|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
164184068|NCT02757352|593042129|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
164184069|NCT02757352|593042130|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
164184070|NCT02757352|593042131|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
164184071|NCT02757352|593042132|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
164184072|NCT02757352|593042133|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
164184073|NCT02757352|593042134|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
164184074|NCT02757352|593042135|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
164184075|NCT02757352|593042136|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
164184076|NCT02757352|593042137|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
164184077|NCT02757352|593042138|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
164184078|NCT02757352|593042129|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
164184079|NCT02757352|593042130|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
164184080|NCT02757352|593042131|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
164184081|NCT02757352|593042132|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
164184082|NCT02757352|593042133|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
164184083|NCT02757352|593042134|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
164184084|NCT02757352|593042135|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
164184085|NCT02757352|593042136|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
164184086|NCT02757352|593042137|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
164184087|NCT02757352|593042138|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
164184088|NCT02757352|593042129|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
164184089|NCT02757352|593042130|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
164184090|NCT02757352|593042131|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
164184091|NCT02757352|593042132|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
164184092|NCT02757352|593042133|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
164184093|NCT02757352|593042134|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
164184094|NCT02757352|593042135|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
164184095|NCT02757352|593042136|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
164184096|NCT02757352|593042137|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
164184233|NCT04750278|593042139|FG000|Overall Study|Non-compliance|0|||
164184097|NCT02757352|593042138|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
164184098|NCT02757352|593042129|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184099|NCT02757352|593042130|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
164184100|NCT02757352|593042131|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184101|NCT02757352|593042132|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184102|NCT02757352|593042133|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184103|NCT02757352|593042134|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184104|NCT02757352|593042135|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184105|NCT02757352|593042136|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184106|NCT02757352|593042137|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184107|NCT02757352|593042138|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184108|NCT02757352|593042129|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
164184109|NCT02757352|593042130|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
164184110|NCT02757352|593042131|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
164184111|NCT02757352|593042132|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184112|NCT02757352|593042133|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184113|NCT02757352|593042134|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184114|NCT02757352|593042135|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184115|NCT02757352|593042136|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184116|NCT02757352|593042137|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184117|NCT02757352|593042138|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184118|NCT02757352|593042129|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
164184119|NCT02757352|593042130|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
164184120|NCT02757352|593042131|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
164184121|NCT02757352|593042132|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
164184122|NCT02757352|593042133|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
164184123|NCT02757352|593042134|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
164184124|NCT02757352|593042135|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
164184125|NCT02757352|593042136|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
164184126|NCT02757352|593042137|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
164184127|NCT02757352|593042138|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
164184128|NCT02757352|593042129|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
164184129|NCT02757352|593042130|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
164184130|NCT02757352|593042131|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
164184131|NCT02757352|593042132|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
164184132|NCT02757352|593042133|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
164184133|NCT02757352|593042134|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
164184134|NCT02757352|593042135|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
164184135|NCT02757352|593042136|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
164184136|NCT02757352|593042137|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
164184137|NCT02757352|593042138|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
164184138|NCT02757352|593042129|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184139|NCT02757352|593042130|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184140|NCT02757352|593042131|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184141|NCT02757352|593042132|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
164184142|NCT02757352|593042133|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
164184143|NCT02757352|593042134|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
164184144|NCT02757352|593042135|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184145|NCT02757352|593042136|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184146|NCT02757352|593042137|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184147|NCT02757352|593042138|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184148|NCT02757352|593042129|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
164184149|NCT02757352|593042130|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
164184150|NCT02757352|593042131|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
164184151|NCT02757352|593042132|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
164184152|NCT02757352|593042133|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
164184153|NCT02757352|593042134|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
164184154|NCT02757352|593042135|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
164184155|NCT02757352|593042136|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
164184156|NCT02757352|593042137|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
164184157|NCT02757352|593042138|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
164184158|NCT02757352|593042129|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
164184159|NCT02757352|593042130|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
164184160|NCT02757352|593042131|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
164184161|NCT02757352|593042132|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
164184162|NCT02757352|593042133|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
164184163|NCT02757352|593042134|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
164184164|NCT02757352|593042135|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
164184165|NCT02757352|593042136|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
164184166|NCT02757352|593042137|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
164184167|NCT02757352|593042138|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
164184168|NCT02757352|593042129|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184169|NCT02757352|593042130|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184170|NCT02757352|593042131|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184171|NCT02757352|593042132|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
164184172|NCT02757352|593042133|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
164184173|NCT02757352|593042134|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
164184174|NCT02757352|593042135|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184175|NCT02757352|593042136|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184176|NCT02757352|593042137|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184177|NCT02757352|593042138|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184178|NCT02757352|593042129|FG000|Follow-Up Period|Adverse Event|0|||
164184179|NCT02757352|593042130|FG001|Follow-Up Period|Adverse Event|0|||
164184180|NCT02757352|593042131|FG002|Follow-Up Period|Adverse Event|0|||
164184181|NCT02757352|593042132|FG003|Follow-Up Period|Adverse Event|0|||
164184182|NCT02757352|593042133|FG004|Follow-Up Period|Adverse Event|0|||
164184183|NCT02757352|593042134|FG005|Follow-Up Period|Adverse Event|0|||
164184184|NCT02757352|593042135|FG006|Follow-Up Period|Adverse Event|1|||
164184185|NCT02757352|593042136|FG007|Follow-Up Period|Adverse Event|0|||
164184186|NCT02757352|593042137|FG008|Follow-Up Period|Adverse Event|2|||
164184187|NCT02757352|593042138|FG009|Follow-Up Period|Adverse Event|0|||
164184188|NCT02757352|593042129|FG000|Follow-Up Period|Lost to Follow-up|0|||
164184189|NCT02757352|593042130|FG001|Follow-Up Period|Lost to Follow-up|0|||
164184190|NCT02757352|593042131|FG002|Follow-Up Period|Lost to Follow-up|0|||
164184191|NCT02757352|593042132|FG003|Follow-Up Period|Lost to Follow-up|0|||
164184192|NCT02757352|593042133|FG004|Follow-Up Period|Lost to Follow-up|0|||
164184193|NCT02757352|593042134|FG005|Follow-Up Period|Lost to Follow-up|0|||
164184194|NCT02757352|593042135|FG006|Follow-Up Period|Lost to Follow-up|0|||
164184195|NCT02757352|593042136|FG007|Follow-Up Period|Lost to Follow-up|0|||
164184196|NCT02757352|593042137|FG008|Follow-Up Period|Lost to Follow-up|1|||
164184197|NCT02757352|593042138|FG009|Follow-Up Period|Lost to Follow-up|0|||
164184198|NCT02757352|593042129|FG000|Follow-Up Period|Lack of Efficacy|0|||
164184199|NCT02757352|593042130|FG001|Follow-Up Period|Lack of Efficacy|0|||
164184200|NCT02757352|593042131|FG002|Follow-Up Period|Lack of Efficacy|0|||
164184201|NCT02757352|593042132|FG003|Follow-Up Period|Lack of Efficacy|0|||
164184202|NCT02757352|593042133|FG004|Follow-Up Period|Lack of Efficacy|0|||
164184203|NCT02757352|593042134|FG005|Follow-Up Period|Lack of Efficacy|0|||
164184204|NCT02757352|593042135|FG006|Follow-Up Period|Lack of Efficacy|0|||
164184205|NCT02757352|593042136|FG007|Follow-Up Period|Lack of Efficacy|0|||
164184206|NCT02757352|593042137|FG008|Follow-Up Period|Lack of Efficacy|1|||
164184207|NCT02757352|593042138|FG009|Follow-Up Period|Lack of Efficacy|1|||
164184208|NCT02757352|593042129|FG000|Follow-Up Period|Withdrawal by Subject|0|||
164184209|NCT02757352|593042130|FG001|Follow-Up Period|Withdrawal by Subject|0|||
164184210|NCT02757352|593042131|FG002|Follow-Up Period|Withdrawal by Subject|0|||
164184211|NCT02757352|593042132|FG003|Follow-Up Period|Withdrawal by Subject|0|||
164184212|NCT02757352|593042133|FG004|Follow-Up Period|Withdrawal by Subject|0|||
164184213|NCT02757352|593042134|FG005|Follow-Up Period|Withdrawal by Subject|0|||
164184214|NCT02757352|593042135|FG006|Follow-Up Period|Withdrawal by Subject|0|||
164184215|NCT02757352|593042136|FG007|Follow-Up Period|Withdrawal by Subject|1|||
164184216|NCT02757352|593042137|FG008|Follow-Up Period|Withdrawal by Subject|6|||
164184217|NCT02757352|593042138|FG009|Follow-Up Period|Withdrawal by Subject|2|||
164184218|NCT04750278|593042139|FG000|Overall Study|Death|9|||
164184219|NCT04750278|593042140|FG001|Overall Study|Death|10|||
164184220|NCT04750278|593042141|FG002|Overall Study|Death|10|||
164184221|NCT04750278|593042139|FG000|Overall Study|Withdrawal by Subject|4|||
164184222|NCT04750278|593042140|FG001|Overall Study|Withdrawal by Subject|1|||
164184223|NCT04750278|593042141|FG002|Overall Study|Withdrawal by Subject|2|||
164184224|NCT04750278|593042139|FG000|Overall Study|Lost to Follow-up|1|||
164184225|NCT04750278|593042140|FG001|Overall Study|Lost to Follow-up|1|||
164184226|NCT04750278|593042141|FG002|Overall Study|Lost to Follow-up|1|||
164184227|NCT04750278|593042139|FG000|Overall Study|Pregnancy|1|||
164184228|NCT04750278|593042140|FG001|Overall Study|Pregnancy|0|||
164184229|NCT04750278|593042141|FG002|Overall Study|Pregnancy|0|||
164184230|NCT04750278|593042139|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
164184231|NCT04750278|593042140|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
164184232|NCT04750278|593042141|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
164184234|NCT04750278|593042140|FG001|Overall Study|Non-compliance|0|||
164184235|NCT04750278|593042141|FG002|Overall Study|Non-compliance|1|||
164184236|NCT04750278|593042139|FG000|Overall Study|Transfer to Outside Facility|0|||
164184237|NCT04750278|593042140|FG001|Overall Study|Transfer to Outside Facility|2|||
164184238|NCT04750278|593042141|FG002|Overall Study|Transfer to Outside Facility|1|||
164184239|NCT04750278|593042139|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
164184240|NCT04750278|593042140|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
164184241|NCT04750278|593042141|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
164184242|NCT04750278|593042139|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
164184243|NCT04750278|593042140|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
164184244|NCT04750278|593042141|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
164184245|NCT01212159|593042142|FG000|Overall Study|Withdrawal by Subject|12|||
164184246|NCT01212159|593042143|FG001|Overall Study|Withdrawal by Subject|12|||
164184247|NCT02776670|593042184|FG000|Overall Study|Adverse Event|0|||
164184248|NCT02776670|593042185|FG001|Overall Study|Adverse Event|2|||
164184249|NCT02776670|593042184|FG000|Overall Study|Protocol Violation|0|||
164184250|NCT02776670|593042185|FG001|Overall Study|Protocol Violation|2|||
164184251|NCT02776670|593042184|FG000|Overall Study|Withdrawal by Subject|0|||
164184252|NCT02776670|593042185|FG001|Overall Study|Withdrawal by Subject|1|||
164184253|NCT02776670|593042184|FG000|Overall Study|Other - Reason not given|0|||
164184254|NCT02776670|593042185|FG001|Overall Study|Other - Reason not given|1|||
164184255|NCT00957424|593042190|FG000|Overall Study|Lost to Follow-up|19|||
164184256|NCT00957424|593042190|FG000|Overall Study|Protocol Violation|3|||
164184257|NCT00957424|593042190|FG000|Overall Study|Withdrawal by Subject|1|||
164184258|NCT01280682|593042195|FG000|Overall Study|Lost to Follow-up|0|||
164184259|NCT01280682|593042196|FG001|Overall Study|Lost to Follow-up|6|||
164184260|NCT01280682|593042195|FG000|Overall Study|Withdrawal by Subject|0|||
164184261|NCT01280682|593042196|FG001|Overall Study|Withdrawal by Subject|7|||
164184262|NCT00431067|593042199|FG000|Overall Study|Other Adverse Event|9|||
164184263|NCT00431067|593042199|FG000|Overall Study|Progressive disease|30|||
164184264|NCT00431067|593042199|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
164184265|NCT03913104|593042211|FG000|Overall Study|Lost to Follow-up|20|||
164184266|NCT03913104|593042211|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
164184267|NCT03913104|593042211|FG000|Overall Study|Withdrawal by Subject|2|||
164184268|NCT01119846|593042212|FG000|Overall Study|Adverse Event|1|||
164184269|NCT01119846|593042213|FG001|Overall Study|Adverse Event|0|||
164184270|NCT01119846|593042214|FG002|Overall Study|Adverse Event|6|||
164184271|NCT01119846|593042212|FG000|Overall Study|Physician Decision|1|||
164184272|NCT01119846|593042213|FG001|Overall Study|Physician Decision|0|||
164184273|NCT01119846|593042214|FG002|Overall Study|Physician Decision|0|||
164184274|NCT01119846|593042212|FG000|Overall Study|Protocol Violation|0|||
164184275|NCT01119846|593042213|FG001|Overall Study|Protocol Violation|0|||
164184276|NCT01119846|593042214|FG002|Overall Study|Protocol Violation|1|||
164184277|NCT01119846|593042212|FG000|Overall Study|Withdrawal by Subject|0|||
164184278|NCT01119846|593042213|FG001|Overall Study|Withdrawal by Subject|0|||
164184279|NCT01119846|593042214|FG002|Overall Study|Withdrawal by Subject|4|||
164184280|NCT01404949|593042215|FG000|Overall Study|Not Treated|1|||
164184281|NCT02007278|593042216|FG000|Overall Study|Failure to comply with an eligibility|0|||
164184282|NCT02007278|593042217|FG001|Overall Study|Failure to comply with an eligibility|1|||
164184283|NCT02007278|593042216|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
164184284|NCT02007278|593042217|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
164184285|NCT02007278|593042216|FG000|Overall Study|Incorrect medication administration|1|||
164184286|NCT02007278|593042217|FG001|Overall Study|Incorrect medication administration|0|||
164184287|NCT02007278|593042216|FG000|Overall Study|Mis-randomization|1|||
164184288|NCT02007278|593042217|FG001|Overall Study|Mis-randomization|1|||
164184289|NCT01429441|593042218|FG000|Overall Study|Adverse Event|5|||
164184290|NCT01429441|593042219|FG001|Overall Study|Adverse Event|1|||
164184291|NCT01429441|593042218|FG000|Overall Study|Death|0|||
164184292|NCT01429441|593042219|FG001|Overall Study|Death|2|||
164184293|NCT01429441|593042218|FG000|Overall Study|Lost to Follow-up|5|||
164184294|NCT01429441|593042219|FG001|Overall Study|Lost to Follow-up|2|||
164184295|NCT01429441|593042218|FG000|Overall Study|Physician Decision|1|||
164184296|NCT01429441|593042219|FG001|Overall Study|Physician Decision|0|||
164184297|NCT01429441|593042218|FG000|Overall Study|Withdrawal by Subject|27|||
164184298|NCT01429441|593042219|FG001|Overall Study|Withdrawal by Subject|18|||
164184299|NCT02279745|593042220|FG000|Overall Study|Adverse Event|7|||
164184300|NCT02279745|593042220|FG000|Overall Study|Death|6|||
164184301|NCT02279745|593042220|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
164184302|NCT02279745|593042220|FG000|Overall Study|Withdrawal by Subject|2|||
164184303|NCT02279745|593042220|FG000|Overall Study|Pregnancy|1|||
164184304|NCT02279745|593042220|FG000|Overall Study|Study Non-compliance|1|||
164184305|NCT02279745|593042220|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
164184306|NCT01606748|593042222|FG000|Overall Study|Adverse Event|1|||
164184307|NCT01606748|593042223|FG001|Overall Study|Adverse Event|0|||
164184308|NCT01606748|593042222|FG000|Overall Study|Progressive Disease|1|||
164184309|NCT01606748|593042223|FG001|Overall Study|Progressive Disease|0|||
164184310|NCT01606748|593042222|FG000|Overall Study|Withdrawal by Subject|1|||
164184311|NCT01606748|593042223|FG001|Overall Study|Withdrawal by Subject|0|||
164184312|NCT01706575|593042225|FG000|Overall Study|Participant Withdrew Consent|4|||
164184313|NCT01706575|593042225|FG000|Overall Study|Lost to Follow-up|2|||
164184314|NCT01706575|593042225|FG000|Overall Study|Started but not Treated|6|||
164184315|NCT03469999|593042228|FG000|Overall Study|Lost to Follow-up|2|||
164184316|NCT03084315|593042229|FG000|Overall Study|Lost to Follow-up|8|||
164184317|NCT03084315|593042230|FG001|Overall Study|Lost to Follow-up|7|||
164184318|NCT03084315|593042229|FG000|Overall Study|Withdrawal by Subject|2|||
164184319|NCT03084315|593042230|FG001|Overall Study|Withdrawal by Subject|2|||
164184320|NCT02155322|593042234|FG000|Overall Study|Adverse Event|1|||
164184321|NCT02155322|593042234|FG000|Overall Study|Physician Decision|1|||
164184322|NCT02155322|593042234|FG000|Overall Study|Relapse/Recurrence|8|||
164184323|NCT02155322|593042234|FG000|Overall Study|Withdrawal by Subject|4|||
164184324|NCT04424914|593042235|FG000|Overall Study|Other|0|||
164184325|NCT04424914|593042236|FG001|Overall Study|Other|0|||
164184326|NCT04424914|593042237|FG002|Overall Study|Other|28|||
164184327|NCT04424914|593042235|FG000|Overall Study|Withdrawal by Subject|3|||
164184328|NCT04424914|593042236|FG001|Overall Study|Withdrawal by Subject|0|||
164184329|NCT04424914|593042237|FG002|Overall Study|Withdrawal by Subject|0|||
164184330|NCT04424914|593042235|FG000|Overall Study|Study terminated by sponsor|23|||
164184331|NCT04424914|593042236|FG001|Overall Study|Study terminated by sponsor|7|||
164184332|NCT04424914|593042237|FG002|Overall Study|Study terminated by sponsor|0|||
164184333|NCT04424914|593042235|FG000|Overall Study|Lost to Follow-up|0|||
164184334|NCT04424914|593042236|FG001|Overall Study|Lost to Follow-up|0|||
164184335|NCT04424914|593042237|FG002|Overall Study|Lost to Follow-up|1|||
164184336|NCT04424914|593042235|FG000|Overall Study|Death|3|||
164184337|NCT04424914|593042236|FG001|Overall Study|Death|1|||
164184338|NCT04424914|593042237|FG002|Overall Study|Death|0|||
164184339|NCT01215435|593042243|FG000|Overall Study|Adverse Event|1|||
164184340|NCT01215435|593042244|FG001|Overall Study|Adverse Event|0|||
164184341|NCT01215435|593042243|FG000|Overall Study|Protocol Violation|2|||
164184342|NCT01215435|593042244|FG001|Overall Study|Protocol Violation|0|||
164184343|NCT01215435|593042243|FG000|Overall Study|Withdrawal Criteria|8|||
164184344|NCT01215435|593042244|FG001|Overall Study|Withdrawal Criteria|11|||
164184345|NCT01215435|593042243|FG000|Overall Study|Lost to Follow-up|3|||
164184346|NCT01215435|593042244|FG001|Overall Study|Lost to Follow-up|0|||
164184347|NCT01215435|593042243|FG000|Overall Study|Unclassified|5|||
164184348|NCT01215435|593042244|FG001|Overall Study|Unclassified|5|||
164184349|NCT00394771|593042245|FG000|Overall Study|Did not meet protocol requirements|1|||
164184350|NCT00394771|593042246|FG001|Overall Study|Did not meet protocol requirements|0|||
164184351|NCT00394771|593042247|FG002|Overall Study|Did not meet protocol requirements|2|||
164184352|NCT00394771|593042248|FG003|Overall Study|Did not meet protocol requirements|0|||
164184353|NCT00394771|593042245|FG000|Overall Study|Protocol Violation|2|||
164184354|NCT00394771|593042246|FG001|Overall Study|Protocol Violation|4|||
164184355|NCT00394771|593042247|FG002|Overall Study|Protocol Violation|9|||
164184356|NCT00394771|593042248|FG003|Overall Study|Protocol Violation|7|||
164184357|NCT00394771|593042245|FG000|Overall Study|Withdrawal by Subject|10|||
164184358|NCT00394771|593042246|FG001|Overall Study|Withdrawal by Subject|6|||
164184359|NCT00394771|593042247|FG002|Overall Study|Withdrawal by Subject|8|||
164184360|NCT00394771|593042248|FG003|Overall Study|Withdrawal by Subject|12|||
164184361|NCT00394771|593042245|FG000|Overall Study|Adverse Event|10|||
164184362|NCT00394771|593042246|FG001|Overall Study|Adverse Event|5|||
164184363|NCT00394771|593042247|FG002|Overall Study|Adverse Event|12|||
164184364|NCT00394771|593042248|FG003|Overall Study|Adverse Event|8|||
164184365|NCT00394771|593042245|FG000|Overall Study|Participant pregnant|0|||
164184366|NCT00394771|593042246|FG001|Overall Study|Participant pregnant|1|||
164184367|NCT00394771|593042247|FG002|Overall Study|Participant pregnant|2|||
164184368|NCT00394771|593042248|FG003|Overall Study|Participant pregnant|2|||
164184369|NCT00394771|593042245|FG000|Overall Study|Lost to Follow-up|15|||
164184370|NCT00394771|593042246|FG001|Overall Study|Lost to Follow-up|15|||
164184371|NCT00394771|593042247|FG002|Overall Study|Lost to Follow-up|13|||
164184372|NCT00394771|593042248|FG003|Overall Study|Lost to Follow-up|10|||
164184373|NCT00394771|593042245|FG000|Overall Study|Other|3|||
164184374|NCT00394771|593042246|FG001|Overall Study|Other|3|||
164184375|NCT00394771|593042247|FG002|Overall Study|Other|1|||
164184376|NCT00394771|593042248|FG003|Overall Study|Other|0|||
164184377|NCT03383692|593042249|FG000|Overall Study|Progressive disease as per RECIST|3|||
164184378|NCT03383692|593042250|FG001|Overall Study|Progressive disease as per RECIST|3|||
164184379|NCT03383692|593042249|FG000|Overall Study|Clinical progression|0|||
164184380|NCT03383692|593042250|FG001|Overall Study|Clinical progression|1|||
164184381|NCT03383692|593042249|FG000|Overall Study|Adverse Event|3|||
164184382|NCT03383692|593042250|FG001|Overall Study|Adverse Event|0|||
164184383|NCT02906033|593042254|FG000|Baseline|Protocol Violation|37|||
164184384|NCT02906033|593042255|FG001|Baseline|Protocol Violation|33|||
164184385|NCT02906033|593042254|FG000|Follow-up|Lost to Follow-up|46|||
164184386|NCT02906033|593042255|FG001|Follow-up|Lost to Follow-up|62|||
164184387|NCT00358956|593042256|FG000|Overall Study|Adverse Event|3|||
164184388|NCT00358956|593042256|FG000|Overall Study|condition under investigation worsened|4|||
164184389|NCT00358956|593042256|FG000|Overall Study|Withdrawal by Subject|1|||
164184390|NCT03417024|593042259|FG000|Overall Study|Study Termination prior to follow-up|11|||
164184391|NCT03417024|593042259|FG000|Overall Study|Physician Decision|2|||
164184392|NCT02195427|593042260|FG000|Overall Study|Did not consent to study extension|13|||
164184393|NCT02195427|593042261|FG001|Overall Study|Did not consent to study extension|9|||
164184394|NCT02195427|593042260|FG000|Overall Study|Withdrawal by Subject|4|||
164184395|NCT02195427|593042261|FG001|Overall Study|Withdrawal by Subject|2|||
164184396|NCT02195427|593042260|FG000|Overall Study|Lost to Follow-up|0|||
164184397|NCT02195427|593042261|FG001|Overall Study|Lost to Follow-up|1|||
164184398|NCT02195427|593042260|FG000|Overall Study|Protocol Violation|7|||
164184399|NCT02195427|593042261|FG001|Overall Study|Protocol Violation|14|||
164184400|NCT02195427|593042260|FG000|Overall Study|Conditional re-treatment at W52|2|||
164184401|NCT02195427|593042261|FG001|Overall Study|Conditional re-treatment at W52|1|||
164184402|NCT00386425|593042262|FG000|Overall Study|Physician Decision|3|||
164184403|NCT00386425|593042263|FG001|Overall Study|Physician Decision|0|||
164184404|NCT00386425|593042264|FG002|Overall Study|Physician Decision|0|||
164184405|NCT00386425|593042262|FG000|Overall Study|Withdrawal by Subject|0|||
164184406|NCT00386425|593042263|FG001|Overall Study|Withdrawal by Subject|1|||
164184407|NCT00386425|593042264|FG002|Overall Study|Withdrawal by Subject|0|||
164184408|NCT03782974|593042267|FG000|Overall Study|Withdrawal by Subject|7|||
164184409|NCT03782974|593042268|FG001|Overall Study|Withdrawal by Subject|7|||
164184410|NCT03782974|593042267|FG000|Overall Study|Pregnancy|1|||
164184411|NCT03782974|593042268|FG001|Overall Study|Pregnancy|0|||
164184412|NCT04607980|593042274|FG000|Overall Study|Adverse Event|3|||
164184413|NCT04607980|593042275|FG001|Overall Study|Adverse Event|4|||
164184414|NCT04607980|593042274|FG000|Overall Study|Death|0|||
164184415|NCT04607980|593042275|FG001|Overall Study|Death|1|||
164184416|NCT04607980|593042274|FG000|Overall Study|Withdrawal by Subject|2|||
164184417|NCT04607980|593042275|FG001|Overall Study|Withdrawal by Subject|5|||
164184418|NCT04607980|593042274|FG000|Overall Study|Lost to Follow-up|4|||
164184419|NCT04607980|593042275|FG001|Overall Study|Lost to Follow-up|8|||
164184420|NCT04607980|593042274|FG000|Overall Study|Protocol Violation|0|||
164184421|NCT04607980|593042275|FG001|Overall Study|Protocol Violation|3|||
164184422|NCT04607980|593042274|FG000|Overall Study|Other|3|||
164184423|NCT04607980|593042275|FG001|Overall Study|Other|0|||
164184424|NCT00448812|593042276|FG000|Year 2|Missed visit but remained in study|4|||
164184425|NCT00448812|593042277|FG001|Year 2|Missed visit but remained in study|1|||
164184426|NCT00448812|593042276|FG000|Year 3|Withdrawal by Subject|1|||
164184427|NCT00448812|593042277|FG001|Year 3|Withdrawal by Subject|3|||
164184428|NCT00448812|593042276|FG000|Year 3|Lost to Follow-up|1|||
164184429|NCT00448812|593042277|FG001|Year 3|Lost to Follow-up|0|||
164184430|NCT00448812|593042276|FG000|Year 3|Missed visit but remained in study|2|||
164184431|NCT00448812|593042277|FG001|Year 3|Missed visit but remained in study|0|||
164184432|NCT00448812|593042276|FG000|Year 5|Missed visit but remained in study|1|||
164184433|NCT00448812|593042277|FG001|Year 5|Missed visit but remained in study|0|||
164184434|NCT02012959|593042278|FG000|Treatment Phase A|Adverse Event|2|||
164184435|NCT02012959|593042279|FG001|Treatment Phase A|Adverse Event|0|||
164184436|NCT02012959|593042280|FG002|Treatment Phase A|Adverse Event|0|||
164184437|NCT02012959|593042281|FG003|Treatment Phase A|Adverse Event|0|||
164184438|NCT02012959|593042282|FG004|Treatment Phase A|Adverse Event|0|||
164184439|NCT01128400|593043756|FG000|Overall Study|Lost to Follow-up|1|||
164184440|NCT01128400|593043757|FG001|Overall Study|Lost to Follow-up|0|||
164184441|NCT01128400|593043758|FG002|Overall Study|Lost to Follow-up|1|||
164184442|NCT01128400|593043756|FG000|Overall Study|Screening failure|1|||
164184443|NCT01128400|593043757|FG001|Overall Study|Screening failure|0|||
164184444|NCT01128400|593043758|FG002|Overall Study|Screening failure|0|||
164184445|NCT01128400|593043756|FG000|Overall Study|were not invited to participate on taste|0|||
164184446|NCT01128400|593043757|FG001|Overall Study|were not invited to participate on taste|0|||
164184447|NCT01128400|593043758|FG002|Overall Study|were not invited to participate on taste|15|||
164184448|NCT01128400|593043756|FG000|Overall Study|Excluded due to sinus problems|0|||
164184449|NCT01128400|593043757|FG001|Overall Study|Excluded due to sinus problems|1|||
164184450|NCT01128400|593043758|FG002|Overall Study|Excluded due to sinus problems|0|||
164184451|NCT03782571|593043764|FG000|Period 1|Withdrawal by Subject|1|||
164184452|NCT03782571|593043765|FG001|Period 1|Withdrawal by Subject|0|||
164184453|NCT03782571|593043766|FG002|Period 1|Withdrawal by Subject|0|||
164184454|NCT03782571|593043767|FG003|Period 1|Withdrawal by Subject|0|||
164184455|NCT03782571|593043764|FG000|Period 3|Subject Unable to Attend V5|1|||
164184456|NCT03782571|593043765|FG001|Period 3|Subject Unable to Attend V5|0|||
164184457|NCT03782571|593043766|FG002|Period 3|Subject Unable to Attend V5|0|||
164184458|NCT03782571|593043767|FG003|Period 3|Subject Unable to Attend V5|0|||
164184459|NCT03782571|593043764|FG000|Period 3|Adverse Event|1|||
164184460|NCT03782571|593043765|FG001|Period 3|Adverse Event|0|||
164184461|NCT03782571|593043766|FG002|Period 3|Adverse Event|0|||
164184462|NCT03782571|593043767|FG003|Period 3|Adverse Event|0|||
164184463|NCT03504189|593043768|FG000|Overall Study|Withdrawal by Subject|1|||
164184464|NCT03504189|593043768|FG000|Overall Study|Screening Failure|1|||
164184465|NCT03504189|593043768|FG000|Overall Study|Device Failure|2|||
164184466|NCT02626000|593043785|FG000|Overall Study|Decision by Sponsor|1|||
164184467|NCT02626000|593043785|FG000|Overall Study|Death|29|||
164184468|NCT01796301|593043786|FG000|Overall Study|Withdrawal by Subject|15|||
164184469|NCT01796301|593043787|FG001|Overall Study|Withdrawal by Subject|15|||
164184470|NCT01796301|593043786|FG000|Overall Study|Lost to Follow-up|3|||
164184471|NCT01796301|593043787|FG001|Overall Study|Lost to Follow-up|3|||
164184472|NCT01796301|593043786|FG000|Overall Study|Death|0|||
164184473|NCT01796301|593043787|FG001|Overall Study|Death|1|||
164184474|NCT01796301|593043786|FG000|Overall Study|Decision by Sponsor|0|||
164184475|NCT01796301|593043787|FG001|Overall Study|Decision by Sponsor|1|||
164184476|NCT02570750|593043796|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
164184477|NCT02570750|593043797|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
164184478|NCT02570750|593043796|FG000|Overall Study|Protocol deviation|4|||
164184479|NCT02570750|593043797|FG001|Overall Study|Protocol deviation|2|||
164184480|NCT02570750|593043796|FG000|Overall Study|Withdrawal by Subject|5|||
164184481|NCT02570750|593043797|FG001|Overall Study|Withdrawal by Subject|0|||
164184482|NCT02570750|593043796|FG000|Overall Study|Lost to Follow-up|2|||
164184483|NCT02570750|593043797|FG001|Overall Study|Lost to Follow-up|2|||
164184484|NCT02570750|593043796|FG000|Overall Study|Adverse Event|2|||
164184485|NCT02570750|593043797|FG001|Overall Study|Adverse Event|1|||
164184486|NCT01884545|593043798|FG000|Overall Study|Lost to Follow-up|6|||
164184487|NCT01884545|593043799|FG001|Overall Study|Lost to Follow-up|4|||
164184488|NCT01884545|593043800|FG002|Overall Study|Lost to Follow-up|9|||
164184489|NCT01884545|593043801|FG003|Overall Study|Lost to Follow-up|4|||
164184490|NCT01884545|593043798|FG000|Overall Study|Patient withdrawn|7|||
164184491|NCT01884545|593043799|FG001|Overall Study|Patient withdrawn|12|||
164184492|NCT01884545|593043800|FG002|Overall Study|Patient withdrawn|5|||
164184493|NCT01884545|593043801|FG003|Overall Study|Patient withdrawn|5|||
164184494|NCT01884545|593043798|FG000|Overall Study|Non-adherence|0|||
164184495|NCT01884545|593043799|FG001|Overall Study|Non-adherence|2|||
164184496|NCT01884545|593043800|FG002|Overall Study|Non-adherence|0|||
164184497|NCT01884545|593043801|FG003|Overall Study|Non-adherence|0|||
164184498|NCT01410240|593043802|FG000|Overall Study|Physician Decision|0|||
164184499|NCT01410240|593043803|FG001|Overall Study|Physician Decision|0|||
164184500|NCT01410240|593043804|FG002|Overall Study|Physician Decision|1|||
164184501|NCT01410240|593043802|FG000|Overall Study|Missed week 6 assessments|1|||
164184502|NCT01410240|593043803|FG001|Overall Study|Missed week 6 assessments|1|||
164184503|NCT01410240|593043804|FG002|Overall Study|Missed week 6 assessments|1|||
164184504|NCT00496587|593043805|FG000|Overall Study|Adverse Event|2|||
164184505|NCT00496587|593043805|FG000|Overall Study|Progressive Disease|24|||
164184506|NCT00496587|593043805|FG000|Overall Study|Withdrawal by Subject|2|||
164184507|NCT00496587|593043805|FG000|Overall Study|Death|1|||
164184508|NCT00496587|593043805|FG000|Overall Study|Complications unrelated|2|||
164184509|NCT00592592|593043810|FG000|Overall Study|Patient found ineligible upon chart review|1|||
164184510|NCT01134263|593043811|FG000|Overall Study|Serious adverse event|2|||
164184511|NCT01134263|593043812|FG001|Overall Study|Serious adverse event|1|||
164184512|NCT01134263|593043813|FG002|Overall Study|Serious adverse event|1|||
164184513|NCT01134263|593043814|FG003|Overall Study|Serious adverse event|1|||
164184514|NCT01134263|593043815|FG004|Overall Study|Serious adverse event|1|||
164184515|NCT01134263|593043811|FG000|Overall Study|Other adverse event|1|||
164184516|NCT01134263|593043812|FG001|Overall Study|Other adverse event|2|||
164184517|NCT01134263|593043813|FG002|Overall Study|Other adverse event|5|||
164184518|NCT01134263|593043814|FG003|Overall Study|Other adverse event|3|||
164184519|NCT01134263|593043815|FG004|Overall Study|Other adverse event|0|||
164184520|NCT01134263|593043811|FG000|Overall Study|Protocol Violation|8|||
164184521|NCT01134263|593043812|FG001|Overall Study|Protocol Violation|7|||
164184522|NCT01134263|593043813|FG002|Overall Study|Protocol Violation|2|||
164184523|NCT01134263|593043814|FG003|Overall Study|Protocol Violation|4|||
164184524|NCT01134263|593043815|FG004|Overall Study|Protocol Violation|2|||
164184525|NCT01134263|593043811|FG000|Overall Study|Lost to Follow-up|4|||
164184526|NCT01134263|593043812|FG001|Overall Study|Lost to Follow-up|3|||
164184527|NCT01134263|593043813|FG002|Overall Study|Lost to Follow-up|5|||
164184528|NCT01134263|593043814|FG003|Overall Study|Lost to Follow-up|3|||
164184529|NCT01134263|593043815|FG004|Overall Study|Lost to Follow-up|1|||
164184530|NCT01134263|593043811|FG000|Overall Study|Withdrawal by Subject|8|||
164184531|NCT01134263|593043812|FG001|Overall Study|Withdrawal by Subject|6|||
164184532|NCT01134263|593043813|FG002|Overall Study|Withdrawal by Subject|16|||
164184533|NCT01134263|593043814|FG003|Overall Study|Withdrawal by Subject|7|||
164184534|NCT01134263|593043815|FG004|Overall Study|Withdrawal by Subject|5|||
164184535|NCT01134263|593043811|FG000|Overall Study|Enrolled, but not treated|1|||
164184536|NCT01134263|593043812|FG001|Overall Study|Enrolled, but not treated|1|||
164184537|NCT01134263|593043813|FG002|Overall Study|Enrolled, but not treated|0|||
164184538|NCT01134263|593043814|FG003|Overall Study|Enrolled, but not treated|1|||
164184539|NCT01134263|593043815|FG004|Overall Study|Enrolled, but not treated|0|||
164184540|NCT01557517|593043816|FG000|Overall Study|Death|1|||
164184541|NCT01557517|593043817|FG001|Overall Study|Death|0|||
164184542|NCT01557517|593043816|FG000|Overall Study|Refused further treatment|0|||
164184543|NCT01557517|593043817|FG001|Overall Study|Refused further treatment|2|||
164184544|NCT01557517|593043816|FG000|Overall Study|Adverse Event|0|||
164184545|NCT01557517|593043817|FG001|Overall Study|Adverse Event|2|||
164184546|NCT01557517|593043816|FG000|Overall Study|Pt declined before treatment started|1|||
164184547|NCT01557517|593043817|FG001|Overall Study|Pt declined before treatment started|0|||
164184548|NCT00162097|593043818|FG000|Overall Study|Participant no longer met study criteria|0|||
164184549|NCT00162097|593043819|FG001|Overall Study|Participant no longer met study criteria|0|||
164184550|NCT00162097|593043820|FG002|Overall Study|Participant no longer met study criteria|0|||
164184551|NCT00162097|593043821|FG003|Overall Study|Participant no longer met study criteria|1|||
164184552|NCT01204918|593043822|FG000|Overall Study|Withdrawal by Subject|4|||
164184553|NCT01204918|593043823|FG001|Overall Study|Withdrawal by Subject|10|||
164184554|NCT01204918|593043824|FG002|Overall Study|Withdrawal by Subject|5|||
164184555|NCT00770913|593043825|FG000|Overall Study|Adverse Event|1|||
164184556|NCT00770913|593043826|FG001|Overall Study|Adverse Event|3|||
164184557|NCT00770913|593043827|FG002|Overall Study|Adverse Event|6|||
164184558|NCT00770913|593043825|FG000|Overall Study|Refusal to continue participation|6|||
164184559|NCT00770913|593043826|FG001|Overall Study|Refusal to continue participation|4|||
164184560|NCT00770913|593043827|FG002|Overall Study|Refusal to continue participation|5|||
164184561|NCT00770913|593043825|FG000|Overall Study|Physician Decision|0|||
164184562|NCT00770913|593043826|FG001|Overall Study|Physician Decision|1|||
164184563|NCT00770913|593043827|FG002|Overall Study|Physician Decision|1|||
164184564|NCT00770913|593043825|FG000|Overall Study|Protocol Violation|3|||
164184565|NCT00770913|593043826|FG001|Overall Study|Protocol Violation|0|||
164184566|NCT00770913|593043827|FG002|Overall Study|Protocol Violation|1|||
164184567|NCT00770913|593043825|FG000|Overall Study|Incorrect drug was allocated|1|||
164184568|NCT00770913|593043826|FG001|Overall Study|Incorrect drug was allocated|0|||
164184569|NCT00770913|593043827|FG002|Overall Study|Incorrect drug was allocated|0|||
164184570|NCT00269477|593043831|FG000|Overall Study|Protocol Violation|5|||
164184571|NCT00269477|593043832|FG001|Overall Study|Protocol Violation|5|||
164184572|NCT00269477|593043833|FG002|Overall Study|Protocol Violation|1|||
164184573|NCT00269477|593043834|FG003|Overall Study|Protocol Violation|0|||
164184574|NCT00269477|593043831|FG000|Overall Study|Missed post-vaccination blood draw|0|||
164184575|NCT00269477|593043832|FG001|Overall Study|Missed post-vaccination blood draw|1|||
164184576|NCT00269477|593043833|FG002|Overall Study|Missed post-vaccination blood draw|0|||
164184577|NCT00269477|593043834|FG003|Overall Study|Missed post-vaccination blood draw|0|||
164184578|NCT00548249|593043835|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
164184579|NCT00548249|593043836|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
164184580|NCT00548249|593043837|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
164184581|NCT00548249|593043838|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
164184582|NCT00548249|593043839|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
164184583|NCT00548249|593043835|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
164184584|NCT00548249|593043836|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
164184585|NCT00548249|593043837|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
164184586|NCT00548249|593043838|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
164184587|NCT00548249|593043839|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
164184588|NCT00548249|593043835|FG000|Overall Study|Protocol Violation|1|||
164184589|NCT00548249|593043836|FG001|Overall Study|Protocol Violation|1|||
164184590|NCT00548249|593043837|FG002|Overall Study|Protocol Violation|4|||
164184591|NCT00548249|593043838|FG003|Overall Study|Protocol Violation|0|||
164184592|NCT00548249|593043839|FG004|Overall Study|Protocol Violation|3|||
164184593|NCT00548249|593043835|FG000|Overall Study|Miscellaneous|2|||
164184594|NCT00548249|593043836|FG001|Overall Study|Miscellaneous|3|||
164184595|NCT00548249|593043837|FG002|Overall Study|Miscellaneous|2|||
164184596|NCT00548249|593043838|FG003|Overall Study|Miscellaneous|0|||
164184597|NCT00548249|593043839|FG004|Overall Study|Miscellaneous|2|||
164184598|NCT00548249|593043835|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
164184599|NCT00548249|593043836|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
164184600|NCT00548249|593043837|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
164184601|NCT00548249|593043838|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
164184602|NCT00548249|593043839|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
164184603|NCT00548249|593043835|FG000|Overall Study|Adverse Event|2|||
164184604|NCT00548249|593043836|FG001|Overall Study|Adverse Event|2|||
164184605|NCT00548249|593043837|FG002|Overall Study|Adverse Event|0|||
164184606|NCT00548249|593043838|FG003|Overall Study|Adverse Event|1|||
164184607|NCT00548249|593043839|FG004|Overall Study|Adverse Event|1|||
164184608|NCT00548249|593043835|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
164184609|NCT00548249|593043836|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
164184610|NCT00548249|593043837|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
164184611|NCT00548249|593043838|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
164184612|NCT00548249|593043839|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
164184613|NCT00548249|593043835|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
164184614|NCT00548249|593043836|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
164184615|NCT00548249|593043837|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
164184616|NCT00548249|593043838|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
164184617|NCT00548249|593043839|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
164184618|NCT00548249|593043835|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
164184619|NCT00548249|593043836|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
164184620|NCT00548249|593043837|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
164184621|NCT00548249|593043838|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
164184622|NCT00548249|593043839|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
164184623|NCT00548249|593043835|FG000|Overall Study|Prolonged hospitalization|0|||
164184624|NCT00548249|593043836|FG001|Overall Study|Prolonged hospitalization|0|||
164184625|NCT00548249|593043837|FG002|Overall Study|Prolonged hospitalization|2|||
164184626|NCT00548249|593043838|FG003|Overall Study|Prolonged hospitalization|1|||
164184627|NCT00548249|593043839|FG004|Overall Study|Prolonged hospitalization|0|||
164184628|NCT00548249|593043835|FG000|Overall Study|Withdrawal by Subject|2|||
164184629|NCT00548249|593043836|FG001|Overall Study|Withdrawal by Subject|0|||
164184630|NCT00548249|593043837|FG002|Overall Study|Withdrawal by Subject|0|||
164184631|NCT00548249|593043838|FG003|Overall Study|Withdrawal by Subject|0|||
164184632|NCT00548249|593043839|FG004|Overall Study|Withdrawal by Subject|0|||
164184633|NCT00548249|593043835|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
164184634|NCT00548249|593043836|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
164184635|NCT00548249|593043837|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
164184636|NCT00548249|593043838|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
164184637|NCT00548249|593043839|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
164184638|NCT00548249|593043835|FG000|Overall Study|Sponsor's request|0|||
164184639|NCT00548249|593043836|FG001|Overall Study|Sponsor's request|0|||
164184640|NCT00548249|593043837|FG002|Overall Study|Sponsor's request|0|||
164184641|NCT00548249|593043838|FG003|Overall Study|Sponsor's request|1|||
164184642|NCT00548249|593043839|FG004|Overall Study|Sponsor's request|0|||
164184643|NCT02347072|593043840|FG000|Overall Study|Adverse Event|2|||
164184644|NCT02347072|593043840|FG000|Overall Study|Withdrawal by Subject|6|||
164184645|NCT02347072|593043840|FG000|Overall Study|Physician Decision|1|||
164184646|NCT02347072|593043840|FG000|Overall Study|Lost to Follow-up|2|||
164184647|NCT02347072|593043840|FG000|Overall Study|Protocol Violation|1|||
164184648|NCT02347072|593043840|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
164184649|NCT01134393|593043843|FG000|Overall Study|Adverse Event|18|||
164184650|NCT01134393|593043843|FG000|Overall Study|Lack of Efficacy|2|||
164184651|NCT01134393|593043843|FG000|Overall Study|Protocol Violation|12|||
164184652|NCT01134393|593043843|FG000|Overall Study|Lost to Follow-up|3|||
164184653|NCT01134393|593043843|FG000|Overall Study|Withdrawal by Subject|11|||
164184654|NCT01134393|593043843|FG000|Overall Study|Other|6|||
164184655|NCT00080483|593043844|FG000|Overall Study|Lost to Follow-up|1|||
164184656|NCT00080483|593043845|FG001|Overall Study|Lost to Follow-up|1|||
164184657|NCT00080483|593043844|FG000|Overall Study|Physician Decision|1|||
164184658|NCT00080483|593043845|FG001|Overall Study|Physician Decision|1|||
164184659|NCT02886884|593043851|FG000|Follow-up|Withdrawal by Subject|0|||
164184660|NCT02886884|593043852|FG001|Follow-up|Withdrawal by Subject|0|||
164184661|NCT02886884|593043853|FG002|Follow-up|Withdrawal by Subject|0|||
164184662|NCT02886884|593043854|FG003|Follow-up|Withdrawal by Subject|1|||
164184663|NCT00625183|593043855|FG000|Overall Study|Disease Progression|1|||
164184664|NCT02670382|593043856|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
164184665|NCT02670382|593043857|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
164184666|NCT03244618|593043858|FG000|Overall Study|Lost to Follow-up|3|||
164184667|NCT03244618|593043859|FG001|Overall Study|Lost to Follow-up|4|||
164184668|NCT03244618|593043858|FG000|Overall Study|Protocol Violation|4|||
164184669|NCT03244618|593043859|FG001|Overall Study|Protocol Violation|3|||
164184670|NCT03244618|593043858|FG000|Overall Study|Withdrawal by Subject|0|||
164184671|NCT03244618|593043859|FG001|Overall Study|Withdrawal by Subject|2|||
164184672|NCT01810783|593043861|FG000|Overall Study|Adverse Event|32|||
164184673|NCT01810783|593043861|FG000|Overall Study|Withdrawal by Subject|22|||
164184674|NCT01810783|593043861|FG000|Overall Study|Lack of Efficacy|12|||
164184675|NCT01810783|593043861|FG000|Overall Study|Lost to Follow-up|10|||
164184676|NCT01810783|593043861|FG000|Overall Study|Protocol Violation|5|||
164184677|NCT01810783|593043861|FG000|Overall Study|Non-compliance with IMP|4|||
164184678|NCT01810783|593043861|FG000|Overall Study|Adminstrative or other reason(s)|23|||
164184679|NCT01810783|593043861|FG000|Overall Study|Enrolled, not treated|1|||
164184680|NCT04776018|593043863|FG000|Overall Study|Death|0|||
164184681|NCT04776018|593043864|FG001|Overall Study|Death|1|||
164184682|NCT04776018|593043865|FG002|Overall Study|Death|4|||
164184683|NCT04776018|593043866|FG003|Overall Study|Death|1|||
164184684|NCT04776018|593043867|FG004|Overall Study|Death|4|||
164184685|NCT04776018|593043868|FG005|Overall Study|Death|0|||
164184686|NCT04776018|593043869|FG006|Overall Study|Death|0|||
164184687|NCT04776018|593043863|FG000|Overall Study|Study terminated by sponsor|2|||
164184688|NCT04776018|593043864|FG001|Overall Study|Study terminated by sponsor|1|||
164184689|NCT04776018|593043865|FG002|Overall Study|Study terminated by sponsor|4|||
164184690|NCT04776018|593043866|FG003|Overall Study|Study terminated by sponsor|0|||
164184691|NCT04776018|593043867|FG004|Overall Study|Study terminated by sponsor|3|||
164184692|NCT04776018|593043868|FG005|Overall Study|Study terminated by sponsor|0|||
164184693|NCT04776018|593043869|FG006|Overall Study|Study terminated by sponsor|0|||
164184694|NCT04776018|593043863|FG000|Overall Study|Withdrawal by Subject|1|||
164184695|NCT04776018|593043864|FG001|Overall Study|Withdrawal by Subject|0|||
164184696|NCT04776018|593043865|FG002|Overall Study|Withdrawal by Subject|0|||
164184697|NCT04776018|593043866|FG003|Overall Study|Withdrawal by Subject|2|||
164184698|NCT04776018|593043867|FG004|Overall Study|Withdrawal by Subject|1|||
164184699|NCT04776018|593043868|FG005|Overall Study|Withdrawal by Subject|0|||
164184700|NCT04776018|593043869|FG006|Overall Study|Withdrawal by Subject|0|||
164184701|NCT04776018|593043863|FG000|Overall Study|Other|0|||
164184702|NCT04776018|593043864|FG001|Overall Study|Other|1|||
164184703|NCT04776018|593043865|FG002|Overall Study|Other|1|||
164184704|NCT04776018|593043866|FG003|Overall Study|Other|0|||
164184705|NCT04776018|593043867|FG004|Overall Study|Other|0|||
164184706|NCT04776018|593043868|FG005|Overall Study|Other|0|||
164184707|NCT04776018|593043869|FG006|Overall Study|Other|0|||
164184708|NCT04776018|593043863|FG000|Overall Study|Lost to Follow-up|0|||
164184709|NCT04776018|593043864|FG001|Overall Study|Lost to Follow-up|0|||
164184710|NCT04776018|593043865|FG002|Overall Study|Lost to Follow-up|1|||
164184711|NCT04776018|593043866|FG003|Overall Study|Lost to Follow-up|0|||
164184712|NCT04776018|593043867|FG004|Overall Study|Lost to Follow-up|0|||
164184713|NCT04776018|593043868|FG005|Overall Study|Lost to Follow-up|0|||
164184714|NCT04776018|593043869|FG006|Overall Study|Lost to Follow-up|0|||
164184715|NCT00793546|593043870|FG000|Overall Study|Death|3|||
164184716|NCT00793546|593043871|FG001|Overall Study|Death|0|||
164184717|NCT00793546|593043870|FG000|Overall Study|Lost to Follow-up|1|||
164184718|NCT00793546|593043871|FG001|Overall Study|Lost to Follow-up|0|||
164184719|NCT00793546|593043870|FG000|Overall Study|Withdrawal by Subject|1|||
164184720|NCT00793546|593043871|FG001|Overall Study|Withdrawal by Subject|1|||
164184721|NCT00793546|593043870|FG000|Overall Study|Study Terminated by Sponsor|8|||
164184722|NCT00793546|593043871|FG001|Overall Study|Study Terminated by Sponsor|27|||
164184723|NCT00793546|593043870|FG000|Overall Study|Other|1|||
164184724|NCT00793546|593043871|FG001|Overall Study|Other|0|||
164184725|NCT00435019|593043873|FG000|Overall Study|Adverse Event|1|||
164184726|NCT00435019|593043874|FG001|Overall Study|Adverse Event|0|||
164184727|NCT00435019|593043873|FG000|Overall Study|Lack of Efficacy|1|||
164184728|NCT00435019|593043874|FG001|Overall Study|Lack of Efficacy|2|||
164184729|NCT00435019|593043873|FG000|Overall Study|Protocol Violation|3|||
164184730|NCT00435019|593043874|FG001|Overall Study|Protocol Violation|1|||
164184731|NCT00435019|593043873|FG000|Overall Study|Personal reasons for withdrawal|8|||
164184732|NCT00435019|593043874|FG001|Overall Study|Personal reasons for withdrawal|7|||
164184733|NCT04503668|593043875|FG000|Overall Study|Incomplete data|4|||
164184734|NCT04503668|593043876|FG001|Overall Study|Incomplete data|3|||
164184735|NCT04503668|593043875|FG000|Overall Study|Withdrawal by Subject|1|||
164184736|NCT04503668|593043876|FG001|Overall Study|Withdrawal by Subject|1|||
164184737|NCT04503668|593043875|FG000|Overall Study|Adverse Event|2|||
164184738|NCT04503668|593043876|FG001|Overall Study|Adverse Event|0|||
164184739|NCT02306694|593043877|FG000|Overall Study|Withdrawal by Subject|3|||
164184740|NCT02306694|593043877|FG000|Overall Study|Lost to Follow-up|1|||
164184741|NCT01907217|593043880|FG000|Overall Study|Withdrawal by Subject|0|||
164184742|NCT01907217|593043881|FG001|Overall Study|Withdrawal by Subject|2|||
164184743|NCT00742027|593043882|FG000|Overall Study|Disease Progression|76|||
164184744|NCT00742027|593043882|FG000|Overall Study|New Cancer Therapy|19|||
164184745|NCT00742027|593043882|FG000|Overall Study|Withdrawal by Subject|18|||
164184746|NCT00742027|593043882|FG000|Overall Study|Death|7|||
164184747|NCT00742027|593043882|FG000|Overall Study|Lost to Follow-up|4|||
164184748|NCT00742027|593043882|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
164184749|NCT00742027|593043882|FG000|Overall Study|Missing|2|||
164184750|NCT00742027|593043882|FG000|Overall Study|Administrative Problems|1|||
164184751|NCT01180049|593043883|FG000|Overall Study|Other|9|||
164184752|NCT01180049|593043884|FG001|Overall Study|Other|7|||
164184753|NCT01180049|593043883|FG000|Overall Study|Lost to Follow-up|8|||
164184754|NCT01180049|593043884|FG001|Overall Study|Lost to Follow-up|6|||
164184755|NCT01180049|593043883|FG000|Overall Study|Death|36|||
164184756|NCT01180049|593043884|FG001|Overall Study|Death|35|||
164184757|NCT01764659|593043885|FG000|Overall Study|Death|1|||
164184758|NCT01764659|593043885|FG000|Overall Study|Physician Decision|1|||
164184759|NCT01210352|593043886|FG000|Overall Study|Adverse Event|0|||
164184760|NCT01210352|593043887|FG001|Overall Study|Adverse Event|0|||
164184761|NCT01210352|593043888|FG002|Overall Study|Adverse Event|0|||
164184762|NCT01210352|593043889|FG003|Overall Study|Adverse Event|0|||
164184763|NCT01210352|593043890|FG004|Overall Study|Adverse Event|0|||
164184764|NCT01210352|593043891|FG005|Overall Study|Adverse Event|0|||
164184765|NCT01210352|593043892|FG006|Overall Study|Adverse Event|0|||
164184766|NCT01210352|593043893|FG007|Overall Study|Adverse Event|2|||
164184767|NCT01210352|593043894|FG008|Overall Study|Adverse Event|1|||
164184768|NCT01210352|593043886|FG000|Overall Study|Lack of Efficacy|0|||
164184769|NCT01210352|593043887|FG001|Overall Study|Lack of Efficacy|0|||
164184770|NCT01210352|593043888|FG002|Overall Study|Lack of Efficacy|0|||
164184771|NCT01210352|593043889|FG003|Overall Study|Lack of Efficacy|0|||
164184772|NCT01210352|593043890|FG004|Overall Study|Lack of Efficacy|0|||
164184773|NCT01210352|593043891|FG005|Overall Study|Lack of Efficacy|0|||
164184774|NCT01210352|593043892|FG006|Overall Study|Lack of Efficacy|1|||
164184775|NCT01210352|593043893|FG007|Overall Study|Lack of Efficacy|0|||
164184776|NCT01210352|593043894|FG008|Overall Study|Lack of Efficacy|0|||
164184777|NCT01210352|593043886|FG000|Overall Study|Physician Decision|0|||
164184778|NCT01210352|593043887|FG001|Overall Study|Physician Decision|0|||
164184779|NCT01210352|593043888|FG002|Overall Study|Physician Decision|0|||
164184780|NCT01210352|593043889|FG003|Overall Study|Physician Decision|0|||
164184781|NCT01210352|593043890|FG004|Overall Study|Physician Decision|0|||
164184782|NCT01210352|593043891|FG005|Overall Study|Physician Decision|0|||
164184783|NCT01210352|593043892|FG006|Overall Study|Physician Decision|0|||
164184784|NCT01210352|593043893|FG007|Overall Study|Physician Decision|1|||
164184785|NCT01210352|593043894|FG008|Overall Study|Physician Decision|2|||
164184786|NCT01210352|593043886|FG000|Overall Study|Withdrawal by Subject|0|||
164184787|NCT01210352|593043887|FG001|Overall Study|Withdrawal by Subject|0|||
164184788|NCT01210352|593043888|FG002|Overall Study|Withdrawal by Subject|1|||
164184789|NCT01210352|593043889|FG003|Overall Study|Withdrawal by Subject|0|||
164184790|NCT01210352|593043890|FG004|Overall Study|Withdrawal by Subject|0|||
164184791|NCT01210352|593043891|FG005|Overall Study|Withdrawal by Subject|0|||
164184792|NCT01210352|593043892|FG006|Overall Study|Withdrawal by Subject|1|||
164184793|NCT01210352|593043893|FG007|Overall Study|Withdrawal by Subject|0|||
164184794|NCT01210352|593043894|FG008|Overall Study|Withdrawal by Subject|1|||
164184795|NCT01210352|593043886|FG000|Overall Study|Patient Discharged Early|0|||
164184796|NCT01210352|593043887|FG001|Overall Study|Patient Discharged Early|0|||
164184797|NCT01210352|593043888|FG002|Overall Study|Patient Discharged Early|1|||
164184798|NCT01210352|593043889|FG003|Overall Study|Patient Discharged Early|0|||
164184799|NCT01210352|593043890|FG004|Overall Study|Patient Discharged Early|0|||
164184800|NCT01210352|593043891|FG005|Overall Study|Patient Discharged Early|0|||
164184801|NCT01210352|593043892|FG006|Overall Study|Patient Discharged Early|0|||
164184802|NCT01210352|593043893|FG007|Overall Study|Patient Discharged Early|0|||
164184803|NCT01210352|593043894|FG008|Overall Study|Patient Discharged Early|0|||
164184804|NCT03396822|593045386|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
164184805|NCT03396822|593045386|FG000|Overall Study|Physician Decision|1|||
164184806|NCT03630705|593045389|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
164184807|NCT03630705|593045390|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
164184808|NCT03630705|593045391|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
164184809|NCT03630705|593045392|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
164184810|NCT03630705|593045389|FG000|Overall Study|Lost to Follow-up|1|||
164184811|NCT03630705|593045390|FG001|Overall Study|Lost to Follow-up|2|||
164184812|NCT03630705|593045391|FG002|Overall Study|Lost to Follow-up|0|||
164184813|NCT03630705|593045392|FG003|Overall Study|Lost to Follow-up|0|||
164184814|NCT03488563|593045393|FG000|Overall Study|Lost to Follow-up|7|||
164184815|NCT03488563|593045394|FG001|Overall Study|Lost to Follow-up|6|||
164184816|NCT03488563|593045395|FG002|Overall Study|Lost to Follow-up|7|||
164184817|NCT03488563|593045393|FG000|Overall Study|Withdrawal by Subject|8|||
164184818|NCT03488563|593045394|FG001|Overall Study|Withdrawal by Subject|7|||
164184819|NCT03488563|593045395|FG002|Overall Study|Withdrawal by Subject|7|||
164184820|NCT03488563|593045393|FG000|Overall Study|Physician Decision|0|||
164184821|NCT03488563|593045394|FG001|Overall Study|Physician Decision|0|||
164184822|NCT03488563|593045395|FG002|Overall Study|Physician Decision|1|||
164184823|NCT03488563|593045393|FG000|Overall Study|Protocol Violation|3|||
164184824|NCT03488563|593045394|FG001|Overall Study|Protocol Violation|2|||
164184825|NCT03488563|593045395|FG002|Overall Study|Protocol Violation|6|||
164184826|NCT03488563|593045393|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
164184827|NCT03488563|593045394|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
164184828|NCT03488563|593045395|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
164184829|NCT03488563|593045393|FG000|Overall Study|Use of prohibited medication|2|||
164184830|NCT03488563|593045394|FG001|Overall Study|Use of prohibited medication|0|||
164184831|NCT03488563|593045395|FG002|Overall Study|Use of prohibited medication|0|||
164184832|NCT03488563|593045393|FG000|Overall Study|Adverse Event|1|||
164184833|NCT03488563|593045394|FG001|Overall Study|Adverse Event|0|||
164184834|NCT03488563|593045395|FG002|Overall Study|Adverse Event|1|||
164184835|NCT03488563|593045393|FG000|Overall Study|Subject returned for ET visit|0|||
164184836|NCT03488563|593045394|FG001|Overall Study|Subject returned for ET visit|1|||
164184837|NCT03488563|593045395|FG002|Overall Study|Subject returned for ET visit|0|||
164184838|NCT03488563|593045393|FG000|Overall Study|Sponsor's decision|0|||
164184839|NCT03488563|593045394|FG001|Overall Study|Sponsor's decision|0|||
164184840|NCT03488563|593045395|FG002|Overall Study|Sponsor's decision|1|||
164184841|NCT00339833|593045399|FG000|Overall Study|Withdrawal by Subject|1|||
164184842|NCT00339833|593045400|FG001|Overall Study|Withdrawal by Subject|2|||
164184843|NCT00339833|593045399|FG000|Overall Study|toothache|0|||
164184844|NCT00339833|593045400|FG001|Overall Study|toothache|1|||
164184845|NCT00339833|593045399|FG000|Overall Study|indigestion|0|||
164184846|NCT00339833|593045400|FG001|Overall Study|indigestion|1|||
164184847|NCT00339833|593045399|FG000|Overall Study|Chest pain|0|||
164184848|NCT00339833|593045400|FG001|Overall Study|Chest pain|1|||
164184849|NCT00339833|593045399|FG000|Overall Study|minor infection|0|||
164184850|NCT00339833|593045400|FG001|Overall Study|minor infection|1|||
164184851|NCT00339833|593045399|FG000|Overall Study|Poor venous access|2|||
164184852|NCT00339833|593045400|FG001|Overall Study|Poor venous access|2|||
164184853|NCT00339833|593045399|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
164184854|NCT00339833|593045400|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
164184855|NCT00339833|593045399|FG000|Overall Study|Error in data records|1|||
164184856|NCT00339833|593045400|FG001|Overall Study|Error in data records|0|||
164184857|NCT00217581|593045401|FG000|Overall Study|Withdrawal by Subject|1|||
164184858|NCT02829047|593045402|FG000|Overall Study|Withdrawal by Subject|1|||
164184859|NCT00329745|593045403|FG000|Overall Study|Protocol Violation|1|||
164184860|NCT00329745|593045404|FG001|Overall Study|Protocol Violation|0|||
164184861|NCT00329745|593045403|FG000|Overall Study|Withdrawal by Subject|0|||
164184862|NCT00329745|593045404|FG001|Overall Study|Withdrawal by Subject|1|||
164184863|NCT00329745|593045403|FG000|Overall Study|Lost to Follow-up|86|||
164184864|NCT00329745|593045404|FG001|Overall Study|Lost to Follow-up|101|||
164184865|NCT01597492|593045405|FG000|Overall Study|Withdrawal by Subject|1|||
164184866|NCT01597492|593045406|FG001|Overall Study|Withdrawal by Subject|2|||
164184867|NCT01597492|593045405|FG000|Overall Study|Adverse Event|3|||
164184868|NCT01597492|593045406|FG001|Overall Study|Adverse Event|0|||
164184869|NCT01597492|593045405|FG000|Overall Study|Lost to Follow-up|0|||
164184870|NCT01597492|593045406|FG001|Overall Study|Lost to Follow-up|2|||
164184871|NCT01597492|593045405|FG000|Overall Study|Other Reason|2|||
164184872|NCT01597492|593045406|FG001|Overall Study|Other Reason|0|||
164184873|NCT03146741|593045407|FG000|Overall Study|Txp with non-HCV+ heart|4|||
164184874|NCT03146741|593045407|FG000|Overall Study|Listeted for MOT|2|||
164184875|NCT03146741|593045407|FG000|Overall Study|Physician Decision|2|||
164184876|NCT03146741|593045407|FG000|Overall Study|Awaiting txp|2|||
164184877|NCT03224624|593045408|FG000|Overall Study|Lost to Follow-up|9|||
164184878|NCT03224624|593045409|FG001|Overall Study|Lost to Follow-up|4|||
164184879|NCT03224624|593045408|FG000|Overall Study|Death|1|||
164184880|NCT03224624|593045409|FG001|Overall Study|Death|0|||
164184881|NCT01424241|593045410|FG000|Overall Study|Withdrawal by Subject|1|||
164184882|NCT01424241|593045410|FG000|Overall Study|Time constraints|2|||
164184883|NCT00482170|593045414|FG000|Overall Study|Adverse Event|5|||
164184884|NCT00482170|593045415|FG001|Overall Study|Adverse Event|14|||
164184885|NCT00482170|593045414|FG000|Overall Study|Withdrawal by Subject|6|||
164184886|NCT00482170|593045415|FG001|Overall Study|Withdrawal by Subject|1|||
164184887|NCT00482170|593045414|FG000|Overall Study|Protocol Violation|2|||
164184888|NCT00482170|593045415|FG001|Overall Study|Protocol Violation|3|||
164184889|NCT00482170|593045414|FG000|Overall Study|Lost to Follow-up|2|||
164184890|NCT00482170|593045415|FG001|Overall Study|Lost to Follow-up|0|||
164184891|NCT00482170|593045414|FG000|Overall Study|Unspecified reason|0|||
164184892|NCT00482170|593045415|FG001|Overall Study|Unspecified reason|2|||
164184893|NCT03230838|593045420|FG000|Overall Study|Withdrawal by Subject|3|||
164184894|NCT03230838|593045421|FG001|Overall Study|Withdrawal by Subject|0|||
164184895|NCT03230838|593045420|FG000|Overall Study|Temperature excursion|1|||
164184896|NCT03230838|593045421|FG001|Overall Study|Temperature excursion|0|||
164184897|NCT00575510|593045424|FG000|Overall Study|Lost to Follow-up|4|||
164184898|NCT00575510|593045425|FG001|Overall Study|Lost to Follow-up|6|||
164184899|NCT00575510|593045426|FG002|Overall Study|Lost to Follow-up|9|||
164184900|NCT00575510|593045424|FG000|Overall Study|Withdrawal by Subject|1|||
164184901|NCT00575510|593045425|FG001|Overall Study|Withdrawal by Subject|0|||
164184902|NCT00575510|593045426|FG002|Overall Study|Withdrawal by Subject|0|||
164184903|NCT00575510|593045424|FG000|Overall Study|Clinic Called Patient|7|||
164184904|NCT00575510|593045425|FG001|Overall Study|Clinic Called Patient|7|||
164184905|NCT00575510|593045426|FG002|Overall Study|Clinic Called Patient|7|||
164184906|NCT00575510|593045424|FG000|Overall Study|Pregnancy|0|||
164184907|NCT00575510|593045425|FG001|Overall Study|Pregnancy|0|||
164184908|NCT00575510|593045426|FG002|Overall Study|Pregnancy|1|||
164184909|NCT02697734|593045429|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
164184910|NCT02697734|593045430|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
164184911|NCT02697734|593045429|FG000|Core Phase - up to Week 48|Adverse Event|1|||
164184912|NCT02697734|593045430|FG001|Core Phase - up to Week 48|Adverse Event|2|||
164184913|NCT02697734|593045429|FG000|Core Phase - up to Week 48|Physician Decision|1|||
164184914|NCT02697734|593045430|FG001|Core Phase - up to Week 48|Physician Decision|0|||
164184915|NCT02697734|593045429|FG000|Optional Extension Phase|Adverse Event|5|||
164184916|NCT02697734|593045430|FG001|Optional Extension Phase|Adverse Event|1|||
164184917|NCT02697734|593045429|FG000|Optional Extension Phase|Physician Decision|0|||
164184918|NCT02697734|593045430|FG001|Optional Extension Phase|Physician Decision|1|||
164184919|NCT02324699|593045431|FG000|Overall Study|study terminated|1|||
164184920|NCT03970200|593045432|FG000|Overall Study|Death|2|||
164184921|NCT03970200|593045433|FG001|Overall Study|Death|2|||
164184922|NCT03970200|593045434|FG002|Overall Study|Death|1|||
164184923|NCT03970200|593045432|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
164184924|NCT03970200|593045433|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
164184925|NCT03970200|593045434|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
164184926|NCT01607346|593045435|FG000|Overall Study|Adverse Event|3|||
164184927|NCT01098162|593045436|FG000|Overall Study|Adverse Event|37|||
164184928|NCT01098162|593045436|FG000|Overall Study|Lack of Efficacy|4|||
164184929|NCT01098162|593045436|FG000|Overall Study|Wish of Patient|7|||
164184930|NCT01098162|593045436|FG000|Overall Study|Lost to Follow-up|9|||
164184931|NCT01098162|593045436|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
164184932|NCT01098162|593045436|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
164184933|NCT01098162|593045436|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
164184934|NCT01098162|593045436|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
164184935|NCT01098162|593045436|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
164184936|NCT01098162|593045436|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
164184937|NCT01098162|593045436|FG000|Overall Study|Other Reason|1|||
164184938|NCT01098162|593045436|FG000|Overall Study|Reason Unknown|26|||
164184939|NCT01605825|593045437|FG000|Overall Study|Adverse Event|4|||
164184940|NCT01605825|593045438|FG001|Overall Study|Adverse Event|2|||
164184941|NCT01605825|593045437|FG000|Overall Study|Withdrawal by Subject|0|||
164184942|NCT01605825|593045438|FG001|Overall Study|Withdrawal by Subject|1|||
164184943|NCT01605825|593045437|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
164184944|NCT01605825|593045438|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
164184945|NCT01605825|593045437|FG000|Overall Study|Non-Compliance with Protocol|3|||
164184946|NCT01605825|593045438|FG001|Overall Study|Non-Compliance with Protocol|0|||
164184947|NCT00380718|593045441|FG000|Overall Study|Adverse Event|1|||
164184948|NCT00380718|593045441|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
164184949|NCT04318132|593045447|FG000|Overall Study|Protocol Violation|0|||
164184950|NCT04318132|593045448|FG001|Overall Study|Protocol Violation|0|||
164184951|NCT04318132|593045449|FG002|Overall Study|Protocol Violation|3|||
164184952|NCT04318132|593045450|FG003|Overall Study|Protocol Violation|0|||
164184953|NCT01863732|593045451|FG000|Overall Study|Adverse Event|2|||
164184954|NCT01863732|593045452|FG001|Overall Study|Adverse Event|0|||
164184955|NCT01863732|593045453|FG002|Overall Study|Adverse Event|3|||
164184956|NCT01863732|593045454|FG003|Overall Study|Adverse Event|3|||
164184957|NCT01863732|593045451|FG000|Overall Study|Lack of Efficacy|1|||
164184958|NCT01863732|593045452|FG001|Overall Study|Lack of Efficacy|0|||
164184959|NCT01863732|593045453|FG002|Overall Study|Lack of Efficacy|2|||
164184960|NCT01863732|593045454|FG003|Overall Study|Lack of Efficacy|1|||
164184961|NCT01863732|593045451|FG000|Overall Study|Lost to Follow-up|2|||
164184962|NCT01863732|593045452|FG001|Overall Study|Lost to Follow-up|2|||
164184963|NCT01863732|593045453|FG002|Overall Study|Lost to Follow-up|1|||
164184964|NCT01863732|593045454|FG003|Overall Study|Lost to Follow-up|1|||
164184965|NCT01863732|593045451|FG000|Overall Study|Physician Decision|1|||
164184966|NCT01863732|593045452|FG001|Overall Study|Physician Decision|0|||
164184967|NCT01863732|593045453|FG002|Overall Study|Physician Decision|1|||
164184968|NCT01863732|593045454|FG003|Overall Study|Physician Decision|0|||
164184969|NCT01863732|593045451|FG000|Overall Study|Pregnancy|0|||
164184970|NCT01863732|593045452|FG001|Overall Study|Pregnancy|0|||
164184971|NCT01863732|593045453|FG002|Overall Study|Pregnancy|0|||
164184972|NCT01863732|593045454|FG003|Overall Study|Pregnancy|1|||
164184973|NCT01863732|593045451|FG000|Overall Study|Technical problems|0|||
164184974|NCT01863732|593045452|FG001|Overall Study|Technical problems|1|||
164184975|NCT01863732|593045453|FG002|Overall Study|Technical problems|1|||
164184976|NCT01863732|593045454|FG003|Overall Study|Technical problems|0|||
164184977|NCT01863732|593045451|FG000|Overall Study|Subject/guardian decision|6|||
164184978|NCT01863732|593045452|FG001|Overall Study|Subject/guardian decision|9|||
164184979|NCT01863732|593045453|FG002|Overall Study|Subject/guardian decision|3|||
164184980|NCT01863732|593045454|FG003|Overall Study|Subject/guardian decision|1|||
164184981|NCT01863732|593045451|FG000|Overall Study|Death|1|||
164184982|NCT01863732|593045452|FG001|Overall Study|Death|0|||
164184983|NCT01863732|593045453|FG002|Overall Study|Death|0|||
164184984|NCT01863732|593045454|FG003|Overall Study|Death|1|||
164184985|NCT00840034|593045458|FG000|Acute Treatment Phase|Adverse Event|6|||
164184986|NCT00840034|593045459|FG001|Acute Treatment Phase|Adverse Event|8|||
164184987|NCT00840034|593045458|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
164184988|NCT00840034|593045459|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
164184989|NCT00840034|593045458|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
164184990|NCT00840034|593045459|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
164184991|NCT00840034|593045458|FG000|Acute Treatment Phase|Physician Decision|0|||
164184992|NCT00840034|593045459|FG001|Acute Treatment Phase|Physician Decision|1|||
164184993|NCT00840034|593045458|FG000|Acute Treatment Phase|Protocol Violation|2|||
164184994|NCT00840034|593045459|FG001|Acute Treatment Phase|Protocol Violation|4|||
164184995|NCT00840034|593045458|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
164184996|NCT00840034|593045459|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
164184997|NCT00840034|593045458|FG000|Taper Phase|Adverse Event|1|||
164184998|NCT00840034|593045459|FG001|Taper Phase|Adverse Event|0|||
164184999|NCT00840034|593045458|FG000|Taper Phase|Lost to Follow-up|1|||
164185000|NCT00840034|593045459|FG001|Taper Phase|Lost to Follow-up|1|||
164185001|NCT00840034|593045458|FG000|Taper Phase|Withdrawal by Subject|1|||
164185002|NCT00840034|593045459|FG001|Taper Phase|Withdrawal by Subject|1|||
164185003|NCT02839876|593045466|FG000|Overall Study|Protocol Violation|10|||
164185004|NCT02839876|593045467|FG001|Overall Study|Protocol Violation|11|||
164185005|NCT01156051|593045469|FG000|Overall Study|Lost to Follow-up|1|||
164185006|NCT01156051|593045470|FG001|Overall Study|Lost to Follow-up|0|||
164185007|NCT01156051|593045469|FG000|Overall Study|patient not compliant with protocol|0|||
164185008|NCT01156051|593045470|FG001|Overall Study|patient not compliant with protocol|1|||
164185009|NCT03816007|593045471|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
164185010|NCT03816007|593045472|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
164185011|NCT03816007|593045471|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
164185012|NCT03816007|593045472|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
164185013|NCT03816007|593045471|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
164185014|NCT03816007|593045472|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
164185015|NCT03628716|593045473|FG000|Overall Study|Adverse Event|1|||
164185016|NCT03628716|593045474|FG001|Overall Study|Adverse Event|1|||
164185017|NCT03628716|593045473|FG000|Overall Study|Death|1|||
164185018|NCT03628716|593045474|FG001|Overall Study|Death|0|||
164185019|NCT03628716|593045473|FG000|Overall Study|Lack of Efficacy|15|||
164185020|NCT03628716|593045474|FG001|Overall Study|Lack of Efficacy|20|||
164185021|NCT03628716|593045473|FG000|Overall Study|Withdrawal by Subject|1|||
164185022|NCT03628716|593045474|FG001|Overall Study|Withdrawal by Subject|2|||
164185023|NCT03628716|593045473|FG000|Overall Study|Study Terminated by Sponsor|1|||
164185024|NCT03628716|593045474|FG001|Overall Study|Study Terminated by Sponsor|0|||
164185025|NCT00856843|593045475|FG000|Overall Study|Withdrawal by Subject|1|||
164185026|NCT00856843|593045476|FG001|Overall Study|Withdrawal by Subject|5|||
164185027|NCT00856843|593045475|FG000|Overall Study|Lack of Efficacy|1|||
164185028|NCT00856843|593045476|FG001|Overall Study|Lack of Efficacy|0|||
164185029|NCT02179749|593045477|FG000|Overall Study|Adverse Event|0|||
164185030|NCT02179749|593045478|FG001|Overall Study|Adverse Event|0|||
164185031|NCT02179749|593045479|FG002|Overall Study|Adverse Event|1|||
164185032|NCT02179749|593045477|FG000|Overall Study|Withdrawal by Subject|0|||
164185033|NCT02179749|593045478|FG001|Overall Study|Withdrawal by Subject|0|||
164185034|NCT02179749|593045479|FG002|Overall Study|Withdrawal by Subject|1|||
164185035|NCT00094536|593045480|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
164185036|NCT00094536|593045480|FG000|Treatment and Follow-up|Adverse Event|4|||
164185037|NCT00094536|593045480|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
164185038|NCT00094536|593045480|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
164185039|NCT00094536|593045480|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
164185040|NCT00094536|593045480|FG000|Treatment and Follow-up|Subject non-compliance|9|||
164185041|NCT00094536|593045480|FG000|Treatment and Follow-up|Unable to attend visits|1|||
164185042|NCT02620384|593045481|FG000|Overall Study|Adverse Event|2|||
164185043|NCT02620384|593045482|FG001|Overall Study|Adverse Event|1|||
164185044|NCT02620384|593045481|FG000|Overall Study|Discharged prior to 2nd dose|2|||
164185045|NCT02620384|593045482|FG001|Overall Study|Discharged prior to 2nd dose|5|||
164185046|NCT02620384|593045481|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
164185047|NCT02620384|593045482|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
164185048|NCT00628927|593045487|FG000|Overall Study|Problems performing blood draw|6|||
164185049|NCT00628927|593045488|FG001|Overall Study|Problems performing blood draw|0|||
164185050|NCT00628927|593045487|FG000|Overall Study|Lost to Follow-up|1|||
164185051|NCT00628927|593045488|FG001|Overall Study|Lost to Follow-up|0|||
164185052|NCT00628927|593045487|FG000|Overall Study|Equipment failure|1|||
164185053|NCT00628927|593045488|FG001|Overall Study|Equipment failure|0|||
164185054|NCT01298141|593045492|FG000|Overall Study|Adverse Event|3|||
164185055|NCT01298141|593045492|FG000|Overall Study|Refusal of Required Study Procedures|1|||
164185056|NCT01298141|593045492|FG000|Overall Study|Withdrawal by Subject|6|||
164185057|NCT01298141|593045492|FG000|Overall Study|Termination of Study by the Investigator|5|||
164185058|NCT01298141|593045492|FG000|Overall Study|Other|5|||
164185059|NCT01298141|593045492|FG000|Overall Study|Lost to Follow-up|1|||
164185060|NCT01298141|593045492|FG000|Overall Study|Death|6|||
164185061|NCT01298141|593045492|FG000|Overall Study|Not treated|4|||
164185062|NCT03338569|593045493|FG000|Overall Study|Physician Decision|8|||
164185063|NCT03338569|593045494|FG001|Overall Study|Physician Decision|3|||
164185064|NCT03338569|593045493|FG000|Overall Study|Withdrawal by Subject|0|||
164185065|NCT03338569|593045494|FG001|Overall Study|Withdrawal by Subject|1|||
164185066|NCT03338569|593045493|FG000|Overall Study|Lost to Follow-up|0|||
164185067|NCT03338569|593045494|FG001|Overall Study|Lost to Follow-up|1|||
164185068|NCT00350779|593045495|FG000|Overall Study|Adverse Event|4|||
164185069|NCT00350779|593045496|FG001|Overall Study|Adverse Event|2|||
164185070|NCT00350779|593045495|FG000|Overall Study|Lack of Efficacy|0|||
164185071|NCT00350779|593045496|FG001|Overall Study|Lack of Efficacy|4|||
164185072|NCT00350779|593045495|FG000|Overall Study|Lost to Follow-up|2|||
164185073|NCT00350779|593045496|FG001|Overall Study|Lost to Follow-up|0|||
164185074|NCT00350779|593045495|FG000|Overall Study|Physician Decision|2|||
164185075|NCT00350779|593045496|FG001|Overall Study|Physician Decision|4|||
164185076|NCT00350779|593045495|FG000|Overall Study|Protocol Violation|3|||
164185077|NCT00350779|593045496|FG001|Overall Study|Protocol Violation|1|||
164185078|NCT00350779|593045495|FG000|Overall Study|Withdrawal by Subject|9|||
164185079|NCT00350779|593045496|FG001|Overall Study|Withdrawal by Subject|8|||
164185080|NCT00350779|593045495|FG000|Overall Study|Patient Moved|2|||
164185081|NCT00350779|593045496|FG001|Overall Study|Patient Moved|1|||
164185082|NCT00350779|593045495|FG000|Overall Study|Non-compliance with study procedures|0|||
164185083|NCT00350779|593045496|FG001|Overall Study|Non-compliance with study procedures|1|||
164185084|NCT00528372|593045497|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
164185085|NCT00528372|593045498|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
164185086|NCT00528372|593045499|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
164185087|NCT00528372|593045500|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
164185088|NCT00528372|593045501|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
164185089|NCT00528372|593045502|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
164185090|NCT00528372|593045503|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
164185091|NCT00528372|593045504|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
164185092|NCT00528372|593045505|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
164185093|NCT00528372|593045497|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
164185094|NCT00528372|593045498|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
164185095|NCT00528372|593045499|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
164185096|NCT00528372|593045500|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
164185097|NCT00528372|593045501|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
164185098|NCT00528372|593045502|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
164185099|NCT00528372|593045503|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
164185100|NCT00528372|593045504|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
164185101|NCT00528372|593045505|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
164185102|NCT00528372|593045497|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
164185103|NCT00528372|593045498|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
164185104|NCT00528372|593045499|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
164185105|NCT00528372|593045500|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
164185106|NCT00528372|593045501|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
164185107|NCT00528372|593045502|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
164185108|NCT00528372|593045503|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
164185109|NCT00528372|593045504|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
164185110|NCT00528372|593045505|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
164185111|NCT00528372|593045497|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
164185112|NCT00528372|593045498|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
164185113|NCT00528372|593045499|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
164185114|NCT00528372|593045500|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
164185115|NCT00528372|593045501|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
164185116|NCT00528372|593045502|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
164185117|NCT00528372|593045503|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
164185118|NCT00528372|593045504|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
164185119|NCT00528372|593045505|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
164185120|NCT00528372|593045497|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
164185121|NCT00528372|593045498|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
164185122|NCT00528372|593045499|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
164185123|NCT00528372|593045500|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
164185124|NCT00528372|593045501|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
164185125|NCT00528372|593045502|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
164185126|NCT00528372|593045503|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
164185127|NCT00528372|593045504|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
164185128|NCT00528372|593045505|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
164185129|NCT00528372|593045497|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
164185130|NCT00528372|593045498|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
164185131|NCT00528372|593045499|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
164185132|NCT00528372|593045500|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
164185133|NCT00528372|593045501|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
164185134|NCT00528372|593045502|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
164185135|NCT00528372|593045503|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
164185136|NCT00528372|593045504|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
164185137|NCT00528372|593045505|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
164185138|NCT00528372|593045497|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
164185139|NCT00528372|593045498|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
164185140|NCT00528372|593045499|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
164185141|NCT00528372|593045500|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
164185142|NCT00528372|593045501|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
164185143|NCT00528372|593045502|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
164185144|NCT00528372|593045503|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
164185145|NCT00528372|593045504|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
164185146|NCT00528372|593045505|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
164185147|NCT00528372|593045497|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
164185148|NCT00528372|593045498|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
164185149|NCT00528372|593045499|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
164185150|NCT00528372|593045500|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
164185151|NCT00528372|593045501|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
164185152|NCT00528372|593045502|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
164185153|NCT00528372|593045503|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
164185154|NCT00528372|593045504|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
164185155|NCT00528372|593045505|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
164185156|NCT00528372|593045497|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
164185157|NCT00528372|593045498|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
164185158|NCT00528372|593045499|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
164185159|NCT00528372|593045500|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
164185160|NCT00528372|593045501|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
164185161|NCT00528372|593045502|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
164185162|NCT00528372|593045503|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
164185163|NCT00528372|593045504|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
164185164|NCT00528372|593045505|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
164185165|NCT00528372|593045497|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
164185166|NCT00528372|593045498|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
164185167|NCT00528372|593045499|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
164185168|NCT00528372|593045500|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
164185169|NCT00528372|593045501|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
164185170|NCT00528372|593045502|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
164185171|NCT00528372|593045503|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
164185172|NCT00528372|593045504|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
164185173|NCT00528372|593045505|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
164185174|NCT00528372|593045497|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
164185175|NCT00528372|593045498|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
164185176|NCT00528372|593045499|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
164185177|NCT00528372|593045500|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
164185178|NCT00528372|593045501|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
164185179|NCT00528372|593045502|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
164185180|NCT00528372|593045503|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
164185181|NCT00528372|593045504|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
164185182|NCT00528372|593045505|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
164185183|NCT00528372|593045497|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
164185184|NCT00528372|593045498|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
164185185|NCT00528372|593045499|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
164185186|NCT00528372|593045500|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
164185187|NCT00528372|593045501|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
164185188|NCT00528372|593045502|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
164185189|NCT00528372|593045503|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
164185190|NCT00528372|593045504|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
164185191|NCT00528372|593045505|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
164185192|NCT00528372|593045497|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
164185193|NCT00528372|593045498|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
164185194|NCT00528372|593045499|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
164185195|NCT00528372|593045500|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
164185196|NCT00528372|593045501|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
164185197|NCT00528372|593045502|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
164185198|NCT00528372|593045503|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
164185199|NCT00528372|593045504|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
164185200|NCT00528372|593045505|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
164185201|NCT00528372|593045497|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
164185202|NCT00528372|593045498|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
164185203|NCT00528372|593045499|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
164185204|NCT00528372|593045500|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
164185205|NCT00528372|593045501|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
164185206|NCT00528372|593045502|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
164185207|NCT00528372|593045503|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
164185208|NCT00528372|593045504|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
164185209|NCT00528372|593045505|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
164185210|NCT00528372|593045497|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
164185211|NCT00528372|593045498|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
164185212|NCT00528372|593045499|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
164185213|NCT00528372|593045500|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
164185214|NCT00528372|593045501|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
164185215|NCT00528372|593045502|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
164185216|NCT00528372|593045503|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
164185217|NCT00528372|593045504|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
164185218|NCT00528372|593045505|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
164185219|NCT01289574|593045508|FG000|Overall Study|Lack of Efficacy|4|||
164185220|NCT01289574|593045509|FG001|Overall Study|Lack of Efficacy|0|||
164185221|NCT01289574|593045510|FG002|Overall Study|Lack of Efficacy|1|||
164185222|NCT01289574|593045508|FG000|Overall Study|Lost to Follow-up|2|||
164185223|NCT01289574|593045509|FG001|Overall Study|Lost to Follow-up|0|||
164185224|NCT01289574|593045510|FG002|Overall Study|Lost to Follow-up|1|||
164185225|NCT01289574|593045508|FG000|Overall Study|Withdrawal by Subject|1|||
164185226|NCT01289574|593045509|FG001|Overall Study|Withdrawal by Subject|1|||
164185227|NCT01289574|593045510|FG002|Overall Study|Withdrawal by Subject|1|||
164185228|NCT01289574|593045508|FG000|Overall Study|Adverse Event|0|||
164185229|NCT01289574|593045509|FG001|Overall Study|Adverse Event|1|||
164185230|NCT01289574|593045510|FG002|Overall Study|Adverse Event|0|||
164185231|NCT01289574|593045508|FG000|Overall Study|Subject wanted alternate treatment|0|||
164185232|NCT01289574|593045509|FG001|Overall Study|Subject wanted alternate treatment|1|||
164185233|NCT01289574|593045510|FG002|Overall Study|Subject wanted alternate treatment|0|||
164185234|NCT00262002|593045511|FG000|Overall Study|Adverse Event|2|||
164185235|NCT00262002|593045512|FG001|Overall Study|Adverse Event|1|||
164185236|NCT00262002|593045513|FG002|Overall Study|Adverse Event|0|||
164185237|NCT00262002|593045514|FG003|Overall Study|Adverse Event|0|||
164185238|NCT00262002|593045515|FG004|Overall Study|Adverse Event|0|||
164185239|NCT00262002|593045516|FG005|Overall Study|Adverse Event|1|||
164185240|NCT00262002|593045517|FG006|Overall Study|Adverse Event|0|||
164185241|NCT00262002|593045511|FG000|Overall Study|Withdrawal by Subject|4|||
164185242|NCT00262002|593045512|FG001|Overall Study|Withdrawal by Subject|2|||
164185243|NCT00262002|593045513|FG002|Overall Study|Withdrawal by Subject|0|||
164185244|NCT00262002|593045514|FG003|Overall Study|Withdrawal by Subject|1|||
164185245|NCT00262002|593045515|FG004|Overall Study|Withdrawal by Subject|2|||
164185246|NCT00262002|593045516|FG005|Overall Study|Withdrawal by Subject|2|||
164185247|NCT00262002|593045517|FG006|Overall Study|Withdrawal by Subject|2|||
164185248|NCT00262002|593045511|FG000|Overall Study|Lost to Follow-up|2|||
164185249|NCT00262002|593045512|FG001|Overall Study|Lost to Follow-up|0|||
164185250|NCT00262002|593045513|FG002|Overall Study|Lost to Follow-up|0|||
164185251|NCT00262002|593045514|FG003|Overall Study|Lost to Follow-up|2|||
164185252|NCT00262002|593045515|FG004|Overall Study|Lost to Follow-up|0|||
164185253|NCT00262002|593045516|FG005|Overall Study|Lost to Follow-up|1|||
164185254|NCT00262002|593045517|FG006|Overall Study|Lost to Follow-up|0|||
164185255|NCT00262002|593045511|FG000|Overall Study|Inapropriate enrollment|0|||
164185256|NCT00262002|593045512|FG001|Overall Study|Inapropriate enrollment|1|||
164185257|NCT00262002|593045513|FG002|Overall Study|Inapropriate enrollment|0|||
164185258|NCT00262002|593045514|FG003|Overall Study|Inapropriate enrollment|0|||
164185259|NCT00262002|593045515|FG004|Overall Study|Inapropriate enrollment|0|||
164185260|NCT00262002|593045516|FG005|Overall Study|Inapropriate enrollment|0|||
164185261|NCT00262002|593045517|FG006|Overall Study|Inapropriate enrollment|0|||
164185262|NCT00262002|593045511|FG000|Overall Study|Protocol Violation|3|||
164185263|NCT00262002|593045512|FG001|Overall Study|Protocol Violation|2|||
164185264|NCT00262002|593045513|FG002|Overall Study|Protocol Violation|0|||
164185265|NCT00262002|593045514|FG003|Overall Study|Protocol Violation|2|||
164185266|NCT00262002|593045515|FG004|Overall Study|Protocol Violation|5|||
164185267|NCT00262002|593045516|FG005|Overall Study|Protocol Violation|3|||
164185268|NCT00262002|593045517|FG006|Overall Study|Protocol Violation|2|||
164185269|NCT00262002|593045511|FG000|Overall Study|Unable to classify|0|||
164185270|NCT00262002|593045512|FG001|Overall Study|Unable to classify|0|||
164185271|NCT00262002|593045513|FG002|Overall Study|Unable to classify|0|||
164185272|NCT00262002|593045514|FG003|Overall Study|Unable to classify|0|||
164185273|NCT00262002|593045515|FG004|Overall Study|Unable to classify|0|||
164185274|NCT00262002|593045516|FG005|Overall Study|Unable to classify|0|||
164185275|NCT00262002|593045517|FG006|Overall Study|Unable to classify|2|||
164185276|NCT02526160|593047428|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
164185277|NCT02526160|593047429|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
164185278|NCT02526160|593047428|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
164185279|NCT02526160|593047429|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
164185280|NCT02526160|593047428|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
164185281|NCT02526160|593047429|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
164185282|NCT02526160|593047428|FG000|Open-Label Treatment Extension Period I|Death|0|||
164185283|NCT02526160|593047429|FG001|Open-Label Treatment Extension Period I|Death|1|||
164185284|NCT02526160|593047428|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
164185285|NCT02526160|593047429|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
164185286|NCT02526160|593047428|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
164185287|NCT02526160|593047429|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
164185288|NCT02526160|593047428|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
164185289|NCT02526160|593047429|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
164185290|NCT02526160|593047428|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
164185291|NCT02526160|593047429|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
164185292|NCT04227405|593047430|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
164185293|NCT04227405|593047431|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
164185294|NCT04227405|593047430|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
164185295|NCT04227405|593047431|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
164185296|NCT04227405|593047430|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
164185297|NCT04227405|593047431|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
164185298|NCT03536663|593047432|FG000|Endexo|Protocol Violation|1|||
164185299|NCT01775787|593047433|FG000|First 7-10 Days|Adverse Event|0|||
164185300|NCT01775787|593047434|FG001|First 7-10 Days|Adverse Event|1|||
164185301|NCT01775787|593047433|FG000|First 7-10 Days|family emergency|0|||
164185302|NCT01775787|593047434|FG001|First 7-10 Days|family emergency|1|||
164185303|NCT01775787|593047433|FG000|First 7-10 Days|time commitment|0|||
164185304|NCT01775787|593047434|FG001|First 7-10 Days|time commitment|2|||
164185305|NCT01775787|593047433|FG000|First 7-10 Days|concerns with using IV|1|||
164185306|NCT01775787|593047434|FG001|First 7-10 Days|concerns with using IV|2|||
164185307|NCT01775787|593047433|FG000|Second 7-10 Days|time commitment|0|||
164185308|NCT01775787|593047434|FG001|Second 7-10 Days|time commitment|1|||
164185309|NCT01775787|593047433|FG000|Second 7-10 Days|concerns with using IV|0|||
164185310|NCT01775787|593047434|FG001|Second 7-10 Days|concerns with using IV|1|||
164185311|NCT01502956|593047435|FG000|Overall Study|Death|0|||
164185312|NCT01502956|593047436|FG001|Overall Study|Death|2|||
164185313|NCT01502956|593047435|FG000|Overall Study|Lost to Follow-up|14|||
164185314|NCT01502956|593047436|FG001|Overall Study|Lost to Follow-up|11|||
164185315|NCT01502956|593047435|FG000|Overall Study|Physician Decision|2|||
164185316|NCT01502956|593047436|FG001|Overall Study|Physician Decision|3|||
164185317|NCT01502956|593047435|FG000|Overall Study|Withdrawal by Subject|8|||
164185318|NCT01502956|593047436|FG001|Overall Study|Withdrawal by Subject|10|||
164185319|NCT01616758|593047437|FG000|Overall Study|Adverse Event|1|||
164185320|NCT01616758|593047437|FG000|Overall Study|Withdrawal by Subject|2|||
164185321|NCT01616758|593047437|FG000|Overall Study|Disease progression|18|||
164185322|NCT01616758|593047437|FG000|Overall Study|Study termination by Sponsor|1|||
164185323|NCT04076319|593047442|FG000|Overall Study|Withdrawal by Subject|2|||
164185324|NCT04076319|593047443|FG001|Overall Study|Withdrawal by Subject|0|||
164185325|NCT04076319|593047442|FG000|Overall Study|Death|1|||
164185326|NCT04076319|593047443|FG001|Overall Study|Death|0|||
164185327|NCT01054222|593047444|FG000|Overall Study|Lack of Efficacy|1|||
164185328|NCT01054222|593047444|FG000|Overall Study|Lost to Follow-up|4|||
164185329|NCT01054222|593047444|FG000|Overall Study|Withdrawal by Subject|6|||
164185330|NCT03252145|593047448|FG000|Overall Study|Withdrawal by Subject|1|||
164185331|NCT03252145|593047449|FG001|Overall Study|Withdrawal by Subject|0|||
164185332|NCT03252145|593047448|FG000|Overall Study|Complicating Disease|1|||
164185333|NCT03252145|593047449|FG001|Overall Study|Complicating Disease|2|||
164185334|NCT01763827|593047453|FG000|Overall Study|Withdrawal by Subject|1|||
164185335|NCT01763827|593047454|FG001|Overall Study|Withdrawal by Subject|0|||
164185336|NCT01763827|593047455|FG002|Overall Study|Withdrawal by Subject|0|||
164185337|NCT01763827|593047456|FG003|Overall Study|Withdrawal by Subject|0|||
164185338|NCT01763827|593047457|FG004|Overall Study|Withdrawal by Subject|2|||
164185339|NCT01763827|593047458|FG005|Overall Study|Withdrawal by Subject|0|||
164185340|NCT01763827|593047453|FG000|Overall Study|Decision by sponsor|2|||
164185341|NCT01763827|593047454|FG001|Overall Study|Decision by sponsor|0|||
164185342|NCT01763827|593047455|FG002|Overall Study|Decision by sponsor|3|||
164185343|NCT01763827|593047456|FG003|Overall Study|Decision by sponsor|0|||
164185344|NCT01763827|593047457|FG004|Overall Study|Decision by sponsor|2|||
164185345|NCT01763827|593047458|FG005|Overall Study|Decision by sponsor|1|||
164185346|NCT01763827|593047453|FG000|Overall Study|Lost to Follow-up|0|||
164185347|NCT01763827|593047454|FG001|Overall Study|Lost to Follow-up|1|||
164185348|NCT01763827|593047455|FG002|Overall Study|Lost to Follow-up|1|||
164185349|NCT01763827|593047456|FG003|Overall Study|Lost to Follow-up|1|||
164185350|NCT01763827|593047457|FG004|Overall Study|Lost to Follow-up|2|||
164185351|NCT01763827|593047458|FG005|Overall Study|Lost to Follow-up|1|||
164185352|NCT00667563|593047461|FG000|Overall Study|Protocol Violation|24|||
164185353|NCT03130959|593047464|FG000|Overall Study|Disease progression|19|||
164185354|NCT03130959|593047465|FG001|Overall Study|Disease progression|7|||
164185355|NCT03130959|593047466|FG002|Overall Study|Disease progression|12|||
164185356|NCT03130959|593047467|FG003|Overall Study|Disease progression|7|||
164185357|NCT03130959|593047468|FG004|Overall Study|Disease progression|12|||
164185358|NCT03130959|593047469|FG005|Overall Study|Disease progression|3|||
164185359|NCT03130959|593047470|FG006|Overall Study|Disease progression|6|||
164185360|NCT03130959|593047471|FG007|Overall Study|Disease progression|3|||
164185361|NCT03130959|593047472|FG008|Overall Study|Disease progression|15|||
164185362|NCT03130959|593047473|FG009|Overall Study|Disease progression|8|||
164185363|NCT03130959|593047464|FG000|Overall Study|Study drug toxicity|2|||
164185364|NCT03130959|593047465|FG001|Overall Study|Study drug toxicity|2|||
164185365|NCT03130959|593047466|FG002|Overall Study|Study drug toxicity|1|||
164185366|NCT03130959|593047467|FG003|Overall Study|Study drug toxicity|2|||
164185367|NCT03130959|593047468|FG004|Overall Study|Study drug toxicity|1|||
164185368|NCT03130959|593047469|FG005|Overall Study|Study drug toxicity|1|||
164185369|NCT03130959|593047470|FG006|Overall Study|Study drug toxicity|3|||
164185370|NCT03130959|593047471|FG007|Overall Study|Study drug toxicity|0|||
164185371|NCT03130959|593047472|FG008|Overall Study|Study drug toxicity|3|||
164185372|NCT03130959|593047473|FG009|Overall Study|Study drug toxicity|3|||
164185373|NCT03130959|593047464|FG000|Overall Study|Other reasons|0|||
164185374|NCT03130959|593047465|FG001|Overall Study|Other reasons|0|||
164185375|NCT03130959|593047466|FG002|Overall Study|Other reasons|0|||
164185376|NCT03130959|593047467|FG003|Overall Study|Other reasons|0|||
164185377|NCT03130959|593047468|FG004|Overall Study|Other reasons|0|||
164185378|NCT03130959|593047469|FG005|Overall Study|Other reasons|1|||
164185379|NCT03130959|593047470|FG006|Overall Study|Other reasons|1|||
164185380|NCT03130959|593047471|FG007|Overall Study|Other reasons|0|||
164185381|NCT03130959|593047472|FG008|Overall Study|Other reasons|0|||
164185382|NCT03130959|593047473|FG009|Overall Study|Other reasons|0|||
164185383|NCT03130959|593047464|FG000|Overall Study|Subject request to discontinue therapy|0|||
164185384|NCT03130959|593047465|FG001|Overall Study|Subject request to discontinue therapy|0|||
164185385|NCT03130959|593047466|FG002|Overall Study|Subject request to discontinue therapy|1|||
164185386|NCT03130959|593047467|FG003|Overall Study|Subject request to discontinue therapy|1|||
164185387|NCT03130959|593047468|FG004|Overall Study|Subject request to discontinue therapy|0|||
164185388|NCT03130959|593047469|FG005|Overall Study|Subject request to discontinue therapy|0|||
164185389|NCT03130959|593047470|FG006|Overall Study|Subject request to discontinue therapy|1|||
164185390|NCT03130959|593047471|FG007|Overall Study|Subject request to discontinue therapy|1|||
164185391|NCT03130959|593047472|FG008|Overall Study|Subject request to discontinue therapy|0|||
164185392|NCT03130959|593047473|FG009|Overall Study|Subject request to discontinue therapy|0|||
164185393|NCT03130959|593047464|FG000|Overall Study|Not reported|0|||
164185394|NCT03130959|593047465|FG001|Overall Study|Not reported|0|||
164185395|NCT03130959|593047466|FG002|Overall Study|Not reported|0|||
164185396|NCT03130959|593047467|FG003|Overall Study|Not reported|1|||
164185397|NCT03130959|593047468|FG004|Overall Study|Not reported|0|||
164185398|NCT03130959|593047469|FG005|Overall Study|Not reported|1|||
164185399|NCT03130959|593047470|FG006|Overall Study|Not reported|0|||
164185400|NCT03130959|593047471|FG007|Overall Study|Not reported|0|||
164185401|NCT03130959|593047472|FG008|Overall Study|Not reported|0|||
164185402|NCT03130959|593047473|FG009|Overall Study|Not reported|1|||
164185403|NCT03130959|593047464|FG000|Overall Study|Adverse Event unrelated to drug|0|||
164185404|NCT03130959|593047465|FG001|Overall Study|Adverse Event unrelated to drug|0|||
164185405|NCT03130959|593047466|FG002|Overall Study|Adverse Event unrelated to drug|1|||
164185406|NCT03130959|593047467|FG003|Overall Study|Adverse Event unrelated to drug|1|||
164185407|NCT03130959|593047468|FG004|Overall Study|Adverse Event unrelated to drug|1|||
164185408|NCT03130959|593047469|FG005|Overall Study|Adverse Event unrelated to drug|0|||
164185409|NCT03130959|593047470|FG006|Overall Study|Adverse Event unrelated to drug|1|||
164185410|NCT03130959|593047471|FG007|Overall Study|Adverse Event unrelated to drug|0|||
164185411|NCT03130959|593047472|FG008|Overall Study|Adverse Event unrelated to drug|1|||
164185412|NCT03130959|593047473|FG009|Overall Study|Adverse Event unrelated to drug|1|||
164185413|NCT03130959|593047464|FG000|Overall Study|Participant withdrew consent|0|||
164185414|NCT03130959|593047465|FG001|Overall Study|Participant withdrew consent|1|||
164185415|NCT03130959|593047466|FG002|Overall Study|Participant withdrew consent|0|||
164185416|NCT03130959|593047467|FG003|Overall Study|Participant withdrew consent|2|||
164185417|NCT03130959|593047468|FG004|Overall Study|Participant withdrew consent|1|||
164185418|NCT03130959|593047469|FG005|Overall Study|Participant withdrew consent|0|||
164185419|NCT03130959|593047470|FG006|Overall Study|Participant withdrew consent|0|||
164185420|NCT03130959|593047471|FG007|Overall Study|Participant withdrew consent|0|||
164185421|NCT03130959|593047472|FG008|Overall Study|Participant withdrew consent|0|||
164185422|NCT03130959|593047473|FG009|Overall Study|Participant withdrew consent|2|||
164185423|NCT03130959|593047464|FG000|Overall Study|Administrative reason by sponsor|1|||
164185424|NCT03130959|593047465|FG001|Overall Study|Administrative reason by sponsor|0|||
164185425|NCT03130959|593047466|FG002|Overall Study|Administrative reason by sponsor|1|||
164185426|NCT03130959|593047467|FG003|Overall Study|Administrative reason by sponsor|0|||
164185427|NCT03130959|593047468|FG004|Overall Study|Administrative reason by sponsor|0|||
164185428|NCT03130959|593047469|FG005|Overall Study|Administrative reason by sponsor|0|||
164185429|NCT03130959|593047470|FG006|Overall Study|Administrative reason by sponsor|0|||
164185430|NCT03130959|593047471|FG007|Overall Study|Administrative reason by sponsor|0|||
164185431|NCT03130959|593047472|FG008|Overall Study|Administrative reason by sponsor|0|||
164185432|NCT03130959|593047473|FG009|Overall Study|Administrative reason by sponsor|0|||
164185433|NCT03130959|593047464|FG000|Overall Study|Lost to Follow-up|1|||
164185434|NCT03130959|593047465|FG001|Overall Study|Lost to Follow-up|0|||
164185435|NCT03130959|593047466|FG002|Overall Study|Lost to Follow-up|0|||
164185436|NCT03130959|593047467|FG003|Overall Study|Lost to Follow-up|0|||
164185437|NCT03130959|593047468|FG004|Overall Study|Lost to Follow-up|0|||
164185438|NCT03130959|593047469|FG005|Overall Study|Lost to Follow-up|0|||
164185439|NCT03130959|593047470|FG006|Overall Study|Lost to Follow-up|0|||
164185440|NCT03130959|593047471|FG007|Overall Study|Lost to Follow-up|0|||
164185441|NCT03130959|593047472|FG008|Overall Study|Lost to Follow-up|0|||
164185442|NCT03130959|593047473|FG009|Overall Study|Lost to Follow-up|0|||
164185443|NCT02384538|593047488|FG000|Overall Study|Adverse Event|1|||
164185444|NCT02384538|593047489|FG001|Overall Study|Adverse Event|4|||
164185445|NCT02384538|593047488|FG000|Overall Study|Lack of Efficacy|4|||
164185446|NCT02384538|593047489|FG001|Overall Study|Lack of Efficacy|4|||
164185447|NCT02384538|593047488|FG000|Overall Study|Withdrew Consent|0|||
164185448|NCT02384538|593047489|FG001|Overall Study|Withdrew Consent|4|||
164185449|NCT02384538|593047488|FG000|Overall Study|Other|1|||
164185450|NCT02384538|593047489|FG001|Overall Study|Other|3|||
164185451|NCT04446429|593047492|FG000|Overall Study|Lost to Follow-up|6|||
164185452|NCT04446429|593047493|FG001|Overall Study|Lost to Follow-up|0|||
164185453|NCT05205005|593047494|FG000|Overall Study|Withdrawal by Subject|1|||
164185454|NCT05205005|593047495|FG001|Overall Study|Withdrawal by Subject|0|||
164185455|NCT05205005|593047494|FG000|Overall Study|Adverse Event|1|||
164185456|NCT05205005|593047495|FG001|Overall Study|Adverse Event|0|||
164185457|NCT02187029|593047496|FG000|Overall Study|Adverse Event|0|||
164185458|NCT02187029|593047497|FG001|Overall Study|Adverse Event|1|||
164185459|NCT02187029|593047498|FG002|Overall Study|Adverse Event|1|||
164185460|NCT02187029|593047499|FG003|Overall Study|Adverse Event|0|||
164185461|NCT02187029|593047496|FG000|Overall Study|Study Terminated by Sponsor|0|||
164185462|NCT02187029|593047497|FG001|Overall Study|Study Terminated by Sponsor|0|||
164185463|NCT02187029|593047498|FG002|Overall Study|Study Terminated by Sponsor|10|||
164185464|NCT02187029|593047499|FG003|Overall Study|Study Terminated by Sponsor|3|||
164185465|NCT02187029|593047496|FG000|Overall Study|Withdrawal by Subject|1|||
164185466|NCT02187029|593047497|FG001|Overall Study|Withdrawal by Subject|0|||
164185467|NCT02187029|593047498|FG002|Overall Study|Withdrawal by Subject|0|||
164185468|NCT02187029|593047499|FG003|Overall Study|Withdrawal by Subject|0|||
164185469|NCT03042910|593047500|FG000|Overall Study|Adverse Event|1|||
164185470|NCT03042910|593047500|FG000|Overall Study|Disease Progression|2|||
164185471|NCT03042910|593047500|FG000|Overall Study|Withdrawal by Subject|3|||
164185472|NCT03042910|593047500|FG000|Overall Study|Enrolled but not treated|1|||
164185473|NCT02985021|593047501|FG000|Overall Study|Inability to comply with study procedures|1|||
164185474|NCT02187861|593047502|FG000|Overall Study|Adverse Event|2|||
164185475|NCT02187861|593047503|FG001|Overall Study|Adverse Event|1|||
164185476|NCT02187861|593047504|FG002|Overall Study|Adverse Event|2|||
164185477|NCT02187861|593047505|FG003|Overall Study|Adverse Event|1|||
164185478|NCT02187861|593047502|FG000|Overall Study|Death|0|||
164185479|NCT02187861|593047503|FG001|Overall Study|Death|3|||
164185480|NCT02187861|593047504|FG002|Overall Study|Death|1|||
164185481|NCT02187861|593047505|FG003|Overall Study|Death|2|||
164185482|NCT02187861|593047502|FG000|Overall Study|Physician Decision|0|||
164185483|NCT02187861|593047503|FG001|Overall Study|Physician Decision|1|||
164185484|NCT02187861|593047504|FG002|Overall Study|Physician Decision|0|||
164185485|NCT02187861|593047505|FG003|Overall Study|Physician Decision|3|||
164185486|NCT02187861|593047502|FG000|Overall Study|Progressive Disease|4|||
164185487|NCT02187861|593047503|FG001|Overall Study|Progressive Disease|42|||
164185488|NCT02187861|593047504|FG002|Overall Study|Progressive Disease|19|||
164185489|NCT02187861|593047505|FG003|Overall Study|Progressive Disease|22|||
164185490|NCT02187861|593047502|FG000|Overall Study|Withdrawal by Subject|0|||
164185491|NCT02187861|593047503|FG001|Overall Study|Withdrawal by Subject|0|||
164185492|NCT02187861|593047504|FG002|Overall Study|Withdrawal by Subject|3|||
164185493|NCT02187861|593047505|FG003|Overall Study|Withdrawal by Subject|3|||
164185494|NCT02187861|593047502|FG000|Overall Study|Other|0|||
164185495|NCT02187861|593047503|FG001|Overall Study|Other|1|||
164185496|NCT02187861|593047504|FG002|Overall Study|Other|7|||
164185497|NCT02187861|593047505|FG003|Overall Study|Other|1|||
164185498|NCT01491841|593047507|FG000|Overall Study|Screen Failure|10|||
164185499|NCT01491841|593047507|FG000|Overall Study|Withdrawal by Subject|1|||
164185500|NCT01301079|593047508|FG000|Overall Study|Lost to Follow-up|2|||
164185501|NCT01301079|593047509|FG001|Overall Study|Lost to Follow-up|2|||
164185502|NCT04105842|593047510|FG000|Overall Study|Withdrawal by Subject|2|||
164185503|NCT00313586|593047511|FG000|Overall Study|Disease progression|14|||
164185504|NCT00313586|593047512|FG001|Overall Study|Disease progression|19|||
164185505|NCT00313586|593047513|FG002|Overall Study|Disease progression|10|||
164185506|NCT00313586|593047514|FG003|Overall Study|Disease progression|3|||
164185507|NCT00313586|593047511|FG000|Overall Study|Adverse Event|12|||
164185508|NCT00313586|593047512|FG001|Overall Study|Adverse Event|18|||
164185509|NCT00313586|593047513|FG002|Overall Study|Adverse Event|3|||
164185510|NCT00313586|593047514|FG003|Overall Study|Adverse Event|10|||
164185511|NCT00313586|593047511|FG000|Overall Study|Death|11|||
164185512|NCT00313586|593047512|FG001|Overall Study|Death|8|||
164185513|NCT00313586|593047513|FG002|Overall Study|Death|1|||
164185514|NCT00313586|593047514|FG003|Overall Study|Death|7|||
164185515|NCT00313586|593047511|FG000|Overall Study|Withdrawal by Subject|13|||
164185516|NCT00313586|593047512|FG001|Overall Study|Withdrawal by Subject|6|||
164185517|NCT00313586|593047513|FG002|Overall Study|Withdrawal by Subject|6|||
164185518|NCT00313586|593047514|FG003|Overall Study|Withdrawal by Subject|2|||
164185519|NCT00313586|593047511|FG000|Overall Study|Alternative therapy|3|||
164185520|NCT00313586|593047512|FG001|Overall Study|Alternative therapy|6|||
164185521|NCT00313586|593047513|FG002|Overall Study|Alternative therapy|2|||
164185522|NCT00313586|593047514|FG003|Overall Study|Alternative therapy|0|||
164185523|NCT00313586|593047511|FG000|Overall Study|Other complicating disease|2|||
164185524|NCT00313586|593047512|FG001|Overall Study|Other complicating disease|2|||
164185525|NCT00313586|593047513|FG002|Overall Study|Other complicating disease|0|||
164185526|NCT00313586|593047514|FG003|Overall Study|Other complicating disease|0|||
164185527|NCT00313586|593047511|FG000|Overall Study|Did not achieve HI-major/better response|10|||
164185528|NCT00313586|593047512|FG001|Overall Study|Did not achieve HI-major/better response|7|||
164185529|NCT00313586|593047513|FG002|Overall Study|Did not achieve HI-major/better response|2|||
164185530|NCT00313586|593047514|FG003|Overall Study|Did not achieve HI-major/better response|1|||
164185531|NCT00313586|593047511|FG000|Overall Study|Physician Decision|2|||
164185532|NCT00313586|593047512|FG001|Overall Study|Physician Decision|1|||
164185533|NCT00313586|593047513|FG002|Overall Study|Physician Decision|0|||
164185534|NCT00313586|593047514|FG003|Overall Study|Physician Decision|0|||
164185535|NCT00313586|593047511|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
164185536|NCT00313586|593047512|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
164185537|NCT00313586|593047513|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
164185538|NCT00313586|593047514|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
164185539|NCT00313586|593047511|FG000|Overall Study|Lost insurance|0|||
164185540|NCT00313586|593047512|FG001|Overall Study|Lost insurance|1|||
164185541|NCT00313586|593047513|FG002|Overall Study|Lost insurance|0|||
164185542|NCT00313586|593047514|FG003|Overall Study|Lost insurance|0|||
164185543|NCT00313586|593047511|FG000|Overall Study|Moved|0|||
164185544|NCT00313586|593047512|FG001|Overall Study|Moved|1|||
164185545|NCT00313586|593047513|FG002|Overall Study|Moved|0|||
164185546|NCT00313586|593047514|FG003|Overall Study|Moved|0|||
164185547|NCT00313586|593047511|FG000|Overall Study|Death before starting treatment|1|||
164185548|NCT00313586|593047512|FG001|Overall Study|Death before starting treatment|0|||
164185549|NCT00313586|593047513|FG002|Overall Study|Death before starting treatment|0|||
164185550|NCT00313586|593047514|FG003|Overall Study|Death before starting treatment|0|||
164185551|NCT00264290|593047515|FG000|Intervention (8 Weeks)|Adverse Event|1|||
164185552|NCT00264290|593047516|FG001|Intervention (8 Weeks)|Adverse Event|0|||
164185553|NCT04472494|593047517|FG000|Pre-treatment|Other reasons|2|||
164185554|NCT04472494|593047518|FG001|Pre-treatment|Other reasons|0|||
164185555|NCT04472494|593047517|FG000|Treatment|Death|5|||
164185556|NCT04472494|593047518|FG001|Treatment|Death|2|||
164185557|NCT04472494|593047517|FG000|Treatment|Hospital discharge|1|||
164185558|NCT04472494|593047518|FG001|Treatment|Hospital discharge|1|||
164185559|NCT00707980|593047519|FG000|Overall Study|Adverse Event|49|||
164185560|NCT00707980|593047519|FG000|Overall Study|Lack of Efficacy|35|||
164185561|NCT00707980|593047519|FG000|Overall Study|Non-Compliance with Study Drug|28|||
164185562|NCT00707980|593047519|FG000|Overall Study|Protocol Deviations|19|||
164185563|NCT00707980|593047519|FG000|Overall Study|Withdrawal of Consent|81|||
164185564|NCT00707980|593047519|FG000|Overall Study|Lost to Follow-up|59|||
164185565|NCT00707980|593047519|FG000|Overall Study|Other|39|||
164185566|NCT01909973|593047523|FG000|Overall Study|Lost to Follow-up|1|||
164185567|NCT01909973|593047524|FG001|Overall Study|Lost to Follow-up|0|||
164185568|NCT01152996|593047525|FG000|Overall Study|Withdrawal by Subject|142|||
164185569|NCT01152996|593047525|FG000|Overall Study|Adverse Event|115|||
164185570|NCT01152996|593047525|FG000|Overall Study|Lost to Follow-up|112|||
164185571|NCT01152996|593047525|FG000|Overall Study|Lack of Efficacy|68|||
164185572|NCT01152996|593047525|FG000|Overall Study|Noncompliance|41|||
164185573|NCT01152996|593047525|FG000|Overall Study|Other|36|||
164185574|NCT01152996|593047525|FG000|Overall Study|Protocol Violation|22|||
164185575|NCT01152996|593047525|FG000|Overall Study|Elevated liver enzymes|1|||
164185576|NCT01535443|593047529|FG000|Overall Study|Physician Decision|3|||
164185577|NCT00760487|593047531|FG000|Overall Study|Unilateral implantation|3|||
164185578|NCT02260817|593047532|FG000|Overall Study|Lost to Follow-up|0|||
164185579|NCT02260817|593047533|FG001|Overall Study|Lost to Follow-up|14|||
164185580|NCT02260817|593047532|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
164185581|NCT02260817|593047533|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
164185582|NCT02260817|593047532|FG000|Overall Study|Observation, no biopsy|0|||
164185583|NCT02260817|593047533|FG001|Overall Study|Observation, no biopsy|1|||
164185584|NCT02260817|593047532|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
164185585|NCT02260817|593047533|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
164185586|NCT02260817|593047532|FG000|Overall Study|Protocol Violation|0|||
164185587|NCT02260817|593047533|FG001|Overall Study|Protocol Violation|14|||
164185588|NCT03299101|593047534|FG000|Overall Study|Lost to Follow-up|1|||
164185589|NCT03299101|593047534|FG000|Overall Study|Withdrawal by Subject|5|||
164185590|NCT03299101|593047534|FG000|Overall Study|Surgery was changed|3|||
164185591|NCT03299101|593047534|FG000|Overall Study|Not enough time to complete prehab|1|||
164185592|NCT03585712|593047538|FG000|Treatment Period 1|Protocol Violation|1|||
164185593|NCT03585712|593047539|FG001|Treatment Period 1|Protocol Violation|0|||
164185594|NCT03585712|593047540|FG002|Treatment Period 1|Protocol Violation|0|||
164185595|NCT03585712|593047538|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
164185596|NCT03585712|593047539|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
164185597|NCT03585712|593047540|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
164185598|NCT03585712|593047538|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
164185599|NCT03585712|593047539|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
164185600|NCT03585712|593047540|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
164185601|NCT03585712|593047538|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
164185602|NCT03585712|593047539|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
164185603|NCT03585712|593047540|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
164185604|NCT00621517|593047542|FG000|Overall Study|Lost to Follow-up|3|||
164185605|NCT00621517|593047543|FG001|Overall Study|Lost to Follow-up|3|||
164185606|NCT00621517|593047542|FG000|Overall Study|Withdrawal by Subject|3|||
164185607|NCT00621517|593047543|FG001|Overall Study|Withdrawal by Subject|4|||
164185608|NCT00621517|593047542|FG000|Overall Study|Adverse Event|1|||
164185609|NCT00621517|593047543|FG001|Overall Study|Adverse Event|0|||
164185610|NCT02071082|593047544|FG000|Overall Study|Enrolled and Never Treated|1|||
164185611|NCT02071082|593047545|FG001|Overall Study|Enrolled and Never Treated|1|||
164185612|NCT02071082|593047544|FG000|Overall Study|Adverse Event|0|||
164185613|NCT02071082|593047545|FG001|Overall Study|Adverse Event|1|||
164185614|NCT02071082|593047544|FG000|Overall Study|Withdrew Consent|0|||
164185615|NCT02071082|593047545|FG001|Overall Study|Withdrew Consent|4|||
164185616|NCT02071082|593047544|FG000|Overall Study|Lost to Follow-up|1|||
164185617|NCT02071082|593047545|FG001|Overall Study|Lost to Follow-up|1|||
164185618|NCT02101359|593047546|FG000|Overall Study|Not included|23|||
164185619|NCT02101359|593047547|FG001|Overall Study|Not included|13|||
164185620|NCT02101359|593047546|FG000|Overall Study|Withdrawal by Subject|5|||
164185621|NCT02101359|593047547|FG001|Overall Study|Withdrawal by Subject|4|||
164185622|NCT02101359|593047546|FG000|Overall Study|Lost to Follow-up|1|||
164185623|NCT02101359|593047547|FG001|Overall Study|Lost to Follow-up|0|||
164185624|NCT02101359|593047546|FG000|Overall Study|Protocol Violation|0|||
164185625|NCT02101359|593047547|FG001|Overall Study|Protocol Violation|2|||
164185626|NCT00494221|593047548|FG000|Overall Study|Death|15|||
164185627|NCT00494221|593047549|FG001|Overall Study|Death|9|||
164185628|NCT00494221|593047550|FG002|Overall Study|Death|14|||
164185629|NCT00494221|593047548|FG000|Overall Study|Withdrawal by Subject|1|||
164185630|NCT00494221|593047549|FG001|Overall Study|Withdrawal by Subject|2|||
164185631|NCT00494221|593047550|FG002|Overall Study|Withdrawal by Subject|0|||
164185632|NCT01900431|593047551|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
164185633|NCT01900431|593047552|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
164185634|NCT01900431|593047553|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
164185635|NCT01900431|593047551|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
164185636|NCT01900431|593047552|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
164185637|NCT01900431|593047553|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
164185638|NCT01900431|593047551|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
164185639|NCT01900431|593047552|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
164185640|NCT01900431|593047553|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
164185641|NCT01900431|593047551|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
164185642|NCT01900431|593047552|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
164185643|NCT01900431|593047553|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
164185644|NCT01900431|593047551|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
164185645|NCT01900431|593047552|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
164185646|NCT01900431|593047553|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
164185647|NCT01900431|593047551|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
164185648|NCT01900431|593047552|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
164185649|NCT01900431|593047553|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
164185650|NCT01900431|593047551|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
164185651|NCT01900431|593047552|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
164185652|NCT01900431|593047553|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
164185653|NCT01900431|593047551|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
164185654|NCT01900431|593047552|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
164185655|NCT01900431|593047553|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
164185656|NCT01900431|593047551|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
164185657|NCT01900431|593047552|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
164185658|NCT01900431|593047553|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
164185659|NCT01841567|593047557|FG000|Overall Study|Adverse Event|3|||
164185660|NCT03172364|593047558|FG000|Overall Study|Adverse Event|1|||
164185661|NCT03172364|593047559|FG001|Overall Study|Adverse Event|1|||
164185662|NCT03172364|593047558|FG000|Overall Study|Protocol Violation|1|||
164185663|NCT03172364|593047559|FG001|Overall Study|Protocol Violation|0|||
164185664|NCT00630747|593047560|FG000|Overall Study|Death|1|||
164185665|NCT00630747|593047560|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
164185666|NCT00630747|593047560|FG000|Overall Study|Returned to country of origin|1|||
164185667|NCT02732327|593047561|FG000|Overall Study|Protocol Violation|0|||
164185668|NCT02732327|593047562|FG001|Overall Study|Protocol Violation|1|||
164185669|NCT00603382|593047565|FG000|Overall Study|Adverse Event|0|||
164185670|NCT00603382|593047566|FG001|Overall Study|Adverse Event|1|||
164185671|NCT00603382|593047567|FG002|Overall Study|Adverse Event|1|||
164185672|NCT00603382|593047568|FG003|Overall Study|Adverse Event|2|||
164185673|NCT00603382|593047569|FG004|Overall Study|Adverse Event|1|||
164185674|NCT00603382|593047570|FG005|Overall Study|Adverse Event|2|||
164185675|NCT00603382|593047565|FG000|Overall Study|Lack of Efficacy|14|||
164185676|NCT00603382|593047566|FG001|Overall Study|Lack of Efficacy|9|||
164185677|NCT00603382|593047567|FG002|Overall Study|Lack of Efficacy|3|||
164185678|NCT00603382|593047568|FG003|Overall Study|Lack of Efficacy|6|||
164185679|NCT00603382|593047569|FG004|Overall Study|Lack of Efficacy|6|||
164185680|NCT00603382|593047570|FG005|Overall Study|Lack of Efficacy|11|||
164185681|NCT00603382|593047565|FG000|Overall Study|Protocol Violation|1|||
164185682|NCT00603382|593047566|FG001|Overall Study|Protocol Violation|0|||
164185683|NCT00603382|593047567|FG002|Overall Study|Protocol Violation|1|||
164185684|NCT00603382|593047568|FG003|Overall Study|Protocol Violation|2|||
164185685|NCT00603382|593047569|FG004|Overall Study|Protocol Violation|1|||
164185686|NCT00603382|593047570|FG005|Overall Study|Protocol Violation|0|||
164185687|NCT00603382|593047565|FG000|Overall Study|Lost to Follow-up|0|||
164185688|NCT00603382|593047566|FG001|Overall Study|Lost to Follow-up|1|||
164185689|NCT00603382|593047567|FG002|Overall Study|Lost to Follow-up|1|||
164185690|NCT00603382|593047568|FG003|Overall Study|Lost to Follow-up|1|||
164185691|NCT00603382|593047569|FG004|Overall Study|Lost to Follow-up|0|||
164185692|NCT00603382|593047570|FG005|Overall Study|Lost to Follow-up|1|||
164185693|NCT00603382|593047565|FG000|Overall Study|Physician Decision|0|||
164185694|NCT00603382|593047566|FG001|Overall Study|Physician Decision|0|||
164185695|NCT00603382|593047567|FG002|Overall Study|Physician Decision|2|||
164185696|NCT00603382|593047568|FG003|Overall Study|Physician Decision|0|||
164185697|NCT00603382|593047569|FG004|Overall Study|Physician Decision|1|||
164185698|NCT00603382|593047570|FG005|Overall Study|Physician Decision|3|||
164185699|NCT00603382|593047565|FG000|Overall Study|Withdrawal by Subject|3|||
164185700|NCT00603382|593047566|FG001|Overall Study|Withdrawal by Subject|3|||
164185701|NCT00603382|593047567|FG002|Overall Study|Withdrawal by Subject|1|||
164185702|NCT00603382|593047568|FG003|Overall Study|Withdrawal by Subject|1|||
164185703|NCT00603382|593047569|FG004|Overall Study|Withdrawal by Subject|0|||
164185704|NCT00603382|593047570|FG005|Overall Study|Withdrawal by Subject|1|||
164185705|NCT00583102|593047571|FG000|Overall Study|Adverse Event|3|||
164185706|NCT01078298|593047572|FG000|Overall Study|Lost to Follow-up|12|||
164185707|NCT01078298|593047573|FG001|Overall Study|Lost to Follow-up|13|||
164185708|NCT01078298|593047572|FG000|Overall Study|Withdrawal by Subject|31|||
164185709|NCT01078298|593047573|FG001|Overall Study|Withdrawal by Subject|33|||
164185710|NCT01078298|593047572|FG000|Overall Study|Protocol Violation|6|||
164185711|NCT01078298|593047573|FG001|Overall Study|Protocol Violation|6|||
164185712|NCT01078298|593047572|FG000|Overall Study|Adverse Event|6|||
164185713|NCT01078298|593047573|FG001|Overall Study|Adverse Event|5|||
164185714|NCT01078298|593047572|FG000|Overall Study|Death|2|||
164185715|NCT01078298|593047573|FG001|Overall Study|Death|0|||
164185716|NCT01078298|593047572|FG000|Overall Study|Did not meet entrance criteria|0|||
164185717|NCT01078298|593047573|FG001|Overall Study|Did not meet entrance criteria|1|||
164185718|NCT01078298|593047572|FG000|Overall Study|Other|24|||
164185719|NCT01078298|593047573|FG001|Overall Study|Other|32|||
164185720|NCT02432144|593047575|FG000|Overall Study|Participant Non-Compliance|1|||
164185721|NCT00958412|593047578|FG000|Overall Study|Study prematurely terminated|18|||
164185722|NCT02552888|593047579|FG000|Overall Study|Lost to Follow-up|1|||
164185723|NCT02552888|593047580|FG001|Overall Study|Lost to Follow-up|1|||
164185724|NCT00398216|593049334|FG000|Overall Study|Adverse Event|4|||
164185725|NCT00398216|593049335|FG001|Overall Study|Adverse Event|2|||
164185726|NCT00398216|593049336|FG002|Overall Study|Adverse Event|5|||
164185727|NCT00398216|593049337|FG003|Overall Study|Adverse Event|7|||
164185728|NCT00398216|593049338|FG004|Overall Study|Adverse Event|2|||
164185729|NCT00398216|593049334|FG000|Overall Study|Protocol Violation|2|||
164185730|NCT00398216|593049335|FG001|Overall Study|Protocol Violation|4|||
164185731|NCT00398216|593049336|FG002|Overall Study|Protocol Violation|5|||
164185732|NCT00398216|593049337|FG003|Overall Study|Protocol Violation|7|||
164185733|NCT00398216|593049338|FG004|Overall Study|Protocol Violation|5|||
164185734|NCT00398216|593049334|FG000|Overall Study|Lost to Follow-up|1|||
164185735|NCT00398216|593049335|FG001|Overall Study|Lost to Follow-up|6|||
164185736|NCT00398216|593049336|FG002|Overall Study|Lost to Follow-up|4|||
164185737|NCT00398216|593049337|FG003|Overall Study|Lost to Follow-up|4|||
164185738|NCT00398216|593049338|FG004|Overall Study|Lost to Follow-up|1|||
164185739|NCT00398216|593049334|FG000|Overall Study|Death|0|||
164185740|NCT00398216|593049335|FG001|Overall Study|Death|3|||
164185741|NCT00398216|593049336|FG002|Overall Study|Death|0|||
164185742|NCT00398216|593049337|FG003|Overall Study|Death|0|||
164185743|NCT00398216|593049338|FG004|Overall Study|Death|0|||
164185744|NCT00398216|593049334|FG000|Overall Study|Withdrawal by Subject|1|||
164185745|NCT00398216|593049335|FG001|Overall Study|Withdrawal by Subject|0|||
164185746|NCT00398216|593049336|FG002|Overall Study|Withdrawal by Subject|3|||
164185747|NCT00398216|593049337|FG003|Overall Study|Withdrawal by Subject|1|||
164185748|NCT00398216|593049338|FG004|Overall Study|Withdrawal by Subject|2|||
164185749|NCT00398216|593049334|FG000|Overall Study|administrative reasons|3|||
164185750|NCT00398216|593049335|FG001|Overall Study|administrative reasons|4|||
164185751|NCT00398216|593049336|FG002|Overall Study|administrative reasons|4|||
164185752|NCT00398216|593049337|FG003|Overall Study|administrative reasons|3|||
164185753|NCT00398216|593049338|FG004|Overall Study|administrative reasons|3|||
164185754|NCT00398216|593049334|FG000|Overall Study|entrance criteria|0|||
164185755|NCT00398216|593049335|FG001|Overall Study|entrance criteria|0|||
164185756|NCT00398216|593049336|FG002|Overall Study|entrance criteria|0|||
164185757|NCT00398216|593049337|FG003|Overall Study|entrance criteria|0|||
164185758|NCT00398216|593049338|FG004|Overall Study|entrance criteria|2|||
164185759|NCT01048944|593049339|FG000|Overall Study|Protocol Violation|8|||
164185760|NCT01048944|593049340|FG001|Overall Study|Protocol Violation|10|||
164185761|NCT01048944|593049341|FG002|Overall Study|Protocol Violation|10|||
164185762|NCT01048944|593049342|FG003|Overall Study|Protocol Violation|2|||
164185763|NCT01962948|593049343|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
164185764|NCT01962948|593049344|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
164185765|NCT01962948|593049345|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
164185766|NCT01962948|593049346|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
164185767|NCT00376532|593049347|FG000|Overall Study|Lack sufficient blood sample|6|||
164185768|NCT00376532|593049348|FG001|Overall Study|Lack sufficient blood sample|6|||
164185769|NCT01133704|593049349|FG000|Overall Study|Death|44|||
164185770|NCT01133704|593049350|FG001|Overall Study|Death|26|||
164185771|NCT01133704|593049349|FG000|Overall Study|Patient refused to continue|4|||
164185772|NCT01133704|593049350|FG001|Overall Study|Patient refused to continue|0|||
164185773|NCT01133704|593049349|FG000|Overall Study|Study Closure|1|||
164185774|NCT01133704|593049350|FG001|Overall Study|Study Closure|0|||
164185775|NCT02207400|593049351|FG000|Overall Study|Adverse Event|1|||
164185776|NCT02207400|593049352|FG001|Overall Study|Adverse Event|1|||
164185777|NCT02207400|593049351|FG000|Overall Study|Lost to Follow-up|6|||
164185778|NCT02207400|593049352|FG001|Overall Study|Lost to Follow-up|7|||
164185779|NCT02207400|593049351|FG000|Overall Study|Protocol Violation|1|||
164185780|NCT02207400|593049352|FG001|Overall Study|Protocol Violation|1|||
164185781|NCT02207400|593049351|FG000|Overall Study|Withdrawal by Subject|8|||
164185782|NCT02207400|593049352|FG001|Overall Study|Withdrawal by Subject|4|||
164185783|NCT02207400|593049351|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
164185784|NCT02207400|593049352|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
164185785|NCT02849704|593049353|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
164185786|NCT02849704|593049354|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
164185787|NCT02849704|593049353|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
164185788|NCT02849704|593049354|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
164185789|NCT02849704|593049353|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
164185790|NCT02849704|593049354|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
164185791|NCT03519919|593049358|FG000|Overall Study|Withdrawal by Subject|1|||
164185792|NCT03519919|593049358|FG000|Overall Study|Lack of Efficacy|1|||
164185793|NCT03519919|593049358|FG000|Overall Study|Screen Failure|1|||
164185794|NCT03076996|593049359|FG000|Overall Study|Withdrawal by Subject|2|||
164185795|NCT03076996|593049359|FG000|Overall Study|Lost to Follow-up|3|||
164185796|NCT03076996|593049359|FG000|Overall Study|Literacy precluded participation|1|||
164185797|NCT00587795|593049364|FG000|Overall Study|Withdrawal by Subject|1|||
164185798|NCT00587795|593049365|FG001|Overall Study|Withdrawal by Subject|0|||
164185799|NCT02144077|593049366|FG000|Overall Study|Withdrawal by Subject|3|||
164185800|NCT02144077|593049367|FG001|Overall Study|Withdrawal by Subject|3|||
164185801|NCT02144077|593049366|FG000|Overall Study|Adverse Event|2|||
164185802|NCT02144077|593049367|FG001|Overall Study|Adverse Event|3|||
164185803|NCT02144077|593049366|FG000|Overall Study|Lost to Follow-up|2|||
164185804|NCT02144077|593049367|FG001|Overall Study|Lost to Follow-up|2|||
164185805|NCT02144077|593049366|FG000|Overall Study|Protocol Violation|1|||
164185806|NCT02144077|593049367|FG001|Overall Study|Protocol Violation|2|||
164185807|NCT02144077|593049366|FG000|Overall Study|Death|0|||
164185808|NCT02144077|593049367|FG001|Overall Study|Death|1|||
164185809|NCT02144077|593049366|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
164185810|NCT02144077|593049367|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
164185811|NCT01869777|593049368|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
164185812|NCT01951573|593049369|FG000|Washout Period|Adverse Event|0|||
164185813|NCT01951573|593049370|FG001|Washout Period|Adverse Event|1|||
164185814|NCT04399889|593049371|FG000|Overall Study|Death|5|||
164185815|NCT04399889|593049372|FG001|Overall Study|Death|1|||
164185816|NCT04399889|593049373|FG002|Overall Study|Death|1|||
164185817|NCT00943592|593049374|FG000|Overall Study|Death|3|||
164185818|NCT00460239|593049375|FG000|Overall Study|Physician Decision|0|||
164185819|NCT00460239|593049376|FG001|Overall Study|Physician Decision|1|||
164185820|NCT00460239|593049377|FG002|Overall Study|Physician Decision|0|||
164185821|NCT00460239|593049378|FG003|Overall Study|Physician Decision|0|||
164185822|NCT00460239|593049379|FG004|Overall Study|Physician Decision|0|||
164185823|NCT00460239|593049380|FG005|Overall Study|Physician Decision|2|||
164185824|NCT00460239|593049381|FG006|Overall Study|Physician Decision|0|||
164185825|NCT00460239|593049382|FG007|Overall Study|Physician Decision|0|||
164185826|NCT00460239|593049383|FG008|Overall Study|Physician Decision|0|||
164185827|NCT00460239|593049375|FG000|Overall Study|Withdrawal by Subject|0|||
164185828|NCT00460239|593049376|FG001|Overall Study|Withdrawal by Subject|0|||
164185829|NCT00460239|593049377|FG002|Overall Study|Withdrawal by Subject|0|||
164185830|NCT00460239|593049378|FG003|Overall Study|Withdrawal by Subject|0|||
164185831|NCT00460239|593049379|FG004|Overall Study|Withdrawal by Subject|0|||
164185832|NCT00460239|593049380|FG005|Overall Study|Withdrawal by Subject|1|||
164185833|NCT00460239|593049381|FG006|Overall Study|Withdrawal by Subject|0|||
164185834|NCT00460239|593049382|FG007|Overall Study|Withdrawal by Subject|0|||
164185835|NCT00460239|593049383|FG008|Overall Study|Withdrawal by Subject|0|||
164185836|NCT02438280|593049391|FG000|Overall Study|Physician Decision|1|||
164185837|NCT02438280|593049392|FG001|Overall Study|Physician Decision|0|||
164185838|NCT04217317|593049393|FG000|Overall Study|Lack of Efficacy|4|||
164185839|NCT04217317|593049393|FG000|Overall Study|Physician Decision|1|||
164185840|NCT02087943|593049394|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
164185841|NCT02087943|593049395|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
164185842|NCT02087943|593049396|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
164185843|NCT02087943|593049397|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
164185844|NCT02087943|593049398|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
164185845|NCT02087943|593049394|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
164185846|NCT02087943|593049395|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
164185847|NCT02087943|593049396|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
164185848|NCT02087943|593049397|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
164185849|NCT02087943|593049398|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
164185850|NCT02087943|593049394|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
164185851|NCT02087943|593049395|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
164185852|NCT02087943|593049396|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
164185853|NCT02087943|593049397|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
164185854|NCT02087943|593049398|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
164185855|NCT02087943|593049394|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
164185856|NCT02087943|593049395|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
164185857|NCT02087943|593049396|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
164185858|NCT02087943|593049397|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
164185859|NCT02087943|593049398|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
164185860|NCT02087943|593049394|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
164185861|NCT02087943|593049395|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
164185862|NCT02087943|593049396|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
164185863|NCT02087943|593049397|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
164185864|NCT02087943|593049398|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
164185865|NCT02087943|593049394|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
164185866|NCT02087943|593049395|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
164185867|NCT02087943|593049396|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
164185868|NCT02087943|593049397|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
164185869|NCT02087943|593049398|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
164185870|NCT02087943|593049394|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
164185871|NCT02087943|593049395|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
164185872|NCT02087943|593049396|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
164185873|NCT02087943|593049397|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
164185874|NCT02087943|593049398|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
164185875|NCT02087943|593049394|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
164185876|NCT02087943|593049395|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
164185877|NCT02087943|593049396|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
164185878|NCT02087943|593049397|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
164185879|NCT02087943|593049398|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
164185880|NCT02087943|593049394|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
164185881|NCT02087943|593049395|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
164185882|NCT02087943|593049396|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
164185883|NCT02087943|593049397|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
164185884|NCT02087943|593049398|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
164185885|NCT02087943|593049394|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
164185886|NCT02087943|593049395|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
164185887|NCT02087943|593049396|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
164185888|NCT02087943|593049397|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
164185889|NCT02087943|593049398|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
164185890|NCT01690299|593049399|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
164185891|NCT01690299|593049400|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
164185892|NCT01690299|593049401|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
164185893|NCT01690299|593049402|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
164185894|NCT01690299|593049403|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
164185895|NCT01690299|593049404|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
164185896|NCT01690299|593049399|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
164185897|NCT01690299|593049400|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164185898|NCT01690299|593049401|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164185899|NCT01690299|593049402|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164185900|NCT01690299|593049403|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164185901|NCT01690299|593049404|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164185902|NCT01690299|593049399|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
164185903|NCT01690299|593049400|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
164185904|NCT01690299|593049401|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
164185905|NCT01690299|593049402|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
164185906|NCT01690299|593049403|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
164185907|NCT01690299|593049404|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
164185908|NCT01690299|593049399|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
164185909|NCT01690299|593049400|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
164185910|NCT01690299|593049401|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
164185911|NCT01690299|593049402|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
164185912|NCT01690299|593049403|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
164185913|NCT01690299|593049404|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
164185914|NCT01690299|593049399|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
164185915|NCT01690299|593049400|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
164185916|NCT01690299|593049401|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
164185917|NCT01690299|593049402|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
164185918|NCT01690299|593049403|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
164185919|NCT01690299|593049404|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
164185920|NCT01690299|593049399|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
164185921|NCT01690299|593049400|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
164185922|NCT01690299|593049401|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
164185923|NCT01690299|593049402|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
164185924|NCT01690299|593049403|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
164185925|NCT01690299|593049404|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
164185926|NCT01690299|593049399|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
164185927|NCT01690299|593049400|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
164185928|NCT01690299|593049401|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
164185929|NCT01690299|593049402|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
164185930|NCT01690299|593049403|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
164185931|NCT01690299|593049404|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
164185932|NCT01690299|593049399|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
164185933|NCT01690299|593049400|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
164185934|NCT01690299|593049401|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
164185935|NCT01690299|593049402|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
164185936|NCT01690299|593049403|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
164185937|NCT01690299|593049404|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
164185938|NCT01690299|593049399|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
164185939|NCT01690299|593049400|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
164185940|NCT01690299|593049401|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
164185941|NCT01690299|593049402|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
164185942|NCT01690299|593049403|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
164185943|NCT01690299|593049404|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
164185944|NCT01690299|593049399|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
164185945|NCT01690299|593049400|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
164185946|NCT01690299|593049401|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
164185947|NCT01690299|593049402|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
164185948|NCT01690299|593049403|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
164185949|NCT01690299|593049404|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
164185950|NCT01882803|593049409|FG000|Overall Study|Disease Progression|1|||
164185951|NCT01882803|593049409|FG000|Overall Study|Withdrawal by Subject|9|||
164185952|NCT01882803|593049409|FG000|Overall Study|Death|68|||
164185953|NCT01882803|593049409|FG000|Overall Study|Physician Decision|3|||
164185954|NCT01882803|593049409|FG000|Overall Study|Lost to Follow-up|3|||
164185955|NCT01882803|593049409|FG000|Overall Study|Follow-up Completed|39|||
164185956|NCT01882803|593049409|FG000|Overall Study|Study Terminated by the Sponsor|6|||
164185957|NCT02869893|593049410|FG000|Overall Study|participant aversion to IV|5|||
164185958|NCT02869893|593049410|FG000|Overall Study|participant fear of MRI scanner|2|||
164185959|NCT01563913|593049411|FG000|Overall Study|Physician Decision|1|||
164185960|NCT01563913|593049412|FG001|Overall Study|Physician Decision|0|||
164185961|NCT01563913|593049411|FG000|Overall Study|Spouse Passed Away|1|||
164185962|NCT01563913|593049412|FG001|Overall Study|Spouse Passed Away|0|||
164185963|NCT03066778|593049413|FG000|Overall Study|Death|195|||
164185964|NCT03066778|593049414|FG001|Overall Study|Death|205|||
164185965|NCT03066778|593049413|FG000|Overall Study|Withdrawal by Subject|5|||
164185966|NCT03066778|593049414|FG001|Overall Study|Withdrawal by Subject|7|||
164185967|NCT00551525|593049415|FG000|Overall Study|Protocol Violation|5|||
164185968|NCT05259917|593049421|FG000|Overall Study|Protocol Violation|0|||
164185969|NCT05259917|593049422|FG001|Overall Study|Protocol Violation|0|||
164185970|NCT05259917|593049423|FG002|Overall Study|Protocol Violation|1|||
164185971|NCT05259917|593049424|FG003|Overall Study|Protocol Violation|0|||
164185972|NCT05259917|593049425|FG004|Overall Study|Protocol Violation|0|||
164185973|NCT05259917|593049426|FG005|Overall Study|Protocol Violation|0|||
164185974|NCT05259917|593049421|FG000|Overall Study|Lost to Follow-up|0|||
164185975|NCT05259917|593049422|FG001|Overall Study|Lost to Follow-up|0|||
164185976|NCT05259917|593049423|FG002|Overall Study|Lost to Follow-up|1|||
164185977|NCT05259917|593049424|FG003|Overall Study|Lost to Follow-up|0|||
164185978|NCT05259917|593049425|FG004|Overall Study|Lost to Follow-up|0|||
164185979|NCT05259917|593049426|FG005|Overall Study|Lost to Follow-up|1|||
164185980|NCT05259917|593049421|FG000|Overall Study|Physician Decision|0|||
164185981|NCT05259917|593049422|FG001|Overall Study|Physician Decision|1|||
164185982|NCT05259917|593049423|FG002|Overall Study|Physician Decision|0|||
164185983|NCT05259917|593049424|FG003|Overall Study|Physician Decision|0|||
164185984|NCT05259917|593049425|FG004|Overall Study|Physician Decision|0|||
164185985|NCT05259917|593049426|FG005|Overall Study|Physician Decision|0|||
164185986|NCT05259917|593049421|FG000|Overall Study|Withdrawal by Subject|0|||
164185987|NCT05259917|593049422|FG001|Overall Study|Withdrawal by Subject|1|||
164185988|NCT05259917|593049423|FG002|Overall Study|Withdrawal by Subject|0|||
164185989|NCT05259917|593049424|FG003|Overall Study|Withdrawal by Subject|0|||
164185990|NCT05259917|593049425|FG004|Overall Study|Withdrawal by Subject|1|||
164185991|NCT05259917|593049426|FG005|Overall Study|Withdrawal by Subject|1|||
164185992|NCT05259917|593049421|FG000|Overall Study|Trial Termination by Sponsor|7|||
164185993|NCT05259917|593049422|FG001|Overall Study|Trial Termination by Sponsor|2|||
164185994|NCT05259917|593049423|FG002|Overall Study|Trial Termination by Sponsor|3|||
164185995|NCT05259917|593049424|FG003|Overall Study|Trial Termination by Sponsor|5|||
164185996|NCT05259917|593049425|FG004|Overall Study|Trial Termination by Sponsor|11|||
164185997|NCT05259917|593049426|FG005|Overall Study|Trial Termination by Sponsor|4|||
164185998|NCT05259917|593049421|FG000|Overall Study|Other|1|||
164185999|NCT05259917|593049422|FG001|Overall Study|Other|0|||
164186000|NCT05259917|593049423|FG002|Overall Study|Other|2|||
164186001|NCT05259917|593049424|FG003|Overall Study|Other|0|||
164186002|NCT05259917|593049425|FG004|Overall Study|Other|0|||
164186003|NCT05259917|593049426|FG005|Overall Study|Other|0|||
164186004|NCT00303472|593049427|FG000|Treatment Period|Adverse Event|0|||
164186005|NCT00303472|593049428|FG001|Treatment Period|Adverse Event|0|||
164186006|NCT00303472|593049429|FG002|Treatment Period|Adverse Event|0|||
164186007|NCT00303472|593049430|FG003|Treatment Period|Adverse Event|0|||
164186008|NCT00303472|593049431|FG004|Treatment Period|Adverse Event|1|||
164186009|NCT00303472|593049432|FG005|Treatment Period|Adverse Event|0|||
164186010|NCT00303472|593049433|FG006|Treatment Period|Adverse Event|0|||
164186011|NCT00303472|593049427|FG000|Treatment Period|Death|0|||
164186012|NCT00303472|593049428|FG001|Treatment Period|Death|0|||
164186013|NCT00303472|593049429|FG002|Treatment Period|Death|0|||
164186014|NCT00303472|593049430|FG003|Treatment Period|Death|1|||
164186015|NCT00303472|593049431|FG004|Treatment Period|Death|0|||
164186016|NCT00303472|593049432|FG005|Treatment Period|Death|0|||
164186017|NCT00303472|593049433|FG006|Treatment Period|Death|1|||
164186018|NCT00303472|593049427|FG000|Treatment Period|Withdrawal by Subject|0|||
164186019|NCT00303472|593049428|FG001|Treatment Period|Withdrawal by Subject|0|||
164186020|NCT00303472|593049429|FG002|Treatment Period|Withdrawal by Subject|0|||
164186021|NCT00303472|593049430|FG003|Treatment Period|Withdrawal by Subject|1|||
164186022|NCT00303472|593049431|FG004|Treatment Period|Withdrawal by Subject|0|||
164186023|NCT00303472|593049432|FG005|Treatment Period|Withdrawal by Subject|1|||
164186024|NCT00303472|593049433|FG006|Treatment Period|Withdrawal by Subject|0|||
164186025|NCT00303472|593049427|FG000|Treatment Period|Other|0|||
164186026|NCT00303472|593049428|FG001|Treatment Period|Other|0|||
164186027|NCT00303472|593049429|FG002|Treatment Period|Other|0|||
164186028|NCT00303472|593049430|FG003|Treatment Period|Other|0|||
164186029|NCT00303472|593049431|FG004|Treatment Period|Other|1|||
164186030|NCT00303472|593049432|FG005|Treatment Period|Other|0|||
164186031|NCT00303472|593049433|FG006|Treatment Period|Other|1|||
164186032|NCT00303472|593049427|FG000|Treatment Period|Disease Progression (to AML)|0|||
164186033|NCT00303472|593049428|FG001|Treatment Period|Disease Progression (to AML)|0|||
164186034|NCT00303472|593049429|FG002|Treatment Period|Disease Progression (to AML)|0|||
164186035|NCT00303472|593049430|FG003|Treatment Period|Disease Progression (to AML)|0|||
164186036|NCT00303472|593049431|FG004|Treatment Period|Disease Progression (to AML)|1|||
164186037|NCT00303472|593049432|FG005|Treatment Period|Disease Progression (to AML)|0|||
164186038|NCT00303472|593049433|FG006|Treatment Period|Disease Progression (to AML)|0|||
164186039|NCT00303472|593049427|FG000|Treatment Extension (Optional)|Adverse Event|1|||
164186040|NCT00303472|593049428|FG001|Treatment Extension (Optional)|Adverse Event|0|||
164186041|NCT00303472|593049429|FG002|Treatment Extension (Optional)|Adverse Event|1|||
164186042|NCT00303472|593049430|FG003|Treatment Extension (Optional)|Adverse Event|0|||
164186043|NCT00303472|593049431|FG004|Treatment Extension (Optional)|Adverse Event|0|||
164186044|NCT00303472|593049432|FG005|Treatment Extension (Optional)|Adverse Event|0|||
164186045|NCT00303472|593049433|FG006|Treatment Extension (Optional)|Adverse Event|0|||
164186046|NCT00303472|593049427|FG000|Treatment Extension (Optional)|Death|2|||
164186047|NCT00303472|593049428|FG001|Treatment Extension (Optional)|Death|0|||
164186048|NCT00303472|593049429|FG002|Treatment Extension (Optional)|Death|1|||
164186049|NCT00303472|593049430|FG003|Treatment Extension (Optional)|Death|0|||
164186050|NCT00303472|593049431|FG004|Treatment Extension (Optional)|Death|0|||
164186051|NCT00303472|593049432|FG005|Treatment Extension (Optional)|Death|0|||
164186052|NCT00303472|593049433|FG006|Treatment Extension (Optional)|Death|0|||
164186053|NCT00303472|593049427|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
164186054|NCT00303472|593049428|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
164186055|NCT00303472|593049429|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
164186056|NCT00303472|593049430|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
164186057|NCT00303472|593049431|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
164186058|NCT00303472|593049432|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
164186059|NCT00303472|593049433|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
164186060|NCT00303472|593049427|FG000|Treatment Extension (Optional)|Physician Decision|0|||
164186061|NCT00303472|593049428|FG001|Treatment Extension (Optional)|Physician Decision|4|||
164186062|NCT00303472|593049429|FG002|Treatment Extension (Optional)|Physician Decision|2|||
164186063|NCT00303472|593049430|FG003|Treatment Extension (Optional)|Physician Decision|3|||
164186064|NCT00303472|593049431|FG004|Treatment Extension (Optional)|Physician Decision|2|||
164186065|NCT00303472|593049432|FG005|Treatment Extension (Optional)|Physician Decision|0|||
164186066|NCT00303472|593049433|FG006|Treatment Extension (Optional)|Physician Decision|0|||
164186067|NCT00303472|593049427|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
164186068|NCT00303472|593049428|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
164186069|NCT00303472|593049429|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
164186070|NCT00303472|593049430|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
164186071|NCT00303472|593049431|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
164186072|NCT00303472|593049432|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
164186073|NCT00303472|593049433|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
164186074|NCT00303472|593049427|FG000|Treatment Extension (Optional)|Other|0|||
164186075|NCT00303472|593049428|FG001|Treatment Extension (Optional)|Other|2|||
164186076|NCT00303472|593049429|FG002|Treatment Extension (Optional)|Other|4|||
164186077|NCT00303472|593049430|FG003|Treatment Extension (Optional)|Other|2|||
164186078|NCT00303472|593049431|FG004|Treatment Extension (Optional)|Other|1|||
164186079|NCT00303472|593049432|FG005|Treatment Extension (Optional)|Other|0|||
164186080|NCT00303472|593049433|FG006|Treatment Extension (Optional)|Other|0|||
164186081|NCT00303472|593049427|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
164186082|NCT00303472|593049428|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
164186083|NCT00303472|593049429|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
164186084|NCT00303472|593049430|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
164186085|NCT00303472|593049431|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
164186086|NCT00303472|593049432|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
164186087|NCT00303472|593049433|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
164186088|NCT03517449|593049441|FG000|Overall Study|Death|184|||
164186089|NCT03517449|593049442|FG001|Overall Study|Death|236|||
164186090|NCT03517449|593049441|FG000|Overall Study|Lost to Follow-up|0|||
164186091|NCT03517449|593049442|FG001|Overall Study|Lost to Follow-up|2|||
164186092|NCT03517449|593049441|FG000|Overall Study|Withdrawal by Subject|7|||
164186093|NCT03517449|593049442|FG001|Overall Study|Withdrawal by Subject|26|||
164186094|NCT03517449|593049441|FG000|Overall Study|Participants Ongoing|220|||
164186095|NCT03517449|593049442|FG001|Overall Study|Participants Ongoing|152|||
164186096|NCT01808222|593049445|FG000|Overall Study|mpMR scan was not performed|1|||
164186097|NCT02912455|593049447|FG000|Overall Study|Withdrawal by Subject|0|||
164186098|NCT02912455|593049448|FG001|Overall Study|Withdrawal by Subject|1|||
164186099|NCT02912455|593049447|FG000|Overall Study|Lack of Efficacy|0|||
164186100|NCT02912455|593049448|FG001|Overall Study|Lack of Efficacy|1|||
164186101|NCT02912455|593049447|FG000|Overall Study|Lost to Follow-up|2|||
164186102|NCT02912455|593049448|FG001|Overall Study|Lost to Follow-up|1|||
164186103|NCT00073008|593049449|FG000|Overall Study|Missing|6|||
164186104|NCT00073008|593049450|FG001|Overall Study|Missing|6|||
164186105|NCT00073008|593049449|FG000|Overall Study|Withdrawal by Subject|2|||
164186106|NCT00073008|593049450|FG001|Overall Study|Withdrawal by Subject|2|||
164186107|NCT00073008|593049449|FG000|Overall Study|Lost to Follow-up|1|||
164186108|NCT00073008|593049450|FG001|Overall Study|Lost to Follow-up|3|||
164186109|NCT00073008|593049449|FG000|Overall Study|Death|46|||
164186110|NCT00073008|593049450|FG001|Overall Study|Death|47|||
164186111|NCT00073008|593049449|FG000|Overall Study|"Other selected on Case Report Form"|7|||
164186112|NCT00073008|593049450|FG001|Overall Study|"Other selected on Case Report Form"|5|||
164186113|NCT01778751|593049460|FG000|Overall Study|Lost to Follow-up|1|||
164186114|NCT01778751|593049461|FG001|Overall Study|Lost to Follow-up|0|||
164186115|NCT01778751|593049460|FG000|Overall Study|Withdrawal by Subject|0|||
164186116|NCT01778751|593049461|FG001|Overall Study|Withdrawal by Subject|2|||
164186117|NCT01778751|593049460|FG000|Overall Study|Transfered care|1|||
164186118|NCT01778751|593049461|FG001|Overall Study|Transfered care|0|||
164186119|NCT03337048|593049462|FG000|Overall Study|Withdrawal by Subject|2|||
164186120|NCT03337048|593049463|FG001|Overall Study|Withdrawal by Subject|0|||
164186121|NCT03337048|593049464|FG002|Overall Study|Withdrawal by Subject|0|||
164186122|NCT02669667|593049465|FG000|Overall Study|Lost to Follow-up|0|||
164186123|NCT02669667|593049466|FG001|Overall Study|Lost to Follow-up|0|||
164186124|NCT02669667|593049467|FG002|Overall Study|Lost to Follow-up|0|||
164186125|NCT02669667|593049468|FG003|Overall Study|Lost to Follow-up|0|||
164186126|NCT02669667|593049469|FG004|Overall Study|Lost to Follow-up|0|||
164186127|NCT02669667|593049470|FG005|Overall Study|Lost to Follow-up|1|||
164186128|NCT02669667|593049471|FG006|Overall Study|Lost to Follow-up|0|||
164186129|NCT00636961|593049479|FG000|Period 1|Administrative problems|1|||
164186130|NCT00636961|593049480|FG001|Period 1|Administrative problems|1|||
164186131|NCT00636961|593049479|FG000|Period 2|Adverse Event|1|||
164186132|NCT00636961|593049480|FG001|Period 2|Adverse Event|0|||
164186133|NCT01428115|593049484|FG000|Overall Study|Lack of Efficacy|3|||
164186134|NCT01428115|593049484|FG000|Overall Study|Lost to Follow-up|10|||
164186135|NCT01428115|593049484|FG000|Overall Study|Pregnancy|1|||
164186136|NCT01428115|593049484|FG000|Overall Study|Protocol Violation|3|||
164186137|NCT01428115|593049484|FG000|Overall Study|Withdrawal by Subject|4|||
164186138|NCT02774005|593049485|FG000|Overall Study|Adverse Event|8|||
164186139|NCT02774005|593049485|FG000|Overall Study|Withdrawal by Subject|23|||
164186140|NCT02774005|593049485|FG000|Overall Study|Lost to Follow-up|7|||
164186141|NCT02774005|593049485|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
164186142|NCT02774005|593049485|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
164186143|NCT02774005|593049485|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
164186144|NCT02774005|593049485|FG000|Overall Study|Death|1|||
164186145|NCT02774005|593049485|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
164186146|NCT02774005|593049485|FG000|Overall Study|Lack of compliance with study medication|4|||
164186147|NCT02774005|593049485|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
164186148|NCT02774005|593049485|FG000|Overall Study|another study|1|||
164186149|NCT02774005|593049485|FG000|Overall Study|cardiologist imposed travel restriction|1|||
164186150|NCT01790516|593049486|FG000|Overall Study|Physician Decision|1|||
164186151|NCT01790516|593049487|FG001|Overall Study|Physician Decision|0|||
164186152|NCT01402986|593049488|FG000|Overall Study|Withdrawal by Subject|7|||
164186153|NCT01402986|593049489|FG001|Overall Study|Withdrawal by Subject|10|||
164186154|NCT01402986|593049490|FG002|Overall Study|Withdrawal by Subject|7|||
164186155|NCT01402986|593049491|FG003|Overall Study|Withdrawal by Subject|13|||
164186156|NCT01402986|593049488|FG000|Overall Study|Death|0|||
164186157|NCT01402986|593049489|FG001|Overall Study|Death|0|||
164186158|NCT01402986|593049490|FG002|Overall Study|Death|0|||
164186159|NCT01402986|593049491|FG003|Overall Study|Death|2|||
164186160|NCT01402986|593049488|FG000|Overall Study|Lost to Follow-up|0|||
164186161|NCT01402986|593049489|FG001|Overall Study|Lost to Follow-up|0|||
164186162|NCT01402986|593049490|FG002|Overall Study|Lost to Follow-up|0|||
164186163|NCT01402986|593049491|FG003|Overall Study|Lost to Follow-up|1|||
164186164|NCT01402986|593049488|FG000|Overall Study|Other|2|||
164186165|NCT01402986|593049489|FG001|Overall Study|Other|5|||
164186166|NCT01402986|593049490|FG002|Overall Study|Other|1|||
164186167|NCT01402986|593049491|FG003|Overall Study|Other|6|||
164186168|NCT01085084|593049492|FG000|Overall Study|Withdrawal by Subject|1|||
164186169|NCT01085084|593049493|FG001|Overall Study|Withdrawal by Subject|0|||
164186170|NCT01085084|593049494|FG002|Overall Study|Withdrawal by Subject|0|||
164186171|NCT01085084|593049492|FG000|Overall Study|Lost to Follow-up|2|||
164186172|NCT01085084|593049493|FG001|Overall Study|Lost to Follow-up|1|||
164186173|NCT01085084|593049494|FG002|Overall Study|Lost to Follow-up|1|||
164186174|NCT01085084|593049492|FG000|Overall Study|Adverse Event|4|||
164186175|NCT01085084|593049493|FG001|Overall Study|Adverse Event|3|||
164186176|NCT01085084|593049494|FG002|Overall Study|Adverse Event|6|||
164186177|NCT01085084|593049492|FG000|Overall Study|Treatment Failure|0|||
164186178|NCT01085084|593049493|FG001|Overall Study|Treatment Failure|1|||
164186179|NCT01085084|593049494|FG002|Overall Study|Treatment Failure|2|||
164186180|NCT02749799|593049495|FG000|Overall Study|Adverse Event|2|||
164186181|NCT02749799|593049495|FG000|Overall Study|Lost to Follow-up|4|||
164186182|NCT02749799|593049495|FG000|Overall Study|Protocol Violation|1|||
164186183|NCT02749799|593049495|FG000|Overall Study|Withdrawal by Subject|1|||
164186184|NCT03749109|593049496|FG000|Overall Study|Adverse Event|2|||
164186185|NCT03749109|593049497|FG001|Overall Study|Adverse Event|0|||
164186186|NCT02070978|593049498|FG000|Overall Study|Adverse Event|6|||
164186187|NCT02070978|593049499|FG001|Overall Study|Adverse Event|2|||
164186188|NCT02070978|593049500|FG002|Overall Study|Adverse Event|0|||
164186189|NCT02070978|593049498|FG000|Overall Study|Lost to Follow-up|1|||
164186190|NCT02070978|593049499|FG001|Overall Study|Lost to Follow-up|3|||
164186191|NCT02070978|593049500|FG002|Overall Study|Lost to Follow-up|4|||
164186192|NCT02070978|593049498|FG000|Overall Study|Withdrawal by Subject|3|||
164186193|NCT02070978|593049499|FG001|Overall Study|Withdrawal by Subject|5|||
164186194|NCT02070978|593049500|FG002|Overall Study|Withdrawal by Subject|3|||
164186195|NCT02070978|593049498|FG000|Overall Study|Protocol Violation|1|||
164186196|NCT02070978|593049499|FG001|Overall Study|Protocol Violation|0|||
164186197|NCT02070978|593049500|FG002|Overall Study|Protocol Violation|3|||
164186198|NCT02070978|593049498|FG000|Overall Study|Lack of Efficacy|0|||
164186199|NCT02070978|593049499|FG001|Overall Study|Lack of Efficacy|1|||
164186200|NCT02070978|593049500|FG002|Overall Study|Lack of Efficacy|0|||
164186201|NCT02070978|593049498|FG000|Overall Study|Death|0|||
164186202|NCT02070978|593049499|FG001|Overall Study|Death|0|||
164186203|NCT02070978|593049500|FG002|Overall Study|Death|2|||
164186204|NCT02070978|593049498|FG000|Overall Study|Un-specified|3|||
164186205|NCT02070978|593049499|FG001|Overall Study|Un-specified|2|||
164186206|NCT02070978|593049500|FG002|Overall Study|Un-specified|2|||
164186207|NCT02070978|593049498|FG000|Overall Study|Terminated by Sponsor|33|||
164186208|NCT02070978|593049499|FG001|Overall Study|Terminated by Sponsor|40|||
164186209|NCT02070978|593049500|FG002|Overall Study|Terminated by Sponsor|39|||
164186210|NCT03178851|593049501|FG000|Overall Study|Death|48|||
164186211|NCT03178851|593049502|FG001|Overall Study|Death|2|||
164186212|NCT03178851|593049503|FG002|Overall Study|Death|25|||
164186213|NCT03178851|593049501|FG000|Overall Study|Withdrawal by Subject|8|||
164186214|NCT03178851|593049502|FG001|Overall Study|Withdrawal by Subject|0|||
164186215|NCT03178851|593049503|FG002|Overall Study|Withdrawal by Subject|0|||
164186216|NCT03178851|593049501|FG000|Overall Study|Lost to Follow-up|5|||
164186217|NCT03178851|593049502|FG001|Overall Study|Lost to Follow-up|2|||
164186218|NCT03178851|593049503|FG002|Overall Study|Lost to Follow-up|0|||
164186219|NCT03178851|593049501|FG000|Overall Study|Adverse Event|0|||
164186220|NCT03178851|593049502|FG001|Overall Study|Adverse Event|0|||
164186221|NCT03178851|593049503|FG002|Overall Study|Adverse Event|1|||
164186222|NCT03178851|593049501|FG000|Overall Study|Study Termination by Sponsor|31|||
164186223|NCT03178851|593049502|FG001|Overall Study|Study Termination by Sponsor|7|||
164186224|NCT03178851|593049503|FG002|Overall Study|Study Termination by Sponsor|26|||
164186225|NCT03951753|593049504|FG000|Overall Study|Adverse Event|1|||
164186226|NCT03951753|593049505|FG001|Overall Study|Adverse Event|0|||
164186227|NCT03951753|593049506|FG002|Overall Study|Adverse Event|3|||
164186228|NCT03951753|593049504|FG000|Overall Study|Withdrawal by Subject|3|||
164186229|NCT03951753|593049505|FG001|Overall Study|Withdrawal by Subject|1|||
164186230|NCT03951753|593049506|FG002|Overall Study|Withdrawal by Subject|0|||
164186231|NCT03951753|593049504|FG000|Overall Study|Lost to Follow-up|0|||
164186232|NCT03951753|593049505|FG001|Overall Study|Lost to Follow-up|0|||
164186233|NCT03951753|593049506|FG002|Overall Study|Lost to Follow-up|1|||
164186234|NCT01905592|593049509|FG000|Overall Study|Disease Progression|51|||
164186235|NCT01905592|593049510|FG001|Overall Study|Disease Progression|110|||
164186236|NCT01905592|593049509|FG000|Overall Study|Toxicity|1|||
164186237|NCT01905592|593049510|FG001|Overall Study|Toxicity|16|||
164186238|NCT01905592|593049509|FG000|Overall Study|Physician Decision|0|||
164186239|NCT01905592|593049510|FG001|Overall Study|Physician Decision|2|||
164186240|NCT01905592|593049509|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
164186241|NCT01905592|593049510|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
164186242|NCT01905592|593049509|FG000|Overall Study|Protocol Violation|0|||
164186243|NCT01905592|593049510|FG001|Overall Study|Protocol Violation|1|||
164186244|NCT01905592|593049509|FG000|Overall Study|Sponsor's decision|1|||
164186245|NCT01905592|593049510|FG001|Overall Study|Sponsor's decision|1|||
164186246|NCT01905592|593049509|FG000|Overall Study|Not treated|7|||
164186247|NCT01905592|593049510|FG001|Overall Study|Not treated|3|||
164186248|NCT01905592|593049509|FG000|Overall Study|Withdrawal by Subject|10|||
164186249|NCT01905592|593049510|FG001|Overall Study|Withdrawal by Subject|2|||
164186250|NCT02669043|593049511|FG000|Overall Study|Didn't meet I/E criteria|4|||
164186251|NCT01483599|593049513|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
164186252|NCT01483599|593049514|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
164186253|NCT01483599|593049515|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
164186254|NCT01483599|593049516|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
164186255|NCT01483599|593049517|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
164186256|NCT01483599|593049518|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
164186257|NCT01483599|593049519|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
164186258|NCT01483599|593049520|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
164186259|NCT01483599|593049521|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
164186260|NCT01483599|593049522|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
164186261|NCT01483599|593049523|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
164186262|NCT01483599|593049524|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
164186263|NCT01483599|593049525|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
164186264|NCT01483599|593049526|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
164186265|NCT01483599|593049513|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
164186266|NCT01483599|593049514|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
164186267|NCT01483599|593049515|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
164186268|NCT01483599|593049516|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
164186269|NCT01483599|593049517|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
164186270|NCT01483599|593049518|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
164186271|NCT01483599|593049519|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
164186272|NCT01483599|593049520|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
164186273|NCT01483599|593049521|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
164186274|NCT01483599|593049522|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
164186275|NCT01483599|593049523|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
164186276|NCT01483599|593049524|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
164186277|NCT01483599|593049525|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
164186278|NCT01483599|593049526|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
164186279|NCT01483599|593049513|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
164186280|NCT01483599|593049514|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186281|NCT01483599|593049515|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186282|NCT01483599|593049516|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186283|NCT01483599|593049517|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186284|NCT01483599|593049518|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186285|NCT01483599|593049519|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186286|NCT01483599|593049520|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186287|NCT01483599|593049521|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186288|NCT01483599|593049522|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186289|NCT01483599|593049523|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186290|NCT01483599|593049524|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186291|NCT01483599|593049525|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186292|NCT01483599|593049526|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186293|NCT01483599|593049513|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
164186294|NCT01483599|593049514|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
164186295|NCT01483599|593049515|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
164186296|NCT01483599|593049516|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
164186297|NCT01483599|593049517|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
164186298|NCT01483599|593049518|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
164186299|NCT01483599|593049519|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
164186300|NCT01483599|593049520|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
164186301|NCT01483599|593049521|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
164186302|NCT01483599|593049522|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
164186303|NCT01483599|593049523|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
164186304|NCT01483599|593049524|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
164186305|NCT01483599|593049525|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
164186306|NCT01483599|593049526|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
164186307|NCT01483599|593049513|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
164186308|NCT01483599|593049514|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
164186309|NCT01483599|593049515|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
164186310|NCT01483599|593049516|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
164186311|NCT01483599|593049517|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
164186312|NCT01483599|593049518|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
164186313|NCT01483599|593049519|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
164186314|NCT01483599|593049520|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
164186315|NCT01483599|593049521|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
164186316|NCT01483599|593049522|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
164186317|NCT01483599|593049523|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
164186318|NCT01483599|593049524|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
164186319|NCT01483599|593049525|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
164186320|NCT01483599|593049526|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
164186321|NCT01483599|593049513|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
164186322|NCT01483599|593049514|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
164186323|NCT01483599|593049515|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
164186324|NCT01483599|593049516|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
164186325|NCT01483599|593049517|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
164186326|NCT01483599|593049518|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
164186327|NCT01483599|593049519|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
164186328|NCT01483599|593049520|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
164186329|NCT01483599|593049521|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
164186330|NCT01483599|593049522|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
164186331|NCT01483599|593049523|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
164186332|NCT01483599|593049524|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
164186333|NCT01483599|593049525|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
164186334|NCT01483599|593049526|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
164186335|NCT01483599|593049513|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
164186336|NCT01483599|593049514|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
164186337|NCT01483599|593049515|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
164186338|NCT01483599|593049516|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
164186339|NCT01483599|593049517|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
164186340|NCT01483599|593049518|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
164186341|NCT01483599|593049519|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
164186342|NCT01483599|593049520|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
164186343|NCT01483599|593049521|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
164186344|NCT01483599|593049522|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
164186345|NCT01483599|593049523|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
164186346|NCT01483599|593049524|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
164186347|NCT01483599|593049525|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
164186348|NCT01483599|593049526|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
164186349|NCT01483599|593049513|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
164186350|NCT01483599|593049514|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
164186351|NCT01483599|593049515|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
164186352|NCT01483599|593049516|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
164186353|NCT01483599|593049517|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
164186354|NCT01483599|593049518|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
164186355|NCT01483599|593049519|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
164186356|NCT01483599|593049520|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
164186357|NCT01483599|593049521|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
164186358|NCT01483599|593049522|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
164186359|NCT01483599|593049523|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
164186360|NCT01483599|593049524|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
164186361|NCT01483599|593049525|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
164186362|NCT01483599|593049526|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
164186363|NCT01483599|593049513|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
164186364|NCT01483599|593049514|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
164186365|NCT01483599|593049515|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
164186366|NCT01483599|593049516|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
164186367|NCT01483599|593049517|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
164186368|NCT01483599|593049518|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
164186369|NCT01483599|593049519|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
164186370|NCT01483599|593049520|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
164186371|NCT01483599|593049521|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
164186372|NCT01483599|593049522|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
164186373|NCT01483599|593049523|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
164186374|NCT01483599|593049524|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
164186375|NCT01483599|593049525|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
164186376|NCT01483599|593049526|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
164186377|NCT01483599|593049513|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
164186378|NCT01483599|593049514|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
164186379|NCT01483599|593049515|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
164186380|NCT01483599|593049516|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
164186381|NCT01483599|593049517|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
164186382|NCT01483599|593049518|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
164186383|NCT01483599|593049519|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
164186384|NCT01483599|593049520|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
164186385|NCT01483599|593049521|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
164186386|NCT01483599|593049522|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
164186387|NCT01483599|593049523|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
164186388|NCT01483599|593049524|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
164186467|NCT04304508|593052260|FG001|Overall Study|Other|6|||
164186389|NCT01483599|593049525|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
164186390|NCT01483599|593049526|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
164186391|NCT02109445|593049527|FG000|Overall Study|Symptomatic deterioration|2|||
164186392|NCT02109445|593049527|FG000|Overall Study|Adverse Event|1|||
164186393|NCT00966355|593049532|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
164186394|NCT00966355|593049533|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
164186395|NCT00966355|593049534|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
164186396|NCT00966355|593049532|FG000|Overall Study|newly diagnosed advanced HCC|11|||
164186397|NCT00966355|593049533|FG001|Overall Study|newly diagnosed advanced HCC|12|||
164186398|NCT00966355|593049534|FG002|Overall Study|newly diagnosed advanced HCC|10|||
164186399|NCT00966355|593049532|FG000|Overall Study|Lost to Follow-up|5|||
164186400|NCT00966355|593049533|FG001|Overall Study|Lost to Follow-up|4|||
164186401|NCT00966355|593049534|FG002|Overall Study|Lost to Follow-up|3|||
164186402|NCT00401193|593052243|FG000|Overall Study|Adverse Event|1|||
164186403|NCT00401193|593052244|FG001|Overall Study|Adverse Event|3|||
164186404|NCT00401193|593052245|FG002|Overall Study|Adverse Event|1|||
164186405|NCT00401193|593052243|FG000|Overall Study|Protocol Violation|3|||
164186406|NCT00401193|593052244|FG001|Overall Study|Protocol Violation|1|||
164186407|NCT00401193|593052245|FG002|Overall Study|Protocol Violation|1|||
164186408|NCT00401193|593052243|FG000|Overall Study|Lost to Follow-up|6|||
164186409|NCT00401193|593052244|FG001|Overall Study|Lost to Follow-up|5|||
164186410|NCT00401193|593052245|FG002|Overall Study|Lost to Follow-up|1|||
164186411|NCT00401193|593052243|FG000|Overall Study|Withdrawal by Subject|2|||
164186412|NCT00401193|593052244|FG001|Overall Study|Withdrawal by Subject|0|||
164186413|NCT00401193|593052245|FG002|Overall Study|Withdrawal by Subject|1|||
164186414|NCT00401193|593052243|FG000|Overall Study|Other Event|3|||
164186415|NCT00401193|593052244|FG001|Overall Study|Other Event|2|||
164186416|NCT00401193|593052245|FG002|Overall Study|Other Event|2|||
164186417|NCT01844817|593052246|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
164186418|NCT01844817|593052247|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
164186419|NCT01844817|593052246|FG000|Treatment|Progressive Disease|27|||
164186420|NCT01844817|593052247|FG001|Treatment|Progressive Disease|36|||
164186421|NCT01844817|593052246|FG000|Treatment|Adverse Event|17|||
164186422|NCT01844817|593052247|FG001|Treatment|Adverse Event|9|||
164186423|NCT01844817|593052246|FG000|Treatment|Withdrawal by Subject|10|||
164186424|NCT01844817|593052247|FG001|Treatment|Withdrawal by Subject|6|||
164186425|NCT01844817|593052246|FG000|Treatment|Death|10|||
164186426|NCT01844817|593052247|FG001|Treatment|Death|8|||
164186427|NCT01844817|593052246|FG000|Treatment|Lost to Follow-up|0|||
164186428|NCT01844817|593052247|FG001|Treatment|Lost to Follow-up|1|||
164186429|NCT01844817|593052246|FG000|Treatment|Other|0|||
164186430|NCT01844817|593052247|FG001|Treatment|Other|3|||
164186431|NCT02447328|593052250|FG000|Overall Study|Withdrawal by Subject|1|||
164186432|NCT00314808|593052258|FG000|Overall Study|Disease Progression without AE|4|||
164186433|NCT00314808|593052258|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
164186434|NCT04304508|593052259|FG000|Overall Study|Subject Decision|29|||
164186435|NCT04304508|593052260|FG001|Overall Study|Subject Decision|39|||
164186436|NCT04304508|593052261|FG002|Overall Study|Subject Decision|37|||
164186437|NCT04304508|593052262|FG003|Overall Study|Subject Decision|48|||
164186438|NCT04304508|593052259|FG000|Overall Study|Death|6|||
164186439|NCT04304508|593052260|FG001|Overall Study|Death|1|||
164186440|NCT04304508|593052261|FG002|Overall Study|Death|8|||
164186441|NCT04304508|593052262|FG003|Overall Study|Death|5|||
164186442|NCT04304508|593052259|FG000|Overall Study|Non-compliance With Study Drug|3|||
164186443|NCT04304508|593052260|FG001|Overall Study|Non-compliance With Study Drug|1|||
164186444|NCT04304508|593052261|FG002|Overall Study|Non-compliance With Study Drug|2|||
164186445|NCT04304508|593052262|FG003|Overall Study|Non-compliance With Study Drug|0|||
164186446|NCT04304508|593052259|FG000|Overall Study|Switching To Other Therapy|1|||
164186447|NCT04304508|593052260|FG001|Overall Study|Switching To Other Therapy|1|||
164186448|NCT04304508|593052261|FG002|Overall Study|Switching To Other Therapy|1|||
164186449|NCT04304508|593052262|FG003|Overall Study|Switching To Other Therapy|2|||
164186450|NCT04304508|593052259|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
164186451|NCT04304508|593052260|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
164186452|NCT04304508|593052261|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
164186453|NCT04304508|593052262|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
164186454|NCT04304508|593052259|FG000|Overall Study|Withdrawal by Subject|7|||
164186455|NCT04304508|593052260|FG001|Overall Study|Withdrawal by Subject|5|||
164186456|NCT04304508|593052261|FG002|Overall Study|Withdrawal by Subject|11|||
164186457|NCT04304508|593052262|FG003|Overall Study|Withdrawal by Subject|6|||
164186458|NCT04304508|593052259|FG000|Overall Study|Logistical Difficulties|2|||
164186459|NCT04304508|593052260|FG001|Overall Study|Logistical Difficulties|2|||
164186460|NCT04304508|593052261|FG002|Overall Study|Logistical Difficulties|3|||
164186461|NCT04304508|593052262|FG003|Overall Study|Logistical Difficulties|2|||
164186462|NCT04304508|593052259|FG000|Overall Study|Missing Information|1|||
164186463|NCT04304508|593052260|FG001|Overall Study|Missing Information|2|||
164186464|NCT04304508|593052261|FG002|Overall Study|Missing Information|1|||
164186465|NCT04304508|593052262|FG003|Overall Study|Missing Information|3|||
164186466|NCT04304508|593052259|FG000|Overall Study|Other|7|||
164186468|NCT04304508|593052261|FG002|Overall Study|Other|5|||
164186469|NCT04304508|593052262|FG003|Overall Study|Other|4|||
164186470|NCT04304508|593052259|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
164186471|NCT04304508|593052260|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
164186472|NCT04304508|593052261|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
164186473|NCT04304508|593052262|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
164186474|NCT04304508|593052259|FG000|Overall Study|Physician Decision|3|||
164186475|NCT04304508|593052260|FG001|Overall Study|Physician Decision|4|||
164186476|NCT04304508|593052261|FG002|Overall Study|Physician Decision|9|||
164186477|NCT04304508|593052262|FG003|Overall Study|Physician Decision|7|||
164186478|NCT04304508|593052259|FG000|Overall Study|Study drug never administered|10|||
164186479|NCT04304508|593052260|FG001|Overall Study|Study drug never administered|4|||
164186480|NCT04304508|593052261|FG002|Overall Study|Study drug never administered|4|||
164186481|NCT04304508|593052262|FG003|Overall Study|Study drug never administered|4|||
164186482|NCT04304508|593052259|FG000|Overall Study|Adverse Event|49|||
164186483|NCT04304508|593052260|FG001|Overall Study|Adverse Event|50|||
164186484|NCT04304508|593052261|FG002|Overall Study|Adverse Event|51|||
164186485|NCT04304508|593052262|FG003|Overall Study|Adverse Event|56|||
164186486|NCT04304508|593052259|FG000|Overall Study|Lost to Follow-up|1|||
164186487|NCT04304508|593052260|FG001|Overall Study|Lost to Follow-up|5|||
164186488|NCT04304508|593052261|FG002|Overall Study|Lost to Follow-up|2|||
164186489|NCT04304508|593052262|FG003|Overall Study|Lost to Follow-up|3|||
164186490|NCT02113007|593052269|FG000|Overall Study|Progressive disease|2|||
164186491|NCT00885378|593052270|FG000|Overall Study|Lack of Efficacy|2|||
164186492|NCT00885378|593052271|FG001|Overall Study|Lack of Efficacy|2|||
164186493|NCT00885378|593052270|FG000|Overall Study|Withdrawal by Subject|1|||
164186494|NCT00885378|593052271|FG001|Overall Study|Withdrawal by Subject|2|||
164186495|NCT00885378|593052270|FG000|Overall Study|Lost to Follow-up|1|||
164186496|NCT00885378|593052271|FG001|Overall Study|Lost to Follow-up|2|||
164186497|NCT00885378|593052270|FG000|Overall Study|Poor/Noncompliance|2|||
164186498|NCT00885378|593052271|FG001|Overall Study|Poor/Noncompliance|2|||
164186499|NCT00885378|593052270|FG000|Overall Study|Protocol Violation|2|||
164186500|NCT00885378|593052271|FG001|Overall Study|Protocol Violation|0|||
164186501|NCT02579382|593052272|FG000|Main Study Phase|Lost to Follow-up|0|||
164186502|NCT02579382|593052273|FG001|Main Study Phase|Lost to Follow-up|0|||
164186503|NCT02579382|593052274|FG002|Main Study Phase|Lost to Follow-up|2|||
164186504|NCT02579382|593052275|FG003|Main Study Phase|Lost to Follow-up|0|||
164186505|NCT02579382|593052272|FG000|Main Study Phase|Withdrew Consent|0|||
164186506|NCT02579382|593052273|FG001|Main Study Phase|Withdrew Consent|0|||
164186507|NCT02579382|593052274|FG002|Main Study Phase|Withdrew Consent|0|||
164186508|NCT02579382|593052275|FG003|Main Study Phase|Withdrew Consent|2|||
164186509|NCT02579382|593052272|FG000|Main Study Phase|Lack of Efficacy|0|||
164186510|NCT02579382|593052273|FG001|Main Study Phase|Lack of Efficacy|0|||
164186511|NCT02579382|593052274|FG002|Main Study Phase|Lack of Efficacy|0|||
164186512|NCT02579382|593052275|FG003|Main Study Phase|Lack of Efficacy|1|||
164186513|NCT02579382|593052272|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
164186514|NCT02579382|593052273|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
164186515|NCT02579382|593052274|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
164186516|NCT02579382|593052275|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
164186517|NCT02579382|593052272|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
164186518|NCT02579382|593052273|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
164186519|NCT02579382|593052274|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
164186520|NCT02579382|593052275|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
164186521|NCT02579382|593052272|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
164186522|NCT02579382|593052273|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
164186523|NCT02579382|593052274|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
164186524|NCT02579382|593052275|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
164186525|NCT02579382|593052272|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
164186526|NCT02579382|593052273|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
164186527|NCT02579382|593052274|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
164186528|NCT02579382|593052275|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
164186529|NCT02579382|593052272|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
164186530|NCT02579382|593052273|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
164186531|NCT02579382|593052274|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
164186532|NCT02579382|593052275|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
164186533|NCT02579382|593052272|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
164186534|NCT02579382|593052273|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
164186535|NCT02579382|593052274|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
164186536|NCT02579382|593052275|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
164186537|NCT03091738|593052276|FG000|Overall Study|Adverse Event|1|||
164186538|NCT03091738|593052276|FG000|Overall Study|Lost to Follow-up|1|||
164186539|NCT01826981|593052277|FG000|Overall Study|Lack of Efficacy|0|||
164186540|NCT01826981|593052278|FG001|Overall Study|Lack of Efficacy|1|||
164186541|NCT01826981|593052279|FG002|Overall Study|Lack of Efficacy|0|||
164186542|NCT01826981|593052280|FG003|Overall Study|Lack of Efficacy|0|||
164186543|NCT01826981|593052281|FG004|Overall Study|Lack of Efficacy|5|||
164186544|NCT01826981|593052282|FG005|Overall Study|Lack of Efficacy|0|||
164186545|NCT01826981|593052283|FG006|Overall Study|Lack of Efficacy|0|||
164186546|NCT01826981|593052284|FG007|Overall Study|Lack of Efficacy|8|||
164186547|NCT01826981|593052285|FG008|Overall Study|Lack of Efficacy|7|||
164186548|NCT01826981|593052286|FG009|Overall Study|Lack of Efficacy|0|||
164186549|NCT01826981|593052287|FG010|Overall Study|Lack of Efficacy|1|||
164186550|NCT01826981|593052288|FG011|Overall Study|Lack of Efficacy|0|||
164186551|NCT01826981|593052289|FG012|Overall Study|Lack of Efficacy|0|||
164186552|NCT01826981|593052290|FG013|Overall Study|Lack of Efficacy|3|||
164186553|NCT01826981|593052291|FG014|Overall Study|Lack of Efficacy|0|||
164186554|NCT01826981|593052277|FG000|Overall Study|Lost to Follow-up|0|||
164186555|NCT01826981|593052278|FG001|Overall Study|Lost to Follow-up|0|||
164186556|NCT01826981|593052279|FG002|Overall Study|Lost to Follow-up|0|||
164186557|NCT01826981|593052280|FG003|Overall Study|Lost to Follow-up|0|||
164186558|NCT01826981|593052281|FG004|Overall Study|Lost to Follow-up|1|||
164186559|NCT01826981|593052282|FG005|Overall Study|Lost to Follow-up|1|||
164186560|NCT01826981|593052283|FG006|Overall Study|Lost to Follow-up|0|||
164186561|NCT01826981|593052284|FG007|Overall Study|Lost to Follow-up|1|||
164186562|NCT01826981|593052285|FG008|Overall Study|Lost to Follow-up|0|||
164186563|NCT01826981|593052286|FG009|Overall Study|Lost to Follow-up|1|||
164186564|NCT01826981|593052287|FG010|Overall Study|Lost to Follow-up|1|||
164186565|NCT01826981|593052288|FG011|Overall Study|Lost to Follow-up|1|||
164186566|NCT01826981|593052289|FG012|Overall Study|Lost to Follow-up|1|||
164186567|NCT01826981|593052290|FG013|Overall Study|Lost to Follow-up|0|||
164186568|NCT01826981|593052291|FG014|Overall Study|Lost to Follow-up|0|||
164186569|NCT01826981|593052277|FG000|Overall Study|Withdrew Consent|0|||
164186570|NCT01826981|593052278|FG001|Overall Study|Withdrew Consent|0|||
164186571|NCT01826981|593052279|FG002|Overall Study|Withdrew Consent|0|||
164186572|NCT01826981|593052280|FG003|Overall Study|Withdrew Consent|0|||
164186573|NCT01826981|593052281|FG004|Overall Study|Withdrew Consent|0|||
164186574|NCT01826981|593052282|FG005|Overall Study|Withdrew Consent|0|||
164186575|NCT01826981|593052283|FG006|Overall Study|Withdrew Consent|1|||
164186576|NCT01826981|593052284|FG007|Overall Study|Withdrew Consent|1|||
164186577|NCT01826981|593052285|FG008|Overall Study|Withdrew Consent|0|||
164186578|NCT01826981|593052286|FG009|Overall Study|Withdrew Consent|0|||
164186579|NCT01826981|593052287|FG010|Overall Study|Withdrew Consent|0|||
164186580|NCT01826981|593052288|FG011|Overall Study|Withdrew Consent|1|||
164186581|NCT01826981|593052289|FG012|Overall Study|Withdrew Consent|0|||
164186582|NCT01826981|593052290|FG013|Overall Study|Withdrew Consent|1|||
164186583|NCT01826981|593052291|FG014|Overall Study|Withdrew Consent|0|||
164186584|NCT01826981|593052277|FG000|Overall Study|Adverse Event|0|||
164186585|NCT01826981|593052278|FG001|Overall Study|Adverse Event|0|||
164186586|NCT01826981|593052279|FG002|Overall Study|Adverse Event|0|||
164186587|NCT01826981|593052280|FG003|Overall Study|Adverse Event|0|||
164186588|NCT01826981|593052281|FG004|Overall Study|Adverse Event|1|||
164186589|NCT01826981|593052282|FG005|Overall Study|Adverse Event|0|||
164186590|NCT01826981|593052283|FG006|Overall Study|Adverse Event|0|||
164186591|NCT01826981|593052284|FG007|Overall Study|Adverse Event|0|||
164186592|NCT01826981|593052285|FG008|Overall Study|Adverse Event|0|||
164186593|NCT01826981|593052286|FG009|Overall Study|Adverse Event|0|||
164186594|NCT01826981|593052287|FG010|Overall Study|Adverse Event|0|||
164186595|NCT01826981|593052288|FG011|Overall Study|Adverse Event|0|||
164186596|NCT01826981|593052289|FG012|Overall Study|Adverse Event|0|||
164186597|NCT01826981|593052290|FG013|Overall Study|Adverse Event|0|||
164186598|NCT01826981|593052291|FG014|Overall Study|Adverse Event|0|||
164186599|NCT01826981|593052277|FG000|Overall Study|Upper G-I Haemorrhage|0|||
164186600|NCT01826981|593052278|FG001|Overall Study|Upper G-I Haemorrhage|0|||
164186601|NCT01826981|593052279|FG002|Overall Study|Upper G-I Haemorrhage|0|||
164186602|NCT01826981|593052280|FG003|Overall Study|Upper G-I Haemorrhage|0|||
164186603|NCT01826981|593052281|FG004|Overall Study|Upper G-I Haemorrhage|0|||
164186604|NCT01826981|593052282|FG005|Overall Study|Upper G-I Haemorrhage|0|||
164186605|NCT01826981|593052283|FG006|Overall Study|Upper G-I Haemorrhage|0|||
164186606|NCT01826981|593052284|FG007|Overall Study|Upper G-I Haemorrhage|0|||
164186607|NCT01826981|593052285|FG008|Overall Study|Upper G-I Haemorrhage|0|||
164186608|NCT01826981|593052286|FG009|Overall Study|Upper G-I Haemorrhage|0|||
164186609|NCT01826981|593052287|FG010|Overall Study|Upper G-I Haemorrhage|0|||
164186610|NCT01826981|593052288|FG011|Overall Study|Upper G-I Haemorrhage|0|||
164186611|NCT01826981|593052289|FG012|Overall Study|Upper G-I Haemorrhage|0|||
164186612|NCT01826981|593052290|FG013|Overall Study|Upper G-I Haemorrhage|1|||
164186613|NCT01826981|593052291|FG014|Overall Study|Upper G-I Haemorrhage|0|||
164186614|NCT01826981|593052277|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186615|NCT01826981|593052278|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186616|NCT01826981|593052279|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186617|NCT01826981|593052280|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186618|NCT01826981|593052281|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186619|NCT01826981|593052282|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186620|NCT01826981|593052283|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186621|NCT01826981|593052284|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
164186622|NCT01826981|593052285|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186623|NCT01826981|593052286|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186624|NCT01826981|593052287|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186625|NCT01826981|593052288|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186626|NCT01826981|593052289|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186627|NCT01826981|593052290|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186628|NCT01826981|593052291|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186629|NCT02213380|593052294|FG000|Underwent Randomization|Withdrawal by Subject|2|||
164186630|NCT02213380|593052295|FG001|Underwent Randomization|Withdrawal by Subject|0|||
164186631|NCT02213380|593052294|FG000|Underwent Randomization|Not treated|3|||
164186632|NCT02213380|593052295|FG001|Underwent Randomization|Not treated|3|||
164186633|NCT02213380|593052294|FG000|Per-protocol Analysis|Protocol Violation|32|||
164186634|NCT02213380|593052295|FG001|Per-protocol Analysis|Protocol Violation|36|||
164186635|NCT03746405|593052296|FG000|Overall Study|Withdrawal by Subject|3|||
164186636|NCT03746405|593052297|FG001|Overall Study|Withdrawal by Subject|0|||
164186637|NCT03746405|593052296|FG000|Overall Study|technical difficulties|0|||
164186638|NCT03746405|593052297|FG001|Overall Study|technical difficulties|2|||
164186639|NCT03479008|593052298|FG000|Overall Study|Withdrawal by Subject|3|||
164186640|NCT00412932|593052299|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
164186641|NCT00412932|593052299|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
164186642|NCT00412932|593052299|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
164186643|NCT00412932|593052299|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
164186644|NCT00412932|593052299|FG000|Olmesartan (Olm) 20 mg|Other|1|||
164186645|NCT00412932|593052299|FG000|Olmesartan 40 mg|Adverse Event|4|||
164186646|NCT00412932|593052299|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
164186647|NCT00412932|593052299|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
164186648|NCT00412932|593052299|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
164186649|NCT00412932|593052299|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
164186650|NCT00412932|593052299|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
164186651|NCT00412932|593052299|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
164186652|NCT02753816|593052300|FG000|Overall Study|Protocol Violation|0|||
164186653|NCT02753816|593052301|FG001|Overall Study|Protocol Violation|1|||
164186654|NCT02753816|593052302|FG002|Overall Study|Protocol Violation|0|||
164186655|NCT01473940|593052303|FG000|Induction Therapy|Death|0|||
164186656|NCT01473940|593052304|FG001|Induction Therapy|Death|0|||
164186657|NCT01473940|593052305|FG002|Induction Therapy|Death|1|||
164186658|NCT01473940|593052306|FG003|Induction Therapy|Death|1|||
164186659|NCT01473940|593052303|FG000|Induction Therapy|Progressive Disease|0|||
164186660|NCT01473940|593052304|FG001|Induction Therapy|Progressive Disease|1|||
164186661|NCT01473940|593052305|FG002|Induction Therapy|Progressive Disease|1|||
164186662|NCT01473940|593052306|FG003|Induction Therapy|Progressive Disease|0|||
164186663|NCT01473940|593052303|FG000|Maintenance Therapy|Progressive Disease|1|||
164186664|NCT01473940|593052304|FG001|Maintenance Therapy|Progressive Disease|2|||
164186665|NCT01473940|593052305|FG002|Maintenance Therapy|Progressive Disease|1|||
164186666|NCT01473940|593052306|FG003|Maintenance Therapy|Progressive Disease|4|||
164186667|NCT02630563|593052309|FG000|Overall Study|Administrative|1|||
164186668|NCT00929994|593052310|FG000|Overall Study|Withdrawal by Subject|1|||
164186669|NCT00929994|593052310|FG000|Overall Study|medical issue unrelated to intervention|4|||
164186670|NCT00929994|593052310|FG000|Overall Study|employment|1|||
164186671|NCT02061813|593052312|FG000|Overall Study|Withdrawal by Subject|1|||
164186672|NCT02061813|593052312|FG000|Overall Study|Protocol Violation|2|||
164186673|NCT01705080|593052313|FG000|Overall Study|Missed visit|10|||
164186674|NCT01705080|593052314|FG001|Overall Study|Missed visit|4|||
164186675|NCT01705080|593052315|FG002|Overall Study|Missed visit|1|||
164186676|NCT01705080|593052313|FG000|Overall Study|Death|4|||
164186677|NCT01705080|593052314|FG001|Overall Study|Death|4|||
164186678|NCT01705080|593052315|FG002|Overall Study|Death|6|||
164186679|NCT01705080|593052313|FG000|Overall Study|Withdrawal by Subject|61|||
164186680|NCT01705080|593052314|FG001|Overall Study|Withdrawal by Subject|44|||
164186681|NCT01705080|593052315|FG002|Overall Study|Withdrawal by Subject|9|||
164186682|NCT01704755|593052317|FG000|Overall Study|Adverse Event|4|||
164186683|NCT01704755|593052318|FG001|Overall Study|Adverse Event|1|||
164186684|NCT01704755|593052317|FG000|Overall Study|Lost to Follow-up|3|||
164186685|NCT01704755|593052318|FG001|Overall Study|Lost to Follow-up|4|||
164186686|NCT01704755|593052317|FG000|Overall Study|Withdrew consent|1|||
164186687|NCT01704755|593052318|FG001|Overall Study|Withdrew consent|1|||
164186688|NCT01704755|593052317|FG000|Overall Study|Other (not specified)|3|||
164186689|NCT01704755|593052318|FG001|Overall Study|Other (not specified)|1|||
164186690|NCT01704755|593052317|FG000|Overall Study|Withdrew consent and personal issues|1|||
164186691|NCT01704755|593052318|FG001|Overall Study|Withdrew consent and personal issues|0|||
164186692|NCT02256917|593052325|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
164186693|NCT02256917|593052325|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
164186694|NCT02256917|593052325|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
164186695|NCT02256917|593052325|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
164186696|NCT02256917|593052325|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
164186697|NCT02933528|593052326|FG000|Overall Study|Lost to Follow-up|2|||
164186698|NCT02982863|593052327|FG000|Overall Study|Not eligible patients|809|||
164186699|NCT02982863|593052328|FG001|Overall Study|Not eligible patients|4261|||
164186700|NCT02982863|593052329|FG002|Overall Study|Not eligible patients|1852|||
164186701|NCT02982863|593052330|FG003|Overall Study|Not eligible patients|1400|||
164186702|NCT02982863|593052331|FG004|Overall Study|Not eligible patients|492|||
164186703|NCT01753115|593052332|FG000|Overall Study|Lost to Follow-up|3|||
164186704|NCT01753115|593052333|FG001|Overall Study|Lost to Follow-up|6|||
164186705|NCT01753115|593052334|FG002|Overall Study|Lost to Follow-up|8|||
164186706|NCT01753115|593052332|FG000|Overall Study|Withdrawal by Subject|6|||
164186707|NCT01753115|593052333|FG001|Overall Study|Withdrawal by Subject|5|||
164186708|NCT01753115|593052334|FG002|Overall Study|Withdrawal by Subject|6|||
164186709|NCT01753115|593052332|FG000|Overall Study|Subject non-compliant|3|||
164186710|NCT01753115|593052333|FG001|Overall Study|Subject non-compliant|3|||
164186711|NCT01753115|593052334|FG002|Overall Study|Subject non-compliant|0|||
164186712|NCT01753115|593052332|FG000|Overall Study|Used excluded drug|0|||
164186713|NCT01753115|593052333|FG001|Overall Study|Used excluded drug|1|||
164186714|NCT01753115|593052334|FG002|Overall Study|Used excluded drug|0|||
164186715|NCT04313400|593052338|FG000|Overall Study|Withdrawal by Subject|0|||
164186716|NCT04313400|593052339|FG001|Overall Study|Withdrawal by Subject|0|||
164186717|NCT04313400|593052340|FG002|Overall Study|Withdrawal by Subject|0|||
164186718|NCT04313400|593052341|FG003|Overall Study|Withdrawal by Subject|0|||
164186719|NCT04313400|593052342|FG004|Overall Study|Withdrawal by Subject|0|||
164186720|NCT04313400|593052343|FG005|Overall Study|Withdrawal by Subject|4|||
164186721|NCT04313400|593052344|FG006|Overall Study|Withdrawal by Subject|1|||
164186722|NCT04313400|593052338|FG000|Overall Study|Adverse Event|0|||
164186723|NCT04313400|593052339|FG001|Overall Study|Adverse Event|0|||
164186724|NCT04313400|593052340|FG002|Overall Study|Adverse Event|0|||
164186725|NCT04313400|593052341|FG003|Overall Study|Adverse Event|0|||
164186726|NCT04313400|593052342|FG004|Overall Study|Adverse Event|0|||
164186727|NCT04313400|593052343|FG005|Overall Study|Adverse Event|1|||
164186728|NCT04313400|593052344|FG006|Overall Study|Adverse Event|0|||
164186729|NCT04313400|593052338|FG000|Overall Study|Lost to Follow-up|0|||
164186730|NCT04313400|593052339|FG001|Overall Study|Lost to Follow-up|0|||
164186731|NCT04313400|593052340|FG002|Overall Study|Lost to Follow-up|0|||
164186732|NCT04313400|593052341|FG003|Overall Study|Lost to Follow-up|0|||
164186733|NCT04313400|593052342|FG004|Overall Study|Lost to Follow-up|0|||
164186734|NCT04313400|593052343|FG005|Overall Study|Lost to Follow-up|1|||
164186735|NCT04313400|593052344|FG006|Overall Study|Lost to Follow-up|0|||
164186736|NCT02091414|593052345|FG000|Overall Study|Withdrawal by Subject|2|||
164186737|NCT02091414|593052345|FG000|Overall Study|Death|2|||
164186738|NCT02521792|593052349|FG000|Overall Study|Study Terminated|6|||
164186739|NCT01188668|593052350|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
164186740|NCT01188668|593052350|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
164186741|NCT01188668|593052350|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
164186742|NCT00902746|593052351|FG000|Overall Study|Protocol Violation|7|||
164186743|NCT00902746|593052351|FG000|Overall Study|Withdrawal by Subject|16|||
164186744|NCT00902746|593052351|FG000|Overall Study|Adverse Event|8|||
164186745|NCT00902746|593052351|FG000|Overall Study|Lost to Follow-up|3|||
164186746|NCT00902746|593052351|FG000|Overall Study|Physician Decision|2|||
164186747|NCT02081001|593052352|FG000|Overall Study|Adverse Event|0|||
164186748|NCT02081001|593052353|FG001|Overall Study|Adverse Event|0|||
164186749|NCT02081001|593052354|FG002|Overall Study|Adverse Event|0|||
164186750|NCT02081001|593052355|FG003|Overall Study|Adverse Event|0|||
164186751|NCT02081001|593052356|FG004|Overall Study|Adverse Event|1|||
164186752|NCT02081001|593052357|FG005|Overall Study|Adverse Event|0|||
164186753|NCT02081001|593052358|FG006|Overall Study|Adverse Event|0|||
164186754|NCT02081001|593052359|FG007|Overall Study|Adverse Event|0|||
164186755|NCT02081001|593052360|FG008|Overall Study|Adverse Event|0|||
164186756|NCT02081001|593052361|FG009|Overall Study|Adverse Event|0|||
164186757|NCT02081001|593052362|FG010|Overall Study|Adverse Event|0|||
164186758|NCT02081001|593052363|FG011|Overall Study|Adverse Event|0|||
164186759|NCT02937636|593052368|FG000|Overall Study|Other (Not specified)|3|||
164186760|NCT02937636|593052369|FG001|Overall Study|Other (Not specified)|2|||
164186761|NCT00359294|593052370|FG000|Overall Study|Progressive disease|1|||
164186762|NCT00359294|593052371|FG001|Overall Study|Progressive disease|1|||
164186763|NCT00359294|593052372|FG002|Overall Study|Progressive disease|2|||
164186764|NCT00359294|593052373|FG003|Overall Study|Progressive disease|3|||
164186765|NCT00359294|593052374|FG004|Overall Study|Progressive disease|2|||
164186766|NCT00359294|593052370|FG000|Overall Study|Withdrawal by Subject|0|||
164186767|NCT00359294|593052371|FG001|Overall Study|Withdrawal by Subject|0|||
164186768|NCT00359294|593052372|FG002|Overall Study|Withdrawal by Subject|0|||
164186769|NCT00359294|593052373|FG003|Overall Study|Withdrawal by Subject|0|||
164186770|NCT00359294|593052374|FG004|Overall Study|Withdrawal by Subject|1|||
164186771|NCT00359294|593052370|FG000|Overall Study|Not treated|0|||
164186772|NCT00359294|593052371|FG001|Overall Study|Not treated|0|||
164186773|NCT00359294|593052372|FG002|Overall Study|Not treated|0|||
164186774|NCT00359294|593052373|FG003|Overall Study|Not treated|1|||
164186775|NCT00359294|593052374|FG004|Overall Study|Not treated|0|||
164186776|NCT00359294|593052370|FG000|Overall Study|Physician Decision|0|||
164186777|NCT00359294|593052371|FG001|Overall Study|Physician Decision|0|||
164186778|NCT00359294|593052372|FG002|Overall Study|Physician Decision|1|||
164186779|NCT00359294|593052373|FG003|Overall Study|Physician Decision|0|||
164186780|NCT00359294|593052374|FG004|Overall Study|Physician Decision|0|||
164186781|NCT04208412|593052375|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
164186782|NCT04208412|593052376|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
164186783|NCT04208412|593052375|FG000|Overall Study|Withdrawal by Subject|1|||
164186784|NCT04208412|593052376|FG001|Overall Study|Withdrawal by Subject|0|||
164186785|NCT04208412|593052375|FG000|Overall Study|Lost to Follow-up|0|||
164186786|NCT04208412|593052376|FG001|Overall Study|Lost to Follow-up|1|||
164186787|NCT02588092|593052379|FG000|Overall Study|Death|4|||
164186788|NCT02588092|593052380|FG001|Overall Study|Death|3|||
164186789|NCT02588092|593052381|FG002|Overall Study|Death|3|||
164186790|NCT02588092|593052382|FG003|Overall Study|Death|3|||
164186791|NCT02588092|593052383|FG004|Overall Study|Death|2|||
164186792|NCT02588092|593052384|FG005|Overall Study|Death|2|||
164186793|NCT02588092|593052385|FG006|Overall Study|Death|2|||
164186794|NCT02588092|593052386|FG007|Overall Study|Death|1|||
164186795|NCT02588092|593052387|FG008|Overall Study|Death|5|||
164186796|NCT02588092|593052388|FG009|Overall Study|Death|2|||
164186797|NCT02588092|593052379|FG000|Overall Study|Withdrawal by Subject|0|||
164186798|NCT02588092|593052380|FG001|Overall Study|Withdrawal by Subject|0|||
164186799|NCT02588092|593052381|FG002|Overall Study|Withdrawal by Subject|0|||
164186800|NCT02588092|593052382|FG003|Overall Study|Withdrawal by Subject|0|||
164186801|NCT02588092|593052383|FG004|Overall Study|Withdrawal by Subject|0|||
164186802|NCT02588092|593052384|FG005|Overall Study|Withdrawal by Subject|1|||
164186803|NCT02588092|593052385|FG006|Overall Study|Withdrawal by Subject|1|||
164186804|NCT02588092|593052386|FG007|Overall Study|Withdrawal by Subject|2|||
164186805|NCT02588092|593052387|FG008|Overall Study|Withdrawal by Subject|0|||
164186806|NCT02588092|593052388|FG009|Overall Study|Withdrawal by Subject|0|||
164186807|NCT02588092|593052379|FG000|Overall Study|Started Another Treatment|0|||
164186808|NCT02588092|593052380|FG001|Overall Study|Started Another Treatment|0|||
164186809|NCT02588092|593052381|FG002|Overall Study|Started Another Treatment|0|||
164186810|NCT02588092|593052382|FG003|Overall Study|Started Another Treatment|0|||
164186811|NCT02588092|593052383|FG004|Overall Study|Started Another Treatment|1|||
164186812|NCT02588092|593052384|FG005|Overall Study|Started Another Treatment|0|||
164186813|NCT02588092|593052385|FG006|Overall Study|Started Another Treatment|0|||
164186814|NCT02588092|593052386|FG007|Overall Study|Started Another Treatment|1|||
164186815|NCT02588092|593052387|FG008|Overall Study|Started Another Treatment|0|||
164186816|NCT02588092|593052388|FG009|Overall Study|Started Another Treatment|0|||
164186817|NCT02588092|593052379|FG000|Overall Study|Sponsor Decision|0|||
164186818|NCT02588092|593052380|FG001|Overall Study|Sponsor Decision|0|||
164186819|NCT02588092|593052381|FG002|Overall Study|Sponsor Decision|0|||
164186820|NCT02588092|593052382|FG003|Overall Study|Sponsor Decision|0|||
164186821|NCT02588092|593052383|FG004|Overall Study|Sponsor Decision|0|||
164186822|NCT02588092|593052384|FG005|Overall Study|Sponsor Decision|0|||
164186823|NCT02588092|593052385|FG006|Overall Study|Sponsor Decision|0|||
164186824|NCT02588092|593052386|FG007|Overall Study|Sponsor Decision|0|||
164186825|NCT02588092|593052387|FG008|Overall Study|Sponsor Decision|1|||
164186826|NCT02588092|593052388|FG009|Overall Study|Sponsor Decision|1|||
164186827|NCT01348100|593052389|FG000|Overall Study|Subject Withdrew Consent|0|||
164186828|NCT01348100|593052390|FG001|Overall Study|Subject Withdrew Consent|0|||
164186829|NCT01348100|593052391|FG002|Overall Study|Subject Withdrew Consent|2|||
164186830|NCT01348100|593052392|FG003|Overall Study|Subject Withdrew Consent|0|||
164186831|NCT01348100|593052393|FG004|Overall Study|Subject Withdrew Consent|1|||
164186832|NCT01348100|593052394|FG005|Overall Study|Subject Withdrew Consent|0|||
164186833|NCT01348100|593052395|FG006|Overall Study|Subject Withdrew Consent|1|||
164186834|NCT01348100|593052389|FG000|Overall Study|Protocol Deviation|0|||
164186835|NCT01348100|593052390|FG001|Overall Study|Protocol Deviation|0|||
164186836|NCT01348100|593052391|FG002|Overall Study|Protocol Deviation|0|||
164186837|NCT01348100|593052392|FG003|Overall Study|Protocol Deviation|1|||
164186838|NCT01348100|593052393|FG004|Overall Study|Protocol Deviation|0|||
164186839|NCT01348100|593052394|FG005|Overall Study|Protocol Deviation|0|||
164186840|NCT01348100|593052395|FG006|Overall Study|Protocol Deviation|0|||
164186841|NCT01348100|593052389|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
164186842|NCT01348100|593052390|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
164186843|NCT01348100|593052391|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
164186844|NCT01348100|593052392|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
164186845|NCT01348100|593052393|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
164186846|NCT01348100|593052394|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
164186847|NCT01348100|593052395|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
164186848|NCT01348100|593052389|FG000|Overall Study|Lost to Follow-up|0|||
164186849|NCT01348100|593052390|FG001|Overall Study|Lost to Follow-up|0|||
164186850|NCT01348100|593052391|FG002|Overall Study|Lost to Follow-up|0|||
164186851|NCT01348100|593052392|FG003|Overall Study|Lost to Follow-up|0|||
164186852|NCT01348100|593052393|FG004|Overall Study|Lost to Follow-up|0|||
164186853|NCT01348100|593052394|FG005|Overall Study|Lost to Follow-up|0|||
164186854|NCT01348100|593052395|FG006|Overall Study|Lost to Follow-up|1|||
164186855|NCT01348100|593052389|FG000|Overall Study|Administrative Problems|0|||
164186856|NCT01348100|593052390|FG001|Overall Study|Administrative Problems|0|||
164186857|NCT01348100|593052391|FG002|Overall Study|Administrative Problems|0|||
164186858|NCT01348100|593052392|FG003|Overall Study|Administrative Problems|0|||
164186859|NCT01348100|593052393|FG004|Overall Study|Administrative Problems|0|||
164186860|NCT01348100|593052394|FG005|Overall Study|Administrative Problems|1|||
164186861|NCT01348100|593052395|FG006|Overall Study|Administrative Problems|1|||
164186862|NCT03882957|593052396|FG000|Overall Study|Did not complete all three arms|1|||
164186863|NCT03762681|593052401|FG000|Part 1|Withdrawal by Subject|0|||
164186864|NCT03762681|593052402|FG001|Part 1|Withdrawal by Subject|0|||
164186865|NCT03762681|593052403|FG002|Part 1|Withdrawal by Subject|0|||
164186866|NCT03762681|593052404|FG003|Part 1|Withdrawal by Subject|1|||
164186867|NCT03762681|593052405|FG004|Part 1|Withdrawal by Subject|0|||
164186868|NCT03762681|593052406|FG005|Part 1|Withdrawal by Subject|0|||
164186869|NCT03762681|593052407|FG006|Part 1|Withdrawal by Subject|0|||
164186870|NCT03762681|593052408|FG007|Part 1|Withdrawal by Subject|0|||
164186871|NCT03762681|593052401|FG000|Part 2a|Pandemic Travel Restrictions|0|||
164186872|NCT03762681|593052402|FG001|Part 2a|Pandemic Travel Restrictions|0|||
164186873|NCT03762681|593052403|FG002|Part 2a|Pandemic Travel Restrictions|0|||
164186874|NCT03762681|593052404|FG003|Part 2a|Pandemic Travel Restrictions|0|||
164186875|NCT03762681|593052405|FG004|Part 2a|Pandemic Travel Restrictions|0|||
164186876|NCT03762681|593052406|FG005|Part 2a|Pandemic Travel Restrictions|0|||
164186877|NCT03762681|593052407|FG006|Part 2a|Pandemic Travel Restrictions|0|||
164186878|NCT03762681|593052408|FG007|Part 2a|Pandemic Travel Restrictions|1|||
164186879|NCT03148067|593052409|FG000|Overall Study|Lost to Follow-up|3|||
164186880|NCT03148067|593052409|FG000|Overall Study|Death|1|||
164186881|NCT00435188|593052411|FG000|Overall Study|Death|1|||
164186882|NCT00435188|593052412|FG001|Overall Study|Death|6|||
164186883|NCT00435188|593052411|FG000|Overall Study|Withdrawal by Subject|16|||
164186884|NCT00435188|593052412|FG001|Overall Study|Withdrawal by Subject|11|||
164186885|NCT00435188|593052411|FG000|Overall Study|Lost to Follow-up|5|||
164186886|NCT00435188|593052412|FG001|Overall Study|Lost to Follow-up|6|||
164186887|NCT01915771|593052413|FG000|Day 1|Withdrawal by Subject|1|||
164186888|NCT01915771|593052413|FG000|Day 15|Withdrawal by Subject|1|||
164186889|NCT00334295|593052415|FG000|Overall Study|Patients received fewer than 3 injection|5|||
164186890|NCT03755518|593052422|FG000|Overall Study|Lack of Efficacy|10|||
164186891|NCT03755518|593052422|FG000|Overall Study|Adverse Event|7|||
164186892|NCT03755518|593052422|FG000|Overall Study|Study Terminated by Sponsor|5|||
164186893|NCT03755518|593052422|FG000|Overall Study|Death|1|||
164186894|NCT03755518|593052422|FG000|Overall Study|Withdrawal by Subject|3|||
164186895|NCT03755518|593052422|FG000|Overall Study|Progressive Disease|4|||
164186896|NCT03755518|593052422|FG000|Overall Study|Bone Marrow Transplant|4|||
164186897|NCT03755518|593052422|FG000|Overall Study|Physicians Decision|1|||
164186898|NCT03755518|593052422|FG000|Overall Study|Relapse|1|||
164186899|NCT03755518|593052422|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
164186900|NCT03755518|593052422|FG000|Overall Study|Withdrawal by PI|1|||
164186901|NCT01714609|593052423|FG000|Overall Study|Protocol Violation|1|||
164186902|NCT01714609|593052424|FG001|Overall Study|Protocol Violation|0|||
164186903|NCT03403621|593052425|FG000|Overall Study|Withdrawal by Subject|2|||
164186904|NCT03403621|593052426|FG001|Overall Study|Withdrawal by Subject|2|||
164186905|NCT00395642|593052428|FG000|Overall Study|Death|4|||
164186906|NCT00395642|593052428|FG000|Overall Study|Lost to Follow-up|1|||
164186907|NCT00395642|593052428|FG000|Overall Study|Physician Decision|7|||
164186908|NCT00395642|593052428|FG000|Overall Study|Withdrawal by Subject|1|||
164186909|NCT00659776|593052432|FG000|Overall Study|Withdrawal by Subject|12|||
164186910|NCT00659776|593052433|FG001|Overall Study|Withdrawal by Subject|2|||
164186911|NCT00659776|593052434|FG002|Overall Study|Withdrawal by Subject|0|||
164186912|NCT01738191|593052437|FG000|Overall Study|Withdrawal by Subject|4|||
164186913|NCT01738191|593052438|FG001|Overall Study|Withdrawal by Subject|1|||
164186914|NCT02483572|593052439|FG000|Overall Study|Withdrawal by Subject|1|||
164186915|NCT02483572|593052440|FG001|Overall Study|Withdrawal by Subject|0|||
164186916|NCT02483572|593052439|FG000|Overall Study|Lost to Follow-up|1|||
164186917|NCT02483572|593052440|FG001|Overall Study|Lost to Follow-up|0|||
164186918|NCT02483572|593052439|FG000|Overall Study|Physician Decision|0|||
164186919|NCT02483572|593052440|FG001|Overall Study|Physician Decision|1|||
164186920|NCT04811664|593052441|FG000|Overall Study|Lost to Follow-up|78|||
164186921|NCT04811664|593052442|FG001|Overall Study|Lost to Follow-up|125|||
164186922|NCT04811664|593052443|FG002|Overall Study|Lost to Follow-up|46|||
164186923|NCT04811664|593052441|FG000|Overall Study|Withdrawal by Subject|39|||
164186924|NCT04811664|593052442|FG001|Overall Study|Withdrawal by Subject|76|||
164186925|NCT04811664|593052443|FG002|Overall Study|Withdrawal by Subject|12|||
164186926|NCT04811664|593052441|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
164186927|NCT04811664|593052442|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
164186928|NCT04811664|593052443|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
164186929|NCT04811664|593052441|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
164186930|NCT04811664|593052442|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
164186931|NCT04811664|593052443|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
164186932|NCT04811664|593052441|FG000|Overall Study|Protocol Violation|0|||
164186933|NCT04811664|593052442|FG001|Overall Study|Protocol Violation|5|||
164186934|NCT04811664|593052443|FG002|Overall Study|Protocol Violation|11|||
164186935|NCT04811664|593052441|FG000|Overall Study|Study Terminated by Sponsor|4|||
164186936|NCT04811664|593052442|FG001|Overall Study|Study Terminated by Sponsor|3|||
164186937|NCT04811664|593052443|FG002|Overall Study|Study Terminated by Sponsor|34|||
164186938|NCT04811664|593052441|FG000|Overall Study|Early Study Closure|3|||
164186939|NCT04811664|593052442|FG001|Overall Study|Early Study Closure|7|||
164186940|NCT04811664|593052443|FG002|Overall Study|Early Study Closure|79|||
164186941|NCT04811664|593052441|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
164186942|NCT04811664|593052442|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
164186943|NCT04811664|593052443|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
164186944|NCT02717442|593052444|FG000|Overall Study|Study Terminated by Sponsor|31|||
164186945|NCT02717442|593052445|FG001|Overall Study|Study Terminated by Sponsor|29|||
164186946|NCT02717442|593052444|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
164186947|NCT02717442|593052445|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
164186948|NCT02717442|593052444|FG000|Overall Study|Other - Not Specified|2|||
164186949|NCT02717442|593052445|FG001|Overall Study|Other - Not Specified|0|||
164186950|NCT00723697|593052447|FG000|Overall Study|Physician questionnaires not received|2|||
164186951|NCT00723697|593052447|FG000|Overall Study|Missing Informed Consent Form|10|||
164186952|NCT00723697|593052447|FG000|Overall Study|Other exclusion criteria applied|6|||
164186953|NCT03275389|593052448|FG000|Overall Study|Lost to Follow-up|10|||
164186954|NCT03275389|593052449|FG001|Overall Study|Lost to Follow-up|10|||
164186955|NCT03275389|593052450|FG002|Overall Study|Lost to Follow-up|19|||
164186956|NCT03275389|593052451|FG003|Overall Study|Lost to Follow-up|12|||
164186957|NCT03275389|593052452|FG004|Overall Study|Lost to Follow-up|11|||
164186958|NCT03275389|593052453|FG005|Overall Study|Lost to Follow-up|12|||
164186959|NCT03275389|593052454|FG006|Overall Study|Lost to Follow-up|21|||
164186960|NCT03275389|593052455|FG007|Overall Study|Lost to Follow-up|15|||
164186961|NCT03275389|593052456|FG008|Overall Study|Lost to Follow-up|12|||
164186962|NCT03275389|593052457|FG009|Overall Study|Lost to Follow-up|14|||
164186963|NCT03275389|593052448|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
164186964|NCT03275389|593052449|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
164186965|NCT03275389|593052450|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
164186966|NCT03275389|593052451|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
164186967|NCT03275389|593052452|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
164186968|NCT03275389|593052453|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
164186969|NCT03275389|593052454|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
164186970|NCT03275389|593052455|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
164186971|NCT03275389|593052456|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
164186972|NCT03275389|593052457|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
164186973|NCT03275389|593052448|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
164186974|NCT03275389|593052449|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
164186975|NCT03275389|593052450|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
164186976|NCT03275389|593052451|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
164186977|NCT03275389|593052452|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
164186978|NCT03275389|593052453|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
164186979|NCT03275389|593052454|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
164186980|NCT03275389|593052455|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
164186981|NCT03275389|593052456|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
164186982|NCT03275389|593052457|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
164186983|NCT03275389|593052448|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164186984|NCT03275389|593052449|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
164186985|NCT03275389|593052450|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164186986|NCT03275389|593052451|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
164186987|NCT03275389|593052452|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164186988|NCT03275389|593052453|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164186989|NCT03275389|593052454|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164186990|NCT03275389|593052455|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164186991|NCT03275389|593052456|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164186992|NCT03275389|593052457|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164186993|NCT03275389|593052448|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
164186994|NCT03275389|593052449|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
164186995|NCT03275389|593052450|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
164186996|NCT03275389|593052451|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
164186997|NCT03275389|593052452|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
164186998|NCT03275389|593052453|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
164186999|NCT03275389|593052454|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
164187000|NCT03275389|593052455|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
164187001|NCT03275389|593052456|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
164187002|NCT03275389|593052457|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
164187003|NCT03275389|593052448|FG000|Overall Study|Other|0|||
164187004|NCT03275389|593052449|FG001|Overall Study|Other|4|||
164187005|NCT03275389|593052450|FG002|Overall Study|Other|3|||
164187006|NCT03275389|593052451|FG003|Overall Study|Other|2|||
164187007|NCT03275389|593052452|FG004|Overall Study|Other|2|||
164187008|NCT03275389|593052453|FG005|Overall Study|Other|2|||
164187009|NCT03275389|593052454|FG006|Overall Study|Other|0|||
164187010|NCT03275389|593052455|FG007|Overall Study|Other|0|||
164187011|NCT03275389|593052456|FG008|Overall Study|Other|1|||
164187012|NCT03275389|593052457|FG009|Overall Study|Other|0|||
164187013|NCT00978341|593052462|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
164187014|NCT00978341|593052463|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
164187015|NCT03035916|593052464|FG000|Overall Study|Puncture failed|0|||
164187016|NCT03035916|593052465|FG001|Overall Study|Puncture failed|2|||
164187017|NCT03035916|593052466|FG002|Overall Study|Puncture failed|0|||
164187018|NCT03885999|593052467|FG000|Overall Study|Adverse Event|1|||
164187019|NCT01451554|593052468|FG000|Overall Study|Withdrawal by Subject|14|||
164187020|NCT01451554|593052469|FG001|Overall Study|Withdrawal by Subject|9|||
164187021|NCT02452554|593052470|FG000|Overall Study|Death|2|||
164187022|NCT02452554|593052471|FG001|Overall Study|Death|1|||
164187023|NCT02452554|593052472|FG002|Overall Study|Death|0|||
164187024|NCT02452554|593052473|FG003|Overall Study|Death|0|||
164187025|NCT02452554|593052474|FG004|Overall Study|Death|0|||
164187026|NCT02452554|593052475|FG005|Overall Study|Death|0|||
164187027|NCT02452554|593052470|FG000|Overall Study|Lack of Efficacy|13|||
164187028|NCT02452554|593052471|FG001|Overall Study|Lack of Efficacy|14|||
164187029|NCT02452554|593052472|FG002|Overall Study|Lack of Efficacy|9|||
164187030|NCT02452554|593052473|FG003|Overall Study|Lack of Efficacy|1|||
164187031|NCT02452554|593052474|FG004|Overall Study|Lack of Efficacy|5|||
164187032|NCT02452554|593052475|FG005|Overall Study|Lack of Efficacy|8|||
164187033|NCT02452554|593052470|FG000|Overall Study|Physician Decision|0|||
164187034|NCT02452554|593052471|FG001|Overall Study|Physician Decision|1|||
164187035|NCT02452554|593052472|FG002|Overall Study|Physician Decision|0|||
164187036|NCT02452554|593052473|FG003|Overall Study|Physician Decision|0|||
164187037|NCT02452554|593052474|FG004|Overall Study|Physician Decision|0|||
164187038|NCT02452554|593052475|FG005|Overall Study|Physician Decision|0|||
164187039|NCT02452554|593052470|FG000|Overall Study|Withdrawal by Subject|1|||
164187040|NCT02452554|593052471|FG001|Overall Study|Withdrawal by Subject|0|||
164187041|NCT02452554|593052472|FG002|Overall Study|Withdrawal by Subject|2|||
164187042|NCT02452554|593052473|FG003|Overall Study|Withdrawal by Subject|0|||
164187043|NCT02452554|593052474|FG004|Overall Study|Withdrawal by Subject|0|||
164187044|NCT02452554|593052475|FG005|Overall Study|Withdrawal by Subject|1|||
164187045|NCT02452554|593052470|FG000|Overall Study|Ineligible|0|||
164187046|NCT02452554|593052471|FG001|Overall Study|Ineligible|1|||
164187047|NCT02452554|593052472|FG002|Overall Study|Ineligible|0|||
164187048|NCT02452554|593052473|FG003|Overall Study|Ineligible|0|||
164187049|NCT02452554|593052474|FG004|Overall Study|Ineligible|0|||
164187050|NCT02452554|593052475|FG005|Overall Study|Ineligible|0|||
164187051|NCT02452554|593052470|FG000|Overall Study|Never Received Treatment|1|||
164187052|NCT02452554|593052471|FG001|Overall Study|Never Received Treatment|0|||
164187053|NCT02452554|593052472|FG002|Overall Study|Never Received Treatment|0|||
164187054|NCT02452554|593052473|FG003|Overall Study|Never Received Treatment|0|||
164187055|NCT02452554|593052474|FG004|Overall Study|Never Received Treatment|0|||
164187056|NCT02452554|593052475|FG005|Overall Study|Never Received Treatment|0|||
164187057|NCT04378569|593054361|FG000|Overall Study|Adverse Event|0|||
164187058|NCT04378569|593054362|FG001|Overall Study|Adverse Event|0|||
164187059|NCT04378569|593054363|FG002|Overall Study|Adverse Event|2|||
164187060|NCT04378569|593054364|FG003|Overall Study|Adverse Event|0|||
164187061|NCT04378569|593054365|FG004|Overall Study|Adverse Event|3|||
164187062|NCT04378569|593054366|FG005|Overall Study|Adverse Event|3|||
164187063|NCT04378569|593054361|FG000|Overall Study|Lost to Follow-up|0|||
164187064|NCT04378569|593054362|FG001|Overall Study|Lost to Follow-up|3|||
164187065|NCT04378569|593054363|FG002|Overall Study|Lost to Follow-up|1|||
164187066|NCT04378569|593054364|FG003|Overall Study|Lost to Follow-up|0|||
164187067|NCT04378569|593054365|FG004|Overall Study|Lost to Follow-up|1|||
164187068|NCT04378569|593054366|FG005|Overall Study|Lost to Follow-up|1|||
164187069|NCT04378569|593054361|FG000|Overall Study|Protocol Violation|0|||
164187070|NCT04378569|593054362|FG001|Overall Study|Protocol Violation|0|||
164187071|NCT04378569|593054363|FG002|Overall Study|Protocol Violation|0|||
164187072|NCT04378569|593054364|FG003|Overall Study|Protocol Violation|0|||
164187073|NCT04378569|593054365|FG004|Overall Study|Protocol Violation|0|||
164187074|NCT04378569|593054366|FG005|Overall Study|Protocol Violation|1|||
164187075|NCT04378569|593054361|FG000|Overall Study|Withdrawal by Subject|0|||
164187076|NCT04378569|593054362|FG001|Overall Study|Withdrawal by Subject|6|||
164187077|NCT04378569|593054363|FG002|Overall Study|Withdrawal by Subject|7|||
164187078|NCT04378569|593054364|FG003|Overall Study|Withdrawal by Subject|4|||
164187079|NCT04378569|593054365|FG004|Overall Study|Withdrawal by Subject|5|||
164187080|NCT04378569|593054366|FG005|Overall Study|Withdrawal by Subject|4|||
164187081|NCT04378569|593054361|FG000|Overall Study|Lack of response|0|||
164187082|NCT04378569|593054362|FG001|Overall Study|Lack of response|0|||
164187083|NCT04378569|593054363|FG002|Overall Study|Lack of response|1|||
164187084|NCT04378569|593054364|FG003|Overall Study|Lack of response|0|||
164187085|NCT04378569|593054365|FG004|Overall Study|Lack of response|1|||
164187086|NCT04378569|593054366|FG005|Overall Study|Lack of response|1|||
164187087|NCT03638466|593054370|FG000|Overall Study|Early Termination|0|||
164187088|NCT03638466|593054371|FG001|Overall Study|Early Termination|1|||
164187089|NCT02576977|593054372|FG000|Overall Study|Adverse Event|13|||
164187090|NCT02576977|593054373|FG001|Overall Study|Adverse Event|2|||
164187091|NCT02576977|593054372|FG000|Overall Study|Death|73|||
164187092|NCT02576977|593054373|FG001|Overall Study|Death|60|||
164187093|NCT02576977|593054372|FG000|Overall Study|Screen failure|1|||
164187094|NCT02576977|593054373|FG001|Overall Study|Screen failure|0|||
164187095|NCT02576977|593054372|FG000|Overall Study|Study Terminated at Selected Sites|27|||
164187096|NCT02576977|593054373|FG001|Overall Study|Study Terminated at Selected Sites|50|||
164187097|NCT02576977|593054372|FG000|Overall Study|Withdrawal by Subject|11|||
164187098|NCT02576977|593054373|FG001|Overall Study|Withdrawal by Subject|11|||
164187099|NCT02576977|593054372|FG000|Overall Study|Final Disposition Unknown|0|||
164187100|NCT02576977|593054373|FG001|Overall Study|Final Disposition Unknown|1|||
164187101|NCT02576977|593054372|FG000|Overall Study|Lost to Follow-up|1|||
164187102|NCT02576977|593054373|FG001|Overall Study|Lost to Follow-up|0|||
164187103|NCT02576977|593054372|FG000|Overall Study|Progressive Disease|0|||
164187104|NCT02576977|593054373|FG001|Overall Study|Progressive Disease|1|||
164187105|NCT04530838|593054374|FG000|Overall Study|Other|2|||
164187106|NCT04530838|593054375|FG001|Overall Study|Other|1|||
164187107|NCT04530838|593054376|FG002|Overall Study|Other|0|||
164187108|NCT04530838|593054374|FG000|Overall Study|Physician Decision|0|||
164187109|NCT04530838|593054375|FG001|Overall Study|Physician Decision|0|||
164187110|NCT04530838|593054376|FG002|Overall Study|Physician Decision|1|||
164187111|NCT04530838|593054374|FG000|Overall Study|Death|0|||
164187112|NCT04530838|593054375|FG001|Overall Study|Death|0|||
164187113|NCT04530838|593054376|FG002|Overall Study|Death|1|||
164187114|NCT04530838|593054374|FG000|Overall Study|Adverse Event|0|||
164187115|NCT04530838|593054375|FG001|Overall Study|Adverse Event|1|||
164187116|NCT04530838|593054376|FG002|Overall Study|Adverse Event|0|||
164187117|NCT04530838|593054374|FG000|Overall Study|No longer meets eligibility criteria|1|||
164187118|NCT04530838|593054375|FG001|Overall Study|No longer meets eligibility criteria|0|||
164187119|NCT04530838|593054376|FG002|Overall Study|No longer meets eligibility criteria|2|||
164187120|NCT04530838|593054374|FG000|Overall Study|Withdrawal by parent/guardian|5|||
164187121|NCT04530838|593054375|FG001|Overall Study|Withdrawal by parent/guardian|2|||
164187122|NCT04530838|593054376|FG002|Overall Study|Withdrawal by parent/guardian|2|||
164187123|NCT02362425|593054381|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
164187124|NCT02362425|593054382|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
164187125|NCT02362425|593054383|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
164187126|NCT02362425|593054384|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
164187127|NCT02362425|593054381|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
164187128|NCT02362425|593054382|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
164187129|NCT02362425|593054383|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
164187130|NCT02362425|593054384|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
164187131|NCT02362425|593054381|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
164187132|NCT02362425|593054382|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
164187133|NCT02362425|593054383|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
164187134|NCT02362425|593054384|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
164187135|NCT02362425|593054381|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
164187136|NCT02362425|593054382|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
164187137|NCT02362425|593054383|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
164187138|NCT02362425|593054384|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
164187139|NCT02362425|593054381|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
164187140|NCT02362425|593054382|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
164187141|NCT02362425|593054383|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
164187142|NCT02362425|593054384|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
164187143|NCT02362425|593054381|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
164187144|NCT02362425|593054382|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
164187145|NCT02362425|593054383|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
164187146|NCT02362425|593054384|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
164187147|NCT02362425|593054381|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
164187148|NCT02362425|593054382|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
164187149|NCT02362425|593054383|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
164187150|NCT02362425|593054384|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
164187151|NCT02362425|593054381|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
164187152|NCT02362425|593054382|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
164187153|NCT02362425|593054383|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
164187154|NCT02362425|593054384|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
164187155|NCT02155309|593054386|FG000|Overall Study|Protocol Violation|0|||
164187156|NCT02155309|593054387|FG001|Overall Study|Protocol Violation|0|||
164187157|NCT02155309|593054388|FG002|Overall Study|Protocol Violation|1|||
164187158|NCT02688764|593054392|FG000|Overall Study|Adverse Event|3|||
164187159|NCT02688764|593054393|FG001|Overall Study|Adverse Event|3|||
164187160|NCT02688764|593054392|FG000|Overall Study|AE/Kidney transplant|1|||
164187161|NCT02688764|593054393|FG001|Overall Study|AE/Kidney transplant|0|||
164187162|NCT02688764|593054392|FG000|Overall Study|AE/Lack of efficacy|1|||
164187163|NCT02688764|593054393|FG001|Overall Study|AE/Lack of efficacy|0|||
164187164|NCT02688764|593054392|FG000|Overall Study|AE/Non-compl.|1|||
164187165|NCT02688764|593054393|FG001|Overall Study|AE/Non-compl.|0|||
164187166|NCT02688764|593054392|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
164187167|NCT02688764|593054393|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
164187168|NCT02688764|593054392|FG000|Overall Study|AE/Other|0|||
164187169|NCT02688764|593054393|FG001|Overall Study|AE/Other|1|||
164187170|NCT02688764|593054392|FG000|Overall Study|AE/Physician decision|1|||
164187171|NCT02688764|593054393|FG001|Overall Study|AE/Physician decision|0|||
164187172|NCT02688764|593054392|FG000|Overall Study|AE/Withd. parent|3|||
164187173|NCT02688764|593054393|FG001|Overall Study|AE/Withd. parent|0|||
164187174|NCT02688764|593054392|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
164187175|NCT02688764|593054393|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
164187176|NCT02688764|593054392|FG000|Overall Study|AE/Withd. subject|1|||
164187177|NCT02688764|593054393|FG001|Overall Study|AE/Withd. subject|0|||
164187178|NCT02688764|593054392|FG000|Overall Study|Kidney transplant|10|||
164187179|NCT02688764|593054393|FG001|Overall Study|Kidney transplant|4|||
164187180|NCT02688764|593054392|FG000|Overall Study|Lack of Efficacy|3|||
164187181|NCT02688764|593054393|FG001|Overall Study|Lack of Efficacy|2|||
164187182|NCT02688764|593054392|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
164187183|NCT02688764|593054393|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
164187184|NCT02688764|593054392|FG000|Overall Study|Non-compliance with study drug|4|||
164187185|NCT02688764|593054393|FG001|Overall Study|Non-compliance with study drug|0|||
164187186|NCT02688764|593054392|FG000|Overall Study|Non-compl./Physician decision|2|||
164187187|NCT02688764|593054393|FG001|Overall Study|Non-compl./Physician decision|0|||
164187188|NCT02688764|593054392|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
164187189|NCT02688764|593054393|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
164187190|NCT02688764|593054392|FG000|Overall Study|Non-compl./Withd. subject|0|||
164187191|NCT02688764|593054393|FG001|Overall Study|Non-compl./Withd. subject|2|||
164187192|NCT02688764|593054392|FG000|Overall Study|Phosphorus level outside safe range|0|||
164187193|NCT02688764|593054393|FG001|Overall Study|Phosphorus level outside safe range|1|||
164187194|NCT02688764|593054392|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
164187195|NCT02688764|593054393|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
164187196|NCT02688764|593054392|FG000|Overall Study|Study drug taste/Withd. parent|1|||
164187197|NCT02688764|593054393|FG001|Overall Study|Study drug taste/Withd. parent|0|||
164187198|NCT02688764|593054392|FG000|Overall Study|Subject moving out|2|||
164187199|NCT02688764|593054393|FG001|Overall Study|Subject moving out|0|||
164187200|NCT02688764|593054392|FG000|Overall Study|Subject taken off dialysis|1|||
164187201|NCT02688764|593054393|FG001|Overall Study|Subject taken off dialysis|0|||
164187202|NCT02688764|593054392|FG000|Overall Study|Withdrawal by parent|3|||
164187203|NCT02688764|593054393|FG001|Overall Study|Withdrawal by parent|0|||
164187204|NCT03026283|593054394|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
164187205|NCT03026283|593054395|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
164187206|NCT03026283|593054396|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
164187207|NCT03026283|593054397|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
164187208|NCT03026283|593054398|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
164187209|NCT03026283|593054399|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
164187210|NCT03026283|593054400|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
164187211|NCT03026283|593054401|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
164187212|NCT03026283|593054394|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
164187213|NCT03026283|593054395|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
164187214|NCT03026283|593054396|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
164187215|NCT03026283|593054397|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
164187216|NCT03026283|593054398|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
164187217|NCT03026283|593054399|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
164187218|NCT03026283|593054400|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
164187219|NCT03026283|593054401|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
164187220|NCT03026283|593054394|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
164187221|NCT03026283|593054395|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
164187222|NCT03026283|593054396|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
164187223|NCT03026283|593054397|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
164187224|NCT03026283|593054398|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
164187225|NCT03026283|593054399|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
164187226|NCT03026283|593054400|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
164187227|NCT03026283|593054401|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
164187228|NCT03026283|593054394|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
164187229|NCT03026283|593054395|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
164187230|NCT03026283|593054396|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
164187231|NCT03026283|593054397|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
164187232|NCT03026283|593054398|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
164187233|NCT03026283|593054399|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
164187234|NCT03026283|593054400|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
164187235|NCT03026283|593054401|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
164187236|NCT03026283|593054394|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
164187237|NCT03026283|593054395|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
164187238|NCT03026283|593054396|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
164187239|NCT03026283|593054397|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
164187240|NCT03026283|593054398|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
164187241|NCT03026283|593054399|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
164187242|NCT03026283|593054400|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
164187243|NCT03026283|593054401|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
164187244|NCT03026283|593054394|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
164187245|NCT03026283|593054395|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
164187246|NCT03026283|593054396|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
164187247|NCT03026283|593054397|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
164187248|NCT03026283|593054398|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
164187249|NCT03026283|593054399|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
164187250|NCT03026283|593054400|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
164187251|NCT03026283|593054401|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
164187252|NCT03026283|593054394|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
164187253|NCT03026283|593054395|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
164187254|NCT03026283|593054396|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
164187255|NCT03026283|593054397|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
164187256|NCT03026283|593054398|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
164187257|NCT03026283|593054399|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
164187258|NCT03026283|593054400|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
164187259|NCT03026283|593054401|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
164187260|NCT03026283|593054394|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
164187261|NCT03026283|593054395|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
164187262|NCT03026283|593054396|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
164187263|NCT03026283|593054397|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
164187264|NCT03026283|593054398|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
164187265|NCT03026283|593054399|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
164187266|NCT03026283|593054400|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
164187267|NCT03026283|593054401|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
164187268|NCT03026283|593054394|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
164187269|NCT03026283|593054395|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
164187270|NCT03026283|593054396|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
164187271|NCT03026283|593054397|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
164187272|NCT03026283|593054398|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
164187273|NCT03026283|593054399|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
164187274|NCT03026283|593054400|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
164187275|NCT03026283|593054401|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
164187276|NCT02501161|593054402|FG000|Overall Study|Adverse Event|2|||
164187277|NCT02501161|593054403|FG001|Overall Study|Adverse Event|6|||
164187278|NCT02501161|593054402|FG000|Overall Study|Lost to Follow-up|7|||
164187279|NCT02501161|593054403|FG001|Overall Study|Lost to Follow-up|4|||
164187280|NCT02501161|593054402|FG000|Overall Study|Withdrawal by Subject|10|||
164187281|NCT02501161|593054403|FG001|Overall Study|Withdrawal by Subject|15|||
164187282|NCT02501161|593054402|FG000|Overall Study|Other|3|||
164187283|NCT02501161|593054403|FG001|Overall Study|Other|0|||
164187284|NCT00824655|593054404|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
164187285|NCT00824655|593054405|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
164187286|NCT00824655|593054404|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
164187287|NCT00824655|593054405|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
164187288|NCT04336475|593054406|FG000|Overall Study|pain|1|||
164187289|NCT04336475|593054407|FG001|Overall Study|pain|0|||
164187290|NCT04336475|593054406|FG000|Overall Study|upper respiratory infection|1|||
164187291|NCT04336475|593054407|FG001|Overall Study|upper respiratory infection|0|||
164187292|NCT04336475|593054406|FG000|Overall Study|Lost to Follow-up|0|||
164187293|NCT04336475|593054407|FG001|Overall Study|Lost to Follow-up|2|||
164187294|NCT02906579|593054422|FG000|Overall Study|Adverse Event|1|||
164187295|NCT02906579|593054422|FG000|Overall Study|Physician Decision|1|||
164187296|NCT02030119|593054423|FG000|Overall Study|Withdrawal by Subject|3|||
164187297|NCT02030119|593054424|FG001|Overall Study|Withdrawal by Subject|1|||
164187298|NCT02030119|593054425|FG002|Overall Study|Withdrawal by Subject|5|||
164187299|NCT02030119|593054426|FG003|Overall Study|Withdrawal by Subject|3|||
164187300|NCT02030119|593054423|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
164187301|NCT02030119|593054424|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
164187302|NCT02030119|593054425|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
164187303|NCT02030119|593054426|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
164187304|NCT00759655|593054427|FG000|Overall Study|Termination of the study by sponsor|1|||
164187305|NCT00905567|593054441|FG000|Washout|Withdrawal by Subject|0|||
164187306|NCT00905567|593054442|FG001|Washout|Withdrawal by Subject|1|||
164187307|NCT00621257|593054450|FG000|Overall Study|Lost to Follow-up|4|||
164187308|NCT00621257|593054451|FG001|Overall Study|Lost to Follow-up|0|||
164187309|NCT00621257|593054452|FG002|Overall Study|Lost to Follow-up|2|||
164187310|NCT00621257|593054453|FG003|Overall Study|Lost to Follow-up|4|||
164187311|NCT00621257|593054454|FG004|Overall Study|Lost to Follow-up|7|||
164187312|NCT00621257|593054450|FG000|Overall Study|Adverse Event|0|||
164187313|NCT00621257|593054451|FG001|Overall Study|Adverse Event|1|||
164187314|NCT00621257|593054452|FG002|Overall Study|Adverse Event|1|||
164187315|NCT00621257|593054453|FG003|Overall Study|Adverse Event|0|||
164187316|NCT00621257|593054454|FG004|Overall Study|Adverse Event|0|||
164187317|NCT00621257|593054450|FG000|Overall Study|Physician Decision|0|||
164187318|NCT00621257|593054451|FG001|Overall Study|Physician Decision|2|||
164187319|NCT00621257|593054452|FG002|Overall Study|Physician Decision|0|||
164187320|NCT00621257|593054453|FG003|Overall Study|Physician Decision|1|||
164187321|NCT00621257|593054454|FG004|Overall Study|Physician Decision|1|||
164187322|NCT00621257|593054450|FG000|Overall Study|Withdrawal by Subject|0|||
164187323|NCT00621257|593054451|FG001|Overall Study|Withdrawal by Subject|0|||
164187324|NCT00621257|593054452|FG002|Overall Study|Withdrawal by Subject|0|||
164187325|NCT00621257|593054453|FG003|Overall Study|Withdrawal by Subject|1|||
164187326|NCT00621257|593054454|FG004|Overall Study|Withdrawal by Subject|1|||
164187327|NCT00184002|593054455|FG000|Overall Study|Adverse Event|9|||
164187328|NCT00184002|593054455|FG000|Overall Study|Death|3|||
164187329|NCT00184002|593054455|FG000|Overall Study|Physician Decision|1|||
164187330|NCT00184002|593054455|FG000|Overall Study|Withdrawal by Subject|4|||
164187331|NCT02075008|593054465|FG000|Overall Study|Technical problems|1|||
164187332|NCT02075008|593054465|FG000|Overall Study|Pregnancy|1|||
164187333|NCT02075008|593054465|FG000|Overall Study|Physician Decision|1|||
164187334|NCT02075008|593054465|FG000|Overall Study|Lost to Follow-up|1|||
164187335|NCT02075008|593054465|FG000|Overall Study|Lack of Efficacy|1|||
164187336|NCT02075008|593054465|FG000|Overall Study|Death|1|||
164187337|NCT02075008|593054465|FG000|Overall Study|Adverse Event|5|||
164187338|NCT02075008|593054465|FG000|Overall Study|Withdrawal by Subject|6|||
164187339|NCT02075008|593054465|FG000|Overall Study|Study terminated by Sponsor|159|||
164187340|NCT02821416|593054466|FG000|Overall Study|Adverse Event|0|||
164187341|NCT02821416|593054467|FG001|Overall Study|Adverse Event|1|||
164187342|NCT02821416|593054466|FG000|Overall Study|Withdrawal by Subject|2|||
164187343|NCT02821416|593054467|FG001|Overall Study|Withdrawal by Subject|0|||
164187344|NCT02821416|593054466|FG000|Overall Study|Lost to Follow-up|1|||
164187345|NCT02821416|593054467|FG001|Overall Study|Lost to Follow-up|0|||
164187346|NCT01763203|593054470|FG000|Overall Study|Death|4|||
164187347|NCT01763203|593054471|FG001|Overall Study|Death|7|||
164187348|NCT01763203|593054470|FG000|Overall Study|Lost to Follow-up|12|||
164187349|NCT01763203|593054471|FG001|Overall Study|Lost to Follow-up|12|||
164187350|NCT01763203|593054470|FG000|Overall Study|Withdrawal by Subject|8|||
164187351|NCT01763203|593054471|FG001|Overall Study|Withdrawal by Subject|12|||
164187352|NCT01763203|593054470|FG000|Overall Study|Moved out of study region|7|||
164187353|NCT01763203|593054471|FG001|Overall Study|Moved out of study region|10|||
164187354|NCT01763203|593054470|FG000|Overall Study|Physician Decision|2|||
164187355|NCT01763203|593054471|FG001|Overall Study|Physician Decision|1|||
164187356|NCT02756819|593054472|FG000|Overall Study|Lost for observation|23|||
164187357|NCT02756819|593054472|FG000|Overall Study|Patient's unwillingness|16|||
164187358|NCT02756819|593054472|FG000|Overall Study|Insufficient efficacy|2|||
164187359|NCT02756819|593054472|FG000|Overall Study|Adverse Event|2|||
164187360|NCT02756819|593054472|FG000|Overall Study|Reason not Specified|9|||
164187361|NCT01639703|593054475|FG000|Overall Study|Withdrawal by Subject|5|||
164187362|NCT01639703|593054475|FG000|Overall Study|Other reason|7|||
164187363|NCT00878800|593054477|FG000|Overall Study|Adverse Event|0|||
164187364|NCT00878800|593054478|FG001|Overall Study|Adverse Event|0|||
164187365|NCT00878800|593054479|FG002|Overall Study|Adverse Event|2|||
164187366|NCT00878800|593054480|FG003|Overall Study|Adverse Event|0|||
164187367|NCT00878800|593054481|FG004|Overall Study|Adverse Event|1|||
164187368|NCT00878800|593054477|FG000|Overall Study|Progressive disease|1|||
164187369|NCT00878800|593054478|FG001|Overall Study|Progressive disease|5|||
164187370|NCT00878800|593054479|FG002|Overall Study|Progressive disease|6|||
164187371|NCT00878800|593054480|FG003|Overall Study|Progressive disease|5|||
164187372|NCT00878800|593054481|FG004|Overall Study|Progressive disease|13|||
164187373|NCT00878800|593054477|FG000|Overall Study|Withdrew consent|1|||
164187374|NCT00878800|593054478|FG001|Overall Study|Withdrew consent|1|||
164187375|NCT00878800|593054479|FG002|Overall Study|Withdrew consent|0|||
164187376|NCT00878800|593054480|FG003|Overall Study|Withdrew consent|1|||
164187377|NCT00878800|593054481|FG004|Overall Study|Withdrew consent|1|||
164187378|NCT00878800|593054477|FG000|Overall Study|Death|0|||
164187379|NCT00878800|593054478|FG001|Overall Study|Death|0|||
164187380|NCT00878800|593054479|FG002|Overall Study|Death|1|||
164187381|NCT00878800|593054480|FG003|Overall Study|Death|0|||
164187382|NCT00878800|593054481|FG004|Overall Study|Death|0|||
164187383|NCT00878800|593054477|FG000|Overall Study|Other|1|||
164187384|NCT00878800|593054478|FG001|Overall Study|Other|1|||
164187385|NCT00878800|593054479|FG002|Overall Study|Other|0|||
164187386|NCT00878800|593054480|FG003|Overall Study|Other|0|||
164187387|NCT00878800|593054481|FG004|Overall Study|Other|1|||
164187388|NCT02457195|593054487|FG000|Overall Study|Adverse Event|3|||
164187389|NCT02457195|593054487|FG000|Overall Study|Protocol Violation|2|||
164187390|NCT02457195|593054487|FG000|Overall Study|Withdrawal by Subject|4|||
164187391|NCT05980013|593054489|FG000|Overall Study|Withdrawal by Subject|0|||
164187392|NCT05980013|593054490|FG001|Overall Study|Withdrawal by Subject|1|||
164187393|NCT05980013|593054489|FG000|Overall Study|Device Error|0|||
164187394|NCT05980013|593054490|FG001|Overall Study|Device Error|1|||
164187395|NCT03739710|593054491|FG000|Overall Study|Screen Failed|81|||
164187396|NCT04892446|593054494|FG000|Overall Study|Death|4|||
164187397|NCT04892446|593054495|FG001|Overall Study|Death|4|||
164187398|NCT04892446|593054496|FG002|Overall Study|Death|0|||
164187399|NCT04892446|593054494|FG000|Overall Study|Withdrew consent|3|||
164187400|NCT04892446|593054495|FG001|Overall Study|Withdrew consent|0|||
164187401|NCT04892446|593054496|FG002|Overall Study|Withdrew consent|1|||
164187402|NCT04892446|593054494|FG000|Overall Study|Investigator's discretion|1|||
164187403|NCT04892446|593054495|FG001|Overall Study|Investigator's discretion|1|||
164187404|NCT04892446|593054496|FG002|Overall Study|Investigator's discretion|0|||
164187405|NCT04892446|593054494|FG000|Overall Study|Study terminated by sponsor|0|||
164187406|NCT04892446|593054495|FG001|Overall Study|Study terminated by sponsor|0|||
164187407|NCT04892446|593054496|FG002|Overall Study|Study terminated by sponsor|2|||
164187408|NCT02328937|593054499|FG000|Period 1|Lost to Follow-up|0|||
164187409|NCT02328937|593054500|FG001|Period 1|Lost to Follow-up|0|||
164187410|NCT02328937|593054501|FG002|Period 1|Lost to Follow-up|0|||
164187411|NCT02328937|593054502|FG003|Period 1|Lost to Follow-up|1|||
164187412|NCT02328937|593054503|FG004|Period 1|Lost to Follow-up|0|||
164187413|NCT02328937|593054504|FG005|Period 1|Lost to Follow-up|0|||
164187414|NCT02328937|593054499|FG000|Period 2|Adverse Event|0|||
164187415|NCT02328937|593054500|FG001|Period 2|Adverse Event|0|||
164187416|NCT02328937|593054501|FG002|Period 2|Adverse Event|1|||
164187417|NCT02328937|593054502|FG003|Period 2|Adverse Event|0|||
164187418|NCT02328937|593054503|FG004|Period 2|Adverse Event|0|||
164187419|NCT02328937|593054504|FG005|Period 2|Adverse Event|0|||
164187420|NCT00435461|593054511|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
164187421|NCT00435461|593054512|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
164187422|NCT00435461|593054513|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
164187423|NCT00435461|593054511|FG000|Overall Study|Protocol Violation|6|||
164187424|NCT00435461|593054512|FG001|Overall Study|Protocol Violation|9|||
164187425|NCT00435461|593054513|FG002|Overall Study|Protocol Violation|10|||
164187426|NCT00435461|593054511|FG000|Overall Study|Participant randomized(inadequate score)|1|||
164187427|NCT00435461|593054512|FG001|Overall Study|Participant randomized(inadequate score)|0|||
164187428|NCT00435461|593054513|FG002|Overall Study|Participant randomized(inadequate score)|0|||
164187429|NCT00435461|593054511|FG000|Overall Study|Compliance less than 80 percent|1|||
164187430|NCT00435461|593054512|FG001|Overall Study|Compliance less than 80 percent|0|||
164187431|NCT00435461|593054513|FG002|Overall Study|Compliance less than 80 percent|0|||
164187432|NCT00435461|593054511|FG000|Overall Study|In error, two study medications switched|1|||
164187433|NCT00435461|593054512|FG001|Overall Study|In error, two study medications switched|0|||
164187434|NCT00435461|593054513|FG002|Overall Study|In error, two study medications switched|0|||
164187435|NCT00435461|593054511|FG000|Overall Study|Lack of Efficacy|2|||
164187436|NCT00435461|593054512|FG001|Overall Study|Lack of Efficacy|1|||
164187437|NCT00435461|593054513|FG002|Overall Study|Lack of Efficacy|0|||
164187438|NCT00435461|593054511|FG000|Overall Study|Withdrawal by Subject|1|||
164187439|NCT00435461|593054512|FG001|Overall Study|Withdrawal by Subject|0|||
164187440|NCT00435461|593054513|FG002|Overall Study|Withdrawal by Subject|2|||
164187441|NCT00435461|593054511|FG000|Overall Study|Randomized in error|1|||
164187442|NCT00435461|593054512|FG001|Overall Study|Randomized in error|0|||
164187443|NCT00435461|593054513|FG002|Overall Study|Randomized in error|0|||
164187444|NCT00435461|593054511|FG000|Overall Study|Participant could not tolerate symptoms|0|||
164187445|NCT00435461|593054512|FG001|Overall Study|Participant could not tolerate symptoms|0|||
164187446|NCT00435461|593054513|FG002|Overall Study|Participant could not tolerate symptoms|1|||
164187447|NCT00435461|593054511|FG000|Overall Study|Participant could not swallow capsule|0|||
164187448|NCT00435461|593054512|FG001|Overall Study|Participant could not swallow capsule|0|||
164187449|NCT00435461|593054513|FG002|Overall Study|Participant could not swallow capsule|1|||
164187450|NCT00435461|593054511|FG000|Overall Study|Pregnancy|2|||
164187451|NCT00435461|593054512|FG001|Overall Study|Pregnancy|0|||
164187452|NCT00435461|593054513|FG002|Overall Study|Pregnancy|0|||
164187453|NCT00435461|593054511|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
164187454|NCT00435461|593054512|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
164187455|NCT00435461|593054513|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
164187456|NCT00435461|593054511|FG000|Overall Study|Participant ended study one day early|1|||
164187457|NCT00435461|593054512|FG001|Overall Study|Participant ended study one day early|0|||
164187458|NCT00435461|593054513|FG002|Overall Study|Participant ended study one day early|0|||
164187459|NCT00435461|593054511|FG000|Overall Study|Noncompliance with study requirements|1|||
164187460|NCT00435461|593054512|FG001|Overall Study|Noncompliance with study requirements|1|||
164187461|NCT00435461|593054513|FG002|Overall Study|Noncompliance with study requirements|1|||
164187462|NCT00435461|593054511|FG000|Overall Study|Adverse Event|1|||
164187463|NCT00435461|593054512|FG001|Overall Study|Adverse Event|2|||
164187464|NCT00435461|593054513|FG002|Overall Study|Adverse Event|6|||
164187465|NCT00435461|593054511|FG000|Overall Study|Non-Compliance of diary|2|||
164187466|NCT00435461|593054512|FG001|Overall Study|Non-Compliance of diary|0|||
164187467|NCT00435461|593054513|FG002|Overall Study|Non-Compliance of diary|1|||
164187468|NCT00435461|593054511|FG000|Overall Study|Lost to Follow-up|1|||
164187469|NCT00435461|593054512|FG001|Overall Study|Lost to Follow-up|1|||
164187470|NCT00435461|593054513|FG002|Overall Study|Lost to Follow-up|2|||
164187471|NCT04676724|593054516|FG000|Overall Study|Adverse Event|2|||
164187472|NCT04676724|593054517|FG001|Overall Study|Adverse Event|0|||
164187473|NCT04676724|593054516|FG000|Overall Study|Lost to Follow-up|1|||
164187474|NCT04676724|593054517|FG001|Overall Study|Lost to Follow-up|0|||
164187475|NCT04676724|593054516|FG000|Overall Study|Physician Decision|0|||
164187476|NCT04676724|593054517|FG001|Overall Study|Physician Decision|1|||
164187477|NCT04676724|593054516|FG000|Overall Study|Withdrawal by Subject|3|||
164187478|NCT04676724|593054517|FG001|Overall Study|Withdrawal by Subject|2|||
164187479|NCT02782377|593054520|FG000|Overall Study|Physician Decision|5|||
164187480|NCT00237692|593054521|FG000|Overall Study|Lost to Follow-up|9|||
164187481|NCT00237692|593054522|FG001|Overall Study|Lost to Follow-up|3|||
164187482|NCT00237692|593054523|FG002|Overall Study|Lost to Follow-up|5|||
164187483|NCT00237692|593054524|FG003|Overall Study|Lost to Follow-up|3|||
164187484|NCT00237692|593054521|FG000|Overall Study|Death|1|||
164187485|NCT00237692|593054522|FG001|Overall Study|Death|2|||
164187486|NCT00237692|593054523|FG002|Overall Study|Death|2|||
164187487|NCT00237692|593054524|FG003|Overall Study|Death|3|||
164187488|NCT00237692|593054521|FG000|Overall Study|Excluded - did not meet criteria|4|||
164187489|NCT00237692|593054522|FG001|Overall Study|Excluded - did not meet criteria|3|||
164187490|NCT00237692|593054523|FG002|Overall Study|Excluded - did not meet criteria|5|||
164187491|NCT00237692|593054524|FG003|Overall Study|Excluded - did not meet criteria|9|||
164187492|NCT00237692|593054521|FG000|Overall Study|Withdrawal by Subject|4|||
164187493|NCT00237692|593054522|FG001|Overall Study|Withdrawal by Subject|6|||
164187494|NCT00237692|593054523|FG002|Overall Study|Withdrawal by Subject|10|||
164187495|NCT00237692|593054524|FG003|Overall Study|Withdrawal by Subject|4|||
164187496|NCT00685360|593054525|FG000|Overall Study|Lost to Follow-up|0|||
164187497|NCT00685360|593054526|FG001|Overall Study|Lost to Follow-up|1|||
164187498|NCT00685360|593054527|FG002|Overall Study|Lost to Follow-up|2|||
164187499|NCT00685360|593054525|FG000|Overall Study|Adverse Event|4|||
164187500|NCT00685360|593054526|FG001|Overall Study|Adverse Event|6|||
164187501|NCT00685360|593054527|FG002|Overall Study|Adverse Event|4|||
164187502|NCT00685360|593054525|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
164187503|NCT00685360|593054526|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
164187504|NCT00685360|593054527|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
164187505|NCT00685360|593054525|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
164187506|NCT00685360|593054526|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
164187507|NCT00685360|593054527|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
164187508|NCT00685360|593054525|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
164187509|NCT00685360|593054526|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
164187510|NCT00685360|593054527|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
164187511|NCT00685360|593054525|FG000|Overall Study|Protocol Deviation|0|||
164187512|NCT00685360|593054526|FG001|Overall Study|Protocol Deviation|1|||
164187513|NCT00685360|593054527|FG002|Overall Study|Protocol Deviation|1|||
164187514|NCT00803712|593056562|FG000|Overall Study|Noncompliance|3|||
164187515|NCT00803712|593056563|FG001|Overall Study|Noncompliance|0|||
164187516|NCT00803712|593056562|FG000|Overall Study|Adverse Event|5|||
164187517|NCT00803712|593056563|FG001|Overall Study|Adverse Event|0|||
164187518|NCT00803712|593056562|FG000|Overall Study|Death|8|||
164187519|NCT00803712|593056563|FG001|Overall Study|Death|7|||
164187520|NCT00803712|593056562|FG000|Overall Study|Lost to Follow-up|3|||
164187521|NCT00803712|593056563|FG001|Overall Study|Lost to Follow-up|1|||
164187522|NCT00803712|593056562|FG000|Overall Study|Withdrawal by Subject|2|||
164187523|NCT00803712|593056563|FG001|Overall Study|Withdrawal by Subject|4|||
164187524|NCT00803712|593056562|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
164187525|NCT00803712|593056563|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
164187526|NCT00803712|593056562|FG000|Overall Study|Protocol criteria (other)|0|||
164187527|NCT00803712|593056563|FG001|Overall Study|Protocol criteria (other)|2|||
164187528|NCT00803712|593056562|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
164187529|NCT00803712|593056563|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
164187530|NCT00803712|593056562|FG000|Overall Study|Administrative decision|2|||
164187531|NCT00803712|593056563|FG001|Overall Study|Administrative decision|3|||
164187532|NCT00803712|593056562|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
164187533|NCT00803712|593056563|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
164187534|NCT02823470|593056564|FG000|Overall Study|Adverse Event|1|||
164187535|NCT02823470|593056565|FG001|Overall Study|Adverse Event|0|||
164187536|NCT02823470|593056564|FG000|Overall Study|Study terminated by sponsor|8|||
164187537|NCT02823470|593056565|FG001|Overall Study|Study terminated by sponsor|15|||
164187538|NCT01310127|593056567|FG000|Overall Study|Protocol Violation|1|||
164187539|NCT01310127|593056568|FG001|Overall Study|Protocol Violation|1|||
164187540|NCT01310127|593056567|FG000|Overall Study|advanced psc cataract outlier|1|||
164187541|NCT01310127|593056568|FG001|Overall Study|advanced psc cataract outlier|0|||
164187542|NCT01490840|593056569|FG000|Phase 1|Lost to Follow-up|1|||
164187543|NCT01490840|593056570|FG001|Phase 1|Lost to Follow-up|0|||
164187544|NCT01490840|593056569|FG000|Phase 1|Adverse Event|2|||
164187545|NCT01490840|593056570|FG001|Phase 1|Adverse Event|1|||
164187546|NCT01490840|593056569|FG000|Phase 1|Withdrawal by Subject|6|||
164187547|NCT01490840|593056570|FG001|Phase 1|Withdrawal by Subject|5|||
164187548|NCT01490840|593056569|FG000|Phase 1|Visit 6a omitted|1|||
164187549|NCT01490840|593056570|FG001|Phase 1|Visit 6a omitted|0|||
164187550|NCT01490840|593056569|FG000|Phase 2|Withdrawal by Subject|4|||
164187551|NCT01490840|593056570|FG001|Phase 2|Withdrawal by Subject|3|||
164187552|NCT01490840|593056569|FG000|Phase 2|Permanent interruption of fingolimod|0|||
164187553|NCT01490840|593056570|FG001|Phase 2|Permanent interruption of fingolimod|1|||
164187554|NCT01490840|593056569|FG000|Phase 2|Lost to Follow-up|1|||
164187555|NCT01490840|593056570|FG001|Phase 2|Lost to Follow-up|1|||
164187556|NCT01490840|593056569|FG000|Phase 2|Adverse Event|1|||
164187557|NCT01490840|593056570|FG001|Phase 2|Adverse Event|1|||
164187558|NCT01025284|593056574|FG000|Overall Study|Investigator Decision|0|||
164187559|NCT01025284|593056575|FG001|Overall Study|Investigator Decision|1|||
164187560|NCT01025284|593056576|FG002|Overall Study|Investigator Decision|0|||
164187561|NCT01025284|593056574|FG000|Overall Study|Withdrawal by Subject|0|||
164187562|NCT01025284|593056575|FG001|Overall Study|Withdrawal by Subject|1|||
164187563|NCT01025284|593056576|FG002|Overall Study|Withdrawal by Subject|0|||
164187564|NCT01465230|593056577|FG000|Overall Study|Withdrawal by Subject|2|||
164187565|NCT01738919|593056583|FG000|Overall Study|Lost to Follow-up|1|||
164187566|NCT01738919|593056584|FG001|Overall Study|Lost to Follow-up|0|||
164187567|NCT01738919|593056583|FG000|Overall Study|Immigrated|0|||
164187568|NCT01738919|593056584|FG001|Overall Study|Immigrated|1|||
164187569|NCT01738919|593056583|FG000|Overall Study|Withdrawal by Subject|0|||
164187570|NCT01738919|593056584|FG001|Overall Study|Withdrawal by Subject|1|||
164187571|NCT01738919|593056583|FG000|Overall Study|Not treated in accordance to guidelines|0|||
164187572|NCT01738919|593056584|FG001|Overall Study|Not treated in accordance to guidelines|1|||
164187573|NCT00547248|593056585|FG000|Overall Study|Protocol Violation|0|||
164187574|NCT00547248|593056586|FG001|Overall Study|Protocol Violation|0|||
164187575|NCT00547248|593056587|FG002|Overall Study|Protocol Violation|1|||
164187576|NCT00547248|593056588|FG003|Overall Study|Protocol Violation|1|||
164187577|NCT00547248|593056585|FG000|Overall Study|Migrated/moved from study area|0|||
164187578|NCT00547248|593056586|FG001|Overall Study|Migrated/moved from study area|0|||
164187579|NCT00547248|593056587|FG002|Overall Study|Migrated/moved from study area|2|||
164187580|NCT00547248|593056588|FG003|Overall Study|Migrated/moved from study area|0|||
164187581|NCT00547248|593056585|FG000|Overall Study|Withdrawal by Subject|0|||
164187582|NCT00547248|593056586|FG001|Overall Study|Withdrawal by Subject|0|||
164187583|NCT00547248|593056587|FG002|Overall Study|Withdrawal by Subject|7|||
164187584|NCT00547248|593056588|FG003|Overall Study|Withdrawal by Subject|1|||
164187585|NCT00534248|593056589|FG000|Overall Study|Adverse Event|19|||
164187586|NCT00534248|593056590|FG001|Overall Study|Adverse Event|29|||
164187587|NCT00534248|593056589|FG000|Overall Study|Lost to Follow-up|353|||
164187588|NCT00534248|593056590|FG001|Overall Study|Lost to Follow-up|375|||
164187589|NCT00534248|593056589|FG000|Overall Study|Other protocol specified criteria|13|||
164187590|NCT00534248|593056590|FG001|Overall Study|Other protocol specified criteria|3|||
164187591|NCT00534248|593056589|FG000|Overall Study|Physician Decision|10|||
164187592|NCT00534248|593056590|FG001|Overall Study|Physician Decision|7|||
164187593|NCT00534248|593056589|FG000|Overall Study|Protocol Violation|3|||
164187594|NCT00534248|593056590|FG001|Overall Study|Protocol Violation|4|||
164187595|NCT00534248|593056589|FG000|Overall Study|Withdrawal by Subject|263|||
164187596|NCT00534248|593056590|FG001|Overall Study|Withdrawal by Subject|255|||
164187597|NCT02849171|593056591|FG000|Overall Study|Withdrawal by Subject|1|||
164187598|NCT02849171|593056591|FG000|Overall Study|Not treated|1|||
164187599|NCT02532257|593056592|FG000|Overall Study|Adverse Event|2|||
164187600|NCT02532257|593056592|FG000|Overall Study|Physician Decision|4|||
164187601|NCT02532257|593056592|FG000|Overall Study|Withdrawal by Subject|3|||
164187602|NCT02532257|593056592|FG000|Overall Study|Progressive Disease|10|||
164187603|NCT02259400|593056593|FG000|Overall Study|Death|0|||
164187604|NCT02259400|593056594|FG001|Overall Study|Death|2|||
164187605|NCT03498313|593056598|FG000|Experimental Period 1|Adverse Event|1|||
164187606|NCT03498313|593056599|FG001|Experimental Period 1|Adverse Event|0|||
164187607|NCT03498313|593056600|FG002|Experimental Period 1|Adverse Event|0|||
164187608|NCT03498313|593056601|FG003|Experimental Period 1|Adverse Event|1|||
164187609|NCT03498313|593056602|FG004|Experimental Period 1|Adverse Event|0|||
164187610|NCT03498313|593056603|FG005|Experimental Period 1|Adverse Event|0|||
164187611|NCT03498313|593056598|FG000|Experimental Period 1|Withdrawal by Subject|0|||
164187612|NCT03498313|593056599|FG001|Experimental Period 1|Withdrawal by Subject|1|||
164187613|NCT03498313|593056600|FG002|Experimental Period 1|Withdrawal by Subject|0|||
164187614|NCT03498313|593056601|FG003|Experimental Period 1|Withdrawal by Subject|0|||
164187615|NCT03498313|593056602|FG004|Experimental Period 1|Withdrawal by Subject|0|||
164187616|NCT03498313|593056603|FG005|Experimental Period 1|Withdrawal by Subject|0|||
164187617|NCT03498313|593056598|FG000|Washout Period 1|Anovulation|1|||
164187618|NCT03498313|593056599|FG001|Washout Period 1|Anovulation|0|||
164187619|NCT03498313|593056600|FG002|Washout Period 1|Anovulation|0|||
164187620|NCT03498313|593056601|FG003|Washout Period 1|Anovulation|0|||
164187621|NCT03498313|593056602|FG004|Washout Period 1|Anovulation|0|||
164187622|NCT03498313|593056603|FG005|Washout Period 1|Anovulation|0|||
164187623|NCT03498313|593056598|FG000|Washout Period 1|Withdrawal by Subject|0|||
164187624|NCT03498313|593056599|FG001|Washout Period 1|Withdrawal by Subject|3|||
164187625|NCT03498313|593056600|FG002|Washout Period 1|Withdrawal by Subject|0|||
164187626|NCT03498313|593056601|FG003|Washout Period 1|Withdrawal by Subject|1|||
164187627|NCT03498313|593056602|FG004|Washout Period 1|Withdrawal by Subject|0|||
164187628|NCT03498313|593056603|FG005|Washout Period 1|Withdrawal by Subject|1|||
164187629|NCT03498313|593056598|FG000|Experimental Period 2|Adverse Event|0|||
164187630|NCT03498313|593056599|FG001|Experimental Period 2|Adverse Event|0|||
164187631|NCT03498313|593056600|FG002|Experimental Period 2|Adverse Event|0|||
164187632|NCT03498313|593056601|FG003|Experimental Period 2|Adverse Event|0|||
164187633|NCT03498313|593056602|FG004|Experimental Period 2|Adverse Event|1|||
164187634|NCT03498313|593056603|FG005|Experimental Period 2|Adverse Event|2|||
164187635|NCT03498313|593056598|FG000|Washout Period 2|Physician Decision|1|||
164187636|NCT03498313|593056599|FG001|Washout Period 2|Physician Decision|0|||
164187637|NCT03498313|593056600|FG002|Washout Period 2|Physician Decision|0|||
164187638|NCT03498313|593056601|FG003|Washout Period 2|Physician Decision|1|||
164187639|NCT03498313|593056602|FG004|Washout Period 2|Physician Decision|0|||
164187640|NCT03498313|593056603|FG005|Washout Period 2|Physician Decision|1|||
164187641|NCT03498313|593056598|FG000|Washout Period 2|Withdrawal by Subject|3|||
164187642|NCT03498313|593056599|FG001|Washout Period 2|Withdrawal by Subject|2|||
164187643|NCT03498313|593056600|FG002|Washout Period 2|Withdrawal by Subject|0|||
164187644|NCT03498313|593056601|FG003|Washout Period 2|Withdrawal by Subject|0|||
164187645|NCT03498313|593056602|FG004|Washout Period 2|Withdrawal by Subject|2|||
164187646|NCT03498313|593056603|FG005|Washout Period 2|Withdrawal by Subject|0|||
164187647|NCT03498313|593056598|FG000|Washout Period 2|Anovulation|0|||
164187648|NCT03498313|593056599|FG001|Washout Period 2|Anovulation|0|||
164187649|NCT03498313|593056600|FG002|Washout Period 2|Anovulation|0|||
164187650|NCT03498313|593056601|FG003|Washout Period 2|Anovulation|0|||
164187651|NCT03498313|593056602|FG004|Washout Period 2|Anovulation|0|||
164187652|NCT03498313|593056603|FG005|Washout Period 2|Anovulation|1|||
164187653|NCT02372383|593056604|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
164187654|NCT02372383|593056605|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
164187655|NCT02372383|593056606|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
164187656|NCT03084302|593056607|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
164187657|NCT03084302|593056607|FG000|Overall Study|No valid objective monitor data|6|||
164187658|NCT01255904|593056608|FG000|Overall Study|Physician Decision|1|||
164187659|NCT01255904|593056609|FG001|Overall Study|Physician Decision|4|||
164187660|NCT00305227|593056610|FG000|Overall Study|Lost to Follow-up|7|||
164187661|NCT00305227|593056611|FG001|Overall Study|Lost to Follow-up|6|||
164187662|NCT00694356|593056613|FG000|Overall Study|Adverse Event|1|||
164187663|NCT00694356|593056614|FG001|Overall Study|Adverse Event|0|||
164187664|NCT00694356|593056615|FG002|Overall Study|Adverse Event|0|||
164187665|NCT00694356|593056613|FG000|Overall Study|Progressive Disease|2|||
164187666|NCT00694356|593056614|FG001|Overall Study|Progressive Disease|6|||
164187667|NCT00694356|593056615|FG002|Overall Study|Progressive Disease|6|||
164187668|NCT00741598|593056620|FG000|Overall Study|Lost to Follow-up|3|||
164187669|NCT00741598|593056621|FG001|Overall Study|Lost to Follow-up|4|||
164187670|NCT00741598|593056620|FG000|Overall Study|Lack of Efficacy|1|||
164187671|NCT00741598|593056621|FG001|Overall Study|Lack of Efficacy|2|||
164187672|NCT00741598|593056620|FG000|Overall Study|Physician Decision|1|||
164187673|NCT00741598|593056621|FG001|Overall Study|Physician Decision|1|||
164187674|NCT00741598|593056620|FG000|Overall Study|Pregnancy|1|||
164187675|NCT00741598|593056621|FG001|Overall Study|Pregnancy|0|||
164187676|NCT00741598|593056620|FG000|Overall Study|Withdrawal by Subject|3|||
164187677|NCT00741598|593056621|FG001|Overall Study|Withdrawal by Subject|2|||
164187678|NCT01042392|593056622|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
164187679|NCT01042392|593056623|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
164187680|NCT01042392|593056624|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
164187681|NCT01042392|593056625|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
164187682|NCT01042392|593056622|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
164187683|NCT01042392|593056623|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
164187684|NCT01042392|593056624|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
164187685|NCT01042392|593056625|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
164187686|NCT01042392|593056622|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
164187687|NCT01042392|593056623|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
164187688|NCT01042392|593056624|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
164187689|NCT01042392|593056625|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
164187690|NCT01042392|593056622|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
164187691|NCT01042392|593056623|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
164187692|NCT01042392|593056624|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
164187693|NCT01042392|593056625|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
164187694|NCT01042392|593056622|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
164187695|NCT01042392|593056623|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
164187696|NCT01042392|593056624|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
164187697|NCT01042392|593056625|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
164187698|NCT01042392|593056622|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
164187699|NCT01042392|593056623|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
164187700|NCT01042392|593056624|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
164187701|NCT01042392|593056625|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
164187702|NCT01042392|593056622|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
164187703|NCT01042392|593056623|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
164187704|NCT01042392|593056624|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
164187705|NCT01042392|593056625|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
164187706|NCT01042392|593056622|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
164187707|NCT01042392|593056623|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
164187708|NCT01042392|593056624|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
164187709|NCT01042392|593056625|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
164187710|NCT01042392|593056622|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
164187711|NCT01042392|593056623|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
164187712|NCT01042392|593056624|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
164187713|NCT01042392|593056625|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
164187714|NCT03117361|593056626|FG000|Overall Study|Progressive disease|5|||
164187715|NCT03117361|593056626|FG000|Overall Study|Death|1|||
164187716|NCT03117361|593056626|FG000|Overall Study|Physician Decision|2|||
164187717|NCT03117361|593056626|FG000|Overall Study|On study treatment at the end of study|1|||
164187718|NCT03117361|593056626|FG000|Overall Study|Treatment-related adverse event|1|||
164187719|NCT03318003|593056627|FG000|Overall Study|Withdrawal by Subject|1|||
164187720|NCT03318003|593056628|FG001|Overall Study|Withdrawal by Subject|1|||
164187721|NCT03318003|593056627|FG000|Overall Study|fetal loss|0|||
164187722|NCT03318003|593056628|FG001|Overall Study|fetal loss|1|||
164187723|NCT02072941|593056629|FG000|Overall Study|Withdrawal by Subject|29|||
164187724|NCT02072941|593056630|FG001|Overall Study|Withdrawal by Subject|21|||
164187725|NCT02072941|593056629|FG000|Overall Study|Lost to Follow-up|4|||
164187726|NCT02072941|593056630|FG001|Overall Study|Lost to Follow-up|4|||
164187727|NCT02072941|593056629|FG000|Overall Study|Death|3|||
164187728|NCT02072941|593056630|FG001|Overall Study|Death|2|||
164187729|NCT02072941|593056629|FG000|Overall Study|Removed by Study Staff|2|||
164187730|NCT02072941|593056630|FG001|Overall Study|Removed by Study Staff|2|||
164187731|NCT01247350|593056633|FG000|Overall Study|Adverse Event|0|||
164187732|NCT01247350|593056634|FG001|Overall Study|Adverse Event|0|||
164187733|NCT01247350|593056635|FG002|Overall Study|Adverse Event|1|||
164187734|NCT01247350|593056636|FG003|Overall Study|Adverse Event|0|||
164187735|NCT01247350|593056637|FG004|Overall Study|Adverse Event|0|||
164187736|NCT01247350|593056633|FG000|Overall Study|Withdrawal by Subject|0|||
164187737|NCT01247350|593056634|FG001|Overall Study|Withdrawal by Subject|0|||
164187738|NCT01247350|593056635|FG002|Overall Study|Withdrawal by Subject|0|||
164187739|NCT01247350|593056636|FG003|Overall Study|Withdrawal by Subject|1|||
164187740|NCT01247350|593056637|FG004|Overall Study|Withdrawal by Subject|0|||
164187741|NCT01247350|593056633|FG000|Overall Study|Entry criteria not met|0|||
164187742|NCT01247350|593056634|FG001|Overall Study|Entry criteria not met|0|||
164187743|NCT01247350|593056635|FG002|Overall Study|Entry criteria not met|0|||
164187744|NCT01247350|593056636|FG003|Overall Study|Entry criteria not met|0|||
164187745|NCT01247350|593056637|FG004|Overall Study|Entry criteria not met|1|||
164187746|NCT00169104|593056638|FG000|Overall Study|Withdrawal by Subject|2|||
164187747|NCT00169104|593056639|FG001|Overall Study|Withdrawal by Subject|0|||
164187748|NCT00169104|593056638|FG000|Overall Study|Protocol Violation|0|||
164187749|NCT00169104|593056639|FG001|Overall Study|Protocol Violation|1|||
164187750|NCT00169104|593056638|FG000|Overall Study|Physician Decision|0|||
164187751|NCT00169104|593056639|FG001|Overall Study|Physician Decision|1|||
164187752|NCT00715299|593056645|FG000|Overall Study|Withdrawal by Subject|1|||
164187753|NCT00715299|593056645|FG000|Overall Study|Adverse Event|3|||
164187754|NCT00715299|593056645|FG000|Overall Study|failed the pre-screen exercise test|2|||
164187755|NCT02020889|593056646|FG000|Overall Study|Adverse Event|0|||
164187756|NCT02020889|593056647|FG001|Overall Study|Adverse Event|1|||
164187757|NCT02020889|593056646|FG000|Overall Study|Lack of Efficacy|1|||
164187758|NCT02020889|593056647|FG001|Overall Study|Lack of Efficacy|0|||
164187759|NCT02020889|593056646|FG000|Overall Study|Lost to Follow-up|1|||
164187760|NCT02020889|593056647|FG001|Overall Study|Lost to Follow-up|0|||
164187761|NCT02020889|593056646|FG000|Overall Study|Physician Decision|2|||
164187762|NCT02020889|593056647|FG001|Overall Study|Physician Decision|0|||
164187763|NCT02020889|593056646|FG000|Overall Study|Withdrawal by Subject|3|||
164187764|NCT02020889|593056647|FG001|Overall Study|Withdrawal by Subject|2|||
164187765|NCT01540981|593056648|FG000|Overall Study|Withdrawal by Subject|1|||
164187766|NCT01540981|593056649|FG001|Overall Study|Withdrawal by Subject|0|||
164187767|NCT00809094|593056650|FG000|Overall Study|Lost to Follow-up|0|||
164187768|NCT00809094|593056651|FG001|Overall Study|Lost to Follow-up|1|||
164187769|NCT00232557|593056652|FG000|Overall Study|Lost to Follow-up|3|||
164187770|NCT00232557|593056653|FG001|Overall Study|Lost to Follow-up|5|||
164187771|NCT02768792|593056658|FG000|Overall Study|Adverse Event|1|||
164187772|NCT04819438|593056659|FG000|Overall Study|Withdrawal by Subject|1|||
164187773|NCT04819438|593056660|FG001|Overall Study|Withdrawal by Subject|0|||
164187774|NCT04819438|593056659|FG000|Overall Study|Adverse Event|0|||
164187775|NCT04819438|593056660|FG001|Overall Study|Adverse Event|1|||
164187776|NCT04819438|593056659|FG000|Overall Study|Protocol Violation|0|||
164187777|NCT04819438|593056660|FG001|Overall Study|Protocol Violation|1|||
164187778|NCT04607135|593056662|FG000|Overall Study|Physician Decision|1|||
164187779|NCT04607135|593056662|FG000|Overall Study|Withdrawal by Subject|1|||
164187780|NCT04607135|593056662|FG000|Overall Study|Equipment not working|3|||
164187781|NCT03465709|593056663|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
164187782|NCT03465709|593056663|FG000|Overall Study|Withdrawal by Subject|3|||
164187783|NCT05359952|593056664|FG000|Overall Study|Lost to Follow-up|1|||
164187784|NCT05359952|593056665|FG001|Overall Study|Lost to Follow-up|0|||
164187785|NCT03836209|593056666|FG000|Overall Study|Adverse Event|5|||
164187786|NCT03836209|593056667|FG001|Overall Study|Adverse Event|2|||
164187787|NCT03836209|593056666|FG000|Overall Study|Death|4|||
164187788|NCT03836209|593056667|FG001|Overall Study|Death|1|||
164187789|NCT03836209|593056666|FG000|Overall Study|Lack of Efficacy|7|||
164187790|NCT03836209|593056667|FG001|Overall Study|Lack of Efficacy|10|||
164187791|NCT03836209|593056666|FG000|Overall Study|Physician Decision|7|||
164187792|NCT03836209|593056667|FG001|Overall Study|Physician Decision|11|||
164187793|NCT03836209|593056666|FG000|Overall Study|Protocol Violation|0|||
164187794|NCT03836209|593056667|FG001|Overall Study|Protocol Violation|3|||
164187795|NCT03836209|593056666|FG000|Overall Study|Withdrawal by Subject|2|||
164187796|NCT03836209|593056667|FG001|Overall Study|Withdrawal by Subject|10|||
164187797|NCT03836209|593056666|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
164187798|NCT03836209|593056667|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
164187799|NCT01768559|593056669|FG000|Overall Study|Randomized but not treated|0|||
164187800|NCT01768559|593056670|FG001|Overall Study|Randomized but not treated|0|||
164187801|NCT01768559|593056671|FG002|Overall Study|Randomized but not treated|1|||
164187802|NCT01768559|593056669|FG000|Overall Study|Adverse Event|15|||
164187803|NCT01768559|593056670|FG001|Overall Study|Adverse Event|2|||
164187804|NCT01768559|593056671|FG002|Overall Study|Adverse Event|5|||
164187805|NCT01768559|593056669|FG000|Overall Study|Lack of Efficacy|6|||
164187806|NCT01768559|593056670|FG001|Overall Study|Lack of Efficacy|4|||
164187807|NCT01768559|593056671|FG002|Overall Study|Lack of Efficacy|0|||
164187808|NCT01768559|593056669|FG000|Overall Study|Poor compliance to protocol|0|||
164187809|NCT01768559|593056670|FG001|Overall Study|Poor compliance to protocol|3|||
164187810|NCT01768559|593056671|FG002|Overall Study|Poor compliance to protocol|2|||
164187811|NCT01768559|593056669|FG000|Overall Study|Other than specified|9|||
164187812|NCT01768559|593056670|FG001|Overall Study|Other than specified|8|||
164187813|NCT01768559|593056671|FG002|Overall Study|Other than specified|5|||
164187814|NCT00398047|593056672|FG000|Overall Study|all patient progressed before completion|3|||
164187815|NCT01737879|593056673|FG000|Overall Study|Death|1|||
164187816|NCT01737879|593056673|FG000|Overall Study|Sponsor decision|40|||
164187817|NCT01386944|593056687|FG000|Overall Study|Adverse Event|26|||
164187818|NCT01386944|593056687|FG000|Overall Study|Lack of Efficacy|14|||
164187819|NCT01386944|593056687|FG000|Overall Study|Lost to Follow-up|8|||
164187820|NCT01386944|593056687|FG000|Overall Study|Unspecified reason|8|||
164187821|NCT00531947|593056691|FG000|Overall Study|Adverse Event|5|||
164187822|NCT00531947|593056692|FG001|Overall Study|Adverse Event|10|||
164187823|NCT00531947|593056691|FG000|Overall Study|Lost to Follow-up|12|||
164187824|NCT00531947|593056692|FG001|Overall Study|Lost to Follow-up|9|||
164187825|NCT00531947|593056691|FG000|Overall Study|Withdrawal by Subject|14|||
164187826|NCT00531947|593056692|FG001|Overall Study|Withdrawal by Subject|19|||
164187827|NCT00531947|593056691|FG000|Overall Study|Protocol Violation|2|||
164187828|NCT00531947|593056692|FG001|Overall Study|Protocol Violation|1|||
164187829|NCT00531947|593056691|FG000|Overall Study|Non-Compliance|4|||
164187830|NCT00531947|593056692|FG001|Overall Study|Non-Compliance|7|||
164187831|NCT00531947|593056691|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
164187832|NCT00531947|593056692|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
164187833|NCT02383355|593056693|FG000|Overall Study|Adverse Event|2|||
164187834|NCT02383355|593056694|FG001|Overall Study|Adverse Event|0|||
164187835|NCT00524680|593056695|FG000|Overall Study|progression|0|||
164187836|NCT00524680|593056696|FG001|Overall Study|progression|0|||
164187837|NCT00524680|593056697|FG002|Overall Study|progression|0|||
164187838|NCT00524680|593056698|FG003|Overall Study|progression|1|||
164187839|NCT00524680|593056695|FG000|Overall Study|Adverse Event|2|||
164187840|NCT00524680|593056696|FG001|Overall Study|Adverse Event|0|||
164187841|NCT00524680|593056697|FG002|Overall Study|Adverse Event|0|||
164187842|NCT00524680|593056698|FG003|Overall Study|Adverse Event|1|||
164187843|NCT00524680|593056695|FG000|Overall Study|Other|0|||
164187844|NCT00524680|593056696|FG001|Overall Study|Other|1|||
164187845|NCT00524680|593056697|FG002|Overall Study|Other|2|||
164187846|NCT00524680|593056698|FG003|Overall Study|Other|3|||
164187847|NCT00524680|593056695|FG000|Overall Study|Withdrawal by Subject|1|||
164187848|NCT00524680|593056696|FG001|Overall Study|Withdrawal by Subject|0|||
164187849|NCT00524680|593056697|FG002|Overall Study|Withdrawal by Subject|1|||
164187850|NCT00524680|593056698|FG003|Overall Study|Withdrawal by Subject|1|||
164187851|NCT01146561|593056701|FG000|Overall Study|Withdrawal by Subject|1|||
164187852|NCT01146561|593056701|FG000|Overall Study|Lost to Follow-up|1|||
164187853|NCT03092791|593056709|FG000|Overall Study|Lost to Follow-up|0|||
164187854|NCT03092791|593056710|FG001|Overall Study|Lost to Follow-up|0|||
164187855|NCT03092791|593056711|FG002|Overall Study|Lost to Follow-up|0|||
164187856|NCT03092791|593056712|FG003|Overall Study|Lost to Follow-up|0|||
164187857|NCT03092791|593056713|FG004|Overall Study|Lost to Follow-up|0|||
164187858|NCT03092791|593056714|FG005|Overall Study|Lost to Follow-up|0|||
164187859|NCT03092791|593056715|FG006|Overall Study|Lost to Follow-up|1|||
164187860|NCT03092791|593056716|FG007|Overall Study|Lost to Follow-up|0|||
164187861|NCT03092791|593056709|FG000|Overall Study|Withdrawal of Consent|0|||
164187862|NCT03092791|593056710|FG001|Overall Study|Withdrawal of Consent|0|||
164187863|NCT03092791|593056711|FG002|Overall Study|Withdrawal of Consent|0|||
164187864|NCT03092791|593056712|FG003|Overall Study|Withdrawal of Consent|0|||
164187865|NCT03092791|593056713|FG004|Overall Study|Withdrawal of Consent|4|||
164187866|NCT03092791|593056714|FG005|Overall Study|Withdrawal of Consent|12|||
164187867|NCT03092791|593056715|FG006|Overall Study|Withdrawal of Consent|6|||
164187868|NCT03092791|593056716|FG007|Overall Study|Withdrawal of Consent|4|||
164187869|NCT03092791|593056709|FG000|Overall Study|Study Termination|0|||
164187870|NCT03092791|593056710|FG001|Overall Study|Study Termination|0|||
164187871|NCT03092791|593056711|FG002|Overall Study|Study Termination|0|||
164187872|NCT03092791|593056712|FG003|Overall Study|Study Termination|0|||
164187873|NCT03092791|593056713|FG004|Overall Study|Study Termination|55|||
164187874|NCT03092791|593056714|FG005|Overall Study|Study Termination|46|||
164187875|NCT03092791|593056715|FG006|Overall Study|Study Termination|53|||
164187876|NCT03092791|593056716|FG007|Overall Study|Study Termination|55|||
164187877|NCT03092791|593056709|FG000|Overall Study|Death|0|||
164187878|NCT03092791|593056710|FG001|Overall Study|Death|0|||
164187879|NCT03092791|593056711|FG002|Overall Study|Death|0|||
164187880|NCT03092791|593056712|FG003|Overall Study|Death|0|||
164187881|NCT03092791|593056713|FG004|Overall Study|Death|0|||
164187882|NCT03092791|593056714|FG005|Overall Study|Death|1|||
164187883|NCT03092791|593056715|FG006|Overall Study|Death|0|||
164187884|NCT03092791|593056716|FG007|Overall Study|Death|1|||
164187885|NCT03092791|593056709|FG000|Overall Study|Reason Not Specified|0|||
164187886|NCT03092791|593056710|FG001|Overall Study|Reason Not Specified|0|||
164187887|NCT03092791|593056711|FG002|Overall Study|Reason Not Specified|0|||
164187888|NCT03092791|593056712|FG003|Overall Study|Reason Not Specified|0|||
164187889|NCT03092791|593056713|FG004|Overall Study|Reason Not Specified|1|||
164187890|NCT03092791|593056714|FG005|Overall Study|Reason Not Specified|1|||
164187891|NCT03092791|593056715|FG006|Overall Study|Reason Not Specified|0|||
164187892|NCT03092791|593056716|FG007|Overall Study|Reason Not Specified|0|||
164187893|NCT02182830|593056720|FG000|Overall Study|Not Treated|1|||
164187894|NCT02182830|593056721|FG001|Overall Study|Not Treated|1|||
164187895|NCT02182830|593056720|FG000|Overall Study|Trial stopped, reason missing|3|||
164187896|NCT02182830|593056721|FG001|Overall Study|Trial stopped, reason missing|3|||
164187897|NCT02182830|593056720|FG000|Overall Study|Consent withdrawn|8|||
164187898|NCT02182830|593056721|FG001|Overall Study|Consent withdrawn|8|||
164187899|NCT02182830|593056720|FG000|Overall Study|Lost to Follow-up|3|||
164187900|NCT02182830|593056721|FG001|Overall Study|Lost to Follow-up|3|||
164187901|NCT04399538|593056722|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
164187902|NCT04399538|593056723|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
164187903|NCT04399538|593056724|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
164187904|NCT04399538|593056725|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
164187905|NCT04399538|593056726|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
164187906|NCT04399538|593056722|FG000|Double-Blind Treatment|Adverse Event|0|||
164187907|NCT04399538|593056723|FG001|Double-Blind Treatment|Adverse Event|0|||
164187908|NCT04399538|593056724|FG002|Double-Blind Treatment|Adverse Event|0|||
164187909|NCT04399538|593056725|FG003|Double-Blind Treatment|Adverse Event|0|||
164187910|NCT04399538|593056726|FG004|Double-Blind Treatment|Adverse Event|1|||
164187911|NCT04399538|593056722|FG000|Follow-Up|Adverse Event|0|||
164187912|NCT04399538|593056723|FG001|Follow-Up|Adverse Event|0|||
164187913|NCT04399538|593056724|FG002|Follow-Up|Adverse Event|0|||
164187914|NCT04399538|593056725|FG003|Follow-Up|Adverse Event|0|||
164187915|NCT04399538|593056726|FG004|Follow-Up|Adverse Event|1|||
164187916|NCT04399538|593056722|FG000|Follow-Up|Withdrawal by Subject|0|||
164187917|NCT04399538|593056723|FG001|Follow-Up|Withdrawal by Subject|0|||
164187918|NCT04399538|593056724|FG002|Follow-Up|Withdrawal by Subject|0|||
164187919|NCT04399538|593056725|FG003|Follow-Up|Withdrawal by Subject|2|||
164187920|NCT04399538|593056726|FG004|Follow-Up|Withdrawal by Subject|0|||
164187921|NCT00586898|593056731|FG000|Overall Study|Adverse Event|1|||
164187922|NCT00586898|593056731|FG000|Overall Study|Patiemt Non-compliance|1|||
164187923|NCT00586898|593056731|FG000|Overall Study|Evaluable for Toxicity Only|5|||
164187924|NCT01588405|593056732|FG000|Overall Study|Adverse Event|1|||
164187925|NCT01588405|593056732|FG000|Overall Study|Clinical Worsening|1|||
164187926|NCT00893971|593056733|FG000|Overall Study|Physician Decision|3|||
164187927|NCT03268005|593056734|FG000|Overall Study|Death|2|||
164187928|NCT03268005|593056735|FG001|Overall Study|Death|1|||
164187929|NCT03268005|593056734|FG000|Overall Study|Lost to Follow-up|2|||
164187930|NCT03268005|593056735|FG001|Overall Study|Lost to Follow-up|2|||
164187931|NCT03268005|593056734|FG000|Overall Study|Withdrawal by Subject|11|||
164187932|NCT03268005|593056735|FG001|Overall Study|Withdrawal by Subject|11|||
164187933|NCT01926197|593056736|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
164187934|NCT01926197|593056737|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
164187935|NCT01926197|593056736|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
164187936|NCT01926197|593056737|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
164187937|NCT00492232|593056738|FG000|Placebo Run-in|Adverse Event|0|||
164187938|NCT00492232|593056739|FG001|Placebo Run-in|Adverse Event|2|||
164187939|NCT00492232|593056738|FG000|Placebo Run-in|Protocol Violation|0|||
164187940|NCT00492232|593056739|FG001|Placebo Run-in|Protocol Violation|3|||
164187941|NCT00492232|593056738|FG000|Placebo Run-in|Lost to Follow-up|0|||
164187942|NCT00492232|593056739|FG001|Placebo Run-in|Lost to Follow-up|3|||
164187943|NCT00492232|593056738|FG000|Placebo Run-in|Withdrawal by Subject|0|||
164187944|NCT00492232|593056739|FG001|Placebo Run-in|Withdrawal by Subject|8|||
164187945|NCT00492232|593056738|FG000|Placebo Run-in|Pregnancy|0|||
164187946|NCT00492232|593056739|FG001|Placebo Run-in|Pregnancy|1|||
164187947|NCT00492232|593056738|FG000|Placebo Run-in|Entrance criteria not met|0|||
164187948|NCT00492232|593056739|FG001|Placebo Run-in|Entrance criteria not met|45|||
164187949|NCT00492232|593056738|FG000|Placebo Run-in|Other|0|||
164187950|NCT00492232|593056739|FG001|Placebo Run-in|Other|6|||
164187951|NCT00492232|593056738|FG000|Placebo Run-in|Missing|0|||
164187952|NCT00492232|593056739|FG001|Placebo Run-in|Missing|2|||
164187953|NCT00492232|593056738|FG000|Double-Blind Treatment|Adverse Event|1|||
164187954|NCT00492232|593056739|FG001|Double-Blind Treatment|Adverse Event|2|||
164187955|NCT00492232|593056738|FG000|Double-Blind Treatment|Protocol Violation|3|||
164187956|NCT00492232|593056739|FG001|Double-Blind Treatment|Protocol Violation|7|||
164187957|NCT00492232|593056738|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
164187958|NCT00492232|593056739|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
164187959|NCT00492232|593056738|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
164187960|NCT00492232|593056739|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
164187961|NCT00492232|593056738|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
164187962|NCT00492232|593056739|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
164187963|NCT00492232|593056738|FG000|Double-Blind Treatment|Other|6|||
164187964|NCT00492232|593056739|FG001|Double-Blind Treatment|Other|5|||
164187965|NCT00492232|593056738|FG000|Double-Blind Treatment|Randomized not treated|1|||
164187966|NCT00492232|593056739|FG001|Double-Blind Treatment|Randomized not treated|0|||
164187967|NCT00492232|593056738|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
164187968|NCT00492232|593056739|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
164187969|NCT00980655|593056740|FG000|Overall Study|Adverse Event|13|||
164187970|NCT00980655|593056741|FG001|Overall Study|Adverse Event|31|||
164187971|NCT00980655|593056740|FG000|Overall Study|Death|0|||
164187972|NCT00980655|593056741|FG001|Overall Study|Death|7|||
164187973|NCT00980655|593056740|FG000|Overall Study|Protocol Violation|2|||
164187974|NCT00980655|593056741|FG001|Overall Study|Protocol Violation|7|||
164187975|NCT00980655|593056740|FG000|Overall Study|Withdrawal by Subject|0|||
164187976|NCT00980655|593056741|FG001|Overall Study|Withdrawal by Subject|4|||
164187977|NCT00980655|593056740|FG000|Overall Study|Lost to Follow-up|0|||
164187978|NCT00980655|593056741|FG001|Overall Study|Lost to Follow-up|1|||
164187979|NCT00980655|593056740|FG000|Overall Study|Parent/legal guardian request|1|||
164187980|NCT00980655|593056741|FG001|Overall Study|Parent/legal guardian request|0|||
164187981|NCT00980655|593056740|FG000|Overall Study|Other|0|||
164187982|NCT00980655|593056741|FG001|Overall Study|Other|1|||
164187983|NCT04162795|593056745|FG000|Overall Study|Other|16|||
164187984|NCT04162795|593056745|FG000|Overall Study|Screen failures|10|||
164187985|NCT01416155|593056746|FG000|Overall Study|Adverse Event|8|||
164187986|NCT01416155|593056746|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
164187987|NCT01416155|593056746|FG000|Overall Study|Withdrawal by Subject|33|||
164187988|NCT01416155|593056746|FG000|Overall Study|Investigator decision|8|||
164187989|NCT01416155|593056746|FG000|Overall Study|Other|7|||
164187990|NCT00829829|593056750|FG000|Overall Study|Protocol Violation|0|||
164187991|NCT00829829|593056751|FG001|Overall Study|Protocol Violation|3|||
164187992|NCT00829829|593056752|FG002|Overall Study|Protocol Violation|0|||
164187993|NCT00829829|593056750|FG000|Overall Study|Adverse Event|4|||
164187994|NCT00829829|593056751|FG001|Overall Study|Adverse Event|4|||
164187995|NCT00829829|593056752|FG002|Overall Study|Adverse Event|3|||
164187996|NCT00829829|593056750|FG000|Overall Study|Withdrawal by Subject|8|||
164187997|NCT00829829|593056751|FG001|Overall Study|Withdrawal by Subject|4|||
164187998|NCT00829829|593056752|FG002|Overall Study|Withdrawal by Subject|2|||
164187999|NCT00829829|593056750|FG000|Overall Study|Decision by the Sponsor|1|||
164188000|NCT00829829|593056751|FG001|Overall Study|Decision by the Sponsor|0|||
164188001|NCT00829829|593056752|FG002|Overall Study|Decision by the Sponsor|2|||
164188002|NCT00829829|593056750|FG000|Overall Study|Lost to Follow-up|7|||
164188003|NCT00829829|593056751|FG001|Overall Study|Lost to Follow-up|3|||
164188004|NCT00829829|593056752|FG002|Overall Study|Lost to Follow-up|3|||
164188005|NCT00829829|593056750|FG000|Overall Study|Other than specified above|2|||
164188006|NCT00829829|593056751|FG001|Overall Study|Other than specified above|2|||
164188007|NCT00829829|593056752|FG002|Overall Study|Other than specified above|1|||
164188008|NCT00382109|593056753|FG000|Overall Study|Adverse Event|3|||
164188009|NCT00382109|593056754|FG001|Overall Study|Adverse Event|0|||
164188010|NCT00382109|593056753|FG000|Overall Study|Physician Decision|6|||
164188011|NCT00382109|593056754|FG001|Overall Study|Physician Decision|1|||
164188012|NCT00382109|593056753|FG000|Overall Study|Withdrawal by Subject|1|||
164188013|NCT00382109|593056754|FG001|Overall Study|Withdrawal by Subject|0|||
164188014|NCT00382109|593056753|FG000|Overall Study|ineligible|2|||
164188015|NCT00382109|593056754|FG001|Overall Study|ineligible|0|||
164188016|NCT00382109|593056753|FG000|Overall Study|Other|0|||
164188017|NCT00382109|593056754|FG001|Overall Study|Other|2|||
164188018|NCT00382109|593056753|FG000|Overall Study|consent withdrawal|0|||
164188019|NCT00382109|593056754|FG001|Overall Study|consent withdrawal|1|||
164188020|NCT03251482|593058707|FG000|Overall Study|Withdrawal by Subject|0|||
164188021|NCT03251482|593058708|FG001|Overall Study|Withdrawal by Subject|1|||
164188022|NCT03251482|593058709|FG002|Overall Study|Withdrawal by Subject|0|||
164188023|NCT03251482|593058710|FG003|Overall Study|Withdrawal by Subject|0|||
164188024|NCT03251482|593058711|FG004|Overall Study|Withdrawal by Subject|0|||
164188025|NCT03859648|593058716|FG000|Overall Study|Lost to Follow-up|1|||
164188026|NCT03859648|593058716|FG000|Overall Study|Adverse Event|1|||
164188027|NCT01990573|593058722|FG000|Overall Study|Physician Decision|0|||
164188028|NCT01990573|593058723|FG001|Overall Study|Physician Decision|0|||
164188029|NCT01990573|593058724|FG002|Overall Study|Physician Decision|1|||
164188030|NCT03335813|593058735|FG000|Overall Study|Withdrawal by Subject|1|||
164188031|NCT00697593|593058743|FG000|Overall Study|Adverse Event|3|||
164188032|NCT00697593|593058743|FG000|Overall Study|Protocol Violation|1|||
164188033|NCT00697593|593058743|FG000|Overall Study|Lack of Efficacy|3|||
164188034|NCT00697593|593058743|FG000|Overall Study|Suspension of the study by sponsor|12|||
164188035|NCT05133323|593058748|FG000|Overall Study|Lack of Efficacy|0|||
164188036|NCT05133323|593058749|FG001|Overall Study|Lack of Efficacy|0|||
164188037|NCT05133323|593058750|FG002|Overall Study|Lack of Efficacy|1|||
164188038|NCT05133323|593058748|FG000|Overall Study|Withdrawal by Subject|2|||
164188039|NCT05133323|593058749|FG001|Overall Study|Withdrawal by Subject|1|||
164188040|NCT05133323|593058750|FG002|Overall Study|Withdrawal by Subject|0|||
164188041|NCT04152083|593058763|FG000|Overall Study|Lost to Follow-up|2|||
164188042|NCT04152083|593058764|FG001|Overall Study|Lost to Follow-up|1|||
164188043|NCT04152083|593058763|FG000|Overall Study|Adverse Event|1|||
164188044|NCT04152083|593058764|FG001|Overall Study|Adverse Event|0|||
164188045|NCT04152083|593058763|FG000|Overall Study|Randomized but not treated|3|||
164188046|NCT04152083|593058764|FG001|Overall Study|Randomized but not treated|2|||
164188047|NCT02087670|593058765|FG000|Overall Study|Withdrawal by Subject|3|||
164188048|NCT02087670|593058766|FG001|Overall Study|Withdrawal by Subject|2|||
164188049|NCT00411450|593058767|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
164188050|NCT03904420|593058768|FG000|Overall Study|Study terminated|2|||
164188051|NCT03904420|593058769|FG001|Overall Study|Study terminated|2|||
164188052|NCT00614874|593058770|FG000|Overall Study|Protocol Violation|1|||
164188053|NCT00614874|593058770|FG000|Overall Study|Withdrawal by Subject|1|||
164188054|NCT04435808|593058771|FG000|Overall Study|Study stopped by DSMB|0|||
164188055|NCT04435808|593058772|FG001|Overall Study|Study stopped by DSMB|1|||
164188056|NCT00807612|593058773|FG000|Overall Study|Death|8|||
164188057|NCT00807612|593058773|FG000|Overall Study|Study early termination|5|||
164188058|NCT00807612|593058773|FG000|Overall Study|Withdrawal by Subject|1|||
164188059|NCT00705341|593058774|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
164188060|NCT00705341|593058775|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
164188061|NCT00705341|593058776|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
164188062|NCT00705341|593058777|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
164188063|NCT00705341|593058774|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
164188064|NCT00705341|593058775|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
164188065|NCT00705341|593058776|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
164188066|NCT00705341|593058777|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
164188067|NCT04978337|593058784|FG000|Overall Study|Withdrawal by Subject|0|||
164188068|NCT04978337|593058785|FG001|Overall Study|Withdrawal by Subject|1|||
164188069|NCT01436227|593058789|FG000|Overall Study|Adverse Event|7|||
164188070|NCT01436227|593058789|FG000|Overall Study|Death|1|||
164188071|NCT01436227|593058789|FG000|Overall Study|Lack of Efficacy|1|||
164188072|NCT01436227|593058789|FG000|Overall Study|Lost to Follow-up|3|||
164188073|NCT01436227|593058789|FG000|Overall Study|Physician Decision|1|||
164188074|NCT01436227|593058789|FG000|Overall Study|Withdrawal by Subject|7|||
164188075|NCT01436227|593058789|FG000|Overall Study|Disease progression, relapse|6|||
164188076|NCT00972283|593058790|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
164188077|NCT00972283|593058791|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
164188078|NCT00972283|593058790|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
164188079|NCT00972283|593058791|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
164188080|NCT00972283|593058790|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
164188081|NCT00972283|593058791|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
164188082|NCT00972283|593058790|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
164188083|NCT00972283|593058791|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
164188084|NCT00972283|593058790|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
164188085|NCT00972283|593058791|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
164188086|NCT00972283|593058790|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
164188087|NCT00972283|593058791|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
164188088|NCT00972283|593058790|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
164188089|NCT00972283|593058791|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
164188090|NCT00972283|593058790|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
164188091|NCT00972283|593058791|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
164188092|NCT00972283|593058790|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
164188093|NCT00972283|593058791|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
164188094|NCT00972283|593058790|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
164188095|NCT00972283|593058791|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
164188096|NCT03124537|593058792|FG000|Overall Study|Lost to Follow-up|3|||
164188097|NCT03124537|593058793|FG001|Overall Study|Lost to Follow-up|5|||
164188098|NCT03124537|593058792|FG000|Overall Study|App Crash, Incomplete Data|7|||
164188099|NCT03124537|593058793|FG001|Overall Study|App Crash, Incomplete Data|8|||
164188100|NCT00830518|593058796|FG000|Overall Study|Progressive Disease|18|||
164188101|NCT00830518|593058797|FG001|Overall Study|Progressive Disease|8|||
164188102|NCT00830518|593058796|FG000|Overall Study|Symptomatic Deterioration|4|||
164188103|NCT00830518|593058797|FG001|Overall Study|Symptomatic Deterioration|1|||
164188104|NCT00830518|593058796|FG000|Overall Study|Adverse Event|14|||
164188105|NCT00830518|593058797|FG001|Overall Study|Adverse Event|1|||
164188106|NCT00830518|593058796|FG000|Overall Study|Withdrawal by Patient|2|||
164188107|NCT00830518|593058797|FG001|Overall Study|Withdrawal by Patient|0|||
164188108|NCT00830518|593058796|FG000|Overall Study|Reason not Specified|8|||
164188109|NCT00830518|593058797|FG001|Overall Study|Reason not Specified|1|||
164188110|NCT02756364|593058800|FG000|Overall Study|Site Terminated by Sponsor|24|||
164188111|NCT02756364|593058801|FG001|Overall Study|Site Terminated by Sponsor|30|||
164188112|NCT02756364|593058802|FG002|Overall Study|Site Terminated by Sponsor|21|||
164188113|NCT02756364|593058800|FG000|Overall Study|Death|20|||
164188114|NCT02756364|593058801|FG001|Overall Study|Death|15|||
164188115|NCT02756364|593058802|FG002|Overall Study|Death|18|||
164188116|NCT02756364|593058800|FG000|Overall Study|Withdrawal by Patient|2|||
164188117|NCT02756364|593058801|FG001|Overall Study|Withdrawal by Patient|1|||
164188118|NCT02756364|593058802|FG002|Overall Study|Withdrawal by Patient|8|||
164188119|NCT02756364|593058800|FG000|Overall Study|Lost to Follow-up|0|||
164188120|NCT02756364|593058801|FG001|Overall Study|Lost to Follow-up|1|||
164188121|NCT02756364|593058802|FG002|Overall Study|Lost to Follow-up|1|||
164188122|NCT02223364|593058803|FG000|Overall Study|Protocol Violation|3|||
164188123|NCT02223364|593058804|FG001|Overall Study|Protocol Violation|0|||
164188124|NCT02223364|593058805|FG002|Overall Study|Protocol Violation|3|||
164188125|NCT02223364|593058803|FG000|Overall Study|subject expired before surgery|1|||
164188126|NCT02223364|593058804|FG001|Overall Study|subject expired before surgery|0|||
164188127|NCT02223364|593058805|FG002|Overall Study|subject expired before surgery|0|||
164188128|NCT02223364|593058803|FG000|Overall Study|Physician Decision|1|||
164188129|NCT02223364|593058804|FG001|Overall Study|Physician Decision|0|||
164188130|NCT02223364|593058805|FG002|Overall Study|Physician Decision|0|||
164188131|NCT02984267|593058806|FG000|Overall Study|Protocol Violation|1|||
164188132|NCT02984267|593058807|FG001|Overall Study|Protocol Violation|0|||
164188133|NCT02984267|593058806|FG000|Overall Study|Withdrawal by Subject|0|||
164188134|NCT02984267|593058807|FG001|Overall Study|Withdrawal by Subject|1|||
164188135|NCT02685072|593058808|FG000|Treatment Period|Lost to Follow-up|12|||
164188136|NCT02685072|593058809|FG001|Treatment Period|Lost to Follow-up|6|||
164188137|NCT02685072|593058808|FG000|Treatment Period|Withdrawal by Subject|1|||
164188138|NCT02685072|593058809|FG001|Treatment Period|Withdrawal by Subject|3|||
164188139|NCT02685072|593058808|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
164188140|NCT02685072|593058809|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
164188141|NCT01994902|593058810|FG000|Test Period 1|Withdrawal by Subject|3|||
164188142|NCT01994902|593058811|FG001|Test Period 1|Withdrawal by Subject|0|||
164188143|NCT01994902|593058810|FG000|Test Period 1|device deficiency with adverse event|0|||
164188144|NCT01994902|593058811|FG001|Test Period 1|device deficiency with adverse event|1|||
164188145|NCT01994902|593058810|FG000|Test Period 1|Adverse Event|2|||
164188146|NCT01994902|593058811|FG001|Test Period 1|Adverse Event|1|||
164188147|NCT01994902|593058810|FG000|Test Period 1|Lack of Efficacy|0|||
164188148|NCT01994902|593058811|FG001|Test Period 1|Lack of Efficacy|1|||
164188149|NCT01994902|593058810|FG000|Test Period 1|bag too small|1|||
164188150|NCT01994902|593058811|FG001|Test Period 1|bag too small|0|||
164188151|NCT01994902|593058810|FG000|Test Period 2|Withdrawal by Subject|0|||
164188152|NCT01994902|593058811|FG001|Test Period 2|Withdrawal by Subject|2|||
164188153|NCT01994902|593058810|FG000|Test Period 2|Lack of Efficacy|0|||
164188154|NCT01994902|593058811|FG001|Test Period 2|Lack of Efficacy|1|||
164188155|NCT01994902|593058810|FG000|Test Period 2|Other|0|||
164188156|NCT01994902|593058811|FG001|Test Period 2|Other|3|||
164188157|NCT03597139|593058812|FG000|Overall Study|Adverse Event|3|||
164188158|NCT03597139|593058813|FG001|Overall Study|Adverse Event|0|||
164188159|NCT03597139|593058812|FG000|Overall Study|Protocol Non-compliance|1|||
164188160|NCT03597139|593058813|FG001|Overall Study|Protocol Non-compliance|0|||
164188161|NCT05052697|593058815|FG000|Substudy A|Lost to Follow-up|0|||
164188162|NCT05052697|593058816|FG001|Substudy A|Lost to Follow-up|0|||
164188163|NCT05052697|593058817|FG002|Substudy A|Lost to Follow-up|0|||
164188164|NCT05052697|593058818|FG003|Substudy A|Lost to Follow-up|0|||
164188165|NCT05052697|593058819|FG004|Substudy A|Lost to Follow-up|0|||
164188166|NCT05052697|593058820|FG005|Substudy A|Lost to Follow-up|1|||
164188167|NCT05052697|593058821|FG006|Substudy A|Lost to Follow-up|0|||
164188168|NCT05052697|593058822|FG007|Substudy A|Lost to Follow-up|0|||
164188169|NCT05052697|593058823|FG008|Substudy A|Lost to Follow-up|0|||
164188170|NCT05052697|593058824|FG009|Substudy A|Lost to Follow-up|0|||
164188171|NCT05052697|593058825|FG010|Substudy A|Lost to Follow-up|0|||
164188172|NCT05052697|593058826|FG011|Substudy A|Lost to Follow-up|0|||
164188173|NCT05052697|593058827|FG012|Substudy A|Lost to Follow-up|0|||
164188174|NCT05052697|593058828|FG013|Substudy A|Lost to Follow-up|0|||
164188175|NCT05052697|593058829|FG014|Substudy A|Lost to Follow-up|0|||
164188176|NCT05052697|593058830|FG015|Substudy A|Lost to Follow-up|2|||
164188177|NCT05052697|593058831|FG016|Substudy A|Lost to Follow-up|0|||
164188178|NCT05052697|593058832|FG017|Substudy A|Lost to Follow-up|0|||
164188179|NCT05052697|593058833|FG018|Substudy A|Lost to Follow-up|0|||
164188180|NCT05052697|593058834|FG019|Substudy A|Lost to Follow-up|0|||
164188181|NCT05052697|593058835|FG020|Substudy A|Lost to Follow-up|0|||
164188182|NCT05052697|593058836|FG021|Substudy A|Lost to Follow-up|0|||
164188183|NCT05052697|593058837|FG022|Substudy A|Lost to Follow-up|0|||
164188184|NCT05052697|593058838|FG023|Substudy A|Lost to Follow-up|0|||
164188185|NCT05052697|593058839|FG024|Substudy A|Lost to Follow-up|0|||
164188186|NCT05052697|593058840|FG025|Substudy A|Lost to Follow-up|0|||
164188187|NCT05052697|593058841|FG026|Substudy A|Lost to Follow-up|0|||
164188188|NCT05052697|593058842|FG027|Substudy A|Lost to Follow-up|0|||
164188189|NCT05052697|593058843|FG028|Substudy A|Lost to Follow-up|0|||
164188190|NCT05052697|593058844|FG029|Substudy A|Lost to Follow-up|0|||
164188191|NCT05052697|593058845|FG030|Substudy A|Lost to Follow-up|0|||
164188192|NCT05052697|593058846|FG031|Substudy A|Lost to Follow-up|0|||
164188193|NCT05052697|593058847|FG032|Substudy A|Lost to Follow-up|0|||
164188194|NCT05052697|593058848|FG033|Substudy A|Lost to Follow-up|0|||
164188195|NCT05052697|593058815|FG000|Substudy A|No longer met eligibility criteria|0|||
164188196|NCT05052697|593058816|FG001|Substudy A|No longer met eligibility criteria|0|||
164188197|NCT05052697|593058817|FG002|Substudy A|No longer met eligibility criteria|0|||
164188198|NCT05052697|593058818|FG003|Substudy A|No longer met eligibility criteria|0|||
164188199|NCT05052697|593058819|FG004|Substudy A|No longer met eligibility criteria|0|||
164188200|NCT05052697|593058820|FG005|Substudy A|No longer met eligibility criteria|0|||
164188201|NCT05052697|593058821|FG006|Substudy A|No longer met eligibility criteria|0|||
164188202|NCT05052697|593058822|FG007|Substudy A|No longer met eligibility criteria|0|||
164188203|NCT05052697|593058823|FG008|Substudy A|No longer met eligibility criteria|0|||
164188204|NCT05052697|593058824|FG009|Substudy A|No longer met eligibility criteria|0|||
164188205|NCT05052697|593058825|FG010|Substudy A|No longer met eligibility criteria|0|||
164188206|NCT05052697|593058826|FG011|Substudy A|No longer met eligibility criteria|0|||
164188207|NCT05052697|593058827|FG012|Substudy A|No longer met eligibility criteria|0|||
164188208|NCT05052697|593058828|FG013|Substudy A|No longer met eligibility criteria|1|||
164188209|NCT05052697|593058829|FG014|Substudy A|No longer met eligibility criteria|0|||
164188210|NCT05052697|593058830|FG015|Substudy A|No longer met eligibility criteria|0|||
164188211|NCT05052697|593058831|FG016|Substudy A|No longer met eligibility criteria|0|||
164188212|NCT05052697|593058832|FG017|Substudy A|No longer met eligibility criteria|0|||
164188213|NCT05052697|593058833|FG018|Substudy A|No longer met eligibility criteria|0|||
164188214|NCT05052697|593058834|FG019|Substudy A|No longer met eligibility criteria|0|||
164188215|NCT05052697|593058835|FG020|Substudy A|No longer met eligibility criteria|0|||
164188216|NCT05052697|593058836|FG021|Substudy A|No longer met eligibility criteria|0|||
164188217|NCT05052697|593058837|FG022|Substudy A|No longer met eligibility criteria|0|||
164188218|NCT05052697|593058838|FG023|Substudy A|No longer met eligibility criteria|0|||
164188219|NCT05052697|593058839|FG024|Substudy A|No longer met eligibility criteria|0|||
164188220|NCT05052697|593058840|FG025|Substudy A|No longer met eligibility criteria|0|||
164188221|NCT05052697|593058841|FG026|Substudy A|No longer met eligibility criteria|0|||
164188222|NCT05052697|593058842|FG027|Substudy A|No longer met eligibility criteria|0|||
164188223|NCT05052697|593058843|FG028|Substudy A|No longer met eligibility criteria|0|||
164188224|NCT05052697|593058844|FG029|Substudy A|No longer met eligibility criteria|0|||
164188225|NCT05052697|593058845|FG030|Substudy A|No longer met eligibility criteria|0|||
164188226|NCT05052697|593058846|FG031|Substudy A|No longer met eligibility criteria|0|||
164188227|NCT05052697|593058847|FG032|Substudy A|No longer met eligibility criteria|0|||
164188228|NCT05052697|593058848|FG033|Substudy A|No longer met eligibility criteria|0|||
164188229|NCT05052697|593058815|FG000|Substudy A|Not vaccinated|0|||
164188230|NCT05052697|593058816|FG001|Substudy A|Not vaccinated|0|||
164188231|NCT05052697|593058817|FG002|Substudy A|Not vaccinated|0|||
164188232|NCT05052697|593058818|FG003|Substudy A|Not vaccinated|1|||
164188233|NCT05052697|593058819|FG004|Substudy A|Not vaccinated|0|||
164188234|NCT05052697|593058820|FG005|Substudy A|Not vaccinated|0|||
164188235|NCT05052697|593058821|FG006|Substudy A|Not vaccinated|0|||
164188236|NCT05052697|593058822|FG007|Substudy A|Not vaccinated|0|||
164188237|NCT05052697|593058823|FG008|Substudy A|Not vaccinated|1|||
164188238|NCT05052697|593058824|FG009|Substudy A|Not vaccinated|0|||
164188239|NCT05052697|593058825|FG010|Substudy A|Not vaccinated|0|||
164188240|NCT05052697|593058826|FG011|Substudy A|Not vaccinated|0|||
164188241|NCT05052697|593058827|FG012|Substudy A|Not vaccinated|0|||
164188242|NCT05052697|593058828|FG013|Substudy A|Not vaccinated|0|||
164188243|NCT05052697|593058829|FG014|Substudy A|Not vaccinated|0|||
164188244|NCT05052697|593058830|FG015|Substudy A|Not vaccinated|0|||
164188245|NCT05052697|593058831|FG016|Substudy A|Not vaccinated|0|||
164188246|NCT05052697|593058832|FG017|Substudy A|Not vaccinated|0|||
164188247|NCT05052697|593058833|FG018|Substudy A|Not vaccinated|0|||
164188248|NCT05052697|593058834|FG019|Substudy A|Not vaccinated|0|||
164188249|NCT05052697|593058835|FG020|Substudy A|Not vaccinated|0|||
164188250|NCT05052697|593058836|FG021|Substudy A|Not vaccinated|0|||
164188251|NCT05052697|593058837|FG022|Substudy A|Not vaccinated|0|||
164188252|NCT05052697|593058838|FG023|Substudy A|Not vaccinated|0|||
164188253|NCT05052697|593058839|FG024|Substudy A|Not vaccinated|0|||
164188254|NCT05052697|593058840|FG025|Substudy A|Not vaccinated|0|||
164188255|NCT05052697|593058841|FG026|Substudy A|Not vaccinated|0|||
164188256|NCT05052697|593058842|FG027|Substudy A|Not vaccinated|0|||
164188257|NCT05052697|593058843|FG028|Substudy A|Not vaccinated|0|||
164188258|NCT05052697|593058844|FG029|Substudy A|Not vaccinated|0|||
164188259|NCT05052697|593058845|FG030|Substudy A|Not vaccinated|0|||
164188260|NCT05052697|593058846|FG031|Substudy A|Not vaccinated|0|||
164188261|NCT05052697|593058847|FG032|Substudy A|Not vaccinated|0|||
164188262|NCT05052697|593058848|FG033|Substudy A|Not vaccinated|0|||
164188263|NCT05052697|593058815|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188264|NCT05052697|593058816|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188265|NCT05052697|593058817|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188266|NCT05052697|593058818|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188267|NCT05052697|593058819|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188268|NCT05052697|593058820|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188269|NCT05052697|593058821|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188270|NCT05052697|593058822|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188271|NCT05052697|593058823|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188272|NCT05052697|593058824|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188273|NCT05052697|593058825|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188274|NCT05052697|593058826|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188275|NCT05052697|593058827|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188276|NCT05052697|593058828|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188277|NCT05052697|593058829|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188278|NCT05052697|593058830|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188279|NCT05052697|593058831|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188280|NCT05052697|593058832|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188281|NCT05052697|593058833|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
164188282|NCT05052697|593058834|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
164188283|NCT05052697|593058835|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188560|NCT02427802|593058864|FG000|Overall Study|Death|0|||
164188284|NCT05052697|593058836|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
164188285|NCT05052697|593058837|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
164188286|NCT05052697|593058838|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188287|NCT05052697|593058839|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188288|NCT05052697|593058840|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188289|NCT05052697|593058841|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188290|NCT05052697|593058842|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188291|NCT05052697|593058843|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188292|NCT05052697|593058844|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188293|NCT05052697|593058845|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188294|NCT05052697|593058846|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188295|NCT05052697|593058847|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188296|NCT05052697|593058848|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188297|NCT05052697|593058815|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188298|NCT05052697|593058816|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188299|NCT05052697|593058817|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188300|NCT05052697|593058818|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188301|NCT05052697|593058819|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188302|NCT05052697|593058820|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188303|NCT05052697|593058821|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188304|NCT05052697|593058822|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188305|NCT05052697|593058823|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188306|NCT05052697|593058824|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188307|NCT05052697|593058825|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188308|NCT05052697|593058826|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188309|NCT05052697|593058827|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188310|NCT05052697|593058828|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188311|NCT05052697|593058829|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188312|NCT05052697|593058830|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188313|NCT05052697|593058831|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188314|NCT05052697|593058832|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
164188315|NCT05052697|593058833|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188316|NCT05052697|593058834|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188317|NCT05052697|593058835|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188318|NCT05052697|593058836|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188319|NCT05052697|593058837|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188320|NCT05052697|593058838|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188321|NCT05052697|593058839|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188322|NCT05052697|593058840|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188323|NCT05052697|593058841|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188324|NCT05052697|593058842|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188325|NCT05052697|593058843|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188326|NCT05052697|593058844|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188327|NCT05052697|593058845|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188328|NCT05052697|593058846|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188329|NCT05052697|593058847|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188330|NCT05052697|593058848|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188331|NCT05052697|593058815|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188332|NCT05052697|593058816|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188333|NCT05052697|593058817|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188334|NCT05052697|593058818|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188335|NCT05052697|593058819|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188336|NCT05052697|593058820|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188337|NCT05052697|593058821|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188338|NCT05052697|593058822|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188339|NCT05052697|593058823|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188340|NCT05052697|593058824|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188341|NCT05052697|593058825|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188342|NCT05052697|593058826|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188343|NCT05052697|593058827|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188344|NCT05052697|593058828|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188345|NCT05052697|593058829|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188346|NCT05052697|593058830|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188347|NCT05052697|593058831|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188348|NCT05052697|593058832|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188349|NCT05052697|593058833|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188350|NCT05052697|593058834|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
164188351|NCT05052697|593058835|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188352|NCT05052697|593058836|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188353|NCT05052697|593058837|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188354|NCT05052697|593058838|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188355|NCT05052697|593058839|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188356|NCT05052697|593058840|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188357|NCT05052697|593058841|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188358|NCT05052697|593058842|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188359|NCT05052697|593058843|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188360|NCT05052697|593058844|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188361|NCT05052697|593058845|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188362|NCT05052697|593058846|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188363|NCT05052697|593058847|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188364|NCT05052697|593058848|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188365|NCT05052697|593058815|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188366|NCT05052697|593058816|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188367|NCT05052697|593058817|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188368|NCT05052697|593058818|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188369|NCT05052697|593058819|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188370|NCT05052697|593058820|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188371|NCT05052697|593058821|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188372|NCT05052697|593058822|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188373|NCT05052697|593058823|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188374|NCT05052697|593058824|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188375|NCT05052697|593058825|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188376|NCT05052697|593058826|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188377|NCT05052697|593058827|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188378|NCT05052697|593058828|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188379|NCT05052697|593058829|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188380|NCT05052697|593058830|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188381|NCT05052697|593058831|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188382|NCT05052697|593058832|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
164188383|NCT05052697|593058833|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188384|NCT05052697|593058834|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188385|NCT05052697|593058835|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188386|NCT05052697|593058836|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188387|NCT05052697|593058837|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188388|NCT05052697|593058838|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188389|NCT05052697|593058839|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188390|NCT05052697|593058840|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
164188391|NCT05052697|593058841|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188392|NCT05052697|593058842|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
164188393|NCT05052697|593058843|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188394|NCT05052697|593058844|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188395|NCT05052697|593058845|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188396|NCT05052697|593058846|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188397|NCT05052697|593058847|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188398|NCT05052697|593058848|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188399|NCT05052697|593058815|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188400|NCT05052697|593058816|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188401|NCT05052697|593058817|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188402|NCT05052697|593058818|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188403|NCT05052697|593058819|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188404|NCT05052697|593058820|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188405|NCT05052697|593058821|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188406|NCT05052697|593058822|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188407|NCT05052697|593058823|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188408|NCT05052697|593058824|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188409|NCT05052697|593058825|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188410|NCT05052697|593058826|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188411|NCT05052697|593058827|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188412|NCT05052697|593058828|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188413|NCT05052697|593058829|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188414|NCT05052697|593058830|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188415|NCT05052697|593058831|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188416|NCT05052697|593058832|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188417|NCT05052697|593058833|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188418|NCT05052697|593058834|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188419|NCT05052697|593058835|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188420|NCT05052697|593058836|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188561|NCT02427802|593058865|FG001|Overall Study|Death|4|||
164188421|NCT05052697|593058837|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188422|NCT05052697|593058838|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188423|NCT05052697|593058839|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188424|NCT05052697|593058840|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188425|NCT05052697|593058841|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188426|NCT05052697|593058842|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188427|NCT05052697|593058843|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
164188428|NCT05052697|593058844|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188429|NCT05052697|593058845|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
164188430|NCT05052697|593058846|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
164188431|NCT05052697|593058847|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
164188432|NCT05052697|593058848|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188433|NCT05052697|593058815|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188434|NCT05052697|593058816|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188435|NCT05052697|593058817|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188436|NCT05052697|593058818|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188437|NCT05052697|593058819|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188438|NCT05052697|593058820|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188439|NCT05052697|593058821|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188440|NCT05052697|593058822|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188441|NCT05052697|593058823|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188442|NCT05052697|593058824|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188443|NCT05052697|593058825|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188444|NCT05052697|593058826|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188445|NCT05052697|593058827|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188446|NCT05052697|593058828|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188447|NCT05052697|593058829|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188448|NCT05052697|593058830|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188449|NCT05052697|593058831|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188450|NCT05052697|593058832|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188451|NCT05052697|593058833|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188452|NCT05052697|593058834|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188453|NCT05052697|593058835|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188454|NCT05052697|593058836|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188455|NCT05052697|593058837|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188456|NCT05052697|593058838|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188457|NCT05052697|593058839|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188458|NCT05052697|593058840|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188459|NCT05052697|593058841|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188460|NCT05052697|593058842|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188461|NCT05052697|593058843|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
164188462|NCT05052697|593058844|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
164188463|NCT05052697|593058845|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
164188464|NCT05052697|593058846|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
164188465|NCT05052697|593058847|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
164188466|NCT05052697|593058848|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188467|NCT05052697|593058815|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188468|NCT05052697|593058816|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188469|NCT05052697|593058817|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188470|NCT05052697|593058818|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188471|NCT05052697|593058819|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188472|NCT05052697|593058820|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188473|NCT05052697|593058821|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188474|NCT05052697|593058822|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188475|NCT05052697|593058823|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188476|NCT05052697|593058824|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188477|NCT05052697|593058825|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188478|NCT05052697|593058826|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188479|NCT05052697|593058827|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188480|NCT05052697|593058828|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188481|NCT05052697|593058829|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188482|NCT05052697|593058830|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188483|NCT05052697|593058831|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188484|NCT05052697|593058832|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188485|NCT05052697|593058833|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188486|NCT05052697|593058834|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188487|NCT05052697|593058835|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188488|NCT05052697|593058836|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188489|NCT05052697|593058837|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188490|NCT05052697|593058838|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188491|NCT05052697|593058839|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188492|NCT05052697|593058840|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188493|NCT05052697|593058841|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188494|NCT05052697|593058842|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188495|NCT05052697|593058843|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188496|NCT05052697|593058844|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188497|NCT05052697|593058845|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188498|NCT05052697|593058846|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188499|NCT05052697|593058847|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
164188500|NCT05052697|593058848|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188501|NCT05052697|593058815|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188502|NCT05052697|593058816|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188503|NCT05052697|593058817|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188504|NCT05052697|593058818|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188505|NCT05052697|593058819|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188506|NCT05052697|593058820|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188507|NCT05052697|593058821|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188508|NCT05052697|593058822|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188509|NCT05052697|593058823|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188510|NCT05052697|593058824|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188511|NCT05052697|593058825|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188512|NCT05052697|593058826|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188513|NCT05052697|593058827|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188514|NCT05052697|593058828|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188515|NCT05052697|593058829|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188516|NCT05052697|593058830|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188517|NCT05052697|593058831|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188518|NCT05052697|593058832|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188519|NCT05052697|593058833|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188520|NCT05052697|593058834|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188521|NCT05052697|593058835|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188522|NCT05052697|593058836|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188523|NCT05052697|593058837|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188524|NCT05052697|593058838|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188525|NCT05052697|593058839|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188526|NCT05052697|593058840|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188527|NCT05052697|593058841|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188528|NCT05052697|593058842|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188529|NCT05052697|593058843|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
164188530|NCT05052697|593058844|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
164188531|NCT05052697|593058845|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
164188532|NCT05052697|593058846|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188533|NCT05052697|593058847|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188534|NCT05052697|593058848|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188535|NCT03796676|593058849|FG000|Overall Study|Adverse Event|2|||
164188536|NCT03796676|593058850|FG001|Overall Study|Adverse Event|1|||
164188537|NCT03796676|593058851|FG002|Overall Study|Adverse Event|2|||
164188538|NCT03796676|593058849|FG000|Overall Study|Lost to Follow-up|2|||
164188539|NCT03796676|593058850|FG001|Overall Study|Lost to Follow-up|1|||
164188540|NCT03796676|593058851|FG002|Overall Study|Lost to Follow-up|0|||
164188541|NCT03796676|593058849|FG000|Overall Study|Protocol Violation|0|||
164188542|NCT03796676|593058850|FG001|Overall Study|Protocol Violation|0|||
164188543|NCT03796676|593058851|FG002|Overall Study|Protocol Violation|1|||
164188544|NCT03796676|593058849|FG000|Overall Study|Withdrawal by Subject|1|||
164188545|NCT03796676|593058850|FG001|Overall Study|Withdrawal by Subject|1|||
164188546|NCT03796676|593058851|FG002|Overall Study|Withdrawal by Subject|0|||
164188547|NCT03796676|593058849|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
164188548|NCT03796676|593058850|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
164188549|NCT03796676|593058851|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
164188550|NCT01900899|593058854|FG000|Overall Study|Withdrawal by Subject|7|||
164188551|NCT01900899|593058855|FG001|Overall Study|Withdrawal by Subject|1|||
164188552|NCT01900899|593058854|FG000|Overall Study|Migrated from study area|2|||
164188553|NCT01900899|593058855|FG001|Overall Study|Migrated from study area|0|||
164188554|NCT02772809|593058856|FG000|Overall Study|not completed some tasks|6|||
164188555|NCT00534105|593058862|FG000|Overall Study|Lost to Follow-up|23|||
164188556|NCT00534105|593058863|FG001|Overall Study|Lost to Follow-up|39|||
164188557|NCT02427802|593058864|FG000|Overall Study|Adverse Event|11|||
164188558|NCT02427802|593058865|FG001|Overall Study|Adverse Event|3|||
164188559|NCT02427802|593058866|FG002|Overall Study|Adverse Event|7|||
164188562|NCT02427802|593058866|FG002|Overall Study|Death|1|||
164188563|NCT02427802|593058864|FG000|Overall Study|Lost to Follow-up|13|||
164188564|NCT02427802|593058865|FG001|Overall Study|Lost to Follow-up|8|||
164188565|NCT02427802|593058866|FG002|Overall Study|Lost to Follow-up|8|||
164188566|NCT02427802|593058864|FG000|Overall Study|Physician Decision|4|||
164188567|NCT02427802|593058865|FG001|Overall Study|Physician Decision|2|||
164188568|NCT02427802|593058866|FG002|Overall Study|Physician Decision|4|||
164188569|NCT02427802|593058864|FG000|Overall Study|Withdrawal by Subject|10|||
164188570|NCT02427802|593058865|FG001|Overall Study|Withdrawal by Subject|5|||
164188571|NCT02427802|593058866|FG002|Overall Study|Withdrawal by Subject|11|||
164188572|NCT02427802|593058864|FG000|Overall Study|Protocol Violation|3|||
164188573|NCT02427802|593058865|FG001|Overall Study|Protocol Violation|1|||
164188574|NCT02427802|593058866|FG002|Overall Study|Protocol Violation|1|||
164188575|NCT02427802|593058864|FG000|Overall Study|protocol specific treatment unrelated|18|||
164188576|NCT02427802|593058865|FG001|Overall Study|protocol specific treatment unrelated|11|||
164188577|NCT02427802|593058866|FG002|Overall Study|protocol specific treatment unrelated|11|||
164188578|NCT02226120|593058867|FG000|Overall Study|Adverse Event|60|||
164188579|NCT02226120|593058867|FG000|Overall Study|Death|172|||
164188580|NCT02226120|593058867|FG000|Overall Study|Study terminated by sponsor|1|||
164188581|NCT02226120|593058867|FG000|Overall Study|Technical problems|4|||
164188582|NCT02226120|593058867|FG000|Overall Study|Lost to Follow-up|13|||
164188583|NCT02226120|593058867|FG000|Overall Study|Physician Decision|21|||
164188584|NCT02226120|593058867|FG000|Overall Study|Withdrawal by parent/guardian|36|||
164188585|NCT02226120|593058867|FG000|Overall Study|Non-compliance with study drug|10|||
164188586|NCT02226120|593058867|FG000|Overall Study|Protocol deviation|1|||
164188587|NCT02226120|593058867|FG000|Overall Study|missing treatment disposition pages|2|||
164188588|NCT03034135|593058869|FG000|Overall Study|Withdrawal by Subject|2|||
164188589|NCT00467558|593058872|FG000|Overall Study|Lost to Follow-up|2|||
164188590|NCT00467558|593058873|FG001|Overall Study|Lost to Follow-up|0|||
164188591|NCT02636439|593058875|FG000|Overall Study|Adverse Event|2|||
164188592|NCT02636439|593058876|FG001|Overall Study|Adverse Event|2|||
164188593|NCT02636439|593058875|FG000|Overall Study|Lost to Follow-up|1|||
164188594|NCT02636439|593058876|FG001|Overall Study|Lost to Follow-up|0|||
164188595|NCT02636439|593058875|FG000|Overall Study|Non-compliance|1|||
164188596|NCT02636439|593058876|FG001|Overall Study|Non-compliance|1|||
164188597|NCT02636439|593058875|FG000|Overall Study|Personal reasons|2|||
164188598|NCT02636439|593058876|FG001|Overall Study|Personal reasons|0|||
164188599|NCT02494401|593058877|FG000|Overall Study|Lost to Follow-up|22|||
164188600|NCT02494401|593058878|FG001|Overall Study|Lost to Follow-up|25|||
164188601|NCT02494401|593058877|FG000|Overall Study|Withdrawal by Subject|3|||
164188602|NCT02494401|593058878|FG001|Overall Study|Withdrawal by Subject|2|||
164188603|NCT05188729|593058879|FG000|Overall Study|Withdrawal by Subject|0|||
164188604|NCT05188729|593058880|FG001|Overall Study|Withdrawal by Subject|0|||
164188605|NCT05188729|593058881|FG002|Overall Study|Withdrawal by Subject|0|||
164188606|NCT05188729|593058882|FG003|Overall Study|Withdrawal by Subject|0|||
164188607|NCT05188729|593058883|FG004|Overall Study|Withdrawal by Subject|0|||
164188608|NCT05188729|593058884|FG005|Overall Study|Withdrawal by Subject|0|||
164188609|NCT05188729|593058885|FG006|Overall Study|Withdrawal by Subject|0|||
164188610|NCT05188729|593058886|FG007|Overall Study|Withdrawal by Subject|0|||
164188611|NCT05188729|593058887|FG008|Overall Study|Withdrawal by Subject|0|||
164188612|NCT05188729|593058888|FG009|Overall Study|Withdrawal by Subject|1|||
164188613|NCT05188729|593058889|FG010|Overall Study|Withdrawal by Subject|0|||
164188614|NCT05188729|593058890|FG011|Overall Study|Withdrawal by Subject|0|||
164188615|NCT05188729|593058891|FG012|Overall Study|Withdrawal by Subject|0|||
164188616|NCT05188729|593058879|FG000|Overall Study|Lost to Follow-up|0|||
164188617|NCT05188729|593058880|FG001|Overall Study|Lost to Follow-up|0|||
164188618|NCT05188729|593058881|FG002|Overall Study|Lost to Follow-up|0|||
164188619|NCT05188729|593058882|FG003|Overall Study|Lost to Follow-up|0|||
164188620|NCT05188729|593058883|FG004|Overall Study|Lost to Follow-up|0|||
164188621|NCT05188729|593058884|FG005|Overall Study|Lost to Follow-up|0|||
164188622|NCT05188729|593058885|FG006|Overall Study|Lost to Follow-up|0|||
164188623|NCT05188729|593058886|FG007|Overall Study|Lost to Follow-up|0|||
164188624|NCT05188729|593058887|FG008|Overall Study|Lost to Follow-up|0|||
164188625|NCT05188729|593058888|FG009|Overall Study|Lost to Follow-up|0|||
164188626|NCT05188729|593058889|FG010|Overall Study|Lost to Follow-up|1|||
164188627|NCT05188729|593058890|FG011|Overall Study|Lost to Follow-up|1|||
164188628|NCT05188729|593058891|FG012|Overall Study|Lost to Follow-up|0|||
164188629|NCT00520767|593058893|FG000|Overall Study|Death|2|||
164301036|NCT03938259|593478408|FG001|Overall Study|unable to establish baseline for ventilation|1|||
164301037|NCT02435992|593478411|FG000|Overall Study|non compliance with protocol|2|||
164301038|NCT02435992|593478412|FG001|Overall Study|non compliance with protocol|0|||
164301039|NCT02435992|593478413|FG002|Overall Study|non compliance with protocol|1|||
164301040|NCT02435992|593478414|FG003|Overall Study|non compliance with protocol|0|||
164301041|NCT02435992|593478415|FG004|Overall Study|non compliance with protocol|0|||
164301042|NCT02435992|593478411|FG000|Overall Study|Adverse Event|11|||
164301043|NCT02435992|593478412|FG001|Overall Study|Adverse Event|6|||
164301044|NCT02435992|593478413|FG002|Overall Study|Adverse Event|12|||
164301045|NCT02435992|593478414|FG003|Overall Study|Adverse Event|0|||
164301082|NCT03879772|593478416|FG000|Overall Study|Withdrawal by Subject|0|||
164301083|NCT03879772|593478417|FG001|Overall Study|Withdrawal by Subject|1|||
164301084|NCT03879772|593478418|FG002|Overall Study|Withdrawal by Subject|3|||
164301085|NCT03879772|593478419|FG003|Overall Study|Withdrawal by Subject|1|||
164301086|NCT03879772|593478420|FG004|Overall Study|Withdrawal by Subject|1|||
164301087|NCT03879772|593478416|FG000|Overall Study|Protocol Violation|0|||
164301088|NCT03879772|593478417|FG001|Overall Study|Protocol Violation|0|||
164301089|NCT03879772|593478418|FG002|Overall Study|Protocol Violation|3|||
164301090|NCT03879772|593478419|FG003|Overall Study|Protocol Violation|1|||
164301091|NCT03879772|593478420|FG004|Overall Study|Protocol Violation|2|||
164301092|NCT03879772|593478416|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
164301093|NCT03879772|593478417|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
164301094|NCT03879772|593478418|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
164301095|NCT03879772|593478419|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
164301096|NCT03879772|593478420|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
164301097|NCT00389610|593478432|FG000|Overall Study|Disease Progression|0|||
164301098|NCT00389610|593478433|FG001|Overall Study|Disease Progression|19|||
164301099|NCT00389610|593478432|FG000|Overall Study|Death|0|||
164301100|NCT00389610|593478433|FG001|Overall Study|Death|1|||
164301101|NCT00389610|593478432|FG000|Overall Study|Physician Decision|0|||
164301102|NCT00389610|593478433|FG001|Overall Study|Physician Decision|1|||
164301103|NCT00389610|593478432|FG000|Overall Study|Withdrawal by Subject|0|||
164301104|NCT00389610|593478433|FG001|Overall Study|Withdrawal by Subject|1|||
164301105|NCT00887809|593478434|FG000|Overall Study|Patient Not Treated|3|||
164301106|NCT00887809|593478435|FG001|Overall Study|Patient Not Treated|0|||
164301107|NCT00887809|593478434|FG000|Overall Study|Death|1|||
164301108|NCT00887809|593478435|FG001|Overall Study|Death|0|||
164301109|NCT01210313|593478454|FG000|Overall Study|Withdrawal by Subject|3|||
164301110|NCT01210313|593478454|FG000|Overall Study|Adverse Event|2|||
164301111|NCT01210313|593478454|FG000|Overall Study|Distant recurrence|4|||
164301112|NCT01210313|593478454|FG000|Overall Study|Non-compliance|7|||
164301113|NCT03773978|593478459|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
164301114|NCT03773978|593478460|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
164301115|NCT03773978|593478459|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
164301116|NCT03773978|593478460|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
164301117|NCT03773978|593478459|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
164301118|NCT03773978|593478460|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
164301119|NCT03773978|593478459|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
164301120|NCT03773978|593478460|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
164301121|NCT03773978|593478459|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
164301122|NCT03773978|593478460|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
164301123|NCT03773978|593478459|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
164301124|NCT03773978|593478460|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
164301125|NCT03773978|593478459|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
164301126|NCT03773978|593478460|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
164301127|NCT03773978|593478459|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
164301128|NCT03773978|593478460|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
164301129|NCT03773978|593478459|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
164301130|NCT03773978|593478460|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
164301131|NCT03773978|593478459|FG000|DBW Period|Adverse Event|2|||
164301132|NCT03773978|593478460|FG001|DBW Period|Adverse Event|2|||
164301133|NCT03773978|593478459|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
164301134|NCT03773978|593478460|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
164301135|NCT03773978|593478459|FG000|DBW Period|Withdrawal by Subject|2|||
164301136|NCT03773978|593478460|FG001|DBW Period|Withdrawal by Subject|1|||
164301137|NCT03773978|593478459|FG000|DBW Period|Due to epidemic or pandemic|5|||
164301138|NCT03773978|593478460|FG001|DBW Period|Due to epidemic or pandemic|6|||
164301139|NCT03773978|593478459|FG000|DBW Period|Study team decision|1|||
164301140|NCT03773978|593478460|FG001|DBW Period|Study team decision|0|||
164301141|NCT03113487|593478461|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
164301142|NCT03777982|593478462|FG000|Overall Study|Physician Decision|0|||
164301143|NCT03777982|593478463|FG001|Overall Study|Physician Decision|1|||
164301144|NCT00870740|593478464|FG000|Overall Study|Adverse Event|2|||
164301145|NCT00870740|593478465|FG001|Overall Study|Adverse Event|1|||
164301146|NCT00870740|593478466|FG002|Overall Study|Adverse Event|3|||
164301147|NCT00870740|593478467|FG003|Overall Study|Adverse Event|2|||
164301148|NCT00870740|593478468|FG004|Overall Study|Adverse Event|1|||
164301149|NCT00870740|593478469|FG005|Overall Study|Adverse Event|6|||
164301150|NCT00870740|593478464|FG000|Overall Study|Consent Withdrawn|6|||
164301151|NCT00870740|593478465|FG001|Overall Study|Consent Withdrawn|3|||
164301152|NCT00870740|593478466|FG002|Overall Study|Consent Withdrawn|4|||
164301153|NCT00870740|593478467|FG003|Overall Study|Consent Withdrawn|6|||
164301154|NCT00870740|593478468|FG004|Overall Study|Consent Withdrawn|6|||
164301155|NCT00870740|593478469|FG005|Overall Study|Consent Withdrawn|5|||
164301156|NCT00870740|593478464|FG000|Overall Study|Investigator Decision|2|||
164301157|NCT00870740|593478465|FG001|Overall Study|Investigator Decision|0|||
164301158|NCT00870740|593478466|FG002|Overall Study|Investigator Decision|1|||
164301159|NCT00870740|593478467|FG003|Overall Study|Investigator Decision|0|||
164301160|NCT00870740|593478468|FG004|Overall Study|Investigator Decision|0|||
164301161|NCT00870740|593478469|FG005|Overall Study|Investigator Decision|0|||
164301162|NCT00870740|593478464|FG000|Overall Study|Subject Non-compliance|0|||
164301163|NCT00870740|593478465|FG001|Overall Study|Subject Non-compliance|0|||
164301164|NCT00870740|593478466|FG002|Overall Study|Subject Non-compliance|0|||
164301165|NCT00870740|593478467|FG003|Overall Study|Subject Non-compliance|0|||
164301166|NCT00870740|593478468|FG004|Overall Study|Subject Non-compliance|0|||
164301167|NCT00870740|593478469|FG005|Overall Study|Subject Non-compliance|1|||
164301168|NCT00870740|593478464|FG000|Overall Study|Death|0|||
164301169|NCT00870740|593478465|FG001|Overall Study|Death|0|||
164301170|NCT00870740|593478466|FG002|Overall Study|Death|0|||
164301171|NCT00870740|593478467|FG003|Overall Study|Death|0|||
164301172|NCT00870740|593478468|FG004|Overall Study|Death|1|||
164301173|NCT00870740|593478469|FG005|Overall Study|Death|0|||
164301174|NCT00870740|593478464|FG000|Overall Study|Other|2|||
164301175|NCT00870740|593478465|FG001|Overall Study|Other|5|||
164301176|NCT00870740|593478466|FG002|Overall Study|Other|2|||
164301177|NCT00870740|593478467|FG003|Overall Study|Other|4|||
164301178|NCT00870740|593478468|FG004|Overall Study|Other|3|||
164301179|NCT00870740|593478469|FG005|Overall Study|Other|5|||
164301180|NCT01502293|593478477|FG000|Overall Study|Progressive Disease|20|||
164301181|NCT01502293|593478478|FG001|Overall Study|Progressive Disease|12|||
164301182|NCT01502293|593478479|FG002|Overall Study|Progressive Disease|2|||
164301183|NCT01502293|593478477|FG000|Overall Study|Withdrawal by Subject|3|||
164301184|NCT01502293|593478478|FG001|Overall Study|Withdrawal by Subject|3|||
164301185|NCT01502293|593478479|FG002|Overall Study|Withdrawal by Subject|1|||
164301186|NCT01502293|593478477|FG000|Overall Study|Adverse Event|0|||
164301187|NCT01502293|593478478|FG001|Overall Study|Adverse Event|2|||
164301188|NCT01502293|593478479|FG002|Overall Study|Adverse Event|0|||
164301189|NCT01502293|593478477|FG000|Overall Study|Reason Not Specified|2|||
164301190|NCT01502293|593478478|FG001|Overall Study|Reason Not Specified|0|||
164301191|NCT01502293|593478479|FG002|Overall Study|Reason Not Specified|0|||
164301192|NCT01502293|593478477|FG000|Overall Study|Physician Decision|0|||
164301193|NCT01502293|593478478|FG001|Overall Study|Physician Decision|0|||
164301194|NCT01502293|593478479|FG002|Overall Study|Physician Decision|1|||
164301195|NCT03944577|593478484|FG000|Overall Study|Adverse Event|3|||
164301196|NCT00391586|593478485|FG000|Overall Study|Progressive disease|13|||
164301197|NCT00391586|593478485|FG000|Overall Study|Adverse Event|5|||
164301198|NCT00391586|593478485|FG000|Overall Study|Physician Decision|2|||
164301199|NCT00391586|593478485|FG000|Overall Study|Death|4|||
164301200|NCT03011099|593478486|FG000|Overall Study|Withdrawal by Subject|0|||
164301201|NCT03011099|593478487|FG001|Overall Study|Withdrawal by Subject|2|||
164301202|NCT03058146|593478488|FG000|Overall Study|Withdrawal by Subject|4|||
164301203|NCT03058146|593478489|FG001|Overall Study|Withdrawal by Subject|1|||
164301204|NCT03058146|593478488|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
164301205|NCT03058146|593478489|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
164301206|NCT03041181|593478490|FG000|Overall Study|Disease Progression|1|||
164301207|NCT03041181|593478491|FG001|Overall Study|Disease Progression|2|||
164301208|NCT02667119|593478492|FG000|Overall Study|Lost to Follow-up|3|||
164301209|NCT02667119|593478493|FG001|Overall Study|Lost to Follow-up|0|||
164301210|NCT00521079|593478496|FG000|Overall Study|Adverse Event|7|||
164301211|NCT00521079|593478497|FG001|Overall Study|Adverse Event|1|||
164301212|NCT00521079|593478496|FG000|Overall Study|Lost to Follow-up|2|||
164301213|NCT00521079|593478497|FG001|Overall Study|Lost to Follow-up|1|||
164301214|NCT00521079|593478496|FG000|Overall Study|Withdrawal by Subject|5|||
164301215|NCT00521079|593478497|FG001|Overall Study|Withdrawal by Subject|3|||
164301216|NCT04123470|593478500|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
164301217|NCT04123470|593478501|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
164301218|NCT04123470|593478500|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
164301219|NCT04123470|593478501|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
164301220|NCT04123470|593478500|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
164301221|NCT04123470|593478501|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
164301222|NCT04123470|593478500|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
164301223|NCT04123470|593478501|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
164301224|NCT03435211|593478502|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
164301225|NCT05972993|593478503|FG000|Overall Study|Lost to Follow-up|2|||
164301226|NCT05972993|593478504|FG001|Overall Study|Lost to Follow-up|0|||
164301227|NCT05972993|593478505|FG002|Overall Study|Lost to Follow-up|1|||
164301228|NCT05972993|593478506|FG003|Overall Study|Lost to Follow-up|0|||
164301229|NCT05972993|593478507|FG004|Overall Study|Lost to Follow-up|0|||
164301230|NCT05972993|593478508|FG005|Overall Study|Lost to Follow-up|0|||
164301231|NCT05972993|593478509|FG006|Overall Study|Lost to Follow-up|0|||
164301232|NCT05972993|593478510|FG007|Overall Study|Lost to Follow-up|2|||
164301233|NCT05972993|593478511|FG008|Overall Study|Lost to Follow-up|0|||
164301234|NCT03818256|593478513|FG000|Overall Study|Withdrawal by Subject|2|||
164301235|NCT03818256|593478514|FG001|Overall Study|Withdrawal by Subject|2|||
164301236|NCT03818256|593478513|FG000|Overall Study|Adverse Event|3|||
164301237|NCT03818256|593478514|FG001|Overall Study|Adverse Event|1|||
164301238|NCT03818256|593478513|FG000|Overall Study|Lost to Follow-up|0|||
164301239|NCT03818256|593478514|FG001|Overall Study|Lost to Follow-up|5|||
164301240|NCT03818256|593478513|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
164301241|NCT03818256|593478514|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
164301242|NCT03818256|593478513|FG000|Overall Study|Not reporting for scheduled visits|1|||
164301243|NCT03818256|593478514|FG001|Overall Study|Not reporting for scheduled visits|0|||
164301244|NCT03818256|593478513|FG000|Overall Study|Non-compliant with investigational product|1|||
164301245|NCT03818256|593478514|FG001|Overall Study|Non-compliant with investigational product|0|||
164301246|NCT02749422|593478515|FG000|Overall Study|Lost to Follow-up|0|||
164301247|NCT02749422|593478516|FG001|Overall Study|Lost to Follow-up|2|||
164301248|NCT02749422|593478515|FG000|Overall Study|Ineligible|0|||
164301249|NCT02749422|593478516|FG001|Overall Study|Ineligible|1|||
164301250|NCT00911170|593478517|FG000|Treatment Period|Randomized in error|1|||
164301251|NCT00911170|593478518|FG001|Treatment Period|Randomized in error|1|||
164301252|NCT00911170|593478517|FG000|Treatment Period|Ineligibility determined|1|||
164301253|NCT00911170|593478518|FG001|Treatment Period|Ineligibility determined|3|||
164301254|NCT00911170|593478517|FG000|Treatment Period|Protocol deviation|1|||
164301255|NCT00911170|593478518|FG001|Treatment Period|Protocol deviation|2|||
164301256|NCT00911170|593478517|FG000|Treatment Period|Adverse Event|9|||
164301257|NCT00911170|593478518|FG001|Treatment Period|Adverse Event|10|||
164301258|NCT00911170|593478517|FG000|Treatment Period|Withdrawal by Subject|4|||
164301259|NCT00911170|593478518|FG001|Treatment Period|Withdrawal by Subject|4|||
164301260|NCT00911170|593478517|FG000|Treatment Period|Disease progression|0|||
164301261|NCT00911170|593478518|FG001|Treatment Period|Disease progression|2|||
164301262|NCT00911170|593478517|FG000|Treatment Period|Physician Decision|5|||
164301263|NCT00911170|593478518|FG001|Treatment Period|Physician Decision|5|||
164301264|NCT00911170|593478517|FG000|Treatment Period|Lost to Follow-up|0|||
164301265|NCT00911170|593478518|FG001|Treatment Period|Lost to Follow-up|1|||
164301266|NCT00911170|593478517|FG000|Treatment Period|Death|6|||
164301267|NCT00911170|593478518|FG001|Treatment Period|Death|9|||
164301268|NCT00911170|593478517|FG000|Long Term Follow-Up|Continuing in study|274|||
164301269|NCT00911170|593478518|FG001|Long Term Follow-Up|Continuing in study|269|||
164301270|NCT00911170|593478517|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
164301271|NCT00911170|593478518|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
164301272|NCT00911170|593478517|FG000|Long Term Follow-Up|Physician Decision|5|||
164301273|NCT00911170|593478518|FG001|Long Term Follow-Up|Physician Decision|4|||
164301274|NCT00911170|593478517|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
164301275|NCT00911170|593478518|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
164301276|NCT00911170|593478517|FG000|Long Term Follow-Up|Death|116|||
164301277|NCT00911170|593478518|FG001|Long Term Follow-Up|Death|121|||
164301278|NCT02681523|593478519|FG000|Overall Study|Adverse Event|1|||
164301279|NCT02681523|593478519|FG000|Overall Study|Patient Non-compliance|1|||
164301280|NCT00554216|593480122|FG000|Overall Study|Lost to Follow-up|92|||
164301281|NCT00554216|593480123|FG001|Overall Study|Lost to Follow-up|31|||
164301282|NCT00554216|593480124|FG002|Overall Study|Lost to Follow-up|63|||
164301283|NCT00554216|593480122|FG000|Overall Study|Adverse Event|16|||
164301284|NCT00554216|593480123|FG001|Overall Study|Adverse Event|16|||
164301285|NCT00554216|593480124|FG002|Overall Study|Adverse Event|36|||
164301286|NCT00554216|593480122|FG000|Overall Study|Withdrawal by Subject|92|||
164301287|NCT00554216|593480123|FG001|Overall Study|Withdrawal by Subject|31|||
164301288|NCT00554216|593480124|FG002|Overall Study|Withdrawal by Subject|43|||
164301289|NCT00554216|593480122|FG000|Overall Study|Non compliance|10|||
164301290|NCT00554216|593480123|FG001|Overall Study|Non compliance|4|||
164301291|NCT00554216|593480124|FG002|Overall Study|Non compliance|5|||
164301292|NCT00554216|593480122|FG000|Overall Study|Pregnancy|2|||
164301293|NCT00554216|593480123|FG001|Overall Study|Pregnancy|1|||
164301294|NCT00554216|593480124|FG002|Overall Study|Pregnancy|14|||
164301295|NCT00554216|593480122|FG000|Overall Study|Restricted med|3|||
164301296|NCT00554216|593480123|FG001|Overall Study|Restricted med|1|||
164301297|NCT00554216|593480124|FG002|Overall Study|Restricted med|1|||
164301298|NCT00554216|593480122|FG000|Overall Study|Other|12|||
164301299|NCT00554216|593480123|FG001|Overall Study|Other|7|||
164301300|NCT00554216|593480124|FG002|Overall Study|Other|10|||
164301301|NCT00554216|593480122|FG000|Overall Study|Lack of Efficacy|15|||
164301302|NCT00554216|593480123|FG001|Overall Study|Lack of Efficacy|3|||
164301303|NCT00554216|593480124|FG002|Overall Study|Lack of Efficacy|0|||
164301304|NCT01347112|593480125|FG000|Overall Study|Withdrawal by Subject|1|||
164301305|NCT01347112|593480126|FG001|Overall Study|Withdrawal by Subject|7|||
164301306|NCT01347112|593480125|FG000|Overall Study|Lost to Follow-up|3|||
164301307|NCT01347112|593480126|FG001|Overall Study|Lost to Follow-up|5|||
164301308|NCT05462756|593480131|FG000|Treatment Period|Adverse Event|3|||
164301309|NCT05462756|593480132|FG001|Treatment Period|Adverse Event|0|||
164301310|NCT05462756|593480131|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
164301311|NCT05462756|593480132|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
164301312|NCT05462756|593480131|FG000|Treatment Period|Death|0|||
164301404|NCT00463567|593480149|FG004|Overall Study|Administrative problems|3|||
164301405|NCT00463567|593480150|FG005|Overall Study|Administrative problems|2|||
164301406|NCT00463567|593480151|FG006|Overall Study|Administrative problems|2|||
164301407|NCT00463567|593480145|FG000|Overall Study|Lack of Efficacy|4|||
164301408|NCT00463567|593480146|FG001|Overall Study|Lack of Efficacy|9|||
164301409|NCT00463567|593480147|FG002|Overall Study|Lack of Efficacy|9|||
164301410|NCT00463567|593480148|FG003|Overall Study|Lack of Efficacy|17|||
164301411|NCT00463567|593480149|FG004|Overall Study|Lack of Efficacy|1|||
164301412|NCT00463567|593480150|FG005|Overall Study|Lack of Efficacy|0|||
164301413|NCT00463567|593480151|FG006|Overall Study|Lack of Efficacy|1|||
164301414|NCT00463567|593480145|FG000|Overall Study|Abnormal lab value(s)|1|||
164301415|NCT00463567|593480146|FG001|Overall Study|Abnormal lab value(s)|1|||
164301416|NCT00463567|593480147|FG002|Overall Study|Abnormal lab value(s)|2|||
164301417|NCT00463567|593480148|FG003|Overall Study|Abnormal lab value(s)|1|||
164301418|NCT00463567|593480149|FG004|Overall Study|Abnormal lab value(s)|1|||
164301419|NCT00463567|593480150|FG005|Overall Study|Abnormal lab value(s)|0|||
164301420|NCT00463567|593480151|FG006|Overall Study|Abnormal lab value(s)|0|||
164301421|NCT00463567|593480145|FG000|Overall Study|Abnormal test procedure result(s)|1|||
164301422|NCT00463567|593480146|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164301423|NCT00463567|593480147|FG002|Overall Study|Abnormal test procedure result(s)|6|||
164301424|NCT00463567|593480148|FG003|Overall Study|Abnormal test procedure result(s)|2|||
164301425|NCT00463567|593480149|FG004|Overall Study|Abnormal test procedure result(s)|0|||
164301426|NCT00463567|593480150|FG005|Overall Study|Abnormal test procedure result(s)|2|||
164301427|NCT00463567|593480151|FG006|Overall Study|Abnormal test procedure result(s)|0|||
164301428|NCT00463567|593480145|FG000|Overall Study|Death|1|||
164301429|NCT00463567|593480146|FG001|Overall Study|Death|0|||
164301430|NCT00463567|593480147|FG002|Overall Study|Death|2|||
164301431|NCT00463567|593480148|FG003|Overall Study|Death|0|||
164301432|NCT00463567|593480149|FG004|Overall Study|Death|0|||
164301433|NCT00463567|593480150|FG005|Overall Study|Death|0|||
164301434|NCT00463567|593480151|FG006|Overall Study|Death|0|||
164301435|NCT01432730|593480152|FG000|Period 1|Adverse Event|2|||
164301436|NCT01432730|593480153|FG001|Period 1|Adverse Event|0|||
164301437|NCT01432730|593480152|FG000|Period 2|Adverse Event|0|||
164301438|NCT01432730|593480153|FG001|Period 2|Adverse Event|4|||
164301439|NCT00641667|593480154|FG000|Overall Study|Withdrawal by Subject|1|||
164301440|NCT00641667|593480154|FG000|Overall Study|Adverse Event|1|||
164301441|NCT00641667|593480154|FG000|Overall Study|Physician Decision|1|||
164301442|NCT00641667|593480154|FG000|Overall Study|Worsening of underlying disease|3|||
164301443|NCT01235741|593480155|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
164301444|NCT01235741|593480156|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
164301445|NCT01235741|593480157|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
164301446|NCT01235741|593480155|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
164301447|NCT01235741|593480156|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
164301448|NCT01235741|593480157|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
164301449|NCT01235741|593480155|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
164301450|NCT01235741|593480156|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
164301451|NCT01235741|593480157|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
164301452|NCT01235741|593480155|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
164301453|NCT01235741|593480156|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
164301454|NCT01235741|593480157|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
164301455|NCT01235741|593480155|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
164301456|NCT01235741|593480156|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
164301457|NCT01235741|593480157|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
164301458|NCT01235741|593480155|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
164301459|NCT01235741|593480156|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
164301460|NCT01235741|593480157|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
164301461|NCT01235741|593480155|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
164301462|NCT01235741|593480156|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
164301463|NCT01235741|593480157|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
164301464|NCT01235741|593480155|FG000|Randomized to Treatment|Adverse Event|0|||
164301465|NCT01235741|593480156|FG001|Randomized to Treatment|Adverse Event|1|||
164301466|NCT01235741|593480157|FG002|Randomized to Treatment|Adverse Event|1|||
164301467|NCT01235741|593480155|FG000|Randomized to Treatment|Sponsor terminated study|0|||
164301468|NCT01235741|593480156|FG001|Randomized to Treatment|Sponsor terminated study|35|||
164301469|NCT01235741|593480157|FG002|Randomized to Treatment|Sponsor terminated study|34|||
164301470|NCT01235741|593480155|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
164301471|NCT01235741|593480156|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
164301472|NCT01235741|593480157|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
164301473|NCT01235741|593480155|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
164301474|NCT01235741|593480156|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
164301475|NCT01235741|593480157|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
164301476|NCT01235741|593480155|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
164301477|NCT01235741|593480156|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
164301478|NCT01235741|593480157|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
164301479|NCT01705509|593480158|FG000|Inclusion CPET|Screen Failure|5|||
164301480|NCT01705509|593480158|FG000|Inclusion CPET|Withdrawal by Subject|2|||
164301481|NCT01705509|593480158|FG000|CPET w/ Ranexa|Screen Failure|2|||
164301482|NCT00904033|593480159|FG000|Overall Study|Withdrawal by Subject|1|||
164301483|NCT00904033|593480160|FG001|Overall Study|Withdrawal by Subject|1|||
164301484|NCT00904033|593480161|FG002|Overall Study|Withdrawal by Subject|0|||
164301485|NCT00904033|593480162|FG003|Overall Study|Withdrawal by Subject|0|||
164301486|NCT00904033|593480159|FG000|Overall Study|Physician Decision|0|||
164301487|NCT00904033|593480160|FG001|Overall Study|Physician Decision|0|||
164301488|NCT00904033|593480161|FG002|Overall Study|Physician Decision|1|||
164301489|NCT00904033|593480162|FG003|Overall Study|Physician Decision|0|||
164301490|NCT00904033|593480159|FG000|Overall Study|Unable to obtain final blood draw|0|||
164301491|NCT00904033|593480160|FG001|Overall Study|Unable to obtain final blood draw|0|||
164301492|NCT00904033|593480161|FG002|Overall Study|Unable to obtain final blood draw|0|||
164301493|NCT00904033|593480162|FG003|Overall Study|Unable to obtain final blood draw|2|||
164301494|NCT01774721|593480166|FG000|Overall Study|Death|133|||
164301495|NCT01774721|593480167|FG001|Overall Study|Death|152|||
164301496|NCT01774721|593480166|FG000|Overall Study|Withdrawal by Subject|20|||
164301497|NCT01774721|593480167|FG001|Overall Study|Withdrawal by Subject|14|||
164301498|NCT01774721|593480166|FG000|Overall Study|Lost to Follow-up|6|||
164301499|NCT01774721|593480167|FG001|Overall Study|Lost to Follow-up|7|||
164301500|NCT01774721|593480166|FG000|Overall Study|Did not meet eligibility criteria|0|||
164301501|NCT01774721|593480167|FG001|Overall Study|Did not meet eligibility criteria|3|||
164301502|NCT01774721|593480166|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
164301503|NCT01774721|593480167|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
164301504|NCT01774721|593480166|FG000|Overall Study|Study terminated by sponsor|5|||
164301505|NCT01774721|593480167|FG001|Overall Study|Study terminated by sponsor|0|||
164301506|NCT01774721|593480166|FG000|Overall Study|Disease progression|5|||
164301507|NCT01774721|593480167|FG001|Overall Study|Disease progression|0|||
164301508|NCT00118417|593480170|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
164301509|NCT00118417|593480171|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
164301510|NCT00118417|593480170|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
164301511|NCT00118417|593480171|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
164301512|NCT00118417|593480170|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
164301513|NCT00118417|593480171|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
164301514|NCT00118417|593480170|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
164301515|NCT00118417|593480171|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
164301516|NCT00118417|593480170|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
164301517|NCT00118417|593480171|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
164301518|NCT02978781|593480172|FG000|Part A|Adverse Event|1|||
164301519|NCT02978781|593480173|FG001|Part A|Adverse Event|1|||
164301520|NCT02978781|593480174|FG002|Part A|Adverse Event|0|||
164301521|NCT02978781|593480175|FG003|Part A|Adverse Event|0|||
164301522|NCT02978781|593480176|FG004|Part A|Adverse Event|0|||
164301523|NCT02978781|593480172|FG000|Part A|Withdrawal by Subject|0|||
164301524|NCT02978781|593480173|FG001|Part A|Withdrawal by Subject|1|||
164301525|NCT02978781|593480174|FG002|Part A|Withdrawal by Subject|0|||
164301526|NCT02978781|593480175|FG003|Part A|Withdrawal by Subject|0|||
164301527|NCT02978781|593480176|FG004|Part A|Withdrawal by Subject|0|||
164301528|NCT02978781|593480172|FG000|Part B|Withdrawal by Subject|0|||
164301529|NCT02978781|593480173|FG001|Part B|Withdrawal by Subject|0|||
164301530|NCT02978781|593480174|FG002|Part B|Withdrawal by Subject|0|||
164301531|NCT02978781|593480175|FG003|Part B|Withdrawal by Subject|1|||
164301532|NCT02978781|593480176|FG004|Part B|Withdrawal by Subject|0|||
164301533|NCT02978781|593480172|FG000|Part C|Adverse Event|0|||
164301534|NCT02978781|593480173|FG001|Part C|Adverse Event|0|||
164301535|NCT02978781|593480174|FG002|Part C|Adverse Event|0|||
164301536|NCT02978781|593480175|FG003|Part C|Adverse Event|0|||
164301537|NCT02978781|593480176|FG004|Part C|Adverse Event|2|||
164301538|NCT02978781|593480172|FG000|Part C|Withdrawal by Subject|0|||
164301539|NCT02978781|593480173|FG001|Part C|Withdrawal by Subject|0|||
164301540|NCT02978781|593480174|FG002|Part C|Withdrawal by Subject|0|||
164301541|NCT02978781|593480175|FG003|Part C|Withdrawal by Subject|0|||
164301542|NCT02978781|593480176|FG004|Part C|Withdrawal by Subject|1|||
164301543|NCT02978781|593480172|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
164301544|NCT02978781|593480173|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
164301545|NCT02978781|593480174|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
164301546|NCT02978781|593480175|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
164301547|NCT02978781|593480176|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
164301548|NCT01383356|593480177|FG000|Period 1|Adverse Event|5|||
164301549|NCT01383356|593480178|FG001|Period 1|Adverse Event|3|||
164301550|NCT01383356|593480177|FG000|Period 1|Non-compliance|3|||
164301551|NCT01383356|593480178|FG001|Period 1|Non-compliance|0|||
164301552|NCT01383356|593480177|FG000|Period 1|Out of Range Mid-study-Test|0|||
164301553|NCT01383356|593480178|FG001|Period 1|Out of Range Mid-study-Test|1|||
164301554|NCT01383356|593480177|FG000|Period 1|Personal|0|||
164301555|NCT01383356|593480178|FG001|Period 1|Personal|2|||
164301556|NCT02035267|593480179|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
164301557|NCT02035267|593480180|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
164301558|NCT02035267|593480181|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
164301559|NCT02035267|593480182|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
164301560|NCT02035267|593480179|FG000|Overall Study|Adverse Event|0|||
164301561|NCT02035267|593480180|FG001|Overall Study|Adverse Event|0|||
164301562|NCT02035267|593480181|FG002|Overall Study|Adverse Event|1|||
164301563|NCT02035267|593480182|FG003|Overall Study|Adverse Event|0|||
164301564|NCT02035267|593480179|FG000|Overall Study|Lost to Follow-up|0|||
164301565|NCT02035267|593480180|FG001|Overall Study|Lost to Follow-up|0|||
164301566|NCT02035267|593480181|FG002|Overall Study|Lost to Follow-up|0|||
164301567|NCT02035267|593480182|FG003|Overall Study|Lost to Follow-up|1|||
164301568|NCT02035267|593480179|FG000|Overall Study|Other unspecified|0|||
164301569|NCT02035267|593480180|FG001|Overall Study|Other unspecified|1|||
164301570|NCT02035267|593480181|FG002|Overall Study|Other unspecified|0|||
164301571|NCT02035267|593480182|FG003|Overall Study|Other unspecified|0|||
164301572|NCT02054104|593480184|FG000|Overall Study|Did not want to continue due to college classes|1|||
164301573|NCT02054104|593480185|FG001|Overall Study|Did not want to continue due to college classes|0|||
164301574|NCT02054104|593480184|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
164301575|NCT02054104|593480185|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
164301576|NCT02054104|593480184|FG000|Overall Study|No evidence of immunologic response|2|||
164301577|NCT02054104|593480185|FG001|Overall Study|No evidence of immunologic response|2|||
164301578|NCT02054104|593480184|FG000|Overall Study|Disease Progression On Study|4|||
164301579|NCT02054104|593480185|FG001|Overall Study|Disease Progression On Study|5|||
164301580|NCT02054104|593480184|FG000|Overall Study|Diagnosis of lymphoma|0|||
164301581|NCT02054104|593480185|FG001|Overall Study|Diagnosis of lymphoma|1|||
164301582|NCT02054104|593480184|FG000|Overall Study|Inconclusive response|0|||
164301583|NCT02054104|593480185|FG001|Overall Study|Inconclusive response|1|||
164301584|NCT00084136|593480188|FG000|PI Comparison|Death|10|||
164301585|NCT00084136|593480189|FG001|PI Comparison|Death|9|||
164301586|NCT00084136|593480190|FG002|PI Comparison|Death|0|||
164301587|NCT00084136|593480188|FG000|PI Comparison|Lost to Follow-up|11|||
164301588|NCT00084136|593480189|FG001|PI Comparison|Lost to Follow-up|8|||
164301589|NCT00084136|593480190|FG002|PI Comparison|Lost to Follow-up|0|||
164301590|NCT00084136|593480188|FG000|PI Comparison|Withdrawal by Subject|33|||
164301591|NCT00084136|593480189|FG001|PI Comparison|Withdrawal by Subject|30|||
164301592|NCT00084136|593480190|FG002|PI Comparison|Withdrawal by Subject|0|||
164301593|NCT00084136|593480188|FG000|PI Comparison|Clinic site closed|1|||
164301594|NCT00084136|593480189|FG001|PI Comparison|Clinic site closed|0|||
164301595|NCT00084136|593480190|FG002|PI Comparison|Clinic site closed|0|||
164301596|NCT00084136|593480188|FG000|NRTI Comparison|Death|20|||
164301597|NCT00084136|593480189|FG001|NRTI Comparison|Death|0|||
164301598|NCT00084136|593480190|FG002|NRTI Comparison|Death|18|||
164301599|NCT00084136|593480188|FG000|NRTI Comparison|Lost to Follow-up|14|||
164301600|NCT00084136|593480189|FG001|NRTI Comparison|Lost to Follow-up|0|||
164301601|NCT00084136|593480190|FG002|NRTI Comparison|Lost to Follow-up|12|||
164301602|NCT00084136|593480188|FG000|NRTI Comparison|Withdrawal by Subject|54|||
164301603|NCT00084136|593480189|FG001|NRTI Comparison|Withdrawal by Subject|0|||
164301604|NCT00084136|593480190|FG002|NRTI Comparison|Withdrawal by Subject|38|||
164301605|NCT00084136|593480188|FG000|NRTI Comparison|Clinic site closed|12|||
164301606|NCT00084136|593480189|FG001|NRTI Comparison|Clinic site closed|0|||
164301607|NCT00084136|593480190|FG002|NRTI Comparison|Clinic site closed|14|||
164301608|NCT00084136|593480188|FG000|NRTI Comparison|Not reason above|1|||
164301609|NCT00084136|593480189|FG001|NRTI Comparison|Not reason above|0|||
164301610|NCT00084136|593480190|FG002|NRTI Comparison|Not reason above|0|||
164301611|NCT00836693|593480196|FG000|Overall Study|Adverse Event|4|||
164301612|NCT00836693|593480197|FG001|Overall Study|Adverse Event|1|||
164301613|NCT00836693|593480196|FG000|Overall Study|Sponsor Decision|0|||
164301614|NCT00836693|593480197|FG001|Overall Study|Sponsor Decision|1|||
164301615|NCT00836693|593480196|FG000|Overall Study|Physician Decision|2|||
164301616|NCT00836693|593480197|FG001|Overall Study|Physician Decision|0|||
164301617|NCT00836693|593480196|FG000|Overall Study|Withdrawal by Subject|9|||
164301618|NCT00836693|593480197|FG001|Overall Study|Withdrawal by Subject|4|||
164301619|NCT00836693|593480196|FG000|Overall Study|Protocol Violation|1|||
164301620|NCT00836693|593480197|FG001|Overall Study|Protocol Violation|0|||
164301621|NCT00836693|593480196|FG000|Overall Study|Lost to Follow-up|1|||
164301622|NCT00836693|593480197|FG001|Overall Study|Lost to Follow-up|0|||
164301623|NCT02633306|593480200|FG000|Overall Study|Withdrawal by Subject|3|||
164301624|NCT01657019|593480201|FG000|Overall Study|Withdrawal by Subject|65|||
164301625|NCT01657019|593480201|FG000|Overall Study|Adverse Event|55|||
164301626|NCT01657019|593480201|FG000|Overall Study|Lost to Follow-up|48|||
164301627|NCT01657019|593480201|FG000|Overall Study|Protocol Violation|6|||
164301628|NCT01657019|593480201|FG000|Overall Study|Lack of Efficacy|3|||
164301629|NCT01657019|593480201|FG000|Overall Study|Other|58|||
164301630|NCT01213472|593480202|FG000|Overall Study|Recurrence/Progressive disease|25|||
164301631|NCT01213472|593480202|FG000|Overall Study|Withdrawal by Subject|1|||
164301632|NCT01213472|593480202|FG000|Overall Study|Physician Decision|1|||
164301633|NCT00129402|593480219|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
164301634|NCT00129402|593480220|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
164301635|NCT00129402|593480221|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
164301636|NCT00129402|593480222|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
164301637|NCT00129402|593480223|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
164301638|NCT00129402|593480224|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
164301639|NCT00129402|593480225|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
164301640|NCT00129402|593480219|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
164301641|NCT00129402|593480220|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
164301642|NCT00129402|593480221|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
164301643|NCT00129402|593480222|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
164301644|NCT00129402|593480223|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
164301645|NCT00129402|593480224|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
164301646|NCT00129402|593480225|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
164301647|NCT00129402|593480219|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
164301648|NCT00129402|593480220|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
164301649|NCT00129402|593480221|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
164301650|NCT00129402|593480222|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
164301651|NCT00129402|593480223|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
164301652|NCT00129402|593480224|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
164301653|NCT00129402|593480225|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
164301654|NCT00129402|593480219|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
164301655|NCT00129402|593480220|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
164301656|NCT00129402|593480221|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
164301657|NCT00129402|593480222|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
164301658|NCT00129402|593480223|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
164301659|NCT00129402|593480224|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
164301660|NCT00129402|593480225|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
164301661|NCT00129402|593480219|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
164301662|NCT00129402|593480220|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
164301663|NCT00129402|593480221|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
164301664|NCT00129402|593480222|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
164301665|NCT00129402|593480223|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
164301666|NCT00129402|593480224|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
164301667|NCT00129402|593480225|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
164301668|NCT00129402|593480219|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
164301669|NCT00129402|593480220|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
164301670|NCT00129402|593480221|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
164301671|NCT00129402|593480222|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
164301672|NCT00129402|593480223|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
164301673|NCT00129402|593480224|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
164301674|NCT00129402|593480225|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
164301675|NCT00129402|593480219|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
164301676|NCT00129402|593480220|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
164301677|NCT00129402|593480221|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
164301678|NCT00129402|593480222|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
164301679|NCT00129402|593480223|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
164301680|NCT00129402|593480224|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
164301681|NCT00129402|593480225|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
164301682|NCT00129402|593480219|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
164301683|NCT00129402|593480220|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
164301684|NCT00129402|593480221|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
164301685|NCT00129402|593480222|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
164301686|NCT00129402|593480223|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
164301687|NCT00129402|593480224|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
164301688|NCT00129402|593480225|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
164301689|NCT00129402|593480219|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
164301690|NCT00129402|593480220|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
164301691|NCT00129402|593480221|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
164301692|NCT00129402|593480222|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
164301693|NCT00129402|593480223|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
164301694|NCT00129402|593480224|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
164301695|NCT00129402|593480225|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
164301696|NCT00129402|593480219|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
164301697|NCT00129402|593480220|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
164301698|NCT00129402|593480221|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
164301699|NCT00129402|593480222|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
164301700|NCT00129402|593480223|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
164301701|NCT00129402|593480224|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
164301702|NCT00129402|593480225|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
164301703|NCT00129402|593480219|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
164301704|NCT00129402|593480220|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
164301705|NCT00129402|593480221|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
164301706|NCT00129402|593480222|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
164301707|NCT00129402|593480223|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
164301708|NCT00129402|593480224|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
164301709|NCT00129402|593480225|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
164301710|NCT00129402|593480219|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
164301711|NCT00129402|593480220|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
164301712|NCT00129402|593480221|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
164301713|NCT00129402|593480222|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
164301714|NCT00129402|593480223|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
164301715|NCT00129402|593480224|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
164301716|NCT00129402|593480225|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
164301717|NCT00129402|593480219|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
164301718|NCT00129402|593480220|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
164301719|NCT00129402|593480221|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
164301720|NCT00129402|593480222|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
164301721|NCT00129402|593480223|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
164301722|NCT00129402|593480224|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
164301723|NCT00129402|593480225|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
164301724|NCT02131259|593480226|FG000|Overall Study|Progressive disease|751|||
164301725|NCT02131259|593480226|FG000|Overall Study|Adverse Event|341|||
164301726|NCT02131259|593480226|FG000|Overall Study|Lost to Follow-up|7|||
164301727|NCT02131259|593480226|FG000|Overall Study|Relocation|32|||
164301728|NCT02131259|593480226|FG000|Overall Study|Other|63|||
164301729|NCT02131259|593480226|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
164301730|NCT02131259|593480226|FG000|Overall Study|Progressive disease/relocation|1|||
164301731|NCT02131259|593480226|FG000|Overall Study|Progressive disease/other|2|||
164301732|NCT02131259|593480226|FG000|Overall Study|AE/lost to follow-up|1|||
164301733|NCT02131259|593480226|FG000|Overall Study|AE/other|1|||
164301734|NCT02131259|593480226|FG000|Overall Study|Progressive disease/AE/other|1|||
164301735|NCT02131259|593480226|FG000|Overall Study|Missing|3|||
164301736|NCT01472289|593480231|FG000|Overall Study|Death|2|||
164301737|NCT00907335|593480232|FG000|Overall Study|Withdrawal by Subject|2|||
164301738|NCT00907335|593480233|FG001|Overall Study|Withdrawal by Subject|0|||
164301739|NCT00907335|593480232|FG000|Overall Study|Adverse Event|4|||
164301740|NCT00907335|593480233|FG001|Overall Study|Adverse Event|1|||
164301741|NCT00907335|593480232|FG000|Overall Study|Lost to Follow-up|2|||
164301742|NCT00907335|593480233|FG001|Overall Study|Lost to Follow-up|0|||
164301743|NCT03131570|593480234|FG000|Overall Study|Adverse Event|1|||
164301744|NCT03131570|593480235|FG001|Overall Study|Adverse Event|0|||
164301745|NCT04596267|593480236|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
164301746|NCT04596267|593480237|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
164301747|NCT04596267|593480236|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
164301748|NCT04596267|593480237|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
164301749|NCT00071058|593480238|FG000|Overall Study|brain tumor-removed from study|1|||
164301750|NCT04189952|593480242|FG000|Follow-up Period|Death|1|||
164301751|NCT04189952|593480242|FG000|Follow-up Period|Withdrawal by Subject|1|||
164301752|NCT01498068|593480243|FG000|Overall Study|Withdrawal by Subject|1|||
164301753|NCT01498068|593480244|FG001|Overall Study|Withdrawal by Subject|1|||
164301754|NCT00361296|593480248|FG000|Overall Study|Physician Decision|1|||
164301755|NCT00361296|593480248|FG000|Overall Study|Lack of Efficacy|2|||
164301756|NCT00198822|593480249|FG000|Overall Study|Lost to Follow-up|14|||
164301757|NCT00198822|593480250|FG001|Overall Study|Lost to Follow-up|20|||
164301758|NCT00198822|593480251|FG002|Overall Study|Lost to Follow-up|21|||
164301759|NCT00453206|593480255|FG000|Overall Study|Death|1|||
164301760|NCT04672239|593480258|FG000|Week 2 Survey|Failed survey check items|1|||
164301761|NCT04672239|593480259|FG001|Week 2 Survey|Failed survey check items|2|||
164301762|NCT04672239|593480260|FG002|Week 2 Survey|Failed survey check items|3|||
164301763|NCT04672239|593480258|FG000|Week 2 Survey|Partially completed survey|7|||
164301764|NCT04672239|593480259|FG001|Week 2 Survey|Partially completed survey|1|||
164301765|NCT04672239|593480260|FG002|Week 2 Survey|Partially completed survey|4|||
164301766|NCT04672239|593480258|FG000|Week 2 Survey|Withdrawal by Subject|0|||
164301767|NCT04672239|593480259|FG001|Week 2 Survey|Withdrawal by Subject|1|||
164301768|NCT04672239|593480260|FG002|Week 2 Survey|Withdrawal by Subject|0|||
164301769|NCT04672239|593480258|FG000|Week 2 Survey|Lost to Follow-up|3|||
164301770|NCT04672239|593480259|FG001|Week 2 Survey|Lost to Follow-up|2|||
164301771|NCT04672239|593480260|FG002|Week 2 Survey|Lost to Follow-up|5|||
164301772|NCT04672239|593480258|FG000|Week 6 Survey|Failed survey check items|2|||
164301773|NCT04672239|593480259|FG001|Week 6 Survey|Failed survey check items|2|||
164301774|NCT04672239|593480260|FG002|Week 6 Survey|Failed survey check items|2|||
164301775|NCT04672239|593480258|FG000|Week 6 Survey|Partially completed survey|3|||
164301776|NCT04672239|593480259|FG001|Week 6 Survey|Partially completed survey|3|||
164301777|NCT04672239|593480260|FG002|Week 6 Survey|Partially completed survey|2|||
164301778|NCT04672239|593480258|FG000|Week 6 Survey|Withdrawal by Subject|1|||
164301779|NCT04672239|593480259|FG001|Week 6 Survey|Withdrawal by Subject|1|||
164301780|NCT04672239|593480260|FG002|Week 6 Survey|Withdrawal by Subject|1|||
164301781|NCT04672239|593480258|FG000|Week 6 Survey|Withdrawn by PI|0|||
164301782|NCT04672239|593480259|FG001|Week 6 Survey|Withdrawn by PI|1|||
164301783|NCT04672239|593480260|FG002|Week 6 Survey|Withdrawn by PI|0|||
164301784|NCT04672239|593480258|FG000|Week 6 Survey|Lost to Follow-up|12|||
164301785|NCT04672239|593480259|FG001|Week 6 Survey|Lost to Follow-up|2|||
164301786|NCT04672239|593480260|FG002|Week 6 Survey|Lost to Follow-up|5|||
164301787|NCT04672239|593480258|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
164301788|NCT04672239|593480259|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
164301789|NCT04672239|593480260|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
164301790|NCT04672239|593480258|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
164301791|NCT04672239|593480259|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
164301792|NCT04672239|593480260|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
164301793|NCT04672239|593480258|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
164301794|NCT04672239|593480259|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
164301795|NCT04672239|593480260|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
164301796|NCT04672239|593480258|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
164301797|NCT04672239|593480259|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
164301798|NCT04672239|593480260|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
164301799|NCT04672239|593480258|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
164301800|NCT04672239|593480259|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
164301801|NCT04672239|593480260|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
164301802|NCT04672239|593480258|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
164301803|NCT04672239|593480259|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
164301804|NCT04672239|593480260|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
164301805|NCT04672239|593480258|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
164301806|NCT04672239|593480259|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
164301807|NCT04672239|593480260|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
164301808|NCT03866577|593480263|FG000|Overall Study|Protocol Violation|0|||
164301809|NCT03866577|593480264|FG001|Overall Study|Protocol Violation|0|||
164301810|NCT03866577|593480265|FG002|Overall Study|Protocol Violation|0|||
164301811|NCT03866577|593480266|FG003|Overall Study|Protocol Violation|0|||
164301812|NCT03866577|593480267|FG004|Overall Study|Protocol Violation|0|||
164301813|NCT03866577|593480268|FG005|Overall Study|Protocol Violation|0|||
164301814|NCT03866577|593480269|FG006|Overall Study|Protocol Violation|0|||
164301815|NCT03866577|593480270|FG007|Overall Study|Protocol Violation|0|||
164301816|NCT03866577|593480271|FG008|Overall Study|Protocol Violation|0|||
164301817|NCT03866577|593480272|FG009|Overall Study|Protocol Violation|0|||
164301818|NCT03866577|593480273|FG010|Overall Study|Protocol Violation|0|||
164301819|NCT03866577|593480274|FG011|Overall Study|Protocol Violation|1|||
164301820|NCT03866577|593480275|FG012|Overall Study|Protocol Violation|0|||
164301821|NCT03866577|593480263|FG000|Overall Study|Withdrawal by Subject|0|||
164301822|NCT03866577|593480264|FG001|Overall Study|Withdrawal by Subject|0|||
164301823|NCT03866577|593480265|FG002|Overall Study|Withdrawal by Subject|0|||
164301824|NCT03866577|593480266|FG003|Overall Study|Withdrawal by Subject|0|||
164301825|NCT03866577|593480267|FG004|Overall Study|Withdrawal by Subject|0|||
164301826|NCT03866577|593480268|FG005|Overall Study|Withdrawal by Subject|0|||
164301827|NCT03866577|593480269|FG006|Overall Study|Withdrawal by Subject|0|||
164301828|NCT03866577|593480270|FG007|Overall Study|Withdrawal by Subject|0|||
164301829|NCT03866577|593480271|FG008|Overall Study|Withdrawal by Subject|1|||
164301830|NCT03866577|593480272|FG009|Overall Study|Withdrawal by Subject|1|||
164301831|NCT03866577|593480273|FG010|Overall Study|Withdrawal by Subject|0|||
164301832|NCT03866577|593480274|FG011|Overall Study|Withdrawal by Subject|0|||
164301833|NCT03866577|593480275|FG012|Overall Study|Withdrawal by Subject|0|||
164301834|NCT03866577|593480263|FG000|Overall Study|Not qualified for IVIg infusion|0|||
164301835|NCT03866577|593480264|FG001|Overall Study|Not qualified for IVIg infusion|0|||
164301836|NCT03866577|593480265|FG002|Overall Study|Not qualified for IVIg infusion|0|||
164301837|NCT03866577|593480266|FG003|Overall Study|Not qualified for IVIg infusion|0|||
164301838|NCT03866577|593480267|FG004|Overall Study|Not qualified for IVIg infusion|0|||
164301839|NCT03866577|593480268|FG005|Overall Study|Not qualified for IVIg infusion|0|||
164301840|NCT03866577|593480269|FG006|Overall Study|Not qualified for IVIg infusion|0|||
164301841|NCT03866577|593480270|FG007|Overall Study|Not qualified for IVIg infusion|0|||
164301842|NCT03866577|593480271|FG008|Overall Study|Not qualified for IVIg infusion|0|||
164301843|NCT03866577|593480272|FG009|Overall Study|Not qualified for IVIg infusion|1|||
164301844|NCT03866577|593480273|FG010|Overall Study|Not qualified for IVIg infusion|0|||
164301845|NCT03866577|593480274|FG011|Overall Study|Not qualified for IVIg infusion|0|||
164301846|NCT03866577|593480275|FG012|Overall Study|Not qualified for IVIg infusion|0|||
164301847|NCT04825678|593480276|FG000|Overall Study|Decision by Sponsor|2|||
164301848|NCT04825678|593480277|FG001|Overall Study|Decision by Sponsor|3|||
164301849|NCT04825678|593480276|FG000|Overall Study|Withdrawal of Consent From Study|7|||
164301850|NCT04825678|593480277|FG001|Overall Study|Withdrawal of Consent From Study|9|||
164301851|NCT04825678|593480276|FG000|Overall Study|Lost to Follow-up|3|||
164301852|NCT04825678|593480277|FG001|Overall Study|Lost to Follow-up|4|||
164301853|NCT04825678|593480276|FG000|Overall Study|Never Received Investigational Product|1|||
164301854|NCT04825678|593480277|FG001|Overall Study|Never Received Investigational Product|1|||
164301855|NCT01342211|593480278|FG000|Overall Study|Lost to Follow-up|0|||
164301856|NCT01342211|593480279|FG001|Overall Study|Lost to Follow-up|0|||
164301857|NCT01342211|593480280|FG002|Overall Study|Lost to Follow-up|0|||
164301858|NCT01342211|593480281|FG003|Overall Study|Lost to Follow-up|1|||
164301859|NCT01342211|593480282|FG004|Overall Study|Lost to Follow-up|0|||
164301860|NCT01342211|593480278|FG000|Overall Study|Adverse Event|0|||
164301861|NCT01342211|593480279|FG001|Overall Study|Adverse Event|0|||
164301862|NCT01342211|593480280|FG002|Overall Study|Adverse Event|0|||
164301863|NCT01342211|593480281|FG003|Overall Study|Adverse Event|0|||
164301864|NCT01342211|593480282|FG004|Overall Study|Adverse Event|1|||
164301865|NCT01342211|593480278|FG000|Overall Study|Withdrawal by Subject|0|||
164301866|NCT01342211|593480279|FG001|Overall Study|Withdrawal by Subject|0|||
164301867|NCT01342211|593480280|FG002|Overall Study|Withdrawal by Subject|0|||
164301868|NCT01342211|593480281|FG003|Overall Study|Withdrawal by Subject|1|||
164301869|NCT01342211|593480282|FG004|Overall Study|Withdrawal by Subject|0|||
164301870|NCT01342211|593480278|FG000|Overall Study|Randomized, but not Treated|0|||
164301871|NCT01342211|593480279|FG001|Overall Study|Randomized, but not Treated|2|||
164301872|NCT01342211|593480280|FG002|Overall Study|Randomized, but not Treated|0|||
164301873|NCT01342211|593480281|FG003|Overall Study|Randomized, but not Treated|0|||
164301874|NCT01342211|593480282|FG004|Overall Study|Randomized, but not Treated|1|||
164301875|NCT05430854|593480283|FG000|Overall Study|Trial terminated by Sponsor|39|||
164301876|NCT05430854|593480284|FG001|Overall Study|Trial terminated by Sponsor|50|||
164301877|NCT05430854|593480285|FG002|Overall Study|Trial terminated by Sponsor|46|||
164301878|NCT05430854|593480283|FG000|Overall Study|Withdrawal by Subject|0|||
164301879|NCT05430854|593480284|FG001|Overall Study|Withdrawal by Subject|3|||
164301880|NCT05430854|593480285|FG002|Overall Study|Withdrawal by Subject|0|||
164301881|NCT01824836|593480288|FG000|Overall Study|Adverse Event|48|||
164301882|NCT01824836|593480288|FG000|Overall Study|Withdrawal by Subject|63|||
164301883|NCT01824836|593480288|FG000|Overall Study|Other complicating disease|116|||
164301884|NCT01824836|593480288|FG000|Overall Study|Disease progression|5|||
164301885|NCT01824836|593480288|FG000|Overall Study|Alternative therapy|2|||
164301886|NCT01824836|593480288|FG000|Overall Study|Depression|1|||
164301887|NCT01824836|593480288|FG000|Overall Study|Non-compliance|3|||
164301888|NCT01824836|593480288|FG000|Overall Study|Patient regained ovarian function|3|||
164301889|NCT01824836|593480288|FG000|Overall Study|Lost to Follow-up|8|||
164301890|NCT01824836|593480288|FG000|Overall Study|Physician Decision|2|||
164301891|NCT01824836|593480288|FG000|Overall Study|Research office was closed|3|||
164301892|NCT01824836|593480288|FG000|Overall Study|Relocation|3|||
164301893|NCT01824836|593480288|FG000|Overall Study|Insurance-related issue|1|||
164301894|NCT01824836|593480288|FG000|Overall Study|Transportation issue|1|||
164301895|NCT01824836|593480288|FG000|Overall Study|Patient transferred care|1|||
164301896|NCT01824836|593480288|FG000|Overall Study|Unknown reasons|4|||
164301897|NCT01824836|593480288|FG000|Overall Study|Never started treatment|16|||
164301898|NCT03253393|593480289|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
164301899|NCT03253393|593480290|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
164301900|NCT03253393|593480291|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
164301901|NCT01987453|593482441|FG000|Overall Study|Death|0|||
164301902|NCT01987453|593482442|FG001|Overall Study|Death|0|||
164301903|NCT01987453|593482443|FG002|Overall Study|Death|1|||
164301904|NCT01987453|593482441|FG000|Overall Study|Lack of Efficacy|1|||
164301905|NCT01987453|593482442|FG001|Overall Study|Lack of Efficacy|12|||
164301906|NCT01987453|593482443|FG002|Overall Study|Lack of Efficacy|0|||
164301907|NCT05291520|593482446|FG000|Overall Study|Lost to Follow-up|0|||
164301908|NCT05291520|593482447|FG001|Overall Study|Lost to Follow-up|0|||
164301909|NCT05291520|593482448|FG002|Overall Study|Lost to Follow-up|1|||
164301910|NCT01354899|593482453|FG000|Overall Study|discharge from the hospital|2|||
164301911|NCT01354899|593482453|FG000|Overall Study|Protocol Violation|1|||
164301912|NCT01421719|593482458|FG000|Overall Study|Withdrawal by Subject|4|||
164301913|NCT01124006|593482459|FG000|Overall Study|Withdrawal by Subject|2|||
164301914|NCT01124006|593482460|FG001|Overall Study|Withdrawal by Subject|2|||
164301915|NCT01124006|593482461|FG002|Overall Study|Withdrawal by Subject|0|||
164301916|NCT01124006|593482459|FG000|Overall Study|Lost to Follow-up|1|||
164301917|NCT01124006|593482460|FG001|Overall Study|Lost to Follow-up|0|||
164301918|NCT01124006|593482461|FG002|Overall Study|Lost to Follow-up|1|||
164301919|NCT01124006|593482459|FG000|Overall Study|Other|0|||
164301920|NCT01124006|593482460|FG001|Overall Study|Other|0|||
164301921|NCT01124006|593482461|FG002|Overall Study|Other|1|||
164301922|NCT01357850|593482471|FG000|Overall Study|Lost to Follow-up|1|||
164301923|NCT01357850|593482472|FG001|Overall Study|Lost to Follow-up|0|||
164301924|NCT01357850|593482473|FG002|Overall Study|Lost to Follow-up|0|||
164301925|NCT01357850|593482474|FG003|Overall Study|Lost to Follow-up|0|||
164301926|NCT02736890|593482475|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
164301927|NCT02736890|593482476|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
164301928|NCT02736890|593482475|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
164301929|NCT02736890|593482476|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
164301930|NCT02351856|593482477|FG000|Overall Study|Adverse Event|2|||
164301931|NCT02351856|593482477|FG000|Overall Study|Physician Decision|5|||
164301932|NCT02351856|593482477|FG000|Overall Study|Study terminated by sponsor|1|||
164301933|NCT02904954|593482478|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
164301934|NCT02904954|593482479|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
164301935|NCT02904954|593482478|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
164301936|NCT02904954|593482479|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
164301937|NCT02904954|593482478|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
164301938|NCT02904954|593482479|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
164301939|NCT02904954|593482478|FG000|Adjuvant Durvalumab|Recurrence|2|||
164301940|NCT02904954|593482479|FG001|Adjuvant Durvalumab|Recurrence|0|||
164301941|NCT02904954|593482478|FG000|Adjuvant Durvalumab|Adverse Event|2|||
164301942|NCT02904954|593482479|FG001|Adjuvant Durvalumab|Adverse Event|6|||
164301943|NCT02904954|593482478|FG000|Adjuvant Durvalumab|Participant wishes|12|||
164301944|NCT02904954|593482479|FG001|Adjuvant Durvalumab|Participant wishes|7|||
164301945|NCT02904954|593482478|FG000|Adjuvant Durvalumab|Physician Decision|2|||
164301946|NCT02904954|593482479|FG001|Adjuvant Durvalumab|Physician Decision|1|||
164301947|NCT02904954|593482478|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
164301948|NCT02904954|593482479|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
164301949|NCT02904954|593482478|FG000|Adjuvant Durvalumab|Death|0|||
164301950|NCT02904954|593482479|FG001|Adjuvant Durvalumab|Death|1|||
164301951|NCT02904954|593482478|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
164301952|NCT02904954|593482479|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
164301953|NCT01198795|593482480|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
164301954|NCT01198795|593482480|FG000|Overall Study|Withdrawal by Subject|17|||
164301955|NCT01198795|593482480|FG000|Overall Study|Lost to Follow-up|15|||
164301956|NCT01198795|593482480|FG000|Overall Study|Adverse Event|9|||
164301957|NCT01198795|593482480|FG000|Overall Study|Lack of Efficacy|5|||
164301958|NCT01198795|593482480|FG000|Overall Study|Protocol Violation|2|||
164301959|NCT01198795|593482480|FG000|Overall Study|Other Reason|4|||
164301960|NCT00753506|593482481|FG000|Overall Study|Withdrawal by Subject|4|||
164301961|NCT00753506|593482482|FG001|Overall Study|Withdrawal by Subject|1|||
164301962|NCT00753506|593482481|FG000|Overall Study|Lost to Follow-up|2|||
164301963|NCT00753506|593482482|FG001|Overall Study|Lost to Follow-up|0|||
164301964|NCT00753506|593482481|FG000|Overall Study|Other reason|1|||
164301965|NCT00753506|593482482|FG001|Overall Study|Other reason|1|||
164301966|NCT03819114|593482483|FG000|Overall Study|Protocol Violation|0|||
164301967|NCT03819114|593482484|FG001|Overall Study|Protocol Violation|1|||
164301968|NCT03819114|593482485|FG002|Overall Study|Protocol Violation|1|||
164301969|NCT03819114|593482486|FG003|Overall Study|Protocol Violation|0|||
164301970|NCT03819114|593482483|FG000|Overall Study|Lost to Follow-up|0|||
164301971|NCT03819114|593482484|FG001|Overall Study|Lost to Follow-up|0|||
164301972|NCT03819114|593482485|FG002|Overall Study|Lost to Follow-up|1|||
164301973|NCT03819114|593482486|FG003|Overall Study|Lost to Follow-up|0|||
164301974|NCT04226742|593482487|FG000|Overall Study|Lost to Follow-up|16|||
164301975|NCT04226742|593482488|FG001|Overall Study|Lost to Follow-up|13|||
164301976|NCT04226742|593482487|FG000|Overall Study|Withdrawal by Subject|5|||
164301977|NCT04226742|593482488|FG001|Overall Study|Withdrawal by Subject|3|||
164301978|NCT01936870|593482495|FG000|Overall Study|No Visit After Treatment|176|||
164301979|NCT01936870|593482495|FG000|Overall Study|Protocol Violation|12|||
164301980|NCT01936870|593482495|FG000|Overall Study|No Drug Administration|1|||
164301981|NCT00248040|593482500|FG000|Overall Study|transplantectomy|2|||
164301982|NCT00248040|593482501|FG001|Overall Study|transplantectomy|1|||
164301983|NCT00248040|593482502|FG002|Overall Study|transplantectomy|3|||
164301984|NCT00248040|593482500|FG000|Overall Study|transplant cancelled post treat start|1|||
164301985|NCT00248040|593482501|FG001|Overall Study|transplant cancelled post treat start|0|||
164301986|NCT00248040|593482502|FG002|Overall Study|transplant cancelled post treat start|0|||
164301987|NCT00248040|593482500|FG000|Overall Study|Death|0|||
164301988|NCT00248040|593482501|FG001|Overall Study|Death|0|||
164302042|NCT02395471|593482509|FG000|Overall Study|Withdrawal by Subject|2|||
164302043|NCT02395471|593482510|FG001|Overall Study|Withdrawal by Subject|1|||
164302044|NCT02395471|593482509|FG000|Overall Study|Physician Decision|1|||
164302045|NCT02395471|593482510|FG001|Overall Study|Physician Decision|0|||
164302046|NCT02395471|593482509|FG000|Overall Study|Protocol Violation|0|||
164302047|NCT02395471|593482510|FG001|Overall Study|Protocol Violation|1|||
164302048|NCT02395471|593482509|FG000|Overall Study|Failure to swollow sponge twice|1|||
164302049|NCT02395471|593482510|FG001|Overall Study|Failure to swollow sponge twice|0|||
164302050|NCT02395471|593482509|FG000|Overall Study|Patient did not return for procedure|0|||
164302051|NCT02395471|593482510|FG001|Overall Study|Patient did not return for procedure|1|||
164302052|NCT02395471|593482509|FG000|Overall Study|Subject not eligible|1|||
164302053|NCT02395471|593482510|FG001|Overall Study|Subject not eligible|0|||
164302054|NCT03038880|593482516|FG000|Overall Study|Death|1|||
164302055|NCT03038880|593482517|FG001|Overall Study|Death|2|||
164302056|NCT03038880|593482518|FG002|Overall Study|Death|0|||
164302057|NCT03038880|593482516|FG000|Overall Study|Physician Decision|2|||
164302058|NCT03038880|593482517|FG001|Overall Study|Physician Decision|1|||
164302059|NCT03038880|593482518|FG002|Overall Study|Physician Decision|0|||
164302060|NCT03926611|593482523|FG000|Overall Study|Adverse Event|0|||
164302061|NCT03926611|593482524|FG001|Overall Study|Adverse Event|0|||
164302062|NCT03926611|593482525|FG002|Overall Study|Adverse Event|0|||
164302063|NCT03926611|593482526|FG003|Overall Study|Adverse Event|3|||
164302064|NCT03926611|593482527|FG004|Overall Study|Adverse Event|1|||
164302065|NCT03926611|593482528|FG005|Overall Study|Adverse Event|3|||
164302066|NCT03926611|593482529|FG006|Overall Study|Adverse Event|0|||
164302067|NCT03926611|593482523|FG000|Overall Study|Lack of Efficacy|1|||
164302068|NCT03926611|593482524|FG001|Overall Study|Lack of Efficacy|2|||
164302069|NCT03926611|593482525|FG002|Overall Study|Lack of Efficacy|0|||
164302070|NCT03926611|593482526|FG003|Overall Study|Lack of Efficacy|0|||
164302071|NCT03926611|593482527|FG004|Overall Study|Lack of Efficacy|1|||
164302072|NCT03926611|593482528|FG005|Overall Study|Lack of Efficacy|0|||
164302073|NCT03926611|593482529|FG006|Overall Study|Lack of Efficacy|1|||
164302074|NCT03926611|593482523|FG000|Overall Study|Physician Decision|0|||
164302075|NCT03926611|593482524|FG001|Overall Study|Physician Decision|0|||
164302076|NCT03926611|593482525|FG002|Overall Study|Physician Decision|0|||
164302077|NCT03926611|593482526|FG003|Overall Study|Physician Decision|0|||
164302078|NCT03926611|593482527|FG004|Overall Study|Physician Decision|0|||
164302079|NCT03926611|593482528|FG005|Overall Study|Physician Decision|1|||
164302080|NCT03926611|593482529|FG006|Overall Study|Physician Decision|0|||
164302081|NCT03926611|593482523|FG000|Overall Study|Protocol Violation|1|||
164302082|NCT03926611|593482524|FG001|Overall Study|Protocol Violation|0|||
164302083|NCT03926611|593482525|FG002|Overall Study|Protocol Violation|0|||
164302084|NCT03926611|593482526|FG003|Overall Study|Protocol Violation|1|||
164302085|NCT03926611|593482527|FG004|Overall Study|Protocol Violation|1|||
164302086|NCT03926611|593482528|FG005|Overall Study|Protocol Violation|1|||
164302087|NCT03926611|593482529|FG006|Overall Study|Protocol Violation|1|||
164302088|NCT03926611|593482523|FG000|Overall Study|Technical problems|0|||
164302089|NCT03926611|593482524|FG001|Overall Study|Technical problems|0|||
164302090|NCT03926611|593482525|FG002|Overall Study|Technical problems|0|||
164302091|NCT03926611|593482526|FG003|Overall Study|Technical problems|0|||
164302092|NCT03926611|593482527|FG004|Overall Study|Technical problems|0|||
164302093|NCT03926611|593482528|FG005|Overall Study|Technical problems|1|||
164302094|NCT03926611|593482529|FG006|Overall Study|Technical problems|0|||
164302095|NCT03926611|593482523|FG000|Overall Study|Withdrawal by Subject|1|||
164302096|NCT03926611|593482524|FG001|Overall Study|Withdrawal by Subject|1|||
164302097|NCT03926611|593482525|FG002|Overall Study|Withdrawal by Subject|1|||
164302098|NCT03926611|593482526|FG003|Overall Study|Withdrawal by Subject|0|||
164302099|NCT03926611|593482527|FG004|Overall Study|Withdrawal by Subject|0|||
164302100|NCT03926611|593482528|FG005|Overall Study|Withdrawal by Subject|1|||
164302101|NCT03926611|593482529|FG006|Overall Study|Withdrawal by Subject|3|||
164302102|NCT03926611|593482523|FG000|Overall Study|Covid-19 pandemic|0|||
164302103|NCT03926611|593482524|FG001|Overall Study|Covid-19 pandemic|0|||
164302104|NCT03926611|593482525|FG002|Overall Study|Covid-19 pandemic|1|||
164302105|NCT03926611|593482526|FG003|Overall Study|Covid-19 pandemic|0|||
164302106|NCT03926611|593482527|FG004|Overall Study|Covid-19 pandemic|1|||
164302107|NCT03926611|593482528|FG005|Overall Study|Covid-19 pandemic|2|||
164302108|NCT03926611|593482529|FG006|Overall Study|Covid-19 pandemic|0|||
164302109|NCT02612779|593482530|FG000|Overall Study|Administrative reason by sponsor|4|||
164302110|NCT02612779|593482531|FG001|Overall Study|Administrative reason by sponsor|1|||
164302111|NCT02612779|593482530|FG000|Overall Study|No longer meet study criteria|0|||
164302112|NCT02612779|593482531|FG001|Overall Study|No longer meet study criteria|1|||
164302113|NCT02612779|593482530|FG000|Overall Study|Disease progression|29|||
164302114|NCT02612779|593482531|FG001|Overall Study|Disease progression|2|||
164302115|NCT02612779|593482530|FG000|Overall Study|Study drug toxicity|10|||
164302116|NCT02612779|593482531|FG001|Overall Study|Study drug toxicity|1|||
164302117|NCT02612779|593482530|FG000|Overall Study|Death|1|||
164302118|NCT02612779|593482531|FG001|Overall Study|Death|0|||
164302119|NCT02612779|593482530|FG000|Overall Study|Adverse event unrelated to study drug|5|||
164302120|NCT02612779|593482531|FG001|Overall Study|Adverse event unrelated to study drug|0|||
164302121|NCT02612779|593482530|FG000|Overall Study|Participant withdrew consent|4|||
164302122|NCT02612779|593482531|FG001|Overall Study|Participant withdrew consent|0|||
164302123|NCT02612779|593482530|FG000|Overall Study|Lost to Follow-up|1|||
164302124|NCT02612779|593482531|FG001|Overall Study|Lost to Follow-up|0|||
164302125|NCT02612779|593482530|FG000|Overall Study|Maximum clinical benefit|10|||
164302126|NCT02612779|593482531|FG001|Overall Study|Maximum clinical benefit|1|||
164302127|NCT02612779|593482530|FG000|Overall Study|Other reasons|4|||
164302128|NCT02612779|593482531|FG001|Overall Study|Other reasons|0|||
164302129|NCT03041038|593482532|FG000|Overall Study|Withdrawal by Subject|4|||
164302130|NCT03041038|593482533|FG001|Overall Study|Withdrawal by Subject|0|||
164302131|NCT03041038|593482532|FG000|Overall Study|Lost to Follow-up|1|||
164302132|NCT03041038|593482533|FG001|Overall Study|Lost to Follow-up|1|||
164302133|NCT03041038|593482532|FG000|Overall Study|Protocol Violation|1|||
164302134|NCT03041038|593482533|FG001|Overall Study|Protocol Violation|1|||
164302135|NCT00763035|593482534|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
164302136|NCT00763035|593482535|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
164302137|NCT00763035|593482534|FG000|First Intervention|Adverse Event|0|||
164302138|NCT00763035|593482535|FG001|First Intervention|Adverse Event|1|||
164302139|NCT00763035|593482534|FG000|Second Intervention|Adverse Event|1|||
164302140|NCT00763035|593482535|FG001|Second Intervention|Adverse Event|0|||
164302141|NCT00763035|593482534|FG000|Second Intervention|Physician Decision|2|||
164302142|NCT00763035|593482535|FG001|Second Intervention|Physician Decision|0|||
164302143|NCT02796170|593482536|FG000|Overall Study|Lost to Follow-up|3|||
164302144|NCT02796170|593482537|FG001|Overall Study|Lost to Follow-up|0|||
164302145|NCT01527370|593482538|FG000|Overall Study|Withdrawal by Subject|4|||
164302146|NCT01527370|593482538|FG000|Overall Study|Physician Decision|1|||
164302147|NCT01527370|593482538|FG000|Overall Study|Death|1|||
164302148|NCT02177032|593482541|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
164302149|NCT02177032|593482542|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
164302150|NCT02177032|593482543|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
164302151|NCT02177032|593482544|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
164302152|NCT02177032|593482541|FG000|Overall Study|Lost to Follow-up|0|||
164302153|NCT02177032|593482542|FG001|Overall Study|Lost to Follow-up|2|||
164302154|NCT02177032|593482543|FG002|Overall Study|Lost to Follow-up|0|||
164302155|NCT02177032|593482544|FG003|Overall Study|Lost to Follow-up|0|||
164302156|NCT02177032|593482541|FG000|Overall Study|OTHER|2|||
164302157|NCT02177032|593482542|FG001|Overall Study|OTHER|0|||
164302158|NCT02177032|593482543|FG002|Overall Study|OTHER|1|||
164302159|NCT02177032|593482544|FG003|Overall Study|OTHER|0|||
164302160|NCT02177032|593482541|FG000|Overall Study|Withdrawal by Subject|1|||
164302161|NCT02177032|593482542|FG001|Overall Study|Withdrawal by Subject|0|||
164302162|NCT02177032|593482543|FG002|Overall Study|Withdrawal by Subject|1|||
164302163|NCT02177032|593482544|FG003|Overall Study|Withdrawal by Subject|0|||
164302164|NCT00930046|593482545|FG000|Overall Study|Wound catheter malfunctioned|1|||
164302165|NCT00930046|593482546|FG001|Overall Study|Wound catheter malfunctioned|2|||
164302166|NCT01598532|593482547|FG000|Overall Study|Lost to Follow-up|3|||
164302167|NCT01598532|593482547|FG000|Overall Study|Did not meet inclusion criteria|8|||
164302168|NCT00912808|593482548|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
164302169|NCT00912808|593482549|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
164302170|NCT00912808|593482548|FG000|Washout|Withdrawal by Subject|0|||
164302171|NCT00912808|593482549|FG001|Washout|Withdrawal by Subject|1|||
164302172|NCT00912808|593482548|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
164302173|NCT00912808|593482549|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
164302174|NCT00912808|593482548|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
164302175|NCT00912808|593482549|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
164302176|NCT00702221|593482550|FG000|Overall Study|Adverse Event|4|||
164302177|NCT00702221|593482551|FG001|Overall Study|Adverse Event|3|||
164302178|NCT02900378|593482552|FG000|Randomization (Visit 2)|Adverse Event|14|||
164302179|NCT02900378|593482553|FG001|Randomization (Visit 2)|Adverse Event|11|||
164302180|NCT02900378|593482552|FG000|Randomization (Visit 2)|Death|1|||
164302181|NCT02900378|593482553|FG001|Randomization (Visit 2)|Death|4|||
164302182|NCT02900378|593482552|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
164302183|NCT02900378|593482553|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
164302184|NCT02900378|593482552|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
164302185|NCT02900378|593482553|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
164302186|NCT02900378|593482552|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
164302187|NCT02900378|593482553|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
164302188|NCT02900378|593482552|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
164302189|NCT02900378|593482553|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
164302190|NCT02900378|593482552|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
164302191|NCT02900378|593482553|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
164302192|NCT01134055|593482556|FG000|Overall Study|Adverse Event|5|||
164302193|NCT01134055|593482557|FG001|Overall Study|Adverse Event|2|||
164302194|NCT01134055|593482558|FG002|Overall Study|Adverse Event|2|||
164302195|NCT01134055|593482559|FG003|Overall Study|Adverse Event|2|||
164302196|NCT01134055|593482560|FG004|Overall Study|Adverse Event|5|||
164302206|NCT01134055|593482556|FG000|Overall Study|Withdrawal by Subject|3|||
164302207|NCT01134055|593482557|FG001|Overall Study|Withdrawal by Subject|3|||
164302208|NCT01134055|593482558|FG002|Overall Study|Withdrawal by Subject|1|||
164302209|NCT01134055|593482559|FG003|Overall Study|Withdrawal by Subject|2|||
164302210|NCT01134055|593482560|FG004|Overall Study|Withdrawal by Subject|0|||
164302211|NCT01134055|593482561|FG005|Overall Study|Withdrawal by Subject|0|||
164302212|NCT01134055|593482562|FG006|Overall Study|Withdrawal by Subject|8|||
164302213|NCT01134055|593482556|FG000|Overall Study|Protocol Violation|0|||
164302214|NCT01134055|593482557|FG001|Overall Study|Protocol Violation|0|||
164302215|NCT01134055|593482558|FG002|Overall Study|Protocol Violation|0|||
164302216|NCT01134055|593482559|FG003|Overall Study|Protocol Violation|1|||
164302217|NCT01134055|593482560|FG004|Overall Study|Protocol Violation|1|||
164302218|NCT01134055|593482561|FG005|Overall Study|Protocol Violation|0|||
164302219|NCT01134055|593482562|FG006|Overall Study|Protocol Violation|0|||
164302220|NCT01134055|593482556|FG000|Overall Study|Physician Decision|0|||
164302221|NCT01134055|593482557|FG001|Overall Study|Physician Decision|0|||
164302222|NCT01134055|593482558|FG002|Overall Study|Physician Decision|0|||
164302223|NCT01134055|593482559|FG003|Overall Study|Physician Decision|0|||
164302224|NCT01134055|593482560|FG004|Overall Study|Physician Decision|0|||
164302225|NCT01134055|593482561|FG005|Overall Study|Physician Decision|0|||
164302226|NCT01134055|593482562|FG006|Overall Study|Physician Decision|1|||
164302227|NCT03345784|593482565|FG000|Overall Study|Withdrawal by Subject|2|||
164302228|NCT03345784|593482566|FG001|Overall Study|Withdrawal by Subject|1|||
164302229|NCT04798196|593482568|FG000|Overall Study|Lost to Follow-up|3|||
164302230|NCT04798196|593482569|FG001|Overall Study|Lost to Follow-up|1|||
164302231|NCT04798196|593482570|FG002|Overall Study|Lost to Follow-up|3|||
164302232|NCT01249261|593482578|FG000|Overall Study|Withdrawal by Subject|1|||
164302233|NCT01249261|593482579|FG001|Overall Study|Withdrawal by Subject|0|||
164302234|NCT01967940|593482586|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
164302235|NCT01967940|593482587|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
164302236|NCT01967940|593482588|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
164302237|NCT01967940|593482589|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
164302238|NCT01967940|593482586|FG000|Part 2|Adverse Event|0|||
164302239|NCT01967940|593482587|FG001|Part 2|Adverse Event|0|||
164302240|NCT01967940|593482588|FG002|Part 2|Adverse Event|0|||
164302241|NCT01967940|593482589|FG003|Part 2|Adverse Event|1|||
164302242|NCT01967940|593482586|FG000|Part 2|Unknown Reason|0|||
164302243|NCT01967940|593482587|FG001|Part 2|Unknown Reason|0|||
164302244|NCT01967940|593482588|FG002|Part 2|Unknown Reason|0|||
164302245|NCT01967940|593482589|FG003|Part 2|Unknown Reason|1|||
164302246|NCT01550003|593482590|FG000|Overall Study|Adverse Event|0|||
164302247|NCT01550003|593482591|FG001|Overall Study|Adverse Event|9|||
164302248|NCT01550003|593482592|FG002|Overall Study|Adverse Event|15|||
164302249|NCT01550003|593482590|FG000|Overall Study|Lack of Efficacy|4|||
164302250|NCT01550003|593482591|FG001|Overall Study|Lack of Efficacy|11|||
164302251|NCT01550003|593482592|FG002|Overall Study|Lack of Efficacy|15|||
164302252|NCT01550003|593482590|FG000|Overall Study|Protocol Violation|0|||
164302253|NCT01550003|593482591|FG001|Overall Study|Protocol Violation|3|||
164302254|NCT01550003|593482592|FG002|Overall Study|Protocol Violation|2|||
164302255|NCT01550003|593482590|FG000|Overall Study|Lost to Follow-up|1|||
164302256|NCT01550003|593482591|FG001|Overall Study|Lost to Follow-up|4|||
164302257|NCT01550003|593482592|FG002|Overall Study|Lost to Follow-up|8|||
164302258|NCT01550003|593482590|FG000|Overall Study|Consent withdrawn|2|||
164302259|NCT01550003|593482591|FG001|Overall Study|Consent withdrawn|11|||
164302260|NCT01550003|593482592|FG002|Overall Study|Consent withdrawn|23|||
164302261|NCT01550003|593482590|FG000|Overall Study|Missing|1|||
164302262|NCT01550003|593482591|FG001|Overall Study|Missing|0|||
164302263|NCT01550003|593482592|FG002|Overall Study|Missing|2|||
164302264|NCT01550003|593482590|FG000|Overall Study|Study closure as announced by sponsor|7|||
164302265|NCT01550003|593482591|FG001|Overall Study|Study closure as announced by sponsor|6|||
164302266|NCT01550003|593482592|FG002|Overall Study|Study closure as announced by sponsor|24|||
164302267|NCT01550003|593482590|FG000|Overall Study|Protocol Noncompliance|1|||
164302268|NCT01550003|593482591|FG001|Overall Study|Protocol Noncompliance|0|||
164302269|NCT01550003|593482592|FG002|Overall Study|Protocol Noncompliance|0|||
164302270|NCT01550003|593482590|FG000|Overall Study|Study closure|0|||
164302271|NCT01550003|593482591|FG001|Overall Study|Study closure|1|||
164302272|NCT01550003|593482592|FG002|Overall Study|Study closure|1|||
164302273|NCT01550003|593482590|FG000|Overall Study|Patient reached adulthood|0|||
164302274|NCT01550003|593482591|FG001|Overall Study|Patient reached adulthood|1|||
164302275|NCT01550003|593482592|FG002|Overall Study|Patient reached adulthood|0|||
164302276|NCT01550003|593482590|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
164302277|NCT01550003|593482591|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
164302278|NCT01550003|593482592|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
164302279|NCT01550003|593482590|FG000|Overall Study|Sponsor's order|0|||
164302280|NCT01550003|593482591|FG001|Overall Study|Sponsor's order|3|||
164302281|NCT01550003|593482592|FG002|Overall Study|Sponsor's order|3|||
164302282|NCT01550003|593482590|FG000|Overall Study|Sponsor's decision|1|||
164302283|NCT01550003|593482591|FG001|Overall Study|Sponsor's decision|5|||
164302284|NCT01550003|593482592|FG002|Overall Study|Sponsor's decision|4|||
164302285|NCT01550003|593482590|FG000|Overall Study|Subject mother passed away|0|||
164302286|NCT01550003|593482591|FG001|Overall Study|Subject mother passed away|1|||
164302287|NCT01550003|593482592|FG002|Overall Study|Subject mother passed away|0|||
164302288|NCT01550003|593482590|FG000|Overall Study|Discontinuation|0|||
164302289|NCT01550003|593482591|FG001|Overall Study|Discontinuation|1|||
164302290|NCT01550003|593482592|FG002|Overall Study|Discontinuation|0|||
164302291|NCT01550003|593482590|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
164302292|NCT01550003|593482591|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
164302293|NCT01550003|593482592|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
164302294|NCT01550003|593482590|FG000|Overall Study|Site closure|0|||
164302295|NCT01550003|593482591|FG001|Overall Study|Site closure|2|||
164302296|NCT01550003|593482592|FG002|Overall Study|Site closure|0|||
164302297|NCT01550003|593482590|FG000|Overall Study|Pregnancy|0|||
164302298|NCT01550003|593482591|FG001|Overall Study|Pregnancy|1|||
164302299|NCT01550003|593482592|FG002|Overall Study|Pregnancy|0|||
164302300|NCT01550003|593482590|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
164302301|NCT01550003|593482591|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
164302302|NCT01550003|593482592|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
164302303|NCT01550003|593482590|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
164302304|NCT01550003|593482591|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
164302305|NCT01550003|593482592|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
164302306|NCT01550003|593482590|FG000|Overall Study|Switching to adult rheumatologist|0|||
164302307|NCT01550003|593482591|FG001|Overall Study|Switching to adult rheumatologist|0|||
164302308|NCT01550003|593482592|FG002|Overall Study|Switching to adult rheumatologist|1|||
164302309|NCT01550003|593482590|FG000|Overall Study|Patient transition to adult care|0|||
164302310|NCT01550003|593482591|FG001|Overall Study|Patient transition to adult care|0|||
164302311|NCT01550003|593482592|FG002|Overall Study|Patient transition to adult care|1|||
164302312|NCT01550003|593482590|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
164302313|NCT01550003|593482591|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
164302314|NCT01550003|593482592|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
164302315|NCT01550003|593482590|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
164302316|NCT01550003|593482591|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
164302317|NCT01550003|593482592|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
164302318|NCT01550003|593482590|FG000|Overall Study|Per Sponsor request|1|||
164302319|NCT01550003|593482591|FG001|Overall Study|Per Sponsor request|0|||
164302320|NCT01550003|593482592|FG002|Overall Study|Per Sponsor request|1|||
164302321|NCT01550003|593482590|FG000|Overall Study|Patient not compliance|0|||
164302322|NCT01550003|593482591|FG001|Overall Study|Patient not compliance|0|||
164302323|NCT01550003|593482592|FG002|Overall Study|Patient not compliance|1|||
164302324|NCT01550003|593482590|FG000|Overall Study|Non-compliance|0|||
164302325|NCT01550003|593482591|FG001|Overall Study|Non-compliance|0|||
164302326|NCT01550003|593482592|FG002|Overall Study|Non-compliance|1|||
164302327|NCT01550003|593482590|FG000|Overall Study|Study closed|0|||
164302328|NCT01550003|593482591|FG001|Overall Study|Study closed|1|||
164302329|NCT01550003|593482592|FG002|Overall Study|Study closed|0|||
164302330|NCT01550003|593482590|FG000|Overall Study|Transitioned to adult rheumatology|0|||
164302331|NCT01550003|593482591|FG001|Overall Study|Transitioned to adult rheumatology|0|||
164302332|NCT01550003|593482592|FG002|Overall Study|Transitioned to adult rheumatology|1|||
164302333|NCT05567783|593482593|FG000|Overall Study|Death|2|||
164302334|NCT05567783|593482594|FG001|Overall Study|Death|3|||
164302335|NCT05567783|593482595|FG002|Overall Study|Death|0|||
164302336|NCT05567783|593482593|FG000|Overall Study|Lost to Follow-up|25|||
164302337|NCT05567783|593482594|FG001|Overall Study|Lost to Follow-up|19|||
164302338|NCT05567783|593482595|FG002|Overall Study|Lost to Follow-up|17|||
164302339|NCT05567783|593482593|FG000|Overall Study|Physician Decision|10|||
164302340|NCT05567783|593482594|FG001|Overall Study|Physician Decision|7|||
164302341|NCT05567783|593482595|FG002|Overall Study|Physician Decision|9|||
164302342|NCT05567783|593482593|FG000|Overall Study|Study Terminated by Sponsor|924|||
164302343|NCT05567783|593482594|FG001|Overall Study|Study Terminated by Sponsor|937|||
164302344|NCT05567783|593482595|FG002|Overall Study|Study Terminated by Sponsor|941|||
164302345|NCT05567783|593482593|FG000|Overall Study|Withdrawal by Subject|23|||
164302346|NCT05567783|593482594|FG001|Overall Study|Withdrawal by Subject|27|||
164302347|NCT05567783|593482595|FG002|Overall Study|Withdrawal by Subject|24|||
164302348|NCT05567783|593482593|FG000|Overall Study|Incarcerated|1|||
164302349|NCT05567783|593482594|FG001|Overall Study|Incarcerated|0|||
164302350|NCT05567783|593482595|FG002|Overall Study|Incarcerated|0|||
164302351|NCT05567783|593482593|FG000|Overall Study|Participant randomized in error|4|||
164302352|NCT05567783|593482594|FG001|Overall Study|Participant randomized in error|2|||
164302353|NCT05567783|593482595|FG002|Overall Study|Participant randomized in error|2|||
164302354|NCT03675126|593482598|FG000|Overall Study|Study Terminated by Sponsor|9|||
164302355|NCT03675126|593482598|FG000|Overall Study|Death|2|||
164302356|NCT03675126|593482598|FG000|Overall Study|Withdrawal by Subject|4|||
164302357|NCT00001959|593482599|FG000|Overall Study|newly diagnosed colon cancer|1|||
164302358|NCT00001959|593482599|FG000|Overall Study|disabling sedation|1|||
164302395|NCT02594124|593482619|FG006|Overall Study|Withdrawal by Subject|13|||
164302396|NCT02594124|593482620|FG007|Overall Study|Withdrawal by Subject|19|||
164302397|NCT02594124|593482621|FG008|Overall Study|Withdrawal by Subject|0|||
164302398|NCT02594124|593482613|FG000|Overall Study|Physician Decision|0|||
164302399|NCT02594124|593482614|FG001|Overall Study|Physician Decision|2|||
164302400|NCT02594124|593482615|FG002|Overall Study|Physician Decision|0|||
164302401|NCT02594124|593482616|FG003|Overall Study|Physician Decision|0|||
164302402|NCT02594124|593482617|FG004|Overall Study|Physician Decision|0|||
164302403|NCT02594124|593482618|FG005|Overall Study|Physician Decision|0|||
164302404|NCT02594124|593482619|FG006|Overall Study|Physician Decision|0|||
164302405|NCT02594124|593482620|FG007|Overall Study|Physician Decision|1|||
164302406|NCT02594124|593482621|FG008|Overall Study|Physician Decision|0|||
164302407|NCT02594124|593482613|FG000|Overall Study|Commercial drug|0|||
164302408|NCT02594124|593482614|FG001|Overall Study|Commercial drug|1|||
164302409|NCT02594124|593482615|FG002|Overall Study|Commercial drug|6|||
164302410|NCT02594124|593482616|FG003|Overall Study|Commercial drug|3|||
164302411|NCT02594124|593482617|FG004|Overall Study|Commercial drug|0|||
164302412|NCT02594124|593482618|FG005|Overall Study|Commercial drug|0|||
164302413|NCT02594124|593482619|FG006|Overall Study|Commercial drug|7|||
164302414|NCT02594124|593482620|FG007|Overall Study|Commercial drug|11|||
164302415|NCT02594124|593482621|FG008|Overall Study|Commercial drug|2|||
164302416|NCT02594124|593482613|FG000|Overall Study|Reason Not Specified|1|||
164302417|NCT02594124|593482614|FG001|Overall Study|Reason Not Specified|3|||
164302418|NCT02594124|593482615|FG002|Overall Study|Reason Not Specified|4|||
164302419|NCT02594124|593482616|FG003|Overall Study|Reason Not Specified|0|||
164302420|NCT02594124|593482617|FG004|Overall Study|Reason Not Specified|0|||
164302421|NCT02594124|593482618|FG005|Overall Study|Reason Not Specified|1|||
164302422|NCT02594124|593482619|FG006|Overall Study|Reason Not Specified|1|||
164302423|NCT02594124|593482620|FG007|Overall Study|Reason Not Specified|6|||
164302424|NCT02594124|593482621|FG008|Overall Study|Reason Not Specified|1|||
164302425|NCT05523089|593482622|FG000|Overall Study|Withdrawal by Subject|1|||
164302426|NCT05523089|593482623|FG001|Overall Study|Withdrawal by Subject|0|||
164302427|NCT05523089|593482624|FG002|Overall Study|Withdrawal by Subject|0|||
164302428|NCT05523089|593482622|FG000|Overall Study|Lost to Follow-up|1|||
164302429|NCT05523089|593482623|FG001|Overall Study|Lost to Follow-up|0|||
164302430|NCT05523089|593482624|FG002|Overall Study|Lost to Follow-up|0|||
164302431|NCT05530252|593482625|FG000|Overall Study|Lost to Follow-up|1|||
164302432|NCT05530252|593482626|FG001|Overall Study|Lost to Follow-up|1|||
164302433|NCT05530252|593482627|FG002|Overall Study|Lost to Follow-up|1|||
164302434|NCT01350999|593482628|FG000|Overall Study|Adverse Event|4|||
164302435|NCT01350999|593482629|FG001|Overall Study|Adverse Event|9|||
164302436|NCT01350999|593482630|FG002|Overall Study|Adverse Event|10|||
164302437|NCT01350999|593482628|FG000|Overall Study|Voluntary withdrawal|3|||
164302438|NCT01350999|593482629|FG001|Overall Study|Voluntary withdrawal|4|||
164302439|NCT01350999|593482630|FG002|Overall Study|Voluntary withdrawal|6|||
164302440|NCT01350999|593482628|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
164302441|NCT01350999|593482629|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
164302442|NCT01350999|593482630|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
164302443|NCT04040933|593484542|FG000|Overall Study|Protocol Violation|1|||
164302444|NCT04040933|593484542|FG000|Overall Study|Withdrawal by Subject|2|||
164302445|NCT02066181|593484543|FG000|Overall Study|Withdrawal by Subject|1|||
164302446|NCT02066181|593484544|FG001|Overall Study|Withdrawal by Subject|1|||
164302447|NCT02141295|593484548|FG000|Overall Study|Adverse Event|1|||
164302448|NCT02141295|593484549|FG001|Overall Study|Adverse Event|18|||
164302449|NCT02141295|593484550|FG002|Overall Study|Adverse Event|11|||
164302450|NCT02141295|593484548|FG000|Overall Study|Physician Decision|2|||
164302451|NCT02141295|593484549|FG001|Overall Study|Physician Decision|19|||
164302452|NCT02141295|593484550|FG002|Overall Study|Physician Decision|14|||
164302453|NCT02141295|593484548|FG000|Overall Study|Study terminated by sponsor|0|||
164302454|NCT02141295|593484549|FG001|Overall Study|Study terminated by sponsor|6|||
164302455|NCT02141295|593484550|FG002|Overall Study|Study terminated by sponsor|6|||
164302456|NCT02141295|593484548|FG000|Overall Study|Non-compliance|0|||
164302457|NCT02141295|593484549|FG001|Overall Study|Non-compliance|1|||
164302458|NCT02141295|593484550|FG002|Overall Study|Non-compliance|0|||
164302459|NCT02141295|593484548|FG000|Overall Study|Progressive disease|3|||
164302460|NCT02141295|593484549|FG001|Overall Study|Progressive disease|32|||
164302461|NCT02141295|593484550|FG002|Overall Study|Progressive disease|50|||
164302462|NCT02141295|593484548|FG000|Overall Study|Reason not specified|0|||
164302463|NCT02141295|593484549|FG001|Overall Study|Reason not specified|9|||
164302464|NCT02141295|593484550|FG002|Overall Study|Reason not specified|10|||
164302465|NCT02141295|593484548|FG000|Overall Study|Withdrawal by Subject|0|||
164302466|NCT02141295|593484549|FG001|Overall Study|Withdrawal by Subject|9|||
164302467|NCT02141295|593484550|FG002|Overall Study|Withdrawal by Subject|4|||
164302468|NCT02536976|593484551|FG000|Overall Study|Physician Decision|0|||
164302469|NCT02536976|593484552|FG001|Overall Study|Physician Decision|1|||
164302470|NCT01671319|593484555|FG000|Overall Study|Withdrawal by Subject|1|||
164302471|NCT02144610|593484556|FG000|Overall Study|Physician Decision|1|||
164302472|NCT02144610|593484557|FG001|Overall Study|Physician Decision|0|||
164302473|NCT02144610|593484556|FG000|Overall Study|Withdrawal by Subject|1|||
164302474|NCT02144610|593484557|FG001|Overall Study|Withdrawal by Subject|5|||
164302475|NCT02144610|593484556|FG000|Overall Study|Death|2|||
164302476|NCT02144610|593484557|FG001|Overall Study|Death|2|||
164302477|NCT02144610|593484556|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
164302478|NCT02144610|593484557|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
164302479|NCT02144610|593484556|FG000|Overall Study|Other|0|||
164302480|NCT02144610|593484557|FG001|Overall Study|Other|1|||
164302481|NCT00706238|593484563|FG000|Overall Study|Disease progression|4|||
164302482|NCT00706238|593484563|FG000|Overall Study|Other|1|||
164302483|NCT01193244|593484564|FG000|Overall Study|Withdrawal by Subject|79|||
164302484|NCT01193244|593484565|FG001|Overall Study|Withdrawal by Subject|97|||
164302485|NCT01193244|593484564|FG000|Overall Study|Other|303|||
164302486|NCT01193244|593484565|FG001|Overall Study|Other|278|||
164302487|NCT01193244|593484564|FG000|Overall Study|Lost to Follow-up|6|||
164302488|NCT01193244|593484565|FG001|Overall Study|Lost to Follow-up|15|||
164302489|NCT00628108|593484566|FG000|Overall Study|Adverse Event|0|||
164302490|NCT00628108|593484567|FG001|Overall Study|Adverse Event|3|||
164302491|NCT00628108|593484566|FG000|Overall Study|Withdrawal by Subject|1|||
164302492|NCT00628108|593484567|FG001|Overall Study|Withdrawal by Subject|0|||
164302493|NCT03848832|593484568|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
164302494|NCT03848832|593484569|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
164302495|NCT03848832|593484570|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
164302496|NCT03848832|593484568|FG000|Overall Study|Withdrawal by Subject|0|||
164302497|NCT03848832|593484569|FG001|Overall Study|Withdrawal by Subject|0|||
164302498|NCT03848832|593484570|FG002|Overall Study|Withdrawal by Subject|1|||
164302499|NCT03848832|593484568|FG000|Overall Study|Withdrawal (Covid-19)|0|||
164302500|NCT03848832|593484569|FG001|Overall Study|Withdrawal (Covid-19)|2|||
164302501|NCT03848832|593484570|FG002|Overall Study|Withdrawal (Covid-19)|0|||
164302502|NCT03848832|593484568|FG000|Overall Study|Physician Decision|2|||
164302503|NCT03848832|593484569|FG001|Overall Study|Physician Decision|1|||
164302504|NCT03848832|593484570|FG002|Overall Study|Physician Decision|3|||
164302505|NCT03848832|593484568|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
164302506|NCT03848832|593484569|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
164302507|NCT03848832|593484570|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
164302508|NCT03848832|593484568|FG000|Overall Study|Adverse Event|1|||
164302509|NCT03848832|593484569|FG001|Overall Study|Adverse Event|0|||
164302510|NCT03848832|593484570|FG002|Overall Study|Adverse Event|0|||
164302511|NCT00865566|593484571|FG000|Overall Study|Death|1|||
164302512|NCT00865566|593484572|FG001|Overall Study|Death|11|||
164302513|NCT00865566|593484571|FG000|Overall Study|Lost to Follow-up|314|||
164302514|NCT00865566|593484572|FG001|Overall Study|Lost to Follow-up|315|||
164302515|NCT00865566|593484571|FG000|Overall Study|Withdrawal by Subject|45|||
164302516|NCT00865566|593484572|FG001|Overall Study|Withdrawal by Subject|65|||
164302517|NCT00865566|593484571|FG000|Overall Study|Physician Decision|0|||
164302518|NCT00865566|593484572|FG001|Overall Study|Physician Decision|1|||
164302519|NCT00865566|593484571|FG000|Overall Study|Participant relocated|78|||
164302520|NCT00865566|593484572|FG001|Overall Study|Participant relocated|107|||
164302521|NCT00865566|593484571|FG000|Overall Study|Participant unable to adhere|27|||
164302522|NCT00865566|593484572|FG001|Overall Study|Participant unable to adhere|42|||
164302523|NCT00865566|593484571|FG000|Overall Study|Other; N=245 due to early study closure|154|||
164302524|NCT00865566|593484572|FG001|Overall Study|Other; N=245 due to early study closure|139|||
164302525|NCT00865566|593484571|FG000|Overall Study|HIV infection|5|||
164302526|NCT00865566|593484572|FG001|Overall Study|HIV infection|7|||
164302527|NCT01039376|593484573|FG000|Overall Study|Lost to Follow-up|5|||
164302528|NCT01039376|593484574|FG001|Overall Study|Lost to Follow-up|12|||
164302529|NCT01039376|593484573|FG000|Overall Study|Physician Decision|15|||
164302530|NCT01039376|593484574|FG001|Overall Study|Physician Decision|10|||
164302531|NCT01039376|593484573|FG000|Overall Study|Withdrawal by Subject|20|||
164302532|NCT01039376|593484574|FG001|Overall Study|Withdrawal by Subject|32|||
164302533|NCT01039376|593484573|FG000|Overall Study|Study terminated by Sponsor|90|||
164302534|NCT01039376|593484574|FG001|Overall Study|Study terminated by Sponsor|72|||
164302535|NCT00785785|593484575|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
164302536|NCT00785785|593484576|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
164302537|NCT00785785|593484575|FG000|Core Phase up to 36 Months|Adverse Event|31|||
164302538|NCT00785785|593484576|FG001|Core Phase up to 36 Months|Adverse Event|21|||
164302539|NCT00785785|593484575|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
164302540|NCT00785785|593484576|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
164302541|NCT00785785|593484575|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
164302542|NCT00785785|593484576|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
164302543|NCT00785785|593484575|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
164302544|NCT00785785|593484576|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
164302545|NCT00785785|593484575|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
164302546|NCT00785785|593484576|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
164302547|NCT00785785|593484575|FG000|Core Phase up to 36 Months|Administrative problems|3|||
164302548|NCT00785785|593484576|FG001|Core Phase up to 36 Months|Administrative problems|3|||
164302549|NCT00785785|593484575|FG000|Core Phase up to 36 Months|Death|5|||
164302550|NCT00785785|593484576|FG001|Core Phase up to 36 Months|Death|8|||
164302551|NCT00785785|593484575|FG000|Core Phase up to 36 Months|Disease progression|139|||
164302552|NCT00785785|593484576|FG001|Core Phase up to 36 Months|Disease progression|119|||
164302553|NCT00785785|593484575|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
164302554|NCT00785785|593484576|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
164302555|NCT00785785|593484575|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
164302556|NCT00785785|593484576|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
164302557|NCT00785785|593484575|FG000|Optional Extension Phase|Adverse Event|4|||
164302558|NCT00785785|593484576|FG001|Optional Extension Phase|Adverse Event|5|||
164302559|NCT00785785|593484575|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
164302560|NCT00785785|593484576|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
164302561|NCT00785785|593484575|FG000|Optional Extension Phase|Lost to Follow-up|1|||
164302562|NCT00785785|593484576|FG001|Optional Extension Phase|Lost to Follow-up|0|||
164302563|NCT00785785|593484575|FG000|Optional Extension Phase|Administrative problems|2|||
164302564|NCT00785785|593484576|FG001|Optional Extension Phase|Administrative problems|0|||
164302565|NCT00785785|593484575|FG000|Optional Extension Phase|Death|1|||
164302566|NCT00785785|593484576|FG001|Optional Extension Phase|Death|5|||
164302567|NCT00785785|593484575|FG000|Optional Extension Phase|Disease progression|22|||
164302568|NCT00785785|593484576|FG001|Optional Extension Phase|Disease progression|70|||
164302569|NCT00785785|593484575|FG000|Optional Extension Phase|Protocol deviation|0|||
164302570|NCT00785785|593484576|FG001|Optional Extension Phase|Protocol deviation|2|||
164302571|NCT00785785|593484575|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
164302572|NCT00785785|593484576|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
164302573|NCT02453321|593484577|FG000|Overall Study|Weakness|1|||
164302574|NCT02453321|593484578|FG001|Overall Study|Weakness|1|||
164302575|NCT02453321|593484579|FG002|Overall Study|Weakness|2|||
164302576|NCT02453321|593484577|FG000|Overall Study|Deep Venous Thrombosis|0|||
164302577|NCT02453321|593484578|FG001|Overall Study|Deep Venous Thrombosis|1|||
164302578|NCT02453321|593484579|FG002|Overall Study|Deep Venous Thrombosis|0|||
164302579|NCT03252925|593484580|FG000|Overall Study|Withdrawal by Subject|1|||
164302580|NCT03252925|593484581|FG001|Overall Study|Withdrawal by Subject|0|||
164302581|NCT03252925|593484580|FG000|Overall Study|Protocol Violation|6|||
164302582|NCT03252925|593484581|FG001|Overall Study|Protocol Violation|0|||
164302583|NCT03252925|593484580|FG000|Overall Study|Adverse Event|1|||
164302584|NCT03252925|593484581|FG001|Overall Study|Adverse Event|0|||
164302585|NCT03252925|593484580|FG000|Overall Study|Lost to Follow-up|6|||
164302586|NCT03252925|593484581|FG001|Overall Study|Lost to Follow-up|6|||
164302587|NCT01244893|593484582|FG000|Baseline|Protocol Violation|0|||
164302588|NCT01244893|593484583|FG001|Baseline|Protocol Violation|1|||
164302589|NCT01244893|593484582|FG000|1-Week Follow Up|Lost to Follow-up|1|||
164302590|NCT01244893|593484583|FG001|1-Week Follow Up|Lost to Follow-up|0|||
164302591|NCT00357552|593484584|FG000|Screening|Did not meet eligibility criteria|84|||
164302592|NCT00357552|593484584|FG000|Weeks 0 to 24|Death|1|||
164302593|NCT00357552|593484584|FG000|Weeks 24 to 104|Death|3|||
164302594|NCT00357552|593484584|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
164302595|NCT00521404|593484587|FG000|Overall Study|Adverse Event|13|||
164302596|NCT00521404|593484587|FG000|Overall Study|Disease Progression|33|||
164302597|NCT00521404|593484587|FG000|Overall Study|Investigator decision|5|||
164302598|NCT00521404|593484587|FG000|Overall Study|Withdrawal of consent|3|||
164302599|NCT00521404|593484587|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
164302600|NCT00521404|593484587|FG000|Overall Study|Other|7|||
164302601|NCT04555616|593484590|FG000|Overall Study|Death|1|||
164302602|NCT04555616|593484591|FG001|Overall Study|Death|0|||
164302603|NCT04555616|593484592|FG002|Overall Study|Death|1|||
164302604|NCT04555616|593484590|FG000|Overall Study|Withdrawal by Subject|2|||
164302605|NCT04555616|593484591|FG001|Overall Study|Withdrawal by Subject|1|||
164302606|NCT04555616|593484592|FG002|Overall Study|Withdrawal by Subject|0|||
164302607|NCT00882557|593484593|FG000|Overall Study|Withdrawal by Subject|1|||
164302608|NCT00882557|593484594|FG001|Overall Study|Withdrawal by Subject|0|||
164302609|NCT00882557|593484593|FG000|Overall Study|Trouble with Vein Access|1|||
164302610|NCT00882557|593484594|FG001|Overall Study|Trouble with Vein Access|0|||
164302611|NCT00882557|593484593|FG000|Overall Study|Randomized Not Treated|0|||
164302612|NCT00882557|593484594|FG001|Overall Study|Randomized Not Treated|1|||
164302613|NCT02282605|593484595|FG000|Overall Study|negative SA result on Day -1|3|||
164302614|NCT02282605|593484596|FG001|Overall Study|negative SA result on Day -1|0|||
164302615|NCT02282605|593484597|FG002|Overall Study|negative SA result on Day -1|0|||
164302616|NCT00711191|593484598|FG000|Overall Study|Adverse Event|1|||
164302617|NCT00711191|593484599|FG001|Overall Study|Adverse Event|1|||
164302618|NCT00711191|593484600|FG002|Overall Study|Adverse Event|2|||
164302619|NCT00711191|593484598|FG000|Overall Study|Objective progression or relapse|2|||
164302620|NCT00711191|593484599|FG001|Overall Study|Objective progression or relapse|3|||
164302621|NCT00711191|593484600|FG002|Overall Study|Objective progression or relapse|7|||
164302622|NCT00711191|593484598|FG000|Overall Study|Withdrawal by Subject|0|||
164302623|NCT00711191|593484599|FG001|Overall Study|Withdrawal by Subject|1|||
164302624|NCT00711191|593484600|FG002|Overall Study|Withdrawal by Subject|3|||
164302625|NCT02404025|593484601|FG000|Overall Study|Adverse Event|1|||
164302626|NCT02404025|593484601|FG000|Overall Study|Lack of Efficacy|3|||
164302627|NCT02230670|593484603|FG000|Overall Study|Adverse Event|1|||
164302628|NCT02230670|593484604|FG001|Overall Study|Adverse Event|2|||
164302629|NCT02230670|593484603|FG000|Overall Study|Withdrawal by Subject|2|||
164302630|NCT02230670|593484604|FG001|Overall Study|Withdrawal by Subject|2|||
164302631|NCT02230670|593484603|FG000|Overall Study|Physician Decision|0|||
164302632|NCT02230670|593484604|FG001|Overall Study|Physician Decision|1|||
164302633|NCT02230670|593484603|FG000|Overall Study|Protocol Violation|0|||
164302634|NCT02230670|593484604|FG001|Overall Study|Protocol Violation|1|||
164302635|NCT02230670|593484603|FG000|Overall Study|Progression to Child-Pugh C|1|||
164302636|NCT02230670|593484604|FG001|Overall Study|Progression to Child-Pugh C|2|||
164302637|NCT01907854|593484609|FG000|Overall Study|Protocol Violation|1|||
164302638|NCT01907854|593484610|FG001|Overall Study|Protocol Violation|1|||
164302639|NCT01907854|593484609|FG000|Overall Study|Withdrawal by Subject|9|||
164302640|NCT01907854|593484610|FG001|Overall Study|Withdrawal by Subject|7|||
164302641|NCT01907854|593484609|FG000|Overall Study|Lost to Follow-up|2|||
164302642|NCT01907854|593484610|FG001|Overall Study|Lost to Follow-up|2|||
164302643|NCT01907854|593484609|FG000|Overall Study|Unclassified|4|||
164302644|NCT01907854|593484610|FG001|Overall Study|Unclassified|3|||
164302645|NCT01744977|593484611|FG000|Overall Study|Withdrawal by Subject|1|||
164302646|NCT01744977|593484612|FG001|Overall Study|Withdrawal by Subject|2|||
164302647|NCT01744977|593484611|FG000|Overall Study|Death|2|||
164302648|NCT01744977|593484612|FG001|Overall Study|Death|3|||
164302649|NCT01744977|593484611|FG000|Overall Study|Lost to Follow-up|2|||
164302650|NCT01744977|593484612|FG001|Overall Study|Lost to Follow-up|0|||
164302651|NCT01744977|593484611|FG000|Overall Study|No longer meets inclusion|6|||
164302652|NCT01744977|593484612|FG001|Overall Study|No longer meets inclusion|0|||
164302653|NCT01750229|593484615|FG000|Randomized Crossover Phase|Adverse Event|1|||
164302654|NCT01750229|593484615|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
164302655|NCT01750229|593484615|FG000|Long-term Follow-up Phase|Adverse Event|2|||
164302656|NCT01750229|593484615|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
164302657|NCT03774576|593484616|FG000|Period 2|Adverse Event|1|||
164302658|NCT01746901|593484617|FG000|Naloxone Challenge Phase|Adverse Event|2|||
164302659|NCT01746901|593484618|FG001|Naloxone Challenge Phase|Adverse Event|0|||
164302660|NCT01746901|593484619|FG002|Naloxone Challenge Phase|Adverse Event|0|||
164302661|NCT01746901|593484620|FG003|Naloxone Challenge Phase|Adverse Event|0|||
164302662|NCT01746901|593484621|FG004|Naloxone Challenge Phase|Adverse Event|0|||
164302663|NCT01746901|593484622|FG005|Naloxone Challenge Phase|Adverse Event|0|||
164302664|NCT01746901|593484623|FG006|Naloxone Challenge Phase|Adverse Event|0|||
164302665|NCT01746901|593484624|FG007|Naloxone Challenge Phase|Adverse Event|0|||
164302666|NCT01746901|593484625|FG008|Naloxone Challenge Phase|Adverse Event|0|||
164302667|NCT01746901|593484617|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
164302668|NCT01746901|593484618|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
164302669|NCT01746901|593484619|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
164302670|NCT01746901|593484620|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
164302671|NCT01746901|593484621|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
164302672|NCT01746901|593484622|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
164302673|NCT01746901|593484623|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
164302674|NCT01746901|593484624|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
164302675|NCT01746901|593484625|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
164302676|NCT01746901|593484617|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164302677|NCT01746901|593484618|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
164302678|NCT01746901|593484619|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164302679|NCT01746901|593484620|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164302680|NCT01746901|593484621|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164302681|NCT01746901|593484622|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164302682|NCT01746901|593484623|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164302683|NCT01746901|593484624|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164302684|NCT01746901|593484625|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164302685|NCT01746901|593484617|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
164302686|NCT01746901|593484618|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
164302687|NCT01746901|593484619|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
164302688|NCT01746901|593484620|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
164302689|NCT01746901|593484621|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
164302690|NCT01746901|593484622|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
164302691|NCT01746901|593484623|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
164302692|NCT01746901|593484624|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
164302693|NCT01746901|593484625|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
164302694|NCT01746901|593484617|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
164302695|NCT01746901|593484618|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
164302903|NCT03815929|593484670|FG002|Overall Study|Physician Decision|0|||
164302696|NCT01746901|593484619|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
164302697|NCT01746901|593484620|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
164302698|NCT01746901|593484621|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
164302699|NCT01746901|593484622|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
164302700|NCT01746901|593484623|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
164302701|NCT01746901|593484624|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
164302702|NCT01746901|593484625|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
164302703|NCT01746901|593484617|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164302704|NCT01746901|593484618|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
164302705|NCT01746901|593484619|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
164302706|NCT01746901|593484620|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164302707|NCT01746901|593484621|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164302708|NCT01746901|593484622|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164302709|NCT01746901|593484623|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164302710|NCT01746901|593484624|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164302711|NCT01746901|593484625|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164302712|NCT01746901|593484617|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
164302713|NCT01746901|593484618|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
164302714|NCT01746901|593484619|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
164302715|NCT01746901|593484620|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
164302716|NCT01746901|593484621|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
164302717|NCT01746901|593484622|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
164302718|NCT01746901|593484623|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
164302719|NCT01746901|593484624|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
164302720|NCT01746901|593484625|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
164302721|NCT01746901|593484617|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
164302722|NCT01746901|593484618|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
164302723|NCT01746901|593484619|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
164302724|NCT01746901|593484620|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
164302725|NCT01746901|593484621|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
164302726|NCT01746901|593484622|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
164302727|NCT01746901|593484623|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
164302728|NCT01746901|593484624|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
164302729|NCT01746901|593484625|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
164302730|NCT01746901|593484617|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
164302731|NCT01746901|593484618|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
164302732|NCT01746901|593484619|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
164302733|NCT01746901|593484620|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
164302734|NCT01746901|593484621|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
164302735|NCT01746901|593484622|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
164302736|NCT01746901|593484623|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
164302737|NCT01746901|593484624|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
164302738|NCT01746901|593484625|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
164302739|NCT01746901|593484617|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
164302740|NCT01746901|593484618|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
164302741|NCT01746901|593484619|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
164302742|NCT01746901|593484620|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
164302743|NCT01746901|593484621|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
164302744|NCT01746901|593484622|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
164302745|NCT01746901|593484623|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
164302746|NCT01746901|593484624|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
164302747|NCT01746901|593484625|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
164302748|NCT01746901|593484617|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
164302749|NCT01746901|593484618|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
164302750|NCT01746901|593484619|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
164302751|NCT01746901|593484620|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
164302752|NCT01746901|593484621|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
164302753|NCT01746901|593484622|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
164302754|NCT01746901|593484623|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
164302755|NCT01746901|593484624|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
164302756|NCT01746901|593484625|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
164302757|NCT01746901|593484617|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
164302758|NCT01746901|593484618|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
164302759|NCT01746901|593484619|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
164302983|NCT02760498|593484677|FG004|Overall Study|Not treated|0|||
164302760|NCT01746901|593484620|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
164302761|NCT01746901|593484621|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
164302762|NCT01746901|593484622|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
164302763|NCT01746901|593484623|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
164302764|NCT01746901|593484624|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
164302765|NCT01746901|593484625|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
164302766|NCT03594110|593484626|FG000|Interventional Part|Participant concerned about study treatment|23|||
164302767|NCT03594110|593484627|FG001|Interventional Part|Participant concerned about study treatment|28|||
164302768|NCT03594110|593484626|FG000|Interventional Part|Doctor advice|38|||
164302769|NCT03594110|593484627|FG001|Interventional Part|Doctor advice|40|||
164302770|NCT03594110|593484626|FG000|Interventional Part|Participants' wish|89|||
164302771|NCT03594110|593484627|FG001|Interventional Part|Participants' wish|68|||
164302772|NCT03594110|593484626|FG000|Interventional Part|Adverse event-non-fatal events|119|||
164302773|NCT03594110|593484627|FG001|Interventional Part|Adverse event-non-fatal events|116|||
164302774|NCT03594110|593484626|FG000|Interventional Part|Study drug stopped, reason missing|336|||
164302775|NCT03594110|593484627|FG001|Interventional Part|Study drug stopped, reason missing|294|||
164302776|NCT03594110|593484626|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
164302777|NCT03594110|593484627|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
164302778|NCT03594110|593484626|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
164302779|NCT03594110|593484627|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
164302780|NCT03594110|593484626|FG000|Interventional Part|Contraindicated drug started|32|||
164302781|NCT03594110|593484627|FG001|Interventional Part|Contraindicated drug started|18|||
164302782|NCT03594110|593484626|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
164302783|NCT03594110|593484627|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
164302784|NCT03594110|593484626|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
164302785|NCT03594110|593484627|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
164302786|NCT03594110|593484626|FG000|Non-interventional Part|Withdrawal by Subject|3|||
164302787|NCT03594110|593484627|FG001|Non-interventional Part|Withdrawal by Subject|4|||
164302788|NCT03594110|593484626|FG000|Non-interventional Part|Lost to Follow-up|45|||
164302789|NCT03594110|593484627|FG001|Non-interventional Part|Lost to Follow-up|41|||
164302790|NCT02968004|593484628|FG000|Main Study Phase|Adverse Event|1|||
164302791|NCT02968004|593484629|FG001|Main Study Phase|Adverse Event|0|||
164302792|NCT02968004|593484628|FG000|Main Study Phase|Withdrawal by Subject|0|||
164302793|NCT02968004|593484629|FG001|Main Study Phase|Withdrawal by Subject|1|||
164302794|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
164302795|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
164302796|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
164302797|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
164302798|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
164302799|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
164302800|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
164302801|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
164302802|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
164302803|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
164302804|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
164302805|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
164302806|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
164302807|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
164302808|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
164302809|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
164302810|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
164302811|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
164302812|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
164302813|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
164302814|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
164302815|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
164302816|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
164302817|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
164302818|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
164302819|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
164302820|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
164302821|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
164302822|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
164302823|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
164302824|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
164302825|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
164302826|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
164302827|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
164302828|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
164302829|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
164302830|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
164302831|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
164302832|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
164302833|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
164302834|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
164302835|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
164302836|NCT00803569|593484631|FG000|Overall Study|Progressive Disease|3|||
164302837|NCT00803569|593484631|FG000|Overall Study|Noncompliance|1|||
164302838|NCT04298697|593484632|FG000|Overall Study|Lost to Follow-up|5|||
164302839|NCT04298697|593484633|FG001|Overall Study|Lost to Follow-up|5|||
164302840|NCT04298697|593484634|FG002|Overall Study|Lost to Follow-up|1|||
164302841|NCT04298697|593484635|FG003|Overall Study|Lost to Follow-up|0|||
164302842|NCT04298697|593484632|FG000|Overall Study|Withdrawal by Subject|0|||
164302843|NCT04298697|593484633|FG001|Overall Study|Withdrawal by Subject|3|||
164302844|NCT04298697|593484634|FG002|Overall Study|Withdrawal by Subject|2|||
164302845|NCT04298697|593484635|FG003|Overall Study|Withdrawal by Subject|3|||
164302846|NCT03995368|593484636|FG000|Overall Study|Lost to Follow-up|1|||
164302847|NCT03995368|593484637|FG001|Overall Study|Lost to Follow-up|4|||
164302848|NCT03995368|593484638|FG002|Overall Study|Lost to Follow-up|1|||
164302849|NCT03995368|593484636|FG000|Overall Study|Did not meet inclusion criteria|1|||
164302850|NCT03995368|593484637|FG001|Overall Study|Did not meet inclusion criteria|6|||
164302851|NCT03995368|593484638|FG002|Overall Study|Did not meet inclusion criteria|3|||
164302852|NCT03995368|593484636|FG000|Overall Study|Withdrawal by Subject|0|||
164302853|NCT03995368|593484637|FG001|Overall Study|Withdrawal by Subject|1|||
164302854|NCT03995368|593484638|FG002|Overall Study|Withdrawal by Subject|1|||
164302855|NCT03592186|593484639|FG000|Overall Study|Withdrawal by Subject|1|||
164302856|NCT03592186|593484640|FG001|Overall Study|Withdrawal by Subject|0|||
164302857|NCT03592186|593484639|FG000|Overall Study|Lost to Follow-up|16|||
164302858|NCT03592186|593484640|FG001|Overall Study|Lost to Follow-up|11|||
164302859|NCT02072668|593484644|FG000|Second Intervention|Lost to Follow-up|1|||
164302860|NCT02072668|593484645|FG001|Second Intervention|Lost to Follow-up|0|||
164302861|NCT01353898|593484646|FG000|Overall Study|Study site terminated|0|||
164302862|NCT01353898|593484647|FG001|Overall Study|Study site terminated|0|||
164302863|NCT01353898|593484648|FG002|Overall Study|Study site terminated|0|||
164302864|NCT01353898|593484649|FG003|Overall Study|Study site terminated|0|||
164302865|NCT01353898|593484650|FG004|Overall Study|Study site terminated|0|||
164302866|NCT01353898|593484651|FG005|Overall Study|Study site terminated|1|||
164302867|NCT01352793|593484653|FG000|Overall Study|Lost to Follow-up|289|||
164302868|NCT01352793|593484654|FG001|Overall Study|Lost to Follow-up|125|||
164302869|NCT01352793|593484653|FG000|Overall Study|Withdrawal by Subject|120|||
164302870|NCT01352793|593484654|FG001|Overall Study|Withdrawal by Subject|55|||
164302871|NCT01352793|593484653|FG000|Overall Study|Protocol Violation|44|||
164302872|NCT01352793|593484654|FG001|Overall Study|Protocol Violation|23|||
164302873|NCT01352793|593484653|FG000|Overall Study|Adverse Event|44|||
164302874|NCT01352793|593484654|FG001|Overall Study|Adverse Event|10|||
164302875|NCT01352793|593484653|FG000|Overall Study|Physician Decision|1|||
164302876|NCT01352793|593484654|FG001|Overall Study|Physician Decision|0|||
164302877|NCT01352793|593484653|FG000|Overall Study|Pregnancy|26|||
164302878|NCT01352793|593484654|FG001|Overall Study|Pregnancy|8|||
164302879|NCT01352793|593484653|FG000|Overall Study|Other|25|||
164302880|NCT01352793|593484654|FG001|Overall Study|Other|7|||
164302881|NCT01352793|593484653|FG000|Overall Study|Medication error|2|||
164302882|NCT01352793|593484654|FG001|Overall Study|Medication error|2|||
164302883|NCT01352793|593484653|FG000|Overall Study|Death|1|||
164302884|NCT01352793|593484654|FG001|Overall Study|Death|0|||
164302885|NCT01352793|593484653|FG000|Overall Study|Randomized but not vaccinated|8|||
164302886|NCT01352793|593484654|FG001|Overall Study|Randomized but not vaccinated|0|||
164302887|NCT01352793|593484653|FG000|Overall Study|No longer meets eligibility criteria|25|||
164302888|NCT01352793|593484654|FG001|Overall Study|No longer meets eligibility criteria|15|||
164302889|NCT04322526|593484657|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
164302890|NCT04322526|593484658|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
164302891|NCT04322526|593484657|FG000|Washout (1 Week)|Lost to Follow-up|1|||
164302892|NCT04322526|593484658|FG001|Washout (1 Week)|Lost to Follow-up|2|||
164302893|NCT00993967|593484659|FG000|Overall Study|Adverse Event|8|||
164302894|NCT00993967|593484659|FG000|Overall Study|Death|1|||
164302895|NCT00993967|593484659|FG000|Overall Study|Lost to Follow-up|14|||
164302896|NCT00993967|593484659|FG000|Overall Study|Withdrawal by Subject|36|||
164302897|NCT00993967|593484659|FG000|Overall Study|Protocol Violation|2|||
164302898|NCT03815929|593484668|FG000|Overall Study|Lost to Follow-up|2|||
164302899|NCT03815929|593484669|FG001|Overall Study|Lost to Follow-up|1|||
164302900|NCT03815929|593484670|FG002|Overall Study|Lost to Follow-up|0|||
164302901|NCT03815929|593484668|FG000|Overall Study|Physician Decision|2|||
164302902|NCT03815929|593484669|FG001|Overall Study|Physician Decision|2|||
164302904|NCT03815929|593484668|FG000|Overall Study|Withdrawal by Subject|0|||
164302905|NCT03815929|593484669|FG001|Overall Study|Withdrawal by Subject|0|||
164302906|NCT03815929|593484670|FG002|Overall Study|Withdrawal by Subject|1|||
164302907|NCT03313037|593484671|FG000|Overall Study|Protocol Violation|4|||
164302908|NCT03313037|593484672|FG001|Overall Study|Protocol Violation|1|||
164302909|NCT03313037|593484671|FG000|Overall Study|Other|1|||
164302910|NCT03313037|593484672|FG001|Overall Study|Other|1|||
164302911|NCT03313037|593484671|FG000|Overall Study|Withdrawal by Subject|4|||
164302912|NCT03313037|593484672|FG001|Overall Study|Withdrawal by Subject|3|||
164302913|NCT03313037|593484671|FG000|Overall Study|No longer meets eligibility criteria|1|||
164302914|NCT03313037|593484672|FG001|Overall Study|No longer meets eligibility criteria|7|||
164302915|NCT03313037|593484671|FG000|Overall Study|Lost to Follow-up|9|||
164302916|NCT03313037|593484672|FG001|Overall Study|Lost to Follow-up|8|||
164302917|NCT03313037|593484671|FG000|Overall Study|Randomized but not treated|1|||
164302918|NCT03313037|593484672|FG001|Overall Study|Randomized but not treated|0|||
164302919|NCT02760498|593484673|FG000|Overall Study|Adverse Event|3|||
164302920|NCT02760498|593484674|FG001|Overall Study|Adverse Event|3|||
164302921|NCT02760498|593484675|FG002|Overall Study|Adverse Event|1|||
164302922|NCT02760498|593484676|FG003|Overall Study|Adverse Event|1|||
164302923|NCT02760498|593484677|FG004|Overall Study|Adverse Event|0|||
164302924|NCT02760498|593484678|FG005|Overall Study|Adverse Event|6|||
164302925|NCT02760498|593484673|FG000|Overall Study|Death|7|||
164302926|NCT02760498|593484674|FG001|Overall Study|Death|5|||
164302927|NCT02760498|593484675|FG002|Overall Study|Death|5|||
164302928|NCT02760498|593484676|FG003|Overall Study|Death|7|||
164302929|NCT02760498|593484677|FG004|Overall Study|Death|0|||
164302930|NCT02760498|593484678|FG005|Overall Study|Death|23|||
164302931|NCT02760498|593484673|FG000|Overall Study|Lost to Follow-up|0|||
164302932|NCT02760498|593484674|FG001|Overall Study|Lost to Follow-up|0|||
164302933|NCT02760498|593484675|FG002|Overall Study|Lost to Follow-up|0|||
164302934|NCT02760498|593484676|FG003|Overall Study|Lost to Follow-up|0|||
164302935|NCT02760498|593484677|FG004|Overall Study|Lost to Follow-up|0|||
164302936|NCT02760498|593484678|FG005|Overall Study|Lost to Follow-up|3|||
164302937|NCT02760498|593484673|FG000|Overall Study|Non-compliance with study drug|0|||
164302938|NCT02760498|593484674|FG001|Overall Study|Non-compliance with study drug|2|||
164302939|NCT02760498|593484675|FG002|Overall Study|Non-compliance with study drug|0|||
164302940|NCT02760498|593484676|FG003|Overall Study|Non-compliance with study drug|0|||
164302941|NCT02760498|593484677|FG004|Overall Study|Non-compliance with study drug|0|||
164302942|NCT02760498|593484678|FG005|Overall Study|Non-compliance with study drug|0|||
164302943|NCT02760498|593484673|FG000|Overall Study|Participant decision|1|||
164302944|NCT02760498|593484674|FG001|Overall Study|Participant decision|4|||
164302945|NCT02760498|593484675|FG002|Overall Study|Participant decision|2|||
164302946|NCT02760498|593484676|FG003|Overall Study|Participant decision|2|||
164302947|NCT02760498|593484677|FG004|Overall Study|Participant decision|1|||
164302948|NCT02760498|593484678|FG005|Overall Study|Participant decision|6|||
164302949|NCT02760498|593484673|FG000|Overall Study|Sponsor decision|0|||
164302950|NCT02760498|593484674|FG001|Overall Study|Sponsor decision|0|||
164302951|NCT02760498|593484675|FG002|Overall Study|Sponsor decision|0|||
164302952|NCT02760498|593484676|FG003|Overall Study|Sponsor decision|3|||
164302953|NCT02760498|593484677|FG004|Overall Study|Sponsor decision|0|||
164302954|NCT02760498|593484678|FG005|Overall Study|Sponsor decision|0|||
164302955|NCT02760498|593484673|FG000|Overall Study|Physician Decision|3|||
164302956|NCT02760498|593484674|FG001|Overall Study|Physician Decision|4|||
164302957|NCT02760498|593484675|FG002|Overall Study|Physician Decision|1|||
164302958|NCT02760498|593484676|FG003|Overall Study|Physician Decision|4|||
164302959|NCT02760498|593484677|FG004|Overall Study|Physician Decision|0|||
164302960|NCT02760498|593484678|FG005|Overall Study|Physician Decision|2|||
164302961|NCT02760498|593484673|FG000|Overall Study|Disease progression|21|||
164302962|NCT02760498|593484674|FG001|Overall Study|Disease progression|19|||
164302963|NCT02760498|593484675|FG002|Overall Study|Disease progression|20|||
164302964|NCT02760498|593484676|FG003|Overall Study|Disease progression|18|||
164302965|NCT02760498|593484677|FG004|Overall Study|Disease progression|4|||
164302966|NCT02760498|593484678|FG005|Overall Study|Disease progression|55|||
164302967|NCT02760498|593484673|FG000|Overall Study|Withdrawal by Subject|4|||
164302968|NCT02760498|593484674|FG001|Overall Study|Withdrawal by Subject|7|||
164302969|NCT02760498|593484675|FG002|Overall Study|Withdrawal by Subject|5|||
164302970|NCT02760498|593484676|FG003|Overall Study|Withdrawal by Subject|1|||
164302971|NCT02760498|593484677|FG004|Overall Study|Withdrawal by Subject|0|||
164302972|NCT02760498|593484678|FG005|Overall Study|Withdrawal by Subject|6|||
164302973|NCT02760498|593484673|FG000|Overall Study|Other than specified|1|||
164302974|NCT02760498|593484674|FG001|Overall Study|Other than specified|6|||
164302975|NCT02760498|593484675|FG002|Overall Study|Other than specified|0|||
164302976|NCT02760498|593484676|FG003|Overall Study|Other than specified|3|||
164302977|NCT02760498|593484677|FG004|Overall Study|Other than specified|1|||
164302978|NCT02760498|593484678|FG005|Overall Study|Other than specified|0|||
164302979|NCT02760498|593484673|FG000|Overall Study|Not treated|0|||
164302980|NCT02760498|593484674|FG001|Overall Study|Not treated|0|||
164302981|NCT02760498|593484675|FG002|Overall Study|Not treated|0|||
164302982|NCT02760498|593484676|FG003|Overall Study|Not treated|0|||
164303022|NCT04323124|593484686|FG000|Overall Study|Coming from a red zone (COVID)|0|||
164303023|NCT04323124|593484687|FG001|Overall Study|Coming from a red zone (COVID)|0|||
164303024|NCT04323124|593484688|FG002|Overall Study|Coming from a red zone (COVID)|0|||
164303025|NCT04323124|593484689|FG003|Overall Study|Coming from a red zone (COVID)|0|||
164303026|NCT04323124|593484690|FG004|Overall Study|Coming from a red zone (COVID)|1|||
164303027|NCT04323124|593484691|FG005|Overall Study|Coming from a red zone (COVID)|1|||
164303028|NCT04323124|593484692|FG006|Overall Study|Coming from a red zone (COVID)|0|||
164303029|NCT04323124|593484693|FG007|Overall Study|Coming from a red zone (COVID)|0|||
164303030|NCT04323124|593484694|FG008|Overall Study|Coming from a red zone (COVID)|0|||
164303031|NCT04323124|593484695|FG009|Overall Study|Coming from a red zone (COVID)|0|||
164303032|NCT04323124|593484696|FG010|Overall Study|Coming from a red zone (COVID)|0|||
164303033|NCT04323124|593484697|FG011|Overall Study|Coming from a red zone (COVID)|0|||
164303034|NCT04323124|593484698|FG012|Overall Study|Coming from a red zone (COVID)|0|||
164303035|NCT04323124|593484699|FG013|Overall Study|Coming from a red zone (COVID)|0|||
164303036|NCT04323124|593484700|FG014|Overall Study|Coming from a red zone (COVID)|0|||
164303037|NCT04323124|593484686|FG000|Overall Study|No longer meets eligibility criteria|0|||
164303038|NCT04323124|593484687|FG001|Overall Study|No longer meets eligibility criteria|0|||
164303039|NCT04323124|593484688|FG002|Overall Study|No longer meets eligibility criteria|0|||
164303040|NCT04323124|593484689|FG003|Overall Study|No longer meets eligibility criteria|0|||
164303041|NCT04323124|593484690|FG004|Overall Study|No longer meets eligibility criteria|0|||
164303042|NCT04323124|593484691|FG005|Overall Study|No longer meets eligibility criteria|0|||
164303043|NCT04323124|593484692|FG006|Overall Study|No longer meets eligibility criteria|0|||
164303044|NCT04323124|593484693|FG007|Overall Study|No longer meets eligibility criteria|1|||
164303045|NCT04323124|593484694|FG008|Overall Study|No longer meets eligibility criteria|0|||
164303046|NCT04323124|593484695|FG009|Overall Study|No longer meets eligibility criteria|0|||
164303047|NCT04323124|593484696|FG010|Overall Study|No longer meets eligibility criteria|0|||
164303048|NCT04323124|593484697|FG011|Overall Study|No longer meets eligibility criteria|0|||
164303049|NCT04323124|593484698|FG012|Overall Study|No longer meets eligibility criteria|0|||
164303050|NCT04323124|593484699|FG013|Overall Study|No longer meets eligibility criteria|1|||
164303051|NCT04323124|593484700|FG014|Overall Study|No longer meets eligibility criteria|1|||
164303052|NCT04323124|593484686|FG000|Overall Study|Study terminated by sponsor|0|||
164303053|NCT04323124|593484687|FG001|Overall Study|Study terminated by sponsor|0|||
164303054|NCT04323124|593484688|FG002|Overall Study|Study terminated by sponsor|0|||
164303055|NCT04323124|593484689|FG003|Overall Study|Study terminated by sponsor|0|||
164303056|NCT04323124|593484690|FG004|Overall Study|Study terminated by sponsor|0|||
164303057|NCT04323124|593484691|FG005|Overall Study|Study terminated by sponsor|0|||
164303058|NCT04323124|593484692|FG006|Overall Study|Study terminated by sponsor|0|||
164303059|NCT04323124|593484693|FG007|Overall Study|Study terminated by sponsor|0|||
164303060|NCT04323124|593484694|FG008|Overall Study|Study terminated by sponsor|0|||
164303061|NCT04323124|593484695|FG009|Overall Study|Study terminated by sponsor|0|||
164303062|NCT04323124|593484696|FG010|Overall Study|Study terminated by sponsor|0|||
164303063|NCT04323124|593484697|FG011|Overall Study|Study terminated by sponsor|2|||
164303064|NCT04323124|593484698|FG012|Overall Study|Study terminated by sponsor|1|||
164303065|NCT04323124|593484699|FG013|Overall Study|Study terminated by sponsor|0|||
164303066|NCT04323124|593484700|FG014|Overall Study|Study terminated by sponsor|0|||
164303067|NCT04586205|593484701|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
164303068|NCT04586205|593484702|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
164417652|NCT01474512|593899504|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
164417653|NCT01474512|593899505|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
164417654|NCT01474512|593899506|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
164417655|NCT01474512|593899489|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
164417656|NCT01474512|593899490|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
164417657|NCT01474512|593899491|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
164417658|NCT01474512|593899492|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
164417659|NCT01474512|593899493|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
164417660|NCT01474512|593899494|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
164417661|NCT01474512|593899495|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
164417662|NCT01474512|593899496|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
164417663|NCT01474512|593899497|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
164417664|NCT01474512|593899498|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
164417665|NCT01474512|593899499|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
164417666|NCT01474512|593899500|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
164417667|NCT01474512|593899501|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
164417668|NCT01474512|593899502|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
164417669|NCT01474512|593899503|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
164417670|NCT01474512|593899504|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
164417671|NCT01474512|593899505|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
164417672|NCT01474512|593899506|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
164417673|NCT01474512|593899489|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
164417674|NCT01474512|593899490|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
164417675|NCT01474512|593899491|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
164417676|NCT01474512|593899492|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
164417677|NCT01474512|593899493|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
164417678|NCT01474512|593899494|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
164417679|NCT01474512|593899495|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
164417680|NCT01474512|593899496|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
164417681|NCT01474512|593899497|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
164417682|NCT01474512|593899498|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
164417683|NCT01474512|593899499|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
164417684|NCT01474512|593899500|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
164417685|NCT01474512|593899501|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
164417686|NCT01474512|593899502|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
164417687|NCT01474512|593899503|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
164417688|NCT01474512|593899504|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
164417689|NCT01474512|593899505|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
164417690|NCT01474512|593899506|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
164417691|NCT01474512|593899489|FG000|Post-Treatment Follow-Up|Death|0|||
164417692|NCT01474512|593899490|FG001|Post-Treatment Follow-Up|Death|0|||
164417693|NCT01474512|593899491|FG002|Post-Treatment Follow-Up|Death|0|||
164417694|NCT01474512|593899492|FG003|Post-Treatment Follow-Up|Death|0|||
164417695|NCT01474512|593899493|FG004|Post-Treatment Follow-Up|Death|0|||
164417696|NCT01474512|593899494|FG005|Post-Treatment Follow-Up|Death|0|||
164417697|NCT01474512|593899495|FG006|Post-Treatment Follow-Up|Death|0|||
164417698|NCT01474512|593899496|FG007|Post-Treatment Follow-Up|Death|0|||
164417699|NCT01474512|593899497|FG008|Post-Treatment Follow-Up|Death|0|||
164417700|NCT01474512|593899498|FG009|Post-Treatment Follow-Up|Death|0|||
164417701|NCT01474512|593899499|FG010|Post-Treatment Follow-Up|Death|0|||
164417702|NCT01474512|593899500|FG011|Post-Treatment Follow-Up|Death|0|||
164417703|NCT01474512|593899501|FG012|Post-Treatment Follow-Up|Death|0|||
164417704|NCT01474512|593899502|FG013|Post-Treatment Follow-Up|Death|0|||
164417705|NCT01474512|593899503|FG014|Post-Treatment Follow-Up|Death|0|||
164417706|NCT01474512|593899504|FG015|Post-Treatment Follow-Up|Death|0|||
164417707|NCT01474512|593899505|FG016|Post-Treatment Follow-Up|Death|1|||
164417708|NCT01474512|593899506|FG017|Post-Treatment Follow-Up|Death|0|||
164417709|NCT01118962|593899509|FG000|Overall Study|Adverse Event|2|||
164417710|NCT01118962|593899509|FG000|Overall Study|Lack of Efficacy|1|||
164417711|NCT01118962|593899509|FG000|Overall Study|Protocol Violation|1|||
164417712|NCT01118962|593899509|FG000|Overall Study|Withdrawal by Subject|4|||
164417713|NCT01118962|593899509|FG000|Overall Study|Pregnancy|1|||
164417714|NCT01118962|593899509|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
164417715|NCT01089556|593899512|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
164417716|NCT01089556|593899513|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
164417717|NCT01089556|593899514|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
164417718|NCT01089556|593899515|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
164417719|NCT01089556|593899516|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
164417720|NCT01089556|593899517|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
164417721|NCT01089556|593899512|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
164417722|NCT01089556|593899513|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
164417723|NCT01089556|593899514|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
164417724|NCT01089556|593899515|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
164417725|NCT01089556|593899516|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
164417726|NCT01089556|593899517|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
164417727|NCT01089556|593899512|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
164417728|NCT01089556|593899513|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
164417729|NCT01089556|593899514|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
164417730|NCT01089556|593899515|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
164417731|NCT01089556|593899516|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
164417732|NCT01089556|593899517|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
164417733|NCT01089556|593899512|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
164417734|NCT01089556|593899513|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
164417735|NCT01089556|593899514|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
164417736|NCT01089556|593899515|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
164417737|NCT01089556|593899516|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
164417738|NCT01089556|593899517|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
164417739|NCT01089556|593899512|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
164417740|NCT01089556|593899513|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
164417741|NCT01089556|593899514|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
164417742|NCT01089556|593899515|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
164417743|NCT01089556|593899516|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
164417744|NCT01089556|593899517|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
164417745|NCT01089556|593899512|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
164417746|NCT01089556|593899513|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
164417747|NCT01089556|593899514|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
164417748|NCT01089556|593899515|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
164417749|NCT01089556|593899516|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
164417750|NCT01089556|593899517|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
164417751|NCT01089556|593899512|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
164417752|NCT01089556|593899513|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
164417753|NCT01089556|593899514|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
164417754|NCT01089556|593899515|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
164417755|NCT01089556|593899516|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
164417756|NCT01089556|593899517|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
164417757|NCT01089556|593899512|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
164417758|NCT01089556|593899513|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
164417759|NCT01089556|593899514|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
164417760|NCT01089556|593899515|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
164417761|NCT01089556|593899516|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
164417762|NCT01089556|593899517|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
164417763|NCT01089556|593899512|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
164417764|NCT01089556|593899513|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
164417765|NCT01089556|593899514|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
164417766|NCT01089556|593899515|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
164417767|NCT01089556|593899516|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
164417768|NCT01089556|593899517|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
164417769|NCT01089556|593899512|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
164417770|NCT01089556|593899513|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
164417771|NCT01089556|593899514|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
164417772|NCT01089556|593899515|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
164417773|NCT01089556|593899516|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
164417774|NCT01089556|593899517|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
164417775|NCT01089556|593899512|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
164417776|NCT01089556|593899513|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
164417777|NCT01089556|593899514|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
164417778|NCT01089556|593899515|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
164417779|NCT01089556|593899516|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
164417780|NCT01089556|593899517|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
164417781|NCT01089556|593899512|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
164417782|NCT01089556|593899513|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
164417783|NCT01089556|593899514|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
164417784|NCT01089556|593899515|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
164417785|NCT01089556|593899516|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
164417786|NCT01089556|593899517|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
164417787|NCT01089556|593899512|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
164417788|NCT01089556|593899513|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
164417789|NCT01089556|593899514|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
164417790|NCT01089556|593899515|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
164417791|NCT01089556|593899516|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
164417792|NCT01089556|593899517|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
164417793|NCT01089556|593899512|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
164417794|NCT01089556|593899513|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
164417795|NCT01089556|593899514|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
164417796|NCT01089556|593899515|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
164417797|NCT01089556|593899516|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
164417798|NCT01089556|593899517|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
164417799|NCT01089556|593899512|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
164417800|NCT01089556|593899513|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
164417801|NCT01089556|593899514|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
164417802|NCT01089556|593899515|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
164417803|NCT01089556|593899516|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
164417804|NCT01089556|593899517|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
164417805|NCT01757665|593899523|FG000|Overall Study|Still on Study - Visit Completed|240|||
164417806|NCT01757665|593899524|FG001|Overall Study|Still on Study - Visit Completed|30|||
164417807|NCT01757665|593899523|FG000|Overall Study|Still on Study - Visit Pending|398|||
164417808|NCT01757665|593899524|FG001|Overall Study|Still on Study - Visit Pending|40|||
164417809|NCT01757665|593899523|FG000|Overall Study|Still on Study - Missed Visit|14|||
164417810|NCT01757665|593899524|FG001|Overall Study|Still on Study - Missed Visit|1|||
164417811|NCT01757665|593899523|FG000|Overall Study|Death|25|||
164417812|NCT01757665|593899524|FG001|Overall Study|Death|8|||
164417813|NCT01757665|593899523|FG000|Overall Study|Explant|1|||
164417814|NCT01757665|593899524|FG001|Overall Study|Explant|2|||
164417815|NCT01757665|593899523|FG000|Overall Study|Withdrawal by Subject|10|||
164417816|NCT01757665|593899524|FG001|Overall Study|Withdrawal by Subject|0|||
164417819|NCT01757665|593899523|FG000|Overall Study|Not Implanted with Device|5|||
164417820|NCT01757665|593899524|FG001|Overall Study|Not Implanted with Device|1|||
164417821|NCT00594906|593899525|FG000|Overall Study|Physician Decision|1|||
164417822|NCT00594906|593899526|FG001|Overall Study|Physician Decision|0|||
164417823|NCT00594906|593899525|FG000|Overall Study|Physician Decision|0|||
164417824|NCT00594906|593899526|FG001|Overall Study|Physician Decision|1|||
164417825|NCT00594906|593899525|FG000|Overall Study|Death|0|||
164417826|NCT00594906|593899526|FG001|Overall Study|Death|1|||
164417827|NCT01027364|593899532|FG000|Overall Study|Adverse Event|1|||
164417828|NCT01027364|593899533|FG001|Overall Study|Adverse Event|0|||
164417829|NCT01027364|593899534|FG002|Overall Study|Adverse Event|1|||
164417830|NCT01027364|593899535|FG003|Overall Study|Adverse Event|0|||
164417831|NCT01027364|593899532|FG000|Overall Study|Lost to Follow-up|1|||
164417832|NCT01027364|593899533|FG001|Overall Study|Lost to Follow-up|0|||
164417833|NCT01027364|593899534|FG002|Overall Study|Lost to Follow-up|0|||
164417834|NCT01027364|593899535|FG003|Overall Study|Lost to Follow-up|0|||
164417835|NCT01027364|593899532|FG000|Overall Study|Protocol Violation|1|||
164417836|NCT01027364|593899533|FG001|Overall Study|Protocol Violation|0|||
164417837|NCT01027364|593899534|FG002|Overall Study|Protocol Violation|0|||
164417838|NCT01027364|593899535|FG003|Overall Study|Protocol Violation|1|||
164417839|NCT01027364|593899532|FG000|Overall Study|Withdrawal by Subject|1|||
164417840|NCT01027364|593899533|FG001|Overall Study|Withdrawal by Subject|2|||
164417841|NCT01027364|593899534|FG002|Overall Study|Withdrawal by Subject|0|||
164417842|NCT01027364|593899535|FG003|Overall Study|Withdrawal by Subject|0|||
164417843|NCT01394250|593899536|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
164417844|NCT01394250|593899537|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
164417845|NCT01394250|593899536|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
164417846|NCT01394250|593899537|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
164417847|NCT02222896|593899538|FG000|Abdomen|Did not qualify|34|||
164417848|NCT02222896|593899539|FG001|Abdomen|Did not qualify|10|||
164417849|NCT02222896|593899540|FG002|Abdomen|Did not qualify|32|||
164417850|NCT02222896|593899538|FG000|Groin|Did not qualify|43|||
164417851|NCT02222896|593899539|FG001|Groin|Did not qualify|9|||
164417852|NCT02222896|593899540|FG002|Groin|Did not qualify|40|||
164417853|NCT01865617|593899542|FG000|Overall Study|Death|27|||
164417854|NCT01865617|593899543|FG001|Overall Study|Death|3|||
164417855|NCT01865617|593899544|FG002|Overall Study|Death|1|||
164417856|NCT01865617|593899545|FG003|Overall Study|Death|1|||
164417857|NCT01865617|593899546|FG004|Overall Study|Death|5|||
164417858|NCT01865617|593899547|FG005|Overall Study|Death|1|||
164417859|NCT01865617|593899548|FG006|Overall Study|Death|11|||
164417860|NCT01865617|593899549|FG007|Overall Study|Death|1|||
164417861|NCT01865617|593899550|FG008|Overall Study|Death|11|||
164417862|NCT01865617|593899551|FG009|Overall Study|Death|3|||
164417863|NCT01865617|593899552|FG010|Overall Study|Death|32|||
164417864|NCT01865617|593899553|FG011|Overall Study|Death|6|||
164417865|NCT01865617|593899554|FG012|Overall Study|Death|13|||
164417866|NCT01865617|593899542|FG000|Overall Study|Lost to Follow-up|2|||
164417867|NCT01865617|593899543|FG001|Overall Study|Lost to Follow-up|0|||
164417868|NCT01865617|593899544|FG002|Overall Study|Lost to Follow-up|0|||
164417869|NCT01865617|593899545|FG003|Overall Study|Lost to Follow-up|0|||
164417870|NCT01865617|593899546|FG004|Overall Study|Lost to Follow-up|0|||
164417871|NCT01865617|593899547|FG005|Overall Study|Lost to Follow-up|0|||
164417872|NCT01865617|593899548|FG006|Overall Study|Lost to Follow-up|0|||
164417873|NCT01865617|593899549|FG007|Overall Study|Lost to Follow-up|0|||
164417874|NCT01865617|593899550|FG008|Overall Study|Lost to Follow-up|0|||
164417875|NCT01865617|593899551|FG009|Overall Study|Lost to Follow-up|0|||
164417876|NCT01865617|593899552|FG010|Overall Study|Lost to Follow-up|0|||
164417877|NCT01865617|593899553|FG011|Overall Study|Lost to Follow-up|0|||
164417878|NCT01865617|593899554|FG012|Overall Study|Lost to Follow-up|0|||
164417879|NCT01865617|593899542|FG000|Overall Study|Withdrawal by Subject|1|||
164417880|NCT01865617|593899543|FG001|Overall Study|Withdrawal by Subject|0|||
164417881|NCT01865617|593899544|FG002|Overall Study|Withdrawal by Subject|0|||
164417882|NCT01865617|593899545|FG003|Overall Study|Withdrawal by Subject|0|||
164417883|NCT01865617|593899546|FG004|Overall Study|Withdrawal by Subject|0|||
164417884|NCT01865617|593899547|FG005|Overall Study|Withdrawal by Subject|0|||
164417885|NCT01865617|593899548|FG006|Overall Study|Withdrawal by Subject|0|||
164417886|NCT01865617|593899549|FG007|Overall Study|Withdrawal by Subject|0|||
164417887|NCT01865617|593899550|FG008|Overall Study|Withdrawal by Subject|0|||
164417888|NCT01865617|593899551|FG009|Overall Study|Withdrawal by Subject|0|||
164417889|NCT01865617|593899552|FG010|Overall Study|Withdrawal by Subject|0|||
164417890|NCT01865617|593899553|FG011|Overall Study|Withdrawal by Subject|0|||
164417891|NCT01865617|593899554|FG012|Overall Study|Withdrawal by Subject|0|||
164417892|NCT01865617|593899542|FG000|Overall Study|Patient proceeded to new therapy|0|||
164417893|NCT01865617|593899543|FG001|Overall Study|Patient proceeded to new therapy|0|||
164417894|NCT01865617|593899544|FG002|Overall Study|Patient proceeded to new therapy|0|||
164417895|NCT01865617|593899545|FG003|Overall Study|Patient proceeded to new therapy|0|||
164417896|NCT01865617|593899546|FG004|Overall Study|Patient proceeded to new therapy|2|||
164417897|NCT01865617|593899547|FG005|Overall Study|Patient proceeded to new therapy|0|||
164417898|NCT01865617|593899548|FG006|Overall Study|Patient proceeded to new therapy|0|||
164417899|NCT01865617|593899549|FG007|Overall Study|Patient proceeded to new therapy|0|||
164417900|NCT01865617|593899550|FG008|Overall Study|Patient proceeded to new therapy|0|||
164417901|NCT01865617|593899551|FG009|Overall Study|Patient proceeded to new therapy|0|||
164417902|NCT01865617|593899552|FG010|Overall Study|Patient proceeded to new therapy|0|||
164417903|NCT01865617|593899553|FG011|Overall Study|Patient proceeded to new therapy|0|||
164417904|NCT01865617|593899554|FG012|Overall Study|Patient proceeded to new therapy|0|||
164417905|NCT01865617|593899542|FG000|Overall Study|Other|0|||
164417906|NCT01865617|593899543|FG001|Overall Study|Other|0|||
164417907|NCT01865617|593899544|FG002|Overall Study|Other|0|||
164417908|NCT01865617|593899545|FG003|Overall Study|Other|0|||
164417909|NCT01865617|593899546|FG004|Overall Study|Other|0|||
164417910|NCT01865617|593899547|FG005|Overall Study|Other|0|||
164417911|NCT01865617|593899548|FG006|Overall Study|Other|1|||
164417912|NCT01865617|593899549|FG007|Overall Study|Other|0|||
164417913|NCT01865617|593899550|FG008|Overall Study|Other|0|||
164417914|NCT01865617|593899551|FG009|Overall Study|Other|0|||
164417915|NCT01865617|593899552|FG010|Overall Study|Other|0|||
164417916|NCT01865617|593899553|FG011|Overall Study|Other|0|||
164417917|NCT01865617|593899554|FG012|Overall Study|Other|0|||
164417918|NCT02500979|593899555|FG000|Period 1|Hyperglycemia|1|||
164417919|NCT02500979|593899556|FG001|Period 1|Hyperglycemia|0|||
164417920|NCT02500979|593899555|FG000|Period 1|Severe non-compliance to protocol|0|||
164417921|NCT02500979|593899556|FG001|Period 1|Severe non-compliance to protocol|1|||
164417922|NCT02500979|593899555|FG000|Period 1|Adverse Event|1|||
164417923|NCT02500979|593899556|FG001|Period 1|Adverse Event|0|||
164417924|NCT02500979|593899555|FG000|Period 1|Subject decision|2|||
164417925|NCT02500979|593899556|FG001|Period 1|Subject decision|0|||
164417926|NCT02500979|593899555|FG000|Period 2|Change in risk|1|||
164417927|NCT02500979|593899556|FG001|Period 2|Change in risk|0|||
164417928|NCT03772314|593899559|FG000|Overall Study|Adverse Event|7|||
164417929|NCT03772314|593899560|FG001|Overall Study|Adverse Event|2|||
164417930|NCT01613027|593899561|FG000|Overall Study|Lost to Follow-up|5|||
164417931|NCT01613027|593899561|FG000|Overall Study|Switched Physician|1|||
164417932|NCT01613027|593899561|FG000|Overall Study|Lack of Efficacy|1|||
164417933|NCT01613027|593899561|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
164417934|NCT04267614|593899564|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
164417935|NCT04267614|593899564|FG000|Overall Study|Lost to Follow-up|115|||
164417936|NCT00119262|593899568|FG000|Overall Study|Lack of Efficacy|0|||
164417937|NCT00119262|593899569|FG001|Overall Study|Lack of Efficacy|3|||
164417938|NCT00119262|593899568|FG000|Overall Study|Withdrawal by Subject|12|||
164417939|NCT00119262|593899569|FG001|Overall Study|Withdrawal by Subject|11|||
164417940|NCT00119262|593899568|FG000|Overall Study|Adverse Event|33|||
164417941|NCT00119262|593899569|FG001|Overall Study|Adverse Event|35|||
164417942|NCT00119262|593899568|FG000|Overall Study|other disease|0|||
164417943|NCT00119262|593899569|FG001|Overall Study|other disease|2|||
164417944|NCT00119262|593899568|FG000|Overall Study|ineligble|1|||
164417945|NCT00119262|593899569|FG001|Overall Study|ineligble|2|||
164417946|NCT00119262|593899568|FG000|Overall Study|others|0|||
164417947|NCT00119262|593899569|FG001|Overall Study|others|5|||
164417948|NCT03632434|593899574|FG000|Overall Study|Withdrawal by Subject|2|||
164417949|NCT04297241|593899575|FG000|Overall Study|Withdrawal by Subject|1|||
164417950|NCT04297241|593899575|FG000|Overall Study|Adverse Event|1|||
164417951|NCT04297241|593899575|FG000|Overall Study|Physician Decision|3|||
164417952|NCT02836613|593899582|FG000|Overall Study|Accidental drowning|1|||
164417953|NCT02836613|593899583|FG001|Overall Study|Accidental drowning|0|||
164417954|NCT02836613|593899582|FG000|Overall Study|Lost to Follow-up|0|||
164417955|NCT02836613|593899583|FG001|Overall Study|Lost to Follow-up|1|||
164417956|NCT02836613|593899582|FG000|Overall Study|Withdrawal by Subject|0|||
164417957|NCT02836613|593899583|FG001|Overall Study|Withdrawal by Subject|2|||
164417958|NCT03881059|593899584|FG000|Treatment Period - Part A|Adverse Event|1|||
164417959|NCT03881059|593899585|FG001|Treatment Period - Part A|Adverse Event|3|||
164417960|NCT03881059|593899586|FG002|Treatment Period - Part A|Adverse Event|4|||
164417961|NCT03881059|593899584|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
164417962|NCT03881059|593899585|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
164417963|NCT03881059|593899586|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
164417964|NCT03881059|593899584|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
164417965|NCT03881059|593899585|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
164417966|NCT03881059|593899586|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
164417967|NCT03881059|593899584|FG000|Treatment Period - Part A|Other reasons|2|||
164417968|NCT03881059|593899585|FG001|Treatment Period - Part A|Other reasons|1|||
164417969|NCT03881059|593899586|FG002|Treatment Period - Part A|Other reasons|0|||
164417970|NCT03881059|593899584|FG000|Treatment Period - Part B|Adverse Event|0|||
164417971|NCT03881059|593899585|FG001|Treatment Period - Part B|Adverse Event|0|||
164417972|NCT03881059|593899586|FG002|Treatment Period - Part B|Adverse Event|3|||
164417973|NCT03881059|593899584|FG000|Treatment Period - Part B|Death|0|||
164417974|NCT03881059|593899585|FG001|Treatment Period - Part B|Death|1|||
164417975|NCT03881059|593899586|FG002|Treatment Period - Part B|Death|1|||
164417976|NCT03881059|593899584|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
164417977|NCT03881059|593899585|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
164417978|NCT03881059|593899586|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
164417979|NCT03881059|593899584|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
164417980|NCT03881059|593899585|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
164417981|NCT03881059|593899586|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
164417982|NCT03881059|593899584|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
164417983|NCT03881059|593899585|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
164417984|NCT03881059|593899586|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
164417985|NCT03881059|593899584|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
164417986|NCT03881059|593899585|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
164417987|NCT03881059|593899586|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
164417988|NCT03881059|593899584|FG000|Treatment Period - Part B|Other reasons|4|||
164417989|NCT03881059|593899585|FG001|Treatment Period - Part B|Other reasons|3|||
164417990|NCT03881059|593899586|FG002|Treatment Period - Part B|Other reasons|3|||
164417991|NCT00786474|593899591|FG000|Overall Study|Death|5|||
164417992|NCT00786474|593899592|FG001|Overall Study|Death|4|||
164417993|NCT00786474|593899591|FG000|Overall Study|Withdrawal by Subject|23|||
164417994|NCT00786474|593899592|FG001|Overall Study|Withdrawal by Subject|31|||
164417995|NCT00786474|593899591|FG000|Overall Study|Lost to Follow-up|3|||
164417996|NCT00786474|593899592|FG001|Overall Study|Lost to Follow-up|3|||
164417997|NCT00786474|593899591|FG000|Overall Study|Physician Decision|2|||
164417998|NCT00786474|593899592|FG001|Overall Study|Physician Decision|1|||
164417999|NCT00786474|593899591|FG000|Overall Study|Other|4|||
164418000|NCT00786474|593899592|FG001|Overall Study|Other|4|||
164418001|NCT04276090|593899593|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
164418002|NCT04276090|593899594|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
164418003|NCT01799720|593899595|FG000|Overall Study|Withdrawal by Subject|3|||
164418004|NCT01799720|593899596|FG001|Overall Study|Withdrawal by Subject|0|||
164418005|NCT01799720|593899597|FG002|Overall Study|Withdrawal by Subject|0|||
164418006|NCT01799720|593899595|FG000|Overall Study|Protocol Violation|0|||
164418007|NCT01799720|593899596|FG001|Overall Study|Protocol Violation|1|||
164418008|NCT01799720|593899597|FG002|Overall Study|Protocol Violation|0|||
164418009|NCT01799720|593899595|FG000|Overall Study|Pregnancy|0|||
164418010|NCT01799720|593899596|FG001|Overall Study|Pregnancy|0|||
164418011|NCT01799720|593899597|FG002|Overall Study|Pregnancy|1|||
164418012|NCT01088529|593899599|FG000|Overall Study|Did not receive study treatment|0|||
164418013|NCT01088529|593899600|FG001|Overall Study|Did not receive study treatment|1|||
164418014|NCT02838628|593899602|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
164418015|NCT02838628|593899603|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
164418016|NCT02838628|593899602|FG000|Recurrence Follow-up Period|Adverse Event|1|||
164418017|NCT02838628|593899603|FG001|Recurrence Follow-up Period|Adverse Event|0|||
164418018|NCT02838628|593899602|FG000|Recurrence Follow-up Period|Non-compliance|0|||
164418019|NCT02838628|593899603|FG001|Recurrence Follow-up Period|Non-compliance|1|||
164418020|NCT02838628|593899602|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
164418021|NCT02838628|593899603|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
164418022|NCT02838628|593899602|FG000|Recurrence Follow-up Period|Other un-specified|1|||
164418023|NCT02838628|593899603|FG001|Recurrence Follow-up Period|Other un-specified|1|||
164418024|NCT00147225|593899609|FG000|Overall Study|Withdrawal by Subject|1|||
164418025|NCT00147225|593899610|FG001|Overall Study|Withdrawal by Subject|0|||
164418026|NCT00147225|593899611|FG002|Overall Study|Withdrawal by Subject|1|||
164418027|NCT00147225|593899612|FG003|Overall Study|Withdrawal by Subject|0|||
164418028|NCT00147225|593899613|FG004|Overall Study|Withdrawal by Subject|0|||
164418029|NCT00147225|593899614|FG005|Overall Study|Withdrawal by Subject|1|||
164418030|NCT00147225|593899609|FG000|Overall Study|Adverse Event|0|||
164418031|NCT00147225|593899610|FG001|Overall Study|Adverse Event|0|||
164418032|NCT00147225|593899611|FG002|Overall Study|Adverse Event|1|||
164418033|NCT00147225|593899612|FG003|Overall Study|Adverse Event|1|||
164418034|NCT00147225|593899613|FG004|Overall Study|Adverse Event|0|||
164418035|NCT00147225|593899614|FG005|Overall Study|Adverse Event|0|||
164418036|NCT00147225|593899609|FG000|Overall Study|Screen Failure|0|||
164418037|NCT00147225|593899610|FG001|Overall Study|Screen Failure|0|||
164418038|NCT00147225|593899611|FG002|Overall Study|Screen Failure|0|||
164418039|NCT00147225|593899612|FG003|Overall Study|Screen Failure|0|||
164418040|NCT00147225|593899613|FG004|Overall Study|Screen Failure|1|||
164418041|NCT00147225|593899614|FG005|Overall Study|Screen Failure|0|||
164418042|NCT00147225|593899609|FG000|Overall Study|Chemotherapy Changed|0|||
164418043|NCT00147225|593899610|FG001|Overall Study|Chemotherapy Changed|0|||
164418044|NCT00147225|593899611|FG002|Overall Study|Chemotherapy Changed|0|||
164418045|NCT00147225|593899612|FG003|Overall Study|Chemotherapy Changed|0|||
164418046|NCT00147225|593899613|FG004|Overall Study|Chemotherapy Changed|0|||
164418047|NCT00147225|593899614|FG005|Overall Study|Chemotherapy Changed|1|||
164418048|NCT01032044|593899615|FG000|Overall Study|Protocol Violation|14|||
164418049|NCT01032044|593899616|FG001|Overall Study|Protocol Violation|8|||
164418050|NCT01032044|593899615|FG000|Overall Study|Adverse Event|0|||
164418054|NCT01567865|593899625|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
164418055|NCT01567865|593899626|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
164418056|NCT01567865|593899627|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
164418057|NCT01567865|593899628|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
164418058|NCT01567865|593899625|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
164418059|NCT01567865|593899626|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
164418060|NCT01567865|593899627|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
164418061|NCT01567865|593899628|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
164418062|NCT01051063|593899641|FG000|Overall Study|Death|2|||
164418063|NCT01051063|593899642|FG001|Overall Study|Death|2|||
164418064|NCT01051063|593899641|FG000|Overall Study|Withdrawal by Subject|1|||
164418065|NCT01051063|593899642|FG001|Overall Study|Withdrawal by Subject|1|||
164418066|NCT01051063|593899641|FG000|Overall Study|Termination of the study|5|||
164418067|NCT01051063|593899642|FG001|Overall Study|Termination of the study|0|||
164418068|NCT01051063|593899641|FG000|Overall Study|Moved from the study site area|1|||
164418069|NCT01051063|593899642|FG001|Overall Study|Moved from the study site area|0|||
164418070|NCT01051063|593899641|FG000|Overall Study|Other|1|||
164418071|NCT01051063|593899642|FG001|Overall Study|Other|0|||
164418072|NCT01051063|593899641|FG000|Overall Study|Lost to Follow-up|0|||
164418073|NCT01051063|593899642|FG001|Overall Study|Lost to Follow-up|1|||
164418074|NCT05569954|593899643|FG000|Overall Study|Lost to Follow-up|3|||
164418075|NCT05569954|593899644|FG001|Overall Study|Lost to Follow-up|4|||
164418076|NCT05569954|593899643|FG000|Overall Study|Protocol Violation|1|||
164418077|NCT05569954|593899644|FG001|Overall Study|Protocol Violation|2|||
164418078|NCT05569954|593899643|FG000|Overall Study|Withdrawal by Subject|4|||
164418079|NCT05569954|593899644|FG001|Overall Study|Withdrawal by Subject|2|||
164418080|NCT03857841|593899654|FG000|Overall Study|Death|1|||
164418081|NCT03857841|593899655|FG001|Overall Study|Death|0|||
164418082|NCT03857841|593899656|FG002|Overall Study|Death|0|||
164418083|NCT03857841|593899657|FG003|Overall Study|Death|0|||
164418084|NCT03857841|593899654|FG000|Overall Study|Study Terminated by Sponsor|1|||
164418085|NCT03857841|593899655|FG001|Overall Study|Study Terminated by Sponsor|0|||
164418086|NCT03857841|593899656|FG002|Overall Study|Study Terminated by Sponsor|0|||
164418087|NCT03857841|593899657|FG003|Overall Study|Study Terminated by Sponsor|0|||
164418088|NCT00384059|593899658|FG000|Infant Series|Not consented|2|||
164418089|NCT00384059|593899659|FG001|Infant Series|Not consented|6|||
164418090|NCT00384059|593899658|FG000|Infant Series|Withdrawal by Subject|2|||
164418091|NCT00384059|593899659|FG001|Infant Series|Withdrawal by Subject|2|||
164418092|NCT00384059|593899658|FG000|Infant Series|Adverse Event|1|||
164418093|NCT00384059|593899659|FG001|Infant Series|Adverse Event|2|||
164418094|NCT00384059|593899658|FG000|Infant Series|Protocol Violation|1|||
164418095|NCT00384059|593899659|FG001|Infant Series|Protocol Violation|2|||
164418096|NCT00384059|593899658|FG000|Infant Series|Lost to Follow-up|0|||
164418097|NCT00384059|593899659|FG001|Infant Series|Lost to Follow-up|1|||
164418098|NCT00384059|593899658|FG000|After Infant Series|Protocol Violation|2|||
164418099|NCT00384059|593899659|FG001|After Infant Series|Protocol Violation|3|||
164418100|NCT00384059|593899658|FG000|After Infant Series|Withdrawal by Subject|2|||
164418101|NCT00384059|593899659|FG001|After Infant Series|Withdrawal by Subject|2|||
164418102|NCT00384059|593899658|FG000|After Infant Series|Failed to Return|0|||
164418103|NCT00384059|593899659|FG001|After Infant Series|Failed to Return|2|||
164418104|NCT00384059|593899658|FG000|After Infant Series|Adverse Event|0|||
164418105|NCT00384059|593899659|FG001|After Infant Series|Adverse Event|1|||
164418106|NCT00384059|593899658|FG000|After Infant Series|Physician Decision|0|||
164418107|NCT00384059|593899659|FG001|After Infant Series|Physician Decision|1|||
164418108|NCT00384059|593899658|FG000|After Infant Series|Lost to Follow-up|0|||
164418109|NCT00384059|593899659|FG001|After Infant Series|Lost to Follow-up|1|||
164418110|NCT00384059|593899658|FG000|Toddler Dose|Lost to Follow-up|1|||
164418111|NCT00384059|593899659|FG001|Toddler Dose|Lost to Follow-up|1|||
164418112|NCT00384059|593899658|FG000|Toddler Dose|Failed to return|0|||
164418113|NCT00384059|593899659|FG001|Toddler Dose|Failed to return|1|||
164532318|NCT00394953|594320531|FG001|First Treatment Period|Not defined|1|||
164532319|NCT00394953|594320530|FG000|Second Treatment Period|Adverse Event|2|||
164532320|NCT00394953|594320531|FG001|Second Treatment Period|Adverse Event|5|||
164532321|NCT00394953|594320530|FG000|Second Treatment Period|Death|8|||
164532322|NCT00394953|594320531|FG001|Second Treatment Period|Death|4|||
164532323|NCT00394953|594320530|FG000|Second Treatment Period|Lack of Efficacy|9|||
164532324|NCT00394953|594320531|FG001|Second Treatment Period|Lack of Efficacy|47|||
164532325|NCT00394953|594320530|FG000|Second Treatment Period|Withdrawal by Subject|3|||
164532326|NCT00394953|594320531|FG001|Second Treatment Period|Withdrawal by Subject|3|||
164532327|NCT00394953|594320530|FG000|Second Treatment Period|Lost to Follow-up|0|||
164532328|NCT00394953|594320531|FG001|Second Treatment Period|Lost to Follow-up|1|||
164532329|NCT00394953|594320530|FG000|Second Treatment Period|Renal transplant|4|||
164532330|NCT00394953|594320531|FG001|Second Treatment Period|Renal transplant|6|||
164532331|NCT00394953|594320530|FG000|Second Treatment Period|Not defined|3|||
164532332|NCT00394953|594320531|FG001|Second Treatment Period|Not defined|8|||
164532333|NCT02446886|594320540|FG000|Overall Study|Adverse Event|1|||
164532334|NCT02446886|594320541|FG001|Overall Study|Adverse Event|3|||
164532335|NCT02446886|594320540|FG000|Overall Study|Withdrawal by Subject|1|||
164532336|NCT02446886|594320541|FG001|Overall Study|Withdrawal by Subject|1|||
164532337|NCT03021954|594320549|FG000|Overall Study|Lost to Follow-up|10|||
164532338|NCT03021954|594320550|FG001|Overall Study|Lost to Follow-up|43|||
164532339|NCT03021954|594320549|FG000|Overall Study|Subjects had avulsion trauma|4|||
164532340|NCT03021954|594320550|FG001|Overall Study|Subjects had avulsion trauma|1|||
164532341|NCT02196714|594320553|FG000|Overall Study|Protocol Violation|0|||
164532342|NCT02196714|594320554|FG001|Overall Study|Protocol Violation|0|||
164532343|NCT02196714|594320555|FG002|Overall Study|Protocol Violation|1|||
164532344|NCT02196714|594320556|FG003|Overall Study|Protocol Violation|0|||
164532345|NCT04079803|594320560|FG000|Overall Study|Withdrawal by Subject|0|||
164532346|NCT04079803|594320561|FG001|Overall Study|Withdrawal by Subject|0|||
164532347|NCT04079803|594320562|FG002|Overall Study|Withdrawal by Subject|1|||
164532348|NCT00807235|594320567|FG000|Overall Study|Adverse Event|1|||
164532349|NCT00807235|594320568|FG001|Overall Study|Adverse Event|0|||
164532350|NCT01679405|594320571|FG000|Overall Study|Death|2|||
164532351|NCT01679405|594320572|FG001|Overall Study|Death|5|||
164532352|NCT04677179|594320573|FG000|Induction Treatment Period|Adverse Event|1|||
164532353|NCT04677179|594320574|FG001|Induction Treatment Period|Adverse Event|0|||
164532354|NCT04677179|594320575|FG002|Induction Treatment Period|Adverse Event|0|||
164532355|NCT04677179|594320576|FG003|Induction Treatment Period|Adverse Event|0|||
164532356|NCT04677179|594320577|FG004|Induction Treatment Period|Adverse Event|0|||
164532357|NCT04677179|594320578|FG005|Induction Treatment Period|Adverse Event|0|||
164532358|NCT04677179|594320579|FG006|Induction Treatment Period|Adverse Event|0|||
164532359|NCT04677179|594320580|FG007|Induction Treatment Period|Adverse Event|0|||
164532360|NCT04677179|594320581|FG008|Induction Treatment Period|Adverse Event|0|||
164532361|NCT04677179|594320582|FG009|Induction Treatment Period|Adverse Event|0|||
164532362|NCT04677179|594320573|FG000|Induction Treatment Period|Physician Decision|1|||
164532363|NCT04677179|594320574|FG001|Induction Treatment Period|Physician Decision|0|||
164532364|NCT04677179|594320575|FG002|Induction Treatment Period|Physician Decision|1|||
164532365|NCT04677179|594320576|FG003|Induction Treatment Period|Physician Decision|0|||
164532366|NCT04677179|594320577|FG004|Induction Treatment Period|Physician Decision|0|||
164532367|NCT04677179|594320578|FG005|Induction Treatment Period|Physician Decision|0|||
164532368|NCT04677179|594320579|FG006|Induction Treatment Period|Physician Decision|0|||
164532369|NCT04677179|594320580|FG007|Induction Treatment Period|Physician Decision|0|||
164532370|NCT04677179|594320581|FG008|Induction Treatment Period|Physician Decision|0|||
164532371|NCT04677179|594320582|FG009|Induction Treatment Period|Physician Decision|0|||
164532372|NCT04677179|594320573|FG000|Induction Treatment Period|Protocol Violation|0|||
164532373|NCT04677179|594320574|FG001|Induction Treatment Period|Protocol Violation|1|||
164532374|NCT04677179|594320575|FG002|Induction Treatment Period|Protocol Violation|0|||
164532375|NCT04677179|594320576|FG003|Induction Treatment Period|Protocol Violation|0|||
164532376|NCT04677179|594320577|FG004|Induction Treatment Period|Protocol Violation|0|||
164532377|NCT04677179|594320578|FG005|Induction Treatment Period|Protocol Violation|0|||
164532378|NCT04677179|594320579|FG006|Induction Treatment Period|Protocol Violation|0|||
164532379|NCT04677179|594320580|FG007|Induction Treatment Period|Protocol Violation|0|||
164532380|NCT04677179|594320581|FG008|Induction Treatment Period|Protocol Violation|0|||
164532381|NCT04677179|594320582|FG009|Induction Treatment Period|Protocol Violation|0|||
164532382|NCT04677179|594320573|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
164532383|NCT04677179|594320574|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
164532384|NCT04677179|594320575|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
164532385|NCT04677179|594320576|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
164532386|NCT04677179|594320577|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
164532387|NCT04677179|594320578|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
164532388|NCT04677179|594320579|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
164532389|NCT04677179|594320580|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
164532390|NCT04677179|594320581|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
164532391|NCT04677179|594320582|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
164532392|NCT04677179|594320573|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
164532393|NCT04677179|594320574|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
164532394|NCT04677179|594320575|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
164532395|NCT04677179|594320576|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
164532396|NCT04677179|594320577|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
164532397|NCT04677179|594320578|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
164532398|NCT04677179|594320579|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
164532399|NCT04677179|594320580|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
164532400|NCT04677179|594320581|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
164532401|NCT04677179|594320582|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
164532402|NCT04677179|594320573|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
164532403|NCT04677179|594320574|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
164532404|NCT04677179|594320575|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
164532405|NCT04677179|594320576|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
164532406|NCT04677179|594320577|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
164532407|NCT04677179|594320578|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
164532408|NCT04677179|594320579|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
164532409|NCT04677179|594320580|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
164532410|NCT04677179|594320581|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
164532411|NCT04677179|594320582|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
164532412|NCT04677179|594320573|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
164532413|NCT04677179|594320574|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
164532414|NCT04677179|594320575|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
164532415|NCT04677179|594320576|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
164532416|NCT04677179|594320577|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
164532417|NCT04677179|594320578|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
164532418|NCT04677179|594320579|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
164532419|NCT04677179|594320580|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
164532420|NCT04677179|594320581|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
164532421|NCT04677179|594320582|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
164532422|NCT04677179|594320573|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
164532423|NCT04677179|594320574|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
164532424|NCT04677179|594320575|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
164532425|NCT04677179|594320576|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
164532426|NCT04677179|594320577|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
164532427|NCT04677179|594320578|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
164532428|NCT04677179|594320579|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
164532429|NCT04677179|594320580|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
164532430|NCT04677179|594320581|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
164532431|NCT04677179|594320582|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
164532432|NCT04677179|594320573|FG000|Extension Treatment Period|Lack of Efficacy|0|||
164532433|NCT04677179|594320574|FG001|Extension Treatment Period|Lack of Efficacy|0|||
164532434|NCT04677179|594320575|FG002|Extension Treatment Period|Lack of Efficacy|0|||
164532435|NCT04677179|594320576|FG003|Extension Treatment Period|Lack of Efficacy|0|||
164532436|NCT04677179|594320577|FG004|Extension Treatment Period|Lack of Efficacy|0|||
164532437|NCT04677179|594320578|FG005|Extension Treatment Period|Lack of Efficacy|0|||
164532438|NCT04677179|594320579|FG006|Extension Treatment Period|Lack of Efficacy|6|||
164532439|NCT04677179|594320580|FG007|Extension Treatment Period|Lack of Efficacy|0|||
164532440|NCT04677179|594320581|FG008|Extension Treatment Period|Lack of Efficacy|0|||
164532441|NCT04677179|594320582|FG009|Extension Treatment Period|Lack of Efficacy|0|||
164532442|NCT04677179|594320573|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
164532443|NCT04677179|594320574|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
164532444|NCT04677179|594320575|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
164532445|NCT04677179|594320576|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
164532446|NCT04677179|594320577|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
164532447|NCT04677179|594320578|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
164532448|NCT04677179|594320579|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
164532449|NCT04677179|594320580|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
164532450|NCT04677179|594320581|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
164532451|NCT04677179|594320582|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
164532452|NCT04677179|594320573|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
164532453|NCT04677179|594320574|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
164532454|NCT04677179|594320575|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
164532455|NCT04677179|594320576|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
164532456|NCT04677179|594320577|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
164532457|NCT04677179|594320578|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
164532458|NCT04677179|594320579|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
164532459|NCT04677179|594320580|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
164532460|NCT04677179|594320581|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
164532461|NCT04677179|594320582|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
164532462|NCT04677179|594320573|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
164532463|NCT04677179|594320574|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
164532464|NCT04677179|594320575|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
164532465|NCT04677179|594320576|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
164532466|NCT04677179|594320577|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
164532467|NCT04677179|594320578|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
164532468|NCT04677179|594320579|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
164532469|NCT04677179|594320580|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
164532470|NCT04677179|594320581|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
164532471|NCT04677179|594320582|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
164532472|NCT04677179|594320573|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
164532473|NCT04677179|594320574|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
164532474|NCT04677179|594320575|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
164532475|NCT04677179|594320576|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
164532476|NCT04677179|594320577|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
164532477|NCT04677179|594320578|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
164532478|NCT04677179|594320579|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
164532479|NCT04677179|594320580|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
164532480|NCT04677179|594320581|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
164532481|NCT04677179|594320582|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
164532482|NCT04677179|594320573|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
164532483|NCT04677179|594320574|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
164532484|NCT04677179|594320575|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
164532485|NCT04677179|594320576|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
164532486|NCT04677179|594320577|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
164532487|NCT04677179|594320578|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
164532488|NCT04677179|594320579|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
164532489|NCT04677179|594320580|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
164532490|NCT04677179|594320581|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
164532491|NCT04677179|594320582|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
164532492|NCT04677179|594320573|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
164532493|NCT04677179|594320574|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
164532494|NCT04677179|594320575|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
164532495|NCT04677179|594320576|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
164532496|NCT04677179|594320577|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
164532497|NCT04677179|594320578|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
164532498|NCT04677179|594320579|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
164532499|NCT04677179|594320580|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
164532500|NCT04677179|594320581|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
164532501|NCT04677179|594320582|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
164532502|NCT04677179|594320573|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
164532503|NCT04677179|594320574|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
164532504|NCT04677179|594320575|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
164532505|NCT04677179|594320576|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
164532506|NCT04677179|594320577|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
164532507|NCT04677179|594320578|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
164532508|NCT04677179|594320579|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
164532509|NCT04677179|594320580|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
164532510|NCT04677179|594320581|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
164532511|NCT04677179|594320582|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
164532512|NCT01536015|594320583|FG000|Overall Study|Adverse Event|1|||
164532513|NCT01536015|594320584|FG001|Overall Study|Adverse Event|4|||
164532514|NCT01536015|594320583|FG000|Overall Study|Lost to Follow-up|0|||
164532515|NCT01536015|594320584|FG001|Overall Study|Lost to Follow-up|1|||
164532516|NCT01536015|594320583|FG000|Overall Study|Inclusion Criterion not met|2|||
164532517|NCT01536015|594320584|FG001|Overall Study|Inclusion Criterion not met|0|||
164532518|NCT01536015|594320583|FG000|Overall Study|Study closure|5|||
164532519|NCT01536015|594320584|FG001|Overall Study|Study closure|5|||
164532520|NCT02988622|594320587|FG000|Overall Study|Lost to Follow-up|17|||
164532521|NCT03562247|594320588|FG000|Overall Study|Lost to Follow-up|3|||
164532522|NCT03562247|594320589|FG001|Overall Study|Lost to Follow-up|1|||
164532523|NCT03562247|594320590|FG002|Overall Study|Lost to Follow-up|1|||
164532524|NCT03261700|594320591|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
164532525|NCT03261700|594320592|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
164532526|NCT01204398|594320593|FG000|Overall Study|Adverse Event|1|||
164532527|NCT01281969|594320596|FG000|Overall Study|not randomized didn't meet criteria|0|||
164532528|NCT01281969|594320597|FG001|Overall Study|not randomized didn't meet criteria|0|||
164532529|NCT01281969|594320598|FG002|Overall Study|not randomized didn't meet criteria|7|||
164532530|NCT01281969|594320596|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
164532531|NCT01281969|594320597|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
164532532|NCT01281969|594320598|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
164532533|NCT01281969|594320596|FG000|Overall Study|not randomized, child consent not given|0|||
164532534|NCT01281969|594320597|FG001|Overall Study|not randomized, child consent not given|0|||
164532535|NCT01281969|594320598|FG002|Overall Study|not randomized, child consent not given|2|||
164532536|NCT01257425|594320599|FG000|Overall Study|Lack of Efficacy|3|||
164532537|NCT01257425|594320600|FG001|Overall Study|Lack of Efficacy|3|||
164532538|NCT01257425|594320599|FG000|Overall Study|Adverse Event|1|||
164532539|NCT01257425|594320600|FG001|Overall Study|Adverse Event|1|||
164532540|NCT01257425|594320599|FG000|Overall Study|Protocol Violation|1|||
164532541|NCT01257425|594320600|FG001|Overall Study|Protocol Violation|1|||
164532542|NCT01257425|594320599|FG000|Overall Study|Withdrawal by Subject|0|||
164532543|NCT01257425|594320600|FG001|Overall Study|Withdrawal by Subject|1|||
164532544|NCT01257425|594320599|FG000|Overall Study|Death|1|||
